Datasets:

llmunlearn

/

unlearn_dataset

like 1

Follow

Unlearning of LLMs 6

**Specifications table**TableSubject areaBiologyMore specific subject areaMicrobiology, GenomicsType of dataGenomic sequence, gene prediction and annotation of *Brachybacterium* sp. isolate EE-P12How data was acquiredWhole genome was sequenced with an Illumina HiSeq. 2500 sequencing systemData formatDraft genome assembly and gene annotationExperimental factorsGenomic DNA from pure cultureExperimental featuresThe genome was assembled with Velvet version 1.2.10 and annotated with RAST serverData source locationA laboratory-scale anaerobic digester, Kazan, RussiaData accessibilityData are in public repository. This whole genome project has been deposited at DDBJ/ENA/GenBank under the accession QXCP00000000 (<https://www.ncbi.nlm.nih.gov/nuccore/QXCP00000000>). The 16S rRNA gene sequence has been deposited at GenBank under the accession number MH802677 (<https://www.ncbi.nlm.nih.gov/nuccore/MH802677>). **Value of the data**•Draft genome assembly of *Brachybacterium* sp. will increase the knowledge of its ecology and genetics and create an opportunity for comparative studies with other bacteria.•Draft genome data can be useful for the scientific community working in the field of application of brachybacteria in several biotechnological processes.•The draft genome will accelerate functional genomics research. 1. Data {#s0005} ======= In the present work, we describe the draft genome sequence data and genome annotation of *Brachybacterium* sp. strain EE-P12 isolated from a laboratory-scale mesophilic biogas reactor fed with chicken manure as monosubstrate. In addition, we included the 16S rRNA gene sequence data of the strain EE-P12. The 16S rRNA gene sequence of the strain EE-P12 determined in this study had a 1376 bp-length. [Fig. 1](#f0005){ref-type="fig"} demonstrates the neighbor-joining phylogenetic tree derived from 16S rRNA gene sequences of the strain EE-P12 and its taxonomic neighbors. The assembly of the draft genome sequence of *Brachybacterium* sp. strain EE-P12 generated 21 contigs (\> 500 bp) with an N~50~ of 412,638, a total length of 3,964,988 bp and G+C content of 72.2%. The RAST server predicted 3600 coding sequences. The pie chart demonstrating the counts for each subsystem feature and the subsystem coverage is shown in [Fig. 2](#f0010){ref-type="fig"}. In addition, the genome of *Brachybacterium* sp. strain EE-P12 was demonstrated to encode at least 3 rRNAs and 55 tRNAs. [Table 1](#t0005){ref-type="table"} shows the comparison of the genomic feature of *Brachybacterium* sp. strain EE-P12 with some other *Brachybacterium* species. The strain *Brachybacterium* sp. strain EE-P12 possesses several genes responsible for monosaccharides and proteins degradation and fermentation processes (such as mixed acid fermentation, lactate fermentation and acetyl-CoA fermentation to butyrate). Several genes responsible for resistance to toxic compounds (such as mercury, cobalt, zinc and cadmium) and several fluoroquinolones were also observed.Fig. 1Phylogenetic tree derived from 16S rRNA gene sequences of the strain EE-P12 (NCBI accession number of 16S rRNA gene: [MH802677](ncbi-n:MH802677){#ir0005}) and its taxonomic neighbors (type strains from the LPSN content). Analysis was conducted in MEGA7 [@bib3] using the neighbor-joining method based on Jukes-Cantor evolutionary distances. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. *Pseudoclavibacter soli* KP02 was used as the outgroup.Fig. 1Fig. 2An overview of the subsystem categories assigned to the genome of *Brachybacterium* sp. strain EE-P12. The whole genome sequence of the strain EE-P12 was annotated using the RAST server (annotation scheme: RASTtk) [@bib7].Fig. 2Table 1Comparison of the genomic feature of *Brachybacterium* sp. strain EE-P12 with other *Brachybacterium* species.Table 1***Organism****DB accession number****Isolation source****Contigs****Genome size (bp)****G + C*****(%)*****CDS****rRNA + tRNA**Brachybacterium* sp. EE-P12<https://www.ncbi.nlm.nih.gov/nuccore/QXCP00000000>Anaerobically digested chicken manure213,964,98872.236003 + 55*B. alimentarium* 341_9GCA_002332305.1Cheese rinds704,263,08670.036733 + 51*B. faecium* DSM 4810GCA_000023405.1Poultry deep litter13,614,99272.031229 + 50*B. ginsengisoli* DCY80GCA_002407065.1Soil of a ginseng field13,953,25371.634649 + 50*B. massiliense* mt5GCA_900184245.1Human gut83,865,48870.6354916 + 52*B. nesterenkovii* CIP 104813GCA_900163655.1Milk product1193,021,97272.426413 + 50*B. squillarum* M-6-3GCA_000225825.2Salt-fermented seafood83,191,47972.828596 + 50 2. Experimental design, materials and methods {#s0010} ============================================= The *Brachybacterium* sp. strain EE-P12 was isolated from a laboratory-scale mesophilic biogas reactor fed with chicken manure as monosubstrate and operated at high ammonia loads (\>5.0 NH~4~--N g L^−1^) [@bib1]. The bacterial strain *Brachybacterium* sp. EE-P12 was cultured on LB agar at +37 °C for 2 days of incubation. Genomic DNA from the bacterial strain EE-P12 was extracted using a FastDNA spin kit (MP Biomedicals, USA) as previously described [@bib2] and stored at --20 °C until processing. The quality of the obtained DNA was estimated by agarose gel electrophoresis, concentration and purity were measured by spectrophotometric analysis, confirming the ratio of absorbance at 260 nm and 280 nm of between 1.8 and 2.0. Next, the identification of the species affiliation was performed using morphological characteristics and biochemical tests followed by sequencing of its 16 S rRNA gene with an ABI PRISM 3130xl Genetic Analyzer (Thermo Fisher Scientific, USA). In addition, we constructed the phylogenetic tree based on the 16 S rRNA gene sequences using MEGA 7 software [@bib3]. A library for whole genome sequencing was prepared from genomic DNA as described previously [@bib2]. Finally, whole genome sequencing was performed at Joint KFU-Riken Laboratory, Kazan Federal University (Kazan, Russia) with the HiSeq. 2500 Sequencing System (Illumina, USA), HiSeq PE Rapid Cluster Kit v2 (Illumina, USA) and HiSeq Rapid SBS Kit v2 (500 cycles) (Illumina, USA). Sequence read quality was assessed using FastQC v0.11.5 [@bib4], the filtered reads were then assembled using Velvet version 1.2.10 [@bib5], and the contigs dataset was ordered using Mauve version 2.4.0 [@bib6] with default parameters. The genome sequence of *Brachybacterium* sp. was annotated using the RAST server (annotation scheme: RASTtk) [@bib7]. The rRNA and tRNA genes numbers were identified using RNAmmer 1.2 [@bib8] and tRNA scan-SE 1.23 [@bib9], respectively. Transparency document. Supplementary material {#s0020} ============================================= Supplementary material. The reported study was funded by the Russian Foundation for Basic Research (Russia) \[Grant no. 16-34-60093 mol_a\_dk\]. Transparency data associated with this article can be found in the online version at <https://doi.org/10.1016/j.dib.2018.11.104>.

Introduction {#Sec1} ============ Disease subtyping helps to develop personalized treatments that better fit individual patients. It does, however, remain a challenge in data analysis because of the many different approaches to clustering patients based on their data. Nevertheless, if we can identify subclasses of disease, then it will assist the development of better models that are more specific to individual groups of patients and should therefore improve prediction and understanding of the underlying characteristics of the disease in question. Cluster techniques have an effective track record in this field. Clustering methods that divide (sometimes thousands of) patients into subgroups of manageable portions can offer many advantages in medicine \[[@CR1]\]. However, the quality of traditional algorithms such as K-means, DB-scan, and Fuzzy C-means can be both biased and variable (due to limited samples, inherent model bias and noise). For this reason, consensus clustering approaches have been developed \[[@CR2]\]. These approaches have typically dealt with model bias and variability but not sample variance which this paper will explore through resampling approaches. Discovering subtypes have become increasingly important as more data becomes available. Wu et al. identify clear cell renal cell carcinoma (ccRCC) as one of the most important subtypes of renal cell carcinoma. This paper highlights the importance of molecular typing for individuals for the personalized care of cancer as well as improving overall accuracy. Unsupervised consensus clustering has been used in order to discover a new subpopulation of ccRCC. An unsupervised consensus clustering approach has enabled the identification of three distinct subtypes based on hierarchical clustering. This is highly important because of the ability to identify stable categories with gene expression patterns. Also, the clusters show clinical meaning which may be informative of tumor behavior and prognosis \[[@CR3]\]. Zhu et al. proposed a novel subspace clustering guided unsupervised feature selection (SCUFS) model. This algorithm learns by representation based subspace clustering. This algorithm learns the data distribution in that it uncovers the underlying multi-subspace structure of the data. The results show that subspace clustering guided unsupervised feature selection model outperform other approaches \[[@CR4]\]. Choosing the right clustering method is not an easy task as different methods can return different results. Combining the results of several methods can lead to better groupings. Moreover, bootstrap techniques can be used to resample datasets in order to build more confidence in clusters \[[@CR5]\]. Consensus clustering which explores the consensus over different clustering algorithms can increase overall confidence compared to each individual input cluster method \[[@CR6]\]. An even higher confidence can be given to "robust clusters" which enforces maximum agreement across input clustering methods \[[@CR6]\]. Swift et al. used robust and consensus clustering in order to improve the confidence in discovered clusters \[[@CR7]\]. For a good review of consensus clustering methods, please see \[[@CR8]\]. Weighted-kappa can be used to evaluate the consistency of clustering results. This statistical metric measures the interagreement among decisions made by two or more observers. It can therefore be used to compare different allocations of data to clusters and generates a score that ranges between − 1 and + 1 from poor agreement strength to very good agreement strength \[[@CR9]\]. Having identified subclasses of patients, supervised learning can be used in disease prediction. Decision trees and Bayesian classifiers perform well \[[@CR10]\] and have the added advantages of being transparent in how they model the data (unlike many black box approaches). Tucker et al. incorporated a model that combined unsupervised learning to identify subclasses with supervised learning to predict health outcomes for patients \[[@CR11]\]. The results showed that it both improved the prediction and enabled better understanding by clinicians \[[@CR11]\]. We expand on this by exploring how consensus methods can be used to identify individual models for each discovered subgroup, which aids understanding as well as improving prediction. In this article, we have analyzed patients affected by systemic sclerosis (SSc). The aim of this article is to combine unsupervised learning that identifies potential subclasses and supervised learning that helps to predict health outcomes based upon these subclasses. We have designed a novel algorithm that has performed better than supervised learning alone by incorporating unsupervised learning (K-means clustering). We have named this algorithm *nearest consensus clustering*. In the next section, the disease will be explained followed by the data and methods in Sect. [3](#Sec3){ref-type="sec"}, including the new algorithm. We will then describe the set of experiments undertaken, and in Sect. [4](#Sec9){ref-type="sec"}, the results are documented before conclusions are drawn. In particular, thanks to a partnership between the Computer Science Department at Brunel University London and the Centre for Rheumatology and Connective Tissue Diseases (CTDs) at the Royal Free London Hospital, it was possible to work on a dataset of more than 600 systemic sclerosis subjects with the disease onset between January 1995 and December 2003, followed for up to 15 years. Systemic Sclerosis {#Sec2} ================== In order to allow for a better understanding of our paper, it is important to state briefly the definition of systemic sclerosis (SSc) illness which is the main clinical problem in our research. Systemic sclerosis is an uncommon connective tissue disorder with multisystem involvements and a chronic and often progressive course \[[@CR12]\]. The comparison and interpretation epidemiological studies have become quite difficult not only because of the rarity and clinical heterogeneity of SSc but also the lack of universally used classification and diagnosis criteria \[[@CR13]\]. The understanding of the above disease and its stages has been improved. However, the causes of SSc are still unclear. There are three key pathophysiologic processes that account for its occurrence: vasculopathy of small vessels, immune response leading to production of autoantibodies, and vascular fibrosis in multiple organs \[[@CR14]\]. The research community has validated a few clinical outcome measurements for specific SSc manifestations. The thickened skin is the main characteristic for SS illness, so there are skin thickness assessments in 17 different anatomic surfaces. The total skin score can range from 0 (no thickening) to 51 (severe thickening). The patterns of skin involvement are the most widely accepted clinical method of dividing SSc into groups \[[@CR15]\]. The clinical test is the main criteria to diagnose the SSc. Skin induration, with a characteristic symmetric distribution patterns, institutes the diagnosis with high degree of confidence. Thickness biopsy can make certain of the disease occurrence \[[@CR12]\]. Also, ACA (anti-centromere antibodies), ATA (anti-topoisomerase I antibodies), and ARA (anti-RNA polymerase III antibodies) are highly specific to predict SSc \[[@CR16]\]. In SSc, each organ can be affected but some are clearly more affected than others. The gastrointestinal tract involvement is the most region that might be affected by SSc. Up to 90% of patients could have complications in any site of gastrointestinal tract \[[@CR17]\]. Also, pulmonary fibrosis complications can be found in about 75% patients and it could affect small areas of the lung \[[@CR18]\]. Pulmonary arterial hypertension is another serious complication of SSc that develops usually later in the disease and nonspecific symptoms \[[@CR19]\]. The other complication is scleroderma renal crisis that is rare but very severe and life-threatening complication, one of the few medical emergencies in rheumatology \[[@CR20]\]. Data and Methods {#Sec3} ================ Data {#Sec4} ---- Systemic sclerosis is an uncommon connective tissue disorder with multisystem involvements and a chronic and often progressive course \[[@CR12]\]. The diagnosis of systemic sclerosis is made on the clinical grounds, and it is generally plain in patients with established disease. In fact, the presence of skin induration, with a characteristic symmetric distribution pattern associated with typical internal organ manifestations, establishes the diagnosis with a high degree of confidence, while a full-thickness biopsy of the skin is sometimes required to make certain of its occurrence \[[@CR12]\]. Digital pitting scars and radiologic evidences of pulmonary fibrosis are useful to perform a diagnosis as well as the Raynaud's phenomenon, although for this sign, a nailfold capillaroscopy can be requested. This procedure is a non-invasive, low-cost, and reproducible imaging method allowing the evaluation of structural changes in peripheral microcirculation, which is mainly used in the differentiation between primary and secondary Raynaud's phenomenon \[[@CR21]\]. The 677 patients in our data have the following distinct features: ### General and Subset Data {#Sec5} Subset: char indicating the systemic sclerosis subcategory, with only two possible options. Patients without skin thickening in areas proximal to elbows and knees were grouped into the limited cutaneous subset (L), whereas patients with skin thickening that acted both areas distal and proximal to elbows and knees were grouped into the diuse cutaneous subset (D); it is marked as "2" when it is with skin thickening and "1" when it is without skin thickening. Its values take only "1" or "2" (binary).Gender: char indicating the sex of patient, "m" for males and "f" for females; in the dataset, it takes "1" or "2," where "1" refers to M and "2" refers to F.Age: number indicating the years of patient at disease onset (integer values). ### Blood Tests Results {#Sec6} abs: string indicating the detected autoantibodies. Next to it, there is a list of 16 columns, each one labeled as a specific autoantibody acronym and filled with a binary value to indicate its absence or presence; e.g., "0" is absent and "1" is present (binary values).Hb: value indicating the measure of hemoglobin; it is expressed in grams per deciliter. Normal range for men 13.5 to 17.5 g per deciliter and normal range for women 12.0 to 15.5 g per deciliter.Cr: value indicating the measure of creatinine in that test. It tells your doctor your stage of kidney disease. It can be calculated by serum creatinine level, age, sex, and race. Baseline for Cr is between 60 and 90 ml/min/1.73 m^2^. ### Lung Function Test Results {#Sec7} FVC: value indicating the measure of forced vital capacity in that test; it is expressed in liters.DLCO: value indicating the measure of diffusing capacity for carbon monoxide. It is expressed in liters.T2RIP: number of months between disease onset and death.T2PF: number of months between disease onset and pulmonary fibrosis.T2PAH: number of months between disease onset and pulmonary arterial hypertension. ### Anti-Body Information {#Sec8} The following antibodies are marked in the dataset as binary values "1" or "0":ACA is the most frequently discovered, and it is associated with the limited cutaneous subset of SSc, although a small proportion of ACA-positive patients can develop a diffuse cutaneous SSc \[[@CR22]\].ATA also known as anti-Scl-70, is associated with a higher prevalence of arthritis, tendon friction rubs, severe pulmonary fibrosis, cardiac involvement, and scleroderma renal crisis \[[@CR22]\].ARA are strongly associated with the diffuse cutaneous subset and correlated with severity of skin involvement \[[@CR23]\]. Every organ can be clinically affected due to systemic sclerosis, so we are particularly interested to go explore different organ complications in this study since we want to predict the occurrence of these estimating if they might happen before or after a specific temporal threshold to better intervene. For instance, pulmonary arterial hypertension (PAH) is serious complication of SSc; it can affect both subsets in similar proportions, and it develops usually later in the disease as a debilitating and progressive disorder characterized by a blood pressure increase in arteries of the lungs. It is defined by right heart catheterization as a mean pulmonary arterial pressure not less than 25 mmHg with a pulmonary capillary wedge pressure not greater than 15 mmHg. The natural history of SSc-associated PAH is variable, but in many patients, it follows a downhill course with the development of right heart failure and death. It usually presents with nonspecific symptoms of exertional dyspnea, fatigue, angina, and exertional near-syncope. With the disease progression, symptoms and signs of right ventricular failure appear \[[@CR12]\]. SSc shows heterogeneous clinical manifestations with a wide variability in presentation, severity, and outcome: some patients reveal fast and fatal progression, whereas others have a benign course \[[@CR24]\]. Then, considering the disease susceptibility, there are three principal factors: age, gender, and ethnicity. Similar to other autoimmune connective tissue diseases, women are almost four times more likely than men to develop SSc; this strong female predominance is most pronounced in the childbearing years and declines after menopause \[[@CR24]\]. We explore SSc data, provided by Royal Free London Hospital for 677 patients where we want to predict time to death and time to PAH---a common comorbidity in SSc. The aim of our proposed algorithm is to cluster the patients within three groups and to predict time to develop PAH and to predict time to death for each group. The patients have been selected as follows:Select all patients from the original dataset who died within the first 5 years and all patients who still alive over 5 years. The predicted class will have two values "1" representing patients who could die before 5 years and "2" representing patients who could die after 5 years. The novel algorithm was applied on this resulted dataset in order to predict time to death.Select all patients from the original dataset who develop PAH within the first 5 years and all patients who still not develop PAH over 5 years. The predicted class will have two values "1" which means the patient could develop PAH before 5 years and "2" the patient could develop PAH after 5 years. Also, the novel algorithm was applied on this resulted dataset in order to predict time to develop PAH. We also explore our approach on a freely available breast cancer data provided by the UCI machine learning repository. It consists of 10 attributes and 699 patients, where we want to predict whether a tumor is benign or malignant. Consensus Clustering {#Sec9} ==================== Consensus clustering involves combining multiple cluster results. It takes a number of different clustering methods as inputs in order to find a single consensus clustering that is a better fit than each individual clustering method. Consensus clustering is needed because it represents a way of reconciling clustering information which arises from different experimental sources or from multiple runs of the same nondeterministic algorithm \[[@CR25]\]. It is also a method of finding clusters that are more stable and less sensitive to starting values based on a membership principle. It considers multiple input clusterings where items that have been clustered repeatedly together in the inputs will be more likely to appear in the consensus clustering. For example, consensus clustering can use different clusterings as inputs that have been generated with different clustering methods or starting parameters \[[@CR26]\] in order to remove bias. Alternatively, input clusterings can be generated by resampling the original dataset in order to generate a more stable consensus clustering by removing sampling bias. The first task to build consensus clustering involves the construction of an *n x n* "agreement matrix" based on input clustering results. This matrix contains cells that represent the number of agreements among the input clustering methods used for clustering together each pair of objects, represented by the indexing row and column. This matrix is then employed to group objects based on their cluster agreement by rewarding clusters with high agreement between members and penalizing clusters with low agreement \[[@CR9]\]. The input methods used to generate the agreement matrix can be from the results of different clustering methods as was explored in \[[@CR7]\]. However, here, we are concerned with sampling bias so we use different clustering results from K-means applied to repeated resampling of the data. Consensus clusters are built that reward variables if they have high cluster agreement and penalizes variables if they have low agreement. Figure [1](#Fig1){ref-type="fig"} shows a general schematic of how consensus clustering works \[[@CR27]\].Fig. 1Consensus clustering algorithm (schematic) Nearest Consensus Clustering Algorithm {#Sec10} ====================================== Our proposed method attempts to deal with the natural variation in many clustering methods as well as sample variance by using the consensus approach in combination with C4.5 decision tree classifiers. C4.5 is a decision tree method used for classification that is transparent in that it generates a tree structure that can be interpreted. The tree is inferred based on the information gain ratio measure \[[@CR28]\]. Data is split into a training and testing set. The training data undergoes resampling to build a set of consensus clusters. A separate tree is then inferred from each of these consensus clusters. Next, each test data point is scored based upon the distance to each discovered consensus cluster using a single linkage approach with Euclidean distance. This is used to assign the appropriate decision tree to be used to classify the data point. We explore a number of distance metrics within this, e.g., single linkage, further linkage, and average linkage. Figure [2](#Fig2){ref-type="fig"} is a general schematic figure that explains the proposed nearest consensus clustering algorithm. In this example, the training data has been divided into three clusters, using consensus clustering of multiple K-means with resampled data. The decision tree (DT) is then constructed from each consensus cluster. When classifying test data, our algorithm aligns the test data (denoted by an "x") to the nearest consensus cluster (here cluster 3) by using the single linkage measure (nearest neighbor). The associated decision tree is then used to classify the test data point (here DT3).Fig. 2Nearest consensus clustering classification: training and testing data (schematic figure) The following pseudocode explains the steps that are used orderly to build the new algorithm. {#MO3} Experiments {#Sec11} =========== In this paper, we compare nearest consensus clustering classification to results with standard K-means clustering of patients, the C4.5 Decision Tree (with no clustering of patients), and nearest K-means (without consensus clustering). In detail, we apply out nearest consensus clustering by running K-means on the training data for ten repeated resampled datasets in order to produce an agreement matrix. This aims to capture the sampling bias. K-means clustering is then applied to the agreement matrix to create the consensus clusters. Cross-validation which is an evaluation technique used to assess the predictive capabilities of a specific model on unseen examples is used to determine the accuracy. It is performed by partitioning the original data into a training set to learn the model, and a test set to evaluate it, then crossing-over both the training and validation sets in multiple iterations so that each data point is used for validation \[[@CR27]\]. The current datasets in this were randomly resampled into training dataset 80 and 20% for ten times. In the first set of results, we explore three methods:i)Using simple K-means alone to identify clusters (with no resampling/consensus) for building each decision tree---we call this "nearest K-means."ii)A standard decision tree with no clustering at all.iii)The full nearest consensus clustering algorithm described above. We explore these based upon the resulting decision trees, the cluster membership, the predictive accuracy, and Kaplan-Meier curves forA)The SSc for predicting time to pulmonary hypertensionB)The SSc for predicting time to deathC)The Breast Cancer data for predicting tumor type We then perform the following analyses:D)We perform a full sensitivity analysis of these methods.E)We explore the impact of changing the number of clusters, K, on the accuracies.F)We compare our proposed approach with other similar combinations of clustering/classifiers. In particular, we have explored hierarchical clustering and PAM and hierarchical clustering as opposed to K-means, and support vector machines (SVMs) instead of decision trees. SVM is the often considered the most consistently accurate classifier. The disadvantage of this algorithm is the complexity of determining the number of support vectors. It works by transforming data and conducting a simple scaling so that the classes are linearly separable \[[@CR29]\]. PAM clustering is a similar method to K-means in that it splits the dataset into K groups but here medoids (rather than centroids) must be represented by a data point. These data points correspond to the most centrally located point in each cluster \[[@CR30]\]. Hierarchical clustering is another clustering method that partitions the dataset into groups using a dendrogram tree structure \[[@CR31]\].G)Finally, we explore a small follow up piece of data analysis on the discovered groups within the clinical context. Results {#Sec12} ======= Systemic Sclerosis: Time to Develop Pulmonary Arterial Hypertension {#Sec13} ------------------------------------------------------------------- We have run C4.5 Decision Tree (without clustering), nearest K-means (without consensus), and nearest consensus cluster classification to the systemic sclerosis data in order to predict time to develop pulmonary arterial hypertension. The following plot (Fig. [3](#Fig3){ref-type="fig"}) shows the results of these experiments as well as the result of each individual cluster model on all of the test data (K1, K2, and K3). Notice first that each individual cluster model classifies the test data worse than ones that attempt to model all clusters. In addition, the standard decision tree and nearest K-means produce a better and less variable set of errors. Nearest consensus cluster classification performs better than all other algorithms with lower error and reduced variance (significantly better than nearest K-means with *t* test, *p* = 0.040), indicating that sampling bias is an issue that need to be addressed when identifying patient subgroups.Fig. 3Comparison of K-means, decision tree, nearest K-means, and nearest CC for time to develop pulmonary arterial hypertension class in systemic sclerosis dataset If we now look at the decision trees inferred from each consensus cluster found in SS dataset when time to develop pulmonary arterial hypertension class needs to be predicted (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, and [6](#Fig6){ref-type="fig"}), we can see that the trees are very different, indicating a different set of required criteria for each subset of patients that have been discovered. For example, group 1 is considerably smaller than group 2 and group3 and all trees involve different combinations of important variables. This highlights the importance of separating out these cohorts of patients when diagnosing. For instance, in group 3, knowing the DLCO, age, and FVC test result, has more of an impact on predicting time to develop pulmonary arterial hypertension whereas in group 1, knowing only the Hb, ACA, and others has more impact for predicting time to develop pulmonary arterial hypertension. Figure [5](#Fig5){ref-type="fig"} is very simple decision tree that only rely on the Hb variable, so from the Hb attribute values for the first group, time to develop pulmonary arterial hypertension can be predicted.Fig. 4Consensus clustering decision tree for group 1 in SS dataset and time to develop pulmonary arterial hypertension classFig. 5Consensus clustering decision tree for group 2 in SS dataset and time to develop pulmonary arterial hypertension classFig. 6Consensus clustering decision tree for group 3 in SS Dataset and time to develop pulmonary arterial hypertension class If we now explore the difference between the attributes in each discovered consensus cluster, we see notable differences (Table [1](#Tab1){ref-type="table"}). It looks like that Cr (which is the value indicating the measure of creatinine in that test) in group 2 is smaller than group 1 and group 3. When Cr is greater than 90, this means it is normal and this is what we have found in group 2 and group 3, but when it goes below this value, it is not normal. The reference range for the time period for Cr was 60--97 μmol/L. Interestingly, these features do not appear in the decision trees, perhaps because they have been separated already by the identification of the different subgroups. By identifying these different subgroups and exploring their characteristics, we can better understand how they differ and what focused tests may be more appropriate for different patients when making prognoses. By identifying the characteristics of each consensus cluster, we can identify the likelihood of patients belonging to any of these cohorts and apply more appropriate clinical tests as identified in the cohort-specific decision trees. This is essentially what the algorithm does when in the testing phase.Table 1Proportion/means values for SS attributes in CC (time to develop PAH)Group1Group2Group3ProportionSubset (without skin thickening)56%62%55%Subset (with skin thickening)44%38%45%Gender male16%16%14%Gender female84%84%86%Proportion (patients have an event)ACA**22%28%35%**ATA20%20%18%ARA**15%1%12%**U3RNP**4%6%0%**NRNP10%6%4%PMSCL4%4%6%Th-RNP0%2%0%KU1%3%0%Jo12%3%0%RO4%7%8%LA1%1%6%SM0%0%1%DSDNA2%1%0%ANA18%16%12%ANA NEG.2%4%6%MeansGroup 1Group 2Group 3Hb12.5912.7812.71Cr**97.0684.5393.46**FVC88.5289.3290.37DLCO65.5863.3865.48Age48.1148.349.91 We now explore disease-free survival analysis: the Kaplan-Meier estimator, also known as product limit estimator, is a nonparametric statistic method used to estimate the survival function in reference to an event of interest, such as death or a disease complication \[[@CR32]\]. The estimator is plotted over time to obtain the Kaplan-Meier curve, which is constituted by a series of horizontal steps of declining magnitude that, when a large sample is taken, approaches the true survival function for that population. The curve can be estimated easily if the patient is followed until death by computing the fraction surviving at each time, but in most cases, there are a number of patients that tend to drop out for different reasons. Nevertheless, the Kaplan-Meier analysis allows this information from both censored and uncensored observations to be considered, and the dependent variable is composed of two parts, the time to event and the event status, which records if the event of interest occurred or not. Censored data is where the event is only partially known because it has not happened yet---for example, in the SSc data, we may only know that a patient has not developed pulmonary arterial hypertension for *at least* X years at any point in time. The Kaplan-Meier curve is defined as the probability of surviving in a given length of time while considering time in many small intervals, taking into account only three weak hypotheses \[[@CR33]\]. It is required to assume that the censored patients are characterized by the same survival prospects as those who continued to be followed, that the survival probabilities are the same for patients recruited early and late in the study, and finally that the event of interest happens at the specified time \[[@CR32]\]. We carry out a survival analysis in order to determine how long a patient survives or how long from diagnosis before a patient develops a disease-associated internal organ complication, in relation to the discovered subgroups. By grouping subjects based on the nearest consensus clustering classification, we can then analyze if the discovered clusters are able to separate systemic sclerosis patients into subpopulations that show different symptoms and disease progression, for helping physicians to make better informed diagnosis and more focused interventions. The following graph shows the percentage of patients survived from that organ complication on the *y*-axis, while on the *x*-axis the time to development of pulmonary arterial hypertension measured in months. Figure [7](#Fig7){ref-type="fig"} shows the Kaplan-Meier curves for the three main clusters: cluster 1 is blue, cluster 2 is green, and cluster 3 is yellow. The graph shows clearly that 18% of the patients with the third group were affected of pulmonary hypertension after 120 months while about 10% of the patients were affected after 120 months in the first group.Fig. 7Kaplan-Meier curves by nearest consensus clustering on time to develop pulmonary arterial hypertension dataset. With time to develop pulmonary arterial hypertension in months on the *x*-axis and percentage of patients survived from that organ complication on the *y*-axis, the graph illustrates the survival curves obtained grouping patients based on nearest consensus clustering Systemic Sclerosis: Time to Death {#Sec14} --------------------------------- We have repeated the same algorithms in order to predict time to death (T2RIP). The dataset was divided into three groups. Note that these groups are not the same as for the T2PAH experiments as the data selected will be different. The following boxplot (Fig. [8](#Fig8){ref-type="fig"}) shows that nearest consensus clustering classification performs better than nearest K-means although nearest K-means has less variation (*t* test *p* value = 0.041).Fig. 8Comparison of K-means, decision tree, nearest K-means, and nearest CC for time to death class in systemic sclerosis dataset The consensus clustering decision trees which predict time to death class for the three groups of patients can be found in the [Electronic Supplementary Material](#MOESM1){ref-type="media"}. Figure [9](#Fig9){ref-type="fig"} shows that almost 35% of the patients from the first group died after 110 months while 15% of patients from groups 2 and 3 died.Fig. 9Kaplan-Meier curves by nearest consensus clustering on *time to death dataset*. With *time to death* in months on the *x*-axis and percentage of patients survived on the *y*-axis, the graph illustrates the survival curves obtained grouping patients based on nearest consensus clustering Again, we see notable differences between the attributes in each discovered consensus (Table [2](#Tab2){ref-type="table"}). It looks like that Cr (which is the value indicating the measure of creatinine in that test) in group 1 is smaller than group 1 and group 3. When Cr is greater than 90, this means it is normal and this is what we have found in group 2 and group 3, but when it goes below this value, it is not normal. The baseline that has been used in order to distinguish between the groups is whereas Cr is normal or not. Also, it is clear that DLCO is the smallest in the third group.Table 2Proportion/mean values for SS attributes in CC (time to death)Group1Group2Group3ProportionSubset (without skin thickening)55%56%56%Subset (with skin thickening)45%44%44%Gender male12%2%18%Gender female88%98%82%Proportion (patients have an event)ACA**24%25%25%**ATA23%24%22%ARA**13%10%10%**U3RNP**4%6%5%**NRNP7%4%8%PMSCL2%7%4%Th-RNP0%1%2%KU1%1%2%Jo11%1%1%RO4%6%7%LA1%2%1%SM0%0%1%DSDNA1%1%1%ANA21%5%18%ANA NEG.1%4%4%MeansGroup1Group2Group3Hb12.7212.5312.58Cr**87.419396.28**FVC87.2188.6587.33DLCO666462.56Age485149 Other decision trees for time to death subgroups can be found in [Electronic Supplementary Material](#MOESM1){ref-type="media"}. In order to aid reproducibility, we now explore the freely available breast cancer dataset available from the UCI repository. K-means, decision tree, nearest K-means, and nearest CC classification were applied in order to predict whether the tumor was malignant or benign. The results can be found completely in [Electronic Supplementary Material](#MOESM1){ref-type="media"}. Sensitivity Analysis {#Sec15} -------------------- Specificity, sensitivity, precision, and recall have been used to evaluate the results. We have computed all of these measures for K-means, decision tree, nearest K-means, and nearest CC classification for time to develop pulmonary arterial hypertension and BC dataset results. Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"} show the results.Table 3Metrics measures results for three K-means groups, decision tree, nearest K-means, and nearest CC for time to develop pulmonary arterial hypertension classK1K2K3DTNKDTNCCCSensitivity0.59210.53450.51440.72330.73220.7544Specificity0.69210.65370.67450.80210.80210.8256Precision0.62110.55340.46880.72340.71330.8134Recall0.59210.53450.51440.72330.73220.7544Table 4Metrics measures results for three K-means groups, decision tree, nearest K-means, and nearest CC for BC datasetK1K2K3DTNKDTNCCCSensitivity0.74210.71780.84160.78220.74220.8311Specificity0.78320.74320.86430.80120.77210.8532Precision0.79340.73230.87110.83210.78950.8687Recall0.74210.71780.84160.78220.74220.8311 The above results show that nearest consensus clustering classification has improved the learning significantly as it looks like that nearest consensus clustering perform much better than K-means, decision tree, and nearest K-means. Impact of Different Number of Clusters (K) {#Sec16} ------------------------------------------ We briefly explore the effect of different values of K (K-means clustering method) on accuracy. We have run nearest consensus cluster classification to the systemic sclerosis data in order to predict time to develop pulmonary arterial hypertension and time to death five times for each class as each time K has different value. The following two plots show the results of these experiments as well as the result of each individual consensus cluster classification model on all of the test data (K = 3, K = 4, K = 5, K = 7, K = 10). Regarding time to develop pulmonary arterial hypertension, notice first that nearest consensus cluster classification for K = 3 (NCC3) and K = 4 (NCC4) classify the test data quite similar than the others and perform better than NCC5 and NCC7, while the NCC10 improves error and grown variation but it has noise (Fig. [10](#Fig10){ref-type="fig"}).Fig. 10Comparison of nearest CC classification for time to develop pulmonary arterial hypertension class with different values of K In relation to time to death (T2RIP), notice first that nearest consensus cluster classification for K = 4 (NCC4) perform better and less variation than K = 3 (NCC3). Also, NCC4 classifies the test data better than NCC5, NCC7, and NCC10 (Fig. [11](#Fig11){ref-type="fig"}).Fig. 11Comparison of nearest CC classification for time to death class with different values of K Comparison to Other Clusterings/Classifiers {#Sec17} ------------------------------------------- Finally, we briefly compare our new method with some other cluster/classifier combinations including support vector machine when it runs individually and when it merges with K-means in order to make sure if the proposed method performs better or not, and also, hierarchical clustering decision tree and PAM decision tree. Table [5](#Tab5){ref-type="table"} shows the results.Table 5Accuracy comparison between the proposed algorithm and othersTime to deathTime to developClassifierAccuracyAccuracyDecision tree0.7540.701Nearest K-means0.7240.696Nearest CC0.7810.722SVM0.7210.689SVM_K-means0.7520.711Hierarchical clustering DT0.7130.725PAMDT0.7490.731 Conclusions and Future Work {#Sec18} =========================== In this paper, a set of algorithms were tested on systemic sclerosis dataset and breast cancer for simultaneously identifying subgroups of patients and diagnosing them based on these subgroups. The results illustrate issues with firstly ignoring the existence of subgroups of patients (with worse error rates) and secondly using standard clustering methods such as K-means (with higher variance in errors due to sample variance and method bias). The paper introduces a novel approach that exploits consensus clustering methods and single linkage distance metrics to deal with these issues. Our method, nearest consensus clustering classification integrates decision trees, consensus clustering, and single linkage metrics which has improved the classification and reduced the variance when tested on breast cancer data from the UCI repository and a dataset for systemic sclerosis from the Royal Free hospital in London. This new model can be used by clinics to cluster patients and discover key features in each group for classifying more confidently. Future work will look at using other resampling methods, a further exploration of other linkage methods, and kappa measures to identify relationships between resampled cluster distances and the associated classification accuracies. We would also like to explore the prediction of other complications and how they interact using multiclass models. Electronic Supplementary Material ================================= {#Sec19} ESM 1(DOCX 345 kb) **Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. The project is joint funded by the Brunel University and the UCL Royal Free Hospital, London.

1. Introduction {#sec0005} =============== Extrahepatic portal vein obstruction (EHPVO) is a chronic entity characterized by obstruction of the extrahepatic portal vein with or without the involvement of the intrahepatic portal veins that leads to prehepatic portal hypertension, cavernoma formation, and dilation of portosystemic collateral veins \[[@bib0005],[@bib0010]\]. After liver transplantation, it is estimated that 1--8.5% of the pediatric patients will develop portal vein complications, in the case of portal vein thrombosis (PVT) it can jeopardize short and long-term outcomes of the transplant \[[@bib0015],[@bib0020]\]. Thus, in children with prehepatic portal hypertension secondary to PVT, a meso-Rex bypass (MRB) procedure should be considered to redirect the portal blood flow into the intrahepatic portal system \[[@bib0025],[@bib0030]\]. MRB has shown to substantially improve portal hypertension. Though, as any other procedure MRB is not exempt from complications. Failure of the MRB due to occlusion has been reported to occur in 10% \[[@bib0035],[@bib0040]\] to 40% of patients \[[@bib0045],[@bib0050]\] at a 6-month follow-up. Early thrombosis leading to MRB failure is believed to be related to a variety of factors, including an inadequate graft type for bypass creation, undiagnosed hypercoagulable disorders that can lead to intraluminal thrombus formation, poor patient selection (i.e., those with a primitive intrahepatic portal venous system) \[[@bib0055]\], bypass contraction or kinking that decreases the intraluminal area, and portal perfusion steal phenomenon, among others. Cornerstones of management of failed MRB includes anticoagulation, endovascular intervention, direct thrombectomy, revision and re-do of MRB, or conversion to a portosystemic shunt (PSS) \[[@bib0060]\]. Herein, we present a case report following the SCARE guidelines \[[@bib0065]\], of a patient with biliary atresia associated with polysplenia syndrome (BA-PS) that underwent liver transplantation and subsequent MRB, then developed a portal steal phenomenon due to a large collateral vein. During the revision of the bypass we report an innovative approach in which the collateral vein that was causing the diversion of the portal flow was used to create an autologous venous conduit for the re-do MRB. 2. Presentation of case {#sec0010} ======================= A 3-year-old female with a diagnosis of BA-PS had a Kasai portoenterostomy procedure at 12 weeks of age. Due to the progression of her liver disease, she was listed for transplant at the age of 6 months with a Pediatric End-Stage Liver Disease (PELD) of 13. Four months later she underwent an orthotopic liver transplant with a whole graft from an ABO incompatible 7-month-old deceased donor (DD). Within a year of transplant, the patient developed symptoms of prehepatic portal hypertension secondary to PVT and was referred to our team for surgical consultation. Fourteen months after transplantation we performed a mesenteric to left portal vein bypass also known as MRB. The bypass was done using an ABO compatible DD iliac vein. During surgery, a spontaneous portosystemic shunt was identified and the decision at the time was not to ligate since the intraoperative Doppler demonstrated velocities ranging between 30 and 50 cm/s. The patient had an uncomplicated post-surgical course and repeat Doppler ultrasounds at 1 week (52 cm/s) and 1-month (16.5 cm/s) post-MRB demonstrated continued left portal vein flow. Six months after the initial MRB the patient again developed symptoms of portal hypertension, splenomegaly with platelets of 89,000/mcL and a serum ammonia of 101 mcmol/L. We hypothesized that a large splenorenal collateral vein was potentially causing a portal venous perfusion steal phenomenon ([Fig. 1](#fig0005){ref-type="fig"}A and B). Therefore, 10 months after the initial MRB, the patient was taken to the operating room for revision of the MRB. Prior to surgery, the proposed plan was to take down the collateral and attempt a re-do MRB using the patient's internal jugular or convert to a splenorenal shunt. During surgery, the MRB was found patent and collapsed with no flow in the presence of a dominant left sided collateral vein. In the process of taking down this collateral to mitigate the steal we realized that this vessel was potentially suitable for an autologous venous conduit. This collateral was dissected to create an 8 cm × 8 mm autologous vein conduit that was used to revise the previous bypass. This was anastomosed to the left portal vein at the Rex recess and a portogram demonstrated adequate intrahepatic portal system ([Fig. 1](#fig0005){ref-type="fig"}C), followed by anastomosis to the spleno-mesenteric junction ([Fig. 1](#fig0005){ref-type="fig"}D). A CT scan was performed 1 week after surgery demonstrating conduit patency. Then, a Doppler ultrasound which demonstrated continued adequate flow within the bypass (40 cm/s) 1 month after re-do MRB. On follow-up, CT scan demonstrated sustained patency at 1- ([Fig. 2](#fig0010){ref-type="fig"}) and 6-month follow up. Serum ammonia (34 mcmol/L), and platelets (314,000/mcL) were within normal limits six months after re-do MRB.Fig. 1**A)** CT scan before the revision of the MRB showing a large splenorenal collateral vein (arrow), and the Rex recess (\*). **B)** 3D reconstruction before the revision of the MRB showing a large splenorenal collateral vein (arrow). **C)** Intraoperative portogram performed during the revision of the MRB (arrow), showing a normal intrahepatic portal system. **D)** Image showing the re-do MRB (arrow) that was performed using a splenorenal collateral vein as an autologous venous conduit, Rex recess (\*).Fig. 1Fig. 2**A)** CT scan 1 month after the re-do MRB showing a patent conduit (arrow). **B)** 3D reconstruction of the re-do MRB 1 month after the operation.Fig. 2 3. Discussion {#sec0015} ============= It is estimated that the biliary atresia prevalence ranges from 0.5 to 2.6 per 10,000 live birth, and the variability of biliary atresia prevalence globally has been attributed to different ethnical, genetic, and environmental factors. Biliary atresia can present as an isolated finding, in combination with other congenital anomalies, or as part of a syndrome, within the former clinical presentation the BA-PS has been described \[[@bib0070]\]. Children with BA-PS have an inflammatory cholangiopathy that can lead to fibrosis, and biliary cirrhosis, causing portal hypertension. Thus, the development of portosystemic collaterals (i.e., spontaneous shunts) is frequently seen in these cases. Although the portal vein resistance decreases after transplant, shunts might remain open allowing for the non-physiological diversion of the portal venous flow. In addition, the typical anastomosis between the donor portal vein to an often atretic or hypoplastic portal vein seen in biliary atresia has a higher risk of thrombosis \[[@bib0030],[@bib0075], [@bib0080], [@bib0085]\]. In the past when conservative management of children with portal hypertension failed, selective PSS were performed. However, in the last decade the use of MRB has increased in popularity as it creates a more physiological state by redirecting the mesenteric blood flow back into the liver ([Fig. 3](#fig0015){ref-type="fig"}) \[[@bib0090]\]. This is accomplished by using a conduit to connect the mesenteric venous system to the left portal vein in the space of Rex. This effectively allows for access to the lower resistance intrahepatic portal system and avoids the hepato-fugal nature of surgical portosystemic shunts \[[@bib0030],[@bib0075]\]. Although both MRB and PSS have proven to be effective in relieving portal hypertension, evidence suggests that MRB have the additional benefit of improvement in platelet count, international normalized ratio (INR), and somatic growth \[[@bib0090]\].Fig. 3Drawing of a MRB in a patient with and biliary atresia associated with polysplenia syndrome and portal vein thrombosis (PVT) after transplant.Fig. 3 Autologous venous conduits are preferred in MRB, with the most common conduit being the internal jugular vein, however other options such as an autogenous saphenous vein, splenic vein, right gastroepiploic vein, inferior mesenteric vein or umbilical vein have been described in the literature \[[@bib0030],[@bib0095]\]. In this case, after clinical suspicion of MRB failure, a decision was made to perform a revision and re-do using an autologous internal jugular vein, the rationale being that the DD allograft led to an increased risk of thrombosis. However, the absence of a thrombus inside the conduit prompted us to consider a portal steal phenomenon as the main cause of MRB failure. At times, the capacity of a primitive intrahepatic portal venous system will not suffice to accommodate the increased blood flow immediately after MRB, redirecting blood flow back into the low-pressure system of large collateral vessels. Failure to ligate portosystemic collaterals at the time of surgery will not only significantly decrease the amount of blood flow redirected to the liver, depriving the patient from the additional benefits of hepatopetal flow restoration, but will also fail to address the main goal of surgical treatment, which is to decrease the risk of future gastroesophageal variceal bleeding episodes. Therefore, our group now favors taking down collaterals at the time of liver transplant or MRB to avoid the development of portal steal phenomenon and subsequent thrombosis \[[@bib0075]\]. 4. Conclusion {#sec0020} ============= This case reports the option of using a large collateral vein as an alternative for an autologous venous conduit in a MRB and demonstrates that re-do of a MRB is a feasible option with good outcomes. In addition, in children with longstanding portal hypertension ligation of large collaterals during liver transplantation or MRB should be performed to avoid portal steal phenomenon post-procedure. Conflict of interest {#sec0025} ==================== None. Sources of funding {#sec0030} ================== None. Ethical approval {#sec0035} ================ This is a case report and is exempt for ethical approval at the authors institution. Consent {#sec0040} ======= Written informed consent was obtained from the mother of the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. Author contribution {#sec0045} =================== RBB, FLV, DA, LB, GPF, and MIRD did significantly contribute to the conception or design of the work, the acquisition, and interpretation of data/findings. All authors have participated sufficiently in the work to take public responsibility for appropriate portions of the content. All authors critically revised the final manuscript. All authors approved the final version of the manuscript to be published. Registration of research studies {#sec0050} ================================ Not applicable. Guarantor {#sec0055} ========= Ruben Blachman-Braun. Provenance and peer review {#sec0060} ========================== Not commissioned, externally peer-reviewed. Authors acknowledge the 3-D software form EDDA Technology that help with the reconstruction of the 3-D images and Jill Rhead (Medical Illustrator) for creating the meso-Rex bypass image presented in this article.

Dear Editor: Lichen sclerosus (LS) is a chronic, inflammatory, mucocutaneous disorder of the genital and extragenital skin that present with significant sclerosis and atrophy. According to a recent study by Nelson and Peterson[@B1], the prevalence of male LS was only 0.0014% in a population of 42,648,923 male patients. Male genital LS (MGLS) develops almost exclusively in uncircumcised patients[@B2]. MGLS can cause itching, pain, and burning sensation of the penis. Furthermore, it can cause urinary or sexual dysfunction[@B3]. We report a rare case of circumferential balanopreputial adhesion due to MGLS. A 21-year-old man presented with a whitish atrophic patch on the glans and prepuce for several years. Six months before visiting Pusan National University Hospital (PNUH), he underwent emergency circumcision because of acute urinary retention and paraphimosis. However, the circumcision had not been fully performed due to adhesion of the glans and foreskin around the whitish atrophic patch. After the operation, his voiding function was conserved until the day of visiting PNUH. However, physical examination showed an unretractable prepuce with complete circumferential balanopreputial adhesion ([Fig. 1A, B](#F1){ref-type="fig"}). Histopathological findings showed cleft like space separating basal layer from pale upper dermis. Hydropic degenerations of the basal cells and lymphocyte infiltrations in the upper dermis were also seen. Mild homogenous collagen bundles in the upper dermis were observed compared to relatively normal deep dermis ([Fig. 1C\~F](#F1){ref-type="fig"}). Based on these findings, we diagnosed the lesion as LS. The patient was referred to the urology department for reconstructive surgery, but he refused any further invasive treatment. In Korea, MGLS is an especially rare dermatosis, and we assume that the extremely high circumcision rate among Koreans might be the leading cause of its rarity. Furthermore, circumferential balanopreputial adhesion due to MGLS has not been reported in Korean literatures ([Table 1](#T1){ref-type="table"}). Despite the significance of urinary or sexual dysfunction in patients with MGLS, most of the Korean dermatologic reports are not focused on the functional loss in patients with MGLS ([Table 1](#T1){ref-type="table"}). Our patient had not only a skin lesion but also voiding difficulty due to paraphimosis. Although skin biopsy was not performed at that time, we presumed that the paraphimosis might have been caused by the inner adhesion of glans and prepuce that had been triggered by the long lasted MGLS lesion. Moreover, a complete circumferential balanopreputial adhesion and unretractable prepuce could induce sexual dysfunction and urinary dysfunction in the near future. Chronic exposure to urine has been proposed to play a role in the etiogenesis of MGLS. Especially in uncircumcised males, dribbled urine becomes occluded between the inner prepuce and glans. Occlusion and koebnerization precipitate inflammation, which progresses to sclerosis[@B4]. The incidence of MGLS in Korea is expected to increase after a few decades, as the circumcision rate in Korea is steeply decreasing[@B5]. Therefore, Korean dermatologists should always be aware that functional impairment could be caused by MGLS, as in our case. Thus, we described a rare and instructive Korean case of MGLS with circumferential balanopreputial adhesion. **CONFLICTS OF INTEREST:** The authors have nothing to disclose. {#F1} ###### Korean reports of male genital lichen sclerosus  Author Age (yr) Site Functional impairment Balanopreputial adhesion -------------------- ---------- ---------------- ---------------------------- -------------------------- Kim et al. (1977) 21 Glans ND − Choi et al. (1982) 24 Glans, prepuce ND − Kim et al. (1990) 59 Glans Urinary frequency, dysuria − Lee et al. (2002) 66 Glans ND − Lee et al. (2008) 30\~39 Glans, prepuce ND − Oh et al. (2008) ND Prepuce ND ND Oh et al. (2008) ND Glans ND ND You et al. (2016) 14 ND ND ND Present case 21 Glans, prepuce Voiding difficulty \+ ND: not described.

\section{Introduction} \label{sec:intro} In this paper, we investigate high-order finite difference schemes for the Hamilton-Jacobi equation \begin{equation}\label{P1} \left. \begin{aligned} u_{x_1} \cdots u_{x_n} &= f& &\text{in } (0,1]^n\\ u &=0& &\text{on } \partial [0,1]^n \setminus (0,1]^n, \end{aligned}\right\} \end{equation} where $f\ge 0$. This Hamilton-Jacobi equation is the continuum limit of nondominated sorting, which is an algorithm for arranging points in Euclidean space into layers by peeling away extremal points. Nondominated sorting is fundamental in multi-objective optimization problems, which are ubiquitous in science and engineering, and more recently in machine learning. For more details on the connection to nondominated sorting and applications, we refer the reader to \cite{calder2014,calder2015PDE,calder2017,calder2016direct,hsiao2015,hsiao2015b,hsiao2012,deb2002,deuschel1995,hammersley1972}. The Hamilton-Jacobi equation \eqref{P1} has a unique non-decreasing viscosity solution. In order to select the viscosity solution of \eqref{P1}, the finite difference scheme is required to be monotone~\cite{barles1991}. Roughly speaking, the monotonicity property leads to a maximum principle for the scheme, which is one of the main techniques for proving stability and ensuring convergence to the viscosity solution. Unfortunately, all monotone schemes are necessarily first order at best~\cite{caldernotes}. It has been observed~\cite{barles1991,oberman2015filtered} that the monotonicity property can be relaxed to hold only approximately, with a residual error that vanishes as the grid is refined, while still ensuring the scheme converges to the viscosity solution. This allows one to design so-called filtered schemes, which blend together high-order nonmonotone schemes with monotone first-order schemes in such a way that the resulting filtered scheme is approximately monotone. The idea at a high level is to use the higher order scheme in regions where the solution is smooth while falling back on the monotone scheme near singularities. High order filtered schemes have received a lot of attention recently \cite{oberman2015filtered,lions1995convergence,froese2013convergent,bokanowski2016efficient,warin2013some,sahu2017high,sahu2016high}. In this paper, we show how to construct arbitrary order filtered upwind finite schemes for the Hamilton-Jacobi equation \eqref{P1}. The upwind direction for this Hamilton-Jacobi equation is to look backwards along the coordinate axes. Therefore, our upwind schemes all use backward difference quotients in order to follow the flow of the characteristics and select the viscosity solution. This allows the schemes to be solved in a single pass yielding fast (linear complexity) algorithms. We prove that our filtered schemes are stable and convergent for any order, and we present numerical simulations investigating rates of convergence. Our numerical simulations lead to two surprising conclusions that merit future work. First, we observe that backward differences (without filtering) for the two dimensional version of \eqref{P1} appear to be stable for order $k\leq 2$, borderline stable for $k=3$ (numerical solutions remain bounded but do not converge), and highly unstable for $k\geq 4$. We recall that it is a classical fact that backward differences for the one-dimensional version of \eqref{P1} (e.g., $u'(x)=f(x)$) are stable for order $k\leq 6$ and unstable for $k\geq 7$. It would be interesting to prove the order $k=2$ scheme is stable for \eqref{P1}, and examine the situation in higher dimensions. We note the filtered higher order schemes are stable for any $k$. Second, we observe that filtering higher order schemes with first order monotone schemes is only successful at increasing accuracy for order $k=2$. For order $k\geq 3$, we find that the filtering relies too much on the first order scheme, and while the schemes are stable and convergent, the order of accuracy is closer to first order. This is true even when the solution of \eqref{P1} is smooth. As far as we are aware, this observation has not appeared in the literature on filtered schemes; the existing literature~\cite{oberman2015filtered,lions1995convergence,froese2013convergent,bokanowski2016efficient,warin2013some,sahu2017high,sahu2016high} has only considered numerical experiments with second order schemes. This observation refutes the conventional wisdom that one can filter any higher order scheme---the choice of the higher order scheme may be crucial, and would be an interesting problem to pursue in future work. We should note that while some filtered schemes show higher order convergence rates in some test cases, there are no proofs that any schemes have convergence rates better than first order in general. This is a limitation in the viscosity solution theory; in fact, since solutions are not classical, the best provable rate in general is $O(\sqrt{h})$, with a one-sided $O(h)$ rate when the solution is semi-concave~\cite{caldernotes}. Even in the special case where the solution of the Hamilton-Jacobi equation is smooth, it is generally difficult to prove a higher order convergence rate, since it requires a strong stability result for the higher order scheme and the maximum principle is unavailable. The coefficients of the difference quotients in our schemes can be obtained by solving a small linear system involving a Vandermonde matrix, as is common in the literature. As an interesting addition to the paper, we give explicit formulas for the coefficients for arbitrary order backward difference quotients, and give simple direct proofs of the formulas. We expect these coefficients have appeared explicitly before in the literature, but we include the results for completeness. Our method extends to computing the coefficients for nonsymmetric and offset centered differences, which we explore in Section \ref{sec:diff}. We do not explicitly invert the Vandermonde matrix, but this could be done via an LU factorization as was given in ~\cite{turner1966vandermonde}. In \cite{calder2015PDE} a fast approximate nondominated sorting algorithm was developed based on estimating the distribution of the data, which is the right-hand side $f$, and solving the Hamilton-Jacobi equation \eqref{P1} numerically. The algorithm is called PDE-based ranking and was shown to be significantly faster than nondominated sorting in low dimensions. The higher order filtered schemes developed in this paper can be directly used in the PDE-based ranking algorithm to improve the accuracy with minimal additional computational cost. Thus, this work has the potential to have a broad impact in applications of nondominated sorting. This paper is organized as follows. In Section \ref{sec:scheme} we present our filtered schemes and prove stability and convergence. In Section \ref{sec:sims} we present the results of numerical simulations, and in Section \ref{sec:diff} we give explicit formulas for the coefficients of various difference quotients. \section{Filtered schemes} \label{sec:scheme} In this section we introduce our filtered schemes and prove stability and convergence. \subsection{ Backward differences} \label{sec:bfd} Since the upwind direction for \eqref{P1} is the negative orthant, our higher order schemes will all use backward difference quotients. The following theorem gives the exact coefficients for all backward different quotients for first derivatives. We expect this is known in the literature, but we give the proof for completeness. \begin{theorem}\label{BackwardDiff} Let $k$ be a positive integer and $f\in C^{k +1}$. Then $$f'(x) = \frac{1}{h}\sum_{i=1}^{k}c_i\left[f(x-ih) - f(x)\right] + O(h^k)$$ where $$c_i = \frac{(-1)^{i}}{i}\binom {k}{i} \ \ \text{for } i = 1, \dots, k.$$ \end{theorem} The proof relies on an elementary lemma, which is useful to state independently.\begin{lemma}\label{BinomialPowerZero} For any given integer $m$ and positive integer $n \geq 2,$ $$\sum_{i=0}^{n} (i+m)^k\binom {n}i (-1)^i = 0,$$ for all $k=1,2, \dots, n-1.$ \end{lemma} \begin{proof} Let $$ q_0(x) = x^m(x-1)^{n} = \sum_{i=0}^{n}\binom {n}i x^{i+m}(-1)^{n-i}.$$ For $k \geqslant 1,$ define $$q_k(x) = x\frac{dq_{k-1}(x)}{dx}.$$ So, $$ q_k(x) = \sum_{i=0}^{n}(i+m)^k\binom {n}i x^{i+m}(-1)^{n-i}.$$ It's can also be observed that for all $k \leq n-1, q_k(1) = 0.$\\ Therefore, $$\sum_{i=0}^{n} (i+m)^k\binom {n}i (-1)^i = (-1)^{-n}q_k(1) = 0.$$ \end{proof} We now give the proof of Theorem \ref{BackwardDiff}. \begin{proof} By using a Taylor series expansion, we obtain \begin{equation}\label{TaylorExpansion2} \sum_{i=1}^{k}c_i\left[\sum_{j=1}^{k}\frac{(-ih)^j}{j!} f^{(j)}(x)\right] + O(h^{k+1})= \sum_{i=1}^{k}c_i\left[f(x-ih) - f(x).\right] \end{equation} Rearranging the left hand side of equation \eqref{TaylorExpansion2}, we deduce $$\sum_{i=1}^{k}c_{i}\left[\sum_{j=1}^{k}\frac{(-ih)^j}{j!} f^{(j)}(x)\right] + O(h^{k+1}) = \sum_{j=1}^{k}\frac{h^j}{j!}f^{(j)}(x) \left[\sum_{i=1}^{k}c_{i}\cdot (-i)^j \right] + O(h^{k+1}).$$ By binomial expansion, $$\sum_{i=1}^{k}c_{i}\cdot (-i) = -\sum_{i = 1}^{k}\binom {k}{i}(-1)^{i} = \binom {k}{0} - \sum_{i = 0}^{k}\binom {k}{i}(-1)^{i}= 1.$$ By Lemma \ref{BinomialPowerZero}, for $j = 2, \dots, k,$ $$\sum_{i=1}^{k}c_{i} (-i) ^j = (-1)^{j}\sum_{i = 1}^{k} i^{j-1} \binom {k}{i}(-1)^{i} =(-1)^{j}\sum_{i = 0}^{k} i^{j-1} \binom {k}{i}(-1)^{i}= 0.$$ Thus, $$\sum_{i=1}^{k}c_{i}\left[\sum_{j=1}^{k}\frac{(-ih)^j}{j!} f^{(j)}(x)\right] = hf'(x) + O(h^{k+1}).$$ Therefore, we yield $$f'(x) = \frac{1}{h}\sum_{i=1}^{k}c_i\left[f(x-ih) - f(x)\right] + O(h^k)$$ as desired. \end{proof} We can also express the backward difference quotient in a more usual form. \begin{corollary}\label{ExplicitBackward} Let $k$ be a positive integer and $f\in C^{k +1}$. Then $$f'(x) = \frac{1}{h}\sum_{i=0}^{k}d_i \cdot f(x-ih) + O(h^k)$$ where \begin{eqnarray*} d_0 &=& 1 + \frac{1}{2} + \cdots + \frac{1}{k}, \ \ \text{ and}\\ d_i &=& \frac{(-1)^{i}}{i}\binom {k}{i}, \ \ \text{for } i =1, \dots, k.\qedhere \end{eqnarray*} \end{corollary} \begin{proof} It's easy to see that $d_i = c_i$ (defined as in Theorem \ref{BackwardDiff}) for $i \neq 0.$ In the case when $i = 0,$ we have \begin{eqnarray*} d_0 &=& -\sum_{i=1}^{k} d_i \\ &=& \sum_{i=1}^{k} \frac{(-1)^{i-1}}{i}\binom {k}{i}\\ &=& \int_0^1\sum_{i=1}^k \binom {k}{i}(-x)^{i-1} dx \\ &=& \int_0^1\frac{1-(1-x)^k}{x} dx\\ &=& \int_0^1 1 + (1-x) + \cdots + (1-x)^{k-1} dx\\ &=& \left[ x - \frac{(1-x)}{2} - \frac{(1-x)^2}{3} - \cdots - \frac{(1-x)^k}{k} \right]_{x=0}^{x=1} \\ &=& 1 + \frac{1}{2} + \cdots + \frac{1}{k}. \end{eqnarray*} \qedhere \end{proof} \subsection{High-order filtered finite difference schemes} The Hamilton-Jacobi equation \eqref{P1} does not have smooth or even Lipschitz solutions, due to a gradient singularity near the boundary where $x_i=0$. Indeed, in the special case that $f=1$ the viscosity solution is $u=n(x_1\cdots x_n)^{1/n}$. Following \cite{calder2017} we first perform a singularity factorization before solving the Hamilton-Jacobi equation. In particular, let $u$ be the viscosity solution of \eqref{P1} and define \begin{equation} w (x) =\frac{ u ( x)}{n \left( x_{1}\cdots x_{n} \right)^{1/n}}. \label{eq:factor} \end{equation} It is possible to show \cite{calder2017} that $w$ is Lipschitz continuous and satisfies \begin{equation}\label{eq:wlip} [w]_{1;[0,1]^n} \leq \sqrt{n}[f^{1/n}]_{1;[0,1]^n}. \end{equation} We can also show that $w$ is the unique bounded viscosity solution of the Hamilton-Jacobi equation \begin{equation}\label{P3} \prod_{i=1}^n (w + nx_i w_{x_i}) = f\ \ \text{ on } (0,1]^n. \end{equation} Although it appears that \eqref{P3} does not have a boundary condition, it is in fact encoded into the Hamilton-Jacobi equation, since $w (0) ^{n} = f (0)$. See \cite{calder2017} for more details on the above two statements. The idea from \cite{calder2017}, which we borrow here, is to solve \eqref{P3} numerically and then undo the transformation \eqref{eq:factor} to obtain a numerical approximation of $u$. The work in \cite{calder2017} explored first order finite difference schemes for \eqref{P3} and proved optimal convergence rates of $ O (\sqrt{h})$. We extend these ideas here to higher order filtered schemes. In light of Corollary \ref{ExplicitBackward} we define for $u:\left[0,1 \right] ^{n}\to \mathbb{R}$ the $k ^{\rm th}$-order backward difference quotient to be \begin{equation} \nabla^{k,-}_{i} u(x) =\frac{1}{h}\sum_{j=0}^{k}d_j u(x-jhe_i). \label{eq:backwarddifference} \end{equation} Here, $h>0$ is the grid resolution, and as a convention we take $u (x) = 0$ whenever $x\not\in \left[ 0,1 \right]^{n}$. The boundary value is irrelevant and does not enter into the scheme. By Corollary \ref{ExplicitBackward} we have that \[\nabla^{k,-}_{i} u(x) = u_{x_i}(x) + O(h^k)\] whenever $u\in C^{ k +1}$. We define the first order upwind scheme approximating the left-hand side of \eqref{P3} to be \begin{equation} F_{1} \left( x,w \right) = \begin{cases} \displaystyle\prod_{i=1}^{n}\left( w(x)+nx_i \dqi{1} w(x) \right), & \text{if } \forall i,\,w(x)+nx_i \dqi{1} w(x)\geq 0\\ -\infty,& \text{otherwise.} \end{cases} \label{eq:F1} \end{equation} The first order scheme from \cite{calder2017} corresponds to solving \[ F_{1}( x, w)= f ( x) \ \ \text{in } [0,1]^{n}_{h},\] where $\Omega_h:=\Omega \cap h\mathbb{Z}^n$ for any $\Omega\subset\mathbb{R}^n$. This scheme has a unique solution, and is monotone, stable, and convergent to the viscosity solution. Furthermore, this scheme can be solved with a (linear time) fast sweeping algorithm visiting each grid point exactly once. For more details on this scheme, we refer the reader to \cite{calder2017}. We define the $k ^{\rm th }$-order upwind finite difference scheme approximating the left-hand side of \eqref{P3} by \begin{equation} F_{k} \left( x,w \right) = \prod_{i=1}^{n}\left( w(x)+nx_i \nabla^{k,-}_{i} w(x) \right). \label{eq:Fk} \end{equation} The $k ^{\rm th }$-order upwind finite difference scheme is then given by \begin{equation} F_{k}( x, w)= f ( x) \ \ \text{in } [0,1]^{n}_{h}. \label{eq:Fk2} \end{equation} We note that this scheme is not monotone and may not have a unique solution. We can construct a solution with a fast sweeping method, as we did with the first order scheme, but there is no guarantee that the scheme will be stable or convergent to the viscosity solution. In Section \ref{sec:sims} we present results of simulations suggesting that the second order scheme is stable and convergent, but higher order schemes are unstable. The $k ^{\rm th }$-order \emph{filtered} upwind finite difference approximation of the left-hand side of \eqref{P3} is given by \begin{equation} G_k \left( x,w \right) = \begin{cases} F_k(x,w), & \text{if } |F_k(x,w)-F_1(x,w)|\le \sqrt{h} \text{ and } x\in [kh,1]^n ,\\ F_1(x,w),& \text{otherwise.} \end{cases} \label{eq:Gk} \end{equation} The $k ^{\rm th }$-order \emph{filtered} upwind finite difference scheme is then given by \begin{equation} G_{k}( x, w)= f ( x) \ \ \text{in } [0,1]^{n}_{h}. \label{eq:Gk2} \end{equation} The idea behind the filtering is that when the solution is smooth we should have $|F_k-F_1|\leq Ch$ and so the higher order scheme is selected. In regions where the solution is not smooth, the filtered scheme falls back on the monotone and stable first order scheme. The key property of filtered schemes is that any solution $w_h$ of \eqref{eq:Gk2} also satisfies \begin{equation} f(x) - \sqrt{h} \leq F_{1}( x, w_h) \leq f ( x)+ \sqrt{h} \ \ \text{in } [0,1]^{n}_{h}. \label{eq:filtProperty} \end{equation} By approximately solving the first order scheme, the solutions of the filtered schemes inherit the stability and convergence properties of the first-order scheme. We note that solutions of \eqref{eq:Gk2} may not be unique, since the scheme is not monotone. We compute the solution as follows: At each grid point we solve both of the schemes $F_1=f$ and $F_k=f$ for $w_h(x)$, taking the largest root when there are multiple solutions. We then take the solution of $F_k=f$ and check if the first property in \eqref{eq:Gk} is satisfied. If so, we choose this solution for $w_h(x)$, otherwise we select the solution of $F_1=f$. We analyze stability and convergence in the next section. \subsection{Stability and convergence} We prove here stability and convergence of the filtered schemes given in \eqref{eq:Gk2}. \begin{theorem} Assume that $f\ge 0$ and let $w_{h}$ be a solution of \eqref{eq:Gk2}. Then we have \begin{equation} 0\le w_h \le \left( \max_{[0,1]^n}f + \sqrt{h}\right) ^{1/n} \ \ \text{in } [0,1]^n_h. \label{eq:stability} \end{equation} \label{thm:stability} \end{theorem} \begin{proof} At the minimum of $w_h$, we have $x_i \dqi{1} w_h (x) \leq 0$. Since $w_h+ n x_i\dqi{1} w_h (x) \geq 0$ for all $i = 1, 2, \dots, n,$ it follows that \[\min{w_h} \geq - n x_i\dqi{1} w_h (x)\geq 0.\] This establishes a lower bound of $w_h.$ To determine an upper bound of $w_h$, we note that the filtered scheme satisfies \[0 \leq F_1(x,w_h) \leq f(x) + \sqrt{h}.\] At the maximum of $w_h$, we have $x_i\dqi{1} w_h(x) \geq 0.$ Since $0 \leq w_h(x),$ it follows that \[\left(\max{w_h}\right)^n \leq \prod_{i=1}^{n}\left( w(x)+nx_i \nabla^{k,-}_{i} w(x) \right) \leq f(x) +\sqrt{h} \leq \max{f} +\sqrt{h}.\] Thus $\max{w_h} \leq (\max{f} +\sqrt{h})^{1/n}$. This establishes an upper boundary of $w_h.$ Therefore, \[0\le w_h \le \left( \max_{[0,1]^n}f + \sqrt{h} \right) ^{1/n} \ \ \text{in } [0,1]^n_h,\] and the stability follows. \end{proof} Given the stability result in Theorem \ref{thm:stability}, it is now a standard application of the Barles-Souganidis framework~\cite{barles1991} to prove convergence of the filtered scheme \eqref{eq:Gk2} to the viscosity solution of \eqref{P3}. In fact, the proof of convergence of the filtered schemes is very similar to the results in \cite{calder2017}. Let us mention, however, that these convergence results do not establish any convergence rate. The best provable convergence rate for the filtered scheme is still $O (\sqrt{ h})$. In practice, we do often see far better convergence rates for the filtered schemes, and we present simulations investigating convergence rates in Section \ref{sec:sims}. \section{Numerical simulations} \label{sec:sims} We run simulations on both backward difference schemes and filtered schemes of orders 1, 2, 3, 5, 8, and 13 with two probability density functions $f_1$ and $f_2$ that were introduced before in \cite{calder2017}. The function $f_1$ is defined as follows: \[f_1(x) = \frac{1}{4(k+1)^2}\prod_{i=1}^2 \left(\sum_{j=1}^2 \sin(kx_j)^2 + 2k + 2kx_i\sin(2kx_i)\right),\] where $k>0$. In the simulations, we set $k=20$. The solution of \eqref{P1} in this case is known to be \[u_1(x) = \frac{1}{k+1}\sqrt{x_1x_2} \left(\sin(kx_1)^2 + \sin(kx_2)^2+ 2k\right).\] We note that the solution $u_1$ is smooth on $(0,1]^2$. The function $f_2$ is defined as follows: \[f_2(x) = \frac{1}{(C+2)^2}\left(w_2(x) + 2(1+C)x(2)\right)\left( w_2(x) + 2x(1)\right).\] where $x(i) = x_{\pi_x(i)}$ for a permutation $\pi_x$ such that $x(1)\leq x(2)$, and \[w_2(x) =C\max\{x_1, x_2\} + x_1 + x_2.\] We set $C=10$ in the simulations. The solution in this case is known to be \[u_2(x) = 2\sqrt{x_1x_2} w_2(x).\] The function $f_2$ is Lipschitz and the solution $u_2$ has a gradient discontinuity. This is common in Hamilton-Jacobi equations due to crossing characteristics. Given these $f_1$ and $f_2$, we gather the errors from their numerical solutions compared to the known solutions for each order of each scheme in different mesh sizes $h$. These errors are measured in both the $L^1$ norm and the $L^\infty$ norm as numerical evidence of the rate of convergence. The results from the simulations are shown in Figure \ref{fig:F2_d1} - Figure \ref{fig:F3_d4}. Note that here we use ``S'' to denote ``backward difference scheme'' and ``FS'' to denote ``filtered scheme''. \begin{figure} \centering \includegraphics[scale=0.65]{F2_d1} \caption{Errors in the $L^1$ norm from order 1, 2, 3 schemes when $f = f_1$}\label{fig:F2_d1} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F2_d2} \caption{Errors in the $L^1$ norm from order 5, 8, 13 schemes when $f = f_1$}\label{fig:F2_d2} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F2_d3} \caption{Errors in the $L^\infty$ norm from order 1, 2, 3 schemes when $f = f_1$}\label{fig:F2_d3} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F2_d4} \caption{Errors in the $L^\infty$ norm from order 5, 8, 13 schemes when $f = f_1$}\label{fig:F2_d4} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F3_d1} \caption{Errors in the $L^1$ norm from order 1, 2, 3 schemes when $f = f_2$}\label{fig:F3_d1} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F3_d2} \caption{Errors in the $L^1$ norm from order 5, 8, 13 schemes when $f = f_2$}\label{fig:F3_d2} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F3_d3} \caption{Errors in the $L^\infty$ norm from order 1, 2, 3 schemes when $f = f_2$}\label{fig:F3_d3} \end{figure} \begin{figure} \centering \includegraphics[scale=0.65]{F3_d4} \caption{Errors in the $L^\infty$ norm from order 5, 8, 13 schemes when $f = f_2$}\label{fig:F3_d4} \end{figure} The results from the simulations suggest that the unfiltered $2^{\rm nd}$ order backward difference scheme is convergent with a second order rate. On the other hand, the backward difference schemes of order higher than two appear to be unstable. In fact, the errors for the unfiltered schemes for order $k=5,8,13$ are so large they are not shown in the figures. Observing the errors from filtered schemes in both the $L^1$ norm and the $L^\infty$ norm, we see that the $2^{\rm nd}$ order filtered scheme also tends to give better accuracy than the $1^{\rm st}$ order one, but other higher order filtered schemes only give comparable accuracies to the $1^{\rm st}$ order scheme. A further investigation shows that high order filtered schemes rely most of the time on the first order scheme in solving \eqref{P1}. This explains why higher order filtered schemes do not produce better accuracy than lower order ones. To give a better idea, we show the fraction of grid points for which the $k^{\rm th}$ order scheme is being used for various mesh sizes and orders when setting $f=f_1$ in Table \ref{f2L1}. Since setting $f = f_2$ gives a similar result, we omit showing the same table of data in this case. This explains why filtering is not successful for higher order schemes. It would be interesting to determine why this is happening and whether it can be improved by using different schemes or a different type of filtering. \begin{table}[!t] \centering \begin{tabular}{|c|c|c|c|c|c|c|} \hline Mesh size $h$& $1^{\rm st}$ order& $2^{\rm nd}$ order& $3^{\rm rd}$ order& $5^{\rm th}$ order& $8^{\rm th}$ order & $13^{\rm th}$ order\\ \hline $3.33\times10^{-2}$&$95.06\%$ &$54.31\%$ &$45.00\%$ &$44.81\%$&$22.69\%$ &$4.88\%$ \\ $6.67\times10^{-3}$&$98.75\%$ &$81.09 \%$ &$81.61\%$ &$75.41\%$&$33.95\%$ &$7.59\%$\\ $1.59\times10^{-3}$&$99.69\%$ &$97.69\%$ &$97.42\%$ &$85.61\%$ &$37.92\%$ &$8.78\%$\\ $3.92\times10^{-5}$&$99.92\%$ &$99.84\%$ &$98.57\%$ &$87.29\%$ &$39.15\%$ &$8.97\%$\\ $9.78\times10^{-6}$&$99.98\%$ &$99.96\%$ &$97.82\%$ &$87.03\%$ &$39.43\%$ &$9.00\%$\\ \hline \end{tabular} \caption{Fraction of grid points for which the $k^{\rm th}$ order scheme being used in the filtered schemes.} \label{f2L1} \end{table} \section{Explicit formulas for difference quotients} \label{sec:diff} Our proof of the backward difference formulas in Section \ref{sec:bfd} can be extended to more general difference quotients. We present these results in this section. The first part will present results regarding the coefficients of finite difference quotients for $f'$. The second part will be devoted for generalizing the coefficients of finite difference quotients for $f^{(n)}$ where $n$ is any positive integer. Although we expect some of these coefficients to have appeared in the literature before, we include this section for completeness of the paper. Additionally, we hope to provide different approaches for proving the formulas that may be simpler and more direct. \subsection{Other finite differences for $f'(x)$} We begin by introducing the notation for an extension of binomial coefficient. \begin{definition} \label{nchooseK} Let $r$ be a real number and $k$ be a positive integer. Define $$\binom {r}{0} = 1 \text{ and } \binom {r}{k} = \frac{r\cdot (r-1) \cdots (r - (k-1))}{k!}.$$ \end{definition} We found that Lemma \ref{BinomialPowerZero} can be used for computing the $k-$order forward difference quotients as well. Compared to backward differences, these quotients simply have opposite signs as stated in Theorem \ref{ForwardDiff} and Corollary \ref{ExplicitForward}. \begin{theorem}[Forward Difference] Let $k$ be a positive integer. Then $$f'(x) = \frac{1}{h}\sum_{i=1}^{k}c_i\left[f(x+ih) - f(x)\right] + O(h^k),$$ where $$c_i = \frac{(-1)^{i-1}}{i}\binom {k}{i},$$ for $i = 1,2, \dots, n.$ \end{theorem}\label{ForwardDiff} \begin{corollary}\label{ExplicitForward} Let $k$ be a positive integer. Then $$f'(x) = \frac{1}{h}\sum_{i=0}^{k}d_i\cdot f(x+ih) + O(h^k),$$ where $$d_0 = -1 - \frac{1}{2} - \cdots - \frac{1}{k}, \text{ and}$$ $$d_i = \frac{(-1)^{i-1}}{i}\binom {k}{i},$$ for $i = 1,2, \dots, n.$ \end{corollary} The proofs for both of the above theorem and corollary will be omitted as they can be proceeded in the same way as the proofs for Theorem \ref{BackwardDiff} and Corollary \ref{ExplicitBackward}, respectively.\\ Another finite difference quotient that is often implemented is centered difference quotient. With Lemma \ref{BinomialPowerZero}, we can also generalize centered difference quotients as shown in Theorem \ref{CenteredDiff} \begin{theorem}[Centered Difference] Let $m$ and $n$ be a positive integers. Then $$f'(x) =\frac{1}{h}\sum_{i=-m}^{n}c_i\left[f(x+ih) - f(x)\right] + O(h^{n+m}),$$ where $c_0 = 0,$ and $$c_i = (-1)^{i-1}\frac{\binom {n+m}{i+m}}{i\binom {n+m}{m}},$$ for $i = -m, -m + 1, \dots, -1, 1, \dots, n.$ \end{theorem}\label{CenteredDiff} \begin{proof} By using a Taylor series expansion, we obtain \begin{equation}\label{TalorExpansion3} \sum_{i=-m}^{n}c_{i}\left[\sum_{j=1}^{n+m}\frac{(ih)^j}{j!} f^{(j)}(x)\right] + O(h^{n+m+1})= \sum_{i=-m}^{n}c_{i}\left[f(x+ih) - f(x)\right]. \end{equation} We claim that $c_0 = 0$ and $$c_i = (-1)^{i-1}\frac{\binom {n+m}{i+m}}{i\binom {n+m}{m}},$$ for $i \neq 0$, reduce the left hand side of equation \eqref{TalorExpansion3} to $hf'(x) + O(h^{k+1}).$\\ Rearranging the left hand side of equation \eqref{TalorExpansion3}, we deduce $$\sum_{i=-m}^{n}c_{i}\left[\sum_{j=1}^{n+m}\frac{(ih)^j}{j!} f^{(j)}(x)\right] + O(h^{n+m+1}) = \sum_{j=1}^{k}\frac{h^j}{j!}f^{(j)}(x) \left[\sum_{i=-m}^{n}c_{i}\cdot i^j \right] + O(h^{n+m+1}).$$ By binomial expansion, \begin{eqnarray*} \sum_{i=-m}^{n}c_{i}\cdot i &=& \frac{1}{\binom {n+m}{m}} \left[ \sum_{i = -m}^{n}\binom {n+m}{i+m}(-1)^{i-1} + \binom{n+m}{m} \right]\\ &=& \frac{1}{\binom {n+m}{m}} \left[ \sum_{i = 0}^{n+m}\binom {n+m}{i}(-1)^{i} + \binom{n+m}{m} \right] \ \ \ \ = 1. \end{eqnarray*} By Lemma \ref{BinomialPowerZero}, for $j = 2, \dots, n+m,$ \begin{eqnarray*} \sum_{i=-m}^{n}c_{i}\cdot i ^j &=& \frac{1}{\binom {n+m}{m}} \left[ \sum_{i = -m}^{n}i^{j-1}\binom {n+m}{i+m}(-1)^{i-1} \right] \\ &=& \frac{1}{\binom {n+m}{m}} \left[ \sum_{i = 0}^{n+m}(i-m)^{j-1}\binom {n+m}{i}(-1)^{i} \right]\ \ \ \ \ = 0. \end{eqnarray*} Thus, $$\sum_{i=-m}^{n}c_{i}\left[\sum_{j=1}^{n+m}\frac{(ih)^j}{j!} f^{(j)}(x)\right] + O(h^{n+m+1}) = hf'(x) + O(h^{n+m+1}),$$ and the desired result follows. \end{proof} The next finite difference quotient that will be introduced in Theorem \ref{ArithmeticType1} uses arithmetic progression differences in computing $f'(x).$ Essential lemmas for proving its coefficients are given below. \begin{lemma}\label{FractionalSum1} For any given real number $r$ and positive integer $p$, $$\sum_{i = 0}^{p}\binom{-r}{i} \binom{r + p}{p-i} = 1.$$ \end{lemma} \begin{proof} Writing $$(x+1)^p = (x+1)^{-r} (x+1)^{(r + p) } = \left[ \sum_{i = 0}^{\infty} \binom{-r}{i} x^i\right] \left[ \sum_{j = 0}^{\infty} \binom{r+p}{j} x^j\right],$$ one can compare the coefficient of $x^p$ on both sides of the equation and yield $$1 = \sum_{i = 0}^{p}\binom{-r}{i} \binom{r+ p}{p-i}.$$ \end{proof} \begin{corollary}\label{G0} For any given real number $r$ and positive integer $p$, the polynomial $$G_0(\lambda) = \sum_{i = 0}^{p}\binom{-r + \lambda}{i}\binom{r + p - \lambda}{p-i} = 1.$$ \end{corollary} \begin{lemma}\label{zeroCoefficient2} For any given real number $r$ and positive integer $p,$\\ define $s_{r}^{[0]}(x)=x^r(x+1)^{-r}$, and for $k\geq 1,$ $$s_{r}^{[k]}(x)=x\frac{d\left[s_{r}^{[k-1]}(x) \right]}{dx}.$$ Then for $k = 1, 2, \dots, p$, $$Q_{r,p}^{[k]}(x)=x^{-r} \cdot (x+1)^{r +p} \cdot s_{r}^{[k]}(x)$$ is a polynomial of degree less than $p.$ \end{lemma} \begin{proof} We will show, by mathematical induction, that for all $k\geq 1,$ $$s_{r}^{[k]}(x)=g(x)\cdot x^r \cdot (x+1)^{-(r+k)},$$ where $g(x)$ is a polynomial of degree less than $k$.\\ It is true for $k =1$ because $$s_{r}^{[1]}(x)=r\cdot x^r\cdot(x+1)^{-(r+1)}.$$ Let's assume that this is true for some positive integer $l.$ Then we will have that \begin{eqnarray*} s_{r}^{[l+1]}(x)&=&x\frac{d\left[s_{r}^{[l]}(x) \right]}{dx}\\ &=& x\left[ \left[ g'(x)\cdot x^r + rx^{r-1}\cdot g(x)\right] \cdot (x+1)^{-(r+l)} \right]\\ &\ \ \ & -x\left[ (r+l)(x+1)^{-(r+l+1)}\cdot g(x) \cdot x^r\right]\\ &=& \left[\left[ x g'(x) +rg(x)\right] \cdot (x+1) - (r+l)x g(x)\right]\cdot x^r \cdot (x+1)^{-(r+l+1)}. \end{eqnarray*} Since $g(x)$ has degree less than $l$, it is not difficult to see that $$\left[ x g'(x) +rg(x)\right] \cdot (x+1) - (r+l)x g(x)$$ has degree less than $l+1.$ Hence, $g(x)$ has degree less than $k$ for all $k\geq 1.$\\ Therefore, for $k = 1, 2, \dots, p,$ $$Q_{r,p}^{[k]}(x)=x^{-r}(x +1)^{r + p} \cdot s_{r}^{[k]}(x) = (x+1)^{p-k} g(x)$$ is a polynomial of degree less than $p.$ \end{proof} \begin{lemma}\label{FractionalZeroSum} For any given real number $r$ and positive integer $p$, $$\sum_{i = 0}^{p} (r+i)^k \binom{-r}{i} \binom{r + p}{p-i} = 0,$$ for $k = 1, 2, \dots, p.$ \end{lemma} \begin{proof} Let $s_{r}^{[0]}(x)=x^r(x+1)^{-r}$, and for $k\geq 1,$ $$s_{r}^{[k]}(x)=x\frac{d\left[s_{r}^{[k-1]}(x) \right]}{dx}.$$ By letting, $$Q_{r,p}^{[k]}(x)=x^{-r} \cdot (x+1)^{r+p} \cdot s_{r}^{[k]}(x),$$ one will have that the coefficient of $x^{p}$ is $$\sum_{i = 0}^{p} (r+i)^k \binom{-r}{i} \binom{r + p}{p-i} .$$ By Lemma \ref{zeroCoefficient2}, for $k = 1, 2, , \dots, p$ , the polynomial $Q_{r,p}^{[k]}(x)$ is of degree less than $p.$ Therefore, $$\sum_{i = 0}^{p} (r+i)^k \binom{-r}{i} \binom{r + p}{p-i} =0.$$ \end{proof} \begin{theorem}[Arithmetic Progression Difference] Let $a$ be a real number, $d$ be a nonzero real numbers, and $k$ be a positive integer such that $0 \notin \lbrace a_1,a_2, \dots, a_k \rbrace,$ where $a_i = a + d(i-1).$ Then $$f'(x) = \frac{1}{h}\sum_{i=1}^{k}c_{a_i}\left[f(x+a_i h) - f(x)\right] + O(h^k),$$ where $$c_{a_i} = \frac{1}{a_i}\binom {-a_1/d}{i-1} \binom {a_k/d}{k-i},$$ for $i = 1,2, \dots, k.$ \end{theorem}\label{ArithmeticType1} \begin{proof} By using a Taylor series expansion, we obtain \begin{equation}\label{TalorExpansion} \sum_{i=1}^{k}c_{a_i}\left[\sum_{j=1}^{k}\frac{(a_i h)^j}{j!} f^{(j)}(x)\right] + O(h^{k+1})= \sum_{i=1}^{k}c_{a_i}\left[f(x+a_i h) - f(x)\right]. \end{equation} We claim that $$c_{a_i} = \frac{1}{a_i}\binom {-a_1/d}{i-1} \binom {a_k/d}{k-i} $$ reduces the left hand side of equation \eqref{TalorExpansion} to $hf'(x) + O(h^{k+1}).$\\ Rearranging the left hand side of equation \eqref{TalorExpansion}, we deduce $$\sum_{i=1}^{k}c_{a_i}\left[\sum_{j=1}^{k}\frac{(a_i h)^j}{j!} f^{(j)}(x)\right] + O(h^{k+1}) = \sum_{j=1}^{k}\frac{h^j}{j!}f^{(j)}(x) \left[\sum_{i=1}^{k}c_{a_i}\cdot a_i^j \right] + O(h^{k+1}).$$ By Lemma \ref{FractionalSum1}, $$\sum_{i=1}^{k}c_{a_i}\cdot a_i = \sum_{i = 1}^{k}\binom{-a_1/d}{i-1} \binom{a_k/d}{k-i} = \sum_{i = 0}^{k-1}\binom{-a/d}{i} \binom{a/d + (k-1)}{k-i-1} = 1.$$ By Lemma \ref{FractionalZeroSum}, for $j = 2, \dots, k,$ \begin{eqnarray*} \sum_{i=1}^{k} c_{a_i} \cdot a_i ^j &=& \sum_{i = 1}^{k} a_i^{j-1} \binom{- a_1 /d}{i-1} \binom{a_k /d}{k-i} \\ &=& d^{j-1}\cdot \sum_{i = 0}^{k-1} {(a/d+i)}^{j-1} \binom{-a/d}{i} \binom{a/d + (k-1)}{k-i-1} = 0. \end{eqnarray*} Thus, $$\sum_{i=1}^{k}c_{a_i}\left[\sum_{j=1}^{k}\frac{(ih)^j}{j!} f^{(j)}(x)\right] + O(h^{k+1}) = hf'(x) + O(h^{k+1}),$$ and the desired result follows. \end{proof} \subsection{General forms of finite differences for $f^{(n)}$} We extend the idea from previous results to generalize the coefficients of finite difference quotients for $f^{(n)}$. In computing them, we need to solve for the inverses of the matrices defined as in Theorem \ref{matrix1} and \ref{matrix2}. Because of its generality, the results presented in this section will also hold for all the previous results. Indeed, the first columns of these inverses represent the coefficients of a finite difference quotient for $f'$, the second columns represent the coefficients of a finite difference quotient for $f''$, and so on. Some notations and lemmas that are essential for proving them are given below. \begin{lemma}\label{PowerLeadingCoef} For any given real numbers $r, \lambda,$ and positive integer $p,$\\ define $t_{\lambda, r}^{[0]}(x)=x^r(x+1)^{-(r-\lambda)}$, and for $k\geq 1,$ $$t_{\lambda, r}^{[k]}(x)=x\frac{d\left[t_{\lambda, r}^{[k-1]}(x) \right]}{dx}.$$ Then for $k = 1, 2, \dots, p$, the coefficient of the term $x^{p}$ in the polynomial $$R_{\lambda, r,p}^{[k]}(x)=x^{-r} \cdot (x+1)^{(r-\lambda) +p} \cdot t_{\lambda, r}^{[k]}(x)$$ is $\lambda^k.$ \end{lemma} \begin{proof} We will show by mathematical induction that for all $k\geq 1,$ $$t_{\lambda, r}^{[k]}(x)=g(x)\cdot x^r \cdot (x+1)^{-r+\lambda+k},$$ where $g(x)$ is a polynomial of degree $k$ with the leading coefficient of $\lambda^k$.\\ It is true when $k =1$ because $$t_{\lambda, r}^{[1]}(x)=(\lambda x + r)\cdot x^r \cdot(x+1)^{-r+\lambda+1}.$$ Let's assume that this is true for some positive integer $l.$ Then we will have that \begin{eqnarray*} t_{\lambda, r}^{[l+1]}(x)&=&x\frac{d\left[t_{\lambda, r}^{[l]}(x) \right]}{dx}\\ &=& x\left[ \left[ g'(x)\cdot x^r + rx^{r-1}\cdot g(x)\right] \cdot (x+1)^{-r+\lambda+l} \right]\\ &\ \ & -x\left[ \left[ r-\lambda+l\right] (x+1)^{-r+\lambda+l+1}\cdot g(x) \cdot x^r\right]\\ &=& \left[\left[ x g'(x) +rg(x)\right] \cdot (x+1) - (r - \lambda +l)x\cdot g(x)\right]\cdot x^r \cdot (x+1)^{-r+\lambda+l+1}. \end{eqnarray*} Since the leading term of $g(x)$ is $\lambda^l x^{l}$, it follows that the leading coefficient of \\ $\left[ x g'(x) +rg(x) \right] \cdot (x+1) - (r - \lambda +l)x\cdot g(x)$ is $$\left[ (l +r)\lambda^l - (r-\lambda + l)\lambda^l \right] x^{l+1} = \lambda^{l+1} x^{l+1}.$$ Hence, $g(x)$ is a polynomial of degree $k$ with the leading coefficient of $\lambda^k$ for all $k\geq 1.$\\ Therefore, for $k = 1, 2, \dots, p,$ the coefficient of the term $x^{p}$ in the polynomial $$R_{\lambda, r,p}^{[k]}(x)=x^{-r}(x+1)^{-r+\lambda + p} \cdot t_{\lambda, r}^{[k]}(x)$$ is $\lambda^k.$ \end{proof} \begin{lemma}\label{FractionalPolynomial} Let $r$ be a real number and $p$ be a positive integer. Define the polynomial $$H_i(\lambda) = \binom{-r + \lambda}{i} \binom{r + p - \lambda}{p-i}.$$ Then, for $i = 1, \dots, p,$ \[ H_i(\lambda ^*) = \begin{cases} 1 \text{ if } \lambda ^*= r + i,\\ 0 \text{ if } \lambda ^* = r + j, \text{ where } 0 \leq j \leq p \text{ and } j \neq i. \end{cases} \] \end{lemma} \begin{proof} In the case when $\lambda = r + i,$ we directly compute $$H_i(r+i) = \binom{-r + (r+i)}{i} \binom{r + p - (r+i)}{p-i} = \binom{i}{i} \binom{p - i}{p-i} = 1.$$ In other cases, we express $H_i$ as a product of linear functions of $\lambda$ and yield \begin{eqnarray*} \binom{-r + \lambda}{i} \binom{r + p - \lambda}{p-i} &=& H_i(\lambda)\\ &=& (-1)^{p-i}\frac{(\lambda-r)\cdot (\lambda-(r+1))\cdots (\lambda-(r+p))}{(\lambda-(r+i))\cdot i!\cdot (p-i)!}. \end{eqnarray*} From here, it is difficult to see that for $i = 1, \dots, p,$ $$H_i(\lambda ^*) = 0 \text{ if } \lambda ^* = r + j, \text{ where } 0 \leq j \leq p \text{ and } j \neq i.$$ \end{proof} \begin{lemma}\label{GK} For any given real number $r$ and positive integer $p$, the polynomial $$G_k(\lambda) = \sum_{i = 0}^{p} (r+i)^k \binom{-r + \lambda}{i} \binom{r + p - \lambda}{p-i}= \lambda^k,$$ for $k = 1, 2, \dots, p.$ \end{lemma} \begin{proof} In the similar fashion to the proof for Lemma \ref{FractionalZeroSum}, we have that, for $k = 1, 2, \dots, p,$ the expression $$\sum_{i = 0}^{p} (r+i)^k \binom{-r + \lambda}{i} \binom{r + p - \lambda}{p-i}$$ is the coefficient of $x^{p}$ in the polynomial $R_{\lambda, r, p}^{[k]}(x)$ from the previous theorem. Hence, $$\sum_{i = 0}^{p} (r+i)^k \binom{-r + \lambda}{i} \binom{r + p - \lambda}{p-i} = \lambda^k.$$ Thus, it automatically holds when we define the polynomial $$G_k(\lambda) = \sum_{i = 0}^{p} (r+i)^k \binom{-r + \lambda}{i} \binom{r + p - \lambda}{p-i}.$$ \end{proof} \begin{definition}\label{Sigma} Let $S = \lbrace s_1,s_2, \dots, s_n \rbrace$ be a set containing real numbers. Define $\sigma_0(S) = 1$ and $$\sigma_k(S) = \sum_{a_1<a_2<\cdots<a_k \in S} a_1\cdot a_2 \cdot \cdots a_k,$$ for $i = 1, 2, \dots, n.$ \end{definition} \begin{lemma} \label{matrix1} For any real number $a,$ nonzero real number $d,$ and positive integer $n$ such that $0 \notin T = \lbrace a, a+d, \dots, a+(n-1)d \rbrace$, define $A$ to be an $n\times n-$matrix with $$A_{ij} = (a+(j-1)d)^i.$$ Then $A^{-1} = B,$ where $$B_{ij} = \frac{(-1)^{i+j}}{a+(i-1)d} \cdot \frac{\sigma_{n-j}(T - \lbrace a+(i-1)d\rbrace)}{d^{n-1}(i-1)!(n-i)!}.$$ \end{lemma} \begin{proof} We will first show that $AB = I_n.$ By directly computing the product of $A$ and $B$, we deduce \begin{eqnarray*} (AB)_{ij} &=& \sum_{k=1}^n A_{ik} \cdot B_{kj}\\ &=& \sum_{k=1}^n (a+(k-1)d)^i\cdot \left[ \frac{(-1)^{k+j}}{a+(k-1)d} \cdot \frac{\sigma_{n-j}(T - \lbrace a+(k-1)d\rbrace)}{d^{n-1}(k-1)!(n-k)!}\right]\\ &=& \sum_{k=1}^n (-1)^{k+j}(a+(k-1)d)^{i-1} \cdot \frac{\sigma_{n-j}(T - \lbrace a+(k-1)d\rbrace)}{d^{n-1}(k-1)!(n-k)!}\\ &=& d^{i-j}\cdot \sum_{k=0}^{n-1} (-1)^{k+j+1}(a/d+k)^{i-1} \cdot \frac{\sigma_{n-j}(T - \lbrace a+kd\rbrace)}{d^{n-j}(k)!(n-k-1)!}. \end{eqnarray*} We note that $(AB)_{ij}$ equals the coefficient of $x^{j-1}$ in the polynomial $d^{i-j}\cdot G_{i-1}(\lambda),$ where $G(\lambda)$ is defined as in Corollary \ref{G0} and Lemma \ref{GK} (by setting $r = a/d$) . Thus, by Corollary \ref{G0} and Lemma \ref{GK}, \[ (AB)_{ij}=\begin{cases} 1 & \text{if } i = j,\\ 0 & \text{if } i \neq j. \end{cases} \] This establishes $AB = I_n$ as desired. \\ Now we will show that $BA = I_n.$ By directly computing the product of $B$ and $A$, we deduce \begin{eqnarray*} (BA)_{ij}&= &\sum_{k=1}^n B_{ik} \cdot A_{kj}\\ &=& \sum_{k=1}^n \left[ \frac{(-1)^{i+k}}{a+(i-1)d} \cdot \frac{\sigma_{n-k}(T - \lbrace a+(i-1)d\rbrace)}{d^{n-1}(i-1)!(n-i)!}\right](a+(j-1)d)^k\\ &=& \frac{a+(j-1)d}{a+(i-1)d}\left[\sum_{k=1}^n (-1)^{i+k}(a+(j-1)d)^{k-1} \cdot \frac{\sigma_{n-k}(T - \lbrace a+(i-1)d\rbrace)}{d^{n-1}(i-1)!(n-i)!}\right]\\ &=& \frac{a+(j-1)d}{a+(i-1)d} \left[\sum_{k=1}^n (-1)^{i+k}(a/d+j-1)^{k-1} \cdot \frac{\sigma_{n-k}(T - \lbrace a+(i-1)d\rbrace)}{d^{n-k}(i-1)!(n-i)!}\right]\\ &=&\frac{a+(j-1)d}{a+(i-1)d} \cdot H_i(a/d + j-1), \end{eqnarray*} where $H_i$ is defined as in Lemma \ref{FractionalPolynomial}. Thus, by Lemma \ref{FractionalPolynomial}, \[ (BA)_{ij}=\begin{cases} 1 & \text{if } i = j,\\ 0 & \text{if } i \neq j. \end{cases} \] This establishes $BA = I_n.$ Therefore, $A^{-1} = B.$ \end{proof} \begin{lemma} \label{matrix2} For any positive integers $m, n,$ and nonzero real number $d$, let the set $T = \lbrace -md, -(m-1)d, \dots, -d, d, \dots, nd\rbrace$ and define the $(m+n)\times (m+n)-$matrix $$A = \begin{bmatrix} C \ D \end{bmatrix} $$ where $C$ is an $(m+n) \times m-$matrix with $C_{ij} = \left[(j-m-1)d \right]^i$ and $D$ is an $(m+n)\times n-$matrix with $D_{ij} = (jd)^i.$ Then $$ A^{-1} = B = \begin{bmatrix} C^* \\ D^* \end{bmatrix} $$ where $C^*$ is an $m\times (n+m)-$matrix with $$C^*_{ij} =(-1)^{i+j+1}\cdot \frac{\sigma_{n+m-j}(T - \lbrace(i-m-1)d\rbrace)}{d^j \cdot (i-1)!(n+m-i+1)!},$$ and $D^*$ is an $n\times (n+m)-$matrix with $$D^*_{ij} =(-1)^{m+i+j}\cdot \frac{\sigma_{n+m-j}(T - \lbrace id\rbrace)}{d^j \cdot (m+i)!(n-i)!}.$$ \end{lemma} The proof for Lemma \ref{matrix2} is omitted since it can be proceeded in the similar way as the proof for Lemma \ref{matrix1}. The reader who is interested in proving it may set $d =1$ for simplicity. Once the case $d =1$ is proven, it is not difficult to see that the result also holds in the case $d \neq 1$. It is not practical to explicitly express matrix $B$. However, it is not too difficult to express the first, the last, and the second last columns of $B$. We already show how to compute the first column in the previous two sections (aka Theorem \ref{BackwardDiff} - \ref{ArithmeticType1}). In this section, we will only show how to compute the last and the second last columns. Their proofs will be omitted due to the fact that they are derived directly from Lemma \ref{matrix1} and Lemma \ref{matrix2}.\\ \textbf{Computing the last column of $B$} \begin{theorem}\label{lastCol1} Let $a$ be a real number, $d$ be a nonzero real number, and $n$ be a positive integer such that $0 \notin \lbrace a_1,a_2, \dots, a_n \rbrace,$ where $a_i = a + d(i-1).$ Then $$f^{(n)}(x) = \frac{1}{h^n}\sum_{i=1}^{n}c_{a_i}\left[f(x+a_i h) - f(x)\right] + O(h),$$ where $$c_{a_i} = \frac{(-1)^{n+i}}{a_i} \cdot \frac{1}{d^{n-1}(i-1)!(n-i)!},$$ for $i = 1,2, \dots, n.$ \end{theorem} \begin{theorem}\label{lastCol2} For any positive integers $m, n,$ and nonzero real number $d$, let $a_i = i\cdot d.$ Then $$f^{(m+n)}(x) = \frac{1}{h^{m+n}}\sum_{i=-m}^{n}c_{a_i}\left[f(x+a_i h) - f(x)\right] + O(h),$$ where $c_{a_0} = 0,$ and $$c_{a_i} = (-1)^{n+i}\cdot \frac{1}{d^{n+m} \cdot (m+i)!(n-i)!},$$ for $i = -m, \dots, -1, 1, \dots, n.$\\ \end{theorem} \textbf{Computing the second last column of $B$} \begin{theorem}\label{secondLastCol1} Let $a$ be a real number, $d$ be a nonzero real number, and $n$ be a positive integer such that $0 \notin \lbrace a_1,a_2, \dots, a_n \rbrace,$ where $a_i = a + d(i-1).$ Then $$f^{(n-1)}(x) = \frac{1}{h^{n-1}}\sum_{i=1}^{n}c_{a_i}\left[f(x+a_i h) - f(x)\right] + O(h^2),$$ where $$c_{a_i} = \frac{(-1)^{n+i-1}}{a_i} \cdot \frac{\frac{n}{2}(a_1 + a_n) - a_i}{d^{n-1}(i-1)!(n-i)!},$$ for $i = 1,2, \dots, n.$ \end{theorem} \begin{theorem}\label{secondLastCol2} For any positive integers $m, n,$ and nonzero real number $d$, let $a_i = i\cdot d.$ Then $$f^{(m+n-1)}(x) = \frac{1}{h^{m+n-1}}\sum_{i=-m}^{n}c_{a_i}\left[f(x+a_i h) - f(x)\right] + O(h^2),$$ where $c_{a_0} = 0,$ and $$c_{a_i} = (-1)^{n+i-1}\cdot \frac{ \frac{n^2-m^2}{2} - i }{d^{n+m-2} \cdot (m+i)!(n-i)!},$$ for $i = -m, \dots, -1, 1, \dots, n.$ \end{theorem} \section{Conclusions} \label{sec:conc} In this paper, we showed how to construct filtered schemes for the Hamilton-Jacobi equation continuum limit of nondominated sorting by combining high order possibly unstable schemes with first order monotone and stable schemes. We proved that the filtered schemes are stable and convergent for all orders. We then investigated both high-order unfiltered and filtered schemes for the Hamilton-Jacobi equation by implementing both schemes for order $k=1, 2, 3, 5, 8,$ and $13$ numerically solving the equations in various mesh sizes. The errors from their numerical solutions compared to the known solutions were measured in the $L^1$ norm and the $L^\infty$ norm. Our results suggest that the unfiltered schemes of order higher than $2$ are unstable while the $1^{\rm st}$ order and $2^{\rm nd}$ order unfiltered schemes remain stable. Moreover, we see that the $2^{\rm nd}$ order unfiltered scheme shows $2^{\rm nd}$ order accuracy. Similarly to the unfiltered schemes, we see that the $2^{\rm nd}$ order filtered scheme seems to show $2^{\rm nd}$ order accuracy. However, it turns out that the filtered schemes of order higher than $2$ only exhibit a $1^{\rm st}$ order convergence rate. Upon further investigation, this appears to be due to fact that the filtering relies too often on the $1^{\rm st}$ order scheme. Future work would include proving stability of the second order unfiltered scheme, and investigating techniques to improve the accuracy of the higher order filtered schemes.

Background ========== Liver cancer is one of the most common malignant tumors worldwide and the third leading cause of cancer-related death. Because of its high malignancy and fast progression, most patients with high-grade cancers have tumors that are unresectable. To date, no remedy has shown efficacy in these patients \[[@B1],[@B2]\]. It is important that we develop an efficient and safe drug for patients with liver cancer. The strategy of \"Cancer Targeting Gene-Viro-Therapy\" (CTGVT), was developed in 2001 \[[@B3]\] and has shown promise in the treatment of cancer. It combines the advantages of gene therapy and oncolytic viral therapy. Oncolytic adenoviruses can replicate themselves in cancer cells and lyse the carcinoma, but very inefficient in normal cells. Tumor suppressor genes can replicate together with oncolytic viral vectors, thereby greatly enhancing the ability to induce cancer cell death \[[@B4]\]. The advantage of this combination is to enable the oncolytic adenovirus to harbor antitumor genes, thereby facilitating them to specifically and efficiently kill cancer cells. Cancer Targeting Dual Gene-Viro-Therapy (CTGVT-DG) with a combination of two viruses carrying compensatory or synergetic genes has shown near eradication of tumors in nude mice \[[@B5]-[@B7]\]. Cancer Targeting Gene-Viro-Therapy Specific for Liver Cancer (CTGVT-LC) is a modification of CTGVT that can specifically target liver cancer. It is predicted that excellent antitumor drugs will arise from CTGVT and its modifications but are unlikely to result from gene or viral therapy alone \[[@B8]\]. Adenoviruses have been modified in various ways to improve their specificity in cancer cells. In such viruses, E1A, an early adenovirus gene, is controlled by cancer specific promoters, such as the survivin promoter \[[@B9]\], to regulate specific replication of adenoviruses. The CR2 domain of E1A (bp924- bp947) is known to interact with the Rb protein, repressing Rb activation and increasing the replication of the adenovirus. Deletion of this 24 bp domain results in the adenovirus selectively targeting various cancer cells with dysfunction of the Rb pathway \[[@B10],[@B11]\]. The E1B 55kDa gene has been deleted to form the cancer-specific adenovirus ONYX-015 \[[@B12]\]. It is now believed that E1B 55kDa functions as a result of late viral RNA export rather than p53 inactivation, as was previously believed \[[@B13]\]. Heat shock can cause phenocopy of E1B 55KDa late function in most cancer cells \[[@B14]\]. However, when an adenovirus is modified, its anti-tumor efficacy is usually reduced. The E1B 19kDa protein was deleted in previous studies to enhance the anti-tumor efficacy of an adenovirus, specifically its ability to inhibit cell apoptosis by blocking the function of the proapoptotic proteins Bax, Bak, p53 and TNF \[[@B15]\]. α-fetoprotein (AFP) is an established marker of liver cancer, and it is present at increased levels in the serum of approximately 75% of all liver cancer patients \[[@B16]\]. The high levels of AFP are an indication of the specific activity of the AFP promoter in liver cancer, and it may be used to improve the safety of gene therapy in AFP positive liver cancer cells. AFP promoter was used to control the anti-tumor gene cytosine deaminase and cytosine deaminase specially expressed in liver cancer cells \[[@B17]\]. The adenovirus with the key replicative gene E1A under the control of AFP promoter can specially replicate in AFP positive liver cancer cell lines \[[@B18],[@B19]\]. All this indicates that AFP promoter as a potential regulatory element in liver cancer therapy. HCCS1 was discovered as a liver cancer specific tumor suppressor gene that is frequently mutated in liver cancer \[[@B20],[@B21]\]. A previously constructed oncolytic adenovirus, ZD55-HCCS1, has been shown to elicit strong anti-tumor efficacy \[[@B22]\]. WPRE (Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element) is a cis-acting RNA element that is capable of increasing the expression of genes located upstream \[[@B23]\] and can be used in various kinds of vectors to promote gene expression \[[@B24]\]. In this study, we constructed a new oncolytic adenovirus vector by deleting 24 bp of E1A, as well as the genes encoding E1B 55kDa and E1B 19kDa. We also utilized a survivin promoter(denoted as SP) to control E1A, and named it as Ad.SP.E1A(Δ24).ΔE1B (also denoted Ad.SPDD). This quadruple-regulated adenovirus, Ad.SPDD, exhibited improved safety and enhanced efficacy compared with ZD55 (similar to ONYX-015), an adenovirus with an E1B 55kD deletion that was previously developed in our laboratory showing capacity to target cancer cells \[[@B4]-[@B7],[@B25],[@B26]\]. Moreover, this adenovirus with complete E1B deletion permits the insertion of large gene expression cassettes. To enhance both anti-tumor efficacy and specificity, the HCCS1 expression cassette AFP-HCCS1-WPRE-SV40 was introduced into the vector Ad.SP.E1A(Δ24).ΔE1B to produce Ad.(AFP-HCCS1-WPRE)SP.E1A(Δ24).ΔE1B (also denoted Ad.SPDD-HCCS1). Additionally, owing to the lack of a commercial primary antibody specific for HCCS1, another adenovirus, Ad.SPDD-HCCS1HA, in which HCCS1 is fused to an HA tag named HCCS1HA, was developed at the same time to detect the expression of the HCCS1 protein. Ad.SPDD-HCCS1 showed a potent anti-tumor effect specific for liver cancer in both in vitro and in vivo experiments, with induction of the mitochondrial apoptosis pathway as its underlying mechanism. Our CTGVT-LC strategy using Ad.SPDD-HCCS1 may be a promising therapy for selectively targeting liver cancer. Results ======= Liver cancer-specific transcriptional activity of the AFP promoter ------------------------------------------------------------------ The transcriptional activity of the commercialized SV40EAFP in different cell lines was detected using a luciferase reporter assay. In addition to being present in three normal cell lines, SV40EAFP activity was observed in four AFP positive and two AFP negative liver cancer cell lines. As shown in Figure [1A](#F1){ref-type="fig"}, the SV40EAFP promoter exhibited 33%-123% as high activity as the pGL3-control in the AFP positive cell lines Hep3B, Huh-6, HepG2 and Huh-7, whereas this activity was only 1%-4% as high in the AFP negative cell lines BEL7404 and SMMC7721, as well as in the normal cell lines MRC-5, QSG7701 and L-02. These results suggested that SV40EAFP was especially active in AFP positive liver cancer cell lines. {#F1} Virus construction and characterization --------------------------------------- The quadruple-regulated adenoviruses Ad.SPDD, Ad.SPDD-HCCS1, and Ad.SPDD-HCCS1HA were constructed as shown in Figure [1B](#F1){ref-type="fig"}. Virus identification utilizing PCR amplification and sequencing of the PCR products of E1A confirmed the insertion of the gene expression cassettes and the deletion of 24 bp of E1A, as well as that the virus stocks were free of wild-type adenovirus contamination (Additional file [1](#S1){ref-type="supplementary-material"}). Western blotting was also performed to detect adenovirus gene expression in Huh-7 cells (Figure [1C](#F1){ref-type="fig"}). All viruses expressed E1A, whereas all viruses except for the wild-type adenovirus (Ad.WT) failed to express E1B 19KDa and E1B 55KDa. Anti-HA antibody detection revealed the expression of HCCS1, which was observed only for Ad.SPDD-HCCS1HA. The HCCS1HA gene was expressed at particularly high levels in Huh-7 cells, as observed via the detection of HA tag-specific antibody expressed in Ad.SPDD-HCCS1HA-infected MRC-5 and Huh-7 cells (Additional file [2](#S2){ref-type="supplementary-material"}). Ad.SPDD exhibited less toxicity and an enhanced ability to lyse cancer cells than ZD55 -------------------------------------------------------------------------------------- The levels of E1A expressed by Ad.SPDD, ZD55, and Ad.WT in MRC-5 and Huh-7 cells were detected by western blot analysis. The expression of E1A by ZD55 and Ad.WT in MRC-5 cells was strong, although only traces of E1A were observed to be expressed by Ad.SPDD. However, there was no significant difference in E1A expression by Ad.SPDD, ZD55 and Ad.WT in Huh-7 cells, indicating that the survivin promoter can specifically control the expression of E1A by Ad.SPDD in cancer cells (Figure [2A](#F2){ref-type="fig"}). {#F2} The replicative ability of Ad.SPDD, ZD55, and Ad.WT in both normal and cancer cell lines was tested. Ad.SPDD replicated nearly as efficiently as ZD55 and Ad.WT in Huh-7 and Hep3B cells, but its replication was weaker in MRC-5 cells (Figure [2B](#F2){ref-type="fig"}, Additional file [3](#S3){ref-type="supplementary-material"}). In MRC-5 and Huh-7 cells, the adenovirus titer at 8 hours after infection was used as negative control, and it showed very low titer compared to the titer at 48 hours post infection (Figure [2C](#F2){ref-type="fig"}). A cell viability assay was performed to examine the cytotoxicity of Ad.SPDD and ZD55 on MRC-5 and Huh-7 cells. Ad.SPDD showed lower toxicity than did ZD55 on MRC-5 cells at an MOI of 50, whereas it exhibited higher cytotoxicity than ZD55 on Huh-7 cells at an MOI of 5 (Figure [2D](#F2){ref-type="fig"}). These results demonstrated the reduced toxicity and enhanced efficacy associated with the quadruple-regulated adenovirus Ad.SPDD compared with ZD55. Ad.SPDD-HCCS1 specifically targeted liver cancer in vitro --------------------------------------------------------- The cytotoxicity of the viruses against both normal and cancer cell lines was evaluated by a crystal violet staining assay and an MTT assay. As shown in Figure [3A](#F3){ref-type="fig"}, the cytopathic effects of Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA were equal to that of ZD55-HCCS1 in the AFP positive liver cancer cell lines Huh-7 and HepG2. The cytopathic effects were lower in the AFP-negative cancer cell lines 786-O, A549, and the normal cell line MRC-5, as expected. This finding suggests that Ad.SPDD-HCCS1 possesses a higher specificity for AFP positive liver cancer than does ZD55-HCCS1. Cell viability was measured either 4 days after viral infection at different MOIs (Figure [3B](#F3){ref-type="fig"}) or was detected each day till the 4th day after a viral infection at an MOI of 10 (Figure [3C](#F3){ref-type="fig"}). The Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA showed potent cytotoxicity against Huh-7 cells, similar to ZD55-HCCS1, and elicited time-dependent and dose-dependent effect. However, both the adenoviruses showed little cytotoxicity on MRC-5 cells. Notably, both in the crystal violet staining assay and the MTT assay, ZD55-HCCS1 damaged the normal cell line MRC-5 to some extent after infection at an MOI of 10, indicating a potential safety hazard with clinical use at high doses. However, Ad.SPDD-HCCS1 had no observable cytotoxic effect even at an MOI of 100. {#F3} Antitumor efficacy of Ad.SPDD-HCCS1 on tumor xenografts ------------------------------------------------------- In addition to its liver cancer-specific cytotoxicity in vitro, the antitumor efficacy of the new construct was also evaluated in vivo on Huh-7 tumor xenografts that had been established in nude mice. These tumors had a high degree of malignancy and grew rapidly. In the PBS group, most mice either had tumor sizes of more than 2000 mm^3^or died within 2 months. At the end of the experiment, only one nude mouse remained in the PBS group, and this mouse was very weak. However, the nude mice in the Ad.SPDD, Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA groups were all alive. The mean tumor volume of the Ad.SPDD, Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA groups was 835.93 mm^3^, 272.60 mm^3^and 436.99 mm^3^, respectively (Figures [4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}), indicating that our newly designed Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA constructs were able to strongly inhibit liver cancer growth. {#F4} To further determine whether the gene or virus can efficiently exist in the tumor tissue and induce tumor suppression, tumor sections from the Ad.SPDD-, Ad.SPDD-HCCS1- and Ad.SPDD-HCCS1HA-treated mice were stained with hematoxylin and eosin (H&E) and analyzed. As shown in Figure [4C](#F4){ref-type="fig"}, there were large necrotic regions in the tumor sections from Ad.SPDD-HCCS1- and Ad.SPDD-HCCS1HA-treated mice. Smaller necrotic areas were also observed in the tumor sections from Ad.SPDD-treated mice. We examined the expression of the adenovirus capsid protein hexon and HCCS1 (via an HA-tag-specific antibody) by immunohistochemical staining, and we found significant positive staining by hexon-specific antibody in the adenoviruses treated groups, but only Ad.SPDD-HCCS1HA infected tumor shows positive staining by HA tag-specific antibody (Figure [4C](#F4){ref-type="fig"}). Compared with the negative result in the PBS group, both the viral replication and HCCS1 expression in the tumor xenograft suggested that the efficacy of tumor suppression may have resulted from the function of both the virus and the expressed gene. Ad.SPDD-HCCS1 induced apoptosis of liver cancer cells both in vitro and in vivo ------------------------------------------------------------------------------- Because Ad.SPDD-HCCS1 effectively inhibited tumor growth, several assays were performed to investigate the underlying mechanism. As shown in Figure [5A](#F5){ref-type="fig"}, infection with Ad.SPDD-HCCS1 apparently caused nuclear fragmentation and chromatin condensation in the Huh-7 cells. When the virus-infected tumor cells were subjected to flow cytometric assay after Annexin V-FITC/PI staining, we found that the percentage of Annexin-V positive cells in the Ad.SPDD-HCCS1- or Ad.SPDD-HCCS1HA-infected cell samples was similar to that in the ZD55-HCCS1-infected cell sample, and all of these cell samples had a higher percentage of Annexin-V positive cells than the mock- and Ad.SPDD- infected cell samples (Figure [5B](#F5){ref-type="fig"}). In addition to this in vitro test, virus-treated tumor xenografts were sectioned and analyzed for apoptosis. TUNEL analysis revealed that Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA each elicited profound apoptosis in the tumors (Figure [5C](#F5){ref-type="fig"}), whereas no apoptosis was observed in sections from PBS-treated mice. Taken together, the results showed that the anti-tumor characteristics of the virus resulted partly from its induction of apoptosis. {#F5} Ad.SPDD-HCCS1 induced apoptosis of liver cancer cells via the mitochondrial/caspase-9/caspase-3 pathway ------------------------------------------------------------------------------------------------------- To further understand the mechanism by which Ad.SPDD-HCCS1 caused apoptosis of liver cancer cells, we evaluated the key apoptosis-related proteins caspase-3, caspase-8 and caspase-9. As shown in Figure [6A](#F6){ref-type="fig"}, the precursors of caspase-3 and caspase-9 were present in decreased amounts, indicating the activation of caspase-3 and caspase-9, 48 hours after viral infection of Huh-7 cells compared with before viral infection. Little difference in the amount of the caspase-8 precursor that was present was shown even 96 hours post virus treatment compared with before viral infection, indicating that the apoptosis induced by Ad.SPDD-HCCS1 may occur via the mitochondrial pathway. We further tested the changes in the mitochondrial membrane potential, Δψ~m~, of the virus-infected cells with a JC-1 probe. A marked increase in JC-1 monomers was found in Ad.SPDD-HCCS1- and Ad.SPDD-HCCS1HA- treated Huh-7 cells, indicating a drop in Δψm, but not in Ad.SPDD-infected Huh-7 cells (Figure [6B](#F6){ref-type="fig"}). These results suggested that Ad.SPDD-HCCS1 induced the apoptosis of liver cancer cells via the mitochondrial pathway. {#F6} Discussion ========== In this study, we successfully constructed a quadruple-regulated adenovirus named Ad.SPDD-HCCS1 with specificity for liver cancer cells. This adenovirus was generated with the following: the survivin promoter (SP) driving the E1A gene; the deletion of both of the Rb binding domains of E1A; the whole of E1B, including the genes encoding E1B-19K and E1B-55K; and the liver cancer-specific expression cassette AFP-HCCS1-WPRE-SV40, which was inserted upstream of E1A. Although a dual- or triple-regulated vector was studied in previous studies, to our knowledge no quadruple-regulated adenoviral vectors have previously been reported. It is well known that modifying an adenovirus to improve its specificity usually reduces the replication capacity of the adenovirus while lowering its antitumor efficacy. It is important to achieve an effective balance between safety and efficacy when designing an adenovirus to target liver cancer. The quadruple-regulated adenovirus Ad.SPDD satisfied both specificity and efficacy. It showed improved replication in cancer cells and enhanced antitumor effects on Huh-7 cells compared to ZD55, along with a much lower toxicity than ZD55 against the normal cell line MRC-5 according to the MTT assay. The reduced toxicity might result in a better safety profile in vivo. Moreover, the complete deletion of E1B in Ad.SPDD allowed space for the insertion of an expression cassette with large genes. The cytotoxicity and anti-tumor capacity of Ad.SPDD-HCCS1 were detected in vitro and in vivo, respectively; its anti-liver-cancer activity was as good as that of ZD55-HCCS1. More significantly, Ad.SPDD-HCCS1 exhibited decreased toxicity than ZD55-HCCS1, as shown by both a crystal violet staining assay and an MTT assay, suggesting that Ad.SPDD-HCCS1 is a significantly better construct than ZD55-HCCS1 for liver cancer targeting. In the Figure [3C](#F3){ref-type="fig"} it seems that the Ad.SPDD-HCCS1 and Ad.SPDD-HCCS1HA elicited similar effect as the Ad.SPDD, although indeed they showed significant difference, with the P value smaller than 0.001. However, in Figure [3B](#F3){ref-type="fig"}, Huh-7 cells infected with Ad.SPDD-HCCS1, Ad.SPDD-HCCS1HA at an MOI of 100 showed a lot of difference with Ad.SPDD. This is due to the dose-dependent effect of the adenoviruses, the HCCS1 gene carried by adenovirus exhibited its function in the condition of sufficient expression. The AFP promoter was used in this work to drive HCCS1 to improve its safety. As many patients with liver carcinoma have liver cirrhosis, but not normal liver, and some liver cirrhosis are AFP positive. Yao F et al. found that the percentage of AFP positive samples in patients with liver cirrhosis is smaller than that with liver cancer, and the AFP mRNA in samples of liver cirrhosis is lower than that of liver cancer \[[@B27]\]. This indicated the special AFP promoter activity in liver cancer cells, though with slight activity in cirrhosis. Otsuru A et al. found that in liver cirrhosis sections only a small number of cells showed positive hybridization by in situ hybridization analysis of AFP mRNA, but the majority of tumor cells showed positive hybridization \[[@B28]\]. This indicates that AFP promoter may be a specific anti-liver-cancer cell promoter, and combines it with other safety regulatory element will possibly improve its safety further. In the Ad.SPDD-HCCS1 or Ad.SPDD-HCCS1HA, there are two promoters, survivin promoter driving E1A and AFP promoter driving HCCS1 or HCCS1HA, in the adjacent region, it is possible that they may cis activate each other with the enhancers. However, in Ad.SPDD, the survivin promoter used is just 269 bp, a very short promoter, and it possesses essential sites for binding transcription factors \[[@B29]\]. It should not affect the AFP promoter. As to the enhancer on the AFP promoter\'s effect on survivin promoter, Figure [3B](#F3){ref-type="fig"} and [3C](#F3){ref-type="fig"} preclude this possibility. Ad.SPDD-HCCS1 or Ad.SPDD-HCCS1HA didn\'t show any enhanced cytoxicity on MRC-5 compared to Ad.SPDD. This indicated two issue, one is that HCCS1 is specially expressed in the Huh-7 cells, which is demonstrated by additional file [2](#S2){ref-type="supplementary-material"} and another one is that the AFP-HCCS1-SV40 cassette didn\'t enhance the cytotoxicity of the vector adenovirus Ad.SPDD, indicating that the survivin promoter activity is not elevated in MRC-5 by AFP promoter. In the hypothesis that the survivin promoter is enhanced by the AFP promoter, Ad.SPDD-HCCS1 or Ad.SPDD-HCCS1HA will show more cytoxicity on MRC-5 than Ad.SPDD due to the elevated replicative ability in MRC-5, but this is opposite to the shown results. Ad.SPDD-HCCS1 may specifically inhibit liver cancer in two ways. First, the adenovirus replicated in the liver cancer cells caused lysis. Second, the amplification of the tumor suppressor gene HCCS1 was accompanied by replication of the oncolytic adenoviral vector, while it also induced apoptosis through the mitochondrial/caspase-9/caspase-3 pathway. The mechanism by which Ad.SPDD-HCCS1 kills liver cancer cells was demonstrated to be mitochondria-triggered apoptosis. Despite detecting apoptosis both in vitro and in vivo, the level of ATP in the infected cells increased. This is not consistent with the phenomenon of apoptosis, in which the cellular ATP level decreases. It is known that, of the three main types of programmed cell death, only autophagy leads to an increase in cellular ATP levels. It has been reported that autophagy occurs in the progression of adenoviral infection of cells. Therefore, we proposed that autophagy might have contributed to the inhibitory effect of Ad.SPDD-HCCS1on liver cancer cells. To test this hypothesis, we co-infected Huh-7 cells with an LC3-EGFP plasmid and Ad.SPDD-HCCS1, but no punctate fluorescence was observed (data not shown). In addition, the apoptosis rate measured by the Annexin V-FITC/PI flow cytometric assay and the death rate measured by the MTT cell viability test were similar (approximately 30 percent). Thus, we cannot confirm the involvement of autophagy in this phenomenon, although we speculate that necrosis-like cell death, as reported by Abou El Hassan MA \[[@B30]\], may be occurring. Some non-classical programmed cell death phenomena may also have occurred as a result of viral replication and transgene expression. Because Ad.SPDD-HCCS1 treatment increased the total ATP level without altering the rate of cell death, it is possible that viral replication plays a role. Ad.SPDD-HCCS1 showed a potent and specific anti-liver cancer efficacy. As such, we believe that Ad.SPDD-HCCS1 could bee a promising candidate for the treatment of AFP positive liver cancer. Conclusions =========== Quadruple-regulated adenoviruses carrying an AFP promoter-controlled HCCS1 gene showed reduced toxicity and excellent anti-liver cancer efficacy in this study. The adenoviral vector Ad.SPDD had less toxicity and more efficacy than the previously constructed cancer-specific adenovirus ZD55. The gene-armed oncolytic adenovirus Ad.SPDD-HCCS1 exhibited liver-cancer specificity and observable anti-liver-cancer capacity both in vitro and in vivo. This work provides a feasibility study for generating effective cancer specificity and anti-cancer efficacy by using an adenoviral vector with a combination of modifications. Using the Ad.SPDD-HCCS1 construct seems to be a promising strategy for future clinical application in liver cancer therapy. Methods ======= Cell lines and cell culture --------------------------- The human liver cancer cell lines Huh-7 and Huh-6 were obtained from the RIKEN Cell Bank (Ibaraki, Japan). The human liver cancer cell lines HepG2, Hep3B and BEL7404; the human colorectal cancer cell line SW620; the human renal carcinoma cell line 786-O; the human normal liver cell lines L-02 and QSG-7701; and the human lung fibroblast cell line MRC-5 were purchased from the Cell Bank of the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). The human embryonic kidney 293 cell line (HEK293) was obtained from Microbix Biosystems Inc. (Toronto, Ontario, Canada). All cell lines were cultured according to the instructions of the corresponding providers. Luciferase Reporter Assay ------------------------- The pGL3-Basic and pGL3-Control reporter plasmids were purchased from Promega (Madison, WI), whereas the pCMV-β-gal normalization plasmid was obtained from Invitrogen (Carlsbad, CA). The AFP promoter with an SV40 enhancer, SV40EAFP, was purchased from Invivogen (San Diego, CA) and cloned into pGL3-Basic to form the reporter plasmid pGL3-SV40EAFP. Cells were seeded in 24-well plates at 80% confluence and transfected with reporter plasmids and pCMV-β-gal using Lipofectamine 2000 (Invitrogen). Cells were harvested 48 hours later, and the luciferase activity was detected using the Luciferase Assay System (Promega). Plasmid and virus construction ------------------------------ The adenoviral packaging vector pBHGE3 was obtained from Microbix Biosystem Inc. The adenoviral shuttle vectors pCA13Δ, pAd.surP-E1AΔ24, and pAd.AFP-E1A-ΔE1B had previously been constructed by our group pAd.surP-E1AΔ24 and pAd.AFP-E1A-ΔE1B were digested with EcoRI and XbaI, respectively, to obtain surP-E1AΔ24 and pAd. ΔE1B, respectively. These were ligated to form pAd.SP. ΔE1B. The promoters SV40EAFP and WPRE were inserted into pCA13Δ by using the restriction enzymes Sal I and BamHI, respectively. HCCS1 was amplified by PCR using forward (5\'-CGGGAATTCATGATGGAGGAGGAGGAA-3\') and reverse (5\'-TTAGGATCCCTCGAGCTACGTCCATCTCACCTG-3\') primers. HCCS1HA was amplified by PCR using forward (5\'-CGGGAATTCATGATGGAGGAGGAGGAA-3\') and reverse (5\'-TTACTCGAGTTATCAGGCGTAGTCGGGACGTCGTAGGGGTAC- GTCC ATCTCACCTGTTC -3\') primers, with ZD55-HCCS1 as the template. The PCR products were digested with EcoRI and XhoI and cloned into pCA13-AFP-WPRE to construct pCA13-HCCS1 and pCA13-HCCS1HA. The HCCS1 and HCCS1HA expression cassettes were released and introduced into pAd.SPDD to produce pAd.SPDD-HCCS1 and pAd.SPDD-HCCS1HA. The adenoviruses Ad.SPDD, Ad.SPDD-HCCS1 and Ad.SP.DD-HCCS1HA were generated by homologous recombination between the corresponding plasmid and pBHGE3 in the HEK293 cells, using the Effectene Transfection Reagent (Qiagen, Germany) as the transfection reagent. The viruses were amplified in HEK293 cells and purified by ultracentrifugation in a cesium chloride gradient. The titers of the viruses were measured in HEK293 cells. Adenovirus replication assay in vitro ------------------------------------- MRC-5, Huh-7 and Hep3B cells were seeded in 6-well plates at a density of 1 × 10^5^per well and infected with Ad.SPDD, ZD55 or wild-type adenovirus at an MOI of 10. The cells were washed with PBS 3 times 8 hours post-infection and fresh medium was added. All cells and the culture medium were collected 48 hours post-infection, and the adenoviruses were titered, after being released by three freeze-thaw cycles. MRC-5 and Huh-7 cells with the indicated adenoviruses infected for 8 hours were also collected after washing with PBS for 3 times, the cells were titered after three freeze-thaw cycles as a negative control to 48 hours\' infected cells. Western blot assay ------------------ Cells were treated with different agents at an MOI of 10 and harvested at the indicated times. Western blot analysis was carried out according to standard procedures. E1A-, caspase-3-, and actin-specific antibodies and secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Caspase-8- and caspase-9-specific antibodies were purchased from Cell Signaling Technology (Beverly, MA). The E1B 55kDa-specific antibody was purchased from Oncogene (Cambridge, MA), the E1B 19kDa-specific antibody was purchased from Calbiochem (San Diego, CA), and the Hexona-specific antibody was obtained from Millipore (Billerica, MA). Animal experiments ------------------ The animal experiments were conducted according to the U.S. Public Health Service Policy on Humane Care and the Use of Laboratory Animals. The experiments were also approved by the Institutional Animal Care and Use Committee. Four-week-old male BALB/c nude mice were purchased from the Shanghai Experimental Animal Center (Shanghai, China). A total of 8 × 10^6^Huh-7 cells was injected subcutaneously in the right rear back of each mouse to establish the xenograft tumor. When the tumor size reached 100-150 mm^3^, the mice were randomly divided into 4 groups and intratumorally injected with adenovirus (5 × 10^8^PFU per mouse each time) or PBS four times in the first 5 days, with no virus injected on the third day. Subsequently, the lengths and widths of the tumors were measured every four days. Tumor volume (mm^3^) was calculated as length × (width)^2^/2. Immunohistochemical analysis and TdT-mediated dUTP nick end labeling assays --------------------------------------------------------------------------- Tumor tissues were collected four days post-injection, fixed in 4% formaldehyde overnight, and embedded in paraffin. Subsequently, 5- μm-thick sections were cut and subjected to H&E staining, immunohistochemistry and TdT-mediated dUTP nick end labeling assay (TUNEL). The expression of hexon and HCCS1 with an HA Tag were detected separately using a goat anti-hexon (Chemicon) and a rabbit anti-HA (Santa Cruz) antibody, respectively. The immunohistochemistry assay was performed using the rabbit or goat SP (HRP) staining system (Westang Biotechnology, Shanghai, China). The TUNEL assay was performed according to the manufacturer\'s instructions (R&D systems). Cytotoxicity assay ------------------ For the crystal violet staining, the cells were infected with the various viruses at the indicated MOI. Four days later, the cells were stained with 2% crystal violet in 20% methanol for 1 h, then washed carefully and photographed. For the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay, cells infected with viruses at different MOI were cultured at 37°C for 4 d after infection, then 20 μl of MTT solution (Sigma) was added per well (5 mg/ml) and the cells were incubated at 37°C for 4 h. The supernatant was then removed, and 100 μl of 0.04 M HCl-isopropanol solution was added to each well. Cell viability was measured by absorbance at dual wavelengths (595 nm and 650 nm) using a Microplate Reader (Bio-Rad). The viability of cells infected with viruses at an MOI of 10 was detected in the same way on days 1 to 4. Hoechst33258 staining --------------------- Cells were infected with different viruses at an MOI of 10. Forty-eight hours later, the cells were fixed with 4% paraformaldehyde, stained with Hoechst33258 (Molecular Probes, Eugene, OR) at 1 μg/ml for 1 min, and then visualized with a microscope. Flow cytometric analysis ------------------------ Cells were infected with various viruses at an MOI of 10, and both adherent and suspended cells were collected 48 hours post-infection. Detection of apoptosis was performed following the manufacturer\'s instructions for the Annexin V-FITC Apoptosis Detection kit (BioVision). For analysis of the mitochondrial membrane potential, the collected cells were stained with the JC-1 fluorescent probe (Beyotime, Nantong, China) and analyzed using a FACSCalibur flow cytometer. Statistical analysis -------------------- All data were analyzed using Student\'s t test or a one-way analysis of variance (ANOVA) using the software R and subsequently shown as the mean+SD. The P value results are shown as P \< 0.05:\*, P \< 0.01:\*\*, or P \< 0.001:\*\*\* in the figures. A one-way ANOVA was performed using R software when there were more than two groups in the comparison analysis. The TukeyHSD command was also used to comparatively assess the P values between two independent groups. The survival curves were created in Sigma plot, and the P values were calculated using GraphPad Prism 5.0 using the log-rank test. List of abbreviations ===================== Ad.SPDD: Ad.SP.E1A(Δ24).ΔE1B; HCCS1: Hepatocellular carcinoma suppressor 1; CTGVT: Cancer Targeting Gene-Viro-Therapy; CTGVT-LC: Cancer Targeting Gene-Viro-Therapy Specific for Liver Cancer; AFP: α-fetoprotein; WPRE: Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element; TUNEL: TdT-mediated dUTP nick end labeling assay; and MTT: 3-(4, 5-dimethylthiazol-2-yl)-2; 5-diphenyl tetrazolium bromide. Competing interests =================== The authors declare that they have no competing interests. Authors\' contributions ======================= XHN, HWD and LXY designed and wrote the study. HWD and ZKJ constructed the plasmids. HWD, GJF, and SLY produced and identified the viruses. WN and LHG amplified and purified the viruses. XHN, HWD, CY, DM, and LXR performed the cytotoxic experiments. XHN, HWD, and CX did the animal experiments. XHN, HWD, and LXY performed the statistical analysis and data interpretation. All authors read and approved the manuscript. Supplementary Material ====================== ###### Additional file 1 **Identification of the viruses at the DNA level**. (A) Blast sequence results for the region covering the deleted 24 bp of E1A (B) Identification of the E1B region of the viruses in order to detect wild type adenovirus contamination, by PCR amplification assay. Ad.WT and ZD55 virus DNA were tested as positive controls. (C)-(E) PCR results of positions at which the HCCS1 gene cassette, HCCS1 gene and SV40EAFP promoter were inserted. pAd.SPDD-HCCS1HA was used as positive control. pAd.SPDD was tested as negative control. ###### Click here for file ###### Additional file 2 **HCCS1HA was specifically expressed in Huh-7 cells**. MRC-5 and Huh-7 cells were infected with Ad.SPDD-HCCS1HA at an MOI of 10. The cells were collected for western blot 48 hours post infection. An anti-HA antibody was used to detect the expression of HCCS1HA. Actin was used as a loading control. ###### Click here for file ###### Additional file 3 **Ad.SPDD, ZD55, and Ad.WT exhibit similar replicative ability in Hep3B cells**. Hep3B cells were infected with Ad.SPDD, ZD55, or Ad.WT at an MOI of 10. The adenoviral titers were measured 48 hours post infection. (NS: not significant, p \> 0.05) ###### Click here for file Acknowledgements ================ The authors declare no conflict of interests related to this study. We thank Drs. Zhengxuan Shen and Youcheng Xu for valuable suggestions regarding the manuscript and the staff at the Cell Analysis Center of the Institute of Biochemistry and Cell Biology for professional and technical assistance. This work was supported by grants from the National Nature Science Foundation of China (No. 30623003), the National Basic Research Program of China (973 Program) (No. 2010CB529901), the Important National Science & Technology Specific Project of the Hepatitis and Hepatoma Related Program (2008ZX10002-023), and the National Basic Research Committee of Science and Technology (Nos. 06ZR14072 and 074119508).

Introduction {#Sec1} ============ Pancreatic cancer remains one of the deadliest cancer types. In 2018, there were an estimated 458,918 new cases of pancreatic cancer, and 432,242 deaths as a result of pancreatic cancer in 185 countries worldwide^[@CR1],[@CR2]^. Pancreatic cancer is predicted to become the second leading cause of cancer death after lung cancer, within the next decade in Western countries^[@CR3]^. At present, the only curative treatment for patients with pancreatic cancer is surgery. However, only a minority of patients are eligible for resection and disease recurrence is a frequent event in many such patients. Historically, gemcitabine-based therapy has been the mainstay for treatment of pancreatic cancer^[@CR4]^. More recently the combination of gemcitabine plus capecitabine has been regarded as the new standard of care in the adjuvant setting^[@CR5]^. Patients with metastatic disease are treated with either FOLFIRINOX or gemcitabine plus nab-paclitaxel as first-line in patients with good performance status^[@CR6],[@CR7]^. In order to reduce the dismal pancreatic cancer mortality rates, it is essential to discover novel biomarkers for use in the early detection of pancreatic cancer, to discover novel therapeutic targets and to develop novel and more effective therapeutic agents^[@CR8],[@CR9]^. Monoclonal antibodies (mAbs) are excellent tools for the discovery of novel overexpressed cell surface antigens and their specific targeting for diagnostic and therapeutic purposes^[@CR10],[@CR11]^. To date, 36 mAbs have been approved for cancer treatment in the U.S. and/or European Union, although none for pancreatic cancer yet^[@CR12],[@CR13]^. As tumour heterogeneity has been reported both between (i.e. inter-tumour heterogeneity) and within tumours (i.e. intra-tumour heterogeneity) in patients with pancreatic cancer, and between primary tumours and their metastatic counterparts, it has not been possible to find a magic and universal drug for the treatment of such patients^[@CR14],[@CR15]^. As a result, over the past few years, our work has been focused on the discovery of overexpressed cell surface antigens in human pancreatic cancer using a panel of pancreatic cancer cell lines derived from patients at different stages of their disease as the source of tumour immunogen and in the antibody screening and the study of such mAbs for use in cancer diagnosis and therapy. We reported recently the development of two novel antibodies against an antigen with high level of expression in pancreatic cancer (i.e. CD109) using the human pancreatic cancer cell line BxPC-3 (derived from a primary tumour) as the source of tumour immunogen^[@CR9],[@CR16]^. BxPC-3 is a moderate to poorly differentiated cell line derived from a 61-year-old Caucasian female with a primary body of pancreas adenocarcinoma in whom no metastatic disease was found and who died 6 months later despite chemotherapy and radiation^[@CR16]^. Here, we report the development of two novel mouse mAbs using CFPAC-1, a cancer cell line established from liver metastasis of a patient with pancreatic cancer, as the source of tumour immunogen^[@CR17]^. As there is no complete concordance between the expression level of some genes and their protein products in the primary pancreatic cancer and the corresponding metastatic lesions, our strategy was to develop other antibodies against antigens with high levels of expression in the primary and/or metastatic pancreatic cancer using both the primary and metastatic pancreatic cancer cell lines as immunogen^[@CR18]--[@CR21]^. Indeed, some of the immunogenic antigens may only be overexpressed in the primary tumour cells (i.e. BxPC-3) and not the metastatic pancreatic tumour cells and vice versa. Using a panel of human pancreatic cancer cell lines established from patients at different stages of their diseases and tumour tissue arrays from patients with pancreatic cancer, we found that the overexpressed target antigens recognised by these two novel antibodies are integrin α3 and CD26. Thus, in addition to their diagnostic and therapeutic potential, these antibodies will be valuable tools for unravelling the role of integrin α3 and CD26 in the progression and complex biology of pancreatic cancer Results {#Sec2} ======= Development of two novel mouse mAbs KU44.22B and KU44.13A {#Sec3} --------------------------------------------------------- A panel of hybridomas was generated by fusing lymphocytes from mice immunised with CFPAC-1 human pancreatic cancer cells and SP2 myeloma cells. Flow cytometry and ELISA revealed that the antigen recognised by mAb KU44.22B was widely expressed across pancreatic and other cancer cell lines, particularly in the human pancreatic cancer cells BxPC-3 (MFI = 357), CFPAC-1 (MFI = 283), AsPC-1 (MFI = 265) and Capan-2 (MFI = 107), as well as the ovarian cancer cell lines SKOV-3 (MFI = 687) and CaOV-3 (MFI = 836), the glioblastoma cell line A172 (MFI = 466) and the head and neck cancer cell line HN-5 (MFI = 118; Fig. [1](#Fig1){ref-type="fig"} and Supplementary Figs. [1](#MOESM1){ref-type="media"} and [2](#MOESM1){ref-type="media"}). On the other hand, mAb KU44.13A recognised an antigen with overexpression limited to AsPC-1 human pancreatic cancer cells (MFI = 437) and to a lower extent HPAF-II (MFI = 48) and the ovarian cell line SKOV-3 (MFI = 38; Fig. [1](#Fig1){ref-type="fig"} and Supplementary Figs. [1](#MOESM1){ref-type="media"} and [2](#MOESM1){ref-type="media"}). While in the ELISA, cancer cell monolayers were treated with the primary antibodies, for flow cytometry tumour cells were treated with trypsin prior to incubation with the primary antibody. As the results of ELISA show, the highest levels of target antigen recognised by mAb KU44.13A were found in human pancreatic cancer cell lines derived from ascites (i.e. AsPC-1 and HPAF-II) and lymph node metastasis (Supplementary Fig. [1](#MOESM1){ref-type="media"}). Using the mouse isotyping kits, novel mAbs KU44.22B and KU44.13A were found to be of IgG1κ and IgG2a isotypes respectively (data not shown).Figure 1Expression level of the antigens recognised by novel mAbs KU44.22B and KU44.13A on human pancreatic and other cancer cell lines determined by flow cytometry. The two novel mAbs KU44.22B and KU44.13A are directed against integrin α3 and CD26 respectively {#Sec4} ----------------------------------------------------------------------------------------------- The results of SDS-PAGE stained gels showed that mAb KU44.22B immunoprecipitated a 140 KDa protein identified as integrin α3 by mass spectrometry whereas mAb KU44.13A immunoprecipitated a protein of approximately 110 kDa corresponding to CD26 from the lysates of CaOV3 and ASPC-1 cells respectively (Fig. [2A,B](#Fig2){ref-type="fig"} left panel, and Table [1](#Tab1){ref-type="table"}, full-length gels are presented in Supplementary Fig. [3](#MOESM1){ref-type="media"}). In addition, using the lysis buffer described in methods, mAb KU44.22B precipitated a protein of approximately 260 kDa that could not be identified by mass spectrometry (Fig. [2A](#Fig2){ref-type="fig"}, left panel). However, using RIPA lysis buffer, this additional protein was not immunoprecipitated by mAb KU44.22B (Supplementary Fig. [3C](#MOESM1){ref-type="media"}). The faint protein band of \~65 KDa in the antibody samples and controls yielded a single peptide which matched to serum albumin. Neither of the two novel mAbs were able to detect the target antigens by Western blot (Fig. [2A,B](#Fig2){ref-type="fig"}, middle panel). To confirm the identity of the target antigens, immunoprecipitation with the novel mAbs and the anti-integrin α3 and anti-CD26 commercial antibodies, followed by immunodetection by Western blot with the same commercial antibodies was performed. As shown in Fig. [2A,B](#Fig2){ref-type="fig"}, right panel, both antigens were immunodetected with the commercial mAbs.Figure 2Immunoprecipitation and immunodetection by Western blot of (**A**) integrin α3 and (**B**) CD26 antigen with novel mAbs KU44.22B and KU44.13A using lysates from CaOV-3 ovarian cancer cells and AsPC-1 pancreatic cancer cells respectively. *Left panel:* Immunoprecipitation was performed with novel mAbs (**A**) KU44.22B and (**B**) KU44.13A (5 µg) using sheep anti-mouse dynabeads. Protein bands around \~140 KDa and \~ 260KDa were immunoprecipitated with mAb KU44.22B (A; left panel) and \~110 KDa by mAb KU44.13A (B; left panel) respectively and stained with SimplyBlue™ SafeStain. The \~50/25 KDa bands represent heavy and light chains of the anti-mouse antibody. \*(**B**) left panel corresponds to a cropped gel; vertically sliced images of juxtaposed lanes that were non-adjacent in the gel have a clear separation delineating the boundary between the gels. *Middle panel:* Integrin α3 and CD26 antigen were immunoprecipitated with mAbs (**A**) KU44.22B and (**B**) KU44.13A (5 µg) respectively, and probed with the same antibody (30 µg/ml). Target antigens were not immunodetected with either of the mAbs. *Right panel:* Integrin α3 and CD26 antigen were immunoprecipitated with mAbs (**A**) KU44.22B and (**B**) KU44.13A respectively (5 µg) or commercial anti-integrin α3 and anti-CD26 antibodies (2 µg) and immunodetected with commercial mAbs sc-374242 and ab89398 as described in Methods. Immunodetection of target antigens immunoprecipitated by novel mAbs and probed with commercial mAbs confirmed the target identity. MW: molecular weight marker.Table 1Identification of proteins recognised by novel mAbs KU44.13A and KU44.22B by mass spectrometry.Band No.mAbProtein Hits\ Matches/Sequences1KU44.13AP27487 Dipeptidyl peptidase 4/CD26 OS = Homo sapiens GN = DPP4 PE = 1 SV = 2Mass: 88907 Score: 198 Matches: 5(5) Sequences: 3(3)*[Start-End]{.ul}[Score]{.ul}[Peptide]{.ul}*176--18435K.IEPNLPSYR.I598--61189R.LGTFEVEDQIEAAR.Q659--66973R.WEYYDSVYTER.Y2KU44.22BP26006 Integrin alpha-3 OS = Homo sapiens GN = ITGA3 PE = 1 SV = 5Mass: 117735 Score: 245 Matches: 4(4) Sequences: 4(4)*[Start-End]{.ul}[Score]{.ul}[Peptide]{.ul}*44--60107K.EAGNPGSLFGYSVALHR.Q68--7646R.YLLLAGAPR.E144--15667R.YTQVLWSGSEDQR.R462--47127R.ARPVINIVHK.T MAb KU44.22B inhibits the growth *in vitro* of Capan-2 cancer cells, increases migration of BxPC-3 and CFPAC-1 cancer cell lines and induces receptor downregulation and internalisation {#Sec5} ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- We investigated the effect of treatment with these two novel antibodies on the growth and migration *in vitro* of a panel of human pancreatic and other cancer cell lines. At 300 nM, mAb KU44.22B inhibited the growth of Capan-2 human pancreatic cancer cells by 94% with an IC50 value of 4.5 nM (Fig. [3](#Fig3){ref-type="fig"}) whereas it inhibited the growth of CFPAC-1 cells by 20% (data not shown). Interestingly, treatment with this mAb did not have any effect on the growth of the other cell lines tested including the ovarian cancer cell lines SKOV-3 and CaOV-3, and the glioblastoma cell line A172, despite having higher levels of integrin α3 cell surface expression than Capan-2 cells (data not shown). On the other hand, treatment with mAb KU44.22B increased migration of BxPC-3 and to a lesser extent CFPAC-1 cancer cells (Fig. [4](#Fig4){ref-type="fig"}) and induced-receptor downregulation and internalisation (Fig. [5](#Fig5){ref-type="fig"}). In contrast, treatment with mAb KU44.13A did not have any effect on the growth or migration of any of the cell lines tested and did not induce receptor downregulation (data not shown, and Fig. [5](#Fig5){ref-type="fig"}).Figure 3Effect of novel mAb KU44.22B on the growth of Capan-2 human pancreatic cancer cells determined by SRB assay as described in Methods. Novel mAb KU44.22B inhibits the growth of Capan-2 human pancreatic cancer cells with IC50 = 4.5 nM.Figure 4Effect of novel mAbs KU44.22B and KU44.13A on the migration of BxPC-3 and CFPAC-1 human pancreatic cancer cells using the IncuCyte ZOOM® Live-Cell Imaging instrument (Essen Bioscience, UK) as described in Methods. Treatment with mAb KU44.22B (300 nM) significatively increases the migration of BxPC-3 and CFPAC-1 cells.Figure 5Internalisation studies of novel mAbs KU44.22B and KU44.13A in BxPC-3 and AsPC-1 human pancreatic cancer cells determined by (**A**,**B**) Immunofluorescence, BxPC-3 and AsPC-1 cancer cells were grown to near confluency and incubated with purified mAbs KU44.22B and KU44.13A respectively (50 μg/ml) or control (PBS/1% BSA) at 4 °C for 1 h and subsequently at 37 °C for extra 30 min to allow internalisation. Cells were then fixed, permeabilised and incubated with anti-mouse secondary antibody (Alexa Fluor 488; 1:200) at 4 °C for 1 h for detection using Nikon eclipse i80 microscope; and (**C**,**D**) ELISA, BxPC-3 and AsPC-1 cancer cells were grown to near confluency 96-well plates and incubated with purified mAbs KU44.22B and KU44.13A respectively (50 μg/ml) or control (PBS/1% BSA) at 4 °C for 1 h and subsequently at 37 °C for extra 30 min to allow internalisation. Cells were then fixed, permeabilised and incubated with HRP-conjugated rabbit anti-mouse (1:1000, STAR13B, AbD Serotec) and the absorbance of each sample measured at 450 nm. Immunohistochemical detection of the antigen recognised by novel mAbs KU44.22B and KU44.13A {#Sec6} ------------------------------------------------------------------------------------------- To explore the diagnostic potential of the novel mAbs, immunohistochemical staining was performed in Capan-2 (mAb KU44.22B) and AsPC-1 (mAb KU44.13A) tumour cell pellets. The results showed that both mAbs were able to immunodetect the target antigens in formalin-fixed paraffin-embedded tumour sections (Figs. [6](#Fig6){ref-type="fig"} and [7](#Fig7){ref-type="fig"}).Figure 6Examples of immunohistochemical staining of formalin-fixed, paraffin-embedded Capan-2 cancer cell pellets (**A-B**) and human pancreatic tissue microarrays (**C--F**) using novel mAb KU44.22B (15 μg/ml). Staining was performed as described in Methods section. (**A**) Negative control; (**B**) Staining of Capan-2 cells with mAb KU44.22B; (**C**) 2/3 + membrane, 2 + cytoplasm (C7); **(D**) 2 + membrane (B5); (**E**) 2 + membrane, 1 + cytoplasm (C3); (**F**) Normal pancreas tissue (F3); magnification 200×.Figure 7Examples of immunohistochemical staining of formalin-fixed, paraffin-embedded AsPC-1 cancer cell pellets (**A-B**) and human pancreatic tissue microarrays (**C--F**) using novel mAb KU44.13A (10 μg/ml). Staining was performed as described in Methods section. (**A**) Negative control; (**B)** Staining of AsPC-1 cells with mAb KU44.13A; (**C**) 2 + membrane, 1 + cytoplasm (C3); (**D**) 1 + membrane/cytoplasm (B3); (**E**) 2 + cytoplasm/membrane (D4); (**F**) Normal pancreas tissue (F8); magnification 200×. Then, we examined the relative expression of integrin α3 and CD26 (immunodetected by mAbs KU44.22B and KU44.13A respectively) in tissue arrays containing 48 specimens from patients with pancreatic cancer. Of these, three samples contained no tumour in the integrin α3 slide and 14 in the CD26 slide and therefore were excluded from the study. Of 45 cases, 64% of tissue samples were integrin α3 positive, with intensity ranging from 1 + weak (n = 17, 37.8%) to 2+ moderate (n = 12, 26.6%). Staining predominated in the membrane and/or the cytoplasm of cancer cells and did not correlate with the disease grade (Fig. [6C--E](#Fig6){ref-type="fig"}; Supplementary Table [1](#MOESM1){ref-type="media"}). In contrast, normal pancreatic tissue was negative or showed only weak cytoplasmic diffuse staining (Fig. [6F](#Fig6){ref-type="fig"}). On the other hand, of 34 cases, CD26 was overexpressed in 64% of samples, with intensity 1 + weak (n = 16, 47.6%) to 2 + moderate (n = 6, 17.7%; Fig. [7C--E](#Fig7){ref-type="fig"}; Supplementary Table [2](#MOESM1){ref-type="media"}). Similarly, there was no correlation with tumour grading and weak cytoplasmic staining was seen in normal pancreatic tissue (Fig. [7F](#Fig7){ref-type="fig"}). Discussion {#Sec7} ========== Pancreatic cancer is a highly aggressive and devastating cancer type, responsible for an increasing number of cancer related incidence and deaths^[@CR1],[@CR2],[@CR22]^. The complex biology of pancreatic cancer and its microenvironment, the unavailability of reliable biomarkers for its early detection, the non-specific clinical presentation and the primary and secondary resistance to current therapeutic interventions are some of the attributing factors. Therefore, to improve the poor outcomes for patients diagnosed with pancreatic cancer, it is imperative to develop a screening technique for its early diagnosis, to discover novel therapeutic targets and to develop more effective and less toxic therapeutic agents. Monoclonal antibodies are excellent agents for use in both diagnosis and therapy of human cancer. The exquisite specificity of the antibodies for the target antigen also makes them ideal tools for investigating the biological, diagnostic, prognostic and predictive value of their target antigens and for use in targeted therapy of human cancers^[@CR10],[@CR11],[@CR23],[@CR24]^. We have previously reported the generation of two novel anti-CD109 mAbs by means of hybridoma technology using BxPC-3 human pancreatic cancer cells, a cell line derived from a primary tumour, as the source of immunogen^[@CR9]^. However, human cancers are heterogeneous in nature, a characteristic feature which contributes to the response of short duration or development of resistance to current therapies^[@CR21]^. Both inter-tumour heterogeneity (i.e. heterogeneity between individuals), and intra-tumour heterogeneity (i.e. heterogeneity within the same tumour) as well as heterogeneity between the primary tumour and its metastatic counterparts have been reported in pancreatic cancer^[@CR14],[@CR15],[@CR19]^. Here, using the human pancreatic cancer cell line CFPAC-1, which was isolated from a patient with liver metastasis, we describe the production and characterisation of two other novel mAbs. We have shown that these two novel antibodies are directed against integrin α3 (KU44.22B) and CD26 (KU44.13A). We found overexpression of the target antigen integrin α3 recognised by the novel mAb KU44.22B in several human pancreatic cancer cell lines as well as human glioblastoma, ovarian and head and neck cancer cell lines as determined by ELISA and flow cytometry (Fig. [1](#Fig1){ref-type="fig"} and Supplementary Figs. [1](#MOESM1){ref-type="media"} and [2](#MOESM1){ref-type="media"}). This mAb inhibited the growth *in vitro* of Capan-2 cells (Fig. [3](#Fig3){ref-type="fig"}), increased migration of BxPC-3 and CFPAC-1 cells (Fig. [4](#Fig4){ref-type="fig"}) and induced receptor downregulation and internalisation (Fig. [5](#Fig5){ref-type="fig"}). While mAb KU44.22B was not able to recognise integrin α3 by Western blot, it proved useful for the immunohistochemical detection of the target antigen in formalin-fixed paraffin-embedded tissue sections from cancer cell pellets and tissue microarrays (Figs. [2](#Fig2){ref-type="fig"} and [6](#Fig6){ref-type="fig"}). Integrins are a family of heterodimeric (αβ) cell surface receptors that participate in cell-cell and cell-matrix interactions^[@CR25]^. Their 18 α and 8 β subunits associate in different combinations and form at least 24 heterodimers with functional and tissue specificity^[@CR26]^. Of these, integrin α3 (also known as ITGA3, CD49c, and VLA-3 subunit alpha) is a 140 KDa protein thought to be involved in the hepatocyte growth factor (HGF)/c-Met signal pathway contributing to tumour progression^[@CR27]^. The integrin α3 subunit is believed to join a β1 subunit to form a complex that interacts with extracellular matrix proteins including members of the laminin family^[@CR28]^. To our knowledge, this is the first report of anti-tumour activity *in vitro* of an anti-integrin α3 antibody in pancreatic cancer. At 300 nM, mAb KU44.22B inhibited the growth of Capan-2 cells by 94% and with an IC50 value of 4.5 nM (Fig. [3](#Fig3){ref-type="fig"}). However, as our hybridomas were grown in medium containing 3% FBS. it may be possible that the mouse antibodies purified on Protein G affinity column contain low level of calf antibodies. If this is the case, the actual IC50 value of mAb KU44.22B in Capan-2 cells could be even lower than 4.5 nM. The adaptation of the mouse hybridoma grown in serum-free medium or the purification of the mouse hybridoma supernatants using anti-mouse IgG affinity column could help increase the purity of the antibodies by eliminating potential contaminant calf antibodies. In another study, a mouse mAb (BCMab1), which was raised against aberrantly glycosylated integrin α3β1 on the human bladder cancer cell line T24, was accompanied by potent antitumor activity in subcutaneous and orthotopic bladder cancer mouse models^[@CR29]^. Interestingly, we found that the anti-tumour activity of mAb KU44.22B was limited only to Capan-2 cells despite the high level of expression of its target antigen in other cancer cell lines (Fig. [1](#Fig1){ref-type="fig"}), which suggests that Capan-2 cell line is more dependent on integrin α3 for survival than any of the other cell lines examined. Further studies should be conducted to unravel the biological mechanisms that determine response to treatment with anti-integrin α3 mAb KU44.22B and to develop and investigate the therapeutic potential of the humanised version of this antibody in tumours with high levels of anti-integrin α3 *in vivo*. Since Capan-2 is a non-migratory pancreatic cell line, the effect mAb KU44.22B on its migration could not be explored. However, treatment of BxPC-3 and CFPAC-1 cells with KU44.22B was accompanied by an increase in the migration of these tumour cells *in vitro* (Fig. [4](#Fig4){ref-type="fig"}). Indeed, integrin α3 has been reported to have both pro-migratory and anti-migratory effects in different tumour types. For example, depletion of integrin α3 was reported to increase the migration of prostate cancer cell lines and has been correlated with the disease grade and stage in prostate cancer^[@CR30]^. Similarly, low integrin α3 expression was found to be associated with increased metastasis of certain colon cancers^[@CR31]^. In contrast, in other studies integrin α3 was reported to have opposite effect by being overexpressed in glioma stem-like cells and contributing to the invasive nature of such cells^[@CR32],[@CR33]^. ITGA3 (the protein coding gene for integrin α3) was found to be significantly associated with higher risk of recurrence and lower DFS in patients with colorectal tumours^[@CR34]^ and shorter survival in pancreatic cancer^[@CR35]^. High levels of ITGA3 correlate with more aggressive phenotypes and poor prognosis in patients with colorectal cancer and pancreatic ductal adenocarcinoma^[@CR36],[@CR27]^. More recently, in another study overexpression of ITGA3 has been associated with a poor prognosis in patients with pancreatic cancer and ablation of ITGA3 was reported to be accompanied by a significant decrease in the EGFR expression and tumour growth^[@CR37]^. ITGA3 expression may therefore be a biomarker of diagnostic and prognostic values in pancreatic cancer^[@CR38]^. Our study here demonstrated integrin α3 overexpression in a wide TMA from pancreatic cancer patients by IHC with weak staining of normal pancreatic tissue (Fig. [6](#Fig6){ref-type="fig"}). Further studies with mAb KU44.22B are warranted and should help to determine the expression pattern, prognostic significance and predictive value of integrin α3 in patients with pancreatic cancer and other forms of cancer. This antibody is also an excellent tool in helping us understand the complex role of integrin α3 in tumour biology and its potential as target for therapy with monoclonal antibody-based drugs and other forms of therapeutics^[@CR26]^. Using immunoprecipitation followed by mass spectrometry, we found that the antigen recognised by the second mAb KU44.13A is CD26. Of the cell lines examined, CD26 overexpression was found to be limited to those derived from ascites specifically AsPC-1 pancreatic cells and to a lower extent HPAF-II pancreatic cancer cells and SKOV-3 ovarian cancer cells (Fig. [1](#Fig1){ref-type="fig"} and Supplementary Figs. [1](#MOESM1){ref-type="media"} and [2](#MOESM1){ref-type="media"}). Treatment with anti-CD26 mAb KU44.13A did not have any effect on cell proliferation, migration or receptor downregulation on the cell lines tested (data not shown and Fig. [5](#Fig5){ref-type="fig"}). While this mAb was not able to detect CD26 by Western blot, it was capable of detecting CD26 by immunohistochemistry in formalin-fixed paraffin-embedded tissue sections (Figs. [2](#Fig2){ref-type="fig"} and [7](#Fig7){ref-type="fig"}). CD26 (also known as Dipeptidyl peptidase-4 \[DPP4/DPPIV\] or ADCP2) is a 110 KDa membrane-associated peptidase. It is expressed in endothelial cells, fibroblasts and lymphocytes, on the apical surfaces of epithelial and acinar cells, and in a soluble form in plasma^[@CR39]^. It is believed to play a role in tumour development through its association with intracellular proteins and its effect seems to be dependent on the tumour type and its microenvironment^[@CR40]^. While CD26 has been shown to have a tumour suppressor effect in melanoma, ovarian cancer, non-small cell lung cancer, prostate cancer, endometrial cancer, neuroblastoma and glioma cell lines, it has been reported to be a marker of tumour aggressiveness in T-anaplastic large cell lymphoma, T-leukaemia, malignant mesothelioma, colorectal cancer and Ewing sarcoma cell lines^[@CR40],[@CR41]^. Furthermore, CD26 has been reported to have higher levels of expression in pancreatic cancer tissue than in normal tissue and knockdown of CD26 expression inhibited cell growth, migration, invasion and colony formation, increases cell apoptosis of pancreatic cancer cells *in vitro* and decreased tumour growth and liver metastasis *in vivo*^[@CR42]^. CD26 has been reported to be secreted in the serum of patients with different cancer types and therefore it has been proposed as a potential tumour biomarker of diagnostic and prognostic value in a wide range of cancers including pancreatic cancer^[@CR40]--[@CR42]^. CD26 has also been suggested as a cancer stem cell marker in different types of cancer and a potential therapeutic target^[@CR43]--[@CR45]^. Although our anti-CD26 novel mAb KU44.13A did not show any effect on cell proliferation or migration on the panel of cell lines evaluated in this study, treatment with other anti-CD26 monoclonal antibodies have shown to reduce tumour growth *in vitro* and *in vivo* and improve survival in malignant mesothelioma, renal cell carcinoma and anaplastic large cell T-cell lymphoma^[@CR46]--[@CR49]^. We found moderate membranous and/or cytoplasmic staining of human pancreatic cancer tissue microarrays and cell pellets with anti-CD26 mAb KU44.13A (Fig. [7](#Fig7){ref-type="fig"}). Although there is no published research on the immunohistochemical staining of CD26 in pancreatic cancer, it has been shown that stromal CD26 expression following preoperative chemoradiotherapy has significant association with tumour recurrence and poor prognosis in patients with rectal cancer^[@CR50]^. A positive association was also reported between high CD26 expression and tumour stage, development of metastasis and poor outcome in patients with colorectal cancer^[@CR51]^. Finally, the results of a recent phase 1 clinical trial of the humanised anti-CD26 mAb YS110 in patients with mesothelioma, renal cell carcinoma and urothelial carcinoma CD26-expressing tumours showed a favourable safety profile and encouraged disease stabilisation in a subset of patients^[@CR52]^. Further studies with our novel mAb KU44.13A in a larger panel of patients' tumour specimens are warranted and should unravel the relative expression, prognostic significance and predictive value of CD26 in patients with pancreatic cancer as well as other cancer types. In conclusion, in this study, we reported the production of two novel monoclonal antibodies against integrin α3 and CD26 on human pancreatic cancer cells, using the liver metastasis pancreatic cancer cell line CFPAC-1 as immunogen. These antibodies would be excellent tools for investigating the diagnostic, prognostic and predictive value of such antigens in pancreatic cancer, and studying their roles in the complex biology of pancreatic cancer and other cancer types. Further investigation are warranted to determine the therapeutic potential of these mAbs, particularly the conjugated and/or humanised versions with more effector ADCC (antibody-dependent cell-mediated cytotoxicity) and/or CDC (complement-dependent cytotoxicity) functions, for use in antibody-based targeted therapy of tumours with overexpression of these antigens^[@CR53],[@CR54]^. Methods {#Sec8} ======= Cancer cell lines and cell culture {#Sec9} ---------------------------------- A panel of ten human pancreatic cancer cell lines (BxPC-3 \[RRID:CVCL_0186\], Capan-2 \[RRID:CVCL_0026\], MIA PaCa-2 \[RRID:CVCL_0428\], PANC-1 \[RRID:CVCL_0480\], AsPC-1 \[RRID:CVCL_0152\], HPAF-II \[RRID:CVCL_0313\], CFPAC-1 \[RRID:CVCL_1119\], Capan-1, Hs766T \[RRID:CVCL_0334\] and FA-6) were used in this study and cultured as described previously^[@CR9],[@CR55]^. SP2 myeloma cells (RRID:CVCL_2199) were purchased from European Collection of Cell Cultures (ECACC, UK). HN5 (head and neck cancer cells), SKOV-3 and CaOV-3 (ovarian cancer cells), DiFi (colorectal cancer cells), A172 (glioblastoma cells) and SP2 myeloma cells were grown in Dulbecco's Modified Eagle's Medium supplemented with 10% FBS and antibiotics. All culture media and additives were purchased from Sigma Aldrich, UK. MIA PaCa-2, PANC-1, and Capan-1 were authenticated by American Type Culture Collection (ATCC, UK). Generation and screening of novel monoclonal antibodies {#Sec10} ------------------------------------------------------- The mice immunisation was performed at St George's University of London, following ethical approval and under Home Office animal license as described previously^[@CR9]^. All experiments were performed in accordance with relevant guidelines and regulations. A group of female BALB/c mice (aged 5--6 weeks) were immunised subcutaneously (s.c) at two sites and intraperitoneally (i.p.) with a total number of 10 million CFPAC-1 human pancreatic cancer cells per immunisation per mouse (3 sites; 100 μl per site). Immunisation was repeated 2 times every 2 weeks and the final injection was administered 3--4 days before collection of lymphocytes from the spleen of immunised mice. B-lymphocytes derived from the spleen of immunised mice were fused with SP2 myeloma cells by 50% polyethylene glycol (PEG; Sigma Aldrich). Cells were cultured in HAT medium (Sigma Aldrich) supplemented with 20% FBS, 10% Hybridoma Cloning Supplement (Santa Cruz Biotechnology, USA) and antibiotics. Antibodies secreted from novel hybridomas were screened by ELISA as described previously^[@CR9]^. Newly formed positive hybridomas were selected, cloned twice by limiting dilution technique, adapted to growth medium containing 3% FBS, grown in roller bottles and the hybridoma supernatants were harvested and purified for further studies as described below. Flow cytometry {#Sec11} -------------- The cell surface expression of target antigens recognised by novel mAbs was determined using flow cytometry as described previously^[@CR9],[@CR56]^. Briefly, cells were trypsinised and approximately 1 × 10^6^ tumour cells were incubated by rotation for 1 h at 4 °C with novel mouse mAbs KU44.22B or KU44.13A (10 μg/ml) or control (i.e. PBS), followed by incubation with FITC-conjugated goat anti-mouse IgG secondary antibody (1:200; STAR9B, AbD Serotec; RRID:AB_321920) for 45 min at 4 °C. A minimum of 10,000 events were recorded by excitation with an argon laser at 488 nm and analysed using the FL-1 detector (FITC detector; 525 nm) of a BD FACScalibur flow cytometer using CellQuest Pro software (Becton-Dickinson Ltd, UK; RRID:SCR_014489). Isotyping and purification of novel monoclonal antibodies {#Sec12} --------------------------------------------------------- Isotyping of novel mAbs was determined using a mouse mAb isotyping kit (AbD Serotec, UK) according to the manufacturer's protocol and the antibodies were purified by affinity chromatography as described previously^[@CR9]^. Briefly, novel mouse mAbs were purified by salt fractionation (solid ammonium sulphate (\[NH~4~\]~2~SO~4~; 45% of saturation − 270 g/L; Fisher Scientific) followed by affinity chromatography using a 5 ml HiTrap Protein G HP column in an ÄKTAprime plus chromatography system (GE Healthcare, UK), as described previously^[@CR9]^. The purified antibodies were filtered through a 0.2 µm syringe filter (Merck Millipore, UK), aliquoted and stored at −20 °C for further studies. Internalisation studies {#Sec13} ----------------------- Immunofluorescence staining of tumour cells and ELISA were used to determine whether treatment with novel antibodies resulted in down-regulation of the target antigen as described previously^[@CR9]^. Briefly, pancreatic cancer cells were grown to near confluency in RPMI/10% FBS in Lab-Tek 8-well chamber slides (VWR, UK) or 96-well plates, respectively. Cells were incubated with mAbs KU44.22B or KU44.13A (50 µg/ml) or control (i.e. PBS/1%BSA alone) for 1 h at 4 °C to allow antibody binding, followed by incubation at 37 °C for 30 min to allow antibody internalisation. A control slide was maintained at 4 °C. Cells were fixed with 4% formaldehyde for 10 min, the cell membrane permeabilised with 0.5% Triton-X 100 for 15 min and non-specific binding blocked with PBS/1%BSA for 1 h at 4 °C. Cells in immunofluorescence slides were then incubated with Alexa Fluor 488 secondary antibody (1:200; Fisher Scientific; RRID:AI_1001) for 1 h at 4 °C, mounted in Vectashield with DAPI (Vector laboratories, UK) and examined using Nikon eclipse i80 microscope and Nikon NIS-Elements software as described previously (RRID:SCR_014329)^[@CR57]^. Cells in ELISA plates were incubated under the same conditions above with the primary antibodies and then incubated with HRP-conjugated rabbit anti-mouse (1:1000, STAR13B, AbD Serotec; RRID:AB_321921). Following several washes, the absorbance of each sample was measured at 450 nm as described previously^[@CR9]^ Effect of novel mAbs on growth and migration of pancreatic cancer cells {#Sec14} ----------------------------------------------------------------------- The effect of novel mAbs on the growth of human cancer cell lines was investigated using the Sulforhodamine B (SRB) colorimetric assay^[@CR9],[@CR58]^. Gen5 software was used to determine the IC50 through non-linear least squares curve fitting, as described previously^[@CR56],[@CR59]^. The effect of novel mAbs on the migration of human pancreatic cancer cells BxPC-3, AsPC-1 and CFPAC-1 was investigated using the IncuCyte ZOOM® Live-Cell Imaging instrument (Essen Bioscience, UK) as described previously^[@CR9]^. Approximately 1 × 10^3^ cancer cells per well were seeded in duplicate in an IncuCyte™ ClearView 96-well Cell Migration Plate (Essen Bioscience, UK) along with 300 nM mAbs or control (i.e. medium alone). Cells were allowed to settle for 15 min at room temperature before transfer to an incubator at 37 °C for 30 min to pre-incubate the cells in the presence of treatment. Then, 200 μl of chemoattractant (i.e. 10% FBS medium) or control (i.e. 0.5% FBS medium) were added to the appropriate wells of the reservoir plate and the insert plate placed into the pre-filled reservoir plate. The plate was then transferred to the IncuCyte ZOOM® Live-Cell Imaging Instrument (Essen Bioscience) and allowed to warm to 37 °C for 15 min before any condensation accumulated on the plate lid or bottom was wiped away. The plate was imaged at 10x objective using the Chemotaxis Scan Type - Phase channel. The IncuCyte™ Chemotaxis Cell Migration Software Module (Essen Bioscience) was used for data analysis. Whole-well images of cells on both the bottom and the top of the plate membrane were captured every 2 h over 48 h and all images were processed using automatic algorithms to quantify cell area on each side of the membrane. Immunoprecipitation and mass spectrometry {#Sec15} ----------------------------------------- To identify the target antigens recognised by the novel antibodies, immunoprecipitation and mass spectrometry were performed using protein identification service provided by the University of York (UK) as described previously^[@CR9]^. Briefly, novel mAbs (5 μg) were incubated overnight at 4 °C by gentle rotation (14 rpm) with 1 ml AsPC-1 (mAb KU44.13A) or CaOV-3 (mAb KU44.22B) tumour cell lysates (prepared with lysis buffer containing 50 mM Tris-HCl pH 7.2, 150 mM NaCl, 2 mM MgCl~2~, 2 mM CaCl~2~, 0.1% NaN~3~, 100 mM DTT, 1% Triton X-100 and 50 mM N-ethylmaleimide), and then incubated with 50 μl pre-washed Dynabeads sheep anti-mouse IgG for 1 h at 4 °C (ThermoFisher Scientific). The immunocomplexes were captured on a DynaMag™-2 for 2 min, the supernatants aspirated, and the samples washed 3 times with PBS. The complexes were then eluted by mixing beads with LDS sample buffer (25% NuPAGE LDS buffer \[4 × \], 10% reducing agent \[10 × \] and 65% distilled water; Invitrogen, UK), heated to 95 °C for 5 min and analysed by SDS-PAGE. The SDS-PAGE gels were stained with SimplyBlue™ SafeStain (ThermoFisher Scientific) and the protein bands were excised (Supplementary Fig. [3A,B](#MOESM1){ref-type="media"}), and in gel digested with trypsin for subsequent mass spectrometry analysis. Identification of isolated protein was performed by mass spectrometry under contract at the University of York's protein identification facility, as described previously^[@CR9]^. The UniProt_human_SP database was used for protein identification. Western blotting {#Sec16} ---------------- The ability of the novel antibodies to recognise the target antigen in Western blot was investigated as described previously^[@CR9]^. Briefly, proteins immunoprecipitated with novel mAbs KU44.22B and KU44.13A (5 µg) or commercial mAbs anti-integrin α3 (2 µg; sc-374242; Santa Cruz Biotechnology, UK; RRID:AB_10985868) or anti-CD26 (2 µg; ab89398; Abcam, UK; RRID: AB_2277416) were analysed by SDS-PAGE under reducing conditions, prior to Western blotting. The transfer of proteins from 4--12% Bis-Tris-gels to Immobilon-FL PVDF membranes (Merck Millipore, UK) was performed using the XCell II^TM^ Mini-Cell Blot Module kit (Invitrogen, UK) at a constant voltage of 30 V on ice for 2 h. PVDF membranes were probed with novel mAbs (30 μg/ml), commercial anti-integrin α3 mouse mAb (1:100 dilution) or commercial anti-CD26 rat mAb (1:500 dilution) overnight at 4 °C and subsequently incubated for 1 h at room temperature with secondary goat anti-mouse antibody (1:10,000; RRID:926_32210) or secondary goat anti-rat antibody (1:5,000; RRID:925-68076, both from LI-COR Biosciences, UK) respectively. For visualisation, the blots were analysed using the Oddysey® CLx instrument (LI-COR Biosciences; RRID:SCR_014579). Immunohistochemical staining {#Sec17} ---------------------------- AsPC-1 and Capan-2 cancer cell pellets and human pancreatic cancer tissue microarrays (PA483e, Insight Biotechnology/US Biomax) were used to determine whether novel monoclonal antibodies immunodetect the target antigens in formalin-fixed paraffin-embedded tissue sections using the VENTANA BenchMark ULTRA IHC/ISH System (Roche, UK). Tissue sections were deparaffinised and rehydrated through a series of alcohols followed by heat induced antigen retrieval with standard CC1 (Tris-EDTA buffer pH 7.8) at 95 °C for 36 min and incubation for 1 h with either mAb KU44.22B (15 µg/ml) or mAb KU44.13A (10 µg/ml). An anti-mouse IgG detection system (UltraView Universal DAB Detection Kit, Ventana) was used for amplification and primary antibody detection. The slides were then counterstained with haematoxylin II for 8 min followed by Bluing reagent. The slides were then washed, dehydrated, cleared, mounted in DPX mounting medium (VWR) and coverslipped as described previously^[@CR60]^. Supplementary information ========================= {#Sec18} SupplementaryInformation **Publisher's note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information ========================= is available for this paper at 10.1038/s41598-019-57287-w. This work was supported by Kingston University London towards a PhD project and The Ralph Bates Pancreatic Cancer Research Fund fellowship. We thank Dr. Wai Liu and Dr. Daniel Fowler (St George's University of London) for conducting the immunisation procedure for this study, and Dr. Soozana Puvanenthiran and Dr. Said Khelwatty for their helps with the staining of the immunohistochemical staining of TMAs on the VENTANA BenchMark Ultra IHC/ISH system. H.M. conceived and designed the experiments. G.A.P. performed the experiments and data analysis. H.M., A.D., A.W., S.M. and I.B. helped with technical training and data analysis. G.A.P. and H.M. wrote the paper and A.D., A.W., S.M. and I.B. went through the manuscript, edited and approved the final version of the manuscript. All data generated or analysed during this study are included in this published article (and its Supplementary Information Files). The authors declare no competing interests.

1. Introduction {#sec1-tropicalmed-03-00026} =============== Melioidosis is an emerging and fatally infectious disease that is endemic to Southeast Asia and northern Australia \[[@B1-tropicalmed-03-00026]\]. However, its incidence may be underestimated in many regions, such as India, South America, and Africa, because the disease is difficult to diagnose due to its very diverse clinical manifestations and the use of inadequate bacterial isolation and identification methods. Annual disease rates could be increasing worldwide as a result of transmission by travelers that were exposed to contaminants in melioidosis-endemic areas \[[@B2-tropicalmed-03-00026],[@B3-tropicalmed-03-00026],[@B4-tropicalmed-03-00026]\]. Overall, approximately 165,000 human melioidosis cases occur annually worldwide, and approximately 89,000 people die annually from this disease \[[@B5-tropicalmed-03-00026]\]. To date, no systematic international estimation of the clinical or sub-clinical incidence of melioidosis has been performed using a consistent, standardized, and quality-controlled method under the same health- or medically-controlled conditions. This makes it difficult to adequately compare the incidence of the disease among countries or regions and to predict the disseminated scope of melioidosis. The pathogen underlying melioidosis is an environmental saprophyte and Gram-negative bacterium called *Burkholderia pseudomallei* that is usually found in the soil and surface water, and is sometimes seen in air particles \[[@B6-tropicalmed-03-00026],[@B7-tropicalmed-03-00026]\]. People acquire melioidosis from directly contacting, ingesting or inhaling soil, water or dust contaminated with *B. pseudomallei* \[[@B8-tropicalmed-03-00026],[@B9-tropicalmed-03-00026],[@B10-tropicalmed-03-00026]\]. Nevertheless, melioidosis cases are usually clustered during the rainy season, particularly after the appearance of a heavy rainfall, cyclone, or typhoon \[[@B11-tropicalmed-03-00026],[@B12-tropicalmed-03-00026],[@B13-tropicalmed-03-00026]\]. The transmission modes of melioidosis probably differ because people's customs and lifestyles, as well as the geographical position of melioidosis case clusters differ. In this review, we focus on studies of the incidence of melioidosis in Taiwan that provide insight into the mechanism of melioidosis transmission. 2. Underestimated Period of Melioidosis in Taiwan (1984--2004) {#sec2-tropicalmed-03-00026} ============================================================== The first reported case of melioidosis in Taiwan involved a patient who acquired melioidosis with multilobar pneumonia by drowning in the Philippines in 1984 \[[@B14-tropicalmed-03-00026]\]. Between 1984 and 2000, 12 pulmonary and two subcutaneous melioidosis cases and one melioidosis case with a mycotic aneurysm were reported \[[@B15-tropicalmed-03-00026]\]. Of those patients, 73.3% (11/15) had no overseas travel history. Because the symptoms of melioidosis are protean, melioidosis can go undetected. Its prevalence may therefore have been underestimated by physicians in Taiwan during the earlier years of its presence. Because *B. pseudomallei* is an uncertain airborne disease that belongs to a group of 'selected agents' that could be utilized to develop bacterial weapons for bioterrorism \[[@B16-tropicalmed-03-00026]\], melioidosis in Taiwan has been classified as a notifiable disease since 2000. This means that all of the culture-confirmed cases of melioidosis should be reported to the Centers for Disease Control (CDC) at the Department of Health in Taiwan. No case was reported from 2000 to 2002, five were reported in 2003, and 13 were reported in 2004. However, *B. pseudomallei* has consistently been isolated from soil at a depth of 30--60 cm in paddies in Taiwan and other countries \[[@B17-tropicalmed-03-00026],[@B18-tropicalmed-03-00026]\]. In synthetic soil or water media, *B. pseudomallei* can survive for 150 days or more, indicating that affected Taiwanese individuals may have acquired melioidosis from indigenous bacteria, rather than by traveling to endemic areas \[[@B19-tropicalmed-03-00026]\]. To explore the potential for exposure to *B. pseudomallei* in Taiwan, an indirect ELISA (enzyme-linked immunosorbent assay) that targeted the truncated flagellin of the bacterium was developed \[[@B20-tropicalmed-03-00026]\]. Seropositive rates of approximately 4%, 2.8%, and 5% were detected in northern, central, and southern Taiwan, respectively \[[@B21-tropicalmed-03-00026]\]. Approximately 3% of the positive cases were patients with diabetes mellitus, which is a risk factor for melioidosis \[[@B22-tropicalmed-03-00026]\]. 3. An Outbreak of Melioidosis in Taiwan (2005) {#sec3-tropicalmed-03-00026} ============================================== In 2005, after a typhoon event, melioidosis cases were clustered in the Er-Ren River Basin of Taiwan during a three-month period \[[@B23-tropicalmed-03-00026]\]. In 2005, while 0.3 cases/100,000 population were infected throughout the entire population of Taiwan, the incidence of melioidosis reached 122 cases/100,000 population in the area downstream of the Er-Ren River Basin. In the affected area, the incidence rates were higher than the 7.98--21.3 cases/100,000 population and 5.4--24.2 cases/100,000 population in Thailand and northern Australia, respectively \[[@B24-tropicalmed-03-00026],[@B25-tropicalmed-03-00026],[@B26-tropicalmed-03-00026]\]. Approximately 75% of these melioidosis patients had *B. pseudomallei* bacteremia, 50% had concomitant pleuropulmonary infections, and 20% died during hospitalization \[[@B27-tropicalmed-03-00026]\]. Pulsed-field gel electrophoresis (PFGE) typing revealed that two distinct genotypic clones appeared during this outbreak \[[@B27-tropicalmed-03-00026]\]. These two distinct types have been demonstrated to be ST58 and ST99 by the multilocus sequencing typing (MLST) method \[[@B28-tropicalmed-03-00026]\]. When compared with the seropositive rates of anti-*B. pseudomallei* flagellin antibodies of 2.8--5% in Taiwanese individuals before 2005, the rates were increased to as high as 36.6%, 21.6%, and 10.9% in the downstream, midstream, and upstream regions of the Er-Ren River, respectively. Those seropositive rates were associated with the incidence of melioidosis as follows: 120 cases/100,000 population in the downstream region, 68 cases/100,000 population in the midstream region and 36 cases/100,000 population in the upstream regions. However, *B. pseudomallei* was only isolated from the soil in the upstream region and never from the mid- or downstream regions, although PCR positivity to *B. pseudomallei*-specific amplicons was relatively higher in mid- and downstream regions than in upstream regions. People seemed to have acquired melioidosis through exposure to contaminated soil that had flowed down from the upstream river due to the heavy rain that was associated with the typhoon \[[@B26-tropicalmed-03-00026]\]. However, 70% (28/40) of the melioidosis patients in this outbreak denied recent contact with mud or dirty water before their illness \[[@B27-tropicalmed-03-00026]\]. Approximately 32.8--34.8% of the 105 adults who lived in the mid- and downstream areas of the Er-Ren River acknowledged having been flooded during this typhoon event \[[@B26-tropicalmed-03-00026]\]. After this outbreak, melioidosis was widely recognized as an indigenously emerging and fatally infectious disease in Taiwan. The CDC (Taiwan) reinforced the education and management of melioidosis using medical resources and improved the regulation of notifiable melioidosis in Taiwan. Thus, the numbers of melioidosis cases reported in the CDC database since this issue arose are more reliable than they previously were \[[@B29-tropicalmed-03-00026]\]. From 2005 to 2007, the average incidences of melioidosis were 0.03 cases/100,000 population in northern Taiwan, 0.29 cases/100,000 in central Taiwan and 1.98 cases/100,000 in southern Taiwan. The disease incidence was associated with PCR positivity for *B. pseudomallei*-specific amplicons, which was found in 1.3%, 10.1% and 19.4% of environmental samples in northern, central, and southern Taiwan, respectively. Viable *B. pseudomallei* was cultivated only from the soil in southern Taiwan (south of the Tropic of Cancer; isolation rate, 12.6%), and environmental isolates were never found in central and northern Taiwan (north of the Tropic of Cancer) \[[@B30-tropicalmed-03-00026]\]. *B. pseudomallei* is usually isolated from moist soil or water in tropical and subtropical countries, and is rarely found in temperate countries \[[@B1-tropicalmed-03-00026]\]. Although the favorable physical (pH and water content) and chemical (nutrients, salinity, organic, and inorganic compounds) conditions for the growth of *B. pseudomallei* are inconsistent in many soil studies \[[@B19-tropicalmed-03-00026],[@B31-tropicalmed-03-00026],[@B32-tropicalmed-03-00026],[@B33-tropicalmed-03-00026],[@B34-tropicalmed-03-00026]\], *B. pseudomallei* can thrive in rice fields when nutrients (e.g., fertilizer) are depleted during agriculture practices and rice field management \[[@B31-tropicalmed-03-00026]\]. After harvesting rice, the straw is frequently burned in the rice field in Taiwan. The presence or absence of *B. pseudomallei* related to rice field management in Taiwan is unknown. However, the soil, even if relatively dry, may act as a reservoir during the dry season, with an increase in the proliferation and potential for mobilization from soil into water in the wet season \[[@B35-tropicalmed-03-00026]\]. 4. A Plateau in the Incidence of Melioidosis in Taiwan (2008--2012) {#sec4-tropicalmed-03-00026} =================================================================== In 2008--2012, the annual incidence of melioidosis among the entire Taiwanese population increased to 0.19 cases/100,000 population as compared with 0.07 cases/100,000 population in 2007 \[[@B36-tropicalmed-03-00026]\]. Most of the cases were geographically clustered in the Er-Ren River Basin (size, 108 km^2^; population, 79,790 people) and Zoynan region (size, 60 km^2^; population, 127,438 people) in Taiwan \[[@B36-tropicalmed-03-00026],[@B37-tropicalmed-03-00026]\]. The average incidences of melioidosis in both regions reached 16.7 cases/100,000 population (Er-Ren River Basin) and 10.9 cases/100,000 population, respectively, from 2008 to 2011 (Zoynan region). Approximately 62.5--67% of melioidosis patients were unemployed and had no recent travel history because most patients were elderly or had chronic diseases, such as diabetes, renal failure, or cancer \[[@B37-tropicalmed-03-00026],[@B38-tropicalmed-03-00026]\]. Acute pulmonary melioidosis predominated (\>70%). Furthermore, 88% of melioidosis cases were found during the rainy season, and 22% of the patients died \[[@B38-tropicalmed-03-00026]\]. Based on molecular tracing observations, ST99 (multilocus sequencing typing) was prevalent in the Er-Ren River Basin in 2005, but ST58 was found in the Zoynan region in 2008--2009, indicating that the epidemic strains of melioidosis were altered because the environmental foci contaminated with *B. pseudomallei* differed \[[@B28-tropicalmed-03-00026]\]. Two hot spots for melioidosis occurred 10.3 km apart, but the climatic conditions, including rainfall and wind strength, were different because the topographical characteristics differed, as described below. The Er-Ren River Basin is a plain, and the Zoynan Region is a hilly area. Rainfall that lasts for a period of 4--7 days is a trigger factor associated with an increase in melioidosis cases in both areas. However, rainfall lasting 6--8 days and wind with a speed \>19 m/s (\>17.2 m/s is defined as a typhoon) and a specific angle of wind direction (150°, 220°, or 280°) are associated with increases in the number of melioidosis cases in the flat Er-Ren River Basin. In the hilly Zoynan region, these wind speeds, when combined with rainfall lasing five days, was also associated the incidence of melioidosis \[[@B37-tropicalmed-03-00026]\]. In Taiwan, over 80% of melioidosis cases occurred in the rainy season when the typhoon appeared \[[@B13-tropicalmed-03-00026],[@B26-tropicalmed-03-00026],[@B27-tropicalmed-03-00026]\]. It is not surprising that the wind speed (\>19 m/s) was associated with the occurrence of melioidosis in Taiwan. When considering the epidemiological survey described above, in the Er-Ren River Basin, *B. pseudomallei* was isolated from upstream areas, but melioidosis cases were increased in the mid- and downstream areas \[[@B26-tropicalmed-03-00026]\]. The direction of the sampled site contaminated with *B. pseudomallei* at the hot spot is from the southeast to northwest. Thus, the wind, with a 150° angle, as a vector could assist the transmission of *B. pseudomallei* to the patients if the airborne particles (aerosols) were generated from contaminated soil or water. In contrast, in the Zoynan region, if a strong northwest wind originating from a counterclockwise cyclone occurred during the season the typhoon appeared, the incidence of melioidosis should be higher in the southeast districts, even though *B. pseudomallei* is isolated from environments in the northwestern region. In particular, the hills located south of the Zoynan region become a natural barrier to obstruct the transmission of aerosols contaminated with *B. pseudomallei*. Indeed, 96% (80/83) of melioidosis cases occurred north of the hilly Zoynan region, but rare cases occurred south of the Zoynan region \[[@B37-tropicalmed-03-00026]\]. To test this hypothesis, we first demonstrated that the concentration of *B. pseudomallei*-specific amplicons was increased in the rainy season when the typhoon appeared when compared with that in the dry season when the appearance of a typhoon is rare \[[@B39-tropicalmed-03-00026]\]. By sampling randomly but with an even distribution geographically as much as possible, several sites contaminated with *B. pseudomallei* in the northwestern wetted, cropped, or non-cropped soil of the hot spots were identified. The concentration of *B. pseudomallei*-specific amplicons in aerosols was positively correlated with the incidence of melioidosis and the appearance of a northwesterly wind. Moreover, the isolation rate in the superficial layers of the contaminated cropped field in the northwest was correlated with PCR positivity for aerosols that were collected from the southeast from 2011--2013. The genotype ST58 of *B. pseudomallei* was identified from soil, aerosol, and human isolates. The airborne transmission of melioidosis was demonstrated to move from contaminated soil to aerosols and/or to humans in the Zoynan region \[[@B6-tropicalmed-03-00026]\]. 5. A New Hot Spot of Melioidosis in Taiwan (At the Present Time) {#sec5-tropicalmed-03-00026} ================================================================ From 2000 to 2017, 516 melioidosis cases were reported in Taiwan. As melioidosis is a tropical disease, approximately 86% (444/516) of cases are geographically distributed south of the Tropic of Cancer in Taiwan ([Figure 1](#tropicalmed-03-00026-f001){ref-type="fig"}A). Over 50% (223/444) of the cases were successively clustered in the Er-Ren River Basin in 2005 and in the Zoynan region in 2008--2012, and in Siaogang--Fengshan, more sporadic cases with subcutaneously localized infection have occurred since 2003 ([Figure 1](#tropicalmed-03-00026-f001){ref-type="fig"}B). Usually, acute pulmonary melioidosis with bacteremia is clustered after extreme climate events, for example, heavy rainfall and typhoons, but melioidosis with localized infection can occur in dry seasons. For example, patients who were admitted with melioidosis 7--14 days after heavy monsoonal rainfall (188 mm) were more ill or were more likely to die (rainfall \>211 mm) in Australia \[[@B40-tropicalmed-03-00026]\]. Over 1000 mm of rainfall during the wet season and a wind speed of \>19 m/s (Er-Ren River Basin) were indicators for melioidosis occurrence in Taiwan \[[@B27-tropicalmed-03-00026],[@B37-tropicalmed-03-00026],[@B38-tropicalmed-03-00026]\]. The genotype ST1001 of *B. pseudomallei* was found in melioidosis patients dwelling in Siaogang--Fengshan in 2016. ST58 was prevalent in soil and human isolates during 2008--2012, while ST1001 has been sporadically found in humans and the environment. Both representative strains, vgh07 (ST58) and vgh16 (ST1001), have been sequenced. The vgh07 (ST58) strain contains 16 genomic islands, including a potential pathogenic island that harbors an invasive hemolytic gene, but vgh16 (ST1001) did not harbor any genomic island \[[@B41-tropicalmed-03-00026],[@B42-tropicalmed-03-00026]\]. When the BALB/c mice were infected with the strains intravenously and the strains were re-isolated from liver extracts and used to re-infect the mice intravenously, repeatedly, the phenotypic levels of 3-hydroxytetradecanoic acid (an indicator of lipopolysaccharide of *B. pseudomallei*), biofilm formation and flagellar expression in both types were significantly increased when compared with those in the original parent strains. Moreover, the survival rates of the mice infected with both types that re-isolated from liver extracts were obviously decreased, indicating that the animals, as reservoirs, could increase the virulence of *B. pseudomallei* \[[@B43-tropicalmed-03-00026]\]. An environmental strain isolated from Pahang, Malaysia, was reported to show up-regulation of adhesins, virulence factors, and stress response-related proteins when the strain was injected intra-peritoneally into a mouse and re-isolated from the spleen \[[@B44-tropicalmed-03-00026]\]. If ST1001 persists in animals that serve as reservoirs for a long time, this strain can develop an increased virulence. More research is needed to explore the molecular links among the environment, animals, and humans in Siaogang-Fengshan. However, since 2015, political considerations have resulted in a CDC (Taiwan) policy that involves tightly regulating the biosecurity and biosafety of *B. pseudomallei*. The ability to use a large panel of *B. pseudomallei* strains for molecular typing, as was previously possible, is now restricted. Only six strains, including ST1001, were identified in the soil (*n* = 3), animals (*n* = 1), and humans (*n* = 2) in Siaogang-Fengshan from 2015 to 2017. Their virulence in animals has not yet been determined. 6. Unresolved Problems Related to Melioidosis Dissemination in Taiwan {#sec6-tropicalmed-03-00026} ===================================================================== Melioidosis in Taiwan has successively clustered in certain areas, such as the Er-Ren River Basin, Zoynan regions, and Siaogang-Fengshan, consisting of small-sized regions with areas containing approximately 5--7.5 km^2^, and has spread through different transmission modes or via exposure to different environmental foci \[[@B36-tropicalmed-03-00026]\]. As our insight into the geographical distribution of melioidosis cases and environmental foci improves, physicians will be able to increase alertness and awareness, leading to better control of the disease. However, the pH value, solar strength, moisture, organic or inorganic content, temperature changes, and salinity of soil each affect the growth of *B. pseudomallei* in the environment \[[@B9-tropicalmed-03-00026],[@B19-tropicalmed-03-00026],[@B31-tropicalmed-03-00026],[@B32-tropicalmed-03-00026],[@B33-tropicalmed-03-00026],[@B34-tropicalmed-03-00026]\]. To detect the presence of *B. pseudomallei* in the environment, the PCR detection rates are usually higher than those of microbiological cultures in our studies \[[@B6-tropicalmed-03-00026],[@B26-tropicalmed-03-00026],[@B30-tropicalmed-03-00026],[@B36-tropicalmed-03-00026]\]. The presence of phages in *B. pseudomallei* strains has been reported to decrease their successful isolation from environmental samples \[[@B45-tropicalmed-03-00026]\]. Both *B. cenocepacia* and *B. multivorans*, which are antagonistic to *B. pseudomallei*, are widely distributed throughout the rice fields of Taiwan \[[@B46-tropicalmed-03-00026]\]. The secondary metabolites of *Bacillus amyloliquefaciens* isolated from soil can kill *B. pseudomallei* in vitro \[[@B47-tropicalmed-03-00026]\]. The amoeba *Paravahlkampfia ustiana* and some *Acanthamoeba* sp. are predators that graze on *B. pseudomallei*, while *Hartmannella* spp. and *Acanthamoeba astronyxis* may be reservoirs of *B. pseudomallei* in soil or water \[[@B48-tropicalmed-03-00026],[@B49-tropicalmed-03-00026],[@B50-tropicalmed-03-00026]\]. The physical or chemical parameters influencing the growth of *B. pseudomallei* in the environment are not completely understood in Taiwan. Although the geographical distribution of *B. pseudomallei* in the environment is very uneven, high isolation rates in soil or water are usually associated with a high incidence of melioidosis in surveys using a large area \[[@B26-tropicalmed-03-00026],[@B30-tropicalmed-03-00026],[@B36-tropicalmed-03-00026]\]. However, melioidosis-clustered cases are distributed within 5--7.5 km^2^ of the hot spot regions with high-density populations, but an environment contaminated with *B. pseudomallei* was located \>5 km away from the periphery of the hot spot \[[@B6-tropicalmed-03-00026],[@B36-tropicalmed-03-00026]\]. When most of the patients in a population are elderly or have diabetes and cannot participate in outdoor activities, a characterization of the vectors that carry contaminated *B. pseudomallei* should be performed \[[@B37-tropicalmed-03-00026],[@B38-tropicalmed-03-00026]\]. The airborne transmission of infectious agents from aerosols to humans has been epidemiologically demonstrated using molecular linking and statistical methods. However, the finding that the isolation rates of *B. pseudomallei* in aerosols are very low contradicts the notion that the contaminated sources are contained in aerosols \[[@B6-tropicalmed-03-00026]\]. Additionally, in a rice paddy field in Ubon Ratchathani, northeast Thailand, *B. pseudomallei* was never isolated from air and rainwater samples during a 13-month prospective study \[[@B7-tropicalmed-03-00026]\]. In the absence of improved isolation techniques, it is uncertain whether environmental uncultivated *B. pseudomallei* can be considered an infective source. Alternatively, it remains unclear how people become easily exposed to contaminated water or soil. In Taiwan, approximately 20% of water samples that were obtained in the Zoynan regions after 2012 appeared to contain *B. pseudomallei*-specific amplicons \[[@B36-tropicalmed-03-00026]\]. In contrast, the content of *B. pseudomallei* in samples obtained from rice field water is reportedly as high as 60% in Thailand \[[@B7-tropicalmed-03-00026]\]. The occupational risk of melioidosis is correlated with a farmer's exposure to contaminated soil through agricultural activity; approximately 86% of those diagnosed with melioidosis also lived near a river in Liao \[[@B1-tropicalmed-03-00026],[@B51-tropicalmed-03-00026]\]. Spatial analysis revealed that, in northern Australia, melioidosis is particularly endemic in Townsville, north Queensland, where one set of melioidosis cases was clustered in the area of the old course of a major waterway \[[@B52-tropicalmed-03-00026]\]. In the Northern Territory of Australia, all of the *B. pseudomallei*-positive environmental sites (*n* = 104) were permanently waterlogged, or waterlogged during the wet season, or were irrigated \[[@B53-tropicalmed-03-00026]\]. Water serving as a transmission vehicle for *B. pseudomallei* has been suggested when melioidosis case clusters are associated with the water supply \[[@B54-tropicalmed-03-00026],[@B55-tropicalmed-03-00026]\]. Ingestion of or contact with water contaminated with *B. pseudomallei* is probably the transmission mode. However, more importantly, Taiwanese individuals, especially the elderly or patients, drink boiled water or routinely avoid being in close proximity to rivers or waterlogged areas. The *A. lenticulata* PT-14 strain was isolated from a well after a flood disaster caused by a typhoon and could become a host of the endosymbiont *Burkholderia* spp., as the 16S RNA genes of the bacterium were detected in the amoeba. *A. lenticulata* is widely distributed in aquatic and terrestrial environments and frequently contains various bacterial endosymbionts, such as *Mycobacterium*sp., *Legionella*sp., and *Burkholderia*sp. \[[@B56-tropicalmed-03-00026],[@B57-tropicalmed-03-00026],[@B58-tropicalmed-03-00026]\]. In an in vitro study, *A. lenticulata* PT-14 displayed endosymbiosis with *B. pseudomallei* vgh07 (ST58) and vgh16 (ST1001) (data not shown). The levels of *A. lenticulata* distributed in river or drinking water reservoirs differ according to season; specifically, certain 18S RNA genes of *A. lenticulata* are frequently detected during September to November \[[@B59-tropicalmed-03-00026],[@B60-tropicalmed-03-00026]\], a period in which typhoon invasion usually occurs. Typhoons are an important environmental phenomenon that triggers the incidence of melioidosis case clusters and is associated with high detection rates of *B. pseudomallei*-specific amplicons in water \[[@B13-tropicalmed-03-00026],[@B35-tropicalmed-03-00026],[@B36-tropicalmed-03-00026]\]. The intracellular survival of bacteria in amoeba was not only evolutionally designed to protect the bacteria from the harsh conditions of the environment, but also to enable the bacteria to develop a virulence that allows intracellular growth in mammals \[[@B61-tropicalmed-03-00026]\]. Thus, endosymbiotic *B. pseudomallei*, if they exist, not only interfere with microbiological cultures using filtered water, likely from sampling in Taiwan, but also become an alternative transmission mode of melioidosis from water to humans. 7. Conclusions {#sec7-tropicalmed-03-00026} ============== As an emerging and fatally infectious disease, melioidosis occurs because of exposure to soil or water contaminated with *B. pseudomallei*. Over 50% (223/444) of melioidosis cases were successively clustered in the Er-Ren River Basin in 2005 and in the Zoynan region in 2008--2012, and cases were also sporadically distributed throughout the Siaogang-Fengshan region in Taiwan. Subcutaneous inoculation, ingestion, and inhalation of contaminated soil or water are the main routes of melioidosis transmission. In 2005, individuals in the Taiwanese population acquired melioidosis seemingly through exposure to contaminated soil that flowed downstream from an upstream river area. While the upstream area had soil from which *B. pseudomallei* was isolated at high rates, the downstream region had a high incidence of melioidosis and high sero-prevalence for anti-*B. pseudomallei* antibodies. In 2008--2012, in the Zoynan region, melioidosis-clustered cases increased after typhoon events. In a prospective study, aerosols that contained *B. pseudomallei*-specific DNA were well distributed in the densely populated districts, but were rarely found in their surrounding areas. The concentration of specific DNA in aerosols was correlated with the melioidosis incidence and northwesterly wind in this endemic area. The isolation rate in the superficial layers of the contaminated crop field in the northwest was correlated with the PCR positivity of aerosols collected from the southeastern district over a two-year period. Because a strong northwest wind originating from a counterclockwise cyclone occurred during the wet season with a typhoon, the number of melioidosis cases was increased in a southeast district when *B. pseudomallei* was isolated from the northwestern region. Thus, melioidosis is airborne and was transmitted from contaminated soils to aerosols and/or to humans in Zoynan regions from 2008 to 2012. *B. pseudomallei* vgh07 (a representative strain of ST58) and its similar strain, which has a high virulence, have been prevalent in human and environmental isolates; however, the vgh16 strain (a representative strain of ST1001) and similar strains, with low virulence, were isolated from 2003 to 2016. If the ST1001 strain shows long-term persistence in animals or the environment as reservoirs, it could develop an increased virulence and potentially cause another outbreak in Taiwan. Although airborne transmission from aerosols to humans can occur in Taiwan, *B. pseudomallei* has a very low isolation rate in aerosols. Ingesting or coming into contact with water contaminated with *B. pseudomallei* is the likeliest mode of melioidosis transmission. However, more importantly, drinking boiling water and routinely avoiding proximity to rivers or waterlogged areas are common practices among the Taiwanese population. Most of the patients with melioidosis denied having contact with contaminated soil or water. Alternatively, the aim of endosymbiont *B. pseudomallei* to protect itself in harsh environments and develop a virulence to allow its intracellular growth in mammalian cells is likely another mode of melioidosis dissemination in Taiwan. This project was supported by MOST (Ministry of Science and Technology, ROC) grants (MOST105-2320-B-017-003-MY3 \[Y.-L.C.\] and MOST106-2314-B-075B-009-MY3 \[Y.-S.C.\]). P.-T.H. collected and analyzed data, performed experiments and wrote the paper; W.-T.H. and H.-K.H. collected data; Y.-L.C. and Y.-S.C. analyzed the data, and wrote and led the manuscript. All authors have read and approved the final manuscript. The authors declare no conflict of interest. {#tropicalmed-03-00026-f001} [^1]: These authors contributed equally to this work.

\section{Introduction} The evolution of cooperative behavior among seemingly competing organisms presents a challenge to the theory of natural selection \cite{axelrod:1984}. An action that benefits others and comes at a cost to oneself should eventually disappear. On the contrary, there are numerous biological and social settings in animal and human societies where cooperation is ubiquitous \cite{dugatkin:1997,sigmund:2006,nowakbook:2006}. Evolutionary game theory (EGT) \cite{maynardsmith:1973,maynardsmith:1982} provides a simple framework to study this puzzle. In each generation agents play a finite number of games and receive reward according to a specified payoff matrix, usually the \emph{prisoner's dilemma} game \cite{rc65}. At the end of each generation, players are reproduced proportional to their relative fitness, subject to mutation. Thus EGT mimics natural selection by increasing the relative abundance of better performing (in terms of accumulated reward) individuals. The prisoner's dilemma (PD) is one of the most widely used games to study the evolution of cooperation \cite{doebeli_2005,Fogel:1995, boyd:1989, Farrell_Ware:1989}. PD is a simultaneous two player game where each player decides whether to cooperate (C) or defect (D). Mutual cooperation gives higher payoff than mutual defection. But if one player cooperates the other player is better off defecting. Thus each player has an incentive to ``free ride" at a cost to the cooperative player. In the absence of any special mechanism defecting players would outperform cooperative players and (by natural selection) become dominant \cite{nowak_fiverules}. The game serves as a metaphor for various real-world settings where there is a conflict between individual and group interest \cite{Hardin_1968_Commons}. Although many solutions have been put forth to resolve this puzzle, most of these models rely on some notion of direct or indirect reciprocity. In direct reciprocity \cite{trivers:1971, NowakSigmund1993} agents interact repeatedly, and after each interaction they update their response based on how cooperative (kind) or non cooperative (unkind) the other agent was. Indirect reciprocity \cite{nowak_id:1998, leimar:2001,nowak_nature:2005} relies on the notion that individuals are kind to those who are kind to others. Both models assume agents recognize their partner and know their previous interactions. In large dynamic settings such an assumption would require advanced cognitive abilities. Approaches that do not require reciprocity include kin selection and group selection models. In kin selection \cite{hamilton:1964,taylor:1992} agents are favorably biased towards their genetic relatives. It requires agents to differentiate between kin and non-kin agents and does not explain cooperative outcomes observed in unrelated individuals. Group selection \cite{traulsen_nowak:2006a,wilson:1975} addresses these issues by proposing that selection works not only on individuals but also on groups. Agents form groups and cooperate with other agents in the same group. An interesting addition to the above reciprocity-free models of cooperation is the \emph{tag-mediated} partner selection \cite{riolo_axelrod:2001,riolo:1997}. Tags are simple observable traits or cultural artifacts which agents use to favorably bias their interactions with agents having similar tags. Experimental results \cite{riolo:1997} show that a tag based model can produce stable cooperation even in single round prisoner's dilemma game. In this paper, we are interested in developing a model of cooperation that does not require an agent's type or its past interaction to be known explicitly. Our model is based on the notion that individuals are averse to income inequalities. This concept has been formalized and widely studied within behavioral economics as \emph{inequity aversion} \cite{diffavers}. It was introduced to account for outcome anomalies between experimental results and theoretical models. In the inequity aversion model, as proposed by Fehr and Schmidt \cite{diffavers}, individuals enforce income equality by forgoing monetary payoff. If the material payoffs of players $i,\ j$ are $x_i,\ x_j$, respectively, the \emph{experienced utility} (which players maximize) of player $i$ is given by \[ U_i(x_i,x_j) = x_i - k_1 \cdot max(x_j-x_i,0) - k_2 \cdot max(x_i-x_j,0) \] where $k_1<k_2$ and $0 \leq k_2 \leq 1$ are inequity aversion sensitivity parameters. It follows from the above equation that the experienced utility is maximized when inequity is zero. The condition $k_1 < k_2$ implies that the decrease in a player's utility is higher when it is behind (in terms of payoff) than when it is ahead. Fehr and Schmidt \cite{diffavers} show that the above model can account for cooperation observed in various human interactions. Here we study the effect of using the social paradigm of inequity aversion as a criterion for partner selection. Instead of defining experienced utility we simply allow agents to use accumulated payoff to select their game partner. Thus inequity aversion in our context implies that agents avoid interacting with other agents whose accumulated payoff is higher or lower than their own payoff. Our experimental results show that cooperation can emerge even if individuals receive only rudimentary environmental signals about others' well-being (and not their type or specific behavior). It supports the hypotheses that inequity aversion promotes cooperation among non kin \cite{evolve_ia}. We also observe a strong correlation between cooperation and inequity aversion that indicates a possible coevolution of these two behaviors \cite{evolve_ia}. The rest of the paper is organized as follows. We first present the model and define the partner selection bias as a function of income inequality. We then evaluate the model by considering both the well-mixed and the spatially structured population and highlight the evolutionary dynamics of cooperation and inequity aversion. We also study the effects of various parameters on the fraction of cooperative players in the environment and then conclude. \section{Model} In this section we first introduce the general model where agents interact in a well-mixed population. We later present the model with spatial constraints. \emph{Agents.} The model consists of a fixed number of agents $N$. Each agent is either the cooperative or defecting type. The cooperative type always plays cooperate, and the defecting type always plays defect. Agents have an associated parameter $\lambda$ which gives a measure of how sensitive or tolerant they are to payoff inequality. A player's type and sensitivity parameter are subjected to evolutionary changes (see evolutionary step below). Players also have an accumulated reward which is initialized to zero at the start of each generation and updated according to the payoff received in each game. \emph{Payoff matrix.} The payoff received by each player is specified by the standard prisoner's dilemma game: \[ \begin{pmatrix} b-c & -c\\ b& 0 \end{pmatrix}.\] Cooperative players provide benefit $b$ to their opponent and incur a cost $c$ ($b>c>0$). Defecting players neither provide benefit nor incur any cost. Given the payoff structure, the dominant strategy for each player, irrespective of what the other player does, is to defect. Thus players end up with a payoff of zero instead of the mutually beneficial payoff $b\ -\ c$. This characterizes the dilemma between individual interest and group well-being. Without loss of generality, we use the following normalized payoff matrix: \[ \begin{pmatrix} 1 & 0\\ 1+c/b & c/b \end{pmatrix}.\] This allows us to study the game as a function of a single cost-to-benefit parameter, $0<c/b < 1$ \cite{fu_nowak2010,langer:2008}. \begin{figure}[t] \begin{center} \includegraphics[width=0.35\textwidth,height=1.6in]{prob_interact2} \caption{$ {\cal P}(i,j)$ for different values of $r_j$ and $\lambda_i=\{ 5,1,0.5\}$ when $r_i=0$ and $\lambda_j=0$.} \label{fig:probinter} \end{center} \end{figure} \begin{figure*}[t] \begin{minipage}[b]{0.74\linewidth} \begin{minipage}[b]{1.0\linewidth} \centering \subfloat[]{\label{fig:coop_across_gen}\includegraphics[width=1.0\textwidth,height=0.75in]{coop_across_gen}} \end{minipage} \begin{minipage}[b]{1.0\linewidth} \centering \subfloat[]{\label{fig:lambda_across_gen}\includegraphics[width=1.0\textwidth,height=0.75in]{lambda_across_gen}} \end{minipage} \end{minipage} \hspace{0.01cm} \begin{minipage}[b]{0.24\linewidth} \centering \subfloat[]{\label{fig:coop_lambda}\includegraphics[width=1.0\textwidth,height=1.75in]{coop_lambda}} \end{minipage} \caption{(a) The fraction of cooperative players $f_c$ across generations for a typical run for $N=250,\ N_s=8$, and $c/b=0.45$. (b) The corresponding average $\lambda$ value of cooperative players. (c) The corresponding number of games with C-C, C-D, and D-D interactions vs $\lambda$.} \end{figure*} \emph{Partner selection and interaction.} In each generation, agents are selected sequentially (random order) and play a single round of the prisoner's dilemma game. Players use their accumulated payoff and sensitivity parameter to determine their game partner. The search space variable $N_s \in N$ gives the subset of agents from which players choose their partner. Denote $r_i,\ r_j$ as the accumulated payoff and $\lambda_i,\lambda_j$ as the sensitivity parameters of players $i,\ j$, respectively. The probability that player $i$ would accept player $j$ is given by \[ \phi(i,j) = e^{-\lambda_i |r_i-r_j|} .\] Given the search space $N_s$, player $i$ selects player $j$ such that the above probability is maximized, $j= \argmax_{j \in N_s} \phi(i,j)$. We similarly define $\phi(j,i)$ as the probability that player $j$ would accept player $i$ as its partner. The probability of interaction between players $i$ and $j$ is given by \begin{eqnarray} {\cal P}(i,j) & = &\phi(i,j) \phi(j,i) \nonumber \\ & = & e^{-(\lambda_i+\lambda_j)|r_i-r_j|}. \label{eqn:probi} \end{eqnarray} The interaction is bilateral or with mutual consent since the probability of interaction depends on both players' sensitivity parameters. We set the range of the sensitivity parameter $\lambda \in [0,5]$. If $\lambda_i=\lambda_j=0$, players are indifferent to inequity, and as $\lambda$ increases, they become increasingly inequity averse. The upper limit of $5$ ensures that the probability ${\cal P}(i,j)$ is close to zero, even for small payoff differences. To illustrate, Figure.~\ref{fig:probinter} gives the probability of interaction between players $i$ and $j$ for different values of $\lambda_i$ when $i$'s accumulated reward $r_i=0$ and $\lambda_j=0$. For $r_j=1$ and $\lambda_i=0.5$, the probability of interaction ${\cal P}(i,j)=0.6$ which decreases to ${\cal P}(i,j)=0.006$ for $\lambda_i=5$. Once the partner is selected, the PD game is played with the probability given in Equation.~(\ref{eqn:probi}). If both players are cooperative, their accumulated payoff increases by $1$. If only one of the players is cooperative, the defecting player's accumulated payoff increases by $1+c/b$, and the cooperative player's accumulated payoff remains unchanged. We note that, unlike tag-mediated models of cooperation \cite{riolo:1997} where an agent's tags remain fixed in a given generation, in our model the accumulated payoff serves as a dynamic tag which changes after each interaction. \emph{Evolutionary step.} At the end of each generation agents are reproduced using the \emph{binary tournament } procedure \cite{suzuki:2005,goldberg:1991}: \begin{list}{}{\labelsep=0.3em \labelwidth=1em \leftmargin=1.5em \parsep -0em \partopsep -0.0em \itemsep 0.2em} \item [(1)] Two distinct agents are randomly selected for a tournament, and the agent with the higher fitness value is declared the winner (we use the accumulated reward as the fitness value). \item[(2)] A copy of the winner, called the \emph{offspring}, is added to the new generation and the above procedure is repeated $N$ times. \end{list} Additionally, a mutation is applied to each offspring. The mutation value gives the probability with which the offspring's type is randomly reset to either the cooperative or defecting type. Since the sensitivity parameter is a continuous variable, we apply mutation by adding, with probability $\mu$, Gaussian noise with mean $0$ and deviation $1$ to the inherited $\lambda$ value \cite{riolo_axelrod:2001}. The accumulated reward of the offspring is set to zero. The algorithm in Table~\ref{algo:a_interact} provides the pseudo code of the model. \begin{algorithm}[H] \caption{Algorithm for agent interaction} \begin{algorithmic} \REQUIRE $\mu,N,N_s$. \WHILE {generation $g \leq g^{max}$ } \FORALL{agents $i$ $\in$ $N$ } \STATE {select $N_s \in N$ agents randomly} \STATE $j= \argmax_{j \in N_s} \phi(i,j)$ \STATE{With Probability ${\cal P}(i,j)$, \textsc{Play}$(i,j)$} \STATE {Update accumulated payoff $r_i,r_j$} \ENDFOR \STATE {New Set Of Players $N$ = EvolutionaryStep($N$, $\mu$)} \ENDWHILE \end{algorithmic} \label{algo:a_interact} \end{algorithm} \section{Results and Discussion} We recall that $N$ is the number of agents, $N_s$ is the search space, and $c/b$ is the cost-to-benefit ratio. We denote the fraction of cooperative players with $f_c$. C-C denotes the cooperative-cooperative player interaction. We similarly define C-D and D-D interactions. For all experiments, we set $\mu=0.1$ and initialize $\lambda$ to a uniform value between $[0,5]$. The initial fraction of cooperative players is set to $10\%$. We report the results by averaging across $20$ runs, with each run consisting of $15000$ generations. Our results cover the following aspects: (1) the evolutionary dynamics of $f_c$, $\lambda$, and the correlation between them, (2) the change in the fraction of games with C-C, C-D, and D-D interactions as $\lambda$ value changes, (3) the effect of number of agents and search space on $f_c$ as the cost-to-benefit ratio $c/b$ increases, and (4) the effect of spatial constraints on $f_c$. \begin{figure*}[t] \centering \subfloat[]{\label{fig:coopN}\includegraphics[width=0.32\textwidth,height=1.78in]{diffn}}\hspace{0.5em} \subfloat[]{\label{fig:coopNs}\includegraphics[width=0.32\textwidth,height=1.78in]{diffns}}\hspace{0.5em} \subfloat[]{\label{fig:htmap}\includegraphics[width=0.32\textwidth,height=1.81in]{htmap}} \caption{(a) \emph{f$_c$} vs $c/b$ for $N_s=8$ and $N=\left\{100,200,300 \right\}$. (b) $f_c$ vs $c/b$ for $N=150$ and $N_s=\left\{6,8,10,12\right\}$. (c) Color map depicting $f_c$ on the $N_s-N$ plane for $c/b=0.4$. \label{fig:params} \end{figure*} \subsection{Mixed population} Figure~\ref{fig:coop_across_gen} shows the fraction of cooperative players $f_c$ across generations for a typical run (with $N=250,\ N_s=8$ and $c/b=0.45$). Figure~\ref{fig:lambda_across_gen} gives the corresponding average $\lambda$ value of cooperative players. We observe high levels of cooperation $f_c \geq 0.75$ interrupted by brief periods of defection. The generations when the fraction of cooperative players falls significantly are highlighted to show the close correlation between $f_c$ and $\lambda$. Across all simulations we observe that an increase or decrease in the fraction of cooperative players is preceded by an increase or decrease in the average $\lambda$ value. For example, as shown in Figures~\ref{fig:coop_across_gen} and ~\ref{fig:lambda_across_gen}, from generation $7100$ to $7500$, the average $\lambda$ value decreases gradually from $4.2$ to $0.3$. We see a corresponding decrease in the $f_c$ value from $0.84$ to $0.08$. At the start of each generation, as the accumulated payoff of all players is $0$, the probability of interaction between any two players is $1$, irrespective of $\lambda$. So in the initial stages, defecting players have a slight advantage (since the cooperative players would not reject them as a game partner), and their accumulated payoff increases. But after the first few games, the cooperative agents involved in C-D interactions start forming temporary clusters sharing a common payoff. If these cooperative players are sufficiently inequity averse, in the subsequent iterations, they are more likely to interact within these clusters, and their payoff increases. The defecting players who initially exploit the cooperative players face a form of ``social exclusion" from these groups. Thus inequity aversion allows cooperative players to seek new partners and form groups with whom they can share more equitable payoffs. As the interactions proceed, cooperative players that are more tolerant (small $\lambda$ value) to income inequality continue to interact with defecting agents. They are outperformed by cooperative players with relatively high $\lambda$ value and die out. Over generations the average $\lambda$ of cooperative players increases, which further reduces the likelihood of C-D interactions until cooperation becomes dominant. However, this cooperation due to the temporary clustering effect is not permanent. When cooperation is established, agents have a high $\lambda$ value. At this stage, the cooperative agents with a relatively smaller $\lambda$ value have a slight advantage as they are more likely to tolerate inequality and play the game. And since cooperative agents are dominant, with high probability these agents interact with other cooperative agents, and their accumulated payoff increases. The environment faces a slight selection pressure towards higher tolerance levels (lower $\lambda$ value). As this happens gradually over generations, at some threshold $\lambda$, agents become vulnerable to invasion by defectors, and the cooperation levels fall sharply. The system remains in this state until by chance, due to mutation, a few cooperative players with a relatively high $\lambda$ value emerge and reestablish cooperation. To further validate the correlation between $f_c$ and $\lambda$, Figure~\ref{fig:coop_lambda} shows the number of games with C-C, C-D, and D-D interactions as a function of $\lambda$. For a low $\lambda$ value C-D and D-D interactions dominate. As the $\lambda$ value increases, cooperative clusters emerge, and C-C becomes dominant. The cycles of cooperation and defection are not regular or periodic, and how often the system goes into the defection state and how quickly it recovers depends on the parameters $N,\ N_s$, and $c/b$. In general we observe that as the cost-to-benefit ratio $c/b$ increases or $N_s$ decreases, it takes longer for the system to recover from the defection state. \begin{figure*}[t] \begin{minipage}[b]{0.48\linewidth} \begin{minipage}[b]{1.0\linewidth} \centering \subfloat[]{\label{fig:2dcoop_across_gen}\includegraphics[width=1.0\textwidth,height=0.6in]{2dcoop_across_gen}} \end{minipage} \begin{minipage}[b]{1.0\linewidth} \centering \subfloat[]{\label{fig:2dlambda_across_gen}\includegraphics[width=1.0\textwidth,height=0.6in]{2dlambda_across_gen}} \end{minipage} \end{minipage} \hspace{0.01cm} \begin{minipage}[b]{0.24\linewidth} \centering \subfloat[]{\label{fig:2dwithin_across}\includegraphics[width=1.0\textwidth,height=1.45in]{2dwithin_across}} \end{minipage} \hspace{0.01cm} \begin{minipage}[b]{0.24\linewidth} \centering \subfloat[]{\label{fig:2ddiffn}\includegraphics[width=1.0\textwidth,height=1.45in]{2ddiffn}} \end{minipage} \caption{(a) The fraction of cooperative players $f_c$ across generations for a typical run with $N=12\times12$ and $c/b=0.45$. (b) The corresponding average $\lambda$ value of cooperative players. (c) The corresponding fraction of games ($f_g$) within and outside the clusters for the first few generations. (d) $f_c$ vs $c/b$ for different grid sizes.} \end{figure*} Figures~\ref{fig:coopN} and ~\ref{fig:coopNs} show the fraction of cooperative players vs the cost-to-benefit ratio for different values of $N$ and $N_s$, respectively. Across both simulations, as $c/b$ increases, $f_c$ decreases, and for $c/b \geq 0.5$, cooperation disappears. With respect to $N$, we observe the $f_c$ value decreases marginally for $0.3 \leq c/b \leq 0.5$ as $N$ decreases. The change in $f_c$ is considerably higher with respect to change in $N_s$ values. As the search space increases, $f_c$ increases. The search space affects the probability of selecting an agent from within the temporary clusters that emerge. A higher search space value translates to a higher probability of interaction within the cluster. We also observe a ``thresholding'' effect; that is, for a fixed change in $N_s$ the increase in the $f_c$ value is higher for smaller values of $N_s$. Figure~\ref{fig:htmap} shows a color map of $f_c$ for different values of $N_s$ (along the $X$ axis) and $N$ (along the $Y$ axis) with $c/b=0.45$. For a high ($N_s \geq 12$) or low search space ($N_s \leq 4$), $f_c$ does not change with $N$. \subsection{Two-dimensional lattice} We now consider the spatial prisoner's dilemma game \cite{szabo_tiffmode:1998,nowak_robert:1992} where each player occupies a cell in a square lattice. Similar to the well-mixed population model, agents are either the cooperative or defecting type and use their accumulated payoff to select their game partner and interact. But due to spatial constraints an agent's search space is restricted to its four neighboring cells. We also change the \emph{binary tournament} procedure to reflect an agent's fixed position. For each offspring cell to be added to the new generation, two distinct agents are randomly selected from the neighborhood of the cell. The agent with the higher fitness values is declared the winner and the offspring inherits the winner's type and $\lambda$ value. Mutation is applied as discussed in the previous model. Figures~\ref{fig:2dcoop_across_gen} and ~\ref{fig:2dlambda_across_gen} show the evolutionary dynamics of $f_c$ and $\lambda$ for a typical run with $N=12\times12$ and $c/b=0.45$ for the first $2000$ generations (similar behavior is seen in subsequent generations). Across all simulations, we observe that the cooperation in the spatial prisoner's dilemma is more ``robust" (i.e., unlike the previous model where cooperation almost disappears before recovering, here we see stable cooperation). The increase and decrease in the $f_c$ value are marginal but are still closely correlated with the increase and decrease in the $\lambda$ value. While a single cooperative agent surrounded by defectors is always outperformed, cooperative players that are sufficiently inequity averse and adjacent to each other have two advantages: (1) the temporary clustering that arises due to sharing a common payoff and (2) the clustering provided by spatial constraints. Like the previous model, in the initial games of a generation, if cooperative and defecting agents interact, the inequity in accumulated payoff ensures that in the subsequent iterations the probability of C-D interactions decreases. And as is traditionally the case, the spatial constraint further improves the performance of cooperative players since players in the interior of the cluster enjoy the benefit of mutual cooperation. Figure~\ref{fig:2dwithin_across} shows the fraction of interactions (for the above sample run) within and outside the clusters for the first few generations. The corresponding snapshots for the first $40$ generations along with the size of the largest cooperative cluster (given below each plot) are shown in Figure.~\ref{fig:snap}. Defecting players are in black. We observe the cooperative players become dominant by generation $32$. Figure~\ref{fig:2ddiffn} shows the fraction of cooperators vs $c/b$ for different grid sizes. We observe $f_c$ does not change with $N$, and similar to the well-mixed model, cooperation disappears for $c/b \geq 0.5$. \begin{figure*}[t] \centering \subfloat{\label{fig:snap0}\includegraphics[width=0.11\textwidth,height=0.8in]{sc0}}\hspace{0.4em} \subfloat{\label{fig:snap1}\includegraphics[width=0.11\textwidth,height=0.8in]{sc1}}\hspace{0.4em} \subfloat{\label{fig:snap2}\includegraphics[width=0.11\textwidth,height=0.8in]{sc2}}\hspace{0.4em} \subfloat{\label{fig:snap3}\includegraphics[width=0.11\textwidth,height=0.8in]{sc3}}\hspace{0.4em} \subfloat{\label{fig:snap4}\includegraphics[width=0.11\textwidth,height=0.8in]{sc4}}\hspace{0.4em} \subfloat{\label{fig:snap5}\includegraphics[width=0.11\textwidth,height=0.8in]{sc5}}\hspace{0.4em} \subfloat{\label{fig:snap6}\includegraphics[width=0.11\textwidth,height=0.8in]{sc6}}\hspace{0.4em} \subfloat{\label{fig:snap7}\includegraphics[width=0.11\textwidth,height=0.8in]{sc7}}\hspace{0.4em}\\ \subfloat{\label{fig:snap8}\includegraphics[width=0.11\textwidth,height=0.8in]{sc8}}\hspace{0.4em} \subfloat{\label{fig:snap9}\includegraphics[width=0.11\textwidth,height=0.8in]{sc9}}\hspace{0.4em} \subfloat{\label{fig:snap10}\includegraphics[width=0.11\textwidth,height=0.8in]{sc10}}\hspace{0.4em} \subfloat{\label{fig:snap11}\includegraphics[width=0.11\textwidth,height=0.8in]{sc11}}\hspace{0.4em} \subfloat{\label{fig:snap12}\includegraphics[width=0.11\textwidth,height=0.8in]{sc12}}\hspace{0.4em} \subfloat{\label{fig:snap13}\includegraphics[width=0.11\textwidth,height=0.8in]{sc13}}\hspace{0.4em} \subfloat{\label{fig:snap14}\includegraphics[width=0.11\textwidth,height=0.8in]{sc14}}\hspace{0.4em} \subfloat{\label{fig:snap15}\includegraphics[width=0.11\textwidth,height=0.8in]{sc15}}\hspace{0.4em}\\ \subfloat{\label{fig:snap16}\includegraphics[width=0.11\textwidth,height=0.8in]{sc16}}\hspace{0.4em} \subfloat{\label{fig:snap17}\includegraphics[width=0.11\textwidth,height=0.8in]{sc17}}\hspace{0.4em} \subfloat{\label{fig:snap18}\includegraphics[width=0.11\textwidth,height=0.8in]{sc18}}\hspace{0.4em} \subfloat{\label{fig:snap19}\includegraphics[width=0.11\textwidth,height=0.8in]{sc19}}\hspace{0.4em} \subfloat{\label{fig:snap20}\includegraphics[width=0.11\textwidth,height=0.8in]{sc20}}\hspace{0.4em} \subfloat{\label{fig:snap21}\includegraphics[width=0.11\textwidth,height=0.8in]{sc21}}\hspace{0.4em} \subfloat{\label{fig:snap22}\includegraphics[width=0.11\textwidth,height=0.8in]{sc22}}\hspace{0.4em} \subfloat{\label{fig:snap23}\includegraphics[width=0.11\textwidth,height=0.8in]{sc23}}\hspace{0.4em}\\ \subfloat{\label{fig:snap24}\includegraphics[width=0.11\textwidth,height=0.8in]{sc24}}\hspace{0.4em} \subfloat{\label{fig:snap25}\includegraphics[width=0.11\textwidth,height=0.8in]{sc25}}\hspace{0.4em} \subfloat{\label{fig:snap26}\includegraphics[width=0.11\textwidth,height=0.8in]{sc26}}\hspace{0.4em} \subfloat{\label{fig:snap27}\includegraphics[width=0.11\textwidth,height=0.8in]{sc27}}\hspace{0.4em} \subfloat{\label{fig:snap28}\includegraphics[width=0.11\textwidth,height=0.8in]{sc28}}\hspace{0.4em} \subfloat{\label{fig:snap29}\includegraphics[width=0.11\textwidth,height=0.8in]{sc29}}\hspace{0.4em} \subfloat{\label{fig:snap30}\includegraphics[width=0.11\textwidth,height=0.8in]{sc30}}\hspace{0.4em} \subfloat{\label{fig:snap31}\includegraphics[width=0.11\textwidth,height=0.8in]{sc31}}\hspace{0.4em}\\ \subfloat{\label{fig:snap32}\includegraphics[width=0.11\textwidth,height=0.8in]{sc32}}\hspace{0.4em} \subfloat{\label{fig:snap33}\includegraphics[width=0.11\textwidth,height=0.8in]{sc33}}\hspace{0.4em} \subfloat{\label{fig:snap34}\includegraphics[width=0.11\textwidth,height=0.8in]{sc34}}\hspace{0.4em} \subfloat{\label{fig:snap35}\includegraphics[width=0.11\textwidth,height=0.8in]{sc35}}\hspace{0.4em} \subfloat{\label{fig:snap36}\includegraphics[width=0.11\textwidth,height=0.8in]{sc36}}\hspace{0.4em} \subfloat{\label{fig:snap37}\includegraphics[width=0.11\textwidth,height=0.8in]{sc37}}\hspace{0.4em} \subfloat{\label{fig:snap38}\includegraphics[width=0.11\textwidth,height=0.8in]{sc38}}\hspace{0.4em} \subfloat{\label{fig:snap39}\includegraphics[width=0.11\textwidth,height=0.8in]{sc39}}\hspace{0.4em}\\ \caption{Snapshots for first $40$ generations on $12\times 12$ grid and $c/b=0.45$. Defecting players are in dark. The labels give the size of the largest cooperative cluster.} \label{fig:snap} \end{figure*} \section{Conclusion} We developed a model of agent interaction that is motivated by the social paradigm that individuals are inequity-averse and prefer to interact with others within the same social strata. We presented the results by considering both the well-mixed and the spatially structured populations across different parameter values. In general, cooperation becomes dominant when the cost of cooperation is low and is more robust for a structured population. Our results support the hypotheses that inequity aversion promotes cooperation among non kin \cite{evolve_ia}. It allows individuals to seek new partners with whom they can share more equitable payoffs. And if the equitable payoff increases the relative fitness of such individuals (as is the case with the prisoner's dilemma), natural selection would guarantee that inequity averse cooperative agents emerge. We also observe a strong correlation between inequity aversion and cooperation that points to the coevolution of these behaviors. Brosnan \cite{evolve_ia} provides an extensive discussion of inequity aversion observed in other species \cite{range:2008,heidary:2008}, including capuchin monkeys \cite{brosnan:2003}, which ``elucidate evolutionary precursors to inequity aversion" \cite{brosnan:2004}. We believe the model presented in this paper is an important step towards better understanding coevolution of cooperation and inequity aversion. In the future, we intend to evaluate the model by considering generic random networks and to incorporate other social factors like group membership, dominance rank, context of interaction, etc., which have been shown to effect the overall response to inequity \cite{evolve_ia}. \bibliographystyle{plain}

\section{Introduction} Bottlebrush polymers are important representatives of the class of complex multibranched structures, where the sets of $f_c$ side chains are periodically tethered at $n$ branching points to a linear polymer backbone \cite{Sheiko08}. The properties of such molecules are governed by competition of the steric repulsion between the side chains and the configurational entropy of the main backbone chain. In particular, this leads to enhanced stiffness of the backbone which causes the considerable elongation of molecule in solvent \cite{Tereo99,Kawaguchi98}; the side-chain molecules attend the extended cylindrical shapes in solvents \cite{Liang17,Lopez15}. In turn, the molecular entanglement in melts of such molecules is significantly suppressed and their conformational degrees of freedom are lowered \cite{Namba00,Sheiko08,Rzayev12}, which dictates the viscoelastic properties of such molecules. These peculiarities can be processed and controlled in a wide range by varying the structural parameters such as grafting density of the side chains, their lengths and position along the backbone. \begin{figure}[b!] \begin{center} \includegraphics[width=63mm]{Hyper-2.eps} \includegraphics[width=53mm]{Hyper-4.eps} \caption{ \label{Brush} Schematic representation of the open (left) and circular (right) bottlebrush polymer containing $f_c$ linear side chains and $f_r$ side chains in form of closed loops. } \end{center} \end{figure} Loop formation in macromolecules plays an important role in a number of biochemical processes such as stabilisation of globular proteins \cite{Pace88,Nagi97}, DNA compactification in the nucleus \cite{Fraser06,Simonis06,Dorier09} etc. Cyclic (or ring) macromolecules in general exhibit a number of unique properties in comparison to their linear analogues. In particular, they are characterized by a more compact coil conformation due to their lower conformational degree of freedom and thus diffuse much faster in melts than linear polymer chains of the same molecular weight, thus exhibiting very different viscoelastic and phase transition behavior \cite{r1,r2}. Cyclic polymers are thus finding their application as viscosity modifiers, since their addition in small amounts to linear matrices increases the viscosity \cite{Vlas,Kenna}. Numerous analytical and numerical studies have been conducted to analyse the cyclisation probability and loop size distributions in long flexible macromolecules \cite{Chan89,Rubio93,Redner80,Hsu04,Duplantier89, Wittkop96,Zhou01,Toan06,Shin14}. In particular, the so-called rosette polymers, containing a single branching point with $f_c$ linear chains and $f_r$ circular loops eliminating have been studied recently in our previous works \cite{Metzler,Paturej20}. In this concern, it is worthwhile to consider the generalised multibranched structures, where some amount $f_r$ of side chains at each the branching point are closed and form loops (see Fig. \ref {Brush}). One more closely related architecture of a branched polymer is a so-called decorated ring polymer: a bottlebrush polymer that has its backbone looped (see Fig. \ref {Brush}). The cyclic polystyrenes with multiple branching have been synthesized and analyzed recently in Refs. \cite{Hossain1,Hossain2}. In our present study, we will focus on conformational properties of the above mentioned complex polymer structures in the regime of dilute solution. In particular, the size ratio of gyration radii of a branched polymer $\langle R_g^2 \rangle_{\rm branched}$ to that of the linear chain $\langle R_g^2 \rangle_{\rm chain}$ of the the same total molecular weight \begin{equation} g=\frac{\langle R_g^2 \rangle_{\rm branched}}{\langle R_g^2 \rangle_{\rm chain}} \label{gratio} \end{equation} is often used to characterize the impact of the complex topology of structure on the effective elongation in solvent (it is also referred to as the shrinking factor). Here and below, $\langle (\ldots) \rangle$ denotes averaging over an ensemble of possible polymer conformations. Originally, this value was introduced by Zimm \cite{Zimm49} and evaluated for the so-called star polymer structures, containing only one branching point, as well as for a single closed ring. Another important quantity that characterizes the effective size of a polymer coil is hydrodynamic radius $R_h$, which is directly obtained in dynamic light scattering experiments. To compare $R^2_g$ and $R^{-1}_h$, it is convenient to introduce the universal size ratio \begin{equation} \rho=\sqrt{\langle R_g^2 \rangle} /\langle R_H \rangle. \label{hratio} \end{equation} The exact analytical result for the ratio (\ref{hratio}) in $d=3$ dimensions have been evaluated for the linear chain \cite{Zimm49,burchard,dunweg} and single closed ring \cite{burchard,fukatsu,Uehara2016}. Note, that the above mentioned quantities can be estimated exactly in the case of ideal Gaussian polymers without taking into account an excluded volume effect. Recently, both the analytical and numerical estimates for the universal ratios (\ref{gratio}), (\ref{hratio}) have been obtained in Refs. \cite{Metzler,Paturej20,Budkov} for so-called rosette structure, containing single branching point with $f_r$ closed rings and $f_c$ linear chains, which can be considered as bottlebrush polymers with $n=2$. { Note that the probability distribution functions of the gyration radii of Gaussian star and rosette structures have been derived analytically in Ref. \cite{Budkov} as well. } In this approach, an estimate for the Gaussian bottlebrush polymers containing $n$ branching points of functionality $f$ is found in Ref. \cite{Nakamura}. {There is a number of studies dedicated to conformational properties (and in particular the size ratios) of bottlebrush polymers with linear side chains \cite{Ma94,ZHIPING92,Paturej16,Chremos18,Pan22,Theodorakis}. In particular, a thorough comparative study of size properties of bottlebrush polymer structures with linear, star and ring polymers is performed in Ref. \cite{Chremos18}. The aim of the present study is to continue these investigations to the case when the side chains form the closed loops. This problem is closely related with the process called loop extrusion in chromatin \cite{Alipour12,Fudenberg16,Goloborodko16,Mirny21}, serving as one of the mechanisms of compaction of long DNA molecules in nuclei. Moreover, we will consider the case when the backbone chain form a closed loop (the case of ``decorated ring''), which is of great interest in particular since DNA often has a closed ring shape \cite{DNA1,DNA2}.} The layout of the paper is as follows. In Section \ref{M} we introduce the continuous chain model for both structures that is followed by analytical calculation in Section \ref{Calc}. The Wei's method is introduced in Section \ref{met1} that is followed by Results and Discussions is Section \ref{RD}. We finish this work with concluding remarks in Section \ref{C}. \section{The model} \label{M} An analytical description is performed in the framework of continuous chain model. Here, the individual polymer chain is presented as a trajectory of length $L$ parameterised by a radius vector $\vec{r}(s)$ with $s$ changing from $0$ to $L$. The trajectories connectivity is determined by the hamiltonian\cite{desCloiseaux}: \begin{equation} H^0=\frac{1}{2}\int_0^L \left(\frac{d\vec{r}(s)}{ds}\right)^2. \label{H_0} \end{equation} We consider a generalized case when each of the $n-1$ branching points on the backbone linear chain can contain $f_c$ side chains and $f_r$ rings. Mathematically this topology is defined by the partition function: \begin{eqnarray} &&Z_{bb}=\frac{1}{Z_0}\int D\vec{r} \prod_{k=1}^{n-1}\delta(\vec{r_k}(L_b)-\vec{r_{k+1}}(0))\nonumber\\ &&\times\prod_{i=1}^{f_c+f_r}\delta(\vec{r_k}(L)-\vec{r_i}(0))\prod_{j=1}^{f_r}\delta(\vec{r_j}(L)-\vec{r_j}(0)){\rm e}^{-\sum_{j=1}^{F}H_j^0}. \label{Zbb} \end{eqnarray} Here, the first set of $\delta$-functions describes the backbone that consists of $n$ segments with each consecutive segment starting at the end of the previous one. The second and the third sets of $\delta$-functions stands for the fact that each of the branching points serves as a starting point for $f_c+f_r$ outgoing trajectories. Note that here we consider the case when all the side chains are of the same length $L$, however the segments of the backbone are of the different length $L_b$ such that $\lim_{L\rightarrow\infty}(L_b/L)=a$. In this case the total length of the backbone is $nL_b$. The total number of trajectories for this structure being $F=n+(n-1)(f_c+f_r)$. For the case of decorated ring, that is a bottlebrush polymer that has two end points of its backbone chain looped, the partition function is presented as: \begin{eqnarray} &&Z_{dr}=\frac{1}{Z_0}\int D\vec{r}\,\, \delta(\vec{r_n}(L_b)-\vec{r_{0}}(0))\nonumber\\ &&\times\prod_{k=0}^{n-1}\delta(\vec{r_k}(L_b)-\vec{r_{k+1}}(0))\prod_{i=1}^{f_c+f_r}\delta(\vec{r_k}(L)-\vec{r_i}(0))\nonumber\\ &&\times\prod_{j=1}^{f_r}\delta(\vec{r_j}(L)-\vec{r_j}(0)){\rm e}^{-\sum_{j=1}^FH_j^0}. \label{Zdr} \end{eqnarray} Here, an additional condition $\delta(\vec{r_n}(L)-\vec{r_{0}}(0))$ stands for its end points looping. The total number of trajectories in this case is $F=n(f_c+f_r+1)$. Within this model, any observable of interest can be calculated as an average over an ensemble of all possible trajectories: \begin{equation} \langle(\ldots)\rangle = \frac{1}{Z}\int D\vec{r} {\rm e }^{-\sum_{j=1}^{F}H_j^0}, \label{Zaver} \end{equation} where $Z$ is a partition function given either by Eq. (\ref{Zbb}) or Eq. (\ref{Zdr}). \section{Gaussian approximation for analyzing the size characteristics of polymers} \label{Calc} \subsection{Radius of gyration and hydrodynamic radius definitions and calculation strategies} In terms of continuous chain model introduced above, the size measures of polymer structure can be defined as: \begin{eqnarray} &&\langle R^2_g\rangle = \frac{1}{2(FL)^2}\sum_{i,j=1}^F\int_0^L\int_0^L\langle(\vec{r_i}(s_2)-\vec{r_j}(s_2))^2\rangle,\label{RGdef}\\ &&\langle R^{-1}_h\rangle = \frac{1}{(FL)^2}\sum_{i,j=1}^F\int_0^L\int_0^L\langle|\vec{r_i}(s_2)-\vec{r_j}(s_2)|^{-1}\rangle,\label{RHdef} \end{eqnarray} here $s_2$ and $s_1$ stand for positions along and referred as ``restriction points''. The calculation of the gyration radius within this model is performed by making use of identity \cite{desCloiseaux}: \begin{eqnarray} &&\langle(\vec{r}_i(s_2)-\vec{r}_j(s_1))^2\rangle = - 2 \frac{d}{d|\vec{k}|^2}\xi(\vec{k})_{\vec{k}=0},\nonumber\\ &&\xi(\vec{k})\equiv\langle{\rm e}^{-\iota\vec{k}(\vec{r}_i(s_2)-\vec{r}_j(s_1))}\rangle.\label{identity_g} \end{eqnarray} The crucial point in the calculation of the hydrodynamic radius is exploiting the following equality \cite{Haydukivska14}: \begin{equation} |\vec{r}|^{-1} = (2\pi)^{-d} \int\, d\vec{k}\, 2^{d-1} \pi^{\frac{d-1}{2}} \Gamma\left(\frac{d-1}{2}\right) \, k^{1-d}{\rm e}^{i\vec{r}\vec{k}}. \end{equation} With this Fourier transformation the average in the integrand in expression (\ref{RHdef}) can be rewritten as: \begin{eqnarray} &&\langle|\vec{r}_i(s_2)-\vec{r}_j(s_1)|^{-1}\rangle = (2\pi)^{-d} \int\, d\vec{k}\, 2^{d-1} \pi^{\frac{d-1}{2}} \Gamma\left(\frac{d-1}{2}\right) \, k^{1-d} \xi(\vec{k}).\label{identity_h} \end{eqnarray} Note that in both identities the averaging is performed for the same expression $\langle{\rm e}^{i\vec{k}(\vec{r}_i(s_2)-\vec{r}_j(s_1))}\rangle$. In the Gaussian case, performing the averaging according to (\ref{Zaver}) for a single polymer chain of length $L$ leads to an expression: \begin{equation} \langle{\rm e}^{i\vec{k}(\vec{r}_i(s_2)-\vec{r}_j(s_1))}\rangle={\rm e}^{-\frac{\vec{k}^2}{2}(s_2-s_1)}, \end{equation} and the application of the identities (\ref{identity_g}) and (\ref{identity_h}) results in: \begin{eqnarray} &&\langle(\vec{r}_i(s_2)-\vec{r}_j(s_1))^2\rangle=d(s_2-s_1),\\ &&\langle|\vec{r}_i(s_2)-\vec{r}_j(s_1)|^{-1}\rangle= \frac{\Gamma\left(\frac{d-1}{2}\right)}{\sqrt{2}\Gamma\left(\frac{d}{2}\right)}(s_2-s_1)^{-1/2}. \end{eqnarray} After performing integrating over $s_1$ and $s_2$ and dividing by $L^2$ the final expressions for a single polymer chain are: \begin{eqnarray} &&\langle R^2_g\rangle_{{\rm chain}}=\frac{dL}{6},\\ &&\langle R^{-1}_h\rangle_{{\rm chain}}=\frac{\sqrt{2}\Gamma\left(\frac{d-1}{2}\right)}{\Gamma\left(\frac{d}{2}\right)}\frac{4}{3}L^{-\frac{1}{2}}. \end{eqnarray} The size ratio between those two size characteristics as defined by expression (\ref{hratio}) is given by: \begin{equation} \rho_{{\rm chain}}=\frac{\sqrt{\langle R^2_g\rangle}_{{\rm chain}}}{\langle R^{-1}_h\rangle_{{\rm chain}}^{-1}}=\frac{\sqrt{2d}\Gamma\left(\frac{d-1}{2}\right)}{\Gamma\left(\frac{d}{2}\right)}\frac{4}{3\sqrt{6}}, \end{equation} which reproduces a well-known value \cite{Teraoka02}. \subsection{Calculation of size characteristics} \begin{figure}[t!] \begin{center} \includegraphics[width=100mm]{Diagrams-1.eps} \caption{ \label{D:1} Schematic representation of the contributions into the gyration and hy\-drodynamic radius of rosette polymer. Here, solid line represents polymer trajectory and bullets represent restriction points.} \end{center} \end{figure} It is convenient to use a diagram technique for schematic presentations of contribution into $\xi(\vec{k})$. In the case of bottlebrush structure, the set of diagrams consists of five diagrams given on Fig. \ref{D:1} (those corresponding to rosette structures and being calculated previously in our works \cite{Metzler,Paturej20}) and three additional ones presented on Fig. \ref{D:2}. Here, the length of the each segment plays an important role and has to be accounted for. The analytical expressions corresponding to all the diagrams are provided in the Appendix. \begin{figure}[b!] \begin{center} \includegraphics[width=100mm]{Diagrams-2.eps} \caption{ \label{D:2} Schematic representation of the contributions into the gyration and hydrodynamic radius of bottlebrush polymer. Notations are the same like on Fig. \ref{D:1}.} \end{center} \end{figure} The size characteristics of interest can in general be presented as: \begin{eqnarray} && R_{x}= \frac{L^p}{(an+(f_r+f_c)(n-1))^2}\left((n-1)\left[f_c\xi_{1,x}(1)+f_r\xi_{2,x}(1)\right.\right.\nonumber\\&&\left.\left.+\frac{f_c(f_c-1)}{2}\xi_{3,x}(1,1)+\frac{f_r(f_r-1)}{2}\xi_{5,x}(1,1)+f_rf_c\xi_{4,x}(1,1)\right.\right.\nonumber\\ &&\left.+2f_c\xi_{3,x}(1,a)+\xi_{3,x}(a,a)+2f_r\xi_{4,x}(1,a)\right]+n\xi_{1,x}(a)\nonumber\\ &&+\left.\sum_{i=1}^{n-2}(n-i-1)\left[f_c^2\xi_{7,x}(1,1)+2f_c\xi_{7,x}(1,a)+\xi_{7,x}(a,a)+2f_cf_r\xi_{8,x}(1,1)\right.\right.\nonumber\\ &&\left.\left.+2f_r\xi_{8,x}(1,a)+f_r^2\xi_{6,x}(1,1)\right]\right).\label{gen_b} \end{eqnarray} Here, $p$ is equal to $1$ for the gyration radius and $-1/2$ for the hydrodynamic radius and $x$ stands to the indexes $g$ or $h$. In the case of gyration radius the summations are easily performed and the following expression results: \begin{eqnarray} &&\langle R^2_g\rangle_{bb}= \frac{dL}{(an+(f_r+f_c)(n-1))^2}\left(\frac{a^3n^3}{6}\right.\nonumber\\ &&+\left.\frac{n-1}{6}\left((an^2-2an+3n-3)f_c^2+(2a^2n^2-a^2n+3an-2)f_c\right.\right.\nonumber\\ &&\left.\left.+\frac{1}{2}(4a^2n^2-2a^2n+2an-1)f_r+(an^2-2an+n-1)f_r^2\right.\right.\nonumber\\ &&\left.\left.+2(an^2-2an+2n-2)f_cf_r\right)\right).\label{Rgbb} \end{eqnarray} With $f_r=0$, the above expression restores that for the bottlebrush polymer with linear side chains, derived in Ref. \cite{Nakamura}. To evaluate an estimate for the size ratio (\ref{gratio}), we divide this expression by the value of gyration radius of a single chain with the same total molecular weight, that is $\langle R^2_g\rangle_{chain}=\frac{dL(an+(f_r+f_c)(n-1))}{6}$. The graphic representation of resulting expression for some values of $n,f_c,f_r$ are given on Fig. \ref{g_bottle}. Correspondingly, we evaluated an expression for hydrodynamic radius: \begin{eqnarray} &&\langle R^{-1}_h\rangle_{bb}=\frac{\sqrt{\frac{2}{L}}\Gamma\left(\frac{d-1}{2}\right)}{(f_c+f_r)^3\Gamma\left(\frac{d}{2}\right)} \left(\frac{4a^{\frac{3}{2}}n}{3}+\frac{n-1}{12}\left((16(2a^{\frac{3}{2}}+f_c^2))(\sqrt{2}-1)\right.\right.\nonumber\\ &&+(32(1+a)^{\frac{3}{2}}-32a^{\frac{3}{2}}-16\sqrt{2})f_c+12\arctan\left(\frac{1}{2\sqrt{a}}\right)(4a+1)f_r\nonumber\\ &&\left.-6f_r\pi(f_r-1)(\sqrt{2}-2)+24\sqrt{a}f_r+3f_rf_c(4-\pi+10\arctan\left(\frac{1}{2}\right))\right)\nonumber\\ &&+\frac{4}{3}\sum_{i=1}^{n-2}(n-i-1)\left(f_c^2(ai+2)^{\frac{3}{2}}+2f_c(ai+a+1)^{\frac{3}{2}}-2f_c(ai+1)^{\frac{3}{2}}(f_c+1)\right.\nonumber\\ &&+(ai+2a)^{\frac{3}{2}}-2(a(i+1))^{\frac{3}{2}}(f_c+1)\left.+(ai)^{\frac{3}{2}}(f_c-1)^2\right)\nonumber\\ &&+2f_cf_r\sum_{i=1}^{n-2}(n-i-1)\left(\frac{1}{2}\arctan\left(\frac{1}{2\sqrt{ai+1}}\right)(4ai+5)\right.\nonumber\\&&\left.-\frac{1}{2}\arctan\left(\frac{1}{2\sqrt{ai}}\right)(4ai+1)\right.\left.+\sqrt{ai+1}-\sqrt{ai}\right)\nonumber\\ &&+2f_r\sum_{i=1}^{n-2}(n-i-1)\left(\frac{1}{2}\arctan\left(\frac{1}{2\sqrt{ai+a}}\right)(4ai+4a+1)\right.\nonumber\\ &&\left.-\frac{1}{2}\arctan\left(\frac{1}{2\sqrt{ai}}\right)(4ai+1)+\sqrt{ai+a}-\sqrt{ai}\right)\nonumber\\ &&-f_r^2\sum_{i=1}^{n-2}\frac{n-i-1}{\sqrt{4ai+2}}\left((4ai+2)\left(\arctan\left(\frac{4ai+1+\sqrt{4ai+2}}{2\sqrt{ai}}\right)\right.\right.\nonumber\\&&\left.\left.+\arctan\left(\frac{\sqrt{4ai+2}-4ai-1}{2\sqrt{ai}}\right)\right)\right.-2\arcsin\left(\frac{1}{\sqrt{4ai+1}}\right)\sqrt{4ai+2}\nonumber\\ &&\left.-2\arctan\left(\frac{1}{2\sqrt{ai}}\right)\sqrt{4ai+2}\right). \label{Rhbb} \end{eqnarray} Here $L$ is the length of the side chain and $L_b=aL$. The ratio (\ref{hratio}) for the bottlebrush structures can be evaluated next on the base of (\ref{Rgbb}) and (\ref{Rhbb}). The graphic representation of resulting expression for some values of $n,f_c,f_r$ are presented on Fig. \ref{ro_b}. For the case of decorated ring structures, we again need to consider three additional diagrams (see fig. \ref{D:3}) besides of those already considered for bottlebrush structures. \begin{figure}[t!] \begin{center} \includegraphics[width=100mm]{Diagrams-3.eps} \caption{ \label{D:3} Schematic representation of contributions into the gyration and hydrodynamic radii of decorated ring polymer. Notations are the same like on Fig. \ref{D:1}.} \end{center} \end{figure} \begin{table}[b!] \begin{tabular}{| c | c | c | c | c |} \hline $f_c$ & $f_r$ & $n$ & $\rho$\\ \hline $0$ & $1$ & $2$ & $\frac{\sqrt{22}}{32\sqrt{\pi}}\left(3\pi\sqrt{2}-2\pi\sqrt{6}-4\arctan(2\sqrt{2})+2\arcsin\left(\frac{\sqrt{3}}{3}\right)\right.$\\ & & & $\left.+9\pi-6\arctan\left(\frac{5}{\sqrt{2}}\right)\right)$\\ \hline $0$ & $2$ & $2$ & $\frac{\sqrt{6}}{36\sqrt{\pi}}\left(3\pi\sqrt{2}-4\pi\sqrt{6}+30\pi-16\arctan(2\sqrt{2})\right.$\\ & & & $\left.-24\arctan\left(\frac{5}{\sqrt{2}}\right)+8\arcsin\left(\frac{\sqrt{3}}{3}\right)\right)$ \\ \hline $0$ & $1$ & $3$ & $\frac{\sqrt{69}}{216\sqrt{\pi}}\left(21\pi-3\pi\sqrt{3}-2\arctan\left(\frac{24\sqrt{7}}{103}\right)\sqrt{42}+12\arctan\left(\frac{\sqrt{6}}{4}\right)\right.$\\ & & & $\left.+12\arcsin\left(\frac{\sqrt{3}}{\sqrt{11}}\right)\right)$ \\ \hline $0$ & $2$ & $3$ & $\frac{\sqrt{74/\pi}}{486}\left(3\pi\left(18-2^{\frac{3}{2}}-3^{\frac{3}{2}}\right)-8\arctan\left(\frac{24\sqrt{7}}{103}\right)\sqrt{42}\right.$\\ & & & $\left.+48\left(\arctan\left(\frac{\sqrt{6}}{4}\right)+\arcsin\left(\frac{\sqrt{3}}{\sqrt{11}}\right)\right)\right)$\\ \hline $1$ & $0$ & $2$ & $\frac{\sqrt{35}}{96\sqrt{\pi}}\left(5\sqrt{10}+\sqrt{2}+20-6\sqrt{6}+18\sqrt{2}\arcsin\left(\frac{\sqrt{3}}{3}\right)\right)$\\ \hline \end{tabular} \caption{Size ratio (\ref{hratio}) for a set of decorated rings with fixed parameters $n$, $f_r$, $f_c$, assuming $a=1$.}\label{Table2} \end{table} Similarly to Eq.(\ref{gen_b}), the general expression for size characteristics reads: \begin{eqnarray} && R_{x}= \frac{L^p}{((f_r+f_c+a)n)^2}\left(n\left(f_c\xi_{1,x}(1)+f_r\xi_{2,x}(1)\right.\nonumber\right.\\ &&\left.+\frac{f_c(f_c-1)}{2}\xi_{3,x}(1,1)+\frac{f_r(f_r-1)}{2}\xi_{5,x}(1,1)+f_rf_c\xi_{4,x}(1,1)\right)\nonumber\\ &&+\xi_{1,x}(na)+f_cn\xi_{4,x}(1,an)+f_r n\xi_{5,x}(1,an)\nonumber\\ &&+\left.\sum_{i=1}^{n-1}(n-i-1)\left(f_c^2\xi_{9,x}(1,1)+2f_rf_c\xi_{11,x}(1,1)+f_r^2\xi_{10,x}(1,1)\right)\right).\label{gen_dr} \end{eqnarray} For the gyration radius of decorated ring structure we thus have \begin{eqnarray} &&\langle R^2_g\rangle_{dr}= \frac{dL}{(an+(f_r+f_c)n)^2}\left(\frac{a^3n^3}{12}+\frac{n}{12}\left((an^2-a+6n)f_c^2\right.\right.\nonumber\\ &&\left.\left.+(2a^2n^2+6an-4)f_c+(2a^2n^2+2an-1)f_r\right.\right.\nonumber\\ &&\left.\left.+(an^2-a+2n)f_r^2+(2an^2-2a+8n-8)f_cf_r\right)\right). \label{Rgdr} \end{eqnarray} Again, to evaluate the size ratio (\ref{gratio}), we divide this expression by $\langle R^2_g\rangle_{chain}$ of the same total molecular weight, and give some graphical representations on Fig. \ref{g_bottle}. The expressions for hydrodynamic radius of decorated ring structure is much more cumbersome and we give here examples of this expression for several simple cases of $n,f_c$ and $f_r$ in Table \ref{Table2}. \section{Numerical results: Wei's method}\label{met1} To evaluate the size ratio (\ref{gratio}) of multibranched structures as compared with linear chain, we also applied the method originally developed by Wei \cite{Wei}. As the first step, we present the polymer structure as a mathematical graph, containing $M$ junction points (e.g. for a bottlebrush polymer with $n$ branching points of functionality $f_c$ one has $M=nf_c+2$, where two free ends of backbone are included into consideration as junction points with functionality $1$). The Kirchhoff matrix ${\bf K}$ of the size $M\times M$ of the given graph is then defined as follows. Its diagonal elements $K_{ii}$ equal the degree of vertex $i$, whereas the non-diagonal elements $K_{ij}$ equal $-1$ when the vertices $i$ and $j$ are adjacent and $0$ otherwise. Let $\lambda_2,\ldots,\lambda_M$ be $(M-1)$ non-zero eigenvalues of the $M\times M$ Kirchhoff matrix ($\lambda_1$ is $0$). The $g$-ratio of the radii of gyration of a given branched structure and that of a linear chain with the same length is given by: \begin{equation} g=\frac{\sum_{j=2}^{M}1/\lambda_j^{{\rm network}}}{\sum_{j=2}^{M}1/\lambda_j^{{\rm chain}}}, \label{gwei} \end{equation} where $\lambda_j^{{\rm network}}$ and $\lambda_j^{{\rm chain}}$ are network and chain Kirchhoff matrix eigenvalues. \begin{figure}[b!]\begin{center} \includegraphics[width=60mm]{wei20g.eps} \end{center} \caption{The size ratio of the bottlebrush (filled squares) and decorated ring (open squares) at $n=3$, $f_c=2$, $f_r=0$, obtained in numerical simulations with application of Wei formula (\ref{gwei}), as functions of a single link length $l$.} \label{g-data} \end{figure} This quantity is determined within the Wei's approach by extrapolating to infinite length of links $l$, so that the total number of junction points in resulting graph (and the size of corresponding Kirchhof matrix) is $M=l((f_c+2f_r)n+n+2)$. In our analysis, we considered the structures with number of $l$ up to 20. The set of eigenvalues of corresponding Kirchhof matrix was evaluated for the structures presented on Fig. 1 at different $n$ and values of $g$ were estimated according to Eq. (\ref{gwei}). Figure \ref{g-data} presents examples of simulation data for the case $n=3$ and $f_c=2$, $f_r=0$. For the finite link length $l$, the values of parameters differ from those for infinitely long polymer chains and the finite-size deviation can be fitted by: \begin{eqnarray} g(l) = g + b/l,\label{fit} \end{eqnarray} where $a$, $b$ are constants. The size ratio estimates were obtained by us by least-square fitting of (\ref{fit}). These are presented in Fig. \ref{g_bottle} and compared with analytical results. Note also, that we found this method to be less reliable with increasing the number of internal closed loops in structures, due to emergence of negative eigenvalues in corresponding graphs \cite{Li01}. \section{Results and Discussion} \label{RD} \begin{figure}[t!] \begin{center} \includegraphics[width=70mm]{g_bb_W.eps} \includegraphics[width=70mm]{g_dr_W.eps} \caption{ \label{g_bottle} The size ratio (\ref{gratio}) for bottlebrush polymers (left) and decorated rings (right) as functions of $n$ with two different sets of side chain types.} \end{center} \end{figure} \begin{figure}[b!] \begin{center} \includegraphics[width=70mm]{g_rings.eps} \includegraphics[width=70mm]{ro_rings.eps} \caption{ \label{g_ring} The size ratios (\ref{gratio}) on the left and (\ref{hratio}) on the right as functions of $n$ for toothbrushes and decorated rings with only one closed side chain.} \end{center} \end{figure} We start by considering a size ratio (\ref{gratio}) of the gyration radius of branched polymers with $f_c$ linear branches and $f_r$ branches in form of closed loops at each of branching points, as given by (\ref{Rgbb}) and (\ref{Rgdr}) for open and closed backbones correspondingly, and that of a linear chain of the same total molecular weight. Here we limit the discussion to the case with $a=1$ that corresponds to the backbone segment between the branching points being of the same length as the side chains. Note that at $n=3$ and $f=f_c+1,f_r=0$ we restore the corresponding expression for the so-called pom-pom polymer architecture \cite{Zimm49,Radke96}, containing two branching points each of functionality $f$. As examples, the values at some fixed parameters are presented on Fig. \ref{g_bottle} in comparison with our numerical data, obtained by application of Wei's method. At any value of $n$, the value of $g$ is smaller than $1$, which describes the shrinking of the branched structure in comparison with the linear one. This effect is increasing with increasing $n$. In the case of decorated ring (Fig. \ref{g_bottle},right) this compactification of the effective structure size at each $n$ is more pronounced. Furthermore, presence of side loops in turn leads to shrinking of the effective size of considered structures as compared with effect caused by linear side chains. Another important point to note is that both analytical and numerical methods provide results that are in a good agreement, though the path integration method allows to obtained the exact values of parameters for the case of Gaussian polymers, while the Wei's method provides only approximate values. { Separately we considered the case $f_c=0$, $f_r=1$ (see Fig. \ref{g_ring}), which may be related to a problem of so-called loop extrusion (formation a set of single loops along the fibre) in chromatin \cite{Alipour12,Fudenberg16,Goloborodko16,Mirny21}. Loop extrusion is the compaction process, that organizes DNA. An expected compactification (decreasing of the radii of gyration as compared with linear fiber) is observed. } \begin{figure}[t!] \begin{center} \includegraphics[width=70mm]{ro_bb.eps} \includegraphics[width=70mm]{ro_dr.eps} \caption{ \label{ro_b} The size ratio (\ref{hratio}) for bottlebrush polymers (left) and decorated rings (right) as functions of $n$ with two different sets of side chain types.}\end{center} \end{figure} An estimate for another important size ratio, defined by (\ref{hratio}) have been evaluated on the basis of expressions (\ref{Rgbb}), (\ref{Rgdr}), (\ref{Rhbb}). As examples, the estimates at some fixed values of parameters are presented on Fig. \ref{ro_b}. Interesting to note, that dependence on the number of branching points $n$ is very different for bottlebrush structures with open and closed backbones. In the first case, the size ratio decreases with $n$ at small $n$ and then start to increase (left panel of \ref{ro_b}). For the case of decorated rings, the behaviour is crucially defined by the type of side branches: it decreases in presence of linear side chains, while looped side chains stimulate the size ratio to increase. For small values of $n$ and closed side chains, a much smaller ratio in comparison with open side chains might be explained by more compact and thus more dense structure, so that the difference between gyration and hydrodynamic radii is very small. \section{Conclusions} \label{C} The aim of the present study was to analyze the impact of the structural parameters like the number of branching points $n$ and their functionalities (number of linear $f_c$ and circular $f_r$ side branches) on the effective size measures of bottlebrush and decorated rings polymers in solutions. In particular, the averaged size of typical conformation of individual molecule defines the diffusivity of such molecules in a solvent and thus impact their viscoelastic and phase transition behavior. Applying the path integration method based on Edwards model of continious chain, we evaluated exact expressions for the gyration and hydrodynamic radii of multibranched structures under considerations. The size ratios of obtained gyration radii of branched structures (given by Eqs. (\ref{Rgbb}) and (\ref{Rgdr})) and that of the linear chain $\langle R_g^2 \rangle_{\rm chain}$ of the the same total molecular weight were used to characterize the impact of the complex topology of structure on the effective size in solvent (the shrinking factor). Our results quantitatively describe the shrinking of the branched structure in comparison with the linear one; this effect is increasing with increasing $n$ and is more pronounced in the case of decorated ring. Presence of side loops leads to further shrinking of the effective size of considered structures as compared with linear side chains. These results are confirmed also by numerical simulations performed by us within the frame of so-called Wei's method, which encounters some limitations however in presence of multiple closed loops in a structure. Expressions for hydrodynamic radius of considered structures is evaluated as well. The subject of the forthcoming study will be to go beyond the simplified Gaussian approximation by taking into account the excluded volume effect between monomers. This, in particular, will allow us to evaluate the impact of steric effects, caused by side branches in open and lopped form, on the effective size measure of the backbone chain and to analyze the conformational properties of considered structures more deeply. \section*{ Acknowledgements} Authors would like to acknowledge the support from the National Academy of Sciences of Ukraine, Project KPKBK 6541230. K.H. would like to acknowledge the support from the National Science Center, Poland (Grant No. 2018/30/E/ST3/00428). \section*{Appendix} The analytical expressions corresponding to all the diagrams shown on Figs. \ref{D:1}, \ref{D:2}, \ref{D:3}, needed to calculate the gyration radius of considered polymer structures, are listed below: \begin{eqnarray} &&\xi_{1,g}=d\frac{L^3}{6},\\ &&\xi_{2,g}=d\frac{L^3}{12},\\ &&\xi_{3,g}=d\frac{L_1L_2(L_1+L_2)}{2},\\ &&\xi_{4,g}=d\frac{L_1L_2(3L_1+L_2)}{6},\\ &&\xi_{5,g}=d\frac{L_1L_2(L_1+L_2)}{6},\\ &&\xi_{6,g}=d\left(\frac{L_1L_2(L_1+L_2)}{6}+i L_b L_1 L_2\right),\\ &&\xi_{7,g}=d\left(\frac{L_1L_2(L_1+L_2)}{2}+i L_b L_1 L_2\right),\\ &&\xi_{8,g}=d\left(\frac{L_1L_2(3L_1+L_2)}{6}+i L_b L_1 L_2\right),\\ &&\xi_{9,g}=d\left(\frac{L_1L_2(L_1+L_2)}{2}+i L_b L_1 L_2+\frac{i L_b L_1 L_2}{n}\right),\\ &&\xi_{10,g}=d\left(\frac{L_1L_2(L_1+L_2)}{6}+i L_b L_1 L_2+\frac{i L_b L_1 L_2}{n}\right),\\ &&\xi_{11,g}=d\left(\frac{L_1L_2(3L_1+L_2)}{6}+i L_b L_1 L_2+\frac{i L_b L_1 L_2}{n}\right). \end{eqnarray} Here, $L, L_1,\,L_2,\,L_b$ are the lengths of the segments with $L_b$ being the length between the branching points. Note that diagrams $\xi_{1,g}$ and $\xi_{2,g}$ describe contributions from ether a chain or closed ring and thus they depend on only one parameter; for diagrams $\xi_{4,g},\xi_{8,g}$ and $\xi_{11,g}$, $L_1$ is the length of the looped trajectory with a restriction point and $L_2$ of the open one (unlike the rest of the diagrams these three are not symmetrical with respect to $L_1$ and $L_2$). The number of backbone segments between the considered branching points is denoted by $i$, thus changing from $1$ to $n$. In the same way, we can present the list of expressions used to evaluate the hydrodynamic radius: \begin{eqnarray} &&\xi_{1,h}=C_{\xi}\frac{4L^{3/2}}{3},\\ &&\xi_{2,h}=C_{\xi}\frac{\pi L^{3/2}}{2},\\ &&\xi_{3,h}=C_{\xi}\frac{4(L_1+L_2)^{3/2}-4L_1^{3/2}-4L_2^{3/2}}{3},\\ &&\xi_{4,h}=C_{\xi}\left(L_2\sqrt{L_1}+\left(\frac{L_2^{3/2}}{2}+2\sqrt{L_2}L_1\right)\arcsin\left(\frac{L_2}{\sqrt{4L_1L_2+L_2^2}}\right)\right.\nonumber\\ &&\left.-\frac{\pi L_2^{3/2}}{4}\right),\\ &&\xi_{5,h}=C_{\xi}\pi\left(L_1\sqrt{L_2}+L_2\sqrt{L_1}-\sqrt{L_2}\sqrt{L_1}\sqrt{L_1+L_2}\right),\\ &&\xi_{6,h}=\frac{C_{\xi}}{\sqrt{4L_2L_bi+L_1L_2+L_2^2}}\left(L_2\sqrt{L_1}\right.\nonumber\\ &&\left(\arctan\left(\frac{4L_bi+L_2+\sqrt{L_2(4L_bi+L_1+L_2)}}{2\sqrt{L_1L_bi}}\right)\right.\nonumber\\ &&\left.-\arctan\left(\frac{4L_bi+L_2-\sqrt{L_2(L_bi+L_1+L_2)}}{2\sqrt{L_1L_bi}}\right)\right)(4L_bi+L_1+L_2)\nonumber\\ &&\left.-2\sqrt{L_2(4L_bi+L_1+L_2)}\left( L_1\sqrt{L_2}\arcsin\left(\frac{L_2}{\sqrt{L_2(4L_bi+L_2)}}\right)\right.\right.\nonumber\\ &&\left.\left.+L_2\sqrt{L_1}\arctan\left(\frac{\sqrt{L_1}}{2\sqrt{L_bi}}\right) \right) \right),\\ &&\xi_{7,h}=C_{\xi}\frac{4}{3}\left((L_bi)^{\frac{3}{2}}-(L_bi+L_1)^{\frac{3}{2}}-(a+L_2)^{\frac{3}{2}}+(L_bi+L_1+L_2)^{\frac{3}{2}}\right),\\ &&\xi_{8,h}=C_{\xi}\frac{\sqrt{L_1}}{2}\left(\arctan\left(\frac{\sqrt{L_1}}{2\sqrt{L_bi+L_2}}\right)(4L_bi+L_1+4L_2)\right.\nonumber\\ &&\left.-\arctan\left(\frac{\sqrt{L_1}}{2\sqrt{L_bi}}\right)(4L_bi+L_1)+2\sqrt{(L_bi+L_2)L_1}-2\sqrt{L_bi L_1}\right),\\ &&\xi_{9,h}=\frac{4C_{\xi}}{3n^{\frac{3}{2}}}\left(((L_1+L_2+L_bi)n-L_bi^2)^{\frac{3}{2}}-((L_2+L_bi)n-L_bi^2)^{\frac{3}{2}}\right.\nonumber\\ &&\left.-((L_1+L_bi)n-L_bi^2)^{\frac{3}{2}}+(L_bi(n-i))^{\frac{3}{2}}\right),\\ &&\xi_{10,h}=\frac{C_{\xi}}{\sqrt{L_2n((4L_bi+L_1+L_2)n-4L_bi^2)}}\left(L_2\sqrt(L_1)\right.\times\nonumber\\ &&\left.\left(\arctan\left(\frac{4L_bi(n-i)-\sqrt{L_2}\sqrt{(4L_bi+L_1n+L_2n)-4L_bi^2}\sqrt{n}+L_2n}{2\sqrt{n(n-i)L_1iL_b}}\right)\right.\right.\nonumber\\ &&\left.-\arctan\left(\frac{(4L_bi(n-i)+L_2n+\sqrt{L_2n((4L_bin+L_1+L_2)-4L_bi^2)}}{2\sqrt{L_1iL_b(n-i)n}}\right)\right)\nonumber\\ &&\times((4L_bin+L_1+L_2)-4L_bi^2)\nonumber\\ &&+2\sqrt{L_2n((4L_bi+L_1+L_2)n-4L_bi^2)}L_1 L_2\times\nonumber\\ &&\left.\left(\frac{1}{\sqrt{L_1}}\arcsin\left(\frac{\sqrt{L_2n}}{4L_bin+L_2n-4L_bi^2}\right)\right.\right.\nonumber\\ &&\left.\left.+\frac{1}{\sqrt{L_2}}\arctan\left(\frac{\sqrt{L_1n}}{\sqrt{L_bi(n-i)}}\right)\right)\right),\\ &&\xi_{11,h}=\frac{C_{\xi}\sqrt{L_2}}{2n^{\frac{3}{2}}}\left(\sqrt{n}\arcsin\left(\frac{\sqrt{nL_2}}{\sqrt{(4L_bi+4L_1+L_2)n-4L_bi^2}}\right)\right.\nonumber\\ &&\times((4L_bi+4L_1+L_2)n-4L_bi^2)-\sqrt{n}\arcsin\left(\frac{\sqrt{nL_2}}{\sqrt{(4L_bi+L_2)n-4L_bi^2}}\right)\nonumber\\ &&\left.\times((4L_bi+L_2)n-4L_bi^2)+2\sqrt{L_2L_bin+L_1L_2n-L_2L_bi^2}n\right.\nonumber\\ &&\left.-2\sqrt(L_2L_bin-L_2L_bi^2)n\right). \end{eqnarray} Here, $C_{\xi}=\frac{\sqrt{2}\Gamma\left(\frac{d-1}{2}\right)}{\Gamma\left(\frac{d}{2}\right)}$. \section*{References}

\section{Introduction} In this paper, we investigate stationary solutions of the non-local aggregation equation \begin{equation} \label{eq1} \partial_t\rho =\nabla\cdot(\rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)) \end{equation} in $\mathbb{R}^N$ where $G$ is a bounded purely attractive and integrable interaction potential and $\rho\in L^1(\mathbb{R}^N)\cap L^m(\mathbb{R}^N)$ a non-negative function satisfying $\|\rho\|_{L^1}=1$. Since we can rescale time in \eqref{eq1}, we assume the potential $G$ to be normalized, i.e. $\|G\|_{L^1}=1$, and state all results depending on the coefficient $\varepsilon>0$. Due to the theory of gradient flows in \cite{ambrosiogiglisavare}, we can consider the aggregation equation \eqref{eq1} for probability density functions $\rho\in L^m(\mathbb{R}^N)$ formally as a gradient flow in the Wasserstein metric of the energy functional \begin{equation} \label{eq2} E[\rho]=\int_{\mathbb{R}^N}\frac{\varepsilon}{m}\rho^m(x)\,dx-\frac{1}{2}\int_{\mathbb{R}^N}\int_{\mathbb{R}^N}G(x-y)\rho(y)\rho(x)\,dydx. \end{equation} Equation \eqref{eq1} is discussed in \cite{topazbertozzilewis} for $m=3$ to model biological aggregation. The non-linear diffusion models an anti-crowding motion acting locally repulsive while the attractive potential models a non-local aggregative behaviour. Performing some weakly non-linear and asymptotic analysis, so-called clump solutions with sharp edges are obtained in \cite{topazbertozzilewis} as stationary solutions of \eqref{eq1} which is one reasonable behaviour for biological swarming. In \cite{burgerdifrancescofranek}, it is shown for $N=1$ and $m=2$ that a unique stationary solution of \eqref{eq1} exists if the coefficient $\varepsilon$ satisfies $0<\varepsilon<1$ and that a stationary solution of \eqref{eq1} is compactly supported. In \cite{burgerfetecauhuang}, it can be found for $N=1$ a detailed discussion about stationary states of \eqref{eq1} for any $m>1$ partly based on numerical experiments. These observations are the starting point for this work. Aggregation equations with a Newtonian or Bessel potential, which do not fall into the class of potentials considered in this paper, are widely studied due to the Keller-Segel model for chemotaxis \cite{kellersegel}. This model reads in a simplified form as \begin{align} \begin{split} \label{kellersegel} \partial_t\rho & =\Delta\rho-\nabla\cdot(\rho\nabla\phi),\\ -\Delta\phi+\alpha\phi & =\rho \end{split} \end{align} with $\alpha\geq0$. For an extensive summary about results of the Keller-Segel system until 2003 see e.g.\ the review \cite{horstmann} and the references therein. Here, we only focus on thresholds which allow us to characterize properties of solutions of system \eqref{kellersegel} in $\mathbb{R}^N$. In \cite{dolbeaultperthame,blanchetdolbeaultperthame}, it is shown for $N=2$ and $\alpha=0$, depending on the conserved total mass $M=\|\rho\|_{L^1}$, that for $M>8\pi$ solutions of system \eqref{kellersegel} blow up in finite time and that for $M<8\pi$ a global in time weak solution of \eqref{kellersegel} exists which converges with exponential rate \cite{camposdolbeault} to the self-similar solution of \eqref{kellersegel}. The critical case $M=8\pi$ is considered in \cite{blanchetcarrillomasmoudi} where the existence of a global in time solution with a finite second moment blowing up in infinite time is proved whereas the existence of a stationary solution with an infinite second moment is shown in the critical case in \cite{blanchetcarlencarrillo}. Considering the Keller-Segel system \eqref{kellersegel} with a homogeneous non-linear diffusion \begin{align} \begin{split} \label{kellersegeldegenerate} \partial_t\rho & =\Delta\rho^m-\nabla\cdot(\rho\nabla\phi),\\ -\Delta\phi+\alpha\phi & =\rho, \end{split} \end{align} we basically end up with equation \eqref{eq1} with a Newtonian or Bessel potential since we can rewrite \eqref{kellersegeldegenerate} as \begin{equation} \label{kellersegeldegeneraterewritten} \partial_t\rho=\nabla\cdot(\nabla\rho^m-\rho\nabla(G\ast\rho)) \end{equation} with a Newtonian or Bessel potential $G$. In \cite{bedrossianrodriguezbertozzi}, existence and uniqueness of weak solutions of \eqref{kellersegeldegeneraterewritten} are proved in $\mathbb{R}^N$ for $N\geq3$ for a wide class of attractive interaction potentials $G$ including the Newtonian and Bessel potentials. This result covers the well-posedness of weak solutions obtained in \cite{bertozzislepcev} for smooth attractive potentials and extends the existence theory for the Bessel potential in \cite{sugiyama2}. Existence and uniqueness of solutions to \eqref{kellersegeldegeneraterewritten} with respect to entropy solution are considered in \cite{burgercapassomorale} and for $N=1$ the uniqueness of solutions to \eqref{kellersegeldegeneraterewritten} is shown in \cite{burgerdifrancesco} using the pseudo-inverse of the Wasserstein distance. Moreover, in \cite{bedrossianrodriguezbertozzi} it is determined for $N\geq3$ a critical exponent of the degenerate diffusion and a critical mass such that similar results as for the Keller-Segel system \eqref{kellersegel} for $N=2$ are obtained. In addition, for subcritical exponents it is shown that a global in time solution exists whereas in the supercritical case a finite time blow-up can occur for a certain class of problems. In particular, for the Newtonian and Bessel potential these results are also partly obtained in \cite{blanchetcarrillolaurencot} and \cite{sugiyama1,sugiyama2} respectively where the critical exponent is $m=2-\frac{2}{N}$. Some of the results in \cite{bedrossianrodriguezbertozzi} are extended in \cite{bedrossianrodriguez} to $\mathbb{R}^2$. Regarding stationary solutions, equation \eqref{kellersegeldegeneraterewritten} is considered with a Newtonian or regularized Newtonian potential in \cite{kimyao}. Among others, it is shown via some mass comparison that there is a unique radially symmetric stationary solution for $m>2-\frac{2}{N}$ in dimensions $N\geq3$ which is monotonically decreasing and compactly supported. See also \cite{liebyau} for radial uniqueness results for stationary solutions of \eqref{kellersegeldegeneraterewritten} with a Newtonian potential. In addition, it is derived in \cite{kimyao} that continuous, radially symmetric and compactly supported solutions of equation \eqref{kellersegeldegeneraterewritten} with a Newtonian or regularized Newtonian potential are asymptotically converging in the subcritical case to the unique radial stationary solution as $t\rightarrow\infty$. The asymptotic behaviour towards stationary solutions in the critical case is considered in \cite{yao}. The symmetry of stationary solutions of equation \eqref{kellersegeldegeneraterewritten} with a Newtonian potential is investigated in \cite{stroehmer} in three dimensions. It is shown via some variant of the moving plane method that compact stationary solutions are radially symmetric. Combining the results in \cite{kimyao} and \cite{stroehmer}, one can conclude that compact stationary solutions of equation \eqref{kellersegeldegeneraterewritten} with a Newtonian interaction are unique in the subcritical case in three dimensions. The ideas of \cite{kimyao} and \cite{stroehmer} were recently used in \cite{carrillocastorinavolzone} to show that there is a unique compact stationary solution of equation \eqref{kellersegeldegeneraterewritten} with a Newtonian potential for $N=2$. This unique compact stationary solution coincides with the global minimizer of the corresponding energy. For results in the supercritical case $0<m<2-\frac{2}{N}$ and $N\geq3$ see e.g.\ \cite{bianliu}. Recently, using continuous Steiner symmetrization techniques it was shown in \cite{carrillohittmeirvolzoneyao} for $N\geq1$ that all stationary solutions of equation \eqref{kellersegeldegeneraterewritten} are radially symmetric and monotonically decreasing if the interaction potential $G$ is radially symmetric, purely attractive and satisfies some growth assumptions. In particular, in case of a Newtonian interaction it is proved that there is a unique stationary solution. Moreover, for $N=2$ it is shown that a weak solution is converging towards this unique stationary solution as $t\rightarrow\infty$. Furthermore, in \cite{chayeskimyao} the non-local aggregation equation \eqref{kellersegeldegeneraterewritten} with a symmetric attractive $C^2$-potential is considered on a torus. For $m=2$, it is shown in the subcritical case $\varepsilon>\max_{k\neq0}\big\{|\hat{G}(k)|\,\big|\,\hat{G}(k)>0\big\}$, where $\hat{G}$ denotes the Fourier transform of $G$, that the global minimizer is the constant solution and the energy of a weak solution converges exponentially fast to the energy of the constant solution with a rate depending on the initial data. In the supercritical case, it is found that a strictly positive solution, in particular the constant solution, is not a local minimizer of the energy. Similar results regarding such a phase transition were obtained before in \cite{chayespanferov} for an aggregation equation with linear diffusion. Recently, many results were achieved considering non-local aggregation equations without diffusion in the space of probability measures. Instead of the diffusion and a purely attractive potential, a potential which acts locally repulsive and non-locally attractive is considered. Particularly, power-law potentials are widely studied. Depending on the potential, a rich variety of pattern formation is observed, see e.g.\ \cite{bertozzikolokolnikovsunuminskyvonbrecht}. In \cite{balaguecarrillolaurentraoul1}, the dimensionality of local minimizers of the corresponding energy is determined out of the strength of the local repulsive behaviour and in \cite{balaguecarrillolaurentraoul2}, the stability of radially symmetric solutions is investigated. Aggregation equations of this type do allow for stationary solutions not being radially symmetric, in contrast to aggregation equations with a degenerate diffusion and a suitable attractive potential as we consider here. This is due to the symmetry result in \cite{carrillohittmeirvolzoneyao}. Regarding power-law potentials, the regularity of local minimizers is studied in \cite{carrillodelgadinomellet} and, if the repulsive part behaves like the Newtonian potential, the existence of unique radially symmetric and compactly supported stationary solutions is derived in \cite{fetecauhuangkolokolnikov,fetecauhuang}. Recently, for certain parameters of the power-law potential, explicit radially symmetric stationary solutions are obtained in \cite{carrillohuang}. Especially for power-law potentials, the existence of a global minimizer of the corresponding energy is shown in \cite{choksifetecautopaloglu} via the concentration-compactness principle of Lions \cite{lions} and in \cite{carrillochipothuang} via the discrete setting and some compactness observation. In \cite{canizocarrillopatacchini,simioneslepcevtopaloglu}, the existence of global minimizers is obtained for more general potentials. Additionally, it is shown in \cite{canizocarrillopatacchini} that global minimizers are compactly supported. The strategy in \cite{canizocarrillopatacchini} is to consider the problem first in a given ball instead of the whole space because this setting allows to derive the existence of a global minimizer. If there exists a probability measure such that its energy is less than the limit of the interaction potential at infinity, then it is shown that the diameter of the support of the global minimizer for the problem restricted to the ball is bounded from above independently of the size of the ball. This result is used to conclude that a compact global minimizer of the energy exists in the whole space. The approach in \cite{canizocarrillopatacchini} is similar to the one in \cite{auchmutybeals}. In this paper, assuming that the interaction potential $G$ is bounded and radially strictly monotonically decreasing, we derive a sharp condition for stationary solutions of \eqref{eq1} being compactly supported which we then use to show that global minimizers of the energy functional \eqref{eq2}, if they exist, have compact support. In \cite{bedrossian}, it is proved that a global minimizer of the energy functional \eqref{eq2} exists for $m=2$ and $0<\varepsilon<1$ as well as for $m>2$ and all $\varepsilon>0$. In \cite{burgerdifrancescofranek}, it is shown for $m=2$ that the threshold for the coefficient $\varepsilon$ is sharp. For a bounded, radially symmetric and purely attractive potential, we also characterize for $1<m<2$ a threshold $\varepsilon_0$ such that a global minimizer exists for all coefficients $0<\varepsilon\leq\varepsilon_0$. We prove this statement by adapting the compactness considerations of \cite{canizocarrillopatacchini} to our problem instead of following the approach in \cite{bedrossian} via the concentration-compactness principle of Lions \cite{lions} which only applies to $m\geq2$. Moreover, for $m=2$ and $0<\varepsilon<1$ we show in arbitrary dimensions that the global minimizer of the energy functional \eqref{eq2} is unique up to a translation and that it is the unique stationary solution of \eqref{eq1} up to a translation. This stationary solution is radially symmetric and monotonically decreasing. We use several ideas from the proof for $N=1$ in \cite{burgerdifrancescofranek} as well as the symmetry result in \cite{carrillohittmeirvolzoneyao} and compactness considerations from \cite{canizocarrillopatacchini} to prove the uniqueness in higher dimensions. For $m>2$, we prove that a compact stationary solution of \eqref{eq1} exists for all $\varepsilon>0$ if the interaction potential $G$ is bounded and strictly radially monotonically decreasing. For $1<m<2$, we show the existence of a constant $\varepsilon_0>0$ depending on the interaction potential and the exponent $m$ of the degenerate diffusion such that a compact stationary solution of \eqref{eq1} exists for all $0<\varepsilon\leq\varepsilon_0$. The results for $m\neq2$ are conjectured in \cite{burgerfetecauhuang}. Furthermore, our results complement some findings in \cite{burgerfetecauhuang} where it is shown for $N=1$ that for all $L>0$ there is some coefficient $\varepsilon>0$ such that a radially symmetric and monotonically decreasing stationary solution of \eqref{eq1} with support $[-L,L]$ exists. We extend this statement to arbitrary dimensions. In addition, under the assumptions that for $m\neq2$ there is a unique radially symmetric and monotonically decreasing stationary solution of \eqref{eq1} with the coefficient $\varepsilon$ strictly increasing with the size of the support (which we prove for $m=2$ and which is indicated by numerical results in \cite{burgerfetecauhuang} for $m\neq2$), we show the following. For $1<m<2$, this unique stationary solution coincides with the global minimizer of the energy \eqref{eq2} for coefficients $\varepsilon>0$ not greater than $\varepsilon_0$ but loses this property for coefficients with a larger value. In particular, under these assumptions we show that $\varepsilon_0<\varepsilon_1$ where $\varepsilon_1$ denotes the threshold for the existence of a compact stationary solution of \eqref{eq1}. Numerically, it is also observed in \cite{burgerfetecauhuang} that stationary solutions of \eqref{eq1} being only local minimizers may exist. Due to the additional non-linearity arising for $m\neq2$, it seems to be rather difficult to prove the uniqueness result which holds for $m=2$. However, numerical observations in \cite{burgerfetecauhuang} indicate that uniqueness should also be valid for $m\neq2$. So, this question stays an open problem for now. Besides, another interesting open problem not considered in the present paper concerns the long-time asymptotic of solutions to the aggregation equation \eqref{eq1} with a bounded attractive potential. The paper is organized as follows: we state some assumptions of the interaction potential and the main result of the paper in Section \ref{notationandmainresult}. In Section \ref{preliminaries}, we show that under these assumptions stationary solutions of \eqref{eq1} are continuous in $\mathbb{R}^N$ as well as radially symmetric and monotonically decreasing. In Section \ref{compactness}, we derive a condition to characterize compact stationary solutions of \eqref{eq1} and prove that global minimizers of the energy functional \eqref{eq2} are compactly supported. The existence of a global minimizer of the energy given in \eqref{eq2} is shown in Section \ref{globalminimizers}. In Section \ref{stationarysolutions} we prove in arbitrary dimensions for $m=2$ uniqueness of stationary solutions of \eqref{eq1} up to a translation and consequently we show the uniqueness of the global minimizer of the corresponding energy. Finally, we discuss the existence of stationary solutions of \eqref{eq1} with positive energy in Section \ref{discussion}. \section{Notation and main result} \label{notationandmainresult} In the entire paper, we suppose the interaction potential $G$ to satisfy that \begin{enumerate}[label=(G\arabic*)] \item\label{(G1)} $G$ is non-negative and $\mathrm{supp}\,G=\mathbb{R}^N$, \item\label{(G2)} $G\in\,W^{1,1}(\mathbb{R}^N)\cap L^{\infty}(\mathbb{R}^N)\cap C^2(\mathbb{R}^N)$ with $\|G\|_{L^1}=1$, \item\label{(G3)} $G$ is radially symmetric and strictly monotonically decreasing, i.e.\ $G(x)=g(|x|)$ and $g^\prime(r)<0$ for all $r>0$, \item\label{(G4)} $g^{\prime\prime}(0)<0$ and $\lim_{r\rightarrow +\infty}g(r)=0$. \end{enumerate} Especially, $G$ being bounded plays an important role in our further considerations. We define \begin{equation} \mathcal{P}^{M}(\mathbb{R}^N)\coloneqq\Big\{f\in L_+^1(\mathbb{R}^N)\,\Big|\,\int_{\mathbb{R}^N}f(x)\,dx=M\Big\} \end{equation} and for $M=1$ we use the abbreviated notation $\mathcal{P}(\mathbb{R}^N)$. Moreover, we write \begin{equation} \mathcal{P}_R(\mathbb{R}^N)\coloneqq\Big\{f\in L_+^1(\mathbb{R}^N)\,\Big|\,\int_{\mathbb{R}^N}f(x)\,dx=1,\,\mathrm{supp}\,f\subset\overline{B_R(0)}\Big\}. \end{equation} We consider stationary solutions of \begin{equation} \label{eq1b} \partial_t\rho =\nabla\cdot(\rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)) \end{equation} in $\mathbb{R}^N$ and minimizers of the corresponding energy \begin{equation} \label{eq2b} E[\rho]=\int_{\mathbb{R}^N}\frac{\varepsilon}{m}\rho^m(x)\,dx-\frac{1}{2}\int_{\mathbb{R}^N}\int_{\mathbb{R}^N}G(x-y)\rho(y)\rho(x)\,dydx \end{equation} in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. As a main result of this paper, we will prove that for $m=2$ a stationary solution of \eqref{eq1b} is unique up to a translation: \begin{thm} \label{uniquenesstheoremformequals2} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}, $m=2$ and $0<\varepsilon<1$, then there exists up to a translation a unique stationary solution $\rho\in L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b}. Moreover, $\rho$ has the following properties: \begin{itemize} \item $\rho\in C^2(\mathrm{supp}\,\rho)\cap C(\mathbb{R}^N)$. \item $\mathrm{supp}\,\rho=\overline{B_R(0)}$ for some $R>0$ depending on $\varepsilon$. \item $\rho$ is radially symmetric. \item $\rho$ is monotonically decreasing with increasing radius. \item $\rho$ is the unique (up to a translation) global minimizer of the energy $E$ in $L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. \end{itemize} \end{thm} \section{Continuity and symmetry of stationary solutions} \label{preliminaries} First, we recall some results being obtained among others in \cite[Section 2 and Section 3]{burgerdifrancescofranek} for $m=2$ which can be straightforwardly extended to all $m>1$. \begin{lem} \label{resultsfromburgerdifrancescofranek} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}, then the following results are satisfied for $m>1$ and $\varepsilon>0$: \begin{enumerate}[label=(\roman*)] \item\label{results(i)} The total mass $\int_{\mathbb{R}^N}\rho(x,t)\,dx$ of a solution of \eqref{eq1b} is preserved. \item\label{results(ii)} The center of mass $\int_{\mathbb{R}^N}x\rho(x,t)\,dx$ of a solution of \eqref{eq1b} is preserved. \item\label{results(iii)} If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a stationary solution of \eqref{eq1b}, then it holds that \begin{equation*} \varepsilon\rho^{m-1}-G\ast\rho=C \end{equation*} almost everywhere on every connected component of $\mathrm{supp}\,\rho$ where the constant $C$ may be different for each connected component. Moreover, we have $\rho^{m-1}\in C^2(\mathrm{supp}\,\rho)$ and $|\nabla\rho^{m-1}|\leq C^{\prime}$ in $\mathrm{supp}\,\rho$. \item\label{results(iv)} If $\rho$ is a minimizer of the energy functional $E$ given in \eqref{eq2b} in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$, then we have \begin{equation*} \rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)=0 \end{equation*} almost everywhere in $\mathbb{R}^N$. \item\label{results(v)} If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a solution to \begin{equation*} \rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)=0, \end{equation*} then $\rho$ is a stationary point of the energy $E$ given in \eqref{eq2b}. \item\label{results(vi)} If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a connected stationary solution of \eqref{eq1b}, then we have \begin{equation*} \varepsilon\rho^{m-1}(x)=(G\ast\rho)(x)+2E[\rho]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho^m(y)\,dy \end{equation*} for all $x\in\,\mathrm{supp}\,\rho$. \end{enumerate} \end{lem} In addition, in \cite[Corollary 2.3]{burgerdifrancescofranek} it is shown for $N=1$ that a stationary solution of \eqref{eq2b} is continuous in $\mathbb{R}$. It is easy to prove this result for higher dimensions. \begin{lem} \label{continuityofstationarysolution} If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a stationary solution of \eqref{eq1b}, $m>1$, $\varepsilon>0$ and $G$ satisfies \ref{(G1)}-\ref{(G4)}, then $\rho$ is continuous in $\mathbb{R}^N$. \end{lem} \begin{proof} By Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(iii)}, a stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} satisfies after differentiation and multiplication by $\rho$ \begin{equation*} \varepsilon\frac{m-1}{m}\nabla(\rho^m)=\rho\nabla(G\ast\rho). \end{equation*} Due to \ref{(G2)}, \ref{(G4)} and $\rho\in\mathcal{P}(\mathbb{R}^N)$, we have $|\nabla(G\ast\rho)(x)|\leq C^\prime$ such that we obtain $\|\nabla(\rho^m)\|_{L^p}\leq \varepsilon^{-1}\frac{m}{m-1}C^\prime\|\rho\|_{L^p}$ for some $p\geq1$. Since $\rho\in L^1(\mathbb{R}^N)\cap L^m(\mathbb{R}^N)$, it follows that $\rho^m\in W^{1,1}(\mathbb{R}^N)$ and by Sobolev embedding we conclude for $N>1$ that $\rho^m\in L^p(\mathbb{R}^N)$ for all $1\leq p\leq\frac{N}{N-1}$. Hence, $\rho^m\in W^{1,p}(\mathbb{R}^N)$ and repeating the argument for $1<p<N$ it follows $\rho^m\in W^{1,q}(\mathbb{R}^N)$ for all $1\leq q\leq\frac{Np}{N-p}$. By Sobolev embedding, we conclude that $\rho^m\in C(\mathbb{R}^N)$ if $q>N$. Otherwise, we repeat the argument for $p<q<N$ until $\rho^m\in W^{1,r}(\mathbb{R}^N)$ for some $r>N$. \end{proof} Using a continuous Steiner symmetrization, in \cite[Section 2]{carrillohittmeirvolzoneyao} it is shown under suitable assumptions of the interaction potential that certain stationary solutions of an aggregation equation with a degenerate diffusion are radially symmetric and monotonically decreasing up to a translation. Due to our assumptions of the interaction potential $G$, in particular its radial symmetry, strict monotonicity and boundedness, and due to Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(iii)}, the symmetry result \cite[Theorem 2.2]{carrillohittmeirvolzoneyao} applies such that we can state the following theorem. \begin{thm} \label{symmetryofstationarysolutions} If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a stationary solution of \eqref{eq1b}, $m>1$, $\varepsilon>0$ and $G$ satisfies \ref{(G1)}-\ref{(G4)}, then $\rho$ is radially symmetric and monotonically decreasing up to a translation. In particular, $\rho$ has a connected support. \end{thm} \section{Compactness of stationary solutions} \label{compactness} In \cite{canizocarrillopatacchini}, the existence of a global minimizer of the energy functional \begin{equation*} F[\mu]=\frac{1}{2}\int_{\mathbb{R}^N}\int_{\mathbb{R}^N}W(x-y)\,d\mu(y)d\mu(x) \end{equation*} is shown with $\mu$ being a probability measure and $W$ an appropriate interaction potential. One key idea to obtain this result is first considering a global minimizer of $F$ in the space of probability measures with support in a given ball and to show that in a fixed neighbourhood of each point of the support of this global minimizer there is at least a certain amount of mass concentrated. To derive this statement, one has to assume that the given ball is large enough and that the potential $W$ is unstable, i.e.\ that a probability measure $\mu$ with $F[\mu]<\lim_{|x|\rightarrow\infty}W(x)$ exists. Under a suitable condition for the energy, we perform a calculation similar to a part of the proof in \cite[Lemma 2.6]{canizocarrillopatacchini} to conclude that stationary solutions of \eqref{eq1b}, i.e.\ solutions $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ to the equation \begin{equation} \rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)=0 \end{equation} in $\mathbb{R}^N$ are compactly supported. \begin{lem} \label{condforcompsupp} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a stationary solution of \eqref{eq1b}, $m>1$, $\varepsilon>0$ and if there exists a constant $K<0$ such that \begin{equation} \label{condforcompsuppeq1} 2E[\rho]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho^m(y)\,dy\leq K, \end{equation} then $\rho$ is compactly supported. \end{lem} \begin{proof} Let $A<0$ with $K<A$ and $-G(0)<A$. By our assumptions of $G$, we know that there is an $r>0$ with $-G(x)>A$ for all $|x|>r$. Since $\rho$ has connected support due to Theorem \ref{symmetryofstationarysolutions}, by Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(vi)} it follows that \begin{equation*} \begin{aligned} K & \geq 2E[\rho]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho^m(y)\,dy\\ & =\varepsilon\rho^{m-1}(z)-\int_{\mathbb{R}^N}G(z-y)\rho(y)\,dy\\ & \geq-G(0)\int_{B_r(z)}\rho(y)\,dy+A\int_{\mathbb{R}^N\setminus B_r(z)}\rho(y)\,dy\\ & =(-G(0)-A)\int_{B_r(z)}\rho(y)\,dy+A \end{aligned} \end{equation*} for $z\in\,\mathrm{supp}\,\rho$. Due to $-G(0)-A<0$ and $K-A<0$, we obtain \begin{equation*} \int_{B_r(z)}\rho(y)\,dy\geq\frac{A-K}{A+G(0)}\eqqcolon C>0. \end{equation*} The constant $C$ is independent from $z$ such that this bound holds for every $z\in\,\mathrm{supp}\,\rho$ and we conclude that $\rho$ has a compact support because otherwise we obtain a contradiction. \end{proof} The proof of Lemma \ref{condforcompsupp} can be obtained more directly using Theorem \ref{symmetryofstationarysolutions}, Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(iv)} and the continuity of a stationary solution of \eqref{eq1b} in $\mathbb{R}^N$ (cf. Lemma \ref{continuityofstationarysolution}). However, we will use in Section \ref{globalminimizers} the above argumentation to show the existence of global minimizers of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. Using the continuity of a stationary solution of \eqref{eq1b} in $\mathbb{R}^N$, we can actually show that $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ being a compact stationary solution of \eqref{eq1b} is equivalent to the existence of a constant $K<0$ such that \begin{equation*} 2E[\rho]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho^m(y)\,dy\leq K \end{equation*} is satisfied. \begin{lem} \label{compsuppsatisfycond} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. If $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is a compact stationary solution of \eqref{eq1b}, $m>1$ and $\varepsilon>0$, then there exists a constant $K<0$ such that \begin{equation*} 2E[\rho]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho^m(y)\,dy\leq K \end{equation*} is satisfied. \end{lem} \begin{proof} Due to the symmetry result of Theorem \ref{symmetryofstationarysolutions} and since $\rho$ has compact support, there exists an $R<\infty$ such that we can assume that $\mathrm{supp}\,\rho=\overline{B_R(0)}$ without loss of generality. Then, by Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(vi)} and by the continuity of $\rho$ in $\mathbb{R}^N$ it follows that \begin{equation*} 2E[\rho]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho^m(y)\,dy=-(G\ast\rho)(R). \end{equation*} Now, choose $K=-(G\ast\rho)(R)$. \end{proof} \begin{rmk} \label{differentcompcond} Using the definition of the energy $E$, we can rewrite the compactness condition in Lemma \ref{condforcompsupp} for a stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} as \begin{equation} \label{differentcompcondeq1} \int_{\mathbb{R}^N}\varepsilon\rho^m(x)\,dx-\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx\leq K \end{equation} with a constant $K<0$. Using Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(vi)}, we can also rewrite the compactness condition as \begin{equation} \label{differentcompcondeq2} \varepsilon\rho^{m-1}(x)-(G\ast\rho)(x)\leq K \end{equation} for all $x\in\,\mathrm{supp}\,\rho$. Moreover, due to \ref{(G3)} and \ref{(G4)}, a stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} with non-compact support has to satisfy equation \eqref{condforcompsuppeq1}, \eqref{differentcompcondeq1} or \eqref{differentcompcondeq2} with equality and $K=0$. \end{rmk} \begin{cor} \label{propcompandnoncompsol} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}, $m>1$ and $\varepsilon>0$. A compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} satisfies (after a translation such that the center of mass is in zero) \begin{equation} \label{equationforcompactsolution} \varepsilon\rho^{m-1}(x)=(G\ast\rho)(x)-(G\ast\rho)(R) \end{equation} for all $x\in\,\mathrm{supp}\,\rho$ where $\mathrm{supp}\,\rho=\overline{B_R(0)}$ for some $R<\infty$. Moreover, we have \begin{equation*} \|\rho\|_{L^{m}}^{m}=\frac{1}{\varepsilon}\Big(\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx-(G\ast\rho)(R)\Big) \end{equation*} and the energy of a compact stationary solution of \eqref{eq1b} can be written as \begin{equation*} \begin{aligned} E[\rho] & =\int_{\mathbb{R}^N}\varepsilon\Big(\frac{1}{m}-\frac{1}{2}\Big)\rho^m(y)\,dy-\frac{1}{2}(G\ast\rho)(R)\\ & =\Big(\frac{1}{m}-\frac{1}{2}\Big)\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx-\frac{1}{m}(G\ast\rho)(R). \end{aligned} \end{equation*} A non-compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} satisfies \begin{equation} \label{equationforconnectednoncompactsolution} \varepsilon\rho^{m-1}(x)=(G\ast\rho)(x) \end{equation} in $\mathbb{R}^N$. Moreover, we have \begin{equation*} \|\rho\|_{L^{m}}^{m}=\frac{1}{\varepsilon}\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx \end{equation*} and the energy of a non-compact stationary solution of \eqref{eq1b} can be written as \begin{equation*} \begin{aligned} E[\rho] & =\int_{\mathbb{R}^N}\varepsilon\Big(\frac{1}{m}-\frac{1}{2}\Big)\rho^m(y)\,dy\\ & =\Big(\frac{1}{m}-\frac{1}{2}\Big)\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx. \end{aligned} \end{equation*} \end{cor} \begin{proof} By Lemma \ref{continuityofstationarysolution} and Theorem \ref{symmetryofstationarysolutions}, a stationary solution of \eqref{eq1b} is continuous as well as radially symmetric and monotonically decreasing. Using Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(vi)}, we immediately obtain equations \eqref{equationforcompactsolution} and \eqref{equationforconnectednoncompactsolution}. These equation can be used to calculate the $L^m$-norm and the energy $E$ of $\rho$. \end{proof} \begin{rmk} \label{mequals2nononcompact} For $m=2$, there cannot exist a non-compact stationary solution $\rho\in L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b}, which satisfies $\mathrm{supp}\,\rho=\mathbb{R}^N$ due to Theorem \ref{symmetryofstationarysolutions}, since when integrating \eqref{equationforconnectednoncompactsolution} over $\mathbb{R}^N$ we obtain $\varepsilon=1$. Using a Fourier transform, it is shown in the proof of \cite[Theorem 3.5]{burgerdifrancescofranek} that if $\varepsilon=1$ (the critical case for $m=2$), then no $\rho\in L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ satisfying $\varepsilon\rho(x)=(G\ast\rho)(x)$ in $\mathbb{R}^N$ exists. For $m\neq 2$, we cannot exclude the existence of a non-compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} via the Fourier approach. \end{rmk} \begin{thm} \label{negenergy} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. Every stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} (compact or non-compact) has negative energy if $m\geq 2$ and $\varepsilon>0$. \end{thm} \begin{proof} By Corollary \ref{propcompandnoncompsol}, for $m\geq2$ no compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} with non-negative energy exists. Furthermore, for $m>2$ no non-compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} with non-negative energy exists due to Corollary \ref{propcompandnoncompsol} and the existence of a non-compact stationary solution of \eqref{eq1b} for $m=2$ is excluded by Remark \ref{mequals2nononcompact}. \end{proof} \begin{rmk} \label{stationarysolutionswithpositiveenergy} By Corollary \ref{propcompandnoncompsol}, we directly see that for $1<m<2$ and $\varepsilon>0$ a non-compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b}, if it exists, has positive energy. Moreover, for $1<m<2$ and $\varepsilon>0$ the compactness condition from Lemma \ref{condforcompsupp} does not exclude the existence of compact stationary solutions of \eqref{eq1b} with positive energy in contrast to $m\geq 2$. \end{rmk} \begin{thm} \label{globmincomp} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}, $m>1$ and $\varepsilon>0$. If a global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ exists, it is compactly supported. \end{thm} \begin{proof} For $1<m\leq 2$, a global minimizer, if it exists (cf.\ Section \ref{globalminimizers}), has non-positive energy such that, due to Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(iv)} and \ref{results(vi)}, it applies Lemma \ref{condforcompsupp}. Therefore, let $m>2$ and assume that $\rho$ is a non-compact global minimizer, i.e.\ \begin{equation*} \varepsilon\rho^{m-1}(x)=(G\ast\rho)(x). \end{equation*} Since $\rho$ is radially symmetric and monotonically decreasing by Riesz symmetric decreasing rearrangement inequality and since we have $\int_{\mathbb{R}^N}\rho(x)\,dx=1$, it holds that $\rho(x)|B_{|x|}(0)|\leq1$ such that we conclude that $\rho(x)\leq C|x|^{-N}$. Moreover, using that $G$ is positive and radially symmetric by conditions \ref{(G1)} and \ref{(G3)}, for $|x|>1$ we estimate that \begin{equation*} \begin{aligned} (G\ast\rho)(x)&=\int_{\mathbb{R}^N}G(x-y)\rho(y)\,dy\geq\rho(x)\int_{B_{|x|}(0)}G(x-y)\,dy\\ & \geq\rho(x)\int_{B_1(x-\frac{x}{|x|})}G(x-y)\,dy=\rho(x)\int_{B_1(0)}G\Big(\frac{x}{|x|}-y\Big)\,dy=C^\prime\rho(x) \end{aligned} \end{equation*} with $C^\prime$ dependent on $G$ but independent from $x$ because of the radial symmetry of $G$. Therefore, we have \begin{equation*} \varepsilon\rho^{m-1}(x)-(G\ast\rho)(x)\leq\rho(x)(\varepsilon C^{m-2}|x|^{-N(m-2)}-C^\prime) \end{equation*} which contradicts for large $|x|>1$ the assumption that $\rho$ is a non-compact stationary solution of (1) since $m>2$. \end{proof} \section{Existence of global minimizers} \label{globalminimizers} In the following, we prove the existence of a global minimizer of the energy \begin{equation*} E[\rho]=\int_{\mathbb{R}^N}\frac{\varepsilon}{m}\rho^m(x)\,dx-\frac{1}{2}\int_{\mathbb{R}^N}\int_{\mathbb{R}^N}G(x-y)\rho(y)\rho(x)\,dydx \end{equation*} in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ without using the concentration-compactness principle \cite{lions} if the interaction potential $G$ satisfies \ref{(G1)}-\ref{(G4)}. For $m\geq2$, we obtain the same result as in \cite{bedrossian} and for $1<m<2$ we determine coefficients $\varepsilon>0$ which allow the existence of a global minimizer. Using the concentration-compactness principle it is proved in \cite[Theorem II.1]{lions} that a global minimizer of $E$ exists if and only if the strict subadditivity condition \begin{equation} \inf_{\rho\in L^m\cap\mathcal{P}}E[\rho]<\inf_{\rho\in L^m\cap\mathcal{P}^M}E[\rho]+\inf_{\rho\in L^m\cap\mathcal{P}^{(1-M)}}E[\rho] \end{equation} is satisfied for all $M\in(0,1)$. Moreover, in \cite{lions} the interaction potential does not need to be necessarily radially symmetric and monotonically decreasing. However, verifying that the strict subadditivity condition is satisfied may not be straightforward. In \cite[Corollary II.1]{lions} this condition is shown to be satisfied if either $1<m\leq2$ and $\inf_{\rho\in L^m\cap\mathcal{P}}E[\rho]<0$ or $G(\tau x)\geq\tau^{-k}G(x)$ for all $\tau\geq1$ and almost every $x\in\mathbb{R}^N$ and $\inf_{\rho\in L^m\cap\mathcal{P}}E[\rho]<0$. If the interaction potential $G$ is non-negative, radially symmetric and monotonically decreasing, it is proved in \cite{bedrossian} that a global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ exists for any coefficient $\varepsilon>0$ if $m>2$ and for any $0<\varepsilon<1$ if $m=2$. Moreover, it is shown that a global minimizer is radially symmetric and monotonically decreasing if the interaction potential $G$ is radially symmetric and strictly monotonically decreasing. The strategy of the proof is to use a suitable scaling argument to observe that, under the above assumptions of $\varepsilon$ and $m$, for every $M>0$ a function $\rho\in C_0^\infty(\mathbb{R}^N)\cap L^m(\mathbb{R}^N)\cap\mathcal{P}^{M}(\mathbb{R}^N)$ with $E[\rho]<0$ exists. Together with Riesz symmetric decreasing rearrangement inequality, this statement is used to show that for $M_1>M_2$ the relation \begin{equation} \label{massminrelation} \inf_{\rho\in L^m\cap\mathcal{P}^{M_1}}E[\rho]<\inf_{\rho\in L^m\cap\mathcal{P}^{M_2}}E[\rho]. \end{equation} is satisfied. This conclusion is used to derive the existence of a radially symmetric and monotonically decreasing global minimizer using Riesz symmetric decreasing rearrangement inequality and following the approach of the concentration-compactness principle of Lions \cite{lions}. More precisely, the inequality \eqref{massminrelation} is needed to rule out that dichotomy occurs. We prove the existence of global minimizers of $E$ with a potential satisfying \ref{(G1)}-\ref{(G4)} using some ideas in \cite{canizocarrillopatacchini} instead of the concentration-compactness principle \cite{lions}. In \cite{canizocarrillopatacchini}, the existence of global minimizers is investigated in a slightly different setting. More precisely, an interaction energy functional \begin{equation*} F[\mu]=\frac{1}{2}\int_{\mathbb{R}^N}\int_{\mathbb{R}^N}W(x-y)\,d\mu(y)d\mu(x) \end{equation*} with $\mu$ being a probability measure and $W$ an appropriate interaction potential is analysed. It is shown that if considering the problem on a given ball, then the diameter of the support of a global minimizer of $F$ is bounded independently of the size of the given ball. This observation is used to conclude that a global minimizer of the problem in the whole space exists. A similar approach can also be found in \cite{auchmutybeals}. Moreover, this strategy allows to consider the case $\inf_{\rho\in L^m\cap\mathcal{P}}E[\rho]=0$ for $1<m<2$ which is not covered by the approach in \cite{lions}. We will obtain in this section the following result: \begin{thm} \label{existenceofglobalmin} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. Let one of the following conditions be satisfied: \begin{itemize} \item[(i)] $1<m<2$ and $0<\varepsilon\leq\varepsilon_0\coloneqq\sup_{\rho\in L^m\cap\mathcal{P}}\frac{m}{2}\|\rho\|_{L^m}^{-m}\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx$ \item[(ii)] $m=2$ and $0<\varepsilon<1$ \item[(iii)] $m>2$ and $\varepsilon>0$ \end{itemize} Then, there exists a global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ which is radially symmetric and monotonically decreasing. If $1<m\leq2$ and the corresponding condition (i) or (ii) for the coefficient $\varepsilon$ is not satisfied, then there exists no global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. \end{thm} First, let us remark that a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ cannot have positive energy. So, if we want to obtain a global minimizer for $1<m<2$, we have to assume at least that $\varepsilon$ is chosen such that a function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with $E[\rho]\leq0$ exists. If we assume that a function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with $E[\rho]=0$ exists but none with $E[\rho]<0$, then $\rho$ is already a global minimizer. Therefore, it is enough to consider the case that $E[\rho]<0$ for some $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. Following an analogous idea given in \cite[Lemma 2.5]{canizocarrillopatacchini}, we define \begin{equation*} \rho_n\coloneqq\frac{1}{\int_{B_n(0)}\rho(x)\,dx}\chi_{B_n(0)}\rho. \end{equation*} By Lebesgue's monotone convergence theorem, we obtain \begin{equation*} E[\rho_n]\rightarrow E[\rho]\quad\mathrm{for}\quad n\rightarrow\infty \end{equation*} such that a function $\hat{\rho}\in L^m(\mathbb{R}^N)\cap\mathcal{P}_S(\mathbb{R}^N)$ with $E[\hat{\rho}]<0$ exists for some large enough but finite constant $S$. In particular, there exists a $\hat{\rho}\in L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ with $E[\hat{\rho}]<0$ for all $R\geq S$. In the following, we always denote by $S$ the finite constant we just obtained. \begin{lem} \label{globminrestricteddomain} Let $m>1$, $\varepsilon>0$ and let $G$ satisfy \ref{(G1)}-\ref{(G4)}. Then, there exists a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ for every $R>0$. \end{lem} \begin{proof} Since $G$ is bounded from above, we have $\inf_{\rho\in L^m\cap\mathcal{P}_R}E[\rho]>-\infty$. Let $(\rho_n)_{n\in\mathbb{N}}$ denote a minimizing sequence for $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$. Since $G$ is bounded from above and $(\rho_n)_{n\in\mathbb{N}}$ a minimizing sequence, it holds that $(\rho_n)_{n\in\mathbb{N}}$ is bounded in $L^m(\mathbb{R}^N)$. So, there exists a subsequence $(\rho_{n_k})_{k\in\mathbb{N}}$ such that $\rho_{n_k}$ converges weakly in $L^m(\mathbb{R}^N)$ to some $\rho_R\in L^m(\mathbb{R}^N)$. Further, $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ is convex and closed in $L^m(\mathbb{R}^N)$ since $L^m(\overline{B_R(0)})$ is closed in $L^m(\mathbb{R}^N)$ and since the embedding of $L^m(\overline{B_R(0)})$ in $L^1(\overline{B_R(0)})$ as well as the mass constraint is continuous in $L^1(\overline{B_R(0)})$. Therefore, $L^m({\mathbb{R}^N})\cap\mathcal{P}_R(\mathbb{R}^N)$ is weakly closed in $L^m(\mathbb{R}^N)$ and we have $\rho_R\in L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$. Obviously, $E$ is weakly lower semi-continuous in $L^m(\mathbb{R}^N)$ such that $E[\rho_R]=\inf_{\rho\in L^m\cap\mathcal{P}_R}E[\rho]$. \end{proof} Performing similar calculations as in \cite[Lemma 2.3]{canizocarrillopatacchini}, we get the following result for a global minimizer of the energy in the restricted setting. \begin{lem} Let $m>1$, $\varepsilon>0$ and let $G$ satisfy \ref{(G1)}-\ref{(G4)}. Let $\rho_R$ be a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$, then we have \begin{equation} \label{equationforglobalminimizer} \varepsilon\rho_R^{m-1}(x)-(G\ast\rho_R)(x)=2E[\rho_R]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho_R^m(y)\,dy \end{equation} almost everywhere in $\mathrm{supp}\,\rho_R$. \end{lem} \begin{proof} Let $\psi\in C_0^\infty(\mathbb{R}^N)$ and define \begin{equation*} f(x)\coloneqq\Big(\psi(x)-\int_{\mathbb{R}^N}\psi(y)\rho_R(y)\,dy\Big)\rho_R(x) \end{equation*} for all $x\in\mathbb{R}^N$ and $\rho_{\delta}\coloneqq\rho_R+\delta f$ with $\delta>0$. Then, it holds that \begin{equation*} \int_{\mathbb{R}^N}\rho_{\delta}(x)\,dx=\int_{\mathbb{R}^N}\rho_R(x)\,dx+\delta\int_{\mathbb{R}^N}f(x)\,dx=1. \end{equation*} Moreover, we have \begin{equation*} \psi(x)-\int_{\mathbb{R}^N}\psi(y)\rho_R(y)\,dy\geq -2\|\psi\|_{L^\infty(\mathbb{R}^N)} \end{equation*} such that $\rho_{\delta}(x)\geq(1-2\delta\|\psi\|_{L^{\infty}(\mathbb{R}^N)})\rho_{R}(x)$. So, for sufficiently small $\delta>0$ we have $\rho_{\delta}\in L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ and since $\rho_R$ is a global minimizer in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$, it follows that $E[\rho_{\delta}]\geq E[\rho_R]$. Therefore, we obtain \begin{equation*} \begin{aligned} & \frac{1}{\delta}\big(E[\rho_{\delta}]-E[\rho_R]\big)\big|_{\delta=0}\\ & \quad =\int_{\mathbb{R}^N}\Big(\varepsilon\rho_R^{m-1}(x)-(G\ast\rho_R)(x)-2E[\rho_R]\Big)\rho_R(x)\psi(x)\,dx\\ & \quad\quad +\int_{\mathbb{R}^N}\Big(\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho_R^m(y)\,dy\Big)\rho_R(x)\psi(x)\,dx\\ & \quad \geq0. \end{aligned} \end{equation*} Since this inequality holds for all $\psi\in C_0^\infty(\mathbb{R}^N)$, we conclude that \begin{equation*} \varepsilon\rho_R^{m-1}(x)-(G\ast\rho_R)(x)=2E[\rho_R]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho_R^m(y)\,dy \end{equation*} holds almost everywhere in $\mathrm{supp}\,\rho_R$. \end{proof} Taking into consideration the proof of Lemma \ref{condforcompsupp} and the strategy in \cite{canizocarrillopatacchini}, for $R\geq S$ we obtain for each point in the support of a global minimizer $\rho_R$ a lower bound for the mass in a certain neighbourhood. The size of the neighbourhood as well as of the lower bound do not depend on $R$. This is because of $E[\rho_R]\leq E[\rho_S]<0$ for all $R\geq S$, where $\rho_R$ denotes a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ and $\rho_S$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_S(\mathbb{R}^N)$ respectively, since we can now choose \begin{equation*} K=2E[\rho_S] \end{equation*} in the proof of Lemma \ref{condforcompsupp}. By Riesz symmetric decreasing rearrangement inequality, we know that the global minimizer $\rho_R$ is radially symmetric and monotonically decreasing, i.e.\ it has connected support. As in \cite[Lemma 2.9]{canizocarrillopatacchini}, due to our above considerations about mass concentration, we obtain an upper bound $D<+\infty$ for the diameter of the support of $\rho_R$ for all $R>0$. Using that, as in \cite[Lemma 2.10]{canizocarrillopatacchini} we prove the following statement. \begin{lem} \label{globalminimizerformsmaller2} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. Let $1<m<2$ and $\varepsilon>0$ be small enough such that a function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with $E[\rho]\leq0$ exists. Then, there exists a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. \end{lem} \begin{proof} As argued before, we only need to consider the case $E[\rho]<0$. We can conclude analogously as in the proof for a global minimizer in \cite[Lemma 2.10]{canizocarrillopatacchini} and include the proof for the convenience of the reader. Let $D$ denote the upper bound of the diameter of the support of a global minimizer $\rho_R$ for all $R>0$ and let $\rho_D$ be a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_D(\mathbb{R}^N)$. Then, we show that $\rho_D$ actually is a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. First, consider a function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with compact support, i.e.\ $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ for some $R>0$. Then, $E[\rho_R]\leq E[\rho]$ with $\rho_R$ denoting a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$. Since the diameter of the support of $\rho_R$ is bounded by $D$, we have $\rho_R\in L^m(\mathbb{R}^N)\cap\mathcal{P}_D(\mathbb{R}^N)$. Therefore, it holds that $E[\rho_D]\leq E[\rho]$ for all $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with compact support. Now, consider some function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ without further restrictions. If $n$ is chosen large enough, it holds that $\rho(B_n(0))>0$. Define \begin{equation*} \rho_n\coloneqq\frac{1}{\int_{B_n(0)}\rho(x)\,dx}\chi_{B_n(0)}\rho \end{equation*} for $n$ large enough and observe that $E[\rho_n]\rightarrow E[\rho]$ as $n\rightarrow\infty$ by Lebesgue's monotone convergence theorem. Since $\rho_n$ is compactly supported, we have $E[\rho_D]\leq E[\rho_n]$ for all $n$. Therefore, it holds that $E[\rho_D]\leq E[\rho]$. Due to $E[\rho_D]<0$ by assumption, we have shown that $\rho_D$ is a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. \end{proof} By our previous approach, we can also prove the existence of global minimizers for $m\geq2$, which is obtained in \cite{bedrossian} via the concentration-compactness principle of Lions \cite{lions}, if we assume the interaction potential $G$ to be bounded. Notice that for $m=2$, no function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with $E[\rho]=0$ exists due to Lemma \ref{compsuppsatisfycond} and since no non-compact stationary solution of \eqref{eq1b} exists for $m=2$ (cf.\ Remark \ref{mequals2nononcompact}). So, for $m=2$ we also obtain as in \cite{bedrossian} the existence of a global minimizer for every $0<\varepsilon<1$. Furthermore, there cannot exist a global minimizer of $E$ in $L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ for $\varepsilon\geq1$ because of the non-existence of a stationary solution of \eqref{eq1b} as shown in \cite[Lemma 3.4 and Theorem 3.5]{burgerdifrancescofranek}. Keep in mind, it is also impossible for $1<m<2$ that a global minimizer exists for coefficients $\varepsilon>0$ not satisfying the condition in Lemma \ref{globalminimizerformsmaller2}. For $m>2$, we assume by contradiction that there exists no upper bound for the diameter of the support of global minimizers $\rho_R$ of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ for all $R>0$. Then, we can use equation \eqref{equationforglobalminimizer} and the argumentation in the proof of Theorem \ref{globmincomp} to show that a global minimizer $\rho_S$ of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_S(\mathbb{R}^N)$ satisfies \begin{equation*} 2E[\rho_S]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho_S^m(y)\,dy\leq\rho_S(x)(\varepsilon C^{m-2}|x|^{-N(m-2)}-C^\prime)<0 \end{equation*} if $S$ is chosen large enough such that there exists a point $x\in\,\mathrm{supp}\,\rho_S$ with $|x|>1$ large enough. We have to show that there exists a constant $K<0$ such that \begin{equation*} 2E[\rho_R]-\int_{\mathbb{R}^N}\varepsilon\Big(\frac{2}{m}-1\Big)\rho_R^m(y)\,dy\leq K<0 \end{equation*} for all $R\geq S$. We can use this constant $K$ as in the proof of Lemma \ref{condforcompsupp} to obtain a uniform upper bound for the diameter of the support of $\rho_R$. Choosing a point $x\in\,\mathrm{supp}\,\rho_S$ such that $\varepsilon C^{m-2}|x|^{-N(m-2)}-C^\prime<0$, we are done if it holds that $\rho_R(x)\geq c>0$ for all $R\geq S$ since we can choose $K=c(\varepsilon C^{m-2}|x|^{-N(m-2)}-C^\prime)$. Let us assume the contrary, i.e. $\rho_R(x)\rightarrow0$ as $R\rightarrow\infty$, and note that $\rho_R$ is radially symmetric and monotonically decreasing. If $\int_{\mathbb{R}^N}\rho_\infty(x)\,dx=1$, then we have $E[\rho_\infty]=E[\rho_S]$ and $\rho_\infty\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ which means that there exists a global minimizer $\rho_R$ of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ with $\mathrm{supp}\,\rho_R\subset\mathrm{supp}\,\rho_S$ for all $R\geq S$. We exclude $\rho_\infty\equiv0$ since $E[\rho_R]\leq E[\rho_S]<0$. Furthermore, for every $\delta>0$ we find a constant $R^\prime>0$ such that $\inf_{\rho\in L^m\cap\mathcal{P}}E[\rho]>E[\rho_R]-\delta$ for all $R\geq R^\prime$. Therefore, assuming that $\int_{\mathbb{R}^N}\rho_\infty(x)\,dx=M\in(0,1)$ we obtain a contradiction by inequality \eqref{massminrelation} (which holds for $m>2$) since $E[\rho_R]\rightarrow E[\rho_\infty]\geq\inf_{\rho\in L^m\cap\mathcal{P}^M}E[\rho]$. \begin{lem} \label{noexistenceofglobminformsmaller2} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. Let $1<m\leq2$ and $\varepsilon>\frac{m}{2}\|G\|_{L^{\frac{1}{m-1}}}$, then there exists no global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. \end{lem} \begin{proof} By H\"older's inequality and Young's inequality for convolutions, we obtain for $1\leq r\leq2$ \begin{equation*} \begin{aligned} \|(G\ast\rho)\rho\|_{L^1} & \leq\|G\ast\rho\|_{L^{\frac{r}{r-1}}}\|\rho\|_{L^r}\leq\|G\|_{L^{\frac{r}{2r-2}}}\|\rho\|_{L^r}^2\\ & \leq\|G\|_{L^{\frac{r}{2r-2}}}\|\rho\|_{L^{\frac{3r-2}{r}}}^{\frac{3r-2}{r}}\|\rho\|_{L^1}^{2-\frac{3r-2}{r}}. \end{aligned} \end{equation*} For $1<m\leq2$, we can choose $r\geq1$ such that $m=\frac{3r-2}{r}$ to conclude that \begin{equation*} E[\rho]\geq\frac{\varepsilon}{m}\|\rho\|_{L^m}^m-\frac{1}{2}\|G\|_{L^{\frac{1}{m-1}}}\|\rho\|_{L^m}^m\geq\Big(\frac{\varepsilon}{m}-\frac{1}{2}\|G\|_{L^{\frac{1}{m-1}}}\Big)\|\rho\|_{L^m}^m. \end{equation*} Obviously, there cannot exist a global minimizer with positive energy such that we exclude the existence of a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ for $\varepsilon>\frac{m}{2}\|G\|_{L^{\frac{1}{m-1}}}$. \end{proof} \begin{rmk} \label{noexistenceofcompstatsolformsmaller2} Analogously as in Lemma \ref{noexistenceofglobminformsmaller2}, we can state a result for the non-existence of compact stationary solutions of \eqref{eq1b} in case of $1<m\leq2$. Considering Lemma \ref{condforcompsupp}, we conclude that there cannot exist a compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} for $1<m\leq2$ if $\varepsilon>\|G\|_{L^{\frac{1}{m-1}}}$. \end{rmk} However, these estimates do not imply that a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ exists for all coefficients $\varepsilon\leq\frac{m}{2}\|G\|_{L^{\frac{1}{m-1}}}$ or that a compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} exists for all coefficients $\varepsilon\leq\|G\|_{L^{\frac{1}{m-1}}}$. The threshold for the existence of a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ can be specified for $1<m\leq2$ by \begin{equation} \varepsilon_0\coloneqq\sup_{\rho\in L^m\cap\mathcal{P}}\frac{m}{2}\frac{\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx}{\|\rho\|_{L^m}^m}. \end{equation} \begin{lem} Let $G$ be bounded and satisfy \ref{(G1)}-\ref{(G4)}. Let $1<m<2$, then there exists a compactly supported function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ such that $\varepsilon_0$ is attained. \end{lem} \begin{proof} Let us denote by $(\rho_n)_{n\in\mathbb{N}}$ a maximizing sequence in $L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$ for $\frac{m}{2}\|\rho\|_{L^m}^{-m}\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx$. Due to $G$ being bounded and $(\rho_n)_{n\in\mathbb{N}}$ being a maximizing sequence, it follows that $(\rho_n)_{n\in\mathbb{N}}$ is bounded in $L^m(\mathbb{R}^N)$. Therefore, as in the proof of Lemma \ref{globminrestricteddomain}, we can conclude that \begin{equation} \varepsilon_{0,R}\coloneqq\sup_{\rho\in L^m\cap\mathcal{P}_R}\frac{m}{2}\frac{\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx}{\|\rho\|_{L^m}^m} \end{equation} is attained for some $\rho_{0,R}\in L^m(\mathbb{R}^N)\cap\mathcal{P}_R(\mathbb{R}^N)$. Note that $(\rho_{0,R})_{R\geq R^\prime}$ is a maximizing sequence for the problem in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$, i.e. $\varepsilon_{0,R}\rightarrow\varepsilon_0$ as $R\rightarrow\infty$ and in particular $\varepsilon_{0,R}\geq\varepsilon_{0,R^\prime}$ for all $R\geq R^\prime$ where $R^\prime$ is chosen large enough. Due to $\|(G\ast\rho)\rho\|_{L^1}\leq\|G\|_{L^{\frac{m}{2m-2}}}\|\rho\|_{L^m}^2$, the $L^m$-norm of this maximizing sequence is bounded from below by a constant greater than zero, i.e. $\|\rho_{0,R}\|_{L^m}\geq\delta>0$ for all $R\geq R^\prime$. We use the lower bound of the $L^m$-norm to estimate that \begin{equation} 2E[\rho_{0,R}]-\int_{\mathbb{R}^N}\varepsilon_{0,R}\Big(\frac{2}{m}-1\Big)\rho_{0,R}^m(y)\,dy\leq-\varepsilon_{0,R^\prime} \Big(\frac{2}{m}-1\Big)\delta^m \end{equation} for all $R\geq R^\prime$. Choosing $K=-\varepsilon_{0,R^\prime}\big(\frac{2}{m}-1\big)\delta^m$ in Lemma \ref{condforcompsupp}, we obtain $\mathrm{supp}\,\rho_{0,R}\subset B_D(0)$ for all $R>0$ where $D$ depends on $R^\prime$ but is independent from $R\geq R^\prime$. Hence, $\rho_{0,R}\in L^m(\mathbb{R}^N)\cap\mathcal{P}_D(\mathbb{R}^N)$ for all $R>0$ and, similar as in the proof of Lemma \ref{globalminimizerformsmaller2}, it follows $\varepsilon_0=\varepsilon_{0,D}$. \end{proof} To sum up, we have now proved the statement of Theorem \ref{existenceofglobalmin} concerning the existence of a global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ depending on the exponent $m$ of the degenerate diffusion and the coefficient $\varepsilon$. \section{Uniqueness of stationary solutions} \label{stationarysolutions} In the following, we prove for $m=2$ in arbitrary dimensions the uniqueness of stationary solutions of \eqref{eq1b} up to a translation. In \cite{burgerdifrancescofranek}, it is shown for $N=1$ that a stationary solution of \eqref{eq1b} is unique up to a translation. As in \cite{burgerfetecauhuang} for $N=1$, we also derive for $m\neq2$ in higher dimensions that there are coefficients $\varepsilon$ such that compact stationary solutions of \eqref{eq1b} exist. First, we sketch the strategy in \cite[Section 4]{burgerdifrancescofranek} which is used to conclude for $N=1$ that up to a translation a unique stationary solution in $L^2(\mathbb{R})\cap\mathcal{P}(\mathbb{R})$ of \eqref{eq1b} exists for $m=2$ and $0<\varepsilon<1$. \begin{itemize} \item Stationary solutions of \eqref{eq1b} have connected support for $N=1$. \item Stationary solutions of \eqref{eq1b} are compactly supported for $N=1$. \item For any stationary solution of \eqref{eq1b} there exists a symmetric stationary solution of \eqref{eq1b} with the same energy if $N=1$. \item A stationary solution $\rho\in L^2(\mathbb{R})\cap\mathcal{P}(\mathbb{R})$ of \eqref{eq1b} with $|\mathrm{supp}\,\rho|\geq|\mathrm{supp}\,\rho_{\mathrm{min}}|$, where $\rho_{\mathrm{min}}$ is a global minimizer of $E$ in $L^2(\mathbb{R})\cap\mathcal{P}(\mathbb{R})$, is a minimizer. \item For every $L>0$, a unique function $\rho$ with $\mathrm{supp}\,\rho=[-L,L]$ exists which is symmetric, monotonically decreasing on $\{x>0\}$, compact and satisfies \begin{equation*} \varepsilon\rho(x)=\int_{-L}^{L}G(x-y)\rho(y)\,dy-(G\ast\rho)(L) \end{equation*} for some $\varepsilon>0$. This follows considering the eigenvalue problem \begin{equation*} \varepsilon\rho^{\prime}(x)=\int_0^L\big(G(x-y)-G(x+y)\big)\rho^{\prime}(y)\,dy \end{equation*} via the strong version of the Krein-Rutman theorem (see Theorem \ref{strongversionkreinrutman}). \item The eigenvalue $\varepsilon$ in the above eigenvalue problem is strictly monotonically increasing on $\{x>0\}$ with the size $L$ of the support of $\rho$. It holds that $\varepsilon\searrow 0$ as $L\searrow 0$ and $\varepsilon\nearrow1$ as $L\nearrow +\infty$. \item Using the above results and that the global minimizer is symmetric and monotonically decreasing, one can show for $\varepsilon<1$ that up to a translation a unique stationary solution $\rho\in L^2(\mathbb{R})\cap\mathcal{P}(\mathbb{R})$ of \eqref{eq1b} exists for $N=1$ which coincides with the global minimizer of $E$ in $L^2(\mathbb{R})\cap\mathcal{P}(\mathbb{R})$. \end{itemize} Due to Theorem \ref{symmetryofstationarysolutions}, we already know that a stationary solution of \eqref{eq1b} is radially symmetric and monotonically decreasing in higher dimensions. In particular, it has a connected support. As observed in Remark \ref{mequals2nononcompact}, for $m=2$ there cannot exist a stationary solution of \eqref{eq1b} with non-compact support. By Theorem \ref{globmincomp} and Theorem \ref{existenceofglobalmin}, we also know that the global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is radially symmetric, monotonically decreasing and has compact support. Following the last three points used for the proof for $N=1$, in higher dimensions we show for $m=2$ and $0<\varepsilon<1$ that there is a unique stationary solution of \eqref{eq1b} up to a translation which coincides with the global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$. Moreover, as in \cite[Section 3.1]{burgerfetecauhuang} for $N=1$, we deduce in higher dimensions in case of $m\neq 2$ for any $R>0$ the existence of a coefficient $\varepsilon>0$ such that there is a radially symmetric stationary solution of \eqref{eq1b} with support $\overline{B_R(0)}$. For radially symmetric functions $\rho$ and $G$, i.e.\ $\rho(x)=\tilde{\rho}(|x|)$ and $G(x)=g(|x|)$, we can write \begin{equation*} \begin{aligned} (G\ast\rho)(x) & =\int_{\mathbb{R}^N}G(x-y)\rho(y)\,dy=\int_0^{+\infty}\Big(\int_{\partial B_s(0)}G(x-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,ds\\ & =\int_0^{+\infty}\Big(\int_{\partial B_s(0)}G(|x|e_1-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,ds. \end{aligned} \end{equation*} Using that $\int_{\partial B_s(0)}\nabla G(x-y)\,d\sigma(y)$ is parallel to $x$ and rotationally invariant, it is shown in \cite[Lemma 3.2]{bertozzicarrillolaurent} that it holds \begin{equation} \nabla(G\ast\rho)(x)=\int_0^{+\infty}\Big(\int_{\partial B_s(0)}\nabla G(|x|e_1-y)\cdot e_1\,d\sigma(y)\Big)\tilde{\rho}(s)\,ds\,\frac{x}{|x|}. \end{equation} Similarly, we also derive \begin{equation} \nabla(G\ast\rho)(x)=\int_0^{+\infty}\Big(\int_{\partial B_s(0)}G(|x|e_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y)\Big)\tilde{\rho}^{\prime}(s)\,ds\,\frac{x}{|x|}. \end{equation} Using the radial symmetry of $G$, it is useful to observe that we have \begin{equation} \label{rotationjustwithg} \int_{\partial B_s(0)}G(re_1-y)\,d\sigma(y)=\frac{s^{N-1}}{r^{N-1}}\int_{\partial B_r(0)}G(se_1-y)\,d\sigma(y) \end{equation} and \begin{equation} \label{rotationwithgandcos} \int_{\partial B_s(0)}G(re_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y)=\frac{s^{N-1}}{r^{N-1}}\int_{\partial B_r(0)}G(se_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y). \end{equation} In the radial case, the energy functional reads \begin{equation*} \begin{aligned} E[\tilde{\rho}]= & \int_0^{+\infty}\frac{\varepsilon}{m}\tilde{\rho}^m(r)\omega_N r^{N-1}\,dr\\ & -\frac{1}{2}\int_0^{+\infty}\int_0^{+\infty}\omega_N r^{N-1}\tilde{\rho}(r)\Big(\int_{\partial B_s(0)}G(re_1-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,dsdr \end{aligned} \end{equation*} where $\omega_N$ denotes the surface area of the unit sphere in $\mathbb{R}^N$. Let us now state the strong version of the Krein-Rutman theorem as in \cite[Theorem 4.10]{burgerdifrancescofranek}. \begin{thm}[Krein-Rutman theorem, strong version] \label{strongversionkreinrutman} Let $X$ be a Banach space. Let $K\subset X$ be a solid cone, i.e.\ $\lambda K\subset K$ for all $\lambda\geq 0$ and $K$ has a non-empty interior $K_0$. Let $T$ be a compact linear operator which is strongly positive with respect to $K$, i.e.\ $T[u]\in K_0$ if $u\in K\setminus\{0\}$. Then: \begin{itemize} \item[(i)] The spectral radius $r(T)$ is strictly positive and $r(T)$ is a simple eigenvalue with an eigenvector $v\in K_0$. There is no other eigenvalue with a corresponding eigenvector $v\in K$. \item[(ii)] $|\lambda|<r(T)$ for all other eigenvalues $\lambda\neq r(T)$. \end{itemize} \end{thm} Following the approach for $N=1$ in \cite[Section 4]{burgerdifrancescofranek}, finding in higher dimensions a compact, radially symmetric and monotonically decreasing function $\rho\in C^2(\mathrm{supp}\,\rho)$ vanishing on the boundary and satisfying \begin{equation*} \varepsilon\rho(x)=(G\ast\rho)(x)-(G\ast\rho)(\tilde{x}) \end{equation*} with $\tilde{x}\in\partial(\mathrm{supp}\,\rho)$, means finding $\tilde{\rho}\in C^2(\mathrm{supp}\,\tilde{\rho})$ with $\mathrm{supp}\,\tilde{\rho}=[0,R]$ such that \begin{equation*} \begin{aligned} & \tilde{\rho}(R)=0,\quad -\tilde{\rho}^{\prime}(r)=u(r),\quad u\geq 0, \\ & \varepsilon u=\int_0^R H(r,s)u(s)\,ds\quad\mathrm{with}\quad H(r,s)\coloneqq\int_{\partial B_s(0)}G(re_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y). \end{aligned} \end{equation*} This is equivalent since we have \begin{equation*} \begin{aligned} \varepsilon\rho(x) & =\varepsilon\int_{|x|}^R -\tilde{\rho}^{\prime}(r)\,dr\\ & =-\int_{|x|}^R\int_0^R\Big(\int_{\partial B_s(0)}G(re_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y)\Big)\tilde{\rho}^{\prime}(s)\,dsdr\\ & =-\int_{|x|}^R\int_0^R\Big(\int_{\partial B_s(0)}\partial_r G(re_1-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,dsdr\\ & =-\int_0^R\Big(\int_{\partial B_s(0)}G(Re_1-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,ds\\ & \quad +\int_0^R\Big(\int_{\partial B_s(0)}G(|x|e_1-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,ds\\ & =(G\ast\rho)(x)-(G\ast\rho)(\tilde{x}) \end{aligned} \end{equation*} with $|\tilde{x}|=R$. In order to simplify notation, let us define \begin{align} Y_R & \coloneqq\{\tilde{\rho}\in C([0,R])\,\big|\,\tilde{\rho}(R)=0\},\\ \mathcal{H}_R[u](r) & \coloneqq \int_0^R\Big(\int_{\partial B_s(0)}G(re_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y)\Big)u(s)\,ds,\\ \mathcal{G}_R[\tilde{\rho}] & \coloneqq \int_0^R\Big(\int_{\partial B_s(0)}G(re_1-y)-G(Re_1-y)\,d\sigma(y)\Big)\tilde{\rho}(s)\,ds. \end{align} To prove the following result about uniqueness of a function with the above properties via the strong version of the Krein-Rutman theorem as in \cite[Proposition 4.11]{burgerdifrancescofranek} for $N=1$, it is enough to show that if $u\geq 0$, then $\mathcal{H}_R[u](r)\geq 0$ holds for all $r\in[0,R]$ and $\mathcal{H}_R[u](0)=0$. Moreover, for $u\in\{f\in C^1([0,R])\,\big|\,f(0)=0\}$ satisfying $u\geq0$ and $u\not\equiv0$ we must have $(\mathcal{H}[u])^{\prime}(0)>0$. \begin{thm} \label{uniquenessviakreinrut} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. For every $R>0$ there exists a unique, radially symmetric function $\rho\in C^2(\overline{B_R(0)})\cap\mathcal{P}(\mathbb{R}^N)\cap C(\mathbb{R}^N)$ with $\mathrm{supp}\,\rho=\overline{B_R(0)}$ and with radial representative $\tilde{\rho}$ such that $\tilde{\rho}^{\prime}(r)\leq 0$ for $r\geq0$, $\tilde{\rho}^{\prime\prime}(0)<0$ and such that $\rho$ solves \begin{equation*} \varepsilon\rho(x)=(G\ast\rho)(x)-(G\ast\rho)(R) \end{equation*} in $\overline{B_R(0)}$ for some coefficient $\varepsilon=\varepsilon(R)>0$. Moreover, $\varepsilon(R)$ is the largest eigenvalue of the compact operator $\mathcal{G}_R$ in the Banach space $Y_R$ and any other eigenfunction of $\mathcal{G}_R$ in $Y_R$ with \begin{equation*} \int_0^{+\infty}\tilde{\rho}(r)\omega_N r^{N-1}\,dr=1 \end{equation*} has the corresponding eigenvalue $\varepsilon^{\prime}$ satisfying $|\varepsilon^{\prime}|<\varepsilon(R)$. \end{thm} \begin{proof} Let us split up $H(r,s)$ into \begin{equation*} \begin{aligned} H(r,s) & =\int_{\partial B_s(0)\cap\{y_1>0\}}G(re_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y)\\ & \quad +\int_{\partial B_s(0)\cap\{y_1<0\}}G(re_1-y)\frac{y\cdot e_1}{|y|}\,d\sigma(y). \end{aligned} \end{equation*} For any $y_1>0$ there exists $\tilde{y}_1<0$ such that we have $-y_1=\tilde{y}_1$ as well as $\frac{y\cdot e_1}{|y|}=-\frac{\tilde{y}\cdot e_1}{|\tilde{y}|}$ with $y=(y_1,\ldots,y_N)$ and $\tilde{y}=(\tilde{y}_1,\ldots,y_N)$ on $\partial B_s(0)$. Let $r\geq 0$, then it holds that $|r-y_1|\leq|r-\tilde{y}_1|$, i.e.\ we have $|re_1-y|\leq|re_1-\tilde{y}|$ and $g(|re_1-y|)\geq g(|re_1-\tilde{y}|)$ and equality holds if and only if $r=0$ since $g$ is strictly monotonically decreasing. Therefore, we have $G(re_1-y)\frac{y\cdot e_1}{|y|}\geq-G(re_1-\tilde{y})\frac{\tilde{y}\cdot e_1}{|\tilde{y}|}$ such that $H(r,s)\geq 0$ for all $r\in[0,R]$ and an equality holds if and only if $r=0$. Due to $u$ being non-negative, we directly see that $\mathcal{H}_R[u](r)\geq 0$ holds for all $r\in[0,R]$ and $\mathcal{H}_R[u](0)=0$. Finally, calculating the derivative of $\mathcal{H}_R[u]$ at the point $r=0$ for $u\not\equiv 0$ \begin{equation*} \frac{d}{dr}\mathcal{H}_R[u](r)\Big|_{r=0}=-\int_0^{+\infty}\int_{\partial B(0,s)}g^{\prime}(|y|)\frac{y_1^2}{|y|^2}\,d\sigma(y)\,u(s)\,ds>0 \end{equation*} yields the desired inequality. \end{proof} Using the properties of the radially symmetric case as in Theorem \ref{uniquenessviakreinrut}, following the proofs for $N=1$ in \cite[Section 3.1]{burgerfetecauhuang} we also obtain in case of $m\neq2$ for all $R>0$ the existence of a compact, radially symmetric stationary solution of \eqref{eq1b} with $\mathrm{supp}\,\rho=\overline{B_R(0)}$ in higher dimensions. Due to the additional non-linearity arising for $m\neq2$, it seems to be difficult to obtain the uniqueness as in Theorem \ref{uniquenessviakreinrut}. \begin{thm} \label{existenceviakreinrutmanforgeneralm} Let $G$ satisfy \ref{(G1)}-\ref{(G4)}. For every $R>0$ there exists a radially symmetric function $\rho\in\mathcal{P}(\mathbb{R}^N)\cap C(\mathbb{R}^N)$ with $\mathrm{supp}\,\rho=\overline{B_R(0)}$ and with radial representative $\tilde{\rho}$ such that $\tilde{\rho}^{\prime}(r)\leq0$ for $r\geq0$, $\tilde{\rho}(R)=0$ and $\rho$ solves \begin{equation*} \varepsilon\rho^{m-1}(x)=(G\ast\rho)(x)-(G\ast\rho)(R) \end{equation*} in $\overline{B_R(0)}$ for some coefficient $\varepsilon>0$. \end{thm} Analogously to the one-dimensional case in \cite[Proposition 4.12]{burgerdifrancescofranek}, we can prove the following result in higher dimensions. \begin{lem} \label{eigenvalueandsupport} In case of $m=2$ the simple eigenvalue $\varepsilon(R)$ from Theorem \ref{uniquenessviakreinrut} is uniquely determined as a function of $R$ and $\varepsilon(R)$ is strictly monotonically increasing with $R$, $\varepsilon(R)\searrow 0$ as $R\searrow 0$ and $\varepsilon(R)\nearrow1$ as $R\nearrow +\infty$. \end{lem} \begin{proof} We adapt the approach in \cite[Proposition 4.12]{burgerdifrancescofranek} for $N=1$ to our setting. Let $u_R$ denote the unique eigenfunction from Theorem \ref{uniquenessviakreinrut} with corresponding eigenvalue $\varepsilon(R)$. We conclude, as was the idea in the proof of \cite[Proposition 4.12]{burgerdifrancescofranek}, by considering \begin{equation} \varepsilon(R)u_R(r)=\mathcal{H}_R[u_R](r), \end{equation} multiplying by $r^{N-1}u_{R+\delta}(r)$ and taking into consideration that $H(r,s)=\frac{s^{N-1}}{r^{N-1}}H(s,r)$ due to \eqref{rotationwithgandcos}. Then, we obtain for every $\delta>0$ \begin{equation*} \begin{aligned} & \varepsilon(R)\int_0^R r^{N-1}u_R(r)u_{R+\delta}(r)\,dr=\int_0^R r^{N-1}\mathcal{H}_R[u_R](r)u_{R+\delta}(r)\,dr\\ & \quad=\int_0^R\int_0^R H(r,s)u_R(s)\,ds\,u_{R+\delta}(r)\,dr\\ & \quad=\int_0^R s^{N-1}u_R(s)\Big(\int_0^{R+\delta}H(s,r)u_{R+\delta}(r)\,dr\Big)ds\\ & \quad\quad-\int_0^R s^{N-1}u_R(s)\Big(\int_R^{R+\delta}H(s,r)u_{R+\delta}(r)\,dr\Big)ds\\ & \quad=\varepsilon(R+\delta)\int_0^R s^{N-1}u_R(s)u_{R+\delta}(s)\,ds\\ & \quad\quad-\int_0^R s^{N-1}u_R(s)\Big(\int_R^{R+\delta}H(s,r)u_{R+\delta}(r)\,dr\Big)ds. \end{aligned} \end{equation*} Since we know by the proof of Theorem \ref{uniquenessviakreinrut} that it holds $u_R(r)>0$ for $r\in(0,R]$, we have shown that $\varepsilon(R+\delta)>\varepsilon(R)$. \end{proof} Now, we prove for $m=2$ in arbitrary dimensions that there is a unique stationary solution of \eqref{eq1b} up to a translation. \begin{proof}[Proof of Theorem \ref{uniquenesstheoremformequals2}] By Theorem \ref{existenceofglobalmin}, we know that a radially symmetric and monotonically decreasing global minimizer of $E$ in $L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ exists for $\varepsilon<1$. Therefore, the minimizer is connected and has compact support as shown in Theorem \ref{globmincomp}. Due to Corollary \ref{propcompandnoncompsol}, Theorem \ref{uniquenessviakreinrut} and Lemma \ref{eigenvalueandsupport}, we know that a unique stationary solution of \eqref{eq1b} with these properties exists such that we conclude that the global minimizer of the energy $E$ in $L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is unique. Moreover, by Corollary \ref{propcompandnoncompsol} and Remark \ref{mequals2nononcompact}, for $m=2$ no stationary solution $\rho\in L^2(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} with a non-compact support and due to Theorem \ref{symmetryofstationarysolutions} no stationary solution of \eqref{eq1b} not being radially symmetric and monotonically decreasing exists. Therefore, we have proved that a stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} is unique. \end{proof} \section{Discussion of stationary solutions with positive energy} \label{discussion} In this section, we discuss if a stationary solution of \eqref{eq1b} with positive energy may exist. We assume that the interaction potential $G$ satisfies \ref{(G1)}-\ref{(G4)}. We know by Theorem \ref{uniquenesstheoremformequals2} that for $m=2$ there exists for every $0<\varepsilon<1$ and $R>0$ a triple $(\varepsilon,R,\rho)$ where each component uniquely determines the other ones such that \begin{equation*} \rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)=0 \end{equation*} is satisfied. Here, $\rho$ is a radially symmetric and monotonically decreasing function $\rho\in C^2(\overline{B_R(0)})\cap\mathcal{P}(\mathbb{R}^N)\cap C(\mathbb{R}^N)$ with $\mathrm{supp}\,\rho=\overline{B_R(0)}$. If one would like to derive this result for $m\neq2$, even when being able to prove uniqueness in Theorem \ref{existenceviakreinrutmanforgeneralm}, which is indicated by numerical calculations in \cite[Section 4.2]{burgerfetecauhuang}, one cannot simply follow the approach in the proof of Lemma \ref{eigenvalueandsupport} since for general $m>1$ one obtains \begin{equation*} \begin{aligned} & \varepsilon(R+\delta)(m-1)\int_0^R r^{N-1}\tilde{\rho}_{R+\delta}^{m-2}(r)u_R(r)u_{R+\delta}(r)\,dr\\ & -\varepsilon(R)(m-1)\int_0^R r^{N-1}\tilde{\rho}_R^{m-2}(r)u_R(r)u_{R+\delta}(r)\,dr\\ & \quad=\int_0^R r^{N-1}u_R(r)\Big(\int_R^{R+\delta}H(r,s)u_{R+\delta}(s)\,ds\Big)dr. \end{aligned} \end{equation*} Out of this equation, one could still conjecture that the coefficient $\varepsilon$ is strictly monotonically increasing with the size of the support as is also suggested by numerical results in \cite[Section 4.2]{burgerfetecauhuang}. However, in case of $m>2$ we can at least show that the size of the support of a compact stationary solution of \eqref{eq1b} is bounded from below by the coefficient $\varepsilon$. Using the reverse H\"older inequality, we obtain \begin{equation} \label{estimateforrhoinnorm} \varepsilon\|\rho\|_{L^{m-1}}^{m-1}=\varepsilon\|\rho^{m-1}\|_{L^1}\geq\varepsilon\|\rho\|_{L^1}^{m-1}|\mathrm{supp}\,\rho|^{2-m}=\varepsilon|\mathrm{supp}\,\rho|^{2-m}. \end{equation} Since we assume the stationary solution of \eqref{eq1b} to be compactly supported, it holds that $\varepsilon\rho^{m-1}(x)<G\ast\rho(x)$ in $\mathrm{supp}\,\rho$. Integrating over $\mathrm{supp}\,\rho$ and extending the integration domain on the right hand side to the whole space, using inequality \eqref{estimateforrhoinnorm} we obtain that \begin{equation*} \varepsilon|\mathrm{supp}\,\rho|^{2-m}<1. \end{equation*} So, we derived for $m>2$ a lower bound for the size of the support depending on the coefficient $\varepsilon$ which reads for a radially symmetric and monotonically decreasing stationary solution of \eqref{eq1b} with $\mathrm{supp}\,\rho=\overline{B_R(0)}$ as \begin{equation*} |B_R(0)|>\varepsilon^{\frac{1}{m-2}}. \end{equation*} Such a relation is also obtained for $N=1$ in \cite[Section 4.2]{burgerfetecauhuang} by assuming the stationary solution of \eqref{eq1b} to be approximately a characteristic function which is suitably scaled to have unit mass. If $m>2$, then there exists for every $\varepsilon>0$ a radially symmetric and monotonically decreasing stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} being compactly supported due to Theorem \ref{existenceofglobalmin}, the compactness of global minimizers of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ (Theorem \ref{globmincomp}) and Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(iv)}. In contrast, if $1<m<2$, we only know that there exists for all coefficients $\varepsilon$ not greater than some $\varepsilon_0>0$ a radially symmetric and monotonically decreasing stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} being compactly supported due to Theorem \ref{existenceofglobalmin}, Theorem \ref{globmincomp} and Lemma \ref{resultsfromburgerdifrancescofranek}\ref{results(iv)}. The constant $\varepsilon_0$ depends on the interaction potential $G$ and the exponent $m$ of the degenerate diffusion (cf.\ Remark \ref{noexistenceofcompstatsolformsmaller2}) and marks the threshold where we can find a function $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ such that we have $E[\rho]\leq0$. These observations complement the results in the theoretical part of \cite{burgerfetecauhuang}. It is shown in \cite[Theorem 3.7]{burgerfetecauhuang} for $N=1$ that for $m>2$ there exists for every $L>0$ a coefficient $\varepsilon>0$ such that there is a stationary solution of \eqref{eq1b} with $\mathrm{supp}\,\rho=[-L,L]$ which is symmetric and monotonically decreasing on $\{x>0\}$. We extended this result in Theorem \ref{existenceviakreinrutmanforgeneralm} to arbitrary dimensions. In the numerical part of \cite{burgerfetecauhuang}, it is suggested that there may exist a compactly supported stationary solution of \eqref{eq1b} for all coefficients $\varepsilon>0$ which is proved here as remarked above. Moreover, for $1<m<2$ it is shown in \cite[Theorem 3.9]{burgerfetecauhuang} for $N=1$ that for every $L>0$ there exists a coefficient $\varepsilon>0$ such that there is a stationary solution of \eqref{eq1b} with $\mathrm{supp}\,\rho=[-L,L]$ which is symmetric and monotonically decreasing on $\{x>0\}$. Again, we extended this result in Theorem \ref{existenceviakreinrutmanforgeneralm} to arbitrary dimensions. In the numerical part of \cite{burgerfetecauhuang}, it is suggested that in this case a compactly supported stationary solution of \eqref{eq1b} exists for any coefficient $\varepsilon$ smaller than a constant $\varepsilon_1>0$ and that these stationary solutions are just local minimizers but could turn into global minimizers for coefficients $\varepsilon$ smaller than some $\varepsilon_0<\varepsilon_1$. As remarked above, this statement is proved here only in terms of stationary solutions of \eqref{eq1b} which are global minimizers of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$, i.e.\ for $0<\varepsilon\leq\varepsilon_0$. Obviously, and also pointed out in Lemma \ref{noexistenceofglobminformsmaller2} and Remark \ref{noexistenceofcompstatsolformsmaller2}, for $1<m<2$ the condition for being a compact stationary solution of \eqref{eq1b} is less strict than for being a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ because the latter forces the energy to be non-positive which does not need to hold for compactness of stationary solutions of \eqref{eq1b} in case of $1<m<2$ (cf.\ Remark \ref{stationarysolutionswithpositiveenergy}). By Corollary \ref{propcompandnoncompsol}, we know that we can write the energy of a compactly supported stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} with $\mathrm{supp}\,\rho=\overline{B_R(0)}$ as \begin{equation*} E[\rho]=\int_{\mathbb{R}^N}\varepsilon\Big(\frac{1}{m}-\frac{1}{2}\Big)\rho^m(y)\,dy-\frac{1}{2}(G\ast\rho)(R). \end{equation*} So, depending on the interaction potential $G$ and the size of the support of the stationary solution of \eqref{eq1b} there could exist a compactly supported stationary solution of \eqref{eq1b} with positive energy for $1<m<2$. Now, assume that there is a triple $(\varepsilon,R,\rho)$ where each component uniquely determines the other ones and which solves $\rho\nabla(\varepsilon\rho^{m-1}-G\ast\rho)=0$ with $\rho$ being a radially symmetric and monotonically decreasing function $\rho\in C^2(B_R(0))\cap\mathcal{P}(\mathbb{R}^N)\cap C(\mathbb{R}^N)$ and $\mathrm{supp}\,\rho=\overline{B_R(0)}$. In addition, assume that $\varepsilon$ is strictly increasing with the size of the support. Then, there has to exist a compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} which is no global minimizer. To convince ourselves about that let $\varepsilon=\varepsilon_0$, i.e.\ there exists a $\rho_0\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ such that $E[\rho_0]=0$ and there is no $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with $E[\rho]<0$. Then, by Theorem \ref{existenceofglobalmin} we know that $\rho_0$ is a global minimizer of $E$ which has compact support due to Theorem \ref{globmincomp}. Considering Theorem \ref{existenceviakreinrutmanforgeneralm}, there is a radially symmetric and monotonically decreasing stationary solution $\rho\in\mathcal{P}(\mathbb{R}^N)\cap C(\mathbb{R}^N)$ of \eqref{eq1b} with $\mathrm{supp}\,\rho\supset\,\mathrm{supp}\,\rho_0$. Since we assumed the coefficient $\varepsilon$ to increase strictly with $R$, we have $E[\rho]>0$ because of $\varepsilon>\varepsilon_0$. To sum up, if we were able to prove uniqueness in Theorem \ref{existenceviakreinrutmanforgeneralm} for $1<m<2$ and if we were able to prove that the coefficient $\varepsilon$ is strictly increasing with the size of the support of the resulting unique function, then we would have shown that a unique compactly supported, radially symmetric and monotonically decreasing stationary solution of \eqref{eq1b} exists for coefficients $\varepsilon$ smaller than some value $\varepsilon_1$. This stationary solution is a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ for coefficients $\varepsilon\leq\varepsilon_0$ but loses this property for coefficients with a larger value. In particular, we would have shown that the threshold $\varepsilon_0$ for the existence of a global minimizer of $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ is strictly smaller than the threshold $\varepsilon_1$ for the existence of a compact stationary solution of \eqref{eq1b}. The value $\varepsilon_1$ is presumably determined by the condition for a stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} to be compact, i.e.\ by Remark \ref{differentcompcond} and Theorem \ref{symmetryofstationarysolutions} it is presumably the smallest coefficient such that there is no radially symmetric and monotonically decreasing $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ satisfying \begin{equation*} \varepsilon\rho^{m-1}(x)-(G\ast\rho)(x)<0 \end{equation*} in $\mathrm{supp}\,\rho$. In \cite[Section 4.2]{burgerfetecauhuang}, it is also shown formally for $1<m<2$ that the non-linear eigenvalue problem \begin{equation*} \varepsilon\rho^{m-1}(x)-(G\ast\rho)(x)=0 \end{equation*} governs for $N=1$ the limiting profile for a stationary solution of \eqref{eq1b} with support $[-L,L]$ and $L\rightarrow\infty$. So, for $1<m<2$ the threshold for the existence of a compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} can be estimated by \begin{equation} \varepsilon_1<\frac{2}{m}\varepsilon_0=\sup_{\rho\in L^m\cap\mathcal{P}}\frac{\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx}{\|\rho\|_{L^m}^m}. \end{equation} We obtain a strict inequality since the function attaining the supremum is a global minimizer of the energy $E$ in $L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ with coefficients $\varepsilon_0$ and has to be compactly supported. Considering equation \eqref{equationforconnectednoncompactsolution} in Corollary \ref{propcompandnoncompsol}, we know that every non-compact stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} satisfies $\varepsilon=\|\rho\|_{L^m}^{-m}\int_{\mathbb{R}^N}(G\ast\rho)(x)\rho(x)\,dx$. Therefore, we can estimate that under our assumptions a stationary solution $\rho\in L^m(\mathbb{R}^N)\cap\mathcal{P}(\mathbb{R}^N)$ of \eqref{eq1b} cannot exist for $1<m<2$ if $\varepsilon\geq\frac{2}{m}\varepsilon_0$. \section*{Acknowledgements} The author would like to thank Angela Stevens for numerous critical discussions and financial support, and Martin Burger for some useful comments and suggestions.

\section{Introduction} Sampling theory has traditionally drawn tools from functional and complex analysis. Past successes, such as the Shannon-Nyquist theorem and recent advances in frame theory, have relied heavily on the application of geometry and analysis. The reliance on geometry and analysis means that the results are geometrically rigid. There is evidence that topology has an important -- and largely unexplored -- impact on sampling problems. For instance, the space of bandlimited functions over the real line is infinite-dimensional, while the space of bandlimited functions over a compact subset is finite dimensional. There is a subtle interplay between the topology of the domain of the functions being sampled, and the class of functions themselves. For instance, one often wishes to sample from classes of non-bandlimited functions. The correct algebraic tool for modeling all of these situations is the \emph{sheaf}; a tool which is sensitive to the topology of the domain and allows local structure to derive global inferences. For instance, bandlimited functions over manifolds can be encoded in a sheaf. Most sampling problems that have been studied in the literature assume that samples are scalar-valued and are collected uniformly in some fashion. The theory of \emph{sheaf morphisms} formalizes and generalizes the sampling process, allowing each sample to be vector-valued and of different dimensions. This chapter makes several contributions to sampling theory. It proves a general sampling theorem for sheaves using the language of exact sequences. The Shannon-Nyquist theorem is a special case of this more general sampling theorem, and we show how a sheaf-theoretic approach emphasizes the impact of topology by solving several different sampling problems involving non-bandlimited functions. The solution to these problems shows that the topology of the domain has a varying level of importance depending on the class of functions and the specific sampling question being studied. \subsection{Historical context} Sampling theory has a long and storied history, about which a number of recent survey articles \cite{benedetto_1990,feichtinger_1994,unser_2000,smale_2004} have been written. Since sampling plays an important role in applications, substantial effort has been expended on practical algorithms. Our approach is topologically-motivated, like the somewhat different approach of \cite{NiySmaWeiHom,chazal_2009}, so it is less constrained by specific timing constraints. Relaxed timing constraints are an important feature of bandpass \cite{vaughan_1991} and multirate \cite{unser_1998} algorithms. We focus on signals with local control, of which splines \cite{unser_1999} are an excellent example. Sheaf theory has not been used in applications until fairly recently. The catalyst for new applications was the technical tool of \emph{cellular sheaves}, developed in \cite{Shepard_1985}. Since that time, an applied sheaf theory literature has emerged, for instance \cite{ghrist_2011,Lilius_1993,GhristCurryRobinson,RobinsonQGTopo,RobinsonLogic}. Our sheaf-theoretic approach allows sufficient generality to treat sampling on non-Euclidean spaces. Others have studied sampling on non-Euclidean spaces, for instance general Hilbert spaces \cite{pesenson_2001}, Riemann surfaces \cite{schuster_2004}, symmetric spaces \cite{ebata_2006}, the hyperbolic plane \cite{feichtinger_2011}, combinatorial graphs \cite{pesenson_2010}, and quantum graphs \cite{pesenson_2005,pesenson_2006}. We show that sheaves provide unified sufficiency conditions for perfect reconstruction on abstract simplicial complexes, which encompass all of the above cases. A large class of local signals are those with \emph{finite rate of innovation} \cite{groechening_1992, vetterli_2002}. Our ambiguity sheaf is a generalization of the Strang-Fix conditions as identified in \cite{dragotti_2007}. With our approach, one can additionally consider reconstruction using richer samples than simply convolutions with a function. \section{A unifying example} \label{sec:unifying} A celebrated consequence of the Cauchy integral formula is that the Taylor series of a holomorphic function evaluated at a point is sufficient to determine its value anywhere in its domain, if this is connected. Analytic continuation is therefore a very strong kind of reconstruction from a single sample. Analytic continuation relies both on (1) a restricted space of functions (merely smooth functions do not suffice) and (2) a rather large amount of information at the sample point (not just the value of the function, but also all of its derivatives). These two constraints are essential to understand the nature of reconstruction from samples, so the admittedly special case of analytic continuation is informative. Consider the space of holomorphic functions $C^\omega(U,\mathbb{C})$ on a connected open set $U\subseteq \mathbb{C}$. Without loss of generality, suppose that $U$ contains the origin. Then the function $a:C^\omega(U,\mathbb{C}) \to l^1$ given by \begin{equation*} a(f) = \left(f(0), f'(0), \dotsc, \frac{f^{(n)}(0)}{n!}, \dotsc \right) \end{equation*} for $f\in C^\omega(U,\mathbb{C})$ is a linear transformation. Because $a$ computes the Taylor series of $f$, whenever $a(f)=a(g)$ it must follow that $f=g$ on $U$. This means that as a linear transformation, the sampling function $a$ has a trivial kernel. Conversely, the trivial kernel of $a$ witnesses the fact that the original $f \in C^\omega(U,\mathbb{C})$ can be recovered from the sampled value $a(f)$. This is by no means necessarily true for all sampling functions. For instance, the sampling function $b:C^\omega(U,\mathbb{C}) \to l^1$ given by \begin{equation*} b(f) = \left(0, f'(0), \dotsc, \frac{f^{(n)}(0)}{n!}, \dotsc \right) \end{equation*} has a one-dimensional kernel. This means that reconstruction of an analytic function from its image through $b$ is ambiguous -- it is known only up to the addition of a constant. But there is more information available than merely the \emph{dimension} of $\ker b$, since it is a subspace of $C^\omega(U,\mathbb{C})$. Indeed, if we restrict the domain of $b$ to be the subspace $Z \subset C^\omega(U,\mathbb{C})$ of analytic functions whose value at the origin is zero, then the intersection $Z \cap \ker b$ is trivial. Reconstruction succeeds on $Z$ using $b$ for sampling even though using $b$ on its whole domain is ambiguous. Sampling a function in $C^\omega(U,\mathbb{C})$ can be represented generally as a function $s:C^\omega(U,\mathbb{C}) \to l^1$. Observe that $s$ could take the form of the functions $a$ or $b$ above, in which a function is evaluated in the immediate vicinity of a single point. However, $s$ could also be given by \begin{equation*} s(f) = (\dotsc, f(-1), f(0), f(1), \dotsc) \end{equation*} or many other possibilities. In this general setting, the simplest way to determine whether reconstruction is ambiguous is to examine $\ker s$. Recognizing that we may wish to restrict the class of functions under discussion, it is useful to understand how the subspace $\ker s$ is included within $C^\omega(U,\mathbb{C})$. This situation can also be described as the following \emph{exact sequence} of linear functions \begin{equation*} \xymatrix{ 0 \to A \ar[r]^i & C^\omega(U,\mathbb{C}) \ar[r]^s & l^1 \to 0, } \end{equation*} which means that $\ker s = \mathop{\text{image}} i$. Observe that the zero at the beginning of the sequence indicates that the map $i$ is injective, so that $A = \ker s$. Likewise, the zero at the end of the sequence indicates that $s$ is surjective. If $f \in C^\omega(U,\mathbb{C})$ is fixed (but unknown) and $s(f)$ is known, then clearly $f$ can only be known to be one of the preimages $i^{-1}(f) \subseteq A$. If there is only one preimage (as in the case of $a$ above), then reconstruction is said to be \emph{unambiguous}. This example contrasts sharply with the situation of sampling data from the space of \emph{all} smooth functions. In this case, one has a diagram like \begin{equation*} \xymatrix{ 0\to C \ar[r]^i & C^\infty(U,\mathbb{C}) \ar[r]^c & l^1 \to 0, } \end{equation*} because in this case $C$ is quite large. The analytic functions are a subset $C^\omega(U,\mathbb{C}) \subset C^\infty(U,\mathbb{C})$. This can be expressed diagrammatically as \begin{equation*} \xymatrix{ & & 0 \ar[d] & 0 \ar[d] & \\ &0 \ar[r]^i\ar[d] & C^\omega(U,\mathbb{C}) \ar[r]^a\ar[d] & l^1 \ar[r]\ar[d]& 0 \\ 0\ar[r]&C \ar[r]^i & C^\infty(U,\mathbb{C}) \ar[r]^c & l^1\ar[r]& 0\\ } \end{equation*} in which every possible composition of linear maps with the same domain and codomain are equal. This shows how the two classes of functions and their samples are related, and the technique will be used in later sections as a kind of algebaic bound. \section{Local data} Vector spaces of functions such as $C^k(U,\mathbb{C})$ are rather global in nature -- an element of such a space \emph{is} a function! In contrast, evaluating a function at a particular point $x$ corresponds to a linear transformation that is only sensitive to a function's value at or nearby $x$. Because function evaluation is a local process, reconstructing the global function space element from these samples appears counterintuitive. The local sampling versus global reconstruction paradox is resolved because reconstruction theorems only exist for certain suitably constrained vector spaces. For instance, the Paley-Wiener space $PW_B$ consists of functions $f$ whose Fourier transform \begin{equation*} \hat{f}(\omega) = \int_{-\infty}^{\infty} f(x) e^{-2\pi i \omega x} dx \end{equation*} is supported on $[-B,B]$. We say that each $f\in PW_B$ has \emph{bandwidth $B$}. The Shannon-Nyquist theorem asserts that functions in $PW_{1/2}$ are uniquely determined by their values on the integers, which is best explained by the fact that every $f\in PW_{1/2}$ has a cardinal series decomposition \begin{equation*} f(x) = \sum_{n=-\infty}^\infty f(n) \frac{\sin\pi(x-n)}{\pi(x-n)} \end{equation*} where each \emph{sinc function} given by $\sinc(x-n)=\frac{\sin(x-n)}{x-n}$ has bandwidth $1/2$ or less. Moreover, the set of sinc functions is orthonormal over the usual inner product in $PW_{1/2}$, so we have that \begin{equation} \label{eq:int_samp_sinc} f(x) = \int_{n=-\infty}^\infty f(n) \frac{\sin\pi(x-n)}{\pi(x-n)}\, dx. \end{equation} Even though the support of $\sinc \pi(x-n)$ is $\mathbb{R}$, it decays away from $n$. This means that in \eqref{eq:int_samp_sinc}, the effect of values of $f$ far away from $n$ will have little effect on $f(n)$. So in the case of $PW_B$, sampling via \eqref{eq:int_samp_sinc} is only \emph{approximately} local. Because of this, global constraints -- such as those arising from compactness -- on the function space play an important role in sampling theorems. This section formalizes the above intuition, by constructing a \emph{sheaf theoretic} framework for discussing sampling. Sheaves are the correct mathematical formalism for discussing local information. Section \ref{sec:defs} distills an axiomatic framework that precisely characterizes what ``local'' means. Section \ref{sec:cohomology} defines the cohomology functor for sheaves, which assembles this local information into global information. With the definition of a \emph{sheaf morphism} in Section \ref{sec:transformations}, these tools allow the statement of general conditions under which a sampling suffices to reconstruct a function in a particular space in Section \ref{sec:general_sampling}. \subsection{Sheaves represent local data} \label{sec:defs} A local model of data should be flexible enough to capture both analytic and non-analytic functions. Because portions of the data in one region will not necessarily be related to those farther away, the model should allow us to infer global effects only when they are appropriate to the kind of function under study. Spaces of continuous functions exhibit several properties related to locality. As a concrete example, consider the following properties of $C^k(U,\mathbb{C})$ when $k \ge 0$: \begin{enumerate} \item \emph{Restriction}: Whenever $V \subseteq U$ are open sets, there is a linear map $C^k(U,\mathbb{C}) \to C^k(V,\mathbb{C})$ that is given by restricting the domain of a function defined on $U$ to one defined on $V$. \item \emph{Uniqueness}: Whenever a function is the zero function on some open set, then all of its restrictions are zero functions also. The converse is true also: suppose $f \in C^k(V,\mathbb{C})$, and that $\{U_1,\dotsc\}$ is an open cover of $V$. If the restriction of function $f$ to each $U_k$ is the zero function on $U_k$, then $f$ has to be the zero function on $V$. \item \emph{Gluing}: If $U$ and $V$ are open sets and $f \in C^k(U,\mathbb{C})$, $g \in C^k(V,\mathbb{C})$ then whenever $f(x)=g(x)$ for all $x\in U \cap V$ there is a function $h \in C^k(U \cup V,\mathbb{C})$ that restricts to $f$ and $g$. \end{enumerate} The gluing property provides a condition by which local information (the elements $f\in C^k(U,\mathbb{C})$, $g\in C^k(V,\mathbb{C})$) can be assembled into global information in $C^k(U\cup V,\mathbb{C})$, provided a consistency condition is met. We will call this specification of $f$ and $g$ a \emph{section} when they restrict to the same element in $C^k(U \cap V,\mathbb{C})$. This can also be illustrated diagrammatically \begin{equation*} \xymatrix{ &C^k(U \cup V,\mathbb{C})\ar[dr]\ar[dl]&\\ C^k(U,\mathbb{C})\ar[dr]&&C^k(V,\mathbb{C})\ar[dl]\\ &C^k(U\cap V,\mathbb{C})&\\ } \end{equation*} where the arrows represent the restrictions of functions from one domain to the next. Specifically, when two functions on the middle level are mapped to the same function on the bottom level, they are both images of a function on the top level. Let's formalize these properties to obtain a more general construction, in which the data are not necessarily encoded as continuous functions. It is usually unnecessary to consider \emph{all} open sets; what's really relevant is the intersection lattice. In this chapter, we need a concept of space that is convenient for computations. The most efficient such definition is that of a simplicial complex. \begin{definition} An \emph{abstract simplicial complex} $X$ on a set $A$ is a collection of ordered subsets of $A$ that is closed under the operation of taking subsets. We call each element of $X$ a \emph{face}. A face with $k+1$ elements is called a $k$-dimensional face (or a $k$-face), though we usually call a $0$-face a \emph{vertex} and a $1$-face an \emph{edge}. If all of the faces of an abstract simplicial complex $X$ are of dimension $n$ or less, we say that $X$ is an $n$-dimensional simplicial complex. If $X$ is a 1-dimensional simplicial complex, we usually call $X$ a \emph{graph}. The \emph{face category} has the elements of $X$ for its objects, and setwise inclusions of one element of $X$ into another for its morphisms. If $a$ and $b$ are two faces in an abstract simplicial complex $X$ with $a \subset b$ and $|a| < |b|$, we will write $a \attach b$ and say that $a$ is \emph{attached} to $b$. Finally, a collection $Y$ of faces of $X$ is called a \emph{closed subcomplex} if whenever $b \in Y$ and $a \attach b$, then $a\in Y$ also. \end{definition} Sometimes simplicial complexes arise naturally from the problem, for instance the connection graph for a network, but it is helpful to have a procedure to obtain a simplicial complex from a topological space. Suppose that $X$ is a topological space and that $\col{U} = \{U_1,\dotsc\}$ is an open cover of $X$. \begin{definition} The \emph{nerve} $N(\col{U})$ is the abstract simplicial complex whose vertices are given by the elements of $\col{U}$, and whose $k$-faces $\{U_{i_0},\dotsc,U_{i_k}\}$ are given by the nonempty intersections $U_{i_0} \cap \dotsb \cap U_{i_k}$. \end{definition} \begin{figure} \begin{center} \includegraphics[width=3in]{nerve} \caption{The nerve of two covers: (left) with a nonempty triple intersection (right) without a triple intersection} \label{fig:nerve} \end{center} \end{figure} \begin{example} \label{eg:nerve} Figure \ref{fig:nerve} shows two covers and their associated nerves. In the left diagram, the sets $A$, $B$, and $C$ have nonempty pairwise intersections and a nonempty triple intersection $A \cap B \cap C$, so the nerve is a 2-dimensional abstract simplicial complex. In the right diagram, $A \cap B \cap C$ is empty, so the nerve is only 1-dimensional. \end{example} The concept of local information over a simplicial complex is a straightforward generalization of the three properties (restriction, uniqueness, and gluing) for continuous functions. The resulting mathematical object is called a \emph{sheaf}. \begin{definition} \label{df:sheaf} A \emph{sheaf} $\shf{F}$ on an abstract simplicial complex $X$ is a covariant functor from the face category of $X$ to the category of vector spaces. Explicitly, \begin{itemize} \item for each element $a$ of $X$, $\shf{F}(a)$ is a vector space, called the \emph{stalk at $a$}, \item for each attachment of two faces $a\attach b$ of $X$, $\shf{F}(a\attach b)$ is a linear function from $\shf{F}(a)\to \shf{F}(b)$ called a \emph{restriction}, and \item for every composition of attachments $a\attach b \attach c$, the restrictions satisfy $\shf{F}(b\attach c) \circ \shf{F}(a\attach b)=\shf{F}(a\attach b\attach c)$. \end{itemize} We will usually refer to $X$ as the \emph{base space} for $\shf{F}$. \end{definition} \begin{remark} Although sheaves have been extensively studied over topological spaces (see \cite{Bredon} or the appendix of \cite{Hubbard} for a modern, standard treatment), the resulting definition is ill-suited for application to sampling. Instead, we follow a substantially more combinatorial approach introduced in the 1980 thesis of Shepard \cite{Shepard_1980}. \end{remark} \begin{figure} \begin{center} \includegraphics[width=3.25in]{continuous_sheaf1} \caption{A sheaf of continuous functions over an interval (compare with Figure \ref{fig:continuous_sheaf2})} \label{fig:continuous_sheaf1} \end{center} \end{figure} \begin{example} \label{eg:continuous_sheaf1} The space of continuous functions over a topological space can be represented as a sheaf. For instance, Figure \ref{fig:continuous_sheaf1} shows one way to organize the space of continuous functions over the interval $(-2,2)$ in terms of spaces of continuous functions over smaller intervals. (See Example \ref{eg:continuous_sheaf2} for another encoding of continuous functions as a sheaf.) In this particular sheaf model, the base space is given by an abstract simplicial complex $X$ over three abstract vertices, which we label suggestively as $\{-2\}$, $\{0\}$, $\{2\}$. The simplicial complex $X$ has two edges as shown in the diagram. We define the sheaf $\shf{C}$ over $X$ by assigning spaces of continuous functions to each face, and define the restrictions between stalks to be the process of ``actually'' restricting the functions. \end{example} \begin{example} \label{eg:analytic_sheaf} Coming back to Section \ref{sec:unifying}, a sheaf of analytic functions can be constructed as a subsheaf of the previous example by merely replacing the stalks with spaces of analytic functions defined over the appropriate intervals. \end{example} Notice that the definition of a sheaf captures the \emph{restriction} locality property, but does not formalize the \emph{uniqueness} or \emph{gluing} properties. Some authors \cite{Bredon, Curry, Iverson, Godement_1958} explicitly require these properties from the outset, calling the object defined in Definition \ref{df:sheaf} a \emph{presheaf}, regarding it as incomplete. Although the difference between sheaves and presheaves is useful in navigating certain technical arguments, every presheaf has a unique \emph{sheafification}. Because of this, our strategy follows the somewhat more economical treatment set forth in \cite{Shepard_1980, Robinson_tspbook}, which removes this distinction. As a consequence of this choice, we explicitly define collections of \emph{sections}, which effectively implement the sheafification. \begin{definition} \label{df:section} Suppose $\shf{F}$ is a sheaf on an abstract simplicial complex $X$ and that $\col{U}$ is a collection of faces of $X$. An assignment $s$ which assigns an element of $\shf{F}(a)$ to each face $a\in\col{U}$ is called a \emph{section} supported on $\col{U}$ when for each attachment $a\attach b$ of faces in $\mathcal{U}$, $\shf{F}(a\attach b)s(a)=s(b)$. We will denote the space of sections of $\shf{F}$ over $\col{U}$ by $\shf{F}(\col{U})$, which is easily checked to be a vector space. A \emph{global section} is a section supported on $X$. If $r$ and $s$ are sections supported on $\col{U} \subset \col{V}$, respectively, in which $r(a)=s(a)$ for each $a \in \col{U}$ we say that \emph{$s$ extends $r$}. \end{definition} \begin{example} \label{eg:sample_sheaf} Consider $Y\subseteq X$ a subset of the vertices of an abstract simplicial complex. The sheaf $\shf{S}$ which assigns a vector space $V$ to vertices in $Y$ and the trivial vector space to every other face is called a \emph{$V$-sampling sheaf supported on $Y$}. To every attachment of faces of different dimension, $S$ will assign the zero function. For a finite abstract simplicial complex $X$, the space of global sections of a $V$-sampling sheaf supported on $Y$ is isomorphic to $\bigoplus_{y\in Y} V$. \end{example} \begin{figure} \begin{center} \includegraphics[width=3.25in]{continuous_sheaf2} \caption{Another sheaf of continuous functions over an interval (compare with Figure \ref{fig:continuous_sheaf1})} \label{fig:continuous_sheaf2} \end{center} \end{figure} \begin{example} \label{eg:continuous_sheaf2} Figure \ref{eg:continuous_sheaf2} shows a sheaf whose global sections are continuous functions that is essentially dual to the one in Example \ref{eg:continuous_sheaf1}. (Although it is straightforward to generalize the construction to cell complexes of arbitrary dimension, we will work over an interval to keep the exposition simple.) Specifically, consider a simplicial complex with two vertices $v_1$ and $v_2$ and one edge $e$ between them. The stalk over each vertex is a space of continuous functions as in Example \ref{eg:continuous_sheaf1}, though we require the functions to be continuous over a \emph{closed} interval. However, the stalk over the edge is merely $\mathbb{R}$. The restriction in this case evaluates functions at an appropriate endpoint. If we name the sheaf $\shf{C}$, then for $f \in \shf{C}(v_1)=C([0,1],\mathbb{R})$, \begin{equation*} \left(\shf{C}(v_1\attach e)\right)(f)=f(1), \end{equation*} and \begin{equation*} \left(\shf{C}(v_2\attach e)\right)(g)=g(1), \end{equation*} for $g \in \shf{C}(v_2)=C([1,2],\mathbb{R})$. Observe that the global sections of this sheaf are precisely functions that are continuous on $[0,2]$. \end{example} This second example of a sheaf of continuous function can be easily recast to describe discrete timeseries as well. However, it is convenient to discriminate between the restrictions ``to the left'' versus those ``to the right.'' This is most conveniently described by the concept of orientation. Recall that an abstract simplicial complex $X$ consists of \emph{ordered} sets. For $a$ a $k$-face and $b$ a $k+1$-face, define the \emph{orientation index} \begin{equation*} [b:a]= \begin{cases} +1&\text{if the order of elements in }a\text{ and }b\text{ agrees,}\\ -1&\text{if it disagrees, or}\\ 0&\text{if }a\text{ is not a face of }b.\\ \end{cases} \end{equation*} \begin{example} \label{eg:grouping_sheaf} If $V$ is a vector space, then the $m$-term grouping sheaf $\shf{V}^{(m)}$ has the diagram \begin{equation*} \xymatrix{ \ar[r]^{\sigma_+} & V^{m-1} & V^m \ar[r]^{\sigma_+} \ar[l]^{\sigma_-} & V^{m-1} & \ar[l]^{\sigma_-} } \end{equation*} in which the restrictions are given by \begin{equation*} \sigma_-(x_1,\dotsc,x_m)=(x_1,\dotsc,x_{m-1})\text{ and }\sigma_+(x_1,\dotsc,x_m)=(x_2,\dotsc,x_m). \end{equation*} Observe that the sampling sheaf defined in Example \ref{eg:sample_sheaf} is merely $V^{(1)}$, and that the space of global sections of all grouping sheaves are isomorphic. \end{example} Sheaves can also describe spaces of piecewise continuous functions, as the next example shows. \begin{figure} \begin{center} \includegraphics[width=3in]{pl_sheaf} \caption{An example of a sheaf $\shf{PL}$ over a graph} \label{fig:pl_sheaf} \end{center} \end{figure} \begin{example} \label{eg:pl_def} Suppose $G$ is a graph in which each vertex has finite degree. Let $\shf{PL}$ be the sheaf constructed on $G$ that assigns $\shf{PL}(v)=\mathbb{R}^{1+\deg v}$ to each edge $v$ of degree $\deg v$ and $\shf{PL}(e)=\mathbb{R}^2$ to each edge $e$. The stalks of $\shf{PL}$ specify the value of the function (denoted $y$ below) at each face and the slopes of the function on the edges (denoted $m_1,...,m_k$ below). To each attachment of a degree $k$ vertex $v$ into an edge $e$, let $\shf{PL}$ assign the linear function \begin{equation*} \left(\shf{PL}(v\attach e)\right)(y,m_1,...,m_e,...,m_k)= \begin{pmatrix} y+([e:v]-1)\frac{1}{2}m_e\\ m_e \end{pmatrix}. \end{equation*} The global sections of this sheaf are \emph{piecewise linear functions} on $G$; see Figure \ref{fig:pl_sheaf}. \end{example} \subsection{Sheaf cohomology} \label{sec:cohomology} \begin{figure} \begin{center} \includegraphics[width=1.25in]{coho_moti} \caption{A sheaf over a small abstract simplicial complex} \label{fig:coho_moti} \end{center} \end{figure} The space of global sections of a sheaf is important in applications. Although Definition \ref{df:section} is not constructive, one can compute this space algorithmically. Specifically, consider the abstract simplicial complex $X$ shown in Figure \ref{fig:coho_moti}, which consists of an edge $e$ between two vertices $v_1$ and $v_2$. Suppose $s$ is a global section of a sheaf $\shf{S}$ on $X$. This means that \begin{equation*} \shf{S}(v_1\attach e)s(v_1) = s(e) = \shf{S}(v_2 \attach e)s(v_2). \end{equation*} Since the above equation is written in a vector space, we can rearrange it to obtain the equivalent specification \begin{equation*} \shf{S}(v_1\attach e)s(v_1) - \shf{S}(v_2 \attach e)s(v_2) = 0, \end{equation*} which could be written in matrix form as \begin{equation*} \begin{pmatrix} \shf{S}(v_1\attach e) & -\shf{S}(v_2\attach e) \end{pmatrix} \begin{pmatrix} s(v_1)\\ s(v_2) \end{pmatrix} =0. \end{equation*} This purely algebraic manipulation shows that computing the space of global sections of a sheaf is equivalent to computing the kernel of a particular matrix as in Section \ref{sec:unifying}. Clearly this procedure ought to work for arbitrary sheaves over arbitrary abstract simplicial complexes, though it could get quite complicated. \emph{Cohomology} is a systematic way to perform this computation, and it results in additional information as we'll see in later sections. The vector $\begin{pmatrix} s(v_1)\\ s(v_2) \end{pmatrix}$ above suggests that we should define following formal \emph{cochain} vector spaces $C^k(X;\shf{F})=\bigoplus_{a\text{ a }k\text{-face of }X}\shf{F}(a)$ to represent the possible choices of data over the $k$-faces. In the same way, the matrix \begin{equation*} \begin{pmatrix} \shf{S}(v_1\attach e) & -\shf{S}(v_2\attach e) \end{pmatrix} \end{equation*} generalizes into the \emph{coboundary map} $d^k:C^k(X;\shf{F})\to C^{k+1}(X;\shf{F})$, which we now define. The coboundary map $d^k$ takes an assignment $s$ on the $k$-faces to a different assignment $d^ks$ whose value at a $(k+1)$-face $b$ is \begin{equation*} (d^ks)(b)=\sum_{a\text{ a }k\text{-face of} X} [b:a]\shf{F}(a\attach b)s(a). \end{equation*} Together, we have a sequence of linear maps \begin{equation*} \xymatrix{ 0\to C^0(X;\shf{F}) \ar[r]^{d^0} & C^1(X;\shf{F}) \ar[r]^{d^1} & C^2(X;\shf{F}) \ar[r]^{d^2} & \dotsb } \end{equation*} called the \emph{cochain complex}. As in the simple example described above, the kernel of $d^k$ consists of data specified on $k$-faces that is consistent, when tested on the $(k+1)$-faces. However, it can be shown that $d^{k+1}\circ d^k=0$, so that the image of $d^k$ is a subspace of the kernel of $d^{k+1}$. This means that the image of $d^k$ is essentially redundant information, since it is already known to be consistent when tested on the $(k+2)$-faces. Because of this fact, only those elements of the kernel of $d^k$ that are \emph{not} already known to be consistent are really worth mentioning. This leads to the definition of sheaf cohomology: \begin{definition} The $k$-th \emph{sheaf cohomology} of $\shf{F}$ on an abstract simplicial complex $X$ is \begin{equation*} H^k(X;\shf{F})=\ker d^k / \mathop{\text{image}} d^{k-1}. \end{equation*} \end{definition} As an immediate consequence of this construction, we have the following useful statement. \begin{proposition} \label{prop:global_coho} $H^0(X;\shf{F})=\ker d^0$ consists precisely of those assignments $s$ which are global sections, so a global section is determined entirely by its values on the vertices of $X$. \end{proposition} \subsection{Transformations of local data} \label{sec:transformations} Sheaves can be used to represent local data and cohomology can be used to infer the resulting globally-consistent data. However interesting this theory may be, we need to connect it to the process of sampling. Indeed, as envisioned in Section \ref{sec:unifying}, sampling is a \emph{transformation} between two spaces of functions -- from functions with a continuous domain to functions with a discrete domain. Such a transformation arising from sampling respects the local structure of the function spaces. This kind of transformation is called a \emph{sheaf morphism}. There are two aspects to a sheaf morphism: (1) its effect on the base space, and (2) its effect on stalks. The effect on the base space should be to respect local neighborhoods, which means that a sheaf morphism must at least specify a continuous map. Since we have restricted our attention to abstract simplicial complexes rather than general topological spaces, the analog of a continuous map is a simplicial map. \begin{definition} A \emph{simplicial map} from one abstract simplicial complex $X$ to another $Y$ is a function $f$ from the set of simplices of $X$ to the simplices of $Y$ that additionally satisfies two properties: \begin{enumerate} \item If $a \attach b$ is an attachment of two simplices in $X$, then $f(a) \attach f(b)$ is an attachment of simplices in $Y$, and \item The dimension of $f(a)$ is no more than the dimension of $a$, a simplex in $X$. \end{enumerate} \end{definition} The last condition means a simplicial map takes vertices to vertices, edges either to edges or vertices, and so on. \begin{figure} \begin{center} \includegraphics[width=2.5in]{simp_map} \caption{The simplicial complexes $X$ (left) and $Y$ (right) for Example \ref{eg:simp_map}} \label{fig:simp_map} \end{center} \end{figure} \begin{example} \label{eg:simp_map} Consider the simplicial complexes $X$ and $Y$ shown in Figure \ref{fig:simp_map}. The function $F:X\to Y$ given by \begin{equation*} F(v_1)=w_1,\; F(v_2)=w_2,\; F(v_3)=w_2 \end{equation*} determines a simplicial map, in which $F(e_1)=w_2$, $F(e_2)=F(e_3)=F(f)=g_1$. In contrast, any function that takes $v_1$ to $w_1$, $v_2$ to $w_2$, and $v_3$ to $w_3$ cannot be a simplicial map because the image of $e_2$ should be an edge from $w_1$ to $w_3$, but no such edge exists. \end{example} \begin{definition} Suppose that $f:X\to Y$ is a simplicial map, and that $\shf{F}$ is a sheaf on $Y$ and $\shf{G}$ is a sheaf on $X$. A \emph{sheaf morphism} (or simply a \emph{morphism}) $m:\shf{F}\to \shf{G}$ along $f$ assigns a linear map $m_a:\shf{F}(f(a)) \to \shf{G}(a)$ to each face $a \in X$ so that for every attachment $a\attach b$ in the face category of $X$, $m_b \circ \shf{F}(f(a)\attach f(b)) = \shf{G}(a\attach b) \circ m_a$. \end{definition} Usually, we describe a morphism by way of a commutative diagram like the one below \begin{equation*} \xymatrix{ \shf{F}(f(a))\ar[d]_{\shf{F}(f(a)\attach f(b))}\ar[r]^{m_a} & \shf{G}(a) \ar[d]^{\shf{G}(a\attach b)}\\ \shf{F}(f(b))\ar[r]^{m_b} & \shf{G}(b)\\ } \end{equation*} \begin{remark} The reader is cautioned that a sheaf morphism and its underlying simplicial map ``go opposite ways.'' \end{remark} Cohomology is a functor from the category of sheaves and sheaf morphisms to the category of vector spaces. This indicates that cohomology preserves and reflects the underlying relationships between data stored in sheaves. \begin{proposition} \label{prop:coho_functor} Suppose that $\shf{R}$ is a sheaf on $X$ and that $\shf{S}$ is a sheaf on $Y$. If $m:\shf{R}\to\shf{S}$ is a morphism of these sheaves, then $m$ induces linear maps $m^k:H^k(X,\shf{R})\to H^k(Y,\shf{S})$ for each $k$. (Note that the simplicial map associated to $m$ is a function $Y\to X$.) \end{proposition} As a consequence, $m^0$ is a linear map from the space of global sections of $\shf{R}$ to the space of global sections of $\shf{S}$. Because of this, it is possible to describe the process of sampling using a sheaf morphism. \begin{definition} \label{df:sampling_morphism} Suppose that $\shf{F}$ is a sheaf on an abstract simplicial complex $X$, and that $\shf{S}$ is a $V$-sampling sheaf on $X$ supported on a closed subcomplex $Y$. A \emph{sampling morphism} (or \emph{sampling}) of $\shf{F}$ is a morphism $s:\shf{F}\to \shf{S}$ that is surjective on every stalk. \end{definition} \begin{example} The diagram below shows a morphism (vertical arrows) between two sheaves, namely the sheaf of continuous functions defined in Example \ref{eg:continuous_sheaf1} (top row) and the sampling sheaf defined in Example \ref{eg:sample_sheaf} (bottom row): \begin{equation*} \xymatrix{ C((-2,0),\mathbb{R}) \ar[r]\ar[d]^{e_{-1}} & C((-1,0),\mathbb{R})\ar[d] & C((-1,1),\mathbb{R}) \ar[d]^{e_0}\ar[r] \ar[l] & C((0,1),\mathbb{R})\ar[d]\\ \mathbb{R} \ar[r] & 0 & \mathbb{R} \ar[r]\ar[l] & 0 \\ } \end{equation*} In the diagram, $e_x$ represents the operation of evaluating a continuous function at $x$. As in Section \ref{sec:unifying}, this sampling morphism takes a continuous function $f\in C((-2,1),\mathbb{R})$ to a vector $(f(-1),f(0))$. \end{example} In algebraic topology, special emphasis is placed on \emph{sequences} of maps of the form \begin{equation*} \xymatrix{ \dotsb \ar[r] & A_1 \ar[r]^{m_1} & A_2 \ar[r]^{m_2} & A_3 \ar[r]^{m_3} & A_4 \ar[r]^{m_4} & \dotsb, } \end{equation*} where the $A_k$ are vector spaces and the $m_k$ are linear maps. We will denote this sequence by $(A_\bullet,m_\bullet)$. For instance, the cochain complex described in the previous section is a sequence of vector spaces. A linear map satisfies the dimension theorem, which relates the size of its kernel, cokernel, and image. In some sequences, the dimension theorem is extremely useful -- these are the exact sequences. \begin{definition} A sequence $(A_\bullet,m_\bullet)$ of vector spaces is called \emph{exact} if $\ker m_k = \mathop{\text{image}} m_{k-1}$. \end{definition} Via the dimension theorem, exact sequences can encode information about linear maps, namely \begin{enumerate} \item $\xymatrix{0 \to A \ar[r]^m & B}$ is exact if and only if $m$ is injective, \item $\xymatrix{A \ar[r]^m & B \to 0}$ is exact if and only if $m$ is surjective, and \item $\xymatrix{0 \to A \ar[r]^m & B \to }$ is exact if and only if $m$ is an isomorphism. \end{enumerate} Observe that the cochain complex $(C^\bullet(X;\shf{S}),d^\bullet)$ is exact if and only if $H^k(X;\shf{S})=0$ for all $k$. \begin{remark} Sequences of sheaf morphisms (instead of just vector spaces) are surprisingly powerful, and play an important role in the general theory of sheaves. However, if the direction of the morphisms is allowed to change across the sequence, like \begin{equation*} \xymatrix{ \shf{A} & \shf{B} \ar[r]\ar[l] & \shf{C}, } \end{equation*} the resulting construction can represent all linear, shift-invariant filters \cite{Robinson_GlobalSIP, Robinson_tspbook}. \end{remark} \section{The general sampling theorems} \label{sec:general_sampling} Given a sampling morphism, we can construct the \emph{ambiguity sheaf} $\shf{A}$ in which the stalk $\shf{A}(a)$ for a face $a\in X$ is given by the kernel of the map $\shf{F}(a)\to \shf{S}(a)$. If $a\attach b$ is an attachment of faces in $X$, then $\shf{A}(a\attach b)$ is given by $\shf{F}(a\attach b)$ restricted to $\shf{A}(a)$. This implies that the sequence of sheaves \begin{equation*} \xymatrix{ 0\to \shf{A} \ar[r] & \shf{F} \ar[r]^{s} & \shf{S} \to 0 } \end{equation*} induces short exact sequences of cochain spaces \begin{equation*} 0 \to C^k(X;\shf{A}) \to C^k(X;\shf{F}) \to C^k(X;\shf{S}) \to 0, \end{equation*} one for each $k$. Together, these sequences of cochain spaces induce a long exact sequence (via the well-known Snake lemma; see \cite{Hatcher_2002} for instance) \begin{equation*} 0\to H^0(X;\shf{A}) \to H^0(X;\shf{F}) \to H^0(X;\shf{S}) \to H^1(X;\shf{A}) \to \dotsb \end{equation*} An immediate consequence is therefore \begin{corollary} (Sheaf-theoretic Nyquist theorem) \label{thm:nyquist} The global sections of $\shf{F}$ are identical with the global sections of $\shf{S}$ if and only if $H^k(X;\shf{A})=0$ for $k=0$ and $1$. \end{corollary} The cohomology space $H^0(X;\shf{A})$ characterizes the \emph{ambiguity} in the sampling. When $H^0(X;\shf{A}$ is nontrivial, there are multiple global sections of $\shf{F}$ that result in the same set of samples. In contrast, $H^1(X;\shf{A})$ characterizes the \emph{redundancy} of the sampling. When $H^1(X;\shf{A}$ is nontrivial, then there are sets of samples that correspond to \emph{no} global section of $\shf{F}$. Optimal sampling therefore consists of identifying minimal closed subcomplexes $Y$ so the resulting ambiguity sheaf $\shf{A}$ has $H^0(X;\shf{A})=H^1(X;\shf{A})=0$. \begin{remark} Corollary \ref{thm:nyquist} is also useful for describing boundary value problems for differential equations. The sheaf $\shf{F}$ can be taken to be a sheaf of solutions to a differential equation \cite{Ehrenpreis_1956}. The sheaf $\shf{S}$ can be taken to have support only at the boundary of the region of interest, and therefore specifies the possible boundary conditions. In this case, the space of global sections of the ambiguity sheaf $\shf{A}$ consists of all solutions to the differential equation that \emph{also} satisfy the boundary conditions. \end{remark} Let us place bounds on the cohomologies of the ambiguity sheaf. To do so, we construct two new sheaves associated to a given sheaf $\shf{F}$ and a closed subcomplex $Y \subseteq X$. These new sheaves allow us to study reconstruction from a collection of rich samples. \begin{definition} For a closed subcomplex $Y$ of $X$, let $\shf{F}^Y$ be the sheaf whose stalks are the stalks of $\shf{F}$ on $Y$ and zero elsewhere, and whose restrictions are either those of $\shf{F}$ on $Y$ or zero as appropriate. There is a surjective sheaf morphism $\shf{F}\to \shf{F}^Y$ and an induced ambiguity sheaf $\shf{F}_Y$ which can be constructed in exactly the same way as $\shf{A}$ before. \end{definition} Thus, the dimension of each stalk of $\shf{F}^Y$ is larger than that of any sampling sheaf supported on $Y$, and the dimension of stalks of $\shf{F}_Y$ are therefore as small as or smaller than that of any ambiguity sheaf. Because global sections are determined by their values at the vertices (Proposition \ref{prop:global_coho}), obtaining rich samples from $\shf{F}^Y$ at all vertices evidently allows reconstruction. This idea works for all degrees of cohomology, which generalizes the notion of oversampling. \begin{proposition} (Oversampling theorem) \label{prop:oversample} If $X^k$ is the closed subcomplex generated by the $k$-faces of $X$, then $H^k(X^{k+1};\shf{F}_{X^k})=0$. \end{proposition} On the other hand, not taking enough samples leads to an ambiguous reconstruction problem. This can be detected by the presence of nontrivial global sections of the ambiguity sheaf. \begin{theorem} (Sampling obstruction theorem) \label{thm:obstruction} Suppose that $Y$ is a closed subcomplex of $X$ and $s:\shf{F}\to \shf{S}$ is a sampling of sheaves on $X$ supported on $Y$. If $H^0(X,\shf{F}_Y) \not= 0$, then the induced map $H^0(X;\shf{F})\to H^0(X;\shf{S})$ is not injective. \end{theorem} Succinctly, $H^0(X,\shf{F}_Y)$ is an obstruction to the recovery of global sections of $\shf{F}$ from its samples. \subsection{Proofs of the general sampling theorems} \begin{proof} (of Proposition \ref{prop:oversample}) By direct computation, the $k$-cochains of $\shf{F}_{X^k}$ are \begin{eqnarray*} C^k(X^{k+1};\shf{F}_{X^k})&=&C^k(X^{k+1};\shf{F})/C^k(X^k;\shf{F})\\ &=&\bigoplus_{a\text{ a }k\text{-face of}X} \shf{F}(a) / \bigoplus_{a\text{ a }k\text{-face of}X} \shf{F}(a)\\ &=& 0. \end{eqnarray*} \qed \end{proof} As an immediate consequence, $H^0(X;\shf{F}_Y)=0$ when $Y$ is the set of vertices of $X$. \begin{proof} (of Theorem \ref{thm:obstruction}) We begin by constructing the ambiguity sheaf $\shf{A}$ as before so that \begin{equation*} \xymatrix{ 0\to \shf{A} \to \shf{F} \ar[r]^{s} & \shf{S} \to 0 } \end{equation*} is a short exact sequence of sheaves. Observe that $\shf{S}\to \shf{F}^Y$ can be chosen to be injective, because the stalks of $\shf{S}$ have dimension not more than the dimension of $\shf{F}$ (and hence $\shf{F}^Y$ also). Thus the induced map $H^0(X;\shf{S})\to H^0(X;\shf{F}^Y)$ is also injective. Therefore, by a diagram chase on \begin{equation*} \xymatrix{ 0\to H^0(X;\shf{A}) \ar[r] & H^0(X;\shf{F}) \ar[d]^{\cong} \ar[r]^{s}& H^0(X;\shf{S})\ar[d]\\ 0\to H^0(X;\shf{F}_Y) \ar[r] & H^0(X;\shf{F}) \ar[r] & H^0(X;\shf{F}^Y)\\ } \end{equation*} we infer that there is a surjection $H^0(X;\shf{A})\to H^0(X;\shf{F}_Y)$. By hypothesis, this means that $H^0(X;\shf{A})\not= 0$, so in particular $H^0(X;\shf{F})\to H^0(X;\shf{S})$ cannot be injective. \qed \end{proof} \section{Examples} This section shows the unifying power of a sheaf-theoretic approach to sampling, by focusing on three rather different examples. The examples differ in terms of how ``local'' the reconstruction is; those that are less local show a greater impact of the topology of the base space on reconstruction. Specifically, we examine \begin{enumerate} \item \emph{Bandlimited functions}, in which reconstruction is global. Topology strongly impacts the number of samples required: if we instead consider bandlimited functions on a compact space, we obtain finite Fourier series. (The sampling \emph{rate} is unchanged, however.) \item \emph{Quantum graphs}, in which reconstruction is somewhat local. Sometimes nontrivial topology in the domain is detected, sometimes not. \item \emph{Splines}, in which there are only local constraints on the functions. Topology plays almost no role in the reconstruction of splines from their samples. \end{enumerate} Of course, the case of $PW_B$ is rather well-known -- but we show that it has a sheaf-theoretic interpretation. In rather stark contrast to the case of $PW_B$ is the vector space consisting of the B-splines associated to a particular knot sequence. The functions in this space are determined via a locally finite, piecewise polynomial partition of unity. Since B-splines are determined locally, it makes sense that reconstructing them from local samples is possible. Importantly, sampling theorems obtained for spaces of B-spline are less sensitive to global topological properties. Spaces of solutions to linear differential equations are a kind of intermediate between $PW_B$ and the space of B-splines. While a degree $k$ differential equation defines its solution locally, there are $k$ linearly independent such solutions. Additionally, the topology of the underlying space on which the differential equation is written impacts the process of reconstruction from samples. \cite{pesenson_2005,pesenson_2006,RobinsonQGTopo} The unifying power of sheaf theory means that all of the examples in this section can be treated in the same way, according to the following procedure: \begin{enumerate} \item \emph{Encode} the function space to be sampled as a sheaf, \item \emph{Specify} the sampling sheaf and sampling morphism, \item \emph{Construct} the ambiguity sheaf associated to the sampling morphism, \item \emph{Compute} the cohomology of the ambiguity sheaf, and \item \emph{Collect} conditions for perfect reconstruction based on this computation. \end{enumerate} \subsection{Bandlimited functions} \label{sec:bandlimited} \begin{figure} \begin{center} \includegraphics[width=3.25in]{nyquist_setup} \caption{The sheaves used in proving the traditional Nyquist theorem} \label{fig:nyquist_setup} \end{center} \end{figure} In this section, we prove the traditional form of the Nyquist theorem by showing that appropriate bandlimiting is a sufficient condition for $H^0(X;\shf{A})=0$, where $\shf{A}$ is an ambiguity sheaf, and $X$ is an abstract simplicial complex for the real line $\mathbb{R}$. We begin by specifying the following 1-dimensional simplicial complex $X$. Let $X^0=\mathbb{Z}$ and $X^1=\{(n,n+1)\}$. We construct the sheaf $\shf{C}$ of signals according to their Fourier transforms (see Figure \ref{fig:nyquist_setup}) so that for every simplex, the stalk of $\shf{C}$ is the vector space $M(\mathbb{R},\mathbb{C})$ of complex-valued measures on $\mathbb{R}$. To relate translation in the spatial domain and the frequency domain, each restriction to the left is chosen to be the identity, and each restriction to the right is chosen to be multiplication by $e^{2\pi i \omega}$. In essence, $\shf{C}$ is the sheaf of \emph{local Fourier transforms} of functions on $\mathbb{R}$. Observe that the space of global sections of $\shf{C}$ is therefore just $M(\mathbb{R},\mathbb{C})$. Construct the sampling sheaf $\shf{S}$ whose stalk on each vertex is $\mathbb{C}$ and each edge stalk is zero. We construct a sampling morphism by the zero map on each edge, and by the integral \begin{equation*} m(f)=\int_{-\infty}^\infty f(\omega) d\omega = f((-\infty,\infty)) \end{equation*} on each vertex. Then the ambiguity sheaf $\shf{A}$ has stalks $M(\mathbb{R},\mathbb{C})$ on each edge, and $\{f\in M(\mathbb{R},\mathbb{C}) : m(f)=0\}$ on each vertex $\{n\}$. \begin{theorem}(Traditional Nyquist theorem) Suppose we replace $M(\mathbb{R},\mathbb{C})$ with $M_B(\mathbb{R},\mathbb{C})$, the set of measures whose support is contained in $[-B,B]$. Then if $B\le 1/2$, the resulting ambiguity sheaf $\shf{A}_B$ has $H^0(X;\shf{A}_B)=0$. Therefore, each such function can be recovered uniquely from its samples on $\mathbb{Z}$. \end{theorem} \begin{proof} The elements of $H^0(X;\shf{A}_B)$ are given by the measures $f$ supported on $[-B,B]$ for which \begin{equation*} \int_{-B}^B f(\omega) e^{2\pi i n \omega} d\omega=(e^{2\pi i n \omega} f)([-B,B])=0 \end{equation*} for all $n$. Observe that if $B\le 1/2$, this is precisely the statement that the Fourier series coefficients of $f$ all vanish; hence $f$ must vanish. This means that the only global section of $\shf{A}_B$ is the zero function. (Ambiguities can arise if $B>1/2$, because the set of functions $\{e^{-2\pi in\omega}\}_{n\in\mathbb{Z}}$ is then \emph{not} complete.) \qed \end{proof} \begin{figure} \begin{center} \includegraphics[width=2in]{circle_measures} \caption{The sheaf $\shf{C}$ of local Fourier transforms of functions on a circle with $N$ vertices} \label{fig:circle_measures} \end{center} \end{figure} Sampling on the circle can be addressed by a related construction of a sheaf $\shf{C}$. As indicated in Figure \ref{fig:circle_measures}, the stalk over each edge and vertex is still $M(\mathbb{R},\mathbb{C})$. Again, the restrictions are chosen so that left-going restrictions are identities, and the right-going restrictions consist of multiplying measures by $e^{2\pi i \omega}$. Intuitively, this means that functions that are local to an edge or a vertex do not reflect any nontrivial topology. Since the topology is no longer that of a line, there are some important consequences. The space of global sections of $\shf{C}$ on the circle is \emph{not} $M(\mathbb{R},\mathbb{C})$, and now depends on the number $N$ of vertices on the circle.\footnote{$N$ must be at least 3 to use an abstract simplicial complex model of the circle. If $N$ is 1 or 2, one must instead use a CW complex. This does not change the analysis presented here.} One may conclude from a direct computation that the value of any global section at a vertex must be a measure $f$ satisfying \begin{equation*} e^{2\pi i \omega N} f(\omega) = f(\omega). \end{equation*} Of course, this means that the support of $f$ must be no larger than the set of fractions $\frac{1}{N}\mathbb{Z}$ because at each $\omega$ either $f(\omega)$ must vanish, or $(e^{2\pi i \omega N}-1)$ must vanish. Hence a global section describes a function whose (global) Fourier transform is discrete. If we instead consider the sheaf of bandlimited functions $\shf{C}_B$ by replacing each $M(\mathbb{R},\mathbb{C})$ by $M_B(\mathbb{R},\mathbb{C})$, the resulting space of global sections is finite dimensional. Perhaps surprisingly, this does not impact the required sampling rate. \begin{corollary} If $\shf{C}_B$ is sampled at each each vertex, then a sampling morphism will fail to be injective on global sections if $B>1/2$. \end{corollary} (If $B<1/2$, some sampling morphisms -- such as the zero morphism -- are still not injective.) \begin{proof} Merely observe that for a sampling sheaf $\shf{S}$ a necessary condition for injectivity is that \begin{eqnarray*} \dim H^0(\shf{C}_B) &\le& \dim H^0(\shf{S})\\ (2N+1)B &\le& N\\ B &\le& N/(2N+1) < 1/2\\ \end{eqnarray*}\qed \end{proof} \subsection{Wave propagation (quantum graphs)} \label{sec:quantum_graph} A rich source of interesting sheaves arise in the context of differential equations \cite{Ehrenpreis_1956}. Sampling problems are interesting in spaces of solutions to differential equations, because they are restricted enough to have relatively relaxed sampling rates. Although a differential equation describes a function locally, continuity and boundary conditions allow topology to influence which of these locally defined functions can be extended globally. Consider the differential equation \begin{equation} \label{eq:helmholtz} \frac{\partial^2 u}{\partial x^2} + k^2 u = 0 \end{equation} on the real line, in which $k$ is a complex scalar parameter called the \emph{wavenumber}. The general solution to this differential equation is the linear combination of two traveling waves, namely \begin{equation*} u(x) = c_1 e^{ikx} + c_2 e^{-ikx}. \end{equation*} This means that locally and globally, a given solution is described by an element of $\mathbb{C}^2$. Let us now generalize to the case of solutions to \eqref{eq:helmholtz} over a graph $X$. In order for the space of solutions to be well defined, it is necessary to assign a length to each edge. We shall write $L(e)$ for the length of edge $e$, which is a positive real number. \begin{definition} The \emph{transmission line sheaf} $\shf{T}$ on $X$ has stalks given by \begin{enumerate} \item $\shf{T}(e)=\mathbb{C}^2$ over each edge $e$, and \item $\shf{T}(v)=\mathbb{C}^{\deg v}$ over each vertex $v$, whose degree is $\deg v$. \end{enumerate} Without loss of generality, assume that each edge $e$ that is attached to a vertex $v$ is assigned a number from $\{1,\dotsc,\deg v\}$. If $e$ is the $m$-th edge attached to vertex $v$, the restriction $\shf{T}(v\attach e_m)$ is given by \begin{equation*} \shf{T}(v\attach e_m)(u_1,\dotsc,u_{\deg v})= \begin{cases} \left(u_m,e^{-ikL(e_m)}\left(\frac{2}{\deg v}\sum_{j=1}^{\deg v} u_j-u_m\right)\right)&\text{if }[e_m:v] = 1\\ \left(e^{ikL(e_m)}\left(\frac{2}{\deg v}\sum_{j=1}^{\deg v} u_j-u_m\right),u_m\right)&\text{if }[e_m:v] = -1\\ \end{cases} \end{equation*} \end{definition} Although the definition of a transmission line sheaf is combinatorial, it is an accurate model of the space of solutions on its \emph{geometric realization}. Under an appropriate definition of the Laplacian operator on the geometric realization of $X$ (such as is given in \cite{Zhang_1993,Baker_2006,Baker_2007}), the sheaf of solutions to \eqref{eq:helmholtz} is isomorphic to a transmission line sheaf. \cite{RobinsonQGTopo} Additionally, there are sensible definitions for bandlimitedness in this geometric realization, which give rise to Shannon-Nyquist theorems. \cite{pesenson_2005,pesenson_2006} However, our focus will remain combinatorial and topological. We note that others \cite{pesenson_2008,pesenson_2010} have obtained results in general combinatorial settings, though we will focus on the impact of the topology of $X$ on sampling requirements. The easiest sampling result for transmission line sheaves follows immediately from Proposition \ref{prop:global_coho}, namely that a global section of a transmission line sheaf $\shf{T}$ on $X$ is completely specified by its values on the vertices of $X$. This result is clearly inefficient; merely consider the simplicial complex $X$ for the real line with vertices $X^0=\mathbb{Z}$ and edges $X^1=\{(n,n+1)\}$. We have already seen that the space of sections of a tranmission line sheaf on $X$ is merely $\mathbb{C}^2$, yet oversampling would have us collect samples at infinitely many vertices! The missing insight is that the topology of $X$ impacts the global sections of a transmission line sheaf. \begin{figure} \begin{center} \includegraphics[width=3.5in]{triangle} \caption{The graph $X$ for Example \ref{eg:triangle} (left) and $Y$ for Example \ref{eg:star} (right)} \label{fig:triangle} \end{center} \end{figure} \begin{figure} \begin{center} \includegraphics[width=4in]{sample_star} \caption{Sampling a star at a leaf (left) and at its center (right)} \label{fig:sample_star} \end{center} \end{figure} Changing the edge length in the simplicial complex model for $\mathbb{R}$ does not change the space of global sections of a transmission line sheaf. Another siuation in which edge length does not matter is shown in the next example. \begin{example} \label{eg:star} Consider the space $Y$ shown at right in Figure \ref{fig:triangle}. The coboundary map $d^0$ for a transmission line sheaf over $Y$ is given by \begin{equation*} \begin{pmatrix} -e^{ikL(e_1)}&0&0 &1&0&0\\ -1&0&0 &-\frac{1}{3}e^{-ikL(e_1)}&\frac{2}{3}e^{-ikL(e_1)}&\frac{2}{3}e^{-ikL(e_1)}\\ 0&-e^{ikL(e_2)}&0 &0&1&0\\ 0&-1&0 &\frac{2}{3}e^{-ikL(e_2)}&-\frac{1}{3}e^{-ikL(e_2)}&\frac{2}{3}e^{-ikL(e_2)}\\ 0&0&-e^{ikL(e_3)} &0&0&1\\ 0&0&-1 &\frac{2}{3}e^{-ikL(e_3)}&\frac{2}{3}e^{-ikL(e_3)}&-\frac{1}{3}e^{-ikL(e_3)}\\ \end{pmatrix}, \end{equation*} which has rank 5 -- in other words $\dim H^0(Y;\shf{T})=1$ for any transmission sheaf $\shf{T}$. This means that reconstruction of sections requires at least one dimension of measurements; a lower bound. If we consider a sampling morphism $\shf{T}\to\shf{T}^Z$ for some set of vertices $Z$, this induces an injective map on global sections. To see this, consider sampling at any one of the leaf nodes or at the center. If we sample at a leaf node only, as shown in Figure \ref{fig:sample_star} at left, the ambiguity sheaf $\shf{A}$ has a coboundary matrix given by \begin{equation*} \begin{pmatrix} 0&0 &1&0&0\\ 0&0 &-\frac{1}{3}e^{-ikL(e_1)}&\frac{2}{3}e^{-ikL(e_1)}&\frac{2}{3}e^{-ikL(e_1)}\\ -e^{ikL(e_2)}&0 &0&1&0\\ -1&0 &\frac{2}{3}e^{-ikL(e_2)}&-\frac{1}{3}e^{-ikL(e_2)}&\frac{2}{3}e^{-ikL(e_2)}\\ 0&-e^{ikL(e_3)} &0&0&1\\ 0&-1 &\frac{2}{3}e^{-ikL(e_3)}&\frac{2}{3}e^{-ikL(e_3)}&-\frac{1}{3}e^{-ikL(e_3)}\\ \end{pmatrix}, \end{equation*} which has rank 5, implying that the ambiguity sheaf has only trivial global sections. On the other hand, sampling at the center yields a different ambiguity sheaf $\shf{B}$, whose coboundary matrix is \begin{equation*} \begin{pmatrix} -e^{ikL(e_1)}&0&0\\ -1&0&0\\ 0&-e^{ikL(e_2)}&0 \\ 0&-1&0\\ 0&0&-e^{ikL(e_3)}\\ 0&0&-1\\ \end{pmatrix}, \end{equation*} which also has trivial kernel. \end{example} If we instead consider a different topology, for instance a circle, then edge lengths do have an impact on the global sections of the resulting transmission line sheaf. \begin{example} \label{eg:triangle} Consider the simplicial complex $X$ shown at left in Figure \ref{fig:triangle}, in which the edges are oriented as marked. Because $X$ has a nontrivial loop, the lengths of the edges impact the space of global sections of a transmission line sheaf over $X$. Specifically, if $\shf{T}$ is a transmission line sheaf, its coboundary $d^0:C^0(X;\shf{T})\to C^1(X;\shf{T})$ is given by \begin{equation*} \begin{pmatrix} 0&0&-e^{ikL(e_1)}&0&1&0 \\ 0&0&0&-1&0&e^{-ikL(e_1)} \\ 1&0&0&0&-e^{ikL(e_2)}&0\\ 0&e^{-ikL(e_2)}&0&0&0&-1\\ -e^{ikL(e_3)}&0&1&0&0&0 \\ 0&-1&0&e^{-ikL(e_3)}&0&0 \\ \end{pmatrix}. \end{equation*} This matrix has full rank unless $e^{-ik\left(L(e_1)+L(e_2)+L(e_3)\right)}=1$, a condition called \emph{resonance}. Therefore, the space of global sections of $\shf{T}$ has dimension \begin{equation*} \dim H^0(X;\shf{T}) = \begin{cases} 2 & \text{if } k \left(L(e_1)+L(e_2)+L(e_3)\right) \in 2\pi\mathbb{Z}\\ 0 & \text{otherwise} \end{cases}, \end{equation*} and an easy calculation shows that sampling at any one of the vertices results in an injective map on global sections. \end{example} Based on the previous examples, a sound procedure is to consider the dimension of the space of global sections of $\shf{T}$ to be a lower bound on how much information is to be obtained through sampling. (Clearly, this may not be enough in some situations, especially if the sampling morphisms are not injective on stalks.) As described in \cite{RobinsonQGTopo}, a general lower bound on the dimension of $H^0(\shf{T})$ is $n+1$, where $n$ is the number of resonant loops. (A tighter lower bound exists, but its expression is complicated by the presence of degree 1 vertices.) Therefore, topology plays an important role in acquiring enough information to recover global sections of $\shf{T}$ from samples. \subsection{Polynomial splines} \label{sec:spline_knots} Section \ref{sec:bandlimited} showed how limiting the support of the Fourier transform of a function permitted it to be reconstructed by its values at a discrete subset. Because of the Paley-Weiner theorem, the smoothness of a function is reflected in the decay of its Fourier transform. On the other hand, Section \ref{sec:quantum_graph} showed that applying smoothness constraints directly to the function also enables perfect recovery. This suggests that as we consider smoother functions, we can reconstruct them from more widely spaced samples. In this section, we consider sampling from polynomial splines, which are functions whose smoothness is explicitly controlled. A $C^k$ degree $n$ polynomial spline has $k$ continuous derivatives and is constructed piecewise from degree $n$ polynomial segments (see Figure \ref{fig:piecepoly}). Because of this, a polynomial spline is infinitely differentiable on all of its domain except at a discrete set of \emph{knot points}, where it has $k$ continuous derivatives. \begin{figure} \begin{center} \includegraphics[width=2.5in]{piecepoly} \caption{A polynomial spline with two quadratic segments, joined at a knot with continuous first derivatives} \label{fig:piecepoly} \end{center} \end{figure} For instance, consider a degree $n$ polynomial spline that has two knots: one at $0$ and one at $L$. Require it to have $C^{n-1}$ smoothness across its three segments: $(-\infty,0)$, $(0,L)$, and $(L,\infty)$. To obtain $n-1$ continuous derivatives at $x=0$, such a spline should have the form \begin{equation*} f(x)=\begin{cases} a_{n}^- x^n + \sum_{k=0}^{n-1} a_k x^k&\text{for } x \le 0\\ a_{n}^+ x^n + \sum_{k=0}^{n-1} a_k x^k&\text{for } 0\le x \le L \\ \end{cases} \end{equation*} In a similar way, to obtain $n-1$ continuous derivatives at $x=L$, the spline should be of the form \begin{equation*} f(x)=\begin{cases} b_{n}^- (x-L)^n + \sum_{k=0}^{n-1} b_k (x-L)^k&\text{for } 0 \le x \le L\\ b_{n}^+ (x-L)^n + \sum_{k=0}^{n-1} b_k (x-L)^k&\text{for } x \ge L \\ \end{cases} \end{equation*} But clearly on $0 \le x \le L$, these two definitions should agree so that $f$ is a well-defined function. This means that for all $x$, \begin{eqnarray*} a_{n}^+ x^n + \sum_{k=0}^{n-1} a_k x^k &=&b_{n}^- (x-L)^n + \sum_{k=0}^{n-1} b_k (x-L)^k\\ &=&\sum_{i=0}^{n-1} b_i \sum_{k=0}^i \binom{i}{k} x^k (-L)^{i-k} + b_n^- \sum_{k=0}^n \binom{n}{k}x^k(-L)^{n-k}\\ &=&\sum_{k=0}^{n-1} x^k \sum_{i=k}^{n-1}\binom{i}{k}(-L)^{i-k}b_i + \sum_{k=0}^n x^k \binom{n}{k}(-L)^{n-k}b_n^-\\ &=&\sum_{k=0}^{n-1}x^k\left(\sum_{i=k}^{n-1}\binom{i}{k}(-L)^{i-k}b_i + \binom{n}{k}(-L)^{n-k}b_n^-\right)+b_n^-x^n. \end{eqnarray*} By linear independence, this means that \begin{eqnarray*} a_n^+&=&b_n^-\\ a_k&=&\sum_{i=k}^{n-1}\binom{i}{k}(-L)^{i-k}b_i + \binom{n}{k}(-L)^{n-k}b_n^-\\ \end{eqnarray*} Notice that if the $a$ variables are given, then this is a triangular system for the $b$ variables. Using this computation, we can define $\shf{PS}^n$, the sheaf of $n$-degree polynomial splines on $\mathbb{R}$ with knots at each of the integers. This sheaf is built on the simplicial complex $X$ for $\mathbb{R}$, whose vertices are $X^0=\mathbb{Z}$ and whose edges are $X^1=\{(m,m+1)\}$. Because a degree $n$ spline at any given knot can be defined by $n+2$ real values on the two segments adjacent to that knot, we assign \begin{equation*} \shf{PS}^n(\{m\}) = \mathbb{R}^{n+2} \end{equation*} for each $m\in\mathbb{Z}$. Specifically, we will think of these as defining $(a_0,\dotsc,a_{n-1},a_n^-,a_n^+)$ in our calculation above. The spline on each segment is merely a degree $n$ polynomial, so that \begin{equation*} \shf{PS}^n(\{(m,m+1)\}) = \mathbb{R}^{n+1}. \end{equation*} For each knot, there are two restriction maps: one to the left and one to the right. They are given by \begin{equation*} \shf{PS}^n(\{m\}\attach\{m,m+1\})= \begin{pmatrix} 1& \dotsb &0 &0 &0\\ \vdots& &\vdots &\vdots &\vdots\\ 0& \dotsb &1 &0 &0\\ 0& \dotsb &0 &0 &1\\ \end{pmatrix} \end{equation*} and \begin{equation*} \shf{PS}^n(\{m+1\}\attach\{m,m+1\})= \begin{pmatrix} 1&-L & L^2 & -L^3 & \dotsb & (-L)^n& 0\\ & 1 & -2L & 3L^2 & \dotsb & \binom{n}{1}(-L)^{n-1}& 0\\ & & 1 & -3L & \dotsb & \binom{n}{2}(-L)^{n-2}& 0\\ & & & 1 & \dotsb & \binom{n}{3}(-L)^{n-3}& 0\\ & & & & & \vdots& \vdots \\ & & & & & \binom{n}{k}(-L)^{n-k}& 0 \\ & & & & & \vdots& \vdots \\ & & & & & 1& 0\\ \end{pmatrix} \end{equation*} \begin{remark} Observe that $L=1$, $\shf{PS}^1$ reduces to the sheaf $\shf{PL}$ given in Example \ref{eg:pl_def}, for the special case of the graph being a line (so all vertices have degree 2). \end{remark} \begin{figure} \begin{center} \includegraphics[width=2in]{ps_global} \caption{The simplicial complex used in Lemma \ref{lem:ps_global}} \label{fig:ps_global} \end{center} \end{figure} \begin{lemma} \label{lem:ps_global} Consider $\shf{PS}^n$ on the simplicial complex shown in Figure \ref{fig:ps_global}, which has $k+2$ vertices and and $k+1$ edges. The sheaf has nontrivial global sections that vanish at the endpoints if and only if $k>n+1$. If $k \le n+1$, then the only global section which vanishes at both endpoints is the zero section. \end{lemma} \begin{proof} Consider the ambiguity sheaf $\shf{A}$ associated to the sampling morphism $\shf{PS}^n \to (\shf{PS}^n)^Y$ where $Y$ consists of the two endpoints. Observe that the global sections of $\shf{A}$ correspond to global sections of $\shf{PS}^n$ that vanish at the endpints, so the lemma follows by reasoning about $H^0(\shf{A})$. The matrix for the coboundary map $d^0:C^0(\shf{A})\to C^1(\shf{A})$ has a block structure \begin{equation*} \begin{pmatrix} A & 0 & & 0 \\ B & A & \dotsb & 0 \\ 0 & B & & 0\\ & & & \vdots \\ & & & A\\ & & & B\\ \end{pmatrix}, \end{equation*} where the $(n+1)\times(n+2)$ blocks are \begin{equation*} A=\begin{pmatrix} 1& \dotsb &0 &0 &0\\ \vdots& &\vdots &\vdots &\vdots\\ 0& \dotsb &1 &0 &0\\ 0& \dotsb &0 &0 &1\\ \end{pmatrix},\; B= \begin{pmatrix} -1& \dotsb &* &* &0\\ \vdots& &\vdots &\vdots &\vdots\\ 0& \dotsb &-1 &* &0\\ 0& \dotsb &0 &-1 &0\\ \end{pmatrix}. \end{equation*} Clearly both such blocks are of full rank. Thus the coboundary matrix has a nontrivial kernel whenever it has more rows than columns: \begin{eqnarray*} (n+2)k &>& (n+1)(k+1)\\ nk + 1k &>& nk + n + k + 1\\ k &>& n+1\\ \end{eqnarray*} as desired. \qed \end{proof} This lemma implies that unambiguous reconstruction from samples is possible provided the gaps between samples are small enough. Increased smoothness allows the gaps to larger without inhibiting reconstruction. Because of this, it is convenient to define distances between vertices. \begin{definition} On a graph $G$, define the \emph{edge distance} between two vertices $v,w$ to be \begin{equation*} \ed(v,w)=\begin{cases} \min_p\{\text{\# edges in }p\text{ such that }p\text{ is a }\\\text{PL-continuous path from }v\to w\}\\ \infty\text{ if no such path exists} \end{cases} \end{equation*} From this, the maximal distance to a vertex set $Y$ is \begin{equation*} \med(Y)=\max_{x\in X^0} \{\min_{y\in Y}\; \ed(x,y)\}. \end{equation*} \end{definition} \begin{corollary} Suppose that $Y\subseteq \mathbb{Z}$, which we take to be a subset of vertices of $X$. If $\med Y \le n+2$, then the sampling morphism $\shf{PS}^n \to (\shf{PS}^n)^Y$ induces an injective linear map on global sections. \end{corollary} Observe that if we instead consider sampling of polynomial splines on the circle, very little changes. In particular, the proof of Lemma \ref{lem:ps_global} doesn't change at all. Indeed, we can change the context from polynomial splines on the real line to piecewise linear functions $\shf{PL}$ on a graph. We'll focus on the special case of a sampling morphism $s:\shf{PL}\to \shf{PL}^Y$ where $Y$ is a subset of the vertices of $X$. Excluding one or two vertices from $Y$ does not prevent reconstruction in this case, because the samples include information about slopes along adjacent edges. \begin{figure} \begin{center} \includegraphics[width=1.75in]{pl_cases} \includegraphics[width=1.5in]{pl_cases_g3} \caption{Graphs $G_1$, and $G_2$ (left) and $G_3$ (right) for Lemma \ref{lem:pl_cases}. Filled vertices represent elements of $Y$, empty ones are in the complement of $Y$.} \label{fig:pl_cases} \end{center} \end{figure} \begin{lemma} \label{lem:pl_cases} Consider $\shf{PL}_Y$, the subsheaf of $\shf{PL}$ whose sections vanish on a vertex set $Y$ and the graphs $G_1$, $G_2$, and $G_3$ as shown in Figure \ref{fig:pl_cases}. There are no nontrivial sections of $\shf{PL}_Y$ on $G_1$ and $G_2$, but there are nontrivial sections of $\shf{PL}_Y$ on $G_3$. \end{lemma} \begin{proof} If a section of $\shf{PL}$ vanishes at a vertex $x$ with degree $n$, this means that the value of the section there is an $(n+1)$-dimensional zero vector. The value of the section on every edge adjacent to $x$ is then the $2$-dimensional zero vector. Since the dimensions in each stalk of $\shf{PL}$ represent the value of the piecewise linear function and its slopes, linear extrapolation to the center vertex in $G_1$ implies that its value is zero too. A similar idea applies in the case of $G_2$. The stalk at $v$ has dimension 3. Any section at $v$ that extends to the left must actually lie in the subspace spanned by $(0,0,1)$ (coordinates represent the value, left slope, right slope respectively). In the same way, any section at $w$ that extends to the right must lie in the subspace spanned by $(0,1,0)$. Any global section must extend to $e$, which must therefore have zero slope and zero value. Finally $G_3$ has nontrivial global sections, spanned by the one shown in Figure \ref{fig:pl_cases}.\qed \end{proof} \begin{proposition}(Unambiguous sampling) Consider the sheaf $\shf{PL}$ on a graph $X$ and $Y\subseteq X^0$. Then $H^0(X;\shf{F}_Y)=0$ if and only if $\med(Y) \le 1$. \end{proposition} \begin{figure} \begin{center} \includegraphics[width=2.5in]{pl_sampling} \caption{The three families of subgraphs that arise when $\med(Y)>1$. Filled vertices represent elements of $Y$, empty ones are in the complement of $Y$.} \label{fig:pl_sampling} \end{center} \end{figure} \begin{proof} ($\Leftarrow$) Suppose that $x\in X^0 \backslash Y$ is a vertex not in $Y$. Then there exists a path with one edge connecting it to $Y$. Whence we are in the case of $G_1$ of Lemma \ref{lem:pl_cases}, so any section at $x$ must vanish. ($\Rightarrow$) By contradiction. Assume $\med(Y)>1$. Without loss of generality, consider $x\in X^0\backslash Y$, whose distance to $Y$ is exactly 2. Then one of the subgraphs shown in Figure \ref{fig:pl_sampling} must be present in $X$. But case $G_3$ of Lemma \ref{lem:pl_cases} makes it each of these has nontrivial sections at $x$, merely looking at sections over the subgraph. \qed \end{proof} \begin{proposition}(Non-redundant sampling) Consider the case of $s:\shf{PL}\to \shf{PL}^Y$. If $Y=X^0$, then $H^1(X;\shf{A})\not= 0$. If $Y$ is such that $\med(Y)\le 1$ and $|X^0\backslash Y|+\sum_{y\notin Y} \deg y = 2|X^1|$, then $H^1(X;\shf{A})=0$. \end{proposition} \begin{proof} The stalk of $\shf{A}$ over each edge is $\mathbb{R}^2$, and the stalk over a vertex in $Y$ is trival. However, the stalk over a vertex of degree $n$ not in $Y$ is $\mathbb{R}^{n+1}$. Observe that if $H^0(X;\shf{A})=0$, then $H^1(X;\shf{A})=C^1(X;\shf{A})/C^0(X;\shf{A})$. Using the degree sum formula in graph theory, we compute that $H^1(X;\shf{A})$ has dimension $2|X^1| - \sum_{y\notin Y} (\deg y + 1)$. \qed \end{proof} \section{Conclusions} This chapter has shown that exact sequences of sheaves are a unifying principle for sampling theory. These tools provide a general basis for discussing locality, and reveal general, precise conditions under which reconstruction succeeds. Several sampling problems for bandlimited and non-bandlimited functions were discussed. The use of sheaves in sampling is essentially unexplored otherwise, and there remain many open questions. We discuss two such questions here with a relationship to bandlimited functions. The first question is rather connected to the existing literature on sampling. We showed that although the number of samples required for the reconstruction of a bandlimited function may vary, the sampling \emph{rate} necessary appears to be the same. Specifically, we found that the bandwidth $B$ required for reconstructing functions on the real line and the circle was constrained to be less than $1/2$. Others (for instance \cite{pesenson_2005,pesenson_2010}) have found that this remains the case for other domains as well. Therefore, it seems fitting to ask ``Is the $B<1/2$ in the Nyquist Theorem invariant with respect to changes in topology and geometry?'' The second question is a bit more subtle. If a function is bandlimited, this means that its Fourier transform has bounded support. However, the Fourier transform is intimately related to the spectrum of the Laplacian operator. On the other hand, because cohomological obstructions play a role in sampling, we had to consider the cochain complex for sheaves of functions. These two threads of study are in fact closely related through Hodge theory via the study of Hilbert complexes \cite{Bruning_1992}. Indeed, if $\shf{F}$ and $\shf{S}$ are sheaves of Hilbert spaces then their cochain complexes are Hilbert complexes, and they have a Hodge decomposition, along with an associated Laplacian operator. Therefore, there may be a way to discuss the concept of ``bandwidth'' for general sheaves of Hilbert spaces. \begin{acknowledgement} This work was partly supported under Federal Contract No. FA9550-09-1-0643. The author also wishes to thank the editor for the invitation to write this chapter. Portions of this article appeared in the proceedings of SampTA 2013, published by EURASIP. \end{acknowledgement} \bibliographystyle{plain}

\section{Introduction} The standard model for the outburst of a classical nova is a thermonuclear runaway (TNR) in the accreted hydro\-gen-rich envelope on top of a white dwarf in a close binary system (\cite{Starr89} 1989, 1993, 1995; \cite{Truran82} 1982, 1990). Spherically symmetric models of the runaway, based on realistic nuclear reaction rate networks and mixing-length theory (MLT) of convection, have been investigated by many authors (\cite{Starr74} 1974, 1985; \cite{Prialnik78} 1978; \cite{MacD80} 1980), and the results were in good agreement with observational data, such as the total amount of energy released and the metallicity and the abundances of the expelled envelope material, provided considerable enrichment of the atmosphere with CNO-elements was assumed. Although the actual numbers depend on the mass of the white dwarf and the accretion rate, typical enhancements of up to a factor of 10 relative to solar values were required for models of fast novae. Despite of the success of these models, two questions remain to be answered: \begin{itemize} \item 1. Where does the enrichment come from? \item 2. What is changed if one avoids the mixing-length theory of convection? \end{itemize} In this paper we concentrate on the second question and will eliminate one suggested answer to the first one in passing. We shall mainly follow the arguments given in a recent work by us (Kercek, Hillebrandt \& Truran 1998; henceforth referred to as KHT), where these questions were addressed by direct two-dimensional simulations. For convenience we first summarize here the numerical method as well as the main results obtained in KHT. In KHT (as well as here) we performed numerical simulations based upon the hydro-code PROMETHEUS (Fryxell et al. 1989), a PPM-type code with nuclear reactions included. Curvature effects were ignored and the surface layers of the white dwarf as well as its envelope were represented by a plane-parallel sheet. The advantage of this approach was that periodic boundary conditions could be used, thereby avoiding common problems of numerical simulations of free convection, namely that reflecting boundaries may act like a containment and may affect the flow patterns in an unphysical way. Effects coming from the finite numerical resolution were investigated and it was found that, as far as the general properties of the simulations were concerned, a grid of moderate resolution. e.g. 220 $\times$ 100 (horizontal $\times$ vertical) grid points, covering a total of 1800km $\times$ 1000km of the white dwarf's surface and atmosphere, was sufficient to obtain stable results for integral quantities such as the energy generation rate and the rate of mixing of carbon and oxygen from the white dwarf into the atmosphere. In our version of PROMETHEUS, nuclear reactions are incorporated by solving together with the hydrodynamics a nuclear reaction network including 12 nuclear species, i.e., $^1$H, $^4$He, $^{12}$C, $^{13}$C, $^{13}$N, $^{14}$N, $^{15}$N, $^{14}$O, $^{15}$O, $^{16}$O, $^{17}$O, and $^{17}$F, linked by reactions described in Wallace \& Woosley (1981). The reaction rates are taken from Thielemann (private communication). Following \cite{Mueller86} (1986), we solve the network equations and the energy source equation simultaneously to avoid numerical instabilities. Since the accretion process prior to the TNR needs several $10^5$ years in order to get an initial model for the multi-dimensional simulations, one has to calculate the accretion phase and the slow stages of the burning by means of one-dimensional implicit hydro codes. Here as well as in KHT we used a model computed to the onset of the vehement phase of the TNR by \cite{Glasner97} (1997). During this early phase, hydrogen-rich matter of solar composition (Z = 0.015) is accreted onto the surface of a 1 M$_{\odot}$ C+O white dwarf at an accretion rate of 5.0$\cdot$10$^{-9}$M$_{\odot}$yr$^{-1}$. As the temperature rises at the bottom of the envelope convection sets in. Convection is taken into account by the MLT in the one dimensional model. The model provides the density, temperature, entropy, and composition profiles at the point at which the temperature at the bottom of the envelope reaches 10$^8$ K. The mass of the hydrogen shell is then about $2 \cdot 10^{-5}$M$_{\odot}$ and the metallicity is now Z = 0.02. This model was mapped onto a radial row of the 2D grid in KHT, relaxed for several hundred dynamical time scales, and then mapped onto the full 2D grid. In the present work, the same procedure is applied to a 3D grid. Finally, an initial perturbation is superimposed upon this hydrostatic configuration. The main features of the 2D flow fields which showed up in KHT were the appearance of small persistent coherent structures of very high vorticity (and velocity) compared to the background flow. Although they were not fully resolved they caused effects that were essentially independent of the resolution. During the early phase of the thermonuclear runaway they dominated the flow patterns and resulted in very little overshoot and mixing. At late times, after steady slow mixing and with increasing nuclear energy production, they became weak, but showed up again after hydrogen had mainly been burnt and the energy generation rate dropped. The net effect was that KHT did find some self-enrichment, but on time-scales much longer than in previous calculations. Moreover, for initially solar composition of the accreted gas the rise time of the temperature was very long, of the order of 1000s, and peak temperatures never exceeded 2$\cdot$10$^8$K. Therefore these models did not resemble the properties of a fast nova. Of course, the question arises if these conclusions would remain valid if the assumption of 2D symmetry were drop\-ped. First, one does not expect to find the small-scale stable vortices in 3D because they are a property of plane-parallel 2D flows, as was discussed in KHT. On the other hand, one also expects the dominant linear scale of convective eddies to be smaller in 3D than in 2D and, therefore, mixing and convective overshooting could be even less efficient than was found by KHT. In the following sections we will answer this question. In Sect. 2 we briefly describe the parameters of the models we have computed. In Sect. 3 we present and discuss the results of two sets of computations, one with solar initial composition of the accreted gas and a second with 5 times higher metal abundances. Some conclusions and an outlook follow in Sect. 4. We will concentrate on the astrophysical aspects of our simulations and leave results and questions related to the physics of turbulent combustion in the so-called well stirred regime to a forthcoming paper. \section{The models} The computational grid of our present computations covers a fraction of 1000km (vertical) $\times$ 1800km $\times$ 1800km (lateral) of the white dwarf's surface and atmosphere by 100 $\times$ 220 $\times$ 220 grid points in a Cartesian mesh. This is equivalent to the ``low resolution'' case of KHT. The lateral grid is equidistant whereas in vertical direction we use a non-equidistant grid with the highest spatial resolution (5km) in the white dwarf's surface and the bottom layers of its atmosphere. As an initial perturbation we increase the temperature by 1\% in 20 zones right on top of the white dwarf. In contrast to KHT, we choose a somewhat larger perturbed area in order to save computer time. This, however, is not a problem since the initial conditions are a bit artificial anyhow, and we saw in our previous 2D simulations that information about the initial perturbation is lost after about 15s. Since we fix the initial conditions according to the model of \cite{Glasner97} (1997) the only parameter which still can be varied within reasonable limits is the initial metallicity of the atmosphere. But, because solving the reactive Euler-equations in 3D with realistic equations of state is ``expensive'' (on 512 processors of a CRAY T3E one time-step needs about 8s CPU-time, and about 2$\times$10$^5$ time-steps are required per simulation), we cannot perform an extensive parameter study. We decided rather to choose solar composition for a first simulation (in order to compare the results with our earlier 2D computations) and to increase the metallicity to 10\% in a second run. This second simulation is meant to investigate whether or no moderately higher CNO abundances lead to significantly more violent nuclear burning, thereby changing a ``slow'' nova to a fast one. Although it is certainly of interest to increase C and O by another factor of 2 to 3 in order to match the conditions which would give a fast nova in 1D simulations, we did not do it because of obvious inconsistencies of our initial model in that case. Combustion in novae is peculiar because convective overturn times are much shorter than the nuclear reaction time-scale. Therefore, in general, stirring proceeds much faster then nuclear burning. In our approach to this problem, namely by direct numerical simulations, we resolve the large scale inhomogeneities and velocity fluctuations well, but the small scale dissipation and mixing is dominated by numerical discretization effects. This is not a problem as far as the energy transport by convective motions is concerned because the energy flux is predominantly carried by the largest eddies. Mixing by turbulent motions, however, happens on very small scales which are definitely not resolved in our computations. Therefore we will overestimate the mixing due to the numerical diffusion of matter on the grid scale. But since, as we shall show, even with our treatment mixing is too slow for a fast nova to occur, direct simulations are a conservative approach to the problem under consideration here. \section{Results of the 3D simulations} \subsection{The case of near-solar metallicity (Z=0.02)} In this subsection we present and discuss the results we have obtained for an atmosphere of nearly solar metallicity, the main emphasis being on a comparison with KHT. The initial abundances were obtained by evolving the accreted atmosphere of a given metallicity through steady hydrogen burning to the vehement stage of the TNR. We shall first analyse the evolution of the convective flow fields, and then discuss integral quantities such as the laterally averaged temperature and the nuclear composition. We computed this model over about 400s. \subsubsection{The evolution of the flow fields} In order to visualize our results we present them in the form of 2-dimensional cuts and iso-surfaces in three dimensions. The 2D-cuts show, colour-coded, the absolute values of the velocity as a function of time. They indicate where in the atmosphere of the white dwarf most of the convective transport is happening and can easily be compared with our earlier 2D results. In contrast, the iso-surfaces of the absolute values of the velocity field at fixed times are used to discuss the characteristic structure and scales of the convective eddies. Figure \ref{flow-3D} gives the temporal evolution of the velocities for a typical 2D cut. As in the 2D simulations of KHT, the surface layer is ignited by an ``ignition string'' perpendicular to the plane shown. After a couple of seconds the entire surface layer is burning and the first convective eddies form. This stage is reached a little earlier than in the 2D simulations, mainly because a larger volume was perturbed initially. From then on the evolution is very different from the 2D case. No regular structures appear. In contrast, the flow field is very irregular. Violent eruptions occur occasionally at later times, followed by periods of rather quiet burning. Towards the end of the computations, convective motions extend all the way into the upper atmosphere. The evolution of the convective patterns can be seen more clearly in the iso-surface plots Figs. \ref{vel-ata-3D} to \ref{vel-cza-3D}. Figure \ref{vel-ata-3D}, taken at 50s, shows that most of the fast eddies in the beginning are confined to a narrow layer near to the white dwarf's surface, extending over roughly 150km. This burning layer is well separated from an upper convective zone with large but slow eddies. But even the convective motions near the surface are slow in comparison to the sound velocity which is above 10$^8$cm/s there. During this phase, the burning matter does not expand significantly and also the upper atmosphere is only moderately heated from below. Consequently, the temperature rises in the burning region above 10$^8$K, and the burning becomes more violent. As is shown in Fig. \ref{vel-bmm-3D}, after about 100s, convective velocities begin to exceed 10$^7$cm/s and some eddies start to penetrate into the upper atmosphere. From then on very efficient heat transport by convection leads to an expansion of the atmosphere, and energy going into lift-off, and adiabatic energy losses balance essentially gains from nuclear burning. After 200s, finally, the entire atmosphere is well stirred by convective eddies of all sizes with typical velocities around 6$\cdot$10$^6$cm/s (see Fig. \ref{vel-cza-3D}). It is obvious that the flow fields in 3D are very different from the ones in 2D, as computed in KHT, and one expects that this will also effect integral quantities. When we stopped this set of computations after 400s, the nuclear energy generation rate is approximately constant throughout the white dwarf's atmosphere and a stage of nearly steady hydrogen burning is reached. The average nuclear energy generation rate has come down to a few times 10$^{13}$erg/g/s, missing the conditions for a fast nova by far. The total energy released by nuclear reactions is 5.8$\cdot$10$^{44}$erg which should be compared with the value of 2.1$\cdot$10$^{45}$erg for our 2D simulation at the same time. \subsubsection{Temperature evolution, energy generation and convective mixing} The temperature evolution of this near-solar metallicity model is depicted in Figs. \ref{temp-3D} and \ref{avtemp-3D}, and the corresponding energy generation rates are given in Fig. \ref{qnuc-3D}. In Fig. \ref{temp-3D} we picked the temperature of the hottest zone and plotted it as a function of time. The first short drop reflects the ignition phase. The following rapid rise to the peak value of about 1.1$\cdot$10$^8$K is due to degenerate nuclear burning without efficient convective energy transport and expansion, as was discussed in the previous subsection. This phase is followed by some expansion and adiabatic cooling, accompanied by the onset of more efficient convective energy transport and mixing. Consequently, the maximum temperature rises again, but now its peak value is found a bit further out in the atmosphere. These temperatures are typically 10 to 20 \% below what we have obtained in our 2D simulations mainly because, as we shall see, mixing of fresh C and O from the white dwarf into the hydrogen-rich atmosphere is slower in 3D than in 2D. Figure \ref{avtemp-3D} shows snapshots of the temperature distribution, averaged over horizontal planes. With the exception of a clear spike at 98s, indicating nuclear burning in a well confined surface layer, the distributions are very smooth, reflecting the nearly adiabatic average temperature gradient of a fully convective stratified atmosphere. These effects are more clearly seen in the vertical profiles of the nuclear energy generation rate, again averaged over horizontal planes, given in Fig. \ref{qnuc-3D}. For the first about 100s we observe a rapid increase of the energy generation rate in the layers just on top of the white dwarf, and convective energy transport is insufficient to induce fast burning in the outer parts. Towards the end of this simulations one can see that a stage of nearly steady burning is reached throughout most of the atmosphere. Finally, in Figs. \ref{avC12-3D} and \ref{avmetall-3D} we show the mass fraction of $^{12}$C and the total metallicity for the same snapshots as in the previous figures. The sharp discontinuity at 5.5$\cdot$18$^8$cm in the initial values presents the white dwarf's surface. The initial mass fraction of $^{12}$C is about 0.06 \% only because steady hydrogen burning prior to the TNR has transfered most of the originally solar CNO isotopes into $^{14}$N, whereas the metallicity is untouched. One can see in Fig. \ref{avC12-3D} as well as in Fig. \ref{avmetall-3D} that fresh $^{12}$C is mixed into the atmosphere by convective undershoot at a very moderate rate only. By the time the electron degeneracy is largely removed (after about 100s) mixing has just doubled the metallicity in most of the burning zones. This is the main reason why we did not obtain a violent outburst. \subsubsection{Mass loss and nucleosynthesis} In concluding this section, we want to discuss briefly possible observable consequences of this model. Peak outflow velocities are reached after 170s and they amount to 5$\cdot$10$^6$cm/s at a radius of 6400km which is far below the escape velocity from the white dwarf of about 6$\cdot$10$^8$cm/s (see Fig. \ref{avvelx-3D}). Typically, the velocities are also a factor of two below those we obtained in the 2D run at the same instants of time. Therefore, although we are loosing mass from our computational grid by outflow (see Fig. \ref{avdens-3D}), there is no direct mass ejection from the white dwarf. In contrast, mass loss will happen in form of a wind from the outer atmosphere which was not included in our computations. Conclusions concerning the chemical composition of the wind, therefore, are rather uncertain. Nevertheless we can obtain rough estimates by looking at the abundances we find in the computational domain. As can be seen in Figs. \ref{avO15-3D} through \ref{avF17-3D}, after about 400s (in reality already after 200s) the composition of freshly synthesized (radioactive) isotopes is homogeneously distributed throughout the white dwarf's atmosphere. Since we expect that fast convective mixing will proceed all the way out to optically thin regions one can also expect that this composition is a fair representation of the matter which is lost from the white dwarf ejected in the wind. At late times, radioactive decay heating by these isotopes dominates the energy production in all but the innermost layers of the atmosphere, but the overall enrichment of CNO isotopes is only moderate, probably not more than a factor of five to six relative to the initial values. \subsection{A model with Z=0.1} In one-dimensional nova simulations initial metal abundances largely in excess of their solar values are required to drive a fast outburst. Since we have demonstrated that self-enrichment of the atmosphere by convective undershoot and dredge-up of matter from the white dwarf does not happen during the outburst, we decided to run a model in which the atmosphere was already enriched from the start. In order to avoid large inconsistencies (this model was not evolved in the same way as the low-metallicity one), we increased Z to 0.1 only and constructed a new equilibrium model which had the same temperature structure as before. Burning was then ignited by raising the temperature by 1\% in 20 zones of the bottom layer of the accreted atmosphere, and all other properties of the model were identical to the previous one. Of course, an enrichment by a factor of five is still below what is commonly assumed in 1D simulations but one might hope for more violent burning and, therefore, also faster mixing of C and O already in this case, if convective motions are treated properly. However, as we shall demonstrate, this is not the case. We find that the evolution proceeds considerably faster than in the low-metallicity case, but the final outcome is not too different in both cases. Since the flow patterns look very similar to those shown in Fig. \ref{flow-3D}, with the exception that already after about 80s velocities above 10$^7$cm/s are observed, and after about 150s peak velocities reach 2$\cdot$10$^7$cm/s, nearly a factor of 2 higher than in the low-metallicity run. The second effect is that peak temperatures are now a bit higher (see Figs. \ref{temp-3D_2} and \ref{avtemp-3D_2}, to be compared with Figs. \ref{temp-3D} and \ref{avtemp-3D}), and also the energy generation rate exceeds the previous one, but not by much. After 160s a state of burning is reached which is nearly indistinguishable from the low-metallicity case at 400 seconds. Even the metallicity in the atmosphere (Fig. \ref{avmetall-3D_2}) is only moderately higher than before. We therefore conclude that, although originally higher CNO-abundances speed up the thermonuclear burning, going to 5 times solar metallicity is still insufficient for a fast nova. The reason seems to be that, despite the fact that the consumption of hydrogen is faster in the beginning, the time scale for the temperature rise is still too long, i.e. on the order of 100s. This, in turn, means that, as before, the atmosphere begins to expand and cool once the temperature exceeds 10$^8$K, much too low for a fast nova. Very fast mixing of white dwarf material into the atmosphere during the early phase of the TNR could, in principle, overcome this problem but we do not find such a mixing. In contrast, the 3D simulations mix even less than the 2D models of KHT. \section{Summary and conclusions} We have presented the first 3-dimensional simulations of thermonuclear models of classical novae. We have shown that the results differ, in several aspects, considerably from those of previous 2-dimensional simulations and we conclude that this and similar problems have to be carried out in 3D in order to give reliable results. The main reason is that the flow fields in 3D are very different from those in 2D and, therefore, all quantities which depend on them, such as convective energy transport and mixing, will also differ in both cases. For example, in 3D we find, not unexpectedly, more power in small scale motions than in our previous 2D simulations which leads to less convective undershoot into the white dwarf's surface and consequently less dredge-up of C and O. This, in turn, makes explosive hydrogen burning less violent, weakening the chances for getting a fast nova that way. Therefore we arrive at the conclusion that self-enrich\-ment of the accreted atmosphere with C and O during the outburst is very unlikely, if not impossible, and our simulations rule out one of the suggestions for changing a slow nova into a fast one. A more likely solution to this problem seems to be large enrichment prior to the outburst by either shear-induced instabilities at the interface between the white dwarf and its atmosphere (like in an accretion belt) or some kind of diffusive or convective mixing during the long quiet accretion phase. Finally, we want to point out that the type of numerical simulations we have performed leave room for improvements. Firstly, as was mentioned already in the introduction, in our numerical method mixing on small scales is due to numerical diffusion. It is difficult to estimate quantitatively its effect. It appears to be safer to include mixing by small scale turbulence explicitly by a subgrid model, as was done for the propagation of nuclear flames by Niemeyer \& Hillebrandt (1995). Secondly, the kind of problems we have tackled here with brute force, namely a problem in which the typical velocities are far below the sound velocity, should be better approached by means of (nearly incompressible) implicit hydrodynamics schemes which are presently being developed. It is obvious that one would like to explore a larger fraction of the parameter space, but this can only be done with more efficient codes. {\it Acknowledgments.} The authors are grateful for many enlightening discussions with Stanford E. Woosley, Jens C. Niemeyer and Hans Ritter. They thank Ami Glasner and Eli Livne for supplying the initial model, Ewald M\"uller for an earlier version of the PROMETHEUS code, and Rudi Fischer and Jakob Pichlmeier for their help in preparing a parallel version of the code. They also thank the staff members of the Rechenzentrum Garching for their support during the computations. This work was supported in part by NASA under Grant NAG 5-3076, by DOE under contract No. B341495 at the University of Chicago, and by the Deutsche Forschungsgemeinschaft under Grant Hi 534/3-1. The computations were performed at the Rechenzentrum Garching on a Cray T3E.

\section{Introduction} Consider the problem of compressing correlated sources at sensor nodes in a distributed fashion where the sensors may wish to communicate with each other on a wireless network. Assume also that each of these sensors can have access to a correlated observation to the source or random field of interest. This observation can be used as side information available at the decoder to minimize the distortion between the original source and the estimate at the legitimate decoder (referred to as Bob). In addition to this, we assume that each of the encoders (referred to as Alice) wishes to leak the least possible amount of information about its source to an eavesdropper (referred to as Eve), e.g. an untrusted sensor, who may capture such information during the communication between nodes. The above scenario involves many of the major information-theoretic issues on source and channel coding problems. In terms of source coding, Slepian-Wolf~\cite{slepian1973noiseless} and Wyner-Ziv~\cite{wyner1976rate} introduced the problem of source coding with side information at the decoder. This topic has been the focus of intense study and some remarkable progress has already been made in theoretical and practical aspects. On the other hand, extensive research has been done during the recent years on secure communications over noisy channels. The traditional focus was on cryptography, based on computational complexity where security only depends on the intractability assumption of NP-complete problems that must be solved prior to decoding. Another approach is the information-theoretic notion of secrecy, introduced by Shannon in~\cite{shannon1949communication}, where security is measured through the equivocation rate (i.e. the remaining uncertainty about the message) at the eavesdropper. The wiretap channel was introduced by Wyner~\cite{wyner1975wire}, who showed that it is possible to send information at a positive rate with perfect secrecy as long as the channel of the legitimate user is less noisy than the channel of the eavesdropper. Csisz\`ar-Korner~\cite{csiszar1978broadcast} extends this result to the setting of general broadcast channels with any arbitrary equivocation rate. Several extensions of the wiretap and fading channels have been done (cf. \cite{it2008special,liang2009information} and references therein). So far, very few work has been reported on source coding (or compression) problems with security constraints. One can identify two approaches in the literature on secure source coding. In fact, it is assumed either that there already exists a secure rate-limited channel between Alice and Bob, which allows the system to use secret keys, or the decoders have access to side information about the source. In the scenario of secret key sharing, both lossless and lossy compression have been studied in various contexts~\cite{yamamoto1983source,yamamoto1988rate,yamamoto1994coding,yamamoto1997rate,liu2009securing,merhav2006shannon}. For the second scenario where side information is available at both decoders, the case of lossless source coding has been recently studied in~\cite{prabhakaran2007secure,gunduz2008secure,gunduz2008lossless,tandon2009securea}. Whereas the general lossy source coding problem has not been fully solved, some particular cases can be derived as part of previous work. It is important to mention here that if the side informations between Bob and Eve are degraded then the result follows as a special case of~\cite{merhav2008shannon}. In this paper, we investigate the problem of secure lossy source coding of memoryless sources in the presence of an eavesdropper with different correlated side informations at the decoders of Bob and Eve, as it is shown in Fig.~\ref{fig:schema}. In this setting the channels between encoder and decoders are assumed to be noiseless so that they cannot provide any advantage to increase security. Our goal is to understand the minimum amount of information that needs to be revealed to Eve to satisfy the distortion constraint at Bob. We provide a complete characterization of the rate-distortion-equivocation region for the case of arbitrary correlated side informations. Several special cases of interest are also considered. As an application example, we consider the case of secure lossy source coding of a binary source, where the side information at Bob (resp. Eve) is the output of a binary erasure channel (resp. a binary symmetric channel) with the source as the input. This model is of interest since neither Bob nor Eve can always be a lessnoisy decoder. The organization of this paper is as follows. Section II states definitions along with the main results, while Section III provides several special cases and discussion. The sketch of the proofs are relegated to Section IV. Finally, Section V presents an application example to binary sources and Section VI summarizes the paper. \subsection*{Notations} For any sequence~$(x_i)_{i\in{\mathbb N}^*}$, notation $x_k^n$ stands for the collection $(x_k,x_{k+1},\dots, x_n)$. $x_1^n$ is simply denoted by $x^n$. By extension, for any subset $J\subset\{1,\dots,n\}$, notation $x_J$ stands for the collection $(x_j)_{j\in J}$. The cardinality of an alphabet is denoted by $\norm{\cdot}$. For every $\epsilon>0$, we denote $\epsilon$-typical and conditional $\epsilon$-typical sets by $\typ{X}$ and $\typ{Y|x^n}$, respectively. Following~\cite{cover2006elements}, entropy is denoted by $H(\cdot)$ and mutual information by $I(\cdot;\cdot)$. Let $X$, $Y$ and $Z$ be three random variables on some alphabets with probability distribution~$p$. If $p(x|y,z)=p(x|y)$ for each $x,y,z$, then they form a Markov chain, which is denoted by $X-\!\!\!\!\minuso\!\!\!\!- Y-\!\!\!\!\minuso\!\!\!\!- Z$. For each $x\in{\mathbb R}$, notation $[x]_+$ stands for $\max(0;x)$. For each $a,b\in[0,1]$, $a\star b = a(1-b) + (1-a)b$. \section{Problem Definition and Main Results} \begin{figure}[!b] \centering \begin{tikzpicture} \node (A) at (0,0) {$A^n$}; \node (alice) at (1.5,0) [rectangle,draw,blue] {Alice}; \node (B) at (6,2) {$B^n$}; \node (bob) at (6,1) [rectangle,draw,blue] {Bob}; \node (hatA) at (7.5,1) [right,blue] {$\hat A^n\,:\ d(A^n,\hat A^n)\lesssim D$}; \node (eve) at (6,-1) [rectangle,draw,red] {Eve}; \node (E) at (6,-2) {$E^n$}; \node (D) at (7.5,-1) [right,red] {$\frac1n H(A^n|W E^n)\gtrsim\Delta$}; \draw[->] (A) to (alice); \draw[->] (B) to (bob); \draw[->] (alice) to node[anchor=south]{$W$} node[anchor=north]{(rate $R$)} (5,0) to (5,1) to (bob); \draw[->,blue] (bob) to (hatA); \draw[->] (5,0) to (5,-1)to (eve); \draw[->] (E) to (eve); \draw[->,red] (eve) to (D); \end{tikzpicture} \caption{Secure lossy source coding in the presence of side information at the decoders.} \label{fig:schema} \end{figure} \subsection{Problem Definition} In this section, we give a more rigorous formulation of the context depicted in Fig.~\ref{fig:schema}. Let ${\mathcal A}$, ${\mathcal B}$ and ${\mathcal E}$ be three finite sets. Alice, Bob and Eve observe the sequences of random variables $(A_i)_{i\in{\mathbb N}^*}$, $(B_i)_{i\in{\mathbb N}^*}$ and $(E_i)_{i\in{\mathbb N}^*}$ respectively, which take values on ${\mathcal A}$, ${\mathcal B}$ and ${\mathcal E}$, resp. For each $i\in{\mathbb N}^*$, the random variables $A_i$, $B_i$ and $E_i$ are distributed according to the joint distribution $p(a,b,e)$ on ${\mathcal A}\times{\mathcal B}\times{\mathcal E}$. Moreover, they are independent across time $i$. Let $d : {\mathcal A}\times{\mathcal A} \to [0\,;d_{max}]$ be a finite distortion measure \emph{i.e.}, such that $0\leq d_{max} < \infty$. We also denote by $d$ the component-wise mean distortion on ${\mathcal A}^n\times{\mathcal A}^n$ \emph{i.e.}, for each $a^n,b^n\in{\mathcal A}^n$, $d(a^n,b^n) = \frac1n\,\sum_{i=1}^n d(a_i,b_i)$. \begin{defi} An $(n,R)$-code for source coding in this setup is defined by \begin{itemize} \item An encoding function at Alice $f : {\mathcal A}^n \to \{1,\dots,2^{nR}\}$, \item A decoding function at Bob $g : \{1,\dots,2^{nR}\}\times{\mathcal B}^n \to {\mathcal A}^n$. \end{itemize} \end{defi} \begin{defi} A tuple $(R,D,\Delta)\in{\mathbb R}_+^3$ is said to be \emph{achievable} if, for any $\epsilon>0$, there exists an $(n,R+\epsilon)$-code $(f,g)$ such that: \begin{eqnarray*} {\mathbb E}\left[ d(A^n,g(f(A^n),B^n)) \right] &\leq& D+\epsilon \ ,\\ \dfrac1n\,H(A^n|f(A^n),E^n) &\geq& \Delta-\epsilon \ . \end{eqnarray*} The set of all achievable tuples is denoted by ${\mathcal R}^*$ and is referred to as the \emph{rate-distortion-equivocation region}. \end{defi} \subsection{Main Result} The proof of the following theorem is given in Sections~\ref{sec:achievability} and~\ref{sec:converse}. \begin{theo} \label{th:region} Region ${\mathcal R}^*$ is the set of all tuples $(R,D,\Delta)$ such that there exist random variables $U$, $V$ on some finite sets ${\mathcal U}$, ${\mathcal V}$, respectively, and a function $\hat A : {\mathcal V}\times{\mathcal B} \to {\mathcal A}$ such that $U-\!\!\!\!\minuso\!\!\!\!- V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain and \begin{eqnarray*} R &\geq& I(V;A|B) \ ,\\ D &\geq& {\mathbb E}[d(A,\hat A(V,B))] \ ,\\ \Delta &\leq& \Big[ H(A|VB) + I(A;B|U) - I(A;E|U) \Big]_+ \ . \end{eqnarray*} \end{theo} The first two inequalities in Theorem~\ref{th:region} are classical in rate-distortion theory. Let us give some intuition on the third one. The first term $H(A|VB)$ corresponds to the equivocation rate at Bob. Alice thus exploits the available distortion at Bob to increase the equivocation rate at Eve. Moreover, for a given random variable $V$, which determines the rate $R$ and the distortion level $D$, auxiliary variable~$U$ may be tuned to make Bob \emph{more capable} than Eve \emph{i.e.}, maximize $I(A;B|U)-I(A;E|U)$. This quantity represents the gain (or the loss) at Eve in terms of equivocation rate. The following proposition gives upper bounds on the cardinalities of alphabets ${\mathcal U}$ and ${\mathcal V}$. The proof is omitted here and will be provided in an extended version of this paper. \begin{prop} \label{prop:card} In the single-letter characterization of the rate-distortion-equivocation region~${\mathcal R}^*$ given by Theorem~\ref{th:region}, it suffices to consider sets~${\mathcal U}$ and~${\mathcal V}$ such that $\norm{{\mathcal U}}\leq\norm{{\mathcal A}}+2$ and $\norm{{\mathcal V}}\leq(\norm{{\mathcal A}}+2)(\norm{{\mathcal A}}+1)$. \end{prop} \section{Special Cases of Interest} In this section, we derive optimal regions of some special cases of Theorem~\ref{th:region}. \subsection{Lossless Secure Source Coding} The lossless secure source coding problem corresponds to a zero distortion level at Bob ($D=0$). In this case, the following corollary, which can also be found in~\cite{prabhakaran2007secure,gunduz2008secure}, directly follows from Theorem~\ref{th:region} (simply set $V=A$): \begin{coro} \label{th:lossless} A tuple $(R,0,\Delta)$ is achievable i.f.f. there exists a random variable $U$ on some finite set ${\mathcal U}$, such that $U-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain and \begin{eqnarray*} R &\geq& H(A|B) \ ,\\ \Delta &\leq& \Big[ I(A;B|U) - I(A;E|U) \Big]_+ \ . \end{eqnarray*} \end{coro} \subsection{Bob Has No Side Information} \begin{coro} \label{coro:noSI} If Bob has no side information, then region ${\mathcal R}^*$ reduces to the set of all tuples $(R,D,\Delta)$ such that there exist random variables $U$, $\hat A$ on ${\mathcal U}$ and~${\mathcal A}$, respectively, such that $U-\!\!\!\!\minuso\!\!\!\!- \hat A-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- E$ form a Markov chain and \begin{eqnarray*} R &\geq& I(\hat A;A) \ ,\\ D &\geq& {\mathbb E}[d(A,\hat A)] \ ,\\ \Delta &\leq& \Big[ H(A|\hat A) - I(A;E|U) \Big]_+ \ . \end{eqnarray*} \end{coro} Note that, as opposed to the secure lossless source coding problem~\cite{gunduz2008secure}, in our situation, non-zero secrecy is still achievable when Bob has no side information. In fact, Alice can exploit the available distortion at Bob to increase the equivocation rate at Eve. \subsection{Bob Has Less Noisy Side Information Than Eve} \begin{defi} The side information $B$ is \emph{less noisy} than the side information $E$ if \[ I(U;B) \geq I(U;E) \ , \] for each random variable $U$ such that $U-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain. \end{defi} Note that the \emph{less noisy} condition is strictly weaker than the \emph{stochastically degraded} one. \begin{coro} \label{coro:lessnoisy} If Bob has less noisy side information than Eve, then region ${\mathcal R}^*$ reduces to the set of all tuples $(R,D,\Delta)$ such that there exist a random variable $V$ on some finite set ${\mathcal V}$, and a function $\hat A : {\mathcal V}\times{\mathcal B} \to {\mathcal A}$ such that $V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain and \begin{eqnarray*} R &\geq& I(V;A|B) \ ,\\ D &\geq& {\mathbb E}[d(A,\hat A(V,B))] \ ,\\ \Delta &\leq& \Big[ H(A|VB) + I(A;B) - I(A;E) \Big]_+ \ . \end{eqnarray*} \end{coro} In this case, random variable~$U$ of Theorem~\ref{th:region} is set to a constant value and hence Wyner-Ziv coding~\cite{wyner1976rate} achieves the optimal performance. \subsection{Eve Has Less Noisy Side Information Than Bob} \begin{coro} If Eve has less noisy side information than Bob, then region ${\mathcal R}^*$ reduces to the set of all tuples $(R,D,\Delta)$ such that there exist a random variable $V$ on some finite set ${\mathcal V}$, and a function $\hat A : {\mathcal V}\times{\mathcal B} \to {\mathcal A}$ such that $V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain and \begin{eqnarray*} R &\geq& I(V;A|B) \ ,\\ D &\geq& {\mathbb E}[d(A,\hat A(V,B))] \ ,\\ \Delta &\leq& H(A|VE) \ . \end{eqnarray*} \end{coro} In this case, random variable~$U$ of Theorem~\ref{th:region} is set to random variable $V$ and hence Wyner-Ziv coding~\cite{wyner1976rate} achieves the optimal performance. Therefore it is not surprising that the equivocation rate at Eve corresponds to the case where Eve can reliably decode $V$. Here, Alice can only exploit the available distortion at Bob to achieve a non-zero equivocation rate at Eve. \section{Sketch of Proof of Theorem~\ref{th:region}} \subsection{Proof of Achievability} \label{sec:achievability} In this section, we prove the achievability part of Theorem~\ref{th:region} \emph{i.e.}, we prove the following proposition: \begin{prop} \label{prop:achievability} Let $U$, $V$ be random variables on some finite sets ${\mathcal U}$, ${\mathcal V}$, respectively, such that $U-\!\!\!\!\minuso\!\!\!\!- V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain, and $\hat A : {\mathcal V}\times{\mathcal B} \to {\mathcal A}$. If \begin{eqnarray*} R &\geq& I(V;A|B) \ ,\\ D &\geq& {\mathbb E}[d(A,\hat A(V,B))] \ ,\\ \Delta &\leq& \Big[ H(A|VB) + I(A;B|U) - I(A;E|U) \Big]_+ \ , \end{eqnarray*} then $(R,D,\Delta)$ is achievable. \end{prop} \emph{Proof:} Let $\epsilon>0$ and define \begin{eqnarray*} \Delta^* &=& \big[ H(A|VB) + I(A;B|U) - I(A;E|U) \big]_+ \ ,\\ \delta &=& \frac\epsilon{5 \cdot \max\left\{ d_{max}\ ,\ \Delta^* \right\}} \ . \end{eqnarray*} For a sufficiently large $n$, we build an $(n,R+\epsilon)$-code $(f,g)$ which achieves the required distortion and equivocation rate levels. \subsubsection{Codebook generation} Randomly pick $2^{nS_1}$ sequences $u^n(s_1)$ from $\typ{U}$ and divide them into $2^{nR_1}$ equal size bins $\{B_1(r_1)\}_{r_1\in\{1,\dots,2^{nR_1}\}}$. Then, for each codeword $u^n(s_1)$, randomly pick $2^{nS_2}$ sequences $v^n(s_1,s_2)$ from $\typ{V|u^n(s_1)}$ and divide them into $2^{nR_2}$ equal size bins $\{B_2(s_1,r_2)\}_{r_2\in\{1,\dots,2^{nR_2}\}}$. \subsubsection{Encoding} Assume that sequence $A^n$ is produced at Alice. Look for a codeword $u^n(s_1)$ such that $(u^n(s_1),A^n)\in\typ{U,A}$. Then look for a codeword $v^n(s_1,s_2)$ such that $(v^n(s_2),A^n)\in\typ{V,A|u^n(s_1)}$. Let $B_1(r_1)$ and $B_2(s_1,r_2)$ be the bins of $u^n(s_1)$ and $v^n(s_1,s_2)$, respectively. Alice sends the message $f(A^n) \triangleq (r_1,r_2)$ on the error-free channel. \subsubsection{Decoding} Assume that Bob receives $(r_1,r_2)$ from Alice and his side information sequence $B^n$. Now look for the unique codeword $u^n(s_1)\in B_1(r_1)$ such that $(u^n(s_1),B^n)\in\typ{U,B}$. Then look for the unique codeword $v^n(s_1,s_2)\in B_2(s_1,r_2)$ such that $(v^n(s_1,s_2),B^n)\in\typ{V,B|u^n(s_1)}$. Compute the estimate $g(r_1,r_2,B^n)\in{\mathcal A}^n$ using the component-wise relation $g_i(r_1,r_2,B^n) \triangleq \hat A(v_i(s_1,s_2),B_i)$ for each $i=\{1,\dots,n\}$. \subsubsection{Errors and constraints} \begin{itemize} \item For $n$ large enough, $\pr{(A^n,B^n)\not\in\typ{A,B}}<\delta$. \item In the first encoding step, Alice needs to find (at least) one codeword $u^n(s_1)$ such that $(u^n(s_1),A^n)\in\typ{U,A}$. If $S_1>I(U;A)$, then the probability that this step fails can be upper bounded by $\delta$ for a sufficiently large $n$. Similarly, the second encoding step requires the condition $S_2>I(V;A|U)$ to succeed with a probability higher than $1-\delta$. \item In the first decoding step, Bob looks for the \emph{unique} codeword $u^n(s_1)\in B_1(r_1)$ such that $(u^n(s_1),B^n)\in\typ{U,B}$. If $S_1-R_1<I(U;B)$, then the probability that there exists another admissible codeword can be lowered below $\delta$ for a large $n$. Similarly, the second decoding step requires the condition $S_2-R_2<I(V;B|U)$ to succeed with a probability higher than $1-\delta$. \end{itemize} Defining the global transmitted rate $R+\epsilon=R_1+R_2$ and putting all inequalities together, we prove that a sufficient condition for the above code to work with an error probability lower than $5\delta$ is given by: \begin{eqnarray*} R+\epsilon &=& R_1+R_2 \\ &>& I(U;A) - I(U;B) + I(V;A|U) - I(V;B|U) \\ &\stackrel{(a)}{=}& I(V;A) - I(V;B) \\ &\stackrel{(b)}{=}& I(V;A|B) \ , \end{eqnarray*} where step~$(a)$, resp.~$(b)$, follows from the Markov chain $U-\!\!\!\!\minuso\!\!\!\!- V-\!\!\!\!\minuso\!\!\!\!- (A,B)$, resp. $V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- B$. This condition is verified under the given assumption on $R$ \emph{i.e.}, $R \geq I(V;A|B)$. \subsubsection{Distortion at Bob} Denote by $F$ the event ``An error occurred during the encoding or decoding steps.'' We now check that our code achieves the required distortion level at Bob: \begin{eqnarray*} {\mathbb E}\left[ d(A^n,g(f(A^n),B^n)) \right] &\leq& \pr{\bar{F}} {\mathbb E}\left[ d(A^n,g(r_1,r_2,B^n)) \,\Big| \bar{F} \right] + \pr{F}\,d_{max}\\ &\leq& \dfrac1n \sum_{i=1}^n {\mathbb E}\left[ d(A_i,\hat A(v_i(s_1,s_2),B_i)) \,\Big| \bar{F} \right] + \epsilon \\ &=& {\mathbb E}\left[ d(A,\hat A(V,B)) \right] + \epsilon \\ &\leq& D + \epsilon \ . \end{eqnarray*} \subsubsection{Equivocation Rate at Eve} The equivocation rate at Eve can be lower bounded as follows: \begin{eqnarray*} \frac1n\,H(A^n|f(A^n),E^n) &\geq& \frac{\pr{\bar{F}}}n\,H(A^n|r_1 r_2 E^n, \bar{F}) \\ &\geq& \frac{1-5\delta}n \Big[ H(A^n) - I(A^n;r_1 E^n) - I(A^n;r_2|r_1 E^n) \Big] \\ &\geq& \frac{1-5\delta}n \Big[ H(A^n) - I(A^n;U^n E^n) - H(r_2) \Big] \\ &=& (1-5\delta) \Big[ H(A) - I(A;UE) - \frac1n\,H(r_2) \Big] \\ &\geq& (1-5\delta) \Big[ H(A|UE) - R_2 \Big] \\ &\geq& \Big[ H(A|UE) - R_2 \Big] - 5\delta \Big[ H(A|UE) - R_2 \Big] \ . \end{eqnarray*} If $R_2 > I(V;A|U) - I(V;B|U)$, the equivocation rate can thus be bounded as follows: \begin{eqnarray*} \frac1n\,H(A^n|f(A^n),E^n) &\geq& \Big[ H(A|UE) - R_2 \Big] - 5\delta \Big[ H(A|UE) - I(V;A|U) + I(V;B|U) \Big]_+ \\ &\geq& \Big[ H(A|UE) - R_2 \Big] - \epsilon \ , \end{eqnarray*} where the last inequality follows after some straightforward derivation from the definition of~$\delta$ and the Markov chain $U-\!\!\!\!\minuso\!\!\!\!- V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- B$. Thus, each $\Delta \leq H(A|UE) - R_2$ is achievable. The above constraint on $R_2$ together with the latter inequality yield the given sufficient condition. \endproof Note that our coding scheme can be interpreted as a simple binning operation to transmit~$U$, followed by a Wyner--Ziv coding~\cite{wyner1976rate} to transmit~$A$ with side information $(U,B)$ at Bob. \subsection{Proof of Converse} \label{sec:converse} In this section, we prove the converse part of Theorem~\ref{th:region} \emph{i.e.}, we prove the following proposition: \begin{prop} \label{prop:converse} Let $(R,D,\Delta)$ be an achievable tuple. There exist two random variables $U$, $V$ and a function $\hat A : {\mathcal V}\times{\mathcal B} \to {\mathcal A}$, such that $U-\!\!\!\!\minuso\!\!\!\!- V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ form a Markov chain and \begin{eqnarray*} R &\geq& I(V;A|B) \ ,\\ D &\geq& {\mathbb E}[d(A,\hat A(V,B))] \ ,\\ \Delta &\leq& \Big[ H(A|VB) + I(A;B|U) - I(A;E|U) \Big]_+ \ . \end{eqnarray*} \end{prop} \emph{Proof:} Let $\epsilon>0$. There exists an $(n,R+\epsilon)$-code $(f,g)$ s.t.: \begin{eqnarray*} {\mathbb E}\left[ d(A^n,g(f(A^n),B^n)) \right] &\leq& D+\epsilon \ ,\\ \dfrac1n\,H(A^n|f(A^n),E^n) &\geq& \Delta-\epsilon \ . \end{eqnarray*} Denote by $W=f(A^n)$ the transmitted message. The following Markov chain holds for each subset $J\subset\{1,\dots,n\}$:\footnote{ $J^c$ denotes the complement of $J$ in $\{1,\dots,n\}$: $J^c = \{1,\dots,n\} \setminus J$. } \begin{equation} \label{eq:chaine} (W,A_J,B_J,E_J)-\!\!\!\!\minuso\!\!\!\!- A_{J^c} -\!\!\!\!\minuso\!\!\!\!- (B_{J^c},E_{J^c}) \ . \end{equation} For each $i\in\{1,\dots,n\}$, define $U_i$ and $V_i$ such that \begin{eqnarray} U_i &=& (W,B_{i+1}^n,E^{i-1}) \label{eq:defU} \ ,\\ V_i &=& (W,A^{i-1},B^{i-1},B_{i+1}^n,E^{i-1}) \label{eq:defV} \ . \end{eqnarray} From Equation~\eqref{eq:chaine}, $U_i-\!\!\!\!\minuso\!\!\!\!- V_i-\!\!\!\!\minuso\!\!\!\!- A_i-\!\!\!\!\minuso\!\!\!\!- (B_i,E_i)$ form a Markov chain. \subsubsection{Rate} \begin{eqnarray*} n(R+\epsilon) &\geq& H(W) \\ &\stackrel{(a)}{=}& I(W ; A^n B^n E^n) \\ &\stackrel{(b)}{\geq}& I(W ; A^n E^n | B^n) \\ &\stackrel{(c)}{=}& \sum_{i=1}^n I(W ; A_i E_i | A^{i-1} B^n E^{i-1}) \\ &=& \sum_{i=1}^n I(W A^{i-1} B^{i-1} B_{i+1}^n E^{i-1} ; A_i E_i | B_i) - I(A^{i-1} B^{i-1} B_{i+1}^n E^{i-1} ; A_i E_i | B_i) \\ &\stackrel{(d)}{=}& \sum_{i=1}^n I(W A^{i-1} B^{i-1} B_{i+1}^n E^{i-1} ; A_i E_i | B_i) \\ &\stackrel{(e)}{\geq}& \sum_{i=1}^n I(V_i ; A_i | B_i) \ , \end{eqnarray*} where \begin{itemize} \item step~$(a)$ follows from $W=f(A^n)$, \item step~$(b)$ from the non-negativity of mutual information, \item step~$(c)$ from the chain rule for conditional mutual information, \item step~$(d)$ from the independence of the random variables $A$, $B$ and $E$ across time, \item step~$(e)$ from the non-negativity of mutual information and Equation~\eqref{eq:defV}. \end{itemize} Following the usual technique, we now define an independent random variable $Q$ uniformly distributed over the set $\{1,\dots,n\}$, and $A=A_Q$, $B=B_Q$, $E=E_Q$, $U=(Q,U_Q)$, and $V=(Q,V_Q)$. $U-\!\!\!\!\minuso\!\!\!\!- V-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$ still form a Markov chain and $(A,B,E)$ is distributed according to the joint distribution $p(a,b,e)$ \emph{i.e.}, the original distribution of $(A_i,B_i,E_i)$. Then \begin{eqnarray} R + \epsilon &\geq& \frac1n \sum_{i=1}^n I(V_Q ; A_Q | B_Q, Q=i) \nonumber\\ &=& I(V_Q ; A_Q | B_Q Q) \nonumber\\ &=& I(V;A|B) \label{eq:converse_rate}\ . \end{eqnarray} \subsubsection{Distortion at Bob} Bob reconstructs $g(W,B^n)$. The $i$-th coordinate of this estimate writes \[ g_i(W,B^{i-1},B_i,B_{i+1}^n) \triangleq \hat A_i(V_i,B_i) \ . \] The component-wise mean distortion at Bob is: \begin{eqnarray*} {\mathbb E}\big[ d(A^n,g(f(A^n),B^n)) \big] &=& \frac1n \sum_{i=1}^n {\mathbb E}[ d(A_i,\hat A_i(V_i,B_i)) ] \\ &=& \frac1n \sum_{i=1}^n {\mathbb E}[ d(A_Q,\hat A_Q(V_Q,B_Q))\ |\ Q=i] \\ &=& {\mathbb E}\big[ d(A_Q,\hat A_Q(V_Q,B_Q)) \big] \\ &=& {\mathbb E}\big[ d(A,\hat A(V,B)) \big] \ , \end{eqnarray*} where we defined function $\hat A$ on ${\mathcal V}\times{\mathcal B}$ by \[ \hat A(V,B) = \hat A(Q,V_Q,B_Q) \triangleq \hat A_Q(V_Q,B_Q) \ . \] Consequently, \begin{equation} \label{eq:converse_distortion} {\mathbb E}[ d(A,\hat A(V,B)) ] \leq D + \epsilon \ . \end{equation} \subsubsection{Equivocation Rate at Eve} \begin{eqnarray*} H(A^n|W,E^n) &=& H(A^n|W) - I(A^n ; E^n | W) \\ &=& H(A^n|W B^n) + I(A^n;B^n | W) - I(A^n ; E^n | W) \\ &\stackrel{(a)}{=}& H(A^n|W B^n) + I(A^n ; B^n) - I(W ; B^n) - I(A^n ; E^n) + I(W ; E^n) \\ &\stackrel{(b)}{=}& \sum_{i=1}^n H(A_i|W A^{i-1} B^n) + I(A_i;B_i) - I(A_i ; E_i) - I(W B_{i+1}^n ; B_i) + I(W E^{i-1}; E_i) \\ &\stackrel{(c)}{=}& \sum_{i=1}^n H(A_i|W A^{i-1} B^n E^{i-1}) + I(A_i;B_i) - I(A_i ; E_i) - I(W B_{i+1}^n ; B_i) \\ &&\hspace{2.7cm} +\ I(W E^{i-1}; E_i) + I(E_i ; B_{i+1}^n | W E^{i-1}) - I(B_i ; E^{i-1} | W B_{i+1}^n) \\ &=& \sum_{i=1}^n H(A_i|W A^{i-1} B^n E^{i-1}) + I(A_i;B_i) - I(A_i ; E_i) \\ &&\hspace{5.5cm} +\ I(E_i ; W B_{i+1}^n E^{i-1}) - I(B_i ; W B_{i+1}^n E^{i-1})\\ &\stackrel{(d)}{=}& \sum_{i=1}^n H(A_i|V_i B_i) + I(A_i;B_i) - I(A_i ; E_i) + I(E_i ; U_i) - I(B_i ; U_i) \\ &\stackrel{(e)}{=}& \sum_{i=1}^n H(A_i|V_i B_i) + I(A_i;B_i|U_i) - I(A_i;E_i|U_i) \ , \end{eqnarray*} where \begin{itemize} \item step~$(a)$ follows from the Markov chain $W-\!\!\!\!\minuso\!\!\!\!- A^n-\!\!\!\!\minuso\!\!\!\!- (B^n,E^n)$, \item step~$(b)$ from the chain rules for conditional entropy and mutual information, and the fact that random variables $A_i$, $B_i$ and $E_i$ are independent across time, \item step~$(c)$ from the Markov chain $A_i-\!\!\!\!\minuso\!\!\!\!- W A^{i-1}-\!\!\!\!\minuso\!\!\!\!- E^{i-1}$ (see Equation~\eqref{eq:chaine}) and Csiszar and Korner's equality~\cite{csiszar1978broadcast}, \item step~$(d)$ from the definitions of random variables $U_i$ and $V_i$ (Equations~\eqref{eq:defU} and~\eqref{eq:defV}, resp.), \item step~$(e)$ from the Markov chain $U_i-\!\!\!\!\minuso\!\!\!\!- A_i-\!\!\!\!\minuso\!\!\!\!- (B_i,E_i)$. \end{itemize} Now, using auxiliary random variable $Q$ defined above, \begin{eqnarray*} \frac1n H(A^n|W,E^n) &=& \frac1n \sum_{i=1}^n H(A_Q|V_Q B_Q, Q=i) + I(A_Q;B_Q|U_Q, Q=i) - I(A_Q;E_Q|U_Q, Q=i) \\ &=& H(A|V B) + I(A;B|U) - I(A;E|U) \ . \end{eqnarray*} Moreover, $H(A^n|W,E^n)\geq0$, consequently, \begin{equation} \label{eq:converse_equivocation} \Big[ H(A|V B) + I(A;B|U) - I(A;E|U) \Big]_+ \geq \Delta - \epsilon \ . \end{equation} This proves Proposition~\ref{prop:converse}. \endproof \section{Application Example: Coding Binary Source with BEC and BSC Side Informations} \begin{figure}[!b] \centering \begin{tikzpicture} \node (A) at (0,.5) {$A$}; \node (A0) at (0,0) {$0$}; \node (A1) at (0,-2) {$1$}; \node (B) at (3,.5) {$B$}; \node (B0) at (3,0) {$0$}; \node (Be) at (3,-1) {$e$}; \node (B1) at (3,-2) {$1$}; \node (E) at (-3,.5) {$E$}; \node (E0) at (-3,0) {$0$}; \node (E1) at (-3,-2) {$1$}; \draw[->] (A0) to node[auto,swap]{$1-p$} (E0); \draw[->] (A0) to node[auto,swap]{$p$} (E1); \draw[->] (A1) to node[auto]{$p$} (E0); \draw[->] (A1) to node[auto]{$1-p$} (E1); \draw[->] (A0) to node[auto]{$1-\epsilon$} (B0); \draw[->] (A0) to node[auto,swap]{$\epsilon$} (Be); \draw[->] (A1) to node[auto]{$\epsilon$} (Be); \draw[->] (A1) to node[auto,swap]{$1-\epsilon$} (B1); \end{tikzpicture} \caption{Considered model for source and side informations.} \label{fig:example} \end{figure} Consider the source model depicted in Fig.~\ref{fig:example} where the source is binary and the side informations at Bob and Eve are the outputs of a binary symmetric channel (BSC) with crossover probability $p\in[0,1/2]$ and a binary erasure channel (BEC) with erasure probability $\epsilon\in[0,1/2]$, respectively, with input $A$. Let $h_2$ denotes the binary entropy function given by $h_2(x) = -x\log_2(x) -(1-x)\log_2(1-x)$. According to the values of the parameters $(p,\epsilon)$ as summarized in Fig.~\ref{fig:cas}, it is not difficult to show by means of standard manipulations that the broadcast channel with input $A$ and outputs $(B,E)$ satisfies the following properties: \begin{enumerate} \item[(a)] The side information $E$ is a stochastically degraded version of $B$, \emph{i.e.}, there exists a random variable $\tilde E$ such that $A-\!\!\!\!\minuso\!\!\!\!- B-\!\!\!\!\minuso\!\!\!\!- \tilde E$ form a Markov chain and $P_{\tilde E|A}=P_{E|A}$, \item[(b)] The side information $B$ is lessnoisy than $E$, \emph{i.e.}, for all random variable $U$ such that $U-\!\!\!\!\minuso\!\!\!\!- A-\!\!\!\!\minuso\!\!\!\!- (B,E)$, $I(U;B)\geq I(U;E)$, \item[(c)] The side information $B$ is more capable than $E$, \emph{i.e.}, $I(A;B)\geq I(A;E)$, \item[(d)] Any of the above relations hold between the side informations $B$ and $E$. \end{enumerate} \begin{figure}[!h] \centering \begin{tikzpicture} \node (ci) at (-.4,0) {}; \node (c0) at (0,0) {}; \node (c1) at (2,0) {}; \node (c2) at (4,0) {}; \node (c3) at (6,0) {}; \node (c4) at (8,0) {}; \node (e) at (9,0) {}; \draw[->] (ci) to (e); \draw (c0) -- (c1) node[midway,anchor=north] {$(a)$}; \draw (c1) -- (c2) node[midway,anchor=north] {$(b)$}; \draw (c2) -- (c3) node[midway,anchor=north] {$(c)$}; \draw (c3) -- (c4) node[midway,anchor=north] {$(d)$}; \draw (0,2pt) -- (0,-2pt) node[anchor=south] {$0$}; \draw (2,2pt) -- (2,-2pt) node[anchor=south] {$2p$}; \draw (4,2pt) -- (4,-2pt) node[anchor=south] {$4p(1-p)$}; \draw (6,2pt) -- (6,-2pt) node[anchor=south] {$h_2(p)$}; \draw (8,2pt) -- (8,-2pt) node[anchor=south] {$1$}; \draw (e) node[anchor=south] {$\epsilon$}; \end{tikzpicture} \caption{The different regions as a function of $\epsilon$.} \label{fig:cas} \end{figure} Observe that this model is of interest since neither Bob nor Eve can always be a lessnoisy decoder for all values of $(p,\epsilon)$. Thus in general $U$ is neither constant nor equal to $V$. We also remark that Corollary~\ref{coro:lessnoisy} provides the {rate-distortion-equivocation} region when $\epsilon$ lies in regions~$(a)$ or $(b)$. Otherwise, only Theorem~\ref{th:region} applies for the general case. \begin{figure}[!b] \centering \begin{tikzpicture} \node (A) at (0,.5) {$A$}; \node (A0) at (0,0) {$0$}; \node (A1) at (0,-2) {$1$}; \node (V) at (-3,.5) {$V$}; \node (V0) at (-3,0) {$0$}; \node (V1) at (-3,-2) {$1$}; \node (U) at (-6,.5) {$U$}; \node (U0) at (-6,0) {$0$}; \node (U1) at (-6,-2) {$1$}; \draw[->] (A0) to node[auto,swap] {$1-\alpha$} (V0); \draw[->] (A0) to node[auto,swap] {$\alpha$} (V1); \draw[->] (A1) to node[auto] {$\alpha$} (V0); \draw[->] (A1) to node[auto] {$1-\alpha$} (V1); \draw[->] (V0) to node[auto,swap] {$1-\beta$} (U0); \draw[->] (V0) to node[auto,swap] {$\beta$} (U1); \draw[->] (V1) to node[auto] {$\beta$} (U0); \draw[->] (V1) to node[auto] {$1-\beta$} (U1); \end{tikzpicture} \caption{Binary auxiliary random variables.} \label{fig:aux} \end{figure} From now on, let the distortion function at Bob $d$ be the Hamming distance and assume for simplicity that the source is uniform distributed, i.e., $\pr{A=0}=\pr{A=1}=1/2$. We know from the cardinality constraints given in Proposition~\ref{prop:card} that it suffices to consider sets ${\mathcal U}$ and ${\mathcal V}$ such that $\norm{{\mathcal U}}\leq 4$ and $\norm{{\mathcal V}}\leq 12$. Moreover, from the following proposition, we can restrict our attention to the auxiliary variables $(U,V)$ obtained as the outputs of a degraded binary symmetric broadcast channel with input $A$, as it is depicted in Fig.~\ref{fig:aux}. Notice that $V$ is identical to the auxiliary variable used by Wyner and Ziv~\cite{wyner1976rate} for the rate-distortion function of a binary source in the case where there is no eavesdropper. \begin{prop} \label{prop:binary_rv} In the case considered in this section, and depicted in Fig.~\ref{fig:example}, region ${\mathcal R}^*$ is the set of all tuples $(R,D,\Delta)$ such that there exist $\alpha,\beta\in[0,1/2]$ satisfying \begin{eqnarray*} R &\geq& \varepsilon\,(1-h_2(\alpha)) \ ,\\ D &\geq& \varepsilon\,\alpha \ ,\\ \Delta &\leq& \Big[ \varepsilon\,h_2(\alpha) + (1-\varepsilon)\,h_2(\alpha\star\beta) - h_2(p\star\alpha\star\beta) + h_2(p) \Big]_+ \ . \end{eqnarray*} \end{prop} \emph{Proof:} The achievability part of Proposition~\ref{prop:binary_rv} is a direct application of Theorem~\ref{th:region}: define auxiliary random variables $U$ and $V$ as depicted in Fig.~\ref{fig:aux}, and function $\hat A$ on ${\mathcal V}$ by $\hat A(v) = v$. Expressions of Proposition~\ref{prop:binary_rv} follow after some straightforward derivations. The converse part needs more arguments. The proof is omitted here and will be provided in an extended version of this paper. \endproof \begin{table*}[!b] \caption{Some achievable tuples and corresponding auxiliary random variables.} \label{tab:numeric} \centering \begin{tabular}{l||cc|cc} & Lossless secure source coding & Slepian-Wolf & Lossy secure source coding & Wyner-Ziv \\ \hline Rate $R$ & 0.469 & 0.469 & 0.375 & 0.375 \\ Distortion $D$ & 0 & 0 & 0.015 & 0.015 \\ Equivocation Rate $\Delta$ & 0.039 & 0 & 0.133 & 0.126 \\ \hline $\alpha$ & 0 & 0 & 0.031 & 0.031 \\ $\beta$ & 0.078 & 0 & 0.050 & 0 \end{tabular} \end{table*} We now numerically compute some achievable values for $p=0.1$ and $\varepsilon=h_2(p)=0.469$ (see Fig.~\ref{fig:Delta=fD}). In the case of lossless compression (columns \#1 and \#2 of Table~\ref{tab:numeric}), the auxiliary random variable $V$ is set to be $A$ \emph{i.e.}, $\alpha=0$. The additional variable $U$ actually enables a non-zero equivocation level, as noted in~\cite{gunduz2008secure}. Assume that the coding rate is limited to a maximum of $80\%$ of the required rate for perfect reconstruction of the source (column \#3). This induces a distortion of $1.5\%$ at Bob and then an equivocation rate of $0.126\,$bits at Eve is achievable. This means that even a small increase in the distortion at Bob can be fully exploited by Alice to achieve very significant gains (more than third times in this case) in terms of equivocation rate at Eve. Moreover, in the situation considered in this paragraph, Wyner-Ziv coding actually achieves the optimal performance for distortion levels higher than $0.036$ as shown in Fig.~\ref{fig:Delta=fD} \begin{figure}[!t] \centering \includegraphics[width=9cm]{Delta=fD} \caption{Equivocation rate at Eve as a function of the distortion at Bob.} \label{fig:Delta=fD} \end{figure} \section{Summary and Discussions} The problem of secure lossy source coding of memoryless sources in the presence of an eavesdropper with different correlated side informations at the legitimate decoder (Bob) and the eavesdropper (Eve) was investigated. A complete characterization of the rate-distortion-equivocation region was derived for the case of arbitrary correlated side information at the decoders. It was shown that both the available distortion at the legitimate decoder and the statistical properties of the side informations can be exploited by the encoder (Alice) to increase the equivocation rate at the eavesdropper. An application example to secure lossy source coding of a binary source, where the side information at Bob (resp. Eve) is the output of a binary erasure channel (resp. a binary symmetric channel) with the source as the input, was considered. This model is of interest since neither Bob nor Eve can always be a lessnoisy decoder and thus the encoding strategy needed to achieve the optimal equivocation rate is rather tricky. In the case where the source is uniformly distributed, we proved that it is optimal to consider binary auxiliary random variables and provided corresponding expressions for the rate-distortion-equivocation region. As future and on-going work, it would be of interest to extend the results in the present work to the more general setting in which the encoder wishes to maximize not only the equivocation rate, but also an arbitrary measure of the equivocation distortion at the eavesdropper. \bibliographystyle{IEEEtran}

Background {#Sec1} ========== Ovarian cancer (OC) is the most lethal gynecological malignancy and the second leading cause of cancer-related death in women \[[@CR1]\]. About 75% of patients are diagnosed at the late stage of the disease \[[@CR2], [@CR3]\], due to the lack of predictive biomarkers. The standard therapeutic protocol, including cisplatin-based combination chemotherapy and cytoreductive surgery, leads to an overall 5-year survival rate of only 15--30% for metastatic OC \[[@CR4], [@CR5]\], due to the onset of platinum resistance during the treatment \[[@CR6]\]. In recent years, recognition of the role of inherited mutations in the DNA repair genes BRCA1 and BRCA2 in a proportion of OC patients led to the introduction of new therapeutic strategies targeting other DNA repair pathways, using poly-ADP ribose polymerase (PARP) inhibitors, such as Olaparib \[[@CR7]\]. PARP inhibitors (PARPi) are able to abrogate PARP functionality, this bringing to the accumulation of single strand breaks (SSBs), which in turn are converted into double strand breaks (DSBs) that cells are not able to repair, causing cancer cell death \[[@CR8]\]. PARPi act by blocking the catalytic domain of PARP enzymes, but these agents can also trap PARP proteins on the double-stranded DNA helix, this leading to cytotoxic lesions \[[@CR9]\]. This strategy has been approved as treatment option for OC patients bearing BRCA1/2 gene mutation \[[@CR10]\]. Moreover, it is now well established that a significant proportion of sporadic ovarian cancers present BRCA-like functional abnormalities (the so-called "BRCAness" syndrome), this opening the possibility of a wider application of treatment regimens specifically designed for familial BRCA-mutated tumors, such as PARPi \[[@CR11], [@CR12]\]. However, long-term Olaparib administration might lead to PARPi resistance, which is currently under investigation. To date, the potential mechanisms involved in PARPi resistance are represented by DNA repair restoration \[[@CR13], [@CR14]\], PI3K/AKT pathway activation \[[@CR15]\] and miRNA dysregulation \[[@CR16]--[@CR18]\], but further investigation is needed to clarify the complexities of pathways underlying PARPi-related clinical resistance. Neuropilin 1 (NRP1) is a transmembrane glycoprotein belonging to a family of non-tyrosine kinase receptors \[[@CR19]--[@CR22]\], which acts as a receptor for various types of ligands, such as the class 3 semaphorins in neurons, the vascular endothelial growth factor (VEGF) family in endothelial cells, the platelet-derived growth factor (PDGF) in megakaryocytes and the keratinocyte growth factor (KGF) in adipose-derived mesenchymal stem cells \[[@CR23]--[@CR25]\]. NRP1 has been shown to play a critical role in tumorigenesis, cancer invasion and angiogenesis, through the activation of VEGF, PI3K, and AKT pathways \[[@CR26], [@CR27]\]. NRP1 protein is highly expressed in different cancer types, such as breast \[[@CR28]\], colorectal \[[@CR22]\], myeloid leukemia \[[@CR29]\], glioma \[[@CR20]\], pancreatic \[[@CR30]\], and prostate \[[@CR31]\] tumors. Some studies also reported an increased NRP1 expression in OC with respect to normal ovarian tissue \[[@CR32]\] and to benign ovarian tumors \[[@CR33]\]. In OC, NRP1 has been shown to promote unlimited growth through the evasion of contact inhibition \[[@CR34]\], and higher NRP1 expression has been correlated with a shorter survival \[[@CR32], [@CR35]\], indicating that this protein could be a potential prognostic marker and a molecular target for therapy. Moreover, a comprehensive bioinformatics network analysis demonstrated that NRP1 is involved in multidrug resistance in OC \[[@CR36]\]. miRNAs comprise a class of non-coding single-stranded RNAs containing about 21--24 nucleotides, encoded by endogenous genes, which can trigger target mRNA degradation or translation inhibition by targeting its 3′-UTRs \[[@CR37], [@CR38]\]. miRNAs are involved in the post-transcriptional regulation of the expression of over 30% of human genes, thus impacting almost every cellular process, and changes in miRNAs expression play a key role in human pathologies, including cancer \[[@CR39], [@CR40]\]. In cancer, aberrantly expressed tumor-suppressor or oncogenic miRNAs are involved in tumor progression, metastasis, and drug resistance \[[@CR41], [@CR42]\]. So, the modulation of miRNA expression in cancer cells, through inhibiting oncogenic miRNAs or restoring tumor-suppressor miRNAs, could represent a viable approach for improving cancer therapy \[[@CR43]\]. Some specific miRNAs, such as miR-148 and miR-124, have been shown to act as upstream suppressors of NRP1 signaling \[[@CR44], [@CR45]\]. In cholangiocarcinoma, NRP1 contribution to the growth and metastasis of tumor cells is regulated by miR-320 \[[@CR46]\]. In pancreatic cancer, NRP1 is negatively regulated by miR-141, a member of the miR-200 family, and the miR-141/NRP1 axis represents a potentially valuable diagnostic and therapeutic target for this tumor \[[@CR47]\]. Almost all the members of miR-200 family (miR-200a, miR-200b, miR-200c and miR-141), have been shown to be upregulated in OC \[[@CR48]\]. In particular, the function of miR-200c upregulation in OC \[[@CR49], [@CR50]\] is controversial, since it acts as a tumor-promoter by enhancing epithelial-mesenchymal transition, invasiveness, tumor growth and metastasis \[[@CR51]\], but on the other hand its overexpression improves the response of OC to various chemotherapeutic agents \[[@CR52]\], and its loss is associated with the acquisition of drug resistance \[[@CR53]\]. Indeed, an interaction between miR-200 family and NRP1 3'UTR has been previously demonstrated by luciferase reporter experiments and Western blot assays in embryonic stem cells \[[@CR54]\], but to date still little is known about the upstream miRNAs regulating NRP1 in OC and the molecular mechanisms by which miRNAs/NRP1 axis modulates drug resistance in this tumor. Therefore, the present study has been designed to investigate if miR-200c could regulate NRP1 in OC, and to assess how miRNA-regulated NRP1 contributes to PARPi resistance. Methods {#Sec2} ======= OC tissue samples {#Sec3} ----------------- A total of 40 human ovarian specimens was obtained from patients who underwent surgical treatment at the Department of Maternal and Child and Urological Sciences at Sapienza University of Rome between November 2015 and July 2017. Ovarian tumor samples were obtained from n. 28 patients (median age 61 years; range 44--91 years) who underwent radical cytoreductive surgery followed by cisplatin-based chemotherapy (CHT), while normal ovarian samples were obtained from n. 12 patients (median age 61 years; range 53--73 years) with benign ovarian cysts. The 28 patients diagnosed with OC included 26 patients with serous and 2 with mucinous carcinomas. Of the 28 carcinomas, 2 were classified as International Federation of Gynecology and Obstetrics (FIGO) stage II, 21 as stage III, and 5 as stage IV. With regard to the histologic grade, 5 were G1 and 23 were G3. In 16 cases, post-CHT samples were available for study. Patients provided their full consent for the donation of the tissue prior to any surgical procedure. All specimens were stored at − 80 °C until RNA extraction. Cell cultures and treatments {#Sec4} ---------------------------- The human OC cell lines UWB1.289 (serous, BRCA1-null), UWB1.289 + BRCA1 (serous, BRCA1 restored), and SKOV3 were purchased from the American Type Culture Collection (ATCC-LGC Promochem, Teddington, UK). The UWB cell lines were cultured in a 1:1 mixture of RPMI-1640 (Sigma-Aldrich) and HUMEC (Thermo Fisher Scientific) medium, supplemented with 3% fetal bovine serum (FBS; Invitrogen) and antibiotics. The media for the UWB1.289 + BRCA1 cell line was further supplemented with 200 μg/mL of G-418 solution (Roche Diagnostics, Manheim, Germany) to maintain the expression of the BRCA1 protein. SKOV3 cells were maintained in RPMI (Sigma-Aldrich), supplemented with 10% FBS and antibiotics. Olaparib (AZD-2281) was purchased from Selleckchem (Suffolk, UK) and used in vitro at concentrations ranging from 1.5 to 10 μM, for the indicated times. Olaparib powder was first dissolved at 10 mM in dimethyl sulfoxide (DMSO; Sigma, St. Louis, MO, USA), diluted to its final concentration with culture medium, and freshly added to the cells every day for the duration of treatment. DMSO alone was used as control in untreated cells at 0.1% (v/v) concentration. Chloroquine (CQ) was purchased from Sigma and used at a final concentration of 10 μM. Cell viability assay {#Sec5} -------------------- Cells were seeded onto 96-well plates at a density of 5 × 10^3^ cells/well, then treated or not with Olaparib for 72 or 144 h at increasing concentrations (1.5, 5 or 10 μM). At the end of time point, cells were incubated with 0.5% MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma, St. Louis, MO, USA) for 4 h at 37 °C. The supernatant was then discarded, the MTT was dissolved with 100 μL of DMSO and absorbance read at OD = 550 nm with an ELISA Microplate Reader (Bio-Rad, Hercules, CA, USA). Cell viability in Olaparib-treated cells was calculated in comparison to control samples (DMSO), arbitrarily set to 100%, having six determinations per assay for each experimental condition. Colony formation assay {#Sec6} ---------------------- Cells, previously treated with Olaparib for 144 h, were seeded in 6-well plates in triplicate at a density of 2--4 × 10^3^ cells/well, and incubated at 37 °C for 10--14 days to allow colonies to grow, with medium change every 3 days. Colonies were stained with 0.1% crystal violet for 5 min at room temperature (RT) and photographed. Then, crystal violet was solubilized in 30% acetic acid in water for 15 min at RT, and absorbance was measured using the Biochrom Libra S22 UV/VIS spectrophotometer (Biochrom, Berlin, DE) at a wavelength of 595 nm. 30% acetic acid in water was used as blank control. Colony formation capacity in Olaparib-treated cells was calculated in comparison to control samples (DMSO), arbitrarily set to 1. Immunofluorescence analysis {#Sec7} --------------------------- Immunofluorescence was performed as previously described \[[@CR55]\]. Cells, treated or not with Olaparib for 144 h, were seeded on coverslips onto 24-well plates at a density of 5 × 10^4^ cells/well, and fixed in 4% paraformaldehyde for 30 min at room temperature, followed by treatment with 0.1 M glycine in PBS for 20 min and with 0.1% Triton X-100 in PBS for additional 5 min to allow permeabilization. Cells were then incubated with anti-phospho-histone H2A.X (Ser139) antibodies (γH2AX; Cell Signalling, Inc. Danvers, MA, USA). After appropriate washing in PBS, primary antibodies were visualized using TexasRed-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Nonspecific fluorescence was determined by omitting primary antibody. Nuclei were visualized using 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma-Aldrich). The single stained and merged images were acquired with a Zeiss ApoTome microscope (40× magnification) using the Axiovision software (Carl Zeiss, Jena, Germany). γH2AX fluorescence intensity was measured using ImageJ software (v. 10.2), evaluating at least six random microscopic fields for each condition. Cell cycle and apoptosis analysis by flow cytometry {#Sec8} --------------------------------------------------- For cell cycle analysis, cells were treated with 1.5 μM and 5 μM Olaparib for 72 h, then collected and washed twice with phosphate buffered saline (PBS). After fixation in 70% ice-cold ethanol overnight at 4 °C, cell pellets were washed twice with ice-cold PBS and treated with RNase A for 15 min at 37 °C. Propidium iodide (PI) was added to each sample and DNA content was determined by collecting 10,000 events using a BD FACS Calibur Flow Cytometer (BD Biosciences). Data were analyzed using ModFit 3.1 software (BD Biosciences). Apoptosis was analyzed by using Annexin A5 FITC/7-AAD Kit (Beckman Coulter), following the manufacturer's instructions. Briefly, cells were treated with Olaparib for 144 h. Approximately 2 × 10^5^ cells were stained with Annexin A5 FITC and 7-Amino-Actinomycin (7-AAD) for 15 min at RT in the dark. Fluorescence intensities of treated samples and controls were collected with a CytoFLEX flow cytometer (Beckman Coulter, Germany). Quadrant analysis was performed using the Kaluza software (Beckman Coulter) to quantify viable cells (7-AAD-negative/Annexin A5-negative), early apoptotic cells (Annexin A5-positive/7-AAD-negative), and late apoptotic cells (Annexin A5-positive/7-AAD-positive). Experiments were performed at least twice. For each point, the sum of early and late apoptotic cells was plotted. Western blot analysis {#Sec9} --------------------- Cells, treated or not with 1.5 μM and 5 μM Olaparib for the indicated times, were lysed in RIPA buffer. Total proteins (50--100 μg) were resolved under reducing conditions by 7--15% SDS-PAGE and transferred to Immobilon-FL membranes (Merck Millipore, Billerica, MA, USA), as previously described \[[@CR56]\]. Membranes were blocked in TBS containing 0.1% Tween 20 (TBS-T) and 5% milk for 1 h at 25 °C and then incubated overnight at 4 °C with the following primary antibodies: anti-Neuropilin 1 (A-12) (NRP1) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-phospho-histone H2A.X (Ser139) (γH2AX), anti-Cyclin B1, anti-phospho-AKT (Ser473) (phAKT), anti-AKT, anti-cleaved Caspase-3, anti-cleaved PARP1 (PARP1) (Cell Signalling) and anti-β-Tubulin (Sigma-Aldrich). Membranes were then incubated with the appropriate horseradish peroxidase- (HRP-) conjugated secondary antibody (Santa Cruz Biotechnology) for 1 h at 25 °C. Bound antibody was detected by enhanced chemiluminescence detection reagents (Pierce Biotechnology Inc., Rockford, IL, USA), according to the manufacturer's instructions. Tubulin served to estimate the protein equal loading. Densitometric analysis was performed using Quantity One Program (Bio-Rad Laboratories S.r.l., Segrate, MI, Italy). Quantitative real-time PCR (qRT-PCR) {#Sec10} ------------------------------------ Cells were harvested and total RNA was extracted with the use of TRIzol reagent (Invitrogen). Quantity and quality of the extracted RNA were assessed by NanoDrop (Thermo Fisher Scientific). For mRNA detection, cDNA was generated with oligo (dT) from 1 μg of RNA using the SuperScript III Reverse Transcriptase Kit (Invitrogen). Quantitative real-time PCR assays (qRT-PCR) were conducted in triplicate on an ABI 7500 Real Time instrument (Applied Biosystems by Life Technologies, Carlsbad, CA, USA) as previously described \[[@CR57]\]. Briefly, the abundance of NRP1 was quantified using the appropriate Taq-Man gene expression assay kit (Applied Biosystems). β-actin mRNA was used as endogenous control. For miRNA detection, 40 ng of RNA were retro-transcribed with a specific primer for miR-200c-3p (Thermo Fisher Scientific). Expression of miR-200c-3p was analyzed by using sequence-specific TaqMan MicroRNA Assays (Applied Biosystems). U6 small nuclear RNA levels were used as internal control. siRNA-mediated downregulation of NRP1 {#Sec11} ------------------------------------- The NRP1-specific (siNRP) short interfering RNA, which specifically knock down NRP1 gene expression, as well as negative control siRNA (siNC), which does not lead to the specific degradation of any cellular mRNA, was purchased from Santa Cruz Biotechnology. SKOV3 cells were seeded in 6 well-plate at a density of 0.8 × 10^5^ cells/well and transfected with siRNA at a final concentration of 50 nM using the HiPerfect Transfection Reagent (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions for long term transfection. The achievement of an efficient knockdown without cytotoxicity at 144 h after the initial transfection was confirmed by performing a time-course experiment. Silenced cells, treated or not with Olaparib (5 μM), were collected and processed for RNA and protein extraction. NRP1 silencing was confirmed by both Western blot and qRT-PCR experiments. miRNA conserved target sites prediction in 3′ UTR of NRP1 {#Sec12} --------------------------------------------------------- The RNA22 v2 (<https://cm.jefferson.edu/rna22/Interactive/>) and the TargetScan (<http://www.targetscan.org/vert_72/>) predictions were used to identify the putative miRNA target sites in 3′ UTRs of *NRP1* gene. The *NRP1* gene symbol and human species were retrieved from the database. The 3′ UTR of *NRP1* transcript ENST00000374875.1 was selected to analyze the potential binding site of miRNAs. Transfection of miR-200c in SKOV3 cell line {#Sec13} ------------------------------------------- Plasmid vector encoding miR-200c and empty pCMV vector were obtained from OriGene Company. Both vectors had Geneticin (G418) resistance as a marker for screening aims. SKOV3 cells were seeded in a 12 well-plate at a density of 0.5 × 10^6^ cells/well and transfected with 1 μg of pCMV-miR-200c plasmid (miR-200c) or the corresponding empty vector (CTRL) using Lipofectamine 3000 (ThermoFisher Scientific), following the manufacturer's instructions. 48 h post-transfection, cells were resuspended in fresh culture medium supplemented with 0.5 mg/ml G418 and distributed in 96 well-plate. The cells were kept under G418 selection for a couple of weeks in order to obtain G418 resistant clones. One clone from each transfection with pCMV empty vector and pCMV-miR-200c was obtained and used in our studies. Statistical analysis {#Sec14} -------------------- All data reported were verified in at least two different experiments and plotted as means ± standard deviations. The differences between control and experimental groups were analyzed by GraphPad Prism 7, using two-tailed unpaired t test. Pearson's coefficient correlation was used for correlation assay. *P* values \< 0.05 were considered as statistically significant. Results {#Sec15} ======= Variable cytotoxic effects of prolonged Olaparib treatment in different OC cell lines are mediated by differential DNA damage repair and activation of apoptosis/autophagy. We first confirmed the differential effect of Olaparib treatment on OC cell lines depending on BRCA status, by performing a dose- and time-curve evaluation of cell viability through MTT assay in the BRCA1-null UWB1.289 cell line (UWB), the UWB1.289 + BRCA1 cells (UWB-BRCA), in which BRCA1 expression was permanently restored, and the BRCA wild-type SKOV3 cell line. As expected, the sensitivity of the BRCA1-null UWB cells to Olaparib was greater than both its BRCA1 restored counterpart UWB-BRCA and the BRCA wild-type SKOV3 cells (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). Olaparib, by inhibiting PARP proteins, rapidly induces DNA damage, which can be measured by γH2AX expression at 24 h, in the three cell lines. In particular, evaluation of γH2AX foci by both immunofluorescence (IF) and Western blot analysis after prolonged Olaparib treatment (144 h) confirmed the persistence of DNA damage only in cells with impaired DNA repair (UWB cells) (Additional file [1](#MOESM1){ref-type="media"}: Figure S2). Cell cycle analysis of the three cell lines showed a significant arrest in G2 phase (4n) upon Olaparib treatment, with a corresponding decrease of cell percentage in both G1 (2n) and S phases, particularly evident in UWB and UWB-BRCA cells. Consistent with this observation, cells exposed to Olaparib and, particularly, UWB and UWB-BRCA cells, showed increased expression of Cyclin B1, a G2/M-regulating protein. The distribution of cell cycle fractions in G1, S and G2 phase and the expression of Cyclin B1 are shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S3. When assessing the effect of prolonged Olaparib treatment (144 h) on colony forming efficiency, we observed that Olaparib significantly inhibited clonogenic ability of BRCA-null UWB cells, while it had no effect on the BRCA wild-type SKOV3 cells, as expected (Fig. [1](#Fig1){ref-type="fig"}). However, interestingly, a partial inhibition was achieved at the higher Olaparib dose in UWB-BRCA cells (60% inhibition compared to control samples; Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Differential effect of Olaparib on clonogenic ability of OC cell lines. UWB, UWB-BRCA and SKOV3 cells were treated with Olaparib for 144 h, then seeded at low concentration and allowed to grow for 12 days. The effect of Olaparib on cell clonogenicity was determined by colony formation assay. The images are representative pictures of colonies stained with crystal violet. Colony forming efficiency was calculated by crystal violet absorbance. Mean values obtained from two independent experiments, each performed in triplicate, are reported in graph. Error bars represent standard deviations. \*\*, *p* \< 0.005, \*\*\*, *p* \< 0.0005 vs. control (DMSO) These data confirmed what previously observed about Olaparib effects \[[@CR7]\] but also pointed out a partial efficacy of prolonged Olaparib treatment on UWB-BRCA cells. So, we investigated if the variable response of UWB-BRCA cells upon Olaparib treatment was due to the induction of different intracellular pathways. We assessed the induction of apoptosis by performing flow cytometry assays with Annexin A5 FITC/7-AAD double staining. Treatment of UWB-BRCA and SKOV3 cell lines with Olaparib (5 μM) for 144 h did not significantly increase the percentage of cells undergoing early or late apoptosis when compared to mocked control cells. Indeed, Olaparib treatment induced a consistent increase in the number of apoptotic UWB cells (from about 10% in DMSO to almost 21% in 5 μM Olaparib) (Fig. [2](#Fig2){ref-type="fig"}a). So, Annexin A5 FITC/7-AAD double staining confirmed that cytotoxic effects of Olaparib were evident only in UWB cells. Furthermore, Western blot analysis showed that both caspase-3 and PARP1 cleavage/activation were strongly evident only in UWB cells upon Olaparib treatment at both doses (Fig. [2](#Fig2){ref-type="fig"}b), in accordance with the data obtained by FACS analysis. Fig. 2Effects of Olaparib treatment on apoptosis/autophagy induction in OC cell lines. UWB, UWB-BRCA and SKOV3 cells were treated for 144 h with Olaparib. **a**) The percentages of early apoptotic and late apoptotic cells were obtained by flow cytometry quadrant analysis with annexin A5 FITC/7-AAD double staining, and expressed as histograms. **b)** The expression of the apoptosis related proteins phAKT (Ser473), AKT, cleaved Caspase 3 and cleaved PARP1 was determined by Western blot analysis. Tubulin expression was used as internal control. The images are representative of at least two independent experiments. CF, cleaved form of PARP1. **c)** The expression of the autophagy related proteins LC3 and P62 was assessed by Western blot analysis. **d**) UWB and UWB-BRCA cells were treated for 144 h with Olaparib (5 μM), Chloroquine (CQ, 10 μM) or a combination of them, and the expression of LC3 and P62 was assessed. The intensity of the LC3-II and P62 bands was evaluated by densitometric analysis, normalized with LC3-I and Tubulin, respectively, and reported in graph. Error bars represent standard deviations. \*, *p* \< 0.05, \*\*, *p* \< 0.005 vs. control (DMSO) Since PI3K/AKT molecular pathway is a pivotal signal involved in cell survival and apoptosis, we also assessed by Western blot analysis the activation of AKT phosphorylation at Ser473. As reported in Fig. [2](#Fig2){ref-type="fig"}b, phosphorylation levels of AKT protein (phAKT) upon treatment with Olaparib were unaffected in SKOV3 cells, and markedly reduced in a dose-dependent way in UWB cells, whilst AKT total levels were unchanged, this confirming the central role of the AKT signal transduction pathway in the Olaparib-mediated cell death. Interestingly, the treatment of UWB-BRCA cells with Olaparib led to a significant downregulation of phAKT expression, without concomitant upregulation of cleaved Caspase 3 and cleaved PARP1 expression. Since AKT represents a key inhibitor of autophagy, we explored if the reduced phosphorylation state of AKT in UWB-BRCA cells was suggestive of autophagy activation. The classical hallmarks of autophagy, represented by LC3-I to LC3-II conversion and P62 protein degradation, were evaluated through Western blot analysis (Fig. [2](#Fig2){ref-type="fig"}c). We observed a significant increase in the LC3-II/LC3-I ratio in UWB-BRCA cells treated with Olaparib 1.5 or 5 μM (2.3 and 2.5 fold, respectively). Autophagy activation in these cells was also confirmed by the degradation of P62 protein (0.7 and 0.3 fold, respectively). Conversely, UWB and SKOV3 cells did not show a significant modulation of both LC3-II/LC3-I ratio and P62 (Fig. [2](#Fig2){ref-type="fig"}c). To investigate the involvement of autophagy in PARPi-resistance, we assessed apoptosis induction upon Olaparib treatment in the presence or not of the autophagy inhibitor Chloroquine (CQ). Treatment with CQ induced the accumulation of LC3-II and P62 in both UWB and UWB-BRCA cell lines (Fig. [2](#Fig2){ref-type="fig"}d), this reflecting autophagy inhibition. Concurrent treatment with Olaparib and CQ did not induce apoptosis activation in UWB-BRCA cells and significantly decreased the expression of the apoptosis markers cleaved Caspase 3 and cleaved PARP1 in UWB cells (Fig. [2](#Fig2){ref-type="fig"}d). These results suggest that in OC cell lines autophagy does not represent a cytoprotective response, but rather contributes to the cytotoxic effect of Olaparib. Olaparib treatment modulates NRP1 expression in UWB and UWB-BRCA cells {#Sec16} ---------------------------------------------------------------------- NRP1 is a membrane receptor known to promote tumor growth and drug resistance in several cancers, including OC \[[@CR19], [@CR30], [@CR34], [@CR36]\]. Firstly, we performed qRT-PCR to assess the mRNA expression of NRP1 in ovarian cancer specimens. In contrast with previous observations \[[@CR32]\], we found that NRP1 expression was significantly lower in OC samples (0.6 fold change with respect to normal ovarian tissue) (Fig. [3](#Fig3){ref-type="fig"}a). A low NRP1 protein expression was also confirmed in UWB and UWB-BRCA cells, derived from serous OC, whilst SKOV3 cells, derived from the ascites of an ovarian adenocarcinoma patient, showed a high basal expression of NRP1 protein (5 fold, with respect to UWB cells) (Fig. [3](#Fig3){ref-type="fig"}b). This differential expression among the three cell lines was also confirmed at mRNA level by qRT-PCR (Fig. [3](#Fig3){ref-type="fig"}c). We then investigated if chemotherapeutic treatment would be able to change NRP1 expression in OC patients. A total of 16 OC samples from the patient cohort were selected, based on the availability of pre- and post-CHT samples, and NRP1 expression was assessed in CHT-naïve and post-CHT OC samples by qRT-PCR. We identified a significantly increased expression of NRP1 mRNA transcript in post-CHT samples (1.7 fold increase with respect to pre-CHT samples) (Fig. [3](#Fig3){ref-type="fig"}d). Such correlation between CHT and increase of NRP1 expression supports the hypothesis of a role of NRP1 in drug response and potentially drug resistance. To test this hypothesis in our model, we assessed NRP1 expression in OC cell lines after treatment with Olaparib (1.5 and 5 μM) for 144 h. As shown in Fig. [3](#Fig3){ref-type="fig"}e, the treatment induced an upregulation of NRP1 protein in UWB and UWB-BRCA cell lines at both doses (1.7 and 3.1 fold in UWB cells and 1.8 and 7.3 fold in UWB-BRCA cells, respectively). Such upmodulation was confirmed to be significant at mRNA level only in UWB-BRCA cells (Fig. [3](#Fig3){ref-type="fig"}f). As for SKOV3 cells, Olaparib treatment did not affect NRP1 protein or mRNA expression (Fig. [3](#Fig3){ref-type="fig"}e, f). Our results suggest that Olaparib-mediated upregulation of NRP1 in OC cell lines expressing low basal levels of this protein might represent a drug resistance mechanism. Fig. 3Effect of Olaparib on NRP1 expression in OC. **a**) The expression pattern of NRP1 was assessed by qRT-PCR assays in OC tumor tissues from 28 patients and noncancerous ovarian tissues from 12 healthy donors. \*\*\*, *p* \< 0.0005. **b, c)** Basal NRP1 protein (**b**) and mRNA (**c**) levels in UWB, UWB-BRCA and SKOV3 cells were assessed by Western blot analysis and qRT-PCR, respectively. **d)** The expression pattern of NRP1 was assessed by qRT-PCR assays in OC tumor biopsies from 16 patients obtained before and after platinum-based chemotherapy (CHT). \*\*, *p* \< 0.005. **e, f)** NRP1 protein (**e**) and mRNA (**f**) expression after Olaparib treatment for 144 h were evaluated by Western blot analysis and qRT-PCR, respectively. For Western blot analysis, tubulin expression was used as internal control, and the images are representative of at least three independent experiments. The intensity of the bands was evaluated by densitometric analysis, normalized and reported as relative expression with respect to control (DMSO). For qRT-PCR, each experiment was performed in triplicate and mRNA levels were normalized to GAPDH mRNA expression. Error bars represent standard deviations. \*, *p* \< 0.05 vs. UWB cells (**c**) or vs control (DMSO) (**f**) NRP1 silencing restores sensitivity to Olaparib treatment in resistant OC cells {#Sec17} ------------------------------------------------------------------------------- To confirm the role of NRP1 in Olaparib resistance, we introduced a specific siRNA (siNRP) in the drug-resistant SKOV3 cell line. The efficiency of NRP1 silencing was assessed at 48, 72 and 144 h by Western blot analysis. As reported in Fig. [4](#Fig4){ref-type="fig"}a, a significant reduction of NRP1 expression (70%) was achieved as early as 48 h after silencing (0.3 fold with respect to nonspecific control siRNA, siNC), then reached 90% efficiency after 144 h (0.1 fold). NRP1 silencing was also performed on SKOV3 cells untreated or treated with Olaparib (5 μM) for 144 h. Western blot analysis confirmed that Olaparib treatment did not affect NRP1 silencing efficiency (0.03 fold versus siNC in both untreated and treated cells) (Fig. [4](#Fig4){ref-type="fig"}b). Then, cells were subjected to both MTT and clonogenic assay, to assess the effect of NRP1 silencing on SKOV3 response to Olaparib. The MTT assay demonstrated that viability of NRP1-silenced cells was reduced by 36% upon Olaparib treatment, whilst siNC-transfected cells treated with Olaparib showed a 7% reduction with respect to DMSO controls (Fig. [4](#Fig4){ref-type="fig"}c). As shown in Fig. [4](#Fig4){ref-type="fig"}d, Olaparib treatment did not affect clonogenicity of siNC cells, whilst in NRP1-silenced cells it determined a significant reduction in colony formation capacity (0.2 fold with respect to DMSO controls). So, NRP1 silencing was able to restore Olaparib efficacy. Moreover, the role of NRP1 in PARPi resistance is further confirmed by Western blot analysis assessing apoptosis pathway activation (reduction of AKT phosphorylation, cleavage of Caspase 3 and PARP1) in NRP1-silenced SKOV3 cells treated with Olaparib (Fig. [4](#Fig4){ref-type="fig"}e). Altogether, these data demonstrate that: i) inhibition of NRP1 restored the sensitivity of drug-resistant cells to Olaparib, ii) NRP1 signaling axis is an important determinant of PARPi tolerance, and iii) modulation of NRP1 expression represents a potential approach to overcome drug resistance in OC. Fig. 4Effect of NRP1 silencing on Olaparib resistance. SKOV3 cells were transfected with NRP1-specific siRNA (siNRP) or nonspecific control siRNA (siNC). **a, b)** NRP1 expression was assessed at 48, 72 or 144 h from transfection (**a**), and after Olaparib treatment at 144 h (**b**) by Western blot analysis. Tubulin expression was used as internal control. The images are representative of at least three independent experiments. **c, d)** The effect of Olaparib on cell viability and clonogenicity of silenced SKOV3 cells was determined by MTT assay and colony formation assay, respectively. Mean values obtained from two independent experiments, each performed in triplicate, are reported in graph. Error bars represent standard deviations. \*\*, *p* \< 0.005, \*\*\*, *p* \< 0.0005 vs. siNC-transfected cells or vs. control (DMSO). **e**) The expression of the apoptosis related proteins phospho-AKT (Ser473), AKT, cleaved caspase 3 and cleaved PARP1 in silenced SKOV3 cells treated or not with Olaparib was assessed by Western blot analysis. Tubulin expression was used as internal control. The images are representative of at least two independent experiments NRP1 expression in OC cell lines is regulated by miR-200c {#Sec18} --------------------------------------------------------- As demonstrated above, high expression of NRP1 is correlated with PARPi-resistance of SKOV3 cells. We employed two widely used miRNA target prediction algorithms, RNA22 v2 (<https://cm.jefferson.edu/rna22/Interactive/>) and TargetScan Human 7.2 (<http://www.targetscan.org/vert_72/>), to pull potential miRNAs that directly regulate NRP1. In particular, we found two conserved binding sites for the miR-200 family members (one for miR-141-3p/200a-3p and another for miR-429/200bc-3p), which have been previously demonstrated to directly target the 3'UTR of the most prevalent NRP1 transcript \[[@CR54]\] (Fig. [5](#Fig5){ref-type="fig"}a). Indeed, we focused on miR-200c-3p (from now on referred to as miR-200c), which is predicted to target NRP1 with a percentile score of 68% with 7-nucleotide complementarity (Fig. [5](#Fig5){ref-type="fig"}a), since it has been previously identified as an inducer of sensitivity against various anti-cancer agents \[[@CR52]\], and its low expression has been implicated in paclitaxel resistance in OC \[[@CR51]\]. We observed that the expression level of miR-200c was higher in OC specimens with respect to normal ovarian tissue (Fig. [5](#Fig5){ref-type="fig"}b), in accordance to what previously reported \[[@CR48]\], and is negatively correlated with that of NRP1 in OC specimens, as shown by correlation analysis (Fig. [5](#Fig5){ref-type="fig"}c). Such inverse correlation was also confirmed at protein and mRNA levels in OC cells. In fact, miR-200c basal expression was consistently high in UWB-BRCA cells (5 fold, with respect to UWB cells) and very low in SKOV3 cells (0.05 fold, with respect to UWB cells) (Fig. [5](#Fig5){ref-type="fig"}d). The increase of NRP1 expression upon treatment in UWB and UWB-BRCA corresponded to a significant decrease of miR-200c expression in these cells, with no variations in SKOV3 cells, in which Olaparib did not modulate NRP1 levels (Fig. [5](#Fig5){ref-type="fig"}e). These data supported the role of miR-200c as a negative regulator of NRP1 in OC. Fig. 5miR-200c-mediated regulation of NRP1 expression in OC cell lines. **a**) Schematic representation of the conserved target sites for miR-141/200a-3p (red) and miR-429/200bc-3p (green) in the 3′ UTR of human NRP1, and Targetscan prediction of miR-200c-3p binding site within the NRP1 3′-UTR. **b)** The expression pattern of miR-200c was assessed by qRT-PCR assays in OC tumor tissues from 28 patients and noncancerous ovarian tissues from 12 healthy donors. \*\*\*, *p* \< 0.0005. **c)** Correlation analysis between NRP1 and miR-200c expression was performed in OC tumor tissues from 28 patients. **d, e**) UWB, UWB-BRCA and SKOV3 cells were analyzed at basal conditions (**d**) or after Olaparib treatment (**e**), and miR-200c expression was determined by qRT-PCR analysis. Each experiment was performed in triplicate, and miRNA levels were normalized to U6 expression. Error bars represent standard deviations. \*, *p* \< 0.05, \*\*, *p* \< 0.005, \*\*\*, *p* \< 0.0005 vs. UWB cells (**d**) or vs control (DMSO) (**e**) To further validate our hypothesis of NRP1/miR-200c interaction, we investigated the effects of miR-200c overexpression in SKOV3 cells, expressing low levels of miR-200c and high levels of NRP1. First, we confirmed that transfection of miR-200c mimics into SKOV3 cells significantly downmodulated NRP1 expression, as reported in Additional file [1](#MOESM1){ref-type="media"}: Figure S4. Cells were then stably transfected with a plasmid carrying the precursor of miR-200c (pCMV-miR-200c) and its corresponding vector control (pCMV), and the expression levels of miR-200c were measured by qRT-PCR. We observed that miR-200c was highly increased in the pCMV-miR-200c group (miR-200c) compared to pCMV empty vector (CTRL) (Fig. [6](#Fig6){ref-type="fig"}a), this confirming the miRNA transfection efficiency. Both mRNA and protein expression of NRP1 were assessed in miR-200c-transfected SKOV3 cells by qRT-PCR and Western blot analysis, respectively. Exogenous expression of miR-200c could effectively decrease the levels of NRP1 protein by 80% (Fig. [6](#Fig6){ref-type="fig"}b) and of NRP1 mRNA by 60% (Fig. [6](#Fig6){ref-type="fig"}c). Fig. 6Effect of miR-200c overexpression on NRP1. SKOV3 cells were stably transfected with a plasmid carrying the precursor of miR-200c (miR-200c) and its corresponding vector control (CTRL). miR-200c expression was assessed by qRT-PCR analysis (**a**). NRP1 protein (**b**) and mRNA (**c**) expression were evaluated by Western blot analysis and qRT-PCR, respectively. For Western blot analysis, tubulin expression was used as internal control, and the images are representative of at least three independent experiments. The intensity of the bands was evaluated by densitometric analysis, normalized and reported as relative expression with respect to control (CTRL). For qRT-PCR, each experiment was performed in triplicate. miRNA levels were normalized to U6 expression, while mRNA levels were normalized to GAPDH mRNA expression. Error bars represent standard deviations. \*\*, *p* \< 0.005 vs. CTRL miR-200c sensitizes resistant SKOV3 cells to Olaparib by activating apoptosis {#Sec19} ----------------------------------------------------------------------------- To confirm the role of miR-200c in Olaparib resistance, SKOV3 cells stably transfected with pCMV-miR-200c (miR-200c) or empty pCMV vector (CTRL) were treated or not with Olaparib (5 μM) for 144 h and used for functional assays. The results of MTT assay revealed that, in miR-200c-transfected SKOV3 cells, Olaparib treatment reduced viability by about 37%, compared to the untreated samples, whilst the reduction of viability after Olaparib treatment was only 9%, compared to DMSO controls, in cells transfected with CTRL vector (Fig. [7](#Fig7){ref-type="fig"}a). Similarly, a significant decrease in colony forming efficiency after Olaparib treatment was observed only in miR-200c-transfected cells (0.6 fold with respect to untreated controls) (Fig. [7](#Fig7){ref-type="fig"}b). We investigated if miR-200c overexpression would influence SKOV3 ability to repair DNA damage induced by Olaparib. To test this hypothesis, we performed immunofluorescence staining to measure the intensity of γH2AX foci in miR-200c-transfected and CTRL-transfected SKOV3 cells after Olaparib treatment at 144 h. As described above for parental SKOV3 cells, at 144 h γH2AX expression levels in CTRL-transfected cells were similar between Olaparib-treated cells and DMSO controls, while we observed an increase of γH2AX expression after Olaparib treatment in miR-200c-transfected cells (Fig. [7](#Fig7){ref-type="fig"}c). Such results suggest that miR-200c overexpression might hinder DNA repair in Olaparib-resistant cells, this leading to a persistent DNA damage and a subsequently greater effectiveness of PARPi. Fig. 7Effect of miR-200c overexpression on SKOV3 response to Olaparib. SKOV3 cells were stably transfected with a plasmid carrying the precursor of miR-200c (miR-200c) and its corresponding vector control (CTRL), then treated for 144 h with Olaparib. **a, b)** Cell viability and colony forming efficiency were determined by MTT assay and clonogenic assay, respectively. Mean values obtained from two independent experiments, each performed in triplicate, are reported in graph. Error bars represent standard deviations. \*\*\*, *p* \< 0.0005 vs. CTRL cells or vs. control (DMSO). **c)** The presence of γH2AX foci (red) was assessed by immunofluorescence analysis. Nuclei (blue) were visualized with 4′, 6-diamidino-2-phenylindole (DAPI). Images were captured under ApoTome microscope at 40x magnification**.** Quantification of γH2AX foci was determined by measuring red fluorescence intensity with ImageJ software. Mean values obtained from measurements of five microscopic fields randomly taken from three independent experiments are reported in graph. Error bars represent standard deviations. \*\*, *p* \< 0.005 vs. control (DMSO) To confirm such conclusion, we assessed if miR-200c overexpression was able to restore PARPi ability to induce apoptosis. Flow cytometry assays with Annexin A5 FITC/7-AAD double staining demonstrated that Olaparib treatment significantly increased the percentage of apoptotic cells in SKOV3 overexpressing miR-200c (from around 2% in DMSO to approximately 10% in 5 μM Olaparib) and not in CTRL-transfected cells (Fig. [8](#Fig8){ref-type="fig"}a). Furthermore, Western blot analysis showed expression of cleaved Caspase 3 and cleaved PARP1 upon Olaparib treatment only in the miR-200c-transfected cells, and not in the CTRL-transfected cells (Fig. [8](#Fig8){ref-type="fig"}b). These data strongly suggested that miR-200c regulates apoptosis induction by Olaparib in SKOV3 cells. In agreement with what observed for UWB cells, Olaparib treatment at 144 h did not induce autophagy activation in miR-200c-transfected cells, as reported in Additional file [1](#MOESM1){ref-type="media"}: Figure S5. Fig. 8Effect of miR-200c overexpression on Olaparib-induced apoptosis. SKOV3 cells were stably transfected with a plasmid carrying the precursor of miR-200c (miR-200c) and its corresponding vector control (CTRL), then treated for 144 h with Olaparib. **a)** The percentages of early apoptotic and late apoptotic cells were obtained by flow cytometry quadrant analysis with annexin A5 FITC/7-AAD double staining, and expressed as histograms. **b)** The expression of the apoptosis related proteins phAKT (Ser473), AKT, cleaved Caspase 3 and cleaved PARP1 was determined by Western blot analysis. Tubulin expression was used as internal control. The images are representative of at least two independent experiments. CF, cleaved form of PARP1 Altogether, our data suggest that miR-200c overexpression is able to restore SKOV3 susceptibility to Olaparib by targeting NRP1. Discussion {#Sec20} ========== OC represents the fifth principal cause of cancer-related death in women \[[@CR3]\]. Its high mortality-to-incidence ratio is essentially due to the absence of OC-specific symptoms and the lack of effective screening strategies. Currently, medical options for OC treatment may include a combination of surgery, chemotherapy and radiation. Nevertheless, the general prognosis in OC patients remains poor, with a 5-year survival rate of about 30% \[[@CR4]\]. It is known that approximately 10--15% of ovarian cancer patients harbor a germline mutation in genes encoding BRCA1 and BRCA2 proteins, which are involved in the process of homologous recombination (HR) that mediates repair of double stranded DNA breaks \[[@CR58]\]. OC patients with BRCA1/2 mutations exhibit impaired ability to repair double-stranded DNA breaks via HR. In this scenario, PARP inhibitors, affecting a second DNA repair pathway, the base excision repair (BER), are able to induce death through a mechanism called synthetic lethality. So, PARPi have been recently approved for treatment of tumors with BRCA1/2 mutations \[[@CR10]\]. Nevertheless, the clinical response rates to Olaparib (AZD-2281), a small molecular inhibitor of PARP1, are below 50% among OC patients with confirmed BRCA1/2 inactivation \[[@CR59], [@CR60]\], while a subset of patients without germline BRCA mutations might harbor the so-called "BRCAness" phenotype, an impairment in the HR pathway due to other causes (somatic mutations, as well as epigenetic regulations or mutations in other HR pathways) that could be associated with improved response rate and survival after treatment with these drugs \[[@CR11], [@CR12]\]. At present, one of the major problems of oncologists is the identification of the most appropriate set of patients that could benefit of the treatment with PARPi. In addition, many OC patients develop local recurrence and distant metastases, often accompanied by resistance to both first-line treatments and PARPi \[[@CR13], [@CR18]\]. So, a better understanding of the function of PARP inhibition and the comprehension of drug resistance mechanisms are needed both to predict PARPi clinical efficacy by identifying responsive patients beyond BRCA mutation, and to improve the clinical management of OC patients by introducing novel effective clinical protocols based on combinatorial therapies. Firstly, we explored the effect of prolonged Olaparib treatment in three OC cell lines and confirmed a differential drug response profile depending on BRCA status. As expected, we observed that treatment with Olaparib is capable of inducing DNA damage and G2/M phase cell-cycle arrest in all the OC cell lines, but such alterations lead to activation of apoptotic pathways only in sensitive UWB cells, maybe due to the persistence of DNA strand breaks, which are restored at 144 h in UWB-BRCA and SKOV3 cells, with subsequent no apoptosis induction following Olaparib treatment. In agreement with our data, lymphoblastoid cells with mono-allelic mutations of BRCA1 showed a persistent DNA damage upon Olaparib treatment, which rendered them hypersensitive to gamma radiation \[[@CR61]\]. However, our results pointed out a partial reduction of clonogenic ability induced by Olaparib in UWB-BRCA cells. Interestingly, in these cells we also observed the activation of autophagy upon Olaparib treatment. It is known that autophagy can be upregulated in response to DNA damage, and in the context of cancer it might function as an adaptive cytoprotective response \[[@CR62]\], representing a selective advantage for tumor cells by enhancing drug resistance and aggressiveness, or might act as an alternative to apoptosis to eliminate transformed cells \[[@CR63]--[@CR65]\]. In ovarian cancer cells, this alternative role of autophagy has been suggested to depend on the BRCA status \[[@CR66]\]. Our data demonstrates that in the partially resistant UWB-BRCA cells, prolonged Olaparib treatment determines autophagy activation, but fails to stimulate apoptosis. Notably, we found that the autophagy inhibitor chloroquine (CQ) did not induce apoptosis activation in Olaparib-treated UWB-BRCA cells, and reduced the ability of Olaparib to induce apoptosis activation in UWB cells, this indicating an essential role of autophagy in Olaparib citotoxicity in OC cells. It has been previously demonstrated that NRP1 regulation by various miRNAs plays an important role in mediating tumor growth and angiogenesis \[[@CR44]--[@CR47]\]. Moreover, some previous studies reported NRP1 overexpression in OC with respect to normal ovarian tissue \[[@CR32]\] and to benign ovarian tumors \[[@CR33]\], as well as a correlation between higher NRP1 expression and shorter survival time \[[@CR32], [@CR35]\]. However, there is no full consistency among different studies about the correlation of NRP1 expression with OC hystotype or clinicopathological staging. Interestingly, in our work we observed a lower NRP1 expression in OC with respect to normal ovarian tissues in a total cohort of 40 patients, in which we can find a strong prevalence of serous histotype among the 28 OC samples. Our findings on OC tissues are consistent with the observation that NRP1 basal levels are lower in OC cell lines derived from serous OC (UWB and UWB-BRCA cells) with respect to those found in cells from peritoneal adenocarcinoma (SKOV3 cells). Moreover, a comparative analysis of NRP1 expression between pre- and post-chemotherapy OC samples points out an involvement of NRP1 in OC adaptive response to therapy, this further strengthened by the finding of NRP1 upmodulation in sensitive cells upon prolonged Olaparib treatment. Indeed, we demonstrated that Olaparib could significantly upmodulate NRP1 mRNA and protein only in UWB-BRCA cells, suggesting that in these cells NRP1 expression was sufficient to modulate drug sensitivity, this restricting the effect of Olaparib on cell viability and apoptosis induction. Our data, indicating that NRP1 levels may regulate OC cell lines resistance to PARPi, are in agreement with bioinformatics network analysis suggesting the potential role of NRP1 in drug resistance \[[@CR36]\]. Thus, blocking NRP1 expression in OC cells might provide an avenue to increase the sensitivity of drug-resistant cells to Olaparib. Results revealed that downregulation of NRP1 in SKOV3 resistant cells inhibited viability, decreased colony forming potential and induced apoptosis upon Olaparib treatment, indicating that depletion of NRP1 is able to restore sensitivity to PARPi. Noncoding RNAs, including miRNAs, are endogenous regulatory elements that play a key role in cellular events such as proliferation, differentiation and apoptosis, in both physiological and pathological conditions \[[@CR39]\]. In cancer, miRNAs might affect tumor development, progression and drug resistance. Consequently, antagonizing oncogenic miRNAs or restoration of tumor suppressive miRNAs, could represent a reliable tool for improving the cancer therapy \[[@CR41]--[@CR43]\]. However, since each miRNA may regulate several target genes and signaling pathways, miRNA-based treatment requires a careful choice of the potential target. Increasing evidence show that aberrant expression of miRNAs belonging to the miR-200 family (comprising miR-200a, miR-200b, miR-200c, miR-429 and miR-141) is involved in OC development, as well as in chemoresistance \[[@CR67]--[@CR69]\]. Some of these miRNAs have been shown to interact with NRP1 3′-UTR \[[@CR54]\] and to negatively regulate NRP1 signaling \[[@CR47]\]. We focused our attention on miR-200c, since it is highly expressed in OC, maybe contributing to epithelial-mesenchymal transition, invasiveness, tumor growth and metastasis \[[@CR51]\]. On the other hand, the loss of miR-200c is associated with the acquisition of resistance against various chemotherapeutic agents in different types of cancer, including OC \[[@CR52]\]. To date, the function and molecular basis of miR-200c in drug resistance is still undefined. The data obtained about miR-200c expression in our cohort of patients are consistent with previous literature assessing upregulation of miR-200c in OC \[[@CR48]--[@CR50]\], and confirmed an inverse correlation with NRP1 expression. Our study displayed that overexpression of miR-200c reversed the resistance to Olaparib in OC cells through modulating NRP1 expression. Consistent with our findings, other studies reported a correlation between low expression of miR-200c and paclitaxel resistance in OC \[[@CR70]\], and a restoration of paclitaxel sensitivity upon miR-200c overexpression in chemotherapy-resistant cancer cell lines \[[@CR53], [@CR71], [@CR72]\] and in a xenograft tumor model \[[@CR72]\], this confirming miR-200c as an important control point for the development of chemoresistance in OC. Our results suggest that tumors with NRP1 downmodulation or miR-200c upmodulation may be more susceptible to PARP inhibition or other strategies based on synthetic lethality. Future studies will determine whether expression levels of NRP1/miR-200c can serve as determinants of therapeutic strategy and of clinical outcome for OC patients. Indeed, the efficacy in OC cellular models of this novel therapeutic approach, based on the downmodulation of NRP1 through the overexpression of specific miRNA molecules, provides a rationale to translate in vitro experiments in preclinical mouse models. The proposed approach, designed to be administered in combination with PARPi to increase therapeutic efficacy with minimal toxicities, has the potential to develop more effective and less toxic therapeutic protocols for the clinical management of OC patients. Next, we will set up in vivo experiments to test the effects of miR-200c upregulation in overcoming PARPi-related resistance on xenograft mouse models. Future studies will also encompass the role of cancer stem cells (CSCs) in Olaparib resistance mechanisms, by analyzing the efficacy of miR-200c, as monotherapy and in combination with Olaparib, on stemness-related pathways. We think that the development of adjuvant molecular strategies that specifically sensitize CSCs will further contribute to OC eradication. Conclusions {#Sec21} =========== In summary, our data describe the PARPi-related response profile of three OC cell lines, clarifying the role of DNA damage, cell cycle arrest and induction of apoptosis/autophagy in PARPi-related resistance, and demonstrate that PARPi sensitivity can be restored by acting on the miR-200c/NRP1 axis. In fact, we showed that miR-200c overexpression increases the response of drug resistant OC cells to Olaparib by targeting NRP1, and that both selective inhibition of NRP1 and stable overexpression of miR-200c might represent a promising approach to improve Olaparib efficacy. Thus, we think that our study will contribute to the design of novel therapeutic strategies for optimizing the clinical use of PARPi in OC patients. Additional file =============== {#Sec22} **Additional file 1: Figure S1.** Differential effects of Olaparib treatment on cell viability in OC cell lines. **Figure S2.** Effects of prolonged Olaparib exposure on DNA damage in OC cell lines. **Figure S3.** Induction of G2/M cell cycle arrest by Olaparib in OC cell lines. **Figure S4.** Effect of miR-200c overexpression on NRP1. **Figure S5.** Effect of miR-200c overexpression on autophagy induction 7-AAD : 7-amino-actinomycin D DMSO : Dimethyl sulfoxide DSBs : Double strand breaks miRNA : MicroRNA NRP1 : Neuropilin 1 OC : Ovarian cancer OLA : Olaparib PARPi : PARP inhibitors PI : Propidium iodide siRNA : Small interfering RNA SSBs : Single strand breaks **Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information ========================= **Supplementary information** accompanies this paper at 10.1186/s13046-019-1490-7. The authors are grateful to Dr. Graziella Bernardini for her technical assistance. SCe conceived the project. EV, GG, FM, EA, PP, LS and CDV conducted experiments. EV and SCe wrote the manuscript and prepared Figs. EV, FM, EA and SCe analyzed and interpreted the data. SCa, RM and CD provided reagents/materials/analysis tools. ClaM and PBP acquired and managed patients. RM, FR, AA and CM gave comments and reviewed the manuscript. CM and SCe supervised the study. All authors read and approved the final manuscript. This research was conducted with the help of the PRIN 2017 supporting grants (no. ATZ2YK and no. F8ZB89), the Italian Association for Cancer Research (AIRC) grant (no. IG17007) and the LazioInnova grant 2018 (no. 85--2017- 13750). All data generated during the current study are included within the article. The use of clinical samples of OC or healthy ovarian tissue complied with the Declaration of Helsinki 1975, revised in 2008, and has been approved by the Institutional Review Board of the Department of Maternal and Child and Urological Sciences of the Sapienza University of Rome. Written consent was obtained from all subjects. Not applicable. The authors declare that they have no competing interests.

Introduction {#Sec1} ============ Molecular cloning techniques are widely used in molecular biology and biochemistry to construct recombinant DNA molecules. Traditionally, cloning requires appropriate restriction enzyme sites in the DNA insert and plasmid for ligation. However, when researchers wish to manipulate a short region of DNA, only hundreds of base pairs (bps) in length, in a plasmid, appropriate restriction sites near the region of interest are frequently limited; thus, researchers often manipulate a larger DNA fragment instead. Alternatively, polymerase chain reaction (PCR)-based site-directed mutagenesis can be used to engineer DNA sequences in the original plasmid, but such processes require multiple steps to change more than one base pair and can generate sequence errors in unexpected regions^[@CR1]^. To date, a few restriction enzyme-independent methods have been developed by using the CRISPR (clustered regularly interspaced short palindromic repeat)-Cas (CRISPR associated) system^[@CR2]--[@CR9]^. Type II Cas9 and type V Cpf1 (also called Cas12a) are representative RNA-guided DNA endonucleases that specifically induce DNA double strand breaks at desired sites containing protospacer-adjacent motif (PAM) sequences, 5′-NGG-3′ for SpCas9 derived from *Streptococcus pyogenes* and 5′-TTN-3′ for FnCpf1 from *Francisella novicida*^[@CR10],[@CR11]^. Therefore, researchers can cleave DNA in a region lacking an appropriate enzyme site by using CRISPR endonucleases. Furthermore, it is both inexpensive and easy to change DNA target sites by simply altering the guide RNA sequence. Previously, Jiang *et al*. developed the Cas9-Assisted Targeting of CHromosome segments (CATCH) method^[@CR12],[@CR13]^ and Lei *et al*. developed the Cpf1-assisted Cutting and Taq DNA ligase-assisted Ligation (CCTL) method^[@CR14]^. CATCH use the CRISPR-Cas system to separate large gene segments and CCTL use the system to induce sticky end; these approaches showed that CRISPR endonucleases can be used to generate greater flexibility in the choice of cleavage sites. These methods adapted the CRISPR system for DNA cleavage and facilitated the introduction of sites into regions that are difficult to modify *via* PCR. On the other hand, Wang *et al*.^[@CR15]^ developed a seamless DNA cloning method by using CRISPR-Cas9 and Gibson assembly, and showed a simple way to insert new DNA fragment by targeting one site using one guide RNA with Cas9 protein. In this study, following to the previous methods, we demonstrated a precise DNA cloning method that involves cleaving a part of the backbone plasmid using two kinds of guide RNAs with CRISPR-Cas9 and ligating new DNA fragments using Gibson assembly^[@CR16]^. Using this method, we altered an antibiotic resistance gene in a DNA plasmid in one step and ultimately constructed plasmids encoding adenine base editors (ABEs)^[@CR17],[@CR18]^, consisting of Cas9 variants that recognize non-canonical PAM sequences, 5′-NGA-3′ for the VQR Cas9 variant, 5′-NGCG-3′ for the VRER Cas9 variant^[@CR19],[@CR20]^, and 5′-NG-3′ for the SpCas9-NG variant^[@CR21]^, fused with adenosine deaminases. Furthermore, we confirmed the function of the new DNA plasmids (VQR-ABE, VRER-ABE, and NG-ABE) in human cell lines. Results and Discussion {#Sec2} ====================== Replacement of selection marker {#Sec3} ------------------------------- Selection markers such as antibiotic resistance genes are crucial for obtaining user-defined cell lines; it is frequently necessary to exchange an existing selection marker with a desired one. We first demonstrated a precise DNA cloning method by replacing the *hph* (hygromycin B phosphotransferase; Hyg-R) gene with the *pac* (puromycin N-acetyl-transferase; Puro-R) gene in a DNA plasmid. We prepared a pXY-Hyg-AAVS1 vector (6.4kbp) that includes the Hyg-R gene as the backbone plasmid and a PX459 plasmid that includes the Puro-R gene as a donor plasmid (or a PCR template) as shown in Fig. [1a](#Fig1){ref-type="fig"}. To cleave the Hyg-R gene from the backbone plasmid *in vitro*, we treated the pXY-Hyg-AAVS1 plasmid with recombinant Cas9 protein complexed with two single-guide RNAs (sgRNAs) that target sites flanking the Hyg-R gene within 100 bp of the Hyg-R gene boundaries in the backbone plasmid^[@CR22]^ (Fig. [1b](#Fig1){ref-type="fig"} and Supplementary Fig. [1](#MOESM1){ref-type="media"}). The insert DNA fragments containing the Puro-R gene were amplified from the PX459 plasmid using a pair of PCR primers that contained about 20 bp of additional sequence homologous to sequences flanking Hyg-R in the backbone plasmid. The backbone plasmid lacking the Hyg-R gene and the insert DNA fragments containing Puro-R gene were then mixed and re-ligated *via* the Gibson assembly process. We then transformed the ligated samples into E. coli DH5α competent cells and incubated them in LB plate containing ampicillin. To measure the cloning efficiency, we identified that eight of ten colonies successfully contain Puro-R gene via restriction enzyme cutting experiments (Fig. [1c](#Fig1){ref-type="fig"}, Supplementary Fig. [2](#MOESM1){ref-type="media"}) and one of eight was further confirmed by Sanger sequencing (Supplementary Fig. [3](#MOESM1){ref-type="media"}). As an end result, we obtained a re-constructed backbone plasmid that contained the Puro-R gene, named pXY-Puro-AAVS1. To test whether it would confer puromycin resistance, we separately transfected pXY-Hyg-AAVS1 and pXY-Puro-AAVS1 into HeLa cells and cultivated them in media containing puromycin. As expected, HeLa cells transfected with pXY-Puro-AAVS1 were selectively viable in medium containing 1 μg/ml of puromycin (Fig. [1d](#Fig1){ref-type="fig"}), indicating the successful replacement of the selection marker in the backbone plasmid.Figure 1Replacement of antibiotic resistance gene. (**a**) Cloning scheme for exchanging antibiotic resistance genes. Recombinant Cas9 proteins are represented as scissors. Regions that are homologous between the backbone pXY-Hyg-AAVS1 plasmid and the PCR products are indicated in orange and blue. The PCR products and the backbone vector were attached by Gibson assembly. (**b**) Agarose gel image showing DNA cleavage of the backbone plasmid pXY-hyg-AAVS1 via CRISPR-Cas9 for vector preparation. (Lane 1: DNA marker, lane 2: uncut plasmid, lane 3, cut plasmid by CRISPR-Cas9). Full-length gel is presented in Supplementary Fig. [1](#MOESM1){ref-type="media"}. (**c**) Summarized table of the cloning efficiency. The linearized vectors were transformed into *E. coli* DH5α competent cells without Gibson assembly reaction as a negative control. The mixtures of linearized vectors and Puro-R amplicons were transformed into the DH5α cells after Gibson reaction. After incubating the DH5α cells in LB plate containing ampicillin, the number of survived colonies were counted on the LB plate (total colonies). Among the ten colonies evaluated by enzyme cutting experiments (tested colonies), eight colonies were successfully constructed (positive colonies). (**d**) Photomicrographs of HeLa cells treated with puromycin (1 μg/ml) after transfection with pXY-Hyg-AAVS1 (left) and pXY-Puro-AAVS1 (right) with 40-fold magnification. Precise replacement of ABE (7.10) with VQR-ABE and VRER-ABE {#Sec4} ----------------------------------------------------------- Recently, CRISPR base editors that enable direct conversion of DNA bases without generating double-stranded DNA breaks have been developed. Gaudelli *et al*.^[@CR17]^ constructed an adenine base editor (ABE version 7.10) that consists of deactivated Cas9 (dCas9) or Cas9 nickase (nCas9) linked with wild-type tRNA adenosine deaminase (TadA) -- evolved TadA\* heterodimer. Because the ABE is based on wild-type (WT) Cas9, it is limited to targeting DNA sequences that contain a 5′-NGG-3′ PAM. On the other hand, Kleinstiver *et al*.^[@CR19]^ engineered WT Cas9 to expand targetable DNA sequences by altering PAM sequence recognition. The SpCas9 VQR variant (D1135V/R1335Q/T1337R) recognizes 'NGA' PAM sequences and the VRER variant (D1135V/G1218R/R1335E/T1337R) recognizes 'NGCG' PAM sequences. Compared to WT Cas9, the VQR and VRER variants have 6 and 9 substitutions, respectively, and the total lengths of the variable regions are about 600 bp in each case; thus, DNA fragments in a relatively short region must be exchanged to re-construct VQR-ABE and VRER-ABE. Toward this aim, we first prepared the ABE (7.10) vector plasmid encoding WT nCas9 as a backbone plasmid and the two plasmids encoding the VQR or VRER Cas9 variants as donor plasmids (Fig. [2a](#Fig2){ref-type="fig"}). We also designed sgRNAs that target just outside of the region to be exchanged in the backbone plasmid. To remove the region of interest from the ABE (7.10) backbone plasmid, we treated it *in vitro* with recombinant Cas9 protein complexed with the sgRNAs. The two insert DNA fragments containing the VQR or VRER Cas9 variants were amplified from the VQR and VRER donor plasmids with primers that also contained about 20 bp of additional sequence homologous to sequences flanking sites of interest in the backbone plasmid for Gibson Assembly. The backbone plasmid lacking the region to be exchanged and the insert DNA fragments containing the VQR or VRER variants were then independently mixed and re-ligated *via* the Gibson assembly process. We ultimately obtained two re-constructed plasmids based on the ABE (7.10) backbone that contain the VQR and VRER variants, named VQR-ABE and VRER-ABE, respectively. We confirmed the substitution of DNA sequences by Sanger sequencing as shown in Fig. [2b](#Fig2){ref-type="fig"}.Figure 2Construction of VQR-ABE and VRER-ABE. (**a**) The WT ABE (7.10) plasmid was prepared as a backbone; VQR and VRER plasmids were used as donors. Deep blue regions encode the WT TadA--evolved TadA\* heterodimer. The region to be exchanged in ABE (7.10) was cleaved by CRISPR-Cas9 and the two donor DNA fragments were amplified by PCR. PCR amplicons were attached to the initial backbone vector by Gibson assembly. (**b**) Sanger sequencing data from the regions of interest in the VQR-ABE (top) and VRER-ABE (bottom) plasmids. Red boxes indicate mutations in each plasmid. Successful gene editing with VQR-ABE and VRER-ABE plasmids in human HEK293T cells {#Sec5} --------------------------------------------------------------------------------- To investigate the adapted breadth of PAM sequences recognized by the ABEs encoded by the VQR-ABE and VRER-ABE plasmids, we examined the base editing efficiency of each plasmid at endogenous DNA site in human cell lines. As shown in Fig. [3a](#Fig3){ref-type="fig"}, we transfected the various Cas-ABE plasmids together with sgRNAs into human HEK293T cells and analyzed the base editing efficiencies at the target sites by using targeted deep sequencing. For the VQR-ABE plasmid, we first selected an endogenous target site containing an 'NGA' PAM sequence in the *EMX1* gene, which was used in the previous experiment^[@CR19]^. Targeted deep sequencing data showed that VQR-ABE converted 12.8% of adenines within the target window to guanine, whereas ABE (7.10) was unable to induce significant substitutions (Fig. [3b](#Fig3){ref-type="fig"}, Supplementary Table [1](#MOESM1){ref-type="media"})^[@CR23],[@CR24]^. We further tested the VQR-ABE plasmid at another four endogenous target sites. As a result, we found that VQR-ABE converted from 1.1 to 23.1% of adenines within the target windows to guanine, indicating that the VQR-ABE can successfully edit endogenous target sites containing 'NGA' PAM sequences, compared to ABE (7.10) and the negative control (Fig. [3c](#Fig3){ref-type="fig"}, Supplementary Fig. [4](#MOESM1){ref-type="media"}, and Table [1](#MOESM1){ref-type="media"}). It is noteworthy that WT ABE (7.10) partially induced A-to-G conversion at target sites having non-canonical 'NGA' PAM sequences, similar to the previous study that WT SpCas9 showed low activity on non-canonical 'NGA' PAM sequences^[@CR20]^. Similarly, we tested the base editing efficiency of the VRER-ABE plasmid at endogenous target sites containing 'NGCG' PAM sequences. We also confirmed that the VRER-ABE can successfully edit such sequences, compared to ABE (7.10) and the negative control (Fig. [3d](#Fig3){ref-type="fig"}, Supplementary Fig. [5](#MOESM1){ref-type="media"}, and Supplementary Table [2](#MOESM1){ref-type="media"}).Figure 3Activity of VQR-ABE and VRER-ABE *in vivo*. (**a**) Human HEK293T cells were transfected with three sets of ABE and sgRNA plasmids. Genomic DNA from treated cells was prepared and analyzed by targeted deep sequencing. (**b**) To test the activity of the VQR-ABE plasmid, one target site containing an 'NGA' PAM in the *EMX1* gene was selected (top). The tables show the substitution ratios at each position in the target site after treatment with ABE (7.10) (middle) and VQR-ABE (bottom). The dominant sequence at each position is shown in blue and sequences with a significant level of editing are shown in orange. (**c**,**d**) The graphs show the conversion ratios of A to G at various target sites containing NGA (**c**) or NGCG (**d**) PAMs in human cells for VQR-ABE (**c**) and VRER-ABE (**d**) compared to the negative control and ABE (7.10). All experiments were repeated three times and the error bars in these figures mean the standard error of the mean. Construction of NG-ABE plasmids and successful gene editing in human HEK293T cells {#Sec6} ---------------------------------------------------------------------------------- More recently, Nishimasu *et al*.^[@CR21]^ developed a new Cas9 variant (R1335V/L1111R/D1135V/G1218R/ E1219F/A1322R/T1337R), named SpCas9-NG, that recognizes a 5′-NG-3′ PAM sequence. To expand the application area of ABEs, we next constructed a 'NG' PAM targetable ABE, named NG-ABE. In this case, we prepared a further engineered ABE (7.10) vector plasmid, named ABEmax^[@CR25]^ as a backbone plasmid and synthetic DNA fragments that have all of seven mutations as insert donors. As described above, we removed the region of interest from the ABEmax backbone plasmid via CRISPR-Cas9 and re-ligated the plasmid with the synthetic insert DNA *via* the Gibson assembly (Fig. [4a](#Fig4){ref-type="fig"}).Figure 4Construction of NG-ABE and its activity test in HEK293T cells. (**a**) The WT ABEmax plasmid was prepared as a backbone and a synthetic DNA that has seven mutations for targeting 'NG' PAM was used as an insert DNA. The region to be exchanged in ABEmax was cleaved by CRISPR-Cas9 and the synthetic DNA was attached to the initial backbone vector by Gibson assembly. (**b**) To test the activity of the NG-ABE plasmid *in vivo*, Human HEK293T cells were transfected with NG-ABE and sgRNA plasmids. Genomic DNA from treated cells was prepared and analyzed by targeted deep sequencing. The tables show the substitution ratios at each position in the target site after treatment with ABEmax (top) and NG-ABE (bottom) in one target site containing an 'NGT' PAM in the *MECP2* gene. The dominant sequence at each position is shown in blue and sequences with a significant level of editing are shown in orange. (**c**) The graphs show the conversion ratios of A to G at various target sites containing NGT or NGA PAMs in human cells for NG-ABE compared to the negative control and ABEmax. All experiments were repeated three times and the error bars in these figures mean the standard error of the mean. To evaluate the base editing efficiency of the NG-ABE plasmids at endogenous DNA sites in HEK293T cells, we prepared six kinds of sgRNAs that were designed to target 'NGT' or 'NGA' PAM sequences, which were used in the previous study^[@CR21]^. We measured the base editing efficiencies at the target sites by using the targeted deep sequencing. For the target site in the *MECP2* gene, 23.4% of adenines within the target window were converted to guanine via NG-ABE, whereas WT ABEmax showed no significant substitutions as shown in Fig. [4b](#Fig4){ref-type="fig"}. In addition, we measured that A-to-G conversions were induced at the ratios of 4.3--32.5% within the target windows for all target sites that we tested, indicating the successful gene editing of NG-ABE on target sites having 'NG' PAMs, compared to ABEmax and the negative control (Fig. [4c](#Fig4){ref-type="fig"}, Supplementary Fig. [6](#MOESM1){ref-type="media"}, and Table [3](#MOESM1){ref-type="media"}). We found that ABEmax also induced A-to-G conversion at target sites having non-canonical 'NGA' PAM sequences, similar to the above experiments. In conclusion, we have demonstrated an easy-to-use and restriction enzyme-free DNA cloning method by combining Cas9-mediated DNA cleavage and Gibson assembly. With this method, we replaced an antibiotics resistance marker in a backbone plasmid as a proof of concept and substituted a few base pairs of Cas9 sequence to generate VQR-ABE, VRER-ABE, and NG-ABE plasmids, which can target non-canonical NGA, NGCG, and NG PAMs, in one step. Compared to site-directed mutagenesis, this method avoids unpredictable errors in the vector plasmid caused by repeated PCR and is not limited by the length of the DNA region that will be changed. Although this method needs PAM sequences near DNA cleavage sites in the backbone plasmid, it undoubtedly expands the cleavage sites compared to the restriction enzymes. Given its precise and practical nature, we expect that this method will be useful to a broad range of researchers. Materials and Methods {#Sec7} ===================== *In vitro* transcription of single-guide RNAs {#Sec8} --------------------------------------------- Forward oligo sequences, containing the T7 RNA polymerase promoter and the 20 bp target sequence, and a common reverse oligo sequence, containing the guide RNA scaffold region, were synthesized by Macrogen. The two oligo sequences were extended by phusion polymerase (Thermo Fisher Scientific, Thermo Scientific^TM^, catalog number: F530L) in a mixture containing 5X Phusion HF Buffer (F-518L, F-538L (Phusion Green), F-520L (Detergent-free)), 10 mM dNTPs, and distilled water. After template extension, the resulting DNAs were purified using an MG^TM^PCR sv kit (MGmed). The template DNAs were transcribed by T7 RNA polymerase (New England Biolabs, catalog number: M0251L) in a mixture containing 100 mM MgCl~2~, 100 nM NTPs, 10x T7 RNA buffer (New England Biolabs), DEPC-treated water, and 100U RNase inhibitor (New England Biolabs, catalog number: M0314L). After overnight incubation at 37 °C, DNA templates were destroyed with DNase I (RNase-free) (New England Biolabs, catalog number: M0303L) and the RNA products were purified with an RNeasy MinElute Cleanup Kit (QIAGEN, catalog number: 74204). Expression and purification of Cas9 protein {#Sec9} ------------------------------------------- Plasmid pET28a-SpCas9, for recombinant SpCas9 protein expression in *E*. *coli*, was provided by Prof. Jin-Soo Kim. Competant BL21-Pro cells (CP111, Ezynomics), transformed with pET28a-SpCas9, were grown to mid-log phase (OD~600~ nm \~0.4--0.5) in LB medium containing kanamycin at 37 °C with shaking at 200 rpm. Protein expression was induced with the addition of 0.8 mM IPTG, after which cells were incubated overnight at 18 °C with shaking at 200 rpm. Cell pellets were obtained by centrifugation at 4 °C (3,100 × g, 20 min). After cells were resuspended in lysis buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 10 mM imidazole), 2 mg/ml lysozyme and 1 mM PMSF were added. The lysate was incubated for 1 hour on ice and sonicated (amplitude 25%, 1 s ON/1 s OFF, pulse 30 times) eight times. The lysate was then cleared by centrifugation at 4 °C (18,000 × g, 30 min). The supernatant was filtered through a 0.45-um syringe filter and then incubated with Ni-NTA agarose for 1 h with rotation at 4 °C. The resin was then washed twice with wash buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 20 mM imidazole). The bound proteins were eluted with elution buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 250 mM imidazole). The eluted proteins were diluted with storage buffer (150 mM NaCl, 20 mM HEPES, 0.1 mM EDTA, 1 mM DTT, 2% sucrose, 20% glycerol). The concentration of the purified protein was determined on an SDS-PAGE gel (Supplementary Fig. [7](#MOESM1){ref-type="media"}). *In vitro* DNA cleavage using CRISPR-Cas9 {#Sec10} ----------------------------------------- 1 μg of SpCas9 protein and 0.35 μg of both sgRNA1 and sgRNA2 were pre-incubated for 5 minutes at room temperature, after which 1ug of pXY-Hyg-AAVS1 plasmid or ABE (7.10) plasmid, 3.1 NEB buffer, and DEPC water were added to the SpCas9--sgRNA complexes to the final volume 50 ul. The mixture was incubated at 37 °C for 4 hours to allow cleavage to take place. Products were mixed with loading dye containing SDS and analyzed on a 1.5% agarose gel. Gibson assembly {#Sec11} --------------- The cleaved backbone plasmid were prepared by *in vitro* cleavage using CRISPR-Cas9 and appropriate PCR product were amplified using PCR templates; pSpCas9(BB)-2A-Puro (PX459) was a gift from Feng Zhang (Addgene plasmid \# 48139; <http://n2t.net/addgene:48139>; RRID:Addgene_48139), MSP469 was a gift from Keith Joung (Addgene plasmid \# 65771; <http://n2t.net/addgene:65771>; RRID:Addgene_65771) and MSP1101 was a gift from Keith Joung (Addgene plasmid \# 65773; <http://n2t.net/addgene:65773>; RRID:Addgene_65773). The backbone plasmid and insert PCR product mixed in a volume of 10 μl containing 2U T5 exonuclease (New England Biolabs, catalog number: M0363S), 12.5U phusion DNA polymerase (Thermo Fisher Scientific, Thermo Scientific^TM^, catalog number: F530L), 2kU Taq DNA ligase (New England Biolabs, catalog number: M0208S), 0.2 M Tris-HCl (pH 7.5), 0.2 M MgCl~2~, 2 mM dNTP, 0.2 M dithiothreitol, PEG 8000, and 1 mM NAD and incubated at 50 °C for 1 hour. The products were then transformed into 100 μl of DH5α competent cells. Single transformed colonies were inoculated into LB medium containing antibiotics. DNA products were isolated from cells using a DNA prep kit (MGmed). Restriction enzyme cutting experiment {#Sec12} ------------------------------------- 300 ng of Plasmid DNA was incubated with 1 unit of KpnI (New England Biolabs, catalog number: R31452S) and StuI (Enzynomic, catalog number: R025S) at 37 °C for 1 hour. Cleavage products were loaded and analyzed on 1.2% agarose gel. Transfection of pXY-Hyg-AAVS1 and pXY-Puro-AAVS1 plasmids into HeLa cells and of ABE plasmids into HEK293T cells {#Sec13} ---------------------------------------------------------------------------------------------------------------- Both HeLa cells (ATCC^®^ CCL-2^™^) and HEK293T cells (ATCC^®^ CRL-3216™) were cultivated in DMEM medium and the cell density was estimated with a hemocytometer and microscope. 1 × 10^5^ of both cells per well were cultivated in 24-well plates over-night. 100 μl of Opti-MEM medium and 2 μl of lipofectamine 2000 were added to 1 μg of plasmid (pXY-Hyg-AAVS1 or pXY-Puro-AAVS1) or both 750 ng of ABE plasmid and 250 ng of sgRNA plasmid. Each mixture was incubated for 20 minutes at room temperature. After incubation, each mixture was added drop-wise to the corresponding cells. After 3 days, HEK293T cells were detached with 0.05% Trypsin-EDTA. And 1 μg/ml of puromycin was added to the cultivated HeLa cell medium. After puromycin was added, HeLa cells were treated by trypan blue (Sigma-Aldrich, catalog number: T8154). Images were captured after 5-minute incubation by a microscope with 40- and 100- fold magnifications. Targeted deep sequencing {#Sec14} ------------------------ HEK293T cells which were cultivated in 3 days were pelleted by centrifugation. The cell pellet was mixed with 100 μl of Proteinase K extraction buffer \[40 mM Tris-HCl (pH 8.0), 1% Tween-20, 0.2 mM EDTA, 10 mg of proteinase K, 0.2% nonidet P-40\] and incubated at 60 °C for 15 minutes followed by an incubation at 98 °C for 5 minutes. Genomic DNAs of the HEK293T cells were amplified using SUN-PCR blend (SUN GENETICS) and the resulting PCR products were analyzed using an Illumina Mini-Seq instrument. The results of Mini-seq were analyzed using BE-Analyzer (<http://www.rgenome.net/be-analyzer/>)^[@CR23]^. PCR primers used in this study are shown in Supplementary Table [4](#MOESM1){ref-type="media"}. Supplementary information ========================= {#Sec15} Supplementary Information **Publisher's note:** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. You Kyeong Jeong and Jihyeon Yu contributed equally. Supplementary information ========================= **Supplementary information** accompanies this paper at 10.1038/s41598-019-41356-1. This work was supported by National Research Foundation of Korea (NRF) Grants (no. 2018M3A9H3022412), Next Generation BioGreen 21 Program grant no. PJ01319301, Technology Innovation Program funded by the Ministry of Trade, Industry and Energy (no. 20000158), and Korea Healthcare technology R&D Project grant no. HI16C1012 to S.B. Y.K.J., J.Y. and S.B. designed this project. Y.K.J. and J.Y. performed the experiments and analyzed the data. S.B. supervised the research. Y.K.J., J.Y. and S.B. wrote the manuscript. Competing Interests {#FPar1} =================== The authors declare no competing interests.

\section{Introduction} Let $G$ be a bipartite graph with color classes $V$ and $F$. Nodes in $V$ are called variable nodes, nodes in $F$ are called factor nodes. Fix two integers $d,k\ge 2$. Assume that all the variable nodes have degree $d$, and all the factor nodes have degree $k$. Graphs satisfying the conditions above will be called $(d,k)$-biregular factor graphs. Let $h_0,h_1,\dots,h_k$ be a symmetric concave sequence, that is, \begin{align*} h_i&=h_{k-i} &\forall 0\le i\le k,\\ 2h_i&\ge h_{i-1}+h_{i+1} &\forall 1\le i\le k-1. \end{align*} We use the notations $h_i$ and $h(i)$ interchangeably. We define the Hamiltonian $H_G:\{0,1\}^V\to\mathbb{R}$ as follows. For $x\in \{0,1\}^V$, we set \[H_G(x)=\sum_{f\in F} h\left(\sum_{v\in \partial f} x_v\right).\] Here $\partial f$ denotes the set of neighbors of $f$. Given a non-negative real parameter $\beta$ called the \emph{inverse temperature}, we define the \emph{partition function} $Z_G(\beta)$ by \[Z_G(\beta)=\sum_{x\in \{0,1\}^V} \exp\left(-\beta H_G(x)\right).\] We also define the \emph{free energy density} $\Phi_G(\beta)$ as \[\Phi_G(\beta)=\frac{\log Z_G(\beta)}{|V|}.\] A sequence of finite graphs has large girth if the length of the shortest cycle tends to infinity. \begin{theorem}\label{TheoremFO} Let $G_1,G_2,\dots$ be a large girth sequence of $(d,k)$-biregular factor graphs. Then \[\lim_{n\to\infty}\Phi_{G_n}(\beta)=\Phi(\beta),\] where $\Phi(\beta)$ is specified below. \end{theorem} Using the same potentials as above, one can define the set of Gibbs measures $\mathcal{G}$ on the \break {$(d,k)$-biregular} infinite tree $\mathbb{T}$. Since $\mathbb{T}$ is a tree, all the extremal elements of $\mathcal{G}$ are Markov-chains. Thus, they can be described by an assignment of messages to each directed edge of $\mathbb{T}$ such that these messages form a BP-fixed point. We will be particularly interested in BP-fixed points that are symmetric in the sense that for all directed edges of $\mathbb{T}$ that are directed from variable nodes to factor nodes, the messages are all equal. Using the so called log-likelihood parametrization, we will see that these symmetric BP-fixed points correspond to the zeros of the function \begin{align*} F(\beta,t)&=-t+(d-1)\log\left(\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1}+it)}{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i}+it)}\right). \end{align*} See Subsection \ref{subsecT} for a more detailed explanation. The next lemma characterizes the zero set of $F$. \begin{lemma}\label{lemmafix} There is a $\beta_c\in (0,\infty]$, and a differentiable monotone increasing function \break $\mathfrak{g}:(\beta_c,\infty)\to \mathbb{R}_{>0}$ with $\lim_{\beta \to \beta_c} \mathfrak{g}(\beta)=0$, such that \begin{align*} \{(\beta,t)\in \mathbb{R}_{\ge 0}\times \mathbb{R}\quad |\quad F(\beta,t)=0\}=&\mathbb{R}_{\ge 0}\times \{0\}\\ &\cup\{(\beta,+\mathfrak{g}(\beta))\quad|\quad \beta\in(\beta_c,\infty)\}\\ &\cup\{(\beta,-\mathfrak{g}(\beta))\quad|\quad \beta\in(\beta_c,\infty)\}. \end{align*} \end{lemma} We extend the function $\mathfrak{g}$ by setting $\mathfrak{g}(\beta)=0$ for all $\beta\le \beta_c$. Note that the zero $(\beta,\mathfrak{g}(\beta))$ corresponds to the extremal Gibbs-measure $\mu_1$ with all $1$ boundary conditions. Similarly, the zero $(\beta,-\mathfrak{g}(\beta))$ corresponds to the extremal Gibbs-measure $\mu_0$ with all $0$ boundary conditions. In particular, they coincide if and only if $\beta\le \beta_c$. It will be crucial later that we have a first order phase transition, that is, $\mathfrak{g}$ is continuous at $\beta_c$. For $(\beta,t)$ such that $F(\beta,t)=0$, we define the Bethe-approximation \[\Phi(\beta,t)=- d\cdot t\cdot t_v +\frac{d}{k}\log \left(\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it)\right) -(d-1) H_2(t_v),\] where $H_2(x)=-x\log x-(1-x)\log(1-x)$, and \[t_v=\frac{\exp(\frac{d}{d-1}t)}{1+\exp(\frac{d}{d-1}t)}.\] \begin{theorem}\label{TheoremFO2} For the limiting constant in Theorem \ref{TheoremFO}, we have \[\Phi(\beta)=\Phi(\beta,\mathfrak{g}(\beta)).\] \end{theorem} We prove that $\limsup_{n\to\infty} \Phi_{G_n}(\beta)\le\Phi(\beta,\mathfrak{g}(\beta))$ by showing that \[\limsup_{n\to\infty} (\Phi_{G_n}(\beta))'\le(\Phi(\beta,\mathfrak{g}(\beta)))'\] for any $\beta\neq \beta_c$. For a $(d,k)$-biregular factor graph $G$ and a $\beta\ge 0$, we define the Gibbs probability measure $\mu_G^\beta$ on $\{0,1\}^V$ by setting \[\mu_G^\beta(x)=\frac{\exp(-\beta H_G(x))}{Z_G(\beta)}.\] Let $X\in \{0,1\}^V$ a random vector with law $\mu_G^\beta$, and let $a$ be a uniform random factor node independent from $X$. Then \begin{equation*} \Phi_G'(\beta)=\frac{d}{k}\mathbb{E}\left(-h\left(\sum_{i\in \partial a} X_i\right)\right), \end{equation*} where the expectation is over the random choice of $X$ and $a$. Taking an appropriate subsequential weak limit of the Gibbs measures $\mu_{G_n}^\beta$ one can obtain a Gibbs measure $\mu$ on the $(d,k)$-biregular infinite tree $\mathbb{T}$ with the following property. Let $a$ be a fixed variable node of $\mathbb{T}$, let $X\in \{0,1\}^V$ a random vector with law $\mu$, then \[\limsup_{n\to\infty} \Phi_{G_n}'(\beta)=\frac{d}{k}\mathbb{E}\left(-h\left(\sum_{i\in \partial a} X_i\right)\right),\] where the expectation over a random choice of $X$. The next lemma is a crucial ingredient of the proof. \begin{lemma}\label{lemma4} For a fixed $\beta$, let $\mu$ be a Gibbs measure on $\mathbb{T}$. Fix a factor node $a$. Let $X$ be a random element of $\{0,1\}^V$ with law $\mu$. Let $X^{(1)}$ and $X^{(0)}$ be random elements of $\{0,1\}^V$ with law $\mu_1$ and $\mu_0$. Then \[\mathbb{E} h\left(\sum_{i\in\partial a} X_i\right) \ge \mathbb{E}h\left(\sum_{i\in\partial a} X_i^{(1)}\right)=\mathbb{E}h\left(\sum_{i\in\partial a} X_i^{(0)}\right).\] In other words, among all Gibbs-measures, the local expected energy at a factor node is minimized by the Gibbs-measure with all $1$ or all $0$ boundary conditions. \end{lemma} We will later see that \[\frac{d}{k}\mathbb{E}h\left(\sum_{i\in\partial a} X_i^{(1)}\right)=-(\Phi(\beta,\mathfrak{g}(\beta)))'.\] Thus, putting everything together, we get the desired inequality \[\limsup_{n\to\infty} (\Phi_{G_n}(\beta))'\le(\Phi(\beta,\mathfrak{g}(\beta)))'\] for any $\beta\neq \beta_c$. See Section \ref{putt} for more details. This method that we use to obtain an upper bound on the asymptotic free energy density is called interpolation scheme. This method has been applied by Dembo, Montanari, Sun~\cite{dembo2013factor} and Sly, Sun \cite{sly2014counting} to obtain similar results. To prove that $\liminf_{n\to\infty} \Phi_{G_n}(\beta)\ge\Phi(\beta,\mathfrak{g}(\beta))$, we will use an inequality of Ruozzi \cite{ruozzi2012bethe}. In fact this inequality provides us the even stronger statement that $\Phi_{G_n}(\beta)\ge\Phi(\beta,\mathfrak{g}(\beta))$ for all $n$. \textbf{The structure of the paper.} In Section \ref{sec2}, we recall the notion of BP fixed points and their relation to extremal Gibbs-measures. We calculate the derivative of the Bethe-approximation with respect to the inverse temperature. We also state a few well-known correlation inequalities. In Section \ref{sec3}, we characterize the zero set of $F$. In Section \ref{sec4}, we prove Lemma \ref{lemma4}. Finally, Section~\ref{putt} contains the proof of Theorem \ref{TheoremFO} and Theorem \ref{TheoremFO2}. \textbf{Acknowledgements.} The author is grateful to P\'eter Csikv\'ari and Mikl\'os Ab\'ert for their comments. The author was partially supported by the ERC Consolidator Grant 648017. \section{Preliminaries}\label{sec2} \subsection{BP fixed point on finite trees} For a more detailed introduction to belief propagation, we refer the reader to Chapter 14 of the book by M\'ezard and Montanari \cite{mezard2009information}. We also try to follow their notations in this subsection. For our limited purposes in this subsection, a factor graph will mean a triple $(G,V,F)$, where $G$ is a finite bipartite graph, $(V,F)$ is a proper two coloring of the nodes of $G$, moreover, we also assume that each vertex in $F$ has degree $k$. As before, nodes in $V$ are called variable nodes, and nodes in $F$ are called factor nodes. Given a factor node $a$ and $x_{\partial a}\in \{0,1\}^{\partial a}$, we define \[\psi_a(x_{\partial a})=\exp\left(-\beta h\left(\sum_{i\in \partial a} x_i\right) \right),\] where $\beta\ge 0$ is a fixed parameter. With each factor graph $(G,V,F)$, we associate a random vector $x\in \{0,1\}^V$, by setting \[p(x)=\frac{1}{Z} \prod_{a\in F} \psi_a(x_{\partial a})\] for all $x\in \{0,1\}^V$. Here $Z$ is an appropriate normalizing constant. Let $ai$ be an edge of $G$ such that $a\in F$ and $i\in V$. We define $\left(\nu_{i\to a}(x_i)\right)_{x_i\in \{0,1\}}$, as the marginal of $x_i$ in the random vector corresponding to the factor graph obtained from $G$ by deleting the factor node $a$. We define $\left(\hat{\nu}_{a\to i}(x_i)\right)_{x_i\in \{0,1\}}$, as the marginal of $x_i$ in the random vector corresponding to the factor graph obtained from $G$ by deleting factor nodes in $\partial i\backslash a$. For the proof of the next lemma, see for example \cite[Theorem 14.1]{mezard2009information}. \begin{lemma} \label{lemmameseq} If $G$ is a forest, then the messages $\nu_{i\to a}(x_i)$ and $\hat{\nu}_{i\to a}(x_i)$ are uniquely determined by the following equations. For each edge $ai$ of $G$ such that $a\in F$ and $i\in V$, and $x_i\in \{0,1\}$, we have \begin{align*} \nu_{i\to a}(x_i)&=\frac{\prod_{b\in \partial i\backslash a} \hat{\nu}_{b\to i}(x_i)}{\sum_{y_i}\prod_{b\in \partial i\backslash a} \hat{\nu}_{b\to i}(y_i)},\\ \hat{\nu}_{a\to i}(x_i)&=\frac{\sum_{x_{\partial a\backslash i}} \psi_a(x_{\partial a})\prod_{j\in \partial a\backslash i} {\nu}_{j\to a}(x_i)}{\sum_{y_{\partial a}} \psi_a(y_{\partial a})\prod_{j\in \partial a\backslash i} {\nu}_{j\to a}(y_i)}. \end{align*} \end{lemma} Let $F_R$ be a subset of function nodes, $V_R$ be the subset of variable nodes adjacent to $F_R$, and $R=F_R\cup V_R$. Assume that the subgraph of $G$ induced by $R$ is a connected. Then we have the following formula for the marginal $x_{V_R}$, provided that $G$ is a forest. \begin{equation}\label{eqmarg} p(x_{V_R})=\frac{1}{Z}\prod_{a\in F_R} \psi_a(x_{\partial a}) \prod_{a\in \partial R} \hat{\nu}_{a\to i(a)}(x_{i(a)}), \end{equation} where $i(a)$ is the unique neighbor of $a$ in $V_R$. For a proof, see \cite[Section 14.2.3]{mezard2009information}. It will be more convenient to use the so called log-likelihood ratio to parametrize the messages. That is, let \[u_{i\to a}=\log\frac{\nu_{i\to a}(1)}{\nu_{i\to a}(0)}\quad\text{ and }\quad\hat{u}_{a\to i}=\log\frac{\hat{\nu}_{a\to i}(1)}{\hat{\nu}_{a\to i}(0)}.\] With these notations, the equations in Lemma \ref{lemmameseq} become \begin{align} u_{i\to a}&=\sum_{b\in \partial i\backslash a} \hat{u}_{b\to i},\label{ueq1}\\ \hat{u}_{a\to i}&=\log\frac{\sum_{x_{\partial a}, x_i=1 } \psi_a(x_{\partial_a}) \exp\left(\sum_{j\in \partial a\backslash i} x_j u_{j\to a}\right)}{\sum_{x_{\partial a}, x_i=0 } \psi_a(x_{\partial_a}) \exp\left(\sum_{j\in \partial a\backslash i} x_j u_{j\to a}\right)}\label{ueq2}. \end{align} Moreover, Equation \eqref{eqmarg} becomes \[p(x_R)=\frac{1}{Z}\prod_{a\in F_R} \psi_a(x_{\partial a}) \exp\left(\sum_{a\in \partial R} x_{i(a)}\hat{u}_{a\to i(a)}\right).\] Note that the normalizing constant $Z$ can be different from the constant in Equation \eqref{eqmarg}. \subsection{BP fixed points on the $(d,k)$-biregular infinite tree}\label{subsecT} Let $\mathbb{T}$ be an infinite connected tree with a proper two coloring $(V,F)$, such that the nodes in $V$ have degree $d$, and the nodes in $F$ have degree $k$. We call $\mathbb{T}$ the $(d,k)$-biregular infinite tree. To each edge $ai$ of $\mathbb{T}$ with $a\in F$ and $i\in V$, we assign two real numbers $u_{i\to a}$ and $\hat{u}_{a\to i}$. We say the these numbers from a BP fixed point, if they satisfy Equation \eqref{ueq1} and Equation \eqref{ueq2} for all edges. We will be particularly interested in BP fixed points such that for all edges, we have $u_{i\to a} =t$ for a given $t$. Such a fixed point exists, if and only if \begin{equation}\label{BPfixedpointEq} t=(d-1)\log \frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}}\exp(-\beta h_{i+1}+ti)}{\sum_{i=0}^{k-1} {{k-1}\choose{i}}\exp(-\beta h_{i}+ti)}. \end{equation} This motivates the definition of the function $F(\beta,t)$ in the Introduction. Now, we shall discuss the analogue of Equation \eqref{eqmarg}. To do this, we need the notion of Gibbs measures. Let $\mu$ be a measure on $\{0,1\}^V$. We say that $\mu$ is a Gibbs measure, if it satisfies the following property for every finite subset $V_R$ of $V$. Let $F_R$ be the set of function nodes that has a neighbor in $V_R$, let $R=V_R\cup F_R$. Note that $\partial R\subset V$. Let $X$ be a random element of $\{0,1\}^V$ with law $\mu$. Then for all $x_{\partial R}\in \{0,1\}^{\partial R}$ and $x_{V_R}\in \{0,1\}^{V_R}$, we have \[\mathbb{P}(X_{V_R}=x_{V_R}|X_{\partial R}=x_{\partial R})=\frac{1}{Z} \prod_{a\in R_F} \psi_a(x_{\partial a}),\] where $Z$ only depends on $x_{\partial R}$, but not on $x_{V_R}$. A Gibbs measure is called extremal if it can not be written as a non-trivial convex combination of two different Gibbs measures. \begin{lemma}\label{lemma5} Let $\mu$ be an extremal Gibbs measure. Then there is a BP fixed point $(u_{i\to a}),(\hat{u}_{a\to i})$ with the following property. Let $F_R$ be a finite subset of function nodes, $V_R$ be the subset of variable nodes adjacent to $F_R$, and $R=F_R\cup V_R$. Assume that the subgraph of $G$ induced by $R$ is a connected. Let $X$ be a random element of $\{0,1\}^V$ with law $\mu$, then for any $x_{V_R}\in \{0,1\}^{V_R}$, we have \[\mathbb{P}(X_{V_R}=x_{V_R})=\frac{1}{Z}\prod_{a\in F_R} \psi_a(x_{\partial a}) \exp\left(\sum_{a\in \partial R} x_{i(a)}\hat{u}_{a\to i(a)}\right),\] where $Z$ only depend on the choice of $V_R$. \end{lemma} For pairwise models this was proved by Zachary \cite{zachary1983countable}. Since our setting is slightly different, we provide a proof in the appendix, although the original proof can be repeated almost word by word. \subsection{Bethe-approximation}\label{subsecbethe} Let $G$ be a finite $(d,k)$-biregular factor graph. For $i\in V$, let $\tau_i$ be a probability distribution on $\{0,1\}$. For $a\in F$, let $\tau_a$ be a probability distribution on $\{0,1\}^{\partial a}$. We say that $\tau=\left((\tau_i)_{i\in V},(\tau_a)_{a\in F}\right)$ is in the local marginal polytope $\mathcal{T}$, if for all $i\in V$ and $a\in V$ such that $ai$ is an edge of $G$, we have \[\tau_i(x_i)=\sum_{x_{\partial a\backslash i}} \tau_a(x_{\partial a}).\] For an element $\tau\in \mathcal{T}$, we define the Bethe approximation at inverse temperature $\beta$ as \begin{align*} \Phi_G(\beta,\tau)=&\frac{1}{|V|}\Bigg(-\beta \sum_{a\in F} \sum_{x_{\partial a}} \tau_a(x_{\partial a}) h\left(\sum_{i\in \partial a} x_i\right)\\&-\sum_{a\in F}\sum_{x_{\partial a}}\tau_a(x_{\partial a})\log \tau_a(x_{\partial a}) +(d-1)\sum_{i\in V}\sum_{x_i}\tau_i(x_i)\log \tau_i(x_i)\Bigg) . \end{align*} Let $t=t(\beta)$ be a solution of Equation \eqref{BPfixedpointEq}. With the help of this, we will construct an element $\tau=\tau^{(\beta)}$ of $\mathcal{T}$. For any $a\in F$, we set \[\tau_a(x_{\partial a})=\frac{1}{Z} \exp\left(-\beta h\left(\sum_{i\in \partial a} x_i\right)+t\sum_{i\in \partial a} x_i\right ),\] where \[Z=\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it).\] Let \[t_v=\frac{\exp(\frac{d}{d-1}t)}{1+\exp(\frac{d}{d-1}t)}.\] For $i\in V$, we set \begin{align*} \tau_i(0)&=1-t_v,\\ \tau_i(1)&=t_v. \end{align*} Then $\tau$ is indeed an element of $\mathcal{T}$. To see this, let $a\in F$, $j\in \partial a$, and set $x_j=1$. Then \begin{align*} \sum_{x_{\partial a\backslash j}} \tau_a(x_a)&=\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1} +(i+1)t)}{\sum_{i=0}^{k} {{k}\choose{i}} \exp(-\beta h_{i} +it)}\\&=\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1} +(i+1)t)}{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1} +(i+1)t)+\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i} +it)}\\&=\left(1+\exp(-t)\left( \frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1} +it)}{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i} +it)}\right)^{-1}\right)^{-1} \\&=\left(1+\exp(-t)\exp\left(-\frac{t}{d-1}\right)\right)^{-1}=t_v=\tau_j(1). \end{align*} With this choices of $\tau=\tau^{(\beta)}$, we have \begin{align*} {\Phi_G(\beta,\tau)}=&- \frac{d}{k} \frac{\sum_{i=0}^k {{k}\choose{i}} it(\beta)\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))}+\frac{d}{k}\log \sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))\\& -(d-1) H_2(t_v(\beta)) \end{align*} where $H_2(x)=-x\log x-(1-x)\log(1-x)$. Note that \begin{align*} &\frac{\sum_{i=0}^k {{k}\choose{i}} i\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))} \\&=k\exp(t(\beta))\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1}+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta)) \\&=k\exp(t(\beta))\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1}+it(\beta))}{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_i+it(\beta))+\exp(t(\beta))\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1}+it(\beta))} \\&=k\exp(t(\beta))\left(\exp(t(\beta))+\left(\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1}+it(\beta))}{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_i+it(\beta))}\right)^{-1}\right)^{-1} \\&=\frac{k\exp(t(\beta))}{\exp(t(\beta))+\exp(-\frac{t(\beta)}{d-1})}=k\frac{\exp(\frac{d}{d-1}t(\beta))}{1+\exp(\frac{d}{d-1}t(\beta))}\\&=kt_v. \end{align*} Thus, \begin{align*} {\Phi_G(\beta,\tau)}=&- d t(\beta)t_v(\beta) +\frac{d}{k}\log \sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))\\& -(d-1) H_2(t_v(\beta)) \end{align*} Note that ${\Phi_G(\beta,\tau)}$ only depends on $t$, but not on the graph $G$. Thus we introduce the notation \begin{align*}\Phi(\beta,t(\beta))&=- d t(\beta)t_v(\beta) +\frac{d}{k}\log \sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))\\& -(d-1) H_2(t_v(\beta)). \end{align*} Assume that for each $\beta$, we have a solution $t(\beta)$ of Equation \eqref{BPfixedpointEq}. Fix a $\beta$ such that derivative $t'(\beta)$ exists. In the rest of this subsection, our aim is to give a formula for $\partial_\beta \Phi(\beta,t(\beta))$. Now \begin{align*} \partial_\beta &\frac{d}{k}\log \sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))\\&= \frac{d}{k}\frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))}+t'(\beta)\frac{d}{k}\frac{\sum_{i=0}^k {{k}\choose{i}} it(\beta)\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))}\\&=\frac{d}{k}\frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))}+dt'(\beta)t_v(\beta), \end{align*} Note that $H_2'(x)=-\log\frac{x}{1-x}$. Thus \[H_2(t_v(\beta))'=-\log\frac{t_v}{1-t_v} t_v'(\beta)\] Differentiating, we get \begin{align*} \partial_\beta &\Phi(\beta,t(\beta))\\&=\frac{d}{k}\frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))}+t_v'(\beta)((d-1)\log\frac{t_v(\beta)}{1-t_v(\beta)}-dt(\beta))\\&=\frac{d}{k}\frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))}. \end{align*} From this, one can easily obtain the following theorem \begin{lemma}\label{interpol} Assume that for each $\beta$, we have a solution $t(\beta)$ of Equation \eqref{BPfixedpointEq}. Furthermore, assume that $t(\beta)$ is continuous and differentiable at all but finitely many points. Then for any $\beta_1\ge 0$, we have \[\Phi(\beta_1,t(\beta_1))-\Phi(0,t(0))=\frac{d}{k}\int_0^{\beta_1} \frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+it(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+it(\beta))} d\beta.\] \end{lemma} \subsection{Correlation inequalities} \begin{lemma}\label{FKG} Let $X$ be a finite set, and let $\nu:X\to\mathbb{R}_{\ge 0}$ and $f,g:X\to \mathbb{R}$. Assume that for any $x,y\in X$, we have \[f(x)\le f(y) \Rightarrow g(x)\le g(y).\] Then \[\left(\sum_{x\in X} \nu(x)f(x)\right)\left(\sum_{x\in X} \nu(x)g(x)\right)\le \left(\sum_{x\in X} \nu(x)\right)\left(\sum_{x\in X} \nu(x)f(x)g(x)\right).\] Also, if for any $x,y\in X$, we have \[f(x)\le f(y) \Rightarrow g(x)\ge g(y).\] Then \[\left(\sum_{x\in X} \nu(x)f(x)\right)\left(\sum_{x\in X} \nu(x)g(x)\right)\ge \left(\sum_{x\in X} \nu(x)\right)\left(\sum_{x\in X} \nu(x)f(x)g(x)\right).\] \end{lemma} \begin{proof} Consider a total ordering $\le$ of $X$ such that $x\le y$ implies $f(x)\le f(y)$. Then, since every totally ordered set forms a distributive lattice, we can apply the FKG inequality \cite{fortuin1971correlation}, to get the statement. \end{proof} We also need the following consequence. \begin{lemma}\label{FKG2} Let $X$ be a finite set, and let $\nu,f,g:X\to\mathbb{R}_{\ge 0}$ and $K:X\to \mathbb{R}$. Assume that for any $x,y\in X$, we have \[K(x)\le K(y) \Rightarrow \frac{f(x)}{g(x)}\le \frac{f(y)}{g(y)}.\] Then \[\left(\sum_{x\in X} \nu(x)f(x)\right)\left(\sum_{x\in X} \nu(x)g(x) K(x)\right)\le \left(\sum_{x\in X} \nu(x)g(x)\right)\left(\sum_{x\in X} \nu(x)f(x)K(x)\right).\] Also, if for any $x,y\in X$, we have \[K(x)\le K(y) \Rightarrow \frac{f(x)}{g(x)}\ge \frac{f(y)}{g(y)}.\] Then \[\left(\sum_{x\in X} \nu(x)f(x)\right)\left(\sum_{x\in X} \nu(x)g(x) K(x)\right)\ge \left(\sum_{x\in X} \nu(x)g(x)\right)\left(\sum_{x\in X} \nu(x)f(x)K(x)\right).\] \end{lemma} \begin{proof} Apply the previous lemma for $\nu\cdot g$, $\frac{f}{g}$, $K$. \end{proof} For $v,w\in \{0,1\}^k$, we define $v\vee w,v\wedge w\in \{0,1\}^k$ as their component wise maximum and minimum, respectively. A function $f:\{0,1\}^k\to \mathbb{R}_{\ge 0}$ is called log-supermodular, if for all $v,w\in \{0,1\}^k$, we have \[f(v)f(w)\le f(v\vee w)f(v\wedge w).\] We will need the following consequence of the so called Four Function Theorem \cite{ahlswede1978inequality}. \begin{lemma}\label{lsmmarg} Let $f:\{0,1\}^k\to \mathbb{R}_{\ge 0}$ be a log-supermodular function. Then $f$ has log-supermodular marginals. In other words, let $\ell<k$, and define $g:\{0,1\}^\ell\to \mathbb{R}_{\ge 0}$ as \[g(v_1,v_2,\dots,v_\ell)=\sum_{(v_{\ell+1},v_{\ell+2},\dots,v_k)\in \{0,1\}^{k-\ell}} f(v_1,v_2,\dots,v_k).\] Then $g$ is log-supermodular. \end{lemma} \section{The proof of Lemma \ref{lemmafix}}\label{sec3} For $v=(v_1,v_2,\dots,v_k)\in \{0,1\}^k$, we define \[|v|=\sum_{i=1}^k v_i,\] and \[H(v)=h_{|v|}.\] For $v=(v_1,v_2,\dots,v_{k-1})\in \{0,1\}^{k-1}$, the vectors $(v_1,v_2,\dots,v_{k-1},0)$ and $(v_1,v_2,\dots,v_{k-1},1)$ are denoted by $v0$ and $v1$, respectively. Observe that \begin{align*} F(\beta,t)&=-t+(d-1)\log\left(\frac{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i+1}+it)}{\sum_{i=0}^{k-1} {{k-1}\choose{i}} \exp(-\beta h_{i}+it)}\right) \\&=-t+(d-1)\log \left(\frac{\sum_{v\in \{0,1\}^{k-1}} \exp\left(-\beta H(v1)+|v|t\right)}{\sum_{v\in \{0,1\}^{k-1}} \exp\left(-\beta H(v0)+|v|t\right)}\right) \end{align*} By the symmetry of the sequence $h_0,h_1,\dots, h_k$, we have \[F(\beta,-t)=-F(\beta,t).\] From the observation that $F(\beta,-t)=-F(\beta,t)$, it is straightforward to see that $F(\beta,0)=0$ for any $\beta$. It also shows that we can restrict our attention to the case $t>0$. \begin{lemma}\label{lemmaconcave} For any fixed $\beta\ge 0$, the function $t\mapsto F(\beta,t)$ is concave on $\mathbb{R}_{\ge 0}$. \end{lemma} \begin{proof} Let us introduce the function \begin{align*} F_2(t_1,t_2,\dots, t_{k-1})=-\frac{1}{k-1}\sum_{i=1}^{k-1} t_i&+(d-1)\log\left(\sum_{v\in \{0,1\}^{k-1}} \exp\left(-\beta H(v1)+\sum_{i=1}^{k-1}v_i t_i\right)\right)\\&-(d-1)\log\left(\sum_{v\in \{0,1\}^{k-1}} \exp\left(-\beta H(v0)+\sum_{i=1}^{k-1}v_i t_i\right)\right) \end{align*} We claim that if $t_1=t_2=\dots=t_{k-1}=t$, then $\partial_{t_{k-1}}^2 F_2(t_1,t_2,\dots,t_{k-1})\le 0$. First, let us define \begin{align*} A&=A(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v11)+\sum_{i=1}^{k-2} v_i t_i\right)\\ B&=B(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v01)+\sum_{i=1}^{k-2} v_i t_i\right)\\ C&=C(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v10)+\sum_{i=1}^{k-2} v_i t_i\right)\\ D&=D(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v00)+\sum_{i=1}^{k-2} v_i t_i\right) \end{align*} It is straightforward from the definition of $H$ that we have $B=C$. With these notations, we have \[F_2(t_1,t_2,\dots, t_{k-1})=-\frac{1}{k-1}\sum_{i=1}^{k-1} t_i+(d-1)\log\left(A\exp(t_{k-1})+B\right)-(d-1)\log\left(C\exp(t_{k-1})+D\right).\] Thus, a direct computation gives us that \[\partial_{t_{k-1}}^2 F_2(t_1,t_2,\dots,t_{k-1})=\frac{(d-1)\exp(t_{k-1})(BC-AD)(AC\exp (2t_{k-1})-BD)}{\left(A\exp(t_{k-1})+B\right)^2 \left(C\exp(t_{k-1})+D\right)^2}.\] We define the function $f$ on $\{0,1\}^k$ as \[f(v)=\exp\left(-\beta H(v)+\sum_{i=1}^{k-2} v_i t_i\right).\] Since $f$ is logsupermodular, it has logsupermodular marginals by Lemma \ref{lsmmarg}, in particular, \[BC\le AD.\] \begin{lemma} If $(t_1,t_2,\dots,t_{k-2})\in \mathbb{R}_{\ge 0}^{k-2}$, then \[A\ge D.\] \end{lemma} \begin{proof} Let us consider the function \[R(t_1,t_2,\dots,t_{k-2})=\log A(t_1,t_2,\dots,t_{k-2})-\log D(t_1,t_2,\dots,t_{k-2}).\] From the symmetry of the sequence $h_0,h_1,\dots,h_k$, we see that $R(0)=0$. Thus, the statement will follow, once we prove that all the partial derivatives of $R$ are non-negative on $\mathbb{R}_{\ge 0}^{k-1}$. For simplicity of notation, we will show this for $\partial_{t_{k-2}} R$. First, let us define \begin{align*} A^\sharp &=A^\sharp(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-3}} \exp\left(-\beta H(v111)+\sum_{i=1}^{k-3} v_i t_i\right)\\ B^\sharp &=B^\sharp(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-3}} \exp\left(-\beta H(v011)+\sum_{i=1}^{k-3} v_i t_i\right)\\ C^\sharp &=C^\sharp(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-3}} \exp\left(-\beta H(v100)+\sum_{i=1}^{k-3} v_i t_i\right)\\ D^\sharp &=D^\sharp(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-3}} \exp\left(-\beta H(v000)+\sum_{i=1}^{k-3} v_i t_i\right) \end{align*} Then, we have \[R=\log\left(A^\sharp\exp(t_{k-2})+B^\sharp\right)-\log\left(C^\sharp\exp(t_{k-2})+D^\sharp\right),\] and \[\partial_{t_{k-2}} R=\frac{\exp(t_{k-2})(A^\sharp D^\sharp-B^\sharp C^\sharp)}{(A^\sharp\exp(t_{k-2})+B^\sharp)(C^\sharp\exp(t_{k-2})+D^\sharp)}\ge 0,\] since the inequality $A^\sharp D^\sharp \ge B^\sharp C^\sharp$ can be proved like above. \end{proof} Combining the lemma above with the facts $B=C$ and $t_{k-2}>0$, we have \[AC\exp(2t_{k-1})-BD\ge DC-BD=0.\] Therefore, \[\partial_{t_{k-1}}^2 F_2(t_1,t_2,\dots,t_{k-1})=\frac{(d-1)\exp(t_{k-1})(BC-AD)(AC\exp(2t_{k-1})-BD))}{\left(A\exp(t_{k-1})+B\right)^2 \left(C\exp(t_{k-1})+D\right)^2}\le 0.\] By symmetry, we have $\partial_{t_{i}}^2 F_2(t_1,t_2,\dots,t_{k-1})\le 0$ for any $1\le i\le k-1$. In particular, $\partial_{t_{i}} F_2(t_1,t_2,\dots,t_{k-1}) $ monotone decreasing. By the chain rule, we have \[\partial_t F(\beta,t)=\sum_{i=1}^{k-1} \partial_{t_i} F_2(t,t,\dots,t)\] is monotone decreasing. This concludes the proof of Lemma \ref{lemmaconcave} \end{proof} \begin{lemma}\label{betacexists} For any fixed $\beta\ge 0$, the function $t\mapsto F(\beta,t)$ has a unique positive zero, if and only if $\partial_t F(\beta,0)>0$. If $\partial_t F(\beta,0)\le 0$, then $t\mapsto F(\beta,t)$ has no positive zero. \end{lemma} \begin{proof} Observe that $F(\beta,0)=0$ and \[\lim_{t\to \infty} F(\beta,t)=-\infty.\] The statement follows by combining these observation with Lemma \ref{lemmaconcave}. \end{proof} \begin{lemma}\label{difft} Consider a $\beta\ge 0$ such that $\partial_t F(\beta,0)>0$. Let $t^+$ be the unique positive zero of $t\mapsto F(\beta,t)$. Then $\partial_t F(\beta,t^+)<0$. \end{lemma} \begin{proof} Let $f(t)=F(\beta,t)$. Since $f(0)=f(t^+)=0$ and $f'(0)>0$, we have a local maximum point $t_0$ of $f$ in the interval $(0,t)$. Then $f'(t_0)=0$ and $f(t_0)>f(t^+)$. By Lemma \ref{lemmaconcave}, $f$ is concave on $[0,\infty)$. It follows that $f'(t^+)<0$. \end{proof} \begin{lemma}\label{monotonbeta} The function $\beta\mapsto \partial_t F(\beta,0)$ is monotone increasing. \end{lemma} \begin{proof} By the symmetry of the sequence $h_0,h_1,\dots,h_k$, we have \[\sum_{v\in \{0,1\}^{k-1}} \exp(-\beta H(v1))=\sum_{v\in \{0,1\}^{k-1}} \exp(-\beta H(v0))=\frac{1}{2}\sum_{v\in \{0,1\}^{k}} \exp(-\beta H(v)).\] By differentiating, we see that \begin{align*} \partial_t F(\beta,0)=-1+(d-1)\left(\frac{\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v1))}{\sum_{v\in \{0,1\}^{k-1}} \exp(-\beta H(v1))}-\frac{\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v0))}{\sum_{v\in \{0,1\}^{k-1}} \exp(-\beta H(v0))}\right). \end{align*} Here we have \begin{align*} &\frac{\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v1))}{\sum_{v\in \{0,1\}^{k-1}} \exp(-\beta H(v1))}-\frac{\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v0))}{\sum_{v\in \{0,1\}^{k-1}} \exp(-\beta H(v0))}\\ &\qquad= \frac{\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v1))-\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v0))}{\frac{1}{2}\sum_{v\in \{0,1\}^{k}} \exp(-\beta H(v))}. \end{align*} We set \[\gamma=\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v1))-\sum_{v\in \{0,1\}^{k-1}} |v|\exp(-\beta H(v0)).\] Note that \[\gamma=\sum_{\substack{v\in \{0,1\}^{k}\\v_k=1}} (|v|-1)\exp(-\beta H(v))-\sum_{\substack{v\in \{0,1\}^{k}\\v_k=0}} |v|\exp(-\beta H(v)).\] By symmetry, we have \begin{align*} k\gamma &=\sum_{i=1}^k\left(\sum_{\substack{v\in \{0,1\}^{k}\\v_i=1}} (|v|-1)\exp(-\beta H(v))-\sum_{\substack{v\in \{0,1\}^{k}\\v_i=0}} |v|\exp(-\beta H(v))\right)\\ &=\sum_{v\in \{0,1\}^k} \left(|v|(|v|-1)-(k-|v|)|v|\right) \exp(-\beta H(v))\\ &=\sum_{v\in \{0,1\}^k} \left(2\left(|v|-\frac{k}{2}\right)^2 -\frac{k^2}{2}+(k-1)|v|\right) \exp(-\beta H(v)). \end{align*} For $v=(v_1,v_2,\dots,v_{k})\in \{0,1\}^{k}$, we set $\bar{v}=(1-v_1,1-v_2,\dots,1-v_{k})\in \{0,1\}^{k}$. Now we have \begin{align*} \sum_{v\in \{0,1\}^k} |v|\exp(-\beta H(v))&=\frac{1}{2} \sum_{v\in \{0,1\}^k} (|v|\exp(-\beta H(v))+|\bar{v}|\exp(-\beta H(\bar{v}))\\&=\frac{1}{2} \sum_{v\in \{0,1\}^k} (|v|+|\bar{v}|)\exp(-\beta H(v))\\&=\frac{k}{2}\sum_{v\in \{0,1\}^k} \exp(-\beta H(v)). \end{align*} Therefore, \[k\gamma=\sum_{v\in \{0,1\}^k} \left(2\left(|v|-\frac{k}{2}\right)^2 -\frac{k}{2}\right) \exp(-\beta H(v)).\] We set $f(v)=2\left(|v|-\frac{k}{2}\right)^2 -\frac{k}{2}$. Now we have, \[\partial_t F(\beta,0)=-1+\frac{2(d-1)}{k}\cdot\frac{\sum_{v\in \{0,1\}^k} f(v)\exp(-\beta H(v))}{\sum_{v\in \{0,1\}^k} \exp(-\beta H(v))}.\] Taking derivative with respect to $\beta$, we have \begin{align*} \partial_\beta \partial_t F(\beta,0)&=\frac{2(d-1)}{k} \cdot \frac{\left(\sum_{v\in \{0,1\}^k} f(v)\exp(-\beta H(v))\right)\left(\sum_{v\in \{0,1\}^k} H(v)\exp(-\beta H(v))\right)}{\left(\sum_{v\in \{0,1\}^k} \exp(-\beta H(v))\right)^2}\\&\qquad-\frac{2(d-1)}{k} \cdot\frac{\left(\sum_{v\in \{0,1\}^k} H(v)f(v)\exp(-\beta H(v))\right)\left(\sum_{v\in \{0,1\}^k} \exp(-\beta H(v))\right)}{\left(\sum_{v\in \{0,1\}^k} \exp(-\beta H(v))\right)^2}\\&\ge 0, \end{align*} by Lemma \ref{FKG}. \end{proof} \begin{lemma}\label{diffbeta} Let $t>0$. For $\beta\ge 0$, we have $\partial_\beta F(\beta,t) \ge 0$ \end{lemma} \begin{proof} We have \[\sum_{v\in \{0,1\}^{k-1} } \exp(-H(v1)+|v|t)=\exp(-t)\sum_{\substack{v\in \{0,1\}^{k}\\ v_k=1} } \exp(-H(v)+|v|t).\] By symmetry, we have \begin{align*} k\sum_{v\in \{0,1\}^{k-1} } &\exp(-\beta H(v1)+|v|t)\\&=\exp(-t)\sum_{i=1}^k \sum_{\substack{v\in \{0,1\}^{k}\\ v_i=1} } \exp(-\beta H(v)+|v|t)\\ &=\exp(-t) \sum_{v\in \{0,1\}^{k} } |v|\exp(-\beta H(v)+|v|t)\\ &=\frac{1}{2}\exp(-t) \sum_{v\in \{0,1\}^{k} } \left(|v|\exp(-\beta H(v)+|v|t) +|\bar{v}|\exp(-\beta H(\bar{v})+|\bar{v}|t) \right)\\ &=\frac{1}{2}\exp(-t) \sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))\left(|v|\exp(|v|t) +(k-|v|)\exp((k-|v|)t) \right). \end{align*} Similarly, \begin{multline*} k\sum_{v\in \{0,1\}^{k-1} } \exp(-\beta H(v0)+|v|t)\\=\frac{1}{2} \sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))\left((k-|v|)\exp(|v|t) +|v|\exp((k-|v|)t) \right). \end{multline*} Let us introduce the notations, \begin{align*} f(s)&=s\exp(st) +(k-s)\exp((k-s)t),\\ g(s)&=(k-s)\exp(st) +s\exp((k-s)t). \end{align*} \begin{lemma}\label{fperg} We have \[\frac{f(s)}{g(s)}=\frac{f(k-s)}{g(k-s)}.\] If $t>0$, then the function $s\mapsto \frac{f(s)}{g(s)}$ is monotone decreasing on the interval $(-\infty,\frac{k}2]$, and monotone decreasing on the interval $[\frac{k}2,\infty)$. \end{lemma} \begin{proof} It follows by the examination of the derivative \[\partial_s \frac{f(s)}{g(s)}=-\frac{2k\exp(kt)\left(t(k-2s)+\sinh(t(k-2s))\right)}{\left((k-s)\exp(st) +s\exp((k-s)t)\right)^2}.\] \end{proof} We have \begin{align*} \partial_\beta &F(\beta,t)\\&=(d-1)\partial_\beta \log\frac{\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))f(|v|)}{\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))g(|v|)}\\&=(d-1)\frac{\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))f(|v|)\right)\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))g(|v|)H(|v|)\right)}{\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))f(|v|)\right)\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))g(|v|)\right)}\\ &\qquad -(d-1)\frac{\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))f(|v|)H(|v|)\right)\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))g(|v|)\right)}{\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))f(|v|)\right)\left(\sum_{v\in \{0,1\}^{k} } \exp(-\beta H(v))g(|v|)\right)}\ge 0, \end{align*} where in the last step we used Lemma \ref{FKG2}. The assumptions of Lemma~\ref{FKG2} were verified in Lemma~\ref{fperg}. \end{proof} We define \[\beta_c=\inf \{\beta\quad|\quad \partial_t F(\beta,0)>0\}.\] Note that $F(0,t)=-t$, thus $\partial_t F(0,0)<0$. By continuity of $\partial_t F(\beta,0)$, it follows that $\beta_c>0$ and $\partial_t F(\beta_c,0)=0$. It follows from Lemma \ref{betacexists} combined with Lemma \ref{monotonbeta} that $t\mapsto F(\beta,t)$ has a unique positive zero if and only if $\beta>\beta_c$. For $\beta>\beta_c$, we define $\mathfrak{g}(\beta)$ as the unique positive zero of $t\mapsto F(\beta,t)$. For $\beta>\beta_c$, we have $\partial_t F(\beta,\mathfrak{g}(\beta))<0$ by Lemma \ref{difft} and $\partial_\beta F(\beta,\mathfrak{g}(\beta))\ge 0$ by Lemma \ref{diffbeta}. By the implicit function theorem, $\mathfrak{g}$ is differentiable at $\beta$ with derivative $-\frac{\partial_\beta F(\beta,\mathfrak{g}(\beta))}{\partial_t F(\beta,\mathfrak{g}(\beta))}\ge 0$. Thus, it follows that $\mathfrak{g}$ is differentiable and monotone increasing. Since $\mathfrak{g}$ is nonnegative and monotone increasing $t_0=\lim_{\beta\to\beta_c} \mathfrak{g}(\beta)$ exist and $t_0\in \mathbb{R}_{\ge 0}$. Since the zero set of $F$ is a closed set, we see that $F(\beta_c,t_0)=0$. Then it follows that we must have $t_0=0$. \section{Minimizing the expected energy} \label{sec4} Fix a $\beta$, and let us define \begin{align*} m(t_1,t_2,\dots, t_{k-1})&=\log\left(\sum_{v\in \{0,1\}^{k-1}} \exp\left(-\beta H(v1)+\sum_{i=1}v_i t_i\right)\right)\\&-\log\left(\sum_{v\in \{0,1\}^{k-1}} \exp\left(-\beta H(v0)+\sum_{i=1}v_i t_i\right)\right). \end{align*} Let $(u_{i\to a}),(\hat{u}_{a\to i})$ be a BP fixed point on the $(d,k)$-biregular tree $\mathbb{T}$. By Equation \eqref{ueq1} and Equation \eqref{ueq2}, we have \begin{equation}\label{genfix} u_{i\to a}=\sum_{b\in \partial i\backslash a} m((u_{j\to b})_{j\in \partial b\backslash i}). \end{equation} \begin{lemma}\label{monotonmess} The function $m(t_1,t_2,\dots, t_{k-1})$ is monotone increasing in each variable. \end{lemma} \begin{proof} By symmetry, it is enough to prove that it is increasing in $t_{k-1}$. First, let us define \begin{align*} A&=A(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v11)+\sum_{i=1}^{k-2} v_i t_i\right)\\ B&=B(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v01)+\sum_{i=1}^{k-2} v_i t_i\right)\\ C&=C(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v10)+\sum_{i=1}^{k-2} v_i t_i\right)\\ D&=D(t_1,t_2,\dots,t_{k-2})=\sum_{v\in \{0,1\}^{k-2}} \exp\left(-\beta H(v00)+\sum_{i=1}^{k-2} v_i t_i\right) \end{align*} With these notations, we have \[m(t_1,t_2,\dots, t_{k-1})=\log\left(A\exp(t_{k-1})+B\right)-(d-1)\log\left(C\exp(t_{k-1})+D\right).\] Thus, a direct computation gives us that \[\partial_{t_{k-1}} m(t_1,t_2,\dots,t_{k-1})=\frac{\exp(t_{k-1})(AD-BC)}{\left(A\exp(t_{k-1})+B\right) \left(C\exp(t_{k-1})+D\right)}.\] As in the proof of Lemma \ref{lemmaconcave}, we have \[BC\le AD,\] which gives the statement. \end{proof} \begin{lemma}\label{lemmahatar} Let $(u_{i\to a}),(\hat{u}_{a\to i})$ be a BP fixed point on the $(d,k)$-biregular tree $\mathbb{T}$. Then, for each edge $ia$, we have \[-\mathfrak{g}(\beta)\le u_{i\to a}\le \mathfrak{g}(\beta). \] \end{lemma} \begin{proof} By examining the formula \eqref{genfix}, we see that \[u_{i\to a}\le (d-1)\beta(h_{\lfloor k/2\rfloor}-h_0).\] We set $t_0=(d-1)\beta(h_{\lfloor k/2\rfloor}-h_0)$, and for $n\ge 0$, we set \[t_{n+1}=(d-1)m(t_n,t_n,\dots,t_n).\] Using Lemma \ref{monotonmess}, by induction, we see that $u_{i\to a}\le t_{n}$ for all $n$. Thus, \[u_{i\to a}\le\lim_{n\to\infty} t_n=\mathfrak{g}(\beta).\] The inequality, $-\mathfrak{g}(\beta)\le u_{i\to a}$ can be proved the same way. \end{proof} Fix a $\beta\ge 0$. For $t\in \mathbb{R}^k$, we define \[a_\beta(t)=\frac{\sum_{v\in \{0,1\}^k} -H(v)\exp(-\beta H(v)+(v,t))}{\sum_{v\in \{0,1\}^k} \exp(-\beta H(v)+(v,t))},\] where $(v,t)=\sum_{i=1}^k v_it_i$. Let $t^*=(\mathfrak{g}(\beta),\mathfrak{g}(\beta),\dots,\mathfrak{g}(\beta))\in \mathbb{R}^k$. \begin{lemma}\label{lemmaabeta} We have \[\max_{t\in [-\mathfrak{g}(\beta),\mathfrak{g}(\beta)]^k} a_\beta(t)=a_\beta(t^*)=a_\beta(-t^*).\] \end{lemma} \begin{proof} Let $z=\exp(\mathfrak{g}(\beta))$. Fix any $t\in [-\mathfrak{g}(\beta),\mathfrak{g}(\beta)]^k$. For $i\in \{0,1,\dots, k\}$, we introduce the notations \begin{align*} e(i)&=\sum_{\substack{v\in \{0,1 \}^k\\ |v|=i}} \exp((v,t)),\\ f(i)&=\frac{e(i)}{{{k}\choose{i}}},\\ N_i&=z^{i}+z^{k-i}. \end{align*} \begin{lemma}\label{lemmamonN} For $0\le i\le \lfloor \frac{k}2\rfloor$, the function \[\frac{f(i)+f(k-i)}{z^{i}+z^{k-i}}=\frac{f(i)+f(k-i)}{N_i}\] is monotone increasing. \end{lemma} \begin{proof} It follows from Newton's inequality \cite[Theorem 144.]{hardy1952inequalities} that $\frac{f(i+1)}{f(i)}$ is monotone decreasing. Also note that \[\frac{f(1)}{f(0)}=\frac{\sum_{i=1}^k \exp(t_i)}{k}\le z\] and \[\frac{f(k-1)}{f(k)}=\frac{\sum_{i=1}^k \exp(-t_i)}{k}\ge z^{-1}.\] Thus, \begin{equation}\label{korlat} z\ge \frac{f(1)}{f(0)}\ge \frac{f(i+1)}{f(i)}\ge \frac{f(k-1)}{f(k)}\ge z^{-1}. \end{equation} We need to prove that for $i<\frac{k}{2}$, we have \[\frac{f(i+1)+f(k-i-1)}{N_{i+1}}\ge \frac{f(i)+f(k-i)}{N_{i}}.\] Using the notations $\alpha=\frac{f(i+1)}{f(i)}$ and $\gamma=\frac{f(k-i)}{f(k-i-1)}$, this is equivalent to \[\alpha N_i-N_{i+1}+\frac{f(k-i-1)}{f(i)}\left(N_i-\gamma N_{i+1}\right)\ge 0.\] We distinguish two cases. \begin{itemize} \item First case: $N_i-\gamma N_{i+1}\le 0$. Since $\frac{f(j+1)}{f(j)}$ is monotone decreasing, we have \[\frac{f(k-i-1)}{f(i)}\le \alpha^{k-2i-1}.\] Also note $\alpha\ge \gamma$. Thus, \begin{align*} \alpha N_i-N_{i+1}+&\frac{f(k-i-1)}{f(i)}\left(N_i-\gamma N_{i+1}\right)\\&\ge \alpha N_i-N_{i+1}+\alpha^{k-2i-1} \left(N_i-\gamma N_{i+1}\right)\\&\ge \alpha N_i-N_{i+1}+\alpha^{k-2i-1} \left(N_i-\alpha N_{i+1}\right)\\ &=N_i(\alpha+\alpha^{k-2i-1})-N_{i+1}(1+\alpha^{k-2i}). \end{align*} Therefore, it is enough to prove that \[\frac{N_{i+1}}{N_{i}}\le \frac{\alpha+\alpha^{k-2i-1}}{1+\alpha^{k-2i}}.\] \begin{lemma} Let us consider the function \[q(x)=\frac{x+x^{k-2i-1}}{1+x^{k-2i}}.\] Then for any $x>0$, we have $q(x)=q(x^{-1})$. Moreover, $q(x)$ is monotone increasing on $(0,1]$, and it is monotone decreasing on $[1,\infty)$. Consequently, for $z\ge 1$, we have \[\min_{x\in [z^{-1},z]} q(x)=q(z)=q(z^{-1}).\] \end{lemma} \begin{proof} The first statement can be verified by a direct calculation. The second statement can be obtained by investigating the derivative \[q'(x)=\frac{(k-2i-1)(x^{k-2i}-x^{k-2i+2})+x^2-x^{2(k-2i)}}{x^2(1+x^{k-2i})^2}.\] Note that here we need to use that $2i<k$. The third statement follows by combining the previous two. \end{proof} Recall our observation in \eqref{korlat} that $z^{-1}\le \alpha\le z$. Thus combining this with the previous lemma, we get \[\frac{\alpha+\alpha^{k-2i-1}}{1+\alpha^{k-2i}}=q(\alpha)\ge \min_{x\in [z^{-1},z]} q(x)=q(z)=\frac{N_{i+1}}{N_i}.\] Thus the statement follows. \item Second case: $N_i-\gamma N_{i+1}\ge 0$. Since $\frac{f(j+1)}{f(j)}$ is monotone decreasing, we have \[\frac{f(k-i-1)}{f(i)}\ge \gamma^{k-2i-1}.\] Also note $\alpha\ge \gamma$. Thus, \begin{align*} \alpha N_i-N_{i+1}+&\frac{f(k-i-1)}{f(i)}\left(N_i-\gamma N_{i+1}\right)\\&\ge \gamma N_i-N_{i+1}+\gamma^{k-2i-1} \left(N_i-\gamma N_{i+1}\right)\\ &=N_i(\gamma+\gamma^{k-2i-1})-N_{i+1}(1+\gamma^{k-2i}). \end{align*} We can be finish the proof the same way as we did in the previous case. \end{itemize} Now we are ready to finish the proof of Lemma \ref{lemmaabeta}. Observe that \begin{align*} a_\beta(t)&=\frac{\sum_{v\in \{0,1\}^k} -H(v)\exp(-\beta H(v)+(v,t))}{\sum_{v\in \{0,1\}^k} \exp(-\beta H(v)+(v,t))}\\&=\frac{\sum_{i=0}^k -h_i \exp(-\beta h_i) e(i)}{\sum_{i=0}^k \exp(-\beta h_i) e(i)}\\ &=\frac{\sum_{i=0}^k -h_i \exp(-\beta h_i) (e(i)+e(k-i))}{\sum_{i=0}^k \exp(-\beta h_i) (e(i)+e(k-i))}. \end{align*} \end{proof} In particular, \[a_\beta(t^*)=\frac{\sum_{i=0}^k -h_i{{k}\choose{i}} (z^i+z^{k-i})\exp(-\beta h_i)}{\sum_{i=0}^k {{k}\choose{i}} (z^i+z^{k-i})\exp(-\beta h_i)}.\] Thus, the statement of the theorem follows from Lemma~\ref{FKG2} with the choice of $X=\{0,1,\dots,k\}$, $\nu(i)=\exp(-\beta h_i)$, $f(i)= (e(i)+e(k-i))$, $g(i)={{k}\choose{i}}(z^i+z^{k-i})$, $K(i)=h_i$. The conditions Lemma~\ref{FKG2} are verified in Lemma \ref{lemmamonN}. \end{proof} Now we prove Lemma \ref{lemma4} in slightly different form. \begin{lemma}\label{lemma22} For a fixed $\beta$, let $\mu$ be a Gibbs measure on $\mathbb{T}$. Fix a factor node $a$. Let $X$ be a random element of $\{0,1\}^V$ with law $\mu$. Then \[\mathbb{E}\left(-h\left(\sum_{i\in\partial a} X_i\right)\right) \le a_\beta(\mathfrak{g}(\beta),\mathfrak{g}(\beta),\dots,\mathfrak{g}(\beta)).\] \end{lemma} \begin{proof} Since the set of Gibbs-measures form a simplex \cite[Chapter 7.3]{georgii2011gibbs}, we may assume that that $\mu$ is extremal. Let $(u_{i\to a}),(\hat{u}_{a\to i})$ be the corresponding BP fixed point provided by Lemma~\ref{lemma5}. This lemma also gives that \[\mathbb{E}\left(-h\left(\sum_{i\in\partial a} X_i\right)\right)=a_\beta((u_{i\to a})_{i\in\partial a}).\] By Lemma \ref{lemmahatar}, we have $u_{i\to a}\in [-\mathfrak{g}(\beta),\mathfrak{g}(\beta))]$. Thus by Lemma \ref{lemmaabeta}, we have \[\mathbb{E}\left(-h\left(\sum_{i\in\partial a} X_i\right)\right)=a_\beta((u_{i\to a})_{i\in\partial a})\le a_\beta(\mathfrak{g}(\beta),\mathfrak{g}(\beta),\dots,\mathfrak{g}(\beta)).\] \end{proof} \section{Putting everything together: The proof of Theorem \ref{TheoremFO}}\label{putt} For a $(d,k)$-biregular factor graph $G$ and a $\beta\ge 0$, we define the Gibbs probability measure $\mu_G^\beta$ on $\{0,1\}^V$ by setting \[\mu_G^\beta(x)=\frac{\exp(-\beta H_G(x))}{Z_G(\beta)}.\] Note that \[\Phi_G'(\beta)=\frac{1}{|V|}\sum_{x\in \{0,1\}^V}\frac{-H_G(x)\exp(-\beta H_G(x))}{Z_G(\beta)}.\] This can be also expressed as follows. Let $X\in \{0,1\}^V$ a random vector with law $\mu_G^\beta$, and let $a$ be a uniform random factor node independent from $X$. Then \begin{equation}\label{phiGexp} \Phi_G'(\beta)=\frac{d}{k}\mathbb{E}\left(-h\left(\sum_{i\in \partial a} X_i\right)\right), \end{equation} where the expectation is over the random choice of $X$ and $a$. By Fatou's lemma, we have \[\limsup_{n\to\infty} (\Phi_{G_n}(\beta_1)-\Phi_{G_n}(0))\le \int_0^{\beta_1} \limsup_{n\to\infty} \Phi_{G_n}'(\beta) d\beta.\] Now our aim is to give an upper bound on $\limsup_{n\to\infty} \Phi_{G_n}'(\beta)$. Recall the formula \eqref{phiGexp} for $\Phi_{G_n}'(\beta)$. Taking an appropriate subsequential weak limit one can obtain a Gibbs measure $\mu$ on the $(d,k)$-biregular infinite tree $\mathbb{T}$ with the following property. Let $a$ be a fixed variable node of $\mathbb{T}$, let $X\in \{0,1\}^V$ a random vector with law $\mu$, then \[\limsup_{n\to\infty} \Phi_{G_n}'(\beta)=\frac{d}{k}\mathbb{E}\left(-h\left(\sum_{i\in \partial a} X_i\right)\right),\] where the expectation over a random choice of $X$. We do not give more details of this weak limit argument, we refer to \cite{sly2014counting} instead, where the same idea was applied. Using Lemma \ref{lemma22}, we obtain that \[\limsup_{n\to\infty} \Phi_{G_n}'(\beta)=\frac{d}{k}\mathbb{E}\left(-h\left(\sum_{i\in \partial a} X_i\right)\right)\le \frac{d}{k} \frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+i\mathfrak{g}(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+i\mathfrak{g}(\beta)) .\] Therefore, by Lemma \ref{interpol}, we have \[\limsup_{n\to\infty} (\Phi_{G_n}(\beta_1)-\Phi_{G_n}(0))\le \int_0^{\beta_1} \frac{d}{k} \frac{-\sum_{i=0}^k {{k}\choose{i}} h_i\exp(-\beta h_i+i\mathfrak{g}(\beta))}{\sum_{i=0}^k {{k}\choose{i}} \exp(-\beta h_i+i\mathfrak{g}(\beta))} d\beta=\Phi(\beta_1,\mathfrak{g}(\beta_1))-\Phi(0,g(0)).\] Now it is easy to check that $\Phi_{G_n}(0)=\Phi(0,\mathfrak{g}(0))=\log 2$. Therefore, \[\limsup_{n\to\infty} \Phi_{G_n}(\beta_1)\le \Phi(\beta_1,\mathfrak{g}(\beta_1)).\] Since the sequence $h_i$ is concave, our graphical models fall into the category of log-supermodular graphical models. Therefore the results of Ruozzi \cite{ruozzi2012bethe} can be applied to obtain that \[\Phi_{G_n}(\beta_1)\ge \Phi(\beta_1,\tau)\] for any $\tau$ in the local marginal polytope of $G$. Choosing $\tau$ by using the fixed point $\mathfrak{g}(\beta_1)$ as it was done in Subsection \ref{subsecbethe}, we obtain that \[\Phi_{G_n}(\beta_1)\ge \Phi(\beta_1,\mathfrak{g}(\beta_1)).\] Consequently, \[\liminf_{n\to\infty} \Phi_{G_n}(\beta_1)\ge \Phi(\beta_1,\mathfrak{g}(\beta_1)).\] Thus, the statement follows.

Introduction {#Sec1} ============ Dietary restriction (DR) is characterized by reduced food intake without inducing poor nutrition and subsumes numerous interventions including general calorie restriction (CR), protein restriction (PR) and various fasting protocols. Short-term DR -- usually excercised for several days to weeks-- has an extraordinary power to reduce cellular damage susceptibility by promoting resistance towards ischemic insults in rodent models of injury to the liver,^[@CR1],[@CR2]^ kidney^[@CR3],[@CR4]^ brain,^[@CR5]^ and heart.^[@CR6]^ Furthermore, DR has also been proven highly effective in preventing or ameliorating chemotoxic injury to the heart (secondary to doxorubicin)^[@CR7]^ and the kidney (secondary to cisplatinum)^[@CR8]^ and successfully improved survival in a murine chemotoxic stress model.^[@CR9]^ Possible mechanisms contributing to this phenomenon are versatile and include improvement of insulin sensitivity and reduction of oxidative stress and free radical induced damage, as well as modification of DNA repair. Alterations in the mechanistic target-of-rapamycin(mTOR)-signaling and other pathways, such as 5′ adenosine monophosphate-activated protein kinase and sirtuin overexpression also contribute to the effect. Whether DR conveys similar beneficial effects in humans is unknown. However, considering the lack of therapeutic options to prevent AKI in the clinical setting, it would provide a powerful strategy to protect organ integrity in those cases in which a critical impact can be anticipated, e.g. prior to scheduled major surgery or before administration of toxic agents.^[@CR10]^ Due to its functional and structural properties, the kidney is especially sensitive to ischemic as well as toxic attacks, two mechanisms that are central to the pathophysiology of contrast media-induced acute kidney injury (CI-AKI). With an incidence of up to 50% in patients at risk, CI-AKI after percutaneous coronary intervention (PCI) or angiography is a main inducement of hospital-acquired AKI and has been associated with prolonged hospital stay, increased costs, aggravation or initiation of persistent kidney damage, and increased mortality.^[@CR11]^ Given the exponentially increasing number of angiographic procedures requiring contrast media administration,^[@CR12]^ the need for strategies to avoid these problems is growing. Various risk factors for CI-AKI have been identified, i.e. old age,^[@CR13]^ chronic kidney disease,^[@CR14]^ congestive heart failure,^[@CR15]^ hypovolemia^[@CR16]^ and high-volume contrast media^[@CR17],[@CR18]^ administration. Despite a multitude of clinical trials investigating putative protective compounds, to date restoring fluid volume balance still remains the only widely accepted preventive strategy.^[@CR19]^ Short-term DR has been proven to be feasible and safe in living kidney donors.^[@CR20]^ Recently, in a first proof-of-principle clinical trial we showed that a 40%-calorie restriction given over 7 days prior to major cardiac surgery -- a procedure associated with a high rate of postoperative ischemic AKI -- might attenuate impairment of kidney function mirrored by a significantly reduced increase of serum creatinine at 48 h after surgery.^[@CR21]^ Here, we report the results of a prospective, single-center, randomized, controlled clinical trial that tested the hypothesis that a 4-day diet with a 40% reduction of calorie intake prevents CI-AKI in at-risk-patients undergoing PCI. Subjects and Methods {#Sec2} ==================== Study participants {#Sec3} ------------------ Approval of the study protocol was obtained from the local institutional review board (Ethics committee of the University of Cologne, Cologne, Germany). 80 consecutive adult patients (\>18 years) scheduled for elective PCI at the University Hospital of Cologne, who carried at least one of the following risk factors for developing CI-AKI were enrolled: age \>70 years, chronic kidney disease with a pre-existing serum creatinine above the normal range (i.e. \>1.1 mg/dL in men, \>0.9 mg/dL in women), diabetes mellitus, congestive heart failure NYHA 3--4, reduced left ventricular ejection fraction (\<50%), or peripheral vascular disease. Exclusion criteria were end-stage renal disease, kidney transplantation, pregnancy and breastfeeding, weight loss of more than 1 kg within 2 weeks prior to enrollment unless due to diuretic medication, body mass index (BMI) \<18.5 kg/m^2^ or \>35 kg/m^2^, evidence of malignancy or uncontrolled infection, known allergies or intolerance against ingredients of the formula diet used, or the inability to give informed consent. The study was operated in accordance with the Declaration of Helsinki and the good clinical practice guidelines by the International Conference on Harmonization, registered with the German Clinical Trial Register (<https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID> = DRKS00004361; Date of registration: 23/04/2013; DRKS-ID: DRKS00004361) and reported to the Federal Institute for Drugs and Medical Devices (BfArM, EudraCT-no: 2012-003696-18), (full study protocol attached in Supplemental document) Study design {#Sec4} ------------ Between 6 to 4 days prior to the scheduled day of PCI (day 0), potentially qualifying patients were contacted for a screening visit by a member of the study team. After obtaining informed consent anthropometric characteristics were assessed using a bioimpedance scale (Tanita BC-418 Segmental Body Composition Analyzer, Arlington Heights, Illinois 60005, USA). If eligible, patients were randomly allocated in a 1:1 ratio to either receiving a dietary-restricted (DR group) or an ad-libitum diet (control group) using an internet-based computer-randomization system (ALEA Randomisation Service, Amsterdam, NL; provided by the Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany). Block randomization or stratification was not performed. After randomization, a member of the study team provided a formula diet (Fresubin energy fibre, Fresenius Kabi™, Bad Homburg, Germany) containing 60% of the daily energy expenditure (DEE), as calculated using the Mifflin-St. Jeor equation and individually assessed activity factors to patients in the DR group. All participants in the DR group were instructed not to consume extra food or calorie-containing beverages like alcohol, fruit juices or soft drinks. The diet commenced on pre-interventional day −4 and was maintained until the pre-interventional indicated fasting state. In the control group patients were allowed to ingest food at their own discretion and were encouraged to stick to their normal eating habits, thereby ensuring non-restricted calorie intake. All participants in both groups were provided with diaries and reported their food consumption on a daily basis. In addition, regular phone calls ascertained patients' wellbeing and served to monitor adherence to the designated protocol. Re-assessment of all participants was performed on day −1, and blood and urine samples were collected on day 0 immediately prior to PCI to obtain pre-PCI baseline data. All patients received volume therapy as standard of care to prevent CI-AKI. Interventional procedures as well as volume therapy were carried out according to the local standard (1 ml/kg body weight per hour for 12 h before and after PCI) and were not influenced by the study protocol. Other putative measures of organ protection, e.g. remote ischemic preconditioning, were not performed throughout the study. Iohexol (Accupaque™ 300, GE Healthcare, Braunschweig, Germany) was used as contrast agent in all patients. Dosing was at the discretion of the treating physician performing the PCI and not influenced by study personnel. Outcome parameters {#Sec5} ------------------ Change in serum creatinine (Δ creatinine) from pre-PCI baseline (0 h) to 48 h after the initiation of PCI was analyzed as primary endpoint. Secondary endpoints were the change of serum creatinine from pre-PCI baseline to 24 h after PCI, the change in urinary Neutrophil gelatinase-associated lipocalin (NGAL) from pre-PCI baseline to 24 h after PCI, the change of cystatin C from pre-PCI baseline to 24 h and 48 h after PCI, the incidence of CI-AKI defined as an increase in serum creatinine of ≥0.5 mg/dL or ≥25% of the pre-PCI baseline value within 48 h after PCI, incidence of AKI as defined by Kidney disease: Improving Global Outcomes (KDIGO) criteria (creatinine parameter only),^[@CR22]^ mortality, hospitalization and/or need for renal replacement treatment (RRT) within 4 weeks after PCI, and progression of the following biochemical safety parameters from pre-PCI baseline to 24 h and 48 h after PCI: C-reactive protein (CRP), white cell blood count (WBC), creatine kinase (CK), creatine kinase muscle brain type (CK-MB), and lactate dehydrogenase (LDH). Reported changes of laboratory results were calculated as value at specified time point post PCI minus pre-PCI baseline value (day 0). The decision for initiation of RRT was performed solely by the treating physician and not effected by study personnel. Data collection {#Sec6} --------------- Baseline demographic characteristics including co-morbidities and medication were assessed after study inclusion. All blood and urine samples at pre-PCI baseline and within 48 h after PCI were obtained at pre-specified time points. Body weight and body composition data were documented at the screening visit and at hospital admittance (day -1). All participants were asked to collect a 24 hour-urine sample at day −2, and calculation of the daily protein intake was carried out by estimating urinary urea nitrogen appearance with the equation proposed by Maroni *et al*.^[@CR23]^. Patients were encouraged to document any additional food intake on a daily basis. Additionally, the general condition was reported in a 3-point-ordinal scale (rather good, fair, rather not good) as was the sense of hunger (minor, moderate, severe). Duration of PCI, amount of contrast media used and other variables were extracted from the medical records. All patients were followed up until hospital discharge; the occurrence of re-hospitalization, RRT and death was assessed by a telephone call at week 4 after PCI. Documentation of adverse events was performed starting with the first study-related procedure and ending with the last telephone contact at week 4. Statistical analysis {#Sec7} -------------------- A previously published trial^[@CR24]^ conducted at the Cologne University Hospital observed an increase in serum creatinine 48 h after contrast medium exposure of 0.16 ± 0.24 mg/dl (remote ischemic preconditioning) and 0.47 ± 0.48 mg/dl (no preconditioning), corresponding to a standardized effect size of 0.82. To prove this effect with a power of 80%, a minimum inclusion of 24 patients per group was calculated. To compensate for a 20% effect reduction due to dropouts, 1.56 × 24^[@CR25]^ patients were included in each group, i.e. after rounding 40 patients. Primary analysis was performed in an intention-to-treat (ITT) approach and patients were included as randomized. The analysis of the per-protocol group included all randomized patients that were treated according to the protocol (e.g. no delay of surgery), patients in the DR group were included if they had consumed no more than 60% of DEE + 200 kcal within the DR period. Pre specified subgroup analyses were executed for gender, BMI, CI-AKI risk groups, and administered contrast agent volume. Primary analysis was the treatment comparison by analysis of co-variance (ANCOVA) in the ITT population with covariate serum creatinine at day 0. Missing values were replaced with a last-observation-carried-forward approach. Secondary serum creatinine outcomes were also evaluated by ANCOVA. Other quantitative outcomes were analyzed by Mann-Whitney-U tests, qualitative outcomes by Chi-square or exact Fisher tests. Missing values were not replaced in the secondary endpoint analyses as well as in the per-protocol analysis. No race/ethnicity-specific analyses were performed, since all included patients were caucasian. Data are reported as means (± standard deviation, SD), medians (interquartile range, IQR), or numbers \[n (% of total)\]. All statistical testing was two-sided and a p-value \< 0.05 was considered significant. Analysis software was SAS 9.3, SAS Institute Inc., Cary, USA and IBM SPSS Statistics Version 23. Results {#Sec8} ======= The first patient was included July 10, 2013, the last follow up visit scheduled on October 7, 2016. During this period, 257 potentially eligible patients were identified and contacted. Of these, 177 were found not eligible in pre-screening telephone contact or declined their participation. Eventually, 80 patients were screened, and all of them randomized into the two groups (40 in each group). The recruitment was ended after reaching the enrollment goal as planned. All randomized patients were included in the ITT analysis (Fig. [1](#Fig1){ref-type="fig"}). Patient demographics as well as clinical characteristics are shown in Table [1](#Tab1){ref-type="table"}.Figure 1Patient flow and randomization. DR: dietary restriction.Table 1Patient demographics and clinical characteristics.DR group (n = 40)control group (n = 40)total (n = 80)page \[years\], median(Q1--Q3)74.0 (71.5,78.5)73.5 (70.5,78.0)74.0 (71.0,78.0)0.912male, \[n\]28 (70.0%)31 (77.5%)59 (73.8%)0.446weight at screening \[kg\], median(Q1--Q3)81.8 (73.8,92.0)82.5 (76.8,89.8)82.5 (76.1,91.4)0.874BMI at screening \[kg/m^2^\], median(Q1--Q3)28.0 (25.5,31.0)28.0 (25.0,29.5)28.0 (25.0,30.5)0.619Creatinine at screening \[mg/dL\], median(Q1--Q3)1.4 (1.1,1.9)1.1 (1.0,1.4)1.3 (1.0,1.5)0.009Creatinine day 0 \[mg/dL\], median(Q1--Q3)1.3 (1.1,1.7)1.1 (0.9,1.4)1.2 (1.0,1.5)0.004eGFR (CKD-EPI) \[ml/min/1.73m2\], median(Q1--Q3)45 (32,58)58 (47,71)51 (42,66)0.003Peripheral arterial disease, \[n\]2 (5.0%)5 (12.5%)7 (8.8%)0.235Congestive heart failure, \[n\]10 (25.0%)6 (15.0%)16 (20.0%)0.264Valve disease, \[n\]13 (32.5%)11 (27.5%)24 (30.0%)0.626Coronary artery disease, \[n\]26 (65.0%)31 (77.5%)57 (71.3%)0.217Atrial fibrillation, \[n\]12 (30.0%)11 (27.5%)23 (28.8%)0.805Pulmonary hypertension, \[n\]5 (12.5%)7 (17.5%)12 (15.0%)0.531Hypertension, \[n\]35 (87.5%)26 (65.0%)61 (76.3%)0.018Diabetes mellitus, \[n\]13 (32.5%)12 (30.0%)25 (31.3%)0.809Pace maker, \[n\]3 (7.5%)2 (5.0%)5 (6.3%)0.644AICD, \[n\]1 (2.5%)0 (0.0%)1 (1.3%)0.314Mehran Score6560.200≤2 risk factors for CI-AKI, \[n\]27 (67.5%)31 (77.5%)58 (72.5%)0.317\>2 risk factors for CI-AKI, \[n\]13 (32.5%)9 (22.5%)22 (55%)0.317ACEI / ARB, \[n\]32 (80.0%)31 (77.5%)63 (78.8%)0.785Aldosterone antagonist, \[n\]6 (15.0%)8 (20.0%)14 (17.5%)0.556Beta blocker, \[n\]32 (80.0%)31 (77.5%)63 (78.8%)0.785Calcium antagonist, \[n\]12 (30.0%)8 (20.0%)20 (25.0%)0.302Lipid-lowering drugs, \[n\]26 (65.0%)33 (82.5%)59 (73.8%)0.075Antiplatelet therapy, \[n\]30 (75.0%)35 (87.5%)65 (81.3%)0.152Diuretic, \[n\]27 (67.5%)29 (72.5%)56 (70.0%)0.626DR: dietary restriction; AICD: Automated Implantable Cardioverter-Defibrillator; ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; CI-AKI: contrast media-induced acute kidney injury; eGFR: estimated glomerular filtration rate; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration. According to the patients' diary recordings the median daily calorie intake was 1212(1070,1404) kcal accounting for 60(59,60)% of the calculated DEE in the DR group and 1597(1440,1876) kcal representing 81(70,95)% of the calculated DEE in the control group which would imply a true between-group calorie reduction of only 20%. However, in contrast to the DR group in which the calculation of additionally consumed calories was presumably precise since patients only added minor amounts of comestibles or countable items (e.g. 1 apple, 3 biscuits, etc.) an accurate assessment of valid calorie uptake in the control group was hindered by incomplete or unspecific reports on consumed food quantities. Furthermore, all patients in the control group indicated that they had not changed their diets and had not carried out a calorie restriction on their own. Consequently, the median weight loss in the control group was −0.7(−1.0,0.1) kg whereas patients in the DR group lost −2.3(−2.9,1.5) kg (p \< 0.001). In the DR group the considerable weight change was largely due to a decrease in total body water with −2.1 (−4.1,1.0) kg as compared to the control group with −1.1 (−1.6,0.6) kg; p = 0.002). In between-group difference was also evident in the estimated daily protein intake, based on the urinary urea nitrogen appearance (DR: 57(51,64) g/day vs. control group: 69(52,87) g/day, p \< 0.033). Anthropometric and bioimpedance characteristics are summarized in Table [2](#Tab2){ref-type="table"} and Supplemental Table [1](#Tab1){ref-type="table"}.Table 2Anthropometric characteristics and biochemical parameters.DR group (n = 40)control group (n = 40)pΔ weight: screening to day −1, \[kg\]−2.3 (−1.9,2.5)−0.7 (−1.0,−0.1)\<0.001Δ body water: screening to day −1, \[kg\]−2.1 (−4.1,−1.0)−1.1 (−1.6,0.6)0.002calculated daily energy expenditure (DEE), \[kcal\]2178 (1821,2370)2094 (1893,2286)0.394reported calorie intake, \[kcal\]1212 (1067,1404)1597 (1440,1876)\<0.001reported calorie intake, \[% of DEE\]60 (59,60)81 (70,95)\<0.001daily protein intake calculated from urinary urea nitrogen appearance, \[g/kg\]0.7 (0.6,0.9)0.9 (0.7,1.0)0.039DR: dietary restriction; values presented as median (interquartile range). Δ-values represent changes of parameters between specified time points. Despite using a computer-generated randomization system there was a significant difference in median serum creatinine at the timepoint of screening (DR group: 1.4(1.1,1.9) mg/dL, control group: 1.2(1.0,1.4) mg/dL; p = 0.009) and at pre-PCI baseline (DR group: 1.3(1.1,1.7) mg/dL, control group: 1.1(0.9,1.4) mg/dL; p = 0.004), which was also reflected in a difference in eGFR CKD-EPI (estimated glomerular filtration rate Chronic Kidney Disease Epidemiology Collaboration) before PCI: DR group: 50(34,62) mL/min, control group 62(50,79) ml/min/1.73m^2^; p = 0.002). The total dose of administered contrast media was not different between the two groups (DR: 85(60,120) mL vs. control group: 90(73,128) mL, p = 0.329). With 6(3,9) in the DR group and 5(3,7.5) in the control group the median Mehran's score predicting the risk on CI-AKI was statistically not different (p = 0.200), representing a low to moderate risk for CI-AKI in both groups.^[@CR26]^ In 15 patients (37.5%) in the DR group and 18 patients (45%) of the control group percutaneous transluminal coronary angioplasty/additional stenting was performed. Coronary intervention-related parameters are summarized in Table [3](#Tab3){ref-type="table"}.Table 3Percutaneous Angiography Data.DR group (n = 40)control group (n = 40)total (n = 80)pDuration of angiography \[min\], median (Q1--Q3)56 (39,85)4 (35,66)50 (35,77)0.179Dosing of contrast agent \[mL\], median (Q1--Q3)85 (60,120)90 (73,127.5)90 (60,125)0.329≤100 mL contrast agent, \[n\]26 (66.7%)24 (60.0%)50 (62.5%)0.644\>100 mL contrast agent, \[n\]13 (33.3%)16 (40.0%)29 (36.3%)0.485PTCA/Stenting, \[n\] (%)15 (37.5%)18 (45.0%)33 (82.5%)0.6501 vessel coronary artery disease, \[n\]11 (27.5%)4 (10.0%)15 (18.8%)0.0452 vessel coronary artery disease, \[n\]8 (20.0%)10 (25.0%)18 (22.5%)0.5923 vessel coronary artery disease, \[n\]8 (20.0%)13 (32.5%)21 (26.3%)0.204DR: dietary restriction; PTCA: Percutaneous transluminal coronary angioplasty. Primary outcome {#Sec9} --------------- With a median Δ creatinine from pre-PCI baseline to 48 h post PCI of 0.03 (−0.15, 0.14) \[mean ± SD: 0.06 ± 0.33\] mg/dL for DR group vs. 0.09 (−0.03, 0.22) \[mean ± SD: 0.10 ± 0.20\] mg/dL for control group (p = 0.797), there was no difference in the primary endpoint (Fig. [2](#Fig2){ref-type="fig"}). Of note, although creatinine was significantly higher directly before PCI in the DR group compared to the control group, the inclusion of this parameter as a covariate in the analysis showed no significant influence on outcome (p = 0.947). Also, anthropometric and bioimpedance characteristics did not significantly affect the primary endpoint (Supplemental Table [2](#Tab2){ref-type="table"}+[3](#Tab2){ref-type="table"}).Figure 2Intention-to-treat analysis: Evolution of serum creatinine (median, IQR) from pre-percutaneous coronary intervention (PCI) to 24 h and 48 h post PCI. (**A**) Development of serum creatinine from pre-PCI (0 h) baseline to 48 h post PCI. (**B**) Change of serum creatinine (Δ creatinine) from pre-PCI baseline to specified time points. DR: dietary restriction. Secondary outcomes {#Sec10} ------------------ There were no differences between the DR group and the control group with regard to the creatinine changes from pre-PCI baseline to 24 h. Also, the additionally assessed dynamics of the biochemical parameter urea, NGAL (only pre-PCI baseline to 24 h), CRP, WBC, CK and LDH did not show a difference between the groups from pre-PCI baseline to 24 h and 48 h (Table [4](#Tab4){ref-type="table"}). Cystatin C slightly increased at 24 h in the control group, while there was no change in the DR group. Interestingly, a slight decrease in cystatin C at 48 h was observed in the DR group (48 h: CR: −0.10(−0.20, 0.10) mg/L, control: 0.00 (0.00, 0.14) mg/L; p = 0.045). For cystatin C evolution see Fig. [3](#Fig3){ref-type="fig"}.Table 4Secondary endpoints: biochemical parameters.DR group (n = 40)control group (n = 40)pCystatin C: d0 \[mg/L\]1.5 (1.15,2.0)1.2 (1.0,2.0)\<0.001   Δ Cystatin C: d0 to 24 h post PCI, \[mg/L\]0.0 (−0.1,0.1)0.1 (0.0,0.2)0.077   Δ Cystatin C: d0 to 48 h post PCI, \[mg/L\]−0.1 (−0.2,0.1)0.0 (0.0,0.1)0.045NGAL in urine: d0, \[µmol/L\]13.8 (10.0,26.3)10 (10.0,15.8)0.058   Δ NGAL: d0 to 24 h post PCI, \[µmol/L\]2.5 (−0.1,27,2)5.9 (0.0,13.0)0.914CK: d0, \[U/L\]103 (67,121)84 (62,114)0.364   Δ CK: d0 to 24 h post PCI, \[U/L\]−8 (−23,10)−1 (−17,26)0.265   Δ CK: d0 to 48 h post PCI, \[U/L\]−3 (−20,20)7 (−12,26)0.278CK-MB: d0, \[U/L\]14 (12,18)15 (13,16)0.957   Δ CK-MB: d0 to 24 h post PCI, \[U/L\]−1 (−4,1)0 (−2,3)0.119   Δ CK-MB: d0 to 48 h post PCI, \[U/L\]−2 (−5,1)−3 (−6,1)0.323LDH: d0, \[U/L\]197 (183,244)202 (182,232)0.899   Δ LDH: d0 to 24 h post PCI, \[ng/L\]10 (−22,34)12 (−2,29)0.513   Δ LDH: d0 to 48 h post PCI, \[ng/L\]−2 (−23,31)2 (−13,26)1.000CRP: d0, \[mg/L\]3.0 (3.0,3.5)3.0 (3.0,3.4)0.995   Δ CRP: d0 to 24 h post PCI, \[mg/L\]0.0 (0,0.7)0.0 (0,0.6)0.645   Δ CRP: d0 to 48 h post PCI, \[mg/L\]0.8 (0.0,2.80.3 (0.0,2.4)0.692WBC: d0, \[x1E9/L\]6.0 (5.0,7.7)6.4 (45.5,7.9)0.695   Δ WBC: d0 to 24 h post PCI, \[x1E9/L\]0.93 (0.21,1.62)1.25 (0.42,2.11)0.316   Δ WBC: d0 to 48 h post PCI, \[x1E9/L\]1.36 (0.68,1.70)1.05 (0.22,1.81)0.506Parameters measured in serum unless otherwise indicated. 0 h indicates baseline value before PCI. Values presented as median (interquartile range). DR: dietary restriction; CK: creatine kinase; CK-MB: muscle-brain type creatine kinase; CRP: C-reactive protein; LDH: lactate dehydrogenase; NGAL: neutrophil gelatinase--associated lipocalin; WBC: white blood cell count. Δ-values represent changes of parameters from pre-PCI baseline (d0) to specified time points after PCI.Figure 3Intention-to-treat analysis: Evolution of serum cystatin C (median, IQR) from pre-percutaneous coronary intervention (PCI) to 24 h and 48 h post PCI (**A**) Development of median serum cystatin C from pre-PCI (0 h) baseline to 48 h post PCI. (**B**) Median values showing the change of serum cystatin C (Δ cystatin C) from pre-PCI baseline to specified time points. DR: dietary restriction. With 22.5% (DR) and 20.0% (control) the incidence of AKI defined according to the KDIGO criteria was similar (p = 0.602). When CI-AKI was defined as an increase in creatinine by \>25% or 0.5 mg/dl within 48 h, the incidence was 17.5% and 20% in the DR group and the control group, respectively (p = 0.775) (Table [5](#Tab5){ref-type="table"}). No death was reported during the course of the study and no patient received RRT. There was no difference in the number of hospitalizations in both groups (DR: n = 1, control: n = 1)Table 5Secondary endpoints: clinical parameters.DR group (n = 40)control group (n = 40)total (n = 80)pAKI, \[n\]9 (22.5%)8 (20%)17 (21.3%)0.602KDIGO 1, \[n\]8 (20%)8 (20%)16 (20.0%)KDIGO 2, \[n\]0 (0.0%)0 (0.0%)0 (0.0%)KDIGO 3, \[n\]1 (2.5%)0 (0.0%)1 (2.5%)CI-AKI, \[n\]7 (17.5%)8 (20.0%)15 (18.8%)0.775DR: dietary restriction; AKI: acute kidney injury; KDIGO: Kidney Disease: Improving Global Outcomes; CI-AKI: Contrast induced acute kidney injury defined as an increase in serum creatinine by ≥0.5 mg/dL or by 25% from pre-PCI baseline within 48 hours. Subgroup analyses {#Sec11} ----------------- Subgroup analyses were performed for gender, BMI (BMI \< 25 vs. BMI ≥ 25) and administered contrast agent volume (≤100 mL, \>100 mL) as well as CI-AKI risk factors (≤ 2 vs. \>2 risk factors as defined by the inclusion criteria). No between-group differences were seen with regard to gender and BMI. However, in the subset of patients that had received ≤100 mL of contrast agent, there was a significant difference in Δ creatinine between the two groups with a decrease in creatinine at 48 h in the DR group and a further increase in the control group (DR n = 26: −0.03(−0.20,0.08) mg/dL vs. control n = 24: 0.10(−0.08,0.24) mg/dL; p = 0.041). No difference in creatinine kinetics could be noted for patients that had received more than 100 mL contrast agent. Moreover, a significant beneficial impact of DR was also detected in the subgroup of patients with ≤2 risk factors for CKI-AKI (n = 27) with a decrease in creatinine of −0.06 (−0.12,0.07) mg/dL at 24 h and of −0.01 (−0.18,0.07) mg/dL at 48 h in the DR group vs. an increase of 0.02 (−0.03,0.14) mg/dL at 24 h and 0.09(−0.03,0.16) mg/dL at 48 h in the control group (24 h: p = 0.039; 48 h: p = 0.030), respectively. No differences regarding Δ creatinine were noted in patients with more than 2 risk factors (DR: n = 13, control: n = 9; 24 h: p = 0.647; 48 h: p = 0.744). Results of subgroup analyses are displayed in Fig. [4](#Fig4){ref-type="fig"}.Figure 4Subgroup analyses showing the median change of serum creatinine (Δ creatinine) from pre-PCI baseline to specified time points (**A**) subsets of patients with administration of ≤100 mL contrast agent (DR: n = 26, control: n = 24) and patients with administration of \>100 mL contrast agent (DR n = 13, control: n = 16) (**B**) subsets of patients with ≤2 risk factors (DR: n = 27, control: n = 31) and \>2 risk factors (DR: n = 13, control n = 9) for CI-AKI as defined by the inclusion criteria (age \> 70 years, chronic kidney disease with a pre-existing serum creatinine above upper level of the normal range (i.e. \>1.1 mg/dL in men, \>0.9 mg/dL in women), diabetes mellitus, congestive heart failure NYHA 3--4 or reduced left ventricular ejection fraction (\<50%) or peripheral vascular disease). DR: dietary restriction. Per-protocol analysis {#Sec12} --------------------- As in the primary analysis no statistically significant differences were found with regard to the primary outcome parameter. However, per-protocol analysis confirmed the findings of the intention-to-treat analysis and revealed a difference in cystatin C increment in favor for the DR group 48 h after PCI (CR n = 30: --0.1(−0.2,0.1) mg/L, control n = 32: 0(0,0.14) mg/L; p = 0.018). Moreover, the subgroup analysis of the per-protocol population confirmed the finding, that only patients with ≤2 risk factors for CI-AKI showed a benefit of DR (n = 24) with a slight decrease in creatinine of −0.03(−0.18,0.10) mg/dL at 48 h, compared to an increase of 0.09(−0.04,0.18) mg/dL in the control group (n = 30) (p = 0.033). Likewise, only the subset of patients that had received ≤100 ml of contrast agent experienced a decrease of creatinine in the DR group after 48 h (n = 24: −0.03(−0.2,0.09) mg/dL, whereas an increment was noted in the control group (n = 24: 0.1(−0.08,0.24) mg/dL, p  = 0.058). Safety and feasibility {#Sec13} ---------------------- Adverse events were assessed in the period starting with the first study-related procedure and ending with the last telephone contact at week 4 post-PCI. The diet was generally well tolerated. In 59.4% of documentations DR patients described their general condition during the diet as "rather good", 36.9% reported a "fair" condition and only 3.8% of patients felt "rather not good". In only 5.6% a sense of hunger was reported as "severe" while the majority of patients (66.3%) classified this sensation as "minor". One hospitalization due to progression of coronary artery disease was recorded in each group and classified as serious adverse event. Cardiac biomarkers (creatine kinase, muscle-brain type creatine-kinase) showed no differences in the DR group in comparison to the control group (Table [4](#Tab4){ref-type="table"}). Likewise, DR had no negative impact on markers of inflammation (CRP, WBC) or cellular integrity (LDH), supporting the favorable safety profile of the intervention. Discussion {#Sec14} ========== In this randomized controlled trial, 4-day DR aiming for a 40% reduction of calorie intake in patients at risk for CI-AKI showed no beneficial impact on the increase in serum creatinine at 48 h after PCI. Analysis of urinary NGAL -- a marker of tubular injury -- and incidence of AKI post-PCI was in line with this result. A small but significant protective effect was observed when cystatin C was used to monitor kidney function. Notably, DR proved to be effective in preventing CI-AKI (as mirrored by creatinine kinetics) in distinct subgroups of patients, i.e. those that received only a low contrast agent volume (≤100 mL) and those with a low- to intermediate-risk for CI-AKI prior to the intervention. This suggests that the applied DR regime provided only low-effective protection which was not appropriate to counteract a more severe insult. At last, our study clearly showed that short-term DR in patients undergoing PCI is feasible, well tolerated and safe. Conducting a trial on CI-AKI one should also take into account that a controversial discussion about risk of CI-AKI as well as clinical relevance has emerged during the realization of this study. In a meta-analyses of 28 studies, involving 107,335 patients, Aycock *et al*. reported no difference in the rates of acute kidney injury, the receipt of renal replacement therapy and mortality in patients receiving contrast-enhanced CT versus those receiving non-contrast CT. Apart from the observational and largely retrospective nature of the analysis, which is also stated as an obvious limitation by the author, Aycock *et al*. quote, that this finding, which differs from the results of previous analyses by other authors, may be partially due to the fact that only patients undergoing CT scans were evaluated and patients undergoing other procedures were not included. Another important point is that "There is an inherent selection bias that comes from these studies as a result. Because none of the studies randomized patients to either contrast or non-contrast material, the type of CT scan ordered would have been prompted by indication for the scan or baseline renal function because of physician fear of postcontrast acute kidney injury"^[@CR27]^ In another retrospective study, Wilhelm-Leen *et al*. examined the risk of contrast-associated nephropathy among patients hospitalized in the United States in 2009. 5,931,523 hospitalizations were included in the analysis, where Willhelm-Leen and colleagues found no difference for the risk for developing AKI in patients to whom radiocontrast was and was not administered. An important limitation is, that the administrative diagnosis of AKI exclusively served as the definition of AKI. One has to expect this to be less sensitive than clinical data, leading to an underestimation of overall incidence of AKI. Secondly, as the authors point out, the certainty in which the administration of contrast preceded the diagnosis of AKI could not be specified. Taken together, the recent data suggest, that the risk of CI-AKI might have been overestimated in the past, but even the authors admit that "the relationship between radiocontrast administration and AKI is highly confounded, unpredictable, and sometimes bidirectional".^[@CR28]^ In any case pathophysiology of CI-AKI in detail is still a matter of debate as are the different mechanisms that contribute to the phenomenon. Besides direct toxicity on renal tubular epithelial cells, reactive oxygen species formation and reduction of nitric oxide production as well as endothelial injury lead to hemodynamic alterations that promote renal medullary hypoxia.^[@CR29],[@CR30]^ Most of the published clinical trials investigating preventive strategies have focused on one mechanism at a time and pharmacologic compounds that are usually administered directly before or together with the contrast media.^[@CR19]^ However, such strategies are probably not appropriate to allow for profound protective adaptations on a cellular level and none of these approaches has reached the clinical setting. Recently, the principle of dietary preconditioning has gained large interest in this respect and might provide a distinct and innovative therapeutic approach.^[@CR3],[@CR10],[@CR31]^ It has been known since more than 100 years that long-term reduction of food intake delays the aging process leading to an extension of healthy lifespan^[@CR32],[@CR33]^ and various recent studies suggested that this effect is evolutionary conserved in a wide variety of species from yeast to mammals including primates.^[@CR34]^ With the likely cause responsible for this phenomenon being a robust and longstanding enhancement of cellular stress resistance^[@CR35],[@CR36]^ a short-term protection from acute stressors is achieved by brief periods of DR. With respect to the kidney, Mitchell *et al*. published a proof-of-concept study in a murine renal ischemia reperfusion injury model in which DR conducted for 2 to 4 weeks completely prevented death from AKI and dramatically ameliorated renal failure.^[@CR3]^ Likewise, we showed recently that a 4-week 30%-CR strongly protects from toxic renal failure after cisplatinum application in mice.^[@CR35]^ Despite a plethora of studies investigating dietary interventions with respect to weight control, only scarce data is available concerning the impact of DR protocols on organ protection in humans. In a large-scale clinical trial the administration of a calorie-restricted enteral feeding protocol in critically ill patients led to a significantly lower rate of renal replacement therapy.^[@CR37]^ Furthermore, Jongbloed *et al*. confirmed the feasibility and safety of a preoperative calorie- and protein-restricted diet in healthy kidney donors as well as in morbidly obese patients undergoing bariatric surgery.^[@CR38]^ In a preliminary analysis, this workgroup also observed a significantly lower incidence of acute renal graft rejection after transplantation in the DR group as compared to a non-dieting control group (personal communication by R.W.F. de Bruin, Erasmus MC, Rotterdam, The Netherlands). Recently, in a randomized controlled clinical trial evaluating the effects of a 7-day preoperative CR (60% of DEE) on renal function in patients undergoing cardiac surgery, a small albeit significant improvement on creatinine kinetics was revealed at 48 h after surgery and before discharge.^[@CR21]^ Similar to the here reported trial, more pronounced beneficial effects were detected in distinct patient subgroups. Despite these promising data, the magnitude of the observed effects is considerably lower than it could have been expected from animal experiments. This may well be due to the fact that an effective clinical DR protocol has not been established yet. In contrast to rodent models, we simply do not know the optimal mode and extent of nutritional deprivation in order to achieve optimal protection in humans. Besides, reaching the same protection as in rodents may require longer-term exposure to DR in humans. Notwithstanding, with DR being a highly conserved and universally active hormetic principle, its exploitation might be beneficial for damage prevention in various settings -- including those cases in which no alternative therapies exist. More recent data from cell culture and animal models regarding the restriction of specific components of the diet (e.g. protein reduction or restriction of sulfur-containing amino acids) show, that these regimens may activate the underlying cellular mechanisms in a targeted and more efficient fashion.^[@CR39]^ Further research is therefore needed in order to refine DR protocols with respect to timing and formulation. In this context, the results of the study at hand as well as our previous work in cardiopulmonary bypass surgery provide a good basis showing -- albeit modest -- first positive effects in CI-AKI associated with a good safety profile and feasibility. This study has several limitations, some of which derive from its design and the principle problem of adherence in diet studies. Blinding was not feasible given the fact that a reduction of calorie intake would readily be noticed by study participants. The widely accepted Mifflin-St. Jeor equation that was used in this study to calculate DEE, as any alternative published equation, might not be applicable in the given population. In addition, concealed adherence problems in the DR group and unintended dieting in the control group might have distorted the results as it has been observed in primate trials.^[@CR40]^ In general, a precise surveillance of food intake and therefore calorie administration especially in the control group in our study was hindered by the ambulatory trial design and the difference between the modes of diet (formula diet vs. regular food) might represent an influential factor. The use of a formula diet at 100% of calculated DEE could serve as a control in future studies, although ingesting the large amount of formula diet to meet calorie requirements may be challenging. In addition, the calculation of protein intake based on the urinary urea nitrogen appearance potentially leads to an overestimation of protein intake due to activation of nitrogen sparing responses. Calculation of the protein intake of the DR group from the amount of the ingested formula diet instead would suggest a reduction to approximately 45.5 g/day. Eventually, although the significantly profound weight-loss in the DR group in addition to the -- probably even still overestimated -- reduced protein intake indicates a true dietary effect, the aimed-for between-group difference in nutritional intake of 40% was probably not achieved. The fact that the control group might have consumed less calories than 100% of their DEE contributed to this fact. Thus, the true effect of DR might be underestimated Finally, despite the implementation of risk factors for CI-AKI in the inclusion criteria targeted for enrollment of patients at risk for CI-AKI, the protocol-inherent necessity of a time frame of 4 days before PCI consequently excluded high-risk patients (e.g. cardiogenic shock, intra-aortic balloon pump, etc.), which are usually subject to prompt PCI. Consequently, increase of creatinine lagged behind the assumed standardized effect, and calculated group size in this trial was presumably too small to obtain an appreciation of the true potential of DR. Conclusion {#Sec15} ========== The results from this randomized controlled trial show that a 4-day 40%-DR does not prevent CI-AKI at 48 h after PCI. However, analysis of distinct subgroups detected discrete signals of renal protection. This finding together with the good safety and feasibility profile warrants further studies in order to appreciate the true protective effect of dietary interventions. Supplementary information ========================= {#Sec16} Supplemental material. **Publisher's note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information ========================= is available for this paper at 10.1038/s41598-020-61895-2. We thank Cornelia Boehme for excellent help with recruitment and data collection. FG received a research funding from Koeln Fortune, University of Cologne and the German Research Foundation. Designed research: F.G., R.M., I.B., T.B. and V.B. Conducted research: F.G., K.J.R.H.A., M.R.S., E.P. and V.B. Provided essential materials: I.B., T.B., R.P., S.B. and F.G. Analyzed data or performed statistical analysis: F.G., I.B. and V.B. Wrote paper: F.G., V.B. and R.M. Study protocol is provided as Supplemental material. Data described in the manuscript, code book, and analytic code will be made available upon request. The Department II of Internal Medicine and Center for Molecular Medicine Cologne received a research support grant by Fresenius Kabi.

Introduction {#sec1} ============ Peptide nucleic acids (PNA) are synthetic nucleic acid analogues wherein the negatively charged sugar-phosphate backbone is replaced with charge-neutral amide linkages.^[@ref1]^ Nucleobases (A, C, T, and G) are spaced along the peptide backbone such that PNA hybridization with DNA and RNA obeys the rules of Watson--Crick base pairing.^[@ref2],[@ref3]^ PNA offer several advantages over DNA and RNA, including greater binding affinity for complementary oligos,^[@ref4]^ innate resistance to both nuclease and protease degradation,^[@ref5],[@ref6]^ and the ability to form hybrids with less sensitivity to changes in temperature, pH, and ionic strength.^[@ref3],[@ref7]^ These attributes make PNA oligomers ideal candidates for application as antisense therapeutics that block expression of complementary mRNA,^[@ref8],[@ref9]^ therapeutic inhibitors of post-transcriptional gene regulatory micro-RNA (miRNA),^[@ref9]^ and biosensor probes for detection of target nucleic acid hybridization.^[@ref10]−[@ref12]^ A critical requirement for therapeutic or biosensing applications of PNA is stable conjugation to either an intracellular therapeutic delivery platform or a biosensing substrate. In the absence of a delivery vector, PNA therapeutic efficacy is hindered by poor intracellular bioavailability and lack of activity.^[@ref13],[@ref14]^ It is therefore necessary to chemically modify PNA by fusion with cell penetrating peptides or formulation into delivery systems that can mediate cellular internalization and cytoplasmic release.^[@ref9],[@ref11],[@ref15],[@ref16]^ Similarly, biosensing applications require stable integration of PNA at high surface densities onto analytical devices capable of reproducible and sensitive detection of hybridization events.^[@ref10],[@ref12]^ This communication describes a versatile, automated method of synthesizing PNA from a nanostructured material, porous silicon (PSi). The large internal surface area (\>100m^2^/cm^3^), biocompatibility, tunable pore geometry, and biodegradability of PSi have motivated a large body of research into PSi technologies for drug delivery and label-free biosensing.^[@ref17]−[@ref21]^ However, the only reported method of PNA attachment to PSi thus far has been nonspecific adsorption,^[@ref22]^ and there are no published studies for delivery of PNA-based therapeutics using PSi delivery vehicles. Methods have been established for peptide synthesis directly from PSi,^[@ref23]−[@ref25]^ and our group has shown that base-by-base synthesis of DNA directly within PSi films (referred to as in situ synthesis) significantly increases DNA loading relative to attachment of presynthesized oligos.^[@ref26]^ Herein, the first use of PSi as a platform for the automated synthesis and label-free characterization of PNA is reported. It is shown that in situ PNA synthesis increases PNA loading relative to conjugation of the presynthesized molecule. The advantage of this approach is demonstrated for intracellular delivery of a well-characterized anti-miR-122 PNA,^[@ref27]^ which targets a liver-specific miRNA whose suppression has been linked to decreased hepatitis C viremia.^[@ref28]^ Application of this conjugation strategy in selective, label-free nucleic-acid biosensing is also successfully accomplished using a model 16mer PNA probe. Results and Discussion {#sec2} ====================== In Situ PNA Synthesis from PSi {#sec2.1} ------------------------------ PNA synthesized in situ from PSi was compared to PNA loading into PSi using conventional physical adsorption and direct nucleic acid conjugation strategies (detailed methods available in [Supporting Information](#notes-1){ref-type="notes"}). PSi films were etched from p-type Si (0.01 Ω-cm) using 15% hydrofluoric acid in ethanol to form 10-μm-thick single layers (70% porosity, 30 nm average pore diameter) that were then thermally oxidized at 800 °C for 30 min.^[@ref26]^ Anti-miR122 PNA (NH~2~-ACA AAC ACC ATT GTC ACA CTC CA-COOH) was synthesized from the PSi substrate following functionalization with 3-aminopropyltriethoxysilane (APTES). For postsynthesis conjugation and physical adsorption to PSi, the same PNA was synthesized from Rink Amide LL resin (EMD Millipore). For postsynthesis conjugation, cysteine was added to the C-terminus (referred to as "cys-PNA") to provide a reactive thiol used for conjugating to APTES-functionalized PSi via an amine-to-sulfhydryl heterobifunctional cross-linker, *N*-succinimidyl 3-(2-pyridyldithio) propionate (SPDP). All PNA syntheses were performed using fluorenylmethyloxycarbonyl chloride (Fmoc) solid phase chemistry within a PS3 automated peptide synthesizer (Protein Technologies).^[@ref2]^ In situ PNA synthesis was characterized by reflectometry and matrix assisted laser desorption-ionization mass spectrometry (MALDI-MS) (Figure [1](#fig1){ref-type="fig"}; experimental methods available in [Supporting Information](#notes-1){ref-type="notes"}). Reflectometry was used to monitor PNA synthesis from the PSi film by measuring PSi film optical thickness (Figure [1](#fig1){ref-type="fig"}a). Increases in optical thickness are directly proportional to the amount of monomer coupled to growing PNA oligos within the PSi film.^[@ref19]^ Addition of the first 9 bases resulted in a stepwise increase in optical thickness, while the change in optical thickness was increasingly nonlinear for the addition of bases 10--23. To verify synthesis of the desired PNA sequence, in situ synthesized PNA was analyzed by mass spectrometry at two critical points during synthesis: after completion of the 9-mer miRNA seed-targeting sequence and after the full 23-mer anti-miR (Figure [1](#fig1){ref-type="fig"}b). The seed-targeting sequence of therapeutic PNA is the most important miRNA-binding motif,^[@ref27]^ whereas the full 23-mer sequence improves PNA target specificity and anti-miR activity.^[@ref27]^ MALDI spectra of the 9-mer seed-targeting sequence contained a single peak corresponding to the expected molecular weight of the 3-APTES-conjugated PNA, 2485 Da, and two additional, closely spaced peaks corresponding to Na^+^ and K^+^ adducts were resolved at 2507 and 2523 Da, respectively. MALDI spectra of the full 23-mer PNA revealed an intense peak at the expected *m*/*z* for the full PNA oligo, 6243 Da, as well as a series of less intense peaks grouped at molecular weights corresponding to PNA sequences that were truncated during synthesis. It is postulated that steric crowding of the growing PNA oligos within nanosized pores causes the partial truncation seen during in situ synthesis.^[@ref29]^ The molecular length of 3-APTES is approximately 8 Å,^[@ref30]^ and each PNA base extends a growing oligo by approximately 3.5 Å.^[@ref31]^ Thus, the full, 23-mer PNA is estimated to be 8.9 nm in length. Electrochemical porosification of Si produces a Gaussian-like distribution of pore sizes, so while the average pore diameter of PSi films in this study is 30 nm, it is estimated that approximately 40% of the pores are between 10 and 25 nm in diameter.^[@ref32]^ To investigate whether the yield of longer oligos can be improved by increasing the minimum pore size, anti-miR122 PNA was synthesized from a PSi film that was first exposed to a pore-widening solution of potassium hydroxide (KOH) in ethanol at room temperature for 20 min (Figure S4a in the [Supporting Information](#notes-1){ref-type="notes"}). Pore widening increased the average pore diameter by 5 nm and decreased the number of pores with diameter less than 25 nm by ∼20%, resulting in increased shifts in optical thickness during in situ synthesis (Figure S4b in the [Supporting Information](#notes-1){ref-type="notes"}). These data suggest that longer oligos can be more efficiently synthesized within a porous silicon matrix by increasing the average pore size, and although it was outside the scope of our testing, it may also be beneficial to utilize a fabrication method that yields more homogeneous pores. Since pore widening improved synthesis of the 23-mer anti-miR122, it was implemented for in vitro functional studies, i.e., cytotoxicity and bioactivity assays (all other studies were done with non-pore-widened substrates). Overall, these results, combined with subsequent experimental readouts, are a promising demonstration of successful synthesis of functional 23-mer PNA from PSi, with highly efficient growth of the vital anti-miR122 PNA seed sequence. {#fig1} Optical thickness measurements were also used to determine the amount of anti-miR122 PNA loaded within PSi through in situ synthesis compared to standard methods of physical adsorption and conjugation of presynthesized PNA (Figure [1](#fig1){ref-type="fig"}e). Consistent with our previous studies of DNA conjugation to PSi,^[@ref26]^ PNA loading from in situ synthesis was 8-fold greater than the amount of PNA loading achieved from conjugation to a PSi surface. This corresponds to a yield of 8.6 × 10^--4^ mol PNA/g PSi, or 5.3 g PNA/g PSi for anti-miR122 synthesized in situ in non-pore-widened PSi, quantified by measuring the absorbance at 260 nm of PNA released after dissolution of the PSi matrix. It is postulated that during PNA loading by direct conjugation, PNA preferentially attaches nearer to the pore openings at the film surface, thereby restricting access of PNA deeper into the pores. Interestingly, there was no significant difference in the loading efficiency of in situ synthesis and physical adsorption within the pores. It is hypothesized that, in the case of nonspecific PNA loading by adsorption, lack of PNA covalent binding allows PNA to freely diffuse further into the pores and achieve a level of loading similar to in situ synthesis. Although nonspecific adsorption yielded a similar level of loading, we show in the following sections that the covalent attachment achieved from in situ synthesis provides more sustained release in the context of therapeutic PNA delivery and a more stable and reproducible substrate for biosensing. Intracellular Delivery of In Situ Synthesized Therapeutic PNA {#sec2.2} ------------------------------------------------------------- To evaluate the potential of therapeutic delivery of in situ synthesized PNA from PSi, the in vitro PNA temporal release profiles were compared for physically adsorbed and in situ synthesized PNA from PSi films (Figure [2](#fig2){ref-type="fig"}a). Release of PNA synthesized in situ was significantly (*p* \< 0.005) less than adsorbed PNA at every time point within the first 24 h, and overall, the PNA synthesized in situ showed reduced initial burst and more sustained release profiles. Because in situ synthesized PNA are covalently attached to pore walls, it is anticipated that hydrolytic degradation of the PSi matrix is the primary mechanism of PNA release, providing a means for more sustained PNA delivery when compared to physical adsorption.^[@ref18],[@ref25]^ Mass spectra in Figure [1](#fig1){ref-type="fig"}b provide support for a surface-degradation PNA release mechanism, as the molecular weight of the PNA released from in situ films corresponds to 3-APTES-conjugated PNA. For eventual in vivo applications, it is anticipated that reducing the burst release upon initial contact with physiological (aqueous) environments will ultimately improve drug bioavailability at the site of action, especially for intravenous delivery applications. PNA anti-miR activity is dependent upon delivery into the cytoplasm where active micro-RNA is located.^[@ref27]^ To demonstrate the application of in situ PNA synthesis for therapeutic purposes, anti-miR122-loaded multilayer PSi films ([Supporting Information](#notes-1){ref-type="notes"} Figure S5) were ultrasonically fractured to produce PNA-functionalized PSi nanoparticles (PSNPs). The resultant PSNP mean size (236 nm) and size distribution were determined by Nanoparticle Tracking Analysis^[@ref33]^ (NTA) and confirmed by scanning electron microscopy (SEM) (Figure [2](#fig2){ref-type="fig"}b). ![(a) Cumulative release of physically adsorbed PNA and in situ synthesized PNA in PBS at 37 °C. Release of in situ synthesized PNA was significantly lower (*p* \< 0.005) for time points within the boxed region. (b) PNA--PSNP size distribution characterized by NTA. Inset: Representative SEM image demonstrating PSNP size and morphology (scale bar = 400 nm). (c--f) Confocal micrographs of Huh7 cells incubated for either 1 or 24 h with (c and d) free PNA, or (e and f) PNA--PSNPs at a 2 μM dose of anti-miR-122 PNA (3.7 μg/mL PSNPs for PNA--PSNP treatments). Labels: Hoechst nuclear dye (blue), Alexa-488 labeled PNA (green). (g) PSNPs had no significant effect on Huh7 cell viability relative to untreated negative control samples, in contrast to a 2′OMe-modified AMO delivered with Fugene 6 (*p* \< 0.05). (h) Anti-miR122 activity indicated by luciferase activity in Huh7 psiCHECK-miR122 cells 44 h after treatment with free PNA, empty PSNPs, or PNA--PSNPs (2 μM dose of anti-miR-122 PNA, 3.7 μg/mL PSNPs). Results are normalized to cell number and expressed relative to luciferase activity in Huh7 psiCHECK-miR122 control cells without treatment. Dashed green line indicates anti-miR122 activity 44 h after treatment with 2 μM of an optimized anti-miR-122 AMO^[@ref34]^ delivered via the Fugene 6 commercial transfection reagent.](bc-2014-001092_0003){#fig2} Huh 7 human hepatic carcinoma cells were selected for evaluation of PNA--PSNP cellular uptake, cytotoxicity, and anti-miR activities because they express elevated levels of miR122 and thus provide a good platform for testing anti-miR122 therapies (detailed cell culture and biological assay methods can be accessed in the [Supporting Information](#notes-1){ref-type="notes"}).^[@ref27],[@ref35]^ Intracellular delivery of a 2 μM dose of fluorescently labeled free or in situ synthesized PSNP anti-miR122 PNA was evaluated by confocal microscopy (Figure [2](#fig2){ref-type="fig"}c--f). At each treatment time, cells treated with PNA--PSNPs showed greater intracellular delivery of PNA relative to those treated with free PNA. Additionally, a lactate dehydrogenase enzymatic assay was used to compare the cytotoxicity of PNA--PNSPs to that of a 2′OMe-modified anti-miR oligonucleotide (AMO) delivered by the commercial transfection reagent, Fugene 6 (Promega) (Figure [2](#fig2){ref-type="fig"}g). Consistent with previous studies on the cytotoxicity of thermally oxidized PSi nanoparticles,^[@ref36]^ no reduction in cell viability was observed for the PSNP concentration investigated in this study (2 μM PNA, 3.7 μg/mL), whereas the AMO treatment led to a 25% decrease in cell viability at an equivalent AMO dose of 2 μM. Finally, Huh7 cells stably transfected with a psiCHECK-miR122 *Renilla* luciferase reporter for endogenous miR122 activity^[@ref35]^ were used to determine the anti-miR activity of PNA in situ synthesized on pore-widened PSi prior to ultrasonic particle formation (Figure [2](#fig2){ref-type="fig"}h). With this reporter, luciferase is translated upon inhibition of miR122. PSNP delivery of a 2 μM dose of in situ synthesized anti-miR122 PNA triggered a significant, 44% increase in luciferase activity at 44 h after treatment, while treatment with an equivalent dose of free PNA or empty PSNPs had no significant effect relative to untreated controls. These results provide evidence that PSNPs improve the intracellular delivery and bioactivity of therapeutic PNA without the need for fusion with cell-penetrating peptides, or use of cytotoxic transfection reagents, such as that used to deliver the AMO control in this study. DNA Biosensing using in Situ Synthesized PNA Probes {#sec2.3} --------------------------------------------------- To demonstrate the utility of in situ PNA synthesis in biosensing, a model 16-mer probe PNA was synthesized from a 10 μm thick single-layer PSi film. For biosensing applications, PNA probes must be stably bound to the PSi substrate to achieve accurate and reproducible detection;^[@ref37]^ hence, the PNA adsorption approach is not an effective approach for fabricating PSi biosensors (Figure S6 in the [Supporting Information](#notes-1){ref-type="notes"}). Biosensor selectivity was evaluated by incubating with 10 μM solutions containing either a 100% complementary DNA target (NH~2~-A CGA GGA CCA TAG CTA-COOH) or a 100% mismatch DNA sequence (NH~2~-G GTT TCT GAT GCT GAC-COOH). As shown in Figure [3](#fig3){ref-type="fig"}, negligible change in optical thickness was observed following incubation with either the mismatch DNA sequence or buffer alone, suggesting that there are no significant nonspecific binding events. In contrast, incubation with the complementary DNA target significantly increased the film optical thickness, confirming that DNA hybridized to the complementary PNA probe molecules. This is the first demonstration of selective nucleic acid biosensing with a covalently functionalized PNA--PSi biosensor. Further studies will be conducted to investigate whether PSi nucleic acid biosensors based on in situ synthesized PNA have superior selectivity and sensitivity relative to traditional DNA probe molecules, as has been suggested for other biosensing platforms.^[@ref10],[@ref12]^ {#fig3} Conclusions {#sec3} =========== A new method for automated PNA synthesis from PSi has been developed and applied for drug delivery and biosensing. The optical properties of nanostructured PSi were exploited to nondestructively monitor synthesis progression with single-base resolution. In situ synthesis addresses the need for efficient, covalent conjugation of PNA to PSi, as demonstrated by 8-fold greater PNA loading when compared to covalent attachment of presynthesized PNA to the surface via a cross-linker. The versatility of this in situ synthesized PNA platform was demonstrated by employing it for proof-of-concept drug delivery and nucleic acid biosensing applications. In situ synthesized anti-miR122-loaded PSi nanoparticles were biocompatible and increased the intracellular delivery and bioactivity of therapeutic PNA, while PNA probes synthesized from a PSi biosensor exhibited selective hybridization to DNA target molecules. Taken together, these studies demonstrate the utility of this conjugation strategy for developing improved systems for controlled intracellular delivery of PNA therapeutics, as well as more selective and sensitive nucleic acid biosensors. Detailed experimental methods and schematics for in situ synthesis, physical adsorption, and direct conjugation of PNA. Detailed mass spectrometry experimental methods. In situ PNA synthesis in pore-widened PSi. Experimental methods for in vitro PNA release study. Experimental methods for generating porous silicon nanoparticles, including characterization of multilayer PSi film by scanning electron microscopy. Cell culture protocols and experimental methods for biological assays. Adsorbed PNA surface stability study. This material is available free of charge via the Internet at <http://pubs.acs.org>. Supplementary Material ====================== ###### bc5001092_si_001.pdf The authors declare no competing financial interest. The authors gratefully acknowledge Brian Evans for helpful discussions and assistance with peptide synthesis and HPLC, and Dr. Christopher Nelson for help with confocal microscopy and cell culture. The authors would also like to thank Dr. Alexander Deiters' group at North Carolina State University for kindly providing the cell lines used in this study, Dr. Robert Coffey's group at Vanderbilt University for access and assistance to the Nanosight used for NTA analysis, and Dr. John McLean's group at Vanderbilt University for providing access and technical expertise with MADLI-MS. This work was supported in part by the National Science Foundation (DMR-120701 and ECCS-0746296), the Army Research Office (W911NF-09-1-0101), and a National Science Foundation Graduate Research Fellowship to KRB. Confocal Imaging was performed in part through the use of the VUMC Cell Imaging Shared Resource, (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and Ey008126). PNA : peptide nucleic acid PSi : porous silicon miR : microRNA

INTRODUCTION ============ *In vitro* cancer cell culture experiments provide the opportunity of analysing and modelling the complex mechanisms of tumour biology through facile experimental manipulations, global as well as detailed mechanistic studies. They are, therefore, of significant aid in molecular biomedical research. A crucial role of cancer cell lines for medical, scientific and pharmaceutical institutions was elucidated by systematic analysis on lung cancer cell lines ([@gks1012-B1],[@gks1012-B2]). They revealed not only the amazingly complex role of the cancer genome but also identified and characterized driver mutations in those cell lines. Further studies on cancer cell lines lead to the characterization of tumor protein 53 (TP53) and the understanding of multiple genetic mutations, mutant allele-specific imbalances and copy number losses in cancer ([@gks1012-B3]). Moreover, the ability to translate these findings to clinical applications had led to rational therapeutic drug selection ([@gks1012-B6]). For example, activating mutations in the epidermal growth factor receptor (EGFR) kinase domain have major clinical implications in lung cancer, and it was shown in cell line experiments that tumours with this mutation are sensitive to tyrosine kinase inhibitors ([@gks1012-B7]). However, repeatedly a varying response to treatment or targeted manipulation of gene expression was observed in diverse cancer cell lines. This was attributed to a diverse genetic background and, subsequently, a diverse gene expression. Thus, information on these diverse gene expression profiles in cancer cell lines may be crucial to experimental designs of modelling cancer *in vitro* and testing for novel therapeutic approaches. We have, therefore, generated CellLineNavigator, a workbench for the biomedical community, which allows querying the transcriptom of a great variety of cancer cell lines to screen for the most suitable cell line for upcoming experiments. To enlarge the scope of this database, the data were linked to common functional and genetic databases, enabling querying for a more systematic view on cell line expression profiles. In summary, we have generated a comprehensive database containing expression profiles of 317 cancer cell lines representing 57 different pathological states and 28 individual tissues. This database will aid the design of *in vitro* experiments in cancer research, as it will allow taking the genetic background of these cell lines into consideration. The CellLineNavigator database is publicly available at <http://www.medicalgenomics.org/celllinenavigator/>. MATERIALS AND METHODS ===================== Data source, data processing ---------------------------- Genome-wide expression data of multiple cell lines, freely available at ArrayExpress \[database ID: E-MTAB-37 ([@gks1012-B8])\], were publicly provided by Greshock *et al.* (Laboratory of Cancer Metabolism Drug Discovery, GlaxoSmithKline, Collegeville, PA, USA). The cell lines were handled as previously described ([@gks1012-B9]). Briefly, the transcript abundance of 317 cancer cell lines was analysed using the Affymetrix Human Genome-U133 Plus2 GeneChip technology. This chip covers the complete human genome for analysis of \>45 000 transcripts and \>19 000 genes. All data were available in technical triplicates. Corresponding information on tissue site and disease state was supported for each cell line ([Figure 1](#gks1012-F1){ref-type="fig"}). Figure 1.Distribution of tissues within CellLineNavigator. The differential expression was analysed using the R-Project ([@gks1012-B10])/bioconductor ([@gks1012-B11]) suite with the following additional libraries: 'affy' ([@gks1012-B12]), 'hgu133plus2.db' ([@gks1012-B13]) and 'frma' ([@gks1012-B14],[@gks1012-B15]). After quality control, two microarray experiments (cell line SNU398---Replicate 1 and cell line SNU423---Replicate 2) were neglected for further analysis because of insufficient RNA level detection. All data were normalized using the 'expresso' function of the 'affy' package and following settings: background adjustment method: 'mas', normalization method: 'quantiles', PerfectMatch (PM) adjustment method: 'mas' and the method used for the computation of expression values: 'medianpolish'. Next, we calculated the expression median for each probe set for all cell lines. These values were subsequently used as control to calculate log2 transformed expression ratios (*M*-values), after the median expression was calculated for each cancer cell line. *M*-values representing the expression levels of tissue sites and disease states were calculated accordingly. Gene expression barcodes were generated using the 'frma' (frozen robust multiarray analysis) (default options) and 'barcode' (output: *Z*-score) function implemented in the 'frma' package. A frma *Z*-score of \>5 suggested that a gene is expressed in a particular tissue. The frma *Z*-score was generated to allow comparison of the expression profiles with data already present at medicalgenomics.org ([@gks1012-B16],[@gks1012-B17]) and other microarray data sets processed with the frma method. Official gene symbols and National Center for Biotechnology Information (NCBI) Entrez GeneIDs were assigned to the data using the 'hgu133plus2.db' package. To enable an integrative comparison and querying between gene expression and biological function information, all data were linked to commonly used and established bioinformatics databases and knowledge repositories, such as NCBI Entrez database ([@gks1012-B18]), HUGO Gene Nomenclature Committe (HGNC) ([@gks1012-B19]), Human Protein Reference Database (HPRD) ([@gks1012-B20]), Online Mendelian Inheritance in Man (OMIM) ([@gks1012-B21]), BioGPS ([@gks1012-B22]), Nextbio ([@gks1012-B23]) and Gent ([@gks1012-B24]). Moreover, the Kyoto Encyclopaedia of Genes and Genomes (KEGG) ([@gks1012-B25]) was connected to identify gene signalling and molecular pathway associations. Data on cellular component, biological process and molecular function were collected from the Gene Ontology database ([@gks1012-B26]). Finally, the CellLineNavigator was cross-linked to our RNA-Seq expression profiling database on normal tissues, RNA-Seq Atlas ([@gks1012-B16]), and our liver-specific Library of Molecular Associations \[LoMA ([@gks1012-B17])\]. Data organization and Webinterface ---------------------------------- The backbone of CellLineNavigator is a Linux-Postgre SQL-Apache-PHP stack implemented in a content management system (Drupal: <http://drupal.org/>). The database organization is founded on a menu, allowing to directly accessing the following sections: news, data, search, download and help section. Information on current statistics and recent changes were posted in the news section to keep the users up-to-date, whereas the download section provides the possibility to download the complete CellLineNavigator database in tab separated text file format. CellLineNavigator may easily be accessed through a simple (data section) or advanced querying interface (search section). The data section offers the possibility to explore tissues (default) or disease states ([Figure 2](#gks1012-F2){ref-type="fig"}). Filtering options for expression levels within individual tissues or disease states are supported. The default filter is set to list all genes with a different expression level of at least 2-fold in comparison with the respective control. Six additional levels of expression filtering are supported (from 1.5- to 5-fold). However, the user may also set the filter criteria to none (no filter) or no regulation (list all genes whose *M*-values are in the range of −1 to +1). Figure 2.The data section offers the possibility to explore tissues or disease states. In default, the user will get a list of all genes that have shown a different expression level of at least 2-fold in comparison with the respective control within the specific tissues. The set view option allows the user to switch between tissues and disease state views. Additional six filter options for expression levels are supported (default 2-fold). Further, the user can set the expression filter criteria to none (no filter) or no regulation (list all genes whose *M*-values are in the range of −1 to +1). To allow users a more customizable way in displaying the data, the user may change the cut-off criteria for differentially expressed genes (default: 2-fold). To allow users a high degree of flexibility to access CellLineNavigator, we implemented an advanced search section, offering the user 'Fulltext search' or 'Explore profile' options ([Figure 3](#gks1012-F3){ref-type="fig"}). The 'Fulltext search' may be used to query for individual genes provided by the user to query for expression levels within specific cell lines, tissues or disease states (or any combination of all). Using the 'Explore profile' query option, the user may query for specific expression levels classified in the fields of (i) genes (ii) KEGG pathway maps (iii) gene ontologies (iv) cell lines (v) tissues or (vi) disease states. Again, a combination of all query types is possible. Moreover, the user may also define cut-off criteria to filter for specific expression levels. The resulting gene list is shown in an interface providing the same features mentioned in the data section with one exception, the filter criteria is adjusted to the preceding query. These features may again be used for further filtering the resulting gene list. Figure 3.The search section allows users to choose between the 'Fulltext search' or 'Explore profile' option. In the 'Fulltext search', the user can provide a gene list that can be queried for expression levels within specific cell lines, tissue sides or disease states (or any combination of all). The 'Explore Profile' allows the user to query for specific expression levels classified in the fields (i) gene, (ii) KEGG pathway maps, (iii) Gene Ontology, (iv) cell line, (v) tissue side or (vi) disease state. A combination of all query types is possible. Additionally, the user may define a cut-off criteria to filter for specific expression levels. To allow users a more customizable way of displaying the expression results, an extra option for setting the regulation view is supported (default: 2-fold). Moreover, a powerful resource within our database extending the full impact of the individual gene--cell line relations is provided in the details section ([Figure 4](#gks1012-F4){ref-type="fig"}). This section may be accessed by either clicking on the detail link or the specific expression icon in the results tables. It provides additional information on gene symbol, description, aliases, chromosomal location, Entrez ID, Ensembl ID, Gene Ontology, KEGG pathway and expression profiles. Although the expression profiles were individualized to the previous user query, for example, did the user click on the expression icon of tissue side 'bladder', the details view will show a barchar with an overview of the expression within all tissues and, more importantly, with a barchar representing the specific expression values of the cell lines corresponding to the tissue of interest. For further comparison with already available data at medicalgenomics.org, such as RNA-Seq Atlas, the details view may be switched from *M*-value to frma *Z*-score representation. Figure 4.The details section offers a powerful option to access the full impact of the individual gene--cell line relation. The expression profiles are individualized to the previous user query, for example, if the user is interested in the expression of the tissue 'bladder', the details view display a barchar showing an overview of the expression within all tissues and, more importantly, with a barchar representing the specific expression values of the cell line(s) corresponding to the to the tissue 'bladder'. Further, additional information on gene symbol, description, aliases, chromosomal location, Entrez ID, Ensembl ID, Gene Ontology and KEGG pathway are supported. Finally, a major strength of the database is its direct connection to the Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources ([@gks1012-B27]). Gene lists generated in CellLineNavigator may automatically be transferred to the DAVID analysis tools. DISCUSSION ========== The current scope of biomedical studies on tumorigenesis requires a tremendous amount of human tumour material. Stringent restrictions on the international exchange of biological reagents and increasing requirements from institutes, ethics committees and government are limiting the availability of those human tumour materials. Thus, *in vitro* cell culture is highly useful for modelling the complex mechanisms of cancer development to identify molecular mechanisms related to tumour development and potential therapeutic targets. Cell lines are capable of infinite replication and, therefore, offer an unlimited source of biomedical material that can be distributed to laboratories worldwide and thus, allow direct comparison of research results if originating from identical material. As a matter of fact, these cell lines are widely used in biomedical research. However, the detailed knowledge about their genetic profiles is still limited and has not been summarized in a large comparative database. Diverse biological behaviour of cancer cell lines may result from diverse underlying genetic profiles and expression signatures, which may differ significantly among immortalized tumour cell lines. The awareness of these differences makes it useful/necessary to take the diverse gene expression signatures into account, especially while planning targeted strategies to influence the biological behaviour. Large scale microarray experiments to unravel the genetic profile of these cell lines are available through public databases, such as ArrayExpress ([@gks1012-B8]) of Gene Expression Omnibus ([@gks1012-B28]). However, the analysis of these data is hardly feasible for biologists or physicians without substantial bioinformatics skills or at least knowledge on microarray analysis. Even with profound experience in microarray technology, analysis of such data is complex and time consuming task. So far to our knowledge, the Gene Expression Atlas ([@gks1012-B8]) is the only database that provides access to these cell line expression profiles. However, the main focus of this database is not on cancer cell lines, and thus, it just contains the expression profile of ∼90 cell lines from various species. Moreover, not only the classification into specific phenotypes but also data collected from multiple laboratories are incomplete and, therefore, exhibit multiple experimental conditions, making a comparison between the multiple expression profiles extremely difficult. The database, CellLineNavigator, presented here contains gene expression profiles of \>300 human cancer cell lines. These expression profiles were generated in the same laboratory under nearly the same experimental conditions and thus, guarantee a highest degree on comparability. Further, depending on phenotypic information, these cell lines were classified into corresponding tissues of origin and disease states. The main focus of CellLineNavigator is not simply on summarizing these data but rather on an easy and user friendly availability as well as the linkage to advanced bioinformatics analyses tools. To guarantee easy data access and connectivity, we implemented a mostly self-explaining Web application as a user friendly front end to the data base. This Web application allows users to query for (i) differentially expressed genes; (ii) pathological (e.g. melanoma) or physiological (e.g. lung) conditions or (iii) gene names or functional attributes, such as KEGG pathway maps. A combination of all query types is possible. Comparative analysis of differential gene expression between cell lines or diseases of interest will initially often result in (large) lists of genes being differentially regulated. To further characterize the differences between the respective samples and thus a major advance in the usability of this database, these collections of genes need to be further characterized with respect to functional or structural similarities. We, therefore, chose to link and provide an automated data transfer of gene lists of interest to DAVID, a large bioinformatics suite providing functional and structural analyses, such as pathway enrichment, gene ontology enrichment or analysis of functional domains. This automated linkage to DAVID brings our database resource and analysis tool to the next level of not only comparing genetic changes but also functionally and structurally characterizing the differences by means of advanced bioinformatics. In summary, CellLineNavigator is the first database providing comprehensive summary, display and analysis options for gene expression data of the most commonly used cancer cell lines. It provides access to large microarray data sets without advanced bioinformatics skills. Thus, CellLineNavigator may be of significant aid for *in vitro* modelling of cancer mechanisms and testing of novel therapeutic approaches. FUNDING ======= Boehringer Ingeheim Funds and Roche (to AT). Funding for open access charge: Department of Medicine I of the Johannes Gutenberg University Mainz. *Conflict of interest statement*. None declared.

Introduction {#s1} ============ In virtually every context where they have been studied, inequalities in health outcomes based on living standards or on social hierarchy (as observed through various measures of socio-economic position, SEP) have been identified.[@pone.0093032-Marmot1] This association is hypothesised to arise mainly on the basis of causal pathways, encompassing healthcare access and utilisation, psychosocial determinants, health knowledge and behaviours, as well as environmental hazards.[@pone.0093032-Marmot2]--[@pone.0093032-Stowasser1] As one of these pathways, health-seeking behaviour comprises several sequential decisions and actions through which individuals proceed in their contact with the healthcare system; including experiencing and reporting symptoms, seeking care, choosing a provider, paying for care, adhering to treatment, as well as timing and intensity of follow-up visits. Health-seeking behaviour includes preventive (immunisation or screening) and curative care (after the onset of symptoms). A review of socio-economic determinants of health-seeking behaviour in low and middle income countries indicated that a variety of individual and households-level indicators have been used to reflect socio-economic position, including education, occupation, absolute or relative poverty level, and access to material, financial and productive resources (income, landholding, assets).[@pone.0093032-Tipping1] Rigorously evaluated interventions, such as conditional cash transfer (CCT) programs, showed that provision of cash transfers to female heads of households can lead to an increase in healthcare utilization patterns.[@pone.0093032-Lagarde1] Socio-economic status is hypothesised to influence health-seeking behaviour through several mechanisms, such as material and intellectual resources and access to health facilities.[@pone.0093032-Mechanic1], [@pone.0093032-Andersen1] However, individuals rarely make health-related decisions in a social vacuum and their socio-economic position is not solely an individual-level characteristic. Therefore, the association between SEP and health-seeking behaviour can be examined on various levels, spanning from the individual and familial environment, to the wider community and country. Objectives {#s1a} ---------- The objective of this systematic review is to identify and synthesise evidence published in the previous two decades about the existence, magnitude and trends in socio-economic gradients in health-seeking behaviours related to maternal and child health in Egypt. Firstly, a summary of the types and dimensions of health-seeking behaviour analysed by included studies is presented. Secondly, we synthesise the evidence regarding the extent of gradients identified, and lastly, limitations of current evidence and recommendations for future research are outlined. Maternal health-seeking behaviour for the purposes of this review refers to the timing and intensity of care, as well as provider choice and cost incurred during pregnancy, childbirth and in the immediate post-partum period. Child health-seeking behaviour is defined as actions taken in relation to healthcare for children under five years of age. Preventive and curative health-seeking behaviours are included. Methods {#s2} ======= Data sources and search strategy {#s2a} -------------------------------- Four databases (Medline, Embase, Global Health and Web of Science) were searched in September 2013 for material published in English from 1992 to 2013. Where available, MeSH terms were combined with free-text terms capturing components of health-seeking behaviour (access, utilization, provider selection, and cost of care), a wide range of indicators of socio-economic position (education, literacy, employment, wealth, income, consumption, expenditure, assets, poverty, indebtedness) and geographic limitation to Egypt. The reference lists of included articles were also screened. The complete search strategy is presented in [Table 1](#pone-0093032-t001){ref-type="table"}. The review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline ([Table S1](#pone.0093032.s001){ref-type="supplementary-material"}).[@pone.0093032-Moher1] The review protocol was not registered. 10.1371/journal.pone.0093032.t001 ###### MeSH and text search terms used in databases searched according to algorithm (1 AND 2 AND 3). {#pone-0093032-t001-1} Search Concept Text search terms MeSH terms ------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- **Database** (Medline, Embase, Global Health and Web of Science) (Medline, Embase and Global Health) **1. Health-seeking behaviour** ((health OR health-care OR healthcare OR health-related OR provider OR help OR care OR therap[\*](#nt101){ref-type="table-fn"} OR treatment) AND (seeking OR behavio?r OR decision OR choice[\*](#nt101){ref-type="table-fn"} OR utili?ation OR narrative OR network)) OR ((illness OR sick[\*](#nt101){ref-type="table-fn"}) AND (perception OR narrative)) OR ((out?of?pocket OR private OR health) AND (expen[\*](#nt101){ref-type="table-fn"} OR cost[\*](#nt101){ref-type="table-fn"} OR payment OR fee OR charge)) OR pathways to doctor OR pathways to the doctor OR health-seeking OR help-seeking OR care-seeking **Medline:** Attitude to Health, Health Behavior, Illness Behavior, Direct Service Costs, Cost of Illness, Fees, Medical. **Embase:** health related behavior, patient attitude, health care utilization, health care access. **Global Health:** health care utilization, social barriers, Health care costs. **2. Socio-economic determinants** socio-economic OR socioeconomic OR social status OR social class OR social position OR economic position OR poverty OR inequalit[\*](#nt101){ref-type="table-fn"} OR gradient[\*](#nt101){ref-type="table-fn"} OR deprivation OR SES OR SEP OR employment OR occupation OR unemployment OR education[\*](#nt101){ref-type="table-fn"} OR school[\*](#nt101){ref-type="table-fn"} OR graduat[\*](#nt101){ref-type="table-fn"} OR literacy OR numeracy OR income OR wage OR pension OR salary OR wealth OR asset[\*](#nt101){ref-type="table-fn"} OR loan OR debt OR borrow[\*](#nt101){ref-type="table-fn"} OR consumption OR expenditure OR spend[\*](#nt101){ref-type="table-fn"} OR housing OR crowding OR determinant[\*](#nt101){ref-type="table-fn"} OR sociodemographic **Medline:** Socioeconomic Factors, Sociometric Techniques, Social Class. **Embase:** Social status. **Global Health:** Socioeconomic status. **3. Egypt** Egypt[\*](#nt101){ref-type="table-fn"} **Medline, Embase, Global Health:** Egypt. \* Truncation symbol. Study selection and data extraction {#s2b} ----------------------------------- Abstracts of all references identified in searches were screened and discarded if they did not contain data from Egypt or maternal or child health-seeking behaviour as an outcome measure. Cognizant of the fact that SEP indicators may be included in analyses as confounders and may thus not be identified as exposures in the abstracts, full-text versions of remaining references were screened. At this stage, we eliminated studies without SEP as an exposure or confounder, those in which the SEP variable used was not clearly defined, and those not presenting any statistical test (p value, confidence interval or standard error) of the association between SEP and health-seeking behaviour. Descriptive information abstracted from studies included study design, study objective, study population and data sources, type of health-seeking behaviour examined and measures of SEP used. We classified each study according to its main objective into one of the following three groups: SEP was the main determinant examined by the study, SEP was one of the several risk factors examined by the study or SEP was one of the confounders used in the study. Abstracted information on study findings included type of statistical analysis and tests used, crude and adjusted parameters that quantified the association between SEP measure(s) and health-seeking behaviour outcomes and confounders included in adjusted analyses, if any. No data were obtained from investigators, but results were confirmed with authors of Stephenson et al (2012). For the results of Gwatkin et al (2007), binary significance levels of the concentration indices (\<0.05, \>0.05) were calculated by using the standard errors by this study. Analysis {#s2c} -------- No meta-analysis was performed due to insufficient number of comparable estimates for any single health-seeking behaviour. Findings of studies were described and synthesised in a narrative format. The results of analyses are presented separately for each dimension of health-seeking behaviour: 1) Seeking any care, 2) Type of care sought/received, 3) Intensity of care received, and 4) Cost of care incurred, based on a conceptual approach used by Pokhrel and colleagues.[@pone.0093032-Pokhrel1] A risk of bias assessment was developed based on the Newcastle-Ottawa quality assessment scale.[@pone.0093032-Wells1] This tool was used in consideration of the strengths and limitations of the available evidence. Results {#s3} ======= A total of 786 unique references were identified and screened. The majority (83%) of excluded references did not examine any component of health-seeking behaviour. From 64 references reviewed in full-text, 10 articles met the inclusion criteria ([Figure 1](#pone-0093032-g001){ref-type="fig"}). Six studies examined maternal health-seeking behaviours and five studies child health-seeking behaviours ([Tables 2](#pone-0093032-t002){ref-type="table"} and [3](#pone-0093032-t003){ref-type="table"}, respectively, studies listed in chronological order by year of publication); one study included both behaviours. Among the ten included studies, nine set out to examine the association between socio-economic position and health-seeking behaviour, either as the main exposure or one of several main exposures. {#pone-0093032-g001} 10.1371/journal.pone.0093032.t002 ###### Descriptive characteristics of included maternal health-seeking behaviour studies. {#pone-0093032-t002-2} \# Author, Year Study design Study sample and objective Exposure: SEP definition Outcome: Health-seeking behaviour(s) -- type, definition and level in sample ---- ---------------------------------------------------- ----------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 1 Abdel Houssein, 1997[@pone.0093032-AbdelHoussein1] Cross-sectional Pregnant women in third trimester attending 6 randomly selected MCH centers in Alexandria, all pregnant women in third trimester interviewed (no date of study provided), n = 240. SEP: One of risk factors. **IS: Education level** (no information on number or types of categories). **HH: Family SES score** based on education (woman and husband), monthly per capita income (no further information), crowding and household sanitation. **Pattern of attendance of ANC clinics:** based on timing of initial visit (1^st^ ANC visit during 1^st^ trimester) and total number of ANC visits for current pregnancy; classified (no further information) into adequate and inadequate. Level: 28.8% adequate. 2 Yassin et al., 2003[@pone.0093032-Yassin1] Cross-sectional 6 villages in Beni Sueif, all mothers of children less than one year old living in an area around a sentinel site (no date of study provided), n = 231. SEP: One of risk factors. **IS: Literacy** (binary), **occupation** (binary). **IO: Spouse literacy** (binary), **spouse occupation** (binary). **HH: Land ownership** (binary), **house ownership** (binary), **cattle ownership** (binary), **access to potable water** (binary), **meat consumed \<4 times in previous month** (binary). **Receipt of any ANC** at local primary center during most recent pregnancy (with child \<1 year old). Level: 33.8% received any ANC. 3 Gwatkin et al., 2007[@pone.0093032-Gwatkin1] Cross-sectional EDHS 1995, 2000. Population representative sample of ever-married women. Last birth among women with at least one birth in the five years preceding the survey, n: 1995 = 7797, 2000 = 7953. SEP: Main determinant. **HH: DHS Wealth index quintile.** **Any ANC by a medically-trained person** (at least one consultation from a doctor, nurse or trained midwife). Level: 1995: 42.5%, 2000: 55.7%. **Multiple (3+) ANC visits with medically-trained person.** Level: 1995: 34.9%, 2000: 43.7%. **Delivery with skilled attendance** (doctor, nurse or midwife). Level: 1995: 46.2%, 2000: 60.9%. **Delivery location: Public facility.** Level: 1995: 17.9%, 2000: 22.2%. **Delivery location: Private facility.** Level: 1995: 14.6%, 2000: 26.0%. **Delivery location: Home (woman's or another home).** Level: 1995: 67.0%, 2000: 51.7%. 4 Khadr, 2009[@pone.0093032-Khadr1] Cross-sectional EDHS 1995, 2000, 2005 Population representative sample of ever-married women. Last birth among currently married women with at least one birth in the 5-years preceding survey; n: 1995 = 7828, 2000 = 7823, 2005 = 9744. SEP: Main determinant. **IS: Education level** (no education, some primary, primary to secondary, completed secondary and higher). **HH: DHS Wealth index quintile.** **Any ANC received** (no further definition). Level: 1995: 42.4%, 2000: 54.1%, 2005: 71.4%. **Regular ANC received** (4+ visits during pregnancy). Level: 1995: 31.0%, 2000: 40.7%, 2005: 61.3%. **Delivery with skilled attendance** (no further definition). Level: 1995: 41.7%, 2000: 55.8%, 2005: 70.5%. **Home delivery.** Level: 1995: 64.5%, 2000: 49.1%, 2005: 33.6%. 5 Chiang et al., 2012[@pone.0093032-Chiang1] Cross-sectional 2007 survey of married women \<50 years from a Giza village, n = 189. SEP: One of risk factors. **IS: Woman\'s education** (no primary, completed primary or higher), **existence of cash income** (binary). **IO: Husband\'s education** (primary school or lower, higher than primary). **Regular ANC (4+ visits) during most recent pregnancy. Level: 48.7%. Delivery with skilled medical professional at most recent delivery.** Level: 79.4%. **Delivery in a health facility at most recent delivery.** Level: 61.4%. 6 Stephenson et al., 2012[@pone.0093032-Stephenson1] Cross-sectional EDHS 2008. Population representative sample of ever-married women. Last birth among women with at least one birth in the five years preceding the survey, n = 7813. SEP: One of risk factors. **C: Community-level economic prosperity** - mean score of household wealth (DHS wealth score) per PSU (primary sampling unit), continuous variable. **Any ANC received** (from a medically trained person). Level: 73.23%. **Regular ANC received** (4+ visits). Level: 65.75%. **First ANC visit received in 1^st^ trimester.** Level: 59.48%. **Delivery in a health facility.** Level: 71.25%. EDHS -- Egypt Demographic and Health Survey. Measures of SEP: **IS**: Individual -- self, **IO:** Individual-- other (spouse, mother, etc), **HH:** Household-level, **C**: Community-level. 10.1371/journal.pone.0093032.t003 ###### Descriptive characteristics of included child health-seeking behaviour studies. {#pone-0093032-t003-3} \# Author, Year Study design Study sample and objective Exposure: SEP -- type, definition, level in sample Outcome: Health-seeking behaviour(s) -- type, definition and level in sample ---- ------------------------------------------------ --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 1 Reichler et al., 1998[@pone.0093032-Reichler1] Cross-sectional Nationally-representative survey of children under 48 months of age surveyed one month after second National Immunisation Day (NID, polio) round in 1995, n = 4188 children from 3216 households. SEP: One of risk factors. **HH: Radio in household** (binary), **TV in household** (binary). **Number of doses of OPV (oral poliomyelitis vaccine) received.** Level: 0 doses: 9% (CI95%: 7.1%--9.9%). Level: 1 dose: 17% (CI95%: 14.6%--19.7%). Level: 2 doses: 74% (CI95%: 71.4%--77.3%). 2 Yount, 2003[@pone.0093032-Yount1] Cross-sectional. Two Governorates Linkages Survey 1995--1997, children \<5 years with diarrhoea in past 2 weeks in 12 rural villages of Minya governorate, n = 129 children, 152 episodes of care-seeking. SEP: Confounder in analysis of gender. **IO: Maternal education** (binary). **HH: Major asset ownership** (binary). If reported symptoms of diarrhoea: **Type of provider sought** (episodes, n = 152). Other:15%, Lay:16%, Pharmacist: 40%, Doctor: 29%. **Location of care** (episodes, n = 152). Other: 28%, Public:12%, Private: 21%, Pharmacy: 39%. **Cost of care** (children, n = 129). Free, ≤ 1 EPG, \> 1 EGP (Proportions by category not provided, but median expenditure for boys 0.5 EGP, girls 0.2 EPG). 3 Yount, 2004[@pone.0093032-Yount2] Cross-sectional Two Governorates Linkages Survey 1995--1997, Minya governorate, children \<5 years of age of currently married women who were sick in 2 weeks before interview, n = 1579. SEP: One of risk factors. **IO: Mother\'s education level** (none, primary, preparatory, secondary and higher, **mother\'s ever-employment for cash** (binary), **mother\'s ownership of assets** (none, one, two or more), **father\'s years education** (none, 1--11, 12+). **HH: Number of assets/durables owned:**(none, low \[1 asset/0--2 durables\], medium \[≤1 asset, 3+ durables\], high \[2+ assets\]. (Assets include 6 items of means of transportation, land and building ownership; Durables are 10 household assets such as TV, fridge etc.) If reported symptoms of illness (with diarrhoea, fever, cough or rash): **Utilized private treatment (private doctor).** Level: 18.8%. 4 Fadel, et al. 2007[@pone.0093032-Fadel1] Pros-pective cohort 257 healthy infants (0--9 months) followed for 12 months (October 1999--October 2000) in Assiut university primary health center catchment area, n = 631 diarrhoeal episodes. SEP: One of risk factors. **IO: Mother\'s education, father\'s education** (illiterate, literate/primary, preparatory, secondary, university/higher), **mother\'s employment status** (binary). **HH: TV ownership** (binary), **Radio ownership** (binary). If reported symptoms of diarrhoea in preceding 2 weeks: **Sought any treatment** (caretakers of children sought medical care outside the home). Level: 53.1% of diarrhoeal episodes (335 of 631). **Utilized private treatment** (medical care not under government control). Level: 37.3% of diarrhoeal episodes for which care was sought (210 of 335). 5 Gwatkin,et al, 2007[@pone.0093032-Gwatkin1] Cross-sectional EDHS 1995, 2000 (children under 5 years), n immunization: 1995 = 2085, 2000 = 2170; treatment for ARI: 1995 = 2479, 2000 = 1032; treatment for fever: 1995 = 4295, 2000 = 1923; treatment for diarrhoea: 1995 = 1701, 2000 = 771. SEP: Main determinant. **HH: DHS Wealth index quintile** **Coverage of immunisations:** BCG: 1995: 94.7%, 2000: 99.3%. Measles: 1995: 89.2%, 2000: 96.9%. DPT(3 doses): 1995: 83.0%, 2000: 94.0%. Hepatitis B: 1995: 57.0%, 2000 not reported. Full basic: 1995: 79.1%, 2000: 92.2%. No basic (not received full basic): 1995: 2.5%, 2000: 0.2%. **Sought any medical treatment.** Fever: 1995: 47.6%, 2000: 35.1%. ARI: 1995: 61.7%, 2000: 66.0%. Diarrhoea: 1995: 47.5%, 2000: 46.3%. **Utilized private treatment.** Fever: 1995: 34.8%, 2000: 21.7%. ARI: 1995: 43.5%, 2000: 41.5%. Diarrhoea: 1995: 33.2%, 2000: 30.0%. **Utilized public treatment.** Fever: 1995:12.0%, 2000: 12.6%. ARI: 1995: 17.1%, 2000: 23.1%. Diarrhoea: 1995: 13.7%, 2000: 15.6%. EDHS -- Egypt Demographic and Health Survey EGP -- Egyptian pound BCG -- Bacillus Calmette--Guérin (TB) DPT- Diphtheria, pertussis (whooping cough) and tetanus. Measures of SEP: **IO:** Individual -- other (spouse, mother, etc), **HH:** Household-level. Maternal health-seeking behaviours {#s3a} ---------------------------------- Three of the six studies analysing maternal health-seeking behaviours were based on the nationally representative population-level Demographic and Health surveys (DHS) collected between 1995 and 2008.[@pone.0093032-Gwatkin1]--[@pone.0093032-Stephenson1] The remaining three studies analysed small samples of (\<250) women in specific geographic locations; the city of Alexandria,[@pone.0093032-AbdelHoussein1] six villages in Beni Sueif governorate [@pone.0093032-Yassin1] and a Giza village.[@pone.0093032-Chiang1] All six studies were based on cross-sectional data. Four studies analysed whether women received any ante-natal care (ANC) or ANC from a medical professional during pregnancy ([Figure 2](#pone-0093032-g002){ref-type="fig"}, [Table 2](#pone-0093032-t002){ref-type="table"}). The proportion of women receiving any ANC in the samples used by the studies ranged from 33.8% to 71.4% for any ANC and 42.5% to 73.2% for any ANC with a medical professional. Four studies examined ANC regularity (number of ANC visits during pregnancy) and one study each looked at the timing of the first ANC visit and at the pattern of ANC use (combining regularity and timing into one indicator). In regard to delivery care, four studies assessed various characteristics of the health provider (skilled or traditional birth attendant) or facility (any, public, private, home) where women sought care. {#pone-0093032-g002} Four studies of maternal health-seeking behaviour used women\'s individual-level SEP measures; education or literacy appeared in four studies and employment-related SEP measurement reflected in occupation status and cash income earnings were used by one study each. Two studies evaluated individual-level SEP measures (education and occupation) of the spouse. All studies that analysed DHS surveys relied partly or solely on quintiles of the wealth index, a household-level measure.[@pone.0093032-Rutstein1] Other household-level measures of SEP included family socio-economic status (SES) based on a score suggested in 1983 by Fahmy and Sherbini [@pone.0093032-Fahmy1] and binary variables indicating ownership of various assets (land, house, cattle), access to potable water, and monthly meat consumption. One study examined the association between health-seeking behaviour and community-level economic prosperity, which was constructed as mean of the DHS household-level wealth scores within each survey primary sampling unit (PSU). Two of the six studies showed the absolute levels of health-seeking behaviours under investigation for each SEP category. To assess the existence and magnitude of the association between SEP and maternal health-seeking behaviours, four studies used odds ratio measure of effect and two studies presented the value of the concentration index, both relative effect measures. ### Ante-natal care {#s3a1} The two studies which analysed more than one DHS survey both reported only a crude measure of association between SEP and health-seeking behaviours (Gwatkin 2007, Khadr 2009), shown in [Table 4](#pone-0093032-t004){ref-type="table"}. However, their use of concentration index, a method which quantifies the extent of a SEP gradient, allowed for comparison of time trends. Concentration index is formally expressed as twice the area under the Lorenz curve of inequality, showing the cumulative distribution of an outcome according to cumulative distribution of wealth. Concentration index values range between -1, indicating absolute inequality of the outcome concentrated among the poorest and +1, showing absolute inequality concentrated among the wealthiest, with 0 signifying perfect equality. The definitions of health-seeking behaviours reported were similar (except for a difference in receiving 'regular' ANC, where definition varied between Gwatkin ≥3 and Khadr ≥4 visits). Both studies showed that women from lower wealth quintiles were significantly less likely to have received any ANC and regular ANC than women from richer wealth quintiles. Concentration index values for 1995 and 2000 differed between the two studies for the four indicators they both evaluated. Wealth score and quintile became available to users of the DHS starting with the 2005 survey, and authors calculated their own wealth index for the two prior surveys, possibly using different component variables, which may be the main reason for this difference. For both indicators of ante-natal care, the concentration index value decreased between the 1995 and 2005 surveys, but remained higher for regular ANC than for any ANC use. Khadr found that while the concentration index value for these two ANC behaviours based on education level remained significant and concentrated among women with higher SEP; the values were closer to equality than the concentration index values based on wealth quintile. 10.1371/journal.pone.0093032.t004 ###### Summary of results from included maternal health-seeking studies. {#pone-0093032-t004-4} \# Author, Year Statistical method, type of analysis, effect estimate Results and confounders (if applicable) ---- ---------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 1 Abdel Houssein, 1997[@pone.0093032-AbdelHoussein1] **Crude analysis:** Not reported. **Adjusted analysis:** Logistic regression. **Effect estimate:** Odds ratio. **Pattern of attendance of ANC clinics:** Education (number of categories not reported): OR 1.42 (0.64--3.13), p = 0.387. SEP (ref category not specified) OR 1.38 (0.75--2.56), p = 0.302. **Confounders:** age group (\<20, 21--29, 30+), parity (0, 1--4, 5+), knowledge about adequate ANC use, level of risk, and health belief model score. 2 Yassin et al., 2003[@pone.0093032-Yassin1] **Crude analysis:** Logistic regression. **Effect estimate:** Odds ratio. **Any ANC:** Maternal literacy (ref: literate) OR 3.3 (1.6--6.7), p\<0.001. Maternal occupation (ref: unskilled worker) OR 0.8 (0.3--1.8), p\>0.05. Paternal literacy (ref: literate) OR 3.1 (1.4--6.9), p\<0.01. Paternal occupation (ref: unskilled worker) OR 1.8 (0.7--4.5), p\>0.05. Land ownership (ref: yes) OR 3.6 (1.4--9.3), p\<0.01. House ownership (ref: yes) OR 1.0 (0.3--3.5), p\>0.05. Cattle ownership (ref: yes) OR 0.5 (0.3--1.1), p\>0.05. Access to safe water OR 1.1 (0.6--2.2), p\>0.05. Meat consumption (ref: \<4 times/month) OR 0.9 (0.4--2.1), p\>0.05. 3 Gwatkin et al., 2007[@pone.0093032-Gwatkin1] **Crude analysis:** Concentration index (CoI)[\*](#nt104){ref-type="table-fn"}. **Effect estimate:** Concentration index value. **Any ANC by a medically trained person:** Women from households in lower quintiles were less likely to receive but CoI decreased from 0.2703 (p\<0.05) in 1995 to 0.2028 (p\<0.05) in 2000. **Multiple (3+) ANC visits:** Women from households in lower quintiles were less likely to receive multiple ANC visits, but CoI decreased from 0.3580 (p\<0.05) in 1995 to 0.2614 (p\<0.05) in 2000. **Delivery with skilled attendance:** Women from households in lower quintiles were less likely to deliver with skilled medical assistance, but CoI decreased from 0.2911 (p\<0.05) in 1995 to 0.2189 (p\<0.05) in 2000. **Delivery location:** Public or Private facility: Women from households in lower quintiles were less likely to deliver in private facilities (CoI1995: 0.4379, p\<0.05; CoI2000: 0.3422, p\<0.05) and in public facilities (CoI1995: 0.2472, p\<0.05; CoI2000: 0.1708, p\<0.05), both indexes decreased between 1995 and 2000. **Delivery location: Home:** Women from households in lower quintiles were more likely to deliver at home and gradient increased over time (CoI1995: −0.1630, p\<0.05; CoI2000: −0.2457, p\<0.05). 4 Khadr, 2009[@pone.0093032-Khadr1] **Crude analysis:** Concentration index (CoI). **Effect estimate:** Concentration index value. **Any ANC received:** Education: CoI value has remained the same (0.41) between 1995 and 2005 (p\<0.001). Wealth: Decreased inequality from 0.50 (1995) to 0.45 (2005) but significant (p\<0.001). **Regular ANC received:** Education: Decreased inequality from 0.49 (1995) to 0.39 (2005) but significant (p\<0.001). Wealth: Decrease in inequality from 0.60 (1995) to 0.49 (2005) but significant (p\<0.001). **Delivery with skilled attendance:** Education: Decrease in inequality from 0.41 (1995) to 0.37 (2005) but significant (p\<0.001). Wealth Decrease in inequality from 0.55 (1995) to 0.47 (2005) but significant (p\<0.001). **Home delivery:** Education: Decrease in inequality from −0.42 (1995) to −0.35 (2005) but significant (p\<0.001). Wealth: Decrease in inequality from −0.53 (1995) to −0.47 (2005) but significant (p\<0.001). 5 Chiang et al., 2012[@pone.0093032-Chiang1] **Crude analysis:** Logistic regression. **Effect estimate:** Odds ratio. **Regular ANC:** Maternal education (ref: no primary education) OR 5.59 (2.98--10.47), p\<0.01. Cash income (ref: no) OR 0.52 (0.25--1.09), p\>0.05. Husband education (ref: ≤primary) OR 2.31 (1.26--4.23), p\<0.01. **Delivery with skilled medical professional:** Maternal education (ref: no primary education) OR 2.98 (1.36--6.54), p\<0.01. Cash income (ref: no) OR 0.79 (0.34--1.85), p\>0.05. Husband education (ref: ≤primary) OR 2.38 (1.05--5.36), p\<0.05. **Delivery in a health facility:** Maternal education (ref: no primary education) OR 5.42 (2.78--10.57), p\<0.01. Cash income (ref: no) OR 0.51 (0.25--1.04), p\>0.05. Husband education (ref: ≤primary) OR 2.82 (1.46--5.42), p\<0.01. 6 Stephenson et al., 2012[@pone.0093032-Stephenson1] **Crude analysis:** Not reported. **Adjusted analysis:** Multi-level logistic regression. **Effect estimate:** Odds ratio. **Any ANC received:** OR 1.0 (1.0--1.0), p\>0.05. **Regular ANC received:** OR 1.0 (1.0--1.0), p\>0.05. **First ANC in 1^st^ trimester:** OR 1.0 (1.0--1.0), p\>0.05. Delivery in a health facility: OR 1.0 (1.0--1.0), p\>0.05. **Confounders:** Woman\'s age, marriage duration, partner age difference, death of a child, number of living children, sex ratio of children, education (woman and partner), employment status (woman and partner), household wealth, reproductive health knowledge, media exposure, violence justification, and decision-making autonomy. \* Only values of standard error (SE) were provided by this study. Binary significance levels (\<0.05, \>0.05) were calculated by multiplying the SE by 1.96 to obtain the upper and lower confidence intervals. In order to approximate the level of community affluence, Stevenson et al (2012) constructed a community level wealth index based on the household wealth index of respondents in the same primary sampling units. This study concluded that community-level economic prosperity was not associated with any ANC, regular ANC or timely ANC (first visit in first trimester of pregnancy) use. Receiving regular ANC in a Giza village was associated with primary or higher education level - both woman\'s as well as her husband\'s, but not with woman\'s cash income, in crude analysis (Chiang 2012). Crude analysis of a sample from villages in Beni Sueif showed a significant positive association between maternal and paternal literacy (individual-level) and land ownership (household-level) with the likelihood of receiving any ANC (Yassin 2003). A study in Alexandria reported that neither education nor family SES score were significantly associated with adequate pattern of ANC clinic attendance among women attending an ANC clinic, when adjusted for woman\'s age group, parity, knowledge of ANC use, level of medical risk, and health belief model score (Abdel Houssein 1997). ### Delivery care {#s3a2} The concentration index values for obtaining skilled delivery care appeared to have decreased between 1995 and 2005, yet the values remained significant, and higher based on wealth quintile than on education level (Gwatkin 2007, Khadr 2009). Gwatkin and colleagues reported that women from lower household wealth quintiles were significantly less likely to deliver in private facilities and in public facilities, compared to women from higher quintile households, in both 1995 and 2000, but the concentration index value had decreased over this timeframe. Both Gwatkin and Khadr concluded that women from lower wealth quintiles were significantly more likely to deliver at home in all surveys analysed. However, whereas Gwatkin reported that the concentration index value increased between 1995 and 2000, Khadr noted a decrease between 1995 and 2005. Khadr\'s analysis showed that the concentration index value for home delivery was smaller when SEP was measured by education level rather than household wealth quintile, but remained significant, favouring women with higher SEP. Using the 2008 DHS, Stephenson et al reported no significant difference, in adjusted analysis, in the odds of delivery in any health facility compared to at home based on community-level wealth. Lastly, crude analysis of health-seeking behaviour in a Giza village revealed that higher level woman\'s and husband\'s education were significantly positively associated with the odds of delivery with a skilled medical professional and delivery in any health facility. However, woman\'s cash income was not associated with either delivery-related health-seeking behaviour (Chiang 2012). Child health-seeking behaviours {#s3b} ------------------------------- Five studies analysing SEP determinants of health-seeking behaviour for children were identified; two included assessment of immunisation coverage and four examined aspects of curative health-seeking for common childhood illnesses ([Figure 2](#pone-0093032-g002){ref-type="fig"}, [Table 3](#pone-0093032-t003){ref-type="table"}). Two studies analysed nationally-representative samples; one by following up on National Immunisation Days (Reichler 1998) and the other examined two rounds of EDHS (Gwatkin 2007). Two papers reported findings from samples in Minia governorate based on the Two Governorates Linkages Survey (Yount 2003 and Yount 2004), and the remaining study assessed health-seeking behaviours for infants in a primary health centre catchment area in Assiut (Fadel 2007). Although this study included prospective cohort data collection method, all findings were based on cross-sectional analyses. Between the two studies examining receipt of immunisations, socio-economic determinants of both disease-specific coverage (BCG, measles, DPT, Hepatitis B, polio), as well as overall immunisation status based on national guidelines (full basic immunisation, no basic immunisation) were assessed. In regard to curative care, health-seeking behaviours following reported childhood illnesses (any illness, diarrhoea, acute respiratory infection-ARI, or fever) were examined, specifically whether any medical care was sought, the type of medical provider and health facility approached, and cost incurred. Three of the five studies used measures of parental SEP, namely maternal and paternal education level and employment status, and maternal asset ownership. All three studies using individual-level variables also used household-level measures of SEP, the remaining two studies analysed solely household-level measures. The household-level SEP measures included DHS wealth quintiles, binary TV and radio ownership, and major asset ownership. Four of the five studies showed the absolute levels of health-seeking behaviours under investigation for each SEP category. The assessment of the association between SEP and maternal health-seeking behaviours was conducted using relative effect measures in four studies (three used odds ratios and one concentration index value) and absolute measure in one study (risk difference). ### Immunisation coverage {#s3b1} Both studies examining the association between SEP and receipt of immunisations presented only crude effect estimates ([Table 5](#pone-0093032-t005){ref-type="table"}). In their analysis of polio vaccine coverage during the 1995 National Immunisation Days, Reichler et al concluded that children living in households with a radio or a TV were significantly more likely to have received two oral polio virus vaccine doses than one or zero doses. Using concentration index based on household wealth quintile, Gwatkin et al reported that children from lower quintile households were less likely to be immunised against BCG, measles, and DPT (3 doses) than those from higher quintiles, although the concentration index value had decreased between 1995 and 2000. The concentration index value for Hepatitis B immunisation was only available for 1995 and showed the highest level (higher coverage among children from wealthier quintile households) among the various vaccines. Children from lowest wealth quintile households were significantly more likely to have received no basic immunisation coverage, and the concentration index value declined only marginally in the five-year period between surveys. 10.1371/journal.pone.0093032.t005 ###### Summary of results from included child health-seeking studies. {#pone-0093032-t005-5} \# Author, Year Statistical method, type of analysis, effect estimate Results and confounders (if applicable) ---- ------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 1 Reichler et al., 1998[@pone.0093032-Reichler1] **Crude analysis:** T-test. **Effect estimate:** Risk difference. Children in households with a radio were more likely to have received 2 doses (77%) than one (69%) or no doses of OPV (72%), p\<0.01. Children in households with a TV were more likely to have received 2 doses (94%) than one (86%) or no doses of OPV (84%), p\<0.001. 2 Yount, 2003[@pone.0093032-Yount1] **Crude analysis:** Not reported. **Adjusted analysis:** Logistic regression. **Effect estimate:** Odds ratio. **Type of provider**: Household assets (ref: none) Any: Pharmacist OR 1.78 (p\>0.05), Doctor OR 2.46 (p\>0.05). Maternal education (ref: none) Any: Pharmacist OR 2.10 (p\>0.05), Doctor OR 0.75 (p\>0.05). **Location of care**: Household assets (ref: none) Any: Public OR 3.65 (p\>0.05), Pharmacy OR 2.01 (p\>0.05), Private OR 2.20 (p\>0.05). Maternal education (ref: none) Any: Public OR 0.66 (p\>0.05), Pharmacy OR 2.09 (p\>0.05), Private OR 0.72 (p\>0.05). **Cost of care** (categorical variable, 3 levels): Household assets (ref: none) Any: OR 0.76 (p\>0.05). Maternal education: not reported. **Confounders**: child gender and age; severity, cause and duration of diarrhoea; presence and gender of siblings; and family members\' involvement in decision-making. 3 Yount, 2004[@pone.0093032-Yount2] **Crude analysis:** Not reported. **Adjusted analysis:** Logistic regression. **Effect estimate:** Odds ratio. **Odds of utilizing private treatment:** Father\'s education (ref: 0 years): 1--11 years OR 0.84 (p\>0.05); 12+ years OR 1.10 (p\>0.05). Maternal ever-employment (ref: no): Yes: OR 0.79 (p\>0.05). Maternal education (ref: none): Primary/preparatory: OR 0.81 (p\>0.05), secondary or more: OR 0.92 (p\>0.05). Maternal assets (ref: none): One OR 0.74(p\<0.05), Two or more: OR 0.79 (p\>0.05). Household assets/durables (ref: none): Low: OR 1.84 (p\<0.01), Medium: OR 2.55 (p\<0.001), High: OR 3.62 (p\<0.001). **Confounders**: child gender and age; severity, cause and duration of illness; presence and gender of siblings; religion; urban/rural residence; maternal social resources and social constraints; and proximity of health services. 4 Fadel, et al. 2007[@pone.0093032-Fadel1] **Crude analysis:** X^2^ test. **Adjusted analysis:** Logistic regression. **Effect estimate:** Odds ratio. **Crude analysis - Utilized treatment:** Mother\'s education p = 0.285, Father\'s education p = 0.339, Mother\'s employment status p = 0.486, TV ownership p = 0.042 (diarrhoeal episodes where households have TV more likely to utilize care), Radio ownership p = 0.196. **Utilized private providers, if utilized treatment:** Mother\'s education p\<0.001 (higher levels of education are more likely to utilize private providers), Father\'s education p = 0.020 (higher levels of education are more likely to utilize private providers), Mother\'s employment status p\<0.001 (working mothers are more likely to utilize private providers), TV ownership, Radio ownership: not reported. **Adjusted analysis - Utilized treatment:** Mother\'s education, Father\'s education, Mother\'s employment status, Radio ownership: not reported. TV ownership (ref: not clear) OR 0.63, p = 0.418. **Confounders**: Perception of severe attack, vomiting, bloody stool, fever, duration of episode, age of infant, frequency of stool, presence of cough, associated any symptoms with diarrhoea, watery stool, history of child death, presence of preschool children, using self-prescribed drugs. **Utilized public versus private providers:** Mother\'s education (ref: illiterate): reads/writes/primary: OR 0.04 (p\<0.001), preparatory: OR 0.02 (p\<0.001), secondary: OR 0.04 (p\<0.01), university/higher: OR 0.07 (p\<0.01). Father\'s education (ref: illiterate): reads/writes/primary: OR 2.04 (p = 0.212), preparatory: OR 1.27 (p = 0.726), secondary: OR 0.82 (p = 0.785), university/higher: OR 1.93 (p = 0.209). Mother\'s employment status (ref: not working): working: OR 0.61 (p = 0.278). TV ownership, radio ownership: not reported. **Confounders**: age and sex of infant, mother\'s age and mother\'s perception of diarrhoeal episode severity. 5 Gwatkin, et al, 2007[@pone.0093032-Gwatkin1] **Crude analysis:** Concentration index (CoI)[\*](#nt105){ref-type="table-fn"}. **Effect estimate:** Concentration index value. **Coverage of immunisation:** BCG: Children from lower quintiles less likely covered, CoI decreased from 0.0317 (p\<0.05) in 1995 to 0.004 (p\<0.05) in 2000. Measles: Children from lower quintiles less likely covered, CoI decreased from 0.058 (p\<0.05) in 1995 to 0.009 (p\<0.05) in 2000. DPT: Children from lower quintiles less likely covered, CoI decreased from 0.0691 (p\<0.05) in 1995 to 0.0022 (p\>0.05) in 2000. HepB: Children from lower quintiles less likely covered, 0.0984 (p\<0.05) in 1995, no 2000 estimate. Full basic: Children from lower quintiles less likely covered, CoI decreased from 0.0819 (p\<0.05) in 1995 to 0.0052 (p\>0.05) in 2000. No basic: Children from lower quintiles more likely to have no coverage, CoI decreased from −0.7434 (p\<0.05) in 1995 to −0.7212 (p\>0.05) in 2000. **Sought any treatment**: Fever: Children from lower quintiles less likely to receive, CoI decreased from 0.1076 (p\<0.05) in 1995 to 0.077 (p\<0.05) in 2000. ARI: Children from lower quintiles less likely to receive, CoI decreased from 0.0965 (p\<0.05) in 1995 to 0.0897 (p\<0.05) in 2000. Diarrhoea: Children from lower quintiles less likely to receive, CoI increased from 0.0357 (p\<0.05) in 1995 to 0.0688 (p\<0.05) in 2000. **Utilized private provider:** Fever: Children from lower quintiles less likely to receive, CoI increased from 0.1609 (p\<0.05) in 1995 to 0.1928 (p\<0.05) in 2000. ARI: Children from lower quintiles less likely to receive, CoI increased from 0.1543 (p\<0.05) in 1995 to 0.1932 (p\<0.05) in 2000. Diarrhoea: Children from lower quintiles less likely to receive, CoI increased from 0.1095 (p\<0.05) in 1995 to 0.1713 (p\<0.05) in 2000. **Utilized public treatment**: Fever: Children from lower quintiles more likely to receive, CoI increased from −0.0411 (p\>0.05) in 1995 to −0.1240 (p\<0.05) in 2000. ARI: Children from lower quintiles more likely to receive, CoI increased from −0.0469 (p\<0.05) in 1995 to −0.0892 (p\<0.05) in 2000. Diarrhoea: Children from lower quintiles more likely to receive, CoI decreased from −0.1446 (p\<0.05) in 1995 to −0.1180 (p\<0.05) in 2000. \* Only values of standard error (SE) were provided by this study. Binary significance levels (\<0.05, \>0.05) were calculated by multiplying the SE by 1.96 to obtain the upper and lower confidence intervals. ### Curative care {#s3b2} In terms of the first dimension of curative health-seeking, seeking advice from a medical provider, Gwatkin\'s crude analysis showed that children from lower quintiles were less likely to receive care with symptoms of fever, acute respiratory infection (ARI) and diarrhoea compared to children from higher quintile households. However, whereas the concentration index value decreased between 1995 and 2000 for symptoms of fever and ARI, these values increased with respect to diarrhoea. The highest concentration index value in 2000 for this dimension was seen in health-seeking for symptoms of ARI. In a small sample of infants in Assiut, Fadel examined the association between SEP and seeking medical advice following symptoms of diarrhoea. In crude analysis, only household TV ownership was marginally positively associated with seeking care, but ceased to be significant in adjusted analysis. Four studies examined the association between SEP and type of care chosen for childhood illness among the subsamples of children for whom any medical care was sought. In the nationally-representative DHS surveys, Gwatkin reported results of a crude association, finding that children from lower quintile households were less likely to have received care from a private provider. Whereas the concentration index value was smaller for symptoms of diarrhoea compared to ARI or fever in both surveys, the value had increased for all three illnesses between 1995 and 2000. Among infants in Assiut for whom medical care was sought for diarrhoea, utilisation of private care was associated with higher levels of both mother\'s and father\'s education, as well as mother\'s employment status in crude analysis (Fadel 2007). Among these three SEP indicators, only mother\'s education remained significantly positively associated with private care utilisation in adjusted analysis. In a sample of children taken for care for diarrhoea, fever, cough or rash in Minia, adjusted odds of seeking a private doctor were significantly higher for those with higher number of maternal as well as household assets, but not associated with maternal or paternal education or maternal ever-employment (Yount 2004). Analysing a smaller sample of children with diarrhoea in Minia, Yount (2003) found that neither the type of medical provider (doctor, pharmacist, other, lay) nor the type of facility (public, private, pharmacy) sought was associated with maternal education or household assets in adjusted analysis. This study also found no association, after adjustment for various confounders, between household asset ownership and cost of care incurred. Discussion {#s4} ========== Studies using nationally representative datasets found evidence of an association between SEP and maternal health-seeking behaviours. Women living in lower wealth quintile households were less likely than those from wealthier households to receive any and regular ANC, to deliver with skilled attendance and in health facilities. The magnitude of this association appeared smaller when women\'s SEP position was measured by education level compared to household wealth. However, no association was found between community-level affluence and maternal health-seeking behaviours. These differences in the existence and extent of SEP gradients raise the question whether material/financial resources may be a more important determinant of utilisation (potentially via direct and indirect costs of care) than women\'s knowledge of the need for care or its availability. On the other hand, the only adjusted analysis of a small sample found that women\'s education or household-level SES score did not predict the pattern of ANC attendance among women attending ANC clinics, potentially suggesting that once women access ANC care, determinants other than SEP contribute to the intensity of care they receive. Children from wealthier households were significantly more likely to have been immunised, for separate illnesses and for a combination of basic immunisations, compared to children from poorer households. Analysis of time trends revealed that this gradient had decreased between 1995 and 2000, potentially as a result of high overall immunisation coverage. Crude analysis of a nationally representative sample showed that the gradient in care-seeking for symptoms of childhood illnesses favoured children from higher wealth quintile households, but while remaining significant, decreased over time. A significant and increasing inequality in private provider use based on household wealth was identified for all three childhood illnesses examined. This may be a result of the fact that the cost of private care is higher than of public care.[@pone.0093032-Yip1], [@pone.0093032-Rashad1] However, in smaller samples from Upper Egypt, conflicting results about the existence of an association between SEP and utilisation of any curative care and private provider selection for child illnesses were reported. This may be due to real differences between the populations from which samples were drawn, or be partially or fully explained by the difference in analysis methods (crude versus adjusted) or definition of illness (diarrhoea and any illness). The evidence on existence of an association between SEP and the cost of care-seeking was limited to one study (not adjusted for provider type) of a small sample, and therefore carried limited generalizability. Limitations of available evidence {#s4a} --------------------------------- We considered selection bias, information bias (related to exposure or outcome) and analysis methods in assessing data quality of each study ([Table 6](#pone-0093032-t006){ref-type="table"}). 10.1371/journal.pone.0093032.t006 ###### Risk of bias in included studies. {#pone-0093032-t006-6} Health-seeking behaviour Maternal Child -------------------- ----------------------------------------------------------------------------------------------------------------- ---------- ------- ---- ---- ---- ---- ---- ---- ---- ---- ---- **Selection** Representativeness (consecutive or obviously representative) − ? \+ \+ ? \+ \+ ? ? ? \+ Missing data or loss to follow up minimal ? ? \+ \+ ? \+ ? ? ? ? \+ **Exposure (SEP)** Clear definition of exposure − \+ ? \+ \+ ? \+ \+ \+ \+ ? Ascertainment of exposure ? \+ \+ \+ \+ \+ \+ \+ \+ ? \+ **Outcome (HSB)** Clear definition of outcome − \+ \+ \+ \+ \+ \+ ? ? \+ \+ Ascertainment of outcome − \+ ? ? \+ \+ ? \+ \+ \+ ? **Analysis** Statistical test used to analyze the data is clearly described[\*](#nt107){ref-type="table-fn"} and appropriate \+ \+ \+ \+ \+ ? \+ \+ \+ \+ \+ Minimal adjustment for age (maternal, child), parity (maternal) and gender (child) \+ − − − − \+ − \+ \+ \+ − Correctly adjusting for several indicators of SEP − NA NA NA NA − NA − − − NA SEP -- socio-economic position, HSB -- health-seeking behaviour. \* Presenting a test of statistical significance was one of the inclusion criteria. NA -- not applicable (no adjusted analysis was conducted). Key: + Low risk of bias, ? Potential/unclear risk of bias, - High risk of bias. Five studies used nationally representative survey data. Whereas the remaining smaller surveys considered selection bias (by including, for example, all women attending ANC, all mothers living in villages, or utilising simple random sampling in a community), they often neglected to describe the specifics of the population their samples represent. It was unclear whether sample sizes were calculated based on sufficient power to detect gradients in health-seeking behaviours, or whether previously collected data was used in analysis of health-seeking. Therefore, the findings of several such studies have limited generalizability not only on the general population level, but also for the understanding of local-level determinants of health-seeking. All included studies relied on cross-sectional analysis, and no analysis of individual-level time patterns of health-seeking behaviours was presented. Two of the included studies specifically analysed socio-economic determinants of health-seeking behaviours. Seven studies attempted to identify determinants of health-seeking behaviours and one paper included SEP as a confounder in analysis of gender. Studies using separate variables, such as education level or binary asset ownership described the definition and categorisation of exposure categories better than those using component variables (SES score, household wealth quintile). Potential bias may stem from data collection methods -- studies failed to report on and examine which member of the household reported on the various indicators of SEP (own, other members\' or household-level) and whether this person could do so reliably. Limitations in the definitions of health-seeking behaviours in included studies relate mainly to type of provider or facility. The method of categorising health providers into skilled or unskilled and health facilities into public or private was not always made explicit and may have relied of respondents\' self-report. This concern is particularly pertinent to the use of pharmacies without previous medical consultation, a common practice in Egypt. The existence and extent of an SEP gradient by provider type may change as a result of the inclusion and categorization of pharmacies. Misclassification may have occurred in regard to type of provider, because many public sector medical professionals also practice privately. In addition, respondents may not know, correctly recall, or be willing to report the level of medical qualification of the provider used. The recall period used by studies for reporting of health-seeking behaviours seemed appropriate -- longer for maternal care where information surrounding a birth is more likely to be remembered, and shorter (two weeks preceding survey or prospective data collection) for events related to child health. Child curative care relies heavily on the perception and reporting of child ill health. However, only Yount 2004 and Fadel 2007 used perceived severity of illness in their adjusted analyses of health-seeking determinants. On the conceptual level, the use of such an approach also challenges the underlying assumption that all perceived childhood illness symptoms ought to be attended to by a health provider. Several important gaps in the body of evidence are present. In regard to maternal health-seeking, no study analysed SEP determinants of the type of facility (public or private) chosen by users of ante-natal care. Further, no study modelled the intensity of ANC care as a continuous variable, which would enable detailed analysis of the dose-response effects of SEP. No analysis of post-natal care, a crucial component of the maternal health package, was identified. Neither the determinants of facility level (health centre, hospital) nor of a combination of provider qualification and facility characteristics were examined for delivery care health-seeking. Lastly, expenditures related to maternal health-seeking and their association with SEP were not examined by any study. In comparison with maternal care, available evidence for child health-seeking included more dimensions of behaviours related to curative, but less for preventive care. No studies analysed types of providers and facilities approached or costs encountered in obtaining childhood immunisations. No evidence examining gradients in intensity of care (number of visits made and types of providers approached, if more than one) received for childhood illnesses was identified. Lastly, the type of symptoms for which curative health-seeking was analysed is limited to three; no evidence examining other important issues, such as childhood injuries or mental health was identified. The use of a statistical test to assess the existence and extent of SEP gradients was an inclusion criterion in this review. However, included studies suffered from several other limitations in their analyses. Six studies only presented results of crude analyses and this was a major limitation of the usefulness of studies that employed nationally-representative data. The usefulness of analyses to policy is also limited by the number of following dimensions of health-seeking behaviour assessed in any given study. A gradient in intensity of care (dimension 3) may not only be a result of inequalities experienced at that point, but also a consequence of accumulated inequalities in seeking care (dimension 1) and the type of provider used (dimension 2). For example, in the only analysis of cost of care identified by this review (Yount, 2003), adjusted analysis did not include provider type and cannot therefore elucidate the SEP gradient in expenditures based on provider choice. Further, all five studies presenting adjusted analyses used various SEP indicators in one adjusted model, thereby controlling for (eliminating) the pathways of association from one SEP indicator through those remaining. Strengths and limitations of systematic review {#s4b} ---------------------------------------------- In addition to limitations of the studies included in this review and the gaps in the body of evidence, limitations of this systematic review were also assessed. The search strategy targeted global and regional databases, but only English sources were searched. Complete retrieval of studies identified for full-text review was achieved. Health-seeking behaviour is not a new concept, although it is a recent term, and care was taken to identify and use as many synonyms and components as possible in the text and MeSH terms used. Likewise, a wide range of potential SEP indicators was compiled and used in searches. However, the search strategy may have missed studies which used socio-economic indicators as confounders, but did not list them in the title, abstract or keywords. One author was responsible for study selection and data extraction. Most studies looked at a range of factors associated with health-seeking behaviours, not solely SEP. Therefore, while no formal assessment of publication bias was conducted, it is possible that studies which failed to find an association between health-seeking behaviour and SEP did not report the estimates. Such studies may also not have been submitted or accepted for publication. Despite the fact that only quantitative studies assessing the existence and extent of SEP gradient were included in the review, it was not possible to produce a summary measure of association due to the variability of definitions, effect estimates and analysis methods in individual studies. Conclusion {#s5} ========== Following large improvements in coverage of maternal and child health interventions in Egypt, socio-economic inequalities, and in particular the rural concentration of poverty, have been identified as the primary determinants of remaining disparities.[@pone.0093032-ElDeeb1], [@pone.0093032-Gipson1] As one of the pathways in this association, health-seeking behaviours could contribute to such gradient in health outcomes. While the body of evidence presented in this study contains several limitations, we have attempted to synthesise the available evidence related to inequalities in dimensions of maternal and child health-seeking behaviour. On the national level, socio-economically patterned inequalities in seeking any care for basic preventive and curative interventions in maternal and child health appear to have narrowed, potentially as a result of increased overall coverage. However, the extent of this gradient seems larger measured by wealth compared to education, and further exploration to determine whether and how knowledge and affordability of care drive these inequalities is necessary. On the other hand, the limited evidence of gradients in intensity of preventive care in maternal, and provider type in child curative care, showed that inequalities may have widened. In studies of more geographically and socially homogenous samples, fewer gradients were identified, signifying that in areas with comparable health service supply, future research will need to examine determinants of health-seeking beyond the traditionally used SEP indicators. Overall, although ten studies examining socio-economic inequalities in health-seeking behaviours were identified, the body of research contains numerous gaps and the quality of available evidence is insufficient to draw a conclusive summary of the extent of gradients in Egypt. Future research needs to address gaps in the assessment of the various dimensions of maternal and child health-seeking behaviours, while carefully defining constructs underlying SEP indicators and correctly modelling this association in statistical analyses. This understanding will be crucial in designing and prioritising interventions to equitably improve maternal and child health outcomes in Egypt.[@pone.0093032-Barros1] Supporting Information {#s6} ====================== ###### **PRISMA guidelines checklist.** (DOCX) ###### Click here for additional data file. [^1]: **Competing Interests:**The authors have declared that no competing interests exist. [^2]: Conceived and designed the experiments: LB OMRC GBP. Analyzed the data: LB OMRC GBP. Wrote the paper: LB OMRC GBP.

All relevant data are within the paper and its Supporting Information files. Introduction {#sec001} ============ In neurons, endosomal transport and sorting of internalized cargo affects the abundance of plasma membrane proteins and regulates a diverse group of cellular processes such as signal transduction and synaptic vesicle recycling \[[@pgen.1005290.ref001]--[@pgen.1005290.ref003]\]. A group of evolutionarily conserved cytosolic proteins referred to as the endosomal sorting complexes required for transport (ESCRT) associate with the endosomal membrane and direct the sorting of internalized cargo \[[@pgen.1005290.ref004],[@pgen.1005290.ref005]\]. Four distinct ESCRT complexes, ESCRT-0, -I, -II and---III, act sequentially to contribute to the sorting of membrane proteins, thus determining if endocytosed receptors are recycled back to the cell surface or are further sorted into intraluminal vesicles (ILVs) within specialized endosomes called multivesicular bodies (MVBs) for their eventual degradation by lysosomes \[[@pgen.1005290.ref006]\]. Receptor degradation rates affect the duration of receptor signaling, and alterations in the turnover of activated receptors have been implicated in a variety of disease processes \[[@pgen.1005290.ref007]--[@pgen.1005290.ref010]\]. The ESCRT-0 complex, composed of HGS and signal transducing adaptor molecule 1 (STAM1) \[[@pgen.1005290.ref011]--[@pgen.1005290.ref013]\], is essential for the initial recognition of ubiquitinated cargo that will be sorted at the endosomal membrane and degraded upon endo-lysosomal fusion \[[@pgen.1005290.ref014],[@pgen.1005290.ref015]\]. HGS is believed to serve as a master regulator of endo-lysosomal trafficking by binding ubiquitinated cargo and initiating the recruitment of the ESCRT-I, -II, and---III components \[[@pgen.1005290.ref016]--[@pgen.1005290.ref019]\]. Given its role in the early stages of endosomal sorting of internalized cell surface receptors, it has been suggested that HGS also plays an important role in the recycling of cargo to the plasma membrane \[[@pgen.1005290.ref020]--[@pgen.1005290.ref022]\]. In addition, HGS can bind synaptosomal associated protein 25 (SNAP-25) and prevent SNARE complex formation, thereby inhibiting neurotransmitter secretion \[[@pgen.1005290.ref023]\] and endosomal fusion \[[@pgen.1005290.ref024]\]. Studies in *Drosophila* have also implicated HGS in synaptic protein homeostasis and synaptic vesicle rejuvenation \[[@pgen.1005290.ref025]\]. However, despite the insights into HGS function gained from the studies described above, the precise role of HGS in endosomal trafficking has not been determined in the mammalian nervous system. Disruption of endosomal transport is associated with many neurological disorders \[[@pgen.1005290.ref026]\]. In some instances, a direct link has been demonstrated between the genetic defect and endosomal dysfunction. For example, mutations in both ESCRT components and endosomal-associated factors have been attributed to neurodegeneration \[[@pgen.1005290.ref026]\]. Mutations in multivesicular body protein 2B (CHMP2B), a component of the ESCRT-III complex, are linked to both frontotemporal dementia and amyotrophic lateral sclerosis \[[@pgen.1005290.ref007],[@pgen.1005290.ref027],[@pgen.1005290.ref028]\]. In addition, mutations in kinesin family member 5A (KIF5A) and SPARTIN, which facilitate endosomal trafficking, are associated with motor neuron dysfunction in hereditary spastic paraplegia \[[@pgen.1005290.ref029]--[@pgen.1005290.ref031]\]. Together, these findings suggest that motor neurons are particularly vulnerable to deficits in endosomal trafficking and that genes in this pathway may be excellent candidate genes for inherited motor neuron diseases. In addition to its association with neurodegeneration in the central nervous system, ESCRT dysfunction is also associated with peripheral demyelinating diseases. Mutations in lipopolysaccharide-induced tumor necrosis factor-alpha factor (LITAF)/SIMPLE, that interacts with HGS and STAM1 in the ESCRT-0 complex \[[@pgen.1005290.ref032],[@pgen.1005290.ref033]\], cause a demyelinating form of Charcot Marie Tooth disease \[[@pgen.1005290.ref034],[@pgen.1005290.ref035]\], suggesting that ESCRT-0 is required for myelin formation or stability. By directing activated receptor tyrosine kinases to the lysosome, ESCRT-mediated endosomal sorting provides a mechanism to prevent aberrant signaling that is believed to result in demyelination and degeneration of peripheral axons. In this study, we used a positional cloning approach to demonstrate that the neurological phenotypes observed in the *tn* mice are due to a point mutation in *Hgs* that leads to hypomorphic expression of HGS. The subsequent reduction of HGS caused motor and sensory deficits that were accompanied by peripheral nerve hypermyelination and dysmyelination. Further analysis of motor function demonstrated that the *tn* mice had reduced muscle development and both structural and functional alterations at the NMJ. These deficits in neuromuscular function were associated with the accumulation of ubiquitinated proteins at the synapse. This report represents the first demonstration that a mutation in an ESCRT-0 component causes a motor and sensory neuropathy and suggests that HGS is required for the sorting of ubiquitinated proteins at the synapse to maintain synaptic transmission at the NMJ. Results {#sec002} ======= Cloning of the *tn* mutation {#sec003} ---------------------------- The *tn* mutation arose spontaneously in a C3H/HeJ inbred mouse line, resulting in a progressive neurodevelopmental disorder that first presents at 3 weeks of age \[[@pgen.1005290.ref036]\]. Homozygous *tn* mice exhibit reduced growth, ataxia, hypokinesis and premature death at 4 to 5 weeks of age (Fig [1A](#pgen.1005290.g001){ref-type="fig"}--[1C](#pgen.1005290.g001){ref-type="fig"}) \[[@pgen.1005290.ref036]\]. These deficits are thought to be due to dysgenesis of the brainstem and spinal cord \[[@pgen.1005290.ref036]\]. To identify the minimal chromosomal region harboring the *tn* mutation, a congenic mouse line was generated by backcrossing the *tn* mutation onto the C57BL/6J genetic background. Analysis of single nucleotide polymorphisms localized the *tn* mutation to a 2.8 Mb region on distal chromosome 11 ([Fig 1D](#pgen.1005290.g001){ref-type="fig"}). We then performed transcriptome analysis of brain RNA to identify nucleotide changes in the coding sequences of the genes located within the *tn* critical region. Sequence analysis of the 87 genes within the *tn* critical region only revealed a single nucleotide substitution in the *Hgs* gene. Genomic sequencing of the *Hgs* gene from the *tn* mice confirmed an adenine to guanine transition at position 265, which resulted in a methionine to valine substitution at amino acid 89 (M89V) ([Fig 1E](#pgen.1005290.g001){ref-type="fig"}). The methionine residue at position 89 of HGS is highly conserved throughout eukaryotic phylogeny ([Fig 1F](#pgen.1005290.g001){ref-type="fig"}). {#pgen.1005290.g001} The M89V substitution is located in the N-terminal [V]{.ul}ps27-[H]{.ul}GS-[S]{.ul}TAM (VHS) domain of HGS that is involved in substrate binding \[[@pgen.1005290.ref037],[@pgen.1005290.ref038]\]. To confirm that this mutation in HGS is responsible for the *tn* phenotype, a genetic complementation assay was performed by breeding mice that were heterozygous for the *tn* allele (*Hgs* ^*tn/+*^) to mice that were heterozygous for a knockout allele of *Hgs* (*Hgs* ^*tm1S/+*^, henceforth referred to as *Hgs* ^*KO/+*^) \[[@pgen.1005290.ref039]\]. The resulting *Hgs* ^*KO/tn*^ offspring exhibited perinatal lethality by postnatal day 40 ([Fig 1C](#pgen.1005290.g001){ref-type="fig"}) and a neurological phenotype similar to the *tn* mice, confirming that the *tn* gene was allelic to *Hgs*. Since the *Hgs* ^*KO/KO*^ mice die by embryonic day 11 \[[@pgen.1005290.ref039]\], the enhanced survival of the *Hgs* ^*KO/tn*^ mice indicated that the *tn* allele was not a null allele of *Hgs*. HGS expression in the nervous system is developmentally regulated {#sec004} ----------------------------------------------------------------- To investigate the distribution of *Hgs* expression *in vivo*, we performed quantitative polymerase chain reaction (qPCR)on reverse-transcribed RNA isolated from 4-week-old *Hgs* ^*+/+*^ wild type mice. *Hgs* was expressed in all tissues examined, with the highest levels of *Hgs* detected in the brain and spinal cord ([Fig 2A](#pgen.1005290.g002){ref-type="fig"}). Consistent with the qPCR data, immunoblot analysis also revealed high levels of HGS in the nervous system of wild type mice ([Fig 2B](#pgen.1005290.g002){ref-type="fig"}). While the *tn* mutation resulted in a significant reduction of HGS in the nervous system of the *Hgs* ^*tn/tn*^ mice, it differentially affected HGS levels in non-neuronal tissues ([Fig 2B](#pgen.1005290.g002){ref-type="fig"}). Examination of the heart, liver, spleen, kidney, adrenal gland, thalamus, testis, and ovaries from the *Hgs* ^*tn/tn*^ mice revealed a striking absence of pathology in these tissues, suggesting that HGS provides an essential function that is unique to the nervous system. {#pgen.1005290.g002} Because *Hgs* ^*tn/tn*^ mice display a progressive neurological disease starting around 3 weeks of age, it was important to establish a developmental profile of *Hgs* expression in the brain. We found that *Hgs* levels undergo a normal down regulation in the *Hgs* ^*+/+*^ mice during early postnatal development ([Fig 2C](#pgen.1005290.g002){ref-type="fig"}). Immunoblot analysis also showed the highest levels of HGS during embryonic development, with abundance decreasing throughout postnatal development (Fig [2D](#pgen.1005290.g002){ref-type="fig"} and [2E](#pgen.1005290.g002){ref-type="fig"}). The M89V mutation led to reduced expression of HGS at all time points examined (Fig [2D](#pgen.1005290.g002){ref-type="fig"}--[2F](#pgen.1005290.g002){ref-type="fig"}), with the most severe loss of HGS occurring during the time when the neurological phenotypes were most pronounced in the *Hgs* ^*tn/tn*^ mice. In addition to the primary immunoreactive band that migrated at approximately 110 kDa, a second higher molecular weight band migrating at approximately 120 kDa, which may represent a post-translationally modified form of HGS \[[@pgen.1005290.ref040]--[@pgen.1005290.ref042]\], was also detected early in development. Absence of cell death in the hippocampus of *Hgs* ^*tn/tn*^ mice {#sec005} ---------------------------------------------------------------- A previous study of a neuronal-specific knockout of *Hgs* demonstrated multiple deficits in the hippocampus that included increased ubiquitin staining of CA3 pyramidal cells, increased CA3 pyramidal cell death, and reduced CA3 pyramidal cell numbers \[[@pgen.1005290.ref043]\]. To determine whether the *Hgs* ^*tn/tn*^ mice exhibited any alterations in the number of CA3 pyramidal cells or an increase in cell death, we measured the number of CA3 cells and looked for evidence of increased cell death by performing Nissl and activated caspase-3 staining, respectively, in the hippocampi of wild type and *Hgs* ^*tn/tn*^ mice. Unlike what was reported for the neuronal-specific *Hgs* knockout mice, we did not detect any change in the number of CA3 pyramidal cells or an increase in cell death markers in the *Hgs* ^*tn/tn*^ hippocampus ([Fig 3A](#pgen.1005290.g003){ref-type="fig"}). In addition, the levels of hippocampal myelin basic protein were similar in the *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice. Moreover, while increased glial fibrillary acid protein (GFAP) abundance is often associated with neurodegeneration, there was no increase in GFAP immunoreactivity in the hippocampus of the *Hgs* ^*tn/tn*^ mice compared to wild type controls ([Fig 3A](#pgen.1005290.g003){ref-type="fig"}). Similar to what we observed in total brain extracts, there was a significant reduction in both HGS and STAM1 levels in the hippocampus of the *Hgs* ^*tn/tn*^ mice. Since mutations in CHMP2B are associated with neurodegeneration in humans, we examined the effect of loss of HGS on CHMP2B levels and found no detectable differences in the hippocampus between the *Hgs* ^*tn/tn*^ or wild type controls. Examination of the levels of the receptor tyrosine kinases TrkA and TrkB, which are putative substrates for HGS, in hippocampal extracts from the *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice also did not reveal any significant differences in expression (Fig [3B](#pgen.1005290.g003){ref-type="fig"} and [3C](#pgen.1005290.g003){ref-type="fig"}). {#pgen.1005290.g003} As a component of the endosome, HGS has been implicated in the maturation of autophagosomes, as the loss of HGS expression results in increased levels of markers of autophagy in mammalian cell lines \[[@pgen.1005290.ref044]\]. To investigate if HGS is required for autophagy in neurons, we examined the expression of the autophagosome marker microtubule-associated protein 1A/1B-light chain 3 (LC3) and the autophagy substrate p62 in hippocampal lysates from wild type and *Hgs* ^*tn/tn*^ mice. In contrast to the increased levels of LC3 and p62 that are observed when autophagy is impaired \[[@pgen.1005290.ref044]\], we detected a reduction in the levels of both LC3 and p62 in the hippocampus of the *Hgs* ^*tn/tn*^ mice as compared to controls (Fig [3B](#pgen.1005290.g003){ref-type="fig"} and [3C](#pgen.1005290.g003){ref-type="fig"}). Together, these data indicate that loss of HGS does not appear to result in increased cell death or a significant impairment of autophagy in the hippocampus of the *Hgs* ^*tn/tn*^ mice. *Hgs* ^*tn/tn*^ mice exhibit motor and sensory deficits {#sec006} ------------------------------------------------------- Several neurological diseases are caused by mutations that lie within genes involved in the endosomal sorting of membrane proteins \[[@pgen.1005290.ref045]--[@pgen.1005290.ref048]\]. To examine whether HGS deficiency resulted in motor and sensory deficits commonly seen in patients with inherited neuropathies, we performed a series of behavioral assays on our mutant *Hgs* mouse lines. By 3 weeks of age, the *Hgs* ^*tn/tn*^ mice exhibited significant motor deficits as demonstrated by the presence of clawed paws, decreased locomotion in an open field assay, impaired rotarod performance and an increased time to transverse an elevated beam compared to controls (Fig [4A](#pgen.1005290.g004){ref-type="fig"}--[4D](#pgen.1005290.g004){ref-type="fig"}). In addition, the *Hgs* ^*tn/tn*^ mice also demonstrated increased tactile sensitivity that was consistent with a heightened pain response when examined using the von Frey assay ([Fig 4E](#pgen.1005290.g004){ref-type="fig"}) and had reduced forelimb muscle strength as compared to age-matched controls ([Fig 4F](#pgen.1005290.g004){ref-type="fig"}). {#pgen.1005290.g004} The initial description of the *tn* mice indicated that the heterozygous *tn* mice displayed motor abnormalities in a prolonged swimming assay \[[@pgen.1005290.ref036]\]. We therefore investigated whether heterozygous *Hgs* ^tn/+^ and *Hgs* ^*KO/+*^ mice also exhibited motor and sensory abnormalities in our assays. Both the *Hgs* ^*KO/+*^ mice and the *Hgs* ^tn/+^ mice displayed increased pain sensitivity and reduced muscle strength (Fig [4E](#pgen.1005290.g004){ref-type="fig"} and [4F](#pgen.1005290.g004){ref-type="fig"}), indicating that the *tn* mutation is a loss-of-function mutation and that a 50% loss of HGS is sufficient to cause peripheral nervous system dysfunction. *Hgs* ^*tn/tn*^ mice display hypermyelination, dysmyelination, myelin infoldings, and increased axonal caliber {#sec007} -------------------------------------------------------------------------------------------------------------- Alterations in axon number or peripheral nerve myelination are common features of inherited peripheral neuropathies and are thought to be important contributors to motor and sensory dysfunction. To examine whether loss of HGS expression results in axonal loss, demyelination, or dysmyelination that could contribute to the behavioral deficits in the *Hgs* ^*tn/tn*^ mice, we compared the sciatic nerves of 4-week-old *Hgs* ^+/+^ and *Hgs* ^*tn/tn*^ mice by transmission electron microscopy. Although no change in the density of myelinated and unmyelinated axons was found in the *Hgs* ^*tn/tn*^ mice (Fig [5A](#pgen.1005290.g005){ref-type="fig"} and [5B](#pgen.1005290.g005){ref-type="fig"}), there was a significant increase in the diameter of myelinated axons and a significant decrease in the diameter of unmyelinated axons in the 4-week-old *Hgs* ^*tn/tn*^ mice as compared to controls ([Fig 5C](#pgen.1005290.g005){ref-type="fig"}). This increase in the average axonal diameter of myelinated fibers was attributed to a shift in distribution towards a greater number of large diameter axons in the *Hgs* ^*tn/tn*^ mice ([Fig 5D](#pgen.1005290.g005){ref-type="fig"}). Morphometric analysis of myelin structure also revealed a small but significant decrease in the G-ratio (the ratio of the inner axonal diameter to the total fiber diameter) of sciatic nerves from the *Hgs* ^*tn/tn*^ mice ([Fig 5E](#pgen.1005290.g005){ref-type="fig"}). This decrease was attributed to a 22% increase in the myelin thickness of small-diameter axons that are between 1.0 to 2.0 μm in diameter ([Fig 5F](#pgen.1005290.g005){ref-type="fig"}, circled region). {#pgen.1005290.g005} Several alterations in myelin structure were also observed in the sciatic nerves of the *Hgs* ^*tn/tn*^ mice ([Fig 5G](#pgen.1005290.g005){ref-type="fig"}). These alterations included the presence of tomacula, a prominent thickening of compact myelin with redundant loops, which likely contributed to the decreased G-ratio observed in the *Hgs* ^*tn/tn*^ mice. Additionally, many regions of the myelin sheaths were disorganized in the *Hgs* ^*tn/tn*^ mice (Fig [5G1](#pgen.1005290.g005){ref-type="fig"}--[5G2](#pgen.1005290.g005){ref-type="fig"}) and contained structural alterations such as myelin infoldings (Fig [5G3](#pgen.1005290.g005){ref-type="fig"}--[5G5](#pgen.1005290.g005){ref-type="fig"}) as compared to controls ([Fig 5G6](#pgen.1005290.g005){ref-type="fig"}). The changes in myelination that were observed in the *Hgs* ^*tn/tn*^ mice could be attributed to loss of HGS in either axons or Schwann cells. However, when we examined HGS expression in the sciatic nerves of wild type mice by indirect immunofluorescence ([Fig 6](#pgen.1005290.g006){ref-type="fig"}), we found that HGS staining did not overlap with the neurofilament staining in sciatic nerve axons. Rather, when Schwann cells were visualized with antibodies to the cytoplasmic protein S100β, HGS localized to the external boundary of the Schwann cell body. These findings are in agreement with a previous study detecting HGS transcripts in Schwann cells \[[@pgen.1005290.ref049]\]. {#pgen.1005290.g006} ESCRT and RTK expression in sciatic nerves of *Hgs* ^*tn/tn*^ mice {#sec008} ------------------------------------------------------------------ In cell culture models, the stability of STAM1 appears to be dependent upon HGS expression in a transcript-independent manner \[[@pgen.1005290.ref016],[@pgen.1005290.ref050]\]. However, this relationship between ESCRT-0 components has not been investigated in the nervous system. We therefore examined the effect of the *tn* mutation on the expression of ESCRT components and their putative substrates in the sciatic nerves of the *Hgs* ^*tn/tn*^ mice. While the HGS levels were reduced by 50% in the sciatic nerves of 4-week-old *Hgs* ^*tn/tn*^ mice compared to controls, there were no significant differences in the levels of STAM1, tumor susceptibility protein 101 (TSG101) or epidermal growth factor receptor substrate 15 (EPS15) in the sciatic nerve extracts from the *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice (Fig [7A](#pgen.1005290.g007){ref-type="fig"}--[7C](#pgen.1005290.g007){ref-type="fig"}). Analysis of receptor tyrosine kinases (RTKs) sorted by the ESCRT pathway showed that loss of HGS resulted in a significant reduction in both the full length (TrkB.FL) and truncated (TrkB.T1) isoforms of TrkB in the sciatic nerves of the *Hgs* ^*tn/tn*^ mice that was not associated with a corresponding reduction in *TrkB* mRNA levels (Fig [7D](#pgen.1005290.g007){ref-type="fig"}--[7F](#pgen.1005290.g007){ref-type="fig"}). In contrast, reduction of HGS did not affect the level of either the epidermal-growth factor receptor (EGFR) or the receptor tyrosine-protein kinase erbB-2 (ERBB2) (Fig [7D](#pgen.1005290.g007){ref-type="fig"} and [7E](#pgen.1005290.g007){ref-type="fig"}). {#pgen.1005290.g007} *Hgs* ^*tn/tn*^ mice have reduced STAM1 expression in the spinal cord but do not exhibit motor neuron loss or altered levels of RTKs {#sec009} ------------------------------------------------------------------------------------------------------------------------------------ Since loss of HGS resulted in a dramatic motor phenotype in the *Hgs* ^*tn/tn*^ mice, but had only a modest effect on peripheral nerve myelination, we examined the effect of reduced HGS expression on the abundance of ESCRT-0 components in the spinal cords of 4-week-old mice (Fig [8A](#pgen.1005290.g008){ref-type="fig"} and [8B](#pgen.1005290.g008){ref-type="fig"}). Despite the significant increase in *Hgs* transcript levels in the *Hgs* ^*tn/tn*^ mice ([Fig 8C](#pgen.1005290.g008){ref-type="fig"}), HGS levels were reduced 70% in the spinal cords of the *Hgs* ^*tn/tn*^ mice compared to controls (Fig [8A](#pgen.1005290.g008){ref-type="fig"} and [8B](#pgen.1005290.g008){ref-type="fig"}). Similarly, we also observed an 80% reduction in the levels of STAM1 in the spinal cords of the *Hgs* ^*tn/tn*^ mice with no corresponding decrease in *Stam1* transcript abundance (Fig [8A](#pgen.1005290.g008){ref-type="fig"}--[8C](#pgen.1005290.g008){ref-type="fig"}). When we examined whether the loss of HGS affected the abundance of other proteins reported to interact with HGS \[[@pgen.1005290.ref051]--[@pgen.1005290.ref053]\], there was no difference in the levels of EPS15 or TSG101 in the spinal cords of the *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice (Fig [8A](#pgen.1005290.g008){ref-type="fig"} and [8B](#pgen.1005290.g008){ref-type="fig"}). Although HGS appears to influence the abundance of some receptor tyrosine kinases in immortalized cell lines \[[@pgen.1005290.ref022],[@pgen.1005290.ref053]--[@pgen.1005290.ref058]\] and TrkB in the sciatic nerves ([Fig 7](#pgen.1005290.g007){ref-type="fig"}), the levels of EGFR, TrkA and TrkB found in the spinal cords of the *Hgs* ^*tn/tn*^ mice were similar to those observed in the *Hgs* ^*+/+*^ control mice (Fig [8A](#pgen.1005290.g008){ref-type="fig"} and [8B](#pgen.1005290.g008){ref-type="fig"}). {#pgen.1005290.g008} To determine if the movement disorder in the *Hgs* ^*tn/tn*^ mice was associated with a loss of motor neurons, we compared motor neuron numbers in the ventral horn of 4- to 5-week-old *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice. Consistent with the axonal density studies on the sciatic nerves, there was no significant difference in the number of motor neurons ([Fig 8D](#pgen.1005290.g008){ref-type="fig"}) in the lumbar 4/5 region between the *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice. However, loss of HGS in the *Hgs* ^*tn/tn*^ mice did result in increased GFAP staining in the lumbar 4/5 region of the spinal cord ([Fig 8E](#pgen.1005290.g008){ref-type="fig"}). Reduced muscle growth and increased acetylcholine receptor expression in *Hgs* ^*tn/tn*^ mice {#sec010} --------------------------------------------------------------------------------------------- The *Hgs* ^*tn/tn*^ mice exhibit several signs of neuromuscular disease, including muscle weakness and decreased motor performance. When we compared the muscle mass between the *Hgs* ^*tn/tn*^ mice and the *Hgs* ^*+/+*^ controls, we detected a significant difference in gastrocnemius weights at 4 weeks of age (Fig [9A](#pgen.1005290.g009){ref-type="fig"} and [9B](#pgen.1005290.g009){ref-type="fig"}). While we did not detect angular muscle fibers or centrally located nuclei in the muscle sections of the *Hgs* ^*tn/tn*^ mice, which are common features of motor neuron disease, there was a 32% reduction in muscle fiber size in the *Hgs* ^*tn/tn*^ mice ([Fig 9C](#pgen.1005290.g009){ref-type="fig"}). These changes were consistent with decreased motor neuron input onto the muscle fibers. Since acetylcholine receptor (AChR) abundance is inversely correlated with motor neuron input onto muscle fibers, we performed qPCR on gastrocnemius muscle RNA isolated from 4-week-old wild type and *Hgs* ^*tn/tn*^ mice. Both the embryonic and adult acetylcholine receptor subunit mRNAs were significantly increased in the gastrocnemius muscles of the *Hgs* ^*tn/tn*^ mice ([Fig 9D](#pgen.1005290.g009){ref-type="fig"}). {#pgen.1005290.g009} Loss of HGS results in structural and functional changes at the NMJ {#sec011} ------------------------------------------------------------------- Alterations in motor endplate structure are found in several models of neuromuscular disease \[[@pgen.1005290.ref059]--[@pgen.1005290.ref062]\]. Using mice that express yellow fluorescent protein (YFP) in the motor axons to visualize motor neuron terminals from tibialis anterior (TA) muscles, we found that every postsynaptic AChR cluster in the wild type mice was innervated by a motor neuron axon ([Fig 9E](#pgen.1005290.g009){ref-type="fig"}). Although all of the AChR clusters from the 4-week-old *Hgs* ^*tn/tn*^ mice were also innervated, we observed a significant increase in the number of terminals that exhibited either terminal swellings or sproutings ([Fig 9F](#pgen.1005290.g009){ref-type="fig"}), which are phenotypes that are often observed in mice with motor neuron disease \[[@pgen.1005290.ref059],[@pgen.1005290.ref062],[@pgen.1005290.ref063]\]. In addition, there was a significant increase in endplate size in the *Hgs* ^*tn/tn*^ mice ([Fig 9G](#pgen.1005290.g009){ref-type="fig"}), which resembles the increase in endplate area observed in mice lacking the vesicular acetylcholine transporter \[[@pgen.1005290.ref061]\]. These results are consistent with the idea that reduced HGS expression results in decreased neurotransmitter release onto *Hgs* ^*tn/tn*^ muscles. By sorting internalized membrane proteins from the endosome to the lysosome, the ESCRT complexes are thought to regulate the turnover of internalized cargo \[[@pgen.1005290.ref026]\]. To investigate whether loss of HGS altered endosome or MVB abundance at motor neuron terminals, we compared the NMJs from wild type and *Hgs* ^*tn/tn*^ TA muscles by electron microscopy ([Fig 10A](#pgen.1005290.g010){ref-type="fig"}). Loss of HGS expression resulted in an increase in the number of endosomal-like structures in the *Hgs* ^*tn/tn*^ mice (Fig [10A](#pgen.1005290.g010){ref-type="fig"} and [10B](#pgen.1005290.g010){ref-type="fig"}). While we did not observe any MVBs in the electron micrographs taken from wild type NMJs, we observed several MVBs (0.23 MVBs/μm^2^) in the motor neuron terminals of the *Hgs* ^*tn/tn*^ mice. No significant difference was observed in the number of autophagosomes in the NMJs of the *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^mice. {#pgen.1005290.g010} HGS is thought to have a role in regulating exocytosis through its interactions with components of presynaptic nerve terminals \[[@pgen.1005290.ref023],[@pgen.1005290.ref052]\]. To test whether HGS is required to maintain neurotransmitter release, we used two-electrode voltage-clamp analysis to study the release of acetylcholine at the NMJs of 3-week-old *Hgs* ^*tn/tn*^ and *Hgs* ^*+/+*^ mice and observed a pronounced effect of HGS reduction on neurotransmitter release in the TA muscles of the *Hgs* ^*tn/tn*^ mice ([Fig 10C](#pgen.1005290.g010){ref-type="fig"}). The amplitude of evoked neurotransmitter release, measured as endplate currents (EPCs) and obtained by stimulating sciatic nerves, was decreased by 50% in the *Hgs* ^*tn/tn*^ mice as compared to controls ([Fig 10C](#pgen.1005290.g010){ref-type="fig"}). The EPC amplitude is determined by both the number of synaptic vesicles released after nerve stimulation (quantal content) and the amplitude of the muscle response to the neurotransmitter released from a single vesicle (quantal amplitude) \[[@pgen.1005290.ref060],[@pgen.1005290.ref064]\]. The amplitude of miniature endplate currents (MEPCs), representing a response to a single quanta or vesicle, was also reduced in the *Hgs* ^*tn/tn*^ mice compared to controls ([Fig 10D](#pgen.1005290.g010){ref-type="fig"}). This finding suggests that there was either a decrease in the amount of neurotransmitter per vesicle or that there was a reduction in the sensitivity or abundance of post-synaptic receptors in the *Hgs* ^*tn/tn*^ mice. However, the increase in AChR expression observed in the *Hgs* ^*tn/tn*^ mice compared to controls, and the similarites between the phenotypes of the *Hgs* ^*tn/tn*^ mice and mice lacking the vesicular ACh transporter, both suggest that there was a reduction in the level of acetylcholine found in the synaptic vesicles of the *Hgs* ^*tn/tn*^ mice. The finding of decreased MEPC amplitudes in the *Hgs* ^*tn/tn*^ mice also suggests that HGS may be required post-synaptically for stable AChR expression. In addition, a reduction in quantal content (the number of vesicles released by evoked stimulation), which is calculated by dividing EPC amplitude by MEPC amplitude, was also observed in the *Hgs* ^*tn/tn*^ mice compared to controls ([Fig 10E](#pgen.1005290.g010){ref-type="fig"}). To further examine the effect of HGS loss on presynaptic function, we measured the frequency of spontaneous neurotransmitter release and determined that there was a 66% decrease in MEPC frequency in the *Hgs* ^*tn/tn*^ mice compared to controls ([Fig 10F](#pgen.1005290.g010){ref-type="fig"}). These findings indicate that loss of HGS severely affects synaptic transmission by reducing acetylcholine release at the NMJ and that these changes in presynaptic function likely contribute to the motor deficits seen in the *Hgs* ^*tn/tn*^ mice. Loss of HGS results in the accumulation of ubiquitinated proteins at the synapse {#sec012} -------------------------------------------------------------------------------- HGS is involved in the sorting of ubiquitinated proteins, and our studies indicate that loss of HGS has a profound effect on synaptic transmission at the NMJ. To investigate whether HGS is required for the sorting of ubiquitinated proteins at the synapse, we examined the level of ubiquitinated proteins in both the total and synaptosomal fractions prepared from cerebral cortices of wild type and *Hgs* ^*tn/tn*^ mice. While the level of ubiquitin conjugates in the spinal cord, sciatic nerve and cortex were similar between the *Hgs* ^*tn/tn*^ mice and controls, we observed a 2-fold increase in the level of ubiquitinated proteins isolated from the cortical synaptosomes of the *Hgs* ^*tn/tn*^ mice (Fig [11A](#pgen.1005290.g011){ref-type="fig"} and [11B](#pgen.1005290.g011){ref-type="fig"}). This compartment-specific effect of HGS reduction on the levels of ubiquitin conjugates suggests that HGS is involved in the sorting of ubiquitinated proteins at the synapse and that proper endosomal sorting at the NMJ is required to maintain synaptic transmission. {#pgen.1005290.g011} Discussion {#sec013} ========== These studies demonstrate that the neurological deficits observed in the *tn* mice are caused by a hypomorphic mutation in the ESCRT-0 component *Hgs* which significantly reduced HGS levels in the central nervous system. By 4 weeks of age, the *Hgs* ^*tn/tn*^ mice show significant defects in motor and sensory function as well as reduced muscle development, increased muscle AChR expression, terminal sproutings and swellings of motor axons, and increased numbers of endosomes and MVBs at the motor neuron axon terminals. In addition to these structural changes in the motor axon terminals, we also observed a significant reduction in both spontaneous and evoked vesicular release of acetylcholine at the NMJs of the *Hgs* ^*tn/tn*^ mice, suggesting that HGS-dependent sorting of proteins at the endosome is required to maintain synaptic transmission at the NMJ. Analysis of the level of ubiquitinated proteins revealed a significant increase in ubiquitin conjugates specifically in the synaptosomal fraction of the *Hgs* ^*tn/tn*^ mice as compared to controls. While the numbers of myelinated and unmyelinated peripheral nerves in the *Hgs* ^*tn/tn*^ mice were similar to the numbers observed in wild type mice, the reduced HGS expression resulted in an increase in myelin thickness and dysmyelination of the sciatic nerve axons in the *Hgs* ^*tn/tn*^ mice. These results demonstrate that HGS is required to support both the myelination of peripheral nerves and synaptic transmission at the NMJ. HGS regulates the sorting and trafficking of ubiquitinated, internalized receptors on the endosome \[[@pgen.1005290.ref042],[@pgen.1005290.ref065],[@pgen.1005290.ref066]\]. Our finding that the M89V mutation in the VHS domain had variable effects on HGS expression in the different non-neuronal tissues examined suggests that HGS stability is dictated, at least in part, by its interaction with specific binding partners \[[@pgen.1005290.ref054]\]. Alternatively, a variable demand for the ESCRT pathway may also be responsible for the differential effects of the M89V mutation on HGS expression in the various *Hgs* ^*tn/tn*^ tissues. There are several similarities between the myelination defects detected in the *Hgs* ^*tn/tn*^ mice and those observed in the brain-derived neurotrophic factor (BDNF)-overexpressing mice \[[@pgen.1005290.ref067]\]. Although we found no evidence for altered *BDNF* levels in the *Hgs* ^*tn/tn*^ mice, there was a significant reduction in TrkB in the sciatic nerves of *Hgs* ^*tn/tn*^ mice as compared to controls. However, there was no difference in the levels of *TrkB* mRNA detected in the *Hgs* ^*tn/tn*^ mice and controls, suggesting that HGS promotes TrkB stability by facilitating recycling to the plasma membrane and preventing trafficking to the lysosome. This conclusion is consistent with previous reports that HGS can regulate the recycling of TrkB.FL in neuronal culture \[[@pgen.1005290.ref055]\]. It is possible that the limited effects of loss of HGS on TrkB expression may reflect a partial loss of HGS in the Schwann cells of the *Hgs* ^*tn/tn*^ mice. Our finding that STAM1 expression is not altered in *Hgs* ^*tn/tn*^ sciatic nerve extracts, but is reduced in spinal cord and brain extracts, may indicate that STAM1 associates with other proteins in Schwann cells to stabilize its expression or that the level of HGS expression was not sufficiently reduced in Schwann cells to destabilize STAM1. In addition, since HGS interacts with the NF2 gene MERLIN in Schwann cells \[[@pgen.1005290.ref068],[@pgen.1005290.ref069]\], loss of this complex may contribute to the changes observed in the levels of TrkB. Since the observed changes in myelin thickness are very subtle, they are unlikely to be a major contributor to the neurological deficits observed in the *tn* mice. Although the *Hgs* ^*tn/tn*^ mice represent the first report linking ESCRT-0 to neuromuscular disease, mutations in the ESCRT-III component CHMP2B have been linked to amyotrophic lateral sclerosis \[[@pgen.1005290.ref027],[@pgen.1005290.ref028]\], and patients with CHMP2B mutations exhibit phenotypes consistent with lower motor neuron disease \[[@pgen.1005290.ref028]\]. The *Hgs* ^*tn/tn*^ mice also show signs of dysfunction of the lower motor neurons, including motor incoordination, muscle weakness, muscle atrophy, hypokinesis, and reduced synaptic transmission at the NMJ. These deficits are not associated with loss of motor neuron cell bodies or axons in the *Hgs* ^*tn/tn*^ mice, or with denervation of the NMJ. In immortalized cell lines, expression of mutant CHMP2B resulted in the formation of dysmorphic endosomes \[[@pgen.1005290.ref007]\], increased levels of autophagy markers, and the formation of ubiquitin-positive inclusions \[[@pgen.1005290.ref028]\], suggesting that the motor neuron damage results from a block in autophagic clearance of ubiquitinated proteins. Although data from mammalian cell lines suggests that HGS is required for the maturation of autophagic vesicles, as depletion of HGS resulted in increased LC3 levels and decreased numbers of LC3/lysosome-associated membrane glycoprotein 1 positive structures in cell culture \[[@pgen.1005290.ref044]\], loss of HGS resulted in reduced levels of the autophagy markers LC3 and p62 in the hippocampus of the *Hgs* ^*tn/tn*^ mice, indicating that loss of HGS does not appear to result in a blockade in autophagy in neurons. Our studies demonstrate that HGS is required for synaptic transmission at the NMJ. The reductions in MEPC and EPC amplitudes and quantal content are consistent with reduced vesicle number and/or release at the NMJ of the *Hgs* ^*tn/tn*^ mice. These findings are also consistent with a previous report that showed that mutation of the neuronal Rab35 GTPase activating protein skywalker in *Drosophila* leads to an increase in the readily releasable pool of vesicles, enhanced neurotransmitter release and increased HGS-dependent protein sorting at the NMJ \[[@pgen.1005290.ref025]\], suggesting that the ESCRT machinery is required for synaptic vesicle rejuvenation and removing defective synaptic vesicle proteins at the NMJ. The increased levels of ubiquitinated synaptic proteins detected in the *Hgs* ^*tn/tn*^ mice suggests that an ESCRT-dependent mechanism for clearing ubiquitinated proteins at synapses is also important to maintaining synaptic transmission in mammals. Alternatively, the increase in ubiquitinated conjugates may be an indirect effect caused by disruption of the endosomal sorting pathway. HGS is known to interact with synaptic vesicle proteins and could therefore directly affect vesicle trafficking \[[@pgen.1005290.ref052],[@pgen.1005290.ref056]\]. For example, by binding to SNAP25 \[[@pgen.1005290.ref023],[@pgen.1005290.ref051]\], HGS can displace vesicle-associated membrane protein 2 and inhibit SNARE complex formation, thereby blocking neurotransmitter secretion and endosomal fusion \[[@pgen.1005290.ref023],[@pgen.1005290.ref070]\]. While the presence of enlarged vesicles would be the predicted effect of HGS loss, we did not detect an increase in the size of the endosomes at motor neuron axon terminals in the *Hgs* ^*tn/tn*^ mice, but instead found an increase in the number of endosomes and MVBs at the NMJs of the *Hgs* ^*tn/tn*^ mice. Previous reports from a proteomic screen identified mammalian uncoordinated-18, a component of the synaptic vesicle fusion protein complex, as a protein that could interact with the ubiquitin-interacting motif of HGS \[[@pgen.1005290.ref071]\]. HGS has also been shown to inhibit the fusion of vesicles with the early endosome \[[@pgen.1005290.ref024]\]. Together, these results provide evidence that HGS interacts with components of the synaptic vesicle release machinery and plays a direct role in synaptic transmission. Given that loss of HGS results in a predominantly neurological phenotype in the *Hgs* ^*tn/tn*^ mice, it is surprising that a neuronal-specific deletion of HGS \[[@pgen.1005290.ref043]\] leads to such a mild phenotype compared to what we observed in our studies. Whereas *Hgs* ^*tn/tn*^ mice die by 5 weeks of age and present with ataxia, decreased muscle size, and reduced strength, the neuronal-specific deletion of HGS did not affect gait or grip strength, and there was no reported effect of HGS loss on viability \[[@pgen.1005290.ref043]\]. However, it is possible that the conditional knockout allele used by Tamai et al. \[[@pgen.1005290.ref043]\], which utilized a rat synapsin Cre driver \[[@pgen.1005290.ref072]\], may not have led to a reduction of HGS in the motor neurons, or that the level of HGS was not reduced as much as what is observed in the *Hgs* ^*tn/tn*^ mice, thereby resulting in a milder phenotype. Identification of the *tn* mutation in HGS has provided a new model for investigating the role of the ESCRT pathway in the nervous system. Our identification of motor and sensory phenotypes in both the *Hgs* ^*tn/+*^ and *Hgs* ^*KO/+*^ mice demonstrates that loss of HGS results in an autosomal dominant inheritance pattern similar to that observed in human cases of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease \[[@pgen.1005290.ref027],[@pgen.1005290.ref028],[@pgen.1005290.ref035]\]. Hereditary neuralgic amyotrophy, an autosomal dominant form of recurrent focal neuropathy, is the only neurological disorder that has been mapped near *HGS* on chromosome 17q25 \[[@pgen.1005290.ref073]\]. Mutations in Septin 9 have been found in many, but not all, cases of hereditary neuralgic amyotrophy, making *HGS* a good candidate gene for other cases of this disease. With our demonstration that HGS is required for motor neuron function, it will now be possible to determine if HGS is involved in other neurological disorders in humans. Materials and Methods {#sec014} ===================== Mice {#sec015} ---- The *tn* mutation spontaneously arose on the C3H/HeJ inbred mouse strain at The Jackson Laboratory in 1959. We generated a congenic line of B6.C3*Hgs* ^*tn*^ mice by backcrossing the *tn* mutation onto the C57BL/6J background for at least 12 generations. The *tn* mice were maintained by intercrossing *tn* sibling heterozygotes (*Hgs* ^*tn/+*^). *Hgs* knockout heterozygotes (*Hgs* ^*tm1Sor/+*^, stock number 003539) were obtained from The Jackson Laboratory, and sibling pairs were intercrossed to maintain the strain. Research was conducted using equal numbers of male and female mice. Wild type littermates or age-matched C57BL/6J mice (*Hgs* ^*+/+*^) were used as controls. All mice were maintained in our breeding colony at the University of Alabama at Birmingham, which is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. All research was approved by the UAB IACUC committee and complied with the United States Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals, and adhered to principles stated in the Guide for the Care and Use of Laboratory Animals, United States National Research Council. Genetic mapping {#sec016} --------------- The *tn* mutation was previously mapped to distal chromosome 11 \[[@pgen.1005290.ref074]\]. Small nucleotide polymorphism (SNP) analysis localized the *tn* mutation to a 2.8 Mb region on the distal end of chromosome 11 flanked by rs27043138 and rs3675603. RNA transcriptome analysis {#sec017} -------------------------- Total RNA was isolated from brain lysates of 4-week-old *Hgs* ^tn/tn^ and *Hgs* ^+/+^ mice using RNA-STAT60 (Tel-Test, Friendswood, TX) and subsequently purified using an RNeasy Mini Kit (Qiagen Sciences, Valencia, CA). RNA-seq experiments were carried out at the Hudson Alpha Genome Services Laboratory (Huntsville, Alabama). Two μg of total RNA underwent quality control (Bioanalyzer; all RIN values \> 9.5), and was prepared for directional RNA sequencing at Hudson Alpha using NEBNext reagents (New England Biolabs) according to manufacturer's recommendations with minor modifications (including the use of custom library adapters and indexes). RNA libraries were quantified with the Kapa Library Quant Kit (Kapa Biosystems), and underwent sequencing (50 bp paired-end directional reads; \~70M reads/sample) on an Illumina sequencing platform (HiSeq2000). DNA sequencing {#sec018} -------------- Exon 4 of *Hgs* was amplified from genomic DNA of *Hgs* ^tn/tn^ and *Hgs* ^+/+^ mice. The PCR products were sequenced by The Genomics Core Facility of the Heflin Center for Genomic Science (Birmingham, AL). Quantitative PCR {#sec019} ---------------- Total RNA was isolated from specified tissues using RNA-STAT60 and reverse transcribed using the Superscript VILO cDNA synthesis kit (Life Technologies). Individual gene assays were purchased from Applied Biosystems for each of the RNAs analyzed. ΔΔCt values were generated using *Hgs* (Mm00468635_m1), *Stam* (Mm00488457_m1), *AChRα* (Mm00431629_m1), *AChRβ* (Mm00680412_m1), *AChRδ* (Mm00445545_m1), *AChrδ* (Mm00437419_m1), *AChRε* (Mm00437411_m1), *Bdnf* (Mm04230607_s1) and TrkB Mm00435422_m1). Taqman gene assays with *18S* (Mm03928990_g1) and *β-actin* (Mm00607939_s1) served as internal standards. qPCR results are shown as the average of three different amplifications of cDNAs that were generated from at least three different mice. Unpaired Student's t tests were conducted on ΔΔCt values from each genotype to determine their significance. Isolation of proteins {#sec020} --------------------- Mice of appropriate age and genotype were asphyxiated with CO~2~ or deeply anesthetized via isoflurane prior to rapid decapitation. Tissues were removed and homogenized in a modified RIPA buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl~2~, 0.5 mM EGTA, 1 mM EDTA, 0.5% SDS, 1% Triton X-100, and 1% sodium deoxycholate. Complete protease inhibitors (Roche, Indianapolis, IN), phosphatase inhibitor cocktail I (Sigma Aldrich, St. Louis, MO), and 50 μM PR-619 (Life Sensors, Malvern, PA) were added to the homogenization buffer. Samples were homogenized in 1X Laemmli buffer, sonicated, and boiled. After homogenization, tissues were centrifuged at 17,000 x g for 10 min at 4°C, and supernatants were removed and immediately frozen at---80°C. Protein concentrations were determined by using the bicinchoninic acid (BCA) protein assay kit from Pierce (Rockford, IL). Immunoblot analysis {#sec021} ------------------- Proteins were resolved on either 10% Tris-glycine gels or 4--20% Novex Tris-glycine gels (Life Technologies) and transferred onto nitrocellulose or PVDF membranes. Immunoblots were probed for HGS, STAM1, TSG101, EPS15, EGFR (Santa Cruz, Dallas, TX), TrkA and TrkB (Millipore, Billerica, MA), CHMP2B (Abcam, Cambridge, MA), ERBB2, p62, LC3 (4108) and cleaved caspase 3 (Cell Signaling, Danvers, MA), mylein basic protein (Biolegend, Dedham, MA), GFAP (Dako, Carpinteria, CA) and ubiquitin (UAB Hybridoma Facility, Birmingham, AL). β-tubulin and β-actin (Developmental Hybridoma Bank, Iowa City, IA) were used for loading controls. Primary antibodies were diluted in 1X phosphate buffered saline containing 0.1% NP-40 and either 2% BSA or 1% non-fat dry milk, and proteins were detected by using an anti-mouse or anti-rabbit HRP-conjugated secondary antibody (Southern Biotechnology Associates, Birmingham, AL) and SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL). Quantitation of immunoblots {#sec022} --------------------------- Blots were scanned using a Hewlett-Packard Scanjet 3970 (Palo Alto, CA) and quantitated using ImageJ (NIH, Bethesda, MD) or UN-SCAN-IT software (Orem, Utah). Each value represents the mean and standard error from at least two blots using at least three different animals per genotype. Unpaired t-tests, corrected for multiple comparisons using the Holm- Šídák method, were utilized to determine significant effects between genotypes. One-way ANOVAs with the Geisser-Greenhouse correction were used to analyze the developmental expression patterns of HGS. Body and muscle wet weight analysis {#sec023} ----------------------------------- Gastrocnemius muscles were collected from 4-week-old *Hgs* ^+/+^ and *Hgs* ^tn/tn^ mice. Muscle and body weights were determined for at least six animals per genotype, and values are reported as the average muscle or body mass ± SE. Hippocampal immunostaining {#sec024} -------------------------- Brain sections were prepared and stained as previously described \[[@pgen.1005290.ref075]\]. Sciatic nerve immunostaining and confocal microscopy {#sec025} ---------------------------------------------------- Sciatic nerves were dissected from 4-week-old wild type mice and immediately submersed in ice cold 4% PFA for 1 h. Sciatic nerves were cryopreserved in PBS containing 30% sucrose overnight at 4°C. Nerves were embedded in OCT (Tissue-Tek; Sakura Finetek USA) and 20 μM sections were cut for analysis. Sections were blocked in PBS containing 10% normal goat serum for 1 h at room temperature. Primary antibodies (HGS, S100β and Neurofilament) were diluted 1:200 in PBS containing 10% normal goat serum and incubated with sections overnight at 4°C. Sections were washed two times with PBS at room temperature and then incubated with secondary antibodies labeled with Alexa Fluor 488 or 568 dye (Invitrogen). Confocal imaging was performed on a Nikon C2 laser scanning confocal microscope using the NIS element advance imaging software package version 4.2 (Nikon, Melville, NY). Images were captured at 40x using a 0.3 μM z-step. ### NMJ immunostaining and confocal imaging {#sec026} Whole mount immunostaining of tibialis anterior (TA) muscles was performed as described \[[@pgen.1005290.ref059]\]. Briefly, TA muscles were dissected and immersed in ice-cold 2% PFA in PBS for 1 h. Muscles were then teased into bundles and transferred to 1% PFA in PBST (PBS + 1% Triton) overnight at 4°C with constant rocking. Endplate size was determined by tracing the circumference of the α-bungarotoxin-positive post-synaptic AChR cluster and computing area using ImageJ software. Quantitation of axonal sprouts and swellings were performed using ImageJ software. Over 150 synapses from *Hgs* ^+/+^ and *Hgs* ^tn/tn^ mice were quantified. Behavioral analysis {#sec027} ------------------- Motor and sensory performance was assayed at 3 to 4 weeks of age with *Hgs* ^+/+^, *Hgs* ^tn/tn^, *Hgs* ^tn/+^, and *Hgs* ^KO/+^ mice (n ≥ 4). Before each behavioral assay, animals were habituated to the testing room for 30 min. Unpaired Student's t-tests were performed on open field, grip strength and von Frey data. Two-way ANOVA was utilized to determine significance between genotypes on rotarod and elevated beam assays. Unpaired Student's t-tests were utilized to determine the significance of each trial. Open field {#sec028} ---------- Animals were handled at least three days prior to open field testing. Locomotor activity was measured in an open-field arena (43.2 cm x 43.2 cm x 30.5 cm) for 15 min by an automatic video tracking system (Med Associated, St. Albans, VT). The first 5 min were not analyzed to account for habituation to the open field chamber. Rotarod {#sec029} ------- Motor coordination and balance were tested by placing mice on an accelerating rotarod (ENV-575, Med Associates) and recording latency to fall. The rotarod initially started rotating at 3.5 rpm and accelerated to 35 rpm over a 5 min period. Each mouse performed 3 trials separated by 1 h. Elevated beam {#sec030} ------------- Motor coordination and proprioception were tested by the elevated beam assay as previously described \[[@pgen.1005290.ref076]\]. Four trials were performed with each trial consisting of 3 repetitions of the assay. Grip strength {#sec031} ------------- The San Diego Instrument Grip Strength System (San Diego, CA) was used to assay mouse grip strength. The maximum amount of force generated from forelimbs was recorded. Each trial consisted of 12 repetitions of the assay with the two highest and two lowest data points dropped from final analysis. Von Frey analysis {#sec032} ----------------- Animals were habituated to an open gridded floor chamber for 5 min. A series of 10 von Frey fibers varying from 0.4 g to 60 g of force (Ugo Basile, Comerio, Italy) was applied from below the wire mesh chamber in ascending order beginning with the smallest fiber. The fiber was applied to the central region of the plantar surface to avoid the foot pads. The hind paw withdrawal threshold was determined by Dixon's formula. NMJ transmission electron microscopy {#sec033} ------------------------------------ TA muscle tissues were fixed in 4% paraformaldehyde in 0.1 M sodium cacodylate buffer for 1 h. Fixed muscle fibers were stained with α-bungarotoxin and dissected to isolate regions of muscles containing NMJs. Muscles were washed in 0.1 M sodium cacodylate buffer and then post-fixed in 1% osmium tetroxide for 1 h in the dark. After rinsing with sodium cacodylate, the samples were dehydrated in increasing concentrations of acetone (50% for 10 min, 75% for 10 min, 90% for 10 min, 95% for 10 min, 100% for 4 x 10 min). Muscles were transitioned to epoxy resin (Electron Microscopy Sciences, Hatfield, IL) by rotating the samples overnight in a 50:50 solution of epoxy:acetone. The samples were then immersed in fresh 100% resin several times throughout the next day and baked at 65°C overnight. Ultra-thin cross-sections were collected using a Leica EM-UC6 ultramicrosome (Buffalo Grove, IL) and stained for contrast with uranyl acetate and lead citrate. Samples were viewed using an FEI Tecnai T-12 electron microscope (Delmont, PA) with a Hamamatsu digital camera (Bridgewater, N.J). Quantitation of motor neuron number {#sec034} ----------------------------------- For quantitation of motor neuron numbers, transverse frozen sections of lumbar spinal cords (L4 /L5) from 7-week-old wt and *axJ* mice were prepared and stained with cresyl violet as previously described \[[@pgen.1005290.ref077]\]. Morphometric analysis of the NMJ {#sec035} -------------------------------- Ultra-thin sections of muscle tissues were scanned for the presence of NMJs. Micrographs were taken at 4400-6500x magnification. A total of 14 synapses were analyzed from *Hgs* ^+/+^ mice (n = 3), and 27 synapses from *Hgs* ^tn/tn^ mice (n = 3) were quantified. Endosomes were defined as single membrane intracellular vesicles that were at least 100 nm in feret diameter, and MVBs were defined as endosomes with at least 2 ILVs within the lumen. Endosomes and MVBs were quantified and normalized to the size of the synapse. Transmission electron microscopy of sciatic nerves {#sec036} -------------------------------------------------- Sciatic nerves were excised from 4-week-old *Hgs* ^+/+^ and *Hgs* ^tn/tn^ mice and immersed in 6% gluteraldehyde/2% paraformaldehyde in 0.1 M sodium cacodylate buffer for at least 1.5 h at room temperature. Samples were processed as described above for NMJ analysis. Morphometric analysis of sciatic nerves {#sec037} --------------------------------------- Photomicrographs for morphometric analysis were obtained by systematically covering adjacent but non-overlapping fields to measure axon and myelin diameter, myelin thickness, and myelin defects. The feret diameter was calculated to determine axon and myelin caliper. The G-ratio was also calculated by dividing the axon diameter by the myelin diameter. Quantitation was performed using ImageJ software. A total of 595 myelinated axons from *Hgs* ^+/+^ mice (n = 3) and 574 axons from *Hgs* ^tn/tn^ mice (n = 3) were quantified. Micrographs taken at 240x magnification were utilized to calculate axon density of myelinated fibers, while micrographs taken at 1100x were used to quantitate the density of unmyelinated fibers. Electrophysiology {#sec038} ----------------- All experiments were carried out *in vitro* at room temperature on the sciatic nerve and TA muscles from 3- to 4-week-old mice. For dissection, mice were deeply anesthetized with isofluorane. The TA muscle was dissected free from the extensor digitorum longus (EDL) muscle, partially bisected, and folded apart to flatten the muscle before pinning it down. Because the sciatic nerve innervates both EDL and TA muscles, we transected the EDL and posterior portion of the TA muscle to eliminate excessive muscle contraction. The TA muscle was perfused with Tyrode\'s solution (137 mM NaCl, 2.8 mM KCl, 1.8 mM CaCl~2~, 1.1 mM MgCl~2~, 11.9 mM NaHCO~3~, 0.33 mM NaH~2~PO~4~, and 11.2 mM dextrose, pH 7.4, when bubbled with a mixture of 95% O~2~ and 5% CO~2~) at 30°C. Intracellular potentials and currents were measured using an Axoclamp-2A amplifier system and glass microelectrodes filled with 3 M KCl (resistance, 10--15 MΩ). Using the two-microelectrode voltage-clamp system, synaptic currents, including miniature endplate currents (MEPCs) and endplate currents (EPCs), were obtained at -60 mV holding potential. The currents were digitized at 50 μs per point and were stored, captured, and analyzed using pClamp 9.0 software (Molecular Devices). EPCs were elicited by stimulating the corresponding sciatic nerve with rectangular pulses of 0.05 ms duration. During single shock stimulation, the nerve was stimulated at 0.2 Hz. The amplitude decay and time to peak of the EPCs and MEPCs were captured and subsequently analyzed with pClamp 9.2 software and the Mini Analysis Program (Synaptosoft). Quantal content was determined by dividing MEPC amplitude with EPC amplitude from the same endplate \[[@pgen.1005290.ref078]--[@pgen.1005290.ref080]\]. Synaptosomal fractionation {#sec039} -------------------------- Synaptosomes were prepared from 4-week-old cerebral cortices of wild type and *tn* mice as described \[[@pgen.1005290.ref081]\]. [^1]: SMW is a paid consultant for Progenra Incorporated. This does not alter the authors' adherence to any of the PLOS Genetics policies on sharing data and materials, and it does not influence the generation or presentation of the data. [^2]: Conceived and designed the experiments: JAWa BJB GPS SEP RJM SMW EP GDK. Performed the experiments: JAWa BJB JHV JAWi MI ADH SEP EP GDK TMD. Analyzed the data: JAWa BJB JHV GPS TMD SEP RJM SMW. Contributed reagents/materials/analysis tools: AJB. Wrote the paper: JAWa BJB JHV JAWi AJB SMW.

\section{\label{intro} Introduction} There is a current interest in small fluctuating systems in contact with heat reservoirs driven by external forces. This focus is driven by the recent possibilities of direct manipulation of nano systems and bio molecules. These techniques also permit direct experimental access to the probability distributions for the work or heat exchanged with the environment \cite{Trepagnier04,Collin05,Seifert06a,Seifert06b, Imparato07,Ciliberto06,Ciliberto07, Ciliberto08}. These single molecule techniques have, moreover, also yielded access to the so-called fluctuation theorems, which relate the probability of observing entropy-generated trajectories, with that of observing entropy-consuming trajectories \cite{Jarzynski97,Kurchan98,Gallavotti96,Crooks99,Crooks00, Seifert05a,Seifert05b,Evans93,Evans94,Gallavotti95, Lebowitz99,Gaspard04,Imparato06, vanZon03,vanZon04,vanZon03a,vanZon04a,Seifert05c}. A fundamental issue is the validity and microscopic underpinning of Fourier's law \cite{Bonetto00,Jackson78}. Here an important problem is the dependence of the heat current $J$ on the system size $N$ and dimensionality. Fourier's law based on energy conservation and a phenomenological transport equation assumes local equilibrium and therefore a current $J\sim 1/N$, yielding a constant heat conductivity $\kappa\propto JN$. However, many studies of one dimensional systems indicate that $J\sim 1/N^\alpha$, where $\alpha$ in general is different from one, signalling the breakdown of Fourier's law, see \cite{Dhar08a,Lepri03,Dhar16}. Regarding ongoing studies of the dependence of $J(N)$ as function of boundary conditions and the spectral properties of the heat baths, see e.g. \cite{Ajanki11,Ash20,Ong14,Yamada18,Amir18,Herrera10,Herrera15,Herrera19,Zhou16,Kundu10a}. A one dimensional system which has been studied extensively is the linear harmonic chain subject to disorder or nonlinearity. In the case of a linear harmonic chain the heat is transmitted ballistically by phonons and the heat current is independent of the system size, corresponding to $\alpha=0$ \cite{Saito11,Kundu11,Fogedby12}. In the particular case where the effective interaction is provided by mass disorder, this issue has been studied in several papers \cite{Casher71,Dhar08a,Dhar08b,Dhar11,Kundu10,Chauduri10,Lee05,Lepri03,Oconnor74,Roy08a,Roy08b}. For more recent papers on the disordered chain, see also \cite{Herrera10,Herrera19,Ash20,Amir18,Ong14,Ajanki11,Kundu10a,Yamada18}. The status regarding the mass-disordered chain has been summarised by Dhar \cite{Dhar08a}, see also Lepri \cite{Lepri03}. Unlike the electronic case, where disorder gives rise to Anderson localisation \cite{Anderson58} of the carriers and thus a vanishing contribution to the current, the case of phonons subject to disorder is different. Translational invariance implies that the low frequency phonon modes are extended and thus contribute to the current \cite{Matsuda62,Matsuda70,Ishii73}. Moreover, unlike the electronic case where only electrons at the Fermi surface contribute, the phonon contributions originate from the full phonon band. At larger frequencies corresponding to larger wave numbers, i.e., smaller wavelengths, the disorder becomes effective and traps the phonons in localised states. As a result the high frequency localised phonons mode do not contribute to the heat current. For an ordered linear chain, where the heat is carried ballistically across the system by extended phonon modes, the heat current and more generally the large deviation function monitoring the heat fluctuations are easily evaluated explicitly by means of standard techniques \cite{Saito07,Kundu11,Fogedby12}. On the other hand, for a disordered system standard techniques using plane wave representations fail and one must resort to transfer matrix methods in order to monitor and analyse the propagation of lattice site vibrations \cite{Matsuda70,Ishii73,Dhar01}. In the mass-disordered case detailed analysis by Matsuda et al. \cite{Matsuda70,Ishii73} based on the Furstenberg's theorem for the product of random matrices \cite{Furstenberg63,O'Connor75} yield a Liapunov exponent $\gamma(\omega)$ depending on the phonon frequency $\omega$. Regarding the definition of the Liapunov exponent, consider the two-by-two random matrix $T_n(\omega)$ relating the pair of displacements $u_n,u_{n-1}$ to the displacements $u_{n+1}, u_n$. Here the Liapunov exponent basically characterises the growth of an ordered product of statistically independent random matrices according to $\prod_{n=1}^N T_n\sim\exp(\gamma(\omega)N)$, or more precisely $(|u_N|^2+|u_{N-1}|^2)^{1/2}\sim\exp(\gamma(\omega) N)$. From the analysis of Matsuda et al. it follows that $\gamma(\omega)\propto\omega^2$ for small $\omega$ and we infer a localisation length $l_c(\omega)=1/\gamma(\omega)$ and in particular a cross-over frequency $\omega_c=\text{A}N^{-1/2}$, where $A$ depends on the disorder; for an ordered chain $A=0$. Consequently, the high frequency phonons for $\omega>\omega_c$, corresponding to small wavelengths, are trapped and do not contribute to the transport, whereas low frequency phonons with $\omega<\omega_c$ carry the heat across the chain. The dependence of $\omega_c$ on the system size $N$ implies a dependence of the scaling exponent $\alpha$ in $J\sim 1/N^\alpha$. Moreover, boundary conditions and spectral properties of the heat reservoirs also influence $\alpha$ \cite{Dhar01}. Assuming that the real part of the frequency dependent damping, $\Gamma'(\omega)\sim |\omega|^s$, one finds $\alpha=3/2+s/2$, the case of an unstructured reservoir, $\Gamma=\text{const.}$, $s=0$ , yields $\alpha=3/2$; note that $s=-1$ results in $\alpha=1$, i.e., Fourier's law. In the present paper we consider a harmonic chain with fixed boundary conditions subject to weak coupling strength disorder. To our knowledge this case has not been discussed previously. Although the techniques used by Matsuda et al. in their pioneering work in the case of mass disorder \cite{Matsuda70,Ishii73} presumably can be applied to the case of coupling strength disorder, we have found the approach in the mass-disordered case by Lepri et al. \cite{Lepri03} using dynamical system theory in conjunction with statistical physics more accessible and transparent. The main part of the paper is thus devoted to the evaluation and discussion of the Liapunov exponent, a central quantity, in the case of coupling strength disorder. We have, moreover, briefly discussed the heat current and the heat fluctuations characterised by the large deviation function. In order to render the paper self-contained for the uninitiated reader, we have presented a review of the methods employed including a series of explicit calculations. These calculations are deferred to a series of appendices. The paper is organised as follows. In Sec.~\ref{model} we introduce the disordered harmonic chain in the presence of both mass disorder and coupling strength disorder, driven at the end points by heat reservoirs, the equations of motion describing the dynamics together with expressions for the heat rates. In Sec.~\ref{green} we present the Green's functions describing the propagation of phonons for the ordered and disordered chain with derivations deferred to Appendix \ref{greensfunction}. In Sec.~\ref{liapunov} we introduce the Liapunov exponent characterising the asymptotics of the transfer matrices. Sec.~\ref{disorder}, which is the central part of the paper, is devoted to a derivation of the Liapunov exponent in the case of weak coupling strength disorder with a technical issue deferred to Appendix \ref{liapunovapp}. In Sec.~\ref{heatldf} we briefly discuss the heat current and the large deviation function with derivations in Appendices \ref{current} and \ref{cgf}. In Sec.~\ref{conclusion} we present a conclusion. \section{\label{model} Model} Here we introduce the model which is the subject of the present study. The disordered harmonic chain of length $N$ is characterised by the Hamiltonian \begin{eqnarray} H=\sum_{n=1}^N\frac{\dot u_n^2}{2m_n}+\frac{1}{2}\sum_{n=1}^{N-1}\kappa_n(u_n-u_{n+1})^2 +\frac{1}{2}\kappa_0 u_1^2+\frac{1}{2}\kappa_Nu_N^2, \label{ham} \end{eqnarray} where $u_n$ is the position of the n-th particle and $\dot u_n$ its velocity, $\dot u_n=du_n/dt$. We consider fixed boundary conditions, i.e., the chain is attached to walls at the endpoints, yielding the on-site potentials $(1/2)\kappa_0u_1^2$ and $(1/2)\kappa_Nu_N^2$. For later purposes we impose both mass disorder and coupling strength disorder, i.e., $m_n$ and $\kappa_n$ are determined by the independent distributions $\pi_1(m_n)$ and $\pi_2(\kappa_n)$. The chain is driven by two reservoirs at temperatures $T_1$ and $T_2$, respectively, acting on the first and last particle in the chain. This configuration is depicted in Fig.~\ref{fig1}. The equations of motion in bulk for $1<n<N$ and the Langevin equations for the endpoints for $n=1$ and $n=N$ are given by \begin{eqnarray} &&m_n\ddot u_n(t)=\kappa_nu_{n+1}(t)+\kappa_{n-1}u_{n-1}(t)-(\kappa_n+\kappa_{n-1})u_n(t), ~~1<n<N, \label{eqmo1} \\ &&m_1\ddot u_1(t)=\kappa_1u_2(t)-(\kappa_1+\kappa_0)u_1(t)-\Gamma\dot u_1(t)+\xi_1(t), \label{lan1} \\ &&m_N\ddot u_N(t)=\kappa_{N-1}u_{N-1}(t)-(\kappa_N+\kappa_{N-1})u_N(t)-\Gamma\dot u_N(t)+\xi_2(t). \label{lan2} \end{eqnarray} The heat reservoirs at the endpoints are characterised by the white noise correlations \begin{eqnarray} &&\langle\xi_1(t)\xi_1(t')\rangle=2\Gamma T_1\delta(t-t'), \label{noi1} \\ &&\langle\xi_2(t)\xi_2(t')\rangle= 2\Gamma T_2\delta(t-t'); \label{noi2} \end{eqnarray} note that the fluctuation-dissipation theorem \cite{Reichl98} implies that the damping $\Gamma$ in the Langevin equations is balanced by the damping $\Gamma$ also appearing in the white noise correlations. We, moreover, consider structureless reservoirs characterised by a single damping constant $\Gamma$. The case of memory effects characterised by a frequency dependent damping $\Gamma(\omega)$ has also been discussed, see e.g. \cite{Dhar01,Casher71}. For later purposes we also note that according to (\ref{lan1}) and (\ref{lan2}) the thermal forces arising from the reservoirs are given by $F_1(t)=-\Gamma\dot u_1(t)+\xi_1(t)$ and $F_2(t)=-\Gamma\dot u_N(t)+\xi_2(t)$, yielding the heat rates \begin{eqnarray} &&\dot Q_1(t)=F_1(t)\dot u_1(t), \label{qr1} \\ &&\dot Q_2(t)=F_2(t)\dot u_N(t). \label{qr2} \end{eqnarray} \section{\label{green} Green's functions} The Green's function plays an important role in the discussion of heat transport and heat fluctuations. Introducing the Fourier transforms \begin{eqnarray} &&u_n(t)=\int\frac{d\omega}{2\pi}\exp(-i\omega t)\tilde u_n(\omega), \label{fou1} \\ &&\xi_{1,2}(t)=\int\frac{d\omega}{2\pi}\exp(-i\omega t)\tilde\xi_{1,2}(\omega), \label{fou2} \end{eqnarray} we can express the equations of motion (\ref{eqmo1}) to (\ref{lan2}) in the form \begin{eqnarray} \sum_{m=1}^NG_{nm}^{-1}(\omega)\tilde u_m(\omega)=\delta_{n1}{\tilde\xi}_1(\omega)+\delta_{nN}{\tilde\xi}_2(\omega), \label{eqmo2} \end{eqnarray} with solutions \begin{eqnarray} \tilde u_n(\omega)=G_{n1}(\omega)\tilde\xi_1(\omega)+G_{nN}(\omega)\tilde\xi_2(\omega), \label{sol} \end{eqnarray} where the Green's function $G_{n1}(\omega)$ and $G_{nN}(\omega)$ describe the influence of the coupling to the reservoirs at the endpoints on the particle at site $n$. Here the end-to-end-point Green's function $G_{1N}(\omega)$ is relevant in the context of heat transfer. \subsubsection{The ordered chain} For the ordered chain with masses $m_n=m$ and coupling strengths $\kappa_n=\kappa$ the derivation of $G_{1N}(\omega)$ is straightforward in a plane wave basis using an equation of motion approach \cite{Fogedby12} or a determinantal approach \cite{Saito07,Kundu11}. For a chain composed of $N$ particles one finds the expression \begin{eqnarray} &&G_{1N}(\omega)= \frac{\kappa\sin p} {\kappa^2\sin p(N+1)-2i\kappa\Gamma\omega\sin pN-(\Gamma\omega)^2\sin p(N-1)}, \label{green1} \\ &&\omega^2=\frac{4\kappa}{m}\sin^2(p/2),~~-\pi<p<\pi. \label{disp} \end{eqnarray} The denominator in (\ref{green1}) shows the resonance structure in the chain. We note that $G_{1N}(\omega)$ is bounded and describes the propagation of ballistic phonons across the chain. The frequency $\omega$ is related to the wavenumber $p$ by the phonon dispersion law (\ref{disp}). The derivation of (\ref{green1}) is presented in Appendix \ref{greensfunction}. \subsubsection{The disordered chain} The mass-disordered chain has been discussed by Dhar \cite{Dhar01,Dhar08a}, see also \cite{Matsuda68,Matsuda70,Ishii73}. In this context the corresponding end-to-end Greens function $G_{1N}(\omega)$ has been derived. Here we extend this analysis to also include coupling strength disorder. For the disordered chain the plane wave assumption used in obtaining (\ref{green1}) is not applicable owing to the random masses and coupling strengths and one must resort to a transfer matrix method \cite{Matsuda70,Ishii73,Dhar01}. The transfer matrix $T_n(\omega)$ connects the pair of sites $(\tilde u_n(\omega),\tilde u_{n-1}(\omega))$ to the pair of sites $(\tilde u_{n+1}(\omega),\tilde u_n(\omega))$ and thus depends on the local disorder. From the bulk equations of motion (\ref{eqmo1}) in Fourier space we obtain \begin{eqnarray} \left(\begin{array}{c}\tilde u_{n+1}(\omega)\\\tilde u_n(\omega)\end{array}\right)= T_n(\omega)\left(\begin{array}{c}\tilde u_n(\omega)\\\tilde u_{n-1}(\omega)\end{array}\right), \label{eqmo3} \end{eqnarray} where the transfer matrix is given by \begin{eqnarray} T_n(\omega)=\left(\begin{array}{cc}\Omega_n(\omega)/\kappa_n &-\kappa_{n-1}/\kappa_n\\1 & 0\end{array}\right); \label{trans1} \end{eqnarray} we have introduced \begin{eqnarray} \Omega_n(\omega)=\kappa_n+\kappa_{n-1}-m_n\omega^2. \label{om} \end{eqnarray} The pair of sites $(\tilde u_N(\omega),\tilde u_{N-1}(\omega))$ are thus related to the pair of sites $(\tilde u_2(\omega),\tilde u_1(\omega))$ by a product of random transfer matrices according to \begin{eqnarray} \left(\begin{array}{c}\tilde u_N(\omega)\\\tilde u_{N-1}(\omega)\end{array}\right)= T_{N-1}(\omega)T_{N-2}(\omega)\cdots T_2(\omega)\left(\begin{array}{c}\tilde u_2(\omega)\\\tilde u_1(\omega)\end{array}\right). \label{eqmo4} \end{eqnarray} Incorporating the coupling to the heat baths at sites $n=1$ and $n=N$ the Green's function $G_{1N}(\omega)$ takes the form \begin{eqnarray} G_{1N}(\omega)=\frac{\kappa_0} {\kappa_0\kappa_NB_{11}(\omega)+i\Gamma\omega(\kappa_NB_{12} (\omega)-\kappa_0B_{21}(\omega))+(\Gamma\omega)^2B_{22}(\omega)}. \label{green2} \end{eqnarray} Here $B(\omega)$ is given by the matrix product \begin{eqnarray} B(\omega)=T_N(\omega)T_{N-1}(\omega)\cdots T_1(\omega); \label{bom} \end{eqnarray} note that in the ordered chain, $m_n=m$ and $\kappa_n=\kappa$, and we have $T_n(\omega)=T(\omega)$, i.e., $B(\omega)=T^N(\omega)$. By insertion of $T^N(\omega)$ given by (\ref{a35}) we readily obtain (\ref{green1}). The derivation of (\ref{green2}) is given in Appendix \ref{greensfunction}. \section{\label{liapunov}The Liapunov exponent} The Liapunov exponent is of importance in determining the properties of the disordered chain. For large $N$ the behaviour of $G_{1N}(\omega)$ in (\ref{green2}) is determined by the asymptotic properties of the matrix product $B(\omega)$ in (\ref{bom}) . This issue has been discussed extensively in seminal papers by Matsuda and Ishii \cite{Matsuda68,Matsuda70,Ishii73} on the basis of the Furstenberg theorem \cite{Furstenberg63,O'Connor75}. A central result is that \begin{eqnarray} \lim_{N\rightarrow\infty}\frac{1}{N}\log(|\tilde u_N(\omega)|^2+|\tilde u_{N-1}(\omega)|^2)=2\gamma(\omega) \label{liap1} \end{eqnarray} with probability one; this is basically an expression of the law of large numbers applied to non commuting independent random matrices. Here $\gamma(\omega)$ is a positive Liapunov exponent depending on the phonon frequency $\omega$ and the disorder. For the norm we infer the scaling behaviour \begin{eqnarray} |\tilde u_N(\omega)|\propto\exp(\gamma(\omega)N), \label{un} \end{eqnarray} and since the matrix $T_N^{-1}(\omega)B(\omega)T_1^{-1}(\omega)$ according to (\ref{eqmo4}) connects the pair of site $(\tilde u_{N}(\omega),\tilde u_{N-1}(\omega))$ to the pair of sites $(\tilde u_{2}(\omega),\tilde u_{1}(\omega))$, the matrix elements $B_{nm}(\omega)$, likewise, scale like \begin{eqnarray} |B_{nm}(\omega)|\propto\exp(\gamma(\omega)N) \label{bom2} \end{eqnarray} for large $N$. For vanishing disorder $\gamma(\omega)=0$ and $B(\omega)$ is bounded, i.e., not growing with $N$. It then follows from (\ref{green2}) that $G_{1N}(\omega)$, likewise, is bounded. Introducing the ratio $z_n(\omega)=\tilde u_n(\omega)/\tilde u_{n-1}(\omega)$ and inserting (\ref{om}), it follows from the bulk equations of motion (\ref{eqmo1}) that $z_n(\omega)$ obeys the non linear stochastic discrete map \begin{eqnarray} z_{n+1}(\omega)= \frac{\kappa_n+\kappa_{n-1}-m_n\omega^2}{\kappa_n}-\frac{\kappa_{n-1}}{\kappa_n}\frac{1}{z_n(\omega)}. \label{map1} \end{eqnarray} We also note from (\ref{un}) that for large $N$ we have $|z_N(\omega)|=|\tilde u_N(\omega)|/|\tilde u_{N-1}(\omega)|\propto\exp(\gamma(\omega))$ or \begin{eqnarray} \gamma(\omega)=\lim_{N\rightarrow\infty}\log| z_N(\omega)|. \label{liap2} \end{eqnarray} Consequently, the Liapunov exponent $\gamma(\omega)$ is determined by the asymptotic properties of the map (\ref{map1}) for large $N$. More precisely, in general the map (\ref{map1}) is stochastic due to the randomness of $m_n$ and $\kappa_n$. However, just as a white Gaussian noise $\xi(t)$ with correlations $\langle\xi(t)\xi(t')\rangle=2\Delta\delta(t-t')$ in a Langevin equation of the form $dx(t)/dt=-dV(x)/dx+\xi(t)$ for a stochastic variable $x(t)$ can drive $x$ into a stationary distribution $P_0(x)\propto\exp(-V/\Delta)$ \cite{Reichl98}, we anticipate that the 'noise' due to the randomness of $m$ and $\kappa$ will drive $z_n$ into a stationary distribution $P_0(z)$. Consequently, according to (\ref{liap2}) we infer \begin{eqnarray} \gamma(\omega)=\int dzP_0(z)\log| z(\omega)|. \label{liap3} \end{eqnarray} The task is thus to determine $P_0(z)$ on the basis of the map (\ref{map1}) and evaluate $\gamma(\omega)$. \section{\label{disorder}Coupling strength disorder} For general values of the frequency the Liapunov exponent $\gamma(\omega)$ is not available in explicit analytical form. However, Matsuda et al. \cite{Matsuda68,Matsuda70} have determined $\gamma(\omega)$ in the low frequency limit in the case of mass disorder. They find \begin{eqnarray} \gamma(\omega)\simeq\frac{1}{8}\frac{\omega^2}{\kappa\langle m\rangle}\langle\delta m^2\rangle, \label{liap4} \end{eqnarray} where the mean mass and the mean square mass deviations are given by $\langle m\rangle$ and $\langle\delta m^2\rangle=\langle(m-\langle m\rangle)^2\rangle$; the averages $\langle\cdots\rangle$ determined by the mass distribution $\pi_1(m_n)$. Here we consider the evaluation of the Liapunov exponent in the case of coupling strength disorder. Rather than attempting to apply the techniques by Matsuda et al. we here use an approach advanced by Lepri et al. \cite{Lepri03} using dynamical system theory \cite{Jackson90} and statistical physics \cite{Reichl98}. From a theoretical physics point a view we believe this method is simpler and more straightforward. \subsection{The case: $\omega=0$, $m_n=m$, $\kappa_n=\kappa$} For $\omega=0$ and vanishing disorder, i.e., $\kappa_n=\kappa$ and $m_n=m$ the map (\ref{map1}) takes the form \begin{eqnarray} z_{n+1}=f(z_n)=2-\frac{1}{z_n}, \label{map2} \end{eqnarray} where we have omitted the $\omega$ dependence. In a plot of $z_{n+1}$ versus $z_n$ the map is composed of two hyperbolic branches. For $|z_n|\rightarrow\infty$ we have $z_{n+1}\rightarrow 2$, for $z_n\rightarrow\pm 0$ we note that $z_{n+1}\rightarrow\mp\infty$. The map has a fixed point $z^\ast$ determined by $f(z^\ast)=z^\ast$, yielding $z^\ast=1$. The evolution of the iterates as a function of $n$ is analysed by considering the increment $z_{n+1}-z_n=-(z_n-1)^2/z_n$. We find that $z_{n+1}-z_n<0$ for $z_n>0$, whereas for $z_n<0$ the increment $z_{n+1}-z_n>0$. At the fixed point $z^\ast=1$ the increment vanishes, i.e, $z_{n+1}-z_n=0$. In other words, as we approach the fixed point through iterates $z_n>1$ the iterates converge to the fixed point; on the other hand, choosing an initial iterate $z_n\lesssim 1$ the iterates move away from the fixed point, corresponding to a marginally stable fixed point. Further inspection of the map in a plot of $z_{n+1}$ versus $z_n$ shows that choosing an initial value $z_n<1$ the iterates eventually make a single excursion to the hyperbola $2-1/z_n$ for $z_n<0$ before returning to the hyperbola for $z_n>0$ and approaching the fixed point. In Fig.~\ref{fig2} we have plotted $z_{n+1}$ versus $z_n$ with the fixed point indicated at $z_{n+1}=z_n=1$; the solid line depicts the map (\ref{map2}). In Fig.~\ref{fig3} we have in a) plotted $z_{n+1}$ versus $z_n$ demonstrating the convergence towards the fixed point at $z^\ast=1$; in b) we have plotted the decreasing increments $z_{n+1}-z_n$ versus $n$. \subsection{The case: $\omega\gtrsim 0$, $m_n=m$, $\kappa_n=\kappa$ } We next consider the case of small $\omega$ and vanishing disorder. From (\ref{map1}) we infer the map \begin{eqnarray} z_{n+1}=2-\frac{m}{\kappa}\omega^2-\frac{1}{z_n}, \label{map3} \end{eqnarray} depicted by a dotted line in Fig.~\ref{fig2}. In this case the map does not have a (real) fixed point. However, analysing the increment $z_{n+1}-z_n=2-(m/\kappa)\omega^2-z_n-1/z_n$ in the vicinity of the value $z=1$ (the position of the fixed point for $\omega=0$) we obtain $z_{n+1}-z_n\approx -(m/\kappa)\omega^2$ and the increment vanishes for small $\omega$. We note that the increment is negative corresponding to a flux of iterates close to the point $z=1$ from the region $z_n>1$ to $z_n<1$. In Fig.~\ref{fig4} we have in a) plotted $z_{n+1}$ versus $z_n$ demonstrating the flux of iterates past the point $z=1$; in b) we have shown that the increments $z_{n+1}-z_n$ as function of $n$ decrease in the vicinity of the point $z=1$. \subsection{The case: $\omega\gtrsim 0$, $m_n=m$, $\delta\kappa_n\approx0$} Finally, we consider the case of small $\omega$ and small coupling strength disorder. Setting $\kappa_n=\langle\kappa\rangle+\delta\kappa_n$, where $\langle\kappa\rangle$ is determined by the coupling strength distribution $\pi_2(\kappa_n)$, and assuming $\delta\kappa_n\ll\langle\kappa\rangle$, we obtain to leading order expanding the map (\ref{map1}) \begin{eqnarray} z_{n+1}= 2-\frac{m}{\langle\kappa\rangle}\bigg(1-\frac{\delta\kappa_n}{\langle\kappa\rangle}\bigg)\omega^2 +\frac{\delta\kappa_{n-1}-\delta\kappa_n}{\langle\kappa\rangle}- \bigg(1+\frac{\delta\kappa_{n-1}-\delta\kappa_n}{\langle\kappa\rangle}\bigg)\frac{1}{z_n}. \label{map4} \end{eqnarray} Furthermore, expanding about the point $z=1$ by setting $z_n=1+\epsilon_n$ we note that the terms $(\delta\kappa_{n-1}-\delta\kappa_n)/\langle\kappa\rangle$ cancels out and we obtain for small $\epsilon_n$ \begin{eqnarray} \epsilon_{n+1}-\epsilon_n\simeq -\epsilon_n^2-\frac{m}{\langle\kappa\rangle}\omega^2 +\frac{m\omega^2}{\langle\kappa\rangle^2}\delta\kappa_n. \label{map5} \end{eqnarray} For large $n$ the iterates compress and constitute a flow near the point $z=1$ in the sense that $\epsilon_n-\epsilon_{n+1}\rightarrow 0$ for small $\omega$. As a consequence we can introduce the continuum limit and make the assumption $\epsilon_n\approx\epsilon(n)$ and $\delta\kappa_n\approx\delta\kappa(n)$, where $n$ is a continuous variable. From (\ref{map5}) we thus obtain the effective Langevin equation \begin{eqnarray} \frac{d\epsilon(n)}{dn}&=&-\epsilon(n)^2-\frac{m}{\langle\kappa\rangle}\omega^2+\eta(n) \label{lan3}, \\ \eta(n)&=&\frac{m\omega^2}{\langle\kappa\rangle^2}\delta\kappa(n), \label{noi3} \end{eqnarray} where we have introduced the 'noise variable' $\eta(n)$ with correlations \begin{eqnarray} &&\langle\eta(n)\eta(n')\rangle=\Delta\delta(n-n'), \label{corkap} \\ &&\Delta=\bigg(\frac{m\omega^2}{\langle\kappa\rangle^2}\bigg)^2\langle\delta\kappa^2\rangle. \end{eqnarray} Expressing the Langevin equation in (\ref{lan3}) in the form $d\epsilon/dn=-dV/d\epsilon+\eta$ the 'potential' has the form $V=(m/\langle\kappa\rangle)\omega^2\epsilon+\epsilon^3/3$ with a linear slope for small $\epsilon$. Since there is no minimum the 'position' $\epsilon$ 'falls down' the slope and escapes for negative $\epsilon$. This is consistent with the behaviour of the iterates near the the point $z=1$ where there is a flow from right to left implying that the stochastic map generates a probability current $J_0$ near $z=1$. In order to proceed we assume that the coupling strength distribution $\pi_2(\kappa)$ has a Gaussian form, implying that the 'noise' driving the Langevin equation (\ref{lan3}) has the structure of Gaussian white noise \cite{Reichl98}. This implies that the probability density $P(\epsilon,n)$ is governed by the Fokker-Planck equation \cite{Risken89} \begin{eqnarray} \frac{\partial P(\epsilon,n)}{\partial n}= \frac{\partial}{\partial\epsilon}\Big(\epsilon^2+\frac{m}{\langle\kappa\rangle}\omega^2\Big)P(\epsilon,n) +\frac{1}{2}\Delta\frac{\partial^2P(\epsilon,n)}{\partial\epsilon^2}. \label{fp} \end{eqnarray} From the continuity equation $\partial P/\partial n=-\partial J_0/\partial\epsilon$ we identify the probability current \begin{eqnarray} J_0=-\Big(\epsilon^2+\frac{m}{\langle\kappa\rangle}\omega^2\Big)P(\epsilon,n) -\frac{1}{2}\Delta\frac{\partial P(\epsilon,n)}{\partial\epsilon}. \label{pc} \end{eqnarray} For small $\omega$ the stationary distribution to leading asymptotic order in $\Delta$ has the form \begin{eqnarray} P_0(\epsilon)\propto\frac{1}{\epsilon^2+(m/\langle\kappa\rangle)\omega^2}+ \Delta\frac{\epsilon}{(\epsilon^2+(m/\langle\kappa\rangle)\omega^2)^3}, \label{stat} \end{eqnarray} for a technical detail see Appendix \ref{liapunovapp}. Finally, from (\ref{liap2}), expanding $\log(|z(\omega)|)\sim 1+\epsilon(\omega)$, we have \begin{eqnarray} \gamma(\omega)=\frac{\int d\epsilon \epsilon P_0(\epsilon)}{\int d\epsilon P_0(\epsilon)}. \label{liap5} \end{eqnarray} Inserting $P_0(\epsilon)$ we note that the first term in (\ref{stat}) for symmetry reasons does not contribute and we obtain by quadrature to order $\Delta$ the Liapunov exponent for small $\omega$ for a coupling strength-disordered chain \begin{eqnarray} \gamma(\omega)\simeq \frac{1}{8}\frac{\omega^2}{\langle\kappa\rangle m} \bigg(\frac{m}{\langle\kappa\rangle}\bigg)^2\langle\delta\kappa^2\rangle. \label{liap6} \end{eqnarray} \subsection{Combining coupling strength disorder and mass disorder} Here we consider as a corollary the case of both coupling strength disorder and mass disorder. In the map (\ref{map1}) we note that in the absence of coupling strength disorder the random mass $m_n$ multiplies $\omega$ and is quenched in the low frequency limit. In the analysis by Matsuda et al. \cite{Matsuda68,Matsuda70} the Liapunov exponent in (\ref{liap4}) only depends on the first and second moment of the mass distribution, i.e., $\langle m\rangle$ and $\langle\delta m^2\rangle$. In other words, the calculation of (\ref{liap4}) does not presuppose a narrow mass distribution. Including mass disorder in the Langevin equation in (\ref{lan3}) by setting $m(n)=\langle m\rangle+\delta m(n)$ we obtain \begin{eqnarray} \frac{d\epsilon(n)}{dn}&=&-\epsilon(n)^2-\frac{\langle m\rangle}{\langle\kappa\rangle}\omega^2+\tilde\eta(n) \label{lan4}, \\ \tilde\eta(n)&=&\frac{\langle m\rangle\omega^2}{\langle\kappa\rangle^2} \delta\kappa(n)-\frac{\omega^2}{\langle\kappa\rangle}\delta m(n) \label{noi4}. \end{eqnarray} Ignoring terms of order $\delta m\delta\kappa$ we obtain the noise correlations \begin{eqnarray} &&\langle\tilde\eta(n)\tilde\eta(n')\rangle=\tilde\Delta\delta(n-n'), \label{corkapr} \\ &&\tilde\Delta=\bigg(\frac{\omega^2}{\langle\kappa\rangle}\bigg)^2 \bigg[\langle\delta m^2\rangle+\bigg(\frac{\langle m\rangle}{\langle\kappa\rangle}\bigg)^2\langle\delta\kappa^2\rangle\bigg], \label{newdel} \end{eqnarray} and correspondingly the Liapunov exponent \begin{eqnarray} &&\tilde\gamma(\omega)\simeq \frac{1}{8}\frac{\omega^2}{\langle\kappa\rangle\langle m\rangle}\langle\delta\tilde m^2\rangle, \label{liap7} \\ &&\langle\delta\tilde m^2\rangle= \langle\delta m^2\rangle+\bigg(\frac{\langle m\rangle}{\langle\kappa\rangle}\bigg)^2\langle\delta\kappa^2\rangle. \label{r-rmqn} \end{eqnarray} For $\delta\kappa =0$ we recover the Liapunov exponent in the mass-disordered case in (\ref{liap4}) first derived by Matsuda et al. \cite{Matsuda68,Matsuda70}, see also \cite{Lepri03}. The presence of weak coupling strength disorder can be incororated by introducing the renormalised mean square mass deviation $\langle\delta\tilde m^2\rangle$ given by (\ref{r-rmqn}). The expressions in (\ref{liap6}) and (\ref{liap7}-\ref{r-rmqn}) constitute the main results of the present analysis. \subsection{Connection to 1D quantum mechanical disorder} The Langevin equations in (\ref{lan3}) and (\ref{lan4}) have the form of a Ricatti equation of the form $\epsilon'=-\epsilon^2-E+V$, where $V=\tilde\eta$ and $E=\omega^2\langle m\rangle/\langle\kappa\rangle$, the prime denoting a derivative. By means of the substitution $\epsilon=\psi'/\psi$ the Ricatti equation is reduced to the 1D stationary Schr\"{o}dinger equation, $-\psi''+V\psi=E\psi$, describing the quantum motion in a random potential $V$ with zero mean and "white noise"correlations $\langle\tilde\eta(n)\tilde\eta(n')\rangle=\tilde\Delta\delta(n-n')$. This problem, relating to Anderson localisation \cite{Anderson58}, has been studied extensively, see e.g. \cite{Nieuwenhuizen83,Lifshits88,Luck04,Grabsch14}. In 1D in the presence of even weak disorder the wave function is localised, characterised by the localisation or correlation length $l_c$. The corresponding Liapunov exponent is thus given by $\gamma=1/l_c$. According to the analysis by Luck \cite{Luck04} one finds in the case of weak disorder $\gamma=\tilde\Delta/8E$ and by insertion the result in (\ref{liap7}). \section{\label{heatldf}Heat Current and heat fluctuations} Here we briefly discuss the implication of a Liapunov exponent for the heat current and heat fluctuations. \subsection{Heat Current} Regarding the heat current we summarise the analysis by Dhar \cite{Dhar01,Dhar08a,Dhar16} below. According to (\ref{qr1}) the fluctuating heat rate from reservoir 1 is given by $\dot Q(t)=(-\Gamma\dot u_1(t)+\xi_1(t))\dot u_1(t)$ and the integrated heat flux by $Q(t)=\int^tdt'\dot Q(t')$. Averaged over the heat reservoirs the mean value $\langle Q(t)\rangle\propto t$ and we obtain the mean heat current $J(N)=\langle Q(t)\rangle/t$, $\langle\cdots\rangle$ denoting a thermal average. For an ordered chain the mean heat current is given by the expression \cite{Casher71,Rubin71,Dhar06,Dhar08a,Fogedby12} \begin{eqnarray} J(N)=\frac{1}{2}(T_1-T_2)\int\frac{d\omega}{2\pi}T(\omega), \label{heat1} \end{eqnarray} where the transmission matrix $T(\omega)$ is expressed in terms of the end-to-end Green's function in (\ref{green1}), \begin{eqnarray} T(\omega)=4(\omega\Gamma)^2|G_{1N}(\omega)|^2. \label{trans2} \end{eqnarray} Since $T(\omega)$ is bounded and the range of $\omega$ is determined by the phonon dispersion law (\ref{disp}) it follows that the heat current $J\propto (T_1-T_2)$, yielding a conductivity $\kappa\propto N$; this behaviour is characteristic of ballistic heat transport. In Appendix \ref{current} we have derived the expression (\ref{heat1}), see also \cite{Fogedby12}, and find that it also holds for the disordered chain with the Green's function (\ref{green2}) for a particular disorder realisation $\{m_n\}$ and $\{\kappa_n\}$. The issue of averaging the current $J(N)$ with respect to the disorder is, however, quite complex and we review the analysis by Dhar \cite{Dhar01,Dhar08a,Dhar16} here. For a system of size $N$ the matrix elements $B_{ij}(\omega)$ in $G_{1N}(\omega)$ scale according to (\ref{bom2}) like $\exp(\tilde\gamma(\omega)N)$, where $\tilde\gamma(\omega)$ for small $\omega$ and both mass disorder and weak coupling strength disorder is given by (\ref{liap7}) and (\ref{r-rmqn}) . Consequently, for $\tilde\gamma(\omega) N\gg 1$ the denominator in $G_{1N}(\omega)$ diverges and the heat current vanishes; this is due to the localised modes which do not carry energy and thus do not contribute to the heat transport. On the other hand, for $\tilde\gamma(\omega) N\ll 1$, corresponding to the extended modes, the Green's function $G_{1N}(\omega)$ is bounded and contributes to the heat current. The limiting case for $\tilde\gamma(\omega) N\approx 1$ defines the correlation or cross-over frequency \begin{eqnarray} \omega_c=(8\langle\kappa\rangle\langle m\rangle)^{1/2}(\langle\delta\tilde m^2\rangle N)^{-1/2}. \label{cross} \end{eqnarray} Consequently, the integration over frequencies in (\ref{heat1}) is cut-off at $\omega=\omega_c$. An approximate expression for the disorder-averaged heat current, characterised by a bar, is thus given by \begin{eqnarray} \overline{J(N)}\simeq\frac{1}{2}(T_1-T_2)\int_{-\omega_c}^{\omega_c}\frac{d\omega}{2\pi}T(\omega). \label{heat2} \end{eqnarray} Owing to the $N$-dependence of the cut-off frequency $\omega_c$ the heat current $\overline{J(N)}$ acquires an explicit $N$ dependence. In the range $|\omega|<\omega_c$ of extended modes Dhar \cite{Dhar01,Dhar08a} uses for $G_{1N}(\omega)$ the unperturbed result given by (\ref{green1}). This is an excellent approximation supported by numerical estimates \cite{Dhar08a}. Since $T(\omega)\sim\omega^2$ for small $\omega$ a simple scaling argument yields $\overline{J(N)}\sim \omega_c^3\sim(\langle\delta\tilde m^2\rangle N)^{-3/2} $, corresponding to the exponent $\alpha=3/2$; note that in the ballistic case $\alpha=0$. We also find that the heat current for large fixed $N$ scales with the mean square renormalised mass according to $\overline{J(N)}\sim\langle\delta\tilde m^2\rangle^{-3/2}$. \subsection{\label{cumulant} Large deviation function} The distribution of heat fluctuations is described by the moment generating characteristic function \cite{Reichl98} \begin{eqnarray} C(\lambda,t)=\langle\exp(\lambda Q(t))\rangle. \label{char1} \end{eqnarray} Correspondingly, the cumulant generating function is given by $\log C(\lambda,t)$. The long time behaviour is characterised by the associated large deviation function $\mu(\lambda)$ according to \begin{eqnarray} C(\lambda,t)=\exp(\mu(\lambda) t). \label{char2} \end{eqnarray} It follows from general principles \cite{Touchette09,Hollander00,Fogedby11a,Fogedby12,Fogedby14b} that the cumulant generating function $\mu(\lambda)$ is downward convex and owing to normalisation passes through the origin, i.e., $\mu(0)=0$. For an ordered chain the large deviation function has been derived by Saito and Dhar \cite{Saito07,Saito11}, see also \cite{Kundu11}. Here we present a derivation in Appendix \ref{cgf}, see also \cite{Fogedby12}. The large deviation function has the form \begin{eqnarray} &&\mu(\lambda)=-\frac{1}{2}\int\frac{d\omega}{2\pi}\log[1+T(\omega)f(\lambda)], \label{ldf} \\ &&T(\omega)=4(\omega\Gamma)^2|G_{1N}(\omega)|^2, \\ &&f(\lambda)=T_1T_2\lambda(1/T_1-1/T_2-\lambda). \label{f} \end{eqnarray} Here the structure of $f(\lambda)$ ensures that $\mu(\lambda)$ satisfies the Gallavotti-Cohen fluctuation theorem \cite{Gallavotti95,Lebowitz99,Fogedby12} valid for driven non equilibrium systems, \begin{eqnarray} \mu(\lambda)=\mu(1/T_1-1/T_2-\lambda). \label{ft} \end{eqnarray} From the structure of (\ref{ldf}) it follows that $\mu(\lambda)$ has branch points determined by the condition $1+T(\omega)f(\lambda)>0$. Since by inspection $0\le T(\omega)\le 1$, see \cite{Fogedby12}, it follows that $f(\lambda)>-1$ yielding the branch points $\lambda_1= 1/T_1$ and $\lambda_2= -1/T_2$. We also note that the fluctuation theorem in (\ref{ft}) implies that $\mu(1/T_1-1/T_2)=0$. In conclusion, the large deviation function is downward convex, crossing the axis at $\lambda=0$ and $\lambda =1/T_1-1/T_2$ and having branch points at $\lambda_1$ and $\lambda_2$. At equal temperature $T_1=T_2$ the large deviation function is positive in the whole range as shown in Fig.~\ref{fig6}. The expression for $\mu(\lambda)$ in (\ref{ldf}) is for a concrete realisation of the quenched mass and coupling strength disorder $\{m_n\}$ and $\{\kappa_n\}$ through the dependence on the Green's function $G_{1N}(\omega)$ in (\ref{green2}). We note, however, that due to the form of $f(\lambda)$ the large deviation function $\mu(\lambda)$ satisfies the Gallavotti-Cohen fluctuation theorem for each disorder realisation and we conclude that the disorder-averaged large deviation function $\overline{\mu(\lambda)}$, likewise, obeys the fluctuation theorem. A further clarification also follows from the Fokker-Planck equation for the joint distribution $P(Q_1,Q_2, \{u_n\}, \{\dot u_n\},t)$ for the heat transfer \cite{Imparato07,Fogedby12,Risken89} \begin{eqnarray} \frac{\partial P}{\partial t} = &&(L_0+L_Q)P, \label{fp1} \\ L_0 P=&&\{P,H\}, \label{fp2} \\ L_QP=&&\Gamma\Bigg(T_1\dot u_1^2\frac{\partial^2P}{\partial Q_1^2}+ 2T_1\dot u_1\frac{\partial^2P}{\partial Q_1\partial\dot u_1}+(\dot u_1^2+T_1)\frac{\partial P}{\partial Q_1}\Bigg) \nonumber \\ +&&\Gamma\Bigg(T_2\dot u_N^2\frac{\partial^2P}{\partial Q_2^2}+ 2T_2\dot u_N\frac{\partial^2P}{\partial Q_2\partial\dot u_N}+(\dot u_N^2+T_2)\frac{\partial P}{\partial Q_2}\Bigg). \label{fp3} \end{eqnarray} As shown in \cite{Fogedby12} the fluctuation theorem here follows from the structure of the operator $L_Q$ and does not depend on the Hamiltonian part $L_0 P$. Since the disorder only enters in the Hamiltonian $H$ in (\ref{ham}) we again infer the validity of the fluctuation theorem. The disorder enters in the transmission matrix $T(\omega)$ given by (\ref{trans2}). In Fig.~\ref{fig5} we have in a) depicted the transmission matrix for $N=10$, $m=1$, $\kappa=1$, and $\Gamma=2$. The blue curve refers to the ordered case for $\langle\delta\tilde m^2\rangle=0$, showing the resonance structure of $G_{1N}(\omega)$. The black curve corresponds to the disordered case for $\sqrt{\langle\delta\tilde m^2\rangle}=0.5$ averaged over 5000 samples. With this choice of parameters the cross-over frequency in (\ref{cross}) is $\omega_c\sim 1.8$ in accordance with Fig.~\ref{fig5}, showing the onset of localised states for $\omega>\omega_c$, yielding a decreasing transmission matrix; in Fig.~\ref{fig5} we have in b) depicted $T(\omega)$ for $N=100$ and $500$ samples showing the same features. Finally, implementing the same approximation as for the heat current in (\ref{heat2}), we express the disorder-averaged large deviation function in the form \begin{eqnarray} \overline{\mu(\lambda)}\simeq- \frac{1}{2}\int_{-\omega_c}^{\omega_c}\frac{d\omega}{2\pi}\log[1+T(\omega)f(\lambda)], \label{ldfav} \end{eqnarray} where $T(\omega)=4(\omega\Gamma)^2|G_{1N}(\omega)|^2$ is expressed in terms of the Green's function $G_{1N}(\omega)$ for the ordered case in (\ref{green1}). We have not investigated the expression in (\ref{ldfav}) further but have determined $\overline{\mu(\lambda)}$ numerically. In Fig.~\ref{fig6} we have depicted the large deviation function for $N=100$ both in the absence of disorder for $\delta\tilde m=0$ and in the presence of disorder choosing $\delta\tilde m=0.5$. Since $T(\omega)$ is reduced in the upper $\omega$ range the large deviation function sampling all frequencies is overall reduced. However, since $f(\lambda)$ has the form of an inverted parabola, the reduction of $\overline{\mu(\lambda)}$ is most pronounced for $\lambda$ close to the edges, as shown in Fig.~\ref{fig6}. \section{\label{conclusion} Conclusion} In this paper we have discussed the disordered harmonic chain subject to coupling strength disorder. A case which to our knowledge has not been studied previously. Using a dynamical system theory approach we have evaluated the Liapunov exponent at low frequency and for weak coupling strength disorder. Including mass disorder we have obtained an expression for the Liapunov exponent which interpolates between coupling strength disorder and mass disorder. In the absence of coupling strength disorder we recover the well-known result by Matsuda et al., see also Lepri. In the general case coupling strength disorder can be incorporated by introducing a renormalised mass disorder. Finally, we have discussed the heat current and the large deviation function and commented on the validity of the Gallavotti-Cohen fluctuation theorem for the disordered chain. \section{\label{appendix}Appendix} \subsection{\label{greensfunction}Greens function} Inserting (\ref{om}) we have in Fourier space the Langevin equations \begin{eqnarray} &&\Omega_1(\omega)\tilde u_1(\omega)=i\omega\Gamma\tilde u_1(\omega)+ \kappa_1\tilde u_2(\omega)+\tilde\xi_1(\omega), \label{a1} \\ &&\Omega_N(\omega)\tilde u_N(\omega)=i\omega\Gamma\tilde u_N(\omega)+ \kappa_{N-1}\tilde u_{N-1}(\omega)+\tilde \xi_2(\omega), \label{a2} \end{eqnarray} and we infer that the inverse Green's function in (\ref{eqmo2}) has the form \begin{eqnarray} G^{-1}(\omega)= \left(\begin{array}{ccccc} \tilde\Omega_1(\omega) &-\kappa_1 & & & \\ -\kappa_1 & \Omega_2(\omega) &-\kappa_2 & & \\ & -\kappa_2 &\cdots & & \\ & & & \Omega_{N-1}(\omega) & -\kappa_{N-1} \\ & & &-\kappa_{N-1} & \tilde\Omega_N(\omega) \end{array}\right), \label{a3} \end{eqnarray} where $\tilde\Omega_1(\omega)=\Omega_1(\omega)-i\Gamma\omega$ and $\tilde\Omega_N(\omega)=\Omega_N(\omega)-i\Gamma\omega$. We note that $G^{-1}(\omega)$ is a symmetric tridiagonal matrix. For the matrix elements we thus have $G_{nm}^{-1}(\omega)=G_{mn}^{-1}(\omega)$ implying $G_{nm}(\omega)=G_{mn}(\omega)$. The symmetry and structure also allows us to derive the useful Schwinger identity \cite{Wang45}. From (\ref{a3}) we have, the $\ast$ indicting a complex conjugate, \begin{eqnarray} G_{nm}^{-1}(\omega)-G_{nm}^{-1\ast}(\omega)= ((\tilde\Omega_1(\omega)-\tilde\Omega_1^\ast(\omega))\delta_{n1}+ (\tilde\Omega_N(\omega)-\tilde\Omega_N^\ast(\omega))\delta_{nN})\delta_{nm}, \label{a4} \end{eqnarray} or \begin{eqnarray} G_{nm}^{-1}(\omega)-G_{nm}^{-1\ast}(\omega)=-2i\omega\Gamma(\delta_{n1}+\delta_{nN})\delta_{nm}. \label{a5} \end{eqnarray} Multiplying by $G(\omega)$ on the left and $G^\ast(\omega)$ on the right and using the symmetry of $G_{nm}(\omega)$ we obtain the Schwinger identity \cite{Wang45} \begin{eqnarray} G_{nm}(\omega)-G_{nm}^\ast(\omega)=2i\omega\Gamma (G_{n1}(\omega)G_{1m}^\ast(\omega)+G_{nN}(\omega)G_{Nm}^\ast(\omega)); \label{a6} \end{eqnarray} the Schwinger identity in (\ref{a6}) is used later in Appendices \ref{current} and \ref{cgf} in deriving the heat current and the cumulant generating function. \subsubsection{Ordered chain - equation of motion method} In the ordered case for $m_n=m$ and $\kappa_n=\kappa$ the Green's functions $G_{n1}(\omega)$ and $G_{nN}(\omega)$ are easily determined by an equation of motion method. Alternatively, one can employ a determinantal scheme noting that the determinant of $G^{-1}(\omega)$ for $\tilde\Omega_1=\tilde\Omega_N=\Omega$ is given by $\kappa^NU_N(\Omega/2\kappa)$, where $U_N(x)$ is the Chebychev polynomial of the second kind; $U_N(\Omega/2\kappa)=\sin p(N+1)/\sin p, \Omega=2\kappa \cos p$ \cite{Lebedev72}. Addressing the equations of motion, which are of the linear difference form, \begin{eqnarray} &&\Omega\tilde u_n(\omega)=\kappa(\tilde u_{n+1}(\omega)+\tilde u_{n-1}(\omega)), \label{a7} \\ &&\Omega\tilde u_1(\omega)=i\Gamma\omega\tilde u_1(\omega)+\kappa\tilde u_2(\omega)+\tilde\xi_1(\omega), \label{a8} \\ &&\Omega\tilde u_N(\omega)=i\Gamma\omega\tilde u_N(\omega)+\kappa\tilde u_{N-1}(\omega)+\tilde\xi_2(\omega), \label{a9} \end{eqnarray} and using the plane wave ansatz $\tilde u_n=A\exp(ipn)+B\exp(-ipn)$ equation (\ref{a7}) yields $\Omega=2\kappa\cos p=\kappa(\exp(ip)+\exp(-ip))$. Inserting $\Omega$ in (\ref{a8}) and (\ref{a9}) we obtain for the determination of $A$ and $B$ the matrix equation \begin{eqnarray} \left(\begin{array}{cc} \kappa-i\Gamma\omega e^{ip} & \kappa-i\Gamma\omega e^{-ip}\\(\kappa e^{ip}-i\Gamma\omega)e^{ipN} &(\kappa e^{-ip}-i\Gamma\omega)e^{-ipN}\end{array}\right)\left(\begin{array}{c}A\\B\end{array}\right)= \left(\begin{array}{c}\xi_1 \\\xi_2\end{array}\right), \label{a10} \end{eqnarray} which readily yields $A$ and $B$ and thus $\tilde u_n(\omega)$ as a function of $\tilde\xi_1(\omega)$ and $\tilde\xi_2(\omega)$. From (\ref{sol}) in Sec. \ref{model} we obtain the Green's functions \begin{eqnarray} &&G_{n1}(\omega)=\frac{\kappa\sin p(N+1-n)-i\Gamma\omega\sin p(N-n)} {\kappa^2\sin p(N+1)-2i\kappa\Gamma\omega\sin pN-(\Gamma\omega)^2\sin p(N-1)},\label{g1}\\ &&G_{nN}(\omega)=\frac{\kappa\sin pn-i\Gamma\omega\sin p(n-1)}{\kappa^2\sin p(N+1)-2i\kappa\Gamma\omega\sin pN -(\Gamma\omega)^2\sin p(N-1)}, \label{a11} \end{eqnarray} and in particular the end-to-end Green's function \begin{eqnarray} G_{1N}(\omega)=\frac{\kappa\sin p}{\kappa^2\sin p(N+1)-2i\kappa\Gamma\omega\sin pN- (\Gamma\omega)^2\sin p(N-1)}, \label{a12} \end{eqnarray} i.e., the expression (\ref{green1}). \subsubsection{Disordered chain - in terms of the transfer matrix} In the disordered case we consider the equations of motion \begin{eqnarray} &&\Omega_n\tilde u_n(\omega)=\kappa_n\tilde u_{n+1}(\omega)+\kappa_{n-1}\tilde u_{n-1}(\omega), \label{a13} \\ &&\Omega_1\tilde u_1(\omega)=i\Gamma\omega\tilde u_1(\omega)+\kappa_1\tilde u_2(\omega)+\tilde\xi_1(\omega), \label{a14} \\ &&\Omega_N\tilde u_N(\omega)=i\Gamma\omega\tilde u_N(\omega)+\kappa_{N-1}\tilde u_{N-1}(\omega)+\tilde\xi_2(\omega). \label{a15} \end{eqnarray} The bulk equation of motion (\ref{a13}) can be expressed in terms of a transfer matrix $T_n$ according to \begin{eqnarray} \left(\begin{array}{c}\tilde u_{n+1}\\\tilde u_n\end{array}\right)= \left(\begin{array}{cc}\Omega_n/\kappa_n &-\kappa_{n-1}/\kappa_n\\1 & 0\end{array}\right) \left(\begin{array}{c}\tilde u_n\\\tilde u_{n-1}\end{array}\right)=T_n \left(\begin{array}{c}\tilde u_n\\\tilde u_{n-1}\end{array}\right), \label{a16} \end{eqnarray} and we have by successive applications \begin{eqnarray} \left(\begin{array}{c}\tilde u_N\\\tilde u_{N-1}\end{array}\right)=T_{N-1}T_{N-2}\cdots T_2 \left(\begin{array}{c}\tilde u_2\\\tilde u_1\end{array}\right). \label{a17} \end{eqnarray} Likewise, from (\ref{a14}) and (\ref{a15}) we obtain \begin{eqnarray} \left(\begin{array}{c}\tilde u_2 \\\tilde u_1\end{array}\right)&=& \left(\begin{array}{cc}(\Omega_1-i\omega\Gamma)/\kappa_1 & -1/\kappa_1 \\1 & 0\end{array}\right) \left(\begin{array}{c}\tilde u_1 \\\tilde \xi_1\end{array}\right), \label{a18} \\ \nonumber \\ \left(\begin{array}{c}\tilde u_N \\\tilde u_{N-1}\end{array}\right)&=& \left(\begin{array}{cc}1 & 0 \\ (\Omega_N-i\omega\Gamma)/\kappa_{N-1} & -1/\kappa_{N-1}\end{array}\right) \left(\begin{array}{c}\tilde u_N \\\tilde \xi_2\end{array}\right). \label{a19} \end{eqnarray} Inserting (\ref{a18}) and (\ref{a19}) in (\ref{a17}) and using $B$ in (\ref{bom}) we have \begin{eqnarray} \left(\begin{array}{c}\tilde u_N \\\tilde \xi_2\end{array}\right)= \tilde T\left(\begin{array}{c}\tilde u_1 \\\tilde \xi_1\end{array}\right), \label{a20} \end{eqnarray} where \begin{eqnarray} \tilde T=\frac{1}{\kappa_0}\left(\begin{array}{cc}0 &1 \\\kappa_N & -i\Gamma\omega\end{array}\right) B\left(\begin{array}{cc}\kappa_0 & 0 \\i\Gamma\omega & 1\end{array}\right). \label{a21} \end{eqnarray} Expanding (\ref{a21}), using $\det\tilde T=-1$, and comparing with (\ref{sol}) for $n=1$ and $n=N$, i.e., \begin{eqnarray} &&\tilde u_1=G_{11}\tilde \xi_1+G_{1N}\tilde \xi_2,\label{u1}\\&&\tilde u_N=G_{N1}\tilde\xi_1+G_{NN}\tilde\xi_2, \label{a22} \end{eqnarray} we infer the end-to-end Green's function \begin{eqnarray} &&G_{1N}=G_{N1}=1/\tilde T_{21}. \label{a24} \end{eqnarray} From (\ref{a21}) we have \begin{eqnarray} \tilde T_{21}=\frac{1}{\kappa_0}(\kappa_0\kappa_NB_{11} +i\Gamma\omega(\kappa_NB_{12}-\kappa_0B_{21})+(\Gamma\omega)^2B_{22}). \label{a29} \end{eqnarray} Finally, from (\ref{a24}) and (\ref{a29}) we obtain (\ref{green2}), i.e., \begin{eqnarray} G_{1N}(\omega)=\frac{\kappa_0}{\kappa_0\kappa_NB_{11}(\omega)+i\Gamma\omega (\kappa_NB_{12}(\omega)-\kappa_0B_{21}(\omega))+(\Gamma\omega)^2B_{22}(\omega)}. \label{a31} \end{eqnarray} \subsubsection{Ordered chain - special case of disordered chain} In the ordered case for $m_n=m$ and $\kappa_n=\kappa$ the transfer matrix $T_n=T$ is independent of the site index $n$. We have \begin{eqnarray} T=\left(\begin{array}{cc}\Omega/\kappa & -1 \\1 & 0\end{array}\right). \label{a32} \end{eqnarray} Setting $\Omega=2\kappa\cos p$ the matrix $T$ has the eigenvalues $\exp(\pm ip)$ forming the diagonal matrix $D$ with matrix elements $\exp(\pm ip)$. Denoting the similarity transformation by $S$ we have $T=SDS^{-1}$ and thus $T^n=SD^nS^{-1}$, where $D^n$ has the diagonal elements $\exp(\pm ipn)$. Finally, the similarity transformation $S$ has to be determined. However, a more direct way is again to apply the plane wave ansazt $\tilde u_n=A\exp(ipn)+B\exp(-ipn)$ to $\tilde u_1$ and $\tilde u_2$ and subsequently determine $A$ and $B$. We obtain in matrix form \begin{eqnarray} \left(\begin{array}{c}\tilde u_{n+1} \\\tilde u_n\end{array}\right)=\frac{1}{\sin p} \left(\begin{array}{cc}\sin pn & -\sin p(n-1) \\\sin p(n-1) & -\sin p(n-2)\end{array}\right) \left(\begin{array}{c}\tilde u_2 \\\tilde u_1\end{array}\right), \label{a34} \end{eqnarray} and we infer from (\ref{eqmo3}) the matrix product \begin{eqnarray} T^q=\frac{1}{\sin p}\left(\begin{array}{cc}\sin p(q+1) & -\sin pq \\\sin pq & -\sin p(q-1)\end{array}\right). \label{a35} \end{eqnarray} We note that $T$ is in accordance with (\ref{trans1}) and that we have the group property $T^nT^m=T^{n+m}$. \subsection{\label{liapunovapp}Liapunov exponent} The evaluation of the Liapunov exponent is given by $\gamma=\langle\epsilon\rangle=\int d\epsilon \epsilon P_0(\epsilon)/\int d\epsilon P_0(\epsilon)$ where $P_0(\epsilon)$ is the solution of the Fokker-Planck equation (\ref{fp}) and (\ref{pc}), i.e., \begin{eqnarray} \Delta P_0'+a'P_0=C. \label{b1} \end{eqnarray} Here a prime denotes a derivative with respect to $\epsilon$ and we have introduced the notation $\Delta=(m\omega^2/\langle\kappa\rangle^2)^2\langle\delta\tilde\kappa^2\rangle$ and $a'(\epsilon)=2(\epsilon^2+(m/\langle\kappa\rangle)\omega^2)$; $C$ is an integration constant. Assuming regularity in $\Delta$ and setting $P_0=P_0^{(1)}+\Delta P_0^{(2)}$ we obtain to leading order \begin{eqnarray} P_0=C\Bigg[\frac{1}{a'}+\Delta\frac{a''}{(a')^3}\Bigg]. \label{b2} \end{eqnarray} This result can be justified by a steepest descent analysis. A particular solution of (\ref{b1}) has the form \begin{eqnarray} P_0(\epsilon)=\frac{C}{\Delta}\int_0^\epsilon d\epsilon'\exp(-(a(\epsilon)-a(\epsilon'))/\Delta). \label{b3} \end{eqnarray} In the exponent $a(\epsilon)=2(\epsilon^3/3+(m/\langle\kappa\rangle)\omega^2\epsilon)$ is a monotonically increasing function passing through the origin. A plot of $\exp(-(a(\epsilon)-a(\epsilon'))/\Delta)$ is schematically depicted in Fig.~\ref{fig7}. For small $\Delta$ the exponential function rises steeply and the main contribution to $P(\epsilon)$ arises from the region $\epsilon'\le\epsilon$. To leading order a steepest descent argument yields $P_0^{(1)}=C/a'$. The next term in the asymptotic expansion is obtained by expanding $a(\epsilon')$, i.e., $a(\epsilon')=a(\epsilon)+a'(\epsilon)(\epsilon'-\epsilon)+(1/2)a''(\epsilon)(\epsilon'-\epsilon)^2$. A straightforward calculation then yields $P_0^{(2)}=Ca''/a'^3$. In conclusion, the expansion in (\ref{stat}) is an asymptotic expansion in $\Delta$, i.e., the leading correction to the steepest descent term. \subsection{\label{current}Heat current} Focussing on the heat reservoir at temperature $T_1$ at the site $n=1$, the integrated heat flux is obtained from (\ref{qr1}), i.e., \begin{eqnarray} Q(t)=\int^t dt'F_1(t')\dot u_1(t'). \label{c1} \end{eqnarray} Inserting $F_1=-\Gamma\dot u_1+\xi_1$ and $u_1$ from (\ref{sol}) we obtain in Fourier space \begin{eqnarray} Q(t)=\int\frac{d\omega}{2\pi}\frac{d\omega'}{2\pi}F(\omega-\omega',t) \left(\begin{array}{cc}\tilde\xi_1(\omega) & \tilde\xi_2(\omega)\end{array}\right)M(\omega,\omega') \left(\begin{array}{c}\tilde\xi_1(\omega') \\\tilde\xi_2(\omega')\end{array}\right), \label{c2} \end{eqnarray} where the matrix elements of $M$ are given by \begin{eqnarray} &&M_{11}(\omega,\omega')=-\omega\omega'\Gamma G_{11}(\omega)G_{11}(-\omega') +\frac{1}{2}\bigg(-i\omega G_{11}(\omega)+i\omega' G_{11}(-\omega')\bigg), \label{c3} \\ &&M_{22}(\omega,\omega')=-\omega\omega'\Gamma G_{1N}(\omega)G_{1N}(-\omega'), \label{c4} \\ &&M_{12}(\omega,\omega')=-\omega\omega'\Gamma G_{11}(\omega)G_{1N}(-\omega') +\frac{1}{2}i\omega' G_{1N}(-\omega'), \label{c5} \\ &&M_{21}(\omega,\omega')=-\omega\omega'\Gamma G_{1N}(\omega)G_{11}(-\omega')-\frac{1}{2}i\omega G_{1N}(\omega). \label{c6} \end{eqnarray} The function $F(\omega,t)=2\sin(\omega t/2)\exp(-i\omega t/2)/\omega$. Moreover, $F(0,t)=t$ and $|F(\omega,t|^2=2\pi t\delta(\omega)$ for large $t$. Finally, using the noise correlations (\ref{noi1}) and (\ref{noi2}) and the Schwinger identity (\ref{a6}), we obtain the mean heat flux $J=\langle Q(t)\rangle/t$ in (\ref{heat1}), i.e., \begin{eqnarray} J=2(T_1-T_2)\int\frac{d\omega}{2\pi}(\omega\Gamma)^2|G_{1N}(\omega)|^2. \label{c7} \end{eqnarray} \subsection{\label{cgf}Large deviation function} The large deviation function function is defined according to \begin{eqnarray} \mu(\lambda)=\lim_{t\rightarrow\infty}\frac{1}{t}\ln\langle\exp(\lambda Q(t))\rangle, \label{d1} \end{eqnarray} where $Q(t)$ is given by (\ref{c2}). Inserting $Q(t)$, using the noise distribution \begin{eqnarray} P(\xi_1,\xi_2)\propto\exp\Bigg[-\frac{1}{2}\int\frac{d\omega}{2\pi}\frac{d\omega'}{2\pi} \left(\begin{array}{cc}\xi_1(\omega)&\xi_2(\omega)\end{array}\right)\Delta^{-1}(\omega-\omega') \left(\begin{array}{c}\xi_1(\omega')\\ \xi_2(\omega')\end{array}\right)\Bigg], \label{d2} \end{eqnarray} where the inverse noise matrix is \begin{eqnarray} \Delta^{-1}(\omega-\omega')= \left(\begin{array}{cc}\Delta^{-1}_1 & 0 \\0 & \Delta^{-1}_2\end{array} \right)\delta(\omega-\omega'), \label{d3} \end{eqnarray} with $\Delta_1=2\Gamma T_1$ and $\Delta_2=2\Gamma T_2$, and using the matrix identity \cite{Zinn-Justin89} \begin{eqnarray} \langle\exp(-(1/2\tilde\xi B\xi)\rangle=\exp(\rm{Tr}\ln(I+\Delta B)), \label{d4} \end{eqnarray} we obtain formally \begin{eqnarray} \mu(\lambda)=-\frac{1}{2t}\rm{Tr}\ln(I+2\lambda F\Delta M); \label{d5} \end{eqnarray} we note that formula (\ref{d4}) follows from (1.5) in Ref. \cite{Zinn-Justin89} setting $b_i=0$ and using $\text{det} A=\exp(\text{Tr} \log A)$. Using the properties of $F$, the limits for $\omega=\omega'$ \begin{eqnarray} &&M_{11}(\omega,\omega)=-M_{22}(\omega,\omega)=\omega^2\Gamma |G_{1N}(\omega)|^2, \label{d6} \\ &&M_{12}(\omega,\omega)=M_{21}(\omega,\omega)^\ast=-\omega^2\Gamma G_{11}(\omega) G_{1N}(\omega)^\ast+(1/2)i\omega G_{1N}(\omega)^\ast, \label{d7} \end{eqnarray} the Schwinger identity (\ref{a6}), and diagonalising $\Delta M$, we obtain the eigenvalue equation for the eigenvalues $\alpha_1(\omega)$ and $\alpha_2(\omega)$ \begin{eqnarray} \alpha^2-2\Gamma\alpha(T_1M_{11}+T_2M_{22})+4\Gamma^2 T_1T_2(M_{11}M_{22}-M_{12}M_{21})=0. \label{d8} \end{eqnarray} For $\mu$ we then obtain \begin{eqnarray} \mu(\lambda)=-\frac{1}{2}\int\frac{d\omega}{2\pi}\ln(1-2\lambda(\alpha_1+\alpha_2)+4\lambda^2\alpha_1\alpha_2), \label{d9} \end{eqnarray} or reduced further the final result \begin{eqnarray} \mu(\lambda)=-\frac{1}{2}\int\frac{d\omega}{2\pi}\ln(1+4\omega^2\Gamma^2|G_{1N}(\omega)|^2f(\lambda)), \label{d10} \end{eqnarray} where \begin{eqnarray} f(\lambda)=T_1T_2\lambda(1/T_1-1/T_2-\lambda). \label{d11} \end{eqnarray} \newpage

\section{Introduction} Multi-task learning (MTL) is a field of machine learning where multiple tasks are learned in parallel while using a shared representation~\cite{caruana1997multitask}. Compared with learning multiple tasks individually, this joint learning effectively increases the sample size for training the model, thus leads to performance improvement by increasing the generalization of the model~\cite{zhang2017survey}. This is particularly helpful in some applications such as medical informatics where (labeled) datasets are hard to collect to fulfill the data-hungry needs of deep learning. MTL has long been studied in machine learning~\cite{ruder2017overview} and has been used successfully across different applications, from natural language processing~\cite{collobert2008unified, luong2015multi, liu2019multi}, computer vision~\cite{wang2009boosted, liu2019end, chen2019multi}, to health informatics~\cite{zhou2011multi, he2016novel, harutyunyan2019multitask}. MTL has also been studied in biomedical and clinical natural language processing (NLP) such as named entity recognition and normalization and the relation extraction. However, most of these studies focus on either one task with multi corpora~\cite{khan2020mt, wang2019cross} or multi-tasks on a single corpus~\cite{xue2019fine, li2017neural, zhao2019neural}. To bridge this gap, we investigate the use of MTL with transformer-based models (BERT) on multiple biomedical and clinical NLP tasks. We hypothesize the performance of the models on individual tasks (especially in the same domain) can be improved via joint learning. Specifically, we compare three models: the independent single-task model (BERT), the model refined via MTL (called \mbox{MT-BERT-Refinement}\xspace), and the model fine-tuned for each task using MT-BERT-Refinement (called \mbox{MT-BERT-Fine-Tune}\xspace). We conduct extensive empirical studies on the Biomedical Language Understanding Evaluation (BLUE) benchmark~\cite{peng2019transfer}, which offers a diverse range of text genres (biomedical and clinical text) and NLP tasks (such as text similarity, relation extraction, and named entity recognition). When learned and fine-tuned on biomedical and clinical domains separately, we find that MTL achieved over 2\% performance on average, created new state-of-the-art results on four BLUE benchmark tasks. We also demonstrate the use of multi-task learning to obtain a single model that still produces state-of-the-art performance on all tasks. This positive answer will be very helpful in the context that researchers are in the hassle of choosing a suitable model for new problems where training resources are limited. Our contribution in this work is three-fold: (1)~We conduct extensive empirical studies on 8 tasks from a diverse range of text genres. (2) We demonstrate that the MTL fine-tuned model (\mbox{MT-BERT-Fine-Tune}\xspace) achieved state-of-the-art performance on average and there is still a benefit to utilizing the MTL refinement model (\mbox{MT-BERT-Refinement}\xspace). Pairwise MTL, where two tasks were trained jointly, further demonstrates which tasks can improve or decrease other tasks. (3) We make codes and pre-trained MT models publicly available. The rest of the paper is organized as follows. We first present related work in Section~\ref{sec:rel}. Then, we describe the multi-task learning in Section~\ref{sec:multitask}, followed by our experimental setup, results, and discussion in Section~\ref{sec:exp}. We conclude with future work in the last section. \section{Related work} \label{sec:rel} Multi-tasking learning (MTL) aims to improve the learning of a model for task t by using the knowledge contained in the tasks where all or a subset of tasks are related~\cite{zhang2017survey}. It has long been studied and has applications on neural networks in the natural language processing domain~\cite{caruana1997multitask}. \citet{collobert2008unified} proposed to jointly learn six tasks such as part-of-speech tagging and language modeling in a time-decay neural network. \citet{changpinyo2018multi} summarized recent studies on applying MTL in sequence tagging tasks. \citet{bingel2017identifying} and \citet{martinezalonso2017when} focused on conditions under which MTL leads to gain in NLP, and suggest that certain data features such as learning curve and entropy distribution are probably better predictors of MTL gains. In the biomedical and clinical domains, MTL has been studied mostly in two directions. One is to apply MTL on a single task with multiple corpora. For example, many studies focused on named entity recognition (NER) tasks~\cite{crichton2017neural, wang2019multitask, wang2019cross}. \citet{zhang2018multitask}, \citet{khan2020mt}, and \citet{mehmood2019multi} integrated MTL in the transformer-based networks (BERT), which is the state-of-the-art language representation model and demonstrated promising results to extract biomedical entities from literature. \citet{yang2019information} extracted clinical named entity from Electronic Medical Records using LSTM-CRF based model. Besides NER, \citet{li2018multi} and \citet{li2019syntax} proposed to use MTL on relation classification task and \citet{du2017novel} on biomedical semantic indexing. \citet{xing2018adaptive} exploited domain-invariant knowledge to segment Chinese word in medical text. The other direction is to apply MTL on different tasks, but the annotations are from a single corpus. \citet{li2017neural} proposed a joint model extract biomedical entities as well as their relations simultaneously and carried out experiments on either the adverse drug event corpus~\cite{gurulingappa2012development} or the bacteria biotope corpus~\cite{deleger2016overview}. \citet{shi2019family} also jointly extract entities and relations but focused on the BioCreative/OHNLP 2018 challenge regarding family history extraction~\cite{liu2018overview}. \citet{xue2019fine} integrated the BERT language model into joint learning through dynamic range attention mechanism and fine-tuned NER and relation extraction tasks jointly on one in-house dataset of coronary arteriography reports. Different from these works, we studied to jointly learn 8 different corpora from 4 different types of tasks. While MTL has brought significant improvements in medicine tasks, no (or mixed) results have been reported when pre-training MTL models in different tasks on different corpora. To this end, we deem that our model can provide more insights about conditions under which MTL leads to gains in BioNLP and clinical NLP, and sheds light on the specific task relations that can lead to gains from MTL models over single-task setups. \section{Multi-task model} \label{sec:multitask} The architecture of the \mbox{MT-BERT}\xspace model is shown in Figure~\ref{fig:architecture}. The shared layers are based on BERT~\cite{devlin2018bert}. The input $X$ can be either a sentence or a pair of sentences packed together by a special token \verb|[SEP]|. If $X$ is longer than the allowed maximum length (e.g., 128 tokens in the BERT's base configuration), we truncate $X$ to the maximum length. When $X$ is packed by a sequence pair, we truncate the longer sequence one token at a time. Similar to~\cite{devlin2018bert}, two additional tokens are added at the start (\verb|[CLS]|) and end (\verb|[SEP]|) of $X$, respectively. Similar to~\cite{lee2020biobert, peng2019transfer}, in the sequence tagging tasks, we split one sentence into several sub-sentences if it is longer than 30 words. \begin{figure*}[ht] \centering \includegraphics[width=.9\textwidth,clip,trim=0 4.7cm 5.2cm 0]{figure1.pdf} \caption{The architecture of the MT-BERT model.} \label{fig:architecture} \end{figure*} In the shared layers, the BERT model first converts the input sequence to a sequence of embedding vectors. Then, it applies attention mechanisms to gather contextual information. This semantic representation is shared across all tasks and is trained by our multi-task objectives. Finally, the BERT model encodes that information in a vector for each token $(h_0,\ldots,h_n)$. On top of the shared BERT layers, the task-specific layer uses a fully-connected layer for each task. We fine-tune the BERT model and the task-specific layers using multi-task objectives during the training phase. More details of the multi-task objectives in the BLUE benchmark are described below. \subsection{Sentence similarity} Suppose that $h_0$ is the BERT's output of the token \verb|[CLS]| in the input sentence pair $(X_1,X_2)$. We use a fully connected layer to compute the similarity score $sim(X_1,X_2)=ah_0+b$, where $sim(X_1,X_2)$ is a real value. This task is trained using the Mean Squared Error (MSE) loss: $(y-sim(X_1,X_2))^2$, where $y$ is the real-value similarity score of the sentence pair. \subsection{Relation extraction} This task extracts binary relations (two arguments) from sentences. After replacing two arguments of interest in the sentence with pre-defined tags (e.g., GENE, or DRUG), this task can be treated as a classification problem of a single sentence $X$. Suppose that $h_0$ is the output embedding of the token \verb|[CLS]|, the probability that a relation is labeled as class $c$ is predicted by a fully connected layer and a logistic regression with softmax: $P(c \vert X)=softmax(ah_0+b)$. This approach is widely used in the transformer-based models~\cite{devlin2018bert, peng2019transfer, liu2019multi}. This task is trained using the categorical cross-entropy loss: $-\sum_c{\delta(y_c=\hat{y})\log(P(c\vert X))}$, where $\delta(y_c=\hat{y})=1$ if the classification $\hat{y}$ of $X$ is the correct ground-truth for the class $c\in C$; otherwise $\delta(y_c=\hat{y})=0$. \subsection{Inference} After packing the pair of premise sentences with hypothesis into one sequence, this task can also be treated as a single sentence classification problem. The aim is to find logical relation $R$ between premise $P$ and hypothesis $H$. Suppose that that $h_0$ is the output embedding of the token \verb|[CLS]| in $X=P\oplus H$, $P(R\vert P\oplus H)=softmax(ah_0+b)$. This task is trained using the categorical cross-entropy loss as above. \subsection{Named entity recognition} The output of the BERT model produces a feature vector sequence $\{h_i\}_{i=0}^n$ with the same length as the input sequence $X$. The MTL model predicts the label sequence by using a softmax output layer, which scales the output for a label $l\in \{1,2,\dots,L\}$ as follows: $P(\hat{y}_i=j\vert x)=\frac{\exp(h_iW_j)}{\sum_{l=1}^L{\exp(h_iW_j)}}$, where $L$ is the total number of tags. This task is trained using the categorical cross-entropy loss: $-\sum_i{\sum_{y_i}{\delta(y_i=\hat{y}_i)\log{P(y_i \vert X)}}}$. \subsection{The training procedure} The training procedure for \mbox{MT-BERT}\xspace consists of three stages: (1) pretraining the BERT model, (2) refining it via multi-task learning (\mbox{MT-BERT-Refinement}\xspace), and (3) fine-tuning the model using the task-specific data (\mbox{MT-BERT-Fine-Tune}\xspace). \begin{table*}[!ht] \centering \begin{tabular}{llllrrr} \toprule Corpus & Task & Metrics & Domain & Train & Dev & Test\\ \midrule ClinicalSTS & Sentence similarity & Pearson & Clinical & 675 & 75 & 318\\ ShARe/CLEFE & NER & F1 & Clinical & 4,628 & 1,075 & 5,195\\ i2b2 2010 & Relation extraction & F1 & Clinical & 3,110 & 11 & 6,293\\ MedNLI & Inference & Accuracy & Clinical & 11,232 & 1,395 & 1,422\\ BC5CDR disease & NER & F1 & Biomedical & 4,182 & 4,244 & 4,424\\ BC5CDR chemical & NER & F1 & Biomedical & 5,203 & 5,347 & 5,385\\ DDI & Relation extraction & F1 & Biomedical & 2,937 & 1,004 & 979\\ ChemProt & Relation extraction & F1 & Biomedical & 4,154 & 2,416 & 3,458\\ \bottomrule \end{tabular} \caption{Summary of eight tasks in the BLUE benchmark. More details can be found in~\cite{peng2019transfer}.} \label{tab:tasks} \end{table*} \subsubsection{Pretraining} The pretraining stage follows that of the BERT using the masked language modeling technique~\cite{devlin2018bert}. Here we used the base version. The maximum length of the input sequences is thus 128. \subsubsection{Refining via Multi-task learning} In this step, we refine all layers in the model. Algorithm~\ref{algo:mtdnn} demonstrates the process of multi-task learning~\cite{liu2019multi}. We first initialize the shared layers with the pre-trained BERT model and randomly initialize the task-specific layer parameters. Then we create the dataset by merging mini-batches of all the datasets. In each epoch, we randomly select a mini-batch $b_t$ of task $t$ from all datasets $D$. Then we update the model according to the task-specific objective of the task $t$. Same as in~\cite{liu2019multi}, we use the mini-batch based stochastic gradient descent to learn the parameters. \begin{algorithm} \SetKwFor{Initialize}{Initialize}{}{end} \Initialize{model parameters $\theta$}{ Shared layer parameters by BERT\; Task-specific layer parameters randomly\; } Create $D$ by merging mini-batches for each dataset\; \For{$epoch$ in $1,2,...,epoch_{max}$}{ Shuffle $D$\; \For{$b_t$ in D}{ Compute loss: $L(\theta)$ based on task $t$\; Compute gradient: $\nabla(\theta)$ \\ Update model: $\theta = \theta - \eta \nabla(\theta)$ \\ } } \caption{\label{algo:mtdnn} Multi-task learning.} \end{algorithm} \subsubsection{Fine-tuning MT-BERT} We fine-tune existing MT-BERT that are trained in the previous stage by continue training all layers on each specific task. Provided that the dataset is not drastically different in context to other datasets, the MT-BERT model will already have learned general features that are relevant to a specific problem. Specifically, we truncate the last layer (softmax and linear layers) of the MT-BERT and replace it with a new one, then we use a smaller learning rate to train the network. \begin{table*}[!ht] \setlength{\tabcolsep}{4pt} \centering \begin{tabular}{lccccc} \toprule Model & ClinicalSTS & i2b2 2010 re & MedNLI & ShARe/CLEFE & \textit{Avg} \\ \midrule \mbox{BlueBERT\textsubscript{clinical}}\xspace & 0.848 & 0.764 & 0.840 & 0.771 & \textit{0.806} \\ \mbox{MT-BlueBERT-Refinement\textsubscript{clinical}}\xspace & 0.822 & 0.745 & 0.835 & 0.826 & \textit{0.807} \\ \mbox{MT-BlueBERT-Fine-Tune\textsubscript{clinical}}\xspace & 0.840 & 0.760 & \textbf{0.846} & \textbf{0.831} & \textbf{\textit{0.819}} \\ \bottomrule \end{tabular} \caption{Test results on clinical tasks.\label{tab:test clinical}} \vspace*{1em} \end{table*} \begin{table*}[!ht] \centering \begin{tabular}{lccccc} \toprule \multirow{2}{*}{Model} & \multirow{2}{*}{ChemProt} & \multirow{2}{*}{DDI} & BC5CDR & BC5CDR & \multirow{2}{*}{\textit{Avg}} \\ & & & disease & chemical\\ \midrule \mbox{BlueBERT\textsubscript{biomedical}}\xspace & 0.725 & 0.739 & 0.866 & 0.935 & \textit{0.816} \\ \mbox{MT-BlueBERT-Refinement\textsubscript{biomedical}}\xspace & 0.714 & 0.792 & 0.824 & 0.930 & \textit{0.815} \\ \mbox{MT-BlueBERT-Fine-Tune\textsubscript{biomedical}}\xspace & \textbf{0.729} & \textbf{0.820} & 0.865 & 0.931 & \textbf{\textit{0.836}} \\ \bottomrule \end{tabular} \caption{Test results on biomedical tasks.\label{tab:test biomedical}} \end{table*} \section{Experiments} \label{sec:exp} We evaluate the proposed MT-BERT on 8 tasks in BLUE benchmarks. We compare three types of models: (1) existing start-of-the-art BERT models fine-tuned directly on each task, respectively; (2) refinement MT-BERT with multi-task training (\mbox{MT-BERT-Refinement}\xspace); and (3) MT-BERT with fine-tuning (\mbox{MT-BERT-Fine-Tune}\xspace). \subsection{Datasets} We evaluate the performance of the models on 8 datasets in the BLUE benchmark used by~\cite{peng2019transfer}. Table~\ref{tab:tasks} gives a summary of these datasets. Briefly, ClinicalSTS is a corpus of sentence pairs selected from Mayo Clinics's clinical data warehouse ~\cite{wang2018medsts}. The i2b2 2010 dataset was collected from three different hospitals and was annotated by medical practitioners for eight types of relations between problems and treatments~\cite{uzuner20112010}. MedNLI is a collection of sentence pairs selected from \mbox{MIMIC-III}~\cite{shivade2017mednli}. For a fair comparison, we use the same training, development and test sets to train and evaluate the models. ShARe/CLEF is a collection of 299 de-identified clinical free-text notes from the \mbox{MIMIC-II} database~\cite{suominen2013overview}. This corpus is for disease entity recognition. In the biomedical domain, the ChemProt consists of 1,820 PubMed abstracts with chemical-protein interactions~\cite{krallinger2017overview}. The DDI corpus is a collection of 792 texts selected from the DrugBank database and other 233 Medline abstracts~\cite{herrero-zazo2013ddi}. These two datasets were used in the relation extraction task for various types of relations. BC5CDR is a collection of 1,500 PubMed titles and abstracts selected from the CTD-Pfizer corpus and was used in the named entity recognition task for chemical and disease entities~\cite{li2016biocreative}. \subsection{Training} Our implementation of MT-BERT is based on the work of~\cite{liu2019multi}.\footnote{\url{https://github.com/namisan/mt-dnn}} We trained the model on one NVIDIA\textregistered~V100 GPU using the PyTorch framework. We used the Adamax optimizer~\cite{kingma2015adam} with a learning rate of $5e^{-5}$, a batch size of 32, a linear learning rate decay schedule with warm-up over 0.1, and a weight decay of 0.01 applied to every epoch of training by following~\cite{liu2019multi}. We use the BioBERT~\cite{lee2020biobert}, BlueBERT base model~\cite{peng2019transfer}, and ClinicalBERT~\cite{alsentzer2019publicly} as the domain-specific language model\footnote{\url{https://github.com/ncbi-nlp/bluebert}}. As a result, all the tokenized texts using wordpieces were chopped to spans no longer than 128 tokens. We set the maximum number of epochs to 100. We also set the dropout rate of all the task-specific layers as 0.1. To avoid the exploding gradient problem, we clipped the gradient norm within 1. To fine-tune the MT-BERT on specific tasks, we set the maximum number of epochs to 10 and learning rate $e^{-5}$. \begin{figure*}[ht] \centering \includegraphics[width=.99\textwidth,clip,trim=0 9cm 2cm 0]{figure2.pdf} \caption{Pairwise MTL relationships in clinical (left) and biomedical (right) domains.} \label{fig:pairwise} \vspace*{1em} \end{figure*} \begin{table*}[!ht] \centering \setlength{\tabcolsep}{4pt} \begin{tabular}{lccccc@{}} \toprule Model & ClinicalSTS & i2b2 2010 re & MedNLI & ShARe/CLEFE & \textit{Avg}\\ \midrule \mbox{MT-ClinicalBERT-Fine-Tune}\xspace & 0.816 & 0.746 & 0.834 & 0.817 & \textit{0.803}\\ \mbox{MT-BioBERT-Fine-Tune}\xspace & 0.837 & 0.741 & 0.832 & 0.818 & \textit{0.807}\\ \mbox{MT-BlueBERT-Fine-Tune\textsubscript{biomedical}}\xspace & 0.824 & 0.738 & 0.824 & 0.825 & \textit{0.803}\\ \mbox{MT-BlueBERT-Fine-Tune\textsubscript{clinical}}\xspace & \textbf{0.840} & \textbf{0.760} & \textbf{0.846} & \textbf{0.831} & \textbf{\textit{0.819}} \\ \bottomrule \end{tabular} \caption{Test results of \mbox{MT-BERT-Fine-Tune}\xspace models on clinical tasks.\label{tab:test clinical fine-tune}} \vspace*{.5em} \end{table*} \begin{table*}[!ht] \centering \begin{tabular}{lccccc} \toprule \multirow{2}{*}{Model} & \multirow{2}{*}{ChemProt} & \multirow{2}{*}{DDI} & BC5CDR & BC5CDR & \multirow{2}{*}{\textit{Avg}} \\ & & & disease & chemical\\ \midrule \mbox{MT-BioBERT-Fine-Tune}\xspace & \textbf{0.729} & 0.812 & 0.851 & 0.928 & \textit{0.830} \\ \mbox{MT-BlueBERT-Fine-Tune\textsubscript{biomedical}}\xspace & \textbf{0.729} & \textbf{0.820} & \textbf{0.865} & \textbf{0.931} & \textbf{\textit{0.836}} \\ \mbox{MT-BlueBERT-Fine-Tune\textsubscript{clinical}}\xspace & 0.714 & 0.792 & 0.824 & 0.930 & \textit{0.815} \\ \bottomrule \end{tabular} \caption{Test results of \mbox{MT-BERT-Fine-Tune}\xspace models on biomedical tasks.\label{tab:test biomedical fine-tune}} \end{table*} \subsection{Results} One of the most important criteria of building practical systems is fast adaptation to new domains. To evaluate the models on different domains, we multi-task learned various MT-BERT on BLUE biomedical tasks and clinical tasks, respectively. \mbox{BlueBERT\textsubscript{clinical}}\xspace is the base BlueBERT model pretrained on PubMed abstracts and MIMIC-III clinical notes, and fine-tuned for each BLUE task on task-specific data. MT- model are the proposed models described in Section~\ref{sec:multitask}. We used the pre-trained \mbox{BlueBERT\textsubscript{clinical}}\xspace to initialize its shared layers, refined the model via MTL on the BLUE tasks (\mbox{MT-BlueBERT-Refinement\textsubscript{clinical}}\xspace). We keep fine-tuning the model for each BLUE task using task-specific data, then got \mbox{MT-BlueBERT-Fine-Tune\textsubscript{clinical}}\xspace. Table~\ref{tab:test clinical} shows the results on clinical tasks. \mbox{MT-BlueBERT-Fine-Tune\textsubscript{clinical}}\xspace created new state-of-the-art results on 2 tasks and pushing the benchmark to 81.9\%, which amounts to 1.3\% absolution improvement over \mbox{BlueBERT\textsubscript{clinical}}\xspace and 1.2\% absolute improvement over \mbox{MT-BlueBERT-Refinement\textsubscript{clinical}}\xspace. On the ShAReCLEFE task, the model gained the largest improvement by 6\%. On the MedNLI task, the MT model gained improvement by 2.4\%. On the remaining tasks, the MT model also performed well by reaching the state-of-the-art performance with less than 1\% differences. When compared the models with and without fine-tuning on single datasets, Table~\ref{tab:test clinical} shows that the multi-task refinement model is similar to single baselines on average. Consider that \mbox{MT-BlueBERT-Refinement\textsubscript{clinical}}\xspace is one model while \mbox{BlueBERT\textsubscript{clinical}}\xspace are 4 individual models, we believe the MT refinement model would bring the benefit when researchers are in the hassle of choosing the suitable model for new problems or problems with limited training data. In biomedical tasks, we used \mbox{BlueBERT\textsubscript{biomedical}}\xspace as the baseline because it achieved the best performance on the BLUE benchmark. Table~\ref{tab:test biomedical} shows the similar results as in the clinical tasks. \mbox{MT-BlueBERT-Fine-Tune\textsubscript{biomedical}}\xspace created new state-of-the-art results on 2 tasks and pushing the benchmark to 83.6\%, which amounts to 2.0\% absolute improvement over \mbox{BlueBERT\textsubscript{biomedical}}\xspace and 2.1\% absolute improvement over \mbox{MT-BlueBERT-Refinement\textsubscript{biomedical}}\xspace. On the DDI task, the model gained the largest improvement by 8.1\%. \subsection{Discussion} \begin{table*}[!ht] \setlength{\tabcolsep}{3pt} \centering \begin{tabular}{lccccc} \toprule \multirow{2}{*}{Model} & BlueBERT & BlueBERT & MT-BioBERT & MT-BlueBERT & MT-BlueBERT \\ & \textsubscript{biomedical} & \textsubscript{clinical} & Fine-Tune & Fine-Tune\textsubscript{biomedical} & Fine-Tune\textsubscript{clinical} \\ \midrule ClinicalSTS & 0.845 & \textbf{0.848} & 0.807 & 0.820 & 0.807\\ i2b2 2010 re & 0.744 & \textbf{0.764} & 0.740 & 0.738 & 0.748\\ MedNLI & 0.822 & 0.840 & 0.831 & 0.814 & \textbf{0.842}\\ ChemProt & 0.725 & 0.692 & \textbf{0.735} & 0.724 & 0.686\\ DDI & 0.739 & 0.760 & \textbf{0.810} & 0.808 & 0.779\\ BC5CDR disease & \textbf{0.866} & 0.854 & 0.849 & 0.853 & 0.848\\ BC5CDR chemical & \textbf{0.935} & 0.924 & 0.928 & 0.928 & 0.914\\ ShARe/CLEFE & 0.754 & 0.771 & 0.812 & 0.814 & \textbf{0.830}\\ \midrule \textit{Avg} & \textit{0.804} & \textit{0.807} & \textbf{\textit{0.814}} & \textit{0.812} & \textit{0.807}\\ \bottomrule \end{tabular} \caption{Test results on eight BLUE tasks.\label{tab:test blue}} \end{table*} \subsubsection{Pairwise MTL} To investigate which tasks are beneficial or harmful to others, we train on two tasks jointly using \mbox{MT-BlueBERT-Refinement\textsubscript{biomedical}}\xspace and \mbox{MT-BlueBERT-Refinement\textsubscript{clinical}}\xspace. Figure~\ref{fig:pairwise} gives pairwise relationships. The directed green (or red and grey) edge from $s$ to $t$ means $s$ improves (or decreases and has no effect on) $t$. In the clinical tasks, ShARe/CLEFE always gets benefits from multi-task learning the remaining 3 tasks as the incoming edges are green. One factor might be that ShARe/CLEFE is an NER task that generally requires more training data to fulfill the data-hungry need of the BERT model. ClinicalSTS helps MedNLI because the nature of both are related and their inputs are a pair of sentences. MedNLI can help other tasks except ClinicalSTS partially because the test set of ClinialSTS is too small to reflect the changes. We also note that i2b2 2010 re can be both beneficial and harmful, depending on which other tasks they are trained with. One potential cause is i2b2 2010 re was collected from three different hospitals and have the largest label size of 8. In the biomedical tasks, both DDI and ChemProt tasks can be improved by MTL on other tasks, potentially because they are harder with largest size of label thus require more training data. In the meanwhile, BC5CDR chemical and disease can barely be improved potentially because they have already got large dataset to fit the model. \subsubsection{MTL on BERT variants} First, we would like to compare multi-task learning on BERT variants: BioBERT, ClinicalBERT, and BlueBERT. In the clinical tasks (Table~\ref{tab:test clinical fine-tune}), \mbox{MT-BlueBERT-Fine-Tune\textsubscript{clinical}}\xspace outperforms other models on all tasks. When compared the MTL models using BERT model pretrained on PubMed only (rows 2 and 3) and on the combination of PubMed and clinical notes (row 4), it shows the impact of using clinical notes during the pretraining process. This observation is consistently as shown in~\cite{peng2019transfer}. On the other hand, \mbox{MT-ClinicalBERT-Fine-Tune}\xspace, which used ClinicalBERT during the pretraining, drops $\sim$1.6\% across the tasks. The differences between ClinicalBERT and BlueBERT are at least in 2-fold. (1) ClinicalBERT used ``cased'' text while BlueBERT used ``uncased'' text; and (2) the number of epochs to continuously pretrained the model. Given that there are limited details of pretraining ClinicalBERT, further investigation may be necessary. In the biomedical tasks, Table~\ref{tab:test biomedical fine-tune} shows that \mbox{MT-BioBERT-Fine-Tune}\xspace and \mbox{MT-BlueBERT-Fine-Tune\textsubscript{biomedical}}\xspace reached comparable results and pretraining on clinical notes has a negligible impact. \subsubsection{Results on all BLUE tasks} Next, we also compare MT-BERT with its variants on all BLUE tasks. Table~\ref{tab:test blue} shows that \mbox{MT-BioBERT-Fine-Tune}\xspace reached the best performance on average and \mbox{MT-BlueBERT-Fine-Tune\textsubscript{biomedical}}\xspace stays closely. While confusing results were obtained when combing variety of tasks in both biomedical and clinical domains, we observed again that MTL models pretrained on biomedical literature perform better in biomedical tasks; and MTL models pretrained on both biomedical literature and clinical notes perform better in clinical tasks. These observations may suggest that it might be helpful to train separate deep neural networks on different types of text genres in BioNLP. \section{Conclusions and future work} In this work, we conduct an empirical study on MTL for biomedical and clinical tasks, which so far has been mostly studied with one or two tasks. Our results provide insights regarding domain adaptation and show benefits of the MTL refinement and fine-tuning. We recommend a combination of the MTL refinement and task-specific fine-tuning approach based on the evaluation results. When learned and fine-tuned on a different domain, MT-BERT achieved improvements by 2.0\% and 1.3\% in biomedical and clinical domains, respectively. Specifically, it has brought significant improvements in 4 tasks. There are two limitations to this work. First, our results on MTL training across all BLUE benchmark show that MTL is not always effective. We are interested in exploring further the characterization of task relationships. For example, it is not clear whether there are data characteristics that help to determine its success~\cite{martinezalonso2017when, changpinyo2018multi}. In addition, our results suggest that the model could benefit more from some specific examples of some of the tasks in Table~\ref{tab:tasks}. For example, it might be of interest to not using the BC5CDR corpus in the relation extraction task in future. Second, we studied one approach to MTL by sharing the encoder between all tasks while keeping several task-specific decoders. Other approaches, such as fine-tuning only the task specific layers, soft parameter sharing~\cite{ruder2017overview}, knowledge distillation~\cite{liu2019improving}, need to be investigated in the future. While our work only scratches the surface of MTL in the medical domain, we hope it will shed light on the development of generalizable NLP models and task relations that can lead to gains from MTL models over single-task setups. \section*{Acknowledgments} This work was supported by the Intramural Research Programs of the NIH National Library of Medicine. This work was also supported by the National Library of Medicine of the National Institutes of Health under award number K99LM013001. We are also grateful to the authors of mt-dnn (\url{https://github.com/namisan/mt-dnn}) to make the codes publicly available.

Published: June 28, 2019 Introduction {#sec1} ============ Transfer ribonucleic acid (tRNA) synthetases play an important role in the central dogma of molecular biology. The specific function of tRNA synthetases is to conjugate tRNAs with the cognate amino acid for correct translation of polypeptides from mRNA. Progressively, highly conserved and non-canonical activities of tRNA synthetases that are unique for each amino acid-charging tRNA synthetase have been discovered. Lysyl-tRNA synthetase (LysRS), a tRNA that charges lysine onto lysine-tRNA for use in ribosome for translation, have also been serving an evolutionarily conserved, non-canonical enzymatic activity to produce diadenosine tetraphosphate (Ap~4~A), a small signaling molecule composed of two adenosine moieties joined through a 5′-5′ linkage by a chain of four phosphates. This non-canonical pathway in LysRS is triggered by the phosphorylation of LysRS on serine 207 (P-s207 LysRS) via p38 mitogen-activated protein kinase activity. Phosphorylation leads to the dissociation of P-s207 LysRS from multi-synthetase complex (MSC) and promotes the production of Ap~4~A ([@bib28]). In turn, the synthesis of Ap~4~A is regulated by the housekeeping protein Ap~4~A hydrolase (Ap~4~AHy) that converts Ap~4~A back into its original building blocks (one molecule of ATP and one molecule of AMP) thereby creating a regulatory feedback to maintain intracellular Ap~4~A levels ([@bib34]). Ap~4~A synthesis activity by LysRS can directly control specific response programming in immune-specialized cells ([@bib27]). Our group has previously demonstrated that non-canonical LysRS activity can drive increased intracellular Ap~4~A and control USF2 transcriptional activity, which up-regulates transforming growth factor-β2 in FcepsilonRI-activated mast cells ([@bib14]). Ap~4~A can enhance phorbol myristate acetate (PMA)-stimulated reactive oxygen species production in lymphocytes ([@bib31]) and has been implicated in key immunological responses ([@bib4], [@bib5], [@bib7], [@bib18]). Another pathway that is driven by the increase of intracellular Ap~4~A is the activation of microphthalmia-associated transcription factor (MITF), a master regulator in melanocyte development ([@bib17]). Hint1, a co-suppressor of MITF, is also inactivated by high intracellular concentration of Ap~4~A and dissociates from Hint1. Released MITF can translocate to the nucleus and initiate transcription of downstream genes ([@bib15]). Ap~4~A is also implicated in the control of antigen presentation. Low levels of Ap~4~A are observed in patients with Chediak-Higashi syndrome ([@bib12]), where delayed major histocompatibility complex (MHC) class II-restricted antigen presentation increases pathogen load ([@bib22]). The expression of MHC class II is a defining feature of antigen-presenting cells (APCs). Among APCs, dendritic cells (DCs) possess vastly efficient antigen cross-presentation response over all other known immune cell types. DCs possess high motility to bring sampled antigens to naive T cells located in lymph nodes to stimulate adaptive immune response. Hence DCs act as connecting linkers between innate and acquired immunity. Immature DCs, although present in blood, are more prevalent in pathogen-prone peripheral tissues. Mature DCs travel toward lymph nodes for the antigen presentation to T and B cells, thus activating acquired immune response ([@bib8]). Harnessing the ability of DC as a professional APC to enhance antigen-specific T cell immune response with high precision is particularly useful for the development of more effective cancer immunotherapy vaccines ([@bib36]). DCs adopt a dynamic behavior by migrating to lymph nodes for naive T or B cell priming and maintaining acquired immune activity ([@bib9]). Hence migratory ability of DC is directly correlated with its ability to stimulate immune response through antigen presentation to naive T and B cells in remotely accessible regions of lymph nodes awaiting stimulation by DCs. We reasoned that if a highly conserved function of APCs such as antigen presentation can be precisely impaired by low levels of intracellular Ap~4~A, APCs may functionally benefit from the increase of intracellular Ap~4~A concentration. We hypothesized that Ap~4~A is able to enhance functional capacities of APCs by improving either mobility or antigen presentation, or both. The NUDT2 gene encodes Ap~4~A hydrolase, a member of the nudix-type family of enzymes that hydrolyze a wide range of pyrophosphates. CD11c^+^ is preferentially expressed in murine DCs. Ap~4~A hydrolase allele was floxed and crossed with a CD11c^+^ promoter-specific Cre mice to generate the deletion of NUDT2 gene in CD11c^+^ cells (*Nudt2*^*fl/fl*^/CD11c-cre mice). The present study is aimed at investigating the immune modulatory effect of Ap~4~A in DCs from *Nudt2*^*fl/fl*^/CD11c-cre mice. We report the influence of Ap~4~A levels over DCs\' viability, motility, and expression of immune activation markers. Results {#sec2} ======= Selective Knockout of Ap~4~A Hydrolase in Dendritic Cells of Nudt2^fl/fl^/CD11c^+^ Mice {#sec2.1} --------------------------------------------------------------------------------------- The intracellular level of Ap~4~A is regulated by two enzymes: lysyl tRNA synthetase (LysRS) and Ap~4~A hydrolase (Ap~4~AHy; [Figure 1](#fig1){ref-type="fig"}A). To investigate the function of Ap~4~A in DCs, we have utilized a floxed Ap~4~A hydrolase allele mouse (*Nudt2*^*fl/fl*^; [Figure 1](#fig1){ref-type="fig"}B), which we crossed with CD11c^+^ transgenic mice thereby targeting deletion of Ap~4~A hydrolase to cells that expresses the transmembrane surface protein CD11c, i.e., DCs ([Figure 1](#fig1){ref-type="fig"}C). The western blot of splenic DC extracts of the mice showed neither any detectable expression of Ap~4~AHy nor any disruption in the expression of MITF and Hint1 in *Nudt2*^*fl/fl*^/CD11c^+^ cells when compared with *Nudt2*^*+/+*^ CD11c^+^ cells, confirming successful knockout of Ap~4~A hydrolase in DCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice ([Figure 1](#fig1){ref-type="fig"}D).Figure 1Generation of Ap~4~A Hydrolase Knockout Mice and Viability of Dendritic Cells(A) The phosphorylated form of Lysyl-tRNA transferase (phosphoSerine 207 LysRS) synthesizes Ap~4~A from ATP and AMP, and is in turn broken down into same by Ap~4~A hydrolase (Ap~4~AHy).(B) The gene locus and mRNA structure of NUDT2. The full open reading frame for Ap~4~AHy (15,412 bp) consists of three exons interspersed with two introns. The Nudix box is nothing but the enzymatically functional site for Ap~4~AHy and is located at exon 3.(C) The deletion of Ap4~A~Hy by gene floxing and deletion strategy. The two *loxP* sites were generated on either side of the gene encompassing the full sequence of exon 3 and a portion of immediate intron upstream to it.(D--F) (D) Western blot showing expression levels of Ap4~A~Hy, MITF, and Hint1 in splenic dendritic cells of *Nudt2*^*+/+*^ and *Nudt2*^*fl/fl*^/CD11c^+^ (Ap~4~A hydrolase knockout) mice (represents four independent experiments). Immature bone marrow-derived cells (BM). (E) and (F) Viability percentage of isolated BMDCs and splenic DCs. Results (mean ± SEM) represent two independent experiments. The significant difference of test in comparision to control. ^ns^p\> 0.05 (Student\'s t test). Based on the increased cellular permeability and binding ability with free amines retained in dead cells than live cells, saturation of cells with amines conjugated to florescent APC-Cy7 probe were measured by using flow cytometry to determine the live and dead cell population percentages. The study has revealed a slight decrease in viability of bone marrow DCs (BMDCs) as well as splenic DCs in case of *Nudt2*^*fl/fl*^/CD11c^+^ mice when compared with *Nudt2*^*+/+*^ mice and is found to be statistically insignificant ([Figures 1](#fig1){ref-type="fig"}E and 1F). Characterization of Ap~4~AHy *Nudt2*^*fl/fl*^/CD11c^+^ DCs {#sec2.2} ---------------------------------------------------------- ### Higher Accumulation of Ap~4~A Is Observed in Nudt2^fl/fl/^CD11c^+^DCs {#sec2.2.1} The intracellular Ap~4~A level of BMDCs generated from *Nudt2*^*fl/fl*^/CD11c^+^ and *Nudt2*^*+/+*^ mice was examined using a diadenosine nucleotide assay. Compared with *Nudt2*^*+/+*^ CD11c^+^ mice, the BMDCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice contained prominently higher levels of Ap~4~A on their third and sixth days of culture (2.3- and 3.2-folds, respectively), whereas the levels reached peak state on eighth day of culture (approximately 32-fold; [Figure 2](#fig2){ref-type="fig"}A).Figure 2Detailed Functional Characterization of *Nudt2*^*fl/fl*^/CD11c-cre DC(A) Intracellular concentrations of Ap~4~A in *Nudt2*^*+/+*^ and *Nudt2*^*fl/fl*^/CD11c-cre BMDC were generated from bone marrow cultured with granulocyte-macrophage colony-stimulating factor and examined on days 3, 6, and 8, using a luciferase assay.(B and C) (B) Western blot of LysRS, Ap~4~AHy, MITF, and Hint1 in *Nudt2*^*+/+*^ and *Nudt2*^*fl/fl*^/CD11c-cre CD11c^+^ splenic cells. Immature bone marrow-derived cells (BM) (C). Real-time PCR result of MITF-specific gene (TRACP5) expression in BMDCs. The results (mean ± SEM) are representative of four independent experiments and the significant difference of test in comparison to control. \*\*p \< 0.01; \*\*\*\*p \< 0.0001 (Mann-Whitney test for multiple comparison). Another correlative activation from the increase in intracellular Ap~4~A concentration is the initiation of LysRS-Ap~4~A-Hint1-MITF pathway. The MITF nuclear localization was examined in splenic DCs and was detected prominently (without concomitant increase in expression) in splenic *Nudt2*^*fl/fl*^/CD11c^+^ cells, but not in *Nudt2*^*+/+*^ CD11c^+^ cells ([Figure 2](#fig2){ref-type="fig"}B). Furthermore, Hint1, a suppressor of MITF, is not present in the nucleus of matured DCs and monocytes and is only present in unmatured BM cells. Hint1 translocation also posits that MITF suppression is released from increased Ap~4~A concentration within *Nudt2*^*fl/fl*^/CD11c^+^ splenic cells. To validate the translocation of MITF in to nucleus, which leads to gene transcription, MITF-specific gene tartrate-resistant acid phosphatase 5 (TRACP5) was examined for expression ([@bib19]). TRACP5 is strongly expressed in both Nudt2^+/+^ and Nudt2^*fl/fl*^ CD11c^+^ cells and is upregulated by 2.97-fold in Nudt2^*fl/fl*^/CD11c^+^ cells compared with Nudt2^+^/^+^ CD11c^+^ cells ([Figure 2](#fig2){ref-type="fig"}C). To review the association of MITF with LysRS, which occurs during activation of MITF, a pull-down of MITF using LysRS antibody via co-immunoprecipitation experiment was performed on BMDCs. MITF is co-immunoprecipitated using LysRS antibody pull-down in both Nudt2^+/+^ and Nudt2^*fl/fl*^ DCs, indicating the that binding of LysRS to MITF occurs at baseline level in DCs and the association is increased in Nudt2^*fl/fl*^ DCs ([Figure S1](#mmc1){ref-type="supplementary-material"}). ### Nudt2^fl/fl^/CD11c^+^ BMDCs Possess Greater Motility with Lower Directional Variation {#sec2.2.2} The *Nudt2*^*fl/fl*^/CD11c^+^ BMDCs have shown vigorous motility as indicated by higher values of distance, speed and displacement compared with *Nudt2*^*+/+*^ BMDCs ([Figures 3](#fig3){ref-type="fig"}A--3D). Less directional variability indicates enhanced organization of cytoskeletal dynamics, and such organization generally requires the activation of small GTPases, such as Rho GTPases. The Rho GTPases play a crucial role in cellular migration, of which Rho, Rac, and Cdc42 are widely studied proteins and are highly conserved among eukaryotes ([@bib30]). To examine a possible relationship between intracellular Ap~4~A increase in DCs and small GTPase activation, active Rac1, cdc42, and RhoA levels were measured (GTP-bound form). The results show a significant decrease in active Rac1 and cdc42, and an increase in RhoA activation levels in case of BMDCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice compared with that of *Nudt2*^*+/+*^ CD11c^+^ mice ([Figure 3](#fig3){ref-type="fig"}E).Figure 3Comparative Motility of DCs from *Nudt2*^*fl/fl*^/CD11c^+^ and *Nudt2*^*+/+*^ Mice(A) Live imaging microscopy of granulocyte-macrophage colony-stimulating factor-treated DCs (8 days). The post-treated DCs on observational Petri dish were chosen randomly (n = 20) and traced minute wise (time lap ≈30 min) to find the change in cell movement and the distance moved.(B) The speed of cellular movement and the ratio between the distance moved and difference of two time frames.(C) Cellular displacement.(D) A still frame taken from the video created for live cell imaging of *Nudt2*^*+/+*^ and *Nudt2*^*fl/fl*^/CD11c^+^ DCs.(E) Small GTPase activation state in *Nudt2*^*+/+*^ and *Nudt2*^*fl/fl*^/CD11c^+^ DCs (n = 2). Results (mean ± SEM) represent two independent experiments. The significant difference of test in comparision to control. \*p \< 0.05, \*\*\*p \< 0.001, and \*\*\*\*p \< 0.0001 (Student\'s t test or Mann-Whitney test for multiple comparison). ### Nudt2^fl/fl^/CD11c^+^ DCs Possess Higher Antigen-Presenting and CD8^+^ T Cell-Priming Potential {#sec2.2.3} The possibility of NUDT2 gene directly controlling fundamental immune activity of DCs was also investigated. It is equally important to know whether Nudt2 is important for DC maturation because its status directly impacts the immune function as APCs. Although DCs are highly specialized immune cells that specialize as APCs, they are initially phagocytic before maturation. A change in phagocytic potential would indicate aberrant DC maturation signaling compared with *Nudt2*^*+/+*^ DCs. To measure the phagocytic potential, uptake of fluorescein isothiocyanate (FITC) dextran by DCs was measured. The phagocytic potential of DCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice was found to be unchanged when compared with that of *Nudt2*^*+/+*^ DCs as the uptake of FITC dextran DCs from *Nudt2*^*fl/fl*^/CD11c + mice was identical to *Nudt2*^*+/+*^ DCs both at 4°C and 37°C ([Figure S2](#mmc1){ref-type="supplementary-material"}). Therefore, these DCs do not differ in phagocytic capacity, a defining attribute in DC maturation status, indicating that DC maturation status is identical. To determine if antigen presentation functionality is affected, the capacity of DCs to trigger proliferation in antigen-specific T cells that requires DCs to present highly specific antigens to these T cells to trigger activation and proliferation was also investigated. The cultures of BMDCs from either the *Nudt2*^*fl/fl*^/CD11c^+^ or the *Nudt2*^*+/+*^/CD11c^+^ mice incubated with OT-1 T cell were co-incubated with positive control SIINFEKL peptides, and have given a similar extent of stimulation of proliferation of CD8^+^ T cells, indicating an overall lack of involvement in the activation of T cells by DCs, which does not require antigen cross-presentation ([Figures 4](#fig4){ref-type="fig"}A and 4B). Remarkably, when cultured with DCs co-incubated either with whole ovalbumin (OVA) or OVA and cytosine-phosphodiester linked guanine ligodeoxynucleotides (CpG ODN), there was an average of 20% and 15% higher stimulus in the proliferation of CD8^+^ T cell population, respectively, by the BMDCs from *Nudt2*^*fl/fl*^/CD11c^+^ mice compared with the *Nudt2*^*+/+*^ BMDCs. *Nudt2* gene is therefore involved in the control of antigen cross-presentation machinery in DCs.Figure 4*Nudt2*^*fl/fl*^/CD11c^+^ DCs\' Potential in Influencing OT-I CD8^+^ T Cells Antigen Cross-Priming(A) The percentage of OT-I CD8^+^ T cells that have proliferated following co-culture for 3 days either with *Nudt2*^*fl/fl*^/CD11c^+^ BMDCs or *Nudt2*^*+/+*^ CD11c^+^ BMDCs (1:10) incubated with SIINFEKL peptide, OVA and CpG ODN. The harvested cells were analyzed by flow cytometry to quantify CD8^+^ CellTrace Violet^+^ population for proliferation.(B) Graph represents the percentage of OT-I CD8^+^ T cells proliferated when cultured with *Nudt2*^*+/+*^ or *Nudt2*^*fl/fl*^/CD11c^+^ DCs in response to different antigenic preparations.(C) IL-12 p40 production by DCs during the above co-culture conditions.(D) mRNA levels for TAP1, TAP2, and TAPASIN in *Nudt2*^*+/+*^ and *Nudt2*^*fl/fl*^/CD11c-cre in splenic DCs measured by RT-PCR. Results (mean ± SEM) represent three independent experiments and the significant difference of test in comparision to control. \*p \< 0.05 (Student\'s t test or Mann-Whitney test for multiple comparison). To determine the involvement of interleukin (IL)-12 p40, which is a DC-specialized T cell activation cytokine that controls enhancement of antigen cross-presentation by *Nudt2*^*fl/fl*^/CD11c^+^ BMDCs, the cytokine levels were measured by ELISA technique. The results revealed a lack of involvement of IL-12 p40 in enhancing the priming of CD8^+^ T cells by *Nudt2*^*fl/fl*^/CD11c^+^ BMDCs as there was no observable difference in the levels of IL-12 p40 between *Nudt2*^*fl/fl*^/CD11c^+^ BMDCs and *Nudt2*^*+/+*^ BMDCs ([Figure 4](#fig4){ref-type="fig"}C). Antigen cross-presentation can also be skewed by the change in expression of TAP proteins required for assembly of short peptides onto MHC-I molecules. The mRNA levels of TAP1, TAP2, and TAPASIN were measured in *Nudt2*^*fl/fl*^/CD11c^+^ DCs as well as in *Nudt2*^*+/+*^ DCs. The results have shown a lack of difference in TAP1, TAP2, or TAPASIN between *Nudt2*^*fl/fl*^/CD11c-cre or *Nudt2*^*+/+*^ DCs indicating lack of their involvement ([Figure 4](#fig4){ref-type="fig"}D). Taken together, *Nudt2* gene is involved in controlling antigen cross-presentation machinery that directly signals T cell proliferation. Discussion {#sec3} ========== This study shows that intracellular Ap~4~A can be upregulated in immune cells of a specific lineage (DCs) within an *in vivo* model. The DCs from these mice are lacking Ap~4~A hydrolase, and a consequent rise in intracellular Ap~4~A amounts is observed, revealing an obvious substantial regulation of Ap~4~A concentrations in DCs by Ap~4~A hydrolase through the NUDT2 gene. The *Nudt2*^*fl/fl*^/CD11c^+^ mice did not exhibit any observable physiological differences to wild-type, leading to the inference that they harbor similar small population of CD11c^+^ cells as are normally present. In addition, their viability remained almost similar. DCs play a pivotal role in adaptive immunity and tolerance. Efficient migration for accurate positioning to capture antigens from invading pathogens and capacity to process the foreign peptides into recognizable MHC-I-bound complexes through antigen-cross presentation are two immutable purposes of DCs. These functions are therefore critical for immune protection. Most of the immature and highly phagocytic DCs begin their voyage from the bone marrow where they are generated, followed by entry into the blood and sequential movement into peripheral lymphoid tissues (PLTs) and non-lymphoid tissues (NLTs). The DCs possess advanced migratory skills, and their main function in NLTs is the carriage and presentation of antigenic components into and within secondary lymphoid organs ([@bib1]). Once primed by the phagocytosis of foreign antigens the enrouted Ag-bearing DCs in lymph nodes begin to build up an immune-stimulatory phenotype, exhibiting increased expression of MHC complexes as well as upregulation of the co-stimulatory molecules and cytokines required for effective T cell priming. The non-retained DCs enter into the blood stream (blood-borne DCs) and deliver the antigenic components to the spleen ([@bib24]) and also to PLTs ([@bib6]). The relationship between *Nudt2* and DC is unknown, but its association with immune function has been speculated. A recent RNA sequencing analysis of *Nudt2* knockout myelogenous leukemia cells revealed that the majority of the target genes are linked to immune-specific processes such as interferon-associated inflammatory responses, MHC-II antigen presentation, allograft rejection, and B cell development ([@bib21]). The current study focused on the influence of Ap~4~A over immune activity of DCs from *Nudt2*^*fl/fl*^/CD11c^+^ mice and has confirmed that *Nudt2* gene has influence over MHC-II antigen presentation. Ap~4~A regulates MITF activation through the release of Hint1 suppression and consequent nuclear localization of MITF. The nuclear localization of MITF, as a result of increase of Ap~4~A, is a hallmark of the LysRS-Ap~4~A-Hint1-MITF pathway ([@bib2], [@bib3], [@bib11], [@bib14], [@bib16], [@bib33]). The LysRS-Ap~4~A-Hint1-MITF pathway has been described in mast cells ([@bib15]), but it was not clear whether the same pathway is active in DCs. The LysRS-Ap~4~A-Hint1-MITF pathway was examined in DCs in this study, and it was revealed that the increase in MITF nuclear localization, but not HINT-1, in response to the elevated Ap~4~A levels is due to the knockout of NUDT2 gene. The binding of MITF to LysRS using co-immunoprecipitation pull down of MITF using LysRS antibody establishes the existence of LysRS-Ap~4~A-Hint1-MITF pathway in DCs and further confirms that Hint1 suppression is lifted so that LysRS can bind active MITF. The BMDCs from *Nudt2*^*fl/fl*^/CD11c-cre mice cultured from undifferentiated monocytes did not show any morphological or phenotypic differences to *Nudt2*^*+/+*^ DCs. Interestingly, the DCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice exhibited a unique pattern of cellular motility with higher velocity and lower directional variability. This suggests that the majority population of DCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice is having uniform directional imprint that may indicate effective migration toward the immune reaction zones. Furthermore, we found such behavior was correlated to the variation in their expression of small GTPases, i.e., cdc42, Rac1, and RhoA. Our findings provide evidence that reduced activation of Rac1 in DCs leads to increased directional motility, consistent with the earlier studies over fibroblasts that had shown their enhancement of directional motility by the inactivation of the same GTPases ([@bib10]). Among small GTPases that are important in cell motility, Rho GTP is critical for inducing actomyosin contraction and inhibiting actin filament disassembly for cell polarity and directional migration ([@bib13], [@bib20]). Upregulation of active Rho is observed in CD11c^+^ DC derived from *Nudt2*^*fl/fl*^ mice. Pharmacologic Rho effector blockades (e.g., ROCK inhibitors) can profoundly decrease DC migration capability. Hence increased bioavailability of RhoGTP can correlate with the increased mobility observed in CD11c^+^ DC derived from *Nudt2*^*fl/fl*^ mice. Increase in Rho activity also causes decreased availability of Rac ([@bib37]), and this is likewise also observed in CD11c^+^ DC derived from *Nudt2*^*fl/fl*^ mice. The defining feature of DCs is their ability to take up antigen in the periphery, through their dendrites; to withdraw those dendrites; and then to migrate to lymph nodes. Upon regaining their former shapes in lymph node, DCs will present antigenic peptides to CD4^+^ and CD8^+^ T cells. Thus DCs may be regarded as the "shape-shifters" of the immune system. Cross-presentation is the intracellular degradation of extrinsic antigen and its presentation by MHC-I. This important DC function activates CD8^+^ T cells during an immunological response to intracellular pathogens ([@bib25], [@bib26]) and is a highly energy-dependent process and requires movement of the cells into finding suitable T cells. Though identical levels of phagocytic potential, Class-II MHC display and expression of co-stimulatory molecules were seen in DCs of *Nudt2*^*fl/fl*^/CD11c^+^ mice, there was an enhancement in their immune functionality. These DCs have increased immune activity in terms of antigen processing and cross-presentation in priming the proliferation of CD8^+^ T cells. *In vitro* antigen presentation assay using OT-1 CD8^+^ T cells is well suited to validate this result as an antigen-specific response. The activation of CD8^+^ T cells of OT-1 mice is exclusive for antigen presentation of OVA through DC cross-presentation machinery, and the subsequent trigger of proliferation in OT-1 CD8^+^ T cells is a highly specific response against cross-presented MHC-I antigen on APCs. CD11c^+^ DC derived from *Nudt2*^*fl/fl*^ mice are capable of driving the proliferation of antigen-specific CD8^+^ T cells without the need for CpG ODN, a potent immune agonist ([@bib29]). However, this observation was found not associated with the expected alteration in the elements of MHC-I machinery, reflecting the possible positive influence of directional motility making effective contact to the T cells and also the rise in the duration of functioning in antigen presentation process. There is direct evidence in support of one of our assumption. Other groups have also reported that overexpression of Rho can directly increase the ability of DC to present OVA peptide to specific T cells ([@bib32]). Our studies indicate that the increased CD8^+^ T cell cross-priming potential of DC from *Nudt2*^*fl/fl*^/CD11c^+^ mice compared with *Nudt2*^*+/+*^ is more likely the result of RhoA activation and RAC1 repression. This is in agreement with the earlier studies ([@bib10], [@bib32], [@bib35]). Another important feature of DCs is their capacity to steer the immune response into clinically beneficial Th1-type immune response by the production of IL-12 ([@bib23]). Without stimulation, IL-12 production is not observed to be different than *Nudt2*^*+/+*^ for CD11c^+^ DC derived from *Nudt2*^*fl/fl*^ mice, indicating that the resultant DCs are not activated immune response without stimuli. Presence of CpG ODN increased IL-12 production but by an identical amount to *Nudt2*^+/+^ mice, suggesting that the CD11c^+^ DC derived from *Nudt2*^*fl/fl*^ mice are neither functionally impaired or overactivated compared with *Nudt2*^*+/+*^ DC counterparts. In conclusion, increased Ap~4~A concentration in DC of *Nudt2*^*fl/fl*^/CD11c^+^ mice led to the localization of MITF into the nucleus during restive conditions compared with *Nudt2*^*+/+*^ DC. These Ap~4~A enriched DCs have prominently exhibited alteration in small GTPases rising their motility and antigen presenting potentiality. This study documents an *in vivo* model that can modulate the intracellular Ap~4~A concentration by knocking out Ap~4~A hydrolase and enhancing antigen cross-presentation by DC. Fundamentally, enhanced antigen cross-presentation in a controlled manner will benefit a wide variety of APC-associated functions such as earlier pathogen recognition by the immune system and better loading and presentation of tumor antigens to cytotoxic CD8^+^ T cells in response to cancer. The highly specific control of intracellular Ap~4~A concentration through manipulation of *NUDT2* gene makes this mechanism an attractive pharmacological target to enhance antigen presentation while keeping the complex repertoire of transcriptional activation of APCs as intact as possible. Limitations of the Study {#sec3.1} ------------------------ The currently studied *Nudt2*^*fl/fl*^/CD11c^+^ mice model is an excellent *in vivo* system to understand the consequences of increased intracellular Ap~4~A. It is important and yet to be determined whether the circulatory DCs in *Nudt2*^*fl/fl*^/CD11c^+^ mice exhibit elevation in antigen presentation to T cells. Also, the identification of key cytokines responsible for DC-specialized T cell activation would become significant. In addition, this study necessitates the elucidation of Ap~4~A-binding proteins that are associated with cellular migration in future. Methods {#sec4} ======= All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}. Supplemental Information {#appsec2} ======================== Document S1. Figures S1 and S2 The present study was supported in part by grants from the National University of Singapore to D.M.K.; Israel Science Foundation, 115/2013, and Hebrew-University-National Research Foundation of Singapore HUJ-CREATE (R182-005-172-281) to E.R. Graphical abstract was created with [bio-render.com](http://bio-render.com){#intref0010}. Author Contributions {#sec5} ==================== S.L.S., N.Q.T., A.S.Y.F., K.H.L., E.G.L.K., and A.L. performed the experimental work. Y.L.C. produced the *Nudt2*^*fl/fl*^/CD11c-cre mice and C.M.Y. designed the experiments. S.L.S. and L.B.P. analyzed the data and drafted the manuscript. D.M.K. and E.R., the principal investigators, conceived the study design and wrote the grant, and with H.N corrected the manuscript. The authors thank Paul Hutchinson and Teoh Guo Hui of the NUS immunology programme flow cytometry facility for their help and advice on the flow cytometry assays used in this study. Declaration of Interests {#sec6} ======================== The authors declare no competing interests. Supplemental Information can be found online at <https://doi.org/10.1016/j.isci.2019.05.045>. [^1]: Lead Contact

\section{Introduction} Low to intermediate mass stars (0.8 to 8 $\rm{M_\odot}$) undergo spectacular structural changes during the last phases of their evolution. According to the interacting stellar wind model (ISW; Kwok Purton and Fitzgerald 1978), the spherically symmetric PNe are formed by the interaction of two isotropic stellar winds, a slow and dense one from the Asymptotic Giant Branch (AGB) phase and a fast and tenuous one during the PN phase. The generalized ISW model considers in addition the contribution of an equatorial density enhancement at the exit of the AGB phase that produces a density contrast leading to the formation of axisymmetric shapes (e.g. Balick 1987) that may range from mildly elliptical to bipolar. In fact, the majority of planetary nebulae (PNe) and proto--PNe (PPNe) show axisymmetric morphologies. In some cases highly collimated, high--speed bipolar outflows are also found. The causes of the equatorial density enhancement and the jet-like outflows are still under debate (e.g. Balick \& Frank 2002) and the two most likely being the presence of magnetic fields (e.g. Garcia--Segura \& L\'opez 2000, Frank \& Blackman 2004) and post-common envelope, close binary nuclei (e.g. Soker \& Livio 1994, De Marco 2009). Sahai and Trauger (1998) proposed as a shaping mechanism for the bipolar and multi--polar PNe, the presence of highly collimated outflows developed during the post--AGB or PPNe phase. All these elements represent the main considerations in recent morphological classification studies of PNe (e.g. Parker et al. 2006, Miszalski et al. 2008, Sahai et al. 2011, Lagadec et al. 2011). However, imaging alone can be in some cases deceiving in describing the real shape of a PN due to the inherent uncertainty introduced by the effects of the projection on the plane of the sky for a three dimensional nebula. The simplest example is that of an axisymmetric nebula, such as a bipolar, with a thick waist observed pole-on, in which case the nebula appears as a round doughnut projected on the sky. In these cases spatially resolved, high spectral resolution spectroscopy becomes an ideal tool to explore the three dimensional structure of the nebula by examining the Doppler shifts in the emission line profile and assuming in a first approximation a homologous expansion for the nebula. Most of these morpho-kinematic studies have been performed on relatively large, spatially resolved PNe (e.g. L\'opez et al. 2012, Clark et al. 2010, Garc\'{\i}a--D\'{\i}az et al. 2009) but they can also be very revealing when studying spatially unresolved, compact PNe, as we show here. \begin{table*} \centering \caption[]{Source Properties} \label{table5} \begin{tabular}{llllllllllll} \hline Name & PNG & RA & Dec & distance (kpc)$\rm ^a$ & V$_{\rm{sys}}($km $\rm{s^{-1}}$) & central star$\rm ^b$ \\ \hline M 1--32 & 011.9+04.2 & 17 56 20.1 & -16 29 04.6 & 4.8$\pm$1.0 & $-105$ & [WO4]pec \\ M 2--20 & 000.4--01.9 & 17 54 25.4 & -29 36 08.2 & 9.5$\pm$1.9 & $+60$& [WC5-6] \\ M 2--31 & 006.0--03.6 & 18 13 16.1 & -25 30 05.3 & 6.3$\pm$1.3 & $+ 155$& [WC4] \\ M 2--42 & 008.2--04.8 & 17 01 06.2 & -34 49 38.6 & 9.5$\pm$1.9 & $+ 105$& wels \\ M 3--15 & 006.8+04.1 & 17 45 31.7 & -20 58 01.8 & 6.8$\pm$1.4 & $+ 100$& [WC4 ] \\ \hline \end{tabular} \medskip{} \begin{flushleft} ${\rm ^a}$ Stanghellini \& Haywood 2010\\ ${\rm ^b}$ Acker \& Neiner 2003 \end{flushleft} \end{table*} In this work, we perform a morpho--kinematic study of five, relatively bright, compact PNe with no discernable structure and with seeing limited angular sizes ranging from 5 to 10 arcsec. No high spatial resolution images for these objects were found in the literature or the usual repositories of images of PNe. These objects were chosen from the the San Pedro Martir kinematic catalogue of Galactic Planetary Nebulae (L\'{o}pez et al. 2012) on the basis of their line emission spectra that show the presence of fast, collimated bipolar outflows. The objects selected are: M 1--32, M 2--20, M 2--31 and M 2--42 and M 3--15. Based on their galactic coordinates, distances and systemic velocities they seem located in the Galactic bulge or close to it, see Table 1. The central stars for four of them have been classified as Wolf-Rayet type (Acker \& Neiner 2003) and the fifth one as a weak emission--line star or wels (Tylenda, Acker \& Stenholm 1993). As mentioned above, the long-slit, spectroscopic observations reveal the presence of highly collimated, fast, bipolar outflows surrounded by a thick equatorial enhancement, as a torus or a ring. We combine these data with the 3--D morpho--kinematic code SHAPE (Steffen \& Lopez 2006, Steffen et al. 2011) to analyze the 3--D structure of these outflows and the relation of their appearance with different projection on the sky. In Section 2, the observation and data reduction are presented. In Section 3, we describe the parameters used in the morpho--kinematic code SHAPE as well as the modelling results. We finish by summing up the results of this work in Section 4. \section{Observations} High--resolution, long-slit spectra of the PNe M 1--32, M 2--20, M 2--31, M2--42 and M 3--15 were obtained using the Manchester echelle spectrometer, MES--SPM (Meaburn et al. 2003) on the 2.1 m telescope at the Observatorio Astron\'omico Nacional at San Pedro Martir Observatory in Baja California, Mexico, in its $f$/7.5 configuration. The observing runs for M 1--32, M2--42, M 2--20, M 2--31 and M 3--15 took place in 2009 July, 2007 June, 2006 July, 2004 June and 2004 June, respectively. In all cases MES-SPM was equipped with a SITE--3 CCD detector with 1024$\times$1024 square pixels, each 24 $\mu$m on a side ($\equiv$0.312 arcsec pixel$^{-1}$). A 90 \AA~ bandwidth filter was used to isolate the 87$^{th}$ order containing the H$\alpha$ and [N~{\sc ii}]{} $\lambda$$\lambda ~$6548,~6584~\AA, nebular emission lines. Two-by-two binning was employed in both the spatial and spectral directions. Consequently, 512 increments, each 0\farcs624{} long gave a projected slit length of 5\farcm32 on the sky. The slit was 150 $\mu$m{} wide ($\equiv$~11~km $\rm{s^{-1}}$ and 1\farcs9). The slit was oriented north -- south (P.A. $= 0\degr$) for M 1--32, M 2--20 and 3--15. For M 2--31 and M 2--42 two slit positions are available, P.A. $= 35\degr$ and P.A. $= 0\degr$ and P.A. = $48\degr$ and P.A. = $-45\degr$, respectively. All the spectroscopic integrations were of 1800~s duration. The wavelength calibration was performed using a Th/Ar calibration lamp to an accuracy of $\pm$ 1 km $\rm{s^{-1}}$ when converted to radial velocity. The stellar continua were not subtracted. Only in two cases, M 2--42 and M 2--31, a very faint continuum could be discerned within the very short spectra range of our single--order echelle spectra. The data reduction was performed using the standard IRAF routines. Individual images were bias subtracted and cosmic rays removed. All spectra were also calibrated to heliocentric velocity. These spectra are part of the SPM Kinematic Catalogue of Galactic Planetary Nebulae; L\'{o}pez et al. 2012) and are available at http://kincatpn.astrosen.unam.mx where images from the digitized sky survey are also shown with the location of the slits overlaid for each object. \section{SHAPE modelling} Modelling with SHAPE follows three main steps. First, defining the geometrical forms to use; SHAPE has a variety of objects such as a sphere, torus, cone, cube, etc. whose basic forms can be modified by the user (e.g. squeeze, twist, boolean, etc). Second, an emissivity distribution is assigned to each individual object or structure, and third, a velocity law is chosen as a function of position. SHAPE gives as result a two dimensional image and synthetic P--V arrays, which are rendered from the 3D model to be compared with the observed data. The parameters of the model are then iteratively adjusted until a satisfactory solution is obtained. Figure 1 presents the expected shapes of bi--dimensional line profiles or position--velocity diagrams (PV) from a spatially resolved, long--slit, spectrum for some representative cases, such as an expanding bubble, a face--on torus, a bipolar nebula with its lower part tilted into the plane of the sky and finally, the same bipolar with an equatorial torus. Figure 2 presents the observed [N~{\sc ii}] ~ emission line spectra with the corresponding synthetic P--V diagrams. These bi--dimensional line profiles clearly show the structure of fast, bipolar outflows and a central thick waist, presumably an equatorial density enhancement in the form of a torus or ring. This information is used in combination with the code SHAPE to iteratively find a combined geometry and expanding velocity field solution that replicates the observed position -- velocity diagrams of the bi-dimensional line profiles. The resultant synthetic P--V diagrams are shown side by side to the observed ones, to their right, in the panels in Figure 2. These were reproduced assuming an axisymmetric geometry and a Hubble--type velocity law increasing linearly with distance from the central star to reconstruct the outflows along the polar direction. A key characteristic of cylindrically symmetric and homologously expanding nebulae is that the P--V diagrams can be stretched in velocity in such a way that the outline of the image and the P--V diagram match. This match determines the factor of proportionality in the mapping between position and velocity. It must however be noted that the SHAPE model cannot constrain the extent of the nebula along the sightline and thus there can be more than one solution to the fit. Moreover, the information in the present cases comes from the line profiles alone (no morphology information) from single slit cuts over the nebula and without a previous knowledge of the position angle of the main axis of the nebula. To our only advantage is the slit width of two arcsec that includes a significant portion of the core of these compact nebulae, providing sufficient information to investigate their inner structure. Considering these limitations we have therefore assumed reasonable sizes for all objects and considered the observed expansion velocities as lower limits. Under these conditions we have selected the simplest solution that best fit the data. The equatorial thick torus/ring component was assumed to expand radially from the central star. Similar solutions have been used for NGC 6337 (Garc\'{i}a--D\'{i}az et al. 2009) and and more recently for BD +30 3639 (Akras \& Steffen 2012). In order to reproduce the line profiles shown in Figure 2, the inclination of the symmetry axes of M 1--32, M 2--20, M 2--31, M 2--42 and M 3--15 were found to be $5\degr$, $55\degr$, $5\degr$ , $77\degr$ and $5\degr$ respectively, with respect to the line of sight, with an uncertainty in this case of the order of 20\%, beyond this figure the line profiles start to show significant tilt differences. In Figure 3, we present the SHAPE mesh models that best fit each of the PN under study, displaying the geometry of the system at four different orientations given by position angle and inclination: $0\degr, 0\degr; 0\degr, 60\degr; 60\degr, 60\degr\ \&\ 90\degr, 90\degr$, before rendering. All models share as common elements the bipolar outflows, the torus or thick ring and an outer shell. \section{Discussion on the individual objects} The unusual, wide line profile of M 1--32 has been noted before by Medina et al. 2006. The P--V diagram shown in Figure 2 (top row, left panels) for this object reveals fast collimated bipolar outflows reaching $\pm 200$ ~km $\rm{s^{-1}}$. The orientation of M 1--32 is nearly pole-on, $5\degr$ with respect to the line of sight as derived from the model, and the torus intersected by the slit is clearly revealed by the bright knots at the centre of the profile. The torus component is expanding radially with a velocity of $\approx$15 km $\rm{s^{-1}}$. Faint extensions beyond the bright equatorial knots disclose the presence of an outer, thin shell. The P--V diagram for M 2--20 (Figure 2, top row, right panels) indicates a tilted axisymmetric structure, either an elliptical or a mild bipolar nebula. The central region is dominated by two bright equatorial knots from a toroidal structure. The knots are displaced one respect to the other due to the inclination of the torus that shows the front and back sides approaching and receding due to its radial expansion. These knots have expansion velocities with respect to the core of $\approx$15 km $\rm{s^{-1}}$. The observed expansion velocity of the lobes with respect to the core is $\pm$ 65 km $\rm{s^{-1}}$ and for an inclination with respect to the line of sight of $55\degr$ the expansion velocity for the bipolar outflow transforms into $\pm$ 125 km $\rm{s^{-1}}$ and 25 km $\rm{s^{-1}}$ for the equatorial toroid. M 2--31 shows for the slit oriented at P.A. = $35\degr$, a P--V diagram (Figure 2, middle row, left panels) dominated by two bright knots located at very nearly the same position along the slit and separated by 30 km $\rm{s^{-1}}$, fainter extensions to these knots reveal a collimated bipolar outflow reaching $\pm$ 90 km $\rm{s^{-1}}$. There is also a faint and seemingly, slightly tilted shell component that surrounds the bright knots or blobs. This tilt indicates an ellipsoidal shell expanding at a similar velocity to the bright knots. The slit oriented at P.A. = $0\degr$ (Figure 2, middle row, right panels) shows the same components except for the tilt in the faint shell which suggests that the slit at P.A. = $35\degr$ lies close to its major axis whereas the slit at P.A. = $0\degr$ cuts across it. Contrary to the previous cases where the bright knots have been identified with emission from a thick toroidal structure, in this case the characteristics of the bi-dimensional line profile indicate that the bright knots are part of an expanding bipolar system, probably a pair of compact, bright lobes, perhaps with a structure similar to the PN Mz 3 (or M 1--92) (Redman et al. 2000) but seen nearly pole-on and with material beyond the knots that expands at significantly larger speed. For M 2--42 its P--V diagram reveals clearly a collimated bipolar structure with both lobes showing knots or condensations at their tips (Figure 2, bottom row, left panels). The lobes have an extent of about 10 arcsec from the centre where again the presence of a conspicuous equatorial torus is indicated by the line profile. The knots are observed to be expanding with a velocity of $\sim$$\pm$15 km $\rm{s^{-1}}$ with respect to the core. Considering the $77\degr$ angle of inclination derived from the model for this nebula, the polar knots expand at a deprojected velocity of $\pm$ 70 km $\rm{s^{-1}}$ from the core. The torus expands radially with a velocity of $\approx$15 km $\rm{s^{-1}}$, very similar to the case of M 1-32. M 3--15 looks nearly as a twin brother to M 2--42 but observed close to the line of sight (Figure 2, bottom row, left panels). The bi-dimensional line profile in this case is dominated by a bright, compact, core containing a central toroid and a nearly pole-on, collimated outflow that extends to $\pm$ 100 km $\rm{s^{-1}}$. An inclination of $5\degr$ with respect to the line of sight is obtained here from the model. \section{Conclusions} In this work, we carried out a morpho--kinematic study of five compact PNe. The data were drawn from the Kinematic Catalogue of Galactic Planetary Nebulae (L\'opez et al. 2012). The sample was selected on the basis of compact PNe with no discernible or apparent structure from their ground--based images, no high spatial resolution imaging available (e.g. {\it HST}) and showing the presence of collimated, high-speed, bipolar outflows in their emission line spectra. Fortuitously, the five PNe selected under the criteria described above turned out to have WR--type central stars. It is worth pointing--out that the SPM catalogue lists at present 84 PNe with WR--type nuclei, 92 spatially resolved bipolar out of which 43 are labeled as showing fast projected outflows and 152 PNe from the galactic bugle region. It is our intention to conduct next a thorough search in the catalogue to select from the lists mentioned above additional PNe that match similar criteria adopted here. In this work, we demonstrate that with practically no morphological information and limited spectral information consisting of long--slit, spatially resolved, echelle spectra combined with the reconstruction code SHAPE, a fair morpho-kinematic representation of the nebulae can be achieved. The process yields a first order description of the main morphological elements of the nebula, the inclination of the main outflow symmetry axis with respect to the line of sight and with it an estimate of the true expansion velocity for the bipolar outflow. We find that these planetary nebulae have very similar structural components and the differences in their emission line spectra derive mostly from their different projection on the sky and degree of collimation of the bipolar outflows. All cases studied here are characterized by the presence of an equatorial density enhancement or toroid, a collimated bipolar outflow and an outer shell. The bipolar expansion velocities range from 70 to 200 km $\rm{s^{-1}}$ whereas the tori are found to expand rather slowly, in the order of 15 to 25 km $\rm{s^{-1}}$. The results of this work strongly indicate the importance of evaluating the true structure of compact PNe for statistical studies that consider the different morphological classes for evolution and population synthesis studies. Given the distance to the galactic bulge, there is a large population of unresolved PNe there that need to be investigated in detail. Whether the fact that all the compact PNe studied here turned out to have a WR-type nucleus has an statistical significance for the bulge PNe with collimated bipolar outflows or not deserves further investigation. Likewise a detailed reinvestigation of the kinematics of PN with WR--type nucleus such as the work of Medina et al. (2006) with spatially resolved, long slit spectra of higher spectral resolution should turn fruitful results and possibly establish a stronger link between PNe with WR--type nuclei and fast, collimated, bipolar outflows. It is also interesting to note that Lopez et al. (2011) associate toroidal structures with close binary central stars and Miszalski (2011) also associates bipolar outflows with close binary nuclei in PNe. Given the characteristics of the present sample, it would be interesting to search for the presence of binary nuclei in these objects. \\ \\ \\ We acknowledge the financial support of DGAPA-UNAM through grants IN110011 and IN100410. S. A. gratefully acknowledges a postdoctoral scholarship from DGAPA-UNAM. The authors are grateful to the anonymous referee for his valuable comments and suggestions. \bibliographystyle{mnras}

Introduction {#Sec1} ============ Fodder tree harvesting is undertaken in a wide range of systems in Africa (Franzel et al. [@CR23]). For instance, in the parklands of West Africa, more than 70 tree species are used for this purpose (Ouedrago et al. [@CR44]). As most tree leaves have high nitrogen content compared with grasses, they augment the low nutritional value of crop residues and natural pastures which are the base for livestock production in Africa (Mekoya [@CR36]). Fodder trees are also used to meet production shortages in pasture in times of extreme climatic conditions such as droughts (Franzel et al. [@CR23]; Balehegn et al. [@CR4]). There has been an increasing interest in fodder trees and their potential to help the rural poor as they have a positive effect on milk production in livestock and hence local income generation (Chakeredza et al. [@CR11]; Place et al. [@CR47]). Several studies from across Africa have documented the positive impacts of fodder trees on human livelihoods (e.g. Franzel [@CR22] in Kenya, Tanzania and Zambia; Wambugu et al. [@CR58] across East Africa; Toth et al. [@CR56] in Malawi). Incorporating this type of trees into agro-silvopastoral systems can also contribute to environmental rehabilitation, e.g. improving soil fertility (Moreno and Obrador [@CR38]). In particular, their inclusion in agro-silvopastoral systems has recently gained prominence as a sustainable and climate resilient livestock production system (Mosquera-Losada et al. [@CR39]; Balehegn [@CR2]). Despite their ecological and economic potential, limited research attention has been given to indigenous fodder trees, compared to exotic species (Le Houèrou [@CR28]). Most indigenous fodder trees are multipurpose and provide multiple benefits and services (e.g. food, fibre, medicine, fire-wood) (Balehegn and Eniang [@CR3]). Indigenous fodder species are often preferred by local farmers over exotic species for being of low cost (seeds or seedlings can be collected the wild), available and accessible to local communities, adapted to local environmental conditions (requiring little or no management input), and resistant to diseases and parasites (Le Houèrou [@CR28]; Bayala et al. [@CR6]). One aspect of indigenous fodder trees which remains understudied is the impacts on plant populations when harvesting from the wild. Wild plant extraction affects the rates of survival, growth and reproduction of harvested individuals (Ticktin [@CR55]). Delays in growth, fruit and seed production, and subsequent regeneration or sprouting, are typical because plant resources (e.g. nutrients) are relocated from reproduction to healing the 'wounds' created from harvesting (Hall and Bawa [@CR25]). These changes can in turn affect the structure and dynamics of harvested plant populations (Ticktin [@CR55]). Slow-growing old-growth tree forest species that occur in low densities and multipurpose tree species are particularly vulnerable to overharvesting (Peters [@CR45]; Gaoue and Ticktin [@CR24]; Houehanou et al. [@CR26]). Harvesting wild plants may also affect forest structure and composition (Ticktin [@CR55]), and forest carbon stocks. While logging is known to affect forest carbon stocks (Nepstad et al. [@CR40]), it has been reported that the removal of small stems for firewood does not significantly influence forest carbon stocks (Lung and Espira [@CR31]), because large stems contribute towards most forest carbon (Marshall et al. [@CR33]). If the shrubs or trees harvested for fodder are small individuals, it is also likely that their removal does not affect forest carbon stocks. Yet, to our knowledge, no study has empirically assessed if this is the case. Considering the increasing interest in carbon finance mechanisms for montane forests in East Africa, this is an important research question. In Africa, many people depend on both lowland and montane forests for their livelihoods (Fisher et al. [@CR20]; [@CR21]). Before indigenous fodder tree harvesting from the wild is further promoted or limited (e.g. under the establishment of a carbon project) we need to understand which species are being used, how are they harvested and the impacts of this harvesting. As highlighted by Swaine et al. ([@CR54]), our current understanding about tropical forest dynamics, much of which has been developed in wet lowland forests, is not always applicable to the tropical forests found at higher elevations in East Africa. The main objectives of this study, focused on three montane forests in Kenya, were to assess: (1) which fodder species and techniques were used, (2) if fodder tree harvesting negatively affected the species populations' involved, and (3) if it significantly reduced forest live tree carbon stocks. We then discuss the implications of the findings for forest management, including reforestation and carbon projects. Materials and methods {#Sec2} ===================== Study area {#Sec3} ---------- This study focused on three isolated forested mountains in northern Kenya: Mt Nyiro (2752 m), Mt Kulal (2285 m) and Mt Marsabit (1707 m) (Fig. [3](#Fig3){ref-type="fig"} Appendix). Most of northern Kenya is characterized by lowland terrain classified as very arid with annual rainfall between 150 and 350 mm (zone VII, Sombroek et al. [@CR51]). However, the mountains we studied are much wetter and cooler, with annual rainfall between 800 and 1400 mm (semi-humid area, zone III Sombroek et al. [@CR51]). Rainfall is concentrated in two wet seasons, from March to May and from October to December, but there is great inter-annual variation with some years having one or no rainy season. All three mountains support similar vegetation types. From lower to higher altitudes, forests can be divided into: (1) 'dry montane forest' (*Croton megalocarpus* Hutch.- *Olea europaea* subsp. *cuspidata* (Wall. and G.Don) Cif. forest association in Mt Marsabit or *O. europaea*-*Juniperus procera* Hochst. ex Endl. forest association in Mt Kulal and Mt Nyiro), (2) 'mixed species forest' (with abundant *Cassipourea malosana* (Baker) Alston and *Olea capensis* L. in all mountains) and (3) 'elfin-like forests' (short trees with twisted stems covered with mosses and lichens) (Bussmann [@CR10]). Because of its lower altitude, no elfin-like forests are found in Mt Marsabit. Some large grassy clearings are also found on top of Mt Kulal and Mt Nyiro. Mt Nyiro, Mt Kulal and Mt Marsabit are part of the Eastern Afromontane Biodiversity Hotspot (Bird Life International [@CR8]). Mt Marsabit is a national park, Mt Nyiro is a forest reserve and Mt Kulal is a community forest. Management guidelines for Mt Marsabit allow free access for non-timber products, but grazing and fodder tree harvesting are restricted to drought events and firewood collection is illegal. Access to Mt Nyiro and Mt Kulal forests is not restricted. Apart from being a dry season grazing ground, they are an important source of firewood and other non-timber forest products (NTFPs) (Cuni-Sanchez et al. [@CR15]). Mt Marsabit forest is an important elephant habitat (Ngene et al. [@CR41]), but there are no elephants on Mt Kulal or Mt Nyiro. Commercial logging never occurred on these mountains because of the steep terrain and remoteness of the area. Mt Nyiro and Mt Kulal are only populated by Samburu pastoralists while different ethnic groups inhabit Mt Marsabit (Fig. [3](#Fig3){ref-type="fig"} Appendix). Herd composition is similar across mountains; people prefer cows over goats for cultural reasons, and sheep are rare. Herd size depends upon household income (i.e., richer people owning more cows) and does not depend upon mountain or ethnic group (unpublished questionnaires). Patterns of fodder harvesting {#Sec4} ----------------------------- Focus-group discussions (FGDs) were organized in twelve permanent villages located around each of the three mountains (3 × 12 = 36, Fig. [3](#Fig3){ref-type="fig"} Appendix) between October and December 2015. This encompassed all major permanent villages in each mountain. Each FGD involved 5--10 male elders including the village chief, as it is a custom in the area. Participants were selected on a voluntary basis after they were explained the purpose of our study. FGDs were facilitated and translated by a person of the same ethnicity of FGD we were working with. All participants in this study were male. As males are generally in charge of herd feeding and because of time constraints, we did not organize a female FGD in each village (note that in the study area females do not talk openly in front of males due to cultural norms). FGDs centered on five topics: the most important fodder trees, their uses, current harvesting techniques, time of the year when fodder tree harvesting takes place and perceptions of the status of their populations (increasing/steady/declining). All plant species mentioned in a FGD were collected for identification and verification of their local name at the Herbarium of University of Nairobi. Field observations were also made in each forest to determine if the plants mentioned in FGDs were present and how they were being collected. Species presence in a mountain and their conservation status were also checked with the literature (e.g. Beentje [@CR7]). In Mt Kulal the Samburu name 'sagumai' was used for two species: *Gymnosporia heterophylla* (Eckl. and Zeyh.) Loes. (synonym = *Maytenus heterophylla*) and *Maytenus undata* (Thunb.) Blakelock. To simplify, *Gymnosporia heterophylla* is used throughout the text, as this species was more abundant. Population density and structure were only assessed for the most important fodder species, i.e. those mentioned in a larger number of FGDs in each mountain. *Prunus africana* (Hook.f.) Kalkman only used for fodder in Mt Nyrio, was also studied because it is listed as vulnerable by the IUCN Red List of Threatened Species. The bark of this species is traded internationally for its use against benign prostatic hyperplasia (Stewart [@CR53]). Population density and structure {#Sec5} -------------------------------- We studied species' density and population structure, as population structure assessments are known to be cost-effective means of providing useful data on the impact of harvesting and other disturbances, contributing to the development of effective management strategies (Botha et al. [@CR9]). Three permanent 0.2 ha rectangular plots (20 × 100 m) were established perpendicular to the main slope in each forest type encountered in each mountain (n = 9 in Mt Kulal, n = 9 in Mt Nyiro but n = 6 in Mt Marsabit, as there is no elfin forest in this mountain). Plots were located \< 100 m from footpaths, which is likely to be representative of an average forest utilization area. Humans access most parts of these forests to collect medicinal plants, travel between villages and allow their cows to reach water points, etc. The only parts of these forests with little human presence and no plant harvesting are very steep rocky areas. Fewer larger rectangular plots were preferred over many small plots because these are better for tree growth monitoring (e.g. Gaoue and Ticktin [@CR24]), which was also an objective of our research for the future (in 5 years). In each plot, tree diameter at 1.3 m along the stem from the ground (or above buttresses if present) and tree height (measured using a handheld laser Nikon Forestry Pro) of each tree ≥ 10 cm diameter were recorded following RAINFOR protocols ([www.rainfor.org](http://www.rainfor.org)), and stems were identified to species where possible. Standing dead trees ≥ 10 cm diameter were also recorded. Stem density (number trees ha^−1^) included all trees ≥ 10 cm diameter. In the plots, we assessed trees ≥ 10 cm diameter because locals mentioned not harvesting branches/bark from small trees so that '*they can grow*' (participant comments during FGDs). Standing dead trees ≥ 10 cm diameter of *Rinorea convallarioides* Eyles, which have a characteristic yellowish color (Fig. [1](#Fig1){ref-type="fig"}) and were particularly abundant in Mt Marsabit, were used to compute dead stems ha^−1^ for this species. For the other species, standing dead stems were found to be \< 1 stem ha^−1^ and are not reported in Table [1](#Tab1){ref-type="table"}. Fig. 1From top to bottom clockwise: (**i**) fodder tree harvesting of *Pavetta gardeniifolia* in Mt Kulal (small branches cut, note how dry is the grassland on top of the mountain during the dry season), (**ii**) fodder tree harvesting of understory *Rinorea convallarioides* in Mt Marsabit (note number of dead yellowish stems of this species), (**iii**) fodder tree harvesting of canopy *Olea capensis* in Mt Kulal (see few branches unharvested on top trees, background of the picture, Samburu pastoralist family in front); and (**iv**) fodder tree harvesting of understory *Xymalos monospora* in Mt Nyiro (note stems pruned \> 6 m, right side picture) Table 1General information about the species studied, mountains where they are found, preference as fodder tree (first/second/third best species for fodder), other uses, perception of declining populations, forest types where it can be found, stem density, percentage of severely pruned trees, dead trees and size-class distribution (SCD) slopesSpeciesMountainFodder treeUsesPerception of declining populationsForest typesStem density (stems ha^−1^)Severely pruned trees (%)Dead trees (stems ha^−1^)SCD slopes*Olea capensis*Mt NyiroFirstFodder, firewoodYesDry, mixed, elfin10--13011− 1.27Mt KulalFirstFodder, firewood, polesNoDry, mixed, elfin10--1102− 1.47Mt MarsabitThirdFodder onlyNoMixed10--1150− 1.97*Olea europaea*Mt NyiroThirdFodder, firewoodNoDry95--1250− 1.40Mt KulalFirewood, poles, (fodder)NoDry30^a^0naMt MarsabitThirdFodder, firewood, poles, food, medicineYesDry10--2000.01*Xymalos monospora*Mt NyiroSecondFodder, polesNoMixed, elfin145--28570− 2.92Mt KulalNoMixed, elfin15--1050− 1.87*Prunus africana*Mt NyiroFodder, firewoodNoMixed, elfin10--200− 0.40Mt KulalNoElfin30--950− 1.43*Pavetta gardeniifolia*Mt KulalThirdFodder onlyNoDry, mixed, elfin15--1350− 3.75*Gymnosporia heterophylla*Mt KulalSecondFodder onlyNoElfin25--450na*Rinorea convallarioides*Mt MarsabitSecondFodder onlyYesMixed50--125220--85− 3.17*Drypetes gerrardii*Mt MarsabitFirstFodder, firewood, polesNoDry, mixed70--4005na^a^Refers to only one plot sampled had this species, na: non-available*na* non-available To allow for visual comparisons of population structure, size-class distributions (SCDs) were constructed and displayed graphically. Size-classes were determined as 5 cm increments in tree diameter for all species except for *R. convallarioides* (for which 2 cm classes were used) as all stems of this species were \< 20 cm in diameter. SCD slope was also used as indicators of population trends. A least-squares linear regression was performed on the data of the SCD, with size-class midpoint (ln transformed) as the independent variable and the average number of individuals per size-class (ln (Ni + 1)) as the dependent variable, as described in Lykke ([@CR32]) and Condit et al. ([@CR14]). In general, negative SCD slopes indicate good recruitment, flat slopes indicate equal numbers of individuals in small and large size-classes and positive slopes indicate poor recruitment (Obiri et al. [@CR43]). The extent of fodder tree harvest was assessed on a categorical scale with two classes: severely pruned (top of main stem cut) and non-severely pruned (top of main stem not cut). The category 'non-severely pruned' included trees with partial pruning (cutting of some branches) and trees with no pruning, as it was difficult to distinguish one from another especially for tall individuals and individuals with large crowns. For each species, the percentage of trees being severely pruned was computed. After sampling the plots in Mt Marsabit, we realized that only six individuals of *Olea europaea* had been sampled, which did not allow for the construction of SCD. As this species was mentioned as being in decline by local communities (see results), we identified two locations in the eastern part of the forest where this species was relatively abundant, we sampled 125 individuals in each and we computed SCD with this data. Fodder tree harvesting might not be the only factor affecting the species' populations studied. Wood harvesting for firewood, medicinal plant collection, illegal logging, grazing of seedlings by wild or domestic animals, and droughts (among others), might also be affecting these tree species' populations. FGDs provided insights into human uses (other than fodder). Because of the remoteness of these mountains, no fodder species studied is commercially traded outside each mountain (FGDs comments and personal observations). For instance, no *Prunus africana* bark reaches Nairobi herbal market (Delbanco et al. [@CR17]). With regard to wild animals, elephants do not target the fodder species we studied (Marsabit NP ranger comment, 2015). Only two individuals of *Drypetes gerrardii* Hutch. had been felled by elephants in our plots in Mt Marsabit. We were unable to assess seedling and saplings in our plots because of the difficulty in finding them during the period in which fieldwork took place (after a long dry season). Although seedling browsing by goats or cows can affect seedling presence, we did not see seedlings even in steep slopes with no browsing. Lack of seedlings might be related to reduced fog presence in these mountains (see Cuni-Sanchez et al. in press). Forest carbon stocks {#Sec6} -------------------- Above ground live tree carbon stocks (AGC) were calculated: (1) including severely pruned trees (named AGC pruned) and (2) including the potential height of these severely pruned trees had they not been pruned (named AGC non-pruned). First, the above ground biomass (AGB) of each tree in the plot was estimated using the Chave et al. ([@CR13]) equation including diameter, wood mass density and tree height. The best taxonomic match wood mass density of each stem was extracted from a global database (Chave et al. [@CR12]; Zanne et al. [@CR61]) following Lewis et al. ([@CR30]). Then, AGB was converted to AGC using the carbon fraction 0.47 (Martin and Thomas [@CR34]). Although carbon fraction varies among species (e.g. Weber et al. [@CR59]) we did not consider this variation as it was beyond the scope of this study. For AGC pruned, tree height measured in the field of the severely pruned trees was used. For AGC non-pruned, the potential heights of these stems were calculated as follows. First, the relationship between tree diameter and height was established using a Power-model (see Feldpausch et al. [@CR19]), for each forest type in each mountain separately (as climate and population origin can shape height-diameter allometry e.g. Vizcaino-Palomar et al. [@CR57]). Then, these relationships were used to estimate tree height for the trees with severely pruned stems. R statistical software R v3.2.1 and RStudio v.0.99.447 were used for all statistical analyses (R Core Team [@CR48]). Differences in AGC were tested using paired t-tests. Results {#Sec7} ======= Patterns of fodder harvesting {#Sec8} ----------------------------- The preferred species for fodder were *Olea capensis, O. europaea* and *Xymalos monospora* (Harv.) Baill. in Mt Nyiro, *O. capensis, Pavetta gardeniifolia* Hochst. ex A.Rich. and *Gymnosporia heterophylla* in Mt Kulal, and *Drypetes gerrardii, Rinorea convallarioides, O. europaea* and *O. capensis* in Mt Marsabit (Table [1](#Tab1){ref-type="table"}). Most species mentioned were multipurpose, with *O. europaea* having several uses in Mt Marsabit (Table [1](#Tab1){ref-type="table"}). Interestingly, *X. monospora* and *Prunus africana* were used for fodder in Mt Nyiro but not in Mt Kulal, despite these two species being abundant in Mt Kulal and both mountains being populated by the same ethnic group. In Mt Nyiro local populations perceived that *O. capensis* populations were declining (Table [1](#Tab1){ref-type="table"}), as some adult trees were dying and there was little natural regeneration (FGD participants' comments). Participants mentioned that '*O. capensis dries up when it is cut too much while X. monospora can be pruned more intensively as it resprourts easily*'. In Mt Marsabit it was perceived that *O. europaea* and *R. convallarioides* populations were declining (Table [1](#Tab1){ref-type="table"}), as some adult trees were dying and there was little natural regeneration for *O. europaea* (FGD participants' comments). Some participants mentioned that in Mt Marsabit *'most tree species' populations are declining because of overexploitation but the situation is worse for O. europaea as it has many uses*'. With regard to *R. convallarioides*, it was mentioned that '*few individuals of this species sprout and now there are many droughts and more people so this species has no time to recover* \[after drought events during which many stems are cut\]'. No species was perceived as declining in Mt Kulal. Fodder tree harvesting was carried out in different ways using different techniques depending on the species: cutting some branches, cutting the main stem, or cutting most branches except the stem apex.(Figure [1](#Fig1){ref-type="fig"}). Some branches: for *O. europaea* and *P. africana*, which tend to be large individuals, male herders climb them to cut a few branches (male as this requires physical strength, not because it is taboo for women). For *Gymnosporia heterophylla, Pavetta gardeniifolia* and *Drypetes gerrardii,* which tend to be smaller individuals, both male and female herders cut a few branches. Main stem: male/female herders cut whole stems of two species: *R. convallarioides* and *X. monospora.* For *R. convallarioides,* stems are generally cut about 1.5 m from the ground. For *X. monospora* trees, which are often multi-stemmed, stems are generally cut about 5 m from the ground. Most branches except stem apex: for *O. capensis,* carried out by males (as this requires physical strength). For this species, trees which are pruned at 75--99% of their crown cover still possess a few top branches that have leaves (Fig. [1](#Fig1){ref-type="fig"}). Leaving these top branches is a traditional practice said to allow the tree to grow and reproduce. With regard to time of the year when fodder tree harvesting takes place, clear differences were observed between mountains. In Mt Kulal and Mt Nyiro it was mentioned that fodder tree harvesting was only necessary at the end of the dry season of some years (drought years) as the large grassy clearings on top of Mt Kulal and Mt Nyiro provided enough pasture. In these two mountains most families bring their animals to the lowlands during the rainy season so that grass can regenerate on the mountains, and the grassy clearings on top are only used during the dry season. In Mt Marsabit it was also mentioned that fodder tree harvesting was only necessary during drought events, during which *R. convallarioides* trees were cut in great numbers. However, field observations and further discussions with some herders indicated that fodder tree harvesting in Mt Marsabit was carried out every dry season (two dry seasons per year) as there was no pasture left outside the forest during the dry seasons. During these dry seasons the only sources of water (wells) are located inside the forest and herders cut branches of trees on the way to these wells. Some villages have to cross \> 2 km of forest to reach the well they use, offering a great opportunity for fodder tree harvesting along the path. This bi-annual fodder tree harvesting is of questionable legitimacy and local people know this, which explains why this was not discussed openly in the FGDs. Species' populations {#Sec9} -------------------- In all mountains studied, *O. capensis* was found at variable densities in all forest types, while *O. europaea* was only found in dry forests and was more abundant in Mt Nyiro (Table [1](#Tab1){ref-type="table"}). *P. africana* was more abundant in Mt Kulal (where it is not used for fodder) than in Mt Nyiro, (where it is used for fodder, see Table [1](#Tab1){ref-type="table"}). In contrast, *X. monospora* was more abundant in Mt Nyiro (where it is used for fodder) than in Mt Kulal (where it is not used for fodder, see Table [1](#Tab1){ref-type="table"}). The other species assessed had variable densities, with *D. gerrardii* being highly abundant in Mt Marsabit (Table [1](#Tab1){ref-type="table"}). Fodder tree harvest pressure was particularly high for *X. monospora* in Mt Nyiro, with 70% of trees being severely pruned (Table [1](#Tab1){ref-type="table"}). Severe pruning affected all diameter classes (Fig. [4](#Fig4){ref-type="fig"} Appendix). With regard to other species, 11% and 2% of *O. capensis* trees were severely pruned in Mt Nyiro and Mt Kulal (respectively), while 5% and 2% of *D. gerrardi* and *R. convallarioides* (respectively) trees were severely pruned in Mt Marsabit (Table [1](#Tab1){ref-type="table"}). In Mt Marsabit a high density of standing dead trees of *R. convallarioides* was observed (Table [1](#Tab1){ref-type="table"}), which was related to overharvesting as reported in FGDs. The population structure of most species studied followed a reverse J, with more individuals in smaller size classes than larger ones (Fig. [2](#Fig2){ref-type="fig"}). The exceptions were (1) *P. africana* and *O. capensis* in Mt Kulal and Mt Nyiro, for which some middle-size diameter classes had more individuals than smaller ones, and (2) *O. europaea* in Mt Marsabit, which had a bell-shaped SCD with no individuals in several small size classes (Fig. [2](#Fig2){ref-type="fig"}). SCD slopes were negative for most species, which indicates a good recruitment (Table [1](#Tab1){ref-type="table"}). The exceptions were *P. africana* in Mt Nyiro (slope was close to 0) and *O. europaea* in Mt Marsabit, which had a flat slope.Fig. 2Size class distribution of *Olea capensis, Xymalos monospora, Prunus africana, O. europaea, Gymnosporia heterophylla, Pavetta gardeniifolia, Drypetes gerrardii,* and *Rinorea convallarioides* for Mt Kulal (black), Mt Nyiro (light grey) and Mt Marsabit (dark grey). Note that if a species was not found in a mountain it is not included in the figure (with exception of *O. europaea* for which only 6 individuals were sampled in Mt Kulal and its size class distribution could not be computed). In total we sampled the following number of individuals (K = Kulal, N = Nyiro, M = Marsabit): Olea capensis (K = 59, N = 73, M = 50), Xymalos monospora, (K = 79, N = 242), Prunus africana (K = 43, N = 44), O. europaea (N = 65, M = 250), Gymnosporia heterophylla (K = 32), Pavetta gardeniifolia (K = 77), Drypetes gerrardii (M = 242) and Rinorea convallarioides (M = 49) Forest carbon stocks {#Sec10} -------------------- The differences in AGC between AGC pruned and AGC non-pruned ranged between 0.1 and 4.7% (Table [2](#Tab2){ref-type="table"}). Mixed and elfin forests in Mt Nyiro, with numerous individuals of the abundant *X. monospora* tree being severely pruned, were the forest types with greater decrease in AGC (2.5 and 4.7% respectively, Table [2](#Tab2){ref-type="table"}). These differences were not significant at *p* \< 0.05.Table 2Above ground live tree carbon stocks (AGC) including severely pruned fodder trees (named AGC pruned), AGC if these trees had not been pruned (named AGC non-pruned), relative change in AGC; and fodder tree dominance (in terms of stem density) for the different types of forests studiedMountainForest typesAGC prunedAGC non-prunedChange AGC (%)Fodder trees amongst the dominant species(Mg C ha^−1^)(Mg C ha^−1^)Mt MarsabitDry54.9 ± 7.855.2 ± 7.70.6 ± 0.5*Drypetes gerrardii*Mixed94.9 ± 26.795.8 ± 26.11.1 ± 1.3*Drypetes gerrardii, Olea capensis, Rinorea convallarioides*Mt KulalDry73.6 ± 14.773.9 ± 15.10.4 ± 0.6*Olea capensis*Mixed145 ± 32.6146.2 ± 33.40.7 ± 0.7*Xymalos monospora, Pavetta gardeniifolia*Elfin74.5 ± 0.874.5 ± 0.80.1 ± 0.1*Xymalos monospora*Mt NyiroDry113.2 ± 26.3113.6 ± 26.40.3 ± 0.1*Olea europaea, Olea capensis*Mixed281.3 ± 62.7287.5 ± 57.42.5 ± 3.7*Xymalos monospora*Elfin183.4 ± 82.7191.9 ± 85.64.7 ± 1.5*Xymalos monospora* Discussion {#Sec11} ========== Patterns of fodder harvesting {#Sec12} ----------------------------- The main tree species used for fodder harvesting differed between mountains, despite Samburu pastoralists living around all three mountains, and all having more cows than goats and no sheep. Ethnicity is known to affect the choice of useful plant species and even plant parts of the same species (Assogbadjo et al. [@CR1]; Sop et al. [@CR52]). While species abundance and availability of alternatives affects the choice of preferred species for certain use (Jusu and Cuni-Sanchez [@CR27]), our results also highlight that local preferences matter. Some of these local preferences can be explained by the harvesting techniques needed for fodder tree harvest ('*it is easier to cut the stem of a small R. convallaroides tree than climb tall O. capensis to cut a few branches'*, participant comment in Mt Marsabit). In other cases local preferences are more difficult to explain: e.g. *X. monospora* and *P. africana* are relatively abundant in Mt Kulal and Samburu herders do not use it for fodder, despite Samburu herders in Mt Nyiro, 50 km away, doing so. *O. capensis, O. europaea* and *Maytenus undata* were also amongst the most important fodder trees in Ethiopia (Mekoya et al. [@CR100]; Balehegn et al. [@CR4]). Fodder tree harvesting techniques differed between species. While for most species a few branches were cut, two species were often severely pruned: *X. monospora* in Mt Nyiro and *R. convallaroides* in Mt Marsabit (in the latter case main stem is cut). Interestingly, some *O. capensis* trees had their top branches unpruned. A similar pattern has been observed when Fulani herders harvest fodder tree of *Khaya senegalensis* (Desv.) A.Juss., an important fodder tree in West Africa (Gaoue and Ticktin [@CR24]). Like for *K. senegalensis*, *O. capensis* were generally either totally pruned or else not harvested at all. This is likely because pruning trees is a dangerous activity (Petit [@CR46]) that requires skill and experience. Large trees with tall and straight trunks are difficult to climb, and according to herders, only courageous and experienced male harvesters exploit them. For these large trees, harvesters maximize the amount of fodder harvested for each tree and thereby reduce the number of trees they need to climb. With regard to size of the trees harvested, harvesters in our study did not prefer particularly large trees. This is different from other studies where harvesters tend to prefer larger trees: e.g. Gaoue and Ticktin ([@CR24]) for *Khaya senegalensis* or Shackleton et al. ([@CR50]) for a number of multipurpose tree species. Impacts on species' populations {#Sec13} ------------------------------- The population structure of two species studied (*O. europaea* in Mt Marsabit and *P. africana*) did not follow a reverse J, suggesting that fodder tree harvesting (combined with other uses) might be having a negative effect on these species' populations. For *O. europaea* in Mt Marsabit, it is likely that it is the combination of fodder and firewood harvesting that is affecting this species. Although firewood harvesting has been strictly prohibited for a number of years in Masrabit national park, law has only been enforced since 2012, and some illegal extraction continues (personal observations). Greater law enforcement, increased community awareness about the need to sustainably manage canopy forest species and other conservation measures might be needed for this species (e.g. enrichment planting). For *P. africana*, fodder harvesting might not be the problem, as *P. africana* populations were similar (with no individuals in several small size classes) in Mt Kulal and Mt Nyiro, despite this species having no use in Mt Kulal. A similar SCD has been reported from dry and intermediate montane forests in Mt Kenya (where its bark is commercialized as medicine, Nguta [@CR42]), and in The Bale Mountains in Ethiopia (where it is a valuable timber species, Young et al. [@CR60]). A review of different studies in Ethiopia showed that there is a need to clarify the natural reproductive strategy of this species (Young et al. [@CR60]), as episodic recruitment might not be related to anthropogenic activities. This species might require special conditions for successful reproduction (e.g. a particularly wet year). Interestingly, local populations did not mention 'declining populations' for this species. The population structure of the other six species studied followed a reverse J, suggesting that fodder tree harvesting (combined with other uses for some species) is not currently having a negative effect on these species' populations. Presumably, such populations are relatively stable and, therefore, these species probably are not of urgent conservation concern in the forests studied, with the exception of *R. convallaroides*. *R. convallaroides* is often severely pruned, it does not sprout and local communities mentioned 'declining populations'. If we had assessed smaller diameter classes (\< 10 cm diameter), or seedlings and saplings, the population structure might have indicated a lack of regeneration. The same applies to *O. capensis*. More research is needed on these two species, so that their conservation status and management strategy can be clearly defined. Overall, it should be highlighted that several factors (harvesting techniques, intrinsic characteristics of the species, other uses) should be considered while trying to relate species' population structure to the impacts of wild harvesting. For instance, although *X. monospora* was severely pruned, fodder harvesting did not seem to negatively affect this species' populations, as it is often multi-stemmed, and it re-sprouts easily. Other studies have highlighted the importance of considering intrinsic characteristics to the species when assessing the impacts of harvesting on plant populations (e.g. Schumann et al. [@CR49]). Our findings can also help suggest species for reforestation programs in montane forests. Instead of planting exotic species such as *Eucalyptus* spp., indigenous multipurpose trees could be used. Several studies have shown that indigenous trees are more useful to rural communities than exotic species (e.g. Faye et al. [@CR18]), and can exhibit growth rates comparable to non-native species (e.g. Bare and Ashton [@CR5]). Among the species we studied, *X. monospora* seems to be a good candidate, as it can withstand severe pruning. This species can be grown from seed, and although germination is slow, the germination rate is quite high (Mojeremane [@CR37]). The potential of this species has already been highlighted by other authors, in view of its prospects and multiple uses, including timber, medicine and edible fruits (Mojeremane [@CR37]). Impacts on forest carbon stocks {#Sec14} ------------------------------- Fodder tree harvesting did not significantly affect forest carbon stocks, even in Mt Nyiro where \> 70% of the dominant *X. monospora* trees were severely pruned. This result is related to the fact that *X. monospora* is a medium-sized understory tree and in this forest most carbon is stored in large trees. For example, in Mt Nyiro, *Podocarpus latifolius* (Thunb.) R.Br. ex Mirb. and *Faurea saligna* Harv. are the largest canopy trees, some of which being \> 1 m diameter (personal observations.). Our finding that fodder tree harvesting did not significantly affect total forest carbon stocks is similar to that of Lung and Espira ([@CR31]) which reported that the removal of small stems for firewood does not significantly influence forest carbon stocks in Kakamega, a transitional moist forest in western Kenya. Implications of the findings and conclusions {#Sec15} -------------------------------------------- Eight tree species were commonly harvested for fodder using different techniques (some branches, main stem, most branches except stem apex). Results indicate that fodder tree harvesting (together with other uses for some species) negatively affected one species (*O. europaea*), did not negatively affect four species, and more information is needed for three other species (*P. africana, O. capensis, R. convallaroides*). Harvesting techniques used, the intrinsic characteristics of the species, and the effect of other uses/factors should be considered when assessing the impacts of plant harvesting from the wild. Among the species we studied, *X. monospora* seems to be a good candidate for reforestation programs, as it can be easily propagated from seed, it is multipurpose and can withstand severe pruning (Mojeremane [@CR37]). With regard to the effects on carbon stocks, fodder tree harvesting did not significantly reduce forest carbon stocks. This suggests that local communities could continue to use these fodder trees even if a carbon project is established, which is particularly important as local communities, who are pastoralists, rely on these forests for their livelihoods (Cuni-Sanchez et al. [@CR15]). Although our study is only a snapshot of current population structure of the studied species, it is a baseline which can be used to monitor changes in fodder harvesting and its impacts related to increasing droughts in northern Kenya and increasing human populations (especially around Mt Marsabit). Future studies could focus on quantifying how much tree fodder is harvested during each major drought event, and how this affects species' population structure. Appendix {#Sec16} ======== See Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}.Fig. 3Selected mountains in northern Kenya and villages where focus-group discussions were organized with regard to main ethnic groups in the area. Black lines refer to major roads, dark grey areas to forests and red dots to villages studied Fig. 4Percentage of severely pruned trees (black) and non-severely pruned trees (grey) of *Xymalos monospora* in Mt Nyiro We are deeply grateful to our study participants, who graciously shared their time, energy, and stories. We are thankful to our field assistants and translators A.M. Aide, H. Lerapo, J. Harugura, M. Galgalo, R.A. Wamuro, S. Wasapicho, J. Lekatap and L. Lemooli for making this research possible, and to P.Ch. Mutiso at the School of Biological Sciences, University of Nairobi, for helping with plant identification. We also thank the kind support given by M. Kirimama, L. Olaka, B. Mamo and NEMA Marsabit Office, T. Kinyua and WARMA Marsabit Office, S. Rucina and NMK, A-S. Delbanco, C.L. Sørensen, P.V. Pompeu and the British Institute in Eastern Africa (BIEA). This research was funded by Marie Curie Actions Intra-European Fellowships (IEF), number 328075, and by the Percy Sladen Fund (the Linnaean Society of London). M.P. is supported by European Research Council Project number 281986.

\section{Introduction} \label{sec:intro} Given query access to a function $f: {\mathbf D} \mapsto {\mathbf R}$, the field of \emph{property testing}~\cite{RS96,GGR98} deals with the problem of determining properties of $f$ without reading all of it. Monotonicity testing~\cite{GGLRS00} is a classic problem in property testing. Consider a function $f: {\mathbf D} \mapsto {\mathbf R}$, where ${\mathbf D}$ is some partial order given by ``$\prec$", and ${\mathbf R}$ is a total order. The function $f$ is monotone if for all $x \prec y$ (in ${\mathbf D}$), $f(x) \leq f(y)$. The \emph{distance to monotonicity} of $f$ is the minimum fraction of values that need to be modified to make $f$ monotone. More precisely, define the distance between functions $d(f,g)$ as $|\{x: f(x) \neq g(x)\}|/|{\mathbf D}|$. Let ${\cal M}$ be the set of all monotone functions. Then the distance to monotonicity of $f$ is $\min_{g \in {\cal M}} d(f,g)$. A function is called $\varepsilon$-far from monotone if the distance to monotonicity is at least $\varepsilon$. A \emph{property tester for monotonicity} is a, possibly randomized, algorithm that takes as input a distance parameter $\varepsilon \in (0,1)$, error parameter $\delta \in [0,1]$, and query access to an arbitrary $f$. If $f$ is monotone, then the tester must accept with probability $>1-\delta$. If it is $\varepsilon$-far from monotone, then the tester rejects with probability $>1-\delta$. (If neither, then the tester is allowed to do anything.) The aim is to design a property tester using as few queries as possible. A tester is called \emph{one-sided} if it always accepts a monotone function. A tester is called \emph{non-adaptive} if the queries made do not depend on the function values. The most general tester is an adaptive two-sided tester. Monotonicity testing has a rich history and the hypergrid domain, $[n]^d$, has received special attention. The boolean hypercube ($n=2$) and the total order ($d=1$) are special instances of hypergrids. Following a long line of work~\cite{EKK+00, GGLRS00,DGLRRS99,LR01,FLNRRS02,AC04,E04,HK04,PRR04,ACCL04,BRW05,BBM11}, previous work of the authors~\cite{ChSe13} shows the existence of $O(\varepsilon^{-1} d\log n)$-query monotonicity testers. Our result is a matching adaptive lower bound that is optimal in all parameters (for unbounded range functions). This closes the question of monotonicity testing for unbounded ranges on hypergrids. This is also the first adaptive bound for monotonicity testing on general hypergrids. \begin{theorem} \label{thm:main} Any (adaptive, two-sided) monotonicity tester for functions $f:[n]^d \mapsto \mathbb{N}$ requires $\Omega(\varepsilon^{-1} d\log n - \varepsilon^{-1}\log \varepsilon^{-1})$ queries. \end{theorem} \subsection{Previous work} \label{sec:prev} The problem of monotonicity testing was introduced by Goldreich et al~\cite{GGLRS00}, with an $O(n/\varepsilon)$ tester for functions $f:\{0,1\}^n \mapsto \{0,1\}$. The first tester for general hypergrids was given by Dodis et al~\cite{DGLRRS99}. The upper bound of $O(\varepsilon^{-1} d\log n)$ for monotonicity testing was recently proven in~\cite{ChSe13}. We refer the interested reader to the introduction of~\cite{ChSe13} for a more detailed history of previous upper bounds. There have been numerous lower bounds for monotonicity testing. We begin by summarizing the state of the art. The known adaptive lower bounds are $\Omega(\log n)$ for the total order $[n]$ by Fischer~\cite{E04}, and $\Omega(d/\varepsilon)$ for the boolean hypercube $\{0,1\}^d$ by Brody~\cite{Br13}. For general hypergrids, Blais, Raskhodnikova, and Yaroslavtsev~\cite{BlJh+12} recently proved the first result, a non-adaptive lower bound of $\Omega(d\log n)$. \Thm{main} is the first adaptive bound for monotonicity testing on hypergrids and is optimal (for arbitrary ranges) in all parameters. Now for the chronological documentation. The first lower bound was the non-adaptive bound of $\Omega(\log n)$ for the total order $[n]$ by Ergun et al~\cite{EKK+00}. This was extended by Fischer~\cite{E04} to an (optimal) adaptive bound. For the hypercube domain $\{0,1\}^d$, Fischer et al~\cite{FLNRRS02} proved the first non-adaptive lower bound of $\Omega(\sqrt{d})$. (This was proven even for the range $\{0,1\}$.) This was improved to $\Omega(d/\varepsilon)$ by Br\"{i}et et al~\cite{BCG+10}. Blais, Brody, and Matulef~\cite{BBM11} gave an ingenious reduction from communication complexity to prove an adaptive, two-sided bound of $\Omega(d)$. (Honing this reduction, Brody~\cite{Br13} improved this bound to $\Omega(d/\varepsilon)$.) The non-adaptive lower bounds of Blais, Raskhodnikova, and Yaroslavtsev~\cite{BlJh+12} were also achieved through communication complexity reductions. We note that our theorem only holds when the range is $\mathbb{N}$, while some previous results hold for restricted ranges. The results of~\cite{BBM11, Br13} provide lower bounds for range $[\sqrt{d}]$. The non-adaptive bound of~\cite{BlJh+12} holds even when the range is $[nd]$. In that sense, the communication complexity reductions provide stronger lower bounds than our result. \subsection{Main ideas} \label{sec:ideas} The starting point of this work is the result of Fischer~\cite{E04}, an adaptive lower bound for monotonicity testing for functions $f:[n] \mapsto \mathbb{N}$. He shows that adaptive testers can be converted to comparison-based testers, using Ramsey theory arguments. A comparison-based tester for $[n]$ can be easily converted to a non-adaptive tester, for which an $\Omega(\log n)$ bound was previously known. We make a fairly simple observation. The main part of Fischer's proof actually goes through for functions over \emph{any partial order}, so it suffices to prove lower bounds for comparison-based testers. (The reduction to non-adaptive testers only holds for $[n]$.) We then prove a comparison-based lower bound of $\Omega(\varepsilon^{-1} d\log n - \varepsilon^{-1}\log \varepsilon^{-1})$ for the domain $[n]^d$. As usual, Yao's minimax lemma allows us to prove determinstic lower bounds over some distribution of functions. The major challenge in proving (even non-adaptive) lower bounds for monotonicity is that the tester might make decisions based on the actual values that it sees. Great care is required to construct a distribution over functions whose monotonicity status cannot be decided by simply looking at the values. But a comparison-based tester has no such power, and optimal lower bounds over all parameters can be obtained with a fairly clean distribution. \section{The reduction to comparison based testers} \label{sec:prelim} Consider the family of functions $f: {\mathbf D} \mapsto {\mathbf R}$, where ${\mathbf D}$ is some partial order, and ${\mathbf R}\subseteq \mathbb{N}$. We will assume that $f$ always takes distinct values, so $\forall x,y, f(x) \neq f(y)$. Since we are proving lower bounds, this is no loss of generality. \begin{definition} \label{def:tester} An algorithm ${\cal A}$ is a \emph{$(t,\varepsilon,\delta)$-monotonicity tester} if ${\cal A}$ has the following properties. For any $f:{\mathbf D}\mapsto {\mathbf R}$, the algorithm ${\cal A}$ makes $t$ (possibly randomized) queries to $f$ and then outputs either ``accept" or ``reject". If $f$ is monotone, then ${\cal A}$ accepts with probability $>1-\delta$. If $f$ is $\varepsilon$-far from monotone, then ${\cal A}$ rejects with probability $>1-\delta$. \end{definition} \def{\tt acc}{{\tt acc}} \def{\tt rej}{{\tt rej}} \def{\mathbf x}{{\mathbf x}} \def{\mathbf a}{{\mathbf a}} Given a positive integer $s$, let ${\mathbf D}^s$ denote the collection of {\em ordered}, $s$-tupled vectors with each entry in ${\mathbf D}$. We define two symbols {\tt acc}~ and {\tt rej}, and denote ${\mathbf D}' = {\mathbf D} \cup \{{\tt acc}, {\tt rej}\}$. Any $(t,\varepsilon,\delta)$-tester can be completely specified by the following family of functions. For all $s\leq t$, ${\mathbf x}\in {\mathbf D}^s$, $y\in {\mathbf D}'$, we consider a function $p^y_{\mathbf x}:{\mathbf R}^s \mapsto [0,1]$, with the semantic that for any ${\mathbf a}\in {\mathbf R}^s$, $p^y_{\mathbf x}({\mathbf a})$ denotes the probability the tester queries $y$ as the $(s+1)$th query, given that the first $s$ queries are ${\mathbf x}_1,\ldots,{\mathbf x}_s$ and $f({\mathbf x}_i) = {\mathbf a}_i$ for $1\leq i\leq s$. By querying ${\tt acc},{\tt rej}$ we imply returning accept or reject. These functions satisfy the following properties. \begin{align} & \forall s \leq t,~ \forall{\mathbf x}\in {\mathbf D}^s,~ \forall {\mathbf a} \in {\mathbf R}^s,~ \sum_{y \in {\mathbf D}'} p^y_{\mathbf x}({\mathbf a}) = 1 \label{eqn:dist}\\ & \forall {\mathbf x}\in {\mathbf D}^t,~ \forall y \in {\mathbf D},~ \forall {\mathbf a} \in {\mathbf R}^t,~ p^y_{\mathbf x}({\mathbf a}) = 0 \label{eqn:time} \end{align} \Eqn{dist} ensures the decisions of the tester at step $(s+1)$ must form a probability distribution. \Eqn{time} implies that the tester makes at most $t$ queries. For any positive integer $s$, let ${\mathbf R}^{(s)}$ denote {\em unordered} sets of ${\mathbf R}$ of cardinality $s$. For reasons that will soon become clear, we introduce new functions as follows. For each $s$, ${\mathbf x}\in {\mathbf D}^s$, $y\in {\mathbf D}'$, and {\em each permutation} $\sigma:[s]\mapsto [s]$, we associate functions $q^y_{{\mathbf x},\sigma}:{\mathbf R}^{(s)} \mapsto [0,1]$, with the semantic $$\textrm{ For any set $S = (a_1 < a_2 < \cdots < a_s) \in {\mathbf R}^{(s)}$, } ~~~~q^y_{{\mathbf x},\sigma}(S) := p^y_{\mathbf x}(a_{\sigma(1)},\ldots,a_{\sigma(s)})$$ That is, $q^y_{{\mathbf x},\sigma_s}(S)$ sorts the answers in $S$ in increasing order, permutes it according to $\sigma$, and passes the permuted ordered tuple to $p^y_{\mathbf x}$. Any adaptive tester can be specified by these functions. The important point to note is that they are finitely many such functions; their number is upper bounded by $(t|{\mathbf D}|)^{t+1}$. These $q$-functions allow us to define comparison based testers. \begin{definition} \label{def:comp} A monotonicity tester ${\cal A}$ is \emph{comparison-based} if for all $s$,${\mathbf x}\in {\mathbf D}^s,y\in{\mathbf D}'$, and permutations $\sigma:[s]\mapsto[s]$, the function $q^y_{{\mathbf x},\sigma}$ is a constant function on ${\mathbf R}^{(s)}$. In other words, the $(s+1)$th decision of the tester given that the first $s$ questions is ${\mathbf x}$, depends only on the {\em ordering} of the answers received, and not on the values of the answers. \end{definition} The following theorem is implicit in the work of Fischer~\cite{E04}. \begin{theorem} \label{thm:fischer} Suppose there exists a $(t,\varepsilon,\delta)$-monotonicity tester for functions $f: {\mathbf D} \mapsto \mathbb{N}$. Then there exists a comparison-based $(t,\varepsilon,2\delta)$-monotonicity tester for functions $f: {\mathbf D} \mapsto \mathbb{N}$. \end{theorem} This implies that a comparison-based lower bound suffices for proving a general lower bound on monotonicity testing. We provide a proof of the above theorem in the next section for completeness. \subsection{Performing the reduction} \label{sec:comp} We basically present Fischer's argument, observing that ${\mathbf D}$ can be any partial order. A monotonicity tester is called \emph{discrete} if the corresponding functions $p^y_{{\mathbf x}}$ can only take values in $\{i/K \ | \ 0 \leq i \leq K\}$ for some finite $K$. Note that this implies the functions $q^y_{{\mathbf x},\sigma}$ also take discrete values. \begin{claim} \label{clm:discrete} Suppose there exists a $(t,\varepsilon,\delta)$-monotonicity tester ${\cal A}$ for functions $f: {\mathbf D} \mapsto \mathbb{N}$. Then there exists a discrete $(t,\varepsilon,2\delta)$-monotonicity tester for these functions. \end{claim} \def\hat{p}{\hat{p}} \begin{proof} We do a rounding on the $p$-functions. Let $K = 100t|{\mathbf D}|^{t}/\delta^2$. Start with the $p$-functions of the $(t,\varepsilon,\delta)$-tester ${\cal A}$. For $y \in {\mathbf D} \cup {\tt acc}$, ${\mathbf x}\in{\mathbf D}^s$, ${\mathbf a}\in {\mathbf R}^s$, let $\hat{p}^y_{{\mathbf x}}({\mathbf a})$ be the largest value in $\{i/K \ | \ 0 \leq i \leq K\}$ at most $p^y_{\mathbf x}({\mathbf a})$. Set $\hat{p}^{\tt rej}_{\mathbf x}({\mathbf a})$ so that \Eqn{dist} is maintained. Note that for $y \in {\mathbf D} \cup {\tt acc}$, if $p^y_{\mathbf x}({\mathbf a}) > 10|{\mathbf D}|t/(\delta K)$, then $$ \left(1 - \frac{\delta}{10|{\mathbf D}|t}\right) p^y_{\mathbf x}({\mathbf a}) ~ \leq ~\hat{p}^y_{\mathbf x}({\mathbf a})~ \leq ~p^y_{\mathbf x}({\mathbf a}).$$ Furthermore, $\hat{p}^{\tt rej}_{\mathbf x}({\mathbf a}) \geq p^{\tt rej}_{\mathbf x}({\mathbf a})$. The $\hat{p}$-functions describe a new discrete tester ${\cal A}'$ that makes at most $t$ queries. We argue that ${\cal A}'$ is a $(t,\varepsilon,2\delta)$-tester. Given a function $f$ that is either monotone or $\varepsilon$-far from monotone, consider a sequence of queries $x_1,\ldots,x_s$ after which ${\cal A}$ returns a {\em correct} decision $\aleph$. Call such a sequence good, and let $\alpha$ denote the probability this occurs. We know that the sum of probabilities over all good query sequences is at least $(1-\delta)$. Now, $$\alpha := p^{x_1}\cdot ~p^{x_2}_{x_1}(f(x_1)) \cdot~ p^{x_3}_{(x_1,x_2)}(f(x_1),f(x_2))\cdots \cdot~ p^{\aleph}_{(x_1,\ldots,x_s)}(f(x_1),\ldots,f(x_s))$$ Two cases arise. suppose all of the probabilities in the RHS are $\geq 10t/\delta K$. Then, the probability of this good sequence arising in ${\cal A}'$ is at least $(1-\delta/10t)^t\alpha \geq \alpha(1-\delta/2)$. Otherwise, suppose some probability in the RHS is $<10t/\delta K$. Then the total probability mass on such good sequences in ${\cal A}$ is atmost $10t/\delta K\cdot|{\mathbf D}|^t \leq \delta/2$. Therefore, the probability of good sequences in ${\cal A}'$ is at least $(1-3\delta/2)(1-\delta/2) \geq 1-2\delta$. That is, ${\cal A}'$ is a $(t,\varepsilon,2\delta)$ tester. \end{proof} \ignore{ Henceforth, we focus on discrete testers. We use the notation $S^{(k)}$ for sets of size $k$ in $S$. As defined, the $p$-functions have a domain $\mathbb{N}^s$, but it will be preferable to replace this with $\mathbb{N}^{(s)}$. This will need some additional notation. Consider $\sigma_s: [s] \mapsto [s]$. Let ${\bf K}$ denote the discrete set of possible probability values. \begin{align} & \forall s \leq t, \forall x_1, x_2, \ldots, x_s \in D, y \in D', \forall \sigma_s: [s] \mapsto [s], \ p_{y, x_1, x_2, \ldots, x_s,\sigma_s}: \mathbb{N}^{(s)} \mapsto {\bf K} \nonumber \\ & \forall s \leq t, \forall x_1, x_2, \ldots, x_s \in D, \forall S \in \mathbb{N}^{(s)}, \sum_{y \in D'} p_{y, x_1, x_2, \ldots, x_s}(S) = 1 \nonumber\\ & \forall x_1, x_2, \ldots, x_t, y \in D, \forall S \in \mathbb{N}^{(t)}, \forall \sigma_t:[t] \mapsto [t], \ p_{y, x_1, x_2, \ldots, x_t, \sigma_t}(S) = 0 \nonumber \end{align} Note that any element of $\mathbb{N}^s$ can be mapped to an element of $\mathbb{N}^{(s)}$ and function $\sigma_s$. More precisely, suppose the function $p_{y, x_1, x_2, \ldots, x_s, \sigma_s}$ has the argument $\{v_1, v_2, \ldots, v_s\}$, where the $v_i$'s are in sorted order. The output value is the probability of selection $y$ as the next query when $f(x_1) = v_{\sigma(1)}$, $f(x_2) = v_{\sigma(2)}$, $\ldots, f(x_s) = v_{\sigma(s)}$. So the tester formulation of the previous section can be converted to this form, and hence any property tester can represented by this finite family of functions. The notion of a comparison-based tester becomes quite clean now. The functions $p_{y, x_1, x_2, \ldots, x_s,\sigma_s}$ are constant functions iff the tester is comparison-based. \begin{claim} \label{clm:map} Consider some explicit strictly monotone function $\phi: \mathbb{N} \mapsto \mathbb{N}$. Consider the tester ${\cal A}'$ that, given input function $f$, actually runs ${\cal A}$ on $\phi \circ f$. Then ${\cal A}'$ is a $(t,\varepsilon,2\delta)$ tester. \end{claim} \begin{proof} Since $\phi$ is a strictly monotone function, the distance to monotonicity of $f$ and $\phi \circ f$ are identical. If $f$ is monotone or $\varepsilon$-far from monotone, the probability that ${\cal A}$ errors of $\phi \circ f$ is at most $2\delta$. \end{proof} } \def{\tt col}{{\tt col}} We introduce some Ramsey theory terminology. For any positive integer $i$, a {\em finite} coloring of $\mathbb{N}^{(i)}$ is a function ${\tt col}_i:\mathbb{N}^{(i)} \mapsto \{1,\ldots,C\}$ for some finite number $C$. An infinite set $X\subseteq \mathbb{N}$ is called {\em monochromatic} w.r.t ${\tt col}_i$ if for all sets $A,B \in X^{(i)}$, ${\tt col}_i(A) = {\tt col}_i(B)$. A {\em $k$-wise} finite coloring of $\mathbb{N}$ is a collection of $k$ colorings ${\tt col}_1,\ldots,{\tt col}_k$. (Note that each coloring is over different sized tuples.) An infinite set $X\subseteq \mathbb{N}$ is $k$-wise monochromatic if $X$ is monochromatic w.r.t. all the ${\tt col}_i$'s. The following is a simple variant of Ramsey's original theorem. (We closely follow the proof of Ramsey's theorem as given in Chap V1, Theorem 4 of~\cite{Bol00}.) \begin{theorem} \label{thm:ramsey} For any $k$-wise finite coloring of $\mathbb{N}$, there is an infinite $k$-wise monochromatic set $X\subseteq \mathbb{N}$. \end{theorem} \begin{proof} We proceed by induction on $k$. If $k = 1$, then this is trivially true; let $X$ be the maximum color class. Since the coloring is finite, $X$ is infinite. We will now iteratively construct an infinite set of $\mathbb{N}$ via induction. Start with $a_0$ being the minimum element in $\mathbb{N}$. Consider a $(k-1)$-wise coloring of $(\mathbb{N} \setminus \{a_0\})$ ${\tt col}'_1,\ldots,{\tt col}'_{k-1}$, where ${\tt col}'_i(S) := {\tt col}_{i+1}(S\cup a_0)$. By the induction hypothesis, there exists an infinite $(k-1)$-wise monochromatic set $A_0\subseteq \mathbb{N}\setminus\{a_0\}$ with respect to coloring ${\tt col}'_i$s. That is, for $1\leq i\leq k$, and any set $S,T\subseteq A_0$ with $|S|=|T|=i-1$, we have ${\tt col}_i(a_0\cup S)={\tt col}_i(a_0\cup T) = C^0_i$, say. \def{\mathbf C}{{\mathbf C}} Denote the collection of these colors as a vector ${\mathbf C}_0 = (C^0_1, C^0_2, \ldots, C^0_k)$. Subsequently, let $a_1$ be the minimum element in $A_0$, and consider the $(k-1)$-wise coloring ${\tt col}'$ of $(A_0 \setminus \{a_1\})$ where ${\tt col}'_i(S) = {\tt col}_{i+1}(S \cup \{a_1\})$ for $S\subseteq A_0\setminus\{a_1\}$. Again, the induction hypothesis yields an infinite $(k-1)$-wise monochromatic set $A_1$ as before, and similarly the vector ${\mathbf C}_1$. Continuing this procedure, we get an infinite sequence $a_0, a_1, a_2, \ldots$ of natural numbers, an infinite sequence of vectors of $k$ colors ${\mathbf C}_0, {\mathbf C}_1, \ldots$, and an infinite nested sequence of infinite sets $A_0 \supset A_1 \supset A_2 \ldots$. Every $A_r$ contains $a_s, \forall s > r$ and by construction, any set $(\{a_r\} \cup S)$, $S\subseteq A_r$, $|S|=i-1$, has color $C^i_r$. Since there are only finitely many colors, some vector of colors occurs infinitely often as ${\mathbf C}_{r_1}, {\mathbf C}_{r_2}, \ldots$. The corresponding infinite sequence of elements $a_{r_1}, a_{r_2}, \ldots$ is $k$-wise monochromatic. \end{proof} \begin{proof} (of \Thm{fischer}) Suppose there exists a $(t,\varepsilon,\delta)$-tester for functions $f:{\mathbf D}\mapsto \mathbb{N}$. We need to show there is a comparison-based $(t,\varepsilon,2\delta)$-tester for such functions. By \Clm{discrete}, there is a discrete $(t,\varepsilon,2\delta)$-tester ${\cal A}$. Equivalently, we have the functions $q^y_{{\mathbf x},\sigma}$ as described in the previous section. We now describe a $t$-wise finite coloring of $\mathbb{N}$. Consider $s \in [t]$. Given a set $A\subseteq \mathbb{N}^{(s)}$, ${\tt col}_s(A)$ is a vector indexed by $(y,{\mathbf x},\sigma)$, where $y\in D'$, ${\mathbf x}\in D^s$, and $\sigma$ is a $s$-permutation, whose entry is $q^y_{{\mathbf x},\sigma}(A)$. The domain is finite, so the number of dimensions is finite. Since the tester is discrete, the number of possible colors entries is finite. Applying \Thm{ramsey}, we know the existence of a $t$-wise monochromatic infinite set ${\mathbf R}\subseteq \mathbb{N}$. We have the property that for any $y,{\mathbf x},\sigma$, and any two sets $A,B \in {\mathbf R}^{(s)}$, we have $q^y_{{\mathbf x},\sigma}(A) = q^y_{{\mathbf x},\sigma}(B)$. That is, the algorithm ${\cal A}$ is a comparison based tester for functions with range ${\mathbf R}$. Consider the strictly monotone map $\phi: \mathbb{N} \mapsto {\mathbf R}$, where $\phi(b)$ is the $b$th element of ${\mathbf R}$ in sorted order. Now given any function $f:{\mathbf D}\mapsto \mathbb{N}$, consider the function $\phi\circ f:{\mathbf D}\mapsto {\mathbf R}$. Consider an algorithm ${\cal A}'$ which on input $f$ runs ${\cal A}$ on $\phi\circ f$. More precisely, whenever ${\cal A}$ queries a point $x$, it gets answer $\phi\circ f(x)$. Observe that if $f$ is monotone (or $\varepsilon$-far from monotone), then so is $\phi\circ f$, and therefore, the algorithm ${\cal A}'$ is a $(t,\varepsilon,2\delta)$-tester of $\phi\circ f$. Since the range of $\phi\circ f$ is ${\mathbf R}$, ${\cal A}'$ is comparison-based. \end{proof}% \section{Lower bounds} \label{sec:dist} \def\widetilde{f}{\widetilde{f}} \def{\tt val}{{\tt val}} We assume that $n$ is a power of $2$, set $\ell:=\log_2 n$, and think of $[n]$ as $\{0,1,\ldots,n-1\}$. For any number $0 \leq z < n$, we think of the binary representation as $z$ as an $\ell$-bit vector $(z_1, z_2, \ldots, z_\ell)$, where $z_1$ is the least significant bit. Consider the following canonical, one-to-one mapping $\phi: [n]^d \mapsto \{0,1\}^{d\ell}$. For any $\vec{y} = (y_1, y_2, \ldots, y_d) \in [n]^d$, we concatenate their binary representations in order to get a $d\ell$-bit vector $\phi(\vec{y})$. Hence, we can transform a function $f:\{0,1\}^{d\ell}\mapsto \mathbb{N}$ into a function $\widetilde{f}:[n]^d \mapsto \mathbb{N}$ by defining $\widetilde{f}(\vec{y}) := f(\phi(\vec{y}))$. We will now describe a distribution of functions over the boolean hypercube with equal mass on monotone and $\varepsilon$-far from monotone functions. The key property is that for a function drawn from this distribution, any deterministic comparison based algorithm errs in classifying it with non-trivial probability. This property will be used in conjunction with the above mapping to get our final lower bound. \subsection{The hard distribution} \label{sec:hard} We focus on functions $f:\{0,1\}^m \mapsto \mathbb{N}$. (Eventually, we set $m = d\ell$.) Given any $x \in \{0,1\}^m$, we let ${\tt val}(x) := \sum_{i = 1}^{m} 2^{i-1} x_i$ denote the number for which $x$ is the binary representation. Here, $x_1$ denotes the least significant bit of $x$. For convenience, we let $\varepsilon$ be a power of $1/2$. For $k \in \{1,\ldots,\frac{1}{2\varepsilon}\}$, we let $$S_k := \{x: {\tt val}(x) \in [2(k-1)\varepsilon 2^m, 2k\varepsilon 2^m-1)~~\}.$$ Note that $S_k$'s partition the hypercube, with each $|S_k| = \eps2^{m+1}$. In fact, each $S_k$ is a subhypercube of dimension $m' := m+1-\log(1/\varepsilon)$, with the minimal element having all zeros in the $m'$ least significant bits, and the maximal element having all ones in those. We describe a distribution ${\cal F}_{m,\varepsilon}$ on functions. The support of ${\cal F}_{m,\varepsilon}$ consists $f(x) = 2{\tt val}(x)$, and $\frac{m'}{2\varepsilon}$ functions indexed as $g_{j,k}$ with $j\in [m']$ and $k\in[\frac{1}{2\varepsilon}]$, defined as follows. $$ g_{j,k}(x) = \left\{ \begin{array} {l l} 2{\tt val}(x) - 2^{j} - 1& \quad \textrm{if $x_j = 1$ and $x \in S_k$}\\ 2{\tt val}(x) & \quad \textrm{otherwise} \end{array} \right. $$ The distribution ${\cal F}_{m,\varepsilon}$ puts probability mass $1/2$ on the function $f=2{\tt val}$ and $\frac{\varepsilon}{m'}$ on each of the $g_{j,k}$'s. All these functions take distinct values on their domain. Note that $2{\tt val}$ induces a total order on $\{0,1\}^m$.\smallskip \noindent \textbf{The distinguishing problem:} Given query access to a random function $f$ from ${\cal F}_{m,\varepsilon}$, we want a deterministic comparison-based algorithm that declares that $f = 2{\tt val}(x)$ or $f \neq 2{\tt val}(x)$. We refer to any such algorithm as a \emph{distinguisher}. Naturally, we say that the distinguisher errs on $f$ if it's declaration is wrong. Our main lemma is the following. \begin{lemma} \label{lem:main-hard} Any deterministic comparison-based distinguisher that makes less than $\frac{m'}{8\varepsilon}$ queries errs with probability at least $1/8$. \end{lemma} \noindent The following proposition allows us to focus on {\em non-adaptive} comparison based testers. \begin{proposition} \label{prop:comp} Given any deterministic comparison-based distinguisher ${\cal A}$ for ${\cal F}_{m,\varepsilon}$ that makes at most $t$ queries, there exists a deterministic {\em non-adaptive} comparison-based distinguisher ${\cal A}'$ making at most $t$ queries whose probability of error on ${\cal F}_{m,\varepsilon}$ is at most that of ${\cal A}$. \end{proposition} \def{\tt ans}{{\tt ans}} \begin{proof} We represent ${\cal A}$ as a comparison tree. For any path in ${\cal A}$, the total number of distinct domain points involved in comparisons is at most $t$. Note that $2{\tt val}(x)$ is a total order, since for any $x,y$ either ${\tt val}(x) < {\tt val}(y)$ or vice versa. For any comparison in ${\cal A}$, there is an outcome inconsistent with this ordering. (An outcome ``$f(x) < f(y)$" where ${\tt val}(x) > {\tt val}(y)$ is inconsistent with the total order.) We construct a comparison tree ${\cal A}'$ where we simply reject whenever a comparison is inconsistent with the total order, and otherwise mimics ${\cal A}$. The comparison tree of ${\cal A}'$ has an error probability at most that of ${\cal A}$ (since it may reject a few $f\neq 2{\tt val}$), and is just a path. Hence, it can be modeled as a non-adaptive distinguisher. We query upfront all the points involving points on this path, and make the relevant comparisons for the output. \end{proof} \def{\tt val}{{\tt val}} \noindent Combined with \Prop{comp}, the following lemma completes the proof of \Lem{main-hard}. \begin{lemma}\label{lem:hard} Any deterministic, non-adaptive, comparison-based distinguisher ${\cal A}$ making fewer than $t \leq \frac{m'}{8\varepsilon}$ queries, errs with probability at least $1/8$. \end{lemma} \begin{proof} Let $X$ be the set of points queried by the distinguisher. Set $X_k =: X \cap S_k$; these form a partition of $X$. We say that a pair of points $(x,y)$ \emph{captures} the (unique) coordinate $j$, if $j$ is the largest coordinate where $x_j \neq y_j$. (By largest coordinate, we refer to the value of the index.) For a set $Y$ of points, we say $Y$ captures coordinate $j$ if there is a pair in $Y$ that captures $j$. \begin{claim}\label{clm:viol} For any $j,k$, if the algorithm distinguishes between ${\tt val}$ and $g_{j,k}$, then $X_k$ captures $j$. \end{claim} \begin{proof} If the algorithm distinguishes between ${\tt val}$ and $g_{j,k}$, there must exist $(x,y)\in X$ such that ${\tt val}(x) < {\tt val}(y)$ and $g_{j,k}(x) > g_{j,k}(y)$. We claim that $x$ and $y$ capture $j$; this will also imply they lie in the same $S_{k'}$ since the $m-j$ most significant bit of $x$ and $y$ are the same. Firstly, observe that we must have $y_j = 1$ and $x_j = 0$; otherwise, $g_{j,k}(y) - g_{j,k}(x) \geq 2({\tt val}(y) - {\tt val}(x)) > 0$ contradicting the supposition. Now suppose $(x,y)$ don't capture $j$ implying there exists $i>j$ which is the largest coordinate at which they differ. Since ${\tt val}(y)>{\tt val}(x)$ we have $y_i=1$ and $x_j=0$. Therefore, we have $$g_{j,k}(y) - g_{j,k}(x) \geq 2({\tt val}(y)-{\tt val}(x)) - 2^{j} - 1 \geq (2^i + 2^j) - \sum_{1 \leq r < i} 2^r - 2^j - 1 > 0.$$ So, $x,y$ capture $j$ and lie in the same $S_{k'}$. If $k'\neq k$, then again $g_{j,k}(y) - g_{j,k}(x) = 2({\tt val}(y)-{\tt val}(x)) > 0$. Therefore, $X_k$ captures $j$. \end{proof} \noindent The following claim allows us to complete the proof of the lemma. \begin{claim}\label{clm:cap} A set $Y$ captures at most $|Y|-1$ coordinates. \end{claim} \begin{proof} We prove by induction on $|Y|$. When $|Y| = 2$, this is trivially true. Otherwise, pick the largest coordinate $j$ captured by $Y$ and let $Y_0 =\{y: y_j = 0\}$ and $Y_1 = \{y:y_j = 1\}$. By induction, $Y_0$ captures at most $|Y_0|-1$ coordinates, and $Y_1$ captures at most $|Y_1| -1$ coordinates. Pairs $(x,y)\in Y_0\times Y_1$ only capture coordinate $j$. Therefore, the total number of captured coordinates is at most $|Y_0| - 1 + |Y_1| - 1 + 1 = |Y| - 1$. \end{proof} \noindent If $|X| \leq m'/8\varepsilon$, then there exist at least $1/4\varepsilon$ values of $k$ such that $|X_k| \leq m'/2$. By \Clm{cap}, each such $X_k$ captures at most $m'/2$ coordinates. Therefore, there exist at least $\frac{1}{4\varepsilon}\cdot\frac{m'}{2} = \frac{m'}{8\varepsilon}$ functions $g_{j,k}$'s that are indistinguishable from the monotone function $2{\tt val}$ to a comparison-based procedure that queries $X$. This implies the distinguisher must err (make a mistake on either these $g_{j,k}$'s or $2{\tt val}$) with probability at least $\min(\frac{\varepsilon}{m'}\cdot\frac{m'}{8\varepsilon}, 1/2) = 1/8$. \end{proof} \subsection{The final bound} \def{\tt val}{{\tt val}} Recall, given function $f:\{0,1\}^{d\ell}\mapsto \mathbb{N}$, we have the function $\widetilde{f}:[n]^d \mapsto \mathbb{N}$ by defining $\widetilde{f}(\vec{y}) := f(\phi(\vec{y}))$. We start with the following observation \begin{proposition}\label{prop:dist} The function $\widetilde{2{\tt val}}$ is monotone and every $\widetilde{g_{j,k}}$ is $\varepsilon/2$-far from being monotone. \end{proposition} \begin{proof} Let $\vec{u}$ and $\vec{v}$ be elements in $[n]^d$ such that $\vec{u} \prec \vec{v}$. We have ${\tt val}(\phi(\vec{u})) < {\tt val}(\phi(\vec{v}))$, so $\widetilde{2{\tt val}}$ is monotone. For the latter, it suffices to exhibit a matching of violated pairs of cardinality $\eps2^{d\ell}$ for $\widetilde{g_{j,k}}$. This is given by pairs $(\vec{u},\vec{v})$ where $\phi(\vec{u})$ and $\phi(\vec{v})$ only differ in their $j$th coordinate, and are both contained in $S_k$. Note that these pairs are comparable in $[n]^d$ and are violations. \end{proof} \begin{theorem}\label{thm:hc} Any $(t,\varepsilon/2,1/16)$-monotonicity tester for $f:[n]^d\mapsto \mathbb{N}$, must have $t\geq \frac{d\log n - \log(1/\varepsilon)}{8\varepsilon}$. \end{theorem} \begin{proof} By \Thm{fischer}, it suffices to show this for comparison-based $(t,\varepsilon/2,1/8)$ testers. By Yao's minimax lemma, it suffices to produce a distribution ${\cal D}$ over functions $f:[n]^d\mapsto \mathbb{N}$ such that any deterministic comparison-based $(t,\varepsilon/2,1/8)$-monotonicity tester for ${\cal D}$ must have $t\geq s$, where $s := \frac{d\log n - \log(1/\varepsilon)}{8\varepsilon}$. Consider the distribution ${\cal D}$ where we generate $f$ from ${\cal F}_{m,\varepsilon}$ and output $\widetilde{f}$. Suppose $t < s$. By \Prop{dist}, the deterministic comparison based monotonicity tester acts as a determinisitic comparison-based distinguisher for ${\cal F}_{m,\varepsilon}$ making fewer than $s$ queries, contradicting \Lem{hard}. \end{proof} \section{Conclusion} In this paper, we exhibit a lower bound of $\Omega(\varepsilon^{-1}d\log n - \varepsilon^{-1}\log \varepsilon^{-1})$ queries on adaptive, two-sided monotonicity testers for functions $f:[n]^d \mapsto \mathbb{N}$, matching the upper bound of $O(\varepsilon^{-1}d\log n)$ queries of~\cite{ChSe13}. Our proof hinged on two things: that for monotonicity on any partial order one can focus on comparison-based testers, and a lower bound on comparison-based testers for the hypercube domain. Some natural questions are left open. Can one focus on some restricted class of testers for the Lipschitz property, and more generally, can one prove adaptive, two-sided lower bounds for the Lipschitz property testing on the hypergrid/cube? Currently, a $\Omega(d\log n)$-query non-adaptive lower bound is known for the problem~\cite{BlJh+12}. Can one prove comparison-based lower bounds for monotonicity testing on a general $N$-vertex poset? For the latter problem, there is a $O(\sqrt{N/\varepsilon})$-query non-adaptive tester, and a $\Omega(N^{\frac{1}{\log\log N}})$-query non-adaptive, two-sided error lower bound~\cite{FLNRRS02}. Our methods do not yield any results for bounded ranges, but there are significant gaps in our understanding for that regime. For monotonicity testing of boolean functions $f:\{0,1\}^n \mapsto \{0,1\}$, the best adaptive lower bound of $\Omega(\log n)$, while the best non-adaptive bound is $\Omega(\sqrt{n})$~\cite{FLNRRS02}. \bibliographystyle{alpha}

Background ========== Arthritis and other rheumatic conditions are a significant public health issue, and are estimated to affect more than 21% of adults \[[@B1]\]. Osteoarthritis (OA), the most common form of arthritis, is a major cause of disability \[[@B2],[@B3]\] and presents a significant burden to health care providers \[[@B4]\]. In approximately 10% of the world\'s population aged 60 years or more, OA-related joint pathology causes significant clinical problems \[[@B5]\]. Rheumatoid arthritis (RA) is less prevalent but is associated with high medical expenses because of the requirement for continuous treatment to slow disease progression, and a high incidence of joint replacements \[[@B6]\]. Hospitalization represents a significant component of the costs associated with arthritis \[[@B7],[@B8]\]. Anemia, defined by the World Health Organization \[[@B9]\] as a hemoglobin concentration below 12 g/dl in women and 13 g/dl in men, is common in people with arthritis. Anemia is associated with increased morbidity, length of hospitalization, and cost of care delivery \[[@B10]\]. In RA, it is estimated that 30-60% of patients are anemic \[[@B11]-[@B14]\]. One of the most frequent causes of anemia in RA patients is \"iron deficiency anemia,\" which can result from gastrointestinal (GI) bleeding related to nonsteroidal anti-inflammatory drug (NSAID) use \[[@B15],[@B16]\]. \"Anemia of chronic disease,\" which does not usually respond to iron supplementation, is another major cause of anemia in patients with RA \[[@B17],[@B18]\]. In a study of 225 patients with RA, anemia of chronic disease accounted for 77% and iron deficiency anemia for 23% of observed anemia \[[@B14]\]. There are few data on the prevalence of anemia in patients with OA, although the prevalence of both conditions is known to increase with age \[[@B5],[@B19]-[@B21]\]. Sex also appears to influence disease prevalence; OA appears to affect more women than men, while current estimates suggest that women are up to three times more likely to develop RA than men \[[@B22]\]. Women are also at a greater risk of becoming anemic than men, particularly during menstruation or pregnancy, when iron requirements are increased \[[@B23]\]. Information on the impact of anemia in arthritic populations is also limited, although there is evidence that anemic RA patients have more severe arthritic disease than nonanemic patients \[[@B14],[@B24],[@B25]\]. Studies in other populations have demonstrated that the clinical impact of anemia is substantial: for example in chronically ill patients, anemia has been associated with an increased risk of mortality and morbidity while also having a negative impact on quality of life \[[@B18]\]; Anand and colleagues also demonstrated that anemic patients with chronic heart failure have greater disease severity and have a higher risk of hospitalization or death \[[@B26]\]. Adverse outcomes related to anemia may be of particular importance in the elderly, in whom anemia (and arthritic disease) is common \[[@B19]\]. Penninx et al. have associated anemia in elderly populations with an increased risk of hospitalization (adjusted relative risk 1.27 \[95% confidence interval \[CI\] 1.12-1.45\]) and mortality (relative risk 1.61 \[95% CI 1.34-1.93\]) \[[@B27]\], as well as disability, poor physical performance, and decreased muscle strength \[[@B28]-[@B30]\]. In community-dwelling older women, even mild anemia and low-normal hemoglobin levels have been identified as independent risk factors for frailty: compared with a hemoglobin concentration of 13.5 g/dl, adjusted odds for frailty of 11.5 g/dl and 12 g/dl were 1.9 (95% CI 1.1-3.4) and 1.5 (95% CI 1.0-2.1) \[[@B31]\]. Anemia has also been linked to increased health care costs and resource utilization \[[@B32]\], with direct medical costs for anemic patients with comorbid conditions up to twice those for nonanemic patients with the same comorbid condition \[[@B33],[@B34]\]. However, data on anemia-associated resource use and cost in people with arthritis remain very sparse. The objective of this study was to assess differences in health resource utilization patterns among arthritis (OA and RA) patients with concomitant anemia compared with those without anemia. We analyzed data from French hospital admissions to test the hypothesis that arthritis patients with concomitant anemia are associated with more health care resource use than nonanemic arthritis patients. Methods ======= Study design ------------ This retrospective cohort study utilized data on secondary care in France from the Programme de Médicalisation des Systèmes d\'Information (PMSI) database. For public and private hospitals, two cohorts were identified from the hospitalizations that occurred during the 2001 calendar year: hospitalizations where there was a primary/secondary diagnosis of arthritis without anemia; and hospitalizations where there was both a primary/secondary diagnosis of arthritis and a primary/secondary diagnosis of anemia. Thus, both cohorts were comprised of arthritis patients, but differed in the presence or absence of anemia diagnosis, respectively. The cohorts were compared for the following measures of hospital resource utilization: length of stay, number of procedures, and mean total cost. The PMSI database covers more than 90% of private and public hospital activity in France and is used by government and regional health authorities as a tool to provide hospital activity indicators for allocating annual budget and forecasting medical needs and resources. Even though the PMSI database is not exhaustive of French hospitals, it guarantees a standardized collection of data that allows the unbiased identification of cases and controls for epidemiological studies. For each hospital stay, the PMSI database includes information on the patient\'s age, sex, and postal region; their primary, secondary, and related diagnoses; procedures undertaken; and length of stay. Use of PMSI to assess the epidemiological and economic burden of illness is recommended by the French guidelines for health economic evaluation \[[@B35]\]. Patients admitted to a hospital were classified by primary diagnosis and then allocated a randomized code to maintain anonymity. Access to patient information thereafter was available only at the hospital admission or hospital stay level. The two study cohorts were identified from the PMSI database using *International Statistical Classification of Diseases and Related Health Problems, 10th Revision*(*ICD-10*) codes \[[@B36]\]. Arthritis, defined as RA and/or OA, included seropositive RA (*ICD-10*code M05), other RA (M06), polyarthrosis (M15), coxarthrosis/hip arthrosis (M16), gonarthrosis/knee arthrosis (M17), arthrosis of first carpometacarpal joint (M18), and other arthrosis (M19). A diagnosis of anemia included iron deficiency anemia (D50.0, D50.1, D50.8, D50.9), vitamin B~12~deficiency anemia (D51.0-D51.3, D51.8, D51.9), folate deficiency anemia (D52.0, D52.1, D52.8, D52.9), other nutritional anemias (D53.0-D53.2, D53.8, D53.9), and acquired hemolytic anemias (D59.0-D59.6, D59.8, D59.9). Patients with alpha and beta thalassemia were not included. Costs ----- Health care resource utilization for length of stay, number of procedures, and total cost of stay in public and private hospitals was analyzed for both study populations. Costs were assessed from the health care system perspective, and were calculated according to the French Diagnosis-Related Group (DRG) system. This system classifies every hospital patient into one of several hundred DRG groups that are intended to be clinically meaningful and homogenous with respect to resource use. The DRG assignment was recorded on the PMSI dataset for each hospitalization. Due to differences in the reference costs and financing systems of public and private hospitals in France, reference cost information was not equivalent in the two sectors and, therefore, was not directly comparable. For individual public hospitals in each region, the mean cost per DRG is calculated and expressed in a synthetic index, called the ISA (Index Synthétique d\'Activité); the number of ISA points represents an index of hospital productivity. For public hospitals, the average ISA value is, in part, calculated by dividing the \"short-term stays\" activity budget by the number of ISA points for this activity. However; for private hospitals or clinics, the ISA point value is calculated from the expenses reimbursed by the public health insurance fund (Social Security Sick Funds) to these hospitals. Furthermore, because the financing systems differ, costing for public and private hospitals has to be performed and interpreted separately. For public hospitals (which represent three quarters of all hospitalized patients), two published lists of reference costs were used to calculate costs for hospital stays for the study populations \[[@B37]\]. The reference costs, calculated from accountability data from a subgroup of 40 public hospitals, were given per DRG for an average length of stay for each DRG, allowing calculation of unit costs per day for each DRG. Total costs of admissions in each of the two study populations were calculated by summing the product of the length of stay for each admission and the appropriate DRG-related unit cost per day for each admission. The reference unit costs per hospital stay per DRG comprised the following: medical and paramedical care (salaries of clinicians, nurses, and other medical staff); pharmaceuticals and drugs; anesthesia (including operation suite); laboratory tests and procedures; intensive care (medical staff salaries, pharmaceuticals, amortization, maintenance, and medical logistics); logistics (amortization and medical material maintenance, medical logistics, food service, central laundry, hospital management); structure (amortization of building and facilities and committed fixed costs); and reanimation costs (costs associated with acute care; similar but not equivalent to intensive care in the US). The average total cost per stay in public hospitals was broken down into these categories. For private hospitals we used the reference cost lists, calculated on all medical fees reimbursed to patients by the Social Security Sick Funds \[[@B38]\], to calculate total costs per stay. Because of the method used for its development, the list of reference costs for private hospitals did not include assessment of detailed items of costs, such as in the public sector. Only total costs of stay per DRG, DRG-related procedures, and medical care corresponding to an invoice sent to the Social Security Sick Fund for reimbursement, were available. Thus, part of the fixed costs, maintenance, logistics, and salaries are not included in the private total costs per stay. Statistical analysis -------------------- Our primary analysis was to describe the resource utilization of hospitalized patients with arthritis in the two study groups (arthritis with anemia cohort and arthritis-only cohort). The description of resource utilization data was done by their means and 95% CIs. Five confounders of the impact of anemia on resource utilization were identified: sex (male, female), age (0-59, 60-69, 70-79, 80+ years), type of primary diagnosis of arthritis (presence or absence of each of the following diagnoses: M05, M06, M15, M16, M17, M19), type of secondary/associated diagnosis of arthritis (presence or absence of each of the following diagnoses: M05, M06, M15, M16, M17, M19), and number of associated diagnoses/comorbidities (none, 1-2, 3-4, 5-6, 6+). In order to eliminate the possible effect of these confounders on resource utilization when comparing arthritis with anemia and arthritis-only cohorts, we randomly generated \"matched-control\" samples from the arthritis without anemia population based on the five confounders. Simple random sampling was performed in the arthritis-only cohort stratified by confounders. The stratum sampling rates were specified as being equal to the actual percentages observed in the arthritis with anemia cohort. Five separate replications of this random process were performed leading to five independent matched-samples. This approach allowed obtaining five control samples (no anemia) comparable to the population with anemia in terms of sociodemographics, diagnostics, and comorbidities. Then the resource utilization data were described and compared between \"matched-control\" samples and the arthritis with anemia population by their means and 95% CIs. To further confirm these results, we also conducted multivariable analyses on the entire study sample, including the confounding variables and the variable \"anemia yes/no.\" We described and compared the adjusted resource utilization for the two study groups (arthritis with anemia cohort and arthritis-only cohort) using analysis of covariance. All data processing and analyses were performed using SAS software (Statistical Analysis System, version 8. 2, SAS Institute, Inc., Cary, NC). Results ======= Results for public and private hospitals are presented separately, because of the inherent differences in care structure and cost capture in the two settings. Public hospitals ---------------- ### Number of hospitalizations In public hospitals in 2001 there were 161,121 hospitalizations for the arthritis without anemia population and 1,941 hospitalizations for the arthritis with anemia population (Table [1](#T1){ref-type="table"}). Overall, the prevalence of anemia with arthritis in public hospitals was 1.2% (1941/163,062). ###### Number of hospitalizations and characteristics of study populations Public Private ------------------------------------------ -------------------- ------------------ ---------------- ------------- Number of hospitalizations, n (%) **161,121 (98.8)** **1,941 (1.2)** 139,783 (99.4) 803 (0.6) Mean age, y (SD) **66.7 (15.1)** **74.6 (13.8)** 67.1 (12.4) 72.2 (12.4) Sex, n (%)  Female **108,514 (67.4)** **1,484 (76.5)** 84,808 (60.7) 601 (74.8)  Male **52,605 (32.7)** **457 (23.5)** 54,970 (39.3) 202 (25.2) Number of associated diagnoses Mean (SD) **2.5 (2.5)** **5.8 (5.8)** 2.2 (2.4) 5.3 (3.3)  Median **2.0** **5.0** 2.0 5.0 ### Characteristics of study population The mean age of the arthritis without anemia population was slightly lower than that of the arthritis with anemia population; 66.7 years and 74.6 years, respectively (Table [1](#T1){ref-type="table"}). In the arthritis with anemia population, three quarters of arthritis patients were female, whereas in the arthritis without anemia population, female patients comprised approximately two thirds of the population (Table [1](#T1){ref-type="table"}). Rheumatoid arthritis (nonseropositive RA; 18.5%), gonarthrosis (11.1%), arthrosis (10.3%), and other primary coxarthrosis (9.8%) represented the most frequently recorded diagnoses in the arthritis without anemia population in public hospitals. The most frequent diagnoses recorded in the hospitalizations of patients with concomitant arthritis and anemia were iron deficiency anemia (17.5%), iron deficiency anemia (secondary to blood loss; 12.7%), and RA (nonseropositive RA; 11.6%), followed by other iron deficiency anemias (7.4%), polyarthrosis (6.4%), and arthrosis (6%). On average, patients with arthritis and anemia had a greater number of associated diagnoses (in addition to arthritis and/or anemia), compared with arthritis patients without anemia (5.8 vs 2.5, respectively; Table [1](#T1){ref-type="table"}). Essential (primary) hypertension was the most common associated diagnosis (comorbidity) in the arthritis with anemia and arthritis without anemia populations, accounting for 5.9% and 7.5% of associated diagnoses, respectively. In the arthritis with anemia population, the most common comorbidities in public hospitals, other than essential hypertension, were blood transfusion (2.4%; as defined by *ICD-10*), atrial fibrillation and flutter (1.4%), diaphragmatic hernia (without obstruction or gangrene; 1.3%), ulcer of the lower limb (1.1%), and elevated erythrocyte sedimentation rate (1.1%). Other than essential hypertension, the most frequently reported comorbidities in the arthritis without anemia population included obesity (1.5%), type 2 diabetes (without complication; 1.4%), other chemotherapy or medical care (1.3%), and atrial fibrillation or flutter (1.2%). ### Hospital treatment of study population, descriptive results Arthritis patients with concomitant anemia stayed significantly longer in public hospitals (mean 11.9 \[95% CI 11.28-12.54\] days) than those without anemia (mean 8.0 \[95% CI 7.99-8.09\] days) (Table [2](#T2){ref-type="table"}). The mean number of procedures performed on patients in public hospitals was also significantly greater for those with concomitant anemia (3.7 \[95% CI 3.48-3.92\] procedures) than for patients without anemia (2.6 \[95% CI 2.58-2.62\] procedures; Table [2](#T2){ref-type="table"}). ###### Resource utilization, descriptive results^a^ Public Private ------------------------------------------- ------------------------------ --------------------------- ------------------------------ --------------------------- **Arthritis without anemia** **Arthritis with anemia** **Arthritis without anemia** **Arthritis with anemia** **n = 161,121** **n = 1,941** **n = 139,783** **n = 803** Mean length of stay, days (SD) **8.0 (9.9)** **11.9 (14.1)** 9.8 (7.8) 10.7 (10.2)  Missing, n **4,403** **26** 2,087 25 Mean number of associated procedures (SD) **2.6 (3.2)** **3.7 (4.9)** 4.3 (2.8) 4.8 (3.7) Mean total cost, € (SD) **4,190 (5,940)** **5,870 (9,433)** 3,380 (2,038) 2,700 (2,100)  Missing, n **4,499** **29** 188 3 ^a^Due to differences in the reference costs and financing systems of public and private hospitals in France, reference cost information was not equivalent in the two sectors and, therefore, was not directly comparable. The types of procedures performed were mainly related to general anesthesia management/use of recovery room services, cardiovascular function monitoring (e.g., electrocardiography), and thoracic or abdominal investigations. In arthritic patients without anemia, procedures generally focused on the arthritis diagnosis, with major surgeries undertaken, such as hip and knee replacements, comprising 7.2% of all procedures in public hospitals. In patients with concomitant anemia, procedures were more focused on identifying the cause of anemia and its monitoring, with hip and knee replacements each representing \<1% of procedures performed in public hospitals. Overall, the mean cost per hospitalization in public hospitals for the arthritis and anemia population was €;5,870 (95% CI 5,447-6,293) and €;4,190 (95% CI 4,161-4,219) for the arthritis without anemia population (Table [2](#T2){ref-type="table"}). In the public hospital sector, anesthesia accounted for a greater proportion of the total cost of stay for arthritic patients without concomitant anemia than those with anemia (13.3 vs 6.0%, Figure [1](#F1){ref-type="fig"}). However, the concomitant anemia population had a higher proportion of cost attributable to laboratory tests and procedures (11.2 vs 8.9%) and reanimation care (9.1 vs 5.2%). {#F1} ### Hospital treatment of study population, comparative results Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"} show the results of the univariable analysis conducted on the \"matched-control\" samples, and the multivariable analysis conducted on the whole population for length of stay, number of procedures, and total cost, adjusting for sex, age, type of primary arthritis diagnosis, type of secondary arthritis diagnoses, and number of associated diagnoses. The results of the univariable analysis conducted on the matched-control samples are consistent with the results of the multivariable analysis for each outcome. ###### Differences between arthritis and anemia versus arthritis without anemia in length of stay, adjusted for age, sex, type of primary diagnosis of arthritis, type of secondary/associated diagnosis of arthritis, and number of associated diagnoses Public Private ------------------------ -------------------- ------------------------------ ---------------------- Univariable analysis Matched sample \#1 **0.91 (0.01 to 1.81)** 0.35 (-0.67 to 1.37) Matched sample \#2 **0.68 (**-**0.20 to 1.56)** 0.47 (-0.55 to 1.49) Matched sample \#3 **1.30 (0.47 to 2.13)** 0.79 (-0.19 to 1.77) Matched sample \#4 **1.00 (0.11 to 1.89)** 0.29 (-0.70 to 1.28) Matched sample \#5 **1.13 (0.28 to 1.98)** 0.03 (-1.07 to 1.13) Multivariable analysis Whole population **1.56 (1.14 to 1.98)** 0.69 (0.22 to 1.16) Legend: Matched samples of arthritis patients with anemia and without anemia were identified based on five confounders: Sample \#1 - gender (male, female); Sample \#2 - age (0--59, 60--69, 70--79, 80+); Sample \#3 - type of primary diagnosis of arthritis; Sample \#4 - type of secondary/associated diagnosis of arthritis; Sample \#5 - number of associated diagnoses/comorbidities (none, 1--2, 3--4, 5--6, 6+). ###### Differences between arthritis and anemia versus arthritis without anemia in number of procedures, adjusted for age, sex, type of primary diagnosis of arthritis, type of secondary/associated diagnosis of arthritis, and number of associated diagnoses Public Private ------------------------ -------------------- ------------------------- ----------------------- Univariable analysis Matched sample \#1 **0.58 (0.29 to 0.87)** 0.17 (-0.16 to 0.50) Matched sample \#2 **0.48 (0.20 to 0.76)** -0.12 (-0.46 to 0.22) Matched sample \#3 **0.45 (0.17 to 0.73)** 0.14 (-0.20 to 0.48) Matched sample \#4 **0.44 (0.16 to 0.72)** 0.02 (-0.32 to 0.36) Matched sample \#5 **0.45 (0.18 to 0.72)** 0.17 (-0.17 to 0.51) Multivariable analysis Whole population **0.52 (0.38 to 0.65)** 0.08 (-0.11 to 0.27) Legend: Matched samples of arthritis patients with anemia and without anemia were identified based on five confounders: Sample \#1 - gender (male, female); Sample \#2 - age (0--59, 60--69, 70--79, 80+); Sample \#3 - type of primary diagnosis of arthritis; Sample \#4 - type of secondary/associated diagnosis of arthritis; Sample \#5 - number of associated diagnoses/comorbidities (none, 1--2, 3--4, 5--6, 6+). ###### Differences between arthritis and anemia versus arthritis without anemia in total cost, adjusted for age, sex, type of primary diagnosis of arthritis, type of secondary/associated diagnosis of arthritis, and number of associated diagnoses Public Private ------------------------ -------------------- ----------------------- ------------------- Univariable analysis Matched sample \#1 **280 (-320 to 880)** 26 (-180 to 232) Matched sample \#2 **144 (-416 to 704)** 28 (-178 to 234) Matched sample \#3 **371 (-193 to 935)** -11 (-219 to 197) Matched sample \#4 **167 (-451 to 785)** -21 (-228 to 186) Matched sample \#5 **374 (-174 to 922)** -58 (-263 to 147) Multivariable analysis Whole population **480 (227 to 734)** -30 (-113 to 52) Legend: Matched samples of arthritis patients with anemia and without anemia were identified based on five confounders: Sample \#1 - gender (male, female); Sample \#2 - age (0--59, 60--69, 70--79, 80+); Sample \#3 - type of primary diagnosis of arthritis; Sample \#4 - type of secondary/associated diagnosis of arthritis; Sample \#5 - number of associated diagnoses/comorbidities (none, 1--2, 3--4, 5--6, 6+). After adjustment using multivariable analysis on the whole population, in public hospitals the mean length of stay for arthritis patients with concomitant anemia, compared with those with arthritis only, was significantly higher, with an additional 1.56 days (95% CI 1.14-1.98; Table [3](#T3){ref-type="table"}) of stay. Arthritic patients with anemia also underwent significantly more procedures than those without anemia (0.52 additional procedures; 95% CI 0.38-0.65; Table [4](#T4){ref-type="table"}). The additional length of stay and number of procedures attributable to anemia in public hospitals represents 20% of the mean length of stay and number of procedures for nonanemic arthritis patients. Furthermore, the total cost per hospitalization for arthritis patients with anemia was €;480 greater (95% CI 227-734) than for patients with arthritis without anemia (Table [5](#T5){ref-type="table"}). The adjusted difference in costs per hospitalization between the two populations (€;480 \[95% CI 227-734\]), represents 11% of the mean cost expenditure for nonanemic arthritis patients. Private hospitals ----------------- ### Number of hospitalizations Overall, in 2001 there were 139,783 private hospitalizations for the arthritis without anemia population and 803 hospitalizations for the arthritis with anemia population. Overall, the prevalence of anemia with arthritis in private hospitals was 0.6% (n = 803/140,586). ### Characteristics of study population As for public hospitalizations, the mean age of the arthritis with anemia population was slightly greater than that of the arthritis without anemia population, 72.2 years and 67.1 years, respectively (Table [1](#T1){ref-type="table"}). Again, female patients comprised approximately three quarters of the arthritis with anemia population and 61% of the arthritis without anemia population (Table [1](#T1){ref-type="table"}). In terms of the primary or secondary diagnoses in the arthritis without anemia population, coxarthrosis (other primary; 20.4%), gonarthrosis (other primary; 17.4%), gonarthrosis (7.5%), and arthrosis (7.2%) were the most frequently reported. In patients with arthritis and anemia, the most common diagnoses were iron deficiency anemia (secondary to blood loss; 18.6%), iron deficiency anemia (17.6%), RA (nonseropositive RA; 9.1%), and coxarthrosis (other primary; 7.8%). Private hospital patients with arthritis and concomitant anemia also had, on average, a greater number of associated diagnoses (in addition to arthritis and/or anemia), than arthritis patients without anemia (5.3 vs 2.2, respectively; Table [1](#T1){ref-type="table"}). Again, similar for public hospitalizations, the most common associated diagnosis was essential (primary) hypertension, accounting for 8.8% and 13.3% of associated diagnoses in the arthritis with anemia and arthritis without anemia populations, respectively. In arthritic patients with anemia, the most common associated diagnoses other than essential hypertension were diaphragmatic hernia (without obstruction or gangrene; 2.8%), diverticular distension of the large intestine (without perforation or abscess; 2.1%), blood transfusion (without reported diagnosis; 2.1%), and pure hypercholesterolemia (2.0%). In arthritic patients without anemia, other than hypertension, the most common associated diagnoses were pure hypercholesterolemia (3.0%), obesity (2.5%), type 2 diabetes (without complication; 2.1%), and varicose veins of the lower extremities (without ulcer or inflammation; 1.5%). ### Hospital treatment of study population, descriptive results In private hospitals, the mean unadjusted length of stay for arthritis patients with anemia was 10.7 (95% CI 9.97-11.39) days, versus 9.8 (95% CI 9.79-9.87) days for arthritis patients without anemia (Table [2](#T2){ref-type="table"}). In private hospitals, patients underwent more procedures than in public hospitals (mean 4.8 \[95% CI 4.57-5.07\] for anemic arthritis patients and 4.3 \[95% CI 4.28-4.30\] for nonanemic patients; Table [2](#T2){ref-type="table"}). As for public hospitals, the types of procedures performed were mainly related to general anesthesia management/use of recovery room services, cardiovascular function monitoring (e.g., electrocardiography), and thoracic or abdominal investigations. In arthritic patients without anemia, procedures generally focused on the arthritis diagnosis, with major surgeries undertaken, such as hip and knee replacements, comprising 12% of all procedures in private hospitals. In patients with concomitant anemia, procedures were more focused on identifying the cause of anemia and its monitoring, with hip and knee replacements (combined) representing 7% (hip and knee combined) of all procedures in private hospitals. In private hospitals, the mean cost per hospitalization for the arthritis and anemia population was €;2,700 (95% CI 2,554-2,846) compared with €;3,380 (95% CI 3,369-3,391) for the arthritis without anemia population (Table [2](#T2){ref-type="table"}). ### Hospital treatment of study population, comparative results Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"} show the results of the univariable and multivariable analysis conducted on the matched-control and whole population samples for length of stay, number of procedures, and total cost, adjusting for sex, age, type of primary arthritis diagnosis, type and number of secondary arthritis diagnoses, and number of associated diagnoses. The results of the univariable analysis conducted on the matched-control samples are consistent with the results of the multivariable analysis for each outcome. In private hospitals, after adjustment using multivariable analysis on the whole population, the differences between the anemic and nonanemic populations in length of stay and number of procedures were more modest than those seen in public hospitals (0.69 days \[95% CI 0.22-1.16\] and 0.08 procedures \[95% CI -0.11 to 0.27\], respectively; Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}). The total cost per private hospitalization was €;30 less (95% CI -113 to 52) for arthritis patients with anemia than for patients with arthritis who did not have concomitant anemia (Table [5](#T5){ref-type="table"}). In both public and private hospitals, the combined total economic burden of all hospitalizations for arthritis patients with and without anemia was €;13.6 million and €;1.15 billion, respectively. Of the €;13.6 million, €;907,590 was attributable to anemia. Discussion ========== This retrospective cross-sectional study assessed the 2001 hospital health care utilization and costs related to anemia in arthritis patients in France. The study showed that, in public hospitals, arthritis patients with concomitant anemia use more health care resources than those without anemia. After adjustment for confounders, the length of stay and number of procedures attributable to anemia were greater in public than in private hospitals. Although it was not possible to directly compare the two populations due to the way in which these costs were calculated, the cost of stay per hospitalization in public hospitals was greater in patients with concomitant anemia than in those without anemia, while in private hospitals anemia was associated with a modest decrease in the total cost of stay. To our knowledge, there are no previous studies looking specifically at the impact of anemia on health care resource use in hospitalized populations in Europe. However, studies assessing overall annual health care utilization have shown that anemia is associated with increased resource use and costs \[[@B32]-[@B34]\]. In a US study based on administrative claims data for anemic adults with RA or one of five other comorbid conditions, utilization of key medical services was significantly higher (*P*\< 0.001) for anemic than nonanemic patients \[[@B34]\]. In addition, anemic patients had higher care (including inpatient) costs than nonanemic patients with the same comorbid condition, and inpatient and outpatient costs more than double those for nonanemic patients after adjustment for confounders. Another US study identified a difference in direct costs between anemic and nonanemic RA patients of more than \$7,000 per year, and showed that anemia also impacts indirect health care costs \[[@B33]\]. Penninx et al. \[[@B27]\] examined the relationship of anemia with death and hospitalization outcomes in a community-based sample of older people. They identified a significant association between anemia and subsequent mortality and hospitalization (relative risk 1.61 \[95% CI 1.34-1.93\] and relative risk 1.27 \[95% CI 1.12-1.45\], respectively) and, consistent with the results from the French public hospital sector in the current study, found that people with anemia who were hospitalized had a significantly longer length of stay than nonanemic patients (25.0 vs 13.7, respectively, *P*\< 0.001) \[[@B27]\]. The use of a national database representative of hospitalizations across France, in conjunction with the large size of the two study populations involved (303,648 hospitalizations, representing 1.6% of all admissions to French hospitals in 2001) adds weight to the findings regarding the impact of anemia in an arthritic population. In addition, the adjustment for key factors that could influence health care resource use, particularly the primary/secondary diagnosis and number of associated diagnoses, helps guard against the possibility that anemia is simply a marker for greater morbidity and severity of underlying disease. Indeed, analysis of the number and types of procedures performed in anemic and nonanemic patients suggests that, in this study, the anemic population has less severe arthritic disease than the nonanemic population. However, this study also has several limitations. First, as the analyzed data is derived from retrospective analysis of medical claims, the findings do not denote causality, but rather focus on identifying temporal association among patient outcomes. We are thus identifying association, not causality, between anemia and increased resource utilization. Second, care must be taken when using DRGs as these are sometimes re-coded for billing purposes and may, therefore, no longer accurately reflect the actual final diagnosis \[[@B39]\]. Indeed, even though DRGs are intended to be clinically consistent with respect to resource use, the calculated costs remain an average estimate that does not reflect the heterogeneity among severity of diseases included in the DRG. Third, the prevalence of anemia in the hospitalized arthritis patients (0.9%) seems low compared with previous estimates of 30-60% prevalence of anemia in people with RA \[[@B11]-[@B14]\], which may have biased the outcome. However, most patients in this analysis were OA patients, in whom the prevalence of anemia may not be as high. Moreover, our study did not include patients with \"anemia of chronic disease,\" a common type of anemia in people with RA \[[@B18],[@B17]\]. Another possible reason for the low percentage of anemic patients in this study is that anemia is often presented and treated in the primary care setting, and thus may have been successfully treated in a proportion of the study population before they were hospitalized. A fourth limitation is that the database identifies \"admission\" and not \"patient,\" so some patients may have been counted twice (if they had two admissions for their arthritis or anemia during the year). Additionally, the database identifies only admissions for which the anemia or arthritis required a specific treatment of the patient during his or her admission. Arthritic/anemic patients who were admitted to the hospital for a reason other than their arthritis/anemia were not identified. Last, anemia was measured as the hemoglobin threshold and did not take into account its severity and clinical impact. It is interesting that the results of this study show an anemia-attributable increase in resource utilization and cost in public but not in private hospitals. A small increase was observed in the length of stay of anemic versus nonanemic patients in the private sector, but this did not translate into increased costs, probably because of the less detailed way in which costs are reported for this sector. In private hospitals, because only total costs of stay per DRG (comprising procedures 0 and medical care corresponding to an invoice sent to the Social Security Sick Fund for reimbursement) were available, part of the fixed costs such as, maintenance, logistics, and salaries, were not included in the private total costs per stay 0. In private hospitals, the anemia-related increase in length of stay was less than half that observed for public hospitals, and there was no difference in the number of procedures undergone by anemic and nonanemic patients. It is possible that the presence of anemia has a greater impact in patients who are generally more unwell than in those who are not as sick. In this study, diagnoses of patients in private hospitals were generally less severe (for example, there were fewer RA patients and the mean number of associated diagnoses was significantly lower) than those in public hospitals, reflecting the different characteristics of the two sectors: public hospitals, which are mostly teaching hospitals, offer more technical and innovative procedures and allow treatment of more severe cases than private centers, which are more sensitive to activity profitability. Furthermore, differences in financial incentives, corresponding to an increased stay in either public or private hospitals, may have also influenced these findings, though this is beyond the current scope of the paper and further studies are warranted. These study findings are important given that iron deficiency, which is an important cause of anemia in arthritis patients, is partially preventable. Although not proven, the upper GI complications associated with nonselective NSAID use, including ulceration, perforation, and bleeding, could contribute to iron deficiency anemia in arthritis patients using these drugs \[[@B15],[@B16],[@B40]\]. Lower GI events are also an important contributor to safety throughout the entire GI tract \[[@B41]-[@B43]\] and may contribute to anemia, although there is no literature in anemic patients per se. Our data showing that anemia increases health care utilization in patients with arthritis suggest that treatment options should be examined carefully with consideration of the complete patient profile. Conclusion ========== In conclusion, the study hypothesis was confirmed in French public hospital settings; a clear difference in health care resource use attributable to anemia, adjusting for five confounders, exists in public hospitalizations. In private hospital settings, the additional resource use due to anemia was not clearly shown. This was probably due to the fact that patients seen in private hospitals have a less severe condition than those in public settings. These French database analyses provide some of the first evidence of the health care utilization and costs related to anemia specifically in patients with arthritis, and can be considered as a measure for the clinical significance of anemia. Overall, these findings warrant closer consideration of anemic arthritis patients in the clinical setting, and further research to better clarify the impact of anemia in populations with arthritis. Analysis of hospital databases in other European and non-European countries would enhance the available evidence regarding the impact of anemia in patients with OA and/or RA. Competing interests =================== R. Diazaraque, G. Zlateva, and L. Niculescu are full-time employees of Pfizer Inc. M. Viala-Danten is a full-time employee of Mapi Values, France, who were paid consultants to Pfizer in connection with this research. This study was funded by Pfizer Inc. Authors\' contributions ======================= GZ contributed to the data analysis, interpretation and writing of the manuscript; RD contributed to the data interpretation and writing of the manuscript; MVD contributed to the statistical analysis, interpretation and writing of the manuscript; LN contributed to the study design, analysis, interpretation and writing of the manuscript. The manuscript has not been submitted or is not simultaneously being submitted elsewhere, and all authors have read and approved the final version of the manuscript. Pre-publication history ======================= The pre-publication history for this paper can be accessed here: <http://www.biomedcentral.com/1471-2318/10/59/prepub> Acknowledgements ================ Ruth Diazaraque, Gergana Zlateva, and Liviu Niculescu are all full-time employees of Pfizer Inc. Murial Viala-Danten is a full-time employee of Mapi Values, France and was a paid consultant to Pfizer in connection with this research. We would also like to thank Florence Baron-Papillon, formerly of Mapi Values, France, for her valuable input in this study. We would like to thank Leigh Prevost, BSc, of PAREXEL, who provided medical writing services and was funded by Pfizer Inc.

Background ========== \"The immense majority of countries who have passed legislation recently do ban both reproductive and therapeutic cloning\" *(Senator Morin, The Standing Senate Committee On Social Affairs, Science And Technology, Ottawa, Canada, Wednesday 18 February, 2004)*. In February 1997 an article was published in *Nature*announcing the birth of what was to become the most famous sheep in history \[[@B1]\]. That sheep, known as Dolly, was the product of asexual reproduction. As the world\'s media unhesitatingly announced, she was a clone. The prospect of a human clone led to immediate calls for regulatory controls on the technology. There were, however, divisions, particularly when it became apparent that the potential uses of the technique were not limited to reproduction. Other potential uses came one step closer when, in the following year, it was announced that embryonic stem cells had been successfully extracted from non-cloned human embryos \[[@B2]\]. Now, a year after the death of Dolly \[[@B3]\], it is appropriate to review the current regulatory position on the creation and use of cloned embryos around the world \[[@B4],[@B5]\] -- particularly considering the public debate that has surrounded the recent cloning experiments in Korea, the granting of the first \"research cloning\" license in the UK, and the past and impending UN cloning debates. This paper is concerned with the creation of *functional*embryos, whether by nuclear transfer or embryo splitting. As this suggests, we will use \'embryo\' to refer to any human entity considered theoretically capable of implantation and development in the womb. Many regulatory positions distinguish between the creation of a cloned embryo for reproductive purposes and for other purposes. For our purposes, the former will be called reproductive cloning (*RC for short*) and the latter non-reproductive cloning (*NRC for short*). This paper will examine the regulatory position of the thirty countries for which we have been able to obtain reliable information (see Table [1](#T1){ref-type="table"}). Where possible, we have relied on copies of the original legislation or of English translations of that legislation. In some situations we have also found it necessary to rely on other published sources \[[@B6]\] and personal communications. ###### Summary of regulation\* **Country** **National legislation and effect, or approach in the absence of national legislation** --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- Australia *Prohibition of Human Cloning Act 2002:*Prohibits both RC and NRC Austria *Act No.275 of 1st July 1992:*Implicitly prohibits both RC and NRC Belgium *Law of 11th May 2003:*Prohibits RC but permits NRC Canada *Assisted Human Reproduction Act 2004:*Prohibits both RC and NRC China *None*Ministerial regulations prohibit RC and allow NRC Denmark *Law No.460 of 1997:*Prohibits both RC and NRC Finland *Medical Research Act No.488 of 1999:*Prohibits RC, *but*NRC might not be included within this prohibition France *Law of July 2004:*Prohibits both RC and NRC Germany *Embryo Protection Act 1990:*Prohibits both RC and NRC Greece *Law 3089 of 23rd December 2002:*Prohibits RC, but does not cover NRC Iceland *Law No. 55 of 29th of May 1996:*Prohibits both RC and NRC India *None*Guidelines reject RC but might allow NRC Ireland *None*Constitutional provision might prohibit both NRC and RC Israel *Prohibition of Genetic Intervention (Human Cloning and Genetic Manipulation of Reproductive Cells) Law 1999:*Imposes a moratorium on RC, silent on NRC Italy *Law of 2003:*Prohibits both RC and NRC Korea *Bioethics Law 2003:*Prohibits RC, silent on NRC Luxembourg *None* Mexico *General Health Law of 7 May 1997:*Prohibits both RC and NRC Netherlands *Embryo Act 2002:*Prohibits RC and imposes a moratorium on NRC New Zealand *Medicines (Restricted Biotechnical Procedures) Amendment Act 2002:*Prohibits RC, silent on NRC Norway *Law No. 100 of 5 December 2003:*Prohibits both RC and NRC Peru *General Law No. 26842 of 9 July 1997:*Prohibits both RC and NRC Portugal *None*Ratified Convention (discussed below) Russia *Law on the Temporary Prohibition of Human Cloning 2002:*Imposes a Moratorium on RC Spain *Law 35 of November 1988:*Prohibits both RC and NRC Sweden *Law No. 115 of 14th March 1991:*Implicitly prohibits both RC and NRC (with possible gaps) Switzerland *Federal Law of 18 December 1998:*Prohibits both RC and NRC Thailand *None* UK *Human Fertilisation and Embryology Act 1990:*Permits NRC under licence *Human Reproductive Cloning Act 2001:*Prohibits RC United States *None*Some states have legislation prohibiting RC or both RC and NRC \* The International Digest of Health Legislation <http://www3.who.int> provides translations of the legislation of Austria (1993, vol 44); Denmark (1997, vol 48); Israel (2000, vol 51), Norway (2003, vol 54), Peru (1998, vol 49), and Switzerland (1999, vol 50, and 2003, vol 54). The Bulletin of Medical Ethics provides translations of the legislation of Finland (Feb 2000, p7) and Germany (Dec 1990, p9). In addition, we have used English translations of the legislation of Greece <http://www.coe.int>, the Netherlands <http://www.minvws.nl>, and Sweden (Ministry of Health and Social Affairs, *Swedish Act concerning Use of Gene Technology on Human Beings and Experiments with Fertilised Ova*, 1991). Understanding the complexity of this \"regulatory patch work\" is essential \[[@B7]\]. It provides a sense of the vast differences between nations, the issues on which there are different views, and the existing regulatory uncertainties. In addition, it highlights both the challenges associated with the regulation of a controversial and rapidly evolving area of science and the need for a regulatory framework that can accommodate this reality. Finally, it demonstrates that policy makers cannot rely on the existence of a single regulatory trend to inform policy development. Only on the banning of RC (reproductive cloning) do the world\'s legislatures and policy-makers display anything approximating a single mind. Senator Morin, who is a member of Canadian Senate, was not right to claim that a majority of recent legislation bans both RC and NRC (non-reproductive cloning). Even looking beyond recent legislation, only a narrow majority of the thirty countries studied actually prohibit NRC. What is more, a large minority of countries have yet to enact national legislation. This paper is divided into sections. The next, section II, will examine the degree of regulatory variation in the countries studied. Section III will ask whether the existence of legislation answers all regulatory questions. Using examples drawn from those countries with legislation, we seek to show how broad interpretative strategies are sometimes required to avoid unintended lacunae. Section IV uses examples to demonstrate the evolving nature of regulatory positions and increasing reliance on legislation. Section V examines the impact of international initiatives in European (ie the European Convention on Human Rights and Biomedicine) and the United Nations. Section VI will explain why the regulatory outcome usuallysays little about the ethical approach adopted by a particular jurisdiction. Section VII is the conclusion. Variation between countries --------------------------- As many commentators have noted, there is great variation in regulatory approaches even within countries that have decided to create relevant laws and policies \[[@B4],[@B5],[@B7],[@B8]\]. No two countries have adopted identical regulatory measures on cloning, though the effect of those adopted in some countries is very similar. There is only one area of regulatory agreement -- no jurisdiction has, yet, adopted legislation or guidelines permitting RC. As a result, there are essentially only two regulatory approaches to RC: prohibition or regulatory silence. Regulatory silence usually means that RC is technically legal in the jurisdiction in question, though if it were attempted, there would likely be a rapid regulatory response. The majority of the countries studied have now enacted national legislation (see Table [1](#T1){ref-type="table"}). Only seven have yet to do so. The absence of national legislation in these seven countries should not, however, be taken to amount to an absence of regulation or, in the case of the US, an absence of state legislation. Legislation is just one of many possible regulatory responses. Ireland provides an illustrative example. The Eighth Amendment to the Irish Constitution (which forms Article 40.3.3) states that, \"The State acknowledges the right to life of the unborn and, with due regard to the equal right to life of the mother, guarantees in its laws to respect, and, as far as practicable, by its laws to defend and vindicate that right.\" While this provision does not mention cloning, it has been taken to protect *in vitro*embryos and thereby prohibit NRC. In addition, doctors must comply with the guidance of the Medical Council, as this body has the power to remove their licence to practise in Ireland. The Medical Council\'s guidelines declare that \" \[t\]he creation of new forms of life for experimental purposes or the deliberate and intentional destruction of human life already formed is professional misconduct\" \[[@B9]\]. Also, it limits the manipulation of sperm or eggs to the \"improvement of health\" and adds that \"if the intention is\...the creation of embryos for experimental purposes, it would be professional misconduct\" \[[@B9]\]. Thus, the absence of legislation in Ireland does not render all things permissible. Variation and non-reproductive cloning (NRC) -------------------------------------------- NRC represents the source of considerable regulatory variation. While NRC is not permitted in seventeen of the countries studied, it could be permitted in *up to thirteen*other countries. Regulatory uncertainties make it impossible to be sure in some of these counties. Also, some countries (such as the US) have many jurisdictions, each capable of adopting a different regulatory position. Given the superficial similarity of many of these countries and jurisdictions, it is hard to explain such stark variation on cultural differences alone \[[@B8],[@B10]\]. Only Belgium and the UK have deliberately enacted or extended legislation for the purpose of permitting the creation of cloned embryos for research \[[@B6],[@B11]\]. The UK licensing authority has, in fact, granted its first licence to conduct NRC \[[@B12]\]. Similarly permissive approaches, albeit non-legislative, have been adopted by China (which issued Ministerial Regulations in August 2003 to allow cloning research for therapeutic purposes) \[[@B6],[@B13]\] and Korea (where the government is in the process of approving limited research on limited somatic nuclear transfer research) \[[@B6]\]. In contrast, Finland, Greece, Israel, Russia and Sweden appear to allow NRC only because their legislation has potential gaps \[[@B14]\]. The Greece legislation is the most striking, because it is the most recently enacted. The Greek Law 3089/2002 explicitly prohibits \'human reproduction\' by any cloning method, but no mention is made of NRC. This must have been deliberate, because the provision allowing embryo research does so by allowing research (with consent) on \"fertilized ova\" that are surplus following assisted reproductive treatment. Indeed, the legislation\'s Explanatory Memorandum declares that \"only reproductive cloning is prohibited. It could be thus construed that therapeutic cloning is permitted\....This position has also been supported in the Report of the National Bioethics Committee regarding the use of stem cells in biomedical research and clinical practice (21.10.2001), submitted to the Prime Minister on 11.1.2002.\" This is nonetheless controversial in Greece, which has ratified both the European Convention on Human Rights and Biomedicine, and its Additional Protocol on cloning (discussed below). The US, India, and Portugal are anomalous. In the US, what little national legislation there is only concerns the use of federal funds \[[@B4]\] and some States (such as California and New Jersey) have even adopted permissive legislation \[[@B15]\]. The Indian Council of Medical Research has declared that \"research on cloning with intent to produce an identical human being, as of today, is prohibited\", but has not declared NRC to be so prohibited \[[@B16]\]. However, an Indian Government policy document \"opens the door to therapeutic cloning considered on a case-by-case basis by the National Bioethics Committee\" \[[@B6]\]. Portugal has no national legislation, but has ratified the European Convention and its Additional Protocol (see below). Legislative gaps and uncertainties ---------------------------------- There are, of course, many nations that have long standing laws that are relevant to cloning technologies. In many of these nations, however, the laws were designed prior to Dolly and the recent advances in stem cell research. As such, how these laws might apply to cloning is sometimes unclear. Also, these laws are not a result of a public and political dialogue about the complex scientific and ethical issues that are associated with cloning and stem cell technologies. \[[@B10]\] In addition, there are a number of countries where recent legislative intervention has failed to answer all legal questions relating to human cloning. The legislation of some countries clearly encompasses somatic cell nuclear transfer (SCNT). The Spanish Law 35 of November 1998 is an example of a pre-Dolly legislation of this type. This Act not only renders it an offence to create identical human beings where it is aimed at race selection, it also renders it an offence to create \"human beings by cloning in any of the variants or any other procedure capable of originating several identical human beings.\" The Canadian Assisted Human Reproduction Act 2004 is an example of post-Dolly legislation of this type. Under this Act, the creation and implantation of a \"human clone\" are prohibited. \"Human clone\" is defined under s. 3 to mean \"an embryo that, as a result of the manipulation of human reproductive material or an *in vitro*embryo, contains a diploid set of chromosomes obtained from a single -- living or deceased -- human being, foetus or embryo\". This clearly captures SCNT. In a number of contrasting countries, SCNT is only captured by a broad, non-literal interpretation of the relevant provisions. The Swedish Law No. 115 of 14 March 1991 is an example of pre-Dolly legislation of this type. This Act only regulates experiments performed on \"fertilised ova\" or gametes \"before fertilisation\". The Finnish Medical Research Act 1999 is a rare example of post-Dolly legislation of this type. This Act has many provisions with respect to research on embryos (including a prohibition on the creation of embryos for research) and it prohibits all research conducted with the aim of cloning a human being. However, s. 2 of the Act defines an embryo as \"a living group of cells resulting from fertilisation not implanted in a woman\'s body\". Thus, the Dolly technique only appears to be covered insofar as its use involves \"research with the aim of cloning human beings\" (Also, s.1 of the Constitution secures the inviolability of human dignity, but there is no authoritative interpretation on whether (and how) this provision could apply to cloning). If this aim is only correctly attributed to RC, then NRC might not be covered at all. The dangers of non-literal interpretation of pre-Dolly provisions should not be exaggerated. Although there are a number of countries that have such legislation (notably, Austria and Germany and, until very recently, France) \[[@B5]\], in reality the courts are likely to adopt a broad, purposive approach to interpretation. A very broad approach was, for example, taken when the domestic courts addressed the UK\'s Human Fertilisation and Embryology Act 1990 \[[@B17]\]. The Act explicitly prohibited only one form of cloning (the creation of a clone by replacing the nucleus of an embryo) leaving the licensing authority to regulate activities such as the creation, storage, and use of *in vitro*embryos. More precisely, the Act imposes a licensing requirement on the creation of an *in vitro*embryo (ss.3(1)(a) and 1(2)); storage or use of *in vitro*embryos (ss.3(1)(b) and 1(2)); storage of gametes (s.4(1)(a)); and use of gametes, unless \'services are provided for the woman and man together\' (s.4(1)(b)). Yet, under s. 1(1) of the Act, \"embryo\" is defined as \"a live human embryo where fertilisation is complete\", including \"an egg in the process of fertilisation\". This raised the question of whether SCNT fell outside the Act altogether. Nonetheless, the House of Lords recently held that SCNT produces a functional embryo that falls within the ambit of this Act (in effect, holding that the Act\'s definition of embryo is non-exhaustive and restricted in purpose) \[[@B18]\]. Evolving nature of the laws --------------------------- Not only is there a great deal of variation between nations and much uncertainty as to the scope of existing laws, many of the existing laws and policies are in a state of flux. Indeed, some countries have built in review provisions. The Dutch legislation, the Embryo Act 2002, presents an example. This Act prohibits procedures undertaken for the purpose of creating genetically identical human individuals and prohibits the creation of embryos for research. Yet, s. 33 of the Act allows for the future repeal of the prohibition on the creation of embryos for research. Likewise, the recently enacted Canadian legislation states that a Parliamentary review of the law is required within three years of proclamation. Some countries, such as Israel, New Zealand and Russia, have even adopted time-limited legislation. The Israel legislation of 1999, for example, states that, *for a period of 5 years*, no intervention will be carried out on human cells for the purpose of human cloning or to bring about the creation of a person by the use of reproductive cells that have undergone permanent intentional genetic modification \[[@B19]\]. What is more, the Act states that the Minister of Health may (upon satisfaction of a number of conditions) permit the creation of a human being through the use of genetically modified cells. Non-legislative bans are often time-limited or chosen because of the ease with which they can be reconsidered. Other countries are in the process of considering a revision to their existing law. Ireland has set up a Commission on Assisted Human Reproduction in 2000 to explore this topic \[[@B20]\] and the Irish government has officially stated its opposition to cloning \[[@B21]\]. There are voices calling for revision of the Germany legislation \[[@B22]\]. The recently passed Italian legislation might have to be reconsidered because a referendum on a disputed law can be forced if 500,000 signatures are obtained and it has been reported that over a million people have signed a petition calling for a referendum \[[@B23]\]. The Swedish legislation might well be amended in the near future, to close the gaps mentioned in the last section. If the Government Bill 2003/04:148 on stem cell research is enacted, it will come into force on the 1st of January 2005. This Bill seeks to extend the existing legislation to make it clear that RC using the somatic nuclear transfer is encompassed *and*to explicitly allow somatic nuclear transfer as a way of creating embryos for non-reproductive purposes. Thus, Sweden is likely to join Belgium and the UK in permitting NRC by legislation. International initiatives ------------------------- ### i) European Convention The European Convention on Human Rights and Biomedicine has now been signed by 31 of the 45 member States of the Council of Europe, of which 15 have also ratified the Convention \[[@B24]\]. It has not been signed by any of the non-member participants (which include Australia, Canada, the Holy See, Mexico, and the US). While this Convention does not specifically address human cloning, a number of its provisions have implications for cloning. Article 18(2) of the Convention prohibits the \"creation of human embryos for research purposes\". The phrase \"human embryos\" is not defined by the Convention and subsequent negotiations of the working party on the protection of the human embryo and fetus appear to have failed to reach agreement on this and other issues. This provision only prohibits NRC if it captures the creation of all *functional*human embryos for research. While the Convention makes provision for referrals of questions of interpretation to the European Court of Human Rights (Article 29), referral is unlikely because the Convention arguably leaves such decisions to the discretion of individual States. The Strasbourg court itself allows individual States a wide discretion (known as the \'margin of appreciation\') in controversial policy areas. The court has, for example, adopted this approach when considering whether the fetus is included in the provision of the European Convention on Human Rights and Fundamental Freedoms that grants \'everyone\' a right to life (see the latest case: *Vo v France*(no. 53924/00)). Moreover, before signing or ratifying the Convention on Human Rights and Biomedicine, any State could make a reservation to this provision insofar as it is inconsistent with their pre-existing law (Article 36). This is what we would expect the UK to do if it eventually signs the Convention. Whether RC is implicitly prohibited by the Convention is more controversial. Those who hold that cloning violates human dignity will no doubt point to Article 1, which requires parties to the Convention to \"protect the dignity and identity of all human beings\". This seems tenuous. There is, however, an Additional Protocol on the Prohibition of Cloning Human Beings \[[@B25]\]. Article 1 of the Additional Protocol declares that, Any intervention seeking to create a human being genetically identical to another human being, whether living or dead, is prohibited. Since \"genetically identical\" is defined, under Article 1(2), as \"sharing with another the same nuclear gene set\", use of the Dolly technique on humans is included within this prohibition. This provision clearly captures RC. What is more controversial is whether it covers NRC. To foreclose this possibility, when the Dutch government signed the Protocol it added an interpretative statement declaring that it \"interprets the term \"human beings\" as referring exclusively to a human individual, ie a human being who has been born\". This interpretative statement is arguably unnecessary, because, in the absence of a definition of human being in the Convention itself, States are free to interpret this provision in accordance with their own national policy. The impact of these international instruments is particularly important with regard to the three countries that have ratified both: Portugal (which has no legislation), Greece (whose legislation only explicitly prohibits RC), and Spain (which has comprehensive legislation in this area). In Greece, the Explanatory Memorandum to the legislation declares that \' \[i\]t could be\...that therapeutic cloning is permitted exactly as in Article 1 paragraph 1 of the Additional Protocol on Cloning\'. We understand that conservative opinion is of the view that this interpretation is in conflict with Article 18(2) of the Convention itself. However, neither the Convention nor the Protocol on Cloning provide any sanctions for violation. ### ii) United Nations The United Nations\' struggle to agree on a cloning treaty exemplifies both the variation of approaches and the challenges associated with seeking consensus in a morally contested area \[[@B26]\]. In December 2001, the UN General Assembly established an Ad Hoc Committee to consider \"the elaboration of an international convention against the reproductive cloning of human beings\" \[[@B27]\]. Since that time, a number of treaty proposals have been considered. A proposal by France and Germany, for example, recommended a narrow ban on RC only, leaving NRC for future debate \[[@B28]\]. A second proposal supported by Spain and the US, argued for a comprehensive ban on cloning, including NRC \[[@B29]\]. The most recent proposal, which was put forward by Costa Rica, would require states to establish criminal offences for all human cloning, including NRC \[[@B30]\]. There has, however, been little consensus on how to proceed. Though all countries agree that RC should be banned, there is deep division regarding NRC. Neither the Ad Hoc cloning committee nor the UN\'s Legal Committee could reach a consensus on which proposal to support and bring before the General Assembly. In November 2003 the Legal Committee voted (80-79) to recommend a two-year deferral on a General Assembly decision -- a compromise that was put forward and supported by most of the members of the Organization of the Islamic Conference. This decision was largely seen as a victory for those countries supporting a more permissive approach to cloning policy \[[@B31]\]. Indeed, some viewed the two year delay as an ideal opportunity for the scientific community to promote the value of NRC \[[@B32]\]. However, in response to pressure from those countries seeking a comprehensive ban, the General Assembly came to yet another compromise. In January 2004 the General Assembly overturned the Legal Committee\'s recommendation and supported a one year delay on the debate over the cloning treaty. This October, the General Assembly re-opened the debate, again with no apparent compromise from either camp \[[@B33]\]. The fact that the deep division at the UN is primarily about NRC reflects the lack of any consistent approach to cloning policy. For example, one would expect an emerging trend toward the banning of NRC, as suggested in the quote by Senator Morin, to be reflected in the building of consensus or, at least, a degree of flexibility at the UN General Assembly. Ethical considerations ---------------------- Few areas of regulation are as evidentially driven by ethical views as the regulation of cloning and cloning research. This is not the place for in-depth analysis of the underlying debate. Elsewhere we have both argued that existing regulatory attempts to prohibit RC have rarely been underpinned by thoughtful exposition of underlying ethical principles \[[@B5],[@B10],[@B34]\]. Policy statements frequently rely on claims that are tautologous, under specified, poorly considered, or a combination of these things. Our claim here is more modest. In this section we seek to show why attempts to understand the ethical basis of the existing law cannot focus solely on the existing regulatory outcomes. And, of course, the regulatory outcome does not, necessarily, represent a jurisdictional consensus on the central ethical issues. Lawyers rarely look to regulatory outcome to understand ethical debates. Unfortunately, in the area of cloning many commentators do that very thing. As our starting quotation demonstrates, politicians and commentators are all too ready to find support for their ethical views in regulatory positions adopted elsewhere. There are, however, varying levels of ethical agreement. Agreement on the appropriate regulatory position does not imply agreement on the underlying ethical principles. Consider the relationship between ethical positions on the moral status (or dignity) of the cloned embryo and NRC. The cloned embryo could be considered to have full, no, or limited moral status \[[@B18],[@B35]\]. The *full status*position would grant the embryo the same level of moral duties as you or I. The *no status*position would grant the embryo no more status or dignity than your hair or nails. The *limited status*position would grant the embryo a fixed or gradualist level of intrinsic moral value between these two extremes. The full status position will require the prohibition of NRC (destructive use of embryos is considered murder) and the no status position will usually require NRC to be permitted (unless such an approach will interfere with the moral interests of those who do matter). The limited status position is, however, potentially compatible with either regulatory position, depending on the particular status given to the early embryo and the weight given to potential benefits of NRC. It follows that the fact that the regulatory position permits or prohibits NRC does not do even tell us what status the embryo is considered to have. This is further complicated by the fact that supporters of the no or limited status position might be prepared to accept more restrictions than are strictly required by their position to protect a more important moral goal. Only supporters of the full status position cannot coherently make such pragmatic compromises \[[@B18]\]. Similarly, the existing positions on RC could be supported by radically different ethical views. Prohibitions could be supported by those who hold that RC is absolutely wrong (eg always violates human dignity) and by those who hold that cloning at present would be wrong. Even time-limited prohibition does not enable us to discern whether it is underpinned by, for example, the view that RC is wrong because of current safety issues or the view that RC is not wrong but the most effective way to get there is by initially prohibiting it. In sum, the majority of regulatory outcomes could be coherently explained by reference to one or more underlying ethical positions. Thus, similar or even identical regulatory outcomes imply less by way of ethical agreement than some may be inclined to believe. Conclusion ========== Cloning laws and policies are far from uniform across the globe and the legal position in some countries remains uncertain. This will give little comfort to scientists and policy makers hoping to gain clear direction from the international position. For the time being at least, policymakers must accept the reality of international \"dissensus\" and scientists wishing to undertaken research on NRC are best advised to consider conducting their research in only a handful of countries. Even where there is agreement as to the regulatory outcome, policy-makers should not confuse this with agreement on underlying ethical principles. Like many topics concerning the developing genetic and reproductive technologies, cloning remains controversial. Competing interests =================== The author(s) declare that they have no competing interests. Authors\' contribution ====================== Both authors contributed to the original concept for the paper, the writing and revision of the manuscript and the analysis of the law. Pre-publication history ======================= The pre-publication history for this paper can be accessed here: <http://www.biomedcentral.com/1472-6939/5/9/prepub> Acknowledgements ================ Professor Caulfield is a Canada Research Chair in Health Law and Policy and would like to thank the Alberta Heritage Foundation for Medical Research, Genome Prairie and the Stem Cell Network for research support. We would like to thank those who provided information on the laws of other jurisdictions, in particular, Tina Garanis-Papadatos (Greece), Salla Lötjönen (Finland), Deirdre Madden (Ireland), André Pereira (Portugal), and Elisabeth Rynning (Sweden). Finally, we would like to thank the reviewers for their useful comments.

Introduction {#s1} ============ The ability to recognize 'self' plays an important role in regulating diverse processes across biological organizational levels ([@bib87]). Analogous to the acquired immunity system, which depends on self-recognition at the cellular and molecular levels ([@bib9]), adaptive organismal social interactions often depend on the recognition of kin and/or group-members to increase cooperation or to suppress inbreeding ([@bib41]; [@bib42]; [@bib65]; [@bib85]; [@bib92]; [@bib94]). One remarkable example of organismal recognition of 'self' comes from colonies of social insects, which depend on a robust non-nestmate discrimination system (more commonly called 'nestmate recognition') to prevent the loss of expensive resources to non-nestmates, and to maintain overall colony integrity ([@bib43]; [@bib89]). As in other self-recognition systems, theoretical models suggest that nestmate recognition in social insect colonies depends on the ability of individual colony members to reliably match colony-specific phenotypic cues, or 'labels', carried by other colony members, to stored neural 'templates' ([@bib15]; [@bib32]; [@bib37]; [@bib39]; [@bib46]; [@bib50]; [@bib66]; [@bib87]; [@bib89]). In some social insect species, the cues used in recognizing individual members of the colony have been reported to be visual ([@bib4]), but in most cases are thought to be chemical ([@bib89]). Cuticular hydrocarbons (CHCs), which evolved to function as hydrophobic, anti-desiccant barriers in terrestrial arthropods, have been co-opted to also function as pheromones in diverse insect communication systems, including nestmate recognition in social insect species ([@bib22]; [@bib89]). Whether the overall profile, or more specific components of it, represent the actual nestmate recognition cue remains unknown. However, previous studies have indicated that variations in the relative amounts of each compound in the CHC profile across individuals from different colonies are likely sufficient for the chemical recognition of nest membership ([@bib89]). Nevertheless, how large groups of hundreds to thousands of individuals coordinate the production and recognition of a robust colony-specific chemical cue remains unknown for most species. Because members of social insect colonies are often genetically related, it was initially assumed that the production of similar colony-specific pheromones by individual colony members is intrinsically driven by shared allelic variants ([@bib25]; [@bib39]; [@bib38]). However, empirical studies revealed that, surprisingly, in many social insect species colony and social environmental factors play the most dominant role in defining colony-specific cues, and can often mask genetic relatedness ([@bib11]; [@bib30]; [@bib44]; [@bib51]; [@bib54]; [@bib74]; [@bib80]). Although these colony 'environmental' factors remain unknown for most social insect species, it has been suggested that contributions from nest building materials ([@bib11]; [@bib23]; [@bib27]; [@bib33]; [@bib74]), the queen ([@bib21]; [@bib20]; [@bib19]; [@bib18]), and diet ([@bib16]; [@bib17]; [@bib54]; [@bib67]; [@bib68]) could, at least in part, provide unique chemical components to the chemical signature shared by colony members. Consequently, empirical and theoretical studies suggested that individual colony members acquire their colony-specific chemical signature largely through a homogenization process involving the exchange of relevant chemicals, including CHCs, through interactions between colony members or contact with nest building materials, often referred to as the 'Gestalt' model ([@bib25]). Empirical evidence in support of this model has been reported for a few ant species, which are known to transfer mixed blends of CHCs between individuals through trophallaxis and grooming via the action of the postpharyngeal gland (PPG) ([@bib10]; [@bib53]; [@bib61]; [@bib76]; [@bib78]; [@bib88]). However, other studies suggest that such CHC homogenization processes might not fully represent how colony-specific chemical cues develop in all social insect species. For example, some ant species do not display robust trophallaxis behaviors, the main mode of chemical transfer across colony members ([@bib76]; [@bib78]), and in others, the CHC profiles of individual colony members are likely modulated by genetic relatedness ([@bib84]), age ([@bib26]; [@bib84]), and/or task ([@bib60]; [@bib82]; [@bib91]; [@bib90]). Together, these data suggest that the regulation of chemical cues in different species is more variable and complex than initially hypothesized ([@bib34]; [@bib62]; [@bib81]), and remains unknown for most social insect species. Consequently, here we investigated the development of CHC profiles and nestmate recognition cues in the European honey bee, *Apis mellifera*, a species of economic importance and one of the best studied social insect species. Numerous previous studies have demonstrated that honey bees exhibit a robust nestmate recognition system that is based on the chemical recognition of pheromones ([@bib89]). Analyses of CHC profiles showed that newly emerged honey bee workers express significantly lower amounts of total CHCs and lower overall CHC chemical diversity in comparison to older foragers, which are expected to elicit the strongest nestmate recognition response from guards at the entrance to the hive ([@bib13]; [@bib48]). Additionally, other studies have suggested that honey bee nestmate recognition cues might be derived from various environmental sources ([@bib30]), and hive building materials such as the honeycomb wax ([@bib12]; [@bib11]; [@bib23]; [@bib27]). Based on these studies, it has been hypothesized that, similar to some ant species, the CHC profile of newly eclosed workers represents a 'blank slate' ([@bib13]; [@bib52]), and that nestmate recognition cues are subsequently acquired by individual workers primarily through the homogenization and transfer of chemicals via direct social interactions and intermediate environmental factors ([@bib14]). Furthermore, it has recently been proposed that the cephalic salivary gland of honey bee workers is functionally analogous to the PPG in ants, and could be involved in the homogenization and transfer of the CHCs between colony members ([@bib59]). However, when and how honey bee chemical nestmate recognition cues mature, and whether CHC homogenization mechanisms play a role in this process have not been directly investigated. Here, we provide empirical evidence that the maturation of the CHC profile of individual honey bee workers is primarily regulated by innate developmental processes associated with age-dependent behavioral tasks and modulated by the social colony environment, and that mature colony-specific recognition cues are primarily associated with the foraging task. Specifically, we find that individual workers exhibit stereotypic quantitative and qualitative changes in their CHC profile as they transition from in-hive tasks to foraging outside, that these changes are associated with innate transcriptional changes in CHC biosynthetic pathway genes, and that only forager honey bees are behaviorally rejected from the entrance of an unrelated hive. Together, our findings suggest that not all members of honey bee colonies display a uniform cuticular chemical profile via the direct acquisition of CHC mixes. Instead, our data indicate that CHC profiles, and likely nestmate recognition cues, in honey bees are more likely a product of a genetically-determined developmental program that is modulated by colony-specific factors. Results {#s2} ======= CHC profiles of individual honey bee workers exhibit qualitative and quantitative age-dependent changes {#s2-1} ------------------------------------------------------------------------------------------------------- Given that newly emerged honey bees have lower amounts of total CHCs, and exhibit less chemical diversity compared to older bees ([@bib13]), we initially sought to determine the age at which the CHC profile of individual honey bee workers matures. To achieve this goal, we analyzed the CHC profiles of individual workers from a single age-cohort that was reintroduced back into its source colony and then collected at different ages. This analysis revealed that the total amount of CHCs increases between one-day post-reintroduction and 14 days post-reintroduction and then remains stable ([Figure 1A](#fig1){ref-type="fig"}, Kruskal-Wallis, H = 9.21, df = 3, p=0.026, FDR pairwise contrasts: Day 1 vs. Day 7 p=0.11, Day 1 vs. Day 14 p=0.036, Day 1 vs. Day 21 p=0.04, Day 7 vs. Day 14 = 0.613, Day 7 vs. Day 21 p=0.691, Day 14 vs. Day 21 p=0.79; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, ANOVA, F(3,28) = 6.40, p=0.002, FDR pairwise contrasts: Day 1 vs. Day 7 p=0.036, Day 1 vs. Day 14 p=0.001, Day 1 vs. Day 18 p=0.007, Day 7 vs. Day 14 = 0.412, Day 7 vs. Day 18 p=0.993, Day 14 vs. Day 18 p=0.305). Additionally, individual compounds vary in total amount across bees of different ages ([Figure 1C,D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1C,D](#fig1s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}, [Table 2](#table2){ref-type="table"}). Independently of the age-related quantitative changes, we also found that the CHC profiles of workers exhibit age-related qualitative changes in the overall CHC chemical composition ([Figure 1B](#fig1){ref-type="fig"}, Permutation MANOVA, F(1,31) = 22.86, R^2^ = 0.43, p\<0.001, FDR pairwise contrasts: Day 1 vs. Day 7 p=0.002, Day 1 vs. Day 14 p=0.002, Day 1 vs. Day 21 p=0.002, Day 7 vs. Day 14 = 0.017, Day 7 vs. Day 21 p=0.002, Day 14 vs. Day 21 p=0.31; [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}, Permutation MANOVA, F(3,28) = 2.35, R^2^ = 0.22, p=0.038, FDR pairwise contrasts: Day 1 vs. Day 7 p=0.024, Day 1 vs. Day 14 p=0.011, Day 1 vs. Day 18 p=0.018, Day 7 vs. Day 14 = 0.406, Day 7 vs. Day 18 p=0.212, Day 14 vs. Day 18 p=0.524), as well as in the relative amounts of individual CHCs ([Figure 1E,F](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1E,F](#fig1s1){ref-type="fig"}, [Table 3](#table3){ref-type="table"}, [Table 4](#table4){ref-type="table"}). These data confirm that not all members of a honey bee colony share a common CHC profile ([@bib48]), and suggest that age-dependent processes might be playing an important role in the regulation of both the quantitative and qualitative dimensions of the cuticular chemical profiles of individual honey bee workers. {ref-type="table"}, statistics for E and F are listed in [Table 3](#table3){ref-type="table"}. Lowercase letters above bars in A and legend in B denote *posthoc* significance (p\<0.05). Sample size per group, N = 8.\ 10.7554/eLife.41855.005Figure 1---source data 1.Amount (ng) of each compound extracted from each bee sample in [Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.](elife-41855-fig1){#fig1} 10.7554/eLife.41855.006 ###### Individual CHCs vary in total amount (ng) across different aged sister bees of a single colony. Numbers represent mean amount (ng) of compound across bees of that age ±standard error. All p-values are from parametric ANOVA or nonparametric Kruskal Wallis ANOVA (denoted by 'KW'). Letters denote statistically significant age groups across individual compounds via Tukey's HSD (ANOVA post-hoc) or Dunn's Test with FDR adjustment (KW post-hoc) (p\<0.05). Compound Name Retention time Day 1 Day 7 Day 14 Foraging p-value -------------------- ----------------------------- ---------------- ---------------------- ---------------------- ---------------------- ----------------------- -------------- C~18:1~ z-(9)-Octadecenoic acid 20.23 146.91 ± 52.98 (A) 1213.9 ± 250.45 (AB) 2193.35 ± 360.14 (B) 2465.05 ± 779.73 (B) 0.004 (KW) C~23:1~ Tricosene 20.72 121.69 ± 7.05 (A) 86.74 ± 9.13 (B) 68.64 ± 9.57 (B) 61.79 ± 9.87 (B) \<0.001 C~23~ Tricosane 21.21 1372.77 ± 115.62 (A) 811.16 ± 97.45 (B) 688.47 ± 50.32 (B) 662.47 ± 70.72 (B) 0.001 (KW) C~24~ Tetracosane 22.79 43.54 ± 2.33 41.8 ± 3.58 46.47 ± 2.67 45.66 ± 4.39 0.756 C~25:1~ Pentacosene 23.89 134.75 ± 7.73 167.38 ± 15.77 131.94 ± 10.87 122.74 ± 13.46 0.123 (KW) C~25~ Pentacosane 24.34 1280.62 ± 78.61 1253.94 ± 145.03 1364.18 ± 51.8 1465.39 ± 195.17 0.663 C~27:1~ Heptacosene 26.87 359.94 ± 109.71 (A) 67.55 ± 5.22 (B) 299.98 ± 33.28 (A) 340.49 ± 29.27 (A) 0.006 C~27~ Heptacosane 27.3 5021.35 ± 335.43 3561.92 ± 394.09 3875.36 ± 135.84 4098.48 ± 688.78 0.071 (KW) 11,13 methyl C~27~ 11- + 13 methyl Heptacosane 27.75 1531.35 ± 58.53 (A) 676.77 ± 53.97 (B) 525.89 ± 19.46 (BC) 501.91 ± 32.38 (C) \<0.001 C~28~ Octacosane 28.67 273.28 ± 26.17 (A) 164.61 ± 17.67 (B) 234.58 ± 29.25 (AB) 179.57 ± 26.62 (AB) 0.018 C~29:1~ Nonacosene 29.71 300.3 ± 21.91 (A) 415.71 ± 19.53 (B) 484.12 ± 21.65 (B) 515.79 ± 37.33 (B) \<0.001 C~29~ Nonacosane 30.05 3891.37 ± 203.93 3361.26 ± 373.3 3535.4 ± 161.9 3421.62 ± 376.05 0.626 (KW) 11,13 methyl C~29~ 11- + 13 methyl Nonacosane 30.48 1888.38 ± 76.35 (A) 621.6 ± 51.82 (B) 490.47 ± 27.34 (B) 482.86 ± 24.65 (B) \<0.001 z(7) C~31:1~ z-(7)-Hentriacontene 32.72 1930.38 ± 95.12 (A) 3030.3 ± 152.07 (B) 3336.99 ± 139.27 (B) 3437.57 ± 146.12 (B) \<0.001 z(9) C~31:1~ z-(9)Hentriacontene 32.85 1572.04 ± 82.09 (A) 2623.84 ± 145.02 (B) 2756.09 ± 101.15 (B) 2748.6 ± 137.39 (B) \<0.001 C~31~ Hentriacontane 33.25 2471.77 ± 155.09 3307.06 ± 347.6 3095.7 ± 150.22 2904.22 ± 351.69 0.158 (KW) C~33:2~ Tritriacontadiene 36.44 818.13 ± 30.77 (A) 3901.71 ± 233.3 (B) 4700.8 ± 289.64 (BC) 5351.18 ± 332.47 (C) \<0.001 (KW) C~33:1~ Tritriacotene 37.13 5228.89 ± 272.19 (A) 8952.18 ± 674.83 (B) 7673.85 ± 413.67 (B) 6778.42 ± 442.85 (AB) \<0.001 (KW) C~33~ Tritriacotane 37.76 282.16 ± 19.8 (A) 523.87 ± 57.72 (B) 485.29 ± 30.47 (B) 440.35 ± 70.92 (AB) 0.009 10.7554/eLife.41855.007 ###### Individual CHCs vary in total amount (ng) across different aged sister bees of a second colony. Numbers represent mean amount (ng) of compound across bees of that age ±standard error. All p-values are from parametric ANOVA or nonparametric Kruskal Wallis ANOVA (denoted by 'KW'). Letters denote statistically significant age groups across individual compounds via Tukey's HSD (ANOVA post-hoc) or Dunn's Test with FDR adjustment (KW post-hoc) (p\<0.05). **C**ompound Name Retention time Day 1 Day 7 **Day 14** **Foraging** **p-value** -------------------- ----------------------------- ---------------- ---------------------- ------------------------ ------------------------ ------------------------ ------------- C~18:1~ z-(9)-Octadecenoic acid 20.23 969.4 ± 284.09 (A) 4062.76 ± 288.4 (B) 4410.73 ± 736.18 (B) 5711.9 ± 1741.17 (B) 0.004 (KW) C~23:1~ Tricosene 20.72 188.84 ± 31.5 (A) 252.45 ± 41.06 (AB) 449.27 ± 129.73 (AB) 692.43 ± 192.5 (B) 0.022 (KW) C~23~ Tricosane 21.21 2243.49 ± 329.45 1154.47 ± 276.64 3173.75 ± 1310.78 6778.99 ± 3385.43 0.108 (KW) C~24~ Tetracosane 22.79 92.03 ± 12.8 106.76 ± 34.59 191.62 ± 59.85 259.68 ± 81 0.078 (KW) C~25:1~ Pentacosene 23.89 223.72 ± 29.37 (A) 369.19 ± 74.13 (AB) 904.72 ± 314.93 (BC) 1000.5 ± 254.7 (C) 0.005 (KW) C~25~ Pentacosane 24.34 2897.27 ± 364.49 2820.94 ± 730.86 8160.17 ± 3143.65 8074.9 ± 3225.52 0.274 (KW) C~27:1~ Heptacosene 26.87 189.37 ± 62.24 (A) 412.19 ± 85.56 (AB) 804.57 ± 288.89 (B) 635.81 ± 116.71 (B) 0.017 (KW) C~27~ Heptacosane 27.3 10263.39 ± 1505.49 9644.33 ± 1394.55 15012.59 ± 3058.18 9042.02 ± 993.34 0.618 (KW) 11,13 methyl C~27~ 11- + 13 methyl Heptacosane 27.75 1373.16 ± 158.58 (A) 722.54 ± 92.7 (AB) 501.89 ± 82.05 (B) 575.83 ± 217.27 (B) 0.004 (KW) C~28~ Octacosane 28.67 284.5 ± 54.42 361.39 ± 56.38 430.28 ± 67.21 331.85 ± 35.45 0.348 C~29:1~ Nonacosene 29.71 420.31 ± 81.15 (A) 1047.99 ± 126.61 (B) 1491.92 ± 256 (B) 925.21 ± 121.1 (B) 0.002 (KW) C~29~ Nonacosane 30.05 5391.23 ± 1071 10175 ± 1632.19 12313.81 ± 2374.12 8962.64 ± 1385.72 0.087 11,13 methyl C~29~ 11- + 13 methyl Nonacosane 30.48 1702.45 ± 166.85 (A) 800.59 ± 95.67 (A) 535.16 ± 66.24 (AB) 382.5 ± 50.73 (B) \<0.001 z(7) C~31:1~ z-(7)-Hentriacontene 32.72 2189.03 ± 291.48 (A) 5370.16 ± 756.21 (B) 6185.18 ± 761.39 (B) 4426.13 ± 737.85 (AB) 0.005 z(9) C~31:1~ z-(9)Hentriacontene 32.85 1465.83 ± 254.41 (A) 4120.89 ± 652.81 (B) 4581.47 ± 665.27 (B) 3361.18 ± 661.26 (AB) 0.012 C~31~ Hentriacontane 33.25 3796.75 ± 847.96 10066.5 ± 1716.97 10082.89 ± 2677.18 7342.33 ± 1569.25 0.121 C~33:2~ Tritriacontadiene 36.44 242.82 ± 53.78 (A) 1724.73 ± 289.89 (B) 1353.86 ± 175.8 (B) 1393.43 ± 313.9 (B) 0.002 C~33:1~ Tritriacotene 37.13 7454.8 ± 1388.34 (A) 18126.35 ± 2516.57 (B) 17031.3 ± 3257.55 (AB) 9630.94 ± 1791.06 (AB) 0.014 C~33~ Tritriacotane 37.76 540.28 ± 149 (A) 2165.09 ± 457.66 (B) 1734.79 ± 523.36 (AB) 1214.4 ± 271.66 (AB) 0.037 (KW) 10.7554/eLife.41855.008 ###### Individual CHCs vary in proportion across different aged sister bees of a single colony. Numbers represent mean percentage of compound across bees of that age ±standard error. All p-values are from parametric ANOVA or nonparametric Kruskal Wallis ANOVA (denoted by 'KW'). Letters denote statistically significant age groups across individual compounds via Tukey's HSD (ANOVA post-hoc) or Dunn's Test with FDR adjustment (KW post-hoc) (p\<0.05). Compound Name Retention time Day 1 Day 7 Day 14 Foraging p-value -------------------- ----------------------------- ---------------- ------------------ ------------------ ------------------ ------------------ -------------- C~18:1~ z-(9)-Octadecenoic acid 20.23 0.51 ± 0.19 (A) 3.55 ± 0.81 (B) 6.05 ± 0.95 (B) 6.68 ± 1.83 (B) \<0.001 (KW) C~23:1~ Tricosene 20.72 0.43 ± 0.03 (A) 0.25 ± 0.02 (B) 0.19 ± 0.03 (B) 0.17 ± 0.03 (B) \<0.001 (KW) C~23~ Tricosane 21.21 4.79 ± 0.33 (A) 2.30 ± 0.18 (B) 1.93 ± 0.16 (B) 1.83 ± 0.14 (B) \<0.001 C~24~ Tetracosane 22.79 0.15 ± 0.01 0.12 ± 0.01 0.13 ± 0.01 0.13 ± 0.01 0.051 C~25:1~ Pentacosene 23.89 0.47 ± 0.02 (A) 0.48 ± 0.03 (A) 0.37 ± 0.03 (AB) 0.35 ± 0.04 (B) 0.006 C~25~ Pentacosane 24.34 4.46 ± 0.17 3.54 ± 0.23 3.82 ± 0.19 4.02 ± 0.35 0.051 (KW) C~27:1~ Heptacosene 26.87 1.25 ± 0.36 (A) 0.19 ± 0.01 (B) 0.85 ± 0.11 (A) 0.98 ± 0.11 (A) 0.002 (KW) C~27~ Heptacosane 27.30 17.45 ± 0.77 (A) 10.05 ± 0.62 (B) 10.79 ± 0.38 (B) 11.06 ± 1.29 (B) 0.001 (KW) 11,13 methyl C~27~ 11- + 13 methyl Heptacosane 27.75 5.38 ± 0.24 (A) 1.95 ± 0.09 (B) 1.47 ± 0.07 (B) 1.43 ± 0.11 (B) \<0.001 C~28~ Octacosane 28.67 0.94 ± 0.06 (A) 0.47 ± 0.03 (B) 0.65 ± 0.08 (AB) 0.51 ± 0.08 (B) 0.001 (KW) C~29:1~ Nonacosene 29.71 1.05 ± 0.06 (A) 1.21 ± 0.04 (AB) 1.35 ± 0.06 (B) 1.46 ± 0.10 (B) 0.001 C~29~ Nonacosane 30.05 13.58 ± 0.33 (A) 9.49 ± 0.55 (B) 9.82 ± 0.37 (B) 9.34 ± 0.47 (B) \<0.001 11,13 methyl C~29~ 11- + 13 methyl Nonacosane 30.48 6.62 ± 0.24 (A) 1.79 ± 0.08 (B) 1.37 ± 0.08 (B) 1.37 ± 0.08 (B) \<0.001 z(7) C~31:1~ z-(7)-Hentriacontene 32.72 6.75 ± 0.23 (A) 8.82 ± 0.39 (B) 9.26 ± 0.26 (B) 9.72 ± 0.44 (B) \<0.001 z(9) C~31:1~ z-(9)Hentriacontene 32.85 5.48 ± 0.16 (A) 7.60 ± 0.23 (B) 7.65 ± 0.16 (B) 7.73 ± 0.26 (B) \<0.001 C~31~ Hentriacontane 33.25 8.58 ± 0.26 9.39 ± 0.55 8.61 ± 0.37 7.90 ± 0.51 0.148 C~33:2~ Tritriacontadiene 36.44 2.88 ±. 14 (A) 11.33 ± 0.46 (B) 13.08 ± 0.77 (B) 15.27 ± 1.26 (B) \<0.001 (KW) C~33:1~ Tritriacotene 37.13 18.29 ± 0.78 (A) 25.97 ± 1.58 (B) 21.26 ± 0.75 (A) 18.88 ± 0.32 (A) \<0.001 C~33~ Tritriacotane 37.76 0.98 ± 0.06 (A) 1.50 ± 0.13 (B) 1.35 ± 0.08 (AB) 1.19 ± 0.13 (AB) 0.012 10.7554/eLife.41855.009 ###### Individual CHCs vary in proportion across different aged sister bees of a second colony. Numbers represent mean percentage of compound across bees of that age ±standard error. All p-values are from parametric ANOVA or nonparametric Kruskal Wallis ANOVA (denoted by 'KW'). Letters denote statistically significant age groups across individual compounds via Tukey's HSD (ANOVA post-hoc) or Dunn's Test with FDR adjustment (KW post-hoc) (p\<0.05). Compound Name Retention time Day 1 Day 7 Day 14 Foraging p-value -------------------- ----------------------------- ---------------- ------------------ ------------------ ------------------ ------------------ -------------- C~18:1~ z-(9)-Octadecenoic acid 20.23 2.47 ± 0.64 (A) 6.06 ± 0.91 (B) 5.34 ± 0.98 (AB) 7.66 ± 1.78 (B) 0.020 (KW) C~23:1~ Tricosene 20.72 0.47 ± 0.06 (AB) 0.36 ± 0.07 (A) 0.51 ± 0.13 (AB) 0.95 ± 0.23 (B) 0.034 C~23~ Tricosane 21.21 5.61 ± 0.71 (A) 1.82 ± 0.63 (B) 3.59 ± 1.50 (AB) 9.13 ± 4.29 (AB) 0.017 (KW) C~24~ Tetracosane 22.79 0.13 ± 0.03 0.11 ± 0.02 0.09 ± 0.02 0.12 ± 0.02 0.662 C~25:1~ Pentacosene 23.89 0.54 ± 0.04 0.55 ± 0.14 1.02 ± 0.32 1.40 ± 0.32 0.050 (KW) C~25~ Pentacosane 24.34 7.09 ± 0.61 4.55 ± 1.73 9.17 ± 3.54 11.10 ± 4.18 0.106 (KW) C~27:1~ Heptacosene 26.87 0.28 ± 0.065 (A) 0.62 ± 0.17 (AB) 0.92 ± 0.29 (AB) 0.91 ± 0.15 (B) 0.030 (KW) C~27~ Heptacosane 27.3 24.41 ± 0.59 (A) 13.81 ± 2.39 (B) 16.22 ± 2.35 (B) 12.97 ± 1.28 (B) 0.012 (KW) 11,13 methyl C~27~ 11- + 13 methyl Heptacosane 27.75 3.76 ± 0.83 (A) 0.93 ± 0.07 (A) 0.57 ± 0.08 (B) 0.44 ± 0.08 (B) \<0.001 (KW) C~28~ Octacosane 28.67 0.68 ± 0.11 0.48 ± 0.04 0.48 ± 0.05 0.49 ± 0.06 0.347 (KW) C~29:1~ Nonacosene 29.71 0.98 ± 0.08 0.93 ± 0.21 1.71 ± 0.24 1.23 ± 0.32 0.095 C~29~ Nonacosane 30.05 12.39 ± 0.80 13.18 ± 1.15 13.80 ± 2.08 13.14 ± 2.02 0.952 11,13 methyl C~29~ 11- + 13 methyl Nonacosane 30.48 4.62 ± 0.95 (A) 1.11 ± 0.09 (A) 0.60 ± 0.05 (B) 0.58 ± 0.10 (B) \<0.001 (KW) z(7) C~31:1~ z-(7)-Hentriacontene 32.72 5.27 ± 0.30 7.30 ± 0.75 7.20 ± 0.96 6.65 ± 1.29 0.450 z(9) C~31:1~ z-(9)Hentriacontene 32.85 3.43 ± 0.24 5.47 ± 0.62 5.25 ± 0.71 4.99 ± 1.04 0.257 C~31~ Hentriacontane 33.25 8.64 ± 0.72 13.02 ± 1.52 10.97 ± 2.13 10.50 ± 2.03 0.418 C~33:2~ Tritriacontadiene 36.44 0.55 ± 0.07 (A) 2.38 ± 0.35 (B) 1.58 ± 0.22 (AB) 2.09 ± 0.49 (B) 0.006 C~33:1~ Tritriacotene 37.13 17.47 ± 1.31 24.51 ± 2.83 19.14 ± 3.06 13.95 ± 2.38 0.056 C~33~ Tritriacotane 37.76 1.21 ± 0.16 2.83 ± 0.51 1.84 ± 0.36 1.73 ± 0.35 0.116 (KW) The CHC profiles of individual workers are task-related {#s2-2} ------------------------------------------------------- Honey bee workers exhibit age-related division of labor, which is characterized by a stereotypic sequence of in-hive behavioral tasks such as nursing and food handling, followed by the final transition to foraging outside the colony at about three weeks of age ([@bib71]; [@bib75]; [@bib79]). Consequently, under natural colony settings, it is impossible to separate the possible independent impacts of 'age' and 'task' on the expression of forager-specific CHC profiles. Therefore, we next analyzed the CHC profiles of individual nurse and forager bees from single-cohort-colonies (SCC), a well-established experimental approach to uncouple behavioral maturation from chronological age ([@bib7]; [@bib6]; [@bib40]; [@bib70]; [@bib93]). Because these artificial colonies are initially comprised of a single age-cohort of day-old bees, a small proportion of these young workers will accelerate their behavioral maturation to become precocious foragers that are the same age as typical nurses (\~7 days old) ([@bib6]; [@bib40]; [@bib47]). The comparison of the CHC profiles of typical young nurses and precocious foragers of identical age revealed a significant effect of task on the CHC profile of individual workers ([Figure 2A](#fig2){ref-type="fig"}, Permutation MANOVA, F(1,15) = 13.79, R^2^ = 0.50, p\<0.001). Similarly, we observed a significant effect of task on the CHC profiles of individual 'over-aged' nurses and typical-aged foragers at three weeks of age ([Figure 2B](#fig2){ref-type="fig"}, Permutation MANOVA, F(1,15) = 45.41, R^2^ = 0.76, p\<0.001). In contrast, task and age had no effect on total CHC amount ([Figure 2C](#fig2){ref-type="fig"}, Two-way ANOVA, age: F(1,28) = 0.55, p=0.46, task: F(1,28) = 0.37, p=0.55, age\*task: F(1,28) = 5.37, p=0.03). Together, these data suggest that processes associated with the behavioral maturation of honey bee workers, not chronological age, are primarily responsible for the observed forager versus nurse CHC profiles of individual honey bee workers. {ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.](elife-41855-fig2){#fig2} Previous studies in Harvester ants suggested that exposure to the environment outside the nest is sufficient to induce stereotypical changes in the CHC profiles of individual social insects ([@bib91]). Therefore, we next asked whether spending time outside the hive is sufficient to induce the observed forager-specific CHC profile by comparing the CHC profiles between 'undertakers', nurses, and foragers from typical colonies. 'Undertakers' are a small group of highly specialized older pre-foraging workers (2--3 weeks of age), which are responsible for removing dead bees by carrying them outside and away from the colony ([@bib71]; [@bib75]; [@bib79]; [@bib86]). Therefore, because undertakers and foragers perform their respective tasks outside the hive, while nurses and other younger, pre-foraging bees rarely do, we reasoned that if outdoor exposure defines the distinct forager-specific CHC profile then the CHC profiles of undertakers should be more similar to foragers than to nurses. However, we found that the CHC profiles of undertakers are markedly different from those of foragers, and are more similar to those of nurses ([Figure 2D](#fig2){ref-type="fig"}, Permutation MANOVA, F(2,23)=12.60, R^2^ = 0.55, p\<0.001, FDR pairwise contrasts: undertaker vs. forager p=0.003, undertaker vs. nurse p=0.176, forager vs. nurse p=0.003). These data suggest that some outdoor exposure is not sufficient to drive forager-specific CHC profiles. We next asked whether the CHC profiles of foragers are a direct consequence of their behavioral state by using 'big back colonies' ([@bib5]; [@bib95]), which allowed us to compare active foragers to bees of a similar age and behavioral state that are unable to forage outside (see Materials and methods). We found that the overall CHC profiles of 'big-back' bees were different from those of their actively foraging sisters ([Figure 2E](#fig2){ref-type="fig"}, Permutation MANOVA, F(1,14)=5.91, R^2^ = 0.313, p\<0.001). These data suggest that the physiological transition to foraging behaviors is not the sole factor that defines forager-specific CHC profiles, and that it could be modulated by additional factors associated with the act of foraging itself and/or extended exposure to various outdoor environmental factors. However, the fact that foraging nestmates express very similar CHC profiles, which are markedly different from those of non-nestmate foragers sharing a similar foraging environment ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, Permutation MANOVA, F(1,15) = 12.5, R^2^ = 0.47, p\<0.001) suggests that forager-specific CHC profiles are not simply defined by the foraging environment. Additionally, to test whether extended exposure to outdoor environmental factors induces predictable changes in CHCs, we compared the relative amounts of individual compounds between forager bees and in-hive bees across our various experiments. We did not find a single compound that varied between foragers and in-hive bees in a consistent manner across our experiments (e.g. always increases or always decreases in association with foraging activity) ([Table 5](#table5){ref-type="table"}), indicating that CHCs do not change in a stereotypic manner in association with extended outdoor exposure, as they do in Harvester ants ([@bib91]). Nevertheless, to further examine whether forager-specific CHC profiles were solely environmentally determined, we also analyzed the CHC profiles of typical-age foragers that were forced to revert to a nursing state ([@bib72]). However, we did not find any differences between the CHC profiles of reverted nurses and active foragers ([Figure 2F](#fig2){ref-type="fig"}). These data suggest that once foragers acquire their signature CHC profile, it remains stable independent of the task they perform and despite the typical short CHC half-life in insects ([@bib49]). Together, these data suggest that forager-specific CHC profiles are derived from a combination of factors associated with an innate behavioral maturation process, as well as being physically engaged in foraging activity. 10.7554/eLife.41855.013 ###### CHCs vary in relative proportion between foragers and in-hive bees across studies. Numbers represent difference in mean percentage of each compound in forager bees relative to in-hive bees. 'Hive 1' denotes forager bees minus Day 14 bees corresponding to [Figure 1](#fig1){ref-type="fig"}; 'Hive 2' denotes forager bees minus Day 14 bees corresponding to [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; 'SCC week 1' and 'SCC week 3' denote forager bees minus nurse bees corresponding to [Figure 2A and B](#fig2){ref-type="fig"}, respectively; 'Undertaker' denotes forager bees minus undertaker bees corresponding to [Figure 2D](#fig2){ref-type="fig"}; 'Big-back' denotes forager bees minus big-back bees corresponding to [Figure 2E](#fig2){ref-type="fig"}. Statistics using Student's t-test or Mann-Whitney U between the forager and in-hive bee group. Asterisks (\*) or plus sign (+) denote statistical significance for t-test or Mann-Whitney U, respectively. 'ns' denotes non-significant differences. Compound Hive 1 Hive 2 SCC 1 week SCC 3 weeks Undertaker 'Big-back' -------------------- ------------ -------- ------------- ------------- ------------ ------------ C~18:1~ ns ns 3.71 (+) ns −8.86 (\*) ns C~23:1~ ns ns 0.51 (+) 1.56 (+) 0.78 (+) ns C~23~ ns ns 3.48 (+) 11.45 (\*) 10.8 (+) −0.85 (+) C~24~ ns ns 0.25 (+) 0.54 (+) 0.52 (\*) −0.09 (+) C~25:1~ ns ns 1.28 (+) 4.15 (+) 1.66 (\*) ns C~25~ ns ns 11.58 (+) 24.22 (+) 21.12 (+) −3.83 (+) C~27:1~ ns ns 1.43 (+) 2.18 (+) ns −0.29 (+) C~27~ ns ns 8.83 (\*) 9.38 (\*) ns −8.35 (+) 11,13 methyl C~27~ ns ns ns −0.35 (\*) −0.23 (+) −0.45 (\*) C~28~ ns ns ns ns −0.07 (\*) −0.05 (\*) C~29:1~ ns ns 0.69 (+) ns −1.08 (\*) ns C~29~ ns ns −4.19 (\*) −3.31 (\*) −2.58 (\*) ns 11,13 methyl C~29~ ns ns ns −0.24 (+) −0.52 (\*) ns z(7) C~31:1~ ns ns −2.92 (\*) −5.53 (+) −4.78 (+) 1.6 (+) z(9) C~31:1~ ns ns −2.94 (\*) −5.23 (+) −2.93 (+) ns C~31~ ns ns −6.09 (+) −6.75 (+) −2.12 (\*) ns C~33:2~ ns ns −1.25 (+) −6.63 (+) −2.9 (+) ns C~33:1~ −2.38 (\*) ns −13.81 (\*) −21.39 (+) −8.07 (+) 6.65 (\*) C~33~ ns ns −1.1 (+) −1.56 (+) −0.48 (\*) The development of individual CHC profiles is a regulated process modulated by the colony environment {#s2-3} ----------------------------------------------------------------------------------------------------- Previous work indicates that guard bees will accept foraging-age nestmates and reject foraging-age non-nestmates, independent of genetic relatedness ([@bib30]). This suggests that factors associated with the hive environment play a dominant role in specifying the colony-specific chemical signatures used for nestmate recognition. Yet, our data also indicate that CHC profile development in individual workers is a developmentally-regulated process that is closely associated with the age-dependent division of labor among workers. To address this potential conundrum, we next asked whether the effects of task and colony environment on the development of CHC profiles of individual workers are independent by using a reciprocal cross-fostering strategy. To achieve our goal, we introduced cohorts of newly eclosed bees from two different typical colonies back into their source colony, as well as a reciprocal foster colony, and then recollected marked workers from both cohorts in each reciprocal colony at different ages. CHC analyses revealed that through Day 14, the CHC profiles of bees were more similar to the profiles of their same-aged non-nestmate sisters than those of unrelated nestmates of similar age ([Figure 3A](#fig3){ref-type="fig"}, Two-way Permutation MANOVA, foster colony (environment): F(1,31) = 2.19, R^2^ = 0.06, p=0.06, source colony (genetics): F(1,31) = 5.94, R^2^ = 0.16, p\<0.001, foster colony\*source colony: F(1,31)=0.46, R^2^ = 0.01, p=0.82; [Figure 3B](#fig3){ref-type="fig"}, Two-way Permutation MANOVA, foster colony: F(1,31) = 1.13, R^2^ = 0.03, p=0.33, source colony: F(1,31) = 3.18, R^2^ = 0.09, p=0.02, foster colony\*source colony: F(1,31) = 1.78, R^2^ = 0.05, p=0.15; sample size assessment depicted in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} indicates sample size is adequate). In contrast, once workers shift to foraging activity, we found that the CHC profiles of fostered bees are different from the profiles of both foraging sisters raised in the source colony and unrelated host foragers of similar age ([Figure 3C](#fig3){ref-type="fig"}, Two-way Permutation MANOVA, foster colony: F(1,31) = 4.04, R^2^ = 0.10, p=0.02, source colony: F(1,31) = 7.65, R^2^ = 0.19, p=0.001, foster colony\*source colony: F(1,31)=0.48, R^2^ = 0.01, p=0.67). Together, these data suggest that genetic variations, or other long-term effects associated with the source colony, play an important role in defining the CHC profiles of individuals during the early phases of the age-dependent behavioral development of worker honey bees. However, by the time bees start foraging, the mature CHC profile of individual workers is defined by an interaction between factors associated with both the source and foster colonies ([Figure 3C](#fig3){ref-type="fig"}). {ref-type="fig"}.](elife-41855-fig3){#fig3} The development of CHC profiles of individual workers is associated with the regulation of CHC biosynthesis genes {#s2-4} ----------------------------------------------------------------------------------------------------------------- Homogenization models for the development of colony-specific nestmate recognition cues predict that cue specificity is acquired by individuals via physical contact with other colony members and/or environmental sources of hydrocarbons ([@bib14]; [@bib25]; [@bib53]; [@bib61]; [@bib76]; [@bib78]; [@bib88]). However, because our data indicate that the maturation of the CHC profile of individual honey bees is actually regulated in association with the stereotypic age-dependent division of labor in this species, we next hypothesized that the CHC profiles of worker honey bees develop, at least in part, via an intrinsic age-dependent regulation of the CHC biosynthetic pathways in the pheromone producing oenocytes ([@bib22]; [@bib35]; [@bib56]; [@bib96]). Thus, we next examined whether age and/or task are associated with the mRNA expression levels of genes that encode elongases and desaturases, the primary CHC diversity producing classes of enzymes in the CHC biosynthesis pathway ([@bib22]). To identify candidate genes for our analyses, we first used a bioinformatic approach to identify all putative members of both protein families in the honey bee genome ([Table 6](#table6){ref-type="table"}). Subsequently, we used real-time quantitative RT-PCR to compare mRNA levels of each candidate gene in dissected abdominal cuticles from bees of different ages raised in their source colony (sisters of the bees analyzed for [Figure 1](#fig1){ref-type="fig"}- [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), as well as foraging sister bees raised in either their source colony or an unrelated foster-colony. Our analyses revealed that the expression levels of at least one elongase and two desaturase genes are associated with either age or colony environment ([Figure 4](#fig4){ref-type="fig"} and [Table 7](#table7){ref-type="table"}). Thus, our data suggest that individual worker honey bees regulate CHC expression through an innate age-dependent developmental process that is further modulated by other factors such as task and the social environment. {ref-type="table"} for results for all studied genes). Black bars represent bees raised in their own colony. Grey bars represent sister forager bees that were raised in an unrelated colony ('Fostered'). (**D**) Heat map of relative expression levels of all genes tested. Aging bee statistics using ANOVA followed by Tukey HSD post-hoc, or Kruskal-Wallis followed by Dunn's Test with FDR adjustment post-hoc, with letters denoting *posthoc* statistical significance (p\<0.05). Between colony statistics using Mann-Whitney U test, with asterisks above grey bars denoting statistical significance from foraging bees raised in their own colony (\*, p\<0.05). Sample size per group, N = 4.\ 10.7554/eLife.41855.018Figure 4---source data 1.Average C~t~ scores across three technical replicates for each bee sample for every elongase and desaturase gene, including those corresponding to [Figure 4](#fig4){ref-type="fig"}.](elife-41855-fig4){#fig4} 10.7554/eLife.41855.019 ###### CHC biosynthesis genes, BLAST E-values, and quantitative real-time PCR primers used in this study. BLAST E-values listed with known *Drosophila melanogaster* enzyme gene compared to. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- Gene Function BLAST E-value\ Forward primer Reverse primer Previously published (*D. melanogaster* gene) -------------- ------------------------------------------ -------------------------- ---------------------------- ----------------------------- ---------------------- LOC724867 Elongase 2E-37 (*EloF*) TGGGACCGGAATATCAAAAA GCAGTAAAAGTGCCGCTACC [@bib35] LOC724552 Elongase 1E-38 (*EloF*) TCGGTAATCATGGAGTTATATAAGGA ATCTTGGTCCAGCTGATAAGG [@bib35] LOC550828 Elongase 1E-37 (*EloF*) TCGTCAAAGTTTTGGGTCCT GACCTCCCCATCCTGCTATC LOC409638 Elongase 9E-38 (*EloF*) TGGATCGATTCCACGAGATA CATCAGCTTTGGCCCTAAAA LOC413789 Elongase 2E-38 (*EloF*) CAGATCTGGTGCACGGGTA TTCTCCATTATCCTCGGTCCT [@bib35] LOC100578829 Elongase 1E-36 (*EloF*) ATGGCCTCGTTCGGTATTTT ACGAATTGGACCATTTGCAC [@bib35] LOC726467 Elongase 2E-13 (*Elo68α*) GAGTTCATTACTTTCATTGTTTTCCA AACATCCATGACCAAAAACCA [@bib35] LOC725842 Elongase 5E-10 (*Elo68α*) ATTAACGTATCACGGTTTTTATCAT TTAATTCCTGCTTTCGTAACACT [@bib35] LOC725031 Elongase 1E-8 (*Elo68α*) TGGAACACATTGCTTGCATC TGTCCAAAAACCAGACACGA [@bib35] GB51249 Elongase 7E-7 (*EloF*) ATGTCGATTTTAATGCAATACGTG AAACTTTTACACCATATACGTAGCTCA [@bib35] LOC412166 Desaturase 5E-174 (*desat1*) CGCTGCTCATATCTTTGGAA ATTTCCCAATTCTGCCGTTT [@bib35] LOC551527 Desaturase 1E-138 (*desat1*) TTAATGGTCCGAAAGCATCC CCCATGTAGGAATTACAAAGCA [@bib35] LOC552417 Desaturase 2E-137 (*desat1*) TACGTTTCGTGCTGATGCTT ACCAACCCATATGCGAGAAG [@bib35] LOC100576797 Desaturase 8E-127 (*desat1*) ACGGGTGAACTTGGTGGTTA TTTTGTTGCAGCTCGATTCA [@bib35] LOC552176 Desaturase 2E-113 (*desat1*) ACTACCGGATTCGGCATAACT CTGTGATCCAATGCCCATCT [@bib35] LOC727166 Desaturase 4E-56 (*desat1*) TGGTCTGGAATATCAAGGAAGG ACCGAATTCACCACATTTCC LOC727333 Desaturase 4E-54 (*desat1*) GGGCCCATAAAACATACGAA TGTATGGATCTTTATCAGTCCCATAAT [@bib35] eIF3-S8 Eukaryotic translation initiation factor TCTTGGACCAGCAGTAGCAG GCATATCGAGCATTTCCGTA ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- 10.7554/eLife.41855.020 ###### Genes differ in relative mRNA expression level between bees of different ages (Age), and foraging sister bees raised in two different colonies (Hive). Numbers represent mean relative mRNA expression level ±standard error across four biological replicates. All p-values are from parametric ANOVA or nonparametric Kruskal Wallis ANOVA (denoted by 'KW'). Letters denote statistically significant age groups across individual compounds via Tukey's HSD (ANOVA post-hoc) or Dunn's Test with FDR adjustment (KW post-hoc) (p\<0.05). ----------------------------------------------------------------------------------------------------------------------------------------------------------- Gene Day 1 Day 7 Day 14 Forager FDR adjusted p-value\ Fostered FDR adjusted p-value\ *Age* *Hive* -------------- ----------------- ------------------ ------------------ ----------------- ----------------------- ------------------ ----------------------- LOC724867 1.22 ± 0.19 2.41 ± 0.75 12.62 ± 7.23 1.58 ± 0.88 0.328 (KW) 1.22 ± 0.18 1 (KW) LOC724552 1.05 ± 0.26 1.28 ± 0.66 2.94 ± 1.65 0.09 ± 0.02 0.177 (KW) 0.03 ± 0.01 0.456 LOC550828 1.02 ± 0.12 4.09 ± 1.99 6.17 ± 2.10 0.38 ± 0.09 0.097 (KW) 0.30 ± 0.06 0.53 (KW) LOC409638 1.14 ± 0.21 2.47 ± 0.41 4.36 ± 1.65 2.81 ± 0.26 0.097 (KW) 4.07 ± 0.67 0.530 LOC413789 1.03 ± 0.10 4.17 ± 0.68 5.31 ± 2.07 1.98 ± 0.15 0.056 (KW) 2.38 ± 1.21 1 (KW) LOC100578829 0.84 ± 0.08 2.30 ± 0.42 3.34 ± 0.71 3.12 ± 0.43 0.056 3.61 ± 2.25 0.53 (KW) LOC726467 0.58 ± 0.18 0.12 ± 0.06 0.19 ± 0.06 0.03 ± 0.01 0.064 (KW) 0.02 ± 0.00 0.53 (KW) LOC725842 1.10 ± 0.27 0.46 ± 0.24 0.98 ± 0.47 0.05 ± 0.03 0.081 (KW) 0.01 ± 0.00 0.53 (KW) LOC725031 0.92 ± 0.04 (A) 0.61 ± 0.09 (BC) 0.71 ± 0.10 (AB) 0.33 ± 0.04 (C) 0.005 0.43 ± 0.10 0.573 GB51249 1.16 ± 0.20 2.78 ± 0.44 4.98 ± 1.88 3.11 ± 0.25 0.097 (KW) 4.14 ± 0.79 0.530 LOC412166 1.06 ± 0.07 0.84 ± 0.12 1.08 ± 0.06 0.61 ± 0.05 0.081 (KW) 0.76 ± 0.43 0.456 (KW) LOC551527 0.92 ± 0.18 5.62 ± 1.08 4.89 ± 1.37 5.18 ± 0.82 0.056 4.99 ± 1.48 1 LOC552417 0.93 ± 0.06 0.62 ± 0.07 1.19 ± 0.49 1.76 ± 0.97 0.352 (KW) 1.76 ± 0.69 0.897 (KW) LOC100576797 1.24 ± 0.17 6.38 ± 2.48 7.61 ± 2.01 1.96 ± 0.32 0.081 (KW) 0.44 ± 0.22 (\*) 0.015 LOC552176 1.08 ± 0.03 (A) 1.87 ± 0.10 (B) 2.51 ± 0.27 (B) 2.18 ± 0.11 (B) 0.003 1.76 ± 0.26 0.53 LOC727166 1.42 ± 0.23 3.99 ± 0.67 6.41 ± 1.47 3.89 ± 0.77 0.056 8.58 ± 1.86 1 LOC727333 1.16 ± 0.10 4.96 ± 1.44 5.11 ± 1.12 2.77 ± 0.91 0.081 1.95 ± 0.09 0.53 (KW) ----------------------------------------------------------------------------------------------------------------------------------------------------------- Age and task play a role in defining nestmate recognition cues in honey bee colonies {#s2-5} ------------------------------------------------------------------------------------ Because previous studies have indicated that nestmate recognition in honey bee colonies is likely driven by components of the CHCs profile ([@bib89]), and our discovery that the CHC profiles of individual workers seem to mature in association with the well-described age-dependent division of labor in this species ([@bib71]; [@bib75]; [@bib79]), we next hypothesized that, in honey bees, nestmate recognition cues themselves mature in association with age-dependent division of labor, and reach maturation during foraging. To test this hypothesis, we investigated the behavioral responses of guard bees to related and unrelated focal bees of different ages (Day 1, Day 7, Day 14, and foragers on Day 21). At each test colony, the behavioral responses of guards to random related and unrelated returning foragers of unknown age were used as the benchmark for the baseline level of nestmate recognition behavior. Behavioral observations revealed that bees are accepted at the entrance of their own colony, regardless of age ([Figure 5A](#fig5){ref-type="fig"}, Pearson's Chi-Squared, Day1: χ^2^ = 49.05, df = 2, p\<0.001, Day 7: χ^2^ = 19.07, df = 2, p\<0.001, Day 14: χ^2^ = 44.89, df = 2, p\<0.001, Day 21: χ^2^ = 28.32, df = 2, p\<0.001). In contrast, at the entrance to an unrelated colony, bees were accepted on Days 7 and 14, but rejected as foragers (Day 21) ([Figure 5B](#fig5){ref-type="fig"}, Day1: χ^2^ = 11.61, df = 2, p=0.003, Day 7: χ^2^ = 15.51, df = 2, p\<0.001, Day 14: χ^2^ = 11.91, df = 2, p=0.002, Day 21: χ^2^ = 7.35, df = 2, p=0.04). These data support the hypothesis that nestmate recognition cues in honey bee colonies mature in association with age-dependent division of labor, and suggest that nestmate recognition is specific to behavioral interactions between guards and foragers at the entrance to the hive. {ref-type="fig"}.](elife-41855-fig5){#fig5} Surprisingly, we also observed that while young Day 1 bees are accepted by related guards, they are often rejected by unrelated guards ([Figure 5B](#fig5){ref-type="fig"}). This finding contradicts the broadly accepted 'blank slate' hypothesis, which predicts that because day-old bees are devoid of any defining chemical signatures, they should be always accepted by guards independent of relatedness ([@bib13]). While we do not yet know which specific components of the CHC profile of young bees, if any, might have triggered a rejection by unrelated guards in our colonies, one plausible interpretation of these data is that the observed response of guards to unrelated Day 1 bees is an artifactual experimental outcome of a forced behavioral interaction between two bee groups, which in colonies with a typical demography, do not normally interact in the context of the hive entrance. Discussion {#s3} ========== The ability of colonies of social insects to reliably recognize group membership is one of the remarkable adaptations that enabled their immense ecological success. Yet, the molecular and physiological mechanisms that underlie this complex trait remain unknown for most species. In the well-studied honey bee, previous studies suggested that the chemical cues that drive nestmate recognition are absent in newly eclosed bees, and subsequently develop primarily through the homogenization and transfer of chemicals between colony members via direct interactions such as allogrooming and trophallaxis, and indirect interactions such as physical contact with wax and other nest materials ([@bib14]; [@bib13]). However, the data we present here suggest that the overall development of individual CHC profiles of honey bee workers primarily depends on an innate developmental process that is associated with the stereotypic age-dependent division of labor in this species, and that colony-specific cues are likely only carried by foragers. Therefore, we posit that it is unlikely that CHC profiles in honey bees develop through homogenization and transfer mechanisms between nestmates and hive materials. Furthermore, given the established implicated role of CHCs in nestmate recognition ([@bib89]), we additionally posit that CHC homogenization mechanisms are unlikely to play a key role in the production of colony-specific cues in honey bees. A major line of investigation in understanding nestmate recognition of social insects has been to determine how colony-specific cues are determined. Cue specificity has historically been proposed to be determined by mechanisms under genetic control or acquired from the environment ([@bib25]). Although our studies do not directly address the mechanism by which cue specificity is determined in honey bees, data from cross-fostering experiments suggest that cue development and specificity are defined by interactions between factors derived from the colony-of-origin of individual workers and the actual hive environment they develop in. Therefore, our data suggest that CHC profiles of honey bee workers develop via a biphasic process that is governed, at least in part, by the intrinsic physiology of individual workers, the specific behavioral tasks they are engaged in, and the hive environment they age in. In phase one, similar to other social insect species ([@bib77]), the total CHC amount builds up, possibly to increase the resistance of workers to desiccation while still inside the protective hive environment ([@bib22]). In phase two, the total amount of CHCs remains constant but the relative abundances of individual components shift in association with the age-dependent behavioral maturation of workers, at least in part, via the transcriptional regulation of CHC biosynthetic enzymes. Which specific components of the honey bee CHC profile represent the nestmate recognition cue remains unknown. Although it has been shown that CHCs are likely used for nestmate recognition in honey bees ([@bib89]), it is unlikely that all components of the CHC profile contribute to this process ([@bib1]; [@bib29]; [@bib28]; [@bib58]; [@bib73]). In fact, it has previously been shown that alkenes seem to play a more prominent role in nestmate recognition in the honey bee than alkanes ([@bib29]). Our data also indicate that although unrelated foragers raised in the same colony are equally accepted, their overall CHC profiles remain somewhat qualitatively different ([Figure 3C](#fig3){ref-type="fig"}). These data provide two important insights. First, guards are not likely using the full CHC profile of individuals to determine group membership. Second, differences in the CHC profiles of co-fostered nestmate foragers of similar age that originated from different source colonies indicate that the chemical profiles of individual workers are not likely to be the product of a stochastic CHC homogenization and transfer between colony members. The observation that the mRNA expression levels of genes that encode CHC-biosynthesis enzymes vary in association with age and/or task further indicate that the primary mechanism for the dynamic regulation of the CHC profile of individual honey bee workers is directly associated with the well-established age-dependent division of labor in the honey bee ([@bib71]; [@bib75]; [@bib79]). Although these data do not directly exclude the possibility that some particular CHCs are transferred across colony members, they do indicate that the overall observed qualitative age- and task-dependent changes in the CHC profiles of individual workers are affected by intrinsic molecular dynamics of the CHC synthesis pathway. However, our studies also importantly show that genetically-related bees that age in different colonies exhibit qualitatively different CHC profiles and CHC biosynthesis gene expression levels, which suggests that the CHC synthesis process is also plastic and could be modulated by factors associated with the hive/social environment. We were initially surprised by our observation that Day one bees are accepted at the entrance to their source colony but rejected by guards at the entrance of an unrelated colony since previous studies hypothesized that the lower amounts of total CHCs in young bees represent a 'blank slate' in terms of the nestmate recognition cue because these bees are readily 'accepted' when introduced into unrelated colonies ([@bib13]). In fact, this phenomenon was exploited here to introduce cohorts of bees to foster colonies, typically by placing the new bees on the top frames of experimental hives. This apparent conundrum highlights an important, yet often underappreciated, aspect of the nestmate recognition system in honey bees and other social insect species, which is that the 'rejection' behavior by guards is highly contextual. Conceptually analogous to other biological systems responsible for the detection of 'self' versus 'non-self' (*e.g.*, the acquired immunity system in vertebrates), behaviors associated with nestmate recognition are restricted to interactions between guards and incoming bees at the entrance to the hive ([@bib24]). Therefore, we speculate that because nestmate recognition is spatially restricted to specific behavioral interactions between entering bees and guards at the entrance, the commonly observed 'acceptance' of day old bees outside the specific context of the hive entrance actually represents the lack of behavioral 'rejection' rather than a true self-recognition-dependent 'acceptance'. Consequently, the observation that Day one bees are rejected at the entrance of an unrelated colony suggests that nestmate recognition of young bees either depends on components of the CHC profile that are already present in Day one bees, non-CHC chemical cues, or an altogether different sensory modality. Alternatively, because newly eclosed bees usually perform cell cleaning behaviors at the interior of the hive, and therefore do not typically interact with guards at the hive entrance ([@bib71]; [@bib75]; [@bib79]), differences in rejection of Day one bees between these two colonies might represent an experimental artifact resulting from differences in tolerance to the forced behavioral interaction between two bee groups that normally do not interact. Additionally, it has previously been shown that observed levels of guarding behaviors in honey bees are plastic, and could fluctuate in response to various environmental factors such as seasonal weather patterns, overall colony size, food availability, and 'robbing' pressures from other colonies or predators ([@bib31]). Likewise, more extreme forms of plasticity in nestmate recognition systems have been reported in other social species. For example, some social insects can switch between using visual or chemosensory modalities for nestmate recognition under different circumstances ([@bib4]). Together, it seems that instead of being driven by simple binary decisions, nestmate recognition systems in the honey bee and other social insect species depend on a plastic recognition of 'friends' versus 'foes' as part of a broader group-level optimization of colony fitness. In conclusion, we propose that nestmate recognition cue production and acquisition in honey bees are not likely to be primarily driven by CHC homogenization and transfer mechanisms as previously described in some ant species ([@bib10]; [@bib53]; [@bib61]; [@bib76]; [@bib78]; [@bib88]). Instead, we propose a new model for the regulation of nestmate recognition in honey bee colonies, which stipulates that unknown factors associated with the hive environment play a direct or indirect role in defining the developmental kinetics and specificity of nestmate recognition cues by modulating the cellular and molecular processes that are responsible for pheromone synthesis. Thus, it is plausible that the colony/social environment drives the intrinsic development of similar pheromone profiles by individual colony members, which in typical honey bee hives, is associated with the physiological processes that drive age-dependent division of labor. If true, this model could resolve previous seemingly contradictory data which suggested that honey bee CHC profiles are defined by genetic ([@bib64]) versus environmental ([@bib30]) factors, as well as open the door for comparative mechanistic studies of how complex social traits evolve and function in different social insect clades. Materials and methods {#s4} ===================== Animal husbandry and bee collections {#s4-1} ------------------------------------ Honey bee (*Apis mellifera*) colonies were reared and managed using standard beekeeping techniques across two locations near St. Louis, MO: Tyson Research center (38° 31'N, 90° 33'W) and a residential home. For all experiments that included collections of bees at specific ages, capped brood frames were taken from a colony and placed in a humidified 32°C incubator. Once eclosed, about 1000 bees (\<24 hr old) were marked with a spot of paint (Testors, Vernon Hills, IL, USA) on their thorax, and then reintroduced into either their source or a foster colony, depending upon the experiment. For collections of bees at specific ages, marked bees were collected from internal frames of the colony one day post reintroduction (Day 1), seven days post reintroduction (Day 7), 14 days (Day 14) post reintroduction, and as returning foragers, identified by pollen loads on their hind legs or having a distended abdomen due to nectar loads, between 18 and 21 days post reintroduction. Bees used for chemical and molecular analyses were placed in individual 1.7 mL microtubes and immediately placed on dry ice. All samples were kept at −80°C until further analysis. Single-cohort colonies {#s4-2} ---------------------- Single-cohort colonies (SCC) were established as previously reported ([@bib7]; [@bib6]; [@bib40]; [@bib70]; [@bib93]). In short, about 1000 newly eclosed bees (\<24 hr old) were placed in a small wooden nucleus hive-box with a young, unrelated mated queen, one honey frame from their source colony, an empty comb frame, and three new frames with wax covered plastic foundation. Bees were collected as typical-aged nurses and precocious foragers one week after introduction, and as over-aged nurses and typical-aged foragers at three weeks after introduction. Bee samples were collected and stored as above. Undertaker collection {#s4-3} --------------------- To induce 'undertaking' behavior, about 1000 dead bees were placed into the top of two different colonies, and the first 20 bees that were observed removing dead bees from the colony were collected from the entrance. Returning foragers and in-hive nurses of unknown ages were also collected from each colony at the same time. Samples were stored and processed as described above. Big-back colony {#s4-4} --------------- Big-back colonies were established as previously described ([@bib5]; [@bib95]). In short, bees were introduced in two cohorts to a 5-frame hive box containing three empty comb frames, two brood frames, and a new queen. In the first cohort, 200 day-old bees were collected as described above and marked on the thorax with paint. Half of these bees were marked with a plastic tag attached to the thorax (\~3 mm diameter,\~1 mm thick; 'big-back' bees). Day-old bees in the other cohort were collected and introduced 4 days later as described above to increase the proportion of precocious foragers in the first group. The entrance to the colony was blocked by a piece of Plexiglas with holes in it that prevented 'big-back' bees from leaving the hive, but allowed paint marked bees to leave. Bees were collected at 7 days of age: returning foragers were collected as described above, and 'big-back' bees were collected as they were attempting to leave the hive via the holes in the plastic. Reversion colony {#s4-5} ---------------- Reversion colonies were made by collecting \~1000 foragers from a single source colony by vacuuming them directly into a sealed 5-frame hive box containing two brood frames, one honey frame, and two empty comb frames. The hive was sealed and moved to a new location \~30 miles away from the source colony, and a new queen was added that night. The hive was sealed for 3 days, and then was opened to allow normal foraging activity to resume. During this time, in the absence of nurses, some foragers reverted back to nursing behaviors ([@bib72]). Actively foraging bees were collected at the hive entrance as described above and reverted nurses were collected from internal frames as described above. Cross-fostering experiment {#s4-6} -------------------------- 1000 day-old bees from two independent source colonies were collected and marked as above. Half of the bees in each marked cohort were randomly reintroduced to both their own source colony and the reciprocal foster colony. Subsequently, marked bees of defined age were recollected from internal frames of each colony as described above. Nestmate recognition assay {#s4-7} -------------------------- Every day over a three-week period, newly eclosed bees (\<24 hr old) from a single source colony were collected as described above, uniquely color-marked, and then reintroduced into their source colony. Subsequently, on each experimental day, bees from the following groups were collected, placed in individual 15 mL plastic tubes (Corning, Corning, NY, USA), and chilled on wet ice in an ice cooler up to 10 min before the assay in order to limit heat related stress: bees of the focal age (identified by color of mark), returning nectar foragers (denoted by distended abdomen and lack of pollen) of unknown age from the source colony, and returning nectar foragers of unknown age from an unrelated colony. All foragers, which served as behavioral controls, were painted the same color as the experimental bees just after collection. Tubes were numbered in a randomized order and blinded to the experimenter conducting the behavioral assays. Fifteen bees per group were prepared for each colony each experimental day. Behavioral assays were conducted simultaneously at two colonies (source and unrelated) by two researchers, as well as recorded using digital video cameras. As described previously ([@bib27]; [@bib31]), acceptance at the colony entrance was used as a proxy for nestmate recognition by placing individual bees on a modified entrance platform and recording the behavioral reactions of guard bees for \~5 min. Bees were considered 'Rejected' if they were bit, stung and/or dragged by at least one guard bee ([Video 1](#video1){ref-type="video"}). Bees were considered 'Accepted' if they were approached by guards, antennated and/or licked and then left alone (not bit), if they immediately entered the colony and were not removed by other bees, or if they remained on the platform and did not receive aggression ([Video 2](#video2){ref-type="video"}). After 5 min, focal bees that remained on the platform outside the colony were removed before the next assay. All behaviors were scored in real time, and videos were retained as back-up. All behavioral assays were conducted during a period of 10 days, between 12 and 4pm, with two days focusing on each age of experimental bee (N = 20--30 bees per group). ###### An interaction between a guard and focal bee scored as 'Rejected'. The focal bee is marked with a green dot on its thorax. 10.7554/eLife.41855.023 ###### An interaction between a guard and focal bee scored as 'Accepted'. The focal bee is marked with a pink dot on its thorax. 10.7554/eLife.41855.024 Cuticular hydrocarbon extractions and GC analysis {#s4-8} ------------------------------------------------- CHCs were extracted from whole bees by placing individual bees into 6 mL glass vials fitted with 16 mm PTFE/silica septa screw caps (Agilent Crosslab, Santa Clara, CA, USA). Bee CHCs were extracted in 500 µL hexane containing 10 ng/μl of octadecane (C~18~) and 10 ng/μl of hexacosane (C~26~) (Millipore Sigma, St. Louis, MO), which served as injection standards. To achieve efficient extraction, each vial was gently agitated by vortexing (Fisher Scientific, Waltham, MA, USA) for 2 min at minimum speed. Extracts were immediately transferred to new 2 mL glass vials fitted with 9 mm PTFE lined caps (Agilent Crosslab, Santa Clara, CA, USA). In cases where experiments involved forager honey bees, all bees (including non-foragers) had their hind legs removed prior to extraction, in order to ensure removal of pollen. 100 µL of each extract was transferred to a new 2 mL glass vial and stored at −20°C for further analysis; the remaining 400 µL was stored at −80°C as back-up. Representative pooled samples of foragers and nurses of known age were first analyzed by combined gas chromatography/mass spectrometry (GC/MS) for compound identification. Samples were run from 150^0^ (3 min hold) to 300^0^ at 5^0^/min. Compounds were identified by their fragmentation pattern as compared to synthetic compounds. For profile characterizations of individual bees, samples were analyzed using an Agilent 7890A gas chromatograph system with a flame ionization detector (GC/FID) and PTV injector (cool-on-column mode), and outfitted with a DB-1 20 m x 0.18 mm Agilent 121--1022 fused silica capillary column (Agilent Technologies, IncSanta Clara, CA, USA). Sample volumes of 1.0 μl were injected onto the column. Helium was the carrier gas and applied at a constant flow rate of 1 ml/min. Analysis of the extract was carried out with a column temperature profile that began at 50C (held for 1 min) and was ramped at 36.6 °C/min to 150C and then at 5 C/min to 280C, where it was held for 10 min. The injector and FID temperatures were programmed to 280C and 300C, respectively. Agilent OpenLAB CDS (EZChrom Edition) software was used to calculate the retention time and total area of each peak. Data were normalized to known quantity (ng) of internal standard hexacosane and all ng data are listed in source data. CHC biosynthesis gene identification, RNA Isolation and Quantitative Real-Time PCR {#s4-9} ---------------------------------------------------------------------------------- Members of the highly conserved desaturase and elongase gene families were identified in the honey bee genome by using the protein BLAST search tool (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) with annotated *Drosophila melanogaster* amino acid sequences (<https://flybase.org>) of elongase and desaturase genes known to play a role in CHC biosynthesis ([@bib22]). Initial homologs in the honey bee genome were chosen by picking the top match (highest total score and query cover, lowest E value) for each *D. melanogaster* gene, and possible paralogs of these putative genes were identified by subsequently using the NCBI protein BLAST tool (RRID:[SCR_004870](https://scicrunch.org/resolver/SCR_004870)) with these genes' amino acid sequences. Many of these putative elongase and desaturase genes have previously been identified as possible CHC biosynthesis pathway genes in the honey bee ([@bib35]). E-values from the BLAST scans of the honey bee genome by using three canonical *Drosophila melanogaster* CHC biosynthesis genes, *EloF* (elongase subfamily), *Elo68α* (elongase subfamily), and *desat1* (fatty acid desaturase subfamily), are listed in [Table 6](#table6){ref-type="table"}. To measure mRNA levels of individual genes, the cuticles from the abdomens of four bees per group were dissected out, and total RNA was extracted using the Trizol Reagent (Life Technologies, Grand Island, NY, USA). SuperScript II (Life Technologies, Grand Island, NY, USA) reverse transcriptase was used to generate cDNA templates from 500 ng of total RNA per sample by using random hexamers. A Bio-Rad (Hercules, CA, USA) CFX Connect Real-Time PCR Detection System and Bio-Rad iTaq Universal SYBR Green Supermix were subsequently used for estimating relative differences in mRNA levels across samples (N = 4 per group, run in triplicate technical replications). Expression levels of the *EIF3-S8,* a housekeeping gene that has previously been used as a reference gene in honey bee studies of gene expression by us and others ([@bib2]; [@bib36]; [@bib40]; [@bib57]; [@bib69]), was used as a loading control. To further ensure that the reported expression data for the experimental genes are robust, we first confirmed that the raw *EIF3-S8* C~t~ values per total RNA used in the individual RT reactions were not affected by any of the studied groups included in our current study (Kruskal-Wallis, H = 3.299, df = 4, p=0.5091). C~t~ data is listed in [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}. The specific RT-PCR primers for each gene-specific assay are listed in [Table 6](#table6){ref-type="table"}. Statistical analysis {#s4-10} -------------------- All CHC analyses included a set of 19 peaks that represent well-established honey bee CHCs, identified by comparing GC traces to published data ([@bib48]). For the comparisons of total CHCs across groups (as in [Figure 1A](#fig1){ref-type="fig"}), total ng of all identified CHCs in each bee were analyzed using ANOVA followed by Tukey's HSD in R 3.3.2 ([@bib83]). For the remainder of the datasets, the relative proportion of each compound in each sample was calculated and then used in further statistical analysis. For each dataset, a permutation MANOVA was run using the ADONIS function in the vegan package of R (RRID:[SCR_011950](https://scicrunch.org/resolver/SCR_011950)) with Bray-Curtis dissimilarity measures ([@bib63]). Pairwise comparisons with FDR p-value correction were subsequently run on experiments where more than two groups were compared. Data were visualized using non-metric multidimensional scaling (metaMDS function in the vegan package of R (RRID:[SCR_011950](https://scicrunch.org/resolver/SCR_011950)) ([@bib63])) using Bray-Curtis dissimilarity, and either 2 or three dimensions in order to minimize stress to \<0.1. For [Table 1](#table1){ref-type="table"}, [Table 2](#table2){ref-type="table"}, [Table 3](#table3){ref-type="table"}, and [Table 4](#table4){ref-type="table"} an ANOVA followed by Tukey's HSD post-hoc comparison, or Kruskal-Wallis followed by Dunn's Test with FDR adjustment was performed using total ng ([Table 1](#table1){ref-type="table"} and [Table 2](#table2){ref-type="table"}) or proportions ([Table 3](#table3){ref-type="table"} and [Table 4](#table4){ref-type="table"} of each compound across bees of the four time point collections. For cross-fostering studies, power was assessed by performing pseudo multivariate dissimilarity-based standard error, a method for assessing sample-size adequacy in multivariate data, as described in and using code from [@bib3]. For behavioral data, the proportion of bees accepted by guard honey bees was calculated for each experimental group at each colony at each day of age. A Pearson's chi-square was run for each day of age at each colony with subsequent pairwise comparisons. For qPCR data, relative expression levels were calculated as previously described ([@bib40]; [@bib45]; [@bib97]), using *eIF3-S8* as a loading control. Fold-expression data were generated by using the 2^-ΔΔCT^ method ([@bib55]) and designating a single individual from the 'Day 1' group ([Figure 5](#fig5){ref-type="fig"}) as a calibrator. For statistical analyses, the 2^-ΔΔCT^ scores were compared within each gene across bees of different groups using an ANOVA followed by Tukey's HSD post-hoc comparison, or Kruskal-Wallis followed by Dunn's Test with FDR adjustment. Overall test p-values were then adjusted using FDR correction to account for 16 independent comparisons ([@bib8]). Funding Information =================== This paper was supported by the following grants: - http://dx.doi.org/10.13039/100000001National Science Foundation 1545778 to Yehuda Ben-Shahar. - http://dx.doi.org/10.13039/100000001National Science Foundation 1707221 to Yehuda Ben-Shahar. - http://dx.doi.org/10.13039/100000001National Science Foundation 1754264 to Yehuda Ben-Shahar. - http://dx.doi.org/10.13039/501100000038Natural Sciences and Engineering Research Council of Canada to Joel D Levine. - http://dx.doi.org/10.13039/501100000024Canadian Institutes of Health Research to Joshua J Krupp, Joel D Levine. We thank Tyson Research Center faculty and staff and Ellen Hartz for beekeeping assistance. We thank Anthony Cantu and Brice Henson for assistance in bee collections, Iris Chin for assistance with dissections and RNA extractions, and Kyle Skottke for assistance with hive construction. Additional information {#s5} ====================== No competing interests declared. Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing---original draft, Writing---review and editing. Formal analysis, Validation, Writing---review and editing. Data curation, Validation, Writing---review and editing. Formal analysis, Methodology, Writing---review and editing. Resources, Formal analysis, Validation, Methodology, Writing---review and editing. Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Writing---original draft, Project administration, Writing---review and editing. Additional files {#s6} ================ 10.7554/eLife.41855.025 Data availability {#s7} ----------------- All data generated or analysed during this study are included in the manuscript and supporting files. All CHC chemical data are included in the data source files. 10.7554/eLife.41855.027 Decision letter Scott Kristin Reviewing Editor University of California, Berkeley United States In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included. Thank you for submitting your article \"Chemical signatures of honey bee group membership develop via a socially-modulated innate process\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Kristin Scott as the Reviewing Editor and Catherine Dulac as the Senior Editor. The reviewers have opted to remain anonymous. The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Summary: The ability to tell nestmates from non-nestmates is a central feature in the biology of social insects. Even though substantial effort has been dedicated to identifying the underlying chemical signatures, this process is still rather poorly understood. The current study presents a detailed analysis of the diversity and temporal dynamics of cuticular hydrocarbon (CHC) profiles, which are thought to be the main chemical cues mediating non-nestmate discrimination, in the honeybee. CHCs were examined across bees of different ages and behavioral castes, gene expression was quantified for genes involved in CHC synthesis, and behavioral experiments were performed to assay nestmate recognition behavior. The experiments and analyses are well-conceived and well-executed, and the results are generally clear, with some concerns to be addressed. Overall, the authors make a compelling case that several different factors are important in determining the CHC profile of individual bees, and that a model of simple CHC sharing among individual colony members is an oversimplification. Essential revisions: 1\) A significant shortcoming of this manuscript is that we don\'t know which of the CHCs studied (if any) are actually used for nestmate recognition. Probably some of them are, maybe even many of them, but CHCs also have other functions that are unrelated to nestmate recognition (e.g. barriers to desiccation, microbial infection, and abrasion). The authors should be very clear throughout the paper that they are studying entire CHC profiles, which is not the same thing as studying the CHCs used for nestmate recognition. 2\) While the authors\' evidence argues against simple Gestalt-style odor sharing, this really seems like a straw man. Many current researchers of social insect chemical ecology do not still subscribe to this view, especially not in the strict sense presented here. Current models for the dynamic of labels in nestmate recognition are much more nuanced, and there are numerous studies (in ants, bees, and wasps) showing that nestmates of different types (different castes, different tasks, different ages, social parasites) can have different cuticular hydrocarbon profiles. The Introduction and Discussion oversimplify the data on ants, what is known about colony \"Gestalt\" odors, and what exactly the concept of a \"Gestalt\" odor is. Several key papers are not cited and discussed. This gives off the impression that the current data on honeybees imply that bees are fundamentally different from ants, when in fact several studies on ants have suggested similar dynamics. For example, it has been shown that age (Cuvillier-Hot et al., 2001) and worker \"subcaste\"/task group (Wagner et al., 1998; Martin and Drijfhout 2009) can be an important determinant of CHCs in ants, i.e. not all workers in a colony necessarily display the same CHC profile. Therefore, as the authors show here for honeybees, there is evidence that at least in some ants the individual CHC profile changes as a function of age and age-related task differences. But that doesn\'t necessarily contradict the concept of a \"Gestalt\" odor component in the sense that workers from the same colony still smell sufficiently similar to each other (e.g. via genetic similarity, allogrooming, shared nest material and food sources, etc.) and thus can be distinguished from non-nestmates. An illustration of this idea can e.g. be found in Figure 2 of Sturgis and Gordon, 2012 (a review that seems very relevant to the current paper). Please thoroughly revise the manuscript in light of a more careful consideration of the social insect literature and qualify statements about how the current findings contradict the concept of a \"Gestalt\" odor in nestmate recognition. Examples are in the Introduction paragraph five, Results first and fourth paragraph, (I don\'t see the \"potential conundrum\"), fifth paragraph (but this also doesn\'t mean that these factors are not important, i.e. it could be a mix of the two -- a Gestalt component interacting with an individual component), and then of course throughout the Discussion section. I\'m listing these and a few other additional studies that seem to be very relevant to the claims of the current manuscript but are not currently discussed below. A few additional specific thoughts on CHCs and nestmate recognition: Introduction paragraph one: individuals usually do not recognize relatedness per se (in fact I don\'t know of any case of strict kin-recognition in social insects), but use some proxy of relatedness (spatial proximity, colony odor, etc.); paragraph three: I\'m not sure this really is the consensus in the field. My impression is that genetics does play an important role in this context, but that other factors (like the ones you list below) are important as well. The Gestalt odor then integrates these different factors over the individuals in a colony; Also in paragraph three: why \"passive\"? Many of the factors thought to contribute to this process are active (allogrooming, trophalaxis...). For example, queens of social parasites often actively groom and chew on resident workers before entering a host colony. This seems to be an adaptive behavior specifically aimed at achieving chemical camouflage; Again in paragraph three: I\'m not aware of ant species that do not display allogrooming behavior (can you provide a reference?); Paragraph four: maybe mention above that the \"blank slate\" idea also applies to ants? 3\) Figure 1 and related passages: subsection "CHC profiles of individual honey bee workers exhibit qualitative and quantitative age-dependent changes": There is no significant increase between days 1 and 7. I would reformulate this to \"increases between one-day post-reintroduction and 14 days post-reintroduction and then remains stable\"; I would also mention the post-hoc statistics showing which groups exactly are different from each other here. This is currently only given in the figure itself. It\'s kind of nice though, because the qualitative changes seem to broadly coincide with the quantitative changes in Figure 1A. Regarding this analysis and the data in Table 1, is there a technical reason that limits you to working with proportions? The way you analyze these data forces you to keep the change in overall amount separate from \"qualitative\", i.e. relative changes in proportion. But it seems that the picture would be much clearer if you could simply show which compounds change quantitatively with age, and which ones do not. As it is now, you might well recover compounds that change in relative proportion, but that are completely invariable in terms of quantity, while you might miss some that change significantly in quantity but remain relatively stable in overall proportion. It\'s straightforward to calculate proportions from the quantities of all compounds, but you can\'t do it the other way around. So I feel that presenting the data the former way would be more informative. It would also be helpful to use the same color codes for different compounds in the Figure 1C,D and Figure 1---figure supplement 1C,D panels. 4\) Figure 2 and related passages: The environmental experience of undertakers and foragers is probably quite different, in contrast to the perspective of the authors. Unless the authors can determine the time spent outside for undertakes and foragers, it is plausible that differences in environmental exposure contribute to CHC profiles, putting a hole in the argument that environmental exposure is not important to the development of CHC profiles. This is something that the authors will have to grapple with in their revision. Additionally, in subsection "The CHC signatures of individual workers are task-related": I find it confusing that you present significant p-values to back up a statement that something is not different. Also, how old are the undertakers? According to what you write above, they should differ as long as undertakers are less than seven days and foragers are more than seven days old. If you look at Figure 2D it indeed looks like the undertakers have less CHCs than foragers, even though the difference is not statistically significant. I would therefore be careful with how you phrase this here. Something like \"we did not detect a statistically significant difference\" might be better than \"we found that.... undertakers do not differ from foragers\". Such a negative finding would have to be backed up by a careful statistical power analysis and then refer to specific effect sizes etc. So to me it looks like undertakers are very similar to nurses both in terms of total amount and profile quality; Second paragraph, final sentence: Is this a valid comparison? 5\) Figure 3 and related passages: subsection "The development of individual CHC profiles is a regulated process modulated by the colony environment": Here again, I think this should be formulated more carefully. This section hinges on the conclusion that workers from the same colony don\'t differ at days 7 and 14, but they do at foraging onset. So for the important negative results the authors should present a careful power analysis to show that they would be able to detect the kinds of effect sizes observed between foragers if they were present at earlier time points. Looking at Figure 3, this is really far from clear -- the data actually look quite messy in that there appears to be some separation in all three cases, but there is also always a lot of overlap. So you\'d really have to convince the reader that C is in fact different from A and B. I also find the term \"natal sisters\" confusing. If I understand correctly, these are the sisters that were put back into the natal colony of the fostered individuals, but they are not natal to the colony the experimental bees were fostered into. I would reformulate this to avoid the possible confusion. Change \"factors associated with the natal colony\" to \"genetics or other factors associated with the natal colony\"? 6\) Figure 4: This figure is not very informative and I would move it to the supplement. The trees are essentially not resolved -- I would collapse all nodes with less than 50 percent bootstrap support -- the displayed topology is quite misleading. Also, for ML analyses it\'s more informative to display the single ML tree with branch lengths and then map bootstrap support onto that tree (rather than presenting a consensus tree without branch length). Finally, how were the outgroups chosen and how can you be sure they\'re actual outgroups? I couldn\'t find any justification in the Materials and methods. 7\) Figure 5 and related passages: The authors chose to conduct qPCR to measure gene expression, and they use a single reference gene based on previously published studies. The standard for these types of analyses would be to use several reference genes that are first validated in the specific context of a given study. Furthermore, there are quite a few genes being tested, and that should be taken into account in multiple-comparison corrections, i.e. p-values for significance cutoffs should be adjusted accordingly. Based on the current data I could probably be convinced that there is some dynamic gene regulation going on, but looking at Figure 5 and the associated supplementary table, I find it really hard to say which of the indicated changes are actually real and biologically meaningful and which ones are spurious. Also, given the availability of RNA-seq approaches, it seems surprising that the authors still opted for qPCRs -- RNA-seq would be much broader in scope and the statistical analysis would be more robust. I therefore feel that this is somewhat of a weakness of this study, and if at all possible, I would collect RNA-seq data in addition to the qPCR data. Patterns that hold up across both datasets would then be quite convincing. Figure 5 and the legend: remove indications of p\<0.1 -- these are not significant. 8\) The authors present data showing that CHCs differ across ages and tasks and, separately, that expression of elongases and desaturases differ across ages and tasks, and the authors argue that these are manifestations of the same underlying process. Thus, it seems important to test the relationship between these two. For example, since desaturases catalyze the formation of double bonds in alkenes, are there more alkenes produced by bees that express higher levels of desaturases? 9\) Figure 6 and related passages: subsection "Age and task play a role in defining nestmate recognition cues in honey bee colonies.": Shouldn\'t statistical comparisons be between natal foragers and other types of natal bees? It\'s not intuitive to say that they are accepted by showing comparisons that show significant differences. Figure 6A: Again, this is not very intuitive. What this panel is supposed to show is that bees of all ages are accepted into their own colony at the same rate as foragers from the same colony are. However, all the statistical comparisons are between natal bees and bees from a different colony, rather than between different types of natal bees and natal foragers. What this really shows is that, as expected, natal bees of any kind are accepted into their colony more readily than foreign foragers. If that\'s the message of this figure then I would present it as such. If, on the other hand, this is supposed to compare different types of natal bees to natal foragers as a baseline, then the statistics would have to be done differently. For example, it looks like 14 day old bees are much more readily accepted into the colony than foragers. If these statistical comparisons have in fact been done and they are all non-significant, then I would indicate this with bars labeled \"ns\" in the figure. It would also be helpful to have standard errors on the bars. First paragraph, penultimate sentence: Same problem here. All of these comparisons are statistically significant, so it\'s not obvious how they support the claim made here. These don\'t seem to be the most relevant statistical comparisons. Figure 6B: Similar problems here. Comparisons that are not significant should be indicated. Also in paragraph two: I\'m not sure how this follows from the previous experiments and the last experiment (Figure 6C) doesn\'t seem particularly relevant to the rest of the study. The alarm pheromone experiment is also challenging as different doses may yield different results. Removing Figure 6C would strengthen the manuscript. References: Greene, M.J. and D.M. Gordon (2003) Cuticular hydrocarbons inform task decisions. Nature 423:32. Greene, M.J., Pinter-Wollman, N., and D.M. Gordon (2013) Interactions with combined chemical cues inform harvester ant foragers\' decisions to leave the nest in search of food. PLoS ONE 8(1):e52219. \[Editors\' note: further revisions were requested prior to acceptance, as described below.\] Thank you for resubmitting your work entitled \"Chemical signatures of honey bee group membership develop via a socially-modulated innate process\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Catherine Dulac (Senior Editor), Kristin Scott (Reviewing Editor), and one reviewer. The manuscript has been improved but there are a few textual changes that need to be addressed before acceptance. Specifically, care should be taken to use the term CHCs instead of chemical signatures or recognition cues, as detailed below. The discussion of the Gestalt model and implications from this study should be more nuanced, as described below. Reviewer \#2: The revised manuscript is much improved, especially the way the results are presented. There are still a couple of issues where I think the authors should present their findings more carefully though. Maybe most importantly, as was already noted in the first round of reviews, it is not known which cues honeybees actually use for non-nestmate discrimination. What the authors study here are the dynamic changes in cuticular hydrocarbon profiles, without knowledge of their actual biological function. It is of course reasonable to say in the Introduction that CHCs have been implicated in non-nestmate discrimination, and to later discuss the possible implications of their findings in that context, but I would leave it at that, and be very careful in how to phrase this. I think that would further strengthen the manuscript. For example, I would change the title from \"Chemical signatures of honey bee group membership...\" to \"Honey bee cuticular hydrocarbon profiles...\" -- you really don\'t know whether the observed changes are signatures of group membership, at least in any biologically meaningful sense. If anything, the results in subsection "The development of individual CHC profiles is a regulated process modulated by the colony environment", for example, suggest that they are not. Similarly, in the Abstract, I would replace all mentions of \"nestmate recognition cues\" with \"cuticular hydrocarbon profiles\". Same in Discussion paragraph one. Introduction final paragraph: you don\'t know what the \"colony-specific nestmate recognition cues\" are, so you can\'t say anything about that directly. As an aside, and I know it sounds bulky, I prefer \"non-nestmate discrimination\" over \"nestmate recognition\". At a behavioral level, what is usually measured is that social insects discriminate against (attack) non-nestmates, not whether they recognize nestmates (you could make a similar argument for models of the underlying neuronal computation). I know that\'s not necessarily reflected in the literature and I would therefore leave it up to the authors, but in my opinion this is a better way to think about the behavior. I still find it somewhat unfortunate how the study is set up in the Introduction, and how the findings are summarized. E.g. \"Yet, whether \"Gestalt\"-like mechanisms regulate nestmate recognition systems in other social insect species remains mostly unexplored.\"; \"However, whether \"Gestalt\"-like homogenization mechanisms play a role in honey bee nestmate recognition remains unknown.\"; and then the brief summary at the start of the final paragraph of the Introduction, saying that the authors\' findings from honey bees contradict a Gestalt model. I don\'t think they do. You really don\'t know what the nestmate recognition cues are, and whether you\'re even capturing them in your analyses, so you can\'t exclude that the Gestalt model actually applies to these cues, and that the age-dependent changes you pick up here are either irrelevant (to the bees), or represent e.g. desiccation barriers and/or task group recognition cues that are superimposed on colony recognition cues (but have nothing to do with non-nestmate discrimination). Same problem Discussion final paragraph. Subsection "The CHC signatures of individual workers are task-related" paragraph three, sentence four: Doesn\'t this argue for some sort of Gestalt (or maybe genetic) effect? 10.7554/eLife.41855.028 Author response > Essential revisions: > > 1\) A significant shortcoming of this manuscript is that we don\'t know which of the CHCs studied (if any) are actually used for nestmate recognition. Probably some of them are, maybe even many of them, but CHCs also have other functions that are unrelated to nestmate recognition (e.g. barriers to desiccation, microbial infection, and abrasion). The authors should be very clear throughout the paper that they are studying entire CHC profiles, which is not the same thing as studying the CHCs used for nestmate recognition. We thank the reviewers for bringing our attention to this important point. As described in details below, we now reemphasize in the Introduction, Results, and Discussion that our analyses and data interpretations primarily focused on the phenotypic plasticity of the overall CHC profile of individual bees, and that the chemical identity of the components that might be used specifically for nestmate recognition in honey bees remains unknown: "Whether the overall profile, or more specific components of it, represent the actual nestmate recognition cue remains unknown. However, previous studies have indicated that variations in the relative amounts of each compound in the CHC profile across individuals from different colonies are likely sufficient for the chemical recognition of nest membership (van Zweden and D'Ettorre, 2010)." "Because previous studies have indicated that nestmate recognition in honey bee colonies is likely driven by components of the CHCs profile (van Zweden and D'Ettorre, 2010), and our discovery that the CHC profiles of individual workers seem to mature in association with the well-described age-dependent division of labor in this species (Robinson, 1992; Smith et al., 2008; Søvik et al., 2015), we next hypothesized that, in honey bees, nestmate recognition cues themselves mature in association with age-dependent division of labor, and reach maturation during foraging." "Which specific components of the honey bee CHC profile represent the nestmate recognition cue remains unknown. Although it has been shown that CHCs are likely the main chemicals used for nestmate recognition in honey bees (van Zweden and D'Ettorre, 2010), it is unlikely that all components of the CHC profile contribute to this process (Akino et al., 2004; Dani et al., 2005, 2001; Martin et al., 2008; Ruther et al., 2002). In fact, it has previously been shown that alkenes seem to play a more prominent role in nestmate recognition in the honey bee than alkanes (Dani et al., 2005). Our data also indicate that although unrelated foragers raised in the same colony are equally accepted, their overall CHC profiles remain somewhat qualitatively different (Figure 3C). These data provide two important insights. First, guards are not likely using the full CHC profile of individuals to determine group membership. Second, differences in the CHC profiles of co-fostered nestmate foragers of similar age that originated from different source colonies indicate that the chemical profiles of individual workers are not likely to be the product of a stochastic CHC homogenization and transfer between colony members." > 2\) While the authors\' evidence argues against simple Gestalt-style odor sharing, this really seems like a straw man. Many current researchers of social insect chemical ecology do not still subscribe to this view, especially not in the strict sense presented here. Current models for the dynamic of labels in nestmate recognition are much more nuanced, and there are numerous studies (in ants, bees, and wasps) showing that nestmates of different types (different castes, different tasks, different ages, social parasites) can have different cuticular hydrocarbon profiles. The Introduction and Discussion oversimplify the data on ants, what is known about colony \"Gestalt\" odors, and what exactly the concept of a \"Gestalt\" odor is. Several key papers are not cited and discussed. This gives off the impression that the current data on honeybees imply that bees are fundamentally different from ants, when in fact several studies on ants have suggested similar dynamics. For example, it has been shown that age (Cuvillier-Hot et al., 2001) and worker \"subcaste\"/task group (Wagner et al., 1998; Martin and Drijfhout, 2009) can be an important determinant of CHCs in ants, i.e. not all workers in a colony necessarily display the same CHC profile. Therefore, as the authors show here for honeybees, there is evidence that at least in some ants the individual CHC profile changes as a function of age and age-related task differences. But that doesn\'t necessarily contradict the concept of a \"Gestalt\" odor component in the sense that workers from the same colony still smell sufficiently similar to each other (e.g. via genetic similarity, allogrooming, shared nest material and food sources, etc.) and thus can be distinguished from non-nestmates. An illustration of this idea can e.g. be found in Figure 2 of Sturgis and Gordon, 2012 (a review that seems very relevant to the current paper). We agree with the reviewers that our original introduction to the Gestalt model was oversimplified. We also regret the omission of key papers related to it. Because the use and interpretation of what "Gestalt" means has been somewhat loose in different studies of nestmate recognition systems, we made a choice to interpret it as it was originally framed by Crozier and Dix (1979), and used by previous studies of nestmate recognition in honey bees. As we understand it in the context of the current study, the "Gestalt" model refers to the mechanism by which colony-specific cues are acquired by individual colony members (i.e. homogenization of chemicals primarily through contact with other colony members and hive materials) rather than the actual identity or sources of the cue, and therefore, here we interpreted our data specifically in this context. To address this important point, we revised the relevant sections in the Introduction as follows: "Consequently, empirical and theoretical studies suggested that individual colony members acquire their colony-specific chemical signature via a cue homogenization process involving the exchange of relevant chemicals through interactions between colony members or contact with nest building materials, often referred to as the "Gestalt" model (Crozier and Dix, 1979). Empirical evidence in support of the "Gestalt" model have been reported for a few ant species, which are known to transfer mixed blends of CHCs between individuals through trophallaxis and grooming via the action of the postpharyngeal gland (PPG) (Boulay et al., 2000; Lenoir et al., 2001; Meskali et al., 1995; Soroker et al., 1994; Victoria Soroker et al., 1995; Van Zweden et al., 2010). However, other studies suggest that many of the predictions of the classic "Gestalt" model might not fully represent the processes that drive the development of chemical nestmate recognition cues in all social insect species. For example, some ant species do not display robust trophallaxis behaviors, the main mode of chemical transfer across colony members (Soroker et al., 1994; Soroker et al., 1995), and in others, the chemical profiles of individual colony members are likely modulated by genetic relatedness (Teseo et al., 2014), age (Cuvillier-Hot et al., 2001; Teseo et al., 2014), and/or task (Martin and Drijfhout, 2009; Sturgis et al., 2012; Wagner et al., 2001, 1998). Together, these data suggest that the regulation of chemical nestmate recognition cues in different species is more variable and complex than initially hypothesized (Esponda et al., 2015; Newey, 2011; Sturgis and Gordon, 2012)." "Based on these studies, it has been hypothesized that, similar to some ant species, the CHC profile of newly eclosed workers represents a "blank slate" (Breed et al., 2004; Lenoir et al., 1999), and that, similar to predictions of the classic "Gestalt" model, nestmate recognition cues are subsequently acquired by individual workers via the homogenization and transfer of chemicals through direct social interactions and intermediate environmental factors (Breed et al., 2015). Furthermore, it has recently been proposed that the cephalic salivary gland of honey bee workers is functionally analogous to the PPG in ants, and is likely involved in the "Gestalt"-like homogenization and transfer of the chemical cues shared by all colony members (Martin et al., 2018). However, whether "Gestalt"-like homogenization mechanisms play a role in honey bee nestmate recognition remains unknown." > Please thoroughly revise the manuscript in light of a more careful consideration of the social insect literature and qualify statements about how the current findings contradict the concept of a \"Gestalt\" odor in nestmate recognition. Examples are in the Introduction paragraph five, Results first and fourth paragraph, (I don\'t see the \"potential conundrum\"), fifth paragraph (but this also doesn\'t mean that these factors are not important, i.e. it could be a mix of the two -- a Gestalt component interacting with an individual component), and then of course throughout the Discussion section. I\'m listing these and a few other additional studies that seem to be very relevant to the claims of the current manuscript but are not currently discussed below. If we understand this comment correctly, the reviewers refer to the term "Gestalt" to describe actual components of the chemical profile or "odor" that signals group membership, and thus interpret the concept of a \"Gestalt\" as an odor that is similar across nestmates. However, the concept of a nestmate recognition cue in itself implies that a similar odor (or chemical profile) is shared between nestmates, which we fully agree with. Therefore, as we describe above, here we interpreted "Gestalt", and related concepts, according to their meaning in the original model, which uses "Gestalt" to the describe the physiological and behavioral processes that mediate the development and acquisition of colony-specific nestmate recognition cues by individual colony members (e.g., homogenization mechanisms), but not the specific chemical identities of the cues. Therefore, we respectfully argue that our claim that the data presented here do not support the predictions of the Gestalt model still holds. In addition to our response to the previous comment, we clarify this important point in the revised text as follows: "Here we provide empirical evidence that, in contrast to predictions of the classic "Gestalt model", which stipulates that nestmate recognition cues are primarily directly acquired from the environment, other group members, or hive building materials, the maturation of the pheromonal profile of individual honey bee workers is primarily regulated by innate developmental processes associated with age-dependent behavioral tasks and modulated by the social colony environment. Specifically, we find that individual workers exhibit stereotypic quantitative and qualitative changes in their CHC profile as they transition from in-hive tasks to foraging outside, that these changes are associated with innate transcriptional changes in CHC biosynthetic pathway genes, and that the foraging task is directly associated with the final maturation of the colony-specific nestmate recognition cue. Together, our findings suggest that not all members of honey bee colonies display a uniform chemical signature via the direct acquisition of CHCs. Instead, our data indicate that nestmate recognition cues in honey bees are more likely a product of a genetically-determined developmental program that is modulated by colony-specific factors." ""Gestalt"-like models for the development of colony-specific nestmate recognition cues predict that cue specificity is acquired by individuals via physical contact with other colony members and/or environmental sources of hydrocarbons (Breed et al., 2015; Crozier and Dix, 1979; Lenoir et al., 2001; Meskali et al., 1995; Soroker et al., 1994; Victoria Soroker et al., 1995; Van Zweden et al., 2010). However, because our data indicate that the maturation of the CHC profile of individual honey bees is actually regulated in association with the stereotypic age-dependent division of labor in this species, we next hypothesized that the CHC profiles of worker honey bees develop, at least in part, via an intrinsic age-dependent regulation of the CHC biosynthetic pathways in the pheromone producing oenocytes (Chung and Carroll, 2015; Falcón et al., 2014; Makki et al., 2014; Yew and Chung, 2015)." "Thus, in contrast to the previous assumption that the CHC profiles of worker bees are primarily a product of their interactions with other colony members and/or nest materials, our data suggest that individual worker honey bees regulate CHC expression through an innate age-dependent developmental process that is further modulated by other factors such as task and the social environment." "In the well-studied honey bee, previous studies suggested that the chemical cues that drive nestmate recognition develop via a "Gestalt"-like homogenization and transfer of chemicals between colony members through direct interactions such as allogrooming and trophallaxis, and indirect interactions such as physical contact with wax and other nest materials (Breed et al., 2015). However, the data we present here suggest that nestmate recognition cues in the honey bee primarily depend on an innate developmental process that is associated with the stereotypic age-dependent division of labor in this species, and do not completely mature until bees make their final behavioral transition to foraging." "In conclusion, we propose that nestmate recognition cue production and acquisition in honey bees is not likely to be driven by processes that are analogous to the "Gestalt"-like mechanisms as previously described in some ant species (Boulay et al., 2000; Lenoir et al., 2001; Meskali et al., 1995; Soroker et al., 1994; Victoria Soroker et al., 1995; Van Zweden et al., 2010). Instead, we propose a new model for the regulation of nestmate recognition in honey bee colonies, which stipulates that unknown factors associated with the hive environment play a direct or indirect role in defining the developmental kinetics and specificity of nestmate recognition cues by modulating the cellular and molecular processes that are responsible for pheromone synthesis." > A few additional specific thoughts on CHCs and nestmate recognition: Introduction paragraph one: individuals usually do not recognize relatedness per se (in fact I don\'t know of any case of strict kin-recognition in social insects), but use some proxy of relatedness (spatial proximity, colony odor, etc.); We revised this statement as follows: "adaptive organismal social interactions often depend on the ability of individuals to recognize kin and/or group-members to increase cooperation or to suppress inbreeding" > Paragraph three: I\'m not sure this really is the consensus in the field. My impression is that genetics does play an important role in this context, but that other factors (like the ones you list below) are important as well. The Gestalt odor then integrates these different factors over the individuals in a colony; Here we argue that the overall emerging consensus in the literature is that relative to hive and other environmental factors, genetic background seems to play a very minor role in defining the colony-specific nestmate recognition cue in honey bees. In our opinion, the data we present here further support this view. Nevertheless, we toned-down this statement in the revised text as follows: "However, empirical studies revealed that, surprisingly, colony and social environmental factors play the most dominant role in defining colony-specific cues, and can often mask genetic relatedness (Breed et al., 1988; Downs and Ratnieks, 1999; Heinze et al., 1996; Lahav et al., 2001; Liang and Silverman, 2000; Singer and Espelie, 1996; Stuart, 1988)." > Also in paragraph three: why \"passive\"? Many of the factors thought to contribute to this process are active (allogrooming, trophalaxis...). For example, queens of social parasites often actively groom and chew on resident workers before entering a host colony. This seems to be an adaptive behavior specifically aimed at achieving chemical camouflage; Our original reason for using the term "passive" here was to contrast the "passive" acquisition of chemicals from other sources vs. "active" production of the chemicals by the individual. In retrospect, this is clearly confusing. To clarify, we deleted this adverb throughout the revised text. > Again in paragraph three: I\'m not aware of ant species that do not display allogrooming behavior (can you provide a reference?); We thank the reviewers for pointing out the mischaracterization of the phenotype. We revised the text as follows: "For example, some ant species do not display robust trophallaxis behaviors" > Paragraph four: maybe mention above that the \"blank slate\" idea also applies to ants? We revised the text as follows: "Based on these studies, it has been hypothesized that, similar to some ant species, the CHC profile of newly enclosed workers represents a "blank slate" (Breed et al., 2004; Lenoir et al., 1999), and that, similar to predictions of the classic "Gestalt" model, nestmate recognition cues are subsequently acquired by individual workers via the homogenization and transfer of chemicals through direct social interactions and intermediate environmental factors (Breed et al., 2015)." > 3\) Figure 1 and related passages: subsection "CHC profiles of individual honey bee workers exhibit qualitative and quantitative age-dependent changes": There is no significant increase between days 1 and 7. I would reformulate this to \"increases between one-day post-reintroduction and 14 days post-reintroduction and then remains stable\"; We revised the text as follows: "This analysis revealed that the total amount of CHCs increases between one-day post-reintroduction and 14-days post-reintroduction and then remains stable" > I would also mention the post-hoc statistics showing which groups exactly are different from each other here. This is currently only given in the figure itself. It\'s kind of nice though, because the qualitative changes seem to broadly coincide with the quantitative changes in Figure 1A. We have revised the text as follows: "(Figure 1B, Permutation MANOVA, F(1,31) = 22.86, R^2^ = 0.43, p \< 0.001, FDR pairwise contrasts: Day 1 vs. Day 7 p = 0.002, Day 1 vs. Day 14 p = 0.002, Day 1 vs. Day 21 p = 0.002, Day 7 vs. Day 14 = 0.017, Day 7 vs. Day 21 p = 0.002, Day 14 vs. Day 21 p = 0.31; Figure 1 ---figure supplement 1B, Permutation MANOVA, F(3,28) = 2.35, R^2^ = 0.22, p = 0.038, FDR pairwise contrasts: Day 1 vs. Day 7 p = 0.024, Day 1 vs. Day 14 p = 0.011, Day 1 vs. Day 18 p = 0.018, Day 7 vs. Day 14 = 0.406, Day 7 vs. Day 18 p = 0.212, Day 14 vs. Day 18 p = 0.524)" > Regarding this analysis and the data in Table 1, is there a technical reason that limits you to working with proportions? The way you analyze these data forces you to keep the change in overall amount separate from \"qualitative\", i.e. relative changes in proportion. But it seems that the picture would be much clearer if you could simply show which compounds change quantitatively with age, and which ones do not. As it is now, you might well recover compounds that change in relative proportion, but that are completely invariable in terms of quantity, while you might miss some that change significantly in quantity but remain relatively stable in overall proportion. It\'s straightforward to calculate proportions from the quantities of all compounds, but you can\'t do it the other way around. So I feel that presenting the data the former way would be more informative. It would also be helpful to use the same color codes for different compounds in the Figure 1C,D and Figure 1---figure supplement 1C,D panels. Since most studies in this field rely on relative proportions of individual compounds and overall profiles using relative proportions, we believe that it is helpful to show differences in relative proportions between bees of different ages. However, we agree with the reviewers that changes in relative proportion do not necessarily depict changes in quantity, so we now also include graphs and tables depicting changes in quantity as follows: Changes in quantity: Table 1, Table 2, Figure 1C,D, Figure 1---figure supplement 1C,D. Changes in proportion: Table 3, Table 4, Figure 1E,F, Figure 1---figure supplement 1E,F. > 4\) Figure 2 and related passages: The environmental experience of undertakers and foragers is probably quite different, in contrast to the perspective of the authors. Unless the authors can determine the time spent outside for undertakes and foragers, it is plausible that differences in environmental exposure contribute to CHC profiles, putting a hole in the argument that environmental exposure is not important to the development of CHC profiles. This is something that the authors will have to grapple with in their revision. We now include new data that addresses this comment. We have made the following modifications to the results and conclusions of this section: "These data suggest that some outdoor exposure is not sufficient to drive forager-specific CHC signatures. We next asked whether the CHC signatures of foragers are a direct consequence of their behavioral state by using "big back colonies" (Ben-Shahar et al., 2000; Withers et al., 1995), which allowed us to compare active foragers to bees of a similar age and behavioral state that are unable to forage outside (see Materials and methods). We found that the overall CHC profiles of "big-back" bees were different from those of their actively foraging sisters (Figure 2E, Permutation MANOVA, F(1,14)=5.91, R^2^ = 0.313, p \< 0.001). These data suggest that the physiological transition to foraging behaviors is not the sole factor that defines forager-specific CHC profiles, and that it could be modulated by additional factors associated with the act of foraging itself and/or extended exposure to various outdoor environmental factors. However, the fact that foraging nestmates express very similar CHC profiles, which are markedly different from those of non-nestmate foragers sharing a similar foraging environment (Figure 2---figure supplement 1, Permutation MANOVA, F(1,15) = 12.5, R^2^ = 0.47, p \< 0.001) suggests that forager-specific chemical signatures are not simply defined by the foraging environment. Additionally, to test whether extended exposure to outdoor environmental factors induces predictable changes in CHCs, we compared the relative amount of individual compounds between forager bees and in-hive bees across our various experiments. We did not find a single compound that varied between foragers and in-hive bees in a consistent manner across our experiments (e.g. always increases or always decreases in association with foraging activity) (Table 5), indicating that CHCs do not change in a stereotypic manner in association with extended outdoor exposure, as they do in Harvester ants (Wagner et al., 2001). Nevertheless, to further examine whether forager-specific CHC profiles were solely environmentally determined, we also analyzed the CHC profiles of typical-age foragers that were forced to revert to a nursing state (Robinson et al., 1992). However, we did not find any differences between the CHC profiles of reverted nurses and active foragers (Figure 2F). These data suggest that once foragers acquire their signature CHC profile, it remains stable independent of the task they perform and despite the typical short CHC half-life in insects (Kent et al., 2007). Together, these data suggest that forager-specific CHC signatures are derived from a combination of factors associated with an innate behavioral maturation process, as well as being physically engaged in foraging activity." > Additionally, in subsection "The CHC signatures of individual workers are task-related": I find it confusing that you present significant p-values to back up a statement that something is not different. We agree that this is confusing. We have now included the post-hoc statistics here to demonstrate that foragers and nurses are not statistically significantly different. The statistics originally cited were for the overall MANOVA, which included nurses, undertakers and foragers, and whose low p-value was driven by comparison of foragers with nurses. "(Figure 2D, Permutation MANOVA, F(2,23)=12.60, R^2^ = 0.55, p \< 0.001, FDR pairwise contrasts: undertaker vs. forager p = 0.003, undertaker vs. nurse p = 0.176, forager vs. nurse p = 0.003)" > Also, how old are the undertakers? According to what you write above, they should differ as long as undertakers are less than seven days and foragers are more than seven days old. Undertakers are usually 2-3 weeks old, which we have made note of in the text. "'Undertakers' are a small group of highly specialized older pre-foraging workers (2-3 weeks of age), which are responsible for removing dead bees by carrying them outside and away from the colony (Robinson, 1992; Smith et al., 2008; Søvik et al., 2015; Trumbo et al., 1997)." > If you look at Figure 2D it indeed looks like the undertakers have less CHCs than foragers, even though the difference is not statistically significant. I would therefore be careful with how you phrase this here. Something like \"we did not detect a statistically significant difference\" might be better than \"we found that.... undertakers do not differ from foragers\". Such a negative finding would have to be backed up by a careful statistical power analysis and then refer to specific effect sizes etc. So to me it looks like undertakers are very similar to nurses both in terms of total amount and profile quality; Second paragraph, final sentence: Is this a valid comparison? We have included new data that addresses this comment, as described in our response to point 4. > 5\) Figure 3 and related passages: subsection "The development of individual CHC profiles is a regulated process modulated by the colony environment": Here again, I think this should be formulated more carefully. This section hinges on the conclusion that workers from the same colony don\'t differ at days 7 and 14, but they do at foraging onset. So for the important negative results the authors should present a careful power analysis to show that they would be able to detect the kinds of effect sizes observed between foragers if they were present at earlier time points. Looking at Figure 3, this is really far from clear -- the data actually look quite messy in that there appears to be some separation in all three cases, but there is also always a lot of overlap. So you\'d really have to convince the reader that C is in fact different from A and B. To address this comment, we now include a multivariate power analysis as described in (Anderson and Santana-Garcon, 2015) in Figure 3---figure supplement 1. Additionally, while our visualization method is separate from our statistical test, it unfortunately does not fully recapitulate the statistical significance found in this data set, therefore we now include more detailed statistics as follows: "CHC analyses revealed that through Day 14, the CHC profiles of bees were more similar to the profiles of their same-aged non-nestmate sisters than those of unrelated nestmates of similar age (Figure 3A, Two-way Permutation MANOVA, foster colony (environment): F(1,31) = 2.19, R^2^ = 0.06, p = 0.06, source colony (genetics): F(1,31) = 5.94, R^2^ = 0.16, p \< 0.001, foster colony\*source colony: F(1,31)=0.46, R^2^ = 0.01, p = 0.82; Figure 3B, Two-way Permutation MANOVA, foster colony: F(1,31) = 1.13, R^2^ = 0.03, p = 0.33, source colony: F(1,31) = 3.18, R^2^ = 0.09, p = 0.02, foster colony\*source colony: F(1,31) = 1.78, R^2^ = 0.05, p = 0.15; sample size assessment depicted in Figure 3---figure supplement 1 indicates sample size is adequate)." > I also find the term \"natal sisters\" confusing. If I understand correctly, these are the sisters that were put back into the natal colony of the fostered individuals, but they are not natal to the colony the experimental bees were fostered into. I would reformulate this to avoid the possible confusion. We thank the reviewers for pointing out this confusion. We have eliminated this term and have clarified these comparisons in the text. > Change \"factors associated with the natal colony\" to \"genetics or other factors associated with the natal colony\"? We thank the reviewers for this suggestion and have made this change: "Together, these data suggest that genetic variations, or other long-term effects associated with the source colony, play an important role in defining the CHC profiles of individuals during the early phases of the age-dependent behavioral development of worker honey bees." > 6\) Figure 4: This figure is not very informative and I would move it to the supplement. The trees are essentially not resolved -- I would collapse all nodes with less than 50 percent bootstrap support -- the displayed topology is quite misleading. Also, for ML analyses it\'s more informative to display the single ML tree with branch lengths and then map bootstrap support onto that tree (rather than presenting a consensus tree without branch length). Finally, how were the outgroups chosen and how can you be sure they\'re actual outgroups? I couldn\'t find any justification in the Materials and methods. To address this concern, we replaced the protein tree with a table that describes the protein BLAST E-values used to identify honey bee genes that encode enzymes that play a role in insect CHC biosynthesis by using well-characterized representative genes in *Drosophila melanogaster* (Table 6). > 7\) Figure 5 and related passages: The authors chose to conduct qPCR to measure gene expression, and they use a single reference gene based on previously published studies. The standard for these types of analyses would be to use several reference genes that are first validated in the specific context of a given study. We agree with the reviewers that a careful choice of control genes is essential for robust quantification of mRNA expression levels by using relative qRT-PCR data. We also agree that in some experimental contexts, using more than one control gene increases the confidence that the described changes in gene expression represent differences in the focal rather than changes in the expression of the putative "control" gene. In fact, in the current study we originally attempted to use the same two control genes we (Greenberg et al., 2012) and others have used in past honey bee studies. However, in contrast to our previous studies of brain tissues, here we found that only the *EIF3-S8* gene was reliably amplified from abdominal RNA tissues. In contrast, the same *Arp1* assay we successfully used in brain studies does not work reliably with abdominal tissues. Therefore, after careful consideration, we decided to only use a single control gene for C~t~ normalization instead of the geometric average of two different control genes. Although previously published studies by others have used *EIF3-S8* as a single control gene expression in studies of gene expression in honey bee cuticular tissues (e.g. Richards et. al, 2008), we made sure that the raw C~t~ values of *EIF3-S8* were not affected by any of the experimental conditions included in the current studies. Nevertheless, to clarify this important technical point, we added the following statement: "Expression levels of the *EIF3-S8,* a housekeeping gene that has previously been used as a reference gene in honey bee studies of gene expression by us and others (Alaux et al., 2009; Fischer and Grozinger, 2008; Greenberg et al., 2012; Mao et al., 2015; Richard et al., 2008), was used as a loading control. To further ensure that the reported expression data for the experimental genes are robust, we first confirmed that the raw *EIF3-S8* C~t~ values per total RNA used in the individual RT reactions were not affected by any of the studied groups included in our current study (Kruskal-Wallis, H = 3.299, df = 4, p = 0.5091)." > Furthermore, there are quite a few genes being tested, and that should be taken into account in multiple-comparison corrections, i.e. p-values for significance cutoffs should be adjusted accordingly. Based on the current data I could probably be convinced that there is some dynamic gene regulation going on, but looking at Figure 5 and the associated supplementary table, I find it really hard to say which of the indicated changes are actually real and biologically meaningful and which ones are spurious. To address this concern, we added FDR adjusted p-values to Table 7, and now only show expression data for genes whose FDR adjusted p-value is \< 0.05 (Figure 5). > Also, given the availability of RNA-seq approaches, it seems surprising that the authors still opted for qPCRs -- RNA-seq would be much broader in scope and the statistical analysis would be more robust. I therefore feel that this is somewhat of a weakness of this study, and if at all possible, I would collect RNA-seq data in addition to the qPCR data. Patterns that hold up across both datasets would then be quite convincing. We respectfully disagree with the reviewers that not using RNA-seq data represent a weakness of our study. In our experience, RNA-seq is an excellent hypothesis-generating approach, which we often use as an effective tool for the discovery phase of our projects. However, we find that in our hands, the unavoidable high level of quantitative noise, and the obvious statistical issues associated with multiple comparisons, significantly reduce the detection power of RNA-seq, especially for small-effect genes, which makes it a weak tool for testing gene-centric hypotheses. However, because here we are testing a very specific hypothesis about a group of candidate genes, we hope that the reviewers would agree with us that the actual potential for gaining additional mechanistic insights is minimal, and therefore, does not justify the additional costs and time associated with adding the suggested RNA-seq study. > Figure 5 and the legend: remove indications of p\<0.1 -- these are not significant. The revised text only describes significant p-values (p\<0.05). > 8\) The authors present data showing that CHCs differ across ages and tasks and, separately, that expression of elongases and desaturases differ across ages and tasks, and the authors argue that these are manifestations of the same underlying process. Thus, it seems important to test the relationship between these two. For example, since desaturases catalyze the formation of double bonds in alkenes, are there more alkenes produced by bees that express higher levels of desaturases? The bees used for the qPCR analysis are from the same group(s) as those in Figure 1---figure supplement 1, which demonstrate this relationship. We have made a note of this in the manuscript ("source colony (sisters of the bees analyzed for Figure 1---figure supplement 1)"). Unfortunately, bees are unable to be used for both CHC extraction and RNA extraction (CHC extraction occurs at room temperature and likely degrades RNA, RNA extraction requires dissection, which makes the animal unusable for CHC extraction), so the exact same bees cannot be used to identify an exact relationship. In terms of linking the two analyses, this would certainly be an interesting future direction, but something that we cannot currently address. Because these enzymes likely have complex function, are involved in other processes other than producing CHCs, might have varying threshold values of when they are active, etc., it is difficult to make claims about specific enzymes controlling specific CHCs. Indeed, we do see an increase in some desaturase genes and some alkenes, but because the relationships between specific enzymes and compounds are complex, we do not feel comfortable to speculate about any possible causal relationships. Therefore, to avoid overinterpretation of our data, we currently focus our data interpretations on the intrinsic changes in gene expression levels in association with age and hive environment to support the more conservative data interpretation that age and the hive environment influence innate processes related to CHC synthesis. We address this in the revised text as follows: "\[These data\] indicate that the overall observed qualitative age- and task-dependent changes in the CHC profiles of individual workers are affected by intrinsic molecular dynamics of the CHC synthesis pathway. However, our studies also importantly show that genetically-related bees that age in different colonies exhibit qualitatively different CHC profiles and CHC biosynthesis gene expression levels, which suggests that the CHC synthesis process is also plastic, and could be modulated by factors associated with the hive/ social environment." > 9\) Figure 6 and related passages: subsection "Age and task play a role in defining nestmate recognition cues in honey bee colonies.": Shouldn\'t statistical comparisons be between natal foragers and other types of natal bees? It\'s not intuitive to say that they are accepted by showing comparisons that show significant differences. Figure 6A: Again, this is not very intuitive. What this panel is supposed to show is that bees of all ages are accepted into their own colony at the same rate as foragers from the same colony are. However, all the statistical comparisons are between natal bees and bees from a different colony, rather than between different types of natal bees and natal foragers. What this really shows is that, as expected, natal bees of any kind are accepted into their colony more readily than foreign foragers. If that\'s the message of this figure then I would present it as such. If, on the other hand, this is supposed to compare different types of natal bees to natal foragers as a baseline, then the statistics would have to be done differently. For example, it looks like 14 day old bees are much more readily accepted into the colony than foragers. If these statistical comparisons have in fact been done and they are all non-significant, then I would indicate this with bars labeled \"ns\" in the figure. It would also be helpful to have standard errors on the bars. First paragraph, penultimate sentence: Same problem here. All of these comparisons are statistically significant, so it\'s not obvious how they support the claim made here. These don\'t seem to be the most relevant statistical comparisons. Figure 6B: Similar problems here. Comparisons that are not significant should be indicated. We thank the reviewers for pointing out this somewhat confusing data presentation. To clarify, we now describe all possible pair-wise comparisons, including those that are not significant (Figure 5). Because these comparisons are based on Pearson's Chi-square analyses of proportional data (accepted/rejected bees), standard error bars cannot be applied. > Also in paragraph two: I\'m not sure how this follows from the previous experiments and the last experiment (Figure 6C) doesn\'t seem particularly relevant to the rest of the study. The alarm pheromone experiment is also challenging as different doses may yield different results. Removing Figure 6C would strengthen the manuscript. We agree that this figure does not fit with the main findings of the paper, and have decided to remove it from the revised manuscript. \[Editors\' note: further revisions were requested prior to acceptance, as described below.\] > The manuscript has been improved but there are a few textual changes that need to be addressed before acceptance. Specifically, care should be taken to use the term CHCs instead of chemical signatures or recognition cues, as detailed below. The discussion of the Gestalt model and implications from this study should be more nuanced, as described below. > > Reviewer \#2: > > The revised manuscript is much improved, especially the way the results are presented. There are still a couple of issues where I think the authors should present their findings more carefully though. Maybe most importantly, as was already noted in the first round of reviews, it is not known which cues honeybees actually use for non-nestmate discrimination. What the authors study here are the dynamic changes in cuticular hydrocarbon profiles, without knowledge of their actual biological function. It is of course reasonable to say in the Introduction that CHCs have been implicated in non-nestmate discrimination, and to later discuss the possible implications of their findings in that context, but I would leave it at that, and be very careful in how to phrase this. I think that would further strengthen the manuscript. For example, I would change the title from \"Chemical signatures of honey bee group membership...\" to \"Honey bee cuticular hydrocarbon profiles...\" -- you really don\'t know whether the observed changes are signatures of group membership, at least in any biologically meaningful sense. If anything, the results in subsection "The development of individual CHC profiles is a regulated process modulated by the colony environment", for example, suggest that they are not. Similarly, in the Abstract, I would replace all mentions of \"nestmate recognition cues\" with \"cuticular hydrocarbon profiles\". Same in Discussion paragraph one. Introduction final paragraph: you don\'t know what the \"colony-specific nestmate recognition cues\" are, so you can\'t say anything about that directly. We agree with the reviewer that not all changes in the CHC profiles of individual workers we have identified here are directly relevant to the cues that regulate nestmate recognition. Therefore, we now make it clearer throughout the revised text that the specific identity of the specific compounds that comprise the cue for nestmate recognition remain unknown, and that not all changes in the CHC profile of individuals are directly related to the development of nestmate recognition cues, and place more separation in the conclusions drawn from our CHC results and nestmate recognition cues as described below: 1\) We have revised the title as follows: "The cuticular hydrocarbon profiles of honey bee workers develop via a socially-modulated innate process" 2\) "Here we show that in the honey bee (*Apis mellifera*), the colony-specific CHC profile completes its maturation in foragers..." 3\) "Therefore, the CHC profiles of individual honey bees are not likely produced through homogenization and transfer mechanisms, but instead mature in association with age-dependent division of labor." 4\) "Whether the overall profile, or more specific components of it, represent the actual nestmate recognition cue remains unknown. However, previous studies have indicated that variations in the relative amounts of each compound in the CHC profile across individuals from different colonies are likely sufficient for the chemical recognition of nest membership" 5\) "Here we provide empirical evidence that the maturation of the CHC profile of individual honey bee workers is primarily regulated by innate developmental processes associated with age-dependent behavioral tasks and modulated by the social colony environment, and that mature colony-specific recognition cues are primarily associated with the foraging task." 6\) "Instead, our data indicate that CHC profiles, and likely nestmate recognition cues, in honey bees are more likely a product of a genetically-determined developmental program that is modulated by colony-specific factors." 7\) "However, the data we present here suggest that the overall development of individual CHC profiles of honey bee workers primarily depends on an innate developmental process" 8\) "Therefore, we posit that it is unlikely that CHC profiles in honey bees develop through homogenization and transfer mechanisms between nestmates and hive materials. Furthermore, given the established implicated role of CHCs in nestmate recognition (van Zweden and D'Ettorre, 2010), we additionally posit that CHC homogenization mechanisms are unlikely to play a key role in the production of colony-specific cues in honey bees." 9\) "Which specific components of the honey bee CHC profile represent the nestmate recognition cue remains unknown. Although it has been shown that CHCs are likely used for nestmate recognition in honey bees (van Zweden and D'Ettorre, 2010), it is unlikely that all components of the CHC profile contribute to this process (Akino et al., 2004; Dani et al., 2005, 2001; Martin et al., 2008; Ruther et al., 2002)." > As an aside, and I know it sounds bulky, I prefer \"non-nestmate discrimination\" over \"nestmate recognition\". At a behavioral level, what is usually measured is that social insects discriminate against (attack) non-nestmates, not whether they recognize nestmates (you could make a similar argument for models of the underlying neuronal computation). I know that\'s not necessarily reflected in the literature and I would therefore leave it up to the authors, but in my opinion this is a better way to think about the behavior. We thank the reviewer for bringing up this important distinction. In our view, describing the main focus of this study as either \"non-nestmate discrimination\" or \"nestmate recognition\" is contextual. We prefer to continue using the term \"nestmate recognition\" when referring to this trait in general, and \"non-nestmate discrimination\" when referring to the actual behavioral assays used to measure it. We clarify this in the revised manuscript as follows: "One remarkable example of organismal recognition of "self" comes from colonies of social insects, which depend on a robust non-nestmate discrimination system (more commonly called "nestmate recognition") to prevent the loss of expensive resources to non-nestmates, and to maintain overall colony integrity (Hefetz, 2007; van Zweden and D'Ettorre, 2010)." > I still find it somewhat unfortunate how the study is set up in the Introduction, and how the findings are summarized. E.g. \"Yet, whether \"Gestalt\"-like mechanisms regulate nestmate recognition systems in other social insect species remains mostly unexplored.\"; \"However, whether \"Gestalt\"-like homogenization mechanisms play a role in honey bee nestmate recognition remains unknown.\"; and then the brief summary at the start of the final paragraph of the Introduction, saying that the authors\' findings from honey bees contradict a Gestalt model. I don\'t think they do. You really don\'t know what the nestmate recognition cues are, and whether you\'re even capturing them in your analyses, so you can\'t exclude that the Gestalt model actually applies to these cues, and that the age-dependent changes you pick up here are either irrelevant (to the bees), or represent e.g. desiccation barriers and/or task group recognition cues that are superimposed on colony recognition cues (but have nothing to do with non-nestmate discrimination). Same problem Discussion final paragraph. Subsection "The CHC signatures of individual workers are task-related" paragraph three, sentence four: Doesn\'t this argue for some sort of Gestalt (or maybe genetic) effect? We regret not making our rationale and data interpretations clearer. The primary hypothesis we tested here was derived from the assumptions originally proposed by the gestalt model, which suggested that colony-specific chemical cues are an emergent phenomenon that develops via CHC homogenization and transfer across nestmates. Previous studies suggested that in the honey bees, this mechanism may explain the development and propagation of colony specific chemical signatures. However, the data we present here suggest that this process in more complex than originally thought, and involves both innate processes as well as interactions with colony factors. Nevertheless, to address this concern, we have toned down our data interpretations in terms of its implication for the overall validity of the gestalt model. Therefore, we removed the term "gestalt" from most of the manuscript, and refocused it on determining when and how CHC profiles and recognition cues develop in honey bees, and whether CHC homogenization mechanisms might be sufficient to explain our observation. Key revised statements are described below: 1\) "Consequently, here we investigated the development of CHC profiles and nestmate recognition cues in the European honey bee, *Apis mellifera*" 2\) "However, when and how honey bee chemical nestmate recognition cues mature, and whether CHC homogenization mechanisms play a role in this process have not been directly investigated." 3\) "Therefore, we posit that it is unlikely that CHC profiles in honey bees develop through homogenization and transfer mechanisms between nestmates and hive materials. Furthermore, given the established implicated role of CHCs in nestmate recognition (van Zweden and D'Ettorre, 2010), we additionally posit that CHC homogenization mechanisms are unlikely to play a key role in the production of colony-specific cues in honey bees." 4\) "Therefore, our data suggest that CHC profiles of honey bee workers develop via a biphasic process..." 5\) "In conclusion, we propose that nestmate recognition cue production and acquisition in honey bees are not likely to be primarily driven by CHC homogenization and transfer mechanisms as previously described in some ant species"

\section{Introduction} The polarized beams foreseen for the ILC allow sensitive probes of Left and Right-handed electrons' neutral current couplings, both at the nominal collision energies (250, 350, 500, 1000~GeV) and in the ``radiative return'' to the $Z$ boson. At a collider with unpolarized beams, for example at LEP, measurement of the tau lepton polarisation in tau-pair events provides a similar measurement of the chirality of the neutral current interactions. At the ILC, it will be possible to simultaneously use both of these methods. The relation between these two measurements will be affected both by the true beam polarization -- providing a powerful check for systematic effects -- and the universality of the chiral interactions between lepton generations -- a particularly interesting topic in these days of flavor anomalies. We discuss studies of the extraction of tau polarisation information at an electron positron collider such as the ILC. Several different methods to extract polarisation observables are studied. \section{Polarimeters} The distribution of a tau lepton's decay products depends on the orientation of its spin. Polarization-sensitive observables, known as polarimeters, make use of this dependence to reconstruct the spin orientation. We study hadronic decays of the tau, which offer greater sensitivity to the tau's polarisation. Optimal tau polarimeter vectors can be rather simply defined in the case of \ensuremath{\tau^\pm \to \pi^\pm \nu}\ (which we sometimes abbreviate as ``$\tau \rightarrow \pi$'') and \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ (``$\tau \rightarrow \rho$'') decays, see e.g.~\cite{Tauola}. The polarimeter vectors are defined in the tau rest frames as follows: for \ensuremath{\tau^\pm \to \pi^\pm \nu}, it is the direction of the neutrino momentum, while for \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ it is the direction of the vector $\mathbf{P} = 2 (\mathbf{q} \cdot \mathbf{p_\nu}) \mathbf{q} - m_q^2 \mathbf{p_\nu}$, where $\mathbf{q} = \mathbf{p}_{\pi^\pm} - \mathbf{p}_{\pi^0}$, and $\mathbf{p_\nu}, \mathbf{p}_{\pi^\pm}, \mathbf{p}_{\pi^0}$ are respectively the 3-momenta of the neutrino, charged and neutral pions. To distinguish taus of different helicity, we consider the cosine of the angle this polarimeter vector makes to the tau flight direction: we call this the ``polarimeter''. We refer to this form of the polarimeters as ``optimal''; example distributions are shown in Fig.~\ref{fig:polmc}. Extracting this optimal form of the polarimeter requires knowledge of the tau neutrino momentum, which is obviously not directly measurable, or equivalently of the parent tau momentum. It also requires the reconstruction of every visible particle produced in the tau decay, and the correct identification of the tau decay mode. \begin{figure}[htb] \centering \includegraphics[width=0.4\textwidth]{MCPiPol.pdf} \includegraphics[width=0.4\textwidth]{MCRhoPol.pdf} \\ \caption{ ``Optimal'' polarimeter distributions for \ensuremath{\tau^\pm \to \pi^\pm \nu}\ (left) and \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ (right) decays of $\pm$ helicity tau leptons, reconstructed using MC truth information.} \label{fig:polmc} \end{figure} ``Approximate'' polarimeters can be defined, reconstructed based only on the momenta of visible tau decay products. In the 2-body decay \ensuremath{\tau^\pm \to \pi^\pm \nu}, the energy of the pion is an optimal polarimeter for taus of known energy, however due to the spread in beam energies at a real collider and the resulting spread in tau energies, its sensitivity is slightly decreased. In the case of \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}, one can arrive at an approximate polarimeter by integrating over possible neutrino momenta, as described in \cite{duflot}. In the case of \ensuremath{\tau^\pm \to \pi^\pm \nu}\ decays, the approximate method retains almost all the sensitivity of the ``optimal'' analysis, while for \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ decays the sensitivity of the ``approximate'' method is significantly smaller than the ``optimal'' one. \section{Approximate polarimeters at ILC-500} High-mass tau pairs at ILC-500 provide an experimental challenge due to the large boost, leading to very highly collimated tau jets whose constituents can be challenging to resolve. We here summarize results presented in~\cite{Jeans:2019brt}. Tau-pair event samples were generated using \texttt{WHIZARD} version 1.95~\cite{whizard, omega}, taking into account the ILC beam energy spread, beamstrahlung and initial state radiation. After decaying the taus using \texttt{TAUOLA}~\cite{Tauola}, events were fully simulated and reconstructed using standard ILD tools based on \texttt{ddsim/DD4hep}~\cite{dd4hep} and \texttt{MarlinReco}~\cite{marlinreco}. The principal output of the reconstruction is a collection of Particle Flow Objects (PFO), corresponding to reconstructed final state particles. An event selection was developed to select high-mass pairs of taus, and to reject other processes. A selection efficiency of around 60\% was achieved for high-mass tau pairs with at least one hadronic tau decay, with around 1.5--4\% contamination from non-tau backgrounds, depending on the assumed beam polarisation. The separation of the single-prong hadronic decay modes to one, two, or three pion modes achieved an efficiency of between 90\% and 60\%, depending on the decay mode. One-- and two--pion decays were used to calculate ``approximate'' polarimeters from reconstructed information. Pseudo-experiments carried out on simulated polarimeter distributions were used to estimate the statistical precision achievable at ILC-500: better than 1\% for the 1.6/ab of data in each of the \ensuremath{\mathrm{e^-_{L80} e^+_{R30}}}\ and \ensuremath{\mathrm{e^-_{R80} e^+_{L30}}}\ polarisations, and around 2\% in the like-sign polarisations for which 0.4/ab was assumed. The influence of various experimental effects was also investigated: use of the ``approximate'' form of the polarimeters; signal inefficiency and background contamination; and ECAL energy resolution, shown in Fig.~\ref{fig:chealPolPrec}. Each of these factors gives rise to a similar level of degradation in experimental precision, which is degraded by a factor of around two compared to the ideal result. \begin{figure}[htb] \includegraphics[width=0.4\textwidth]{drawpexpresults0Jenny.pdf} \includegraphics[width=0.4\textwidth]{drawpexpresults1Jenny.pdf} \\ \caption{Statistical precision on the tau polarisation at ILC-500, in the \ensuremath{\mathrm{e^-_{L80} e^+_{R30}}}\ and \ensuremath{\mathrm{e^-_{R80} e^+_{L30}}}\ polarizations, at various levels of ``cheating'', from optimal MC information (``MC-optimal'') to full simulation and realistic reconstruction (``no cheat (Sel/Bg)''). Triangles (open circles) correspond to the \ensuremath{\tau^\pm \to \pi^\pm \nu}\ (\ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}) decays, and IDR-L/S refer to two ILD models~\cite{Jeans:2019brt}. } \label{fig:chealPolPrec} \end{figure} \section{Reconstruction of the tau momentum in di-tau events} To go beyond the approximate polarimeters described above, explicit reconstruction of the tau momentum is required. We discuss several ways in which the tau momenta can be directly reconstructed in the \ensuremath{e^- e^+ \to \tau^- \tau^+}\ process. We study these methods using the MC truth information of di-tau events generated by WHIZARD, taking into account the effects of ISR and the beam energy spread and beamstrahlung expected at ILC-250. Tau leptons are decayed by TAUOLA. No detector simulation or realistic reconstruction algorithms were applied. \subsection{Cone method} In the case of a di-tau event both of whose taus decay hadronically, if the two tau leptons are back-to-back and each carry the nominal beam energy, the tau momenta can be calculated to within a 2-fold ambiguity. These assumptions are applicable to tau pairs produced at the nominal centre-of-mass energy, with no energy loss via ISR or beamstrahlung. The assumed energy and invariant mass of the tau define both the energy of the neutrino and the angle which it makes to the visible tau momentum. Equivalently, one can calculate the angle which the tau momentum makes to the visible momentum, defining a cone around the visible momentum on which the tau momentum lies. The two taus in an event are assumed to be back-to-back in the collision frame. The intersections of the two cones in an event then represent tau momentum directions which are consistent with all assumptions and constraints. The number of possible solutions is either 2 (in the case of intersecting cones, as illustrated in Fig.~\ref{fig:conemeth}) or 0 (if the cones do not intersect). The assumptions made above are not valid in the case of significant initial state radiation, or non-nominal beam energy, for example due to beamstrahlung. Under such conditions, the cones often do not intersect, leading to an inefficiency of the method, or, if they do intersect, to inaccurate reconstruction. \begin{figure}[htb] \centering \includegraphics[width=0.6\textwidth]{Conemethod.pdf} \caption{ Illustration of the cone method, showing the cone intersections corresponding to the tau momentum solutions. } \label{fig:conemeth} \end{figure} \begin{figure}[htb] \centering \includegraphics[width=0.4\textwidth]{effCone.pdf} \includegraphics[width=0.4\textwidth]{ConeEff.pdf} \\ \caption{Distribution of \ensuremath{e^- e^+ \to \tau^- \tau^+}\ events in their invariant mass \mtt, for all events and for those in which the cone method identifies a solution. The right plot shows the cone method's efficiency as a function of \mtt.} \label{fig:ConeEff} \end{figure} Fig.~\ref{fig:ConeEff} shows the original distribution of events in the tau invariant mass \mtt\ and the distribution of events for which the cone method found a solution. The ratio of the two is also shown, demonstrating that while the cone method has a reasonable efficiency of $\sim70\%$ for events at $\mtt \sim 250~$GeV, the efficiency drops to around $20\%$ by $\mtt=240~$GeV and $< 5\%$ by $\mtt=200~$GeV. Even a rather modest deviation from the method's assumptions can have a strong effect on the ability to identify a solution. For events for which the cone method does not find a solution, one possible option is to take the midpoint of cone surfaces as a solution for the tau momentum direction. We call this ``Midpoint method''. This can always find a solution, however it may be far from the true one, particularly for events whose taus are in reality not back-to-back, such as those preceded by ISR. Figure~\ref{fig:polcomp} compares the polarimeters calculated using the cone and midpoint methods with the MC truth values. In the case of \ensuremath{\tau^\pm \to \pi^\pm \nu}\ decays, the polarimeter reconstructed using the cone method is in good agreement with the optimal one, while for \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ decays the reconstruction is noticeably worse. Events in which the cone method fails -- predominantly those with \mtt\ far from the nominal centre-of-mass energy -- are then passed to the midpoint method. Comparisons of the extracted polarimeter with the MC truth for these events are shown in the same figure. The accuracy of polarimeter reconstruction is markedly worse, since the assumptions are, in general, broken more severely for such events. \begin{figure}[htb] \centering \includegraphics[width=0.4\textwidth]{conePolPi.pdf} \includegraphics[width=0.4\textwidth]{ConePolRho.pdf} \\ \includegraphics[width=0.4\textwidth]{MidPiPol.pdf} \includegraphics[width=0.4\textwidth]{MidRhoPol.pdf} \\ \caption{ Correlation between reconstructed and true polarimeters for \ensuremath{\tau^\pm \to \pi^\pm \nu}\ (left) and \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ (right) decays, for events reconstructed using the cone (upper), and midpoint (lower) methods. } \label{fig:polcomp} \end{figure} \subsection{Impact parameter method} We here describe a new tau reconstruction method which is much less sensitive to ISR, which allows reconstruction of tau momenta and optimal polarimeters for events at different effective centre-of-mass energies. This is achieved by including information of tau decay daughters' trajectories close to the interaction point: in other words, their impact parameters. The vertex detectors being designed for ILC have superb single hit resolution, low mass to minimize multiple scattering, and will be placed within $\sim 15$~mm of the interaction point. This provides an excellent measurement of the impact parameter. Use of the impact parameter to reconstruct tau leptons from Higgs boson decay has already been demonstrated in~\cite{Jeans:2015vaa}. The event topology in \ensuremath{e^- e^+ \to \tau^- \tau^+}\ is significantly different, so the methods therein developed are not directly applicable. The ILC and other electron-positron Higgs factories typically have an interaction region that has a very small transverse size (significantly smaller than the impact parameter resolution), and somewhat long in the $z$ direction along the beams. In the case of the ILC, the beam size at 250 GeV will be $7~nm \times 700~nm \times 0.3~mm$. We therefore assume that the primary interaction occurs along the beam line $x=y=0$, and that $z$ component of the interaction point is unknown. We additionally assume that ISR has negligible transverse momentum (or in other words that the taus are back-to-back in the x-y projection of the nominal CM frame), and that any energy loss due to ISR can be modelled as a single photon collinear with one of the incoming beams. \begin{figure}[htb] \centering \includegraphics[width=0.6\textwidth]{choose.pdf} \caption{Schematic image of calculating tau direction.} \label{cartoon} \end{figure} We then consider a plane which contains the $z$ axis (ie the beam axis), at some angle $\phi$ to the $x$ axis, as illustrated in Fig.~\ref{cartoon}. The interaction point lies somewhere along the $z$ axis, and therefore within the plane. Since the taus are back-to-back, their momenta also lie in the plane at a particular value of $\phi$. The intersection of the trajectories of charged tau daughters with this plane can be calculated (in this study we assume these trajectories can be approximated as straight lines near the IP); these intersections correspond to the decay points of the tau leptons. If we take some general interaction position along the $z$-axis, defined by its coordinate $z_{\rm{IP}}$, then the flight direction of the taus is defined, being between the intersection point and the decay points. For each choice of $\phi$ and $z_{\rm{IP}}$ the two tau 4-momenta can be calculated by applying 4-momentum conservation and assuming a single ISR photon. By comparing this calculated 4-momentum to the visible tau 4-momentum, the invariant mass of each tau's missing momentum (i.e. the mass of the invisible tau decay products) can be calculated. Since we are concerned mostly with hadronic tau decays, we choose the values of $\phi$ and $z_{\rm{IP}}$ which result in neutrino masses closest to zero. The equations are difficult (even impossible?) to solve analytically, so we use a graphical method to find solutions. Figure~\ref{choose} shows the extracted invisible invariant masses for the two taus depending on the choice of $\phi$ and $z_{\rm{IP}}$, and the positions of the identified local minima which are taken as potential solutions. \begin{figure}[H] \centering \includegraphics[width=0.9\textwidth]{chooseSol.pdf} \caption{Dependence of the invisible masses on $\phi$ and $z_{\rm{IP}}$. The color scale represents the invisible invariant mass of the two taus (left, center) and their sum (right). Red triangles correspond to the identified solutions, local minima in the right-hand plot. } \label{choose} \end{figure} The number of identified solutions in \ensuremath{e^- e^+ \to \tau^- \tau^+}\ events is shown in Fig.~\ref{nsol}, for all events, and for those in which ISR carries less than 5~GeV of transverse momentum. Half of the method's inefficiency is due to cases in which there is large missing transverse momentum; once these events are removed, the average efficiency to identify at least one solution is around 75\%. The angle between the reconstructed and true tau directions is shown in the same figure: the reconstructed direction is typically within a few mrad of the true direction. \begin{figure}[htbp] \centering \includegraphics[width=0.4\textwidth]{nsolwISR.pdf} \includegraphics[width=0.4\textwidth]{nsolnoISR.pdf} \\ \includegraphics[width=0.4\textwidth]{angImp.pdf} \caption{Top: The number of solutions, in all \ensuremath{e^- e^+ \to \tau^- \tau^+}\ events (left) and those with small ($<5$~GeV) ISR transverse momentum (right). Bottom: The angle between the true and reconstructed tau directions. } \label{nsol} \end{figure} Figure~\ref{ISReff} shows the distribution in \mtt\ of all events and of those in which at least one solution is found. It also shows their ratio -- the method's efficiency -- for the entire sample, and when considering only events whose ISR has small transverse momentum $<5~$GeV: such events can probably be experimentally identified by a search for visible photons far from the tau jets. The efficiency in this subsample is around 80\% at high \mtt, and remains in the range 60-70\% down to very small \mtt$\sim 10~$GeV. There is an interesting structure around the $Z$ peak which is not yet fully understood. \begin{figure}[htb] \centering \includegraphics[width=0.4\textwidth]{impEff.pdf} \\ \includegraphics[width=0.4\textwidth]{impEff2.pdf} \includegraphics[width=0.4\textwidth]{impEffISRpt.pdf} \caption{Upper: distribution of \ensuremath{e^- e^+ \to \tau^- \tau^+}\ events in \mtt, and distribution of events in which at least one ``impact parameter method'' solution was found. Lower: \mtt\ dependence of the efficiency of the method in all events (left), and in events with small ISR transverse momentum (right).} \label{ISReff} \end{figure} Once the tau momenta have been reconstructed, polarimeter information can be calculated using the ``optimal'' forms with maximal sensitivity. Figure~\ref{imppol} shows the distributions of polarimeters for taus of positive and negative helicity, calculated using the solutions found by the impact parameter method. A clear difference between taus of positive and negative helicity is seen. The figure also shows the correlation between the true and reconstructed polarimeters, which shows the rather good reconstruction quality for the majority of events, with only a rather small probability of mis-reconstruction by a large amount. \begin{figure}[htb] \centering \includegraphics[width=0.4\textwidth]{imppipol.pdf} \includegraphics[width=0.4\textwidth]{imprhopol.pdf} \\ \includegraphics[width=0.4\textwidth]{2dImpPi.pdf} \includegraphics[width=0.4\textwidth]{2dImpRho.pdf} \caption{ Top: Polarimeters for \ensuremath{\tau^\pm \to \pi^\pm \nu}\ and \ensuremath{\tau^\pm \to \pi^\pm \pi^0 \nu}\ calculated using solutions found using the impact parameter method. Bottom: comparison between the reconstructed and true polarimeters. } \label{imppol} \end{figure} These studies will be continued in the remaining period of the Snowmass study. We will estimate the precision with which the tau polarisation can be measured at ILC-250, comparing the different reconstruction techniques. At present, we ignore the effects of detector resolution: these will also be included in a future update of this work. \section{Conclusion} We first reported on our previous full-simulation study which showed that the tau polarization can be measured to better than 1\% at ILC-500. We further studied the reconstruction of tau polarisation at ILC-250, using particle momenta at MC level. Several techniques to fully reconstruct \ensuremath{e^- e^+ \to \tau^- \tau^+}\ events were investigated, however they fail to accurately reconstruct events with large energy loss through ISR. We developed a new reconstruction method which makes use of charged particle impact parameter information, as provided by the precise vertex detectors planned for ILC experiments. In a study at the MC level, this method seems to provide efficient and accurate reconstruction of tau leptons, allowing polarization information to be efficiently extracted. In future work, we will investigate the effect of full detector simulation and reconstruction, quantify the precision with which the tau polarisation can be measured at ILC-250 at $\mtt \sim 250$ and $\sim m_Z$, and compare the proposed reconstruction methods. \bibliographystyle{unsrt}

The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. Clinical, bioumoral, and instrumental data are unsuitable for public deposition as they contain identifying patient information. The de-identified data set is available upon request from the corresponding author. Introduction {#s1} ============ Obesity and the Metabolic Syndrome (MS) contribute to early atherosclerosis, which is closely associated with Coronary Artery Disease (CAD). The basic atherosclerotic mechanisms include altered lipid profile and inflammatory processes [@pone.0105610-Berliner1], [@pone.0105610-Nordestgaard1]. Recently, it has been evidenced that atherosclerosis, surprisingly found in pre-modern human beings, could be due to a basic predisposition rather than to contemporary lifestyles [@pone.0105610-Thompson1]. Mounting evidence continues to support a key role for immune/allergic mechanisms in various phases of atherosclerosis [@pone.0105610-Xu1], as confirmed by an up-to-date research showing that IgE stimulates human and mouse arterial cell apoptosis as well as cytokine expression, and promotes atherogenesis in ApoE-/- mice [@pone.0105610-Wang1]. Despite some criticisms [@pone.0105610-Rothenbacher1], findings suggest that increased circulating levels of eotaxin, an eosinophil chemoattractant cytokine implicated in allergic responses, are detected in the serum of patients with CAD [@pone.0105610-Emanuele1], [@pone.0105610-Ardigo1]. Further observations have evidenced that the expression of Tenascin C controls eotaxin levels in apo E-/- mice, confirming its key role in the development of atherosclerosis [@pone.0105610-Wang2]. The over-expression of eotaxin and the CCR3 receptor in human atherosclerosis has been highlighted also by genomic differential expression technology [@pone.0105610-Haley1]. What is more, Eotaxin was positively associated with liver triglycerides in animal models [@pone.0105610-Duval1]. It should be stressed that ectopic fat storage forms the pathological basis of the unclassified Non-Alcoholic Fatty Liver Disease (NAFLD), or non-Alcoholic Hepatic Steatosis (HS). The latter, well-detected by Ultrasound (US) [@pone.0105610-Tarantino1], is closely associated with CAD [@pone.0105610-Tarantino2], which has gained great relevance in recent years. US bears good sensitivity and specificity (92 and 100% respectively) for the histological diagnosis of NAFLD [@pone.0105610-Hamaguchi1]. Obese people show increased Intramuscular TriGlycerides (ImTG) accumulation [@pone.0105610-Rabl1]; this fat deposition, which is due to an altered production of mitochondrial ATP, is linked to Insulin Resistance (IR), a mechanism central also to HS, and global CAD risk [@pone.0105610-Shimabukuro1]. By increasing the number of reflections and thus, muscle echo intensity, ImTG can easily be evaluated by US [@pone.0105610-Pillen1]. Waist Circumference (WC) and Waist to Hip ratio (WHR) are strictly associated with CAD [@pone.0105610-deKoning1]. The concentration of High Density Lipoprotein-cholesterol (HDL) negatively predicts CAD [@pone.0105610-Barter1]. Common carotid Intima-Media Thickness (IMT) is a sensitive method to detect early atherosclerosis [@pone.0105610-Fathi1]. Since there is still debate over the possible role of eotaxin in CAD, we tried to shed light on this controversy and elucidate some aspects of the complex mechanisms involved in the early atherosclerosis affecting NAFLD patients. Accordingly, relationships were sought between serum eotaxin and strict CAD risk factors, such as IMT, HS and arterial blood pressure. We further analyzed possible associations between eotaxin and j) anthropometric measures, jj) metabolic profile, jjj) HS grade at US and liver enzymes, jjjj) inflammation/immune markers, such as IL-1β, with its strictly related C-Reactive Protein (CRP) and Interleukin-6 (IL-6), fibrinogen, ferritin, Tumor Necrosis F-alpha (TNF-α), as well as Spleen Longitudinal Diameter (SLD) [@pone.0105610-Tarantino3], jjjjj) angiogenetic factors---the former secreted by adipose tissue-derived stem cells, i.e., Vascular Endothelial Growth Factor (VEGF) [@pone.0105610-Heinonen1] and the latter synthesized, stored and released by platelets upon activation, i.e., Platelet-Derived Growth Factor-BB (PDGF-BB) [@pone.0105610-Qi1], both of which play an important role in vascular remodeling during atherosclerosis, and finally jjjjjj) circulating levels of the heat shock protein-70 (HSP-70)---a chaperone involved in inflammation, endoplasmic reticulum stress and apoptosis at liver and endothelial level [@pone.0105610-Tarantino4]. Patients and Methods {#s2} ==================== This cross-sectional study was carried out screening 125 consecutive, long-lasting obese individuals, referred to our out-patient metabolic unit from May 2012 to April 2013, who had been on a balanced low calorie, low fat (25% of calories) diet during the three months prior to enrolment and were characterized by sedentary life-style. The research protocols were approved by the Ethics Committee of the Federico II University Medical School of Naples (assigned protocol number: 231-05). All participants provided their written informed consent to participate in this study. The Department of Clinical Medicine and Surgery of the Federico II University Medical School of Naples (Italy) approved the conduction of this study. Of the initial group of participants, 12 were excluded because they had problems performing abdominal US for NAFLD screening (intestinal meteorism), nine others because they had taken steroids (six for bronchial asthma, two for rheumatoid arthritis and one for IBD), and eight had undergone therapy with one or more drugs known to alter laboratory data, i.e., aspirin, statins, fibrates and metformin. Six patients were excluded for a history of hepatic co-morbidities (HBV/HCV infection or alcohol abuse). Ten patients were excluded for lack of adherence to the protocol. Eighty obese patients with NAFLD formed the final population. Anthropometric and metabolic profile {#s2a} ------------------------------------ The three degrees of obesity (light, moderate and severe) were established on the basis of BMI cut-off points of 30--34.9, 35--39.9 and\>40 kg/m^2^, respectively. Visceral obesity was identified by measuring WC at the midpoint between the lower border of the rib cage and the iliac crest. Hip circumference was measured around the widest part of the buttocks, with the tape parallel to the floor, and Waist to Hip ratio (WHR) was calculated following the guide-lines for Europid reported in the "Waist Circumference and Waist--Hip Ratio: Report of a WHO Expert Consultation Geneva, 8--11 December 2008". Accordingly, reference values of the waist circumference were set at 96 cm for men and 83 cm for women; WHR for general risk and obesity: 0.96 for men and 0.83 for women. IR status was determined by the HOmeostatic Metabolic Assessment (HOMA), which was assessed by the formula: fasting insulin (µU/mL) x fasting glucose (mg/dL)/405. Moreover, as the repeated HOMA measurements presented a high within-person variability in obese patients, HOMA values were averaged on the basis of at least five determinations to avoid misclassification. Criteria for diagnosing NAFLD {#s2b} ----------------------------- Obese patients, independently of evident hepatic cytolysis, were diagnosed as having NAFLD if they satisfied j) an inclusion criterion, i.e., the presence of hyper-echogenity, the so-called "bright liver", based on a three--grade scale at US, as discussed below and jj) an exclusion criterion, i.e., the absence of any viral, autoimmune, metabolic disease, e.g. Wilson disease, hemochromatosis or anti-trypsin deficiency, which were ruled out by appropriate testing, following the generally accepted diagnostic guidelines. Furthermore, in case of hyper-transaminasemia, celiac disease was excluded estimating IgA anti-tissue trans-glutaminase antibodies. Alcohol abuse was screened according to DSM-IV diagnostic criteria and by means of the MAST (Michigam Alcohol Screening Test) and CAGE (Cut down, Annoyed, Guilty, Eye opener) tests, as well as by random tests for blood alcohol concentrations and the use of surrogate markers such as Mean Corpuscular Volume. Ultrasound evaluation {#s2c} --------------------- US measurements were performed operating on an Esaote system, i.e., Technos Partner (Genoa, Italy). Specifically, transverse scanning was performed to measure Subcutaneous Adipose Tissue (SAT) and Visceral Adipose Tissue (VAT) using an eleven linear probe and a 3.5 MHz convex probe, respectively. SAT was defined as the thickness between the skin-fat interface and the linea alba, avoiding compression. VAT was defined as the distance between the anterior wall of the aorta and the internal face of the recto-abdominal muscle perpendicular to the aorta, measured one cm above the umbilicus. When the aortic walls were not visualized, as when they were obscured by bowel gas, the Doppler scan was used. Spleen Longitudinal Diameter (SLD) was chosen to evaluate spleen volume and was carried out by postero-lateral scanning with a 3.5 MHz convex probe. Maximum length (the optically greatest overall longitudinal dimension obtained from one of the two poles) and cranio-caudal length (the optically maximal transversal dimension intercepting one of the two poles) were measured; the resulting values were then averaged, since the two measurements do not always coincide. The classification of HS, commonly known as "bright liver", was based on the following scale of hyper-echogenity: grade 0 =  absent, grade 1 =  light, grade 2 =  moderate, grade 3 =  severe, indicating the difference between the densities of the liver and the right kidney. Technically, echo intensity can be influenced by many factors, particularly gain intensity. To avoid confounding factors that could modify echo intensity and thus bias comparisons, mean brightness levels of both liver and right kidney cortex were obtained on the same longitudinal sonographic plane. Muscle ultrasound, performed by an eleven linear probe at the level of the biceps muscle of the left superior arm, is a feasible and reliable technique to visualize altered muscle tissue, as in case of ImTG, since it is non-invasive and provides results in real-time. Infiltration of fat and fibrous tissue increases muscle echo intensity, i.e., the muscles appears whiter at the ultrasound image. To describe muscle echo intensity, Heckmatt et al. proposed a four-grade visual scale, where grade I represented normal muscle and grade IV severely increased muscle echo intensity with total loss of bone echo (we chose biceps versus humerus) [@pone.0105610-Heckmatt1]. Brightness levels of the liver and biceps were calculated three times directly from the frozen images. The common carotid, the carotid bulb and the near and far wall segments of the internal carotid were scanned bilaterally with a 7.5-MHz linear array transducer, according to the consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, endorsed by the Society for Vascular Medicine [@pone.0105610-Stein1]. Subjects were examined in the supine position with the head turned 45° contra-lateral to the side of scanning. Images were obtained in longitudinal sections, with a single lateral angle of isonation, optimizing the image for the far wall. IMT was defined as the distance between the lumen-intima and the media-adventitia ultrasound interfaces. Measurements were performed off-line and consisted of six manual measurements at equal distances along 1 cm on the far wall of the common carotid. Left and right IMT were averaged. Blood pressure measurements {#s2d} --------------------------- Systolic/Diastolic Arterial Pressure (SBP, DBP) was the average of three consecutive readings taken by the physician during the day, during usual practice hours, after allowing the subjects to rest for five minutes in the sitting position. Patients on antihypertensive drugs maintained a balanced therapeutic regimen throughout the study. Laboratory data {#s2e} --------------- Serum TriGlycerides (TG), HDL, basal insulin, ALT, γ-GT, Alkaline Posphatase (AP), CholinEsterase (CHE), glycemia, ferritin, fibrinogen and insulin were performed by in-house standard procedures. Hs-CRP values were determined by the ELISA test, with reference values ranging between 0.3 and 8.6 mg/L in healthy men and between 0.2 and 9.1 mg/L in healthy women (BioCheck, Inc CA, USA). HSP-70 was determined using a high sensitivity EIA kit by Enzo Life Sciences International, Inc., PA, USA as described in detail in a previous report [@pone.0105610-Tarantino4]. Bead-based assay {#s2f} ---------------- Human eotaxin singleplex was performed according to Bio-Rad systems protocol (Bio-Rad Lab., Inc., Hercules, CA, USA) as reported elsewhere [@pone.0105610-ArellanoGarcia1], [@pone.0105610-Lde1]. Sera samples were diluted four times with suitable buffer. Initially, the 96-well filter bottom plate was pre-wet. Fifty microliters of diluted microparticle solution and 50 µl of sample were added to each well in duplicate. Thereafter, the plate was incubated for 1 h and washed three times with wash buffer. Afterwards, 25 µl of diluted biotin antibody were added to each well and incubated for 1 h. The plate was then washed as described above and 50 µl of diluted Streptavidin-PE were added to each well and the plate incubated for 10 min. All incubations were performed at room temperature on an orbital shaker set at 15 g. Finally, the plate was washed again with 100 µl of wash buffer. The median relative fluorescence units were measured using the Luminex 200 analyzer (Luminex, Austin, TX, USA). Eotaxin concentrations were calculated using a standard curve. Control range used for eotaxin id was 19.4±7.2 pg/mL. The coefficient of variation, calculated by SD/mean x 100 for the intra-assay and inter-assay was \<10% and \<12%, respectively. To establish whether eotaxin levels correlated to the other cytokines present in the Human Cytokine 27-Plex Panel (Bio-Rad Lab., Inc., Hercules, CA, USA), i.e., IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, eotaxin (CCL11), basic FGF, G-CSF, GMCSF, IFN-g, IP-10 (CXCL10), MCP-1 (CCL2), MIP-1a (CCL3), MIP-1b (CCL4), PDGF-bb, RANTES (CCL5), TNF- α and VEGF, we evaluated, by means of the procedure reported above, the following parameters in relation to the respective control ranges: for IL-1b: 0.37±0.21 pg/mL, for IL-6: 4.01±2.58 pg/mL, for TNF-α: 5.76±3.44 pg/mL, for VEGF: 0.44±0.21 pg/mL and for PDGF-BB: 73.53±48.95 pg/mL. Statistics {#s2g} ---------- Age, BMI, WHR, SAT, VAT, ALT, AP, γ-GT, HOMA, SBP, DBP, common carotid IMT, TG, CRP, fibrinogen, ferritin, eotaxin, TNF-α, IL-6, Il-1β, VEGF, PDGF-BB were not normally distributed when analyzed by the Shapiro-Wilk (S-W) test, p\<0.05, and were expressed as median plus 25--75 inter-quartile range (IQR). Data for WC, CHE HDL cholesterol, SLD, derived from a normally distributed population (S-W, p\>0.05), are shown as mean plus SD. At univariate analysis, to assess the independent effect of a quantitative variable on the prediction of another variable, the linear regression analysis (least squares) was used, evaluating the coefficient with its standard error, 95% confidence intervals (CI) and t (t-stat or t-values). A t-stat greater than 1.96 with a significance less than 0.05 indicates that the independent variable is a significant predictor of the dependent variable within and beyond the sample. The scatter plots display the correlation. At multivariate analysis, the multiple regression (Backward Stepwise Selection) was adopted, firstly entering all variables if p = 0.05 in the model, and then removing if p = 0.1 the non-significant variables sequentially, with a maximum number of 15 steps. To avoid multi-collinearity, i.e., situations in which the predictors are correlated with each other to some degree, the variance inflation factor and tolerance were set at\>10 and \<0.1, respectively. Similarly, to assess which variables contribute more or less to the regression equation, the magnitude of standardized coefficient beta (β) was calculated. Finally the zero order correlation coefficients, indicating the simple correlation coefficients, were evaluated. To evaluate the intra/inter-observer variability of the measurements, the mean difference in the measurements of the observers was first calculated. Next, the concordance correlation coefficient (ρ~c~), which measures precision and accuracy, was adopted to evaluate the degree of pair observations at US, with values\>0.8 considered as indicators of good reliability. MedCalc, version 12--7 (MedCalc Software, Broekstraat 52, 9030 Mariakerke, Belgium) and SyStat 13 (Cranes Software International, Bangalore, India) were the statistical packages employed. Results {#s3} ======= The demographic assessment, anthropometric measures, laboratory data and instrumental findings of our study population are shown in [Table 1](#pone-0105610-t001){ref-type="table"}. 10.1371/journal.pone.0105610.t001 ###### Characteristics of Obese Patients (n 80). {#pone-0105610-t001-1} Parameter Mean+/−SD or median plus (25--75 IQR) Parameter Mean+/−SD or median plus (25--75 IQR) ---------------------------------- --------------------------------------- ------------------------ --------------------------------------- Age (years) 46 (34--53) HDL Females mg/dL 49.3+/−15 Gender M/F 36/44 HDL Males mg/dL 42.7+/−9 Obesity Degree I/II/III (n) 18/26/46 TG mg/dL 123.5 (83.5--188) BMI 42.3 (38.1--46.8) CRP mg/mL 0.56 (0.27--1.3) WC Females (cm) 118.9+/−12.5 Fibrinogen g/L 295.5 (256--357.5) WC Males (cm) 129.3+/−14 Ferritin Females ng/mL 41.5 (20--69) WHR Females 0.95 (0.93--0.97 Ferritin Males ng/mL 167.5 (85--234) WHR Males 0.98 (0.96--1) SLD cm 11.3+/−1.5 HS Grade 1/2/3 at US (n) 22/48/10 IMT (mm) 0.09 (0.07--011) SAT (cm) 2.6 (2.1--3.1) Eotaxin pg/mL 24.6 (6.17--77.5) VAT (cm) 7.5 (6--9.4) TNF- α pg/mL 41.8 (8.1--112.7) ImTG Score I/II/III/IV at US (n) 11/23/30/16 IL-6 pg/mL 5.7 (2.3--17.5) ALT (U/L) 28 (21.5--29) IL-1β pg/mL 0.44 (0.2--1.08) CHE (U/L) 9671.4+/−1882.2 VEGF pg/mL 0.2 (0.2--1.14) AP (U/L) 73 (61--91) PDGF-BB pg/mL 468.3 (163.8--1306.3) γ-GT(U/L) 25 (16.5--42.5) HSP-70 ng/mL 0.24 (0.10--0.67) HOMA 2.78 (1.85--4.18) Fasting insulin µU/mL 10.9 (7.5--15.8) SBP mm Hg 130 (120--140) DBP mm Hg 80 (80--90) Values expressed as means plus/minus standard deviation or median plus 25--75 interquartile range, according to their distribution. Abbreviations: Waist Circumference WC, Body Mass Index BMI, Waist to Hip ratio WHR, Subcutaneous Adipose Tissue SAT, Visceral Adipose Tissue VAT, High Density Lipoprotein-cholesterol HDL, TriGlycerides TG, C Reactive Protein CRP, Spleen Longitudinal Diameter SLD, Tumor Necrosis Factor alpha TNF-α, Interleukin-6 IL-6, Interleukin-1β IL-1β, UltraSound US, ALanine aminoTransferase ALT, CHolinEsterase CHE, Alkaline Phosphatase AP, Gamma-Glutamyl Transglutaminase γ-GT, Vascular Endothelial Growth Factor VEGF, Platelet-Derived Growth Factor-BB PDGF-BB, Heat Shock Protein-70 HSP-70, High Density Lipoprotein cholesterol HDL, HOmeostatic Metabolic Assessment HOMA, Systolic Blood Pressure SPP, Diastolic Blood Pressure DBP, Intima-Media Thickness IMT. It is noteworthy to stress that the patients in our series presented high grade obesity, i.e., grade II and III, with very large waists, and therefore with evident visceral adiposity. When analyzing the laboratory data, the patients selected were characterized by normal or slightly elevated liver enzymes. At the instrumental analysis, most of our obese patients showed a light/moderate grade of HS at US, without significantly enlarged spleen. The moderately increased IMT value clearly evidenced an asymptomatic, early stage atherosclerosis in this population, in agreement with the non advanced median age of the participants. Furthermore, data concerning blood pressure, revealed that only mild hypertension was present among our patients. The values of circulating eotaxin were increased when compared to our reference values. Correlations: univariate analysis {#s3a} --------------------------------- The predictions between serum eotaxin concentrations and anthropometric data, inflammation markers, liver parameters (including enzymes and HS grade), angiogenetic factors and cardiovascular risk factors are represented in [Table 2](#pone-0105610-t002){ref-type="table"}. Of some interest were the relationships between eotaxin concentrations and the following specific immune regulators, i.e., TNF- α, IL-6, IL-1β on the one hand, and between eotaxin and angiogenetic factors, i.e., VEGF as well as PDGF-BB on the other. Among the metabolic parameters, anthropometric data and US features of excess body weight, a significant prediction was only found comparing eotaxin to HOMA. IMT was well predicted by eotaxin. When analyzing other cardiovascular risk factors associated with serum eotaxin, blood pressure determinations were non significant, as was HS grade. Furthermore, HSP-70 was not predicted by seum eotaxin. 10.1371/journal.pone.0105610.t002 ###### Report of Predictions Using Eotaxin As Dependent Variable. {#pone-0105610-t002-2} Coefficient Std. Error 95% CI t P ----------------------- ------------- ------------ ------------------- ------- ------------ Eotaxin/WC −0.001 0.018 −0.038 to 0.034 −0.11 0.91 Eotaxin/BMI 0.0005 0.010 −0.02 to 0.02 0.005 0.99 Eotaxin/WHR 0.0001 0.0006 −0.0003 to 0.0002 1.94 0.06 Eotaxin/SAT −16.06 12.79 −41.53 to 9.40 −1.25 0.2 Eotaxin/VAT −1.68 3.9 −9.45 to 6.09 −0.43 0.66 Eotaxin/Fibrinogen 0.05 0.09 −0.13 to 0.24 0.56 0.57 Eotaxin/CRP −1.12 4.58 −10.31 to 7.92 −0.26 0.79 Eotaxin/SLD −1.62 6.38 −14.32 to 11.07 −0.25 0.79 Eotaxin/Ferritin 0.038 0.073 −0.10 to 0.18 0.52 0.6 Eotaxin/TNF-α 0.30 0.076 0.14 to 0.45 3.9 **0.0002** Eotaxin/IL-6 1.59 0.48 0.62 to 2.5 3.3 **0.0016** Eotaxin/IL-1β 25.86 7.11 11.70 to 40.02 3.63 **0.0005** Eotaxin/US −10.91 15.38 −41.5 to 19.71 0.70 0.48 Eotaxin/ALT −0.01 0.02 −0.054 to 0.02 −0.64 0.52 Eotaxin/CHE 0.0017 0.0052 −0.012 to 0.0087 −0.33 0.73 Eotaxin/AP −0.18 0.37 −0.93 to 0.56 −0.5 0.61 Eotaxin/*γ-GT* 0.37 0.48 −0.59 to 1.34 0.77 0.44 Eotaxin/VEGF 3.11 1.23 0.65 to 5.57 2.5 **0.013** Eotaxin/PDGF-BB 0.015 0.006 0.0031 to 0.028 2.49 **0.015** Eotaxin/HSP-70 4.74 7.95 −11.09 to 20.58 0.59 0.55 Eotaxin/HDL −0.006 0.015 −0.03 to 0.02 −0.41 0.67 Eotaxin/HOMA 5.89 2.45 1.01 to 10.77 2.4 **0.018** Eotaxin/Triglycerides −0.031 0.12 −0.26 to 0.2 −0.27 0.78 Eotaxin/SBP 0.025 0.68 −1.33 to 1.38 0.036 0.97 Eotaxin/DBP 0.048 1.19 −2.33 to 2.43 0.04 0.96 Eotaxin/IMT 705.15 281.69 144.34 to 1265.95 2.50 0.014 Linear Regression with Coefficients and their Standard Error, 95% Confidence Intervals, t values and significance level expressed as P. Abbreviations: Waist Circumference WC, Body Mass Index BMI, Waist to Hip ratio WHR, Subcutaneous Adipose Tissue SAT, Visceral Adipose Tissue VAT, C Reactive Protein CRP, Spleen Longitudinal Diameter SLD, Tumor Necrosis Factor alpha TNF-α, Interleukin-6 IL-6, Interleukin-1β IL-1β, UltraSound US, ALanine aminoTransferase ALT, CHolinEsterase CHE, Alkaline Phosphatase AP, Gamma-Glutamyl Transglutaminase γ-GT, Vascular Endothelial Growth Factor VEGF, Platelet-Derived Growth Factor-BB PDGF-BB, Heat Shock Protein-70 HSP-70, High Density Lipoprotein HDL, HOmeostatic Metabolic Assessment HOMA, Systolic Blood Pressure SPP, Diastolic Blood Pressure DBP, Intima-Media Thickness IMT. Correlating indices of fat storage at US (SAT, VAT, HS and ImTG), ImTG score was well predicted by HS grade (coefficient  = 0.51, standard error  = 0.17, 95% CI  = 0.17 to 0.85, t = 2.1, P = 0.003) and VAT (coefficient  = 0. 12, standard error  = 0.4, 95% CI = 0.04 to 0.20, t = 3.1, P = 0.0026). Liver laboratory test such as ALT, γ-GT, AP values were not predicted by eotaxin levels in our series ([Table 2](#pone-0105610-t002){ref-type="table"}). Interestingly, HS grade was predicted by ALT values (coefficient  = 6.8, standard error = 2.9, 95% CI = 0.87 to 12.8, t = 2.28, P = 0.025) and γ-GT values (coefficient  = 10.65, standard error  = 3.7, 95% CI = 3.27 to 18, t = 2. 87, P = 0.005). Finally, HOMA predicted the grade of HS severity at US (coefficient  = 0.056, standard error  = 0.015, 95% CI = 0.025 to 0.088, t = 3.6, P = 0.0005), resulting to be one of the strongest relationships. The most important correlations are shown in [Figure 1 (A-F)](#pone-0105610-g001){ref-type="fig"}. {#pone-0105610-g001} Correlations: multivariate analysis {#s3b} ----------------------------------- At the multiple regression analysis, using the stepwise method, two independent variables contextually predicted the dependent variable IMT, i.e., serum eotaxin levels and HS grade at US (beta 0.30, P = 0 0.005 and beta 0.32, P = 0. 0038, respectively). The remaining variables not included in the model were HDL, TG, HOMA and CRP. The zero order correlation coefficients between IMT and eotaxin, HDL, TG, HOMA CRP and HS at US were 0.27, −0.08, 0.07, 0.18, −0.045, and 0.28, respectively. Finally, at the multiple regression, forcing the stepwise method, among ALT, AST, γ-GT, AP, CHE and SLD, only spleen volume was retained, predicting HS at US (coefficient  = 0.1815, standard error  = 0.03767, beta = 0.48. P = \<0.0001). Agreement {#s3c} --------- The intra/inter-observational variability of UltraSound estimations was not significant, the mean difference being 1.9, 2.9, 2.4, 3.1, 2.4 and 3.9%, and 2.3, 3.1, 3. 9, 3.1, 2.6 and 3.4% for the HS, ImTG, SAT, VAT, SLD and common carotid IMT, respectively, with a ρ~c~ of 0.91. Discussion {#s4} ========== The key finding of this research can be summarized as follows: Firstly, a clear relationship exists between serum concentrations of eotaxin and TNF α, IL-6, IL-1β. These cytokines have marked effects on numerous cell types which, in turn, secrete a variety of inflammatory mediators, creating complex networks of interactions and leading to multiple inflammatory cascades. Secondly, serum concentrations of eotaxin were significantly related to the serum levels of angiogenetic factors, i.e., VEGF as well as PDGF-BB. The former and latter findings confirm the body of pertinent knowledge that an inflammatory/immune interplay could be evidenced in the induction of atherosclerosis, but also in the maintenance of this process by determining impaired angiogenesis and/or endothelial cell dysfunction. In fact, IL-1 β and TNFα have potent effects on vessel wall components---particularly on endothelial cells, and may influence the mechanisms involved in vessel occlusion and repair [@pone.0105610-Bhagat1]. As determined by multivariate analysis, the most important factors in predicting patients with early atherosclerosis were both eotaxin levels and the severity of HS at US, even if we were unable to show any association between these two variables, which likely contribute, in an independent fashion, to determine or worsen the atheromatosus process. Among the metabolic parameters, a significant prediction was found comparing eotaxin to IR, as detected by HOMA, but not to the other two classic CAD risks, i.e., HDL, TG. Of relative interest is the association, detected only at univariate analysis, of HS with ALT and *γ-GT*, although two limitations in its interpretation must be acknowledged: the small size of the cohort studied and the values of liver enzymes not exceeding twice the normal values). Discussing possible mechanisms and explanations for these findings, we hypothesize that eotaxin is released by the smooth muscle cells present in the atheromatous vessels only by activated cells, after a stimulus by either TNF-α or IL-1β. This interpretation is supported by Ghaffar et al. [@pone.0105610-Ghaffar1], whose study demonstrated increased eotaxin expression in smooth muscle cultures after treatment with both the aforementioned cytokines. That IR (evaluated by HOMA), the main mechanism underlying HS (confirmed also by the findings of this research) and which plays a key role in linking HS to CVD [@pone.0105610-Ghaffar1], could mediate the increased release of eotaxin from competent cells, surely cannot be inferred by this work, although this hypothesis is suggestive. In any case, the relationship between IR and eotaxin could be based on the GH/IGF axis, which is altered in NAFLD [@pone.0105610-Savastano1]. This hypothesis finds support in a recent study showing that IGFBP-3 inhibits TNF-α, CRP and high glucose-induced NF-κB activity in human aortic endothelial cells, and subsequently suppresses monocyte adhesion in the same cells through the IGFBP-3 receptor [@pone.0105610-Mohanraj1]. Very scarce data was found in relation to the link between eotaxin and IMT when comparing our results with relevant findings from other reports found in the literature by search sources (MEDLINE/SCOPUS) during the last decade, in which plasma eotaxin levels accurately identified individuals with clinically significant atherosclerotic heart disease [@pone.0105610-Emanuele1] and were associated with the presence and extend of angiographic coronary artery disease [@pone.0105610-Ardigo1]. The results of the present study on obese patients suffering from NAFLD allows us to confirm the main role of eotaxin in the atherosclerotic process (likely early stage), a process that is more and more reckoned to be based on immune-allergic mechanisms. As to the limitations of the present study, we first of all should pinpoint the reduced sample size of the selected population. A further drawback is that we did not perform liver biopsies because of technical (repeated passages due to the amount of subcutaneous adipose tissue could increase procedure risks) and ethical issues (lack of significant hepatic cytolysis). Neither was adiposity evaluated by MRI, nor was arterial stiffness detected by means of pulse wave velocity, both known to be more precise methods. It should, however, be emphasized that the major advantage of IMT is that it is completely non-invasive and can be repeatedly performed in follow-up studies. It is also relatively inexpensive, and the technology widely available. Increased IMT has been shown to consistently predict future vascular events [@pone.0105610-Jeevarethinam1]. IMT is an alternative to coronary calcium scans and does not expose patients to any radiation. The NIH, as reported in their public access, also accepts IMT (but not coronary calcium scanning, which utilization needs further studies) to follow patients for atherosclerotic disease progression [@pone.0105610-Nathan1]. Furthermore, compared to other more sophisticated methods, it has proven to be very reliable [@pone.0105610-Schroeder1]. Given the experience accumulated in experimental settings and in human disease showing that the systemic inflammatory response is triggered by pro-inflammatory cytokines, crucial future research in obese patients should be directed towards the study of the interplay between cytokine/chemokines and other angiogenetic factors; in fact, basic Fibroblast Growth Factor (b-FGF), which activates monocytes to promote the endothelial cell proliferation involved in plaque development [@pone.0105610-Pakala1], seems to be one of the most promising lines of research. Conclusion {#s5} ========== The atherosclerotic process is not fully understood. Canonical data link hyperlipidemia, hypertension and cigarette smoking---which together increase risk manifold---to atherogenesis. Obese individuals with NAFLD are a properly selected population to study this illness in an early phase. IMT can be reduced by lifestyle modifications and therapeutic interventions. However, only recently have we appreciated that inflammation couples dyslipidaemia to atheroma formation. Leukocyte recruitment and expression of pro-inflammatory cytokines characterize early atherogenesis, which is initiated by inflammatory processes in the endothelial cells of the vessel wall in response LDL particles [@pone.0105610-Williams1]. Moreover, inflammatory pathways promote thrombosis, a late and dreaded complication of atherosclerosis, which is responsible for myocardial infarctions and most strokes. The clinical implications of this work, summarized in a straightforward and circumspect manner, could consist in identifying the triggers for inflammation, and unraveling the details of the inflammatory pathways may eventually furnish new therapeutic targets. [^1]: **Competing Interests:**The authors have declared that no competing interests exist. [^2]: Wrote the paper: GT. Conceived the study: GT. Drafted the manuscript: GT. Collected clinical and laboratory data: CF. Critically revised the text: GC. Stored sera: NL. Performed US imaging: SG. Carried out laboratory determinations: SC FC EG. Ran the statistical analysis of the data: GT.

All work was performed at the Hospital Clínico Veterinario, ULPGC, Trasmontaña s/n, Arucas, Gran Canaria, Spain. Two posters containing preliminary results were presented at the 22nd Congress of the European College of Veterinary Internal Medicine, Maastricht, 6--8th September 2012, and the 12th Congress of the Federation for European Laboratory Animal Science Associations, Barcelona, 10--13th June 2013. CEN : European Committee for Standardization GDH : glucose dehydrogenase GO : glucose oxidase PBGM : portable blood glucose meter WB : whole blood In humans, self‐monitoring of blood glucose is crucial for the management of insulin‐treated diabetes and has allowed more accurate treatment dosing and has contributed to a reduction in disease complications.[1](#jvim12397-bib-0001){ref-type="ref"} In veterinary medicine, portable blood glucose meters (PBGM) allow owners and practitioners to obtain glucose measurements easily and make immediate therapeutic decisions. Although specific PBGM have been developed for small animals, they are not available everywhere and those developed for humans are widely used. Many studies have been published where these "human" devices have been tested in dogs and other animals,[2](#jvim12397-bib-0002){ref-type="ref"}, [3](#jvim12397-bib-0003){ref-type="ref"}, [4](#jvim12397-bib-0004){ref-type="ref"}, [5](#jvim12397-bib-0005){ref-type="ref"}, [6](#jvim12397-bib-0006){ref-type="ref"}, [7](#jvim12397-bib-0007){ref-type="ref"}, [8](#jvim12397-bib-0008){ref-type="ref"}, [9](#jvim12397-bib-0009){ref-type="ref"} and at the time this study was performed, the previous study in dogs had been published in 2009[9](#jvim12397-bib-0009){ref-type="ref"} and new PBGM had been developed and become available since then. In published studies, not all PBGM were accurate enough to be used in dogs and even those specifically developed for animals led to inappropriate clinical interpretation.[3](#jvim12397-bib-0003){ref-type="ref"} Our aim was to assess the analytical accuracy and precision of 9 available PBGM in canine whole blood (WB) and plasma samples, based on a standardized systematic evaluation approved by the European Committee for Standardization (CEN), the recommendations of the ISO 15197:2003.[10](#jvim12397-bib-0010){ref-type="ref"} However, during the review of this manuscript the ISO 15197:2013 was released and, therefore, results were reanalyzed based on the current standard.[11](#jvim12397-bib-0011){ref-type="ref"} Both ISO 15197:2003 and 2013 are international standards utilized to evaluate accuracy and precision of these devices for human blood.[10](#jvim12397-bib-0010){ref-type="ref"}, [11](#jvim12397-bib-0011){ref-type="ref"}, [12](#jvim12397-bib-0012){ref-type="ref"}, [13](#jvim12397-bib-0013){ref-type="ref"} They establish minimum performance criteria for blood glucose monitoring systems, based on analytical precision and accuracy and specify the procedures to demonstrate the systems' conformity to these standards.[10](#jvim12397-bib-0010){ref-type="ref"}, [11](#jvim12397-bib-0011){ref-type="ref"} Materials and Methods {#jvim12397-sec-0008} ===================== Setting and Design {#jvim12397-sec-0009} ------------------ A total of 9 PBGM were assessed for accuracy and precision in canine blood samples based on ISO 15197:2003 guidelines. The samples were obtained in the Veterinary Teaching Hospital and all measurements were performed in its clinical laboratory. Glucose Monitoring Systems and Reference Method {#jvim12397-sec-0010} ----------------------------------------------- The following PBGM were assessed by using a single meter of each brand: AccuChek Aviva Nano[1](#jvim12397-note-0101){ref-type="fn"} (Aviva), FreeStyle Freedom Lite[2](#jvim12397-note-0102){ref-type="fn"} (Freestyle), Glucocard G+ meter (GT 1820)[3](#jvim12397-note-0103){ref-type="fn"} (Glucocard), Hemocue Glucose 201^+^ [4](#jvim12397-note-0104){ref-type="fn"} (Hemocue), OneTouch UltraEasy[5](#jvim12397-note-0105){ref-type="fn"} (Ultra), OneTouch VerioPro[5](#jvim12397-note-0105){ref-type="fn"} (Verio) and OneTouch Vita[5](#jvim12397-note-0105){ref-type="fn"} (Vita), Optium Xceed[2](#jvim12397-note-0102){ref-type="fn"} (Optium), and StatStrip Xpress Glucose Hospital Meter[6](#jvim12397-note-0106){ref-type="fn"} (StatStrip). Their main features are summarized in Table [1](#jvim12397-tbl-0001){ref-type="table-wrap"}. The different devices and strips or cuvettes were donated by their manufacturers. All are currently widely available and used in human medicine and were the most recent models at the time this study was performed (April 2011--April 2012). ###### Main features of the evaluated devices according to their manufacturers. PBGM Sample (μL) Measurement Range (mg/dL) Measurement Time (seconds) Measurement Method -------------------------------- ------------- --------------------------- ---------------------------- -------------------- AccuChek Aviva Nano 0.6 10--600 5 GDH Freestyle Freedom Lite 0.3 20--500 5 GDH Glucocard G+ meter (GT 1820) 0.6 10--600 5.5 GDH Hemocue Glucose 201^+^ 5 0--400 40--240 GDH OneTouch Ultra 1 20--600 5 GO OneTouch VerioPro 0.4 20--600 5 GDH OneTouch Vita 0.4 20--600 5 GO Optium Xceed 1.5 20--500 5 GDH Statstrip Xpress Glucose H. M. 0.6 10--600 6 GO PBGM, portable blood glucose meters; GDH, glucose dehydrogenase; GO, glucose oxidase. John Wiley & Sons, Ltd As a reference method, the hospital\'s automated laboratory analyzer (Catalyst[7](#jvim12397-note-0107){ref-type="fn"}), based on a multilayered, dry‐slide technology, hexokinase method, was employed on plasma samples, as in routine clinical practice.[8](#jvim12397-note-0008){ref-type="fn"}Quality controls for the reference method and each device were performed following manufacturer′s instructions. The reference method typically shows coefficients of variation below 5% for most measurements and less than 1% for glucose.[8](#jvim12397-note-0008){ref-type="fn"} Samples and Protocol {#jvim12397-sec-0011} -------------------- Whole blood samples were collected from 59 client‐owned dogs with diabetes, insulinoma and other unrelated diseases, attending the Veterinary Teaching Hospital between May 2011 and April 2012. Most samples were obtained for clinical purposes and opportunistically included in this assessment. The protocol was approved by the Animal Welfare Ethics Committee (Comité Ético de Bienestar Animal, ULPGC; Reference number 007/2011). They were extracted from the jugular, cephalic, or saphenous vein, with a syringe (22G‐needle). Immediately after sampling, 100 μL of WB was separated to be used on all of the PBGM and the rest was poured into lithium‐heparin tubes[10](#jvim12397-bib-0010){ref-type="ref"}, [11](#jvim12397-bib-0011){ref-type="ref"} and centrifuged. After plasma separation, 300 μL were used in the automated laboratory analyzer, to measure glucose and other routine analytes, and the rest, to measure plasma glucose with all the PBGM. To avoid glucose consumption in the sample, all measurements were performed consecutively, with a maximum delay of 20 minutes between sampling and testing. To avoid systematic bias because of sample processing, PBGM were randomly and blindly extracted from an opaque container and measurements were performed in the initial order and then shifted several times during the assay. All devices were operated and calibrated according to the manufacturers' instructions. Samples were classified according to their glucose concentration, measured by the reference method, into normoglycemic (73--143 mg/dL), hypoglycemic, and hyperglycemic. In addition, for each ISO‐established interval samples were collected as recommended: 5 \<50 mg/dL, 15 between 51 and 80 mg/dL, 20 between 81 and 120 mg/dL, 30 between 121 and 200 mg/dL, 15 between 201 and 300 mg/dL, 10 between 301 and 400 mg/dL, and 5 \>400 mg/dL. Following ISO recommendations, when patient samples were not available for a specific range, euglycemic WB samples were either incubated at room temperature to allow for erythrocyte glucose consumption[8](#jvim12397-bib-0008){ref-type="ref"}, [10](#jvim12397-bib-0010){ref-type="ref"}, [11](#jvim12397-bib-0011){ref-type="ref"} or Glucose G7528[9](#jvim12397-note-0009){ref-type="fn"} was added.[10](#jvim12397-bib-0010){ref-type="ref"}, [11](#jvim12397-bib-0011){ref-type="ref"} After direct addition of glucose, one of the meters (Glucocard) was used as a preliminary estimation that the sample was within the aimed glucose range. In that case, if this range was confirmed by the reference method, the rest of the procedure was completed. When analytical errors were warned by a device, the measurement was repeated attempting to correct the error, until it was obtained. If, after a third attempt, the error persisted, the value was defined as missing. When values outside the measurable range were obtained (LO or HI), the value immediately below or above the limit, respectively, was entered. A total of 100 (WB and plasma) samples were used to assess accuracy: glucose was measured in each sample with the 9 PBGM and the reference method. According to ISO 15197:2003 requirements for human use, a PBGM is considered accurate if 95% of the measurements are within ±15 mg/dL from the reference when glucose is \<75 mg/dL, and within ±20% when glucose is ≥75 mg/dL.[10](#jvim12397-bib-0010){ref-type="ref"} The results were also analyzed following the ISO 15197:2013 requirements[11](#jvim12397-bib-0011){ref-type="ref"} that establish narrower accuracy limits (±15 mg/dL from the reference when glucose is \<100 mg/dL, and within ±15% when glucose is ≥100 mg/dL). Error grid analysis assessment for type 1 diabetes[11](#jvim12397-bib-0011){ref-type="ref"} was performed to asses clinical risk for each measurement (see Fig [2](#jvim12397-fig-0002){ref-type="fig"}).[14](#jvim12397-bib-0014){ref-type="ref"} To define a PBGM as accurate, the ISO 15197:2013 requires 99% of the values to be within zones A and B.[11](#jvim12397-bib-0011){ref-type="ref"} Precision was assessed on 23 samples, 8 in the hypoglycemic and hyperglycemic ranges, and 7 in the normoglycemic range. On each sample, 3 measurements were performed with each PBGM. Hematocrit was assessed in 90 samples, either by a microhematocrit centrifuge (StatSpin VT[7](#jvim12397-note-0107){ref-type="fn"}), or by the hospital\'s automated analyzer (Lasercyte Dx[7](#jvim12397-note-0107){ref-type="fn"}), and was classified as low (\<37%), normal (37--55%), or high (\>55%), following the reference of the automated analyzer. Statistical Analysis {#jvim12397-sec-0012} -------------------- To assess accuracy, PBGM values and the reference method were compared using paired Student\'s *t* or Wilcoxon\'s test. The differences between the PBGM and the reference method were plotted against the reference values in Bland‐Altman plots. Passing‐Bablok linear regression analysis was performed to detect constant and proportional bias. If the 95% CI for the slope did not include 1, this was considered evidence of proportional bias. If the 95% CI for the *y* intercept did not include 0, this was considered evidence of constant bias.[15](#jvim12397-bib-0015){ref-type="ref"} To assess precision, mean, standard deviation, and coefficient of variation were calculated for each device. Interference by hematocrit was assessed comparing the differences between PBGM and the reference method in low, normal, and high hematocrit samples (Kruskall‐Wallis test) and evaluating their correlation with hematocrit values (Spearman tests). Statistical analyses were performed by a commercial statistical software package.[10](#jvim12397-note-0010){ref-type="fn"} Differences were considered significant when two‐tailed *P* was below .05. Results {#jvim12397-sec-0013} ======= One hundred samples from 57 dogs with glucose concentrations ranging from 29 to 579 mg/dL were included in the study and analyzed for accuracy and 23 of them (same range) were also analyzed for precision. A total of 43 samples were treated to complete the required number for hypo‐ and hyperglycemic ranges: 6 were incubated at room temperature and to 27, glucose was added, respectively. The other 10 were included in the normoglycemic range, as they did not fall within the expected limits. Analytical errors, warned by Aviva, Ultra, Verio, Optium, and StatStrip, included insufficient volume in the strip chamber, incorrect application of the sample, and defective strips. Verio and Hemocue failed to measure 1 hyper‐ and 1 hypoglycemic sample, respectively. Accuracy {#jvim12397-sec-0014} -------- Mean differences in glucose concentrations (mean and SD) obtained with the reference method and the 9 PBGM assessed (both for WB and plasma) are displayed in Table [2](#jvim12397-tbl-0002){ref-type="table-wrap"}. WB glucose concentration was lower for all PBGMs compared with the reference method (175.30 \[SD 115.74\] mg/dL), though the Aviva PBGM was the most accurate (155.98 \[SD 105.79\] mg/dL) (*P* \< .005). Regarding plasma samples, the most exact were Freestyle (174.41 \[SD 111.70\] mg/dL) (*P* = .665) and StatStrip (179.22 \[SD 129.16\] mg/dL) (*P* = .148). ###### Deviation from "trueness": Reference mean values and devices' mean differences from reference \[mg/dL (SD)\] for WB and P, for the whole range and per glycemic interval. Device Blood Source Mean difference with reference (SD) --------------------------- -------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------- ------------------------------------------------------- Reference value Mean (SD) 175.30 (115.74) 51.38 (14.98) 106.15 (22.30) 265.04 (106.39) Aviva WB 19.32 (28.19) 1.38 (12.61)[d](#jvim12397-note-0007){ref-type="fn"} 8.87 (13.05) 32.67 (33.67)[d](#jvim12397-note-0007){ref-type="fn"} P −10.90 (15.20) −6.54 (3.48) −5.69 (6.40) −16.31 (19.82) FreeStyle WB 74.15 (55.24) 18.69 (13.60) 40.38 (21.09) 116.60 (48.83) P 0.89 (20.48)[b](#jvim12397-note-0006){ref-type="fn"} −2.00 (4.95)[d](#jvim12397-note-0007){ref-type="fn"} 1.49 (9.85)[d](#jvim12397-note-0007){ref-type="fn"} 1.19 (28.21)[d](#jvim12397-note-0007){ref-type="fn"} Glucocard WB 48.18 (30.84) 25.54 (10.62) 40.64 (11.60) 60.44 (39.02) P 28.10 (20.21) 15.46 (5.97) 24.97 (6.62) 34.06 (26.97) Hemocue WB 47.83 (49.15)[a](#jvim12397-note-0005){ref-type="fn"} 2.75 (20.93)[d](#jvim12397-note-0007){ref-type="fn"} 22.08 (15.92) 80.02 (51.00) P −10.79 (32.66) −19.15 (9.61) −18.49 (7.85) −2.27 (45.07)[d](#jvim12397-note-0007){ref-type="fn"} Ultra WB 38.7 (30.99) 16.92 (13.16) 27.15 (13.53) 54.23 (36.56) P −64.71 (43.32) −6.62 (11.41)[d](#jvim12397-note-0007){ref-type="fn"} −40.87 (17.16) −99.81 (31.91) Verio WB 29.96 (32.45)[a](#jvim12397-note-0005){ref-type="fn"} 6.77 (11.19)[d](#jvim12397-note-0007){ref-type="fn"} 14.44 (10.09) 49.25 (37.28) P −13.19 (14.42)[a](#jvim12397-note-0005){ref-type="fn"} −5.42 (5.47) −8.38 (7.16) −19.17 (17.81) Vita WB 38.82 (30.95) 16.46 (12.69) 25.15 (11.56) 54.58 (36.25) P −59.61 (40.45) −3.61 (9.61)[d](#jvim12397-note-0007){ref-type="fn"} −35.80 (13.71) −94.13 (26.76) Optium WB 38.57 (34.76) 10.85 (14.96) 19.03 (15.32) 61.96 (34.78) P −48.56 (31.95) −13.46 (9.67) −39.00 (11.99) −65.83 (35.90) StatStrip WB 33.28 (30.28) 12.62 (11.09) 20.44 (15.21) 49.26 (34.57) P −3.92 (26.87)[c](#jvim12397-note-0006){ref-type="fn"} 4.85 (4.78) 5.62 (7.32) −14.04 (35.64) WB, whole blood; P, plasma; PBGMs, portable blood glucose meters. ^a^ One hundred determinations were obtained for all devices, except Verio (99 WB and 98 P samples) and Hemocue (99 WB samples). Normoglycemia is defined between 73 and 143 mg/dL. ^b,\ c^All PBGMs showed significant differences with the reference in both whole blood and plasma, for the whole glucose range, with the exception of ^b^Freestyle (*P* = .665) and ^c^StatStrip (*P* = .148) in plasma samples, and Vita and Ultra for the same samples in the hypoglycemic range (*P* = .200 and *P* = .059, respectively) and Hemocue (*P* = .729), in hyperglycemia. ^d^ *P* \> .05 (nonsignificant) compared with reference by glycemic ranges. John Wiley & Sons, Ltd When evaluating the different glycemic intervals in WB (Table [2](#jvim12397-tbl-0002){ref-type="table-wrap"}), in the hypoglycemic range, only 2 devices showed similar values to the hexokinase method (51.38 \[SD 14.98\] mg/dL), Aviva (*P* = .678) and Hemocue (*P* = .605), whereas Verio reached the limit of statistical significance (*P* = .05). For the normoglycemic and hyperglycemic intervals, all devices showed significantly lower values than the reference (*P* \< .005). For the corresponding plasma samples (Table [2](#jvim12397-tbl-0002){ref-type="table-wrap"}), Freestyle and StatStrip were similar to the reference (175.30 \[SD 115.74\] mg/dL) for all glycemic intervals (*P* = .686 and *P* = .148, respectively), Vita and Ultra, in the hypoglycemic range (*P* = .200 and *P* = .059, respectively) and Hemocue (*P* = .729), in the hyperglycemic range. None of the devices fulfilled ISO 15197:2013 accuracy requirements for WB (95% of values within the global glycemic range) (Fig [1](#jvim12397-fig-0001){ref-type="fig"}A). The most accurate PBGM was Aviva with 74% of total measurements within the limits. For plasma, standards were only achieved by Aviva, and approached by FreeStyle and Verio with 97%, 92%, and 91.92% of values within limits, respectively (Fig [1](#jvim12397-fig-0001){ref-type="fig"}B). {#jvim12397-fig-0001} Even the previous, somewhat laxer, ISO 15197:2003 accuracy requirements, were not fulfilled by any device. The 2 most accurate, Aviva and Verio, showed 82% and 64% of total measurements within the limits, respectively. For plasma, the requirements were achieved by Aviva, FreeStyle, and Verio with 99%, 95%, and 99% of values within limits, respectively, and were approached by StatStrip, with 92% of the values within the limits. Regarding the EG analysis for WB (Fig [2](#jvim12397-fig-0002){ref-type="fig"}), most satisfied the requirements, with all (Aviva, Verio, and StatStrip) or 99% of the values (Optium, Ultra, and Vita) falling within zones A and B. The rest of the devices approached the EG requirements (Fig [2](#jvim12397-fig-0002){ref-type="fig"}). In plasma, all of the PBGM passed the analysis with 99% of values in zones A--B for Optium and Hemocue and 100% for the rest (data not shown). {ref-type="ref"} ISO 15197:2013 requires that 99% of the values fall within zones A--B for a device to be considered accurate.](JVIM-28-1405-g002){#jvim12397-fig-0002} According to Passing‐Bablok linear regression analysis, 6 devices showed both proportional and constant errors (Glucocard, Hemocue, Ultra, Verio, Vita, and StatStrip) in WB and in plasma (Aviva, Glucocard, Hemocue, Vita, Optium, and StatStrip). Constant errors alone were shown in WB for Aviva, Freestyle, and Optium, and in plasma for Freestyle, Ultra, and Verio. Additional accuracy analyses were performed and similar results were obtained regardless of whether the samples were pretreated (incubation at room temperature or addition of glucose) or not (data not shown). Precision {#jvim12397-sec-0015} --------- Figure [3](#jvim12397-fig-0003){ref-type="fig"} summarizes the results of precision assessment. Aviva and Verio had the smallest coefficient of variation (CV) both in WB (CV = 4.5% \[SD 2.7%\] and CV = 4.8% \[SD 2.3%\] respectively, range 0.8--59.9%) and in plasma (CV = 2.7% \[SD 1.2%\] and CV = 2.9% \[SD 2.4%\], range 0.47--27.8%). {#jvim12397-fig-0003} Hematocrit Interference {#jvim12397-sec-0016} ----------------------- Hematocrit was assessed in 90 samples (glucose 34--489 mg/dL), with 17 in the low (35 \[20--40\]%), 71 in the normal (45 \[37--54\]%), and 2 in the high hematocrit range (59.5 \[59--60\]%). When mean differences were compared, only Hemocue showed smaller errors in the low hematocrit range (−29.53 \[SD 54.92\] mg/dL) when compared with the normal (−49.34 \[SD 41.91\] mg/dL) and high intervals (−64.5 mg/dL \[SD 20.51\]) (*P* = .018). Negative correlations of the error with hematocrit were found for Freestyle, Hemocue, Ultra, and Vita (*r* = −0.243 − \[−0.371\]; *P* \< .021). Discussion {#jvim12397-sec-0017} ========== In this assessment of PBGM in dogs, all devices showed significantly lower average WB glucose values than the reference and none fulfilled previous or current ISO accuracy requirements. Only Aviva achieved the requirements in plasma and was the most accurate of the devices tested. The EG analysis in WB was passed by 6 of the devices and, in plasma, by all. Likewise, Aviva was the most precise PBGM, followed by Verio, both with CV below 5% in WB. CV was reduced in most of the glucose meters by the use of plasma samples (Fig [3](#jvim12397-fig-0003){ref-type="fig"}). Constant error, a type of bias that could potentially be corrected by calibration, was shown in WB for Aviva, Freestyle, and Optium, and in plasma for Freestyle, Ultra, and Verio. These results, in agreement with previous studies, support the need to assess accuracy and precision in every PBGM before it is used in dogs for clinical or research purposes.[3](#jvim12397-bib-0003){ref-type="ref"}, [9](#jvim12397-bib-0009){ref-type="ref"} Not only inappropriate therapeutic decisions could be made when using inaccurate PBGM, but, when used for research, results might also lead to false conclusions. Indeed, most often, no information is given on the accuracy or precision of the PBGM in animal research studies.[16](#jvim12397-bib-0016){ref-type="ref"}, [17](#jvim12397-bib-0017){ref-type="ref"}, [18](#jvim12397-bib-0018){ref-type="ref"} Portable blood glucose meters are often selected based on their brand or series of models, assuming that there are no differences in accuracy among them.[16](#jvim12397-bib-0016){ref-type="ref"}, [19](#jvim12397-bib-0019){ref-type="ref"} However, as interpreted by previous results,[2](#jvim12397-bib-0002){ref-type="ref"}, [3](#jvim12397-bib-0003){ref-type="ref"}, [4](#jvim12397-bib-0004){ref-type="ref"}, [5](#jvim12397-bib-0005){ref-type="ref"}, [6](#jvim12397-bib-0006){ref-type="ref"}, [8](#jvim12397-bib-0008){ref-type="ref"}, [9](#jvim12397-bib-0009){ref-type="ref"}, [20](#jvim12397-bib-0020){ref-type="ref"} and in accordance with this study, there is not a preferred brand to recommend and every PBGM should be evaluated independently (Fig [1](#jvim12397-fig-0001){ref-type="fig"}a,b). This study also assesses the effect of hematocrit on PBGM accuracy. Previous studies have shown that PBGM yield higher glucose concentrations than the reference method in euglycemic, anemic dogs and cats.[5](#jvim12397-bib-0005){ref-type="ref"}, [7](#jvim12397-bib-0007){ref-type="ref"}, [8](#jvim12397-bib-0008){ref-type="ref"}, [20](#jvim12397-bib-0020){ref-type="ref"} In this study, 90 samples with a wide glucose (34--489 mg/dL) and hematocrit range (20--60%) were included. Four PBGM (Freestyle, Hemocue, Ultra, and Vita) showed interferences by hematocrit. Although clinical glucose control may not be as tight in dogs as in humans, the accuracy requirements for glucose meters should not be laxer.[7](#jvim12397-bib-0007){ref-type="ref"} This perception of permissive glucose control can lead PBGM to be judged as "acceptable" for clinical use,[7](#jvim12397-bib-0007){ref-type="ref"}, [8](#jvim12397-bib-0008){ref-type="ref"}, [9](#jvim12397-bib-0009){ref-type="ref"}, [20](#jvim12397-bib-0020){ref-type="ref"} especially if evaluations are mostly based on less stringent approaches, such as error grid analysis. The current 15197:2013 standard requires both analytical and EG criteria to be fulfilled, but the latter seem to be redundant in this study. Indeed, most of the devices fulfilled the EG criteria for WB without satisfying the analytical accuracy demands and, if a device fulfilled the analytical ISO requirements, it also passed the EG analysis. In fact, clinical consequences depend on the specific needs of patients and their circumstances. Indeed, the amplitude of the acceptable limits can be crucial in some cases, such as in tight glycemic control protocols, where an imprecision and bias below 2% have been estimated to be needed to achieve 95% accuracy in insulin administration.[21](#jvim12397-bib-0021){ref-type="ref"} Thus, although optimal glucose control is less feasible in animals, accuracy should be strictly evaluated with rigorous analytical criteria. The ISO 15197:2003 and 15197:2013 are standardized systematic evaluations approved by the CEN and followed by manufacturers that get the Conformité Européenne (CE) mark for their products.[12](#jvim12397-bib-0012){ref-type="ref"}, [13](#jvim12397-bib-0013){ref-type="ref"} The methodology and statistical tests in previous studies have been essentially the same[2](#jvim12397-bib-0002){ref-type="ref"}, [3](#jvim12397-bib-0003){ref-type="ref"}, [4](#jvim12397-bib-0004){ref-type="ref"}, [5](#jvim12397-bib-0005){ref-type="ref"}, [6](#jvim12397-bib-0006){ref-type="ref"}, [7](#jvim12397-bib-0007){ref-type="ref"}, [8](#jvim12397-bib-0008){ref-type="ref"}, [9](#jvim12397-bib-0009){ref-type="ref"} as those used here. In fact, the ISO includes these accepted analytical tests with tightening standards.[22](#jvim12397-bib-0022){ref-type="ref"} Its detailed methodology makes it a reliable tool also in veterinary medicine and allows direct comparison among studies. Of the 9 devices assessed in this study, only Optium had been previously evaluated in dogs,[5](#jvim12397-bib-0005){ref-type="ref"} with similar results to those here reported. Most of the devices analyzed in this study fulfill the ISO 15197:2003 and 2013 for human capillary blood.[12](#jvim12397-bib-0012){ref-type="ref"}, [13](#jvim12397-bib-0013){ref-type="ref"} We are not aware of a known explanation for this interspecies gap in accuracy, but given the difference in performance between WB and plasma samples, we suggest that the cellular fraction must contain the source of error in canine samples. Furthermore, some interference with hematocrit was detected in 4 of the devices. Overall, when assessed in dogs, Aviva is the best option, regarding both accuracy and precision. Freestyle, Verio, and StatStrip were accurate in plasma samples, but were less precise. There were several limitations in this study: the use of a single device of each PBGM, the use of venous (instead of capillary) blood, the incubation of or glucose addition to samples, the use of lithium‐heparin anticoagulant for many samples and the lack of specific PBGM for animals. To assess more than 1 device of the 9 different PBGM would not have been feasible with the resources available. Indeed, assessing all the devices simultaneously was already a challenge. Multiple potential sources of error such as temperature, altitude, humidity, sample volume, hemolysis, or pharmacological factors have been described to interfere with the measurements.[23](#jvim12397-bib-0023){ref-type="ref"}, [24](#jvim12397-bib-0024){ref-type="ref"} Although not all can be accounted for, in this study, we obtained and processed the samples in relatively stable conditions and in very similar conditions to those of routine clinical practice.[4](#jvim12397-bib-0004){ref-type="ref"} Finally, incubation of or glucose addition to the samples, despite being accepted by the ISO, might also be considered as sources of error. Nevertheless, after performing the additional accuracy evaluations for the untreated and treated samples, the similarity in the results obtained after stratification support that this was not the fact in this study. In humans, small but significant differences have been found between capillary and venous glucose.[21](#jvim12397-bib-0021){ref-type="ref"}, [25](#jvim12397-bib-0025){ref-type="ref"} In fact, PBGM are calibrated to show venous‐equivalent concentrations. Thus, some additional inaccuracy should be expected when venous samples are used instead of capillary blood.[25](#jvim12397-bib-0025){ref-type="ref"} Different ways to obtain capillary blood have been developed in small animals,[7](#jvim12397-bib-0007){ref-type="ref"}, [19](#jvim12397-bib-0019){ref-type="ref"} but venous sampling remains the most usual way to obtain blood in veterinary practice. This fact allowed us to obtain the necessary number of samples from routine clinical practice. The OneTouch devices were the only ones specifically recommended for capillary blood only (Table [1](#jvim12397-tbl-0001){ref-type="table-wrap"}). Despite this, (OneTouch) Verio showed the second most accurate results for whole venous blood. Differences between capillary and venous samples in dogs have been evaluated before, proving negligible for most of the devices and glucose concentrations assessed (2--6 mg/dL).[5](#jvim12397-bib-0005){ref-type="ref"}, [7](#jvim12397-bib-0007){ref-type="ref"} Blood collection with sodium‐fluoride as a glycolysis inhibitor is considered the gold standard for glucose determinations.[26](#jvim12397-bib-0026){ref-type="ref"} However, we intended to reproduce what is most frequently done in our routine veterinary practice, where samples often are collected into lithium‐heparin tubes before analysis. Early processing limited potential glucose consumption by the blood cells. In fact, according to the manufacturers, lithium heparin is an appropriate anticoagulant for all the devices[27](#jvim12397-bib-0027){ref-type="ref"}, [28](#jvim12397-bib-0028){ref-type="ref"}, [29](#jvim12397-bib-0029){ref-type="ref"}, [30](#jvim12397-bib-0030){ref-type="ref"}, [31](#jvim12397-bib-0031){ref-type="ref"}, [32](#jvim12397-bib-0032){ref-type="ref"}, [33](#jvim12397-bib-0033){ref-type="ref"}, [34](#jvim12397-bib-0034){ref-type="ref"}, [35](#jvim12397-bib-0035){ref-type="ref"} and, in previous studies, it did not interfere with the results.[3](#jvim12397-bib-0003){ref-type="ref"}, [4](#jvim12397-bib-0004){ref-type="ref"}, [8](#jvim12397-bib-0008){ref-type="ref"} Conclusions {#jvim12397-sec-0018} =========== When glycemic control is assessed, advantages of PBGM are to obtain easy, fast, and relatively cheap measurements with minimal volumes. However, even for humans, important variability in accuracy has been demonstrated. The disparity among devices in this study confirms the need of accuracy evaluations before its use in dogs and the ISO 15197:2013 is an excellent tool for this purpose in animals, as it is in humans. Although none of the PBGM fulfills the ISO requirements for whole venous blood, overall, AccuChek Aviva Nano is the best option among those evaluated, given its accuracy, precision, and lack of interference by hematocrit. During the performance of this study, the authors were supported by a predoctoral fellowship (FUNCIS ID41/2008) (YBC) and grants EFSD/JDRF/Novo Nordisk Programme for Type 1 Diabetes 2008 (AMW, CM, JCW) and PI08/01113 and PI11/02441 (YBC, AMW, JCW, CM), from the Spanish National Research Program. We are grateful to Natalia Navarro and Fidela González (Menarini Diagnostics), Vanessa Fernández (Roche Diagnostics), Álvaro Ladra (Abbott Científica), Juani Perera and Yeray Hernández (Izasa‐Cultek), and Celio Falcón (Lifescan Johnson and Johnson) for providing the glucose meters and test strips. *Conflict of Interest Declaration*: The authors disclose no conflict of interest. The manufacturers had no role in the funding, design, analysis, or reporting of the results. Roche Diagnostics, Mannheim, Germany Abbott Diabetes Care Ltd., Witney, Oxon, UK Arkray‐Menarini Diagnostics, Shiga, Japan Hemocue AB, Ängelholm, Sweden LifeScan Inc., Milpitas, CA Nova Biomedical, Waltham, MA IDEXX Laboratories, ME Siska WD, Rosen NK, Christian JA, Taddeo DA, DeNicola DB. Vet Clin Pathol. Proceedings of the 13th Annual Congress of the European Society for Veterinary Clinical Pathology; 2011 September 1--3; Dublin, Ireland. American Society for Veterinary Clinical Pathology, 2011 Sigma‐Aldrich Chemie Gmbh, Steinheim, Germany IBM SPSS Statistics Version 20; SPSS Inc., Chicago, IL

Introduction {#s1} ============ There is arguably no better place to witness first-hand the impact that diet and microbes have on health and the way the brain functions, than in developing countries of Africa. The parasites and pathogens that can debilitate Westerners have long been known, and the resilience of the local Africans to many of these agents has played its part in the evolution of the hygiene hypothesis, understanding chronic diseases, and creation of a range of vaccines, including against the Ebola virus ([@B1]). Having been party to the study of Hadza hunter gatherers ([@B2]) and noting that they too can live to be elderly, it is clearly not a simple task to unmask the role of diet, microbes, and lifestyle in longevity. It is challenging to dissect the effects of microbes on brain function. To date, the focus has been on pain, anxiety, depression ([@B3]), centered in the amygdala within the limbic system, and linked through the vagus nerve. These studies have not examined the more positive emotions of happiness, drive, and contentment that often appear to be in high abundance among Africans, despite their often-dire predicament. This paper will explore the potential interplay between food, microbes and lifestyle, and challenge researchers to verify rodent research in humans. Trying to Understand the Microbiota Through Retracing Human Evolution {#s2} ===================================================================== While the environments of Canada and east Africa certainly differ to a large extent, as do diets for the majority of citizens, there are also commonalities. For example, the vaginal microbiota shares the same dominant *Lactobacillus* strains across continents, likely indicating their contribution to successful reproduction ([@B4]). In search of increasing our understanding of microbiome evolution, studies have been performed on ancient hunter gatherers in Africa and South America. While they are not free from influence by modern society, some of the habits remain intact. A recent study showed that the Hadza gut microbiota is influenced by seasonal dietary intake, varying from meat to certain fruits ([@B2]). The resultant increase in diversity is likely a hallmark of how humans used to consume food, except that Westernized societies have access to clean water, unlike the Hadza who live in the Central Rift Valley in Tanzania, have significant hand-fecal (human and animal) exposure, and drink untreated water. Indeed, the introduction of un-milled maize to individuals normally consuming baobab, roots, berries, and honey significantly changed their gut microbiota ([@B5]). But, how such seasonality and microbial patterns influence mood has not been studied. The ability to cover great distances in bare feet, hunting animals, securing a temporary home, and providing for women and offspring cannot only be a measure of testosterone and Y chromosomes. If that were the case, the same drive would arguably be present in Hadza hunter gatherers who have assimilated into the lifestyles of Westernized Africans, consuming processed foods, using pharmaceutical agents, and receiving vaccines. Indeed, testosterone levels in one group of Hadza were found not to change with age, and not to be linked to total energy expenditure ([@B6]). The loss of *Treponema* sp. and acquisition of *Bifidobacterium* sp. has been reported in Westernized hunter gatherers, the *Treponema* being more suitable for degradation of unrefined plants, and the bifidobacteria better suited to utilizing gluco- and galacto-based saccharides of Western foods ([@B7]). So, diet and lifestyle do alter the microbiota, but this does not prove a correlation with changes in energy and happiness. Norway, Denmark, and Sweden are ranked in the category of happiest places to live ([@B8]), based upon governance, personal freedom, opportunity, education, safety, and healthcare. Suicide rates are around 11 per 100,000, yet approximately half Norwegians will suffer depression at some point in their life ([@B9]). Are rates of depression a more suitable measure of happiness and contentment, and if so, what about depression amongst hunter gatherers? Based on observations from Papua New Guinea reporting no depression in hunter gatherers, an explanation was consumption of omega-3 fatty acids, access to regular sunlight, exercise, social interaction, and healthier sleep ([@B10]). So, could a supplement of certain probiotic strains, vitamin D, and omega-3 fatty acids reduce depression rates in countries where people have good access to employment, housing, education, and healthcare? These are questions that require investigation. The Gap Between Mouse Studies and Humans {#s3} ======================================== Much has been made of the link between autism and the gut microbiota ([@B11]). One study using a mouse model suggested that *Bacteroides fragilis* therapy had potential to resolve behavioral symptoms in autistic humans ([@B12]). Whether an already unnatural mouse develops autism does not then translate into a therapeutic breakthrough for autistic children, particularly when analytical flaws in the study were exposed by others ([@B13]). Such studies lead to internet blogs that distort the reality and raise hope for a cure in parents. Although scientists have little control over how lay people or the media represent their work, the way that conclusions are presented and the rigor of the review process to minimize sensationalizing results have a major impact. The basis of too many microbiome studies, to date, has been rodent experiments, or observational studies in humans, neither of which prove cause and effect. In the case at hand, parents desperate to help their autistic child might look to fecal microbiota transplant or a *B. fragilis* probiotic that does not exist and will take many years to develop, believing these treatments will alleviate certain behaviors. It is not for me to say that such interventions will or will not work, but there should be a better scientific basis for suggesting they might be effective. Instead, the senior author of the mouse paper ([@B12]) published a review in the same journal Cell ([@B14]) reiterating the link between the gut microbiota and the brain including autism spectrum disorder as if it was proven in humans, when almost all the citations refer to mouse experiments, and human observations. Indeed, the review itself cites numerous other reviews making the same points based on rodent experiments. The possibility that vast numbers of microbes in the intestinal tract with the potential to produce compounds that include neurochemicals ([@B15], [@B16]) can influence the brain is compelling. That the vagus nerve is a main conduit for such signaling ([@B17]) is suggested by the vastness of innervation and sensory fibers, and by vagotomy studies ([@B18]), but other sites especially in the urogenital and respiratory tracts served by this nerve also have microbiotas ([@B19]). Indeed, afferent nerves within the vagus innervate almost all visceral organs, and in the airways and lungs, vagal sensory neurons are the major afferent supply and close to 20% terminate there ([@B20]). The airway microbiota contains a number of species quite capable of influencing the nervous system ([@B21], [@B22]). These discoveries have led to the concept of a gut-lung axis, influenced by diet and the microbiota ([@B23], [@B24]). The importance of the vagus nerve in the microbe-gut-brain axis ([@B25]) has led to exploration of chronically stimulating the nerve to treat Crohn\'s disease ([@B26]). However, vagus nerve stimulation therapy is not without difficulty, and requires a wire with three helical contacts and a one-pin battery, which can potentially lead to infections, delayed arrhythmias, hoarseness, dyspnea, coughing, and vocal cord damage emphasizing the linkage between the nerve and sites other than the gut ([@B27]). In studies of the gut-brain access via the vagus nerve, it may prove challenging to deduce the extent to which organisms in the gut vs. other sites linked to the nerve, are impacting the brain. Of note, the contribution of the vagus nerve to monitoring the microbiome is based on marginal evidence apart from a few vagotomy studies, and such animals suffer from impaired gastrointestinal functions. In addition to the vagus nerve, the intestinal mucosa has sensory functions and neurons, endocrine cells, and immune cells which act as detectors ([@B28]). This makes it possible for the brain to control important functions such as gut motility. What has so far been lacking is identification of molecules produced by microbes that are responsible for brain effects. Arguably, the tools are available to identify these in humans through use of various metabolomic and proteomic methods, and access through surgical procedures. Descriptions of what could, and indeed should, be done in humans, has been lacking from the multitude of reviews on the gut-brain axis, with one exception. Hooks et al. ([@B29]) recently raised similar salient points as those made here, including the relevance of rodent studies to humans ([@B30]), and calling for research that deciphers the complexity of the multipathway systems. Notably, they state "*It could be well-worth working with relevant public health and media experts on how to communicate this exciting body of work responsibly*" \[([@B29]), page 27\]. They also add to the discussion the potentially important role of environmental factors in brain related illness, an issue that will be discussed below. The impact of microbial metabolites on the brain is unclear. Only a few G protein-coupled transmembrane molecular sensors have been identified metabolites in the Na~v~1.8-expressing vagal afferents that detect neurotransmitters, hormones, nutrients ([@B31]). Certainly, omics tools could be applied now to patients with multiple sclerosis and other brain related illnesses who are receiving fecal microbiota transplants (FMT) ([@B32]) or are taking a variety of probiotics, thereby supporting or rebuking the theories based on rodents. Such research could also be applied to verify other mouse-based studies, for example that suggest FMT from a lean donor can make an obese recipient lose weight ([@B33]). Eleven years after this widely cited study, no such conclusive human verification has occurred. The translation of *in vitro* and animal studies to human experimentation has at least started to occur, with encouraging results against depression by daily ingestion of probiotic bifidobacteria for 6 weeks ([@B34]). The selection of the *Bifidobacterium longum* NCC3001 subspecies *longum* strain was from mouse studies 6 years prior showing that ingestion normalized anxiety-like behavior and hippocampal brain derived neurotrophic factor (BDNF) levels ([@B35]). The study utilized a range of evaluative tools. Functional MRI analysis showed that reduced responses to negative emotional stimuli in multiple brain areas, including amygdala and fronto-limbic regions, occurred with probiotic treatment compared to placebo. The lack of change in serum inflammatory markers suggested the benefit did not accrue through down-regulation of inflammation. The unchanged levels of neurotrophins and neurotransmitters 5-HT, substance P, and CGRP, would suggest that gut bacteria were not increasing the circulatory levels of at least these three neurotransmitters, even though reductions were noted in urinary levels of phenylacetyglutamine, creatine, 4-cresol sulfate, and trimethylamine-N-oxide. It was no surprise that the fecal microbiota was unchanged, as 16 s rRNA Illumina sequencing is not sensitive enough to detect differences and probiotic strains do not necessarily alter microbial abundances. As to how the probiotic strain was mediating the clinical outcome the answer remains to be found but given the success of this study of 44 subjects, additional trials are warranted, perhaps accompanied by metagenomic, or transcriptomic analyses to see if the bifidobacteria were influencing other microbes or host circuitry. A challenge for researchers wanting to use microbes to prevent autism spectrum disorder is that interventions will likely need to be tested while the fetus is developing and during early life. This will ethically be more difficult as microbiota manipulation through FMT, probiotics or prebiotics tends not to be target specific, so how the intervention affects other developmental processes will be of concern. On the other hand, if these gut-brain and microbiome-host linkages are true, then the development of every human is already being influenced by a series of microorganisms and in-depth studies during pregnancy and the first year after birth could help to reveal some of the processes. For example, a probiotic strain that improves gut barrier integrity and therefore helps increase adsorption of arachidonic acid, docosahexaenoic acid, and omega-3 polyunsaturated fatty acids, critical for brain growth and cognitive development, could well be tested ([@B36], [@B37]), with implications for later-in-life ([@B38]). As it stands, there are similarities between the challenges facing the microbiome area, still in its infancy, and methodological issues in the field of nutritional epidemiology ([@B39]). The author, Ioannidis, viewed most nutritional variables could be correlated with one another if large enough data sets were analyzed. Confounding factors add to the complexity and meta-analyses become weighted averages interpreted by the examiners. As with foods that can contain thousands of chemicals with the most abundant assumed to be responsible for harm or health, so too assumptions are made that abundant microbial taxa are the key influencer. Probing low abundance species and ruling out contamination remain challenges in microbiome studies. As noted above, the propensity of journals to increase manuscript Altmetric scores does not mean the paper or its conclusions represent meaningful results. Ioannidis\' call for exploration of new avenues of research and pivotal human trials should drive granting agencies to redirect funds away from often pointless or non-correlative animal experiments. Probiotics {#s4} ========== As eluded to by Hooks et al. ([@B29]), the field of probiotics which faced cynicism in the earlier days of its reemergence ([@B40]), is yet again being slated for its lack of usefulness. Unfortunately, the number of people who not understand what probiotics are, and what they are not, is reflected in these commentaries. This is illustrated by a commentary on the Hsiao et al. paper ([@B12]) that referred to the *B. fragilis* strain as a probiotic ([@B41]), which until proven to confer a health benefit on the host, it is not a probiotic ([@B42]). One recent poorly designed and analyzed paper stated in its title a link between small intestinal bacterial overgrowth, probiotics, and metabolic acidosis ([@B43]), when no such correlation was found ([@B44]). An Israeli group published studies with a product they referred to as "probiotic" but that had failed to meet the well-documented criteria as a probiotic \[it did not show a health benefit: ([@B45])\]. They tested it in only a handful of healthy subjects and claimed the strains did not colonize and therefore could not be effective ([@B46], [@B47]), even though colonization is not a prerequisite for probiotic strains. In addition, they claimed that probiotics in general might cause harm if used to prevent antibiotic-associated diarrhea, even when no harm was shown. A much more thorough study of almost 400 subjects in a double-blind design, showed that a multi-strain probiotic could in fact correct undesired changes in microbiota composition and function, caused by antibiotic treatments or by cesarean birth ([@B48]). This adds to the meta-analysis data showing the benefits of probiotics to prevent antibiotic-associated diarrhea ([@B49]). As Hooks et al. noted, too many microbiome studies, of which the two recent ones are examples ([@B46], [@B47]), "oversell" their limited findings, and in doing so damage a reputable scientific field of probiotics. Such overselling is not exclusive to microbiome research, and of course it can be found across the scientific literature, including for some probiotic studies. But, the point of importance is that such negativity should not lead to cessation of good investigative studies on the potential for microbial interventions to provide a benefit to human mental health. In addition to the example highlighted above ([@B34]), several other excellent studies have shown that probiotic therapy can improve mental health. In a New Zealand study of 423 women, *Lactobacillus rhamnosus* HN001 taken during pregnancy and post-partum significantly reduced depression and anxiety scores compared to placebo ([@B50]). In a study investigating neurocognitive impairment in 10 HIV-1 infected patients, 6 months intake of a product containing *Lactobacillus plantarum* DSM 24730, *Streptococcus thermophilus* DSM 24731, *Bifidobacterium breve* DSM 24732, *Lactobacillus paracasei* DSM 24733, *Lactobacillus delbrueckii* subsp. *bulgaricus* DSM 24734, *Lactobacillus acidophilus* DSM 24735, *Bifidobacterium longum* DSM 24736, and *Bifidobacterium infantis* DSM 24737 showed significant improvements in Rey auditory verbal learning test (immediate and delayed recall), Rey-Osterrieth complex figure test (copy immediate and delayed recall), phonological verbal fluency test, Toronto alexithymia scale-20, State-trait anxiety inventory Y-2, and time and weight estimation test scores ([@B51]). Interestingly, while one strain of *B. longum* was shown in a small study to improve memory and reduce stress ([@B52]), another paired with *L. helveticus* showed no effect on psychological outcome measure (Cohen\'s d range = 0.07--0.16) ([@B53]). Although study designs and subject characteristics differed, it is worth investigating strain to strain variations. Environmental and Socio-Economic Confounders {#s5} ============================================ As has been well-documented, mental health, and well-being are affected by a number of factors, not the least of which are socio-economic status and environmental pollutants. Such confounders must be considered in human studies if we are to truly differentiate the role of microbes in alleviating depression, anxiety, and improving treatment of conditions emanating from the brain. Whether this is lack of exposure to coastal waters ([@B54]), unemployment ([@B55]), being in a household where illness, and death are prevalent ([@B56]) or being exposed to small pollutant particles penetrating the blood brain barrier ([@B57]), these can influence depression. One study has even suggested that exposure to air pollutants in early life can alter the gut microbiome and increase the risk of various diseases ([@B58]). A number of pesticides have been clearly shown to induce neurological disease ([@B59]). In some developing countries, sexually transmitted infections and excessive blood or hair mercury levels can be a result of poverty and women trading sex for fish from polluted lakes ([@B60]). In every clinical study, efforts are made to match confounding issues in the active and placebo arms, but perhaps not to the extent of measuring levels of heavy metals and pesticides. These are not only issues for developing countries, but certainly the contamination risk appears to be higher. In a study performed in Mwanza, Tanzania, probiotic *L. rhamnosus* GR-1 yogurt intake correlated with reduced adsorption of mercury, and arsenic in pregnant women consuming contaminated fish from Lake Victoria ([@B61]). The lactobacilli were shown to bind to the metals. The subsequent creation of a network of 282 production units across east Africa that make probiotic yogurt made with the GR-1 or *L. rhamnosus* GG generic strain Yoba known also strengthen gut barrier function ([@B62]), has the potential to not only reduce toxin uptake and improve nutrient adsorption, but also indirectly improve mental health and well-being. By increasing family income for the producers and along the value chain, the resultant lifestyle, and socio-economic changes could impact rates of depression and anxiety. This whole-view of society is vital if diseases are to be effectively treated. Unless women are empowered, children are fed, income allows for education and healthcare, and crop losses are minimized, then disease more easily proliferates. A single vaccine or pharmaceutical agent can undoubtedly save lives, but the cost to society in waiting for them to be developed, tested, implemented, and paid for is invariably long; and by the time the shareholders reap the benefits from the consumers directly or countries donating funds for product use, many lives could have been saved or improved in developing countries by simpler remedies borne out of local empowerment. This is not to imply that a probiotic can cure Ebola or malaria, but a practical, affordable probiotic food could indeed be as effective in improving health and well-being, as a capsule imported from the North at a price many-fold higher. Concluding Remarks {#s6} ================== Health is not a single event. Rather, it is a continuum along which peaks and troughs occur, some more dramatic than others. Microbes are present throughout, and it will be generations before we know how best to program their functionality to impart health and wellness for as long as possible. But, we need scientific rigor in conjunction with translational speed and regulatory flexibility. It need not be driven by large multinationals. The Hadza have managed without central heating, air conditioning, sugary soda, and automobiles. Some of them live to be very old. Many of them seem happier than the Western scientists who visit them. While fellow humans change the environment in which they live, it may be wise for us to first understand not only the microbes that live in and on the Hadza and the species that surround them, but also how the complexities of human cells, microbes, chemicals, food, and the ecosystem intermingle. Research into the microbiome has to extend beyond rodent models, as recently shown by a study of over one thousand subjects that identified microbial metabolites correlating with mental quality of life and depression ([@B63]). Cancer has been cured many times over in rodents without necessarily doing the same in humans, and clear concerns about animal models and microbiota studies translating to humans have been expressed ([@B64]--[@B67]). In addition to studies not taking account of the influence of coprophagy ([@B68]), many experimental tools and models used to manipulate the microbiome of laboratory rodents are inherently flawed, including the use of antibiotics which have neuro-active and neuro-toxic effects and therefore can influence gut-brain outcomes ([@B69]). Concepts can be tested in humans through FMT, probiotics, prebiotics, and dietary alterations. Access to tissue and real-time responses is more feasible now with non-invasive surgery. Such studies will help to clarify conflicting data ([@B70]) and make it possible to develop novel approaches to treatment of humans suffering from a range of brain-associated illnesses. Surely, the 17 years it apparently takes to translate science into something that makes a difference to human life ([@B71]) is not set in stone? Author Contributions {#s7} ==================== The author confirms being the sole contributor of this work and has approved it for publication. Conflict of Interest Statement ------------------------------ GR has consulted on the topic of probiotics for Seed, Acerus Pharma, KGK Synergize, Bayer Consumer Health, Chr Hansen, Metagenics, and Standard Process in the past three years. He receives no licensing fees from the sale of probiotics and has no stock ownership or patents on the topic. [^1]: Edited by: John Bienenstock, McMaster University, Canada [^2]: Reviewed by: Bruno Bonaz, Centre Hospitalier Universitaire de Grenoble, France; Laurent Gautron, University of Texas Southwestern Medical Center, United States [^3]: This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology

\section{Introduction} We study the following geometric inverse problem, first considered by M.~Lassas and T.~Saksala in \cite{LS}, see also \cite{LS1}. Let $M=(M^n,g)$ be a complete, connected Riemannian manifold. For $x\in M$, let $D_x\colon M\times M\to\mathbb R$ be the {\em distance difference function} defined by \begin{equation}\label{e:defD_x} D_x(y,z) = d(x,y) - d(x,z), \qquad y,z\in M, \end{equation} where $d$ is the geodesic distance in $M$. Fix a set $F\subset M$, called the \textit{observation domain}, and consider the restrictions $D_x|_{F\times F}$ of distance difference functions to $F\times F$. The set of all these restrictions is called the \textit{distance difference data} for $M$ and~$F$; we emphasize that it is just a set of functions on $F\times F$ without any additional structure. The problem is to reconstruct the manifold $M$ and its metric from this set of functions. More generally, we consider a variant of the problem where one knows partial distance difference data $\{D_x|_{F\times F}\}_{x\in U}$ for some region $U\subset M$ and the goal is to determine the geometry of~$U$. The notion of distance difference data does not look very natural but it is a convenient way to represent the following information: For each $x\in M$, we are given a function on~$F$ that equals the distance function $d(x,\cdot)|_F$ up to an unknown additive constant. For a motivation, imagine that $M\simeq D^3$ is the Earth, the metric $g$ represents the speed of propagation of elastic waves, and $F=\partial M$ is the Earth's surface. (Here we generalize our set-up and allow $M$ to have a boundary.) Assume that micro-earthquakes occur frequently at unknown points inside the Earth. When a micro-earthquake occurs at a point $x\in M$ at time~$t$, it produces an elastic wave which arrives to a point $y\in F$ at time $t+d(x,y)$. Thus an observer on the surface can learn the function $t+d(x,\cdot)|_F$. Since the value of $t$ is unknown, the same information is represented by the distance difference function $D_x|_{F\times F}$. Having observed many such events, one collects distance difference data $\{D_{x_i}|_{F\times F}\}$ for a large set of points $\{x_i\}\subset M$. Idealizing the situation, we assume that one knows the data for all $x\in M$ or at least for all points from some ``active'' region $U\subset M$. The goal is to learn as much as possible about the metric $g$ from these data. Clearly the best one can hope for is to reconstruct $(M,g)$ up to a Riemannian isometry. Like in \cite{LS} and \cite{LS1}, we actually consider a simpler variant of the problem where the manifold $M$ has no boundary and the observation domain $F$ has a nonempty interior. In some cases the problem for a manifold with boundary can be reduced to the simpler variant by means of a suitable extension of the manifold, see Section~\ref{sec:boundary}. We refer to \cite{LS,LS1} for more thorough discussion of distance difference representations and their connections to a variety of inverse problems. See also \cite{KKL,Kyr} for discussion and applications of the more basic \textit{distance representation}, that is a map $\mathcal R_F\colon M\to \mathcal C(F)$ defined by $\mathcal R_F(x)=d(x,\cdot)|_F$ for all $x\in M$. All results of this paper concerning $\mathcal D_F$ trivially imply similar statements about $\mathcal R_F$. \subsection*{Definitions and statement of the results} Now we proceed with formal definitions and statements. For a complete, connected, boundaryless Riemannian manifold $M=(M^n,g)$ and a set $F\subset M$ define a map $\mathcal D_F\colon M\to \mathcal C(F\times F)$ by $$ \mathcal D_F(x)=D_x|_{F\times F} $$ where $D_x$ is the distance difference function defined by \eqref{e:defD_x}. The target space $\mathcal C(F\times F)$ of $\mathcal D_F$ is the space of continuous functions on $F\times F$ equipped with the sup-norm distance: $$ \|f_1-f_2\|=\sup_{y,z\in F}\{|f_1(y,z)-f_2(y,z)|\}, \qquad f_1,f_2\in\mathcal C(F\times F) . $$ The map $\mathcal D_F$ is called the \textit{distance difference representation} of $M$. The triangle inequality implies that $$ \|\mathcal D_F(x)-\mathcal D_F(y)\| \le 2d(x,y) $$ for all $x,y\in M$. Thus $\mathcal D_F$ is a 2-Lipschitz map. Note that the norm $\|\mathcal D_F(x)\|$ may be infinite if $F$ is unbounded but the distance $\|\mathcal D_F(x)-\mathcal D_F(y)\|$ is always finite. Our first goal is to show that the set $\mathcal D_F(M)\subset\mathcal C(F\times F)$ is a homeomorphic image of~$M$. In particular this implies that the distance difference data determines the topology of~$M$. This was previously known in the case when $M$ is compact, see \cite[Theorem 2.3]{LS}. In fact, the proof in \cite{LS} shows that $\mathcal D_F$ is injective, and by compactness of~$M$ it follows that $\mathcal D_F$ is a homeomorphism onto its image. In Theorem \ref{t:inverse} below we extend this result to the non-compact case. Moreover we show that the inverse map $\mathcal D_F^{-1}$ is locally Lipschitz. \begin{theorem}\label{t:inverse} Let $M^n$ be a complete, connected Riemannian manifold without boundary, $n\ge 2$, and let $F\subset M$ be a subset with a nonempty interior. Then the map $\mathcal D_F\colon M\to\mathcal C(F\times F)$ is a homeomorphism onto its image and the inverse map $\mathcal D_F^{-1}\colon\mathcal D_F(M)\to M$ is locally Lipschitz. \end{theorem} The local Lipschitz constant of $\mathcal D_F^{-1}$ at a point $\mathcal D_F(x_0)$ (and the radius of a neighborhood where this constant works) can be estimated in terms of geometric parameters such as the size of~$F$, the distance from $x_0$ to~$F$, curvature and injectivity radius bounds in a suitably large ball. For details, see Propositions \ref{p:holder} and \ref{p:bilip} in Section~\ref{sec:inverse}. In the compact case the effective version of Theorem \ref{t:inverse} is stated as Corollary~\ref{cor:bilip} below. We denote by $\operatorname{diam}(M)$ the diameter, $\operatorname{Sec}_M$ the sectional curvature, and $\operatorname{inj}_M$ the injectivity radius of a Riemannian manifold~$M$. For $n\ge 2$ and $D,K,i_0>0$ we denote by $\mathcal M(n,D,K,i_0)$ the class of all compact boundaryless Riemannian $n$-manifolds $M$ with $\operatorname{diam}(M)\le D$, $|\operatorname{Sec}_M|\le K$ and $\operatorname{inj}_M\ge i_0$. \begin{corollary}\label{cor:bilip} Let $M\in\mathcal M(n,D,K,i_0)$ and assume that a set $F\subset M$ contains a ball of radius~$\rho_0$. Then the map $\mathcal D_F\colon M\to \mathcal D_F(M)\subset\mathcal C(F\times F)$ is a bi-Lipschitz homeomorphism with a bi-Lipschitz constant determined by $n$, $D$, $K$, $i_0$, $\rho_0$. \end{corollary} Now consider the problem of unique determination of a Riemannian metric from the distance difference data. Our informal set-up is the following. There is an unknown Riemannian manifold $M$ and an unknown open set $U\subset M$. We know the topology and differential structure of the observation domain $F$ and we are given the subset $\mathcal D_F(U)$ of $\mathcal C(F\times F)$. Our result is that these data determine the geometry of the domain $(U,g|_U)$ uniquely up to a Riemannian isometry. The precise statement is the following. \begin{theorem}\label{t:reconstruction} Let $M_1=(M_1^n,g_1)$ and $M_2=(M_2^n,g_2)$ be complete, connected, boundaryless Riemannian manifolds and $n\ge 2$. Assume that $M_1$ and $M_2$ share a nonempty subset $F$ which is open in both manifolds, and they induce the same topology and the same differential structure on $F$. For $i=1,2$, let $\mathcal D_F^i$ denote the distance difference representation of $M_i$ in $\mathcal C(F\times F)$. Let $U_1\subset M_1$ and $U_2\subset M_2$ be open sets such that the subsets $\mathcal D_F^1(U_1)$ and $\mathcal D_F^2(U_2)$ of $\mathcal C(F\times F)$ coincide. Then the map $\phi \colon U_1\to U_2$ defined by \begin{equation}\label{e:def-phi} \phi=(\mathcal D_F^2)^{-1}\circ \mathcal D_F^1|_{U_1} \end{equation} is a Riemannian isometry between $(U_1,g_1|_{U_1})$ and $(U_2,g_2|_{U_2})$, that is, $\phi$ is a diffeomorphism between $U_1$ and $U_2$ and $\phi_*g_1=g_2$. \end{theorem} Theorem \ref{t:reconstruction} applied to $U=M$ yields that the distance difference data $\mathcal D_F(M)$ determine the isometry type of $(M,g)$. In the case when $M$ is compact this was known due to M.~Lassas and T.~Saksala \cite{LS}. In \cite{LS1} the result was extended to the following situation: $U$ is a pre-compact region bounded by a smooth hypersurface $\partial U$ and $F$ is a neighborhood of $\partial U$ in $M\setminus U$. The proofs in \cite{LS} and \cite{LS1} are based on the same approach: first it is shown that the two Riemannian manifolds in question are projectively equivalent and then certain delicate properties of projective equivalences imply that they are actually isometric. The last part requires the knowledge of global distance difference data and it does not work in the localized setting of Theorem~\ref{t:reconstruction} (where $U$ can be separated away from~$F$). Another question left open in \cite{LS} and \cite{LS1} is whether the determination of metric is stable with respect to variations of the distance difference data. Our proof of Theorem \ref{t:reconstruction} is based on a different technique, which works as well for metric spaces with locally bounded curvature in the sense of Alexandrov. With a standard compactness argument, this implies stability of metric determination within the class $\mathcal M(n,D,K,i_0)$: If two manifolds $M_1$ and $M_2$ from this class share an open set $F$ and their distance difference data are Hausdorff-close subsets of $\mathcal C(F\times F)$, then the manifolds are close in Gromov--Hausdorff (and hence in $C^{1,\alpha}$) topology. See Proposition \ref{p:stability} for details. \subsection*{Organization of the paper} The proofs of the theorems are based mainly on distance comparison inequalities implied by Toponogov's theorem. These inequalities are collected in Section \ref{sec:toponogov}. Another key ingredient of the proof is a minimizing geodesic extension property, see Proposition \ref{p:extension}. This proposition, which may be of independent interest, provides a lower bound on the length of a minimizing extension of a geodesic beyond a non-cut point in terms of the length of a minimizing extension beyond the other endpoint. The proof of Proposition \ref{p:extension} is contained in sections \ref{sec:extension} and~\ref{sec:sasaki}. In Section \ref{sec:inverse} we prove Theorem \ref{t:inverse} and Corollary \ref{cor:bilip}. In Section \ref{sec:reconstruction} we prove Theorem \ref{t:reconstruction} and observe that the proof implies stability of the metric determination, see Proposition \ref{p:stability}. In Section \ref{sec:boundary} we obtain some partial generalizations of our results to manifolds with boundaries. \subsection*{Acknowledgements} The author thanks Matti Lassas, Yaroslav Kurylev, Charles Fefferman, and Hariharan Narayanan for discussions that attracted the author's attention to the problem and inspired some ideas of the proofs. \section{Distance comparison estimates} \label{sec:toponogov} In this section we set up notation and prepare some tools from comparison geometry. These are pretty standard implications of Toponogov's comparison theorem and they hold in all Alexandrov spaces of curvature bounded below, see \cite{BBI,BGP}. We include all formulations and proofs since we need to handle local curvature bounds. Let $M=(M^n,g)$, $n\ge 2$, be a complete, connected, boundaryless Riemannian manifold. We use notation $|xy|$ for the distance $d(x,y)$ between points $x,y\in M$. We denote by $B_r(x)$ the geodesic ball of radius $r>0$ centered at~$x\in M$, by $L(\gamma)$ the length of a path $\gamma$ in~$M$, and by $SM$ the unit tangent bundle of~$M$. For $x,y\in M$, we denote by $[xy]$ any minimizing geodesic connecting $x$ and~$y$. In cases when a minimizing geodesic is not unique, we assume that some choice of $[xy]$ is fixed for each pair $x,y$. For $x,y,z\in M$ we denote by $\angle yxz$ the angle between the directions of $[xy]$ and $[xz]$ in $T_xM$. In order to handle local curvature bounds we introduce the following quantity. \begin{definition}\label{d:lcr} For $x\in M$, we define the \textit{lower curvature radius} at $x$, denoted by $\operatorname{lcr}(x)$ or $\operatorname{lcr}_M(x)$, as the supremum of all $r>0$ such that $\operatorname{Sec}_M\ge -1/r^2$ everywhere in the ball $B_{2r}(x)$. \end{definition} Clearly $x\mapsto\operatorname{lcr}(x)$ is a positive 1-Lipschitz function on~$M$. The lower curvature radius naturally rescales with the metric. That is, for a rescaled Riemannian manifold $\lambda M:=(M,\lambda^2g)$, where $\lambda>0$, one has $\operatorname{lcr}_{\lambda M}(x)=\lambda\cdot\operatorname{lcr}_M(x)$. We need the following variant of Toponogov's comparison theorem. \begin{proposition}\label{p:toponogov} Let $x,y,z\in M$ and $K>0$ be such that $\operatorname{Sec}_M\ge-K$ everywhere in the ball $B_{2r}(x)$ where $r=\max\{|xy|,|xz|\}$. Let $\bar x,\bar y,\bar z$ be points in the rescaled hyperbolic plane $K^{-1/2}\mathbb H^2$ such that $|\bar x\bar y|=|xy|$, $|\bar x\bar z|=|xz|$, and $\angle\bar y\bar x\bar z=\angle yxz$. Then $|yz|\le |\bar y\bar z|$. In particular, if $\operatorname{lcr}(x)\ge 1\ge \max\{|xy|,|xz|\}$ then the inequality $|yz|\le |\bar y\bar z|$ holds for $\bar x,\bar y,\bar z$ constructed as above in the standard hyperbolic plane $\mathbb H^2$. \end{proposition} \begin{proof} The first part is essentially the hinge version of Toponogovs's theorem, see \cite[Ch.~11, Theorem 70]{Pe}. The difference is that in the standard formulation of Toponogov's theorem the curvature bound $\operatorname{Sec}_M\ge-K$ is assumed everywhere on~$M$. However from the proof in e.g.\ \cite{Pe} one can see that the curvature bound needs to hold only on the union of all minimizing geodesics from $y$ to points of~$[xz]$. Thus the refined formulation works as well. The second part follows from the first one and the definition of $\operatorname{lcr}(x)$ by setting $K=1$. \end{proof} In the rest of this section we deduce several inequalities used throughout the paper. \begin{lemma}\label{l:1var-ineq} For any $p,x,y\in M$, $$ |py| \le |px| - |xy|\cos\angle pxy + C \frac{|xy|^2}{ \min\{ |px|, \operatorname{lcr}(x) \} } $$ where $C>0$ is an absolute constant. \end{lemma} \begin{proof} Let $\alpha=\angle pxy$. By rescaling we may assume that $\min\{ |px|, \operatorname{lcr}(x) \}=1$. Thus $|px|\ge 1$, $\operatorname{lcr}(x)\ge 1$, and we need to prove that \begin{equation}\label{e:1var-ineq1} |py| \le |px| - |xy|\cos\alpha + C |xy|^2 . \end{equation} We may also assume that $|xy|<1/2$, otherwise \eqref{e:1var-ineq1} holds for any $C\ge 4$ due to the triangle inequality $|py|\le|px|+|xy|$. Let $p_1\in[px]$ be such that $|p_1x|=1$. Pick $\bar p_1,\bar x,\bar y\in\mathbb H^2$ such that $|\bar p_1\bar x|=1$, $|\bar x\bar y|=|xy|$ and $\angle\bar p_1\bar x\bar y=\alpha$. By Proposition \ref{p:toponogov} we have $|p_1y| \le |\bar p_1\bar y|$. Consider the distance function $f=|\bar p_1 \cdot|$ on $\mathbb H^2$. This function is smooth on $\mathbb H^2\setminus\{\bar p_1\}$ and its derivative at $\bar x$ in the direction of $[\bar x\bar y]$ equals $-\cos\alpha$. Thus $$ |p_1y| \le |\bar p_1\bar y| \le |\bar p_1\bar x| - |\bar x\bar y|\cos\alpha + C |\bar x\bar y|^2 = |p_1x| - |xy|\cos\alpha + C |xy|^2 $$ where $C$ is an absolute constant determined by the maximum second derivative of~$f$ on $B_2(\bar p_1)\setminus B_{1/2}(\bar p_1)$. This and the triangle inequality $|py|\le |pp_1|+|p_1y|$ imply \eqref{e:1var-ineq1} and the lemma follows. \end{proof} \begin{lemma}\label{l:short-median} Let $p,q,x,y\in M$ be such that $x\in [pq]$ and $$ r:=\min\{|px|,|qx|,\operatorname{lcr}(x)\} > 0 . $$ Then \begin{equation}\label{e:1stvar} \bigl| |px| - |py| - |xy|\cos\angle pxy \bigr| \le C \frac{|xy|^2}r . \end{equation} and \begin{equation}\label{e:short-median} |py|+|yq| \le |pq| + 2C \frac{|pz|^2}{r} \end{equation} where $C>0$ is the absolute constant from Lemma \ref{l:1var-ineq}. \end{lemma} \begin{proof} Let $\alpha=\angle pxy$, then $\angle qxy=\pi-\alpha$. By Lemma \ref{l:1var-ineq} we have \begin{equation}\label{e:median1} |py| \le |px| - |xy|\cos\alpha + C \frac{|xy|^2}{r} \end{equation} and, using $q$ in place of $p$, \begin{equation}\label{e:median2} |qy| \le |qx| + |xy|\cos\alpha + C \frac{|xy|^2}{r} . \end{equation} Summing \eqref{e:median1} and \eqref{e:median2} yields \eqref{e:short-median}. Subtracting \eqref{e:median2} from the triangle inequality $|py|+|qy|\ge |pq|$ yields $$ |py| \ge |px| - |xy|\cos\alpha - C \frac{|xy|^2}{r} . $$ This and \eqref{e:median1} implies \eqref{e:1stvar}. \end{proof} \begin{lemma}\label{l:shortcut} Let $x,y,z\in M$ and $\alpha=\pi-\angle yxz$. Then $$ |xy|+|xz|-|yz| \ge c \alpha^2 \min\{|xy|,|xz|,\operatorname{lcr}(x)\} $$ where $c>0$ is an absolute constant. \end{lemma} \begin{proof} By rescaling we may assume that $\min\{|xy|,|xz|,\operatorname{lcr}(x)\}=1$. Let $y_1\in[xy]$ and $z_1\in[xz]$ be the points at distance $1$ from~$x$. The triangle inequality $|yz|\le|yy_1|+|y_1z_1|+|z_1z|$ implies that $$ |xy|+|xz|-|yz| \ge |xy_1|+|xz_1|-|y_1z_1| =2-|y_1z_1|. $$ Thus it suffices to show that $|y_1z_1|\le 2-c\alpha^2$ for a suitable constant $c>0$. Pick $\bar x,\bar y_1,\bar z_1\in\mathbb H^2$ such that $|\bar x\bar y_1|=|\bar x\bar z_1|=1$ and $\angle \bar y_1\bar x\bar z_1=\pi-\alpha$. By Proposition \ref{p:toponogov} we have $|y_1z_1|\le |\bar y_1\bar z_1|$. It remains to show that $|\bar y_1\bar z_1|\le 2-c\alpha^2$. This follows from the hyperbolic law of cosines $$ \cosh|\bar y_1\bar z_1| = \cosh^2 1 - \sinh^2 1 \cdot \cos\alpha = \cosh 2 - \sinh^2 1 \cdot (1-\cos\alpha) $$ and an elementary inequality $1-\cos\alpha \ge \frac2{\pi^2} \alpha^2$. \end{proof} \begin{lemma}\label{l:lipexp} Let $x,y,z\in M$. 1. If, for some $K,R>0$, one has $|xy|\le R$ and $\operatorname{Sec}_M\ge-K$ everywhere in the ball $B_{2R}(x)$, then \begin{equation}\label{e:lipexp} |yz| \le C_{K,R}\cdot \angle yxz + \bigl| |xy|-|xz| \bigr| . \end{equation} where $C_{K,R}>0$ is determined by $K$ and $R$. 2. If $|xy|\le\operatorname{lcr}(x)$, then \begin{equation}\label{e:lipexp1} |yz| \le 2|xy|\cdot \angle yxz + \bigl| |xy|-|xz| \bigr| . \end{equation} \end{lemma} \begin{proof} 1. Let $\alpha=\angle yxz$. We may assume that $|xy|\le|xz|$, otherwise swap $x$ and $y$. Let $z_1\in[xz]$ be such that $|xz_1|=|xy|$. Pick points $\bar x,\bar y,\bar z_1$ in the rescaled hyperbolic plane $K^{-1/2}\mathbb H^2$ such that $|\bar x\bar y|=|\bar x\bar z_1|=|xy|$ and $\angle \bar y\bar x\bar z_1=\alpha$. By Proposition \ref{p:toponogov} we have $$ |yz_1|\le |\bar y\bar z_1| \le C_{K,R}\cdot\alpha $$ where $C_{K,R}$ equals $1/2\pi$ times the length of the circle of radius $R$ in $K^{-1/2}\mathbb H^2$. Therefore $$ |yz| \le |yz_1|+|z_1z| \le C_{K,R}\cdot\alpha + |xz|-|xy| $$ by the triangle inequality and the construction of~$z_1$. 2. Rescale the metric by the factor $|xy|^{-1}$ and observe that in the rescaled space the assumptions of the first part are satisfied for $K=R=1$. Hence \eqref{e:lipexp} holds with the constant $C_{1,1}=\sinh1\le 2$. Rescaling the metric back yields \eqref{e:lipexp1}. \end{proof} \begin{notation}\label{n:dir} For $x\in M$ and a set $B\subset M$, we denote by $\operatorname{dir}(x,B)$ or $\operatorname{dir}_M(x,B)$ the subset of the unit sphere $S_xM\subset T_xM$ consisting of the initial directions of all minimizing geodesics from $x$ to points of~$B$. \end{notation} \begin{lemma}\label{l:dirvol} For any $K,R>0$ there exist $\lambda_{K,R}>0$ such that the following holds. Let $x\in M$ and let $B\subset B_R(x)$ be a measurable set. Assume that $\operatorname{Sec}_M\ge-K$ everywhere in the ball $B_{2R}(x)$. Then \begin{equation}\label{e:dirvol} \mathcal H^{n-1}(\operatorname{dir}(x,B)) \ge \lambda_{K,R}^{n-1} \cdot \frac{\operatorname{vol}(B)}{\operatorname{diam}(B)} \end{equation} where $\mathcal H^{n-1}$ denotes the $(n-1)$-dimensional Hausdorff measure. \end{lemma} \begin{proof} Let $K,R,x,B$ be as above. Let $d_{\min}$ and $d_{\max}$ denote the supremum and infimum of distances from $x$ to points of~$B$. Then $d_{\max}-d_{\min}\le\operatorname{diam}(B)$. For $r>0$, denote by $S(r)$ the sphere of radius $r$ centered at~$x$, i.e., $S(r)=\{y\in M: |xy|=r\}$. By the co-area formula for Lipschitz functions (see e.g.\ \cite[Theorem 3.2.11]{Federer}) applied to the distance function of $x$, $$ \operatorname{vol}(B) = \int_{d_{\min}}^{d_{\max}} \mathcal H^{n-1}(B\cap S(r))\, dr . $$ Hence there exists $r\in [d_{\min},d_{\max}]$ such that \begin{equation}\label{e:slicevol} \mathcal H^{n-1}(B\cap S(r))\ge \frac{\operatorname{vol}(B)}{d_{\max}-d_{\min}} \ge \frac{\operatorname{vol}(B)}{\operatorname{diam}(B)} . \end{equation} Now consider the set $\Sigma=\operatorname{dir}(x,B\cap S(r))\subset\operatorname{dir}(x,B)$ and the map $v\mapsto\exp_x(rv)$ from $\Sigma$ onto $B\cap S(r)$. By Lemma \ref{l:lipexp}, this map is $C_{K,R}$-Lipschitz, hence $$ \mathcal H^{n-1}(B\cap S(r)) \le C_{K,R}^{n-1} \mathcal H^{n-1}(\Sigma) . $$ This and \eqref{e:slicevol} imply \eqref{e:dirvol} for $\lambda_{K,R}=C_{K,R}^{-1}$. \end{proof} \section{Minimizing geodesic extensions} \label{sec:extension} The main result of this section in Proposition \ref{p:extension}, which is a quantitative version of the fact that the cut point relation in a Riemannian manifold is symmetric. Recall that a point $x\in M$ is a \textit{cut point} of $p\in M$ if a minimizing geodesic $[px]$ cannot be extended as a minimizing geodesic beyond~$x$. This can occur in two cases: either there are two distinct minimizing geodesics from $p$ to $x$, or $p$ and $x$ are conjugate points along $[px]$. Both properties are symmetric with respect to $p$ and $x$, hence so is the cut point relation. Thus, if $[px]$ admits a minimizing extension beyond $p$, then it also admits a minimizing extension beyond $x$. Proposition \ref{p:extension} provides a lower bound on the length of this extension. \begin{proposition}\label{p:extension} For any $K,R_0>0$ there exists $\lambda_0=\lambda_0(K,R_0)>0$ such that the following holds. Let $M$ be a complete Riemannian manifold, $p,x\in M$, $r_0>0$, and assume the following geometric bounds: \begin{enumerate} \item $|px|\le R_0$; \item $|\operatorname{Sec}_M|\le K$ everywhere in the ball $B_{R_0+3r_0}(p)$; \item $\operatorname{inj}_M(x)\ge r_0$. \end{enumerate} Suppose that $p$ belongs to a minimizing geodesic $[qx]$ for some $q\in M$. Then there exists a minimizing extension $[py]$ of $[px]$ such that \begin{equation}\label{e:extension} |xy| \ge \lambda_0 \min\{ |pq| , r_0, K^{-1/2} \} . \end{equation} \end{proposition} Our main application of Proposition \ref{p:extension} is the following. \begin{corollary}\label{cor:1stvar} For any $K,R_0,r_0>0$ there exists $\Lambda=\Lambda(K,R_0,r_0)>0$ such that the following holds. Let $M$ be a complete Riemannian manifold, $p,x\in M$, and assume the bounds (1)--(3) from Proposition \ref{p:extension}. Suppose that $p$ belongs to a minimizing geodesic $[qx]$ for some $q\in M$. Then, for every $z\in M$, \begin{equation}\label{e:cor1stvar} \bigl| |px| - |pz| - |xz|\cos\angle pxz \bigr| \le \frac{\Lambda |xz|^2}{\min\{ |px|,|pq|, 1 \}} . \end{equation} \end{corollary} First we deduce Corollary \ref{cor:1stvar} from Proposition \ref{p:extension}. \begin{proof}[Proof of Corollary \ref{cor:1stvar}] Let $[py]$ be a minimizing extension of $[px]$ provided by Proposition \ref{p:extension}. We apply the first part of Lemma \ref{l:short-median} to $p,y,x,z$ and obtain \begin{equation}\label{e:cor1stvar1} \bigl| |px| - |pz| - |xz|\cos\angle pxz \bigr| \le \frac{C |xz|^2}{\min\{ |xy|,|px|,\operatorname{lcr}(x) \}} \end{equation} where $C$ is an absolute constant. The assumption (2) of Proposition \ref{p:extension} implies that $\operatorname{lcr}(x)\ge\min\{K^{-1/2},r_0\}$. This inequality, \eqref{e:extension} and \eqref{e:cor1stvar1} imply \eqref{e:cor1stvar} for a suitable $\Lambda$ determined by $K$, $r_0$, and $\lambda_0$. \end{proof} The proof of Proposition \ref{p:extension} occupies the rest of this section and the next section. In this section we prove Proposition \ref{p:extension} assuming a technical estimate stated as Lemma \ref{l:beta-vs-alpha}. The next section is devoted to the proof of Lemma \ref{l:beta-vs-alpha}. First observe that the statement of Proposition \ref{p:extension} is scale invariant. We replace $M$ by a rescaled manifold $\lambda M$ where $\lambda=\max\{r_0^{-1},K^{1/2}\}$ and change the parameters $K,R_0,r_0$ accordingly. The resulting manifold, for which we reuse the notation $M$, satisfies $|\operatorname{Sec}_M|\le 1$ in the ball $B_{R_0+3}(p)$ and $\operatorname{inj}_M(x)\ge 1$. The desired inequality \eqref{e:extension} now takes the form \begin{equation}\label{e:extension1} |xy| \ge \lambda_0 \min\{ |pq| , 1 \} . \end{equation} Thus it suffices to prove the proposition for $K=r_0=1$. This is assumed throughout the rest of the proof. Our goal is to prove that there is a minimizing extension $[py]$ of $[px]$ satisfying \eqref{e:extension1} for a suitable $\lambda_0$ determined by $R_0$. Since $|\operatorname{Sec}_M|\le 1$ in $B_{R_0+3}(p)$, the lower curvature radius (see Definition \ref{d:lcr}) is bounded below by~1 in the ball $B_{R_0+1}(p)$. All points appearing in the proof belong to this ball. Let $p,q,x$ be as in the formulation of Proposition \ref{p:extension}. We may assume that $|px| > 1/2$. Indeed, since $\operatorname{inj}_M(x)\ge 1$ and $|\operatorname{Sec}_M|\le 1$ on $B_1(x)$, any geodesic of length~1 with midpoint at~$x$ is minimizing. Thus if $|px|\le 1/2$ then there is a minimizing extension $[py]$ of $[px]$ with $|xy|=1/2$ and \eqref{e:extension1} holds for any $\lambda_0\le 1/2$. Define $L=|px|$ and $$ r_1 = \tfrac1{10}\min\{|pq|, 1 \} . $$ Since $|px| > 1/2$, we have \begin{equation}\label{e:L-vs-r1} L > 1/2 \ge 5r_1 . \end{equation} Let $\gamma\colon[0,+\infty)\to M$ be the unit-speed geodesic starting at $p$ and containing $[px]$, in particular $\gamma(0)=p$ and $\gamma(L)=x$. Pick $r\in(0,r_1]$, let $y=\gamma(L+r)$, and assume that the geodesic arc $\gamma|_{[0,L+r]}=[px]\cup[xy]$ is not minimizing. We are going to show that this non-minimality implies a lower bound on $r/r_1$, see \eqref{e:case1} below. Let $L_1=|py|$. Fix a minimizing geodesic $[py]$ and parametrize it by arc length as $\gamma_1\colon[0,L_1]\to M$. Let $\alpha$ and $\beta$ be the angles between $\gamma$ and $\gamma_1$ at $p$ and~$y$, that is, $\alpha=\angle(\dot\gamma(0),\dot\gamma_1(0))$ and $\beta=\angle(\dot\gamma(L+r),\dot\gamma_1(L_1))$. Since $[px]\cup[xy]$ is a non-minimizing geodesic, we have $L_1<L+r$ and $\alpha,\beta>0$. Also note that \begin{equation}\label{e:L1-vs-r1} L_1\ge L-r \ge 4r_1 \ge 4r \end{equation} by the triangle inequality, \eqref{e:L-vs-r1}, and the inequality $r\le r_1$. \begin{lemma}\label{l:beta-vs-alpha} Under the above assumptions, \beta\le C_1\alpha $ where $C_1$ is a positive number determined by~$R_0$. \end{lemma} The proof Lemma \ref{l:beta-vs-alpha} is given in Section~\ref{sec:sasaki}. Here we prove Proposition \ref{p:extension} assuming that Lemma \ref{l:beta-vs-alpha} holds true. By \eqref{e:L1-vs-r1} we have $L(\gamma_1)=L_1>2r$, hence there is a point $z=\gamma_1(L_1-2r)$ on $\gamma_1$ such that $|xz|=2r$ and $|pz|=L_1-2r$. Since $[pq]\cup[px]$ is a minimizing geodesic, the triangle inequality implies that $$ |pq|+L = |qx| \le |qz| + |xz| . $$ We add $|pz|$ to both sides of this inequality and rewrite it as \begin{equation}\label{e:pqzx} |pq|+|pz|-|qz| \le |xz|+|pz|-L = |xz|+L_1-2r-L < |xz|-r . \end{equation} Here the last inequality follows from the fact that $L_1<L+r$. Lemma \ref{l:shortcut} applied to $p,q,z$ yields the following estimate on the left-hand side of \eqref{e:pqzx}: \begin{equation}\label{e:pq+pz-qz} |pq|+|pz|-|qz| \ge c\alpha^2 \min\{|pq|,|pz|,\operatorname{lcr}(p)\} . \end{equation} Observe that $|pq|\ge r_1$ by the definition of $r_1$, $|pz|=L_1-2r\ge r_1$ by \eqref{e:L1-vs-r1}, and $\operatorname{lcr}(p)\ge 1\ge r_1$. Thus the minimum in \eqref{e:pq+pz-qz} is bounded below by $r_1$ and we obtain $$ |pq|+|pz|-|qz| \ge c\alpha^2r_1 . $$ This inequality and \eqref{e:pqzx} imply the estimate \begin{equation}\label{e:xz-lower} |xz| - r > c\alpha^2r_1 . \end{equation} Now we estimate $|xz|-r$ from above. Let $x_1$ be the midpoint of $[zy]$. Note that $|x_1z|=|x_1y|=r=|xy|$. The second part of Lemma \ref{l:lipexp} applied to $y,x,x_1$ implies that \begin{equation}\label{e:xx1-bound} |xx_1|\le 2\beta r \le 2C_1\alpha r . \end{equation} where the second inequality follows from Lemma \ref{l:beta-vs-alpha}. Applying the second part of Lemma \ref{l:short-median} to points $y,z,x_1,x$ and taking into account \eqref{e:xx1-bound} yields that $$ |xz|-r = |xz|+|xy|-|yz| \le \frac{2C |xx_1|^2}{\min\{ |x_1y|, |x_1z|, \operatorname{lcr}(x_1) \}} = 2C \frac{|xx_1|^2}{r}\le C_2\alpha^2 r $$ where $C_2=8CC_1^2$. This and \eqref{e:xz-lower} imply that \begin{equation}\label{e:case1} r > cC_2^{-1} r_1 . \end{equation} Recall that this holds for any $r\in(0,r_1]$ such that $\gamma|_{[0,L+r]}$ is not minimizing. Now define $\lambda_0= \frac1{10}\min \{1, cC_2^{-1} \}$ and apply the above argument to $$ r = 10\lambda_0 r_1 = \lambda_0\min\{|pq|,1\}. $$ If the geodesic arc $\gamma|_{[0,L+r]}=[px]\cup[xy]$ is not minimizing then \eqref{e:case1} holds and hence $10\lambda_0>cC_2^{-1}$, contrary to the definition of~$\lambda_0$. This contradiction shows that $[px]\cup[xy]$ is a minimizing extension of $[px]$ with $|xy|=\lambda_0\min\{|pq|,1\}$, so \eqref{e:extension1} is satisfied. This finishes the proof of Proposition \ref{e:extension}. \section{Proof of Lemma \ref{l:beta-vs-alpha}} \label{sec:sasaki} Here we prove Lemma \ref{l:beta-vs-alpha} left from the previous section. Recall that we are dealing with two unit-speed geodesics $\gamma\colon[0,L+r]\to M$ and $\gamma_1\colon[0,L_1]\to M$ between points $p=\gamma(0)=\gamma_1(0)$ and $y=\gamma(L+r)=\gamma_1(L_1)$. We have \begin{enumerate} \item $|L-L_1|\le r\le 1/10$, \item $|\operatorname{Sec}_M|\le 1$ in the ball $B_{R_0+3}(p)$ where $R_0$ is an upper bound for~$L$. \item $\operatorname{inj}_M(x)\ge 1$ where $x=\gamma(L)$. \end{enumerate} Our goal is to show that \begin{equation}\label{e:beta-goal} \beta\le C_1\alpha \end{equation} where $\alpha=\angle(\dot\gamma(0),\dot\gamma_1(0))$, $\beta=\angle(\dot\gamma(L+r),\dot\gamma_1(L_1))$ and $C_1$ is a positive number determined by~$R_0$. Throughout this section we denote by $C$ various absolute positive constants. The precise value of $C$ may change between the formulas (and even within one formula). By $C_1$, $C_2$, etc, we denote positive constants depending on $R_0$ whose values stay fixed (within this section). We denote by $R$ the curvature tensor of $M$. Since $R$ can be expressed in terms of sectional curvatures, we have an estimate \begin{equation}\label{e:curvtensor} |R(u,v)w| \le C\cdot |u\wedge v|\cdot |w| \end{equation} for any $u,v,w\in TM$ tangent to $M$ at a point where $|\operatorname{Sec}_M|\le 1$. Let $z=\gamma(L_1)$. By construction and assumptions (1)--(3), the points $y$ and $z$ belong to the ball $B_{1/5}(x)$, $\operatorname{inj}_M(x)\ge 1$ and $|\operatorname{Sec}_M|\le 1$ on $B_1(x)$. For a smooth path $\sigma$ connecting $z$ to $y$, let $P_\sigma\colon T_yM\to T_zM$ denote the Levi-Civita parallel transport along $\sigma$. Recall that $L(\sigma)$ denotes the length of a path $\sigma$. \begin{lemma}\label{l:Psigmav0} There exists a smooth path $\sigma$ connecting connecting $z$ to $y$ and such that \begin{equation}\label{e:Lsigma} L(\sigma)\le C_2\alpha \end{equation} and \begin{equation}\label{e:Psigmav0} |P_\sigma(\dot\gamma(L_1))-\dot\gamma_1(L_1)| \le C_2\alpha, \end{equation} where $C_2=Ce^{CL_1}$ and $C$ is an absolute constant. \end{lemma} \begin{proof} This lemma follows from the fact that, if $|\operatorname{Sec}_M|\le 1$, then the time $L_1$ map of the geodesic flow is Lipschitz with Lipschitz constant $Ce^{CL_1}$. To avoid discussion of the geodesic flow and the metric on~$SM$, we give a direct proof of the lemma. Connect the vectors $\dot\gamma(0)$ and $\dot\gamma_1(0)$ in $S_pM$ by a circle arc of length $\alpha$ and parametrize this arc as $s\mapsto u(s)$, $s\in[0,\alpha]$, where $u(0)=\dot\gamma(0)$, $u(\alpha)=\dot\gamma_1(0)$, and $|\frac d{ds} u(s)|=1$. Consider the family of geodesics $\gamma_s\colon[0,L_1]\to M$, $s\in[0,\alpha]$, defined by the initial data $\gamma_s(0)=p$ and $\dot\gamma_s(0)=u(s)$. Define $\sigma(s)=\gamma_s(L_1)$ and $V(s)=\dot\gamma_s(L_1)$ for all $s\in[0,\alpha]$. Note that the path $\sigma\colon[0,\alpha]\to M$ connects $z$ to~$y$, $V(0)=\dot\gamma(L_1)$, and $V(\alpha)=\dot\gamma_1(L_1)$. Let $J_s$ be the Jacobi field along $\gamma_s$ defined by $J_s(t)=\frac d{ds} \gamma_s(t)$. Then $$ \frac \nabla{ds} V(s) = \frac \nabla{ds} \frac d{dt}\Big|_{t=L_1} \gamma_s(t) = \frac \nabla{dt}\Big|_{t=L_1} \frac d{ds} \gamma_s(t) = J_s'(L_1) . $$ where $J_s'$ is a notation for $\frac\nabla{dt}J_s(t)$. The Jacobi field $J_s(t)$ satisfies the Jacobi equation $$ J_s''= R(J_s,\dot\gamma_s)\dot\gamma_s, $$ where $J_s''$ is a notation for $\frac\nabla{dt}\frac\nabla{dt}J_s$. Hence $ |J_s''| \le C\cdot |J_s| $ due to \eqref{e:curvtensor} and the curvature bound $|\operatorname{Sec}_M|\le 1$ that we have everywhere on~$\gamma_s$. This and the initial data $J_s(0)=0$ and $|J_s'(0)|=|\frac d{ds} u(s)|=1$ imply that $|J_s(L_1)|$ and $|J_s'(L_1)|$ are bounded by $C_2=Ce^{CL_1}$ where $C$ is an absolute constant. Thus \begin{equation}\label{e:Lsigma1} L(\sigma) = \int_0^\alpha | J_s(L_1) | \,ds \le C_2\alpha \end{equation} and \begin{equation}\label{e:nablaV1} \int_0^\alpha \left| \frac\nabla{ds} V(s) \right| \,ds = \int_0^\alpha \left| J'_s(L_1) \right| \,ds \le C_2\alpha . \end{equation} Note that \eqref{e:Lsigma1} implies \eqref{e:Lsigma}. It remains to prove \eqref{e:Psigmav0}. Let $W$ be the parallel vector field along $\sigma$ with initial data $W(0)=V(0)$. Then \begin{equation}\label{e:nablaV2} |W(\alpha)-V(\alpha)| \le \int_0^\alpha \left| \frac\nabla{ds} (W(s) - V(s)) \right| \,ds = \int_0^\alpha \left| \frac\nabla{ds} V(s) \right| \,ds \le C_2\alpha \end{equation} by \eqref{e:nablaV1}. Since $W(\alpha)=P_\sigma(V(0))=P_\sigma(\dot\gamma(L_1))$ and $V(\alpha)=\dot\gamma_1(L_1)$, the desired inequality \eqref{e:Psigmav0} follows from \eqref{e:nablaV2}. \end{proof} \begin{lemma}\label{l:Psigma} Let $\sigma_0,\sigma_1\colon[0,1]\to B_1(x)$ be smooth paths connecting $z$ to~$y$. Then, for every $v\in S_zM$, \begin{equation}\label{e:Psigma} | P_{\sigma_1}(v)- P_{\sigma_0}(v) | \le C (L(\sigma_1)+L(\sigma_2))^2 \end{equation} where $C$ is an absolute constant. \end{lemma} \begin{proof} Let $\ell=L(\sigma_1)+L(\sigma_2)$. Due to our curvature and injectivity radius bounds, the ball $B_1(x)$ is bi-Lipschitz equivalent, with an absolute bi-Lipschitz constant, to a unit ball in $\mathbb R^n$ (see e.g.\ \cite[Ch.~5, Theorem 27]{Pe}). Hence, by the Euclidean isoperimetric inequality, the paths $\sigma_0$ and $\sigma_1$ span a 2-disc of area no greater than~$C\ell^2$. More precisely, $\sigma_0$ and $\sigma_1$ can be connected by a smooth homotopy $\Sigma\colon[0,1]\times[0,1]\to M$, $\Sigma(0,\cdot)=\sigma_0$, $\Sigma(1,\cdot)=\sigma_1$, with fixed endpoints $\Sigma(\cdot,0)=z$ and $\Sigma(\cdot,1)=y$, and $\operatorname{area}(\Sigma)\le C\ell^2$. Here $\operatorname{area}(\Sigma)$ is the surface area parametrized by $\Sigma$. It can be expressed by the formula $$ \operatorname{area}(\Sigma) = \iint \left| \Sigma_s(s,t) \wedge \Sigma_t(s,t) \right| \,dsdt . $$ where $\Sigma_s= \frac{\partial\Sigma}{\partial s}(s,t)$ and $\Sigma_t= \frac{\partial\Sigma}{\partial t}(s,t)$. Fix $v\in S_zM$ and construct a smooth vector field $W=W(s,t)$ along $\Sigma$ as follows. For every $s\in[0,1]$, let $W(s,\cdot)$ be the parallel vector field along the path $\Sigma(s,\cdot)$ with initial data $W(s,0)=v$. Then $ \frac\nabla{dt} W(s,t)=0 $ and therefore \begin{equation}\label{e:nabla2} \left|\frac{\nabla}{dt} \frac{\nabla}{ds} W\right| = \left|\frac{\nabla}{dt} \frac{\nabla}{ds} W - \frac{\nabla}{ds} \frac{\nabla}{dt} W\right| = |R(\Sigma_t,\Sigma_s) W| \le C |\Sigma_t \wedge \Sigma_s | \end{equation} where we have omitted the arguments $(s,t)$. The last inequality follows from \eqref{e:curvtensor} and the fact that $|W(s,t)|=|v|=1$. Since $W(\cdot,0)$ is constant, $\frac{\nabla}{ds} W$ vanishes at $t=0$. Hence, by integration, \eqref{e:nabla2} implies that $$ \left|\frac{\nabla}{ds} W(s,1)\right| \le \int_0^1 \left| \frac{\nabla}{dt} \frac{\nabla}{ds} W \right| dt \le C \int_0^1 |\Sigma_t \wedge \Sigma_s | \, dt . $$ Recall that $W(s,1)$ belong to one tangent space $T_yM$ for all $s$. Now integration with respect to $s$ yields that $$ | W(1,1)-W(0,1) | \le C \iint \left| \Sigma_s \wedge \Sigma_t \right| \,dsdt = C \operatorname{area}(\Sigma) \le C\ell^2. $$ Since $W(1,1)=P_{\sigma_1}(v)$ and $W(0,1)=P_{\sigma_0}(v)$, the lemma follows. \end{proof} Now we are in a position to prove Lemma~\ref{l:beta-vs-alpha}. Let $\sigma$ be a path constructed in Lemma \ref{l:Psigmav0}. We may assume that $\alpha<1/(2C_2)$, otherwise \eqref{e:beta-goal} holds for any $C_1\ge 10C_2$ since $\beta\le\pi$. Then \eqref{e:Lsigma} implies that $L(\sigma)<1/2$, hence $\sigma$ is contained in the ball $B_1(x)$. We apply Lemma \ref{l:Psigma} to the paths $\sigma_0=[zy]$ and $\sigma_1=\sigma$, both reparametrized by $[0,1]$, and $v=\dot\gamma(L_1)$. Since $\sigma_0$ is a reparametrization of $\gamma|_{[L_1,L+r]}$, we have $P_{\sigma_0}(\dot\gamma(L_1))=\dot\gamma(L+r)$. Thus, by Lemma \ref{l:Psigma}, $$ |\dot\gamma(L+r) - P_\sigma(\dot\gamma(L_1))| \le C(L(\sigma)+|zy|)^2 \le 4C L(\sigma)^2 \le 2C L(\sigma) $$ since $|zy|\le L(\sigma)\le 1/2$. This and \eqref{e:Lsigma} imply that $$ |\dot\gamma(L+r) - P_\sigma(\dot\gamma(L_1))| \le C_3\alpha $$ for a suitable constant $C_3=C_3(R_0)>0$. This and \eqref{e:Psigmav0} imply that \begin{equation}\label{e:sasaki1} |\dot\gamma(L+r) - \dot\gamma_1(L_1)| \le (C_2+C_3)\alpha . \end{equation} On the other hand, $|\dot\gamma(L+r) - \dot\gamma_1(L_1)| = 2\sin\frac\beta2 \ge 2\beta/\pi$. This and \eqref{e:sasaki1} imply the estimate \eqref{e:beta-goal} with $C_1=\frac\pi2(C_2+C_3)$. This finishes the proof of Lemma~\ref{l:beta-vs-alpha}. \section{Invertibility of $\mathcal D_F$} \label{sec:inverse} In this section we prove Theorem \ref{t:inverse} and Corollary \ref{cor:bilip}. The proof consists of two steps. First, in Proposition \ref{p:holder} we show that $\mathcal D_F$ is a homeomorphism onto its image and obtain a preliminary H\"older estimate on $\mathcal D_F^{-1}$. Second, in Proposition \ref{p:bilip} we show that $\mathcal D_F$ is locally bi-Lipschitz. The two propositions are combined in subsection \ref{subsec:proof-inverse} into a proof of Theorem \ref{t:inverse} and Corollary \ref{cor:bilip}. Let $M$ and $F$ be as in Theorem \ref{t:inverse}. By rescaling we may assume that $F$ contains a ball of radius~1. The center of this ball is denoted by $q_0$. We also assume that this ball $B_1(q_0)$ is not the whole $M$. In particular this implies that $\operatorname{diam}(M)\ge 1$. \subsection{Preliminary H\"older estimate} First we show that $\mathcal D_F$ is a homeomorphism onto its image $\mathcal D_F(M)\subset\mathcal C(F\times F)$. Since $\mathcal D_F$ is a 2-Lipschitz map, we only need to prove that $\mathcal D_F$ is injective and its inverse map is continuous. This follows from the next proposition, which also shows that $\mathcal D_F^{-1}$ is locally H\"older continuous with exponent~$1/2$. \begin{proposition}\label{p:holder} For every $n\ge 2$ and $K,R,\nu>0$ there exist $C_0>0$ and $\delta_0>0$ such that the following holds. Let $M^n$ be a complete Riemannian manifold, $F\subset M$, and assume that $F$ contains a unit ball $B_1(q_0)\subsetneq M$ with $\operatorname{vol}(B_1(q_0))\ge \nu$ and that $\operatorname{Sec}_M\ge -K$ everywhere in $B_{3R+3}(q_0)$. Then for every $x\in B_R(q_0)$ and $y\in M$ such that $$ \|\mathcal D_F(x)-\mathcal D_F(y)\|<\delta_0, $$ one has \begin{equation}\label{e:holder} |xy| \le C_0 \|\mathcal D_F(x)-\mathcal D_F(y)\|^{1/2} . \end{equation} \end{proposition} \begin{remark} Proposition \ref{p:holder} requires only a lower curvature bound and its proof can be modified to work for any finite-dimensional Alexandrov space of curvature bounded below. The bound $\operatorname{vol}(B_1(q_0))\ge\nu$ is a non-collapsing assumption. If $M$ has two-sided curvature bounds, then $\operatorname{vol}(B_1(q_0))$ is bounded away from 0 in terms of the curvature bounds and the injectivity radius $\operatorname{inj}_M(q_0)$, see \cite[Ch.~6, Theorem 27]{Pe}. \end{remark} \begin{proof}[Proof of Proposition \ref{p:holder}] Let $M,F,q_0$ be as in the proposition, $x\in B_R(q_0)$ and $y\in M\setminus\{x\}$. Let $\delta=\|\mathcal D_F(x)-\mathcal D_F(y)\|$ and assume that $\delta<\delta_0$ where $\delta_0$ is sufficiently small, depending on the parameters $n,K,R,\nu$. The required bounds on $\delta_0$ are accumulated in the course of the proof. We denote by $C_1$, $c_1$, etc, various positive constants determined by $n,K,R,\nu$. We may assume that $|q_0x|\le|q_0y|$, otherwise swap $x$ and~$y$. Let $a=|q_0y|-|q_0x|$. For every $p\in F$ we have $$ \bigl| |py|-|px|-a \bigr| = | D_y(p,q_0)-D_x(p,q_0) | \le \|\mathcal D_F(y)-\mathcal D_F(x)\| \le \delta . $$ Therefore \begin{equation}\label{e:py-px} |py| \ge |px| + a - \delta \ge |px| - \delta \end{equation} for all $p\in F$. \begin{lemma}\label{l:alpha0} There exists $\alpha_0=\alpha_0(n,K,R,\nu)$ such that the following holds. For any $M,q_0,x,y$ as above, there is a point $q\in B_{1/2}(q_0)$ such that $|qx|\ge1/10$ and \angle qxy\le \pi-\alpha_0 $ (for some choice of minimizing geodesics $[xy]$ and $[xq]$ defining this angle). \end{lemma} \begin{proof} Since $\operatorname{diam}(M)\ge 1$, there is a point $q_1\in M$ such that $|q_0q_1|\le 2/5$ and $|xq_1|\ge 1/5$. Indeed, if $|q_0x|\ge1/5$ then one can take $q_1=q_0$, otherwise let $q_1$ be any point such that $|q_0q_1|=2/5$. We are going to choose $q$ from the ball $B:=B_{1/10}(q_1)$. This guarantees that $q\in B_{1/2}(q_0)$ and $|qx|\ge 1/10$. By the Bishop-Gromov inequality (see \cite[Ch.~9, Lemma 36]{Pe}), we have a lower bound on the volume ratio $$ \frac{\operatorname{vol}(B)}{\operatorname{vol}(B_{2}(q_1))} \ge c_1 = c_1(n,K) > 0. $$ Therefore \begin{equation}\label{e:volB} \operatorname{vol}(B) \ge c_1 \operatorname{vol}(B_{2}(q_1)) \ge c_1 \operatorname{vol}(B_{1}(q_0)) \ge c_1\nu . \end{equation} This and Lemma \ref{l:dirvol} imply a lower bound \begin{equation}\label{e:c_2} \mathcal H^{n-1}(\operatorname{dir}(x,B)) \ge c_2 = c_2(n,K,R,\nu) > 0 . \end{equation} Here we use the assumptions that $x\in B_R(q_0)$ and $\operatorname{Sec}_M\ge -K$ on $B_{3R+3}(q_0)$. They imply that $B\subset B_{R+1}(x)$ and $\operatorname{Sec}_M\ge -K$ on $B_{2R+2}(x)$. Hence Lemma \ref{l:dirvol}, \eqref{e:volB}, and the fact that $\operatorname{diam}(B)<1$ imply \eqref{e:c_2} for $c_2=\lambda_{K,R+1}^{n-1}c_1\nu$ where $\lambda_{K,R+1}$ is the constant from Lemma \ref{l:dirvol}. Fix a minimizing geodesic $[xy]$ and let $v\in S_xM$ be its direction at~$x$. For $\alpha>0$ let $\Sigma_\alpha$ denote the set of all $u\in S_xM$ such that $\angle(u,v)>\pi-\alpha$. In other words, $\Sigma_\alpha$ is the $\alpha$-neighborhood of $-v$ in the unit sphere $S_xM$. The volume $\mathcal H^{n-1}(\Sigma_\alpha)$ of this neighborhood goes to 0 as $\alpha\to 0$. Hence for a sufficiently small $\alpha_0=\alpha_0(n,c_2)>0$ we have $\mathcal H^{n-1}(\Sigma_{\alpha_0})< c_2$. This and \eqref{e:c_2} imply that that there exists $u\in\operatorname{dir}(x,B)$ such that $u\notin\Sigma_{\alpha_0}$ and hence $\angle(u,v)\le\pi-\alpha_0$. By the definition of $\operatorname{dir}(x,B)$, the vector $u$ is the initial direction of a minimizing geodesic $[xq]$ for some $q\in B$, hence the result. \end{proof} Fix $q\in B_{1/2}(q_0)$ and minimizing geodesics $[xq]$ and $[xy]$ constructed in Lemma~\ref{l:alpha0}. We define $$ r_1=\min\{1/30,K^{-1/2}\} $$ and require that $\delta_0\le r_1$. The curvature bound assumed in Proposition \ref{p:holder} implies a bound on the lower curvature radius (see Definition \ref{d:lcr}): \begin{equation}\label{e:lcr-bound} \operatorname{lcr}(z)\ge r_1 \quad\text{for all $z\in B_{R+2}(q_0)$} \end{equation} Recall that $|qx|\ge 1/10 \ge 3r_1$. Hence there exists $p\in [qx]$ such that $|pq|=r_1$. Note that \begin{equation}\label{e:px-bounds} 2r_1 \le |px| \le R+1 \end{equation} and \begin{equation}\label{e:py-ge-r1} |py| \ge |px|-\delta \ge r_1 \end{equation} due to \eqref{e:py-px}, \eqref{e:px-bounds} and the requirement that $\delta<\delta_0\le r_1$. Define $$ \beta = \angle xpy = \pi-\angle qpy . $$ \begin{lemma}\label{l:beta} $\beta\le C_2\delta^{1/2}$ for some $C_2>0$ determined by $n,K,R,\nu$. \end{lemma} \begin{proof} Both $p$ and $q$ belong to the ball $B_1(q_0)$ and hence to~$F$. Therefore $$ D_x(q,p)-D_y(q,p) \le \|\mathcal D_F(x)-\mathcal D_F(x)\| = \delta . $$ Substituting $D_x(q,p) = |qx|-|px| = |pq|$ and $D_y(q,p)=|qy|-|py|$ yields that \begin{equation}\label{e:pqy-shortcut} |pq|+|py|-|qy| \le \delta . \end{equation} On the other hand, by Lemma \ref{l:shortcut}, \begin{equation}\label{e:pqy-shortcut2} |pq|+|py|-|qy| \ge c\beta^2\min\{|pq|,|py|,\operatorname{lcr}(p)\} = c\beta^2 r_1 , \end{equation} where $c>0$ is an absolute constant. The last identity in \eqref{e:pqy-shortcut2} follows from \eqref{e:lcr-bound}, \eqref{e:py-ge-r1}, and the construction of~$p$. Now \eqref{e:pqy-shortcut} and \eqref{e:pqy-shortcut2} imply that $\beta \le C_2\delta^{1/2}$ where $C_2=(cr_1)^{-1/2}$. \end{proof} By \eqref{e:py-ge-r1}, there is a point $x_1\in [py]$ such that \begin{equation}\label{e:px1-ge-r1} |px_1| = |px|-\delta \ge r_1 . \end{equation} By \eqref{e:px-bounds}, we have $|px_1|\le |px| \le R+1$. The curvature bounds assumed in Proposition \ref{p:holder} imply that $\operatorname{Sec}_M\ge-K$ everywhere in the ball $B_{2R+2}(p)$. Hence, by Lemma \ref{l:lipexp} applied to $p,x,x_1$, \begin{equation}\label{e:xx_1} |xx_1| \le C_3\beta + \delta \le C_4 \delta^{1/2} \end{equation} where $C_3$ is the constant $C_{K,R+1}$ from Lemma \ref{l:lipexp} and $C_4=C_3C_2+r_1^{1/2}$. The last inequality in \eqref{e:xx_1} follows from Lemma \ref{l:beta} and the assumption that $\delta<\delta_0\le r_1$. We may assume that \begin{equation}\label{e:xy-lower} |xy|>2C_4\delta^{1/2} , \end{equation} otherwise \eqref{e:holder} holds for any $C_0\ge 2C_4$. By \eqref{e:xx_1} and \eqref{e:xy-lower}, $$ |x_1y|\ge |xy|-|xx_1| > \frac12 |xy| . $$ This inequality, \eqref{e:lcr-bound} and \eqref{e:px1-ge-r1} imply that $$ \min\{|px_1|,|x_1y|,\operatorname{lcr}(x_1)\} \ge \frac12 \min\{ |xy|,r_1 \} . $$ Now we apply the second part of Lemma \ref{l:short-median} to points $p$, $y$, $x_1$, $x$ and obtain that \begin{equation}\label{e:pxy-excess-above} |px| + |xy| - |py| \le \frac{4C |xx_1|^2}{\min\{ |xy|, r_1 \}} \le \frac{C_5 \delta}{\min\{ |xy|, r_1 \}} \end{equation} where the second inequality follows from \eqref{e:xx_1}. Here $C$ is the absolute constant from Lemma \ref{l:short-median} and $C_5=4CC_4^2$. On the other hand, recall that $\angle pxy=\angle qxy\le\pi-\alpha_0$ by Lemma \ref{l:alpha0}. This and Lemma \ref{l:shortcut} imply that $ |px| + |xy| - |py| \ge c\alpha_0^2 \min\{ |px|, |xy|, \operatorname{lcr}(x) \} \ge c\alpha_0^2 \min\{ |xy|, r_1 \} $$ where the second inequality follows from \eqref{e:lcr-bound} and \eqref{e:px-bounds}. This and \eqref{e:pxy-excess-above} imply \begin{equation}\label{e:holder-almost-final} \min\{ |xy|, r_1 \}^2 \le C_6 \delta \end{equation} where $C_6=c^{-1} C_5 \alpha_0^{-2}$. We require that $\delta_0< C_6^{-1}r_1^2$, then $r_1^2 \ge C_6\delta_0 > C_6\delta$. This and \eqref{e:holder-almost-final} imply that $|xy|\le C_6^{1/2}$, thus \eqref{e:holder} holds for any $C_0\ge C_6^{1/2}$. Collecting all estimates obtained above, we conclude that \eqref{e:holder} holds for $$ C_0 := \max\{ 2C_4, C_6^{1/2} \} $$ provided that $$ \delta < \delta_0 := \min \{ r_1, C_6^{-1}r_1^2 \} . $$ Since all constants in the argument are determined by $n,K,R,\nu$, this proves Proposition~\ref{p:holder}. \end{proof} \subsection{Local bi-Lipschitz continuity} Proposition~\ref{p:holder} implies that $\mathcal D_F$ is a homeomorphism onto its image. Thus, in order to prove Theorem \ref{t:inverse} it suffices to verify that $\mathcal D_F$ is locally bi-Lipschitz. This is established in the following proposition. \begin{proposition}\label{p:bilip} For every $n\ge 2$ and $K,R,i_0>0$ there exist $c_0>0$ and $r_0>0$ such that the following holds. Let $M^n$ be a complete Riemannian manifold, $F\subset M$, and assume that $F$ contains a unit ball $B_1(q_0)\subsetneq M$, and that $|\operatorname{Sec}_M|\le K$ and $\operatorname{inj}_M\ge i_0$ everywhere in the ball $B_{3R+3}(q_0)$. Then for all $x,y\in B_R(q_0)$ such that $|xy|<r_0$, one has \begin{equation}\label{e:bilip} \|\mathcal D_F(x)-\mathcal D_F(y)\| \ge c_0 |xy| . \end{equation} \end{proposition} \begin{proof} Let $M,F,q_0$ be as in the proposition. Fix $x,y\in B_R(q_0)$. We begin with a lemma similar to Lemma \ref{l:alpha0}. \begin{lemma}\label{l:theta0} There exists $\theta_0=\theta_0(n,K,R,i_0)>0$ such that the following holds. For any $M,q_0,x,y$ as above, there exist $q_1,q_2\in B_{1/2}(q_0)$ such that $|q_1x|\ge1/10$, $|q_2x|\ge1/10$, and \begin{equation}\label{e:theta0} |\cos\angle q_1xy- \cos\angle q_2xy| \ge \theta_0 \end{equation} for some choice of minimizing geodesics $[xy]$, $[xq_1]$ and $[xq_2]$ defining the above angles. \end{lemma} \begin{proof} As in the proof of Lemma \ref{l:alpha0}, fix $q_1\in M$ such that $|q_0q_1|\le 2/5$ and $|xq_1|\ge 1/5$, and let $B=B_{1/10}(q_1)$. The bounds on curvature and injectivity radius imply a lower bound on the volume of $B$: $$ \operatorname{vol}(B) \ge c_1=c_1(n,K,i_0) > 0 . $$ Similarly to \eqref{e:c_2}, this and Lemma \ref{l:dirvol} imply a lower bound $$ \mathcal H^{n-1}(\operatorname{dir}(x,B)) \ge c_2 = c_2(n,K,R,i_0) > 0 . $$ Fix minimizing geodesics $[xy]$ and $[xq_1]$, let $v$ and $u_1$ be their directions at~$x$ and $\alpha=\angle(v,u_1)$. For $\theta>0$, consider the set $$ \Sigma_\theta = \{ u\in S_xM : |\cos\angle(u,v)-\cos\alpha|<\theta \} $$ in the unit sphere $S_xM$. Observe that $\mathcal H^{n-1}(\Sigma_\theta)\to 0$ as $\theta\to 0$ uniformly in $\alpha$. Hence there exists $\theta_0=\theta_0(n,c_2)$ such that $\operatorname{dir}(x,B)$ contains a vector $u_2\notin\Sigma_{\theta_0}$. This vector is the initial direction of a minimizing geodesic $[xq_2]$ where $q_2\in B$. By the definition of $\Sigma_{\theta_0}$, \eqref{e:theta0} holds for $q_1$, $q_2$ and the minimizing geodesics $[xy]$, $[xq_1]$, $[xq_2]$ fixed above. \end{proof} Fix $q_1,q_2$ and minimizing geodesics $[xy]$, $[xq_1]$ and $[xq_2]$ constricted in Lemma~\ref{l:theta0}. For each $i=1,2$, let $p_i$ be the point on $[xq_i]$ such that $|q_ip_i|=1/20$. Note that $|p_ix|=|q_ix|-|q_ip_i|\ge 1/20$. We apply Corollary \ref{cor:1stvar} to $q_i,p_i,x,y$ and obtain $$ \bigl| |p_ix|-|p_iy| - |xy| \cos\alpha_i \bigr| \le C_7 |xy|^2 , \qquad i=1,2, $$ where $\alpha_i=\angle p_ixy=\angle q_ixy$ and $C_7$ is a constant determined by $K,R,i_0$. Hence \begin{multline*} |D_x(p_1,p_2)-D_y(p_1,p_2)| = \bigl| (|p_1x|-|p_1y|) - (|p_2x|-|p_2y|) \bigr| \\ \ge |xy|\cdot|\cos\alpha_1-\cos\alpha_2| - 2C_7 |xy|^2 \ge \theta_0|xy| - 2C_7 |xy|^2 \end{multline*} where the last inequality follows from Lemma \ref{l:theta0}. Since both $p_1$ and $p_2$ belong to to $B_1(q_0)$ and hence to $F$, this implies \begin{equation}\label{e:bilip1} \|\mathcal D_F(x)-\mathcal D_F(y)\| \ge \theta_0|xy| - 2C_7 |xy|^2 . \end{equation} If $|xy|<r_0:=\theta_0/4C_7$, then the right-hand side of \eqref{e:bilip1} is bounded below by $\theta_0|xy|/2$ and hence \eqref{e:bilip} holds for $c_0=\theta_0/2$. This finishes the proof of Proposition~\ref{p:bilip}. \end{proof} \subsection{Proof of Theorem \ref{t:inverse} and Corollary \ref{cor:bilip}} \label{subsec:proof-inverse} Now we deduce Theorem \ref{t:inverse} and Corollary \ref{cor:bilip} from Propositions \ref{p:holder} and \ref{p:bilip}. As explained in the beginning of this section, we rescale $M$ so that, upon the rescaling, $F$ contains a unit ball $B_1(q_0)$ and $B_1(q_0)\ne M$. Note that in the case of Corollary \ref{cor:bilip} one can use the rescaling factor equal to $\min\{\rho_0,i_0,1\}^{-1}$. Fix $x_0\in M$ and choose geometric bounds $K,R,i_0,\nu$ such that Propositions \ref{p:holder} and \ref{p:bilip} apply to any $x\in B_1(x_0)$. Namely pick any $R\ge |q_0x_0|+1$, let $K$ be the supremum of $|\operatorname{Sec}_M|$ over the ball $B_{3R+3}(q_0)$, let $i_0$ be the infimum of $\operatorname{inj}_M$ over the same ball, and let $\nu$ be the volume of the ball of radius $\min\{i_0,1\}$ in the $n$-sphere equipped with a metric of constant curvature~$K$. Proposition \ref{p:bilip} provides positive numbers $r_0$ and $c_0$ such that \eqref{e:bilip} holds for all pairs $x,y\in B_1(x_0)$ such that $|xy|<r_0$. We may assume that $r_0\le 1$. Proposition \ref{p:holder} implies that there exists $\delta_1>0$ such that $|xy|<r_0$ for all $x\in B_1(x_0)$ and $y\in M$ such that $ \|\mathcal D_F(x)-\mathcal D_F(y)\| < 2\delta_1 $. In particular, if $\|\mathcal D_F(x)-\mathcal D_F(x_0)\| < \delta_1$ and $\|\mathcal D_F(y)-\mathcal D_F(x_0)\| < \delta_1$, then both $x$ and $y$ belong to the ball $B_{r_0}(x_0)\subset B_1(x_0)\subset B_R(q_0)$ and $|xy|<r_0$. This and \eqref{e:bilip} imply that $\mathcal D_F^{-1}$ is $c_0^{-1}$-Lipschitz within the ball of radius $\delta_1$ centered at $\mathcal D_F(x_0)$. This finishes the proof of Theorem \ref{t:inverse}. To prove Corollary \ref{cor:bilip}, observe that in the case of compact $M$ the parameters above can be chosen independently of $x_0$ and uniformly for all $M\in\mathcal M(n,D,K,i_0)$. The above argument shows that, if $F$ contains a unit ball $B_1(q_0)\ne M$, then $\mathcal D_F^{-1}$ has a global Lipschitz constant $\max\{c_0^{-1},\delta_1^{-1}\operatorname{diam}(M)\}$, which is determined by $n,D,K,i_0$. The initial rescaling adds the dependence on $\rho_0$. \section{Determination of the metric} \label{sec:reconstruction} In this section we prove Theorem \ref{t:reconstruction}. Let $M_i$, $F$, $U_i$, $\mathcal D_F^i$, $i=1,2$, be as in Theorem \ref{t:reconstruction}. We denote the distances in $M_1$ and $M_2$ by $d_1$ and $d_2$. By Theorem \ref{t:inverse}, $\mathcal D_F^i|_{U_i}$ is a locally bi-Lipschitz homeomorphism between $U_i$ and its image $\mathcal D_F^i(U_i)$. Hence the map $\phi\colon U_1\to U_2$ given by \eqref{e:def-phi} is well-defined and it is a locally bi-Lipschitz homeomorphism between $U_1$ and~$U_2$. Our goal is to prove that $\phi$ is a Riemannian isometry. By the definition of $\phi$ we have \begin{equation}\label{e:phi} \mathcal D_F^1(x) = \mathcal D_F^2(\phi(x)) \end{equation} for all $x\in U_1$. First we show that the distance difference data determines the metric of the observation domain $F$. \begin{lemma}\label{l:g-on-F} $g_1|_F=g_2|_F$. \end{lemma} \begin{proof} Fix a point $q_0\in F$. For $i\in\{1,2\}$ and $x\in U_i$ define a function $f_x^i\colon F\to\mathbb R$ by $$ f_x^i(y) = \mathcal D^i_F(x)(y,q_0) = d_i(x,y) - d_i(x,q_0) , \qquad y\in F. $$ By \eqref{e:phi} we have $f^1_x=f^2_{\phi(x)}$ for all $x\in U_1$. Hence the two sets $\{f^1_x\}_{x\in U_1}$ and $\{f^2_x\}_{x\in U_2}$ coincide. If the function $f_x^i$ is differentiable at $y\in F$, then $x$ is connected to $y$ by a unique minimizing geodesics of $M_i$, and the velocity of this geodesic at $y$ is the Riemannian gradient of $f^i_x$ at~$y$ with respect to~$g_i$. In particular the derivative $d_yf^i_x$ is a co-vector of unit norm with respect to $g_i$. Thus \begin{equation}\label{e:unit-covector} \|d_yf^1_x\|_{g_1}= 1=\|d_yf^2_{\phi(x)}\|_{g_2} = \|d_yf^1_x\|_{g_2} \end{equation} whenever the function $f^1_x=f^2_{\phi(x)}$ is differentiable at~$y$. For every $y\in F$ and every vector $v\in\operatorname{dir}_{M_1}(y,F)$ (see Notation \ref{n:dir}) there exists $x\in U_1$ such that $f^1_x$ is differentiable at~$y$ and the $g_1$-gradient of $f^1_x$ at $y$ equals $-v$. To construct such $x$, pick $x_0\in U_i$ such that $v$ is the direction of a minimizing geodesic $[yx_0]$ at $y$, and let $x$ be any point from $([yx_0]\cap U_i)\setminus\{x_0\}$. By Lemma \ref{l:dirvol} it follows that the set of co-vectors $$ \{ d_yf^1_x : x\in U_1 \text{ and $f^1_x$ is differentiable at $y$} \} \subset T_y^*M_1 $$ has a positive $(n-1)$-dimensional Hausdorff measure. By \eqref{e:unit-covector}, all these co-vectors have unit norms with respect to both $g_1$ and $g_2$. Thus the Euclidean norms defined by $g_1$ and $g_2$ on the co-tangent space at $y$ agree on a set of positive measure. Hence these norms coincide and so do the metric tensors $g_1$ and $g_2$ at~$y$. Since $y\in F$ is arbitrary, the lemma follows. \end{proof} For any subset $F'\subset F$, the distance difference data $\mathcal D^i_F(U_i)$ determines $\mathcal D^i_{F'}(U_i)$, hence it suffices to prove the theorem for $F'$ in place of~$F$. More precisely, let $F'\subset F$ be a set with a nonempty interior. Then the distance difference representations $\mathcal D_{F'}^i\colon M_i\to\mathcal C(F'\times F')$ are injective by Theorem \ref{t:inverse}, $\mathcal D_{F'}^1(U_1)=\mathcal D_{F'}^2(U_2)$ since $\mathcal D_{F}^1(U_1)=\mathcal D_{F}^2(U_2)$, and $\mathcal D_{F'}^1(x) = \mathcal D_{F'}^2(\phi(x))$ for all $x\in U_1$ due to \eqref{e:phi}. These properties imply that \begin{equation}\label{e:phiprime} \phi = (\mathcal D^2_{F'})^{-1}\circ\mathcal D^1_{F'}|_{U_1} \end{equation} (compare with \eqref{e:def-phi}), therefore Theorem \ref{t:reconstruction} follows from a similar statement with $F'$ in place of~$F$. In particular, we may replace $F$ by a small geodesic ball of the metric $g_1$. By Lemma \ref{l:g-on-F}, this ball is a ball of $g_2$ as well. Since small geodesic balls are convex, this and Lemma \ref{l:g-on-F} imply that \begin{equation} \label{e:diF} d_1|_{F\times F}=d_2|_{F\times F} . \end{equation} In the sequel we assume that $F$ is a convex geodesic ball in both $M_1$ and $M_2$ and hence \eqref{e:diF} holds. Our next step is to handle the intersection $F\cap U_i$. \begin{lemma}\label{l:UF} $U_1\cap F=U_2\cap F$ and $\phi|_{U_1\cap F}$ is the identity map. \end{lemma} \begin{proof} Fix $q\in F$ and let $x\in U_1\cap F$. Consider a function $f\colon F\to\mathbb R$ defined by $$ f(y) = \mathcal D_F^1(x)(y,q) = d_1(x,y)-d_1(x,q) $$ and observe that it attains its minimum at~$x$. Let $\tilde x=\phi(x)$. By \eqref{e:phi} we have \begin{equation}\label{e:UF1} f(y) = \mathcal D_F^2(\phi(x))(y,q) = d_2(\tilde x,y)-d_2(\tilde x,q) \end{equation} for all $y\in F$. Suppose that $\tilde x\ne x$. Consider a minimizing geodesic $\gamma$ of $M_2$ connecting $x$ and $\tilde x$ and pick a point $y\in\gamma\cap F\setminus\{x\}$. For this point $y$ we have $d_2(\tilde x,y)<d_2(\tilde x,x)$ and hence, by \eqref{e:UF1}, $f(y)<f(x)$. This contradicts the fact that $f(x)$ is the minimum of~$f$, therefore $\tilde x=x$. Thus $\phi|_{U_1\cap F}$ is the identity, in particular $U_1\cap F\subset U_2$. Switching the roles of $M_1$ and $M_2$ shows that $U_1\cap F=U_2\cap F$. \end{proof} Lemma \ref{l:UF} allows us to assume that $F\cap U_i=\emptyset$ for each $i\in\{1,2\}$. Indeed, by Lemma \ref{l:UF} and Lemma \ref{l:g-on-F} the restriction $\phi|_{U_1\cap F}$ is a Riemannian isometry, hence it suffices to prove that the restriction of $\phi$ to any open set containing $U_1\setminus F$ is an isometry as well. Recall that $F$ is a geodesic ball (with respect to both $g_1$ and~$g_2$), i.e.\ $F=B_{3\rho}(q_0)$ for some $q_0\in F$ and $\rho>0$. Thus we may replace each $U_i$ by $U_i'=U_i\setminus \overline B_{2\rho}(q_0)$ and prove the theorem for $U_i'$ in place of $U_i$, $i=1,2$. Then replacing $F$ by $F'=B_{\rho}(q_0)$ does not change the map $\phi$, see \eqref{e:phiprime}, hence it suffices to prove the theorem for $F'$ and $U_i'$ in place of $F$ and~$U_i$. We reuse the notation $F$ and $U_i$ for $F'$ and $U_i'$ and thus assume that $F\cap U_i=\emptyset$. The next lemma tells that $\phi$ maps certain unparametrized geodesics of $U_1$ to unparametrized geodesics of $U_2$. This is similar to \cite[Lemma 2.9]{LS}. We give a different proof since the argument in \cite{LS} uses more regularity assumptions than those guaranteed by curvature bounds. \begin{lemma}\label{l:dirphi} Let $x\in U_1$ and let $\gamma$ be a minimizing geodesic of $M_1$ connecting $x$ to $q\in F$. Then there exists a minimizing geodesic $\tilde\gamma$ of $M_2$ connecting $\phi(x)$ to~$q$ and such that $\phi(\gamma\cap U_1)=\tilde\gamma\cap U_2$ and $\gamma\cap F=\tilde\gamma\cap F$. \end{lemma} \begin{proof} Let $\tilde x=\phi(x)$. Since $g_1|_F=g_2|_F$ and $F$ is convex in both $M_1$ and $M_2$, $\gamma\cap F$ is a minimizing geodesic arc in $M_2$ as well as in $M_1$. First we show that a suitable extension of this arc in $M_2$ is a minimizing geodesic connecting $\tilde x$ to~$q$. Fix $p\in\gamma\cap F\setminus\{q\}$. Since $\gamma$ is a minimizing geodesic of $M_1$, we have $$ \mathcal D^1_F(x)(q,p) = d_1(x,q)-d_1(x,p) = d_1(q,p) . $$ This, \eqref{e:phi}, and \eqref{e:diF} imply that $\mathcal D^2_F(\tilde x)(q,p) = d_2(q,p)$, or, equivalently $$ d_2(q,\tilde x)=d_2(q,p)+d_2(p,\tilde x) . $$ This implies that there is a minimizing geodesic of $M_2$ connecting $\tilde x$ to $q$ and containing~$p$. Denote this geodesic by $\tilde\gamma$. By the convexity of $F$ we have $\tilde\gamma\cap F=\gamma\cap F$. It remains to prove that $\phi(\gamma\cap U_1)=\tilde\gamma\cap U_2$. Let $y\in\gamma\cap U_1$ and $\tilde y=\phi(y)$. The same argument applied to $y$ in place of $x$ shows that $\tilde y$ belongs to either $\tilde\gamma$ or to a minimizing extension of $\tilde\gamma$ beyond $\tilde x$. Let us show that $\tilde y$ belongs to $\tilde\gamma$ rather than an extension. Since $\dim M_1\ge 2$, there is a point $z\in F$ satisfying a strict triangle inequality $$ d_1(x,z)< d_1(x,y)+d_1(y,z) . $$ Subtracting the identity $d_1(x,p)=d_1(x,y)+d_1(y,p)$ yields that $$ \mathcal D_F^1(x)(z,p) < \mathcal D_F^1(y)(z,p) $$ and hence, by \eqref{e:phi}, \begin{equation}\label{e:dirphi1} \mathcal D_F^2(\tilde x)(z,p) < \mathcal D_F^2(\tilde y)(z,p) \end{equation} On the other hand, if $\tilde y$ belongs to an extension of $\tilde\gamma$ beyond $\tilde x$, then $$ d_2(\tilde y,p)=d_2(\tilde y,\tilde x)+d_2(\tilde x,p) . $$ Subtracting this from the triangle inequality $d_2(\tilde y,z)\le d_2(\tilde y,\tilde x)+d_2(\tilde x,z)$ yields that $ \mathcal D^2_F(\tilde y)(z,p)\le \mathcal D^2_F(\tilde x)(z,p) $, contrary to \eqref{e:dirphi1}. Therefore $\tilde y$ belongs to $\tilde\gamma$. This proves that $\phi(\gamma\cap U_1)\subset\tilde\gamma$. Switching the roles of $M_1$ and $M_2$ yields that $\phi^{-1}(\tilde\gamma\cap U_2)\subset\gamma$. Hence $\phi(\gamma\cap U_1)=\tilde\gamma\cap U_2$ and the lemma follows. \end{proof} Now we begin the main part of the proof of Theorem \ref{t:reconstruction}. Fix $x\in U_1$ and pick two distinct minimizing $M_1$-geodesics $\gamma_1,\gamma_2$ from $x$ to points $q_1,q_2\in F$, respectively. Let $\alpha\in(0,\pi]$ be the angle between $\gamma_1$ and $\gamma_2$ at~$x$. For each $i\in\{1,2\}$, fix a point $p_i\in\gamma_i\cap F\setminus\{q_i\}$. Let $y$ be a point on $\gamma_2$ close to~$x$. By Corollary \ref{cor:1stvar} applied to $q_1,p_1,x,y$ we have $$ d_1(y,p_1)=d_1(x,p_1) - d_1(x,y)\cos\alpha + O(d_1(x,y)^2), \qquad y\in\gamma_2,\ y\to x. $$ Subtracting the identity $d_1(y,p_2)=d_1(x,p_2) - d_1(x,y)$ we obtain $$ \mathcal D_F^1(y)(p_1,p_2) = \mathcal D_F^1(x)(p_1,p_2) +(1-\cos\alpha) d_1(x,y) + O(d_1(x,y)^2), \quad y\in\gamma_2,\ y\to x. $$ Hence there exists a limit \begin{equation}\label{e:1-cos} \lim_{y\in\gamma_2,y\to x} \frac{\mathcal D_F^1(y)(p_1,p_2)-\mathcal D_F^1(x)(p_1,p_2)}{d_1(x,y)} = 1 -\cos\alpha . \end{equation} Let $\tilde x=\phi(x)$. Let $\tilde\gamma_1$ and $\tilde\gamma_2$ be minimizing $M_2$ geodesics corresponding to $\gamma_1$ and $\gamma_2$ as in Lemma \ref{l:dirphi}. In particular we have $q_i,p_i\in\tilde\gamma_i$ for $i=1,2$. Let $\tilde\alpha$ be the angle between $\tilde\gamma_1$ and $\tilde\gamma_2$ at $\tilde x$. Similarly to \eqref{e:1-cos}, for points $\tilde y\in\tilde\gamma_2$ close to $\tilde x$ we have \begin{equation}\label{e:1-costilde} \lim_{\tilde y\in\tilde\gamma_2,\tilde y\to\tilde x} \frac{\mathcal D_F^2(\tilde y)(p_1,p_2)-\mathcal D_F^2(\tilde x)(p_1,p_2)}{d_2(\tilde x,\tilde y)} = 1 -\cos\tilde\alpha . \end{equation} If $y\in\gamma_2\cap U_1$ and $\tilde y=\phi(y)$, then $\tilde y\in\tilde\gamma_2\cap U_2$ by Lemma \ref{l:dirphi}, and $$ \mathcal D_F^1(y)(p_1,p_2)-\mathcal D_F^1(x)(p_1,p_2) = \mathcal D_F^2(\tilde y)(p_1,p_2)-\mathcal D_F^2(\tilde x)(p_1,p_2) $$ by \eqref{e:phi}. This, \eqref{e:1-cos} and \eqref{e:1-costilde} imply that \begin{equation}\label{e:cosfrac} \lim_{y\in\gamma_2,y\to x} \frac{d_2(\tilde x,\phi(y))}{d_1(x,y)} = \frac{1 -\cos\tilde\alpha}{1 -\cos\alpha} \end{equation} By switching the roles of $\gamma_1$ and $\gamma_2$, the same relation holds for $y\in\gamma_1$, $y\to x$. Hence \begin{equation}\label{e:limeq} \lim_{y\in\gamma_1,y\to x} \frac{d_2(\tilde x,\phi(y))}{d_1(x,y)} = \lim_{y\in\gamma_2,y\to x} \frac{d_2(\tilde x,\phi(y))}{d_1(x,y)} . \end{equation} Since $\gamma_1$ and $\gamma_2$ are arbitrary minimizing geodesics from $x$ to points of~$F$, the limits in \eqref{e:limeq} do not depend on $\gamma_1$ and $\gamma_2$. Thus there exists $\lambda=\lambda(x)>0$ such that, for any minimizing $M_1$-geodesic $\gamma$ from $x$ to a point of $F$, \begin{equation}\label{e:conformal} \lim_{y\in\gamma,y\to x} \frac{d_2(\tilde x,\phi(y))}{d_1(x,y)} = \lambda . \end{equation} We now show that $\lambda=1$. Lemma \ref{l:dirphi} allows us to a define map $$ \psi\colon \operatorname{dir}_{M_1}(x,F) \to \operatorname{dir}_{M_2}(\tilde x,F) $$ (see Notation \ref{n:dir}) as follows: if $v\in\operatorname{dir}_1(x,F)$ is the initial direction of a minimizing $M_1$-geodesic $\gamma$ connecting $x$ to $q\in F$, then $\psi(v)$ is the initial direction of the $M_2$-geodesic $\tilde\gamma$ corresponding to $\gamma$ as in Lemma \ref{l:dirphi}. By \eqref{e:cosfrac} and \eqref{e:conformal} we have \begin{equation}\label{e:anglefrac} 1 -\cos\angle_{g_2}(\psi(v_1),\psi(v_2)) = \lambda (1 -\cos\angle_{g_1}(v_1,v_2)) \end{equation} for all $v_1,v_2\in\operatorname{dir}_{M_1}(x,F)$, where $\angle_{g_i}$ denotes the angle with respect to $g_i$. Observe that $$ |v_1-v_2|^2 = 2(1 -\cos\angle(v_1,v_2)) $$ for any two unit vectors $v_1,v_2$ in a Euclidean space. Hence \eqref{e:anglefrac} can be rewritten as $$ \|\psi(v_1)-\psi(v_2)\|^2_{g_2} = \lambda \|v_1-v_2\|^2_{g_1}, \qquad \forall v_1,v_2\in \operatorname{dir}_1(x,F). $$ Thus $\psi$ it a homothetic map that multiplies all distances by a constant factor~$\sqrt\lambda$. Hence $\psi$ can be extended to an affine map $\Psi\colon T_xM_1\to T_{\tilde x}M_2$ with the same property: $$ \|\Psi(v_1)-\Psi(v_2)\|_{g_2} = \sqrt\lambda \|v_1-v_2\|_{g_1},\qquad \forall v_1,v_2\in T_xM_1. $$ The set $\operatorname{dir}_{M_2}(\tilde x,F)$ is contained in the intersection of the unit sphere $S_{\tilde x}M_2$ and the image $\Psi(S_xM_1)$. The latter is a Euclidean sphere of radius $\sqrt\lambda$. Suppose that $\lambda\ne 1$, then the intersection of the two spheres is a submanifold of dimension at most $n-2$. On the other hand, by Lemma \ref{l:dirvol} the set $\operatorname{dir}_{M_2}(\tilde x,F)$ have a positive $(n-1)$-dimensional measure, a contradiction. Thus $\lambda=1$. Since $\lambda=1$, \eqref{e:anglefrac} implies that $\psi$ preserves angles: \begin{equation}\label{e:psi-preserves-angles} \angle_{g_2}(\psi(v_1),\psi(v_2)) = \angle_{g_1}(v_1,v_2) \end{equation} for all $v_1,v_2\in\operatorname{dir}_{M_1}(x,F)$. Recall that $\phi$ is a locally bi-Lipschitz map. Hence, by Rademacher's theorem, it is differentiable almost everywhere. Assume that $\phi$ is differentiable at the point $x$ that we are considering. Then the definition of $\psi$, \eqref{e:conformal} and the fact that $\lambda=1$ imply that $d_x\phi(v)=\psi(v)$ for all $v\in\operatorname{dir}_{M_1}(x,F)$. By Lemma \ref{l:dirvol}, $\operatorname{dir}_{M_1}(x,F)$ is a set positive measure in $S_xM_1$. Hence it contains $n$ linearly independent vectors $v_1,\dots,v_n$. For each $i=1,\dots,n$, we have $$ d_x\phi(v_i)=\psi(v_i) \in S_{\tilde x}M_2 . $$ This and \eqref{e:psi-preserves-angles} imply that $$ g_2( d_x\phi(v_i),d_x\phi(v_j) ) = g_1(v_i,v_j) . $$ Therefore $d_x\phi$ is a linear isometry between $T_xM_1$ and $T_{\tilde x}M_2$ equipped with their Euclidean structures determined by $g_1$ and $g_2$. Thus the derivative $d_x\phi$ is a linear isometry for almost all $x\in U_1$. Hence $\phi$ is a locally 1-Lipschitz map with respect to $d_1$ and $d_2$. The same argument applies to $\phi^{-1}$, therefore $\phi$ is a locally distance preserving map. By the Myers-Steenrod theorem (\cite{MS}, see also \cite[Ch.~5, Theorem 18]{Pe}) this implies that $\phi$ is a Riemannian isometry. This finishes the proof of Theorem \ref{t:reconstruction}. \subsection{Stability} Here we show that the determination of a manifold by distance difference data is stable in a suitable sense. We add a number of simplifying assumptions to the setting of Theorem \ref{t:reconstruction}. First, the unknown manifold $M$ is assumed compact, and we assume a priory bounds on its diameter, sectional curvature, and injectivity radius. That is, the manifold belongs to the class $\mathcal M(n,D,K,i_0)$ defined in the introduction. Second, we a dealing with determination of the whole manifold $M$ (rather than a subset $U$) by the full distance difference data $\mathcal D_F(M)$. Third, we assume that the metric of the observation domain $F$ is known. To bring a ``practical'' flavour to our set-up, imagine that we know the distance difference data $\mathcal D_F(M)$ with some error. More precisely, suppose that we are given approximate distance difference data $\{\widetilde\mathcal D_F(x_i)\}$, where $\{x_i\}$ is $\delta$-net in $M$ and $\widetilde\mathcal D_F(x_i)$ is the distance difference function $\mathcal D_F(x_i)$ measured with an absolute error~$\delta$. This implies that the set $\{\widetilde\mathcal D_F(x_i)\}$ is a $3\delta$-approximation of the distance difference data $\mathcal D_F(M)$ in the sense of Hausdorff distance between subsets of $\mathcal C(F\times F)$. Our goal is to show that these approximate data determine the manifold up to an error $\varepsilon(\delta)$ in the Gromov--Hasdorff sense, where $\varepsilon(\delta)\to 0$ as $\delta\to 0$. Explicit bounds on $\varepsilon(\delta)$ and an actual reconstruction procedure is outside the scope of this paper. The precise statement of our stability result is the following. \begin{proposition}\label{p:stability} For every $\varepsilon>0$, $n\ge 2$ and $D,K,i_0,\rho_0>0$ there exists $\delta>0$ such that the following holds. Let $M_1=(M_1^n,g_1)$ and $M_2=(M_2^n,g_2)$ belong to $\mathcal M(n,D,K,i_0)$. Assume that $M_1$ and $M_2$ share a nonempty subset $F$ which is open in both manifolds, they induce the same topology and the same differential structure on $F$, and $g_1|_F=g_2|_F$. In addition, assume that $F$ contains a geodesic ball of radius $\rho_0$. For $i=1,2$, let $\mathcal D_F^i$ denote the distance difference representation of $M_i$ and suppose that $ d_H(\mathcal D_F^1(M_1) , \mathcal D_F^2(M_2)) < \delta $ where $d_H$ is the Hausdorff distance in $\mathcal C(F\times F)$. Then $d_{GH}(M_1,M_2)<\varepsilon$ where $d_{GH}$ denotes the Gromov-Hausdorff distance. \end{proposition} \begin{proof}[Proof sketch] It suffices to consider the case when $F$ is a geodesic ball of radius $\rho_0$. We may further assume that $\rho_0<\min\{i_0/2,K^{-1/2}\}$. Then every ball of radius $\rho_0$ is convex. In particular, $M_1$ and $M_2$ induce the same distances in~$F$. Suppose that the statement of the proposition is false. Then there exist a sequence $\delta_k\to 0$ and sequences $\{M_{1,k}\}$, $\{M_{2,k}\}$, $k=1,2,\dots$, of Riemannian manifolds from $\mathcal M(n,D,K,i_0)$ and geodesic balls $F_k=B_{\rho_0}(q_k)\subset M_{1,k}\cap M_{2,k}$ satisfying the assumptions of the proposition for $\delta=\delta_k$ and such that the Gromov-Hausdorff distance $d_{GH}(M_{1,k},M_{2,k})$ is bounded away from~0. Recall that the class $\mathcal M(n,D,K,i_0)$ is pre-compact in Gromov-Hausdorff topology, see \cite[Ch.~10]{Pe}. Hence, by passing to a subsequence if necessary, we may assume that metric pairs $(M_{1,k},F_k)$ and $(M_{2,k},F_k)$ converge to some pairs $(\bar M_1,\bar F)$ and $(\bar M_2,\bar F)$ in the Gromov-Hausdorff sense, where $\bar M_1$ and $\bar M_2$ are compact metric spaces and $\bar F$ is a ball of radius $\rho_0$ in both $\bar M_1$ and $\bar M_2$. Furthermore $\bar M_1$ and $\bar M_2$ induce the same metric on~$\bar F$. Let $\mathcal D_{\bar F}^1$ and $\mathcal D_{\bar F}^2$ be distance difference representations of $\bar M_1$ and $\bar M_2$ in $\mathcal C(\bar F\times\bar F)$. The distance functions of points of $\bar M_1$ and $\bar M_2$ are in a natural sense limits of distance functions in $M_{1,k}$ and $M_{2,k}$. Since $d_H(\mathcal D_{F_k}^1(M_{1,k}) , \mathcal D_{F_k}^2(M_{2,k})) < \delta_k\to 0$, it follows that $\mathcal D_{\bar F}^1(M_1)=\mathcal D_{\bar F}^2(M_2)$. Since the convergent spaces $M_{1,k}$ and $M_{2,k}$ are from $\mathcal M(n,D,K,i_0)$, the limit spaces $\bar M_1$ and $\bar M_2$ are $n$-dimensional Alexandrov spaces with two-sided curvature bounds. Such spaces are $C^{1,\alpha}$ Riemannian manifolds for every $\alpha\in(0,1)$, see \cite{ABN}, moreover the Gromov-Hausdorff convergence is actually a $C^{1,\alpha}$ convergence, see \cite[Ch.~10]{Pe}. One can see that all ingredients of the proof of Theorem \ref{t:reconstruction} work for such spaces $\bar M_1$ and $\bar M_2$. Then Theorem \ref{t:reconstruction} implies that $\bar M_1$ and $\bar M_2$ are isometric, contrary to the assumption that the Gromov-Hausdorff distance $d_{GH}(M_{1,k},M_{2,k})$ is bounded away from~0. \end{proof} \section{Distance differences on the boundary} \label{sec:boundary} In this section we consider a variant of the problem where $M=(M^n,g)$ is a complete, connected Riemannian manifold with boundary and $F=\partial M$. The distance $d(x,y)$ between $x,y\in M$ is the length of a shortest path (possibly touching the boundary) from $x$ to~$y$ in~$M$. This distance defines the distance difference representation $\mathcal D_F\colon M\to \mathcal C(F\times F)$ in the usual way. We attach a collar $\tilde F:=\partial M\times [0,+\infty)$ to $M$ along the boundary and equip the resulting manifold $\tilde M=M\cup\tilde F$ with a complete Riemannian metric $\tilde g$ extending $g$. Now $M$ is a subset of $\tilde M$ bounded by a smooth hypersurface $F=\partial M$. Denote by $\tilde d$ the distance in $\tilde M$ induced by $\tilde g$ and by $\mathcal D_{\tilde F}$ the distance difference representation of $\tilde M$ in $\mathcal C(\tilde F\times\tilde F)$. Note that $d(x,y)\ge \tilde d(x,y)$ for all $x,y\in M$. \begin{lemma}\label{l:DtildeF} In the above notation, \begin{equation}\label{e:DtildeF} \|\mathcal D_{\tilde F}(x)-\mathcal D_{\tilde F}(y)\| \le \|\mathcal D_F(x)-\mathcal D_F(y)\| \end{equation} for all $x,y\in M$. \end{lemma} \begin{proof} Let $x,y\in M$ and $p,q\in\tilde F$. Consider a minimizing geodesic $[xp]$ of $\tilde M$ and let $x_1$ be the first point where this geodesic crosses the boundary, i.e., $x_1$ is the point of $[xp]\cap F$ nearest to~$x$. The interval $[xx_1]$ of $[xp]$ is a minimizing geodesic of $\tilde M$ contained in $M$, hence it is a shortest path in~$M$. Thus $d(x,x_1)=\tilde d(x,x_1)$. By the triangle inequality, $$ \tilde d(y,p) \le \tilde d(y,x_1)+\tilde d(x_1,p) = \tilde d(y,x_1)+\tilde d(x,p) - \tilde d(x,x_1) . $$ Since $\tilde d(y,x_1)\le d(y,x_1)$ and $\tilde d(x,x_1)=d(x,x_1)$, it follows that $$ \tilde d(y,p) \le \tilde d(x,p) + d(y,x_1)- d(x,x_1) . $$ Similarly, $$ \tilde d(x,q) \le \tilde d(y,q) + d(x,y_1)- d(y,y_1) $$ where $y_1$ is the point on $[yq]\cap F$ nearest to~$y$. Summing the last two inequalities yields that $$ \tilde d(y,p) + \tilde d(x,q) \le \tilde d(x,p) + \tilde d(y,q) + \mathcal D_F(y)(x_1,y_1)-\mathcal D_F(x)(x_1,y_1) $$ or, equivalently, $$ \mathcal D_{\tilde F}(y)(p,q) - \mathcal D_{\tilde F}(x)(p,q) \le \mathcal D_F(y)(x_1,y_1)-\mathcal D_F(x)(x_1,y_1) . $$ The right-hand side is bounded by $\|\mathcal D_F(y)-\mathcal D_F(x)\|$, therefore $$ \mathcal D_{\tilde F}(y)(p,q) - \mathcal D_{\tilde F}(x)(p,q) \le \|\mathcal D_F(y)-\mathcal D_F(x)\| . $$ Since $p$ and $q$ are arbitrary points of $\tilde F$, \eqref{e:DtildeF} follows. \end{proof} Now we prove an analogue of Theorem \ref{t:inverse} for boundary distances. \begin{proposition}\label{p:dM-bilip} Let $M^n$ be a complete, connected Riemannian manifold with boundary, $n\ge 2$, and $F=\partial M$. Then the map $\mathcal D_F\colon M\to\mathcal C(F\times F)$ is a homeomorphism onto its image and the inverse map $\mathcal D_F^{-1}\colon\mathcal D_F(M)\to M$ is locally Lipschitz. \end{proposition} \begin{proof} Consider $\tilde M=(\tilde M,\tilde g)$ and $\tilde F$ constructed as above. By Theorem \ref{t:inverse}, the map $\mathcal D_{\tilde F}\colon \tilde M \to \mathcal C(\tilde F\times\tilde F)$ is injective and its inverse $\mathcal D_{\tilde F}^{-1}\colon \mathcal D_{\tilde F}(\tilde M)\to \tilde M$ is locally Lipschitz. Consider the map $I\colon\mathcal D_{\tilde F}(M)\to\mathcal D_F(M)$ defined by $I(\mathcal D_{\tilde F}(x))=\mathcal D_{F}(x)$, $x\in M$. By Lemma \ref{l:DtildeF}, $I$ does not decrease distances. Hence $\mathcal D_F=I\circ\mathcal D_{\tilde F}|_M$ is injective and its inverse is locally Lipschitz with respect to $\tilde d|_{M\times M}$. Since $\tilde d|_{M\times M}$ is locally bi-Lipschitz equivalent to $d$, the result follows. \end{proof} The next Proposition \ref{p:boundary} asserts that $(M,g)$ is uniquely determined by its distance difference data on the boundary provided that the boundary is nowhere concave. We say that the boundary $\partial M$ of $M$ is \textit{nowhere concave} if for every $x\in\partial M$ the second fundamental form of $\partial M$ at $x$ with respect to the inward-pointing normal vector has at least one positive eigenvalue. The nowhere concavity ensures that the boundary distance function uniquely determines the $C^\infty$-jet of the metric at the boundary (see the proof below). This is the only implication of nowhere concavity that we need; any other condition allowing the determination of the $C^\infty$-jet would work just as well. It is plausible that the boundary assumption in Proposition \ref{p:boundary} can be removed but it is essential for our method to work. \begin{remark} Recently M. V. de Hoop and T. Saksala \cite{HS}, using a different approach, obtained a similar result under weaker {\it visibility} assumptions on the boundary. For compact manifolds Proposition \ref{p:boundary} can be deduced from the results of~\cite{HS}. \end{remark} \begin{proposition}\label{p:boundary} Let $M_1=(M_1^n,g_1)$ and $M_2=(M_2^n,g_2)$, $n\ge 2$, be complete, connected Riemannian manifolds with a common boundary $F=\partial M_1=\partial M_2$, which is nowhere concave in both $M_1$ and $M_2$. Let $\mathcal D_F^i$ denote the distance difference representation of $M_i$ in $\mathcal C(F\times F)$, $i=1,2$, and assume that $\mathcal D_F^1(M_1)=\mathcal D_F^2(M_2)$. Then $M_1$ and $M_2$ are isometric via an isometry fixing the boundary. \end{proposition} \begin{proof} Define $\phi \colon M_1\to M_2$ by $\phi=(\mathcal D_F^2)^{-1}\circ \mathcal D_F^1$. We are going to show that $\phi$ is an isometry fixing the boundary. Proposition \ref{p:dM-bilip} implies that $\phi$ is well defined and it is a homeomorphism between $M_1$ to $M_2$. Hence it maps boundary to boundary, i.e., $\phi(F)=F$. Moreover, $\phi|_F=\mbox{id}_F$. Indeed, a point $x\in F$ is determined by $\mathcal D^1_F(x)$ as the unique minimum point of a function $\mathcal D^1_F(x)(\cdot,x_0)$ where $x_0$ is an arbitrary fixed point of~$F$. If $x'=\phi(x)$ then $\mathcal D^1_F(x)=\mathcal D^2_F(x')$ and hence $x'$ is the unique minimum point of the same function. Thus $\phi(x)=x$ and $\mathcal D_F^1(x)=\mathcal D_F^2(x)$ for all $x\in F$. Let $d_1$ and $d_2$ denote the distances in $M_1$ and $M_2$, resp. Then $d_1|_{F\times F}=d_2|_{F\times F}$. Indeed, for any $x,y\in F$, $$ d_1(x,y)= \mathcal D^1_F(x)(y,x)= \mathcal D^2_F(x)(y,x) = d_2(x,y) $$ where the second identity follows from the fact that $\phi(x)=x$. Since the boundary $F$ is nowhere concave in $M_i$, $i=1,2$, the boundary distance function $d_i|_{F\times F}$ determines the $C^\infty$-jet of $g_i$ at the boundary (in e.g.\ boundary normal coordinates), see \cite{LSU,UW,Z}. Thus $g_1$ and $g_2$ have the same $C^\infty$-jet at the boundary. As in the beginning of this section, we attach a collar $\tilde F:=F\times[0,+\infty)$ to the boundary of $M_1$ and equip $\tilde F$ with a Riemannian metric $g$ smoothly extending~$g_1$. Since $g_1$ and $g_2$ have the same $C^\infty$-jet at the boundary, the metric $g$ smoothly extends $g_2$ as well. Thus we obtain two complete Riemannian manifolds $(\tilde M_i,\tilde g_i)$, $i=1,2$, where $\tilde M_i=M_i\cup\tilde F$ and $\tilde g_i=g_i\cup g$. Let $d_{\tilde F}$ denote the length distance in $\tilde F$ (induced by $g$), $\tilde d_i$ the distance in $\tilde M_i$, and $D_{\tilde F}^i$ the distance difference representations of $\tilde M_i$ in $\mathcal C(\tilde F\times\tilde F)$, $i=1,2$. Note that the distances $d_i$ and $d$ may differ from the respective restrictions of $\tilde d_i$ since they are determined by shortest paths in possibly non-convex subsets $M_i$ and $\tilde F$. We are going to show that $D_{\tilde F}^1(M_1)= D_{\tilde F}^2(M_2)$. More precisely, we prove that \begin{equation}\label{e:tildeF} \mathcal D^1_{\tilde F}(x) = \mathcal D^2_{\tilde F}(\phi(x)) \end{equation} for all $x\in M_1$. Let $x\in M_1$ and $y\in\tilde F$. The distance $\tilde d_1(x,y)$ equals the infimum of lengths of piecewise smooth paths in $\tilde M_1$ crossing $F$ finitely many times. Hence \begin{equation}\label{e:tilded} \tilde d_1(x,y) = \inf \left\{ d_1(x,y_0) + \sum_{j=1}^N \bigl(d_{\tilde F}(y_{j-1},x_j)+d_1(x_j,y_j)\bigr) + d_{\tilde F}(y_N,y) \right\} \end{equation} where the infimum is taken over all finite sequences $y_0,\dots,y_N$ and $x_1,\dots,x_N$ in~$F$. For $x'=\phi(x)\in M_2$, the distance $\tilde d_2(x',y)$ is given by the same formula with $x'$ in place of $x$ and $d_2$ in place of $d_1$. By the definition of $\phi$ there is a constant $\tau=\tau(x)\in\mathbb R$ such that $d_2(x',y_0)=d_1(x,y_0)+\tau$ for all $y_0\in F$. Since $d_1|_{F\times F}=d_2|_{F\times F}$, we have $d_2(x_j,y_j)=d_1(x_j,y_j)$ for any $x_j,y_j\in F$. This and \eqref{e:tilded} imply that $\tilde d_2(x',y)=\tilde d_1(x,y)+\tau$. Since $\tau$ does not depend on $y$, this implies that $$ \tilde d_2(x',y) - \tilde d_2(x',z) = \tilde d_1(x,y) - \tilde d_1(x,z) $$ for all $y,z\in\tilde F$, and \eqref{e:tildeF} follows. By Theorem \ref{t:reconstruction}, \eqref{e:tildeF} implies that $\phi$ is an isometry from $M_1$ to $M_2$. This finishes the proof of Proposition \ref{p:boundary}. \end{proof}

World wide, \~340 000 patients are diagnosed with renal cell carcinoma (RCC) annually.^[@bib1]^ The majority (75%) is of the clear cell subtype, ccRCC.^[@bib2]^ A problematic therapeutic feature of ccRCC is that if curative surgery fails, traditional radio- or chemotherapy have very limited effect.^[@bib3]^ Despite recent advances using targeted anti-angiogenic therapies, the 5-year survival for patients with metastatic disease is still only a dismal 10%. Increased understanding of this disease that could result in development of new therapies is therefore of great importance. ccRCC derives its name from the histologically empty (clear) appearance of the cancer cells, caused by large deposits of glycogen and lipid droplets in the cytoplasm.^[@bib4]^ The initiating genetic event seems to be loss of function of the tumor suppressor protein von Hippel Lindau, pVHL, found in over 90% of all cases.^[@bib5],\ [@bib6]^ This results in aberrant activation of the hypoxia inducible factors HIF-1*α* and HIF-2*α*, transcription factors normally active only at hypoxia, controlling the cellular adaptation to oxygen shortage, such as induction of angiogenesis, cell cycle arrest and pro-survival factors.^[@bib7],\ [@bib8]^ The resulting pseudohypoxic phenotype in ccRCC tumors leads to massive angiogenesis, as well as an extensive metabolic reprogramming, including a shift from mitochondrial oxidative phosphorylation to non-oxygen-requiring glycolysis. In normal cells, when oxygen is abundant, glycolysis is used to metabolize glucose into pyruvate, which enters the citric acid cycle in the mitochondria. ATP is subsequently produced by oxidative phosphorylation, driven by the reducing equivalents formed in the citric acid cycle. During hypoxic conditions, pyruvate is instead fermented to lactate and excreted from the cell. Already in the 1930s the German physiologist Otto Warburg described that tumor cells preferentially utilize the glycolytic pathway to produce lactate also when oxygen is available, a phenomenon today known as the Warburg effect. Although such aerobic glycolysis yields less ATP per molecule of glucose than its full oxidation to CO~2~ and H~2~O in mitochondrial metabolism, this pathway provides tumor cells with building blocks needed for growth and proliferation. The current view is that even though increased aerobic glycolysis is one of the characteristics of tumor cells, mitochondrial and other metabolic pathways are usually still maintained alongside with a high glycolytic rate in most cancer forms.^[@bib9]^ Recent studies indicate that the metabolism of ccRCC tumors differs from other cancer forms in that most pathways besides glycolysis are downregulated.^[@bib10],\ [@bib11],\ [@bib12],\ [@bib13]^ In this report, we show that the number and respiratory capacity of mitochondria are strongly reduced in ccRCC cells, which instead exhibit high glycolytic activity. We hypothesized that this renders ccRCC cells highly sensitive to inhibition of glycolysis. To test this hypothesis, we exposed primary ccRCC cells to 3-bromopyruvate (3BrPA), a pyruvate analog primarily described as a glycolytic inhibitor. We show that primary human ccRCC cells, in contrast to normal kidney cells and also established ccRCC cell lines, were highly sensitive to inhibition by 3BrPA. The possibility to utilize metabolic inhibitors might be a promising therapeutic alternative to specifically target ccRCC tumors that should be further studied. Results ======= ccRCC tumors contain few mitochondria and are highly glycolytic --------------------------------------------------------------- To validate the metabolic characteristics of ccRCC cells described above, we analyzed the expression of genes involved in the glycolytic pathway in ccRCC tumor and normal kidney samples included in The Cancer Genome Atlas (TCGA) data set. As shown in [Figure 1a](#fig1){ref-type="fig"}, the majority of analyzed glycolytic genes were expressed at elevated levels in ccRCC compared with matched normal samples. This was confirmed at the protein level, as exemplified by immunohistochemical stainings of GLUT1 in ccRCC and normal kidney tissue samples ([Figure 1c](#fig1){ref-type="fig"}, upper panel). The expression levels of the glycolytic genes were also confirmed to be clearly elevated in ccRCC tumors compared with other cancers included in the TCGA data collection, as illustrated in [Figure 1d](#fig1){ref-type="fig"}. In contrast, genes involved in mitochondrial regulation and oxidative phosphorylation were downregulated in ccRCC samples compared with normal kidney samples ([Figure 1b](#fig1){ref-type="fig"}). We next analyzed the mitochondrial content in ccRCC tumors. Staining of ccRCC and normal kidney tissue for mitochondrial encoded cytochrome *c* oxidase II (MTCO2) revealed high expression in normal epithelial cells of the proximal tubules, whereas the expression in ccRCC cells was strongly reduced ([Figure 1c](#fig1){ref-type="fig"}, lower panel). The low mitochondrial load in ccRCC samples was further substantiated using electron microscopy. Images of ccRCC tissue clearly demonstrated the characteristic accumulation of cytoplasmic lipid droplets and glycogen deposits, but also that very few, if any, mitochondria could be detected ([Figure 2a](#fig2){ref-type="fig"}). With purpose to obtain an *in vitro* model allowing for further characterization of the metabolic features of ccRCC cells, tumor as well as normal primary proximal tubular cells from patients diagnosed with ccRCC were isolated and cultured. As a quantification of the mitochondrial load in cultured ccRCC cells, the ratio between mitochondrial and nuclear DNA was determined with quantitative PCR analysis. In [Supplementary Figure 1A](#sup1){ref-type="supplementary-material"}, the reduction in mitochondrial DNA content of primary ccRCC cells compared with normal kidney cells is clearly demonstrated. These data urged us to analyze the capacity of ccRCC cells to utilize mitochondrial oxidative phosphorylation for energy production. Measurement of cellular oxygen consumption rate (OCR) by the Seahorse technique can be used to quantify mitochondrial respiration. As shown in [Figure 2b](#fig2){ref-type="fig"}, the basal OCR per cell was up to 10 times higher in normal cells compared with ccRCC tumor cells, indicating a very low usage of oxidative phosphorylation as energy source in ccRCC cells. Addition of oligomycin, an inhibitor of the ATP synthase, reduced OCR in normal cells, as expected. However, the already very low basal OCR levels of the ccRCC cells prohibited us from detecting any further reduction in response to oligomycin treatment in these cells. The uncoupler FCCP disrupts the mitochondrial proton gradient driving ATP production, giving a measurement of maximal respiratory capacity. OCR measurements after addition of FCCP showed a slight increase in oxygen consumption in the primary ccRCC cells, indicating that some respiratory activity was present in these cells; however, compared with the primary normal samples the ccRCC cells displayed a remarkably low respiratory capacity ([Figure 2c](#fig2){ref-type="fig"}). The low mitochondrial respiratory rate of primary ccRCC cells was further illustrated by treatment with As~2~O~3~, which inhibits mitochondrial respiration. As~2~O~3~ had negligible effect on primary ccRCC cells, while normal primary kidney epithelial cells did not tolerate this treatment ([Figure 2d](#fig2){ref-type="fig"}). Similarly, treatment with the mitochondrial complex I-inhibitor metformin at concentrations reported to induce cell death in several cancer cell lines^[@bib14],\ [@bib15],\ [@bib16]^ had no effect on viability of primary ccRCC cells ([Supplementary Figure 1B](#sup1){ref-type="supplementary-material"}). Together, these results confirm that ccRCC cells do not rely on oxidative phosphorylation for ATP production, instead indicating a critical role for glycolysis in their energy metabolism. 3BrPA inhibits the growth of primary ccRCC cells ------------------------------------------------ The low mitochondrial capacity and high glycolytic profile of ccRCC cells suggest inhibition of glycolysis as a potentially effective method to limit energy supply in these cells. To test this hypothesis, we chose to use the glycolytic inhibitor 3BrPA ([Supplementary Figure 2A](#sup1){ref-type="supplementary-material"}). The effect of 3BrPA was first studied using WST-1 assay. As shown in [Figure 3a](#fig3){ref-type="fig"}, three out of four tested tumors were sensitive to 50 *μ*M 3BrPA, whereas all four tested normal cultures were largely unaffected after 3 days of treatment ([Figure 3b](#fig3){ref-type="fig"}). Following treatment for 6 days, the effect was even stronger in the tumor cells. Again, this treatment period was also well tolerated by the normal kidney cells ([Supplementary Figure 2B and C](#sup1){ref-type="supplementary-material"}). Interestingly, cells from the only primary ccRCC culture that did not respond to 3BrPA treatment (R104T) showed an elevated basal OCR and increased maximal respiratory capacity in the Seahorse assay, suggesting retained mitochondrial capacity and less dependence on glycolysis in this specific tumor ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). The colorimetric WST-1 assay is based on the reduction of a tetrazolium salt into a formazan dye by the succinate-tetrazolium reductase system in the respiratory chain of mitochondria. The very low mitochondrial content of the ccRCC tumor cells might thus interfere with the results. We therefore shifted to counting the number of dead and live cells using the viability and cell count assay on the Nucleocounter 3000. The viability of ccRCC samples compared with normal samples after 24 h treatment with increasing concentrations of 3BrPA is shown in [Figure 3c](#fig3){ref-type="fig"}. Tumor cell viability was decreased already at 25 *μ*M 3BrPA, whereas normal cells tolerated significantly higher concentrations. The IC~50~ values of each of these cultures are presented in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. In [Figures 3d and e](#fig3){ref-type="fig"} the relative number of dead cells from the same experiments are shown. Again, the dramatic difference in the toxicity of 3BrPA towards ccRCC tumor cells compared with normal kidney cells is clearly seen. The amount of apoptotic cells after 3BrPA treatment was also determined by flow cytometry analysis of Annexin V/Propidium Iodide-stained cells. [Figure 3f](#fig3){ref-type="fig"} shows the increase in double-positive apoptotic primary ccRCC cells after 24-h treatment with 50 μM 3BrPA. 3BrPA inhibits lactate excretion and ATP production in ccRCC cells ------------------------------------------------------------------ 3BrPA has been described as an inhibitor of glycolysis, by blocking the activity of hexokinase or glyceraldehyde dehydrogenase.^[@bib17],\ [@bib18]^ In the final step of aerobic glycolysis, pyruvate is converted into lactate; thus measurement of lactate excretion can be used as an estimate of aerobic glycolytic flux. In primary ccRCC cells, addition of 3BrPA resulted in a significant reduction in the amount of lactate in media within 1 h ([Figure 4a](#fig4){ref-type="fig"}). The same treatment also resulted in a dramatic decrease in intracellular ATP levels ([Figure 4b](#fig4){ref-type="fig"}). These results suggest that 3BrPA inhibits glycolysis in primary ccRCC cells, resulting in the depletion of ATP levels. Established renal carcinoma cell lines are less sensitive to 3BrPA treatment ---------------------------------------------------------------------------- Established ccRCC cell lines are regularly used for *in vitro* studies of ccRCC. Therefore, we analyzed the effects of 3BrPA in the established ccRCC cell lines 786-O and WT7. Intriguingly, the viability of these cells was not affected by treatment with 50 μM 3BrPA ([Figure 5a](#fig5){ref-type="fig"}). The 786-O cell line is established from a ccRCC tumor that lacks functional VHL, and WT7 is a subclone of this cell line where VHL has been reintroduced. Both these cell lines lack HIF-1*α* expression.^[@bib19]^ Five additional ccRCC cell lines (SKRC7, SKRC10, SKRC17, SKRC21 and SKRC52), commonly used to study this tumor type *in vitro*, were included in these studies, in order to determine whether also other ccRCC cell lines were equally resistant to 3BrPA, and also to ensure that the lack of HIF-1α was not a determining factor in the resistance of the established cell lines to 3BrPA treatment. All tested continuous ccRCC cell lines showed an increased resistance to glycolytic inhibition by 3BrPA treatment compared with primary ccRCC cells, although they appeared somewhat more sensitive than primary normal kidney cells ([Figures 5b and c](#fig5){ref-type="fig"}). The individual IC~50~ values of each cell line are presented in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. Cell cycle analysis of 3BrPA-treated cells revealed no major effects in primary normal or ccRCC cells, whereas the established cell lines showed a tendency towards S-phase arrest after treatment with 50 *μ*M 3BrPA ([Supplementary Figure 4](#sup1){ref-type="supplementary-material"}). Notably, 786-O and WT-7 cells displayed an increased basal OCR relative to primary ccRCC cells ([Figure 5d](#fig5){ref-type="fig"}), and the maximal respiratory capacity was also higher in these cells. As a comparison, the basal OCR of the breast cancer cell line MCF7 is also shown. In line with these findings, quantifications of the mitochondrial DNA content indicated a higher mitochondrial load in the established cell lines compared with primary ccRCC cells ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}). These results suggest that established cell lines are less dependent on glycolysis than primary ccRCC cells, and thus less sensitive to glycolytic inhibition by 3BrPA. MCT1 is highly expressed in ccRCC cells --------------------------------------- Being a pyruvate analogue, 3BrPA has been reported to be transported into cells by the monocarboxylate transporter 1 (MCT1 or *SLC16A1*),^[@bib20]^ a proton-linked pump that catalyzes the transport of monocarboxylates such as lactate and pyruvate across the cell membrane. The expression of this pump is induced in hypoxic and glycolytic cells. Data obtained from publically available gene expression data sets, together with the TCGA, showed that ccRCC tumors express *SLC16A1* at significantly higher levels than normal kidney cells ([Figure 6a](#fig6){ref-type="fig"}). These data were confirmed at the protein level in cultured primary ccRCC and normal kidney cells ([Figure 6b](#fig6){ref-type="fig"}). The increased resistance of the established ccRCC cell lines to 3BrPA treatment raised the question regarding the expression of *SLC16A1* in these cells. As exemplified in [Figure 6b](#fig6){ref-type="fig"}, protein levels of MCT1 in the SKRC17 cell line were almost as high as in the primary ccRCC cells. Similar results were obtained also from the other cell lines. Indeed, quantification of the relative expression levels of *SLC16A1* mRNA in these different cell types confirmed a pattern where primary normal cells displayed low expression levels of *SLC16A1*, whereas both the primary ccRCC cells and the established cell lines expressed increased levels of this transporter ([Figure 6c](#fig6){ref-type="fig"}). Discussion ========== In ccRCC cells, the pseudohypoxic state following HIF activation due to loss of VHL results in a shift from mitochondrial to glycolytic metabolism.^[@bib21]^ Recently, a significant difference in the metabolic profile of ccRCC compared with other investigated tumor types was described.^[@bib10]^ Even though the Warburg effect is seen in many cancer forms, ccRCC seems to be uniquely dependent on glycolysis, showing a reduction of most other energy-generating metabolic processes. Investigating the functional basis for this shift, we studied ccRCC tissue by electron microscopy and immunohistochemistry, finding a severe reduction in the number of mitochondria. Despite using a protocol developed for mitochondrial visualization,^[@bib22]^ few if any mitochondria could be detected in the cytoplasm of ccRCC cells. This was reflected in primary ccRCC cells in culture by a very low basal OCR as measured by the Seahorse technique, low mitochondrial DNA content and a correspondingly high tolerance to inhibitors of mitochondrial respiration at concentrations shown to be lethal to other tumor cells in culture.^[@bib14],\ [@bib15],\ [@bib16]^ The low mitochondrial content results in a limited ability of primary ccRCC cells to increase OCR and flux through the electron transport chain after uncoupling of the mitochondrial ATPase, illustrated by addition of the uncoupler FCCP in the Seahorse assay. ccRCC cells thus seem to be unable to switch to oxidative phosphorylation for energy production, implying a low risk for development of resistance upon glycolytic inhibition. Constitutive HIF signaling also renders ccRCC tumors exceptionally well vascularized. The capillary network supplies tumor cells well with oxygen and nutrients, which might explain how they can rely almost solely on glycolysis. This renders ccRCC cells more vulnerable to anti-angiogenic therapy,^[@bib23]^ and as we hypothesize, to inhibition of the glycolytic pathway. The latter aspect was tested by exposing primary ccRCC cells to the glycolytic inhibitor 3BrPA, a compound shown to be well tolerated *in vivo*,^[@bib24],\ [@bib25]^ recently approved for phase I clinical trials in metastatic liver cancer. We found that primary ccRCC cells indeed were sensitive to 3BrPA at concentrations tolerated by normal primary kidney cells. Addition of 3BrPA to primary ccRCC cells resulted in reduced lactate excretion and a drastic drop in ATP production, suggesting that 3BrPA treatment induced cell death due to energy depletion following inhibition of the glycolytic pathway. The inhibitory effect of 3BrPA on glycolysis has both been described to function through targeting of glyceraldehyde dehydrogenase as well as of the rate-limiting enzyme hexokinase, catalyzing the conversion of glucose to glucose-6-phosphate in the first step of the glycolytic reaction.^[@bib17],\ [@bib18]^ Interestingly, recent studies suggest that hexokinase, highly expressed in ccRCC tumor cells, has an oncogenic function in these cells,^[@bib26]^ further arguing for the benefit of using 3BrPA as a therapeutic agent in ccRCC. Although 3BrPA has mainly been described as an inhibitor of glycolysis, it has also been reported to target mitochondrial function by inhibiting mitochondrially bound hexokinase^[@bib17],\ [@bib27]^ or by inhibiting the activity of succinate dehydrogenase (complex II in the respiratory chain).^[@bib28],\ [@bib29]^ These effects seem to vary depending on concentration, cell type and on the carbon source available for energy metabolism, where the greatest inhibitory effect of 3BrPA on mitochondrial function was found when glucose supply was limited.^[@bib28]^ However, in the case of ccRCC cells, their nutrient-rich environment and low mitochondrial content implies that the toxic effect of 3BrPA on these cells most likely acts through glycolytic inhibition. In further support of this theory is our results demonstrating a high tolerance of primary ccRCC cells to known inhibitors of the respiratory chain, as well as the reduction in lactate excretion following 3BrPA treatment. Uptake of 3BrPA has been reported to be dependent on the monocarboxylate transporter MCT1, or *SLC16A1*. The expression of this lactate transporter correlates to a more pronounced glycolytic profile.^[@bib20]^ In this study we showed that the levels of *SLC16A1* was elevated both in ccRCC tissue samples and in cultured primary ccRCC cells compared with normal kidney cells, suggesting an increased uptake of 3BrPA specifically in ccRCC tumor cells. The low *SLC16A1* levels found in primary normal kidney cells probably limit their uptake of 3BrPA. Although this may add a level of protection towards any off-target effects of high-dose 3BrPA treatment, we do not believe that the low *SLC16A1* levels is the main explanation for the increased resistance of the normal cells to 3BrPA. One of the normal kidney cell samples (R124N) displayed elevated expression of *SLC16A1* compared with the others, yet these cells did not show an increased sensitivity to 3BrPA treatment, arguing that the absolute levels of *SLC16A1* is not the critical factor determining sensitivity to 3BrPA. Instead, we hypothesize that the cellular metabolic feature is a crucial aspect, where the constrained glycolytic profile of ccRCC cells renders them highly sensitive, whereas normal cells with a broader metabolic repertoire will be spared. We additionally found that established ccRCC cell lines also were less sensitive to 3BrPA treatment, despite the presence of *SLC16A1* at almost the same elevated levels as in the primary ccRCC cells. No correlation between 3BrPA IC~50~ values and SLC16A1 expression levels was found among the continuous cell lines. Expression levels of *SLC16A1* in the SKRC10 cell line was significantly higher compared with the other established cell lines. Again, this was not reflected in any difference in the sensitivity of these cells to 3BrPA. The tested cell lines displayed higher mitochondrial DNA content and a marked increase in mitochondrial respiration compared with primary ccRCC cells. These findings infer an elevated capacity to utilize other metabolic pathways in established cell lines, a lower dependence on glycolysis for energy production and thus a higher tolerance to glycolytic inhibition. Of note, ccRCC cells isolated from one patient did not respond to 3BrPA treatment (R104T). Seahorse analysis revealed a higher basal OCR and increased maximal respiratory capacity of these cells, suggesting a higher mitochondrial content and lower dependence on glycolysis for energy production. Together, these data imply that cells relying on functional glycolysis for energy production will be selectively sensitive to 3BrPA treatment. The extreme glycolytic profile of primary ccRCC cells is probably a property of tumor cells *in vivo*, retained in primary ccRCC cells, that is lost in cell lines during establishment and propagation. These results point to the importance of using relevant model systems, and that established cell lines not always give a correct reflection of the tumor type they are derived from. Hence, screening for metabolic inhibitors using established cell lines might give misleading results and promising candidates might be overlooked. In summary, our results demonstrate that primary ccRCC tumor cells are highly sensitive to glycolytic inhibition by 3BrPA, suggesting that the possibility to utilize pharmaceuticals targeting glycolysis, thereby disrupting energy metabolism, should be further studied in ccRCC tumors. Materials and Methods ===================== Cell culture and isolation of primary cells ------------------------------------------- Primary human ccRCC cells were isolated and cultured from patient nephrectomies as described previously,^[@bib30]^ with ethical approval from the Lund University ethical committee (LU680-08 and LU 289-07). Tumors were classified as ccRCCs by an experienced pathologist. Normal samples were collected from healthy kidney cortex farthest from the tumor. 786-O cells were obtained from ATCC. SKRC10 and SKRC17 were kindly provided by E. Oosterwijk (Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands). All cells were grown in DMEM high glucose supplemented with 10% FBS and 1% penicillin/streptavidin (Thermo Scientific, Waltham, MA, USA), except for SKRC7, SKRC10, SKRC17, SKRC21 and SKRC52, which were kept in RPMI. All cell lines were regularly checked for mycoplasma. 3-Bromopyruvate --------------- 3-Bromopyruvate was obtained from Sigma-Aldrich (St. Louis, MO, USA). A fresh stock solution of 20 mM 3BrPA in PBS was prepared for each experiment. WST-1 cell growth assay ----------------------- Cells were seeded in triplicates in 96-well plates. The following day 3BrPA or vehicle was added in a total volume of 100 *μ*l media and cells were incubated for 1--6 days. WST-1 (10 *μ*l) solution (Roche, Basel, Switzerland) was added to cells and absorbance was measured after 4 h incubation. Nucleocounter cell viability assay ---------------------------------- Cells were seeded in 24-well plates and incubated with or without 3BrPA for 24 h. Adherent and floating cells were collected and the number of live and dead cells was determined using the cell count and viability assay on the Nucleocounter NC3000 (ChemoMetec, Allerod, Denmark) according to the manufacturer\'s protocol. Measurement of mitochondrial respiration ---------------------------------------- Measurement of OCR was performed on a Seahorse XF24 Extracellular Flux Analyzer (SeaHorse Bioscience, North Billerica, MA, USA). Cells were seeded to confluency in a XF24 Seahorse assay plate. The following day media was changed to unbuffered XF Assay medium and the plate was incubated in a non-CO~2~ chamber for 2 h after which the OCR was analyzed according to the manufacturer\'s instructions. Maximal respiratory capacity was determined after injection of 4 *μ*g/ml oligomycin (Sigma-Aldrich), 4 *μ*M FCCP (Abcam, Cambridge, UK) and 5 *μ*M Rotenone (Sigma-Aldrich) according to instructions for the Cell Mito Stress Test. OCR was corrected to number of cells. Each sample was run in three to five replicates. Electron microscopy ------------------- Tissue samples were fixed in 2% paraformaldehyde and 1% glutaraldehyde in 0.1 M Sorensen phosphate buffer PH 7.4, followed by 1% Osmiumtetroxid in 0.5 M potassium cyanoferrate buffer. After dehydration, embedding and sectioning, samples were analyzed at the Lund University Bioimaging Center using a Tecnai biotwin 120 kV transmission electron microscope (FEI, Hillsboro, OR, USA). Mitochondrial DNA content ------------------------- Total DNA was isolated using the Allprep RNA/DNA kit from Qiagen (Limburg, Netherlands). DNA samples were diluted to 0.4 ng/*μ*l and a quantitative PCR was performed using primers for nuclear and mitochondrial encoded genes. The relative mitochondrial DNA content of each sample was determined by dividing the levels of mitochondrial DNA by the nuclear encoded genes. For primer sequences see [Supplementary Table 2](#sup1){ref-type="supplementary-material"}. Lactate assay ------------- Cells were seeded into 96-well plates. The following day, 3BrPA was added to the media and 1 h later lactate concentration in cell medium was determined spectrophotometrically using a Lactate Assay Kit from BioVision (Milpitas, CA, USA) according to the manufacturer\'s instructions. The assay was performed under serum-free conditions. Intracellular ATP measurement ----------------------------- Intracellular ATP levels were determined using the Cell Viability Kit SL (BioThema, Handen, Sweden). Cells were seeded in triplicates in a 96-well plate. Twenty-four hours later cells were treated with 3BrPA for 1 h, after which intracellular ATP levels were determined according to the manufacturer\'s instructions. Immunohistochemistry -------------------- Tissue samples or cultured cells were fixed in 4% neutral buffered formalin and embedded in paraffin according to the standard protocols. Immunohistochemical stainings were performed as described previously.^[@bib30]^ Antibodies used were anti-MTCO2 (Abcam), anti-SLC16A1 (Sigma-Aldrich) and anti-Glut1 (Chemicon, Merck Millipore, Darmstadt, Germany). Quantitative Real-Time PCR -------------------------- Total RNA was isolated using the the RNeasy mini kit from Qiagen. cDNA synthesis was performed using M-MuLV reverse transcriptase and random hexamers (Thermo Scientific). Quantitative real-time PCR was performed with the SYBR Green PCR Master Mix (Thermo Scientific) on an Mx 3005 P QPCR system (Agilent Technologies, Santa Clara, CA, USA). The comparative *C*~t~ method was used to quantify relative RNA levels and three separate housekeeping genes (HMBS, RPL13A, YWHAZ) were used for normalization. Primer sequences are listed in [Supplementary Table 2](#sup1){ref-type="supplementary-material"}. FACS analysis ------------- Flow cytometry was performed on a FACS Calibur (BD Biosciences, San Jose, CA, USA). Percentage of apoptotic double-positive cells was determined after staining with Propidium Iodide (Sigma-Aldrich) and Annexin V-APC (BD Biosciences) according to the manufacturer\'s protocols. Cell cycle analysis was performed on fixated cells stained with Propidium Iodide. The percentage of cells in each stage of the cell cycle was determined using the Dean/Jett/Fox algorithm in the FlowJo software (Tree Star Inc., Ashland, OR, USA). Bioinformatic analysis ---------------------- Level 3 RNA-seq data containing mRNA gene-level RSEM estimates were downloaded from The Cancer Genome Atlas (TCGA) data portal (<http://tcga-data.nci.nih.gov/tcga/dataAccessMatrix.htm>) by November 2013. The data comprised 505 ccRCCs and 70 normal kidney specimens analyzed on the Illumina HiSeq platform. RNA-seq data from the following cancer types included in the TCGA data collection were also downloaded for comparisons: BLCA, Bladder Urothelial Carcinoma; BRCA, Breast invasive carcinoma; COAD, Colon adenocarcinoma; GBM, Glioblastoma multiforme; HNSC, Head and Neck squamous cell carcinoma; KICH, Kidney Chromophobe; KIRC, Kidney renal clear cell carcinoma; LAML, Acute Myeloid Leukemia; LGG, Brain Lower Grade Glioma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; OV, Serous Cystadenocarcinoma; PRAD, Prostate adenocarcinoma; READ, Rectum adenocarcinoma; SKCM, Stomach adenocarcinoma; THCA, Thyroid Carcinoma; UCEC, Uterine Corpus Endometrial Carcinoma. RSEM estimate values were multiplied by 10^6^ followed by adding an offset of 10 and subsequently log2 transformed. Two additional data sets (Wang *et al.* GSE14762^[@bib31]^ and Liu *et al.* GSE16441^[@bib32]^) with mRNA expression data of ccRCC and normal kidney were obtained from the Gene Set Omnibus data repository (GEO; <http://www.ncbi.nlm.nih.gov/geo/>). We would like to thank Christina Möller and Elise Nilsson for excellent technical assistance. Lina Gefors at the Lund University Bioimaging Center is acknowledged for electron microscopy. This work was funded by Marianne & Marcus Wallenberg Foundation, the National Association against Kidney Disease, Governmental funding of Clinical Research within the National Health Service (ALF), SUS foundations and donations, and the Malmö General Hospital Research Fund for cancer research. ccRCC : clear cell renal cell carcinoma pVHL : von Hippel Lindau protein 3BrPA : 3-bromopyruvate HIF-1*α* : hypoxia inducible factor 1α HIF-2α : hypoxia inducible factor 2α TCGA : The Cancer Genome Atlas MTCO2 : mitochondrial encoded cytochrome c oxidase II OCR : oxygen consumption rate MCT1 : monocarboxylate transporter 1 [Supplementary Information](#sup1){ref-type="supplementary-material"} accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis) Edited by C Munoz-Pinedo The authors declare no conflict of interests. Supplementary Material {#sup1} ====================== ###### Click here for additional data file. ###### Click here for additional data file. ###### Click here for additional data file. ###### Click here for additional data file. ###### Click here for additional data file. ###### Click here for additional data file. ###### Click here for additional data file. {#fig1} {#fig2} {#fig3} {#fig4} {#fig5} {#fig6}

Iwabuchi BL, Gosselin LA. Implications of acute temperature and salinity tolerance thresholds for the persistence of intertidal invertebrate populations experiencing climate change. Ecol Evol. 2020;10:7739--7754. 10.1002/ece3.6498 1. INTRODUCTION {#ece36498-sec-0001} =============== Recent and predicted future changes in seawater temperature, air temperature, and seawater salinity are significant climate change‐related threats to many marine invertebrates (Byrne, [2012](#ece36498-bib-0005){ref-type="ref"}; Wernberg, Smale, & Thomsen, [2012](#ece36498-bib-0064){ref-type="ref"}), creating conditions that have the potential to cause alterations in species abundance and distribution (Hawkins et al., [2008](#ece36498-bib-0023){ref-type="ref"}). Average global sea surface temperature (SST) has been changing at a rate of 1.1°C per century (IPCC, [2014](#ece36498-bib-0028){ref-type="ref"}) and is projected to increase by 0.5--1.8°C by the year 2100 relative to 1986--2005. In turn, sea surface salinity (SSS) trends vary among regions, with certain regions having experienced ocean water freshening by as much as 0.2 PSU from 1950--2008, while other regions became more saline by as much as 0.2 PSU and others yet experienced no significant change (Durack & Wijffels, [2010](#ece36498-bib-0013){ref-type="ref"}; IPCC, [2014](#ece36498-bib-0028){ref-type="ref"}). It is predicted that SSS will become less saline in high latitude regions that currently have low SSS and more saline in subtropical regions with high SSS (Collins et al., [2013](#ece36498-bib-0009){ref-type="ref"}). Rates of change in global SST and SSS vary by region (IPCC, [2014](#ece36498-bib-0028){ref-type="ref"}), such that populations and communities may experience localized trends in climate‐related conditions. One region in which local trends in SST and SSS are well defined is the coast of Vancouver Island, Canada. Yearly SSS minima along the coasts of Vancouver Island have remained unchanged since 1935 (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). SST along the same coasts, however, is increasing; during summertime, when SST is highest and most stressful for coastal marine animals, SST has been increasing linearly since 1935 at a rate of 0.821--0.967°C per century (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Given these changing environmental conditions, for populations to persist in their present‐day range they must either (a) already have broad enough tolerances to function under future environmental conditions or (b) acquire increased tolerance thresholds, through local adaptation and acclimatization, rapidly enough to keep pace with the changing conditions (Clarke, [2003](#ece36498-bib-0008){ref-type="ref"}; Sanford & Kelly, [2011](#ece36498-bib-0049){ref-type="ref"}). Local adaptation in tolerance thresholds to environmental parameters, such as temperature, is known to occur in coastal marine organisms, even with moderate gene flow among populations (e.g., populations of the marine snail *Chlorostoma funebralis* displaying different thermal tolerances despite evidence of extensive gene flow; Gleason & Burton, [2013](#ece36498-bib-0018){ref-type="ref"}) and is hypothesized to be quite common (Sanford & Kelly, [2011](#ece36498-bib-0049){ref-type="ref"}), but has not been examined in most marine species. In fact, neither of the above two options are well understood for most coastal marine invertebrates, constraining our ability to predict how populations will respond to future changes in climate conditions. Furthermore, to date studies of local adaptation in tolerance thresholds to environmental parameters by marine species have primarily involved comparisons of populations located across a range of latitudes (Compton, Rijkenberg, Drent, & Piersma, [2007](#ece36498-bib-0010){ref-type="ref"}; Fangue, Hofmeister, & Schulte, [2006](#ece36498-bib-0015){ref-type="ref"}; Kelly, Sanford, & Grosberg, [2011](#ece36498-bib-0032){ref-type="ref"}; Kuo & Sanford, [2009](#ece36498-bib-0036){ref-type="ref"}; Leong, Sun, & Edmands, [2018](#ece36498-bib-0037){ref-type="ref"}; Morley, Hirse, Portner, & Peck, [2009](#ece36498-bib-0040){ref-type="ref"}; Sunday, Bates, & Dulvy, [2010](#ece36498-bib-0060){ref-type="ref"}; Sunday et al., [2019](#ece36498-bib-0061){ref-type="ref"}; Woolsey, Keith, Byrne, Schmidt‐Roach, & Baird, [2015](#ece36498-bib-0067){ref-type="ref"}; Zippay & Hofmann, [2010](#ece36498-bib-0069){ref-type="ref"}), an approach that cannot distinguish temperature or salinity effects from latitudinal effects. Comparisons of populations located at a same latitude are thus preferable. In the context of predicting the effects of future climate change on marine populations, it is informative to understand how past climate‐related conditions have shaped present‐day tolerance thresholds. In particular, the responsiveness of populations to altered climate conditions can be indirectly assessed by examining the extent to which present‐day tolerance thresholds vary among populations of given species relative to existing spatial variation in climate conditions (Bennett, Wernberg, Arackal Joy, de Bettignies, & Campbell, [2015](#ece36498-bib-0003){ref-type="ref"}; Sanford & Kelly, [2011](#ece36498-bib-0049){ref-type="ref"}; Sorte, Jones, & Miller, [2011](#ece36498-bib-0054){ref-type="ref"}). Such intraspecific variation in tolerance thresholds remains poorly understood, likely due to the logistic challenges of such studies. Assessments of the link between interpopulation variation and local environmental conditions are most effective when (a) specimens are collected from two or more populations that are distant enough to have limited gene flow and to experience distinct climates (Bennett et al., [2015](#ece36498-bib-0003){ref-type="ref"}), (b) all studied populations are located at a same latitude to avoid confounding latitudinal effects (Bernardo, [1996](#ece36498-bib-0004){ref-type="ref"}; Levitan, [2000](#ece36498-bib-0038){ref-type="ref"}), and (c) tolerance thresholds of all populations are tested at the same time in a common garden setting using similar methodology (Byrne, [2012](#ece36498-bib-0005){ref-type="ref"}). The southern region of Vancouver Island in British Columbia, Canada, provides an excellent setting to study the relationship between present‐day tolerance thresholds of intertidal invertebrate populations and local environmental conditions. Populations on east and west coasts of the island have experienced persistent (\>82 years) regional differences in extreme SST and SSS, with east coast surface waters reaching extreme temperatures that are 5.2°C warmer and extreme salinities that are 8.7 PSU lower during the most stressful months than on the west coast (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Correspondingly, the highest daily rock surface temperatures in the intertidal zone during summertime (July--August) low tides are 3.9--4.2°C warmer on the east coast than on the west coast (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}), thus exposing populations of intertidal animals on the two coasts to distinct emersion temperature conditions at low tide. In addition, populations of marine animals on the east and west coasts are separated by dispersal distances \>350 km around the south of the island, a substantially greater distance than the average neighborhood size of 10--100 km in marine invertebrates (Palumbi, [2004](#ece36498-bib-0042){ref-type="ref"}), suggesting limited gene flow between east and west coast populations. For researchers, however, travel distances by road across the island are only \~150 km, allowing the sampling of intertidal animals from each coast and their return to a common laboratory within a few hours. Furthermore, the coastal waters of the Northeast Pacific are of particular interest due to their high primary productivity, high coastal biomass, and high species diversity (Croom, Wolotira, & Henwood, [1995](#ece36498-bib-0011){ref-type="ref"}) which may be threatened by changing climate conditions. If tolerance thresholds of intertidal species adapt rapidly in response to local SST, SSS, and temperature during low tide emersion, then the persistent and substantial differences in these conditions between the east and west coasts of Vancouver Island, coupled with substantial dispersal distances that restrict genetic mixing of populations, would be expected to have promoted divergence in tolerance thresholds between populations of these two coasts. We therefore hypothesized that east coast populations of marine species should currently exhibit greater tolerance to elevated temperature and to reduced salinity than west coast populations. To test this hypothesis, we examined 4 species of intertidal invertebrates that have substantial populations on both coasts of Vancouver Island: the marine snails *Nucella lamellosa, Littorina scutulata* and *Littorina sitkana,* and the barnacle *Balanus glandula* (Figure [1](#ece36498-fig-0001){ref-type="fig"}). As in many benthic invertebrate species, generation time in 3 of these species is relatively short, with individuals starting to reproduce after only 1 year in *L. sitkana* (Reid, [1996](#ece36498-bib-0047){ref-type="ref"}), *L. scutulata* (Chow, [1987](#ece36498-bib-0007){ref-type="ref"}), and *B. glandula* (Barnes & Barnes, [1956](#ece36498-bib-0002){ref-type="ref"}), providing opportunity for rapid evolutionary responses to selective pressures. *N. lamellosa* have a longer generation time, reportedly reaching maturity at 3--4 years of age (Marko, [2004](#ece36498-bib-0039){ref-type="ref"}; Spight, [1975](#ece36498-bib-0057){ref-type="ref"}). Additionally, these species differ in terms of dispersal abilities, and thus possibly in gene flow: *L. scutulata* and *B. glandula* have dispersing planktonic larvae, whereas *L. sitkana* and *N. lamellosa* have benthic direct‐developing larvae (Strathmann, [1987](#ece36498-bib-0059){ref-type="ref"}). Dispersal ability is of particular interest for studies of interpopulation variation, as local adaptation might be more likely in species with limited dispersal capability (Endler, [1977](#ece36498-bib-0014){ref-type="ref"}; Foden et al., [2013](#ece36498-bib-0016){ref-type="ref"}; Scheltema, [1971](#ece36498-bib-0050){ref-type="ref"}). Lastly, these species also differ in terms of habitat preference, with *L. sitkana*, *L. scutulata,* and *B. glandula* all occupying the mid‐intertidal zone to high intertidal zone, while *N. lamellosa* inhabits the low to mid‐intertidal zone. The habitat preference of a species is important to consider when studying tolerance thresholds, as the mid‐intertidal zone to high intertidal zone experiences greater temperature and salinity stress than the low intertidal zone (Somero, [2002](#ece36498-bib-0052){ref-type="ref"}; Stephenson, [1942](#ece36498-bib-0058){ref-type="ref"}). Thus, it is likely that species inhabiting the high intertidal zone will have more robust tolerance to increased temperature and reduced salinity conditions than low intertidal species. {#ece36498-fig-0001} Determining the tolerance thresholds of local populations that have been exposed to different climate conditions for extended periods of time will help understand how intertidal species may respond to future changes in climate conditions. The present study therefore aimed to determine (a) the extent to which populations of intertidal invertebrates, exposed to different levels of temperature and salinity stress over many generations, have diverged in their acute tolerance thresholds to these stresses, and also (b) if present‐day acute tolerance thresholds of intertidal invertebrates might be sufficient to survive future temperature and salinity extremes that are predicted for these coasts. Using a series of common garden experiments, the study specifically compared the responses of populations inhabiting the east and west coasts of Vancouver Island to elevated temperature during low tide emersion, elevated water temperature, and low salinity. In addition, the inclusion of species with direct development as well as species with planktonic larval development provided insight into the influence of dispersal ability on local tolerance thresholds to temperature and salinity conditions. 2. MATERIALS AND METHODS {#ece36498-sec-0002} ======================== 2.1. Study sites and animals {#ece36498-sec-0003} ---------------------------- For each species of intertidal invertebrate examined in this study, individuals were collected from two populations, one population on the east coast of Vancouver Island (British Columbia, Canada) and the other on the west coast of the island; each population was subsampled from 3 replicate sites per coast, with sites on both coasts being located at similar latitudes. The 3 sites on the west coast of the island were located within Barkley Sound, and the 3 sites on the east coast were located in the Strait of Georgia between Fanny Bay and Royston (Figure [2](#ece36498-fig-0002){ref-type="fig"}). Sites within a single coast were 2.5--8.9 km from each other and were selected based on the following criteria: (a) consisting of rocky substrata and (b) experiencing low to moderate wave action. The latter criterion was confirmed by direct observations and by the presence of *Nucella lamellosa*, an intertidal gastropod that does not colonize wave‐exposed habitats (Kitching, [1976](#ece36498-bib-0033){ref-type="ref"}). East and west coast sites nevertheless differed somewhat in substratum, being dominated by boulders on the east coast and by bedrock on the west coast, and by tidal amplitude, tides reaching a maximum height of 5.2 m at east coast sites and 3.9 m at west coast sites (Table [1](#ece36498-tbl-0001){ref-type="table"}). {#ece36498-fig-0002} ###### Coordinates and characteristics of the intertidal zone at each east and west coast site on Vancouver Island, British Columbia, Canada Site Latitude (N) Longitude (W) Substrate Max. tidal height (m) ---------------- -------------- --------------- -------------------- ----------------------- West coast Fleming Island 48°53.07′ 125°07.40′ Bedrock & boulders 3.9 Ross Islets 48°52.33′ 125°09.72′ Bedrock & boulders 3.9 Grappler Inlet 48°49.91′ 125°07.10′ Bedrock & gravel 3.9 East coast Site A 49°32.26′ 124°51.55′ Boulders & gravel 5.2 Site B 49°33.50′ 124°52.30′ Boulders & mud 5.2 Site C 49°36.84′ 124°54.15′ Boulders & gravel 5.2 Maximum tidal height refers to the highest high tide recorded in the summer (April--September) of 2015 and 2016 as per chart datum. John Wiley & Sons, Ltd Adults of 4 species of rocky intertidal invertebrates were examined: the snails *N. lamellosa*, *L. sitkana*, and *L. scutulata*, and the barnacle *B. glandula* (Figure [1](#ece36498-fig-0001){ref-type="fig"}). These species were selected based on the presence of a large number of individuals of the species at all study sites. In addition to experiments determining tolerance thresholds, the upper limit of intertidal distribution of each population was also assessed. At each of the 3 sites per coast, three 5 m wide vertical transects through the intertidal zone were carefully surveyed at low tide; for each species, the highest vertical extent of distribution of live individuals within the transect, relative to chart datum, was measured. Then, for each species, these measurements of upper extent of distribution were averaged among the 3 transects per site, and the averages for the 3 sites per coast were then averaged to obtain a single overall average upper limit of distribution for the population (Appendix [S1](#ece36498-sup-0001){ref-type="supplementary-material"}D). 2.2. Field collection of animals {#ece36498-sec-0004} -------------------------------- All three common garden experiments in this study were carried out at the Bamfield Marine Sciences Centre (BMSC), on the west coast of Vancouver Island. A separate collection of animals was carried out for each trial of these experiments, with collections at all east and west coast sites being carried out in a 36 hr period. Animals collected on east coast sites were accessed by road and travel time to bring animals from the field to BMSC was 2.0--6.5 hr. West coast sites were accessed by boat, and travel time to BMSC was approximately 2.5 hr. The duration of emersion experienced by all animals was within the timeframe of a low tide emersion period. Heat stress on the trip from east coast sites to BMSC was prevented by placing animals in a cooler containing bags of seawater (11--14°C) as well as ice packs covered by towels; temperature within the cooler always remained below 17°C during transportation, as monitored by Thermochron^®^ iButton temperature loggers (model DS1921G‐F5) placed within the cooler. On the west coast, potential heat stress was minimized by the shorter travel duration and by keeping animals in shaded conditions. Individuals of each snail species (*L. sitkana, L. scutulata* and *N. lamellosa*) and small rocks with at least 10 individual *B. glandula* were collected at each site on days when the daytime low tide dropped below 1.5 m. At the time of collection, adult individuals of each species were collected near the upper limit of the intertidal distribution of the species (Appendix [S1](#ece36498-sup-0001){ref-type="supplementary-material"}D) and were obtained from on (*L. sitkana, L. scutulata* and *B. glandula*) or under (*N. lamellosa*) intertidal rock surfaces that lay outside tide pools. Upon arrival at BMSC, healthy adults of *N. lamellosa*, *L. sitkana*, and *L. scutulata* were distributed among experimental cages, one species per cage. Experimental cages consisted of plastic containers with screened walls allowing free movement of water through the cage. Ten adult *B. glandula* of a similar size were haphazardly selected on each rock and labeled with a small dot of an oil‐based paint marker on one of their lateral plates. All caged animals were then immediately placed in trays containing aerated seawater filtered to 200 µm, held at 15.0--17.5°C and 30--32 PSU. During all circumstances wherein animals were submerged in seawater (i.e., prior to and during experiments), *N. lamellosa* were held in tanks that were isolated from *L. sitkana*, *L. scutulata,* and *B. glandula*, preventing the exchange of odors and thus stress associated with the proximity of predator and prey. 2.3. Tolerance experiments {#ece36498-sec-0005} -------------------------- Three experiments were performed during the summer months (June--August) to compare tolerance thresholds between the east and west coast populations of the 4 study species. These experiments tested population tolerance thresholds to (a) elevated ambient temperature during low tide emersion, (b) elevated water temperature when immersed, and (c) decreased salinity when immersed. Animals were tested as soon as possible after collecting from the field to ensure they were still habituated to the warm summertime conditions experienced in the field; animals were held in the laboratory, unfed, for only 48--72 hr prior to experimentation, to allow them to stabilize after field collection and travel and to ensure they were healthy at the start of the experiments. ### 2.3.1. Emersion temperature tolerance {#ece36498-sec-0006} To determine tolerance thresholds to emersion temperature, individuals were subjected to a series of species‐specific temperature treatments (Table [2](#ece36498-tbl-0002){ref-type="table"}). *L. sitkana* and *L. scutulata* were collected from the 6 study sites on 28 and 29 July 2015; *N. lamellosa* and *B. glandula* were collected on 13 and 14 August 2015. ###### Summary of emersion temperature, water temperature, and salinity tolerance experimental designs for each of the four species Species Emersion temperature tolerance experiment Water temperature tolerance experiment Salinity tolerance experiment ----------------------- ------------------------------------------- ---------------------------------------- ------------------------------- -------------------- --- ---- ----- ---------------- --- ---- ----- ------------------------------------------- *Nucella lamellosa* 3 8 576 25, 28, 30, 32 4 7 168 25, 28, 29 4 5 120 25, 20, 18, 16, 14, 12, 10, 8, 6, 4, 2 *Littorina scutulata* 5 10 1,500 36, 38, 40, 42, 45 4 10 240 24, 28, 31, 34 5 10 300 25, 20, 18, 16, 14, 12, 10, 8, 6, 4, 2, 0 *Littorina sitkana* 5 10 1,500 36, 38, 40, 42, 45 4 10 240 24, 28, 31, 34 5 10 300 25, 20, 18, 16, 14, 12, 10, 8, 6, 4, 2, 0 *Balanus glandula* 5 10 900 37, 42, 45 4 10 240 24, 28, 31, 34 5 10 300 25, 20, 18, 16, 14, 12, 10, 8, 6, 4, 2 In the case of emersion tolerance experiments, separate groups of animals were placed in each of the temperature treatments, and temperature treatments for a given species were carried out simultaneously. In both the water temperature and salinity experiments, all individuals of a given species experienced all water temperature treatments or salinity treatments expressed in the table (except for those dying before reaching the final experimental treatment). Furthermore, water temperature and salinity treatments were carried out sequentially, starting with the lowest temperature in the case of water temperature experiments, and the highest salinity, in the case of salinity experiments. John Wiley & Sons, Ltd Immediately before starting each trial of the emersion temperature experiment, cages (or rocks, in the case of *B. glandula*) were removed from the holding tanks, and residual water was blot‐dried from the animals and cages. Next, the replicate cages (*N. lamellosa*, *L. sitkana*, *L. scutulata*) or rocks (*B. glandula*) were placed in either air‐tight plastic bags or containers that retained high levels of relative humidity and thus minimized desiccation stress throughout the experiment. To ensure high relative humidity, three 4 × 4 cm paper towels saturated with seawater were also added to each bag or container. At the time of sealing the containers, just before moving these to the temperature treatment incubators, sensors (iButton^®^ model DS1923 humidity loggers) inside the containers indicated relative humidity was at least 80%; relative humidity then increased over the following 1--2 hr in all containers, stabilizing at levels of 90%--98%. The bags and containers were transferred into temperature‐controlled incubators, preset to the desired temperature treatment, for a 12 hr duration. The 12 hr duration of these emersion temperature treatments was chosen so as to slightly exceed the maximum duration of emersion conditions during a low tide in the field; the longer duration of treatments in the water temperature and the salinity tolerance experiments, as described below, is consistent with the longer‐term exposure of intertidal animals to seawater in the field. After the 12 hr treatment, cages or rocks were submerged in aerated seawater at 17°C for a 12 hr recovery period. Animals were then checked for mortality using species‐specific procedures involving the inspection of inactive organisms for movement responses via gentle probing or timed seawater immersion; details of the procedure are listed in Appendix [S1](#ece36498-sup-0001){ref-type="supplementary-material"}A. The temperature treatments used in this experiment where chosen, based on preliminary trials (Appendix [S1](#ece36498-sup-0001){ref-type="supplementary-material"}B) with each species, to ensure mortality outcomes ranging from 0% to 100%. The binomial mortality data (i.e., alive or dead) were used to calculate the temperature lethal to 50% of individuals (LT~50~) for each site and species using general linear model (GLM) analysis in R statistical software (R Core Team, [2015](#ece36498-bib-0046){ref-type="ref"}); the LT~50~ values calculated for each of the 3 sites of a same coast were then averaged to represent the population average thermal tolerance. ### 2.3.2. Water temperature tolerance {#ece36498-sec-0007} Animals used in water temperature tolerance experiments were collected from east and west coast sites on 3 and 4 August 2016, respectively. Cages were distributed among aerated experimental tanks containing 30--32 PSU, 200 µm filtered seawater preheated to a desired temperature treatment. Preliminary water temperature tolerance experiments revealed that all species survived temperatures up to 24°C. To gradually warm the animals up to this temperature, they were exposed to a 1°C increase in seawater temperature per day until 25°C was reached; details of the procedure are listed in Appendix [S1](#ece36498-sup-0001){ref-type="supplementary-material"}C. Then, to determine water temperature tolerances of east and west coast populations, animals from each site were exposed to progressively warmer temperatures, starting at 25°C and increasing at 3°C intervals (Table [2](#ece36498-tbl-0002){ref-type="table"}), with one exception: In the last *N. lamellosa* temperature treatment, there was a malfunction of the heater units resulting in a temperature increase of only 1°C from 28°C to 29°C (Table [2](#ece36498-tbl-0002){ref-type="table"}). Animals were exposed to a given temperature treatment for 36 hr, followed by an 8 hr recovery period at 17°C, and then a 4 hr mortality check (Appendix [S1](#ece36498-sup-0001){ref-type="supplementary-material"}A) at room temperature (\~20°C). Surviving animals were then placed in the next warmer temperature treatment for 36 hr (Table [2](#ece36498-tbl-0002){ref-type="table"}). Water temperature treatments for each species ceased when all animals had died. The temperature at death (TAD) of each animal in the experiment was then used to calculate the average TAD for each species, for each site. ### 2.3.3. Salinity tolerance {#ece36498-sec-0008} East and west coast animals were collected on 22 and 23 June 2016. All seawater used in the experiment, including salinity treatments and recovery periods, was filtered to 200 µm and held at 17--19°C. Reduced salinities in this experiment were obtained by mixing filtered seawater with deionized water. To determine salinity tolerances of east and west coast populations, animals were exposed to 12 progressively decreasing salinity treatments, starting at 25 PSU, then decreasing to 20 PSU, and from then on decreasing at 2 PSU intervals (Table [2](#ece36498-tbl-0002){ref-type="table"}). Within each treatment, animals were exposed to a given salinity for 33 hr, followed by a 12 hr recovery period at 30 PSU, and then monitored for mortality over a 3 hr period at room temperature (\~20°C). Surviving animals were then placed in the next reduced salinity treatment. The salinity at death (SAD) of each individual animal in the experiment was then used to calculate the average SAD for each species, for each site. 2.4. Present‐day tolerance thresholds relative to predicted future conditions {#ece36498-sec-0009} ----------------------------------------------------------------------------- The second goal of the study, to determine if present‐day tolerance thresholds of these intertidal populations might be overwhelmed in the near future by extreme levels of acute temperature and salinity stress, was addressed in two steps. In the first step, present‐day tolerance thresholds to temperature and salinity were compared to the most extreme SST, SSS and emersion temperature conditions recorded on each coast. All data on extreme temperature and salinity conditions for the two coasts were obtained from Iwabuchi and Gosselin ([2019](#ece36498-bib-0029){ref-type="ref"}). The most extreme (warmest) SST conditions on each coast were identified by seeking the highest summertime (July and August) SST reported for 2006--2016 for each coast. Extreme SSS conditions were defined by the lowest SSS reported from 2006--2016, which on the east coast occurs in June and July, and on the west coast occurs in January and February (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Extreme emersion temperatures were defined by the highest intertidal rock surface temperatures recorded at 1.5 m and 2.25 m tidal heights during daytime low tides in the summers (July and August) of 2015--2016 (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). The next step, assessing whether acute conditions might jeopardize the persistence of these populations in the near future, consisted of estimating how long it would take for extreme conditions of two parameters that are becoming more stressful over time, SST and emersion temperature, to reach levels matching the present‐day tolerance thresholds of each population (i.e., assuming no evolution of tolerance thresholds). Although it is possible that future rates of change in these parameters might differ from present‐day rates, SST has been increasing linearly since monitoring started in 1935 (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}), and thus our calculations of future SST and of emersion temperatures were based on the assumption of continued linear rates of change. This was accomplished by extrapolating forward based on present‐day extreme levels and known rates of change for each parameter, to determine the year when extremes of each parameter would reach the present‐day tolerance threshold of each population. For SST, the rate of change for each coast was based on long‐term (1935--2016) datasets from coastal lighthouse monitoring stations. In contrast, no long‐term dataset exists for intertidal rock surface temperature in this region, so there was no direct way of quantifying rates of change to predict future levels of intertidal substratum temperature. Predictions of future trends in air temperature on these same coasts, however, have been reported (White et. al.,  [2016](#ece36498-bib-0065){ref-type="ref"}); these trends in air temperature were used to predict future substratum temperature. While air temperature and intertidal substratum temperature are often quite different at any given moment (Judge, Choi, & Helmuth, [2018](#ece36498-bib-0031){ref-type="ref"}), the prediction of long‐term rate of change in air temperature was nevertheless used here as a rough estimator of long‐term rate of change in low tide substratum temperature. 2.5. Statistical analysis {#ece36498-sec-0010} ------------------------- In the immersion temperature and salinity experiments, each animal was exposed to a series of increasingly stressful conditions and was monitored over time for survival. This allowed us to determine the temperature or salinity at which death occurred for each individual. For those two parameters, tolerance thresholds were quantified using average temperature at death (TAD) and average salinity at death (SAD), with each individual animal being a replicate measure. That approach, however, could not be used in the emersion temperature experiment because the treatment consisted of one emersion period, simulating an extended low tide, and each individual had to be exposed to one treatment condition for the full duration (12 hr); as a result, different individuals were placed in different temperature conditions, and each individual experienced only one treatment. Thus, emersion temperature tolerance thresholds were determined by calculating LT~50~ values. All statistical analyses of data from emersion temperature, water temperature, and salinity experiments, as well as upper limits of intertidal distribution, were completed using R Statistical software (R Core Team, [2015](#ece36498-bib-0046){ref-type="ref"}). In each case, data were tested for normality using the Shapiro--Wilk test and for homogeneity of variance using the Fligner--Killeen test. The tolerance thresholds of east and west coast populations to elevated emersion temperature were compared using a general linear mixed model (GLMM) with a binomial distribution (i.e., alive or dead) for each species. In this model, both temperature and coast were designated fixed effects, while site was random. To determine if there were differences in tolerance thresholds to elevated water temperature or reduced salinity between east and west coast populations of a species, TAD and SAD were compared between populations using mixed model nested analysis of variance (ANOVA). In both analyses, coast was treated as a fixed effect whereas site was classified as a random effect and was nested within coast. Finally, to determine the interspecific relationships between upper limit of intertidal distribution and tolerance thresholds (i.e., emersion LT~50~, TAD, SAD), Pearson correlation analyses were performed for each species using the Hmisc package in R. 3. RESULTS {#ece36498-sec-0011} ========== 3.1. Tolerance experiments {#ece36498-sec-0012} -------------------------- ### 3.1.1. Emersion temperature tolerance {#ece36498-sec-0013} Intraspecific variation in emersion temperature tolerance was detected in 2 of the 4 species; emersion temperature tolerance thresholds differed significantly between east and west coast populations of *N. lamellosa* and *B. glandula,* but not in *L. sitkana* and *L. scutulata* (Table [3](#ece36498-tbl-0003){ref-type="table"}). In the 2 species with significant intraspecific variation, east coast populations were more tolerant of elevated emersion temperature than west coast populations; this same trend was also apparent in *L. sitkana* but was not significant (Table [3](#ece36498-tbl-0003){ref-type="table"}). For *N. lamellosa*, the LT~50~ of the east coast population was 1.4°C higher than that of the west coast population; in *B. glandula,* the LT~50~ of the east coast population was 1.5°C higher than that of the west coast population (Figure [3](#ece36498-fig-0003){ref-type="fig"}). ###### Results of general linear mixed model (GLMM) with binomial distribution analyzing the effect of location (i.e., east or west coast) on mortality of invertebrate populations in response to emersion temperature treatments Estimate *SE* Pr(\>\|z\|) ----------------------------------------------------------------- ---------- --------- ------------- *Nucella lamellosa* [^a^](#ece36498-note-0004){ref-type="fn"} Intercept 57.8012 5.5259 \<0.001 Temperature −1.9187 0.1836 \<0.001 West coast −2.2929 0.4291 **\<0.001** *Littorina scutulata* [^b^](#ece36498-note-0005){ref-type="fn"} Intercept 51.9691 2.8634 \<0.001 Temperature −1.3349 0.0724 \<0.001 West coast 0.6323 0.7117 0.374 *Littorina sitkana* [^c^](#ece36498-note-0006){ref-type="fn"} Intercept 56.9818 3.29223 \<0.001 Temperature −1.3889 0.07901 \<0.001 West coast −1.3231 0.87964 0.133 *Balanus glandula* [^d^](#ece36498-note-0007){ref-type="fn"} Intercept 47.9282 3.745 \<0.001 Temperature −1.1347 0.08824 \<0.001 West coast −1.9533 0.32441 **\<0.001** Shown are the estimated coefficients, standard errors (*SE*), and statistical significance for the explanatory variables. Each row labeled as West coast in this table represents a comparison with the East coast population. 8 animals × 3 replicates × 4 treatments. 10 animals × 5 replicates × 5 treatments. 10 animals × 5 replicates × 5 treatments. 10 animals × 5 replicates × 3 treatments. John Wiley & Sons, Ltd {#ece36498-fig-0003} Interspecific variation in emersion temperature tolerance was significantly related to the upper limit of intertidal distribution of these species (Table [4](#ece36498-tbl-0004){ref-type="table"}). This was primarily due to the low intertidal species (*N. lamellosa)* displaying a considerably lower tolerance (8.7--11.3°C) to emersion temperature than the upper intertidal species (*L. sitkana, L. scutulata, B. glandula)*. No species survived emersion temperatures greater than 42°C (Figure [3](#ece36498-fig-0003){ref-type="fig"}). ###### Pearson correlation analyses of the relationship between upper limit of intertidal distribution of east and west coast populations and tolerance thresholds to elevated emersion and sea surface temperatures and to reduced salinity (*n* = 4) Parameter East West ---------------------------- -------- ------- -------- ------- Emersion LT~50~ .9546 .0454 .9871 .0130 Water temperature at death .9953 .0045 .9915 .0085 Salinity at death −.8315 .1685 −.9327 .0673 John Wiley & Sons, Ltd ### 3.1.2. Water temperature tolerance {#ece36498-sec-0014} Intraspecific variation in water temperature tolerance was detected in 2 species. Water temperature tolerance differed significantly between east and west coast populations of *B. glandula* (Nested ANOVA: *F* ~1,\ 4~ = 9.97, *p* = .034) and *L. scutulata* (Nested ANOVA: *F* ~1,\ 4~ = 9.30, *p* = .045), although in this case it was the west coast populations displaying slightly higher (0.4°C) tolerance thresholds to elevated water temperature than east coast populations (Figure [4](#ece36498-fig-0004){ref-type="fig"}). Water temperature tolerance did not differ between east and west coast populations of *N. lamellosa* (Nested ANOVA: *F* ~1,\ 4~ = 0.39, *p* = .566) or *L. sitkana* (Nested ANOVA: *F* ~1,\ 4~ = 2.69, *p* = .177). {#ece36498-fig-0004} Interspecific variation in water temperature tolerance was also significantly related to the upper limit of intertidal distribution of these species on both coasts (Table [4](#ece36498-tbl-0004){ref-type="table"}). Here again, the trend was mainly due to *N. lamellosa* being substantially less tolerant and distributed lower in the intertidal zone than the 3 other species (Figure [4](#ece36498-fig-0004){ref-type="fig"}). Water temperature tolerance did not exceed 34°C for any of the species. ### 3.1.3. Salinity tolerance {#ece36498-sec-0015} Intraspecific variation in salinity tolerance, between east and west coast populations, was not detected in *N. lamellosa* (Nested ANOVA: *F* ~1,4~ = 0.510, *p* = .524), *L. scutulata* (Nested ANOVA: *F* ~1,4~ = 1.140, *p* = .351), *L. sitkana* (Nested ANOVA: *F* ~1,4~ = 0.175, *p* = .714), or *B. glandula* (Nested ANOVA: *F* ~1,4~ = 0.604, *p* = .518). Salinity tolerance differed among species, however, with *N. lamellosa* (*M* = 5.07, *SD* = 0.543) being less tolerant of reduced salinity than *L. sitkana* (*M* = 0.187, *SD* = 0.214)*;* *t*(10) = 20.5, *p* \< .001), *L. scutuata* (*M* = 1.52, *SD* = 0.806); (*t*(10) = 8.94, *p* \< .001), and *B. glandula* (*M* = 2.62, *SD* = 2.37); (*t*(6) = 2.46, *p* = .049), as seen in Figure [5](#ece36498-fig-0005){ref-type="fig"}. Interspecific variation in SAD, however, was not quite significantly related to the upper limit of intertidal distribution (Table [4](#ece36498-tbl-0004){ref-type="table"}). {#ece36498-fig-0005} 3.2. Present‐day tolerance thresholds relative to predicted future conditions {#ece36498-sec-0016} ----------------------------------------------------------------------------- For the 3 upper intertidal species examined herein, emersion LT~50~ values for east and west coast populations were substantially higher than the warmest emersion temperature recorded at 2.25 m on the respective coast (Figure [6a,b](#ece36498-fig-0006){ref-type="fig"}). The temperature tolerance thresholds of east coast populations of upper intertidal species were 5.6--8.3°C higher than the highest rock surface temperature recorded on the east coast, while west coast temperature tolerances were 9.5--10.2°C higher than the warmest rock surface temperature recorded on that coast. In contrast, east and west coast populations of the low intertidal species *N. lamellosa* had emersion LT~50~ values that were 1.4 and 2.8°C lower, respectively, than present‐day highest substratum temperatures reported at 1.5 m on either coast (Figure [6a,b](#ece36498-fig-0006){ref-type="fig"}). Finally, if substratum temperature increases at the same rate as summertime air temperature (i.e., 0.8°C per century on the east coast and 1.1°C per century on the west coast, White et al., [2016](#ece36498-bib-0065){ref-type="ref"}); then, it would take several centuries before predicted maximum emersion temperatures reach present‐day LT~50~ values of east and west coast populations of the 3 upper intertidal species (Figure [6c,d](#ece36498-fig-0006){ref-type="fig"}). No such calculations were made for *N. lamellosa*, as emersion temperature tolerances of this species are already exceeded by present‐day maximum temperatures of exposed rock surfaces at 1.5 m. {ref-type="ref"}); extrapolations of those temperatures into the future were based on predicted rates of change in air temperature on each coast by White et al. ([2016](#ece36498-bib-0065){ref-type="ref"})](ECE3-10-7739-g006){#ece36498-fig-0006} Present‐day water temperature tolerances of east and west coast populations in all 4 species were considerably greater than the warmest extreme SST recorded on each coast in July and August from 2006 to 2016 (Figure [7a,b](#ece36498-fig-0007){ref-type="fig"}). East coast populations displayed temperature tolerance thresholds that were 7.8--12.7°C greater than the highest reported extreme SST on the east coast, and tolerance thresholds of west coast populations were 12.1--17.4°C greater than the highest reported SST on that coast. Although maximum summertime SSTs are predicted to become progressively warmer in the future on both coasts of Vancouver Island (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}), maximum SSTs are not expected to match present‐day acute immersion temperature tolerance of any of the 4 species for several hundred years (Figure [7c,d](#ece36498-fig-0007){ref-type="fig"}). However, the higher present‐day SSTs on the east coast, coupled with the current rate of increase in SST on the east coast, may create conditions that threaten east coast population persistence sooner than west coast population persistence. {ref-type="ref"})](ECE3-10-7739-g007){#ece36498-fig-0007} Populations of all 4 species were able to tolerate acute exposure to salinities substantially lower than the lowest SSS conditions recorded on either coast from 2006 to 2016 (Figure [8a,b](#ece36498-fig-0008){ref-type="fig"}). Upper intertidal species were the most tolerant of low salinities, with present‐day salinity tolerance thresholds of east coast populations enabling them to withstand salinity conditions 10.2--13.7 PSU lower than the single lowest SSS presently occurring on the east coast, and west coast populations tolerating acute exposure to salinity conditions 22.4--24.0 PSU lower than the single lowest SSS reported for that coast. Although not quite as tolerant of low salinities as the upper intertidal species, *N. lamellosa* could withstand acute exposure to SSS conditions 8.6 (east) and 19.4 (west) PSU lower than the lowest SSS conditions presently experienced on each respective coast (Figure [8a,b](#ece36498-fig-0008){ref-type="fig"}). Given the long‐term trend of increasing minimum SSS on the east coast and the absence of a trend on the west coast since 1935 (i.e., no detectable change in minimum SSS, Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}), there is no indication that yearly minimum SSS conditions will become more stressful for the populations studied here for the foreseeable future. {ref-type="ref"})](ECE3-10-7739-g008){#ece36498-fig-0008} 4. DISCUSSION {#ece36498-sec-0017} ============= 4.1. Extent of interpopulation variation in tolerance thresholds {#ece36498-sec-0018} ---------------------------------------------------------------- Populations of marine invertebrates living on the east and west coasts of Vancouver Island have been exposed to distinct extremes in SST and SSS conditions at least since monitoring started in 1935, and probably for considerably longer (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Intertidal species inhabiting these two coasts also experience different extreme emersion temperatures during the warmest time of the year (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Given the early age at first reproduction in these species (1--4 years), east and west coast populations will have experienced these distinct environmental conditions over many generations, providing opportunity for divergent trends in tolerance thresholds. The measures of temperature and salinity tolerance thresholds reported herein, however, suggest a very modest degree of divergence among populations in acute tolerance of extreme temperature and salinity conditions. The finding that best supported the local adaptation hypothesis was the difference between east and west coast populations in acute tolerance to elevated emersion temperatures in two species, *B. glandula* and *N. lamellosa,* with east coast populations of these species displaying higher emersion temperature tolerance than west coast populations. These higher tolerance thresholds of the east coast populations are consistent with the higher summertime (June--July) rock surface temperatures documented on this coast relative to the west coast. However, summertime rock surface temperatures at low tide were 4.2°C warmer on the east coast (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}), whereas tolerance thresholds to elevated emersion temperatures were ≤1.5°C higher in east coast populations of these species. In addition, no divergence in emersion temperature tolerance was detected between east and west coast populations of the 2 other species, *L. sitkana* and *L. scutulata*. Consequently, emersion temperature tolerance in these 4 species suggests modest or no local adaptation or phenotypic variation between these populations. East coast populations of intertidal organisms also experience July and August seawater temperatures that are on average 5.2°C warmer than on the west coast (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). This historical difference in summer SST, however, did not lead to corresponding differences in tolerance of acute exposure to elevated water temperature. Tolerance thresholds to elevated seawater temperature differed between east and west coast populations only in 2 species, *B. glandula* and *L. scutulata,* and these differences were not consistent with summertime SST on those coasts; east coast populations of these two species were less tolerant of elevated SST than west coast populations. Although SSS fluctuates seasonally on both coasts of Vancouver Island (Pickard & McLeod, [1953](#ece36498-bib-0043){ref-type="ref"}), the SSS on the east coast drops substantially lower (8.7 PSU) than on the west coast each year (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Accordingly, it was hypothesized that east coast populations of intertidal invertebrates would be more tolerant of reduced salinity than west coast populations of the same species. That, however, was not the case; east and west coast populations of each species had similar tolerance thresholds to low SSS. This lack of interpopulation differences contrasts with previous reports that low‐salinity tolerance can become locally adapted in populations of benthic invertebrates, as shown in *L. sitkana, L. scutulata*, and *Littorina subrotunda* (Sokolova & Boulding, [2004](#ece36498-bib-0051){ref-type="ref"}; Yamada, [1989](#ece36498-bib-0068){ref-type="ref"}). The lack of divergence in salinity tolerance in the present study may be an indication that SSS is not the most important cause of salinity stress in these populations. Rather, salinity tolerance may be determined mainly by exposure to heavy rainfall during low tide emersion, directly exposing these animals to freshwater for several hours (Dong, Han, & Huang, [2014](#ece36498-bib-0012){ref-type="ref"}). The large volume of seasonal rainfall experienced throughout the Pacific Northwest (Thomson, [1981](#ece36498-bib-0062){ref-type="ref"}; Tully & Dodimead, [1957](#ece36498-bib-0063){ref-type="ref"}) would cause frequent exposure of intertidal animals on both coasts of Vancouver Island to fully freshwater conditions at low tide, causing them to develop similar salinity tolerance thresholds. If so, this would be an important consideration given that future increases in precipitation are predicted for the North Pacific region (IPCC, [2014](#ece36498-bib-0028){ref-type="ref"}). 4.2. Dispersal ability {#ece36498-sec-0019} ---------------------- This study included 2 species with dispersing planktonic larvae (*B. glandula, L. scutulata*) as well as 2 species with direct development and thus limited dispersal capabilities (*N. lamellosa, L. sitkana*). Although it has been suggested that gene flow might be more restricted in direct‐developing than in planktonic‐dispersing species (Yamada, [1989](#ece36498-bib-0068){ref-type="ref"}), leading to greater interpopulation divergence in species with direct development, the findings of the present study, which tested animals from a single generation, did not support that hypothesis. Divergence between east and west coast populations in tolerance to elevated emersion temperature was similar in *N. lamellosa* (1.4°C; direct development) and *B. glandula* (1.5°C; planktonic), and there was no divergence between populations *of L. sitkana* (direct‐developing) or between populations of *L. scutulata* (planktonic). As for immersion temperature tolerance, divergence in tolerance thresholds only occurred in species with planktonic development. Finally, there was no evidence of divergence in tolerance to reduced salinity in either direct‐developing or planktonic‐dispersing species. While these findings are inconsistent with the postulate that direct developers have an increased potential for local adaptation relative to species with planktonic development (Chevin, Lande, & Mace, [2010](#ece36498-bib-0006){ref-type="ref"}; Endler, [1977](#ece36498-bib-0014){ref-type="ref"}; Hellberg, [1996](#ece36498-bib-0024){ref-type="ref"}; Sanford & Kelly, [2011](#ece36498-bib-0049){ref-type="ref"}; Yamada, [1989](#ece36498-bib-0068){ref-type="ref"}), the present findings add to a growing body of evidence suggesting local adaption is equally common in direct developers and planktonic dispersers (Sotka, [2012](#ece36498-bib-0055){ref-type="ref"}). 4.3. Present‐day tolerance thresholds vs present and future conditions {#ece36498-sec-0020} ---------------------------------------------------------------------- Temperature and salinity conditions are not equally stressful year‐round; rather, stress induced by these factors peaks during a limited time of year when conditions reach extreme levels; accordingly, the present analysis focused on the most extreme conditions occurring locally each year rather than use annual or seasonal averages. For populations on each coast, present‐day immersion TAD values were all substantially higher than the warmest SST recently recorded on the respective coast, SAD values were lower than the lowest SSS, and emersion temperature tolerance thresholds of 3 of the 4 species were greater than the warmest emersion temperature on each coast. These findings indicate the populations are not living close to the edge of their upper thermal limits (Sanford & Kelly, [2011](#ece36498-bib-0049){ref-type="ref"}), at least in terms of tolerance of acute conditions, and that acute exposure to the most extreme heat and low‐salinity conditions presently occurring on both costs is not a threat to their persistence. The only exception to this was *N. lamellosa,* in which emersion temperature tolerance was lower than present‐day maximum rock surface temperatures, seeming to suggest that *N. lamellosa* populations should not be able to persist at these sites. However, individual *N. lamellosa* position themselves in crevices or under rocks or algae during low tide (pers. obs.), where thermal stress can be substantially lower than on nearby exposed rock surfaces (Garrity, [1984](#ece36498-bib-0017){ref-type="ref"}). This would explain why *N. lamellosa* is almost exclusively found in cryptic microhabitats at low tide and suggests the persistence of *N. lamellosa* at a given site is likely dependent on availability of these cryptic microhabitats. Although the exact rates of change in climate‐related parameters in the future have yet to be determined and will partly depend on future production of greenhouse gasses (IPCC, [2014](#ece36498-bib-0028){ref-type="ref"}), long‐term monitoring of SST and SSS along the coasts of Vancouver Island has revealed consistent, linear rates of change in these parameters since monitoring began in 1935 (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Those rates are thus likely to closely approximate rates of change in SST and SSS for the near future, and were therefore used as best available estimators of rates of change when predicting future conditions. On Vancouver Island, the yearly minimum SSS has been increasing on the east coast since 1935, thus becoming less stressful, while minimum SSS conditions on the west coast have not changed (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Over the same time period, peak summertime SST has been increasing linearly on both coasts and so is expected to become increasingly stressful in the future (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). Furthermore, maximum substratum temperature in the intertidal zone during low tide emersion is also expected to increase along both coasts into the future (Iwabuchi & Gosselin, [2019](#ece36498-bib-0029){ref-type="ref"}). However, even if tolerance thresholds of these intertidal populations were to remain unchanged, future extreme levels of these abiotic factors are not likely to overwhelm present‐day acute tolerance thresholds for quite some time. Thus, despite a seemingly limited capacity for evolution of acute tolerance thresholds, exposure to seasonal acute temperature stress is not expected to be an immediate threat to the persistence of these populations. Nevertheless, our predictions suggest that increasing emersion temperature in the future would become a threat to the persistence of all these populations sooner than acute stress from extreme levels of SST or SSS. 4.4. Implications for population persistence {#ece36498-sec-0021} -------------------------------------------- The persistence of coastal populations of marine organisms faced with increasing abiotic stress will depend on overcoming three types of challenges: (a) periodic acute exposure to extreme levels of stressors, (b) chronic exposure to elevated levels of stressors, and (c) indirect effects caused by impacts of the stressors on other parts of the community. The present study examined the first of these challenges and revealed that acute exposure to extreme levels of 3 climate parameters (elevated substratum temperature and SST, and reduced salinity) do not appear to be a threat to the persistence of these species on Vancouver Island in the near future. However, the acute tolerances of larval and early benthic phases should also be taken into consideration when predicting population persistence, as different stages of life can display different tolerance thresholds (Hamilton & Gosselin, [2020](#ece36498-bib-0019){ref-type="ref"}). In addition, the persistence of populations in a given region also depends on whether individuals can survive chronic (i.e., long‐term) exposure to sublethal climate‐related stressors, as even moderate levels of climate‐related stress can affect the performance of organisms if they are subjected to these conditions for prolonged periods (Whiteley & Mackenzie, [2016](#ece36498-bib-0066){ref-type="ref"}). Exposure to increased temperature conditions for extended periods can negatively affect intertidal animals, such as causing decreased foraging activity and growth rate (Pincebourde, Sanford, & Helmuth, [2008](#ece36498-bib-0044){ref-type="ref"}) and reducing upper tolerance limits (Nguyen et al., [2011](#ece36498-bib-0041){ref-type="ref"}; Sorte et al., [2011](#ece36498-bib-0054){ref-type="ref"}). As emersion temperature increases on the coasts of Vancouver Island, this parameter will likely impose increased levels of chronic stress on populations well into the future. More work on chronic effects, especially with regards to heat stress, is needed, as the implications of chronic effects for the persistence of coastal invertebrate populations are underrepresented in the literature relative to studies focusing on marine vertebrates or terrestrial biota. Population persistence also depends on impacts of climate‐related stressors on other parts of the community, which then have secondary effects on other species (Harley et al., [2006](#ece36498-bib-0021){ref-type="ref"}; Kordas, Harley, & O'Connor, [2011](#ece36498-bib-0035){ref-type="ref"}). Although a population may be sufficiently tolerant of abiotic conditions to withstand acute and chronic exposure to the climate conditions of a given area, the population may still be at risk from cascading community level changes that occur when less tolerant organisms are affected by changing climate conditions (Helmuth, Mieszkowska, Moore, & Hawkins, [2013](#ece36498-bib-0025){ref-type="ref"}). These indirect effects of climate change have been demonstrated to negatively impact marine ecosystems in a variety of ways, including disruptions to food webs (Ainsworth et al., [2011](#ece36498-bib-0001){ref-type="ref"}; Hoegh‐Guldberg & Bruno, [2010](#ece36498-bib-0027){ref-type="ref"}; Johnson et al., [2011](#ece36498-bib-0030){ref-type="ref"}), increased predation pressure (Harley, [2011](#ece36498-bib-0020){ref-type="ref"}), altered interactions with competing species (Hawkins et al., [2008](#ece36498-bib-0023){ref-type="ref"}; Kordas et al., [2011](#ece36498-bib-0035){ref-type="ref"}), changes to community composition (Sagarin, Barry, Gilman, & Baxter, [1999](#ece36498-bib-0048){ref-type="ref"}; Southward, Hawkins, & Burrows, [1995](#ece36498-bib-0056){ref-type="ref"}) or increased prevalence of diseases (Harvell et al., [2002](#ece36498-bib-0022){ref-type="ref"}; Hoegh‐Guldberg & Bruno, [2010](#ece36498-bib-0027){ref-type="ref"}) and parasites (Poulin & Mouritsen, [2006](#ece36498-bib-0045){ref-type="ref"}). Although indirect effects could be major determinants of population persistence, there is presently limited information regarding the effects of single indirect stressors, and indirect effects of combinations of climate stressors are even less well understood. Of the above 3 types of climate‐related challenges, the most immediate threat to population persistence could be acute effects, as a single extreme event could extirpate vulnerable populations; thus, the focus of this study is on acute effects. In that regard, the likelihood of persistence of coastal populations will be enhanced if they are capable of adjusting their tolerance thresholds over time (Bennett et al., [2015](#ece36498-bib-0003){ref-type="ref"}; Knight, [2010](#ece36498-bib-0034){ref-type="ref"}; Somero, [2010](#ece36498-bib-0053){ref-type="ref"}). There are concerns, however, that the rate of change in tolerance thresholds may not be fast enough to keep pace with climate change (Henson et al., [2017](#ece36498-bib-0026){ref-type="ref"}). The present study revealed minimal divergence in acute tolerance thresholds between east and west coast populations, supporting the hypothesis that tolerance thresholds to extreme conditions change very slowly in these species. Faced with a warming environment, a slow rate of change in tolerance thresholds could lead to extirpation of a population in the near future if the population has narrow safety margins (i.e., tolerance thresholds only slightly higher than the most stressful conditions presently occurring in the inhabited region; Bennett et al., [2015](#ece36498-bib-0003){ref-type="ref"}). However, the populations examined herein all had large acute thermal and salinity safety margins relative to the most extreme conditions in their environment, and present‐day acute tolerance thresholds are predicted to remain higher than future extreme conditions for an extended period of time, likely a few centuries; this finding suggests a slow rate of change in tolerance thresholds might be sufficient for these populations to overcome future increases in acute temperature conditions. CONFLICT OF INTEREST {#ece36498-sec-0023} ==================== None declared. AUTHOR CONTRIBUTIONS {#ece36498-sec-0024} ==================== **Brianna L. Iwabuchi:** Data curation (lead); formal analysis (lead); funding acquisition (supporting); methodology (equal); writing‐original draft (lead); writing--review and editing (equal). **Louis A. Gosselin:** Conceptualization (lead); data curation (supporting); formal analysis (supporting); funding acquisition (lead); methodology (equal); supervision (lead); writing--original draft (supporting); writing--review and editing (equal). Supporting information ====================== ###### Appendix S1 ###### Click here for additional data file. Thanks to Dr. L. Fraser and Dr. M. Sewell for discussion and comments on the manuscript, as well as to Dr. S. Rollans and P. Antonelli for assistance with methods of statistical analysis, and to H. Hamilton, A. McLeod, and D. Richards for providing support with field work. Thank you also to the directors and members of the Bamfield Marine Sciences Centre for providing the facilities and equipment necessary to make this study possible. This research was supported by an NSERC Discovery Grant (RGPIN‐2014‐04779) to LAG and by a TRU ENVS Fellowship Award and a WCUMSS Graduate Student Award to BLI. DATA AVAILABILITY STATEMENT {#ece36498-sec-0026} =========================== Data available from the Dryad data repository (<https://doi.org/10.5061/dryad.x95x69pfm>).

\section{Introduction} Dirac Hartree--Fock (DHF) is a well-established method for molecules and clusters that require accurate treatment of relativistic effects such as core orbital contraction, spin-orbit coupling, and spin-spin interactions. There has been extensive research efforts utilizing four-component DHF based on Gaussian type orbitals.\cite{Clementi91_487,Visscher94_120,Visscher97_68,Gropen97_937,Jensen99_6211,Grant98_1,Quiney00_283,Hirao01_6526,Hirao02_10122,Shiozaki13_204113} Within the DHF framework, relativistic effects can be introduced through both one-body and two-body interactions. The one-body term includes scalar relativity and one-electron spin-orbit coupling arising from the interaction with the nuclear potential. Including one-body relativistic corrections is computationally inexpensive. There are a number of widely used techniques to account for these effects in existing electronic structure methods, including one-component and two-component frameworks. On the other hand, the two-electron operator is complicated and computationally expensive. Without going to the full quantum-electrodynamical (QED) regime, the two-electron operator includes the Dirac-Coulomb, Gaunt, and gauge (in the Coulomb gauge) terms with increasing complexity.\cite{Dyall94_2118,Dyall07_book,Wolf15_book} From the point of view of relativistic particle interactions, these terms lead to two-electron scalar relativity, spin-own-orbit, spin-other-orbit, spin-spin interactions, and also retardation effects from the finite speed of light. Since these important two-electron relativistic effects are computationally expensive, one often has to resort to well-designed algorithms and well-calibrated approximations to strike a balance between theoretical accuracy and computational feasibility. Various techniques have been explored to lower the computational scaling of four-component calculations, such as the quaternion formalism,\cite{Jensen99_6211} resolution of the identity,\cite{Shiozaki13_204113,Malkin20_184101} and quasi-four component approximations.\cite{Peng06_044102,Cheng07_104106} These techniques are all based on the reduction of the dimensionality either in the matrix formalism or in the integral formation. In this work, we introduce a maximally component- and spin-separated formalism that minimizes the floating point operation (FLOP) count in the DHF formation. In the new approach introduced here, the component- and spin-separations are carried out in the restricted kinetic balance (RKB) condition within the Pauli matrix representation. All integrals are retained in the one-component electron repulsion integral (ERI) format instead of in the two-spinor or four-spinor basis. With the Pauli components, the physics of different two-electron spin interactions is easy to recognize and categorize. This work lays the theoretical and computational foundation for practical applications of four-component Dirac Hartree--Fock and correlated relativistic electronic structure methods. \section{Dirac-Coulomb-Gaunt Hartree--Fock Formalism in Pauli Matrix Representation} \subsection{Brief Review of the Dirac Hartree--Fock Equation in the Four-Spinor and Two-Spinor Basis} The one-electron Dirac equation is written in the four-spinor form $\phi = \begin{pmatrix} \psi^L\\ \psi^S \end{pmatrix}$, where $\psi^L$ and $\psi^S$ are two-spinors of the large and small components. The Dirac equation can be written as \begin{equation} \begin{pmatrix} \mathbf{I}\otimes V & c \boldsymbol\sigma \cdot {\bf p} \\ c \boldsymbol\sigma \cdot {\bf p} & \mathbf{I}\otimes (V - 2m c^2) \end{pmatrix} \begin{pmatrix} \psi^L \\ \psi^S \end{pmatrix} =E \begin{pmatrix} \psi^L \\ \psi^S \end{pmatrix} \label{eq:1eDirac} \end{equation} where $\mathbf{p}=-i\boldsymbol\nabla$ is the momentum operator and $\boldsymbol\sigma$ are Pauli matrices. \begin{align} \mathbf{I}&=\begin{pmatrix} 1 & 0\\ 0&1 \end{pmatrix}, \boldsymbol\sigma_x=\begin{pmatrix} 0 & 1\\ 1&0 \end{pmatrix}, \boldsymbol\sigma_y=\begin{pmatrix} 0 & -i\\ i&0 \end{pmatrix}, \boldsymbol\sigma_z=\begin{pmatrix} 1 & 0\\ 0&-1 \end{pmatrix}. \label{eq:PauliMatrix} \end{align} For the one-electron system, $V$ is the nuclear potential that gives rise to scalar relativistic and spin-orbit effects. For many electron systems, the leading-order two-electron interactions that enter the molecular potential are described by the Coulomb and Gaunt terms: \begin{align} V_{ee} &= \sum_{i=1}^N \sum_{j>i} (g^C(i,j)-g^G(i,j))\\ g^C(i,j) &= \frac{1}{r_{ij}} \\ g^G (i,j) &=\frac{\boldsymbol{\alpha}_i \cdot \boldsymbol{\alpha}_j}{r_{ij}} \end{align} where the components of the $\boldsymbol{\alpha}$ matrices are defined as \begin{equation} {\alpha}_{i,J} = \begin{pmatrix} {\bf 0}_2 & \boldsymbol\sigma_J \\ \boldsymbol\sigma_J & {\bf 0}_2 \end{pmatrix}, \quad J = \{x, y, z\} \end{equation} where $i$ is $i$-th electron. Note that in this work we do not consider the gauge term which only arises in the non-quantum-electrodynamic treatment of the Coulomb gauge. To cast the Dirac equation in a finite basis and formulate the Dirac-Coulomb Hartree--Fock (DC-HF) and Dirac-Coulomb-Gaunt Hartree--Fock (DCG-HF) Hamiltonians, the four-spinor molecular orbitals (MO) are expanded in two-spinor basis \begin{equation} \psi^L_p = \sum_{{\tau}}\sum_{\mu = 1}^{N}c_{\mu\tau,p}^L {\chi}_{\mu\tau}^L, \quad \psi^S_p = \sum_{\tau}\sum_{\mu = 1}^{N}c_{\mu\tau,p}^S {\chi}_{\mu\tau}^S \end{equation} where $\tau\in\{\alpha,\beta\}$ and $N$ is the number of spatial basis functions. The large component basis is defined as \begin{equation} {\chi}_{\mu\alpha}^L = \begin{pmatrix} {\chi}_\mu \\ 0 \end{pmatrix} , \quad \quad {\chi}_{\mu\beta}^L = \begin{pmatrix} 0 \\ {\chi}_{\mu} \end{pmatrix} \label{eq:largespinor} \end{equation} where ${\chi}_\mu$ denotes the spatial basis functions. The relationship between the large and small component two-spinor basis can be defined via the restricted kinetic balance (RKB) condition.\cite{Havriliak84_1910,Ishikawa83_111,Dyall90_25} \begin{equation} {\chi}_\mu^S = \frac{1}{2mc}\boldsymbol\sigma\cdot {\bf p} {\chi}_\mu^L \label{eq:rkb} \end{equation} This relationship ensures the correct symmetry relation (opposite parity) between the small and large components and hence the correct nonrelativistic limit of the positive energy states.\cite{Liu10_1679} For a detailed discussion of different choices of balanced bases, see Ref \citenum{Kutzelnigg11_423}. Note that the RKB condition can only be applied to the uncontracted basis functions of all the atoms in a molecule as a whole, although the idea of ``from atoms to molecule'',\cite{Cheng07_104106} where \cref{eq:rkb} is applied to the uncontracted basis functions of individual atoms, is more efficient. A brief discussion regarding the related issues will be presented in the Conclusion section. For the Dirac-Coulomb-Gaunt Hamiltonian, the Fock matrix in the four-spinor molecular orbital representation is \begin{align} f_{pq} &= h_{pq} + V_{pq}^C + V_{pq}^G\label{eq:4spinorfock}\\ V_{pq}^C &=\sum_{i=1}^{N_e}[(pq|ii)-(pi|iq)]\label{eq:4spinorcoulomb}\\ V_{pq}^G &= -\sum_{i=1}^{N_e}[(p\boldsymbol\alpha q|\cdot i\boldsymbol\alpha i)-(p\boldsymbol\alpha i|\cdot i\boldsymbol\alpha q)] \label{eq:4spinorgaunt} \end{align} where $N_e$ is the number of electrons, $i$ is the index for occupied orbitals, and $p,q$ are indices for general four-spinor MOs. \Crefrange{eq:4spinorfock}{eq:4spinorgaunt} only sum over positive energy levels. Additionally, we use Mulliken notation for the two-electron integrals. We also introduce ``$|\cdot$'' notation to indicate that the integral is a dot product of $\boldsymbol\alpha$ (or $\boldsymbol\sigma$). The expression of the Dirac-Coulomb-Gaunt Hamiltonian in the four-spinor basis is the simplest, but also the most computationally expensive to construct due to the fact that it is four times the length of the atomic orbital space. Therefore, dimension reduction techniques are usually carried out to lower the computational cost through component and/or spin separation. Unfortunately, dimension reduction procedures inevitably lead to an increased complexity in the underlying mathematical expression. The four-component Fock matrix can be separated into four blocks ($LL, LS, SL, SS$) in the two-spinor basis. For example, the four blocks in the Dirac-Coulomb matrix are, \begin{align} V_{pq}^{C,LL} &= \sum_{i=1}^{N_e}[(p^Lq^L|i^Li^L)+(p^Lq^L|i^Si^S)-(p^Li^L|i^Lq^L)]\label{eq:vcll}\\ V_{pq}^{C,SS} &= \sum_{i=1}^{N_e}[(p^Sq^S|i^Li^L)+(p^Sq^S|i^Si^S)-(p^Si^S|i^Sq^S)]\label{eq:vcss}\\ V_{pq}^{C,LS} &= -\sum_{i=1}^{N_e} (p^L i^L|i^S q^S)\\ V_{pq}^{C,SL} &= -\sum_{i=1}^{N_e} (p^S i^S|i^L q^L) \end{align} and the corresponding Gaunt contributions are \begin{align} V_{pq}^{G,LL} &= \sum_{i=1}^N (p^L \boldsymbol\sigma i^S|\cdot i^S \boldsymbol\sigma q^L)\\ V_{pq}^{G,SS} &= \sum_{i=1}^N (p^S \boldsymbol\sigma i^L|\cdot i^L \boldsymbol\sigma q^S)\\ V_{pq}^{G,LS} &= -\sum_{i=1}^N [(p^L \boldsymbol\sigma q^S|\cdot i^L \boldsymbol\sigma i^S)+(p^L \boldsymbol\sigma q^S|\cdot i^S \boldsymbol\sigma i^L)-(p^L \boldsymbol\sigma i^S|\cdot i^L \boldsymbol\sigma q^S)]\\ V_{pq}^{G,SL} &= -\sum_{i=1}^N [(p^S \boldsymbol\sigma q^L|\cdot i^L \boldsymbol\sigma i^S)+(p^S \boldsymbol\sigma q^L|\cdot i^S \boldsymbol\sigma i^L)-(p^S \boldsymbol\sigma i^L|\cdot i^S \boldsymbol\sigma q^L)]\label{eq:vgsl} \end{align} The DCG Hamiltonian in the two-spinor MO basis can be transformed to the two-spinor atomic orbital basis as \begin{align} V_{\mu{\tau_1},\nu{\tau_2}}^{C,LL} &=\sum_{\lambda\tau_4\kappa\tau_3}D_{\lambda{\tau_4},\kappa{\tau_3}}^{LL}[ (\mu^L_{\tau_1}\nu^L_{\tau_2}|\kappa^L_{\tau_3}\lambda^L_{\tau_4})-(\mu^L_{\tau_1}\lambda^L_{\tau_4}|\kappa^L_{\tau_3}\nu^L_{\tau_2})] +D_{\lambda{\tau_4},\kappa{\tau_3}}^{SS} [(\mu^L_{\tau_1}\nu^L_{\tau_2}|\kappa^S_{\tau_3}\lambda^S_{\tau_4})] \label{eq:fLL}\\ V_{\mu\tau_1,\nu\tau_2}^{C,SS} &= \sum_{\lambda\tau_4\kappa\tau_3}D_{\lambda\tau_4,\kappa\tau_3}^{LL}[(\mu^S_{\tau_1}\nu^S_{\tau_2}|\kappa^L_{\tau_3}\lambda^L_{\tau_4})] +D_{\lambda{\tau_4},\kappa{\tau_3}}^{SS}[(\mu^S_{\tau_1}\nu^S_{\tau_2}|\kappa^S_{\tau_3}\lambda^S_{\tau_4})-(\mu^S_{\tau_1}\lambda^S_{\tau_4}|\kappa^S_{\tau_3}\nu^S_{\tau_2})] \label{eq:fSS}\\ V_{\mu\tau_1\nu\tau_2}^{C,LS} &=-\sum_{\lambda\tau_4\kappa\tau_3}D_{\lambda\tau_4,\kappa\tau_3}^{LS}(\mu^L_{\tau_1} \lambda^L_{\tau_4}|\kappa^S_{\tau_3} \nu^S_{\tau_2}) \label{eq:fLS}\\ V_{\mu\tau_1\nu\tau_2}^{C,SL} &=-\sum_{\lambda\tau_4\kappa\tau_3}D_{\lambda\tau_4,\kappa\tau_3}^{SL}(\mu^S_{\tau_1} \lambda^S_{\tau_4}|\kappa^L_{\tau_3} \nu^L_{\tau_2})] \label{eq:fSL}\\ \notag\\ V^{G, LL}_{\mu\tau_1,\nu\tau_2} &= \sum_{\lambda\tau_4\kappa\tau_3} D_{\lambda\tau_4,\kappa\tau_3}^{SS} (\mu^L_{\tau_1} \boldsymbol\sigma \lambda^S_{\tau_4} | \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \nu^L_{\tau_2}) \label{eq:fLLG}\\ V^{G,SS}_{\mu\tau_1,\nu\tau_2} &= \sum_{\lambda\tau_4\kappa\tau_3} D_{\lambda_{\tau_4},\kappa_{\tau_3}}^{LL} (\mu^S _{\tau_1}\boldsymbol\sigma \lambda^L _{\tau_4}| \cdot \kappa ^L_{\tau_3} \boldsymbol\sigma \nu^S_{\tau_2}) \label{eq:fSSG}\\ V^{G,LS}_{\mu\tau_1,\nu\tau_2}&= -\sum_{\lambda\tau_4\kappa\tau_3} \{ D_{\lambda\tau_4,\kappa\tau_3}^{LS} (\mu^L_{\tau_1} \boldsymbol\sigma \nu^S_{\tau_2} | \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \lambda^L_{\tau_4}) +D_{\lambda\tau_4,\kappa\tau_3}^{SL}[ (\mu^L_{\tau_1} \boldsymbol\sigma \nu^S_{\tau_2} | \cdot \kappa ^L_{\tau_3} \boldsymbol\sigma \lambda^S_{\tau_4}) - (\mu^L _{\tau_1}\boldsymbol\sigma \lambda^S_{\tau_4} | \cdot \kappa ^L_{\tau_3} \boldsymbol\sigma \nu^S_{\tau_2})] \} \label{eq:fLSG}\\ V^{G,SL}_{\mu\tau_1,\nu\tau_2} &= -\sum_{\lambda\tau_4\kappa\tau_3} \{ D_{\lambda\tau_4,\kappa\tau_3}^{SL} (\mu^S_{\tau_1} \boldsymbol\sigma \nu^L_{\tau_2} | \cdot \kappa ^L_{\tau_3} \boldsymbol\sigma \lambda^S_{\tau_4}) +D_{\lambda\tau_4,\kappa\tau_3}^{LS}[ (\mu^S_{\tau_1} \boldsymbol\sigma \nu^L_{\tau_2} | \cdot \kappa ^S _{\tau_3}\boldsymbol\sigma \lambda^L_{\tau_4}) - (\mu^S _{\tau_1}\boldsymbol\sigma \lambda^L _{\tau_4}| \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \nu^L_{\tau_2})]\} \label{eq:fSLG} \end{align} where $\tau_1,\tau_2,\tau_3,\tau_4\in\{\alpha,\beta\}$, and the density matrix in spin block formation is \begin{equation} D_{\mu\tau_1,\nu\tau_2}^{XY}=\sum_{i=1}^{N_e} c_{\mu\tau_1,i}^X c_{\nu\tau_2,i}^{Y*} \quad X,Y=\{L,S\} \end{equation} \Crefrange{eq:fLL}{eq:fSLG} show that the Dirac-HF Hamiltonian can be conveniently constructed in the two-spinor atomic orbital basis. Based on these expressions, there are two approaches to construct the DCG-HF Hamiltonian from non-relativistic real-valued atomic basis integrals depending on how the kinetic-balance condition (\cref{eq:rkb}) is incorporated in the two-spinor basis. In the first approach, small component bases are first generated with an appropriate kinetic-balance condition and the Dirac-HF equation can be completely reformulated in a scalar basis expansion. In this approach, only the electron-repulsion integrals are needed. However, the dimension of the small component basis is usually 2$\sim$3 times larger than that for the large component and the basis can easily become linearly dependent. The second approach takes advantage of the restricted-kinetic-balance condition (\cref{eq:rkb}) in the two-spinor form. \Cref{eq:rkb} gives rise to a vector form of the small component basis. As a result, the two-spinor atomic basis becomes spin-dependent and the integral-density contraction in \crefrange{eq:fLL}{eq:fSLG} require a spin-separation step. Although the construction of the Dirac-HF Hamiltonian is more complicated, the dimension of the problem remains $2N$. Note that these two approaches are well documented and we refer the readers to Ref. \citenum{Dyall07_book} for a detailed discussion. We include these expressions herein for the sake of completeness of the theory and benchmark sections. In this work, we introduce a further spin separation step in the Pauli matrix representation. The following method can be considered as a completely component- and spin-separated technique for the Dirac-HF equation. \subsection{Dirac-Coulomb-Gaunt in Pauli Matrix Basis} In this section, we will use the two-spinor integral $(\mu_{\tau_1}^L\nu_{\tau_2}^L|\kappa_{\tau_3}^S\lambda_{\tau_4}^S)$ as an example to show how component- and spin-separation can be carried out in the Pauli matrix basis. Using the Dirac identity,\cite{Dyall07_book} \begin{align} (\boldsymbol{\sigma}\cdot\boldsymbol{\mu})(\boldsymbol{\sigma}\cdot\boldsymbol{\nu})&=\mathbf{I}~\left(\boldsymbol{\mu}\cdot\boldsymbol{\nu}\right)+i\boldsymbol{\sigma}\cdot\boldsymbol{\mu}\times\boldsymbol{\nu} \label{eq:diracidentity} \end{align} the integral can be written as \begin{align} &(\mu_{\tau_1}^L\nu_{\tau_2}^L|\kappa_{\tau_3}^S\lambda_{\tau_4}^S) \notag \\ = & \frac{\delta_{\tau_1 \tau_2} }{4m^2c^2} (\mu_{\tau_1}^L\nu_{\tau_1}^L| \boldsymbol\sigma(2) \cdot \mathbf{p}(2) \frac{1}{r_{12}} \boldsymbol\sigma(2) \cdot \mathbf{p}(2) |\kappa_{\tau_3}^L\lambda_{\tau_4}^L) \nonumber \\ =& \frac{\delta_{\tau_1 \tau_2}}{4m^2c^2} [(\xi_{\tau_3}^\dagger \mathbf{I} \xi_{\tau_4}) \boldsymbol\nabla_\kappa \cdot \boldsymbol\nabla_\lambda (\mu\nu |\kappa\lambda) + i \sum_{J=x,y,z} (\xi_{\tau_3}^\dagger \boldsymbol\sigma_J \xi_{\tau_4}) (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\lambda)_J (\mu\nu |\kappa\lambda) ] \label{eq:2spinprLLSS} \end{align} where $\boldsymbol\nabla_\kappa$ is nuclear coordinate derivative of the atomic basis $\chi_\kappa$. $\mathbf{I}(2)$ and $\boldsymbol\sigma(2)$ are the identity and Pauli matrix for electron 2. $\xi_\tau$ is spin representation, where \begin{equation} \xi_\alpha = \begin{pmatrix} 1 \\ 0 \end{pmatrix} \quad\quad \xi_\beta = \begin{pmatrix} 0 \\ 1 \end{pmatrix} \notag \end{equation} and we have \begin{align} &\xi_\alpha^\dagger \boldsymbol\sigma_x \xi_\beta = 1; \quad \xi_\beta^\dagger \boldsymbol\sigma_x \xi_\alpha = 1 \notag\\ &\xi_\alpha^\dagger \boldsymbol\sigma_y \xi_\beta = -i; \quad \xi_\beta^\dagger \boldsymbol\sigma_y \xi_\alpha = i \notag\\ &\xi_\alpha^\dagger \boldsymbol\sigma_z \xi_\alpha = 1; \quad \xi_\beta^\dagger \boldsymbol\sigma_z \xi_\beta = -1 \notag\\ &\xi_\alpha^\dagger \, \mathbf{I}\, \xi_\alpha = 1; \quad \xi_\beta^\dagger \, \mathbf{I}\, \xi_\beta = 1 \notag \end{align} otherwise zero. The two terms in \cref{eq:2spinprLLSS} are two-electron spin-free and spin-orbit contributions arising from the Dirac-Coulomb operator (\cref{eq:4spinorcoulomb}). For the Gaunt term, a similar component- and spin-separation can be achieved. For example, \begin{align} &(\mu^L _{\tau_1} \boldsymbol\sigma \nu^S _{\tau_2}| \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \lambda ^L _{\tau_4}) \notag \\ =& \frac{1}{(2mc)^2}(\mu^L _{\tau_1} \boldsymbol\sigma(1) \boldsymbol\sigma(1)\cdot \mathbf{p}(1) \nu^L _{\tau_2} | \cdot \boldsymbol\sigma(2) \cdot \mathbf{p}(2) \kappa ^L_{\tau_3} \boldsymbol\sigma(2) \lambda ^L _{\tau_4})\nonumber \\ =&~\xi_{\tau_1}^\dagger (1) \xi_{\tau_1} (1) \xi_{\tau_3}^\dagger (2) \xi_{\tau_4} (2) \big[\mathbf{I}(1)\mathbf{I}(2) \boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu \nonumber \\ &+i (\mathbf{I}(1)\boldsymbol\sigma(2)+\mathbf{I}(2)\boldsymbol\sigma(1)) \cdot \boldsymbol\nabla_\kappa \times \boldsymbol\nabla_\nu \notag\\ &+(\boldsymbol\sigma(1)\cdot\boldsymbol\sigma(2)) (\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu) - (\boldsymbol\sigma(1)\cdot \boldsymbol\nabla_\kappa) (\boldsymbol\sigma(2)\cdot\boldsymbol\nabla_\nu) \big] (\mu\nu|\kappa\lambda)\label{eq:2spinorGaunt} \end{align} The detailed derivation can be found in the Appendix A. In the final expression of \cref{eq:2spinorGaunt}, the first two contributions are the two-electron spin-free and spin-orbit interactions. The final two contributions arise from the spin-spin interaction which only exists in the Gaunt term. Careful observation of \cref{eq:2spinprLLSS} and \cref{eq:2spinorGaunt} shows that all two-spinor terms can be organized into the Pauli matrix representation of ($\mathbf{I},\boldsymbol\sigma_x,\boldsymbol\sigma_y,\boldsymbol\sigma_z$) in the form of \begin{equation} {\bf G}^{XY} = \frac{1}{2}{\bf G}^{XY}_s \otimes \mathbf{I} +\frac{1}{2} \sum_{J=x,y,z} {\bf G}^{XY}_J \otimes \boldsymbol\sigma_J \end{equation} where ${\bf G}_s$ and ${\bf G}_J$ are the spin-free and spin-dependent parts of the two-spinor general matrix/tensor, and $\{X,Y\}\in\{L,S\}$. In fact, both two-spinor Fock $\mathbf{F}^{XY}$ and density $\mathbf{P}^{XY}$ matrices can also be written in the Pauli matrix representation,\cite{Li18_169} \begin{align} {\bf Q} = \begin{pmatrix} {\bf Q}_{\alpha\alpha} &{\bf Q}_{\beta\alpha} \\ {\bf Q}_{\beta\alpha} &{\bf Q}_{\beta\beta} \end{pmatrix}& =\frac{1}{2} \begin{pmatrix} {\bf Q}_s + {\bf Q}_z & {\bf Q}_x - i {\bf Q}_y\\ {\bf Q}_x+i{\bf Q}_y & {\bf Q}_s-{\bf Q}_z \end{pmatrix} =\frac{1}{2}{\bf Q}_s \otimes \mathbf{I} + \frac{1}{2}\sum_{J=x,y,z} {\bf Q}_J \otimes \boldsymbol\sigma_J \\ {\bf Q}_s &= {\bf Q}_{\alpha\alpha} +{\bf Q}_{\beta\beta}\notag\\ {\bf Q}_x &= {\bf Q}_{\alpha\beta} +{\bf Q}_{\beta\alpha}\notag\\ {\bf Q}_y &= i({\bf Q}_{\alpha\beta} -{\bf Q}_{\beta\alpha})\notag\\ {\bf Q}_z &= {\bf Q}_{\alpha\alpha} -{\bf Q}_{\beta\beta}\notag \end{align} where $\mathbf{Q}\in\{\mathbf{F}^{XY},\mathbf{P}^{XY}\}$ and $\{X,Y\}\in\{L,S\}$. These mathematical expressions suggest that the two-spinor form of the Dirac Hamiltonian can be completely cast in the Pauli matrix representation, achieving the maximally component- and spin-separated Dirac Hamiltonian. In the next section, we show that the resulting algebraic expressions turn out to be very complicated. However, upon successful implementation, we are rewarded with an optimally efficient four-component Dirac Hartree--Fock equation, as will be shown in the Results and Discussion Section. \subsection{Building Dirac Hartree--Fock Matrix with Pauli Components} A unique advantage of building the DCG-HF matrix in the spin-separated Pauli spinor representation is that terms with the same integral type can be combined. For example, since the spin-free and spin-spin interactions in \cref{eq:2spinorGaunt} share a same integral type of $\boldsymbol\nabla\cdot\boldsymbol\nabla$, they can be combined in the final contraction step, resulting in a computational algorithm of potentially minimal FLOP count. Since the complete derivation is very lengthy and complex, we only present a brief derivation procedure in Appendix A and the final expressions in the main text. \subsubsection{Dirac-Coulomb} The non-relativistic Coulomb contribution (first and third term in \cref{eq:vcll}) only appears in the $LL$ block of the two-spinor Fock matrix, which can be written in Pauli representation as \begin{align} V^{LL}_{\mu\nu,s}&= \sum_{\kappa\lambda } D_{\lambda\kappa, s}^{LL}[ 2(\mu\nu|\kappa\lambda)-(\mu\lambda|\kappa\nu)]\\ V^{LL}_{\mu\nu,J}&= -\sum_{\kappa\lambda } D_{\lambda\kappa,J}^{LL}(\mu\lambda|\kappa\nu) \end{align} where $J=x,y,z$. Note that the non-relativistic contributions to the Pauli $J=x,y,z$ components of the $LL$ block are all exchange type. The rest of Dirac--Coulomb contribution involves two-center 2nd-derivatives or four-center 4th-derivatives of electron-repulsion integrals and a prefactor of $\frac{1}{(2mc)^2}$ or $\frac{1}{(2mc)^4}$. The $LL$ block of the relativistic part (second term in \cref{eq:vcll}) of the two-spinor Dirac--Coulomb matrices in Pauli representation is \begin{align} V^{C,LL}_{\mu\nu,s}&=2\sum_{\kappa\lambda}D^{SS}_{\lambda\kappa ,s} \boldsymbol\nabla_\kappa \cdot \boldsymbol\nabla_\lambda (\mu\nu |\kappa\lambda) + 2i \sum_{J=x,y,z} D^{SS}_{\lambda\kappa J} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\lambda)_J (\mu\nu |\kappa\lambda) \end{align} where $\boldsymbol\nabla_\kappa \cdot \boldsymbol\nabla_\lambda (\mu\nu|\kappa\lambda)$ and $(\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\lambda)_J(\mu\nu|\kappa\lambda)$ are the dot-product and the $J$-th component of the cross-product of the $\kappa$ and $\lambda$ center gradients. The Dirac-Coulomb contributions to the $SS$ block (first term in \cref{eq:vcss}) are contracted with the scalar part of the $LL$ density matrix, \begin{align} V_{\mu\nu,s}^{C,SS} &= 2\sum_{\kappa\lambda} D^{LL}_{\lambda\kappa ,s} \boldsymbol\nabla_\mu\ \cdot \boldsymbol\nabla_\nu(\mu\nu|\kappa\lambda)\\ V_{\mu\nu,J}^{C,SS} &= 2i\sum_{\kappa\lambda} D^{LL}_{\lambda\kappa ,s} (\boldsymbol\nabla_\mu\ \times \boldsymbol\nabla_\nu)_J(\mu\nu|\kappa\lambda) \end{align} The rest of $SS$ block, known as the $(SS|SS)$ contribution, involves $(p^Sq^S|r^Ss^S)$ type of four-center ERI 4th-derivatives. The $(SS|SS)$ Dirac-Coulomb term is often ignored in practice due to its large computational cost of ERI 4th-derivatives and its small contribution on the order of $\frac{1}{c^4}$. For the completeness of the derivation and cost analysis, the $(SS|SS)$ contribution to the Dirac-Coulomb $SS$ block is presented in Appendix B. The Dirac-Coulomb contributions to the $LS$ block are all exchange type integrals: \begin{align} V_{\mu\nu,s}^{C,LS} = \big[ &-D_{\lambda\kappa,s}^{LS} (\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu) -i D_{\lambda\kappa,x}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_x\notag\\ &-iD_{\lambda\kappa,y}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_y -iD_{\lambda\kappa,z}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_z \big](\mu\lambda|\kappa\nu)\\ V_{\mu\nu,z}^{C,LS} =\big[ &-D_{\lambda\kappa,z}^{LS} (\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu) - D_{\lambda\kappa,y}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_x\notag\\ &+D_{\lambda\kappa,x}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_y -iD_{\lambda\kappa,s}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_z \big](\mu\lambda|\kappa\nu)\\ V_{\mu\nu,x}^{C,LS} = \big[ &-D_{\lambda\kappa,x}^{LS} (\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu) -i D_{\lambda\kappa,s}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_x\notag\\ &-D_{\lambda\kappa,z}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_y +D_{\lambda\kappa,y}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_z \big](\mu\lambda|\kappa\nu)\\ V_{\mu\nu,y}^{C,LS} = \big[ &-D_{\lambda\kappa,y}^{LS} (\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu) + D_{\lambda\kappa,z}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_x\notag\\ &-i D_{\lambda\kappa,s}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_y - D_{\lambda\kappa,x}^{LS} (\boldsymbol\nabla_\kappa\times\boldsymbol\nabla_\nu)_z \big](\mu\lambda|\kappa\nu) \end{align} Additionally, for the $SL$ block, we can take advantage of the relation \begin{equation} V^{C,SL} = V^{\dagger C,LS}\notag \end{equation} and only compute the $V^{C,LS}$ matrix elements directly. \subsubsection{Gaunt in Pauli Components} Next, we consider the Gaunt contribution to the Dirac Hartree--Fock matrix. The Gaunt contribution to the $LL$ and $SS$ blocks are all exchange type: \begin{align} V^{G,LL}_{\mu\nu,s} = 3\big[ &D^{SS}_{\lambda \kappa,s} \boldsymbol\nabla_\lambda \cdot \boldsymbol\nabla_\kappa -i D^{SS}_{\lambda \kappa,z}(\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\kappa)_z\notag\\ -i &D^{SS}_{\lambda \kappa,x}(\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\kappa)_x -i D^{SS}_{\lambda \kappa,y}(\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\kappa)_y \big] (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,LL}_{\mu\nu,z} = & \big\{ -D^{SS}_{\lambda\kappa,z} [- (\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_x - (\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_y + (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_z] \nonumber \\ & -i D^{SS}_{\lambda\kappa,s} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\kappa)_z -D^{SS}_{\lambda\kappa,x} [(\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_z + (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_x]\notag \\ &-D^{SS}_{\lambda\kappa,y} [(\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_z + (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_y] \big\}(\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,LL}_{\mu\nu,x}= & \big\{ -D^{SS}_{\lambda\kappa,x} [ (\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_x - (\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_y - (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_z] \nonumber \\ & -i D^{SS}_{\lambda\kappa,s} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\kappa)_x -D^{SS}_{\lambda\kappa,y} [(\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_y + (\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_x]\notag\\ &-D^{SS}_{\lambda\kappa,z} [(\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_z + (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_x] \big\}(\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,LL}_{\mu\nu,y} = & \big\{ -D^{SS}_{\lambda\kappa,y} [ -(\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_x + (\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_y - (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_z] \nonumber \\ & -i D^{SS}_{\lambda\kappa,s} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\kappa)_y -D^{SS}_{\lambda\kappa,x} [(\boldsymbol\nabla_\lambda)_x (\boldsymbol\nabla_\kappa)_y + (\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_x]\notag\\ &-D^{SS}_{\lambda\kappa,z} [(\boldsymbol\nabla_\lambda)_y (\boldsymbol\nabla_\kappa)_z + (\boldsymbol\nabla_\lambda)_z (\boldsymbol\nabla_\kappa)_y] \big\}(\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,SS}_{\mu\nu,s} &= \big[ 3D^{LL}_{\lambda\kappa,s}\boldsymbol\nabla_\mu\cdot \boldsymbol\nabla_\nu +i D^{LL}_{\lambda\kappa,z} (\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_z + iD^{LL}_{\lambda\kappa,x} (\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_x + iD^{LL}_{\lambda\kappa,y} (\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_y\big] (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,SS}_{\mu\nu,z} = \big\{ -D^{LL}_{\lambda\kappa,z}[-(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_x -(\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_y + (\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_z ] +3i D^{LL}_{\lambda\kappa,s} (\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_z \nonumber \\ - D^{LL}_{\lambda\kappa,x} [(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_z + (\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_x] - D^{LL}_{\lambda\kappa,y} [(\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_y + (\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_z] \big\} (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,SS}_{\mu\nu,x} = \big\{ -D^{LL}_{\lambda\kappa,x}[(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_x -(\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_y - (\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_z ] +3i D^{LL}_{\lambda\kappa,s} (\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_x \nonumber \\ - D^{LL}_{\lambda\kappa,z} [(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_z + (\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_x] - D^{LL}_{\lambda\kappa,y} [(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_y + (\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_x] \big\} (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,SS}_{\mu\nu,y} = \big\{ -D^{LL}_{\lambda\kappa,y}[-(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_x +(\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_y - (\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_z ] +3i D^{LL}_{\lambda\kappa,s} (\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_y \nonumber \\ - D^{LL}_{\lambda\kappa,x} [(\boldsymbol\nabla_\mu)_x(\boldsymbol\nabla_\nu)_y + (\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_x] - D^{LL}_{\lambda\kappa,z} [(\boldsymbol\nabla_\mu)_z(\boldsymbol\nabla_\nu)_y + (\boldsymbol\nabla_\mu)_y(\boldsymbol\nabla_\nu)_z] \big\} (\mu\lambda|\kappa\nu) \end{align} The Gaunt contribution to the $LS$ and $SL$ blocks includes both Coulomb and exchange integrals: \begin{align} V^{G,LS}_{\mu\nu,s}&= -2\sum_{\kappa\lambda} \big[ D^{LS}_{\lambda\kappa,s}\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu -i \sum_{J=x,y,z}D^{LS}_{\lambda\kappa,J} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\kappa)_J\notag\\ &- D^{SL}_{\lambda\kappa,s}\boldsymbol\nabla_\nu\cdot\boldsymbol\nabla_\lambda -i \sum_{J=x,y,z}D^{SL}_{\lambda\kappa,J} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\lambda)_J \big] (\mu\nu|\kappa\lambda)\notag\\ &+ \big[ D^{SL}_{\lambda\kappa ,s}\boldsymbol\nabla_\lambda\cdot \boldsymbol\nabla_\nu -i D^{SL}_{\lambda\kappa,z} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\nu)_z \nonumber \\ &- i D^{SL}_{\lambda\kappa,y} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\nu)_y - iD^{SL}_{\lambda\kappa,x} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\nu)_x \big] (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{G,LS}_{\mu\nu,z} &=-\big\{ 2D^{SL}_{\lambda\kappa,z}\boldsymbol\nabla_\lambda\cdot \boldsymbol\nabla_\nu +2D^{SL}_{\lambda\kappa,y} (\boldsymbol\nabla_\lambda \times\boldsymbol\nabla_\nu)_x -2D^{SL}_{\lambda\kappa,x} (\boldsymbol\nabla_\lambda \times\boldsymbol\nabla_\nu)_y -i D^{SL}_{\lambda\kappa,s} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\nu)_z \nonumber \\ &+D^{SL}_{\lambda\kappa,z}\big[ -(\boldsymbol\nabla_\lambda)_x(\boldsymbol\nabla_\nu)_x - (\boldsymbol\nabla_\lambda)_y(\boldsymbol\nabla_\nu)_y +(\boldsymbol\nabla_\lambda)_z(\boldsymbol\nabla_\nu)_z\big] \nonumber \\ &+ D^{SL}_{\lambda\kappa,x} \big[ (\boldsymbol\nabla_\nu)_x (\boldsymbol\nabla_\lambda)_z + (\boldsymbol\nabla_\nu)_z (\boldsymbol\nabla_\lambda)_x\big] + D^{SL}_{\lambda\kappa,y} \big[ (\boldsymbol\nabla_\nu)_y (\boldsymbol\nabla_\lambda)_z + (\boldsymbol\nabla_\nu)_z (\boldsymbol\nabla_\lambda)_y\big] \big\} (\mu\lambda|\kappa\nu)\notag\\ &-2\sum_{\kappa\lambda} \big[ -i D^{LS}_{\lambda\kappa,S} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\kappa)_z +D^{LS}_{\lambda\kappa,z}(\boldsymbol\nabla_\kappa \cdot \boldsymbol\nabla_\nu) -\sum_{K=x,y,z} D^{LS}_{\lambda\kappa,K} (\boldsymbol\nabla_\nu)_K(\boldsymbol\nabla_\kappa)_z \notag\\ &+i D^{SL}_{\lambda\kappa,s} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\lambda)_z +D^{SL}_{\lambda\kappa,z}(\boldsymbol\nabla_\nu \cdot \boldsymbol\nabla_\lambda) -\sum_{K=x,y,z} D^{SL}_{\lambda\kappa,K} (\boldsymbol\nabla_\lambda)_z(\boldsymbol\nabla_\nu)_K\big] (\mu\nu|\kappa\lambda) \end{align} \begin{align} V^{G,LS}_{\mu\nu,x} &=-\big\{ 2D^{SL}_{\lambda\kappa,x}\boldsymbol\nabla_\lambda\cdot \boldsymbol\nabla_\nu -2D^{SL}_{\lambda\kappa,y} (\boldsymbol\nabla_\lambda \times\boldsymbol\nabla_\nu)_z +2D^{SL}_{\lambda\kappa,z} (\boldsymbol\nabla_\lambda \times\boldsymbol\nabla_\nu)_y -i D^{SL}_{\lambda\kappa,s} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\nu)_x \nonumber \\ &+D^{SL}_{\lambda\kappa,x}\big[ (\boldsymbol\nabla_\lambda)_x(\boldsymbol\nabla_\nu)_x - (\boldsymbol\nabla_\lambda)_y(\boldsymbol\nabla_\nu)_y -(\boldsymbol\nabla_\lambda)_z(\boldsymbol\nabla_\nu)_z\big] \nonumber \\ &+ D^{SL}_{\lambda\kappa,y} \big[ (\boldsymbol\nabla_\nu)_x (\boldsymbol\nabla_\lambda)_y + (\boldsymbol\nabla_\nu)_y (\boldsymbol\nabla_\lambda)_x\big] + D^{SL}_{\lambda\kappa,z} \big[ (\boldsymbol\nabla_\nu)_x (\boldsymbol\nabla_\lambda)_z + (\boldsymbol\nabla_\nu)_z (\boldsymbol\nabla_\lambda)_x\big] \big\} (\mu\lambda|\kappa\nu)\notag\\ &-2\sum_{\kappa\lambda} \big[ -i D^{LS}_{\lambda\kappa,s} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\kappa)_x +D^{LS}_{\lambda\kappa,x}(\boldsymbol\nabla_\kappa \cdot \boldsymbol\nabla_\nu) -\sum_{K=x,y,z} D^{LS}_{\lambda\kappa,K} (\boldsymbol\nabla_\nu)_K(\boldsymbol\nabla_\kappa)_x \notag\\ &+i D^{SL}_{\lambda\kappa,s} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\lambda)_x +D^{SL}_{\lambda\kappa,x}(\boldsymbol\nabla_\nu \cdot \boldsymbol\nabla_\lambda) -\sum_{K=x,y,z} D^{SL}_{\lambda\kappa,K} (\boldsymbol\nabla_\lambda)_J(\boldsymbol\nabla_\nu)_K\big] (\mu\nu|\kappa\lambda) \end{align} \begin{align} V^{G,LS}_{\mu\nu,y} &=-\big\{ 2D^{SL}_{\lambda\kappa,y}\boldsymbol\nabla_\lambda\cdot \boldsymbol\nabla_\nu +2D^{SL}_{\lambda\kappa,x} (\boldsymbol\nabla_\lambda \times\boldsymbol\nabla_\nu)_z -2D^{SL}_{\lambda\kappa,z} (\boldsymbol\nabla_\lambda \times\boldsymbol\nabla_\nu)_x -i D^{SL}_{\lambda\kappa,s} (\boldsymbol\nabla_\lambda \times \boldsymbol\nabla_\nu)_y \nonumber \\ &+D^{SL}_{\lambda\kappa,y}\big[ -(\boldsymbol\nabla_\lambda)_x(\boldsymbol\nabla_\nu)_x + (\boldsymbol\nabla_\lambda)_y(\boldsymbol\nabla_\nu)_y -(\boldsymbol\nabla_\lambda)_z(\boldsymbol\nabla_\nu)_z\big] \nonumber \\ &+ D^{SL}_{\lambda\kappa,x} \big[ (\boldsymbol\nabla_\nu)_x (\boldsymbol\nabla_\lambda)_y + (\boldsymbol\nabla_\nu)_y (\boldsymbol\nabla_\lambda)_x\big] + D^{SL}_{\lambda\kappa,z} \big[ (\boldsymbol\nabla_\nu)_y (\boldsymbol\nabla_\lambda)_z + (\boldsymbol\nabla_\nu)_z (\boldsymbol\nabla_\lambda)_y\big] \big\} (\mu\lambda|\kappa\nu)\notag\\ &-2\sum_{\kappa\lambda} \big[ -i D^{LS}_{\lambda\kappa,s} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\kappa)_y +D^{LS}_{\lambda\kappa,J}(\boldsymbol\nabla_\kappa \cdot \boldsymbol\nabla_\nu) -\sum_{K=x,y,z} D^{LS}_{\lambda\kappa,K} (\boldsymbol\nabla_\nu)_K(\boldsymbol\nabla_\kappa)_y \notag\\ &+i D^{SL}_{\lambda\kappa,s} (\boldsymbol\nabla_\nu \times \boldsymbol\nabla_\lambda)_y +D^{SL}_{\lambda\kappa,y}(\boldsymbol\nabla_\nu \cdot \boldsymbol\nabla_\lambda) -\sum_{K=x,y,z} D^{SL}_{\lambda\kappa,K} (\boldsymbol\nabla_\lambda)_y(\boldsymbol\nabla_\nu)_K\big] (\mu\nu|\kappa\lambda) \end{align} Additionally, for the $SL$ block, we have the symmetry \begin{equation} V^{G,SL} = V^{\dagger G,LS}\notag \end{equation} \subsubsection{Core Hamiltonian in Pauli Components} Finally, the core Hamiltonian is then defined as \begin{align} h^{LL}_{\mu\nu,s} &= 2\langle\mu|V|\nu\rangle,\quad h^{LL}_{\mu\nu,J}=0\\ h^{LS}_{\mu\nu,s} &= 2\langle\mu|T|\nu\rangle,\quad h^{LS}_{\mu\nu,J}=0\\ h^{SS}_{\mu\nu,s} &= 2\bigg[\frac{1}{4m^2c^2}\boldsymbol\nabla_\mu\cdot\boldsymbol\nabla_\nu\langle\mu|V|\nu\rangle-\langle\mu|T|\nu\rangle\bigg]\\ h^{SS}_{\mu\nu,J}&=\frac{2i}{4m^2c^2}(\boldsymbol\nabla_\mu \times \boldsymbol\nabla_\nu)_J \langle\mu|V|\nu\rangle \end{align} where $J=x,y,z$. $T$ and $V$ are kinetic energy and electron-nuclear potential energy operators. \subsection{Dirac Hartree--Fock Equation} Collecting all Pauli components for core-Hamiltonian, Dirac-Coulomb, and Gaunt terms, the Fock matrix in Pauli representation can be constructed: \begin{align} \mathbf{F}^{XY}_\Gamma = \mathbf{h}^{XY}_\Gamma + \mathbf{V}^{XY}_\Gamma + \frac{1}{(2mc)^2}\mathbf{V}^{C,XY}_\Gamma + \frac{1}{(2mc)^2}\mathbf{V}^{G,XY}_\Gamma + \frac{1}{(2mc)^4}\mathbf{V}^{C(4), XY}_{\Gamma} \end{align} where $X,Y \in\{L,S\}$ and $\Gamma\in\{s,x,y,z\}$. The corresponding two-spinor Fock matrix and density matrix can be constructed from their Pauli components: \begin{equation} {\bf F}^{XY} =\frac{1}{2} \begin{pmatrix} {\bf F}^{XY}_s+{\bf F}^{XY}_z & {\bf F}^{XY}_x - i {\bf F}^{XY}_y\\ {\bf F}^{XY}_x+i{\bf F}^{XY}_y & {\bf F}^{XY}_s-{\bf F}^{XY}_z \end{pmatrix} ,\quad {\bf P}^{XY} =\frac{1}{2} \begin{pmatrix} {\bf P}^{XY}_s+{\bf P}^{XY}_z & {\bf P}^{XY}_x - i {\bf P}^{XY}_y\\ {\bf P}^{XY}_x+i{\bf P}^{XY}_y & {\bf P}^{XY}_s-{\bf P}^{XY}_z \end{pmatrix} \end{equation} Finally, the four-component Dirac equation in the restricted-kinetic-balanced condition is expressed as \begin{align} \begin{pmatrix} {\bf F}^{LL} & {\bf F}^{LS} \\ {\bf F}^{SL} & {\bf F}^{SS} \end{pmatrix} \begin{pmatrix} {\bf C}^+_L &{\bf C}^-_L \\ {\bf C}^+_S &{\bf C}^-_S \end{pmatrix} = \begin{pmatrix} \mathbf{I}\otimes{\bf S} & {\bf 0} \\ {\bf 0} & \mathbf{I} \otimes \frac{1}{2mc^2}{\bf T} \end{pmatrix} \begin{pmatrix} {\bf C}^+_L &{\bf C}^-_L \\ {\bf C}^+_S &{\bf C}^-_S \end{pmatrix} \begin{pmatrix} \boldsymbol{\epsilon}^+ &{\bf 0} \\ {\bf 0} &\boldsymbol{\epsilon}^- \end{pmatrix} \label{eq:fourcomp} \end{align} where $\mathbf{S}$ and $\mathbf{T}$ are the one-component overlap and kinetic matrices. $ \boldsymbol{\epsilon}^+ $, $ \boldsymbol{\epsilon}^-$ are the eigenvalues with corresponding molecular orbitals $\begin{pmatrix} {\bf C}^+_{L} \\ {\bf C}^+_{S} \end{pmatrix}$ and $\begin{pmatrix} {\bf C}^-_{L} \\ {\bf C}^-_{S} \end{pmatrix}$ for positive- and negative-energy solutions, respectively. \vspace{20pt} Although the resulting integral-density contraction scheme during the four-component Fock-build is complicated, there are many unique advantages that lead to a highly efficient four-component method: \begin{itemize} \item The algorithm presented here achieves the maximal component- and spin-separation so that all contractions are essentially done in the one-component framework. In such a framework, terms that use the same type of electron-repulsion integrals can be effectively combined, possibly leading to a minimal FLOP-count algorithm. \item The Pauli matrix representation is ideal for including external electromagnetic field perturbations, because the effects of each component of the electromagnetic field are completely decoupled and spin/component-separated.\cite{Li20_4533,Li19_6824,Li19_739,Li19_3162,Li19_348} \item We also argue that the spin-separation in Pauli matrix representation allows for a clear understanding of how different types of spin physics, including two-electron spin-free, spin-orbit, and spin-spin interactions are manifested in electronic structure and light-matter coupling. \end{itemize} In the next section, we substantiate these claims with more details of the computational implementation, and an analysis of computational cost. \section{Benchmark and Discussion} \subsection{Analysis of Computational Cost} As for any form of four-component DHF implementation, the assembly of integrals needed for the Pauli matrix formalism presented in this work also involves computations of two-center 2nd-derivatives of electron repulsion integrals (ERIs). If the $(SS|SS)$ Dirac-Coulomb term is requested, additional four-center 4th-derivatives of ERIs are needed. Although there is no need to assemble real-valued ERIs into two-spinor or four-spinor forms, it is necessary to construct unique integrals needed throughout the Dirac-Coulomb-Gaunt Fock build. For example, in addition to the normal ERI terms, $(\mu\nu|\kappa\lambda)$, four integrals, including $\boldsymbol\nabla\cdot\boldsymbol\nabla$, $(\boldsymbol\nabla\times\boldsymbol\nabla)_x$, $(\boldsymbol\nabla\times\boldsymbol\nabla)_y$, and $(\boldsymbol\nabla\times\boldsymbol\nabla)_z$, are constructed from two-center ERI 2nd-derivatives in order to form the Dirac-Coulomb Fock matrix with an algorithm using an optimal FLOP count. In the current development, a total of 24 unique integrals are constructed from ERI and ERI 2nd-derivatives in order to form the Dirac-Coulomb-Gaunt Fock matrix without the $(SS|SS)$ contributions. The following discussion and cost analyses are based on the in-core formalism in which all unique integrals are computed and stored in memory. The computational cost for the $(SS|SS)$ contribution is separated from the Dirac-Coulomb term as it is often ignored in practical calculations. The four-spinor form of the Dirac-Fock build is not considered here because it is mathematically more computationally expensive than those in the two-spinor, scalar basis, or Pauli matrix representation. In the case of the scalar basis formalism, we assume the small component basis is generated through the action of the momenta $\mathbf{p}$ or the unrestricted-kinetic-balance (UKB) condition. For the UKB scalar-basis based method, the following analysis assumes an algorithm of optimal FLOP and storage with all integrals in the scalar one-component form. A detailed analysis for the UKB scalar basis is presented in Appendix C. \begin{table*}[h] \centering \begin{threeparttable} \caption{Analysis of memory requirement in terms of the equivalent number of unique real-valued one-component 4-index electron-repulsion-integral tensors needed for forming the four-component Dirac-Coulomb-Gaunt Hamiltonian. $N$ number of atomic basis functions are used in this estimate. Restricted-kinetic-balanced (RKB) basis is compared with the unrestricted-kinetic-balanced (UKB) scalar basis. Dense matrices with no integral or matrix symmetry are considered.} \label{tab:RAM} \footnotesize \begin{tabular*}{6.5in}{@{\extracolsep{\fill} } lcccc} \hline \hline \multirow{2}{*}{Four-Component Scheme} & \multicolumn{3}{c}{Equivalent \# of Real-Valued $N^4$ ERI Tensors} & \multirow{2}{*}{Total}\\ \cline{2-4} & Dirac-Coulomb$^{[a]}$ & $(SS|SS)$& Gaunt & \\ \hline Pauli Matrix RKB Basis & 5& 31 & 19 & 55\\ Two-Spinor RKB Basis$^{[b]}$ & 64 & 32& 64 & 160 \\ UKB Scalar Basis$^{[c]}$ & 7.25 & 39 & 6.25 &52.5 \\ \hline \hline \end{tabular*} \begin{tablenotes} \item[a] Dirac-Coulomb without the $(SS|SS)$ contribution. \item[b] Two-spinor integrals are stored as complex-valued quantities, occupying two double-precision storage. \item[c] For scalar-basis based approach, we assume there are $\frac{N}{2}$ number of $L>0$ atomic basis function in this set, resulting in a total of 2.5$N$ number of smaller component basis functions. For the memory requirement estimation, see Appendix C. \end{tablenotes} \end{threeparttable} \end{table*} \begin{table*}[h] \centering \begin{threeparttable} \caption{Analysis of FLOP count in double-precision operations for forming the four-component Dirac-Coulomb-Gaunt Hamiltonian. $N$ number of atomic basis functions are used in this estimate. Restricted-kinetic-balanced (RKB) basis is compared with the unrestricted-kinetic-balanced (UKB) scalar basis. FLOP counts are separated into Coulomb $\mathbf{J}$ and exchange $\mathbf{K}$ contractions. Dense matrices with no integral or matrix symmetry are considered.} \label{tab:FLOP} \footnotesize \begin{tabular*}{6.5in}{@{\extracolsep{\fill} } lcccc} \hline \hline \multirow{2}{*}{Four-Component Scheme} & \multicolumn{3}{c}{Number of Integral-Density Contractions $(\mathbf{J},\mathbf{K})$} &\multirow{2}{*}{Total FLOP$^{[b]}$}\\ \cline{2-4} & Dirac-Coulomb$^{[a]}$ & $(SS|SS)$ & Gaunt & \\ \hline Pauli Matrix RKB Basis & $(9, 20)$ & $(12,33)$ &$(28, 57)$ & $636N^4$\\ Two-Spinor RKB Basis & $(48,48)$ & $(16, 16)$ &$(64,64)$ &$2048N^4$ \\ UKB Scalar Basis$^{[c]}$ & $(54,54)$ & $(156, 156)$&$(25,100)$ &$2180N^4$ \\ \hline \hline \end{tabular*} \begin{tablenotes} \item[a] Dirac-Coulomb without the $(SS|SS)$ contribution. \item[b] Floating point operation (FLOP) is defined as an arithmetic procedure ($+,-,\times,\div$) of two double-precision numbers. Because integrals for Pauli matrix RKB basis and UKB scalar basis are stored as real-valued matrices and density matrices are complex-valued, each contraction step requires 4$N^4$ FLOPs. For two-spinor RKB basis, because integrals are complex-valued, each contraction step requires 8$N^4$ FLOPs. \item[c] For scalar-basis based approach, we assume there are $\frac{N}{2}$ number of $L>0$ atomic basis function in this set, resulting in a total of 2.5$N$ number of smaller component basis functions. For the estimation of operation count, see Appendix C. \end{tablenotes} \end{threeparttable} \end{table*} \Cref{tab:RAM} and \Cref{tab:FLOP} lists the estimated computational costs in terms of memory requirement and FLOP count for forming the Dirac-Fock matrix from assembled integrals, comparing several different four-component formalisms. In this estimate, we used a Kramers-unrestricted condition where all four Pauli components are non-zero. The cost analysis for UKB scalar basis is based on the assumption that 50\% of the basis functions have a non-zero angular momentum. For all methods considered in \Cref{tab:RAM} and \Cref{tab:FLOP}, the computational cost of real-valued ERI and ERI derivatives are considered equivalent. We also assume the computational cost of assembling the ERI and ERI derivatives into the corresponding two-spinor form is the same as assembling them into unique one-component integrals needed for the Pauli matrix formalism. With these valid assumptions, the difference in computational cost for all four-component implementations comes from the different ways of computing the integral-density contractions in order to form the Dirac-Fock matrix. For the Pauli matrix formalism presented in this work, and the method based on the UKB scalar basis, instead of assembling ERI and ERI derivatives into the two-spinor form, all integrals remain in the one-component form. As a result, for storing integrals in memory, the Pauli matrix and scalar basis formalisms have a smaller memory storage requirement as shown in \Cref{tab:RAM}. As discussed previously, the maximal component- and spin-separation in the Pauli spinor representation allows for combining all integral-density contractions of a same integral type. As a result, the four-component Dirac equation in the Pauli matrix representation is likely to be the method with minimal FLOP count. \Cref{tab:FLOP} shows the FLOP count for each type of ${\bf{J}}$ and ${\bf{K}}$ contractions with the density. For the Dirac-Coulomb terms we see that the Pauli matrix formalism has the minimum FLOP count for both ${\bf{J}}$ and ${\bf{K}}$ matrices compared to the two-spinor basis and the UKB scalar basis by a factor of $\frac{1}{2}$ or smaller. For the $(SS|SS)$ contribution, the ${\bf{J}}$ FLOP count of the Pauli matrix formalism is the minimum of the three, but the ${\bf{K}}$ FLOP count is more than the two-spinor formalism. The UKB scalar basis ends up being more than 5-10 times as expensive overall than the Pauli matrix, or two-spinor formalism. The UKB scalar basis method is particularly disadvantageous for the $(SS|SS)$ term simply because the large $N_S^4$ operation. Finally, for the Gaunt term we see that the UKB scalar basis has the lowest number of FLOPs for the ${\bf{J}}$ contraction, but the Pauli matrix formalism has the lowest number for the ${\bf{K}}$ contraction. While there isn't one single four-component scheme that has the lowest number of FLOPs for every kind of contraction term, the Pauli matrix formalism is optimal in 4 out of 6 types of integral-density contractions considered here. We see that after including all of the contracted terms for the Dirac-Coulomb-Gaunt Hartree--Fock procedure, the Pauli matrix formalism has the best scaling FLOP prefactor by a factor of $\frac{1}{3}$ or smaller, where the two-spinor and UKB scalar form are comparable. \subsection{Integral and Contraction Timings} For the following timing benchmarks, we use a lanthanum dimer with a bond distance of 3.0 \AA \, and the uncontracted ANO-RCC basis set.\cite{Widmark04_2851,Widmark05_6575,Borin08_11431} Computations were performed on an Intel\textsuperscript{\textregistered} Xeon\textsuperscript{\textregistered} W 2.5 GHz CPU. Additionally, Chronus Quantum was compiled using the Clang Compiler version 12.0.0. Additionally, the integrals are computed using the LIBCINT library\cite{Sun15_1664}, with a development version of the Chronus Quantum electronic structure software package.\cite{Li20_e1436} Note that the timings serve the purpose to show the relative costs of computationally dominant steps in Dirac Hartree--Fock build. They should not be used as calibrations of the performance of the program as the code optimization is beyond the scope of this article. \begin{figure}[ht] \begin{center} \includegraphics[width=3.75in]{graphics/timings_anorcc2.pdf}\\ \caption{Wall-clock timings for the computation of integrals (solid lines with empty circles) and the duration of the AO-direct density-integral contraction (dashed lines with filled circles) for the lanthanum dimer using the uncontracted ANO-RCC basis. The time-reversal symmetry is turned off. The Schwarz integral screening threshold of $10^{-12}$ is used. The timings for the Dirac-Coulomb and the Gaunt two-body terms, shown in black and blue, respectively, were collected from a single DHF build. Logarithmic wall-clock times are plotted against logarithmic number of CPU cores. The lines are included in this plot are linear interpolations to guide the eye.} \label{fig:timings} \end{center} \end{figure} While \Cref{tab:FLOP} analyzes the computational cost at the theoretical limit in the absence of all symmetries, benchmark calculations presented here take advantage of integral symmetries and matrix hermiticity. Note that all calculations assume the Kramers' unrestricted case unless otherwise noted. Although both the Dirac-Coulomb (without $(SS|SS)$) and Gaunt integrals are two-center second derivatives, the Gaunt integrals have a 2-fold symmetry whereas the integral symmetry is 4-fold for Dirac-Coulomb integrals (without $(SS|SS)$). The four-center derivatives of the $(SS|SS)$ term has an 8-fold symmetry. \Cref{fig:timings} shows the wall-clock time for the lanthanum dimer system per number of cores and for each type of two-body integral and density contractions respectively, based on the Pauli spinor representation formalism presented here. For DC-HF, the $(SS|SS)$ term is also included. The ratio of the contraction times on a single CPU core for the Dirac-Coulomb and the Gaunt term is $\sim1:4.3$. This ratio is close to the theoretical limit of DCG in Pauli representation when integral and matrix symmetries are considered. The lower computational cost for DC contraction is mainly due to the higher symmetry of the underlying integrals. The ratio of the computational cost for calculating the integrals needed for the Dirac-Coulomb and the Gaunt terms is $\sim1.7:1$. In addition to two-center second derivatives, the Dirac-Coulomb term also includes the four-center fourth-derivatives of integrals arising from the $(SS|SS)$ contribution. As a result, the Dirac-Coulomb integrals are more computationally expensive than those for the Gaunt term. The overall ratio of the computational cost, including both integral evaluation and contraction, for the Dirac-Coulomb and the Gaunt terms is $\sim1:1.5$ on a single CPU core. \Cref{fig:timings} also shows that on a single CPU core the cost of computing the Dirac-Coulomb term is dominated by the integral evaluations, whereas it is the contraction step that is the more expensive step for the Gaunt term. The timing ratios between the integral evaluation and contraction are $3:1$ and $1:2.4$ for the Dirac-Coulomb and the Gaunt terms, respectively, on a single CPU core. The times for Dirac-Coulomb and Gaunt contractions decrease roughly $1/n$ for every increase in $n$ CPU cores used. The computational cost of calculating two-electron repulsion integrals and integral derivatives also decreases when increasing the number of CPU cores computing in parallel. The contraction step in AO-direct benefits more from the parallelization, as it is FLOP-bound. At around 8 cores, the cost of the Gaunt contraction decreases below the the cost of integral derivative evaluations. Next, \cref{fig:Aucluster} shows the timing comparison for building the Dirac-Hartree-Fock matrix with the Dirac-Coulomb operator using the RKB spinor and RKB Pauli representations respectively. Computations were performed on an Intel\textsuperscript{\textregistered} Xeon\textsuperscript{\textregistered} Platinum 8160 CPU. Additionally, Chronus Quantum was compiled using the Intel\textsuperscript{\textregistered} C++ Compiler version 19.0.1.144. RKB spinor calculations were performed using PySCF.\cite{Chan18_e1340} In order to compare these implementations on the same footing, the calculations in our RKB spinor method for these results were computed utilizing time-reversal symmetry, and the contractions are done using an atomic-orbital direct scheme. The observed ratio of wall-clock times between the two representations for linear Au chains agrees with the time complexity analysis in \cref{tab:FLOP}, where the RKB spinor representation is roughly 3 times slower than the RKB Pauli method. Additionally, we present timings for the Dirac-Fock build in our RKB Pauli representation in \cref{tab:FLOP}, split into both the density contraction and integral build times for a 24-core parallel calculation. To showcase this comparison we used bulky Au cluster calculations from Au$_{20}$ to Au$_{40}$. Since the RKB Pauli representation greatly reduces the density-integral contraction time, it can be seen that the computational cost of the integral build step dominates the overall computational cost. For a Dirac-Coulomb calculation with $\sim$6000 basis functions, the RKB Pauli based density contraction only takes a little more than 2 hours on a 24-core workstation (2.5 GHz Intel Xeon W). \begin{figure}[htbp] \centering \includegraphics[width=.45\textwidth]{graphics/spinor_v_pauli_timing.pdf} \includegraphics[width=.45\textwidth]{graphics/proposal_au_cluster.pdf} \vspace{-10pt} \caption{({\bf Left}) Single-core timing comparison for building the Dirac-Hartree-Fock matrix with the Dirac-Coulomb operator without the $(SS|SS)$ term using the RKB spinor and the RKB Pauli representation, respectively. A series of Au linear chains (Au$_2$ to Au$_{12}$) were used for this test with the uncontracted Jorge-DZ-DKH basis using an AO direct algorithm. A Schwarz screening threshold of $10^{-12}$ is used in each calculation. ({\bf Right}) 24-core parallel performance of the RKB Pauli Dirac-Hartree-Fock algorithm with the Dirac-Coulomb operator for building the Dirac-Hartree-Fock matrix. A series of Au clusters (Au$_{20}$ to Au$_{40}$) were used for this result. The RKB spinor results were computed using PySCF\cite{Chan18_e1340} and the RKB Pauli results were computed in ChronusQ.\cite{Li20_e1436}}\label{fig:Aucluster} \end{figure} Including relativistic two-electron contributions is by no means computationally cheap, especially including the Gaunt term which dominates the cost by being an order of magnitude greater than both the Dirac-Coulomb and Bare-Coulomb integrals. However, the method presented here is possibly the optimal algorithm for DHF. Integral and contraction acceleration techniques, such as the fast-multipole-method and density-fitting, can be applied to reduce the computational cost further based on the RKB Pauli formalism. \subsection{Atomic Periodic Trend} \label{atomic} In the data presented in this section, the integrals and the derivatives of integrals with respect to nuclear coordinates are computed with the LIBINT and LIBCINT libraries.\cite{Libint2,Sun15_1664} Additionally, the four-component Dirac Hartree--Fock formalism is implemented in a development version of the Chronus Quantum software package.\cite{Li20_e1436} The speed of light constant used in the following calculations is $137.03599967994$ a.u. The main purpose of this paper is to introduce the methodological foundation and formalism of the four-component Dirac Hartree--Fock equation in the Pauli spinor representation. The four-component framework is validated by comparing the computed energies using the analytical results of the Dirac equation for hydrogenic atoms, shown in Appendix D, and basis set limit tests, shown in Appendix E. When a large uncontracted basis set is used, the calculations show a percent error on the order of $10^{-3} \%$. For benchmarking, we focus on analyzing and comparing the ground state DHF energies with different levels of relativistic two-electron interactions. In order to analyze the importance of relativistic two-electron corrections in Dirac Hartree--Fock, we introduce a Bare-Coulomb approximation in matrix form, \emph{i.e.} only the first term in \cref{eq:vcll} is included. Several atomic series are selected from the periodic table, including the halogens, the coinage metals, and the lanthanides. In this way we can compare each relativistic two-body interaction contribution as a function of element charge, $Z$, although this separation of terms is not unique to the RKB Pauli formalism. In this section we report the ground state energies of these atoms using the uncontracted ANO-RCC basis set\cite{Widmark04_2851,Widmark05_6575,Borin08_11431}. The SCF energies for each atom with different levels of relativistic two-electron interaction are shown in \cref{table:anorccatoms} for each selected atom. \iffalse \begin{table}[htbp] { {\footnotesize \caption{Ground state energies (Hartrees) for selected atoms with the energetic contributions of Dirac-Coulomb and Gaunt terms, computed as $\Delta E^{DC} = E^{DC} - E^{BC}$ and $\Delta E^{G} = E^{DCG} - E^{DC}$ where $E^{DCG}$, $E^{DC}$, and $E^{BC}$ are the SCF energies of Dirac-Coulomb-Gaunt, Dirac-Coulomb, and Bare-Coulomb calculations respectively. The uncontracted Jorge-DZP-DKH basis with finite width nuclei was used for this dataset. } \centering \begin{tabular}{c r r r r r} \hline Atom & Bare-Coulomb & Dirac-Coulomb$^a$ & $\Delta E^{DC}$ & Dirac-Coulomb-Gaunt$^a$ & $\Delta E^{G}$\\ [0.5ex] \hline \multicolumn{2}{l}{Halogen Series}\\ F & $-99.528$ & $-99.492$ & 0.036 & $ -99.480$ & 0.012\\ Cl & $-461.390$ & $-460.931$ & 0.459 & $-460.814$ & 0.117 \\ Br & $-2612.740$ & $-2604.942$ & 7.798 & $-2603.512$ & 1.430 \\ I & $-7155.237$ & $-7115.864$ & 39.374 & $-7109.836$ & 6.028\\ [1ex] \hline \multicolumn{2}{l}{Lanthanide Series}\\ La & $-8545.797$ & $-8493.654$ & $52.143$ & $-8485.888$ & $7.766$ \\ Ce & $-8916.760$ & $-8860.851$ & $55.908$ & $-8852.602$ & 8.250\\ Pr & $ -9297.599$ & $-9237.732$ & $59.866$ & $-9229.020$ & $8.713$ \\ Nd & $-9689.322$ & $-9625.204$ & $64.118$ & $-9616.079$ & $9.125$ \\ Pm & $-10090.308$ & $-10022.111$ & $68.196 $ & $-10012.300$ & 9.811\\ Sm & $-10502.118$ & $-10429.220$ & $72.897$ & $-10418.844$ & $10.376$\\ Eu & $-10924.007$ & $-10846.502$ & $77.505$ & $-10835.538$ & 10.963\\ Gd & $-11357.439$ & $-11274.727$ & $82.712$ & $-11263.145$ & $11.582$\\ Tb & $-11800.963$ & $-11712.893$ & $88.070$ & $-11700.678$ & $12.214$\\ Dy & $-12254.985$ & $-12161.432$ & $93.553$ & $-12148.561$ & 12.871\\ Ho & $-12720.932$ & $-12621.463$ & $99.469$ & $-12607.898$ & $13.565$\\ Er & $-13197.900$ & $-13092.311$ & $105.589$ & $-13078.031$ & $14.281$\\ Tm & $-13686.192$ & $-13574.174$ & $112.018$ & $-13559.171$ & $15.003$ \\ Yb & $-14185.430$ & $-14066.771$ & $118.658$ & $-14050.981$ & $15.790$ \\ Lu & $-14696.968$ & $-14571.361$ & $125.607$ & $-14554.768$ & $16.593$\\ [1ex] \hline \multicolumn{2}{l}{Coinage Metal Series}\\ Cu & $-1657.086$ & $-1653.357$ & 3.729 & $ -1652.612$ & 0.745 \\ Ag & $-5339.277$ & $-5314.617$ & 24.660 & $-5310.646$ & 3.971\\ Au & $-19229.025$ & $-19035.495$ & 193.530 & $-19011.304$ & 24.191\\ [1ex] \hline \end{tabular} {\footnotesize $^{a}$ The $(SS|SS)$ contribution is not included. } \label{table:jorgeatoms} } } \end{table} \fi \begin{table}[htbp] { {\footnotesize \caption{Ground state energies (Hartrees) for selected atoms with the energetic contributions of Dirac-Coulomb and Gaunt terms, computed as $\Delta E^{DC} = E^{DC} - E^{BC}$ and $\Delta E^{G} = E^{DCG} - E^{DC}$ where $E^{DCG}$, $E^{DC}$, and $E^{BC}$ are the SCF energies of Dirac-Coulomb-Gaunt, Dirac-Coulomb, and Bare-Coulomb calculations respectively. The uncontracted ANO-RCC basis with finite width nuclei was used for this dataset. } \centering \begin{tabular}{c r r r r r} \hline Atom & Bare-Coulomb & Dirac-Coulomb & $\Delta E^{DC}$ & Dirac-Coulomb-Gaunt & $\Delta E^{G}$\\ [0.5ex] \hline \multicolumn{2}{l}{Halogen Series}\\ F & $-99.540917$ & $-99.504738$ & $0.036179$ & $-99.492763$ & $0.011975$ \\ Cl & $-461.406677$ & $-460.947164$ & $0.459512$ & $-460.830018$ & $0.117146$ \\ Br & $-2612.852939$ & $-2605.033836$ & $7.819103$ & $-2603.603969$ & $1.429867$ \\ I & $-7155.395184$ & $-7115.798492$ & $39.596692$ & $-7109.770036$ & $6.028456$ \\ [1ex] \hline \multicolumn{2}{l}{Lanthanide Series}\\ La & $-8546.215923$ & $-8493.657945$& $52.557978$ & $-8485.891031$ & $7.766914$ \\ Ce & $-8917.383681$ & $-8861.043868$& $56.339814$ & $-8852.800219$ & $8.243649$ \\ Pr & $-9298.457621$ & $-9238.164865$& $60.292756$ & $-9229.419749$ & $8.745116$ \\ Nd & $-9689.682825$ & $-9625.317052$& $64.365773$ & $-9616.050622$ & $9.266430$ \\ Pm & $-10091.178921$ & $-10022.330954$& $68.847967$ & $-10012.520248$ & $9.810706$ \\ Sm & $-10502.861365$ & $-10429.356216$& $73.505149$ & $-10418.975555$ & $10.380661$ \\ Eu & $-10925.261820$ & $-10846.946858$& $78.314963$ & $-10835.981295$ & $10.965563$ \\ Gd & $-11358.014014$ & $-11274.744433$& $83.269580$ & $-11263.160904$ & $11.583529$ \\ Tb & $-11801.625306$ & $-11712.825124$& $88.800182$ & $-11700.608150$ & $12.216974$ \\ Dy & $-12256.214858$ & $-12161.776442$& $94.438417$ & $-12148.896505$ & $12.879937$ \\ Ho & $-12721.922596$ & $-12621.573979$& $100.348617$ & $-12608.005042$ & $13.568938$ \\ Er & $-13198.887030$ & $-13092.441227$& $106.445803$ & $-13078.151685$ & $14.289542$ \\ Tm & $-13687.098882$ & $-13574.398156$& $112.700726$ & $-13559.365996$ & $15.032160$ \\ Yb & $-14187.311321$ & $-14067.663235$& $119.648086$ & $-14051.865403$ & $15.797831$ \\ Lu & $-14699.426395$ & $-14572.526419$& $126.899976$ & $-14555.924058$ & $16.602362$ \\ [1ex] \hline \multicolumn{2}{l}{Coinage Metal Series}\\ Cu & $-1657.190117$ & $-1653.453398$ & $3.736719$ & $-1652.708252$ & $0.745146$ \\ Ag & $-5339.393098$ & $-5314.625699$ & $24.767399$ & $-5310.654463$ & $3.971236$ \\ Au & $-19231.541954$ & $-19035.579049$ & $195.962905$ & $-19011.375550$ & $24.203499$ \\ [1ex] \hline \end{tabular} \label{table:anorccatoms} } } \end{table} \begin{figure}[htbp] \begin{center} \includegraphics[width=3.75in]{graphics/stacked_Z_trends_anorcc.pdf}\\ \caption{(A) Energetic contributions of Dirac-Coulomb (black) and Gaunt (blue) terms, computed as $\Delta E^{DC} = E^{DC} - E^{BC}$ and $\Delta E^{G} = E^{DCG} - E^{DC}$ where $E^{DCG}$, $E^{DC}$, and $E^{BC}$ are the SCF energies of Dirac-Coulomb-Gaunt, Dirac-Coulomb, and Bare-Coulomb calculations. (B) Percentage of energy contribution of each two-electron term compared to the Bare-Coulomb ground state DHF energy, presented as $\frac{\Delta E^{DC}}{E^{BC}}\times100\%$ and $\frac{\Delta E^{G}}{E^{BC}}\times100\%$. The gray squares correspond to the total relativistic contribution which is $\frac{\Delta E^{DC} + \Delta E^{G}}{E^{BC}}\times100\%$ (C) The ratio of the energy contribution of the Dirac-Coulomb term vs. the Gaunt term $\frac{\Delta E^{DC}}{E^{G}}$ as a function of increasing nuclear charge for the neutral atom series. The power law fit is displayed as the dashed line, corresponding to the equation in the top left corner of each panel.} \label{fig:energy_diff} \end{center} \end{figure} From the computed data, we see that with each successive correction to the bare non-relativistic Coulomb interaction, the ground state energy increases. This is expected as they all arise from the $\frac{1}{r_{12}}$ two-electron repulsion interaction. The relativistic two-electron interaction increases much faster as $Z$ increases in the same element group down the periodic table than the trend across a same row (such as the lanthanides). By comparing Dirac-Coulomb calculations using the uncontracted ANO-RCC basis with the previously published numerically exact values,\cite{Clementi90_1829,Dyall97_207} the observed errors are on the order of $10^{-7} \%$ to $10^{-5} \%$, showing excellent agreement. The periodic trends of the relativistic two-electron interactions are plotted in \cref{fig:energy_diff}. For each data set, a least squares power law fit was applied and displayed as the dashed lines for each subplot in \cref{fig:energy_diff}. \Cref{fig:energy_diff}A shows that the Dirac-Coulomb and Gaunt contributions to the two-body interaction increase polynomially as $Z$ increases. The Dirac-Coulomb term exhibits a near quartic growth with respect to $Z$, while the Gaunt term has a $Z^{3.49}$ dependence. It is more meaningful to analyze the energetic contributions in terms of the percentage of the total energy. In \cref{fig:energy_diff}B, the percent contribution is evaluated with respect to the Bare-Coulomb DHF energy. This plot compares the growth behaviors of relativistic two-electron interactions relative to that exhibited by the Bare-Coulomb ground state energy. It is quite surprising to see that the Gaunt contribution in terms of the percent of the total energy is almost linear with respect to $Z$, suggesting that the relativistic Gaunt interaction behaves almost like the Bare-Coulomb term. \Cref{fig:energy_diff}B also shows that the Dirac-Coulomb contribution exhibits a much faster growth behavior than both the Gaunt and the Bare-Coulomb interaction. As a result, \cref{fig:energy_diff}C shows that the the Dirac-Coulomb interaction is a factor of 3$-$5 times larger than the Gaunt contribution for light elements ($Z<40$), and increases towards a ratio of $\sim$9 near the end of the periodic table. As $Z$ increases, this ratio increases as $\sqrt{Z}$ approximately. \subsection{Coinage Metal Dimers} In this section, the equilibrium bond lengths and dissociation energies for the coinage metal dimer series including Cu$_2$, Ag$_2$, Au$_2$, are computed. The uncontracted ANO-RCC basis set\cite{Widmark05_6575} is used for all calculations throughout this section. For these results we would like to emphasize that agreement with experimental data should not be expected due to the lack of electronic correlation.\cite{Schwerdtfeger99_9457} Analyses presented here aim to provide a qualitative understanding of how the Dirac-Coulomb and Gaunt two-electron relativistic effects change molecular properties compared to the non-relativistic results. Potential energy scans are carried out using the non-relativistic Hartree-Fock (NR-HF), Dirac-Coulomb, and Dirac-Coulomb-Gaunt Hamiltonians to find the equilibrium bond length for each dimer and level of theory, reported in \cref{table:dimer_bonds}. Additionally, the bond dissociation energy ($D_e$) is computed as $D_e = 2E_{\text{atom}} - E_{\text{dimer}}$, where $E_{\text{atom}}$ is the atomic energy and $E_{\text{dimer}}$ is the energy of the dimer at the equilibrium bond length. The theoretical and experimental results for the dissociation energies are presented in \Cref{table:dimer_de}. \begin{table} \caption{The equilibrium bond lengths for each dimer system are reported in \AA. The experimental bond lengths are reported under ``Exp." The uncontracted ANO-RCC basis is used for all calculations.} \centering \begin{tabular}{c r r r r} \hline Dimer & NR-HF & Dirac-Coulomb & Dirac-Coulomb-Gaunt & Exp. \\ [0.5ex] \hline Cu$_2$ & 2.409 & 2.402 & 2.403 & 2.22 [Ref. \citenum{Morse86_1049}] \\ Ag$_2$ & 2.770 & 2.701 & 2.703 & 2.53 [Ref. \citenum{Langridge-Smith91_415}]\\ Au$_2$ & 2.830 & 2.586 & 2.590 & 2.47 [Ref. \citenum{Barrow67_39}] \\[1ex] \hline \end{tabular} \label{table:dimer_bonds} \end{table} \begin{table} \caption{Equilibrium bond dissociation energies ($D_e$) for each dimer system are reported in eV. The experimental dissociation energies are reported under ``Exp." The uncontracted ANO-RCC basis is used for all calculations.} \centering \begin{tabular}{c r r r r} \hline Dimer & NR-HF & Dirac-Coulomb & Dirac-Coulomb-Gaunt & Exp. \\ [0.5ex] \hline Cu$_2$ & 0.600 & 0.549 & 0.547 & 2.01$\pm$0.08 [Ref. \citenum{Morse86_1049}] \\ Ag$_2$ & 0.486 & 0.480 & 0.477 & 1.65$\pm$0.03 [Ref. \citenum{Gingerich80_739}] \\ Au$_2$ & 0.659 & 0.865 & 0.855 & 2.29$\pm$0.02 [Ref. \citenum{Seyse74_5114}] \\[1ex] \hline \end{tabular} \label{table:dimer_de} \end{table} \Cref{table:dimer_bonds} shows that the Dirac-Coulomb computed bond length contracts for all dimers studied here relative to the non-relativistic result. This is mainly due to the core-electron contraction arising from the scalar relativistic effects.\cite{Schwarz02_804} The main takeaway from the equilibrium bond length calculations in \cref{table:dimer_bonds} is that the Gaunt correction to the Dirac-Coulomb two-electron interaction introduces an additional electron-electron repulsion that elongates the bond length by 0.001--0.004\AA. In \cref{table:dimer_de} the Gaunt correction shows a systematic trend that lowers the bond dissociation energy on the order of $\sim$10 meV. This observation suggests that the Gaunt term gives rise to a small yet increasingly important repulsive correction to the bond dissociation energy as the atomic number increases. \section{Conclusion and Perspective} In this work, we introduced a computationally efficient four-component Dirac Hartree--Fock (DHF) formalism within the maximally component- and spin-separated Pauli spinor representation in the restricted-kinetic-balance condition (denoted ``RKB Pauli''). A minimal FLOP count algorithm is developed for the density contraction with the relativistic electron repulsion integrals. All of the required ingredients for this implementation can utilize the non-relativistic atomic orbital electron repulsion integrals and their gradients stored in the one-component form without going through the two-spinor basis construction. Additionally, a detailed cost analysis was presented and compared to other four-component algorithms. Numerical tests shows that the RKB Pauli representation is physically equivalent to the RKB spinor representation, but computationally much cheaper. Additionally, the contribution of relativistic two-electron interactions across the periodic table were analyzed. As expected, both Dirac-Coulomb and Gaunt terms increase the total energy, with the Dirac-Coulomb contribution exhibiting a faster growth as $Z$ increases. The importance of the Gaunt interaction to the total atomic energy increases linearly with respect to the non-relativistic Coulomb contribution while the Dirac-Coulomb term becomes more important relative to the Gaunt term as $Z$ increases. The RKB Pauli formalism of the four-component DHF Hamiltonian presented in this work provides a computationally efficient way to develop relativistic electronic structure theories. Although the final mathematical working expressions are more complicated than those in two-spinor or scalar basis, we are rewarded with an optimal algorithm with a minimal memory requirement and total FLOP count. This work lays the computational foundation for practical applications of four-component DHF, and future developments of correlated wave function methods in the four-component domain. When it comes to computing bond lengths and dissociation energies for metal dimers, our results show that the Gaunt correction introduces an additional electron-electron repulsion that slightly elongates the bond length and increases the bond dissociation energy. Additionally, as expected, electron correlation is vital for making quantitative comparisons with experimental values. For this study, we primarily focused on comparing the computational performance of DHF methods utilizing fully uncontracted basis sets. While introducing contracted basis sets can reduce the resulting DHF matrix size, using \emph{standard} contracted basis sets in 4-component DHF is not recommended.\cite{Faegri01_252,Nieuwpoort91_131} Naively fixing the contraction coefficients for both the large and small components of the wave function can lead to variational collapse.\cite{Nieuwpoort91_131,Liu10_1679} One approach to mitigate this problem is to use the atomic balance basis, proposed and pioneered by Visscher and Liu,\cite{Nieuwpoort91_131,Liu10_1679} which allows the small and large component bases to have their own contraction coefficients derived from an atomic calculation with the uncontracted basis. However, the best way to extend the present method to this case is currently under investigation. \begin{acknowledgement} We would like to thank Prof. Trond Saue for helpful discussions on various kinetic balance conditions in Dirac Hartree-Fock theory. Additionally, X. L. acknowledges support from the U.S. Department of Energy, Office of Science, Basic Energy Sciences, in the Heavy-Element Chemistry program (Grant No. DE-SC0021100) for the development of electronic structure methods within the four-component Dirac framework. The development of the open source software package is supported by the U.S. National Science Foundation (OAC-1663636). The work of E. F. V. on the evaluation of electron repulsion integrals and integral derivatives was supported by the U.S. National Science Foundation (Grant Nos. 1550456 and 1800348). \end{acknowledgement} \subsection*{Appendix A: Spin-Separation for Gaunt Interaction} The Gaunt term integrals can be separate into spin-free, spin-own-orbit, and spin-other-orbit interactions in the Pauli spinor representation. In this section, detailed derivations will be shown for the $(\mu^L\boldsymbol\sigma \nu^S|\cdot \kappa^S\boldsymbol\sigma \lambda^L)$ type of integral which contributes to the exchange term in $V^{G,LL}$ and Coulomb term in $V^{G,LS}$. The $(\mu^L\boldsymbol\sigma \nu^S|\cdot \kappa^S\boldsymbol\sigma \lambda^L)$ integral can be written as (prefactor $\frac{1}{(2mc)^2}$ is ignored for brevity), \begin{align} (\mu^L _{\tau_1} \boldsymbol\sigma \nu^S _{\tau_2}| \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \lambda ^L _{\tau_4}) =& (\mu^L _{\tau_1} \boldsymbol\sigma(1) \boldsymbol\sigma(1)\cdot \mathbf{p}(1) \nu^L _{\tau_2} | \cdot \boldsymbol\sigma(2) \cdot \mathbf{p}(2) \kappa ^L_{\tau_3} \boldsymbol\sigma(2) \lambda ^L _{\tau_4})\nonumber \\ =&-(\mu^L _{\tau_1}\boldsymbol\sigma(1) \boldsymbol\sigma(1)\cdot \boldsymbol\nabla(1) \nu ^L _{\tau_2}| \cdot \boldsymbol\sigma(2) \cdot \boldsymbol\nabla(2) \kappa ^L _{\tau_3} \boldsymbol\sigma(2) \lambda ^L _{\tau_4}) \nonumber \end{align} where we used the restricted-kinetic-balance condition $\mu^S = \frac{1}{2mc}\boldsymbol\sigma\cdot {\bf p} \mu^L$. $\boldsymbol\nabla_\kappa$ and $\boldsymbol\nabla_\nu$ are gradients with respect to basis centers of $\kappa^L$ and $\nu^L$, respectively. We now switch from Mulliken notation to Dirac notation to carry out the spin-separation \begin{align} &-(\mu^L _{\tau_1}\boldsymbol\sigma(1) \boldsymbol\sigma(1)\cdot \boldsymbol\nabla(1) \nu ^L _{\tau_2}| \cdot \boldsymbol\sigma(2) \cdot \boldsymbol\nabla(2) \kappa ^L _{\tau_3} \boldsymbol\sigma(2) \lambda ^L _{\tau_4})\notag\\ =&-\bra{\mu^L _{\tau_1}\boldsymbol\sigma(2)\cdot \boldsymbol\nabla_\kappa \kappa^L_{\tau_3}} \frac{\boldsymbol\sigma(1)\cdot \boldsymbol\sigma(2)}{r_{12}} \boldsymbol\sigma(1)\cdot \boldsymbol\nabla_\nu \ket{\nu^L_{\tau_2} \lambda^L _{\tau_4}}\notag\\ =&\bra{\mu^L _{\tau_1} \kappa^L_{\tau_3}} \boldsymbol\sigma(2)\cdot \boldsymbol\nabla_\kappa \frac{\boldsymbol\sigma(1)\cdot \boldsymbol\sigma(2)}{r_{12}} \boldsymbol\sigma(1)\cdot \boldsymbol\nabla_\nu \ket{\nu^L_{\tau_2} \lambda^L _{\tau_4}}\label{eq:Diracnotation} \end{align} where we used the relationship $\boldsymbol\nabla(2) = -\boldsymbol\nabla_\kappa$ between basis function derivative with respect to the electronic coordinate $\boldsymbol\nabla(2)$ and with respect to basis function center $\boldsymbol\nabla_\kappa$. By using the Dirac identity, $(\boldsymbol\sigma(1)\cdot\boldsymbol\sigma(2))(\boldsymbol\sigma(1)\cdot\boldsymbol\nabla_\nu)=\mathbf{I}(1)~\boldsymbol\sigma(2)\cdot\boldsymbol\nabla_\nu+i\boldsymbol\sigma(1)\cdot\boldsymbol\sigma(2)\times\boldsymbol\nabla_\nu$, \cref{eq:Diracnotation} can be written as, \begin{align} &\bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} \boldsymbol\sigma(2)\cdot \boldsymbol\nabla_\kappa \frac{\boldsymbol\sigma(1)\cdot \boldsymbol\sigma(2)}{r_{12}} \boldsymbol\sigma(1)\cdot \boldsymbol\nabla_\nu \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}}\notag\\ =& \bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} \boldsymbol\sigma(2)\cdot \boldsymbol\nabla_\kappa \frac{1}{r_{12}} [{\bf I}(1) \boldsymbol{\sigma}(2) \cdot \boldsymbol{\nabla}_\nu +i \boldsymbol{\sigma}(1) \cdot \boldsymbol{\sigma}(2)\times \boldsymbol{\nabla}_\nu] \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}}.\label{eq:separation1} \end{align} Additional applications of the Dirac identity are carried out to further spin-separate the two terms in \cref{eq:separation1}: \begin{align} &\bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} \boldsymbol\sigma(2)\cdot \boldsymbol\nabla_\kappa \frac{1}{r_{12}} {\bf I}(1) \boldsymbol{\sigma}(2) \cdot \boldsymbol{\nabla}_\nu \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}}\notag\\ =&\bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} {\bf I}(1)\frac{1}{r_{12}} [{\bf I}(2) \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu +i \boldsymbol{\sigma}(2)\cdot \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu] \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}} \label{eq:separation2} \end{align} and \begin{align} &\bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} \boldsymbol\sigma(2)\cdot \boldsymbol\nabla_\kappa \frac{1}{r_{12}} i \boldsymbol{\sigma}(1) \cdot \boldsymbol{\sigma}(2)\times \boldsymbol{\nabla}_\nu \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}} \nonumber \\ =&\bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} i\frac{1}{r_{12}}[ {\bf I}(2) \boldsymbol{\nabla}_\kappa \cdot (\boldsymbol{\nabla}_\nu \times \boldsymbol{\sigma}(1)) + i \boldsymbol{\sigma}(2) \cdot \boldsymbol{\nabla}_\kappa \times (\boldsymbol{\nabla}_\nu \times \boldsymbol{\sigma}(1)) ] \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}} \notag \\ =&\bra{\mu^L _{\tau_1}\kappa^L_{\tau_3}} \frac{1}{r_{12}}[i {\bf I}(2)\boldsymbol{\sigma}(1) \cdot (\boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu ) + (\boldsymbol{\sigma}(2) \times \boldsymbol{\nabla}_\kappa) \cdot (\boldsymbol{\sigma}(1) \times \boldsymbol{\nabla}_\nu ) ] \ket{\nu^L _{\tau_2} \lambda^L_{\tau_4}} \label{eq:separation3} \end{align} Combining \cref{eq:separation2} and \cref{eq:separation3} into \cref{eq:separation1}, and write the integrals in Mulliken notation, we arrive at the following expression: \begin{align} (\mu^L _{\tau_1} \boldsymbol\sigma \nu^S _{\tau_2}| \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \lambda ^L _{\tau_4})=&~\xi_{\tau_1}^\dagger (1) \xi_{\tau_2} (1) \xi_{\tau_3}^\dagger (2) \xi_{\tau_4} (2) \big[\mathbf{I}(1)\mathbf{I}(2) \boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu \nonumber \\ &+i (\mathbf{I}(1)\boldsymbol\sigma(2)+\mathbf{I}(2)\boldsymbol\sigma(1)) \cdot \boldsymbol\nabla_\kappa \times \boldsymbol\nabla_\nu \notag\\ &+(\boldsymbol\sigma(2) \times \boldsymbol\nabla_\kappa) \cdot (\boldsymbol\sigma(1)\times \boldsymbol\nabla_\nu)\big](\mu\nu|\kappa\lambda)\label{eq:separation4} \end{align} In \cref{eq:separation4}, the integral type of $\mathbf{I}(1)\mathbf{I}(2) \boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu$ gives rise to the spin-free term. The contribution from the integral type of $\mathbf{I}(1)\boldsymbol\sigma(2) \cdot \boldsymbol\nabla(2) \frac{1}{r_{12}}\times \boldsymbol\nabla(1)$ is the spin-other-orbit term, while $\mathbf{I}(2)\boldsymbol\sigma(1) \cdot \boldsymbol\nabla(2) \frac{1}{r_{12}}\times \boldsymbol\nabla(1)$ is the spin-own-orbit term. \iffalse This can be seen as follows, \begin{align} i\boldsymbol\sigma(2) \cdot\boldsymbol\nabla(2) \frac{1}{r_{12}}\times \boldsymbol\nabla(1) &=-i\boldsymbol\sigma(2)\cdot\frac{{\bf r}_{12}}{r_{12}^3}\times\boldsymbol\nabla(1)\notag\\ &=\boldsymbol\sigma(2)\cdot\frac{1}{r_{12}^3} {\bf r}_{12}\times{\bf p}_1 \end{align} thus $\sigma(2) \cdot \nabla_2 \frac{1}{r_{12}}\times \nabla_1\propto \hat{s}(2)\cdot\hat{L}(1)$, while $\sigma(1) \cdot \nabla_2 \frac{1}{r_{12}}\times \nabla_1\propto\hat{s}(1)\cdot \hat{L}(1)$. \fi The last term $(\boldsymbol\sigma(2) \times \boldsymbol\nabla_\kappa) \cdot (\boldsymbol\sigma(1)\times \boldsymbol\nabla_\nu)$ is the spin-spin interaction which can be further separated using the scalar quadruple product rule, \begin{align} (\boldsymbol\sigma(2)\times\boldsymbol\nabla_\kappa)\cdot(\boldsymbol\sigma(1)\times\boldsymbol\nabla_\nu)&=(\boldsymbol\sigma(1)\cdot\boldsymbol\sigma(2))(\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu)-(\boldsymbol\sigma(1)\cdot\boldsymbol\nabla_\kappa)(\boldsymbol\sigma(2)\cdot\boldsymbol\nabla_\nu).\notag \end{align} The final, completely spin-separated expression for the $(\mu^L _{\tau_1} \boldsymbol\sigma \nu^S _{\tau_2}| \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \lambda ^L _{\tau_4})$ integral is \begin{align} (\mu^L _{\tau_1} \boldsymbol\sigma \nu^S _{\tau_2}| \cdot \kappa ^S_{\tau_3} \boldsymbol\sigma \lambda ^L _{\tau_4})=&~\xi_{\tau_1}^\dagger (1) \xi_{\tau_1} (1) \xi_{\tau_3}^\dagger (2) \xi_{\tau_4} (2) \big[\mathbf{I}(1)\mathbf{I}(2) \boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu \nonumber \\ &+i (\mathbf{I}(1)\boldsymbol\sigma(2)+\mathbf{I}(2)\boldsymbol\sigma(1)) \cdot \boldsymbol\nabla_\kappa \times \boldsymbol\nabla_\nu \notag\\ &+(\boldsymbol\sigma(1)\cdot\boldsymbol\sigma(2)) (\boldsymbol\nabla_\kappa\cdot\boldsymbol\nabla_\nu) - (\boldsymbol\sigma(1)\cdot \boldsymbol\nabla_\kappa) (\boldsymbol\sigma(2)\cdot\boldsymbol\nabla_\nu) \big] (\mu\nu|\kappa\lambda) \label{eq:2spinorLSSLAPP} \end{align} \iffalse Similarly, integral $(S \sigma L| \cdot L \sigma S)$ contribute to the exchange part in $f^{SS}(G)$. This can be decomposed as \begin{align} (\mu^S _{\tau_1} \sigma \lambda^L _{\tau_4}| \cdot \kappa ^L_{\tau_3} \sigma \nu^S _{\tau_2}) =&\frac{1}{(2mc)^2} \xi_{\tau_1}^\dagger (1) \xi_{\tau_1} (1) \xi_{\tau_3}^\dagger (2) \xi_{\tau_4} (2)\big[I(1)I(2) \nabla_\mu \cdot \nabla_\nu \nonumber \\ +&i (I(1)\sigma(2) +\sigma(1)I(2))\cdot (\nabla_\mu \times \nabla_\nu) \nonumber \\ &+\sigma(1)\cdot \sigma(2) \nabla_\mu \cdot \nabla_\nu - \sigma(1)\cdot \nabla_\nu \sigma(2) \cdot \nabla_\mu \big] (\mu\lambda|\kappa\nu) \label{eq:2espinorSLLS} \end{align} The $(L\sigma S|\cdot L\sigma S)$ integral contribute to the Coulomb part in $f^{LS}(G)$, \begin{align} (\mu^L _{\tau_1} \sigma \nu^S _{\tau_2}| \cdot \kappa ^L_{\tau_3} \sigma \lambda ^S_{\tau_4}) =& -\frac{1}{(2mc)^2}\xi_{\tau_1}^\dagger (1) \xi_{\tau_1} (1) \xi_{\tau_3}^\dagger (2) \xi_{\tau_4} (2)\big[I(1)I(2) \nabla_\nu\cdot\nabla_\lambda \nonumber \\ +i& (I(1)\sigma(2)-I(2)\sigma(1)) \cdot \nabla_\nu \times \nabla_\lambda \nonumber \\ -&\sigma(1)\cdot\sigma(2) \nabla_\nu\cdot\nabla_\lambda + \sigma(1)\cdot \nabla_\lambda \sigma(2) \cdot \nabla_\nu\big] \label{eq:2espinorLSLS} \end{align} By swapping $\nu$ and $\lambda$ in \cref{eq:2espinorLSLS}, we can also obtain the spin separation for the exchange part in $f^{LS}(G)$. \fi \subsection*{Appendix B: Contributions from $(SS|SS)$} The $SS$ block of the Dirac-Coulomb matrix has contributions from $(p^Sq^S|r^Ss^S)$ types of integral with a prefactor of $\frac{1}{(2mc)^4}$, denoted as $V^{C(4)}$. \begin{equation} V^{C(4),SS}_{\mu\tau_1,\nu\tau_2}=\sum_{\lambda\tau_4\kappa\tau_3}D_{\lambda\tau_4\kappa\tau_3}^{SS}[(\mu^S_{\tau_1}\nu^S_{\tau_2}|\kappa^S_{\tau_3}\lambda^S_{\tau_4})-(\mu^S_{\tau_1}\lambda^S_{\tau_4}|\kappa^S_{\tau_3}\nu^S_{\tau_2})] \end{equation} These contributions are collectively known as the $(SS|SS)$ term, which is often ignored due to its large computational cost and small energetic contribution. The $(SS|SS)$ contribution in the Pauli spinor representation is: \begin{align} V^{C(4), SS}_{\mu\nu , s} &=2\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\nu)(\boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\lambda) + i \sum_{J=x,y,z} D_{\lambda\kappa,J}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\nu) (\boldsymbol{\nabla}_\kappa\times\boldsymbol{\nabla}_\lambda)_J \bigg] (\mu\nu|\kappa\lambda)\nonumber \\ & - \sum_{\lambda\kappa} D_{\lambda\kappa, s}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu)-\sum_{J=x,y,z} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_J( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_J\bigg] (\mu\lambda|\kappa\nu) \nonumber\\ &-i \sum_{\lambda\kappa}\sum_{J=x,y,z} D_{\lambda\kappa,J}^{SS}\bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_J( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu)+(\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_J\bigg] (\mu\lambda|\kappa\nu) \nonumber\\ &-i \sum_{\lambda\kappa} D_{\lambda\kappa, z}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg] (\mu\lambda|\kappa\nu)\nonumber \\ & -i \sum_{\lambda\kappa} D_{\lambda\kappa, y}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \bigg] (\mu\lambda|\kappa\nu)\nonumber \\ & -i \sum_{\lambda\kappa} D_{\lambda\kappa, x}^{SS}\bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{C(4), SS}_{\mu\nu, z} &= 2\sum_{\lambda\kappa} \bigg[i D^{SS}_{\lambda\kappa, s} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_z (\boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\lambda) -\sum_{J=x,y,z} D_{\lambda\kappa,J}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_z (\boldsymbol{\nabla}_\kappa\times\boldsymbol{\nabla}_\lambda)_J \bigg] (\mu\nu|\kappa\lambda)\nonumber \\ &- \sum_{\lambda\kappa} D_{\lambda\kappa, z}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu)-(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z\bigg] (\mu\lambda|\kappa\nu)\nonumber \\ &- \sum_{\lambda\kappa}D_{\lambda\kappa, z}^{SS}\bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y\bigg] (\mu\lambda|\kappa\nu)\nonumber \\ &-i \sum_{\lambda\kappa} D_{\lambda\kappa, s}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu)\bigg](\mu\lambda|\kappa\nu)\nonumber\\ &- \sum_{\lambda\kappa} D_{\lambda\kappa, y}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu)\nonumber \\ &+ \sum_{\lambda\kappa} D_{\lambda\kappa, x}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu)\nonumber \\ &+i \sum_{\lambda\kappa} D_{\lambda\kappa, s}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg](\mu\lambda|\kappa\nu)\nonumber \\ & + \sum_{\lambda\kappa} D_{\lambda\kappa, x}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x\bigg](\mu\lambda|\kappa\nu) \nonumber \\ & + \sum_{\lambda\kappa}D_{\lambda\kappa, y}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{C(4), SS}_{\mu\nu, x} &= 2\sum_{\lambda\kappa} \bigg[i D^{SS}_{\lambda\kappa, s} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_x (\boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\lambda) -\sum_{J=x,y,z} D_{\lambda\kappa,J}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_x (\boldsymbol{\nabla}_\kappa\times\boldsymbol{\nabla}_\lambda)_J \bigg] (\mu\nu|\kappa\lambda) \nonumber \\ & - \sum_{\lambda\kappa} D_{\lambda\kappa, x}^{SS} \bigg[(\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu)-(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg](\mu\lambda|\kappa\nu) \nonumber \\ &-\sum_{\lambda\kappa} D_{\lambda\kappa, x}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \bigg] (\mu\nu|\kappa\lambda) \nonumber \\ &-i\sum_{\lambda\kappa} D_{\lambda\kappa, s}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\nu|\kappa\lambda) \nonumber \\ &+ \sum_{\lambda\kappa} D_{\lambda\kappa, y}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\nu|\kappa\lambda) \nonumber \\ &- \sum_{\lambda\kappa} D_{\lambda\kappa, z}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &+i\sum_{\lambda\kappa} D_{\lambda\kappa, s}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &+ \sum_{\lambda\kappa} D_{\lambda\kappa, y}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &+ \sum_{\lambda\kappa} D_{\lambda\kappa, z}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} V^{C(4), SS}_{\mu\nu, y} &= 2\sum_{\lambda\kappa} \bigg[ iD^{SS}_{\lambda\kappa, s} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_y (\boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\lambda) -\sum_{J=x,y,z} D_{\lambda\kappa,J}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_y (\boldsymbol{\nabla}_\kappa\times\boldsymbol{\nabla}_\lambda)_J \bigg] (\mu\nu|\kappa\lambda) \nonumber \\ &-\sum_{\lambda\kappa}D_{\lambda\kappa, y}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &-\sum_{\lambda\kappa}D_{\lambda\kappa, y}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &-i\sum_{\lambda\kappa}D_{\lambda\kappa, s}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &-\sum_{\lambda\kappa}D_{\lambda\kappa, x}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &+\sum_{\lambda\kappa}D_{\lambda\kappa, z}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ & -i \sum_{\lambda\kappa}D_{\lambda\kappa, s}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z - (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &+ \sum_{\lambda\kappa}D_{\lambda\kappa, x}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \bigg] (\mu\lambda|\kappa\nu) \nonumber \\ &+ \sum_{\lambda\kappa}D_{\lambda\kappa, z}^{SS} \bigg[ (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu)\ \end{align} \iffalse where Coulomb integral \begin{align} J^{SS}_{\mu\nu , s} = \sum_{\lambda\kappa}\frac{2}{(2mc)^4} \bigg[ D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\nu)(\boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\lambda) + i \sum_{j=x,y,z} D_{\lambda\kappa J}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\nu) (\boldsymbol{\nabla}_\kappa\times\boldsymbol{\nabla}_\lambda)_j \bigg] (\mu\nu|\kappa\lambda) \end{align} \begin{align} J^{SS}_{\mu\nu J} = \sum_{\mu\nu}\frac{2}{(2mc)^4} \bigg[i D^{SS}_{\lambda\kappa, s} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_j (\boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\lambda) -\sum_{k=x,y,z} D_{\lambda\kappa K}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\nu)_j (\boldsymbol{\nabla}_\kappa\times\boldsymbol{\nabla}_\lambda)_k \bigg] (\mu\nu|\kappa\lambda) \end{align} For exchange part, contribution from $(\nabla_\mu \cdot \nabla_\lambda)( \nabla_\kappa \cdot \nabla_\nu) $ to K: \begin{equation} K^{SS }_{\mu\nu, s} \leftarrow \frac{1}{(2mc)^4}\sum_{\lambda\kappa} D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) (\mu\lambda|\kappa\nu) \end{equation} \begin{equation} K^{SS }_{\mu\nu J} \leftarrow \frac{1}{(2mc)^4}\sum_{\lambda\kappa} D_{\lambda\kappa J}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) (\mu\lambda|\kappa\nu) \end{equation} contribution from $(\nabla_\mu \cdot \nabla_\lambda)( \nabla_\kappa \times \nabla_\nu) $ to K: \begin{equation} K^{SS }_{\mu\nu, s} \leftarrow i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \sum_{j=x,y,z} D_{\lambda\kappa J}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_j (\mu\lambda|\kappa\nu) \end{equation} \begin{align} K^{SS }_{\mu\nu Z} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \nonumber \\ &+\frac{1}{i}D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x +iD_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu X} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ i D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \nonumber \\ &+D_{\lambda\kappa, s}^{SS} (\nabla_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x -iD_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu Y} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ -i D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \nonumber \\ &+iD_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x +D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \cdot \boldsymbol{\nabla}_\lambda)( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} contribution from $(\nabla_\mu \times \nabla_\lambda)( \nabla_\kappa \cdot \nabla_\nu) $ to K: \begin{align} K^{SS }_{\mu\nu, s} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \nonumber \\ &D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) +D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu Z} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \nonumber \\ &+i D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) -i D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu X} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[\frac{1}{i} D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \nonumber \\ &+ D_{\lambda\kappa S}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) +i D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu Y} \leftarrow &i\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[i D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \nonumber \\ &-i D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) + D_{\lambda\kappa S}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \cdot \boldsymbol{\nabla}_\nu) \bigg] (\mu\lambda|\kappa\nu) \end{align} contribution from $(\nabla_\mu \times \nabla_\lambda)( \nabla_\kappa \times \nabla_\nu) $ to K: \begin{align} K^{SS }_{\mu\nu, s} \leftarrow &-\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa, s}^{SS} \sum_{j=x,y,z} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_j( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_j \nonumber \\ &-i D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y +i D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & +i D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z -i D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & -i D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z +i D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu Z} \leftarrow &-\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa Z}^{SS} \bigg ( -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \bigg) \nonumber \\ &+i D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y -i D_{\lambda\kappa, s}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & + D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & + D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu X} \leftarrow &-\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa X}^{SS} \bigg ( (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \bigg) \nonumber \\ &+ D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y + D_{\lambda\kappa Y}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & + D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & +i D_{\lambda\kappa S}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z -i D_{\lambda\kappa S}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \begin{align} K^{SS }_{\mu\nu Y} \leftarrow &-\frac{1}{(2mc)^4}\sum_{\lambda\kappa} \bigg[ D_{\lambda\kappa Y}^{SS} \bigg ( -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x +(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y -(\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z \bigg) \nonumber \\ &+ D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y + D_{\lambda\kappa X}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & -i D_{\lambda\kappa S}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_x( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + iD_{\lambda\kappa S}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_x \nonumber \\ & + D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_y( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_z + D_{\lambda\kappa Z}^{SS} (\boldsymbol{\nabla}_\mu \times \boldsymbol{\nabla}_\lambda)_z( \boldsymbol{\nabla}_\kappa \times \boldsymbol{\nabla}_\nu)_y \bigg] (\mu\lambda|\kappa\nu) \end{align} \fi \subsection*{Appendix C: Cost Analysis of Dirac-Hartree--Fock in Unrestricted-Kinetic-Balanced Scalar Basis} The computational cost of the four-component method using the unrestricted-kinetic-balanced (UKB) scalar basis strongly depends on the nature of the implementation. This is because upon the generation of small component basis, the kinetic-balance condition no longer directly appears in the two-spinor basis. This allows an implementation in scalar basis to adapt various techniques developed for non-relativistic methods. This is especially true for the Dirac-Coulomb term where Pauli spinors do not enter the integrals. In this analysis, we assume that all integrals and integral-density contractions in UKB scalar basis are in the non-relativistic one-component framework, and all integrals are stored as real-valued quantities. In this discussion, $N_L$ and $N_S$ are the numbers of basis functions for the large and small component, respectively, in UKB scalar basis. We also assume that both the Fock and density matrices are in the quaternion representation so that the following expressions represent the optimal algorithm in terms of both memory requirement and FLOP count. For the Coulomb operator, the contraction pattern can be separated into Coulomb $\mathbf{J}^C$ and exchange $\mathbf{K}^C$ matrices, \begin{align} J_{\mu\nu}^{C,LL} &= \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^L \nu^L|\kappa^L \lambda^L) D^{LL}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma + \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^L \nu^L|\kappa^S \lambda^S) D^{SS}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma \\ J_{\mu\nu}^{C,SS} &= \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^S \nu^S|\kappa^L \lambda^L) D^{LL}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma + \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^S \nu^S|\kappa^S \lambda^S) D^{SS}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma\\ K_{\mu\nu}^{C,LL} &= \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^L \lambda^L|\kappa^L \nu^L) D^{LL}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma \\ K_{\mu\nu}^{C,LS} &= \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^L \lambda^L|\kappa^S \nu^S) D^{LS}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma \\ K_{\mu\nu}^{C,SL} &= \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^S \lambda^S|\kappa^L \nu^L) D^{SL}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma \\ K_{\mu\nu}^{C,SS} &= \sum_{\gamma=0,1,2,3} \sum_{\kappa \lambda} (\mu^S \lambda^S|\kappa^S \nu^S) D^{SS}_{\lambda\kappa, \gamma}\hat{\mathbf{e}}_\gamma \end{align} where $(\hat{\mathbf{e}}_0, \hat{\mathbf{e}}_1, \hat{\mathbf{e}}_2, \hat{\mathbf{e}}_3)$ is the quaternion basis of choice. Based on these expressions, constructing the Coulomb $\mathbf{J}^C$ matrix requires $4\times(N_L^4 + 2N_L^2N_S^2 + N_S^4)$ number of integral-density contraction operations, and the $\mathbf{K}$ matrix requires $4\times(N_L^4+2N_L^2N_S^2+N_S^4)$ operations, where the factor of 4 comes from the contraction with four quaternion components. The memory requirement for building the Dirac-Coulomb matrix is $N_L^4+N_L^2N_S^2+N_S^4$. All $N_S^4$ quantities in the analysis correspond to the contributions from the $(SS|SS)$ term. In order to build the Gaunt operator in UKB scalar basis with the lowest computational cost, the Pauli spin matrices are also cast in the quaternion representation, \begin{equation*} \boldsymbol{\sigma} = \begin{pmatrix}\sum_\gamma \sigma_{x,\gamma} \mathbf{\hat{e}}_\gamma\\ \sum_\gamma \sigma_{y,\gamma} \mathbf{\hat{e}}_\gamma\\ \sum_\gamma \sigma_{z,\gamma} \mathbf{\hat{e}}_\gamma\end{pmatrix}. \end{equation*} As a result, the Gaunt operator under UKB scalar basis can be evaluated with the real scalar ERIs, \begin{align} J_{\mu\nu,\tau}^{G,LS} &= \sum_{\gamma=0,1,2,3} \mathbf{\hat{e}}_\tau\circ \boldsymbol\sigma(1)\cdot\big[\boldsymbol{\sigma}(2)\circ (\mu^L \nu^S|\kappa^L \lambda^S) (D^{LS}_{\kappa\lambda,\gamma}\hat{\mathbf{e}}_\gamma + D^{SL}_{\lambda\kappa,\gamma}\hat{\mathbf{e}}_\gamma)\big] \\ K_{\mu\nu,\tau}^{G,LL} &= \sum_{\gamma=0,1,2,3} \mathbf{\hat{e}}_\tau\circ \boldsymbol\sigma(1)\cdot\big[\boldsymbol{\sigma}(2)\circ (\mu^L \lambda^S | \nu^L \kappa^S) D^{SS}_{\lambda\kappa,\gamma}\hat{\mathbf{e}}_\gamma\big] \\ K_{\mu\nu,\tau}^{G,SS} &= \sum_{\gamma=0,1,2,3} \mathbf{\hat{e}}_\tau\circ \boldsymbol\sigma(1)\cdot\big[\boldsymbol{\sigma}(2)\circ (\lambda^L \mu^S | \kappa^L \nu^S) D^{LL}_{\lambda\kappa,\gamma}\hat{\mathbf{e}}_\gamma\big] \\ K_{\mu\nu,\tau}^{G,LS} &= \sum_{\gamma=0,1,2,3} \mathbf{\hat{e}}_\tau\circ \boldsymbol\sigma(1)\cdot\big[\boldsymbol{\sigma}(2)\circ (\mu^L \lambda^S | \kappa^L \nu^S) D^{SL}_{\lambda\kappa,\gamma}\hat{\mathbf{e}}_\gamma\big] \\ K_{\mu\nu,\tau}^{G,SL} &= \sum_{\gamma=0,1,2,3} \mathbf{\hat{e}}_\tau\circ \boldsymbol\sigma(1)\cdot\big[\boldsymbol{\sigma}(2)\circ (\lambda^L \mu^S | \nu^L \kappa^S) D^{LS}_{\lambda\kappa,\gamma}\hat{\mathbf{e}}_\gamma\big] \end{align} where we use `$\circ$' to represent dot-product in the quaternion space and `$\cdot$' for dot-product in the Pauli spinor space. It is clear that building the $\mathbf{J}^G$ and $\mathbf{K}^G$ matrix requires $4N_L^2N_S^2$ and $16 N_L^2N_S^2$ numbers of integral-density contraction operations with a memory requirement of only $N_L^2N_S^2$. \begin{table}[ht] { \caption{Calculated Dirac-Hartree-Fock ground state energies (Hartrees) for the hydrogen atom and a series of hydrogenic cations compared with the analytical solution of the Dirac equation. The uncontracted Sapporo-DKH3-QZP-2012-no basis is used for all elements except actinides (Ac$^{88+}$, Es$^{98+}$, Md$^{100+}$). Actinide calculations use uncontracted cc-pwCVDZ-X2C basis\cite{Peterson17_084108}. Seven steep $s$ functions are added to the uncontracted basis. Point charge nuclear model is used.} \centering \begin{tabular}{l r r r} \hline element & \adjustbox{stack=ll}{analytical\\solution} & \adjustbox{stack=ll}{uncontracted\\basis} & \adjustbox{stack=ll}{percent error\\($\times 10^{-3}\%$)} \\ [1.0ex] \hline H & $ -0.5000067$ & $ -0.5000029$ & $0.75$ \\ B$^{4+}$ & $ -12.5041630$ & $ -12.5038524$ & $2.48$ \\ F$^{8+}$ & $ -40.5437672$ & $ -40.5428584$ & $2.24$ \\ Al$^{12+}$ & $ -84.6909743$ & $ -84.6891918$ & $2.10$ \\ Cl$^{16+}$ & $ -145.0602703$ & $ -145.0573482$ & $2.01$ \\ Mn$^{24+}$ & $ -315.1443548$ & $ -315.1385013$ & $1.86$ \\ Rb$^{26+}$ & $ -697.4517670$ & $ -697.4334697$ & $2.62$ \\ Mo$^{41+}$ & $ -903.7467394$ & $ -903.7213445$ & $2.81$\\ In$^{48+}$ & $-1241.5414919$ & $-1241.4977248$ & $3.52$ \\ Cs$^{54+}$ & $-1578.8736026$ & $-1578.8504245$ & $1.47$ \\ Ta$^{72+}$ & $-2886.3133130$ & $-2886.2556854$ & $2.00$ \\ Ac$^{88+}$ & $-4499.5659601$ & $-4499.5624725$ & $0.08$ \\ Es$^{98+}$ & $-5794.4853497$ & $-5794.4685369$ & $0.29$ \\ Md$^{100+}$ & $-6087.0342057$ & $-6087.0107482$ & $0.39$ \\[1ex] \hline \end{tabular} \label{table:hydrogenicsteep} } \end{table} \subsection*{Appendix D: Calculations of Hydrogenic Cations/Atom Compared with Analytical Results of Dirac Equation} Energy levels of the relativistic Dirac hydrogen atom and hydrogenic cations can be evaluated analytically using the following relation (in atomic units) \begin{equation} E = c^2 \times \bigg[ \frac{1}{\sqrt{1+(\frac{Z \alpha}{n-(j+1/2)+\sqrt{(j+1/2)^2-Z^2\alpha^2}})^2}} -1 \bigg] \end{equation} where $Z$ is the nuclear charge and $\alpha$ is fine structure constant. For one electron systems in their ground states, $n=1$ and $j=\frac{1}{2}$. In order to validate the four-component Dirac--Hartree--Fock implementation, we compare the computed energies with analytical values in \cref{table:hydrogenicsteep}. For a better description of the steep electronic wave function near the nucleus, seven additional steep $s$ functions are added to the uncontracted basis set, with exponents ranging from 3$^1$ to $3^7$ times the largest exponent in the original basis.\cite{Kaupp08_104101,Liu09_244113} From this series, we see that the largest error between the analytical result and the Dirac Hartree-Fock result is 0.00352 \% for In$^{48+}$ when a uncontracted basis is used, showing good agreement and validating our implementation. \subsection*{Appendix E: Basis Set Limit} In order to compare our results to the ``true'' basis set limit, we can look at the results from Visscher\cite{Dyall97_207} and Hess\cite{Hess94_183} that utilized a numerical grid basis for both point nuclei and finite Gaussian nuclei. As shown in \cref{table:au_atom_data}, we can see that using an uncontracted basis set gives the expected variational upper bound to the numerically exact limit. The error in the ground state energy is only $\sim$0.015 $E_h$ for the Gaussian nuclei model, with all three representations (RKB Pauli, RKB spinor, UKB scalar) behaving similarly. (Additionally the UKB scalar calculation includes the average of configuration method for open shell systems.) \begin{table}[htbp] { {\footnotesize \begin{center} \caption{Ground state energies (Hartrees) for Au atom with the Dirac-Coulomb Hamiltonian with a Gaussian nuclear model uncontracted ANO-RCC basis is used. RKB Pauli, RKB spinor, and UKB scalar results were obtained using ChronusQ,\cite{Li20_e1436} PySCF,\cite{Chan18_e1340} and DIRAC,\cite{DIRAC19} respectively. Note that the UKB scalar basis is transformed to the RKB spinor during the orthonomalization step.\cite{DIRAC20}} \begin{tabular}{l l l} \hline Model & Energy \\ [0.5ex] \hline Numerical Grid [Ref. \citenum{Dyall97_207}] & $-$19035.59510\\ RKB Pauli & $-$19035.57905 \\ RKB Spinor & $-$19035.57905 \\ UKB Scalar & $-$19035.57807\\ [1ex] \hline \end{tabular} {\footnotesize } \label{table:au_atom_data} \end{center} } } \end{table} \iffalse \subsection*{Appendix D: Calculations of Hydrogenic Cations/Atom Compared with Analytical Results of Dirac Equation} Energy levels of relativistic Dirac hydrogen atom and hydrogenic cations can be evaluated analytically using (in atomic units) \begin{equation} E = c^2 \times \bigg[ \frac{1}{\sqrt{1+(\frac{Z \alpha}{n-(j+1/2)+\sqrt{(j+1/2)^2-Z^2\alpha^2}})^2}} -1 \bigg] \end{equation} where $Z$ is the nuclear charge and $\alpha$ is fine structure constant. For one electron systems in their ground states, $n=1$ and $j=\frac{1}{2}$. In order to validate the four-component Dirac--Hartree--Fock implementation, we compare the computed energies with analytical values in \cref{table:hydrogenicsteep}. For a better description of steep electronic wave function near the nucleus, seven additional steep $s$ functions are added to the uncontracted basis set, with exponents ranging from 3$^1$ to $3^7$ times of the largest exponent in the original basis.\cite{Kaupp08_104101,Liu09_244113} \begin{table}[ht] { \caption{Calculated Dirac-Hartree-Fock ground state energies (Hartrees) for the hydrogen atom and a series of hydrogenic cations compared with the analytical solution of the Dirac equation. The contracted and uncontracted Sapporo-DKH3-QZP-2012-no basis is used for all elements except actinides(Ac$^{88+}$, Es$^{98+}$, Md$^{100+}$). Actinide calculations use the contracted and uncontracted cc-pwCVDZ-X2C basis\cite{Peterson17_084108}. Seven steep $s$ functions are added to the uncontracted basis. Point charge nuclear model is used.} \centering \begin{tabular}{l r r r r r} \hline element & \adjustbox{stack=ll}{analytical\\solution} & \adjustbox{stack=ll}{uncontracted\\basis} & \adjustbox{stack=ll}{percent error\\($\times 10^{-3}\%$)} & \adjustbox{stack=ll}{contracted\\basis} & \adjustbox{stack=ll}{percent error\\($\times 10^{-3}\%$)} \\ [1.0ex] \hline H & $ -0.5000067$ & $ -0.5000029$ & $0.75$ & $-0.5000012 $ & $1.09$\\ B$^{4+}$ & $ -12.5041630$ & $ -12.5038524$ & $2.48$ & $-12.5033645$ & $6.39$\\ F$^{8+}$ & $ -40.5437672$ & $ -40.5428584$ & $2.24$ & $-40.5422363$ & $3.78$\\ Al$^{12+}$ & $ -84.6909743$ & $ -84.6891918$ & $2.10$ & $-84.6818350$ & $10.79$\\ Cl$^{16+}$ & $ -145.0602703$ & $ -145.0573482$ & $2.01$ & $-145.0491285$ & $7.68$\\ Mn$^{24+}$ & $ -315.1443548$ & $ -315.1385013$ & $1.86$ & $-314.8363624$ & $97.73$\\ Rb$^{26+}$ & $ -697.4517670$ & $ -697.4334697$ & $2.62$ & $-696.0566401$ & $200.03$\\ Mo$^{41+}$ & $ -903.7467394$ & $ -903.7213445$ & $2.81$ & $-908.9821407 $ & $-579.30$\\ In$^{48+}$ & $-1241.5414919$ & $-1241.4977248$ & $3.52$ & $-1235.2318155 $ & $508.21$\\ Cs$^{54+}$ & $-1578.8736026$ & $-1578.8504245$ & $1.47$ & $-1641.8161956 $ & $-3986.55$ \\ Ta$^{72+}$ & $-2886.3133130$ & $-2886.2556854$ & $2.00$ & $-3133.6073031 $ & $-8567.82$\\ Ac$^{88+}$ & $-4499.5659601$ & $-4499.5624725$ & $0.08$ & $-6837.9490417 $ & $-51969.08$\\ Es$^{98+}$ & $-5794.4853497$ & $-5794.4685369$ & $0.29$ & $-8901.8292394 $ & $-53625.88$\\ Md$^{100+}$ & $-6087.0342057$ & $-6087.0107482$ & $0.39$ & $-9350.5991249 $ & $-53615.03$ \\[1ex] \hline \end{tabular} \label{table:hydrogenicsteep} } \end{table} From this series, we see that the largest error between the analytical result and the Dirac Hartree-Fock result is 0.00352 \% for In$^{48+}$ when a uncontracted basis is used, showing good agreement and validating our implementation. However, when a contracted basis is used, the kinetic-balance condition is poorly satisfied (see the discussion in Appendix F). \subsection*{Appendix E: Basis Set Limit and Nuclear Model Dependence} In order to compare our results to the ``true'' basis set limit, we can look at the results from Vissher\cite{Dyall97_207} and Hess\cite{Hess94_183} that utilized a numerical grid basis for both point nuclei and finite Gaussian nuclei. As shown in \cref{table:au_atom_data}, we can see that using an uncontracted basis set gives the expected variational upper bound to both nuclear models. In fact, by adding seven extra steep $s$ functions\cite{Kaupp08_104101,Liu09_244113} to the uncontracted basis set, we see that we start to approach the numerically exact limit as we have a better description of the tightly contracted core basis functions where the error in the ground state energy is $\sim$0.01 $E_h$ and $\sim$0.06 $E_h$ for the Gaussian and point nuclei models respectively. Comparing the two nuclear models, the point nucleus seems to have a stronger basis set dependence with larger energy fluctuations. While the point charge nuclear model is sufficiently accurate for light elements, it is known that it is not suitable for heavy element calculations.\cite{Wolf15_book} This is because as the number of subatomic particles increases, the size of the nucleus also increases and the finite nuclear effect becomes significant in electronic structure. The Gaussian distribution model is preferred in quantum chemistry calculations because it has analytical integrals when electronic basis functions are described by Gaussian orbitals.\cite{Dyall97_207} \begin{table}[htbp] { {\footnotesize \begin{center} \caption{Ground state energies (Hartrees) for Au atom with the Dirac-Coulomb Hamiltonian. RKB Pauli, RKB spinor, and UKB scalar results were obtained using ChronusQ,\cite{Li20_e1436} PySCF,\cite{Chan18_e1340} and DIRAC,\cite{DIRAC19} respectively. Note that the UKB scalar basis is transformed to the RKB spinor during the orthonomalization step.\cite{DIRAC20}} \begin{tabular}{l l l l l} \hline Basis & Nuclear Type & Energy \\ [0.5ex] \hline Numerical Grid [Ref. \citenum{Dyall97_207}] & Gaussian Nuclei & $-$19035.59510\\ RKB Pauli + Uncontracted 7s-Jorge-DZP-DKH$^b$ & Gaussian Nuclei & $-$19035.58157\\ [2ex] RKB Pauli + Uncontracted Jorge-DZP-DKH & Gaussian Nuclei & $-$19035.49510 \\ RKB Spinor + Uncontracted Jorge-DZP-DKH & Gaussian Nuclei & $-$19035.49510 \\ UKB Scalar + Uncontracted Jorge-DZP-DKH & Gaussian Nuclei & $-$19035.49454 \\ RKB Pauli + Contracted Jorge-DZP-DKH & Gaussian Nuclei & $-$20921.46538 \\ RKB Spinor + Contracted Jorge-DZP-DKH & Gaussian Nuclei & $-$20921.46533\\ UKB Scalar + Contracted Jorge-DZP-DKH & Gaussian Nuclei & $-$20921.46434\\ RKB Pauli + Contracted Sapporo-TZP-2012-NO & Gaussian Nuclei & $-$19909.03219 \\ RKB Spinor + Contracted Sapporo-TZP-2012-NO & Gaussian Nuclei & $-$19909.03217\\ UKB Scalar + Contracted Sapporo-TZP-2012-NO & Gaussian Nuclei & $-$19909.00794\\ [1ex] \hline Numerical Grid [Ref. \citenum{Hess94_183}] & Point Nuclei & $-$19039.84442\\ RKB Pauli + Uncontracted 7s-Jorge-DZP-DKH$^b$ & Point Nuclei & $-$19039.78604\\ [2ex] RKB Pauli + Uncontracted Jorge-DZP-DKH & Point Nuclei & $-$19038.82177\\ RKB Spinor + Uncontracted Jorge-DZP-DKH & Point Nuclei & $-$19038.82176\\ UKB Scalar + Uncontracted Jorge-DZP-DKH & Point Nuclei & $-$19038.82120\\ RKB Pauli + Contracted Jorge-DZP-DKH & Point Nuclei & $-$20958.39143 \\ RKB Spinor + Contracted Jorge-DZP-DKH & Point Nuclei & $-$20958.39138\\ UKB Scalar + Contracted Jorge-DZP-DKH & Point Nuclei & $-$20958.39038\\ RKB Pauli + Contracted Sapporo-TZP-2012-NO & Point Nuclei & $-$19930.55909\\ RKB Spinor + Contracted Sapporo-TZP-2012-NO & Point Nuclei & $-$19930.55907\\ UKB Scalar + Contracted Sapporo-TZP-2012-NO & Point Nuclei & $-$19930.53296\\ [1ex] \hline \end{tabular} {\footnotesize \\$^a$ The $(SS|SS)$ contribution is not included. \\$^b$ Seven additional steep $s$ functions are added to the uncontracted basis set, with exponents ranging from 3$^1$ to $3^7$ times of the largest exponent in the original basis. } \label{table:au_atom_data} \end{center} } } \end{table} \subsection*{Appendix F: ``Prolapse'' of Contracted Basis Sets} In this section, we report contracted and uncontracted basis set results highlighting the effect of ``prolapse'' by comparing the results of the atomic calculations in \cref{table:hydrogenicsteep} and \cref{table:au_atom_data} using contracted and uncontracted basis sets, and comparing \cref{table:sapporoatoms} computed using the contracted Sapporo-TZP-2012 basis set\cite{Koga12_1124} with DKH3 corrections for all non-halogen atoms with those in \cref{table:jorgeatoms}. We see that the difference in absolute energy can be quite large and that the contracted basis set leads to a much lower energy than that of the larger uncontracted basis set in \cref{table:jorgeatoms} and also the numerically exact values\cite{Clementi90_1829,Dyall97_207} for atomic calculations. When examining the contracted basis sets, we see that the ground state energies vary wildly, with an error of $\sim$800 to $\sim$1900 $E_h$, and drop well below the true minimum provided by the numerical grid results. Note this is not a numerical issue or implementation error as the same behavior can reproduced in all DHF implementations using different basis representations tested herein. It is known the variational convergence of the Dirac equation towards the basis set limit is not monotonic and often times unpredictable.\cite{Havriliak84_1910,Nieuwpoort91_131} Finite basis calculations using the kinetic balance condition in the Dirac equation can only guarantee safety from variational collapse,\cite{Havriliak84_1910} but not the variational convergence to the basis set limit. This is because the variational solution of DHF is still bound by an error of $\mathcal{O}(\frac{1}{c^4})$ which can blow up drastically near the nucleus where the integral values are large. The error can be rather significant when using a heavily contracted basis where the kinetic balance condition cannot be satisfactorily met.\cite{Nieuwpoort91_131,Liu10_1679,Dyall97_207} For example, a poor basis set can lead to the energy of a one-electron hydrogen atom that is $>$2 Hartrees lower than the exact solution\cite{Havriliak84_1910}. A Gaussian nucleus can reduce, but still cannot eliminate the error as the mathematical unpinning of the kinetic balance dictates the condition of the variational result.\cite{Dyall97_207} \begin{table}[htbp] { {\footnotesize \caption{Ground state energies (Hartrees) for selected atoms with the energetic contributions of Dirac-Coulomb and Gaunt terms, computed as $\Delta E^{DC} = E^{DC} - E^{BC}$ and $\Delta E^{G} = E^{DCG} - E^{DC}$ where $E^{DCG}$, $E^{DC}$, and $E^{BC}$ are the SCF energies of Dirac-Coulomb-Gaunt, Dirac-Coulomb, and Bare-Coulomb calculations respectively. The contracted Sapporo-TZP-2012 basis set with finite nuclei was used for this dataset.} \centering \begin{tabular}{c r r r r r} \hline Atom & Bare-Coulomb & Dirac-Coulomb$^a$ & $\Delta E^{DC}$ & Dirac-Coulomb-Gaunt$^a$ & $\Delta E^{G}$\\ [0.5ex] \hline \multicolumn{2}{l}{Halogen Series}\\ F & $-99.521$ & $-99.485$ &0.036 & $-99.473$ &0.012 \\ Cl & $-461.335$ & $-460.878$ &0.457 & $-460.761$ &0.117 \\ Br & $-2610.195$ & $-2602.839$ &7.356 & $-2601.493$ &1.346 \\ I & $-7122.764$ & $-7088.140$ &34.624 & $-7082.873$ &5.267 \\ [1ex] \hline \multicolumn{2}{l}{Lanthanide Series}\\ La & $-8705.724$ & $-8653.414$ & $52.310$ & $-8645.657$ & 7.757\\ Ce & $-9097.316$ & $-9041.365$ & $55.951$ & $-9033.196$ & 8.170\\ Pr & $-9496.607$ & $-9436.798$ & $59.809$ & $-9428.138$ & 8.661\\ Nd & $-9912.496$ & $-9848.710$ & $63.786$ & $-9839.553$ & 9.156\\ Pm & $-10339.869$ & $-10271.890$ & $67.979$ & $-10262.222$ & 9.668\\ Sm & $-10777.788$ & $-10705.357$ & $72.431$ & $-10695.141$ & 10.216\\ Eu & $-11230.227$ & $-11153.232$ & $76.996$ & $-11142.463$ & 10.769\\ Gd & $-11687.911$ & $-11606.135$ & $81.776$ & $-11594.429$ & 11.706\\ Tb & $-12170.542$ & $-12083.586$ & $86.956$ & $-12071.631$ & 11.955\\ Dy & $-12664.882$ & $-12572.663$ & $92.219$ & $-12560.094$ & 12.568\\ Ho & $-13170.316$ & $-13072.543$ & $97.773$ & $-13059.330$ & 13.214\\ Er & $-13694.822$ & $-13591.448$ & $103.374$ & $-13577.458$ & $13.991$\\ Tm & $-14223.727$ & $-14114.290$ & $109.437$ & $-14099.942$ & $14.348$\\ Yb & $-14681.491$ & $-14562.199$ & $119.292$ & $-14546.386$ & $15.812$ \\ Lu & $-15274.510$ & $-15148.707 $ & $125.803 $ & $-15132.191 $ & $16.516$\\ [1ex] \hline \multicolumn{2}{l}{Coinage Metal Series}\\ Cu & $-1656.511$ & $-1652.703$ & 3.808 & $-1651.946$ & 0.757 \\ Ag & $-5374.193$ & $-5349.077$ & 25.116 & $-5345.062$ & 4.014 \\ Au & $-20100.797$ & $-19909.032$ & 191.765 & $-19885.166$ & 23.866 \\ [1ex] \hline \end{tabular} {\footnotesize $^{a}$ The $(SS|SS)$ contribution is not included. } \label{table:sapporoatoms} } } \end{table} In order to explore the basis set and nuclear model dependence for the case of the molecular dimer, we compared the computed equilibrium bond lengths and dissociation energies of Au$_2$ using the uncontracted and contracted basis sets with different kinetic balance representations (\cref{table:au2_dimer}). First, we see that the results using the RKB spinor formalism match our implementation of RKB Pauli representation, solidifying that these methods are physically equivalent. The UKB scalar results, computed using DIRAC\cite{DIRAC19}, are also consistent with both RKB formalisms. Although the equilibrium bond lengths are less sensitive the to choice of nuclear model, the point nuclear model seems to lead to a larger dissociation energy compared to that using a Gaussian nucleus. For the uncontracted basis set, we get a reasonable bond length with an overestimation of the dissociation energy compared to experiment. The basis set used in Ref. \citenum{Schwerdtfeger99_9457} is the largest and quite accurate (0.058 E$_h$ above the numerical DHF limit of an Au atom). Based on the benchmark calculations for the Au atom (\cref{table:au_atom_data}), the uncontracted Jorge-DZP-DKH basis with seven additional steep $s$ functions produces the most accurate result, only $\sim$0.014 E$_h$ higher than the numerically exact result. However, the predictions for Au$_2$ from these two different, yet equally accurate basis sets are drastically different. The contracted basis sets perform much worse, but the main takeaway from this data is that both $R_e$ and $D_e$ are extremely sensitive to the type of basis chosen for the calculation. \begin{table}[ht] { \begin{center} \footnotesize \caption{ The equilibrium bond lengths ($R_e$) in \AA\ and bond dissociation energies $D_e$ in eV for Au$_2$ using the Dirac-Coulomb Hamiltonian. RKB Pauli, RKB spinor, and UKB scalar results were obtained using ChronusQ,\cite{Li20_e1436} PySCF,\cite{Chan18_e1340} and DIRAC.\cite{DIRAC19} Note that the UKB scalar basis is transformed to the RKB spinor during the orthonomalization step.\cite{DIRAC20}} \begin{tabular}{l l l l l} \hline Basis & Nuclear Type & $R_e$ & $D_e$ \\ [0.5ex] \hline {Experiment} & & {2.47} [Ref. \citenum{Barrow67_39}] & 2.29$\pm$0.02 [Ref. \citenum{Seyse74_5114}]\\ [1.0ex] RKB Pauli + Uncontracted 7s-Jorge-DZP-DKH$^b$ & Gaussian Nuclei & 2.48 & 3.055\\ RKB Pauli + Uncontracted Jorge-DZP-DKH & Gaussian Nuclei & 2.48 & 3.055\\ RKB Spinor + Uncontracted Jorge-DZP-DKH & Gaussian Nuclei & 2.48 & 3.055 \\ UKB Scalar + Uncontracted Jorge-DZP-DKH & Gaussian Nuclei & 2.48 & 3.085 \\ RKB Pauli + Uncontracted Jorge-DZP-DKH & Point Nuclei & 2.48 & 3.059\\ RKB Spinor + Uncontracted Jorge-DZP-DKH & Point Nuclei & 2.48 & 3.059 \\ UKB Scalar + Uncontracted Jorge-DZP-DKH & Point Nuclei & 2.48 & 3.090 \\ [0.5ex] \hline RKB Pauli + Contracted Jorge-DZP-DKH & Gaussian Nuclei & 2.21 & 8.438\\ RKB Spinor + Contracted Jorge-DZP-DKH & Gaussian Nuclei & 2.21 & 8.438 \\ UKB Scalar + Contracted Jorge-DZP-DKH & Gaussian Nuclei & 2.21 & 8.492 \\ RKB Pauli + Contracted Jorge-DZP-DKH & Point Nuclei & 2.21 & 8.570\\ RKB Spinor + Contracted Jorge-DZP-DKH & Point Nuclei & 2.21 & 8.570 \\ UKB Scalar + Contracted Jorge-DZP-DKH & Point Nuclei & 2.21 & 8.624 \\ [0.5ex] \hline RKB Pauli + Contracted Sapporo-TZP-2012-NO & Gaussian Nuclei & 3.01 & 0.764\\ RKB Spinor + Contracted Sapporo-TZP-2012-NO & Gaussian Nuclei & 3.01 & 0.764 \\ UKB Scalar + Contracted Sapporo-TZP-2012-NO & Gaussian Nuclei & 3.01 & 2.078$^a$\\ RKB Pauli + Contracted Sapporo-TZP-2012-NO & Point Nuclei & 3.00 & 0.902\\ RKB Spinor + Contracted Sapporo-TZP-2012-NO & Point Nuclei & 3.00 & 0.902 \\ UKB Scalar + Contracted Sapporo-TZP-2012-NO & Point Nuclei & 3.00 & 2.318$^a$ \\ [0.5ex] \hline $(25s~23p~14d~10f)$ [Ref. \citenum{Schwerdtfeger99_9457}] & Gaussian Nuclei &2.549 & 0.895 \\ $(24s~18p~14d~8f)\rightarrow[10s~7p~5d~2f]$ [Ref. \citenum{Hirao01_6526}] & Point Nuclei &2.602 & 0.880 \\ [0.5ex] \hline \end{tabular} {\footnotesize \\$^{a}$ The Au$_2$ dimer energy was consistent with both RKB formalisms ($\sim$ 0.0002 $E_h$ difference). The discrepancy is from the Au atomic solution ($\sim$ 0.02 $E_h$ difference). \\$^b$ Seven additional steep $s$ functions are added to the uncontracted basis set, with exponents ranging from 3$^1$ to $3^7$ times of the largest exponent in the original basis. } \label{table:au2_dimer} \end{center} } \end{table} \fi \clearpage \pagebreak

Introduction {#Sec1} ============ The pulse wave packet propagation effects are of considerable interest because of their significance from fundamental and application aspects such as optical communication, information science, digital holography, and image processing. Spatially and temporally localized beams are of interest since they describe the fields associated with dielectric antennae, laser optical systems and other sources emitting focused radiation more realistically than plane waves. It is known that the spatiotemporal shape of these wave-packets is modified during propagation due to the effects of non-stationary diffraction. One of the reasons leading to the transformation of the space-time radiation structure is the interconnected diffraction transformation of the frequency and angular spectra. Many works have been devoted to the study of the propagation of radiation pulses in various media^[@CR1]--[@CR5]^. Non-stationary diffraction effects arising in the propagation of electromagnetic pulses in free space are considered in^[@CR2]^. In^[@CR3],[@CR4]^, the problem of diffraction of a pulsed Gaussian beam in vacuum is solved in the paraxial approximation, and the relationship between the spatial and temporal characteristics of the beam is investigated on the basis of the spectral approach. In^[@CR5]^ an approach to the description of the non-stationary diffraction of extremely short pulses based on a generalization of the stationary Sommerfeld diffraction theory is developed. In recent years, the study of the superluminal and subluminal propagation of ultrashort pulses in free space has been of particular interest. The speed of light propagation in vacuum is one of the fundamental characteristics of electromagnetic waves. A plane monochromatic wave propagates in vacuum at velocity *c*. However, wave packets limited in space and time are used to transmit energy and information. The wave packet propagates at a group velocity that is different from the velocity of individual harmonic components. The phase and group velocities of light pulses can differ significantly in dispersive media such as cold atomic clouds^[@CR6]^, and atomic vapours^[@CR7]--[@CR9]^. In^[@CR10]^ it was demonstrated experimentally and theoretically the possibility of superluminal propagation of the pulse maximum in an amplifying medium. The superluminal effects were also observed in vacuum. The superluminal group velocity of optical Bessel beam pulses has been experimentally demonstrated in several works^[@CR11]--[@CR16]^. Direct measurements of the spatio-temporal electric field of Bessel-X-type pulses generated by a refractive axicon were carried out in^[@CR14],[@CR15]^. The pulsed beam given by the zeroth-order Bessel beam with a Gaussian temporal profile was experimentally studied with fs-range resolution in^[@CR17],[@CR18]^. Recently, non-diffracting optical 2D space-time wave packets in free space were considered^[@CR19]--[@CR21]^. Arbitrary group velocities are observed above or below the speed of light in vacuum by modulating the spatio-temporal spectrum. The effect of the transverse spatial structure of a light beam on its propagation velocity was experimentally discovered in^[@CR22]^. The effect was explained by the delay of peripheral regions of the beam using the geometric optics approach. However, this approach is insufficient, and a rigorous analysis of the problem is possible only within the framework of wave optics, taking into account nonstationary diffraction effects. It was shown in^[@CR23]^ that the slowing down of light also depends on the magnitude of the orbital momentum of the beam. The group velocities manifested by Laguerre-Gauss (LG) modes in vacuum were investigated, and the subluminal effects arising from the twisted nature of the optical phase front were observed and explained in paraxial approximations. However, LG functions are not the solutions of the Helmholtz wave equation in free space, and they can be considered as the modes in vacuum only in paraxial approximation. It was noted in^[@CR24]^, that there is a discrepancy between the theoretical results of^[@CR23]^ and the well-known results for the simple case of Laguerre-Gauss modes. As clarified in^[@CR25]^, the discrepancy in group velocities is due to the distinction between Laguerre-Gauss modes and hypergeometric-Gauss modes, which were used in the experiment and in the theoretical analysis. A reduction in the group velocity below the value of *c* for certain Bessel beam pulses was considered theoretically in^[@CR26]^. An optical buffer in free space that would provide delays on the order of 100 ps over a 1 cm length was proposed. However, as shown in^[@CR27]^, the practical feasibility of this optical buffer is questionable. It was explained in^[@CR28]^, that a structured beam acts as a natural cylindrical waveguide as the beam propagates in free space or in dielectric media, and an optical buffer may be possible in the future with advances in photonics technology. In^[@CR29]^, the group velocity of the LG beam (not pulse) in free space was calculated in the paraxial regime. In^[@CR30]^, it was shown that the addition of orbital angular momentum (OAM) reduces the delay (accelerates) with respect to the same beam with no OAM. The results are explained using a geometrical ray-tracing approach. Note that the pulsed beams were not considered in these works. Of particular interest were propagation-invariant localized pulsed waves that exhibit non-diffracting non-spreading propagation over a large distance^[@CR31]^. In this paper, the theoretical analysis of the nonparaxial propagation of vortex pulsed beams in free space in the framework of the wave approach is carried out, taking into account the non-stationary effects of diffraction. The mutual influence of the spatial distribution of the incident radiation and the temporal shape of the pulse during vacuum propagation is studied. In particular, the subluminal effects arising from the spatial localization of the pulse beam are revealed. The smaller the beam radius is, the slower the propagation speed. A strong change in the pulse shape as a consequence of nonstationary diffraction is demonstrated for tightly focused beams. Spatial modes with azimuthal and radial indices are proposed for the simulation of pulsed beam propagation in free space. Mode representation provides physical insight and computational simplification in the analysis of pulsed beams in free space. The influence of the spatial limitation of the pulse beam on the propagation velocity is studied. It is shown that there is a significant difference between the axial velocity (the velocity measured along the propagation axis at one point of the beam cross-section) and the total pulse beam velocity (when the receiver captures the full cross-section). The on-axis velocity exhibits both superluminal and subluminal behaviours along the propagation distance, whereas the total cross-section velocity is subluminal over the whole distance. The results of this work extend the known results of the propagation of pulsed beams in free space and can be applied in many areas of optics and photonics, such as optical communication, temporal imaging, and supercontinuum generation. Results {#Sec2} ======= First, we find the evolution of each spectral component of the spatiotemporal incident pulse. Then the inverse Fourier transform gives an expression for the electric field in the time domain. It is known that the non-diffracting Bessel beams are the solutions of the Helmholtz wave equation^[@CR32],[@CR33]^. They can be considered as the modal solutions with azimuthal indices in free space. However, Bessel beams have infinite transverse sizes and require infinite power. In practice, quasi-Bessel beams of limited transverse dimensions generated by an axicon or conical lens are used. These beams exhibit no diffraction over a limited propagation distance^[@CR32],[@CR33]^. There are also modal solutions of finite transverse size with discrete azimuthal and radial indices similar to modal solutions in cylindrical waveguides (see section Methods for supporting content). The transverse field profiles of these solutions remain invariant along the effective depth of field. Note that these solutions form a complete set of mutually orthogonal functions in a given interval \[0, *R*~0~\]. Hence, any field in the initial plane *z* = 0 can be decomposed into these modal solutions. Wave propagation is characterized by various velocities: the phase, group, signal envelope amplitude, and energy. The velocities for the pulse amplitude, pulse centre of gravity, and pulse energy flow can be considered for pulse beams: $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{m}=z/{t}_{m}$$\end{document}$, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{c.g.}=\frac{z}{{T}_{c.g.}}$$\end{document}$ and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{E}=\frac{S}{w}$$\end{document}$, where *z* is the propagation distance (detection plane), *t*~m~ is the arrival time of the pulse amplitude, *T*~c.g.~ is the arrival time of the pulse centre of gravity, *S* is the Poynting vector, and *w* is the electromagnetic energy density. The pulse velocity can be determined from Eq. ([25](#Equ25){ref-type=""}) (see section Methods for supporting content). It follows from this that both the group and phase velocities of the modes contribute to the resulting pulse velocity if only an axis part of the beam cross-section is recorded. This means that the velocity of the pulse beam depends on the size of the receiver aperture. The energy flow velocity depends only on the group velocities of the modes; thus, the averaged energy flow velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{E}$$\end{document}$ of a pulsed beam is always subluminal, i.e., $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{E} < c$$\end{document}$. In addition, the instantaneous (local) velocity of propagation can be defined as $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ins}=\frac{dz}{dt}$$\end{document}$ at different distances along the axis of propagation. The arrival time can be determined both for a given beam cross-section point and for the entire beam, i.e., by averaging over the cross-section. The arrival time of the pulse centre of gravity, which is determined by $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${t}_{c.g.}=\bar{t}(\rho ,z)=\frac{\int I(\rho ,z,t)tdt}{\int I(\rho ,z,t)dt}$$\end{document}$, is different for various points of the beam cross-section. The on-axis arrival time is equal to $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{ar}^{axis}=\bar{t}(0,z)$$\end{document}$. If the total cross-section of the pulse beam is recorded, then the arrival time is determined by averaging over the entire cross-section: $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{ar}^{tot}=\langle t(z)\rangle =\frac{{\iint }^{}I(\rho ,z,t)\rho d\rho tdt}{{\iint }^{}I(\rho ,z,t)\rho d\rho dt}$$\end{document}$. The spatiotemporal shape of wave packets is modified during propagation due to the nonstationary effects of diffraction and interference of modes. A strong change in the pulse shape occurs when the beam width and pulse duration decrease. Note that the width of the beam in front of the pulse varies less than in the tail part during the propagation. This indicates that the frontal part (high frequencies) of the pulses is less affected by diffraction. Although the simulation can be performed using the integral representation (see section Methods for supporting content), the simulation results obtained using the modal approach are presented below. The mode representation provides a simplification of calculations in the analysis of pulsed beams in free space. In Fig. [1](#Fig1){ref-type="fig"} the pulse intensities at different distances *z*~k~ are presented. In Fig. [1a,b](#Fig1){ref-type="fig"}, the Bessel-Gauss (BG) pulses are presented in an offset time scale $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t-\frac{({z}_{k}-{z}_{1})}{c}$$\end{document}$, where *z*~*k*~ is the distance, at which the pulse is recorded. It can be seen that the pulses have the same shape at different distances, but they are offset relative to each other. These shifts originate from differences in the time of arrival of the pulse amplitude. This means that the considered pulsed beam experiences subluminal propagation. As the width of the incident beam decreases, the time shift of the amplitude position between the considered pulse and plane-wave propagating at velocity *c* increases.Figure 1Pulse intensities at the distances *z*~k~ = 10, 20, 30, 40, 50 mm in the coordinate system with time delay $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t-\frac{({z}_{k}-{z}_{1})}{c}$$\end{document}$. *τ* = 20 fs; (**a**) *a*~0~ = 100 μm is the radius of Gaussian distribution; *w*~*B*~ = 50 μm is the central peak width of the Bessel function; (**b**) *a*~0~ = 100 μm; *w*~*B*~ = 20 μm. In Fig. [2](#Fig2){ref-type="fig"}, the delay times of the pulsed BG and LG beams (the arrival time of the pulse centre of gravity compared to light in vacuum) $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\Delta T={T}_{ar}^{tot}-{T}_{0}$$\end{document}$, where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{0}=\frac{z}{c}$$\end{document}$, depending on the distance *z* are presented for different values of OAM. It is shown that the delays are higher for pulsed BG beams and increase with increasing OAM.Figure 2Delays in arrival time as a function of distance *z* for the pulsed BG (**a**) and LG (**b**) beams: *a*~0~ = 100 μm; *w*~*B*~ = 100 μm; *w*~0~ = 100 μm; *λ* = 795 nm. In Fig. [3](#Fig3){ref-type="fig"} the dependences of the arrival times of BG pulsed beams relative to a plane-wave pulse on the cone angle *θ* (a), the central peak width (beam radius) *w*~*B*~, and orbital angular momentum *L* at the propagation distance *z* = 1 m are presented. The pulse duration *τ* = 100 fs, and the wavelength *λ* = 710 nm.Figure 3Arrival time delays as a function of the cone angle *θ* (**a**), central peak width *w*~*B*~ (**b**), and orbital angular momentum *L* (**c**) relative to the plane-wave case. The beam parameters are: (**a**,**b**) pulsed BG beam with *τ* = 100 fs, *L* = 0, *λ* = 710 nm; (**c**) pulsed LG beam with *τ* = 100 fs, *w*~0~ = 100 μm, *λ* = 795 nm. It follows from the calculations that a decrease in the velocity compared to the velocity of light *c* leads to a delay of $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta {z}_{B}\approx \frac{z}{2}{\theta }^{2}\approx \frac{z}{2}\frac{{\lambda }^{2}}{{w}_{B}^{2}}$$\end{document}$, where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\theta =si{n}^{-1}(\alpha /k)$$\end{document}$, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${w}_{B}\approx 2.4/(k\,\sin \,\theta )$$\end{document}$ is the central peak width of a Bessel beam, and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$k=\frac{2\pi }{\lambda }$$\end{document}$, where *λ* is the central wavelength. Consequently, for the time delay and the velocity reduction, we obtain $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta T\approx (\frac{z}{c})\frac{{\lambda }^{2}}{{w}_{B}^{2}}$$\end{document}$ and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta v\approx c\frac{{\lambda }^{2}}{{w}_{B}^{2}}$$\end{document}$. These results are in good agreement with the experimental data^[@CR22],[@CR23]^. The time delays presented in Fig. [3a](#Fig3){ref-type="fig"} agree well with the measured delays for the Bessel beam in^[@CR22]^. In^[@CR22]^, it was reported that the group delay increases with the square of the diameter of the Gaussian beam. Here we have shown that the delay time increases as the diameter of the incident beam decreases. However, there is no contradiction between these results. The point is that the incident beam in^[@CR22]^ does not propagate in free space, but it is focused by the lens. The spot size of the focused beam that is responsible for the delay is inversely proportional to the waist of the input beam: $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${w}_{0}=f\lambda /{w}_{in}$$\end{document}$, where *f* is the focal length of the lens, and *w*~*in*~ is the waist of the input beam. Therefore, the larger the diameter of the input beam, the smaller the waist of the focused beam. The calculated delay times depending on OAM are also in good agreement with the measurements in^[@CR23]^, if the paraxial beams with *w*~0~ \>\> *λ* are considered. In Fig. [4a](#Fig4){ref-type="fig"} the delay times $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta {T}^{axis}={T}_{ar}^{axis}-{T}_{0}$$\end{document}$ and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta {T}^{tot}={T}_{ar}^{tot}-{T}_{0}$$\end{document}$, where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{0}=\frac{z}{c}$$\end{document}$, depending on the distance *z*, are presented for the pulsed BG beam. The delay of the centre of gravity of the entire pulse beam relative to the plane wave increases linearly with the distance (Fig. [4a](#Fig4){ref-type="fig"}). However, the delay of the centre of gravity of the axial part of the pulse beam increases only in the region close to the source, and it disappears with increasing propagation distance. In Fig. [4b](#Fig4){ref-type="fig"} the on-axis $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{axis}$$\end{document}$, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ins}^{axis}$$\end{document}$, and total cross-section $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ velocities are presented. The total cross-section velocity depends on the initial parameters of the pulsed beam and remains constant during propagation (Fig. [4b,c](#Fig4){ref-type="fig"}).Figure 4The delays in arrival time *δT* (**a**), the velocities $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$v=c-\delta v$$\end{document}$ (**b**), and the velocity changes *δv* (**c**) as a function of the propagation distance *z*. The beam parameters are: *a*~0~ = 200 μm; *w*~*B*~ = 200 μm; *λ* = 710 nm. It can be seen that the total beam cross-section velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ is less than *c* for spatially structured pulsed beams. However, the on-axis velocity determined on the optical axis at a single point varies with the distance from the source. In this case the instantaneous on-axis velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ins}^{axis}$$\end{document}$ can be higher than *c*, even though the velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{axis}$$\end{document}$ is subluminal (Fig. [4b](#Fig4){ref-type="fig"}). Indeed, it follows from the calculation that the instantaneous on-axis velocity of the pulse becomes superluminal in the Rayleigh diffraction region. The superluminality gradually disappears with distance due to the vanishing of the interference term in (8) (Fig. [4b,c](#Fig4){ref-type="fig"}). This indicates that superluminal propagation is due to interference between different modes (second term in (25)). For $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$z\gg {l}_{d}$$\end{document}$, the average velocity which is estimated as $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\bar{v}}_{ins}^{axis}=(\frac{1}{d}){\int }_{0}^{d}{v}_{ins}^{axis}(z)dz$$\end{document}$, where *T*~*ar*~ is the time of arrival of the pulse centre of gravity, is less than *c* (Fig. [4b](#Fig4){ref-type="fig"}). The velocity difference $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta {v}_{ar}^{axis}=c-{v}_{ar}^{axis}$$\end{document}$decreases, approaching zero with increasing distance (Fig. [4c](#Fig4){ref-type="fig"}). The on-axis velocity of the centre of gravity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{axis}=c-\delta {v}_{axis}$$\end{document}$ increases with distance *d*, since the value $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta {v}_{axis}$$\end{document}$ decreases with distance (Fig. [4](#Fig4){ref-type="fig"}). When *z* → ∞, the velocity difference $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta {v}_{axis}\to 0$$\end{document}$, thus, the on-axis velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{axis}\to c$$\end{document}$. Note that the distance region, where the instantaneous on-axis velocity is higher than *c*, decreases with the decrease in the beam cross-section radius (see Fig. [5](#Fig5){ref-type="fig"}).Figure 5Delays in arrival time *δT* (**a**), the velocities *v* = *c* − *δv* (**b**), and the velocity changes *δv* (**c**) as a function of the propagation distance *z* for a pulsed BG beam with the parameters: *a*~0~ = 100 μm; $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${w}_{B}=2.405/(k\,\sin \,\theta )$$\end{document}$ = 100 μm, where *θ* is the cone angle; *λ* = 710 nm. In Fig. [6](#Fig6){ref-type="fig"}, the delay times and velocities as a function of distance *z* for the pulsed BG, LG and Gauss beams are presented. It can be seen that the velocities $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{axis}$$\end{document}$ and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ in the region close to the source are lower for the BG beam than for the LG and Gauss beams with the same beam waists. Differences in the speed of light on the order of 10^−5^--10^−6^ *c* can be observed for the considered pulsed beams.Figure 6On-axis (**a**) and total cross-section (**b**) velocities *v* = *c* − *δv* as a function of propagation distance for BG, LG, and Gauss pulsed beams. The beam parameters are: BG − *a*~0~ = 100 μm; *w*~*B*~ = 100 μm; LG − *w*~0~ = 100 μm, *w*~0~ = 70 μm; Gauss − *a*~0~ = 100 μm. *λ* = 710 nm. It can be seen that the on-axis velocity varies with the distance approaching the value of *c* at $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$z > {l}_{d}=\frac{k{w}_{0}^{2}}{2}$$\end{document}$, where *l*~d~ is the Rayleigh diffraction length. The total cross-section velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ decreases with wavelength and remains constant throughout the propagation distance. The velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ decreases with the decrease in the beam waist and does not change with distance. In Fig. [7](#Fig7){ref-type="fig"}, the velocities $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{axis}$$\end{document}$ and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ as a function of the distance for different values of the wavelength and beam waist are presented. It can be seen that the on-axis velocity varies with the distance, approaching the value of *c* at $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$z > {l}_{d}=\frac{k{w}_{0}^{2}}{2}$$\end{document}$, where *l*~*d*~ is the Rayleigh diffraction length. The total cross-section velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ decreases with the wavelength and remains constant throughout the propagation distance (Fig. [7a,b](#Fig7){ref-type="fig"}). The velocity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ decreases with the decrease in the beam waist and does not change with distance (Fig. [7a,b](#Fig7){ref-type="fig"}).Figure 7Velocities $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{axis}$$\end{document}$ (red lines) and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ar}^{tot}$$\end{document}$ (black lines) as a function of distance for different values of the wavelength (**a**) and central peak width (cone angle) (**b**) of a Bessel-Gauss beam. The beam parameters are: (**a**) *a*~0~ = 100 μm, *w*~*B*~ = 100 μm; (**b**) *a*~0~ = 100 μm; *λ* = 710 nm. The spatial delays can be approximated by the expression $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta z\approx \frac{z{\lambda }^{2}}{{w}_{0}^{2}}$$\end{document}$. Consequently, for the time delay and the velocity reduction, we obtain $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta T\approx (\frac{z}{c})\frac{{\lambda }^{2}}{{w}_{0}^{2}}$$\end{document}$ and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta v\approx c\frac{{\lambda }^{2}}{{w}_{0}^{2}}$$\end{document}$. Note that the delays increase as the wavelength increases and the beam width decreases. When $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${w}_{0}\to \infty $$\end{document}$, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta v\to 0$$\end{document}$; therefore, there is no delay of the pulse relative to the plane-wave case. Similarly, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\delta v\to 0$$\end{document}$, when $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\lambda \to 0$$\end{document}$. These results indicate that short wavelengths propagate with a speed close to the plane wave velocity *c*, and long wavelengths undergo a delay. In Fig. [8](#Fig8){ref-type="fig"}, the pulse shapes on the propagation axis (*ρ* = 0) corresponding to the terms *I*~0~ and *I*~1~ in (26) and their sum are presented for the BG pulse beam. It is shown that the pulse associated with the interference term *I*~1~ propagates at a higher rate than the pulse corresponding to the term *I*~0~. Therefore, in this case, superluminal behaviour may be observed. This result indicates that the local pulse velocity may be higher than *c*. However, the average velocity, which is estimated by the time of arrival of the pulse at $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$z > {l}_{d}$$\end{document}$, is less than *c*.Figure 8On-axis intensities of BG pulse beam corresponding to the terms *I*~0~ and *I*~1~ in (26): (**a**) *z* = 60 mm; (**b**) *z* = 90 mm. *a*~0~ = 100 μm; *w*~*B*~ = 30 μm; *τ* = 10 fs; *λ* = 710 nm. Discussion {#Sec3} ========== Variation of the propagation velocity with distance is due to the interference of propagating modes; thus, the superluminal and subliminal behaviours can be observed. Note that the arrival time and velocity of the pulse beam depend on the measurement method (size and position of the receiver's aperture). The central and periphery parts of the beam propagate at different velocities; therefore, depending on the size of the aperture of the photodetector and its position in space, the velocities will be different. When only a part of the beam cross-section is registered (for example, at *ρ* = 0), both the phase and group velocities of the modes affect the pulse velocity. Since the phase velocities of the modes exceed the velocity of light *с*, a superluminal propagation of the pulse can be observed near the source, i.e., the pulse propagates over small distances faster than the speed of light in vacuum. However, the average velocity determined by the arrival time of the pulse at $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$z > {l}_{d}$$\end{document}$ is less than *c*, even though the pulse beam experiences superluminal behaviour at some part of the propagation distance. Given that the entire beam cross-section (total pulse power) has been recorded, averaging over the beam cross-section occurs. In this case, the pulse velocity is determined only by the group velocities of the modes, i.e., the measured pulse velocity will be less than the speed of light *с*. Note that the energy velocity is always less than *c*, since it is determined only by the group velocities of the propagating modes. Superluminal behaviour can also be caused by the proximity of the receiving antenna to the emitter, i.e., when the distance between the emitter and receiver $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$d < c\tau $$\end{document}$. It follows from the simulation that the centre of gravity of the pulsed beam exhibits significant superluminal behaviour throughout the propagation. This effect was apparently observed experimentally in^[@CR34]^, where a noticeable superluminality for *z* \< 1 m was detected. In Fig. [9](#Fig9){ref-type="fig"}, the delay times of a microwave pulse with a duration of 2 *ns* depending on the distance *z* are presented. The angular frequency of the carrier is 8.6 GHz (*λ* = 3.5 cm). As shown, that the time delay determined by the time of arrival of the pulse amplitude is almost the same as that determined by the speed of light *c* for all distances. However, the time delay of the pulse centre of gravity differs significantly from the one that is defined by the arrival time of the pulse amplitude for a distance of 1.4 *m*. The instantaneous (punctual) velocity of the pulse centre of gravity in this region is higher than *c*, i.e., superluminal behaviour can be observed. This result is in good agreement with the data of^[@CR34]^, where superluminal behaviour during microwave propagation was observed experimentally. Note that there is no such superluminality in the propagation velocity of the pulse amplitude (Fig. [9](#Fig9){ref-type="fig"}).Figure 9(**a**) Arrival times T~c.g.~ (red -- pulse centre of gravity), T~m~ (black -- pulse maximum), T~0~ = *z/c* (green -- light speed *c*) of the microwave pulse (**a**) and velocities (**b**) as a function of distance *z*. *τ* = 2 ns; *λ* = 3.5 cm. The dispersion effects become significant for strongly focused pulsed beams. It is known that in this case nonparaxial effects become noticeable^[@CR35],[@CR36]^. In this case, the influence of the longitudinal field component *E*~*z*~ and the spin-orbit interaction should also be taken into account^[@CR37],[@CR38]^. In Fig. [10a,b](#Fig10){ref-type="fig"}, the BG pulse intensities at different distances z~k~ are presented. In Fig. [10b](#Fig10){ref-type="fig"}, the pulses are presented in an offset time scale $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t-\frac{({z}_{k}-{z}_{1})}{c}$$\end{document}$, where *z*~*k*~ is the distance, at which the pulse is recorded. In Fig. [10c,d](#Fig10){ref-type="fig"}, the delay times of the pulsed BG beam (the arrival times of the energy $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{E}=z/{v}_{E}$$\end{document}$ (c) and pulse centre of gravity $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{ar}^{tot}$$\end{document}$ (d) compared to light in vacuum), depending on the distance *z*, are presented.Figure 10(**a**) Pulse intensities at the distances *z*~k~ = 200, 400, 600, 800, 1000 μm; (**b**) Pulse intensities in the coordinate system with time delay $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t-\frac{({z}_{k}-{z}_{1})}{c}$$\end{document}$; (**c**,**d**) Delays in arrival time as a function of distance *z*. *a*~0~ = 1 μm; *w*~*B*~= 2 μm; *τ* = 10 fs; *λ* = 630 nm. It is shown that the pulse shape changes during propagation due to dispersion effects. Note that the beam width at the front of the pulse changes less than that at the tail part during the propagation. This observation indicates that the frontal part (high frequencies) of the pulse is less affected by the diffraction. In^[@CR2]^, this effect is linked with the existence of a time-dependent "vacuum dispersion". The pulse front can be called a "diffractive precursor", since diffraction effects mainly develop behind it. As a result, the problem of the diffraction of the pulsed beams becomes analogous to Sommerfeld and Brillouin's problem of the propagation of a signal with a sharp leading edge in a medium with a time-dependent dispersion^[@CR39],[@CR40]^. The front part (precursor) has a small amplitude and a high frequency. The main part of the signal (the signal body) always propagates at a speed less than *c*. This part of the signal is usually recorded by the detector. As the sensitivity of the detector increases, the speed obtained from the measurements will approach speed *c*. The slowing down of the light propagation velocity in waveguides is well known and can be explained by the delays of modes. In^[@CR41]^, it is shown that at this delay also depends on the magnitude of the orbital angular momentum (helicity of the wave front) and the spin angular momentum (polarization) of the propagating beam. Therefore, it can be assumed that a polarization similar to the orbital angular momentum will affect the propagation velocity in the free space of pulsed beams with OAM and SAM. A detailed analysis of these effects will be presented in future work. The obtained results do not contradict the experimental data obtained for femtosecond, picosecond, and nanosecond time-domain pulses in the visible and THz regions. A number of effects have been discovered where light travels over small distances faster than the speed of light in vacuum. In this regard, the question arises whether it is possible to exchange information superluminally^[@CR42],[@CR43]^. As emphasized in^[@CR43]^, the information content of the signal tends to decrease during superluminal propagation due to noise and for this reason superluminal information exchange is impossible. Here, it is shown that the superluminal signal can be obtained only for the axial part of the incident pulsed beam. Only an axial point on the cross-section of the pulsed beam can propagate for short distances at a velocity *v* \> *c*. The entire pulse beam always propagates at *v* \< *c*. Hence, the information (for example, an image encoded with spatial beams) carried by the entire pulse beam can be transmitted only subluminally. Indeed, a single pixel of the image does not transmit information about the entire image, or the image information cannot be decoded from a point (pixel) on the receiver plane. Despite the fact that individual pixels can be transmitted superluminally, they do not contain all of the original information. If the receiver detects a total incident pulse beam, superluminal signal transmission does not occur. It was experimentally established that single photons travel at the group velocity^[@CR44]^. Recently, it was shown that, depending on the measurement scheme, the group velocity can be defined differently^[@CR45]^. Different versions of the group velocity of the Bessel-Gauss pulses have been considered, depending on how the pulse is recorded in the output plane, namely, integrally or with spatial resolution. In^[@CR22]^, it is shown that transverse structuring of a photon results in a decrease in the group velocity along the axis of propagation. It has now been shown that the on-axis part of arbitrary pulsed beams propagates at variable speeds, exhibiting both superluminal and subluminal behaviours. The effect comes from a rigorous calculation of the impulse evolution. Usually, the terms "group" and "phase" velocities are used to describe the pulse velocity. However, these velocities are well defined only for plane waves. In the case of spatially structured pulsed beams, the term "impulse velocity" is more appropriate (see also^[@CR46]^). Indeed, the impulse velocity incorporates the group and phase velocities of a set of spatial mode components. The superluminal effect is due to interference between different modes (second term in (26)). The interference terms disappear due to the orthogonality of the modal functions if integration across the entire beam cross-section is taken. Therefore, the superluminal effect can be observed if only the pulsed beam electric field is measured at one point in the transverse plane (for example, *ρ* = 0). There is no superluminal effect if the entire cross-section of the pulse beam is recorded. Methods {#Sec4} ======= The Maxwell equations describing the propagation of light are reduced to$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\nabla }\times {\nabla }\times \overrightarrow{E}=-\,\frac{1}{{c}^{2}}\frac{{\partial }^{2}\overrightarrow{E}}{\partial {t}^{2}}$$\end{document}$$To solve Eq. ([1](#Equ1){ref-type=""}), let us make the following simplifying assumptions. We assume that the considered field is quasi-monochromatic, i.e., the spectrum with a central frequency *ω*~0~ has a width *Δω* such that $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\varDelta \omega /\omega \ll 1$$\end{document}$. This is valid for most sources of radiation used in the experiments. It is possible to separate a rapidly changing part of the electric field using the approximation of slowly changing amplitudes:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overrightarrow{E}(\overrightarrow{r},t)=\frac{1}{2}\overrightarrow{x}[E(\overrightarrow{r},t)\,{\exp }(\,-\,i{\omega }_{0}t)+conj.],$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\overrightarrow{r},t)$$\end{document}$ is the slowly changing function of time (relative to the period of the optical wave), $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overrightarrow{r}=(x,y,z)$$\end{document}$. Substituting (2) into Eq. ([1](#Equ1){ref-type=""}), we find that the Fourier components $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\overrightarrow{r},\omega -{\omega }_{0})$$\end{document}$, defined as$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\overrightarrow{r},\omega -{\omega }_{0})={\int }_{-\infty }^{\infty }E(\overrightarrow{r},t)\,{\exp }[i(\omega -{\omega }_{0})t]dt,$$\end{document}$$satisfy the Helmholtz equation$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${{\nabla }}^{2}\overrightarrow{E}+{k}^{2}\overrightarrow{E}=0,$$\end{document}$$where *k* = *ω*/*c* is the wavenumber. There are exact solutions to the Helmholtz equation in the form of Bessel modes or non-diffracting beams^[@CR32],[@CR33],[@CR47],[@CR48]^:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$J(\alpha ,\rho ,z,\omega )={J}_{l}(\alpha ,\rho )\,{\exp }\{i\beta (\omega )z\},$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${J}_{l}(\alpha ,\rho )$$\end{document}$ is the Bessel function of the first kind, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\alpha =k\,\sin \,\theta $$\end{document}$, *θ* is the cone angle of the Bessel beam, *l* is the azimuthal index corresponding to OAM, and *β* is the propagation constant. Each spectral component propagates independently according to Eq. ([4](#Equ4){ref-type=""}). Note that the Bessel beams have infinite transverse size and require infinite power. In practice, the quasi-Bessel beams of bounded transverse dimensions, which are generated by an axicon or conical lens, are used. These beams exhibit no diffraction over a limited propagation distance^[@CR32],[@CR33]^. This property of Bessel beams allows for useful applications in various areas such as three-dimensional imaging^[@CR49]^, nonlinear optics^[@CR50]^, dispersion compensation^[@CR51]^, and wireless communication^[@CR52]^. Consider the incident pulsed beam $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,0,t)={A}_{0}\psi (\rho )f(t)$$\end{document}$ in the plane *z* = 0, the envelope of which is described by the function $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$f(t)={\exp }(-\,{t}^{2}/2{\tau }^{2}+i{\omega }_{0}t)$$\end{document}$, where *τ* is the input pulse width. The frequency spectrum of this signal is determined by the expression$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$F(\omega -{\omega }_{0})=(1/\sqrt{2\pi }){\int }_{-\infty }^{\infty }f(t){e}^{-i\omega t}dt=(\frac{\tau }{\sqrt{2\pi }}){\exp }[-{(\omega -{\omega }_{0})}^{2}{\tau }^{2}/2].$$\end{document}$$ The evolution of the spatial distribution of the field for a given spectral frequency component is determined by$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,\omega -{\omega }_{0})={\int }_{0}^{{\alpha }_{max}}\alpha {J}_{l}(\alpha \rho ){c}_{l}(\alpha )F(\omega -{\omega }_{0})\exp (i\beta (\omega )z)d\alpha ,$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{l}(\alpha )={\int }_{0}^{\infty }\rho {J}_{l}(\alpha \rho )\psi (\rho )d\rho $$\end{document}$, *F*(*ω*) is the frequency spectrum of the incident pulse, and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\beta ={({k}^{2}-{\alpha }^{2})}^{\frac{1}{2}}$$\end{document}$. Decomposition (7) is called the Fourier-Bessel integral (see, for example^[@CR48]^). Substituting (6) into (7), we obtain$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,\omega -{\omega }_{0})={\int }_{0}^{{\alpha }_{max}}\alpha {J}_{l}(\alpha \rho ){c}_{l}(\alpha )\exp [-\frac{{(\omega -{\omega }_{0})}^{2}{\tau }^{2}}{2}]\exp (i\beta (\omega )z)d\alpha $$\end{document}$$ The inverse Fourier transform of (7) gives an expression for the electric field in the time domain:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,t)=\frac{1}{2\pi }{\int }_{-\infty }^{\infty }E(\rho ,z,\omega -{\omega }_{0}){\exp }[-i(\omega -{\omega }_{0})t]d\omega .$$\end{document}$$ Expand *β*(*ω*) in a Taylor series in the neighbourhood of *ω*~0~:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\beta (\omega )=\sum _{m=0}\frac{{(\omega -{\omega }_{0})}^{m}}{m!}{\gamma }_{m}={\gamma }_{0}+(\omega -{\omega }_{0}){\gamma }_{1}+\frac{{(\omega -{\omega }_{0})}^{2}}{2!}{\gamma }_{2}+\ldots ,$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\gamma }_{m}=\frac{{d}^{m}}{d{\omega }^{m}}\beta (\omega )|\omega ={\omega }_{0}$$\end{document}$, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\gamma }_{1}=\frac{d\beta }{d\omega }=\frac{1}{c}\frac{d\beta }{dk}$$\end{document}$. Substituting (8) into (9), we obtain$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,t)=\frac{\tau }{2\pi }{\int }_{0}^{{\alpha }_{max}}\alpha {c}_{l}(\alpha ){J}_{l}(\alpha \rho )\exp (i\beta ({\omega }_{0})z)f(t,z,\tau )d\alpha ,$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$f(t,z,\tau )=\sqrt{\frac{2\pi }{{\tau }^{2}-iz{\gamma }_{2}}}{\exp }[-\frac{{(t-z{\gamma }_{1})}^{2}}{2({\tau }^{2}-iz{\gamma }_{2})}]$$\end{document}$. There are also modal solutions of finite transverse dimensions with discrete azimuthal and radial indices similar to the modes in cylindrical waveguides. The transverse field profiles of these solutions remain invariant along the effective depth of field (diffraction-free region), i.e., exhibit modal properties. Note that these solutions form a complete set of mutually orthogonal functions in a given interval \[0, *R*~0~\]. Hence, any field in the initial plane *z* = 0 can be decomposed into these modal solutions. The normalized Bessel functions with radial *p* and azimuthal *l* indices can be considered as the modal solutions of Eq. ([4](#Equ4){ref-type=""}) within the effective depth of field:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\psi }_{pl}(\rho ,\varphi )=\frac{{J}_{l}({\mu }_{pl}\frac{\rho }{{R}_{0}}){\exp }(il\varphi )}{(\sqrt{\pi }{R}_{0}{J}_{l+1}({\mu }_{pl}))},$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mu }_{1},{\mu }_{2},\ldots $$\end{document}$ are the positive zeros of the Bessel function $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${J}_{l}(z)$$\end{document}$. It follows from the orthogonality condition for Bessel functions^[@CR47],[@CR48],[@CR53],[@CR54]^$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\int }_{0}^{{R}_{0}}{J}_{m}({\mu }_{i}\rho /{R}_{0}){J}_{m}({\mu }_{j}\rho /{R}_{0})\rho d\rho =\frac{{R}_{0}^{2}}{2}{[{J}_{m+1}({\mu }_{i})]}^{2}{\delta }_{ij},$$\end{document}$$that these modes satisfy the equation$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\int }_{0}^{2\pi }{\int }_{0}^{{R}_{0}}{\psi }_{pl}^{\ast }(\rho ,\varphi ){\psi }_{pl}(\rho ,\varphi )\rho d\rho d\varphi =1.$$\end{document}$$ Analogously to the Fourier-Bessel expansion^[@CR47],[@CR48],[@CR53],[@CR54]^$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$f(r,0)=\mathop{\sum }\limits_{k=1}^{\infty }{c}_{k}{J}_{m}({\mu }_{k}r),$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{k}=\frac{2}{{R}_{0}^{2}{[{J}_{m+1}({\mu }_{k})]}^{2}}{\int }_{0}^{{R}_{0}}tf(t){J}_{m}({\mu }_{k}t)dt,$$\end{document}$an arbitrary electric field at *z* = 0 can be expanded in the series of these discrete modes:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,0,\omega )=\mathop{\sum }\limits_{k=1}^{\infty }{c}_{k}{J}_{m}({\mu }_{k}\frac{\rho }{{R}_{0}}),$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\mu }_{1},{\mu }_{2},\ldots $$\end{document}$ are the positive zeros of the function *J*~*m*~(*z*),$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{k}=(\frac{2}{({R}_{0}^{2}{[{J}_{m+1}({\mu }_{k})]}^{2})}){\int }_{0}^{{R}_{0}}\rho f(\rho ){J}_{m}({\mu }_{k}\rho /{R}_{0})d\rho .$$\end{document}$$ Note that in^[@CR55]^, this decomposition of the field was used when considering the scattering of light by small particles. In Fig. [11a](#Fig11){ref-type="fig"}, the normalized Bessel mode intensities (12) with OAM *l* = 0 and different radial indices *p* as a function of the transverse coordinate are presented. In Fig. [11b](#Fig11){ref-type="fig"}, the powers of the Bessel modes as a function of the radial distance *ρ* are presented. In contrast to Bessel beams, the considered Bessel beams are shown to have finite transverse size and finite power.Figure 11Intensities of normalized Bessel modes (**a**) and powers of Bessel modes (**b**) with different radial indices *p* and zero azimuthal index *l* = 0 as a function of the transverse coordinate *ρ*. The evolution of the electric field is determined by the expression$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,\omega -{\omega }_{0})=F(\omega -{\omega }_{0})\sum _{pl}{c}_{pl}{\psi }_{pl}(\rho ){\exp }(i{\beta }_{pl}(\omega )z),$$\end{document}$$where *c*~*pl*~ are the modal coefficients depending on the incident field, and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\beta }_{pl}(\omega )=k{(1-{(\frac{{\mu }_{pl}}{(k{R}_{0})})}^{2})}^{\frac{1}{2}}$$\end{document}$ is the propagation constant of the mode with radial *p* and azimuthal *l* indices, respectively. The coefficients *c*~*pl*~ are determined by the incident pulse field $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,0,t)=E(\rho ,0)f(t)$$\end{document}$:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{pl}={\int }_{0}^{\infty }{\int }_{0}^{2\pi }E(\rho ,0){\psi }_{pl}^{\ast }(r,\varphi )\rho d\rho d\varphi .$$\end{document}$$ Substituting the frequency spectrum (8) into (15), it can be obtained that$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,\omega -{\omega }_{0})=(\frac{\tau }{\sqrt{2\pi }})\mathop{\sum }\limits_{p=1}^{N}{c}_{pl}{\psi }_{pl}(\rho ){\exp }(i{\beta }_{pl}z){\exp }[-\frac{{(\omega -{\omega }_{0})}^{2}{\tau }^{2}}{2}]$$\end{document}$$ The inverse Fourier transform of (17) gives an expression for the electric field in the time domain:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,z,t)=(\frac{\tau }{\sqrt{2\pi }})\mathop{\sum }\limits_{p=1}^{N}{c}_{pl}{\psi }_{pl}f(t,z,\tau ),$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$f(t,z,\tau )=\frac{{\exp }[i(t-{\gamma }_{0,p}z)]}{{({\tau }^{2}+i{\gamma }_{2,p}z)}^{\frac{1}{2}}}{\exp }\{-\frac{{(t-{\gamma }_{1,p}z)}^{2}}{2({\tau }^{2}+i{\gamma }_{2,p}z)}\}.$$\end{document}$ It can be seen from (18) that the electric field of each mode reaches its maximum value at$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t=z{\gamma }_{1}=z\frac{d\beta }{d\omega }=\frac{z}{c}\frac{d\beta }{dk},$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{g}=c{(\frac{d\beta }{dk})}^{-1}=c{[1-{\mu }_{pl}^{2}/({R}^{2}{k}^{2})]}^{\frac{1}{2}}$$\end{document}$ is the group velocity of the mode. The higher the mode number (radial *p* and azimuthal *l* indices) or larger the transverse wave number is, the lower the group velocity. This result is consistent with the natural waveguide idea discussed in^[@CR28]^, where the slowing of a Bessel light beam is shown with the increase in the transverse wave number. Recently, a differential group delay of the space-time wave packet in free space of approximately 150 ps was recorded^[@CR20]^. These order group delays can be observed if high-order modes are used. The group velocity of the mode acquires a maximum value of *c* when *λ* → 0, which corresponds to the approximation of geometric optics. The phase velocity of the mode is equal to:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ph}=\frac{\omega }{\beta }=c{[1-{\mu }_{pl}^{2}/({R}^{2}{k}^{2})]}^{\frac{-1}{2}}.$$\end{document}$$ It can be seen from above, that $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{g} < c$$\end{document}$, $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ph} > c\,$$\end{document}$and $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{g}{v}_{ph}={c}^{2}$$\end{document}$. The higher the mode number is, the greater the phase velocity. However, this does not mean that energy or information can be transmitted at this rate. The term $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\tau (z)={\tau }_{0}{(1+\frac{{\gamma }_{2,p}^{2}{z}^{2}}{{\tau }_{0}^{4}})}^{\frac{1}{2}}$$\end{document}$ defines the change in pulse width due to modal dispersion. A limited number of modes *N* can be taken in summation (18). In Fig. [12](#Fig12){ref-type="fig"}, the coefficients *c*~*pl*~ as a function of the radial mode number are presented for the pulsed BG beam. It is shown that a limited number of propagating modes are excited in free space. This greatly simplifies computations compared to the integration using (11).Figure 12Modal coefficients *c*~*pl*~ (**a**,**c**,**e**) and their squares (**b**,**d**,**f**) as a function of the radial index *p*: (**a**,**b**) BG beam; (**c**, **d**) LG beam; (**e**,**f**) Gauss beam. *a*~0~ = 50 μm, *w*~*B*~ = 50 μm. Note that the intensity distributions along the radius of the Bessel-Gauss beam in different planes perpendicular to the beam axis obtained by modal decomposition (17) are in good agreement with the results of numerical calculations obtained using the Fresnel diffraction integral^[@CR56]^. For Bessel-Gauss beams the diffraction spreading is significantly less than for Gaussian beams, i.e., these beams have a sharp radiation pattern. Consider the incident pulsed beams at *z* = 0 with Gaussian, Bessel-Gauss, and Laguerre-Gauss spatial distributions, respectively:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,0,t)={A}_{0}{\exp }\,(\,-\,{\rho }^{2}/{a}_{0}^{2})f(t);$$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,0,t)={A}_{0}{\exp }(\,-\,{\rho }^{2}/{a}_{0}^{2}){J}_{l}(\alpha \rho ){\exp }(il\varphi )f(t);$$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$E(\rho ,0,t)={A}_{0}{\psi }_{pl}(\rho ,\varphi )f(t);$$\end{document}$$where *a*~0~ is the Gaussian beam radius,$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\psi }_{pl}(\rho ,\varphi )={(\frac{1}{\pi {w}_{0}^{2}})}^{\frac{1}{2}}{[\frac{p!}{(p+l)!}]}^{\frac{1}{2}}{({\rho }^{2}/{w}_{0}^{2})}^{\frac{l}{2}}\exp (-\,\frac{{\rho }^{2}}{2{w}_{0}^{2}}){L}_{p}^{l}({\rho }^{2}/{w}_{0}^{2})\exp (il\varphi ).$$\end{document}$$ The integrals (16) for the considered beam pulses can be calculated analytically^[@CR57]^. The following expressions for modal coefficients are obtained for Gaussian, BG and LG pulsed beams, respectively:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{p}=\frac{{A}_{0}\sqrt{2}{a}_{0}}{{R}_{0}{J}_{1}({\mu }_{p})}{\exp }\{-\frac{{a}_{0}^{2}{\mu }_{p}^{2}}{4{R}_{0}^{2}}\};$$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{pl}=\frac{{A}_{0}{a}_{0}^{2}}{\sqrt{\pi }{R}_{0}{J}_{l+1}({\mu }_{p}{R}_{0})}{\exp }[-({\alpha }^{2}+{\mu }_{p}^{2}){a}_{0}^{2}/4]{I}_{l}(\frac{\alpha {\mu }_{p}}{2}{a}_{0}^{2})$$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${c}_{pl}={A}_{0}{B}_{0}{({\mu }_{p}\frac{{w}_{0}}{{R}_{0}})}^{l}{\exp }(-{\mu }_{p}^{2}{w}_{0}^{2}/(2{R}_{0}^{2})){L}_{p}^{l}({\mu }_{p}^{2}{w}_{0}^{2}/{R}_{0}^{2}),$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${B}_{0}=2(\frac{{w}_{0}}{{R}_{0}}){(-1)}^{p}{(\frac{p!}{(p+l)!})}^{\frac{1}{2}}/{J}_{l+1}({\mu }_{p}).$$\end{document}$ The intensity distribution $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$I(\rho ,z,t)={|E(\rho ,z,t)|}^{2}\,$$\end{document}$is determined by the expression$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$I(\rho ,z,t)={I}_{0}+{I}_{1}=\frac{1}{2\pi }\mathop{\sum }\limits_{p=1}^{N}{|{c}_{pl}|}^{2}{|{\psi }_{pl}|}^{2}{|{Q}_{pl}|}^{2}+\frac{1}{2\pi }\mathop{\sum }\limits_{p=1}^{N}\mathop{\sum }\limits_{n=1}^{N}{c}_{pl}^{\ast }{c}_{nl}{\psi }_{pl}^{\ast }{\psi }_{nl}{Q}_{pl}^{\ast }{Q}_{nl},\,p\ne n$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${Q}_{pl}=\frac{{\exp }[i(t-{\gamma }_{0,p}z)]}{{({\tau }^{2}+i{\gamma }_{2,p}z)}^{\frac{1}{2}}}{\exp }\{-\frac{{(t-{\gamma }_{1,p}z)}^{2}}{2({\tau }^{2}+i{\gamma }_{2,p}z)}\}.$$\end{document}$ It can be seen, that the first term in (26) is the sum of the intensities of the modes and contains only the group velocities of the modes, while the second term, representing the interference of the modes, includes both the phase $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{ph}=\frac{1}{{\gamma }_{0,p}}$$\end{document}$ and group $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{g}=\frac{1}{{\gamma }_{1,p}}$$\end{document}$ velocities. This observation indicates that only the second term is responsible for the superluminal effect that occurs due to the interference between modes. If the integration of intensity across the entire cross-section is taken, then the power (total intensity) *P*(*z*, *t*) is determined by$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$P(z,t)=\langle I(\rho ,z,t)\rangle =\frac{1}{2\pi }\sum (\frac{{|{c}_{pl}|}^{2}}{b}){\exp }\{-\frac{{(t-{\gamma }_{1,p}z)}^{2}}{{b}^{2}{\tau }^{2}}\},$$\end{document}$$where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$b={(1+\frac{{\gamma }_{2,p}^{2}{z}^{2}}{{\tau }^{4}})}^{\frac{1}{2}}.$$\end{document}$ The cross-terms in (26) describing the interference between different modes become zero due to the orthogonality condition (13). Consequently, the mode intensity components in (27) reach their maximum values, when $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t=z{\gamma }_{1,p}=\frac{z}{{v}_{g}}$$\end{document}$, i.e., only the subluminal propagation can be observed by measuring the total intensity over the entire beam cross-section. This result means that the observation of superluminal or subluminal behaviour depends on the method of measurement, i.e., the aperture size of the receiving antenna (the detector). The pulse velocity at a given point can be determined from Eq. ([26](#Equ26){ref-type=""}). It follows from (26) that both the group and phase velocities of the modes contribute to the resulting speed of the pulse. The average time of arrival of the centre of gravity of the total beam can be calculated analytically: $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${T}_{ar}^{tot}=\langle t\rangle =\mathop{\sum }\limits_{p=1}^{N}{|{c}_{pl}|}^{2}{\gamma }_{1,p}z$$\end{document}$. The velocity of the centre of gravity of the total beam is given by $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{c.g.}^{tot}=z/\langle t\rangle $$\end{document}$, where $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\gamma }_{1,p}$$\end{document}$ is determined by the group velocities of the modes, and hence $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${v}_{c.g.}^{tot} < c$$\end{document}$. It is clear that this velocity depends on the parameters of the incident pulse beam and remains constant during propagation. The average width of pulses changes during propagation. The modal dispersion of the pulse beam, defined as $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\sigma }_{\tau }^{2}=\langle {(\varDelta t)}^{2}\rangle =\langle {t}^{2}\rangle -{\langle t\rangle }^{2}$$\end{document}$, is given by$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\sigma }_{\tau }^{2}=\mathop{\sum }\limits_{p=1}^{N}{|{c}_{pl}|}^{2}({\gamma }_{1,p}^{2}{z}^{2}+\frac{{\tau }^{2}}{2}+\frac{{\gamma }_{2,p}^{2}{z}^{2}}{(2{\tau }^{2})})-{(\mathop{\sum }\limits_{p=1}^{N}{|{c}_{pl}|}^{2}{\gamma }_{1,p}z)}^{2}.$$\end{document}$$ Thus, the pulse width increases with the propagation distance depending on the group velocities, the dispersion of the group velocities, and the pulse duration. Conclusions {#Sec5} =========== Thus, the theoretical analysis of the nonparaxial propagation of localized wave packets in free space on the basis of the wave approach is carried out. Fourier-Bessel modes with azimuthal and radial indices are proposed to describe the nonparaxial propagation of arbitrary pulse beams in free space. The modal approach is shown to provide clear physical insight into the subluminal and superluminal behaviours of arbitrary pulsed beams in free space, which arise from the interference of modes and depend on the parameters of the pulsed beam, the aperture of the measuring system and the range of the propagation distance. The velocities for the pulse amplitude, pulse centre of gravity, and pulse energy flow are considered for Gaussian, Bessel-Gauss, and Laguerre-Gauss pulsed beams. The importance of the measurement method in the observation of the superluminal effect is emphasized. Usually the spatial dimensions of receivers are smaller than the transverse beam sizes. This indicates that the interference terms (second term in Eq. ([26](#Equ26){ref-type=""})) will contribute to the velocity of the pulse beam in the measurements. The second term in Eq. ([26](#Equ26){ref-type=""}), representing the interference of the modes, includes both the phase and group velocities of modes. The phase velocities *v*~*ph*~ \> *c* (see Eq. ([19](#Equ19){ref-type=""})). This indicates that only the second term is responsible for the superluminal effect that occurs due to interference between modes. Thus, superluminal propagation occurs due to interference between spatial modes, and its observation is possible if only a part of the beam cross-section is recorded. It is shown that the pulse beam propagates in free space with variable velocity along the axis. This observation indicates that the average propagation velocity of a pulsed beam with specified initial parameters (pulse duration, beam radius, OAM, and frequency spectrum) depends on the distance between the source and the receiver. The change in propagation velocity along the axis with distance is due to the interference of the propagating modes; hence, superluminal and subliminal behaviours can be observed along the propagation axis. It is shown that the on-axis velocity varies with distance, approaching the fundamental value of *c* at large distances. The velocity of the spatially averaged total pulsed beam is defined by Eq. ([27](#Equ27){ref-type=""}). It is clear that the modal intensity components in Eq. ([27](#Equ27){ref-type=""}) reach their maximum values, when $\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t=\frac{z}{{v}_{g}}$$\end{document}$, i.e., only the subluminal propagation can be observed by measuring the total intensity over the entire beam cross-section. Simulations showed that the velocity of the total pulsed beam is always less than the velocity of the plane wave *c* and remains constant during propagation. As follows from Eqs. ([26](#Equ26){ref-type=""}) and ([27](#Equ27){ref-type=""}), this is true for incident pulsed beams with arbitrary transverse distribution. A similar result was demonstrated in^[@CR45]^ for the Bessel-Gauss pulses using the concept of a spatially averaged group velocity^[@CR22]^ and in^[@CR58]^ for the Gaussian, Bessel-Gauss and Laguerre-Gauss pulsed beams using a rigorous modal approach. Although the local on-axis velocity of the pulse may be higher than *c*, the average velocity, which is estimated from the arrival time of the pulse at *z* \> *l*~*d*~, is less than *c*. The obtained results do not contradict the experimental data on the observation of superluminal and subluminal effects. The slowing down of the speed of propagation with the decrease in the spatial dimensions of the incident pulsed beam is shown. This phenomenon can be used, for example, in all-optical switching using slow light^[@CR59]^. In conclusion, the effect of inconstancy of the pulse beam propagation velocity with distance arises due to the interference of propagating modes; thus, it is possible to observe superluminal and subliminal behaviours. It is shown that the observation of superluminal propagation is possible if only an axial part of the beam cross-section is recorded. Although the decrease in the speed of light for paraxial beams is hardly noticeable, it should be taken into account when accurate distance determination is required. These results are particularly important in applications such as time-of-flight measurements, radio and satellite communications, free-space optical communication, astrophysics, and in quantum information and gravitational wave experiments. **Publisher's note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This work is funded by the Russian Science Foundation (RSF) (17-19-01461). N.I. Petrov contributed to this work. The authors declare no competing interests.

Background ========== Neurofibromatosis type 1 (NF-1) is one of the most common genetic disorders, affecting between 1 in 3000 to 3500 individuals \[[@B1],[@B2]\]. NF-1 is caused by defect in the gene responsible for the production of the protein neurofibromin, a tumor suppressor gene linked to the long arm of chromosome 17 \[[@B3]\]. Inheritance is autosomal dominant, although about 50% of cases develop sporadically as new mutations \[[@B2]\]. The clinical diagnosis is made according to the diagnostic criteria established by the National Institute of Health Consensus Development Conference in 1987 \[[@B4]\]. When a neurological deficit is present in the spine in a patient with a neurofibromatosis, the cause should accurately be defined to prevent serious complications that may be related to spinal deformity or structural instability \[[@B5]-[@B7]\]. Evaluation of patients with NF-1 has routinely been performed with plain film radiographs and MRI \[[@B5],[@B8]-[@B12]\]. However, computed tomography (CT) has recently been described for the assessment of an abnormal spinal curvature \[[@B13]-[@B20]\]. Advances in multidetector CT (MDCT) technology allow computer manipulation of the axial CT source data and generation of orthogonal two-dimensional (2D) images and three-dimensional (3D) volume rendered (VR) images. These VR images demonstrate the surface of the vertebral body, and a translucent display allows visualization of surgical instrumentation through the vertebral bodies. The VR images, which do not require additional radiation, can be rotated and viewed from 360 degrees, have led to an increased demand for MDCT imaging of the spine at our institution, a major cancer center. In fact, MDCT is now the standard of care for assessing the spine in patients with trauma in many emergency departments \[[@B21],[@B22]\]. To the best of our knowledge, no reports exist in the literature on the use of MDCT with the VR series, including the translucent display, for evaluation of the spine in patients with NF-1. As additional time for processing and interpretation of the 3D VR images are required, we sought to determine which characteristics would be best assessed by MDCT with the 3-D VR images. To do this, we compared MDCT with the VR series to plain radiographs and MRI, as well as MDCT to the VR images of the spine in patients with NF-1. The purpose was not to test which of the aforementioned modalities best evaluates certain abnormalities compared to MDCT, rather to determine where MDCT and the VR images may provide the most information, thus benefiting this patient population. Methods ======= The Institutional Review Board at The University of Texas MD Anderson Cancer Center approved this study and waived the requirement for informed consent. Data acquisition was performed in compliance with all applicable Health Insurance Portability and Accountability Act regulations. MDCT examinations of the spine, performed at our institution between 2003 and 2013, were retrospectively reviewed. Inclusion criteria for this study included patients with NF-1 for whom MDCT was requested. Plain radiographs, MR examinations, and MDCT examinations, including with sagittal and coronal reformatted, and VR images were retrospectively reviewed by 3 neuroradiologists (JMD, LK and NGT) by consensus. The reviewers evaluated abnormalities on the studies to determine if MDCT with the VR images demonstrated findings better than on plain films and MR in the following categories: A) bony abnormalities such as remodeling from dural ectasia, dysplasia, and fusion, B) abnormal spinal curvature, C) nerve sheath tumors, and D) instrumentation. In addition, MDCT was compared to the VR images in the aforementioned 4 categories. The MR examinations included the following parameters: sagittal T1-weighted (TR, 400--650 ms; TE, 9--19 ms) and fast spin echo (FSE) T2- weighted (TR, 3000--6100; TE, 90--110 ms), axial T1 pre-gadolinium (TR, 350--850 ms; TE 9--14 ms), axial T1 post gadolinium (TR 400-750ms; TE 9-19ms) and sagittal T1 post gadolinium (TR 400--800; TE 9-18ms). Axial imaging was acquired at 4--5 mm section thickness with section gap of 1 mm and sagittal imaging was acquired at a slice thickness of 5--8 mm with section gap of 1--2 mm and. Intravenous gadolinium (Omniscan, GE Medical Systems) was administrated in all cases. The MDCT examination was performed on a multidetector CT scanner (GE Medical Systems), with the following parameters: 140 kV, 220 to 250 mA, and a 1.25-mm slice thickness. Post-processing was performed by a trained technologist on an Advantage AW4.2 workstation (GE Medical Systems) using Volume View software (GE Medical Systems). The MDCT scans were acquired without, or without and with intravenous contrast (Optiray, Mallinckrodt Inc., St. Louis, MO). Bone algorithm and soft tissue windows were available and reviewed in all cases. The post-processing provided imaging in the sagittal and coronal planes in all patients. The 3-D VR images with translucent display was available for patients with surgical instrumentation. Results ======= Seventy-three consecutive patients (52 female, 21 male), age 7--81 years (median age 38 years ± 15.3 years) with NF-1 and MDCT imaging of the spine were identified and included in this study. The patient demographics are included in Table [1](#T1){ref-type="table"}. ###### Patient demographics and associated abnormality **Patient \#** **Age** **Sex** **Abnormality** ---------------- --------- --------- ------------------------------------------------------------- 1 19 F Neurofibrosarcoma 2 14 F Neurofibrosarcoma 3 70 F nst 4 30 M nst, rib abnormalities 5 42 M None 6 44 F nst, instrumentation 7 44 F nst, instrumentation 8 37 F nst 9 32 F nst 10 24 F Scoliosis 11 55 F Scoliosis 12 43 M Scoliosis, instrumentation 13 12 M Scoliosis, nst 14 63 F Scoliosis, nst 15 18 F Scoliosis, nst 16 38 F Bony fusion, dural ectasia, nst, scoliosis, instrumentation 17 36 F Bony fusion, dural ectasia, scoliosis, instrumentation 18 42 F Dural ectasia, scoliosis 19 20 F Dural ectasia, wedge deformity, scoliosis, nst 20 20 F Scoliosis, instrumentation 21 20 F Scoliosis, instrumentation 22 16 M nst 23 29 F Bone dysplasia, scoliosis 24 54 F Bone dysplasia, scoliosis 25 44 F Scoliosis, instrumentation 26 40 F Bone fusion, scoliosis 27 55 F None 28 39 F Instrumentation 29 56 F Scoliosis, instrumentation 30 63 M Instrumentation 31 30 F Bone fusion, scoliosis 32 38 F Post laminectomy 33 27 F Post laminectomy 34 81 F Scoliosis 35 20 F Bone fusion, scoliosis, instrumentation 36 29 F Scoliosis, instrumentation 37 24 F Scoliosis 38 28 M Post laminectomy 39 56 F Instrumentation 40 19 F nst 41 27 M Instrumentation 42 53 F None 43 47 M Post laminectomy 44 28 M nst 45 16 F Instrumentation 46 54 F Bone dysplasia, scoliosis 47 28 F Instrumentation 48 38 M Soft tissue sarcoma 49 23 M Instrumentation 50 40 F nst 51 49 F Instrumentation 52 31 F None 53 20 M nst 54 26 M Scoliosis 55 48 M nst 56 39 F Scoliosis, instrumentation 57 49 F Instrumentation 58 45 M None 59 45 F None 60 53 M Instrumentation 61 39 M Scoliosis 62 51 F Scoliosis 63 28 F Instrumentation 64 27 F Scoliosis, instrumentation 65 22 F Instrumentation 66 43 F Instrumentation 67 49 F Instrumentation 68 47 M Scoliosis 69 7 M Instrumentation 70 13 F Instrumentation 71 38 M nst 72 45 F Scoliosis 73 9 F Scoliosis nst: nerve sheath tumor. Two-view plain radiographs of the spine were also obtained in 24 patients between 0 and 132 days (median 0 days ± 26.3 days) to when the MDCT study was performed. When compared to plain radiographs, the MDCT and VR images were rated as better in the evaluation of findings in 19 of 24 patients for a total of 30 findings. This included the following categories A) bony abnormalities (n = 6), B) abnormal spinal curvature (n = 5), C) nerve sheath tumors (n = 7), and D) instrumentation (n = 12). More specific information is available in the Table [2](#T2){ref-type="table"}. ###### MDCT/VR added to plain radiographs **Patient \#** **CT/VR additional findings** ---------------- --------------------------------------------------- 1 Vertebral body and transverse process destruction 2 Sacral destruction, nst 3 nst 7 nst, instrumentation 12 Scoliosis, instrumentation 13 nst 16 Dural ectasia, bony fusion, scoliosis,   nst, instrumentation 17 Dural ectasia, bony fusion,   Scoliosis, instrumentation 22 nst 24 Bone dysplasia, scoliosis 25 Scoliosis, instrumentation 28 Instrumentation 30 Instrumentation 41 Instrumentation 47 Instrumentation 48 Soft tissue sarcoma 49 Instrumentation 60 Instrumentation 63 Instrumentation nst: nerve sheath tumor. MR examinations were performed in 36 patients between 1 and 183 days (median 0 days ± 29.3 days) in relation to when the MDCT examinations were acquired. The MDCT and VR study was better than MR in evaluating the findings of NF-1 in 24 of 36 patients for a total of 40 findings, including the following categories A) bony abnormalities (n = 12), B) abnormal spinal curvature (n = 10), C) nerve sheath tumors (n = 3), and D) instrumentation (n = 15). More specific information is available in the Table [3](#T3){ref-type="table"}. ###### MDCT/VR added to MRI **Patient \#** **CT/VR additional findings** ---------------- ------------------------------------------- 1 Vertebral body and transverse   Process destruction 4 Ribbon ribs 6 nst, instrumentation 11 Scoliosis 12 Scoliosis, instrumentation 13 Transverse process destruction, nst 16 Bony fusion, dural ectasia   Scoliosis, instrumentation 17 Bony fusion, dural ectasia   Scoliosis, instrumentation 18 Dural ectasia, scoliosis 19 Dural ectasia, wedge deformity, scoliosis 22 nst 24 Bone dysplasia, scoliosis 25 Scoliosis, instrumentation 28 Instrumentation 45 Instrumentation 46 Bone dysplasia, scoliosis 47 Instrumentation 49 Instrumentation 51 Instrumentation 57 Instrumentation 60 Instrumentation 63 Instrumentation 64 Scoliosis, instrumentation 66 Instrumentation nst: nerve sheath tumor. When the VR images were compared to the orthogonal MDCT in all 73 patients, it was rated as helpful in 41 of 73 patients for a total of 60 findings, including the following categories: A: bony abnormalities (n = 11), B: abnormal spinal curvature (n = 24), C: nerve sheath tumors (n = 0), and D) instrumentation (n = 25). More specific information is available in the accompanying Table [4](#T4){ref-type="table"}. ###### Volume rendered series added to MDCT **Patient \#** **VR additional information** ---------------- -------------------------------- 1 Transverse process destruction 10 Scoliosis 11 Scoliosis 12 Scoliosis, instrumentation 13 Transverse process destruction   Scoliosis 15 Scoliosis 16 Bony fusion, dural ectasia   Scoliosis, instrumentation 17 Bony fusion, dural ectasia   Scoliosis, instrumentation 18 Scoliosis 19 Wedge deformity, scoliosis 24 Scoliosis 25 Scoliosis, instrumentation 26 Bony fusion, scoliosis 28 Instrumentation 29 Scoliosis, instrumentation 30 Instrumentation 31 Bone fusion, scoliosis 33 Post laminectomy 35 Bone fusion, scoliosis   Instrumentation 36 Scoliosis, instrumentation 41 Instrumentation 45 Instrumentation 46 Bone dysplasia, scoliosis 47 Instrumentation 49 Instrumentation 51 Instrumentation 56 Scoliosis, instrumentation 57 Instrumentation 60 Instrumentation 61 Scoliosis 62 Scoliosis 63 Instrumentation 64 Scoliosis, instrumentation 65 Instrumentation 66 Instrumentation 67 Instrumentation 68 Scoliosis 69 Instrumentation 70 Instrumentation 72 Scoliosis 73 Scoliosis Discussion ========== Our results demonstrated that more information can be obtained when MDCT is performed in addition to plain radiographs and MRI in patients with NF-1. Furthermore, our results show that the VR images provide additional information to that of MDCT alone. We found MDCT and the VR images to be particularly beneficial, in the evaluation of bony abnormalities such as remodeling from dural ectasia, bone dysplasia and fusion, abnormal spinal curvature, and spinal instrumentation, but less so for nerve sheath tumors. Dural ectasia, a characteristic finding of NF-1, is an expansion of the thecal sac, which may result in posterior vertebral body scalloping and lateral thoracic meningocele formation. Widening of the spinal canal and enlargement of the neural foramen is often associated with dural ectasia \[[@B7],[@B8],[@B23],[@B24]\]. Destabilization of the vertebrae may also occur, leading to spontaneous subluxation or dislocation \[[@B25],[@B26]\]. Spinal meningoceles, which are observed in 60-85% of patients with NF-1 can cause headache, coughing, dyspnea, sometimes with back pain with or without motor and sensory symptoms and should be treated surgically when possible \[[@B27]-[@B29]\]. MDCT and VR were particularly useful in evaluating these bony abnormalities. This included bony dysplasia in all cases with plain radiographs and MRI, and in 2 of 4 cases when VR was compared to MDCT (Figure [1](#F1){ref-type="fig"}). This related to better definition of the bony structures with MDCT, thinner section imaging in the coronal and sagittal planes, and the VR images that allowed a compete view of the spine on 1 image, and rotation of the images allowing visualization from 360 degrees. {#F1} Spinal deformities associated with NF-1 may be dystrophic or nondystrophic \[[@B8],[@B9],[@B30],[@B31]\]. Although non-dystrophic deformities resemble idiopathic scoliosis, progression to the dystrophic form can occur, and careful follow up is necessary \[[@B9],[@B32]\]. Features of dystrophic deformities include vertebral scalloping, rib penciling and spindling of the transverse process, wedging of one or more vertebral bodies, paraspinal or intraspinal soft tissue masses, subluxed or displaced vertebral bodies, frame enlargement and defective pedicles \[[@B3],[@B5]\]. Dystrophic spinal deformities may exhibit severe angulations and rapid progression \[[@B7],[@B9],[@B31],[@B33],[@B34]\]. As a general rule, the more severe the dystrophic changes identified in the vertebral bodies, the higher the likelihood that the scoliotic curvature will deteriorate. Surgical management of dystrophic spinal neurofibromatosis deformities requires an early and aggressive approach \[[@B17],[@B34]-[@B37]\] and is a demanding procedure \[[@B5],[@B35],[@B38],[@B39]\], so precise delineation of spinal abnormalities is absolutely essential (Figure [1](#F1){ref-type="fig"}). The variable and sometimes rapid progressive course of dystrophic scoliosis in children with NF-1 complicates management \[[@B8]\]. In our study, the MDCT study was helpful in all cases for the evaluation of bony dysplasia and fusion, especially in patients with scoliosis. The separation of NF-1 associated scoliosis into dystrophic and nondystrophic curves is made with plain radiographs and may suffer from the inability of such imaging to identify early bone changes \[[@B9]\]. If dystrophic changes are noted on plain radiographs, MRI has been considered essential to further investigate the intraspinal contents, particularly when surgical management of scoliosis is anticipated \[[@B5],[@B6]\]. However, the interpretation of MRI findings is difficult, because of the complex three plane deformity of kyphoscoliotic curvatures \[[@B5],[@B35]\]. In our series, MDCT with VR was helpful in 5 of 7 patients with an abnormal spinal curvature compared to plain radiographs, and in 10 of 11 cases when compared to MRI. In addition, the VR images were graded as helpful in 24 of 31 patients with an abnormal spinal curvature when compared to the MDCT study alone. We found the VR images to be most helpful in the evaluation of a complex spinal curvature, as the entire spine is visualized on a single image that can be rotated to allow visualization from 360 degrees (Figure [1](#F1){ref-type="fig"}C, D). The VR images are less helpful if the abnormal curvature is not complex and does not extend out of the sagittal or coronal plane. Although the risk of malignant transformation is low, estimated to be about 2-6%, \[[@B40],[@B41]\] this has been described as a major element in the natural history of NF-1 \[[@B42]\]. It is believed that most malignant peripheral nerve sheath tumors arise from plexiform neurofibromas and the most common age of presentation is 20--50 years old \[[@B5],[@B41],[@B43]\]. The goal is to achieve complete removal of the tumor whenever it is safe to do so, because the recurrence rate is high in partially resected tumors \[[@B23]\]. MDCT and the VR images may be performed in patients with both benign and malignant nerve sheath tumors to assess for bone destruction, which, while not diagnostic, is suggestive of a malignant lesion \[[@B44]\] (Figure [2](#F2){ref-type="fig"}). In our study, we found the MDCT studies to be helpful in the evaluation of bone remodeling and destruction related to nerve sheath tumors. For assessment of the nerve sheath tumor, the MDCT study demonstrated nerve sheath tumors better than plain radiographs, however, MDCT was only of benefit when compared to MRI for large lesions that were outside of the field of view on MRI. {#F2} Postoperatively, because of a high incidence of failure of fusion, some authors recommend routine tomographic evaluations 6 months after spinal surgery and a direct augmentation procedure if evidence of failure is present \[[@B28],[@B39]\]. Our results suggest that MDCT imaging, especially utilizing the VR images with translucent display (Figure [3](#F3){ref-type="fig"}), is well suited for the evaluation of the post-operative spine in patients with NF-1. This is because the surgical instrumentation and adjacent bony structures are better visualized due to a significant reduction in streak artifact related to metallic hardware \[[@B45],[@B46]\], a particular advantage over MR imaging where there is decreased visualization of the metallic construct and the osseous structures (Figure [3](#F3){ref-type="fig"}). This is maybe helpful in the evaluation of instrumentation failure, including loosening and breakage. In 24 of 31 patients with surgical instrumentation, the VR images with translucent display aided the MDCT in evaluation of the surgical construct. The VR images were helpful if the instrumentation extended over multiple vertebral body levels, but less helpful for shorter segment instrumentation, such as 2-level anterior cervical fusion. {#F3} The patients in our series represent a small portion of all patients with NF-1 seen at our institution. MDCT imaging is not performed in all patients, mostly in patients with more severe forms of scoliosis and spinal dysplasia and when clinical symptoms require further imaging. Therefore, our results may have a selection bias and may appear to exaggerate the benefit of MDCT in this patient population. However, we have demonstrated areas where MDCT is beneficial in the evaluation of abnormalities related to NF-1, including bony abnormalities such as dural ectasia, fusion, and dysplasia, abnormal spinal curvature, and spinal instrumentation. The MDCT study has higher costs than plain radiographs; however, we have demonstrated the benefit of MDCT and VR images over plain radiographs for patients with NF-1 in the evaluation of bony abnormalities, scoliosis, and the assessment of surgical instrumentation. Further studies, including cost-benefit analysis, may be undertaken to help determine the exact role of this technique for this patient population. There may be an increased risk of tumor transformation due to radiation from the MDCT studies. However, we feel that the risks are outweighed by the benefits to patients with NF-1, as MDCT provides additional information in the evaluation of the spine in assessment of the aforementioned abnormalities. Failure to obtain a complete evaluation of the spine in patients with complex abnormalities may prove detrimental in surgical planning and following spinal instrumentation. As previously stated, the VR images, which provide additional information over the MDCT study alone, are generated by computer manipulation of the axial raw without the need for additional radiation to the patient. Efforts are currently undergoing to further reduce the MDCT radiation dose \[[@B47],[@B48]\]. Herein, we have sought to illustrate the use of MDCT imaging of the spine in patients with NF-1 and demonstrate the role of MDCT to MR imaging in this setting and its role as a complementary examination. Further studies may be undertaken with larger number of the assessed abnormalities, to determine the exact role of MDCT and alternate imaging modalities in patients with NF-1, and this study may serve as the basis for those studies. In addition, evaluation of MDCT imaging may provide an opportunity for further research to refine understanding of scoliosis in patients with NF-1. Conclusion ========== MDCT with VR is beneficial for the evaluation of the spine in patients with NF-1. Bony abnormalities, abnormal spinal curvature, and surgical instrumentation are particularly well demonstrated with the VR images. These abnormalities may be severe and associated with significant consequences if not appropriately addressed. Accurate imaging is essential in the evaluation of these patients with complex anatomy for diagnostic purposes and pre-operative and post-operative assessment. Abbreviations ============= NF-1: Neurofibromatosis type 1; CT: Computed tomography; MDCT: Multidetector CT; 2D: Two-dimensional; 3D: Three-dimensional; VR: Volume rendered. Competing interests =================== The authors declare that they have no competing interests. Authors' contributions ====================== JMD conceived of the study, participated in its design and coordination, and helped to draft the manuscript. YMMM participated in its design and coordination, and helped to draft the manuscript. LK conceived of the study, participated in its design and coordination, and helped to draft the manuscript. JMS participated in its design and coordination, and helped to draft the manuscript. IEM participated in its design and coordination, and helped to draft the manuscript. NGT conceived of the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

\section*{Abstract} In this work we develop an innovative hierarchical clustering method to divide a sample of undirected weighted networks into groups. The methodology consists of two phases: the first phase is aimed at putting the single networks in a broader framework by including the characteristics of the population in the data, while the second phase creates a subdivision of the sample on the basis of the similarity between the community structures of the processed networks. Starting from the representation of the team's playing style as a network, we apply the method to group the Italian Serie A teams' performances and consequently detect the main 15 tactics shown during the 2015-2016 season. The information obtained is used to verify the effect of the styles of play on the number of goals scored, and we prove the key role of one of them by implementing an extension of the Dixon and Coles model \citep{dixon1997modelling}. \section{Introduction} In recent years the exponential growth of available data and the progressive opening up to 'statistical culture' by football operators have led to the development of several studies in this field \citep{anderson2013numbers}. The unique nature of association football means that simple statistics do not allow a detailed measurement of team performances: in fact, the signal contained in the data is hardly extractable since many accidental events may increase the noise, especially if data consist only of low counts such as the number of goals scored during the match \citep{pena2012network}. As a consequence, the \emph{playing style} (or \emph{tactic}) is certainly an element of primary importance in this sport \citep{pena2015can}. Generally speaking, it is possible to define it as a combination of two different aspects: the \textit{offensive} playing style, defined as the way a team moves the ball on the pitch, and the \textit{defensive} playing style, defined as the way a team defends against the way the opposing team moves the ball on the pitch. In this work we focus on the former, and so later in the discussion the term 'playing style' will be used only to refer to the offensive playing style. Over time, some studies have addressed this issue: for example, \citet{hughes2005analysis} compare the length of passing sequences, \citet{gyarmati2014searching} analyse the passing structures to find similarities and differences between teams, \citet{cintia2015harsh} and \citet{cintia2015network} propose a pass-based performance indicator to predict the outcome of the matches and \citet{pena2014markovian} studies the possession by using a Markov process. In statistical terms, the playing style could be adequately represented by a weighted network \citep{brandt2015graph, clemente2015social}. Most of the papers in this field consider a team's players as nodes and the passes between them as edges to extract information on the tactics \citep{pena2012network, clemente2015using, pina2017network}. Unfortunately, this formulation makes comparisons between different playing styles not immediate as the players vary from squad to squad. In view of this, this paper considers networks whose nodes are different areas of the pitch and whose edges describe the movements of the ball between these areas; in so doing the playing styles are properly summarised and it is also possible to make comparisons because the pitch is obviously shared between the teams. The aim of the paper is to group the networks in order to compare the different styles played by football teams during the season. In order to do this, we propose a novel clustering method for network data, the aim of which is to divide the $n$ weighted networks into clusters according to a specific criterion. The authors are not aware of specific methods to detect clusters of networks, although some models \citep[e.g., the bayesian model proposed by][for binary networks]{durante2016nonparametric} can be applied for this purpose, so the present paper suggests an initial proposal in this field of research. In this scenario, a couple of aspects should be considered: the network is, in fact, a set of connected nodes, but also a unit drawn from a more general population of networks. In view of the above, after the preprocessing phase that puts the networks in a sample framework, the method defines the similarity between networks on the basis of the similarity between community structures detected by the Louvain method \citep{blondel2008fast}. The methodology has a hierarchical agglomerative structure: from the initial situation in which each unit is assigned to a separate group, the process creates a sequence of nested subdivisions of data. The method, by clustering the performances of the teams as networks, identifies the main styles of play, and this information is used to verify whether and how a team's playing style affects the number of goals scored by implementing an extension of the Dixon and Coles model \citep{dixon1997modelling}. The paper is organised as follows: in Section 2 we create the networks from the available data; in Section 3 the clustering method is developed; in Section 4 the method is applied to the analysis of tactics and in Section 5 an overview of the main results is provided. \section{Data} \label{sectiondata} Different approaches are available to analyze association football tactics \citep{anderson2013numbers}. Among them, the representation of the playing style as a network is particularly useful \citep{pena2012network}. In this work, for each combination of match and team (i.e., for each of the two teams playing a specific match) the playing style is represented by a network whose nodes are the different areas into which the pitch is divided and whose edges describe the movements of the ball between these areas: this specification is preferable to the one that considers the players as nodes and the passes between them as edges \citep{clemente2015using} because it allows immediate comparison between different tactics since the nodes (i.e. the areas of the pitch) are shared between the teams. Specifically, we consider weighted undirected networks \citep{newman2010networks}. The first factor to consider is the shape and the number of areas $K$ identifying the different nodes. As regards the first aspect, for the sake of simplicity the areas are obtained by dividing both the length and the width of the pitch into equal segments \citep{borrie2002temporal, narizuka2014statistical}. As regards the second aspect, in a preliminary study we have compared the partitions obtained by the clustering method presented in Section \ref{sectionproposedmethodology} with various values of $K$ ($K=9$, $K=12$, $K=18$), finding deep differences between the three scenarios. This evidence represents a critical issue since we are not aware of specific information to set $K$: consequently, the choice of $K$ is based purely on subjective considerations, and we decide to choose $K=9$ because it is associated with the best known subdivision of the length of the pitch (defense zone - midfield zone - attack zone) and with the best known suddivision of the width of the pitch (right zone - central zone - left zone) The available data - provided by InStat (\url{http://instatfootball.com/}) - refer to the 380 matches of the Italian Serie A TIM 2015-2016 season; since each match is made up of two distinct networks - one for the home team and one for the away team -, the sample size is $n=760$. For each combination of match and team, the available data detect spatial coordinates $(x,y)$ of specific plays made by the team's players during the match, with the $x$ position along the horizontal axis - i.e., the length of the pitch - and the $y$ position along the vertical axis - i.e., the width of the pitch -. These plays are divided into 12 categories, which can be summarised in four macro categories: \begin{itemize \item Passes: the starting position of a pass. It includes: accurate passes, inaccurate passes, assists, accurate crosses and inaccurate crosses. \item Dribbling: the starting position of a dribble. It includes: successful dribbles and unsuccessful dribbles. \item Tackles: the position of a tackle. It includes: successful tackles, unsuccessful tackles, challenges won and challenges lost. \item Shots: the position of the shot. \end{itemize} Starting from the spatial coordinates, each play is assigned to one of the nine areas, labeled by the numbers from 1 to 9 (see Figure 1). Hence the weight of the edge linking node $i$ and node $j$ is represented by the number of pairs of consecutive plays made by the players of the team without interruption from the players of the opposing team and which take place in areas $i$ and $j$ respectively. If an event is not preceded and followed by a teammate's play, this is ignored as an isolated event; moreover, the proposed structure allows the creation of \emph{self-loops} when $i=j$. The main characteristics of the networks are summarised in Appendix A. Naturally, the networks are only an approximation of the playing styles: the data do not consider the movements of the players when in possession of the ball. As a consequence, the ball is considered to have passed only through the $i$ and $j$ areas in the time between two consecutive events which have occurred in those areas. Based purely on football considerations, one is justified in expecting the teams whose playing style is strongly characterised by the movements with the ball by the players to be different from the teams where this is more limited; the level of accuracy affecting the approximation therefore changes according to the unit considered. Nevertheless, the study of the number of plays recorded by our data during the season is informative with regard to this loss of information: the average number of events during the 380 matches, taking into account the effective playing time of an Italian football match \citep{Santinigoal}, is 23.96 per minute ($sd=1.62$), an amount that the authors consider satisfactory. \begin{figure} \begin{center} \includegraphics[width=1\textwidth,height=6.8cm]{IMMsuddivisionecampodacalcio.pdf} \caption{Division of the pitch into nine areas. The pitch measurements are 105 $\times$ 68 m: the areas are obtained by dividing both the length and the width of the pitch into three equal segments. The teams attack from left to right. } \label{IMMsuddivisionecampodacalcio} \end{center} \end{figure} \section{Proposed methodology} \label{sectionproposedmethodology} In this section we propose a clustering method for network data, the aim of which is to divide the $n$ undirected weighted networks into groups according to a specific criterion: the only constraint required is that the statistical units share the set of nodes $\mathcal{K}=\{k_1, k_2,\dots,k_K\}$. The procedure has a hierarchical structure: in contrast to the partitioning approach, in which at each step the statistical units are reallocated in a number of clusters fixed a priori, the hierarchical approach creates nested subdivisions of data \citep[for this and further differences see][]{kaufman1990finding}. The method is agglomerative: starting from an initial state in which the number of groups is equal to the number of networks, the algorithm continues until all the units belong to the same group. As a consequence, the partition at step $h$ can be obtained from the previous one by merging two clusters. We use an \emph{ad hoc} measure of similarity to compare the groups, and the number of clusters - if it is not known a priori - is defined by the analysis of the corresponding dendrogram. In addition, the methodology consists of two phases: the preprocessing phase, that requires the specification of a threshold, and the merging phase. A simulation study is provided in Appendix B. \subsection{Similarity between networks} \label{sectionsimilaritybetweennetworks} Focusing on a single network, the core of the cluster analysis is represented by a set of procedures known as \emph{analysis of community structure}; it is essential in many applications to detect communities of nodes with frequent connections within communities and sparse connections between communities in order to find latent relationships in the data \citep{newman2010networkscap11}. In this context, the Louvain method \citep{blondel2008fast} is certainly a widely used approach, and it represents the starting point of this paper. Focusing now on a sample of $n$ networks with $K$ shared nodes, a \emph{naive} clustering method consists of detecting the $n$ community structures and merging, step by step, the networks whose partitions are most similar. The limit of this approach is clear, since every unit is taken individually regardless of its close relationship with the rest of the data. In this scenario, a couple of aspects should be taken into account: the network is, in fact, considered on the one hand as a set of connected nodes, and on the other as a unit drawn from a more general population of networks. Regarding the latter, it is essential to stress that: \begin{itemize \item The average number of connections can vary between the networks, with some networks sparsely connected and others densely connected. \item The weight of the edges can vary within the networks. \item The weight of a specific edge can vary between the networks. As a consequence, the community structures can differ considerably. \end{itemize} In view of the above, it is first of all necessary to define the concept of \emph{similarity} between networks. The method considers the community structures detected by the Louvain method after including the population's characteristics in the units: in other words, the similarity between networks $R_{t}, R_{s}$ is determined according to the similarity of the community structures of the networks $R^{'}_{t}, R^{'}_{s}$, with the network $R^{'}$ representing appropriate processing of starting network $R$. \subsection{First phase: preprocessing of the networks} \label{firstphase} The procedure to obtain $R^{'}$ is described below. Considering the sequence of weights linked to the edge connecting nodes $i$ and $j$ in $n$ networks $w_{ij}=(w_{ij}^1,\dots,w_{ij}^n)$, we define: \begin{equation} b_{ij}=\max(w_{ij}^1,\dots,w_{ij}^n) \quad \quad a_{ij}=\min(w_{ij}^1,\dots,w_{ij}^n) \label{formulamassimominimo} \end{equation} with $i,j=1,\dots,K$ and then \emph{normalize} vector $w_{ij}$: \begin{equation} u^{t}_{ij}=\begin{cases} \frac{w_{ij}^t-a_{ij}}{b_{ij}-a_{ij}} \in [0,1] & \text{if $a_{ij} \neq b_{ij}, \quad t=1,\dots,n$}\\ 0.5 & \text{if $a_{ij} = b_{ij}, \quad t=1,\dots,n$} \end{cases} \label{normalizzazione} \end{equation} For the sake of simplicity, if $a_{ij}=b_{ij}$ the value $u^t_{ij}$ is set equal to the expected value of a random variable with continuous uniform distribution $U(0,1)$. Therefore a high value of the normalized quantity means the relationship between the pair of nodes is numerically significant compared to that observed in the other units, while a low value means the relationship is numerically inferior to the others. The decision to change the values of $a$ and $b$ according to the pair of nodes considered allows the distributive differences between the sequences of weights $w_{ij}$ to be included in the analysis, an essential topic which has already been discussed. Unfortunately, the normalization is functional but not comprehensive because another problem commonly arises in this context. Let us consider the following example: \begin{figure} \begin{center} \includegraphics[width=0.75\textwidth,height=6cm]{IMMproblematicalouvain.pdf} \caption{Example of problem in the application of Louvain method.} \label{IMMproblematicalouvain} \end{center} \end{figure}let $K=5$ and $R_1$ be a network in which all the normalized weights are extremely low $u_{1,l}=0.05$ except for the edge between node 1 and node 2 which weighs twice as much as the previous ones $u_{1,h}=0.10$ (see the bottom left of Figure \ref{IMMproblematicalouvain}). Let $R_2$ also be a network in which all the normalized weights are definitely higher $u_{2,l}=0.40$ and, as in $R_1$, the edge between the first two nodes weighs twice as much ($u_{2,h}=0.8$, see the up of Figure \ref{IMMproblematicalouvain}). The community structures of the two networks are identical (see the bottom right of Figure \ref{IMMproblematicalouvain}): in each case the first two nodes belong to a cluster distinct from the one containing the remaining nodes and consequently the two units have maximum similarity, assuming of course the use of a measure of similarity that assigns maximum value if the partitions are identical. However in the first case the group including nodes 1 and 2, considering the particularly low normalized quantity $u_{1,h}$, is found only because the other weights of the network are even smaller; evidently in this situation detecting this cluster is counterproductive as $u_{1,h}$ is much lower than the other connections observed in the sample between the first pair of nodes. The reason for this critical issue lies in the use of the Louvain method which, by construction, compares the edges within the network regardless of the broader framework of this paper. For this reason, a possible approach to limit the problem consists of introducing a threshold $s \in [0,1]$. Starting from the normalized weight $u_{ij}^t$ (\ref{normalizzazione}) we obtain the value $w^{ ' t}_{ij}$ defined as follows: \begin{equation} w^{ ' t}_{ij}=\begin{cases} u_{ij}^t & \text{if $u_{ij}^t > s$} \qquad t=1,\dots,n\\ 0 & \text{if $u_{ij}^t \leq s$} \qquad t=1,\dots,n \label{pesinormalizzatiSunico} \end{cases} \end{equation} Hence the processed network $R'$ has the same nodes as starting network $R$, whereas the weights are $w^{'}_{ij}$ instead of $w_{ij}$. The choice of the threshold plays a central role: indeed numerically formula (\ref{pesinormalizzatiSunico}) does not alter the weights greater than $s$, while it sets all the other ones to zero. In view of the above, on the one hand a high threshold value ensures that only the communities characterised by remarkable connections for the population are detected; on the other hand it does not discriminate between weights less than or equal to $s$. Conversely, a near-zero threshold value involves the problem of the example provided but does not involve loss of information. At the interpretative level, the two proposed adjustments - normalization first, followed by introduction of threshold - relate to two complementary and jointly necessary aspects: the aim of the former is to unify the range of observable values so as not to penalise the connections between pairs of nodes that are sparser than others due to the population's characteristics; conversely, the aim of the latter is to curb the negative implications of the Louvain method due to its application \emph{network by network}. The choice of $s$ represents the last fundamental step in the preprocessing phase. Considering the possible distributive differences between the sequences of weights $w_{ij}$, it is reasonable to vary $s$ according to the value of the couple $(i,j)$. We therefore define: \begin{equation} s_{ij}=q ( u_{ij},\alpha) \qquad \qquad i,j=1,\dots,K \label{sogliavariabile} \end{equation} with $u_{ij}=(u_{ij}^1,\dots,u_{ij}^n)$ and $q(x,\alpha)$ quantile of order $\alpha$ for $x$. Formula (\ref{sogliavariabile}) appears to be a reasonable compromise: the threshold could vary depending on the distributive characteristics of the vector $u_{ij}$ despite the specification of a single scalar $\alpha$. Formally, formula (\ref{pesinormalizzatiSunico}) is updated as follows: \begin{equation} w^{ ' t}_{ij}=\begin{cases} u_{ij}^t & \text{if $u_{ij}^t > s_{ij}$} \qquad t=1,\dots,n\\ 0 & \text{if $u_{ij}^t \leq s_{ij}$} \qquad t=1,\dots,n \end{cases} \label{pesinormalizzatiSvariabile} \end{equation} Since the cluster analysis is typically an unsupervised learning technique, frequently the choice of $\alpha$ can not be achieved by using a training set \citep[see, e.g., ][]{hastie2009elements}: as a consequence, although a simulation study (see Appendix B) may provide some useful information, the value of the threshold shall be selected on the basis of the analyst choice to place more emphasis on one of the two abovementioned aspects. \subsection{Second phase: merging phase} \label{paragrafofase2} Starting from the new networks, it is possible to detect the $n$ community structures present in the sample. As the methodology would like to create groups composed of networks with similar connections between nodes, before the application of the Louvain method the weight of every self-loop is set to zero. Indeed, two networks whose adjacency matrices share the entries outside the main diagonal could present deeply different community structures if the diagonal elements are considered, an aspect that inevitably causes undesirable effects in the reliability of the clustering method. Clearly, the interpretation of the community structures changes radically when considering the processed networks rather than the starting ones: any community denotes a relationship between nodes which is particularly surprising for the population and not necessarily identifiable by the analysis of the original units. Given the nature of the methodology, it is now possible to justify the use of undirected networks since the utilisation of directed ones does not induce improvements. Theoretically, the inclusion of the edges' direction adds useful information because the role of connection $i \rightarrow j$ is different from that of connection $j \rightarrow i$. However, the proposed method detects only the community structures that, by definition, do not have direction and therefore it cannot, by construction, capture this aspect. As a consequence, for the sake of simplicity we have considered undirected networks. The tool used to define the similarity between a pair of partitions is the Adjusted Rand Index \citep[or ARI, ][]{hubert1985comparing}, the most common corrected-for-chance version of the Rand Index \citep{rand1971objective}. By calculating this index for each pair of units it is possible to create a \emph{similarity matrix} and so to merge the groups using the UPGMA method \citep{sokal1958statistical}: the procedure ends when all the networks belong to the same cluster. The choice of the number of groups $N_G$ represents the last fundamental step in the merging phase. In this context, the evaluation of the difference between the maximum values of similarity (i.e., the maximum values of ARI) in two successive steps of the method is common practice for the hierarchical procedures \citep[see, e.g.,][]{azzalini2012data}: for example, a significant drop in similarity provides guidance that the clusters are too different to proceed with subsequent unions. Obviously, as often happens in this field, the criterion cited can be accompanied by qualititative evaluations by the analyst. \subsection{The algorithm} A brief overview of the procedure is provided in Algorithm \ref{euclid}. Let $R=\{ R_1,\dots,R_n \}$ be a sample of $n$ undirected weighted networks, with $\mathcal{K}=\{k_1, k_2,\dots,k_K\}$ the set of nodes shared between the networks. The value $w_{ij}^t$ is the weight of the edge connecting node $i$ and node $j$ in network $t$, with $t=1,\dots,n$ e $i,j=1,\dots,K$. The possible absence of connection between a couple of nodes involves a zero weight linked to that edge. Let $\alpha_0$ also be the selected value for $\alpha$. The algorithm is structured as follows: in the first phase, calculate quantity $w_{ij}^{'t}$ by the normalization of data and the introduction of the threshold (line \ref{riga1}), therefore obtain the new sample $R^{'}=\{R_1^{'},\dots,R_n^{'}\}$ (line \ref{riga2}). In the second phase, set the self-loops of the networks to zero (line \ref{riga3}), detect the community structure for every network using the Louvain method (line \ref{riga4}) and create the similarity matrix (line \ref{riga5}). Finally, two steps proceed iteratively: obtain the pair of groups with maximum similarity using the UPGMA method (if it is not unique, the pair is randomly chosen from those that maximize the ARI) and merge the pair of groups selected at the previous step (lines \ref{riga9}-\ref{riga14}). The procedure ends when all the networks belong to the same group. \begin{algorithm} \caption{Clustering method for sample of networks}\label{euclid} \begin{algorithmic}[1] \State \textbf{Start:} each network is assigned to a separate group \Procedure{First phase}{} \For { \textit{t} \text{in $1:n$}, \textit{i} \text{in $1:K$}, \textit{j} \text{in $1:K$} } $ w^{ ' t}_{ij} \gets$ Formulas (\ref{formulamassimominimo}),(\ref{normalizzazione}),(\ref{sogliavariabile}),(\ref{pesinormalizzatiSvariabile}) \label{riga1} \EndFor \State \textbf{for} \textit{t} \text{in $1:n$} \textbf{obtain} $R^{'}_{t}$ new network \label{riga2}, with $\mathcal{K}$ as set of nodes and weights $w_{ij}^{'t}$ \EndProcedure \Procedure{Second phase}{} \For { \textit{i} \text{in $1:K$} } $ w^{ ' }_{ii} \gets \textbf{0}$ \label{riga3} \EndFor \For { \textit{t} \text{in $1:n$} } $ c^{ t} \gets$ \text{community structure of $R_t^{'}$ by Louvain Method} \label{riga4} \EndFor \For { \text{$t_1$ in $1:(n-1)$}, \text{$t_2$ in $(t_1+1):n$} } $s(R^{'}_{t_1},R^{'}_{t_2}) \gets ARI(c^{t_1},c^{t_2})$ \label{riga5} \EndFor \While{number of groups $\neq 1$} \label{riga9} \If{pairs of groups with max similarity using the UPGMA method $>1$} \State select a pair of groups randomly from those that maximize the ARI \Else \{the pair of groups with max similarity is unique\} \State select it \textbf{end if} \EndIf \State Merge the pair of groups selected \textbf{end while} \label{riga14} \EndWhile \EndProcedure \end{algorithmic} \end{algorithm} \section{Analysis of playing styles} \subsection{Application of the method} The first aspect to consider in the application of the clustering method is the choice of the threshold $s$: since we do not have either a training set or external information for set $\alpha$, it is based on the balance between the two contrasting features presented in Section \ref{firstphase}. The selected value for $\alpha$ is 0.95. Such a high threshold is aimed at sacrificing strong relationships detected in the data in order to obtain community structures characterised by incredibly deep connections between nodes: in so doing, the problem related to the \emph{network by network} application of the Louvain method is considerably reduced. On the other hand, the methodology does not consider the obvious heterogeneity in the large set of values which are less than or equal to the threshold. Once the method is applied, the analysis of the dendrogram provides useful indications about the procedure: in the first phase the examination of the number of mergers with maximum similarity, i.e. the number of steps whose maximum ARI is equal to one, is informative. The value found is 519, and the corresponding partition consists of 59 clusters with more than one unit and 182 singletons. This subdivision shows all the 241 different playing styles of the Italian Serie A TIM 2015-2016 season: the following mergers group these tactics proposing clusters characterised by increasing heterogeneity. The final selection of the number of groups is based on the balance of statistical criteria and practical necessities. As explained in Section \ref{paragrafofase2}, the evaluation of the difference between the maximum values of similarity in two successive steps of the method is common practice when choosing $N_G$ which, on the other hand, should not be too high to allow the analysis of the partition obtained. In the case of 26 groups, the maximum ARI is less than 0.10 (ARI$=0.092$), a decidedly low value: as a consequence, the selected value is $N_G=15$ in order, at least, to obtain a manageable number of clusters. The detailed description of the groups is provided in Appendix C. \subsection{Modelling final scores} \label{modellingfinalscores} Modelling the final result of a football match represents a field of deep interest in sports analysis. Moving from the paper written by \citet{maher1982modelling}, several authors have proposed increasingly complex models: \citet{dixon1997modelling}, \citet{baio2010bayesian} and \citet{koopman2015dynamic} are only a few examples. The aim of this section is to verify whether and how a team's playing style affects the number of goals scored. In a preliminary study we have considered a model which is able to bring together the main features of Maher's approach and the information about playing styles, i.e. the Poisson regression with canonical link function. This simple model seems to suggest that the on-the-wings playing style (see Appendix C) affects the number of goals scored (for all the details, contact J.Diquigiovanni). This explorative model undoubtedly represents an oversimplification of the phenomenon, and it is unnecessary to focus on it: so as to verify the role of the group 15, an extension of the Dixon and Coles model is implemented as follows. Let $X_k \sim Poisson(\lambda_k)$ be the number of goals scored by the home team in match $k$ with $k=1,\dots,380$ and let $Y_k\sim Poisson(\mu_k)$ be the number of goals scored by the away team on the same occasion; therefore a home team $i$ and an away team $j$ are implicitly assigned to every match $k$ with $1 \leq i \neq j \leq 20$. For convenience, the matches are considered chronologically and the season is divided into a series of half-weekly time points. \citet{dixon1997modelling} propose the use of a `pseudolikelihood' $L_t(\alpha_i,\beta_i,\rho,\gamma; i=1,\dots,20)$ for each time point $t$, with: \begin{equation} \log(\lambda_k)=\gamma + \alpha_{i(k)} + \beta_{j(k)} \quad \quad \log(\mu_k)=\alpha_{j(k)} + \beta_{i(k)} \label{ciao1ciao2} \end{equation} and with $\gamma$ parameter which allows for the home effect, $\alpha_{i(k)}$,$\beta_{i(k)}$ parameters which measure respectively the attack and defence rates of the teams, $i(k)$, $j(k)$ indices which denote the home and away teams. So as to verify the effect of the on-the-wings playing style on the number of goals scored, the suggested adjustment is conceptually simple. Starting from equations (\ref{ciao1ciao2}) , we obtain: \begin{equation*} \log(\lambda_k)=\gamma + \alpha_{i(k)} + \beta_{j(k)} + \delta c_{i(k)} \quad \quad \log(\mu_k)=\alpha_{j(k)} + \beta_{i(k)} + \delta c_{j(k)} \label{lambdamumodificato} \end{equation*} with $c_{i(k)}=1$ if the playing style of team $i$ during match $k$ is assigned to group 15, 0 otherwise; $\delta$ effect of this tactic on the number of goals scored. In addition, for convenience, the constraint $-\sum_{i=1}^{19} \alpha_i=\alpha_{20}$ is used instead of the one used by Dixon and Coles $\sum_{i=1}^{20} \alpha_i=20$. In contrast to the original model, the time points are not homogeneously distributed over the season, but the specific day of the year on which the match $k$ takes place is considered. This adjustment is due to the fact that nowadays, unlike when Dixon and Coles carried out the study, the teams play almost every day of the week and so a more precise subdivision of the season is recommended. Since the quantity of interest is $\delta$, the inference focuses only on this parameter. Starting from the composite profile likelihood \citep[see, e.g.,][]{libropseudoveros} defined as: \begin{equation*} L_t^P(\delta)=L_t(\delta, \hat{\alpha}_{i_{\delta}},\hat{\beta}_{i_{\delta}},\hat{\rho}_{\delta},\hat{\gamma}_{\delta})=L_t(\delta,\hat{\theta}_{\delta}) \end{equation*} with $\theta=(\alpha_i,\beta_i,\rho,\gamma)$ set of nuisance parameters, it is possible to construct confidence intervals on the basis of the composite likelihood ratio statistic \citep{varin2011overview}. Let us define $\psi=(\delta,\theta)$, $u_t(\psi)=\nabla_{\psi} \log L_t(\psi)=\nabla_{\psi} l_t(\psi)$, the sensitivity matrix at time $t$ as $H_t(\psi)=E_{\psi} \{- \nabla_{\psi} u_t(\psi)\}$, the variability matrix at time $t$ as $J_t(\psi)= var_{\psi} \{ u_t(\psi)\}$, the Godambe information matrix \citep{godambe1960optimum} at time $t$ as $G_t(\psi)= H_t(\psi) J_t(\psi)^{-1} H_t(\psi)$ and with $H_t^{\delta \delta}$ ($J_t^{\delta \delta}, G_t^{\delta \delta}$ respectively) the inverse of $H_t(\psi)$ ($J_t(\psi), G_t(\psi)$ respectively) pertaining to $\delta$. Therefore according to the asymptotic result proposed by \citet{satterthwaite1946approximate}, the confidence intervals are defined as follows: \begin{equation*} \biggl\{ \delta : \frac{2 \bigl( l_t^P (\hat{\delta}) - l_t^P (\delta) \bigl)}{ (H_t^{\delta \delta})^{-1} G_t^{\delta \delta}} < \chi^2_{1;{1-\alpha}} \biggr\} \end{equation*} Since there is only one parameter of interest, the solution provided corresponds to that established by \citet{geys1999pseudolikelihood}. From a computational point of view, \citet{varin2011overview} propose the following quantities to estimate the sensitivity and variability matrix when the sample size is large: \begin{equation*} \hat{H}_t(\psi)= -\frac{1}{|A_t|} \sum_{k \in A_t} \nabla u^k (\hat{\psi}_{CL}) \quad \quad \hat{J}_t(\psi)= \frac{1}{|A_t|} \sum_{k \in A_t} u^k (\hat{\psi}_{CL}) u^k (\hat{\psi}_{CL})^T \end{equation*} with $A_t= \{ k: t_k < t \}$, $|A_t|$ cardinality of $A_t$, $u^k (\psi)$ score associated with log-likelihood term $l^k(\psi)$ such that $l_t(\psi)=\sum_{k \in A_t} l^k(\psi)$, $\hat{\psi}_{CL}$ maximum composite likelihood estimate. As a consequence, in order to have a satisfactory sample size, the confidence intervals are computed from February 14th, 2016 ($t=61$), whereas the start of the season is used to optimize the choice of the parameter $\xi$ through the procedure described by Dixon and Coles; the selected value is 0.003 and this remains constant for the whole season. In addition, the last five matches of each team are not considered since the achieving of the team goal - whether this is to survive relegation or to win the league - may involve a lack of effort affecting the performances. As a result, the confidence intervals are computed to April 17th, 2016 ($t=84$) for an overall amount of 24 distinct matchdays: note that, by construction, the progressive increase in the data considered causes a decrease in the width of the intervals, with obvious improvements in inference. Figure \ref{IMM5} \begin{figure} \begin{center} \includegraphics[width=1\textwidth,height=8.5cm]{IMMINTERVALLII} \caption{95\% confidence intervals and point estimates (horizontal dashes) for parameter $\delta$. The dashed lines divide the time points into months (February-March-April).} \label{IMM5} \end{center} \end{figure} shows the 95\% confidence intervals. The results should be approached with particular caution since the composite profile likelihoods are not independent: nevertheless, the evidence in the period considered involves fairly inferential conclusions. Indeed, all the intervals include only positive values: the on-the-wings playing style seems to affect the number of goals scored positively. While maintaining its typical oscillatory trend, the sequence of point estimates is a decreasing one: a possible explanation is that, after an initial adjustment period, the teams take technical-tactical precautions to limit this tactic, causing a decrease in its attacking efficiency. \section{Discussion} We have developed an innovative hierarchical clustering method to divide a sample of undirected weighted networks into clusters. The procedure represents a flexible solution as the choice of the threshold $s$ allows the characteristics of the population to be managed on a case-by-case basis, and so a varied set of scenarios can be properly addressed. On the other hand, the balance of the trade-off between the loss of information and the reliability of community structures is a potential limit in an unsupervised context: as illustrated through simulations, a good choice of $s$ produces great results, whereas some others adversely affect the partition. The application of the methodology to the analysis of playing styles shows decidedly interesting results: the building up of the offensive manoeuvre from the lateral zones of the field has a positive effect on the number of goals scored by a team. The high internal heterogeneity of groups - necessary to obtain a manageable number of clusters - obviously lessens the effectiveness of the approach, and consequently the effect of the tactics detected on the final outcome of a match. Unfortunately, the adjustment made to the Dixon and Coles model does not allow the final result of a game to be forecast as the teams' playing styles are available only at the end of the match. To use the proposed method in this context, we plan to construct a model to predict the tactic of a team on the basis of its previous performances; additionally, thanks to the proliferation of in-running betting, it is also possible to use the information about the playing style during the first half of the match to predict the overall tactic in a certain game. \section*{Supplementary material} \subsection*{Appendix A} The following analysis focuses on the features that may mark a generic population of networks (see Section \ref{sectionsimilaritybetweennetworks}). The first aspect to investigate is the average weight of the different units; since the Italian teams differ considerably as regards passing ability, one is justified in expecting this value to vary according to the network considered. Figure \ref{PesomediodegliarchiNUOVO} shows the kernel density estimation of the average weight according to the team's position in the standings at the end of the season. Specifically, the teams are divided into four categories, high ranking (positions 1-5), middle-high ranking (positions 6-10), middle-low ranking (positions 11-15) and low ranking (positions 16-20). The figure seems to suggest that teams with middle-high and middle-low rankings have similar distributions, whereas the top teams differ greatly from the teams in the relegation zone. Indeed, the first quintile of the rightmost distribution is greater than the ninth decile of the leftmost one. Another element of particular interest concerns the connections between the areas of the pitch: also in this case there is high heterogeneity, with an average value ranging from 0.11 - observable in the relationship between zone 3 (left defense) and zone 7 (right attack), see Figure \ref{IMMsuddivisionecampodacalcio} - to 25.59, observable in the relationship between zone 4 (left midfield) and zone 5 (central midfield). In particular, the two edges linking nodes (3,7) and (1,9) - left defense/right attack and right defense/left attack respectively - present a highly asymmetrical distribution of weights: in addition to the inflation of zero (91\% and 89\% respectively), they are characterised by the minimum variance (0.12 and 0.15 respectively) and the lowest maximum value, i.e. three. This evidence is not completely surprising as the nodes involved refer to areas diametrically opposed on the pitch: the almost complete absence of connections suggests that the ones which were detected are accidental and fully assimilable to the long passes which ended up off the pitch (and so were not counted). As a consequence, in the application of the clustering method all the weights of the abovementioned edges are set to zero in order not to modify the community structures on the basis of fortuitous events. \begin{figure} \begin{center} \includegraphics[width=\textwidth,height=7.5cm]{PesomediodegliarchiNUOVO} \caption{Kernel density estimation of the average weight of the edges for high ranking teams (black line), middle-high ranking teams (red line), middle-low ranking teams (blue line) and low ranking teams (green line). The dashed lines display the medians, while the continuous lines display the first quintile (black line) and the ninth decile (green line) of the respective distributions.} \label{PesomediodegliarchiNUOVO} \end{center} \end{figure} The graphical-descriptive analysis can be also informative with regard to a question of vital importance concerning the utility of the proposed methodology: the approach described in Section \ref{sectionproposedmethodology} requires a preprocessing phase aimed at managing the characteristics of the sample which, if it is of little use, represents a meaningless complication compared to a simpler comparison between the community structures of the starting networks. Let's consider two contrasting teams as regards the quality of ball possession: Napoli and Frosinone. The former showed incredibly dense possession as evidenced by the maximum value for the median, third quartile and maximum concerning the average number of connections between nodes during a match. On the other hand the latter, who were dramatically relegated to Serie B ConTe.it at the end of the season, showed sporadic possession as evidenced by the minimum value for the first quartile, mean, median and third quartile concerning the same quantity. For each of the 38 matches played by each of the two teams, it is possible to calculate the ratio of a specific edge's weight to the overall weight of the network in order to find differences between the two teams without considering the overall number of connections. By comparing the average values of these quantities between the two teams, it is noticeable that 10 of the 11 edges with the lowest relative weight - accounting for 1.52\% and 3.57\% respectively of Napoli's and Frosinone's overall weight - are common to the two teams, as are 10 of the 11 connections with the highest relative weight - accounting for 74.28\% and 70.26\% respectively -. Table \ref{zonepiumenocollegate} summarises this evidence. In view of the above, there is a clear consideration to be made: the directions in which the playing styles are mainly developed are shared by the teams due to the football-specific dynamics, i.e. in statistical terms due to the characteristics of the population studied. As a consequence, a clustering method considering the broader framework in which the single network is placed is strongly recommended. \begin{table} [ \centering \begin{tabular}{r r r | r r r} \hline $\downarrow$ Edge & \% Napoli & \% Frosinone & $\uparrow$ Edge & \% Napoli & \% Frosinone\\ \hline (4,1) & - &0.404 & (5,4)&14.78&7.48\\ (9,6) & 0.410 &0.373& (6,5)&10.77&6.81\\ (9,3) & 0.207 &0.446& (9,4)&9.53&7.05\\ (6,3) & 0.207&0.287& (7,6)&6.31&7.28\\ (9,2) & 0.191 &0.454& (4,3)&6.13&6.79\\ (8,2) & 0.122 &-& (3,2)&5.15&6.96\\ (7,2) & 0.098 &0.455& (6,1)&4.79&5.97\\ (7,1) & 0.082&0.365& (9,8)&4.65&-\\ (8,3) & 0.074 & 0.201& (5,2)&4.37&6.97\\ (9,1) & 0.051 &0.157& (2,1)&3.97&5.85\\ (8,1) & 0.039 &0.267& (8,7)&3.83&4.47\\ (7,3) & 0.036 & 0.160 & (6,2)&-&4.63\\ \hline Total & 1.52 &3.57&Total&74.28&70.26\\ \end{tabular} \caption{Labels and relative weights of the edges with the lowest and highest relative weight for Napoli and Frosinone. } \label{zonepiumenocollegate} \end{table} \subsection*{Appendix B} The following brief simulation study is aimed at evaluating the suitability of the proposed clustering method. In particular, the impact of the value chosen for $\alpha$ on the reliability of the methodology is analyzed. Moreover, the results are compared to those obtained by an alternative approach. \textbf{Scenarios} Let $R=\{ R_1,\dots,R_n \}$ be a sample of $n$ undirected weighted networks, with $\mathcal{K}=\{k_1, k_2,\dots,k_K\}$ the set of nodes shared between the networks. In addition, let the sample be partitioned into two groups, with $n_1$ and $n_2$ the respective sizes. In all the scenarios, we set $n=100, K=30, n_1=n_2=50$. For the sake of simplicity, the nodes are labelled with numbers from 1 to 30 and with an even/odd node we refer to a node labelled with an even/odd number, respectively. The study is structured into two scenarios, subdivided in their turn into two subscenarios of differing complexity. A graphical representation of the first scenario is provided in Figure \ref{networkscenario1}, of the second one in Figure \ref{fanculo}. \begin{figure}[] \centering% {\includegraphics[width=0.75\textwidth,height=6cm]{SIMU2GRUPPO2modificato}}\qquad \qquad {\includegraphics[width=0.75\textwidth,height=6cm]{SIMU2GRUPPO1modificato}} \caption{Scenario 1. A network belonging to the first group (at the top) and a network belonging to the second group (at the bottom) are represented: the dashed lines represent connections generated independently from $X$, the continuous lines represent connections generated independently from $Y$. } \label{networkscenario1} \end{figure} In the first scenario, the networks belonging to the first group are characterised by connections between nodes generated independently from a discrete random variable $X$, whereas those belonging to the second group are characterised by connections between nodes generated independently from a discrete random variable $Y$. Thus: \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{First subscenario}: $D_X=\{4,5,6,7\}$ the support of $X$, $D_Y=\{10,11,12,13\}$ the support of $Y$ and $\pi_X=\pi_Y=\{0.4,0.3,0.2,0.1\}$ the probability vector of $X$ and $Y$. \item \textit{Second subscenario}: $D_X=\{4,5,6,7,8\}$ the support of $X$, $D_Y=\{5,6,7,8,9\}$ the support of $Y$ and $\pi_X=\pi_Y=\{0.1,0.25,0.3,0.25,0.1\}$ the probability vector of $X$ and $Y$. \end{itemize} The community structures are completely random for all the units, but the networks of the first group differ from those of the second group with regard to their overall weight. The second subscenario displays a higher complexity than the first one since the difference in the overall weight between the two groups drops. The purpose of this scenario is to replicate one of the features shown in Appendix A, namely that the average weight of the different units varies according to the team considered. In the second scenario: \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item the weight of each edge linking two \emph{even} nodes is generated independently from the discrete random variable $X_1$ in the first group and from the discrete random variable $Y_1$ in the second group. \item the weight of each edge linking two \emph{odd} nodes is generated independently from the discrete random variable $X_2$ in the first group and from the discrete random variable $Y_2$ in the second group. \item the weight of each edge linking an \emph{even} node with one of the first eight \emph{odd} nodes \{1,3,\dots,13,15\} is generated independently from $X_1$ in the first group and from $Y_1$ in the second group. \item the weight of each edge linking an \emph{even} node with one of the remaining \emph{odd} nodes \{17,19,\dots,27,29\} is generated independently from $X_2$ in the first group and from $Y_2$ in the second group. \end{itemize} For the sake of simplicity, let us define $E_{X_1}$ ($E_{X_2},E_{Y_1},E_{Y_2}$ respectively) the set of edges whose weights are generated from $X_1$ ($X_2, Y_1, Y_2$ respectively). Thus: \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{First subscenario}: $D_{X_1}=\{10,11,12\}, D_{X_2}=\{2,3,4\}, D_{Y_1}=\{9,10,11\}, D_{Y_2}=\{3,4,5\}$ the supports of $X_1, X_2, Y_1, Y_2$; $\pi_{X_1}=\{0.46,0.46,0.08\}, \\ \pi_{X_2}=\{0.8,0.1,0.1\}, \pi_{Y_1}=\{0.64,0.18,0.18\}, \pi_{Y_2}=\{0.1,0.1,0.8\}$ the probability vectors of $X_1, X_2, Y_1,Y_2$. \item \textit{Second subscenario}: $D_{X_1}=\{12,13,14,15,16,17\}, D_{X_2}=\{1,2,3,4,5,6\}, D_{Y_1}=\{11,12,13,14,15,16\}, D_{Y_2}=\{2,3,4,5,6,7\}$ the supports of $X_1, X_2, Y_1, Y_2$; \\ $\pi_{X_1}=\pi_{Y_2}=\{0.18,0.18,0.18,0.18,0.18,0.10\}, \pi_{X_2}=\pi_{Y_1}= \\ \{0.10,0.18,0.18,0.18,0.18,0.18\}$ the probability vectors of $X_1, X_2, Y_1,Y_2$. \end{itemize} \begin{figure}[] \centering% {\includegraphics[width=0.75\textwidth,height=6cm]{SIMU1GRUPPO1modificato}}\qquad \qquad {\includegraphics[width=0.75\textwidth,height=6cm]{SIMU1GRUPPO2modificato}} \caption{Scenario 2. A network belonging to the first group (at the top) and a network belonging to the second group (at the bottom) are represented: the continuous red lines represent connections generated independently from $X_1$, the dashed black lines represent connections generated independently from $X_2$, the dashed red lines represent connections generated independently from $Y_1$, the continuous black lines represent connections generated independently from $Y_2$.} \label{fanculo} \end{figure} The second subscenario displays a higher complexity than the first one since the difference in the weights of the edges between the two groups drops; the purpose of this scenario is to replicate another one of the features shown in Appendix A, namely the one where the teams share the directions in which the playing styles are mainly developed but where some different trends between the teams can be detected in the densely and sparsely connected areas of the pitch . Every scenario is developed for three values of $\alpha$: 0.3, 0.7, 0.95. The methodology is compared to the \emph{naive} approach introduced in Section \ref{sectionsimilaritybetweennetworks}: it consists of considering each starting network on its own, detecting its community structure and merging, step by step, the networks whose partitions are most similar. Even in this case every self-loop is set to zero for the reason described in Section \ref{paragrafofase2}. The suitability of the methods is examined by comparing the partition obtained requiring $N_G=2$ with the real subdivision of the sample; to do so we use the ARI \citep{hubert1985comparing}. The simulations are achieved by using programming language R \citep{Rsoftware}, the detection of community structures by \emph{igraph} package \citep{igraph} and the computation of ARI by \emph{pdfCluster} package \citep{pdfCluster}. Every scenario is evaluated using $N=1000$ replications. \textbf{Results} \begin{figure}[] \centering% {\includegraphics[width=0.75\textwidth,height=11cm]{SIM1.pdf}}\qquad \qquad {\includegraphics[width=0.75\textwidth,height=11cm]{SIM2.pdf}} \caption{Results of the simulation study.} \label{figurasimulazioni} \end{figure} Figure \ref{figurasimulazioni} displays the box-plots of ARI concerning the 1000 replications for each scenario. The first scenario shows an improvement in the method when the highest value for $\alpha$ is considered: the choice of $\alpha=0.95$ allows only the particularly surprising connections for the population to be included and therefore enables the differences between the two groups to be detected. The low values of the agreement with the real partition are easily explained since the arbitrary nature of community structures involves networks belonging to the same group having, by construction, low similarity. A decidedly positive aspect is noticed when moving through subscenarios: the performance of the procedure remains almost unchanged despite the fact that the groups are less dissimilar. The second scenario shows a complete failure in the \emph{naive} approach: the fact that $E_{X_1}=E_{Y_1}$ and $E_{X_2}=E_{Y_2}$ between groups involves the community structures between the two subpopulations being identical, and so the normalization of the weights seems to be a fundamental adjustment to improve the quality of the partitions. The remarks concerning the role of $\alpha$ vary according to the subscenario considered: in the first one the choices of $\alpha=0.30$ and $\alpha=0.95$ allow the differences between the two groups to be managed, whereas intermediate value $\alpha=0.70$ produces decidedly unsatisfactory results. On the other hand, in the second one the differences between groups are so minimal that only a value as high as $\alpha=0.95$ achieves the goal. Overall, the methodology provides a reasonable compromise in the handling of the different aspects characterising the clustering of networks, but the impact of the value of $\alpha$ on the results represents an undeniable limit in an unsupervised context. \subsection*{Appendix C} The objective criterion used to identify the main characteristics of a specific group consists of the evaluation of the percentage of times that, considering the networks of that cluster, pairs and triads of nodes are allocated to the same community: a high value for this quantity means that the group is made up of playing styles with frequent connections between those pairs and triads of areas. A brief description of the groups is provided below (for all the two-dimensional and three-dimensional arrays reporting the described percentages, contact J.Diquigiovanni). For the sake of clarity, the clusters are divided into 6 categories identifying the main macro typologies of playing styles. Figure \ref{tabellagruppisquadre} shows the number of networks allocated to each group for each team. \begin{figure} \begin{center} \includegraphics[width=\textwidth,height=18cm]{graficosquadregruppi} \caption{Number of networks allocated, for each team, to each group.} \label{tabellagruppisquadre} \end{center} \end{figure} \textbf{Sparse playing style} \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{Group 1}, made up of 347 networks. The group includes almost half of the units, which are characterised by the absence of any significant connection between the areas of the pitch; the size of the cluster is not entirely surprising as the value chosen for $\alpha$ is particularly high. It is mainly made up of low ranking teams, which are allocated to this group 67\% of the time; on the other hand, Napoli (four out of 38 networks), Roma (five out of 38 networks) and Fiorentina (five out of 38 networks) are the least involved teams. \end{itemize} \textbf{Long ball playing style} \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{Group 2}, made up of 41 networks. This playing style is characterised by long passes between the right defense zone and the central attack zone (1-8). Despite the fact that the group is mainly made up of middle-low and low ranking teams (66\%), there is no lack of high ranking teams (20\%). \item \textit{Group 3}, made up of 24 networks. This playing style is characterised by long passes involving the central defense zone (2-8, 2-9). The low ranking teams are the most numerous in the group (38\%). \item \textit{Group 4}, made up of 8 networks. This playing style is characterised by long passes between the central defense zone and the right attack zone (2-7): all the networks of the group share this community. The use of this tactic is distributed homogeneously between the teams. \end{itemize} \textbf{Dense playing style} \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{Group 5}, made up of 38 networks. This playing style is characterised by ball possession in the defense zone (1-3, 1-2-3). The high and middle-high ranking teams are the most numerous in the group (71\%). \item \textit{Group 6}, made up of 46 networks. This playing style is characterised by connections between the central defense zone and the lateral midfield zones (2-4, 2-6, 2-4-6). The low ranking teams are the least numerous in the group (11\%). \item \textit{Group 7}, made up of 21 networks. This playing style is characterised by connections between the central defense zone and the central/right midfield zones (2-5, 5-6, 2-5-6). The use of this tactic is distributed homogeneously between the teams. \item \textit{Group 8}, made up of 34 networks. This playing style is characterised by ball possession in the offensive zones (4-7, 8-9). The high and middle-high ranking teams are the most numerous in the group (68\%). \item \textit{Group 9}, made up of 50 networks. This playing style is characterised by ball possession in the offensive zones (4-9,5-7,6-7,4-8-9,5-6-7). The high ranking teams are the most numerous in the group (64\%). \end{itemize} \textbf{Mixed playing style} \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{Group 10}, made up of 28 networks. This playing style is characterised by long passes between the left defense zone and the left attack zone (3-9) and by connections between the left defense zone and the central midfield zone (3-5). The high and middle-high ranking teams are the most numerous in the group (68\%). \item \textit{Group 11}, made up of 23 networks. This playing style is characterised by long passes between the left defense zone and the central attack zone (3-8) and by connections between the right defense zone and the central midfield zone (1-5). The use of this tactic is distributed homogeneously between the teams. \end{itemize} \textbf{Rapid attack playing style} \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{Group 12}, made up of 13 networks. This playing style is characterised by connections between the right midfield zone and the central attack zone (6-8). The low ranking teams are the most numerous in the group (46\%). \item \textit{Group 13}, made up of 16 networks. This playing style is characterised by connections between the central midfield zone and the central attack zone (5-8). The low ranking teams are not present in this group. \item \textit{Group 14}, made up of 19 networks. This playing style is characterised by connections between the left midfield zone and the central attack zone (4-8) and between the lateral zones of the attack (7-9). The high and middle-high ranking teams are the most numerous in this group (74\%). \end{itemize} \textbf{On-the-wings playing style} \begin{itemize}[noitemsep,topsep=0pt,parsep=0pt,partopsep=0pt] \item \textit{Group 15}, made up of 52 networks. This playing style is characterised by connections between the lateral zones of the defense and the adjacent lateral zones of the midfield (1-6,3-4): 87\% of the networks present at least one of the two communities. The high ranking teams are the most numerous (50\%), with Fiorentina (nine networks) and Napoli (six networks) the most involved teams. In view of the importance of this cluster (see Section \ref{modellingfinalscores}), a graphical representation is provided in Figure \ref{gruppo13}. \begin{figure} \begin{center} \includegraphics[width=0.75\textwidth,height=7cm]{gruppo13.pdf} \caption{Graphical representation of the on-the-wings playing style.} \label{gruppo13} \end{center} \end{figure} \end{itemize} In view of the above, it is now possible to extrapolate some information about either the league or the teams. For example, Juventus were on an incredible winning streak (26 out of 28 matches) after a disastrous start of the season characterised by only 12 points in the first ten matches. Consequently, it is certainly surprising that only two of the ten matches in which Juventus displayed a sparse playing style (Group 1) refer to that critical starting period. This evidence, in spite of its simplicity, seems to confirm a clich\'e on Italian football: the team which plays better does not always win. \section*{Acknowledgements} This work was partially funded by grant CPDA154381/15 from the University of Padova, Italy. The authors are grateful to Lazar Petrov, Italian lead of InStat, and Lorenzo Favaro, CEO of SportAnalisi, who provided data. We also thank Daniele Durante and Nicola Sartori for fundamental comments and advices, and David Dandolo for providing the code on the Dixon and Coles model \citep{dandolo2017modellazione}.

Doping is a process in which atomic impurities are intentionally added to a host material to modify its properties. It has had a revolutionary impact in changing or introducing electronic[@b1][@b2], magnetic[@b3][@b4], optical[@b5][@b6], and catalytic[@b7] properties for various applications. Transition Metal Oxides with strongly correlated electron systems usually have complex electronic phase diagrams that are exceptionally sensitive to the orbital occupancy of electrons and chemical/carrier doping. Electronic phase transitions observed in ABO~3~ perovskite systems and their interfaces[@b8][@b9] are of broad interest in materials physics to understand both fundamentally appealing band structure and exciting potential applications in oxide electronic devices[@b10]. Specifically, the monotonic shift of carrier transport and magnetic properties with various 4*f* rare earth lanthanide elements correlated with the steric effect found in the rare-earth based perovskites like *R*BO~3~ (where *R* = rare earth lanthanide elements) can act as an excellent platform for revealing the underlying strong correlation physics[@b11]. In this study we report a novel electronic doping strategy via super-hydrogenic dopants in oxides which can be a very interesting approach for fundamental understanding as well as potential applications. As we know, the radius of hydrogen atom in free space is about 0.5 Å; but the whole situation changes when this atom is placed into a high dielectric constant material. The Rydberg radius of that atom becomes much larger - the free space radius multiplied by the dielectric constant of the system, these kind of super-hydrogenic atoms can be realized in wide band-gap oxides (with high dielectric constants) by doping them with *n* or *p* type dopants. It has been also predicted that at very low concentrations (of about only 1%) these super hydrogenic orbitals will overlap with each other to create a band and this band may cause magnetic (ferro or antiferro) effects in the material[@b12][@b13]. Along with magnetic effects, novel transport and optical properties can also be found in these systems. In addition to our current study involving NdGaO~3~ (NGO), this novel approach can be also utilized to study other exotic materials like rare-earth oxides (mostly with R~2~O~3~ formula) which exhibit large band-gap, high dielectric constant with potential applications in electronic and photonic technologies. In this paper we report the origin of room-temperature ultraviolet (UV) and blue emission in NdGaO~3~ (NGO) bulk systems and the subsequent quench of PL by Ce^4+^ doping in the place of Nd^3+^ ions in NGO as a case study of super-hydrogenic dopant (SHD). NGO is a paramagnetic insulator, which undergoes a magnetic phase transition into an antiferromagnetic phase at \~1 K due to strong super-exchange interaction[@b14]. It has an orthorhombic perovskite structure with lattice constants *a* = 5.43 Å, *b* = 5.50 Å and *c* = 7.71 Å while its orthorhombically distorted pseudo cubic cell has a lattice constant of 3.87 Å. It is close to lattice constants of many perovskite materials and therefore generally used as substrates for colossal magneto-resistance thin film and other perovskite thin film growth. Due to the very low dielectric loss of NGO in the GHz frequency range[@b15], it has been extensively utilized as substrates for high-temperature superconducting film fabrications in microwave devices as well. Rare earth based oxides, perovskites and their interfaces are of great interest in optical studies as rare earth ions can serve as emission centers for laser systems, such as Nd:YAG (Nd-doped Y~3~Al~5~O~12~)[@b16][@b17]. The photoluminescence (PL) properties of the Nd^3+^ ion in NGO single crystals were studied by Orera *et al.*[@b18], where the samples were excited by light from a tungsten lamp. But, no emission was detected in NGO even at low temperatures. In this letter, we report for the first time ultraviolet (UV) and blue emission in NGO single crystals and poly-crystalline bulk samples obtained by the excitation of a 325 nm laser. There are two bands of UV emission peaks around 360 and 390 nm while blue emission peaks are centered at 420 nm. Further, we have seen a drop in the PL intensity of the sharp blue emission lines at 390 nm by systematic doping of Ce in NGO poly-crystalline bulk samples. This PL quench can be explained by the concept of "super-hydrogenic dopant". Results ======= Material Characterization ------------------------- [Figure 1](#f1){ref-type="fig"} shows elemental composition and structural analysis of an NGO poly-crystalline bulk sample. We have used Rutherford Backscattering Spectroscopy (RBS) to calculate the composition of NdGaO~3~ target and [Fig. 1(a)](#f1){ref-type="fig"} shows a best simulation fit which clarifies that for pure NdGaO~3~ bulk samples the elemental composition was ideal -- Nd:Ga:O ≈1:1:3. Further RBS and Particle Induced X-ray Emission Spectroscopy (PIXE) were used to find the Ce dopant level in doped NGO poly-crystalline samples. Unfortunately, Ce elemental level measurements using RBS and PIXE were not possible as the atomic mass or Ce (Z = 57) and Nd (Z = 58) are comparable and thus the signals of Ce and Nd overlap with each other in both RBS and PIXE spectra. Followed by RBS-PIXE, we instead tried the Secondary Ion Mass Spectroscopy (SIMS) technique for quantifying the Cerium dopant in the doped NGO samples \[[Fig. 1(b)](#f1){ref-type="fig"}\]. Five samples were measured, with nominal concentrations of 0%; 0.2%; 0.5%; 1.0%; 5.0%, respectively. Numbers in the [Fig. 1(b)](#f1){ref-type="fig"} mean that 0.2% Ce doped NGO has \~0.22% Ce doping & 0.5% Ce doped NGO target has \~0.53% Ce doping and so on. The measurements show that the actual concentration of Ce correlates very well with the desired values in general. Initially it was found that the SIMS peak of Ce (140) overlaps with peak of Ga2 (69 + 71), so all the final values were obtained after decomposing of Ce (140) and Ga2 (69 + 71) overlapping peaks. It is also important to note that in most of the doped bulk samples (except in the 5% doped sample) the Ce concentration is very uniform throughout the samples up to a thickness level of 800 nm, while in the 5% Ce-NGO sample the Ce concentration is low on the surface but then from about 100 nm thickness the Ce concentration level reaches the desired 5% and remains uniform over the next 700 nm. In [Fig. 1(c)](#f1){ref-type="fig"} we have shown the structural analysis of pure and doped NGO samples using X-ray Diffraction technique (XRD). All doped samples have been studied for structural information, here we have plotted powder XRD patterns of the pure, the most highly doped (5%) and one intermediate (1%) doped NGO bulk samples. In theta-2theta scans from 20 to 80° we find various different XRD peaks of NGO, among which the (112), (001), (123) and (024) peaks are prominent. Under magnified XRD scans for the (112) peak of \[[Fig. 1(c)](#f1){ref-type="fig"}-inset\], it can be seen that the peak shifts slightly towards a higher angle with Ce doping, which indicates a smaller lattice spacing and can be attributed to the smaller ionic radii of Ce^4+^ ion (0.97 Å or 1.07 Å depending on coordination number 8 or 10) compared to ionic radii of Nd^3+^ in NGO as the co-ordination number of Nd^3+^ in NGO is 9 and the corresponding ionic radius is 1.16 Å, a value \~10% larger. Further analysis was done to realize the electronic state of dopant Ce in the NGO crystal structure, as it is well known that Ce(III) state yields XPS peaks near 880 eV & 886 eV while the Ce(IV) state exhibits XPS peaks near 882 eV & 890 eV. In the actual XPS measurements we found a mixture of all these peaks \[see [Fig 1(d)](#f1){ref-type="fig"}\], indicating a mixture of Ce^3+^ and Ce^4+^ states (be discussed in detail later)\]. Photoluminescence Study ----------------------- Room temperature PL spectra were measured in the range of 330 nm to 700 nm. However, no PL was detected above 450 nm, which is consistent with the results reported[@b18]. [Figure 2(a)](#f2){ref-type="fig"} shows room-temperature PL spectra of two NGO single crystals excited by a laser intensity of 1.5 MW/cm^2^. Generally, PL spectra of NGO single crystals exhibit a very sharp UV emission peak at 388 nm. There are a few of emission peaks, which can overall be categorized into three bands. The first band around 360 and the second one around 390 nm are UV emission peaks while the third one around 420 nm pertains to blue emission. The characteristic energy level diagram of rare earth ions Ln^3+^, known as Dieke diagram only changes slightly in different crystal structures[@b19]. The wavelength values of three emission centers (360, 390 and 420 nm) correspond to the wavenumbers of 27700, 25600 and 23800 cm^−1^, respectively. The ground state of Nd^3+^ is ^4^I~9/2~. The 325 nm laser excites electrons in the ground state ^4^I~9/2~ to energy levels of \~30769 cm^−1^, which are ^2^L~15/2~, ^4^D~7/2~ and ^2^I~13/2~ levels \[schematized in red in [Fig. 2(b)](#f2){ref-type="fig"}\]. Then the excited electrons relax into lower energy levels such as ^4^D~3/2~, ^2^P~3/2~ and ^2^P~1/2~. Based on the energy level diagram of Nd^3+^ [@b17], the PL emission around 360 nm pertains to the optical transition ^4^D~3/2~ → ^4^I~9/2~; the emission around 390 nm corresponds to the optical transitions ^4^D~3/2~ → ^4^I~11/2~ and ^2^P~3/2~ → ^4^I~9/2~; and the emission around 420 nm can be ascribed to the optical transitions ^4^D~3/2~ → ^4^I~13/2~, ^2^P~3/2~ → ^4^I~11/2~ and ^2^P~1/2~ → ^4^I~9/2~. Such possible emission processes are schematized in [Fig. 2(b)](#f2){ref-type="fig"}. Invariably, the crystal field in NGO participates in optical emissions, mainly resulting in the energy level and emission peak splitting, which is not included in the schematic. Further systematic studies of room temperature UV-VIS absorption, pump-probe spectroscopy, laser intensity variation and low-temperature PL emission were carried out on NGO single crystals for a better understanding of optical properties of this material (see the [Supplementary Material](#S1){ref-type="supplementary-material"}). It is worthwhile to point out that no photoemission was seen in NGO under the tungsten lamp excitation[@b18]. Our PL measurements with various laser excitation intensity show that the PL signal is linear with laser excitation intensity ([Supplementary Material](#S1){ref-type="supplementary-material"}) and we have used a 325 nm laser with a spot size of \~800 nm and a power of 10 mW, corresponding to an excitation intensity of \~1.5 MW/cm^2^, which could be several orders of magnitude higher than the intensity of the tungsten lamp through a 0.5 m double monochromator[@b18]. This justifies the different observations of two types of measurements. Super-hydrogenic Dopant ----------------------- [Figure 3](#f3){ref-type="fig"} discusses the systematic drop in PL intensity leading to a quench of the PL lines. [Figure 3(b)](#f3){ref-type="fig"} shows the peak height of the 390 nm PL line as a function of Ce doping in NGO poly-crystalline bulk samples. Here we have focused at the most prominent PL peak of 390 nm which most likely originates from ^4^D~3/2~ → ^4^I~11/2~ and/or ^2^P~3/2~ → ^4^I~9/2~ transition of Nd^3+^. We find that initially the PL peak height of the 390 nm line in pure NGO poly-crystalline sample was ≈10 k counts, which drastically drops to almost half i.e. ≈5.2 k at only 0.2% elemental doping of Ce^4+^ and finally the 390 nm PL peak intensity completely suppressed by only 5% elemental doping of Ce^4+^. [Figure 3(b)](#f3){ref-type="fig"} shows a clear near-exponential systematic decrease of the peak intensity as the Ce elemental doping level is increased. As Ce^4+^ replaces Nd^3+^, it donates an extra electron to the system. As this electron doping forms a deep level it does not contribute to the electrical conductivity of the material. Using the doping-dependent drop in the peak height shown in [Fig. 3(b)](#f3){ref-type="fig"} we can calculate the effective Bohr radius of the extra dopant electron. Using Avogadro number, molecular weight and density of NGO we can calculate the number of NGO molecules per unit volume that comes out to be \~3.46 × 10^22^/cm^3^. We find that the total PL almost quenches near 5% Ce doping -- so that means effective Bohr radii of 5% Ce atoms envelops almost all the Nd^3+^ ion centers which are clearly the source of PL in this study. This assumes that all Ce ions are in the 4+ state. To determine the valence of the Ce we refer to [Fig. 1(d)](#f1){ref-type="fig"}, where we have calculated the area under the curve for all these XPS peaks and find that 45% of the Ce is in the 4+ state while 55% is in 3+. This means that only 45% of Ce doping in the 5% Ce-NGO sample contributes to PL quench, corresponding to an "effective" doping of approximately 2.2% and an electron concentration of \~3.81 × 10^20^/cm^3^ related to the quenching, so the volume occupied by each Ce dopant electron comes out to be \~2.62 × 10^−21^ cm^3^. This value further leads to an effective Ce^4+^ electronic radius of \~8.5 Å if we assume all PL quench happened precisely at 5% Ce doping level. The simple calculation procedure described above can be represented by the mathematical equation shown below: where *x* -- Dopant concentration required to completely quench the PL signal. N -- The Avogadro number; M -- The molecular weight of the material (here it is NdGaO~3~); *d* -- The density of the material. The mathematical relationship clearly shows that the SHD radius varies inversely with the cube root of *x* if the material system is unchanged. Physically we can also visualize the phenomena -- as we know all the Nd^3+^ ion centres acts as the source the PL and effective radius of the Ce^4+^ dopant electron is acting like a cloak covering some n number of Nd^3+^ ion centers hence reducing the intensity of the PL peak. If lower dopant concentration causes complete PL quench then it clearly means effective SHD Ce^4+^ radius has to be larger. Now, if we assume that the precise doping level (where all the PL quenches) lies somewhere between 2 to 5% of Ce^4+^ doping then we find that the SHD radius spans from 0.85 nm (for 5% doping) to 1.15 nm (for 2% doping). Using the free space Rydberg radius value of 0.5 Å and considering the bulk dielectric constant of NGO of \~20.2 we estimate a SHD radius of 1.01 nm which lies exactly in the middle of our experimental range of 0.85--1.15 nm. Discussion ========== In this study we have reported the PL properties of NGO single crystals and polycrystalline bulk samples where UV (\~360 and \~390 nm) and blue emission (\~420 nm) lines were observed. The observed UV and blue emission can be understood based on the energy level diagram of the Nd^3+^ ion. Following the observation of NGO PL emission we have seen a systematic quench of one sharp UV line (390 nm) with very small amount of Ce^4+^ doping in the place of Nd^3+^. This PL quench has been explained by the novel idea of a super-hydrogenic dopant where the SHD radius is enhanced by the large dielectric constant of the host. The experimentally derived range of SHD radius comes out to be 0.85 nm to 1.15 nm where the predicted radius of 1.01 nm (from the bulk dielectric constant of the host) in the middle of that range. Thus using PL quenching we may able to estimate the Bohr radius of other super hydrogenic dopants in wide band-gap solids with large dielectric constants with the possibility of new functionalities. In final remark, we would like to add that although SHD means super-hydrogenic dopant -- it clearly has nothing to do with doping using hydrogen atom/ions. Any element which can act as an electronic dopant can be a SHD in a host with large dielectric constant. However, in terms of the host material we need rare-earth based oxides and perovskite materials like NdGaO~3~, NdAlO~3~ or Lu~2~O~3~, Nd~2~O~3~, Gd~2~O~3~ etc. to study SHD using the sharp photo luminesces from the rare earth atoms. This sharp atomic PL lines and their subsequent quench (with doping) are very crucial to study, understand and quantify the effect of SHD and its dimension. Other perovskite systems (widely used in oxide-electronics research) like SrTiO~3~, KTaO~3~ etc. may not be the ideal systems to study SHD phenomena as they usually have broad PL emission originating from band-edge or defect states. Methods ======= Sample Preparation ------------------ In this study we have initially used (1 1 0) oriented NGO single crystal (5 × 5 × 0.5 mm^3^) from CrysTec GmbH, Germany, for the single crystal study of the NGO pure system. Further, we have prepared one pure NGO poly-crystalline pellet and five different Ce doped NGO poly-crystalline pellets. For the pure NGO bulk sample we have used the high purity (99.995% or higher) powders of Nd~2~O~3~ and Ga~2~O~3~. Moreover, for other five doped NGO bulk samples high purity CeO~2~ powder was used along with Nd~2~O~3~ and Ga~2~O~3~ powders. At first, the powders are mixed for about 1 h by hand using mortar and pestle and the mixed powder was calcined at 1000 °C for ≈12 h in an oven at a closed environment in atmospheric pressure. The calcined powder is then further ground in mortar and pestle again and then subsequently pressed into 1-in diameter pellets by hydraulic press. Finally, the pellets were sintered at 1350 °C under the same atmospheric pressure for ≈16 h. Measurement and characterization -------------------------------- PL properties of NGO single crystals and thin films were studied by exciting with the 325 nm line of a He-Cd laser with a spot size of \~800 nm and a power of 10 mW, (laser intensity \~1.5 MW/cm^2^) and recorded using a JY-Horiba LabRAM HR spectrometer. Further elemental composition, valence and structural analyses were done using Rutherford backscattering spectroscopy ((using 3.5 Mev singletron accelerator)), secondary ion mass spectroscopy (using ToF-SIMS-IV from ION-TOF GmbH), x-ray photoelectron spectroscopy (using Axis Ultra Delay Line Detector from Kratos Analytical) and x-ray diffraction (using Empyrean powder XRD system from PANalytical). Additional Information ====================== **How to cite this article**: Ghosh, S. *et al.* Origin and Quenching of Novel ultraviolet and blue emission in NdGaO3: Concept of Super-Hydrogenic Dopants. *Sci. Rep.* **6**, 36352; doi: 10.1038/srep36352 (2016). **Publisher's note**: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Material {#S1} ====================== ###### Supplementary Information We would like to acknowledge Prof. J.M.D. Coey for enlightening discussions. We thank the National Research Foundation (NRF) Singapore under the Competitive Research Program (CRP) "Control of Exotic Quantum Phenomena at Strategic Interfaces and Surfaces for Novel Functionality by *In-Situ* Synchrotron Radiation" (R-398-001-062-281) and "Tailoring Oxide Electronics by Atomic Control" (R-380-000-010-281); the National University of Singapore (NUS) Office of the Deputy President (Research and Technology) \[ODPRT\] for a cross-faculty grant MIPS (MID IR Photonics Project) (Grant no. - R398-000-082-646) and FRC (ARF Grant No. R-144-000-278-112) for financial support. **Author Contributions** S.G. and S.S. have equal contribution the overall project and they have prepared the manuscript together. S.G. prepared all samples with Z.Q.L. and A.P. and did the sample characterization with the help of M.M (RBS and XRD), N.Y. (SIMS) and S.P. (XPS). S.S. did all the PL measurement with the help if T.B., S.B.D and S.T., Z.Q.L. made the initial samples and measurements along with C.B.T., W.M.L. and Z.H. Y.C. and M.A. helped in the theoretical understanding and discussions. X.H.H. and S.J.C. helped Z.Q.L. with some initial PL measurement. J.Q.C. did femtosecond measurement shown in [Supplementary Information](#S1){ref-type="supplementary-material"}. C.X.C. and T.Y. did the low temperature PL measurement shown in [Supplementary Information](#S1){ref-type="supplementary-material"}. A.A. and T.V. led the whole research project and also helped shaping up the final manuscript. {#f1} {#f2} {#f3} [^1]: These authors contributed equally to this work. [^2]: Present address: Indian Institute of Science Education and Research, Bhopal, Madhya Pradesh, 462066, India.

\section{Introduction} \label{introduccion} \section{Introduction} The potential of SPs to confine the electromagnetic field to regions well below the diffraction limit has been widely exploited to manipulate the light--matter interaction at subwavelength scales enabling a rich variety of applications \cite{maier_nature,review,dereux}. In particular, the coupling of optical emitters, such as atoms, molecules or quantum dots, to SP modes provides an enhancement of the emission rate several orders of magnitude relative to the case in which the same emitter is localized in an unbounded medium. This property has been used to bring the size of laser sources of light to the nanoscale, to reduce the lasing threshold \cite{laser,laser1} as well as to improve the efficiency of single photon sources \cite{SPS}. In addition, SP mode environments can provide an enhancement together a significant directional control of the energy transfer between quantum emitters over distances larger than the F\"orster energy transfer range \cite{forster,barnes,vasili1,ETMM,Jones}. Significant progress made in nanoscale fabrication techniques and an extensive wealth of theoretical analysis have not only allowed an advanced light manipulation via SPs at optical frequencies (where optical emitters are placed on metallic SP environments), but have also led to a rapidly developing field in light control by plasmonic excitation in the terahertz (THz) frequency range \cite{THz}. Possibilities have been widened with the advent of other plasmonic materials with lower losses and greater confinement of the electromagnetic field, such as metal--alloys, heavily doped wide--band semiconductors, and graphene \cite{shalaev}. Due to their unique property to guide SPs by one--atom--thin layer from microwaves to the mid--infrared regimes \cite{Xia,nikitin10,nikitin100}, graphene has attracted significant interest from the nanophotonics research community. The electronic linear band structure of graphene makes a SP mass depending on the Fermi--level position and consequently electrically tunable and long--lived SPs are supported by graphene. One of the major challenges for most of applications is to build more smaller plasmonic constituent elements to control light at subwavelength scales, in particular from microwaves to the mid--infrared regimes which comprises a crossover between electronic and optics. In this way, graphene--plasmonic has found a great variety of sophisticated applications, such as photonic devices capable to achieve invisibility \cite{Naserpour,Tuz}, electrically tunable THz antennas \cite{jornet,filter,gomez_diaz,cuevas6} and efficient THz waveguides \cite{depineguias}. The propagation characteristics of graphene plasmonic waveguides have been investigated in different geometrical structures, such as planar waveguides \cite{marocico,shadrivov,cuevas0} ribbons \cite{nikitinguias,christensenguias}, grooves \cite{liuguias} and graphene--cylinders with circular cross--section \cite{enguetaguias}. The ability of plasmonic graphene wires to guide light confined well below the diffraction limit has the key advantage for tailoring light--matter interactions \cite{vasili2,martinmoreno}, opening routes for novel electrically controllable devises capable to improve the single emitter emission as well as the energy transfer rate between optical emitters \cite{biehs, shahbazyan2,arruda2,cuevas3,ETesfera,cuevas3bis}. Methods for controlling the relative positions of single emitters and SP wires with high experimental accuracy have been reported. In \cite{gruber}, it was described the use of electron beam lithography to create a polymer template that enables the controlled deposition of a small number of quantum dots in areas that measure about 50nm across. Alternatively, in \cite{roop} the authors have reported the use of a microfluidic device for positioning at desired locations and moving quantum dots around a single metallic nanowire with a 12nm spatial accuracy. This paper deals with the study about the energy transfer rate between single emitters, a donor and acceptor, located near a graphene--coated wire. In a recent work \cite{cuevas4}, we have revealed that the interplay between an optical emitter and SP excitations on a graphene layer strongly influences the energy transfer process between two single optical emitters placed close to a graphene--coated cylinder. However, in that work we have focused on a two--dimensional model in which each of the optical emitters is considered as an infinitely thin wire extending along the $z$ axis of the cylinder and with its dipole moment in the computational $x-y$ plane. As a consequence, only localized surface plasmons, \textit{i.e.}, SPs whose wave vector component along the wire axis is equal to zero, are excited, leading to an optical energy transfer from donor to acceptor within the $x-y$ plane. Our motivation for this work is to extend the study realized in \cite{cuevas4} to the case of quantum dot optical emitters. Unlike the two--dimensional approach, SPs propagating along the waveguiding structure, \textit{i.e.}, SPs with a non null wave vector component along the wire axis, are excited and consequently the energy can be transferred between two distant optical emitters placed near the graphene--wire at a distance $\Delta z$ from each other. In this sense, the present work can be considered as an extension to the cylindrical geometry case of our previous study about the effect of SPs on the resonant energy transfer on a planar graphene waveguide \cite{olivo}. This paper is organized as follows. In section 2, we sketch the boundary--value problem for the diffraction problem of a dipole emitter located in close proximity to a graphene--coated wire. Because of the translational symmetry of the system along the direction of the wire axis, the transverse components of the electromagnetic fields are obtained from their longitudinal components for which we derive integral expressions for the scattered fields. We then include a second dipole emitter and deal with the problem of the coupled system. By using contour integration in the complex plane, we have applied a method developed in Ref. \cite{olivo} to perform the field integration. This method which is based on the residues theorem enables a fast calculation of the contribution of each one of the wire modes to the energy transfer rate. In section 3 we present numerical results obtained under different dipole moment configurations. Concluding remarks are provided in Section 4. The Gaussian system of units is used and an $\mbox{exp}(-i\, \omega\, t)$ time--dependence is implicit throughout the paper, where $\omega$ is the angular frequency, $t$ is the time coordinate, and $i=\sqrt{-1}$. The symbols Re and Im are used for denoting the real and imaginary parts of a complex quantity, respectively. \section{Theory} \label{teoria} We consider the energy transfer rate between a donor D and an acceptor A electric dipoles placed close to a graphene--coated wire, as illustrated in Figure 1. The energy transfer in the presence of the graphene--coated wire normalized to that in an unbounded medium 1 (without graphene waveguide), is given by \cite{novotny} \begin{eqnarray}\label{ETn} F_{ET}=\frac{|\hat{n}_A\cdot \textbf{E}_D(\textbf{r}_A)|^2}{|\hat{n}_A\cdot \textbf{E}_0(\textbf{r}_A)|^2}, \end{eqnarray} where the electric field $\textbf{E}_D(\textbf{r})$ is the electric field in the presence of a graphene--coated wire (see \ref{ap2}), $\textbf{E}_0(\textbf{r})$ is due to an electric dipole in an unbounded medium (see \ref{ap1}), $\hat{n}_A$ is a unit vector along the induced polarization of the acceptor (whose direction is assumed to be fixed) and $\textbf{r}_A$ is the position of the acceptor. \begin{figure} \centering \resizebox{0.5\textwidth}{!} {\includegraphics{grafeno1.eps}} \caption{\label{fig:epsart} Schematic illustration of the graphene--coated wire. Both donor and acceptor emitters are placed outside the graphene--wire at $\textbf{r}_D=\rho_D \hat{x}$ and $\textbf{r}_A=\rho_A \hat{\rho}+\phi_A \hat{\phi}+z\hat{z}$, respectively. The graphene--wire ($\varepsilon_1=2.13$, $\mu_1=1$ and surface conductivity $\sigma$) is embedded in a transparent medium with constitutive parameters $\varepsilon_2$, $\mu_2=1$. }\label{grafeno} \end{figure} We consider the case in which the donor is placed outside the graphene--coated wire ($\rho_D>a$). Without loss of generality we choose $\phi_D=0, \, z_D=0$, \textit{i.e.} the donor position $\textbf{r}_D=\rho_D \hat{x}$ as shown in Figure 1. By using Eqs. (\ref{campos_transversales}), (\ref{E2z}) and (\ref{H2z}) we obtain the transverse components of the scattered electric field for $\rho>a$, \begin{eqnarray}\label{camporho} E^{(2)}_{\rho}(\textbf{r})= \sum_{m=-\infty}^{+\infty}\int_{-\infty}^{+\infty} dk_z e^{i m \phi} e^{i k_z z} \nonumber\\ \times \left[ -\frac{k_0 m}{\gamma^{(2)}} \frac{H_m(\gamma^{(2)}\rho)}{\gamma^{(2)}\rho} a_m^{(2)} + i \frac{k_z}{\gamma^{(2)}} H'_m(\gamma^{(2)}\rho) b_m^{(2)}\right], \end{eqnarray} and \begin{eqnarray}\label{campophi} {E}^{(2)}_{\phi}(\textbf{r})= -\sum_{m=-\infty}^{+\infty}\int_{-\infty}^{+\infty} dk_z e^{i m \phi} e^{i k_z z} \nonumber \\ \times \left[ i\frac{k_0}{\gamma^{(2)}} H'_m(\gamma^{(2)}\rho) a_m^{(2)} + \frac{k_z m}{\gamma^{(2)}} \frac{H_m(\gamma^{(2)}\rho)}{\gamma^{(2)} \rho} b_m^{(2)}\right], \end{eqnarray} where the complex amplitudes $a_m^{(2)}$ and $b_m^{(2)}$ are given by expressions (\ref{am}) and (\ref{bm}), respectively. The integration path in Eqs. (\ref{camporho}) and (\ref{campophi}) is set along the real $k_z$ axis and poles, i.e., zeroes of the denominator in $a_m^{(2)}$ and $b_m^{(2)}$ amplitudes, close to that axis give rise to poor numerical convergence. To avoid this difficulty we have applied a method developed in Ref. \cite{olivo} to perform such integration which requires the application of the residues theorem to extract each pole contribution of the integrals (\ref{camporho}) and (\ref{campophi}). \begin{figure} \centering \resizebox{0.5\textwidth}{!} {\includegraphics{figura2.eps}} \caption{\label{fig:epsart} Singularities and path of integration in the complex plane $k_z={\rm Re\mit}\,k_z+i\,{\rm Im\mit}\,k_z$ for the electromagnetic fields. Pole singularities representing the propagation constant of the eigenmodes supported by the graphene--coated wire, like waveguide (WG) or surface plasmon (SP) modes, are illustrated with crosses and circles, respectively. The vertical lines drawn from the branch point $k_1=k_0 \sqrt{\varepsilon_1}$ to $+i\infty$ ($-k_1$ to $-i\infty$) are the branch cut lines. Integration path with vertical branch cuts and poles captured. }\label{figura2} \end{figure} In order to perform the calculation of these pole contributions to the field, we deform the integration path in (\ref{camporho}) and (\ref{campophi}) into a semicircle of large radius ($|k_z|\rightarrow \infty$) avoiding the branch point and pole singularities. If $z>0$ the contour of integration is deformed to the upper--half plane ${\rm Im\mit} k_{z}>0$ (see Figure \ref{figura2}) whereas, if $z<0$ the contour of integration is deformed to the lower--half plane ${\rm Im\mit} k_{z}<0$. The integration along the branch cut $B_1$ results in a volume wave \cite{wait,michalski}, which consist of a continuous spectrum of radiation modes. Here, we focus on distances between emitters of the same order than the propagation length of the graphene wire eigenmodes, thus the intensity of the electric field reached by the excitation of these modes dominates the energy transfer process and the volume wave mode contribution can be neglected. Then, the application of the residues theorem to Eqs. (\ref{camporho}), (\ref{campophi}) and (\ref{E2z}) gives the following components of the scattered fields \begin{eqnarray}\label{camporho1} E^{(2)}_{\rho}(\textbf{r})= 2 \pi i \sum_{m=-\infty}^{+\infty} e^{i m \phi} e^{i \alpha_m z} \nonumber\\ \times \left[ -\frac{k_0 m}{\gamma_m^{(2)}} \frac{H_m(\gamma_m^{(2)}\rho)}{\gamma_m^{(2)}\rho} \mbox{Res} \, a_m^{(2)} + i \frac{\alpha_m}{\gamma_m^{(2)}} H'_m(\gamma_m^{(2)}\rho) \mbox{Res}\, b_m^{(2)}\right], \end{eqnarray} \begin{eqnarray}\label{campophi1} {E}^{(2)}_{\phi}(\textbf{r})=- 2\pi i \sum_{m=-\infty}^{+\infty}\ e^{i m \phi} e^{i \alpha_m z}\nonumber \\ \times \left[ i\frac{k_0}{\gamma_m^{(2)}} H'_m(\gamma_m^{(2)}\rho) \mbox{Res}\, a_m^{(2)} + \frac{\alpha_m m}{\gamma^{(2)}} \frac{H_m(\gamma_m^{(2)}\rho)}{\gamma_m^{(2)} \rho} \mbox{Res} \, b_m^{(2)}\right], \end{eqnarray} \begin{eqnarray}\label{campoz1} E^{(2)}_z(\textbf{r})=2 \pi i \sum_{m=-\infty}^{+\infty} e^{i m \phi} e^{i \alpha_m z} H_m(\gamma_m^{(2)} \rho) \mbox{Res} \, b^{(2)}_m, \end{eqnarray} where $\alpha_m$ is the propagation constant of a particular eigenmode, $\gamma_m^{(2)}=\sqrt{k_0^2 \varepsilon_2-\alpha_m^2}$ and Res is the residue of the integrand in (\ref{camporho}), (\ref{campophi}) and (\ref{E2z}) at the pole $\alpha_m$. \begin{eqnarray}\label{Res} \mbox{Res}\, a_m^{(2)}= \lim_{k_z \to \alpha_m}(k_z-\alpha_m) a_m^{(2)}, \nonumber \\ \mbox{Res}\, b_m^{(2)}= \lim_{k_z \to \alpha_m}(k_z-\alpha_m) b_m^{(2)}. \nonumber \\ \end{eqnarray} Inserting the expressions for $\textbf{E}^{(2)}(\textbf{r})=E_{\rho}^{(2)}\hat{\rho}+E_{\phi}^{(2)}\hat{\phi}+E_{z}^{(2)}\hat{z}$ into Eq. (\ref{ETn}) we obtain the following expression for the normalized energy transfer rate, \begin{eqnarray}\label{ETnmodos} F_{ET}=\sum_{mn} F_{nm} = \sum_n F_{nn}+\sum_{n<m} (F_{nm}+F_{mn}), \end{eqnarray} where \begin{eqnarray}\label{ETnmodo} F_{mn}=\frac{\hat{n}_A\cdot \textbf{E}_m(\textbf{r}_A) \, \hat{n}_A\cdot \textbf{E}_n^*(\textbf{r}_A) }{|\hat{n}_A\cdot \textbf{E}_0(\textbf{r}_A)|^2}. \end{eqnarray} The terms in the first sum in Eq. (\ref{ETnmodos}) represent the contribution of each of the $n$ eigenmode channels to the normalized energy transfer rate whereas each term in the second sum arises from the interference between $m$ and $n$ mode channels, \begin{equation}\label{Flj} I_{nm}=F_{n,m}+F_{m,n} \approx \cos [({\rm Re\mit} \alpha_{\mbox{\tiny{n}}}-{\rm Re\mit} \alpha_{\mbox{\tiny{m}}}) z]. \end{equation} \section{Results} In this section, we apply the formalism sketched in previous section to calculate the energy transfer rate between two emitters localized close to a graphene--coated wire. In all the calculations we assume that the core is made of a transparent material with constitutive parameters $\varepsilon_1 = 2.13,\,\mu_1=1$ (corresponding to Polymethylpentene) and is embedded in vacuum ($\varepsilon_2 = \mu_2 = 1$). In order to obtain separate contributions of different SP modes, firstly the propagation constant of these modes are obtained by requiring the denominator in the amplitudes $a_m^{(2)}$ and $b_m^{(2)}$ to be zero (see \ref{ap2}), \begin{equation}\label{dispersion2} \begin{array}{ll} D_{m}=\left[-g_m+\frac{4 \pi}{c}\sigma \frac{m k_z}{(\gamma^{(2)})^2 a} j_m(x_1)\right] \left[g_m-\frac{4 \pi}{c} \sigma \frac{m k_z}{(\gamma^{(1)})^2 a} h_m(x_1)\right] \\ -\left[k_0(h_m(x_2)-j_m(x_1))+\frac{4\pi}{c}\sigma i k_0^2 a j_m(x_1) h_m(x_2)\right]\\ \times \left[k_0(\varepsilon_2 h_m(x_2)-\varepsilon_1 j_m(x_1))+\frac{4\pi}{c}\sigma i (\frac{1}{a}+\frac{m^2 k_z^2}{(\gamma^{(1)} \gamma^{(2)})^2 a^3})\right] = 0, \end{array} \end{equation} where $x_j=\gamma^{(j)}a$ ($j=1,\,2$) and $j_m(x)=\frac{J'_m(x)}{x J_m(x)}$, $h_m(x)=\frac{H'_m(x)}{x H_m(x)}$. This condition is the dispersion relation of SPs and it determines the complex propagation constant $k_z=\alpha_m$ in terms of all the parameters of the graphene--coated wire. Equation (\ref{dispersion2}) has complex solutions with the same modulus and opposite signs, corresponding to SP propagation along the directions $\pm{z}$. We have found the complex roots of equation (\ref{dispersion2}) by adapting a numerical code based on Newton Raphson method. In our examples we have selected the solution with ${\rm Re\mit}\,\alpha_m > 0$ corresponding to wave propagation along the $+z$ direction. In the $m = 0$ case, Eq. (\ref{dispersion2}) is decoupled into two independent equations: an equation whose solutions have the longitudinal component of the magnetic field $H_z = 0$ (TM$z$ polarization), \begin{eqnarray}\label{dispersionTMz} \varepsilon_2 h_0(x_2)-\varepsilon_1 j_0(x_1)+\frac{4\pi}{c}\sigma i \frac{1}{k_0 a}= 0, \end{eqnarray} and another equation whose solutions have the longitudinal component of the electric field $E_z = 0$ (TE$z$ polarization), \begin{eqnarray}\label{dispersionTEz} h_0(x_2)-j_0(x_1)+\frac{4\pi}{c}\sigma i k_0 a j_0(x_1) h_0(x_2)= 0. \end{eqnarray} In the limit $a \rightarrow \infty$, taking into account the asymptotic expressions of the Bessel and Hankel functions \cite{abramowitz}, the dispersion equation (\ref{dispersionTMz}) converges to the TM dispersion equation of a single graphene sheet \cite{depineguias} \begin{eqnarray}\label{dispersionTM} \frac{\gamma^{(1)}}{\varepsilon_1}+\frac{\gamma^{(2)}}{\varepsilon_2}+\frac{4 \pi \sigma}{c k_0}\frac{\gamma^{(1)}}{\varepsilon_1}\frac{\gamma^{(2)}}{\varepsilon_2}=0, \end{eqnarray} whereas Eq. (\ref{dispersionTEz}) converges to the TE dispersion equation of a single graphene sheet \begin{eqnarray}\label{dispersionTE} \gamma^{(1)}+\gamma^{(2)}+\frac{4 \pi \sigma}{c k_0}\gamma^{(1)}\gamma^{(2)}=0. \end{eqnarray} In the general case $m\not=0$, the modes are not decomposed into independent polarizations, and to calculate the propagation constant of these modes we must solve Eq. ($\ref{dispersion2}$). As in the planar waveguides case, the energy transfer through the graphene--coated wire due to excitation of SPs is much greater than the corresponding energy transfer through the excitation of wave guided modes (modes which are evanescent outside the graphene--coated wire and standing waves in the insulator core) \cite{cuevas0,olivo}. This is true because graphene SP modes are highly localized in comparison with waveguide (or fiber) modes \cite{enguetaguias}. In addition, $s$--polarized SPs only exist for frequencies such as $\hbar \omega/ \mu_c>1.667$ where the imaginary part of the graphene conductivity is negative (see appendix \ref{grafeno}). For frequencies bellow this value, $\omega<1.667 \mu_c/\hbar$, (the frequency range studied in this work) only $p$--polarized SPs are well defined. Thus, as we have verified, the $p$--polarized SP modes contributions dominate the energy transfer process on the frequency region presented in figure \ref{dispersion} and consequently all other mode contributions, which are solution of Eq. (\ref{dispersion2}), can be neglected in equation (\ref{ETnmodos}). Figure \ref{dispersion} shows the propagation constant $\alpha_m$ ($0\leq m \leq 4$) of SPs as a function of the frequency $\omega/c$ for $a=1\mu$m. The Kubo parameters are $\mu_c=0.5$eV, $\gamma_c=0.1$meV and $T=300$K. With this value of $\mu_c$, $p$--polarized SPs are supported by the graphene wire for frequency values less than $\omega/c \approx 4\mu$m$^{-1}$. These figures also show the curves corresponding to the propagation constant of SPs supported by a single graphene sheet interface (dotted line), \textit{i.e.}, a system with the flat graphene sandwiched between two dielectric half space with permittivities $\varepsilon_1$ and $\varepsilon_2$, calculated by solving Eq. (\ref{dispersionTM}). \begin{figure} \centering \resizebox{0.45\textwidth}{!} {\includegraphics{dispersion.eps}} \caption{\label{fig:epsart} Dispersion curves for graphene--coated wire SP modes, calculated for $\mu_c=0.5$eV, $T=300$K, $\gamma_c=0.1$meV, $\varepsilon_1=2.13$ and $\varepsilon_2=1$. (a) ${\rm Re\mit}\,\alpha_m$ and (b) $L=1/(2{\rm Im\mit}\,\alpha_m)$ as a function of $\omega/c$. The black dashed line in (a) corresponds to the light line in medium 2. }\label{dispersion} \end{figure} From Figure \ref{dispersion}a we see that SP curves exist to the right of the light line of the inner dielectric medium. As in the metallic wire case \cite{dereux}, the $m=0$ mode goes down to $\omega/c=0$ approaching the light line from the right. The modes with $m>0$ intersects the light line at a finite $\omega/c$ value. Figure \ref{dispersion}b shows the propagation length $L$ of the SPs calculated as $L=\frac{1}{2\, {\rm Im\mit}\,\alpha}$. For $\omega/c$ frequency values large enough, both functions ${\rm Re\mit} \alpha_m(\omega/c)$ and $L(\omega/c)$ take a value which is almost equal to that of the single graphene sheet interface. \begin{figure} \centering \resizebox{0.45\textwidth}{!} {\includegraphics{omega0p158.eps}} \caption{\label{fig:epsart} (a) Contribution of the SP$_0$ and the SP$_1$ ($F_{00}$ and $F_{11}$), to the normalized energy transfer rate between two dipoles, both placed at a distance $l=0.5\mu$m from the surface of the graphene wire ($\rho_D=\rho_A=1.5\mu$m, $\phi_D=\phi_A=0$, $z_D=0$), as a function of the separation $z$ along the wire. The frequency $\omega/c=0.185\mu$m$^{-1}$ and the dipole moments are oriented along the radial direction. (b) Normalized energy transfer rate as a superposition of the SP$_0$ and SP$_1$ modes as a function of the $z$ separation between the donor and acceptor. The waveguide parameters are the same as in figure \ref{dispersion}. }\label{omegac0p158} \end{figure} Once the SP propagation constants are calculated, the contribution of each modes to the energy transfer rate between donor and acceptor can be obtained by using Eq. (\ref{ETnmodo}). To illustrate the interesting case where the coherent interference between these SP channels leads to large spatial variations, we chose a frequency value for which two of the plasmonic bands plotted in Figure \ref{dispersion} show a significant difference in their propagation constant values. Figure \ref{omegac0p158} shows the contribution of SP$_0$ and SP$_1$ modes (SP modes with $m=0$ and $m=1$) to the energy transfer rate ($F_{mn}$ with $m=n=0$ and $m=n=1$) as a function of the separation $z$ between the donor and acceptor and for $\omega/c=0.158\mu$m$^{-1}$. The locations are $\textbf{r}_D=1.5\mu$m$\hat{\rho}$ and $\textbf{r}_A=1.5\mu$m$\hat{\rho}+z\hat{z}$ for the donor and acceptor, respectively, and both dipole moments are aligned along the $\rho$ direction (the directions of the dipole moments are shown in the graphs by the directions of the arrows). As can be seen in Figure \ref{dispersion}, only SPs with $m=0$ and $m=1$ are propagating and as a consequence only these modes carry energy through the graphene wire. Figure \ref{omegac0p158}a shows that the energy transfer contribution curves reach a maximum value for a certain value of the $z$ separation, $z_{max,m=0} \approx 300\mu$m for the SP$_0$ mode and $z_{max,m=1} \approx 100 \mu$m for the SP$_1$ mode. On the other hand, from Figure \ref{dispersion}b we determine the propagation lengths of SP modes resulting: $L_{m=0}=148.5\mu$m for the SP$_0$ mode and $L_{m=1}=51.5\mu$m for the SP$_1$ mode. This result suggests that the maximum contributions to the total normalized energy transfer rate are reached at a distance, between the donor and acceptor, two times larger than the SP propagation lengths. This fact can be understood as follows: due to the $\hat{\rho}$--component of the SP electric field (\ref{camporho1}) depends on the $z$ distance as $E_{z}(z) \approx e^{i \alpha_m z}=e^{i {\rm Re\mit} \alpha_m z-{\rm Im\mit} \alpha_m z}$, and the fact that in the absence the graphene wire, the field of the donor is written as (refer to \ref{ap1} for its derivation) $E_{0,z}(z) = \frac{e^{i k_2 z}}{z}$, it follows that the energy transfer contribution of either of the two SP channels (\ref{camporho1}) can be written as \begin{equation} F_{SP} = |\frac{E_{\rho}(z) }{E_{0,z}(z) }|^2 =z^2 e^{-2 {\rm Im\mit} \alpha_m z}, \end{equation} which reaches its maximum value at $z=\frac{1}{{\rm Im\mit} \alpha_m}=2 L$. It is worth noting that, if the same donor--acceptor configuration (where both donor and acceptor dipole moments are oriented perpendicularly to the graphene surface) is placed near a planar graphene system, such as a single graphene sheet or a planar graphene waveguide, then the maximum energy transfer value is reached at a donor--acceptor separation which coincides with the SP propagation length \cite{olivo}. This difference lies in the geometry of the system through which the energy emitted by the donor dipole travels. As its required by energy conservation, in the planar graphene case (2D case), the plasmonic energy amplitude is proportional to $1/length$ ($length = \mbox{distance between the emission and the observation point}$) whereas for the wire case (1D case) this amplitude is constant. Figure \ref{omegac0p158}b shows the energy transfer rate between the donor and acceptor as a coherent superposition of the SP$_0$ and the SP$_1$ contributions and calculated by using Eq. (\ref{ETnmodos}). Due to the presence of the interference term $I_{nm}$ with $n=0$ and $m=1$, this curve shows a pronounced spatial oscillation whose period $\Lambda=17.2\mu$m, a value that can be calculated within the framework of the model in Eq. (\ref{Flj}), where the interference term between the SP$_0$ and SP$_1$ is written as \begin{equation}\label{Ilj} I_{0,1}=F_{0,1}+F_{1,0} \approx \cos [({\rm Re\mit} \alpha_{\mbox{\tiny{1}}}-{\rm Re\mit} \alpha_{\mbox{\tiny{0}}}) z]. \end{equation} Equation (\ref{Flj}) shows a periodic spatial dependence along $z$ direction with a period $\Lambda=2 \pi / ({\rm Re\mit} \alpha_{\mbox{\tiny{0}}}-{\rm Re\mit} \alpha_{\mbox{\tiny{1}}})=2 \pi/(0.794\mu\mbox{m}^{-1}-0.428\mu\mbox{m}^{-1}) \approx 17.2\mu$m, where we have used the values of the SP propagation constants calculated in Figure \ref{dispersion}a for $\omega/c=0.158\mu$m$^{-1}$. \begin{figure}[htbp!] \centering \resizebox{0.45\textwidth}{!} {\includegraphics{omega0p158yy_zz.eps}} \caption{\label{fig:epsart} Contribution of the SP$_0$ and the SP$_1$ ($F_{00}$ and $F_{11}$), to the normalized energy transfer rate between two dipoles, both placed at a distance $l=0.5\mu$m from the surface of the graphene wire ($\rho_D=\rho_A=1.5\mu$m, $\phi_D=\phi_A=0,\, \mbox{and}\,\, z_D=0$), as a function of the separation $z$ along the wire. The frequency $\omega/c=0.185\mu$m$^{-1}$ and the dipole moments are oriented along the $\hat{z}$ direction (a) and along $\hat{\phi}$ direction (b). The inset in (b) shows the total energy transfer rate as a superposition of the SP$_0$ and SP$_1$ modes as a function of the $z$ separation between the donor and acceptor. The waveguide parameters are the same as in figure \ref{dispersion}. }\label{omegac0p158yy_zz} \end{figure} We next consider the case where the two dipole moments are parallel to the surface of the cylinder but perpendicular to the axis of the cylinder, $\hat{p}_D=\hat{p}_A=\hat{\phi}$ as shown in the inset in Figure \ref{omegac0p158yy_zz}a. Since the electric field component of the SP$_0$ along the $\hat{\phi}$ direction is zero \cite{depineguias}, the $m=0$ plasmonic order is not coupled to the dipole incident field, and as a consequence the energy transfer contribution associated to this order is zero [we have numerically verified this assertion]. In Figure \ref{omegac0p158yy_zz}a we have plotted the energy transfer contribution of the SP$_1$ mode. As in the previously presented case where the donor and acceptor dipole moments are perpendicular to the graphene cylinder, we also observe that the maximum normalized energy transfer rate is obtained for a value of the $z$ separation two times larger than the propagation length of the SP, $z_{max} \approx 100\mu$m$=2L_{m=1}$. In Figure \ref{omegac0p158yy_zz}b we have plotted the energy transfer contribution for the case where the two dipole moments are parallel to the axis of the cylinder, $\hat{p}_D=\hat{p}_A=\hat{z}$. Unlike previous configurations, the distance $z_{max}\approx 600\mu$m for the $m=0$ order and $z_{max}\approx 200\mu$m for the $m=1$ order. These values represent fourfold the SP propagation length of the $m=0$ and $m=1$ orders. This fact can be understood by taking into account that, in the absence of the graphene cylinder, the $z$ component of the donor electric field for $x_A=x_D$ is written as (see \ref{ap1}) \begin{equation} E_{0,z}(z) \approx \frac{e^{i k_1 z}}{z^2}, \end{equation} while the $\hat{z}$ component of the SP electric field is as in Eq. (\ref{E2z}), $E_{z}(z) \approx e^{i \alpha_m z}=e^{i {\rm Re\mit} \alpha_m z-{\rm Im\mit} \alpha_m z}$. Thus, the energy transfer contribution of either of the two SP channels (\ref{campoz1}) can be written as \begin{equation} F_{SP} = |\frac{E_{\rho}(z) }{E_{0,z}(z) }|^2 =z^4 e^{-2 {\rm Im\mit} \alpha_m z}, \end{equation} which reaches its maximum value at $z=\frac{2}{{\rm Im\mit} \alpha_m}=4 L_m$. Note that the values of the normalized energy transfer rate shown in Fig. \ref{omegac0p158yy_zz}b (donor--acceptor emitters with dipole moment oriented parallel to the wire axis) are approximately two orders of magnitude larger than that corresponding to perpendicular orientation plotted in Figs. \ref{omegac0p158} and \ref{omegac0p158yy_zz}a. This is true because the energy transfer rate without graphene wire decays as $z^{-4}$ for donor--acceptor emitters oriented parallel to the wire axis whereas it decay as $z^{-2}$ for other orientations of the emitters. In the inset in Figure \ref{omegac0p158yy_zz}b we plotted the curve corresponding to the energy transfer rate as a superposition of the SP$_0$ and SP$_1$ modes as a function of the $z$ separation between the donor and acceptor. This curve presents an oscillation whose spatial period is the same as in Figure \ref{omegac0p158}b, $\Lambda=17.2\mu$m. It is worth noting that the calculation of the energy transfer for small donor--acceptor separations ($z \approx \lambda=2 \pi c/\omega$) is a limitation of the presented model. At these distances, the contribution of the radiative modes, which are excluded in our model, is not negligible and our calculations depart significantly from experimental values. Since the emitter--SP coupling decreases with the emitter--cylinder distance, we expect this effect becomes even more pronounced when emitters are far away from the surface of the cylinder. \section{Conclusions} \label{conclusiones} In conclusion, we have examined the energy transfer rate behavior from a donor to an acceptor close to a graphene--coated wire of circular cross section. We developed an analytical classical method and obtained a rigorous solution for the electromagnetic field in an integral form. By solving the eigenmodes dispersion equation, which is related to the study of the non--trivial solutions to the boundary value problem in the absence of external sources, we have obtained the complex propagation constants of the graphene--wire SPs. This allowed us to calculate the contribution of each of these SPs to the total energy transfer rate. In all the presented examples, we have provide a comprehensive analysis about the strong impact of SPs on the energy transfer rate between two single emitters in terms of their kinematic characteristics. Our calculations show that the SP maximum contribution to the total normalized energy transfer is reached when the donor--acceptor distance is twice the value of the SP propagation length for the configuration when both dipole moments are oriented perpendicular to the wire axis. This result differ from that obtained for planar graphene systems, such as a single graphene sheet or a planar graphene waveguide for which the maximum energy transfer value is reached at a donor--acceptor separation which coincides with the SP propagation length. In case where the dipole moments of both the donor and acceptor are parallel to the wire axis, these maximum contributions are reached at a distance four times larger than the SP propagation lengths. In addition, we have obtained a simple relation, which uses the SP dispersion relation, that allows us to calculate the spatial dependence of the normalized energy transfer rate between two quantum emitters. Although in our examples only it is consider three polarization directions, the method described in section \ref{teoria} allows to calculate the energy transfer regarding an arbitrary dipole moment orientation in relation to the graphene--coated wire. In particular, from the presented results it can be inferred that, for an arbitrary orientation of the dipole moments, each of the modal plasmonic contributions to the normalized energy transfer rate will have two characteristic lengths related with the propagation length of the SPs involved. Finally, the research can be continued by considering graphene--coated wire with a finite lenght. In this case, reflections at the wire facets modify the dispersion relation of SPs playing a key role in the energy transfer process. A simple semi--analytical approach used in case of a metallic wire \cite{lalane} considers the field confinement in the transverse wire direction and reflections at the wire ends as two completely independent problems. This procedure leads to dispersion curves of an infinite cylinder but with an intermode spacing which is proportional to the inverse wire length (Fabry--Perot modes). A most rigorous approach that could be applied to the graphene--coated wire takes into account the formulation of the equivalence theorem to obtain a dispersion relation of the Fabry--Perot modes \cite{bordo}. As a result of applying these two approaches, the energy transfer rate would be enhanced at the frequencies corresponding to Fabry--Perot modes. Although we could planning such study in a future, as a first step, we believe that our contribution can be valuable for experimentalist, which using the dispersion relation of SPs, can calculate the interaction distance between a pair of quantum emitters by using a simple relation. \section*{Acknowledgment} The authors acknowledge the financial support of Consejo Nacional de Investigaciones Cient\'{\i}ficas y T\'ecnicas (CONICET). Discussions with Vasilios Karanikolas (Materials Science Department, School of Natural Sciences, University of Patras, Patras, Greece) are gratefully acknowledged.

Introduction ============ Hepatocellular carcinoma (HCC) is one of the most malignant solid tumors and is the second leading cause of cancer-related mortality \[[@B1]\]. The established risk factors of HCC are viral hepatitis, alcohol abuse, and non-alcoholic fatty liver disease \[[@B2]\]. HCC is often diagnosed at an advanced stage, and it is not amenable to standard chemotherapy and is resistant to radiotherapy. In most cases, surgical resection and liver transplantation remain the only curative treatment options. Frequent tumor metastasis and recurrence after surgical intervention lead to the dismal outcome of patients with HCC. The 5-year survival rate of patients with HCC is approximately 5%, and over 650,000 people die of HCC each year worldwide \[[@B3]\]. The prediction of the prognosis and accurate patient stratification are crucial to optimize personalised treatment. This is currently performed by several staging scores, including the Barcelona Clinic Liver Cancer (BCLC) stage and the Cancer of the Liver Italian Program (CLIP) score \[[@B4],[@B5]\]. Modifications of these staging systems by the addition of new biomarkers, in particular those better reflecting tumor aggressiveness, are likely to improve the prognostic assessment of HCC patients and could therefore fulfill a clinical need. Researchers have found some new prognostic markers of HCC, such as squamous cellular carcinoma antigen, SOX9, and L1 cell adhesion molecule \[[@B6]-[@B9]\]. The microRNAs (miRNAs) are a class of highly conserved short noncoding RNAs, which suppress protein expression by inhibiting translation or inducing mRNA degradation by binding to the 3′UTR of target mRNAs\[[@B10],[@B11]\]. Beyond the involvement in diverse biological processes, it has been well demonstrated that deregulation or dysfunction of miRNAs can contribute to cancer development \[[@B12],[@B13]\]. MiR-25 is a member of the miR-106b\~25 cluster, which includes miR-106b, miR-93 and miR-25, that is located within intron 13 of the minichromosome maintenance protein 7(MCM7) gene on chromosome 7q22.1 \[[@B14],[@B15]\]. Accumulating evidence has shown that up-regulation of miR-25 is associated with the prognosis of several human malignant solid tumors, including those of the stomach, ovary and prostate \[[@B16]-[@B18]\]. Recently, Li Y et al. found that the miR-106b\~25 cluster was overexpressed in HCC tissues as well as cell lines, suggesting an important role of miR-106b\~25 cluster in carcinogenesis and development of HCC \[[@B19]\]. However, the clinical relevance of miR-25 has not been studied yet, and whether miR-25 expression has influence on the prognosis of HCC is still unknown. Therefore, in the present study, we investigated the feasibility of miR-25 as a novel prognostic biomarker for HCC. Materials and methods ===================== Patients and Tissue Specimens ----------------------------- A total of 131 fresh specimens of HCC and paracarcinomatous liver tissues were obtained from 131 patients who underwent hepatic resection at Provincial Hospital affiliated to ShanDong University between June 2006 and July 2012. Among all the subjects, the mean follow-up period was 47 months (from 11 months to 65 months), and there was no censored case. All these tissues were immediately stored in liquid nitrogen and kept freshly frozen at − 80°C. Written informed consent was accomplished from the patients for publication of this study and any accompanying images. Study protocol was approved by the Ethics Committee of Provincial Hospital affiliated to ShanDong University. Before surgical therapy, none of the patients had received neoadjuvant chemotherapy, radiation therapy, or immunotherapy. Related important clinical information, including age, gender, serum level of α-fetoprotein (AFP), liver cirrhosis, Hepatitis B virus infection, tumor diameter, number of tumor nodules, and TNM stage were collected from each patient's medical records. Clinical staging was performed according to the 2002 American Joint Committee on Cancer/International Union Against Cancer TNM staging system \[[@B20]\]. Patient characteristics were shown in Table [1](#T1){ref-type="table"}. ###### Relationship between miR-25 expression level and clinicopathologic parameters of hepatocellular carcinoma **Factor** **No.** **miR-25 expression** **P value** ----------------------------- --------- ----------------------- ------------- Gender         Male 81 8.34 ± 4.85     Female 50 8.11 ± 4.63 0.62 Age at diagnosis(year)         ≤50 53 8.01 ± 5.11     \>50 78 8.49 ± 3.89 0.21 Tumor size(cm)         ≤5 62 7.99 ± 5.13     \>5 69 9.01 ± 3.79 0.13 Tumor number         Solitary 70 8.13 ± 4.34     Multiple 61 8.57 ± 4.89 0.51 TNM stage         I-II 72 6.34 ± 3.12     III-IV 59 11.01 ± 5.61 0.01 Vein invasion         Presence 79 9.12 ± 4.89     Absence 52 7.31 ± 4.19 0.24 Cirrhosis         Negative 44 7.12 ± 3.19     Positive 87 8.89 ± 5.38 0.17 Hepatitis B virus infection         Negative 42 6.17 ± 4.65     Positive 89 9.21 ± 4.13 0.09 Serum AFP level (ng/ml)         ≤25 54 6.02 ± 3.87     \>25 77 10.99 ± 5.44 0.02 AFP,α-fetoprotein. RNA isolation and quantitative RT-PCR of miRNA-25 ------------------------------------------------- Total RNA was isolated from frozen specimen by homogenizing tissue in Trizol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. The purity and concentration of RNA were determined using NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). The differentially expressed amount of the miR-25 was validated in triplicate by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Briefly, 2 ug of RNA was added to RT reaction, and then, the cDNA served as the template for amplification of PCR with sequence-specific primers (Sangon Biotech, Shanghai, China) using SYBR PrimeScript miRNA RT-PCR kit (Takara Biotechnology Co. Ltd, Dalian, China) on the 7500 Real-Time PCR systems (Applied Biosystems, Carlsbad, CA, USA). The PCR cycling profile was denatured at 95°C for 30 s, followed by 40 cycles of annealing at 95°C for 5 s, and extension at 60°C for 34 s. Small nucleolar RNA U6 was used as an internal standard for normalization. The cycle threshold (C~T~) value was calculated. The 2^-ΔCT^ (ΔC~T~=C~TmiR25~-C~TU6\ RNA~) method was used to quantify relative amount of miR-25. Statistical analysis -------------------- Statistical analyses were performed using SPSS 13.0 soft-ware (Chicago, Ill., USA) and GraphPad Prism 5 (GraphPad Software Inc., CA, USA). The comparison of the expression level of miR-25 between HCC tissues and adjacent normal tissues was performed using the two-sample Student's t test. The correlation between the expression level of miR-25 and clinicopathological characters was assessed with the two-sample Student's t test. Survival rate was analyzed by log-rank test, and survival curves were plotted according to Kaplan--Meier. Multivariate analysis of the prognostic factors was performed with Cox regression model. All tests were two tailed and results with P\<0.05 were considered statistically significant. Results ======= The expression level of miR-25 in HCC samples and its relationship with clinicopathological characteristics ----------------------------------------------------------------------------------------------------------- The expression of miR-25 was significantly upregulated in HCC tissues (mean relative expression level: 8.287, SD=4.711) when compared with adjacent normal tissues(mean relative expression level: 4.177, SD=2.386, P\<0.0001, Figure [1](#F1){ref-type="fig"}). The relationship between miR-25 expression level with clinicopathological variables of HCC patients was shown in Table [1](#T1){ref-type="table"}. The relative miR-25 expression levels were significantly positively correlated with serum AFP (p=0.02) and TNM stage (p=0.01). {#F1} However, there was no significantly correlation of miR-25 expression with other clinical features such as gender (p=0.62), age (p=0.21), liver cirrhosis (p=0.17), Hepatitis B virus infection (p=0.09), vein invasion (p=0.24), tumor diameter (p=0.13), or number of tumor nodules (p=0.51). The expression levels of miR-25 correlate with prognosis of patients with HCC ----------------------------------------------------------------------------- Considering that the level of miR-25 expression was significantly correlated with TNM stage and serum AFP level, we hypothesized that miR-25 might affect the prognosis of HCC patients. To confirm this possibility, the miR-25 expression level and the prognosis of patients with HCC were analyzed by using the Kaplan--Meier method. The results indicated that patients who had high miR-25 expression had a shorter overall survival than patients who had low miR-25 expression (median overall survival, 31 months versus 42.9 months, p=0.0192; Figure [2](#F2){ref-type="fig"}). The multivariate Cox regression analysis indicated that miR-25 expression (HR=2.179; p=0.001), TNM stage (HR=1.782; p=0.014), and vein invasion (HR=1.624; p=0.020) were independent prognostic factors for overall survival (shown in Table [2](#T2){ref-type="table"}). {#F2} ###### multivariate analyses of prognostic factors in hepatocellular carcinoma **Variable** **Subset** **Overall survival** ----------------------------- ------------------- ---------------------- ------------- ------- miR-25 expression High/low 2.179 1.876-4.335 0.001 Gender Male/female 0.982 0.901-1.003 0.652 Age at diagnosis \>50/≤50 1.231 0.922-1.523 0.212 Tumor size \>5/≤5 1.479 0.991-2.127 0.090 Tumor number Multiple/solitary 1.854 0.823-2.132 0.121 TNM stage III-IV/I-II 1.782 1.389-2.993 0.014 Vein invasion Presence/absence 1.624 1.233-1.981 0.020 Cirrhosis Positive/negative 1.027 0.876-1.535 0.320 Hepatitis B virus infection Positive/negative 1.002 0.892-1.337 0.417 Serum AFP level \>25/≤25 1.377 0.882-1.335 0.398 CI, confidence interval; HR, hazard ratio; miR-25, microRNA-25. Discussion ========== Although a growing number of novel treatment strategies have been developed for HCC, such as molecular targeted therapy and gene therapy, to our disappointment, satisfactory therapeutic outcomes have not been achieved \[[@B21],[@B22]\]. Considering that the survival rate of HCC is still low, further identification of new prognostic markers remains important for the prevention and treatment of HCC. The discovery that noncoding components of the genome, including microRNA, can contribute to the pathogenesis of cancer has led investigators to contemplate using these molecules to guide clinical decision making \[[@B23]\]. So far, there are more than 1000 microRNAs annotated by the latest version of miRBase. The expression of miRNAs is remarkably deregulated in HCC, strongly suggesting that miRNAs are involved in the initiation and progression of this disease. MiR-25 is a member of the miR-106b\~25 cluster, which includes miR-106b, miR-93 and miR-25, that is located within intron 13 of the minichromosome maintenance protein 7 (MCM7) gene on chromosome 7q22.1 \[[@B14]\]. Previous studies have shown that the expression of miR-25 was up-regulated significantly in human stomach cancer, ovarian cancer, and prostate cancer \[[@B16]-[@B18]\]. In the study by Kim BH et al., miR-25 was found to be up-regulated in human gastric carcinoma tissues when compared to adjacent non-neoplastic tissues. The high expression of miR-25 in gastric carcinoma tissues may be a high risk factor associated with tumor penetration through serosa, lymph node metastasis, distant metastasis, and poor long-term survival in patients undergoing radical resection and adjuvant systemic chemotherapy \[[@B16]\]. Poliseno L et al. found that miR-106b\~25 cluster was aberrantly overexpressed in human prostate cancer, which potentiated cellular transformation both in vitro and in vivo. They demonstrated that the intronic miR-106b\~25cluster cooperated with its host gene MCM7 in cellular transformation both in vitro and in vivo \[[@B17]\]. Zhang H et al. have found that miR-25 was strongly up-regulated in ovarian cancer tissue versus adjacent non-tumor tissue. The expression levels of miR-25 in ovarian cancer cell lines were similar with ovarian cancer samples compared with the normal ovarian epithelial cells. Overexpression of miR-25 in ovarian cancer cells enhanced cell proliferation whereas down-regulation of miR-25 induced apoptosis. The effects of miR-25 abrogation were partly mediated by the intrinsic apoptosis pathway. Many pro-apoptotic proteins such as Bim, Bax and caspase-3 were up-regulated after transfection \[[@B18]\]. However, investigators also found that expression of miR-25 was down-regulated in other cancer. Li Q et al. found that the expression of miR-25 was down-regulated in colon cancer, and miR-25 might suppress the proliferation and migration of colon cancer cells as a tumor suppressor gene in vitro and in vivo \[[@B24]\]. Therefore, we speculate that the function of miR-25 is tissue specific. Li Y et al. have found that miR-25 was strongly up-regulated in HCC tissue when compared with the corresponding paired non-tumor samples. However, the clinical significance of miR-25 gene expression in HCC remains unclear. In the present study, we found that miR-25 expression was proven to be associated with advanced TNM stage, suggesting that miR-25 might be involved in the carcinogenesis and metastasis of HCC. More importantly, we proved that patients with a high expression of miR-25 tended to have shorter survival than patients with lower levels, indicating that high miR-25 level is a marker of poor prognosis for patients with HCC. However, the precise molecular mechanisms behind the altered expression of miR-25 in HCC and its function are not very clear. In the study by Li Y et al., knock-down studies for the miR-106b-25cluster, which includes miR-106b, miR-93 and miR-25, showed that the expression of the cluster was necessary for cell proliferation and for anchorage independent growth \[[@B19]\]. Additional studies are needed to more clearly and comprehensively articulate the molecular mechanisms of both the cause and the effects of altered expression of miR-25 in the development and/or progression of HCC. In summary, to the best of our knowledge, the present study is the first to report the differential expression of miR-25 in HCC and the possible use of miR-25 as a novel prognostic marker in HCC. The present findings demonstrate high expression of miR-25 in HCC tissue, which is associated with a poor prognosis in HCC patients. Further studies are needed to elucidate the mechanisms of action of miR-25 in HCC. Competing interests =================== The authors declare that they have no competing interests. Authors' contributions ====================== ZXS and JZ carried out the experimental studies and drafted the manuscript. ZHR, WMG, and YGW carried out part of the experimental studies. CKQ designed the experiments and modified the manuscript. All authors read and approved the final manuscript. Acknowledgement =============== This work was supported by Department of science and technology of Shandong Province (No. 2013GSF11862).

Background ========== Many aspects of muscle development and maintenance were elucidated through genetic screens in the free-living nematode *C. elegans*\[[@B1]-[@B3]\]. Subsequently, homologs of these genes can be found in other organisms using bioinformatics, allowing a broader understanding of how they may function. Most of the studies investigating muscle development and maintenance in *C. elegans*focus on the location of the proteins or examine their genetic and biochemical nature. There is less work on determining what happens to these muscle proteins (and hence changes in muscle composition) over the course of normal development \[[@B4],[@B5]\]. The formation, maintenance and degradation (wasting) of muscles involve a suite of proteins, many that are highly conserved \[[@B6]-[@B12]\]. The wasting of muscles over time is known as sarcopenia \[[@B13]\]. Sarcopenia is attributed to many factors including aging, hormone balance, decreased physical activity, malnutrition and oxidative stress \[[@B14],[@B15]\]. In *C. elegans*, contraction-related injury of pharynx muscles causes sarcopenia \[[@B15]\]. Sarcopenia normally occurs slowly over the lifetime of an organism. However, several genetic diseases such as Duchenne muscular dystrophy (DMD) generate similar, but hastened, wasting phenotypes \[[@B16]\]. In these cases, however, muscles can never regenerate due to their genetic predisposition. While genetic disorders may mimic sarcopenia, some organisms undergo rapid muscle wasting that is normal to specific stages of their lifecycle. Some reports indicate that this targeted degradation of muscle proteins is actually adaptive and not pathological. Thus, sarcopenia provides resources that can be utilized for other metabolic functions. \[[@B17]\]. The decrease in muscle protein content, presumably, would be accompanied by a decrease in transcription of those genes. Our lab has focused on the interaction between the parasitic nematode *Heterodera glycines*and *Glycine max*\[[@B18]-[@B26]\]. *H. glycines*is the major parasite of *G. max*and is responsible for causing losses approaching a billion dollars annually for the agricultural industry in the U.S. \[[@B27]\]. Thus, knowledge on the regulation of muscle development is not only relevant to muscle senescence, probable nutrient recycling, for better understanding its developmental biology and for understanding parasitism, but may, in turn, lead to better nematode control measures. The *[C]{.ul}. [e]{.ul}legans-[H]{.ul}. [g]{.ul}lycines*database (CeHg database) allows us to assign function and better understand *H. glycines*genes \[[@B26]\]. The CeHg database connects the vast information on *C. elegans*gene function with *H. glycines*expressed sequence tags (ests) to rapidly identify essential *H. glycines*genes that could be attributed to a specific defect (i.e. lethality \[[@B26]\]). In fact, one *H. glycines*gene predicted to be essential using this bioinformatics approach, was shown to be essential through gene silencing using RNAi \[[@B26]\]. RNAi decreased the transcript abundance of the targeted gene, causing nematode death. \[[@B26]\]. We believe that the CeHg database can identify genes important to muscle biology and sarcopenia in *H. glycines*during its lifecycle. The genetically-defined *[unc]{.ul}oordinated*(*unc*) genes perform many functions in *C. elegans*. The protein products of the *unc*genes are involved in muscle focal adhesion, architecture and stimulation (via neuromuscular connections). However, null alleles of *unc*genes can exhibit [P]{.ul}aralyzed [A]{.ul}rrested at [T]{.ul}wo-fold stage (*pat*) phenotypes. The *unc*mutants all display uncoordinated motion, slow movement, or paralysis \[[@B3]\]. The *unc*family of mutants contains 114 different members \[[@B3],[@B28]\]. We believe that much of the muscle degeneration observed in *H. glycines*would likely involve transcriptional regulation of *H. glycines*homologs of *unc*genes whose protein products are involved in (1) the acto-myosin complex, (2) muscle focal adhesion or (3) other aspects of muscle composition and regulation. In this paper, we use an in-house bioinformatics database \[[@B26]\] to identify *H. glycines*homologs of *unc*genes. We identify *H. glycines*homologs of genes composing (1) acto-myosin complex, (2) muscle focal adhesion and (3) other aspects of muscle composition and regulation. We determine the transcript abundance of these *H. glycines unc*homologs using RT-PCR. Gene expression for many of these *Hg*-*unc*homologs is high during the mobile phase of *H. glycines*development and is lower during the sedentary phase of *H. glycines*life cycle. Results ======= Identification of unc genes in *H. glycines* -------------------------------------------- *Unc*gene products compose various parts of the body wall muscle (Fig. [1](#F1){ref-type="fig"}). We identified 45 *H. glycines*est homologs of *C. elegans unc*genes (*Hg-unc*) (Figs. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). We confirmed the identification of the *Hg-unc*genes by performing manual blast searches of the *C. elegans unc*genes in Genbank. We also identified other *H. glycines*ests (dystrophin \[*Hg-dys-1*\], neprilysin \[*Hg-nep-1*\], actin \[*Hg-act-1*\], talin \[*Hg-talin*\], *pat-6*\[*Hg-pat-6*\]) whose mutants exhibit *unc*phenotypes or whose protein products interact with UNC proteins in *C. elegans*. However, the original *unc*mutant screens did not identify them (Figs. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). ![A Diagrammatic representation of a muscle cross-section shows the dense body (DB) and M-line (M). This section is divided into four regions; A, muscle; B, basal lamina; C, hypodermis; D, cuticle. The M-line is composed of *unc-89*. Arrows point toward the position of actin and myosin. The *unc*genes studied and their relative positions are provided to the right. Genes in red are part of this study. Genes in black were not studied. Figure adapted from \[6, 73, 74\].](1471-213X-7-35-1){#F1} ![*H. glycines*est homologs of *C. elegans unc*genes. Column headings provide the *unc*gene, *H. glycines*est sequence, e-value, and gene function. The genes are divided into six groups (Group I-VI) based on the following arbitrarily selected significance intervals: E-values between 0 and 1E-100 (Group I), between 1E-100 and 1E-80 (Group II), between 1E-80 and 1E-60 (Group III), between 1E-60 and 1E-40 (Group IV), between 1E-40 and 1E-20 (Group V) and E-values \> 1E-20 (Group VI) \[26\]. In yellow are the genes used for RT-PCR experiments.](1471-213X-7-35-2){#F2} ![*H. glycines*est homologs of *C. elegans unc*genes. Column headings provide the *unc*gene, *H. glycines*est sequence, e-value, and gene function. The genes are divided into six groups (Group I-VI) based on the following arbitrarily selected significance intervals: E-values between 0 and 1E-100 (Group I), between 1E-100 and 1E-80 (Group II), between 1E-80 and 1E-60 (Group III), between 1E-60 and 1E-40 (Group IV), between 1E-40 and 1E-20 (Group V) and E-values \> 1E-20 (Group VI) \[26\]. In yellow are the genes used for RT-PCR experiments. The previously published *H. glycines*muscle gene, *Hg-unc-*87 \[19\] is presented in cyan.](1471-213X-7-35-3){#F3} Transcript abundance of *unc*genes involved in thin filament composition and maintenance ---------------------------------------------------------------------------------------- We identified a decline in transcript abundance for *Hg-unc-87*during the transition from the mobile to the sedentary phase of the *H. glycines*lifecycle \[[@B19]\]. This observation indicates that microfilament degradation occurs during muscle wasting. Bioinformatics analyses identified several *H. glycines*ests that are homologous to *C. elegans*thin filament genes, including *Hg-act-1*, *Hg-unc-27*, *Hg-unc-60A*, *Hg-unc-60B*and *Hg-unc-78*(Figs. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). RT-PCR revealed a substantial decline in actin transcript abundance occurring between the J2 stage and 15 dpi nematodes (Fig. [4](#F4){ref-type="fig"}). RT-PCR revealed a substantial decline in transcript abundance of *Hg-unc-27*occurring between the J2 stage and 15 dpi nematodes (Fig. [4](#F4){ref-type="fig"}). We examined the expression profile of the two *Hg*-*unc-60*isoforms (A and B) and *Hg-unc-78*. *Hg-unc-60A*is the non-muscle *unc-60*isoform, while *Hg-unc-60B*is the muscle-specific isoform) RT-PCR of *Hg-unc-60A*reveals little change in transcript abundance occurring throughout the *H. glycines*lifecycle (Fig. [4](#F4){ref-type="fig"}). However, RT-PCR reveals a substantial decline in transcript abundance occurring for *Hg-unc-60B*between the J2 stage and 15 dpi nematodes (Fig. [4](#F4){ref-type="fig"}). The decline in transcript abundance for *Hg-unc-60B*and not *Hg-unc-60A*, occurring between the J2 stage and 15 dpi nematodes, is in agreement with its muscle-specific activity. RT-PCR reveals little change in transcript abundance occurring throughout the *H. glycines*lifecycle for *Hg-unc-78*(Fig. [4](#F4){ref-type="fig"}). {#F4} Transcript abundance of *unc*genes involved in thick filament composition and maintenance ----------------------------------------------------------------------------------------- Bioinformatics analyses identified *H. glycines*ests homologous to *C. elegans*thick filament genes (Figs. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Transcript abundance of *H. glycines unc*genes whose homologous gene products compose thick filaments in *C. elegans*was measured using RT-PCR. RT-PCR revealed a substantial decline in transcript abundance of *Hg-unc-15*and *Hg-unc-54*occurring between the J2 stage and 15 dpi nematodes (Fig. [5](#F5){ref-type="fig"}). Furthermore, transcript levels of *Hg-unc-89*also decline between the J2 stage and 15 dpi nematodes (Fig. [5](#F5){ref-type="fig"}). {#F5} Transcript abundance of focal adhesion complex genes ---------------------------------------------------- Bioinformatics analyses also identified *H. glycines*ests homologous to *C. elegans*focal adhesion genes (Figs. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). *H*g-*unc-97*transcript levels decrease in abundance between the J2 and 15 dpi nematodes, as shown by RT-PCR (Fig. [6](#F6){ref-type="fig"}). We explored the focal adhesion complex further by examining the transcript abundance of *Hg-unc-112*, *Hg-pat-6*and *Hg-talin*. *Hg-unc-112*, *Hg-pat-6*and *Hg-talin*transcript levels decrease between the J2 stage and 15 dpi nematodes (Fig. [6](#F6){ref-type="fig"}). Bioinformatics analyses did not identify homologs of other focal adhesion complex proteins. {#F6} RT-PCR of *H. glycines*ests homologous to *C. elegans unc*genes --------------------------------------------------------------- Bioinformatics analyses identified *H. glycines*ests homologous to *C. elegans*genes whose protein products function in other aspects of muscle biology (Figs. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}) These *H. glycines unc*genes include *Hg-unc-9*, *Hg-unc-22*(twitchin), *Hg-unc-31*(CAPS), *Hg-unc-52*(perlecan), *Hg-unc-101*, *Hg-unc-115*, *Hg-unc-110*(*Hg-twk-18*), *Hg-dys-1*, and *Hg-nep-1*. RT-PCR analysis indicated that modest changes in transcript abundance occur for *Hg-unc-9*, *Hg-unc-22, Hg-unc-31*, *Hg*-*unc-52*, *Hg-unc-101*, *Hg-unc-115, Hg-dys-1*, and *Hg-nep-1*between the J2 stage and 15 dpi nematodes (Fig. [7](#F7){ref-type="fig"}). RT-PCR also indicated that *Hg-unc-110*transcript abundance decreases substantially between the J2 stage and 15 dpi nematodes (Fig. [7](#F7){ref-type="fig"}). {#F7} Discussion ========== Use of the CeHg database to identify *unc*genes in *H. glycines* ---------------------------------------------------------------- Body wall muscle degradation accompanies the sedentary phase of *H. glycines*as it feeds from the syncytium. Thus, important transcriptional, translational, and post-translational changes occur at this time. We began our analysis of *H. glycines*muscle wasting by identifying *H. glycines*homologs of *C. elegans*muscle genes. We then identified the transcript abundance of those genes whose protein products compose the acto-myosin complex, muscle focal adhesion complex, neuromuscular connections and potassium channels. The acto-myosin complex is composed of interdigitating thin and thick filaments that are bundled by UNC-87 \[[@B29]-[@B31]\]. Previously, we observed a decline in transcript abundance of *Hg-unc-87*\[[@B19]\]. This demonstrated that depletion of components of the acto-myosin complex may occur during the sedentary phase of the *H. glycines*lifecycle. Actin and troponin I (*unc-27*) are primary components of the thin filaments. Actin is not classified as an *unc*gene. However, the *unc-92*mutant of *C. elegans*maps to the actin locus and may actually be actin. Recently, Willis et al. \[[@B11]\], found that the actin family in *C. elegans*is composed of five highly conserved isoforms (act-1--5) and yields an *unc*phenotype \[[@B11]\]. Only one actin gene is present in *H. glycines*\[[@B32]\]. *Unc-27*is involved in thin filament maintenance. UNC-27 forms a complex with troponin C (PAT-10) and troponin T \[[@B33]-[@B35]\] to accomplish calcium-dependent regulation of the acto-myosin interaction \[[@B36]\]. Mutant *unc-27*disorganizes dense body positioning. Mutant *unc-27*causes less well-defined sarcomeres with small regions of thin filaments interspersing within the overlap of A-bands \[[@B37]\]. We found that, as expected, *Hg-act-1*and *Hg-unc-27*experience a substantial decrease in expression between J2 and 15 dpi nematodes The dynamic nature of actin filaments is under control of the actin interacting proteins UNC-60 and UNC-78. UNC-60 is the [a]{.ul}ctin [d]{.ul}epolymerizing [f]{.ul}actor (ADF) cofilin. Mutations in *unc-60*cause disorganization in muscles by preventing bundling of thin filaments with myosin into functional contractile units \[[@B38]\]. However, in *C. elegans*the *unc-60*gene actually encodes two completely different protein products. UNC-60A and UNC-60B are products of SUP-12-dependent alternative splicing \[[@B39]\]. UNC-60A and UNC-60B perform distinct roles in actin dynamics \[[@B40]\]. UNC-60A is the non-muscle cofilin isoform while the UNC-60B is the muscle-specific cofilin. Like *C. elegans*\[[@B41]\], *H. glycines*has orthologous mRNA sequences for both *unc-60A*and *unc-60B*. UNC-78 is the muscle-specific [a]{.ul}ctin [i]{.ul}nteracting [p]{.ul}rotein (AIP). UNC-78 works in concert with UNC-60B to depolymerize microfilaments into actin monomers \[[@B40]-[@B43]\]. Unlike *unc-60*, *unc-78*does not appear to have multiple splice variants that perform distinct muscle and non-muscle functions. Our examination of *unc-60*, indicates that the muscle-specific *unc-60*isoform, *Hg-unc-60B*, exhibits a substantial decrease in transcript abundance between J2 and 15 dpi nematodes. This is consistent with its important role in muscle organization. As expected, the non-muscle *unc-60*isoform, *Hg-unc-60A*, does not exhibit changes in transcript abundance during the *H. glycines*lifecycle. *Hg-unc-78*, a gene whose protein product regulates actin polymerization does not experience a substantial change in gene expression during the transition from the J2 stage to the sedentary phase. These observations, taken together with the substantial decrease in transcript abundance of the actin bundling muscle gene *Hg-unc-87*\[[@B19]\], indicate that major changes in transcript abundance occur for *Hg-act-1*, *Hg-unc-27*and the protein products (i.e. *Hg*-UNC-60B) that regulate actin in the body wall muscles. Myosin metabolism and muscle mass --------------------------------- Thick filaments are major components of muscles. In *C. elegans*, myosin (UNC-54), paromyosin (UNC-15) and myosin heavy chain A (MYO3) compose thick filaments. Thick filaments are anchored to the M-line on one side and bound to the dense body on the side by the protein titin \[[@B44]\]. UNC-89 organizes muscles by assembling thick filaments into A-bands \[[@B45]\]. UNC-89 is also essential for M-line assembly \[[@B45]\]. There are three UNC-89 isoforms n *C. elegans*\[[@B45]\]. Our RT-PCR analysis demonstrates a decrease in transcript abundance for *Hg*-*unc-15*, *Hg*-*unc-54*and *Hg*-*unc-89*occurring during muscle wasting. Thus, a decrease in transcript abundance for actin and myosin gene products occurs during muscle wasting as nematodes are becoming sedentary during their parasitic feeding stages. Loss of muscle mass occurs in mutants for muscle genes. For example, loss of muscle mass is a characteristic of DMD, caused by *dys-1*mutants. However, in *C. elegans*, DMD-like muscle defects also require dystrobrevin (DYB-1). A microarray experiment explored the complexities of the *dys-1*mutant background \[[@B46]\]. Microarrays of *dys-1*revealed 44 total probe sets are induced while 71, including *unc-89*, are suppressed \[[@B46]\]. It is not clear how a decrease in transcript abundance of *unc-89*is involved in DMD. Differential expression of myosin transcripts was also observed in that study \[[@B46]\]. Muscle focal adhesion complex degradation and muscle mass --------------------------------------------------------- The focal adhesion complex is composed of numerous proteins. In *C. elegans*, UNC-97 is part of the PINCH family of proteins that are composed of five [**l**]{.ul}in-11 [**i**]{.ul}sl-1 [**m**]{.ul}ec-3 \[[@B47]\] (LIM) domains. LIM domains are found in proteins with wide-ranging cellular roles including fate determination of cells, cytoskeleton, organ development and intracellular trafficking. LIM domains have a consensus amino acid sequence CX~2~CX~16--23~HX~2~CX~2~CX~2~CX~16--23~CX~2--3~(C, H, D) and are putative structural motifs for binding zinc \[[@B47],[@B48]\]. The tandem nature of the LIM domains provides potential for multiple protein-protein interactions. The LIM domain-containing protein family is characterized by its ability to attach to body wall muscles, vulval muscles, and mechanosensory neurons \[[@B49],[@B50]\]. *C. elegans*UNC-97 does this by positioning itself with the β-integrin PAT-3 of muscles \[[@B50]\]. A splice-site mutation of *unc-97*displays an *unc*phenotype, while the phenotype displayed by RNAi is *pat*and is embryonic lethal. Thus, UNC-97 is necessary for assembly and stability of muscular adherens junctions \[[@B50]\]. In *C. elegans*, the structural components that secure myofibers to the extracellular matrix, such as integrin, vinculin, talin, and α-actinin are conserved. This complex is similar in organization to adherens junctions in tissue culture cells \[[@B50]\]. The depletion of UNC-97 function leads to the disruption of these focal adhesion structures as well as of the mechanosensory neurons \[[@B50]\]. Further biochemical studies show the integrin-linked kinase (PAT-4) binds UNC-97. PAT-4 binds at the first Zn^+2^-binding module of the first LIM domain through an interaction with the N-terminal-most region of ankyrin repeat 1 (ANK1). In *C. elegans*, a biochemical interaction occurs between the sex-linked UNC-98 and UNC-97 \[[@B51]\]. This interaction requires the first two LIM domains of UNC-97 and all four Zn^+2^-fingers of UNC-98 \[[@B51]\]. The biological role for LIM domain 4, the most highly conserved LIM domain of UNC-97, remains elusive. Other proteins composing focal adhesion complex are UNC-112, a novel protein required for integrin localization \[[@B52]\]; PAT-6, responsible for assembling integrin adhesion complexes \[[@B53]\] and TALIN, a protein requiring β-integrin for its incorporation into focal adhesion-like structures \[[@B54]\]. Our bioinformatics analysis identified the focal adhesion complex genes *Hg-unc-97*, *Hg-unc-112*, *Hg-talin*, and *Hg-pat-6*. A modest decrease in transcript abundance occurs for these genes between the J2 and 15 dpi nematodes. These results demonstrate that the deterioration of focal adhesion sites, by depletion of *Hg-*UNC-97, *Hg-*UNC-112, *Hg-*TALIN, and *Hg-*PAT-6, may not be a major contributor to body wall muscle wasting. *Unc*metabolism and muscle mass ------------------------------- *Unc*gene products perform other important roles in muscle biology. For example, UNC-9, is a neuromuscular gap junction protein \[[@B55]\]; UNC-22 (twitchin) is involved in muscle A-band structure \[[@B56],[@B57]\]; UNC-31(CAPS) is involved in the neuromuscular junction and neurosecretion \[[@B58]\], UNC-52 (perlecan), is a muscle basement membrane heparan sulfate proteoglycan protein \[[@B59]\]. Mutant *unc-52*can also exhibit a *pat*phenotype, depending on the mutant allele \[[@B60]\]; UNC-101, is a clathrin-associated protein having intense expression in muscles and pharynx; UNC-115, is an actin-binding, LIM domain containing protein that is involved in neuronal axon guidance \[[@B61],[@B62]\] and UNC-110, is a potassium channel subunit protein involved in body wall muscle control \[[@B63]\]. Dystrophin (*dys-1*) and neprilysin (*nep-1*) are other genes whose mutants exhibit *unc*-like phenotypes. The *dys-1*gene is the *C. elegans*Duchenne muscular dystrophy homolog. The *dys-1*gene product is part of the dystrophin-glycoprotein complex that is found in the plasma membranes of muscle cells. The dystrophin-glycoprotein complex is responsible for linking the intracellular cytoskeleton to the extracellular matrix and thought to be important for organizing signal molecules \[[@B64]\] and mechanical integrity \[[@B65]\]. The *nep-1*gene product is involved in the neuronal network of pharyngeal pumping \[[@B66]\]. We observed only modest changes in gene expression occurring for many of the other *H. glycines unc*gene homologs. However, the *H. glycines*homolog of the body wall muscle-specific potassium channel protein, UNC-110, experiences a substantial decrease in transcript abundance between the J2 and 15 dpi nematodes. This decrease in transcript abundance is similar to the decrease in transcript abundance shown for the acto-myosin genes. It is not clear how a decrease in abundance for potassium channel proteins like *Hg-*UNC-110 would contribute to the sedentary nature of *H. glycines*during later stages of parasitism. However, potassium channels do perform major roles in muscle function in *C. elegans*\[[@B63],[@B67],[@B68]\]. At least 42 genes exist in the *C. elegans*genome that encode [tw]{.ul}o-P domain [K]{.ul}(+) (TWK) channels. These K+ channel subunits contain four transmembrane domains and two pore regions. *Unc-110*is *twk-18*and in *C. elegans*, TWK-18 localizes to the body wall muscle. The *twk-18*mutant confers both uncoordinated movement and paralysis, probably a consequence of their expression of much larger potassium currents \[[@B63]\]. The locomotion defect caused by mutants in K+ channel genes \[[@B63],[@B67],[@B68]\] indicates how the substantial decrease in *Hg-unc-110*transcript abundance could contribute to the lack of mobility in *H. glycines*during its sedentary phase. Conclusion ========== Our results demonstrate a decrease in transcript abundance for a specific subset of *H. glycines*homologs of *unc*genes. This decrease in transcript abundance correlates to the sedentary phase of the *H. glycines*lifecycle. We show a substantial decrease in transcript abundance of genes composing the acto-myosin complex and also for the K+ channel homolog *Hg-unc-110*during muscle wasting. Deterioration of focal adhesion sites does not appear to account for much of the muscle mass lost during sarcopenia in *H. glycines*. Methods ======= Plant and nematode materials and RNA isolation ---------------------------------------------- Plant and nematode materials were grown at the United States Department of Agriculture Soybean Genomics and Improvement Laboratory as described previously \[[@B21]\] according to the moisture replacement system \[[@B69]\]. Our study uses eggs and J2 stage nematodes that are composed of male and female nematodes. This was done because at this time it is not possible to distinguish between immature male and females at the egg and J2 stages. Hatching and subsequent migration of J2s are identical between male and female nematodes. Thus, it is likely that, concerning muscle biology, males and females are nearly identical at the egg and J2 stages. The later stages we use (15 and 30 dpi) are composed entirely of sedentary parasitic female nematodes because that was the focus of this study. Briefly, *G. max*cv. Peking seeds were grown in a sand mix in standard greenhouse conditions. To promote hatching, eggs from the *H. glycines*isolate TN8 (susceptible reaction) were incubated in sterile water at room temperature on a rotary shaker at 25 rpm. After two days on the rotary shaker, the J2s were collected and concentrated by centrifugation to approximately 5,200 J2/ml. Replicate experiments were performed and completed by running one experiment to completion and then collecting data. A second experiment was then run at approximately one month later after the first experiment was completed. Thus, we isolated different isolations of *H. glycines*eggs, J2, 15 dpi and 30 dpi nematodes for each experiment. Four plants contained in a beaker were inoculated with 5,200 J2 nematodes. For RT-PCR experiments, recovery of the 15 and 30 dpi *H. glycines*samples from *G. max*roots was performed according to \[[@B69]\] and also done previously in our lab \[[@B19]\]. Briefly, *H. glycines*-infected *G. max*roots grown for either 15 or 30 dpi were dipped into water to remove sand. At 15 and 30 dpi, female *H. glycines*are partially emerged from the root, facilitating collection of pure nematode samples. Roots were lightly massaged to liberate female *H. glycines*into a sieve of 150 μm pore size (VWR Scientific; Bridgeport, NJ). This filtration step would remove any additional male nematodes that were remaining in the root. To obtain egg and J2 samples, mature females were harvested at 30 dpi and crushed. The eggs were sifted through a 250 μm sieve and captured onto a 25 μm sieve. The eggs were hatched for two days in distilled water on a rotary shaker at 25 rpm. Pure J2 suspensions are made by sifting them through a 41 μm nylon mesh and collected with a low-speed centrifugation. The RT-PCR samples (J2, 15 dpi female, 30 dpi female or eggs) were flash-frozen in liquid nitrogen and ground to a fine powder using mortar and pestle chilled in liquid nitrogen. Total RNA extraction was performed using the method of Mujer et al. \[[@B70]\]. CeHg database analysis ---------------------- The CeHg bioinformatics database \[[@B26]\] is a database containing 300,773 ests and 6,630 genomic sequences from *C. elegans*and 24,438 ests and 231 genomic sequences from *H. glycines*(May, 2006). These *C. elegans*and *H. glycines*sequences were used to create a local database using SQLServer2000. The sequences were imported into our local database. Subsequently we created a unigene set using the contig assembly program Seqman (DNAStar Inc.; Madison, WI) resulting in 3,782 contigs of 2 or more sequences and 4,522 singletons for *H. glycines*. These sequences were then blasted against the local *C. elegans*database. Parsing of the results of the blast searches was done with customized Perl scripts. These scripts extracted the best hits from the blast results, E-value, score and identities values. The parsed results were imported back into the database. SQL scripts were written to query the CeHg database for *C. elegans*genes having high homology. Our data base was then linked to WormBase \[[@B71]\] and PubMed \[[@B72]\] to identify *H. glycines*ests homologous to *C. elegans unc*genes. These results then were confirmed by performing manual blast searches of each *C. elegans unc*gene against the *H. glycines*sequences. RT-PCR ------ RNA was extracted from nematodes as previously described and treated with DNase I to remove genomic DNA. The cDNA was reversed transcribed from RNA using SuperScript First Strand Synthesis System for RT-PCR (Invitrogen; Grand Island, NY) with oligo d(T) as the primer according to manufacturer\'s instructions. All the primer sets were initially tested for specificity with a mixture of RNAs for all stages of nematodes. Genomic DNA contamination was assessed by PCR as described previously \[[@B19]\]. We performed this experiment to identify any contaminating genomic DNA that may exist in our cDNA. We used *Hg-unc-87*PCR primers (forward primer: 5\'GACAACACGGAGATTCCACTTCAG3\'; reverse primer, 5\'CTGGTCTGGTCGATGCTCTGCTC3\') that amplify different size fragments in the presence of genomic DNA as compared to pure cDNA. RT-PCR reactions containing no template and reactions using RNA processed in parallel but with no Superscript reverse transcriptase also served as controls for RT-PCR and produced no amplicon. After we determined that no contaminating genomic DNA existed in our cDNA, we performed RT-PCR. Relative quantities of expression using their respective primers (Fig. [8](#F8){ref-type="fig"}) were determined using an Mx3000P Real-Time PCR system following manufacturer\'s instructions (Stratagene; La Jolla, CA). DNA accumulation was measured using SYBR Green and ROX was used as reference dye. Only one product was present in each reaction as indicated by the SYBR Green dissociation curves of amplified products and by assay of terminal reactions by gel electrophoresis in 1% TBE agarose, thus ensuring that the product was of proper size. Template DNA was denatured for 10 minutes at 96°C, followed by PCR cycling temperatures set for denaturing for 30 seconds at 96°C, annealing for 60 seconds at 55°C and extension for 30 seconds at 72°C. The standard curve for the expression comparisons was constructed from the J2 stage sample. The J2 stage sample was diluted over a five-log range and used in parallel RT-PCR assays. All RT-PCR assays were conducted in triplicate. Threshold cycle (C~t~) values were plotted against the dilution series. PCR efficiencies were equal between the target and endogenous control. C~t~values and relative abundance were calculated using software supplied with the Mx3000P Real-Time PCR system. Our RT-PCR data was standardized against an est (CB380016) determined to experience no change in expression during *H. glycines*development. The relative abundance of mRNA was compared to that of CB380016 in the different sample types to calculate fold change. For each gene, a ratio was established between the control (CB380016) and the gene of interest (GOI) for the egg J2, 15 dpi and 30 dpi samples. To calculate fold expression, the ratio between CB380016 and the GOI at 15 dpi was set to a value of one. Other fold expression values for egg, J2 and 30 dpi were calculated using the ratio obtained at 15 dpi for GOI as the denominator. The ratio of the GOI for egg, J2 and 30 dpi, respectively, was used as the numerator. The value obtained after calculation was fold expression for those time-points. Standard error was used in the analyses. {#F8} Abbreviations ============= est, expressed sequence tag; SCN, soybean cyst nematode; DMD, Duchenne muscular dystrophy; LIM, [l]{.ul}in-11, [i]{.ul}sl-1, [m]{.ul}ec-3; CeHg, *C. elegans H. glycines*database; uncoordinated, *unc*; zinc finger, Zn^+2^-finger; RT-PCR, real-time quantitative PCR; nt, nucleotide; bp, base pair; J2, second stage juvenile; dpi, days post inoculation Acknowledgements ================ We gratefully acknowledge support from the United Soybean Board project number 5214. The authors thank Andrea Skantar, Mark Tucker, and Susan Meyer for critical reading of the manuscript. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture.

According to the chain of events described some years ago by Dzau and Braunwald, cardiovascular and renal disease, the most frequent causes of morbidity and mortality in industrial countries, can be regarded as progressing along a sort of continuum ([Figure 1](#f1-vhrm-5-939){ref-type="fig"}).[@b1-vhrm-5-939],[@b2-vhrm-5-939] The continuum starts with cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking, etc) and evolves with progression of atherosclerotic lesions and organ damage. Hence, the continuum may become clinically manifest with the major clinical syndromes (myocardial infarction, stroke, heart failure, end-stage renal disease), which may ultimately lead to death.[@b1-vhrm-5-939],[@b2-vhrm-5-939] The outcome associated with late stages of the continuum is remarkably poor. For example, one out of two patients with New York Heart Association (NYHA) stage IV congestive heart failure dies within one year, and approximately 80% of all patients with congestive heart failure die within 10 years.[@b3-vhrm-5-939] It is important to note that therapeutic interventions at each step of the continuum can slow down or block its progression, with potentially measurable outcome benefits. In this setting, the blood pressure control remains a fundamental mechanism for prevention of cardiovascular disease.[@b4-vhrm-5-939] Role of the renin--angiotensin system ===================================== Over the last two decades, a growing number of experimental and clinical studies provided evidence of an important role played by angiotensin II along the different steps of the cardiovascular disease continuum.[@b5-vhrm-5-939] It is well known that angiotensin II is produced through the aminoacid cleavage of angiotensin I operated by the angiotensin-converting enzyme (ACE) in some tissues including the lung, as well as in the myocardium, through the effects of specific proteases on angiotensin I. Angiotensin II raises blood pressure (BP) through direct vasoconstriction mediated by AT1 receptor stimulation, and sodium and water retention mostly mediated by the stimulation of the synthesis of aldosterone.[@b6-vhrm-5-939] In addition, angiotensin II enhances oxidative stress by stimulating NADPH oxidase, with consequent generation of reactive oxygen species.[@b7-vhrm-5-939],[@b8-vhrm-5-939] Reactive oxygen species, by enhancing inactivation of nitric oxide produced by endothelial cells, accelerate the progression of atherosclerosis and induce plaque destabilization.[@b7-vhrm-5-939],[@b8-vhrm-5-939] Moreover, angiotensin II may trigger intracellular reactions leading to myocite and vascular hypertrophy, fibrosis and apoptosis. Finally, in patients with chronic congestive heart failure, activation of the renin--angiotensin system may contribute to the progressive remodeling and dilatation of cardiac chambers. Stimulation of the AT2 receptors by angiotensin II is believed to promote biologic effects that are opposite to those of AT1 receptor stimulation. Indeed, AT2 receptor stimulation induces vasodilatation and inhibits fibrosis and inflammation. Although the effects of AT2 receptor stimulation are complex, the balance is believed to be positive.[@b9-vhrm-5-939] In patients taking ACE-inhibitors, the blunted production of angiotensin II and the consequent reduced stimulation of AT1- and AT2 receptor may induce an 'escape phenomenon', which consists in the accumulation of angiotensin I and production of angiotensin II through alternative synthetic bio-pathways (cathepsine C, chimases).[@b10-vhrm-5-939] This phenomenon, well described in patients with congestive heart failure, may be prognostically important. For example, the risk of mortality in patients with heart failure under chronic treatment with ACE-inhibitors is directly related to the circulating levels of angiotensin II.[@b11-vhrm-5-939] Impact of ATs receptor blockade =============================== The above scenario depicts a strong rationale for the specific and selective blockade of AT1 receptors through specific drugs. Of note, blockade of AT1 receptors is also accompanied by an over-stimulation of AT2 receptors by angiotensin II. The degree of AT2 stimulation is proportional to the selectivity of AT1 blockade.[@b12-vhrm-5-939] Over the last two decades, several AT1 receptor blockers (ARBs) have been extensively investigated at different steps of the cardiovascular disease continuum ([Figure 2](#f2-vhrm-5-939){ref-type="fig"}). Despite the common mechanism of action, each molecule is characterized by a distinct pharmacological profile and a different degree of AT1 selectivity, which is highest for valsartan.[@b12-vhrm-5-939] Obvious economic constrains precluded the executions of major outcome-based studies at each step for each of the available ARB drugs. On the other hand, however, the conclusions of studies conducted in a given clinical setting with specific ARBs are hardly applicable to different clinical settings or to different ARBs. In view of the above considerations, the aim of the present review was to provide a comparative assessment of different ARBs at different steps of the cardiovascular disease continuum. Only the principal randomized intervention trials were included in this review. Clinical trials have been retrieved from PubMed/MEDLINE using the terms 'renin--angiotensin system', 'angiotensin receptor blockers', 'hypertension', 'diabetic nephropathy', 'stroke', 'heart failure', and 'left ventricular hypertrophy'. We searched for studies published in any language up to March 31, 2009. Hypertension and high cardiovascular risk ========================================= Arterial hypertension is probably the most important risk factor for cardiovascular diseases. At any age, there is a positive and graded relation between the usual BP and the risk of cardiovascular and stroke mortality.[@b13-vhrm-5-939] Intervention studies have conclusively demonstrated that a relation also exists between the degree of BP reduction and the outcome benefit.[@b4-vhrm-5-939],[@b14-vhrm-5-939] In patients with hypertension, the concomitance of additional risk factors, target organ damage or cardiac and renal disease substantially increases the total cardiovascular risk, requiring a more aggressive therapeutic approach with more stringent treatment goals, in order to prevent further progression of the cardiovascular continuum.[@b15-vhrm-5-939] In this respect, the role of renin--angiotensin system activation even in the early steps of the continuum has been confirmed by the positive results obtained with different ARBs in terms of reduction of cardiovascular morbidity and mortality in different populations. The Study on Cognition and Prognosis in the Elderly (SCOPE) study[@b16-vhrm-5-939] was a double-blind, randomized study conducted in 4,964 patients aged 70--89 years, with systolic (160--179 mmHg) or diastolic (90--99 mmHg) hypertension and a Mini Mental State Examination test score \>24. Patients were randomized to candesartan titrated to 16 mg once daily or placebo on top of other antihypertensive drugs as needed by the single patients. Consequently, active drugs were used by 84% of patients in the placebo group. The mean duration of follow-up was 3.7 years. The primary outcome, a composite of cardiovascular death, nonfatal stroke and nonfatal myocardial infarction, occurred in 26.7% of patients in the candesartan group and 30.0% of patients in the placebo group (risk reduction 10.9%; *P* = 0.19). Candesartan-based treatment reduced nonfatal stroke by 27.8% (95% confidence interval \[CI\]: 1.3 to 47.2; *P* = 0.04), and all stroke by 23.6% (95% CI: −0.7 to 42.1; *P* = 0.056). There were no differences between the candesartan group and the placebo group with regard to dementia, cognitive decline or mean change in Mini Mental State Examination test. The Losartan Intervention for End Point Reduction (LIFE) study[@b17-vhrm-5-939] was designed to compare a treatment based on losartan with a treatment based on atenolol in patients with hypertension and left ventricular (LV) hypertrophy diagnosed by electrocardiography. Overall, 9193 patients were randomized to losartan titrated to 100 mg daily or atenolol titrated to 100 mg daily and followed for a mean of 4.8 years. The primary cardiovascular event, a composite of death, myocardial infarction, or stroke occurred in 11% of patients allocated to losartan and 13% of patients allocated to atenolol (*P* = 0.021) despite a similar reduction of BP in the two groups. Stroke was the only component of the primary endpoint which was significantly reduced by losartan compared to atenolol (5% vs 7%; *P* = 0.001). In the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) study,[@b18-vhrm-5-939] 15,245 hypertensive patients aged 50 years or older were randomly allocated in a double-blind fashion to valsartan (80--160 mg daily) or amlodipine (5--10 mg daily). The mean duration of follow-up was 4.2 years. The primary endpoint was a composite of cardiac mortality and morbidity. Although BP was reduced by both treatments, the effects of amlodipine were more pronounced, especially during the first months of the study. Despite the better BP control achieved in the amlodipine group, the primary composite endpoint occurred almost equally in the two groups (10.6% vs 10.4%; *P* = 0.49), and the rate of fatal and nonfatal stroke (a secondary outcome measure of the study) was similar between treatments. New-onset diabetes, a prespecified endpoint, occurred at a rate of 32.1 per 1,000 patient-years in the valsartan group, and 41.1 per 1,000 patient-years in the amlodipine group (23% risk reduction in the valsartan group, *P* \< 0.0001). In the JIKEI study,[@b19-vhrm-5-939] 3,081 Japanese patients aged between 20 and 79 years (mean, 65 years) who were receiving a conventional treatment for high BP, coronary heart disease or heart failure were randomly assigned to valsartan (40--160 mg per day) or to a treatment without ARBs according to a prospective, randomized, open-label blinded-endpoint (PROBE) design. The primary endpoint was a composite of cardiovascular morbidity and mortality (admission to hospital for stroke, transient ischemic attack, myocardial infarction, congestive heart failure, angina pectoris, dissecting aneurysm of the aorta). During a median follow-up of 3.1 years, the primary endpoint occurred in 6.0% of patients receiving valsartan and 9.7% of patients not receiving ARBs (hazard ratio 0.61; *P* = 0.0002). This difference was largely accounted for by 40% lower incidence of stroke and TIA in the valsartan group compared to the control group (1.9% versus 3.1%; *P* = 0.028). In addition, also angina pectoris requiring hospitalization (1.2% versus 3.4%; *P* = 0.0001) and heart failure (1.2% versus 2.3%; *P* = 0.029) were less frequent in the valsartan group than in the control group. Mortality did not differ between the two groups. In the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) study,[@b20-vhrm-5-939] 25,620 patients with a variety of conditions sharing an increased vascular risk (history of coronary artery disease, cerebrovascular disease, peripheral occlusive disease or diabetes with organ damage) were randomized to ramipril 10 mg daily, telmisartan 80 mg daily or the combination of both. Duration of follow-up was five years. The primary endpoint, a composite of nonfatal myocardial infarction, nonfatal stroke, cardiovascular death or hospitalization for heart failure occurred in 16.5% of patients allocated to ramipril, 16.7% of patients allocated to telmisartan and 16.3% of patients in the combination group. The pre-specified hypothesis of noninferiority of telmisartan versus ramipril was demonstrated (*P* = 0.001) and the results were consistent across the single components of the primary outcome. However, the combination of telmisartan and ramipril did not differ from ramipril alone (*P* = 0.38) and was associated with a higher incidence of adverse events including hypotension, syncope and renal dysfunction.[@b20-vhrm-5-939] These findings suggest that the degree of renin--angiotensin system activation or angiotensin II escape may not have been so high in these patients to benefit from a dual blockade of the renin--angiotensin system. Differences among the available ARBs have been documented in head-to-head comparative studies. In general, the new-generation ARBs including irbesartan,[@b21-vhrm-5-939] telmisartan,[@b22-vhrm-5-939] candesartan,[@b23-vhrm-5-939] and valsartan[@b24-vhrm-5-939] proved more effective than losartan in lowering BP in hypertensive patients. Implications in patients with hypertension and high cardiovascular risk ----------------------------------------------------------------------- Although all ARBs are effective in lowering BP, only a few event-based studies have demonstrated the value of this class of drugs in reducing cardiovascular events in patients with hypertension and high cardiovascular risk. Taken together, these studies suggest that: Losartan demonstrated better efficacy than the beta-blocker atenolol in reducing cardiovascular morbidity and mortality, accounted for by a reduction of stroke.Valsartan demonstrated similar efficacy on cardiovascular morbidity and mortality versus amlodipine, despite better BP control obtained with the calcium channel blocker. When used on top of optimized treatment, valsartan induced a reduction of cardiovascular morbidity and mortality, accounted for by a positive effect on the occurrence of stroke, angina, and heart failure.Telmisartan was the only ARB which demonstrated therapeutic equivalence versus the ACE-inhibitor ramipril. Myocardial infarction ===================== Patients with acute myocardial infarction frequently present with signs and symptoms of heart failure or left ventricular dysfunction. In these patients, ACE-inhibitors are effective in reducing mortality and morbidity, especially in the subsets at higher risk.[@b25-vhrm-5-939] Two major studies tested the hypothesis that an ARB was noninferior or superior to an ACE-inhibitor in these patients. In the Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan (OPTIMAAL),[@b26-vhrm-5-939] 5,477 patients aged 50 years or more (mean age 67 years) with acute myocardial infarction and heart failure during the acute phase or a new Q-wave anterior infarction or reinfarction, were randomized to losartan titrated to 50 mg once daily or captopril titrated 50 mg three times daily. The primary endpoint was all-cause mortality. The trial was designed as a noninferiority trial of losartan versus captopril, with a prespecified right-sided noninferiority margin (95% confidence margin) of 1.10. Over a mean follow-up of 2.7 years, there were 499 deaths (18%) in the losartan group and 447 deaths (16%) in the captopril group (relative risk 1.13; 95% CI: 0.99--1.28; *P* = 0.07). Since the achieved upper 95% confidence margin (1.28) was superior to the pre-specified value of 1.10, the OPTIMAAL trial did not satisfy the prespecified criteria for noninferiority of losartan versus captopril. As expected, losartan was better tolerated than captopril, with fewer patients discontinuing study medication (17% vs 23%; *P* \< 0.0001). The Valsartan in Acute Myocardial Infarction (VALIANT) trial[@b27-vhrm-5-939] was a double-blind, randomized comparison between captopril titrated to 50 mg three times daily, valsartan titrated to 160 mg twice daily and their combination in 14,703 patients with myocardial infarction complicated by LV systolic dysfunction, heart failure, or both. The primary endpoint was all-cause mortality. Duration of follow-up was 24.7 months. The trial was designed as a noninferiority trial of valsartan versus captopril, with a prespecified upper 97.5% confidence limit of 1.13. During follow-up, 958 patients died in the captopril group, 979 patients died in the valsartan group, and 941 patients died in the valsartan plus captopril group. The hazard ratio in the valsartan group compared to the captopril group was 1.00 and its 97.5% CI ranged between 0.90 and 1.11 (*P* = 0.98). Therefore, since the achieved upper 97.5% confidence margin (1.11) was within the prespecified margin of 1.13, the VALIANT study satisfied the prespecified criteria for noninferiority of valsartan versus captopril (*P* = 0.004). The valsartan plus captopril combination was not superior to captopril alone (*P* = 0.73) and the adverse events, particularly hypotension and renal dysfunction, were more frequent in the combination group. The statistical techniques of imputing placebo ([Figure 3](#f3-vhrm-5-939){ref-type="fig"}) showed that the size of the estimated benefit of valsartan in this study was comparable to that observed in three major placebo-controlled studies conducted with ACE-inhibitors in this kind of patients. Results of VALIANT are consistent with those of ONTARGET in showing the lack of additional outcome benefits by the dual blockade of the renin--angiotensin system in patients at high vascular risk (ONTARGET) or after myocardial infarction complicated by left ventricular dysfunction or heart failure (VALIANT). As discussed above, these data suggest that the degree of renin--angiotensin system activation may be not so high to require a dual blockade in these patients. Implications in patients with myocardial infarction --------------------------------------------------- The above data suggest that, in patients with myocardial infarction and evidence of heart failure of left ventricular dysfunction: Valsartan, titrated up to 160 mg twice daily, provides the same benefits, in terms of survival and cardiovascular events, as captopril titrated up to 50 mg three times dailyThese results can not be extended to losartan 50 mg daily, which, contrary to valsartan, failed to demonstrate noninferiority versus captopril titrated up to 50 mg three times daily in a comparable cohort of patients. Congestive heart failure ======================== Activation of the renin--angiotensin system is a typical feature in chronic heart failure and its inhibition remains an important therapeutic target in these patients. However, it has been clearly demonstrated that morbidity and mortality remain very high in patients with chronic heart failure despite current standard medical therapy with diuretics, beta-blockers, ACE-inhibitors, and aldosterone antagonists. The need to improve outcome in these patients, as well as the evidence of an escape phenomenon to ACE-inhibitors, prompted several major trials specifically designed to investigate two main aspects: (a) head-to-head comparison between ACE-inhibitors and ARBs; (b) assessment of the clinical value of complete suppression of the renin angiotensin system, as provided by the combination of ACE-inhibitors with ARBs, in comparison with either component alone. ### Congestive heart failure with reduced ejection fraction In the Evaluation of Losartan in the Elderly (ELITE) study,[@b28-vhrm-5-939] 722 patients with heart failure NYHA class II--IV and ejection fraction of 40% or less were randomized to losartan titrated to 50 mg once daily or captopril titrated to 50 mg three times daily. Duration of follow-up was 48 weeks. The primary endpoint was the persisting increase in serum creatinine, the secondary endpoint was a composite of death and hospital admission for heart failure. While the primary endpoint did not differ between the groups, the secondary endpoint occurred in 9.4% of patients in the losartan group and 13.2% of patients in the captopril group (risk reduction 32%; *P* = 0.075). Total mortality was significantly lower in the losartan group (4.8%) than in the captopril group (8.7%) (*P* = 0.035). The encouraging results of ELITE study prompted the execution of the Evaluation of Losartan in the Elderly (ELITE) II Study.[@b29-vhrm-5-939] In this study, 3,152 patients with heart failure NYHA class II--IV and LV ejection fraction of 40% or less were randomized to losartan titrated 50 mg once daily or captopril titrated 50 mg three times daily. The study, planned as a superiority trial, was designed to test the hypothesis of a 30% reduction in mortality in the losartan group with respect to captopril. There were no significant differences in all-cause mortality between losartan (11.7%) and captopril (10.4%). Also the other prespecified endpoints did not differ between the groups. Losartan was better tolerated than captopril, as suggested by the lower rate of discontinuation due to adverse effects (9.7% vs 14.7%; *P* \< 0.001). Thus, ELITE II suggested that losartan is not superior to captopril in patients with heart failure, although it might offer an advantage in patients unable to tolerate ACE-inhibitors because of cough or angioedema. The Valsartan Heart Failure Trial (Val-HeFT)[@b30-vhrm-5-939] was a randomized, placebo-controlled, double-blind study between valsartan titrated to 160 mg twice daily and placebo in 5,010 patients with heart failure and LV ejection fraction of 40% or less. The mean duration of follow-up was 23 months. The incidence of primary composite endpoint of mortality and morbidity (defined as resuscitated cardiac arrest or rehospitalization for heart failure) was lower by 13.2% in the valsartan group compared to the placebo group (*P* = 0.009). All-cause mortality did not differ between the groups (19.7% vs 19.4%). The most frequently used ACE-inhibitors were enalapril, lisinopril, captopril, ramipril and quinapril at a mean daily dose of 17 mg, 19 mg, 80 mg, 6 mg and 23 mg, respectively. The Val-Heft study suggested that a full blockade of the renin--angiotensin system by adding valsartan to ACE-inhibitors in patients with heart failure and reduced ejection fraction reduces the combined endpoint of morbidity and mortality. This may be due to the very high degree of renin--angiotensin system activation in these patients, requiring a dual blockade to be fully reversed. An unexpected finding from a post hoc analysis of the Val-Heft study was a significant adverse effect of valsartan on outcome in the subset of patients who were being treated with both an ACE-inhibitor and a beta-blocker at baseline. These findings were not confirmed in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-ADDED trial, where the effect of candesartan were maintained in the subgroup of patients treated with beta-blockers.[@b31-vhrm-5-939] The CHARM-ALTERNATIVE study[@b32-vhrm-5-939] compared the effects of candesartan, titrated to 32 mg daily, with placebo in 2,028 patients with heart failure and LV ejection fraction of 40% or less who were both treated at best of their condition and intolerant to ACE-inhibitors. As compared to placebo, candesartan significantly reduced the primary composite endpoint of cardiovascular death or hospitalization for heart failure (33% vs 40%, hazard ratio 0.77; *P* = 0.0004) after a median follow-up of 33.7 months. All-cause mortality did not differ between the groups. In the CHARM-ADDED trial,[@b31-vhrm-5-939] 2,548 patients with heart failure and LV ejection fraction of 40% or less who were treated with a background therapy including ACE-inhibitors and other drugs (but excluding ARBs) were randomized to candesartan titrated to 32 mg daily or placebo. The median follow-up was 41 months. Candesartan reduced the primary composite outcome (the same as in CHARM-ALTERNATIVE) by 15% (*P* = 0.011). However, the rate of all-cause mortality did not differ (*P* = 0.086) between candesartan (30%) and placebo (32%). In this study, the ACE-inhibitors more frequently used were enalapril, lisinopril, captopril and ramipril at a mean daily dose of 17 mg, 17 mg, 82 mg and 7 mg, respectively. Overall, the study suggested that a complete blockade of the renin--angiotensin system achieved by adding candesartan to ACE-inhibitors is useful in patients with heart failure and reduced ejection fraction. ### Congestive heart failure with 'normal' ejection fraction It is well known that ejection fraction is 45% or higher in about half of patients with congestive heart failure. The prognostic impact of congestive heart failure with normal ejection fraction is controversial, as well as the most appropriate treatment in these patients. In the CHARM-PRESERVED study,[@b33-vhrm-5-939] 3,023 patients with chronic heart failure and LV ejection fraction greater than 40% were randomized to candesartan titrated to 32 mg daily or placebo on top of their background therapy. The primary outcome was cardiovascular death or admission to hospital for congestive heart failure. Duration of follow-up was 37 months. The incidence of primary outcome was 22% with candesartan and 24% with placebo (*P* = 0.118). While cardiovascular death did not differ between the groups, fewer patients in the candesartan group had a new hospitalization for re-exacerbation of heart failure once (230 vs 279; *P* = 0.017). About 19% of patients received also an ACE-inhibitor, 55% a beta-blocker and 11% received spironolactone. The Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE)[@b34-vhrm-5-939] was a comparative study between irbesartan 300 mg daily and placebo in 4,128 patients aged 60 years or more and heart failure with LV ejection fraction greater than 40%. Duration of follow-up was 49.5 months. The primary composite endpoint (all-cause death or hospitalization for heart failure, myocardial infarction, unstable angina, arrhythmia, or stroke) occurred in 742 (36.0%) patients in the irbesartan group and 763 (37.0%) in the placebo group (*P* = 0.35). All-cause mortality and the rate of hospitalization did not differ between the groups (*P* = 0.98 and *P* = 0.44, respectively). There were no significant differences in the other prespecified endpoints. Interestingly, about 25% of patients received an ACE-inhibitor, 58% a beta-blocker and 15% received spironolactone. Implications in patients with heart failure ------------------------------------------- Taken together, these data suggest that, in patients with chronic congestive heart failure, reduced ejection fraction and concomitant treatment with ACE-inhibitors: Losartan was not superior to captopril in reducing all-cause mortality or cardiovascular events. The relatively low dose of losartan (50 mg) may contribute to explain these results.The combined blockade of the renin--angiotensin system achieved by valsartan titrated to 320 mg daily, or candesartan titrated to 32 mg daily, in addition to ACE-inhibitors, reduced the composite endpoint of all-cause mortality and hospitalization for heart failure. These data suggest that an incomplete blockade of the renin--angiotensin system, possibly associated with the 'escape' phenomenon under ACE-inhibition, may be an important basic mechanism explaining the high risk of morbidity and mortality in these patients.Since none of the other available ARBs has been investigated in outcome-based studies in these patients with poor short- and long-term outcome, extrapolation of results obtained with valsartan and candesartan to other ARBs should not be allowed. Conversely, as resulting from studies with candesartan and irbesartan, there is no evidence that AT1 blockade reduces the primary outcome of morbidity and mortality in patients with chronic heart failure and preserved ejection fraction, although a modest benefit with candesartan may be observed in terms of fewer hospitalization for heart failure. Diabetic nephropathy ==================== Approximately 40% of patients with type 2 diabetes develop nephropathy, which is the main determinant of end-stage renal disease. Prevention, early identification and appropriate treatment of nephropathy in these patients are therefore of vital importance. Reduction of proteinuria is associated with renal and cardiovascular protection. There is large evidence from animal and human studies that inhibition of the renin--angiotensin system reduces proteinuria.[@b35-vhrm-5-939],[@b36-vhrm-5-939] In this setting, the evidence that ACE-inhibitors reduce proteinuria and slow the progression of renal damage in patients with type 1 diabetes can not be extrapolated to patients with type 2 diabetes because of the substantial differences between these two groups of patients in terms of potential mechanisms of glomerular disease and demographic and metabolic features. Over the last decade, several studies conducted with ARBs in patients with type 2 diabetes provided important data for a better management of these patients. In particular, three major trials were conducted in patients with type 2 diabetes and early (one study) or more advanced (two studies) nephropathy. In the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA) study,[@b37-vhrm-5-939] 590 hypertensive patients with type 2 diabetes and early nephropathy (defined by microalbuminuria) were randomized to placebo, irbesartan 150 mg or irbesartan 300 mg on top of background therapy and followed for two years. The primary outcome was the time to onset of diabetic nephropathy, defined by persistent albuminuria (\>200 μg per minute). The primary endpoint was achieved by 14.9% of patients with placebo, 9.7% of patients with irbesartan 150 mg (*P* = 0.08) and 5.2% of patients with irbesartan 300 mg (*P* = 0.001). These effects were independent of BP changes. In the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study,[@b38-vhrm-5-939] 1,513 patients with type 2 diabetes and nephropathy were randomized to losartan titrated to 100 mg per day, or placebo, on top of conventional treatment. Follow-up lasted a mean of 3.4 years. The primary outcome, a composite of doubling of the baseline serum creatinine, end-stage renal disease, or death occurred in 43.5% of patients in the losartan group and 47.1% of patients in the placebo group (16% risk reduction, *P* = 0.02). The Irbesartan Diabetic Nephropathy Trial (IDNT)[@b39-vhrm-5-939] was a randomized, double-blind comparison between irbesartan 300 mg, amlodipine 10 mg and placebo in 1,715 hypertensive patients with type 2 diabetes and established nephropathy with macroproteinuria. Duration of follow-up was 2.6 years. The incidence of a primary composite endpoint consisting of doubling of serum creatinine, development of end-stage renal disease, or death from any cause, was reduced by 20% with irbesartan compared to placebo (*P* = 0.02), and by 23% with irbesartan compared to amlodipine (*P* = 0.006). Similarly to the IRMA study, these differences were not explained by differences in achieved BP between the treatments. There were no significant differences between the groups in the rate of death from any cause or cardiovascular events. Implications in patients with diabetes and nephropathy ------------------------------------------------------ Overall, these data suggest that: in patients with type 2 diabetes and early nephropathy (microalbuminuria), irbesartan 300 mg is more effective than placebo in preventing the progression to macroproteinuria. In patients with type 2 diabetes and more advanced nephropathy (macroproteinuria), losartan is more effective than placebo, and irbesartan more effective than placebo and amlodipine, in preventing the composite outcome of end-stage renal disease, doubling of serum creatinine or death. Conclusions =========== The overall message of the trials examined in this review is that intervention with ARBs at different steps of the cardiovascular disease continuum is effective to slow down or block the disease progression, with consequent measurable benefits. However, generalization of results to all available ARBs for any step of the continuum may be misleading because differences among available ARBs emerged from these studies. In deciding the choice of the ARB in the individual patient along specific steps of the cardiovascular disease continuum, the driving concept should be that, despite the shared mechanism of action, each molecule is characterized by specific pharmacological properties that are likely to influence its clinical efficacy. Therefore, according to the principles of evidence-based-medicine, the tempting attitude of applying conclusions of studies conducted in specific clinical settings with a specific ARB to different contexts or to different ARBs should be avoided. The simple conclusion bullets outlined below may help in driving our clinical choices. Valsartan on top of optimized pharmacological therapy reduced the risk of cardiovascular events and, in particular, the risk of stroke in patients with high cardiovascular risk. In patients with heart failure and LV dysfunction, valsartan on top of optimized therapy including an ACE-inhibitor, significantly reduced morbidity/mortality combined endpoint and significantly reduced the rate of re-hospitalization due to worsening of heart failure, thereby improving quality of life in these patients and reducing health care costs. In patients with myocardial infarction complicated by heart failure or LV dysfunction, alone or combined, valsartan was the sole ARB which reduced morbidity and mortality, with a protective effect similar to the ACE-inhibitor comparator captopril. Valsartan is therefore the ARB with the largest scientific documentation along the different steps of the cardiovascular disease continuum.Losartan was superior to the beta-blocker atenolol in reducing the risk of stroke in patients with hypertension and LV hypertrophy. In patients with type 2 diabetes and nephropathy, losartan in addition to conventional therapy reduced proteinuria and the progression to end stage renal disease. In patients with chronic heart failure, losartan proved to be an alternative therapeutic option in patients intolerant to ACE-inhibitors.Candesartan on top of optimized pharmacological therapy reduced morbidity and mortality, as well as the rehospitalization rate, in patients with heart failure and LV dysfunction.Irbesartan reduced proteinuria and progression to end stage renal disease in patients with type 2 diabetes and nephropathy.Telmisartan reduced cardiovascular events in a broad population of patients with high cardiovascular risk, with a protective effect similar to the ACE-inhibitor comparator ramipril.Other ARBs, although effective in reducing BP levels, are not supported by event-based studies dealing with cardiac or renal end organ protection. **Disclosures** The authors report no conflicts of interest in this work. {#f1-vhrm-5-939} {#f2-vhrm-5-939} {#f3-vhrm-5-939}

Trunschke J, Sletvold N, Ågren J. The independent and combined effects of floral traits distinguishing two pollination ecotypes of a moth‐pollinated orchid. Ecol Evol. 2019;9:1191--1201. 10.1002/ece3.4808 1. INTRODUCTION {#ece34808-sec-0001} =============== Among‐population variation in interactions with pollinators may result in divergent selection on floral traits, promoting floral diversification (Grant, [1949](#ece34808-bib-0034){ref-type="ref"}, [1994](#ece34808-bib-0035){ref-type="ref"}; Stebbins, [1970](#ece34808-bib-0062){ref-type="ref"}; [Van der Niet](#ece34808-bib-0069){ref-type="ref"} & Johnson, [2012](#ece34808-bib-0069){ref-type="ref"}; Van der Niet, Peakall, & Johnson, [2014](#ece34808-bib-0070){ref-type="ref"}), and the formation of pollination ecotypes (Anderson, Alexandersson, & Johnson, [2010](#ece34808-bib-0002){ref-type="ref"}; Johnson, [1997](#ece34808-bib-0036){ref-type="ref"}; Van der Niet, Pirie, Shuttleworth, Johnson, & Midgley, [2014](#ece34808-bib-0071){ref-type="ref"}). However, ecotypes (e.g., Armbruster, [1985](#ece34808-bib-0005){ref-type="ref"}; Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}; Van der Niet, Pirie, et al., [2014](#ece34808-bib-0071){ref-type="ref"}) and closely related species (e.g., Campbell, Waser, & Melendez‐Ackerman, [1997](#ece34808-bib-0013){ref-type="ref"}; Sun, Schlüter, Gross, & Schiestl, [2015](#ece34808-bib-0065){ref-type="ref"}) commonly differ in multiple traits that can be strongly correlated within and across populations, and the relative contribution of different traits to adaptive differentiation is usually poorly known. Because of strong trait correlations, experimental approaches are required to determine the independent and combined effects of individual traits on pollination success and plant fitness (Campbell, [2009](#ece34808-bib-0012){ref-type="ref"}; Castellanos, Wilson, & Thomson, [2004](#ece34808-bib-0015){ref-type="ref"}; Schemske & Bradshaw, [2008](#ece34808-bib-0056){ref-type="ref"}). The effects of two traits on fitness can be additive, such that they influence fitness independently, or non‐additive, such that the effect of one trait depends on the expression of the other. For example, traits enhancing pollinator visitation and those improving efficiency of pollen transfer should affect pollen removal and pollen receipt non‐additively because total pollen transfer is the product of number of pollinator visits and mean amount of pollen transferred per visit (Sletvold & Ågren, [2011](#ece34808-bib-0058){ref-type="ref"}). In pollen‐limited populations with sufficiently large trait variation, such non‐additive effects should be reflected as correlational selection. Yet, few studies have experimentally tested for non‐additive effects of floral characters affecting attraction of pollinators and those affecting efficiency of pollen transfer (Boberg & Ågren, [2009](#ece34808-bib-0010){ref-type="ref"}; Fenster, Cheely, Dudash, & Reynolds, [2006](#ece34808-bib-0030){ref-type="ref"}; Fenster, Reynolds, Williams, Makowsky, & Dudash, [2015](#ece34808-bib-0031){ref-type="ref"}; Sletvold & Ågren, [2011](#ece34808-bib-0058){ref-type="ref"}), and the prevalence of correlational selection on floral traits is largely unknown (but see e.g., Maad, [2000](#ece34808-bib-0044){ref-type="ref"}; Chapurlat, Ågren, & Sletvold, [2015](#ece34808-bib-0016){ref-type="ref"}; Toräng et al., [2017](#ece34808-bib-0068){ref-type="ref"}). In hermaphroditic species, pollinator‐mediated selection through components of male and female fitness may differ for several reasons. First, the effect of a given floral character on pollen removal and pollen receipt may differ in both magnitude and direction (Delph & Ashman, [2006](#ece34808-bib-0023){ref-type="ref"}; Ellis & Johnson, [2010](#ece34808-bib-0026){ref-type="ref"}). Second, opportunity for selection (the variance in relative fitness; Crow, [1958](#ece34808-bib-0019){ref-type="ref"}) may differ between male and female reproductive success. Bateman's principle predicts that the variance in siring success will be higher than the variance in female reproductive success because of differences in the relative importance of mate and resource limitation for male and female function (Bateman, [1948](#ece34808-bib-0007){ref-type="ref"}). However, not all components of male reproductive success are likely to display greater variance than does female fitness. For example, pollen removal may be considerably less variable than pollen receipt and fruit set, particularly if pollen is packed into units, such as orchid pollinia, facilitating efficient pollen transfer to flower visitors (Johnson & Edwards, [2000](#ece34808-bib-0037){ref-type="ref"}; Johnson, Neal, & Harder, [2005](#ece34808-bib-0038){ref-type="ref"}). The few available comparisons of opportunity for selection through male and female reproductive success in plants suggest that the direction of the difference varies (Delph & Ashman, [2006](#ece34808-bib-0023){ref-type="ref"}; and references therein), but differences in the approach used to estimate male reproductive success complicates comparisons across studies (Ashman & Morgan, [2004](#ece34808-bib-0006){ref-type="ref"}). More specifically, because pollen removal and male reproductive success may be weakly correlated (Johnson et al., [2005](#ece34808-bib-0038){ref-type="ref"}; Snow & Lewis, [1993](#ece34808-bib-0061){ref-type="ref"}), estimates of opportunity for selection through pollen removal may not reflect opportunity through male reproductive success. Understanding the effect of trait variation on pollen removal is still of interest as pollen removal is an important aspect of pollen transfer, and can be considered one component of male reproductive success. In southern Sweden*,* plant stature and floral morphology differ between two distinct ecotypes of the moth‐pollinated orchid *Platanthera bifolia*. The woodland ecotype begins to flower about 2 weeks earlier and produces taller inflorescences, and more and larger flowers with longer spurs compared to the grassland ecotype (Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}). A reciprocal transplant experiment indicated that morphological differences have a genetic basis (Boberg & Ågren, [2009](#ece34808-bib-0010){ref-type="ref"}). Reduced pollen removal and female fitness following shortening of spurs (Boberg & Ågren, [2009](#ece34808-bib-0010){ref-type="ref"}; Nilsson, [1988](#ece34808-bib-0049){ref-type="ref"}) suggest that the difference in spur length is important for the reproductive success of the woodland ecotype in its home environment, whereas the adaptive significance of the difference in plant height has not been examined. Plant height can be expected to be important for shading avoidance and efficient light capture but should also influence long‐distance attraction and the number of pollinator visits (Donnelly, Lortie, & Aarssen, [1998](#ece34808-bib-0024){ref-type="ref"}; Dudash, Hassler, Stevens, & Fenster, [2011](#ece34808-bib-0025){ref-type="ref"}; Engel & Irwin, [2003](#ece34808-bib-0027){ref-type="ref"}; Walsh, Arnold, & Michaels, [2014](#ece34808-bib-0074){ref-type="ref"}). Moreover, because spur length should influence the efficiency of pollen transfer at each visit (Muchhala & Thomson, [2009](#ece34808-bib-0045){ref-type="ref"}; Nilsson, [1988](#ece34808-bib-0049){ref-type="ref"}), non‐additive effects of these two traits on pollen transfer and female reproductive success can be expected (Sletvold & Ågren, [2011](#ece34808-bib-0058){ref-type="ref"}). Here, we examine the independent and combined effects of plant height and spur length on pollen removal and measures of female reproductive success in a woodland population of *P. bifolia* using two approaches. First, we manipulated plant height and spur length to match trait values previously documented in the grassland ecotype and examined the effects on pollen removal, pollen receipt, and fruit production in a field experiment. Second, we examined the effects of naturally occurring trait variation in the woodland population by quantifying pollinator‐mediated selection through pollen removal and female fitness on plant height, spur length, and two additional traits potentially influencing attractiveness to pollinators (number of flowers and individual flower size). Pollinator‐mediated selection through female fitness was quantified by comparing estimates of selection among plants receiving supplemental hand‐pollination (non‐pollinator‐mediated selection) and estimates of selection among open‐pollinated plants (net selection; Sandring & Ågren, [2009](#ece34808-bib-0055){ref-type="ref"}; Sletvold & Ågren, [2010](#ece34808-bib-0057){ref-type="ref"}). Specifically, we tested the predictions that: (a) Reductions in plant height and spur length to those observed in the grassland ecotype reduce pollen removal, pollen receipt, and fruit production in the woodland population, (b) Effects of plant height and spur length on pollen transfer are non‐additive, resulting in pollinator‐mediated correlational selection, and (c) The opportunity for selection is higher and pollinator‐mediated selection is stronger through female fitness than through pollen removal. 2. MATERIAL AND METHODS {#ece34808-sec-0002} ======================= 2.1. *Platanthera bifolia* and its ecotypes {#ece34808-sec-0003} ------------------------------------------- *Platanthera bifolia* (L.) Rich. is a long‐lived terrestrial orchid that is widespread in the temperate regions across Eurasia (Delforge, [2005](#ece34808-bib-0022){ref-type="ref"}). The species is found in a wide range of habitats including grasslands, moorlands, marshes, and woodlands, and occurs at elevations up to 2,500 m asl. Flowering starts in early‐ to mid‐June in southern Sweden and individual plants produce a single inflorescence in which flowers open sequentially from bottom to top within a few days (Figure [1](#ece34808-fig-0001){ref-type="fig"}). Flowers are white, and at night emit a strong scent that is dominated by benzenoids and linalool (Tollsten & Bergström, [1989](#ece34808-bib-0066){ref-type="ref"}, [1993](#ece34808-bib-0067){ref-type="ref"}). Sugar‐rich nectar is secreted from unicellular hairs that cover the inside walls of the spur (Stpiczynska, [1997](#ece34808-bib-0064){ref-type="ref"}). The species is nocturnally pollinated and attracts a variety of sphingid and noctuid moths (Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}; Claessens, Gravendeel, & Kleynen, [2008](#ece34808-bib-0017){ref-type="ref"}; Nilsson, [1983](#ece34808-bib-0048){ref-type="ref"}). Pollen is organized in massulae, which are packaged into two sectile pollinia per flower (hundreds of massulae per pollinium). Pollen from a given pollinium can be deposited in several flowers. {#ece34808-fig-0001} On the island Öland, southern Sweden, *P. bifolia* occurs as two morphologically distinct ecotypes in woodlands and grasslands, respectively (Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}). The two ecotypes differ in flowering phenology, plant height, and floral traits (Boberg & Ågren, [2009](#ece34808-bib-0010){ref-type="ref"}; Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}), but do not differ in the composition of the floral scent (Tollsten & Bergström, [1993](#ece34808-bib-0067){ref-type="ref"}). The woodland ecotype is usually found on deep moraine and clay soils with relatively tall ground vegetation, whereas the grassland ecotype is found on thin, nutrient‐poor sandy soils with short ground vegetation. On Öland, woodland populations are predominantly pollinated by the long‐proboscis hawkmoth *Sphinx ligustri* (proboscis length mean ± *SE*, 39.1 ± 2.2 mm, *N* = 52; data from Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}), whereas grassland populations are pollinated by various moths with markedly shorter proboscis (*Deilephila porcellus* 17.9 ± 1.0 mm, *N* = 22 \[Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}\], *Hyles gallii* 25.13 ± 0.49 mm, *N* = 2, and *Cucullia umbratica* 19.47 ± 0.06 mm, *N* = 11; measurements of specimens collected in *P. bifolia* populations on Öland). For the present study, we selected a large woodland population in the central part of Öland (Gråborg; N56°40′, E16°35′). 2.2. Experimental trait manipulation {#ece34808-sec-0004} ------------------------------------ To examine the effects of reduced plant height and spur length on pollination success and fruit production in the woodland ecotype, we conducted a field experiment with four treatments: (1) tall plants with long spurs (unmanipulated control), (2) tall plants with shortened spurs, (3) shortened plants with long spurs, and (4) shortened plants with shortened spurs. Phenotypic manipulations (plant height, 38 cm vs. 27 cm; spur length, 36 mm vs. 21 mm) corresponded to the respective mean trait values previously documented in the study population (long‐spurred) and in a nearby population of the grassland ecotype (short‐spurred; Melösa, N56°51′, E16°51′; Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}). In the year of the field experiment, plants in the Gråborg population were somewhat taller (mean ± *SE*, 42.8 ± 1.3 cm) and produced somewhat longer spurs (38.5 ± 0.8 mm; *N* = 23) compared to the previous year. In early June 2015, we marked close to 200 bolting plants and bagged them to prevent pollinator visitation before the start of the experiment. Once flowering, we recorded plant height as the distance from the ground to the uppermost flower of the inflorescence to the nearest 0.1 cm with a ruler, counted the number of flowers, and measured corolla height and width (vertical and horizontal distance between petal tips), and spur length (from entrance to tip) to the nearest 0.01 mm on the second fully expanded flower of each experimental plant. Flower size was quantified as the product of corolla height and width. The experiment was staggered over a 2‐week period in mid‐June 2015. On each of five experimental days, we established three to six blocks, for a total of 24 blocks. Each block contained four plants (one plant of each of the four treatments). Any senescent flowers and/or buds were removed prior to the experiment. Plants were assigned to blocks such that all plants in a block had the same number of open flowers (mean \[range\] number of open flowers, 18 \[12--23\], *N* = 24 blocks). Within a block, the four treatments were randomly assigned with the exception that plants in treatment three (shortened plants with long spurs) had to have spurs that were at least 36 mm long. If a given plant did not meet this criterion, a new plant with the same number of open flowers was selected among plants bagged for the experiment. Experimental plants were cut above the basal leaves and were kept in floristic vials filled with water and added orchid liquid fertilizer (BAYER Garden, NPK 2:1:1). Spur manipulations were conducted in the lab at the nearby biological field station in Skogsby (Station Linné). Each spur on an inflorescence was manipulated by carefully squeezing the nectar from the tip upwards, and then gently folding and fixing the spur tip with a thin piece of green elastic tape to obtain a length of either 36 or 21 mm (Figure [1](#ece34808-fig-0001){ref-type="fig"}a). In the control treatment (unmanipulated tall plants and long spurs), we attached a small piece of tape to each spur to control for effects of tape application. After spur manipulations, all inflorescences were returned to the field, and the vials were mounted on bamboo sticks placed besides the remaining basal leaves in each original plant position. Inflorescence height was manipulated by adjusting the height of the vial, such that the top flower was positioned at either 38 or 27 cm (Figure [1](#ece34808-fig-0001){ref-type="fig"}b) above the ground. The height of inflorescences in the control treatment was adjusted to their original height prior to cutting. In the field, experimental inflorescences were exposed to pollinators for three consecutive nights and after each night the number of pollinia removed and the number of massulae received was scored for all flowers (see Supporting Information Figure [S1](#ece34808-sup-0001){ref-type="supplementary-material"}). Total number of pollinia removed per plant was calculated based on observations after the third night, the number of flowers receiving pollen during the experiment was noted, and cumulative pollen receipt per pollinated flower was quantified as the sum of the number of new massulae recorded on stigmas after each of the three nights. After the third night, all inflorescences were brought to the field station, where they were kept outdoors, and covered by a net cage to prevent further pollination. Inflorescences were provided with fertilized water on a weekly basis, and the number of fruits produced was scored after 4 weeks when fruits were maturing. Two plants were excluded from the analysis of pollen removal and receipt due to damage by slugs during flowering, and 11 plants were excluded from the analysis of fruit production due to withering during fruit maturation. In addition, we excluded from estimates of pollen receipt per pollinated flower observations where entire pollinia were found on stigmas due to the uncertainty regarding the number of massulae in contact with the stigmatic surface in these cases (number of flowers, and number of individuals affected, control, 15, 10; plant height reduced, 8, 6; spur length reduced, 13, 7; both traits reduced, 5, 5). As a result, the final sample sizes for analyzing effects of plant height and spur length on pollen receipt in pollinated flowers were as follows: control, 18 plants; plant height reduced, 21 plants; spur length reduced, 12 plants; and both traits reduced, 13 plants. 2.3. Pollinator‐mediated selection {#ece34808-sec-0005} ---------------------------------- In 2016, we quantified phenotypic selection via pollen removal and female fitness on four floral traits (plant height, number of flowers, corolla size, and spur length) in the same population. We marked about 220 plants at bolting, and once individual plants had opened at least one‐third of their flowers, floral traits were measured in the same way as described above. To separate selection through female fitness mediated by pollinators and by other selective agents, we estimated selection both among open‐pollinated control plants (net selection), and among plants receiving supplemental hand‐pollination (non‐pollinator‐mediated selection; Sandring & Ågren, [2009](#ece34808-bib-0055){ref-type="ref"}; Sletvold & Ågren, [2010](#ece34808-bib-0057){ref-type="ref"}). Two‐thirds of the marked plants were randomly assigned to the open‐pollinated control (C), and one‐third received supplemental hand‐pollination (HP). Fewer plants were assigned to the hand‐pollination treatment, because variance in female fitness is expected to be lower in this treatment compared to the open‐pollinated control. Supplemental pollinations were performed by collecting a pollinium with a toothpick from a plant not included in the experiment, or from another plant within the hand‐pollination treatment, and gently brushing it across the stigma of the receiving flower. Each plant was pollinated on three to four occasions throughout flowering, and each time, all open flowers were pollinated with pollen from a minimum of two different donors at least 5 m away from the recipient. At the end of flowering, we recorded for each plant the total number of pollinia removed by carefully inspecting all flowers with a hand lens. At fruit maturation, we counted the number of fruits produced and harvested up to three mature fruits per plant. Fruits were brought to the lab and individually weighed to the nearest 0.01 mg as an estimate of seed production. For each plant, female fitness was quantified as the product of number of fruits and mean fruit mass. Grazing by hare and inflorescence breakage reduced the final sample sizes to 119 plants in the open‐pollinated control and 58 plants in the hand‐pollination treatment. 2.4. Statistical analysis {#ece34808-sec-0006} ------------------------- For the analysis of the first experiment, we coded plant height as tall (treatments 1 and 2) or short (treatments 3 and 4), and spur length as long (treatments 1 and 3) or short (treatments 2 and 4). We then examined the effects of plant height (tall vs. short) and spur length (long vs. short) and their interaction on pollen removal and components of female fitness (the number of flowers receiving pollen, the mean number of massulae received by pollinated flowers, and the number of fruits produced) with mixed‐effect models, which included block as a random factor, using the lme4 package (Bates, Mächler, Bolker, & Walker, [2015](#ece34808-bib-0008){ref-type="ref"}) and the car package (Fox & Weisberg, [2011](#ece34808-bib-0032){ref-type="ref"}) to obtain type III sum of squares and *p*‐values in the software R. For significance tests, all response variables were square‐root transformed prior to analysis to obtain normality of residuals. We used posthoc Tukey test to identify statistically significant differences between treatments. To estimate least‐square means, we re‐analyzed the model using untransformed data and the package lmerTest (Kuznetsova, Brockhoff, & Christensen, [2017](#ece34808-bib-0041){ref-type="ref"}). We used one‐way ANOVA to test for differences in phenotypic traits and female reproductive success between pollination treatments in the selection study. Correlations among phenotypic traits were quantified by calculating Pearson's correlation coefficients separately by treatment. Phenotypic traits did not differ between the two pollination treatments (one‐way ANOVA, all *p* \> 0.05), and trait correlations were of intermediate strength (range, 0.100--0.555; Supporting Information Table [S1](#ece34808-sup-0001){ref-type="supplementary-material"}) with the strongest correlations recorded between plant height and number of flowers, and between flower size and spur length. We quantified pollen removal failure in the control treatment as 1---mean proportion of pollinia removed, and pollen limitation of seed production as PL = 1---(mean female fitness in the open‐pollinated control treatment/mean female fitness in the hand‐pollination treatment). For the analysis of phenotypic selection, we calculated relative pollen removal and relative female fitness (individual values divided by population mean values) and standardized traits separately by pollination treatment (open‐pollinated control and supplemental hand‐pollination, respectively). The opportunity for selection through pollen removal and through female fitness was quantified as the variance in relative pollen removal and relative female fitness, respectively. We used *F* test for dependent samples (Lee, [1992](#ece34808-bib-0043){ref-type="ref"}; Pitman, [1939](#ece34808-bib-0053){ref-type="ref"}) to compare the variance in relative pollen removal and relative female fitness. We estimated phenotypic selection through pollen removal and female fitness with multiple regression models (Lande & Arnold, [1983](#ece34808-bib-0042){ref-type="ref"}), in which relative fitness (relative number of pollinia removed, or relative female fitness) was regressed on the four standardized traits (plant height, number of flowers, flower size, and spur length). To test for nonlinear quadratic and correlational selection, we examined models that in addition included quadratic terms and interactions among standardized traits. Quadratic selection gradients were estimated as twice the value of partial regression coefficients for quadratic terms (Stinchcombe, Agrawal, Hohenlohe, Arnold, & Blows, [2008](#ece34808-bib-0063){ref-type="ref"}). Selection gradients estimated in the open‐pollinated control (*β* ~C~) represent total, net selection, whereas gradients estimated in the hand‐pollination treatment (*β* ~HP~) represent non‐pollinator‐mediated selection. We quantified pollinator‐mediated selection through female fitness (∆*β* ~Poll~) by subtracting selection gradients observed in the hand‐pollination treatment (*β* ~HP~) from those observed in the open‐pollination control treatment (*β* ~C~). Statistical significance of pollinator‐mediated selection through female fitness was assessed with ANCOVA models, which included the four standardized traits, and their interactions with pollination treatment (open‐pollinated control vs. supplemental hand‐pollinated) as independent variables and relative female fitness as dependent variable. A significant interaction between a given trait and pollination treatment would indicate pollinator‐mediated selection on that trait. We used the plotting and diagnostic functions of the car package within the R software (Fox & Weisberg, [2011](#ece34808-bib-0032){ref-type="ref"}) to check for outliers, normality and heteroscedasticity of residuals, and collinearity among variables. Collinearity was not problematic (variance inflation factors \<2), and residuals were all normally distributed and homoscedastic. The shapes of fitness surfaces were explored by producing two‐dimensional added‐variable plots for quadratic selection, and by using the gam and visgam function in the package mgcv (Wood, [2017](#ece34808-bib-0076){ref-type="ref"}) in R to visualize three‐dimensional surfaces for correlational selection. All statistical analyses were performed in the software R version 3.3.2 (R Developmental Core Team, [2016](#ece34808-bib-0054){ref-type="ref"}) using the R Studio interface. 3. RESULTS {#ece34808-sec-0007} ========== 3.1. Effects of plant height and spur length on pollen removal {#ece34808-sec-0008} -------------------------------------------------------------- Both plant height and spur length affected pollen removal (Figure [2](#ece34808-fig-0002){ref-type="fig"}a, Table [1](#ece34808-tbl-0001){ref-type="table"}). Tall plants had more than twice as many pollinia removed compared to short plants (main‐effect least‐square mean ± *SE*, 6.3 ± 0.9 vs. 2.9 ± 0.9), and long‐spurred plants had 1.5 times more pollinia removed compared to short‐spurred plants (5.5 ± 0.9 vs. 3.7 ± 0.9; Supporting Information Table [S2](#ece34808-sup-0001){ref-type="supplementary-material"}). As predicted, the difference in pollen removal between long‐spurred and short‐spurred plants tended to be larger among tall plants (least‐square mean ± *SE*, 7.5 ± 1.1 vs. 5.1 ± 1.1 pollinia removed) than among short plants (3.6 ± 1.1 vs. 2.3 ± 1.1 pollinia removed), but the plant height × spur length interaction was far from statistically significant (*p* = 0.497, Table [1](#ece34808-tbl-0001){ref-type="table"}). {ref-type="table"}). \*\*\**p* \< 0.001, \*\**p* \< 0.01, \**p* \< 0.05](ECE3-9-1191-g002){#ece34808-fig-0002} ###### The effect of plant height, spur length, and their interaction on number of pollinia removed, number of flowers receiving pollen, mean number of massulae received per pollinated flower, and number of fruits, analyzed with linear mixed‐effect models that included block as a random effect Source of variation *df* *F* *p* ------------------------------------------------ ------ ------- ------------- No. of pollinia removed Plant height 1 9.32 **0.003** Spur length 1 6.24 **0.015** Plant height × spur length 1 0.47 0.497 No. of flowers receiving pollen Plant height 1 1.67 0.201 Spur length 1 21.36 **\<0.001** Plant height × spur length 1 0.11 0.743 No. of massulae received per pollinated flower Plant height 1 3.83 0.056 Spur length 1 6.62 **0.013** Plant height × spur length 1 1.95 0.176 No. of fruits Plant height 1 5.26 **0.026** Spur length 1 16.00 **\<0.001** Plant height × spur length 1 0.46 0.500 Statistically significant effects (*p* \< 0.05) are indicated in bold. John Wiley & Sons, Ltd 3.2. Effects of plant height and spur length on pollen receipt and fruit production {#ece34808-sec-0009} ----------------------------------------------------------------------------------- Spur length significantly affected both components of pollen receipt, whereas plant height did not affect the number of flowers receiving pollen and its effect on number of massulae received per pollinated flower was only marginally significant (Figure [2](#ece34808-fig-0002){ref-type="fig"}b--c, Table [1](#ece34808-tbl-0001){ref-type="table"}). The number of flowers receiving pollen was 2.5 times higher among plants with long spurs compared to plants with short spurs (main‐effect least‐square mean ± *SE*, 4.7 ± 0.6 vs. 1.9 ± 0.6 flowers; Supporting Information Table [S2](#ece34808-sup-0001){ref-type="supplementary-material"}, Figure [2](#ece34808-fig-0002){ref-type="fig"}b), but was not significantly affected by plant height or the plant height × spur length interaction (Table [1](#ece34808-tbl-0001){ref-type="table"}). The number of massulae received per pollinated flower was 1.5 times higher among long‐spurred than among short‐spurred plants (10.4 ± 1.0 vs. 6.7 ± 1.2) and tended to be higher among tall than among short plants (9.7 ± 1.1 vs. 7.4 ± 1.1, *p* = 0.056; Figure [2](#ece34808-fig-0002){ref-type="fig"}c, Table [1](#ece34808-tbl-0001){ref-type="table"}); the plant height × spur length interaction was not statistically significant (*p* = 0.176, Table [1](#ece34808-tbl-0001){ref-type="table"}). Long‐spurred plants produced almost twice as many fruits compared to short‐spurred plants (5.1 ± 0.7 vs. 2.6 ± 0.7 fruits; Figure [2](#ece34808-fig-0002){ref-type="fig"}d, Supporting Information Table [S2](#ece34808-sup-0001){ref-type="supplementary-material"}), and tall plants produced 1.6 times more fruits than did short plants (4.8 ± 0.7 vs. 3.0 ± 0.7 fruits). As predicted, the difference in fruit production between long‐spurred and short‐spurred plants tended to be larger among tall plants (6.4 ± 0.8 fruits vs. 3.1 ± 0.8 fruits) than among short plants (3.9 ± 0.8 vs. 2.2 ± 0.9), but the plant height × spur length interaction was far from statistically significant (*p = *0.500, Table [1](#ece34808-tbl-0001){ref-type="table"}). 3.3. Pollen removal, fruit production, and opportunity for selection {#ece34808-sec-0010} -------------------------------------------------------------------- In the open‐pollinated control treatment, on average 82% ± 17.9% of pollinia were removed (*N* = 118; Supporting Information Table [S3](#ece34808-sup-0001){ref-type="supplementary-material"}) and pollen removal failure was thus 0.18. Fruit set was 75% ± 20.6% (Supporting Information Table [S3](#ece34808-sup-0001){ref-type="supplementary-material"}), and pollen limitation of female fitness 0.13. The opportunity for selection through pollen removal was lower than that through female fitness (0.14 vs. 0.62; *F* test for dependent samples, *df* = 115, *r* = 0.558, *p* \< 0.001). 3.4. Selection via pollen removal {#ece34808-sec-0011} --------------------------------- There was selection for more and larger flowers, but no statistically significant selection on plant height or spur length via pollen removal (Table [2](#ece34808-tbl-0002){ref-type="table"}). ###### Estimates of net selection (*β* ~C~; quantified in open‐pollinated control treatment, *N* = 119), non‐pollinator‐mediated selection (*β* ~HP~; quantified as selection among plants receiving supplemental hand‐pollination, *N* = 58), and pollinator‐mediated selection (∆*β* ~Poll~ = *β* ~C~−*β* ~HP~) via pollen removal and female fitness in a woodland population of the orchid *Platanthera bifolia* on the island Öland, SE Sweden Phenotypic trait Pollen removal Female fitness ------------------------------- ------------------- ---------------- -------------------- ------------- ------------------- ------------- -------------------- ----------- Directional selection Plant height −0.024 ± 0.026 0.356 0.096 ± 0.056 0.088 −0.117 ± 0.070 0.099 **0.213 ± 0.094** **0.024** No. of flowers **0.287 ± 0.023** **\<0.001** **0.543 ± 0.050** **\<0.001** **0.496 ± 0.065** **\<0.001** 0.048 ± 0.086 0.580 Flower size **0.073 ± 0.025** **0.004** 0.019 ± 0.054 0.733 0.063 ± 0.066 0.343 −0.044 ± 0.089 0.619 Spur length −0.013 ± 0.025 0.608 0.105 ± 0.054 0.053 0.129 ± 0.071 0.074 −0.024 ± 0.093 0.800 Quadratic selection Plant height 0.021 ± 0.051 0.681 −0.104 ± 0.100 0.303 0.017 ± 0.181 0.925 −0.121 ± 0.218 0.580 No. of flowers 0.048 ± 0.044 0.276 **0.202 ± 0.087** 0.022 0.138 ± 0.093 0.151 0.066 ± 0.131 0.615 Flower size −0.041 ± 0.041 0.311 0.009 ± 0.082 0.914 −0.056 ± 0.126 0.662 0.064 ± 0.157 0.683 Spur length −0.066 ± 0.054 0.228 −0.101 ± 0.106 0.344 −0.075 ± 0.165 0.649 −0.025 ± 0.205 0.902 Correlational selection Plant height × no. of flowers −0.052 ± 0.043 0.233 0.082 ± 0.086 0.339 −0.128 ± 0.127 0.318 0.210 ± 0.160 0.190 Plant height × flower size 0.032 ± 0.030 0.293 0.022 ± 0.060 0.718 −0.135 ± 0.087 0.128 0.157 ± 0.110 0.157 Plant height × spur length −0.003 ± 0.040 0.941 0.058 ± 0.079 0.464 0.018 ± 0.099 0.854 0.040 ± 0.131 0.762 No. of flowers × flower size **0.070 ± 0.026** **0.010** **−0.184 ± 0.053** **\<0.001** 0.171 ± 0.089 0.060 **−0.355 ± 0.109** **0.001** No. of flowers × spur length −0.026 ± 0.025 0.303 **0.101 ± 0.050** **0.046** 0.100 ± 0.094 0.293 0.001 ± 0.113 0.994 Flower size × spur length 0.042 ± 0.035 0.235 0.038 ± 0.072 0.597 0.139 ± 0.107 0.202 −0.101 ± 0.135 0.457 Selection gradients (±*SE*) were estimated with multiple regression models, in which relative pollen removal or relative female fitness (number of fruits × mean fruit mass) were regressed on standardized traits. Statistically significant selection gradients (*p* \< 0.05) are indicated in bold. John Wiley & Sons, Ltd 3.5. Selection via female fitness {#ece34808-sec-0012} --------------------------------- Among open‐pollinated plants, there was strong directional selection through female fitness for more flowers, whereas selection for taller plants and for longer spurs only approached statistical significance (Table [2](#ece34808-tbl-0002){ref-type="table"}, Figure [3](#ece34808-fig-0003){ref-type="fig"}). Relative female fitness increased disproportionately with number of flowers (significant positive quadratic selection gradient; Table [2](#ece34808-tbl-0002){ref-type="table"}, Supporting Information Figure [S2](#ece34808-sup-0001){ref-type="supplementary-material"}). In addition, there was significant negative correlational selection on number of flowers × flower size, and positive correlational selection on number of flowers × spur length (Table [2](#ece34808-tbl-0002){ref-type="table"}, Supporting Information Figure [S3](#ece34808-sup-0001){ref-type="supplementary-material"}) indicating selection favoring the combinations of many and small flowers, and many flowers with long spurs. However, these estimates of correlational selection were strongly influenced by a few plants with particularly high female fitness and should be interpreted with caution (Supporting Information Figure [S3](#ece34808-sup-0001){ref-type="supplementary-material"}). {#ece34808-fig-0003} Pollinators mediated selection for taller plants (*F* ~1,167~ = 8.59, *p* = 0.004, ANCOVA; Figure [3](#ece34808-fig-0003){ref-type="fig"}), and the negative correlational selection on number of flowers and flower size (significant treatment × number of flowers × flower size interaction, *F* ~1,147~ = 13.99, *p* = 0.0003, ANCOVA; Table [2](#ece34808-tbl-0002){ref-type="table"}). Net selection for more flowers was mainly driven by factors other than pollinators, as indicated by the strong selection observed in the hand‐pollination treatment (Table [2](#ece34808-tbl-0002){ref-type="table"}). 4. DISCUSSION {#ece34808-sec-0013} ============= The two ecotypes of the moth‐pollinated orchid *P. bifolia* occurring in southern Sweden differ in several traits likely to influence interactions with pollinators including plant height and nectar spur length: the woodland ecotype is taller and produces nectar spurs that are longer than those produced by the grassland ecotype. Here, we have shown with a field experiment that both differences are important for pollination success and fruit production in a woodland population. However, we did not detect any significant interaction effects of the two traits on reproductive success, and whereas pollinators mediated significant selection for taller plants, no current pollinator‐mediated selection on spur length was detected in this population. Below, we discuss the results in relation to the maintenance of the two ecotypes, and the power of experimental approaches for the identification of adaptive traits and agents of selection. Woodland populations grow in tall vegetation and, as expected, plant height affected both pollen removal and fruit production. Reduction of plant height to that of the grassland ecotype, which grows in shorter vegetation, decreased pollen removal and fruit production, and there was pollinator‐mediated selection for taller plants. Pollinators mediate selection for taller inflorescences also in other orchid (Sletvold & Ågren, [2010](#ece34808-bib-0057){ref-type="ref"}; Sletvold, Grindeland, & Ågren, [2010](#ece34808-bib-0059){ref-type="ref"}) and non‐orchid species (Ågren, Hellström, Toräng, & Ehrlén, [2013](#ece34808-bib-0001){ref-type="ref"}; Paudel et al., [2016](#ece34808-bib-0051){ref-type="ref"}). Moreover, pollinator‐mediated selection on inflorescence height can be expected to be stronger in tall than in short vegetation (Sletvold, Grindeland, & Ågren, [2013](#ece34808-bib-0060){ref-type="ref"}), which is consistent with the difference in plant height between the woodland and the grassland ecotype of *P. bifolia*. Optimal inflorescence height should depend on how this trait affects interactions also with other biotic agents and responses to the abiotic environment (Falster & Westoby, [2003](#ece34808-bib-0028){ref-type="ref"}). In the present study, the strong pollinator‐mediated selection for taller plants through female fitness (selection gradient Δ*β* ~poll~ = 0.213) was opposed by non‐pollinator‐mediated selection for shorter plants (*β* ~HP~ = −0.117) and net selection on plant height was not statistically significant. Tall plants should have an advantage over short plants when it comes to light capture in tall vegetation, but this should contribute to selection for tall rather than for short plants and can thus not explain the documented non‐pollinator‐mediated selection for shorter plants. Stronger grazing pressure on tall inflorescences may counteract the advantage of increased pollinator attraction (Ågren et al., [2013](#ece34808-bib-0001){ref-type="ref"}; Cariveau, Irwin, Brody, Garcia‐Mayeya, & Ohe, [2004](#ece34808-bib-0014){ref-type="ref"}; Gomez, [2003](#ece34808-bib-0033){ref-type="ref"}). However, grazed plants were not included in the selection analysis, and plant height did not differ between plants damaged by grazers and plants included in the analysis (data not shown). Additional studies are needed to test whether tall plants are more prone to experience drought stress, or whether non‐pollinator‐mediated selection for shorter plants is driven by some other biotic or abiotic environmental factors. The length of the nectar spur should influence the morphological fit between flowers and pollinators, and therefore the efficiency of pollen transfer (Darwin, [1862](#ece34808-bib-0021){ref-type="ref"}; Nilsson, [1988](#ece34808-bib-0049){ref-type="ref"}). Here, we showed that shortening of spurs to a length corresponding to that of the grassland ecotype decreased the number of pollinia removed, the number of flowers receiving pollen, the mean amount of pollen received per flower, and fruit production in a long‐spurred woodland population of *P. bifolia*. This is in line with previous experiments conducted in the same geographic area demonstrating strong negative effects of nectar‐spur shortening on both pollen removal and receipt in the woodland ecotype (Boberg & Ågren, [2009](#ece34808-bib-0010){ref-type="ref"}; Nilsson, [1988](#ece34808-bib-0049){ref-type="ref"}). A strong effect of spur length or floral tube depth on pollen transfer has been demonstrated experimentally in several systems (e.g., Johnson & Steiner, [1997](#ece34808-bib-0039){ref-type="ref"}; Muchhala & Thompson, [2009](#ece34808-bib-0045){ref-type="ref"}; Sletvold & Ågren, [2011](#ece34808-bib-0058){ref-type="ref"}). Together with demonstration of pollinator‐mediated selection on spur length (e.g., Sletvold & Ågren, [2010](#ece34808-bib-0057){ref-type="ref"}; Sletvold et al., [2010](#ece34808-bib-0059){ref-type="ref"}), geographic covariation between flower tube depth and tongue length of pollinators (Anderson & Johnson, [2009](#ece34808-bib-0003){ref-type="ref"}; Boberg et al., [2014](#ece34808-bib-0011){ref-type="ref"}; Newman, Manning, & Anderson, [2014](#ece34808-bib-0046){ref-type="ref"}, [2015](#ece34808-bib-0047){ref-type="ref"}) and phylogenetic analyses of trait evolution and pollinator shifts (Koopman & Ayers, [2005](#ece34808-bib-0040){ref-type="ref"}; Whittall & Hodges, [2007](#ece34808-bib-0075){ref-type="ref"}), this suggests that pollinators have been important for the evolution of the lengths of nectar spurs and floral tubes in a wide range of species. Although strong effects on pollen removal and fruit production were observed when spur length was reduced to a length observed in the grassland ecotype, there was no current pollinator‐mediated selection on spur length. This shows that effects on pollen removal and fruit production were weak across the phenotypic range present in the study population, and points to the general problem of determining the adaptive significance of a trait when natural variation is limited and corresponds to a flat part of the fitness landscape. Traits that have been subject to consistent stabilizing selection are expected to show limited variation (Cresswell, [1998](#ece34808-bib-0018){ref-type="ref"}; Fenster, [1991](#ece34808-bib-0029){ref-type="ref"}; Van Kleunen, Meier, Saxenhofer, & Fischer, [2008](#ece34808-bib-0072){ref-type="ref"}), and in this situation experimental crosses between divergent populations (Schemske & Bradshaw, [2008](#ece34808-bib-0056){ref-type="ref"}; Toräng et al., [2017](#ece34808-bib-0068){ref-type="ref"}) or phenotypic manipulation (Campbell, [2009](#ece34808-bib-0012){ref-type="ref"}; Peakall & Handel, [1993](#ece34808-bib-0052){ref-type="ref"}) may be required to characterize the relationship between trait expression and components of fitness. For example, effects of plant height on pollinator visitation in the sexually deceptive orchid *Chiloglottis trilabra* were documented only when the range of plant height was extended well beyond the natural variation (Peakall & Handel, [1993](#ece34808-bib-0052){ref-type="ref"}). The results illustrate that experimental manipulation may be needed for determining the adaptive significance of traits with limited variation. Traits enhancing pollinator visitation and traits increasing efficiency of pollen transfer are expected to affect pollination success non‐additively (Benitez‐Vieyra, Medina, Glinos, & Cocucci, [2006](#ece34808-bib-0009){ref-type="ref"}; Engel & Irwin, [2003](#ece34808-bib-0027){ref-type="ref"}; Sletvold & Ågren, [2011](#ece34808-bib-0058){ref-type="ref"}). However, although the effect of spur length on pollen removal and female fitness tended to be stronger among tall plants than among short plants, the plant height × spur length interaction was far from statistically significant. Because the variances in both pollinia removal and fruit production were high, substantially larger sample sizes would be required for interaction effects of the estimated magnitudes to be statistically significant. The lack of pollinator‐mediated correlational selection on plant height and spur length is not surprising given the absence of a significant plant height × spur length interaction when traits were manipulated, and the limited range in spur length in this population. A few previous studies report correlational selection supporting the hypothesis of non‐additive effects on fitness of traits important for pollinator attraction and efficiency of pollen transfer, respectively (Benitez‐Vieyra et al., [2006](#ece34808-bib-0009){ref-type="ref"}; Chapurlat et al., [2015](#ece34808-bib-0016){ref-type="ref"}; Cuartas‐Dominguez & Medel, [2010](#ece34808-bib-0020){ref-type="ref"}), and there was correlational selection for more flowers with longer spurs in the studied population of *P. bifolia*. However, the supplemental hand‐pollination showed that this correlational selection was not mediated by pollinators (Table [2](#ece34808-tbl-0002){ref-type="table"}). So far, only Chapurlat et al. ([2015](#ece34808-bib-0016){ref-type="ref"}) have demonstrated pollinator‐mediated correlational selection on an attraction and an efficiency trait experimentally (number of flowers and spur length in the orchid *Gymnadenia conopsea*). Additional studies are required to determine whether current pollinator‐mediated selection on such traits is frequent, and whether its occurrence can be predicted based on the phenotypic variance present in a given population. The woodland ecotype produces larger flowers than does the grassland ecotype, which may be important for its reproductive success. Flower size was not manipulated in the current study, but the phenotypic selection analysis indicated significant selection for increased flower size through pollen removal. This suggests that flower size directly, or indirectly through correlated traits, influenced either visitation rate or efficiency of pollen removal in this year. While large flowers should contribute to a prominent floral display, a previous experiment in the same woodland population found no effect of reduced perianth size on pollination success (Boberg & Ågren, [2009](#ece34808-bib-0010){ref-type="ref"}). This suggests that the visual display of individual flowers is not the target trait of selection. The mechanism behind the positive effect of flower size on pollen removal deserves further study. The relative strength of selection through pollen removal and female fitness should depend on the relationship between trait expression and absolute measures of these components of fitness, the variance in trait expression, and the opportunity for selection, that is, the variance in relative fitness. Trait manipulation indicated that plant height and spur length can strongly affect both pollen removal and female fitness. However, in the natural population opportunity for selection through female fitness was markedly larger than through pollen removal, and pollinator‐mediated selection on plant height was significant only through female fitness. Still, opportunity for selection could not explain all differences in selection observed. Despite lower opportunity for selection through pollen removal, number of flowers and flower size were subject to significant selection through pollen removal, but not to pollinator‐mediated selection through female fitness indicating that variation in these traits was more important for pollen removal than for successful pollen receipt. Pollen removal has been used as a proxy for male fitness in some studies (e.g., O'Connell & Johnston, [1998](#ece34808-bib-0050){ref-type="ref"}; Maad, [2000](#ece34808-bib-0044){ref-type="ref"}; Benitez‐Vieyra et al., [2006](#ece34808-bib-0009){ref-type="ref"}). However, siring success depends not only on pollen removal but also on the proportion of removed pollen reaching conspecific stigmas, and the proportion of those that successfully fertilize ovules that develop into mature seeds. It is therefore not surprising that the link between pollen removal and successful pollen export to other plants (Johnson et al., [2005](#ece34808-bib-0038){ref-type="ref"}) and siring success (Snow & Lewis, [1993](#ece34808-bib-0061){ref-type="ref"}) can be weak, and additional studies are required to determine whether selection through pollen removal mirrors selection through male fitness. Taken together, the results of the present study suggest that pollinator‐mediated selection has contributed to the divergence in both spur length and plant height between the grassland and woodland ecotype of *P. bifolia*. A history of consistent directional or stabilizing selection is expected to reduce the magnitude of trait variation in natural populations. As illustrated by this study, a combination of trait manipulation and examination of current phenotypic selection and its causes may therefore often be required for a full understanding of the functional and adaptive significance of trait divergence. CONFLICT OF INTEREST {#ece34808-sec-0014} ==================== None declared. AUTHOR CONTRIBUTION {#ece34808-sec-0015} =================== J.T., N.S., and J.Å. planned and designed the study. J.T. performed the experiments and analyzed data, and J.T., N.S., and J.Å. wrote the paper. Supporting information ====================== ######   ###### Click here for additional data file. We thank Lovisa Dück for help in the field, Dave Karlsson, Anne Wilks, and Kenneth Pantzar at the research station Linné on Öland for help and support during field work. We are grateful to Börje Karlsson for allowing us to work on his land. This study was financially supported by grants from the Swedish Research Council to JÅ, Swedish Research Council Formas to NS and the Swedish Phytogeographical Society to JT. DATA ACCESSIBILITY {#ece34808-sec-0016} ================== The data have been archived in Dryad and are accessible under <https://doi.org/10.5061/dryad.6k9v66n>.

\section{Introduction} Resonance fluorescence from a single atom exhibits non-classical features~\cite{Resonance-Fluorescence}, which become evident in the correlation functions of the emitted light~\cite{MandelWolf}. Non-classical properties emerge from the quantum nature of the scatterer, such as the discrete spectrum of the electronic bound states of the scattering atom. They can be enhanced or suppressed by several scatterers forming a regular array~\cite{Mandel,Skornia,Vogel85}. In this case, at the solid angles which satisfy the von-Laue condition~\cite{Ashcroft}, the light in the far field is in a squeezed coherent state, while for a large number of atoms it can exhibit vacuum squeezing at scattering angles, for which the elastic component of the scattered light is suppressed~\cite{Vogel85}. When the atoms of the array are strongly coupled with the mode of a high-finesse resonator, emission into the cavity mode is in general expected to be enhanced. The properties of the light at the cavity output will depend on the phase-matching conditions, determined by the angle between laser and cavity wave vector and by the periodicity of the atomic array. The coherence properties of the light at the cavity output may however be significantly different from the ones predicted in free space. An interesting example is found when the geometry of the setup is such that the atoms coherently scatter light into the cavity mode. In this case the intracavity-field intensity becomes independent of the number of atoms $N$ as $N$ increases, while inelastic scattering is suppressed over the whole solid angle in leading order in $1/N$~\cite{Zippilli_PRL04}. These dynamics have been confirmed by experimental observations~\cite{Black03,Slama}, and clearly differ from the behaviour in free space~\cite{Vogel85}. When the geometry of the setup is such that the von-Laue condition is not satisfied, photons can only be inelastically scattered into the cavity mode. The smaller system size for which coherent scattering is suppressed is found for two atoms inside the resonator. The properties of the light at the cavity output for this specific case have been studied in Refs.~\cite{Fernandez_07,Evers}. To the best of our knowledge, however, the scaling of the dynamics with the number of atoms $N$ is still largely unexplored in this regime. In this article we characterize the coherence properties of the light at the cavity output when the light is scattered from a laser into the resonator by an array of atoms and the geometry of the system is such that coherent scattering is suppressed. For the phase-matching conditions, at which in free space the light is in a squeezed-vacuum state~\cite{Vogel85}, we find that inside a resonator and at large $N$ the system behaves as an optical parametric oscillator, which in certain regimes can operate above threshold~\cite{MilburnWalls}. For a small number of atoms $N$, on the contrary, the medium can act as a source of antibunched light. In this case it can either behave as single-photon or, for the saturation parameters here considered, two-photon ``gateway''~\cite{Kubanek08}. The latter behaviour is found for a specific phase-matching condition. We identify the parameter regimes which allow one to control the specific nonlinear optical response of the medium. This article is organized as follows. In Sec.~\ref{Sec:2} the theoretical model is introduced and the basic approximations are discussed, which lead to the derivation of an effective Hamiltonian for the atomic and cavity excitations. In Sec.~\ref{Sec:3} we analyze the light at the cavity output under the condition that there is no coherent scattering into the cavity. The conclusions are drawn and outlooks are discussed in Sec.~\ref{Sec:5}. \section{Theoretical Model} \label{Sec:2} \begin{figure} \centering \subfigure[]{ \includegraphics[width=7cm]{Fig1a}} \hspace{1.5cm} \subfigure[]{ \includegraphics[width=4cm]{Fig1b} } \caption[]{(Color online) (a) An array of atoms, with interparticle distance $d$, is confined along the axis of a standing-wave optical cavity at frequency $\omega_c$ and is transversally driven by a laser, whose wave vector forms the angle $\Theta$ with the cavity axis. The atomic internal transition and the relevant frequency scales are given in (b), with $|1\rangle$ and $|2\rangle$ ground and excited state of an optical transition with frequency $\omega_0$ and natural linewidth $\gamma$. The frequencies $\omega_z=\omega_0-\omega_p$ and $\delta_c=\omega_c-\omega_p$ denote the detunings between the laser frequency $\omega_p$ and the atomic and cavity frequency, respectively. The other parameters are the laser Rabi frequency $\Omega$, the atom-cavity coupling strength $g$, and the decay rate $\kappa$ of the optical cavity. } \label{Fig:lattice} \end{figure} The physical system is composed by $N$ identical atoms which are regularly distributed along the $z$ axis. They are located at the positions $z_j=jd$ where $j=1,\dots,N$ and $d$ is the interparticle distance~\cite{Footnote:0}. An optical dipole transition of the confined atoms interacts with the mode of a standing wave cavity, whose wave vector $k$ is parallel to the atomic array, as illustrated in Fig.~\ref{Fig:lattice}. Moreover, the atoms are transversally driven by a laser and scatter photons into the cavity mode. We denote by $\omega_p$ the frequency of the laser mode, whose polarization is assumed to be linear and parallel to the polarization of the cavity mode, and $a$ and $a^{\dagger}$ the annihilation and creation operators, respectively, of a cavity photon at frequency $\omega_c$ (with $[a,a^{\dagger}]=1$). Cavity and laser mode couple to the atomic dipolar transition at frequency $\omega_0$ with ground and excited states $|1\rangle$ and $|2\rangle$. The Hamiltonian governing the coherent dynamics of cavity mode and the atoms is given by \begin{align}\label{fullHamil} \mathcal{H}=&\hbar\omega_c a^{\dag}a+\hbar\omega_0\sum_{j=1}^{N} S_j^z\nonumber\\ &+\hbar g\sum_{j=1}^{N} \cos{(kz_j+\varphi)}(S_j^{\dag}a+a^{\dag}S_j)\nonumber\\ &+i\hbar\Omega\sum_{j=1}^{N}(S_j^{\dag}e^{-{\rm i}\omega_p t} e^{{\rm i}(k_pz_j\cos\Theta-\phi_L)}-{\rm H.c.})\,, \end{align} where $\Omega$ is the strength of the coupling between laser and atomic transition, and $g$ the cavity vacuum Rabi frequency. The operators $S_j=|1\rangle_j\langle2|$ and $S_j^\dag$ indicate the lowering and raising operators for the atom at the position $z_j$, and $S_j^z=\frac{1}{2}(|2\rangle_j\langle2|-|1\rangle_j\langle1|)$ is the $z$ component of the pseudo-spin operator. In Eq.~(\ref{fullHamil}) we have introduced the angle $\varphi$, which is the phase offset of the standing wave at the atomic positions, the phase of the laser $\phi_L$, and the angle $\Theta$ between the laser and the cavity wave vector. We remark that in the present study we neglect the atomic motion, and consider that the size of the atomic wavepacket is much smaller than the laser wavelength and interparticle distance. We refer the reader to \cite{Fernandez_07} for a quantitative study on the effects of the mechanical motion on the nonlinear optical processes in this kind of system. In the rest of this section we will introduce and discuss the approximations, which allow us to solve the dynamics and determine the properties of the cavity field. For simplicity we also set $k=k_p$: The difference between the laser and cavity wave numbers can in fact be neglected for the purpose of this study. \subsection{Weak excitation limit} We resort to the Holstein-Primakoff representation for the spin operator~\cite{holstein} \begin{eqnarray}\label{HPnapp} &&S_j^{\dag}=b_j^{\dag}(1-b_j^{\dag}b_j)^{1/2}\,,\\ &&S_j=(1-b_j^{\dag}b_j)^{1/2}b_j,\nonumber\\ &&S_j^z=b_j^{\dag}b_j-\frac{1}{2},\nonumber \end{eqnarray} where $b_j$ ($b_j^\dagger$) is the bosonic operator annihilating (creating) an excitation of the atom at $z_j$, such that $[b_j,b^\dag_{j'}]=\delta_{jj'}$. In the limit in which the atomic dipoles are driven below saturation, we treat saturation effects in the lowest non-vanishing order of a perturbative expansion, whose small parameter is the total excited-state population of the atoms, denoted by ${\cal N}_{\rm tot}$. We denote the detuning of the laser from the atomic transition by \begin{equation} \omega_z=\omega_0-\omega_p\,. \end{equation} and by $\gamma$ the natural linewidth. In the low saturation limit, $|\omega_z+{\rm i}\gamma/2|\gg\sqrt{N}\Omega$, then ${\cal N}_{\rm tot}\ll N$ and we can expand the operators on the right-hand side of the equations~(\ref{HPnapp}) in second order in the small parameter $\langle b_j^{\dagger}b_j\rangle \ll 1$, obtaining \begin{eqnarray}\label{HP1} &&S_j^{\dag}\approx b_j^{\dag} -\frac{1}{2}b_j^{\dag}b_j^{\dag}b_j\,,\\ &&S_j\approx b_j-\frac{1}{2}b_j^{\dag}b_j b_j\,. \end{eqnarray} For $N\gg 1$ the dynamics is expected to be irrelevantly affected by the assumptions on the boundaries. Therefore, we take periodic boundary conditions on the lattice, such that $z_{N+1}=z_1$. The atomic excitations are studied in the Fourier transformed variable $q$, quasimomentum of the lattice, which is defined in the Brillouin zone (BZ) $q\in(-G_0/2, G_0/2]$ with $G_0=2\pi/d$ the primitive reciprocal lattice vector. Correspondingly, we introduce the operators $b_q$ and $b_q^{\dagger}$, defined as \begin{eqnarray} \label{Fourier} &&b_q=\frac{1}{\sqrt{N}}\sum_{j=1}^N b_j e^{-{\rm i}qjd}\,,\\ &&b_{q}^{\dagger}=\frac{1}{\sqrt{N}}\sum_{j=1}^N b_j^{\dagger} e^{{\rm i}qjd}\,, \end{eqnarray} which annihilate and create, respectively, an excitation of the spin wave at quasimomentum $q$ and fulfilling the commutation relation $[b_q,b_{q'}^{\dagger}]=\delta_{q,q'}$. After rewriting the Hamiltonian in Eq.~(\ref{fullHamil}) in terms of spin-wave operators, we find \begin{equation}\label{Hgeneral} \mathcal{H}\approx-\frac{N\hbar\omega_z}{2}+H_{\rm pump}+{\cal H}^{(2)}+{\cal H}^{(4)}\,, \end{equation} where the first term on the Right-Hand Side (RHS) is a constant and will be discarded from now on, while \begin{equation} \label{H:pump} H_{\rm pump}={\rm i}\hbar\Omega\sqrt{N}\left(b_{Q'}^{\dag}e^{-{\rm i}(\omega_pt+\phi_L)} -b_{Q'}e^{{\rm i}(\omega_pt+\phi_L)}\right) \end{equation} is the linear term describing the coupling with the laser. Term \begin{align} {\cal H}^{(2)}=&\hbar\omega_c a^{\dag}a+\hbar\omega_0 \sum_{q\in BZ}b_q^{\dag}b_q\nonumber\\ &+\frac{\hbar g\sqrt{N}}{2}\left[(b_{Q}^{\dagger}\;e^{i\varphi}+b_{-Q}^{\dagger}\;e^{-i\varphi})a+{\rm H.c.}\right]\label{Hharm} \end{align} determines the system dynamics when the linear pump is set to zero and the dipoles are approximated by harmonic oscillators (analog of the classical model of the elastically bound electron), while \begin{align} {\cal H}^{(4)}&=-\frac{\hbar g}{4\sqrt{N}}\sum_{q_1,q_2\in BZ}(b^{\dag}_{q_1} b^{\dag}_{q_2}b_{q_1+q_2-Q}a\;e^{i\varphi}\nonumber\\ &+b^{\dag}_{q_1}b^{\dag}_{q_2}b_{q_1+q_2+Q}a\;e^{-i\varphi}+{\rm H.c.})\nonumber\\ &-i\frac{\hbar\Omega}{2\sqrt{N}}\sum_{q_1,q_2\in BZ}(b_{q_1}^{\dag}b_{q_2}^{\dag}b_{q_1+q_2-Q'}e^{-{\rm i}(\omega_pt+\phi_L)}-{\rm H.c.})\label{Hnharm} \end{align} accounts for the lowest-order corrections due to saturation. In Eqs.~(\ref{Hharm}) and~(\ref{Hnharm}) we have denoted by $\pm Q$ and $Q'$ the quasimomenta of the spin waves which couple to the cavity and laser mode, respectively, and which fulfill the phase matching conditions \begin{eqnarray} &&Q=k+G\,,\label{phase:1}\\ &&Q'=k\cos\Theta +G'\,,\label{phase:2} \end{eqnarray} with reciprocal vectors $G,G'$ such that $Q,Q'\in$ BZ. The atoms scatter coherently into the cavity mode when the von-Laue condition is satisfied, namely one of the two relations is fulfilled: \begin{eqnarray} \label{vonLaue} &&2k\sin^2(\Theta/2)=nG_0\,,\\ &&2k\cos^2(\Theta/2)=n'G_0\,, \end{eqnarray} with $n,n'$ integer numbers. In free space, the von-Laue condition corresponds to Eq. (\ref{vonLaue}): for these angles one finds squeezed-coherent states in the far field~\cite{Vogel85}. When the scattered mode for which the von-Laue condition is fulfilled corresponds to a cavity mode, superradiant scattering enhances this behaviour, until the number of atoms $N$ is sufficiently large such that the cooperativity exceeds unity. In this limit one observes saturation of the intracavity-field intensity, which reaches an asymptotic value whose amplitude is independent of $N$ as $N$ is further increased. In the limit $N\gg 1$ the light at the cavity output is in a coherent state, while inelastic scattering is suppressed at leading order in $1/N$~\cite{Zippilli_PRL04}. When the von-Laue condition is not satisfied, classical mechanics predicts that there is no scattering into the cavity mode. These modes of the electromagnetic fields are solely populated by inelastic scattering processes. Moreover, in free space, when \begin{equation} \label{Condition:Squeeze} 2k\sin^2(\Theta/2)=(2n+1)G_0/2\,, \end{equation} then the inelastically scattered light is in a vacuum-squeezed state~\cite{Vogel85}. Inside a standing-wave resonator, on the other hand, the mode is in a vacuum-squeezed state provided that either Eq.~(\ref{Condition:Squeeze}) or an additional relation, \begin{equation} 2k\cos^2(\Theta/2)=(2n+1)G_0/2\,, \end{equation} is satisfied. In the following we will study the field at the cavity output as determined by the dynamics of Hamiltonian~(\ref{Hgeneral}) when $Q'\neq \pm Q$, namely, when the scattering processes which pump the cavity are solely inelastic. We remark that throughout this treatment we do not make specific assumptions about the ratio between the array periodicity $d$ and the light wavelength $\lambda$ (and therefore also consider the situation in which $\lambda\neq 2d$. This situation has been experimentally realized for instance in Refs.~\cite{Kimble,Kinner,Slama,Drewsen}). \subsection{Linear response: Polaritonic modes} We first solve the dynamics governed by Hamiltonian $\mathcal H^{(2)}$ in Eq.~(\ref{Hharm}). In the diagonal form the quadratic part can be rewritten as \begin{equation} \mathcal H^{(2)}=\sum_{j=1}^{2} \hbar\omega_j\gamma_j^{\dag}\gamma_j +\sum_{q\neq Q_s,q\in BZ} \hbar\omega_0 b_q^{\dag}b_q\,, \end{equation} where $Q_s$ labels the spin wave which couples with the cavity mode, such that \begin{eqnarray} \label{Sym:Polariton} &&b_{Q_s}=b_Q \mbox{~~if~~}Q=0,G_0/2\,, \\ &&b_{Q_s}=\frac{b_{Q}\;e^{-i\varphi}+b_{-Q}\;e^{i\varphi}}{\sqrt{2}}\mbox{~~otherwise}\,.\label{Sym:Polariton:1} \end{eqnarray} The resulting polaritonic eigenmodes are \begin{align} &\gamma_1=-a\cos X+b_{Q_s}\sin X\,, \label{polariton:1}\\ &\gamma_2=a\sin X+b_{Q_s}\cos X\,,\label{polariton:2} \end{align} with respective eigenfrequencies \begin{eqnarray}\label{EigenFreqs} &&\omega_{1,2} = \frac{1}{2}\left(\omega_c+\omega_0 \mp \delta\omega\right),\\ &&\delta\omega=\sqrt{\left(\omega_0-\omega_c\right)^2+4\tilde{g}^2N}\;\,, \end{eqnarray} and \begin{equation} \label{angle:X} \tan X=\tilde{g}\sqrt{N}/(\omega_0-\omega_1)\,, \end{equation} which defines the mixing angle $X$. The parameter $\tilde{g}$ is proportional to the coupling strength. In particular, $\tilde{g}=g\cos\varphi$ when $Q=0,G_0/2$ and the cavity mode couples with the spin wave $b_{Q_s}=b_Q$, otherwise $\tilde{g}=g/\sqrt{2}$ and the spin wave is given in Eq.~(\ref{Sym:Polariton:1}). Hamiltonian~(\ref{H:pump}) describes the coupling of the pump with the spin wave $Q'$. When $Q'\neq \pm Q$, photons are pumped into the cavity via inelastic processes, which in our model are accounted for by the Hamiltonian term in Eq.~(\ref{Hnharm}). On the other had, when the dynamics is considered up to the quadratic term (hence, inelastic processes are neglected), only the mode $Q'$ is pumped and the Heisenberg equation of motion for $b_{Q'}$ reads \begin{equation} \label{drive:0} \dot{b}_{Q'}=-{\rm i}\omega_zb_{Q'}-\frac{\gamma}{2}b_{Q'}+\Omega\sqrt{N}{\rm e}^{-{\rm i}\phi_L}+\sqrt{\gamma}b_{q, \rm in}(t)\,, \end{equation} that has been written in the reference frame rotating at the laser frequency $\omega_p$. Here, $\gamma$ is the spontaneous decay rate and $b_{q,\rm in}(t)$ is the corresponding Langevin force operator, such that $\langle b_{q,\rm in}(t)\rangle=0$ and $\langle b_{q,\rm in}(t)b_{q,\rm in}^{\dagger}(t')\rangle=\delta(t-t')$~\cite{MilburnWalls}. The general solution reduces, in the limit in which $|\omega_z|\gg\gamma$, to the form \begin{equation} \label{drive} b_{Q'}\simeq -{\rm i}\frac{\Omega\sqrt{N}}{\omega_z}{\rm e}^{-{\rm i}\phi_L} \end{equation} which is consistent with the expansion to lowest order in Eq.~(\ref{HP1}) provided that $\Omega^2 N\ll \omega_z^2$. In the reference frame rotating at the laser frequency the explicit frequency dependence of the Hamiltonian terms is dropped, and $\omega_1\to \omega_1-\omega_p$, $\omega_2\to \omega_2-\omega_p$, $\omega_0\to \omega_z$, and $\omega_c\to \omega_c-\omega_p\equiv \delta_c$. \subsection{Effective Hamiltonian}\label{sub1} Under the assumptions discussed so far, we derive from Hamiltonian~(\ref{Hgeneral}) an effective Hamiltonian for the polariton $\gamma_1$. The effective Hamiltonian is obtained by adiabatically eliminating the coupling with the other polaritons, according to the procedure sketched in Appendix A, and reads \begin{align}\label{Heff_eq:0} {\cal H}_{\rm eff}=&\hbar\delta\omega_1\gamma^{\dag}_{1}\gamma_{1}\nonumber\\ &+\frac{\hbar}{2}\big(\alpha\gamma^{\dag 2}_1e^{2i\phi_L}+\alpha^\ast\gamma_1^2e^{-2i\phi_L}\big) +\hbar\chi\gamma^{\dag}_1\gamma^{\dag}_1\gamma_1\gamma_1\nonumber\\ &+i\hbar(\nu\gamma_1^{\dag2}\gamma_1e^{i\phi_L}-\nu^*\gamma_1^\dag\gamma_1^2e^{-i\phi_L})\,, \end{align} where~\cite{Footnote:1} \begin{eqnarray} &&\delta\omega_1=\omega_1-\omega_p+\frac{2\Omega^2}{\omega_z}\left(\tilde{S}^2+\frac{\tilde{g} \sqrt{N}}{\omega_z}\tilde{S}\tilde{C}\right)\,,\label{H:shift}\\ &&\alpha=-\frac{\Omega^2}{\omega_z}\big(\tilde{S}^2+\frac{\tilde{g} \sqrt{N}}{\omega_z}\tilde{S}\tilde{C}\big) \left(\delta_{Q',G/2}+\mathcal C_{\alpha}^{k\neq G/2}\right)\,,\label{H:alpha}\\ &&\chi=\frac{\tilde{g}}{\sqrt N}\tilde S^3\tilde C\left[1+ \mathcal C_{\chi}^{k\neq G/2}\right],\label{H:chi}\\ &&\nu= -\frac{\Omega}{4\sqrt{N}}\left(\tilde S^3+\frac{3\tilde g\sqrt{N}}{\omega_z}\tilde{S}^2\tilde{C}\right)\mathcal C_{\nu}^{k\neq G/2}\,,\label{H:nu} \end{eqnarray} with $\tilde{S}=\sin X$ and $\tilde{C}=\cos X$. The terms $\mathcal C_j^{\;k\neq G/2}$ do not vanish when $k\neq G/2$, and their explicit form is \begin{eqnarray} &\mathcal C_\chi^{k\neq G/2}=&\left(\frac{1}{2}+\frac{1}{2}\delta_{Q,\pm G_0/4}\cos{(4\varphi)}\right) (1-\delta_{k,G/2}),\nonumber\\ &\mathcal C_\alpha^{k\neq G/2}=&\frac{1}{2}\left(\delta_{Q',Q+G/2}e^{-2i\varphi}+\delta_{Q',-Q+G/2}e^{2i\varphi}\right)\nonumber\\ && \times(1-\delta_{k,G/2}),\nonumber\\ &\mathcal C_\nu^{k\neq G/2} =&\frac{1}{\sqrt2}\Big(\delta_{Q',3Q}e^{-3i\varphi}+\delta_{Q',-3Q}e^{3i\varphi}\Big)(1-\delta_{k,G/2}) \nonumber\,. \end{eqnarray} The coefficients have been evaluated under the requirement $Q'\neq \pm Q$. We now comment on the condition $\Omega^2 N\ll \omega_z^2$, on which the validity of Eq.~(\ref{drive}) is based. When this is not fulfilled, such that $|\langle b_{Q'}\rangle| \sim 1$, Eq.~(\ref{drive:0}) must contain further non-anharmonic terms from the expansion of Eq.~(\ref{HPnapp}) and which account for the saturation effects in $b_{Q'}$. Since this spin mode is weakly coupled to the other modes, which are initially empty, we expect that the polaritons $\gamma_1$ and $\gamma_2$ will remain weakly populated and the structure of their effective Hamiltonian will qualitatively not change. We also note that in the resonant case, when $\omega_z=0$, the form of Hamiltonian in Eq. (\ref{Heff_eq:0}) remains unchanged, while in the coefficients $\delta\omega_1$, $\alpha$, $\nu$, $\chi$ the following substitution $\omega_z\to (\omega_z^2+\gamma^2/4)/\omega_z$ must be performed . A first consequence is that $\alpha=0$, which implies that there are no processes in this order for which polaritons are created (annihilated) in pairs. A further consequence is that spontaneous decay plays a prominent role in the dynamics. We refer the reader to Sec. \ref{Sec:2:E} for a discussion of the related dissipative effects. \subsection{Discussion} \begin{figure} \centering \subfigure[]{ \includegraphics[width=7cm]{Fig2a}\label{Fig:NLproc_alpha} } \subfigure[]{ \includegraphics[width=7cm]{Fig2b}\label{Fig:NLproc_chi} } \subfigure[]{ \includegraphics[width=7cm]{Fig2c}\label{Fig:NLproc_nu} } \caption[]{(Color online) Schematic diagram of transitions which fulfill the phase-matching condition till fourth order. State $|\tilde{n}\rangle$ denote the number state of the polariton mode $\gamma_1$. The blue (light gray) arrows denote the laser-induced couplings and the red (dark gray) arrows denote the creation (annihilation) of polaritons due to the coupling with the cavity field. See text for a detailed discussion.} \label{Fig:NLproc} \end{figure} Let us now discuss the individual terms on the RHS of Eq.~(\ref{Heff_eq:0}). For this purpose it is useful to consider multilevel schemes, which allow one to illustrate the relevant nonlinear processes. The multilevel schemes are depicted in Fig.~\ref{Fig:NLproc}: state $|\tilde{n}\rangle$ is the polariton number state with $\tilde{n}$ excitations. The blue arrows indicate transitions which are coupled by the laser, for which the polariton state is not changed; The red arrows denote transitions which are coupled by the cavity field, for which the polariton state is modified by one excitation. Using this level scheme, one can explain the dynamical Stark shift $\delta\omega_1$ of the polariton frequency in Eq.~(\ref{H:shift}) as due to higher-order scattering processes, in which laser- and cavity-induced transition creates and then annihilates, in inverse sequential order, a polariton. The second term on the RHS has coupling strength given in Eq.~(\ref{H:alpha}), it generates squeezing of the polariton and does not vanish provided that $Q'=G/2$ or $Q'=\pm Q+G/2$. The latter condition is equivalent to the free-space condition~(\ref{Condition:Squeeze}), while the first arises from the fact that the cavity mode couples with the symmetric superposition $b_{Q_s}$ in Eq.~(\ref{Sym:Polariton}). The corresponding phase-matched scattering event is a four-photon process, in which two laser photons are absorbed (emitted) and two polaritonic quanta are created (annihilated). For $Q'=G/2$ and $Q'\neq \pm Q$ the polaritons are created in pairs with quasimomentum $Q$ and $-Q$ (the relation $Q=G/2$ corresponds to $b_{-Q}=b_Q$). This specific term is also present when the geometry of the setup is such that von-Laue condition is fulfilled, and at this order is responsible for the squeezing present in the light at the cavity output. The Kerr-nonlinearity (third term on the RHS) gives rise to an effective interaction between the polaritons and emerges from processes in which polaritons are absorbed and emitted in pairs. It is depicted in Fig.~\ref{Fig:NLproc_chi} for a generic case. This term is directly proportional to the cavity coupling strength and inversely proportional to $\sqrt{N}$. In this order, it is the term that gives rise to anti-bunching. The last term on the RHS, finally, is a nonlinear pump of the polariton mode, whose strength depends on the number of polaritonic excitations. It is found when the phase-matching condition $Q'=\pm3Q+G$ is satisfied, which is equivalent to the relation $\cos\theta=(3+n\lambda/d)$ when laser and optical resonator have the same wavelength, as in the case here considered. This relation can be fulfilled for $n\neq 0$ and specific ratios $\lambda/d$. This term vanishes over the vacuum state, and it pumps a polariton at a time with strength proportional to the number of polariton excitations. In general, photons into the cavity mode are pumped provided that either (i) $Q'=\pm Q$ or (ii) (for $Q'\neq \pm Q$) one of the two conditions are satisfied: $Q'=G/2$ or $Q'=\pm Q+G/2$. We note that the strength of the Rabi frequency and of the cavity Rabi coupling may allow one to tune the relative weight of the various terms in Hamiltonian~(\ref{Heff_eq:0}). Their ratio scales differently with the number of atoms in different regimes, which we will discuss below. Moreover, the interparticle distance of the atomic array constitutes an additional control parameter over the nonlinear optical response of the medium. Further phase-matching conditions are found when considering higher-order terms in the expansion of the spin operators in harmonic-oscillator operators from Eq.~(\ref{HPnapp}). Their role in the dynamics will be relevant, as long as they compete with the dissipative rates, here constituted by the cavity loss rate and spontaneous emission. \subsection{Cavity input-output formalism} \label{Sec:2:E} We consider the full system dynamics, including the atomic spontaneous emission and the cavity quantum noise due to the coupling to the external modes of the electromagnetic field via the finite transmittivity of the cavity mirrors. Denoting by $\kappa$ and $\gamma$ the linewidth of the cavity mode and of the atomic transition, respectively, the Heisenberg-Langevin equations for the operator $a$ and $b_q$ read \begin{eqnarray}\label{HL:a} &&\dot{a}=\frac{1}{{\rm i}\hbar}[a,{\mathcal H}]-\kappa a+\sqrt{2\kappa}a_{\rm in}(t)\,,\\ &&\dot{b}_q=\frac{1}{{\rm i}\hbar}[b_q,{\mathcal H}]-\frac{\gamma}{2} b_q+\sqrt{\gamma}b_{q,\rm in}(t)\,, \end{eqnarray} where $a_{\rm in}$, $b_{q,\rm in}$ are the Langevin operators, which are decorrelated one from the other and fulfill the relations $\langle a_{\rm in}(t) \rangle=0$ and $\langle a_{\rm in}(t)a_{\rm in}^{\dagger}(t')\rangle=\delta(t-t')$. Here, the average $\langle \cdot\rangle$ is taken over the density matrix at time $t=0$ of the system composed by the atomic spins and by the electromagnetic field. The output field $a_{\rm out}$ at the cavity mirror is given by the relation \begin{equation}\label{a_out} a_{\rm out}+a_{\rm in}=\sqrt{2\kappa} a(t)\,. \end{equation} Let us now consider the scattering processes occurring in the system. They can be classified into three types: (i) a laser photon can be scattered into the modes of the external electromagnetic field (emf) by the atoms, without the resonator being pumped in an intermediate time; (ii) a laser photon can be scattered into the cavity mode by the atom and then dissipated by cavity decay; (iii) a laser photon can be scattered into the cavity mode by the atom, then been reabsorbed and emitted into the modes of the external emf. Processes of kind (i) include elastic scattering. They can be the fastest processes, but do not affect the properties of the light at the cavity output. Processes of kind (ii) are the ones which outcouple the intracavity field, but need to be sufficiently slow in order to allow for the build-up of the intracavity field. Processes of kind (iii) are detrimental for the nonlinear optical dynamics we intend to observe, as they introduce additional dissipation (see for instance \cite{Morigi2006,Vitali2006} for an extensive discussion and \cite{Fernandez_07} for a system like the one here considered but composed by two atoms). Processes (iii), i.e., reabsorption of cavity photons followed by spontaneous emission, can be neglected assuming that the laser and cavity mode are far-off resonance from the atomic transition. In this limit, the cavity is pumped by coherent Raman scattering processes and an effective Heisenberg-Langevin equation for the polariton $\gamma_1$ can be derived assuming that its effective linewidth $\kappa_1=\kappa \cos^2 X+(\gamma/2) \sin^2 X$ fulfilling the inequality $\kappa_1\ll \delta\omega$ (that corresponds to the condition for which the vacuum Rabi splitting is visible in the spectrum of transmission~\cite{Kimble:0,Carmichael_VacuumRabi,Kinner,Kasevich,Drewsen}). We find \begin{eqnarray} \label{HL} \dot{\gamma_1}=\frac{1}{{\rm i}\hbar}[\gamma_1,{\mathcal H}_{\rm eff}]-\kappa_1 \gamma_1+\sqrt{2\kappa}\tilde{C} a_{\rm in}(t)+\sqrt{\gamma}\tilde{S} b_{q,\rm in}(t)\,, \end{eqnarray} which determines the dissipative dynamics of the polariton. The field at the cavity output is determined using the solution of the Heisenberg Langevin equation~(\ref{HL}) with Eqs.~(\ref{polariton:1})-(\ref{polariton:2}) in Eq.~(\ref{a_out}). In some calculations, when appropriate we solved the corresponding master equation for the density matrix of the polaritonic modes $\gamma_1$ and $\gamma_2$. Some remarks are in order at this point. Nonlinear-optical effects in an atomic ensemble, which is resonantly pumped by laser fields, have been studied for instance~\cite{Hafezi}, where the nonlinearity is at the single atom level and is generated by appropriately driving a four-level atomic transitions~\cite{Imamoglu}. It is important to note, moreover, that Eq. (\ref{HL}) is valid as long as the loss mechanisms occur on a rate which is of the same order, if not smaller, than the inelastic processes. This leads to the requirement that the atom-cavity system be in the strong-coupling regime. \section{Results} \label{Sec:3} We now study the properties of the light at the cavity output as a function of various parameters, assuming that $Q'=G/2$ and that the relations $Q'\neq \pm Q$ and $Q'\neq \pm 3Q+G$ hold. Under these conditions the effective Hamiltonian in Eq.~(\ref{Heff_eq:0}) contains solely the squeezing and the Kerr-nonlinearity terms, while $\nu=0$. Moreover, we assume the condition $\kappa_1\simeq \kappa>\gamma$. The possible regimes which may be encountered can be classified according to whether the ratio $$\varepsilon=|\alpha/\chi|$$ is larger or smaller than unity. In the first case the medium response is essentially the one of a parametric amplifier. In the second case the Kerr non-linearity dominates, and polaritons can only be pumped in pairs provided that the emission of two polaritons is a resonant process. Let us now focus on the regime in which the system acts as a parametric amplifier, namely, $\varepsilon\gg 1$. In this case one finds that the number of photons at the cavity output at time $t$ is $$\langle a_{out}^\dagger a_{out}\rangle_t\simeq 2\kappa \tilde{C}^2\langle \gamma_1^\dagger\gamma_1\rangle_t\,,$$ with \begin{eqnarray} \langle \gamma_1^\dagger\gamma_1\rangle_t&=&\frac{1}{2}\frac{\alpha^2}{\kappa_1^2-\alpha^2}+{\rm e}^{-2\kappa_1t}\sinh^2(\alpha t)\\ & &+\frac{{\rm e}^{-2\kappa_1t}}{2}\left(1-\kappa_1\frac{\kappa_1\cosh(2\alpha t)+\alpha\sinh(2\alpha t)}{\kappa_1^2-\alpha^2}\right)\,.\nonumber \end{eqnarray} Depending on whether $\alpha>\kappa_1$ or $\alpha<\kappa_1$, one finds that the dynamics of the intracavity polariton corresponds to a parametric oscillator above or below threshold, respectively. In the following we focus on the case below threshold and evaluate the spectrum of squeezing. We first observe that the quadrature $x^{(\theta)}=\gamma_1e^{-i\theta}+\gamma_1^\dag e^{i\theta}$ has minimum variance for $\theta=\pi/4$ and reads~\cite{Fernandez_07} \begin{equation} \langle \Delta x^{(\frac{\pi}{4})^2} \rangle_{st}= \frac{{\kappa}_1}{{\kappa}_1+|{\alpha}|}\,, \end{equation} where the subscript $st$ refers to the expectation value taken over the steady-state density matrix. The squeezing spectrum of the maximally squeezed quadrature is \begin{align}\label{Squeez_spec:0} S_{out}(\omega)=& 1+\int_{-\infty}^{+\infty}\langle:x_{out}^{(\frac{\pi}{4})}(t+\tau),x_{out}^{(\frac{\pi}{4})}(t) :\rangle_{st}e^{-{\rm i}\omega \tau}d\tau \\ =&1-\frac{4{\kappa}\tilde{C}^2 |{\alpha}|}{({\kappa}_1+|{\alpha}|)^2+\omega^2}\,,\label{Squeez_spec} \end{align} where $\langle:\;:\rangle_{st}$ indicates the expectation value for the normally-ordered operators over the steady state, with $$x_{out}^{(\theta)}=a_{\rm out}e^{-i\theta}+a_{\rm out}^\dag e^{i\theta}\,,$$ and $\langle A,B \rangle_{st}=\langle AB\rangle_{st}-\langle A\rangle_{st}\langle B\rangle_{st}$. We now discuss the parameter regime in which these dynamics can be encountered. The relation $\varepsilon\gg 1$ is found provided that $\Omega\gg g$. When $|\omega_z|\gg \Omega\sqrt{N}$, in this limit $|\alpha|\simeq \Omega^2 g^2 N/\omega_z^3$, and squeezing can be observed only for very small values of $\kappa$. Far less demanding parameter regimes can be accessed when relaxing the condition on the laser Rabi frequency, and assuming that $\Omega\sqrt{N} \sim |\omega_z|$. In this case squeezing in the light at the cavity output can be found provided that $\Omega\gg \kappa$ when $g\sqrt{N}\sim |\omega_z|$ \cite{Footnote:3}. Figures~\ref{Squeez}(a) and (b) display the spectrum of squeezing when the system operates as a parametric amplifier below threshold. Here, one observes that squeezing increases with $N$. Comparison between Fig.~\ref{Squeez}(a) and ~\ref{Squeez} (b) shows that squeezing increases also as the single-atom cooperativity increases (provided the corresponding phase-matching conditions are satisfied and the laser Rabi frequency $\Omega\gg g$). These results agree and extend the findings in Ref.~\cite{Fernandez_07}, which were obtained for an array consisting of 2 atoms. \begin{figure} \subfigure[]{ \includegraphics[width=9cm]{Fig3a}} \subfigure[]{ \includegraphics[width=9cm]{Fig3b}} \caption[]{(Color online) Squeezing spectrum for the maximum squeezed quadrature when $k=G/2$, $Q'=G/2$ and $Q'\neq Q$ for $\varphi,\phi_L=0$. The parameters are $\Omega=200\kappa$, $\omega_z=10^3\kappa$ and $N=10,50,100$ atoms (from top to bottom) for (a) $g=4\kappa$ and (b) $g=10\kappa$. The detuning $\delta_c$ is chosen such that $\delta\omega_1$ is zero. The curves are evaluated from Eq. (\ref{Squeez_spec:0}) by numerically calculating the density matrix of the polariton field for a dissipative dynamics, whose coherent term is governed by the effective Hamiltonian in Eq.~(\ref{Heff_eq:0}). The value $g=4\kappa$ is consistent with the experimental data of Ref.~\cite{Reichel}. } \label{Squeez} \end{figure} Let us now focus on the regime when $\varepsilon\ll 1$. Here, the polaritons may be only emitted in pairs into the resonator. In order to characterize the occurrence of these dynamics we evaluate the second-order correlation function at zero time delay in the cavity output defined by \cite{MilburnWalls} \begin{align} g^{(2)}(0)=\frac{\langle a_{\rm out}^{\dag2}a_{\rm out}^2\rangle_{st}}{\langle a_{\rm out}^{\dag}a_{\rm out}\rangle^2_{st}}\,. \end{align} Function $g^{(2)}(0)$ quantifies the probability to measure two photon at the cavity output at the same time. Therefore, subpossonian (superpossonian) statistics are here connected to the value of $g^{(2)}(0)$ smaller (larger) than one, while for a coherent state $g^{(2)}(0)=1$. Subpossonian photon statistics at the cavity output can be found as a result of the dynamics of Eq.~(\ref{Heff_eq:0}). Here, for phase-matching conditions leading to $\nu=0$ and $\alpha\neq 0$, polaritons can only be created in pairs. When the Kerr-nonlinearity is sufficiently large, however, the condition can be reached in which only two polaritons can be emitted into the cavity, while emission of a larger number is suppressed because of the blockade due to the Kerr-term. This is reminiscent of the two-photon gateway realized in Ref.~\cite{Kubanek08}, where injection of two photons inside a cavity, pumped by a laser, was realized by exploiting the anharmonic properties of the spectrum of a cavity mode strongly coupled to an atom. In the case analysed in this paper, the anharmonicity arises from collective scattering by the atomic array, when this is transversally driven by a laser. Moreover, we note that the observation of these dynamics requires $\Omega\sqrt{N}\ll |\omega_z|,g\sqrt{N}$ and $|\alpha|>\kappa$, which reduces to the condition $\Omega^2/\omega_z>\kappa$ when $g\sqrt{N}\sim \omega_z$. Figure~\ref{Fig:2phAnti}(a) displays $g^{(2)}(0)$ as a function of the pump frequency $\omega_p$ for the phase matching conditions giving $\nu=0$ and $\alpha\neq 0$. Function $g^{(2)}(0)$ is evaluated by numerically integrating the master equation with cavity decay, where the coherent dynamics is governed by an effective Hamiltonian which accounts for the effect of both polariton modes and is reported in Eq.~(\ref{Hamilfull}) in the Appendix. Antibunching is here observed over an interval of values of $\omega_p$, about which the cavity mode occupation has a maximum (blue curve in Fig. ~\ref{Fig:2phAnti}(b)). The maximum corresponds to the value of $\omega_p$ for which the emission of two polaritons $\gamma_2$ is resonant. Note that the spin-wave excitation, red curve in Fig. ~\ref{Fig:2phAnti}(b), is still sufficiently small to justify the perturbative expansion at the basis of our theoretical model. Figure~\ref{Fig:2phAnti_c} displays the amplitudes $|\chi|$, determining the strength of the Kerr-nonlinearity, and $|\alpha|$, scaling the squeezing dynamics, in units of $|\delta\omega_1|$ and as a function of $\omega_p$. One observes that for the chosen parameters $|\chi|>|\alpha|$. Maximum antibunching is here found when the cavity mean photon number is maximum. \begin{figure} \centering \subfigure[]{ \includegraphics[width=8cm]{Fig4a}\label{Fig:2phAnti_a}} \subfigure[]{ \includegraphics[width=8cm]{Fig4b}\label{Fig:2phAnti_b}} \subfigure[]{ \includegraphics[width=8.5cm]{Fig4c}\label{Fig:2phAnti_c}} \caption[]{(Color online) (a) Second order correlation function at zero time delay $g^{(2)}(0)$ versus $\omega_p$ (in units of $\kappa$) when the cavity is solely pumped by inelastic processes (here, $k=G/2$, $Q'\neq Q,3Q$ and $Q'=G'/2$ for $\varphi,\phi_L=0$). The correlation function is evaluated numerically solving the master equation for the polaritons in presence of cavity decay, with the coherent dynamics given by Hamiltonian~(\ref{Hamilfull}) (solid line) and by Hamiltonian~(\ref{Heff_eq:0}) (dashed line). (b) Corresponding average number of intracavity photons $\langle a^\dag a\rangle$ (blue upper line) and spin wave occupation $\langle b_Q^\dag b_Q\rangle$ (red lower line). (c) Ratios $|\chi/\delta\omega_1|$ (blue upper line) and $|\alpha/\delta\omega_1|$ (red lower line) versus $\omega_p$. The parameters are $g=80\kappa$, $\Omega=30\kappa$, $\omega_z-\delta_c=70\kappa$, and $N=2$ atoms. At the minimum of $g^{(2)}(0)$, $\omega_z\simeq137\kappa$ and $\delta_c\simeq67\kappa$.}\label{Fig:2phAnti} \end{figure} It is important to notice that emission of polaritons in pairs is possible when the collective dipole of the atomic array is driven. For fixed values of $\Omega$ and $g$, we expect that this effect is washed away as $N$ is increased: this behaviour is expected from the scaling of the ratio $\varepsilon$ with $N$. Taking $k=G/2$ and mixing angles $X\ll 1$, for instance, one finds $\varepsilon\sim \sqrt{N},$ indicating that the strength of the Kerr nonlinearity decreases relative to the coupling $\alpha$ as $N$ grows. This is also consistent with the results reported in Fig. \ref{Squeez}. In this context, the expected dynamics is reminiscent of the transition from antibunching to bunching observed as a function of the number of atoms in atomic ensembles coupled with cavity QED setups~\cite{Hennrich05}. For the results here presented we have assumed the spontaneous emission rate to be smaller than $\kappa$. In general, the predicted nonlinear effects can be observed in cavities with a large single-atom cooperativity and in the so-called good cavity regime~\cite{Kimble:0}. The required parameter regimes for observing squeezing have been realized in recent experiments~\cite{Reichel}. The parameters required in order to observe a two-photon gateway are rather demanding for the regime in which the atoms are driven well below saturation. Nevertheless, a reliable quantitative prediction with an arbitrary number of atoms would require a numerical treatment going beyond the Holstein-Primakoff expansion here employed. \section{Conclusion} \label{Sec:5} An array of two-level atoms coupling with the mode of a high-finesse resonator and driven transversally by a laser can operate as controllable nonlinear medium. The different orders of the nonlinear responses correspond to different nonlinear processes exciting collective modes of the array. Depending on the phase-matching condition and on the strength of the driving laser field a nonlinear process can prevail over others, determining the dominant nonlinear response. These dynamics emerge from the backaction of the cavity mode on the scatterers properties, and are enhanced for large single-atom cooperativities. We have focussed on the situation in which the scattering into the resonator is inelastic, and found that at lowest order in the saturation parameter the light at the cavity output can be either squeezed or antibunched. In the latter case, it can either operate as single-photon or two-photon gateway, depending on the phase-matching conditions. Our analysis permits one to identify the parameter regimes, in which a nonlinear-optical behaviour can prevail over others, thereby controlling the medium response. An interesting outlook is whether the considered effects can be used in order to develop turnstile devices, like the one realised in \cite{Dayan}, for quantum networks. In view of recent experiments coupling ultracold atoms with optical resonators~\cite{Kruse,Slama,Slama_07,Esslinger,Black03,Kinner,Kasevich,Drewsen,Reichel}, these findings show that the coherence properties at the cavity output can be used for monitoring the spatial atomic distribution inside the resonator. Another related question is how the properties of the emitted light depend on whether the atomic distribution is bi- or multiperiodic~\cite{Rist}. In this case, depending on the characteristic reciprocal wave vectors one expects a different nonlinear response at different pump frequency and possibly also wave mixing. When the interparticle distance is uniformly distributed, then coherent scattering will be suppressed. Nevertheless, the atoms will pump inelastically photons into the cavity mode. While in free space the resonance fluorescence is expected to be the incoherent sum of the resonance fluorescence from each atom, inside a resonator one must consider the backaction due to the strong coupling with the common cavity mode. Finally, in this article we neglect the atomic kinetic energy, assuming that the spatial fluctuations of the atomic center of mass at the potential minima are much smaller than the typical length scales determining the coupling with radiation~\cite{Fernandez_07}. It is important to consider, that when the mechanical effects of the scattered light on the atoms is taken into account, conditions could be found where selforganized atomic patterns are observed~\cite{Domokos02,Kruse,Esslinger,Larson,Vidal10,Domokos10,Goldbart}, which are sustained by nonclassical light. The analysis here presented sets the basis for studies towards this direction. \subsection*{Acknowledgments} The authors are grateful to Sonia Fernandez-Vidal, Stefan Rist, Sergey Hritsevitch, and Belen Paredes for stimulating discussions and helpful comments. This work was supported by the European Commission (EMALI MRTN-CT-2006-035369; Integrating project AQUTE; STREP PICC), by the European Science Foundation (EUROQUAM: CMMC), and by the Spanish Ministerio de Ciencia y Innovaci\'on (QOIT, Consolider-Ingenio 2010; QNLP, FIS2007-66944; Ramon-y-Cajal; Juan-de-la-Cierva). G. M. acknowledges the German Research Foundation (DFG) for support (MO1845/1-1). H. H. acknowledges support from the Spanish Ministerio de Ciencia y Innovaci\'on (FPI grant). \newpage

In the last few years, research on the central control of energy homeostasis has been unveiling the crucial role of glial cells, providing us a repository of new molecular targets to design therapeutic treatments for metabolic diseases. Among the glial cells involved in the regulation of food intake, energy expenditure, and glucose homeostasis, tanycytes are in the spotlight due to their privileged position within the brain and their wide spectrum of functions. As specialized ependymoglial cells whose cell bodies form the wall of the third ventricle, tanycytes extend their long processes within hypothalamic areas involved in metabolic control and reach close proximity with blood vessels through their end feet. Tanycytes are consequently considered an interface between the periphery, the cerebrospinal fluid (CSF), and the brain parenchyma. In this strategic position, tanycytes are able to regulate the access of metabolic information into the mediobasal hypothalamus by (1) transporting nutrients and hormones toward metabolic neuronal circuits, (2) sensing the metabolic information, and (3) appropriately releasing cytokines, nutritional metabolites, and/or gliotransmitters to modulate the activity of hypothalamic neurons. Conversely, tanycytes also control brain → periphery exchanges by regulating the secretion of key metabolic neurohormones, such as corticotropin-releasing hormone and thyrotropin-releasing hormone, in the portal vessels of the median eminence ([@B1]). Finally, tanycytes are also known for their role as neural progenitor cells within the hypothalamus, allowing regeneration and plasticity of metabolic neuronal circuits ([@B2]). Interestingly, tanycytes modulate these multiple functions depending on the physiological state of the individual in order to dynamically control energy balance by generating adaptive responses to acute nutritional challenges ([@B3]). The Research Topic "Involvement of tanycytes in the neuroendocrine control of energy homeostasis" aims to report recent advances showing the roles of tanycytes in the neuroendocrine control of energy homeostasis. This topic---containing both review articles and original research contributions---covers a variety of tanycyte functions presented above, as well as different methodologies---ranging from omics to murine physiology---currently used. [Elizondo-Vega et al.](https://doi.org/10.3389/fendo.2019.00244) provide an overview of tanycyte nutrient sensing in the regulation of metabolic homeostasis. Tanycytes respond to nutritional signals (i.e., glucose, amino acids, fatty acids, and vitamins) by different mechanisms, including calcium signaling, metabolic shift, and/or changes in functional properties. This review highlights the need for more detailed analysis about metabolic and signaling pathways activated by nutrient sensing in tanycytes, as well as functional studies connecting tanycyte nutrient sensing with hypothalamic functions in physiological and pathological context. First, signaling pathways involved in tanycyte glucose sensing are further detailed by [Salgado et al.](https://doi.org/10.3389/fnins.2019.00275). Hypothalamic tanycytes express several proteins involved in the glucose sensing mechanisms, in particular glucokinase and its regulator glucokinase regulatory protein (GKRP). Described in the liver, GKRP binds glucokinase and holds it inactive in the nucleus when glucose levels are low, which allows its rapid export and activation when glucose concentration rises. Hypothalamic tanycytes display an inverse dynamic in response to glucose: a rise in glucose levels drives nuclear compartmentalization of glucokinase. The authors reveal here that this differential glucokinase subcellular localization in tanycytes relies, at least in part, on the relative expression between glucokinase and GKRP and the regulation of GKRP expression and/or activity in tanycytes. Secondly, the impact of tanycyte glucose sensing on neuronal functions and physiology is reported in a functional study by [Palma-Chavez et al.](https://doi.org/10.3389/fendo.2019.00647). The authors describe the role of the tanycyte endocannabinoid system in the modulation of arcuate neurons. The deletion of 2-arachidonoylglycerol-producing enzyme, diacylglycerol lipase-alpha (DAGLα), in tanycytes altered the usual response to CSF glucose in terms of neuropeptides produced by arcuate neurons. In addition to nutrients, recent studies have reported that tanycytes actively transport and sense metabolic hormones, such as leptin or ghrelin. A contrasting view is presented here by [Yoo et al.](https://doi.org/10.3389/fnins.2019.00240) who report undetectable expression of leptin receptor in tanycytes as well as a tanycyte-independent regulation of some hypothalamic neuronal functions modulated by leptin signaling. Changes in cell signaling and gene expression observed in tanycytes in response to leptin are proposed to result from indirect regulations. By projecting their endfeet in contact with fenestrated vessels in the external zone of the median eminence, tanycytes also control the release of neurohormones into the hypothalamic-hypophyseal portal system. [Rodríguez-Rodríguez et al.](https://doi.org/10.3389/fendo.2019.00401) review here the control of thyrotropin-releasing hormone release, involved in the regulation of energy expenditure through the control of basal metabolic rate and thermogenesis. Tanycytes express a repertoire of proteins involved in transport, sensing, and metabolism of thyroid hormones necessary to coordinately control the activity of the hypothalamic--pituitary--thyroid axis. Alterations in energy balance regulate the expression and activity of these proteins, making median eminence tanycytes a pivot for thyroid-related regulation of energy balance. This adaptability to the metabolic state is a key feature for tanycytes in the regulation of energy balance. It partly relies on an accurate regulation of gene expression profiles in different tanycyte subpopulations ([Langlet](https://doi.org/10.3389/fendo.2019.00286)). Tanycytes are characterized by their own molecular signature, which is mostly associated with their diverse physiological functions, and the detection of variations in nutrient/hormone levels leads to adequate modulation of their genetic profile in order to adapt tanycyte functions and to finally regulate energy homeostasis. Overall, significant advances have been achieved in the understanding of tanycyte functions in the regulation of energy homeostasis. This Research Topic puts new evidence on the table, points out the current controversies in this field, highlight the missing parts, and, we hope, will encourage researchers to consider tanycytes to solve the puzzle of hypothalamic control of energy balance. Author Contributions {#s1} ==================== FL, JS, and MG-R wrote the paper and critically revised the manuscript. All authors contributed to the article and approved the submitted version. Conflict of Interest {#s2} ==================== The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. **Funding.** This work was partially funded by Swiss National Science Foundation (\#PZ00P3_174120) (to FL), Novartis Foundation for medical-biological research (to FL) and Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) 1180871 (to MG-R) and 1191329 (to JS) as well as ICM-ANID, Project P09-022-F, CINV, Chile (to JS). [^1]: Edited and reviewed by: Hubert Vaudry, Université de Rouen, France [^2]: This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology

\section{Introduction} Let the matrix pair $(A, B)$ denotes the dynamic state equation \begin{align}\label{eqstate-equation} \dot{x}(t)=Ax(t)+Bu(t) \end{align} of the time invariant linear system, where $A\in \mathbb{R}^{n\times n}$ and $B\in \mathbb{R}^{n\times m}$ are the open-loop system matrix and the input matrix, respectively. The dynamic behavior of \eqref{eqstate-equation} is governed by the eigen-structure of $A$, especially the poles (eigenvalues). And in order to change the dynamic behavior of the open-loop system \eqref{eqstate-equation} in some desirable way (to achieve stability or to speed up response), one needs to modify the poles of \eqref{eqstate-equation}. Typically, this may be actualized by the state-feedback control \begin{align}\label{eqfeedback} u(t)=Fx(t), \end{align} where the feedback matrix $F\in \mathbb{R}^{m\times n}$ is to be chosen such that the closed-loop system \begin{align}\label{eqstate-equation2} \dot{x}(t)=(A+BF)x(t)\equiv A_c x(t) \end{align} has specified poles. Mathematically, the {\em state-feedback pole assignment problem} can be stated as: \noindent{\bf State-Feedback Pole Assignment Problem (SFPA)} Given $A\in\mathbb{R}^{n\times n}$, $B\in\mathbb{R}^{n\times m}$ and a set of $n$ complex numbers $\mathfrak{L}=\{\lambda_1, \lambda_2, \ldots, \lambda_n\}$, closed under complex conjugation, find an $F\in\mathbb{R}^{m\times n}$ such that $\lambda(A+BF)=\mathfrak{L}$, where $\lambda(A+BF)$ is the eigenvalue set of $A+BF$. A necessary and sufficient condition for the solvability of the {\bf SFPA} for any set $\mathfrak{L}$ of $n$ self-conjugate complex numbers is that $(A, B)$ is controllable, or equivalently, the controllability matrix $\begin{bmatrix} B&AB&\cdots& A^{n-1}B\end{bmatrix}$ is of full row rank \cite{ XU, Won, Wonh}. Many algorithms have been put forward to solve the {\bf SFPA}, such as the invariant subspace method \cite{ PCK1}, the QR-like method \cite{ MP2, MP3}, etc.. We refer readers to \cite{ASC, BD, Chu0, Ka,RM, PM, Var, FO} for some other approaches. When $m>1$, the solution to the {\bf SFPA} is generally not unique. We may then utilize the freedom of $F$ to achieve some other desirable properties of the closed-loop system. In applications, one sympathetic character for system design is that the eigenvalues of the closed-loop system matrix $A_c$ are insensitive to perturbations, which leads to the following {\em state-feedback robust pole assignment problem}: \noindent{\bf State-Feedback Robust Pole Assignment Problem (SFRPA)} Find a solution $F\in\mathbb{R}^{m\times n}$ to the {\bf SFPA}, such that the closed-loop system is robust, that is, the eigenvalues of $A_c$ are as insensitive to perturbations on $A_c$ as possible. The key to solve the {\bf SFRPA} is to choose an appropriate measure of robustness formulated in quantitative form. Some measures can be found in \cite{XU, KNV, BN, Chu2, Dic}, such as the \texttt{condition number measurement} $\kappa_F(X)=\|X\|_F\|X^{-1}\|_F$, where $X$ is the eigenvector matrix of $A_c$, the \texttt{departure from normality} $\Delta_F(A_c)=\sqrt{\|A_c\|_F^2-\sum_{j=1}^{j=n}|\lambda_j|^2}$ and so on. Ramar and Gourishankar \cite{RG} made an early contribution to the {\bf SFRPA} and since then various optimization methods have been proposed based on different measures \cite{ BN, CB, Chu2, KNV, Dic, Tits, LY}. The most classic methods should be those proposed by Kautsky, Nichols and Van Dooren in \cite{KNV}, where $\kappa_F(X)$ is used as the measure of robustness of the closed-loop system matrix. However, Method $0$ in \cite{KNV} may fail to converge, Method $1$ may suffer from slow convergence, and Method $2/3$ may not perform well on ill-conditioned problems. Based on Method $0$ in \cite{KNV}, Tits and Yang \cite{Tits} proposed a method for solving the {\bf SFRPA} by trying to maximize the absolute value of the determinant of the eigenvector matrix $X$. The optimization processes are iterative, and hence generally expensive. Recently, Chu \cite{Chu2} put forward a Schur-type method for the {\bf SFRPA} by tending to minimize the departure from normality of the closed-loop system matrix $A_c$ via the Schur decomposition of $A_c$. It computes the matrices $X$ and $T$ column by column, where $A_c=XTX^{-1}$, $X,T$ are real and $T$ is upper quasi-triangular, such that the strictly block upper triangular elements of matrix $T$ are minimized in each step. If $\lambda_1,\dots,\lambda_n$ are all real, \textbf{SCHUR} \cite{Chu2} will generate an orthogonal matrix $X$, that is, $A_c=XTX^{-1}$ is the Schur decomposition of $A_c$. This implies that the departures from normality of $A_c$ and $T$ are the same. Hence the strategy aiming to minimize the departure from normality of $T$ is also pliable to $A_c$. However, in case of complex conjugate poles, it cannot produce an orthogonal $X$, suggesting that the departure from normality of $A_c$ is generally not identical to that of $T$. Hence, although it attempts to optimize the departure from normality of $T$, that of $A_c$ may still be large. In this paper, we propose a modified Schur method upon \textbf{SCHUR} \cite{Chu2}, where poles are assigned via the real Schur decomposition of $A_c=XTX^{\top}$, with $X$ being real orthogonal and $T$ being real upper quasi-triangular. In each step (assigning a real pole or a pair of conjugate poles), one optimization problem arises for purpose of minimizing the departure from normality of $T$. When assigning a real pole, we improve the efficiency of \textbf{SCHUR} by computing the SVD of a matrix, instead of computing the GSVD of a matrix pencil. When assigning a pair of conjugate poles, by exploring the properties of the posed optimization problem, we provide a polished way to obtain its suboptimal solution. Numerical examples show that our method outperforms \textbf{SCHUR} when complex conjugate poles are involved. We also compare our method with the MATLAB functions \textbf{place} (an implementation of Method 1 in \cite{KNV}), \textbf{robpole} (an implementation of the method in \cite{Tits}) and the \textbf{O-SCHUR} algorithm (an implementation of an optimization method in \cite{Chu2}) on some benchmark examples and randomly generated examples, where numerical results show that our method is comparable in accuracy and robustness, while with lower computational costs. The paper is organized as follows. In Section 2, we give some preliminaries which will be used in subsequent sections. Our method is developed in Section 3, including both the real case and the complex conjugate case. Numerical results are presented in Section 4. Some concluding remarks are finally drawn in Section 5. \section{Preliminaries} In this section, we briefly review the parametric solutions to the {\bf SFPA}, and the departure from normality. \subsection{Solutions to the SFPA} The parametric solutions to the {\bf SFPA} can be expressed in several ways. In this paper, as in \cite{Chu2}, we formulate it by using the real Schur decomposition of $A_c=A+BF$. Assume that the real Schur decomposition of $A+BF$ is \begin{equation}\label{eqrealschur} A + BF = XTX^{\top}, \end{equation} where $X\in \mathbb{R}^{n\times n}$ is orthogonal, $T\in \mathbb{R}^{n\times n}$ is upper quasi-triangular with only $1\times 1$ and $2\times2$ diagonal blocks. Without loss of generality, we may assume that $B$ is of full column rank. Let \begin{equation}\label{eqqrofb} B=Q\begin{bmatrix}R\\ 0\end{bmatrix}=\begin{bmatrix}Q_1&Q_2\end{bmatrix}\begin{bmatrix}R\\ 0\end{bmatrix}=Q_1R \end{equation} be the QR decomposition of $B$, where $Q\in\mathbb{R}^{n\times n}$ is orthogonal, $Q_1\in \mathbb{R}^{n\times m}$, and $R\in\mathbb{R}^{m\times m}$ is nonsingular and upper triangular. It follows from \eqref{eqrealschur} that \begin{equation}\label{eqchangingofrealschur} AX + BFX - XT =0. \end{equation} Pre-multiplying \eqref{eqchangingofrealschur} by $\diag(R^{-1}, I_{n-m})\begin{bmatrix}Q_1&Q_2\end{bmatrix}^{\top}$ on both sides gives \begin{equation}\label{eqsolve} \left\{ \begin{array}{l} R^{-1}Q_1^{\top}AX + FX - R^{-1}Q_1^{\top}XT=0, \\ Q_2^{\top}(AX -XT)=0. \end{array}\right. \end{equation} Consequently, if we get an orthogonal matrix $X$ and an upper quasi-triangular matrix $T$ from the second equation of \eqref{eqsolve}, then a solution $F$ to the {\bf SFPA} will be obtained immediately from the first equation of \eqref{eqsolve} as \begin{equation} \label{eqsolveoff} F=R^{-1}Q_1^{\top}(XTX^{\top}-A). \end{equation} \subsection{Departure from normality} In this paper, we adopt the departure from normality of $A_c=A+BF$ as a measure of robustness of the closed-loop system matrix as in \cite{Chu2}, which is defined as (\cite{Hen, SSun}) \[ \Delta_F(A_c)=\sqrt{\|A_c\|_F^2-\sum_{j=1}^{n}|\lambda_j|^2}, \] where $\lambda_1,\dots,\lambda_n$ are the poles to be assigned, and hence eigenvalues of $A_c$. Now let $D$ be the block diagonal part of $T$ with only $1\times 1$ and $2\times 2$ blocks on its diagonal. Each $1\times1$ block of $D$ admits a real eigenvalue $\lambda_j$ of $T$, while each $2\times 2$ block of $D$ admits a pair of conjugate eigenvalues $\lambda_{j}=\alpha_j+ i \beta_j, \lambda_{j+1}=\bar{\lambda}_j$ and is of the form $D_{j}=\begin{bmatrix}\begin{smallmatrix}\alpha_j&\delta_j\beta_j\\-\frac{\beta_j}{\delta_j}&\alpha_j \end{smallmatrix}\end{bmatrix}\in \mathbb{R}^{2\times2}$ with $\delta_j\beta_j\ne 0$, where $\delta_j$ is some real number. Let $N=T-D=\begin{bmatrix}\breve{v}_1&\breve{v}_2&\cdots&\breve{v}_n\end{bmatrix}$ be the strictly upper quasi-triangular part of $T$ with $\breve{v}_k=\begin{bmatrix}v_k^\top&0\end{bmatrix}^\top, v_k\in \mathbb{R}^{k-1} \text{or} \ \mathbb{R}^{k-2} $. Direct calculations give rise to \begin{equation}\label{departure} \Delta_F^2(A_c)=\Delta_F^2(T)=\|N\|_F^2+\sum_{j}(\delta_j-\frac{1}{\delta_j})^2\beta_j^2, \end{equation} where the summation is over all $2\times 2$ blocks of $D$. When all poles $\lambda_1,\dots,\lambda_n$ are real, the second part of $\Delta_{F}^2(A_c)$ in \eqref{departure} will vanish. However, when some poles are non-real, not only the strictly block upper triangular part $N$ contributes to the departure from normality, but also the block diagonal part $D$. When some $|\delta_j|$ is large or close to zero, the second term can be pretty large, which means that it is not negligible. \section{Solving the SFRPA via the real Schur form} In this section, we solve the {\bf SFRPA} by finding an orthogonal matrix $X=\begin{bmatrix}x_1&x_2&\cdots&x_{n}\end{bmatrix}$ and an upper quasi-triangular matrix $T=D+N$ satisfying the second equation of \eqref{eqsolve}, such that $\Delta_{F}^2(A_c)$ in \eqref{departure} is minimized. Obtaining a global optimization solution to the problem $\min\{\Delta_F^2(A_c)\}$ is rather difficult. In this paper, we propose an efficient method to get a suboptimal solution, which balances the contributions of $N$ and $D$ to the departure from normality. As in \cite{Chu2}, we compute the matrices $X$ and $T$ column by column. For any matrix $S$, we denote its range space and null space by $\mathcal{R}(S)$ and $\mathcal{N}(S)$, respectively. Assume that we have already obtained $X_{j}=\begin{bmatrix}x_1&x_2&\cdots&x_{j}\end{bmatrix} \in\mathbb{R}^{n\times j}$ and $T_{j} \in\mathbb{R}^{j\times j}$ satisfying \begin{align}\label{eq1} Q_2^\top (AX_{j} - X_{j}T_{j})=0,\qquad X_{j}^\top X_{j}=I_{j}, \end{align} where $T_j$ is upper quasi-triangular and $\lambda(T_j)=\{\lambda_k\}_{k=1}^{k=j}$. We then are to assign the pole $\lambda_{j+1}$ (if $\lambda_{j+1}$ is real) or poles $\lambda_{j+1},\bar{\lambda}_{j+1}$ (if $\lambda_{j+1}$ is non-real) to get $x_{j+1}$, $\breve{v}_{j+1}$ or $x_{j+1}, x_{j+2}$, $\breve{v}_{j+1}, \breve{v}_{j+2}$, such that the departure from normality of $A_c$ is optimized in some sense. This procedure is repeated until all columns of $X$ and $T$ are acquired, and eventually a solution $F$ to the {\bf SFRPA} would be computed from \eqref{eqsolveoff}. In the following subsections we will distinguish two different cases when $\lambda_{j+1}$ is real or non-real. Before this, we shall show how to get the first one (two) column(s) of $X$ and $T$. If $\lambda_1$ is real, the first column of $T$ is then $\lambda_1e_1$, or $T_1=\lambda_1$, and the first column $x_1$ of $X$ must satisfy \begin{equation}\label{initial} Q_2^{\top}(A-\lambda_1I_n)x_1=0, \end{equation} and $\|x_1\|_2=1$. Let the columns of $S\in\mathbb{R}^{n\times r}$ be an orthonormal basis of $\mathcal{N}(Q_2^{\top}(A-\lambda_1I_n))$, then $x_1$ can be chosen to be any unit vector in $\mathcal{R}(S)$. We take \begin{align}\label{x1real} x_1=(S\begin{bmatrix}1& \ldots&1\end{bmatrix}^{\top})/{\|S\begin{bmatrix}1& \ldots&1\end{bmatrix}^{\top}\|_2} \end{align} in our algorithm as in \cite{Chu2}, and then initially set $X_1=x_1,T_1=\lambda_1$. If $\lambda_1=\alpha_1+i\beta_1$ is non-real, to get the real Schur form, we should place $\bar{\lambda}_1=\alpha_1-i\beta_1$ together with $\lambda_1$. Notice that $T_2$ is of the form $T_2=\begin{bmatrix}\begin{smallmatrix}\alpha_{1} & \delta_1 \beta_{1} \\ -\beta_{1}/\delta_1 & \alpha_{1}\end{smallmatrix}\end{bmatrix}$ with $0\ne\delta_1\in\mathbb{R}$, then the first two columns $x_1,x_2\in\mathbb{R}^n$ of $X$ should be chosen to satisfy \begin{align}\label{x1x2} Q_2^{\top}(A\begin{bmatrix}x_1 &x_2\end{bmatrix}-\begin{bmatrix}x_1 &x_2\end{bmatrix}T_2)=0, \quad x_1^\top x_2=0, \quad \|x_1\|_2=\|x_2\|_2=1, \end{align} so that $(\delta_1-\frac{1}{\delta_1})^2\beta_1^2$ is minimized, which obviously achieves its minimum when $\delta_1=1$. Let the columns of $S\in\mathbb{C}^{n\times r}$ be an orthonormal basis of $\mathcal{N}(Q_2^{\top}(A-\lambda_1I_n))$, and $S_R=\mbox{Re}(S)$, $S_I=\mbox{Im}(S)$. Direct calculations show that such $x_1,x_2$ satisfying \eqref{x1x2} with $\delta_1=1$ can be obtained by \begin{align}\label{x1x2get} x_1&=\begin{bmatrix}S_{R}& -S_I\end{bmatrix}\begin{bmatrix}\gamma_1&\ldots& \gamma_r& \zeta_1& \ldots& \zeta_r\end{bmatrix}^{\top}, \qquad x_2&=\begin{bmatrix}S_I& S_R\end{bmatrix}\begin{bmatrix}\gamma_1&\ldots& \gamma_r& \zeta_1& \ldots& \zeta_r\end{bmatrix}^{\top}, \end{align} with $x_1^\top x_2=0$ and $\|x_1\|_2=\|x_2\|_2=1$. Clearly, \begin{equation}\label{initial_com} \begin{split} &x_1^{\top}x_2+x_2^{\top}x_1\\ =&\begin{bmatrix}\gamma_1&\ldots& \gamma_r&\zeta_1& \ldots& \zeta_r\end{bmatrix} \begin{bmatrix}S_R^{\top}S_I+S_I^{\top}S_R&S_R^{\top}S_R-S_I^{\top}S_I\\ S_R^{\top}S_R-S_I^{\top}S_I&-(S_R^{\top}S_I+S_I^{\top}S_R) \end{bmatrix} \begin{bmatrix}\gamma_1&\ldots& \gamma_r& \zeta_1& \ldots& \zeta_r\end{bmatrix}^{\top},\\ &x_1^{\top}x_1-x_2^{\top}x_2\\ =&\begin{bmatrix}\gamma_1&\ldots& \gamma_r& \zeta_1& \ldots& \zeta_r\end{bmatrix} \begin{bmatrix}S_R^{\top}S_R-S_I^{\top}S_I&-(S_R^{\top}S_I+S_I^{\top}S_R)\\ -(S_R^{\top}S_I+S_I^{\top}S_R)&S_I^{\top}S_I-S_R^{\top}S_R \end{bmatrix} \begin{bmatrix}\gamma_1&\ldots& \gamma_r& \zeta_1& \ldots& \zeta_r\end{bmatrix}^{\top}. \end{split} \end{equation} Note that the two matrices in the above two equations are symmetric Hamiltonian systems owning special properties. So we exhibit some simple results about symmetric Hamiltonian system which will be used here and when assigning the complex conjugate poles. Both results can be verified directly, and we omit the proof. \begin{Lemma}\label{Lemma3.1} Let $A, B\in \mathbb{R}^{n\times n}$ satisfying $A^\top=A, B^\top=B.$ If $\lambda$ is an eigenvalue of $\begin{bmatrix}A&B\\B&-A\end{bmatrix}$ and $\begin{bmatrix}x^\top&y^\top\end{bmatrix}^\top$ is the corresponding eigenvector, then \begin{align*} \begin{bmatrix}A&B\\B&-A\end{bmatrix} \begin{bmatrix}x&-y\\y&x\end{bmatrix}=\begin{bmatrix}x&-y\\y&x\end{bmatrix} \begin{bmatrix}\lambda& \\ & -\lambda\end{bmatrix}, \end{align*} and \begin{align*} \begin{bmatrix}B&-A\\-A&-B\end{bmatrix}\begin{bmatrix}x&-y\\y&x\end{bmatrix} \begin{bmatrix}\frac{\sqrt{2}}{2}&-\frac{\sqrt{2}}{2}\\-\frac{\sqrt{2}}{2}&-\frac{\sqrt{2}}{2}\end{bmatrix} =\begin{bmatrix}x&-y\\y&x\end{bmatrix} \begin{bmatrix}\frac{\sqrt{2}}{2}&-\frac{\sqrt{2}}{2}\\-\frac{\sqrt{2}}{2}&-\frac{\sqrt{2}}{2}\end{bmatrix} \begin{bmatrix}\lambda& \\ & -\lambda\end{bmatrix}. \end{align*} \end{Lemma} \begin{Lemma}(Property of Two Hamiltonian Systems)\label{Lemma3.2} Let $A, B\in \mathbb{R}^{n\times n}$ be symmetric, and let $\begin{bmatrix}A&B\\B&-A\end{bmatrix}=U\diag(\Theta, -\Theta) U^\top$ be the spectral decomposition, where $\Theta=\diag(\theta_1, \theta_2, \ldots, \theta_n)$ with $\theta_1\geq \theta_2\geq\ldots \geq\theta_n\geq 0$. If the $j$-th column $u_{j}$ and the $(n+j)$-th column $u_{n+j}$ of $U$ satisfy $u_{n+j}=\begin{bmatrix}&-I_n\\I_n&\end{bmatrix}u_{j}$, then $\begin{bmatrix}B&-A\\-A&-B\end{bmatrix}=U\begin{bmatrix}0&-\Theta\\-\Theta&0\end{bmatrix}U^\top$. \end{Lemma} Applying Lemma \ref{Lemma3.2} to the two symmetric Hamiltonian systems which appeared in \eqref{initial_com}, that is \begin{align*} \begin{bmatrix}S_R^{\top}S_I+S_I^{\top}S_R&S_R^{\top}S_R-S_I^{\top}S_I\\ S_R^{\top}S_R-S_I^{\top}S_I&-(S_R^{\top}S_I+S_I^{\top}S_R) \end{bmatrix}=&U\diag(\Theta, -\Theta) U^\top,\\ \begin{bmatrix}S_R^{\top}S_R-S_I^{\top}S_I&-(S_R^{\top}S_I+S_I^{\top}S_R)\\ -(S_R^{\top}S_I+S_I^{\top}S_R)&S_I^{\top}S_I-S_R^{\top}S_R \end{bmatrix}=&U\begin{bmatrix}0&-\Theta\\-\Theta&0\end{bmatrix}U^{\top}, \end{align*} then if we let \begin{align}\label{gammamunu} \begin{bmatrix}\gamma_1&\ldots& \gamma_r&\zeta_1& \ldots& \zeta_r\end{bmatrix}^\top=U \begin{bmatrix}\mu_1&\ldots&\mu_r& \nu_1&\ldots&\nu_r\end{bmatrix}^{\top}, \end{align} $x_1^{\top}x_2+x_2^{\top}x_1=\sum_{j=1}^r\theta_j(\mu_j^2-\nu_j^2)$ and $x_1^{\top}x_1-x_2^{\top}x_2=-2\sum_{j=1}^r\theta_j\mu_j\nu_j$ follow. Without loss of generality, we may assume that $\theta_1\geq\theta_2\geq\ldots\geq\theta_r\geq0$, then by taking \begin{subequations}\label{munuinitial} \begin{align} &\mu_3=\nu_3=\ldots=\mu_r=\nu_r=0, \quad \mu_1=-\nu_1=\sqrt{\frac{\theta_2}{\theta_1}\mu_2^2}, \\ &\mu_2=\nu_2=\frac{1}{\|\begin{bmatrix}S_R&-S_I\end{bmatrix}U \begin{bmatrix}\sqrt{\frac{\theta_2}{\theta_1}}&1&0&\cdots&0&-\sqrt{\frac{\theta_2}{\theta_1}}&1&0&\cdots&0\end{bmatrix}^{\top}\|_2}, \end{align} \end{subequations} it is easy to verify that \eqref{x1x2} holds with $x_1$ and $x_2$ computed by \eqref{x1x2get} and \eqref{gammamunu}. Hence, we can still choose initial vectors $x_1$ and $x_2$, so that $(\delta_1-\frac{1}{\delta_1})^2\beta_1^2=0$. We then initially set \begin{align}\label{initialnonreal} X_2=\begin{bmatrix}x_1 &x_2\end{bmatrix},\qquad T_2=\begin{bmatrix}\alpha_{1} & \beta_{1} \\ -\beta_{1}& \alpha_{1}\end{bmatrix}. \end{align} Now assume that \eqref{eq1} has been satisfied with $j\geq1$, we shall then assign the next pole $\lambda_{j+1}$. \subsection{Assigning a real pole} Assume that $\lambda_{j+1}$ is real, then the $(j+1)$-th diagonal element of $T$ must be $\lambda_{j+1}$. Comparing the $(j+1)$-th column of $Q_2^{\top}AX - Q_2^{\top}XT=0$ gives rise to \begin{equation} Q_2^\top Ax_{j+1} - Q_2^\top X_{j}v_{j+1}- \lambda_{j+1}Q_2^\top x_{j+1}=0. \end{equation} Recall the definition of the departure from normality of $A_c$ in \eqref{departure} and notice that we are now computing the $(j+1)$-th columns of $X$ and $T$, it is then natural to consider the following optimization problem: \begin{gather}\label{eqreal-opt-equal} \min_{\|x_{j+1}\|_2=1}\|v_{j+1}\|_2^2\\ \mbox{s.t. } M_{j+1} \begin{bmatrix}x_{j+1}\\v_{j+1}\end{bmatrix}=0 ,\label{eqreal-opt-constrain} \end{gather} where \begin{align}\label{M} M_{j+1}=\begin{bmatrix}Q_2^\top(A-\lambda_{j+1}I_n)& -Q_2^\top X_j\\X_j^\top&0\end{bmatrix}. \end{align} Let $r=\dim\mathcal{N}(M_{j+1})$. Then it follows from the controllability of $(A, B)$ that $Q_2^\top(A-\lambda_{j+1} I_n)$ is of full row rank, indicating that $n-m\leq \rank (M_{j+1})\leq n-m+j$ and $\mathcal{N}(M_{j+1})\neq\emptyset$ (\cite{Chu2}). Suppose that the columns of $S=\begin{bmatrix}S_{1}^\top &S_{2}^\top\end{bmatrix}^\top$ with $S_{1}\in\mathbb{R}^{n\times r}, S_{2}\in\mathbb{R}^{j\times r}$ form an orthonormal basis of $\mathcal{N}(M_{j+1})$, then \eqref{eqreal-opt-constrain} shows that \begin{align}\label{eqrealxv} \begin{array}{lll} x_{j+1}=S_{1}y,& v_{j+1}=S_{2}y, &\qquad \forall y\in \mathbb{R}^r. \end{array} \end{align} Consequently, the optimization problem \eqref{eqreal-opt-equal} subject to \eqref{eqreal-opt-constrain} is equivalent to the following problem: \begin{equation}\label{eqreal-opt-equal-2} \min_{y^\top S_{1}^\top S_{1}y=1}y^\top S_{2}^\top S_{2}y. \end{equation} Perceived that the discussions above can also be found in \cite{Chu2}, and the constrained optimization problem \eqref{eqreal-opt-equal-2} is solved via the GSVD of the matrix pencil $(S_1,S_2)$. We put forward a simpler approach here. Actually, since $S^\top S=I_r$, we have $S_{2}^\top S_{2}=I_r-S_{1}^\top S_{1}$. Thus the problem \eqref{eqreal-opt-equal-2} is equivalent to \begin{equation}\label{eqreal-opt-equal-3} \min_{y^\top S_{1}^\top S_{1}y=1}y^\top y, \end{equation} whose minimum value is acquired when $y$ is an eigenvector of $S_1^{\top}S_1$ corresponding to its greatest eigenvalue and satisfies $y^\top S_{1}^\top S_{1}y=1$. Once such $y$ is obtained, $x_{j+1}$ and $v_{j+1}$ can be given by \eqref{eqrealxv}. We may then update $X_j$ and $T_j$ as \begin{align}\label{updatereal} X_{j+1}=\begin{bmatrix}X_j &x_{j+1}\end{bmatrix}\in\mathbb{R}^{n\times (j+1)},\qquad T_{j+1}=\begin{bmatrix}T_j &v_{j+1}\\0 &\lambda_{j+1}\end{bmatrix}\in\mathbb{R}^{(j+1)\times (j+1)}, \end{align} and continue with the next pole $\lambda_{j+2}$. \subsection{Assigning a pair of conjugate poles } In this subsection, we will consider the case that $\lambda_{j+1}$ is non-real. To obtain a real matrix $F$ from the real Schur form of $A_c=A+BF$, we would assign $\lambda_{j+1}$ and $\lambda_{j+2}=\bar{\lambda}_{j+1}$ simultaneously to get the $(j+1)$-th and $(j+2)$-th columns of $X$ and $T$. \subsubsection{Initial optimization problem} Assume that $\lambda_{j+1}=\alpha_{j+1} + i \beta_{j+1} \,\,(\beta_{j+1}\ne 0)$ and let $D_{\delta}=\begin{bmatrix}\alpha_{j+1} & \delta \beta_{j+1} \\ -\beta_{j+1}/\delta & \alpha_{j+1}\end{bmatrix}$ be the diagonal block in $T$ whose eigenvalues are $\lambda_{j+1}$ and $\bar{\lambda}_{j+1}$. By comparing the $(j+1)$-th and $(j+2)$-th columns of $Q_2^{\top}AX - Q_2^{\top}XT=0$, we have \begin{equation} Q_2^\top A \begin{bmatrix}x_{j+1}&x_{j+2}\end{bmatrix} - Q_2^\top X_{j}\begin{bmatrix}v_{j+1}&v_{j+2}\end{bmatrix}- Q_2^\top \begin{bmatrix}x_{j+1}&x_{j+2}\end{bmatrix} D_{\delta}=0. \end{equation} Recalling the form of $\Delta_F^2(A_c)$ in \eqref{departure}, it is then natural to consider the following optimization problem: \begin{subequations}\label{opt1} \begin{align} \min_{\delta, v_{j+1}, v_{j+2}}&\|v_{j+1}\|_2^2 + \|v_{j+2}\|_2^2 + \beta_{j+1}^2 (\delta -\frac{1}{\delta})^2\label{eqcomplex-opt}\\ \mbox{s.t.}\quad &Q_2^\top (A \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix} -X_j \begin{bmatrix}v_{j+1} &v_{j+2}\end{bmatrix} - \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}D_{\delta})=0,\label{eqcomplex-constraina}\\ &X_j^\top \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}=0,\label{eqcomplex-constrainb}\\ &\begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}^\top \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}=I_2.\label{eqcomplex-constrainc} \end{align} \end{subequations} The constraints \eqref{eqcomplex-constraina} and \eqref{eqcomplex-constrainc} are nonlinear. In \cite{Chu2}, the author solves this optimization problem by taking $\delta=1$ and neglecting the orthogonal requirement $x_{j+1}^\top x_{j+2}=0$. These simplify the problem significantly. However, it cannot lead to the real Schur form of the closed-loop system matrix $A_c$, since $x_{j+1}$ is generally not orthogonal to $x_{j+2}$. Moreover, the minimum value of the simplified optimization problem in \cite{Chu2} may be much greater than that of the original problem \eqref{opt1}. We may rewrite the optimization problem \eqref{opt1} into another equivalent form. If we write $\delta=\frac{\delta_2}{\delta_1}$ with $\delta_1,\delta_2>0$, and set $D_0=\begin{bmatrix}\begin{smallmatrix}\alpha_{j+1} & \beta_{j+1} \\ -\beta_{j+1} & \alpha_{j+1}\end{smallmatrix}\end{bmatrix}$, then $D_{\delta}=\begin{bmatrix}\begin{smallmatrix}1/{\delta_1}&\\&1/{\delta_2}\end{smallmatrix}\end{bmatrix} D_0 \begin{bmatrix}\begin{smallmatrix}\delta_1&\\&\delta_2\end{smallmatrix}\end{bmatrix}$. Redefine ${x}_{j+1}\triangleq\frac{x_{j+1}}{\delta_1}, {x}_{j+2}\triangleq\frac{x_{j+2}}{\delta_2}, {v}_{j+1}\triangleq\frac{v_{j+1}}{\delta_1}, {v}_{j+2}\triangleq\frac{v_{j+2}}{\delta_2}$, then the optimization problem \eqref{opt1} is equivalent to \begin{subequations}\label{opt2} \begin{align} \min_{\delta_1, \delta_2, v_{j+1}, v_{j+2}}&\|\delta_1v_{j+1}\|_2^2 + \|\delta_2v_{j+2}\|_2^2 + \beta_{j+1}^2 (\frac{\delta_1}{\delta_2} -\frac{\delta_2}{\delta_1})^2\label{eqcomplex-opt-2}\\ \mbox{s.t.}\quad &Q_2^\top (A \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix} -X_j \begin{bmatrix}v_{j+1} &v_{j+2}\end{bmatrix} - \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}D_0)=0,\label{eqcomplex-opt-2-constraina}\\ &X_j^\top \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}=0,\label{eqcomplex-opt-2-constrainb}\\ &\begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}^\top \begin{bmatrix}x_{j+1}& x_{j+2}\end{bmatrix}=\begin{bmatrix}1/{\delta_1^2}&\\&1/{\delta_2^2}\end{bmatrix}. \label{eqcomplex-opt-2-constrainc} \end{align} \end{subequations} Here the constraint \eqref{eqcomplex-opt-2-constraina} becomes linear. Once a solution to the optimization problem \eqref{opt2} is obtained, we need to redefine \[ v_{j+1}\triangleq\frac{v_{j+1}}{\|x_{j+1}\|_2},\quad v_{j+2}\triangleq\frac{v_{j+2}}{\|x_{j+2}\|_2},\quad x_{j+1}\triangleq\frac{x_{j+1}}{\|x_{j+1}\|_2},\quad x_{j+2}\triangleq\frac{x_{j+2}}{\|x_{j+2}\|_2} \] as the corresponding columns of $T$ and $X$. The constraints \eqref{eqcomplex-opt-2-constraina} and \eqref{eqcomplex-opt-2-constrainb} are linear. Actually, all vectors $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ satisfying these two constraints can be found via the null space of the matrix \begin{align}\label{Mcomplex} M_{j+1}=\begin{bmatrix}Q_2^{\top}(A-(\alpha_{j+1}+i\beta_{j+1})I_n)& -Q_2^{\top}X_j\\ X_j^{\top}&0\end{bmatrix}. \end{align} Specifically, for any $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ satisfying \eqref{eqcomplex-opt-2-constraina} and \eqref{eqcomplex-opt-2-constrainb}, direct calculations show that $M_{j+1}\begin{bmatrix}x_{j+1}+i x_{j+2}\\v_{j+1}+i v_{j+2}\end{bmatrix}=0$. Conversely, for any vector $\begin{bmatrix}z^{\top}&w^{\top}\end{bmatrix}^{\top}\in\mathcal{N}(M_{j+1})$, the vectors $x_{j+1}=\mbox{Re}(z), x_{j+2}=\mbox{Im}(z), v_{j+1}=\mbox{Re}(w), v_{j+2}=\mbox{Im}(w)$ satisfy \eqref{eqcomplex-opt-2-constraina} and \eqref{eqcomplex-opt-2-constrainb}. The constraint \eqref{eqcomplex-opt-2-constrainc} shows that $x_{j+1}^\top x_{j+2}=0$. For any vector $\begin{bmatrix}z^{\top}&w^{\top}\end{bmatrix}^{\top}\in\mathcal{N}(M_{j+1})$ with $\mbox{Re}(z)$ and $\mbox{Im}(z)$ being linearly independent, we may then orthogonalize $\mbox{Re}(z)$ and $\mbox{Im}(z)$ by the Jacobi transformation as follows to get $x_{j+1}$ and $x_{j+2}$ satisfying $x_{j+1}^\top x_{j+2}=0$. Let $\varrho_1=\|\mbox{Re}(z)\|_2^2,\ \varrho_2=\|\mbox{Im}(z)\|_2^2, \ \gamma=\mbox{Re}(z)^{\top}\mbox{Im}(z)$ and $\tau=\frac{\varrho_2-\varrho_1}{2\gamma}$, and define $t$ as \begin{displaymath} t=\left\{ \begin{array}{ll} 1/(\tau+\sqrt{1+\tau^2}), & \text{ if}\quad \tau\geq0,\\ -1/(-\tau+\sqrt{1+\tau^2}), & \text{ if}\quad \tau<0.\\ \end{array} \right. \end{displaymath} Let $c=1/\sqrt{1+t^2}$, $s=tc$. Then $x_{j+1}$ and $x_{j+2}$ obtained by \begin{align} \label{Jocobi_x} \begin{bmatrix}x_{j+1}& x_{j+2} \end{bmatrix}=\begin{bmatrix}\mbox{Re}(z)& \mbox{Im}(z) \end{bmatrix} \begin{bmatrix}c & s\\ -s&c\end{bmatrix} \end{align} satisfy $x_{j+1}^\top x_{j+2}=0$. Moreover, if we let \begin{align}\label{Jocobi_v} \begin{bmatrix}v_{j+1}&v_{j+2}\end{bmatrix}=\begin{bmatrix}\mbox{Re}(w)& \mbox{Im}(w) \end{bmatrix} \begin{bmatrix}c & s\\ -s&c\end{bmatrix}, \end{align} then $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ satisfy \eqref{eqcomplex-opt-2-constraina} and \eqref{eqcomplex-opt-2-constrainb}. Hence, we can get $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ satisfying the constrains \eqref{eqcomplex-opt-2-constraina}-\eqref{eqcomplex-opt-2-constrainc} in this way. Furthermore, \begin{equation} \label{eqortho-one} 1/{\delta_1^2}=\|x_{j+1}\|_2^2=\|x\|_2^2-\omega,\quad 1/{\delta_2^2}=\|x_{j+2}\|_2^2=\|y\|_2^2+\omega, \end{equation} where $x=\mbox{Re}(z)$, $y=\mbox{Im}(z)$, $\omega=\frac{2(x^{\top}y)^2}{\|y\|_2^2-\|x\|_2^2+\sqrt{4(x^{\top}y)^2+(\|y\|_2^2-\|x\|_2^2)^2}}$ if $\|x\|_2<\|y\|_2$; and $\omega=\frac{2(x^{\top}y)^2}{\|y\|_2^2-\|x\|_2^2-\sqrt{4(x^{\top}y)^2 +(\|y\|_2^2-\|x\|_2^2)^2}}$ if $\|x\|_2\ge\|y\|_2$. \subsubsection{The suboptimal strategy} It is hard to get an optimal solution to \eqref{opt2} since it is a nonlinear optimization problem with quadratic constraints. Even if such an optimal solution can be found, the cost will be expensive. So instead of finding an optimal solution, we prefer to get a suboptimal one with less computational cost. Let the columns of $S=\begin{bmatrix}S_1^{\top}&S_2^{\top}\end{bmatrix}^{\top}\in \mathbb{C}^{(n+j)\times r}$ with $S_1\in \mathbb{C}^{n\times r}$ and $S_2\in \mathbb{C}^{j\times r}$ form an orthonormal basis of $\mathcal{N}(M_{j+1})$, and let $S_1=U\Sigma V^{*}$ be the SVD of $S_1$. Since $S_1^{*}S_1+S_2^{*}S_2=I_r$, it follows that $S_2^{*}S_2=V(I_r-\Sigma^{*}\Sigma)V^{*}$. For any vector $\begin{bmatrix}z^{\top}&w^{\top}\end{bmatrix}^{\top}\in \mathcal{N}(M_{j+1})$ with $z\in \mathbb{C}^{n}$ and $w\in \mathbb{C}^{j}$, there exists $b\in \mathbb{C}^{r}$ such that $z=S_1b=U(\Sigma V^{*}b)$ and $w=S_2b$. Hence \begin{align*} \|z\|_2\leq\sigma_1 \|b\|_2 \qquad \text{ and } \qquad \|w\|_2^2\geq (1-\sigma_1^2)\|b\|_2^2, \end{align*} where $\sigma_1$ is the largest singular value of $S_1$. Now suppose that the real part and the imaginary part of $z$ are linearly independent satisfying $\|\mbox{Re}(z)\|_2\leq\|\mbox{Im}(z)\|_2$, and $x_{j+1}, x_{j+2}$, $v_{j+1}, v_{j+2}$ are obtained from the the Jacobi orthogonal process \eqref{Jocobi_x}, \eqref{Jocobi_v}. Define $C=\frac{\|z\|_2}{\|x_{j+1}\|_2}$, then $C\geq\sqrt{2}$ and the objective function in \eqref{eqcomplex-opt-2} becomes \begin{equation}\label{value_cost} \begin{split} &\|\delta_1v_{j+1}\|_2^2 + \|\delta_2v_{j+2}\|_2^2 + \beta_{j+1}^2 (\frac{\delta_1}{\delta_2} -\frac{\delta_2}{\delta_1})^2\\ =&\frac{C^2}{C^2-1}\frac{\|w\|_2^2}{\|z\|_2^2}+\frac{C^4-2C^2}{C^2-1}\frac{\|v_{j+1}\|_2^2}{\|z\|_2^2}+\beta_{j+1}^2(C^2-3+\frac{1}{C^2-1}). \end{split} \end{equation} Obviously, \begin{align}\label{value_cost_ieq} \frac{C^2}{C^2-1}\frac{\|w\|_2^2}{\|z\|_2^2}\leq \frac{C^2}{C^2-1}\frac{\|w\|_2^2}{\|z\|_2^2}+\frac{C^4-2C^2}{C^2-1}\frac{\|v_{j+1}\|_2^2}{\|z\|_2^2}\leq C^2\frac{\|w\|_2^2}{\|z\|_2^2}. \end{align} So the objective function in \eqref{eqcomplex-opt-2} depends on $\frac{\|w\|_2^2}{\|z\|_2^2}$ and $C$ with $\min\frac{\|w\|_2^2}{\|z\|_2^2}=\frac{1-\sigma_1^2}{\sigma_1^2}$. In our suboptimal strategy, we will first take $b$ from $\subspan\{Ve_1\}$, where $e_i$ is the $i$-th column of the identity matrix. With this choice, $\frac{\|w\|_2^2}{\|z\|_2^2}$ achieves its minimum value. And the following theorem shows the relevant results. \begin{Theorem}\label{Theorem3.1} With the notations above, let $u_1$ be the first column of $U$ and assume that $\mbox{Re}(u_1)$ and $\mbox{Im}(u_1)$ are linearly independent. Let $x_{j+1}$ and $x_{j+2}$ be the vectors obtained from $\mbox{Re}(u_1)$ and $\mbox{Im}(u_1)$ via the Jacobi orthogonal process \begin{align*} \begin{bmatrix}x_{j+1}&x_{j+2}\end{bmatrix}=\begin{bmatrix}\mbox{Re}(u_1)&\mbox{Im}(u_1)\end{bmatrix}\begin{bmatrix}c&s\\-s&c\end{bmatrix}, \end{align*} and let \begin{align*} \begin{bmatrix}v_{j+1}&v_{j+2}\end{bmatrix}=\begin{bmatrix}\mbox{Re}(w)&\mbox{Im}(w)\end{bmatrix}\begin{bmatrix}c&s\\-s&c\end{bmatrix}, \end{align*} where $w=S_2Ve_1/\sigma_1$. Then $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ satisfy the constrains \eqref{eqcomplex-opt-2-constraina}-\eqref{eqcomplex-opt-2-constrainc}, and the value of the corresponding objective function specified by \eqref{eqcomplex-opt-2} will be no larger than \[\frac{1}{\min\{\|x_{j+1}\|_2^2, \|x_{j+2}\|_2^2\}}(\frac{1-\sigma_1^2}{\sigma_1^2}+\beta_{j+1}^2).\] \end{Theorem} \begin{proof} The first part of the theorem is obvious. To prove the second part, note that here $b=\frac{Ve_1}{\sigma_1}$, $\|z\|_2=\|u_1\|_2=1, \|w\|_2^2=\frac{1-\sigma_1^2}{\sigma_1^2}$. If $\|\mbox{Re}(u_1)\|_2\leq\|\mbox{Im}(u_1)\|_2$, it then follows directly from \eqref{value_cost}, \eqref{value_cost_ieq} and $C^2-3+\frac{1}{C^2-1}\leq C^2$ with $C=\frac{1}{\|x_{j+1}\|_2}$. The case when $\|\mbox{Re}(u_1)\|_2\geq\|\mbox{Im}(u_1)\|_2$ can be proved similarly. \end{proof} Theorem \ref{Theorem3.1} shows that if $\mbox{Re}(u_1)$ and $\mbox{Im}(u_1)$ are linearly independent, and $\min\{\|x_{j+1}\|_2, \|x_{j+2}\|_2\}$ is not pathologically small, the above procedure will generate $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ satisfying the constrains \eqref{eqcomplex-opt-2-constraina}-\eqref{eqcomplex-opt-2-constrainc}, and the value of the corresponding objective function in \eqref{eqcomplex-opt-2} is not too large. We then take these $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$ as the suboptimal solution. However, if $\mbox{Re}(u_1)$ and $\mbox{Im}(u_1)$ are linearly dependent, we cannot get orthogonal $x_{j+1}$ and $x_{j+2}$ via the Jacobi orthogonal process. Even if $\mbox{Re}(u_1)$ and $\mbox{Im}(u_1)$ are linearly independent, the resulted $\min\{\|x_{j+1}\|_2, \|x_{j+2}\|_2\}$ might be fairly small, which means that the corresponding value of the objective function might be large. In this case, we would choose $b$ from $\subspan\{Ve_1, Ve_2\}$. Define \begin{align}\label{tildexy} &\tilde{x}_1+i\tilde{y}_1=z_1=u_1=\frac{S_1Ve_1}{\sigma_1}, &&w_1=\frac{S_2Ve_1}{\sigma_1},\notag\\ &\tilde{x}_2+i\tilde{y}_2=z_2=u_2=\frac{S_1Ve_2}{\sigma_2}, &&w_2=\frac{S_2Ve_2}{\sigma_2}, \end{align} where $\sigma_1, \sigma_2$ are the first two greatest singular values of $S_1$. Let $b=\begin{bmatrix}\begin{smallmatrix}\frac{Ve_1}{\sigma_1}&\ &\frac{Ve_2}{\sigma_2}\end{smallmatrix}\end{bmatrix} \begin{bmatrix}\begin{smallmatrix}\gamma_1+i\zeta_1\\ \gamma_2+i\zeta_2\end{smallmatrix}\end{bmatrix}$ with $\gamma_1^2+\gamma_2^2+\zeta_1^2+\zeta_2^2=1$, then \begin{align}\label{xyw} x+iy=z=S_1b=\begin{bmatrix}z_1&z_2\end{bmatrix}\begin{bmatrix}\gamma_1+i\zeta_1\\ \gamma_2+i\zeta_2\end{bmatrix}, \quad w=S_2b=\begin{bmatrix}w_1&w_2\end{bmatrix}\begin{bmatrix}\gamma_1+i\zeta_1\\ \gamma_2+i\zeta_2\end{bmatrix}. \end{align} Denoting $\tilde{X}=\begin{bmatrix}\tilde{x}_1&\tilde{x}_2\end{bmatrix}$, $\tilde{Y}=\begin{bmatrix}\tilde{y}_1&\tilde{y}_2\end{bmatrix}$, it can be easily verified that \begin{align} x=\begin{bmatrix}\tilde{X}&-\tilde{Y}\end{bmatrix}\begin{bmatrix}\gamma_1&\gamma_2&\zeta_1& \zeta_2\end{bmatrix}^{\top}, \qquad y=\begin{bmatrix}\tilde{Y}&\tilde{X}\end{bmatrix}\begin{bmatrix}\gamma_1&\gamma_2& \zeta_1& \zeta_2\end{bmatrix}^{\top}, \end{align} and \begin{align}\label{eq-orthogonal} x^{\top}y+y^{\top}x=\begin{bmatrix}\gamma_1& \gamma_2& \zeta_1& \zeta_2\end{bmatrix} \begin{bmatrix}\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X}&\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}\\ \tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X}) \end{bmatrix} \begin{bmatrix}\gamma_1& \gamma_2& \zeta_1& \zeta_2\end{bmatrix}^\top, \end{align} \begin{align}\label{eq-equal-length} x^{\top}x-y^{\top}y=\begin{bmatrix}\gamma_1& \gamma_2& \zeta_1& \zeta_2\end{bmatrix} \begin{bmatrix}\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})\\ -(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})&\tilde{Y}^{\top}\tilde{Y}-\tilde{X}^{\top}\tilde{X} \end{bmatrix} \begin{bmatrix}\gamma_1& \gamma_2& \zeta_1& \zeta_2\end{bmatrix}^\top. \end{align} Obviously, the two matrices in \eqref{eq-orthogonal} and \eqref{eq-equal-length} are symmetric Hamiltonian systems and they satisfy the property in Lemma \ref{Lemma3.2}. Hence we can get the following lemma. \begin{Lemma}\label{Lemma3.3} Let $\phi_m, \phi_M$ be the two smallest singular values of $\begin{bmatrix}\tilde{Y}&\tilde{X}\end{bmatrix}$ and $\begin{bmatrix}\begin{smallmatrix}p_1\\q_1\end{smallmatrix}\end{bmatrix}, \begin{bmatrix}\begin{smallmatrix}p_2\\q_2\end{smallmatrix}\end{bmatrix}$ be the corresponding right singular vectors respectively. Define \begin{align}\label{Omega} \Omega=\begin{bmatrix}p_1&p_2&-q_1&-q_2\\q_1&q_2&p_1&p_2\end{bmatrix}, \end{align} $\Phi=\diag (\phi_1, \phi_2, -\phi_1, -\phi_2)$ with $\phi_1=1-2\phi_m^2$, $\phi_2=1-2\phi_M^2$, then \begin{align}\label{specdecom} \begin{bmatrix}\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})\\ -(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})&\tilde{Y}^{\top}\tilde{Y}-\tilde{X}^{\top}\tilde{X} \end{bmatrix}= \Omega\Phi \Omega^{\top}, \end{align} and \begin{align*} \begin{bmatrix}\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X}&\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}\\ \tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X}) \end{bmatrix} =\Omega\left(\begin{array}{c|c} \begin{array}{cc} &\\ &\\ \end{array} &\begin{array}{cc} \phi_1&\\ &\phi_2\\ \end{array}\\ & \\[-2mm] \hline & \\[-2mm] \begin{array}{cc} \phi_1&\\ &\phi_2\\ \end{array} &\begin{array}{cc} &\\ &\\ \end{array}\\ \end{array}\right)\Omega^{\top}. \end{align*} \end{Lemma} \begin{proof} Since $(\tilde{X}^{\top}-i\tilde{Y}^{\top})(\tilde{X}+i\tilde{Y})=\begin{bmatrix}z_1&z_2\end{bmatrix}^{*} \begin{bmatrix}z_1&z_2\end{bmatrix}=I_2$, so $\tilde{X}^{\top}\tilde{X}+\tilde{Y}^{\top}\tilde{Y}=I_2$ and $\tilde{X}^{\top}\tilde{Y}=\tilde{Y}^{\top}\tilde{X}$. Thus \begin{align*} \begin{bmatrix}\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})\\ -(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})&\tilde{Y}^{\top}\tilde{Y}-\tilde{X}^{\top}\tilde{X}\end{bmatrix} =\begin{bmatrix}I_2-2\tilde{Y}^{\top}\tilde{Y}&-2\tilde{Y}^{\top}\tilde{X}\\ -2\tilde{X}^{\top}\tilde{Y}&I_2-2\tilde{X}^{\top}\tilde{X} \end{bmatrix} =I_4-2\begin{bmatrix}\tilde{Y}^{\top}\\ \tilde{X}^{\top}\end{bmatrix}\begin{bmatrix}\tilde{Y}&\tilde{X}\end{bmatrix}. \end{align*} From the above equation, it obviously holds that $\phi_1, \phi_2$ are the two nonnegative eigenvalues of $\begin{bmatrix}\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})\\ -(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})&\tilde{Y}^{\top}\tilde{Y}-\tilde{X}^{\top}\tilde{X}\end{bmatrix}$ with $\begin{bmatrix}p_1\\q_1\end{bmatrix}$, $\begin{bmatrix}p_2\\q_2\end{bmatrix}$ being the corresponding eigenvectors. Note that $\begin{bmatrix}\tilde{X}^{\top}\tilde{X}-\tilde{Y}^{\top}\tilde{Y}&-(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})\\ -(\tilde{X}^{\top}\tilde{Y}+\tilde{Y}^{\top}\tilde{X})&\tilde{Y}^{\top}\tilde{Y}-\tilde{X}^{\top}\tilde{X}\end{bmatrix}$ is a Hamiltonian matrix, thus the results follow immediately from Lemma \ref{Lemma3.1} and Lemma \ref{Lemma3.2}. \end{proof} Now by defining \begin{align}\label{trans} \begin{bmatrix}\mu_1& \mu_2& \nu_1& \nu_2\end{bmatrix}^{\top}=\Omega^{\top} \begin{bmatrix}\gamma_1& \gamma_2& \zeta_1& \zeta_2\end{bmatrix}^{\top}, \end{align} we have \begin{align}\label{xdoty-xdotxplusydoty} x^{\top}y+y^{\top}x=2\phi_1\mu_1\nu_1+2\phi_2\mu_2\nu_2, \qquad x^{\top}x-y^{\top}y=\phi_1(\mu_1^2-\nu_1^2)+\phi_2(\mu_2^2-\nu_2^2). \end{align} \begin{Theorem}\label{Theorem3.2} With the notations above, there exist $\mu_1, \mu_2, \nu_1, \nu_2\in\mathbb{R}$ such that $x^{\top}y=0$ and $\|x\|_2=\|y\|_2=\frac{\sqrt{2}}{2}$. For these $\mu_1, \mu_2, \nu_1, \nu_2$, let $\gamma_1, \gamma_2, \zeta_1, \zeta_2$ be computed from \eqref{trans}, where $\Omega$ is as in \eqref{Omega}. Then $x_{j+1}=x, x_{j+2}=y, v_{j+1}=\mbox{Re}(w)$ and $v_{j+2}=\mbox{Im}(w)$, where $w$ is computed by \eqref{xyw}, satisfy the constrains \eqref{eqcomplex-opt-2-constraina}-\eqref{eqcomplex-opt-2-constrainc}, and the value of the corresponding objective function in \eqref{eqcomplex-opt-2} will be no larger than $\frac{2(1-\sigma_2^2)}{\sigma_2^2}$. \end{Theorem} \begin{proof} It is easy to check that all solutions of the following system of equations \begin{align}\label{eqtwominimal} \left\{\begin{array}{ll} \phi_1\mu_1\nu_1+\phi_2\mu_2\nu_2&=0,\\ \phi_1(\mu_1^2-\nu_1^2)+\phi_2(\mu_2^2-\nu_2^2)&=0,\\ \mu_1^2+\mu_2^2+\nu_1^2+\nu_2^2&=1. \end{array}\right. \end{align} are \begin{equation}\label{munu1} \begin{array}{lll} \left\{\begin{split} \mu_2&=\pm\sqrt{\frac{\phi_1}{\phi_1+\phi_2}-\nu_2^2}\\ \mu_1&=-\sqrt{\frac{\phi_2}{\phi_1}}\nu_2\\ \nu_1&=\pm\sqrt{\frac{\phi_2}{\phi_1+\phi_2}-\frac{\phi_2}{\phi_1}\nu_2^2} \end{split}\right.& \textrm{and}& \left\{\begin{split} \mu_2&=\pm\sqrt{\frac{\phi_1}{\phi_1+\phi_2}-\nu_2^2}\\%[6pt] \mu_1&=\sqrt{\frac{\phi_2}{\phi_1}}\nu_2\\%[6pt] \nu_1&=\mp\sqrt{\frac{\phi_2}{\phi_1+\phi_2}-\frac{\phi_2}{\phi_1}\nu_2^2} \end{split}\right. \end{array} \end{equation} with $\nu_2^2\leq\frac{\phi_1}{\phi_1+\phi_2}$. Note \eqref{xdoty-xdotxplusydoty} and $\|x\|_2^2+\|y\|_2^2=1$, so with the values in \eqref{munu1}, it holds that $x^{\top}y=0$ and $\|x\|_2=\|y\|_2=\frac{\sqrt{2}}{2}$. Since $\begin{bmatrix}z^\top&w^\top\end{bmatrix}^\top\in\mathcal{N}(M_{j+1})$, so $\begin{bmatrix}\begin{smallmatrix}x_{j+1}&\ &x_{j+2}\\v_{j+1}&\ &v_{j+2}\end{smallmatrix}\end{bmatrix}= \begin{bmatrix}\begin{smallmatrix}x&\ &y\\ \mbox{Re}(w)& \ &\mbox{Im}(w)\end{smallmatrix}\end{bmatrix}$ satisfy the constrains \eqref{eqcomplex-opt-2-constraina}-\eqref{eqcomplex-opt-2-constrainc} with $\delta_1=\delta_2=\frac{\sqrt{2}}{2}$. Hence \begin{align*} &\|\delta_1v_{j+1}\|_2^2 + \|\delta_2v_{j+2}\|_2^2 + \beta_{j+1}^2 (\frac{\delta_1}{\delta_2} -\frac{\delta_2}{\delta_1})^2\\ =&2\|w\|_2^2=2(\gamma_1^2+\zeta_1^2)\frac{1-\sigma_1^2}{\sigma_1^2}+ 2(\gamma_2^2+\zeta_2^2)\frac{1-\sigma_2^2}{\sigma_2^2}\leq\frac{2(1-\sigma_2^2)}{\sigma_2^2}, \end{align*} which completes the proof of the theorem. \end{proof} From the proof of Theorem \ref{Theorem3.2} we can see that with such choice of $x_{j+1},x_{j+2},v_{j+1},v_{j+2}$, the value of the corresponding objective function is just $2\|w\|_2^2$. Define $\xi_1=p_1^{\top}\Xi p_1, \xi_2=p_2^{\top}\Xi p_2, \eta_1=q_1^{\top}\Xi q_1, \eta_2=q_2^{\top}\Xi q_2, \zeta_{12}=q_1^{\top}\Xi p_2, \zeta_{21}=q_2^{\top}\Xi p_1$, with $\Xi=\diag\{ (1-\sigma_1^2)/\sigma_1^2, (1-\sigma_2^2)/\sigma_2^2\}$, it then follows \begin{align}\label{lengthw} \|w\|_2^2= \left\{ \begin{array}{ll} \frac{\phi_2}{\phi_1+\phi_2}(\xi_1+\eta_1)+\frac{\phi_1}{\phi_1+\phi_2}(\xi_2+\eta_2)+ 2\sqrt{\frac{\phi_2}{\phi_1}}\frac{\phi_1}{\phi_1+\phi_2}(\zeta_{21}-\zeta_{12}) & \textrm{if} \ \ (\mu_1\nu_2)\leq0,\\ \frac{\phi_2}{\phi_1+\phi_2}(\xi_1+\eta_1)+\frac{\phi_1}{\phi_1+\phi_2}(\xi_2+\eta_2)+ 2\sqrt{\frac{\phi_2}{\phi_1}}\frac{\phi_1}{\phi_1+\phi_2}(\zeta_{12}-\zeta_{21}) & \textrm{if} \ \ (\mu_1\nu_2)>0.\\ \end{array} \right. \end{align} So in order to get a smaller $\|w\|_2$, we can take $\mu_1, \mu_2, \nu_1, \nu_2$ satisfying $\mu_1\nu_2\leq0$ if $\zeta_{21}\leq\zeta_{12}$, and $\mu_1\nu_2>0$ if $\zeta_{21}>\zeta_{12}$. Till now we have proposed two strategies for computing $x_{j+1}, x_{j+2}, v_{j+1}, v_{j+2}$. The first strategy computes $x_{j+1}, x_{j+2}, v_{j+1}$ and $v_{j+2}$ by using the Jacobi orthogonal process \eqref{Jocobi_x} and \eqref{Jocobi_v} with $z=u_1$ and $w=\frac{S_2Ve_1}{\sigma_1}$. While the second one first computes $\mu_1, \mu_2, \nu_1, \nu_2$ by \eqref{munu1} satisfying $\mu_1\nu_2\leq0$ if $\zeta_{21}\leq\zeta_{12}$, and $\mu_1\nu_2>0$ if $\zeta_{21}>\zeta_{12}$, and then compute $\gamma_1, \gamma_2, \zeta_1, \zeta_2$ from \eqref{trans}, where $\Omega$ is as in \eqref{Omega}, and finally set $x_{j+1}=x, x_{j+2}=y, v_{j+1}=\mbox{Re}(w)$ and $v_{j+2}=\mbox{Im}(w)$, where $x,y,w$ are computed by \eqref{xyw}. We cannot tell which strategy is better. So we suggest to apply both strategies, compare the corresponding values of the objective function and adopt the one which gives better results. Specifically, if the value of the objective function corresponding to the first strategy is smaller, we would update $X_j$ and $T_j$ as \begin{align}\label{updatecomplex1} X_{j+2}=\begin{bmatrix}X_j &\delta_1x_{j+1}&\delta_2x_{j+2}\end{bmatrix}\in\mathbb{R}^{n\times (j+2)},\qquad T_{j+2}=\begin{bmatrix}T_j &\delta_1v_{j+1}&\delta_2v_{j+2}\\ 0 &\alpha_{j+1}&\delta\beta_{j+1}\\0&-\frac{1}{\delta}\beta_{j+1}&\alpha_{j+1}\end{bmatrix}\in\mathbb{R}^{(j+2)\times (j+2)}, \end{align} where $\delta_1=\frac{1}{\|x_{j+1}\|_2}, \delta_2=\frac{1}{\|x_{j+2}\|_2}, \delta=\frac{\delta_2}{\delta_1}$. Otherwise, we update $X_j$ and $T_j$ as \begin{align}\label{updatecomplex2} X_{j+2}=\begin{bmatrix}X_j &\sqrt{2}x&\sqrt{2}y\end{bmatrix}\in\mathbb{R}^{n\times (j+2)},\quad T_{j+2}=\begin{bmatrix}T_j &\sqrt{2}\mbox{Re}(w)&\sqrt{2}\mbox{Im}(w)\\0 &\alpha_{j+1}&\beta_{j+1}\\0&-\beta_{j+1}&\alpha_{j+1}\end{bmatrix}\in\mathbb{R}^{(j+2)\times(j+2)}, \end{align} with $x, y$ and $w$ defined as in \eqref{xyw}. This completes the assignment of the complex conjugate poles $\lambda_{j+1},\lambda_{j+2}=\bar{\lambda}_{j+1}$, and we can then continue with the next pole $\lambda_{j+3}$. These two strategies essentially choose $z$ from $\mathcal{R}(u_1)$ and $\mathcal{R}(\begin{bmatrix}u_1&u_2\end{bmatrix})$, respectively. If the results by these two strategies are not satisfactory, theoretically, we can choose $z$ from a higher dimensional space, i.e. $z\in \subspan\{u_1, u_2, \ldots, u_k\}, k\geq3$, with $u_l$ being the $l$-th column of $U$. However the resulted optimization problem is much more complicated. More importantly, numerical examples show that these two strategies with $k=1,2$ can produce fairly satisfying results for most problems. \subsection{Algorithm} In this part, we give the framework of our algorithm. \begin{algorithm} \renewcommand{\algorithmicrequire}{\textbf{Input:}} \renewcommand\algorithmicensure {\textbf{Output:} } \caption{ Framework of our {\bf Schur-rob} algorithm.} \label{alg:Framwork} \begin{algorithmic}[1] \REQUIRE ~~\\ $A, B$ and $\mathfrak{L}=\{\lambda_1,\dots,\lambda_n\}$ (complex conjugate poles appear in pairs). \ENSURE ~~\\ The feedback matrix $F$. \STATE If $\lambda_1$ is real, compute $x_1$ by \eqref{x1real} and set $X_1=x_1,T_1=\lambda_1,j=1$. If $\lambda_1$ is non-real, compute $x_1,x_2$ by \eqref{x1x2get}, \eqref{gammamunu}, \eqref{munuinitial}, and set $X_2,T_2$ as in \eqref{initialnonreal}, $j=2$. \label{code:fram:extract} \WHILE{$j<n$} \IF{ $\lambda_{j+1}$ is real} \STATE Find $S=\begin{bmatrix}S_1^{\top}&S_2^{\top}\end{bmatrix}^{\top}$, whose columns form an orthonormal basis of $\mathcal{N}(M_{j+1})$ in \eqref{M}; \STATE Compute $y$ by \eqref{eqreal-opt-equal-3}; \STATE Compute $x_{j+1}$ and $v_{j+1}$ by \eqref{eqrealxv}, update $X_j$ and $T_j$ as \eqref{updatereal} and set $j=j+1$. \ELSE \STATE Find $S=\begin{bmatrix}S_1^{\top}&S_2^{\top}\end{bmatrix}^{\top}$, whose columns form an orthonormal basis of $\mathcal{N}(M_{j+1})$ in \eqref{Mcomplex}; \STATE Compute the SVD of $S_1$ as $S_1=U\Sigma V^{*}$; \IF{ $\mbox{Re}(Ue_1)$ and $\mbox{Im}(Ue_1)$ are linearly independent} \STATE Compute $x_{j+1}, x_{j+2}, v_{j+1}, v_{j+2}$ by \eqref{Jocobi_x} and \eqref{Jocobi_v} with $z=\frac{S_1Ve_1}{\sigma_1}, w=\frac{S_2Ve_1}{\sigma_1}$; \STATE Set $\delta_1=\frac{1}{\|x_{j+1}\|_2}, \delta_2=\frac{1}{\|x_{j+2}\|_2}$ and $\delta=\frac{\delta_2}{\delta_1}$; \STATE Compute $dep_1=\|\delta_1v_{j+1}\|_2^2+\|\delta_2v_{j+2}\|_2^2+\beta_{j+1}^2(\delta-\frac{1}{\delta})^2$; \ELSE \STATE Set $dep_1=\infty$; \ENDIF \STATE Let $\tilde{X}=\begin{bmatrix}\tilde{x}_1&\tilde{x}_2\end{bmatrix}$, $\tilde{Y}=\begin{bmatrix}\tilde{y}_1&\tilde{y}_2\end{bmatrix}$ with $\tilde{x}_1, \tilde{y}_1, \tilde{x}_2, \tilde{y}_2$ defined as in \eqref{tildexy}, and compute the spectral decomposition \eqref{specdecom}; \STATE Compute $\mu_1, \mu_2, \nu_1, \nu_2$ by \eqref{munu1} satisfying $\mu_1\nu_2\leq0$ if $\zeta_{21}\leq\zeta_{12}$, and $\mu_1\nu_2>0$ if $\zeta_{21}>\zeta_{12}$, and then compute $\gamma_1, \gamma_2, \zeta_1, \zeta_2$ from \eqref{trans}, where $\Omega$ is as in \eqref{Omega}; \STATE Compute $z$, $w$ by \eqref{xyw}, set $x_{j+1}=\mbox{Re}(z), x_{j+2}=\mbox{Im}(z), v_{j+1}=\mbox{Re}(w)$ and $v_{j+2}=\mbox{Im}(w)$. Compute $dep_2=2[(\gamma_1^2+\zeta_1^2)\frac{1-\sigma_1^2}{\sigma_1^2}+(\gamma_2^2+\zeta_2^2)\frac{1-\sigma_2^2}{\sigma_2^2}]$; \STATE If $dep_1<dep_2$, update $X_{j}$ and $T_{j}$ as in \eqref{updatecomplex1}; otherwise, update them as in \eqref{updatecomplex2}. Set $j=j+2$. \ENDIF \ENDWHILE \STATE Set $X=X_n, T=T_n$, and compute $F$ by \eqref{eqsolveoff}. \end{algorithmic} \end{algorithm} \section{Numerical Examples} In this section, we give some numerical examples to illustrate the performance of our \textbf{Schur-rob} algorithm, and compare it with some of the different versions of \textbf{SCHUR} in \cite{Chu2}, the MATLAB functions \textbf{robpole} \cite{Tits} and \textbf{place} \cite{KNV}. Each algorithm computes a feedback matrix $F$ such that the eigenvalues of $A+BF$ are those given in $\mathfrak{L}$, and $A+BF$ is robust. When applying \textbf{robpole} to all test examples, we set the maximum number of sweep to be the default value $5$. All calculations are carried out on an Intel\textregistered Core\texttrademark i3, dual core, 2.27 GHz machine, with $2.00$ GB RAM. MATLAB R2012a is used with machine epsilon $\epsilon\approx 2.2\times 10^{-16}$. With $\lambda_1\in\mathbb{R}$ fixed, the choice of $x_1$ in \textbf{Schur-rob} ignores the freedom of $x_1$. Inspired by \textbf{O-SCHUR} \cite{Chu2}, we may regard $x_1$ as a free parameter and manage to optimize the robustness. Specifically, we may run \textbf{Schur-rob} with several different choices of $x_1$, and keep the solution $F$ corresponding to the minimum departure from normality. We denote such method as ``\textbf{O-Schur-rob}". In this section, results on precision and robustness obtained by different algorithms are displayed. Here the precision refers to the accuracy of the eigenvalues of computed $A_c=A+BF$, compared with the prescribed poles in $\mathfrak{L}$. Precisely, we list \[ precs=\left\lfloor\min_{1\le j\le n}(-\log(|\frac{\lambda_j-\hat{\lambda}_j}{\lambda_j}|)) \right\rfloor, \] where $\hat{\lambda}_j, j=1, \ldots, n$ are eigenvalues of computed $A_c=A+BF$. Larger values of $precs$ indicate more accurate computed eigenvalues. The robustness is, however, more complicated, since different measures of robustness are used in these algorithms. Specifically, let the spectral decomposition and the real Schur decomposition of $A+BF$ respectively be \[ A+BF=X\Lambda X^{-1},\qquad A+BF=UTU^\top, \] where $\Lambda$ is a diagonal matrix whose diagonal elements are those in $\mathfrak{L}$, $U$ is orthogonal, and $T$ is the real Schur form. The MATLAB function \textbf{place} tends to minimize $\|X^{-1}\|_F$ and \textbf{robpole} aims to maximum $|\det(X)|$. Both measures are closely related to the condition number $\kappa_F(X)=\|X\|_F\|X^{-1}\|_F$. While different versions of \textbf{SCHUR} \cite{Chu2} and our \textbf{Schur-rob} try to minimize the departure from normality of $A_c=A+BF$. Hence, in the following tests, we adopt the following two measures of robustness: the departure from normality of $A_c$ (denoted as ``dep.") and the condition number of $X$ (denoted as $``\kappa_F(X)"$) \begin{Example}{\rm~ Let \begin{align*} \begin{array}{ll} A=\begin{bmatrix}1&0&0\\ 0&I_{n-2}&0\\0& 0.5\times e^\top& 0.5 \end{bmatrix}, & B=\begin{bmatrix}I_{n-1}\\0\end{bmatrix}, \\ \mathfrak{L}=\{ randn(1, n-2), \ 0.5+ki,\ 0.5-ki\}, \end{array} \end{align*} where $e^\top$ is the row vector with its all entries being $1$, ``$randn(1, n-2)$" is a row vector of dimension $n-2$, generated by the MATLAB function \textbf{randn}. We set $k$ as $1e+1, 1e+2, 1e+3, 1e+4, 1e+5$, and apply the four algorithms \textbf{SCHUR}, \textbf{SCHUR-D}, \textbf{O-SCHUR} and \textbf{Schur-rob} on these examples, where ``\textbf{SCHUR-D}" denotes the algorithm combining the $D_k$ varying strategy in \cite{Chu2} with \textbf{SCHUR}. In \cite{Chu2}, the author points out that minimizing the departure from normality via the $D_k$ varying technique can be achieved by optimizing the condition number of $X^\top X$ or $X$, which actually is hard to realize. So here, the numerical results associated with ``\textbf{SCHUR-D}" are obtained by taking many different vectors from the null space of $(6)$ in \cite{Chu2}, which lead to orthogonal columns in $X$ when placing complex conjugate poles, and adopting the one owning the minimal departure from normality as the solution to the {\bf SFRPA}. All numerical results are summarized in Table~\ref{table_add}, which shows that our algorithm outperforms \textbf{SCHUR} and \textbf{O-SCHUR} on these examples with complex conjugate poles to be assigned. \tabcolsep 0.0001in \begin{table} \centering \begin{tabular}{c|c|c|c|c|c|c|c|c} \Xhline{2pt} \multirow{2}*{$(n,k)$} & \multicolumn{4}{c|}{$dep.$}&\multicolumn{4}{c}{$precs$} \\ \Xcline{2-9}{0.1pt} & \textbf{SCHUR} & \textbf{SCHUR-D}& \textbf{O-SCHUR}&\textbf{Schur-rob} & \textbf{SCHUR} & \textbf{SCHUR-D}&\textbf{O-SCHUR}&\textbf{Schur-rob} \\ \Xhline{1pt} (4, 1e+1)&9.5e+1& 2.2e+1 &4.3e+1 & 2.7e+0 & 14&14 & 14&15\\ (4, 1e+2)&1.5e+4 &8.2e+2 & 1.4e+4& 3.3e+2 & 11& 13&11 & 14\\ (4, 1e+3)&1.4e+6& 6.6e+4 &1.2e+6 & 6.6e+2&7&8 &7 & 10\\ (4, 1e+4)&2.9e+8&9.9e+5 &4.3e+7&1.0e+4 &4& 10&6 &13 \\ (4, 1e+5)&1.8e+10&7.3e+6 &1.2e+10 &3.8e+5 & 3& 7 &3 & 10\\ \Xhline{1pt} (20,1e+1)&4.0e+1& 7.6e+0&1.7e+1 &4.6e+0 & 13&14&14 &14 \\ (20,1e+2)& 7.7e+4& 2.6e+2&2.4e+2&1.8e+1 & 9 &12&11 &12 \\ (20,1e+3)&2.0e+5&4.4e+3& 9.3e+4&4.7e+2 &9& 11&10&12 \\ (20,1e+4)&3.2e+7& 2.4e+4&5.2e+6 &1.9e+3 & 6&10& 8& 11 \\ (20,1e+5)&1.7e+9& 1.2e+6&8.8e+8 &6.0e+4 & 3&9&6 &10\\ \Xhline{1pt} (50,1e+1)& 1.1e+1& 2.9e+0&4.4e+0 &4.4e+0 & 13& 12 &13 &13 \\ (50,1e+2)& 2.0e+4& 5.9e+2&8.8e+2 &1.8e+1 & 10& 12 & 11 & 12 \\ (50,1e+3)& 1.1e+6& 7.8e+2&5.8e+4 &5.5e+2 & 8 &11& 9 &12 \\ (50,1e+4)& 8.8e+7&3.2e+4&9.6e+6 &2.1e+3 & 6 &10&7 & 11 \\ (50,1e+5)& 8.4e+9& 2.0e+5&4.8e+8 &3.7e+4 & 3& 9 & 5&10 \\ \Xhline{2pt} \end{tabular} \caption{Numerical results for Example 4.1} \label{table_add} \end{table} }\end{Example} We now compare our \textbf{Schur-rob}, \textbf{O-Schur-rob} algorithms with the MATLAB functions \textbf{place}, \textbf{robpole} and the \textbf{SCHUR}, \textbf{O-SCHUR} algorithms by applying them on some benchmark sets. The tested benchmark sets include eleven illustrated examples from \cite{BN}, ten multi-input CARE examples and nine multi-input DARE examples in benchmark collections \cite{AB, AB2}. All examples are numbered in the order as they appear in the references. \begin{Example}{\rm~ The first benchmark set includes eleven small examples from \cite{BN}. Applying the six algorithms on these examples, all algorithms produce comparable precisions of the assigned poles, which are greater than $10$, and we omit the results here. Table~\ref{table_1} lists two measures of robustness, i.e. $dep.$ and $\kappa_F(X)$, for five examples. The results are generally comparable. The remaining six examples are not displayed in the table, as the results of the six algorithms applying on these examples are quite similar. \tabcolsep 0.02in \begin{table} \centering \begin{tabular}{c|c|c|c|c|c|c} \Xhline{2pt} \multicolumn{2}{c|}{$num.$} & 5 & 7& 8& 9& 11\\ \Xcline{1-7}{1pt} \multirow{6}*{$dep.$}&\textbf{place}& 7.4e-1 &3.5e+0 &1.3e+1 &1.2e+1 & 2.5e-3 \\ & \textbf{robpole} &7.4e-1 & 3.4e+0&5.0e+0 &1.2e+1 & 3.6e-1 \\ & \textbf{SCHUR} & 7.2e-1&7.2e+0 &7.0e+0 &1.9e+1 & 2.3e+0 \\ & \textbf{O-SCHUR} & 7.1e-1& 4.8e+0& 6.0e+0&1.7e+1 & 6.0e-1 \\ & \textbf{Schur-rob} &7.2e-1 &3.7e+0 &7.5e+0 &1.8e+1 & 2.4e-1\\ & \textbf{O-Schur-rob} &7.1e-1 &3.2e+0 &3.3e+0 &1.1e+1 & 1.4e-1\\ \Xcline{1-7}{1pt} \multirow{6}*{$\kappa_F(X)$} &\textbf{place}& 1.5e+2& 1.2e+1&3.7e+1& 2.4e+1&4.0e+0 \\ & \textbf{robpole}&1.5e+2&1.2e+1& 6.2e+0&2.4e+1&4.1e+0\\ & \textbf{SCHUR} &2.7e+3&1.3e+2& 1.1e+1&5.6e+1&6.0e+0 \\ & \textbf{O-SCHUR} & 1.1e+3&4.5e+1&7.5e+0&5.5e+1&4.1e+0\\ & \textbf{Schur-rob} &1.9e+3&2.5e+1&1.2e+1&5.8e+1&4.1e+0\\ & \textbf{O-Schur-rob} &1.2e+3&2.2e+1&9.6e+0&3.3e+1&4.0e+0\\ \Xcline{1-7}{1pt} \Xhline{2pt} \end{tabular} \caption{Robustness of the closed-loop system for the examples from \cite{BN}} \label{table_1} \end{table} Now we apply the six algorithms on ten CARE and nine DARE examples from the SLICOT CARE/DARE benchmark collections \cite{AB, AB2}. Table~\ref{table_2} to Table~\ref{table_5} present the numerical results, respectively. The ``-"s in the first columns in Table~\ref{table_3} and Table~\ref{table_5} corresponding to \textbf{place}, \textbf{robpole}, \textbf{SCHUR} and \textbf{O-SCHUR} mean that all four algorithms fail to output a solution, since the multiplicity of some pole is greater than $m$. Note that the $``precs"$ in the last six columns associated with \textbf{SCHUR} and \textbf{O-SCHUR} in Table~\ref{table_2} and those in the third and eighth columns in Table~\ref{table_3} are also `` -"s, which suggest that there exists at least one eigenvalue of $A+BF$, which owns no relative accuracy compared with the assigned poles. From Table~\ref{table_2}, we know that the relative accuracy $``precs"$ of the poles in example $4$ and $5$ corresponding to \textbf{Schur-rob} and \textbf{O-Schur-rob} are lower than those produced by \textbf{place} and \textbf{robpole}. And the reason is that there are semi-simple eigenvalues in both examples. So how to dispose the issue that semi-simple eigenvalues can achieve higher relative accuracy deserves further exploration and we will treat it in a separate paper. For the sixth column in Table~\ref{table_2}, $``precs"$ from our algorithms are also smaller than those obtained from \textbf{place} and \textbf{robpole} for the existence of poles which are relatively badly separated from the imaginary axis. And this is a weakness of our algorithm. \begin{table} \begin{minipage}{0.5\textwidth} \centering \begin{tabular}{ccccccccccc} \Xhline{2pt} \multicolumn{10}{c}{ $precs$}\\ \Xhline{0.4pt} & $1$& $2$&$3$ & $4$& $5$ & $6$& $7$& $8$& $9$&$10$\\ \textbf{place}&14&14&11&11&11&9 &14&11& 13&11\\ \textbf{robpole}&14&14&12&13&12&11&14&14&13&10\\ \textbf{SCHUR}&12&13&9&6&-&-&-&-&-&-\\ \textbf{O-SCHUR}&14&16&10&7&-&-&-&-&-&-\\ \textbf{Schur-rob}&14&14&12&8&9&6&14&14&12&9\\ \textbf{O-Schur-rob}&15&15&13&8&9&6&14&14&12&9\\ \Xhline{2pt} \end{tabular} \caption{Accuracy for CARE examples} \label{table_2} \end{minipage} \begin{minipage}{0.5\textwidth} \centering \begin{tabular}{cccccccccc} \Xhline{2pt} \multicolumn{10}{c}{ $precs$}\\ \Xhline{0.4pt} & $1$& $2$&$3$ & $4$& $5$ & $6$& $7$& $8$& $9$\\ \textbf{place}&-&15&14& 14&7&11 &5& -& 13\\ \textbf{robpole}&-&15&14&14&7&11&1&-&13\\ \textbf{SCHUR}&-&1&-&14&7&8&1&-&12\\ \textbf{O-SCHUR}&-&1&-&14&8&9&2&-&15\\ \textbf{Schur-rob}&15&15&15&15&8&10&4&-&12\\ \textbf{O-Schur-rob}&15&15&15&15&8&10&4&-&13\\ \Xhline{2pt} \end{tabular} \caption{Accuracy for DARE examples} \label{table_3} \end{minipage \end{table} \tabcolsep 0.001in \begin{table} \centering \begin{tabular}{c|c|c|c|c|c|c|c|c|c|c|c} \Xhline{2pt} \multicolumn{2}{c|}{$num.$} & 1& 2& 3& 4& 5& 6 & 7& 8& 9& 10\\ \Xcline{1-12}{1pt} \multirow{5}*{$dep.$} &\textbf{place}&5.2e+0&3.0e-1&7.3e+2&1.5e+6&2.9e+6&2.3e+7&7.6e+0&2.2e+1&6.1e+0&4.9e+9 \\ & \textbf{robpole}& 5.2e+0&2.9e-1&5.7e+2& 7.5e+5&2.9e+6&2.3e+7&8.1e+0&2.0e+1& 6.0e+0&3.8e+9 \\ & \textbf{SCHUR} &8.4e+1& 7.2e+0&5.0e+2&1.7e+6&3.0e+9 &5.3e+7&6.2e+1& 8.9e+2&7.5e+0& 4.4e+17\\ & \textbf{O-SCHUR} &4.7e+1&2.6e+0& 3.8e+2& 8.0e+5&5.4e+8 &2.6e+7 &7.3e+0&1.7e+2&6.8e+0& 2.3e+17 \\ & \textbf{Schur-rob}&7.6e+0&3.0e-1& 1.4e+2&1.1e+5&7.3e+6&2.3e+7&7.5e+0&2.1e+1&8.4e+0&2.2e+10 \\ & \textbf{O-Schur-rob}&7.3e+0&2.6e-1& 1.4e+2&1.1e+5&2.5e+6&2.3e+7&6.8e+0&2.0e+1&6.8e+0&2.2e+10 \\ \Xcline{1-12}{1pt} \multirow{5}*{$\kappa_F(X)$} &\textbf{place}&7.4e+0&8.0e+0&4.3e+1&1.7e+15&8.5e+4&4.8e+6&1.6e+1&9.8e+1&1.5e+2&2.3e+6 \\ & \textbf{robpole} &7.3e+0&8.0e+0&4.2e+1&2.2e+7&8.9e+4&3.2e+6&1.6e+1&9.0e+1&1.4e+2& 2.3e+6\\ & \textbf{SCHUR} &2.2e+2&1.0e+1&1.7e+3&9.1e+9& 6.0e+11&4.0e+13 &3.5e+8& 6.1e+9&1.3e+9& 4.6e+13\\ & \textbf{O-SCHUR} &1.2e+2& 5.1e+1&2.1e+3&1.0e+9&2.4e+10 &1.2e+8&1.0e+8& 3.7e+9& 4.1e+9&5.7e+13\\ & \textbf{Schur-rob} &1.1e+1& 8.2e+0&9.2e+2&9.0e+7&2.0e+6&3.2e+8&3.3e+1&5.7e+2&6.5e+3&4.3e+6\\ & \textbf{O-Schur-rob} &1.0e+1&8.0e+0&9.1e+2&6.5e+7&1.3e+6&1.2e+8&2.8e+1&4.2e+2&3.4e+3&4.3e+6\\ \Xcline{1-12}{1pt} \Xhline{2pt} \end{tabular} \caption{Robustness of the closed-loop system matrix for ten CARE examples} \label{table_4} \end{table} \tabcolsep 0.02in \begin{table} \centering \begin{tabular}{c|c|c|c|c|c|c|c|c|c|c} \Xhline{2pt} \multicolumn{2}{c|}{$num.$} & 1& 2& 3& 4& 5& 6 & 7& 8& 9\\ \Xcline{1-11}{1pt} \multirow{5}*{$dep.$} &\textbf{place}&-&2.2e-1&3.9e-1&4.3e-1&1.7e+0&1.4e+0&2.3e+1&4.3e+7&8.9e+0 \\ & \textbf{robpole}&-&2.2e-1&3.9e-1&3.6e-1&1.7e+0&1.3e+0&1.8e+1&3.9e+12& 8.0e+0\\ & \textbf{SCHUR} &-&4.1e-1&1.1e+2&5.9e-1&1.8e+0&1.1e+1&3.2e+2&3.4e+2&1.1e+1\\ & \textbf{O-SCHUR} &-&3.3e-1&4.9e+1&4.1e-1&1.7e+0&1.1e+0& 1.7e+2&1.2e+1&8.0e+0 \\ & \textbf{Schur-rob}&1.0e-1&2.5e-1&1.3e+0&3.4e-1& 1.7e+0&2.0e+0&1.9e+1&9.8e+0&9.9e+0\\ & \textbf{O-Schur-rob}&1.0e-1&2.5e-1&1.3e+0&3.4e-1& 1.7e+0&1.2e+0&1.8e+1&9.4e+0&6.6e+0\\ \Xcline{1-11}{1pt} \multirow{5}*{$\kappa_F(X)$} &\textbf{place}&-&5.2e+0& 4.9e+0&5.4e+0&1.8e+1&1.3e+1&2.3e+8&9.2e+292&3.4e+2\\ & \textbf{robpole} &-&5.2e+0&5.0e+0&5.3e+0&1.8e+1&1.2e+1&2.9e+8&1.3e+308&3.0e+2\\ & \textbf{SCHUR} &-&4.0e+7&1.2e+9&5.7e+0& 1.8e+1&5.8e+3&1.9e+11&2.8e+295&4.7e+3\\ & \textbf{O-SCHUR} &-&3.3e+7&8.0e+8&5.4e+0&1.8e+1&1.7e+3&2.0e+11&3.3e+295&2.6e+3\\ & \textbf{Schur-rob} &7.1e+15&5.5e+0&5.6e+0&7.2e+0&1.8e+1&3.8e+1&1.7e+9&5.6e+292&2.2e+4\\ & \textbf{O-Schur-rob} &2.5e+15&5.5e+0&5.5e+0&7.2e+0&1.8e+1&3.8e+1&1.2e+9&5.6e+292&4.7e+3\\ \Xcline{1-11}{1pt} \Xhline{2pt} \end{tabular} \caption{Robustness of the closed-loop system matrix for nine DARE examples} \label{table_5} \end{table} }\end{Example} We now test the five methods \textbf{place}, \textbf{robpole}, \textbf{SCHUR}, \textbf{O-SCHUR} and \textbf{Schur-rob} on some random examples generated by the MATLAB function \textbf{randn}. \begin{Example}{\rm~ This test set includes $33$ examples where $n$ varies from 3 to 25 increased by 2, and $m$ is set to be $2, \lfloor\frac{n}{2}\rfloor, n-1$ for each $n$. The examples are generated as following. We first randomly generate the matrices $A, B$ and $F$ by the MATLAB function \textbf{randn}, and then get $\mathfrak{L}$ using the MATLAB function \textbf{eig}, that is, $\mathfrak{L}=eig(A+BF)$. We then apply the five algorithms on the $A,B$ and $\mathfrak{L}$ as input. Fig.~\ref{fig1} to Fig.~\ref{fig4}, respectively exhibit the departure from normality of the computed $A_c$, the condition number of the eigenvector matrix $X$, the relative accuracy of the poles and the CPU time of the five algorithms applied on these randomly generated examples. In these figures, the $x$-axis represents the number of the $33$ different $(n,m)$. For example, $(3,2)$, $(5,2)$ and $(5,4)$ correspond to $1$, $2$ and $3$ in the $x$-axis, respectively. And the values along the $y$-axis are the mean values over 50 trials for a certain $(n,m)$. \begin{figure}[H] \centering \begin{tabular}{ccc} \begin{minipage}[t]{0.5\textwidth} \includegraphics[width=3.in,height=2.1in]{departure_five_methods.eps} \caption{$dep.$ over 50 trials}\label{fig1} \end{minipage}& \begin{minipage}[t]{0.5\textwidth} \includegraphics[width=3.in,height=2.1in]{condition_five_methods.eps} \caption{$\kappa_F(X)$ over 50 trials}\label{fig2} \end{minipage} \end{tabular} \end{figure} \begin{figure}[H] \centering \begin{tabular}{ccc} \begin{minipage}[t]{0.5\textwidth} \includegraphics[width=3.in,height=2.1in]{precision_five_methods.eps} \caption{$precs$ over 50 trials}\label{fig3} \end{minipage}& \begin{minipage}[t]{0.5\textwidth} \includegraphics[width=3.in,height=2.1in]{time_five_methods.eps} \caption{CPU time over 50 trials}\label{fig4} \end{minipage} \end{tabular} \end{figure} All these figures show that our \textbf{Schur-rob} algorithm can produce comparable or even better results as \textbf{place} and \textbf{robpole}, but with much less CPU time. }\end{Example} \section{Conclusion} Pole assignment problem for multi-input control is generally under-determined. And utilizing this freedom to make the closed-loop system matrix to be insensitive to perturbations as far as possible evokes the state-feedback robust pole assignment problem ({\bf SFRPA}) arising. Based on {\bf SCHUR} \cite{Chu2}, we propose a new direct method to solve the {\bf SFRPA}, which obtains the real Schur form of the closed-loop system matrix and tends to minimize its departure from normality via solving some standard eigen-problems. Many numerical examples show that our algorithm can produce comparable or even better results than existing methods, but with much less computational costs than the two classic methods \textbf{place} and \textbf{robpole}.

**Core tip:** Diabetes is a global burden that can have fatal consequences for human health and has a significant impact on healthcare system costs. Although effective treatments for type 2 diabetes have been developed, many patients have difficulty in achieving their therapeutic goals. Most of these problems are due to difficulties in patients reaching the relevant centers or the lack of care models. Telerehabilitation may be effective as part of the rehabilitation program in the home environment, especially for patients who are unable to participate in conventional center-based rehabilitation due to transport difficulties or work resumption. INTRODUCTION ============ Diabetes is a global burden, and can have fatal consequences on human health and a significant impact on healthcare system economics. Due to its high prevalence, diabetes has become a significant health problem worldwide. Diabetes is a metabolic disease that can cause severe complications and mortality if not treated effectively and quickly\[[@B1]\]. Diabetes is a complex disease in which self-management, training, regular monitoring, and multiple drug use are required to obtain an appropriate treatment outcome. Although an effective treatment for type 2 diabetes has been developed, many patients have difficulty in achieving their therapeutic goals. Most of these problems are due to challenges in patients reaching the relevant centers or the lack of care models\[[@B1]\]. Therefore, it has become necessary to develop new rehabilitation models and practices to cope with the changing needs of the population due to aging and lack of resources for public health. In addition to hospital rehabilitation practices in the acute phase of the disease, another challenge that has emerged in the modern healthcare system is the maintenance of health care outside the hospital, especially in type 2 diabetes\[[@B2]\]. Health care for diabetic patients includes innovative management strategies to improve disease control. Treatment models using technology can be effective in disease management\[[@B3]\]. Diabetes-related symptoms, co-morbidities, and complications may impair quality of life, affect mortality and lead to psychosocial problems. Consequently, these factors influence the exercise and physical capacity of patients. Patients show lower physical activity and reduced cardiorespiratory fitness than healthy individuals. Exercise therapy is thus essential for the management of type 2 diabetes\[[@B4]\]. Regular exercise training along with dietary approaches and pharmacological treatment is recommended to prevent or delay the symptoms and complications of diabetes\[[@B5]\]. Rehabilitation programs are safe and effective, with benefits including enhanced quality of life, increased functional exercise capacity, reduced hospital readmissions, and reduced mortality rate. Exercise programs performed generally consist of supervised and center-based programs\[[@B6]\]. Systematic reviews that have included exercise training in type 2 diabetes defined statistically and clinically significant improvements in blood glucose, HbA1c (8%-9%), lipid profile, and peak oxygen uptake (12%)\[[@B7],[@B8]\]. Furthermore, exercise capacity has been observed to be a strong predictor of all-cause mortality in type 2 diabetes\[[@B9]\]. Exercise-based rehabilitation in a hospital or rehabilitation center results in the best outcome as evidenced by scientific studies. Based on these obvious evidence-based benefits, rehabilitation is recommended by several associations\[[@B10]\]. Despite the various benefits of rehabilitation, attendance at such programs is low. The regularity of rehabilitation programs is the leading problem with high drop-out levels. There are several factors for suboptimal participation which include lack of time, availability, accessibility of a program, psychological barriers, and obligations at home or work. Therefore, new models are needed to increase participation rates, and long-term adherence to recommendations, as well as support new lifestyle change\[[@B11]\]. Telerehabilitation may be effective as a part of the rehabilitation program in the home environment, especially for patients unable to participate in conventional center-based rehabilitation due to transport difficulties or work resumption. The factors associated with suboptimal participation in rehabilitation at home are less prevalent. In telerehabilitation, patients are not limited to the hospital or rehabilitation center environment, hence they are able to perform the exercise program during their daily routine at home\[[@B12]\]. CO-MORBIDITIES AND COMPLICATIONS OF TYPE 2 DIABETES =================================================== Type 2 diabetes is a leading cause of severe morbidities and disabilities. Due to the presence of comorbidities and chronic conditions in addition to type 2 diabetes; diabetes-related healthcare, treatment options, care needs, and associated costs are complicated. In order to provide effective diabetes care, the increased burden of complex comorbidity, can affect treatment quality. Previous studies examining chronic conditions in patients with type 2 diabetes have found an association between an increasing number of comorbidities, increased rates of healthcare use and impaired physical function. It is also stated that patients with type 2 diabetes have more chronic diseases than the non-diabetic population\[[@B13]\]. The development of specific treatments for patients with complex comorbid disease has also gained importance in disease care. Clinical guidelines have recently significantly changed diabetes care with more evidence to provide effective treatment and reduce treatment variation. However, it remains unclear how to successfully define the main goals of interventions in complex comorbid patients. People with type 2 diabetes have a higher risk of cardiovascular complications, end-stage kidney disease and hypertension due to risk factors such as obesity, endothelial dysfunction, vascular inflammation and dyslipidemia. However, individuals with type 2 diabetes have also been shown to have a higher risk of depression, thyroid gland diseases, and chronic obstructive pulmonary disease. Important risk factors for type 2 diabetes are overweight or obesity, an unhealthy diet and physical inactivity, which accounts for approximately 80% of the increase in the prevalence of diabetes. In addition, these risk factors are modifiable risk factors. Physical inactivity alone is estimated to cause 7% of type 2 diabetes burden According to World Health Organization (WHO) reports, as physical activity decreases, non-communicable diseases increase. Diabetes is one of the four main non-communicable diseases along with cardiovascular diseases, cancer and respiratory diseases, and diabetes accounts for most of the burden of disease and early deaths\[[@B14]\]. A decrease in the level of physical activity is considered an urgent public health problem worldwide. In today\'s conditions, the most important causes of physical inactivity are environmental and systemic factors. As our living conditions begin to become sedentary, it becomes increasingly difficult to maintain adequate levels of physical activity\[[@B15]\]. Therefore, more effective disease control and behavioral approaches should be integrated into patients\' lives in order to reduce these comorbidities and complications. REHABILITATION METHODS FOR TYPE 2 DIABETES ========================================== Although drug treatments have been revealed to be effective in treating type 2 diabetes, these treatment approaches are often costly and can have side effects. On the other hand, adopting a healthy lifestyle has become one of the main approaches to relieve the burden of glucose and lipid metabolic disorders in combination with appropriate drug therapy\[[@B15]\]. Consequently, exercise can become a parallel therapy to traditional treatment programs and diet control or medications in patients with type 2 diabetes. Physical therapy and rehabilitation is the cornerstone of diabetes prevention and treatment. Individually developed exercise programs are clinically effective in patients with type 2 diabetes. Table [1](#T1){ref-type="table"} summarizes the major benefits of exercise in individuals with diabetes. Different modes of exercise in patients with type 2 diabetes are important due to their effects such as increased glucose uptake by muscles, improved usage, altered lipid levels, increased high-density lipoprotein and reduced triglyceride and total cholesterol. In individuals with type 2 diabetes, any type of physical activity which requires more muscle work than daily living activities can help lower blood glucose, as the vast majority involve the use of muscles during exercise\[[@B16]\]. ###### Major benefits of exercise in individuals with diabetes **Major benefits** --- -------------------------------------------------------- 1 Increases quality of life 2 Improves blood cholesterol profiles 3 Increases heart function 4 Decreases blood pressure 5 Improves insulin sensitivity and blood glucose control 6 Improves muscular strength 7 Improves gait and balance 8 Helps to lose weight Active and passive joint movement exercises, stretching techniques, strengthening exercises, and aerobic exercise training are some of the most effective physical therapy and rehabilitation techniques that can be used in patients with type 2 diabetes, such as inpatients, outpatients, and prediabetes\[[@B16]\]. Clinical studies in recent years have shown that the combination of both aerobic and resistance exercise training has a significant effect on glycemic control compared to aerobic exercise or resistance exercise alone\[[@B17]\]. Despite the benefits that can be achieved through rehabilitation, the majority of patients cannot participate in the exercise programs offered to them. Some refuse rehabilitation due to socio-demographic factors, others due to long-distance travel or working conditions. As a result, a large number of patients do not benefit from the advantages of rehabilitation programs. For ongoing effective diabetes management, long-term adherence to exercise is required; thus, to improve this adherence rate and solve this issue, new rehabilitation models are needed. Telerehabilitation therapy may be considered part of rehabilitation, as this globally increasing method of delivering healthcare services uses information and communication technologies. Thus, telerehabilitation may be more suitable to a patient's lifestyle and thereby increase the patient's self-management\[[@B18]\]. TELEREHABILITATION ================== The progression in communication facilities and computer-based technologies has led to innovative changes in health. In recent years, with the development of new computer science technologies and advanced telehealth devices, applications in the field of telehealth have been increasing. A review stated that telehealth promises to be a novel 21^st^ century tool in diabetes healthcare to improve quality and reduce the costs by enabling communication with patients\[[@B19]\]. The most encouraging applications in telehealth interventions include telerehabilitation, prevention and lifestyle interventions, chronic disease management (hypertension, diabetes, and heart failure), arrhythmia detection (early detection of atrial fibrillation), and telemonitoring of devices such as pacemakers\[[@B20]\]. In recent years, new telecommunications-based applications in rehabilitation are being developed in the field of medicine all over the world. These approaches are defined as telerehabilitation, which consists of a system controlling remote rehabilitation and should be considered a sub-field of telehealth\[[@B21]\]. "Telerehabilitation" is defined as the delivery of rehabilitation services *via* communication and information technology, including phone, internet, and video conference communications between the patient and the healthcare provider. Clinically, the term telerehabilitation covers a range of rehabilitation services, such as assessment, monitoring, intervention, supervision, education, and counseling\[[@B22]\]. Telerehabilitation is closely associated with and is mostly confused with telehealth or telemonitoring. "Telemonitoring" which is an automated process of data transmission regarding a patient's health status from home to the respective healthcare setting, has proven to be beneficial in patients with chronic diseases, including coronary heart disease, cystic fibrosis, and chronic obstructive pulmonary disease\[[@B23]-[@B26]\]. Telerehabilitation with telemonitoring and interactive health communication systems may benefit people with diabetes in a similar way. "Telehealth" is the use of medical information through electronic communication to improve patients' health status. Telehealth, which covers a broader definition of remote healthcare, does not always include clinical services. Telehealth enables remote communication technology and computer applications to transmit the physiological signals of patients at home, in the community, and institutions to the medical units for analysis and evaluation. Telehealth services include education, patient visit-control service, emergency treatment, and disease prevention. Additionally, it also allows the transmission of physiological signals such as blood pressure or sugar ratio to real-time healthcare providers. Therefore, telehealth aims to make patients independent of the management of their condition\[[@B27],[@B28]\]. According to the WHO, telehealth is the use of telecommunication and virtual technology to deliver healthcare outside traditional healthcare facilities. Well-designed telehealth programs can improve outcomes by facilitating access to healthcare, especially for chronic disease treatment and vulnerable groups. WHO also stated that it is effective in reducing the demand for crowded facilities and is cost saving\[[@B29]\]. The fundamental research on telerehabilitation has been based on a telephonic conversation for follow up and to administer self-assessment measures. Furthermore, telerehabilitation continued to progress in the 1980s with pre-recorded video materials\[[@B30]\]. In the 1990s, live interactive video conferencing was introduced. After the 1990s, due to the emerging needs of people and the rapid development of new communication and computer technologies, the number of articles and new technological support have increased\[[@B31]\]. In the following years, a virtual environment was introduced to healthcare as another technological method. This method allows users to interact with the computer-generated environment in real-time. It is also possible for health professionals to use it in places such as surgery, rehabilitation, education and training (Table [2](#T2){ref-type="table"}). In recent years, smartphones and the applications that can be used with them have revolutionized communication in the medical field. Today, there is a wide range of mobile applications for healthcare professionals, students, patients, and the general public\[[@B32]\]. Telerehabilitation also encourages patients to adopt a healthier lifestyle (smoking cessation, activity tracking) and in adhering to medication use by health information technology applications\[[@B20]\]. ###### Most promising applications of telerehabilitation **Chronic disease management** **Physical activity telemonitoring** ---------------------------------------- -------------------------------------- Prevention and lifestyle interventions Exercise training planning Smoking cessation Exercise training counseling Activity tracking Simultaneous exercise training Adhering to medication Exercise training follow up Telerehabilitation, which involves health services by using electronic communication systems, is an essential treatment option for improving sustainability in patient care and ensuring practicability. Telerehabilitation procedures can provide glycemic control, blood pressure, lipidemia, weight, diet, and complications monitoring as well as exercise awareness particularly in patients with type 2 diabetes, an essential step in disease management. Diabetes education provides interactive seminars, video conferences, and phone calls. During these conversations, patients are encouraged to exercise. Patients can also easily discuss exercises and rehabilitation programs with their physiotherapist. Telerehabilitation allows patients to take part in their treatment and thus adopt exercise by taking responsibility\[[@B6]\]. Using this technology in rehabilitation services is not only beneficial for the clinician but also for the patient. It promotes a sense of personal autonomy and empowerment by enabling active participation in disease management\[[@B33]\] (Table [3](#T3){ref-type="table"}). ###### Advantages of telerehabilitation **Advantages of telerehabilitation** --- ------------------------------------------------------- 1 Improves health service efficiency and processes 2 Improves healthcare quality or effectiveness 3 Saves paperwork and saves time for caregivers 4 Reduces healthcare costs 5 Facilitates and extends access to economic care 6 Improves sustainability 7 Facilitates long-term home care for patients 8 Promotes a sense of personal autonomy in participants Another advantage of telerehabilitation is providing care to inpatients and transferring them home after the acute phase of a disease, therefore, reducing hospital stay and costs for both patients and healthcare providers. These new approaches allow treatment of the acute phase of the disease by overcoming the requirement of a traditional face-to-face inpatient rehabilitation interaction approach. This includes, in particular, patients\' challenges to access traditional rehabilitation infrastructures distant from their homes. Telerehabilitation can never replace face-to-face consultations, but aims to reduce travel and accommodation costs, waiting times and stress on the patient, the patient's family members and caregivers by combining appropriate treatment methods tailored for the patient. Based on all these effects the goal of the telerehabilitation program is to encourage patients with chronic diseases to adopt active behavior and continuously receive medical supervision, thereby enhancing the healthcare behavior of patients. On the other hand, patients can encounter some participation problems and difficulties while using such telecommunication applications. A study investigating the predictive effect of depression and anxiety on patients' willingness to participate in a trial comparing telerehabilitation *vs* center-based cardiac rehabilitation concluded that despite the proven effectiveness of telerehabilitation, several factors influence the willingness to participate in telerehabilitation. It was demonstrated that patients with symptoms of depression are less willing to participate in telerehabilitation\[[@B34]\]. According to a study that evaluated the use of telehealth in diabetic patients\[[@B26]\], the greatest difficulties in using the monitoring systems were operational problems and equipment quality. The same study also evaluated the satisfaction of participants in telehealth using a questionnaire, which indicated that most participants were satisfied with the equipment but expected additional assistance with its operation. After the 3-mo study period, it was concluded that the program was beneficial in increasing HbA1c control. TELEREHABILITATION IN TYPE 2 DIABETES ===================================== In the last decade, the feasibility and effectiveness of telehealth strategies in the treatment of diabetes patients have been discussed in several studies\[[@B3]\]. The applicability of telehealth methods has been proven; however, due to the incidence of inconsistency between the results in different studies, the actual effect of these applications in specific and general clinical situations is not yet known\[[@B35],[@B36]\]. With its proven clinical benefits, its use in clinical practice can become widespread and help reduce the burden of the disease\[[@B3]\]. In addition, there have been many telerehabilitation studies on the musculoskeletal system, neurologic, cardiopulmonary, and orthopedic diseases\[[@B37]-[@B40]\], but there have been few telerehabili-tation studies in type 2 diabetes. In diabetes-related telehealth applications, many systems such as computers, analog telephones, network systems, cell phones, video-conference systems, satellite technologies, and electrocardiography transmission devices are used. Previous telehealth studies in type 2 diabetes observed glycemic control, complications, and quality of life in diabetic patients. These studies indicated that telehealth applications can increase glycemic control and quality of life as well as reduce HbA1c values\[[@B41]-[@B46]\]. In a literature review of studies, only our study conducted in 2019 was found to use telerehabilitation methods in type 2 diabetes\[[@B6]\]. Earlier studies were conducted with exercise training or physical activity alone, and several studies have referred to telehealth practices, including exercise, counseling or other management strategies\[[@B47]-[@B49]\]. The only telerehabilitation study\[[@B6]\] conducted in type 2 diabetes mellitus patients was a double-blind, randomized, controlled trial. The participants in the telerehabilitation group performed breathing and callisthenic exercises, three times a week for six weeks, at home by internet-based video conferences under the supervision of a physiotherapist. To precept the exercises, only the first session of the training was performed at the clinic. The patients measured their heart rate, SpO2 with a pulse oximeter as well as blood pressure themselves during all exercises for safety after the initial intervention by the physiotherapist. At the end of the study period, the telerehabilitation intervention was found to be effective in improving exercise capacity, physical fitness, muscle strength, psychosocial status, and controlling HbA1c levels. Compliance with the intervention was excellent and the telerehabilitation interventions were found to be safe and practicable, which could be an alternative treatment model for type 2 diabetes management. Another study that included exercise, counseling, or management strategies\[[@B47]\] consisted of a program designed to be delivered *via* the internet to improve the participants' diabetes self-management behaviors using behavioral and motivational strategies. Additional strategies included instructions on disease management, diet, and exercise, and the introduction to interventions to deal with the physical and emotional demands of the disease. The interaction between the caregivers and participants included both synchronous (instant messaging and chat) and asynchronous communication (e-mail and bulletin board) methods. The participants also accessed a website to enter their blood sugar readings, exercise programs, weight changes, blood pressure, and medication data. The study caregiver followed participants' logs to monitor changes in their self-management patterns. The study concluded that the participants who received a 6-month diabetes web-based intervention improved their HbA1c, systolic blood pressure, weight, high density lipoprotein, and total cholesterol levels compared to the control group. Glasgow et al\[[@B48]\] included exercise, counseling, or management strategies and evaluated minimal and moderate support versions of internet-based diabetes combined (internet and automated telephone) self-management programs in adults with type 2 diabetes. The internet-based intervention resulted in a greater improvement, compared with the usual care condition, on three of four behavioral outcomes (healthy eating, fat intake, and physical activity). They concluded that more frequent, longer-term, or more personal support might be needed to improve the results of an effective internet-based behavioral change intervention. Marios et al\[[@B49]\] conducted a study that included exercise, counseling, or management strategies. They used telemonitoring to improve exercise adherence, which assessed the number of hours of exercise completed, as well as peak VO~2~, HbA1c and quality of life in a six-month unsupervised, home-based exercise program in people with type 2 diabetes. Cost analysis was also conducted. The exercise group was instructed to record their heart rates during exercise using a monitor and received weekly telephone calls from a physiologist. Although telemonitored patients completed more hours of exercise and demonstrated improved peak VO~2~ compared to controls, they neither improved HbA1c nor quality of life. The exercise volume was also insufficient to improve glycemic control. They concluded that telemonitoring has the potential to enable people with diabetes to meet exercise training guidelines. A systematic review\[[@B2]\] that assessed the quality and the evidence of telerehabilitation and included 10 studies, which was conducted in patients with chronic or long-term conditions and neurologic disorders, suggested that the number of telerehabilitation experiences worldwide is growing. However, evidence of its clinical and economic effectiveness is still insufficient, particularly in routine care. Moreover, these systematic reviews have been interpreted based on a lack of methodological rigor and diversity of approaches used in the studies. There is some evidence concerning users' acceptance and satisfaction, and overall feasibility related to the discipline. However, there is insufficient evidence to state that telerehabilitation is a cost-saving or cost-effective approach, although its potential has been highlighted scientifically. CONCLUSION ========== Technology-based rehabilitation applications are developing rapidly and becoming an essential component of medical care. Therefore, using these new techniques, it is necessary to continue to focus on the individual needs of the patient. Although the telerehabilitation interventions in type 2 diabetes are less well-defined, initial results of small studies are highly favorable. With more extensive, multi-centered randomized controlled studies, clinical guidelines could ultimately improve patient outcomes. However, additional research is needed to interpret long-term outcomes, as well as to enhance effectiveness and cost-effectiveness. Conflict-of-interest statement: The authors declare no conflicts of interest related to this article. Manuscript source: Invited manuscript Peer-review started: January 9, 2020 First decision: February 25, 2020 Article in press: April 18, 2020 Specialty type: Endocrinology and metabolism Country/Territory of origin: Turkey Peer-review report's scientific quality classification Grade A (Excellent): 0 Grade B (Very good): B Grade C (Good): C Grade D (Fair): 0 Grade E (Poor): 0 P-Reviewer: Amiri M, Xie ZJ S-Editor: Zhang L L-Editor: Webster JR E-Editor: Ma YJ [^1]: Author contributions: Duruturk N wrote the paper. Corresponding author: Neslihan Duruturk, PhD, Associate Professor, Physiotherapist, Department of Physiotherapy and Rehabilitation, Baskent University, Faculty of Health Sciences, Ankara 06810, Turkey. <nalkan@baskent.edu.tr>

Background ========== In order to understand cell functioning as a whole, it is necessary to describe, at the molecular level, how gene products interact with each other. This could help to identify new target genes and to design new drugs for treatment of several diseases \[[@B1]-[@B3]\]. Due to the high number of genes involved in these networks, activating or suppressing feedback loops, the dynamics of their interactions is very complex and difficult to infer. With the development of high-throughput technologies, such as DNA microarrays, it is possible to simultaneously analyze the expression of up to thousands of genes and to construct gene networks based on inferences over gene expression data. Several methods to model genetic networks were proposed in the last few years, such as the Bayesian networks \[[@B4]-[@B8]\], Structural Equation Models \[[@B9]\], Probabilistic Boolean Networks \[[@B10]-[@B12]\], Graphical Gaussian Models \[[@B13]\], Fuzzy controls \[[@B14]\], and Differential Equations \[[@B15]\]. Although these methods allow modeling several regulatory networks for which biological information is available, it is difficult to determine the flow of information when there is no *a priori*knowledge. In addition, all of these methods face the same problem, i.e., the number of samples (microarrays) is very small, when compared to the high number of variables (genes) (ill posed problems, related to the \"curse of dimensionality\") \[[@B16]\]. Therefore, it is difficult to infer large scale networks using traditional statistical methods, limiting this inference to only a few genes. As a consequence, modeling and simulating large networks becomes a field of intensive and challenging research. At this point, it is important to define what is considered a \"large\" network. We consider as \"large\" a network in which the number of genes is larger than the number of microarrays experiments, implying in a large number of parameters to be estimated. Some methods have been developed to overcome this problem. For example, Barrera *et al*. use mutual information for dimension reduction \[[@B17]\], with mutual information between genes being computed and then, the highest mutual informations selected. However, this approach is not founded on a statistical test, rendering it very difficult to interpret and identify the actual edges of the network. Therefore, the choice of the threshold parameter to determine whether there is or not a connection, becomes quite subjective. An alternative to model the large number of genes is to construct modules (clusters), where each module is composed by several genes, and then, to construct the module-module networks \[[@B18]-[@B20]\]. A limitation of these methods is that they still are not a gene-gene network, therefore, interpretation of the meaning of each module is difficult, varying with each cluster. Here we present the Sparse Vector Autoregressive model to approach these problems. This method was first applied, with success, in neurosciences, to estimate functional connectivity between several brain areas \[[@B21]\]. Here, we present the Sparse Vector Autoregressive model based on LASSO penalized regression for variable selection to reduce the dimensionality on large gene networks. In cases of multiple time series, a first approach to infer connectivity would be to apply techniques such as multivariate autoregressive modeling (VAR), which allows identification of connectivity by combining graphical modeling methods with the concept of Granger causality \[[@B22]\]. This is an attractive approach since it does not require *a priori*network information. Unfortunately, the current time series methods can only be applied only for cases in which the length of the time-series *T*is much larger than *n*, the number of genes, which is exactly the reverse of the situation commonly found in microarray experiments, for which relatively short time-series are measured over tens of thousands of genes. The Sparse Vector AutoRegressive model (SVAR), on the other hand, estimates the network in a two-stage process involving (i) penalized regression with LASSO regression \[[@B23]\] and (ii) pruning of unlikely connections by means of the False Discovery Rate (FDR) developed by \[[@B24]\]. Extensive simulations were performed with artificial gene networks having scale-free like topologies \[[@B25]\] and stable dynamics. These simulations show that the detection efficiency of connections of the proposed procedure is quite high. An application of the method to actual HeLa cell line data was illustrated by the identification of well known transcription factor targets and circuitries involving important genes in cancer development. Results and discussion ====================== In order to measure the performance of SVAR, intensive simulations were carried out. For this purpose, we simulated hundreds of networks with scale-free like topology since the metabolic network was described as scale-free graphs by \[[@B25]\]. In our case, the graph nodes represent the genes whereas the edges represent the Granger-causal relationships. For details of these artificial regulatory networks, see the Methods section. The number of genes was kept at *n*= 100 and we varied the sample size, i.e., the time-series length (time-series length *T*= 25, 50, 75, 100, 125, 150, 175 and 200 for SVAR and *T*= 110, 125, 150, 175 and 200 for VAR). Notice that, for VAR of order one, *m*= *T*- 1 must be larger than *n*. For each time-series length, we performed 100 simulations, i.e., 100 different scale-free like graphs were generated. The starting conditions of the scale-free like graphs were two fully connected genes (*z*~0~= 2, *z*~*edges*~= 2, where *z*~0~is the initial number of genes and *z*~*edges*~is the initial number of edges), in other words, two nodes with two edges, one pointing to the other. The number of edges added at each iteration is *z*= 1, therefore, each network is composed by 100 genes and 100 edges out of 10,000 possible edges (the maximum number of possible edges is *n*^2^). Notice that since the goal is to construct a network with *n*= 100 genes, we set the number of iterations *T*~*step*~= *n*- *z*~0~= 98. In Figure [1](#F1){ref-type="fig"}, an example of the artificially generated gene expression regulatory network is illustrated. {#F1} It is important to highlight that SVAR was able to identify true positive edges even when the time-series length was lower than the number of genes. Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} show, respectively, the number of true positives inferred by SVAR and VAR for controlled false positives rate, i.e., q-value (error type I rate within rejected hypotheses) thresholds lower than 0.01, 0.05 and 0.10. Since the estimated *β*\'s standard error is proportional to the time series\' length (the greater the time series, the lower is the *β*\'s standard error) we varied only the time series\' length. {#F2} {#F3} {#F4} Analyzing figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}, we obtained the following results: 1\. The capacity of SVAR to identify true positives even when the number of samples is lower than the number of genes is satisfactory. This was found when comparing the performance between SVAR, with the time-series length equal to 50, and VAR, with time-series length equal to 110. Also, in this case, SVAR has identified more true positive edges than VAR (the proportion of the quantity of true positives inferred by SVAR is about 75% higher than the number of true positives inferred by VAR). 2\. By comparing SVAR and VAR when the number of genes is lower than the number of samples, in general, SVAR is slightly more powerful than VAR, since the number of connectivities is larger than the number of samples. 3\. When *m*≫ *n*, where *m*= *T*- 1 and *n*is the number of genes, there is no statistical difference between SVAR and VAR. This could be explained, in this context, because the best *λ*which minimizes the GCV (Generalized Cross-Validation) is near to zero. When *λ*= 0, the SVAR model becomes the traditional VAR model. We have also analyzed the expression profile of a set of 94 cell cycle-regulating genes represented by 48 microarrays, i.e., the number of genes *n*is approximately 2 times larger than the time-series length *T*. Figure [5](#F5){ref-type="fig"} shows the genes that display any connectivity under a false-positive rate (FDR) of 5% (q-value \< 0.05). Genes with no connectivity were excluded. {#F5} The SVAR method reveals at least three gene regulatory networks related to cell transformation and tumor progression, namely: NF*κ*B, p53, and STAT3 transcriptional modules \[[@B26]-[@B28]\], which is in agreement with already well known cell cycle-regulated pathways in several cellular models and in Hela cells themselves. It is important to highlight that the out-degree (number of edges with the gene as their initial vertex) of genes encoding proteins that act as well-known transcriptional factors (p53, NF*κ*B and STAT3) or important genes for cell proliferation control (*p21*, *bai1*, *tsp1*, *a20*) is higher than that of other genes. In a similar analysis, the in-degree (number of edges with the gene as their terminal vertex) of the FGFs (*fgf18*, *fgf20*, *fgfr4*) and of genes involved in cell cycle regulation and apoptosis (*cyclin d1*, *c-myc*, *bcl-2*, *noxa*, *fas*) is also higher, demonstrating the association between their key role in cell homeostasis and their in-degree and/or out-degree values \[[@B29]\]. NF*κ*B is an inducible transcription factor complex formed by heterodimeric association between *relA*and *c-rel*gene products, whose transcriptional activity is regulated by interaction with the inhibitory I*κ*B*α*protein. It has already been demonstrated that activation of NF*κ*B controls cell-cycle progression in HeLa cells by several mechanisms \[[@B30]\]. The SVAR method was not able to identify the relationship between NF*κ*B and its natural targets, such as *A20*, *iap*, *bclx*and *iκBα*genes. However, SVAR is showing that NF*κ*B directly regulates several fibroblast growth factors (FGFs) and the c-Myc protein, which are key regulators of cell proliferation. Indeed, it is noticed that the majority of NF*κ*B transcriptional activity is mediated by interaction with FGFs-related proteins, at the upstream and/or downstream levels. These results support the hypothesis that some of the multiple aspects of tumorigenesis in Hela cells may be related to NF*κ*B -mediated transcription of FGFs-related proteins. As discussed above, the positive NF*κ*B regulation of several well-known natural targets was not detected by SVAR. However, these regulatory processes appear to be present, even in the absence of an evident direct link with NF*κ*B, since all of these transcriptionally regulated genes form a highly related network (Figure [5](#F5){ref-type="fig"}). A20, a zinc finger protein, which is transcriptionally regulated by NF*κ*B in several cell types \[[@B31]\], appears to orchestrate the genes relationship in this network, activating the transcription of well-known anti-apoptotic genes, such as *iap*, *bclx*and *junB*-- NF*κ*B target genes themselves \[[@B32]-[@B34]\] -- towards transduction of the proliferative transcriptional activity of NF*κ*B. The A20 protein is also involved in NF*κ*B regulation, blocking its activity, in a negative feedback mechanism \[[@B35]\]. Although this control is operated at the post-transcriptional level, results obtained using the SVAR method suggest that this process could also be controlled by A20-mediated positive regulation of *iκBα*(Figure [5](#F5){ref-type="fig"}). These results confirm the reliability of SVAR for predicting gene relationship, since *iκBα*, the natural NF*κ*B inhibitor has a key role in controlling the NF*κ*B -regulated cell cycle events in Hela cells, as referred to in literature \[[@B30]\]. Moreover, SVAR showed that this role of *iκBα*in Hela cell cycle progression also appears to be regulated through p53-mediated activation of *iκBα*(Figure [5](#F5){ref-type="fig"}), in agreement with data reported in the literature \[[@B36]\]. In summary, these data support the hypothesis that *iκBα*may be involved in attenuation of tumor progression and be responsible for the mildly invasive phenotype displayed by Hela cells. The p53 protein is a transcription factor that binds to the enhancer/promoter elements of downstream target genes and regulating their transcription and initiating cellular programs that account for most of its tumor-suppressor functions, namely: cell cycle arrest, inhibition of angiogenesis and metastasis, apoptosis induction and DNA repair \[[@B37]\]. The SVAR method was capable of identifying the interactions of several members of the p53 network. IGF-BP3 (IGF-binding protein 3), an inhibitor of insulin-like growth factor, and NOXA, a BCL-2 homology domain 3-only (BH3-only) protein, are transcriptionally activated by p53 in activation of apoptosis in several cell types \[[@B38],[@B39]\]. Our *in silico*results showed that this regulation is also present in Hela cells. Although the *fas*gene is not a known target of p53, its activation could be mediated by other p53 targets, leading to increased apoptosis rate and cell proliferation control. On the other hand, SVAR showed that *bai-1*and *tsp-1*genes are induced by the *p53*gene product in Hela cells. It is known that the *bai-1*gene codes for a member of the secretin receptor family, which contains at least one functional p53-binding site within an intron, and its product is postulated to be an inhibitor of angiogenesis and a tumor growth suppressor \[[@B40]\]. Similarly, the *tsp-1*gene codes for an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions and has been shown to play a role in platelet aggregation, angiogenesis, and tumorigenesis \[[@B41]\]. Taken together, the p53-mediated upregulation of *bai-1*and *tsp-1*genes may be a mechanism to evade cell migration and angiogenesis, features which are commonly absent in Hela cells. We noticed that the classical p53 targets, such as *gadd45*and *p21*, do not appear to be directly regulated by p53 in the SVAR analysis (Figure [5](#F5){ref-type="fig"}). This may be explained by the fact that the time-series length is not large enough. It is important to note that our previous study applying DVAR (Dynamic Vector AutoRegressive) \[[@B42]\], it was possible to identify these connectivities. The observed p53-independent transcriptional regulation of the *p21*gene (Figure [5](#F5){ref-type="fig"}), appears to be unrelated to cell cycle arrest, as discussed below. The STAT3 protein is a member of the STAT protein family. In response to cytokines and growth factors, it forms both homo- or heterodimers with other STAT proteins and the complex translocates to the nucleus, where they act as transcriptional activators. STATs mediate the cell response to different stimuli, playing a key role in several cellular processes, such as cell growth and apoptosis \[[@B43]\]. As shown, using the SVAR method (Figure [5](#F5){ref-type="fig"}), STAT3 regulates the expression of the cycle positive regulator Cyclin D1 and of the anti-apoptotic protein Bcl-2. It has already been reported that constitutive activation of STAT 3 correlates with *cyclin d1*and *bcl-2*gene overexpression, thus providing a novel prognostic marker for head and neck squamous cell carcinoma \[[@B44]\]. Moreover, repression of *p53*gene expression by STAT3 is likely to have an important role in development of tumors \[[@B45]\]. These evidence point to an involvement of STAT3 in cell cycle progression and transformation of Hela cells. Our *in silico*analysis also highlighted an unexpected behavior for the *p21*gene, independently of p53 regulation. This alternative regulation has already been described for other cell types \[[@B46]\], but still remains unclear in the case of Hela cells. Although p21 is not a transcription factor, it is conceivable that indirect effects of p21 on cellular gene expression of well-known cell cycle progression promoters, such as Cyclin D1 and apoptosis inhibitors, such as Bcl-2 may mediate some unexpected functions in Hela cells. These functions appear to be unrelated to growth inhibition and cell cycle arrest, supporting the hypothesis that p53-independent regulation of p21 could be one of the signaling pathways activated during tumorogenesis and/or tumor progression in Hela cells as well as in other cancer types \[[@B47],[@B48]\]. Future efforts directed to evaluate this hypothesis include gene transfection of p21 mutants lacking the p53 and STAT3-binding sites and subsequent, analysis of the newly identified p21 targets gene expression and changes in Hela cells phenotype and tumorigenicity. It is interesting that, even using a small dataset, the SVAR method allowed identification of actual regulations, as detailed above, illustrating the power of this technique. In general, the methods reported in the literature are not based on a statistical test due to difficulties generated by the fact that the number of samples is lower than the number of parameters to be estimated, consequently, they do not provide an objective control for false-positives. The main advantage of the sparse vector autoregressive model (SVAR), compared with other connectivity models, is that it models a Granger-causal network with a number of genes that is larger than the number of samples, in other words, it is useful to model \"large\" networks with a statistical test for each one of the edges. To the best of our knowledge, the approach taken here is the only one that combines these two advantages since other methods which model \"large\" networks usually do not present statistical tests for the edges. Moreover, \"large\" gene-gene networks are commonly dealt with in pairwise comparisons. Using SVAR, it is possible to infer partial Granger-causalities resulting in a lower number of spurious edges than pairwise comparisons. Since SVAR deals with the multivariate case, the definition of Granger causality becomes complex, because of the existence of multi-steps connectivities. In the present report, identification of Granger causality using the SVAR model is related to the definition of partial Granger-causality given by \[[@B49]\]. By definition of Granger\'s causality \[[@B49]\] the SVAR model allows analysis of cycles containing networks. Therefore, there is no *a priori*assumption that the network must be a DAG (Directed Acyclic Graph), as assumed by other methods \[[@B5],[@B9]\]. As a consequence, the SVAR method can be used to model networks with cycles. This is of extreme importance, since it is well-known that genetic regulatory networks maintain their control and balance by a number of positive/negative feedback cycles. There is a class of Bayesian network with MCMC algorithm which may integrate expression data with multiple sources of information \[[@B8]\]. The advantages of integrating multiple sources of information, i.e., adding *a priori*knowledge, is speculative. Integration of *a priori*knowledge maybe interesting to recover more realistic connections and to increase the power of the test. However, it also lead to a bias depending on the kind of information assumed in the model. In this actual stage of development of SVAR, integration of different information is not possible since only gene expression levels are used to estimate Granger causality. Further studies may be focused on integrating biological information to improve the power of SVAR. The experimental comparison between SVAR and other methods is difficult since SVAR is the only one which has a statistical test for gene-gene networks comprising a notion of Granger-causality. The Graphical Gaussian Models reported by Schäfer and Strimmer, which apply partial correlations in the context of (*n \> m*) is the closest one to SVAR, presenting a statistical test, however, the edges obtained by this approach represent instantaneous associations (correlations), failing to provide a notion of Granger-causality, i.e., the edges have no direction. Differently from score functions, which pose difficult interpretations or subjective choices of the threshold to determine where there is (or not) an edge, a statistical test is an objective way to determine whether there is an edge and what is the rate of type I error. In this work, we considered only lags of first order, but it is relatively straightforward to generalize this method to analyze SVAR models with orders higher than one. However, this issue depends on the number of parameters to be estimated and the time series length. The complexity of the proposed inference is linear to the number of genes, since only one regression is performed for each gene. There are other approaches for variable selection based on stepwise methods. Unfortunately, these methods are not consistent when *n \> m*\[[@B50]\], i.e., even increasing the sample size (*T*→ ∞), there is no guarantee that the set of non-zero coefficients is the correct one. This result does not change even if all subsets of variables are explored. In contrast to LASSO, one may choose to use other penalized regressions, such as the more popular Ridge \[[@B51]\] or the non-negative Garrote \[[@B52]\]. Ridge does not set the variables to zero, resulting in models with difficult interpretations. Comparing LASSO to non-negative Garrote, the latter is worse than LASSO when multicolinearity is present in the data \[[@B23]\]. Therefore, LASSO seems to be the most appropriate in identifying gene regulatory networks. Another advantage of SVAR is the fact that it does not require model pre-specification; therefore, this method is unbiased and makes it possible to infer new connections, not just quantifying the dependence level measured by already known edges. Furthermore, it is not necessary to discretize gene expression values to Boolean variables, as in the Boolean network models \[[@B17]\]; therefore, there is no loss of information. In the SVAR approach, to render the application of statistics when (*n \> m*) feasible, we used the fact that the metabolic networks are sparsely connected as part of the solution. Therefore, the number of variables to be analyzed decreases significantly, resulting only in variables whose estimated coefficients are large enough to be tested and rejected as being different from zero. Conclusion ========== In summary, here we introduce the SVAR method to model gene regulatory networks in the present context, where the number of samples is often lower than the number of genes. With this method, it is possible to naturally model networks with feedback loops and to infer partial Granger causalities without any *a priori*information, which minimizes the number of spurious causalities. Moreover, we present a statistical test to control for the false discovery rate, a task which was not previously possible in several other proposed gene regulatory network models. Methods ======= Firstly, we describe the classical vector autoregressive model (VAR) and, then, we explore the feasibility of using LASSO regression as part of a technique for variable selection, by introducing the sparse vector autoregressive model (SVAR). The statistical test for the edges is also presented followed by the control of the false positives. To simplify the description of these methods, we describe both the SVAR and the VAR of order one, but they could easily be generalized to higher orders. After this description, we present the algorithm to construct artificial regulatory networks based on scale-free topology, since metabolic networks were described to have power-law distributions in the nodes\' degrees \[[@B25]\]. We use this artificial network to evaluate the performance of our proposed model. Finally, the SVAR model is applied to actual biological data. Statistical background ---------------------- Granger (1969) \[[@B53]\] defined a concept of causality, which is easy to deal with in the context of VAR models; therefore, it has become quite popular in recent years \[[@B54]\]. The idea is that a cause cannot come after the effect. Thus, in the case of VAR(1) (VAR of order one) \[[@B54]\], if a gene *i*at time (*t*- 1) affects another gene *j*at time *t*, the former should help to predict the target gene expression. A first order VAR model is described as shown: where *T*is the time-series\' length (number of microarrays) *y*~*t*~is an *n*× 1 vector of gene expression (where *n*is the number of genes), the normally distributed disturbance *ε*~*t*~is an *n*× 1 vector with mean zero and covariance matrix Ω, and *A*~1~is an *n*× *n*matrix of parameters (connectivities). The disturbances *ε*~*t*~are serially uncorrelated, but may be contemporaneously correlated. Thus $E(\varepsilon_{t}{\varepsilon^{\prime}}_{t})$ = Ω, where Ω is an *n*× *n*matrix. It is important to highlight that, in this multivariate model, each gene may depend not only on its own past values, but, also, on the past values of the other genes. Thus if *y*~*it*~denotes the *i*th element in *y*~*t*~, the *i*th row yields This model can be estimated by Ordinary Least Squares (OLS), simply by regressing each variable on the lags of itself and the other variables. Therefore, we can re-write it as where *E*~*i*~follows a multivariate Gaussian distribution *N*(0, Ω), with zero mean 0~(*n*×1)~and covariance matrix Ω. We define *m*= *T*- 1 and introduce the notation: $$\beta_{(n \times n)} = {A^{\prime}}_{1} = \lbrack\beta_{1},...,\beta_{n}\rbrack,$$ The explicit solution of the OLS estimator is Therefore, one can carry out separate regression analyses for each gene. In other words, it is possible to separately estimate each column *β*~*i*~of *β*: $$\begin{matrix} {{\hat{\beta}}_{i} = {(X^{\prime}X)}^{- 1}X^{\prime}z_{i}} & {i = 1,...,n} \\ \end{matrix}$$ where *z*~*i*~is the *i*-th column of *Z*. In order to specify the distribution of the *j*-th element of $\hat{\beta}$, let us denote the *j*-th diagonal element of (*X\'X*)^-1^by *w*~*jj*~. Then, we may assert the statistical test as $$\begin{matrix} {\frac{{\hat{\beta}}_{ij}}{\sqrt{{\hat{\sigma}}^{2}w_{jj}}} \sim t(m - n)} & {i = 1,...,n} \\ \end{matrix}$$ under the null hypothesis, where *t*(*m*- *n*) denotes a *t*distribution of (*m*- *n*) degrees of freedom and $${\hat{\sigma}}^{2} = \frac{1}{m - n}(Z - X\hat{\beta})^{\prime}(Z - X\hat{\beta}) = \frac{E^{\prime}E}{m - n}$$ It is to point out that these definitions will work only if *m*\> *n*. Additionally, it is also well known that OLS does not ensure sparse connectivity patterns for *A*. To overcome these problems, in the next section, we introduce the sparse vector autoregressive model. Sparse Vector AutoRegressive (SVAR) ----------------------------------- Consider *Z*, *β*, *X*and *E*as described above. According to \[[@B55]-[@B58]\], the LASSO (Least Absolute Shrinkage and Selection Operator) regression \[[@B23]\] can be carried out by iterative application of: $$\begin{matrix} {{\hat{\beta}}_{i}^{k + 1} = {(X^{\prime}X + \lambda^{2}D({\hat{\beta}}_{i}^{k}))}^{- 1}X^{\prime}z_{i}} & {i = 1,...,n\text{~and~}k = 1,...,N_{it}} \\ \end{matrix}$$ where *N*~*it*~is the number of iterations (we set *N*~*it*~= 30 to our analysis), *λ*is the regularization parameter which determines the amount of penalization enforced, $D({\hat{\beta}}_{i}^{k})$ is a diagonal matrix defined by $$\begin{matrix} {D(\theta) = diag({p^{\prime}}_{\lambda}(\theta)/\theta)} & {k = 1,...,n} \\ \end{matrix}$$ and $${p^{\prime}}_{\lambda}(\theta) = \lambda sign(\theta)$$ At each iteration, the regression coefficients of each gene with all others are weighted according to their current size and several coefficients are successively down-weighted and set to zero. The covariance matrix of the estimators may then be approximated by: $${(X^{\prime}X + \lambda^{2}D(\hat{\beta}))}^{- 1}X^{\prime}X{(X^{\prime}X + \lambda^{2}D(\hat{\beta}))}^{- 1}{\hat{\sigma}}^{2}$$ where *σ*^2^is an estimate of the error variance $${\hat{\sigma}}^{2} = \frac{1}{m - n - c}(Z - X\hat{\beta})^{\prime}(Z - X\hat{\beta}) = \frac{E^{\prime}E}{m - n - c}$$ and *c*is the number of variables *β*set to zero by LASSO regression. When ${\hat{\sigma}}^{2}$ replaces *σ*^2^, we get the result that the statistical test is $$\begin{matrix} {\left. \frac{\hat{\beta}}{\sqrt{{\hat{\sigma}}^{2}w_{jj}}} \right.\sim t(m - n - c)} & {i = 1,...,n} \\ \end{matrix}$$ under the null hypothesis, where *t*(*m*- *n*- *c*) denotes a *t*distribution of (*m*- *n*- *c*) degrees of freedom and *w*~*jj*~is the *j*-th diagonal element of $${(X^{\prime}X + \lambda^{2}D(\hat{\beta}))}^{- 1}X^{\prime}X{(X^{\prime}X + \lambda^{2}D(\hat{\beta}))}^{- 1}$$ It is important to emphasize that the number of variables set to zero in this method will depend on the value of the regularization parameter *λ*, with higher values implying on the selection of fewer variables. In our work, the value of the tuning parameter *λ*was selected as the value that minimizes the generalized cross validation criterion (GCV). Let *q*(*λ*) = *tr*{*X*(*X\'X*+ *λ*^2^*D*(*β*))^-1^*X\'*} and *rss*(*λ*) be the residual sum of squares for the constrained fit with constraint *λ*, the generalized cross-validation statistic can be written as: $$GCV = \frac{1}{m}\frac{rss(\lambda)}{\left\{ 1 - q(\lambda)/m \right\}^{2}}$$ The minimum value for GCV was achieved by the L-BFGS-B algorithm \[[@B59]\], which was implemented in the function *optim*of the R statistical environment. For more details on the statistical properties of LASSO in autoregressive models see \[[@B60]\]. Controlling the number of false-positives ----------------------------------------- To control the type I error in cases of multiple tests of hundreds of edges, we applied the FDR method \[[@B24]\]. Firstly, assume that of the *n*hypotheses tested $\left\{ H_{1}^{0},H_{2}^{0},...,H_{n}^{0} \right\}$, where $H_{j}^{0}$ is the null hypothesis of the *j*-th test and {*p*(1), *p*(2),\...,*p*(*n*)} their corresponding p-values, *n*~0~are the number of true null hypotheses and the other (*n*- *n*~0~) hypotheses are false. Let *p*(1) ≤ *p*(2) ≤ \... ≤ *p*(*n*) be the ordered observed p-values of each test. Define $$l - max\left\{ i:p(i) \leq \frac{i}{n}q \right\}$$ and reject $H_{(1)}^{0}...H_{(l)}^{0}$. If no such *i*exists, reject all null hypothesis. FDR is defined as the expected proportion (*q*) of incorrectly rejected null hypotheses (type I error) in a list of all rejected hypotheses. Artificial regulatory networks ------------------------------ The description that many networks in nature have a power-law degree distribution was first addressed by \[[@B61]\]. In their random graph model, called scale-free graph, it is described how these networks grow and expand, being based on two generic mechanisms, which are common to several networks in the real world. Several networks in the real world start from a small number of nodes and grow by continuous addition of new nodes, therefore, the number of nodes increases throughout the lifetime of the network. When a new node is added to the network, its attachment is preferential, i.e., the probability of a new node connects to the existing nodes is not uniform as in a random graph \[[@B62]\]. There is a higher probability to be linked to a node that already has a large number of connections, resulting in a power-law degree distribution. In other words, the probability *P*(*v*) that a node in the network is connected to *v*other nodes decays as a power-law. Therefore, the degree distribution has a power-law tail *P*(*v*) \~ *v*^-*γ*^, where *γ*is a scalar which represents the rate of decayment of the degree distribution. In our case, the nodes are representing the genes and the connections are the Granger-causal relationships. This scale-free graph can be constructed as below: 1\. Growth: Starting with a small number *z*~0~of genes, at each iteration, a new gene with *z*≤ (*z*~0~) edges are added. This new gene is connected to the genes already present in the network with a preferential attachment. 2\. Preferential attachment: The gene with which the new gene will connect is selected in a non-deterministic fashion. Assume that the probability *π*that a new gene will be connected to gene *i*depends on the degree *d*~*i*~of that gene which is already in the network. Therefore: $$\pi(d_{i}) = \frac{d_{i}}{\sum_{j}d_{j}}$$ Since we are interested in causal relationships, we need to define a direction for each edge. Therefore, there is a third step in our graph construction. In our simulations, the probability attributed to add an edge from *i*to *j*is the same from *j*to *i*, i.e., 0.5. After *T*~*step*~iterations, the constructed random scale-free like network is composed of *n*= *T*~*step*~+ *z*~0~genes and *z*\* *T*~*step*~+ *z*~*edges*~Granger-causal relationships, where *z*~*edges*~is the initial number of edges. The graph constructed using the algorithm described above may be represented by its adjacency matrix *A*, i.e., where there is an edge from gene *i*to gene *j*it was set to *A*\[*i, j*\] = 0.8, and 0 otherwise, in our simulations. This adjacency matrix *A*corresponds to the matrix *A*described in equation 1. The time-series\' lag was set to one in our simulations, therefore, set *m*= *T*- 1. To construct the corresponding time-series for each gene, firstly, generate normally distributed random numbers with zero mean and unit variance for each gene *i*= 1,\...,*n*for the time step *t*= 1, *y*~*i*1~= *ε*~*i*~. Then, use equation 2 to generate the time-series for each gene *i*= 1,\...,*n*, time step *t*= 2,\...,*T*. Implementation -------------- We implemented our program using R \[[@B63]\], a statistical computing environment. Computation was conducted under a Pentium IV CPU 3.06 GHz, 2.5 GB of RAM. Application to real data ------------------------ We applied the SVAR approach to HeLa cell cycle gene expression data collected by Whitfield *et al*. (2002) \[[@B64]\]. Gene expression was measured using microarrays manufactured in the Stanford Microarray Facility. The data used contain 48 time points distributed at one hour intervals with one reading at each time point, synchronized by double thymidine block (described as Experiment 3 in the web page \[[@B65]\]). The 94 genes were selected from actual biological microarray data on the basis of there association with cell cycle regulation and tumor development. The HeLa cell cycle lasts 16 hours. These data were downloaded from: \[[@B65]\]. Authors\' contributions ======================= AF has made substantial contributions to the conception and design of the study, analysis and interpretation of data. JRS has made substantial contributions to the analysis and interpretation of mathematical results. HMGM has made substantial contributions to the analysis and interpretation of biological data. AF, JRS and HMGM have been involved in drafting of the manuscript. RY and SM have discussed the mathematical results. MCS has discussed the biological results. CEF has directed the work. RY, SM, MCS and CEF critically revised the manuscript for important intellectual content. All authors read and approved the final manuscript. Acknowledgements ================ This research was supported by JICA, FAPESP, CAPES, CNPq, FINEP and PRP-USP.

Introduction {#s1} ============ *Paspalum dilatatum* Poir. (common name dallisgrass) is a highly productive C4 grass with a wide distribution within temperate-warm regions and a growing season from late spring to late summer. *P. dilatatum* belongs to the Panicoideae subfamily within the PACMAD clade (Panicoideae, Arundinoideae, Chloridoideae, Micrairoideae, Aristidoideae and Danthonioideae), which contains all C4 grasses. It is believed that the PACMAD clade separated from the lineage that generated the more widely studied Pooideae and Bambusoideae grasses some 40--50 million years ago (Mya) [@pone.0085050-Christin1]. Recently the C4 grasses have attracted considerable interest for bioenergy production and several of the key species under investigation (*Miscanthus giganteus*; *Panicum virgatum*; *Pennisetum purpuretum*) belong to the Paniceae clade and have probably diverged from the *P. dilatatum* clade by only c. 20 Mya. *P. dilatatum* is native to South America with special relevance to dairy and beef production [@pone.0085050-Clayton1], [@pone.0085050-Harlan1] as its forage quality is higher than that of other C4 forage grasses [@pone.0085050-Holt1], [@pone.0085050-Hutton1], [@pone.0085050-Robinson1], and it exhibits tolerance of frost [@pone.0085050-Hacker1], [@pone.0085050-Davies1] and water stress [@pone.0085050-Blom1], [@pone.0085050-Jackson1]. There are several sexual and apomictic cytotypes (4×, 5×, 6×, 7×) and also biotypes of *P. dilatatum* that have been identified due to their morphological and distributional differences [@pone.0085050-Vaio1]. The predominant biotype found has purple anthers and apomictic reproduction (2n = 50), which is widespread in South America and naturalised in other parts of the world including China, USA, India, Japan, New Zealand and South Africa [@pone.0085050-Hayman1]. The sexual biotypes are typically characterised by yellow anthers. The genome constitution of the different ploidy levels has been described as IIJJ for tetraploids and IIJJX for the more common pentaploid biotype [@pone.0085050-SouzaChies1], [@pone.0085050-Miz1]. The I genome has been identified in the diploid *P. intermedium* [@pone.0085050-Burson1], which is believed to be the progenitor of the original genome donor. Cytogenic and phylogenic studies suggest that the donor of the J genome is believed to be *P. juergensii* [@pone.0085050-Burson2]. The donor of the X genome is unknown, though the apomictic character is thought to have originated from this genome. The genome size has been estimated in different biotypes of *P. dilatatum*, with the tetraploid and pentaploid genome contents being 2.43 pg/2C and 2.96 pg/2C per nucleus, respectively [@pone.0085050-Vaio1]. *P. dilatatum* is likely to have more widespread use in livestock grazing systems under predicted climate change scenarios due to its superior drought tolerance and water use efficiency, in comparison to commonly-used C3 grasses. However, conventional breeding methods for improvement of *P. dilatatum* are commonly limited by its asexual reproduction system [@pone.0085050-Burton1]. In apomictic reproduction, seeds are produced without fertilisation, generating uniform progeny that are genetically identical to their parents, restricting the genetic variation available for conventional breeding programs. As a result of this apomictic character, large clonal monocultures are often maintained in production zones, potentially jeopardising the feed-base of the grazing industries if adverse biotic or abiotic pressures emerge. The common type of *P. dilatatum* (apomictic and pentaploid) has a documented susceptibility to *Claviceps paspali*, an ergot fungus, which is the causal agent of "*Paspalum* staggers" in cattle that graze infected pasture [@pone.0085050-Cole1]. To address these issues, advanced novel breeding strategies that employ genetic diversity must be developed and enabled to ensure the production of advanced cultivars to generate options for production systems. Previous efforts to improve dallisgrass through breeding include the use of somaclonal variation [@pone.0085050-Davies2], [@pone.0085050-Akashi1], [@pone.0085050-Burson3] and interspecific hybridisation [@pone.0085050-Burton2], [@pone.0085050-Benett1]. Advanced molecular breeding techniques may be applied to the sexual cytotype or potentially to hybrids produced with the apomictic biotypes as pollen donors or with other closely related *Paspalum* species. Molecular markers are a valuable tool to identify and quantify genetic diversity within and between species, populations and available germplasm. These genetic resources can also link genotypes with economically important traits and assist breeders with germplasm selection and potential crossing schemes [@pone.0085050-Gupta1]. Genomic and transcriptomic resources for *P. dilatatum* are limited to only 77 nucleotide and 37 protein sequences. More broadly in the genus *Paspalum* the number of nucleotide sequences that are available is only 3,472 (NCBI 05/11/2013). Therefore, there is a significant need to increase the genomic resources for this species. Recently, second generation sequencing technology has been applied in a wide variety of areas including whole genome resequencing and *de novo* sequencing; as well as transcriptome analysis [@pone.0085050-Zhou1]. The Roche 454 Life Sciences GS FLX sequencing platform has been widely used for transcriptomic studies in non-model organisms (a full list of publications is directly available from <http://454.com/publications/index.asp>) [@pone.0085050-Vera1], [@pone.0085050-Garg1], [@pone.0085050-Kaur1]. Complete genome sequences have been generated for only a few grasses, as despite the advances made, undertaking to produce a whole genome sequence of a higher plant is still a significant task that requires considerable resources. The genome sequences of particular interest when studying *Paspalum* species are *Sorghum bicolor* L. [@pone.0085050-Paterson1] and foxtail millet, *Setaria italica* [@pone.0085050-Zhang1]. Both of these species are likely to have diverged from the *Paspalum* clade c. 10 Mya and represent two highly relevant genomes for enhancing any generated data. These two related reference genomes could assist in sequence annotation of *P. dilatatum*. Due to the complexities of undertaking complete sequencing of genomes from higher plants, transcriptomic sequencing of *P. dilatatum* would generate an initial resource of gene sequences as well as identifying valuable molecular markers such as EST-Simple Sequence Repeats (SSRs) for molecular breeding to improve the productivity and quality of this forage species. The use of the second-generation sequencing technology is a cost-effective method to obtain large-scale EST sequences of non-model species. For the generation of a resource of largely full length sequences derived from transcriptomics, the longer read length of the GS FLX Titanium chemistry is ideally suited to generate such a data set. The GS FLX platform is the most widely used technology for the identification of SSR motifs and the development of molecular markers in plants [@pone.0085050-Zalapa1]. EST-derived simple sequence repeat (SSR) molecular markers have the advantage that by definition they are genic and therefore can be potentially associated with functional regions, avoiding the non-coding and repetitive DNA in species with large genomes. EST-based molecular markers might also be linked to genes controlling important agronomic traits that could assist breeding programs and have been used to improve crop species [@pone.0085050-Park1], [@pone.0085050-Hougaard1], [@pone.0085050-Zeng1]. Furthermore, due to their conserved location, EST-SSR can be transferable between related species [@pone.0085050-Zeng1]. A recent study has developed a cohort of 17 genomic SSR markers for *Paspalum atratum* Swallen and *Paspalum notatum* Flüggé. These SSRs were evaluated broadly across the Paspalum genus allowing species variability to be distinguished [@pone.0085050-Cidade1]. This study provides the first *de novo* assembly and annotation of a cDNA transcriptome dataset for *P. dilatatum*, derived from multiple tissues of a single plant at the reproductive stage of its life cycle. An extensive collection of EST-SSR molecular markers have subsequently been identified and a subset validated. This has generated a valuable resource of gene sequences and molecular markers for future breeding programs for this important forage species. Materials and Methods {#s2} ===================== Plant material and growth conditions {#s2a} ------------------------------------ *P. dilatatum* cv. Primo, a tetraploid sexually-reproductive cultivar and *P. dilatatum* cv. Relincho, a pentaploid apomictic cultivar, were kindly provided by Gustavo Schrauf (University of Buenos Aires, Argentina) and used as source plant material for all experiments. Individual plants were grown under glasshouse conditions (21°C, 14 h photoperiod/14°C, 10 h dark period). Plant tissues were harvested for RNA isolation from a single clone of *P. dilatatum* cv. Primo at the late reproductive stage, from leaves, stems, roots and mature inflorescences. RNA extraction and cDNA synthesis {#s2b} --------------------------------- Total RNA was isolated using RNeasy® Plant Mini Kit (Qiagen, Hilden, Germany) following manufacturer\'s instructions. RNA integrity was visually assessed on a 1% (w/v) agarose gel stained with SYBR® Safe DNA gel stain (Life Technologies, Carlsbad, USA), before proceeding with cDNA synthesis. A total of 250 ng of total RNA from each RNA extraction was combined to provide a total of 1 µg for use in cDNA synthesis using the SMART™ cDNA Synthesis kit (Clontech Laboratories, Mountain View, USA), according to the manufacturer\'s instructions. Messenger RNA (mRNA) was reverse-transcribed using SMARTScribe™ Reverse Transcriptase and SMART IV™ oligonucleotides. A modified poly-T primer sequence (5′-AAGCAGTGGTATCAACGCAGAGTCGCAGTCGGTACTTTTTTCTTTTTTV-3′) was used instead of the CDS-II primer to reduce sequencing problems associated with the poly-A tails [@pone.0085050-Meyer1]. EST sequence generation {#s2c} ----------------------- Approximately 5 µg of the amplified cDNA library was sheared by nebulisation at 200 kPa for 2 min. The concentration and integrity of the nebulised cDNA sample was determined using a Bioanalyzer 2100, with a DNA 12000 Labchip (Agilent, Santa Clara, USA) according to manufacturer\'s instructions. The GS-FLX titanium shotgun sequence library was then prepared following the manufacturer\'s instructions (Roche Diagnostics, Basel, Switzerland). The quality of sequencing library was then assessed using a Bioanalyzer 2100, fitted with an RNA 6000 Pico Lab Chip (Agilent) according to the manufacturer\'s instructions. Quantification of the sequence library was performed using quantitative real-time PCR. Emulsions were prepared using the Large Volume Emulsion PCR Kit (Roche Diagnostics). Finally, enriched beads were loaded onto one half of a picotitre plate for sequencing following the manufacturer\'s protocol. Assembly and annotation {#s2d} ----------------------- Primary sequence output has been deposited in the sequence read archive of GenBank (accession number SRR1012849). Adapter and poly A sequences were trimmed from all sequence reads and the sequences were then *de novo* assembled, both procedures were performed using Newbler v 2.0.01.14 software (Roche Diagnostics). The coding sequences (CDS) from *Oryza sativa japonica* v6.1, *Sorghum bicolour* v1.0, *Brachypodium distachyon* v1.0 and *Setaria italica* v2.1 were downloaded from the GenBank and Phytozome websites ([www.phytozome.net](http://www.phytozome.net)) and converted into a local custom BLAST database. The *P. dilatatum* sequence contigs were then used as the query sequences in a BLASTn analysis with a threshold E-value of 10^−10^. Only the most significant match was recorded for each sequence contig. The UniRef 90 ([www.ebi.ac.uk/uniref/](http://www.ebi.ac.uk/uniref/)) protein database was downloaded and converted into a custom BLAST database. The *P. dilatatum* sequence contigs were used as queries using BLASTx analysis with a threshold E-value of 10^−10^ and the most significant matches were recorded. Gene Ontology (GO) classification was assigned for each contig that matched the *Oryza sativa* protein database.This was performed by selecting the rice gene IDs that were identified from the initial BLASTn analysis and extracting the GO terms for that subset of genes. EST-SSR Identification and validation {#s2e} ------------------------------------- Identification of di-, tri-, tetra-, penta- and hexanucleotide SSR loci, with minimum repeat numbers of 6, 4, 3, 3, and 3, respectively, and design of corresponding primers was performed using Batch Primer 3 software (<http://probes.pw.usda.gov/batchprimer3/>). The parameters for primer design were as follows: primer length range = 18 to 23 nucleotides (21 optimum); optimum annealing temperature = 55°C; GC content 30--70% (50% optimum). A collection of 96 primer pairs were synthesized for empirical testing. Forward primers were synthesised with the addition of the M13 sequence to the 5′ end, to enable fluorescent tail addition through the PCR amplification process [@pone.0085050-Schuelke1]. Genomic DNA was extracted from fresh leaf tissue from a collection of 49 genotypes from *P. diltatum* cv. Primo and one sample from *P. dilatatum* cv. Relincho using the DNeasy® 96 Plant Kit (QIAGEN) according to the manufacturers\' instructions. PCR reactions were performed in a 12 µL volume containing Immolase PCR buffer, 1.5 mM MgCl~2~, 200 µM dNTPs, 0.016 µM of M13 FAM universal primer, 0.041 µM of M13 tailed forward primer and 0.16 µM of reverse primer, 0.25 units of Immolase DNA polymerase (Bioline, London, UK) and approximately 10 ng of *P. dilatatum* genomic DNA. Cycling conditions were as follows: 95°C for 10 min, followed by 35 cycles of 95°C for 30 sec, 55°C for 30 sec and 72°C for 30 sec and a final elongation step of 72°C for 10 min, performed using an Applied Biosystems Geneamp 9700 thermal cycler (Life Technologies). Amplification products were diluted 40-fold with the addition of water, and 2 µL of product was then combined with 8.95 µL of Hi-Di™ formamide (Life Technologies) and 0.05 µL of GeneScan™ 500 LIZ® Size Standard (Life Technologies). PCR products were processed using an ABI3730xl DNA analyser and amplification product sizes were determined using GeneMapper® v 3.7 software (Life Technologies). Results {#s3} ======= EST sequencing and *de novo* assembly {#s3a} ------------------------------------- After initial sequence base calling and quality assessment had been performed, a total of 324,695 sequence reads, generating a total of 102,539,862 nucleotides were obtained. The average and modal sequence lengths were 338 and 430 nucleotides, respectively. After further quality filtering by removing adapter and primer sequences, reads were *de novo* assembled resulting in 20,169 contigs of a combined length of 9,336,138 bp and 32,751 singletons ([Fasta Files S1](#pone.0085050.s001){ref-type="supplementary-material"}, [S2](#pone.0085050.s002){ref-type="supplementary-material"}). The contig length varied from 104 to 7,877 bp. The majority of the contigs varied in length from 200--499 bp (60.9%) with the largest proportion being 300--399 bp (25%; [Figure 1A](#pone-0085050-g001){ref-type="fig"}). A total of 5,580 contigs (25%) were identified with a length greater than 500 nucleotides. The majority of the contigs (72.8%) were derived from less than 10 reads ([Figure 1B](#pone-0085050-g001){ref-type="fig"}). {#pone-0085050-g001} The minimum accepted sequence length from the unassembled singletons was 50 bp. The average sequence length of the singletons was 374 bp and the largest proportion of the singletons (26.7%) were between 300--399 bp in length and only 25.6% were longer than 400 bp. There were a total of 17 singleton reads (1.8%) that were longer than 600 bp and represent sequences with long repeats of single nucleotides ([Figure 1C](#pone-0085050-g001){ref-type="fig"}). Gene annotation {#s3b} --------------- The *P. dilatatum* sequence contig dataset was reciprocally analysed, using the BLASTn algorithm against the CDS data sets of the relevant grass species with whole genome sequences. These data sets were *Oryza sativa* subsp. *japonica* (v6.1), *Brachypodium distachyon* (v1 assembly), *Sorghum bicolor* (v1.0 release, Sbi1.4 gene set) and foxtail millet (*Setaria italica* v2.1). This analysis revealed that 45.4% of the *P. dilatatum* cDNA contigs matched *O. sativa* genes; 43.7% matched *B. distachyon* genes, 56.2% matched *S. bicolor* genes and 62.5% matched CDS sequences from the foxtail millet assembly ([Figure 2](#pone-0085050-g002){ref-type="fig"} and [Table S1](#pone.0085050.s003){ref-type="supplementary-material"}). A total of 7,994 (39.6%) of the *P. dilatatum* contigs had significant BLASTn matches to sequences from all of the reference genomes, while 7,229 (35.8%) failed to find a significant match sequences from any of the reference genomes. {#pone-0085050-g002} The contigs were compared against the UniRef 90 protein database using the BLASTx algorithm with an E-value cutoff of 10^−10^ to assign putative functional roles and annotations to the *P. dilatatum* trascriptome data set ([Table S1](#pone.0085050.s003){ref-type="supplementary-material"}). A total of 11,417 contigs (56.6%) identified a protein from the uniref data base. Gene ontology (GO) terms were also assigned for the subset of contigs that matched the rice genome. Unigenes were classified into three GO terms: biological process, molecular function and cellular component. A total of 76,093 gene counts and 104,741 annotation counts were assigned. The majority of assignments belonged to the biological process ontology (41.4%) followed by molecular function (34.1%) and cellular components (24.5%). Among the biological process category, response to stress (12%) was the most highly represented category, followed by response to endogenous stimulus (7%), nucleotide binding (7%), cellular process (7%) and signal transduction (7%). Other functional classifications were represented at proportions less than 5% of the total ([Figure 3A](#pone-0085050-g003){ref-type="fig"}). In the molecular function classification class, catalytic activity (12%), protein binding (12%), hydrolase activity (11%), kinase activity (9%) and transferase activity (8%) constituted the major categories ([Figure 3B](#pone-0085050-g003){ref-type="fig"}). The mitochondrion (14%), plasma membrane (14%) and membrane (15%) categories of the cellular component ontology contributed to the largest proportion of annotations followed by nucleus (12%), cytoplasm (8%) and plastid (7%) ([Figure 3C](#pone-0085050-g003){ref-type="fig"}). {#pone-0085050-g003} EST-SSR discovery and validation {#s3c} -------------------------------- The assembled contigs from the EST transcript data were chosen for SSR discovery and validation. Moderate length of sequence is required for SSR motif identification and reliable amplification following primer design. In addition to this, unique locus status for each SSR is desirable, which is best served through analysis of the assembled contigs to avoid partial sequences of ESTs. The 20,169 contigs were processed through batch Primer 3 software for motif identification and design. A total of 2,339 EST-simple sequence repeats (SSR) motifs (di-, tri-, tetra-, penta- or hexa-nucleotide) were identified from a total of 1,989 contigs (11.6%). The most frequent SSRs motifs in *P. dilatatum* transcriptome data set were tri-nucleotide repeats ([Figure 4](#pone-0085050-g004){ref-type="fig"}). {#pone-0085050-g004} High quality primers were designed using BatchPrimer 3 software and a sub-set of 96 primer pairs were synthesised and used for empirical validation. All identified SSRs along with the designed primers are provided in [table S2](#pone.0085050.s004){ref-type="supplementary-material"}. Initial testing of the SSRs was performed on a single DNA sample from a distinct plant of the sexual tetraploid cultivar Primo and a DNA sample from the asexual apomictic cv. Relincho. Acceptable performance, defined as generation of distinct amplification products when resolved through capillary electrophoresis, was obtained for 64% of the SSRs that underwent initial validation. An additional collection of 48 plants from cv. Primo were screened with the selected SSR markers. The data from both rounds of SSR marker analysis was combined. A total of 32 SSR markers were able to identify variation between the sexual and apomictic cultivars, whilst the remaining markers only generated monomorphic marker profiles across all of the samples tested. Within these 32 SSR markers, a subset of eight identified polymorphic features within the samples from the cultivar Primo. The SSR markers typically generated fewer products from samples from cv. Primo than Relincho with median values of 2 and 3 respectively ([Table 1](#pone-0085050-t001){ref-type="table"}). 10.1371/journal.pone.0085050.t001 ###### Details of SSR molecular markers from *P. dilatatum* validated as polymorphic within the current study. {#pone-0085050-t001-1} SSR Id Contig Predicted Product size SSR Motif Motif Lenght Forward Primer Reverse Primer Allele size range Polymorphic in cv. Primo Number of alleles in cv.Primo Number of alleles in cv. Relincho -------- ------------- ------------------------ ----------- -------------- ----------------------- ----------------------- ------------------- -------------------------- ------------------------------- ----------------------------------- Pd0061 contig00359 128 AGGAGC 6 GCAGCTTCATCTCTATGTTTC CTACATCAGGAGTAAGCGATG 139--149 No 1 4 Pd0228 contig01406 177 GGT 3 CTTCATTCCTTCAGATCCACT TACACTGCATACACCGAAGA 153--205 No 4 5 Pd0240 contig01488 227 CCGA 4 AAACTGATGCTCCTCAACC GTACAGCGGGTTGTTCTG 333--377 No 2 3 Pd0297 contig01864 157 CTGTGG 6 GTCCTCCTAGCTGTTGAAGAT AGAAAAGACCTAAGCATGGAC 169--175 No 2 3 Pd0298 contig01883 126 CGC 3 CAAGATCCCTCCCTACTCC ACATAGTCCTCCCCAACC 143--181 No 1 2 Pd0410 contig02637 165 TCG 3 GTCACCTCCTTATAGCCCTTA CAAATCCAAAGACGATGC 180--187 No 1 2 Pd0630 contig04101 170 GCGA 4 AAGAGCTTCCCAACATCC GATATTTCGGAGGAAGAAGAG 440--465 No 2 3 Pd0741 contig04909 181 TCT 3 GTGGATGGATGGATGGAT TTCAGACACACTGCATCAAC 182--204 Yes 4 3 Pd0778 contig05150 184 GCGGAG 6 CTGAAGCAAGGGTAGGAGAT ATCTCCTCCTGAGTTTGTACC 196--202 Yes 2 2 Pd0806 contig05407 157 GGA 3 AGGAGTGAGAGGAAGAACAAC GATGACACAAGCAGTAGCAG 175--189 No 1 2 Pd1298 contig09623 154 GAG 3 TCCACCAAGAGCTCACAT GCATCTGTCGTAGACTCGTAG 118--225 No 3 5 Pd1302 contig09667 183 CCTGTG 6 CAAGGTCATGTTCAACCTCTA ACAGCACAAGAGCTAAAACC 175--236 No 2 3 Pd1357 contig10112 176 AGC 3 ATCATTTTTGCTGCTCTCTC AGTATGGGAGGACGTTGTT 186--194 Yes 2 3 Pd1389 contig10385 159 CGG 3 CTCAGCTCCTAGTCGTCCTA ACATTGCGGATAAATCTGAC 170--177 Yes 2 1 Pd1437 contig10830 150 GCA 3 CAACTTCACCAACAGCAAC TGCTTATTCTTTCTGCGTTC 135--174 No 2 3 Pd1480 contig11038 167 CGG 3 ATCAGAAAGAGGGATTTTGC AAATCAGGGCAAAGAGGTAG 182--185 No 1 2 Pd1488 contig11123 157 AAGAGG 6 CTCCTGGCTTCCTAGATTTAC CAATTGAAACATGGTCTGC 173--189 Yes 2 2 Pd1505 contig11302 149 CGAGCA 6 ATCTTGCTCCATCACCATTA CTTGTCTCCTACCTCACCAC 150--166 No 1 3 Pd1515 contig11456 160 CCG 3 AGTCCACTTTCACTTCCACTC CTCTCCATCCTGCACCTC 171--179 No 2 4 Pd1533 contig11692 153 GGC 3 GGTCTTGAGGAGTGAGAGC GAGAGAAAGCTAGGGTTTTGA 248--267 No 3 4 Pd1594 contig12224 160 GCA 3 TCAGTAGGACACACAACATCA TAGTAGTTGGACGGATTTGAG 165--174 Yes 4 2 Pd1602 contig12343 122 GCG 3 ACTTCCGCTTCTTGTTGAT ATCCAAGTCTAGGGTTCCAC 121--138 No 1 3 Pd1740 contig13647 148 AGCC 4 GGGATTATACAAATGGAGGAG TGTTCGATTCTCATCAGTAGG 156--163 No 1 2 Pd1838 contig14705 162 TTTGTG 6 GAGATGTAATAGCGGTGTTTG CTCAGCTCCACAGTCACAC 176--183 No 1 1 Pd1887 contig15149 140 TCA 3 GGACCAGCAGACACAAAC CCACATCTTCACCTCTCTCTC 269--271 No 1 2 Pd1907 contig15377 139 CCG 3 ACAAGGCCAGAAGGGTTT CAAAAGCAGTGGCAAGAG 150--153 No 1 1 Pd2162 contig18221 176 GCG 3 GTTGTACCTGATGGTGTTGTC CCGATCAAGGGTTTCCTC 289--298 Yes 2 2 Pd2239 contig18901 148 CAT 3 GCTGCTGTTATTCTGTACCTG CCTTCTCTTTCTCTCCAAGAC 160--166 Yes 2 2 Pd2251 contig19078 150 CGG 3 CTTCTGGTCGTAGGTGTAGTC CTCCCCCTTCTTCACTCC 248--264 No 2 4 Pd2273 contig19311 155 GTCCCC 6 ACCGCCAAAAACCAAGAG CTTCTTCTCCGCCTTCTC 166--177 No 1 4 Pd2337 contig20145 116 GCG 3 GGAAGGATTCTCTCCCTAGA CTTCTTGTTGCCGAAGAAT 128--131 No 1 2 Pd2338 contig20158 153 GTG 3 GTCTGCGGCTCTTCTATTC AAATGGACTAGAACCTCGAAC 168--203 No 2 4 Discussion {#s4} ========== Efforts to sequence grass genomes have increased considerably in recent years. The first crop species with a complete genome sequence was rice [@pone.0085050-Goff1], followed by several other species within the Poaceae: sorghum [@pone.0085050-Paterson1], maize [@pone.0085050-Schnable1], brachypodium [@pone.0085050-Initiative1], and most recently foxtail millet [@pone.0085050-Zhang1]. In addition, there are large collections of EST sequences available from species within the Poaceae family (7,180,207 nucleotides ESTs, 20/07/2013) along with collections of next generation RNA sequence based data (1,791 entries in the SRA database 20/07/2013). However, the majority of these studies in recent times have focused on maize (\>1,000 of the RNA based SRA entries for the Poaceae). An EST sequencing approach can provide a valuable collection of cDNA sequences and has been widely used for gene discovery and development of molecular markers, as it is a rapid, cost effective approach that can avoid well known problems associated with repetitive regions and large genome sizes in many non-model organisms where no prior data is available. Even though complete genome sequences have now been generated for some grasses, there are \>11,000 recognised species within the Poaceae [@pone.0085050-Grass1] so it is not surprising that genomic resources have been limited for most grass species, including *P. dilatatum*, prior to this study. Next generation sequencing has been widely used within many crop species due to its low cost and greater sequence yield [@pone.0085050-Wall1]. The availability of next generation sequencing technology enables large sequence data sets to be generated at modest costs. However, *de novo* sequencing of complex, often repetitive genomes, which are common in the Poaceae family, is not trivial. The characterization of genes with low expression levels or genes induced by specific environmental cues, or with spatially-restricted expression patterns can be challenging. Sequencing technologies that generate short reads (35--150 bp) such as the Illumina HiSeq systems are ideally suited to model organisms where reads can be mapped to reference genomes or transcriptome sequences. However, as the GS FLX platform can generate reads of \>400 bp, it has been used for *de novo* annotation in non-model plants such as olive [@pone.0085050-Wall1], [@pone.0085050-Alagna1], chestnut [@pone.0085050-Barakat1], ginseng [@pone.0085050-Sun1],strawberry [@pone.0085050-Shulaev1], bracken fern [@pone.0085050-Der1] and recently, in switchgrass [@pone.0085050-Wang1]. This study reports the generation of genetic resources for *P. dilatatum* using the GS FLX Titanium platform. The EST-dataset generated in the current study provides a significant contribution towards the development of a resource in *P. dilatatum* that facilitates gene discovery and molecular marker development, for breeding programs. The study also provides a basis for future studies into gene expression under specific conditions with biotic or abiotic stresses. The GS FLX platform has a high error rate in homopolymeric regions (i.e., three or more consecutive identical DNA bases) caused by accumulated light intensity variance [@pone.0085050-Margulies1]. Therefore, a modified primer with an interrupted poly d(T) tail was used to avoid the limitations in sequence quality caused by the poly(A) tails of messenger RNA molecules. Similar approaches have been used in other transcriptome studies with significant benefits [@pone.0085050-Sun1], [@pone.0085050-Beldade1]. The data generated was of high quality as the majority of the generated sequence reads assembled into contigs (74%) with an average contig length of 463 bp; which is also comparable to the average contig length obtained in previous studies (454 bp [@pone.0085050-Franssen1], 334 bp [@pone.0085050-Margulies1], 440 bp [@pone.0085050-Sun1]. There were still however a significant proportion of sequence reads that were not assembled into contigs and indicate that further transcriptomic studies could benefit the sequence assembly and provide a comprehensive catalogue of full length cDNA sequences, and also unequivocally identify low quality uninformative reads. A small proportion of singleton reads were longer than 600 bp, a length that is outside of the standard read length of the GS FLX 454 platform using Titanium chemistry. These sequences contain long repeats of single nucleotides, which increases the defined length of the read passed the expected output size. It is likely that these sequence reads are an artefact of the sequencing process and are not derived from *P. dilatatum*, even though they have passed through the standard pipeline approach to sequence quality filtering. [Results](#s3){ref-type="sec"} of comparative sequence analysis reflects taxonomic relationships, with a high proportion of *P. dilatatum* reads matching sequences from other members of the Panicoideae subfamily within the PACMAD clade, (*Sorghum bicolor* L. and *Setaria italica*). From the recent comprehensive and robust assessment of molecular phylogeny for the grass species [@pone.0085050-Grass1], it would appear that the closest taxonomic relationship is between *P. dilatatum* and *Sorghum bicolor* L. However, this taxonomic relationship is not mirrored by the comparative sequence analysis performed in this study, where the highest number of matching sequence reads was obtained from comparisons to *Setaria italica*. This could indicate gene specific evolution that *S. bicolour* has undergone in isolation or potentially some differences in genome assembly and annotation between the two reference genomes. By undertaking the comparative genetic analysis within this study a significant description of the generated cDNA sequences has been attempted. Whilst this study has not focussed on single genes, it is anticipated that the resources generated, the gene ontology, protein as well as the reference genome analysis, will provide assistance to trait specific studies in the future. Despite being described in plant species since 1992 [@pone.0085050-Akkaya1], SSR markers are still widely used for many applications, including population genetics and marker assisted breeding due to their codominant and highly polymorphic nature [@pone.0085050-Luikart1]. EST-SSRs have previously been associated with agronomically important traits in many species including cotton and maize [@pone.0085050-Abdurakhmonov1], [@pone.0085050-Li1]. *De novo* development of a large cohort of SSRs was previously a costly and time-consuming process [@pone.0085050-Squirrell1], [@pone.0085050-Zane1]. However, SSRs can now be rapidly identified in EST databases generated by sequencing of transcriptomes. EST-SSRs have an enhanced cross-species transferability and efficiency of amplification in comparison with SSRs located in non-transcribed regions [@pone.0085050-Barbara1], [@pone.0085050-Kumpatla1], which could derive significant benefits for the c. 400 other *Paspalum* species [@pone.0085050-Chase1]. A small cohort of genomic derived SSR markers were recently developed for *P. atratum* Swallen and *P. notatum* Flüggé and successfully transferred in 35 Paspalum species [@pone.0085050-Cidade1]. The use of SSRs across related species has been previously demonstrated in the Poaceae family: wheat EST-derived SSRs were transferable to eight related species [@pone.0085050-Zhang2] and to important crops including maize, barley and rice [@pone.0085050-Tang1]. Barley (*Hordeum vulgare*) EST-derived SSRs were transferable to *H. chilense* lines and showed polymorphism [@pone.0085050-Castillo1]. The amplification of multiple products from tetraploid genotypes of *P. dilatatum* and amplification of even more products from pentaploid genotype in this study indicates that SSR markers are able to detect loci within the I, J and X genomes of *P. dilatatum*. The frequency of EST- SSRs detected is typically influenced by the DNA template used, the criteria for defining SSRs, and the software and parameters used for identifying SSRs [@pone.0085050-Parchman1], [@pone.0085050-Castoe1], [@pone.0085050-Tangphatsornruang1]. In this study, the frequency of trinucleotide repeat units was predominant, followed by tetra-, penta-, di- and hexanucleotide repeat units. The high frequency of trinucleotide repeat units is consistent with results previously reported in numerous plant species [@pone.0085050-Eujayl1], [@pone.0085050-Varshney1], [@pone.0085050-LaRota1], [@pone.0085050-Gao1], [@pone.0085050-Thiel1], [@pone.0085050-Cardle1]. Polymorphism in trinucleotide repeats in coding regions of a transcript would be more tolerated as they would not cause shift in the amino acid translation [@pone.0085050-Metzgar1]. Conventional plant breeding is a costly and time consuming approach that could be enhanced with molecular marker based system to facilitate the selection of desirable agronomic traits. In apomictic plants, novel approaches for interspecies hybridization must be employed to increase variation and effectively use available germplasm resources. Critically, the selection of germplasm for breeding would benefit from prior genomic characterisation to make informed decisions for cultivar development. As an example the cultivar Primo, used in this study, is characterized with high potential forage production, but was developed based on an interspecific hybridisation and backcross strategy to incorporate *C. paspali* resistance from *P. urvillei* (also a sexual tetraploid *Paspalum* species with a genomic constitution of IIJJ) into *P. dilatatum* [@pone.0085050-Schrauf1]. The application and screening of a modest subset of the discovered SSR markers across the germplasm detailed in this study, has already demonstrated that these SSR are functional across both the sexual and apomictic biotypes of *P. dilatatum*. However, the low level of SSR marker variance that was identified in this study from multiple samples of Primo could potentially be accounted for by the breeding history of the cultivar, which suggests that the value of the markers may be more accurately assessed by screening a more diverse collection of *Paspalum* germplasm. Conclusions {#s5} =========== This study generated a substantial genomic EST-derived resource for the forage grass *Paspalum dilatatum* represented by 20,167 contigs, of which 12,940 have been sequence annotated. Furthermore, a collection of 2,339 SSR primer pairs have been designed and a subset validated for molecular breeding within the cultivated germplasm and can be assessed for efficiency across the genus *Paspalum*, dramatically advancing the available resources for this important forage grass species. Supporting Information {#s6} ====================== ###### **Fasta file of generated contigs from the assembly process.** (TXT) ###### Click here for additional data file. ###### **Fasta file of singletons remaining from the assembly process.** (TXT) ###### Click here for additional data file. ###### **Details and results from the BLAST analysis between the** ***P. dilatatum*** **contigs, and the reference CDS genomes and the UniRef 90 database.** Data is presented in tabular format. (XLSX) ###### Click here for additional data file. ###### **Details of all 2,339 SSR molecular markers identified within the study.** (XLS) ###### Click here for additional data file. [^1]: **Competing Interests:**The authors have declared that no competing interests exist. [^2]: Conceived and designed the experiments: AM SP JGM GCS GES. Performed the experiments: AG SK MD. Analyzed the data: AG NOIC SK. Wrote the paper: AG NOIC AM SP GES JGM GCS. [^3]: Current address: Science, Engineering & Health, RMIT University, Bundoora, Victoria, Australia

\section{Introduction} \label{sec:introduction} Wireless sensor networks (WSNs), a concept that originated in the mid-1990s, have now reached a stage in their evolution that we are beginning to see their actual deployment. It is not unreasonable to expect that in 10-15 years the world will be covered with wireless sensor networks with access to them via the Internet\cite{wireless-sensor-network}. \mbox{IEEE 802.15.4} \cite{IEEE802-15-4-06std} is a popular standard for the physical layer and medium access control for low-power wireless sensor networks. With the growing importance of wireless sensor networks in industrial applications \cite{gungor-hancke09industrial-WSN-survey}, we need analysis and design techniques for multi-hop IEEE~802.15.4 networks. The standard uses CSMA/CA for medium access control, and defines two types of CSMA/CA algorithms - beaconed (or slotted) and beaconless (or unslotted), respectively (see \cite{IEEE802-15-4-06std} for details). In this paper we develop a new approximate analytical technique for multi-hop beaconless \mbox{IEEE 802.15.4} networks, and demonstrate the usefulness of such an analytical tool in designing multi-hop networks with Quality of Service (QoS) objectives. \begin{figure} \begin{center} \includegraphics[scale=0.31]{figures/tree_with_queue.pdf} \caption{A WSN consisting of nodes arranged in a tree topology. Source node $i$ has packet generation rate $\lambda_i$. Relay nodes $6$, $7$ and $8$ forward the data of their predecessors to the base-station, BS.} \label{fig:network} \vspace{-7mm} \end{center} \end{figure} Figure~\ref{fig:network} depicts the queueing schematic of a network of the type that we are concerned with in this paper. There are sensor nodes, namely, 1, 2, 3, 4, 5 and 7, that generate measurement packets according to independent point processes at rate $\lambda_i$ that need to be transported to the base station (BS). The sensor nodes can also serve as \emph{relays} for the traffic of other sensor nodes, e.g., Node~7 is a relay for nodes 2 and 3. Two additional nodes, 6 and 8, serve only as relay nodes, due to the limited range of the radios associated with the sensor nodes. The nodes use unslotted CSMA/CA to contend for the wireless medium and transmit their packets. Even the stability analysis of such networks is a difficult problem (even for networks with single hop traffic; see \cite{bordenave} for a detailed discussion). In principle, the entire network can be modeled via a large coupled Markov chain, with the state at each node being the number of packets in its queue, and the state of the contention process for the head-of-the-line (HOL) packet. Such an approach is well known to be intractable even for a network with a single contention domain (no hidden network) and saturated queues (see \cite{bianchi00performance,kumar-etal04new-insights}). Thus all researchers have taken recourse to developing approximate analyses. Table~\ref{tbl:related-literature} summarizes some of the recent work on modeling approaches for beaconless IEEE~802.15.4 networks where we have listed the major limitations of the proposed models as well. Owing to the need for low power operation and large coverage, in general, a sensor network is multi-hop with the presence of hidden nodes. Further, for networks that carry measurement traffic, the queue occupancies vary with time. Unlike other models, we consider all of these attributes in our modeling approach. \scriptsize \begin{table*}[p] \centering \caption{A comparison of the literature on analytical performance models of CSMA/CA based networks. The bold text in the "Network Scenario and Limitations" columns highlights the limitations of the model that we are able to handle in our model.} \begin{tabular}{|p{23mm}|p{45mm}|p{100mm}|} \hline \textbf{Authors} & \textbf{Network Scenario \& Limitations} & \textbf{Modeling Approach} \\ \hline Kim et al. (2006)\cite{kim-etal06unslotted-CSMACA} & beaconless 802.15.4; \textbf{rare packet arrivals, star network; no hidden nodes; no queueing at nodes}; with ACKs & 2-dim discrete time Markov chain for each node with states: (backoff stage, backoff counter) while in backoff, and separate states when transmitting and idling; with unknown transition probabilities; coupling the per node models to get the unknowns via fixed point approach \\ \hline Qiu et al. (2007)\cite{winet.qiu-etal07general-model-wireless-interference} & 802.11 DCF; (un)saturated, \textbf{star network}; with hidden nodes and ACKs; infinite buffer space & discrete time Markov chain with states as the set of transmitting nodes having unknown transition probabilities, together with RSS measurements between each pair of node to obtain CCA and packet failure probabilities; iterative procedure for solving unknowns \\ \hline Kim et al. (2008)\cite{kim-etal08modeling-802.15.4-single-hop} & beaconless 802.15.4; \textbf{star topology; no hidden nodes; no collisions}; infinite buffer space & unsaturated analysis of single hop network by simple mathematical model of M/G/1 queue; no collision is considered; computes QoS as packet delay and packet loss probability; computes battery life time \\ \hline Singh et al. (2008)\cite{winet.singh-etal08slotted-zigbee-star} & beaconed 802.15.4; (un)saturated, \textbf{star network; no hidden nodes}; with ACKs; infinite buffer; \textbf{equal traffic arrival rate at all nodes} & Markov renewal process at each node with cycle length dependent on the number of nodes available to attempt in the first backoff period of the cycle; transition probabilities and conditional expectations using node decoupling; coupling via stationary probabilites of remaining nodes; saturation analysis results used for the unsaturated case \\ \hline Buratti-Verdone (2009)\cite{buratti-verdone09modeling-802.15.4-beaconless} & beaconless 802.15.4; \textbf{star topology; no hidden nodes; no ACKs and retransmissions; no queuing} & bidimensional process with backoff counter and backoff stage at time $t$; evaluation of sensing, transmission and success probability; computes mean energy spent by each node for a transmission \\ \hline He et al. (2009)\cite{winet.he-etal09slotted-CSMACA} & \textbf{beaconed} 802.15.4; \textbf{saturated, star network; no hidden nodes}; with ACKs; & two Markov chains for each node: one embedded at the end of transmissions in the common channel, and the other during backoffs embedded at each slot; both having states as (backoff stage, backoff counter); chains coupled to get a fixed point approach \\ \hline Martalo et al. (2009)\cite{winet.martalo-etal09slotted-CSMACA} & \textbf{beaconed} 802.15.4; unsaturated, \textbf{star network; no hidden nodes; no ACKs; finite buffer space} & two semi-Markov processes: one for tagged node having unknown transition probabilities, and the other for the shared radio channel that couples all the per node models to obtain the unknown quantities; MGFs used for finding queueing delays \\ \hline Goyal et al. (2009)\cite{goyal-etal09beaconless-zigbee} & beaconless 802.15.4; \textbf{unsaturated star network; no hidden nodes; no queueing at nodes}; with ACKs & tracked the number of nodes with non-empty queues assuming that the probability of $m$ nodes having non-empty queues at any given time is same as the probability of $m-1$ empty nodes getting a new packet to send while a non-empty node is sending its current packet (for coupling individual node models); assumed that the CCA attempt processes of other nodes with non-empty queues are Poisson processes (decoupling) \\ \hline Lauwens et al. (2009)\cite{lauwens-etal09unslotted-CSMACA-analysis} & beaconless 802.15.4; \textbf{saturated, star network; no hidden nodes; no ACKs} & semi-Markov model for each node with unknown and non-homogeneous transition probabilities based on the backoff stage of the node; also found the distribution of backoff intervals and iterated over these together with the stationary probabilities of the semi-Markov processes \\ \hline Jindal-Psounis (2009)\cite{jindal09} & 802.11 DCF; unsaturated, multi-hop network; with hidden nodes and ACKs; infinite buffer space; \textbf{modeling involves details that are specific to 802.11 such as the RTS/CTS mechanism}; & For each of four possible classes of two-edge topologies, derived collision and idle probabilities for each edge in terms of expected service times of the edges; for a general topology, decomposed the local network topology around each edge into a number of two-edge topologies, and derived the collision and idle probabilities for the edge in terms of those of the two-edge topologies in the decomposition; using these probabilities, set up and solved a Markov chain model for each edge (with states as the current backoff window, backoff counter, and time since the last successful/unsuccessful RTS/CTS exchange) to express the expected service times of the edges via a set of fixed point equations, which were solved iteratively to find the achievable rate region under 802.11 in the given topology \\ \hline DiMarco et al. (2010)\cite{dimarco-etal10modeling-ieee-802-15-4-multihop} & beaconless 802.15.4; unsaturated, multi-hop network; \textbf{no queueing at nodes}; with hidden nodes and ACKs & 3-dim discrete time Markov chain for each node having state: (backoff stage, backoff counter, retransmission counter) with CCA and collision probabilities (unknown) as state transition probabilities (decoupling); assumed independence of node processes to find expressions for the CCA and collision probabilities using stationary probabilities of different Markov chains (coupling) \\ \hline Sen-De (2010)\cite{sen-de10modelling-802.15.4-beaconless} & beaconless 802.15.4; unsaturated, multi-hop network; with hidden nodes; \textbf{no queuing; analysis does not match simulation well} & 1-dim Markov model for transmitting node with states being in CCA, backoffs states and data transmission; steady state transmission probability and probability of success (throughput) are obtained through fixed point iterations \\ \hline Shyam-Kumar (2010)\cite{shyam-kumar10me-thesis} & beaconless 802.15.4; (un)saturated, multi-hop network; with hidden nodes and ACKs; infinite buffer; \textbf{analysis does not match simulation well} & saturated analysis using continuous time Markov chain with states as the set of transmitting nodes having unknown transition probabilities; found CCA and failure probabilities using steady state probability of the Markov chain; unsaturated network modeled as a Markov renewal process constituted by the nodes having non-empty queues, saturation analysis results used in each cycle with the set of non-empty nodes \\ \hline Marbach et al. (2011)\cite{marbach11} & \textbf{non-adaptive CSMA characterized by a \emph{fixed} attempt probability on each link}, and a non-zero sensing period on each link; asynchronous, unsaturated, multihop network; \textbf{over-simplified model - does not conform to any existing standard} & intuitively formulated fixed point equations involving node idling probabilities, and transmission attempt rates; showed uniqueness of the fixed point, and asymptotic accuracy for large networks with small sensing period and appropriately decreasing link attempt probabilities; for a given sensing period, characterized the achievable rate region of the simplified CSMA policy by defining a set of arrival rate vectors, and showing that for every member in that set, there exists a policy (a vector of attempt probabilities) such that the link service rates obtained from the fixed point equations exceed the link arrival rates\\ \hline \end{tabular} \label{tbl:related-literature} \vspace{-5mm} \end{table*} \normalsize \subsection*{Our Contributions and Comparison with Related Work} We consider a multi-hop WSN consisting of static sources and relays arranged in a tree topology operating in the beacon-less mode with acknowledgements (ACKs). Each node has an infinite buffer space and may operate in the saturated or unsaturated regime with fixed packet length. Different analysis techniques are developed for networks with hidden nodes and networks without hidden nodes due to the difference in activity lengths perceived by a node in the presence and absence of hidden nodes. Under certain approximations, we model the stochastic process evolving at a node by incorporating the influence of the other nodes in the network by their (unknown) time averaged statistics, and then couple these individual node processes via a system of fixed point equations, which is solved using an iterative scheme to obtain the unknown variables. Although this \emph{decoupling} (or \emph{mean-field}) approximation is popular in such situations, our more detailed model incorporating several issues not considered together hitherto requires a careful handling of the analysis. We identify and calculate two QoS measures for each source node, viz., the packet delivery probability and end-to-end packet delay, in terms of these variables. We observe that in a multi-hop IEEE~802.15.4 network, the packet delivery probability falls sharply before the end-to-end packet delay becomes substantial. The rest of the paper is organized as follows: In Section~\ref{sec:overview-of-standard}, we give an overview of the unslotted CSMA/CA mechanism. Section~\ref{sec:analytical-model} explains the node behaviour and elaborates upon the different analysis techniques used for networks without hidden nodes and networks with hidden nodes. Section~\ref{sec:numerical-and-simulation-results} compares our analysis with simulations. Section~\ref{sec:network-design} demonstrates how the analysis can be used for designing multi-hop networks with QoS objectives. Finally, we conclude the paper in Section~\ref{sec:conclusion}. \section{Unslotted CSMA/CA for Beacon-less IEEE 802.15.4 Networks}\label{sec:overview-of-standard} A typical node behaviour under unslotted CSMA/CA is shown in Figure~\ref{fig:evolution}. A node with an empty queue remains idle until it generates a packet or receives one from its predecessor nodes. When a node has data to send (i.e., has a non-empty queue), it initiates a random back-off with the first back-off period being sampled uniformly from $0$ to \emph{${2^{macminBE}-1}$}, where \emph{macminBE} is a parameter fixed by the standard. For each node, the back-off period is specified in terms of slots where a slot equals 20 symbol times ($T_{\mathsf{s}}$), and a symbol time equals 16 $\mu s$.\footnote{Note, however, that there is no central coordinator that maintains synchrony of the slots \emph{across the nodes}, and hence the CSMA/CA protocol is unslotted.} The node then performs a CCA (\emph{Clear Channel Assessment}) to determine whether the channel is idle. If the CCA succeeds, the node does a \emph{Rx-to-Tx turnaround}, which is $12$ symbol times, and starts transmitting on the channel. The failure of the CCA starts a new back-off process with the back-off exponent raised by one, i.e., to \emph{macminBE+1}, provided that this is less than its maximum value, \emph{macmaxBE}. The maximum number of successive CCA failures for the same packet is governed by \emph{macMaxCSMABackoffs}, exceeding which the packet is discarded at the MAC layer. The standard allows the inclusion of acknowledgements (ACKs) which are sent by the intended receivers on a successful packet reception. Once the packet is received, the receiver performs a \emph{Rx-to-Tx turnaround}, which is again $12$ symbol times, and sends a $22$ symbol fixed size ACK packet. A successful transmission is followed by an \emph{InterFrame Spacing}(IFS) before sending another packet. When a transmitted packet collides or is corrupted by the PHY layer noise, the ACK packet is not generated, which is interpreted by the transmitter as failure in delivery. The node retransmits the same packet for a maximum of \emph{aMaxFrameRetries} times before discarding it at the MAC layer. After transmitting a packet, the node turns to the Rx-mode and waits for the ACK. The \emph{macAckWaitDuration} determines the maximum amount of time a node must wait for in order to receive the ACK before concluding that the packet (or the ACK) has collided. The default values of \emph{macminBE}, \emph{macmaxBE}, \emph{macMaxCSMABackoffs}, and \emph{aMaxFrameRetries} are 3, 5, 4, and 3 respectively. \section{Description of the Modeling Approach} \label{sec:analytical-model} As shown in Figure~\ref{fig:network}, the network consists of sensors, relays and a base-station (BS). We consider time invariant links and static (immobile) nodes. The links are characterized by a predefined target packet error rate (PER) (e.g., a PER of 1\% on each link). We assume that the sensors generate traffic according to independent point processes. These constitute the aggregate external arrival process for the sensor network. Each node transmits its data to the next-hop node according to the topology; throughout this paper, \emph{we shall work with a tree topology so that each transmitter has exactly one receiver node}. The intermediate nodes along a route may be relays in which case they simply forward the incoming traffic, or they may be sensors which transmit their own packets as well as the received packets. Based on the network congestion, the nodes may discard packets due to consecutive failed CCAs or frame retries. Figure~\ref{fig:evolution} shows a typical sample path of the process evolution at a node. \begin{figure}[ht] \begin{center} \includegraphics[height=4cm, width=9cm]{figures/evolution.pdf} \caption{Process evolving at a tagged node as it goes through various states.} \label{fig:evolution} \vspace{-5mm} \end{center} \end{figure} \subsection{Modeling Simplifications} \label{subsec:model-simplify} The process evolutions at various nodes in the system are coupled, and each node (source or relay) can be present in any state; further, different nodes can interact with different subsets of nodes based on their Carrier Sense (CS) range and positions.\footnote{A node $j$ is said to be within the Carrier Sense (CS) range of a node $i$ if any channel activity (transmission) due to node $j$ can be detected (but not necessarily decoded) by node $i$.} Hence, the random process representing the system is multi-dimensional and non-homogeneous. The exact analysis of such a process is intractable. We, therefore, make several simplifications: \begin{description}[leftmargin=0cm] \item [(S1)]All packets are of the same fixed length. \emph{Hence, the DATA transmission duration is fixed.} \item [(S2)]The internode propagation delays are of the order of nanoseconds, and hence can be taken to be zero. \item [(S3)]Collision model (zero packet capture): If a receiver is in the communication range of two or more nodes that are transmitting simultaneously, it does not receive any of those transmitted packets, i.e, all the packets involved in a collision get corrupted unlike an SINR model, where some of the interfering packets may still be received successfully, depending on the SINR threshold. \item [(S4)]The Inter Frame Spacing (IFS) is neglected. \emph{It means that the receiver does not discard the packet received during the IFS.} \item [(S5)] By (S3), a packet is necessarily bad if any other packet is being heard by the same receiver. Even if this is not the case, a packet can be in error due to noise. The packet error probability on each link is fixed and known. \emph{As already mentioned, the links are not time varying and we can empirically obtain the error characteristics of a link.} \item [(S6)]ACK packets are short and, therefore, not corrupted by PHY layer noise. \item[(S7)]A node's CCA succeeds when there is no transmission by any node in its Carrier Sense (CS) range at the time of initiation of its CCA. \emph{Recall that in the standard, the channel state is averaged over the $8$~symbol duration.} \item [(S8)]The time taken by a transmitting node for the activities of successful transmission and collision are the same. We denote this time by $T_{tx}$. \emph{If the transmitted data collides at the receiver, the macAckWaitDuration for the transmitting node is equal to the sum of the turnaround time of $12~T_s$ and the ACK duration of $22~T_s$, a total of $34~T_s$ (see Figure~\ref{fig:transmission}).} \item [(S9)]We assume symmetry in carrier sensing, and signal reception, i.e., \emph{if a node $i$ can detect (respectively decode) the packet transmissions of another node $j$, then node $j$ can also detect (resp. decode) the packet transmissions of node $i$.} \end{description} \begin{figure}[htbp] \begin{center} \includegraphics[scale=0.45]{figures/transmission.pdf} \caption{The transmission period $T_{\mathsf{tx}}$ which includes the DATA transmission time $T_x$, the turnaround time of $12~T_s$, and the MAC ACK duration of $22~T_s$ (or the \emph{macAckWaitDuration} of $34~T_s$, by \textbf{(S8)}).} \label{fig:transmission} \vspace{-5mm} \end{center} \end{figure} \vspace{2mm} \noindent \emph{Decoupling approximation:} We employ an approximation whereby we model each node separately, incorporating the influence of the other nodes in the network by their average statistics, and as if these nodes were independent of the tagged node. This commonly used approximation is also called a ``mean field approximation'', and has been widely used in the wireless networking literature \cite{bianchi00performance,kumar-etal04new-insights,jindal09}. \subsection{Modeling Node Activity} \label{subsec:node-activity-modeling} The channel activity perceived by any node $i$ is only due to the nodes in its CS set (i.e., the set of nodes within its CS range) denoted by $\Omega_i$. Note that $\Omega_i$ does not include node $i$. Let us consider the durations during which the queue at node $i$ is non-empty. During these times, node $i$ alternates between performing CCAs and transmitting the packets from its queue. We model the CCA attempt process at node $i$ as a Poisson process of rate $\beta_i$ \emph{conditioned on being in backoff periods}\cite{goyal-etal09beaconless-zigbee}. For each node $j\in \Omega_i$, consider only those times at which the node is not transmitting (i.e., its queue is empty, or the node is in backoff). We model the CCA attempt process of each node $j\in \Omega_i$ conditioned on these times by an independent Poisson process with rate $\overline{\tau}_j^{(i)}$, $j\in\Omega_i$. By modeling simplification \textbf{(S1)}, we assume that all packets entering node $i$ have the same fixed length, and hence take the same amount of time when being transmitted over the medium (denoted by $T_{\mathsf{tx}}$). Let us now remove the time intervals at node $i$ during which the queue at this node is empty, thereby concatenating all the busy periods at the node. In this conditional time, as a result of the Poisson point process assumption for the attempt process at node $i$, and also for the attempt processes of the nodes in $\Omega_i$, we observe that instants at which packet attempts complete (equivalently, new backoff intervals for the attempts start) are renewal instants. These are denoted by $X^{(k)}_i$ in Figure~\ref{fig:ARP_calc_of_rates}. The corresponding renewal lifetimes are denoted by $W_i^{(k)}$. Figure~\ref{fig:system} shows details of a renewal cycle of node $i$. The dashed transmission durations belong to nodes other than $i$. The cycle always ends with a transmission from node $i$. This last transmission in a cycle always corresponds to a non-collided packet, which, however, could be received in error. \begin{figure}[h] \begin{center} \includegraphics[width=9cm]{figures/ARP_calc_of_rates.pdf} \caption{The renewal process obtained by observing the process at a node $i$ after removing all the idle time periods from the original process shown in Figure~\ref{fig:evolution}. The renewal epochs are denoted by $\{X_i^{(k)}\}$ and the cycle lengths by $\{W_i^{(k)}\}$.} \label{fig:ARP_calc_of_rates} \vspace{-5mm} \end{center} \end{figure} \begin{figure}[h] \begin{center} \includegraphics[scale=0.4]{figures/system.pdf} \caption{Renewal cycles at a tagged node, say $i$: (a) a renewal cycle when there are no hidden nodes in the system (all activity periods on the channel are of length $T_{\mathsf{tx}}$); (b) a renewal cycle when there are hidden nodes (due to hidden node collisions, the activity periods on the channel can be longer than $T_{\mathsf{tx}}$.)} \label{fig:system} \vspace{-5mm} \end{center} \end{figure} Before discussing the difference in activity lengths in the two network types (as shown in Figure~\ref{fig:system}), we list the various packet collision scenarios. Packet collisions in a wireless network with a CSMA MAC can occur due to the presence of hidden nodes. In addition, \emph{there are scenarios where transmissions from two transmitters placed within the CS range of each other can overlap, known as \textbf{Simultaneous Channel Sensing} and \textbf{Vulnerable Window}} (also known as First and Second Collision window respectively, in \cite{goyal-etal09beaconless-zigbee}). These two collision scenarios are explained in Figures~\ref{fig:simul_channel} and \ref{fig:CCAfail}, respectively. Note that we are making use of \textbf{(S2)} to avoid including insignificant timing details here. \begin{figure}[h] \begin{center} \includegraphics[scale=0.45]{figures/simul_channel_sensing.pdf} \caption{Node $j\in \Omega_i$ finishes its backoff, performs a CCA, finds the channel idle and starts transmitting the DATA packet. Node $i$ finishes its backoff anywhere in the shown $12~T_s$ duration and there is no other ongoing transmission in $\Omega_i$, its CCA succeeds and it enters the transmission duration. As a result, the DATA packets may collide at $r(i)\in \Omega_j$ and/or $r(j) \in \Omega_i$.} \label{fig:simul_channel} \vspace{-5mm} \end{center} \end{figure} \begin{figure}[h] \begin{center} \includegraphics[scale=0.45]{figures/CCAfail.pdf} \caption{Vulnerable window of $4~T_s$ in the transmission period of node $j\in \Omega_i$ during which node $i$'s CCA attempt would be successful.} \label{fig:CCAfail} \vspace{-5mm} \end{center} \end{figure} Since the vulnerable window size is small compared to the data transmission duration of a node (see Figure~\ref{fig:CCAfail}), \emph{we shall assume that the probability of a node's CCA initiating in the vulnerable window of another node is negligible}, and therefore, neglect the resulting packet collisions. Further, since the ACK packet size is just a small fraction of DATA packet size (e.g. compare an ACK packet ($22$~symbols) with a DATA packet of length $260$~symbols at PHY layer), \emph{we shall assume that the probability of packet collision involving ACK packets is negligible}. We now return to elucidate the difference in length of activity periods in a renewal cycle. \begin{description}[leftmargin=0cm] \item[(a) Absence of Hidden Nodes:] When a node transmits, all the other nodes in the network can hear it, resulting in CCA failures for other nodes that try to assess the channel in the transmission period. Also if two nodes are involved in simultaneous channel sensing, the activity period may extend from $T_{\mathsf{tx}}$ to a maximum of $(T_{\mathsf{tx}}+12~T_s)$. Since $12~T_s<<T_{\mathsf{tx}}$, we can assume that the activity period is only a single transmission period of duration $T_{\mathsf{tx}}$. \item[(b) Presence of Hidden Nodes:] Since a node's hearing capacity is limited, it may not perceive the activities of all the nodes in the network which may cause dilation of activity period. \begin{figure}[ht] \begin{center} \includegraphics[scale=0.3]{figures/t_eff.pdf} \caption{\emph{Dilation of transmission period as perceived by node $i$}.} \label{fig:t_eff} \vspace{-5mm} \end{center} \end{figure} \if 0 \begin{figure}[ht] \begin{center} \includegraphics[scale=0.35]{figures/hidden_node_explaned.pdf} \caption{\emph{Typical hidden node case and Evolution processes of Node $i$ and Node $j$.}} \label{fig:hidden_node_explained} \vspace{-3mm} \end{center} \end{figure} \fi As shown in the Figure \ref{fig:t_eff}, node $j$ and $k$ are hidden from each other with respect to the receiver node $i$. Suppose node $j$ starts transmitting while nodes $i$ and $k$ are silent. Since node $k$ cannot hear node $j$, it can start its own transmission while the transmission from node $j$ is still going on. For node $i$, this looks like a dilated transmission period, whose length is denoted by $T_{i}^{(\mathsf{eff})}$. \end{description} \section{Derivation of Node Interaction Equations} \label{sec:fixed-pt-eqns-derivation} In the following subsections, we consider the node processes described in Section~\ref{sec:analytical-model}, and identify certain useful steady state quantities at each node, e.g., CCA attempt rate. Then we employ the decoupling approximation (described in Section~\ref{sec:analytical-model}), and detailed stochastic analysis, to write down certain fixed point equations relating these quantities. In doing this, \emph{we assume the network to be stable so that these steady state quantities exist}. Then in Section~\ref{sec:iterative-scheme}, we use an iterative scheme to solve for the unknown variables, and finally use the quantities thus obtained to evaluate the network performance, namely, end-to-end delay and packet delivery probability from each source node. The analysis will be presented for the more general case where hidden nodes may be present in the system; wherever necessary, we shall mention the changes required in the expressions for the special case where no hidden nodes are present in the system. \subsection{Derivation of Fixed Point Equations} \label{subsec:fixed-pt-derivation} We begin by analyzing the process at node $i$ shown in Figures~\ref{fig:ARP_calc_of_rates} and \ref{fig:system}. Consider an epoch at which node $i$ starts its backoffs in order to send the first packet in its queue. At this instant, each node $j \in \Omega_i$ is either empty or performing backoffs for its HOL packet or transmitting its HOL packet. Recall that the rate at which node $i$ completes backoffs during its backoff periods is denoted by $\beta_i$. The activity of node $i$ is affected by the residual rate of CCA attempts by $j \in \Omega_i$ after removing those CCA attempts that fail due to nodes that are hidden from node $i$; this rate is denoted by $\overline{\tau}^{(i)}_j$. Modeling these conditional attempt processes as independent Poisson processes, we define: \begin{eqnarray*} \eta_i = \frac{\beta_i}{\beta_i + \displaystyle{\sum_{j\in\Omega_i}\overline{\tau}_j^{(i)}}} \quad &;& \quad g_i = \frac{1}{\beta_i + \displaystyle{\sum_{j\in\Omega_i}\overline{\tau}_j^{(i)}}} \\ \text{and} \qquad c_i &=& \Bigg(1-e^{-12~T_\mathsf{s}\beta_i}\Bigg) \end{eqnarray*} Thus, $\eta_i$ is the probability that node $i$ makes a CCA attempt before any node in $\Omega_i$, $g_i$ is the mean time until the first CCA attempt, and $c_i$ is the probability that after an attempt by a node in $\Omega_i$, node $i$ attempts within the 12 symbol vulnerable period, thus causing a ``simultaneous'' channel sensing collision (see Figure~\ref{fig:simul_channel}). \if 0 Since ZigBee is designed to operate at fairly low packet generation rates at which packet discard probability (due to successive CCA failures or frame retries) is very low, all the recursive equations written below upto \ref{subsubsec:packet-failure} do not take packet discards into account. \fi \subsubsection{Perceived CCA attempt rate, $\overline{\tau}_j^{(i)}$} \noindent In a network with hidden nodes, in general, $\Omega_j \setminus \Omega_i$ is nonempty. Hence, CCA attempts of node $j$ could be blocked by the activities of nodes in $\Omega_j \setminus \Omega_i$, thus leading to the node~$i$ perceiving a CCA attempt rate from node~$j$ that is less than the CCA attempt rate when $\Omega_j \setminus \Omega_i = \phi$ (absence of hidden nodes). We have denoted this effective CCA attempt rate of node $j$ as perceived by node~$i$ by $\overline{\tau}_j^{(i)}$ for all $j \in \Omega_i$. Define \begin{description} \item [$N_j^{(\mathsf{cca})}(t)$:] Total number of CCAs attempts of Node $j$ in time $(0, t]$ \item [$N_j^{(\mathsf{ccaf_{-i}})}(t)$:] Number of failed CCA attempts of Node $j$ due to the nodes in $\Omega_j \setminus \Omega_i$ in time $(0, t]$ \item [$I_j(t)$:] The time during which node $j$ is not transmitting in time $(0, t]$ \item [$T_{j}^{\mathsf{(bo)}}(t)$:] Time for which node $j$ is in backoff in the interval $(0, t]$ \item [$T_{j}^{\mathsf{(ne)}}(t)$:] Queue non-empty period of node $j$ in the interval $(0, t]$ \end{description} Note that with these definitions, we have \begin{align*} \beta_j &= \lim_{t\rightarrow \infty}\frac{N_{j}^{(\mathsf{cca})}(t)}{T_{j}^{\mathsf{(bo)}}(t)}\text{ a.s} \end{align*} We can further define, \begin{align*} b_j &= \lim_{t\rightarrow \infty}\frac{T_{j}^{\mathsf{(bo)}}(t)}{T_{j}^{\mathsf{(ne)}}(t)}\\ q_j &= \lim_{t\rightarrow \infty}\frac{T_{j}^{\mathsf{(ne)}}(t)}{t} \end{align*} where $b_j$ can be interpreted as the long-term fraction of time node $j$ is in backoff provided it is non-empty, and $q_j$ is the long-term fraction of time that node $j$ is non-empty, which is also the queue non-empty probability of node $j$, assuming the system is ergodic. Then, we can write \begin{align*} \overline{\tau}_j^{(i)} &= \lim_{t\rightarrow \infty}\frac{N_j^{(\mathsf{cca})}(t) - N_j^{(\mathsf{ccaf_{-i}})}(t)}{I_j(t)} \text{ a.s}\\ &= \lim_{t\rightarrow \infty} \frac{\frac{N_{j}^{(\mathsf{cca})}(t)}{T_{j}^{\mathsf{(bo)}}(t)}\times \frac{T_{j}^{\mathsf{(bo)}}(t)}{T_{j}^{\mathsf{(ne)}}(t)}\times \frac{T_{j}^{\mathsf{(ne)}}(t)}{t}\times \left(1 - \frac{N_j^{(\mathsf{ccaf_{-i}})}(t)}{N_j^{(\mathsf{cca})}(t)}\right) }{\frac{I_{j}(t)}{t}} \end{align*} Using the earlier definitions, we have \begin{align} \overline{\tau}_j^{(i)} &= \frac{\beta_j \times b_j \times q_j \times (1 - \alpha_j^{(-i)})}{1 - q_j + q_j \times b_j}\label{eqn:1} \end{align} where $\alpha_j^{(-i)}$ is the probability of CCA failure of node $j$ only due to the nodes in $\Omega_j \setminus \Omega_i$, and is derived below. \subsubsection{Computation of $\alpha_j^{(-i)}$} Using the notation introduced earlier, we can write \begin{align*} \alpha_j^{(-i)} &= \lim_{t\rightarrow \infty} \frac{N_j^{(\mathsf{ccaf_{-i}})}(t)}{N_j^{(\mathsf{cca})}(t)} \text{ a.s}\\ &= \lim_{t\rightarrow \infty} \frac{\frac{N_j^{(\mathsf{ccaf_{-i}})}(t)}{T_j^{(\mathsf{ne})}(t)}}{\frac{N_j^{(\mathsf{cca})}(t)}{T_j^{(\mathsf{ne})}(t)}} \\ \end{align*} Applying the Renewal-Reward Theorem (RRT) \cite{kulkarni95modeling-stochastic-systems}, we have \begin{align} \alpha_j^{(-i)} &= \frac{\frac{\mathbf{N}_j^{(\mathsf{ccaf_{-i}})}}{W_{j}}}{\frac{\mathbf{N}_j^{(\mathsf{cca})}}{W_{j}}} \\ &= \frac{\mathbf{N}_j^{(\mathsf{ccaf_{-i}})}}{\mathbf{N}_j^{(\mathsf{cca})}}\label{eqn:alpha_j_i_exp} \end{align} where $W_j$ is the mean time between the ends of transmission during a busy period of node $j$ (i.e., the mean renewal cycle length). Now, by taking the reward to be the mean number of total CCAs by node $j$ in the renewal cycle, we can write \begin{align*} \mathbf{N}_j^{(\mathsf{cca})} &= \eta_j + (1 - \eta_j)c_j + (1 - \eta_j)(1 - c_j)(\beta_j T_j^{(\mathsf{eff})} + \mathbf{N}_j^{(\mathsf{cca})}) \end{align*} \if 0 Here, the first term says that with probability $\eta_j$ , only one CCA is performed by node $j$ after which it starts transmitting, and the cycle ends. The second term corresponds to an event of simultaneous channel sensing in which node $j$ is involved with some other node that had already started its transmission, as a result of which there is only one CCA performed by node $j$ followed by its data transmission and the cycle ends. In the final term, node $j$ neither starts transmitting first nor it is involved in a simultaneous channel sensing event. \fi Note that node $j$ performs CCAs at the rate of $\beta_j$ for the entire dilated transmission period $T_j^{(\mathsf{eff})}$ i.e., a total of $\beta_j T_j^{(\mathsf{eff})}$ CCAs all of which fail, and the cycle continues after this period. Upon rearranging terms, we have \begin{align}\label{eqn:N_cca_eqn} \mathbf{N}_j^{(\mathsf{cca})} &= \frac{\eta_j + (1 - \eta_j)c_j + (1 - \eta_j)(1 - c_j)\beta_j T_j^{(\mathsf{eff})} }{1 - (1 - \eta_j)(1 - c_j)} \end{align} Again, let the reward be the mean number of failed CCA attempts by node $j$ in a renewal cycle due to transmissions by nodes in $\Omega_j \setminus \Omega_i$, say $\mathbf{N}_j^{(\mathsf{ccaf_{-i}})}$, which we can write, using \textbf{(S7)} as \begin{equation}\label{eqn:ccafail_node_j}\begin{split} \mathbf{N}_j^{(\mathsf{ccaf_{-i}})}&=\left(\frac{\displaystyle{\sum_{k\in \Omega_j \cap \Omega_i} \overline{\tau}_k^{(j)}}}{\beta_j + \displaystyle{\sum_{l\in \Omega_j} \overline{\tau}_l^{(j)}}} \right)(1 - c_j)\left(\mathbf{N}_j^{(\mathsf{ccaf_{-i}})}\right) + \\ &\left(\frac{\displaystyle{\sum_{k\in \Omega_j \setminus \Omega_i} \overline{\tau}_k^{(j)}}}{\beta_j + \displaystyle{\sum_{l\in \Omega_j} \overline{\tau}_l^{(j)}}} \right) (1 - c_j)\left(\beta_j T_{\mathsf{tx}} + \mathbf{N}_j^{(\mathsf{ccaf_{-i}})}\right) \end{split}\end{equation} Clearly, in case of a simultaneous channel sensing event involving node $j$, the cycle ends with zero reward. Therefore, the terms in Equation~\eqref{eqn:ccafail_node_j} only consider the case where node $j$ is not involved in simultaneous channel sensing. The first term in \eqref{eqn:ccafail_node_j} corresponds to transmission attempts by nodes in $\Omega_j \cap \Omega_i$; this results in zero reward, and the cycle continues thereafter. The second term accounts for transmission attempts by nodes in $\Omega_j \setminus \Omega_i$; this results in a total reward of $\beta_j T_{\mathsf{tx}}$ and the cycle continues thereafter. Upon rearranging terms, we have \begin{align*} \mathbf{N}_j^{(\mathsf{ccaf_{-i}})} &= \frac{\left(\frac{\displaystyle{\sum_{k\in \Omega_j \setminus \Omega_i} \overline{\tau}_k^{(j)}}}{\beta_j + \displaystyle{\sum_{l\in \Omega_j} \overline{\tau}_l^{(j)}}} \right)(1 - c_j)\left(\beta_j T_{\mathsf{tx}}\right)}{1 - (1 - \eta_j)(1 - c_j)} \end{align*} Hence from \ref{eqn:alpha_j_i_exp}, the CCA failure probability of node $j$ only due to the nodes in $\Omega_j \setminus \Omega_i$ is given by \begin{align} \alpha_j^{(-i)} &= \frac{\left(\frac{\displaystyle{\sum_{k\in \Omega_j \setminus \Omega_i} \overline{\tau}_k^{(j)}}}{\beta_j + \displaystyle{\sum_{l\in \Omega_j} \overline{\tau}_l^{(j)}}} \right)(1 - c_j)\left(\beta_j T_{\mathsf{tx}}\right)}{\eta_j + (1 - \eta_j)c_j + (1 - \eta_j)(1 - c_j)\beta_j T_j^{(\mathsf{eff})}}\label{eqn:6} \end{align} \remark For networks with no hidden nodes, $\alpha_j^{(-i)} = 0$. \subsubsection{The dilated activity period, $T_i^{(\mathsf{eff})}$} \label{subsubsec:Ti-eff} As mentioned earlier, the length of the dilated activity period as perceived by a node depends upon the set of nodes in its CS range. We propose two different models for calculating $T_i^{(\mathsf{eff})}$. \begin{itemize} \item[1. ] \textbf{$M/D/\infty$ Model :} Since each node has a different set of neighbours, we can make the following approximation to simplify our analysis: \begin{description} \item[(A1)] The mean length of Dilated Activity Period as perceived by node $i$ is equal to the length of mean busy period of an $M/D/\infty$ queue where the deterministic service time is equal to a single transmission period $T_{\mathsf{tx}}$, and the arrival process is approximated as a Poisson process having rate equal to the aggregate transmission initiation rate of \emph{all} the nodes in the CS range of node $i$. \end{description} Figure~\ref{fig:MDinf_approx} represents the $M/D/\infty$ model pictorially. Note that the above assumption is equivalent to saying that all nodes in $\Omega_i$ are hidden from each other, and hence this approximation results in a larger mean for the dilated activity period. Note that the transmission initiation rate of any node $j\in \Omega_i$, as perceived by node $i$, is $\overline{\tau}_j^{(i)}$. For any node $i$, let the aggregate transmission initiation rate for nodes in $\Omega_i$ be \begin{figure}[t] \begin{center} \includegraphics[scale=0.5]{figures/MDinf_approx.pdf} \caption{The $M/D/\infty$ approximation for the calculation of $T_i^{(\mathsf{eff})}$. The nodes in $\Omega_i$ are assumed to be hidden from each other and their transmission initiations are approximated by a Poisson process with a rate of $\zeta_i$ given by Equation~\eqref{eqn:zeta}. The service time for each of these transmissions is $T_{\mathsf{tx}}$.} \label{fig:MDinf_approx} \end{center} \end{figure} \begin{eqnarray} \zeta_i = \sum_{j\in \Omega_i}\overline{\tau}_j^{(i)} \label{eqn:zeta} \end{eqnarray} Assuming node $j\in \Omega_i$ has started transmission and another node $k \in \Omega_i$ starts at time $u < T_{\mathsf{tx}}$, the expression for $T_i^{(\mathsf{eff})}$ can be written recursively as \begin{eqnarray} \textstyle{T_i^{(\mathsf{eff})}} &\textstyle{=}& \textstyle{T_{\mathsf{tx}}\exp\{-\zeta_i T_{\mathsf{tx}}\} + \int_0^{T_{\mathsf{tx}}}(u+T_i^{(\mathsf{eff})})\zeta_i\exp\{-\zeta_i u \}du} \nonumber \\ &\textstyle{=}& \frac{1}{\zeta_i}(\exp\{\zeta_i T_{\mathsf{tx}}\} - 1) \end{eqnarray} \item[2. ] \textbf{Boorstyn et al. \cite{boorstyn-etal87CSMA-throughput-analysis} Model:} For node $i$ in Figure~\ref{fig:t_eff}, Figure~\ref{fig:boorstyn_model} shows its evolution process in conditional time. We see that when nodes in $\Omega_i$ attempt packet transmission, then we have a dilated transmission period, $T_i^{(\mathsf{eff})}$ as perceived by Node $i$. \begin{figure*}[t] \begin{center} \includegraphics[scale=0.5]{figures/boorstyn.pdf} \caption{Evolution Process of Node $i$ in conditional time. We see that when nodes in $\Omega_i$ attempt packet transmission, we have a dilated transmission period, $T_i^{(\mathsf{eff})}$ as perceived by Node $i$.} \label{fig:boorstyn_model} \end{center} \end{figure*} \begin{figure}[h] \begin{center} \includegraphics[scale=0.3]{figures/state_transition_diag.pdf} \caption{State transition diagram for computing $T_i^{(\mathsf{eff})}$ for the nodes in Figure~\ref{fig:t_eff}} \label{fig:state_diagram} \end{center} \end{figure} Here we will use a CTMC model as suggested by Boorstyn et al. \cite{boorstyn-etal87CSMA-throughput-analysis} for determining $T_i^{(\mathsf{eff})}$ during times when node $i$ is non empty. Let $\phi_{i}$ be the state when all the nodes in $\Omega_i$ as well as node $i$ are in backoff. Then the state transition diagram for computing $T_i^{(\mathsf{eff})}$ for the nodes in Figure~\ref{fig:t_eff} is shown in Figure~\ref{fig:state_diagram}. Note that return to $\phi_{i}$ are renewal instants since the transition out of $\phi_{i}$ are all exponentially distributed. By the \emph{insensitivity property} explained in \cite{boorstyn-etal87CSMA-throughput-analysis}, the steady state probability of being in state $\phi_{i}$, say $\pi_{\phi_{i}}$, does not depend on the distribution of packet transmission time except by its mean. So we can take the packet service times to be exponentially distributed. Hence $\pi_{\phi_{i}}$ can be obtained as in \cite{boorstyn-etal87CSMA-throughput-analysis}, i.e., \begin{align}\label{eqn:phi_eqn_1} \pi_{\phi_{i}} &= \left[\sum_{D_{i}\in \mathscr{D}_i} \prod_{j \in D_{i}} \overline{\tau}_j^{(i)} T_{\mathsf{tx}}\right]^{-1} \end{align} where $D_{i}$ is a set of nodes in $\Omega_i$ that are actively transmitting, and $\mathscr{D}_i$ is the collection of all such sets. Again, from the RRT we obtain $\pi_{\phi_i}$ as the ratio of the time the system is in state $\phi_{i}$ and the mean time between the ends of transmission during a busy period of Node~$i$, i.e., \begin{equation*} \resizebox{1.0\hsize}{!}{$\pi_{\phi_{i}} = \frac{\frac{1}{\beta_i + \displaystyle{\sum_{j \in \Omega_i} \overline{\tau}_j^{(i)}}}}{\frac{1}{\beta_i + \displaystyle{\sum_{j \in \Omega_i} \overline{\tau}_j^{(i)}}} + \frac{\beta_i}{\beta_i + \displaystyle{\sum_{j \in \Omega_i} \overline{\tau}_j^{(i)}}} \times T_{\mathsf{tx}} + \frac{\displaystyle{\sum_{j \in \Omega_i} \overline{\tau}_j^{(i)}}}{\beta_i + \displaystyle{\sum_{j \in \Omega_i} \overline{\tau}_j^{(i)}}} \times T_{i}^{(\mathsf{eff})}}$} \end{equation*} which yields \begin{equation}\label{eqn:phi_eqn_2} \pi_{\phi_{i}} = \frac{1}{1 + \beta_i \times T_{\mathsf{tx}} + \left(\displaystyle{\sum_{j \in \Omega_i} \overline{\tau}_j^{(i)}}\right)\times T_{i}^{(\mathsf{eff})}} \end{equation} Hence, from Equation~\eqref{eqn:phi_eqn_1} and \eqref{eqn:phi_eqn_2}, we can obtain $T_{i}^{(\mathsf{eff})}$ for each node $i$. Observe that the dilated activity period computed using the Boorstyn et al. model would be less conservative than the $M/D/\infty$ model. Also note that identification of $\mathscr{D}_{i}$ is an NP-complete combinatorial problem \cite{boorstyn-etal87CSMA-throughput-analysis}; however, efficient algorithms exist that handle networks of arbitrary topology and moderate size (50-100 nodes). \end{itemize} \subsubsection{Probability of CCA failure, $\alpha_i$} The probability of CCA failure is the probability of the occurrence of at least one transmitting node in the CS range of node $i$, given that node $i$ performs a CCA. Defining $N_i^{(\mathsf{cca})}(t)$ and $N_i^{(\mathsf{f})}(t)$ as the total number of CCAs and number of failed CCAs in the interval $(0,t]$, respectively, we have: \begin{eqnarray*} \alpha_i = \lim_{t \to \infty}\frac{N_i^{(\mathsf{f})}(t)}{N_i^{(\mathsf{cca})}(t)} \text{ a.s }= \lim_{t \to \infty}\frac{\frac{N_i^{(\mathsf{f})}(t)}{T_{i}^{\mathsf{(ne)}}(t)}}{\frac{N_i^{(\mathsf{cca})}(t)}{T_{i}^{\mathsf{(ne)}}(t)}} \end{eqnarray*} Applying Renewal-Reward Theorem (RRT) \cite{kulkarni95modeling-stochastic-systems}, we get \begin{eqnarray} \alpha_i &=&\frac{\frac{\mathbf{N}_i^{(\mathsf{f})}}{W_i}}{\frac{\mathbf{N}_i^{(\mathsf{cca})}}{W_i}}\nonumber\\ &=&\frac{\mathbf{N}_i^{(\mathsf{f})}}{\mathbf{N}_i^{(\mathsf{cca})}} \label{eqn:alpha_rates} \end{eqnarray} where $\mathbf{N}_i^{(\mathsf{f})}$ is the mean number of failed CCAs and $\mathbf{N}_i^{(\mathsf{cca})}$ is the mean number of total CCAs in a cycle. $W_i$ is the mean renewal cycle length. \if 0 It is given by \begin{eqnarray*} W_i &=& g_i+\eta_i T_{\mathsf{tx}}+(1-\eta_i)c_i T_{\mathsf{tx}}+(1-\eta_i)(1-c_i)(T^{(\mathsf{eff})}_i+W_i) \end{eqnarray*} The first term is the mean time until any node in $\Omega_i \cup \{i\}$ starts transmission as seen by node $i$. In the second term, with probability $\eta_i$, node $i$ finishes its backoff first and attempts a CCA. Since no other node is transmitting, this CCA succeeds and node $i$ transmits a packet and the cycle ends after the transmission period $T_{\mathsf{tx}}$. Note that this transmission period cannot be dilated because it blocks all the nodes in $\Omega_i$ (ignoring the maximum jitter of $12~T_\mathsf{s}$ due to simultaneous channel sensing). The third terms says that some other node finishes its backoff first \emph{and} starts transmitting further getting involved in a simultaneous channel sensing event with node $i$ (which happen with a probability of $c_i$) due to which node $i$ starts transmitting and the cycle ends after the transmission period $T_{\mathsf{tx}}$ (again note that this transmission period cannot be dilated either). The final term depicts the event in which another node starts transmitting first and node $i$ does not perform a CCA in the vulnerable period. This transmission period is susceptible to dilation and hence taken to be $T_i^{(\mathsf{eff})}$. The final expression for $W_i$ turns out to be \begin{eqnarray*} W_i &=& \frac{g_i+\eta_i T_{\mathsf{tx}}+(1-\eta_i)c_i T_{\mathsf{tx}}+(1-\eta_i)(1-c_i)T_i^{(\mathsf{eff})}}{1-(1-\eta_i)(1-c_i)} \end{eqnarray*} \fi Computation of $\mathbf{N}_i^{(\mathsf{cca})}$ is as in Equation~\eqref{eqn:N_cca_eqn}. Now the mean number of failed CCA attempts by node $i$ in a renewal cycle, i.e., $\mathbf{N}_i^{(\mathsf{f})}$, can be written using \textbf{(S7)} as \begin{eqnarray*} \mathbf{N}_i^{(\mathsf{f})} &=& (1-\eta_i)(1-c_i)\Big(\beta_i T^{(\mathsf{eff})}_i+\mathbf{N}_i^{(\mathsf{f})}\Big) \end{eqnarray*} Rearranging and using Equation~\eqref{eqn:alpha_rates}, the CCA failure probability is given by \begin{eqnarray} \alpha_i &=& \frac{(1-\eta_i)(1-c_i)\beta_i T^{(\mathsf{eff})}_i}{\eta_i + (1-\eta_i)c_i + (1-\eta_i)(1-c_i)\beta_i T^{(\mathsf{eff})}_i} \label{eqn:alpha} \end{eqnarray} \remark Note that for no hidden node network, $T^{(\mathsf{eff})}_i = T_{\mathsf{tx}}$. \subsubsection{Packet failure probability, $\gamma_i$} \label{subsubsec:packet-failure} A transmitted packet can fail to be decoded by its intended receiver due to a collision, or due to noise. We do not take packet capture into account here (see \textbf{(S3)}). Define $M_i(t)$ as the total number of transmissions in interval $(0,t]$, $M_i^{(\mathsf{c})}(t)$ as total number of collisions in interval $(0,t]$ and $l_i$ as the probability of \emph{data} packet error (known by \textbf{(S5)}) on the link between node $i$ and its receiver $r(i)$ due to noise. Recall that ACKs are not corrupted by PHY noise (see \textbf{(S6)}). The probability of packet failure, $\gamma_i$, is defined as: \begin{eqnarray*} \gamma_i&=&\Bigg(\lim_{t \to \infty}\frac{M_i^{(\mathsf{c})}(t)}{M_i(t)}\Bigg)+\Bigg(1-\lim_{t \to \infty}\frac{M_i^{(\mathsf{c})}(t)}{M_i(t)}\Bigg)l_i \text{ a.s } \end{eqnarray*} Dividing each term in limit by $T_{i}^{\mathsf{(ne)}}(t)$ and applying RRT, we get \begin{eqnarray*} \gamma_i &=& \Bigg(\frac{\frac{\mathbf{M}_i^{(\mathsf{c})}}{W_i}}{\frac{\mathbf{M}_i}{W_i}}\Bigg) + \Bigg(1 - \frac{\frac{\mathbf{M}_i^{(\mathsf{c})}}{W_i}}{\frac{\mathbf{M}_i}{W_i}}\Bigg)l_i \end{eqnarray*} where $\mathbf{M}_i^{(\mathsf{c})}$ is the mean number of collided packets, and $\mathbf{M}_i$ is the mean number of transmitted packets in a renewal cycle. If we ignore packet discards, there is a single transmission by node $i$ in each renewal cycle so that $\mathbf{M}_i$ becomes unity. We can rewrite \begin{eqnarray} \gamma_i &=& p_i +(1-p_i )l_i \label{eqn:gamma} \end{eqnarray} where $p_i $ is the probability of packet collision and equals $\mathbf{M}_i^{(\mathsf{c})}$. Since $l_i$ is given for each node $i$, we need to compute probability of packet collision, $p_i$, to compute packet failure probability, $\gamma_i$. We denote the set of nodes that can cause interference in successful reception at $r(i)$ by $I_{r(i)}$, which is composed of two sets: \begin{center} $C^{(1)}_{r(i)}=\{j\in\mathscr{N}: j\in\Omega_i\text{ and }j\in I_{r(i)}\}$\\ $C^{(2)}_{r(i)}=\{j\in\mathscr{N}: j \notin\Omega_i\text{ and }j \in I_{r(i)}\}$ \end{center} such that \begin{eqnarray*} C^{(1)}_{r(i)}\cap C^{(2)}_{r(i)}&=&\emptyset\\ C^{(1)}_{r(i)}\cup C^{(2)}_{r(i)}&=&I_{r(i)} \end{eqnarray*} Note that the receiver $r(i)$ is in $C^{(1)}_{r(i)}$ (see Figure~\ref{fig:interference}). \begin{figure}[ht] \begin{center} \includegraphics[scale=0.45]{figures/interference.pdf} \caption{Interference region around the receiver. $R^{(CS)}$ is the CS range which is assumed to be equal for all nodes by \textbf{(S9)}.} \label{fig:interference} \vspace{-5mm} \end{center} \end{figure} Let the reward be the mean number of collisions of node $i'$s packets in a renewal cycle, say, $\mathbf{M}_i^{(\mathsf{c})}$ , which can be written as \begin{eqnarray*} \mathbf{M}_i^{(\mathsf{c})} &=& (1-\eta_i)(1-c_i)\mathbf{M}_i^{(\mathsf{c})} + \overline{\mathbf{M}}_i^{(\mathsf{c})} \end{eqnarray*} where $\overline{\mathbf{M}}_i^{(\mathsf{c})}$ is mean number of collisions of node $i'$s packets in a renewal cycle when node $i$ attempts a packet transmission or does a simultaneous channel sensing. On rearranging, the packet collision probability at node $i$ is given by \begin{eqnarray} p_i &=& \frac{\overline{\mathbf{M}}_i^{(\mathsf{c})}}{1-(1-\eta_i)(1-c_i)} \label{eqn:p} \end{eqnarray} To compute $\overline{\mathbf{M}}_i^{(\mathsf{c})}$, we first need to find the probability that nodes in a given set are not transmitting using a product approximation due to the unavailability of joint distribution of processes. Let $\overline{h}_i$ be the fraction of time node $i$ is not transmitting (unconditional) and is equal to \begin{eqnarray*} \overline{h}_i &=& \lim_{t\rightarrow \infty}\frac{I_i(t)}{t} \quad \text{ a.s}\\ &=& (1-q_i) + q_ib_i \end{eqnarray*} The expression for $\overline{\mathbf{M}}_i^{(\mathsf{c})}$ can be found as the sum of several components as follows: \begin{description}[leftmargin=0cm] \item[1.] The first term accounts for the fact that Node $i$ started transmitting in the presence of at least one transmission by the hidden nodes set, i.e., $C^{(2)}_{r(i)}$. \begin{eqnarray*} R_i^{(1)} &=& \eta_i\Bigg(1-\prod_{j\in C^{(2)}_{r(i)}}\overline{h}_j\Bigg) \end{eqnarray*} \item[2.] The second term accounts for the scenario when Node $i$ started its transmission as a simultaneous channel sensing with a node in $\Omega_i$ in the presence of at least one transmission by the hidden nodes set, i.e., $C^{(2)}_{r(i)}$.. \begin{eqnarray*} R_i^{(2)} &=& (1-\eta_i)c_i\Bigg(1-\prod_{j\in C^{(2)}_{r(i)}}\overline{h}_j\Bigg) \end{eqnarray*} \item[3.] The third term considers the case where Node $i$ starts transmitting in the absence of any ongoing transmission by a hidden node but it encounters a simultaneous transmission by a node in $C^{(1)}_{r(i)}$ anywhere in the corresponding $12~T_s$ period and/or a transmission by a node in $C^{(2)}_{r(i)}$, i.e., a hidden node anywhere in its activity period $T_{\mathsf{tx}}$. \begin{eqnarray*} \scriptstyle{R_i^{(3)}} &\scriptstyle{=}& \scriptstyle{\eta_i\Bigg(\prod_{j\in C^{(2)}_{r(i)}}\overline{h}_j\Bigg)\Bigg(1-\exp \Bigg\{-12~T_s\Bigg( \displaystyle{\sum_{j\in C^{(1)}_{r(i)}}}\overline{\tau}_j^{(i)} \Bigg) \Bigg\}.} \\ && \scriptstyle{\exp \Bigg\{-T_{\mathsf{tx}}\Bigg(\displaystyle{\sum_{j\in C^{(2)}_{r(i)}}}\overline{\tau}_j\Bigg)\Bigg\}\Bigg) } \end{eqnarray*} where $\overline{\tau}_j$ is the rate of successful CCA attempts of node $j$ over non-transmitting period, $I_j(t)$ and is equal to \begin{align*} \overline{\tau}_j &= \lim_{t \rightarrow \infty }\frac{N^{(\mathsf{cca})}_j(t) - N^{(\mathsf{f})}_j(t)}{I_j(t)} \quad \text{ a.s}\\ &= \frac{\beta_j b_j q_j (1 - \alpha_j)}{1 - q_j + q_jb_j} \end{align*} \item[4.] The fourth term says that Node $i$ started its transmission as a simultaneous channel sensing with a node in $C^{(1)}_{r(i)}$ in the absence of any hidden node. This event surely ends up in a collision at the receiver $r(i)$. \begin{eqnarray*} R_i^{(4)} &=& \Bigg(\frac{\displaystyle{\sum_{j\in C^{(1)}_{r(i)}}\overline{\tau}_j^{(i)}}}{\beta_i+\displaystyle{\sum_{j\in \Omega_i}\overline{\tau}_j^{(i)}}}\Bigg)c_i\Bigg(\prod_{j\in C^{(2)}_{r(i)}}\overline{h}_j\Bigg) \end{eqnarray*} \item[5.] The final term says that Node $i$ started its transmission as a simultaneous channel sensing with a node in $\Omega_i \setminus C^{(1)}_{r(i)}$ in the absence of any hidden node but it encounters a simultaneous transmission by a node in $C^{(1)}_{r(i)}$ and/or by a node in $C^{(2)}_{r(i)}$, i.e., a hidden node. \begin{align*} R_i^{(5)} &= \Bigg(\frac{\displaystyle{\sum_{j\in \Omega_i\setminus C^{(1)}_{r(i)}}\overline{\tau}_j^{(i)}}}{\beta_i+\displaystyle{\sum_{j\in \Omega_i}\overline{\tau}_j^{(i)}}}\Bigg)c_i\Bigg(\prod_{j\in C^{(2)}_{r(i)}}\overline{h}_j\Bigg) \nonumber\\ & \bigg(1-\exp \Bigg\{-12~T_\mathsf{s}\Bigg( \displaystyle{\sum_{j\in C^{(1)}_{r(i)}}}\overline{\tau}_j^{(i)} \Bigg) \Bigg\} \nonumber\\ &\exp \Bigg\{-T_{\mathsf{tx}}\Bigg(\displaystyle{\sum_{j\in C^{(2)}_{r(i)}}}\overline{\tau}_j\Bigg)\Bigg\}\Bigg) \end{align*} \end{description} The overall packet collision probability is given by \begin{eqnarray} p_i &=& \frac{R_i^{(1)}+R_i^{(2)}+R_i^{(3)}+R_i^{(4)}+R_i^{(5)}}{\eta_i+(1-\eta_i)c_i} \label{eqn:p_hidden} \end{eqnarray} The packet failure probability, $\gamma_i$, can now be calculated using Equations~\eqref{eqn:p_hidden} and \eqref{eqn:gamma}. \remark Note that for no hidden node network $C^{(2)}_{r(i)} = \phi$ and $\prod_{j\in C^{(2)}_{r(i)}}\overline{h}_j = 1$ \subsubsection{Average Service Rate ($\sigma_i$)} Each packet that reaches the HOL position in the queue at a node can have multiple backoffs and transmissions before it is successfully transmitted or discarded. We define $\overline{Z}_i$ as the average time spent in backoff, and $\overline{Y}_i$ as the average transmission time until the packet is successfully transmitted or discarded at the MAC layer. Then the average service rate, $\sigma_i$, at node $i$ can be calculated as: \begin{eqnarray} \frac{1}{\sigma_i}=\overline{Z}_i + \overline{Y}_i \label{eqn:sigma} \end{eqnarray} Using the default values from the standard, the mean backoff durations can be calculated (shown in Table~\ref{tab:mean_backoff_durations}). \begin{table}[b] \begin{center} {\scriptsize \begin{tabular}{ccc} \hline \hline \textbf{Backoff} & \textbf{Mean Backoff Duration} & \textbf{Mean Backoff Duration}\\ \textbf{Exponent} & \textbf{with successful CCA($T_\mathsf{s}$)} & \textbf{with failed CCA($T_\mathsf{s}$)}\\ \hline \hline $3$ & $70+20$ & $70+8$\\ \hline $4$ & $150+20$ & $150+8$\\ \hline $5$ & $310+20$ & $310+8$\\ \hline \hline \end{tabular} } \caption{Mean backoff durations in symbol times, $T_\mathsf{s}$} \label{tab:mean_backoff_durations} \end{center} \end{table} Define the following quantities: \begin{align*} \scriptstyle{\overline{B}_i} &\scriptstyle{=} \scriptstyle{\left(70+8+158\alpha_i + 318\alpha_i^2 + 318\alpha_i^3 + 318\alpha_i^4\right)}\\ \scriptstyle{T_i^{(1)}}&\scriptstyle{=}\scriptstyle{\Bigg(\frac{(70+8)(1-\alpha_i)}{(1-\alpha_i^5)}+\frac{236\alpha_i(1-\alpha_i)}{(1-\alpha_i^5)}+\frac{554\alpha_i^2(1-\alpha_i)}{(1-\alpha_i^5)}}\\ &\scriptstyle{+\frac{872\alpha_i^3(1-\alpha_i)}{(1-\alpha_i^5)}+\frac{1190\alpha_i^4(1-\alpha_i)}{(1-\alpha_i^5)}\Bigg) }\\ \scriptstyle{T_i^{(2)}}&\scriptstyle{=}\scriptstyle{(78+158+318+318+318)} \end{align*} where $\overline{B}_i$ refers to the mean backoff duration until the packet is transmitted or discarded due to successive CCA failures, $T_i^{(1)}$ has the interpretation of the mean backoff duration given that the packet transmission was successful, and $T_i^{(2)}$ is the mean time spent in backoff given that the packet was discarded due to successive CCA failures. Then the quantities $\overline{Z}_i$ and $\overline{Y}_i$ can be calculated as: \begin{eqnarray*} \scriptstyle{\overline{Z}_i}&\scriptstyle{=}&\scriptstyle{\alpha_i^5T_i^{(2)}+(1-\alpha_i^5)[T_i^{(1)}+\gamma_i(\alpha_i^5T_i^{(2)}+(1-\alpha^5)} \\ &&\scriptstyle{[T_i^{(1)}+\gamma_i(\alpha_i^5T_i^{(2)}+(1-\alpha_i^5)[T_i^{(1)}+\gamma_i(\alpha_i^5T_i^{(2)}+(1-\alpha_i^5)T_i^{(1)})])])]}\\ \scriptstyle{\overline{Y}_i}&\scriptstyle{=}&\scriptstyle{(1-\alpha_i^5)[T_{\mathsf{tx}}+\gamma_i(1-\alpha_i^5)[T_{\mathsf{tx}}+\gamma_i(1-\alpha_i^5)[T_{\mathsf{tx}}+\gamma_i(1-\alpha_i^5)T_{\mathsf{tx}}]]]} \end{eqnarray*} \subsubsection{Aggregate Arrival Rate ($\nu_i$), Goodput ($\theta_i$) and Discard Probability ($\delta_i$) for a Node} The arrival process at each node consists of packets which are generated at the same node (if it is a sensor) and the packets to be forwarded. The aggregate arrival rate at a node $i$ can be written as: \begin{eqnarray} \nu_i=\lambda_i+\sum_{k\in\mathcal{P}_i}\theta_k \label{eqn:nu} \end{eqnarray} where $\lambda_i$ is the packet generation rate at sensor node $i$, $\mathcal{P}_i$ is the set of all its in-neighbours, and $\theta_i$ is the rate of packet transmission by the node which are \emph{successfully received} at $r(i)$ (known as goodput). An enqueued packet at a node is successfully received by the intended receiver in a manner shown in Figure~\ref{fig:goodput}. \begin{figure}[h] \begin{center} \includegraphics[scale=0.5]{figures/goodput.pdf} \caption{The goodput of a node is defined as the rate of successfully received packets by its receiver.} \label{fig:goodput} \vspace{-5mm} \end{center} \end{figure} Assuming that the queueing system is stable and has a steady-state solution, the goodput $\theta_i$ is given by \begin{eqnarray} \theta_i=\nu_i(1-\delta_i) \label{eqn:theta_arrival} \end{eqnarray} where $\delta_i$ is the probability of discarding a packet due to consecutive CCA failures, or successive failed retransmission attempts, and is given by \begin{eqnarray} \scriptstyle{\delta_i=\alpha_i^5+(1-\alpha_i^5)\gamma_i\Big[\alpha_i^5+(1-\alpha_i^5)\gamma_i\Big[\alpha_i^5+(1-\alpha_i^5)\gamma_i\Big[\alpha_i^5+(1-\alpha_i^5)\gamma_i\Big]\Big]\Big]} \label{eqn:delta} \end{eqnarray} Note that if the queue at node $i$ is saturated, then the goodput $\theta_i$ is equal to $\sigma_i$. Note that while calculating $\sigma_i$, we have taken the packet discards into account. \subsubsection{The node non-empty probability, $q_i$}\label{non_empty_prob} To find the expression for $q_i$, assuming that all the arriving packets reach the HOL position (i.e., no tail drops) and applying Little's Theorem, we get \begin{eqnarray} q_i=\frac{\nu_i}{\sigma_i} \label{eqn:q_arrival} \end{eqnarray} Further, for a saturated node, the quantity $q_i$ is equal to $1$. \subsubsection{Obtaining $b_i$ and $\beta_i$} In order to find $b_i$, the fraction of time a node is in backoff provided it is non-empty, we embed a renewal process in conditional time where the renewal epochs are those instants at which the node enters the random backoff period after a packet transmission or packet discard. We use the RRT to find the expression for $b_i$ as \begin{eqnarray} b_i=\frac{\overline{B}_i}{\overline{B}_i + (1-\alpha_i^5)T_{\mathsf{tx}}} \label{eqn:calc_of_b} \end{eqnarray} The quantity $\beta_i$, the rate of CCA attempts in backoff times, is based on the backoff completion times irrespective of the transmission attempt of the packet since a packet retransmission is considered the same as a new packet transmission. Thus, for the calculation of $\beta_i$, it suffices to observe the process at node $i$ only in the backoff times. Figure~\ref{fig:backoff_times} shows the residual backoff process where after completion of the backoff duration, the node performs a CCA. \begin{figure}[t] \begin{center} \includegraphics[height=30mm, width=93mm]{figures/backoff_times.pdf} \caption{Evolution of backoff periods in conditional (backoff) time. The $y$-axis is in units of a backoff slot ($20 ~T_\mathsf{s}$). The range indicates that the random backoff duration is uniformly distributed within it. The CCA duration, and Rx-to-Tx turnaround duration are 8 and 12 symbol times respectively, as indicated in the boxes.} \label{fig:backoff_times} \vspace{-5mm} \end{center} \end{figure} Using the result of Kumar et al. \cite{kumar-etal04new-insights} with their collision probability replaced by our CCA failure probability, $\alpha_i$, the expression for $\beta_i$ can be written as \begin{eqnarray} \beta_i=\frac{1+\alpha_i+\alpha_i^2+\alpha_i^3+\alpha_i^4}{\overline{B}_i} \label{eqn:beta} \end{eqnarray} \section{Iterative Solution and Calculation of Performance Measures} \label{sec:iterative-scheme} \begin{figure}[ht] \begin{center} \includegraphics[scale=0.38]{figures/iterations.pdf} \caption{The global iteration scheme. The square boxes indicate the derived quantities and the round boxes indicate the known quantities.} \label{fig:iterations} \vspace{-8mm} \end{center} \end{figure} \subsection{Global Iteration Scheme}\label{sec:iterations} The global iteration scheme to solve the fixed point equations derived above is shown in Figure~\ref{fig:iterations}. We start with a vector $\{0,10,\lambda_i,l_i\}$ corresponding to $\{\alpha_i,\overline{\tau}_j^{(i)},\nu_i,l_i\}$ for each node $i$ and node $j \in \Omega_i$, and repeat the procedure until the quantities converge. \subsection{Existence of a fixed point} A careful look at the derivation of the fixed point equations in Section~\ref{subsec:fixed-pt-derivation} reveals that the fixed point variables are $\{(\alpha_i,q_i)\}_{i=1}^N$, where $\alpha_i$ is the CCA failure probability at node $i$, and $q_i$ is the queue non-empty probability at node $i$. These variables are related via the set of equations~\eqref{eqn:1}, \eqref{eqn:6}, \eqref{eqn:phi_eqn_1}, \eqref{eqn:phi_eqn_2}, \eqref{eqn:alpha}, \eqref{eqn:gamma}, \eqref{eqn:p_hidden}, and \eqref{eqn:sigma}-\eqref{eqn:beta}. We observe that all the functions involved in the fixed point equations are continuous (since compositions, sums, and products of continuous functions are continuous, and also minimum of continuous functions is continuous). Hence, the fixed point equations can be represented as a \emph{continous} map from $[0,1]^{2N}$ to $[0,1]^{2N}$. Hence, the existence of a solution to the fixed point equations follows from Brouwer's fixed point theorem. Proving the uniqueness of the fixed point, and convergence of the iterative procedure to the fixed point is out of the scope of this work. For a detailed discussion of the complexity associated with these proofs for general multi-hop topologies, see Section IV.D in \cite{jindal09}. To the best of our knowledge, the only work to have attempted a formal proof of the uniqueness of the fixed point in the context of multi-hop networks is \cite{marbach11}, but that too for a rather simplified version of CSMA policies. However, \emph{in our numerical experiments, the fixed point iterations always converged to a solution}. \subsection{End-to-End Delay Calculation} We use the two parameter Whitt's QNA \cite{whitt83queueing-network-analyzer} to calculate the mean sojourn time at each node based on an approximate Moment Generating Function (MGF) of service time. We can write an expression for service time in a recursive manner by allowing infinite CCAs and retransmissions. To account for the discarded packets, we allow only a fraction of transmitted packets to join the next-hop neighbour's queue based on the discard probability at that node. We denote the service time at node $i$ by $S_i$, and let $B_i$ denote the length of random backoff duration, which is assumed to have an exponential distribution with rate $\beta_i$ for node $i$. Then, $S_i$ can be written as \begin{eqnarray*} S_i &=& \begin{cases} B_i + \tilde{S}_i & \text{w.p. } \alpha_i \\ B_i + T_{\mathsf{tx}} & \text{w.p. } (1-\alpha_i)(1-\gamma_i) \\ B_i + T_{\mathsf{tx}} + \tilde{S}_i & \text{w.p. } (1-\alpha_i)\gamma_i \end{cases} \end{eqnarray*} where $\tilde{S}_i$ is a random variable with the same distribution as $S_i$. The MGF of $B_i$, denoted by $M_{B_i}(z)$, is equal to $\frac{\beta_i}{z+\beta_i}$. Therefore, we can express the MGF $M_{S_i}(z)$ of service time $S_i$ as \begin{eqnarray*} M_{S_i}(z) &=& \frac{\beta_i(1-\alpha_i)(1-\gamma_i)e^{-zT_{\mathsf{tx}}}}{z+\beta_i(1-\alpha_i)(1-\gamma_ie^{-zT_{\mathsf{tx}}})}. \end{eqnarray*} The first two moments of the service time, $\mathbb{E}(S_i)$ and $\mathbb{E}(S_i^2)$ can be calculated by differentiating the MGF $M_{S_i}(z)$: \begin{eqnarray*} \mathbb{E}(S_i) &=& -\frac{d(M_{S_i}(z))}{dz}\Bigg \vert_{z=0} \\ \mathbb{E}(S_i^2) &=& \frac{d^2(M_{S_i}(z))}{dz^2}\Bigg \vert_{z=0} \end{eqnarray*} The QNA procedure commences from the leaf nodes and converges to the base-station in a sequential manner. We first calculate the squared coefficient of variance of service time, denoted by $c_{S_i}^2$, at each node, i.e., \begin{eqnarray*} c_{S_i}^2 &=& \frac{\mathbb{E}(S_i^2)}{(\mathbb{E}(S_i))^2} - 1 \end{eqnarray*} Ignoring the packet discards at the MAC layer, the net arrival rate $\Lambda_i$ at a node $i$ is given by: \begin{eqnarray*} \Lambda_i &=& \begin{cases} \lambda_i + \displaystyle{\sum_{k\in \mathcal{P}_i}}\theta_k & \text{for source-cum-relay nodes} \\ \displaystyle{\sum_{k\in \mathcal{P}_i}}\theta_k & \text{for relay nodes} \end{cases} \end{eqnarray*} For any node $i$, let $\rho_i$ be defined as \begin{eqnarray*} \rho_i &=& \begin{cases} \lambda_i\mathbb{E}(S_i) & \text{for leaf nodes} \\ \Lambda_i\mathbb{E}(S_i) & \text{for internal nodes} \end{cases} \end{eqnarray*} We now calculate the squared coefficient of variance for the departure process ($c_{D_i}^2$) for a node which uses the squared coefficient of variance for the interarrival times at that node ($c_{A_i}^2$). Here we include the probability of a packet discard which is equal to $\delta_i$. \begin{eqnarray*} c_{D_i}^2 &=& (1 - \delta_i)(1 + \rho_i^2(c_{S_i}^2 - 1) + (1-\rho_i^2)(c_{A_i}^2 - 1)) \end{eqnarray*} Further, $c_{A_i}^2$ is calculated as \begin{eqnarray*} c_{A_i}^2 &=& \frac{1}{\Lambda_i}\Bigg(\lambda_i + \displaystyle{\sum_{j\in \mathcal{P}_i}}\Lambda_jc_{D_j}^2\Bigg) \end{eqnarray*} Finally, the mean sojourn time at a node $i$ is given by \begin{eqnarray} \overline{\Delta}_i &=& \frac{\rho_i\mathbb{E}(S_i)(c_{A_i}^2 + c_{S_i}^2)}{2(1-\rho_i)} + \mathbb{E}(S_i) \end{eqnarray} The end-to-end mean packet delay for a source node $j$, provided that the set of nodes along the path from this node to the BS is $L_j$, is given by \begin{eqnarray} \Delta_j &=& \displaystyle{\sum_{i\in L_j}\overline{\Delta}_i} \end{eqnarray} \subsection{Packet Delivery Probability for each Source Node} $p_i^{(del)}$ for each source node $i$ is defined as the fraction of generated packets at source node $i$ that reach the base station without any time bound. Let the set of nodes constituting the path from a source node $i$ to the BS be $L_i$. Assuming that the drop events are independent from node to node, the expression for $p_i^{(del)}$ is \begin{eqnarray} p_i^{(del)} &=& \prod_{j\in L_i}(1-\delta_j) \end{eqnarray} where $\delta_j$ is the packet discard probability of node $j$. \section{Discussion on Validity of the Fixed Point Approach} \label{sec:dtmc-stability} We recall that we developed the analysis under the premise that the system of queues is stable, and, hence, all the steady state quantities involved in the fixed point equations exist. The next question we ask is whether, having performed the above analysis, we can use the results to conclude that the system of queues is indeed stable, which would provide a consistency in the overall approach. We proceed by modeling the CSMA/CA multihop network analyzed in Section~\ref{sec:analytical-model} as a Discrete Time Markov Chain (DTMC), and therefrom, deriving a sufficient condition for the stability of the network. \subsection{A DTMC Model} \label{subsec:dtmc} The system evolves \emph{synchronously} over slotted time (this is an idealization only for the analysis in this section), with the duration of each slot being 1 symbol time \footnote{Note that in a CSMA/CA network, all durations (e.g., backoff, transmission, CCA) are multiples of the symbol time}. We assume that the \emph{start instants of all backoffs are aligned with the slot boundaries}. Further, the external arrival process to each source node is assumed to be Poisson; hence the number of arrivals in successive slots are independent (independent increment property). The evolution of the queueing system can then be modeled as a DTMC embedded at these slot boundaries, with the state of each queue comprising of the following components: \begin{enumerate} \item Queue length at each node \item Residual backoff at each node \item Residual CCA time at each node \item Backoff stage (i.e., the number of CCA attempts for the current packet) at each node \item Transmission state (whether the node is transmitting a packet or not) at each node \item Retransmission stage (the number of retransmissions so far for the current packet) at each node \item Residual packet length when a node is transmitting (in symbol times) \end{enumerate} Note that except the queue lengths, all the other components of the state space are \emph{finite}, while the state space of the queue lengths is countable. Hence, the state space is countable. We denote the state at time step $n$ by $(\mathbf{X}(n),\mathbf{Y}(n))$, where $\mathbf{X}(n)=(X_1(n),\ldots,X_N(n))$ denotes the queue length process, and $\mathbf{Y}(n)$ denotes the rest of the components of the state taken together. Thus, $\mathbf{X}(n)\in\mathbb{Z}^n_+$, and $\mathbf{Y}(n)\in K_y$, where $K_y$ is a finite set of finite valued vectors. We adopt the following convention from \cite{panda} (see Figure 4 in Section~3.1 in \cite{panda}) for counting the queue lengths at each time step: all arrivals that occur during a slot are counted immediately before the end boundary of the slot, all packets that leave the queues during a slot are counted at the end boundary of the slot, and the queue lengths are computed immediately after the end boundary of the slot, so as to account for all the arrivals and departures during the slot. With this setup, the queueing system evolves as a DTMC over the state space $\mathbb{Z}^n_+\times K_y$. The transition probabilities of the DTMC are governed by the distribution of the arrival process, and the backoff distribution. Note that a similar DTMC model was proposed in \cite{kumar-etal04new-insights} for IEEE~802.11 CSMA/CA under saturation assumption. Now note that the operation of the system starts with all the queues empty, i.e., in the state $(\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0})$. \emph{We are, therefore, only interested in the communicating class of the DTMC containing the all-zero state}, $(\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0})$. Let us denote this class by $\mathcal{C}_{0}$. \begin{proposition} \label{prop:irreducible} The class $\mathcal{C}_{0}$ is closed, and aperiodic. \end{proposition} \begin{proof} See the Appendix. \end{proof} It follows from Proposition~\ref{prop:irreducible} that the DTMC evolving from the all-zero state is confined to the class $\mathcal{C}_{0}$. \emph{With abuse of notation, from now on, we denote by $(\mathbf{X}(n),\mathbf{Y}(n))$, the DTMC evolving from the all-zero state.} \subsection{A Sufficient Condition for Network Stability} \label{subsec:stability-conditions} Since we have a DTMC, by ``stability'', we mean that the DTMC $(\mathbf{X}(n),\mathbf{Y}(n))$ is \emph{positive recurrent}. Then, since $(\mathbf{X}(n),\mathbf{Y}(n))$ is also aperiodic, it can be verified that the steady state rates introduced in Section~\ref{sec:analytical-model} \emph{exist}. Therefore, we shall derive conditions for positive recurrence of the DTMC. Note that the queue non-empty probability of queue $i$, $1\leq i\leq N$, in the steady state is\footnote{under the condition of aperiodicity, this limit always exists} \begin{equation*} q_i = \lim_{n\to \infty}\mathsf{Pr}[X_i(n) > 0|\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0}] \end{equation*} We have the following sufficient condition on $q_i$, $1\leq i\leq N$, for positive recurrence of the DTMC $(\mathbf{X}(n),\mathbf{Y}(n))$. \begin{theorem} \label{thm:stability} If $\sum_{i=1}^N q_i\:<\:1$, then the DTMC $(\mathbf{X}(n),\mathbf{Y}(n))$ (evolving from the all-zero state) is positive recurrent. \end{theorem} \begin{proof} See the Appendix. \end{proof} \vspace{2mm} \noindent \textbf{Discussion:} We began this section by asking the question whether the results from our analytical model can be used to verify the initial assumption of stability. Since the analysis involves many approximations, evidently no definite answer can be given to this question. However, we have found from extensive simulations (see Section~\ref{sec:numerical-and-simulation-results} for details of the simulation procedure) that the solution to the fixed point analysis models $\sum_{i=1}^N q_i$ accurately (\emph{within an error of up to 10\%}) for external arrival rates of up to about 6 packets/sec (see Figure~\ref{fig:measure_sum_qi} for example). \begin{figure}[ht] \begin{center} \includegraphics[scale=0.32]{plots/10_Nodes_q_sum_plot_upto_rate_20.pdf} \caption{Plot of measure $\sum_{i=1}^N q_i$ for the topology in Figure~\ref{fig:hidden_10nodes}} \label{fig:measure_sum_qi} \vspace{-8mm} \end{center} \end{figure} This observation along with Theorem~\ref{thm:stability} can support the claim that if $\sum_{i=1}^N q_i < 0.9$ in the solution to the fixed point analysis, then we can safely assume the network to be stable. \section{Numerical and Simulation Results} \label{sec:numerical-and-simulation-results} For the verification of our analytical model, we use QualNet (v4.5) simulator \cite{qualnet} with the default parameter values and a fixed payload size of $70$ bytes. However, the QualNet implementation is devoid of ACKs. Therefore, we compare results only for the ACK\emph{-less} scenarios (although the analysis permits the modeling of ACKs). We use the following simulation models in Qualnet to declare that a packet is in error: \begin{enumerate} \item Collision and Link Error Model: If a receiver is receiving a packet from a node, and there is another transmission in the carrier sense range of the receiver, then the receiver concludes collision of all the packets that are intended for it. In addition, if a receiver $r(i)$ of node $i$ receives a packet successfully from node $i$ since there is no other packet transmission in the receiver's carrier sense range, then the received packet is concluded to be in error with probability $l_i$, the probability of data packet error on the link between node $i$ and the receiver $r(i)$ due to noise. \item Capture Model: If a receiver is receiving a packet from a node, and there is another transmission in the carrier sense range of the receiver, then the receiver computes the PER (from the SINR) of the packet that is meant for it, and rejects the packet if the computed PER is greater than a random number generated between 0 and 1. \end{enumerate} To increase the accuracy of simulation for each arrival rate, we generate the packets for 1500 seconds, and average the results over 25 repetitions with different random number seeds. 1500 seconds was chosen so that even at lower arrival rates ($\leq$ 2pkt/sec), sufficient number of packets would be generated from each source, thereby allowing the simulation to reach steady state. \subsection{Simulation of an Example Network Topology} The network shown in Figure~\ref{fig:hidden_10nodes} has hidden nodes (the dependency graph is also shown). Note that all the nodes are sources (some of which also serve as relays) with identical packet generation rates that are simultaneously increased. Figures~\ref{fig:measure_alpha_for_tree-n10-CS3-PER0.01}, \ref{fig:measure_gamma_for_tree-n10-CS3-PER0.01}, \ref{fig:measure_delta_for_tree-n10-CS3-PER0.01}, and \ref{fig:measure_pdel_for_tree-n10-CS3-PER0.01} are plots of measures $\alpha_i$, $\gamma_i$, $\Delta_i$ and $p^{(\mathsf{del})}_i$ for the nodes in Figure~\ref{fig:hidden_10nodes}. \begin{figure}[ht] \begin{center} \includegraphics[scale=0.32]{figures/hidden_10nodes.pdf} \caption{A 10 nodes TREE topology. Also shown is the dependency graph where the dotted lines connecting two nodes indicate that the nodes are in CS range of each other.} \label{fig:hidden_10nodes} \vspace{-8mm} \end{center} \end{figure} \begin{figure}[ht] \begin{center} \includegraphics[height=7cm, width=9.5cm]{plots/treen10CS3PER001_alpha_plot.jpg} \caption{Plots of CCA failure rate, $\alpha$, for the nodes in Figure~\ref{fig:hidden_10nodes}; blue solid line indicates analytical results, green solid line indicates simulation with Capture Model, and Red dotted line indicates simulation with Collision + PER Model} \label{fig:measure_alpha_for_tree-n10-CS3-PER0.01} \end{center} \end{figure} \begin{figure}[ht] \begin{center} \includegraphics[height=7cm, width=9.5cm]{plots/treen10CS3PER001_gamma_plot.jpg} \caption{Plots of the packet failure probability, $\gamma$, for the nodes in Figure~\ref{fig:hidden_10nodes}; blue solid line indicates analytical results, green solid line indicates simulation with Capture Model, and Red dotted line indicates simulation with Collision + PER Model} \label{fig:measure_gamma_for_tree-n10-CS3-PER0.01} \end{center} \end{figure} \begin{figure}[ht] \begin{center} \includegraphics[height=7cm, width=9.5cm]{plots/treen10CS3PER001_end-to-end-delay.jpg} \caption{Plots of the mean delivery delay, $\Delta$, for the nodes in Figure~\ref{fig:hidden_10nodes}; blue solid line indicates analytical results, green solid line indicates simulation with Capture Model, and Red dotted line indicates simulation with Collision + PER Model} \label{fig:measure_delta_for_tree-n10-CS3-PER0.01} \end{center} \end{figure} \begin{figure}[ht] \begin{center} \includegraphics[height=7cm, width=9.5cm]{plots/treen10CS3PER001_pdel.jpg} \caption{Plots of the average probability of delivery, $P^{(\mathsf{del})}$, for the nodes in Figure~\ref{fig:hidden_10nodes}; blue solid line indicates analytical results, green solid line indicates simulation with Capture Model, and Red dotted line indicates simulation with Collision + PER Model} \label{fig:measure_pdel_for_tree-n10-CS3-PER0.01} \end{center} \end{figure} \if 0 We observe that error in measure $\alpha_i$ decreases at higher arrival rates. Despite significant error in measure $\alpha_i$ at lower arrival rates ($\leq 0.5$ pkts/sec), other measures are within $\pm10\%$ error (though not shown here). This can be attributed to the following reasons: (1) values of measure $\beta_i$ and $b_i$ are more governed by mean time of first and second backoff, and not so much by $\alpha_i$, especially for small values of $\alpha_i$. Same is true for measure $q_i$; (2) since the other measures are obtained from measures $\beta_i$, $b_i$ and $q_i$, they are also not affected much by inaccuracies in measure $\alpha_i$; most importantly, (3) measure $\delta_i$ for hidden node networks is more affected by measure $\gamma_i$ but not by measure $\alpha_i$, since a packet is discarded at the MAC layer only after 5 consecutive CCA failures, the probability of which is very small at such low rates. Error in measure $\gamma_i$ is upto $25\%$ even at higher arrival rates. Error in measure $\Delta_i$ is within $\pm10\%$ for all the arrival rates plotted, and so is true for measure $p^{(\mathsf{del})}_i$. Also at higher arrival rates, the probability of delivery, $p^{(\mathsf{del})}_i$, for relay nodes has more error compared to leaf nodes since the error accumulates due to the error in the discard probability, $\delta_i$, at each node along a path. \fi \vspace{2mm} \noindent \textbf{Observations:} \begin{enumerate} \item We observe from the plots that the errors in the measures increase at higher arrival rates, i.e., the accuracy of the analysis decreases at higher arrival rates. For example, whereas for Nodes 1 to 4, and Nodes 6 to 10, the errors in the packet failure probability, $\gamma_i$, were between 1.5\% and 20\%, for Node 5, the error was up to 22.2\% with arrival rate of 20 packets per second. We will see, however, that the practical operating range of these networks is closer to 1 measurement per second from each node, for which value the approximation is excellent. \item The differences in the simulation measures under the Capture Model and the Collision + Link Error Model were well within 10\% for all nodes at lower arrival rates, and within 20\% even at an arrival rate of 20 packets per second. Hence, we conclude that the Collision + PER Model does not yield performance significantly different from the Capture Model. For other examples illustrating this fact, see \cite{sanjaymeth}. \end{enumerate} \subsection{Extensive Simulation Results} We now present a summary of an extensive simulation study, where we only use Collision + Link Error as the model. We have performed simulations with a variety of scenarios where one or more of the following features were varied: the topology, number of nodes in the network, average number of nodes in the CS range of a node, and the probability of data packet error on the link due to noise. For compact representation of the various cases, we use the following notation: \begin{itemize} \item[(i)] tree-n$N$-CS$m$-PER$l$: These are the cases in which the network is a tree with $N$ nodes (excluding the base station), all of which are sources. On an average, $m$ nodes are in the CS range of a node, i.e., $m=\frac{\sum_{i=1}^N \text{number of nodes in the CS range of node $i$}}{N}$. Moreover, the PER takes the same value, $l$, on all the links. \item[(ii) ] tree$\mathsf{R}$-n$N$-CS$m$-PER$l$: These are the cases in which the network is a tree with $N$ nodes (excluding the base station) such that 10 nodes among them are source nodes, and the rest of the nodes are relay nodes (the ``R'' in ``treeR'' signifies that there are relays as well as sources). On an average, $m$ nodes are in the carrier sense range of a node, and the PER takes the same value, $l$, on all the links. \item[(iii) ] star-n$N$-CS$m$-PER$l$: These are the cases in which the network is a star with $N$ nodes (excluding the base station), all of which are sources, positioned symmetrically on a circle centred at the base station. The $m$ nodes nearest to a node are in the carrier sense range of it, and the PER on all the links has the same value $l$. \item[(iv) ] line-n$N$-CS$m$-PER$l$: These are the cases in which the network is a line with $N$ nodes (excluding the base station) all of which are sources. $m$ nodes on either side of a node are in the carrier sense range of it. The PER on all the links is the same, and is equal to $l$. \end{itemize} For example, the case in Figure~\ref{fig:hidden_10nodes} is tree-n10-CS3-PER0.01. We compute the fractional errors in performance measures as $\frac{\text{Simulation} - \text{Analysis}}{\text{Simulation}}$. The Boorstyn et al. \cite{boorstyn-etal87CSMA-throughput-analysis} model based analysis (see \ref{subsubsec:Ti-eff}) is employed for computing $T_i^{(\mathsf{eff})}$. Table~\ref{tab:error for various topologies} tabulates the accuracy of the analysis compared to simulation, and also the computation times of both simulation and analysis. We use the following notation to indicate the range of errors: (i) \checkmark indicates that the error is within $\pm$ $10\%$; (ii) $+$ indicates overestimate by analysis with error from $10\%$ to $25\%$; (iii) $++$ indicates overestimate by analysis with error more than $25\%$; (iv) $-$ indicates underestimate by analysis with error from $10\%$ to $25\%$; and (v) $--$ indicates underestimate by analysis with error more than $25\%$. The entry in every row is $a, b$, where $a, b \in \{\checkmark, +, ++, -, -- \}$ with $a$ denoting the error summary for a range of $\lambda$ where, the discard probability, $\delta_i \leq 0.01$, and $b$ denoting the error summary for $\lambda > 2$ pkts/sec. \begin{table*}[ht] \begin{center} \begin{tabular}{@{}|c|c|c|c|c|c|@{}} \hline Sl. No & Topology & $\overline{P}^{(\mathsf{del})}$ & $\overline{\Delta}$ & Simulation Time & Analysis Time\\ & & & & (Min, Mean, Max) in seconds & in seconds \\ & & & & per arrival rate until 10pkts/sec & per arrival rate until 10pkts/sec \\ \hline 1 & tree$\mathsf{R}$-n23-CS4-PER0.01 &\checkmark, $-$ & \checkmark, \checkmark & $3120, 9720, 17580$ & $16$ \\ \hline 2 & tree$\mathsf{R}$-n20-CS3-PER0.01 &\checkmark, $-$ & \checkmark, \checkmark & $2220, 7740, 15060$ & $12$ \\ \hline 3 & tree$\mathsf{R}$-n20-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2580, 8640, 16800$ & $14$ \\ \hline 4 & tree$\mathsf{R}$-n19-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2460, 7680, 16020$ & $10$ \\ \hline 5 & tree$\mathsf{R}$-n19-CS2-PER0.01 & \checkmark, \checkmark & \checkmark, \checkmark & $1800, 7440, 14340$ & $10$ \\ \hline 6 & tree$\mathsf{R}$-n20-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2880, 9480, 17040$ & $16$ \\ \hline 7 & tree$\mathsf{R}$-n20-CS2-PER0.01 & \checkmark, $--$ & \checkmark, \checkmark & $2280, 8340, 15180$ & $12$ \\ \hline 8 & tree$\mathsf{R}$-n22-CS4-PER0.01 & \checkmark, $--$ & \checkmark, \checkmark & $3420, 11820, 19680$ & $36$ \\ \hline 9 & tree$\mathsf{R}$-n19-CS2-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2040, 7440, 14340$ & $14$ \\ \hline 10 & tree$\mathsf{R}$-n19-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2460, 8760, 17040$ & $17$ \\ \hline 11 & tree$\mathsf{R}$-n20-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2640, 9180, 17460$ & $17$ \\ \hline 12 & tree$\mathsf{R}$-n19-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2340, 7920, 16740$ & $15$ \\ \hline 13 & tree$\mathsf{R}$-n19-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2400, 8280, 16980$ & $12$ \\ \hline 14 & tree$\mathsf{R}$-n20-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2340, 8340, 16440$ & $11$ \\ \hline 15 & tree$\mathsf{R}$-n19-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2280, 7860, 16260$ & $11$ \\ \hline 16 & tree$\mathsf{R}$-n19-CS2-PER0.01 & \checkmark, $--$ & \checkmark, \checkmark & $1740, 7260, 14220$ & $9$ \\ \hline 17 & tree$\mathsf{R}$-n20-CS3-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2520, 8520, 16020$ & $11$ \\ \hline 18 & tree$\mathsf{R}$-n19-CS2-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $2040, 7560, 14760$ & $10$ \\ \hline 19 & tree$\mathsf{R}$-n19-CS2-PER0.01 & \checkmark, $-$ & \checkmark, \checkmark & $1920, 7140, 14460$ & $9$ \\ \hline 20 & line-n10-CS2-PER0.01 & \checkmark, \checkmark & \checkmark, \checkmark & 780, 6240, 12060& 5 \\ \hline 21 & line-n10-CS3-PER0.01 & \checkmark, \checkmark & \checkmark, \checkmark & 1080, 7860, 13980& 8 \\ \hline 22 & line-n10-CS4-PER0.01 & \checkmark, \checkmark & \checkmark, $+$ & 1260, 8700, 16080 & 12 \\ \hline 23 & star-n20-CS9-PER0.01 & \checkmark, \checkmark & \checkmark, \checkmark &900, 6480 ,12660& 36 \\ \hline 24 & star-n20-CS11-PER0.01 & \checkmark, \checkmark & \checkmark, \checkmark &1140, 7620, 14880 & 48 \\ \hline 25 & tree-n13-CS2-PER0.01 & \checkmark, \checkmark & \checkmark, \checkmark & 960, 7320, 13260 & 5 \\ \hline \end{tabular} \caption{Error in measures $P^{(\mathsf{del})}_i$ and $\Delta_i$ where $\overline{P}^{(\mathsf{del})}$ and $\overline{\Delta}$ are the errors averaged over all nodes for every input arrival rate. Note that run timing of simulation and analysis are in \emph{seconds}.} \label{tab:error for various topologies} \end{center} \end{table*} \vspace{2mm} \noindent \textbf{Observations and Discussion:} \begin{enumerate} \item As can be observed from Table~\ref{tab:error for various topologies}, for small arrival rates at which the discard probability, $\delta_i \leq 0.01$, the errors in both $\overline{P}^{(\mathsf{del})}$, and $\overline{\Delta}$ are less than 10\% in all the scenarios tested, whereas at higher arrival rates, the error in $\overline{P}^{(\mathsf{del})}$ sometimes exceeds 25\% (scenarios 7,8, and 16), which is in agreement with our earlier observation from Figure~\ref{fig:measure_pdel_for_tree-n10-CS3-PER0.01} as well. However, the error in $\overline{\Delta}$ even at higher arrival rates was within 10\% for all but one scenario (scenario 22), where the analysis overestimated the delay within an error of 25\%. One possible explanation for the degradation in the accuracy of the analysis at higher arrival rates can come from the discussion in Section~\ref{sec:dtmc-stability}. Note that at higher arrival rates, the queue non-empty probability of the nodes are typically higher, and hence the condition $\sum_{i=1}^N q_i < 1$ (see Theorem~\ref{thm:stability}) is more likely to be violated, in which case, the system may not be stable, and the validity of the fixed point analysis is questionable. For example, note from Figure~\ref{fig:measure_sum_qi} that for the example topology in Figure~\ref{fig:hidden_10nodes}, $\sum_{i=1}^N q_i$ approaches 1 at around $\lambda = 10$ pkts/sec, and it can be seen from Figures~\ref{fig:measure_alpha_for_tree-n10-CS3-PER0.01}, \ref{fig:measure_delta_for_tree-n10-CS3-PER0.01}, \ref{fig:measure_gamma_for_tree-n10-CS3-PER0.01}, and \ref{fig:measure_pdel_for_tree-n10-CS3-PER0.01} that the errors in the measures are more pronounced for $\lambda \geq 10$ pkts/sec. \item We also observe from Table~\ref{tab:error for various topologies} that the average time to analytically compute the performance measures for each arrival rate (using the Boorstyn~et.al \cite{boorstyn-etal87CSMA-throughput-analysis} model for computing $T^{(\mathsf{eff})}_i$) was of the order of seconds, whereas the average simulation time ran into several hours. Further, it was observed that for hidden-nodes networks with 20 nodes, and an average of 3 nodes in the CS range of a node, the analysis with Boorstyn~et.al \cite{boorstyn-etal87CSMA-throughput-analysis} model for computing $T^{(\mathsf{eff})}_i$ takes around $13$ secs per arrival rate, and if $T^{(\mathsf{eff})}_i$ is computed using $M/D/\infty$, then the analysis takes around $9$ secs per arrival rate. Hence we can trade-off between the accuracy of analysis and computation time since analysis with $M/D/\infty$ model usually incurs more error ($> 25\%$) at higher arrival rates, but less than $10\%$ for $\lambda < 0.5$ pkts/sec. \item Finally, it was observed that the packet discard probability at a node increases to an impractical value much before the average delay at the node becomes substantial, e.g., tree-n10-CS3-PER0.01-Node-1 discards $2$-$5$ packets for every $1000$ packets when the average node delay is $5$-$6$ msec. Hence, the overall packet delivery probabilities for the sources act as performance bottlenecks for these networks. \end{enumerate} \section{Network Design} \label{sec:network-design} In this section, we shall consider a problem of QoS constrained network design for a given positive traffic arrival rate to demonstrate the usefulness of the analytical model in an iterative network design process. Consider the following setting: \emph{a set of sensor nodes and a base station (BS) are deployed over an area; each sensor node is a data source, and can also act as a relay. The transmit power level of each node can be adjusted over a range.} Consider the complete graph over these nodes. Each directed link in this graph will have a certain packet error rate (PER) that \emph{depends on the transmit power level of the sender node on that link.} We consider the following network design problem: for a given traffic arrival rate $\lambda > 0$ at the sensor nodes, \emph{minimize the maximum transmit power level used by the sensor nodes, such that the resulting network has the following properties.} \begin{enumerate} \item Each sensor node has a path to the BS, with the PER on each link in each path being upper bounded by a predefined target threshold $p$. \item For the given $\lambda$, the end-to-end packet delivery probability (i.e., the probability that a packet is not discarded) on any path is at least $p_{\mathrm{del}}$. \item For the given $\lambda$, the mean delay (computed over the successfully delivered packets) on any path is upper bounded by a predefined target $d_{\max}$. \end{enumerate} Note that for a design (network) to satisfy the QoS objectives for a given arrival rate, it is \emph{necessary} that the network satisfies the QoS objectives under zero/light traffic load, i.e., in the limit as $\lambda \to 0$, in which limit a packet that enters the network departs from the network before another packet arrives, i.e., each packet traverses the network $\emph{alone}$, prompting us to call this limit the $\emph{lone packet}$ traffic model (for a more formal proof\footnote{A formal proof is necessary for this seemingly obvious statement since, in CSMA/CA networks, in general, the performance is not monotone with the arrival rates (see, e.g., \cite{borst}); hence, the statement about the lone-packet traffic model needs to be made with care.} of this fact, see \cite{fullpaper}). We, therefore, adopt the following two step approach: \begin{enumerate} \item We first focus on the QoS constrained network design problem under the lone-packet traffic model in Section~\ref{subsec:lone-packet-design}; we formulate the problem as a network design problem on graphs, and propose an algorithm to solve the problem optimally. \item Then, in Section~\ref{subsec:cont-traffic-design}, we combine the lone-packet based design algorithm with the analytical tool developed in Section~\ref{sec:analytical-model} to address the more general (and more complex) problem of QoS constrained network design for a given positive traffic arrival rate. \end{enumerate} Note that we can ensure a given target PER on a link by ensuring that the \emph{average} received power across the link (averaged over shadowing and fading) meets a received power target. Such a target average received power would be obtained by deriving a margin above the minimum value of received power, from statistics of shadowing and fading. If we take this worst case approach over the joint pdf of shadowing and fading, then for a given target PER, the required transmit power on a link is a non-decreasing function of the link length. Hence, the problem of minimizing the maximum transmit power is \emph{equivalent to minimizing the maximum link length in the resulting network}. \subsection{Network Design under the Lone-Packet Model} \label{subsec:lone-packet-design} Given the target PER $p$ on any link, the mean delay on a link under the ``lone packet'' model can be computed using an elementary analysis (see \cite{abhijitmeth}), taking into account the backoff behavior of 802.15.4 CSMA/CA, and using the backoff parameters given in the standard \cite{IEEE802-15-4-06std}. Then, to meet the mean delay requirement of $d_{\max}$ on a path with $h$ hops, we require that \begin{equation} h\leq \left\lfloor\frac{d_{\max}}{\overline{d}_{single-hop}}\right\rfloor\triangleq h_{\max}^{delay} \end{equation} where, $\overline{d}_{single-hop}$ is the mean link delay computed as explained earlier. Again, given the target link PER of $p$, and the number of retries $r$ (obtained from the standard) before a packet is discarded on a link, the packet discard probability on a link can be obtained as $q\:=\:p^{r+1}$. Hence, to ensure a packet delivery probability of at least $p_{del}$ on a path with $h$ hops, we require that \begin{eqnarray} h &\leq \frac{\ln{p_{del}}}{\ln{(1-q)}}&\triangleq h_{\max}^{delivery} \end{eqnarray} Hence, to ensure the QoS constraints under the ``lone packet'' model, we require that the \emph{hop count on each path is upper bounded by $h_{\max}\:=\:\min\{h_{\max}^{delay},h_{\max}^{delivery}\}$}. Thus, the problem of QoS constrained network design under the ``lone packet'' model can be reformulated as the following graph design problem: \emph{Given a set of source nodes $Q$, and a base station (BS), indexed as node 0, consider the graph $G=(V,E)$, where $V=Q\cup \{0\}$, and the edge set $E$ consists of all feasible edges, i.e., edges with PER $\leq\: p$ at maximum possible transmit power. Given a hop count constraint $h_{\max}$, the problem is to extract from $G$, a spanning tree on $Q$ rooted at the BS, such that the hop count on any path is upper bounded by $h_{\max}$, and the maximum edge length in the spanning tree is minimized}. We call this, the MinMax Spanning Tree with Hop Constraint (MMST-HC) problem. The following is an algorithm to obtain an optimal solution to the MMST-HC problem. At each iteration, we prune all edges with edge length more than or same as the maximum edge length in the current feasible solution, form a shortest path tree (SPT) with hop count as cost using only the remaining edges, and keep doing this until the resulting SPT violates the hop constraint, at which point we stop and declare the last feasible solution as the final solution. \subsubsection{\textbf{SPTiEP: Shortest Path Tree based iterative Edge Pruning Algorithm}} \begin{itemize} \item[(i)] \textbf{Initialize: }Set $k\leftarrow 0$, $G^{(0)}\leftarrow G$ \item[(ii)] \textbf{Checking feasibility: }In iteration $k$, find a shortest path tree (SPT) $T^{(k)}$ on the graph $G^{(k)}$. Check if all the paths from the sources to the BS in $T^{(k)}$ satisfy the hop constraint. \begin{itemize} \item If the hop constraint is not met for some of the sources in $T^{(k)}$, \textbf{STOP}. \begin{itemize} \item If $k=0$, declare the problem \emph{infeasible}. \item If $k>0$, output $T^{(k-1)}$ as the final solution. \end{itemize} \item If the hop constraint is met for all the sources in $T^{(k)}$, proceed to the next step. \end{itemize} \item[(iii)] \textbf{Edge pruning: }Let $\overline{w}^{(k)}$ be the maximum edge length in $T^{(k)}$. Remove from $G^{(k)}$, all edges of length $\geq \overline{w}^{(k)}$ to obtain the graph $G^{(k+1)}$. \item[(iv)] \textbf{Iterate: }Set $k\leftarrow k+1$. Go to Step 2. \end{itemize} Since the time complexity of finding an SPT in a graph with $N$ nodes is $O(N\log N)$, it can be easily verified that the time complexity of the SPTiEP algorithm is $O(N^3\log N)$ for a graph with $N$ nodes. Thus, \emph{the SPTiEP algorithm is polynomial time}. \subsubsection{\textbf{Proof of correctness of SPTiEP}} We define \begin{description} \item $\mathcal{F}^{(k)}\:=\:\{T\subset G^{(k)}: \text{$T$ satisfies the hop constraint}\}$: set of all feasible solutions contained in the graph $G^{(k)}$ \item $w_{opt}$: The minmax edge length, i.e., the maximum edge length in an optimal solution \end{description} Also recall the definitions of $T^{(k)}$ and $\overline{w}^{(k)}$ from the description of the algorithm. Clearly, $\mathcal{F}^{(k)}$ is non-empty \emph{if and only if} $T^{(k)}\in \mathcal{F}^{(k)}$. To prove the correctness of SPTiEP algorithm, it is enough to show the following: \begin{proposition} \label{prop:sptiep-correctness} Given that $\mathcal{F}^{(k)}\:\neq \emptyset$, \begin{equation*} \mathcal{F}^{(k+1)}\:=\emptyset\: \Rightarrow w_{opt}=\overline{w}^{(k)} \end{equation*} \end{proposition} \begin{proof} See the Appendix. \end{proof} \subsection{Network Design for a Given Positive Arrival Rate} \label{subsec:cont-traffic-design} Now we come back to the more general problem of QoS constrained network design for a given positive arrival rate. This problem is rendered much more difficult compared to its lone-packet version due to the complex stochastic interaction between contending nodes, which, unlike the lone-packet model, makes it hard to map the QoS constraints to simple explicit constraints on certain graph properties. Therefore, unlike the lone-packet version where we posed the problem as a pure graph design problem, in the positive traffic case, we shall use the analytical model explicitly in an iterative design process to evaluate for QoS, the designs obtained systematically in every iteration. While traditional network simulation tools can also be used, in principle, to evaluate a given network for QoS, \emph{the time required for such network simulation is significantly more than that required by the analysis} (as we saw in Table~\ref{tab:error for various topologies}, and shall see again in our numerical experiments in Section~\ref{subsec:design-exp}), and that makes network simulation, an impractical option in an iterative design process. Also, a naive approach to the design problem would be to consider all possible trees from the given graph $G$, and evaluate each of them for QoS (using either the analysis, or network simulation), and choose one whose maximum edge length is minimum among all those that meet the QoS objectives. While this exhaustive search appears to be the only way that is guaranteed to obtain a feasible solution whenever there exists one, this approach has exponential time complexity (since the number of possible trees is exponential in the number of nodes), and is therefore, not practical. We shall present below, a polynomial time algorithm for the proposed positive traffic design problem, using the SPTiEP algorithm along with the analytical model; note that because of the stochastic nature of the interaction between contending nodes in different possible networks, in absence of an exhaustive evaluation of all possibilities, the algorithm is not theoretically guaranteed to return a feasible solution whenever there exists one; however, in our numerical experiments, the algorithm was always found to return a feasible solution, and moreover, simulations confirmed that designs proposed with the analytical tool did meet the QoS requirements (see Section~\ref{subsec:design-exp}). \subsubsection{\textbf{Extended SPTiEP: An algorithm for QoS constrained network design at given positive arrival rate $\lambda > 0$}} As we had mentioned before, to meet the QoS objectives at a positive arrival rate, it is \emph{necessary} (but not sufficient) to meet the objectives under the lone-packet model. Hence, our design still needs to satisfy the hop count constraint $h_{\max}$ derived from the QoS constraints under the lone-packet model. With this in mind, we proceed as follows: if the outcome of the SPTiEP algorithm meets the QoS constraints at the given $\lambda$, then that is an optimal solution (since it is an optimal solution for the lone-packet design problem, and it is also QoS feasible for the given $\lambda>0$). If, however, the SPTiEP outcome does not meet the QoS constraint, we need to change the design by \emph{adding some of the edges of greater length that were pruned in course of the SPTiEP algorithm}; note that adding edges is the only option as pruning any more edge from the SPTiEP solution will cause us to violate the hop constraint, and hence the lone-packet QoS. The detailed steps are presented below. \begin{enumerate} \item \textbf{Lone-packet design: }Run the SPTiEP algorithm on the graph $G$ to obtain a tree $T_0$. \begin{itemize} \item If $T_0$ does not satisfy the hop constraint, declare the problem infeasible, as we cannot satisfy the QoS objectives even for $\lambda = 0$. \item Else, go to the next step. \end{itemize} \item Set $k\leftarrow 0$. Mark all edge lengths in $G$ as \emph{not examined}. \item \textbf{Checking feasibility for $\lambda>0$: }Evaluate $T_k$ for QoS requirements (i.e., $p_{del}$ and $d_{\max}$) at the given arrival rate $\lambda$, using the analytical model.\footnote{for the purposes of this design, we completely trust the outcome of the analytical model, i.e., we assume the analytical model to be 100\% accurate.} \begin{itemize} \item \textbf{Stopping criteria 1: }If QoS is met, output $T_k$ as the final solution. \item \textbf{Stopping criteria 2: }If QoS is not met, and all edge lengths in $G$ have been \emph{examined}, declare the problem \emph{possibly} infeasible. \item Else, go to next step. \end{itemize} \item Let $\overline{w}_k$ be the maximum edge length in $T_k$. Identify the least edge length $> \overline{w}_k$ in the graph $G$ that is not yet \emph{examined}; let us denote this as $w_{least,k}$. \item \textbf{Edge augmentation: }Augment $T_k$ with all edges (in $G$) of length $\leq w_{least,k}$, to obtain the graph $G_{k+1}$. Mark all the edge lengths in $G_{k+1}$ as \emph{examined}. \vspace{2mm} \noindent \textbf{Comment: } Since our objective is to minimize the maximum edge length, in Steps 4 and 5, we add back the edges pruned during SPTiEP \emph{in increasing order of their lengths}. \item \textbf{Redesign: }Find an SPT $T_{k+1}$ in $G_{k+1}$. Observe that if $T_k$ satisfies the hop constraint, $T_{k+1}$ also satisfies the hop constraint. \item \textbf{Iterate: }Set $k\leftarrow k+1$. Go to Step 3. \vspace{2mm} \noindent \textbf{Comment: } In Steps 6 and 7, we check if the resulting shortest path tree in the augmented graph satisfies the QoS constraints for the given positive arrival rate. Note that in Step 6, there could be several possible SPTs on the graph $G_{k+1}$; while the total network wide traffic load, as well as the total number of nodes is the same in all of these SPTs, the individual loads on the various nodes may vary from one SPT to another, resulting in potentially different delay and delivery performance. Since it is not possible to evaluate all the possible SPTs in polynomial time, we find and evaluate only one of them, and move on to a higher power/edge length design in case of QoS not being satisfied; this may lead to suboptimal design. Moreover, for the same reason, the algorithm may not always return a feasible solution even when there exists one. \end{enumerate} \vspace{2mm} \noindent \textbf{Remarks:} \begin{enumerate} \item It is interesting to note that the above heuristic is basically the reverse procedure of the SPTiEP algorithm, with the additional step of evaluating each design using the analytical model. At the end of each iteration, the maximum edge length in the solution changes at most to the immediate higher value not used in previous iterations. We stop as soon as a QoS feasible solution is obtained in some iteration. \item An alternate approach could be to start with a shortest path tree on the entire graph, and then prune edges, checking for feasibility with positive load in each iteration. But since meeting the lone-packet QoS is necessary to meet the positive-load QoS, we have adopted the above approach of first designing a network satisfying the lone-packet QoS, and then backtracking. \end{enumerate} \subsection{Numerical Experiments} \label{subsec:design-exp} \begin{table*}[Ht] \centering \caption{Execution time comparison of the analysis based design algorithm and qualnet simulation} \label{tbl:exec_time_compare} \footnotesize \begin{tabular}{|c|c|c|c|c|c|c|c|c|c|c|c|c|}\hline Scenarios & \multicolumn{6}{c|}{Algorithm execution time} & \multicolumn{6}{c|}{Qualnet simulation time}\\ & \multicolumn{6}{c|}{in sec} & \multicolumn{6}{c|}{in sec}\\ & \multicolumn{3}{c|}{SPTiEP} & \multicolumn{3}{c|}{E-SPTiEP} & \multicolumn{3}{c|}{SPTiEP outcome} & \multicolumn{3}{c|}{E-SPTiEP outcome}\\ & Average & Max & Min & Average & Max & Min & Average & Max & Min & Average & Max & Min\\ \hline 30 & 0.0468 & 0.2532 & 0.0300 & 0.3827 & 0.5084 & 0.1609 & 2412.3 & 3000.6 & 2041.2 & 1765.7 & 2233.8 & 1326.6\\ \hline \end{tabular} \normalsize \end{table*} To demonstrate the strengths and limitations of the analysis in an iterative design process, we performed several test runs of the proposed algorithm on randomly generated network scenarios. 30 random networks were generated in a $50\times 50\:m^2$ area as follows: The entire area was partitioned into square cells of side 10 meters. Consider the lattice created by the corner points of the cells. 10 source nodes were placed at random over these lattice points. The minimum power level of the nodes is assumed to be sufficient so that all nodes are within CS range of one another, i.e., we have a ``no hidden node'' scenario. We chose the target link PER to be 0.01, $p_{del}=95\%$, and $d_{\max}=25\:msec$. These result in a hop constraint of $h_{\max}=5$ for the ``lone packet'' model. Also, the traffic arrival rate at each source was chosen to be $\lambda = 1$ packet/s, which is actually quite adequate for many wireless sensing applications. The design algorithm using the analytical model was run on the 30 random scenarios. \emph{In each case, the algorithm was found to return a feasible solution.} Also, to validate the solution provided by the algorithm, we performed Qualnet simulation on both the outcome of the SPTiEP algorithm as well as the final solution for each of the 30 cases. The observations are as follows: \textbf{Observations:} \begin{enumerate} \item In all 30 cases, simulations of the final solution showed QoS performance better than the target. That is, \emph{the solution provided by the algorithm using the analytical model did actually satisfy the QoS constraints as verified by the simulation in all cases}. \item In 12 out of the 30 cases, simulations suggested that the SPTiEP solution (``lone packet'' design) met the QoS constraints even for the given $\lambda = 1$ packet/s (and hence was optimal), but the analytical model suggested otherwise. Thus, \emph{the analytical model was somewhat conservative in its prediction of QoS}, which eventually led to a design that used more power than the optimal. \item However, while the analytical model was conservative in its prediction of QoS, the final design met the QoS objectives and predicted the performance to within 10\%., i.e., the model was \emph{quite accurate} in its prediction. \item Finally, we compared the time taken to run the design algorithm using the analytical model against the time taken to run the Qualnet simulations on the designed networks in the 30 cases. To save time, \emph{in each case, we performed Qualnet simulations only for the lone packet design, and the final design obtained using E-SPTiEP algorithm}. While the algorithm was run in MATLAB 7.11 on a Windows Vista based Dell Inspiron 1525 laptop with 3 GB RAM, and 2 GHz Intel Core 2 Duo CPU, the simulations were run in Qualnet 4.5 on a Linux based Dell server with 32 GB main memory, and 3 Ghz clock speed. The results are summarized in Table~\ref{tbl:exec_time_compare}. From Table~\ref{tbl:exec_time_compare}, we see that while \emph{the execution time of the analysis based algorithm is of the order of milliseconds}, simulation of each of the designed networks takes several minutes, which indicates that \emph{if the QoS evaluation step in the iterative design is performed using simulation instead of the analysis, the execution time of the algorithm can go well beyond an hour}. \end{enumerate} From the above discussion, we can summarize the following strengths and limitation of the analytical model for use in a network design process. \begin{enumerate} \item \textbf{Strengths:} \begin{itemize} \item Design based on analysis is much \emph{faster} compared to that based on network simulation, and the predictions are \emph{accurate} to well within 10\% compared to the simulation results. Such speed and accuracy also make the analytical tool a good choice for \emph{online/field-interactive} design process, or even for as-you-go deployment of an impromptu wireless network. \item Designs provided by the analysis based algorithm do actually work, i.e., satisfy the QoS constraints in practice, as validated by simulations of the designed networks. \end{itemize} \item \textbf{Limitation: }The analysis, while quite accurate compared to the simulation, is somewhat \emph{conservative in its prediction of QoS performance}. This may sometimes lead to \emph{suboptimal} design, or even \emph{declaration of infeasibility}, when actually there may exist a feasible solution. \end{enumerate} \section{Conclusion} \label{sec:conclusion} We have developed an approximate stochastic model for the performance analysis of beacon-less \mbox{IEEE 802.15.4} multihop wireless networks, with arrivals. The model permits the estimation of several time-average performance measures. Our model is accurate at small arrival rates (at which packet discard probability is small) in terms of the packet discard probability, failure probability and throughput, and delay. We calculated the mean end-to-end delays and packet delivery probabilities for each source in the network for specific packet generation rates at the source nodes. The results suggest that, for the relatively small size tree networks that we have studied, to operate in the low-discard low-delay region, the packet arrival rates at nodes should not be greater than a packet every few seconds (e.g. a packet inter-generation time of 5 to 10 seconds at the sources). Finally, we have formulated and solved a problem of QoS constrained network design for given positive traffic arrival rate to demonstrate the usefulness of the analytical model in an iterative network design process. \section*{Appendix} \subsection{Proof of Proposition~\ref{prop:irreducible}} \begin{proof} First observe that transition from any state to the all-zero state is possible if we consider a series of "only down" transitions, i.e., no further external arrival occurs into any of the queues, and the packets leave the queues either due to successful transmission, or drop due to excessive retries or CCA failures. \emph{No external arrival} would mean that the number of packets in the system can only decrease in each transition, and eventually we will reach the all-zero state. Note that this is possible since the maximum number of retransmission attempts, and maximum allowed CCA failures are \emph{finite}. Now, suppose the class is open. Then, there exists a state $i\in \mathcal{C}_{0}$, and a state $j\notin \mathcal{C}_{0}$ such that $i\rightarrow j$, but $j\nrightarrow i$. But from our earlier argument, we know, state $j$ can reach the all-zero state. Since both state $i$ and the all-zero state belong to the class $\mathcal{C}_{0}$, the all-zero state can reach state $i$. It follows that $j\rightarrow i$, which is a contradiction. Hence, the class $\mathcal{C}_{0}$ is closed. Clearly, $\mathcal{C}_{0}$ is aperiodic since starting in the all-zero state, the system can remain in the all-zero state if no external arrivals occur in a slot (since the arrival process is Poisson, this event has a positive probability). \end{proof} \subsection{Proof of Theorem~\ref{thm:stability}} \begin{proof} For any $n>0$, \begin{align} \mathsf{Pr}[\cap_{i=1}^N\{X_i(n)=0\}|\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0}]\nonumber\\ = 1\:-\:\mathsf{Pr}[\cup_{i=1}^N\{X_i(n) > 0\}|\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0}]\nonumber\\ \geq 1\:-\:\sum_{i=1}^N \mathsf{Pr}[X_i(n) > 0|\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0}]\label{eqn:union-bnd} \end{align} where, in writing \eqref{eqn:union-bnd}, we have used the union bound. Taking limit as $n\to \infty$ on both sides, \begin{eqnarray} \lim_{n\to \infty}\mathsf{Pr}[\cap_{i=1}^N\{X_i(n)=0\}|\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0}]\nonumber\\ \geq 1\:-\:\sum_{i=1}^N q_i\nonumber\\ > 0,\:\text{when $\sum_{i=1}^N q_i\:<\:1$}\nonumber \end{eqnarray} Thus, if $\sum_{i=1}^N q_i<1$, we have that $\lim_{n\to \infty}\mathsf{Pr}[\cap_{i=1}^N\{X_i(n)=0\}|\mathbf{X}(0)=\mathbf{0},\mathbf{Y}(0)=\mathbf{0}]>0$, which, in conjunction with Proposition~\ref{prop:irreducible}, implies that $(\mathbf{X}(n),\mathbf{Y}(n))$ is positive recurrent. \end{proof} \subsection{Proof of Proposition~\ref{prop:sptiep-correctness}} \begin{proof} Since $\mathcal{F}^{(k)}\:\neq \emptyset$, \begin{equation} \label{eqn:leq} w_{opt}\leq\overline{w}^{(k)} \end{equation} This is because $\overline{w}^{(k)}$ is the maximum edge length of $T^{(k)}$, a feasible solution, while $w_{opt}$ is the maximum edge length of an optimal solution. Again, $\mathcal{F}^{(k+1)}\:=\emptyset\:\Rightarrow\:\nexists\: T\subset G^{(k+1)}$ such that $T$ satisfies hop constraint. But by construction (Step 3 of SPTiEP algorithm), $G^{(k+1)}$ contains in it, all trees with maximum edge length $<\:\overline{w}^{(k)}$. Therefore, no tree with maximum edge length $<\:\overline{w}^{(k)}$ is a feasible solution to the MMST-HC problem. Hence, \begin{equation} \label{eqn:notless} w_{opt}\:\nless \overline{w}^{(k)} \end{equation} Combining \eqref{eqn:leq} and \eqref{eqn:notless}, it follows that $w_{opt}=\overline{w}^{(k)}$. \end{proof} \section*{Acknowledgements} This work was supported by a research grant from the Department of Electronics and Information Technology (DeitY), Government of India, through the Automation Systems Technology (ASTEC) program, and by a DeitY-NSF funded Indo-US project on Wireless Sensor Networks for Protecting Wildlife and Humans.

Introduction ============ The European Mental Health Action Plan for 2013--2020 underlines that mental health is one of the top public health challenges, affecting about 25% of the population every year ([@B54]). Mental health is considering a chronic condition resulting either from an acute, intense confrontation with a stressor, such as is the case in a post-traumatic stress disorder or from the continuing presence of a stressor which may not necessarily be intense ([@B24]). [@B14] have aided understanding of individual mental health through somatic symptoms (e.g., headaches), anxiety/insomnia (e.g., loss of sleep), social dysfunction (e.g., social withdrawal), and depression symptoms (e.g., thoughts of the uselessness of life). One of the proposed actions that the WHO highlighted to 2013--2020 is the need to "reduce psychosocial and job-related stress, enhance stress management and introduce simple programs to promote well-being in the workplace\" ([@B54], p. 11). Therefore, a comprehensive understanding of mental health in the workplace is sorely needed. The Job Demands-Control and Support model (JDCS; [@B32]; [@B31]) is perhaps the most extensively tested and empirically validated model which, in its simplest form, explains workers' mental health as a function of job characteristics: job demands, job control, and job support. Empirical evidence points to high job demands negatively predicting workers' mental health, while job autonomy and job support positively predict workers' mental health ([@B37]). The work-to-family conflict (WFC) defined as "a form of inter-role conflict in which the role pressures from the work domain are, to some extent, incompatible with the family domain" ([@B16], p. 77), is also known for its negative impact on workers' mental health ([@B13]; [@B39]; [@B7]). Moreover, research has shown that job characteristics are relevant to the WFC emergence ([@B39]). This suggests that the WFC may have a crucial role in explaining the relationship between job characteristics and workers' mental health. However, studies have highlighted that men and women may also perceive how their work conflicts with their family in distinct ways ([@B46]). In fact, the traditional "ideal worker" ([@B33]) understands the idea of a man as the earner of the primary paycheck within the family. This idea is in line with the gender ideology, according to which, women are the primary caregivers of the family ([@B33]). Nowadays, the increasing proportion of women in the workplace ([@B46]) has given rise to an overload of their role, since they need to accomplish their work and family responsibilities concomitantly. In accordance with OCDE (Organisation for Economic Co-operation and Development), women in Portugal, where the present study was developed, carry out more unpaid work as compared to other European countries. Specifically, Portuguese women spend more than 5 h per day in unpaid work compared to a bit more than one and a half hours for men ([@B11]). Thus, women, when compared with men, may perceive more interference of job characteristics in their family life ([@B18]; [@B8]; [@B53]), and their mental health may be more affected by their WFC ([@B53]). By integrating the JDCS theory, we explore the effect of job characteristics on workers' mental health by testing a moderated-mediation model, where the WFC acts as the mediator and gender as the moderator of this mediated relationship. This is a promising study in terms of its contribution to research and practice. First, this article responds to the recommendation made by [@B49], stating that it is important to conduct research in order to clarify the mechanisms that explain the relationship between job characteristics and mental health. By the same token, [@B21] also stressed that understanding the mechanisms of the relationship between two variables is more important than establishing the relationship itself. Thus, our goal is to understand the role of the WFC in the relationship between job characteristics and workers' mental health. To our knowledge, there are no previous studies establishing this link. A previous study by [@B10] examined this mediation relationship, however, it focused on a specific sample of contact-center workers, where the majority of participants were single and had no children. Thus, the authors chose to measure the work-to-life conflict instead of the WFC. In the present study, we seek to understand the work and family relationship of a sample of individuals with children and/or who are married or in a common-law relationship. Second, the results of previous studies have proven to be inconclusive as far as gender differences in the WFC ([@B46]) are concerned. Thus, research regarding men and women and their work-family experiences are sorely needed ([@B18]). Therefore, our study may provide new insights into gender differences in the relationship between job characteristics and the WFC and between the WFC and workers' mental health. Furthermore, it contributes to a more comprehensive line of research, focusing on mediation and moderation ([@B21]). Third, this study was conducted in a Portuguese context where gender issues are particularly worrisome. In line with most European countries, 47.5 % of women in Portugal make up the labor force ([@B45]). However, the gender pay gap, i.e., the difference in average gross hourly wage between men and women across the economy, is 16.3% in Europe and 17.8% in Portugal ([@B12]). As previously mentioned, for the paid and non-paid work total, women work more than men ([@B11]). Thus, it is quite clear that although women in Portugal pursue a professional career, they are still required to live up to gender expectations ([@B52]). Furthermore, there is a lack of institutional and organizational support to balance work and family responsibilities ([@B38]). Hence, this study may provide some clarity on the gender issues and work--family relationship in Portugal, namely by offering further understanding on how to prevent the WFC and promote mental health in men and women, thus contributing to the design of more effective policies in this area. Lastly, by testing the importance of the WFC in the relationship between job characteristics and workers' mental health, this study may extend the generalizability of the importance that both job characteristics and the WFC have on workers' mental health. Generally, we hope to contribute to the design of interventions and policies related to workplace mental health prevention and promotion. Theoretical Background and Hypotheses ------------------------------------- ### The Mediating Role of the WFC As [@B37] advanced, the JDCS ([@B32]; [@B31]) is an influential theory for understanding how job characteristics, i.e., demands and resources (control and support) contribute to employee mental-health. Job demands (e.g., workload; time-based demands) may be understood as a perceived lack of potential loss of personal resources for dealing with job requirements ([@B37]). Autonomy refers to the ability to make decisions about work, the ability to be creative and to use and develop new skills, or professional development ([@B32]). A worker has autonomy when he/she has the opportunity to use skills and decision authority (the individual's ability to make a decision on the work itself). Social support is understood as an interpersonal transaction that may include an emotional expression of concern, instrumental assistance, or information ([@B27]). Although the JDCS model includes supervisory and co-worker support as social support since they represent workers' social capital at work ([@B41]) the present study has only taken supervisory support into consideration, as the organization involved in this study was characterized by a well-defined hierarchy without teamwork. The JDCS stated that jobs with low demands, high autonomy, and high support predict workers' well-being. For example, an employee that have heavy workload but enjoy take his/her own decision about how work should be accomplished and perceived that if he/she needs his/her supervisor listen to his/her doubts and give suggestions when needed, more easily fell encouraged to face the work challenges and, consequently, the mental health is positively affected. On the contrary, jobs with high demands, low autonomy, and low support are fatal to employees' mental health ([@B37]). The WFC is grounded on theories of role stress and inter-role conflict ([@B28]) which argue that each individual has limited resources (e.g., time, energy, and attention) to spend on life roles ([@B15]). Conflicts occur when individuals' work participation conflicts with family participation ([@B16]). [@B36] stated that WFC is evoked by the demands of the work role that, in turn, deplete individual' resources (e.g., time, energy, emotions) required to participate in the family role. Therefore, the presence of job characteristics that exhaust workers is fatal for the WFC emergence, whereas the presence of job characteristics that help workers to face work demands are important to prevent the WFC. As such, evidence has shown that job demands are a threat to the work-family balance by promoting WFC ([@B39]). On the contrary, autonomy enables a worker to deal with the demands which, in turn, may prevent the WFC through the management of time and space devoted to work or family roles ([@B19]). Akin to autonomy, supervisory support is related to lower levels of workers' WFC (e.g., [@B35]). According to these results, job characteristics may be seen as important antecedents to a myriad of WFC. [@B51] also acknowledge that the WFC depletes personal resources and restrains accomplishment in the family domain. This framework, in line with the conservation of resources theory ([@B22]), defends that as a result of a loss of resources, mental-health is threatened. It is, therefore, not surprising that a number of prior empirical studies have found that the WFC is negatively related to workers' mental health. For example, high levels of the WFC have been found to be associated with increased levels of metabolic syndrome in younger workers, in addition to shortened hours of sleep ([@B4]). Other stress-related outcomes that have been observed to be WFC outcomes are anxiety ([@B13]), substance abuse ([@B13]), psychological ill-being ([@B42]), and poor perceived health ([@B7]). Taken together, in the presence of high demands, low autonomy and low support the individual's stress arises which affects the performance of the individual in the family role. For example, the individual arrives at home strained and do not contribute to the trivial housework and, as a consequence, a marital discussion emerged. Ultimately, the individual feels that cannot afford the demands of the work and family roles which evoke thoughts of the uselessness of life or loss of sleep. Indeed, considering the effects of job characteristics on WFC and the effects of WFC on mental-health, we argue that WFC could explain the relationship between job characteristics and mental health. Therefore, we predict that: 1. **Hypothesis 1:** The WFC mediates the relationship between job characteristics (i.e., job demands, job control, and supervisory social support) and workers' mental health. ### The Moderating Role of Gender The moderating role of gender is of particular interest in our model in both the relationship between job characteristics and the WFC and in the relationship between the WFC and workers' mental health. According to [@B46], role identities are socially defined and individuals acquire beliefs about social roles expected for women and for men. Indeed, women are viewed as more family-centered and men are viewed as more work-centered ([@B33]). Consequently, men are usually less involved in family activities (i.e., parenting; domestic tasks) ([@B46]) whereas women accumulate more professional work and family responsibilities ([@B17]). Furthermore, according to boundary theories, individuals tend to either segment their work and family in separate spheres or to integrate work and family domains in permeable boundaries ([@B46]). Considering the aforementioned, women, compared to men, have to make extra efforts to adapt their daily agenda in order to keep the boundaries more permeable, which can predict high levels of the WFC ([@B46]). Thus, we are of the opinion that the perception of job characteristics, such as autonomy and supervisory support, which allow individuals to balance their work and family spheres, will be more valuable for women than for men. On the contrary, as women tend to make more efforts to integrate work and family, job demands may be more easily depleting and give rise to a conflict in these domains. In line with the argument of [@B16], "segmenters" are less likely to allow job demands to interrupt the time devoted to family. In other words, the relationship between job characteristics and the WFC may be stronger for women in comparison to men. Our argument is in keeping with previous findings. For instance, the qualitative study of [@B8], conducted in a company in Mexico, concluded that accomplishing work time demands is viewed as a sign of masculinity, thus maintaining women connected to traditional family roles. This means that it is more acceptable for men to deal with these time demands than for women. Hence, this particular job demand more easily creates a WFC for women than for men. Using the Job-Demand Control model ([@B31]), [@B18] analyzed the differences between men and women and observed that the WFC in women is lower when job autonomy is high. In the same vein, [@B53], conducting research in a hospital, concluded that the WFC affects both men and women, but women tend to depend on social support to reduce burnout and decrease turnover when compared with men. Thus, autonomy and supervisory support may be seen as crucial characteristics that enable women to balance their work and family demands. Moreover, when the WFC occurs, it may have stronger implications for the mental health of women than of men. As mentioned above, women are more involved in family activities while also accumulating professional work ([@B46]). Thus, the increased likelihood of role conflict and the lack of personal resources to deal with conflict ([@B51]) may have stronger negative consequences for women than for men. This argument is also in line with previous research. For instance, the study of [@B53], which explored how factors relating to the work--life interface affected the well-being of a sample of hospital doctors, concluded that female doctors were more likely to experience job burnout than men. The longitudinal study of [@B34] also suggested that there might be gender differences in the WFC and well-being across time. More specifically, their findings revealed that unlike men, the WFC perceived at time 1 by women significantly predicted job dissatisfaction, parental distress, and psychological symptoms at Time 2, 1 year later. Taking this together, we established the following hypothesis: 1. **Hypothesis 2:** The mediating role of the WFC is moderated by gender. This variable interacts: first, with job characteristics, so the relationship between job characteristics and the WFC is significantly stronger for women than for men; and second, with the WFC, so the relationship between the WFC and mental health is significantly stronger for women than for men. Materials and Methods {#s1} ===================== Procedure and Participants -------------------------- The Ethics Committee of the Lisbon Academic Medical Center approved the study and data collection protocol. This study is an observational study which was carried out before 2013 (last update of the Declaration of Helsinki). No medical experiments were conducted and no sensitive data was collected, therefore the Ethics Committee did not require a formal consent return. However, a statement of study objectives and purposes and an anonymity and confidentiality warranty were set out at the beginning of the questionnaire, along with the professional identification and contact of the main researcher. Respondents were asked to read these statements before proceeding to answer the questionnaire. They were also informed that their participation was voluntary and they could also freely participate in or give up the study anonymously, at any moment, without any further consequences. The questionnaire link was forwarded by the researcher team to the company contact point, who sent it to respondents via e-mail, in which they were also informed of the respective board of director's authorization to conduct the study, after a presentation of the research protocol. There was no incentive (cash or otherwise) for participating in this study. The respondents were employed at a nationwide technological and services company with a population of 631 workers. Of all the workers invited to answer the questionnaire, 312 (49.44%) responded. Since the goal of this study was to gain an in-depth understanding of the work and family relationship of workers, the questionnaires of workers who reported having at least one child and/or who were married or in a common-law relationship and obtained 254 answers were selected: 100 (39.4%) women and 154 (60.6%) men. The mean age of the respondents was 52.83 years (*SD* = 6.29). A large percentage of the participants (44.1%) had completed secondary schooling and 29.1% of the participants had graduated from university. All respondents worked full-time. The majority of the respondents were married or cohabiting (87.0%) and had children (77.2%). As may be observed in **Table [1](#T1){ref-type="table"}**, the demographic characteristics of women and men were similar. According to the Head of Human Resources, the sample characteristics are in line with the demographic characteristics of the company workers. ###### Demographics of the sample. Sub-sample Women (*n* = 100) Men (*n* = 154) ------------------------------- -------------------- -------------------- Age (mean) *M* = 51.59 *M* = 53.63 (*SD* = 7.61) (*SD* = 6.24) min = 27; max = 62 min = 28; max = 65 **Education (%)** Secondary 64% 61.7% Graduation or higher 36% 38.3% Had children (% Yes) 74.00% 79.20% Married or cohabiting (% Yes) 77.00% 93.50% Measures -------- ### Job Characteristics Job characteristics were measured using the Job Content Questionnaire ([@B30]), which was used in a previous Portuguese study ([@B7]). Items for job demands were: workload and time pressure (7 items) -- "*I have too much to do*" (women α = 0.85 and men α = 0.89); job control (4 items) -- "*I have the opportunity to decide how to organize my work*" (women α = 0.85 and men α = 0.83); supervisory social support (4 items) -- "*My supervisor is concerned about the welfare of those under him*" (women α = 0.91 and men α = 0.89). Items were scored on a four-point rating scale from (1) "*totally disagree*" to (4) "*totally agree.*" In order to examine the psychometric properties of the measure, we performed a CFA. First, we tested a three latent factor model (i.e., job demands, job control, and supervisory social support) through CFA and then we compared this structure with an alternative model, where all the items loaded onto a single latent factor. The three latent factor model showed an acceptable fit to the data \[*women's sample*: χ^2^(85) = 141.86, *p* \< 0.001; SRMR = 0.07; IFI = 0.93; CFI = 0.93; RMSEA = 0.07; *men's sample*: χ^2^(85) = 204.96, *p* \< 0.001; SRMR = 0.07; IFI = 0.91; CFI = 0.91; RMSEA = 0.07\]. The alternative tested model did not show an acceptable fit to the data, \[*women's sample*: χ^2^(87) = 523.36, *p* \< 0.001; SRMR = 0.12; IFI = 0.65; CFI = 0.65; RMSEA = 0.13; *men's sample*: χ^2^(87) = 484.07, *p* \< 0.001; SRMR = 0.13; IFI = 0.58; CFI = 0.57; RMSEA = 0.22\], and differed significantly from the three factor structure model \[*women's sample*: Δχ^2^ (2) = 381.05, *p* \< 0.01; *men's sample*: Δχ^2^ (2) = 279.11, *p* \< 0.01\], which appears to suggest that job demands, job control, and supervisory social support consist of three different and broader types of job characteristics. ### Work-Family Conflict We measured the WFC using 14 items from the extended scale of [@B6]. Example items included "*After work, I am too tired when I come home to do some of the things I'd like to do*" and "*My job takes time from me that I would like to spend with my family/friends.*" The items were answered on a five-point rating scale that ranged from "*hardly ever*" (1) to "*almost always*" (5), (women and men α = 0.92). This scale has previously been validated for the Portuguese population ([@B52]). In order to examine the psychometric properties of the measure, we performed a CFA. We tested a one-factor model, where all the items loaded onto a single latent factor. This single latent factor model showed an acceptable fit to the data \[*women's sample*: χ^2^(73) = 143.14, *p* \< 0.001; SRMR = 0.06; IFI = 0.94; CFI = 0.94; RMSEA = 0.06; *men's sample*: χ^2^(73) = 168.70, *p* \< 0.001; SRMR = 0.06; IFI = 0.93; CFI = 0.93; RMSEA = 0.07), which appears to suggest that the work-family conflict (WFC) consists of one broader variable. ### Workers' Mental Health This variable was measured with a Portuguese version of the General Health Questionnaire (GHQ: [@B14]), which includes four dimensions: somatic complaints (7 items, "*Have you recently been feeling perfectly well and in good health?*," women α = 0.74, men α = 0.82); anxiety (7 items, "*Have you recently lost sleep over worry?,"* women α = 0.90, men α = 0.91); social dysfunction (7 items, "*Have you recently been taking longer over the things you do?*," women α = 0.84, men α = 0.82); and depression (7 items, "*Have you recently felt that life is entirely hopeless?*," women α = 0.87, men α = 0.81). In the GHQ-28, the respondent is asked to compare his/her recent psychological state with his/her usual state. The response scale ranged from 1 (not at all) to 4 (much more than usual). This scale had previously been validated for the Portuguese population ([@B40]). The GHQ-28 is designed for the detection of non-specific psychiatric disorders among individuals in community settings. It focuses on break in normal functioning and not on permanent traits, but also considers the appearance of new and distressing experiences ([@B14]). In order to examine the psychometric properties of the measure, we performed a CFA. First, we tested a four latent factor model (i.e., somatic complains, anxiety, social dysfunction, and depression) through CFA and then we compared this structure with an alternative model, where mental health was considered an overarching second-order variable and somatic complaints, anxiety, social dysfunction and depression dimensions first-order latent variables ([@B14]). The four latent factor model showed an acceptable fit to the data \[*women's sample*: χ^2^(334) = 469.76, *p* \< 0.001; SRMR = 0.06; IFI = 0.92; CFI = 0.92; RMSEA = 0.06; *men's sample*: χ^2^(334) = 643.51, *p* \< 0.001; SRMR = 0.08; IFI = 0.90; CFI = 0.90; RMSEA = 0.07\]. The alternative tested model also showed an acceptable fit to the data \[*women's sample*: χ^2^(346) = 468.14, *p* \< 0.001; SRMR = 0.06; IFI = 0.92; CFI = 0.92; RMSEA = 0.06; *men's sample*: χ^2^(346) = 621.57, *p* \< 0.001; SRMR = 0.08; IFI = 0.90; CFI = 0.90; RMSEA = 0.07\]. In the women's sample, these two models did not differ significantly \[Δχ^2^ (2) = 1.62, *p* = 0.45\], however, in the men's sample, these models differed significantly \[Δχ^2^ (2) = 21.94, *p* \< 0.01\] and the data was observed to fit better with the model that considered a second-order variable including the four dimensions as first-order latent variables. Thus, we considered somatic complaints, anxiety, social dysfunction, and depression to consist of four different dimensions in the same broader construct of poor mental health (women α = 0.93 and men α = 0.92). ### Control Variables Age may be related to the WFC ([@B39]). Thus, we controlled for age (in years). It would be also important to include tenure as a control variable. However, due to confidentiality reasons, the human resources department did not allow us to collect this demographic variable. Though, we collect age. We also recognize that despite tenure and ages were time-related variables, they are distinct. However, in a typical traditional organizational where this study was conducted the workers come in early age to the company and remain a great amount of time working in the same place. This fact helps us to think that age is proportional to tenure. Thus, we control age and we think that in this vein we are controlling the work experience too -- i.e., tenure. Statistical Analyses -------------------- As proposed by [@B2], we followed a two-step approach to analyze our results. Structural equation modeling (SEM) and, in particular, multiple group analysis with the AMOS software package ([@B3]) was used, first to test several measurement models through confirmatory factor analysis (CFA) and then to compare various competing structural models. In all analyses, the maximum likelihood estimation method and the covariance matrix were used. Results ======= Measurement Models and Descriptive Analysis ------------------------------------------- Following established recommendations ([@B25]), evaluation of the overall goodness of fit of the models was based on the combination of several fit indices. Models were compared based on chi-square difference tests, and on other fit indices: the standardized root mean square residual (SRMR), the incremental fit index (IFI), the Bentler comparative fit index (CFI), and the root mean square error of approximation (RMSEA). For IFI and CFI, values above 0.90 represent a good model fit, and for SRMR and RMSEA, values equal to or below 0.07 indicate a good model fit. For each sample, we initially performed a CFA on the full measurement model ([@B2]). This model (five-factor model) included all observed items loading on their respective latent variables (job demands, job control, supervisory social support, WFC, and workers' mental-health). Workers' mental-health had four indicators (observed variables resulting from the sum of the GHQ-28 subscales items): somatic symptoms, anxiety/insomnia, social dysfunction, and depression symptoms. The latent variables were allowed to correlate with each other. We then conducted Harman's single-factor test ([@B44]), which involves a CFA in which all variables are allowed to load onto one general factor (one-factor model). In addition, as we were using more than one sample, we tested whether or not components of the measurement model were invariant (i.e., equivalent) across samples of women and men. Therefore, we ran multiple group CFA on the single scales. Results indicated that, in general, items were equivalent across samples. The one-factor model showed a poor fit to the data across samples \[*women's sample*: χ^2^(490) = 1314.89, *p* \< 0.001; SRMR = 0.12; IFI = 0.65; CFI = 0.65; RMSEA = 0.13; *men's sample*: χ^2^(490) = 1733.19, *p* \< 0.001; SRMR = 0.13; IFI = 0.62; CFI = 0.62; RMSEA = 0.13\]. The five-factor model obtained a good fit across samples \[*women's sample*: χ^2^(480) = 669.27, *p* \< 0.001; SRMR = 0.07; IFI = 0.92; CFI = 0.92; RMSEA = 0.06; *men's sample*: χ^2^(480) = 738.90, *p* \< 0.001; SRMR = 0.07; IFI = 0.92; CFI = 0.92; RMSEA = 0.06\], and all standardized regression coefficients were significant at the 0.001 level. Furthermore, in both samples, the five-factor model fit the data significantly better than the one-factor model \[*women's sample*: Δχ^2^(10) = 645.62, *p* \< 0.001; *men's sample*: Δχ^2^(10) = 994.29, *p* \< 0.001\]. These analyses showed that, across samples, the factor structures of the research variables were consistent with the conceptual model and also that the manifest variables loaded on the latent variables as intended. **Table [2](#T2){ref-type="table"}** shows the means, standard deviations and correlation matrix obtained separately for women's and men's samples. Analyzing the correlations among the studied variables we found a significant negative relationship between supervisor support and WFC for both women (*r* = -0.33, *p* \< 0.01) and men (*r* = -0.24, *p* \< 0.01), a significant positive relationship between job demands and WFC for women (*r* = 0.55, *p* \< 0.01) and for men (*r* = 0.49, *p* \< 0.01), and a significant negative relationship between job control and WFC for women (*r* = -0.35, *p* \< 0.01) and for men (*r* = 0.27, *p* \< 0.01). Regarding the relationship between WFC and mental health we found a significant positive for both women and men (*r* = 0.63, *p* \< 0.01; *r* = 0.69, *p* \< 0.01, respectively). Thus, the correlations are in the expected direction of our hypothesis. ###### Means, standard deviations, and correlation matrix obtained separately for women (*n* = 100) and men (*n* = 154) samples. Variables Women Men 1 2 3 4 5 6 7 8 9 10 -------------------- ------- ------ ------- ------ ------- ---------- ----------- ----------- ----------- ----------- ----------- ----------- ---------- ----------- \(1\) Age 51.59 6.20 53.63 6.24 -- -0.07 -0.03 -0.05 -0.05 0.09 0.03 0.05 0.03 0.06 \(2\) Job demands 2.88 0.67 2.69 0.67 -0.04 -- -0.10 -0.00 0.49\*\* 0.32\*\* 0.39\*\* 0.20\* 0.21\* 0.39\*\* \(3\) Sup. support 3.17 0.59 2.95 0.69 0.00 -0.20\* -- 0.38\*\* -0.24\*\* -0.25\*\* -0.21\*\* -0.30\*\* -0.15 -0.30\*\* \(4\) Job control 2.85 0.65 2.77 0.64 -0.00 -0.03 0.33\*\* -- -0.27\*\* -0.15 -0.23\*\* -0.28\*\* -0.13 -0.26\*\* \(5\) WFC 2.72 0.74 2.55 0.70 0.07 0.55\*\* -0.33\*\* -0.35\*\* -- 0.56\*\* 0.73\*\* 0.27\*\* 0.42\*\* 0.68\*\* \(6\) Somatic c. 1.07 0.50 0.72 0.47 -0.03 0.23\* -0.19 -0.21\* 0.49\*\* -- 0.72\*\* 0.40\*\* 0.45\*\* 0.89\*\* \(7\) Anxiety/ins. 1.13 0.66 0.91 0.61 0.05 0.36\* -0.24\* -0.36\*\* 0.68\*\* 0.74\*\* -- 0.34\*\* 0.56\*\* 0.91\*\* \(8\) Social dys. 0.99 0.36 0.96 0.32 -0.03 0.21\* -0.00 -0.28\*\* 0.39\*\* 0.46\*\* 0.55\*\* -- 0.29\*\* 0.61\*\* \(9\) Depression 0.39 0.51 0.25 0.34 0.02 0.13 -0.15 -0.32\*\* 0.48\*\* 0.48\*\* 0.58\*\* 0.48\*\* -0 0.55\*\* \(10\) GHQ total 1.06 0.44 0.86 0.39 0.00 0.33\*\* -0.20 -0.34\* 0.63\*\* 0.88\*\* 0.93\*\* 0.73\*\* 0.60\*\* -- ∗∗ p \< 0.01; ∗ p \< 0.05. As expected, the job characteristics in both samples were significantly related to the WFC. As predicted, the WFC was significantly related to workers' mental health across samples. Structural Models ----------------- In order to test our hypotheses, we performed a multiple group analysis. This analysis was performed according to the instructions of [@B5], and by using the critical ratio for the difference between parameters method. As recommended, we first tested the structural models separately for the two sub-samples (i.e., women and men), to determine whether it was a full or partial mediation test. We confronted two structural models for both samples: a full-mediation model, which included direct structural paths from job characteristics to the WFC and from the WFC to workers' mental-health, and a partial-mediation model in which we added direct structural paths from job characteristics to workers' mental health. The model that best fit the data for both sub-samples of workers (women and men) was then tested in a multiple group analysis, including both sub-samples analyzed at the same time, with a view to inspecting invariance across the sub-samples (baseline model). The fit of this model was then compared to an alternative model in which we constrained all coefficient paths to be equal in the women and men sub-samples (fully constrained model: fixed measurement weights and fixed structural weights). Finally, by using the AMOS 22.0 program, *Z*-scores (i.e., the critical ratios for differences between two parameters) were also calculated for the baseline model in order to ascertain whether gender differences were statistically significant for the different relations among the studied variables. A *Z*-score above +1.645 or below -1.645 would indicate that observed differences were significant at α = 0.10. A *Z*-score above +1.96 or below -1.96 would indicate that observed differences were significant at α = 0.05. A *Z*-score above + 2.575 or below -2.575 would indicate that observed differences were significant at α = 0.01. The full-mediation model fit the data well across samples \[*women's sample*: χ^2^(511) = 710.35, *p* \< 0.001; SRMR = 0.07; IFI = 0.92; CFI = 0.92; RMSEA = 0.06; *men's sample*: χ^2^(511) = 755.58, *p* \< 0.001; SRMR = 0.07; IFI = 0.93; CFI = 0.93; RMSEA = 0.06\]. We then tested an alternative partial-mediation model with paths from job characteristics to workers' mental-health. These models also provided an acceptable fit in both the women's and men's samples \[*women's sample*: χ^2^(508) = 707.14, *p* \< 0.001; SRMR = 0.07; IFI = 0.92; CFI = 0.92; RMSEA = 0.06; *men's sample*: χ^2^(508) = 774.41, *p* \< 0.001; SRMR = 0.07; IFI = 0.92; CFI = 0.92; RMSEA = 0.06\]. However, the partial-mediation model did not fit the data significantly better \[*women's sample*: Δχ^2^(3) = 3.21, *p* = 0.36\] or worse than the full-mediation model \[*men's sample*: Δχ^2^(3) = -18.83, *p* \< 0.001\]. The full-mediation model was then tested in a multiple group analysis. We started by estimating a baseline model that included the two sub-samples at the same time, and where the structural paths were freely estimated for each group (i.e., the structural paths were unconstrained). The baseline model showed a good fit \[χ^2^(1022) = 1472.88, *p* \< 0.001; SRMR = 0.07; IFI = 0.92; CFI = 0.92; RMSEA = 0.04\]. We then went on to constrain all the coefficient paths to analyze invariance across the groups (fully-constrained model). The fully-constrained model showed an acceptable fit to the data \[χ^2^(1106) = 1612.61, *p* \< 0.001; SRMR = 0.07; IFI = 0.91; CFI = 0.91; RMSEA = 0.04\]. However, by comparing the fully-constrained model with the baseline model, we observed a significant drop in the fit \[Δχ^2^(84) = 139.73, *p* \< 0.001\], which means that some coefficients were different across the two groups under study. Finally, in order to understand whether the significant differences suggested by the comparison between the fully-constrained model and the baseline model were in the relationships among the studied variables, we observed the critical ratios for differences between two parameters. The unstandardized coefficients obtained for the baseline model are presented in **Figure [1](#F1){ref-type="fig"}**, and in **Table [3](#T3){ref-type="table"}** the *Z*-scores for the differences between the two sub-samples are presented. {#F1} ###### Unstandardized coefficients for the baseline model (*n* = 254) and *Z*-scores for differences for gender. Dependent variables ---------------------------------------------- ----------------------- ----------------------- ----------- ----------- Supervisor support (as independent variable) -0.12, n.s. -0.11, n.s. n.a. n.a. Job demands (as independent variable) 0.95^∗∗∗^ 0.78^∗∗∗^ n.a. n.a. Job control (as independent variable) -0.35^∗∗∗^ -0.33^∗∗∗^ n.a. n.a. WFC (as independent variable) n.a. n.a. 0.44^∗∗∗^ 0.39^∗∗∗^ ***Z*-score for differences** **Females vs. Males** **Females vs. Males** Supervisor support (as independent variable) -0.09, n.s. n.a. Job demands (as independent variable) 0.54, n.s. n.a. Job control (as independent variable) -0.12, n.s. n.a. WFC (as independent variable) n.a. 0.50, n.s. WFC, work-to-family conflict; ∗∗ p \< 0.05; ∗∗∗ p \< 0.01; n.a., non-applied; n.s., non-significant. Hypothesis 1 predicted that the WFC would mediate the relationship between job characteristics (i.e., job demands, job control, and supervisory social support) and workers' mental health. Regarding **Figure [1](#F1){ref-type="fig"}** and **Table [3](#T3){ref-type="table"}**, the results obtained indicated that for both sub-samples, the relationship between supervisory social support and the WFC was not significant (for women: *B* = -0.12, n.s.; for men: *B* = -0.11, n.s.; *Z*~women-men~ = -0.09, n.s.), however, both job demands and job control were significantly related to WFC levels, namely: whereas job demands presented a positive relationship (for women: *B* = 0.95, *p* \< 0.001; for men: *B* = 0.78, *p* \< 0.001; *Z*~women-men~ = 0.54, n.s.), job control appeared to contribute negatively to the WFC (for women: *B* = -0.35, *p* \< 0.001; for men: *B* = -0.33, *p* \< 0.001; *Z*~women-men~ = -0.12, n.s.). In addition, we found that for both sub-samples, the WFC was significantly related to workers' mental-health (for women: *B* = 0.44, *p* \< 0.001; for men: *B* = 0.39, *p* \< 0.001; *Z*~women-men~ = 0.50, n.s.). Thus, our hypothesis 1 was partially supported regarding the role of the WFC in explaining the relationship between job demands and job control with workers' mental health. However, as regards the relationship between supervisory social support and workers' mental health, we found no support for the mediating role of the WFC. As for the proposed moderating effect of gender (hypothesis 2), given that the critical ratios for the difference between parameters method (i.e., *Z*-scores) revealed non-significant group differences between women and men in the studied relationships, our hypothesis 2 was refuted by the data. Furthermore, we observed that age did not contribute to explaining variance, namely: for all the studied variables, we found non-significant relationships with age. Additional Analysis ------------------- Previous research (e.g., [@B29]) acknowledges the possibility of the relationship between demands and outcomes (e.g., mental health) present a curvilinear relationship (i.e., an inverted U-shaped relationship). Accordingly, at a certain level demands can contribute positively to the workers' outcomes by leading to individuals' state of activation and energizing ([@B47]; [@B23]). However, when demands are too high or excessive it could lead to a negative impact on workers' outcomes (e.g., employees can feel fatigued and exhausted) ([@B47]; [@B23]). To explore this possibility, we perform additional analyses using SPSS 25.0 version to both samples. More precisely, we used the curve estimation procedure which allows screening the data graphically to determine how the independent variable and the dependent variable are related (i.e., linearly or curvilinear). To strength the results observed by performing the curve estimation procedure, we also performed hierarchical multiple regression analysis. First, to test the main effect of demands on mental health, demands were entered at step one. Second, to determine the non-linear relationship between demands and mental health, the quadratic term (i.e., demands squared) was entered at step two (the quadratic term was calculated by squaring the appropriate continuous variable, as suggested by [@B1]). The results of the linear and curvilinear estimates are represented in **Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}**. Linear regression assumes that a straight line properly represents the relations between demands and the mental health. As can be observed in both figures, the linear model (represented by a continuous line) overlaps to the curvilinear model (represented by a dashed line). As such, there is low evidence for a curvilinear relationship between demands and mental health. At **Table [4](#T4){ref-type="table"}**, the model summary and parameter estimates for the linear and curvilinear (quadratic) models are provided. Once again, we observe better indicators for the linear model \[*women's' sample*: *F*(1,152) = 25.42, *p* \< 0.01; *men's sample*: *F*(1,98) = 9.54, *p* \< 0.01\] than for the curvilinear model \[*women's' sample*: *F*(2,151) = 12.88, *p* \< 0.01; *men's sample*: *F*(2,97) = 4.73, *p* \< 0.01\] in both samples. Furthermore, through the hierarchical multiple regression analysis performed, we observed a significant link between demands and mental health at step one \[*women's' sample*: *B* = 0.19, *p* \< 0.01; *men's sample*: *B* = 0.20, *p* \< 0.01\]. However, when demands squared (the quadratic term) was introduced at step two, once the linear relationship was controlled for in the same model, non-significant relationships were found between demands squared and mental health \[*women's' sample*: *B* = -0.01, n.s.; *men's sample*: *B* = 0.03, n.s.). {#F2} {#F3} ###### Results for the linear and curvilinear (quadratic) regression models for the relationship between job demands and mental health. Equation *R*^2^ *F* *df1* *df2* *p* *b*~0~ *b*~1~ *b*~2~ ----------- ------------- -------------- --------- ------------ ------------- ------------- ------------- -------------- Linear (0.14) 0.09 (25.42) 9.54 \(1\) 1 \(152\) 98 (0.00) 0.00 (0.18) 0.36 (0.20) 0.19 Quadratic (0.15) 0.09 (12.88) 4.73 \(2\) 2 \(151\) 97 (0.00) 0.01 (0.36) 0.29 (0.05) 0.24 (0.03) -0.01 The values presented on the right side of the brackets refer to the females; the values presented within brackets refers to the males. Discussion ========== In this study, we examined an integrated and mediation moderated model in order to verify (1) the mediating role of the WFC in the relationship between job characteristics and workers' mental health and (2) the role that gender plays as moderator of this relationship. The findings of our study seem to contribute to the idea that the WFC is important in explaining the relationship between job characteristics and workers' mental health. Nevertheless, we also found that this relationship is not moderated by gender. Regarding our mediation hypothesis, we observed different results concerning job characteristics. As expected, and in accordance with previous findings, we verified that both demands and control are potential important job characteristics for the emergence of the WFC ([@B19]; [@B39]). This result reinforces the argument that job demands are a source of strain which depletes workers' resources and evokes conflict in the family domain. On the contrary, job autonomy could prevent the WFC, since there is a possible negative contribution to the presence of the WFC. In fact, job demands and job autonomy are considered the core characteristics of the Job Demand-Control ([@B32]). Furthermore, the WFC is significantly related to workers' mental health, as also demonstrated by a number of studies (e.g., [@B4]; [@B7]; [@B42]). This finding seems to emphasize not only the crucial role that job characteristics play in the WFC but also the crucial role that the WFC has in explaining the relationship between job characteristics and workers' mental health. However, the relationship between supervisory support and the WFC is not significant. This result may be related to the fact that we analyzed general social support and not work-family support specifically and, as stressed by the meta-analysis of [@B35], the work-family specific constructs of supervisory support \[e.g., family supportive supervisor behavior ([@B20])\] are more strongly related to the WFC. Another reason which may justify this finding could be the specific context of the organization where this study was conducted. In this organization, the work--family relationship is more dependent on organizational general rules and practices than on supervisory attitudes and actions. Surprisingly, the present findings suggest that overall, men and women perceived the relationship between job characteristics and the WFC and the relationship between the WFC and their mental health equally. Considering the Portuguese context, in which dual-earner families are prevalent and traditional gender expectations subsist ([@B52]), this finding reveals that the effects of work on Portuguese citizens are so critical, that gender does not excel. However, this unexpected result may be due to a number of different reasons. First, it is essential to underline the current Portuguese reality where, due to the economic crisis, Portuguese citizens are experiencing several austerity measures which have brought about increased job demands (e.g., longer working hours) ([@B26]) and job insecurity. In fact, Portuguese work values also point to security and stability as being crucial for workers ([@B9]). Therefore, the impact of work on families' lives is identical for men and women. Second, it may be possible for men and women to present identical results even though they differ in the way they manage their work and family life or in the way they use organizational solutions to deal with their work and family life. Third, despite the subsistence of gender expectations, it should also be noted that there are increasingly more egalitarian attitudes toward men and women across the world (e.g., [@B43]) which, hopefully, will spread to Portugal in the near future. Finally, it is also necessary to draw attention to the fact that the mean age of the respondents was 52.83 years. Hence, we may deduce that the majority of respondents were not parents of young children, which is usually related to more family demands. Thus, for the respondents of this sample, particularly the women, family management may be easier. These hypotheses require further research in order to obtain a better understanding of the possible differences between men and women in their work--family relationship. Limitations, Future Studies, and Practical Implications ------------------------------------------------------- This study has some limitations that should be mentioned. First, the study used a self-report measure (questionnaire) that entails the problems of common method variance and consistency bias, however, as referred to by [@B50], common method variance concerns associated with heavy reliance on self-reported data measurements may be overstated. Second, analyses are based on a cross-sectional design. Hence, it is not possible to draw inferences regarding causal relations among the variables since the arrows that are depicted in **Figure [1](#F1){ref-type="fig"}** should be interpreted as associations. Thus, the causal ordering suggested by these results requires further confirmation in future longitudinal research. Third, this study was conducted in only one Portuguese organization which may compromise the generalizability of the results. Based on these limitations, future studies should continue to analyze our theoretical model. Moreover, as suggested by the meta-analysis of [@B35], the influence of work characteristics on the WFC depends on their relationship with this conflict. Hence, future studies should measure the family supportive supervisor behavior scale created by [@B20] and create job demands and autonomy scales that evoke the relationship with the family role. Furthermore, it is important to recognize that throughout the study we use the term 'gender' to mention the variable 'biological sex' that was used to measure male and female. Our option is solely related to the easy match between this construct and the literature on the WFC. However, the psychological implications of being male or female acknowledged in the gender construct are not integrated into this study. Thus, as stated by [@B46], to fully understand the gender implications, future studies should include the measure of gender belief systems. Future studies should also include different demands using the Job Demands-Resources Model ([@B48]) and explore the possibility of curvilinear relations between different types of demands and workers' outcomes. In terms of theoretical and practical implications for the field of occupational health psychology, this study has built on prior research as it advances the WFC as a contributory mechanism to the explanation of the job characteristics and workers' well-being relationship, as claimed by [@B49]. It should also be noted that the present study may provide some clues for the development of intervention agenda considering prevention of the WFC and, consequently, prevention of workers' mental health deterioration. This study reinforces that job characteristics should be priorities in the future agenda. Furthermore, the results suggest that any intervention designed to reduce the WFC may have effective results for both men and women. Author Contributions ==================== All the authors participated in the development of the article, giving suggestions and by making constant reviews. However, MN was more involved in the data collection, VC and MC were more involved in writing the article and SL in the statistical analysis. Conflict of Interest Statement ============================== The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. [^1]: Edited by: Eva Cifre, Universitat Jaume I, Spain [^2]: Reviewed by: Vicente Martinez-Tur, Universitat de València, Spain; Shiri Lavy, University of Haifa, Israel [^3]: This article was submitted to Organizational Psychology, a section of the journal Frontiers in Psychology

1. Background ============= Diabetes is one of the most prevalent endocrine diseases worldwide, and the number of people with diabetes has more than doubled over the past 30 years ([@A74255REF1]). Diabetes is characterized by beta cell dysfunction and absolute or relative insulin deficiency due to both genetic and environmental causes ([@A74255REF2]-[@A74255REF6]), however, the exact pathophysiological mechanism is still not known. Genome wide association studies have described around 250 gene regions predisposing to type 2 diabetes ([@A74255REF7]), of which more than 90% are genes related to beta cell function ([@A74255REF8], [@A74255REF9]). Knowledge of beta cell function is therefore of great importance in understanding diabetes pathophysiology. Insulin secretion is tightly regulated by glucose, however, other nutrients and hormones also affect insulin secretion, including vitamin D ([@A74255REF10]). Vitamin D is primarily known for its vital role in calcium homeostasis, however, many extra-skeletal effects of vitamin D have become apparent the last years, including effects on beta cells ([@A74255REF11]). Vitamin D is synthesized endogenously in the skin by UV exposure or derived from foods and supplements. The major form of vitamin D in the circulation is 25(OH) vitamin D, which is metabolized primarily in the kidneys by 1-alpha-hydroxylase to generate the active form of vitamin D, 1,25(OH)~2~ vitamin D. 1-alpha-hydroxylase is also expressed in several extra-renal tissues in humans including skin, gastrointestinal tract, placenta, and in the pancreatic beta cells ([@A74255REF12], [@A74255REF13]). This enables local production of 1,25(OH)~2~ vitamin D and permits intracellular regulation of vitamin D levels, also in beta cells ([@A74255REF12], [@A74255REF14]). 1,25(OH)~2~ vitamin D performs the majority of its effects through regulation of gene expression in different tissues and cells through binding to the nuclear vitamin D receptor (VDR), which acts as a transcription factor ([@A74255REF15]). A number of studies have indicated a beneficial role for vitamin D in pancreatic beta cell function. In vivo studies have shown reduced secretion of insulin from pancreatic islets in mice suffering from vitamin D deficiency. The insulin secretion was shown to improve by vitamin D supplementation ([@A74255REF16]). Evidence has also been presented indicating that vitamin D can protect beta cells from cytokine induced apoptosis ([@A74255REF16], [@A74255REF17]). Microarray studies of mice islets have identified genes regulated by 1,25(OH)~2~ vitamin D, among them genes involved in ion transport, lipid metabolism, and insulin secretion ([@A74255REF17]). Previous studies have reported divergent results on the effect of insulin secretion after treatment with 1,25(OH)~2~ vitamin D. Wolden-Kirk et al., did not show an increase in insulin secretion after preincubation of mouse islets with vitamin D followed by stimulation with high levels of glucose ([@A74255REF18]), whereas Jeddi et al., reported that preincubation of rat islets with vitamin D combined with a high glucose concentration increased glucose stimulated insulin secretion ([@A74255REF19]). However, the effects of vitamin D combined with glucose stimulation on insulin secretion in beta cells have not been fully elucidated, especially regarding the difference of effect between vitamin D metabolites. We have recently performed a study to determine the effect of 25(OH) vitamin D and 1,25(OH)~2~ vitamin D on the proteome of the INS1 cell line. The study showed that 31 proteins were differentially expressed after treatment with 1,25(OH)~2~ vitamin D, whereas 25(OH) vitamin D had no such effect ([@A74255REF20]). Among the upregulated proteins were proteins implicated in insulin granule motility and insulin exocytosis, suggesting a positive effect of 1,25(OH)~2~ vitamin D on insulin secretion ([@A74255REF20]) . 2. Objectives ============= The aim of the present study was to assess whether vitamin D would influence glucose stimulated insulin secretion in INS1E beta cells and whether there is a difference in the effect of 1,25(OH)~2~ vitamin D and 25(OH) vitamin D on insulin secretion. 3. Methods ========== 3.1. Culturing INS1E Cells -------------------------- We used the well-established rat insulinoma cell line INS1E and treated the cells with 25(OH) vitamin D and 1,25(OH)~2~ vitamin D prior to glucose stimulation. INS1E is a transformed cell line from rat insulinoma often used as a model for studies of beta cell function and presents an improved cell line compared to INS1. Studies have shown stable growth of INS1E cells over two years in culture and physiological insulin response to glucose, in contrast to INS1 cells ([@A74255REF21]). The cell-line was a kind gift from professor Wollheim ([@A74255REF21]). INS1E cells were grown adherently in RPMI medium (Gibco by Life Technologies, Paisley, UK) with supplements (FBS 10%, Na-pyruvate 0.01 M, HEPES 0.1 µM, penicillin/streptomycin 10 mL and 2-mercaptoetanol 300 µL per 30 mL RPMI) in a humidified atmosphere at 37°C with 5% CO~2~. RPMI was changed two to three times per week and cells sub-cultured to 80% confluence. INS1E cells were grown for four weeks until stable log phase growth. Cells (10^5^ per well in 12-well plates) were seeded in RPMI with supplements. We performed three parallel studies with triplicates. 3.2. Stimulation with Glucose After Pre-Treatment with Vitamin D Metabolites ---------------------------------------------------------------------------- After four passages, INS1E cells were incubated with RPMI with 10 nM 25(OH) vitamin D (Sigma-Aldrich, Netherlands), RPMI with 10 nM 1,25(OH)~2~ vitamin D (Sigma-Aldrich, Israel), or RPMI alone (control cells). The applied concentrations of 25(OH) vitamin D and 1,25(OH)~2~ vitamin D were chosen based on results from previous studies ([@A74255REF18], [@A74255REF22]). Vitamin D was dissolved in ethanol before the given amount was added to the medium. The RPMI, with supplements and vitamin D was replenished once during the 72 hours of preincubation. After 72 hours of preincubation, glucose stimulation was carried out. After gentle removal of RPMI, the cells were incubated with glucose-free Krebs-Ringer buffer for 60 minutes. Cells were subjected to stimulation with (1) Krebs-Ringer buffer or Krebs-Ringer buffer supplemented with (2) 5 mM glucose, (3) 11 mM glucose, or (4) 22 mM glucose in triplicates for 60 minutes. After stimulation, the medium was collected immediately to stop the incubation and centrifuged at 2000 g for 10 minutes. The supernatant was kept at -18°C prior to insulin measurement. The cells were collected by gentle mechanical release, resuspended until homogenous, and counted in an automated cell-counter (Countess, BioRad). The experiment was performed three times over a period of four weeks. The average cell numbers for each experiment are shown in [Table 1](#A74255TBL1){ref-type="table"}. ###### Average Cell Numbers for Experiments 1 - 3 Control Cells 1,25(OH)~2~ Vitamin D + 22 mM Glucose 25(OH) Vitamin D + 22 mM Glucose ------------------ --------------- --------------------------------------- ---------------------------------- **Experiment 1** 7.5 × 10^5^ 5.5 × 10^5^ 4.5 × 10^5^ **Experiment 2** 5.8 × 10^5^ 6.0 × 10^5^ 4.2 × 10^5^ **Experiment 3** 6.1 × 10^5^ 6.8 × 10^5^ 6.6 × 10^5^ 3.3. Insulin Assay RIA Kit -------------------------- Insulin was measured by a RIA kit (Millipore, Missouri, U.S.A.), according to manufacturer's protocol. 3.4. Statistics --------------- None of the parallels were excluded in the calculations. The cells not stimulated with vitamin D metabolites were considered as reference cells in each group. All data were expressed as mean ± SD and analysed using IBM SPSS 23.0. To calculate P values, a two-tailed student t test was applied. P values below 0.05 were regarded as statistically significant. 4. Results ========== As shown in [Figure 1](#A74255FIG1){ref-type="fig"}, there is an increased insulin secretion with increasing levels of glucose in the control cells, in cells preincubated with 1,25(OH)~2~ vitamin D, and in the cells preincubated with 25(OH) vitamin D. The cells treated with 1,25(OH)~2~ vitamin D and stimulated with 22 mM glucose showed a 43% increase in insulin secretion compared to control cells (P = 0.006). Stimulation with 22 mM glucose after preincubation with 25(OH) vitamin D on the contrary showed no effect on insulin secretion. Neither treatment with 1,25(OH)~2~ vitamin D nor 25(OH) vitamin D lead to changes in insulin secretion in the absence of glucose stimulation. {#A74255FIG1} The INS1E cells treated with 1,25(OH)~2~ vitamin D showed a trend towards increased insulin secretion at all glucose concentrations. At 5 mM glucose, there was a 32% increase in the amount of insulin secreted compared to control cells. At 11 mM glucose, a 28% increase was observed. No significant changes were detected when comparing control cells with those pre-treated with 25(OH) vitamin D for any glucose concentrations. The average cell number for each experiment is shown in [Table 1](#A74255TBL1){ref-type="table"}. At 22 mM glucose, the average change in cell numbers between the control cells and the cells treated with 1,25(OH)~2~ vitamin D was -0.36 × 10^5^ cells (-2.0 - 0.7 × 10^5^ cells). The average change in cell number comparing control cells and cells treated with 25(OH) vitamin D was -1.37 × 10^5^ (- 3.0 - 0.5 × 10^5^ cells). Thus, both preincubation with 25(OH) vitamin D and 1,25(OH)~2~ vitamin D led to a slight decrease of cells. 5. Discussion ============= This study has shown that treatment of INS1E cells with 1,25(OH)~2~ vitamin D prior to glucose stimulation at high doses (22 mM) leads to significantly increased insulin secretion compared with control cells. In contrast, preincubation with 25(OH) vitamin D did not alter the glucose stimulated insulin secretion significantly, regardless of the glucose concentration. We found no changes in insulin secretion between the cells preincubated with vitamin D metabolites or vehicle in the absence of glucose. To our knowledge, studies on the effect on insulin secretion of different vitamin D metabolites in INS1E cells have not been carried out before. Yet, these results are in line with several other studies showing an association between 1,25(OH)~2~ vitamin D and insulin release from beta cells ([@A74255REF19], [@A74255REF22]-[@A74255REF25]). Billaudel et al. ([@A74255REF23]), reported that glucose stimulated insulin secretion was reduced in islets from vitamin D deficient rats, whereas incubation with 1,25(OH)~2~ vitamin D had a stimulatory effect on insulin response after six hours. Tanaka et al. ([@A74255REF24]), showed that insulin secretion was decreased in vitamin D deficient rats, but restored to the level of the controls in rats treated with vitamin D. Bourlon et al. ([@A74255REF25]), also reported that insulin secretion was diminished in islets from vitamin D deficient rats and restored by 1,25(OH)~2~ vitamin D combined with 16.7 mM glucose stimulation. Consistent with our results, d'Emden et al., showed a 2.5 fold increase of insulin secretion in response to 10 nM 1,25(OH)~2~ vitamin D in rat islets; this treatment had to last for 96 hours for the effect to become evident ([@A74255REF22]). In 2015, Jeddi et al., reported that preincubation of rat islets for 24 or 48 hours with 1,25(OH)~2~ vitamin D increased glucose stimulated insulin secretion at high levels of glucose (16.7 mM), however, no effects on insulin secretion at low glucose levels were found ([@A74255REF19]). Contrary to our results, Wolden-Kirk et al., reported no significant changes in insulin secretion after treatment with 1,25(OH)~2~ vitamin D on mice islets ([@A74255REF18]). In this study, preincubation with active vitamin D lasted for 24 hours and the glucose levels were either 3 mM or 30 mM. It might be possible that the difference in length of preincubation with vitamin D, the chosen glucose concentrations, and the use of mice islets in this experiment led to the observed differences between their study and ours. The mechanisms of the effects of vitamin D on glucose stimulated insulin secretion in beta cells are not completely understood and both direct and indirect mechanisms have been suggested. Bourlon et al., demonstrated in their study that 1,25(OH)~2~ vitamin D could activate the de novo biosynthesis of insulin in rat islets and suggested this could be caused by increased rate of conversion of proinsulin to insulin ([@A74255REF25]). They also showed that vitamin D required 48 hours in culture to increase insulin secretion from beta cells, which could indicate a genomic effect of vitamin D in beta cells ([@A74255REF25]). Another study from Bourlon et al. ([@A74255REF26]), showed that 1,25(OH)~2~ vitamin D might have a modulatory role on insulin release from beta cells via the cyclic AMP pathway in rat, suggesting also non-genomic effects of vitamin D on insulin release. Vitamin D may stimulate a second messenger system that includes phospholipase C and G-protein receptors, which leads to increased calcium influx and increased intracellular glucose within the beta cells, causing insulin secretion ([@A74255REF27]). In addition, simulation of vitamin D receptor by 1,25(OH)~2~ vitamin D might diminish the dedifferentiation in beta cells seen in type 2 diabetes ([@A74255REF10]). In the present study, treatment with 25(OH) vitamin D, in contrast to 1,25(OH)~2~ vitamin D, did not alter the insulin secretion significantly. This may suggest that the conversion of 25(OH) vitamin D into 1,25(OH)~2~ vitamin D is insufficient in INS1E cells. Our recent proteomic study carried out on INS1 cells to clarify the difference between 25(OH) vitamin D and 1,25(OH)~2~ vitamin D showed that only treatment with 1,25(OH)~2~ vitamin D significantly changed the expression of numerous proteins, including proteins that may affect insulin secretion. On the contrary no effect was seen on the protein expression for 25(OH) vitamin D ([@A74255REF20]). This is in line with our present study and supports the hypothesis that there will be a difference in the effects of different vitamin D metabolites on insulin secretion. The 1-alpha-hydroxylase protein was not detected in the study by Pepaj et al., indicating that this enzyme may not be expressed in INS1 cells, though additional studies are necessary to confirm these results ([@A74255REF20]). INS1E cells are widely used as a model for pancreatic beta cells due to their stability in culture and their well-preserved glucose-induced insulin secretion within the physiological range ([@A74255REF21], [@A74255REF28]). However, it must be taken into consideration that the origin is a transformed cell line from the rat and will differ from islets regarding both function and mechanisms. INS1E cells lack the surrounding alpha and delta cells that normally reside in the pancreas. These are very important for the function of the beta cells and thus, for the secretion of insulin ([@A74255REF29]). Another limitation of the study is that the cells were preincubated with only 10 nM vitamin D metabolites. Future studies could possibly elucidate whether prolonged treatment of 1,25(OH)~2~ vitamin D, at even lower concentrations, would also increase glucose stimulated insulin secretion. Vitamin D could potentially influence the number of INS1E cells in culture by increasing mitosis ([@A74255REF30]) or the apoptotic rate ([@A74255REF31]) and thereby, modify insulin secretion solely due to cell numbers. In order to avoid this bias, the cells were counted before and after treatment with vitamin D metabolites. The cell numbers remained stable throughout the study. A modest reduction of cell numbers was seen in the treated cells compared to the control cells. In conclusion, the effect of preincubation of INS1E cells with vitamin D on insulin secretion appears to depend both on the vitamin D metabolite and glucose concentration. Only 1,25(OH)~2~ vitamin D increased insulin secretion, whereas 25(OH) vitamin D had no such effect. Future studies could clarify this observed difference and elucidate the possible mechanisms for the effect of 1,25(OH)~2~ vitamin D on glucose stimulated insulin secretion in beta cells. **Authors\' Contribution:**Study concept and design: Mette Eskild Bornstedt and Per M Thorsby; acquisition of data: Mette Eskild Bornstedt; analysis and interpretation of data: Mette Eskild Bornstedt, Nina Gjerlaugsen, Milaim Pepaj and May K L Bredahl; drafting of the manuscript: Mette Eskild Bornstedt; critical revision of the manuscript for important intellectual content: Per M Thorsby, May K L Bredahl, Mette Eskild Bornstedt and Milaim Pepaj; statistical analysis: Mette Eskild Bornstedt. **Conflict of Interests:**The authors declare that there is no conflict of interest. **Ethical Considerations:**This study was performed solely in a cell line from rat. The Authors declare no ethical considerations or ethical consideration code for this study or manuscript. **Financial Disclosure:**The authors declare that there are no financial disclosures. **Funding/Support:**This work was supported by the Hormone Laboratory, Department of Medical Biochemistry at Oslo University Hospital. This research did not receive any other specific grant from any funding agency in the public, commercial, or not-for-profit sector.

1. Introduction {#sec1-molecules-22-00562} =============== Though the treatments of coronary artery disease (CAD) have seen prominent improvements over the past decades, CAD is still the leading cause of death in the world. Single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), using radiotracers such as ^99m^Tc-sestamibi, ^99m^Tc-tetrofosmin and ^201^Tl, is the commonly used, standard, and non-invasive clinical screening tool for detecting CAD, risk stratification, and guidance of therapeutic interventions. Its sensitivity and specificity for detecting significant coronary stenosis was 87% and 73%, respectively, in a meta-analysis involving 4480 subjects \[[@B1-molecules-22-00562]\]. However, the application of SPECT MPI is limited for the following reasons: inferior spatial and temporal resolution, incapability of absolute quantification, non-uniform attenuation correction and high uptake in the organs adjacent to the heart \[[@B2-molecules-22-00562]\]. PET isotopes emit positrons. When a positron meets a nearby electron, they annihilate each other and emit two 511-keV photons in opposite direction (discharged at 180° to each other). Only the coincidental detection of two 511-keV photons can be recorded in PET scanners and reconstructed into PET images \[[@B3-molecules-22-00562]\]. Compared with SPECT, PET technology offers a better resolution and effective correction of photo-attenuation and scatter \[[@B4-molecules-22-00562]\], leading to absolute quantification of regional myocardial blood flow and coronary flow reserve \[[@B5-molecules-22-00562]\]. Besides that, patients are exposed to less radiation owing to the short half-lives of positron isotopes \[[@B6-molecules-22-00562],[@B7-molecules-22-00562]\]. Hence, the need for and use of PET applications in healthcare facilities is increasing tremendously \[[@B3-molecules-22-00562],[@B8-molecules-22-00562],[@B9-molecules-22-00562],[@B10-molecules-22-00562]\]. In 2016, the American Society of Nuclear Cardiology and the Society of Nuclear Medicine and Molecular Imaging published a joint position statement on the clinical indications for the significant underutilization of myocardial perfusion PET in America \[[@B11-molecules-22-00562],[@B12-molecules-22-00562]\]. ^13^N-NH~3~, ^82^Rb, and ^15^O-H~2~O are representative clinical PET MPI tracers \[[@B13-molecules-22-00562]\]. As the half-lives of ^15^O-H~2~O and ^13^N-NH~3~ are very short (2 and 10 min, respectively) \[[@B14-molecules-22-00562]\], on-site cyclotrons are required. ^82^Rb has a very short half-life (75 s) but can be conveniently supplied from a bedside generator. However, it has a low myocardial ejection fraction at high flow rates. Hence, it is imperative to develop novel and preferable PET MPI agents. Compared with the aforementioned isotopes, ^18^F has much shorter average positron range (1.03 nm), which results in better spatial resolution and contrast. It also has a longer half-life (110 min), so ^18^F-labeled radiotracers can be supplied at regional cyclotrons and allow treadmill exercises \[[@B15-molecules-22-00562]\]. Thus, the development of ^18^F-labeled MPI agents becomes a hot topic of interest for many researchers. Numerous novel agents have been synthesized and studied in the past decade. Especially a series of reports about ^18^F-flurpiridaz evidently enhanced researchers' confidence on the future of PET MPI agents. Several published reviews have summarized the characteristics of PET MPI agents and compared them with ^13^N-NH~3~, ^82^Rb, and ^15^O-H~2~O \[[@B14-molecules-22-00562],[@B16-molecules-22-00562],[@B17-molecules-22-00562],[@B18-molecules-22-00562],[@B19-molecules-22-00562]\]. However, most of them focused on the MPI agents in clinic status. In this study, we summarized ^18^F-labeled radiotracers in both clinical and preclinical status. According to the chemical structures and mechanism, ^18^F-labeled MPI agents under investigation can be divided into two types: lipophilic cations and analogues of mitochondrial complex-1 (MC-1) inhibitors. Herein, we compared the characteristics, mechanism, and research status of those different tracers. 2. Lipophilic Cations {#sec2-molecules-22-00562} ===================== Mitochondria take up 20--30% of the myocardial intracellular volume, making it an ideal target for MPI. The activation energy of lipophilic cations for moving through hydrophobic barrier of a biological membrane is far lower than that of other cations. Hence, lipophilic cations can pass through phospholipid bilayers of mitochondria without requiring a specific uptake mechanism \[[@B20-molecules-22-00562]\]. Because of delocalized positive charge of lipophilic cations, they accumulated substantially in the mitochondria in a membrane potential-dependent manner \[[@B21-molecules-22-00562]\]. Myocardial ischemia can cause cell death. Loss of mitochondrial membrane potential is an early event in cell death \[[@B22-molecules-22-00562]\]. Lipophilic cations can be used to detect myocardial abnormalities because the uptake of which is sensitive with mitochondrial voltage. Lipophilic cations for MPI include two types such as ammonium cations ([Figure 1](#molecules-22-00562-f001){ref-type="fig"}) and phosphonium cations ([Figure 2](#molecules-22-00562-f002){ref-type="fig"}). 2.1. Ammonium Cations {#sec2dot1-molecules-22-00562} --------------------- ### 2.1.1. 4-^18^F-Fluorotri-*N*-Methylanilinium Iodide (^18^F-FTMA) {#sec2dot1dot1-molecules-22-00562} Studenov et al. synthesized four ^18^F-labeled ammonium salts, represented by ^18^F-FTMA \[[@B23-molecules-22-00562]\]. The studies of acetylcholinesterase (AcChE) inhibition suggested that the myocardial accumulation of ^18^F-FTMA was probably due to the binding with myocardial AcChE (K~i~: 46--49 μM). The biodistribution study in mice revealed that ^18^F-FTMA had low myocardial uptake and heart/liver ratio (\<0.5 during 5--60 min post injection (p.i.)). Hence, it had a limited potential for MPI. ### 2.1.2. ^18^F-Labeled Rhodamines {#sec2dot1dot2-molecules-22-00562} Rhodamine can accumulate in the mitochondria in proportion to mitochondrial membrane potential. ^18^F-FERhB was developed for MPI because the lead unlabeled compound rhodamine-123 could accumulate well in the heart of mouse \[[@B24-molecules-22-00562]\]. The imaging capability of ^18^F-FERhB was related to its stability. For instance, 71% of ^18^F-FERhB got hydrolyzed in mouse serum at 2 h p.i., leading to poor myocardial uptake in the microPET image of a mouse. Whereas 86% of ^18^F-FERhB was still intact in rat serum at the same condition, resulting in considerable increase of myocardial uptake in rats \[[@B25-molecules-22-00562]\]. In the biodistribution study of rats, the myocardial uptake (2.06 ± 0.61% ID/g at 60 min p.i.) was over twice the liver uptake and over 25 times the blood uptake. However, the myocardial image of the rat indicated that the uptake in heart and liver was approximately equal so it might not be a competitive MPI agent. Researchers supposed that ^18^F-FERhB might have better performance in human, since it had a better stability in human serum. Maddahi et al. used ^18^F-FDG as the radiointermediate, and reported the preclinical evaluation of ^18^F-FDG-rhodamine \[[@B26-molecules-22-00562]\]. ^18^F-FDG-rhodamine had a good stability in human plasma in vitro. The heart uptake of ^18^F-FDG-rhodamine was 11.24 ± 1.97% ID/g in rats, which was nearly 4 times higher than other radiofluorinated rhodamine analogues. The low lipophilic characteristic (log P = −1.64 ± 0.03) leads to the low liver uptake. The heart/liver ratio was 21.20 at 60 min p.i. The myocardial extraction of ^18^F-FDG-rhodamine was 27.63 ± 5.12% during the first 15 min of perfusion period, which was higher than ^99m^Tc-MIBI (15 ± 1%) and lower than ^201^Tl (30 ± 5%). Besides that, Maddahi et al. mentioned that ^18^F-FDG-rhodamine hydrolysed in vivo in mice as ^18^F-FERhB. They suggested that mice might not be the suitable animal models for the tests of rhodamine-related compounds \[[@B26-molecules-22-00562]\]. On the other hand, Bartholomä et al. developed a range of different rhodamine cores (rhodamine 6G, rhodamine 101, and tetramethylrhodamine) labeled with ^18^F. They used various rhodamine lactones as the precursors and used ^18^F-fluorodiethylene glycol ester as the prosthetic group \[[@B27-molecules-22-00562]\]. Rhodamine 6G could locate in the mitochondria of isolated rat cardiomyocytes and had superior pharmacologic properties than others. Further first-in-human clinical studies with ^18^F-rhodamine 6G are on the way. So far, there is no follow-up report published in literature concerning its stability and clinical application in human. ### 2.1.3. ^18^F-Labeled BODIPY Derivatives {#sec2dot1dot3-molecules-22-00562} Boron-dipyrromethene (BODIPY) is a class of fluorescent dyes. It contains dipyrromethene and a disubstituted boron atom. BODIPY derivatives accumulate in mitochondria in a mitochondrial membrane potential-dependent manner \[[@B28-molecules-22-00562]\]. They can be labeled with ^18^F by SnCl~4~-promoted ^18^F-^19^F isotopic exchange in aqueous solutions. Li et al. reported a series of ^18^F-labeled BODIPY derivatives \[[@B29-molecules-22-00562],[@B30-molecules-22-00562],[@B31-molecules-22-00562]\]. Most of them had low heart/liver ratio, which limited their potential as MPI agents. 10-(4-(trimethylammonio)phenyl)-5-fluoro-5-^18^F-fluoro-1,3,7,9-tetramethyl-5*H*-dipyrrolo\[1,2-c:2′,1′f\]\[[@B1-molecules-22-00562],[@B3-molecules-22-00562],[@B2-molecules-22-00562]\] diazaborinin-4-ium-5-uide (^18^F-2) was the representative compound \[[@B31-molecules-22-00562]\]. The heart uptake and heart/liver ratio of ^18^F-2 was 8.75% ± 1.04% ID/g and 2.19 ± 0.42 at 60 min p.i. in mice. In addition, all seven reported agents showed certain bone uptake (from 1.03 ± 0.21 to 2.74 ± 0.15% ID/g at 60 min p.i. in mice), indicating the decomposition of agents in vivo. So far, ^18^F-labeled BODIPY derivatives haven't showed remarkable biological properties. However, since BODIPY can be developed as PET/optical dual-modality agents, and the labeling method is mild and simple, novel BODIPY derivatives may be competitive in the future. 2.2. Phosphonium Cations {#sec2dot2-molecules-22-00562} ------------------------ Phosphonium cations were studied much widely than ammonium cations. Most of them showed superior properties in both MPI and detection of apoptosis. The modification of phosphonium cations was focused on the labeling methods and biological properties. The representative agents were ^18^F-FBnTP, ^18^FTPP, ^18^F-FPTP, ^18^F-FHTP, and ^18^F-mFMBTP. ### 2.2.1. ^18^F-Fluorobenzyl Triphenyl Phosphonium (^18^F-FBnTP) Cation {#sec2dot2dot1-molecules-22-00562} ^18^F-FBnTP is the incipient ^18^F-labeled phosphonium cation \[[@B32-molecules-22-00562]\]. In the imaging study of dogs, it showed notable initial uptake and prolonged retention in the myocardium \[[@B21-molecules-22-00562]\]. The clearance from blood pool was rapid (half-life: 19.5 ± 4.4 s), reaching 26.2 ± 7.8% and 13.4 ± 6.3% of activity in the left ventricular wall at 5 and 10 min, respectively. At 60 min p.i., the heart/blood, heart/lung, and heart/liver ratios were 16.6:1, 12.2:1, and 1.2:1, respectively. The detailed anatomy of the heart including the papillary muscle and the left and right atria could be easily recognized because of low background activity in combination with extensive uptake and prolonged retention in the myocardium. ^18^F-FBnTP was eliminated mainly via kidneys than hepatobiliary tract. It is sensitive in detecting small flow defects with similar accuracy all over the myocardium, including the inferior aspect adjacent to the liver. Compared with ex vivo tissue staining, the ischemic area after coronary occlusion assessed by PET was 16% smaller \[[@B33-molecules-22-00562]\]. Compared with ^99m^Tc-tetrofosmin, the accuracy of ^18^F-FBnTP was far better in the determination of mild and severe stenosis. In addition, ^18^F-FBnTP showed stable delineation of the ischemic area with no appreciable washout or redistribution ([Figure 3](#molecules-22-00562-f003){ref-type="fig"}) compared with ^201^Tl \[[@B34-molecules-22-00562]\]. At the beginning, the main limitation of ^18^F-FBnTP was its radiosynthesis. The first report of radiosynthesis took four steps (82 min) with poor radiochemical yield (6%), making it inconvenient for clinical application \[[@B21-molecules-22-00562]\]. Since then, researchers have devoted their efforts to simplifying the synthesis \[[@B35-molecules-22-00562],[@B36-molecules-22-00562]\]. In 2016, Zhang et al. reported a one-step synthesis of ^18^F-FBnTP by a copper-mediated ^18^F-fluorination reaction with a pinacolyl arylboronate precursor \[[@B37-molecules-22-00562]\]. The total radiochemical yield was 60 ± 18% without correction. This was a huge step for the promotion of ^18^F-FBnTP. ### 2.2.2. (4-^18^F-Fluorophenyl)triphenylphosphonium (^18^F-FTPP) Cation {#sec2dot2dot2-molecules-22-00562} Since ^18^F-FBnTP exhibited remarkable biological properties for MPI, researchers tried to develop further novel phosphonium cations with higher radiochemical yield and better biological properties. Zhen et al. reported ^18^F-FTPP (also named ^18^F-TPP) as a potential MPI agent \[[@B38-molecules-22-00562]\]. ^18^F-FTPP was originally developed for tumor imaging. However, besides tumor accumulation, it also showed significant myocardial uptake. The radiochemical yield of ^18^F-FTPP was 10--15% at end of synthesis (EOS). The biodistribution and imaging studies in rats indicated a rapid accumulation of ^18^F-FTPP in the heart (1--2 min) with stable retention for at least 1 h \[[@B39-molecules-22-00562]\]. The heart uptake of ^18^F-FTPP (1.51 ± 0.04% ID/g in rats at 30 min p.i.) was similar with ^99m^Tc-MIBI. The clearance of ^18^F-FTPP from non-target tissues was fast, resulting in high heart/blood ratios (75:1) and favorable heart/lung (4:1) and heart/liver ratios (8:1). In the coronary occlusion model of rabbits, ^18^F-FTPP showed diminished activity in the area of left anterior descending occlusion. The heart uptake of ^18^F-FTPP in the occluded myocardial regions of interest was comparable to that of ^13^N-NH~3~. Compared with ^18^F-FBnTP, ^18^F-FTPP distributes its positive charge over all four aryl groups attached to the phosphorus atom and generates a more uniform lipophilic cationic sphere. However, its potential still needs to be extensively evaluated in further animal studies. ### 2.2.3. ^18^F-Labeled Fluoroalkylphosphonium Derivatives {#sec2dot2dot3-molecules-22-00562} Kim et al. prepared a series of tracers, such as (5-^18^F-fluoropentyl)triphenylphosphonium cation (^18^F-FPTP), (6-^18^F-fluorohexyl)triphenylphosphonium cation (^18^F-FHTP), (2-(2-^18^F-fluoro-ethoxy)ethyl)triphenylphosphonium cation (^18^F-FETP), and (2-(2-^18^F-fluoroethoxy)ethyl) tris(4-methoxyphenyl)phosphonium cation (^18^F-FETMP). ^18^F-FPTP, ^18^F-FHTP, and ^18^F-FETMP used ^18^F-fluoroalkyl-4-methylbenzenesulfonate as radiointermediates \[[@B32-molecules-22-00562],[@B40-molecules-22-00562],[@B41-molecules-22-00562]\]. The radiochemical yields of those tracers were 10--20%, which was similar with that of ^18^F-FTPP. ^18^F-FPTP and ^18^F-FHTP have similar structures and physicochemical properties. The biodistribution of these two tracers are similar in most of the organs except liver. The liver clearance rate of ^18^F-FHTP was much faster than that of ^18^F-FPTP in mice, resulting in over twice heart/liver ratios of ^18^F-FHTP (25.53 ± 5.88 at 2 h p.i.) than that of ^18^F-FPTP (10.72 ± 2.17 at 2 h p.i.). The heart/blood ratios of ^18^F-FHTP were also admirable (138.61 ± 8.10 at 2 h p.i.). In the imaging studies of rats, the myocardial uptakes of both ^18^F-FHTP and ^18^F-FPTP were stable at a constant level for up to 1 h p.i. \[[@B40-molecules-22-00562]\]. Kim et al. compared ^18^F-FPTP, ^18^F-FHTP, and ^18^F-FETP with ^13^N-NH~3~ in rat models ([Figure 4](#molecules-22-00562-f004){ref-type="fig"}) \[[@B42-molecules-22-00562]\]. They found that the first-pass extraction fraction values of these four radio-agents are comparable at low flow velocity (0.5 mL/min), but ^18^F-FPTP, ^18^F-FHTP, and ^18^F-FETP had significantly higher extraction fractions than ^13^N-NH~3~ at higher flow velocity (4.0, 8.0, and 16.0 mL/min, *p* \< 0.05). Small animal PET images with ^18^F-FPTP demonstrated an excellent image quality with a clear delineation of the borders of defects, which was consistent with the size validated by 2,3,5-triphenyltetrazolium chloride (TTC) staining (*r*^2^ = 0.92, *p* \< 0.001) \[[@B40-molecules-22-00562]\]. The structure of ^18^F-FETMP contains methoxy and ethoxy groups to attenuate the lipophilicity. However, the liver uptake of ^18^F-FETMP was much higher than that of ^18^F-FPTP and ^18^F-FHTP, leading to much slower liver clearance \[[@B41-molecules-22-00562]\]. Researchers supposed that the clearance of these radiotracers from liver was dependent on both lipophilicity and the functional groups of the compounds \[[@B43-molecules-22-00562]\]. It is worth mentioning that the studies of these radiotracers in larger animals haven't been reported yet. Hence, their perspectives for MPI need further investigations with big animal models. ### 2.2.4. 4-(^18^F-Fluoromethyl)benzyltriphenyl Phosphonium (^18^F-FMBTP) Cation and (3-(^18^F-Fluoro-methyl)benzyl)trisphenylphosphonium (^18^F-mFMBTP) Cation {#sec2dot2dot4-molecules-22-00562} Zhao et al. reported the preparation of ^18^F-FMBTP and ^18^F-mFMBTP using another kind of radiointermediates, *p*- or *m*-substituted 1-halomethyl-^18^F-fluoromethylbenzenes \[[@B44-molecules-22-00562]\]. They improved the reaction condition and increased the radiochemical yields of *p*- or *m*-radio-intermediates from 12% and 26% to 85% and 92%, respectively. The radiochemical yields of final radiotracers ^18^F-FMBTP and ^18^F-mFMBTP were \~50%, which were far higher than ^18^F-FHTP (10%--20%). ^18^F-mFMBTP had good retention in the myocardium (26.82 ± 3.46% ID/g at 120 min p.i.) and faster liver clearance (1.02 ± 0.2% ID/g at 120 min p.i.). The heart/liver, heart/lung, and heart/blood ratios of ^18^F-mFMBTP were 26.25, 9.97, and 83.98 at 120 min p.i., respectively, which was comparable with ^18^F-FPTP and ^18^F-FHTP. There was certain uptake in the bone of mice. However, fortunately no obvious bone uptake was observed in the PET images of rats ([Figure 5](#molecules-22-00562-f005){ref-type="fig"}) and dogs (the heart/bone ratios of ^18^F-mFMBTP in dogs were \>10 in 120 min p.i.). MicroPET studies of ^18^F-mFMBTP resulted in high contrast images with sustained prominent myocardium uptake and markedly low liver and lung uptake up to 120 min p.i. Furthermore, the heart/liver and heart/lung standardized uptake value (SUV) ratios of ^18^F-mFMBTP in dogs were calculated as 2.83 and 15.19 at 30 min p.i., and 7.76 and 35.28 at 120 min p.i., respectively. On the other hand, other organs and tissues had low background uptake because of excellent metabolic properties of the compound. In brief, *p*- or *m*-substituted 1-halomethyl-^18^F-fluoromethylbenzenes can evidently raise the radiochemical yields of phosphonium cations \[[@B45-molecules-22-00562]\]. Since there was certain uptake of ^18^F-FMBTP and ^18^F-mFMBTP in the bone of mice, the stability and uptake of these radiotracers in bones and other organs of big animals still need to be studied carefully. Besides the agents above, Yuan et al. used the triphenylphosphonium group as a mitochondrial delivery vehicle. They connected the triphenylphosphonium group with BODIPY Green, and developed ^18^F-TPP-Green \[[@B46-molecules-22-00562]\]. In summary, there is an enormous progress in the development of ^18^F-labeled phosphonium cations, especially in the radiosynthesis. Varieties of labeling methods have been used for the preparation of ^18^F-labeled phosphonium cations. The radiochemical yield has been increased from 6% to 60%. In the meantime, some novel ^18^F-labeled phosphonium cations exhibit favorable metabolic properties in the preliminary research. However, most of them have not been studied thoroughly. Additional researches are required to understand the implications of ^18^F-labeled phosphonium cations in MPI of humans. 3. Analogues of MC-1 Inhibitors {#sec3-molecules-22-00562} =============================== MC-1 is the first enzyme of the electron transport complexes. It locates in the inner mitochondrial membrane \[[@B47-molecules-22-00562]\]. MC-1 has an extremely complex structure with over 40 subunits and a molecular mass of approximately 1000 kD \[[@B45-molecules-22-00562]\]. The inhibitors of MC-1 such as rotenone, quinazoline, and pyridazinone can specifically bind to MC-1 and accumulate in the mitochondria. The heart uptake of these compounds is correlated with the myocardial blood flow. Hence, MC-1 inhibitor analogues are developed for MPI ([Figure 6](#molecules-22-00562-f006){ref-type="fig"}). 3.1. ^18^F-Fluorodihydrorotenone (^18^F-FDHR) {#sec3dot1-molecules-22-00562} --------------------------------------------- Rotenone is a neutral lipophilic compound that can inhibit the activity of MC-1. It is widely used as an insecticide. Marshall et al. found that ^125^I-iodorotenone was superior to ^99m^Tc-sestamibi as a blood flow tracer in the isolated rabbit heart \[[@B48-molecules-22-00562]\]. Later, they prepared ^18^F-fluorodihydrorotenone (^18^F-FDHR) \[[@B49-molecules-22-00562]\]. In the study of an isolated rabbit heart, ^18^F-FDHR was more closely related to coronary flow than ^201^Tl. Researchers considered that ^18^F-FDHR was a better blood flow tracer than ^201^Tl. Unfortunately, there is no follow-up study yet to confirm the tracer properties of ^18^F-FDHR in animal models. 3.2. (2-Tert-butyl-4-chloro-5-\[4-(2-^18^F-fluoroethoxymethyl)-benzyloxy\]-2H-pyridazin-3-one (^18^F-Flurpiridaz) {#sec3dot2-molecules-22-00562} ----------------------------------------------------------------------------------------------------------------- Yu et al. developed a series of ^18^F-RP1003, ^18^F-RP1004, ^18^F-RP1005, and ^18^F-flurpiridaz (previously named as BMS-747158-02) radiotracers based on different kinds of MC-1 inhibitors \[[@B50-molecules-22-00562]\]. Among them, pyridaben is considered as the best lead compound. ^18^F-flurpiridaz, a pyridaben analogue specific binding with the PSST subunit of MC-1, is the most promising MPI agent for clinical implementation \[[@B51-molecules-22-00562]\]. ^18^F-flurpiridaz has now been in Phase III clinical trials \[[@B52-molecules-22-00562]\]. The recent reviews considered it as the most promising tracer for MPI \[[@B16-molecules-22-00562],[@B17-molecules-22-00562],[@B53-molecules-22-00562]\]. The biodistribution studies of ^18^F-flurpiridaz in mice showed a significant myocardial uptake and good retention properties (9.5 ± 0.5% ID/g at 60 min p.i.). The heart/liver and heart/lung ratios were 8.3 and 14.1, respectively \[[@B54-molecules-22-00562]\]. In the imaging studies of mouse, rat, rabbit, pig, and non-human primate models, ^18^F-flurpiridaz demonstrated excellent properties with distinct visualization of the right and left ventricular myocardium and contrast between the heart and surrounding organs \[[@B51-molecules-22-00562],[@B54-molecules-22-00562],[@B55-molecules-22-00562],[@B56-molecules-22-00562],[@B57-molecules-22-00562]\]. In coronary occlusion and ischemia/reperfusion models of rats, the images of ^18^F-flurpiridaz displayed clear and stable delineation in the non-perfused segments of myocardium. Sherif et al. demonstrated that the uptake of ^18^F-flurpiridaz in the defect area of myocardium determined by PET was closely correlated with TTC staining (*r* = 0.89, *p \<* 0.01) \[[@B57-molecules-22-00562]\]. Furthermore, the uptake of ^18^F-flurpiridaz did not change at different time points of acquisition in the infarct area of rats produced by ligating the left anterior descending artery. In Phase I clinical trial in human subjects (*n* = 13), no significant adverse events related with ^18^F-flurpiridaz administration were reported \[[@B6-molecules-22-00562]\]. The largest mean dose was absorbed by the kidneys (0.066 mSv/MBq), followed by the heart wall (0.048 mSv/MBq). The radiation dose of ^18^F-flurpiridaz is comparable to or less than that of ^18^F-FDG \[[@B6-molecules-22-00562]\]. In a Phase II, multicenter clinical trial comprising 143 patients, ^18^F-flurpiridaz had more favorable diagnostic accuracy for evaluating multi-coronary artery stenosis, compared with SPECT MPI agents ^99m^Tc-sestamibi, ^99m^Tc-tetrofosmin, and ^201^Tl ([Figure 7](#molecules-22-00562-f007){ref-type="fig"}) \[[@B58-molecules-22-00562]\]. In the Phase III clinical trial comprising 72 sites and 795 subjects \[[@B52-molecules-22-00562]\], ^18^F-flurpiridaz showed a significant reduction in radiation exposure (6.1 ± 0.4 mSv) compared with SPECT (13.2 ± 3.3 mSv). In obese subjects, ^18^F-flurpiridaz showed statistically superior sensitivity, specificity, accuracy, diagnostic confidence, and image quality. 3.3. 2-Tert-butyl-4-chloro-5-(4-(2-^18^F-fluoroethoxy))benzyloxy-2H-pyridazin-3-one (^18^F-FP1OP) and 4-Chloro-2-tert-butyl-5-\[2-\[\[1-\[2-\[2-\[^18^F\]fluroethoxy\]ethoxymethyl\]-1H-1,2,3-triazol-4-yl\]methyl\]phenyl-methoxy\]-3(2H)-pyridazinone (\[^18^F\]Fmpp2) {#sec3dot3-molecules-22-00562} ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ To improve the liver clearance of pyridaben analogues such as ^18^F-flurpiridaz, Mou et al. introduced the polyethylene glycol (PEG) group into the structure and prepared ^18^F-FP1OP, ^18^F-FP2OP, and ^18^F-FP3OP \[[@B59-molecules-22-00562],[@B60-molecules-22-00562]\]. All three tracers had low initial liver uptake (2.72 ± 0.33% ID/g, 6.14 ± 0.48% ID/g, and 2.71 ± 0.93% ID/g, respectively, at 2 min p.i.), indicating that PEG group could be an available functional group to decrease the liver uptake of those tracers. Follow-up study findings also confirmed this point of view \[[@B61-molecules-22-00562],[@B62-molecules-22-00562]\]. ^18^F-FP1OP had shown the prominent potential properties among those three tracers. In the imaging study in pigs, the heart/liver and heart/lung SUV ratios were 1.83 and 4.53 at 2 min p.i., 2.73 and 7.39 at 30 min p.i., and 3.03 and 8.77 at 60 min p.i., respectively. ^18^F-FP1OP can distinguish the normal myocardium, ischemic myocardium, and infarct myocardium after acute infarction ([Figure 8](#molecules-22-00562-f008){ref-type="fig"}). However, the stability of ^18^F-FP1OP in water solution is not good, which limits its further application. Mou et al. hypothesized that the instability of ^18^F-FP1OP might due to its phenolic group \[[@B61-molecules-22-00562]\]. Subsequently, they replaced p-substituted phenolic group with 6-methylene-2-pyridyl and 6-methylene-2-phenyl, prepared ^18^F-FPTP2 \[[@B61-molecules-22-00562]\] and ^18^F-Fmp2 \[[@B61-molecules-22-00562]\], respectively. Both ^18^F-FPTP2 and ^18^F-Fmp2 exhibited excellent stability in water and murine plasma, indicating the replacement of phenolic group was an effective strategy. ^18^F-FPTP2 showed a significant initial heart uptake (39.70 ± 2.81% ID/g at 2 min p.i.) and moderate retention (20.09 ± 1.93% ID/g at 60 min p.i.), indicating that a variety of aromatic rings could be used to form pyridaben analogues. This result may expand the design of pyridaben analogues for MPI. However, the biological properties of ^18^F-FPTP2 and ^18^F-Fmp2 are not as good as ^18^F-FP1OP. Recently, they developed \[^18^F\]Fmpp1, \[^18^F\]Fmpp2 and \[^18^F\]Fmpp3 \[[@B62-molecules-22-00562]\]. Among these three tracers, \[^18^F\]Fmpp2 exhibited the best properties. It was stable in water for at least 3 h. In the whole-body PET/CT images of mini-swine ([Figure 8](#molecules-22-00562-f008){ref-type="fig"}a), it showed excellent initial heart SUV (7.12 at 5 min p.i.) and good retention (5.75 at 120 min p.i.). The heart/liver SUV ratios were 4.12, 5.42 and 5.99 at 30, 60 and 120 min after injection, respectively. Compared with ^18^F-flurpiridaz, \[^18^F\]Fmpp2 has much faster liver clearance, so it may provide better quality images earlier (15--30 min p.i.). Moreover, unlike other MPI agents, the kidney uptake of \[^18^F\]Fmpp2 was low from 30 to 120 min p.i., which might decrease the radiation dose. The metabolic stability of \[^18^F\]Fmpp2 in mice, rats and Chinese mini-swine was different. In the heart of mice, 45% activities of \[^18^F\]Fmpp2 were metabolized at 60 min p.i. while only 13% activities of \[^18^F\]Fmpp2 were metabolized in both the hearts of rat and Chinese mini-swine at 60 min p.i.. Nevertheless, more studies need to be done to evaluate the potential of \[^18^F\]Fmpp2 in ischemic or acute myocardial infarction animal models. Unlike ^18^F-labeled phosphonium cations, the labeling methods of ^18^F-labeled MC-1 inhibitors are similar, by substituting tosyl group with ^18^F. Radiochemical yields of ^18^F-labeled MC-1 inhibitors are, on the whole, favorable. The performance evaluation of ^18^F-labeled analogues of MC-1 inhibitors, especially ^18^F-flurpiridaz, is studied much extensively than ^18^F-labeled phosphonium cations, and thus they might be the target tracers for MPI in the coming future. 4. Conclusions and Perspectives {#sec4-molecules-22-00562} =============================== SPECT is still the first choice of MPI, especially in the developing countries. In 2012, the Chinese Society of Nuclear Medicine performed a general survey of 30 provinces regarding the status of nuclear medicine in China \[[@B63-molecules-22-00562]\]. According to the survey data, the total SPECT examinations were more than 1.44 million cases per year. MPI studies constituted 7% of them. The total PET examinations were 0.31 million cases per year. The cardiac PET examinations constituted only 0.62% of them. In 2016, the survey data indicated that the SPECT and PET examinations in China increase to 2.1 million and 0.47 million cases per year \[[@B64-molecules-22-00562]\]. The cardiac PET examinations constituted only 0.8% of PET examinations. We believe that the almost no PET MPI examinations in China must be due to the lack of commercialized PET agents for MPI. However, the disadvantages of SPECT mentioned above make it difficult to satisfy the clinical application in the coming future. An ideal myocardial perfusion tracer should include the following characteristics: high myocardial extraction fraction, excellent image quality, absolute quantification of myocardial blood flow, one-day protocol for rest and stress MPI, and possibility for long-distance transportation. Due to the excellent features, ^18^F radiotracers become the most prominent isotopes for MPI. ^18^F-flurpiridaz is the most promising MPI agent. The clinical trials with ^18^F-flurpiridaz have shown exciting results. Meanwhile, several ^18^F-labeled radiotracers such as ^18^F-FBnTP, ^18^F-FTTP, ^18^F-FHTP, and ^18^F-Fmpp2 have shown remarkable properties in preclinical studies as well. The characters of those MPI agents were brief summarized in [Table 1](#molecules-22-00562-t001){ref-type="table"}. Many of them exhibited high heart uptake and heart/liver ratios. But most of them still need further studies to meet the criteria of clinic, such as defect delineation, polar maps reversibility, etc. In general, lipophilic cations exhibit superior heart/liver and heart/blood ratios at early time points in small animals. For example, the heart/liver and heart/blood ratios of ^18^F-FHTP are 11.90 ± 3.37 and 71.87 ± 21.63 at 30 min p.i., respectively, in mice. Hence, clear images can be obtained early after injection of ^18^F-FHTP. However, the performances of lipophilic cations in larger animals have not yet been studied extensively. Further great efforts are needed to prove the properties of lipophilic cations in preclinical studies with larger animals and in human clinical trials. On the other hand, studies on ^18^F-labeled MC-1 inhibitors, especially pyridaben analogues, have been extended from preclinical studies involving mice to human clinical trials. Although their target/non-target ratios are not as high as lipophilic cations in mice, they are still more likely to be used in clinical practice because of prolonged retention in myocardium and low background uptake. There was certain concern about the safety of MC-1 inhibitors as the inhibition of MC-1 activity might lead to the death of animals. Fortunately, numerous studies have demonstrated that the use of MC-1 inhibitors is safe for MPI due to their extremely low chemical dose. In addition, the studies of structure-activity relationship based on lipophilic cations or analogues of MC-1 inhibitors reveal that there is extensive scope for the modification of structures. For instance, the benzene ring of phosphonium cations can be connected with various groups and different kinds of aromatic rings can be used as the "side chain" of pyridaben. Thus, more novel ^18^F-labeled MPI tracers may be developed. The superior properties of ^18^F-labeled MPI tracers may likely increase the acceptance of cardiac PET as a routine diagnostic tool in future. This work was sponsored by the National Natural Science Foundation of China (No. 81301251 and 81471707). **Sample Availability:** Not available. T.M. contributed to writing the article. X.Z. contributed literature review and critical revisions to the article. The authors declare no conflict of interest. CAD coronary artery disease SPECT single-photon emission computed tomography MPI myocardial perfusion imaging PET positron emission tomography MC-1 mitochondrial complex-1 SUV standardized uptake value AcChE acetylcholinesterase p.i. post injection PEG polyethylene glycol NDC non-decay-corrected DC decay-corrected 18 F-FTMA 4- 18 F-fluorotri- N -methylanilinium 18 F-FERhB 2- 18 F-fluoroethylrhodamine B 18 F-FDG-rhodamine 18 F-fluoro-2-deoxy- d -glucose-rhodamine BODIPY Boron-dipyrromethene 18 F-2 10-(4-(trimethylammonio)phenyl)-5-fluoro-5- 18 F-fluoro-1,3,7,9-tetramethyl-5 H -dipyrrolo-\[1,2-c:2′,1′f\]\[1,3,2\] diazaborinin-4-ium-5-ide 18 F-FBnTP 18 F-fluorobenzyltriphenylphosphonium 18 F-FTPP (4- 18 F-fluorophenyl)triphenylphosphonium cation 18 F-FPTP ( 18 F-fluoropentyl)triphenylphosphonium cation 18 F-FHTP (6- 18 F-Fluorohexyl) triphenylphosphonium cation 18 F-FETMP (2-(2- 18 F-fluoroethoxy)ethyl) tris(4-methoxyphenyl)phosphonium cation 18 F-FMBTP 4-( 18 F-fluoromethyl)benzyltriphenylphosphonium 18 F-mFMBTP (3-( 18 F-fluoromethyl) benzyl)trisphenylphosphonium 18 F-FDHR 18 F-fluorodihydrorotenone 18 F-flurpiridaz (BMS-747158-02) 2- tert -butyl-4-chloro-5-\[4-(2- 18 F-fluoroethoxymethyl)benzyloxy\]-2 H -pyridazin-3-one 18 F-FP1OP 2- tert -butyl-4-chloro-5-(4-(2- 18 F-fluoroethoxy))benzyloxy-2 H -pyridazin-3-one 18 F-FPTP2 2- tert -butyl-4-chloro-5-((6-((4-(2- 18 F-fluoroethyl)-1 H -1,2,3-triazol-1-yl)methyl)-2-pyridinyl)methoxy)-3(2 H )-pyridazinone 18 F-Fmp2 4-chloro-2- tert -butyl-5-\[2-\[\[1-\[2-\[ 18 F\]fluoroethyl\]-1 H -1,2,3-triazol-4-yl\]methyl\]phenyl-methoxy\]-3(2 H )-pyridazinone \[ 18 F\]Fmpp2 4-chloro-2- tert -butyl-5-\[2-\[\[1-\[2-\[2-\[ 18 F\]fluroethoxy\]ethoxymethyl\]-1 H -1,2,3-triazol-4-yl\]-methyl\]phenylmethoxy\]-3(2 H )-pyridazinone {#molecules-22-00562-f001} {#molecules-22-00562-f002} ![Representative short-axis small-animal PET images of ^18^F-FBnTP at different time points after tracer administration during short-term occlusion, followed by reperfusion. Graph shows mean uptake in defect and remote area. %ID = percentage injected dose; RO = region of interest \[[@B34-molecules-22-00562]\].](molecules-22-00562-g003){#molecules-22-00562-f003} ![Short-, vertical long-, and horizontal long-axis and polar map images of ^13^N-NH~3~ (**A**); ^18^F-FPTP (**B**); ^18^F-FHTP (**C**); or ^18^F-FETP (**D**) in each representative animal. Data were collected between 0--10 and 20--30 min after radiotracer injection (37 MBq). SUV = standardized uptake value \[[@B42-molecules-22-00562]\].](molecules-22-00562-g004){#molecules-22-00562-f004} ![Coronal microPET images in a normal rat. The heart was visible with excellent ratios of heart/liver and heart/lung, and fast clearance from small intestine at 5, 30, 60, and 120 min after iv injection of \[^18^F\]mFMBTP, respectively. Time--activity curves generated from dynamic PET images. \[^18^F\]mFMBTP accumulated specifically in the heart. The \[^18^F\]mFMBTP had excellent heart/liver and heart/lung ratios and in liver and lung was washed out rapidly but was retained in the myocardium for the whole time \[[@B44-molecules-22-00562]\].](molecules-22-00562-g005){#molecules-22-00562-f005} {#molecules-22-00562-f006} ![The ^18^F-flurpiridaz PET (**top**) and MIBI SPECT (**bottom**) images from an 82-year-old man with shortness of breath and an occluded native proximal left anterior descending (LAD) coronary artery and an occluded left internal mammary graft to the LAD and no other significant native CAD. The ^18^F-flurpiridaz images show a severe reversible perfusion defect throughout the territory of the occluded proximal LAD, whereas the MIBI images show only a moderate perfusion defect in the distal LAD territory (apical slices) \[[@B58-molecules-22-00562]\].](molecules-22-00562-g007){#molecules-22-00562-f007} ![(**a**) Whole-body planar images of healthy Chinese mini swine. Images were obtained with 55 MBq of \[^18^F\]FP1OP \[[@B60-molecules-22-00562]\] or 37 MBq of \[^18^F\]Fmpp2 \[[@B62-molecules-22-00562]\] in 5% ethanol solution at 2, 30, 60, and 120 min after injection. B = urinary bladder; H = heart; K = kidney; (**b**) Cardiac PET images of healthy Chinese mini swine (normal) and Chinese mini swine with acute myocardial infarction (AMI). Images were obtained with 55 MBq of \[^18^F\]FP1OP in 5% ethanol solution at 2, 15, 30, and 60 min after injection. Arrows indicate perfusion defect sites of infarction areas (apical and anterior walls) \[[@B60-molecules-22-00562]\].](molecules-22-00562-g008){#molecules-22-00562-f008} molecules-22-00562-t001_Table 1 ###### Comparison of representative ^18^F-labeled compounds as potential MPI agents. Probes ^18^F-FDG-Rhodamine ^18^F-FBnTP ^18^F-FTTP ^18^F-mFMBTP ^18^F-Flurpiridaz ^18^F-Fmpp2 ---------------------- --------------------------------- -------------------- -------------------- --------------------- -------------------------- --------------------- Class ammonium cation phosphonium cation phosphonium cation phosphonium cation MC-1 inhibitors MC-1 inhibitors Charge cationic cationic cationic cationic neutral neutral Log P −1.64 ± 0.03 \-- 1.78 ± 0.05 1.05 ± 0.01 \-- 1.73 ± 0.05 RCY (%) 97.0 ± 1.9 (based on ^18^F-FDG) 62 ± 1.4 (NDC) 10--15 (EOS) 50 (DC) 25 (DC) 58 ± 7.1 (DC) Heart Uptake (%ID/g) 11.24 ± 1.97 (rat) \-- 1.51 ± 0.04 (rat) 27.39 ± 1.46 (mice) 9.5 ± 0.5 (mice) 27.15 ± 3.58 (mice) Heart/Liver Ratio 21.2 (rat) 1.2 (dog) 8 (rat) 4.84 (mice) 8.3 (mice) 3.96 (mice) Heart/Blood Ratio 28.10 (rat) 16.6 (dog) 75.5 (rat) 23.82 (mice) \-- 10.29 (mice) Time point (min) \* \-- 60 30 30 60 30 Current status rats dogs rabbits dogs Clinic trial (Phase III) pigs References 26 21, 32, 37 39 44 53 62 \* Time point means the time point of heart uptake and heart/liver ratios in [Table 1](#molecules-22-00562-t001){ref-type="table"}.

\section{Introduction} An axisymmetric equilibrium, starting point for many linear stability and nonlinear initial-value calculations for toroidal devices, is described by the Grad-Shafranov equation \cite{grad1958, shafranov1958}, \begin{equation} -\Delta^*\psi = \mu_0R^2p'(\psi) + FF'(\psi), \label{eqn:GS0} \end{equation} where primes denote a derivative with respect to $\psi$. In cylindrical $(R,Z,\zeta)$ coordinates, where the toroidal angle $\zeta$ is in the symmetry direction, the Laplacian-like operator $\Delta^*$ has the form \begin{equation} \Delta^*\psi \equiv R^2\nabla\cdot\frac{1}{R^2}\nabla\psi = R\frac{\partial}{\partial R}\frac{1}{R}\frac{\partial\psi}{\partial R} + \frac{\partial^2\psi}{\partial Z^2}. \label{eqn:delStar} \end{equation} The equilibrium is determined by specifying the two source functions on the right, $p(\psi), F(\psi)$, for the plasma pressure and poloidal current, respectively. Although the original references are not easily accessible anymore, derivation of Eq.~\ref{eqn:GS0} can be found in many textbooks (see, for example Jardin\cite{jardin2010}, Freidberg\cite{freidberg2014}). The review article by Takeda and Tokuda\cite{takeda1991}, although somewhat dated, is also still useful. In ``fixed-boundary'' equilibria, a boundary curve $C_b$ in the $(R,Z)$ (poloidal) plane is also specified a priori. Then Eq.~\ref{eqn:GS0} is solved with a Dirichlet boundary condition on $C_b$, typically $\psi=0.$ In ``free-boundary'' equilibria, a distribution of external currents in the poloidal field (PF) coils is given and the plasma boundary is determined as part of the solution. Here, effectively a boundary condition at infinity needs to be imposed, $\psi\rightarrow 0$. Usually this problem in the infinite domain is tackled using an artificial computational boundary, $C_{cb}$, a finite distance away from the plasma. Recently we have introduced a new method that directly and efficiently solves the free-boundary problem in the infinite domain\cite{hanks2019b} without a need for $C_{cb}$. Note that besides $p(\psi)$ and $F(\psi)$, a more general pair of source functions can also be used as input\cite{lutjens1996}. In fact, widely-used EFIT-series of equilibrium codes\cite{lao2005} can calculate equilibria consistent with a wide range of experimental data from kinetic and magnetic diagnostics. A realistic equilibrium that satisfies a number of constraints, for example, for the plasma pressure and safety factor profiles, generally requires $p$ and $F$ to be nonlinear functions of their argument. Therefore, Eq.~\ref{eqn:GS0} is typically a nonlinear equation for the flux function $\psi$, and it is solved numerically. Non-numerical solutions, however, are quite useful in analytic equilibrium and stability studies; they are also very useful in checking and benchmarking of numerical codes. For these reasons, exact analytic solutions of the Grad-Shafranov equation have been sought by a number of workers over the years\cite{mcCarthy1999, atanasiu2004, guazzotto2007}. The most well-known and useful of these, however, is a class of exact solutions that have come to be known as the Solov'ev equilibria\cite{solovev1967}, which assume $p$ and $F^2$ are linear functions of $\psi$. In Eq.~\ref{eqn:GS0} letting $\mu_0p'=-C,~FF'=-AR_0^2,$ where $A,C$ are constants and $R_0$ is the major radius of the torus, leads to the inhomogenous but linear equation \begin{equation} \Delta^*\psi = AR_0^2 + CR^2, \label{eqn:GS1} \end{equation} with the exact Solov'ev solution \begin{equation} \psi = \frac{1}{2}(AR_0^2 + a_0R^2)Z^2 + \frac{1}{8}(C-a_0)(R^2-R_0^2)^2, \label{eqn:gs1Soln} \end{equation} where $a_0$ is another constant. The three arbitrary constants, $a_0, A, C$, can be adjusted to change, for instance, the separatrix geometry\cite{solovev1967}. However, there are not enough degrees of freedom in the solution to specify basic equilibrium parameters such as the plasma $\beta=2\mu_0p/B^2$, safety factor $q$, and at the same time ensure that the solution conforms to a particular plasma boundary. Solutions of the homogeneous equation, \begin{equation} \Delta^*\psi=0, \label{eqn:homogeneous} \end{equation} can provide the needed extra degrees of freedom, since a general solution to Eq.~\ref{eqn:GS1} can be written as $\psi = \psi_p + \psi_h$, where $\psi_p$ is a particular solution of Eq.~\ref{eqn:GS1}, and $\psi_h$ satisfies Eq.~\ref{eqn:homogeneous}. A complete set of multipole solutions of Eq.~\ref{eqn:homogeneous} were found by Reusch and Nielson and applied to PDX vacuum field calculations\cite{reusch1986}. A similar polynomial expansion in powers of $R,Z$ was used by Zheng {\em et al.}\cite{zhengSB1996} to find shaped but up-down symmetric, exact analytic solutions to Eq.~\ref{eqn:GS1}. These were later generalized by Cerfon and Freidberg\cite{cerfon2010} to geometries without up-down symetry, including diverted configurations with one or more $X$-points. In both Zheng\cite{zhengSB1996} and Cerfon\cite{cerfon2010}, the number of constraints, $M$, used to specify the boundary was limited by the degrees of freedom, $N$, in the homogeneous solution. Thus, a more detailed boundary definition required a larger $N$, which translated into a higher order polynomial expansion for the homogeneous solution $\psi_h.$ In this work we show how the requirements of the boundary definition can be decoupled from the polynomial expansion of $\psi_h$ using constrained least-squares. Now the boundary, both ``fixed" and ``free,'' can be defined essentially arbitrarily while still maintaining a fixed and small number of terms in the expansion of $\psi_h.$ The method is explained in Sect. II with various examples of exact tokamak equilibria. Sect. III summarizes our results. \section{Exact solutions with an arbitrary boundary} It is useful to put Eq.~\ref{eqn:GS1} in nondimensional form by transforming the variables. After letting $\psi = (B_0R_0^2){\widetilde\psi}$, $R = R_0{\widetilde R}$, $Z=R_0{\widetilde Z}$, the equation becomes \begin{equation} \Delta^*\psi = A + CR^2, \label{eqn:GS1norm} \end{equation} where we dropped the tildes in normalized variables. Typically $B_0$ is the toroidal field strength at the major radius $R_0.$ A $Z$-independent particular solution is given by \begin{equation} \psi_p = \frac{C}{8}R^4 + \frac{A}{2}R^2\ln{R}. \label{eqn:psiP} \end{equation} The constants $A,C$ can be used to specify, for example, the plasma $\beta$ and the kink safety factor $q^*=\epsilon B_0/B_p,$ where $\epsilon\equiv a/R_0$ is the inverse aspect ratio, and $B_p$ is the poloidal field at the edge. As stated earlier, to satisfy the constraints that help define the boundary, we will need the degrees of freedom provided by the homogeneous solution. \subsection{Homogeneous solution} Following Zheng {\em et al.}\cite{zhengSB1996} we write the homogeneous solution in the form \begin{equation} \psi_h = \sum_{i=0} f_i(R)Z^i. \label{eqn:expansion} \end{equation} Substituting in Eq.~\ref{eqn:homogeneous} leads to the recursion relation \begin{equation} R\frac{\partial}{\partial R}\frac{1}{R}\frac{\partial}{\partial R}f_{i-2}(R) =-i(i-1)f_i(R),~i \ge 2. \end{equation} Clearly the even and odd terms decouple. Letting $f_i(R) = 0$ for $i\ge I$ and integrating yields a solution with $N=2I$ constants of integration (we will assume $I$ is even). Then the homogeneous solution can be written as a sum of polynomial basis functions: \begin{equation} \psi_h(R,Z) = \sum_{i=0}^{I-1}c_iP_i(R,Z) + \sum_{i=1}^{I}d_iQ_i(R,Z), \label{eqn:expansion2} \end{equation} where $P_i$ and $Q_i$ have even and odd order, respectively. For up-down symmetric boundaries, the second sum is not needed. The resulting polynomials for $I=10$, obtained using {\em Mathematica}\cite{mathematica2019}, are shown in the Appendix. The set of arbitrary coefficients, \begin{equation} \{{c_0,c_1,\ldots, c_{I-1}, d_1,d_2,\ldots,d_I}\}, \end{equation} will be determined by the boundary constraints to be explained in the next section. Since the coefficients are arbitrary, each polynomial basis function has to satisfy the homogeneous equation identically, which can be shown to be true by direct substitution. Below we first consider ``limited'' or fixed-boundary tokamak equilibria without $X$-points. \subsection{Exact fixed-boundary equilibria} A common parametrization of shaped plasma boundaries has the form \begin{eqnarray} R(\alpha) & = & 1+ \epsilon\cos[\alpha + \delta(\alpha)\sin\alpha], \nonumber \\ Z(\alpha) & = & \epsilon\kappa(\alpha)\sin\alpha, \label{eqn:parametricCurve} \end{eqnarray} where $(R,Z)$ have been normalized by $R_0$. The triangularity $\delta$ and elongation $\kappa$ are defined in terms of their upper and lower values as: \begin{eqnarray} \delta(\alpha) & = & \frac{1}{2}\left[(\delta_U + \delta_L) + (\delta_U -\delta_L)\sin\alpha\right], \nonumber \\ \kappa(\alpha) & = & \frac{1}{2}\left[(\kappa_U + \kappa_L) + (\kappa_U -\kappa_L)\sin\alpha\right]. \label{eqn:alpha-kappa} \end{eqnarray} The geometric meanings of various terms are shown in Fig.~\ref{fig:geometry}. Note that the parameter $\alpha$ differs from the angle $\theta=\arctan(Z/(R-R_0)).$ The actual triangularities, which measure the shift of the highest and lowest points of the boundary with respect to the geometric center, are $\Delta_U=\sin\delta_U\simeq \delta_U$, and $\Delta_L=\sin\delta_L\simeq\delta_L.$ \begin{figure}[htbp] \begin{center} \includegraphics[width=2in]{asymmetricGeom.pdf} \caption{\em \baselineskip 14pt The boundary curve for $\epsilon=a/R_0=1/3, \delta_U=0.3,~\delta_L=0.6,~\kappa_U=1.5,~\kappa_L=1.8.$} \label{fig:geometry} \end{center} \end{figure} A useful set of boundary constraints uses an equally spaced points on the boundary curve, as shown in Fig.~\ref{fig:geometry}, and take the following form: \begin{eqnarray} \psi(R_j,Z_j) & = & \psi_p(R_j,Z_j) + \psi_h(R_j,Z_j) = \psi_b, \label{eqn:boundaryConst} \\ (R_j, Z_j) & \equiv & (R(\alpha_j),Z(\alpha_j)),~\alpha_j = \frac{2\pi j}{M},~j=0,1,\ldots M-1, \nonumber \end{eqnarray} where $\psi_b$ is the boundary value; we will set $\psi_b=0.$ If the number of constraints exactly matches the degrees of freedom in the homogeneous solution, i.e., if $M=N$, then the set of equations in Eq.~\ref{eqn:boundaryConst} can be solved easily for the $N=2I$ coefficients ($c_i,d_i)$ of Eq.~\ref{eqn:expansion2}, a method adopted by the earlier works\cite{zhengSB1996, cerfon2010}. However, there are obvious advantageous to having $M \gg N$. A highly-shaped boundary may require many more points to specify accurately than the degrees of freedom available in the homogeneous solution. But with $M>N$, the system is overdetermined and the linear system resulting from Eq.~\ref{eqn:boundaryConst} has no solution. \subsection{Least squares solution} We can still find a solution for $M>N$ if we do not demand that all points be located exactly on the boundary, i.e., we stop requiring that Eq.~\ref{eqn:boundaryConst} be satisfied exactly. Instead we seek the ``best'' solution that minimizes, for example, a positive-definite error term. In the least-squares method we minimize the sum of the ``residuals,'' defined by \begin{eqnarray} S & = & \frac{1}{2}\sum_{j=0}^{M-1}w_j\left\{\psi(R_j,Z_j)-\psi_b\right\}^2 \nonumber \\ & = & \frac{1}{2}\sum_{j=0}^{M-1}w_j\left\{\sum_{i=0}^{I-1}c_iP_i(R_j,Z_j) + \sum_{i=1}^{I}d_iQ_i(R_j,Z_j) + \psi_P(R_j,Z_j)- \psi_b \right\}^2 , \label{eqn:Sum} \end{eqnarray} where $(R_j,Z_j),~j=0,1,\ldots, M-1$ are points on the boundary parametrically determined by Eq.~\ref{eqn:parametricCurve}, and $w_j \equiv w(R_j,Z_j)$ is a weight function that can be used to emphasize/de-emphasize some subset of the boundary points. It is not needed for fixed-boundary equilibria and is set to unity. Letting $\psi_b=0$ and seeking a minimum by setting $\partial S/\partial c_k=0,~\partial S/\partial d_l=0$ lead to \begin{eqnarray} \sum_{i=0}^{I-1}c_i\fsAver{P_i,P_k} + \sum_{i=1}^{I}d_i\fsAver{Q_i,P_k} & = & - \fsAver{\psi_P,P_k},~k=0,1,\ldots, I-1,\label{eqn:linearSetP} \\ \sum_{i=0}^{I-1}c_i\fsAver{P_i,Q_l} + \sum_{i=1}^{I}d_i\fsAver{Q_i,Q_l} & = & - \fsAver{\psi_P,Q_l},~l=1,2,\ldots, I, \label{eqn:linearSetQ} \end{eqnarray} where we defined \begin{equation} \fsAver{p,q} \equiv \sum_{j=0}^{M-1}w(R_j,Z_j)p(R_j,Z_j)q(R_j,Z_j). \end{equation} Together Eqs.~\ref{eqn:linearSetP}, \ref{eqn:linearSetQ} form a set of $N=2I$ linear equations for the $N$ coefficients $c_i,d_i$ that can be easily inverted. Again, if the boundary curve is symmetric about the mid-plane, we can set $d_i=0$ above and solve only for the $N=I$ coefficients $c_i$. In this case the parameter $\alpha_j$ in Eq.~\ref{eqn:boundaryConst} can be redefined to cover, for instance, only the lower half of the boundary. \begin{figure}[htbp] \begin{center} \includegraphics[width=6in]{eql_limCombined.pdf} \caption{\em \baselineskip 14pt Various highly-shaped equilibria. The (blue) dots are on the specified boundary curve (Eq.~\ref{eqn:parametricCurve}). The dashed (black) curve is the actual calculated boundary. (a) $\delta_U=0.6$, $\delta_L=0.8$, $\kappa_U=1.4$, $\kappa_L=1.8$. Calculated using $N=2I=12$, degrees of freedom in the polynomial expansion in Eq.~\ref{eqn:expansion2}, and $M=48$, the number of points (constraints) on the boundary (Eq.~\ref{eqn:boundaryConst}). (b) $\delta=0.4$, $\kappa=3, N=I=6$, $M=24$. (c) An equilibrium with negative triangularity: $\delta=-0.4$, $\kappa=1.3, N=I=6, M=24$. For all three equilibria, $\epsilon=a/R_0=1/3$, and the particular solution (Eq.~\ref{eqn:psiP}) has $A=0, C=1$.} \label{fig:limCombined} \end{center} \end{figure} Examples of highly-shaped exact equilibria obtained with this method are shown in Fig.~\ref{fig:limCombined}. For each one, $M$ number of boundary constraints are specified at the indicated points (blue dots in the figures) using Eq.~\ref{eqn:boundaryConst} and the parametric curve of Eq.~\ref{eqn:parametricCurve}. For the asymmetric case in (a), both even and odd basis functions are used in the expansion of $\psi_h$; thus, there are $N=2I$ degrees of freedom in the solution, where $I=6$ is the degree of the highest-order even basis function in Eq.~\ref{eqn:expansion2}. For the up-down symmetric cases ((b) and (c)) only points in the lower half-plane are used. For these, the odd basis functions are not needed; thus they both have $N=I=6$. For all equilibria we use $M=4N$, so the resulting linear system of equations for the coefficients would be overdetermined without the least squares approach. In the figures, the actual calculated boundary is shown with a dashed (black) curve. Clearly the specified boundary (dots) and the actual boundary curve agree very well, although the least squares solution to the boundary constraints is not exact but only minimizes the sum of residuals in Eq.~\ref{eqn:Sum}. Note that, although not shown here, all solutions with $I=4$ (maximum order of even polynomials) also produce acceptable results for these highly-shaped fixed-boundary equilibria. \subsection{Exact equilibria with $X$-points} An $X$-point, where the poloidal field vanishes, introduces three additional constraints that the solution $\psi=\psi_p + \psi_h$ has to satisfy: \begin{eqnarray} \psi(R_X,Z_X) & = & \psi_b, \label{eqn:XpointEqs} \\ \left.\frac{\partial \psi}{\partial R}\right|_{(R_X,Z_X)} & = & 0,~~~\left.\frac{\partial \psi}{\partial Z}\right|_{(R_X,Z_X)} = 0, \nonumber \end{eqnarray} where $(R_X,Z_X) $ is the $X$-point location. Now the separatrix becomes the plasma boundary; for simplicity we still choose $\psi_b\equiv \psi_{sep}=0.$ These three constraints, however, are of a different nature than the boundary constraints in Eq.~\ref{eqn:boundaryConst}; they have to be satisfied exactly (otherwise there is no $X$-point), whereas those in Eq.~\ref{eqn:boundaryConst} can be satisfied in a ``least-squares'' sense--we can tolerate the computational boundary agreeing with the specified boundary only approximately to accommodate the $X$-point(s). Thus, we now have a ``constrained least-squares'' problem, which we solve by introducing a ``Lagrangian ${\cal L}$'' and the Lagrange multipliers $\lambda_j,~j=1,2,3$: \begin{equation} {\cal L}({\bm c}, {\bm d}, {\bm \lambda}) = S + \lambda_1\left.\frac{\partial \psi}{\partial R}\right|_{(R_X,Z_X)} + \lambda_2\left.\frac{\partial \psi}{\partial Z}\right|_{(R_X,Z_X)} +\lambda_3\psi(R_X,Z_X), \label{eqn:lagrangian} \end{equation} where the sum of residuals $S$ is still given by Eq.~\ref{eqn:Sum}. The unknown coefficient vectors $\bm c = \{c_0, c_1,\ldots, c_{I-1}\}$, $\bm d = \{d_1, d_2,\ldots, d_{I}\}$ and $\bm \lambda = \{\lambda_1, \lambda_2, \lambda_3\}$ form the new set of $N+3$ unknowns. They are determined by an augmented set of equations: \begin{eqnarray} \frac{\partial{\cal L}}{\partial c_k} & = & \frac{\partial S}{\partial c_k} + \lambda_1\frac{\partial}{\partial c_k}\left(\frac{\partial \psi}{\partial R}\right)_{(R_X,Z_X)} + \lambda_2\frac{\partial}{\partial c_k}\left(\frac{\partial \psi}{\partial Z}\right)_{(R_X,Z_X)} + \lambda_3\frac{\partial \psi(R_X,Z_X)}{\partial c_k} = 0, \nonumber \\ & & k=0,1,\ldots, I-1, \label{eqn:cEqs} \\ \frac{\partial{\cal L}}{\partial d_l} & = & \frac{\partial S}{\partial d_l} + \lambda_1\frac{\partial}{\partial d_l}\left(\frac{\partial \psi}{\partial R}\right)_{(R_X,Z_X)} + \lambda_2\frac{\partial}{\partial d_l}\left(\frac{\partial \psi}{\partial Z}\right)_{(R_X,Z_X)} + \lambda_3\frac{\partial \psi(R_X,Z_X)}{\partial d_l} = 0, \nonumber \\ & & l=1,2,\ldots, I, \label{eqn:dEqs} \\ \frac{\partial{\cal L}}{\partial\lambda_1} & = & \left(\frac{\partial \psi}{\partial R}\right)_{(R_X,Z_X)} =0, \label{eqn:lambda1}\\ \frac{\partial{\cal L}}{\partial\lambda_2} & = & \left(\frac{\partial \psi}{\partial Z}\right)_{(R_X,Z_X)} =0, \label{eqn:lambda2}\\ \frac{\partial{\cal L}}{\partial\lambda_3} & = & \psi(R_X,Z_X) = 0. \label{eqn:lambda3} \end{eqnarray} These equations guarantee that, among the set of solutions $\{{\bm c}, {\bm d}\}$ that satisfy the $X$-point constraints in Eqs.~\ref{eqn:lambda1}-\ref{eqn:lambda3} exactly, we choose the one that minimizes the residual sum $S$. Recall that $N=2I$ for up-down asymmetric equilibria. For symmetric ones, the coefficients $\bm d$ for the odd basis functions and Eq.~\ref{eqn:dEqs} are not needed, and $N=I$ (see Eq.~\ref{eqn:expansion2}). We find that de-emphasizing the points in the sum of residuals $S$ near an $X$-point leads to better results. Thus, if there is a field-null, we choose a Gaussian weight function in Eq.~\ref{eqn:Sum} of the form \begin{equation} w(R_j,Z_j) = 1 - e^{-\{[(R_j-R_X)^2+(Z_j-Z_X)^2]/\Delta w^2\}}, \end{equation} where $\Delta w$ is an appropriately-chosen width and $(R_X,Z_X)$ is the location of the null-point. Note that $w\rightarrow 0$ near the $X$-point so that those points are less-constrained to be on the parametrically-defined boundary curve of Eq.~\ref{eqn:parametricCurve}, which is necessary to accommodate the $X$-point. \begin{figure}[htbp] \begin{center} \includegraphics[width=6in]{eql_XCombined.pdf} \caption{\em \baselineskip 14pt Exact ``free-boundary'' versions of the fixed-boundary equilibria shown in Fig.~\ref{fig:limCombined}. The (blue) dots are on the specified boundary curve (Eq.~\ref{eqn:parametricCurve}). The dashed (black) curve is the actual calculated boundary. (a) $\delta_U=0.6$, $\delta_L=0.8$, $\kappa_U=1.4$, $\kappa_L=1.8$. Calculated using $N=2I=16$, degrees of freedom in the polynomial expansion in Eq.~\ref{eqn:expansion2}, and $M=64$, the number of points (constraints) on the boundary (Eq.~\ref{eqn:boundaryConst}). (b) $\delta=0.4$, $\kappa=3, N=I=8$, $M=32$. (c) An equilibrium with negative triangularity: $\delta=-0.4$, $\kappa=1.3, N=I=12, M=48$. For all three equilibria, $\epsilon=a/R_0=1/3$, and the particular solution (Eq.~\ref{eqn:psiP}) has $A=0, C=1$.} \label{fig:XCombined} \end{center} \end{figure} Examples of exact equilibria with $X$-points--``free-boundary'' versions of the fixed-boundary equilibria in Fig.~\ref{fig:limCombined}--are shown in Fig.~\ref{fig:XCombined}. We note that in all three cases, the computed boundary (dashed black curve) conforms to the specified boundary (represented by blue dots) very closely, except near the $X$-points where it necessarily deviates in order to satisfy the $X$-point constraints. Thus, even with one or more $X$-points, an exact equilibrium with a parametrically-specified boundary can be calculated using constrained least-squares method. However, all three examples require higher-order polynomial expansions than their fixed-boundary counterparts in Fig.~\ref{fig:limCombined}. The lower single null (LSN) configuration in (a) used an expansion with 16 degrees of freedom, or equivalently, the highest-order even basis function had order $I=8.$ Similarly, $I=8$ for (b), the elongated double-null (DN). The DN configuration with the negative triangularity in (c) required $I=12.$ \section{Summary and discussion} We presented a method to calculate exact Solov'ev equilibria with or without $X$-points for arbitrary plasma cross-sections. Using a least-squares approach to enforce the boundary constraints essentially decouples the accuracy requirements of the boundary specification from the order of the polynomial expansion of the homogeneous solution for the Grad-Shafranov equation. Thus, a much larger number of boundary constraints can be used than the number of degrees of freedom available in the homogeneous solution, ensuring that the numerically-obtained boundary conforms to the specified boundary with high fidelity. Usefulness of the method was illustrated with examples of fixed-boundary equilibria with highly-shaped geometries and their generalization to configurations with one or more $X$-points. These exact solutions, which require nothing more than the inversion of a relatively small linear system of equations, can be easily performed with a symbolic/numerical algebra system such as {\em Mathematica} or {\em Matlab.} They should be highly useful, for example, in benchmarking new equilibrium codes. They may also prove useful in semi-analytic equilibrium and stability calculations. \section*{Acknowledgements} This work was supported by MSIP, the Korean Ministry of Science, ICT and Future Planning, through the KSTAR project. Most of the symbolic and numerical calculations were performed with {\em Mathematica.} \section*{Appendix} The polynomials $P_i(R,Z), Q_i(R,Z)$ of Eq.~\ref{eqn:expansion2} for $I=10$, obtained with {\em Mathematica}\cite{mathematica2019}: \begin{eqnarray} P_0 & : & 1 \\ P_1 & : & \frac{R^2}{2}\nonumber \\ P_2 & : & \frac{R^2}{2}+R^2 (-\log (R))+Z^2\nonumber \\ P_3 & : & \frac{R^2 Z^2}{2}-\frac{R^4}{8}\nonumber \\ P_4 & : & -\frac{15 R^4}{8}+\frac{3}{2} R^4 \log (R)+3 R^2 Z^2-6 R^2 Z^2 \log (R)+Z^4\nonumber \\ P_5 & : & \frac{R^6}{16}-\frac{3 R^4 Z^2}{4}+\frac{R^2 Z^4}{2}\nonumber \\ P_6 & : & \frac{25 R^6}{8}-\frac{15}{8} R^6 \log (R)-\frac{225 R^4 Z^2}{8}+\frac{45}{2} R^4 Z^2 \log (R)+\frac{15 R^2 Z^4}{2}-15 R^2 Z^4 \log (R)+Z^6\nonumber \\ P_7 & : & -\frac{5 R^8}{128}+\frac{15 R^6 Z^2}{16}-\frac{15 R^4 Z^4}{8}+\frac{R^2 Z^6}{2}\nonumber \\ P_8 & : & -\frac{1645 R^8}{384}+\frac{35}{16} R^8 \log (R)+\frac{175 R^6 Z^2}{2}-\frac{105}{2} R^6 Z^2 \log (R) \nonumber \\ & & -\frac{525 R^4 Z^4}{4}+105 R^4 Z^4 \log (R)+14 R^2 Z^6-28 R^2 Z^6 \log (R)+Z^8\nonumber \\ P_9 & : & \frac{7 R^{10}}{256}-\frac{35 R^8 Z^2}{32}+\frac{35 R^6 Z^4}{8}-\frac{7 R^4 Z^6}{2}+\frac{R^2 Z^8}{2} \nonumber \\ Q_1 & : & Z \\ Q_2 & : & \frac{R^2 Z}{2}\nonumber \\ Q_3 & : & \frac{3 R^2 Z}{2}-3 R^2 Z \log (R)+Z^3\nonumber \\ Q_4 & : & \frac{R^2 Z^3}{2}-\frac{3 R^4 Z}{8}\nonumber \\ Q_5 & : & -\frac{75 R^4 Z}{8}+\frac{15}{2} R^4 Z \log (R)+5 R^2 Z^3-10 R^2 Z^3 \log (R)+Z^5\nonumber \\ Q_6 & : & \frac{5 R^6 Z}{16}-\frac{5 R^4 Z^3}{4}+\frac{R^2 Z^5}{2}\nonumber \\ Q_7 & : & \frac{175 R^6 Z}{8}-\frac{105}{8} R^6 Z \log (R)-\frac{525 R^4 Z^3}{8}+\frac{105}{2} R^4 Z^3 \log (R)+\frac{21 R^2 Z^5}{2}-21 R^2 Z^5 \log (R)+Z^7\nonumber \\ Q_8 & : & -\frac{35 R^8 Z}{128}+\frac{35 R^6 Z^3}{16}-\frac{21 R^4 Z^5}{8}+\frac{R^2 Z^7}{2}\nonumber \\ Q_9 & : & -\frac{4935 R^8 Z}{128}+\frac{315}{16} R^8 Z \log (R)+\frac{525 R^6 Z^3}{2}-\frac{315}{2} R^6 Z^3 \log (R) \nonumber \\ & & -\frac{945 R^4 Z^5}{4}+189 R^4 Z^5 \log (R)+18 R^2 Z^7-36 R^2 Z^7 \log (R)+Z^9\nonumber \\ Q_{10} & : & \frac{63 R^{10} Z}{256}-\frac{105 R^8 Z^3}{32}+\frac{63 R^6 Z^5}{8}-\frac{9 R^4 Z^7}{2}+\frac{R^2 Z^9}{2}. \nonumber \end{eqnarray} No attempt has been made to simplify or normalize the polynomials. They are presented in the form found by {\em Mathematica.} Note that $P_{I-1}$ has order $I$, while $Q_I$ has order $I+1$.

Introduction ============ The majority of non-small-cell lung cancers (NSCLCs) are diagnosed at an advanced stage, with a poor prognosis. Until the early 2000s, the first-line treatment was a platinum-based doublet chemotherapy, which was initiated based on the global condition of the patient but without any pathological or molecular selection. The overall survival was poor, \~8 months, whatever may be the type of cytotoxic chemotherapy given.[@b1-lctt-7-083] In 2008, Scagliotti et al demonstrated that a pathology-based selection led to a differential choice of cytotoxic chemotherapy: non-squamous carcinoma was treated more effectively by a platinum--pemetrexed doublet, whereas squamous cell carcinoma was not.[@b2-lctt-7-083] Since several years, extensive molecular characterization of NSCLC is ongoing. Several oncogenic addiction mechanisms have been described. The presence of mutation of the *EGFR* gene, occurring in 10%--15% of NSCLCs, induces tumor sensitivity to targeted therapies, that is, EGFR tyrosine kinase inhibitors (TKIs), such as erlotinib, gefitinib, and afatinib.[@b3-lctt-7-083] These drugs are currently authorized for first-line treatment of EGFR-mutated advanced-stage NSCLC. Among the other oncogenic addictions, \~4% of NSCLCs harbor an *ALK* rearrangement.[@b3-lctt-7-083] Specific ALK TKIs have been developed. Crizotinib is a multi-targeted (ALK, ROS, MET, RON) TKI that shows efficacy in the treatment of ALK-rearranged advanced-stage NSCLC. In this review, we describe the molecular characteristics and the phenotype of ALK-rearranged NSCLC, the mechanism of action of crizotinib, and the results of the early development steps and of the clinical trials that led to approval by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) of crizotinib for first-line treatment of ALK-rearranged advanced-stage NSCLC. We also discuss about the patient selection and the molecular mechanisms of tumor progression with crizotinib. ALK rearrangement in NSCLC ========================== ALK protein is a membranous receptor with an intracellular tyrosine kinase domain. *ALK* rearrangements involve the exon 20 coding for the tyrosine domain, inducing the formation of a fusion gene and the constitutive activation of ALK with stimulation of downstream pathways (PI3K, STAT3, JAK2, and Ras pathways).[@b4-lctt-7-083] The companion gene for the rearrangement is most of the time *EML4.* Other genes have also been involved, such as *TFG, KIF5B*, and *KLC1*. In NSCLC, *ALK* rearrangement occurs preferentially in young patients, with no/light smoking habit and lung adenocarcinoma.[@b5-lctt-7-083],[@b6-lctt-7-083] Tumors with ALK rearrangement tend to have lymph node involvement and brain tropism.[@b6-lctt-7-083] Adenocarcinomas with *ALK* rearrangement have most of the time a solid or acinar pattern, with cribiform architecture and ring cells, expressing TTF1.[@b5-lctt-7-083] Until recently, *ALK* rearrangement was supposed to be mutually exclusive with other oncogene addiction genes *(EGFR, Kras).* However, recent reports using large-scale techniques (such as next-generation sequencing) have described NSCLC harboring both *ALK* rearrangement with other oncogenes, as EGFR mutations.[@b7-lctt-7-083] The diagnosis of *ALK* rearrangement is made by fluorescence in situ hybridization (FISH). The presence of a split signal in ≥15% of tumor cells (based on an analysis of at least 100 nuclei) is consistent with an *ALK* translocation. Other screening assays have been recently developed, such as immunohistochemistry (IHC) assay. ALK IHC seems to have a good negative predictive value.[@b8-lctt-7-083] In Europe, the EMA approval does not precise the technique to be used to prove ALK rearrangement. In a routine practice, ALK IHC is used for ALK screening at diagnosis, and positive IHC assays are confirmed by FISH. Besides, negative IHC in patients with high clinicopathological probability of *ALK* rearrangement also requires a confirmation by FISH. In US, the FDA approval requires a positive FISH assay, based on the use of a Vysis ALK Break Apart FISH Probe Kit (Abbott Molecular, Lake Bluff, IL, USA). Other techniques, such as reverse transcriptase polymerase chain reaction, also allow the diagnosis of *ALK* rearrangement, with interesting sensitivity and specificity, and could be considered alternatively for ALK rearrangement diagnosis.[@b9-lctt-7-083] Preclinical activity of crizotinib ================================== Crizotinib is a multi-targeted TKI that shows activity against not only ALK but also ROS1, RON, and MET. In vitro studies have shown antitumor activity with crizotinib. A large panel of human tumor-derived cell lines (n=602, with 134 NSCLC cell lines) was tested with various experimental antitumor compounds.[@b10-lctt-7-083] Crizotinib had antitumor activity in a subset of cell lines, corresponding to anaplastic large cell lymphoma, NSCLC, and neuroblastoma cell lines. Among the 134 tested NSCLC cell lines, three cell lines had drug sensitivity and harbored an *ALK* rearrangement confirmed by FISH. Phase I and II trials: PROFILE-1001 and PROFILE-1005 ==================================================== Kwak et al conducted a Phase I trial (PROFILE-1001), testing crizotinib in advanced-stage NSCLC with *ALK* rearrangement determined by FISH (n=82).[@b11-lctt-7-083] Performance status (PS) score was 0--2. Most of the patients received crizotinib after at least two lines of treatment. These patients were young (mean age: 52 years), Caucasian (56%), never smoker (76%), and had an adenocarcinoma (96%). The first period of the trial was an escalation-dose phase, with crizotinib given from 50 mg once daily to 300 mg twice daily. The maximum-tolerated dose was 250 mg twice daily (limitation due to fatigue). The second period was an expansion phase, where patients received crizotinib at the maximum-tolerated dose (250 mg twice daily). Overall response rate was 57%, and the estimated 6-month progression-free survival (PFS) was 72%. A retrospective analysis of the patients enrolled in this Phase I trial was performed to evaluate the overall survival (OS).[@b12-lctt-7-083] These patients treated with crizotinib were compared with 36 patients with *ALK*-rearranged NSCLC who were not given crizotinib, 67 patients without *ALK* rearrangement but positive for *EGFR* mutation, and 253 wild-type patients lacking either *ALK* rearrangement or *EGFR* mutation. Median OS of patients treated with crizotinib was not reached, with 1-year OS at 74% and 2-year OS at 54%. For patients treated with crizotinib in second- or third line (n=30), median OS was not reached versus 6 months for patients with *ALK*-rearranged NSCLC with other second- or third-line treatment (hazard ratio \[HR\] =0.36, 95% confidence interval \[CI\] 0.17--0.75, *P*=0.004). Median OS for patients receiving crizotinib was similar to that of *EGFR*-mutated patients (24 months, *P*=0.786). Median OS for patients with *ALK*-rearranged crizotinib-naive NSCLC was similar to that of wild-type patients (20 versus 15 months, *P*=0.244). Updated results of this Phase I trial were published in 2012, based on 143 patients with evaluable tumor response.[@b13-lctt-7-083] Response rate was 60.8%. Median duration of response was 49.1 weeks. Median PFS was 9.7 months, and estimated OS at 6 and 12 months was 87.9% and 74.8%, respectively ([Table 1](#t1-lctt-7-083){ref-type="table"}). The PROFILE-1005 trial was a multicenter, single-arm, open-label Phase II trial, testing crizotinib in patients with *ALK*-rearranged advanced-stage NSCLC who progressed after one or more treatment lines (n=136).[@b14-lctt-7-083] PS was 0--3. Patients with brain metastases were eligible if asymptomatic, or if treated, neurologically stable for at least 2 weeks. One-hundred and thirty-five patients were evaluable for response, with a response rate (primary end point) at 53%. Median duration of response was 43 weeks, and median PFS was 8.5 months ([Table 1](#t1-lctt-7-083){ref-type="table"}). Phase III trial PROFILE-1007: crizotinib in second or third line ================================================================ PROFILE-1007 was a randomized, open-label, Phase III trial, comparing the efficacy of crizotinib to standard chemotherapy in advanced NSCLC, after failure of a platinum-based chemotherapy, with *ALK* rearrangement (determined by FISH).[@b15-lctt-7-083] Three hundred and forty-seven patients were randomized between crizotinib (250 mg twice daily) and either pemetrexed (500 mg/m^2^ intravenously \[IV\], d1d21) or docetaxel (75 mg/m^2^ IV, d1d21). PS score was 0--2. Patients with stable brain metastases who had been treated previously or were untreated and asymptomatic were eligible. Crossover was allowed after progression. Primary end point was PFS. PFS (median) was 7.7 months with crizotinib and 3.0 months with chemotherapy (HR =0.49, 95% CI 0.37--0.64, *P*\<0.0001). PFS (median) with pemetrexed was 4.2 months (HR =0.59, 95% CI 0.43--0.80, *P*\<0.001 in favor of crizotinib). PFS with docetaxel was 2.6 months (HR =0.30, 95% CI 0.21--0.43, *P*\<0.001 in favor of crizotinib). Response rate was 65% with crizotinib and 20% with chemotherapy (*P*\<0.001). OS was similar between the two arms (HR=1.02, 95% CI 0.67--1.54, *P*=0.54) ([Table 1](#t1-lctt-7-083){ref-type="table"}). These results allowed the FDA approval in 2011 and the EMA approval in 2012 of crizotinib (250 mg twice daily) for second-line treatment of advanced NSCLC with *ALK* rearrangement. Phase III trial PROFILE-1014: crizotinib in first line ====================================================== Solomon et al conducted a randomized, open-label, Phase III trial (PROFILE-1014), testing crizotinib in first-line treatment of *ALK*-rearranged advanced NSCLC.[@b16-lctt-7-083] Patients (n=343) with *ALK*-rearranged advanced non-squamous NSCLC (determined by FISH) were randomized between a crizotinib arm (250 mg twice daily, n=172) and a chemotherapy arm (cisplatin 75 mg/m^2^ or carboplatin area under the curve (AUC) 5 or 6, plus pemetrexed 500 mg/m^2^, IV, d1d21, up to six cycles, n=171). PS score was 0--2. Patients with treated brain metastases were eligible if the metastases were neurologically stable for at least 2 weeks before enrollment and if they had no ongoing requirement for glucocorticoids. Crossover was allowed after progression. Primary end point was PFS. PFS (median) was 10.9 months with crizotinib and 7.0 months with chemotherapy (HR =0.45, 95% CI 0.35--0.60, *P*\<0.001) ([Table 1](#t1-lctt-7-083){ref-type="table"}; [Figure 1](#f1-lctt-7-083){ref-type="fig"}). All prespecified subgroups of patients benefited from crizotinib. Response rate was 74% with crizotinib and 45% with chemotherapy (*P*\<0.001). Time to response (median) was 1.4 (crizotinib) and 2.8 months (chemotherapy). Duration of response (median) was 11.3 (crizotinib) and 5.3 months (crizotinib). In 109 patients with brain metastases (52 patients in crizotinib arm and 57 patients in chemotherapy arm), the disease control rate at 12 weeks for brain metastases was 65% with crizotinib versus 46% with chemotherapy. One-year OS was equivalent in both arms (84% in crizotinib arm, 79% in chemotherapy arm), probably due to the crossover. Quality of life was better in the crizotinib arm compared to chemotherapy arm. At data-cutoff, 70% of patients from the chemotherapy arm crossed over to crizotinib arm, and 12% of the patients from the crizotinib arm subsequently received platinum-based chemotherapy. The very low HR for PFS with crizotinib suggests that the benefit of crizotinib in first line is real and clinically meaningful despite a nonoptimal control arm (no bevacizumab, no maintenance treatment with pemetrexed). Safety and drug interaction =========================== Safety results were consistent in all clinical trials ([Table 2](#t2-lctt-7-083){ref-type="table"}). Crizotinib was overall well tolerated. In PROFILE-1014, the most frequent side effects were eye disorders (71%), diarrhea (61%), nausea (56%), peripheral edema (49%), vomiting (46%), and constipation (43%).[@b16-lctt-7-083] Most frequent grade 3--4 side effects were elevated aminotransferases (14%) and neutropenia (11%). Grade 3--4 electrocardiogram prolonged QT interval was observed in 2% of the patients in the crizotinib arm. Fatal pneumonitis occurred in one patient treated with crizotinib (after crossover from chemotherapy arm). Rate of early treatment discontinuation due to side effects was equivalent in crizotinib arm and in chemotherapy arm (12% and 14%, respectively). Interstitial lung disease, a rare potential severe adverse event, was also reported in the literature.[@b17-lctt-7-083] Administration of crizotinib and inhibitors of the CYP3A induces an augmentation of the plasmatic concentrations of crizotinib. Drugs such as protease inhibitors (atazanavir, indinavir, nelfinavir, ritonavir, saquinavir), some azole-class antifungals (itraconazole, ketoconazole, voriconazole), and some macrolides (clarithromycin, telithromycin, troleandomycin) should be avoided during the treatment with crizotinib. Consumption of grapefruit and grapefruit juice should also be avoided. Inducers of the CYP3A, such as carbamazepin, phenobarbital, phenytoin, rifabutin, rifampicin, and St John's wort, should also be avoided, as they decrease the plasmatic concentration of crizotinib. Treatment strategy with crizotinib ================================== Crizotinib received the FDA approval for first-line treatment of *ALK*-rearranged advanced NSCLC in 2013, and the EMA approval for the same indication in November 2015. The question of the best moment to use crizotinib in *ALK*-rearranged NSCLC is relevant. We learned from *EGFR*-mutated NSCLC that first-generation EGFR TKIs (erlotinib, gefitinib) have the same efficacy in first- or second-line treatment.[@b18-lctt-7-083] However, results from the PROFILE trials showed that crizotinib could be more efficient when given in first line compared to subsequent lines. Indeed, response rate was 74% in PROFILE-1014 (first-line setting) versus 59.8% in PROFILE-1005 and 65% in PROFILE-1007 (second-line setting or more). PFS was 10.9 months in PROFILE-1014 (first-line setting) versus 7.7 months in PROFILE-1007 (second-line setting or more). Even if the comparison between different trials is subject to caution, these differences encourage to screen advanced NSCLC for ALK status at the diagnosis, and to use crizotinib in first-line treatment, when it is possible. Mechanisms of resistance to crizotinib ====================================== Despite great response rate, *ALK*-rearranged NSCLC progresses under crizotinib after 8--12 months. The tumor progression occurs notably in the brain. Crizotinib is a substrate of the PgP, which is a membranous transporter overexpressed in the hemato-encephalic barrier and responsible for the efflux of the drug. This pharmacological specificity could explain that around half of the patients treated with crizotinib will have a cerebral progression. Several cellular and molecular resistance mechanisms have been described so far to explain secondary resistance to crizotinib ([Figure 2](#f2-lctt-7-083){ref-type="fig"}).[@b19-lctt-7-083] In half of the cases, the resistance mechanism is ALK dependent *(ALK* amplification and/or *ALK* mutation). Known *ALK* mutations that cause resistance to crizotinib are L1196M, C1156Y, F1174L, G1269A, 1151Tins, L1152R, S1206Y, I1171T, V1180L, D1203N, and G1202R.[@b20-lctt-7-083] The other half of the resistance cases concern ALK-independent mechanisms, such as *EGFR* or *Kras* pathway activation. Among eleven patients with *ALK*-rearranged NSCLC treated with crizotinib, one patient (9%) harbored an *EGFR* mutation, and two patients, a *Kras* mutation (18%) at the time of progression.[@b21-lctt-7-083] HER2 activation has also been involved in acquired resistance to crizotinib.[@b19-lctt-7-083] An analysis of nine cases of crizotinib progression showed the apparition of a phosphorylation of HER2 in four cases (44%). Other mechanisms, such as *Kit* amplification[@b19-lctt-7-083] or IGF1R pathway activation,[@b22-lctt-7-083] have also been described. However, except acquired *EGFR* mutation that opens the possibility of targeted EGFR TKI treatment, the clinical implications of the other ALK-independent mechanisms of crizotinib resistance need to be clarified. It is also important to notice that all these mechanisms have been described in a very limited number of patients. Larger cohorts of patients with documented molecular status at the time of progression are therefore needed. Treatment strategies beyond progression ======================================= Recently, new ALK TKIs have been developed to overcome resistance to crizotinib, such as ceritinib, alectinib, and lorlatinib. After failure of crizotinib, response rates are high, 58% with ceritinib[@b23-lctt-7-083] and 50% with alectinib,[@b24-lctt-7-083] including efficacy in brain metastases. As discussed, acquired *ALK* mutations can be responsible for crizotinib progression. Interestingly, some of these mutations seem to induce different sensitivity to second-generation ALK inhibitors. For example, I1171T mutation, associated with crizotinib resistance, is also associated with resistance to alectinib. C1156Y and L1152R mutations also induce resistance to ceritinib. G1202R mutation seems to induce resistance to crizotinib, alectinib, and ceritinib. A recent report also described a patient with an acquired resistance mutation with crizotinib (C1156Y), who developed another ALK mutation under lorlatinib (L1198F) in addition to the C1156Y mutation.[@b25-lctt-7-083] L1198F mutation is associated with resistance to lorlatinib but confers sensitivity to crizotinib. This patient received again crizotinib with a good tumor response. New molecular screening at the time of progression under crizotinib, through re-biopsy or circulating plasmatic DNA analysis, is therefore advised to guide the best choice of second-generation ALK inhibitor.[@b26-lctt-7-083] Several questions remain concerning the best treatment sequence. Is there an interest for second-generation ALK inhibitors in first-line treatment? The potential addition of PFS with crizotinib and then ceritinib or alectinib could argue for a prescription of these new drugs after failure of crizotinib. However, clinical trials with specific design are needed to answer this question. An ongoing randomized Phase III trial (ALEX study, NCT02075840), comparing alectinib and crizotinib in treatment-naive ALK-positive advanced NSCLC, may partially answer this question. Moreover, the conventional chemotherapy plays a major role in *ALK*-rearranged NSCLCs as these tumors have a high sensitivity to pemetrexed.[@b27-lctt-7-083] The best treatment strategy at the time of progression under crizotinib depends on the profile of progression. A retrospective analysis of patients included in crizotinib-based clinical trials who had tumor progression according to RECIST (n=194) showed that, in patients who continued crizotinib beyond progression because of clinical benefit, OS was longer than in patients who stopped crizotinib (median 29.6 versus 10.8 months; HR =0.30, 95% CI: 0.19--0.46, *P*\<0.0001).[@b28-lctt-7-083] PS was better (0/1) in 96% versus 82% of patients (*P*=0.02), respectively. This retrospective non-randomized analysis does not allow definitive conclusions on the best management at the time of progression under crizotinib but suggests that some patients could benefit from the continuation of crizotinib beyond progression. More likely, patients with slow, oligometastatic progression could be subjected to localized treatment on progression sites, with continuation of crizotinib. Especially, brain progression occurs in around half of the patients under crizotinib, mainly because of poor brain penetration of crizotinib. For low number of symptomatic brain metastases, without extra-brain progression, a local treatment (stereotactic radiotherapy, surgery) could be proposed, with treatment with ALK TKIs (continuation with crizotinib or switch to a second-generation ALK inhibitor).[@b29-lctt-7-083] Whole-brain radiotherapy is another option for the treatment of brain metastases, but results in neurocognitive impairment, and should be reserved for extensive symptomatic brain metastases. Small asymptomatic brain metastases should be followed up, or a switch to a second-generation ALK inhibitor should be proposed. For extensive poly-visceral progression under crizotinib, a switch to a second-generation ALK inhibitor or systemic pemetrexed-based chemotherapy should be proposed. Overall, patients with *ALK*-rearranged advanced NSCLC, who can access sequential crizotinib and second-generation ALK inhibitor treatment, have a prolonged OS, exceeding 4 years.[@b30-lctt-7-083] This long survival, unusual in advanced NSCLC, should be a key component in the treatment decisions for ALK-rearranged NSCLC, with priority given to local treatments on progression sites when possible, and favoring strategies with low-grade side effects. Conclusion ========== Although *ALK* rearrangement is a rare molecular feature in advanced NSCLC, the possibility to use high-efficiency targeted therapies, such as crizotinib, is a major advance and a real improvement in the management of this kind of tumor. The presence of an *ALK* rearrangement fulfills all the criteria for an oncogenic addiction, notably with a high response rate and durable tumor response with crizotinib. Based on the different results of the PROFILE trials, the best strategy is to use crizotinib in first-line setting, with probably a higher efficiency compared to subsequent lines. The best option at the time of the progression remains undefined, and the choice between crizotinib beyond progression, local treatment on the progression site, switch to a next-generation ALK TKI, or systemic pemetrexed-based chemotherapy is based on the phenotype of the tumor progression, on the molecular profile of the tumor at the time of the progression (re-biopsy), and on the physical condition of the patient at the progression. Further clinical trials are warranted to answer these questions. **Disclosure** The authors report no conflicts of interest in this work. {#f1-lctt-7-083} {#f2-lctt-7-083} ###### Efficacy data of crizotinib in clinical trials PROFILE-1001[@b13-lctt-7-083] PROFILE-1005[@b14-lctt-7-083] PROFILE-1007[@b15-lctt-7-083] PROFILE-1014[@b16-lctt-7-083] --------------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- Line of treatment ≥2 ≥2 ≥2 1 Response rate 60.8% 59.8% 65.0% 74.0% Duration of response (median) (weeks) 49.1 45.6 32.1 48.4 PFS (median) (months) 9.7 8.1 7.7 10.9 OS  Median (months) NR NA 20.3 NR  1-Year (%) 74.8 NA NA 84.0 **Abbreviations:** PFS, progression-free survival; OS, overall survival; NR, not reached; NA, not available. ###### Main adverse events with crizotinib in clinical trials PROFILE-1001[@b11-lctt-7-083] PROFILE-1005[@b14-lctt-7-083] PROFILE-1007[@b15-lctt-7-083] PROFILE-1014[@b16-lctt-7-083] ---------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ---- ---- ---- ---- Vision disorder 41 0 52 0 60 0 71 1 Diarrhea 48 0 41 1 60 0 61 2 Nausea 54 0 47 1 55 1 56 1 Vomiting 44 0 39 1 47 1 46 2 Constipation 24 0 28 0 42 2 43 2 Elevated ALAT/ASAT 11 1 28 5 38 16 36 14 Edema 16 0 23 0 31 0 49 1 Fatigue 10 0 18 2 27 2 29 3 Dysgeusia 15 0 17 0 26 0 26 0 Dizziness NA NA 11 0 22 1 18 0 Dyspnea NA NA 1 1 13 4 18 3 Neutropenia 1 0 9 6 NA NA 21 11 Decrease in appetite 13 0 19 0 NA NA 30 2 **Notes:** Adverse events (%) listed if they were reported in at least 10% (PROFILE-1001 and PROFILE-1005) or 15% (PROFILE-1007 and PROFILE-1014) of the patients. **Abbreviations:** ALAT/ASAT, alanine aminotransferase/aspartate aminotransferase; NA, not available.

Introduction ============ A fundamental role of the preoperative assessment testing (PAT) clinic is to assess patients prior to surgery in order to gather information upon which risk assessment and perioperative management decisions are made.[@b1-hsi-suppl.1-2016-001] This process precedes the delivery of anesthetic care, before surgical and non-surgical procedures.[@b2-hsi-suppl.1-2016-001] Lee[@b3-hsi-suppl.1-2016-001] first described the notion of an outpatient PAT clinic in 1949. In the traditional preoperative assessment model, the anesthesiologist who would administer the anesthesia would typically assess the patient on the evening prior to or on the day of the procedure. However, Lee proposed that the patient should rather be seen as soon as the surgeon schedules the patient and the PAT clinic should facilitate the patient arriving in the operating room medically optimized. The increasing prevalence and popularity of same day surgery served as a catalyst for the PAT clinics to form an established role in hospitals across the United States.[@b4-hsi-suppl.1-2016-001] Many benefits arise from PAT clinics for both the hospital and the patient. An efficiently run clinic is associated with an increased cost-effectiveness by lowering preoperative admission time and thus reducing the length of stay and the associated costs.[@b5-hsi-suppl.1-2016-001] These clinics allow for focused assessment of patients and prevent unnecessary investigations and consultations that can potentially delay or cancel surgeries. Furthermore, medical optimization of patients significantly reduces the probability that a procedure will be delayed or postponed for a medical reason; this reduces anxiety for the patient and increases the efficiency of the operating room with a financial benefit to the hospital.[@b6-hsi-suppl.1-2016-001] According to the Centers for Disease Control and Prevention in 2010, \~51.4 million procedures were performed in the United States. A study done from 1994 to 1999, assessing operative mortality in 1.2 million patients in the Medicare System, found that among these procedures, overall operative mortality varied widely between different elective procedures. The procedures considered to have low operative risk included carotid endarterectomy (1.3%) and nephrectomy (2.3%) with more than 10% mortality reported for procedures like mitral valve replacement (10.5%) and esophagectomy (13.6%). Of note, mortality was twice that for patients older than 80 years as compared to patients aged 65--69 years.[@b7-hsi-suppl.1-2016-001] This increased mortality associated with age emphasizes the importance of medical optimization of the multiple and sometimes complex chronic illnesses of the elderly. The role of a preoperative risk assessment clinic is to identify the risk factors associated with increased intra- and postoperative complications. Prompt identification of high-risk patients, timely interventions, anesthesiological care, and medical optimization can lead to significant reduction in peri-and postoperative mortality and morbidity. Several scoring systems, preop testing, and biochemical markers can guide in predicting the complications and mortality.[@b8-hsi-suppl.1-2016-001] According to an Australian study, there was a sixfold increase in mortality in the patients who underwent inadequate preop assessment as compared to those who were thoroughly assessed.[@b9-hsi-suppl.1-2016-001]--[@b11-hsi-suppl.1-2016-001] Aims of a PAT Clinic ==================== PAT clinics are specifically designed to stratify patients' risk with the aim of identifying and mitigating the effect of risk factors associated with high perioperative morbidity and mortality. The clinician participating in a PAT clinic should do so with clear goals in mind. First, it is important to create an open environment for the patient by building rapport with the patient and their relatives, to address the anxiety associated with invasive surgical procedures. The patient should be assessed in a systematic and focused manner following evidenced-based established guidelines with the aim of reducing the morbidity and mortality of the surgery. All necessary investigations and referrals should be done in a timely manner to avoid surgical delays or case cancellations. The aim is not just to clear the patient for surgery, rather to prepare him or her for it. A summary of recommendations should always be provided to the patient in person, and a clear record should be kept in the medical records for all practitioners involved. Setup of a PAT Clinic ===================== Location and design of PAT clinic --------------------------------- There is no single, standard model of care for perioperative programs. Design should be based on the needs, culture, and resources of the institution. The physical location and flow of a PAT clinic should complement the clinical goals set forth by the hospital. The clinic should be accessible via the main entrance of the hospital, or adequate elevators should be available to provide patients easy access to the clinic. The registration area should receive the patient as soon as he or she walks in, and direct patient flow along the evaluation process from their initial vitals and electrocardiogram (EKG) to the seating area waiting should be called. The examination rooms should foster the patient--physician relationship and should not present physical barriers between the two; accommodation for relatives should also be provided. The location of the clinic should allow easy transition of patients to diagnostic facilities commonly used in preoperative assessment such as laboratory, radiology department, and cardiac testing. Support facilities such as drinking water and bathroom facilities should also be provided. Functioning of a PAT clinic --------------------------- When a patient is evaluated at the outpatient surgical department and is deemed to undergo surgery, the secretary of the outpatient department has to book an appointment at the PAT clinic. At the day of the PAT clinic appointment, patients report at the secretary desk of the PAT clinic. The secretary enters the patient's information into the system and completes the registration process. The patient is sent to the waiting room to wait for the nurse to record vital signs and do an EKG. After this, the patient waits in the examination room for the physician. Based on the patient's medical history and the screening, the physician determines if the patient is fit for surgery or if additional examinations are necessary before surgical clearance. Then, the patient has to go to the phlebotomy suite and radiology department for blood work and radiologic testing, if required. When a patient needs additional examinations, the patient goes to the secretary who contacts the designated department to make an appointment for the patient. After these examinations, in most of the times, the patient does not have to return to the PAT clinic. Based on the information gathered by the additional examinations, the physician makes the decisions concerning surgery approval. This is communicated by telephone with the surgical team and the patient. The process of the functioning of a PAT clinic is summarized in [Figure 1](#f1-hsi-suppl.1-2016-001){ref-type="fig"}. Staff and their role -------------------- A preoperative risk assessment clinic should typically employ a multidisciplinary approach in an effort to ensure that patients are fully prepared for their stay in the hospital. For this purpose, such a clinic should include administrative personnel, nursing, and ancillary staff, alongside appropriately trained physicians. ### Role of a physician Traditionally, anesthesiologists have been regarded as preoperative physicians and are concerned with preoperative evaluation, intraoperative anesthesia administration, and acute postoperative management of patients, including that in an intensive care unit (ICU) setting.[@b11-hsi-suppl.1-2016-001] They are skilled in preoperative evaluation and assessment of common risk factors so as to clear patients for surgery. However, a standard anesthesia evaluation does not encompass the optimization of chronic medical problems that may worsen during or after surgery. According to some studies, the preoperative assessment that was not done by the anesthetists was different from that of other medical professionals and the patients who were cleared for surgery previously were not deemed fit by the anesthetist later.[@b12-hsi-suppl.1-2016-001] An internist, on the other hand, is in a position to perform a thorough preoperative review leading to a decrease in the length of stay and fewer complications, thus reducing the associated expenditure of resources. Therefore, internists can serve as suitable mediators to systematize the process of transition of care from the surgical episode to a safe discharge and outpatient follow-up. These findings were corroborated by a study published in the Journal of Hospital Medicine. It was observed that adding a hospitalist-run preoperative analysis to an anesthesia evaluation was associated with reduced length of stay for high-risk patients (American Society of Anesthesiologists (ASA) score of ≥3), fewer surgical cancellations, and a reduction in inpatient mortality rates.[@b13-hsi-suppl.1-2016-001] ### Role of a nurse The nurse is an important member of a preoperative assessment team and plays an important role in identifying patients' needs and risk factors that may affect the surgical outcome.[@b14-hsi-suppl.1-2016-001] A nurse is also responsible for understanding patients' expectations and alleviating their anxiety through adequate education and serves as a conduit for inter-professional communication. With rising costs and shortage of medical staff, nurses have taken over with nurseled clinics, providing for more comprehensive services than medical assessment alone. A review[@b15-hsi-suppl.1-2016-001] of available research on the effectiveness of nurse-led preoperative assessment clinics on patient outcomes showed decreased length of stay, cancellations, non-attendance for the procedure, and patient anxiety. Higher compliance with presurgical testing and avoidance of unnecessary tests were observed. It also showed improved patient satisfaction, preoperative preparation, and understanding of postoperative care needs, but due to the lack of randomized controlled trials or a higher level of evidence, definitive conclusions could not be made. Some studies, however, concluded that preoperative risk assessment screening done by nurses over telephone with complete assessment done by the anesthesiologists on the day of surgery led to far less day of surgery cancellation rates.[@b11-hsi-suppl.1-2016-001],[@b16-hsi-suppl.1-2016-001] ### Role of a psychiatrist and social worker The role of a psychiatrist in a preoperative risk assessment clinic would be to assess the surgical candidates for perioperative anxiety and to identify those at high-risk development of postoperative depression and requiring necessary counseling treatment and follow-ups. The role of a social worker is to provide education and support to the patients and their families. They are well trained and better equipped to provide the necessary education and perioperative assessment of the patient's social needs. Their role also involves anticipating the postoperative complications, making the necessary referrals to rehabilitation centers and nursing homes, facilitating a smooth transition from the inpatient postoperative care to discharge planning, and focusing on decreased length of stay in the hospital. They also collaborate with the patients and families to improve postdischarge outcomes and the delivery of the durable medical equipment (necessitated as per patients' clinical condition).[@b17-hsi-suppl.1-2016-001]--[@b19-hsi-suppl.1-2016-001] ### Ancillary staff Support staffs including patient care technicians are necessary for routine laboratory work, assessment of vital signs, EKG, and collection of other data. In addition, administrative members of the team deal with the storage of information and records and other organizational works. The receptionist has a crucial role of making the necessary appointments, greeting the patients at the clinic, and streamlining the process from preop evaluation to setting up and coordinating the postop appointments. Various purposed models of PAT clinics -------------------------------------- ### Nurse only: chart collation and record review Nurse-led preadmission clinics or services have been implemented in many health services as a strategy to facilitate the admission and assessment of booked surgical cases. Though evidence of effectiveness for nurse-led preadmission services on a wide range of outcomes for elective surgery patients has been reported in various studies, the lack of experimental trials means that the level of evidence is low.[@b15-hsi-suppl.1-2016-001] ### Internal Medicine Preoperative Assessment, Consultation and Treatment center The main purpose of the Internal Medicine Preoperative Assessment, Consultation and Treatment (IMPACT) center is to carefully evaluate patients prior to their surgery and optimize their medical conditions. This helps to minimize the risk of developing complications during and immediately after surgery as well as minimize unnecessary cancellation of surgeries. The components of the IMPACT clinic include evaluate patients undergoing non-cardiac surgery, assess and outline perioperative risks, optimize all chronic medical conditions, order appropriate testing to optimize medical conditions before surgery, coordinate care between specialists preoperatively for complex medical conditions, and make evidence-based recommendations for patients, anesthesiologists, and the surgical team (related to both pre- and postoperative periods). ### Pre-Anesthesia Consultation and Education Pre-Anesthesia Consultation and Education is led by an anesthesiologist. Triage Based Model evaluation High risk/high impact patients ------------------------------------------------------------ Patients are managed based on their ASA (American Society of Anesthesiologists) risk class. ### Perioperative surgical home---future of PAT clinics? The perioperative surgical home (PSH) is a new model developed as a solution for the costly and fragmented perioperative system. PSH as defined by the ASA is a patient-centered model designed to improve health and the delivery of health care and to reduce the cost of care.[@b20-hsi-suppl.1-2016-001] In a PSH model, the internists, family practitioners, surgeons, anesthesiologists, nurses, pharmacists, physical therapists, case managers, social workers, and information technology (IT) experts actively coordinate and provide care. This model considers patient's episode of care as shared and one continuum of care rather than fragmented preoperative, intraoperative, and postoperative care. This model also includes facilitated return to primary care physician or further rehabilitation. PSH is an innovative model, complementary to the patient-centered medical home, that defines methods for improving the patient experience and clinical outcomes and controlling costs for the care of surgical patients. It can reduce unnecessary tests and provide consultations regarding preoperative evaluation, delay in surgeries, postoperative complications, length of stay, and unnecessary admissions after outpatient surgery. Components of PSH ----------------- The important components of surgical home model are as follows: engaged physician leadershipearly patient engagement and educationpatient optimization for surgerytimely schedulingevidence-based protocolsexpert surgical and anesthetic carefacilitated prehabilitation/rehabilitationmeasurement of patient-centered outcomescontinuous performance improvementfacilitated return to primary care. Elements of PSH --------------- ### Preoperative phase Once a mutual decision is made between the patient and the surgeon to proceed with surgery, the patient is referred to the preoperative clinic. The goal of the preoperative clinic is to identify, communicate, and minimize patient's specific risks of surgery and anesthesia. Patient education and engagement should be emphasized in the preoperative clinic. Detailed information about enhanced recovery after surgery (ERAS) program can be given to the patient to decrease anxiety and enhance postoperative recovery and hospital discharge. Preoperative psychological interventions, pamphlets, multimedia information containing planned procedure and education about postoperative feeding, early postoperative mobilization, and pain control and respiratory physiotherapy can be given to reduce the incidence of postoperative complications.[@b21-hsi-suppl.1-2016-001] ERAS program is based on standardized, evidence-based, interdisciplinary care pathways such as preoperative preparation of the patient with medical optimization (physical preconditioning, nutritional supplementation, and fasting prior to surgery), intraoperative management (selecting type of anesthesia and analgesia, goal-directed fluid therapy, transfusion protocols, and minimal use of opioids, NG tubes, urinary catheters, and drains), postoperative pain management, deep vein thrombosis prophylaxis, alimentation, early mobilization, and transition of care to primary care physician or rehabilitation center.[@b22-hsi-suppl.1-2016-001] ### Intraoperative phase Case delays and cancellation can be avoided not only by medically optimizing the patient preoperatively and through good communication but also by creating consensus among anesthesiologists about the criteria for proceeding with scheduled cases.[@b21-hsi-suppl.1-2016-001] ### Postoperative phase Postoperative team consisting of anesthesiologists, surgeons, internists, mid-level providers, and registered nurse should coordinate the postoperative patient care from postanesthesia care unit to ICU or inpatient. Pain management, alimentation, early mobilization, and patient and patient's family education are of greatest concern.[@b21-hsi-suppl.1-2016-001] ### Transition of care Transitional care for 30--90 days post discharge with good hands-off should be provided. Effective communication should be provided to the patient, primary care physician, or rehabilitation service ([Fig. 2](#f2-hsi-suppl.1-2016-001){ref-type="fig"}). Optimal timing of PAT evaluation -------------------------------- There is not enough data specifying the optimal timing for preoperative evaluation. In general, screening should take place from one week to 30 days prior to the date of the scheduled procedure. Factors that have an effect on the timing of presurgical evaluation include patient demographics, clinical condition, invasiveness of the procedure to be performed, and the availability of resources.[@b1-hsi-suppl.1-2016-001] An efficient appointment system in addition to timely reporting of the results of laboratory and radiologic tests is crucial in deciding the most favorable time of preoperative evaluation. Efficacy of PAT Clinic ====================== With the introduction of preoperative risk assessment clinics, there has been increased coordination between preoperative surgical, anesthesia, nursing, and laboratory care and a resultant increase in the efficiency of the perioperative care. There has been increased focus on patient's individualized care based on the information from patient's records, interview, physical examination, and type and invasiveness of the planned procedure. Reducing medically unnecessary preoperative testing --------------------------------------------------- Indiscriminate testing not only increases the risk of iatrogenic injury but also results in surgical delays and increased medicolegal liability for not following an abnormal test.[@b23-hsi-suppl.1-2016-001] It has also been found that the majority of the tests ordered preoperatively are medically unnecessary.[@b24-hsi-suppl.1-2016-001] In an effectively functioning preoperative clinic, there is documentation of medical necessity of every test and imaging ordered based on patient's medical comorbidities and the planned surgical procedure, which results in significant reduction in the number of tests and imagings. This is not only cost effective but also more feasible for the patient without adverse patient events.[@b23-hsi-suppl.1-2016-001] Reduction in the number of subspecialty referrals ------------------------------------------------- These preoperative risk assessment clinics have provided a platform where patients can be optimally risk stratified according to the standard guidelines, reducing the number of multidisciplinary referrals, which ultimately reduces the pressure on the available resources. The physicians can be more selective with referrals concentrating only on those patients with major or multiple risk factors and poor functional capacity.[@b25-hsi-suppl.1-2016-001] The thoughtful use of cardiac testing/procedures in preoperative clinics can dramatically reduce the number and increase the yield of cardiology consultations.[@b26-hsi-suppl.1-2016-001] Reducing the number of cancelled procedures ------------------------------------------- A majority of surgical procedures are cancelled due to nonavailability of beds, inappropriate preparation of patients, or non-attendance of the patients.[@b27-hsi-suppl.1-2016-001] Most of these scenarios are potentially avoidable with proper planning, medical optimization, and communication starting from the preop clinic till the day of surgery. It has been studied that a proper functioning preop clinic reduces the number of cancelled procedures and increases patient acceptance.[@b28-hsi-suppl.1-2016-001],[@b29-hsi-suppl.1-2016-001] Increasing patient's education about surgery -------------------------------------------- Preoperative assessment clinics are also valuable with regard to educating the patient about their surgery.[@b30-hsi-suppl.1-2016-001] Patients are given written information leaflets in addition to verbal explanation about their admission and surgery. An attempt is also made to identify any social issues that might delay the discharge. The patients who undergo preoperative assessment were found to be more satisfied with the amount of information they receive about their procedure as compared to the ones who do not.[@b29-hsi-suppl.1-2016-001] Discussion ========== The preoperative clinics are a backbone to effective perioperative management. However, we are living in an ever-evolving and challenging world of medicine and every project that we undertake has to be evaluated based on cost effectiveness, research-based evidence, and learned experience. Various models have been proposed and reviewed for the effective functioning of a PAT clinic. The optimal model is still undefined and may depend on certain characteristics of the hospital such as types of specialty care provided, socioeconomic differences of the population being served, the expectation of the patients, and whether the facility is private versus academic practice.[@b31-hsi-suppl.1-2016-001] The nurse-led pre admission services have been studied to be effective on a wide range of outcomes for elective surgery patients. However, there are insufficient randomized controlled trials done for this model[@b12-hsi-suppl.1-2016-001] to confidently describe it as an efficient practice. If the preoperative clinic is run by anesthesiologists, it means that they will have to spend more time out of operating room, which is not desirable given the shortage of anesthesiologists as reported by many institutions.[@b31-hsi-suppl.1-2016-001] There is abundant literature regarding the role of internists in the preoperative clinic (IMPACT center). However, it has also been studied that an effective communication and collaboration between specialties, especially between the internists and the surgeon, is required to ensure the safety of mutual patients.[@b32-hsi-suppl.1-2016-001] Also, in this era of advanced technology, there is also increasing trend toward the use of electronic devices to triage the patients using questionnaires before their preoperative clinic visit.[@b33-hsi-suppl.1-2016-001] To summarize, when it comes to effective patient management, nurses, internists, anesthesiologists, IT specialists, and ancillary staff all have their own importance. This thinking has led to the concept of PSH. The PSH is a step toward organizing the fragmented and expensive perioperative care in the US. The various components of this model have already been discussed in detail. In short, it is a patient-centered, physically led, collaborative care model. It serves to coordinate management of surgical patients from preoperative evaluation to postoperative discharge and transition planning in an attempt to integrate an isolated event-like surgery into the patient's complete medical care. It has been recently implemented in Kaiser Permanente (the largest integrated delivery system in California, USA). A prospective study showed that the integration of PSH resulted in simultaneous reduction in the length of stay and skilled nursing facility admission for total knee arthroplasty.[@b34-hsi-suppl.1-2016-001] It is evident that most perioperative complications are related to a lack of coordinated care and a wide variability in its delivery. Therefore, a model such as the PSH is necessary.[@b21-hsi-suppl.1-2016-001] As compared to some of the other models and protocols of perioperative care, the PSH is a much larger conceptual framework that includes coordination of care from the minute the decision to operate was made until 30 days after discharge. The following are the advantages of the preoperative surgical home: The patient's preferences are at the center of this model (patient centered). Thus, patients participate in all decision making.Allowing for a continuous flow of information between various providers, the patient PSH model allows for seamless transition of patients from the isolated surgical event back to their routine medical care.With the coordination of all phases of perioperative care between the patient's physician teams, early identification of patients at high risk for postoperative complications and readmissions may be identified.It also allows for easy tracking of the patient's progress through all three phases of perioperative care. As the PSH model employs a physician-led approach employing teams including hospitalists, stratification and management of patients based on their risk factors are possible. This is particularly important in the management of high-risk patients. Such a multi-specialty approach allows to lower mortality, shorten the hospital length of stay, and lower total inpatient costs. An application of evidence-based protocols across the various disciplines involved in the care of the patient leads to reduced variability, improved outcomes, and adequate optimization of patient care modalities.[@b35-hsi-suppl.1-2016-001]--[@b37-hsi-suppl.1-2016-001]With the coordination of all phases of perioperative care between the patient's physician teams, early identification of patients at high risk for postoperative complications and readmissions may be identified. It also allows for easy tracking of the patient's progress through all three phases of perioperative care. Implementation of the principles of the PSH model allows the patient to get the most appropriate care throughout their surgical experience, leading to better outcomes at lower costs. There are still barriers to the implementation of this model on a wider scale.[@b38-hsi-suppl.1-2016-001] It is still in an early phase, and more studies are required to review its effects in detail. Conclusion ========== The challenges most commonly faced while setting a preoperative clinic is the limitation of finance and shortage of staff.[@b39-hsi-suppl.1-2016-001] In addition, with the ever-increasing number of patients with multiple serious comorbidities scheduled for complex procedures, gathering information and optimizing their care is a challenge in itself. Financial constraints present the major barrier to the PSH model because the extra services provided by the physicians cannot be reimbursed within the existing payment systems. The other constraint is recruitment of staff, including IT personnel for the development of electronic medical records (EMR) templates and social work and nursing coordinators for managing patients with social risk factors. However, with increasing awareness about the usefulness of preoperative risk assessment and a growing body of literature and evidence-based guidelines, these clinics are becoming a medical necessity for the improvement of perioperative care. **ACADEMIC EDITOR:** Professor Charles Phillips, Editor in Chief **PEER REVIEW:** Four peer reviewers contributed to the peer review report. Reviewers' reports totaled 327 words, excluding any confidential comments to the academic editor. **FUNDING:** Authors disclose no external funding sources. **COMPETING INTERESTS:** Authors disclose no potential conflicts of interest. Paper subject to independent expert single-blind peer review. All editorial decisions made by independent academic editor. Upon submission manuscript was subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to human and animal study participants, and compliance with any copyright requirements of third parties. **Author Contributions** Conceived the concepts: HT, SC. Wrote the first draft of the manuscript: HT, SH, HA, SK, OT, RA. Contributed to the writing of the manuscript: HT, SH, HA, SK, OT, RA. Agree with manuscript results and conclusions: HT, SC. Jointly developed the structure and arguments for the paper: HT, SH, HA, SK, OT, RA, SC. Made critical revisions and approved final version: SC. All authors reviewed and approved of the final manuscript. {#f1-hsi-suppl.1-2016-001} ![Elements of perioperative surgical home.[@b20-hsi-suppl.1-2016-001]--[@b23-hsi-suppl.1-2016-001]](hsi-suppl.1-2016-001f2){#f2-hsi-suppl.1-2016-001}

Introduction ============ The epidermal growth factor receptor (EGFR) is recognized as an important molecular target in cancer therapy. Erlotinib (ERT) is an orally-active and potent inhibitor of the EGFR tyrosine kinase (TKI) used in lung cancer and several other cancers \[[@b1-scipharm-2012-80-633], [@b2-scipharm-2012-80-633]\]. Celecoxib (CCB) is a selective cyclooxygenase-2 (COX-2) inhibitor \[[@b3-scipharm-2012-80-633]\]. COX-2 is an inducible enzyme that is overexpressed in pancreatic cancer. Through the conversion of arachidonic acid to prostaglandin, the COX-2 enzyme modulates angiogenesis and metastasis. This currently ongoing clinical trial utilizes erlotinib and celecoxib in non-small-cell lung cancer/head and neck cancer \[[@b4-scipharm-2012-80-633], [@b5-scipharm-2012-80-633]\]. A fast, sensitive, and specific LC/MS/MS method for the simultaneous determination of ERT and its active metabolites in rat plasma, OSI-420 and CCB, is described. After administration of ERT and CCB, blood samples were periodically collected from male Wistar rats. The pharmacokinetic parameters of ERT, OSI-420, and CCB were calculated. Literature reviews reveal that methods have been reported for the analysis of CCB, ERT, and OSI-420, and the HPLC and LC-MS/MS method for the determination of CCB, ERT, and OSI-420 in combination with other drugs was also reported \[[@b6-scipharm-2012-80-633]--[@b17-scipharm-2012-80-633]\]. To the best of our knowledge, no prior reports have described a LC--MS/MS-based method for the simultaneous determination of ERT, OSI-420 & CCB from plasma. Hence, we developed a reverse-phase HPLC method for the simultaneous estimation of ERT, OSI-420 & CCB on a C~18~ column using tandem mass spectroscopy detection, and validated the method before applying it in preclinical experiments. The current study describes a rapid, specific, and simple protein precipitation method using LC-MS/MS for the simultaneous determination of CCB and ERT, along with its major active metabolite OSI-420 in rat plasma, which is suitable for pharmacokinetic and drug-drug interaction studies. The method was validated using authentic pure standards. This method was successfully applied to the pharmaco-kinetic study of CCB with ERT in rats after oral administration of CCB and ERT. Materials and Methods ===================== Chemical and Reagents --------------------- Pure reference standards of celecoxib (CCB), Erlotinib (ERT), and Sitagliptin (SIT) were obtained from Sigma-Aldrich (Germany). Desmethyl erlotinib (OSI-420) was obtained from Selleckchem (USA). Efavirenz (EFV) was obtained from SBC (USA). Acetonitrile (HPLC grade), methanol (HPLC grade), and ammonium acetate (GR-grade) were procured from E Merck (India) Ltd., India. Formic acid was obtained from Sigma-Aldrich (Germany). Ultra pure water of 18 MΩ/cm was obtained from Millipore: Milli-Q purification system (USA). Stock solution, calibration standards and quality control samples ----------------------------------------------------------------- Standard stock solutions of CCB, ERT, OSI-420, SIT, and EFV were prepared in methanol with a final concentration of 1 mg/ml. These solutions were stored at 2--8°C until use. SIT and EFV stock solutions were diluted to achieve a final concentration of 1.2 μg/mL and 1.15 μg/mL, respectively, with the methanol. Analytical standards for CCB, ERT, and OSI-420 were prepared in acetonitrile: water (70:30, v/v) over a concentration range of 1.6 ng/mL to 1144.4 ng/mL, 1.8 ng/mL to 1289.2 ng/mL, and 1.5 ng/mL to 1177.2 ng/mL, respectively, by serial dilution, and the same concentration range for a calibration curve was prepared in the blank, normal rat plasma. Quality control (QC) samples at four different concentration levels 1.6, 3.9, 384.5, 915.6 ng/mL for CCB, 1.8, 4.4, 433.2, 1031.4 ng/mL for ERT, and 1.5, 3.8, 375.4, 893.8 ng/mL for OSI-420 as LLOQC (lower limit of quantitation QC, and low, medium, and high level of QC, respectively) were prepared in three sets, independent of the calibration standards. During analysis, low, medium, and high QC samples were placed after every sixth position of the unknown samples. Sample preparation ------------------ An aliquot of 50 μL of plasma was transferred to a 1 mL Eppendorf microcentrifuge tube, and 150 μL of internal standard solution (containing the final concentration of 1.2 μg/ml and 1.15 μg/ml, for SIT and EFV, in methanol) was added and the sample was vortex-mixed for 5 min. After centrifuging at 10000 rpm for 5 min at 4°C, 0.1 mL of the supernatant was collected and placed in the HPLC, with 10 μL injected onto the LC--MS/MS system. Chromatographic condition ------------------------- A Shimadzu SIL -- 20 AC HT (Shimadzu Corporation, JAPAN) consisted of a flow control valve and a vacuum degasser operated in isocratic mode to deliver the mobile phase at a flow rate of 0.8 ml/min. The chromatographic system consisted of a reverse-phase C~18~ column (50mm×4.6mm i.d., 3μ) (YMC^®^-PACK, JAPAN) and the mobile phase consisted of 80% v/v solvent A: methanol and 20% v/v solvent B: ammonium acetate buffer, 2mM (pH \~4.0 adjusted with 0.1% formic acid). The samples (10 μL) were injected onto the LC-MS/MS system through an auto injector. The auto sampler temperature was kept at 10°C and the column oven was maintained at 40°C. Mass spectrometric condition ---------------------------- Mass spectrometric detection was performed on Thermo Scientific - Finnigan TSQ Quantum Ultra tandem mass spectrometer equipped with a Heated Electron Spray Ionization (HESI) source (San Jose, CA, USA), and Selective Reaction Monitoring (SRM) mode was used for data acquisition with Xcalibur 1.2 software(Thermo-Scientific, San Jose, CA, USA). Peak integration and calibration were carried out by using LC Quan 2.5.2 software (Thermo-Scientific). MS and MS/MS conditions for pure standards of CCB, ERT, OSI-420, SIT, and EFV were optimized by continuous infusion at 5μl/min, using a built-in syringe pump. The transitions monitored were *m/z* −380.1 \> −316.3, 394.5 \> 278.1, 380.3 \> 278.1, and 408.1 \> 127.0, −313.8 \> −243.9 for components CCB, ERT, OSI-420, SIT, and EFV, respectively. All analyses were carried out in a positive and negative ion HESI, set for positive polarity, spray voltage at 3.5 KV, and heated capillary temperature 150°C. Nitrogen sheath gas and auxiliary gas were set at 40 and 30 KPa. For negative polarity, the spray voltage was set at 3.0 KV, and the heated capillary temperature 300°C. The nitrogen sheath gas and auxiliary gas were set at 30 and 40 KPa, with the capillary offset at −35. The argon gas collision-induced dissociation was used with a pressure of 1.5 m Torr with the energy selected at 2100 eV. The total run time for an LC-MS/MS analysis was 5.0 min. Assay Validation ---------------- Specificity was assessed by analysis of six different samples of a blank matrix with and without spiking with CCB, ERT, OSI-420, and IS. Calibration curves were constructed from the working standard solutions of CCB, ERT, and OSI-420 at the concentration range 1.5--1150 ng/mL by plotting peak area ratio (y) of analyte(s) of the internal standard, versus analyte concentration (x). Linearity was assessed by weighted (1/x^2^) linear regression of calibration curves generated in triplicate on three consecutive days, using analyte internal standard peak area ratios. Quality control samples (around 1.5, 4, 400, and 900 ng/mL) were prepared to evaluate the accuracy, precision, recovery, stability, and matrix effect of the assay. Accuracy (expressed as percent nominal, SD) and between- and within-day precision (expressed as percent co-efficient of variation- %CV) were assessed by assay of six replicate QC samples on three different days. The limit of quantification (LOQ) was defined as the lowest concentration in the calibration curve that can be determined with accuracy and precision of no more than 80--120%, ±20%, respectively. The limit of detection (LOD) was defined as a signal-to-noise ratio of 3:1. The extraction recovery for the analytes and IS were determined by assaying two sets of samples: plasma extracts spiked with analytes and IS after extraction (set 1), and plasma spiked with analytes and IS before extraction (set 2). CCB, ERT, and OSI-420 of each batch were prepared at levels of 4, 400, and 900 ng/mL. The percent extraction recoveries of CCB, ERT, OSI-420, and IS were calculated as the percent ratio of set 2 peak area to set 1 peak area. Matrix effect was evaluated to verify whether potential ion suppression or enhancement, due to the co-elution matrix components, existed in the analysis. The peak areas of analytes and the internal standard from the spike-after protein precipitation samples were compared to those of the standard solutions in the mobile phase at the same concentrations. This experiment was carried out with blank plasma samples from six different rats at low and high QC concentrations of CCB, ERT, and OSI-420. Potential sample carry-over was tested by analyzing the upper limit of quantitation (ULOQ, 1150 ng/mL) calibrator of CCB, ERT, and OSI-420 of respective samples, followed by blank samples. Stability experiments were performed to evaluate the analyte stability in stock solutions and in plasma samples under different conditions. Stock solution stability was performed by comparing area response of the stability sample of the analyte with the area response of the sample prepared from fresh stock solutions. To meet the acceptance criteria, percent change should be within ±10% when compared to the fresh stock solution. Bench-top stability, long-term stability, freeze--thaw cycle stability, and autosampler stability were performed at 4 ng/mL and 900 ng/mL of QC levels using six replicates at each level. To meet the acceptance criteria, the nominal percentage should be within ±15% of its respective nominal concentrations. The dilution integrity experiment was performed with an aim to validate the dilution test to be carried out on higher analyte concentrations (above ULOQ), which should be encountered during real sample analysis. A set of plasma samples was prepared containing CCB, ERT, & OSI-420 at a concentration of 4500, 5100, & 4500 ng/mL, respectively, and placed in a −70°C freezer overnight prior to analysis. After thawing, a certain aliquot was diluted 4 & 8 times with Wistar rat plasma and analyzed, respectively. The results of this experiment indicated that the dilution integrity of all the plasma samples was found to be less than 15% of their respective nominal concentrations. Application of method in pharmacokinetic study ---------------------------------------------- Healthy male Wistar rats weighing 200 ± 30g were obtained from Mahaveera Enterprises, Hyderabad and housed at Incozen Therapeutics Pvt Ltd, Hyderabad in appropriate cages. They were maintained under standard laboratory conditions with a regular 12 h day--night cycle in a well-ventilated room with an average temperature of 24--27°C, and relative humidity of 40--60%. Standard pelleted laboratory chow diet (Provimi Animal Nutrition India Private Limited, Bengaluru, India) and water was given *ad libitum* to rats. All of the applicable national and international ethical guidelines for maintenance and experimental studies with Wistar rats were followed. The method was successfully applied to generate the plasma concentration versus time profile of test drugs (CCB and ERT), as well as to detect its active metabolite (OSI-420) in plasma following simultaneous oral administration at 20 mg/kg dose of ERT, and 10 mg/kg dose of CCB in six male Wistar rats. Oral formulations were prepared in suspension form by triturating an accurately weighed amount of powdered compound in methyl cellulose solution (0.5%, w/v water) in a gravimetric dilution pattern. Oral doses of ERT and CCB (20, 10 mg/kg,) were administered using an oral gavage at 5 ml/kg volume in rats after an overnight fast (12 hr), and a fasting restriction was continued until 4 hr post-dose. The blood samples (0.15 ml) were collected from the retro-orbital sinus at predose, 10, 15, 30 min and 1, 2, 4, 6, 8, 12, and 24 hrs post-dose into K~2~-EDTA (dipotassium ethylene-diaminetetraacetic acid) tubes and were kept on an ice bath until further processing. These samples were separated for plasma by centrifugation at 4°C for 10 min at 3000 rpm and then stored at −70°C until further analysis. These samples were simultaneously estimated for the levels of CCB, ERT, and its active metabolite OSI-420. Pharmacokinetic parameters, including the area under the concentration--time curve (AUC), maximum plasma concentration (C~max~), and time to reach the maximum concentration (T~max~), were estimated by means of a non-compartmental analysis using Phoenix WinNonlin (Pharsight Inc., USA, version 6.1). Statistical parameters like mean, standard deviation, and C.V were calculated by using MS-Excel 2007 (Microsoft^®^). Incurred sample reanalysis (ISR) was performed to reconfirm the initial values, and to demonstrate that the assay was reproducible. In the study, ISR was performed on 18 plasma samples from six different rats at Tmax, and the second time the point covered the phase of elimination. Results and discussion ====================== Mass spectrometry ----------------- In order to find most sensitive ionization mode for the components studied, ESI positive ion mode and ESI negative ion mode were tested with various combinations of mobile phases, i.e. acetonitrile and water/ammonium acetate buffer (2 mM)/formic acid (0.1%) in positive and negative ionization mode. It was observed that the signal intensity for \[M + H\]^+^ ions in ESI positive ion mode were 2--10-fold higher for ERT,OSI, and SIT in analyses using acetonitrile: ammonium acetate buffer (2 mM), versus experiments run with ESI negative ion mode. The protonated molecular ion of \[M + H\]^+^, *m/z* 446.4, 370.2, 368.3, and 491.4 amu were obtained for ERT, OSI-420, and SIT & \[M -- H\]^−^, *m/z* −380.1 and −313 amu were obtained for CCB and EFV, respectively. No significant solvent adduct ions or fragment ions were observed in the full scan spectra of all the compounds. Thus, it was decided to utilize positive ion mode & negative ion switching mode for detection and quantitation, on which fragmentation gave prominent and stable product ions. The optimized tube-lens potentials for the protonated \[M+H\]^+^ of component ERT, OSI-420, and SIT were found to be 95, 67, and 122 eV, respectively, the negatively charged \[M-H\]-- of component CCT, and EFV were found to be 110 and 76 eV, respectively. Product ions selected for final mass transition are given in [Fig. 2](#f2-scipharm-2012-80-633){ref-type="fig"}. Liquid chromatography --------------------- Acetonitrile rather than methanol was chosen as the organic modifier because of the analytes' better peak shape. Moderately high acidic ammonium acetate buffer 2 mM, pH\~4, was required to achieve an acceptable peak width and shapes. A reverse-phase C~18~ column (50mm×4.6mm i.d., 3μ) (YMC-PACK®, JAPAN) with methanol: ammonium acetate buffer at flow rate of 0.8 mL/min in iscocratic mode, was applied in the final LC method. With the total analysis time of 5.0min, all components were eluted between in 1.2--4.2min. Representative chromatograms of blank and LOQ level are shown in [Fig. 3](#f3-scipharm-2012-80-633){ref-type="fig"}. Optimization of LC--MS/MS condition ----------------------------------- Final SRM transitions were selected on the basis of the signalto-noise ratio (S/N) with on-column injection analysis. The nitrogen sheath gas, auxiliary gas, argon gas collision- induced dissociation, ion spray voltage, and capillary temperature were set to 40 and 30 KPa, 1.5m Torr, 3500 eV, and 300°C, respectively. The transitions selected were *m/z* −380.1 \> −316.3, 394.5 \> 278.1, 380.3 \> 278.1, and 408.1 \> 127.0, −313.8 \> −243.9 for components CCB, ERT, OSI-420, SIT, and EFV, respectively. Method validation ----------------- Accuracy, precision, selectivity, sensitivity, linearity, and stability were measured and used as the parameter to assess the assay performance. LC--MS/MS analysis of the blank plasma samples showed no interference with the quantification of components CCB, ERT, OSI-420, and internal standards. The specificity of the method was established with pooled and individual plasma samples from six different sources. The retention times of all the analytes and the IS showed less variability with a percent co-efficient of variance (% C.V) well within the acceptable limits of 5%. ### Limit of detection (LOD) and quantification (LOQ) Two criteria were used to define LOQ, i.e., (1) the analytical response at LOQ must be five times the baseline noise and (2) the analytical response at LOQ can be detected with sufficient accuracy (80--120%) and precision (20%). LOD is defined as the lowest concentration of the analyte at which the signal is larger than three times the baseline noise. The measured LOQ and LOD values were 20 and 5 arbitrary units for all three analytes. The LOQ was set at 1.5 ng/mL. These results easily met the requirements of quantifications of all analytes in plasma. ### Linearity The peak area ratios of analytes to IS in rat plasma were linear over the concentration range 1.6--1144.4 ng/mL for CCB and 1.8--1289.2 ng/mL for ERT and 1.5--1117.2 ng/mL for component OSI-420. The calibration model was selected based on the analysis of the data by linear regression with and without intercepts (y = mx + c and y = mx), and on weighting factors (1/x, 1/x^2^ and 1/log x). The best fit for the calibration curve could be achieved by a linear equation of y = mx + c and a 1/x^2^ weighting factor for all components. Mean slopes for CCB, ERT, and OSI420 were found to be 0.00026, 0.07124, and 0.00889, respectively. Mean intercepts for CCB, ERT, and OSI420 were found to be −0.00208, 0.01945, and −0.00522. The correlation coefficients (R^2^) for all components were above 0.99 over the concentration range used. ### Precision and accuracy The within-day precision (expressed by the coefficient of variation of replicate analyses) was estimated on the four quality control levels and the within-batch precision on the nine calibration standard levels. [Table 1](#t1-scipharm-2012-80-633){ref-type="table"} shows the results obtained for the within-batch and between-batch precision for CCB, ERT, and OSI-420. The precision for all these analytes under investigation did not exceeded 15% at any of the concentrations studied and easily met the requirements of validation. ### Recovery The recoveries of CCB, ERT, and OSI-420 from plasma were estimated at their respective low, medium, and high QC levels. Plasma samples (in six replicates) containing all analytes at the QC concentration level were also spiked with their respective internal standards. The absolute recoveries ranged from 73.7 to 78.7%, 88.7 to 90.3%, and 92.2 to 94.4% for CCB, ERT, and OSI-420, respectively. The results are indicated in [Table 2](#t2-scipharm-2012-80-633){ref-type="table"}. ### Stability QC samples were subjected to short-term and long-term storage conditions (−70°C), freeze-thaw stability, autosampler stability, and bench-top stability studies. All stability studies were carried out at two concentration levels (low and high QC) in six replicates. The bench-top stability was studied for low and high QC samples kept at room temperature (25°C) for six hours. Freeze-thaw stability of low and high QC samples was evaluated after three freeze-thaw cycles. The autosampler stability was studied for low and high QC samples which were stored at autosampler conditions at 10°C for 24 hours. The freezer-storage stability of the drug in plasma was determined by comparing the low and high QC samples stored for 30 days at −70°C. The results indicated that each analyte had an acceptable stability under those conditions, as shown in [Table 3](#t3-scipharm-2012-80-633){ref-type="table"}. Application to pharmacokinetic study ------------------------------------ The method described above was successfully applied to a PK drug-drug interaction study, in which plasma concentration of pure markers was determined for up to 24 h after simultaneous oral administration at 20 mg/kg dose of ERT, and 10 mg/kg dose of CCB in male Wistar rats. The plasma concentration-time profiles of CCB, ERT, & its active metabolite OSI-420 are shown in [Fig. 4](#f4-scipharm-2012-80-633){ref-type="fig"}, and could be traceable up to 24 h, 12h, and 12h, respectively. The pharmacokinetic parameters of CCB, ERT, and OSI-420 are presented in [Table 4](#t4-scipharm-2012-80-633){ref-type="table"}. During ISR, it was observed that all of the samples were within ±20% of the initial concentration values, further demonstrating that this method is capable of producing reproducible results over time. Conclusion ========== An LC--MS/MS bioanalytical method for the simultaneous determination of three analytes, CCB, ERT, and OSI-420, was developed and validated in rat plasma. The method was good enough to detect the low concentration of 1.5 ng/mL for all analytes in 50 μL rat plasma, and can further be improved by increasing the plasma volume. Analyte recoveries from spiked control samples were \>73%, using a convenient and fast protein precipitation method. Intra- and inter-day accuracy and precision of the validated method were within the acceptable limits of \<15% and 85 to 115%, respectively, at low and at \<10% of other concentrations. This method was successfully applied to generate a stability profile as well as a PK evaluation of the simultaneous administration of CCB and ERT in rats following oral administration. The authors would like to thank Incozen Therapeutics Pvt. Ltd. (Hyderabad, India) for providing the necessary facilities to carry out the work. **Authors' Statements** ***Competing Interests*** The authors declare no conflict of interest. ***Animal Rights*** The institutional and (inter)national guidelines for the care and use of laboratory animals were followed. See the 'Application of method in pharmacokinetic study' part for details. {#f1-scipharm-2012-80-633} {#f2-scipharm-2012-80-633} {#f3-scipharm-2012-80-633} {#f4-scipharm-2012-80-633} ###### Summary of precision and accuracy from QC samples in wistar rat plasma Drug Spiked concentr. (ng/mL) Within batch (n=6) Between batch (n=3) --------- -------------------------- -------------------- --------------------- ------------------ -------------- ------- ----- CCB 1.6 1.64 ± 0.125 102.2 7.6 1.62 ± 0.139 101.0 8.6 3.9 3.91 ± 0.263 100.2 6.7 3.95 ± 0.271 101.3 6.9 384.5 405.07 ± 21.351 105.3 5.3 399.93 ± 20.331 104.0 5.1 915.5 916.14 ± 56.283 100.1 6.1 921.38 ± 61.516 100.6 6.7 ERT 1.8 1.81 ± 0.179 100.3 9.9 1.85 ± 0.151 102.9 8.2 4.4 4.29 ± 0.285 97.4 6.7 4.45 ± 0.394 101.1 8.9 433.2 403.37 ± 31.347 93.1 7.8 432.34 ± 41.379 99.8 9.6 1031.4 1058.52 ± 44.444 102.6 4.2 1010.71 ± 54.712 98.0 5.4 1.5 1.48 ± 0.149 96.2 10.0 1.5 ± 0.138 97.5 9.2 OSI-420 3.8 3.84 ± 0.308 100.0 8.0 4.02 ± 0.231 104.7 5.7 375.4 387.43 ± 17.18 103.2 4.4 389.71 ± 17.606 103.8 4.5 893.8 930.88 ± 26.121 104.1 2.8 917.36 ± 41.916 102.6 4.6 ###### Extraction recovery in rat plasma (n=6) Drug Concentration (ng/ml) Recovery (%) \% C.V --------- ----------------------- -------------- -------- CCB 3.9 73.7 9.3 384.5 72.7 9.4 915.5 78.7 8.5 ERT 4.4 88.7 7.4 433.2 90.3 6.5 1031.4 86.3 6.4 OSI-420 3.8 93.3 3.4 375.4 94.4 2.3 893.8 92.2 3.3 ###### Stability of analytes in rat plasma (n=6) Drug Nominal concentration (ng/ml) Sample condition --------- ------------------------------- ------------------ ------- ------- ------- ------- ------- ------- ----- ERT 4.4 90.2 7.4 101 5.5 106.3 4.5 100.6 7.5 1031.4 98.6 6.4 100.5 6.7 100.6 9.2 112.7 5.5 OSI-420 3.8 101.7 9.4 107.9 5.4 112.8 4.4 94 8.4 893.8 103.6 4.3 103.2 9.7 109.7 6.5 93.2 6.6 CCB 3.9 96.8 7.2 99.1 2.3 97.5 4.4 105 4.4 915.5 99.2 6.6 98.6 3.5 100 4.6 95.1 7.6 Exposed at ambient temperature (25°C) for 6h; Kept at autosampler temperature (10°C) for 24h; After three freeze-thaw cycles; Stored at −70°C. ###### Pharmacokinetic parameters (Mean ± S.D.) after single-dose oral administration of CCB and ERT simultaneously in Wistar rats Parameters Units CCB ERT OSI-420 (metabolite) -------------- --------- -------------- -------------- ---------------------- C ~max~ μg/ml 1.91 ± 0.2 2.72 ± 0.23 0.48 ± 0.07 AUC ~0--24~ μg.h/ml 13.72 ± 0.67 27.2 ± 3.12 5.57 ± 0.54 AUC ~0--inf~ μg.h/ml 14.94 ± 0.92 31.78 ± 6.44 7.48 ± 1.28 t ~1/2~ h 6.19 ± 0.9 7.94 ± 2.15 11.96 ± 2.01 T ~max~ h 1.08 ± 0.49 2.17 ± 0.98 2 ± 1.1 K ~el~ h-1 0.11 ± 0.02 0.09 ± 0.02 0.06 ± 0.01

\section{Introduction} In this paper we calculate the high energy nonrelativistic asymptotics for the photoionization cross section of the valence electrons of fullerenes $C_N$. We consider the fullerenes which can be treated approximately as having the spherical shape. The photon carries the energy $\omega$ which is much larger than the ionization potential $I$. We find the leading term of the cross section expansion in terms of $1/\omega$. We keep the photon energy to be much smaller than the electron rest energy $mc^2$. Here we consider only the ionization of $s$ states. We employ the relativistic system of units in which $ \hbar=1$; $c=1$ and the squared electron charge $e^2=\alpha=1/137$. The actual potential experienced by the fullerene valence electrons is a multicentered screened Coulomb potential produced by the $C^{+4}$ carbon ions of the fullerene. The ionized electron approaches one of these centers transferring large momentum. The asymptotic of the photoionization cross section $\sigma(\omega)$ in the screened Coulomb field is the same as in the unscreened one \cite{DM}, i.e. $\sigma \sim \omega^{-7/2}$. Thus we expect the observed asymptotic also to be $\sigma \sim \omega^{-7/2}$. However one usually uses a model central potential $V(r)$ for description of the field created by the fullerene. For a model potential the asymptotics may be a different one. We consider spherical fullerene with the radius $R$ and the width of the layer $\Delta\ll R$. The general properties of the potential $V(r)$ are well known--see, e.g. \cite{1}. It is located mostly inside the fullerene layer $R -\Delta/2 \leq r \leq R+\Delta/2$ being negligibly small outside. In the simplest (or even the oversimplified \cite{2}) version it is just the well potential which is constant inside the layer and vanishes outside. Introducing $R_{2,1}=R \pm \Delta/2$ we can present the potential as \begin{equation} V(r)\ =\ -V_0\theta(r-R_1)\Big(1-\theta(r-R_2)\Big); \quad V_0\ >\ 0. \label{1} \end{equation} Recall that $\theta(x)=1$ for $x \geq 0$ while $\theta(x)=0$ for $x<0$. One often uses the Dirac bubble potential \begin{equation} V(r)\ =\ -U_0\delta(r-R), \label{2} \end{equation} in the fullerene studies \cite{3}. Here, as well as in Eqs.(3) and (4) $U_0>0$ are the dimensionless constants. The nowadays calculations are often based on the jellium model \cite{3a} (see, e.g.\cite{3b},\cite{3c}). In this approach the charge of the positive core consisting of nuclei and the internal electrons is assumed to be distributed uniformly in the fullerene layer. The field of the positive core is $V(r)=V_1(r)$ at $0\leq r <R_1$, $V(r)=V_2(r)$ at $R_1\leq r \leq R_2$, and $V(r)=V_3(r)$ at $ r > R_2$ with \begin{equation} V_1(r)\ =\ const=-U_0\frac{3}{2}\frac{R_2^2-R_1^2}{R_2^3-R_1^3} ; \quad V_2(r)=-\frac {U_0}{2(R_2^3-R_1^3)}\Big(3R_2^2-r^2(1+\frac{2R_1^3}{r^3})\Big); \label{2a} \end{equation} $$V_3(r)=-\frac{U_0}{r}.$$ Sometimes model potentials are determined by analytical functions of $r$ with a sharp peak at $r=R$. The Lorentz bubble potential is \begin{equation} V(r) = -\frac{U_0}{\pi}\frac{a}{(r-R)^2+a^2}. \label{3} \end{equation} It describes the Dirac bubble potential at $ a \rightarrow 0$. The Gaussian-type potential \begin{equation} V(r)\ =\ -\frac{V_0}{\pi}\exp{\frac{-(r-R)^2}{a^2}}, \label{4} \end{equation} with $a \approx \Delta \ll R$ was employed in \cite{4}. Strictly speaking our analysis is true for the negative ion $C^{-}_N$. However, since there are many valence electrons in the fullerene shell, we expect it to be true for photoionization of the neutral fullerene $C_N$ as well. As it stands now, the asymptotics for the photoionization cross section is known only for the Dirac bubble potential \cite{5}. Here we demonstrate that the energy behavior of the asymptotic cross section is strongly model dependent. It is determined by the analytical properties of the potential $V(r)$. In Sec. 2 we obtain the general equation for the asymptotics of the photoionization cross section. In Sec.3 we calculate the asymptotics for the potentials mentioned in Introduction. We analyze the results in Sec.4. \section{Asymptotics of the cross section} The photoionization cross section can be presented as (see Eq.(56.3) of \cite{4a} or Eq.(5.76) of \cite{3}) \begin{equation} d\sigma=n_e\frac{mp}{(2\pi)^2}|F|^2d\Omega. \label{5} \end{equation} Here $m$ is the electron mass, $p=|{\bf p}|$, while ${\bf p}$ is the photoelectron momentum, $\Omega$ is the solid angle of the photoelectron, and $n_e$ is the number of electrons in the ionized state. The normalization factor of the photon wave function $n(\omega)=\sqrt{4\pi}/\sqrt{2\omega}$ is included in the photoionization amplitude $F$. Averaging over polarizations of the incoming photon is assumed to be carried out. We consider the photon energy $\omega$ which is much larger than the ionization potential $I$, i.e. $\omega \gg I$. Limiting ourselves by the condition $\omega \ll m$ we can treat the photoelectron in nonrelativistic approximation. The kinetic energy of the photoelectron is $\varepsilon=\omega-I=p^2/2m$. The electron momentum $p$ is much larger than the characteristic momentum $\mu=(2mI)^{1/2}$ of the bound state ($p \gg \mu$). At $\omega \gg I$ the photoionization requires large momentum ${\bf q}={\bf k}-{\bf p}$ to be transferred to the recoil fullerene. Here ${\bf k}$ is the photon momentum, and $k=|{\bf k}|=\omega$. One can see that $k \ll p$ if $I \ll \omega \ll m$ and thus we can put $|{\bf q}|=q=p$. If the electron-photon interaction is written in the velocity form, momentum $q$ is transferred in the initial state in ionization of $s$ states \cite{6}, \cite{3}. Thus the photoelectron can be described by plane wave. Interaction of the photoelectron with the ionized fullerene provides the contributions of the relative order $O(1/p)$ to the amplitude. Hence they contribute to the cross section beyond the asymptotics. The photoionization amplitude can be written as $ F=n(\omega)\int d^3r \psi^*_{\bf p}({\bf r})\gamma\psi(r)$ with $\psi_{\bf p}$ and $\psi$ the wave functions of the photoelectron and the bound electron correspondingly; $\gamma=-i\sqrt{\alpha}{\bf e}\cdot{\bf\nabla}/m$ is the operator of interaction between the photon and electron. In momentum space the amplitude takes the form $$F=\sqrt{\alpha}n(\omega)\int \frac{d^3f}{(2\pi)^3}\psi_{\bf p}({\bf f})\frac{{\bf e}\cdot{\bf f}}{m}\psi({\bf f}-{\bf k}).$$ Since the photoelectron is described by the plane wave, i.e. $\psi_{\bf p}({\bf f})=(2\pi)^3\delta({\bf f}-{\bf p})$, the amplitude of photoionization can be written as \cite{6} \begin{equation} F=N(\omega)\frac{{\bf e}\cdot {\bf p}}{m}\psi(p); \quad N(\omega)=\Big(\frac{4\pi\alpha}{2\omega}\Big)^{1/2}. \label{5a} \end{equation} We replaced $q$ by $p$ in the argument of the Fourier transform of the wave function of the fullerene electron. The latter is $\psi(p)=\int d^3r \psi(r)e^{-i{\bf p}\cdot{\bf r}}$. Now we present the wave function $\psi(p)$ in terms of the Fourier transform of the potential \begin{equation} V(p)=\int d^3r V(r)e^{-i{\bf p}\cdot{\bf r}}=\frac{4\pi}{p}\int _0^{\infty} dr rV(r)\sin{pr}. \label{6} \end{equation} The function $\psi(p)$ can be expressed by the Lippmann--Schwinger equation \cite{3} \begin{equation} \psi=\psi_0+G(\varepsilon_B)V\psi, \label{7} \end{equation} with $G$ the electron propagator of free motion, $\varepsilon_B=-I$ is the energy of the bound state. The matrix element of the propagator is $$ \langle {\bf f}_1|G(\varepsilon_B)|{\bf f}_2\rangle=g(\varepsilon_B, f_1)\delta({\bf f}_1-{\bf f}_2); \quad g(\varepsilon_B, f_1)=\frac{1}{\varepsilon_B-f_1^2/2m}.$$ For a bound state $\psi_0=0$, and thus Eq.(\ref{7}) can be evaluated as $\psi(p)=\langle {\bf p}|GV|\psi\rangle=g(\varepsilon_B, p)J(p)$ with \begin{equation} J(p)=\int\frac{d^3f}{(2\pi)^3}\langle {\bf p}|V|{\bf f}\rangle\langle{\bf f}|\psi\rangle=\int\frac{d^3f}{(2\pi)^3}V({\bf p}-{\bf f})\psi({\bf f}). \label{7a} \end{equation} Putting also $g(\varepsilon_B, p)=-2m/p^2$ we obtain \begin{equation} \psi(p)=-\frac{2m}{p^2}J(p)=-\frac{J(p)}{\omega}. \label{8} \end{equation} The integral $J(p)$ is saturated at $f \sim \mu \ll p$. Thus its dependence on $p$ is determined by that of $V(p)$. Another presentation \begin{equation} J(p)=\int d^3r \psi(r)V(r)e^{-i{\bf p}\cdot{\bf r}}=\frac{4\pi}{p}\int_0^{\infty}dr\chi(r)V(r)\sin{(pr)}; \quad \chi(r)=r\psi(r), \label{7b} \end{equation} can be obtained by the Fourier transformation of the integrand on the right hand side of Eq.(\ref{7a}). We shall demonstrate that the potential can take the form $V(p)=V_1(p)+V_2(p)$ with the two terms corresponding to two fullerene characteristics $R_1$ and $R_2$. In this case $J(p)$ can be presented as \begin{equation} J(p)=V_1(p)\kappa_1+V_2(p)\kappa_2, \label{3xy} \end{equation} where the factors $\kappa_{1,2}$ do not depend on $p$, being determined by the characteristics of the bound state. Thus Eq. (\ref{8}) can be written as \begin{equation} \psi(p)=-\frac{1}{\omega}\Big(V_1(p)\kappa_1+V_2(p)\kappa_2\Big), \label{8N} \end{equation} and Eq.(\ref{5a}) can be presented as \begin{equation} F=-\frac{N(\omega)}{\omega}\frac{{\bf e}\cdot {\bf p}}{m}\sum_{i=1,2}V_i(p)\kappa_i. \label{9} \end{equation} Hence the asymptotics of the photoionization cross section can be expressed through the potential $ V(p)$: \begin{equation} \sigma(\omega)=\frac{4\alpha}{3}\frac{p}{\omega^2}n_e|\sum_iV_i(p)\kappa_i|^2; \quad p=\sqrt{2m\omega}. \label{10} \end{equation} If the potential is determined by analytical function of $R$ and $\Delta$, we have just $J(p)=V(p)\kappa$. It was shown in \cite{DM} that in the simplest case $\kappa=\psi(r=0)$. Thus one can find the asymptotic energy dependence of the photoionization cross section without solving the wave equation. \section{Asymptotics for the model potentials} Start with the well potential defined by Eq.(1). Employing Eq.(\ref{7b}) we find immediately \begin{equation} \psi(p)=-\frac{4\pi V_0R}{\omega p^2}\lambda; \quad \lambda=\cos{(pR_2)}\psi(R_2)-\cos{(pR_1)}\psi(R_1). \label{39} \end{equation} Here we neglected the terms of the order $\Delta/R \ll 1$. The parameter $\lambda$ can be expressed in terms of the fullerene characteristics $R$ and $\Delta$. Note that the function $\psi(r)$ varies noticeably inside the fullerene layer $\Delta$. Hence the difference $\psi(R_2)-\psi(R_1)$ is not small. The photoionization cross section is thus \begin{equation} \sigma=\frac{2^6\alpha\pi^2}{3}\frac{V_0^2R^2}{\omega^2 p^3}n_e\lambda^2. \label{39a} \end{equation} It drops as $\omega^{-7/2}$. For the Dirac bubble potential given by Eq.(2) we obtain employing Eq.(\ref{7b}) \begin{equation} \psi(p)=\frac{4\pi U_0R}{\omega p}\sin{(pR)}\psi(R), \label{50} \end{equation} Thus the cross section is \begin{equation} \sigma=\frac{2^6\alpha\pi^2}{3}\frac{U_0^2R^2}{\omega^2p}\sin^2{(pR)}n_e\psi^2(R); \quad p^2=2m\omega, \label{50} \end{equation} dropping as $\omega^{-5/2}$. This is just the result obtained in \cite{5} by solving the wave equation. Both Dirac bubble and well potentials have singularities on the real axis. However, the wave functions exhibit different behavior at the singular points. This leads to different high energy behavior in these cases. The wave function corresponding to the Dirac bubble potential is continuous at $r=R$ while its first derivative suffers a jump at this point. This can be demonstrated by integration the wave equation \begin{equation} \chi^{(2)}(r)=2mV(r)\chi(r)-2m\varepsilon_B\chi(r), \label{50n} \end{equation} with $V(r)$ determined by Eq.(\ref{2}) over the small interval $R^{-} \leq r \leq R^{+}$ with $R^{\pm}=R\pm\delta, \delta \rightarrow 0$. The wave function of the bound electron in momentum representation can be expressed in terms of these jumps. After two integrations by parts of the expression $$\psi(p)=\frac{4\pi}{p}\int_0^{\infty}dr\sin{(pr)}\chi(r),$$ we find for the Dirac bubble potential \begin{equation} \psi(p)=\frac{4\pi}{p^3}R\sin{(pR)}[\psi'(R^{-})-\psi'(R^{+})] \label{51} \end{equation} $$-\frac{4\pi}{p^3}\Big[\int_0^{R^{-}}dr\sin{pr}\chi^{(2)}(r)+\int_{R^{+}}^{\infty}dr\sin{pr}\chi^{(2)}(r)\Big]$$ Further integration by parts of the second term demonstrates that it is about $1/p$ times the first one. Hence the leading contribution is provided by the first term and the Fourier transform of the function $\psi(r)$ is determined by the jump of the first derivative. This leads to the $\omega^{-5/2}$ law for the cross section. In the case of the well potential one can present the function $\psi(p)$ in similar form, but with two singular points $r=R_{2,1}=R\pm\Delta/2$. The first derivatives $\psi'(r)$ are continuous at these points while the second derivatives experience jumps \cite{Sh}. After three integrations by parts we find $$\psi(p)=-\frac{4\pi}{p^4}\sum_{i=1,2}R_i\cos{(pR_i)}\delta\psi^{(2)}(R_i)$$ where $\delta\psi^{(2)}(R_i)=\psi^{(2)}(R_i+\delta)-\psi^{(2)}(R_i-\delta)$ are the jumps of the second derivative $\psi^{(2)}(R_i)$. Thus the asymptotic wave function in the field of the well potential is $1/p$ times that in the Dirac bubble potential. This provides additional small factor of the order $1/\omega$ in the photoionization cross section given by Eq.(\ref{39a})compared with that for the Dirac bubble potential presented by Eq.(20). The potential $V(r)$ for the jellium model given by Eq.(\ref{2a}) is continuous at the real axis as well as its derivative $V'(r)$. One can see that $V_1(R_1)=V_2(R_1)$ and $V_2(R_2)=V_3(R_2)$. Also $V_1'(R_1)=V_2'(R_1)$, $V_2'(R_2)=V_3'(R_2)$. The second derivative $V^{(2)}(r)$ experiences jumps at $r=R_{1,2}$. Employing Eq.(\ref{7b}) we find after three integrations by parts \begin{equation} \psi(p)=\frac{4\pi}{\omega p^4}\lambda; \quad \lambda=\sum_{i=1,2}R_i\cos{(pR_i)}\psi(R_i)\delta V^{(2)}(R_i); \quad \delta V^{(2)}(R_i)=V^{(2)}(R_i^{+})-V^{(2)}(R_i^{-}). \end{equation} Note that the second derivatives $\psi^{(2)}(r)$ are continuous at $r=R_{1,2}$. This can be seen from the wave equation (21). The cross section is \begin{equation} \sigma=\frac{64\alpha \pi^2}{3\omega^2p^7}n_e\lambda^2. \label{58} \end{equation} It drops as $\omega^{-11/2}$. Turn now to the Lorentz bubble potential determined by Eq.(\ref{3}) with $a \ll R$. Employing Eq.(\ref{6}) and changing the variable of integration $x=r-R$ we present the Fourier transform of the potential as $$V(p)=V_A(p)+V_B(p); \quad V_{A,B}=-4\frac{a}{p}X_{A,B},$$ with \begin{equation} X_A(p)=U_0(-\frac{\partial}{\partial p})\cos{(pR)}\int_{-\infty}^{\infty}dx\cos{(px)}u(x); \label{18} \end{equation} $$X_B(p)=U_0\frac{\partial}{\partial p}\int_{R}^{\infty}dx\cos{((p(x-R))}u(x) \quad u(x)=\frac{1}{x^2+a^2}.$$ Note that $X_A(p)$ is determined by $r$ close to $R$, i.e. by $|R-r|\sim a$. Introducing $r'=x-R$ one can write the second equality as $$X_B(p)=-U_0\int_{0}^{\infty}dr'r'\sin{(pr')}u(R+r').$$ It is dominated by small $r' \sim 1/p$. Since the potential $V_A$ is determined by the space region where the electron density reaches it largest values, we expect it to be the most important one. Neglecting for a while the contribution of $V_B$ we find in the lowest order of expansion in powers of $a/R$ \begin{equation} X_A(p)=\pi \frac{U_0R}{a}e^{-pa}\sin{pR}; \quad V(p)=-4\pi \frac{U_0R}{p}e^{-pa}\sin{pR}. \label{64} \end{equation} We calculate the function $\psi(p)$ by employing Eqs.(\ref{7a}) and (\ref{8}). The potential $V(v)=-4\pi U_0Re^{-va}\sin{(vR)}/v$, with $v=|{\bf p}-{\bf f}|$ can not be expanded in powers of $f$. Note, however that it is sufficient to put $v=p-{\bf p}\cdot{\bf f}/p$ for calculation of the asymptotics of the wave function. Thus we obtain \begin{equation} \psi(p)=4\frac{\pi U_0R}{\omega}\int\frac{d^3f}{(2\pi)^3}\frac{e^{-va}}{v}[\sin {(pR)}\cos{(ftR)}-\cos{(pR)}\sin{(ftR)}]\psi(f); \quad t={\bf p}\cdot{\bf f}/pf. \label{67} \end{equation} Due to the factor in the square brackets the integral over $f$ on the right hand side of Eq.(\ref{67}) is saturated by small $|ft| \sim 1/R \ll 1/a$. This enables to put $v=p$ and $e^{-(p-ft)a}=e^{-pa}$ in the integrand. Since the wave function $\psi(f)$ does not depend on the angular variables, we find immediately \begin{equation} \psi(p)=4\frac{\pi U_0R}{\omega p}e^{-pa}\sin {(pR)}A; \quad A=\frac{4\pi}{R}\int_0^{\infty}\frac{dff}{(2\pi)^3}\sin{(fR)}\psi(f). \label{68} \end{equation} Noting that $A=\psi(R)$, we obtain \begin{equation} \psi(p)=4\frac{\pi U_0R}{\omega p}e^{-pa}\sin {(pR)}\psi(R). \label{69} \end{equation} The cross section \begin{equation} \sigma_A=\frac{64}{3}\frac{\alpha\pi^2U_0^2R^2}{\omega^2p}e^{-2pa}\sin^2{(pR)}n_e\psi^2(R), \label{72} \end{equation} differs from that for the Dirac bubble potential given by Eq.(\ref{50}) by the exponential factor $e^{-2pa}$. Note that the latter is caused by the poles $r=R \pm ia$ of the potential (\ref{3}) in the complex plane. The lowest term of the asymptotic expansion of the function $X_B(p)$ \cite{7} provides the potential $$ V_B(p)=\frac{16U_0a}{p(pR)^3}.$$ From the formal point of view, the corresponding cross section \begin{equation} \sigma_B=\frac{2^{10}\alpha}{3}\frac{U_0^2a^2}{R^6}\frac{\psi^2(r=0)}{\omega^2p^7}, \label{71} \end{equation} dropping as $\omega^{-11/2}$ is the true asymptotics of the photoionization cross section. However, e.g., at characteristic values $R=6 $a.u, $a=\Delta=1$ a.u. the cross section determined by Eq.(\ref{71}) becomes comparable with that determined by Eq.(\ref{72}) only at the photoelectron energies $\varepsilon \geq $ 5 keV. At these energies both cross sections $\sigma_A$ and $\sigma_B$ are more than $10^8$ times smaller than the cross section $\sigma_A$ at $\varepsilon =100$ eV. They have no chances to be observed. Thus only the cross section $\sigma_A$ is of physical interest. Similar analysis can be carried out for the Gaussian-type potential given by Eq.(\ref{4}). Now $V(p)=V_A(p)+V_B(p)$ with $V_{A,B}(p)=-4V_0X_{A,B}(p)/p$. The functions $X_A(p)$ and $X_B(p)$ are given by Eq.(\ref{18}) with $u(x)=e^{-x^2/a^2}$ and $U_0=1$. The observable cross section \begin{equation} \sigma=\frac{64\alpha \pi}{3}\frac{V_0^2R^2a^2}{\omega^2p}e^{-p^2a^2/2}\sin^2{(pR)}n_e\psi^2(R), \label{78} \end{equation} is determined by the potential $V_A$. The Gaussian drop changes to the power behavior $\sigma (\omega) \sim \omega^{-11/2}$ at the photoelectron energies of about $3$ keV. Here the cross section is too small to be detected. \section{Summary} We found that the high energy behavior of the photoionization cross section of fullerenes depends on the form of the function $V(r)$ which is chosen for approximation of the fullerene field. We expressed the asymptotic cross section in terms of the Fourier transform $V(p)$ of the potential $V(r)$ without solving the wave equation. The shape of the function $V(p)$ at large $p$ is known to be determined by the analytical properties of the function $V(r)$ \cite{8}. Thus the latter determine the shape of the asymptotic cross section as well. The three potentials presented by Eqs.(\ref{1})-(\ref{2a})have singularities on the real axis. In each case the cross section exhibits a power drop. The cross section decreases as $\omega^{-5/2}$ in the Dirac bubble potential which turnes to infinity at $r=R$. It behaves as $\omega^{-7/2}$ in the well potential with the finite jumps of $V(r)$. The potential of jellium model is more smooth, and only the second derivatives $V^{(2)}(r)$ experience jumps. In this model the cross section drops as $\omega^{-11/2}$. The Lorentz bubble potential given by Eq.(\ref{3}) has poles in the complex plane. In this case the observable cross section exhibits exponential drop $e^{-2pa}$. The Gaussian type potential determined by Eq.(\ref{4}) with the essential singularity in the complex plane provides Gaussian drop of the photoionization cross section. In both cases these fast drops change to a slower power drop $\omega^{-11/2}$. However this takes place at the energies of several keV where the cross sections become unobservably small.

Introduction {#sec1-1} ============ Plasma exchange (PE) has been successfully tried and recommended for various postpartum microangiopathies such as postpartum hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and HELLP syndrome as per the latest American Society for Apheresis (ASFA) guidelines.\[[@ref1]\] Pregnancy being a hypercoagulable state is prone to the acute episodes of hemolytic anemia, thrombocytopenia, and acute renal failure.\[[@ref2]\] Since laboratory profile of thrombotic microangiopathies is overlapping, hence it poses a great challenge to distinctly label the definite diagnosis in a particular patient. Furthermore, these conditions are associated with high perinatal or maternal morbidity and mortality\[[@ref3]\] demanding early diagnosis and prompt treatment to improve the outcome. Here, we present our experience of PE in patients of postpartum HUS and HELLP syndrome referred to us from the department of Obstetrics and Gynaecology in our institute. Materials and Methods {#sec1-2} ===================== We did a retrospective analysis of our PE records over a period of 1 year (2015--2016) during which five cases of suspected postpartum HUS and four cases of HELLP syndrome (based on their laboratory and clinical profile) were referred to the department of Transfusion Medicine from the department of Obstetrics and Gynaecology of our tertiary care institute. These cases were referred to our institute from the peripheral regional health-care settings. Plasma exchange intervention {#sec2-1} ---------------------------- PE procedures were performed on cell separator Cobe® Spectra (Terumo BCT, Lakewood, Colorado, USA) after priming the disposable kit with group-specific, crossmatched packed red blood cells due to low hemoglobin (\<8 g/dl) of the patients. The replacement fluid used was fresh frozen plasma with a negative balance of 10% to prevent cardiac overload in the patients as these patients were oliguric or anuric. Procedures were done on daily (*n* = 3) or on alternate days (*n* = 6) depending on the clinical condition and hemodialysis requirements of the patients. Ionized calcium was monitored before the start of the procedure, and calcium infusion (1%) was given throughout the procedure. Preprocedure hematological, renal, and liver functions were noted, and these parameters were followed after each PE procedure for analyzing the response to the therapy. Patients were followed telephonically even after their discharge from the hospital. Results {#sec1-3} ======= Patient characteristics of suspected postpartum hemolytic uremic syndrome patients {#sec2-2} ---------------------------------------------------------------------------------- Of the five HUS patients, four were primigravida and one was multigravida. The age of patients ranged from 23 to 30 years. The details of antenatal and delivery outcome of these patients are shown in [Table 1](#T1){ref-type="table"}. The onset of clinical features suggestive of HUS was observed on day 2 in Cases I, II, and V and day 5 postabortion in Case III, and in Case IV, it was postpartum day 7. Patients were referred immediately to our institute with features of oliguria and thrombocytopenia. ###### Clinical profile of patients suspected of postpartum hemolytic uremic syndrome Features Case I Case II Case III Case IV Case V ---------------------------------------------------------------- ------------------------------------------ ------------------------------------------------------------------- ----------------------------------------- -------------------------------------------------- ---------------------------------------------------------- Age (years) 30 24 30 27 23 Gravida Primi Primi Multi (G6P4A1L4) Primi Primi Mode of delivery Term, Emg LSCS Term, LSCS Abortion at 28 Weeks Term, LSCS Term, LSCS Status of baby Alive and healthy Alive and healthy NA Alive and healthy Alive and healthy Antenatal period Uneventful Uneventful Uneventful Uneventful Uneventful Onset of clinical signs and symptoms (postpartum/postabortion) Day 2 Day 2 Day 5 Day 7 Day 2 Time between illness onset and PE 4 days 3 days 2 days 3 days 2 days Presenting clinical features Pedal and facial edema, low urine output low urine output, bleeding from the urethra and ET tube, Jaundice Generalized edema with low renal output Clinical pallor with edema over the face and leg Pallor, edema over the face and leg and low renal output Hemodialysis (number of procedures) 2 ND ND 3 8 Length of hospital stay (days) 20 10 7 14 19 LSCS=Lower segment caesarean section, ET=Endotracheal tube, ND=Not done, PE=Plasma exchange Response to plasma exchange therapy and outcome of suspected hemolytic uremic syndrome patients {#sec2-3} ----------------------------------------------------------------------------------------------- All patients showed improvement in their hematological and renal profile after PE, as shown in [Table 2](#T2){ref-type="table"}. However, only two patients (Case I and Case V) survived on follow-up. One patient (Case II) showed improvement in her biochemical and renal profile; however, she left the hospital against medical advice and on telephonic follow-up found to be expired. Another patient (Case III) underwent two PE procedures, but the patient expired after the second therapeutic plasma exchange (TPE) procedure due to septicemic shock as the patient left the hospital against medical advice. Case IV improved and was discharged; however, on follow up, the patient was found to be expired in a local hospital after getting some treatment for complaints of pain abdomen 1 week after discharge from the hospital. ###### Pre- and post-plasma exchange pattern of laboratory (hematological and renal) profile of the patients Laboratory profile of suspected postpartum hemolytic uremic syndrome patients ------------------------------------------------------------------------------- ---- ---- ----- ----- -------- ------- ------ ------ --- ----- ------- ------- -------- -------- ----- ----- --------- Case I (4) 92 99 46 440 47.58 14.95 1.6 0.5 5 Nil 31.06 18.56 442 530.40 0.1 1 Alive Case II (4) 69 76 80 61 169.30 16.03 1.3 0.3 6 Nil 40.70 28.56 362.44 335.92 0.1 0.2 Expired Case III (2) 82 73 101 138 20.04 13.68 1.26 1.06 4 2 27.49 56.05 238.68 423.44 0.1 0.3 Expired Case IV (5) 66 70 63 96 71.74 35.35 1.41 1.5 9 1 83.18 10.35 689.52 221 1 1.5 Expired Case V (2) 74 82 209 58 22.26 15.88 1.2 1.1 4 2 29.27 22.13 309.40 185.64 0.5 1 Alive PE=Plasma exchange Patient characteristics of suspected HELLP syndrome {#sec2-4} --------------------------------------------------- Of four patients with HELLP syndrome, two were primigravida and the other two were multigravida. The age of patients ranged from 20 to 30 years. The details of antenatal and delivery outcome of these patients are shown in [Table 3](#T3){ref-type="table"}. HELLP syndrome was diagnosed in three of these patients during antenatal period, and one patient had uneventful history during antenatal phase. Patients were referred to our institute with complaints of oliguria, thrombocytopenia, and elevated liver enzymes within 1--5 days of the onset of these clinical signs and symptoms. ###### Clinical profile of patients suspected of HELLP Features Case I Case II Case III Case IV ---------------------------------------------------------------- ---------------------------------- ---------------------------------- ------------------------------------ ------------------------------------------------------------- Age (years) 20 25 30 28 Gravida Primi Multi G3P2002 Primi Multi Mode of delivery NVD for IUFD NVD breech at home LSCS NVD Status of baby Stillbirth Alive Alive Stillbirth Antenatal period hypertension uneventful hypertension in the last trimester hypertension Onset of clinical signs and symptoms (postpartum/postabortion) Day 1 Day 5 Day 5 Day 1 Time between illness onset and PE 6 days 0 day 2 days 7 days Presenting clinical features Oliguria, facial and pedal edema Oliguria, facial and pedal edema Ascites, anuria, pedal edema Increased bilirubin, swelling over the face and pedal edema Hemodialysis (number of procedures) 5 3 Nil 10 Length of hospital stay (days) 21 6 12 31 NVD=Normal vaginal delivery, LSCS=Lower segment caesarean section, IUFD=Intra uterine fetal death, PE=Plasma exchange Liver transaminases (aspartate transaminase and alanine transaminase) were grossly deranged in these patients, whereas they were normal in suspected HUS patients. The details of laboratory profile of all patients are summarized in [Table 4](#T4){ref-type="table"}. ###### Pre- and post-plasma exchange pattern of laboratory (hematological and renal) profile of suspected HELLP patients Laboratory profile of suspected HELLP syndrome patients --------------------------------------------------------- ----- ----- ----- ----- ------- ------- ----- ----- --- ----- ------- ------- -------- -------- ------ ------ ------------------------------ Case I (3) 84 81 117 220 66.62 23.13 0.7 0.3 4 2 31.06 29.06 406.64 495.04 0 1.2 Alive with 88.40 creatinine Case II (2) 78 129 36 63 20.79 23.28 14 8.0 6 Nil 44.98 41.77 426.60 397.80 0.15 0.19 Expired Case III (5) 96 63 65 173 33.97 10.25 8.4 2.0 4 2 64.97 21.42 362.44 134.37 1.2 1.2 Alive with creatinine 97.24 Case IV (3) 112 76 59 279 40.10 23.85 4.0 2.4 9 1 67.83 14.64 545.43 265.20 0 0.6 Alive with creatinine 265.20 PE=Plasma exchange Response to plasma exchange therapy and outcome of suspected HELLP patients {#sec2-5} --------------------------------------------------------------------------- PE was initiated in all of these patients within 7 days of the onset of illness. Three patients were on alternate-day hemodialysis. Of four patients, three had oliguria and one had normal urine output. After PE therapy, urine output and other renal function parameters \[[Table 4](#T4){ref-type="table"}\] improved in the oliguric patients, however, one patient (Case IV) expired due to pulmonary aspiration. Discussion {#sec1-4} ========== Pregnancy is a state of increased prothrombotic activity because of increased concentration of procoagulants, decreased fibrinolytic activity, loss of thrombomodulin, and decreased activity of ADAMTS13 level.\[[@ref4]\] Activation of alternate pathway by systemic infection, hemorrhage, and inflammation along with predisposition due to various mutations in complement pathway regulators results in complement dysregulation.\[[@ref5]\] This dysregulation or loss of this effective control of complement activation results in signs and symptoms of HUS in pregnancy.\[[@ref6]\] Literature supports that pregnancy is a precipitating event for TTP/HUS in women with congenital TTP-HUS who present with the first episode during their first pregnancy associated with the early appearance of signs and symptoms such as severe pallor, oliguria, and renal failure. Four of five patients in our study were primigravida, and all of them presented with low urine output within 1 week of delivery. There was no family history as well as past history of similar illness in these patients. One of them was a multigravida, who developed signs/symptoms of HUS after abortion at 28 weeks most probably due to sepsis following a severe postpartum hemorrhage. The early onset of postpartum HUS has been reported in the age group of 27 ± 6 years,\[[@ref5]\] and our patients were in the range of 23--30 years with the early onset of HUS in postpartum period which is comparable to the study by Shrivastava *et al*. and Wessel *et al*.\[[@ref7][@ref8]\] Since these patients were referred from community health-care centers to our tertiary care center, due to renal insufficiency in postpartum period, hence HUS was considered as provisional diagnosis. PE therapy was started without delay in these patients without waiting for ADAMTS13 inhibitor and complement-level estimation as these tests are not routinely done in our center, and samples are to be sent to the reference laboratories. The early initiation of PE therapy is also supported by the current ASFA guidelines\[[@ref1]\] for TTP-HUS on empirical basis. Since patients went into sepsis due to poor postpartum care so, only 2 of 5 (40%) patients could survive even after extensive PE therapy and alternate hemodialysis despite an early referral. Whereas, in a study by Shrivastava *et al*.,\[[@ref7]\]2 patients of 3 were doing well in their follow-up. Due to high mortality reported with postpartum HUS, it is important for the obstetricians to be aware and consider urgent initiation of PEs in addition to hemodialysis in cases of postpartum/abortion females presenting with acute renal failure and anemia with thrombocytopenia by timely referral or bedside initiation of PE to decrease the mortality associated with the disease. Another complication of pregnancy is HELLP syndrome that presents mostly in the last trimester of pregnancy or in postpartum period in some cases. The exact pathogenesis is not clear, but endothelial dysfunction and inflammatory response may contribute to thrombotic microangiopathy in HELLP. The condition is characterized by signs and symptoms of preeclampsia such as hypertension and proteinuria. All our patients suspected of HELLP had evidence of antenatal hypertension in the last trimester of pregnancy. The coagulation profile and liver functions tests were highly deranged in patients of HELLP syndrome.\[[@ref9]\] The definite treatment for HELLP is to terminate the pregnancy by LSCS, but if the condition is not improving even after delivery, PE is considered in these patients as PE removes circulatory protein-bound platelet aggregates and procoagulant factors released from platelets and endothelial cells. Studies have shown increased maternal mortality and very poor neonatal outcome born to a mother with HELLP syndrome\[[@ref10]\] as observed in our study with stillbirth in 2 of 4 HELLP patients; however, after PE, three of four patients of HELLP survived in our study which further emphasizes the need of urgent initiation of PE procedures on a daily basis. Conclusion {#sec1-5} ========== Thus, increased morbidity and mortality burden of pregnancy-induced microangiopathies can be decreased through the early detection of clinical signs and symptoms in pregnancy/postpartum and timely initiation of PE therapy along with improvement of maternal and child health-care facilities in peripheral health settings in India. Financial support and sponsorship {#sec2-6} --------------------------------- Nil. Conflicts of interest {#sec2-7} --------------------- There are no conflicts of interest.

\section*{Acknowledgments} The operation and installation of the Latin American Giant Observatory would not have been possible without the continuous technical and financial support of the following institutions, agencies and organizations, to whom we are most grateful: \begin{sloppypar} Comisi\'on Nacional de Energ\'{\i}a At\'omica (CNEA), Agencia Nacional de Promoci\'on Cient\'{\i}fica y Tecnol\'ogica (ANPCyT), Consejo Nacional de Investigaciones Cient\'{\i}ficas y T\'ecnicas (CONICET), Fondo para la Investigación Cient\'ifica y Tecnol\'ogica (FonCyT), Ministerio de Ciencia, Tecnología e Innovación Productiva (MinCyT), Universidad Nacional de Cuyo (UnCuyo), Universidad Nacional de Buenos Aires (UBA), Centro At\'omico Bariloche (CAB), Instituto Balseiro (IB), Instituto Ant\'artico Argentina (IAA), Instituto de Astronom\'ia y F\'isica del Espacio, (IAFE), Argentina; Ministerio de Defensa de Argentina, Grant PIDDEF 2014-2017 (8); Universidad Mayor de San Andr\'es (UMSA), Bolivia; Universidade Estadual de Campinas, Universidade Federal de Campina Grande (UFCG), Brasil; Vicerrector\'ia de Investigaci\'on y Extensi\'on de la Universidad Industrial de Santander, Departamento Administrativo de Ciencia, Tecnolog\'ia e Innovaci\'on (COLCIENCIAS), Universidad de Nariño, Colombia; Universidad San Francisco de Quito (USFQ), Escuela Polit\'ecnica Nacional (EPN), Escuela Superior Polit\'ecnica de Chimborazo, Fundación CEDIA, Red CEDIA, Grant: CEPRAIX-2015-4-Astropartículas, Ecuador; Consejo Nacional de Ciencia y Tecnolog\'ia (CONACYT), Grants 194547, 105666, Red de Física de Altas Energías (FAE), Benemérita Universidad Aut\'onoma de Puebla (BUAP), Instituto Nacional de Astrof\'isica, \'Optica y Electr\'onica (INAOE), Universidad Aut\'onoma de Chiapas (UNACH) Universidad Michoacana de San Nicol\'as de Hidalgo (UMSNH), Universidad Polit\'ecnica de Pachuca (UPP), Mexico; Universidad de San Carlos, Guatemala; Comisi\'on Nacional de Investigaci\'on y Desarrollo Aeroespacial (CONIDA), Instituto Geofísico del Per\'u (IGP), Consejo Nacional de Ciencia, Tecnolog\'ia e Innovaci\'on Tecnol\'ogica (CONCYTEC), Fondo para la Innovaci\'on, Ciencia y Tecnolog\'ia (FINCyT), Universidad San Antonio Abad del Cusco, Per\'u; Centro de Investigaciones Energ\'eticas, Medioambientales y Tecnol\'ogicas (CIEMAT), Spain; Consejo de Desarrollo Cient\'ifico y Human\'istico, Tecnol\'ogico y de las Artes (CDCHTA) la Universidad de los Andes, Consejo de Desarrollo Cient\'ifico y Human\'istico, Tecnol\'ogico y de las Artes (CDCHTA) de la Universidad Central de Venezuela, Fondo Nacional de Ciencia Tecnolog\'ia e Innovaci\'on (FONACIT), Universidad Central de Venezuela (UCV), Universidad de Los Andes (ULA), Universidad Sim\'on Bol\'ivar, Telef\'erico de M\'erida, grants CDCH-UCV PG-03-8808-2013/1, CDCHTA-ULA C-1949-15-05-EM, CDCHT-ULA C-1598-08-05-A, Venezuela; Pierre Auger Observatory, Centro Latinoamericano de F\'isica (CLAF), Fondo Regional para la Innovaci\'on Digital en Am\'erica Latina y el Caribe (FRIDA), International Centre for Theoretical Physics (ICTP). \end{sloppypar} \chapter[\texorpdfstring{\color{darkblue}#1}{#1}]{#1} \vfil \begin{center}\includegraphics[height=7cm]{collab}\end{center} \vfil \clearpage } \addtolength{\cftparskip}{6pt} \pagestyle{plain} \begin{document} \begin{center} \def0.153{0.153} \includegraphics[height=0.153\textwidth]{icrc2015_logo}% \hfill% \includegraphics[height=0.153\textwidth]{lago-logo-90}% \end{center} \begin{center} \Large\bf Latin American Giant Observatory: Contributions to the 34th International Cosmic Ray Conference (ICRC 2015) \end{center} \begin{center} \par\noindent {\bf\large LAGO Collaboration} \end{center} \begin{sloppypar}\noindent \input{autores} \end{sloppypar} \vspace{1ex} \begin{center} \rule{0.1\columnwidth}{0.5pt} \raisebox{-0.4ex}{\scriptsize$\bullet$} \rule{0.1\columnwidth}{0.5pt} \end{center} \vspace{1ex} \begin{sloppypar}\noindent \input{Afiliaciones} \end{sloppypar} \clearpage \section*{Acknowledgments} \input{Agradecimientos.tex} \newpage \tableofcontents \addChapter{Latin American Giant Observatory Project} \addPaper{lago-principal.pdf}{H. Asorey and S. Dasso, for the LAGO Collaboration}{LAGO: the Latin American Giant Observatory} \addPaper{sidelnik-lago.pdf}{I. Sidelnik, for the LAGO Collaboration}{The Sites for the Latin American Giant Observatory} \addChapter{Data Science } \addPaper{LAGODataICRC2015.pdf}{H. Asorey, D. Cazar-Ram\'irez, R. Mayo-Garc\'ia, L. A. N\'u\~nez, M. Rodr\'iguez-Pascual, L.A. Torres-Ni\~no, for the LAGO Collaboration}{Data Accessibility, Reproducibility and Trustworthiness with LAGO Data Repository} \addChapter{Space Weather} \addPaper{Sarmiento-lago-space-weather.pdf}{H. Asorey, S. Dasso, L. A. N\'u\~nez, Y. Per\'ez, C. Sarmiento-Cano, M. Su\'arez Dur\'an, for The LAGO Collaboration}{The LAGO Space Weather Program: Directional Geomagnetic Effects, Background Fluence Calculations and Multi-Spectral Data Analysis} \addPaper{LAGO-ICRC-Ecuador.pdf}{Stephany Vargas, Cristina Mantilla, Oscar Mart\'inez, Nicol\'as V\'asquez and Dennis Cazar, for the LAGO Collaboration}{LAGO Ecuador, Implementing a set of WCD detectors for Space Weather research: first results and further developments} \addPaper{Daso-icrc_lago_ant.pdf}{S. Dasso, A. M. Gulisano, J. J. Mas\'ias-Meza and H. Asorey, for the LAGO Collaboration f}{A Project to Install Water-Cherenkov Detectors in the Antarctic Peninsula as part of the LAGO Detection Network} \addChapter{High Energy Astrophysics} \addPaper{Background-Chacaltaya-Sarmiento.pdf}{H. Asorey, P. Miranda, A. N\'u\~nez-Casti\~neyra, L. A. N\'u\~nez, J. Salinas, C. Sarmiento-Cano, R. Ticona, A. Velarde, for the LAGO Collaboration}{Analysis of Background Cosmic Ray Rate in the 2010-2012 Period from the LAGO-Chacaltaya Detectors} \addPaper{Otiniano-LAGOinPeru.pdf}{L Otiniano, S Vargas, F Quispe, W Guevara, for the LAGO Collaboration}{Development of a High Altitude LAGO Site in Per\'u} \addPaper{Calibracion-LAGO.pdf}{A. Galindo, E. Moron, E. Carrasco, I. Torresa, A. Carrami\~nana, for the LAGO Collaboration}{Calibration of Large Water-Cherenkov Detector at the Sierra Negra site of LAGO} \end{document}

During a 2-week period in August 2011, two patients in a long-term care facility in Miami-Dade County, Florida, had gastrointestinal symptoms; microscopic examination of stool specimens showed that both harbored *Strongyloides stercoralis*, an intestinal nematode. A subsequent chart review revealed an additional case within the facility 1 year earlier. Concerned about the possibility of an outbreak, the associate director of patient care services at the facility contacted the Florida Department of Health in Miami-Dade County and the Florida State Department of Health, which contacted CDC. This report describes the subsequent investigation. In May 2012, a serologic and risk-factor survey of residents and staff was performed to assess the prevalence of and associations with infection. *Strongyloides* informational packets were distributed to all residents and staff members, and consent for serologic testing was obtained. In June, blood samples from consenting residents and staff members were tested for *S. stercoralis*--specific antibody testing by crude antigen enzyme-linked immunosorbent assay. This serologic test becomes positive after infection (how long after infection is not well defined), and antibody titers typically drop to \<50% by 6--18 months after successful treatment of the parasite. In a convenience sample of 106 of the 176 facility residents, 12 (11%) had a positive result, as did three from a convenience sample of 26 of the 238 staff members. All 15 persons with positive results reported being born either in North America (five) or the West Indies (10). Thirty-seven long-term care facility residents in the convenience sample were born in the United States or Mexico, and four (10.8%) had results positive for *S. stercoralis*-specific antibody; only one of these persons reported no travel outside of the United States. Six long-term care facility residents reported corticosteroid use in the last 3 months, and none were infected. Because no prior testing had been performed, assessing whether any of the infections had been acquired within the facility was not possible. Recommendations were made to offer testing and treatment to the residents and staff members who had not yet been approached and to extend this offer to incoming residents. Further research is needed to determine the prevalence of *Strongyloides* infection and the risk for transmission to help inform screening strategies for long-term care facilities.

\section{Introduction} In recent days random walks in dynamic random environment have been studied by several authors. Motivation comes among others from non-equilibrium statistical mechanics -derivation of Fourier law- \cite{DOLGOPYAT:LIVERANI:08} and large deviation theory \cite{RASSOULAGHA:SAPPALAINEN:11}. In principle random walk in dynamic random environment contains as a particular case random walk in static random environment. However, mostly, in turning to dynamic environments, authors concentrate more on environments with sufficient mixing properties. In that case the fact that the environment is dynamic helps to obtain self-averaging properties that ensure standard limiting behavior of the walk, i.e., law of large numbers and central limit theorem. In the study of the limiting behavior of the walker, the environment process, i.e., the environment as seen from the position of the walker plays a crucial role. See also \cite{JOSEPH:RASSOULAGHA:10}, \cite{RASSOULAGHA:03} for the use of the environment process in related context. In a translation invariant setting the environment process is a Markov process and its ergodic properties fully determine corresponding ergodic properties of the walk, since the position of the walker equals an additive function of the environment process plus a controllable martingale. The main theme of this paper is precisely the study of the following natural question: if the environment is uniquely ergodic, with a sufficient speed of mixing, then the environment process shares similar properties. In several works (\cite{BOLDREGHINI:IGNATYUK:92}, \cite{BOLDREGHINI:MINLOS:07}, \cite{AVENA:DENHOLLANDER:REDIG:11}) this transfer of ``good properties of the environment'' to ``similar properties of the environment process'' is made via a perturbative argument, and therefore holds only in a regime where the environment and the walker are weakly coupled. An exception is \cite{DOLGOPYAT:LIVERANI:09} in the case of an environment consisting of independent Markov processes. In this paper we consider the context of general Markovian uniquely ergodic environments, which are such that the semigroup contracts at a minimal speed in norm of variation type. Examples of such environments include interacting particle systems in ``the $M<\epsilon$ regime'' \cite{LIGGETT:05} and weakly interacting diffusion processes on a compact manifold. Our conditions on the environment are formulated in the language of coupling. More precisely, we impose that for the environment there exists a coupling such that the distance between every pair of initial configurations in this coupling decays fast enough so that multiplied with $t^d$ it is still integrable in time. As a result we then obtain that for the environment process there exists a coupling such that the distance between every pair of initial configurations in this coupling decays at a speed which is at least integrable in time. In fact we show more, namely in going from the environment to the environment process we essentially loose a factor $t^d$. E.g., if for the environment there is a coupling where the distance decays exponentially, then the same holds for the environment process (with possibly another rate). Once we have controllable coupling properties of the environment process, we can draw strong conclusions for the position of the walker. More precisely, we prove a law of large numbers with an asymptotic speed that depends continuously on the rates, and a central limit theorem with a controllable asymptotic covariance matrix. We also prove recurrence in $d=1$ under condition of zero speed and transience when the speed is non zero, as well as an Einstein relation. Along the way, we develop a general formalism to derive concentration inequalities for functions of a Markov process, based on martingales adapted to quantities like the position of the walker, which is not exactly an additive functional of the environment process. Concentration inequalities for the position of the walker are crucial to obtain transience or recurrence. The formalism to derive these concentration inequalities is in the spirit of \cite{REDIG:VOLLERING:10} but based now on ``backwards'' martingales. These ``backwards'' martingales are different from the classical martingales associated to the generator, or arising in the ``martingale problem''. Using them leads however to a controllable expression of the variance of the walker, as well as for additive functionals of the environment process. We believe that the use of these backwards martingales are interesting per se, and can also play an important role in controlling the deviation from macroscopic behavior (such as hydrodynamic limits) in the context of interacting particle systems. Our paper is organized as follows. The model and necessary notation are introduced in Section \ref{section:model}. Section \ref{section:EP} is dedicated to lift properties of the environment to the environment process. Especially Theorem \ref{thm:EP-estimate} is of great importance and is used frequently in the later sections. Based on the results in Section \ref{section:EP} the Law of Large Numbers and an Einstein Relation are obtained in Section \ref{section:LLN}. A functional Central Limit Theorem is proven in Section \ref{section:CLT}, utilizing the martingale approach detailed in the Appendix. Section \ref{section:RWRE-concentration} further applies the general methods from the Appendix to the specific case of a random walk in dynamic random environment to obtain concentration estimates and therewith statements about recurrence and transience. Finally the Appendix is dedicated to the study of the non-time-homogeneous ``backwards'' martingales and the concentration inequalities they facilitate. \section{The model}\label{section:model} \subsection{Environment} We are interested in studying a random walk $(X_t)_{t\geq0}$ on the lattice $\bZ^d$ which is driven by a second processes $(\eta_t)_{t\geq0}$ on $E^{\bZ^d}$, the (dynamic) environment. This can be interpreted as the random walk moving through the environment, and its transition rates being determined by the local environment around the random walk. To become more precise, the \emph{environment} $(\eta_t)_{t\geq0}$ is a Feller Process on the state space $\Omega:=E^{\bZ^d}$, where $(E,\rho)$ is a compact Polish space with metric $\rho$ (examples in mind are $E=\{0,1\}$ or $E=[0,1]$). We assume that the distance $\rho$ on $E$ is bounded from above by 1. The generator of the Markov process is denoted by $L^E$ and its semigroup by $S_t^E$, both considered on the space of continuous functions $\cC(\Omega;\bR)$. We assume that the environment is translation invariant, i.e. \[ \bP^E_\eta(\theta_x\eta_t \in \cdot ) = \bP^E_{\theta_x\eta}(\eta_t \in \cdot) \] with $\theta_x$ denoting the shift operator $\theta_x\eta(y) = \eta(y-x)$ and $\bP^ E_\eta$ the path space measure of the process $(\eta_t)_{t\geq0}$ starting from $\eta$. Later on we will formulate precise conditions necessary to obtain our results. \subsection{Lipschitz functions} \newcommand{\Omegax}[1]{(\Omega\times\Omega)_{#1}} For practical purposes, we introduce the set of pairs in $\Omega$ which differ at one specific site: \[ \Omegax{x} := \left\{(\eta,\xi) \in \Omega^2 : \eta(x) \neq \xi(x) \text{ and } \eta(y)=\xi(y) \ \forall\,y\in\bZ^d\bs\{x\} \right\},\quad x\in\bZ^d. \] \begin{definition} For any $f:\Omega\to\bR$, we denote by $\delta_f(x)$ the Lipschitz-constant of $f$ when only site $x$ is changed with respect to the distance $\rho$, i.e. \[ \delta_f(x) := \supl_{(\eta,\xi)\in \Omegax{x}}\frac{f(\eta)-f(\xi)}{\rho(\eta(x),\xi(x))}. \] We write \begin{align} \normb{f}:=\suml_{x\in\bZ^d}\delta_f(x). \end{align} \end{definition} Note that $\normb{f}<\infty$ implies that $f$ is globally bounded and that the value of $f$ is uniformly weakly dependent on sites far away. A rougher semi-norm we also use is the oscillation (semi)-norm \begin{align*} \norm{f}_{osc} := \sup_{\eta,\xi \in \Omega}\left(f(\eta)-f(\xi)\right). \end{align*} Generally, those two semi-norms are related by the inequality $\norm{f}_{osc} \leq \normb{f}$. \subsection{The random walker and assumption on rates}\label{subsection:rates} \newcommand{\dalpha}[1][z]{\delta_{\alpha(\cdot,#1)}} The random walker $X_t$ is a process on $\bZ^d$, whose transition rates depend on the state of the environment as seen from the walker. More precisely, the rate to jump from site $x$ to site $x+z$ given that the environment is in state $\eta$ is $\alpha(\theta_{-x}\eta,z)$. We make two assumptions on the jump rates $\alpha$. First, we guarantee that the walker $X_t$ has first moments by assuming \begin{align}\label{eq:rates-moment} \norm{\alpha}_1 := \suml_{z\in\bZ^d}\norm{z}\supl_{\eta\in\Omega}\abs{\alpha(\eta,z)}<\infty. \end{align} More generally, as sometimes higher moments are necessary, we write \[ \norm{\alpha}_p^p := \suml_{z\in\bZ^d}\norm{z}^p\supl_{\eta\in\Omega}\abs{\alpha(\eta,z)}, \quad p\geq1. \] Second, we limit the sensitivity of the rates to small changes in the environment by assuming that \begin{align} \normb{\alpha}:=\sum_{z\in\bZ^d} \normb{\alpha(\cdot,z)}<\infty. \end{align} In Section \ref{section:RWRE-concentration}, we impose the following stronger condition $\norm{\alpha}_1<\infty$: \begin{align} \normb{\alpha}_1:=\sum_{z\in\bZ^d} \norm{z}\normb{\alpha(\cdot,z)}<\infty. \end{align} \subsection{Environment process} While the random walker $X_t$ itself is not a Markov process due to the dependence on the environment, the pair $(\eta_t,X_t)$ is a Markov process with generator \[ Lf(\eta,x) = L^Ef(\cdot,x)(\eta) + \suml_{z\in\bZ^d}\alpha(\theta_{-x}\eta,z)\left[f(\eta,x+z)-f(\eta,x)\right], \] corresponding semigroup $S_t$ (considered on the space of functions continuous in $\eta\in\Omega$ and Lipschitz continuous in $x\in\bZ^d$) and path space measure $\bP_{\eta,x}$. The environment as seen from the walker is of crucial importance to understand the asymptotic behaviour of the walker itself. This process, $(\theta_{-X_t}\eta_t)_{t\geq0}$, is also called the environment process (this name is common in the literature, however in the context of this paper that name can easily be confused with the environment $\eta_t$), which is also a Markov process with generator \[ L^{EP}f(\eta) = L^E f(\eta) + \suml_{z\in\bZ^d}\alpha(\eta,z)\left[f(\theta_{-z}\eta)-f(\eta)\right], \] corresponding semigroup $S_t^{EP}$ (on $\cC(\Omega)$) and path space measure $\bP^{EP}_{\eta}$. Notice that this process is well-defined only in the translation invariant context. \section{Ergodicity of the environment process}\label{section:EP} \subsection{Assumptions on the environment} \newcommand{\sumsup}[1][x]{\suml_{x\in\bZ^d}\supl_{(\eta,\xi)\in\Omegax{#1}}} In this section we will show how we can use a given Markovian coupling of the environment with a fast enough coupling speed to obtain a strong ergodicity properties about the environment process. \begin{assumption}[1a. There exists a strong Markovian coupling $\widehat{\bP}^E$ of the environment (with corresponding expectation $\widehat{\bE}^E$) which satisfies \[ \int_0^\infty t^d \supl_{\eta,\xi\in \Omega} \widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0))\,dt<\infty .\] \end{assumption} This assumption is already sufficient to obtain the law of large numbers for the position of the walker and unique ergodicity of the environment process, but it does not give quite enough control on local fluctuations. The following stronger assumption remedies that. \begin{assumption}[1b. There exists a strong Markovian coupling $\widehat{\bP}^E$ of the environment (with corresponding expectation $\widehat{\bE}^E$) which satisfies \[ \int_0^\infty t^d \sumsup[0] \frac{\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(x),\eta_t^2(x))}{\rho(\eta(0),\xi(0))}\,dt<\infty .\] \end{assumption} \begin{remark} The following \emph{telescoping} argument which will be used several times later on shows how Assumption 1b implies 1a: Fix $\eta,\xi \in \Omega$. Let $(\zeta_n)_{n\geq0}$ be a sequence in $\Omega$ with $\zeta_0=\eta$, $\lim_{n\to\infty}\zeta_n =\xi$ and $|\{x\in\bZ^d : \zeta_n(x)\neq\zeta_{n-1}(x) \}|\leq1$ for all $n\geq1$. This sequence interpolates between the configurations $\eta$ and $\xi$ by single site changes. Using such a sequence, we can \emph{telescope over single site changes}, and using the triangle inequality for each $n$: \[ \widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0)) \leq \sum_{n\in\bN} \widehat{\bE}^E_{\zeta_{n+1},\zeta_n}\rho(\eta_t^1(0),\eta_t^2(0)) .\] We can assume that each site $x\in\bZ^d$ is at most once changed in the sequence $\zeta_n$. Therefore, \[ \sum_{n\in\bN} \widehat{\bE}^E_{\zeta_{n+1},\zeta_n}\rho(\eta_t^1(0),\eta_t^2(0)) \leq \sumsup[x] \widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0)) .\] Using the translation invariance of the environment and $\rho\leq1$ we obtain the estimate \[ \widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0)) \leq \sumsup[0] \frac{\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(x),\eta_t^2(x))}{\rho(\eta(0),\xi(0))} .\] Taking the supremum on the left hand site and integrating over time, we obtain that Assumption 1b indeed implies Assumption 1a. \end{remark} Examples which satisfy Assumption 1a and 1b include: \begin{itemize} \item interacting particle systems in the so-called $M<\epsilon$; \item weakly interacting diffusions on a compact manifold; \item a system of ODEs which converges uniformly to its unique stationary configuration at sufficient speed. \end{itemize} Note that the third example is a deterministic environment and as such any form of condition which measures this convergence purely in probabilistic terms like the total variation distance is bound to fail. \subsection{Statement of the main theorem} The main result of this section is the following theorem, which tells us how the coupling property of the environment lifts to the environment process. \begin{theorem}\label{thm:EP-estimate} Let $f:\Omega\rightarrow \bR$ with $\normb{f}<\infty$. \begin{enumerate} \item Under Assumption 1a, there exists a constant $C_a>0$ so that \[ \supl_{\eta,\xi\in \Omega}\int_0^\infty \abs{S^{EP}_t f(\eta)-S^{EP}_t f(\xi)}\,dt\leq C_a\normb{f}. \] \item Under Assumption 1b, there exists a constant $C_b>0$ so that \[ \sumsup\int_0^\infty \frac{\abs{S^{EP}_t f(\eta)-S^{EP}_t f(\xi)}}{\rho(\eta(x),\xi(x))}\,dt\leq C_b\normb{f}. \] \end{enumerate} \end{theorem} This theorem encapsulates all the technical details and difficulties to obtain results, and subsection \ref{subsection:proof} is dedicated to its proof. In Section \ref{section:convergence-speed} we generalize this result to give more information about decay in time. Here we continue with results we can obtain using Theorem \ref{thm:EP-estimate}. Most results about the environment process just use part a) of the theorem, part b) is needed to obtain the CLT in Section \ref{section:CLT} or more sophisticated deviation estimates in Section \ref{section:RWRE-concentration}. \subsection{Existence of a unique ergodic measure and continuity in the rates} First of, the environment process, i.e. the environment as seen from the walker, is ergodic. \begin{lemma}\label{lemma:ergodicity} Under Assumption 1a the environment process has a unique ergodic probability measure $\mu^{EP}$. \end{lemma} \begin{proof} As $E$ is compact, so is $\Omega$, and therefore the space of stationary measures is non-empty. So we must just prove uniqueness. Assume $\mu,\nu$ are both stationary measures. Choose an arbitrary $f : \Omega\rightarrow \bR$ with $\normb{f}<\infty$. By Theorem \ref{thm:EP-estimate},a, \begin{align*} T\abs{\mu(f)-\nu(f)} &\leq \int\int\int_0^T \abs{S^{EP}_t f (\eta)-S^{EP}_tf(\xi)}\,dt\,\mu(d\eta)\,\nu(d\xi) \\ & \leq \sup_{\eta,\xi\in \Omega} \int_0^\infty\abs{ S^{EP}_t f (\eta)-S^{EP}_t f(\xi)}\,dt<\infty. \end{align*} As $T$ is arbitrary, $\mu(f)=\nu(f)$. As functions $f$ with $\normb{f}<\infty$ are dense in $\cC(\Omega)$, there is at most one stationary probability measure. \qed \end{proof} It is of interest not only to know that the environment process has a unique ergodic measure $\mu^{EP}$, but also to know how this measure depends on the rates $\alpha$. \begin{theorem}\label{thm:mu-continuous} Under Assumption 1a, the unique ergodic measure $\mu^{EP}_{\alpha}$ depends continuously on the rates $\alpha$. For two transition rate functions $\alpha, \alpha'$, we have the following estimate: \[ \abs{\mu^{EP}_{\alpha}(f)-\mu^{EP}_{\alpha'}(f)} \leq \frac{C(\alpha)}{p(\alpha)}\norm{\alpha-\alpha'}_0 \normb{f}, \] i.e. \[ (\alpha,f) \mapsto \mu^{EP}_\alpha(f) \] is continuous in $\norm{\cdot}_0\times \normb{\cdot}$. The functions $C(\alpha), p(\alpha)$ satisfy $C(\alpha)>0, p(\alpha)\in\,]0,1[$. In the case that the rates $\alpha$ do not depend on the environment, i.e. $\alpha(\eta,z)=\alpha(z)$, they are given by $p(\alpha)=1$, \[ C(\alpha) = \int_0^\infty \sup_{\eta,\xi\in \Omega} \widehat{\bE}^E_{\eta,\xi}\rho(\eta^1_t(0),\eta^2_t(0))\,dt. \] \end{theorem} As the proof is a variation of the proof of Theorem \ref{thm:EP-estimate}, it is delayed to the end of Section \ref{subsection:proof}. \subsection{Speed of convergence to equilibrium in the environment process}\label{section:convergence-speed} We already know that under Assumption 1a the environment process has a unique ergodic distribution. However, we do not know at what speed the process converges to its unique stationary measure. Given the speed of convergence for the environment it is natural to believe that the environment process inherits that speed with some form of slowdown due to the additional self-interaction which is induced from the random walk. For example, if the original speed of convergence were exponential with a constant $\lambda$, then the environment process would also converge exponentially fast, but with a worse constant $\widetilde\lambda$. This is indeed the case. \newcommand{\phiK}[1][t]{\phi\left(\frac{#1}{K}\right)} \begin{theorem}\label{thm:EP-phi-estimate} Let $\phi:[0,\infty[\ \to\bR$ be a monotone increasing and continuous function satisfying $\phi(0)=1$ and $\phi(s+t)\leq \phi(s)\phi(t)$. \begin{enumerate} \item Suppose there exists a strong Markovian coupling $\widehat{\bP}^E$ of the environment (with corresponding expectation $\widehat{\bE}^E$) which satisfies \[ \int_0^\infty \phi(t) t^d \supl_{\eta,\xi\in \Omega} \widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0))\,dt<\infty .\] Then there exists a constant $K_0>0$ and a decreasing function $C_a :\ ]K_0,\infty[\ \to [0,\infty[$ so that for any $K>K_0$ and any $f:\Omega\rightarrow \bR$ with $\normb{f}<\infty$, \[ \supl_{\eta,\xi\in \Omega}\int_0^\infty \phiK \abs{S^{EP}_t f(\eta)-S^{EP}_t f(\xi)}\,dt\leq C_a(K)\normb{f}. \] \item Suppose there exists a strong Markovian coupling $\widehat{\bP}^E$ of the environment (with corresponding expectation $\widehat{\bE}^E$) which satisfies \[ \int_0^\infty \phi(t) t^d \sumsup[0] \frac{\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(x),\eta_t^2(x))}{\rho(\eta(0),\xi(0))}\,dt<\infty .\] Then there exists a constant $K_0>0$ and a decreasing function $C_b :\ ]K_0,\infty[\ \to [0,\infty[$ so that for any $K>K_0$ and any $f:\Omega\rightarrow \bR$ with $\normb{f}<\infty$, \[ \sumsup\int_0^\infty \phiK \frac{\abs{S^{EP}_t f(\eta)-S^{EP}_t f(\xi)}}{\rho(\eta(x),\xi(x))}\,dt\leq C_b(K)\normb{f}. \] \end{enumerate} \end{theorem} Canonical choices for $\phi$ are $\phi(t)=\exp(\lambda t)$ or $\phi(t)= (1+t)^\lambda$. In the first case, exponential decay of order $\lambda$ of the environment is lifted to exponential decay of order $\lambda/K$ for any $K>K_0$ in the environment process. In the second case, polynomial decay of order $\lambda$ becomes polynomial decay of order $\lambda - d - \epsilon$ for any $0<\epsilon\leq\lambda-d$. \subsection{Proofs of Theorem \ref{thm:EP-estimate}, \ref{thm:mu-continuous} and \ref{thm:EP-phi-estimate}}\label{subsection:proof} In this section we always assume that Assumption 1a holds. We start with an outline of the idea of the proofs. We have a coupling of the environments $(\eta^1_t,\eta^2_t)$, which we extend to include two random walkers $(X^1_t,X^2_t)$, driven by their corresponding environment. We maximize the probability of both walkers performing the same jumps. Then Assumption 1a is sufficient to obtain a positive probability of both walkers staying together forever. If the walkers stay together, one just has to account for the difference in environments, but not the walkers as well. When the walkers split, the translation invariance allows for everything to shifted that both walkers are back at the origin, and one can try again. After a geometric number of trials it is then guaranteed that the walkers stay together. \begin{proposition}[Coupling construction]\label{prop:coupling-construction} Given the coupling $\widehat{\bP}^E_{\eta,\xi}$ of the environments, we extend it to a coupling $\widehat{\bP}_{\eta,x;\xi,y}$. This coupling has the following properties: \begin{enumerate} \item (Marginals)The coupling supports two environments and corresponding random walkers: \begin{enumerate} \item $\widehat{\bP}_{\eta,x;\xi,y}((\eta^1_t,X_t^1)\in \cdot) = \bP_{\eta,x}((\eta_t,X_t) \in \cdot)$; \item $\widehat{\bP}_{\eta,x;\xi,y}((\eta^2_t,X_t^2)\in \cdot) = \bP_{\xi,y}((\eta_t,X_t) \in \cdot)$; \end{enumerate} \item (Extension of $\widehat{\bP}^E_{\eta,\xi}$) The environments behave as under $\widehat{\bP}^E$: \[ \widehat{\bP}_{\eta,x;\xi,y}((\eta^1_t,\eta_t^2)\in \cdot) = \widehat{\bP}^E_{\eta,\xi}((\eta_t^1,\eta_t^2) \in \cdot); \] \item\label{enum:decoupling-rate} (Coupling of the walkers) $X_t^1$ and $X_t^2$ perform identical jumps as much as possible, the rate of performing a different jump is $\suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X_t^1}\eta_t^1,z)-\alpha(\theta_{-X_t^2}\eta_t^2,z)}$; \item (Minimal and maximal walkers) In addition to the environments $\eta_t^1$ and $\eta_t^2$ and random walkers $X_t^1$ and $X_t^2$, the coupling supports minimal and maximal walkers $Y_t^+$, $Y_t^-$ as well. These two walkers have the following properties: \begin{enumerate} \item $Y_t^- \leq X_t^1-x, X_t^2-y \leq Y_t^+ \quad \widehat{\bP}_{\eta,x;\xi,y}-a.s.$ (in dimension $d>1$, this is to be interpreted coordinate-wise); \item $Y_t^+,Y_t^-$ are independent of $\eta_t^1,\eta_t^2$; \item $\widehat{\bE}_{\eta,x;\xi,y}Y_t^+ = t\gamma^+$ for some $\gamma^+\in\bR^d$; \item $\widehat{\bE}_{\eta,x;\xi,y}Y_t^- = t\gamma^-$ for some $\gamma^-\in\bR^d$. \end{enumerate} \end{enumerate} \end{proposition} \begin{proof} The construction of this coupling $\widehat{\bP}_{\eta,x;\xi,y}$ can be done in the following way: The environments behave according to $\widehat{\bP}^E_{\eta,\xi}$, and $X_0^1=x$, $X_0^2=y$, $Y_0^+=Y_0^-=0$. For each $z\in\bZ^d$ there is an independent Poisson clock with rate $\lambda_z:=\sup_\eta \alpha(\eta,z)$. Whenever such a clock rings, draw an independent $U$ from the uniform distribution in $[0,1]$. If $U<\alpha(\theta_{-X_t^1}\eta_t^1,z)/\lambda_z$, $X_t^1$ performs a jump by $z$, analogue for $X_t^2$. The upper and lower walkers $Y_t^+$ and $Y_t^-$ always jump on these clocks, however they jump by $\max(z,0)$ or $\min(z,0)$ respectively. $N_t$ increases if The properties of the coupling arise directly from the construction, except the last two. Those are a consequence from the first moment condition $\norm{\alpha}_1<\infty$.\qed \end{proof} Now we show how suitable estimates on the coupling speed of the environment translate to properties of the extended coupling. \begin{lemma}\label{lemma:supnorm-coupling-estimate} \[ \widehat{\bE}_{\eta,x;\xi,y}\rho(\eta_t^1(X_t^1), \eta_t^2(X_t^1))\,dt<(\norm{\gamma^{+} - \gamma^{-}}_\infty t + 1)^d\supl_{\eta,\xi\in\Omega}\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0)). \] \end{lemma} \begin{proof} Denote with $R_t \subset \bZ^d$ the set of sites $x$ with $Y_t^-\leq x \leq Y_t^+$(coordinate-wise). Then \begin{align*} &\supl_{\eta,\xi,x,y} \widehat{\bE}_{\eta,x;\xi,y}\rho(\eta_t^1(X_t^1), \eta_t^2(X_t^1))\\ &\quad\leq \supl_{\eta,\xi,x,y} \widehat{\bE}_{\eta,x;\xi,y}\suml_{z\in R_t}\rho(\eta_t^1(x+z), \eta_t^2(x+z))\\ &\quad\leq \widehat{\bE} \left[\suml_{z\in R_t}1\right]\supl_{\eta,\xi,z}\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(z), \eta_t^2(z)) \\ &\quad\leq (\norm{\gamma^{+} - \gamma^{-}}_\infty t + 1)^d \supl_{\eta,\xi\in\Omega}\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0), \eta_t^2(0)). \end{align*} \qed \end{proof} \begin{lemma}\label{lemma:decoupling-estimate} Denote by $\tau:=\inf\{t\geq0:X^1_t\neq X_t^2\}$ the first time the two walkers are not at the same position. Under Assumption 1a, \[ \infl_{\eta,\xi\in\Omega} \widehat{\bP}_{\eta,0;\xi,0}(\tau=\infty) >0 ,\] i.e., the walkers $X^1$ and $X^2$ never decouple with strictly positive probability. \end{lemma} \begin{proof} Both walkers start in the origin, therefore $\tau>0$. The probability $\bP(\exp((\lambda_t))>T)$ that an exponential random variable with time dependent rate $\lambda_t$ is bigger than $T$ is given by $\exp({-\int_0^T\lambda_t\,dt})$. As the rate of decoupling is given by Proposition \ref{prop:coupling-construction},c), we obtain \begin{align} \widehat{\bP}_{\eta,0;\xi,0}(\tau > T) &= \widehat{\bE}_{\eta,0;\xi,0} \exp\left({-\int_0^T \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_t}\eta^1_t,z)- \alpha(\theta_{-X^1_t}\eta^2_t,z)}\,dt}\right) \label{eq:dynamic-rate-poisson}\\ &\geq \exp\left(-\widehat{\bE}_{\eta,0;\xi,0}{\int_0^T \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_t}\eta^1_t,z)- \alpha(\theta_{-X^1_t}\eta^2_t,z)}\,dt}\right) . \nonumber \end{align} By telescoping over single site changes, \begin{align*} &\widehat{\bE}_{\eta,0;\xi,0}\suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_t}\eta^1_t,z)- \alpha(\theta_{-X^1_t}\eta^2_t,z)} \\ &\quad \leq \widehat{\bE}_{\eta,0;\xi,0}\suml_{z\in\bZ^d}\suml_{x\in\bZ^d}\rho(\eta^1_t(X^1_t+x),\eta^2_t(X^1_t+x))\dalpha(x)\\ &\quad \leq \supl_{x\in\bZ^d}\widehat{\bE}_{\eta,0;\xi,0}\rho(\eta^1_t(X^1_t+x),\eta^2_t(X^1_t+x))\normb{\alpha}\\ &\quad \leq \normb{\alpha}(\norm{\gamma^{+} - \gamma^{-}}_\infty t + 1)^d\supl_{\eta,\xi\in\Omega}\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0)), \end{align*} where the last line follows from Lemma \ref{lemma:supnorm-coupling-estimate}. With this estimate, we obtain \begin{align*} \widehat{\bP}_{\eta,\xi}(\tau =\infty ) &\geq \exp\left(- \normb{\alpha}\int_0^\infty(\norm{\gamma^{+} - \gamma^{-}}_\infty t + 1)^d\supl_{\eta,\xi\in\Omega}\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0))\,dt \right) \\ &>0 \quad \text{uniformly in $\eta, \xi$}. \end{align*} \qed \end{proof} \begin{proof}[Proof of Theorem \ref{thm:EP-estimate}, part a)] The idea of the proof is to use the coupling of Proposition \ref{prop:coupling-construction}: We wait until the walkers $X_t^1$ and $X_t^2$, which are initially at the same position, decouple, and then restart everything and try again. By Lemma \ref{lemma:decoupling-estimate} there is a positive probability of never decoupling, so this scheme is successful. Using the time of decoupling $\tau$ (as in Lemma \ref{lemma:decoupling-estimate}), \begin{align} &\int_0^T \abs{\widehat{\bE}_{\eta,0;\xi,0}\ind_{t\geq\tau}\left(f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^2_t}\eta^2_t)\right) }\,dt \nonumber\\ &\quad= \int_0^T \abs{\widehat{\bE}_{\eta0;\xi,0}\ind_{t\geq\tau}\erwc{f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^2_t}\eta^2_t)}{\fF_\tau}}\,dt \nonumber\\ &\quad \leq \int_0^T \widehat{\bE}_{\eta,0;\xi,0}\ind_{t\geq\tau}\abs{ S^{EP}_{t-\tau}f(\theta_{-X^1_\tau}\eta^1_\tau)-S^{EP}_{t-\tau}f(\theta_{-X^2_\tau}\eta^2_\tau) }\,dt \nonumber\\ &\quad = \widehat{\bE}_{\eta,0;\xi,0} \int_0^{(T-\tau)\vee0} \abs{ S^{EP}_{t}f(\theta_{-X^1_\tau}\eta^1_\tau)-S^{EP}_{t}f(\theta_{-X^2_\tau}\eta^2_\tau) }\,dt \label{eq:phi-1}\\ &\quad \leq \widehat{\bP}_{\eta,0;\xi,0}(\tau<\infty) \supl_{\eta,\xi\in\Omega}\int_0^{T} \abs{ S^{EP}_{t}f(\eta)-S^{EP}_{t}f(\xi) }\,dt. \label{eq:phi-2} \end{align} And therefore \begin{align} &\int_0^T \abs{S^{EP}_t f(\eta)-S^{EP}_t f(\xi)}\,dt \nonumber\\ &\quad= \int_0^T \abs{\widehat{\bE}_{\eta,0;\xi,0}f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^2_t}\eta^2_t) }\,dt \nonumber\\ &\quad\leq \int_0^T \widehat{\bE}_{\eta,0;\xi,0}\ind_{t<\tau}\abs{f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^1_t}\eta^2_t) }\,dt \nonumber\\ &\qquad+ \widehat{\bP}_{\eta,0;\xi,0}(\tau<\infty) \supl_{\eta,\xi\in\Omega}\int_0^{T} \abs{ S^{EP}_{t}f(\eta)-S^{EP}_{t}f(\xi) }\,dt \label{eq:phi-3}\\ &\quad\leq \int_0^\infty \widehat{\bE}_{\eta,0;\xi,0}\abs{f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^1_t}\eta^2_t) }\,dt \nonumber\\ &\qquad+ \widehat{\bP}_{\eta,0;\xi,0}(\tau<\infty)\supl_{\eta,\xi\in\Omega}\int_0^T \abs{ S^{EP}_{t}f(\eta)-S^{EP}_{t}f(\xi) }\,dt, \label{eq:phi-4} \end{align} which gives us the upper bound \begin{align} &\supl_{\eta,\xi\in\Omega}\int_0^\infty \abs{S^{EP}_tf(\eta)-S^{EP}_tf(\xi)}\,dt \nonumber\\ &\quad\leq \left(\infl_{\eta,\xi\in\Omega}\widehat{\bP}_{\eta,0;\xi,0}(\tau=\infty)\right)^{-1}\supl_{\eta,\xi\in\Omega}\int_0^\infty \widehat{\bE}_{\eta,0;\xi,0}\abs{f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^1_t}\eta^2_t) }\,dt . \label{eq:phi-5} \end{align} To show that the last integral is finite, we telescope over single site changes, and get \begin{align*} &\int_0^\infty \widehat{\bE}_{\eta,0;\xi,0}\abs{f(\theta_{-X^1_t}\eta^1_t)-f(\theta_{-X^1_t}\eta^2_t) }\,dt \\ &\quad\leq \int_0^\infty \widehat{\bE}_{\eta,0;\xi,0}\suml_{x\in\bZ^d}\rho(\eta^1_t(x+X^1_t),\eta^2_t(x+X^1_t))\delta_f(x)\,dt\\ &\quad\leq \normb{f}\supl_{\eta,\xi,x}\int_0^\infty \widehat{\bE}_{\eta,0;\xi,0}\rho(\eta^1_t(x+X_t^1),\eta^2_t(x+X_t^1))\,dt, \end{align*} which is finite by Lemma \ref{lemma:supnorm-coupling-estimate} and Assumption 1a). Choosing \begin{align} C_a = \left(\infl_{\eta,\xi\in\Omega}\widehat{\bP}_{\eta,0;\xi,0}(\tau=\infty)\right)^{-1}\supl_{\eta,\xi,x}\int_0^\infty \widehat{\bE}_{\eta,0;\xi,0}\rho(\eta^1_t(x+X_t^1),\eta^2_t(x+X_t^1))\,dt \label{eq:phi-6} \end{align} completes the proof. \qed \end{proof} To prove part b) of the theorem, we need the following analogue to Lemma \ref{lemma:decoupling-estimate} using Assumption 1b. \begin{lemma}\label{lemma:triplenorm-coupling-estimate} Under Assumption 1b, for every site-weight function $w:\bZ^d \to [0,\infty[$ with $\norm{w}_1 := \suml_x w(x)<\infty$, we have \[ \sumsup\int_0^\infty \suml_{y\in\bZ^d} w(y)\frac{\widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1))}{\rho(\eta(x),\xi(x))}\,dt\leq const \cdot \norm{w}_1 . \] \end{lemma} \begin{proof} Denote with $R_t \subset \bZ^d$ the set of sites whose $j$th coordinate lies between $Y_t^{j,-}$ and $Y_t^{j,+}$. Then, \begin{align*} & \suml_{y\in\bZ^d} w(y)\widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1)) \\ &\quad= \suml_{y\in\bZ^d} \widehat{\bE}_{\eta,\xi}w(y-X_t^1)\rho(\eta_t^1(y), \eta_t^2(y)) \\ &\quad\leq \suml_{y\in\bZ^d} \widehat{\bE}_{\eta,\xi}\suml_{z\in R_t}w(y-z) \rho(\eta_t^1(y), \eta_t^2(y))\\ &\quad = \suml_{y\in\bZ^d} \bE\left[\suml_{z\in R_t}w(y-z)\right]\widehat{\bE}^E_{\eta,\xi} \rho(\eta_t^1(y), \eta_t^2(y)) \end{align*} by independence of $R_t$ and $(\eta^1_t,\eta^2_t)$. Therewith, \begin{align*} &\sumsup\int_0^\infty \suml_{y\in\bZ^d} w(y)\frac{\widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1))}{\rho(\eta(x),\xi(x))}\,dt \\ &\quad\leq \int_0^\infty \suml_{y\in\bZ^d} \bE\left[\suml_{z\in R_t}w(y-z)\right] \sumsup \widehat{\bE}^E_{\eta,\xi} \frac{\rho(\eta_t^1(y), \eta_t^2(y))}{\rho(\eta(x),\xi(x))}\,dt . \end{align*} Note that by translation invariance the right part is equal to \[ \sumsup[0] \widehat{\bE}^E_{\eta,\xi} \frac{\rho(\eta_t^1(x), \eta_t^2(x))}{\rho(\eta(0),\xi(0))} \] and by construction of $R_t$ and Proposition \ref{prop:coupling-construction}.d , \begin{align*} \suml_{y\in\bZ^d} \bE\left[\suml_{z\in R_t}w(y-z)\right] &= \bE \left[\suml_{z\in R_t} 1\right]\norm{w}_1 = \prod_{j=1}^d(\gamma^{j,+}t - \gamma^{j,-}t+1) \norm{w}_1 \\ &\leq c_w (t^d+1) \end{align*} for some suitable $c_w>0$. Therefore Assumption 1b completes the proof. \qed \end{proof} \begin{proof}[Proof of Theorem \ref{thm:EP-estimate}, part b)] Let $\tau:=\inf\{t\geq0:X^1_t\neq X^2_t\}$. Then we split the integration at $\tau$: \begin{align*} &\sumsup\int_0^\infty \frac{\abs{S_t^{EP} f(\eta)-S_t^{EP} f(\xi)}}{\rho(\eta(x),\xi(x))}\,dt \\ &\quad\leq \sumsup \int_0^\infty \frac{\abs{\widehat{\bE}_{\eta,\xi}\ind_{\tau>t}\left(f(\theta_{-X_t^1}\eta_t^1)-f(\theta_{-X_t^1}\eta_t^2) \right)}}{\rho(\eta(x),\xi(x))} \,dt\\ &\qquad +\sumsup \int_0^\infty\frac{\abs{\widehat{\bE}_{\eta,\xi}\ind_{\tau\leq t} \left(f(\theta_{-X_t^1}\eta_t^1)-f(\theta_{-X_t^2}\eta_t^2)\right)}}{\rho(\eta(x),\xi(x))} \,dt \end{align*} We estimate the first term by moving the expectation out of the absolute value and forgetting the restriction to $\tau>t$: \[ \sumsup \int_0^\infty \suml_{y\in\bZ^d}\delta_f(y)\frac{\widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1))}{\rho(\eta(x),\xi(x))} \,dt. \] By Lemma \ref{lemma:triplenorm-coupling-estimate} with $w = \delta_f$, this is bounded by some constant times $\normb{f}$. For the second term we start by using the Markov property: \begin{align} & \int_0^\infty\abs{\widehat{\bE}_{\eta,\xi}\ind_{\tau\leq t} \left(f(\theta_{-X_t^1}\eta_t^1)-f(\theta_{-X_t^2}\eta_t^2)\right)}\,dt \nonumber\\ &\quad= \int_0^\infty\abs{\widehat{\bE}_{\eta,\xi}\ind_{\tau\leq t} \left(S_{t-\tau}^{EP}f(\theta_{-X_\tau^1}\eta_\tau^1)-S_{t-\tau}^{EP}f(\theta_{-X_\tau^2}\eta_\tau^2)\right)}\,dt \nonumber\\ &\quad\leq \widehat{\bE}_{\eta,\xi}\ind_{\tau<\infty}\int_\tau^\infty\abs{ \left(S_{t-\tau}^{EP}f(\theta_{-X_\tau^1}\eta_\tau^1)-S_{t-\tau}^{EP}f(\theta_{-X_\tau^2}\eta_\tau^2)\right)}\,dt \label{eq:phi-7}\\ &\quad\leq \widehat{\bP}_{\eta,\xi}(\tau<\infty)\supl_{\eta,\xi \in \Omega}\int_0^\infty\abs{S_t^{EP} f(\eta)-S_t^{EP} f(\xi)}\,dt .\label{eq:phi-8} \end{align} By part a) of Theorem \ref{thm:EP-estimate} the integral part is uniformly bounded by $C_a \normb{f}$. So what remains to complete the proof is to show that \begin{align} \sumsup \frac{\widehat{\bP}_{\eta,\xi}(\tau<\infty)}{\rho(\eta(x),\xi(x))}< \infty. \label{eq:phi-9} \end{align} To do so we first use the same idea as in the proof of Lemma \ref{lemma:decoupling-estimate} to obtain \begin{align} &\widehat{\bP}_{\eta,\xi}(\tau<\infty) \nonumber\\ &\quad= 1-\exp\left(- \int_0^\infty \widehat{\bE}_{\eta,\xi} \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X_t^1}\eta_t^1,z) - \alpha(\theta_{-X_t^1}\eta_t^2,z)}\,dt\right) \nonumber\\ &\quad\leq \int_0^\infty \widehat{\bE}_{\eta,\xi} \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X_t^1}\eta_t^1,z) - \alpha(\theta_{-X_t^1}\eta_t^2,z)}\,dt \nonumber\\ &\quad\leq \int_0^\infty \suml_{y\in\bZ^d} w_\alpha(y) \widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1)) \,dt \nonumber \end{align} with \[ w_\alpha(x) := \supl_{(\eta,\xi)\in\Omegax{x}} \suml_{z\in\bZ^d}\abs{\alpha(\eta,z) - \alpha(\xi,z)} \] and $\sum_{x\in\bZ^d}w_\alpha(x)<\infty$. So we get \begin{align*} &\sumsup \frac{\widehat{\bP}_{\eta,\xi}(\tau<\infty)}{\rho(\eta(x),\xi(x))} \\ &\quad\leq \sumsup\int_0^\infty \suml_{y\in\bZ^d} w_\alpha(y) \frac{\widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1))}{\rho(\eta(x),\xi(x))} \,dt, \\ \end{align*} and Lemma \ref{lemma:triplenorm-coupling-estimate} completes the proof, where $C_b$ is the combination of the various factors in front of $\normb{f}$.\qed \end{proof} \begin{proof}[Proof of Theorem \ref{thm:mu-continuous}] Let $\alpha, \alpha'$ be two different transition rates. The goal is to show that \[ \abs{\mu^{EP}_{\alpha}(f)-\mu^{EP}_{\alpha'}(f)} \leq C \normb{f} \] for all $f:\Omega\to\bR$ with $\normb{f}<\infty$. The idea is now to use a coupling $\widehat{\bP}$ similar to the one in Proposition \ref{prop:coupling-construction}. The coupling contains as objects two copies of the environment, $\eta^1$ and $\eta^2$, and three random walks, $X^1,X^{12}$ and $X^2$. The random walk $X^1$ moves on the environment $\eta^1$ with rates $\alpha$, and correspondingly the random walk $X^2$ moves on $\eta^2$ with rates $\alpha'$. The mixed walker $X^{12}$ moves on the environment $\eta^2$ as well, but according to the rates $\alpha$. The walkers $X^1,X^2$ will perform the same jumps as $X^{12}$ with maximal probability. The environments we couple utilizing the Markovian coupling provided by Assumption 1a. We only consider the case where all three walkers start at the origin. We denote by $S_t^{EP,1}$, $S_t^{EP,2}$ the semigroups of the environment process which correspond to the rates $\alpha$ and $\alpha'$. Let $\tau:=\inf\{t\geq0 : X^1_t \neq X^{12}_t \text{ or } X^{12}_t \neq X^{2}_t\}$. \begin{align*} &S_t^{EP,1}f(\eta) - S_t^{EP,2}f(\xi) \\ &\quad = \widehat{\bE}_{\eta,\xi} \left( f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^2}\eta^2_t) \right)\\ &\quad = \widehat{\bE}_{\eta,\xi} \ind_{\tau>t}\left( f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \right)\\ &\qquad + \widehat{\bE}_{\eta,\xi} \ind_{\tau\leq t}\left( f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^2}\eta^2_t) \right) \\ &\quad = \widehat{\bE}_{\eta,\xi} \ind_{\tau>t}\left( f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \right)\\ &\qquad + \widehat{\bE}_{\eta,\xi} \ind_{\tau\leq t}\left( S_{t-\tau}^{EP,1}f(\theta_{-X_\tau^1}\eta^1_\tau) - S_{t-\tau}^{EP,2}f(\theta_{-X_\tau^2}\eta^2_\tau) \right). \\ \end{align*} Therefore, \begin{align} \Psi(T)&:=\sup_{0\leq T'\leq T}\sup_{\eta,\xi\in \Omega} \int_0^{T'} S_t^{EP,1}f(\eta) - S_t^{EP,2}f(\xi) \,dt \nonumber\\ &\leq \sup_{0\leq T'\leq T}\sup_{\eta,\xi\in \Omega} \int_0^{T'} \widehat{\bE}_{\eta,\xi} \ind_{\tau>t}\left( f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \right)\nonumber\\ &\qquad + \widehat{\bE}_{\eta,\xi} \ind_{\tau\leq t}\sup_{\eta,\xi\in \Omega}\left( S_{t-\tau}^{EP,1}f(\eta) - S_{t-\tau}^{EP,2}f(\xi) \right)\,dt \nonumber\\ & \leq \sup_{0\leq T'\leq T}\sup_{\eta,\xi\in \Omega} \left(\widehat{\bE}_{\eta,\xi} \int_0^\tau f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \,dt + \ind_{\tau\leq T'}\Psi(T'-\tau)\right) \nonumber\\ & \leq \sup_{\eta,\xi\in \Omega} \left(\widehat{\bE}_{\eta,\xi} \int_0^\infty f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \,dt + \ind_{\tau\leq T}\Psi(T-\tau)\right). \label{eq:PsiT} \end{align} We will now exploit this recursive bound on $\Psi$. \begin{lemma} Let $\tau_1:= \inf\{t\geq0 : X^1_t \neq X^{12}_t\}$ and $\tau_2:= \inf\{t\geq0 : X^{12}_t \neq X^{2}_t\}$. Set \begin{align*} \beta &:=\sum_{z\in\bZ^d} \sup_{\eta\in\bZ^d}\abs{\alpha(\eta,z)-\alpha'(\eta,z)},\\ p(\alpha)&:= \inf_{\eta,\xi\in\Omega} \widehat{\bP}_{\eta,\xi}(\tau_1=\infty), \\ C(\alpha) &:= \int_0^\infty \left( \norm{\gamma^+(\alpha)-\gamma^-(\alpha)}_\infty t+1\right)^d\sup_{\eta,\xi\in\Omega}\widehat{\bE}^E_{\eta,\xi}\rho(\eta^1_t(0),\eta^2_t(0))\,dt, \end{align*} where $\gamma^+(\alpha),\gamma^-(\alpha)$ are as in Proposition \ref{prop:coupling-construction} for the rates $\alpha$. Let $Y\in\{0,1\}$ be Bernoulli with parameter $p(\alpha)$ and $Y'$ exponentially distributed with parameter $\beta$. Let $Y_1,Y_2,...$ be iid. copies of $Y\cdot Y'$ and $N(T):=\inf\{N\geq0 : \sum_{n=1}^N Y_n>T\}$. Then \[\Psi(T) \leq C(\alpha)\normb{f}\bE N(T) \] \end{lemma} \begin{proof} By construction of the coupling, $\tau_2$ stochastically dominates $Y'$. As we have $\tau=\tau_1\wedge\tau_2$ it follows that $\tau \succeq Y_1$. Using this fact together with the monotonicity of $\Psi$ in \eqref{eq:PsiT}, \begin{align*} \Psi(T) &\leq \sup_{\eta,\xi\in \Omega} \left(\widehat{\bE}_{\eta,\xi} \int_0^\infty f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \,dt + \ind_{\tau\leq T}\Psi(T-\tau)\right) \\ &\leq \sup_{\eta,\xi\in \Omega} \widehat{\bE}_{\eta,\xi} \int_0^\infty f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \,dt + \bE\ \ind_{Y_1\leq T}\Psi(T-Y_1). \end{align*} As $p(\alpha)>0$ by Lemma \ref{lemma:decoupling-estimate} we can iterate this estimate until it terminates after $N(T)$ steps. Therefore we obtain \begin{align*} \Psi(T) &\leq \bE N(T) \sup_{\eta,\xi\in \Omega} \widehat{\bE}_{\eta,\xi} \int_0^\infty f(\theta_{-X_t^1}\eta^1_t) - f(\theta_{-X_t^1}\eta^2_t) \,dt . \end{align*} The integral is estimated by telescoping over single site changes and Lemma \ref{lemma:supnorm-coupling-estimate} in the usual way, yielding \[\Psi(T) \leq C(\alpha)\normb{f}\bE N(T). \] \qed \end{proof} To finally come back to the original question of continuity, \begin{align*} \abs{\mu^{EP}_{\alpha}(f)-\mu^{EP}_{\alpha'}(f)} &= \frac1T \abs{ \int \int \int_0^T S_t^{EP,1}f(\eta) - S_t^{EP,2}f(\xi)\,dt\,\mu^{EP}_{\alpha}(d\eta)\,\mu^{EP}_{\alpha'}(d\xi)} \\ &\leq \frac1T \Psi(T) \leq \frac{1}{T} \bE N(T) C(\alpha) \normb{f} \\ &\konv{T\to\infty} \frac{1}{\bE YY'} C(\alpha) \normb{f}\\ &=\frac{C(\alpha)}{p(\alpha)}\sum_{z\in\bZ^d} \sup_{\eta\in\bZ^d}\abs{\alpha(\eta,z)-\alpha'(\eta,z)} \normb{f}. \end{align*} By sending $\alpha'$ to $\alpha$, the right hand side tends to 0 so that the ergodic measure of the environment process is indeed continuous in the rates $\alpha$. It is also interesting to note that both $p(\alpha)$ and $C(\alpha)$ are rather explicit given the original coupling of the environment. Notably when $\alpha(\eta,z)=\alpha(z)$, i.e. the rates do not depend on the environment, $p(\alpha)=1$ and $C(\alpha) = \int_0^\infty \supl_{\eta,\xi\in \Omega}\widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0))\,dt$. \qed \end{proof} \begin{proof}[Proof of Theorem \ref{thm:EP-phi-estimate}] The proof of this theorem is mostly identical to the proof of Theorem \ref{thm:EP-estimate}. Hence instead of copying the proof, we just state where details differ. A first fact is that the conditions for a) and b) imply Assumptions 1a) and b). In the adaptation of the proof for part a), in most lines it suffices to add a $\phiK$ to the integrals. However, in line \eqref{eq:phi-1}, we use \begin{align} \phiK\leq \phiK[t-\tau]\phiK[\tau] \label{eq:phiK-factor} \end{align} to obtain the estimate \[ \widehat{\bE}_{\eta,0;\xi,0} \phiK[\tau] \int_0^{(T-\tau)\vee0} \phi(t)\abs{ S^{EP}_{t}f(\theta_{-X^1_\tau}\eta^1_\tau)-S^{EP}_{t}f(\theta_{-X^2_\tau}\eta^2_\tau) }\,dt \label{eq:phi-1} \] instead. Thereby in lines \eqref{eq:phi-2}, \eqref{eq:phi-3} and \eqref{eq:phi-4} we have to change $\widehat{\bP}_{\eta,0;\xi,0}(\tau<\infty)$ to $\widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty}$. This change then leads to the replacement of \[ \infl_{\eta,\xi\in\Omega}\widehat{\bP}_{\eta,0;\xi,0}(\tau=\infty)\] by the term \[ 1-\supl_{\eta,\xi\in\Omega}\widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty} \] in the lines \eqref{eq:phi-5} and \eqref{eq:phi-6} (where naturally $C_a$ becomes $C_a(K)$). So all we have to prove that for sufficiently big $K$ \[ \supl_{\eta,\xi\in\Omega}\widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty} < 1. \] In a first step, we show that \[ \supl_{\eta,\xi\in\Omega}\widehat{\bE}_{\eta,0;\xi,0}\phi(\tau)\ind_{\tau<\infty} < \infty. \] As we already saw in the proof of Lemma \ref{lemma:decoupling-estimate}, we can view the event of decoupling as the first jump of a Poisson process with time-dependent and random rates (equation \eqref{eq:dynamic-rate-poisson}). Hence we have \begin{align*} \widehat{\bE}_{\eta,0;\xi,0}\phi(\tau)\ind_{\tau<\infty} &= \int_0^\infty \phi(t)\,d\widehat{\bP}_{\eta,0;\xi,0}(\tau>t)\\ &= \int_0^\infty \phi(t) \widehat{\bE}_{\eta,0;\xi,0} \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_t}\eta^1_t,z)- \alpha(\theta_{-X^1_t}\eta^2_t,z)} \\ &\cdot \exp\left({-\int_0^t \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_s}\eta^1_s,z)- \alpha(\theta_{-X^1_s}\eta^2_s,z)}\,ds}\right) \,dt \\ &\leq \int_0^\infty \phi(t) \widehat{\bE}_{\eta,0;\xi,0} \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_t}\eta^1_t,z)- \alpha(\theta_{-X^1_t}\eta^2_t,z)} \,dt. \end{align*} By telescoping over single site discrepancies and using Lemma \ref{lemma:supnorm-coupling-estimate}, this is less than \[ \int_0^\infty \phi(t) (\norm{\gamma^+-\gamma^-}_\infty+1)^d t^d \supl_{\eta,\xi\in \Omega} \widehat{\bE}^E_{\eta,\xi}\rho(\eta_t^1(0),\eta_t^2(0)) \,dt<\infty \] by assumption. Since $\phi(t/K)$ decreases to 1 as $K\to\infty$, monotone convergence implies \begin{align*} \lim_{K\to\infty} \widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty} = \widehat{\bE}_{\eta,0;\xi,0}\ind_{\tau<\infty}< 1 \end{align*} by Lemma \ref{lemma:decoupling-estimate}. Consequently, there exists a $K_0\geq0$ such that for all $K>K_0$ \[ \widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty} < 1.\] This completes the adaptation of part a). The adaptation of the proof of part b) follows the same scheme, where we add the term $\phiK$ to all integrals. Note that this gives a version of Lemma \ref{lemma:triplenorm-coupling-estimate} as well. Then, in line \eqref{eq:phi-7} we use \eqref{eq:phiK-factor} again and then have to replace $\widehat{\bP}_{\eta,0;\xi,0}(\tau<\infty)$ by $\widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty}$ in lines \eqref{eq:phi-8} and \eqref{eq:phi-9}. To estimate \eqref{eq:phi-9}, we use \begin{align*} \widehat{\bE}_{\eta,0;\xi,0}\phiK[\tau]\ind_{\tau<\infty} &\leq \int_0^\infty \phiK[t] \widehat{\bE}_{\eta,0;\xi,0} \suml_{z\in\bZ^d}\abs{\alpha(\theta_{-X^1_t}\eta^1_t,z)- \alpha(\theta_{-X^1_t}\eta^2_t,z)} \,dt \\ &\leq \int_0^\infty \phiK[t] \suml_{y\in\bZ^d} w_{\alpha} \widehat{\bE}_{\eta,0;\xi,0} \rho(\eta^1_t(y+X_t^1),\eta^2_t(y+X_t^1)) \,dt \end{align*} with $w_\alpha$ as in the original proof. Therefore \begin{align*} &\sumsup \frac{\widehat{\bE}_{\eta,\xi}\phiK[\tau]\inf_{\tau<\infty}}{\rho(\eta(x),\xi(x))} \\ &\quad\leq \sumsup\int_0^\infty \phiK \suml_{y\in\bZ^d} w_\alpha(y) \frac{\widehat{\bE}_{\eta,\xi}\rho(\eta_t^1(y+X_t^1), \eta_t^2(y+X_t^1))}{\rho(\eta(x),\xi(x))} \,dt, \\ \end{align*} which is finite by Lemma \ref{lemma:triplenorm-coupling-estimate}.\qed \end{proof} \section{Law of Large Numbers and Einstein Relation}\label{section:LLN} \subsection{Law of Large Numbers for the position of the walker} \begin{theorem}\label{thm:LLN} Under Assumption 1a, \[ \lim_{T\to\infty}\frac{X_T}{T} = \int \suml_{z\in\bZ^d} z\alpha(\eta,z)\,\mu^{EP}(d\eta) \] in $L_1(\bP_{\nu,0})$ and $\bP_{\nu,0}$-a.s. for any probability measure $\nu$ on $\Omega$. \end{theorem} \begin{proof} First we assume that the only shifts the environment process $\eta_t^{EP}=\theta_{-X_t}\eta_t$ performs are induced by jumps of the walker $X_t$. Assumption 1a does not prohibit the environment to perform shifts itself, but the argument comes more natural when is does not. Let $F_z : D([0,1],\Omega)\to\bR$, $z\in\bZ^d$ count the number of shifts of size $z$ a piece of trajectory performs in the interval $[0,1]$, i.e. \[ F_z(\eta^{EP}_{[t,t+1]}) = \suml_{s\in]0,1]} \ind_{\theta_{-z}\eta^{EP}_{t+s}=\eta^{EP}_{t+s-}}. \] With $F := \sum_{z\in\bZ^d}zF_z$, which is well-defined and in $L^1(\mu^{EP})$ because of the rate condition $\norm{\alpha}_1<\infty$, we then have for any integer $T>0$ \[ X_T - X_0 = \sum_{n=1}^T F(\eta^{EP}_{[n-1,n]}). \] The ergodic theorem then implies \[ \lim_{T\to\infty} \frac{X_T - X_0}{T} = \lim_{T\to\infty}\frac{1}{T}\sum_{n=1}^T F(\eta^{EP}_{[n-1,n]}) = \mu^{EP}(F). \] The same is true for non-integer $T$, as we simply use the fact that $X_T-X_{\lfloor T \rfloor}$ has bounded expectation. Since \begin{align*} \mu^{EP}(F) &= \int \int_0^1 \bE_{\eta,0} \suml_{z\in\bZ^d} z\alpha(\theta_{-X_t}\eta_t,z)\,dt\,\mu^{EP}(d\eta)\\ & = \int \suml_{z\in\bZ^d} z\alpha(\eta,z)\,\mu^{EP}(d\eta), \end{align*} the claim is proven for $\mu^{EP}$ if the environment performs no shifts. In the case that the environment does perform shifts, we introduce an additional auxiliary counting processes $N_t^z$ on $\bN$, $z\in\bZ^d$, where $N_t^z$ increases by one whenever $X_t-X_{t-}=z$ and $N_t^z$ jumps to 0 at rate one to make it stationary. Then $F_z$ counts the number of increments of $N_t^z$ instead of the number of shifts. The rest of the proof is the same. To extend the result to an arbitrary probability measure $\nu$ we use a coupling argument. We look at $\abs{X^1_T-X^2_T}$ under $\widehat{\bP}_{\nu,0;\mu^{EP},0}$, where we slightly modifiy the coupling from Proposition \ref{prop:coupling-construction} so that when the two walkers decouple at a time $\tau$ we restart the coupling of the environment. This restart is done on $\theta_{-X^1_\tau}\eta^{1}_{\tau},\theta_{-X^2_\tau}\eta^{2}_{\tau}$ so that after the decoupling it acts as if both walkers are back at the origin. Then, by Lemma \ref{lemma:decoupling-estimate}, there is at least probability $p>0$ to never decouple initially or after a decoupling. So there is at most a geometric number $N$ of decoupling events at $\tau_1,..\tau_N$, and only at decoupling events the two walkers perform different jumps(one jumps, the other does not). Hence \[ \widehat{\bE}_{\nu,0;\mu^{EP},0} \abs{X^1_T-X^2_T} \leq \widehat{\bE}_{\nu,0;\mu^{EP},0} \suml_{n=1}^N (\abs{X^1_{\tau_n}-X^1_{\tau_n-}}+\abs{X^2_{\tau_n}-X^2_{\tau_n-}}), \] which converges to 0 in $L^1$ and almost surely when diveded by $T$ and sending $T$ to infinity. \qed \end{proof} \subsection{Weak interaction with the environment and an Einstein Relation} It can be interesting to consider random walks which are only weakly affected by an external influence. In the context we study here, that corresponds to rates $\alpha$ which are only weakly dependent on the state $\eta$ of the environment. To study this weak interaction, let $\alpha_\epsilon : \Omega \times \bZ^d \to[0,\infty[\ , 0\leq\epsilon$ be rates for the walker, satisfying the conditions from Section \ref{subsection:rates}. Furthermore we assume that $\epsilon \mapsto \alpha_\epsilon(\eta,z)$ is differentiable in 0 and $\alpha_0(\eta,z)=\alpha_0(z)$, that is for $\epsilon=0$ the walker is independent of the environment. Finally we assume that $\normb{\alpha_\epsilon-\alpha_0}_1 \leq C\epsilon$ for some constant $C>0$. Denote with $v_\epsilon$ the asymptotic speed of the walker with rates $\alpha_\epsilon$. \begin{theorem}\label{thm:second-order} The change of the ergodic measure of the environment process from $\mu^E$, the ergodic measure of the environment, to $\mu^{EP}_\epsilon$, the ergodic measure corresponding to $\alpha_\epsilon$, is a second order influence on the speed $v_\epsilon$ of the walker: \[ \abs{v_\epsilon - \int \suml_{z\in\bZ^d} z \alpha_\epsilon(\eta,z) \,\mu^E(d\eta)} \leq C' \epsilon^2, \] where $C'$ is a constant independent of $\alpha_\epsilon$, $\epsilon\geq0$. \end{theorem} \begin{proof} By Theorem \ref{thm:LLN}, \[ v_\epsilon = \int \suml_{z\in\bZ^d} z \alpha_\epsilon(\eta,z)\,\mu^{EP}_\epsilon(d\eta) . \] Note that $\mu^{EP}_0 = \mu^E$. By Theorem \ref{thm:mu-continuous}, \begin{align*} &\abs{\int \suml_{z\in\bZ^d} z \alpha_\epsilon(\eta,z)\,\mu^{EP}_\epsilon(d\eta) - \int \suml_{z\in\bZ^d} z \alpha_\epsilon(\eta,z)\,\mu^{EP}_0(d\eta)} \\ &\quad\leq C(\alpha_0)\norm{\alpha_\epsilon-\alpha_0}_0 \normb{\suml_{z\in\bZ^d}z\alpha_\epsilon(\cdot,z)} \end{align*} and $C(\alpha_0)$ is in fact independent of $\alpha_0$ as those rates are independent of the environment. The estimates $\norm{\alpha_\epsilon-\alpha_0}_0 \leq \normb{\alpha_\epsilon-\alpha_0}_1 \leq C\epsilon$ and \[ \normb{\suml_{z\in\bZ^d}z\alpha_\epsilon(\cdot,z)} \leq \normb{\alpha_\epsilon}_1 = \normb{\alpha_\epsilon-\alpha_0}_1 \leq C\epsilon\] complete the proof. \qed \end{proof} An \emph{Einstein Relation} is said to hold if the change of speed of the walker because of the external influence is equal to the diffusion constant of the walker in the limit of the influence going to 0, or more precisely \begin{align}\label{eq:ER} \lim_{\epsilon\to 0} \frac{v_\epsilon-v_0}{\epsilon} = \sigma_0^2 \end{align} with $\sigma_0^2 = \sum_{z\in\bZ}z^2\alpha_0(z)$. Note that the typical formulation is in the case $v_0 = 0$. \begin{corollary} The Einstein Relation \eqref{eq:ER} holds iff \[ \suml_{z\in\bZ} z \int \alpha'_0(\eta,z) \,\mu^E(d\eta) = \sum_{z\in\bZ}z^2\alpha_0(z), \] where $\alpha'_0(\eta,z)$ is the derivative in $\epsilon$. Especially, the Einstein Relation holds if \[ \int \alpha'_0(\eta,z) \,\mu^E(d\eta) = z\alpha_0(z) \quad\forall\,z\in\bZ. \] \end{corollary} \begin{proof} By Theorem \ref{thm:second-order}, \[ v_\epsilon = \int \suml_{z\in\bZ^d} z \alpha_\epsilon(\eta,z) \,\mu^E(d\eta) + O(\epsilon^2) \] and hence \[ \lim_{\epsilon\to 0} \frac{v_\epsilon-v_0}{\epsilon} = \suml_{z\in\bZ} z \int \alpha'_0(\eta,z) \,\mu^E(d\eta). \hqed\] \end{proof} \section{Central Limit Theorem}\label{section:CLT} Before starting with the functional central limit theorem for the random walk $(X_t)$ in its random dynamic environment let us quickly discuss the CLT for additive functionals of the environment process. Let us assume that $f:\Omega\to\bR$ with $\normb{f}<\infty$ and $\mu^{EP}(f)=0$. Then \[ \left(L^{EP}\right)^{-1}f(\eta) = -\int_0^\infty S_t^{EP}f(\eta)\,dt, \] where Theorem \ref{thm:EP-estimate} guarantees that the right hand side is well defined. Hence standard arguments provide a functional CLT for additive functionals $\int_0^T f(\eta^{EP}_t)\,dt$ in this context. More work is necessary for a CLT of the position of the walker. The standard approach is to use the fact that the difference between the position of the walker $X_T$ and the cumulate rates $\int_0^T \sum_{z\in\bZ^d}z\alpha(\theta_{-X_t}\eta_t,z)\,dt$ is a martingale. One can prove a CLT for this martingale, and together with the CLT for the drift-adjusted integral obtain a CLT for the position. However, one has to take care that that the variances do not annihilate, and generally there is no explicit formulation of the variance. As the martingales used in the appendix provide an alternative method for obtaining a CLT which does include an explicit formulation of the variance, we explore that approach. \subsection{A second assumption on the environment}\label{section:assumption2} There is one additional assumption on the environment required to easily use the martingales(and the moment estimates they provide). \begin{assumption}[2] There exists a constant $R^E\geq0$ such that for any $f : \Omega \to \bR$ with $\normb{f}<\infty$, \begin{align}\label{eq:assumption-2} \overline{L}^{E}(f-f(\eta))^2(\eta) := \limsup_{\epsilon\to0}\frac{1}{\epsilon}S^E_\epsilon (f-f(\eta))^2(\eta) \leq R^{E}\normb{f}^2 . \end{align} \end{assumption} This assumption might look artificial but the following lemma shows that Assumption 2 is in fact well behaved. \begin{lemma}\label{lemma:A2-fg} Assume Assumption 2. Then, for any $f,g: \Omega\to\bR$ with $\normb{f},\normb{g}<\infty$, the corresponding more general estimate holds: \[ \abs{\overline{L}^E[(f-f(\eta))(g-g(\eta))](\eta)}\leq R^E\normb{f}\normb{g}. \] \end{lemma} \begin{proof} It is a direct consequence of Lemma \ref{lemma:chauchy-schwarz} and Assumption 2. \end{proof} Now we extend Assumption 2 from the environment to the environment process. \begin{lemma}\label{lemma:EP-A2} Under Assumption 2, for any $f : \Omega \to \bR$ with $\normb{f}<\infty$, \[ \overline{L}^{EP}(f-f(\eta))^2(\eta) := \limsup_{\epsilon\to0}\frac{1}{\epsilon}S^{EP}_\epsilon (f-f(\eta))^2(\eta) \leq R^{EP}\normb{f}^2 \] with $R^{EP}=R^E+\normb{\alpha}+2\norm{\alpha}_0$. \end{lemma} \begin{proof} As the generator of the environment process is $L^{EP} = L^E + L^{S}$, with \[ L^{S}f(\eta) = \suml_{z\in\bZ^d}\alpha(\eta,z)\left[f(\theta_{-z}\eta)-f(\eta)\right] \] being the shifts induced by the random walk jumps, all we need to proof is that $L^{S}$ is a bounded operator in terms of the $\normb{\cdot}$-norm: \begin{align*} &\sumsup \left(L^{S}f(\eta)-L^{S}f(\xi)\right) \\ &\quad= \sumsup \suml_{z\in\bZ^d}\left(\alpha(\eta,z)\left[f(\theta_{-z}\eta)-f(\eta)\right] - \alpha(\xi,z)\left[f(\theta_{-z}\xi)-f(\xi)\right] \right) \\ &\quad\leq \sumsup \suml_{z\in\bZ^d}\left(\alpha(\eta,z)-\alpha(\xi,z)\right)\left[f(\theta_{-z}\eta)-f(\eta)\right] \\ &\qquad + \sumsup \suml_{z\in\bZ^d}\alpha(\xi,z)\left[f(\theta_{-z}\eta)-f(\eta) - f(\theta_{-z}\xi)+f(\xi)\right] . \end{align*} The first term is easily estimated by $\normb{\alpha}\norm{f}_{osc}\leq\normb{\alpha}\normb{f}$. For the second term, it is smaller than \begin{align*} \suml_{z\in\bZ^d}\sup_{\xi\in \Omega}\alpha(\xi,z) 2\normb{f} =: 2\norm{\alpha}_{0}\normb{f}. \end{align*} So in total we get \[ \norm{L^{S}}_{\normb{\cdot}\to\normb{\cdot}} \leq \normb{\alpha}+2\norm{\alpha}_0 \] \qed \end{proof} \subsection{CLT for the path of the random walk} The CLT for the path of the random walk is proven in two steps. First we show that a martingale which corresponds to fluctuations in a specific direction converges to Brownian motion. Secondly, we we use the convergence of those martingales to obtain the full functional central limit theorem. \begin{proposition}\label{prop:martingale-CLT} Assume Assumption 1b and 2 as well as $\norm{\alpha}_2<\infty$. Fix $v\in\bR^d$ with $\norm{v}=1$ and write $f:\Omega\times\bZ^d \to \bR, f(\eta,x)=\left<x,v\right>$. Define for each $T>0$ the martingales \[ M_T(t) := T^{-\frac12}\left(\erwc{f(\eta_T,X_T)}{\fF_{tT}}-\erwc{f(\eta_T,X_T)}{\fF_{0}}\right),\quad 0\leq t\leq T. \] Then $(M_T(t))_{0 \leq t\leq 1}$ converges to Brownian motion with variance \[ \int L\left(\Phi_{0,\infty}-\Phi_{0,\infty}(\eta,0) + f-f(\eta,0) \right)^2(\eta,0) \,\mu^{EP}(d\eta), \] where \[ \Phi_{0,\infty}-\Phi_{0,\infty}(\eta,0) = \suml_{z\in\bZ^d}<z,v> \int_0^\infty S_t^{EP}[\alpha(\cdot,z)]-S_t^{EP}[\alpha(\cdot,z)](\eta) \,dt. \] \end{proposition} \begin{proof} By Proposition \ref{prop:point-quadratic-variation}, the predictable quadratic variation is given by \[ \left<M_T\right>_t = \frac1T \int_0^{tT} L\left(S_{T-s}f-S_{T-s}f(\eta_s,X_s)\right)^2(\eta_s,X_s)\,ds. \] We want to take the limit $T\to\infty$, and to that end we first rewrite the inner term via \begin{align*} S_t f(\eta,x) &= \int_0^t S_s^{EP} \suml_{z\in\bZ^d} [\alpha(\cdot,z)\left<z,v\right>](\theta_{-x}\eta) \,ds + \left<x,v\right>\\ &= \Phi_{0,t}(\eta,x) + f(\eta,x) \end{align*} with \[ \Phi_{t,t'}(\eta,x) := \suml_{z\in\bZ^d}\left<z,v\right>\int_t^{t'} S_s^{EP} [\alpha(\cdot,z)](\theta_{-x}\eta) \,ds \] for shorter notation. To replace $\Phi_{0,t}$ by $\Phi_{0,\infty}$, we observe that \begin{align*} & | L\left[\Phi_{0,t}-\Phi_{0,t}(\eta,x) + f-f(\eta,x)\right]^2(\eta,x) \\ &\qquad- L\left[\Phi_{0,\infty}-\Phi_{0,\infty}(\eta,x) + f-f(\eta,x)\right]^2(\eta,x) |\\ &= \left| L\left[(\Phi_{t,\infty}-\Phi_{t,\infty}(\eta,x))(\Phi_{0,t}- \Phi_{0,t}(\eta,x) + \Phi_{0,\infty} - \Phi_{0,\infty}(\eta,x) + 2f-2f(\eta,x)\right](\eta,x) \right| \\ &\leq \left(\overline{L}\left[\Phi_{t,\infty}-\Phi_{t,\infty}(\eta,x)\right]^2(\eta,x)\right)^{\frac12} \\ &\qquad \cdot \left(\overline{L}\left[\Phi_{0,t}- \Phi_{0,t}(\eta,x) + \Phi_{0,\infty} - \Phi_{0,\infty}(\eta,x) + 2f-2f(\eta,x)\right]^2(\eta,x)\right)^{\frac12}, \end{align*} where the last line is a consequence of Lemma \ref{lemma:chauchy-schwarz}. As $\Phi$ is effectively a function of the environment process $\theta_{-x}\eta$, we can use Lemma \ref{lemma:EP-A2} for the estimate \[ \overline{L}\left[\Phi_{t,\infty}-\Phi_{t,\infty}(\eta,x)\right]^2(\eta,x)\leq R^{EP}\normb{\Phi_{t,\infty}}^2. \] The second factor is estimated similarly after first using $(a+b)^2\leq 2a^2+2b^2$ by \begin{align*} &2 R^{EP}\normb{\Phi_{0,t}+\Phi_{0,\infty}}^2 + 8 \overline{L}(f-f(\eta,x))^2(\eta,x) \\ &\leq R^{EP}(\normb{\Phi_{0,t}}+\normb{\Phi_{0,\infty}})^2 + 8 \suml_{z\in\bZ^d}\alpha(\theta_{-x}\eta,z)\left<z,v\right>^2. \end{align*} By the second moment assumption $\norm{\alpha}_2<\infty$ the right summand is bounded, and using Theorem \ref{thm:EP-estimate}, $\normb{\Phi_{0,t}}\leq C_b \normb{\alpha}_1$, and $\normb{\Phi_{t,\infty}}\konv{t\to\infty}0$. Coming back to the quadratic variation of the martingale $M_T$, we can now conclude that \begin{align*} \lim_{T\to\infty} \left<M_T\right>_t &= \lim_{T\to\infty} \frac1T \int_0^{tT} L\left(S_{T-s}f-S_{T-s}f(\eta_s,X_s)\right)^2(\eta_s,X_s)\,ds \\ &= \lim_{T\to\infty} \frac1T \int_0^{tT} L\left(\Phi_{0,\infty}-\Phi_{0,\infty}(\eta_s,X_s) + f-f(\eta_s,X_s) \right)^2(\eta_s,X_s)\,ds \\ &= \lim_{T\to\infty} \frac1T \int_0^{tT} L\left(\Phi_{0,\infty}-\Phi_{0,\infty}(\theta_{-X_s}\eta_s,0) + f-f(\theta_{-X_s}\eta_s,0) \right)^2(\theta_{-X_s}\eta_s,0)\,ds \\ &= t\int L\left(\Phi_{0,\infty}-\Phi_{0,\infty}(\eta,0) + f-f(\eta,0) \right)^2(\eta,0) \,\mu^{EP}(d\eta) . \end{align*} Now that we have the converge of the predictable quadratic variation, all that remains to obtain the CLT for the martingale $M_T$ is to show that its jumps vanish in the limit: \[ \lim_{T\to\infty}\bE\sup_{0\leq t\leq 1} \left(M_T(t)-M_T(t-)\right)^2 =0. \] To obtain this, we use that \begin{align*} &M_T(t)-M_T(t-) \\ &\quad= T^{-\frac12}\left(S_{T-tT}f(\eta_{tT},X_{tT})-S_{T-tT}f(\eta_{tT-},X_{tT-})\right) \\ &\quad= T^{-\frac12}\left(\Phi_{0,T-tT}(\eta_{tT},X_{tT})-\Phi_{0,T-tT}(\eta_{tT-},X_{tT-}) + f(\eta_{tT},X_{tT})-f(\eta_{tT-},X_{tT-})\right) \\ &\quad= T^{-\frac12}\left(\Phi_{0,T-tT}(\eta_{tT},X_{tT})-\Phi_{0,T-tT}(\eta_{tT-},X_{tT-}) + \left<X_{tT}-X_{tT-},v\right>)\right). \\ \end{align*} As we already now that the difference of the two $\Phi$'s is uniformly bounded, it is only necessary to look at the jumps of $X_t$: \begin{align*} &\frac1T\bE\supl_{0\leq t\leq T}\norm{X_t-X_{t-}}^2 \\ &\quad\leq \frac{\lambda^2}{T}\bP(\text{all jumps }\leq \lambda) + \frac1T \bE\supl_{0\leq t\leq T}\norm{X_t-X_{t-}}^2\ind_{\{\text{some jump }> \lambda\}} \\ &\quad\leq \frac{\lambda^2}{T} + \frac1T \suml_{\norm{z}>\lambda} \norm{z}^2 \bP(\exists\ 0\leq t \leq T : X_t -X_{t-}=z) \\ &\quad\leq \frac{\lambda^2}{T} + \frac1T \suml_{\norm{z}>\lambda} \norm{z}^2 T \sup_{\eta \in \Omega}\alpha(\eta,z) \\ &\quad= \frac{\lambda^2}{T} + \suml_{\norm{z}>\lambda} \sup_{\eta \in \Omega}\alpha(\eta,z)\norm{z}^2. \\ \end{align*} By the second moment condition $\norm{\alpha}_2<\infty$, the sum on the right converges to 0 as $\lambda\to\infty$. So when we choose for example $\lambda=T^{\frac14}$, the right hand side converges to 0 as $T\to\infty$, which proves the functional CLT for $(M_T(t))_{0\leq t\leq 1}$. \qed \end{proof} \begin{theorem}\label{thm:CLT} Assume Assumption 1b and 2 and $\norm{\alpha}_2<\infty$. Let \[ v=\int\suml_{z\in\bZ^d}\alpha(\eta,z)z\,\mu^{EP}(d\eta) \] be the asymptotic speed of the random walk $(X_t)_{t\geq0}$. Then \[ \left((T^{-\frac12} (X_{tT}-vtT)\right)_{0\leq t\leq 1} \] converges in probability to a Brownian motion with covariance matrix \begin{align}\label{eq:CLT-var} \Sigma^2 = \int L\left[\left( A_\eta + id_x\right) \left(A_\eta + id_x\right)^T\right](\eta,0)\,\mu^{EP}(d\eta), \end{align} where $A_\eta : \Omega\times\bZ^d \to \bR^d$ with \[ A_\eta(\xi,x) := \suml_{z\in\bZ^d}z\int_0^\infty S_t^{EP}[\alpha(\cdot,z)](\theta_{-x}\xi)-S_t^{EP}[\alpha(\cdot,z)](\eta)\,dt \] and $id_x(\xi,x)=x$. \end{theorem} \begin{proof} Define the $d$-dimensional martingale \[ M_T(t) := T^{-\frac12}\left( \erwc{X_T}{\fF_{tT}}-\erwc{X_T}{\fF_0} \right). \] By Proposition \ref{prop:martingale-CLT} the projection onto any unit vector $u\in\bR^d$ converges to a Brownian motion with variance \begin{align*} &\int L\left( <A_\eta,u> + <id_x,u> \right)^2(\eta,0)\,\mu^{EP}(d\eta) \\ &\quad= u^T \int L\left[\left( A_\eta + id_x\right) \left(A_\eta + id_x\right)^T\right](\eta,0)\,\mu^{EP}(d\eta) \,u. \end{align*} As the projected martingales are adapted to $(\fF_t)$, the $\sigma$-algebra of $M_T$, that implies that $M_T$ converges to a Brownian motion with the given covariance matrix. Since $M_T(1)=T^{-\frac12}\left( X_T - \bE_{\eta_0,0}X_T \right)$ we can already conclude a central limit theorem. To obtain the functional central limit theorem, we simply use the fact that $M_T(t)$ is close to $T^{-\frac12}\left(X_{tT}-vtT\right)$: \begin{align*} T^{\frac12}M_T(t) &= \erwc{X_T}{\eta_{tT},X_{tT}} - \erwc{X_T}{\eta_{0},X_{0}} \\ &= \int_0^{T-tT} \suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\theta_{-X_{tT}}\eta_{tT})+X_{tT} \\ &\qquad - \int_0^T\suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\eta_{0}). \end{align*} When we split the last integral at $tT$, we notice that the part up to $tT$ is close to $vtT$: \begin{align*} &\abs{\int_0^{tT}\suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\eta_{0}) - vtT} \\ &\quad= \abs{\int_0^{tT}\suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\eta_{0})-\int \int_0^{tT}\suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\xi)\,\mu^{EP}(d\xi)} \\ &\quad \leq C_a \normb{\alpha}_1 \end{align*} by Theorem \ref{thm:EP-estimate}. Similarly, the part after $tT$ almost annihilates with the integral from $0$ to $T-tT$: \begin{align*} &\abs{\int_0^{T-tT} \suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\theta_{-X_{tT}}\eta_{tT}) - \int_{tT}^T\suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\eta_{0})} \\ &\quad= \abs{\int_0^{T-tT} \suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\theta_{-X_{tT}}\eta_{tT}) - \bE_{\eta_0,0} \int_{0}^{T-tT}\suml_{z\in\bZ^d}z S_s^{EP}[\alpha(\cdot,z)](\theta_{-X_{tT}}\eta_{tT})} \\ &\quad \leq C_a\normb{\alpha}_1. \end{align*} So \[ \abs{M_T(t) - \frac{X_tT-vtT}{T^{\frac12}}} \leq \frac{2C_a\normb{\alpha_1}}{T^{\frac12}}, \] and the convergence of the drift-adjusted random walk follows to Brownian motion follows from the convergence of $M_T$.\qed \end{proof} \subsection{Some remarks on the variance} A first comment is that the variance \eqref{eq:CLT-var} is indeed non-degenerate. We remember that the generator $L$ acts as a positive operator, as $A_\eta(\eta,0) = 0$ and $id_x(\eta,0)=0$. By splitting $L = L^E + L^{RW}$, we furthermore see that either $L^E \left[A_\eta A_\eta^T\right](\eta)$ is $\mu^{EP}$-a.s. 0, which implies $A_\eta =0$, or the variance is already positive by contributions from the environment alone. If $A_\eta=0$, then the second half becomes \[ L^{RW}\left[id_x id_x^T\right](\eta,0) = \suml_{z\in \bZ^d} z z^T \alpha(\eta,z), \] which is 0 if and only of the rates $\alpha$ are 0 $\mu^{EP}$-a.s., in which case the walker is degenerate by construction. However we can also use the explicit formulation of the variance to study the behaviour as the speed of the environment is increased. For a positive $\lambda$ denote by \[ L^\lambda = \lambda L^E + L^{RW} \] the generator where the environment runs at speed $\lambda$. By noticing that the new system corresponds to one where the rates are scaled by $1/\lambda$ plus a rescaling of time by $\lambda$ (or by following the proof of Theorem \ref{thm:EP-estimate}) one can see that $A^\lambda_\eta \in O(\lambda^{-1})$. Hence \[ \lim_{\lambda\to\infty} \lambda L^E \left[A^{\lambda}_\eta (A^{\lambda}_\eta)^T \right](\eta) = 0 \] and \[ \lim_{\lambda\to\infty} L^{RW} \left[(A^{\lambda}_\eta+id_x) (A^{\lambda}_\eta+id_x)^T \right](\eta) = L^{RW} \left[id_x id_x^T \right](\eta) = \suml_{z\in\bZ^d} z z^T \alpha(\eta,z). \] As the ergodic measure of the environment process converges to $\mu^E$, the ergodic measure of the environment, we obtain that the variance $\Sigma_\lambda^2$ converges to \[ \int \suml_{z\in\bZ^d} z z^T \alpha(\eta,z)\,\mu^E(d\eta), \] the variance when averaging of the environment. \section{Concentration estimates}\label{section:RWRE-concentration} In this section we will obtain detailed results about the deviation from the mean of additive functionals of the environment process and of the position of the walker itself. It is comparatively easy to obtain those from general methods. Let us do a quick overview of the general ingredients we use here to obtain concentration of additive functionals of Markov processes. Those are general and not specific to this setting. One part is the existence of a suitable estimate of the form \begin{align}\label{eq:concentration-condition-1} [L(g-g(y))^2](y) \leq R \normb{g}^2. \end{align} The second part is an estimate of \begin{align}\label{eq:concentration-condition-2} \normb{\int_0^T S_t f\,dt} \leq C_T \normb{f}. \end{align} In general, an estimate of $\norm{\int_0^T S_tf\,dt}_{osc}$ is also convenient, but in our case that is implied, as $\norm{g}_{osc}\leq \normb{g}$ (note that $\normb{\cdot}$ could be any kind of norm-like object in a different context). If estimates \eqref{eq:concentration-condition-1} and \eqref{eq:concentration-condition-2} are satisfied, then concentration estimates follow for additive functionals $\int_0^T f(X_t)\,dt$. The reader is referred to \cite{} for a more in-depth look at those methods. Section \ref{section:concentration} contains similar methods to obtain concentration for $f(X_T)$ instead of additive functionals. In our context, Assumption 1b guarantees \eqref{eq:concentration-condition-2} for the environment, and Theorem \ref{thm:EP-estimate},b) lifts that to the environment process. Similarly, Assumption 2 provides \eqref{eq:concentration-condition-1} for the environment and Lemma \ref{lemma:EP-A2} for the environment process. \subsection{Concentration of additive functionals of the environment process} \begin{theorem}\label{thm:concentration-EP-exp} Assume Assumptions 1b and 2. Then there exists a constant $D>0$ so that for any $f:\Omega \to \bR$ with $\normb{f}<\infty$ the deviation estimate \[ \bP^{EP}_{\nu_1} \left(\int_0^T f(\eta^{EP}_t)\,dt > C_a\normb{f} (r+1) + \int_0^T \nu_2 \left(S^{EP}_t f\right)\,dt\right) \leq e^{-\frac{ r^2}{TD}} \] holds for any $r\geq0$ and any probability measures $\nu_1,\nu_2$ on $\Omega$. In the case that $\nu_1,\nu_2$ are equal and point measures, the same holds with $(r+1)$ replaced by $r$. \end{theorem} The idea of the proof is to use Lemma \ref{lemma:exponential-concentration}. Before starting with the proof, we state a fact which is highly useful to prove the conditions of the general concentration estimates. \begin{lemma}\label{lemma:oL-trick}\mbox{} \begin{enumerate} \item Let $f: \Omega\to\bR$ with $\norm{f}_{osc}<\infty$. Then \[ \overline{L}[(f-f(\eta))^k](\eta) \leq \norm{f}_{osc}^{k-2}\overline{L}(f-f(\eta))^2(\eta); \] \item Fix $\eta\in \Omega$, and let $g_\eta, f_\eta:E\to\bR$ satisfy $f_\eta(\eta),g_\eta(\eta)=0$ and $f_\eta\leq g_\eta$. Then \[ \overline{L} f_\eta \leq \overline{L} g_\eta . \] \end{enumerate} \end{lemma} \begin{proof} a) Is a direct consequence of b) with $f_\eta = (f-f(\eta))^k$ and $g_\eta = \norm{f}_{osc}^{k-2}(f-f(\eta))^2$. b) Follows by definition of $\overline{L}$: $\overline{L} f_\eta = \limsup_{\epsilon\to0}\frac1\epsilon S_\epsilon f_\eta \leq \limsup_{\epsilon\to0} \frac1\epsilon S_\epsilon g_\eta = \overline{L} g_\eta$. \qed \end{proof} \begin{remark} This lemma is completely general and not restricted to this context. \end{remark} \begin{proof}[Proof of Theorem \ref{thm:concentration-EP-exp}] We want to apply Lemma \ref{lemma:exponential-concentration}. So we first prove that \begin{align}\label{eq:proof-1} \overline{L}^{EP} \left(\int_0^{T'} S^{EP}_t f - S^{EP}_tf(\eta)\,dt\right)^k(\eta) < D'\left(C_a\normb{f}\right)^k \end{align} for any $T'>0, \eta \in \Omega$ and $k\in \bN, k\geq2$. Recall that by Theorem \ref{thm:EP-estimate} part a), \[ \norm{\int_0^{T'} S_t^{EP}f}_{osc} \leq C_a \normb{f}. \] Therewith, using Lemma \ref{lemma:oL-trick} a), \begin{align*} &\overline{L}^{EP} \left(\int_0^{T'} S^{EP}_t f - S^{EP}_tf(\eta)\,dt\right)^k(\eta) \\ &\quad\leq \left(C_a\normb{f}\right)^{k-2} \overline{L}^{EP} \left(\int_0^{T'} S^{EP}_t f - S^{EP}_tf(\eta)\,dt\right)^2(\eta). \end{align*} By Lemma \ref{lemma:EP-A2}, \begin{align*} &\overline{L}^{EP} \left(\int_0^{T'} S^{EP}_t f - S^{EP}_tf(\eta)\,dt\right)^2(\eta) \\ &\quad\quad \leq R^{EP}\normb{\int_0^{T'} S^{EP}_t f - S^{EP}_tf(\eta)\,dt }^2 . \end{align*} Using Theorem \ref{thm:EP-estimate} part b) for the estimate \[ \normb{\int_0^{T'} S^{EP}_t f - S^{EP}_tf(\eta)\,dt}\leq C_b\normb{f}, \] we choose $D'= \frac{R^{EP}C_b^2}{C_a^2}$ to obtain \eqref{eq:proof-1}. As a direct consequence, Lemma \ref{lemma:exponential-concentration} implies \[ \bP^{EP}_{\nu_1} \left(\int_0^T f(\eta^{EP}_t)\,dt > C_a\normb{f} (r+1) + \int_0^T \nu_2 \left(S^{EP}_t f\right)\,dt\right) \leq e^{-\frac{ \frac12r^2}{TD'+\frac13r}}. \] Since $\normb{f}\geq \norm{f}_{osc}$, the left-hand-side is in fact 0 for $r\geq \frac{T}{C_a}$. So we can further estimate that probability by replacing $\frac13 r$ by $\frac{T}{3C_a}$. Choosing $D= 2D'+\frac{2}{3C_a}$ completes the proof. \qed \end{proof} \subsection{Concentration estimates for the position of the walker} Note how Theorem \ref{thm:concentration-EP-exp} already gives us a strong concentration property for the rates of the walker $X_t$. However, it is a bit more tricky to obtain good concentration estimates for the position of the walker itself. For concentration results for the position of the walker, we need moment conditions on the transition rates of the walker which are comparable to the strength of the concentration estimate. For example, if the jumps are of bounded size or have some exponential moment, then we obtain a concentration estimate which is Gaussian for small and exponential for large deviations. Note that it is impossible to obtain pure Gaussian concentration, as the example of jumps with rate 1 of size 1 to the right, independent of the environment, i.e. a Poisson process, shows. \begin{theorem}\label{thm:concentration-walker-exp} Assume Assumptions 1b and 2. Also assume that $\normb{\alpha}_1<\infty$ and that there exists some $M<\infty$ so that the bound $\norm{\alpha}_k \leq M^k$ is satisfied for any $k\in\bN$. Then there exist constants $c_1,c_2>0$ so that for any probability distributions $\nu_1,\nu_2$ on $\Omega$ and any $r>0$ \[ \bP_{\nu_1,0}\left( \norm{X_T- \bE_{\nu_2,0}X_T}> c_1 r+2dC_a\normb{\alpha}_1\right) \leq 2de^{-\frac{\frac12 r^2}{Tc_2 + \frac13r}}. \] \end{theorem} If only some moments for the jumps of the walker exist, then we still get a concentration estimate, although it is correspondingly weaker. \begin{theorem}\label{thm:concentration-walker-moment} Assume Assumptions 1b and 2. Fix $p>1$. Assume that $\normb{\alpha}_1<\infty$ and $\norm{\alpha}_p < \infty$. Then there exist a constant $c>0$ depending on the process, but not on $p$, and a constant $c_p$ depending only on $p$ so that for any probability distributions $\nu_1,\nu_2$ on $\Omega$ and any $r>0$ \[ \bP_{\nu_1,0}\left( \norm{X_T- \bE_{\nu_2,0}X_T}> r\right) \leq c_p \frac{c^p(T^{\frac p2}+1)}{r^p}. \] \end{theorem} The remainder of this section will deal with the proofs of the theorems. The next lemma will verify the conditions of more general theorems in Section \ref{section:concentration}, from which the results for the walker are immediate. \begin{lemma}\label{lemma:walker-oL-estimate} Assume Assumptions 1b and 2. For any vector $v\in\bR^d$ with $\norm{v}=1$ we consider the function $f_v : \Omega \times \bZ^d \to \bR, f_v(\eta,x) = <x,v>$. Then \[ \overline{L}\left(S_t f_v- S_t f_v(\eta,x)\right)^k(\eta,x) \leq 2^k (R^{EP})C_b^2 C_a^{k-2}\normb{\alpha}_1^k + 2^k\norm{\alpha}_k^k. \] \end{lemma} \begin{proof} We first note that $f_v$ is in the domain of the generator $L$, with \[ Lf(\eta,x) = \suml_{z\in\bZ^d}\alpha(\theta_{-x}\eta,z)<z,v>. \] Since this is uniformly bounded in $\eta$ and $x$ the condition of Proposition \ref{prop:exponential-point} is satisfied. Also observe that \[ S_t f_v(\eta,x) = \int_0^t S_r^{EP}\underbrace{\left( \suml_{z\in\bZ^d}\alpha(\cdot,z)<z,v>\right)}_{=:g(\cdot)}(\theta_{-x}\eta)\,dr + f_v(\eta,x). \] With this in mind, using Lemma \ref{lemma:oL-trick} \begin{align*} &\overline{L} (S_t f_v -S_t f_v(\eta,x))^k(\eta,x) \\ &\quad= \overline{L} \left( \int_0^r S_r^{EP}g(\theta_{-\cdot}\cdot) - S_r^{EP}g(\theta_{-x}\eta)\,dr + f_v-f_v(\eta,x)\right)^k(\eta,x) \\ &\quad\leq 2^k \overline{L} \left( \int_0^r S_r^{EP}g(\theta_{-\cdot}\cdot) - S_r^{EP}g(\theta_{-x}\eta)\,dr\right)^k(\eta,x) + 2^k \overline{L} \left( f_v-f_v(\eta,x)\right)^k(\eta,x). \end{align*} To estimate the right hand term, as $f_v$ is independent of $\eta$, \begin{align*} \overline{L}\left(f_v-f_v(\eta,x)\right)^k(\eta,x) &= \suml_{z\in\bZ^d}\alpha(\theta_{-x}\eta,z)<z,v>^k \\ &\leq \suml_{z\in\bZ^d} \supl_{\eta \in \Omega}\alpha(\eta,z) \norm{z}^k = \norm{\alpha}_k^k. \end{align*} To treat the left hand term, we first notice that it can be rewritten in terms of the generator of environment process: \[ \overline{L} \left( \int_0^r S_r^{EP}g(\theta_{-\cdot}\cdot) - S_r^{EP}g(\theta_{-x}\eta)\,dr\right)^k(\eta,x) = \overline{L}^{EP} \left( \int_0^r S_r^{EP}g - S_r^{EP}g(\theta_{-x}\eta)\,dr\right)^k(\theta_{-x}\eta). \] Next, we use Theorem \ref{thm:EP-estimate},b) with the fact that $\normb{g}\leq\normb{\alpha}_1$ to obtain that \[ \normb{\int_0^t S_r^{EP}g\,dr}\leq C_b \normb{\alpha}_1. \] Together with Lemma \ref{lemma:EP-A2} we therefore arrive at \[ \overline{L} \left( \int_0^r S_r^{EP}g(\theta_{-\cdot}\cdot) - S_r^{EP}g(\theta_{-x}\eta)\,dr\right)^2(\eta,x) \leq R^{EP}C_b^2\normb{\alpha}_1^2 .\] Higher moments we reduce to second moments via Lemma \ref{lemma:oL-trick} utilizing Theorem \ref{thm:EP-estimate},a): \begin{align*} &\abs{ \int_0^r S_r^{EP}g(\theta_{-\cdot}\cdot) - S_r^{EP}g(\theta_{-x}\eta)\,dr }^k(\eta,x) \\ &\quad\leq C_a^{k-2}\normb{\alpha}_1^{k-2}\left( \int_0^r S_r^{EP}g(\theta_{-\cdot}\cdot) - S_r^{EP}g(\theta_{-x}\eta)\,dr\right)^2(\eta,x) . \end{align*} \qed \end{proof} \begin{proof}[Proof of Theorem \ref{thm:concentration-walker-exp}] Let $e_i$ be an orthonormal basis of $\bR^d$, and write $e_{i+d}:=-e_i$. Then \begin{align*} &\bP_{\nu_1,0}\left( \norm{X_T- \bE_{\nu_2,0}X_T}> r+2dC_a\normb{\alpha}_1\right) \\ &\quad\leq \suml_{i=1}^{2d} \bP_{\nu_1,0}\left( f_{e_i} (X_T) - \bE_{\nu_2,0} f_{e_i}(X_T) > \frac{1}{2d} r+C_a\normb{\alpha}_1\right). \end{align*} Those probabilities we can estimate with Corollary \ref{corollary:exponential-point}, whose condition is satisfied according to Lemma \ref{lemma:walker-oL-estimate} and the conditions of this theorem. At this point we use the fact that \[ S_Tf_{e_i}(\eta,0)-S_Tf_{e_i}(\xi,0) = \int_0^T S^{EP}_t g_i(\eta) - S^{EP}_t g_i(\xi)\,dt \] with $g_i(\eta) = \suml_{z\in\bZ^d} \alpha(\eta,z)f_{e_i}(z)$ to get the estimate $C_a\normb{\alpha}_1$ for the constant $a$ in Corollary \ref{corollary:exponential-point}. The constants $c_1,c_2$ are chosen appropriately. \qed \end{proof} \begin{proof}[Proof of Theorem \ref{thm:concentration-walker-moment}] We will only give a rough sketch of the proof. It is an application of Theorem \ref{thm:moment-estimate} to obtain an estimate on the $p$th moment plus Markov's inequality. To use the estimate in Theorem \ref{thm:moment-estimate}, the general idea is to use the fact that \[ \bE_x X_t = \int_0^t S^{EP}_{s}[\suml{z\in\bZ^d}z\alpha(\cdot,z)](x) + x, \] together with applications of Theorem \ref{thm:EP-estimate}. The first term on the right hand side of the estimate in Theorem \ref{thm:moment-estimate} is the main contributor and can be estimated by \[ T^{\frac p2}2^{\frac p2}\left[(C_b^p\normb{\alpha}_1^p(R^E + \norm{L^J}_{\normb{\cdot}\to\normb{\cdot}})^p +\norm{\alpha}_2^p\right] . \] The second term is estimated by \[ 2^p\left(C_b^p\normb{\alpha}_1^p+\norm{\alpha}_p^p\right) \] and the third by \[ (C_a\normb{\alpha}_1)^p .\] Combining various constants, we then get the estimate \[ \bE_{\nu_1}\norm{X_T-\bE_{\nu_2}X_T}^p \leq c_p C^p(T^{\frac p2}+1). \]\qed \end{proof} \subsection{Transience and recurrence} Using the concentration estimates and the convergence to Brownian motion, questions like transience or recurrence of the walker can be treated rather easily. The following two statements about transience and recurrence are not meant to be exhaustive, instead they showcase how typical use the stronger statements of the previous sections. \begin{theorem}[Transience] Assume Assumptions 1b and 2 and suppose $\norm{\alpha}_{2+\epsilon}<\infty$ for some $\epsilon>0$. If asymptotic speed $v=\lim_{t\to\infty}\frac{X_t}{t}$ is non-zero, then the random walk $X_t$ is transient. \end{theorem} \begin{proof} Since $a:=\sum_{z\in\bZ^d}\sup_{\eta\in \Omega} \alpha(\eta,z)<\infty$, the duration the walker $X_t$ stays at the origin at each visit is at least $exp(a)$-distributed. Hence it is sufficient for transience to show that $\bP_{0,\eta}(X_t=0)$ is integrable in $t$, which can be seen from Theorem \ref{thm:concentration-walker-moment}: \begin{align*} \bP_{\eta,0}(X_t=0) &\leq \bP_{\eta,0}(\abs{X_t-vt}\geq vt) \leq \left(c_{2+\epsilon}c^{2+\epsilon}\frac{t^{\frac{2+\epsilon}{2}}+1}{(vt)^{2+\epsilon}}\right)\wedge 1, \end{align*} where we used the fact that \[ vt = \bE_{\mu^{EP},0}X_t. \] \qed \end{proof} \begin{theorem}[Recurrence] Let the dimension $d=1$ and assume Assumptions 1b and 2. Suppose the walker only has jumps of size 1, i.e. \[ \alpha(\eta,z)= 0 \quad \forall\,\eta\in E^{bZ^d},z\neq \{-1,1\}, \] and that it has 0 speed. Then $X_t$ is recurrent. \end{theorem} \begin{proof} By Theorem \ref{thm:CLT}, $T^{-\frac12}X_{tT}$ converges to Brownian motion. Hence there exists(with probability 1) an infinite sequence $t_1<t_2<\dots$ of times with $X_{t_{2n}}<0$ and $X_{t_{2n+1}}>0$, $n\in\bN$. As the walker has only jumps of size 1, it will traverse the origin between $t_n,t_{n+1}$ for any $n\in \bN$. \qed \end{proof} \section{Appendix: General concentration results}\label{section:concentration} In this section we will prove general concentration results for Markov processes. Hence we will forget the connection to random walks in dynamic random environments. To avoid a clash of notation, we will assume that $F$ is a polish space, elements of it are denoted $x,y$, $(Y_t)_{t\geq0}$ a Feller process on $F$, with generator $A$ and semigroup $(P_t)_{t\geq0}$ (on an appropriate space like $\cC_0(F), \cC_b(F), \cC(F), \cB(F),...$). The canonical filtration is denoted by $(\fF_t)_{t\geq0}$. The method of the proofs will use certain martingale approximation. \begin{notation}\label{notation:martingale} Given $f:F\to \bR$, we define the martingale \begin{align*} M_T^f(t) &:= \erwc{f(Y_T)}{\fF_t} - \erwc{f(Y_T)}{\fF_0}, \quad\quad t\in[0,T], \\ &= P_{T-t}f(Y_t) - P_T f (Y_0). \end{align*} \end{notation} \begin{remark} Note that this martingale is different from the canonical martingale $f(Y_t)-\int_0^t A f(Y_s)\,ds$, but there are some similarities. \end{remark} To avoid questions regarding the domain of the generator $A$, we also introduce (non-linear) versions of $A$ in a natural way which are defined for all functions. \begin{notation} For any $f: F \to \bR$, define \[ \overline{A} f(x) := \limsup_{\epsilon\to0}\frac1\epsilon (P_\epsilon f(x) - f(x)); \] \[ \underline{A} f(x) := \liminf_{\epsilon\to0}\frac1\epsilon (P_\epsilon f(x) - f(x)). \] We call $\overline{A}$ upper generator and $\underline{A}$ lower generator. \end{notation} \begin{remark}\mbox{} \par{a)} Note that $\overline{A} f(x), \underline{A} f(x) \in \bR \cup \{\pm\infty\}$. But if $f \in dom(A)$, then $\overline{A} f = \underline{A} f = A f$. \par{b)} If we look at the martingale \begin{align}\label{eq:classical-martingale} \widetilde{M}^f(t) = f(Y_t)-\int_0^t Af(Y_s)\,ds, \end{align} then its predictable quadratic variation process is given by \begin{align} \left< \widetilde{M}^f \right>_t &= \int_0^t A f^2(Y_s) - 2f(Y_s)Af(Y_s)\,ds \nonumber\\ &= \int_0^t \left[A \left(f-f(Y_s)\right)^2\right](Y_s)\,ds \label{eq:classical-predqv} \end{align} under the assumption that $f,f^2\in dom(A)$. If that is not the case, then we still have an upper (lower) bound on $\left<\widetilde{M}^f\right>$ when using the upper generator $\overline{A}$ (lower generator $\underline{A}$) in \eqref{eq:classical-predqv}. \end{remark} The following lemma shows that $[\overline{A}(f-f(x))(g-g(x))](x)]$ still has the property of a quadratic form. \begin{lemma}\label{lemma:chauchy-schwarz} Let, $f,g : F\to\bR$. Then \[ \abs{\overline{A}[(f-f(x))(g-g(x))](x)}^2 \leq \overline{A}(f-f(x))^2(x)\overline{A}(g-g(x))^2(x). \] \end{lemma} \begin{proof}[Proof of the lemma] Utilizing the definition of $\overline{A}$ and Chauchy-Schwarz inequality, \begin{align*} &\abs{\overline{A}[(f-f(x))(g-g(x))](x)}^2 \\ &\quad\leq \limsup_{\epsilon\to0}\frac1{\epsilon^2}\abs{\bE_x(f(Y_\epsilon)-f(x))(g(Y_\epsilon)-g(x))}^2\\ &\quad\leq \limsup_{\epsilon\to0}\frac1{\epsilon^2}\left[\bE_x(f(Y_\epsilon)-f(x))^2\bE_x(g(Y_\epsilon)-g(x))^2\right] \\ &\quad\leq \left(\overline{A}(f-f(x))^2(x)\right)\left(\overline{A}(g-g(x))^2(x)\right)\\ \end{align*} \qed \end{proof} \begin{remark} It is also interesting to note that \[ \left<f,g\right>_x = A[(f-f(x))(g-g(x))](x) \] is a positive semi-definite bilinear form. This form can be related to the martingales \eqref{eq:classical-martingale} by their predictable covariation process, which is given by \[ \left< \widetilde{M}^f, \widetilde{M}^g \right>_t = \int_0^t \left<f,g\right>_{Y_s}\,ds. \] \end{remark} Before going into details about the martingale $M^f_T$ and its properties we need the following little fact. \begin{lemma}\label{lemma:little-helper} Fix $\delta>0$, $k\in\bN,k\geq2$ and a probability measure $\mu$. Let $f,g : [0,\delta] \to L^k(\mu)$. Assume that \[ \lim_{\epsilon\to0} \frac1\epsilon \mu\left( f(\epsilon)^k \right) = a\in\bR,\quad \lim_{\epsilon\to0} \frac1\epsilon \mu\left( g(\epsilon)^k \right) = 0 .\] Then \[ \lim_{\epsilon\to0} \frac1\epsilon \mu\left( (f(\epsilon)+g(\epsilon))^k\right) = a. \] The same holds true for $\limsup$ and $\liminf$ as long as $\lim_{\epsilon\to0} \frac1\epsilon \mu\left( g(\epsilon)^k \right) = 0$. \end{lemma} \begin{proof} First, \begin{align*} \mu\left( (f(\epsilon)+g(\epsilon))^k \right) &= \suml_{j=0}^k \binom{k}{j} \mu\left( f(\epsilon)^jg(\epsilon)^{k-j}\right). \end{align*} By H\"older's inequality with $p=\frac{k}{j},q=\frac{k}{k-j}$, \[ \mu \left( \abs{f(\epsilon)^jg(\epsilon)^{k-j}} \right) \leq \left(\mu\left( f(\epsilon)^k\right) \right)^{\frac{j}{k}} \left(\mu\left( g(\epsilon)^k\right)\right)^{\frac{k-j}{k}}. \] Therewith and with the assumptions on the limits, \[ \lim_{\epsilon\to0}\frac{1}{\epsilon} \mu\left( \abs{f(\epsilon)^jg(\epsilon)^{k-j}}\right) \leq \left(\lim_{\epsilon\to0}\frac{1}{\epsilon}\mu\left( f(\epsilon)^k\right)^{\frac{j}{k}}\right) \left(\lim_{\epsilon\to0}\frac{1}{\epsilon}\mu\left( g(\epsilon)^k\right)^{\frac{k-j}{k}}\right) = 0 \] for any $j<k$. \qed \end{proof} Now we will state and prove the key lemma regarding the martingale \ref{notation:martingale}. It is very parallel to Lemma 2.5 in \cite{REDIG:VOLLERING:10}, where the identical approach is used to deal with the analogue martingale constructed from $\int_0^T f(Y_t)\,dt$ instead of $f(Y_T)$. \begin{lemma}\label{lemma:point-key-lemma} Fix $k\in \bN, k\geq 2$ If \[ \lim_{\epsilon\to0} \frac{1}{\epsilon} \bE_x \left(P_{T-t-\epsilon}f(Y_\epsilon)-P_{T-t}f(Y_\epsilon)\right)^k=0 \quad \forall\, x\in F,\] then: \begin{enumerate} \item $\limsup\limits_{\epsilon\to0} \frac{1}{\epsilon}\erwc{(M_T^f(t+\epsilon)-M_T^f(t))^k}{\fF_t} = \overline{A}\left(P_{T-t} f(\cdot) - P_{T-t}f(Y_t)\right)^k(Y_t); $ \item $\liminf\limits_{\epsilon\to0} \frac{1}{\epsilon}\erwc{(M_T^f(t+\epsilon)-M_T^f(t))^k}{\fF_t} = \underline{A}\left(P_{T-t} f(\cdot) - P_{T-t}f(Y_t)\right)^k(Y_t). $ \end{enumerate} \end{lemma} \begin{remark} If $\sup_{x\in F} \overline{A} f(x)<\infty$, then the condition is satisfied for any $k\geq2$. \end{remark} \begin{proof} First, \begin{align*} M^f_T(t+\epsilon)-M^f_T(t) &= P_{T-t-\epsilon}f(Y_{t+\epsilon})-P_T f(Y_0) - P_{T-t}f(Y_t)+P_T f(Y_0)\\ &= P_{T-t-\epsilon}f(Y_{t+\epsilon})-P_{T-t}f(Y_{t+\epsilon}) + P_{T-t}f(Y_{t+\epsilon}) -P_{T-t}f(Y_{t}). \end{align*} By our assumptions and the Markov property, \[\lim_{\epsilon\to0} \frac1\epsilon\erwc{(P_{T-t-\epsilon}f(Y_{t+\epsilon})-P_{T-t}f(Y_{t+\epsilon}))^k}{\fF_t} = 0.\] Hence, by Lemma \ref{lemma:little-helper} \begin{align*} &\limsup_{\epsilon\to0}\frac1\epsilon\erwc{(M^f_T(t+\epsilon)-M^f_T(t))^k}{\fF_t} \\ &\quad= \limsup_{\epsilon\to0}\frac1\epsilon\erwc{(P_{T-t}f(Y_{t+\epsilon}) -P_{T-t}f(Y_{t}))^k}{\fF_t} \\ &\quad= \overline{A}\left(P_{T-t} f(\cdot) - P_{T-t}f(Y_t)\right)^k(Y_t). \end{align*} The argument for $\liminf$ is analogue. \qed \end{proof} \begin{proposition}\label{prop:point-quadratic-variation} Assume that for all $0< t \leq T$ and all $x\in F$ $(P_t f -P_t f(x))^2 \in dom(A)$ and \[ \lim_{\epsilon\to0} \frac{1}{\epsilon} \bE_x \left( P_{t-\epsilon}f(Y_\epsilon) - P_{t}f(Y_\epsilon) \right)^2 =0.\] Then the predictable quadratic variation of $M_T^f$ is \begin{align*} \left< M_T^f \right>_t &= \int_0^t A\left(P_{T-s} f(\cdot) - P_{T-s}f(Y_s)\right)^2(Y_s)\, ds . \end{align*} \end{proposition} \begin{proof} By Lemma \ref{lemma:point-key-lemma}, \[ \frac{d}{dt}\left<M^f_T\right>_t = \lim_{\epsilon\downarrow0} \frac1\epsilon \erwc{\left(M^f_T(t+\epsilon)-M^f_T(t)\right)^2}{\fF_t} = A\left(P_{T-t} f(\cdot) - P_{T-t}f(Y_t)\right)^2(Y_t). \] \qed \end{proof} \begin{theorem}\label{thm:point-exponential-martingale} Assume that for all $k\in\bN, k\geq2$, all $x\in F$ and all $0< t \leq T$, \[ \lim_{\epsilon\to0} \frac{1}{\epsilon} \bE_x \left( P_{t-\epsilon}f(Y_\epsilon) - P_{t}f(Y_\epsilon) \right)^k =0.\] Also assume that \[ \supl_{0\leq t \leq T} \supl_{x\in F}\suml_{k=2}^\infty\frac{1}{k!}\overline{A}\left(P_t f - P_t f(x)\right)^k(x)<\infty. \] Write \[ \overline{N}^f_T(t):=\exp\left({M^f_T(t)- \int_0^t \suml_{k=2}^\infty \frac{1}{k!} \overline{A}\left(P_{T-s} f - P_{T-s} f(Y_s)\right)^k(Y_s)\,ds}\right),\quad 0\leq t\leq T; \] \[ \underline{N}^f_T(t):=\exp\left({M^f_T(t)- \int_0^t \suml_{k=2}^\infty \frac{1}{k!} \underline{A}\left(P_{T-s} f - P_{T-s} f(Y_s)\right)^k(Y_s)\,ds}\right),\quad 0\leq t\leq T. \] Then $(\overline{N}_T(t))_{0\leq t\leq T}$ is a supermartingale and $(\underline{N}_T^f(t))_{0\leq t\leq T}$ is a submartingale. If $(P_{T-t}f-P_{T-t}f(x))^k(x)\in dom(A)$ for all $x$ and $k$, then both are equal and a martingale. \end{theorem} \begin{proof} It is sufficient to prove that $\limsup_{\epsilon\to0}\frac1\epsilon\erwc{\overline{N}^f_T(t+\epsilon)-\overline{N}_T^f(t)}{\fF_t}\leq 0$ (or analogue with $\liminf$ for $\underline{N}_T^f$). For a shorter notation, write \[ \psi(s,x,k):= \overline{A}\left(P_{T-s} f - P_{T-s} f(x)\right)^k(x).\] Then \begin{align*} &\limsup_{\epsilon\to0}\frac1\epsilon\erwc{\overline{N}^f_T(t+\epsilon)-\overline{N}_T^f(t)}{\fF_t}\\ &\quad=\overline{N}_T^f(t)\limsup_{\epsilon\to0}\frac1\epsilon\erwc{\exp\left({M^f_T(t+\epsilon)-M^f_T(t)- \int_t^{t+\epsilon} \suml_{k=2}^\infty \frac{1}{k!} \psi(s,Y_s,k)\,ds}\right)-1}{\fF_t} \\ &\quad\leq\overline{N}_T^f(t)\suml_{l=1}^\infty\frac{1}{l!} \limsup_{\epsilon\to0}\frac1\epsilon\erwc{\left({M^f_T(t+\epsilon)-M^f_T(t)- \int_t^{t+\epsilon} \suml_{k=2}^\infty \frac{1}{k!} \psi(s,Y_s,k)\,ds}\right)^l}{\fF_t}. \end{align*} First, since $\overline{N}^f_T(t)>0$, we can ignore it. Next, we study the terms individually in $l$. For $l=1$, as $M^f_T$ is a martingale, we get just the term \[ -\suml_{k=2}^\infty \frac{1}{k!} \psi(t,Y_t,k). \] For $l>1$, we use the fact that \[ \int_t^{t+\epsilon} \suml_{k=2}^\infty \frac{1}{k!} \psi(s,Y_s,k)\,ds \leq \epsilon \supl_{0\leq t \leq T} \sup_{x\in F} \suml_{k=2}^\infty \frac{1}{k!} \psi(t,x,k) = \epsilon\cdot const. \] Therefore \[ \lim_{\epsilon\to0} \frac{1}{\epsilon}\erwc{\left(\int_t^{t+\epsilon} \suml_{k=2}^\infty \frac{1}{k!} \psi(s,Y_s,k)\,ds\right)^l}{\fF_t} = 0, \] and by Lemma \ref{lemma:little-helper}, we can drop that term. Finally, by Lemma \ref{lemma:point-key-lemma}, \[ \limsup_{\epsilon\to0}\frac1\epsilon\erwc{\left(M^f_T(t+\epsilon)-M^f_T(t)\right)^l}{\fF_t} = \psi(s,Y_t,l) .\] So the terms for $l\geq2$ sum to $\suml_{l=2}^\infty \frac{1}{l!} \psi(t,Y_t,l)$, which cancels exactly with the term for $l=1$. \qed \end{proof} As an direct consequence we can estimate the exponential moment of $f(Y_T)$. \begin{proposition}\label{prop:exponential-point} Assume that for all $k\in\bN, k\geq2$, all $x\in F$ and all $0< t \leq T$, \[ \lim_{\epsilon\to0} \frac{1}{\epsilon} \bE_x \left( P_{t-\epsilon}f(Y_\epsilon) - P_{t}f(Y_\epsilon) \right)^k =0.\] Let $\nu_1,\nu_2$ be two arbitrary probability measures on $F$. Then \[ \bE_{\nu_1} e^{f(X_T)-\nu_2(P_T f)} \leq c(\nu_1,\nu_2) \exp\left({\int_0^T \supl_{x\in F} \suml_{k=2}^\infty\frac{1}{k!}\overline{A}\left(P_t f - P_t f(x)\right)^k(x)\,dt}\right), \] and \[ \bE_{\nu_1} e^{f(X_T)-\nu_2(P_T f)} \geq c(\nu_1,\nu_2) \exp\left({\int_0^T \infl_{x\in F} \suml_{k=2}^\infty\frac{1}{k!}\underline{A}\left(P_t f - P_t f(x)\right)^k(x)\,dt}\right), \] with \[ c(\nu_1,\nu_2) = \int e^{P_T f(x) - \nu_2 (P_T f)}\nu_1(dx). \] Notably, $c(\delta_x,\delta_x)=1$. \end{proposition} \begin{proof} As a first observation, \[ \bE_{\nu_1}\left( e^{f(X_T)-\nu_2(P_T f)}\right) = \bE_{\nu_1}\left(e^{P_T f(Y_0) - \nu_2 (P_T f)}\erwc{e^{M_T^f(T)}}{\fF_0} \right). \] Next, we rewrite the conditional expectation as \[ \erwc{e^{M_T^f(T)}}{\fF_0} = \erwc{\overline{N}_T^f(T)e^{\int_0^T\suml_{k=2}^\infty\frac{1}{k!}\overline{A}\left(P_{T-t} f - P_{T-t} f(Y_t)\right)^k(Y_t)\,dt}}{\fF_0}, \] where $\overline{N}_T^f$ is the supermartingale from Theorem \ref{thm:point-exponential-martingale}. As $\overline{N}_T^f$ is positive, we can estimate that term by taking the supremum over the possible values of $Y_t$ in the integral, so that we obtain \[ \erwc{e^{M_T^f(T)}}{\fF_0} \leq \erwc{\overline{N}_T^f(T)}{\fF_0}e^{\int_0^T\sup_{x\in F}\suml_{k=2}^\infty\frac{1}{k!}\overline{A}\left(P_{T-t} f - P_{T-t} f(x)\right)^k(x)\,dt} .\] As $\overline{N}_T^f$ is a supermartingale and $\overline{N}^f_T(0) = 1$, we finally arrive at \[ \bE_{\nu_1} e^{f(X_T)-\nu_2(P_T f)} \leq c(\nu_1,\nu_2) \exp\left({\int_0^T \supl_{x\in F} \suml_{k=2}^\infty\frac{1}{k!}\overline{A}\left(P_{T-t} f - P_{T-t} f(x)\right)^k(x)\,dt}\right). \] Reversing the direction of time yields the claim, and the proof for the other bound is analogue. \qed \end{proof} \begin{corollary}\label{corollary:exponential-point} Let $f: F \to \bR$ be in $dom(L)$ with $\norm{L f}_\infty < \infty$. Assume that \[ \overline{A}(P_t f -P_t f(x))^k(x) \leq c_1 c_2^k \] uniformly in $x \in F$ and $t \in [0,T]$. Then, for any $r>0$, \[ \bP_x\left( f(Y_T) - \bE_x f(Y_T) > r \right) \leq e^{-\frac{\frac12 \left(\frac{r}{c_2}\right)^2}{Tc_1 + \frac13 \frac{r}{c_2}}}. \] If $f$ is bounded, then for any probability measures $\nu_1,\nu_2$ on $F$, \[ \bP_{\nu_1}\left( f(Y_T) - \bE_{\nu_2} f(Y_T) > r + \norm{P_T f}_{osc} \right) \leq e^{-\frac{\frac12 \left(\frac{r}{c_2}\right)^2}{Tc_1 + \frac13 \frac{r}{c_2}}}. \] \end{corollary} \begin{proof} By Markov's inequality, \begin{align*} \bP_{\nu_1}(f(Y_T)-\bE_{\nu_2} f(Y_T) > r ) &\leq \bE_{\nu_1} e^{\lambda f(Y_T)-\bE_{\nu_2} \lambda f(Y_T)} e^{-\lambda r} \\ &\leq e^{T c_1 \sum_{k=2}^\infty \lambda^k c_2^k-\lambda r + \lambda\norm{P_T f}_{osc}}, \end{align*} where the last line is the result from Proposition \ref{prop:exponential-point}. Note that $c(\nu_1,\nu_2)\leq e^{\lambda\norm{P_T f}_{osc}}$ and $c(\delta_x,\delta_x)=e^0$ For now we continue with the term $\lambda\norm{P_T f}_{osc}$ present. Through optimizing $\lambda$, the exponent becomes \[ \frac{r-\norm{P_T f}_{osc}}{c_2}-\left(T c_1+\frac{r-\norm{P_T f}_{osc}}{c_2}\right)\log\left(\frac{r-\norm{P_T f}_{osc}}{T c_1 c_2}+1\right). \] By writing $r'=r-\norm{P_T f}_{osc}$, we continue with \[ \frac{r'}{c_2}-\left(T c_1+\frac{r'}{c_2}\right)\log\left(\frac{r'}{T c_1 c_2}+1\right). \] This step is not necessary in the case of a fixed initial configuration $x$, as then $r'=r$. To show that his term is less than $\frac{-\frac12(\frac{r'}{c_2})^2}{Tc_1+\frac13\frac{r'}{c_2}}$, we first rewrite it as the following inequality: \[ \log\left(\frac{r'}{T c_1 c_2}+1\right) \geq \frac{\frac{\frac12(\frac{r'}{c_2})^2}{Tc_1+\frac13\frac{r'}{c_2}}+\frac{r'}{c_2}}{T c_1+\frac{r'}{c_2}}. \] Through comparing the derivatives, one concludes that the left hand side is indeed bigger than the right hand side. \qed \end{proof} The next lemma is a slightly refined version of Corollary 2.7 in \cite{REDIG:VOLLERING:10}. \begin{lemma}\label{lemma:exponential-concentration} Fix $T>0$ and $f:Y\to\bR$. Assume that for some $T'>T$ and all $k\in\bN, k\geq2$, $\bE_x sup_{0\leq t \leq T'} f(Y_t)^k < \infty.$ Assume also that for some constants $c_1, c_2>0$ the following estimates hold: \[ \sup_{x,y\in X} \sup_{0\leq T' \leq T} \int_0^{T'} P_t f(x)- P_t f(y)\,dt \leq c_1;\] \[ \sup_{x \in X} \sup_{0\leq T' \leq T} \overline{A}\left(\int_0^{T'} P_t f- P_t f(x)\,dt\right)^2(x) \leq c_2 c_1^2. \] Then \[ \bP_{\nu_1}\left( \int_0^T f(X_t)\,dt > c_1(r+1) + \int_0^T \nu_2(P_t f)\,dt \right) \leq e^{- \frac{\frac12r^2}{Tc_2 + \frac13r}} \] for any $r>0$ and any probability measures $\nu_1,\nu_2$ on $F$. If $\nu_1,\nu_2$ are equal and a Dirac measure, then one can replace $(r+1)$ by $r$. \end{lemma} The proof of this lemma is analogue to the proof of Corollary \ref{corollary:exponential-point}, using the corresponding exponential moment bound in Theorem 2.6 in \cite{REDIG:VOLLERING:10}. \begin{theorem}\label{thm:moment-estimate} Let $f: F \to\bR$ and fix $T>0$. Assume that for all $x\in F$ and all $0<t<T$ \[ \lim_{\epsilon\to0} \frac{1}{\epsilon} \bE_x \left(P_{t-\epsilon}f(Y_\epsilon)-P_{t}f(Y_\epsilon)\right)^2=0 .\] Then, for any probability measures $\nu_1, \nu_2$ on $F$ and any $p\geq 2$, \begin{align*} \left(\bE_{\nu_1}\abs{ f(Y_T)-\bE_{\nu_2}f(Y_T) }^p\right)^{\frac1p} & \leq C_p \left[ \left( \bE_{\nu_1}\left(\int_0^T \overline{A}(P_{T-t}f - P_{T-t}f(X_t))^2(X_t)\,dt\right)^{\frac p2}\right)^{\frac1p}\right. \\ &\quad \left. +\left(\bE_{\nu_1}\sup_{0< t \leq T} \abs{P_{T-t}f(Y_t)-P_{T-t}f(Y_{t-})}^p\right)^{\frac1p}\right] \\ &\quad + \left(\int \abs{P_T f(x) - \nu_2(P_T f)}^p\,\nu_1(dx) \right)^{\frac1p} . \end{align*} \end{theorem} The proof is analogue to the proof of Theorem 2.9 in \cite{REDIG:VOLLERING:10}.

INTRODUCTION ============ Protein phosphatases, like protein kinases, represent molecular switches within a wide spectrum of signalling cascades. Protein phosphatase 5 (PP5) belongs to the family of phosphoprotein phosphatases (PPPs) with homologous phosphatase domains, like PP1, PP2A, PP2B and others. PP5 is unique among the PPPs in that it harbours a TPR-domain, which serves as docking site for the molecular chaperone heat-shock protein (Hsp90). Early studies have identified PP5 as part of Hsp90--glucocorticoid receptor (GR) complexes \[[@B1]\], where PP5 was shown to dephosphorylate GR and to affect the translocation of the hormone-activated complex into the nucleus \[[@B2]--[@B4]\]. PP5 also dephosphorylates the kinases ASK1 (apoptosis signal-regulating kinase 1) and DNA---PKC (protein kinase C) after DNA-damage or during cell-cycle control. In addition, PP5 is associated with the G~1~/S-phase checkpoint regulators ATM and ATR (ataxia telangiectasia and Rad3-related) \[[@B5]--[@B9]\]. Hyperphosphorylated tau can also be dephosphorylated by PP5 and other PPP family members \[[@B10],[@B11]\], preventing the misfolded state \[[@B12]--[@B14]\] that is relevant for the development of neurofibrillar tangles in tauopathies such as Alzheimer\'s disease (AD) \[[@B15]--[@B17]\]. Interestingly activity levels of PP5 have been found to be reduced in brains of AD patients \[[@B10]\], making higher phosphatase activities desirable. Despite this, attempts to target phosphatase activities have so far mostly focused on the development of inhibitors for PP2A, which plays a role in pancreatic cancers. With LB-100, a potent inhibitor of PP2A recently entered clinical trials \[[@B18]--[@B22]\]. The phosphatase activity of PP5 is regulated in a complex activation mechanism by its N-terminal Hsp90-interacting tetratricopeptide repeat (TPR) domain and its C-terminal α-helix, called αJ-helix \[[@B23],[@B24]\]. Moreover, PP5 is regulated by binding to the molecular chaperone Hsp90 \[[@B24]--[@B26]\]. In the absence of Hsp90, PP5 exhibits low basal activity. The C-terminal αJ-helix binds to the N-terminal TPR domain of PP5 and locks the enzyme in a latent state \[[@B24]\]. With addition of Hsp90, the C-terminal MEEVD-peptide of the chaperone binds to and stabilizes the phosphatase\'s TPR domain \[[@B1],[@B27],[@B28]\]. The Hsp90--PP5 interaction disrupts the intramolecular contacts between TPR and αJ-helix and gives access to the active site. Hence, the phosphatase activity of PP5 is stimulated and Hsp90-interacting proteins, like the kinase-dedicated Hsp90-cochaperone Cdc37 (cell-division cycle), can be dephosphorylated with higher rates \[[@B29]\]. Whereas *in vivo* studies imply that enhanced PP5 activities could be beneficial in AD and other human diseases, few synthetic activators of PP5 have been described to date. Only the cell signal transmitter arachidonic acid and certain derivatives thereof are known to stimulate PP5 \[[@B25],[@B30],[@B31]\], but the physiological relevance so far remains elusive. In the present study, we use a synthetic library to identify small-molecule compounds that activate PP5. We then analyse their effect on the enzymatics of PP5 and define the mechanism of PP5 stimulation. EXPERIMENTAL ============ Materials --------- The compound library New Chemistry and Discovery Chemistry Collection consisting of 10000 compounds was obtained from ChemDiv. Substances PP5 small-molecule activator (P5SA)-1, P5SA-2, P5SA-3, P5SA-4 and P5SA-5 were purchased from ChemDiv. The C-terminal Hsp90/DAF-21 peptide (AEEDASRMEEVD) was obtained from Biomatik. Protein purification -------------------- Cloning and purification of PPH-5 (protein phosphatase homologue), CeHsp90/DAF-21 (abnormal DAuer formation), YFP-CeHsp90/DAF-21, BAG-1 (Bcl-2 associated athanogene-1), DNJ-13 (DNJ-13 homologue) and CeHsc70 (*C. elegans* heat shock cognate 70) were performed as described before \[[@B32]--[@B35]\]. The human phosphatases PP1, PP2A and PP2B/PP3 were purified as described \[[@B36]--[@B38]\]. The expression clones of rat PP5, PP5-ΔN165 (166--499) and PP5-ΔC8 (1--491) were generated by PCR and insertion of the DNA into the pET28 vector. Expression clones of PP5 428--430, which contains A^428^-A^429^-A^430^ instead of E^428^-V^429^-K^430^ and PP5 428--430/458--460, which contains A^428^-A^429^-A^430^ instead of E^428^-V^429^-K^430^ and A^455^-G^456^-A^457^ instead of M^455^-G^456^-N^457^, were also generated by PCR using primer sequences containing the modified codons. PCR-products were inserted into the pET28b expression plasmid (Merck) and verified by DNA sequencing (GATC Biotech). Proteins were expressed in BL21-CodonPlus (DE3)-RIL bacteria (Stratagene). Bacterial cultures were grown to a *D*~600~ of 0.8 and induced with 1 mM IPTG. Cells were disrupted using a cell disruption machine (IUL Instruments) and the lysate was loaded on to a HisTrap FF column (GE Healthcare). Protein was eluted in a buffer containing 400 mM imidazole. Eluted protein was dialysed and applied to a ResourceQ anion exchange column (GE Healthcare). Finally, proteins were subjected to size exclusion chromatography on Superdex 200 PrepGrade gel filtration columns (GE Healthcare). Protein purity was assessed by SDS/PAGE and the molecular mass was determined on an UltraFlex III MALDI-TOF/TOF mass spectrometer (Bruker). Proteins were frozen in liquid nitrogen in 40 mM HEPES/KOH, pH 7.5, 20 mM KCl, 1 mM DTT and stored at −80°C. Phosphatase assay during screening and rescreening and characterization ----------------------------------------------------------------------- The compound library consisting of 10000 compounds (New Chemistry and Discovery Chemistry Collection, ChemDiv) was screened using a chromometric phosphatase assay with para-nitrophenyl phosphate (pNPP) as substrate. Phosphatase activity was determined by the conversion of pNPP to para-nitrophenole and absorption of the product at 410 nm (ε: 15100 cm^−1^ M^−1^). Assays were performed in 96-well plates in a PerkinElmer EnVision instrument with 50 nM of PPH-5. Reaction volume was 100 μl in a buffer of 40 mM HEPES, pH 7.5, 20 mM KCl, 5 mM MnCl~2~ and 1 mM DTT. The reaction was started by adding pNPP to a final concentration of 60 mM. The slope of the reaction was determined and deviations of \>30% were considered potential hits leading to a collection of 76 initial compounds. The Z-factor of the initial screen was calculated from $$Z = \frac{\left. 3\, \times \,\left( \sigma \right._{P}\, + \,\sigma_{N} \right)}{\left| {\sigma_{P}\, - \,\sigma_{N}} \right|}$$ where by σ~P~ was 0.3, σ~N~ was 0.1, μ~P~ was 1.6 and μ~N~ was 1 resulting in a Z-factor of −1, indicating that many of the initial compounds will drop out later \[[@B39]\]. These 76 compounds were maintained and rescreened individually in a Varian Cary 100 spectrophotometer (Agilent Technologies) in Hellma SUPRASIL precision quarz cells (10-mm path length) and 140 μl of reaction volumes. Finally, five compounds were obtained as reproducible activators and selected for further characterization. Phosphatase assays for characterization of PP5 and PPH-5 properties were performed in 40 mM HEPES/KOH, 20 mM KCl, 5 mM MnCl~2~, 1 mM DTT, pH 7.5 and 60 mM pNPP at 20°C if not indicated otherwise. Phosphatase concentrations ranged from 50 to 500 nM in the assay. If indicated, the CeHsp90/DAF-21 peptide AEEDASRMEEVD was supplemented in the assay at a concentration of 60 μM. Compounds were added at concentrations below the occurrence of solubility problems. These concentrations were 70 μM for P5SA-1, 140 μM for P5SA-2, 50 μM for P5SA-3, 100 μM for P5SA-4 and 45 μM for P5SA-5. Analytical ultracentrifugation ------------------------------ Binding of Hsp90 to PPH-5 was analysed by analytical ultracentrifugation with fluorescence detection as described before \[[@B40]\]. Experiments were performed in a Beckman ProteomeLab XL-A analytical ultracentrifuge (Beckman) equipped with an AU-FDS detector (Aviv Biomedical). Analytical ultracentrifugation (AUC) runs were performed in 40 mM HEPES/KOH, pH 7.5, 20 mM KCl, 1 mM DTT. The concentration of labelled YFP--Hsp90 was 300 nM and 3 μM of PPH-5 were added to form a complex with YFP--Hsp90. Where indicated 60 μM of the C-terminal Hsp90/DAF-21 peptide (AEEDASRMEEVD) was present in the sample. Centrifugation was performed at 20°C and 142000 ***g*** for 12 h. Scans were recorded every 90 s. Data analysis was performed using a dc/dt approach according to Stafford \[[@B41]\]. The dc/dt plots were fit to Gaussian functions in order to obtain the s~20,w~ values of the respective species as described previously \[[@B33]\]. P5SAs were added as indicated. ATPase assay ------------ The ATPase activities of Hsc70 and Hsp90 from *Caenorhabditis elegans* were assessed in a coupled regenerative ATPase assay as described before \[[@B32]\]. Reactions were measured in a Varian Cary 100 spectrophotometer (Agilent Technologies) at 30°C and the depletion of NADH was recorded at 340 nm. Chaperone concentrations were 3 μM and cochaperones were added at a concentration of 5 μM. NMR measurements ---------------- NMR experiments were performed on an 800 MHz spectrometer (Bruker) with cryoprobe. The measurements were done in ^2^H~2~O with phosphate buffer (4 mM KH~2~PO~4~, 16 mM Na~2~HPO~4~, 120 mM NaCl, pH 7.4) and 1%--5% of d6-DMSO. P5SA-2 without protein was recorded in high sensitivity experiments with a high number of scans. The CPMG sequence with an additional Watergate to suppress residual water was used \[[@B42],[@B43]\]. The T~2~ filtering time was set to 400 ms to suppress signals from slowly tumbling molecules. Peak intensities were normalized by comparing residual DMSO peaks. PPH-5 was added as indicated. Crystallization and structure determination ------------------------------------------- Rat PP5 protein was concentrated to 15 mg/ml in 10 mM Tris, pH 7.8, including 3 mM DTT. Optionally, the ligand was added to a final concentration of 1 mM. Crystals were grown at 20°C within 4 weeks by using the hanging drop vapour diffusion method. Drops contained equal volumes of protein and reservoir solutions \[0.2 M Mg(NO~3~)~2~, 20% PEG 3350\]. Crystals were soaked for 30 s in cryo buffer (mother liquor+25% PEG 200) and were subsequently cooled in liquid nitrogen at 100 K. Diffraction datasets were recorded using synchrotron radiation of λ=1.0 Å (1 Å=0.1 nm) at the beamline X06SA, Swiss Light Source (SLS). Collected datasets were processed using the program package XDS \[[@B44]\]. Determination of the crystal structure was performed by molecular replacement using the program PHASER \[[@B45]\]. Human PP5 (PDB ID: 1WAO) \[[@B24]\] was applied as starting model for the ligand structure PP5--P5SA-2. The refined coordinates of PP5--P5SA-2 in turn were employed for the apo-structure of PP5. Model building was carried out with the graphic program MAIN \[[@B46]\] and finalized applying REFMAC5 \[[@B47]\] by conventional crystallographic rigid body, positional and anisotropic temperature factor refinements with current crystallographic values of *R*~work~=23.8%, *R*~free~=27.1%, RMSD bond lengths of 0.005 Å and RMSD bond angle of 0.99° for PP5 apo and *R*~work~=21.4%, *R*~free~=26.1%, RMSD bond length of 0.015 Å and RMSD bond angle of 1.68° for PP5--P5SA-2. Coordinates were confirmed to have good stereochemistry indicated by the Ramachandran plot. The atomic co-ordinates have been deposited at the RCSB Protein Data Bank under the accession codes 4JA9 for PP5 apo and 4JA7 for PP5--P5SA-2. The amino acid numbers in the text reflect the full-length PP5 protein of *Rattus norvegicus*. RESULTS ======= Identification of novel small molecule activators of PPH-5 ---------------------------------------------------------- PP5 is a highly regulated enzyme. The auto-inhibition of the phosphatase is controlled by the N-terminal TPR domain and the C-terminal αJ-helix, implying a complex mechanism to control the turnover rate \[[@B24]\]. We aimed at identifying small molecules which can alter the activity of the phosphatase as these compounds may target the specific rate-controlling mechanism of PP5. PP5 from nematode origin (PPH-5), which contains all the regulatory features of the human protein (Supplementary Figure S1), was used to screen a library of 10000 compounds in 96-well plates. Using the substrate pNPP, we analysed the activity of PPH-5 in the presence of compounds and initially retained 76 molecules from the primary screen. Each of the identified candidates was individually tested resulting in five compounds which reproducibly increase the enzymatic activity of PPH-5 ([Figure 1](#F1){ref-type="fig"}A). All five molecules are smaller than 500 Da ([Figure 1](#F1){ref-type="fig"}B), are stable at room temperature and follow the Lipinsky\'s rules making them good candidates for further optimization. These P5SAs (P5SA-1--5) were applied at different concentrations to determine the apparent *K*~D~-value in the pNPP-based assay yielding constants in the range of 6 to 26 μM and a 3--8-fold activation compared with the basal activity ([Table 1](#T1){ref-type="table"}; Supplementary Figure S2). In particular, P5SA-2 and P5SA-5, with apparent affinity constants of 7.8 and 6.4 μM, displayed a reasonable high affinity and sufficient solubility enabling an enzymatic analysis of their activation mechanisms. {#F1} ###### The enzymatic parameters of nematode PPH-5 and mammalian PP5 are influenced by the P5SAs PPH-5 (*C. elegans*) PP5 (*R. norvegicus*) -------- ---------------------- ----------------------- ----------- ----- ----- ------------ DMSO -- 7.0±0.4 0.62±0.17 -- -- -- P5SA-1 13.3±4.2 3.0±0.2 2.28±0.28 3.7 4.1 at 100 μM P5SA-2 7.8±1.4 2.5±0.1 1.99±0.43 3.2 3.9 at 100 μM P5SA-3 n.d. n.d. n.d. 4.0 2.9 at 30 μM\* P5SA-4 25.7±5.5 5.0±0.3 4.85±0.43 7.8 3.0 at 100 μM P5SA-5 6.4±1.8 4.3±0.3 5.22±0.67 8.4 8.6 at 100 μM Enzymatic parameters were determined using the substrate pNPP in phosphatase assays. Reaction buffer was 40 mM HEPES/KOH, pH 7.5, 20 mM KCl, 5 mM MnCl~2~ and 1 mM DTT. pNPP concentrations were 60 mM with exception of the *K*~M~-determination, where pNPP-concentrations were varied. The 'fold activation' is calculated based on the *k*~cat~ values compared with PPH-5. Used compound concentration are indicated (\*P5SA-3 solubility was not sufficient to titrate fully and precipitation occurred at 30 μM). n.d., not determined Small-molecule activation is highly specific to PP5-like proteins ----------------------------------------------------------------- We first addressed the specificity of the identified activators by analysing unspecific effects on the ATP hydrolysing activity of the ATPases Hsc70 and Hsp90. The P5SAs neither affected the activity of the chaperones, nor abrogated the binding of cofactors to Hsc70 or Hsp90 (Supplementary Figure S3), showing that the compounds do not generally affect protein activities. Next we tested, whether the compounds affect other phosphatases. Since other PPP family members contain phosphatase domains with high sequence similarity, we examined PP1, PP2A and PP2B/PP3. Neither activation nor inhibition of the respective phosphatase\'s activity was detected, implying that the identified molecules are specific activators of PPH-5 ([Figure 1](#F1){ref-type="fig"}C). Also bovine intestinal alkaline phosphatase (BIAP) was not affected by the compounds. We then challenged homologues of PPH-5 from other species. Even at high compound concentrations we could not detect activation of the yeast homologue Ppt1 which harbours an identity of 31% with PPH-5 (Supplementary Figure S1). However, PP5 from *R. norvegicus* with 67% sequence identity to nematode PPH-5 and 98% identity to the human protein exhibited activation when treated with either of the P5SAs at a high compound concentration ([Table 1](#T1){ref-type="table"}). The P5SAs are allosteric regulators of PPH-5 -------------------------------------------- To gain insight into the activation mechanism of P5SAs, we investigated the interaction between the substrate pNPP and the P5SAs during the dephosphorylation reaction. Direct correlation between the small molecules during the hydrolysis of pNPP should be reflected in a lower apparent *K*~M~-value for pNPP in the presence of the activators. Instead, all P5SAs strongly increase the *k*~cat~ value, but only weakly influence the *K*~M~-value for pNPP (Supplementary Figure S4; [Table 1](#T1){ref-type="table"}). Hence, there is only limited influence of the compounds on the substrate pNPP; instead, all compounds act as allosteric activators of PPH-5. To test whether the activators target different steps during the enzymatic reaction, we wondered whether they stimulate in an additive manner. To address this, we measured the combinatorial effects of the P5SAs on the stimulation of pNPP hydrolysis. Compound concentrations of three times of the apparent *K*~D~ value were used by combining the different activators. The observed activities revealed no additional stimulation and complied with the estimations of individual but non-cooperative interaction (Supplementary Figure S5). These results suggest that all identified P5SAs accelerate the rate-limiting step during the enzymatic cycle, even though they may use very different binding strategies to achieve this given the differences in their structure. Allosteric modulators should be able to bind their target protein in the absence of substrate. To confirm direct binding to PPH-5, we employed NMR spectroscopy. We recorded relaxation-edited NMR spectra of P5SA-2 ([Figure 2](#F2){ref-type="fig"}, upper panel). We then added PPH-5 at a concentration of 10 μM. Relaxation-editing strongly attenuates signals from big, slowly tumbling molecules but retains signals from small, fast tumbling moieties \[[@B42]\]. Most of the peaks of P5SA-2 disappeared after addition of PPH-5 ([Figure 2](#F2){ref-type="fig"}). This reflects a much slower tumbling rate of the protein--ligand complex in comparison with the free molecule. Some compound peaks remained unaffected though, indicating that certain moieties of the P5SA-2 molecule are still able to rotate freely even in complex with PPH-5. {#F2} Hsp90 binding is not compromised by the small molecules ------------------------------------------------------- To understand the stimulation mechanism, we then investigated whether stimulation by P5SAs and stimulation by Hsp90 interfere. To this end, we analysed, whether the P5SAs reduce the binding of Hsp90 to the TPR domain. Binding of PPH-5 to YFP-tagged Hsp90 was addressed by analytical ultracentrifugation in sedimentation velocity experiments. In these experiments, YFP--Hsp90 shows a sedimentation coefficient of 6.8 S. Upon complex formation with PPH-5 the sedimentation coefficient of YFP--Hsp90 is increased to 8.9 S enabling analysis of the binding reaction between these two proteins ([Figure 3](#F3){ref-type="fig"}A). This binding event was also observed in the presence of the maximal soluble concentration of each P5SA, where none of the P5SAs visibly reduced the complex formation. We then used the C-terminal MEEVD-containing peptide of Hsp90 as control to disrupt the complex between PPH-5 and YFP--Hsp90. Indeed, complex formation is strongly reduced under these conditions. {#F3} To confirm this from a different perspective, we were interested whether the compound-induced stimulation is affected in the presence of the TPR-binding peptide. Thus we tested the stimulatory potential of the activator P5SA-5 in the presence of the MEEVD-containing peptide. P5SA-5 was chosen, as it shows the highest affinity and stimulation factors among the activators making these measurements possible. With 60 μM of the peptide supplemented, a large excess of MEEVD-containing peptide was used. In the phosphatase assay only a minor influence on the apparent affinity of P5SA-5 was observed despite the high concentration of MEEVD-containing peptide ([Figure 3](#F3){ref-type="fig"}B). Thus, this P5SA appears to utilize a site distinct from the peptide-binding groove of the TPR domain to exert its stimulatory potential. The P5SAs bind to the isolated phosphatase domain of PPH-5 ---------------------------------------------------------- To determine, which parts of the protein are required to obtain the stimulation from the five different P5SAs, we utilized deletion constructs of PP5. The deletion constructs of rat PP5 were generated based on previously published constructs of the highly homologous human protein \[[@B24]\]. The stimulatory potential was recorded by applying the activators at 10 μM and 100 μM (or maximal soluble concentration). Only in the case of P5SA-5, an effect at the lower concentration was detectable, suggesting that the binding preference of the other compounds towards the mammalian PP5 is rather low ([Figure 4](#F4){ref-type="fig"}A; [Table 1](#T1){ref-type="table"}). {#F4} As first mutant, we generated a PP5 protein which lacks the last eight amino acids including Gln^495^ (PP5-ΔC8) which is supposedly involved in maintaining the auto-inhibition of PP5 \[[@B30]\]. The turnover of PP5-ΔC8 with 0.42 s^−1^ is similar to full-length rat PP5. Whereas the deletion of this helix apparently barely influences the enzymatic turnover, the effect on the potential of the compounds was striking. We did not observe a stimulation of the PP5-ΔC8 mutant, as addition of either P5SA did not activate PP5-ΔC8 ([Figure 4](#F4){ref-type="fig"}B) implying that some kind of regulatory function had been altered. Next we generated a mutant, which lacks the entire auto-inhibitory TPR-domain (PP5-ΔN165). The deletion of the TPR-domain in PP5-ΔN165 indeed diminished the auto-inhibition. Compared with the full-length protein, the isolated phosphatase domain showed an increased activity (2.09 s^−1^ compared with 0.36 s^−1^). Remarkably, whereas wild-type (wt)-PP5 is activated by the P5SAs, the P5SAs inhibit the phosphatase activity of the isolated phosphatase domain by up to 70% ([Figure 4](#F4){ref-type="fig"}C). Given that the TPR-domain is not part of this construct, this effect illustrates that the P5SAs can interact with the phosphatase domain of PP5. This distinguishes our activators from established ones, which target the TPR domain \[[@B31]\]. The inhibitory effect towards the phosphatase domain further demonstrates that the allosteric regulation sites can influence the activity of the hydrolysing protein in both directions. In the presence of the full auto-inhibitory domain, P5SAs stimulate the phosphatase activity, in the absence of the self-inhibitory effect of the TPR-domain, their binding to the highly-activated phosphatase domain reduces the turnover rate. P5SA-2 causes a tilting at the TPR-phosphatase interface -------------------------------------------------------- To analyse the mode of interaction directly we solved at molecular resolution the structures of rat PP5 in its apo-state as well as in presence of the ligand P5SA-2. Starting phases were obtained by molecular replacement methods \[[@B45]\] using the coordinates of human PP5 (PDB ID: 1WAO) \[[@B24]\]. The PP5--P5SA-2 dataset were refined to 2.0 Å (*R*~free~=26.1%; PDB ID: 4JA7) whereas the apo-structure yielded a final resolution of 2.3 Å (*R*~free~=27.1%; PDB ID: 4JA9, [Table 2](#T2){ref-type="table"}). In both structures, the first defined amino acid is Gly^23^. The loop connecting the TPR domain with the phosphatase domain (Arg^150^--Arg^158^) is flexible and therefore was not defined in the electron density map. ###### Data collection and refinement statistics PP5 apo PP5 + P5SA-2 -------------------------------------------------------------------------------------- ----------------------- ----------------------- Crystal parameters Space group P4~1~2~1~2 P4~1~2~1~2 Cell constants a=b=50.1 Å, c=379.2 Å a=b=51.1 Å, c=365.7 Å Molecules per AU[\*](#T2TFN1){ref-type="table-fn"} 1 1 Data collection Beamline SLS, PXI--X06SA SLS, PXI--X06SA Wavelength (Å) 1.0 1.0 Resolution range (Å)[^†^](#T2TFN2){ref-type="table-fn"} 40--2.3 (2.4--2.3) 30--2.0 (2.1--2.0) Number of observed reflections 140950 286970 Number of unique reflections[^‡^](#T2TFN3){ref-type="table-fn"} 22932 34075 Completeness (%)[^†^](#T2TFN2){ref-type="table-fn"} 99.5 (99.9) 98.5 (93.1) *R*~merge~ (%)[^†^](#T2TFN2){ref-type="table-fn"}[^§^](#T2TFN4){ref-type="table-fn"} 4.1 (53.7) 3.8 (43.5) I/σ (I)[^†^](#T2TFN2){ref-type="table-fn"} 22.3 (4.4) 28.8 (5.6) Refinement (REFMAC5) Resolution range (Å) 15--2.3 15--2.0 Number of atoms Protein 3757 3749 Water 63 106 *R*~work~/*R*~free~ (%)[^║^](#T2TFN5){ref-type="table-fn"} 23.8/27.1 21.4/26.1 RMSDs[^¶^](#T2TFN6){ref-type="table-fn"} Bond lengths/angles (Å)/(°) 0.005/0.99 0.015/1.68 Average B-factor (Å^2^) 74.1 51.0 Ramachandran plot (%)[\*\*](#T2TFN7){ref-type="table-fn"} 95.2/4.6/0.2 95.7/4.3/0 PDB accession code 4JA9 4JA7 \*Asymmetric unit. †The values in parentheses of resolution range, completeness, *R*~merge~ and I/σ (I) correspond to the last resolution shell. ‡Friedel pairs were treated as identical reflections. §*R*~merge~ (I)=Σ~hkl~Σ~j~ \|I(hkl)j--\<I~hkl~\>\|/Σ~hkl~Σ~j~I(hkl)~j~ where I(hkl)~j~ is the j^th^ measurement of the intensity of reflection hkl and \<I(hkl)\> is the average intensity. *R*=Σ~hkl~ \| \|F~obs~\| − \|F~calc~\| \|/Σ~hkl~ \|F~obs~\|, where *R*~free~ is calculated without a sigma cut-off for a randomly chosen 5% of reflections, which were not used for structure refinement and *R*~work~ is calculated for the remaining reflections. ¶Deviations from ideal bond lengths/angles. \*\*Number of residues in favoured region/allowed region/outlier region. A comparison of the backbone traces of the apo and the PP5--P5SA-2 complex discloses limited structural rearrangements within the phosphatase domain, reflected by an RMSD of the Cα atoms of 0.42 Å ([Figure 5](#F5){ref-type="fig"}A). By contrast, a tilting of the TPR domain up to 10° is observed in the ligand complexed structure (RMSD: 0.84 Å) accompanied by a rearrangement of the αJ helix. These structural domain reorganizations are manifested in a reduction in the crystal lattice constant c by 15 Å. Inspecting the omit maps for both αJ helices ranging from Asn^491^ to Gly^497^ or to Met^498^ respectively, a considerable displacement of the Cα-atom of Gly^497^ by 6.5 Å is observed ([Figures 5](#F5){ref-type="fig"}B and [5](#F5){ref-type="fig"}C). Comparing the structures of the human and rat apo PP5 proteins, we observe a similar positioning of the αJ-helix in both, whereas the TPR domain of the human PP5 is even further tilted relative to the rat PP5--P5SA-2 structure (Supplementary Figure S6). This tilting of the domains and the changes in the αJ helix could well be the reason for the higher activity in the presence of P5SA-2. ![P5SA-2 leads to disintegration of regulatory domain contacts\ (**A**) Stereo view of the backbone superposition of both molecules shown as ribbon plots: PP5 apo with αJ-helix in dark grey and green, PP5--P5SA-2 with αJ-helix in light grey and yellow. The position of the additional electron density which is only visible in the PP5--P5SA-2 structure is indicated by a red arrow. Active site residues are depicted as sticks and the two magnesium ions (black) and one water molecule (red) are shown as balls \[also in (**B**) and (**C**)\]. (**B**) Stereo view of the 2F~o~-F~c~ electron density map (countered at 1σ) for the αJ-helix (T^492^--M^498^) of PP5 apo, in which the αJ-helix has been removed for phase calculations. The position of Gly^497^ is indicated. (**C**) Stereo view of the 2F~o~-F~c~ electron density map (at 1σ) for the αJ-helix (T^492^--G^497^) of PP5 in complex with P5SA-2. The electron density depicted in blue at 1σ indicates the potential binding site of the ligand P5SA-2. The indicated regulatory binding pocket for P5SA-2 was confirmed by mutational studies.](bsr035e210fig5){#F5} The ligand P5SA-2 itself cannot be modelled in the F~0~-F~c~ electron density map. However comparison of the two structures, PP5 apo and the PP5--P5SA-2 complex, assigns a potential binding site of the ligand at the interface between the TPR and the phosphatase domain. The visible parts of the ligand structure imply interactions with the phosphatase domain at amino acids Glu^428^, Val^429^, Lys^430^, Ala^431^, Glu^435^, Met^455^ and Asn^457^. The modulate character of the P5SA-2 interaction would be in agreement with the NMR data of this complex ([Figure 2](#F2){ref-type="fig"}), which suggested that parts of the ligand are not complexed by the protein. In summary, the observed structural rearrangements induced by ligand binding support the functional data on the P5SAs and provide a potential binding site at the phosphatase-TPR domain interface. Mutation of the regulatory pocket affects the turnover rate and the activation potential ---------------------------------------------------------------------------------------- The crystal structure of PP5 in complex with the activator P5SA-2 exposed the amino acid positions involved in ligand binding. To alter the proposed pocket, we designed two different PP5-variants, in which we changed the amino acids complexed by P5SA-2 to alanine. In the first mutant, we changed the residues of both loops forming the potential binding site. Thus the loop E^428^-V^429^-K^430^ was changed to A^428^-A^429^-A^430^ and the loop M^455^-G^456^-N^457^ was changed to A^455^-G^456^-A^457^, resulting in the protein PP5 428--430/455--457. This protein was slightly destabilized compared with the wt protein (result not shown) and the phosphatase activity was reduced to 0.20 s^−1^. Importantly, we could not observe any stimulation with the activator P5SA-2 ([Figure 6](#F6){ref-type="fig"}) and likewise we could not detect stimulation with P5SA-5. {#F6} We then generated a mutant, in which only the loop M^455^-G^456^-N^457^ was replaced. This mutant was as stable as wt protein (result not shown) and its activity was barely affected with a turnover of 0.35 s^−1^. Testing the potential of P5SA-2, no activation could be achieved even at a concentration of 100 μM ([Figure 6](#F6){ref-type="fig"}), implying that indeed this site is important to promote the effect of the activatory compound. We also tested the activator P5SA-5 ([Figure 6](#F6){ref-type="fig"}), which displays the highest affinity to rat PP5 and nematode PPH-5, but was not amendable for X-ray structural analysis. This compound likewise did not stimulate the catalytic activity of either PP5 variant, suggesting that these two compounds target the PP5 enzyme in a similar step. DISCUSSION ========== Targeting phosphatases as potential points of interference in cancer and other diseases has been described and compounds had been identified in the past. The farthest developed compounds, like LB-100, target PP2A for its involvement in various forms of cancer \[[@B19]--[@B22]\]. PP5 is unique in its regulation among the protein phosphatases with its complex regulation, which ensures that substrates are dephosphorylated when recruited to the Hsp90 chaperone network \[[@B26],[@B29]\]. It is controlled by an auto-inhibitory mechanism involving its Hsp90-interacting TPR domain and its C-terminal αJ helix \[[@B1],[@B28]\]. In the present study, we report five compounds (P5SAs) that modulate the activity of PP5. Notably, the P5SAs characterized in our study demonstrate a TPR-independent regulation of PP5 activity. This mechanism is distinct from other PP5 activators described so far, including arachidonic acid and its derivatives, which bind to the TPR domain \[[@B25],[@B30],[@B31]\]. The newly found P5SAs do not share much structural similarity, but each P5SA is able to increase significantly the turnover rate of the enzyme. This approach could in principle be helpful in cases, where PP5-activity is reduced or where increased dephosphorylation of its substrate proteins is desirable. Based on PP5 deletion constructs and X-ray structures we were able to allocate a potential binding region for one compound (P5SA-2) to the phosphatase domain at the interface with the TPR domain. At this junction, residual electron density was observed in the PP5--P5SA-2 complex structure. The F~o~-F~c~ electron density was not sufficient to unambiguously identify the ligand, but this electron density was absent from the apo structure. Substitution of the involved amino acids M^455^-G^456^-N^457^ to A^455^-G^456^-A^457^ and E^428^-V^429^-K^430^ to A^428^-A^429^-A^430^ resulted in loss of the stimulatory potential of the compound P5SA-2, implying that this pocket is indeed involved in regulatory processes, which are altered by the compound. The uncovered binding pocket may thus prove to be one possible checkpoint in the protein structure, where a strong modulatory effect can be obtained. The identified candidates derived here and the regulatory site which is targeted by P5SA-2 is suitable for further optimization and is probably interesting to address various diseases PP5 is involved in. In respect to the stimulation mechanism, the most significant change upon ligand binding exposes a structural reorganization of the phosphatase\'s C-terminus and a tilting of single helices of the TPR domain up to 10°. Limited flexibility in the orientation of the two domains had been observed in the human protein before \[[@B24]\]. In our case, these conformational rearrangements apparently are caused by the compound. Our biochemical data imply that the stimulation involves a release of the auto-inhibition of the phosphatase. The flexibility in domain arrangement of the phosphatase may hint to a more complex mechanism of this protein and potential conformational changes upon binding its protein substrates. Based on these results and previous reports, the targeting of PP5 represents a promising new strategy to influence various diseases originating from hyperphosphorylation. One prominent example is AD, where PP5 is involved in the dephosphorylation of tau protein. Other potential applications for PP5 activators include different types of cancer, where dephosphorylation of certain transcription factors or protein kinases is dysfunctional and contributes to the development of the disease. The described compounds may represent a first step in defining the options and possibilities of the approach to target PP5 in order to alter cellular pathways in diseases. The authors would like to thank Martin Hessling for helpful discussions and critically reading the manuscript. The authors thank Bettina Richter, Helmut Krause and Astrid König for excellent technical assistance. The staff of PXI of the Paul Scherrer Institute, SLS is acknowledged for help with data collection. The authors have submitted a patent application on the compounds described in the present manuscript. AUTHOR CONTRIBUTION =================== Experiments were planned and designed by Veronika Haslbeck and Klaus Richter. Screening of compound libraries was performed by Veronika Haslbeck, Matthias Weiwad and Gunter Fischer. Crystal structures were solved by Ferdinand Alte and Michael Groll. NMR spectra were recorded and analysed by Grzegorz Popowicz, Gerd Gemmecker and Michael Sattler. Mouse experiments were performed by Frank Striggow, Werner Schmidt and Martin Helmuth. Julia Eckl, Adrian Drazic and Frank Braun performed phosphatase assays. The manuscript was written by Veronika Haslbeck, Frank Striggow and Klaus Richter. FUNDING ======= This study was supported by the Deutsche Forschungsgemeinschaft to K.R. \[grant number RI1873/1-3\]; the Fonds der Chemischen Industrie; the ProNet-T^3^ network \[grant number 03IS2211D\]; the Federal Ministry for Education and Research \[grant number 03IS2211I (to F.S.)\]; and the TUM Graduate School (to V.H. and J.E.). AD : Alzheimer's disease BIAP : bovine intestinal alkaline phosphatase GR : glucocorticoid receptor Hsp : heat-shock protein P5SA : protein phosphatase 5 small-molecule activator pNPP : para-nitrophenyl phosphate PP5 : protein phosphatase 5 PPP : phosphoprotein phosphatase SLS : Swiss Light Source TPR : tetratricopeptide repeat wt : wild-type

Recent developments in electronics, photonics, and mechanics have increased the demand for mono- and few-layer two-dimensional (2-D) thin flakes[@b1][@b2], such as graphene[@b1][@b2][@b3][@b4], hexagonal boron nitride (h-BN)[@b5][@b6][@b7][@b8], molybdenum disulphide (MoS~2~)[@b6][@b7][@b8][@b9][@b10][@b11][@b12], and tungsten disulphide (WS~2~)[@b6][@b7][@b8][@b9][@b10][@b11]. The novel properties[@b13][@b14][@b15][@b16][@b17][@b18][@b19] of these materials enable their use for many applications[@b1][@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b20][@b21][@b22][@b23]. Within this broad range of applications, stretchable films that are composed of mono- and few-layer 2-D thin flake functional layers on flexible polymers have attracted interest[@b22][@b24][@b25]. Several methods, including liquid-phase exfoliation, chemical vapour deposition (CVD), and chemical approaches, have been studied for fabricating mono- and few-layer 2-D thin flakes on polymer substrates[@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35]. However, these approaches are "indirect" fabrication approaches[@b26]. After mono- and few-layer 2-D thin flakes are prepared in liquids[@b27][@b28][@b29] or on templates[@b30][@b31][@b32], an additional step is required to "transfer" the 2-D thin flakes to the polymer substrate[@b26][@b33]. Thus, recently developed "transfer-free" processes for attaching graphene and its 2-D analogues on polymer substrates are important[@b26][@b33][@b34][@b35]. However, these "transfer-free" methods have only been applied to graphene. In addition, these methods are unsuitable for use with other 2-D thin flakes. Furthermore, most of these methods require processing temperatures that are greater than 150°C, which common polymers cannot withstand. Here, a room temperature rubbing method that is based on the friction and self-lubricating properties of the 2-D layered materials is proposed for the transfer-free fabrication of few-layer 2-D thin flakes on polymer substrates. Different types of few-layer 2-D thin flakes were directly fabricated on flexible polymer substrates with commercial two-dimensional raw materials (composed of thousands graphite, h-BN, MoS~2~, and WS~2~ atomic layers) after performing rubbing procedures for several minutes at room temperature with no transfer step. Results ======= Advantages of rubbing method ---------------------------- The experiment details are given in [Figure 1](#f1){ref-type="fig"} and the Methods section. This rubbing method has the following important advantages: (1) producing a variety of few-layer 2-D thin flakes, (2) the rapid fabrication procedures (minutes) at room temperature, (3) the direct fabrication on flexible polymer substrates without any transfer step, (4) low raw material costs, and (5) a strong surface adhesion between the few-layer 2-D thin flakes and the flexible polymer substrates. Characterization results of the few-layer 2-D thin flakes --------------------------------------------------------- Commercial 2-D raw materials with thousands of atom layers were used as starting materials (see FSEM images of raw materials in the [Supplementary Information](#s1){ref-type="supplementary-material"}). Because poly(ethylene terephthalate) (PET) films are very smooth (see the FSEM and AFM images of the raw PET in the [Supplementary Information](#s1){ref-type="supplementary-material"}), they were used as flexible polymer substrates for field emission scanning electron microscopy (FSEM), atomic force microscopy (AFM), and other optical characterisations. In addition, polyvinylchloride (PVC) films were used as a flexible polymer substrate for Raman characterisation because the Raman peak positions of the PVC do not interfere with the graphene, MoS~2~, and WS~2~ peak positions. [Figure 2a](#f2){ref-type="fig"} shows that the 514 nm peak in the Raman spectra changes, with a clear red shift of 2*D* from approximately 2720 cm^−1^ for the raw graphite powders to approximately 2690 cm^−1^ for the few-layer graphene. In addition, the *G*/*2D* intensity ratio decreased significantly from the raw graphite powders to the few-layer graphene. When comparing these results with previous findings[@b36][@b37][@b38], the Raman spectra of graphene suggested that five carbon atom layers occurred in the few layers of graphene on the PVC substrate. Furthermore, the polycrystalline features that were revealed by the *D* peak originated from the polycrystalline raw graphite powders (see the *D* peak of the raw graphite powders in [Figure 2a](#f2){ref-type="fig"} and the FSEM image of the raw graphite powders in the [Supplementary Information](#s1){ref-type="supplementary-material"}). [Figure 2b](#f2){ref-type="fig"} contains an AFM image of the few-layer graphene on the PET substrate. The thickness of the graphene layer was approximately 1.15 nm. According to previous research[@b37][@b39], graphene monolayers on substrates are approximately 0.65 \~ 0.95 nm thick. In addition, each additional carbon atom layer is approximately 0.34 nm thick. Thus, based on the calculated graphene thickness on the PET substrate, 5 or fewer carbon atom layers occurred. The AFM results are consistent with the Raman spectra results. [Figure 2c](#f2){ref-type="fig"} shows an AFM image of few-layer h-BN on a PET substrate. The thickness of this layer is approximately 1.70 nm. Based on previous results[@b5][@b40], a monolayer of h-BN on a substrate is approximately 0.60 \~ 0.90 nm thick. In addition, each additional h-BN atom layer is approximately 0.333 nm thick. Thus, the calculated thickness of few-layer h-BN on the PET substrate corresponded with to 5 or fewer atom layers. In addition to the AFM images, [Figures 2d and e](#f2){ref-type="fig"} provide separate FSEM images of the few-layer graphene and h-BN on the PET substrate, respectively. The morphology of these films is very similar, which was expected because the graphite and h-BN have similar layered atom structures. Optical microscopy was used to provide the images of the few-layer graphene and h-BN on the PET substrate ([Figures 2f and g](#f2){ref-type="fig"}, respectively). These flakes are presented on a scale of tens of micrometres. [Figure 3a](#f3){ref-type="fig"} shows the change in the trend for the 514 nm peak in the Raman spectra. Specifically, a 0.4 cm^−1^ blue shift occurs for the Raman peak position between the raw MoS~2~ powders and the few-layer MoS~2~ on the PVC substrate. In addition, a 0.9 cm^−1^ red shift of the *A~1g~* Raman peak position between the raw MoS~2~ powders to the few-layer MoS~2~ on the PVC substrate occurred. By comparing these results with previously observed Raman spectra of few-layer MoS~2~[@b41][@b42][@b43], it was observed that no more than 4 MoS~2~ atom layers occurred on the PVC substrate. An AFM image of the few-layer MoS~2~ on the PET substrate is presented in [Figure 3b](#f3){ref-type="fig"}. The thickness of this layer is approximately 2.95 nm. According to previous research[@b43][@b44], a monolayer of MoS~2~ on a substrate is approximately 0.70 \~ 1.00 nm thick. In addition, each additional MoS~2~ atom layer is approximately 0.62 nm. Thus, the calculated thickness of the few-layer MoS~2~ on the PET substrate corresponds to 5 or fewer MoS~2~ atom layers. The AFM results are consistent with the Raman spectra results. The AFM image of the few-layer WS~2~ on the PET substrate is shown in [Figure 3c](#f3){ref-type="fig"}. The thickness of this film is approximately 3.05 nm. Based on previous results[@b45], a monolayer of MoS~2~ on a substrate is approximately 1.00 nm thick. In addition, each additional WS~2~ atom layer is approximately 0.625 nm. Thus, the calculated thickness of the few-layer WS~2~ on the PET substrate corresponded with 5 or fewer WS~2~ atom layers. The FSEM images of the few-layer MoS~2~ and WS~2~ on the PET substrates are presented in [Figures 3d and e](#f3){ref-type="fig"}, respectively. The morphologies of these films are very similar, which was expected because MoS~2~ and WS~2~ have very similar layered atomic structures. The optical images of the few-layer MoS~2~ and WS~2~ on the PET substrates are provided in [Figures 3f](#f3){ref-type="fig"} and [](#f4){ref-type="fig"}[](#f5){ref-type="fig"}[6](#f6){ref-type="fig"}, respectively. These flakes are presented on a scale of tens of micrometres. Surface stability and related application ----------------------------------------- One major concern regarding the use of few-layer 2-D thin flakes on flexible polymer substrates is the low surface stability of these products[@b46]. This low surface stability results from the poor surface adhesion between the polymer films and the few-layer 2-D thin flakes. This poor adhesion generally necessitates an additional protective layer for further applications. In contrast, our previous results have shown that 2-D sheets fabricated on polymer substrates by rubbing have much stronger surface adhesion[@b47][@b48][@b49]. In the FSEM images ([Figures 2d and e](#f2){ref-type="fig"} and [Figures 3d and e](#f3){ref-type="fig"}), most of the 2-D thin flakes on the PET substrate have embedded boundaries (boundary lines are ambiguous). This finding agrees with previous findings, including those presented in Ref. [@b49]. In addition, these embedded boundaries offer 2-D thin flakes that are much stronger than other materials that are attached to PET films. In this study, the two types of destructive surface treatments that were used indicated that our samples displayed strong surface stability. In this section, graphene/PET films with similar properties were used in destructive surface treatments (details of the destructive surface treatments are provided in the Methods section). These films were used because their changes in resistivity and transparency changes can be tested accurately. Two pieces of the graphene/PET films were used for the following comparative experiments. (1) The tape test was used to reflect the surface adhesion between the polymer film and functional layer. Next, it was observed that the changes in contrast resistivity and transparency were within 0.1%, which indicated that our samples withstood tape testing. (2) Ultrasonic cleaning is generally an important preparatory part of procedures for several applications. Thus, we studied the effects of ultrasonic cleaning on our samples. After 1 hour of ultrasonic cleaning, the contrast resistivity and transparency changes were within 1.0%. Thus, our samples could withstand a long period of ultrasonic cleaning. The high surface stabilities of our samples are beneficial for several applications, including flexible transparent conductive films (TCF) with high stability ([Figures 4a and 4b](#f4){ref-type="fig"}). Here, the application of our TCFs as transparent strain sensors was investigated. These investigations were made because the strain sensor is an important sensor that is used in many different applications where mechanical deformation is analysed. In addition, graphene networks on polymers can form a type of strain gauge, which combines cheap and scalable production with high sensitivity and novel and attractive properties. Polyurethane (PU) films were used as substrates for these strain sensors because PU is more sensitive to strain than PET. [Figure 4c and 4d](#f4){ref-type="fig"} shows two typical curves of changing resistance ΔR as a function of mechanical strain ε. The calculated strain gauge factor (approximately 51) from [Figure 4d](#f4){ref-type="fig"} was comparable with the strain gauge factors for the materials that were fabricated from the CVD grown or liquid-exfoliated graphene[@b50][@b51]. In addition, this graphene gauge resulted in a good linear response over a wide range of mechanical strains, which demonstrates the usefulness of the rubbing method for strain sensing. Discussion ========== Friction, which can be imposed on target substrates at room temperature, is closely linked with self-lubricated layered materials, such as graphite. At the end of the 20th century, friction was predicted to be a potential technique for fabricating graphene on target substrates[@b52]. In 2004, graphene nanosheets with a thickness of between 10 and 100 nm were fabricated on SiO~2~ by using a micromechanical manipulation technique[@b53], and this technique was closely related to the friction technique. In 2005, two-dimensional atomic crystals were observed on a solid surface after rubbing the layered crystals (including graphite) with solid materials[@b54]. However, the target substrates that were reported in these studies were solid materials rather than flexible polymers. In 2012, based on the friction and self-lubrication properties of the two-dimensional layered materials, we proposed rubbing methods for the transfer-free fabrication of two-dimensional nanosheets on flexible polymer substrates at room temperature within minutes of these procedures[@b47][@b48]. However, the thicknesses of the nanosheets that were obtained from our previous rubbing methods were approximately 100 to 200 layers (much thicker than mono- and few-layer 2-D thin flakes, which have layers with less than 10 atoms). In 2013, an innovative smoothing step was developed that uses a self-lubricated smooth rubbing medium that formed by orderly arranged graphite sheets. The function of the smooth rubbing medium surface during the rubbing procedures enabled the fabrication of few-layer graphene (with 2 to 9 carbon atom layers) on the polymer substrate at room temperature[@b49]. However, this smoothing step can only be conducted for graphene and is not suitable for other few-layer 2-D thin flakes. In this study, innovative technical changes have led to the design of a Universal Smoothing Step for different 2-D raw materials (graphite, h-BN, MoS~2~, and WS~2~) and the formation of self-lubricated smooth rubbing mediums with different kinds of orderly arranged 2-D layered sheets. The Universal Smoothing Step and the resulting self-lubricated smooth rubbing mediums are essential for the fabrication of few-layer 2-D thin flakes on polymer substrates. A detailed physical relationship between the formation of the smooth rubbing medium and the fabrication of the few-layer 2-D thin flakes was discovered by analysing the FSEM morphology of the sandpaper after Step-1. In this section, the sandpapers from fabricating all 4 of the few-layer 2-D thin flakes were tested and compared. These sandpapers were marked as Sandpaper-G, Sandpaper-B, Sandpaper-M and Sandpaper-W, which corresponded with the fabrication of few-layer graphene, few-layer h-BN, few-layer MoS~2~ and few-layer WS~2~, respectively. [Figures 5](#f5){ref-type="fig"} and [6](#f6){ref-type="fig"} clearly illustrate that an important change in the sandpapers\' occurred after the "smoothing" procedure in Step-2. In this case, the area of the coarse portion became smaller and the area of the smooth portion became larger. In the smooth areas, the 2-D sheets covered the sandpaper and served as a smooth rubbing medium ([Figures 5e and f](#f5){ref-type="fig"} and [6e and f](#f6){ref-type="fig"}). However, in the coarser portions, the attachment of the 2-D sheets to the sandpaper was disorderly. The smooth rubbing mediums and the 2-D sheets of sandpaper were worked together during the rubbing process in Step-3. The 2-D sheets were rubbed onto the polymer substrates by using "soft pressure" during Step-3. These 2-D sheets were rubbed with the smooth rubbing mediums during Step-3. The self-lubricating property of the smooth rubbing medium is important for fabricating few-layer 2-D thin flakes on polymer films. Because if the rubbing mediums have a high friction coefficient, the 2-D sheets on the polymer substrates can be rubbed away by them. Similar surface fractal evolutions were observed in our previous studies for all of the rubbing surfaces that were used in this study ([Table 1](#t1){ref-type="table"}). These evolutions potentially cause changes in the ratio of coarse portions to smooth portions. The ratio of the coarse portions to smooth portions is important in Step-3. If there were no "smoothing" procedures, the coarse portions would be very large relative to the smooth portions ([Figures 5a and c](#f5){ref-type="fig"} and [6a and c](#f6){ref-type="fig"}). In addition, too many 2-D sheets would be rubbed on the polymer substrates. Finally, the relatively small smooth rubbing mediums would not be sufficient for rubbing the excess 2-D sheets to achieve a desired thickness of only a few layers of 2-D thin flakes. Thus, without these smoothing procedures, more than 10 layers of 2-D nanosheets would occur on the polymer substrates. In contrast, if the "smoothing" time in Step-3 is very long, the areas of the coarse portions are small relative to the areas of the smooth rubbing mediums ([Figures 5b and d](#f5){ref-type="fig"} and [6b and d](#f6){ref-type="fig"}). Thus, the amount of the 2-D sheet that was rubbed on the polymer substrate was small. In addition, the relatively large smooth rubbing mediums can be used to reduce the 2-D sheets to 2-D thin flakes. In addition, the fractal dimensions of the few-layer 2-D thin flakes were similar to the fractal dimensions of the smooth rubbing surfaces ([Table 2](#t2){ref-type="table"}), which indicated that a linkage occurred between fractal evolution and growth in the few-layer 2-D thin flakes. Additional comparative results on the specific conditions of soft contact rubbing step are discussed in the [Supplementary Information](#s1){ref-type="supplementary-material"}. The high resolution FSEM images ([Figure 5e, f](#f5){ref-type="fig"} and [Figure 6e, f](#f6){ref-type="fig"}) clearly show the presence of defects, which may cause existence of small flakes and affect the film surface quality of samples. Since defects can have a strong influence on the properties of 2-D materials based films[@b55][@b56], and on the other side, the control of defects allows making preparation of 2-D materials based films with novel properties[@b56][@b57]. Several potential methods as following may bring further improvements on the quality and deserve future studies: (1) using raw 2-D materials with higher quality, or pre-treat (e.g. ultrasonic cleaning and centrifugation) the raw materials to obtain more homogeneous starting materials, (2) Post-processing on the sandpaper surfaces after smooth rubbing step to obtain smooth rubbing mediums with higher quality. According to the experimental and theoretical reports on the friction properties of mono-and few-layer 2-D materials, double to several atom layers of 2-D materials can lead to a significantly better lubrication property than single atom layer 2-D materials[@b58][@b59]. These could result in the friction increment upon thinning of the 2-D thin flakes when in the range of few-layer. And the development progress of rubbing method from 2012 did show that it becomes more and more difficult to remove layers when approaching mono-layer 2-D thin flake. Thus, the limit on the atom layer numbers of 2-D thin flakes fabricated from current rubbing procedures and the special points of further improvements to get mono-layer 2-D flakes are needed to be explored. In summary, we fabricated different types of few-layer 2-D thin flakes directly on flexible polymer substrates by using commercial 2-D raw materials with thousands of atom layers. During this fabrication process, rubbing procedures were performed for several minutes at room temperature without any transfer step. This rubbing method has the following important advantages: (1) producing a variety of few-layer 2-D thin flakes, (2) the rapid fabrication procedures (minutes) at room temperature, (3) the direct fabrication on flexible polymer substrates without any transfer step, (4) low raw material costs, and (5) a strong surface adhesion between the few-layer 2-D thin flakes and the flexible polymer substrates. The sizes of the few-layer 2-D thin flakes were approximately tens of micrometres. The physical relationship between the formation of the smooth rubbing mediums and the few-layer 2-D thin flakes is discussed based on the morphological changes of the sandpaper surfaces after each step. This study provides highly efficient, low cost, and direct fabrication of few-layer 2-D thin flakes at room temperature. The resulting few-layer 2-D thin flakes strongly adhered to the flexible polymer substrates. These results demonstrated that rubbing methods are potentially important in the fabrication and application of nanomaterials. Methods ======= Raw materials ------------- Polytetrafluoroethylene (PTFE) films are needed to assist the Sandpaper Rubbing Step (Step-1), and PET films are needed as smoothing mediums. PET, PVC and PU films are used as flexible polymer substrates. Several pieces of polishing sandpapers are required for the method. A series of commercial graphite, h-BN, MoS~2~, WS~2~ powders are needed as raw materials. Step-1, Sandpaper Rubbing Step ------------------------------ The commercial raw powders were rubbed between PTFE films and polishing sandpaper ([Figure 1a](#f1){ref-type="fig"}) by applying gentle pressure (0.1 MPa) for 20 seconds. This gentle pressure was transferred by commercial rubber (shown as the yellow rectangles in [Figure 1a](#f1){ref-type="fig"}) that was fixed on commercial glass blocks. In addition, this step was used to apply a thin and uniform layer of powder on the polishing sandpapers. The rubbing track can be described as "revolution without self-rotation" (like the rubbing track from our previous studies[@b47][@b48][@b49]). The rubbing rate was 200 rpm and the rubbing diameter was 0.5 cm. Step-2, Smoothing Step ---------------------- After fixing a PET film on commercial rubber (the light grey piece on the yellow rubber in [Figure 1b](#f1){ref-type="fig"}), we rubbed the polishing sandpaper on the PET film by applying soft pressure (0.04 MPa) over different periods (50--300 seconds for the different 2-D raw materials). This soft pressure was transferred by commercial rubbers (shown as the yellow rectangles in [Figure 1b](#f1){ref-type="fig"}) that were fixed on commercial glass blocks. The rubbing track that was used in this study corresponds with the rubbing track that was used in our previous studies[@b47][@b48][@b49]. Here, a rubbing rate of 200 rpm and a rubbing diameter of 0.5 cm were used. Following this rubbing process, the polishing sandpaper surface had different degrees of smoothness that corresponded with the rubbing periods. Step-3, Soft Contact Rubbing Step --------------------------------- After fixing a polymer film (PET or PVC or PU) on a commercial piece of rubber (the light grey piece on yellow rubber in [Figure 1c](#f1){ref-type="fig"}), the polymer film was rubbed with the polishing sandpaper by applying soft pressure (0.1 MPa) for 40 seconds. This soft pressure was transferred by commercial rubbers (shown as the yellow rectangles in [Figure 1c](#f1){ref-type="fig"}) that were fixed on commercial glass blocks. The rubbing track that was used in this study was the same that was used in our previous studies[@b47][@b48][@b49]. A rubbing rate of 200 rpm and a rubbing diameter of 0.5 cm were used. This rubbing process was used to fabricate the sample. After Step-3, the samples were washed in deionised water in an ultrasonic bath for 1 min. Surface Destructive Treatments ------------------------------ \(1\) Bending test: The sample was bent in a semi-circular shape for 2 seconds. This process was repeated between 1 and 1000 times. (2) Tape test: A commercial tape was pasted and pressed on one piece of the sample at a pressure of 1 MPa for 30 min before tearing the tape off. (3) Long term ultrasonic cleaning test: One piece of the sample was placed an ultrasonic bath containing deionised water and cleaned for 1 hour. Materials characterizations --------------------------- Raman spectra of few-layer graphene and few-layer MoS~2~ on PVC films were characterized by Raman spectrometry (514 nm). The thicknesses of few-layer 2-D thin flakes on PET films were tested by Atomic Force Microscopy (AFM). The sizes and distribution of few-layer graphene on PET films were observed by Optical microscopy. The morphology of few-layer 2-D thin flakes on PET films and the morphology changes of polishing sandpaper surface were characterized by Field emission Scanning Electron Microscopy (FSEM). Sheet resistance and optical transparency measurements of flexible transparent conductive films (few-layer graphene/PET and few-layer graphene/PU films) were taken by Four-probe tester and UV-Vis Spectrophotometry, respectively. Strain sensors fabrication and characterizations ------------------------------------------------ Such sensors were fabricated by printing silver pads (4 cm × 1.0 cm) onto 4 cm × 6.0 cm sized few-layer graphene/PU films\' surfaces to define a patterned specific shape. The strain gauge factors were calculated by testing the resistivity changes under different strain ratios as Ref. [@b50] and Ref. [@b51]. Fractal dimension calculations ------------------------------ The surface evolution behavior on sandpaper surfaces during Step-3 were studied using the fractal power law equations[@b60]: Where ε is the side length unit of box for coverage of boundary, *N(ε)* and *N(nε)* are the numbers of boxes (with different side lengths: *nε*) needed to cover the boundary, *D* is the fractal dimension. In this study, *n* = 1, 2, 3, 4, 5 were used to calculate value of *D* by box-counting method[@b60]. Author Contributions ==================== Y.Y. and S.J. conducted the research. Y.Y. fabricated the 2-D thin flakes on polymers. Y.Y., W.Z. and X.M. carried out the materials characterizations. Y.Y., Y.Z., and G.Z. made the strain sensors and did the device testing. Y.Y. and S.L. did the calculations in this research. Y.Y. drafted the paper and the Supplementary Information. All authors contributed to the final paper. Supplementary Material {#s1} ====================== ###### Supplementary Information Supplementary Information ###### Supplementary Information Supplementary Dataset 1 This work was supported by Award of Academic Newcomers for Doctoral Students (Ministry of Education of the People\'s Republic of China), Key Project of Outstanding Doctoral Dissertation Foundation of Huazhong University of Science and Technology, National Natural Science Foundation of China (No. 61274115), and the National Science and Technology Support Program (2012BA113B00). We acknowledge Analytical and Testing Center of Huazhong University of Science and Technology for testing our samples. {#f1} {#f2} {#f3} {#f4} {#f5} {#f6} ###### Calculated fractal dimensions of the sandpaper surfaces before and after Step-2   Graphene h-BN MoS~2~ WS~2~ --------------------------------------------------------------------------- ---------- ------- -------- ------- Fractal dimensions of smooth parts on the sandpaper surface before Step-2 1.302 1.280 1.343 1.307 Fractal dimensions of coarse parts on the sandpaper surface after Step-2 1.293 1.300 1.303 1.273 ###### Calculated fractal dimensions of the few-layer 2-D thin flakes on PET   Graphene h-BN MoS~2~ WS~2~ ---------------------------------------------- ---------- ------- -------- ------- Fractal dimensions of 2-D thin flakes on PET 1.287 1.317 1.305 1.292

Introduction {#s1} ============ Nature and significance of the local problem {#s1-1} -------------------------------------------- In rural Indian women, multiple missed opportunities impede timely screening of sexually transmitted bloodborne infections (STBBIs) and conditions (anaemia) associated with HIV. Untreated missed infections risk mother-to-infant transmission and adverse outcomes (ie, congenital infection, stillbirth, preterm delivery or low birth weight). The prevalence of anaemia, a related condition, is about 50% in South Asian women and it increases susceptibility to STBBIs.[@R1] Furthermore, in pregnancy, physiological demands for iron and vitamins pose a risk of cardiac complications and postpartum haemorrhage.[@R2] Although public health facilities offer vertical screening programmes for STIs and anaemia, pregnant women are often shunted between facilities, while screening tests are often unnecessarily repeated and not recorded. Moreover, as a result of poor documentation that often gets lost in the health system, treatment plans are not executed, precipitating losses to follow-up. Anecdotally, only 12% of rural public hospitals offer essential antenatal services for HIV, one of the top STIs.[@R3] Screening for other STBBIs is sporadic and performed only when women present for early pregnancy care, which is rare. Furthermore, rural women are unaware of the importance of timely screening for STBBIs. In sum, missed screening opportunities and gaps across the care continuum, from access to retention, translate to poor quality of antenatal care in rural India. Taken together, they result in poor management of STBBIs and anaemia. Delayed detection of STBBIs underestimates their true disease burden. Reported seroprevalence estimates differ greatly for the Southern Indian region: for HIV, prevalence ranges from 0.33% to 3% regionally[@R4] vs 0.6% to 0.9% nationally;[@R6] for syphilis, 11%--12.9% regionally to 1.2%--1.8% nationally;[@R7] for hepatitis B virus (HBV), they are at an endemic high of 4%--5% to 0.9%--11.2% nationally;[@R8] hepatitis C virus (HCV) is at 1.03%;[@R9] []{.ul} *Trichomonas vaginalis* (TV) at 4% and 33%--89% for anaemia.[@R10] Available knowledge {#s1-2} ------------------- ### Rationale {#s1-2-1} In India, frontline healthcare professionals (HCPs) who serve their own communities as peer health navigators play a major role in plugging the gaps in service delivery and in raising health awareness regarding maternal and child health.[@R11] []{.ul} If executed properly, this could result in timely access to screening programmes during antenatal care, ultimately leading to the effective reduction of maternal morbidity and mortality and the prevention of mother-to-infant transmission. Besides, as rapid point-of-care tests (POCTs) have been found to be accurate and effective for screening/triage of STBBIs,[@R13] []{.ul} strategies including POCTs represent the ideal method to offer a potential solution to plug gaps in the care continuum for STBBIs (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}). 10.1136/sextrans-2017-053491.supp1 The global availability of mobile phone technologies for health, mHealth, has enabled greater provision of maternal and child health services for STBBI/HIV through the use of short message services (SMS) and novel mobile applications.[@R16] []{.ul} This mHealth approach has demonstrated success in delivery of reproductive health information, tracking HIV/AIDS care and adherence to antiretroviral treatment.[@R19] []{.ul} mHealth offered by HCPs has increased knowledge with respect to antenatal and neonatal care and catalysed maternal behaviour improvements with positive impact on the offspring's health and growth.[@R22] When integrated within a reproductive sexual health programme, such a promising approach could increase access to quality antenatal care in rural areas and optimise service delivery to hard-to-reach populations. We hypothesised that our proposed integrated, digital, multiplex POCT-based AideSmart! ([figure 1](#F1){ref-type="fig"}) strategy, operationalised by HCPs, that screens and links pregnant women to timely treatment and referral, could reduce the time to HIV/STBBI treatment initiation to possibly impact morbidity in women and transmission to their infants. It could additionally engage and empower patients and HCPs in the technology-driven delivery of connected care. {#F1} Methods {#s2} ======= Context {#s2-1} ------- A SmartApp-based, cloud-connected, multiplexed POCT strategy called AideSmart! (Nitika Pant Pai 2016, McGill University, Montreal Canada) was developed to plug gaps in engagement, timely screening and integrated clinical action and retention during STBBI screening and management (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}). ### Specific aims {#s2-1-1} In a cross-sectional study, we aimed to evaluate whether the AideSmart! strategy offered to participants by frontline HCPs could be feasible, acceptable and impact detection of new infections/conditions and retention in the care of women presenting for antenatal care in rural South India. Intervention {#s2-2} ------------ The AideSmart! strategy ([figure 1](#F1){ref-type="fig"}) consisted of a secure, confidential, encrypted tablet application and linked web-based platform of care. We trained 15 HCPs to screen pregnant women with multiplexed POCTs and to facilitate care through the AideSmart! app. Each HCP followed 35 participants throughout their pregnancy and screened them close to their homes in rural service units. Services included: the provision of evidence-based information, multiplexed POCT quality control and assurance training, digital data collection and connectivity, rapid communication of results, lab integration and clinical follow-up. POCTs for the following infections/conditions were offered: HIV, HBV, HCV, syphilis, TV and anaemia. The HCPs used four POCTs: two rapid multiplexed finger-prick tests (Multiplo HBc/HIV/HCV test (anti-HBc total/anti-HIV-1/2/anti-HCV) and Multiplo TP/HIV test (anti-TP/anti-HIV-1/2)) and two rapid singleton tests (vaginal swab-based OSOM Trichomonas test (TV antigen) and finger-prick Hb test (Mission Hb) for anaemia (haemoglobin in g/L)). HCPs were trained to perform the following tasks ([figure 1](#F1){ref-type="fig"}): (1) use the AideSmart! app; (2) engage with participants, with evidence-based information (in English and Tamil); (3) conduct POCT, maintain quality control logs and extensively monitor the quality of POCT in harsh, field settings; (4) record digital data on each participant; (5) interpret, record, store and provide test results to lab professionals and providers; (6) upload data onto real-time servers at the end of each day; (7) track, communicate and link women to care with built-in links; (8) communicate with laboratories and engage with clinical providers and (9) convey clinical plans to participants, keep them engaged and updated, to encourage follow-up throughout their pregnancy. Study approach {#s2-3} -------------- The cross-sectional study was conducted during April 2015 to December 2016, in a convenient sample of 510 rural pregnant women, recruited from peripheral service units (PSUs). PSUs were spread around the K.V. Kuppam rural development blocks, in the Vellore district ([figure 2](#F2){ref-type="fig"}). PSUs were managed by the Rural Unit for Health and Social Affairs (RUHSA), of the Christian Medical College (CMC) in Vellore, India. {#F2} ### Inclusion/exclusion criteria {#s2-3-1} Pregnant women aged 18 years old or above, able to provide informed consent, with access to a phone were eligible to participate. Women with a mental health or a serious medical condition requiring hospitalisation were excluded. Measures {#s2-4} -------- ### Primary outcome {#s2-4-1} ** *Feasibility* was defined by the metric completion rate, calculated as the proportion of participants successfully screened with POCTs and confirmatory tests (numerator), over the total number of consenting participants (denominator). With a hypothesised completion rate of 80%, with a CI width of 5%--10%, a sample size of 500 pregnant women was deemed sufficient for our estimations. ### Secondary outcomes {#s2-4-2} *Acceptability* was defined as the proportion of pregnant women approached who consented to participate (numerator) over the number that presented for recruitment (denominator). *Preference for the strategy* was defined as whether participants preferred POCTs over conventional laboratory tests. *Preference for referral* was defined as the willingness to recommend the strategy to a friend. *Preference for turnaround time* (TAT) was defined as the time to complete the tests and receive results. *Preference for the mode of follow-up* (ie, face-to-face, phone calls, SMS) and the average number of visits were documented. *Participant satisfaction* was defined as the overall evaluation of the participant's experience with the strategy, as measured by a Likert scale. Statements of HCPs and study participants were also recorded qualitatively. ### Tertiary outcome {#s2-4-3} *Impact* was documented using proportions, defined as: (1) The number of new infections/conditions detected/confirmed relative to the total number of participants screened; (2) The number of linkages to confirmatory tests and treatment initiated over the number of patients that were detected with new infections/conditions; (3) The number of women who were retained in care/follow-up over the number of participants screened for all infections and (4) The number of infants in whom perinatal transmission was prevented, over the total number of infants delivered. The AideSmart! strategy {#s2-5} ----------------------- The HCPs were trained for 2--2.5 months on all study aspects. A pilot evaluation was conducted in 30 participants, with feedback provided to the HCPs in regard to their work flows and processes. Following this, the digital intervention was optimised and processes established to ensure a smooth running of the strategy ([figure 1](#F1){ref-type="fig"}). In order to ensure quality care throughout pregnancy, HCPs were trained to follow assigned pregnant women. Through the app, HCPs performed POCT, data and clinical tasks and engaged with each participant with information on the tablets. The importance of timely STBBI screening during pregnancy, and the need for engagement during treatment so as to prevent mother-to-infant transmission were explained. They communicated test results to the patients and maintained their engagement. A laboratory team, consisting of a phlebotomist and a physician, provided an oversight of the POCT process as well as quality control and assurance. Repeat testing resolved discordant results, and all test results were documented and shared in real-time at the end of the day. With access to digital apps and servers, the results were available to all investigators involved and discussed regularly throughout the study period. During the course of the study, approximately five prototypes of the AideSmart! app were developed and iterated; at multiple time points, bugs were removed and data server incompatibility issues were resolved. These modifications aided the creation of a refined version, resilient for use in a resource-constrained environment, with an improved connected app-based platform. For patients, video and patient-centred content was made available in their local language of Tamil, while for HCPs, data and study-based information was made available in both Tamil and English. Completeness and accuracy of data {#s2-6} --------------------------------- With AideSmart!, the HCPs recorded deidentified and encrypted digital data on a secure platform. Data accuracy was verified on an ongoing basis by the project managers onsite and overseas. Data were communicated in real-time to all stakeholders (clinical providers, researchers, analysts, patients and laboratory professionals), using mobile technologies (SMS, phone calls, videos) to expedite management plans. The principal investigators arranged weekly teleconferences to troubleshoot plans, ensuring completeness and accuracy of the data. Data anonymity was ensured with high-level encryption and confidential password access. Servers were based and operated from Montreal. Analysis {#s2-7} -------- ### Data sources and measurement {#s2-7-1} AideSmart! contained a semistructured validated questionnaire that collected deidentified and anonymised data on the following variables: sociodemographic, risk factor ([table 1](#T1){ref-type="table"}), medical gestational history, patient experience/satisfaction and diagnostic, clinical and follow-up data for each participant throughout their pregnancy, labour and delivery period. ###### Demographic and risk factors data of participants N \% --------------------------- ----- ------ Language  Tamil 461 90.4  English 1 0.2  Telugu 43 8.4  Other 5 1.0 Education  Illiterate 4 0.8  Primary school 8 1.6  Middle school 92 18.0  High school 282 55.3  Bachelor/Master or above 124 24.3 Number of children  0 or 1 415 81.4  2 or 3 93 18.2  4 or 5 2 0.4 Status  Unemployed 488 95.7  Worker 18 3.5  Student 4 0.8 Family monthly income  \<₹5000 182 35.7  ₹5000--15 000 270 52.9  ₹15 001--25 000 42 8.2  \>₹25 000 16 3.1 Condom use  Never 483 94.7  Always 1 0.2  Sometimes 26 5.1 Prior testing history  HIV total 386 75.7   In the past 6 months 296 58.0   6 months to 1 year 9 1.8   \>1 year 81 15.9  HBV total 157 30.8   In the past 6 months 109 21.4   6 months to 1 year 4 0.8   \>1 year 44 8.6  HCV total 6 1.2   In the past 6 months 3 0.6   6 months to 1 year 0 0   \>1 year 3 0.6  Syphilis total 283 55.5   In the past 6 months 214 42.0   6 months to 1 year 6 1.2   \>1 year 63 12.4  Trichomonas 2 0.4  Anaemia 397 77.8 HBV, hepatitis B virus; HCV, hepatitis C virus. Quantitative data analyses {#s2-8} -------------------------- For all key quantitative outcomes (feasibility, acceptability, satisfaction, preference, impact), an analysis of proportions was performed. Clinical management {#s2-9} ------------------- CMC's protocols/algorithms for confirmatory testing were followed ([online supplementary file 3](#SP3){ref-type="supplementary-material"}). All infections/conditions were confirmed, staged and treated as per CMC protocols. The laboratories confirmed all POC test results. For Hepatitis B, molecular test-based referral and staging were performed. Regarding infants born to HBs Ag-positive mothers, ELISA HBsAg test was performed at 9 months and prophylaxis (hepatitis B immunoglobulin (HBIG) and vaccines) was administered. Metronidazole was administered for TV infection, while iron and folic acid were provided for anaemia management. All medications were documented on the application and medication reminders sent to the participant on a daily basis, keeping continuity of care. 10.1136/sextrans-2017-053491.supp3 Ethical considerations {#s2-10} ---------------------- The study investigators had neither perceived nor reported conflicts of interest with any intervention deployed in the study. Results {#s3} ======= Process measures and outcomes {#s3-1} ----------------------------- Data on sociodemographics of participants revealed that participants were young; mean age: 24 years (range: 17--40; SD=4.0); educated: 80% (406/510) were high school graduates and poor: about 89% (452/510) with a monthly income of INR ₹15 000 (US\$300). Seventy-four per cent of women (376/510) were in their second trimester. ### Primary outcome {#s3-1-1} *Feasibility:* Feasibility of the AideSmart! strategy was documented at 91% (466/510). ### Secondary outcomes {#s3-1-2} *Acceptability:* All 510 (100%) pregnant women approached for participation consented. *Preference:* Preference for POCT based screening strategy was high at 73% (359/492); preference for referrals was at 71% (349/492). Other preference measures were: 1. Preference for TAT for POCT test results: 1 hour---47% (232/492); 1 day---35% (174/492). 2. Preference for follow-up with in person visits: 47% (231/492). 3. Preference for follow-up on phone: 27% (131/492). The mean recorded frequency of in-person visits was 3.8 times (SD=1.6); 2.1 times by phone (SD=1.7) during pregnancy. *Participant satisfaction:* 92% (453/491) of participants rated high satisfaction with the strategy. ### Tertiary outcome {#s3-1-3} *Impact:* Baseline screening rates, observed in the past 6 months, by laboratory-confirmed estimates were low, with HIV at 58% (296/510); 42% for syphilis (214/510); 21% for HBV (109/510); 0.6% for HCV (3/510); 0.4% for TV (2/510) and 78% for anaemia (397/510) ([table 1](#T1){ref-type="table"}). With AideSmart!, all consenting participants (100%) were screened at point-of-care; therefore, the incremental increase in screening from baseline was 42% for HIV, 58% for syphilis, 79% for HBV, 91.4% for HCV, 99.6% for TV and 28% for anaemia. At the point-of-care, 239 infections/conditions (46.8%; 239/510) were identified; 112 STIs and 127 cases of anaemia. Of 112 infections, the breakdown of new infections was as follows: 13 HIV, 69 anti-HBc, 11 syphilis, 18 TV and 1 HIV/HCV coinfection. Confirmatory testing of POCT results by CMC labs revealed that 168/239 infections/conditions (70%) were linked to care. Of those, 41 were infections and 127 anaemia. Lab confirmations revealed that all HIV POCT positives were negative (by Western Blot/ELISA) as well as the syphilis (confirmed by TPHA) and the HIV/HCV coinfection. Of 18 Trichomonas POCT positive results, 11 were shown to be positive as obtained by TV smear. All 127 anaemia cases were confirmed to be positive. Of 69 anti-HBc positive cases, 30 were confirmed; the infection resolved naturally in 34 patients. Five were HBs Ag-positive, of which four were referred to a hepatologist for treatment, while one was lost to follow-up, transmission was prevented in 4/5 infants (80%). All four women were further tested for HBV; DNA-reported viral load less than 2000 IU/mL, which was deemed ineligible for treatment as per CMC protocols. Their infants were prophylaxed with HBIG, vaccines at birth with three additional doses at 6, 10 and 14 weeks of age. They were each tested at 9 months with Elisa HBs Ag and found to be negative. Medication intake was recorded diligently through AideSmart! by the HCPs. All (100%) TV-positive participants were administered Metronidazole. Nearly all (98%; 124/127) women with anaemia were treated with iron and folic acid supplements. At the end of the study, reported losses to follow-up were at 5% as 25 women chose to deliver in government facilities that incentivised labour and delivery services. With the strategy, 95.2% were retained in care (486/510). HBV seropositivity was at 1.07% (95% CI 0.44% to 2.55%); TV at 3.11% (95% CI 2.09% to 4.44%) and anaemia at 27.25% (95% CI 23.26% to 31.54%). These estimates are based on laboratory confirmation. Complete data were possible due to real-time documentation. Associations between intervention outcomes and contextual elements {#s3-2} ------------------------------------------------------------------ Unintended consequences (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}). ### Missing data {#s3-2-1} Data were continuously updated in real-time and clinical issues were managed with teleconferences. Only 25 women (5%), who were paid (US\$200) chose to deliver in government facilities and were lost to follow-up in our study. Discussion {#s4} ========== Key findings {#s4-1} ------------ With the AideSmart! strategy, screening rates for STBBIs and anaemia were greatly improved from baseline. All participants were rapidly screened/triaged for STBBIs with POCTs and 47% new infections were detected, of which 70% were rapidly linked to care. With a POCT-based strategy, increases in screening rates were highest for HBV, HCV, syphilis, TV, followed by HIV and anaemia. The participant retention rate was at 95%. As indicated by the metrics, the AideSmart! strategy generated good evidence with respect to feasibility, acceptance, preference, patient satisfaction and impact. The strategy improved the quality of POCT conduct, with a close monitoring of documentation and rapid confirmation of POCT results. Maintenance and recording of clinical data logs aided in quality control, monitoring and real-time surveillance of POCTs in challenging field conditions allowed instant troubleshooting. AideSmart! was linked to cloud-based servers, through which POCT and lab-confirmed results were communicated to providers, researchers and patients in real-time, thusly allowing to effectively integrate POCT results with CMC labs and to deliver results to patients. A rapid TAT from POCT to confirmatory testing and treatment was maintained with integration of lab services at CMC and prompt actions were initiated by physicians, generating high participant and provider satisfaction. Through a close contact with the study participants, patient engagement, performed by HCPs, was high throughout the study, reducing the need for incentivisation. Furthermore, there were minimal losses to follow-up, at only 4.9%, (vs 15%--30% reported anecdotally). Finally, timely treatment and prophylaxis prevented HBV transmission in infants. Strengths {#s4-2} --------- Our study design allowed for documentation of results cross-sectionally in real-time, which aided a complete documentation of data, processes and outcomes. Data quality and integration of results with laboratories were consistently maintained. POCT results were used to screen/triage patients and clinical management was initiated only after lab confirmed results were obtained. Our strategy is unique in that it offers a complete engagement, access, connectivity and retention solution, a step up from many promising digital innovative programmes that offer only one component of care, such as (1) CommCare, a digital data collection software program for frontline HCPs in Zambia;[@R24] (2) eMOCHA (Johns Hopkins), a platform for real-time digital patient data;[@R27] (3) SMS-based follow-up for HAART adherence/clinic attendance in Kenya;[@R28] , ^w1^ (4) pilot connectivity for improved quality POCT testing, available in Zimbabwe.^w2-w7^ Findings from our study {#s4-3} ----------------------- Regarding mother-to-child transmission, HBIG injections and immunisations (passive and active) were administered to infants of HBV-infected mothers who were born free of infection. Even with a high rate of unprotected sexual activity (95% unprotected intercourse), the absence of diagnosed syphilis, HCV and HIV infections may be due to a widespread use of antibiotics that eliminated syphilis and a lower exposure to unsafe injection practices (no HCV), that resulted in a decline in prevalence over time. Impact on people and systems {#s4-4} ---------------------------- Enhanced communication aided by AideSmart! helped patients promote an active follow-up without financial incentives. Continuous monitoring kept stakeholders engaged at all times which impacted the quality of health service. Engagement has far-reaching consequences on subsequent care seeking and screening behaviour as qualitatively documented ([box 1](#B1){ref-type="boxed-text"}). For instance, one mother opined that she was unaware of the importance of screening for infections, but that she will actively ask for it in her next pregnancy. ###### Statements of healthcare professionals (HCPs) and study participants recorded in verbatim **HCPs** *'This project helped us to learn about the various infections in antenatal women as well as earnt to do the tests using the rapid test kits*.' *'As a health aide at the periphery, we were only entering data of antenatal mothers in the registers and following them up when they deliver. Through this project we learnt to do the rapid blood tests.'* *'I was confident to explain about these infections to the pregnant women.\\ Moreover the additional salary support that I have got from the project was useful to my family.'* *'We got an opportunity to make good relationships with antenatal mothers by following them up more frequently every month.'* *'We learnt to educate pregnant women on what they should do during antenatal period. By telling them we also learnt it.'* *'This project was useful to me. Additional income that we have received was certainly an incentive, but more than that I felt happier to have learnt something that I can tell it to the next generations.'* *'I have heard about the infections only by its name but this project has taught me the effects of infections and how it can be prevented*.' **Study participants** *'This project has helped me to detect the infections in me. I came to know how HepB is transmitted from mom to baby. I didn't get tested for Hep B anywhere outside. If I was not tested here, it would have created a problem for my baby.'* *'This project was very useful because from our village all medical facilities are far but now I got tested here in my village. If not, we wouldn't have got tested.'* *'It was useful and moreover it was free. So we got tested or else we can't afford to get these tests done. Now my baby and I are fine.'* *'I'm hearing about these infections (Trichomonas) for the first time. When I heard that I have got the infection, at first, I was afraid but I got tablets from the RUHSA's Sozhamur peripheral clinic and that helped me to have good health to deliver the baby. I want to do this test in the next pregnancy also.'* *'By this project, we came to know about the various infections and easy way of identifying it. Overall it was a useful one for me.'* *'Infections were identified by this test. If it was identified late, it would have been a shock and moreover the tests were done by RUHSA that made us feel safe and it did not cost us anything.'* *'At first when I got tested in an outside medical facility, they said that I didn't have any infections but when we got tested through this project, they found that I have HepB infection. They also told me the ways to stop spreading it to the baby.'* *'I came to know that I have got the infection. I'm happy that we have got it for free.'* *'By this I came to know that I have got an infection and I got the tablets also. My husband doesn't take me to any medical facility. After 3 years of marriage I have become pregnant. I think this time I will deliver the baby safely.'* Observed and anticipated outcomes (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}) Opportunity costs (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}) Limitations {#s4-5} ----------- Convenience sampling has a potential for selection bias and observational designs are limited by observed and unobserved confounding bias. We attempted to minimise verification, incorporation and detection biases by taking appropriate measures during the evaluation. Usefulness of the work (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}). Sustainability (refer to [online appendix 1](#SP1){ref-type="supplementary-material"}). ### Next steps {#s4-5-1} This AideSmart! strategy was recently funded by the Canadian Institutes of Health Research (CIHR), to be reverse-innovated to screen Canadian key populations such as men who have sex with men, injection drug users, immigrants and aboriginals across five provinces. Additional references can be found in the [online supplementary file](#SP2){ref-type="supplementary-material"}. 10.1136/sextrans-2017-053491.supp2 ###### Key messages - We evaluated the feasibility and impact of a digital SmartApp-based multiplexed integrated point-of-care test screening strategy for key STIs and anaemia in rural pregnant women. - Fifteen healthcare workers were trained to offer the strategy close to participants' homes. Acceptability and feasibility of the strategy were at 100% and 92%, respectively. - The strategy impacted detection of 168 infections/conditions in pregnant women, prevented hepatitis B virus transmission to infants, with an overall loss to follow-up rate of 5%. - In the next few years, the strategy will be reverse-innovated and scaled in Canadian provinces, while also transitioned to scale in Indian provinces. Dr Pant Pai acknowledges support of an operating grant from Grand Challenges Canada (2013 Stars in Global Health Award), a FRQS Research-Scholar Salary award, and a CIHR Project Grant \#153149. Test kits were purchased from industry manufacturers. JD, HP and AS contributed equally. **Handling editor:** Jackie A Cassell **Contributors:** NPP: idea and concept, development of App, oversight and execution, write-up of first draft, critique of draft, data analyses, data interpretation. JD: development of app, study execution, write-up of the first draft, data analyses and data interpretation, critique of drafts. PHR, AS: study execution, study co-ordination, data interpretation, critique. RDS, RK, PA: study execution, write-up, critique, oversight of study conduct, data interpretation. RI: oversight and execution, write-up of first draft, critique of draft, data analyses, data interpretation. **Funding:** This study was funded by Fonds de Recherche du Québec - Santé (Research-Scholar Junior 2 Award), Grand Challenges Canada (Grant Number: 0376-01). **Competing interests:** None declared. **Patient consent:** Not required. **Ethics approval:** The study was formally approved by two Institutional Review Boards: (1) McGill University Health Centre, Montreal (approval\# 14--184-BMB) and (2) Christian Medical College, Vellore. **Provenance and peer review:** Not commissioned; externally peer reviewed.

Introduction {#Sec1} ============ Water balance and potassium homeostasis are critically regulated by the aldosterone hormone. Aldosterone binds to the mineralocorticoid receptor, which is expressed in the distal tubules of the kidney, the salivary and sweat glands, the intestinal epithelium, and in the airway epithelium in the lung and heart. Aldosterone binding to the mineralocorticoid receptor results in increased expression of the epithelial sodium channel (ENaC) and the Na^+^-K^+^-ATPase in principal cells of the distal tubule in nephrons, and potassium accumulated in principal cells is secreted into the urine by the renal outer medullary potassium channel. Aldosterone also mediates proton secretion into the urine by induction of H^+^-K^+^-ATPase in intercalated cells, leading to a net sodium-water reabsorption and potassium and proton secretion \[[@CR1]--[@CR3]\]. Pseudohypoaldosteronism (PHA) is a heterogeneous disorder characterized by salt wasting resulting from target organ unresponsiveness to mineralocorticoids. Because the principal effect of aldosterone is to promote potassium and hydrogen secretion, the condition typically presents in the neonatal period with hyperkalemia, metabolic acidosis, and an elevated plasma aldosterone concentration because of loss of negative feedback. We present a case of an infant with the classic presentation of PHA but clinical features that raised suspicion of other problems. Case presentation {#Sec2} ================= A 37-day-old Yemenite Jewish girl was seen in the emergency department of our institution for ongoing restlessness and feeding refusal. The girl was born at term by uncomplicated vaginal delivery after a normal pregnancy. Besides folic acid, no other medications had been used. Her birth weight was 2.435 kg (standard deviation \[SD\], − 1.8); her length was 50 cm (SD, 0.3); and her head circumference was 34 cm (SD, − 1.4). The result of her physical examination was reported as normal. She was first child of healthy, nonconsanguineous Yemenite Jewish parents. Her family history was unremarkable. During the first weeks of life, she failed to gain weight, and gastroesophageal reflux disease was suspected. Empirically, Enfamil AR (Mead Johnson & Co., Chicago, IL, USA) and a proton pump inhibitor (omeprazole 10 mg twice daily) were started with moderate response. At the emergency department, the girl was presented in stable condition with vital signs appropriate for her age (pulse 128 beats/minute, blood pressure 90/50 mmHg, respiratory rate 30 breaths/minute, normal peripheral perfusion) and normal hydration status. Her weight was 3.340 kg (SD, − 2.0); her length was 52 cm (SD, − 1.4); and her head circumference was 36 cm (SD, − 1.5). Her physical examination revealed craniofacial dysmorphism (low-set ears, micrognathia, flat midface, broad nasal bridge, telecanthus, epicanthus, thin upper vermillion) and hypotonia, but the remainder of her examination was unremarkable. No skin or musculoskeletal (including skull and vertebral column) abnormalities were noted. The result of her eye examination was normal. Laboratory tests (see Table [1](#Tab1){ref-type="table"}) revealed hyperkalemic metabolic acidosis. Because the patient's serum anion gap was normal and she had no gastrointestinal loss of bicarbonate, type 4 renal tubular acidosis was the primary working diagnosis. Her elevated ammonia can be explained by hyperkalemia causing reduction of ammonia generation in the proximal tubule leading to impaired ammonia excretion responsible for the metabolic acidosis \[[@CR4]\]. Hyperkalemic metabolic acidosis gave rise to the suspicion of congenital adrenal hyperplasia (CAH). Further testing revealed elevated levels of renin and aldosterone but normal levels of 17-hydroxyprogesterone and 21-α-hydroxylase. The result of a synacthen test to exclude late-onset CAH was normal. Radiologic evaluation showed no abnormalities of the kidneys and the adrenal glands. When CAH was ruled out, hyperkalemic metabolic acidosis together with high levels of renin and aldosterone made the diagnosis of PHA type 1 very likely. Treatment with kayexalate was initiated with gradual normalization of the potassium levels, and it was continued five times per week until it was stopped when the girl reached the age of 2 years. Table 1Laboratory test results at presentationTestResultRange normal valuesBlood Alanine transaminase37 U/L10--50 U/L Aspartate transaminase45 U/L20--60 U/L Glucose88 mg/dl60--105 mg/dl Creatinine0.3 mg/dl0.2--0.6 mg/dl Blood urea nitrogen12 mg/dl8--28 mg/dl Sodium139 mmol/L135--148 mmol/L Potassium7.13 mmol/L3.5--5.8 mmol/L Chloride108 mmol/L96--111 mmol/L Calcium9.7 mg/dl8.0--10.7 mg/L Phosphate7.3 mg/L4.8--8.1 mg/L Magnesium2,2 mg/dl1.6--2.6 mg/dl Lactate91.8 mg/dl4.5--19.8 mg/dl Ammonia185 μg/dl29--70 μg/dlBlood gas (capillary) pH7.207.34--7.43 HCO~3~^−^19 mEq/L19--24 mEq/L Base excess− 6 mEq/L− 7 to − 1 mEq/L Serum anion gap12 mEq/L8--16 mEq/LUrine Sodium (Na^+^)85.4 mmol/L Chloride (Cl)81.1 mmol/L Potassium4.5 mmol/L Fractional excretion of sodium3.3%1--2% Fractional excretion of potassium4.6%10--30% Urine anion gap+ 8.8negativeHormones (blood) 17-α-Hydroxyprogesterone1.1 nmol/L\< 2.5 nmol/L 21-α-HydroxylaseNormal Cortisol26.5 μg/dl5--25 μg/dl Dehydroepiandrosterone1.89 nmol/L35--430 nmol/L Renin5.0 ng/ml/hour0.5--3.9 ng/ml/hour Aldosterone\> 1717 pg/ml25--190 pg/ml Considering the dysmorphic physical signs along with metabolic disturbances, we suspected a congenital anomaly. Chromosome analysis revealed a normal 46XX karyotype. Echocardiography and magnetic resonance imaging (MRI) of the brain (including cervical spine) revealed no abnormalities. The patient was followed closely in the pediatric nephrology and neurology clinics. Whole-genome sequencing was requested, which revealed a missense mutation (c.2525A\>G \[p.Asn842Ser\]) in the cyclin-dependent kinase 13 gene (*CDK13*) located on 7p14.1. Genetic counseling was provided, and the parents underwent genetic testing, which revealed normal *CDK13* genes. Advice for prenatal diagnosis was not given, owing to the very low risk of recurrence. Over time, the girl's psychomotor development was clearly delayed. At the age of 8 years, she is still hypotonic. The result of further neurologic examination was normal. Her head circumference is 50 cm (SD, − 1.3); her length is 123 cm (SD, − 0.8); and her weight is 21 kg (SD, − 1.4). She has had no seizures. She has moderate mental retardation and behavior problems. Her current medications are risperidone, methylphenidate, and clonidine. She has a normal diet and eats independently, but she needs assistance with many general daily activities. She receives appropriate education. She is regularly seen by a neurologist and a psychiatrist in the outpatient clinic. Discussion {#Sec3} ========== PHA is a rare, inherited salt-wasting disorder that was first described by Cheek and Perry in 1958 as a defective renal tubular response to mineralocorticoids in infancy \[[@CR5]\]. This clinical syndrome is caused by end-organ resistance of aldosterone, resulting in hyperkalemic metabolic acidosis with high serum aldosterone levels. PHA can be primary (hereditary) or secondary (acquired) \[[@CR6]\]. The primary form is subclassified into type 1 and type 2. PHA type 1 can be divided into a renal form (autosomal dominant inheritance) and a systemic form (autosomal recessive inheritance). The renal form is more frequent and caused by inactivating mutations in the *NR3C2* gene encoding the aldosterone receptor \[[@CR7]\], resulting in an absence of binding of aldosterone to the receptor \[[@CR8]\]. To date, more than 100 mutations in this gene have been reported \[[@CR2], [@CR9]--[@CR13]\]. The salt loss is restricted to the kidneys and is biochemically accompanied by hyperkalemic metabolic acidosis with elevated plasma renin and aldosterone levels. Generally, the clinical expression of this condition can vary widely. It typically has a mild course followed by spontaneous remission over time \[[@CR14], [@CR15]\]. The systemic form is caused by mutations in the *SSCNN1A*, *SCNN1B*, and *SCNN1G* genes encoding for the ENaC α, β, and γ subunits, respectively, resulting in impairment in channel activity. Mutations in the α subunit are the most common and could involve the ENaC of kidneys (cortical collecting tubules), respiratory airways, colon, and salivary and sweat glands. PHA type 2 (Gordon syndrome or familial hyperkalemic hypertension) shows consistent features of hypertension, hyperkalemia, hyperchloremia, and mild metabolic acidosis. The reabsorption of sodium and the renal function are normal. The renin is low, whereas the aldosterone level can be normal or mildly elevated. In this autosomal dominant type, mutations affecting *WNK4* kinase have been reported and are important in the regulation of ion transport in the kidney, behaving like a gain of function in the thiazide-sensitive NaCl cotransporter. The secondary form (also termed "type 3") may be caused by medications or may be seen with acute pyelonephritis, urologic malformations, and obstructive uropathy \[[@CR16]\]. This secondary PHA is always transient. In the presence of hyponatremia, hyperkalemia, and nongap metabolic acidosis, possible signs of adrenal insufficiency, it is important to exclude CAH. In cases of atypical external genitalia, an urgent karyotype must be done to determine the gender. To differentiate from PHA type 1, investigations should include plasma renin activity, aldosterone, 17-hydroxyprogesterone, dehydroepiandrosterone, cortisol levels, renal ultrasound scan, and a urine steroid profile \[[@CR6]\]. To date, *CDK13*-related disorder has been reported in 44 patients \[[@CR17]\], and although there is a wide phenotypic heterogeneity \[[@CR18]\], all patients are characterized with developmental delay (motor and speech domains) and variable craniofacial features (hypertelorism, flat midface, broad nasal bridge, small mouth, low-set ears); most show mild to moderate intellectual disability. Other common findings are feeding difficulties (gastroesophageal reflux, velopharyngeal dysfunction), structural brain abnormalities (hypoplastic or absent corpus callosum, periventricular leukomalacia or gliosis, Chiari malformations), and structural heart defects (most commonly atrial or ventricular septal defects) \[[@CR17]\]. Bostwick *et al.* reported three patients with renal abnormalities (duplicated or dilated collecting systems, fused renal ectopia) \[[@CR18]\]. To the best of our knowledge, no metabolic abnormalities or electrolyte disturbances have been reported to be related to *CDK13* gene mutations. Cyclin-dependent kinases are a family of serine threonine kinases and are involved in several key cellular processes that include regulation of the cell cycle, transcription, RNA splicing, neurogenesis, and apoptosis \[[@CR19]\]. *CDK13* is involved in pre-mRNA splicing and is a component of the perinucleolar compartment, which is primarily detected in solid tissue-derived cancer cells and rarely present in normal cells \[[@CR20]\]. *CDK13*-related disorder is inherited in an autosomal dominant manner, and all cases are the result of a *de novo CDK13* pathogenic variant. No individuals with *CDK13*-related disorder are known to reproduce \[[@CR21]\]. Although no clinical diagnostic criteria have been published, the clinical findings of developmental delay and facial dysmorphic features are suggestive, and the diagnosis of *CDK13*-related disorder primarily depends on molecular genetic testing. Of the 44 patients reported, 36 were found to have missense mutation affecting the protein kinase domain of *CDK13*. Of these 36, 20 affected amino acid residue 842, and 18 had the same mutation (p.Asn842Ser) as our patient \[[@CR17]\]. Structural anomalies of the heart and brain are common in the patients with mutations affecting amino acid residue 842, although this was not the case in our patient \[[@CR17]\]. Workup for suspected *CDK13* gene mutations should include diligent physical examination; MRI of the brain; echocardiography; and consultations with a neurologist, cardiologist, dietitian, and geneticist. More extensive research may be required (such as radiology of the spine). The follow-up is very individual-dependent but includes neurological follow-up, as well as support in daily life, such as suitable schooling and proper nutrition \[[@CR22]\]. According to the literature, *CDK13* has a key role in the cell cycle, but no interference with the aldosterone signaling pathway or electrolyte balance has been described. No mutations in the previously described *NR3C2* gene (cytogenetic location 4q31.23), encoding the mineralocorticoid receptor, were found in our patient. Although the clinical presentation corresponded to PHA type 1, we could not genetically confirm this. Conclusion {#Sec4} ========== We report a case of a child presenting with PHA with a *CDK13* gene mutation. It is possible that the PHA at presentation was a coincidental finding in this girl with a *CDK13* mutation, but because only limited information is known about *CDK13*-related disorders, further investigation could be more informative to clarify this. **Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Not applicable. RY was responsible for the data collection and obtaining consent and was the main author of the manuscript. AA was responsible for part of the Discussion section. AKK was responsible for part of the Discussion section and for reviewing the paper. MvdA was responsible for writing and finalizing the paper. All authors read and approved the final manuscript. No funding was secured for this study. The data are noted in the report. Additional information can be requested from the corresponding author. Not applicable. Written informed consent was obtained from the patient's legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. The authors declare that they have no competing interests.

\section{Introduction}\label{sec:intro} The understanding and design of new technologies based on magnetic materials, in the fields of spintronics and magnonics, begets and profits from quantitative theoretical approaches. Recently, the central role played by spin-orbit coupling (SOC) has been serendipitously revealed. It underlies many concepts for the generation, manipulation and detection of spin currents~\cite{Maekawa2012}, also at the nanoscale: spin dynamics, current-induced magnetization switching and magnetic stability~\cite{Loth2010,Khajetoorians2013,Oberg2014}. The energy gap in the spin excitation spectrum, from extended materials down to a single adatom, is the result of SOC, being measurable, for instance, with ferromagnetic resonance (FMR)~\cite{Farle1998} or inelastic scanning tunneling spectroscopy (ISTS)~\cite{Heinrich2004,Hirjibehedin2006,Khajetoorians2011,Chilian2011,Khajetoorians2013a,Balashov2009}. Physical intuition suggests a connection between the gap and the magnetic anisotropy energy (MAE), while application of a dc external magnetic field ($B^{\text{ext}}$) should lead to a gap change of $g \mu_{\text{B}} B^{\text{ext}}$ (Zeeman shift). Stoner (electron-hole) excitations, together with SOC, contribute to the spin dynamics, their impact on the energy gap, Zeeman shift and excitation lifetime being expected but fairly unexplored. Up to now, all \emph{ab initio} studies on transverse dynamical spin excitations have neglected SOC. Furthermore, the addressed magnetic states are collinear (\emph{e.g.}~ferromagnetic), since the complexity, both theoretical and computational, increases dramatically in the general case: charge excitations, longitudinal and transverse spin excitations may couple in a non-trivial manner (see discussion in Ref.~\onlinecite{Kambersky1985}). From the tight-binding perspective, the work of Costa {\it et al.}~\cite{Costa2010} has proven invaluable in characterizing the impact of SOC on the spin-wave dispersion and lifetime, going beyond the adiabatic approximation~\cite{Udvardi2009}. Two kinds of theoretical approaches build upon first-principles electronic structure calculations. One type is based on many-body perturbation theory (MBPT)~\cite{Karlsson2000,Kotani2008,Sasioglu2010}, constructing the non-interacting Green function (GF) from the density functional theory (DFT) eigenstates. The other type is based on time-dependent DFT (TDDFT)~\cite{Gross1985a,Liu1989}, and has been applied to bulk systems~\cite{Savrasov1998,Zhukov2004,Kotani2008,Buczek2009,Sasioglu2010,Rousseau2012}, thin films~\cite{Buczek2011} and adatoms on surfaces~\cite{Lounis2010,Lounis2011,Lounis2014}, with pioneering work on SOC~\cite{Matsumoto1990}, but still not starting from a spin-polarized ground state~\footnote{TD spin-current DFT is an alternative~\cite{Vignale1987,Vignale1988,Bencheikh2003}.}. Recently we provided a connection between MBPT and TDDFT, to describe the interaction between electrons and spin excitations~\cite{Schweflinghaus2014}; this link was also found for the theory of spin-fluctuation-mediated superconductivity~\cite{Essenberger2014}. Here we present a method for the calculation of dynamical magnetic response functions based on TDDFT and incorporating SOC. This new scheme is implemented within the Korringa-Kohn-Rostoker (KKR) GF approach~\cite{Papanikolaou2002}. Of interest is the ability to treat an external magnetic field ($\vec{B}^{\mathrm{ext}}$) in any direction, to investigate non-trivial orientations of the magnetic moments and the role of the MAE. We derive a novel magnetization sum rule that constrains the exchange and correlation (xc) kernel when SOC is present, which is essential for the theory and the calculations. By investigating $3d$ metal adatoms on the Cu(111) surface, with a focus on the experimentally studied Fe adatom~\cite{Khajetoorians2011}, we demonstrate that the gap in the excitation spectrum is connected to the MAE through spin dynamics parameters, with electron-hole excitations taking center stage. We also show that, varying the orientation of $\vec{B}^{\mathrm{ext}}$, the properties of the spin-excitations, \emph{i.e.}~excitation energies, lifetimes and $g$-factors, are non-trivial and anisotropic, depending on the orientation of the magnetic moment. Our paper is organized as follows. In Sec.~\ref{sec:dynsusc} the formalism for the dynamical magnetic susceptibility is presented, as is the new magnetization sum rule that applies for the SOC case. Sec.~\ref{sec:compdet} describes the computational details. The results for 3d adatoms on Cu(111) are discussed in Sec.~\ref{sec:alladatoms}, and the interplay between MAE and SOC is explained in Sec.~\ref{sec:feadatom}. Our conclusions are given in Sec.~\ref{sec:conc}, while three appendices provide further details. \section{Dynamical susceptibility}\label{sec:dynsusc} We begin by seeking the change of the spin density matrix, $\delta\rho = \delta n\,\sigma_0 + \delta\vec{m}\cdot\vec{\sigma}$, due to an external time-dependent potential of the same form, $\delta V^{\text{ext}} = \delta V_0^{\text{ext}}\,\sigma_0 + \delta\vec{B}^{\text{ext}}\cdot\vec{\sigma}$. In linear response, \begin{equation} \delta\rho(\vec{r}\,;t) = \!\int\!\mathrm{d}\vec{r}\,'\!\!\int\!\mathrm{d} t'\,\chi(\vec{r}\,,\vec{r}\,';t-t')\cdot\delta V^{\text{ext}}(\vec{r}\,';t') \;\;, \end{equation} with $\vec{\sigma}$ the vector of Pauli matrices and $\sigma_0$ the $2\times2$ unit matrix. Within TDDFT, after Fourier transforming in time, the full response function, $\chi$, is given in terms of the Kohn-Sham (KS) response, $\chi^{\text{KS}}$, and the Hartree-exchange-correlation (Hxc) kernel, $K^{\text{Hxc}}$, through \begin{equation} \chi(\omega) = \left[1- \chi^{\text{KS}}(\omega)\,K^{\text{Hxc}}(\omega)\right]^{-1} \chi^{\text{KS}}(\omega)\label{suscdyson} \end{equation} (here and in the following spatial dependence and integrations are omitted for brevity). We add SOC~\footnote{The radial SOC potential is $\xi(r) = \frac{1}{(Mc)^2}\frac{1}{r}\frac{\mathrm{d} V}{\mathrm{d} r}$} and spin and orbital Zeeman couplings to an external static field to the KS Hamiltonian, self-consistently, \begin{equation} \mathcal{H}^{\text{KS}} = \mathcal{H}^{\text{KS}}_0\sigma_0 + \vec{\sigma}\cdot\vec{B}^{\text{xc}} + \xi\,\vec{L}\cdot\vec{\sigma} + \big(\vec{L} + \vec{\sigma}\big)\cdot\vec{B}^{\text{ext}} \;\;. \label{eq:soczeeman} \end{equation} The KS response is written in terms of the KS GF, $G(E) = \big(E - \mathcal{H}^{\text{KS}}\big)^{\text{--}1}$, as \begin{align} \hspace{-0.5em}\chi^{\text{KS}}_{\alpha\beta}(\omega) = -\frac{1}{\pi}\!\int^{E_{\text{F}}}\!\!\!\!\!\!\!\mathrm{d}&E\;\mathrm{Tr} \big[ \sigma_\alpha\,G(E + \omega + \iu0)\,\sigma_\beta\,\mathrm{Im}\,G(E) \nonumber\\ &+ \sigma_\alpha\,\mathrm{Im}\,G(E)\,\sigma_\beta\,G(E-\omega-\iu0) \big] \;, \label{kssusc} \end{align} with $\alpha,\beta = x,y,z$. The trace is over the spin components, and $2\mathrm{i}\,\mathrm{Im}\,G(E) = G(E+\iu0) - G(E-\iu0)$. $K^{\text{Hxc}}(\omega)$ is the sum of the Hartree kernel, $2/|\vec{r} - \vec{r}\,'|$, and of the xc kernel, which contains the many-body effects. In the adiabatic local spin density approximation (ALSDA), adopted in this work, the xc kernel is local in space and frequency-independent, being a function(al) of the particle and spin densities only. In the absence of SOC, the full response function decouples into a transverse and a longitudinal part. The former describes damped precessional motions of the magnetization, while excitations that change the magnitude of the charge or spin densities are in the latter. Global SU(2) invariance implies the existence of a Goldstone mode: the spin density is an eigenfunction of $\chi^{-1}(\omega\!=\!0)$ with vanishing eigenvalue. This is of utmost importance in numerical calculations, as small inaccuracies in the KS susceptibility and in the xc kernel shift the Goldstone mode to a finite frequency, in the meV range~\cite{Lounis2010,Lounis2011}, where the gap opened by SOC is expected. Corrective schemes were proposed~\cite{Lounis2010,Lounis2011,Rousseau2012} by adjusting one or both of these quantities to place the Goldstone mode at zero frequency, when SOC is neglected. Next we derive a new sum rule, connecting the spin density to the xc magnetic field, SOC and external magnetic field, so that the gap arises unambigously from the latter two. Suppose that the xc magnetic field, $\vec{B}^{\text{xc}}$, lies in the $z$-direction, defining the local spin frame of reference \footnote{If the direction of the xc magnetic field is not the $z$-direction, the final expressions hold after an appropriate rotation of the coordinate system.}. Then the spin density is given by (see Appendix~\ref{app:sumrule}): \begin{align} m_z &= -\frac{1}{\pi}\,\mathrm{Im}\,\mathrm{Tr}\!\int^{E_{\text{F}}}\!\!\!\!\!\!\!\mathrm{d} E\,G_{\uparrow\uparrow}(E)\,\Delta(E)\,G_{\downarrow\downarrow}(E) \;\;.\hspace{-0.5em} \label{sumrulederivation} \end{align} The effective spin splitting is, \emph{cf.}~Eq.~(\ref{eq:soczeeman}) and Appendix~\ref{app:sumrule}: \begin{align} \Delta &= \mathcal{H}^{\text{KS}}_{\uparrow\uparrow} - \mathcal{H}^{\text{KS}}_{\downarrow\downarrow} + \mathcal{H}^{\text{KS}}_{\uparrow\downarrow}\,\widetilde G_\downarrow\,\mathcal{H}^{\text{KS}}_{\downarrow\uparrow} - \mathcal{H}^{\text{KS}}_{\downarrow\uparrow}\,\widetilde G_\uparrow\,\mathcal{H}^{\text{KS}}_{\uparrow\downarrow} \label{delta} \;\;,\hspace{-0.5em} \end{align} where the auxiliary GFs are $\widetilde G_\sigma(E) = \big(E - \mathcal{H}^{\text{KS}}_{\sigma\sigma}\big)^{\text{--}1}$, with $\sigma=\;\uparrow,\downarrow$. Identifying the spin-flip KS susceptibility via Eq.~(\ref{kssusc}), $\chi_{+-} = \big(\chi_{xx} - \mathrm{i}\chi_{xy} + \mathrm{i}\chi_{yx} + \chi_{yy}\big)/4$, we can relate the spin density to the xc magnetic field, $m_z = 2\,\chi^{\text{KS}}_{+-}(\omega=0)\,B^{\text{xc}} + \delta m_z$, where $\delta m_z$ arises from all contributions to $\Delta$, excluding the xc part. The transverse xc kernel in the ALSDA is just $K_\perp = 2 B^{\text{xc}}/m_z$, yielding the magnetization sum rule \begin{equation} m_z(\vec{r}\,) - \!\int\!\!\mathrm{d}\vec{r}\,'\,\chi^{\text{KS}}_{+-}(\vec{r}\,,\vec{r}\,';0)\,K_\perp(\vec{r}\,')\,m_z(\vec{r}\,') = \delta m_z(\vec{r}\,) \;\;. \label{sumrule1} \end{equation} When $\delta m_z(\vec{r}\,) = 0$ (no SOC or external field), the denominator of Eq.~(\ref{suscdyson}) vanishes and the Goldstone mode is recovered. If only an external field is applied, the spin excitation is located at $\omega \sim 2B^{\text{ext}}_z$ (Zeeman shift), while SOC gives rise to a gap even in zero field. If Eq.~(\ref{sumrule1}) is not satisfied due to numerical inaccuracies, $K_\perp(\vec{r}\,)$ is adjusted such that the sum rule holds, using as input the calculated $\delta m_z(\vec{r}\,)$, $m_z(\vec{r}\,)$ and $\chi^{\text{KS}}_{+-}(\vec{r}\,,\vec{r}\,';\omega=0)$. Next we briefly summarize the computational details, before presenting results of our TDDFT formalism for adatoms on Cu(111). \section{Computational details}\label{sec:compdet} The GFs are evaluated by the KKR method~\cite{Papanikolaou2002} where the electronic structure of the adatoms is computed in two steps. First the electronic structure of a 22 layer Cu slab is calculated. Then each adatom is self-consistently embedded on the surface of this slab, in real space, together with 12 nearest-neighbor sites. We consider the Fe adatom relaxed to the surface by 10\% of the interlayer distance of Cu and use, for the sake of comparison, the same vertical distance for all adatoms. We employ the rigid spin approximation, whereby the direction of the spin density is taken to be collinear inside each atomic sphere \footnote{Spin-orbit coupling is a source of intra-atomic non-collinearity of the spin density; this is a small effect for the adatoms considered in this study.}. To tackle canting of the spin moment due to perpendicular external magnetic field and anisotropy easy axis, its direction is updated during the iterations until self-consistency is achieved. The MAE is calculated by band energy differences following the magnetic force theorem~\cite{Weinert1985}, \begin{equation} \quad E_a \approx E_{\text{band}}[B^{\text{xc}}\hat{e}_x] - E_{\text{band}}[B^{\text{xc}}\hat{e}_z] \;\;. \label{mae} \end{equation} For the susceptibility calculations, the proposal of Lounis \emph{et al.}~\cite{Lounis2010,Lounis2011} is extended to an $spdf$ basis built out of regular scattering solutions evaluated at two or more energies, by orthogonalizing their overlap matrix (see Appendix~\ref{app:suscbasis} for details). This basis can reproduce ground state data reliably and is used to include SOC in the GFs, self-consistently The spatial dependence of the susceptibility is restricted to the magnetic adatom; tests including neighboring copper atoms show no significant impact on the transverse spin excitations. The energy integration in Eq.~(\ref{kssusc}) is performed as detailed in Refs.~\onlinecite{Lounis2010,Lounis2011}. \section{Spin excitations of C\lowercase{r}, M\lowercase{n}, F\lowercase{e} and C\lowercase{o} adatoms on the C\lowercase{u}(111) surface}\label{sec:alladatoms} As an application of our method, we explore the spin excitation spectra of $3d$ adatoms on the Cu(111) surface. The groundstate properties and the dynamical spin excitation spectra are described separately. \subsection{Ground state properties} \renewcommand{\arraystretch}{1.1} \begin{table}[b] \begin{ruledtabular} \begin{tabular}{c c c c c} & Cr & Mn & Fe & Co \\ $m^{\text{s}}$ ($\mu_{\text{B}}$) & $\phantom{-}4.07$ & 4.31 & 3.23 & 1.97 \\ $m^{\text{o}}$ ($\mu_{\text{B}}$) & $-0.02$ & 0.02 & 0.55 & 0.52 \\ $E_a$ (meV) & $-0.29$ & $-0.33$ & 4.96 & 2.25 \\ \end{tabular} \end{ruledtabular} \caption{\label{tab1}Spin ($m^{\text{s}}$) and orbital ($m^{\text{o}}$) moments for Cr, Mn, Fe and Co adatoms on the Cu(111) surface, and MAE, see Eq.~(\ref{mae}). All values for the easy axis configuration (in-plane for Cr and Mn, out-of-plane for Fe and Co).} \end{table} The adatom-projected local density of states for Cr, Mn, Fe and Co adatoms on the Cu(111) surface is shown in Fig.~\ref{fig1}, while ground state properties are listed in Table~\ref{tab1}. The spin moment, $m^{\text{s}}$, is maximum for Cr and Mn, and then decreases steadily for Fe and Co. The orbital moment, $m^{\text{o}}$, is small for Cr and Mn, a consequence of the almost half-filled $d$-states, and large for Fe and Co, due to partial occupation of the minority $d$-states. As expected, Cr and Mn adatoms with nearly half-filled $d$-shells have larger spin magnetic moments ($m^{\text{s}}$) and lower orbital magnetic moments ($m^{\text{o}}$) than those of Fe and Co adatoms. The small magnitude of the orbital moments for Cr and Mn correlates with small MAEs, the converse being true for Fe and Co. \begin{figure}[t] \includegraphics[width=\columnwidth]{Fig1v2.pdf}\vspace{-1em} \caption{\label{fig1} Atom-projected total density of states for Cr, Mn, Fe and Co adatoms on the Cu(111) surface (positive for majority and negative for minority spin). Energy measured from the Fermi energy of the substrate.} \end{figure} The preferred orientation of the magnetic moments of Fe and Co is normal to the surface while Cr and Mn lie in-plane. \subsection{Dynamical spin excitations} Now we proceed to the calculations of the dynamical magnetic susceptibility. Eq.~(\ref{suscdyson}) is solved using the full basis expansion of the GFs, but for discussion we define an adatom-averaged quantity, corresponding to the net response to a site-dependent TD external magnetic field: \begin{equation} \overline{\chi}_{\alpha\beta}(\omega) = \!\int\!\mathrm{d}\vec{r}\!\int\!\mathrm{d}\vec{r}\,'\,\chi_{\alpha\beta}(\vec{r}\,,\vec{r}\,';\omega) \;\;. \label{avgsusc} \end{equation} First we discuss the impact of SOC on the adatom-averaged KS susceptibility. $\overline{\chi}^{\text{KS}}_{+-}(\omega)$ is linear for small frequencies. Fig.~\ref{fig2}(a) shows $\mathrm{Im}\,\overline{\chi}^{\text{KS}}_{+-}(\omega)$, describing spin-flip excitations between occupied and empty states (Stoner excitations). SOC is found to have a negligible impact on $\overline{\chi}^{\text{KS}}_{+-}(\omega)$ for the Cr and Mn adatoms, in line with their low orbital magnetic moments and MAEs. For Fe, SOC causes a noticeable change only on $\overline{\chi}^{\text{KS}}_{+-}(\omega = 0)$ ($\sim\!0.2$\%), while for Co there is also an increase in the slope of $\mathrm{Im}\,\overline{\chi}^{\text{KS}}_{+-}(\omega)$ by 12\%. \begin{figure}[t] \includegraphics[width=\columnwidth]{Fig2v3.pdf}\vspace{-1em} \caption{\label{fig2} Density of transverse spin excitations for Cr, Mn, Fe and Co adatoms on the Cu(111) surface ($B^{\text{ext}} = 0$). (a) from $\mathrm{Im}\,\overline{\chi}^{\text{KS}}_{+-}(\omega)$, Eq.~(\ref{kssusc}). (b) from $\mathrm{Im}\,\overline{\chi}_{+-}(\omega)$, Eq.~(\ref{suscdyson}). Dashed lines show the result of the estimate based on the adiabatic approximation (see main text). }\vspace{-1em} \end{figure} Consider now the full response function. The longitudinal and transverse parts of the magnetic susceptibility are weakly coupled by SOC. The imaginary part of the dominant eigenvalue of $\overline{\chi}(\omega)$ corresponds to the density of states of the main magnetic excitation, and is shown in Fig.~\ref{fig2}(b) for all adatoms. Although the resonance energies ($B^{\text{ext}} = 0$) follow the trend of the adatoms' MAE (Table~\ref{tab1}), their positions are strongly shifted from what is expected from a simple approximation (dashed lines in Fig.~\ref{fig2}(b); discussed in the following). We characterize the main resonance in $\overline{\chi}(\omega)$ through a simple model of the spin dynamics, the Landau-Lifshitz-Gilbert (LLG) equation~\cite{Gilbert2004}, widely used for larger magnetic systems: \begin{equation} \frac{\mathrm{d}\vec{m}^{\text{s}}}{\mathrm{d} t} = -\gamma\,\vec{m}^{\text{s}} \times \vec{B}^{\text{eff}} + \eta\,\frac{\vec{m}^{\text{s}}}{m^{\text{s}}}\!\times\!\frac{\mathrm{d}\vec{m}^{\text{s}}}{\mathrm{d} t} \;,\;\; \vec{B}^{\text{eff}} = -\frac{\partial E}{\partial\vec{m}^{\text{s}}} \label{llgeq} \end{equation} with $\vec{m}^{\text{s}}$ the spin moment, $m^{\text{s}}$ its length, $\gamma$ the gyromagnetic ratio (equal to $2\mu_{\text{B}}/\hbar$ for a free electron) and $\eta$ the damping parameter. We set $\hbar = 1$ and absorb $\mu_{\text{B}}$ in $\vec{B}^{\text{eff}}$, so $\gamma = 2$. As discussed by Kittel~\cite{Kittel1949} and found from our calculations, the orbital moment mostly follows the spin moment, $\vec{m}^{\text{o}} \propto \vec{m}^{\text{s}}$, so it is not considered independently. \renewcommand{\arraystretch}{1.1} \begin{table}[b] \begin{ruledtabular} \begin{tabular}{c c c c c} & Cr & Mn & Fe & Co \\ $\bar{E}_a$ (meV) & 0.14 & 0.02 & 4.51 & 1.37 \\ $\gamma$ & 1.63 & 1.74 & 1.73 & 2.36 \\ $\eta$ & 0.07 & 0.05 & 0.33 & 0.80 \\ $g$ (spin only) & 1.63 & 1.74 & 1.64 & 1.84 \\ $g$ (spin+orb) & 1.62 & 1.75 & 1.92 & 2.33 \\ $\tau$ (ps) & 22 & 1200 & 0.11 & 0.091 \end{tabular} \end{ruledtabular} \caption{\label{tab2} Spin dynamics parameters for Cr, Mn, Fe and Co adatoms on the Cu(111) surface, obtained by fitting the transverse susceptibility, Eq.~(\ref{avgsusc}), to the LLG model. Eq.~(\ref{wmax}) defines $\bar{E}_a$. The $g$-factor, Eq.~(\ref{gfactor}), distinguishes $\vec{m}^{\text{s}}\cdot\vec{B}^{\text{ext}}$ or $(\vec{m}^{\text{s}} + \vec{m}^{\text{o}})\cdot\vec{B}^{\text{ext}}$ couplings. $\tau$ for Mn is hard to extract, due to a very narrow spin excitation peak.} \end{table} Suppose $\vec{m}^{\text{s}} = m^{\text{s}}\,\hat{e}_z$ in equilibrium, so $\vec{B}^{\text{eff}} = B^{\text{eff}}\,\hat{e}_z$, and we linearize Eq.~(\ref{llgeq}) adding a small time-dependent perturbation in the $xy$-plane. From $\mathrm{Im}\,\chi_{+-}(\omega)$, the resonance location, $\omega_{\text{max}}$, is given by (Appendix~\ref{app:llg}), \begin{equation} \omega_{\text{max}} = \frac{\gamma\,B^{\text{eff}}}{\sqrt{1 + \eta^2}} \;,\;\; B^{\text{eff}} = \frac{2{E}_a}{m^{\text{s}}} + \left(1 + \frac{m^{\text{o}}}{m^{\text{s}}}\right) B^{\text{ext}} \label{wmax} \end{equation} with a model energy of the form \begin{equation} E = -\frac{E_a}{(m^{\text{s}})^2}(\vec{m}^{\text{s}}\cdot\hat{e}_z)^2 - (\vec{m}^{\text{s}} + \vec{m}^{\text{o}})\cdot\vec{B}^{\text{ext}} \;\;. \end{equation} The spectroscopic $g$-factor is defined as \begin{equation} g = \frac{\mathrm{d} \omega_{\text{max}}}{\mathrm{d} B^{\text{ext}}} = \frac{\gamma}{\sqrt{1 + \eta^2}}\left(1 + \frac{m^{\text{o}}}{m^{\text{s}}}\right) \;\;. \label{gfactor} \end{equation} A non-zero orbital moment (SOC) implies an effective $g \propto \gamma \left(1+\frac{{m}^{\text{o}}}{{m}^{\text{s}}}\right)$, which is the usual explanation for $g \neq 2$ found experimentally (for instance in FMR~\cite{Farle1998}). Damping renormalizes $g$ further by a factor $1/\sqrt{1 + \eta^2}\,$, so that a shift can be expected even without SOC (${m}^{\text{o}} = 0$). Lastly, the inverse of the full-width at half maximum (FWHM, $\Gamma$) of the spin excitation resonance can be used to estimate the corresponding lifetime, $\tau \approx \hbar/(2\Gamma)$. All model parameters are extracted by fitting the LLG form of $\chi_{+-}(\omega)$ given in Eq.~(\ref{eq:llgimchi}) to the first-principles data in Fig.~\ref{fig2}(b), and are collected in~Table~\ref{tab2}. If we neglect dynamical corrections ($\gamma = 2$, $\eta = 0$), the MAE leads to a resonance at $4E_a/m^{\text{s}}$ (dashed lines in Fig.~\ref{fig2}(b); $E_a$ is taken from Table~\ref{tab1}). The downward shift of the resonance energy is due to $\gamma \neq 2$ and an effective $E_a$ smaller than the force theorem estimate (see Table~\ref{tab2}). $\gamma \neq 2$ is determined by the electronic structure, as discussed in Refs.~\onlinecite{Mills1967,Lounis2010,Lounis2011,Chilian2011}. The discrepancy in $E_a$ may originate from the following: the value obtained from Eq.~(\ref{mae}) is an energy difference between two orthogonal magnetic orientations, while the LLG model, see Eq.~(\ref{llgeq}), suggests the dynamics depend on the variation of the energy around the equilibrium direction of the adatom spin. An alternative explanation would be the large DOS peak for Fe and Co at the Fermi energy: the MAE computed from Eq.~(\ref{mae}) is sensitive to peak shifts between the two orientations, which may arise from the frozen potential approximation. The damping parameter $\eta$ plays a minor role for Cr and Mn adatoms, but reduces $g$ for Fe and Co by $5\%$ and $22\%$, respectively. The spin excitation lifetimes are much shorter for the Fe and Co adatoms than for the Cr and Mn adatoms. This is due to the $\Gamma \propto \omega_{\text{max}}$ scaling of the FWHM, and to the connection between $\eta$ and the slope of $\mathrm{Im}\,\overline{\chi}^{\text{KS}}_{+-}(\omega)$, Fig.~\ref{fig2}(a). SOC enhances $\eta$ only for the Co adatom, for the same reason (see discussion of Fig.~\ref{fig2}(a) in the main text). \begin{figure}[t] \includegraphics[width=\columnwidth]{Fig3v5.pdf}\vspace{-1em} \caption{\label{fig3} (a) Frequency $\omega_{\text{max}}$ at which $\mathrm{Im}\,\overline{\chi}$ is maximum vs applied external magnetic field, $B^{\text{ext}}$, for the Fe adatom on Cu(111). The static field was applied normal to the surface, with spin-only (s, squares) or spin and orbital coupling (s+o, diamonds); and in the surface plane, with spin-only (s, down triangles) or spin and orbital coupling (s+o, up triangles). (b) FWHM vs resonance energy, as extracted from the $\mathrm{Im}\,\overline{\chi}$ curves (s+o). The spin moment is normal to the surface (diamonds), canted (down triangles) or in the surface plane (up triangles). Linear fits also shown.}\vspace{-1em} \end{figure} \section{Interplay between magnetic anisotropy and magnetic field}\label{sec:feadatom} Next we focus on the effect of $\vec{B}^{\text{ext}}$ on the spin excitations of the Fe adatom. First we apply the field parallel to the MAE easy axis, resulting in the linear Zeeman shift. $\omega_{\text{max}}$ is shown in Fig.~\ref{fig3}(a) for the spin-only (squares) and spin+orbital (diamonds) Zeeman couplings, see Eq.~(\ref{eq:soczeeman}). In the spin-only case, $g = 1.70$ ($1.64$ using the LLG model, Table~\ref{tab2}). This does not depend on SOC and is related to details of the electronic structure~\cite{Chilian2011}. When the orbital coupling is included, $g$ rises from 1.70 to 1.97, close to the factor $\big(1 + \frac{m^{\text{o}}}{m^{\text{s}}}\big)$, from Eq.~(\ref{wmax}). Using $\frac{m^{\text{o}}}{m^{\text{s}}} = 0.17$ and the data in Table~\ref{tab2}, $g = 1.92$ from the LLG model, in good agreement with the first-principles data. In Ref.~\onlinecite{Khajetoorians2011}, this system was studied by ISTS. The measured gap ($\sim\!1$ meV) is lower than the one found in our calculations ($\sim\!4.6$ meV), which may indicate we overestimated the MAE. The experimental $g$ value ($\sim\!2.1$) is quite close to the one computed including spin and orbital Zeeman couplings ($g = 1.97$). The linewidth is proportional to the resonance energy, Fig.~\ref{fig3}(b) (diamonds), but the slope is larger in the experimental data. When the field is applied perpendicular to the MAE easy axis, the equilibrium direction of the Fe spin moment progressively cants away from the surface normal, becoming parallel to $\vec{B}^{\text{ext}}$ (when $\omega_{\text{max}} \approx 0$). Fig.~\ref{fig3}(a) shows that $\omega_{\text{max}}$ slowly decreases for small $B^{\text{ext}}$, dipping near the critical field, beyond which it increases again, recovering the linear dependence on $B^{\text{ext}}$ for $\omega_{\text{max}} > 5$~meV. In this regime, $g = 1.81$ (spin Zeeman) or $g = 1.93$ (full Zeeman) differ from the values obtained in the previous linear case. This arises from the different values of $m^{\text{o}}$, of $\gamma$ and of $\eta$, making the spin dynamics anisotropic. The FWHM is still linear in $\omega_{\text{max}}$, Fig.~\ref{fig3}(b) (triangles), but it does not extrapolate to zero as in the out-of-plane case. For the same $\omega_{\text{max}}$, the lifetime of the spin excitation strongly depends on the orientation of the spin moment. From Fig.~\ref{fig3}(b), with $\omega_{\text{max}} \sim 4.6$~meV, $\tau \approx 110$ fs (out-of-plane) and $\tau \approx 85$ fs (in-plane), which is a 20\% change. \section{Conclusions}\label{sec:conc} In this paper we presented a detailed first-principles analysis of the spin dynamics of magnetic adatoms, made possible by an extension of TDDFT to spin-polarized systems including SOC. We found a novel and invaluable sum rule connecting the spin density to the xc splitting in the presence of SOC. The key spin dynamics parameters have been extracted from the dynamical magnetic susceptibility, including SOC and spin and orbital Zeeman terms, after mapping to the LLG model, thus legitimating its use down to the atomic limit. Deviations from standard assumptions in spin dynamics models have been found for the MAE (different from the one computed by the force theorem), the gyromagnetic ratio ($\gamma \neq 2$, which may indicate spin pumping~\cite{Tserkovnyak2002}), and the origin and role of the Gilbert damping, $\eta$ (dominated by Stoner excitations, not by SOC). We also find a non-trivial behavior for $g$ and the spin excitation lifetime upon application of a magnetic field along the easy and hard axes of the magnetic anisotropy. The anisotropic nature of the spin dynamics was established, arising from SOC and $\vec{B}^{\text{ext}}$. \begin{acknowledgments} We thank A.~T.~Costa, F.~Guimar\~{a}es and J.~Azpiroz for fruitful discussions. This work is supported by the HGF-YIG Programme VH-NG-717 (Functional Nanoscale Structure and Probe Simulation Laboratory--Funsilab). \end{acknowledgments}

\part{0} \pagerange{\pageref{firstpage}--\pageref{lastpage}} \doi{S0963548301004989} \begin{document} \label{firstpage} \maketitle \begin{abstract} This guide is for authors who are preparing papers for the {\em Journal of Plasma Physics\/} using the \LaTeXe\ document preparation system and the Cambridge University Press JPP class file. \end{abstract} \tableofcontents \section{Introduction} The layout design for the {\em Journal of Plasma Physics\/} has been implemented as a \LaTeXe\ class file. The JPP class is based on the ARTICLE class as discussed in the \LaTeX\ manual (2nd edition). Commands which differ from the standard \LaTeX\ interface, or which are provided in addition to the standard interface, are explained in this guide. This guide is not a substitute for the \LaTeX\ manual itself. Note that the final printed version of papers will use the Monotype Modern typeface rather than the Computer Modern available to authors. Also, the measure in JPP class is different from \LaTeXe\ article class. For these reasons line lengths and page breaks will change and authors should not insert hard breaks in their text. \subsection{Introduction to \LaTeX} The \LaTeX\ document preparation system is a special version of the \TeX\ typesetting program. \LaTeX\ adds to \TeX\ a collection of commands which allow the author to concentrate on the logical structure of the document rather than its visual layout. \LaTeX\ provides a consistent and comprehensive document preparation interface. \LaTeX\ can automatically number equations, figures, tables, and list entries, as well as sections and subsections. Using this numbering system, bibliographic citations, page references and cross-references to any other numbered entity (\eg section, equation, figure, list entry) are quite straightforward. \subsection{General style issues} Use of \LaTeX\ defaults will result in a pleasing uniformity of layout and font selection. Authors should resist the temptation to make \emph{ad hoc} changes to these. Also avoid use of direct formatting unless really necessary. Papers will be edited as usual, and this process may be obstructed by the use of inserted line breaks, etc. For general style issues, authors are referred to the `Preparation of manuscripts' in the back cover of the journal. The language used in the journal is British English, and spelling should conform to this. Use should be made of symbolic references (\verb"\ref") in order to protect against late changes of order, etc. \subsection{Submission of \LaTeX\ articles} Authors who intend to submit a \LaTeX\ article should obtain a copy of the JPP class file. This is available by anonymous FTP from \begin{verbatim} ftp.cup.cam.ac.uk \end{verbatim} You will find the class file and instructions contained in a single zip archive \verb"jpp-cls.zip" in the directory \begin{verbatim} pub/texarchive/journals/latex/jpp-cls \end{verbatim} The \verb"readme.txt" (which is the same directory) tells you how to unzip the \verb"jpp-cls.zip" file. There may also be an `\verb"unpacked"' directory containing all of the files separately, in case of difficulty. If you cannot obtain the JPP files, use the standard \verb"article" class, with the default `\verb"10pt"' option. When submitting the final article, ensure that the following are included and are clearly labelled. \begin{enumerate} \item A hardcopy printout of the article. \item The input file (exactly matching the hardcopy). \item A copy of any user-defined macros. \item If you have used \textsc{Bib}\TeX, the \verb".bib", \verb".bbl" and \verb".bst" files that were used. \item Any other files necessary to prepare the article for typesetting. \end{enumerate} The files for the \emph{final} article should be supplied on a PC or Macintosh disk. Please write on the disk what format it is, as this saves time. Submit the hardcopy and disk by post in the normal way. \subsection{The JPP document class} The use of document classes allows a simple change of style (or style option) to transform the appearance of your document. The CUP JPP class file preserves the standard \LaTeX\ interface such that any document which can be produced using the standard \LaTeX\ ARTICLE class can also be produced with the JPP class. However, the measure (or width of text) is slightly different from that for ARTICLE; therefore line breaks will change and it is possible that equations may need re-setting. \section{Using the JPP class file} First, copy the file \verb"jpp.cls" and \verb"upmath.sty" (see \S\ref{sec:adpkg}) into the correct subdirectory on your system. The JPP document style is implemented as a complete document class, and {\em not\/} a document class option. In order to use the JPP class, replace \verb"article" by \verb"jpp" in the \verb"\documentclass" command at the beginning of your document: \begin{verbatim} \documentclass{article} \end{verbatim} is replaced by \begin{verbatim} \documentclass{jpp} \end{verbatim} Some of the standard document class options should be used. Author-defined mac\-ros should be inserted before \verb"\begin{document}", or in a separate file and should be included with the submission, see \S\ref{secUser}. Authors must not change any of the macro definitions or parameters in \verb"jpp.cls". \subsection{Document class options} In general, the following standard document class options should \emph{not} be used with the JPP class file: \begin{itemize} \item \texttt{10pt}, \texttt{11pt} and \texttt{12pt} -- unavailable; \item \texttt{twoside} is the default (\texttt{oneside} is disabled); \item \texttt{onecolumn} is the default (\texttt{twocolumn} is disabled); \item \texttt{titlepage} is not required and is disabled; \item \texttt{fleqn} and \texttt{leqno} should not be used, and are disabled. \end{itemize} The standard document class options should {\em not\/} be used with the JPP class: \begin{itemize} \item {\tt 10pt}, {\tt 11pt}, {\tt 12pt} -- unavailable. \item {\tt draft}, {\tt twoside} (no associated class file) -- {\tt twoside} is the default. \item {\tt fleqn}, {\tt leqno}, {\tt titlepage}, {\tt twocolumn} -- unavailable. \end{itemize} \ifprodtf The following new class options are provided: \begin{itemize} \item \texttt{prodtf} -- tells the class file that we want to use the production typeface. This automatically resets the odd, even and top margins. \end{itemize} \fi \subsection{Additional `packages' supplied with \texttt{jpp.cls}}\label{sec:adpkg} The following additional package (\verb".sty") files are supplied in the JPP distribution: \begin{itemize} \item \verb"upmath" -- provides `upright' Greek math characters. Requires the AMS \verb"amsbsy" and \verb"amsgen" packages. \end{itemize} If your site does not have the AMS Fonts and \AMSLaTeX\ packages installed, we strongly recommend that your site installs them. With them, you can produce output which is much closer to the final result. The latest AMS Fonts/\AMSLaTeX\ distributions can be found on your nearest CTAN (Comprehensive \TeX\ Archive Network) site. \subsubsection{The \texttt{UPMATH} package} The \verb"upmath" package defines the macros \verb"\mathup" and \verb"\mathbup", which allow access to the symbols in the AMS Euler fonts. The \verb"upmath" package provides macros for upright lower-case Greek (\verb"\ualpha"--\verb"\uxi"), and for bold lower-case Greek (\verb"\ubalpha"--\verb"\ubxi"). The bold upright symbol \verb"\eta" has to be treated differently, in this case use \verb"\uboldeta". The \verb"upmath" package also provides \verb"\upartial" and \verb"\ubpartial". To use the \verb"upmath" package, you need to have the AMS \verb"eurm/b" fonts installed. \section{Additional facilities} In addition to all the standard \LaTeX\ design elements, the JPP class file includes the following features: \begin{itemize} \item Extended commands for specifying a short version of the title and author(s) for the running headlines. \item Abstract environment \item Control of enumerated lists. \item An extended \verb"theorem" environment, enabling you to also typeset unnumbered theorems, etc. \item Ability to create new theorem-like environments for claims, conjectures, examples, problems, remarks, etc. \item The \verb"subequations" and \verb"subeqnarray" environments for sub-numbering equations. \item A \verb"proof" environment. \item A \verb"acknowledgements" environment. \end{itemize} Once you have used these additional facilities in your document, it can be processed only with \verb"jpp.cls". \subsection{Titles, authors' names and running headlines} In the JPP class, the title of the article and the author's name (or authors' names) are used both at the beginning of the article for the main title and throughout the article as running headlines at the top of every page. The title is used on odd-numbered pages (rectos) and the author's name (with initials only for first names) appears on even-numbered pages (versos). The \verb"\pagestyle" and \verb"\thispagestyle" commands should {\em not\/} be used. Similarly, the commands \verb"\markright" and \verb"\markboth" should not be necessary. Although the article title can run to several lines of text, the running headline must be a single line. Moreover, the title can also incorporate new line commands (\eg \verb"\\") but these are not acceptable in a running headline. To enable you to specify an alternative short title and author's name, the standard \verb"\title" and \verb"\author" commands have been extended to take an optional argument to be used as the running headline: \begin{verbatim} \title[A short title]{The full title which can be as long as necessary} \author[Initials and last names of all authors]{The full names of all the authors, using letterspacing and \and before the last name in the list} \affiliation{Author's affiliation} \end{verbatim} Unlike most other document classes, \verb"jpp.cls" does not follow the convention of using the second line of the \verb"\author" command to write the author's affiliation. Rather, this must be entered using the \verb"\affiliation" command as shown above. The \verb"\and" command does not produce separate author/affiliation pairs, but only generates the word `and' in small caps as required by the JPP class. Use the predefined macro \verb"\ls" to get the letterspacing between the letters of the author's name. If there is more than one affiliation, use \verb"\\[\affilskip]" between lines of the \verb"\affiliation", inserting footnote numbers manually. An example will make all this clearer. To produce \medskip \begin{center} {\Large\bf Interesting title} \par\medskip {\large A\ls L\ls A\ls N\ns N.\ns O\ls T\ls H\ls E\ls R$^1$\ns \and\ns J.\,Q.\ns P\ls U\ls B\ls L\ls I\ls C$^2$}\par \medskip {\small $^1$University of Moscow, Moscow, Russia\\[3pt] $^2$Ngonga University, Nairobi, Kenya}\par \medskip {\small (Received 12 June 1992)} \end{center} \medskip \noindent you would type {\small\begin{verbatim} \title[Short title]{Interesting title} \author[A. N. Other and J. Q. Public] {A\ls L\ls A\ls N\ns N.\ns O\ls T\ls H\ls E\ls R$^1$\ns \and\ns J.\,Q.\ns P\ls U\ls B\ls L\ls I\ls C$^2$} \affiliation{$^1$University of Moscow, Moscow, Russia\\[\affilskip] $^2$Ngonga University, Nairobi, Kenya} \date{12 June 1992} \end{verbatim}} The \LaTeX\ \verb"\thanks" command can be used inside the \verb"\author" command to insert an authors `Current address' information as a footnote, appearing at the bottom of the title page. \subsection{Abstract} The JPP class provides for an abstract, produced by \begin{verbatim} \begin{abstract} ... \end{abstract} \end{verbatim} This should appear just \emph{before} the first \verb"\section" command. \subsection{Lists} The JPP style provides the three standard list environments plus an additional unnumbered list: \begin{itemize} \item Numbered lists, created using the \verb"enumerate" environment. \item Bulleted lists, created using the \verb"itemize" environment. \item Labelled lists, created using the \verb"description" environment. \end{itemize} The \verb"enumerate" environment numbers each list item with an italic letter in parentheses; alternative styles can be achieved by inserting a redefinition of the number labelling command after the \verb"\begin{enumerate}". For example, a list numbered with roman numerals inside parentheses can be produced by the following commands: \begin{verbatim} \begin{enumerate} \renewcommand{\theenumi}{\roman{enumi}} \item first item : \end{enumerate} \end{verbatim} This produces the following list: \begin{enumerate} \renewcommand{\theenumi}{\roman{enumi}} \item first item \item second item \item \etc \end{enumerate} In the last example, the item alignment is uneven because the standard list indention is designed to be sufficient for arabic numerals rather than the wider roman numerals. In order to enable different labels to be used more easily, the \verb"enumerate" environment in the JPP style can be given an optional argument which (like a standard \verb"thebibliography" environment) specifies the \emph{widest label}. For example, \begin{enumerate}[(iii)] \renewcommand{\theenumi}{\roman{enumi}} \item first item \item second item \item \etc \end{enumerate} was produced by the following input: \begin{verbatim} \begin{enumerate}[(iii)] \renewcommand{\theenumi}{\roman{enumi}} \item first item : \end{enumerate} \end{verbatim} Once you have used the optional argument on the \verb"enumerate" environment, do not process your document with a standard \LaTeX\ class file. \subsection{Theorem environments}\label{sectTheor} The \verb"\newtheorem" command works as described in the \LaTeX\ manual, but produces spacing and caption typefaces required to the JPP style. The preferred numbering scheme is for theorems to be numbered within sections, as 1.1, 1.2, 1.3, etc., but other numbering schemes are permissible and may be implemented as described in the \LaTeX\ manual. In order to allow authors maximum flexibility in numbering and naming, {\em no\/} theorem-like environments are defined in \verb"jpp.cls". Rather, you have to define each one yourself. Theorem-like environments include Theorem, Definition, Lemma, Corollary, and Proposition. For example, \begin{verbatim} \newtheorem{lemma}{Lemma}[section] \renewcommand{\thelemma}{\Roman{lemma}} \end{verbatim} The new macro which follows can also produce numbered and unnumbered environments. \subsection{Definitions} The \verb"\newdefinition" command can be used to create environments for claims, conjectures, examples, problems, remarks, etc. These are typeset in the way as theorems, except the text is typeset in roman instead of italic. You can have an environment created by \verb"\newdefinition" number in the same sequence as a `Theorem' by adding the optional \verb"[theorem]" argument as below: \begin{verbatim} \newdefinition{definition}[theorem]{Definition} : \begin{definition} This is a definition. \end{definition} \begin{definition*} This is an unnumbered definition. \end{definition*} \end{verbatim} which produces the following: \begin{definition} This is a definition. \end{definition} \begin{definition*} This is an unnumbered definition. \end{definition*} \subsection{Proof environment} The standard \LaTeX\ constructs do not include a proof environment to follow a theorem, lemma etc. (see also $\S$\ref{sectTheor}), and so one has been added for the JPP style. Note the use in the following examples of an optional argument in square braces which may contain any information you may wish to add. For example, \begin{verbatim} \begin{theorem}[2]\label{thenv} Let the scalar function $T(x,y,t,\bmath{\omega})$ be a conserved density for solutions of {\rm(9)}. Then the two-component function \begin{equation} \hbox{\boldit P} = \mathsf{J}{\cal E} T \end{equation} represents the infinitesimal generator of a symmetry group for {\rm (9)}. \end{theorem} \begin{proof}[Proof of Theorem~\ref{thenv}] The assumption about $T$ means that \[ 0 \sim \frac{\partial T}{\partial t} + {\cal E}T \bmath{\omega}_t = \frac{\partial T}{\partial t} + \{ T, H\}, \] where $\partial T / \partial t$ refers to explicit dependence on $t$. The skew symmetry of $\mathsf{J}$ hence implies \begin{equation} \frac{\partial T}{\partial t} \sim \{ H, T\}, \end{equation} whereupon the operation $\mathsf{J}\cal E$, which commutes with $\partial_t$ in its present sense, gives \[ \frac{\partial \hbox{\boldit P}}{\partial t} = \mathsf{J}{\cal E}\{ H, T\}. \] This equation reproduces the characterisation of symmetries that was expressed by (19), thus showing P to represent a symmetry group. \end{proof} \end{verbatim} produces the following text: \begin{theorem}[2]\label{thenv} Let the scalar function $T(x,y,t,\bmath{\omega})$ be a conserved density for solutions of {\rm(9)}. Then the two-component function \begin{equation} \hbox{\boldit P} = \mathsf{J}{\cal E} T \end{equation} represents the infinitesimal generator of a symmetry group for {\rm (9)}. \end{theorem} \begin{proof}[Proof of Theorem~\ref{thenv}] The assumption about $T$ means that \[ 0 \sim \frac{\partial T}{\partial t} + {\cal E}T \bmath{\omega}_t = \frac{\partial T}{\partial t} + \{ T, H\}, \] where $\partial T / \partial t$ refers to explicit dependence on $t$. The skew symmetry of $\mathsf{J}$ hence implies \begin{equation} \frac{\partial T}{\partial t} \sim \{ H, T\}, \end{equation} whereupon the operation $\mathsf{J}\cal E$, which commutes with $\partial_t$ in its present sense, gives \[ \frac{\partial \hbox{\boldit P}}{\partial t} = \mathsf{J}{\cal E}\{ H, T\}. \] This equation reproduces the characterisation of symmetries that was expressed by (19), thus showing P to represent a symmetry group. \end{proof} The final \usebox{\proofbox} will not be included if the \verb"proof*" environment is used. \ifprodtf \smallskip Note: If a proof environment is ended by and unnumbered equation, it is customary for Editors to mark the proof box to be moved up, so that it aligns with the end of the equation. This can be achieved by placing a \verb"\raiseproofboxby" command before the \verb"\end{proof}". A value of \verb"1.5\baselineskip" seems to give the best results. \eg \begin{verbatim} \begin{proof} \raiseproofboxby{1.5\baselineskip} The assumption about $T$ means that : \[ \frac{\upartial T}{\upartial t} \sim \{ H, T\}, \] \end{proof} \end{verbatim} \fi \section{Mathematics and units} The JPP class file will insert the correct space above and below displayed maths if standard \LaTeX\ commands are used; for example use \verb"\[ ... \]" and {\em not\/} \verb"$$ ... $$". Do not leave blank lines above and below displayed equations unless a new paragraph is really intended. \subsection{Numbering of equations} The \verb"subequations" and \verb"subeqnarray" environments have been incorporated into the JPP class file. Using these two environments, you can number your equations (1.1{\it a}), (1.1{\it b}) \etc automatically. For example, you can typeset \begin{subequations} \begin{equation} a_1 \equiv (2\Omega M^2/x)^{\frac{1}{4}} y^{\frac{1}{2}} \end{equation} and \begin{equation} a_2 \equiv (x/2\Omega)^{\frac{1}{2}}k_y/M. \end{equation} \end{subequations} by using the \verb"subequations" environment as follows: \begin{verbatim} \begin{subequations} \begin{equation} a_1 \equiv (2\Omega M^2/x)^{\frac{1}{4}} y^{\frac{1}{2}} \end{equation} and \begin{equation} a_2 \equiv (x/2\Omega)^{\frac{1}{2}}k_y/M. \end{equation} \end{subequations} \end{verbatim} You may also typeset an \verb"array" such as: \begin{subeqnarray} \dot{X} & = & \gamma X - \gamma\delta\eta ,\\ \dot{\eta} & = & {\textstyle\frac{1}{2}} \delta + 2X\eta . \end{subeqnarray} by using the \verb"subeqnarray" environment as follows: \begin{verbatim} \begin{subeqnarray} \dot{X} & = & \gamma X - \gamma\delta\eta ,\\ \dot{\eta} & = & {\textstyle\frac{1}{2}} \delta + 2X\eta . \end{subeqnarray} \end{verbatim} \subsection{AMS fonts -- especially if you do not have them} If you need AMS symbols but do not have the AMS fonts you can ensure that they will be correctly typeset by taking the following steps. Set up user-defined macros that can be redefined by the typesetter to use the correct AMS macros. For example, the blackboard bold symbols, sometimes called shell or outline characters, are obtained with the AMS macro \verb"\mathbb{..}". Instead, use a macro definition such as: \begin{verbatim} \newcommand\BbbE{\ensuremath{\mathsf{E}}} \end{verbatim} This substitutes a sans serif character where you want blackboard bold. You can typeset the input file and the typesetter is alerted to do the substitution. The following example (which uses the \verb"\providecommand" macro) will work without modification by the typesetter, because the \verb"\providecommand" macro will not overwrite any existing \verb"\mathbb" definition. \begin{verbatim} \providecommand\mathbb[1]{\ensuremath{\mathsf{#1}}} ... \newcommand\BbbE{\mathbb{E}} \end{verbatim} Plain \TeX\ provides only \verb"\leq" and \verb"\geq" which typeset the Computer Modern symbols $\realleq$ and $\realgeq$, respectively. These will be redefined at typesetting to use the AMS symbols \verb"\geqslant" and \verb"\leqslant", to give the slanted symbols. If you wish to use AMS fonts with \LaTeXe\ you must be using at least version 2.0. Earlier versions are not supported. \subsection{Typeface} Sometimes, non-italic symbols are required in maths. This section describes how these may be obtained using \LaTeX\ and \verb"jpp.cls". \subsubsection{Roman symbols}\label{roman} The mathematical operators and constants, such as sin, cos, log and exp (and many others) are covered by \LaTeXe\ macros which ensure that they are typeset in roman text, even in math mode: \verb"\sin", \verb"\cos", \verb"\log", \verb"\exp". Where single letters are concerned (\eg d, i, e) just use \verb"\mathrm" in math mode, i.e\ \verb"$E=m\mathrm{c}^2$" which typesets as $E=m\mathrm{c}^2$, giving the correct roman character but with math spacing. When the term involves more than one character (\eg \Real\ or \Imag ) text-character spacing is required: \begin{verbatim} $\mbox{Re}\;x$ \end{verbatim} which typesets as $\Real\;x$. Where such expressions are used repeatedly, macro definitions can reduce typing and editing. The following examples are included in the preamble of the input files for this document, \verb"jppguide.tex", and of the sample article \verb"jppsampl.tex". Authors are encouraged to use them and others like them. \begin{verbatim} \newcommand\Real{\mbox{Re}} \newcommand\Imag{\mbox{Im}} \newcommand\Ai{\mbox{Ai}} \newcommand\Bi{\mbox{Bi}} \end{verbatim} \subsubsection{Multiletter italic symbols} If multiletter symbols are used in maths mode, for example Reynolds, Prandtl numbers, \etc the standard maths mode spacing between them is too large and text-character spacing is required. As described in \S\ref{roman} (but here for italic letters) use for example \begin{verbatim} \newcommand\Rey{\mbox{\textit{Re}}} \newcommand\Pran{\mbox{\textit{Pr}}} \end{verbatim} \subsubsection{Upright and sloping Greek symbols} Like the italic/roman fonts described above, Greek letters for math variables are printed in the Journal in sloping type, whereas constants, operators and units are upright. However, \LaTeX\ normally produces sloping lowercase Greek and upright capitals. The upright lowercase required for example for `pi' and `mu' (micro) are provided by the \verb"upmath" package (from the AMS Euler fonts). If you don't have the AMS font set, you will have to use the normal math italic symbols and the typesetter will substitute the corresponding upright characters. You will make this much easier if you can use the macros \verb"\upi" and \verb"\umu" in your text to indicate the need for the upright characters, together with the following definitions in the preamble, where they can easily be redefined by the typesetter. \begin{verbatim} \providecommand\upi{\pi} \providecommand\umu{\mu} \end{verbatim} Notice the use of \verb"\providecommand", this stops your definitions overwriting the ones used by the typesetter. Sloping uppercase Greek characters can be obtained by using the \verb"\varGamma" \etc macros (which are built into the class file). The few required upright Greek capital letters (\eg capital delta for `difference') are given by the relevant \LaTeX\ macro, \eg \verb"\Delta". \newcommand\lra{\ensuremath{\quad\longrightarrow\quad}} \subsubsection{Sans serif symbols} The \verb"\textsf" and \verb"\mathsf" commands change the typeface to sans serif, giving upright characters. Occasionally, bold-sloping sans serif is needed. You should use the following supplied macros to obtain these fonts.\\[6pt] \verb" \textsf{text} " \lra \textsf{text} \qquad \verb"\mathsf{math} " \lra $\mathsf{math}$\\ \verb" \textsfi{text} " \lra \textsfi{text} \qquad \verb"\mathsfi{math} " \lra $\mathsfi{math}$\\ \verb" \textsfb{text} " \lra \textsfb{text} \qquad \verb"\mathsfb{math} " \lra $\mathsfb{math}$\\ \verb" \textsfbi{text}" \lra \textsfbi{text} \qquad \verb"\mathsfbi{math}" \lra $\mathsfbi{math}$\\[6pt] You can use them like this: \begin{verbatim} \newcommand\ssC{\mathsf{C}} \newcommand\sfsP{\mathsfi{P}} \newcommand\sfbsX{\mathsfbi{X}} \end{verbatim} Note that the bold-slanted font \verb"\testsfbi" and \verb"\mathsfbi" use the slanted sans serif font \verb"cmssi" -- because there is no bold-slanted maths sans serif font in Computer Modern! If you use the supplied sans-serif text and math commands the typesetter will be able to substitute the fonts automatically. \subsubsection{Bold math italic symbols} If you require bold math italic symbols/letters, \LaTeX\ provides several ways of getting them. Firstly, \LaTeX's \verb"\boldmath" switch which can be used like this: \begin{verbatim} $ \mbox{\boldmath $P$} = \mathsf{J}\mathcal{E} T $ \end{verbatim} As you can see it takes quite alot of typing to achieve a bold math italic P. Another problem is that you can't use \verb"\boldmath" in math mode, thus the \verb"\mbox" forces the resulting text into text style (which you may not want). You can cut down on the typing by defining the following macro (which is in the preamble of this guide): \begin{verbatim} \providecommand\boldsymbol[1]{\mbox{\boldmath $#1$}} \end{verbatim} Then for the above example you can define: \begin{verbatim} \newcommand\bldP{\boldsymbol{P}} \end{verbatim} the achieve the same result. This still doesn't remove the default to text style problem. If you have the \verb"amsbsy" package on your system, then you can remove this limitation as well by placing a \verb"\usepackage{amsbsy}" after the \verb"\documentclass" line in your document, and then use \verb"\boldsymbol" for bold math italic symbols (don't define \verb"\boldsymbol" yourself when using \verb"amsbsy"). \subsubsection{Script characters} Script characters should be typeset using \LaTeXe's \verb"\mathcal" command. This produces the Computer Modern symbols such as $\mathcal{E}\,$ and $\mathcal{F}\,$ in your hard copy but the typesetter will substitute the more florid script characters normally seen in the journal. \subsection{Skewing of accents} Accents such as hats, overbars and dots are normally centred over letters, but when these are italic or sloping greek the accent may need to be moved to the right so that it is centred over the top of the sloped letter. For example, \verb"\newcommand\hatp{\skew3\hat{p}}" will produce $\hatp$. \subsection{Units of measure} Numbers and their units of measure should be typeset with fixed spaces that will not break over two lines. This is easily done with user-defined macros. For example,\linebreak \verb"52\dynpercm" typesets as 52\dynpercm , providing the following macro definition has been included in the preamble. \begin{verbatim} \newcommand\dynpercm{\nobreak\mbox{$\;$dynes\,cm$^{-1}$}} \end{verbatim} \section{User-defined macros}\label{secUser} If you define your own macros you must ensure that their names do not conflict with any existing macros in plain \TeX\ or \LaTeX\ (or \AMSLaTeX\ % if you are using this). You should also place them in the preamble to your input file, between the \verb"\documentclass" and \verb"\begin{document}" commands. Apart from scanning the indexes of the relevant manuals, you can check whether a macro name is already used in plain \TeX\ or \LaTeX\ by using the \TeX\ command \verb"show". For instance, run \LaTeX\ interactively and type \verb"\show\<macro_name>" at the \TeX\ prompt. (Alternatively, insert the \verb"\show" command into the preamble of an input file and \TeX\ it.) \begin{verbatim} * \show\Re \end{verbatim} produces the following response from \TeX : \begin{verbatim} > \Re=\mathchar"23C. <*> \show\Re \end{verbatim} By contrast \verb"\Real" is not part of plain \TeX\ or \LaTeX\ and \verb"\show\Real" generates: \begin{verbatim} > \Real=undefined <*> \show\Real \end{verbatim} confirming that this name can be assigned to a user-defined macro. Alternatively, you can just use \verb"\newcommand", which will check for the existence of the macro you are trying to define. If the macro exists \LaTeX\ will respond with: \begin{verbatim} ! LaTeX Error: Command ... already defined. \end{verbatim} In this case you should choose another name, and try again. Such macros must be in a place where they can easily be found and modified by the journal's editors or typesetter. They must be gathered together in the preamble of your input file, or in a separate \verb"macros.tex" file with the command \verb"\input{macros}" in the preamble. Macro definitions must not be scattered about your document where they are likely to be completely overlooked by the typesetter. The same applies to font definitions that are based on Computer Modern fonts. These must be changed by the typesetter to use the journal's \TeX\ typefaces. In this case, you should draw attention to these font definitions on the hard copy that you submit for publication and by placing a comment in your input file just before the relevant definitions, for example \verb \section{Some guidelines for using standard facilities} The following notes may help you achieve the best effects with the standard \LaTeX\ facilities that remain in the JPP style. \subsection{Sections} \LaTeX\ provides five levels of section headings, only four of which are defined in the JPP class file: \begin{itemize} \item[] Heading A -- \verb"\section{...}" \item[] Heading B -- \verb"\subsection{...}" \item[] Heading C -- \verb"\subsubsection{...}" \item[] Heading D -- \verb"\paragraph{...}" \end{itemize} There is no \verb"subparagraph" in the JPP style. To obtain non-bold in a bold heading use the usual \LaTeXe\ commands for changing typeface; for example \verb"\section{Fluctuations in Ca\textsc{ii}}". \begin{table} \caption{An example table} \label{sample-table} \begin{center} \begin{tabular}{cccc} \hline {Figure} & {$hA$} & {$hB$} & {$hC$}\\ \hline 2 & $\exp\;(\upi \mathrm{i} x)$ & $\exp\;(\upi \mathrm{i} y)$ & $0$\\ 3 & $-1$ & $\exp\;(\upi \mathrm{i} x)$ & $1$\\ 4 & $-4+3\mathrm{i}$ & $-4+3\mathrm{i}$ & 1.6\\ 5 & $-2$ & $-2$ & $1.2 \mathrm{i}$ \end{tabular} \end{center} \end{table} \subsection{Tables} The \verb"table" environment is implemented as described in the \LaTeX\ manual to provide consecutively numbered floating inserts for tables. JPP class will cope with most table positioning problems and you should not normally use the optional positional qualifiers \verb"t", \verb"b", \verb"h" on the \verb"table" environment, as this would override these decisions. Table captions should appear at the bottom of the table; therefore you should place the \verb"\caption" command before the \verb"\begin{tabular}". The JPP \verb"table" environment will insert rules above and below the table as required by the JPP style, so you should not attempt to insert these yourself. The only time you need to intervene with the rules is when two or more tables fall one above another. When this happens, you will get two rules together and too much space between the tables; the solution is to add \verb"\norule" before the end of upper table and \verb"\followon" between tables as shown here: \begin{verbatim} ... \end{center} \caption{Dimensionless parameters}\label{dimensionless_p} \norule \end{table} \followon \begin{table} \begin{center} ... \end{verbatim} The JPP style dictates that vertical rules should never be used within the body of the table, and horizontal rules should be used only to span columns with the same headings. Extra space can be inserted to distinguish groups of rows or columns. As an example, table~\ref{sample-table} is produced using the following commands: \begin{verbatim} \begin{table} \caption{An example table} \label{sample-table} \begin{center} \begin{tabular}{cccc} \hline {Figure} & {$hA$} & {$hB$} & {$hC$}\\ \hline 2 & $\exp\;(\upi \mathrm{i} x)$ & $\exp\;(\upi \mathrm{i} y)$ & $0$\\ 3 & $-1$ & $\exp\;(\upi \mathrm{i} x)$ & $1$\\ 4 & $-4+3\mathrm{i}$ & $-4+3\mathrm{i}$ & 1.6\\ 5 & $-2$ & $-2$ & $1.2 \mathrm{i}$ \end{tabular} \end{center} \end{table} \end{verbatim} The \verb"tabular" environment has been modified for the JPP style in the following ways: \begin{enumerate} \item Additional vertical space is inserted above and below a horizontal rule produced by \verb"\hline" \item Tables are centred, and span the full width of the page; that is, they are similar to the tables that would be produced by \verb"\begin{tabular*}{\textwidth}". \item As with normal \LaTeX, if a footnote needs to be inserted into the body of the table, the \verb"tabular" environment should be enclosed in a \verb"minipage" environment of width \verb"\textwidth". \eg \begin{verbatim} \begin{minipage}{\textwidth} \begin{tabular}{cccc} \hline {Figure} & {$hA$} & {$hB$}\footnote{A table must be inside a \verb"minipage" environment if it includes table footnotes.} & {$hC$}\\ ... \end{tabular} \end{minipage} \end{verbatim} \end{enumerate} Commands to redefine quantities such as \verb"\arraystretch" should be omitted. If the original tabular facilities are needed, there is a new environment `\verb"oldtabular"', which has none of the reformatting; it should be used in exactly the same way. \subsection{Illustrations (or figures)} Artwork for all figures must be supplied separately, to be processed by the Printer, and so \LaTeX's picture environment, for example, cannot be used. An approximate amount of space should be left, using the \verb"\vspace" command. The JPP style will cope with most figure positioning problems and you should not normally use the optional positional qualifiers \verb"t", \verb"b", \verb"h" on the \verb"figure" environment, as this would override these decisions. Figure captions should be below the figure itself, therefore the \verb"\caption" command should appear after the space left for the illustration within the \verb"figure" environment. For example, figure~\ref{sample-figure} is produced using the following commands: \begin{figure} \vspace{3cm} \caption{An example figure with space for artwork.} \label{sample-figure} \end{figure} \begin{verbatim} \begin{figure} \vspace{3cm} \caption{An example figure with space for artwork.} \label{sample-figure} \end{figure} \end{verbatim} If a figure caption is too long to fit on the same page as its illustration, the caption may be typeset as `{\small\textsc{Figure X.} \textrm{For caption see facing page.}}', and the longer caption typeset at the bottom of the facing page. Authors should not concern themselves unduly with such details, and may leave pages long. \subsection{Acknowledgments} Acknowledgments should appear at the close of your paper, just before the list of references and any appendices. Use the \verb"acknowledgments" environment, which simply inserts an `Acknowledgments' subsection heading. There is also an \verb"acknowledgment" (or \verb"acknowledegment") environment for typesetting a single acknowledegment. \subsection{Appendices} You should use the standard \LaTeX\ \verb" \part{3} \pagerange{119--126} \date{1 July 1994 and in revised form 30 October 1998} \setcounter{page}{119} \begin{document} \maketitle \begin{abstract} Using Stokes flow between eccentric counter-rotating cylinders as a prototype for bounded nearly parallel lubrication flow, we investigate the effect of a slender recirculation region within the flow field on cross-stream heat or mass transport in the important limit of high P\'{e}clet number \Pen\ where the enhancement over pure conduction heat transfer without recirculation is most pronounced. The steady enhancement is estimated with a matched asymptotic expansion to resolve the diffusive boundary layers at the separatrices which bound the recirculation region. The enhancement over pure conduction is shown to vary as $\epsilon^{\frac{1}{2}}$ at infinite \Pen, where $\epsilon^{\frac{1}{2}}$ is the characteristic width of the recirculation region. The enhancement decays from this asymptote as $\Pen\smh$. \end{abstract} \section{Introduction} The use of integral equations to solve exterior problems in linear acoustics, i.e.\ to solve the Helmholtz equation $(\nabla^2+k^2)\phi=0$ outside a surface $S$ given that $\phi$ satisfies certain boundary conditions on $S$, is very common. A good description is provided by \cite{Martin80}. Integral equations have also been used to solve the two-dimensional Helmholtz equation that arises in water-wave problems where there is a constant depth variation. The problem of wave oscillations in arbitrarily shaped harbours using such techniques has been examined (see for example Hwang \& Tuck 1970; Lee 1971). In a recent paper \cite{Linton92} have shown how radiation and scattering problems for vertical circular cylinders placed on the centreline of a channel of finite water depth can be solved efficiently using the multipole method devised originally by Ursell (1950). This method was also used by \cite{Callan91} to prove the existence of trapped modes in the vicinity of such a cylinder at a discrete wavenumber $k<\upi/2d$ where $2d$ is the channel width. Many water-wave/body interaction problems in which the body is a vertical cylinder with constant cross-section can be simplified by factoring out the depth dependence. Thus if the boundary conditions are homogeneous we can write the velocity potential $\phi(x,y,z,t) = \hbox{Re}\{\phi(x,y)\cosh k(z+h){\rm e}^{-{\rm i}\omega t}\}$, where the $(x,y)$-plane corresponds to the undisturbed free surface and $z$ is measured vertically upwards with $z=-h$ the bottom of the channel. Subsequently Callan {\it et al.} (1991) proved the existence of, and computed the wavenumbers for, the circular cross-section case. It should be noted however that experimental evidence for acoustic resonances in the case of the circular cylinder is given by Bearman \& Graham (1980, pp.~231--232). \mbox{}\cite{Koch83} provided a theory for determining the trapped-mode frequencies for the thin plate, based on a modification of the Wiener--Hopf technique. The use of channel Green's functions, developed in~\S\,\ref{sec:greensfunc}, allows the far-field behaviour to be computed in an extremely simple manner, whilst the integral equation constructed in~\S\,\ref{sec:trapmode} enables the trapped modes to be computed in~\S\,\ref{sec:torus} and the scattering of an incident plane wave to be solved in~\S\,\ref{sec:conc}. Appendix~\ref{app:boundcon} contains comparisons with experiments. \section{Green's functions}\label{sec:greensfunc} \subsection{Construction of equations} We are concerned with problems for which the solution, $\phi$, is either symmetric or antisymmetric about the centreline of the waveguide, $y=0$. The first step is the construction of a symmetric and an antisymmetric Green's function, $\GsPQ$ and $\GaPQ$. Thus we require \begin{equation} (\nabla^2_P+k^2)G_s=(\nabla^2_P+k^2)G_a=0 \label{Helm} \end{equation} in the fluid, where $\bnabla_\rho$ is a gradient operator, except when $P\equiv Q$, \begin{equation} G_{\rm s},G_{\rm a}\sim 1 / (2\upi)\ln r \qquad \mbox{as\ } r\equiv|P-Q|\rightarrow 0, \label{singular} \end{equation} \begin{equation} \frac{\p G_{\rm s}}{\p y}=\frac{\p G_{\rm a}}{\p y}=0 \qquad \mbox{on\ } y=d, \label{wallbc} \end{equation} \begin{equation} \frac{\p G_{\rm s}}{\p y}=0 \qquad \mbox{on\ } y=0, \label{symbc} \end{equation} \begin{equation} G_{\rm a}=0 \qquad \mbox{on\ } y=0, \label{asymbc} \end{equation} and we require $G_s$ and $G_a$ to behave like outgoing waves as $|x|\tti$. One way of constructing $G_s$ or $G_a$ is to replace (\ref{Helm}) and (\ref{singular}) by \begin{equation} (\nabla^2_P+k^2)G_{\rm s}=(\nabla^2_P+k^2)G_{\rm a} = -\delta(x-\xi)\delta(y-\eta) \end{equation} and to assume initially that $k$ has a positive imaginary part. \subsection{Further developments} Using results from \cite{Linton92} we see that this has the integral representation \begin{equation} -\frac{1}{2\upi} \int_0^{\infty} \gamma^{-1}[{\rm e}^{-k\gamma|y-\eta|} + {\rm e}^{-k\gamma(2d-y-\eta)}] \cos k(x-\xi)t\:{\rm d}t, \qquad 0<y,\quad \eta<d, \end{equation} where \[ \gamma(t) = \left\{ \begin{array}{ll} -{\rm i}(1-t^2)\sh, & t\le 1 \\[2pt] (t^2-1)\sh, & t>1. \end{array} \right. \] In order to satisfy (\ref{symbc}) we add to this the function \[ -\frac{1}{2\upi} \pvi B(t)\frac{\cosh k\gamma(d-y)}{\gamma\sinh k\gamma d} \cos k(x-\xi)t\:{\rm d}t \] which satisfies (\ref{Helm}), (\ref{wallbc}) and obtain \begin{equation} B(t) = 2{\rm e}^{-\kgd}\cosh k\gamma(d-\eta). \end{equation} Thus the function \begin{equation} G = -\squart{\rm i}(H_0(kr)+H_0(kr_1)) - \frac{1}{\upi} \pvi\frac{{\rm e}^{-\kgd}}% {\gamma\sinh\kgd} \cosh k\gamma(d-y) \cosh k\gamma(d-\eta) \end{equation} satisfies (\ref{Helm})--(\ref{symbc}). By writing this function as a single integral which is even in $\gamma$, it follows that $G$ is real. \section{The trapped-mode problem}\label{sec:trapmode} The unit normal from $D$ to $\p D$ is $\bmath{n}_q=(-y^{\prime}(\theta), x^{\prime}(\theta))/w(\theta)$. Now $G_a=\squart Y_0(kr)+\Gat$ where $r=\{[x(\theta)-x(\psi)]^2 + [y(\theta)-y(\psi)]^2\}\sh$ and $\Gat$ is regular as $kr\ttz$. In order to evaluate $\p G_a(\theta,\theta)/\p n_q$ we note that \[ \ndq\left(\squart Y_0(kr)\right)\sim\ndq\left(\frac{1}{2\upi} \ln r\right)=\frac{1}{2\upi r^2 w(\theta)}[x^{\prime}(\theta) (y(\theta)-y(\psi))-y^{\prime}(\theta)(x(\theta)-x(\psi))] \] as $kr\ttz$. Expanding $x(\psi)$ and $y(\psi)$ about the point $\psi=\theta$ then shows that \begin{eqnarray} \ndq\left(\squart Y_0(kr)\right) & \sim & \frac{1}{4\upi w^3(\theta)} [x^{\prime\prime}(\theta)y^{\prime}(\theta)- y^{\prime\prime}(\theta)x^{\prime}(\theta)] \nonumber\\ & = & \frac{1}{4\upi w^3(\theta)} [\rho^{\prime}(\theta)\rho^{\prime\prime}(\theta) - \rho^2(\theta)-2\rho^{\prime 2}(\theta)] \quad \mbox{as\ } kr\ttz . \label{inteqpt} \end{eqnarray} \subsection{Computation} For computational purposes we discretize (\ref{inteqpt}) by dividing the interval ($0,\upi$) into $M$ segments. Thus we write \begin{equation} \shalf\phi(\psi) = \frac{\upi}{M} \sumjm\phi(\theta_j)\ndq G_a(\psi,\theta_j)\,w(\theta_j), \qquad 0<\psi<\upi, \label{phipsi} \end{equation} where $\theta_j=(j-\shalf)\upi/M$. Collocating at $\psi=\theta_i$ and writing $\phi_i=\phi(\theta_i)$ etc.\ gives \begin{equation} \shalf\phi_i = \frac{\upi}{M} \sumjm\phi_j K_{ij}^a w_j, \qquad i=1,\,\ldots,\,M, \end{equation} where \begin{equation} K_{ij}^a = \left\{ \begin{array}{ll} \p G_a(\theta_i,\theta_j)/\p n_q, & i\neq j \\[2pt] \p\Gat(\theta_i,\theta_i)/\p n_q + [\rho_i^{\prime}\rho_i^{\prime\prime}-\rho_i^2-2\rho_i^{\prime 2}] / 4\upi w_i^3, & i=j. \end{array} \right. \end{equation} For a trapped mode, therefore, we require the determinant of the $M\times M$ matrix whose elements are \[ \delta_{ij}-\frac{2\upi}{M}K_{ij}^a w_j, \] to be zero. \begin{table} \caption{Values of $kd$ at which trapped modes occur when $\rho(\theta)=a$} \label{tab:kd} \begin{center} \begin{tabular}{cccc} \hline $a/d$ & $M=4$ & $M=8$ & Callan {\it et al.}\\ \hline 0.1 & 1.56905 & 1.56905 & 1.56904\\ 0.3 & 1.50484 & 1.50484 & 1.50484\\ 0.5 & 1.39128 & 1.39131 & 1.39131\\ 0.7 & 1.32281 & 1.32287 & 1.32288\\ 0.9 & 1.34479 & 1.35160 & 1.35185 \end{tabular} \end{center} \end{table} Table~\ref{tab:kd} shows a comparison of results obtained from this method using two different truncation parameters with accurate values obtained using the method of Callan {\it et al.} (1991). \begin{figure} \vspace{16.5pc} \caption{Trapped-mode wavenumbers, $kd$, plotted against $a/d$ for three ellipses:\protect\\ \hbox{{--}\,{--}\,{--}\,{--}\,{--}}, $b/a=0.5$; ---$\!$---, $b/a=1$; ---\,$\cdot$\,---, $b/a=1.5$.}\label{fig:trapmode} \end{figure} An example of the results that are obtained from our method is given in figure~\ref{fig:trapmode}. Figure~\ref{fig:shadcon}\,({\it a},{\it b}) shows shaded contour plots of $\phi$ for these modes, normalized so that the maximum value of $\phi$ on the body is 1. \begin{figure} \vspace{15pc} \caption{Shaded contour plots of the potential $\phi$ for the two trapped modes that exist for an ellipse with $a/d=1.5$, $b/d=0.75$. ({\it a}) Symmetric about $x=0$, $kd=0.96$; ({\it b}) antisymmetric about $x=0$, $kd=1.398$.}\label{fig:shadcon} \end{figure} \subsection{Basic properties} Let \def\thesection.\arabic{equation}a,b{\thesection.\arabic{equation}a,b} \begin{equation} \rho_l = \lim_{\zeta \rightarrow Z^-_l(x)} \rho(x,\zeta), \quad \rho_{\rm u} = \lim_{\zeta \rightarrow Z^{+}_{\rm u}(x)} \rho(x,\zeta) \end{equation}% \def\thesection.\arabic{equation}a,b{\thesection.\arabic{equation}}% be the fluid densities immediately below and above the cat's-eyes. Finally let $\rho_0$ and $N_0$ be the constant values of the density and the vorticity inside the cat's-eyes, so that \begin{equation} (\rho(x,\zeta),\phi_{\zeta\zeta}(x,\zeta))=(\rho_0,N_0) \quad \mbox{for\ } Z_l(x) < \zeta < Z_{\rm u}(x). \end{equation} The Reynolds number \Rey{\it \/} is defined by $u_\tau H/\nu$ ($\nu$ is the kinematic viscosity), the length given in wall units is denoted by $(\;)_+$, and the Prandtl number \Pran{\it \/} is set equal to 0.7. In (\ref{Helm}) and (\ref{singular}), $\tau_{ij}$ and $\tau^\theta_j$ are \begin{subeqnarray} \tau_{ij} & = & (\overline{\overline{u}_i \overline{u}_j} - \overline{u}_i\overline{u}_j) + (\overline{\overline{u}_iu^{SGS}_j + u^{SGS}_i\overline{u}_j}) + \overline{u^{SGS}_iu^{SGS}_j},\\[3pt] \tau^\theta_j & = & (\overline{\overline{u}_j\overline{\theta}} - \overline{u}_j \overline{\theta}) + (\overline{\overline{u}_j\theta^{SGS} + u^{SGS}_j \overline{\theta}}) + \overline{u^{SGS}_j\theta^{SGS}}. \end{subeqnarray} \subsubsection{Calculation of the terms} The first terms in the right-hand side of (3.5a) and (3.5b) are the Leonard terms explicitly calculated by applying the Gaussian filter in the $x$- and $z$-directions in the Fourier space. The interface boundary conditions given by (\ref{Helm}) and (\ref{singular}), which relate the displacement and stress state of the wall at the mean interface to the disturbance quantities of the flow, can also be reformulated in terms of the transformed quantities. The transformed boundary conditions are summarized below in a matrix form that is convenient for the subsequent development of the theory: \begin{equation} \setlength{\arraycolsep}{0pt} \renewcommand{\arraystretch}{1.3} \slsQ_C = \left[ \begin{array}{ccccc} -\omega^{-2}V'_w & -(\alpha^t\omega)^{-1} & 0 & 0 & 0 \\ \displaystyle \frac{\beta}{\alpha\omega^2}V'_w & 0 & 0 & 0 & {\rm i}\omega^{-1} \\ {\rm i}\omega^{-1} & 0 & 0 & 0 & 0 \\ \displaystyle {\rm i}R^{-1}_{\delta}(\alpha^t+\omega^{-1}V''_w) & 0 & -({\rm i}\alpha^tR_\delta)^{-1} & 0 & 0 \\ \displaystyle \frac{{\rm i}\beta}{\alpha\omega}R^{-1}_\delta V''_w & 0 & 0 & 0 & 0 \\ ({\rm i}\alpha^t)^{-1}V'_w & (3R^{-1}_{\delta}+c^t({\rm i}\alpha^t)^{-1}) & 0 & -(\alpha^t)^{-2}R^{-1}_{\delta} & 0 \\ \end{array} \right] . \label{defQc} \end{equation} $\biS^t$ is termed the displacement-stress vector and $\slsQ_C$ the flow-wall coupling matrix. Subscript $w$ in (\ref{defQc}) denotes evaluation of the terms at the mean interface. It is noted that $V''_w = 0$ for the Blasius mean flow. \subsubsection{Wave propagation in anisotropic compliant layers} From (\ref{Helm}), the fundamental wave solutions to (\ref{inteqpt}) and (\ref{phipsi}) for a uniformly thick homogeneous layer in the transformed variables has the form of \begin{equation} \etb^t = \hat{\etb}^t \exp [{\rm i}(\alpha^tx^t_1-\omega t)], \end{equation} where $\hat{\etb}^t=\bmath{b}\exp ({\rm i}\gamma x^t_3)$. For a non-trivial wave, the substitution of (1.7) into (1.3) and (1.4) yields the following determinantal equation: \begin{equation} \mbox{Det}[\rho\omega^2\delta_{ps}-C^t_{pqrs}k^t_qk^t_r]=0, \end{equation} where the wavenumbers $\langle k^t_1,k^t_2,k^t_3\rangle = \langle \alpha^t,0,\gamma\rangle $ and $\delta_{ps}$ is the Kronecker delta. \section{Torus translating along an axis of symmetry}\label{sec:torus} Consider a torus with axes $a,b$ (see figure~\ref{fig:shadcon}), moving along the $z$-axis. Symmetry considerations imply the following form for the stress function, given in body coordinates: \begin{equation} \bmath{f}(\theta,\psi) = (g(\psi) \cos \theta,g(\psi) \sin \theta,f(\psi)). \label{eq41} \end{equation} Because of symmetry, one can integrate analytically in the $\theta$-direction obtaining a pair of equations for the coefficients $f$, $g$ in (4.1), \begin{eqnarray} f(\psi_1) = \frac{3b}{\upi(2(a+b \cos \psi_1))^{\frac{3}{2}}} \int^{2\upi}_0 \frac{(\sin \psi_1 - \sin \psi)(a+b \cos \psi)\sh}% {(1 - \cos (\psi_1 - \psi))(2+\alpha)\sh}, \label{eq42} \end{eqnarray} \begin{eqnarray} g(\psi_1) & = & \frac{3}{\upi(2(a+b \cos \psi_1))^{\frac{3}{2}}} \int^{2\upi}_0 \left(\frac{a+b \cos \psi}{2+\alpha}\right)\sh \left\{ \usebox{\astrutbox} f(\psi)[(\cos \psi_1 - \cos \psi - b \beta_1)S + \beta_1P] \right. \nonumber\\ && \mbox{}\times \frac{\sin \psi_1 - \sin \psi}{1-\cos(\psi_1 - \psi)} + g(\psi) \left[\left(2+\alpha - \frac{(\sin \psi_1 - \sin \psi)^2} {1- \cos (\psi - \psi_1)} - b^2 \gamma \right) S \right.\nonumber\\ && \left.\left.\mbox{} + \left( b^2 \cos \psi_1\gamma - \frac{a}{b}\alpha \right) F(\thalf\upi, \delta) - (2+\alpha) \cos\psi_1 E(\thalf\upi, \delta)\right] \usebox{\astrutbox}\right\} {\rm d}\psi, \label{eq43} \end{eqnarray} \begin{equation} \alpha = \alpha(\psi,\psi_1) = \frac{b^2(1-\cos(\psi-\psi_1))}% {(a+b\cos\psi) (a+b\cos\psi_1)}; \quad \beta - \beta(\psi,\psi_1) = \frac{1-\cos(\psi-\psi_1)}{a+b\cos\psi}. \end{equation} \section{Conclusions}\label{sec:conc} We have shown how integral equations can be used to solve a particular class of problems concerning obstacles in waveguides, namely the Neumann problem for bodies symmetric about the centreline of a channel, and two such problems were considered in detail. \begin{acknowledgments} We would like to acknowledge the useful comments of a referee concerning the solution procedure used in \S\,\ref{sec:conc}. A.\,N.\,O. is supported by SERC under grant number GR/F/12345. \end{acknowledgments} \part{0} \pagerange{\pageref{firstpage}--\pageref{lastpage}} \doi{S0963548301004989} \begin{document} \label{firstpage} \maketitle \begin{abstract} The usual theory of plasma relaxation, based on the selective decay of magnetic energy over the (global) magnetic helicity, predicts a force-free state for a plasma. Such a force-free state is inadequate to describe most realistic plasma systems occurring in laboratory and space plasmas as it produces a zero pressure gradient and cannot couple magnetic fields with flow. A different theory of relaxation has been proposed by many authors, based on a well-known principle of irreversible thermodynamics, the principle of minimum entropy production rate which is equivalent to the minimum dissipation rate (MDR) of energy. We demonstrate the applicability of minimum dissipative relaxed states to various self-organized systems of magnetically confined plasma in the laboratory and in the astrophysical context. Such relaxed states are shown to produce a number of basic characteristics of laboratory plasma confinement systems and solar arcade structure. \end{abstract} \section{Introduction and Motivation:} Self-organization is a natural process [Ortolani and Schnack, 1993] in which a continuous system evolves toward some preferred states showing a form of order on long scales. Examples of such self-organization processes are ubiquitous in nature and in systems studied in the laboratory. These ordered states are very often remarkably robust, and their detailed structures are mostly independent of the way the system is prepared. The final state to which a system evolves generally depends on the boundary conditions, inherent geometry of the particular device, but is relatively independent of the initial conditions. Self-organization in plasma is generally called Plasma Relaxation. The seminal theory for plasma relaxation first proposed by Taylor (1974) yields a force-free state with zero pressure gradient. Taylor's theory was the first to explain the experimentally observed field reversal of the Reversed Field Pinch (RFP). Self-organized states with zero pressure gradient are often far from experimentally realizable scenarios. Any realistic magnetic configuration confining plasma must have a non-zero pressure gradient. Extensive numerical simulations [ Sato et al., 1996, Zhu et al., 1995] have established the existence of self-organized states of plasma with finite pressure, i.e., these states are observed to be governed by the magnetohydrodynamic force balance equation. Numerical simulations [Dasgupta et al, 1995, Watanabe et al, 1997] and experiments [Ono et al., 1993 ] have established that counterhelicity merging of two spheromaks can produce a Field-Reversed Configuration (FRC). The FRC has a zero toroidal magnetic field, and the plasma is confined entirely by poloidal magnetic field. It has a finite pressure, nonzero perpendicular component of current and is more often characterized by a high value of plasma beta. The stability and long life categorize FRC as a relaxed state, which is not obtainable from Taylor model of relaxation. Since spheromaks are depicted as a Taylor state [Rosenbluth and Bussac, 1979], formation of a FRC from the merging of two counterhelicity spheromaks is a unique process from the point of view of plasma relaxation, where a non-force free state (hence non-Taylor state) emerges from the coalescence of two Taylor states. In astrophysical context, particularly solar physics scenario, a 3-D MHD simulation by Amari and Luciano [2000], among others, showed that, after the initial helicity drive, the final ``relaxed state is far from the ... linear force-free model that would be predicted by Taylor's conjecture" and they suggested to derive an alternative variational approach. Such physical processes call for an alternate model for plasma relaxation to broadly accommodate a large number of these observations. In this context, an important work by Turner deserves special attention. Turner first showed (1986) that a relaxed magnetic field configuration which can support/confine a plasma with a finite pressure gradient. Adopting a two-fluid approach, a model of magnetofluid relaxation is constructed for Hall MHD, under the assumptions of minimum energy (magnetic plus fluid) with the constraints of global magnetic helicity hybrid helicity, axial magnetic flux and fluid vorticity. Euler-Lagrange equations resulted from such variational approach show the coupling between the magnetic field and the fluid vorticity. The solutions for such coupled equations are shown to be achieved by the linear superposition of the eigen-vectors of the 'curl' operator (force-free states). These solutions yield magnetic field configurations which can confine plasma with a finite pressure gradient. The principle of ``minimum rate of entropy production" formulated by Prigogine and others [Prigogine, 1947] is believed to play a major role in many problems of irreversible thermodynamics. This principle states that for any steady irreversible processes, the rate of entropy production is minimum. For most irreversible processes in nature, the minimum rate of entropy production is equivalent to the minimum rate of energy dissipation. A magnetized plasma is such a dissipative system and it is appropriate to expect that the principle of minimum dissipation rate of energy has a major role to play in a magnetically confined plasma. It is worth mentioning that Rayleigh [1873] first used the term ``principle of least dissipation of energy" in his works on the propagation of elastic waves in matter. Chandasekhar and Woltjer [1958] considered a relaxed state of plasma with minimum Ohmic dissipation with the constraint of constant magnetic energy and obtained an equation for the magnetic field involving a `double curl' for the magnetic field and remarked that the solution of such equation is ``much wider" than the usual force free solution. Montgomery and Phillips [1988] first used the principle of minimum dissipation rate (MDR) of energy in an MHD problem to understand the steady the steady profile of a RFP under the constraint of a constant rate of supply and dissipation of helicity with the boundary conditions for a conducting wall. Farengo et al [Farengo et al, 1994,1995, 2002, Bouzat, 2006] in a series of papers applied the principle of MDR to a variety of problems ranging from flux-core spheromak to tokamak. In this work, we present an alternative scenario for plasma relaxation which is based on the principle of minimum dissipation rate (MDR) rate of energy. This model gives us a non-force free magnetic field, capable of supporting finite pressure gradient. We demonstrate the this model can reproduce some of the basic characteristics of most of the plasma confining devices in the laboratory as well as the arcade structure of solar magnetic field. A two-fluid generalization of this model for an open system couples magnetic field with flow - so this model is applicable to other astrophysical situations. The plan of the paper is as follows: In section 2, we present a single fluid MDR model for closed system and briefly discuss its applicarions to some of the laboratory plasma confinement devices, such as RFP, Spheromak, Tokamak and FRC. We present the result of a recent numerical simulation to justify our choice of the energy dissipation rate as an effective minimizer in our variation problem. In section 3 we describe a generalized version of the MDR model for open two fluid system and its application to solar arcade problem. We summarize a numerical extrapolation method for non-force free coronal magnetic field based on our MDR model. Section 4 concludes our paper. \section{Single fluid MDR based model} To obtain both the field reversal and a finite pressure gradient for RFP, Dasgupta et al.[ Dasgupta et al., 1998] considered the relaxation of a slightly resistive and turbulent plasma using the principle of MDR under the constraint of constant global helicity. With the global helicity $K_M$ and the dissipation rate $R$ defined as, \begin{equation} K_M = \int_V {\bf A}\cdot{\bf B}dV; \qquad R = \int_V \eta {\bf j}^2 dV, \end{equation} the variational principle $\delta (R-\Lambda K)$ leads to the following Euler-Lagrange equation, \begin{equation}\nabla\times\nabla\times\nabla\times{\bf B}= \Lambda{\bf B}.\end{equation} Solutions of the above equation can be constructed as a superposition of the force free equation using Chandrasekhar-Kendall (CK) eigenfunctions [Chandraskhar and Kendall, 1957] \begin{equation}B = \alpha_1 B_1 + \alpha_2B_2 + \alpha_3B_3, \end{equation} where $\alpha_1, \alpha_2, \alpha_3 $ are constants, to be determined from the boundary conditions, and ${\bf B}_i's$ are obtained from \begin{equation} \nabla\times{\bf B}_i = \lambda_i B_i;\quad (i = 1,2,3);\quad \lambda_i^3 = \Lambda.\end{equation} We have used the analytic continuation of CK eigenfunctions in the complex domain. However, one can easily ascertain that the resulting magnetic field B is real. Moreover, since the superposition of force free fields with different eigenvalues $\lambda_i$ is not a force free field, the resultant magnetic field B is not force free, ${\bf J}\times {\bf B}\neq 0 $. An explicit form of the solution in cylindrical geometry with the boundary conditions for an RFP (perfectly conducting wall) has shown two remarkable features: (1) Such a state can support a pressure gradient; and (2) Field reversal is found in states that are not force free. \begin{figure}[ht] \epsfig{file=RFP-one.eps, width=10.cm, height=8.cm} \epsfig{file=RFP-two.eps, width=10.cm, height=8.cm} \caption{\small\label{fig:RFPI} Left panel: Plot of $F = B_z(a)/\left<B_z\right> $ and $\Theta = B_\theta(a)/\left<B_z\right> $ ($<..> $ is the volume average and $ a$ is the radial distance) showing the field reversal of RFP obtained from MDR model. The dotted curve represents the plot for the minimum energy state of Taylor. Right Panel: Pressure profile of RFP obtained from MDR model.(\textit{from Dasgupta et al., 1998}).} \end{figure} In Figure \ref{fig:RFPI} a plot of the field reversal parameter $F$ against the pinch parameter $\Theta$ is shown. It is found that axial field reverses at a value $\Theta \simeq 2.2$; and the pressure profile of the RFP obtained from our MDR model. A success of this theory is its applicability in a tokamak configuration [Bhattacharya et al., 2000]. In toroidal geometry, the CK eigenfunctions are hypergeometric functions in the large aspect ratio approximation. Equilibria can be constructed under the assumption that the total current J = 0 at the edge. The solution reproduces the q-profile, the toroidal magnetic field, the pressure profile and $\sigma = {\bf J}\cdot {\bf B} /B^2$ for tokamak, which are very close to the observed profiles (e.g., figure \ref{fig:toka-one}). The solutions allow for a tokamak, low-q discharge as well as RFP like behavior with a change of eigenvalue which would essentially determine the amount of volt-sec associated with the discharge characterizing the relaxed state. The poloidal Volt-sec/toroidal flux associated with the discharge can be directly interpreted in terms of the parameter $\lambda r_0$ ($r_0$ is the minor radius of the torus, $\lambda =\sqrt[3]{\Lambda}$) and can be shown to increase with $\lambda r_0$. MDR relaxed state can yield several kinds of solutions with distinct q-profiles. For low values of $\lambda r_0$, the q-profile is monotonically increasing and hence the solutions resemble a tokamak type discarge together with a nearly constant toroidal field, for larger values of $\lambda r_0$ the toroidal field reverses at the edge, signifying an RFP-type behavior and for intermediate values, the relaxed states indicate an ultra low-q type of discharge exhibiting a q-profile with a pitch minimum and $0<q<1 $. In figure \ref{fig:toka-one}, we plot the toroidal magnetic field $B_\phi, \sigma = {\bf J}\cdot{\bf J}/B^2, q$ and pressure profiles for different values of $\lambda r_0$, for a fixed value of the aspect ratio = 4.0. The continuous line corresponds corresponds to $\lambda r_0 = 1.5$, and shows a monotonic increase with $r$, which is the essential feature of tokamak discharge. For this case the the toroidal magnetic field ($B_\phi$) is essentially constant and the pressure profile has a peak at the center of the minor cross section of the torus and falls to zero at the edge. A non-constant behavior is shown by the $\sigma$ profile. The dotted line corresponds to $\lambda r_0= 3.0$. In this case the toroidal field reverses sign at the edge, which corresponds to an RFP like discharge. The q-profile shows a similar behavior. The $\sigma$ profile has a dip at $r=0$ and exhibits a bump near the outer region. Such profiles have been experimentally observed in the ETA-BETA-II device [ Antoni et al, 1983]. For the values $\lambda r_0= 2.5$ the q-profile shows a nonmonotonic behavior as shown in figure \ref{fig:toka-two}. The toroidal magnetic field again peaks at the center and slowly decreases towards the edge, showing a paramagnetic behavior that is typical of ultra low-q discharge [Yoshida et al., 1986]. Pressure profile peaks at the center and goes to zero at the edge. Some of these results have been observed in the SINP tokamak [Lahiri et al, 1996] and were also reported earlier in REPUTE-1 [Yoshida et al., 1986] and in TORIUT-6 [Yamada et al, 1987]. \begin{figure}[ht] \epsfig{file=Tokamak-1.eps, width=10.cm, height=8.cm} \caption{\small\label{fig:toka-one} q-profile, $B_\phi, \sigma$, and pressure profile of (i)Tokamak discharge (continuous line); (ii) RFP discharge (dotted line); (\textit{from Bhattacharya et al., 2000}).} \end{figure} This model has been utilized to obtain the spheromak configuration from the spherically symmetric solution under appropriate boundary conditions relevant to an insulating boundary at the edge [Dasgupta et al., 2002]. These boundary conditions are are consistent with the classical spheromak solution used by Rosenbluth and Bussac [1979]. The most interesting part of this spheromak solution is the non-constant profile for ${\bf J}\cdot{\bf B}/B^2$ plotted against normalized distance from the magnetic axis. This profile shows peaks outside the magnetic axis, and this feature is qualitatively closer to the experimentally observed profile reported by Hart et al. [Hart et al., 1983]. \begin{figure}[ht!] \epsfig{file=Tokamak-II.eps, width=10.cm, height=8.cm} \caption{\small\label{fig:toka-two} q-profile, $B_\phi, \sigma$, and pressure profile of low-q Discharge; (\textit{from Bhattacharya et al., 2000}).} \end{figure} The field-reversed configuration (FRC) is a compact toroidal confinement device [Tuszewski, 1988] which is formed with primarily poloidal magnetic field and a zero or negligibly small toroidal magnetic field. The plasma beta of the FRC is one of the highest for any magnetically confined plasma. FRC can be considered as a relaxed state [Guo et al, 2005, 2006], but it is a distinctly non-Taylor state. The FRC configuration can be obtained for an externally driven dissipative system which relaxes with minimum dissipation. In Bhattacharya et al., [2001] we show that the Euler-Lagrange equations for relaxation under MDR with magnetic energy as the constraint represents an FRC configuration for one choice of eigenvalues. This solution is characterized by high beta, zero helicity and a completely null toroidal field and supports a non-constant pressure profile (non-force free). Another choice of eigenvalue leads to a spheromak configuration. A generalization of this work incorporating flow [Bhattacharya et al., 2003] and taking magnetic and flow energies and cross helicities as constraints also produces the FRC configuration. This state supports field aligned flows with strong shears that may lead to stability and better confinement. \begin{figure}[ht!] \epsfig{file=Spheromak.eps, width=10.cm, height=8.cm} \epsfig{file=Spheroeps-I.eps, width=10.cm, height=8.cm} \caption{\small\label{fig:sphero} Spheromak configuration (left panel) and the non-constant $J_{||}/B$ derived from our model based on MDR (right panel); (\textit{from Dasgupta et al., 2002}).} \end{figure} \subsection{Simulation Results:} To justify the use of the MDR principle in plasma relaxation and the choice of the total dissipation rate as a minimizer in the variational principle we performed a fully 3-D numerical simulations for a turbulent and slightly dissipative plasma using a fully compressible MHD code [Shaikh et al., 2007] with periodic boundary conditions. Fluctuations are Fourier expanded and nonlinear terms are evaluated in real space. Spectral methods provide accurate representation in Fourier space. In our code there is very little numerical dissipation, and hence the ideal invariants are preserved. The selective decay processes (in addition to dissipation) depend critically on the cascade properties associated with the rugged MHD invariants that eventually govern the spectral transfer in the inertial range. This can be elucidated as follows [Biscamp, 2003]. Magnetic vector potential in 3D MHD dominates, over the magnetic field fluctuations, at the smaller Fourier modes, which in turn leads to a domination of the magnetic helicity invariant over the magnetic energy. On the other hand, dissipation occurs predominantly at the higher Fourier modes which give rise to a rapid damping of the energy dissipative quantity $R$. A heuristic argument for this process can be formulated in the following way. The decay rates of helicity $K$ and dissipation rate $R= \int_V\eta j^2 dV$ in the dimensionless form, with the magnetic field Fourier decomposed as ${\bf B}({\bf k},t)= \Sigma_k {\bf b_k}\exp(i{\bf k}\cdot{\bf r}) $, can be expressed as, \begin{equation}\label{comp1} \frac{d K}{dt}= -\frac{2\eta}{S}\Sigma_k k {\bf b_k}^2;\qquad \frac{d R}{dt}= -\frac{2\eta^2}{S^2}\Sigma_k k^4 {\bf b_k}^2 \end{equation} where $S= \tau_R/\tau_A$, is the Lundquist number, $\tau_R, \tau_A$ are the resistive and Alfv\'{e}n time scales, respectively. The Lundquist number in our simulations varies between $10^6$ and $10^7$. We find that at scale lengths for which $k\approx S^{1/2}$, the decay rate of energy dissipation is $\sim O(1)$ . But at these scale lengths, helicity dissipation is only $\sim O(S^{-1/2})\ll 1$. This physical scenario is consistent with our 3D simulations. Figure \ref{fig:sim-three} shows the time evolution of the global helicity $K_M$, total magnetic energy $W_M$ and the total dissipation rate $R$. It is seen that global helicity remains approximately constant, (decaying very slightly during the simulation time) while the magnetic energy decays faster than the global helicity, but the energy dissipation rate decays even faster than the magnetic energy. The results of the simulation show that total dissipation rate can serve as a minimizer during a relaxation process. \begin{figure}[ht] \begin{center} \epsfig{file=Sim-two.eps, width=10.cm, height=8.cm} \end{center} \caption{\small\label{fig:sim-three} Time evolution of decay rates associated with the turbulent relaxation of the ideal MHD invariants, viz, global magnetic helicity $K_M= \int_V {\bf A}\cdot{\bf B}dV$, magnetic energy $W= \int_V B^2/2dV$ and the total dissipation $R=\int_V \eta J^2 dV$, all shown in the same scale. } \end{figure} \section{MDR based relaxation model for two fluid plasma with external drive:} Recently, Bhattacharya and Janaki [2004] developed a theory of dissipative relaxed states in two-fluid plasma with external drive. We describe the plasma (consisting of ions and electrons) by the two-fluid equations. The basic advantages of a two-fluid formalism over the single-fluid or MHD counterpart are: (i) in a two-fluid formalism, one can incorporate the coupling of plasma flow with the magnetic field in a natural way, and (ii) the two-fluid description being more general than MHD, is expected to capture certain results that are otherwise unattainable from a single-fluid description. It should be mentioned that although we are invoking the principle of minimum dissipation rate of energy - instead of the principle of minimum energy - our approach is closely similar to the approach to plasma relaxation including Hall terms, as developed by Turner (1986). In the two-fluid formalism the canonical momentum ${\bf{P}}_j$ canonical vorticity ${\bf{\Omega}}_j$, for the $j$-th species are defined respectively as, \begin{equation} {\bf{P}}_j=m_j{\bf{u}}_j+\frac{q_j}{c}{\bf{A}}, \qquad {\bf{\Omega}}_j=\nabla\times{\bf{P}}_j, \quad (j= i, e). \end{equation} A gauge invariant expression for the generalized helicity is introduced by defining \begin{equation} K_j=\int_V{\bf{P}}_j\cdot{\bf{\Omega}}_j d\tau- \int_V{\bf{P}}_j^\prime\cdot{\bf{\Omega}}_j^\prime dV; \end{equation} which is a relative helicity with respect to reference field having ${\bf{P}}_j^\prime$ as the canonical momentum, and ${\bf{P}}_\alpha$ and ${\bf{P}}_\alpha^\prime$ are different inside the volume of interest and the same outside. The gauge invariance condition holds \begin{equation}\label{omega} ({\bf{\Omega}}_j-{\bf{\Omega}}_j^\prime) \cdot\hat{n} =0 \Rightarrow ({\bf{B}}-{\bf{B}}^\prime)\cdot\hat{n}=0 \qquad ({\bf{\omega}}_j-{\bf{\omega}}_j^\prime) \cdot\hat{n}=0, \quad ({\bf{\omega}}_j=\nabla\times{\bf{u}}_j), \end{equation} under the condition that there is no flow-field coupling at the surface. The above equations then represent natural boundary conditions inherent to the problem. The helicity balance equation for the generalized helicity, obtained from the balance equations for the generalized momentum and vorticity, consists of two terms, the helicity injection terms and helicity dissipation term (containing resistivity and viscosity). The global helicity can be taken as a bounded function following Montgomery et al.,(1988) and it is possible to form a variational problem with the helicity dissipation rates as constraints. Thus, \begin{eqnarray} \frac{d K_\alpha}{dt}&=&-\oint[G_\alpha-{\bf{P}}_\alpha\cdot{\bf {u}}_\alpha]{\bf{\Omega}}_\alpha^\prime\cdot\hat{n}da-\oint({\bf{P}}_\alpha \cdot{\bf{\Omega}}_\alpha){\bf{u}}_\alpha\cdot\hat{n}da \nonumber\\ &-&\oint\left(\frac{\partial{\bf{P}}_\alpha^\prime}{\partial t} \times{\bf{P}}_\alpha^\prime\right)\cdot\hat{n}da -\eta_\alpha^\prime\oint[\{\nabla\times{\bf{B}}+L_\alpha {\bf{\omega}}_\alpha)\}\times{\bf{P}}_\alpha]\cdot\hat{n}da \nonumber\\ &-&2\eta_\alpha^\prime\int[\nabla\times({\bf{B}}+L_\alpha {\bf{\omega}}_\alpha)]\cdot{\bf{\Omega}}_\alpha d\tau \end{eqnarray}with \begin{eqnarray} & &G_\alpha=\left[q_\alpha\phi+\frac{h_\alpha}{n_\alpha}-\frac{m_\alpha u_\alpha^2}{2}\right]; \qquad \eta_\alpha^\prime=\frac{q_\alpha\eta c}{4\pi} \nonumber\\ & & L_\alpha=\frac{4\pi}{q_\alpha c n_\alpha}\frac{\mu_\alpha}{\eta}\equiv~~{\rm{Prandtl~~number.}} \end{eqnarray}The minimization integral is then obtained as, \begin{eqnarray} {\cal{I}}&=&\int \left[(\nabla\times{\bf{B}})\cdot(\nabla\times{\bf{B}})+\frac{4\pi n q L_i}{c}{\bf{\omega}}_i\cdot{\bf{\omega}}_i\right]d\tau \nonumber\\ &+&\lambda_i\int[\nabla\times({\bf{B}}+L_i{\bf{\omega}}_i)]\cdot{\bf{\Omega_i}} d\tau-\lambda_e\int(\nabla\times{\bf{B}})\cdot{\bf{\Omega}}_e d\tau \end{eqnarray} \noindent where $L_i = 4\pi\mu_i/ecn_i \eta$ is the magnetic Prandtl number for ions, $\mu_i$ is the ion viscosity and $\eta$ is the resistivity. We assumed the electron mass $m_e\rightarrow 0. $ The first two terms in the above integral represent the ohmic and viscous dissipation rates while the second two integrals represent the ion and electron generalized helicity dissipation rates. $\lambda_i$ and $\lambda_e$ are the corresponding Lagrange undetermined multipliers.The Euler-Lagrange equations are written as,\begin{eqnarray} & &\nabla\times\nabla\times{\bf{B}}+\frac{(\lambda_i+\lambda_e)q}{c} \nabla\times){\bf{B}}+\frac{\lambda_i}{2}\left( \frac{q L_i}{c}+m_i\right)(\nabla\times){\bf{\omega}}_i=\nabla\psi; \label{mageq}\\ & &\nabla\times\nabla\times{\bf{\omega}}_i+\frac{2\pi n q}{m_i\lambda_i c}\nabla\times{\bf{\omega}}_i+\frac{1}{2 m_i L_i}\left( \frac{q L_i}{c}+m_i\right)(\nabla\times)^2{\bf{B}}= \nabla\chi;\label{floweq} \end{eqnarray} where $\psi$ and $\chi $ are arbitrary gauge functions, with $\nabla^2\psi=\nabla^\chi=0 $. Following Turner (1986) we can write the exact solution of the coupled equations (\ref{mageq}) and (\ref{floweq}) as a linear superposition of two CK eigenfunctions, which are the solutions of $\nabla\times{\bf{Y}}_k=\lambda_k{\bf{Y}}_k $ i.e., \begin{figure}[ht] \begin{center} \epsfig{file=singlearcflow.eps, width=10.cm, height=8.cm} \end{center} \caption{\small\label{fig:flow} Flow lines in the $x$-$z$ plane for $\gamma=1.5$ (\textit{from Bhattacharya et al., 2007}).} \end{figure} \begin{equation} {\bf{B}}={\bf{Y}}_1+\alpha{\bf{Y}}_2 \qquad {\bf{\omega}}_i={\bf{Y}}_1+\beta{\bf{Y}}_2, \end{equation} and $\alpha$ and $\beta$ are constants and quantify the non force-free part, to be obtained from some boundary conditions. \subsection{Application to solar arcade problem} One of the important features of this formalism is the presence of a nontrivial flow and the coupling between the magnetic field and the flow. The solutions of the corresponding Euler-Lagrange equation highlight the role of nonzero plasma flow in securing a steady MDR relaxed state for an open and externally driven system. This model has been very successful in describing the arcade structures observed in Solar corona [Bhattacharya et al., 2007]. To model solar arcade-type magnetic fields, we make some simplified assumptions and consider a 2-D magnetic field in the $x$-$z$ plane with the $x$ direction lying on the photosphere surface and $z$ is the vertical direction. With appropriate boundary conditions and after some lengthy algebra, the solutions for the components of the magnetic fields are obtained as, \begin{figure}[ht] \begin{center} \epsfig{file=solartwo.eps, width=10.cm, height=8.cm} \end{center} \caption{\small\label{fig:arcade}Magnetic field lines in the $x$-$z$ plane corresponding to (i) single arcade structure for $\gamma=1.5$ in left panel and (ii) triple arcade structure for $\gamma=3.36$ in right panel (\textit{from Bhattacharya et al., 2007}).} \end{figure} \begin{eqnarray} & &B_x=\sqrt{\gamma^2-1}\left[2\cos\gamma x-\frac{2\cos\gamma}{\cos\sqrt{\gamma^2-1}}\cos(x\sqrt{\gamma^2-1})\right] e^{-z\sqrt{\gamma^2-1}};\nonumber\\ & &B_y=0;\\ & &B_z=-\left[2\gamma\sin\gamma x-\frac{2\sqrt{\gamma^2-1}\cos\gamma}{\sin\sqrt{\gamma^2-1}}\sin(x\sqrt{\gamma^2-1})\right] e^{-z\sqrt{\gamma^2-1}}\nonumber; \end{eqnarray} with $\gamma = \sqrt{(k^2+\lambda^2)/\lambda^2}$ ($\lambda$ is the eigenvalue and $k$ is the wave number associated with the solution). The same procedures can be adopted for the flow pattern. In figure \ref{fig:arcade} the magnetic field lines in the$x$-$z$ plane is plotted for two different values of the parameter $\gamma$. The arcade structures are obtained by solving the field line equations $\frac{dz}{dx}=\frac{B_z}{B_x}$. It is interesting to note that the arcade structure changes with the change of the single parameter $\gamma$. Figure \ref{fig:flow} plots the flow lines for $\gamma = 1.5$. In cylindrical geometry the solutions of eqn. (\ref{mageq}) can be written in terms of a superposition of Bessel functions. Such solutions yield 3-D Flux ropes, which are plotted in the Figure ({\ref{fig:fluxrope}). \begin{figure}[ht] \begin{center} \epsfig{file=mdr_fr.eps, width=10.cm, height=8.cm} \end{center} \caption{\small\label{fig:fluxrope} Plot of 3-D Fluxrope obtained from the solution eqn.(\ref{mageq}).} \end{figure} \subsection{Non-force Free Coronal Magnetic Field Extrapolation Based on MDR:} An outstanding problem in solar physics is to derive the coronal magnetic field structure from measured photospheric and/or chromospheric magnetograms. A new approach to deriving three-dimensional non-force free coronal magnetic field configurations from vector magnetograms, based on the MDR principle has been recently developed [Hu, Dasgupta, \& Choudhary (2007)]. In contrast to the principle of minimum energy, which yields a linear force-free magnetic field, the MDR gives a more general non-force free magnetic field with flow. The full MDR-based approach requires two layers of vector magnetic field measurements. Its exact solution can be expressed as the superposition of two linear force-free fields with distinct $\lambda$ parameters, and one potential field. The final solution is thus decomposed into three linear force-free extrapolations, with bottom boundary conditions derived from the measured vector magnetograms, at both photospheric and chromospheric levels. The semi-analytic test case shown in Figure~\ref{FIGHu} illustrates the feasibility and the high performance of this method. This extrapolation is easy to implement and much faster than most other nonlinear force-free methods [Hu \& Dasgupta 2007]. It also takes full advantage of multiple layer solar magnetic field measurements, thus gives a more realistic result. \begin{figure}[ht] \begin{center} \epsfig{file=extrapolation.eps, width=13.cm, height=8.cm} \end{center} \caption{3D view of magnetic field lines in a box simulating the typical extrapolation domain. (a) exact solution; (b) numerical extrapolation result. Bottom image at height 0 shows the normal field component distribution with gray scale indicating strongly negative (black) to positive (white) field. The great ressemblance between the exact and the numerical solutions justifies the feasibility and high performance of this method (Hu, Dasgupta, \& Choudhary 2007).} \label{FIGHu} \end{figure} \section{Conclusion} We have demonstrated that a relaxation model based on the minimum dissipation of energy can successfully explain some of the salient observations both in laboratory and space plasma. An MDR based model model in its simpler form is capable of yielding basic characteristics of most of the laboratory plasma confinement devices, and a generalization of this model for two fluid with external drive can couple magnetic field and flow and predict solar arcade structures. The above findings definitely points out that the MDR relaxed states applied to astrophysical plasmas is a worthy case for further investigations. In future we plan to apply this model to investigate magnetic field structure in the sun with an aim to understanding coronal mass ejection. \section{Acknowledgement} We gratefully acknowledge partial supports from NASA LWS grant NNX07A073G, and NASA grants NNG04GF83G, NNG05GH38G, NNG05GM62G, a Cluster University of Delaware subcontract BART372159/SG, and NSF grants ATM0317509, and ATM0428880. \begin{thereferences}{9} \bibitem{Amari2000} Amari, T., and Luciani, J. F., Phys. Rev. Letts., {\bf 84}, 1196, (2000) \bibitem{antoni1983} Antoni, V., S. Martini, S. Ortolini and R. Paccagnella, in \textit{Workshop on Mirror-based and Field-reversed approaches to Magnetic Fusion}, Int. School of Plasma Physics, Varenna, Italy, p. 107, (1983) \bibitem{bhatta2000} Bhattacharya, R., M.S. Janaki and B. Dasgupta, Phys. Plasmas,{\bf 7}, 4801, (2000) \bibitem{bhatta2001} Bhattacharya, R., M.S. Janaki and B. Dasgupta, Phys. Lett. A , {\bf 291A}, 291, (2001) \bibitem{bhatta2003} Bhattacharyya, R., M. S. Janaki and B. Dasgupta, Plasma Phys. Contr. Fusion, {\bf 45}, 63 (2003). \bibitem{bhatta2004} Bhattacharya, R., and M. S. Janaki, Phys. Plasmas, {\bf 11}, 5615 (2004) \bibitem{bhatta2007} Bhattacharya, R., M. S. Janaki, B. Dasgupta, G. P. Zank, Solar Phys. {\bf 240}, 63, (2007) \bibitem{bhiskamp} Biskamp, D. 2003, Magnetohydrodynamic Turbulence, {\it Cambridge University Press}. \bibitem{bouzat} Bouzat, S. and R. Farengo, J. Plasma Phys., {\bf 72}, 443, (2006) \bibitem{chandra1957} Chandrasekhar, S. \& P. C. Kendall, Astrophys. J., {\bf 126}, 457 (1957). \bibitem{chandra1958} Chandrasekhar, S. \& L. Woltjer, Proc. Natl. Acad. Sci. USA, {\bf 44}, 285 (1958). \bibitem{dasgupta1995} Dasgupta, B., T. Sato, T Hayashi, K. Watanabe and T-H Watanabe, Trans. Fusion Tecnol., {\bf 27}, 374, (1995) \bibitem{dasgupta1998} Dasgupta, B., P. Dasgupta, M. S. Janaki, T. Watanabe and T. Sato, Phys. Rev. Lett., {\bf 81}, 3144, (1998) \bibitem{dasgupta2002} Dasgupta, B., M. S. Janaki, R. Bhattacharya, P. Dasgupta, T. Watanabe, and T. Sato, Phys. Rev. E , {\bf E 65}, 046405, (2002) \bibitem{farengo1994} Farengo, R. and J. R Sobehart, Plasma Phys. Contr. Fus., {\bf 36}, 465 (1994) \bibitem{farengo1995} Farengo, R. and J. R. Sobehart. Phys. Rev. E, {\bf 52}, .2102 (1995) \bibitem{farengo2002} Farengo, R. and K. I. Caputi, Plasma Phys. Contr. Fus., {\bf 44}, 1707 (2002) \bibitem{guo2005} Guo, H. Y.., A. L. Hoffman, L. C. Steinhauer, and K. E. Miller, Phys. Rev. Letts, {\bf 95}. 175001, (2005) \bibitem{guo2005} Guo, H. Y., A. L. Hoffman, L. C. Steinhauer, K. E. Miller, and R. D. Milroy, Phys. Rev. Letts, {\bf 97}. 175001, (2006) \bibitem{hu2007} Hu, Q., Dasgupta, B., \& Choudhary, D.P. 2007, AIP CP, {\bf 932}, 376, (2007) \bibitem{hu2007b} Hu, Q., and Dasgupta, B. , \textit{Sol. Phys.}, {\bf 247}, 87, (2008) \bibitem{hart} Hart, G. W., C. Chin-Fatt, A. W. deSilva, G. C. Goldenbaum, R. Hess and R. S. Shaw, Phys. Rev. Lett., {\bf 51}, 1558, (1983) \bibitem{lahiri} Lahiri, S., A. N. S. Iyenger, S. Mukhopadhyay and R. Pal, Nucl. Fusion, {\bf 36}, 254, (1996) \bibitem{mont} Montgomery D. and L. Phillips, Phys. Rev. A, {\bf 38}, 2953 (1988) \bibitem{ono} Ono, Y., A. Morita, and M. Katsurai and M Yamada, Phys. Fluids, {\bf B5}, 3691, (1993) \bibitem{orto} Ortolani, S. and D. D. Schnack, Magnetohydrodynamics of plasma relaxation, \textit{World Scientific,} (1993) \bibitem{prigo} Prigogine, I., \textit{Etude Thermodynamique des Ph\'{e}nom\`{e}nes Irreversibles, Editions Desoer, Li\`{e}ge, (1946) } \bibitem{rayl} Rayleigh, Proc. Math Soc. London, {\bf 363}, 357 (1873) \bibitem{rosen} Rosenbluth, M. N. and M. N. Bussac, Nucl. Fusion, {\bf 19}, 489, (1979) \bibitem{sato} Sato, T. and Complexity Simulation Group: S. Bazdenkov, B.Dasgupta, S. Fujiwara, A. Kageyama, S. Kida, T. Hayashi, R. Horiuchi, H. Muira, H. Takamaru, Y. Todo, K. Watanabe and T.-H. Watanabe, Phys. Plasmas. {\bf 3}, 2135 (1996) \bibitem{dastgeer} Shaikh, D., B. Dasgupta, G. P., Zank, and Q. Hu, \textit{Phys. Plasmas}, {\bf 15}, 012306, (2008) \bibitem{taylor} Taylor, J. B., Phys. Rev. Lett. {\bf 33}, 139 (1974) \bibitem{turner} Turner, L., IEEE Trans. Plasma Sc. {\bf 14} , 849, (1986) \bibitem{tus} Tuszewski, M., Nuc. Fusion, {\bf 28}, 2033, (1988) \bibitem{} Watanabe, T.-H., T. Sato, and T. Hayashi, Phys. Plasmas {\bf 4}, (1997) \bibitem{yamada} Yamada, H., K. Kusano, Y. Kamada, H. Utsumi, Z. Yoshida and N. Inoue, Nucl. Fusion, {\bf 27}, 1169, (1987) \bibitem{yoshida} Yoshida, Z., S. Ishida, K. Hattori, Y. Murakami and J. Morikawa, J. Phys. Soc. Jpn., {\bf 55}, 554, (1986) \bibitem{zhu} Zhu, S., R. Horiuchi, and T. Sato, Phys. Rev. E, {\bf 51}, 6047 (1995). \end{thereferences} \label{lastpage} \end{document}

Background {#Sec1} ========== Gastric cancer (GC) currently ranks fourth in cancer incidence worldwide. Gastric adenocarcinoma is the most common histological type of all malignancies originating in the stomach and known as a heterogeneous disease with diverse phenotypes and genotypes. Although in the last few decades its prevalence has declined to reach a plateau, GC still is the third leading cause of cancer deaths worldwide \[[@CR1]\]. Surgery is the most helpful and reliable procedure to eradicate the disease, especially in the case of primary tumors. Nevertheless, the results for advanced GC remain unfavorable even when extensive surgery had been performed \[[@CR2]\]. Studies from several groups over the past decade have now produced a near-comprehensive catalogue of genetic alterations in GC \[[@CR3]\]. Certain genetic and epigenetic molecular abnormalities such as tumor suppressor gene mutations, gene changes inducing loss of normal cellular adhesion, over-expression or mutations of cell membrane receptors with tyrosine kinase activity or activation of angiogenic factors have been reported to be involved in the pathogenesis and progression of GS \[[@CR4], [@CR5]\]. RNA editing is an important form of post-transcriptional processing, which can alter RNA molecules by deamination of adenosine to form inosine. This reaction is catalyzed by a family of enzymes named adenosine deaminase acting on RNA (ADARs) \[[@CR6]\]. The human genome contains three ADAR genes including ADAR, ADARB1 and ADARB2. The first two are ubiquitously expressed and catalytically active, but, ADARB2 exclusively expressed in the brain and has not shown any catalytic activity so far \[[@CR7]\]. Although both ADAR and ADARB1 have been shown to play roles in tumorigenesis, most of cancer related editing events regulated by ADAR, primarily due to more abundant expression of ADAR and its unique features \[[@CR8]\]. It is estimated that human transcriptome undergoes over 100 million editing events, which may result in codon changes with the consequence of altered protein function, alternative splicing or affect targeting and maturation of microRNAs \[[@CR9]\]. ADAR with the ability to change DNA-encoded genetic information after transcription, could be an important contributor in cancer development \[[@CR10]\]. Hence, the inconsistency in ADAR expression or activity may be a causative factor in a variety of diseases including cancer \[[@CR11]\]. Amplification and overexpression of the ADAR gene occurs in over 8% of breast, lung, and hepatic cancers \[[@CR12]\]. Acute myeloid leukemia was the first cancer that altered mRNA editing was shown to be connected to the disease \[[@CR8]\]. Thereafter, ongoing studies have been elucidate role of ADAR in cancer development and progression. It has been shown that increased ADAR expression correlates with tumor recurrence in lung adenocarcinoma \[[@CR13]\]. In addition, ADAR overexpression is connected with increased malignancy of breast, lung and liver cancer, and silencing of ADAR in breast cancer cells results in increased apoptosis. The latter suggests that ADAR has anti-apoptotic function that promotes cancer progression \[[@CR14]\]. Although significant progress has been made in the management and treatment of GC patients, however, further studies should be conducted to promises discoveries of new biomarkers and more innovative and effective treatments for patients with GC. The main end point of our study is to evaluate expression and copy number variation of ADAR (ADAR1) gene in advanced GC and clarify its correlation with overall survival and histopathological characteristics. Methods {#Sec2} ======= Patients and specimen collection {#Sec3} -------------------------------- Fresh frozen tumor and normal adjacent tissue of 42 patients with stage III and IV gastric adenocarcinoma who underwent surgery at the Cancer Institute of Iran were examined in this study. We included only GC patients that did not receive neoadjuvant therapy. The biological materials were provided by the Iran National Tumor Bank, founded by the Cancer Institute of Tehran University of Medical Sciences, for cancer research. Staging were based on the American Joint Committee on Cancer (AJCC) cancer staging manual \[[@CR15]\]. All samples were transferred in liquid nitrogen from Tumor bank and stored at − 80 °C for further investigations. Complete clinicopathologic data including patient history, histology, clinical, and paraclinical data and follow-up information were gathered from the medical records of every patient. All participants signed written informed consent. RNA/DNA extraction {#Sec4} ------------------ RNA and DNA were purified from normal and tumoral samples using the All-in-one DNA/RNA/Protein Mini-Preps Kit (Biobasic, Canada) following manufacturer's protocol. The RNA quality was verified by electrophoresis on 1.0% agarose gel. Also, the quantity of isolated RNA and DNA was evaluated by NanoPhotometer (NP80, Germany). cDNA synthesis and real-time PCR {#Sec5} -------------------------------- RNA samples were reverse transcribed into complementary deoxyribonucleic acid (cDNA) using Easy™ cDNA Synthesis Kit (Parstous biotechnology, Iran). The cDNA was synthesized from 1 μg of total RNA with random hexamer and oligo (dT) as reaction primers in a final volume of 20 μl following manufacturer's protocol. Obtained cDNA was further amplified by real-time quantitative PCR using RealQ Plus Master Mix Green (Ampliqon, Denmark) based on the kit protocol. The primers used for performing real-time PCR were as follows: for ADAR1 F: 5′AGCTTGGGAACAGGGAATCG3′ and R: 5′CTTCGCAGTCTGGGAGTTGT3′; for GAPDH F: 5′ACACCCACTCCTCCACCTTTG3′ and R: 5′TCCACCACCCTGTTGCTGTAG3′. Real-time PCR mixture contained 10 μl of SYBR green master mix, 1 μl of forward and reverse primers and 2 μl of cDNA. Real-time PCR program for the reaction was based on a holding step at 95 °C for 15 min, followed by 40 cycles of denaturing at 95 °C for 20s, annealing and extending at 60 °C for 40s. Real-time PCR was performed at least three times in the StepOne™ Real-Time PCR System (Applied Biosystems, USA) for each sample and fold change of gene expression was calculated using 2^-∆∆Ct^ method. Quantitative multiplex fluorescent-PCR (QMF-PCR) {#Sec6} ------------------------------------------------ The ADAR gene copy number was quantified by QMF-PCR on a BIOER XP Cycler (Bioer, China). The QMF-PCR technique consists of the quantification of fluorescently labeled test and control amplicons, obtained by a single multiplex PCR amplification. Primers were designed for 5′UTR, exonic and 3′UTR of the ADAR gene. Three other genes including BOD1L, AGBL2 and POR were co-amplified as controls. A tail of universal primer was added to forward primers, except for POR gene which the tail was added to reverse primer. The universal primer was labeled with the fluorescent phosphoramidite 6-FAM dye and all the primers were HPLC purified. Multiplex PCR employed the Multiplex TEMPase Master Mix (Ampliqon, Denmark) following the manufacturers recommendations. Primers stock solution was prepared in a 0.5:1:0.5 ratio of forward primer, reverse primer and fluorescently tagged universal primer, respectively. The reaction started with an initial denaturation of 15 min at 95 °C, followed by 30 cycles at 95 °C for 45 s, 59.8 °C for 45 s and 72 °C for 45 s, and a final extension of 15 min at 72 °C. Primer sequences used for QMF-PCR are shown in Table [1](#Tab1){ref-type="table"}. Table 1List of primer sequences used for QMF-PCR analysis in this study. Universal tail was shown in bold lettersGenePrimer SequenceADAR-3′UTRF**GCCTCCCTCGCGCCA**TAGACTTGGTGCCGTGGTGARGTCGCAGAGCCTCAGTAGTCADAR-ExonicF**GCCTCCCTCGCGCCA**TCGACTTGTAACCGGCCTGARGTTGTAAACGAACCCAGACGGADAR-5′UTRF**GCCTCCCTCGCGCCA**GGGGACCACTTACAAGCTGATGRGTCTGGTCGCAGATTGGTGAAGBL2F**GCCTCCCTCGCGCCA**GCGAGCTGCATTCCATGCGRTCCCAGCTTTGGAAACGCACBOD1LF**GCCTCCCTCGCGCCA**AATGCCTCCGCTTTCAGGCRATCACTTGGCAACTCACACATGGPORFAGCCACTTTGTGCCAGATCAR**GCCTCCCTCGCGCCA**TCCAGCACGTGTTCACATCAUniversalUFAM-GCCTCCCTCGCGCCA One μl of the PCR products was added to 10 μl of formamide and 0.5 μl of GeneScan-500 LIZ size standard (Applied Biosystems, USA). Then, the PCR product was denatured at 95 °C for 3 min and placed on ice to prevent re-annealing until further analysis. Fragment analyses were performed using a POP7 gel on the ABI 3500 Genetic Analyzer (Applied Biosystems, USA). The results were processed with GeneMarker® software V2.7 (SoftGenetics, USA) to obtain electropherograms for each sample. Each product was identified by its size, and the area under peak were imported into an Excel spreadsheet and the copy number of each amplicon was determined by calculating a dosage quotient (DQ) for each fragment \[[@CR16], [@CR17]\]. Cell lines ADAR gene expression and CNV {#Sec7} --------------------------------------- Biological databases are crucial for exploring the molecular mechanisms of cancer, therefore, basal expression of ADAR mRNA and ADAR copy number in 37 GC cell lines were obtained from cancer cell line Encyclopedia (CCLE) \[[@CR18]\]. RNA expression values were reported in reads per kilobase of transcript per million mapped reads (RPKM). Finally, the association of the RNA expression values and gene copy numbers for each cell line was examined. Survival analyses {#Sec8} ----------------- To investigate the relationship between ADAR expression and prognosis of gastric cancer, survival data associated with GC patients were obtained from Kaplan-Meier Plotter \[[@CR19]\]. Overall survival (OS) data for 876 patient (312 low expression and 564 high expression) were analyzed to create Kaplan-Meier plots. These patients were related to GSE14210, GSE15459, GSE22377, GSE29272, GSE51105 and GSE62254 datasets. Statistical analyses {#Sec9} -------------------- All statistical analyses were performed using SPSS 18.0 (SPSS Inc., USA) and GraphPad Prism 8 (GraphPad Software, USA) software. Paired T-test was applied in comparisons of ADAR mRNA levels between GC tissue samples and their paired non-tumor counterparts and unpaired T-test was used for comparison between stage III and IV. The Chi-square test was performed to evaluate correlations between ADAR expression or amplification and clinicopathological parameters. Pearson's correlation coefficient was used to determine the relationship between the expression and CNV of ADAR in GC cell lines. Differences in the OS between the high and low expression groups were estimated and compared by the Kaplan--Meier method with a Mantel--Cox test. Differences were considered significant when the *P*-value was \< 0.05. Results {#Sec10} ======= ADAR gene expression in gastric cancer tissue {#Sec11} --------------------------------------------- Among the 42 tumor specimens tested, average expression of ADAR mRNA was significantly upregulated in the tumor tissues when compared to the adjacent normal tissues of the GS patients (*p* \< 0.01, Fig. [1](#Fig1){ref-type="fig"}). In tumor samples ADAR was expressed 2.8-fold higher than normal tissues. That is to say, the level of ADAR mRNA expression was increased in 32 (76.2.0%) tumors while it was decreased in 6 (14.3%) cases and it has remained unchanged in 4 (9.5%) tumors (Fig. [1b](#Fig1){ref-type="fig"}). The average expression of ADAR mRNA was lower in the stage III in comparison to stage IV (*p* = 0.0225, Fig. [1](#Fig1){ref-type="fig"}c). Fig. 1ADAR gene expression in GC patients (**a**) matched normal and tumor tissues, (**b**) percent of ADAR dysregulation, (**c)** stage IIIC compared with Stage IV ADAR copy number variation {#Sec12} -------------------------- According to DQ of the three segments of ADAR gene, we divided ADAR CNV into deleted, amplified and diploid categories (Fig. [2](#Fig2){ref-type="fig"}). Our results showed 20 (40%) tumors with diploid copy number, 5 (12%) tumors with deleted and 17 (40%) tumors with amplified ADAR gene. Patients with amplification showed significant increase in ADAR gene expression compared with patients with diploid and deleted ADAR copy number (Fig. [3](#Fig3){ref-type="fig"}a). Analysis of ADAR copy number in GC cell line were consistent with tumor specimens. We found a positive correlation (r = 0.61, *p* \< 0.0001) between ADAR copy number and expression (Fig. [3](#Fig3){ref-type="fig"}b). Fig. 2Electropherogram and dosage quotient of a sample with (**a**) and (**d**) diploid copy number, (**b**) and (**e**) amplification, (**c**) and (**f**) deletionFig. 3Correlation of CNV and gene expression in GC patients (**a**) patients and (**b**) GC cell lines Correlations between ADAR expression and CNV with clinicopathological features {#Sec13} ------------------------------------------------------------------------------ Here, we analyzed the association of the ADAR gene CNV and its expression with the clinicopathological features of patients. Forty two tissue samples based on ADAR gene expression were classified into 2 groups: high expression (FC \> 4.56, *n* = 17) and low expression (FC ≤4.56, *n* = 25). This study consisted of 25 patients aged ≥66 years and 17 patients aged \< 66 years (*P* = 0.573). ADAR high expression was significantly associated with metastasis (*p* = 0.008), stage (*p* = 0.008), histology (*p* = 0.015) and size of tumor (*p* = 0.004). Moreover, amplification was significantly associated with metastasis (*p* \< 0.018), stage (p \< 0.018) and size of tumor (*p* = 0.008) in GC patients and tended to be associated with histology (*p* = 0.143). Furthermore, no significant association was detected between ADAR gene CNV and its expression and other clinicopathological parameters, including age, gender, regional lymph node metastases, site of primary tumor and Lymphovascular invasion (Table [2](#Tab2){ref-type="table"}). Table 2Correlation between clinicopathological variables and ADAR expression and CNV in Gastric cancer patientsvariableADAR expression***P*** valueADAR amplification***P*** valueHigh(17)Low(25)Yes(18)No(24)**Age (year)**  ≥ 66^a^11140.57311140.856  \< 66611710**Gender** Male11150.75812140.582 Female610610**Pathological N category** N0110.074110.086 N11405 N2515812 N310596**M classification** M06190.008^\*^7180.018^\*^ M1116116**Site of primary tumor** Antrum460.937460.315 Body813912 Cardia4453 Fundus1203**Histology** Well differentiated050.015^\*^140.143 Moderately differentiated311410 Poorly differentiated10899 Undifferentiated4141**Size of primary tumor**  \< 6.17210.004^\*^8200.008^\*^  ≥ 6.1104104**Tumor stage** Stage 41160.008^\*^1160.018^\*^ Stage 3619718**Lymphovascular invasion** Present14160.19615150.139 Absent3939\* indicates *p*-value \< 0.05. ^a^ the median age at surgery was 66 years Prognostic value of ADAR in gastric cancer {#Sec14} ------------------------------------------ The GC database used in this study, includes 876 samples from six independent datasets. Kaplan--Meier analysis of this dataset indicated that increased ADAR expression was clearly correlated with poorer survival outcomes (Fig. [4](#Fig4){ref-type="fig"}). Patients in the high expression group had a significantly shorter OS than patients in the low expression group (log-rank test, *P* \< 0.0001). Median survival of high and low expression groups were 23.2 and 70.2 months, respectively. Furthermore, median survival of patients with different characteristics was obtained. Patients with high expression of ADAR have significantly lower median survival time in most subgroups (Table [3](#Tab3){ref-type="table"}). Fig. 4Kaplan-Meier survival curves according to high and low expression of ADARTable 3Characteristics and median survival of patients in high and low expression groupsCharacteristicsMedian survival (months)Log-rank PHigh expressionLow expression**Gender** Male (*n* = 544)20.332.11.6e-5 Female (*n* = 236)15.293.24.3e-7**Tumor stage** Stage 1 (*n* = 67)NA^a^NA-- Stage 2 (*n* = 140)2978.60.103 Stage 3 (*n* = 305)22.452.62e-4 Stage 4 (*n* = 148)17.515.930.148**Histology** Well differentiated (*n* = 32)14.545.10.053 Moderately differentiated (*n* = 67)30.456.90.428 Poorly differentiated (*n* = 165)23.6400.105**Lauren classification** Intestinal (*n* = 320)25.999.43.1e-5 Diffuse (*n* = 241)27.8400.038 Mixed (*n* = 32)57.220.90.041**Treatment** Surgery (*n* = 380)45.885.60.217 5-Fluorouracil (*n* = 152)9.221.33.3e-6^a^ NA means no death in follow up threshold Discussion {#Sec15} ========== Application of molecular biomarkers in clinical setting might improve diagnostic and management strategy of GC patients. To date, some molecular markers, including human epidermal growth factor receptor-2, vascular endothelial growth factor receptor 2, urothelial cancer associated 1, excision repair cross-complementation group 1, B-cell lymphoma-2, and Ki-67 have been proposed to have diagnostic and prognostic value in the management of GC patients \[[@CR20], [@CR21]\]. However, the majority of these markers were not able to accurately reflect prognostic value and therapeutic efficiency in advanced GC. Identification of molecular biomarkers might improve patient therapeutic strategy of GC, hence, we evaluated the CNV and expression of ADAR to reveal its alteration and clinical significance in advanced GC. We analyzed mRNA expression level of ADAR in GC tumors and adjacent normal tissues. This revealed that ADAR is remarkably overexpressed in GC tumors. In addition, we compared ADAR expression level in GC stage III and IV. Interestingly, the average expression of ADAR mRNA in stage IV was higher than stage III. Besides, overexpression of ADAR was significantly associated with metastasis, stage, histology and size of tumor, which may indicate that ADAR has a pivotal role in stage III to IV progression of GC. According to ADAR function, overexpression of ADAR could leads to hyper-editing \[[@CR22]\]. Unbalanced editing process has adverse results, and abnormal RNA editing within the transcriptome detected in many kinds of tumors. RNA editing could leads to recoding of a transcript and contribute to carcinogenesis through reducing the activity of tumor suppressors such as bladder cancer associated protein in hepatocellular carcinoma \[[@CR23]\] or enhancing the activity of pro-survival genes such as antizyme inhibitor 1 in cervical cancer \[[@CR24]\]. To determine whether ADAR copy number has variation in tumors, QMF-PCR was conducted. We found that ADAR significantly amplifies in advanced GC. Moreover, our results showed a positive correlation between ADAR gene copy number and its expression at the mRNA level. Correlation between ADAR copy number and ADAR expression has also been reported in breast carcinoma, ovarian adenocarcinoma, lung adenocarcinoma and liver carcinoma \[[@CR24]\]. ADAR frequently amplifies in human cancers consistent with the elevated expression and editing levels of its substrates \[[@CR25]\]. Notably, knockdown of ADAR in lung adenocarcinoma cells with amplified ADAR leads to decreased migration and invasion \[[@CR13]\]. Hence, pharmacological targeting of ADAR promise a potential therapeutic application for tumors with ADAR amplification. Also, we carried out a correlation test between ADAR expression and copy number change in 37 GC cell lines and statistical analysis revealed that ADAR expression was consistently associated with ADAR copy number. The association of gene copy number with gene expression has also been found in other cancer cell lines. Hyman et al. performed a high-resolution analysis in breast cancer cell lines and showed that 44% of the highly amplified genes showing overexpression and 10.5% of the highly overexpressed genes being amplified \[[@CR26]\]. These findings further strengthen our hypothesis that ADAR amplification increases its expression. As previously mentioned, ADAR amplification and overexpression in different cancers have been reported \[[@CR24], [@CR25]\]. Yet, the effects of these genomic and transcriptomic changes on clinicopathological features of GC patients have remained largely unknown. We evaluated the association of the ADAR gene CNV and its expression with the clinicopathological features of patients. The mRNA expression levels of ADAR were positively associated with metastasis, stage, histology and size of tumor. Indeed, ADAR amplification was significantly associated with metastasis, stage and size of tumor. Findings of the current study support the previous study reporting the oncogenic potential of ADAR in GC \[[@CR27]\]. The association between the tumor aggressiveness and the overexpression of ADAR has also been demonstrated in hepatocellular carcinoma and colorectal cancer \[[@CR28], [@CR29]\]. Based on available evidences, the molecular mechanisms of how ADAR promotes GC cell growth and migration might be explained by its role in the regulation of mTOR signaling pathway. Overexpression of ADAR in GC cells increases proliferation and migration but these effects significantly debilitate with rapamycin, the mTOR kinase inhibitor, demonstrating that rapamycin could inhibit the effects of ADAR overexpression on GC cell growth and migration. Together these results suggested that mTOR signaling is important for ADAR mediated GC invasion and metastasis \[[@CR27]\]. Currently, prognosis of GC patients is primarily determined using depth of wall invasion, lymph node or distant metastasis status and age; however, these prognostic factors are limited in clinical practice, and may not result in an accurate prognosis \[[@CR30]\]. To further confirm the prognostic value of ADAR overexpression in GC patients, Kaplan--Meier analysis and log-rank test were performed. The results showed that the overall survival rate of patients with lower expression of ADAR was better than that of patients with high expression, suggesting its prognostic role. Chen et al. found a correlation between high expression of ADAR and a poor prognosis of cervical cancer \[[@CR24]\]. Again, Chan et al. showed a significant correlation between ADAR upregulation and GC patient shorter survival \[[@CR31]\]. Conclusions {#Sec16} =========== The current study demonstrates that ADAR mRNA is overexpressed in GC through DNA copy number amplification. ADAR overexpression and amplification correlate with the main negative clinicopathological factors such as metastasis, tumor size and stage in GC patients. Furthermore, increased ADAR expression was clearly correlated with poorer survival outcomes. Therefore, ADAR overexpression is not only a biomarker of tumor progression but also contributes to tumor progression. We propose ADAR as useful prognostic markers and therapeutic targets for GS. Doubtless, further investigations are necessary to confirm these primary results. GC : Gastric cancer ADAR : Adenosine deaminase acting on RNA cDNA : Complementary deoxyribonucleic acid QMF-PCR : Quantitative multiplex fluorescent-PCR CNV : Copy number variation OS : Overall survival DQ : Dosage quotient **Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Not applicable. The study concept and design involved SS, MRB and JB. Access to biological material provided by HM. SS and JB were responsible for the recruitment and data collection. Data analysis was completed by SS and JB. JB drafted the original manuscript. The article was revised by SS, MRB and HM. All authors read and approved the final version. This work was supported by the Tarbiat Modares University and Iran National Science Foundation (grant number: 97014362). The funders had no role in the study design, data collection, and data analysis, interpretation of data and writing of the manuscript. The datasets used and/or analyzed during the current study are available from the corresponding authors upon reasonable request. This study was approved by Ethics Committee of Tarbiat Modares University with IR.MODARES.RES.1397.205 Code of ethics. All patients provided written informed consent, and the study was conducted in accordance with the Declaration of Helsinki. Not applicable. The authors declare no competing interests.

\section{\@startsection{section}{1}{\z@}{-3.5ex plus -1ex minus -.2ex}{2.3ex plus .2ex}{\large\bfseries}} \def\subsection{\@startsection{subsection}{2}{\z@}{-3.25ex plus -1ex minus -.2ex}{1.5ex plus .2ex}{\normalsize\bfseries}} \makeatother \begin{document} \maketitle \begin{abstract} The ground-state entanglement of a single particle of the N-harmonium system (i.e., a completely-integrable model of $N$ particles where both the confinement and the two-particle interaction are harmonic) is shown to be analytically determined in terms of $N$ and the relative interaction strength. For bosons, we compute the von Neumann entropy of the one-body reduced density matrix by using the corresponding natural occupation numbers. There exists a critical number $N_c$ of particles so that below it, for positive values of the coupling constant, the entanglement grows when the number of particles is increasing; the opposite occurs for $N > N_c$. For fermions, we compute the one-body reduced density matrix for the closed-shell spinned case. In the strong coupling regime, the linear entropy of the system decreases when $N$ is growing. For fixed $N$, the entanglement is found (a) to decrease (increase) for negatively (positively) increasing values of the coupling constant, and (b) to grow when the energy is increasing. Moreover, the spatial and spin contributions to the total entanglement are found to be of comparable size. \end{abstract} PACS numbers: 31.15.-p, 03.67.-a, 05.30.Fk \newpage \section{Introduction} \label{sec:introibo} The most precise determination of the properties of finite many-electron systems is usually done by means of a full-configuration-interaction (FCI) method, where the solution of the corresponding Schr\"odinger equation in a given one-electron basis is expressed in terms of a linear combination of all possible Slater determinants. Its application is naturally reduced to a bunch of small systems because of the enormous number of the involved determinants \cite{Szabo, Helgaker}. Let us highlight that for all FCI approaches the correlation effects, which remain solely in the wave function, are not described by any correlation operator. Moreover, these effects are usually numerically computed as a difference of two variational energy bounds. Thus, up to now the electron correlation is widely and implicitly believed to be a purely methodical effect coming from the inadequate use of a trial wave function of multiconfiguration Hartree-Fock type; so, lacking of physical reality. The application of quantum information ideas and techniques in electronic structure theory has recently allowed to conclude that the electron correlation is closely related to entanglement of electrons. Indeed, it has been proved that while the single Slater determinant in the monoconfigurational Hartree-Fock approximation is a disentangled state, the wavefunction of the multiconfiguration Hartree-Fock approximations (such as, e.g. FCI) accounts for entanglement effects. Therefore, entanglement plays an essential role not only in quantum communication between parties separated by macroscopic distances (see e.g., \cite{NIELSEN, HOR}), but also it is essential to characterize quantum correlations at short distances. The latter problem, where one should necessarily consider the indistinguishable character of the involved particles, has received relatively less attention until a short time ago \cite{CIraciamici, HUAN, WAN, Marzo, Marzo1,TMB10}. This is a serious lack because of its relevance for quantum information processing in various physical systems (see e.g., \cite{Amico, CIraciamici}), to gain deeper insight into non-classical correlations of atomic and molecular systems as well as to fully understand the course of their dissociation processes and chemical reactions \cite{TMB10, Amico, ESQ0}. The main difficulty, however, stems from the fact that the Schr\"odinger equation of most quantum many-body systems cannot be solved analytically. Even numerically, the determination of the wavefunction is, in general, a serious problem. In the last three years an intense effort has been made to determine the entanglement of some real atomic and molecular species such as helium-like atoms \cite{MANZA, Dehesa, Benenti, HOFER, LIN}, of a few processes of diatomic molecules \cite{ESQ1} and elementary chemical reactions \cite{ESQ2}. These works basically focus on the entanglement of bipartite systems, mainly because the characterization of this phenomenon for systems of many indistinguishable constituents is much less known, even at the level of the very notion of entanglement measure \cite{magyares}. Thus, the quantification of entanglement of bound states for model systems enabling analytic solutions of the associated Schrödinger equation is being a promising way to investigate correlation phenomena. Indeed, entanglement between the constituents of any bound system is most conveniently analyzed in such models, enabling to relate it to the bosonic or fermionic character. Up to now, however, only entanglement of some models of two bound electrons have been determined. We refer to the 2-harmonium (or Moshinsky) \cite{HEI, Moshinsky1, NagyP09, YAN, Laetitia}, Crandall and Hooke\cite{MANZA} atoms. In all these models the electron confinement is harmonic, and the electron-electron interaction is of harmonic (2-harmonium), $r_{12}^{-1}$ (Crandall), and Coulombic (Hooke) type. All of them show that when the spin degree of freedom and the indistinguishability of electrons are taken into account, new entanglement aspects\cite{YAN} are encountered as compared to the model of distinguishable particles, although some further clarification is needed. It is also worth noting that some entanglement features of the 2-harmonium atom are also qualitatively reproduced by the other two models, which give a good description for certain two-fermion systems (e.g., two electrons in a quantum dot is approximately described by the Hooke model). Namely, the growth of the entanglement when either the relative strength or the excitation energy is increasing. It is most interesting that recently the entanglement of some real helium-like atoms has been numerically shown to have an increasing dependence on the energy. This has been done both by the use of very accurate one-electron basis functions of Hylleraas-Kinoshita type \cite{Dehesa, LIN} and some Gaussian or Slater type orbital basis sets \cite{HUAN, Benenti}. As well it is observed from the models that the entanglement decrease of these systems in terms of the nuclear charge Z can also be understood as the result of the relative decrease of the electron-electron-interaction. In this work we will study the entanglement of the one-body reduced density matrix of the N-harmonium model for bosons and fermions analytically. Von Neumann (for bosons) and linear (for fermions) entropies will be used. The one-body reduced matrix for the spinless fermionic case has been previously computed \cite{Schilling}. We obtain for the first time an explicit expression of the one-body reduced density matrix for the \textit{closed-shell} spinned fermionic-case. This study will allow us to show that some entanglement features of finite many-par\-ticle systems can be understood by purely kinematical considerations to a certain extent. The N-particle harmonium is a completely-integrable system with an arbitrary number $N$ of particles where both the confinement and the two-particle interaction are harmonic. This model has also been used to study cold atoms \cite{Zinner} and to gain further insight into numerous phenomena of a variety of physical systems up to black holes (see e.g.,\cite{HEI, Bombelli, Johnson, Srednicki, Zinner2, Koscik, LosChinos, ETH}). The paper is structured as follows. First, in Section \ref{sec:atom} we briefly formulate the quantum-mechanical problem of the N-particle harmonium, showing its separability by using the appropriate set of normal coordinates \cite{Moshinskyreturns}, and fixing our notational settings. Then, in Section \ref{sec:bosones} we discuss the general mathematical structure of the one-body reduced density matrix in the bosonic case, obtaining its explicit expression. Moreover, we compute and discuss the analytical expression of the von Neumann entropy of the one-body reduced density matrix for the N-boson harmonium. Further, in Sections \ref{sec:fermions} and \ref{sec:spin} we obtain explicit expressions for the one-body reduced density matrix of the spinned N-fermion harmonium and analyze the linear entropy of the one-body reduced density matrix, with and without the spin degree of freedom. Finally, some concluding remarks and two appendices are given. \section{The N-harmonium problem} \label{sec:atom} The N-harmonium model is a system of $N$ interacting particles (fermions or bosons) which interact harmonically in a three-dimensional harmonic well. It is characterized by the Hamiltonian \begin{equation} H = \frac12 \sum^N_{i=1}|\pp_i|^2 + \frac{k}{2} \sum^N_{i=1}|\rr_i|^2 + \frac{\dl}{2} \sum^N_{i\,<\,j} r_{ij}^2, \label{eq:Mosh-atom} \end{equation} where $r_{ij} := |\rr_i-\rr_j|$, $k$ is the coupling constant of the harmonic well and $\dl$ the coupling of the harmonic interaction between the particles. The treatment of harmonically interacting bosons by means of this Hamiltonian represents the first exact solution of a N-particle system using only conditions on the reduced space of two-particle density matrices \cite{Gido}. This system can be expressed in a separable form (i.e., as a system of uncoupled oscillators) using the set of normal coordinates $\{\vxi_1, ..., \vxi_N\}$ given by \begin{align} \vxi_N := \frac{1}{\sqrt{N}} \sum^N_{i=1} \rr_i \word{and} \vxi_m := \frac{1}{\sqrt{m(m+1)}} \sum^m_{i=1}(\rr_i - \rr_{m+1}), \end{align} with $m \in \{1,\ldots,N-1\}$. This is an orthogonal transformation of the position variables. A similar change of coordinates for momenta results in a canonical transformation, preserving the symplectic form. Let us call the new set of momenta $\{\vXi_m\}$. A direct calculation shows that \begin{align} \sum^{N-1}_{m=1} \vxi_m^2 = \frac{1}{N}\sum^N_{i\,<\,j} r_{ij}^2 = \sum^N_{m=1} \rr_m^2 - \vxi_N^2, \end{align} so that the Hamiltonian \eqref{eq:Mosh-atom} can be expressed in the following separable form \begin{align} H = \mathcal{H}_N + \sum^{N-1}_{m=1} \mathcal{H}_m, \word{where} \mathcal{H}_N = \frac{1}{2} \vXi_N^2 + \frac{1}{2}\om^2 \vxi_N^2 \word{and} \mathcal{H}_m = \frac12 \vXi_m^2 + \frac12 \mu^2 \vxi_m^2, \end{align} where $\om^2 := k$, and $\mu^2 := k + N\dl$ depending on the number of particles. Then, the physical solutions of the associated Schrödinger equation (i.e., the wave functions $\Psi(\xx_1,\cdots, \xx_N)$), can be readily obtained. Here, let us first note that (a) there is a ground state whenever $\mu^2 > 0$, and (b) the particles are no longer bound if the relative interaction strength \begin{align} \frac{\dl}{k} \le -\frac1N. \label{eq:maximum} \end{align} On the other hand, let us comment here that the entanglement problem is formulated in terms of reduced density matrices. Either directly from the resulting one-particle reduced density matrix or, since the particles are assumed to interact pairwise, in terms of the two-particle density matrix \begin{align} \rho(\xx_1,\xx_2;\yy_1,\yy_2) := \int d\xx_3 \cdots d\xx_N \; |\Psi(\xx_1,\xx_2,\xx_3,\cdots, \xx_N) \rangle \langle\Psi(\yy_1,\yy_2,,\xx_3,\cdots, \xx_N)|, \end{align} which carries all the necessary information required for calculating the quantum-mechanical properties of the whole system. The symbol $\xx$ stands for spatial and spin coordinates, $\xx~:=~(\rr,\vs)$. In particular, the ground state energy of the system can be computed by minimizing a simple linear functional of $\rho$. In passing, let us mention that the N-representability problem for this matrix has proved to be a major challenge for quantum chemistry \cite{Mazziotti}. The one-body density matrix, which is the basic variable in reduced density matrix functional theory \cite{Lapernal}, is then given as \begin{align} \rho_1(\xx;\yy) := \int \rho(\xx,\xx_2;\yy,\xx_2) d\xx_2. \end{align} By means of the spectral theorem, $\rho_1(\xx;\yy)$ can be decomposed in terms of its natural spin orbitals $\{\phi_i(\xx)\}$ and its eigenvalues $\{n_i\}$, the \textit{natural occupation numbers}: $\rho_1(\xx;\yy) = \sum_i n_i \phi_i(\xx) \phi_i(\yy)$, where $\sum_i n_i = 1$, with (for fermions) $0 \leq n_i \leq 1/N$. For the case of an assembly of bosons we will compute the von Neumann entropy of the one-body reduced density matrix finding explicitly the occupation numbers of the system, as described in the next section. Recently, there has been a renewed interest in formulating the reduced density matrix theory using Wigner quasidistributions \cite{Laetitia, Dahl09, Pluto}. Our treatment for bosons will be done by using the Wigner function in phase space, what is a natural procedure for these systems. Let us advance that there exists a critical value for the number of particles. Below this critical value (around 3.5), we will show that for positive values of the coupling constant $\dl$ the first occupation number decreases (and consequently the von Neumann entropy grows) as the number of particles is increasing. Above this value, the first occupation number increases as the number of particles is increasing. Moreover, the first occupation number tends to 1 (and the entropy tends to 0) in the limit when the number of particles tends to infinity. Later on, for fermions we use the one-body reduced density matrix to compute an explicit expression for its purity and its linear entropy as well. Let us advance that we will show that in the region of negative coupling $\dl$, the entropy grows when the number of particles is increasing. A similar situation is observed in the attractive case for small values of the coupling constant. For large values of $\dl/k$ the situation is the opposite: when particles are added to the system the entropy decreases. In both bosonic and fermionic cases, we will show that it is possible to calculate these two measures of entanglement as a function of the coupling constant $\dl/k$ and the number of particles. \section{The N-boson harmonium: von Neumann entropy} \label{sec:bosones} In this section we determine the von Neumann entropy of the N-boson harmonium ground state in terms of $N$ and the relative interaction strength $\dl/k$. Taking into account the Gaussian character of the ground-state oscillator wave function, the ground state distribution on phase space is characterized by the Wigner N-body density function \begin{align} &W^{b}_\gs(\rr_1,\ldots,\rr_N;\pp_1,\ldots,\pp_N) = \frac{1}{\pi^{3N}} \, e^{ - 2\mathcal{H}_N/\om} e^{-2 \sum^{N-1}_{m=1} \mathcal{H}_m/\mu} \nonumber \\ &\qquad = \frac{1}{\pi^{3N}} \, \exp\bigg[- (\om - \mu) \, \vxi^2_N - \mu \sum^N_{i=1} \rr_i^2 + \frac{\om - \mu}{\om\mu} \, \vXi^2_N - \frac{1}{\mu} \sum^N_{i=1} \pp_i^2\bigg]. \label{eq:wigner1} \end{align} The energy of the ground state is the total sum of the contributions of each individual oscillator, i.e. $E^b_\gs = \frac32 \big[\om + (N-1) \mu\big] $. On the other hand the one-body density factorizes as a product of two separable quantities, to wit: \begin{align} d^b_1(\rr;\pp) :=& \int W^b_\gs(\rr,\rr_2,\ldots,\rr_N;\pp,\pp_2,\ldots,\pp_N) \, \prod^N_{m=2} d\rr_m d\pp_m \nonumber \\ =& \, e^{-\mu \rr^2 - \frac{1}{\mu} \pp^2} \, \Dl^{\rr}(\rr,\mu,\om,N) \, \Dl^{\pp}(\pp,\mu,\om,N) . \label{kernel} \end{align} It can be shown that the $\Dl$-function fulfills the following recursion relation: \begin{align} \Dl^{\rr}(\rr,\mu,\om,N) :=& \frac{1}{\pi^{3N/2}}\int \exp\bigg[- \frac{\om - \mu}{N} \bigg(\rr + \sum^N_{m=2}\rr_m\bigg)^2 - \mu \sum^N_{m=2} \rr_m^2 \bigg] \, \prod^N_{m=2} d\rr_m \nonumber \\ =& \frac{1}{\mu_{1}^{3/2}} \frac{1}{\pi^{3(N-1)/2}} \int \exp\bigg[- \frac{\om - \mu}{N} \frac{\mu}{\mu_{1}} \bigg(\rr + \sum^{N-1}_{m=2}\rr_m\bigg)^2 - \mu \sum^{N-1}_{m=2} \rr_m^2 \bigg] \, \prod^{N-1}_{m=2} d\rr_m \nonumber \\ =& \frac{1}{\mu_{1}^{3/2}} \frac{1}{\pi^{3(N-1)/2}} \int \exp\bigg[- \frac{\om - \mu_1}{N-1} \frac{\mu}{\mu_{1}} \bigg(\rr + \sum^{N-1}_{m=2}\rr_m\bigg)^2 - \mu \sum^{N-1}_{m=2} \rr_m^2 \bigg] \, \prod^{N-1}_{m=2} d\rr_m \nonumber \\ =& \, ({\rm const.}) \, \Dl^{\rr}\bigg(\sqrt{\frac{\mu}{\mu_1}} \rr,\mu_1,\om,N-1\bigg) , \label{eq:unodensidad} \end{align} where $\mu_m := \frac{m}N \, \om + \frac{N-m}{N} \mu$. The constant $({\rm const.})$ will be determined by normalization so that it will depend on the number of particles as well as on the frequencies. Therefore, \begin{align} \Dl^{\rr}(\rr,\mu,\om,N) &= ({\rm const.}) \, \Dl^{\rr}\Bigg(\sqrt{\frac{\mu}{\mu_1}} \rr,\mu_1,\om,N-1\Bigg) = ({\rm const.}) \, \Dl^{\rr}\Bigg(\sqrt{\frac{\mu}{\mu_2}} \rr,\mu_2,\om,N-2\Bigg) \nonumber \\ &= \ldots = ({\rm const.}) \, \exp\Bigg(-\frac{\om-\mu}{N} \frac{\mu}{\mu_{N-1}} \rr^2\Bigg), \end{align} and in addition that \begin{align} \Dl^{\pp}(\pp,\mu,\om,N) \equiv \Dl^{\rr}(\pp,\mu^{-1},\om^{-1},N), \end{align} so that the expression \eqref{kernel} can be transformed as: \begin{align} d^b_1(\rr;\pp) = \frac{N^3}{\pi^3} \bigg(\frac{\om\mu}{\A_N}\bigg)^{3/2} \exp\bigg( -\frac{N\om\mu}{(N-1)\,\om + \mu} \, \rr^2 - \frac{N}{\om + (N-1)\,\mu} \, \pp^2\bigg), \label{eq:quasi} \end{align} where $\A_N = [(N-1)\, \om +\mu] [\om + (N-1)\,\mu]$. Let us now diagonalize this expression by decomposing it into its set of natural orbitals as well as into its occupation numbers. The task is made easier by noting that the one-body quasidensity is a linear combination of Laguerre polynomials (the phase-space counterpart of the Hermite polynomials). To see that, let us define \begin{align} \ga_N &:= (\om\mu)^{1/4} \bigg[\frac{\om+(N-1)\, \mu}{(N-1)\,\om + \mu}\bigg]^{1/4} , \qquad \la_N := \frac{N\sqrt{\om\mu}}{\sqrt{\A_N}}, \label{mostretes1} \end{align} as well as the symplectic transformation \begin{align} S_N := \begin{pmatrix} \ga_N & 0 \\ 0 & \ga_N^{-1} \end{pmatrix} \word{and} U := S_N \uu \word{where} \uu^T = (\rr,\pp). \label{mostretes2} \end{align} Then the one-body quasidensity function can be rewritten in the Gaussian way as follows, \begin{align} d^b_1(U) = \frac{\la_N^3}{\pi^3} e^{ -\la_N U^2}, \label{eq:gaussian} \end{align} showing that it is actually a \textit{Gibbs state}. Note that $\la_N \le 1$ for all $N$, since $\om + \mu \ge 2\sqrt{\om\mu}$ and $\A_N \ge N^2 \om\mu$ and that $\la_N \rightarrow 1$ when $N \rightarrow \infty$. It is known that associated to any symplectic transformation (say, $S_N$), there is a unitary operator acting on the Hilbert space \cite{PequenoJuan}. Let us use this transformation to find the set of occupation numbers in the basis of Wigner eigenfunctions of the harmonic oscillator. Since the one-body quasidensity function factorizes completely, from now on we work in one dimension. From the series formula \begin{align} (1-t)\sum^{\infty}_{r=0} L_r(x) \, e^{-x/2} \, t^r = e^{-\frac{1+t}{1-t} \frac{x}{2}}, \end{align} where $L_r(x)$ is the Laguerre polynomial, it follows that \begin{align} d^b_1(U) = \sum^{\infty}_{r=0} \frac{(-1)^r}{\pi} \, L_r(2U^2) \, e^{-U^2} \, n_r, \end{align} where the occupation numbers are equal to \begin{align} n_r = \frac{2\la_N}{1+\la_N} \bigg(\frac{1-\la_N}{1+\la_N}\bigg)^r =: (1 - t_N) \, t_N^r, \label{eq:ON} \end{align} fulfilling $\sum_r n_r = 1$ as one should expect. For the sake of completeness we plot the numerical behavior of the one-body quasidensity function of the N-boson harmonium in Figure \ref{graf:Wigner} for different values of the number of bosons. We observe that, as the number of bosons grows, the profiles of the position and momentum densities become narrower and wider, respectively. This clearly indicates that the more precisely the particles are localized in position space, the larger the localization in momentum space, as one should expect according to the position-momentum uncertainty principle. There is no relevant difference for negative values of the coupling constant $\dl$ except that in this case it can be plotted only when $\dl/k \ge -1/N$. \begin{figure}[ht] \centering \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=4cm]{PSN2.png} \caption{$N = 2$} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=4cm]{PSN6.png} \caption{$N = 6$} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=4cm]{PSN20.png} \caption{$N = 20$} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=4cm]{PSN50.png} \caption{$N = 50$} \end{subfigure} \hfill \caption{The one-body quasidensity function \eqref{eq:quasi} is plotted for different values of the number of bosons. Since the one-body quasidensity function factorizes completely, we plot it in one spatial dimension (two dimensions in phase space). The strength $\dl/k$ is taken to be equal to $1$. Note that as the number of bosons grows, the profiles of the position and momentum densities become narrower and wider, respectively.} \label{graf:Wigner} \end{figure} Finally we can compute the von Neumann entropy of the N-boson harmonium explicitly in terms of $N$ and the relative interaction strength $\dl/k$, obtaining the value \begin{align} S(N) :=& - \sum_{r=0} n_r \, \log n_r = - \log (1 - t_N) - \frac{t_N \, \log(1-t_N)}{1 - t_N} \nonumber \\ =& - \frac{\sqrt{\A_N} + N\sqrt{\om\mu}}{2N\sqrt{\om\mu}} \log\bigg[\frac{2N\sqrt{\om\mu}}{ \sqrt{\A_N} + N\sqrt{\om\mu}} \bigg], \label{eq:vNentropy} \end{align} which complements and extends a similar formula encountered by other means in a black-hole context\cite{Srednicki}. \begin{figure}[ht] \centering \includegraphics[width=8cm]{entropiav2.png} \caption{Von Neumann entropy of the one-body reduced density matrix for the N-boson harmonium is plotted as a function of the number of bosons $N$ and the relative interaction strength $\dl/k$. It is apparent that there is a critical point around $N_c \sim 3.5$, where the entanglement acquires its maximum value.} \label{graf:third} \end{figure} \begin{figure}[ht] \centering \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=8.2cm]{Otrabosonicaneg.pdf} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=8.2cm]{Otrabosonica.pdf} \end{subfigure} \hfill \caption{Von Neumann entropy of the one-body reduced density matrix for the N-boson harmonium, whose explicit formula is given in Eq.~\eqref{eq:vNentropy}, is plotted as a function of the number of particles for eight different values of the relative interaction strength $\dl/k$. Note that for each value of the relative strength there is a peak around the critical value $N_c$.} \label{graf:thirdbis} \end{figure} This entanglement measure is numerically examined in Figure \ref{graf:third} in terms of the number $N$ of bosons and $\dl/k$. As it is stated in \eqref{eq:maximum} the minimum value of this relative strength is $-1/N$. There is a critical point around $N_c \sim 3.5$, where the entanglement acquires its maximum value. This is more clearly seen in Figure \ref{graf:thirdbis}, where the explicit dependence of the von Neuman entropy on $N$ is shown. To investigate it in a closer way, we study the dependence of the occupation numbers on the number of bosons and the relative interaction strength. In particular, we plot the first occupation number separately in terms of $N$ and the relative strength. This is done in Figure \ref{graf:occupnum}. Therein, we note that below a critical value of number of particles (around $N_c \sim 3.5$), for \textit{positive} values of the coupling constant $\dl/k$, the first occupation number decreases as the number of particles increases. Beyond this value the situation is reversed: the value of the first occupation number increases as the number of particles increases. This implies that $n_0 \sim 1$ in the limit when the number of particles tends to infinite, which is a necessary condition for the existence of a Bose-Einstein condensation \cite{Pethick}. In summary, the critical point around $N \sim 3.5$ where the von Neumann entropy is maximum is closely connected with the minimum of the first occupation number occurring at such position. It is found that above this critical value the spatial entanglement decreases when we add up more and more particles to the system, so that the degrowth rate increases when the coupling constant is increasing. Moreover, it can be shown that the entropy vanishes when $N$ goes to infinite. \begin{figure}[ht] \centering \includegraphics[width=10cm]{graph2.pdf} \caption{Plot of the first occupation number $n_0 = 1 -t_N$ as a function of the number of particles for different \textit{positive} values of $\dl/k$. As it is displayed, $n_0$ takes its minimum value around a critical value in the number of particles ($\sim 3.5$).} \label{graf:occupnum} \end{figure} \section{The spinless N-fermion harmonium: linear entropy} \label{sec:fermions} In this section we study the spatial entanglement of the N-fermion harmonium (i.e., entanglement without taking into account the spin degree of freedom of the constituents) using the linear entropy of the one-particle density matrix as measure of entanglement of one particle. This measure is a first order approximation of the von Neumann entropy of the reduced one-body density of the system. In fact, it is a lower bound of this entropy. We will consider the case in which the spinless fermions are confined in a one-dimensional well, mainly because the antisymmetric fermion case requires more elaborate computations. Here we have to consider the antisymmetry under exchange of position coordinates $\{r_1,\dots,r_N\}$. Taking into account the Hamiltonian \eqref{eq:Mosh-atom} for the N-fermion harmonium, one has that the ground-state energy of the system is \begin{align} E^f_\gs = \half \om + \sum^{N-1}_{j=1}\mu \big(m +\half\big) = \half \om + \half \mu (N^2-1) \end{align} and the corresponding eigenfunction can be expressed as \begin{align} \Psi^f(\xi_1, \dots,\xi_N) = \frac{1}{\sqrt{N!}} \sum_{J\in S_N} (-)^J J \bigg[ \phi^\om_{n_N}(\xi_N) \prod^{N-1}_{m=1}\phi^\mu_{n_m}(\xi_m)\bigg], \label{eq:spinless} \end{align} where $n_m \in \{0,\cdots,N-1\}$, so that $n_i \neq n_j$ whenever $i \neq j$. The symbol $J$ denotes an element of the permutation group $S_N$ of $N$~elements (acting on the $r$-coordinates), and $\phi^{\nu}_n$ is the single-particle wave function given by an Hermite function of degree $n$ with frequency $\nu$. The collective mode $\xi_N$ is symmetric under any exchange of the position coordinates. Therefore, one has $n_N = 0$; otherwise one would have $n_m = 0$ for some $m \neq N$, and the wave function would not be totally antisymmetric. This eigenfunction can be rewritten as \begin{align} \Psi^f_\gs(\xi_1,...,\xi_N) = ({\rm const.}) \sum_{J\in S_N} (-)^J J \bigg[ \prod^{N-1}_{m=1}\ H_{n_m}(\sqrt{\mu} \, \xi_m) \bigg] e^{-\frac{\om}2 \xi_N^2 - \frac{\mu}2 \sum^{N-1}_{m=1}\xi^2_m}, \label{eq:fermion} \end{align} where $H_n$ is the Hermite polynomial of degree $n$ and now $n_m \in \{1,\cdots,N-1\}$. The exponential power of \eqref{eq:fermion} is the bosonic wave function, counterpart of the Wigner function in \eqref{eq:wigner1}. As an illustrative case let us consider the 3-harmonium system. To produce an antisymmetric wave function there is only one possibility for the degree of the polynomials, namely $n_1 = 1$ and $n_2 = 2$. Then the ground-state eigenfunction is \begin{align} \Psi^f_\gs(\xi_1,\xi_2,\xi_3) = ({\rm const.}) \sum_{J\in S_3} (-)^J J\big[ \psi(\xi)\big] \, e^{-\frac{\om}2 \xi_3^2 - \frac{\mu}2 (\xi^2_1+\xi_2^2)}, \end{align} where $\psi(\xi) := H_1(\sqrt{\mu}\,\xi_1) H_2(\sqrt{\mu}\,\xi_2)$ and $\xi := (\xi_1,\xi_2)$. Note that the six elements of the permutation group $S_3$ are \begin{align*} p_1 = \begin{pmatrix} 1 & 2 & 3 \end{pmatrix}, \; \; p_2 = \begin{pmatrix} 2 & 1 & 3 \end{pmatrix} , \; \; p_3 = \begin{pmatrix} 2 & 3 & 1 \end{pmatrix}, \\ p_4 = \begin{pmatrix} 1 & 3 & 2 \end{pmatrix}, \; \; p_5 = \begin{pmatrix} 3 & 1 & 2 \end{pmatrix}, \; \; p_6 = \begin{pmatrix} 3 & 2 & 1 \end{pmatrix} . \end{align*} The coordinate $\xi$ transforms under the representation of the permutation group in the following form: \begin{align*} R(p_1) \xi &= \xi, \;\; R(p_2) \xi = M_1 \xi, \; \; R(p_3) \xi = M_1 M_2 \xi, \\ R(p_4) \xi &= M_2 \xi, \;\; R(p_5) \xi = M_1M_3 \xi, \;\; R(p_6) \xi = M_3 \xi, \end{align*} where \begin{align*} M_1 = \begin{pmatrix} -1 & 0 \\ 0 & 1 \end{pmatrix}, \;\; M_2 = \begin{pmatrix} \cos \pi/3 & \sin \pi/3 \\ \sin \pi/3 & -\cos \pi/3 \end{pmatrix} \; \; M_3 = \begin{pmatrix} \cos \pi/3 & -\sin \pi/3 \\ -\sin \pi/3 & -\cos \pi/3 \end{pmatrix} . \end{align*} Note that $\det M_i = -1$ and $M^t M = 1$. Any matrix $$ M_\phi = \twobytwo{\cos\phi}{\sin\phi}{\sin\phi}{-\cos\phi} $$ is a reflection in the axis $\theta = \phi/2$. In our case, this means $\theta = \pi/2, \pi/6, -\pi/6$; i.e., three reflection axes at 60-degree angles to each other. The rotations $R(p_3)$ and $R(p_5)$ are products of two reflections each. Thus, the eigenfunction transforms as follows: \begin{align} \Psi^f_\gs(\xi_1,\xi_2,\xi_3) &= ({\rm const.}) \, e^{-\frac{\om}2 \xi_3^2 - \frac{\mu}2 (\xi^2_1+\xi_2^2)} \, \sum^6_{i=1} (-)^{i+1} \psi( R(p_i) \xi) \nonumber \\ &= ({\rm const.})\, e^{-\frac{\om-\mu}2 \xi_3^2 - \frac{\mu}2 (r_1^2 +r_2^2+r_3^2)} \, \sum^6_{i=1} (-)^{i+1} \psi( R(p_i) \xi) \nonumber \\ &= ({\rm const.})\, e^{-\frac{\om-\mu}2 \xi_3^2 - \frac{\mu}2 (r_1^2 +r_2^2+r_3^2)} \, (r_1-r_2)(r_1-r_3)(r_2-r_3). \end{align} Notice that the last equality has been possible because \begin{align} \frac1{12\sqrt{2}}\frac{1}{\mu^{3/2}}\sum^6_{i=1} (-)^{i+1} \psi(\sqrt{\mu}\, R(p_i) \xi) = - \frac1{\sqrt{2}} (\xi_1^3 - 3 \xi_1 \xi_2^2) = (r_1-r_2)(r_1-r_3)(r_2-r_3) \end{align} is a Vandermonde determinant. This 3-fermion result can be extended to the N-fermion system. In fact, general results of the theory of antisymmetric functions ensure that the wave function of a system of spinless fermions is equal to the wave function of the corresponding bosonic system multiplied by the $N$-variable Vandermonde determinant (see Section 3.1 of \cite{Procesi}). So, the ground-state wave function of the spinless N-fermion harmonium described by the Hamiltonian \eqref{eq:Mosh-atom} has the form: \begin{align} \Psi^f(r_1,\cdots,r_N) = ({\rm const.}) \prod_{ i\,<\,j} (r_i - r_j) \, \exp\bigg[- \frac{\om - \mu}{2} \, \xi^2_N - \frac{\mu}{2} \sum^N_{i=1} r_i^2\bigg], \label{eq:fermions} \end{align} where the product-like symbol on the right hand of this expression denotes the Vandermonde determinant: \begin{align} \V_{(r_1, \cdots, r_N)} := \begin{vmatrix} 1 & \cdots & 1 \\ r_1 & \cdots & r_N \\ \vdots & \ddots & \vdots \\ r_1^{N-1} & \cdots & r_N^{N-1} \end{vmatrix} = \prod_{1\leq i\,<\,j\leq N} (r_i - r_j) . \end{align} Concrete calculations \cite{LosChinos, Johnson} have borne out this fact several times. On the other hand, it has been pointed out by several authors that this function is actually a generalization of Laughlin's wave function for the fractional quantum Hall effect\cite{Hall}. This is not surprising since in the Hall effect the magnetic field can be understood as a harmonic potential acting on the electrons. Let us also point out that the Wigner function corresponding to the Gaussian one on the right-hand side of~\eqref{eq:fermions} is nothing but the Wigner N-body quasidensity given by \eqref{eq:wigner1}. Let us now calculate the one-body density of the one-dimensional spinless N-fermion harmonium, which is defined by \begin{align} \rho_1(r;r') = \int dr_2 \cdots dr_N \; \Psi^f(r,r_2,\cdots, r_N) \Psi^f(r',r_2,\cdots, r_N) . \label{eq:rho1} \end{align} For this purpose it is convenient to rewrite the eigenfunction \eqref{eq:fermions} as: \begin{align} \Psi^f(r_1,\cdots, r_N) &= ({\rm const.}) \, \V_{(r_1, \cdots, r_N)} \, e^{-a(r^2_1+\cdots +r_N^2) + b_N(r_1+\cdots+r_N)^2}, \end{align} with $a =\frac{\mu}2$ and $b_N = \frac{\mu-\om}{2N}$. Moreover, we will use the Hubbard-Stratonovich transformation \begin{align} e^{\al\zeta^2} = \sqrt{\frac{\al}{\pi}} \int^{\infty}_{-\infty} dz\, e^{-\al z^2+2\al z\zeta}, \word{with} \al\in \C \word{and} {\rm Re}(\al) > 0, \end{align} where $\zeta = r_2 + \cdots + r_N$ and $\al = 2b_N$. Then the one-body density reads: \begin{align} \rho_1(r;r') &= k_N \, e^{-(a-b_N)(r^2+r'^2)} \int dz \, e^{-2b_N z^2} e^{(N-1)\frac{b_N^2}{2a}(r+r'+2z)^2} \nonumber \\ &\qquad \x \int dz_2 \cdots dz_N \V_{(z_r,z_2, \cdots, z_N)} \, \V_{(z'_{r},z_2, \cdots, z_N)} \, \prod_{j=2}^N e^{- z_j^2}, \end{align} where $k_N$ denotes the normalization constant (to be calculated later), and $z_j := \sqrt{2a}\big[r_j - \frac{b_N}{2a}(r+r'+2z)\big]$ is a convenient change of coordinates. A key observation \cite{Schilling} is that the last expression on the right-hand side is the multiplication of two Slater determinants and therefore, the computation of the reduced density matrix can be done using well-known methods in quantum chemistry. Indeed, with the notation \begin{align} &\beta_N := \sqrt{\frac{\mu-\om}{(N-1)\om+\mu}}, \qquad q_{(r,r')} := \sqrt{\mu}\big[r - \half \beta_N^2(r+r')\big] \nonumber \\ & \qquad \word{and} c_N := \frac{(\mu-\om)^2}{(N-1)\om+\mu}\frac{N-1}{2N}, \label{eq:defintions} \end{align} one can express the one-body density as \begin{align} \label{eq:e7} \rho_1(r;r') = k_N \, e^{-a_N (r^2+r'^2) +2c_N rr'} \int du \, e^{-u^2} \sum^{N-1}_{j=0} \frac{1}{2^j j!}H_j[q_{(r,r')} -\beta_N u] H_j[q_{(r',r)} - \beta_N u] , \end{align} with $a_N := a-b_N-c_N$. This expression can be calculated analytically with the help of the following general formula derived in Appendix \ref{apendicea}: \begin{align} &\int_{-\infty}^{\infty} e^{-u^{2}} H_{k}(q_{(r,r')}-\beta_N u)H_{k}(q_{(r',r)}- \beta_N u)\, du \nonumber \\ & = \sum_{\substack{n_{1},n_{2}=0 \\ n_1+n_2 \, {\rm even}}}^{k} (2\beta_N)^{n_{1}+n_{2}} {k \choose n_{1}} {k \choose n_{2}} H_{k-n_{1}}(-q_{(r,r')}) H_{k-n_{2}}(-q_{(r',r)}) \, \Gamma \left(\frac{n_{1}+n_{2}+1}{2}\right). \end{align} Then the integral at the right-hand side of \eqref{eq:e7} can be expressed as the following power sum: \begin{align} \int du \, e^{-u^2} \sum^{N-1}_{j=0} \frac{1}{2^j j!}H_j[q_{(r,r')} -\beta_N u] H_j[q_{(r',r)} - \beta_N u] = \sqrt{\pi} \sum^{N-1}_{t=0} \sum^{2t}_{s=0} c^N_{t,s} \, r^{2t-s}r'^s , \end{align} where the expansion coefficients $c^N_{r,s}$ depend on the frequencies $\om$, $\mu$ and the number of particles. When $r + s$ is an odd number or bigger than $2(N-1)$, $c^N_{r,s} = 0$. By symmetry it is clear that $c^N_{t,s} = c^N_{s,t}$. In the one fermion case there is only one coefficient $c^1_{0,0} = 1$. For $N$ fermions, the rank of the quadratic form of the $c_{r,s}$ is $2N-1$. In particular, when $N = 2$, we have the expansion coefficients \begin{align} c^2_{0,0} = \frac{2\mu}{\om + \mu}, \quad c^2_{1,1} = \frac{ \mu (\mu^2 + 2 \mu \om +5\om^2)}{(\om+\mu)^2} \word{and} c^2_{2,0} = c^2_{0,2} = \frac{\mu(\om-\mu)(3\om+\mu)}{2(\om+\mu)^2} . \end{align} For completeness, let us mention that the reader will have no difficulty in verifying that $\rho_1(r,r)$ ---the diagonal of \eqref{eq:rho1}--- coincides (except for the difference in the normalization conventions) with the one obtained in \cite[Sect.~V]{Laetitia} by the Wigner function method. Moreover, for $N = 3$ the non-vanishing expansion coefficients are: \begin{align} c^3_{0,0} &= \frac32 \bigg[1+ \frac{(\om -\mu)^2}{(2\om + \mu)^2}\bigg] , \quad c^3_{1,1} = \frac{\mu(-15\om^3+51 \mu\om^2+15\mu^2\om+3\mu^3)}{(2\om+\mu)^3}, \nonumber \\ & c^3_{2,2} = \frac{\mu^2(363\om^4 + 168 \mu\om^3+90\mu^2\om^2+24\mu^3\om+3\mu^4)} {4(2\om+\mu)^4}, \nonumber \\ c^3_{2,0} = c^3_{0,2} &= -\frac{\mu(39\om^3-3 \mu\om^2+ 15\mu^2\om+3\mu^3)}{2(2\om+\mu)^3}, \quad c^3_{4,0} = c^3_{0,4} = \frac{\mu^2(5\om+\mu)^2(\om-\mu)^2}{8(2\om+\mu)^4} \nonumber \\ & \word{and} c^3_{3,1} = c^3_{1,3} = \frac{\mu^2(\om-\mu)(65\om^3+33 \mu\om^2 + 9 \mu^2\om + \mu^3)}{2(2\om+\mu)^4} . \end{align} Except for the difference in the normalization and notation conventions, these coefficients coincide with the ones found in \cite{Schilling}. Keeping all this in mind and determining the normalization constant $k_N$ by imposing that $\int \rho_1(r;r) \, dr = 1$, one finally has the expression \begin{align} \rho_1(r;r') = \frac{1}{\sqrt{\pi}}\frac1{\sqrt{N}} \sqrt{\frac{\om\mu}{(N-1)\om + \mu}} \, e^{-a_N (r^2+r'^2) + 2c_N rr'} \sum^{N-1}_{t=0} \sum^{2r}_{s=0} c^N_{t,s} \, r^{2t-s}r'^s \end{align} for the one-body density of the one-dimensional spinless N-fermion harmonium. Let us now quantify the entanglement of the system by means of the linear entropy associated to the one-body density \cite{Manzano}: \begin{align} S_L = 1 - N \Tr[\rho_1^2], \label{eq:linearentropy} \end{align} where $\Pi_N = N \Tr[\rho_1^2]$ is the \textit{purity} of the system. This entanglement measure, which is a non-negative quantity that vanishes if and only if the state has Slater rank 1 and it is therefore separable, has been recently used in various two-fermion systems \cite{YAN, MANZA} as well as for various helium-like systems \cite{Dehesa, HOFER, LIN} in both ground and excited states. Let us also point out that the linear entropy is a linearization of the von Neumann entropy, and gives a lower bound for this logarithmic entropy. Moreover, in our systems it turns out that \begin{align} \Tr[\rho_1^2] = \int \rho_1(r;r')\rho_1(r';r) \, dr' \, dr &= k^2_N \sum^{N-1}_{t,e=0} \sum^{2t}_{s=0} \sum^{2e}_{f=0} c^N_{t,s} c^N_{e,f} \, \mathcal{I}_{(2t-s+f,2e-f+s)}, \label{eq:otra} \end{align} where, as shown in Appendix \ref{gaussianas}, \begin{align} \mathcal{I}_{(n,m)} &= \mathcal{I}_{(m,n)} \nonumber \\ &= \int^{\infty}_{-\infty} r^n r'^m e^{-2a_N (r^2+r'^2) +4C_N rr'} \, dx \, dy \nonumber \\ &= 2 \sum^n_{i=0}\sum^m_{j=0} \binom{n}{i}\binom{m}{j} (-1)^j \la_1^{-(n+m-i-j+1)/2}\la_2^{-(i+j+1)/2} \nonumber \\ & \quad \x \Ga\Big(\frac{n+m-i-j+1}{2}\Big)\Ga\Big(\frac{n+m+1}{2}\Big) \frac14 [1+(-1)^{n+m-i-j}] [1+(-1)^{i+j}], \label{eq:purity} \end{align} with $\la_1 = 4(a_N-c_N)$ and $\la_2 = 4(a_N+c_N)$. \begin{figure}[ht] \centering \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=7.8cm]{EntropyLv2.pdf} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=7.8cm]{EntropyL2v2.pdf} \end{subfigure} \hfill \caption{Linear entropy of the one-particle density matrix of the N-fermion harmonium as a function of the coupling constant for five different values of $N$. Note the change of behavior when the strength grows.} \label{graf:five} \end{figure} Using expressions \eqref{eq:linearentropy}, \eqref{eq:otra} and \eqref{eq:purity}, we have investigated the dependence of the linear entropy of the system on the relative interaction strength $\dl/k$, as well as on the energy. The results are given in Figure \ref{graf:five}. A first basic observation is that for fixed $N$ the entanglement decreases (increases) when the relative interaction strength is increasing in the negative (positive) region. Moreover, for negative values of the coupling constant, the spatial entanglement of the N-fermion harmonium grows when $N$ is increasing. For small positive values of the coupling constant (i.e., when the fermions attract each other); herein we find that for very small values of $\dl/k$ the entanglement grows again with increasing $N$. In general, we observe that for positive values of the strength we have various regimes of dependence on $N$. In the strong-coupling regime, the linear entropy grows as the number of particles is increasing since the purity decreases with increasing number of particles. For instance, for $\dl/k =10$ the purity is 0.92 for $N=2$ and 0.94 for $N = 10$, whereas for $\dl/k =1$ is 0.998 and 0.992 respectively. \begin{figure}[ht] \centering \includegraphics[width=9cm]{entropiavsenergia.pdf} \hfill \caption{Linear entropy $S_L$ of the N-fermion harmonium versus the ground-state energy $E^f_\gs/\om$ for different values of $N$. The relation between the relative strength $\dl/k$ and the energy is stated in \eqref{eq:relativestrenght}. The entanglement grows when the energy increases.} \label{graf:six} \end{figure} Figure \ref{graf:six} displays the dependence of the linear entropy of the system on the ground state energy $E^f_\gs/\om$ for various values of the number of fermions $N$. We should keep in mind that the relation between the relative interaction strength and the energy is given by \begin{align} \dl/k = \bigg[\frac{2 E^f_\gs/\om-1}{N^2-1} \bigg]^2-1. \label{eq:relativestrenght} \end{align} We find that the entanglement grows when the energy increases. For $N = 2$ this behavior has been recently observed not only in the Moshinsky or 2-fermion harmonium atom but also in other 2-fermion systems \cite{MANZA, Dehesa, Benenti, HOFER, LIN}. The novelty is that this behavior appears to be true also for heavier N-fermion harmonium atoms. It is worth noting that our results can be considered as a generalization of previous results for the entanglement entropy of the fractional quantum Hall effect based in an exact matrix-product representation of the Laughlin wave function \cite{Laugh1, Laugh2, Laugh3}. This well-known wave function, formulated by R. Laughlin to explain the fractional quantum Hall effect, consists of a lone Slater determinant and reads as in \eqref{eq:fermions} except that there is no coupling between the electrons, that is, $\om = \mu$ or $\dl = 0$, and the domain is the complex space. \section{Total entanglement of the spinned N-fermion harmonium} \label{sec:spin} So far, we have considered only spinless particles. This means that in the two previous sections we have determined the spatial entanglement of the N-boson and N-fermion harmonia. Nevertheless, our conclusions for the bosonic system also apply to the total entanglement from a qualitative point of view, because the spin part of the ground-state eigenfunction fully factorizes. For fermionic systems this is no longer true, at least when they are isolated. In fact, for the ground state of two fermions is the product of a two-boson state and an antisymmetric spin state. For a system of fermions with spin in presence of a strong magnetic field, the spin part of the eigenfunction factorizes and so the spatial part must be antisymmetric \cite{Schilling}. In general, however, for the isolated fermionic system the spatial and spin parts of the ground-state wave function are not separable, and antisymmetry must take into consideration both spin and position coordinates. Let us now calculate the total entanglement of the N-fermion harmonium (i.e., the entanglement of both spatial and spin degrees of freedom) using the linear entropy as measure of entanglement. For simplicity, we consider one-dimensional models with an even number (say $2N$) of spinned electrons from now on. The total spin of the system is zero, and all the spatial orbitals are doubly occupied (restricted configuration). This will eventually allow for an easy generalization to closed-shell three-dimensional systems. We define the set of spin natural orbitals in the following way: \begin{equation*} \vf_j (x) = \frac{}{} \left\{ \begin{array}{rl} \phi_{\frac{j-1}{2}}(r) \, \up, & \text{if } j \; \text{is odd}, \\ \phi_{\frac{j }{2}}(r) \, \dn, & \text{if } j \; \text{is even}. \end{array} \right . \end{equation*} The symbols $\up$ and $\dn$ mean spin up and spin down, respectively, and we denote $x := (r, \vs)$, $\vs$ being the spin coordinate. Let us begin with the consideration of the simpler non-interacting case; that is, when $\dl = 0$, and hence $\mu = \om$. The corresponding ground-state eigenfunction is then given by the expression \begin{align} \Psi^f(x_1,\ldots,x_N) &= \frac{1}{\sqrt{2N!}} \sum_{J\in S_{2N}} (-)^J \Bigg[\prod^{2N}_{i=1} \vf_{i-1}(x_{J(i)})\Bigg] \nonumber \\ &= \frac{1}{\sqrt{2N!}} \sum_{J\in S_{2N}} (-)^J \, J \Bigg[\prod^{N}_{i=1} \up_{2i-1} \dn_{2i} \phi^\om_{i-1}(r_{2i-1}) \, \phi^\om_{i-1}(r_{2i})\Bigg] . \label{eq:semifinal} \end{align} In the non-interacting case, the basis of the one-particle Hilbert space is the set of Hermite functions whose degree is less than $N$. Moreover, let us define \begin{align*} H &= \{j\in S_{2N} : j \; {\rm fixes} \; 1, \ldots, N\} \simeq S_N \\ K &= \{j\in S_{2N}: j \; {\rm fixes} \; N+1,\dots, 2N \} \simeq S_N \end{align*} and $\tilde{S}_{N} = H\x K$ the direct product of these two subgroups. The set $S'_{2N} = S_{2N}/\tilde{S}_{N}$ is the set of right cosets in $S_{2N}$, giving the following equivalence relation: $J \sim J'$ if and only if there exists $(j,j') \in \tilde{S}_{N}$ such that $J' = (j,j') J$. Therefore we can reorganize the expression \eqref{eq:semifinal} in the following form: \begin{align} \Psi^f(x_1,\ldots,x_N) &= \frac{1}{\sqrt{2N!}} \sum_{} (-)^J \prod^{N}_{i=1} \up_{J(i)} \prod^{2N}_{i=N+1} \dn_{J(i)} \nonumber \\ &\x \begin{vmatrix} \phi^\om_0(r_{J(1)}) & \cdots & \phi^\om_0(r_{J(N)}) \\ \vdots & \ddots & \vdots \\ \phi^\om_N(r_{J(1)}) & \cdots & \phi^\om_N(r_{J(N)}) \end{vmatrix} \begin{vmatrix} \phi^\om_0(r_{J(N+1)}) & \cdots & \phi^\om_0(r_{J(2N)}) \\ \vdots & \ddots & \vdots \\ \phi^\om_N(r_{J(N+1)}) & \cdots & \phi^\om_N(r_{J(2N)}) , \end{vmatrix} , \label{eq:twoslater} \end{align} where the sum runs over a representative of each coset. The choice of the representative $J\in [J] \in S'_{2N}$ is immaterial. The number of summands is $$ \begin{vmatrix} S_{2N}/\tilde{S}_N\end{vmatrix} = \frac{|S_{2N}|}{|\tilde{S}_{N}|} = \frac{(2N)!}{(N!)^2} = \binom{2N}{N}. $$ For instance, for the four-harmonium ($N = 4$), the eigenfunction can be written in the alternative form: \begin{align*} \Psi^f(x_1,x_2,x_3,x_4) &= \frac{\om^2}{\pi} \frac{1}{\sqrt{3!}} e^{-\frac{\om}2 (r^2_1+r^2_2+r^2_3+r^2_4)} [ (\up_1 \up_2 \dn_3 \dn_4 + \dn_1 \dn_2 \up_3 \up_4)\V_{(1,2)}\V_{(3,4)} \\&- (\up_1 \up_3 \dn_2 \dn_4 + \dn_1 \dn_3 \up_2 \up_4)\V_{(1,3)}\V_{(2,4)} +(\up_1 \up_4 \dn_2 \dn_3 + \dn_1 \dn_4 \up_2 \up_3)\V_{(1,4)}\V_{(2,3)}]. \end{align*} The one-body reduced density matrix corresponding to the wave function \eqref{eq:twoslater} is diagonal in spin space and is given by the expression \begin{align} \rho_1(x,x') = \begin{pmatrix}\rho^{\up\up}_1(r,r') & 0 \\ 0 & \rho^{\dn\dn}_1(r,r') \end{pmatrix} . \end{align} Moreover, it is clear that \begin{align} \rho^{\up\up}_1(r,r') &= \rho^{\dn\dn}_1(r,r') = \int dx_2 \cdots dx_{2N} \, \Psi^f(r,\vs_1,x_2,\ldots,x_N) \Psi^f(r',\vs_1,x_2,\ldots,x_N) |_{\vs_1=\up} \nonumber \\ &= \frac{1}{2N} \frac1{(N-1)!}\int dr_2 \cdots dr_{N} \begin{vmatrix} \vf_0(r) & \cdots & \vf_0(r_N) \\ \vdots & \ddots & \vdots \\ \vf_N(r) & \cdots & \vf_N(r_N) \end{vmatrix} \begin{vmatrix} \vf_0(r') & \cdots & \vf_0(r_N) \\ \vdots & \ddots & \vdots \\ \vf_N(r') & \cdots & \vf_N(r_N) \end{vmatrix} \nonumber \\ &= \frac{1}{2N} \sum^{N-1}_{i=0} \vf_i(r)\vf_i(r'). \end{align} The occupation numbers appear twice, what is a well-known result for atomic and molecular scientists. Let us now consider the general interacting case, for which $\dl \neq 0$, and hence $\mu \neq \om$. The ground-state eigenfunction for the Hamiltonian \eqref{eq:Mosh-atom} is similar to \eqref{eq:spinless}, except that each spatial orbital is doubly occupied. For the same reasons as in the spinless case, the collective mode $\xi_{2N}$ occupies the Hermite function of degree zero. The other coordinates $\{\xi_m\}^{2N-1}_{m=1}$ occupy the other spatial orbitals in such a way that the total wave function is totally antisymmetric under interchange the coordinates $\{x_m\}^{2N}_{m=1}$. The ground-state eigenfunction schematically reads \begin{align} \Psi^f(x_1,...,x_{2N}) = \frac{1}{\sqrt{2N!}} \sum_{J\in S_{2N}} (-)^J \bigg[ \prod^{N}_{i=1} \up_{J(i)} \prod^{2N}_{i=N+1} \dn_{J(i)} \bigg] J \bigg[\phi^\om_{0}(\xi_{2N})\phi^\mu_{0}(\.) \prod^{N}_{m=1}\phi^\mu_{m}(\.)\phi^\mu_{m}(\.)\bigg]. \end{align} For instance, in the particular case $N$ = 4 the eigenfunction has the form \begin{align*} \Psi^f(x_1,x_2,x_3,x_4) &= \frac{1}{\sqrt{4!}} \sum_{J\in S_4} (-)^J \up_{J(1)} \up_{J(2)} \dn_{J(3)} \dn_{J(4)} J \big[\phi^\om_{0}(\xi_4) \phi^\mu_{1}(\xi_1) \phi^\mu_{0}(\xi_3) \phi^\mu_{1}(\xi_2)\big] \\ &= ({\rm const.}) \sum_{J\in S_4} (-)^J \up_{J(1)} \up_{J(2)} \dn_{J(3)} \dn_{J(4)} J \big[\xi_1\xi_2\big] e^{-\frac\om2 \xi_4 - \frac\mu2(\xi_1^2 + \xi_2^2+\xi_3^2)} \\ & = ({\rm const.}) \sum_{S'_4} (-)^J \up_{J(1)} \up_{J(2)} \dn_{J(3)} \dn_{J(4)} \V_{(J(1),J(2))} \V_{(J(3),J(4))} e^{-\frac\om2 \xi_4 - \frac\mu2(\xi_1^2 + \xi_2^2+\xi_3^2)}. \end{align*} Using again that an antisymmetric polynomial is equal to a symmetric polynomial multiplied by a Vandermonde determinant \cite{Procesi}, we can write the ground-state eigenfunction of the general interacting spinned N-fermion system as: \begin{align} \Psi^f(x_1,\ldots,x_{2N}) =& \, ({\rm const.})\, e^{- \frac{\om - \mu}{2} \xi^2_{2N} - \frac{\mu}{2} \sum^{2N}_{i=1} r_i^2} \nonumber \\ &\x\sum_{S'_{2N}} (-)^{J} \Bigg[\prod^{N}_{i=1} \up_{J(i)} \prod^{2N}_{i=N+1} \dn_{J(i)} \Bigg] \V_{(J(1),\ldots,J(N))}\V_{(J(N+1),\ldots,J(2N))}. \end{align} and the corresponding energy is $E^f_\gs = \half (\om+\mu) + \mu (N^2-1)$. Let us define $\eta = r + r_2 + \cdots + r_N$ and $\eta' = r' + r_2+\cdots + r_N$. To compute the one-density we use twice the Hubbard-Stratonovich identity. First to compute $N$ integrals with $\zeta'= r_{N+1} + \cdots + r_{2N}$, and second to compute $N-1$ integrals with $\zeta= r_2 + \cdots + r_N$. Each diagonal element of the one-body density matrix reads: \begin{align} &\rho^{\up\up}_1(r,r') = \rho^{\dn\dn}_1(r,r') \nonumber \\ &= ({\rm const.}) \, e^{-a(r^2+r'^2)} \int dr_2 \cdots dr_N\, e^{- 2a(r^2_2 + \cdots + r^2_N)+b_{2N}(\eta^2+\eta'^2)} \int dz \, e^{-2b_{2N} z^2} e^{N\frac{b_{2N}^2}{2a}(\eta+\eta'+2z)^2} \nonumber \\ &\qquad \x \V_{(r,,2,...,N)}\, \V_{(r',2,\ldots,N)} \int dz_{N+1} \cdots dz_{2N} \, \V_{(z_{N+1},\ldots, z_{2N})}^2 \, \prod_{j=N+1}^{2N} e^{- z_j^2}, \end{align} where $z_j := \sqrt{2a}\big[r_j - \frac{b_{2N}}{2a}(\eta+\eta'+2z)\big]$. Once again, the expression on the right is the total integral of the product of two Slater determinants, that is, $$ \int dz_{N+1} \cdots dz_{2N} \V_{(z_{N+1},\ldots, z_{2N})}^2 \prod_{j=N+1}^{2N} e^{- z_j^2} $$ is a real constant. Therefore \begin{align} &\rho^{\up\up}_1(r,r') = \rho^{\dn\dn}_1(r,r') \nonumber \\ &= ({\rm const.}) \, e^{-a(r^2 + r'^2)} \int dr_2 \cdots dr_N \, e^{-2a(r_2^2 + \cdots+ r_N^2) + b_{2N}(\eta^2+\eta'^2)+d_{N} (\eta+\eta')^2} \, \V_{r,,2,...,N}\, \V_{r',2,\ldots,N} \nonumber \\ &= ({\rm const.}) \, e^{-a(r^2 + r'^2) + b_{2N}(r^2+r'^2)+d_N(r+r')^2} \int dz \, e^{-2 g_N z^2} \, e^{(N-1)\frac{g_N^2}{2a}(r+r'+2z)^2} \nonumber \\ &\qquad \x \int dz_2 \cdots dz_N \, \V_{z_r,,z_2,...,z_N}\, \V_{z'_{r},z_2,\ldots,z_N} \prod^N_{j=2} e^{-z'^2_j}, \end{align} where $z'_j := \sqrt{2a}\big[r_j - \frac{g_N}{2a}(r+r'+2z)\big]$, $d_N = \frac1{8N} \frac{(\mu-\om)^2}{\mu+\om}$ and $g_N = \frac{\mu-\om}{2N} \frac{\mu}{\mu+\om}$. As in the spinless case, let us define \begin{align} &\tilde{q}_{(r,r')} = \sqrt{\mu}\big[r - \half \beta_{2N}^2 (r+r')\big] \word{and} \tilde{c}_{2N} = \frac{(\mu-\om)^2}{(2N-1)\om+\mu}\frac{2N-1}{8N} \end{align} with $\bt_N$ as defined in \eqref{eq:defintions}. Then \begin{align} &\rho^{\up\up}_1(r,r') = \rho^{\dn\dn}_1(r,r') = \frac{1}{2\pi}\frac1{\sqrt{N}} \sqrt{\frac{2\om\mu}{(2N-1)\om + \mu}} \nonumber \\ &\qquad \qquad \x e^{-a'_N(r^2 + r'^2) + 2 \tilde{c}_{2N} rr' } \int du \, e^{-u^2} \sum^{N-1}_{j=0} \frac{1}{2^j j!}H_j[\tilde{q}_{(r,r')} -\beta_{2N} u] H_j[\tilde{q}_{(r',r)} - \beta_{2N} u] , \label{eq:expre} \end{align} with $a'_N := a-b_{2N}- \tilde{c}_{2N}$. \begin{figure}[ht] \centering \includegraphics[width=9cm]{Linearentropyconespin.pdf} \hfill \caption{Linear entropy of the spinned N-fermion harmonium as a function of the relative coupling constant for various values of $N$. Qualitatively, it is similar to the spinless case in Fig.~\ref{graf:five}.} \label{graf:eight} \end{figure} The expression \eqref{eq:expre} is similar to \eqref{eq:e7}, except that we have an even number of fermions: $N \to 2N$ and $c_N \to \tilde{c}_{2N}$. It is now clear that the conclusions for the spinless fermionic case also hold for the full spin case from a qualitative point of view. Figure \ref{graf:eight} plots the linear entropy for the spinless and the spinned cases as functions of the relative strength. \begin{figure}[ht] \centering \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=7.8cm]{LinearS-1_15.pdf} \caption{$\dl/k = -1/15$} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=7.8cm]{LinearS2.pdf} \caption{$\dl/k = 2$} \end{subfigure} \\ \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=7.8cm]{LinearS4.pdf} \caption{$\dl/k = 4$} \end{subfigure} \hfill \begin{subfigure}[b]{.48\textwidth} \centering \includegraphics[width=7.8cm]{LinearS22.pdf} \caption{$\dl/k = 22$} \end{subfigure} \hfill \caption{Linear entropy of the one-body reduced density matrix for the spinless and spinned N-fermion harmonium as a function of the number of particles for different values of $\dl/k$.} \label{graf:LinearS4} \end{figure} For completeness, we have numerically investigated the dependence of the linear entropy on the number of particles for some specific values of the relative coupling in both spinless and spinned cases (i.e., for spatial and total entanglements). Figure \ref{graf:LinearS4} exhibits the results for $\dl/k \in \{-1/15,2,4,22\}$. In the spinned case the behavior is similar to the spinless system, so that the total entanglement behaves similarly as the spatial entanglement. In fact, for small values of the coupling the entropy grows when increasing the number of particles, while in the strong-coupling regime the situation is the opposite. The inclusion of the spin tends to enhance the entropy of the system, being most important this phenomenon for small values of the coupling constant. Note that in turn the contributions of the spin and the spatial one are of comparable size. \begin{figure}[ht] \centering \includegraphics[width=9cm]{entropiavsenergiaspin.pdf} \hfill \caption{Linear entropy $S_L$ of the N-fermion spinned harmonium versus the ground-state energy $E^f_\gs/\om$ for different values of $N$. The relation between the relative strength $\dl/k$ and the energy is stated in \eqref{eq:relativestrenghtsp}.} \label{graf:energyspin} \end{figure} Finally, let us investigate the relative behavior of entanglement and energy. This is done in Figure \ref{graf:energyspin}, where the linear entropy as a function of the ground-state energy is shown for some values of the number of particles. Let us recall here that the relation between the relative coupling and the energy is given by \begin{align} \dl/k = \bigg[\frac{2 E^f_\gs/\om-1}{2 N^2-1} \bigg]^2-1. \label{eq:relativestrenghtsp} \end{align} As in the spinless case, the entropy grows when increasing the ground-state energy. For very large values of the dimensionless energy $E_\gs^f/\om$ (i.e., very large values of the relative strength $\dl / k$) the gap between the spinless and spinned cases decreases. \section{Concluding remarks} \label{sec:conclusion} In this work we have shown that some entanglement features of finite many-particle systems can be understood to a certain extent by purely kinematical considerations. This is done by explicitly analyzing the entanglement of the N-boson and N-fermion harmonium systems. This has been possible because for these harmonic systems we have been able to calculate analytically not only the one-body reduced matrix for bosons and fermions, but also the von Neumann entropy in the bosonic case as well as the linear entropy in the fermionic case. In doing so, we complement and extend to harmonic systems with an arbitrary number of particles the study of entanglement recently done for various two-electron models \cite{HEI, Moshinsky1, NagyP09, YAN, Laetitia, MANZA} as well as some helium-like systems \cite{Dehesa, LIN, HUAN, Benenti} and certain quantum complex networks \cite{manyos}. We have determined the entanglement of these harmonic systems for both spatial and spin degrees of freedom analytically in terms of the number of particles and the relative interaction strength (or coupling constant). We have used the von Neumann entropy and the linear entropy as entanglement quantifiers in the bosonic and fermionic systems, respectively. We have found that for positive couplings the entanglement of the 3-boson harmonium atom is bigger than the one of the 2-boson system, but in general the entanglement of the N-boson harmonium decreases when $N$ is increasing. Moreover, the entanglement of a given N-boson system grows when the positive coupling constant is increasing; that is, when the positive value if the strength of interparticle interaction relative to the confinement well is increasing. On the other hand, globally speaking the spatial entanglement of the N-fermion harmonium grows when $N$ is increasing for both negative and sufficiently small positive values of the coupling constant. Moreover, the entanglement behavior is opposite in the positive strong-coupling regime. On the other hand, entanglement of a given N-fermion system grows when the coupling constant is increasing. The contribution of the spin degree of freedom to the entanglement of the N-fermion system is shown to be of positive comparable size to the contribution of the spatial degrees of freedom. Summarizing, we have shown that in the repulsive case and in the attractive case for relatively small values of the coupling constant, the entanglement of both bosonic and fermionic N-harmonium atoms grows when the number of particles is increasing, basically because purity decreases. However, in the regime of strong coupling the situation is exactly the opposite: purity increases (and hence entanglement decreases) by adding particles to the system. \subsection*{Acknowledgments} CLBR was supported by a Francisco Jos\' e de Caldas scholarship, funded by Colciencias. He very much appreciates the warm atmosphere of the Departamento de F\'{\i}sica At\'omica Molecular y Nuclear, at the Universidad de Granada. IVT and JSD gratefully acknowledge the MINECO grant FIS2011-24540 and the excellence grant FQM-7276 of the Junta de Andaluc\'ia. In addition, the authors are most grateful to A.~R. Plastino as well as to J.~L. Alonso, A. Botero, J.~M. Gracia-Bond\'ia and J.~C. V\'arilly for helpful and illuminating discussions.

\section{Introduction} Graphene has brought a paradigm shift in exploring exotic quantum phenomena in carbon based mesoscopic systems \cite{Geim2007,Ferrari2015,Han2017}. Moving beyond the research on pristine mono and mulitlayer graphene, the focus has now shifted to physically and chemically functionalize them in order to generate new quantum states with promising applications \cite{Elias610,Boukhvalov2009,Robinson2010,Hollen2016}. For example, in the twisted bilayer graphene, one of the layer is rotated by a magic angle of 1.1$^{\circ}$ with respect to the other to create a superconductivity phase \cite{Cao2018,Cao2018a,Yankowitz2019}. By means of chemical functionalization it is shown that when hBN (hexagonal boron nitride) is placed on a trilayer graphene, a gate tunable Mott-insulating phase \cite{Chen2019}, which is the crux of strongly correlated electron physics, can be achieved. While many such examples can be cited, the success is eluding when it comes to induce long range magnetic ordering in the graphene family. The effort in this direction so far had been either through semi-hydrogenation \cite{Sofo2007,Yazyev2008,Zhou2009,Elias610,Boukhvalov2009,McCreary2012,Bonfanti_2018}, transition metal adatoms \cite{Sevincli2008,Uchoa2008,Krasheninnikov2009,Cao2010,Wu2009,Santos2010}, and natural intercalations \cite{Gong2010,Kaloni2011,Bointon2014,Bui2013,Decker2013,Han2018,Hu2013}, vacancies \cite{Yazyev2007,Nair2012,Nanda2012,Padmanabhan2015,Valencia2017,Jiang2018}, or through edge states in the flakes \cite{Rossier2007,Luka2012,Ganguly2017,Hu2019}. \begin{figure} \centering{\includegraphics[width=8.5cm,height=5.5cm]{Fig1.pdf}} \caption{\label{schematic}Schematic illustration of the equilibrium structure and the process of magnetization in fluorine intercalated mono/multilayer graphene. For lower separation ($d$) between the carbon layers, the instability (due to positive intercalation energy, E$^{int}$) makes the intercalated F$_2$ molecules to disintegrate and become adatoms. For intermediate values of $d$, the molecule is stretched to create a pseudoatomic state. The latter forms a suspended spin lattice as confirmed from the spin-density shown. The magnetization (red line) weakens when there is significant charger transfer ($\Delta$Q; blue line) between the carbon and fluorine layers. For large $d$, the carbon layers and the molecules remain independent.} \end{figure} The hydrogenation saturates the $\pi$ bonds and in turn destroys the Dirac bands \cite{Boukhvalov2009}. Although 3\textit{d} transition metal adatoms are capable of creating local spin moments (LSM), these adatoms tend to form clusters, and therefore the long-range magnetic ordering could not be established through them \cite{Nair2012,Zhou2009,Cao2010}. Furthermore, here, the Dirac states are buried deep inside the valence band and the partially occupied 3\textit{d} states occupy the Fermi level \cite{Jiang2018}. The same is observed when the 3\textit{d} transition metals are intercalated \cite{Kaloni2011,Han2018}. The isolated vacancies create paramagnetic phase at low temperature with LSM arising due to the sublattice imbalance led zero mode $\pi$ states and the re-hybridized $\sigma$ dangling states \cite{Edwards2006,Nanda2012}. Unfortunately, the LSM are sensitive to the lattice deformations caused by the vacancies. When the deformation is non-planar, which is often the case in experiments \cite{Jiang2018}, the strength of LSM reduces to zero. Additionally, the vacancies in close neighborhood merge to create Stone-Wales defects \cite{Duplock2004,Yazyev2008}, and diluted vacancies lack spin-spin correlation \cite{Yazyev2008}. Another way to create sublattice imbalance in order to induce magnetism is to form edges in graphene flakes with a particular sublattice \cite{Rossier2007,Luka2012,Ganguly2017,Hu2019}. However, experimental control of flakes with defined crystallographic orientations remains an engineering challenge \cite{Ganguly2017,Hu2019}. We envisage the formation of LSM through pseudoatomization of halogen molecules since in elemental form they have one unpaired spin in their valence orbital. By pseudoatomization, we mean that the halogen-halogen bond length is sufficiently large to weaken the molecular eigenstates, while ions are still loosely bound to form a stretched dimer. Through a combination of computational approaches, here, we show that the pseudoatomized fluorine can be stabilized by intercalating the F$_2$ molecules between the AA-stacked graphene or graphitic slabs. For the later, the layers adjacent to the intercalated F$_2$ are AA-stacked. While AB-stacking for bilayer graphene is considered to be more stable, there are experimental evidences showing stable synthesis of AA-stacked BLG \cite{Lee2008,Liu2009,Borysiuk2011,Lee2016,Horiuchi2003}. More importantly, the electronic structure calculations predict the formation of a suspended ferromagnetically coupled 2D spin lattice out of these pseudoatomized fluorine layer as shown in Fig. \ref{schematic}. This resonates very well with our analysis on free F$_2$ molecule where we show that if F$_2$ molecule is stretched to the bond distance of 1.9$-$2.0 \AA, a weakly bound triplet state is achieved. Earlier calculations carried out using configuration interaction method also predicts a weakly bound triplet state for the F$_2$ dimer when its bond length is close to 1.9 \AA{} \cite{Cartwright1979,Delyagina2003,Hill2014}. Further, the charge transfer from the graphene to fluorine led to formation of a negatively charged F$_2$ (doublet) lattice giving rise to possible mechanism for the pseudoatomization process. In the absence of experimental and theoretical studies on the F$_2$ intercalation, earlier \textit {ab initio} studies have predicted the formation of fluorine adatoms\cite{Sadeghi2015,Santos2014,Liu2012} or adsorption of a singlet F$_2$ on a graphene sheet\cite{Rudenko2013,Yang2018}. The energy barrier for dissociation of adsorbed F$_2$ molecule to atomic state and the intercalated site preference compared to the adatom position is discussed in the appendix. Also, the thermodynamical stability of the suspended fluorine layer is examined through finite temperature \textit {ab initio} molecular dynamics simulations. The results reveal that the formation of pseudoatomized fluorine layer is stable up to a temperature around 100 K, beyond which the graphene layer is transforms to AB stacking and the adatoms are gradually formed. However, if the graphene layers are held fixed, the pseudoatomized fluorine layer remains stable even at room temperature which is worth exploring as recent experimental studies show that mechanically and chemically it is possible to control the interlayer separation in graphene and related systems \cite{Jeon2018,Li2018,Yankowitz2018,Rode2017,Wang2015}. It has been experimentally demonstrated that the interlayer spacing can be controlled mechanically by hydrostatic pressure \cite{Yankowitz2018}. External pressure regulation has also been a viable route to control interlayer spacing in graphene oxide membranes \cite{Li2018}. Other non-trivial ideas include deposition of a gold bar of desired thickness between two graphene layers \cite{Jeon2018}. In this way, along with the separation, the angle between two graphene layers can be tuned. Computationally it has been shown that hydrated cations between graphene layers can be inserted for precise control of interlayer spacing between graphene layers\cite{Yang2019}. In general, experimenters are actively pursuing research on controlling the interlayer spacing in 2D materials in general through chemical and physical means as it opens up several application perspectives in the field of energy materials\cite{Wang2015}. We strongly believe that in future the precise control of interlayer spacing will be experimentally possible. The selection of fluorine over chlorine and bromine intercalation is based on their bond lengths and bond energies which are F$_2$ (1.42 \AA{}, 1.6 eV), Cl$_2$ (2.0 \AA{}, 2.48 eV) and Br$_2$ (2.3 \AA{}, 1.97 eV) \cite{Forslund2003}. Since, the lattice parameter of graphene/graphitic slab is 2.46 \AA, the latter two will not be stretched significantly in order to weaken the molecular eigenstates. Whereas, fluorine can be stretched up to $\sim$ 1 \AA{} so that molecular interactions can be weakened \cite{Delyagina2003}. The weak bond energy felicitate such stretching. We have also examined the possibilities of nitrogen and oxygen as they can provide three and two unpaired spins when pseudoatomized. However, N$_2$ has stronger affinity to be in the singlet state, whereas O$_2$ intercalation leads to an endothermic process. The unsuitability of all elements other than fluorine is discussed quantitatively in the appendix A. The rest of the paper is organized as follows. Section II provides the details of the computational approaches which include DFT, climbing image nugded elastic band (CI-NEB) and \textit{ab initio} molecular dynamics (MD) simulations. Section III presents results and discussion. In this section we first analyze the electronic structure of the free F$_2$ dimer. Next we carried out the stability and dimerization (pseudoatomization) of the intercalated F$_2$ molecules with graphene/graphitic slabs as host. Finally, the electronic and magnetic structure of the pseudoatomized intercalated fluorine layer is presented followed by the discussion on F$_2^-$ doublet formed as a result of charge trnsfer from the graphene to fluorine. Section IV summarizes our findings and concludes the study. In the appendix we have presented further data to compliment the main text. \section{Computational Details} The spin-polarized density functional calculations are carried out using plane wave based pseudopotential approximations as implemented in Quantum Espresso (QE) \cite{Giannozzi2009}. The exchange-correlation functional is treated within the framework of generalized gradient approximation as developed by Perdew, Burke, and Ernzerhof \cite{Perdew1996}. The interlayer van der Waals interactions between graphene layers are considered using the Grimme-D2 correction \cite{grimme2006}. The plane waves are expanded with a kinetic energy cutoff of 30 Ry and the charge density cut off of 300 Ry. While for structural relaxation, a k-point grid of $8 \times8 \times1$ is used, for electronic structure calculations a denser k-point grid of $16 \times16 \times1$ is employed. To obtain the ground state structure for each intercalated system, the separation($d$) between the two mono/multilayer graphene is varied, and for each $d$, structural relaxation is carried out by restricting the out-of-plane motion of the carbon atoms. As each of the calculations are carried out in a periodic arrangement, a vacuum of 15 \AA{} is used to maintain the isolation of the intercalated systems. A set of climbing image nudged elastic band (CI-NEB) method \cite{Henkelman2000} calculations are performed to estimate the potential barrier of F$_2$ molecule stretching and dissociation to atomic state in the considered intercalated systems. Here, we have performed the calculations for free F$_2$ dimer, fluorine intercalated between two monolayer of graphene with full coverage (FF) and half-coverage (HF). Also, the same has been carried out between two sets of AA-stacked bilayers and trilayers (AAA and ABA-stacking). \begin{figure*} \centering \includegraphics[width=17cm,height=5.6cm]{Fig2.pdf} \caption{\label{dimer} (a) and (b) The potential energy of singlet and triplet states of a free F$_2$ dimer as a function of inter-nuclear distance as calculated using coupled cluster based CCSD with 6-311G(d,p) basis sets and pseudopotential method employed on an artificial periodic system (see the computational details) respectively. The singlet configuration ($^1\Sigma_g^+$ ) forms the global minimum and the triplet configuration (1$^3\Pi_u$) forms a local minimum. The eigenstates and charge density of (b) for the (c) $^1\Sigma_g^+$ configuration and (d-e) 1$^3\Pi_u$ configurations.} \end{figure*} The spin-polarized Born-Oppenheimer \textit {ab initio} molecular dynamics calculations are performed using VASP \cite{Kresse1993}. The valence electrons are expanded using plane wave basis sets with a kinetic energy cut-off of 400 eV, whereas the core electrons are approximated using Projector Augmented Wave (PAW) approach \cite{Bloch1994,Kresse1999}. We choose the smallest possible supercell to model fluorine intercalation at 0 K. As we wish to access dynamical stability of intercalated fluorine at finite temperature, we choose a supercell that is twice as large compared to one used at 0 K to give fluorine atoms higher degree of freedom. Such degree of freedom allows formation of fluorine molecule. Here, we have used a k-mesh size of $2\times2\times1$ and time step of 1 fs. The systems are first thermalized at different temperatures (NVT) using Nose-Hoover thermostat for a duration of 2.0 ps followed by production run for 5 ps. The singlet, doublet, and triplet configurations of the free F$_2$ dimer are analysed using the QE based pseudopotential method within the framework of PBE-GGA. Here, the dimer is kept in a cubic box of side 15\AA{} to replicate a periodic system. The free space calculations are also done using coupled cluster with single and double excitation's (CCSD) level of theory\cite{Krishnan1980,Scuseria1988} with a 6-311G(d,p) basis sets as implemented in Gaussian09\cite{g09}. \section{Results and discussion} \subsection{Free F$_2$ dimer} Earlier studies on isolated F$_2$ molecule, carried out using the multireference single- and double-excitation configuration interaction (MRDCI) method\cite{Cartwright1979,Delyagina2003,Hill2014} show that besides the singlet ground state (X$^1\Sigma_g^+$; electronic configuration: $\sigma_g^2\pi_u^4\pi_g^4\sigma_u^0$), an weakly bound covalent triplet state (1$^3\Pi_u$; $\sigma_g^2\pi_u^4\pi_g^3\sigma_u^1$) with a potential well of depth 0.05$-$0.2 eV, can form when the bond length is in the range 1.9 to 2.0 \AA. As we will see in the coming sections, the present study of F$_2$ intercalation stabilizes a triplet bound state for the pseudoatomized F$_2$ dimer. Hence, it is desirable to first examine the electronic and spin structure of the free F$_2$ dimer in further details using the first principles calculations. The total energy of F$_2$ dimer as a function of bond length ($d_{F-F}$) is shown in Fig. \ref{dimer}(a) for the free space configuration using CCSD/6-311G(d,p) method and (b) for the periodic configuration using the pseudopotential method (see the computational details). The noticeable difference among binding energy values obtained from these two methods as well as the MRDCI method is due to the fact that the saturation energy of molecules is very sensitive to the methodology and the basis set considered for the calculations\cite{Lourderaj2002,Kepp2017}. Also, the artificial cubic box that was adopted for the pseudopotential calculations cannot appropriately represent the free space configuration. However, both CCSD and pseudopotential results infer that there is a global minimum around $d_{F-F}$ = 1.42 \AA {}, which corresponds to the ground state singlet X$^1\Sigma_g^+$ configuration whose eigenstates and corresponding charge densities are shown in Fig. \ref{dimer}(c). In addition to the global minimum, a local minimum appears at $d_{F-F}$ = 1.80 \AA {}. The ground state electronic configuration at this local minimum is an excited triplet 1$^3\Pi_u$ state, whose eigenstates and corresponding charge densities are shown in Fig. \ref{dimer} (d) and (e). If we enforce a singlet configuration (not shown here) at this local minimum, the states $\sigma_u$ and $\pi_g$ coincide, and since now they are partially occupied. This initiates hopping among the states leading to increase in the kinetic energy. This kinetic energy driven instability is overcome by Hund's coupling. Now the order and occupancy of the spin-up eigen states is $\sigma_g^1\pi_u^2\pi_g^2\sigma_u^1$ (Fig. \ref{dimer}(d)). The spin-down states are raised above by an average value of 2.22 eV and their order and occupancies are given by $\sigma_g^1\pi_u^2\pi_g^1\sigma_u^0$ (Fig. \ref{dimer} (e)). This electronic configuration agrees well with the aforementioned MRDCI studies. \subsection{Stability of the Fluorine Intercalation} The preceding subsection suggests that if fluorine molecule can be stretched and held at F$-$F distance of around 1.9 \AA{}, magnetic moments can be induced, and it requires to overcome a potential barrier of $\sim$ 1.4 eV (see Fig. \ref{dimer}(a)). In this section, we will find that such a stretching is possible by intercalating fluorine molecule between two AA stacked graphene layers. The optimized structure of this intercalated system is shown in Fig. \ref{energy}(a). The fluorine atoms are found to occupy each carbon hexagons, and the equilibrium position is observed to be midway between two adjacent carbon layers. For our choice of $2 \times 2$ graphene supercell, there are four carbon hexagon center positions available and so a maximum of two F$_2$ dimers can be accommodated between the carbon layers. If all available carbon hexagons are occupied with fluorine, we call it as fully-fluorinated (FF), and if half of them are occupied we call it half fluorinated (HF) system. Depending on the graphene layer thickness, the system are named, e.g. if fluorine intercalated between two single layer of graphene it is named as mono-intercalated (MI) system and simialrly for bilayer and trilayer namings are followed. For MI-FF and MI-HF systems, the F$-$F distance is 1.96 \AA{} and 1.97 \AA{}, respectively, and equilibrium interlayer separation is 5.50 and 5.25 \AA{}, respectively. We examine the stability of fluorine intercalated systems for both MI-FF and MI-HF cases by comparing total energy of intercalated system with respect to AA-stacked bilayer graphene and fluorine molecule. We calculate the intercalation energies at various bilayer graphene separations by taking AA-stacked bilayer graphene at corresponding separation as reference given by the following expressions: \begin{eqnarray}\label{eq:1} E^{Int} (d) &=& E_{G-F} (d) - E_{G} (d) -N E_{F_{2}} \end{eqnarray} Here, $E_{G-F}$ is the total energy of the structurally optimized intercalated system for a given separation $d$ between the upper and lower carbon layers, $E_{G}$ is the energy of the bilayer graphene at respective separation $d$. $E_{F_{2}}$ is the total energy of an isolated F$_2$ molecule and N is the number of F$_2$ molecules intercalated. The equation provides the E$_{Int}$ assuming graphene layers are separated at distance $d$, and then the F$_2$ molecules were intercalated through the layers. \begin{figure*} \includegraphics[width=16.5cm,height=8.5cm]{Fig3.pdf} \caption{\label{energy} (a) The side and top view of the optimized structure where fluorine is intercalated between two graphene monolayers for the case of full fluorination (MI-HF) and half fluorination (HF-FF). (b) The intercalation energy, E$^{Int}$ as defined in eq. \ref{eq:1}, for FF and HF as a function of separation ($d$) between the two adjacent monolayers. (c) Carbon - Fluorine interaction energy (E$_{C-F}^{Int}$), stretching energy of fluorine (E$_{F-F}^{stretch}$) (see eq. \ref{eq:2}), and optimum distance between two neighbouring fluorine atoms ($d_{F-F}$) intercalated between monolayer graphene as a function of interlayer separation. (d) For the MI-HF system, relative potential energies (with respect to initial configuration) along the minimum energy path, as the fluorine molecule stretches from the initial configuration ($d_{F-F}$ = 1.42 \AA) to the final configuration ($d_{F-F}$ = 2.46 \AA) at various values of $d$. Upper inset shows change in total energy of the F$_2$ molecule with change in the F$-$F distance for F$_2$ intercalated at $d$ = 5.25 and 10 \AA, respectively. (f) The local spin moment at each F site, and the charge transfer($\Delta$Q) from graphene to each fluorine atom for MI-FF and MI-HF systems.} \end{figure*} Figure \ref{energy}(b) shows that there exists an $E^{Int}$ energy minima, which is negative for both half and full fluorinated system. Optimum separation ($d_m$) for FF and HF coverage is 5.5 to 5.25 \AA{}, respectively. It is worth noting that as coverage decreases interlayer separation ($d_m$) decreases. Considering the case of MI-FF, we found that for the AA-stacking configuration, the intercalation is observed to be energetically more favourable by $\sim$ 1 eV than that of adatom configuration which is discussed in detail in the appendix. To understand the optimum graphene layer separation and fluorine-fluorine distance, we calculate carbon and fluorine interaction energy ($E^{Int}_{C-F}$), and fluorine and fluorine stretching energy ($E^{stretch}_{F-F}$). $E^{Int}_{C-F}$ and $E^{stretch}_{F-F}$ are given by following equations: \begin{eqnarray}\label{eq:2} E^{Int}_{C-F} (d) &=& \frac{1}{2} [E_{G-F} (d) - E^{stretch}_{F-F} (d)],\nonumber \\ E^{stretch}_{F-F} (d_{F-F}) &=& E_{F_2} (d_{F-F}) - E_{F_2}(d_0). \end{eqnarray} Where, $E^{Int}_{C-F}$ is expressed as difference in total energy of intercalated bilayer graphene and total energy of non-interacting fluorine molecule stretched to the same length as in bilayer graphene. $E^{stretch}_{F-F}$ represents the energy cost to stretch F$_2$ to a bond length $d_{F-F}$, greater than the equilibrium bond length ($d_0\sim 1.42$ \AA). The factor $\frac{1}{2}$ accounts for the fact that the fluorine layer interacts with two neighboring carbon layers. For MI-HF system, the $E^{Int}_{C-F}$ and $E^{stretch}_{F-F}$ are plotted as a function of $d$ in Fig. \ref{energy}(c). There are two factors that lead to optimal separation of graphene layers, for $d$ = 5.25 \AA{} carbon interaction with fluorine is strongest and at the same time, fluorine-fluorine stretching energy have saturated, with local minima at 1.92 \AA. \begin{center} \begin{figure*} \includegraphics[width=16cm,height=6cm]{Fig4.pdf} \caption{\label{figmd}Free standing MI-HF: Average values of (a) total energy, (b) C and F distance ($d_{C-F}$), and the magnetic moments per fluorine at specific temperatures. (c-d) Snapshots of the structure at T = 25 and 125 K respectively. The later presents a critical temperature at which the AA stacked graphene layer transforms to AB stacked layer and the adatom formation starts to take place. The statistical uncertainties of the datas are presented in Fig. \ref{mdall} of appendix. (e-h) repeat (a-d) for fixed MI-HF ($d$ = 5.25\AA)): average values of (e) total energy, (f) C and F distance ($d_{C-F}$), and the magnetic moments per fluorine at specific temperatures. (g) and (h) Snapshot structure at T = 100 K and 300 K, respectively. The stacking is constrained to AA pattern.} \end{figure*} \end{center} The stretching of F$_2$ after intercalation is further examined from the energy contours obtained through the NEB method, and the results for the MI-HF system are shown in Fig. \ref{energy}(d). Here, initial and final configurations represent the molecule with bond distance of 1.42 \AA{} and 2.46 \AA{}, respectively as shown in the lower insets of Fig. \ref{energy}(d). The plot depicts the relative (with $d_{F-F}$ = 1.42 \AA{} intercalated between graphene layers as reference) potential energy as a function of $d_{F-F}$ for various values of $d$. The minimum energy path was found to be coinciding with the line connecting the centers of two neighboring hexagons. The global energy minimum, represented through the yellow squares, found to be shifting towards the initial configuration with increasing $d$. As $d$ approaches 10 \AA, free molecule configuration is achieved, which is further verified by comparing the change in energy of the non-interacting F$_2$ molecule and the intercalated molecule as a function of $d_{F-F}$ (see upper inset of Fig. \ref{energy}(d)). The free fluorine at $d_{F-F}$ $\sim$ 1.9 \AA{} induces magnetic moment close to 1$\mu_B$ on each fluorine atom. It is expected that each pseudoatomic fluorine intercalated between graphene layers would induce similar magnetic moments. However, as shown in Fig. \ref{energy}(e), maximum magnetic moment on fluorine atoms in MI-FF and MI-HF systems are approximately 0.75$\mu_B$ and 0.6$\mu_B$, respectively. For both systems, as $d$ increases, the magnetic moment on fluorine increases initially, and then remains saturated for a certain range of $d$ before it falls rapidly to zero. With large $d$, the molecular F$_2$ stabilizes in singlet configuration, hence does not result in any magnetic moment. Less than expected magnetic moment in the intercalated system can be attributed to the charge transfer from carbon to fluorine. Larger the charge transfer lesser the magnetic moment. Detailed mechanism is explained from electronic structure in later section. We have also studied the stability of intercalated fluorine in multilayer graphene and the magnetic moment on fluorine. In Table \ref{table1}, we have listed the minimum equilibrium interlayer separation ($d_m$), corresponding F$-$F bond distance, intercalation energy, and the magnetic moments for fluorine intercalated between monolayer (MI), bilayer (BI) and trilayer (TI) graphene. Optimized structures for BI and TI systems are discussed in Fig. \ref{ABA} and Fig. \ref{BI} of the appendix. For all cases, intercalation energy is negative, suggesting that pseudoatomization is feasible in multilayer graphene systems as well. Induced magnetic moment only depends on the coverage of fluorine not layers of graphene involved. It is also worth noting that for all coverage and layers of graphene, $d_{F-F}$ is approximately 1.92\AA, it could be because of stable triplet state at similar F$-$F distance observed in non-interacting fluorine molecule. \begin{table} \caption{\label{table1}The values of $d_m$ and $d_{F-F}$ are in \AA{}, $E^{Int}$ in eV, and the average magnetic moment (M) per fluorine atom in $\mu_B$ for the intercalated systems in their ground state.} \begin{tabular}{c|cccc|cccc}\hline \hline Intercalation & \multicolumn{4}{c|}{Full fluorinated} & \multicolumn{4}{c}{Half fluorinated} \\ Stacking& $d_{m}$ & $d_{F-F}$ & $E^{Int}$ & M & $d_{m}$ & $d_{F-F}$ & $E^{Int}$ & M\\ \hline MI & 5.50 & 1.96 & -0.26 & 0.74 & 5.25 & 1.95 & -0.63 & 0.57 \\ \cline{1-9} BI$^{AA}$ & 5.27 & 1.94 & -0.32 & 0.72 & 5.16 & 1.92 & -0.48 & 0.46 \\ \cline{1-9} \cline{1-9} TI$^{AAA}$ & 5.28 & 1.94 & -0.35 & 0.72 & 5.22 & 1.92 & -0.44 & 0.43 \\ \cline{1-9} TI$^{ABA}$ & 5.31 & 1.94 & -0.25 & 0.73 & 5.00 & 1.95 & -0.57 & 0.52 \\ \hline \hline \end{tabular} \end{table} \subsection{Stability at finite temperature} Since the DFT calculations were performed at zero kelvin, it is important to understand the stability of the system as a function of temperature. In order to access the structural integrity of fluorine intercalated between two AA-stacked bilayer graphene at finite temperature and its magnetic characteristics, we have carried out spin-polarized \textit{ab inito} MD calculations. Due to bigger system size and large number of electrons, the calculations have been carried out for a time period of 5 ps at few choices of temperatures upto a maximum of 300 K after the initial thermalization steps. Here, we present MD results for two conditions: half fluorinated i) free standing and ii) fixed graphene layer ($d$ = 5.25 \AA). \begin{center} \begin{figure} \includegraphics[width=8.5cm,height=7.5cm]{Fig5.pdf} \caption{\label{band-dos}The spin polarized band structure and DOS of MI-FF and MI-HF systems for different interlayer graphene separations ($d$). The blue bands represent the F-states in the spin-down channel. The green color shaded regions show the shifting of the graphene Dirac states above the Fermi level implying charge transfer from graphene to fluorine layers. The partial DOS of F-$p$ in spin up and spin down channel are shown in red and blue color, respectively. The total DOS is shown in grey shaded regions.} \end{figure} \end{center} First we discuss half fluorinated free standing graphene. Figure \ref{figmd} (a), shows average value of total energy as a function of temperature, which increases monotonically from $-$612 to $-$611.13 eV with increase in temperature(T) from 25 to 100 K. Detailed statistical time evolution of the system is shown in Fig. \ref{mdall} of appendix. As temperature of system is increased to 125 K, the total energy of the system drops to $-$612.2 eV, which indicates the structural transition. Structural analysis shows that, the system have transformed to AB stacked bilayer graphene, with F forming covalent bond with C at a length $\sim$ 1.42 \AA{} as shown in Fig. \ref{figmd} (d). As a result, the average magnetic moments of fluorine decreases from 0.65 to 0.3 $\mu_{B}$ (Fig. \ref{figmd} (b)). The MD analysis of fully-fluorinated (MI-FF) case shows that the system is stable up to 75 K beyond that magnetic moments of the system vanishes as shown in Fig. \ref{ffmd} of appendix. Furthermore, we carry out the MD simulation of half fluorinated bilayer graphene (with equilibrium separation between graphene, $d$ = 5.25 \AA{}), by freezing position of carbon atoms. We observe that for such system, magnetic moment does not vanish even at room temperature, as shown in Fig. \ref{figmd} (e-h). Structural analysis show that, fluorine atoms remain pseudoatomized and does not form bond with carbon atoms. We may note that as shown in Table \ref{table1} and Fig. \ref{ABA} of the appendix, fluorine intercalation between two sets of ABA graphitic slabs also shows similar stable magnetic layer formation. As graphitic slabs are more stable than the graphene due to layer cohesivity, it is expected that, unlike the case of intercalation between two monolayer graphene, in these trilayer intercalated systems the probability of large scale structural distortion including adatom formation will be significantly lower. \subsection{Magnetization driven by pseudoatomization: A triplet perspective} To understand the cause of magnetic moments in the fluorine intercalated system, we have plotted the spin-polarized band structure in Fig. \ref{band-dos}. The first observation is that the Dirac states remain unperturbed, and the carbon layers remain non-magnetic. However, the Dirac state lies above the Fermi level (E$_F$) to imply that there is a charge transfer from carbon layers to the intercalated fluorine pseudoatoms as indicated through green shaded areas. In an ideal triplet state, there are two empty spin-minority states. However, as a consequence of charge transfer, the otherwise empty spin-minority states (one per F) are now partially occupied. For example, in the case of MI-FF with $d$ = $d_m$ (Fig. \ref{band-dos}(a)), all the F-$p$ states are occupied in the majority spin channel. However, in the minority spin channel, out of the four supposed to be empty states (Fig. \ref{band-dos} (b), shown in blue), one is partially occupied. Similarly, in MI-HF system (Fig. \ref{band-dos}(e)), out of the two supposed to be empty states, only one is partially occupied in the spin down channel, whereas all the F-$p$ states are occupied in the spin up channel (Fig. \ref{band-dos} (d)). These additional spin-down occupancies reduce the magnetic moments from 1$\mu_B$. Table \ref{table1} lists the average LSM per F for intercalated systems in their ground state. For larger $d$ (= 10 \AA), molecular state of fluorine is favoured and hence no magnetization is expected (see Fig. \ref{band-dos} (g-i)). The DOS plotted on the right panel of Fig. \ref{band-dos} compliment the band structures. The magnetization of BI and TI systems are found to be similar to that of the MI systems (see Appendix B) which suggest that the charge transfer mechanism drives the magnetic moments in this family. We also find a direct correlation between the charge transfer and the stability of the system. Increase in charge transfer increases the intercalation energy which perturbs the system. \begin{center} \begin{figure} \includegraphics[width=8.0cm,height=5.0cm]{Fig6.pdf} \caption{\label{fig4}The upper panel shows three different magnetic configurations: ferromagnetic (FM), A-type antiferromagntic (A-AFM), and G-type antiferromagntic (G-AFM). Corresponding to each of these configurations, the LSM at each fluorine site is indicated. The lower panel shows the band structure in A-AFM and G-AFM configurations. The FM band structure is shown in Fig. \ref{band-dos} (b).} \end{figure} \end{center} The correlation among the LSM of the intercalated spin lattice is examined from the total energy of the three spin arrangements: (I) Ferromagnetic (FM), (II) A-type antiferromagnetic (A-AFM) and (III) G-type antiferromagnetic (G-AFM) as shown in Fig. \ref{fig4} (upper panel). The saturated LSM in each of these configurations for the MI-FF system are also indicated in the Fig. \ref{fig4}. The AFM couplings, due to increase in charge transfer ($\Delta$Q), reduce the LSM. As we move from FM to A-AFM to G-AFM ordering, the average LSM ($\Delta$Q) becomes 0.76$\mu_B$ (0.24e), 0.51$\mu_B$ (0.49e), and 0.38$\mu_B$ (0.62e), respectively (see Fig. \ref{fig4}). Since the instability grows with the increase in $\Delta$Q , the FM configuration becomes more stable. For the MI-FF system, the FM configuration is stable over the A-AFM configuration by 0.51 eV and over the G-AFM configuration by 0.76 eV. Subjecting these values to a spin-dimer picture with E$_{\uparrow \uparrow}$ - E$_{\uparrow \downarrow}$ = 2J with J as the magnetic exchange coupling, one can find that E$_{FM}$ - E$_{A-AFM}$ = 4J and E$_{FM}$ - E$_{G-AFM}$ = 8J. This yields an average J of $\sim$ -100 meV favouring parallel alignment. In practice, the J's are expected to be spatially anisotropic due to unequal LSMs and F$-$F bond lengths. \begin{center} \begin{figure} \includegraphics[width=8cm,height=9.2cm]{Fig7.pdf} \caption{\label{doublet} (a) and (b) The potential energy curve of free F$_2^-$ as calculated using the CCSD formalism with 6-311G(d,p) basis set and pseudopotential method with plane wave basis set respectively. These curves infer that the equilibrium bond length lies somewhere between 1.91 to 2.05 \AA{}. (c) and (d) The eigenstates and the charge densities of spin up and spin down channel at $d_{F-F}$ = 2.05 \AA{}, respectively.} \end{figure} \end{center} \subsection{Perspective of formation of a doublet spin lattice} Adding an extra electron to fluorine can create a F$_2^-$ dimer which can stabilize in a doublet state. Since carbon layers transfer substantial electrons to the intercalated fluorine layer, the formation of doublets cannot be ruled out. To understand the charge mediated doublet formation, we first examined a free F$_2^-$ doublet energetics and the spin moments shown in Fig. \ref{doublet}. Our free space CCSD and artificial aperiodic pseudopotential calculations show that the doublet has a bound state with an equilibrium bond length lying around 1.91 and 2.05 \AA respectively. The earlier works using multiconfiguration valence band (VCB) and configuration interaction (CI) methods have also reported formation of a bound state at an average bond length around $\sim$ 1.8$-$2.0 \AA{} \cite{Balint1969,Copsey1971,Ellis1973}. Keeping aside this discrepancy over the equilibrium bond length like the triplet, which might be arising out of the methods using functions and basis sets, our results indeed show that the ionic dimer is elongated to stabilize a doublet. The positioning of the spin resolved eigenstates are shown in Fig. \ref{doublet}(c) and (d). The unoccupied $\pi_g$ state of the triplet configuration is now occupied with the additional electron in the doublet configuration to yield a net magnetic moment of 1$\mu_B$. \begin{figure} \centering \includegraphics[width=8.5cm,height=7.0cm]{Fig8.pdf} \caption{\label{spin-lattice} (left) The local spin moments at each fluorine site of a (a) F$_2^-$ doublet lattice, (b) neutral F$_2$ lattice and (c) F$_2$ intercalated system at $d$ = 5.25 \AA{} separation, and (right) their corresponding spin up and spin down band structures.} \end{figure} As a next step, we considered the fluorine lattice identical to the one formed in the half-fluorinated intercalated system, but free from the adjacent carbon layers. To emulate the configuration, we added one additional electron. The resulted electronic structure is demonstrated in Fig. \ref{spin-lattice}(a). Compared to an isolated doublet in free space, the magnetic moment in the doublet lattice is little more than 1 $\mu_{B}$. This may be due to the fact that the otherwise empty higher lying excited states are now dilute occupied in this charged lattice which in turn alters the occupancy of the hybridized $p$-states of the dimer. This can be observed from Fig. \ref{spin-lattice}(a). For comparison with the doublet lattice, we have shown the band structure of the neutral F$_2$ lattice in Fig. \ref{spin-lattice}(b). The neutral lattice as expected stabilizes in a triplet state with spin moments of 1 $\mu_{B}$ at each fluorine site. A close observation of the band structure shows that the dispersive nature in both the cases are nearly identical except reposition of the bands. In the neutral lattice, there is a shifting of a $\pi_g$ band just above the Fermi level as it has one electron less. In addition, other excited states are now completely unoccupied as they are about 8 eV above the Fermi level (not shown here). As shown in Fig. \ref{spin-lattice}(c), in the intercalated system, F-{$s,p$} dominated bands are resembling the free F$_2$ lattice (doublet and triplet) lattice. While the positioning of the $\pi_g$ bands resemble to that of the doublet lattice, the excited states which were earlier lying close to the Fermi level, they are away from it as in the case of triplet lattice. Therefore, two possible cases arise. (I) As proposed earlier, the triplet state lead to the formation of the spin-lattice with a reduced magnetic moment (less than 1 $\mu_{B}$ per triplet). The reduction is due to increase in the occupancy in the spin-minority channel through charge transfer from the graphene to the F$_2$ lattice. (II) Instead of triplet, the doublet spin-lattice is formed due to the charge transfer. However, as the composite configuration is neutral, unlike the free doublet lattice, here the excited states remain far away from the Fermi level. However, as in the case of full fluorination, the average charge transfer is insufficient to make each pair of fluorine a doublet, it is most likely that the formation of the spin lattice is due to random distribution of triplet and doublet states. The adopted mean-field method is not adequate to eliminate one or the other. \section{Conclusions and Outlook} The present work explores the possibility of inducing stabilized magnetic layer through intercalation of molecules such as such as N$_2$, O$_2$, F$_2$, Cl$_2$, and Br$_2$. Out of these, fluorine provides a sweet spot between bond energy and bond length, leading to pseudoatomization once intercalated between AA-stacked graphene or graphitic slabs. The pseudoatomized configuration, which is basically a stretched dimer, is capable of stabilizing a triplet bound state for the charge neutral fluorine layer or a doublet state with negatively charged (one electron per F$_2$). Our study shows that there is a reasonable charge transfer from the adjacent graphene layers to the fluorine layer. Therefore, there will be a distribution of doublets and triplets in the intercalated layer. Graphene provides added advantage of 2D lattice, as intercalated fluorine can adopt underlying symmetry of graphene, and we observed that the magnetic monolayer of fluorine is stable. \textit{Ab-initio} MD analysis show that, the system can be stabilized upto 100 K, and by keeping the graphene layers fixed can lead even to room temperature stability for the half fluorinated system. Our simulations opens up formation of a suspended magnetic layers via route of pseudoatomization. If experimentally synthesized, this can serve as a platform to study the low temperature physics of mesoscopic spin systems. From the application point of view, the proposed intercalated systems also carry significance. The pseudoatomized fluorine molecule with partial intercalation in graphene, would give rise to uniformly distributed magnets. This can be used as magnetic tape with theoretical density in order of 10$^2$ Tb/inc$^2$, which is significantly higher than latest magnetic tape announced by Sony with storage capacity of 148 Gb/inc$^2$ \cite{sony}. Amongst other systems to form magnetic layers encapsulating F$_2$ in carbon nanotubes at appropriate diameter may be promising in this direction. \section*{acknowledgement} BRKN thanks G.Bhaskaran and S. Ali for useful discussions. This work is supported by the Department of Science and Technology, India, through Grant No. EMR/2016/003791.

\section{Introduction} \label{sec:intro} Quenched disorder has a profound effect on the low-energy, low-temperature and long wavelength properties of quantum systems. The interplay between quantum fluctuations, correlations and disorder fluctuations generally results in strong singularities in the thermodynamical quantities and in the (dynamical) correlation functions\cite{qsg,im}. This type of effect takes place even outside the quantum critical region, e.g. in the quantum paramagnetic phase at zero temperature, $T=0$, where spatial correlations are short ranged\cite{im,vojta}. The origin of this phenomenon, as pointed out by Griffiths\cite{griffiths}, is due to rare regions, in which strong bonds are accumulated by extreme fluctuations, so that the system in these regions is locally in the thermodynamically unstable ferromagnetic phase. As a consequence the excitation energy, $E$, in the rare regions is very small, the relaxation process is very slow and the associated relaxation time, $\tau \sim E^{-1}$, is divergent in the thermodynamic limit. If we consider a finite part of a sample with linear size, $\ell$, the characteristic time-scale of the slowest relaxation process stays also finite and asymptotically given by: \begin{equation} \tau \sim \ell^{z}\;. \label{tau} \end{equation} Here $z=z(\delta)$ is the dynamical exponent, which is generally a continuous function of the quantum control parameter, $\delta$, which measures the distance from the quantum critical point. According to scaling theory\cite{scaling,ijr} the distribution of the low-energy excitations, $n(E,\ell)$, depends on the scaling combination, $E\ell^z$, and for a small but fixed $E$ it is proportional to the volume, $\ell^d$, since the probability of finding a rare region goes linearly with the volume. From this the asymptotic behavior of the distribution function in the thermodynamic limit reads as: \begin{equation} n(E) \sim E^{d/z-1}\;. \label{n_E} \end{equation} Thermodynamical quantities which are obtained through integration of the density of states are also singular. For example the low-temperature behavior of the average linear susceptibility, $\chi(T)$, and that of the specific heat, $c_v(T)$, is expected to scale as\cite{im,vojta} \begin{equation} \chi(T)\sim T^{-1+d/z},\quad c_v(T)\sim T^{d/z}\;, \label{chi_cv} \end{equation} whereas the small-field, $H$, dependence of the zero-temperature magnetization is given by: \begin{equation} m(H) \sim H^{d/z}\;. \label{m_H} \end{equation} One can see from Eq.(\ref{chi_cv}) that the susceptibility is divergent at zero temperature for $z(\delta)>d$, which was noticed first by McCoy\cite{mccoy} in an exact calculation of the random transverse-field Ising chain (RTFIC). Detailed results about Griffiths-McCoy singularities are obtained for one-dimensional (1d) systems partially by numerical investigations (free-fermionic techniques\cite{free_fermion,bigpaper,ijr}, density matrix renormalization method\cite{DMRG,ijl}, quantum Monte Carlo (MC) simulations\cite{QMC}) and by analytical calculations\cite{fisher,s1,ijl,i02} based on the use of a strong disorder renormalization group (SDRG) method\cite{im}. For higher dimensional systems Griffiths-McCoy singularities are studied numerically, either by quantum MC simulations\cite{QMC1} or by numerical implementation of the SDRG method\cite{SDRG1}. Analytical and conjecturedly exact results about Griffiths-McCoy singularities are scarce and these are practically restricted to the RTFIC. Analytical solution of the SDRG equations is first obtained in the vicinity of the quantum critical point\cite{fisher}, i.e. in the weakly disordered and in the weakly ordered Griffiths phases, where the dynamical exponent is shown to diverge as $z(\delta) \sim 1/|\delta|$. The solution is then extended to the complete Griffiths phase\cite{ijl,i02} and the calculated value of $z(\delta)$ is shown to agree with that obtained through a mapping to a random walk problem in a random environment\cite{ir98}. In this paper we use a direct and simple method to calculate exact values of the Griffiths-McCoy singularities in a class of random quantum spin chains. These models include the random tight-binding chain, the random antiferromagnetic XX-chain as well as the RTFIC. The low-energy excitations for each models have the same form: they are obtained from the eigenvalue problem of a symmetric tridiagonal matrix, $\cal M$ see in Eq.(\ref{M_tb}), with random (positive) entries. In the off-critical region of the spin chains there is an even-odd asymmetry: the matrix-elements of $\cal M$ are taken from different distributions at even and odd bonds. We calculate the density of states, $n(E)$, in the center of the band by the Dyson-Schmidt technique\cite{dyson} using the random walk idea by Eggarter and Riedinger\cite{eggarter_riedinger}. In Ref.[\onlinecite{eggarter_riedinger}] $n(E)$ is calculated in the continuum approximation for an even-odd symmetric $\cal M$, which corresponds to the critical point of the random quantum spin chains. In the present paper $\cal M$ has a general even-odd asymmetric form, which corresponds to a strongly disordered quantum Griffiths phase and for which the continuum approximation is no longer valid. Having the exact behavior of $n(E)$ at hand we than calculate the singularities of the thermodynamic quantities (specific heat, susceptibility, magnetization). The structure of the paper is the following. Random quantum chain models studied in this paper are presented in Sec.\ref{sec:random}. In Sec.\ref{sec:density} the density of states of the low energy excitations is calculated by the Dyson-Schmidt technique and the relation of this technique with the SDRG method is discussed. Thermodynamic singularities are calculated in Sec.\ref{sec:therm} and the results are discussed in Sec.\ref{sec:disc}. \section{Random quantum chains} \label{sec:random} \subsection{Random tight-binding model} The first model we consider is a one-dimensional tight-binding model with off-diagonal disorder\cite{cohen} being defined by the Hamiltonian: \begin{equation} {\cal H}=\sum_{i} t_i (|i\rangle\langle i+1|+|i+1\rangle\langle i|)\;, \label{H_tb} \end{equation} with random hopping matrix-elements, $t_i$. The hopping matrix-elements are generally taken from different distributions at even ($t_e$) and odd ($t_o$) sites, so that a quantum control-parameter is defined as: \begin{equation} \delta=\frac{[\ln t_o]_{\rm av}-[\ln t_e]_{\rm av}}{{\rm var}(\ln t_e)+{\rm var}(\ln t_o)}\;, \label{delta} \end{equation} where $[\dots]_{\rm av}$ stands for averaging over quenched disorder and ${\rm var}(x)$ stands for the variance of $x$. For $\delta > 0$ ($\delta < 0$) the model is asymmetric and the particles are preferentially at odd (even) bonds. The symmetric model with $\delta = 0$ corresponds to a quantum critical point. In the basis, $|i\rangle$, the Hamiltonian is represented by a tridiagonal matrix \begin{equation} {\cal M}= \begin{pmatrix} 0 & t_1 & & & & \cr t_1 & 0 & t_2 & & & \cr & t_2 & 0 & t_3& & \cr & & \ddots &\ddots &\ddots & \cr \end{pmatrix} \label{M_tb} \end{equation} and we are interested in its eigenvalue problem: \begin{equation} {\cal M}\vec{\alpha}=E\vec{\alpha} \label{M} \end{equation} and the corresponding density of states, $n(E)$, at the center of the band. \subsection{Random antiferromagnetic XX-chain} The second model is the random antiferromagnetic XX-chain defined by the Hamiltonian: \begin{equation} {\cal H}_{XX}=\sum_{i} J_i (S_i^x S_{i+1}^x+S_i^y S_{i+1}^y) \label{H_XX} \end{equation} in terms of the spin-$1/2$ operators, $S_i^{x,y}$, at cite $i$. Here the $J_i$ exchange couplings are random variables which have different distributions at even ($J_e$) and odd ($J_o$) sites. Using the Jordan-Wigner transformation: $a_j^{\pm}=S_j^x \pm iS_j^y$ and $c^+_i=a_i^+\exp\left[\pi i \sum_{j}^{i-1}a_j^+a_j^-\right]$ and $c_i=\exp\left[\pi i \sum_{j}^{i-1}a_j^+a_j^-\right]a_i^-$ this Hamiltonian is expressed in terms of fermion creation ($c^+_i$) and annihilation ($c_i$) operators as\cite{lsm}: \begin{equation} {\cal H}_{XX}=\sum_{i} \frac{1}{2}(J_i c^+_i c_{i+1} + {\rm h.c.})\;. \label{ferm_XX} \end{equation} The low-energy states of the model contain one fermion, which can be written in the form $|\psi\rangle=\sum_i \alpha_i c^+_i |0 \rangle$, where $|0 \rangle$ denotes the fermionic vacuum. Energies in this one fermion subspace are obtained by the solution of the eigenvalue problem of ${\cal M}$ in Eq.(\ref{M_tb}) with the correspondence: \begin{equation} t_i=J_i/2 \label{corresp_XX} \end{equation} Then the quantum control parameter of the model is just given by $\delta$ in Eq.(\ref{delta}). In the asymmetric model with $\delta>0$ ($\delta<0$) there is enforced dimerization and the system is in the random dimer phase\cite{HYMAN} with preference of odd (even) bonds. On the other hand at the quantum critical point with $\delta=0$ the system is in the so called random singlet phase\cite{fisherxx}. \subsection{Random transverse-field Ising chain} Our third and final model is the RTFIC, which is a prototypical model of random quantum systems having an order-disorder transition\cite{fisher}. This system is defined by the Hamiltonian: \begin{equation} {\cal H}_{I} = -\frac{1}{2}\sum_{i} \lambda_{i}\sigma_i^x \sigma_{i+1}^x-\frac{1}{2}\sum_{i=1}^L h_i \sigma_i^z \label{eq:H} \end{equation} in terms of the Pauli-matrices, $\sigma_i^{x,z}$, at site $i$ and the $\lambda_i$ couplings and the $h_i$ transverse fields are random numbers. As for the XX-chain ${\cal H}_{I}$ is expressed in terms of fermion operators\cite{pfeuty}: \begin{eqnarray} {\cal H}_{I}&=& -\sum_{i}h_i\left( c^+_i c_i-\frac{1}{2} \right)\cr &-& \frac{1}{2}\sum_{i}\lambda_i(c^+_i-c_i)(c^+_{i+1}+c_{i+1}) \label{ferm_I} \end{eqnarray} which is than diagonalized through a canonical transformation. Now the low-energy excitations contain one free fermion, the possible energy of which is given by the positive eigenvalues of the following symmetric matrix\cite{it,bigpaper}: \begin{equation} {\cal T}= \begin{pmatrix} 0 & h_1 & & & & \cr h_1 & 0 &\lambda_1 & & & \cr & \lambda_1 & 0 & h_2& & \cr & & \ddots &\ddots &\ddots & \cr \end{pmatrix} \label{T} \end{equation} This is equivalent to ${\cal M}$ in Eq.(\ref{M_tb}) with the correspondences: \begin{equation} t_{2i-1}=h_i,\quad t_{2i}=\lambda_i \label{corresp_I} \end{equation} Using this relation together with Eq.(\ref{delta}) the control parameter of the RTFIC is given by the difference in the average log-fields and the average log-couplings. For $\delta>0$ ($\delta<0$) the system is in the paramagnetic (ferromagnetic) phase, and $\delta=0$ represents the quantum critical point. We can thus conclude that the low-energy properties of all the three models are related to the eigenvalue problem of ${\cal M}$ in Eq.(\ref{M_tb}). In the next section we calculate the density of states of matrix ${\cal M}$ around $E=0$ by the Dyson-Schmidt method. \section{Density of states at the center of the spectrum} \label{sec:density} Here in the first two subsections we recapitulate the basic ingredients of the Dyson-Schmidt method and present the solution in the continuum approximation. Our findings, which are obtained in the strongly disordered regimes are presented in the last two subsections. \subsection{The random walk method} In order to calculate the density of states of ${\cal M}$ we introduce a new vector, ${\vec \Delta}$, with the components $\Delta_i=\alpha_{i-1}t_{i-1}/\alpha_i$, which satisfy the equations : $\Delta_{i+1}=t_i^2/(E-\Delta_i)$. The basic ingredient of the Dyson-Schmidt method\cite{dyson} is the {\it node counting theorem} of one-dimensional Hamiltonians, which states that the integrated density of states, $N(E)=\int_{-\infty}^E n(E') {\rm d}E'$, is given by the fraction of positive terms in the sequence of $\Delta_i$. At the center of the band, $E=0$, the components of ${\vec \Delta}$ have alternating signs, thus here the "sign variables" $s_i \equiv sign[\Delta_i (-1)^i]$ have a fully ordered state, $\dots \uparrow \uparrow \uparrow \uparrow \uparrow \uparrow \uparrow \uparrow \uparrow \uparrow \dots$ and $N(0)=1/2$. For nonzero $E$ the iterated equations for ${\Delta}_i$ are the following\cite{eggarter_riedinger}: \begin{eqnarray} \Delta_{2i}&=& f_{2i-2} \left(\frac{t_{2i-1}}{t_{2i-2}}\right)^2\Delta_{2i-2} \cr f_{2i-2}&=&\frac{1-E/\Delta_{2i-2}}{1+(E \Delta_{2i-2}-E^2)/t_{2i-2}^2}\;, \label{iterated} \end{eqnarray} which lead to different iteration behaviors for small positive $E$ for various limiting values of ${\Delta}_{2i}$. These are summarized as: \begin{subequations}\label{limits} \begin{align} &\Delta_{2i+1}/\Delta_{2i}<0,& {\rm if}& &\Delta&_{2i} < E \label{a} \\ &f_{2i}=1,& {\rm if}& &E& \gg \Delta_{2i} \gg {\tilde t}^2/E \label{b} \\ &\Delta_{2i+2}/\Delta_{2i} < 1,& {\rm if}& &\Delta&_{2i} \approx {\tilde t}^2/E \label{c} \end{align} \end{subequations} where $\tilde{t}$ denotes the typical (average) value of the matrix-element. According to (\ref{b}) we can identify an interval, $[ E,{\tilde t}^2/E]$, in which the "signs" stays ordered, say $s_i=\uparrow$. There is a finite upper boundary value at $\Delta_{max}={\tilde t}^2/E$, where the iterated sequence is reflected, but $s_i$ stays $\uparrow$ (see (\ref{c}), whereas as the sequence arrives at the lower boundary value, $\Delta_{min}=E$, the "spins" change sign (see (\ref{a}) and the iteration process starts again, however in a new domain with $s_i=\downarrow$. Consequently for a small $E>0$ the sign variables have a fragmented domain structure $\dots \downarrow \downarrow \downarrow \downarrow \uparrow \uparrow \uparrow \uparrow \uparrow \downarrow \downarrow \downarrow \downarrow \dots$ and therefore the fraction of positive terms in the sequence of $\Delta_i$ is somewhat larger than $1/2$, due to extra positive terms appearing at the domain walls. If the typical (average) size of a domain is denoted by $\tilde{\ell}$, then the density of states is asymptotically given by: \begin{equation} N(E)-N(0)=\frac{1}{2\tilde{\ell}}\;. \end{equation} We can thus summarize that to obtain the density of states at the center of the spectrum it is enough to follow the evaluation of the sequence, $\Delta_i$, within one typical domain and calculate its size, $\tilde{\ell}$. Within this domain we formally put $f_{2i-2}=1$ in Eq.(\ref{iterated}) and set i) a reflecting boundary at $\Delta_{max}$ and ii) an absorbing boundary at $\Delta_{min}$. If we introduce the logarithmic variable, $\ln \Delta_{2i}=u_{2i}$, we obtain a random walk (directed polymer) problem: \begin{equation} u_{2i}=2(\ln t_{2i-1}-\ln t_{2i-2})+u_{2i-2}\;, \label{walk} \end{equation} with reflecting $(u=u_{max})$ and absorbing $(u=u_{min})$ boundary conditions. In this language the walker (polymer) starts at $u_0=u_{max}$ and its mean first-passage time (length) at the position $u_{min}$ is just $\tilde{\ell}$, thus $u_{min}=u_{\tilde{\ell}}$. \subsection{Analysis in terms of the diffusion equation} \label{sec:diff} In order to set the length-scales in the random walk problem we use a continuum approximation in which Eq.(\ref{walk}) is transformed into a diffusion equation: \begin{equation} \frac{\partial P(u,\ell)}{\partial \ell}=D\frac{\partial^2 P(u,\ell)}{\partial u^2} -v\frac{\partial P(u,\ell)}{\partial u}\;. \label{diff} \end{equation} Here $P(u,\ell)$ is the probability distribution of the walk, $D=2[var(\ln t_e)+var(\ln t_o)]$ is the diffusion coefficient and $v=2([\ln t_o]_{\rm av}-[\ln t_e]_{\rm av})$ is the drift velocity. The typical size of the transverse fluctuations of the walk is given by: $\tilde{u}=D/v=\delta^{-1}$, whereas the average distance between two reflections, $\xi$, follows from the relation $\tilde{u} \sim \sqrt{D\xi}$, thus we obtain for the correlation length: \begin{equation} \xi \sim D^{-1} \delta^{-2} \end{equation} which agrees with the result of SDRG calculations\cite{fisher}. The continuum approximation and thus the use of the diffusion equation is justified if the correlation length is much larger than the lattice spacing. This condition is satisfied if we are either at the critical point, $\delta=0$, or in the weakly disordered Griffiths phase with $|\delta| \ll 1$. \subsubsection{Critical point} At the critical point both the correlation length, $\xi$, and the typical size of transverse fluctuations, $\tilde{u}$, are divergent and they are related with the length scale, $\tilde{\ell}$, as: $\xi \sim \tilde{\ell}$ and ${\tilde u} \sim \sqrt{D \tilde{\ell}}$. Absorption of the walker in this case is due to {\it typical fluctuations}, when ${\tilde u}$ grows to the order of the width of the strip: ${\tilde u} \sim \Delta u=u_{max}-u_{min}=\ln(\tilde{t}^2/E^2)$. From this follows: \begin{equation} \tilde{\ell} \sim \frac{1}{D} \ln(\tilde{t}^2/E^2)^2\; \end{equation} so that \begin{equation} N(E)-N(0)\sim D\left[\ln(\tilde{t}^2/E^2)\right]^{-2}\;. \end{equation} This is the classical result derived by Eggarter and Riedinger\cite{eggarter_riedinger}. \subsubsection{Weakly disordered Griffiths phase} \label{sec:weak_G} In the weakly disordered Griffiths phase with $1 \ll \delta>0$ the walker is drifted towards the reflecting boundary and both the correlation length and the typical size of the transverse fluctuations are finite, but much larger than the lattice spacing, thus the continuum approximation is valid. In this case $\tilde{u}$ is much smaller than the width of the strip, its absorption takes place with a very small probability: $p(\Delta u) \propto \exp(-\frac{\Delta u}{\tilde{ u}})$, thus it is a rare region effect and due to {\it extreme fluctuations}. Before having such a large fluctuation the walker is reflected several times and the typical number of independent excursions is given by $ \tilde{\ell}/\xi$, the value of which follows from extreme-value statistics\cite{galambos}: $p(\Delta u) \tilde{\ell}/\xi=O(1)$. From this we have \begin{equation} \tilde{\ell} \sim \xi \exp\left(\frac{v}{D}\ln(\tilde{t}^2/E^2)\right) \sim \left(\frac{\tilde{t}}{E}\right)^{1/z}; \label{n_z} \end{equation} with \begin{equation} \frac{1}{z}=\frac{2v}{D}=2\frac{[\ln t_o]_{\rm av}-[\ln t_e]_{\rm av}}{[var(\ln t_e)+var(\ln t_o)]}=2\delta\;. \label{1/z} \end{equation} Here $z$ is just the dynamical exponent defined in Eq.(\ref{tau}). In the weakly disordered Griffiths phase at the center of the band there is a power-law singularity of the density of states: \begin{equation} N(E)-N(0)\sim \left(\frac{\tilde{t}}{E}\right)^{-1/z}\;. \label{N_E} \end{equation} which is equivalent to the form in Eq.(\ref{n_E}). This result for the random antiferromagnetic XX-chain has been presented in\cite{lamas}. \subsection{Analysis in the strongly disordered Griffiths phase} \label{sec:asymptotic} In the strongly disordered Griffiths phase the correlation length is in the order of the lattice spacings and the continuum approximation is not valid. In this case we use discrete variables and denote the (nonlogarithmic) position of the walker at the $j$-th step of the $k$-th independent excursion, which starts at $r(k)$, as $\Delta_{2j}^{(k)}$. Thus $r(k)/k = \xi$ for large $k$ and the normalized position is given by: \begin{equation} \rho_{2j}^{(k)} \equiv \frac{\Delta_{2j}^{(k)}}{\Delta_{max}}= \prod_{j'=1+r(k)}^{j+r(k)} \left(\frac{t_{2j'-1}}{t_{2j'-2}}\right)^2\;. \end{equation} The condition of absorption is formulated as: \begin{equation} \min_{k} \min_{1<j<\Delta r(k)} \rho_{2j}^{(k)}=\frac{\Delta_{min}}{\Delta_{max}}=\frac{\tilde{t}^2}{E^2}\;, \end{equation} where $\Delta r(k)=r(k+1)-r(k)$, which can be replaced by $\Delta r=\infty$. Keeping in mind that $\rho^{(k)}_{2j}$ is typically much larger than its minimum value we can estimate the order of magnitude of the minimum as \begin{equation} \min_{k} \min_{1<j<\infty} \rho_{2j}^{(k)} \propto \min_{k} \left[ y^{(k)} \equiv \sum_j (\rho_{2j}^{(k)})^{-1} \right]^{-1}\;. \label{min2} \end{equation} Here $y^{(k)}$ is a Kesten variable\cite{kesten} for any $k$, the distribution function of which for large arguments displays a singularity: \begin{eqnarray} p(y) \opsim_{y \to \infty} y^{-(1+\mu)}\;. \label{p_asymp} \end{eqnarray} where the exponent, $\mu$, is given by the positive root of the equation: \begin{equation} \left[\left(\frac{t_o^2}{t_e^2}\right)^{\mu}\right]_{\rm av}=1\;. \label{mu} \end{equation} (For a pedagogical introduction to the theory of Kesten variables see Appendix C of Ref.[\onlinecite{im}].) In this way the typical number of excursions, $ \tilde{\ell}/\xi$, follows from extreme-value statistics\cite{galambos}: $\tilde{\ell}/\xi \int_{y_{max}}^{\infty} p(y) {\rm d} y=1$, and we obtain: \begin{equation} \tilde{\ell} \sim \xi \left(\frac{t}{E}\right)^{2\mu}\;. \end{equation} Comparing with Eq.(\ref{n_z}) we see that the dynamical exponent in the strongly disordered Griffiths phase is given by: \begin{equation} \frac{1}{z}=2\mu\;, \label{z_mu} \end{equation} which in the limit $\delta\ll 1$ gives back the result obtained in the weakly disordered Griffiths phase\cite{ijl,i02} in Eq.(\ref{1/z}). Then with the correspondence in Eq.(\ref{z_mu}) the density of states at the center of the band is given in Eq.(\ref{N_E}). \subsection{Relation with the strong disorder renormalization group method} The density of states in the center of the spectrum of $\cal M$ can be analyzed by the SDRG method\cite{im}, too, and here we outline this procedure. The first step in this study is to arrange the matrix-elements, $t_i$, in descending order and use the largest one, $\Omega={\rm max}_i \{t_{i}\}$, to set the energy scale in the system. Let us denote the largest term by $t_j$, which connects sites $j$ and $j+1$ and eliminate the two equations in the eigenvalue problem which contain $t_j$. In second-order perturbational method, which is correct up to $O\left((t_{j-1}/t_j)^2\right)$ and $O\left((t_{j+1}/t_j)^2\right)$ we have for the effective matrix-element, $t'$, between the remaining sites, $j-1$ and $j+2$: \begin{equation} t' \approx \frac{t_{j-1} t_{j+1}}{t_j}\;. \end{equation} This new term has a length, $m'=m_{j-1}+m_{j}+m_{j+1}=3$, where the original matrix-elements have unit lengths. In the following steps we repeat the decimation transformation, during which the energy scale is reduced, the lengths are increased and the distribution functions of the matrix-elements, $R_e(t_e,\Omega)$ and $R_o(t_o,\Omega)$, approach their fixed-point form. This type of RG equations have been analytically solved both at the critical point\cite{fisher} and in the Griffiths phase\cite{ijl,i02}. Here we summarize the known results for the Griffiths phase with $\delta>0$. In the starting steps of the RG both $t_e$ and $t_o$ terms are decimated, but the transformation in later steps become asymmetric. As the typical lengths are growing beyond $m' \sim \xi$ almost exclusively the $t'_o$ terms are decimated and the $t'_e$ terms become very small, such that at the fixed point, $\Omega \to \Omega^*=0$, we have $t'_e/t'_o \to 0$. As a consequence the energy of the low-energy excitations is simply $E \simeq t'_o$. At the fixed point the distribution of $t_o$ is given by\cite{ijl,i02}: \begin{equation} R_o(t_o,\Omega)=\frac{2 \mu}{\Omega} \left(\frac{\Omega}{t_o}\right)^{1-2\mu}\;, \end{equation} where $\mu$ is defined in Eq.(\ref{mu}). This is just equivalent to the distribution of the excitation energies in Eq.(\ref{n_E}), with the dynamical exponent defined in Eq.(\ref{z_mu}). Now to make a correspondence with the random walk method the starting RG steps which lead to an effective $t'_e(k)(\gg t'_o(k))$ of length $m'(k) \sim \xi$ are equivalent to an excursion (between two reflections) of the walk of size $\Delta r(k) \sim \xi$ and the minimal value of $\rho^{(k)}_{2j}$ for this excursion is just the renormalized value of $t'_o(k)$. The analogous quantities in the two approaches are collected in Table \ref{table:1}. \begin{table} \caption{Analogous quantities in the random walk (RW) and in the SDRG methods \label{table:1}} \begin{tabular}{|c||c|c|c|} \hline method & independent unit & length scale & energy scale \\ \hline RW & excursion & size of the excursion & ${\rm min}_j \rho^{(k)}_{2j}$ \\ \hline SDRG & cluster & size of the cluster & $t'_o(k)$ \\ \hline \end{tabular} \end{table} \section{Thermodynamic singularities} \label{sec:therm} Here we consider the random tight-binding model with half filling, as well as the random antiferromagnetic XX-chain and the RTFIC and note that all these models are expressed in terms of free fermions. The common form of the Hamiltonians is given by: \begin{equation} {\cal H}_F=\sum_q E_q (\eta_q^+ \eta_q -1/2) \end{equation} where $E_q$ denotes the $q$-th eigenvalue of ${\cal M}$ and $\eta_q^+$ ($\eta_q$) are fermion creation (annihilation) operators. The ground-state energy per site of this system is given by: \begin{equation} {\cal E}=-\frac{1}{2L} \sum_q E_q=-\frac{1}{2}\int_{E_{min}}^{E_{max}} n(E) E {\rm d} E\; \label{energy_0} \end{equation} and the free energy per site: \begin{eqnarray} &{\cal F}&=-\frac{T}{L} \sum_q \ln \left[2\cosh \left(\frac{E_q}{2T} \right) \right]=\cr &-&T\left\{\ln2 + \int_{E_{min}}^{E_{max}} n(E) \ln\left[\cosh \left(\frac{E}{2T} \right) \right] {\rm d} E \right\}\; \label{free_energy} \end{eqnarray} where $L$ is the length of the chain. From the free energy we obtain the internal energy: \begin{equation} {\cal E}(T)=-\frac{1}{2}\int_{E_{min}}^{E_{max}} n(E) E \tanh\left(\frac{E}{2T} \right){\rm d} E \end{equation} and the specific heat: \begin{equation} c_v(T)=\int_{E_{min}}^{E_{max}} n(E)\left(\frac{E}{2T} \right)^2 \cosh^{-2}\left(\frac{E}{2T} \right){\rm d} E. \end{equation} Now using the form of the density of states at the center of the band we obtain for the low temperature behavior: \begin{equation} c_v(T) \propto {\cal A} T^{1/z} \int_{-\infty}^{\infty} \varepsilon^{1/z+1} \cosh^{-2} \varepsilon\ {\rm d} \varepsilon.\;, \label{cv1} \end{equation} in agreement with the scaling result in Eq.(\ref{chi_cv}). Note that the prefactor in Eq.(\ref{cv1}), ${\cal A}$, is proportional to $\xi^{-1} z^{-1}$, which means that in the weakly disordered Griffiths phase we have: ${\cal A} \sim \delta^3,~\delta \ll 1$, in agreement with the SDRG result\cite{fisher}. Next we consider the random antiferromagnetic XX-chain for which in the Hamiltonian in Eq.(\ref{H_XX}) we introduce a homogeneous ordering field: $H\sum_i S_i^z$. This term with fermionic variables assumes the form: $H/2 \sum_i (c_i^+c_i-1/2)$, thus the eigenvalue matrix $\cal M$ contains also diagonal elements: ${\cal M}_{i,i}=H/4,~\forall i$, and the eigenvalues are shifted by $E \to E+H/4$. The magnetization is obtained through differentiation: \begin{equation} m(H,T)=-\frac{\partial {\cal F}}{\partial H} \sim \int_{-H/4}^{H/4} n(E) \tanh\left(\frac{E}{2T} \right){\rm d} E \label{m_H_T} \end{equation} where we have used the fact that the spectrum of ${\cal M}$ in Eq.(\ref{M_tb}) is symmetric to $E=0$. At zero temperature $m(H,0)$ is singular for small $H$: \begin{equation} m(H,0)\sim N(H/4)-N(-H/4) \sim H^{1/z} \end{equation} as in Eq.(\ref{m_H}). Evaluating the integral in Eq.(\ref{m_H_T}) for small $H$ and $T$, however with $H/T=O(1)$ we obtain for the low-temperature susceptibility: \begin{equation} \chi(T) \sim T^{1/z-1} \end{equation} which corresponds to the scaling result in Eq.(\ref{chi_cv}). \section{Discussion} \label{sec:disc} In this paper we have studied Griffiths-McCoy singularities in random quantum (tight-binding, XX and Ising) spin chains, which can be represented in terms of free fermions. The main step of our investigation is the calculation of the density of states of the low energy excitations, which excitations are eigenvalues of a symmetric tridiagonal matrix with random entries, however with an odd-even asymmetry. This latter problem is solved exactly by the Dyson-Schmidt technique\cite{dyson,eggarter_riedinger} for any value of the quantum control parameter, $\delta$. Previous studies of this problem are restricted to the quantum critical point\cite{eggarter_riedinger}, $\delta=0$, and to the weakly disordered Griffiths phase\cite{lamas}, $\delta \ll 1$. As we described in Sec.\ref{sec:diff} in this problem there are three length scales: the mean-first passage length, $\tilde{\ell}$, the correlation length, $\xi$, and the lattice spacing, $a$. In the different regimes of the quantum control parameter their relative magnitudes are summarized in Table~\ref{table:2}. \begin{table} \caption{Relation between the length-scales in different regimes of the quantum control parameter. \label{table:2}} \begin{tabular}{|c||c|c|} \hline critical point & $\delta=0$ & $\tilde{\ell} \sim \xi \gg a$ \\ \hline weakly dis. Griffiths & $|\delta| \ll 1$ & $\tilde{\ell} \gg \xi \gg a$ \\ \hline strongly dis. Griffiths & $|\delta|=O(1)$ & $\tilde{\ell} \gg \xi \sim a$ \\ \hline \end{tabular} \end{table} In a finite system there is still another length scale given by the size of the system, $L$, and the mean-first passage length can not exceed this value: $\tilde{\ell}\sim L$. Consequently the lowest excitation energy is limited to $E_1 \sim L^{-z}$. In this case one is interested in the distribution of the scaling combination, $E_1 L^{z}$, which in the random walk method in Sec.\ref{sec:asymptotic} is obtained from the statistics of extremes. Here we recall that $E_1$ is just the minimum value of a set of $L/\xi$ independent random numbers, each having the same parent distribution in a power-law form, see Eq.(\ref{p_asymp}). Consequently the distribution of $\epsilon_1=aE_1 L^{z}$ in the large $L$ limit follows the Fr\'echet distribution\cite{galambos}: \begin{equation} \tilde{P}_1(\epsilon_1)=\frac{1}{z} \epsilon_1^{1/z-1} \exp(-\epsilon_1^{1/z})\;, \label{frechet} \end{equation} where $a$ is a nonuniversal constant which depends on the amplitude of the tail in Eq.(\ref{p_asymp}). Here one can go on and consider the second eigenvalue, $E_2$, or more generally the $q$-th smallest eigenvalue, $E_q$. These are all obtained from the theory of extreme value statistics of independent and identically distributed ({\it i.i.d.}) random numbers and their distribution is given by the generalized Fr\'echet distribution, see in\cite{galambos}. In this way we have shown that the distribution of the lowest energy levels of these strongly correlated physical systems are described in a form which holds for {\it i.i.d.} random numbers. This scenario, which is shown here exactly for the specific models is expected to hold generally for all such random quantum systems, even in higher dimensions, for which the low-energy behavior is controlled by a so called strong disorder fixed point in the SDRG framework\cite{extr}. The dynamical exponent, $z$, which is calculated exactly in this paper is found a continuous function of the control parameter, $\delta$. Using the SDRG approach the same result is obtained\cite{ijl,i02}, thus our present study gives further credit to the conjecture that the SDRG method provides asymptotically exact results even far outside the critical point, as far as dynamical quantities are considered. This latter statement is expected to hold for all systems with a strong disorder fixed point. \begin{acknowledgments} This work has been supported by the National Office of Research and Technology under Grant No. ASEP1111 and by the Hungarian National Research Fund under grant No OTKA TO48721, K62588, MO45596. \end{acknowledgments}

\section{Introduction} Heavy ion experiments at the Large Hadron Collider (LHC) and the Relativistic Heavy Ion Collider (RHIC) have set out the goal to produce and study new forms of strongly interacting matter, such as the quark gluon plasma. Besides direct emissions, we can observe this matter at the point of break-up through the hadrons leaving the system. Prominent approaches include the hydrodynamical modelling of the angular distribution and the study of the event-by-event distribution of conserved charges \cite{Hippolyte:2012yu}. The chemical freeze-out, defined as the last inelastic scattering of hadrons before detection, has already been studied in terms of the statistical hadronization model by fitting a chemical potential and a temperature parameter to the pion, kaon, proton and other accessible yields from experiment \cite{Andronic:2005yp,Cleymans:2005xv}. For higher collision energies smaller chemical potential are realized at freeze-out. Repeating the analysis for a series of beam energies provide a manifold of $(T-\mu)$ pairs on the phase diagram, the freeze-out curve in Fig.~\ref{fig:phasediag}. While we know from lattice simulations that the QCD transition is a crossover at zero chemical potential \cite{Aoki:2006we}, a critical end point and a first order transition line may exist in the ($T$-$\mu$) plane. Its experimental search is based on the analysis of event-by-event fluctuations \cite{Stephanov:1999zu}. Parallel to the experimental effort lattice field theory has been able to describe the QCD transition in an increasing detail. The transition temperature has been determined \cite{Tctrilogy,Bazavov:2011nk}, and the curvature of the transition line was also given \cite{Endrodi:2011gv}. The equation of state has been calculated at zero \cite{Borsanyi:2010cj,Borsanyi:2013bia} and small chemical potentials \cite{Borsanyi:2012cr}. Quark number susceptibilities have also been determined both for strange as well as light flavors \cite{Borsanyi:2011sw,Bazavov:2012jq}. All these results have been subject to a continuum extrapolation. \begin{figure} \begin{center} \includegraphics[width=3.5in]{phase_diag_cont} \end{center} \caption{\label{fig:phasediag} The QCD phase diagram for small chemical potentials \cite{Endrodi:2011gv}. A temperature and a chemical potential has been fitted in terms of the statistical hadronization model for every collision energy \cite{Andronic:2005yp,Cleymans:2005xv}. For comparison we show the crossover lines based on two observables from lattice simulations \cite{Endrodi:2011gv}. } \end{figure} The ever-increasing accuracy of fluctuation measurements at RHIC and LHC allows us today to make direct comparisons of lattice results with data. The STAR experiment has recently published the beam-energy and centrality dependence of the net-proton distribution \cite{Adamczyk:2013dal}. For the net electric charge distribution there are preliminary results available both from the STAR \cite{McDonald:2012ts,Sahoo:2012bs} and from the PHENIX collaboration \cite{Mitchell:2012mx}. The strategy for a successful comparison between theory and experiment has been long worked on \cite{Jeon:2000wg,Asakawa:2000wh,Karsch:2012wm}. Here we use the observables suggested in Ref.~\cite{Bazavov:2012vg}. The fluctuations for a conserved quantum number, such as electric charge, are measured in a sub-system, small enough to behave like a grand canonical ensemble, yet large enough to behave like an ensemble. The selection of a subsystem is accomplished through cuts in rapidity and transverse momentum. Still, the fluctuations or even the mean value of net charge depends on the unknown subvolume. To cancel this factor ratios are considered, such as mean/variance, which was described as a baryometer in Refs.~\cite{Karsch:2012wm,Bazavov:2012vg}. Other relevant combinations are listed in Eq.~(\ref{eq:observables}). At zero chemical potential the mean and skewness vanish, leaving us only with the kurtosis and variance to work with at the energies of LHC. RHIC, however, works at non-zero chemical potentials. There we expand the lattice results around zero chemical potential and extrapolate to small but finite values and use then the mean and the skewness, which are now non-zero. In Ref.~\cite{Bazavov:2012vg} these observables were used as baryometer and thermometer, respectively. The rules for such an extrapolation are given by the experimental setting: there is no strangeness input in the colliding nuclei, and the ratio of protons and neutrons in the gold or lead atoms predeterimne the charge-to-baryon ratio in the outcoming hadrons as well. Thus: \begin{eqnarray} \left\langle S\right\rangle=0,&& \left\langle Q\right\rangle=0.4\left\langle B\right\rangle. \label{eq:constraint} \end{eqnarray} These conditions can be respected if we introduce a strange and electric charge chemical potential in addition to the baryochemical potential, as it has already been a method in the statistical hadronization model. \section{Fluctuations from the lattice} We generated finite temperature ensembles using the three-level Symanzik improved gauge action with dynamical stout-improved staggered fermions (see Ref.~\cite{Aoki:2005vt}. The temporal extent of the lattices determine the lattice spacing at a given temperature, we use $N_t=6,~8,~10,~12,~16$ (around $T_c$ these translate to the lattice spacings of $a=0.22, 0.16, 0.13, 0.11$ and $0.08$~fm, respectively). At every lattice spacing and temperature we stored and analyzed every 10th configuration in the rational hybrid Monte Carlo streams. \begin{figure} \includegraphics[width=\textwidth]{kurtstatbins_16} \caption{Statistics behind the fluctuation calculations. The stored configurations have been separated by 10 HMC trajectories, each. Each configuration was analyzed by $(128 \dots 256)\times 4$ random sources. \label{fig1}} \end{figure} In a grand canonical ensemble we obtain the fluctuations as derivatives of the partition function with respect to the chemical potentials: \begin{eqnarray} \frac{\chi_{lmn}^{BSQ}}{T^{l+m+n}}=\frac{\partial^{\,l+m+n}(p/T^4)}{\partial(\mu_{B}/T)^{l}\partial(\mu_{S}/T)^{m}\partial(\mu_{Q}/T)^{n}}. \end{eqnarray} and they are related to the moments of the distributions of the corresponding conserved charges by \begin{eqnarray} \mathrm{ mean:}~~M=\chi_1~~&&~~\mathrm{ variance:}~~\sigma^2=\chi_2 \nonumber \\ \mathrm{ skewness:}~~S=\chi_3/\chi_{2}^{3/2} ~~&&~~ \mathrm{kurtosis:}~~\kappa=\chi_4/\chi_{2}^{2}\,. \label{eq:observables} \end{eqnarray} With these moments we can express the volume independent ratios \begin{eqnarray} ~S\sigma=\chi_3/\chi_{2} \quad&;&\quad \kappa\sigma^2=\chi_4/\chi_{2}\nonumber\\ M/\sigma^2=\chi_1/\chi_2 \quad&;&\quad S\sigma^3/M=\chi_3/\chi_1\,. \label{moments} \end{eqnarray} The chemical potential dependence enters through the fermion determinant ($\det M_i$), allowing for one $\mu_i$ parameter for each of the three dynamical flavor $i=u,d,s$. The actual observables are based on the derivatives of the logarithm of these determinants: \begin{eqnarray} A_j&=\frac{d}{d\mu_j} \log(\det M_j)^{1/4} = &\trt M_j^{-1} M_j'\,,\\ B_j&=\frac{d^2}{(d\mu_j)^2} \log(\det M_j)^{1/4} =&\trt\left( M_j'' M_j^{-1} -M_j' M_j^{-1} M_j' M_j^{-1} \right)\,,\\ C_j&=\frac{d^3}{(d\mu_j)^3} \log(\det M_j)^{1/4} =&\trt\left( M_j' M_j^{-1} -3 M_j'' M_j^{-1} M_j' M_j^{-1}\right.\nonumber\\ && \left. +2 M_j' M_j^{-1} M_j' M_j^{-1} M_j' M_j^{-1} \right)\,,\\ D_j&=\frac{d^4}{(d\mu_j)^4} \log(\det M_j)^{1/4} = &\trt\left( M_j'' M_j^{-1} -4 M_j' M_j^{-1} M_j' M_j^{-1} +12 M_j'' M_j^{-1} M_j' M_j^{-1} M_j' M_j^{-1}\right.\nonumber\\ && \left. -3 M_j'' M_j^{-1} M_j'' M_j^{-1} -6 M_j' M_j^{-1} M_j' M_j^{-1} M_j' M_j^{-1}M_j' M_j^{-1} \right)\,. \end{eqnarray} We calculate these traces for every configuration using $(128\dots256)\times 4$ random sources. The final derivatives emerge as connected and disconnected contributions, e.g. to second order we have \begin{eqnarray} \partial_i\partial_j \log Z&=& \avr{A_iA_j}+\delta_{ij}\avr{B_i}\,. \end{eqnarray} Where products of diagrams appear, a disjoint set of random sources are used, like here in $A_i$ and $A_j$, even when $i=j$. The first (disconnected) term is responsible for most of the noise, lattice artefacts, on the other hand, come mainly from the connected contributions. \section{Results} The quantities that we look at, in order to extract the freeze-out temperature and baryon chemical potential, are the ratios $R_{31}^Q(T,\mu_B)=\chi_3^Q/\chi_{1}^Q$ and $R_{12}^Q(T,\mu_B)=\chi_1^Q/\chi_{2}^Q$ for small chemical potentials, where $\mu_Q(\mu_B)$ and $\mu_S(\mu_B)$ are chosen to satisfy Eqs.~(\ref{eq:constraint}). We also calculated the analogous baryon fluctuations. For details, see the journal version of this work \cite{Borsanyi:2013hza}. \begin{figure} \begin{center} \includegraphics[width=2.9in]{Q3Q1_v2}\hfil \includegraphics[width=2.9in]{B3B1} \end{center} \caption{ Lattice results on the skewness ratio for the charge (left) and the baryon number (right). The colored symbols correspond to lattice QCD simulations at finite-$N_t$. Black points correspond to the continuum extrapolation \cite{Borsanyi:2013hza}; blue pentagons are the $N_t=8$ results from the BNL-Bielefeld collaboration \cite{Bazavov:2012vg} \label{fig:RQ31}} \end{figure} \begin{figure} \begin{center} \includegraphics[width=2.9in]{Q1Q2mu_v2}\hfil \includegraphics[width=2.9in]{B1B2mu} \end{center} \caption{$R_{12}^Q$ as a function of $\mu_B$: the different colors correspond to the continuum extrapolated lattice QCD results, calculated in a range of temperatures around the QCD crossover \cite{Borsanyi:2013hza}. \label{fig:R12Q}} \end{figure} In Fig. \ref{fig:RQ31} we show the ratios $R_{31}^Q$ (left) and $R_{31}^B$ (right) as a function of the temperature. The continuum extrapolations are shown as black dots. For the charge fluctuations we used five lattice spacings. Baryon fluctuations are plagued by greater noise, but are less sensitive to cut-off effects, here we used four spacings. Charge fluctuation results from the BNL-Bielefeld collaboration corresponding to $N_t=8$ (from Ref.~\cite{Bazavov:2012vg}) are also shown for comparison. In Fig. \ref{fig:R12Q} we show our results for $R_{12}^Q$ as a function of the baryon chemical potential: the different curves correspond to different temperatures, in the range where freeze-out is expected. Such expectations may come from the arguments in Ref.~\cite{BraunMunzinger:2003zz} supporting a freeze-out just below the transition. Alternative hints come from the existing estimates from the statistical hadronization model \cite{Andronic:2005yp,Cleymans:2005xv}. Similarly to the electric charge fluctuations, $R_{31}^B$ will allow us to constrain the temperature and using $R_{12}^B$ we can then obtain $\mu_B$. Notice that the ordering of the temperatures in Fig.~\ref{fig:R12Q} (left) and (right) is opposite. Thus, whether the chemical potentials from the charge and the baryon (proton) fluctuations deliver consistent results will very much depend on the associated temperature, which we can extract from the skewness analysis. A possible source for inconsistencies might be the comparison of proton fluctuation data with baryon fluctuations from the lattice, and also the remnant effects of baryon number conservation \cite{Bzdak:2012an}. A cross-check between the freeze-out parameters from proton and electric charge data also test the basic assumption of equilibrium at the time of freeze-out. \begin{figure} \begin{center} \includegraphics[width=2.9in]{B4B2}\hfil \includegraphics[width=2.9in]{kurt_LS_cont} \end{center} \caption{\label{fig:kurtosis} The baryon number (left) and flavor specific (right) kurtosis ($\kappa\times \sigma^2$) prediction from lattice QCD. These parameters are in principle accessible to LHC experiments, and may be used to define the freeze-out temperature for specific flavors, or to the system as a whole. } \end{figure} Finally we show the kurtosis data in the continuum limit in Fig.~\ref{fig:kurtosis}. The kurtosis of baryon number and light vs. strange quark numbers show different sensitivity to temperature, so are the maxima and the deviation point from the hadron resonance gas prediction flavor dependent. The great question that the experiment will have to decide is whether the freeze-out temperatures themselves are flavor dependent \cite{Bellwied:2013cta}. \textbf{Acknowledgments:} This project was funded by the DFG grant SFB/TR55. The work of C. Ratti is supported by funds provided by the Italian Ministry of Education, Universities and Research under the Firb Research Grant RBFR0814TT. S. D. Katz is funded by the ERC grant ((FP7/2007-2013)/ERC No 208740) as well as the "Lend\"ulet" program of the Hungarian Academy of Sciences ((LP2012-44/2012). The numerical simulations were in part performed the GPU cluster at the Wuppertal University as well as on QPACE, funded by the DFG. We acknowledge PRACE for awarding us access to the Blue Gene/Q system (JUQUEEN) at Forschungszentrum J\"ulich, Germany.

{#sp1 .36} {#sp2 .37} {#sp3 .38} {#sp4 .39} {#sp5 .40} {#sp6 .41} {#sp7 .42} {#sp8 .43} {#sp9 .44} {#sp10 .45} {#sp11 .46}

**Core tip:** This manuscript provides an overview of the vascular depression construct, discusses the methods used to measure cerebrovascular disease on magnetic resonance imaging in older adults, and presents the profile of vascular depression in terms of radiological, neuropsychological, and clinical findings. The goal of this paper is to inform the neuroradiology community of the vascular depression diagnosis and to instill the importance of considering this diagnosis when evaluating magnetic resonance imaging scans of older adults. THE VASCULAR DEPRESSION CONSTRUCT ================================= Vascular depression (VD) is a unique subtype of late-life depression (LLD)\[[@B1]-[@B4]\]. The VD construct consists of a group of patients with late-onset depression (LOD), structural brain changes characterized by higher rates of hyperintensities on T2-weighted brain magnetic resonance imaging (MRI)\[[@B3],[@B5],[@B6]\], and greater neuropsychological impairment as compared to early-onset depression (EOD)\[[@B6]-[@B8]\]. Greater severity of MRI hype-rintensities are associated with poor response to antidepressant treatment\[[@B3]\] and a more chronic course of depression\[[@B9]\]. Therefore, the theory of VD suggests that LOD is a product of damage to corticostriatal circuits by cerebrovascular disease, which leads to executive dysfunction and poor antidepressant treatment response\[[@B1],[@B2],[@B4],[@B5],[@B8]\]. Cerebrovascular disease and depression -------------------------------------- The VD subtype proposes that cerebrovascular disease is related to geriatric depressive syndromes, such that vascular risk factors lead to altered regional brain functioning, which leads to depression. However, there may be additional biological or genetic factors that are also determinants of VD. Indeed, there may be a strong genetic influence in the development of white matter hyperintensities (WMHs) in the elderly, and heritability of WMHs is estimated to be between 55% and 80%\[[@B10]-[@B13]\]. Furthermore, there is an association between vascular risk factor burden and new onset of depression in the elderly population\[[@B14]\]. LLD and cardiovascular disease share etiopathogenetic risk factors, such as high homocysteine levels and inflammation, which are also implicated in cognitive impairment\[[@B15]\]. A meta-analysis found a significant association between vascular risk and LLD, with diabetes, heart disease, and stroke identified as strong individual correlates of LLD\[[@B16]\], and a recent study identified midlife cerebrovascular burden as a significant predictor of LLD, even after controlling for a history of depressive symptoms\[[@B17]\]. A review of potential mechanisms underlying the VD construct proposed three hypotheses by which LLD is mediated: White matter disease leading to disrupted connections between brain areas associated with depression and cognition, inflammatory and immune processes leading to neurodegeneration, and reduced cerebral blood flow\[[@B18]\]. However, the etiology of white matter hyperintensities in older depressed adults remains unclear. Depressed elders may have poorer blood flow to prefrontal tissue as cerebrovascular disease progresses\[[@B8],[@B19],[@B20]\]. Additionally, the hippocampus is vulnerable to aging\[[@B21],[@B22]\], and elders also experience reduced metabolism in limbic regions\[[@B21]\]. There is a consistent relationship between depression, vascular disease, and cerebrovascular risk factors\[[@B23]-[@B26]\]. Indeed, cerebrovascular disease is commonly seen in MRI scans of depressed elders\[[@B5],[@B27]-[@B29]\]. In addition, considerable research has shown that ischemic cerebrovascular disease processes contribute to excessive deep WMHs (DWMHs)\[[@B19],[@B30],[@B31]\]. Thomas et al\[[@B18]\] found that all DWMHs in an elderly group with depression were ischemic, while less than a third of DWMHs in an elderly group with no depression were ischemic. However, Thomas *et al*\[[@B18]\] suggested that the high frequency of ischemic lesions in depressed patients is not due to vascular disease, but instead due to a change in DWMHs from nonischemic to ischemic once a certain threshold for ischemic damage is surpassed. The mechanisms underlying the ischemic disease connected to DWMHs are nonspecific; potential pathways include poor endothelial functioning and increased atherosclerosis\[[@B32],[@B33]\]. Age-related changes in cerebral autoregulation and regulation of blood pressure may also lead to WMHs\[[@B34],[@B35]\]. These findings further promote the idea that subtle microvascular changes may be one reason why some people develop their first episode of depression later in life. White matter disease is thought to damage white matter tracts and play a major role in the etiology of LOD by affecting the processes involved in emotional regulation. A meta-analysis of 30 studies found that individuals with LOD were over four times more likely to have significant white matter changes and greater lesion severity than those with EOD\[[@B36]\]. These findings have also been replicated in a more recent meta-analysis\[[@B37]\]. Vascular changes, particularly subcortical white and gray matter lesions, are associated with more severe depressive symptoms. Specifically, in elderly patients with late-onset as opposed to early-onset depressive disorders, deep white matter and basal ganglia hyperintensities are more prevalent\[[@B5],[@B38]-[@B41]\] and are associated with more severe symptoms and poorer prognosis\[[@B3],[@B5],[@B42]-[@B44]\]. The cortico-striato-pallido-thalamo-cortical pathways have been implicated as areas particularly affected by vascular disease in LLD\[[@B45]\]. Additionally, Bella et al\[[@B46]\] suggest that patients exhibiting a VD profile have disruptions in the frontal subcortical circuits connecting the dorsolateral prefrontal cortex and dorsal section of the head of the caudate nucleus. Vascular disease in treatment of depression ------------------------------------------- Vascular risk factors contribute not only to the pathogenesis of depression but also complicate its treatment. Several studies have suggested that older adults with greater WMH volume show a poorer response to antidepressants\[[@B3],[@B30],[@B47]-[@B49]\]. In clinical samples, progression of white matter lesions has occurred alongside a lack of response to antidepressants and recurrence of depression. Patients with LLD with lacunar lesions, as opposed to diffuse white matter lesions, have shown a better response to antidepressant treatment, supporting the view that VD associated with white matter lesions is treatment-resistant\[[@B46]\]. It is hypothesized that the pathology caused by the disruption of prefrontal systems related to white matter lesions is a central mechanism to why these patients do not respond to the typical antidepressant treatment\[[@B1]\]. However, some studies have failed to find a connection between WMH severity and treatment outcomes\[[@B28],[@B50],[@B51]\]. Along with poorer response rates to antidepressants, white matter hyperintensity progression has been shown to predict poorer outcomes\[[@B52]\], higher rates of relapse\[[@B27],[@B42],[@B53]\], and difficulty achieving remission\[[@B42]\]. Indeed, in a study of severely depressed psychiatric inpatients, those who responded to treatment showed significantly less white matter lesion burden\[[@B3]\]. The presence of subcortical gray matter lesions predicted poor outcome up to 64 months following antidepressant monotherapy\[[@B53]\]. Steffens et al\[[@B30]\] found that lesions in the basal ganglia and in the cerebral cortex were associated with the persistence of depressive symptoms, while subcortical white matter lesions were associated with worsening of depressive symptoms over time. Additionally, patients with VD are more likely to suffer from earlier relapse, have a more chronic pattern of depression, and have progressive cognitive decline\[[@B3]\]. Since current pharmacological treatments for depression have been primarily ineffective in VD patients, there is growing interest in controlling lesion progression. If white matter lesions can predict poor antidepressant response, targeting the cerebrovascular processes themselves might be more effective. Most studies of vascular depression are correlative and cannot determine causation. It is unknown if depression puts one at greater risk for developing white matter lesions, if the presence of microvascular ischemia makes one more susceptible to depression, or if both are the result of a common pathological pathway. Another possibility is that untreated depression itself quickens lesion progression and results in additional vascular disease, such as vascular dementia. In a retrospective cohort study of patients in primary care spanning 13 years, Köhler et al\[[@B54]\] found that new onset of depression was associated with twice the likelihood of developing dementia, especially in those with incident vascular disease or whose depression was preceded by stroke or hypertension. Since the current standard psychopharmacologic therapy is ineffective and there are few placebo-controlled trials examining the effect of hyperintensities on antidepressant treatment response, there is a clear need for more careful clinical assessment and follow-up of those with lesion burden. Vascular disease, vascular depression, and cognitive impairment --------------------------------------------------------------- There is an established connection between vascular disease and the development of cognitive impairment (vascular dementia), which co-occurs with MDD at a rate of approximately 20%\[[@B55]\]. Midlife vascular risk factors are also associated with elevated amyloid deposition in late-life\[[@B56]\]. Furthermore, new onset of depression in adults with mild cognitive impairment was found to be associated with deep subcortical WMH severity\[[@B57]\]. Puglisi and colleagues\[[@B58]\] found that VD patients exhibit hemodynamic dysfunction, which may contribute to the development of cognitive impairment. Pennisi and colleagues\[[@B59]\] found differences in intracortical facilitation between patients with VD and patients with vascular cognitive impairment at baseline but not at a two-year follow-up. While the vascular cognitive impairment group did not cognitively decline over the two years, the VD group did show evidence of cognitive decline. Thus, the researchers proposed that the hyperfacilitation observed in the vascular cognitive impairment group may have contributed to the preservation of cognitive functioning as compared to the VD group. They concluded that the risk of dementia in VD may be due to lack of compensatory functional cortical changes or subcortical vascular lesions\[[@B59]\]. Thus, vascular depression might fall on a continuum that would include vascular disease, vascular depression itself, and vascular dementia. Indeed, case studies have reported progression from vascular depression to vascular dementia\[[@B60],[@B61]\]. Vascular depression has been associated with cognitive impairment, most notably in executive functioning and psychomotor speed. Patients with MRI-defined VD were shown to have significantly more psychomotor retardation and significantly worse performance on the Stroop Color-Word Interference Test\[[@B62],[@B63]\] and the Initiation/Perseveration subtest of the Mattis Dementia Rating Scale\[[@B63]\] than non-VD patients. Poor performance on the interference component of the Stroop Color-Word Interference Test exemplifies that response inhibition is low for these patients. Since the inception of the concept of vascular depression, Krishnan and colleagues have redefined their idea into Subcortical Ischemic Depression (SID)\[[@B64]\] and Alexopoulos and colleagues reconceptualized their model into the Depression-Executive Dysfunction Syndrome (DED)\[[@B65]\]. Both of these subtypes reflect different aspects of VD, and shed light on the neuropsychological deficits that arise when VD is defined by MRI or clinical presentation, respectively. Potter et al\[[@B66]\] found that patients with MRI-defined SID had an overall worse neuropsychological profile than depressed older adults without SID. Specifically, SID patients performed worse on measures of working memory and nonverbal memory, after controlling for age, cardiovascular risk, and depression symptoms\[[@B66]\]. Alexopoulos et al\[[@B67]\] found that patients with DED had reduced fluency and visual naming, and psychomotor retardation. Interestingly, both SID and DED definitions predict functional disability at similar rates\[[@B68]\]. Similar patterns of cognitive impairment have been found for constructs that share symptomology with VD. Depressed elderly patients with white matter hyperintensities demonstrate deficits in processing speed and executive functioning\[[@B7]\]. White matter abnormalities in depressed geriatric patients have also been associated with poor response inhibition as measured by the Stroop Color-Word Interference Test\[[@B69]\]. Geriatric depressed antidepressant non-responders show deficits in verbal learning\[[@B70]\], psychomotor speed\[[@B70],[@B71]\], and initiation and perseveration\[[@B71]\]. Impairment in initiation and perseveration has also been associated with relapse and recurrence of LLD\[[@B72]\]. Additionally, a meta-analysis of patients with LLD found that the executive functioning domains of planning and organization were associated with poor antidepressant treatment response\[[@B73]\]. Vascular burden in adults with LLD was predictive of poor processing speed functioning after controlling for age, education, and depressive severity\[[@B74]\]. Additional clinical and physiological characteristics of VD ----------------------------------------------------------- Patients with VD also display characteristics nonspecific to neuropsychological assessment. Older adults with VD have a lower rate of family history of mood disorders than older adults with depression and no vascular disease\[[@B2],[@B63]\]. Patients with vascular dysfunction and depression have demonstrated higher levels of aggressive and auto-aggressive tendencies and increased alexithymia\[[@B75]\]. Additionally, VD patients have been shown to have more disability with activities of daily living than depressed geriatric patients without vascular disease\[[@B68],[@B76]\]. Other features of VD include apathy, lack of insight, and difficulties at work\[[@B46]\]. Older adult women with high cerebrovascular burden and probable depression have been shown to be at a higher risk for later frailty\[[@B77]\] and subsequent shortened lifespan\[[@B78]\]. Furthermore, VD patients exhibit distinct physiological profiles. This includes specific patterns of motor cortex excitability\[[@B79],[@B80]\], higher concentrations of inflammatory markers\[[@B81]\], and higher levels of plasma homocysteine\[[@B82],[@B83]\]. Research into the etiopathology of VD indicates that a genetic variation at aquaporin 4 (AQP4) locus may play a role\[[@B84]\]. Sleep status between VD, non-vascular depression, and normal subjects has also been shown to differ, such that VD patients had higher rates of sleep-related breathing disorders, daytime sleepiness, and disorders of 24-hour sleep structure\[[@B85]\]. METHODOLOGY OF WMH ASSESSMENT ============================= In clinical practice, radiologists are often tasked to evaluate the brain MRI of patients with dementia for structural damages. Although the MRI findings alone are non-specific, there are certain patterns of cerebral atrophy that may lead to additional investigations (*e.g*., PET, fMRI) in addition to the clinical and biological presentations for a definitive diagnosis. We believe that a similar approach can be done in vascular depression if a methodologic assessment of the cerebral white matter signal intensity on FLAIR is performed by the advised radiologists at the request of their referral practitioners. The quantification and localization of white matter hyperintensities is critical for research into the risk factors, etiology, and pathogenesis of VD. Thus, the validity of MRI-defined VD as a distinct diagnostic entity depends on the methodology that is used to characterize lesions. WMHs are typically analyzed using either semi-quantitative ratings or quantitative volumetric analysis. Past research has primarily focused on WMH visual ratings or volume measurement without distinguishing among anatomically distinct WMHs, while recent studies have increasingly used semi-automated or fully automated methods to calculate WMH volume and classify WMHs into localized categories such as periventricular white matter hyperintensities (PVWMHs) and DWMHs (Figure [1](#F1){ref-type="fig"}). MRI hyperintensities most often have been scored for severity using visual rating scales including the Fazekas-modified Coffey rating scale\[[@B39],[@B86]\], the Scheltens rating scale\[[@B87]\], the Boyko Pathology Rating Scale\[[@B88]\], and the Virchow-Robin spaces\[[@B89],[@B90]\]. {#F1} A fundamental issue in standardizing MRI-defined VD is how lesions in these patients are defined. For example, subcortical ischemic disease can involve white or deep gray matter, but VD research focuses primarily on white matter lesions. Hyperintensities can be divided according to location: Periventricular on the periphery of the lateral ventricles, deep white matter, or subcortical gray matter. It has been shown that deep white matter hyperintensities, though having a uniform appearance on conventional imaging, are histologically heterogeneous\[[@B86],[@B91]\]. WMHs may be considered periventricular if they are located within a certain distance from the lateral ventricles or remain contiguous as they spread away from the ventricles. Clear criteria for hyperintensities need to be operationalized so that research is conducted consistently. The Fazekas-modified Coffey rating scale is commonly used in research evaluating VD\[[@B5],[@B51],[@B64],[@B92]\]. This scale measures hyperintensities in three locations on T2-weighted images: Deep white matter, subcortical gray matter, and periventricular spaces. Deep white matter hyperintensities in the frontal, parietal, temporal, or occipital lobes are scored as 0 (absent), 1 (punctate foci), 2 (beginning confluence of foci), and 3 (large confluent areas). Subcortical gray matter hyperintensities are abnormalities in the caudate nucleus, putamen, globus pallidus, thalamus, and internal capsule, and are scored as 0 (absent), 1 (punctate), 2 (multipunctate), and 3 (diffuse). Periventricular hyperintensities are abnormalities immediately adjacent to the lateral ventricles and are scored as 0 (absent), 1 (caps), 2 (smooth halo), and 3 (irregular and extending into the deep white matter). However, the Fazekas scale does not allow for detailed volumetric analysis of white matter hyperintensities. The Scheltens rating scale\[[@B87]\] is based on the size and number of lesions in four separate regions: Periventricular white matter, deep white matter, basal ganglia, and infratentorial area. The periventricular white matter of the frontal caps and occipital caps and bands have ratings of 0 (none), 1 (smooth halo, \> 1-5 mm), and 2 (large confluent lesions, 5-10 mm). The same rating system is used for the remaining three areas: The deep white matter of the frontal, parietal, occipital, and temporal lobes; the basal ganglia including the caudate nucleus, putamen, globus pallidus, thalamus, and internal/external capsule; and the infratentorial area consisting of the cerebellum, mesencephalon, pons, and medulla. The rating system ranges from 0 to 6 with the following descriptors: 0 (none), 1 (≤ 4 mm and *n* ≤ 5), 2 (≤ 4 mm and *n* \> 5), 3 (4-10 mm and *n* ≤ 5), 4 (4-10 mm and *n* \> 5), 5 (≥ 10 mm and *n* ≥ 1), and 6 (confluent). However, this scale may underestimate the significance of punctate lesions since a score of 2 allows for infinite smaller lesions, whereas one large isolated lesion would be rated as a 5. Scheltens rating scales have a greater range than the Fazekas scale, yet Van Straaten et al\[[@B93]\] suggest that the Fazekas scale is most appropriate for classifying different WMH groups. Visual rating scales of WMHs are widely used because they are relatively easy to conduct and there are several scales available with demonstrated reliability and validity. In addition, visual rating scales allow expert raters to utilize clinical judgment to evaluate the specific lesion presentations and patterns. Van Straaten et al\[[@B93]\] confirmed correlations among WMH volume and the three most commonly used visual rating scales, but found greater variability and less correlation among scores in patients who had greater WMH burden. Despite the advantages, visual scales are not well suited for measuring changes in lesions, and cannot quantify lesion volume. Visual scales can be time consuming, making them a poor choice for large datasets, and rely on clinical judgment, which can introduce issues concerning interrater reliability and validity. In addition, visual scales often do not include size and uniform location, making scores from different rating scales incomparable. Although visual scales allow differentiation between periventricular, deep white, and subcortical gray hyperintensity ratings, such classifications are inherently broad and imprecise. For example, WMHs adjacent to the left anterior horn of the lateral ventricle are combined with WMHs located in the right posterior horn of the lateral ventricle in the periventricular classification. Lesions in such disparate regions may have vastly different influences on cognition. Recent imaging techniques have been developed to enable the quantitative volumetric analysis of signal hyperintensities that use semi-automated methods and provide more information on location and size, as well as continuous data\[[@B94]-[@B98]\]. One method uses the software MRIcro\[[@B99]\] to create a region of interest map by semiautomatic intensity thresholding\[[@B100]\] (Figure [2](#F2){ref-type="fig"}). Separate region of interest (ROI) maps for different hyperintensity categories (deep white, periventricular, subcortical gray) are created by gross manual outlining of hyperintensities. The overlap of the intensity ROI and each hyperintensity category ROI is then used to compute the volume and location of the final lesion map. A principle advantage of semi-automated tracing is the ability to exclude areas that are typically hyperintense (*e.g*., pyramidal tracts and hippocampus) from total volume estimates. However, it is more time consuming than visual rating scales. For these reasons, it may be advantageously applied for medium, but not large datasets, where a fully-automated procedure may be more appropriate. {#F2} Fully-automated segmentation techniques\[[@B101]-[@B106]\] eliminate the interrater reliability problem because methods of lesion quantification are standardized and require little user intervention. Additional advantages include the production of quantitative data, the ability to analyze large data sets quickly, and the ability to recognize patterns. Quantitative ratings also allow for more precise measurement, and thus greater sensitivity to smaller lesions and different criteria for classification of white matter lesions. Since fully-automated segmentation techniques take place within MRI analysis software, the finalized lesion maps are amenable to realignment with standardized anatomical atlases. This facilitates ROI analyses that can be more spatially specific than analyses performed on qualitatively scored data. With these advantages, automated methods are potentially superior to visual rating scales for quantifying signal hyperintensities on MRI. Indeed, visual ratings may be less sensitive with the potential for ceiling effects and low discrimination of absolute lesion volumes\[[@B93]\]. Disadvantages of automated methods include requiring computational sophistication, the correct software, and a level of user intervention and troubleshooting. Fully-automated segmentation approaches also need to be evaluated for validity concerns. Validity may be in question because of the potential for interference effects by radiological artifacts. These artifacts may interfere with the segmentation process or with the steps needed to perform regional analyses. For example, fully-automated approaches rely on the brightness of adjacent pixels to identify lesion boundaries. This could lead to a problem in distinguishing pathological lesions from normal anatomical areas that are typically hyperintense (*e.g*., pyramidal tracts and hippocampus). Additionally, motion artifacts may invalidate fully automated analyses on scans that could otherwise be assessed manually on a qualitative rating scale. Therefore, the validity of MRI-defined VD relies on the reliability and validity of the rating scales and techniques used, which currently can still be inconsistent among research studies. More recently, diffusion tensor imaging (DTI) has been used to examine the structural integrity of white matter areas relevant to LLD. In fact, it has been suggested that DTI may be more sensitive in identifying white matter damage than T2-weighted MRI\[[@B107]\]. Fractional anisotropy has shown that white matter changes occur with aging, cognitive dysfunction, expressions of psychopathology\[[@B21]\], and LLD\[[@B108]\]. Lower fractional anisotropy in the anterior thalamic radiation and superior longitudinal fasciculus, both projecting to the frontal lobe, has been associated with LOD\[[@B109]\], while lower fractional anisotropy in cortico-striato-limbic areas has been found in older adults who remained depressed after an antidepressant trial\[[@B21]\]. DTI has revealed microstructural changes in the anterior cingulate cortex, superior and middle frontal gyrus, and right parahippocampal gyrus in association with LLD\[[@B110],[@B111]\]. Functional MRI (fMRI) has also been used to examine the relationship between white matter hyperintensities and LOD. Indeed, white matter lesions have been associated with altered functional connectivity in the brain in LLD\[[@B112]-[@B114]\]. This research suggests that the use of DTI and fMRI techniques may be beneficial in examining vascular depression. Other newer imaging techniques such as MR perfusion have not yet been utilized in this population. PATHOPHYSIOLOGY AND DIAGNOSIS OF VD =================================== Vascular depression is often viewed solely from a geriatric psychiatry perspective. Typically, a clinical diagnosis is made after careful evaluations that include full physical and neuropsychological examinations, despite the possibility that a specific depression symptom profile might not constitute a clinical marker for VD\[[@B115]\]. Vascular depression depends on the assessment of brain lesions and thus is ultimately a neuroradiological diagnosis. A number of researchers have proposed diagnostic criteria to define the VD subtype\[[@B1],[@B2],[@B64],[@B65],[@B67]\], but these have not always been consistent. Without consistent criteria, it is difficult to interpret conflicting findings\[[@B116]\], and since we do not know to what degree the possibly different patient groups overlap, there is no way to evaluate discrepant findings. To provide more clarity on this issue, Sneed et al\[[@B92]\] evaluated patients with LLD and found that the vascular group was most accurately identified by DWMHs. Those in the vascular group were defined by a high probability of having MRI hyperintensities (DWM and periventricular), executive dysfunction, and late age-of-onset. These findings provide empirical evidence that VD is a unique subtype of LLD and the first empirically-based diagnostic criteria for VD\[[@B92]\]. WMH burden can be presented as volume, or as a proportion of the total white matter or intracranial volume, depending on the focus of the study. However, it remains unclear whether quantity or severity better accounts for predictive ability. Taylor et al\[[@B27]\] found that the overall percent increase in white matter hyperintensity volume had greater predictive significance of depressive symptoms and poor outcome than baseline volume. Others have reported similar results wherein greater changes in white matter presentation show greater symptoms and a more chronic course of illness\[[@B9],[@B117],[@B118]\]. This suggests that total lesion volume at any particular time point is not nearly as important as the course of progression, and thus perhaps it may be more important to look at the specific areas in which the lesions are occurring. Quantity of lesions versus a certain pattern of lesions may also be related to clinical expression. Van Straaten et al\[[@B93]\] quantified individual lesions to determine WMH severity, but the number of lesions was not related to depressive symptoms, suggesting that perhaps size of lesions is more relevant. The significance of defined WMH locations has not been agreed upon, as it is unclear whether severity of overall lesion burden or lesion location is the dominant pathological contributor to vascular depression. Differences in WMH load between those with LOD and those with EOD have not consistently been found\[[@B119]\], suggesting that location of lesions, rather than quantity, might be more important in the differential diagnosis. Simpson et al\[[@B42]\] found that hyperintensities were predictive of depressive symptomology when looking at specific areas such as the frontal lobes, basal ganglia, and pons, as opposed to total volume. On the other hand, a three-year follow-up study of a community cohort concluded that WMH severity was a strong predictor of depression risk, with half of MDD elderly meeting criteria for VD\[[@B120]\]. Similarly, in a 12-wk antidepressant nonrandomized controlled trial, WMH severity was found to be associated with depression severity as well as vascular risk factors\[[@B121]\]. Hickie et al\[[@B3]\] reported no correlations between specific lesion locations and outcome, but rather that the burden of total white matter hyperintensity volume led to a poorer outcome in depressed patients. In addition, a two-year longitudinal study found that for every 1% increase in WMH volume, there was a 7% increased risk of poor prognosis\[[@B27]\]. The most consistently reported abnormality described in LLD is the increased number and/or severity of white matter hyperintensities, which mainly occur in subcortical gray and frontal white matter areas\[[@B21],[@B122],[@B123]\]. It is thought that these changes represent vascular pathology in clinically relevant areas, though the debate about lesion severity and location remains. Rabins et al\[[@B114]\] showed a particular dominance of lesions in the frontal lobes and basal ganglia. The locations of these lesions fit with functional imaging changes suggesting frontal and caudate abnormalities in depression, and further support the role of frontostriatal dysfunction in the vascular depression hypothesis. Many studies have focused on the significance of the frontal lobe in the physiopathology of LOD\[[@B67],[@B76],[@B124]-[@B126]\]. MacFall et al\[[@B127]\] further localized significant WMHs in depressed elders to the medial orbital prefrontal cortex. Other studies found that hyperintensities in the basal ganglia, particularly the putamen, predicted depressive symptoms and poorer treatment outcome\[[@B48],[@B124]\]. Lesions in the basal ganglia and subcortical gray matter were also shown to be predictive of failure to respond to treatment\[[@B128]\]. Alexopoulos et al\[[@B129]\] localized WMHs to the frontal white matter lateral to the anterior cingulate cortex (ACC), which predicted lower remission rates after antidepressant treatment. More recently, increased low-theta activity in the subgenual ACC was found to be a possible predictor of antidepressant treatment response to repetitive transcranial magnetic stimulation in patients with treatment-resistant VD\[[@B130]\]. Vascular depression may affect different groups of older adults differently, and is likely overrepresented among African American older adults. In a sample of older adult depressed patients, 61% of African Americans and 10% of Caucasians were classified as having VD\[[@B63]\]. Additional evidence arises from research that shows that the rates of cardiovascular disease risk factors are significantly higher in African Americans compared to Whites. For instance, the rate of hypertension is significantly higher in African Americans (60%) than Whites (38%)\[[@B131],[@B132]\]. African Americans are also more likely to have diabetes\[[@B133],[@B134]\] and significant health concerns for obesity\[[@B135]\]. Indeed, cardiovascular disease is the leading cause of death in African Americans\[[@B136]\]. People with diabetes, hypertension, or individuals that smoke are 2 to 4 times more likely to develop stroke than those without diabetes or hypertension, or nonsmokers\[[@B133],[@B137]\]. Additionally, stroke and stroke-related mortality rates are higher in African Americans compared to Whites across the lifespan\[[@B136],[@B138]\]. Stroke increases the risk for dementia, and in particular, vascular dementia\[[@B139]\]. Indeed, the rate of vascular dementia is higher in African Americans relative to Whites\[[@B140]\]. All of these cardiovascular risk factors combine to suggest that African Americans are at high risk for vascular depression. Differential diagnosis for radiology ------------------------------------ Neuroradiologists examining older adult scans do not typically consider vascular depression as part of the differential diagnosis. Mild and moderate white matter lesions are common in healthy elderly people and have unclear significance, but severe changes are not part of normal aging. White matter changes on MRI independently are of little clinical value to predict depressive symptoms. However, when viewed as a part of an entire clinical presentation, they raise suspicion for further depressive symptoms. For example, the rate of MRI hyperintensities has been found to be higher in populations with LLD compared to age-matched controls, while DWMHs are specifically prevalent in those with LOD\[[@B141]\]. Thus, in practice it would be of clinical utility to take account of the presence of white matter changes on MRI when attempting to predict future depressive symptoms. This may influence decisions regarding the frequency of clinical monitoring and the need for prophylactic antidepressants or other treatments. Neuropsychological assessments can also play a role in the diagnosis of VD. Impairments on tests that measure executive functioning, such as the Trail Making Test\[[@B142]\] and the Stroop Color-Word Interference Test (Stroop Test)\[[@B143]\], have been observed in individuals with diagnoses of VD. Trail A of the Trail Making Test assesses visual scanning, attention, and processing speed. Trail B of the Trail Making Test requires both sequencing and set shifting, and is used to assess divided attention and cognitive flexibility\[[@B144]\]. Patients with lesions in the dorsolateral frontal areas have shown impairment as compared to control participants on the Trail Making Test\[[@B145]\], implicating executive dysfunction corresponding with the disruption of frontal areas. The Stroop Test is used to measure selective attention and response inhibition\[[@B144]\]. Poor performance on the Stroop Test, especially on the interference condition, has been linked to frontal lobe dysfunction\[[@B144]\]. However, it is possible that the Stroop Test activates a more distributed network of brain areas, including the middle frontal gyrus, parietal lobe regions, and temporal lobe regions\[[@B146]\]. More distinguished evidence has been found specifically for anterior cingulate cortex activation during the interference condition\[[@B146],[@B147]\]. The typical use of neuroimaging in psychiatry is to exclude structural lesions or other neurological pathology as causes for clinical presentation; neuroimaging has not yet played a major role in psychiatric diagnoses. Disagreement regarding which hyperintense signals should be viewed as pathological and how they should be graded may contribute to inconsistent diagnoses in this area. However, the evidence pointing to specific neuroimaging correlates of VD imply that a neuroradiological diagnosis or recommendation for a diagnosis can be made. Despite the possibility that radiologists might not have access to a patient's depressive symptomatology, neuropsychological performance, or history of illness, they can contribute to the diagnosis through their understanding of the nature of lesions in addition to the VD presentation. We offer some recommendations based on radiologists' comments on MRI scans that, associated with other data, can be labeled as possible VD symptomatology. For example, a radiologist might report "mild diffuse periventricular white matter T2/FLAIR hyperintensity with scattered hyperintense flair signal in the deep and subcortical white matter," for a scan with a rating of 3 for DWMHs on the Fazekas scale, associated with a score of 24 on the Beck Depression Inventory, Second Edition (BDI-II) and 23 on the Hamilton Depression Rating Scale (HAM-D), and evidence of poor neuropsychological performance. In this case, it is possible that the diagnosis is VD. Table [1](#T1){ref-type="table"} provides additional examples of such scenarios that are described below. ###### Vascular depression profiles **ID** **Neurorad-iologist comments** **Fazekas DWMH rating** **Fazekas PV-WMH rating** **Depression scores** **NP tests** **Ethnicity** **Age** **Other Features** -------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------- --------------------------- ------------------------- ----------------------------------------------------------------------------- ------------------ --------- ----------------------- 1 Multifocal white matter T2/FLAIR hyperintense lesions, the largest of which are located in the left corona radiata and left centrum semiovale, some of which have T1 hyperintensity, most consistent with a condition of microvascular ischemic disease. 2 3 HAM-D = 17; BDI-II = 12 Trail A = 45" (9%ile); Trail B = 240" (\< 1%ile); Stroop = 0.67 (6%ile) African American 56 CIRS-G = 8; MMSE = 29 2 Moderate periventricular and deep white matter foci of hyperintense FLAIR signal, more confluent in the right greater than left frontal lobe, most likely due to microvascular ischemia in this age group, accounting for concomitant cerebral/cerebellar atrophy and ventricular dilatation. 3 3 HAM-D = 22; BDI-II = 22 Trail A = 50" (63%ile); Trail B = 146" (53%ile); Stroop = 0.52 (19%ile) Caucasian 81 CIRS-G = 5; MMSE = 29 3 Scattered deep and subcortical punctate foci of hyperintense FLAIR signal in the bilateral frontal, parietal and temporal lobes. Nonspecific patterns likely to represent sequela of migraine headaches, Lyme infection, vasculitis or microvascular ischemia. 2 3 HAM-D = 20; BDI-II = 14 Trail A = 68" (16%ile); Trail B = 148" (34%ile); Stroop = 0.91 (1%ile) African American 77 CIRS-G = 6; MMSE = 29 4 Diffuse periventricular and deep white matter foci of hyperintense FLAIR signal in the bilateral frontal parietal and temporal lobes, some of which presenting an ovoid shape perpendicular to the long axis of the lateral ventricle. Primary consideration is multiple sclerosis in the appropriate clinical setting. Other possibilities include microvascular ischemia, vasculitis or prior infection. 3 3 HAM-D = 25; BDI-II = 21 Trail A = 92" (\< 1%ile); Trail B = 286" (\< 1%ile); Stroop = 0.44 (32%ile) African American 65 CIRS-G = 6; MMSE = 29 5 Mild periventricular and pontine white matter hyperintense FLAIR signal; additional punctate foci of hyperintense FLAIR in the deep and subcortical frontal-parietal white matter. Nonspecific likely due to microvascular ischemia, migraine headaches, or vasculitis. 2 2 HAM-D = 41; BDI-II = 43 Trail A = 30" (55%ile); Trail B = 120" (\< 1%ile); Stroop = 0.53 (18%ile) African American 53 CIRS-G = 5; MMSE = 28 DWMH: Deep white matter hyperintensities; PVH: Periventricular hyperintensities; HAM-D: Hamilton Rating Scale for Depression; BDI-II: Beck Depression Inventory, 2^nd^ edition; NP: Neuropsychological; %ile: Percentile; CIRS-G: Cumulative Illness Rating Scale -- Geriatrics; MMSE: Mini Mental Status Exam. Case reports ------------ Figure [3](#F3){ref-type="fig"} shows brain scans from a patient who was diagnosed with VD. Patient 1 is a 56-year-old African American female with a HAM-D score of 17 (moderate depression) and a BDI-II score of 12 (minimal depression). She had a Cumulative Illness Rating Scale -- Geriatrics (CIRS-G) score of 8. The CIRS-G assesses the severity of disorders in a geriatric population and consists of 14 medical problems, with each problem rated from 0 being no problem to 4 being extremely severe, for a total score range of 0 to 56\[[@B148]\]. She scored a 29 out of 30 on the Mini Mental Status Exam (MMSE), indicating intact mental status\[[@B149]\]. Her performance on a task of processing speed was in the low average range, while performance on a task of cognitive flexibility was in the impaired range\[[@B150]\]. Her performance on the Stroop Test, as compared to the sample mean from the VD research study she was involved in\[[@B63]\], was in the borderline range, indicating poorer response inhibition than the sample. Using the Fazekas scale, the MRI scan was rated a DWMH score of 2 and a PVWMH score of 3. The radiologist's comment for this patient is as follows: "Multifocal white matter T2/FLAIR hyperintense lesions, the largest of which are located in the left corona radiata and left centrum semiovale, some of which have T1 hyperintensity, most consistent with a condition of microvascular ischemic disease." {#F3} Patient 2 is an 81-year-old Caucasian male with a HAM-D score of 22 (severe depression) and a BDI-II score of 22 (moderate depression). He had a CIRS-G rating of 5 and intact mental status (MMSE = 29). His performance on tasks of processing speed and cognitive flexibility was in the average range\[[@B150]\], and his performance on a task of response inhibition was in the low average range\[[@B63]\]. Using the Fazekas scale, the MRI scan was rated a DWMH score of 3 and a PVWMH score of 3. The radiologist's comment for this patient is as follows: "Moderate periventricular and deep white matter foci of hyperintense FLAIR signal, more confluent in the right greater than left frontal lobe, most likely due to microvascular ischemia in this age group, accounting for concomitant cerebral/cerebellar atrophy and ventricular dilatation." Patient 3 is a 77-year-old African American female with a HAM-D score of 20 (severe depression) and a BDI-II score of 14 (mild depression). She had a CIRS-G rating of 6 and intact mental status (MMSE = 29). Performance on a task of processing speed was in the low average range, while performance on a task of cognitive flexibility was in the average range\[[@B150]\]. Performance on a task of response inhibition was impaired\[[@B63]\]. The MRI scan was rated a Fazekas DWMH rating of 2 and a PVWMH rating of 3, and the radiologist commented "Scattered deep and subcortical punctate foci of hyperintense FLAIR signal in the bilateral frontal, parietal and temporal lobes. Nonspecific patterns likely to represent sequela of migraine headaches, Lyme infection, vasculitis or microvascular ischemia." Patient 4 is a 65-year-old African American male with a HAM-D score of 25 (very severe depression) and a BDI-II score of 21 (moderate depression). He had a score of 6 on the CIRS-G and intact mental status (MMSE = 29). On tasks of processing speed and cognitive flexibility, performance was in the impaired range\[[@B150]\], while on a task of response inhibition, performance was in the average range\[[@B63]\]. Fazekas ratings of 3 were given for both DWMH and PVWMH. The radiologist commented "Diffuse periventricular and deep white matter foci of hyperintense FLAIR signal in the bilateral frontal parietal and temporal lobes, some of which presenting an ovoid shape perpendicular to the long axis of the lateral ventricle. Primary consideration is multiple sclerosis in the appropriate clinical setting. Other possibilities include microvascular ischemia, vasculitis or prior infection." Patient 5 is a 53-year-old African American female with a HAM-D score of 41 (very severe depression) and a BDI-II score of 43 (severe depression). She had a score of 5 on the CIRS-G and intact mental status (MMSE = 28). Performance on a task of processing speed was in the average range while performance on a task of cognitive flexibility was in the impaired range\[[@B150]\]. Performance on a task of response inhibition was in the low average range\[[@B63]\]. The MRI scan was rated a Fazekas DWMH rating of 2 and PVWMH rating of 2. The radiologist noted "Mild periventricular and pontine white matter hyperintense FLAIR signal; additional punctate foci of hyperintense FLAIR in the deep and subcortical frontal-parietal white matter. Nonspecific likely due to microvascular ischemia, migraine headaches, or vasculitis." All of the above cases represent patients who should be considered for a diagnosis of VD. All patients had elevated depression indices and neuropsychological test performance often showed evidence of impairment in areas of executive function. All patients also had intact mental states and relatively low ratings of general illness severity. Combined with Fazekas ratings of 2 and 3, the presentations indicate VD as a possible diagnosis. As such, treatments should be selected with this diagnosis in mind and vascular depression should be included in probable differential diagnoses. In addition to the case series, Table [2](#T2){ref-type="table"} depicts primary and secondary features of VD for radiologists to have a reference guide for creating a database of potential VD cases. Importantly, radiologists will need access to information about patients beyond neuroanatomical scans in order to form such a database. Such information as described in Table [2](#T2){ref-type="table"} should be provided in referral questions and records from psychiatrists and psychologists. ###### Primary and secondary features of vascular depression **Primary features** ----------------------------------------------------------------------------------------------------------------------- Neuroimaging findings consistent with cerebrovascular disease including MRI findings of white matter hyperintensities Presence of cerebrovascular risk factors Cognitive impairment, particularly in areas of processing speed and/or executive functioning **Secondary features** Age \> 50 Poor antidepressant treatment response Psychomotor retardation Marked disability in activities of daily living Lower rate of family history of mood disorders Vascular depression is defined as significant depressive symptomatology occurring in the presence of cerebrovascular disease as evidenced above. MRI: Magnetic resonance imaging. CONCLUSION ========== As the vascular depression hypothesis becomes more refined, the need to identify and treat this population intensifies. In fact, Gonzalez et al\[[@B151]\] estimated that approximately 2.64 million American adults aged 50 years or older meet criteria for VD. Furthermore, Gonzalez et al\[[@B151]\] found that in adults with lifetime major depression, approximately 22% of participants met criteria for the VD subtype. Combined with the increasing aging population, this high incidence rate depicts the importance of accurate identification of these patients. White matter hyperintensities have been shown to have clinical importance in VD, as they predict a poor response to treatment and increased relapse rate, but their cause remains unclear. Interventions to slow lesion progression may ultimately be able to improve depression outcomes. With accurate identification early on in this disorder, treatment options other than antidepressants can be evaluated, since antidepressants are often not effective in VD patients. Alternative treatment options should be considered, such as those that target frontostriatal and planning/ organization networks\[[@B73]\]. Psychosocial treatments such as Problem Solving Therapy have been effective in helping depressed older adults with executive dysfunction\[[@B152]\]. Cognitive remediation strategies that target these areas may also prove to be effective. For example, in a preliminary study, Morimoto et al\[[@B153]\] instituted a frontostriatal-targeted computerized cognitive remediation program with depressed older adult antidepressant non-responders and found that depression scores were significantly lower after four weeks for those with more executive dysfunction. As imaging techniques become increasingly sophisticated, WMHs will be able to be measured with greater accuracy than ever before. However, it is unlikely that this will replace semi-quantitative scoring systems in the foreseeable future. For research purposes, it would be beneficial for there to be a standardized way of scoring VD brains to improve replicability. The importance of white matter hyperintensities in VD also indicates an increased need for the assistance of neuroradiologists in identifying these potential patients. Not only is it crucial for neuroradiologists to consider this diagnosis when evaluating MRI scans of older depressed adults, but it is important to increase the involvement of psychiatrists and psychologists in imaging decisions. The access to neuroimaging needs to be improved such that mental health providers are able to request neuroimaging. Additionally, it would be helpful for mental health providers to inform neuroradiologists of each patient's symptomatology, so that neuroradiologists have background information that may influence possible diagnoses when evaluating imaging. As imaging techniques become more advanced, it becomes more likely that imaging will be brought into the scope of psychiatry and psychology, especially with depressive disorders. The use of imaging within psychiatry and psychology has the power to influence the management of symptoms in a critical way. Psychiatrists, psychologists, and neuroradiologists can and should work together, especially when interpreting subtle white matter changes on MRI. Both lesion severity and location should be considered important pieces of information, until such time when one is delineated as being more influential than the other for treatment or disease progression purposes. In the assessment of an older adult patient who has depression, VD should be included as a rule-out for psychiatrists, psychologists, and neuroradiologists. With clinical, neuropsychological, and radiological indicators that separate vascular depression from other depressive disorders, it is critical that patients be evaluated for this disorder. Conflict-of-interest statement: All authors deny any conflicts of interest related to this work. Manuscript source: Unsolicited manuscript Peer-review started: February 26, 2020 First decision: April 22, 2020 Article in press: May 12, 2020 Specialty type: Radiology, nuclear medicine and medical imaging Country/Territory of origin: United States Peer-review report's scientific quality classification Grade A (Excellent): 0 Grade B (Very good): 0 Grade C (Good): C Grade D (Fair): 0 Grade E (Poor): 0 P-Reviewer: Loeffler-Stastka H S-Editor: Gong ZM L-Editor: A E-Editor: Liu MY [^1]: Author contributions: Rushia SN, Sneed JR and Garcon E designed the review; Rushia SN, Shehab AAS, Motter JN, Egglefield DA, Schiff S, Sneed JR and Garcon E wrote the paper. Corresponding author: Sara N Rushia, BA, Graduate Student, Department of Psychology, The Graduate Center, City University of New York, 365 5^th^ Avenue, New York, NY 10016, United States. <srushia@gradcenter.cuny.edu>

{.101} {.102} {.103}

Background ========== The effect of hemodilution during cardiopulmonary bypass is extensively studied and lower hematocrit levels (\< 22%) caused postoperative organ failure \[[@B1]\]. Renal failure, stroke, perioperative myocardial infarction, prolonged mechanical ventilation and multiorgan failure are much more common in hemodilution conditions \[[@B2]\]. There are several predictors of hemodilution. Prebypass hematocrit values (such as anemia), female gender, Cardiopulmonary bypass (CPB) time, age, renal failure, and small body surface area (BSA) are the strong predictor of hemodilution and consequently blood transfusion \[[@B3]-[@B5]\]. We know that allogenic blood transfusion increases the risk of mortality \[[@B6]\] and morbidity such as pulmonary edema \[[@B7]\], renal failure \[[@B8]\], transfusion complications \[[@B9]\]. There are lots of surgeons still using Crystalloid Cardioplegia for its simplicity, economy and fairly good efficacy in the vast majority of patients. Nevertheless, Crystalloid Cardioplegia presents major disadvantages compared with the same volume of blood cardioplegia \[[@B10]\]. It poorly supplies oxygen; it increases the degree of hemodilution which is already high after circulation of the priming volume and it decreases the oncotic pressure \[[@B11]\]. As we mentioned negative effects of hemodilution and blood transfusion are clarified. We have prospectively investigated the effects of Crystalloid Cardioplegia on hemodilution and necessity of blood transfusion by comparing with blood cardioplegia. Methods ======= Between 2010--2013, One hundred patients were included into our randomized prospective study. We decided to give Crystalloid cardioplegia to the odd-numbered patients and blood cardioplegia to the even numbered patients. Informed consents were obtained from all patients. Institutional board approval from ethical committee of hospital (Süleyman Demirel University, Faculty of Medicine) was also obtained (November 13, 2006/3). Crystalloid cardioplegia (St. Thomas-II solution) have been used in Group-1. Fifteen ml/kg St-Thomas II solution was given both antegrade and retrograde initially. Then in every 20 minutes St-Thomas II solution was given retrograde (7 ml/kg). Just before cross-clamp removal 150 ml St-Thomas II and 250 ml blood were given antegradely (Hot shot). Calafiore blood cardioplegia was used in group-2 patients \[[@B12],[@B13]\]. This solution was given at the 600 ml warm solution and 600 ml cold solution in the induction period then 600 ml cold solution in every 20 minutes both antegradely and retrogradely. Just before cross clamp removal 600 ml warm blood cardiplegia (Hot Shot) with lower potassium (4 mmol) was given antegradely (Table [1](#T1){ref-type="table"}). Patients' characteristics were summarized in Table [2](#T2){ref-type="table"}. ###### Ingredients of calafiore cold blood cardioplegia solution       ------------- -------------------------------------------------------------------------------------- -------------------------------------------- INDUCTION Native blood; 1000 ML Ringer solution; 70 mmol K^+^; 30 ml 8.4% NaHCO~3~; ratio "4/1 600 ml warm solution; 600 ml cold solution MAINTENANCE Same additives with induction 600 ml cold solution HOT SHOT 4 mmol K+ 600 ml warm solution ###### Preoperative characteristics of patients **Variable** **Crystalloid cardioplegia \[no = 50\]** **Blood cardioplegia \[no = 50\]** **p value** ------------------------------------------- ------------------------------------------ ------------------------------------ ------------- Age\* 61 ± 12 63 ± 9 0.651 Male 37 39 0.466 Smoking 34 29 0.012 COPD 12 14 0.834 Hypertension 25 21 0.543 Congestive heart failure (no) 2 3 0.335 Peripheral vascular disease 11 9 0.746 Cerebral vascular disease 6 7 1.00 Average body surface area (BSA m^2^) 1.91 ± 0.5 1.89 ± 2.2 0.855 Body mass index (kg/m^2^)\* 33.4 ± 4.2 29.3 ± 6.8 0.455 Ejection fraction (%)\* 45.6 ± 7.8 50.1 ± 3.6 0.023 Preoperative IABP 2 \- 0.242 Number of diseased vessels\* (range 1--4) 2.1 ± 0.4 1.9 ± 0.6 0.744 LMCA disease (\>50%) 5 3 0.721 Previous MI 31 37 0.462 Previous PTCA or stent 8 11 0.631 Preoperative hematocrit value (%) 38.5 ± 3.7 40.4 ± 5.6 0.563 Preoperative hemoglobine value (gr/dL) 13.3 ± 2.3 13.9 ± 2.9 0.646 \*mean ± SD. *Abbrevations*: *COPD* chronic obstructive pulmonary disease, *IABP IABP* intra-aortic balloon pump, *LMCA* left main coronary artery, *MI* myocardial infarction, *PTCA* Percutaneous transluminal balloon angioplasty. Operative characteristics ------------------------- All patients in both groups had elective operations. All patients underwent primary coronary revascularization. CPB was done in all patients with two stage venous and aortic cannula. Moderate hypothermia (26˚C) and topical cooling with iced saline slush were used in all patients. Myocardial preservation was accomplished as mentioned previously in both groups. CPB was established with a roller pump, non-pulsatile flow after anticoagulation with bovine lung heparin (3 mg/kg) and activated clotting time was maintained for more than 480 s. Membrane oxygenators (Capiox-E Terumo Corp, Tokyo, Japan) were used. Heparin was neutralized by protamine (3.5 mg/kg) at the end of the CPB. All distal anastomoses were done in a single cross-clamp period. Transfusion protocols --------------------- Packed red blood cell transfusion was used when hematocrit (Htc) levels were less than 22% during the intra-operative period. Mostly Packed red blood cell (RBC) added pump reservoir during the CPB period. Transfusion was done when hematocrit \< 18% in the postoperative period. In older patients (\>70 years old) Hct levels \<20% was accept as the lowest limit. Platelet transfusion and fresh frozen plasma was limitedly used in both groups. Fluid regime strictly followed during the postoperative periods. Sample size ----------- According to our previous clinical observations, crystalloid cardioplegia reduces intraoperative Htc levels below 25% in coronary artery bypass graft (CABG) patients. We predicted 10% reduction of Htc levels in blood cardioplegia patients. To detect this difference with 95% confidence limits and power of 80% we needed to enter at least 49 patients into each group \[[@B14]\]. Exclusion criteria ------------------ All re-operative and urgent and emergency procedures, reoperations, bleeding disorders, dialysis dependent renal failure, and anemic patients (preoperative Hct \< 20%) were excluded. Statistical analyses -------------------- Statistical analysis was performed with SPSS software version 10.0 (SPSS Inc., Chicago, IL). Clinical data were expressed as mean values ± standard deviation. Differences were analyzed with Fisher's exact test, *X*^2^-test, unpaired Student's *t*-test and Mann--Whitney test. We investigated the effects of the variables on hemodilution and transfusion requirement by calculating odds ratios (OR) in univariate analyses for all CABG patients. Variables for which the unadjusted *p*-value was ≤0.20 in logistic regression analysis were identified as potential risk markers and included in the full model. We conducted stepwise multivariate analyses by using logistic regression. We reduced the model by using backward elimination and we eliminated potential risk markers by using likelihood ratio tests. Results ======= Average CPB time was 87 ± 14 minutes in crystalloid group, 94 ± 11 in blood cardioplegia group (p = 0.301). Average cross clamp time was 61 ± 15 and 58 ± 23 minutes in both groups respectively (p = 0.433). Low cardiac output developed in 11 patients in crystalloid and 5 patients in blood cardioplegia group (p = 0.044). Positive inotropic drugs were used in 17 patients in crystalloid cardioplegia group, 8 patients in blood cardioplegia group (p = 0.032). Intra-aortic balloon was inserted to five patients in crystalloid group and only one patient in blood cardioplegia group. Dialysis required renal failure was developed only one patient in crystalloid cardioplegia group. Four patients required a second look for hemorrhage in crystalloid group and two patients in blood cardioplegia group (p = 0.677). Radial artery was used in 17 patients in group 1 and 19 patients in group 2. LITA was used 45 patients in group 1 and 47 patients in group 2. Average intraoperative hematocrit (%) value was 18.4 ± 2.3 in crystalloid group 24.2 ± 3.4 in blood cardioplegia group (p \< 0.001). The lowest Htc value was 15% and 20% in both groups respectively (p \< 0.001). 2.3 ± 0.41 units packed RBC transfusion was necessary intra-operatively in crystalloid group, 0.7 ± 0.6 units in blood cardioplegia group (p = 0.001). Average transfused RBC was 2.7 ± 0.8 units in crystalloid group, 0.9 ± 0.4 units blood cardioplegia group (p \< 0.001). Mean intensive care unit (ICU) stay was 2.7 ± 1.2 days in crystalloid group, 1.1 ± 0.45 days in blood cardioplegia group (p = 0.001). Mean hospital stay was 8.6 ± 2.1 versus 6.4 ± 1.1 days in respectively (p \< 0.001). Two patients died in crystalloid group but none in blood cardioplegia group (p = 0.494). Perioperative and postoperative variables were summarized in Table [3](#T3){ref-type="table"}. ###### Perioperative and postoperative variables **Variable** **Crystalloid cardioplegia \[no = 50\]** **Blood cardioplegia \[no = 50\]** **p value** -------------------------------------------------- ------------------------------------------ ------------------------------------ ------------- CPB time (min) 87 ± 14 94 ± 11 0.301 Cross-clamp time 61 ± 15 58 ± 23 0.433 Distal anastomosis (range 1--4) 3.4 ± 0.9 3.1 ± 0.4 0.244 Low cardiac output 11 5 0.044 IABP 5 1 0.031 Positive inotropic drug requirement 17 8 0.032 Renal failure need dialysis 1 \- 1 Revision       Tamponade 1 1 \- Bleeding 3 1 0.677 Ventilation \>48 2 1 1.00 Sternal dehissence 3 \- 0.242 TIA 1 1 \- Stroke 1 \- \- Sternal wound infection 2 1 \- Mediastinitis 1 \- \- Internal thoracic artery       -None 2 3 1.00 -Single 45 47 0.751 -Double 3 \-   Radial artery 17 19 0.835 Saphenous vein 50 50 1.00 Average intraoperative Htc (%) 18.4 ± 2.3 24.2 ± 3.4 \<0.001 Nadir intraoperative Htc (%) 15 20 \<0.001 Average intraoperative Hb (gr/dL) 5.5 ± 1.2 6.7 ± 1.3 0.001 Average intraoperative transfusion of Packed RBC 2.3 ± 0.41 0.7 ± 0.6 0.001 Average transfusion of packed RBC 2.7 ± 0.8 0.9 ± 0.4 \<0.001 Average FFP transfusion 2.1 ± 0.2 1.2 ± 0.8 0.001 Average platelet transfusion 1.2 ± 0.3 \-   Mortality 2 \- 0.494 ICU stay (days) 2.7 ± 1.2 1.1 ± 0.45 0.001 Hospital stay (days) 8.6 ± 2.1 6.4 ± 1.1 \<0.001 SVT 29 21 0.008 *Abbrevations*: *CPB* cardiopulmonary bypass, *IABP* intra-aortic balloon pump, *TIA* transient ischemic attack, *Htc* Hematochrit, *Hb* Hemoglobine, *RBC* Red blood cell, *FFP* fresh frozen packed, *ICU* intensive care unit, *SVT* supraventricular tachycardia. Predictors of intra-operative hemodilution ------------------------------------------ Data for all groups were combined and 11 variables were subjected to statistical analysis as a predictor of intraoperative hemodilution (Htc \< 22%). As shown in Table [4](#T4){ref-type="table"}, univariate analysis identified age (p = 0.009, OR = 2.07), female gender (p = 0.007, OR = 0.89), longer cross-clamp time (\>60 minutes) (p = 0.046, OD = 0.97), BSA \<1.6 m^2^ (p = 0.005, OR = 5.60) and crystalloid cardioplegia (p \< 0.001, OR = 0.36) as predictors of intraoperative hemodilution. The value of -2 log likelihood of multivariate analyses was 421.504. Multivariate analyses confirmed five of six variables. These were age (p = 0.005, OR = 3.78), female gender (p = 0.003, OR = 2.91), longer cross-clamp time (\>60 minutes) (p = 0.001, OD =0.97), BSA \<1.6 m^2^ (p = 0.001, OR = 6.01) and crystalloid cardioplegia (p \< 0.001, OR = 0.19). ###### Effects of various variables on the intraoperative hemodilution (Htc \< 22) based on univariate and multivariate logistic regression analyses   **Univariate** **Multivariate** -------------------------- ---------------- ------------------ --------- ------ ----------- --------- Age 2.07 1.66-3.34 0.009 3.78 2.67-4.33 0.005 Female 0.89 0.42-1.85 0.007 2.91 1.99-3.01 0.003 Diabetes 0.99 0.55-1.88 0.712 1.66 0.2-5.43 0.476 EF 0.92 0.89-0.96 0.101 1.7 0.1-7.8 0.765 CPB time 1.03 0.99-1.10 0.211 2.6 2.1-2.91 0.001 X-clamp time \> 60 0.97 0.91-1.05 0.046 0.97 0.94-1.03 0.001 COPD 3.41 2.13-4.29 0.111 3.94 2.35-6.99 0.178 LITA 0.49 0.25-0.81 0.023 0.65 0.32-1.25 0.230 Radial artery 0.75 0.36-1.42 0.442 2.11 1.01-3.36 0.536 BSA \< 1.60 m^2^ 5.60 4.71-8.95 0.005 6.01 5.67-6.33 0.001 Crystalloid cardioplegia 0.36 0.19-0.62 \<0.001 0.19 0.08-0.35 \<0.001 \*Adjusted for ejection fraction, cross-clamp time, LITA, COPD. *EF* ejection fraction, *CPB* cross-clamp time, *LITA* left internal thoracic artery, *COPD* chronic obstructive pulmonary disease, *BSA* body surface area. Predictors of transfusion requirement of packed red blood cells --------------------------------------------------------------- Data for all groups were combined and 11 variables were subjected to statistical analysis as a predictor of transfusion requirement of packed red blood cell. As shown in Table [5](#T5){ref-type="table"} univariate analysis identified age (p = 0.034, OR = 3.1), female gender (p = 0.004, OR = 1.12), CPB time (p = 0.006, OR = 2.33), longer cross-clamp time (\>60 minutes) (p = 0.003, OD = 2.16), BSA \<1.6 m^2^ (p = 0.001, OR = 3.71) and crystalloid cardioplegia (p \< 0.001, OR = 1.25) as predictors of transfusion requirement. Multivariate analyses confirmed five of six variables. These were female gender (p = 0.023, OR = 3.91), CPB time (p = 0.001, OR = 1.7), longer cross-clamp time (\>60 minutes) (p = 0.001, OD = 4.45), BSA \<1.6 m2 (p \< 0.001, OR = 3.83) and crystalloid cardioplegia (p \< 0.001, OR = 0.78). ###### Effects of various variables on the transfusion requirement of packed red blood cell based on univariate and multivariate logistic regression analyses   **Univariate** **Multivariate** -------------------------- ---------------- ------------------ --------- ------ ----------- --------- Age 3.1 1.11-4.34 0.034 2.3 1.67-3.53 0.065 Female 1.12 0.92-1.85 0.004 3.91 2.99-3.81 0.023 Diabetes 1.23 0.95-2.88 0.844       EF 0.86 0.59-1.96 0.101       CPB time 2.33 1.99-3.10 0.006 1.7 1.1-2.91 0.001 X-clamp time \> 60 min 2.16 1.91-2.55 0.003 4.45 3.94-4.98 0.001 COPD 4.61 1.13-7.29 0.673       LITA 2.34 0.25-4.81 0.123       Radial artery 2.45 1.31-4.02 0.678       BSA \< 1.60 m^2^ 3.71 3.34-4.95 0.001 3.83 3.67-5.13 \<0.001 Crystalloid cardioplegia 1.25 0.91-1.62 \<0.001 0.78 0.18-1.2 \<0.001 \*Adjusted for ejection fraction, cross-clamp time, LITA, COPD. *EF* ejection fraction, *CPB* cross-clamp time, *LITA* left internal thoracic artery, *COPD* chronic obstructive pulmonary disease, *BSA* body surface area. Discussion ========== Cardioplegia protects the heart from ischemic injury and postoperative heart failure during cardiopulmonary arrest period. Initially crystalloid cardioplegia was introduced as an agent to allow for hypothermic hyperkalemic arrest. Various additives were explored to optimize the myocardium during the time of ischemia \[[@B15]\]. Although cardioplegia is generally accepted to be a mandatory tool for myocardial protection during on-pump cardiac surgery, there is still controversy regarding various aspects including its composition, temperature, and mode of delivery. Blood was then found to be the most logical vehicle for delivery of potassium cardioplegia \[[@B16],[@B17]\] The optimal cardioplegic temperature, timing, and routes of delivery were further explored \[[@B18]\]. There are still controversies between crystalloid and blood cardioplegia for better myocardial protection. Øvrum E. and colleagues \[[@B19]\] did not found statistically significant differences between crystalloid and blood cardioplegia. Rinne T \[[@B20]\] demonstrated a higher incidence of spontaneous resumption of sinus rhythm after blood cardioplegia compared with that after crystalloid cardioplegia. But Øvrum E and colleagues \[[@B19]\] found no statistical differences concerning conduction disturbances. Blood as opposed to crystalloid cardioplegia could potentially improve postoperative cardiac outcomes, because it more closely approximates normal physiology caused in part by its oxygen carrying capacity and less associated hemodilution \[[@B15]\]. Intraoperative hemodilution and transfusion requirement becomes most critical subjects in the last decade \[[@B1]-[@B9]\]. Habib RH \[[@B1]\] specifically showed that major complications, including stroke, myocardial infarction, low cardiac output syndrome, renal failure, pulmonary edema, reoperation due to bleeding, sepsis, and multiorgan failure, were increased as the nadir hematocrit during CPB decreased. Moreover, this hematocrit--complications association inevitably resulted in significantly and systematically greater intensive care requirements, hospital stays, operative costs, and death with increasing levels of hemodilution, particularly for the lowest value less than 22%. Defoe and colleagues \[[@B2]\] found that patients with a lower hematocrit during cardiopulmonary bypass were associated with a higher risk of in-hospital mortality. However they did not provide data on transfusion or try to separate the effect of transfusion versus anemia on in-hospital mortality. In addition, somewhat unexpectedly, Habib RH \[[@B1]\] also found that hemodilutional anemia on bypass was associated with long-term adverse effects as well. Ongoren MC \[[@B6]\] found that blood transfusion during or after cardiac operation is associated with an increased risk of death over the subsequent five years. He showed that transfused patients also had twice the 5-year mortality (15% vs 7%) of nontransfused patients. After correction for comorbidities and other factors, transfusion was still associated with a 70% increase in mortality. We did not find statistically significant difference for mortality between two groups. All these statistical studies emphasized the importance of blood saving both intra-operative and postoperative period. Many blood precaution techniques has been developed for reducing the risk of intra-operative hemodilution and blood transfusion \[[@B8],[@B9]\]. Predisposing factor for intra-operative hemodilution and transfusion requirement has been described. Multivariate analyses has proved that previous anemia, female gender \[[@B13]\], low BSA, advanced age, CPB time, and renal failure as predictor of intra-operative hemodilution \[[@B2]-[@B9]\]. Hemodilution during CPB results from the mixing of pump crystalloid and colloid prime solution with the patient's blood, and these two relative volumes, along with pre-CPB, will largely determine the nadir value. In addition to above mentioned variables, the type of cardioplegia also effects intra-operative hemodilution. There weren't any prospective randomized study, identified crystalloid cardioplegia as predictor of hemodilution and transfusion requirement. Eucher PM noticed the hemodilutive effect of crystalloid cardioplegia and described a technique to remove crystalloid cardioplegia by retrograde cardioplegia cannula \[[@B14]\]. We performed this prospective randomized study to identify cristalloid cardioplegia as the predictor of hemodilution. Our multivariate study proved that above mentioned variables (previous anemia, female gender, low BSA, advanced age, CPB time, and renal failure) as predictor of intra-operative hemodilution. But our multivariate analyses also proved that crystalloid cardioplegia is also predictor of intraoperative hemodilution (p \< 0.001, OR = 0.19). Transfusion requirement predictors were also well proved. Our study proved that crystalloid cardioplegia is also strong predictor of transfusion requirement (p \< 0.001, OR = 0.78). The positive effects of blood cardioplegia are well known. We won't discuss this preventive ways of blood cardioplegia because of avoiding confounding information. Another alternative method for applying cardioplegia is minicardioplegia. Its difference from blood cardioplegia consists in the fact that it is applied without diluting the blood in a ratio of 1/4 or 1/8. In the related literature it is possible to find various publications on this topic. In their study, Rıza Türköz et al. found that this method did not necessitate too much volume during pumping and prevented hemodilution from occurring at a high level, while it ensured safe protection of the myocardium \[[@B21]\]. It has been argued in another study that minicardioplegia is more advantageous as regards myocardial edema after ischemic damage \[[@B22]\]. In contrast to these findings, however, there also studies arguing that this method does not provide any advantages over standard blood cardioplegia \[[@B23]\]. Conclusion ========== Crystalloid cardioplegia, compared to blood cardioplegia not only causes much more intra-operative hemodilution but also increases the blood transfusion requirement. Hemodilution and increased transfusion increases the ICU and hospital stay, in the early postoperative period. Abbreviations ============= CPB: Cardiopulmonary bypass; BSA: Body surface area; Htc: Hematocrit; RBC: Red blood cell; CABG: Coronary artery bypass graft; OR: Odds ratios; ICU: Intensive care unit. Competing interests =================== The authors declare that they have no competing interests. Authors' contributions ====================== MG, MD = Author. HB, MD = Data collection, Author, Concept/design, Data analysis/interpretation, Critical revision of article, Approval of article. Both authors read and approved the final manuscript.

1. Introduction {#sec1} =============== Upper cervical spine injuries are rare in the pediatric population, comprising between 0.6 and 9.5% of all cervical injuries \[[@B1]\], and neurologic disability related to pediatric cervical spine injury is uncommon. Patel et al. found that only one-third of children with these injuries had a neurological deficit and half of these cases showed no initial evidence of a radiological anomaly \[[@B2]\]. Many patients with a spinal cord injury without radiographic abnormality show symptoms immediately after injury, but some symptoms may also develop after a latency period of several days \[[@B3]\]. Here, we report a rare case of myelopathy caused by atlantoaxial subluxation without fracture, in which symptoms developed after a 24-year latency period. We describe the case in the context of a discussion of the literature. 2. Case Report {#sec2} ============== The patient was a 38-year-old male who became aware of weakness in the right side of the body for several months without a specific trigger. He also developed motor skills disorder in his right hand that made it difficult for him to drive a car. Weakness in his left lower extremity also gradually developed and he then visited the Department of Neurology at our hospital. At this visit, intracranial process was denied, but hyperesthesia of the right upper and lower extremities was confirmed. Since no other abnormal findings were observed, he was referred to our department for suspected cervical spine pathology. The patient had a history of hospital visits for several weeks for cervical pain after he hit the top of his head severely while diving into a swimming pool at the age of 14 years old. At that time, cervical spine plain X-ray images showed no fracture and he was diagnosed with whiplash injury. After the use of a collar for several weeks, the cervical pain disappeared. At his first visit to our department, his right and left grip strengths were 47 kg and 42 kg, respectively, and no objective muscular depression was apparent in the extremities. There was also no increased deep tendon reflex or pathological reflex. Cervical spine plain X-ray images showed no fracture but indicated an unstable atlantoaxial joint. The atlantodental interval (ADI) was increased to 8 mm during flexion and reduced to ≤3 mm in extension ([Figure 1](#fig1){ref-type="fig"}). Computed tomography (CT) showed no bone chips at the attachment site of the transverse ligament of the atlas ([Figure 2](#fig2){ref-type="fig"}). Magnetic resonance imaging (MRI) showed a high intensity area, which suggested fluid accumulation caused by instability between the anterior arch of the atlas and odontoid process of the axis ([Figure 3](#fig3){ref-type="fig"}). Based on this information, we diagnosed delayed myelopathy due to atlantoaxial subluxation caused by the injury of the transverse ligament of the atlas. Transarticular screw fixation surgery was performed under X-ray fluoroscopic guidance with the atlantoaxial joint in a hat-hook position. After the decortication of the posterior arch of the atlas and lamina of the vertebral arch axis, autologous iliac bone grafting was performed. The postoperative clinical course was uneventful. 4 days after surgery, walking exercises were initiated using a Philadelphia collar. Weakness of the extremities and motor skills disorder gradually improved. The patient was able to go back to work 3 months after surgery and showed no symptoms 6 months after surgery. Cervical spine plain X-ray images obtained 6 months after surgery showed union of grafted bone and no unstable cervical vertebra during flexion and extension ([Figure 4](#fig4){ref-type="fig"}). 3. Discussion {#sec3} ============= The incidence of blunt cervical spine injuries in children is 1% to 2% of all trauma victims requiring hospital admission \[[@B4]\]. The injury level of the cervical spine injury differs depending on age, with upper cervical injury being more common in younger children (0 to 8 years old), while lower cervical spine injury tends to occur more in older children (≥9 years old) \[[@B5], [@B6]\]. Upper cervical spine injuries in children are fundamentally different from those in adults because of anatomical differences in the developing spine. In children, the mass of the head is disproportionately large and the neck muscles are relatively underdeveloped. Furthermore, the vertebral bodies are wedge-shaped, the articulating facets are angled horizontally, the end plates are cartilaginous, and the interspinous ligaments are elastic and lax \[[@B7], [@B8]\]. These features predispose children to upper cervical spine injuries. Fewer fractures occur in children \<8 years old compared to those ≥8 years old because of the greater mobility of the spine and the laxity of the ligaments in younger children. The vertebrae start to ossify and mature at 8 years old. Anteriorly, the vertebral body loses its wedge shape and becomes more rectangular, the orientation of the facets becomes less horizontal and more vertical, and the uncinate process begins to protrude \[[@B9]--[@B12]\]. Atlantoaxial subluxation accompanies fracture of the odontoid process of the axis in many cases. Most fractures of the odontoid in younger children occur at the dens-body synchondrosis, the weakest area of C2 \[[@B13]\]. Traumatic rupture of the transverse ligament as a cause of anatomical feature is extremely rare in children. Mechanisms of injury to the ligament include forced forward flexion and axial loading of the atlas, which opens the ring and causes secondary rupture of the transverse ligament, as in a Jefferson fracture with atlantoaxial subluxation. However, based on the history of injury and imaging findings in our case, we concluded that traumatic injury of the transverse ligament of the atlas occurred after the patient dived into a swimming pool when he was 14 years old. Based on their experience in 4 patients aged 2--9 years old, Floman et al. \[[@B14]\] suggested that conservative treatment is not effective for atlantoaxial subluxation caused by injury of the transverse ligament of the atlas, and that surgical treatment should be performed. Dickman et al. \[[@B15]\] also suggested that early surgery is indicated in children aged ≥14 years old with a type 1 injury of the transverse ligament, whereas conservative treatment with a rigid cervical orthosis is preferred in patients with a type 2 injury with bone fragments in the ligament attachment; however, failure to achieve bone adhesion with such conservative treatment should be corrected with surgical treatment. CT findings obtained at the first visit showed no evidence of fracture at the attachment site of the transverse ligament in our case, indicating a type 1 injury in the Dickman classification. Since the patient showed no neurological symptoms and complained only of cervical pain at the time of the initial trauma, the injury to the transverse ligament of the atlas may have been missed. There have been no previous reports of cases with such a long latency period, but we suggest that myelopathy in our case developed due to microdamage to the spinal cord caused by an unstable atlantoaxial joint at 24 years after the initial injury. This case shows that atlantoaxial ligament injuries are difficult to diagnose and may easily be missed. A high level of suspicion is important in such cases, since neurological compromise or deterioration may occur many years after the injury. The authors declare that they have no conflict of interests. {#fig1} {#fig2} {#fig3} {#fig4} [^1]: Academic Editors: M. Gotoh, M. K. Lyons, and M. H. Zheng

Background {#Sec1} ========== The photocatalytic performance, electrical and gas-sensing properties are strongly influenced by their morphology and size. Many investigations have been carried out to study the controlling of size, morphology and structure of materials during synthesis \[[@CR1]--[@CR4]\]. To achieve this, the studies of the crystal growth, morphology evolution processes and the corresponding mechanisms are significantly important. As an important p-type transition-metal oxide with a narrow band gap varying between 1.2 and 1.8 eV \[[@CR5]\], CuO has been widely studied in thermal conductivity \[[@CR6]\], optoelectronic device systems \[[@CR7]\], CO oxidation \[[@CR8]\], eradication of multi-drug resistant bacteria \[[@CR9]\], Li ion batteries anodes \[[@CR10]\], heterogeneous catalyst for olefin epoxidation \[[@CR11]\], gas sensing \[[@CR12], [@CR13]\] and glucose sensor \[[@CR14]--[@CR18]\]. In the past decade, CuO with different morphologies such as nanoribbons \[[@CR12]\], microworms \[[@CR13]\], nanoplatelets \[[@CR19]\], dandelions \[[@CR20]\], sandwich \[[@CR16]\], nanowires \[[@CR17]\], nanotube arrays \[[@CR21]\], nanourchins \[[@CR2], [@CR18]\] and nanorods \[[@CR22]\] have been successfully synthesized through different methods with the assistance of surfactant such as CTAB, PVP, PEG and SDS. Since the surfactants invariably present residual surfactants or organic additives attached to the surfaces of products can block the active sites, it is a serious issue when considering applications in gas sensing or catalysis. Therefore, it is still a challenge to develop new green surfactant-free methods to synthesize well-defined CuO nanostructures \[[@CR23]\]. Zhang et al. \[[@CR24]\] synthesized flower-like CuO microspheres by a hydrothermal route at 130 °C for 18 h without the assistance of surfactant. Sun et al. \[[@CR23]\] synthesized two-dimensional CuO mesoplates and three-dimensinonal CuO mesospindles by an additive-free complex-precursor solution route. Inspired by the green methods to synthesize various controllable CuO morphologies with surfactant-free building blocks, we present a simply low temperature hydrothermal synthetic method without the assistance of surfactant. And spindle-like, rugby-like, nanoleaves, nanosheets, microspheres and dandelions CuO nanostructures are synthesized through this green method. The synthesis is performed in an ethanol-water mixed solvent using copper source and ammonia as the variable. By designing a time varying experiment, it is verified that the flower- and dandelion-like CuO structures are synthesized by the self-assembly and Ostwald ripening mechanism. X-ray diffraction (XRD), scanning electron microscope (SEM) and UV-visible diffuse reflectance spectra are employed to characterize the obtained CuO nanostructures. Furthermore, these copper oxide nanostructures are found to be high qualified photocatalysts for the degradation of rhodamine B (RhB) under visible light irradiation in the presence of hydroxide water (H~2~O~2~). Methods {#Sec2} ======= Materials and synthesis {#Sec3} ----------------------- Cu(NO~3~)~2~ · 3H~2~O (Cheng Du Kelong Chemical Reagent Company), Cu(COOH)~2~ · H~2~O (Tianjin Guangfu Fine Chemical Research Institute), NH~3~ · H~2~O (25 wt% \~ 28 wt%) (Cheng Du Kelong Chemical Reagent Company) and rhodamin B (RhB) (Tianjin Guangfu Fine Chemical Research Institute) are analytical grade and used without further purification. For a typical CuO nanostructure synthesis, 0.604 g (0.25 mol) of Cu(NO~3~)~2~ · 3H~2~O or 0.5 g (0.25 mol) Cu(COOH)~2~ · H~2~O mixed solution of 60 mL of deionized water and alcohol (the ratio of alcohol and water is 1:1) and stirred until completely dissolved. At the same time, an appropriate amount of NH~3~ · H~2~O is added into the above solution quickly and stirred 30 min. The resulting mixture is then transferred into a Teflon-lined steel autoclave and heated in an oven at 80 °C for 10 h. Finally, the precipitates are separated by centrifugation, washed with deionized water and alcohol for several times and dried at 70 °C for 12 h. Through this method, different morphology and size CuO is synthesized by adjusting the amount of NH~3~ · H~2~O and copper source. The variable parameters are listed in Table [1](#Tab1){ref-type="table"}.Table 1The morphologies and synthesis parameters of CuO nanostructuresSample no.The amount of NH~3~ · H~2~O (mL)Copper sourceMorphologiesA0.5Cu(NO~3~)~2~ · 3H~2~OSpindle-likeB0.5Cu(COOH)~2~ · H~2~ORugby-likeC0.6Cu(NO~3~)~2~ · 3H~2~ONanoleaveD0.6Cu(COOH)~2~ · H~2~ONanosheetE1.5Cu(NO~3~)~2~ · 3H~2~ODandelion-likeF1.5Cu(COOH)~2~ · H~2~OFlower-like Characterization {#Sec4} ---------------- Powder XRD pattern is recorded on an X'Pert Philips diffractometer (Cu Kα radiation: λ = 1.5418 Å, 2θ range 20∼80°, accelerating voltage 40 kV, applied current 150 mA). The morphology of the products is investigated by field emission scanning electron microscopy (SEM, Hitachi S-4800). Photocatalytic properties {#Sec5} ------------------------- The photocatalytic activity of the CuO nanostructures with different morphologies is evaluated by the degradation of a model pollutant RhB under the visible light irradiation with the assistance of hydrogen peroxide (H~2~O~2~) at ambient temperature. The original solution is prepared by mixing 5 mL H~2~O~2~ (30 wt%), 50 mL RhB solution (10^−5^ M) and 20 mg copper oxide powder together and then stirred in the dark for 60 min to ensure an adsorption-desorption equilibrium is established. Afterwards, the dispersion is irradiated by a 350-W xenon lamp equipped with a filter cutoff (λ ≥420 nm) under magnetic stirring. At given time intervals, the dispersion is sampled and centrifuged to separate the catalyst. The adsorption spectrum of the solution is then recorded with an UV-visible spectrophotometer (Shimadzu UV-3600). Results and discussion {#Sec6} ====================== Crystal structures of the prepared CuO nanomaterials {#Sec7} ---------------------------------------------------- Figure [1](#Fig1){ref-type="fig"} shows the XRD patterns of the products under different reaction conditions after hydrothermal treatment. Diffraction peaks are observed at 2θ of 32.5°, 35.5°, 38.7°, 48.7°, 53.7°, 58.2°, 61.5°, 66.3°, 68°, 72.3° and 74.8°. These peaks can be assigned to the (110), (002), (111), (-202), (020), (-113), (-311), (220), (311) and (-222) planes of monoclinic CuO (JCPDS 65-2309). No peaks of impurities such as copper hydroxide or other copper compounds can be detected, suggesting the high purity and similarity of all the as-prepared products.Fig. 1XRD patterns of CuO nanostructures after hydrothermal treatment with different reaction conditions Morphologies of CuO nanostructures synthesized by Cu(NO~3~)~2~ as a copper source {#Sec8} --------------------------------------------------------------------------------- When 0.5 mL of NH~3~ · H~2~O is added in the reaction system, CuO nanostructure with a spindle-like morphology is produced as shown in Fig. [2a](#Fig2){ref-type="fig"} and Fig. [2b](#Fig2){ref-type="fig"}. We can see that the CuO nanostructures are about 600 nm in length and 300 nm in width. When the volume of the NH~3~ · H~2~O is increased to 0.6 mL, the centre of the spindle-like CuO is getting thinner and finally obtains a large number of nanoleaves (Fig. [2c](#Fig2){ref-type="fig"}, [d](#Fig2){ref-type="fig"}). The CuO nanostructures are about 250 nm in length and 130 nm in width. Further increase NH~3~ · H~2~O to 1.5 mL, 3D dandelion-like CuO with hierarchical nanostructures is obtained (Fig. [2e](#Fig2){ref-type="fig"}, [f](#Fig2){ref-type="fig"}). The diameter of the CuO is about 4 μm. As can be seen from the SEM, the dandelion-like CuO is consisted of nanosheets (Fig. [2f](#Fig2){ref-type="fig"}). But further increases in the amount of NH~3~ · H~2~O, the morphology and size of the CuO do not change significantly, all the products remain dandelion-like.Fig. 2Electron microscopy images of CuO obtained by different amount of ammonia: **a**, **b** sample A; **c**, **d** sample C; **e**, **f** sample E Morphologies of CuO nanostructures synthesized by Cu(COOH)~2~ as a copper source {#Sec9} -------------------------------------------------------------------------------- When 0.5 mL of NH~3~ · H~2~O is added in the reaction system, CuO nanostructures with rugby-like morphology are produced as shown in Fig. [3a](#Fig3){ref-type="fig"} and Fig. [3b](#Fig3){ref-type="fig"}. The CuO nanostructures are about 200 nm in length and 130 nm in width. When the volume of the NH~3~ · H~2~O is increased to 0.6 mL, a large number of nanosheets with about 150 nm in length and 100 nm in width can be obtained (Fig. [3c](#Fig3){ref-type="fig"}, [d](#Fig3){ref-type="fig"}). When the amount of the NH~3~ · H~2~O is increased to 1.5 mL, 3D flower-like CuO microstructures consisted of nanosheets with the diameter about 3 μm can be obtained (Fig. [3e](#Fig3){ref-type="fig"}, [f](#Fig3){ref-type="fig"}). The accumulation of nanosheets of dandelion-like CuO is denser than the flower-like CuO, and the diameter of dandelion-like CuO is larger than that of flower-like CuO. Further increase the amount of NH~3~ · H~2~O, the morphology and size of the CuO do not change anymore, all the products remain flower-like CuO microstructures.Fig. 3SEM images of CuO obtained by different volume of ammonia: **a**, **b** sample B; **c**, **d** sample D; **e**, **f** sample F Plausible mechanisms for the formation of CuO nanostructures {#Sec10} ------------------------------------------------------------ When 0.5 mL or 0.6 mL ammonia is added in to the solution, a flocculent precipitation is generated in these blue solutions. The precursor in the blue solution before heat treatment is Cu(OH)~2~. Copper oxide is obtained after heat treats the Cu(OH)~2~ precipitation; the reactions can be summarized as follows:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \mathrm{C}{\mathrm{u}}^{2+} + 2\mathrm{N}{\mathrm{H}}_3\cdotp {\mathrm{H}}_2\mathrm{O}\to \mathrm{C}\mathrm{u}{\left(\mathrm{O}\mathrm{H}\right)}_2\downarrow + 2\mathrm{N}{{\mathrm{H}}_4}^{+} $$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \mathrm{C}\mathrm{u}{\left(\mathrm{O}\mathrm{H}\right)}_2\ \overset{80{}^{\circ}\mathrm{C}}{\to}\mathrm{C}\mathrm{u}\mathrm{O} + {\mathrm{H}}_2\mathrm{O} $$\end{document}$$ Increase the dose of ammonia further, the firstly formed flocculent precipitate dissolved. Then \[Cu(NH~3~)~4~\]^2+^ can be considered as the precursor entity for the formation of CuO. The reactions can be described as follows:$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \mathrm{C}{\mathrm{u}}^{2+} + 4\mathrm{N}{\mathrm{H}}_3\cdotp {\mathrm{H}}_2\mathrm{O}\ \to\ {\left[\mathrm{C}\mathrm{u}{\left(\mathrm{N}{\mathrm{H}}_3\right)}_4\right]}^{2+} + 2\mathrm{O}{\mathrm{H}}^{-} + 4{\mathrm{H}}_2\mathrm{O} $$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\left[\mathrm{C}\mathrm{u}{\left(\mathrm{N}{\mathrm{H}}_3\right)}_4\right]}^{2+} + 2\mathrm{O}{\mathrm{H}}^{-}\overset{80{}^{\circ}\mathrm{C}}{\to }\ \mathrm{C}\mathrm{u}\mathrm{O} + 4\mathrm{N}{\mathrm{H}}_3 + {\mathrm{H}}_2\mathrm{O} $$\end{document}$$ In the present case, CuO particles are synthesized directly by the decomposition of Cu(OH)~2~ or (Cu(NH~3~)~4~)^2+^ precursor under hydrothermal conditions without the presence of various surfactant. The crystal formation process can be divided into two stages: nucleation and crystal growth. When the amount of ammonia is less than 0.6 mL, Cu(OH)~2~ is formed in aqueous reaction medium, which transformed into CuO under hydrothermal conditions \[Eqs. ([1](#Equ1){ref-type=""}) and ([2](#Equ2){ref-type=""})\]. When the amount of ammonia is over 1.5 mL, the soluble \[Cu(NH~3~)~4~\]^2+^ complex is formed, which transformed into CuO under hydrothermal conditions \[Eqs. ([3](#Equ3){ref-type=""}) and ([4](#Equ4){ref-type=""})\]. The different growth unite might affect the competition between thermodynamics and kinetics during the reduction of precursors and nucleation and growth of CuO crystals \[[@CR25]\]. Comparing Fig. [2](#Fig2){ref-type="fig"} with Fig. [3](#Fig3){ref-type="fig"}, we can conclude that the morphologies of CuO are not the same and the sizes of CuO become smaller when the copper source changes from Cu(NO~3~)~2~ to Cu(COOH)~2~. The effect of copper source on the structure of CuO may be that the NO~3~^−^ is inorganic strong acid root and the COOH^−^ is organic weak acid root; in the synthesis of complex precipitation, the anions in the solution affect the nucleation and growth of the copper oxide precursor. From the above analysis, it is safe to say that the ammonia and the acid radical ion have an important effect on the formation of CuO morphology. Both self-assembly and Ostwald ripening mechanism are involved in the process of synthesizing of the dandelion-like and flower-like CuO. To verify this, the time-dependant morphologies of the dandelion- and flower-like CuO are shown in Fig. [4](#Fig4){ref-type="fig"}. We can conclude that after 3 h, CuO microspheres are formed by the self-assembly of particles, but the surface of microspheres is uneven; there are still many small particles attached to the surface of microspheres (Fig. [4a](#Fig4){ref-type="fig"}, [d](#Fig4){ref-type="fig"}). With the extension of reaction time, these particles gradually ripe and the final structures are formed (Fig. [4c](#Fig4){ref-type="fig"}, [f](#Fig4){ref-type="fig"}).Fig. 4SEM images of CuO obtained after different reaction time: **a**, **d** 3 h; **b**, **e** 5 h; **c**, **f** 10 h Photochemical performances {#Sec11} -------------------------- The optical energy band gaps of semiconductors are found to be dependent on their microstructures, so the above as-prepared CuO nanostructures with different morphologies are investigated by UV-vis spectra. Figure [5a](#Fig5){ref-type="fig"} shows the UV-visible spectra of as-prepared CuO products with different morphologies, the absorption edges of spindle-like, rugby-like, nanoleave, nanosheet, dandelion-like and flower-like CuO occur at 975, 1010, 985, 910, 1000 and 960 nm, respectively. Figure [5b](#Fig5){ref-type="fig"} shows the plot of photon energy; we can find that the band gaps of spindle-like, rugby-like, nanoleave, nanosheet, dandelion-like and flower-like CuO are estimated to be 1.27, 1.23, 1.26, 1.36, 1.24 and 1.29 eV, respectively. The effect of the morphology of CuO nanostructure is clearly noted on its band gap. The fundamental photodegradation mechanism involves the acceleration in decomposition of H~2~O~2~ over CuO crystals to generate free radical species, such as .OH, .OOH or .O~2~^−^, which are deemed to be liable for the degradation of the dyes. The related chemical reactions include the electrons (e^−^) in the VB can be excited to the CB and at the same time generate the same number of holes (h^+^) in the VB. The formed e^−^ and h^+^ pairs can be captured by H~2~O~2~ molecules leading to the formation of .OH, .HOO or .O~2~^−^ \[Eqs. ([5](#Equ5){ref-type=""})--([8](#Equ8){ref-type=""})\]; oxidant species react with dye then finally realize complete mineralization with the formation of CO~2~, H~2~O or other inorganic ion \[[@CR23]\].$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \mathrm{C}\mathrm{u}\mathrm{O} + \mathrm{h}\upnu \to {\mathrm{h}}_{\mathrm{vb}+} + {\mathrm{e}}_{\mathrm{c}{\mathrm{b}}^{-}} $$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\mathrm{H}}_2{\mathrm{O}}_2 + {\mathrm{h}}_{\mathrm{vb}+}\to {\kern0.5em }^{.}\mathrm{O}\mathrm{O}\mathrm{H} + {\mathrm{H}}^{+} $$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\mathrm{H}}_2{\mathrm{O}}_2 + {\mathrm{e}}_{\mathrm{c}{\mathrm{b}}^{-}}\to {\kern0.5em }^{.}\mathrm{O}\mathrm{H} + \mathrm{O}{\mathrm{H}}^{-} $$\end{document}$$$$\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {}^{.}\mathrm{O}\mathrm{O}\mathrm{H}\to {\kern0.5em }^{.}{{\mathrm{O}}_2}^{-} + {\mathrm{H}}^{+} $$\end{document}$$Fig. 5**a** UV-vis spectra and (**b**) plot of photon energy of as-prepared CuO products with different morphologies To explore the photochemical performances of the as-prepared CuO nanostructures, photocatalytic activity of CuO is evaluated in the oxidation of RhB under visible light irradiation at ambient temperature in the presence of hydroxide water (H~2~O~2~). The characteristic absorption pick at 554 nm of RhB is monitored to follow the catalytic degradation process. Figure [6a](#Fig6){ref-type="fig"} shows the optical absorption spectra of RhB measured at different intervals in the absence of catalysts and H~2~O~2~; only a slight degradation (2.2 %) of RhB can be detected after 100 min (Fig. [6i](#Fig6){ref-type="fig"}, *A*). Figure [6b](#Fig6){ref-type="fig"} shows the optical absorption spectra of RhB measured at different intervals only with the H~2~O~2~; only 7.4 % of RhB can be detected after 100 min (Fig. [6i](#Fig6){ref-type="fig"}, *B*). Figure [6c](#Fig6){ref-type="fig"}--[h](#Fig6){ref-type="fig"} shows the optical absorption spectra of RhB tested at different intervals in the presence of different nanostructured CuO. It can be found that the degradation rate of nanoleave and nanosheet CuO are both very fast, 91.7 and 93.4 % are reached respectively after 100 min (Fig.[6i](#Fig6){ref-type="fig"}, *E*, *F*). The lowest degradation rate is about 51.1 % by the rugby-like CuO (Fig. [6i](#Fig6){ref-type="fig"}, *D*). The degradation of RhB at 100 min in the presence of above six samples is as follows: nanosheet CuO (93.4 %) \> nanoleave CuO (91.7 %) \> spindle-like CuO (86.9 %) \> flower-like CuO (86 %) \> dandelion-like (75 %) \> rugby-like (51.1 %).Fig. 6Absorption spectra of RhB under visible light irradiation with different CuO nanostructures. **a** Without any catalyst and H~2~O~2~, **b** only with H~2~O~2~, **c** with sample A, **d** with sample B, **e** with sample C, **f** with sample D, **g** with sample E, **h** with sample F, and **i** plot of the extent of photodegradation of RhB which corresponds to *A*, *B*, *C*, *D*, *E*, *F*, *G* and *H* Conclusions {#Sec12} =========== In summary, a green synthesis for spindle-like, rugby-like, nanoleave, nanosheet, dandelion-like and flower-like CuO nanostructures (from 2D to 3D) are successfully achieved through simply hydrothermal synthetic method without the assistance of surfactant. The formation of CuO nanostructures here is basically effected by the amount of ammonia and the copper source. We also found that the flower- and dandelion-like CuO structures are synthesized by the self-assembly and the Ostwald ripening mechanism. Additionally, the CuO nanostructures with different morphologies could serve as a potential photocatalyst on the photodecomposition of RhB aqueous solutions in the presence of H~2~O~2~ under visible light irradiation. **Competing interests** The authors declare that they have no competing interests. **Authors' contributions** XW conceived the study, carried out the acquisition, analyzed and interpreted the data, performed the sequence alignment, and drafted the manuscript. JY and LS helped to revise the manuscript. MG helped to revise the manuscript critically for important intellectual content. All authors have read and approved the final manuscript. This work was financially supported by the NSFC (No. 51371093) and the MOE (No. IRT1251 & 20130211130003) of China.

Introduction {#Sec1} ============ T-cell acute lymphoblastic leukemia (T-ALL) is a high-risk leukemia subtype that accounts for 10--15% of pediatric and 25% of adult ALL cases \[[@CR1]\]. Although the remission rate has significantly improved over the past decade, T-ALL remains a therapeutic challenge due to the high frequency of induction failure \[[@CR2]\] and early relapse, which is mostly resistant to further treatment \[[@CR3]\]. Molecular abnormalities that have frequently been reported in T-ALL include activation mutations of Notch1 and JAK1 and inactivation mutations of PTEN and FBXW7 \[[@CR4]\]. The PI3K-Akt-mTOR signaling axis is an important contributory pathway for T-cell leukemia \[[@CR5], [@CR6]\]. It is frequently upregulated in patients with T-ALL and its activation is correlated with poor prognosis, therapeutic resistance, and disease relapse \[[@CR5], [@CR7]--[@CR9]\]. Deletion of *mTOR complex-1* (*mTORC1*) in a T-ALL mouse model resulted in profound cell-cycle arrest and efficient eradication of T-ALL cells \[[@CR10], [@CR11]\], suggesting that mTORC1 can integrate signals from the PI3K-Akt and MEK--ERK signaling pathways to activate downstream components responsible for tumor cell growth and metabolism \[[@CR12]\]. Tuberous sclerosis is a hereditary syndrome characterized by hamartoma formation in various tissues, which is caused by mutations in either *TUBEROUS SCLEROSIS COMPLEX 1* (*TSC1*) or *TSC2* genes \[[@CR13]\]. The tuberous sclerosis complex (TSC) is typically composed of TSC1, TSC2, and Tre2-Bub2-Cdc16 domain family member 7 (TBC1D7) subunits. It can be regulated through the PI3K-Akt, Ras-ERK-RSK1, LKB1-AMPK, IKKβ, GSK3β, and HIFα-REDD1 signaling pathways, all of which can be activated by several stimuli such as growth factors, inflammation, energy stress, hypoxia, and the Wnt pathway \[[@CR14], [@CR15]\]. Thus far, the TSC is the only known direct inhibitor for activity of the small GTPase Ras homolog enriched in brain (Rheb), which is a critical activator for mTORC1 signaling, i.e., the major promoter of cellular growth and metabolism \[[@CR14], [@CR16]--[@CR19]\]. Therefore, the TSC represents a key controller of the Rheb-mTORC1 signaling network, which is commonly activated via upstream signaling dysregulation due to oncogenic mutation of genes or post-translational protein modifications in tumors. Suppression of Rheb-mTORC1 activation is dependent on translocation of the TSC to the lysosomal surface \[[@CR20], [@CR21]\]. CBAP, also known as TMEM102 (Gene ID:284114), was first identified as an interacting protein of the GM-CSF/IL-3/IL-5 receptor common β-chain and participates in cytokine deprivation-induced apoptosis \[[@CR22]\]. Bioinformatics analyses have revealed that CBAP is a member of the Mab21 subfamily that lies within the nucleotide transferase protein fold superfamily \[[@CR23]\]. Our previous studies have demonstrated that CBAP participates in chemokine-enhanced T-cell migration and adhesion \[[@CR24]\] and in T-cell receptor engagement-induced phosphorylation of ZAP-70 and PLCγ1 \[[@CR25]\]. Since CBAP proteins are highly expressed in many established tumor cell lines, including T-cell leukemia, we examined whether CBAP is also involved in leukemia proliferation and tumorigenesis. By manipulating the expression of the gene encoding CBAP with knockdown/knockout strategies in T-ALL cells, we demonstrate that CBAP participates in tumor cell growth and leukemogenesis in mice. Importantly, we further reveal the underlying mechanism by which CBAP facilitates Akt-mediated suppression of TSC2, which is accompanied by an increase of Rheb-GTP loading and activation of the mTORC1-signaling pathway to promote leukemogenesis. Results {#Sec2} ======= CBAP enhances the growth of leukemia cells {#Sec3} ------------------------------------------ We first observed that CBAP protein expression was higher in a Jurkat T-ALL cell line than in purified human peripheral T lymphocytes (CD3^+^ T cells) (Fig. [1a](#Fig1){ref-type="fig"}), but these latter conversely expressed a higher level of *CBAP* mRNA than Jurkat T cells (Supplementary Fig. [1a](#MOESM1){ref-type="media"}). Interestingly, CBAP protein levels were elevated in all four T-ALL cell lines analyzed, but only in one of the acute myeloid leukemia cell lines we examined (HL60) (Fig. [1b](#Fig1){ref-type="fig"}). To confirm this overexpression of CBAP in leukemic cells, we further verified CBAP protein expression in bone marrow (BM) biopsy sections of T-ALL patients (Table [1](#Tab1){ref-type="table"}) by immunohistochemical (IHC) staining. IHC staining for CD3 was positive and diffuse, confirming that most of the tumor cells in the BM sections are T cells (Fig. [1c](#Fig1){ref-type="fig"}, middle row), and only a few were positive in the BM sections from control patients (Fig. [1d](#Fig1){ref-type="fig"}, middle row). CBAP protein was diffusely overexpressed in T-ALL tumor cells (Fig. [1c](#Fig1){ref-type="fig"}, upper row) when compared with the control (anemia patients), with these latter showing no obvious CBAP expression in normal BM biopsy sections (Fig. [1d](#Fig1){ref-type="fig"}, upper row). We also assessed C-Myc protein expression as a downstream marker of mTORC1 activation and found strong nuclear C-Myc staining in two T-ALL patients but not in the control patients (Fig. [1c](#Fig1){ref-type="fig"}, bottom row). Therefore, we hypothesized that higher CBAP protein expression may confer a beneficial effect on T-ALL cells. To investigate this possibility, we generated a CBAP knockout (KO) Jurkat cell line using the CRISPR/Cas9 technique, and confirmed the absence of CBAP expression by immunoblotting (Supplementary Fig. [1b](#MOESM1){ref-type="media"}, left panel). These CBAP-KO Jurkat cells exhibited reduced chemokine-induced migratory activity (Supplementary Fig. [1c](#MOESM1){ref-type="media"}), which is consistent with our previous observation \[[@CR24]\]. Importantly, CBAP downregulation by either one of two different shRNA knockdown plasmids (sh-CBAP no. 1 and no. 2), or by CRISPR/Cas9 plasmid--mediated KO, caused a significant and consistent reduction in the proliferation rate of Jurkat cells (Fig. [1e](#Fig1){ref-type="fig"}), as well as in CCRF-CEM T-ALL cells (Supplementary Figs. [1b](#MOESM1){ref-type="media"}, right panel, and 1d). We compared control and CBAP-KO Jurkat cells in a cell-cycle analysis using a bromodeoxyuridine (BrdU) and 7-aminoactinomycin D (7-AAD) double-labeling method and found a significant increase in the number of cells undergoing G0/G1 in CBAP-KO Jurkat cells (Fig. [1f](#Fig1){ref-type="fig"}), but no significant difference in the percentages of cells undergoing sub-G0/G1 (i.e., apoptotic) stages (Supplementary Fig. [S1e](#MOESM1){ref-type="media"}) or in the number of annexin V^+^ apoptotic cells (Supplementary Fig. [S1f](#MOESM1){ref-type="media"}), suggesting that CBAP KO mainly affects the cell proliferation rate in Jurkat cells. This finding is consistent with our observation that levels of bcl-2 protein, a major anti-apoptotic protein in hematopoietic cells, increased in CBAP-KO Jurkat cells (Supplementary Fig. [S1g](#MOESM1){ref-type="media"}).Fig. 1CBAP is highly expressed in T-ALL cell lines and patient cells, and it is important for the regulation of cell proliferation. **a**, **b** Immunoblots of CBAP in human peripheral CD3^+^ T lymphocytes and Jurkat cells (**a**), and in a panel of T-ALL and acute myeloid leukemia (AML) cell lines (**b). c**, **d** IHC staining with CBAP, CD3 and c-Myc antibodies was performed on bone marrow biopsy specimens from two T-ALL patients (T-ALL P01 and P02) (**c**) or two anemia patients (BM 01 and 02) (**d**). Scale bars, 10 μm. **e** Growth of leukemic Jurkat cells stably transduced with lentiviruses expressing control shRNA (sh-Ctrl) or CBAP shRNAs (sh-CBAP no. 1 or no. 2), or clones with (CBAP-KO) or without (cr-Ctrl) CBAP knockout using a CRISPR/Cas9-CBAP-targeting vector. Data are expressed as means ± SD (*n* = 4). **f** Cell-cycle distribution of leukemic Jurkat cells without knockout (cr-Ctrl) or with knockout of CBAP (CBAP-KO), measured by BrdU/7-AAD staining. Data are expressed as means ± SD (*n* = 3). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001, according to two-tailed unpaired Student *t* testsTable 1Clinical characteristics of the eight acute lymphoblastic leukemia patientsPatient NoAge (years)GenderBone marrow lymphoblast count (before treatment)Response to TreatmentDisease-free survival (months)Bone marrow CBAP expression^a^P0144Male65.6% (T cell)CR to hCVAD;9.6++P0223Male78% (T cell)CR to hCVAD + MTX;1.2++P0327Male12% (T + B cell)CR to hCVAD9.6++P0429Male60% (Pre-T cell)PD to CDVA1.2+P059Male93% (T cell)CR to TPOG-ALL12+P0624Male79% (T cell)CR to hCVAD+MTX27.6−P0752Male66% (T cell)CR to hCVAD2.4+P0825Male77% (T cell)Unknown^b^Unknown^b^++*ALL* acute lymphoblastic leukemia, *CR* complete remission, *CVAD* cyclophosphamide/vincristine/doxorubicin/dexamethasone, *hCVAD* hyper-CVAD, *CDVA* cyclophosphamide/daunomycin/vincristine/[l]{.smallcaps}-asparaginase, *MTX* methotrexate, *PD* progressive disease, *TPOG* Taiwan Pediatric Oncology Group^a^All bone marrow samples were collected before any treatment regimens. The intensity of CBAP expression detected by immunohistochemical stain was defined as: "−" for negative, "+" for weak staining, "++" for strong staining^b^This patient was transferred to another hospital CBAP is involved in leukemogenesis in vivo {#Sec4} ------------------------------------------ We next investigated the impact of CBAP loss on the leukemogenic potential of Jurkat cells in vivo. We established a leukemic mouse model by transplanting five million Jurkat cells expressing a firefly luciferase reporter gene into *NOD-SCID-IL2Rγc*-deficient (NSG) mice. At 14 and 21 days after transplantation (D), luminescence was significantly lower in mice transplanted with sh-CBAP-expressing Jurkat cells compared with control (sh-Ctrl) Jurkat cells (Fig. [2a](#Fig2){ref-type="fig"}). One mouse died at D14 and another one died at D21 in the control group (Fig. [2a](#Fig2){ref-type="fig"}, upper row). However, transplanted mice could live up to D42 under conditions of reduced CBAP expression (Fig. [2a](#Fig2){ref-type="fig"}, lower row). At D18, representative proportions of human CD45^+^ cells were significantly higher in the BM, peripheral blood leukocytes (PBLs), and spleen of mice that received control (sh-Ctrl) Jurkat cell transplants (Supplementary Fig. [S2a](#MOESM1){ref-type="media"}). Leukemic mice engrafted with sh-Ctrl Jurkat cells displayed a splenomegaly phenotype (Supplementary Fig. [S2b](#MOESM1){ref-type="media"}), and became moribund with severe hind limb paralysis before death. Notably, although all mice eventually succumbed to T-ALL, the mice transplanted with sh-CBAP Jurkat cells developed leukemia over a much longer latency period than those transplanted with sh-Ctrl Jurkat cells (Fig. [2b](#Fig2){ref-type="fig"} and Supplementary Fig. [S3a](#MOESM1){ref-type="media"}). Mice transplanted with CBAP-KO Jurkat cells also exhibited a significantly prolonged latency period compared to those transplanted with the control (cr-Ctrl) Jurkat cells (Fig. [2c](#Fig2){ref-type="fig"} and Supplementary Fig. [S3b](#MOESM1){ref-type="media"}). Introduction of CBAP-GFP fusion protein into CBAP-KO cells could partially rescue cell proliferation in tissue culture (Supplementary Fig. [S3c](#MOESM1){ref-type="media"}), and leukemogenesis in vivo (Fig. [2c](#Fig2){ref-type="fig"}, green line), further supporting the importance of CBAP in leukemic cell proliferation. Moreover, shRNA knockdown of CBAP in CCRF-CEM T-ALL cells also consistently produced cells that exhibited longer disease latency in this leukemic mouse model compared to the control (Fig. [2d](#Fig2){ref-type="fig"} and Supplementary Fig. [S3d](#MOESM1){ref-type="media"}), suggesting that CBAP expression increases the oncogenic activity of leukemia cells in vivo.Fig. 2CBAP downregulation prolongs the survival of leukemic mice. **a** Tracking of leukemia outgrowth by bioluminescence imaging in NSG mice transplanted with sh-Ctrl- or sh-CBAP-expressing Jurkat cells (*n* = 2 per group). + represents mouse death. **b**--**d** Kaplan--Meier plots showing the mortality of NSG mice transplanted with various Jurkat clones (**b**, **c**) or CCRF-CEM clones (**d**) as indicated. Animal numbers in (**b**): for sh-Ctrl, *n* = 12, for sh-CBAP(no.1), *n* = 12, sh-CBAP(no.2), *n* = 5; in (**c**): cr-Ctrl, *n* = 15, CBAP-KO, *n* = 15, CG5, *n* = 15; in **d**: for sh-Ctrl, *n* = 10, sh-CBAP, *n* = 10. The survival results in **b**--**d** were compiled from experiments performed with aforementioned lines (see also results in Supplementary Fig. [S3](#MOESM1){ref-type="media"} for individual clones). The statistical significance of differences in the survival curves between groups was evaluated using the log-rank test Downregulation of CBAP expression in T-ALL cells results in reduced aerobic glycolysis and energy metabolism {#Sec5} ------------------------------------------------------------------------------------------------------------ We next sought to examine CBAP-regulated gene expression signatures in leukemia using a next generation sequencing technique for RNA (RNA-seq). Total mRNA was isolated from two types of CBAP-expressing Jurkat cells (sh-Ctrl cells and CBAP-KO cells expressing CBAP-GFP, with these latter referred to as CBAP-reconstituted cells) and two types of CBAP-deficient Jurkat cells (sh-CBAP cells and CBAP-KO cells expressing GFP). We then generated genome-wide transcriptome profiles for these cell lines (for method, see [supplementary information](#MOESM1){ref-type="media"}). The RNA-seq data have been deposited in NCBI Gene Expression Omnibus (GEO) database (accession number: GSE 69511). Gene sets that presented highly reduced expression in the CBAP-deficient cells were related to metabolism, as assessed by KEGG (Kyoto Encyclopedia of Genes and Genomes) categories (Supplementary Table [S1](#MOESM1){ref-type="media"}), and these metabolic genes represented over 60% of the significantly enriched pathways (false discovery rate (FDR) *q* value \< 0.25) (Fig. [3a](#Fig3){ref-type="fig"}). Of interest, among these downregulated metabolic pathways, most of the gene sets belonged to subgroups linked to carbohydrate metabolism (35.7%) or amino acid metabolism (32.1%) (Table [S1](#MOESM1){ref-type="media"}). A gene set enrichment analysis (GSEA) showed that the gene expression pattern in CBAP-deficient leukemia cells was significantly correlated with signatures of TSC1/TSC2-dependent rapamycin-sensitive genes \[[@CR26]\] (Fig. [3b](#Fig3){ref-type="fig"}). Furthermore, the most represented genes (*P* \< 0.05), i.e., pertaining to the mTORC1-induced gene set, encoded proteins involved in the regulation of glycolysis (i.e. *Aldoa, Pfkl, Pfkp, Pgm1, Glut1*, and *Tpi1*) and lipid biosynthesis (i.e. *Acly, Fasn, Gdpd1, Hsd17b12*, and *Slc25a1*) \[[@CR27]\] (Supplementary Table [S2](#MOESM1){ref-type="media"}). To further validate the results of our transcriptomic analysis, qRT-PCR experiments on expression levels of the aforementioned genes also supported that mRNA levels of many enzymes involved in glycolysis and lipid biosynthesis pathways were significantly reduced (Fig. [3c](#Fig3){ref-type="fig"}). Protein levels of two critical transcriptional factors downstream of mTORC1---c-Myc, which is important for protein translation, and HIF1α, which is important for energy metabolism---were also reduced in the CBAP-deficient Jurkat cells (Fig. [3d](#Fig3){ref-type="fig"}). Finally, critical metabolites in glycolysis (lactate) and glutaminolysis (α-ketoglutarate) were also reduced in CBAP-KO cells (Fig. [3e](#Fig3){ref-type="fig"}), suggesting that indeed the activities of several catabolic pathways such as aerobic glycolysis and glutaminolysis are diminished in the absence of CBAP proteins, resulting in reduced cell growth. These biochemical evidences prompted us to investigate whether CBAP participates in the proliferation of leukemia cells via the mTORC1 pathway since mTORC1 signaling is a well-known master regulator of protein translation, cell growth, metabolism, and cancer cell proliferation \[[@CR28]\]. Treatment with rapamycin, a specific mTORC1 inhibitor, efficiently suppressed phosphorylation of p70S6K (a marker of mTORC1 activation, Fig. [3f](#Fig3){ref-type="fig"}) and cell growth (Fig. [3g](#Fig3){ref-type="fig"}) in both control and CBAP-KO Jurkat cell lines, demonstrating that activation of mTORC1 signaling is essential for Jurkat cell leukemic growth. Although p70S6K phosphorylation was almost completely inhibited in both control and CBAP-KO cells using 1 nM of rapamycin (Fig. [3f](#Fig3){ref-type="fig"}), loss of CBAP and rapamycin treatment had an additive effect in terms of growth suppression (Fig. [3g](#Fig3){ref-type="fig"} and Supplementary Fig. [S5a](#MOESM1){ref-type="media"}). Therefore, apart from the mTORC1 signaling pathway, CBAP might act on another growth pathway (see below).Fig. 3CBAP deficiency reduces aerobic glycolysis and energy metabolism and attenuates the Raf-MEK-ERK--RSK and mTORC1-S6K-4E-BP1 signaling pathways. **a** Functional categories of KEGG gene sets markedly impacted (FDR \< 0.25) by CBAP downregulation. **b** Correlation of CBAP positively-regulated genes and TSC1/TSC2-dependent rapamycin-sensitive genes \[[@CR26]\], as determined by GSEA. **c** qRT-PCR analysis of the mRNA levels of genes involved in the regulation of glycolysis and fatty acid biosynthesis. *Gapdh* was used as an internal control. The data are averages of biologically triplicated experiments. Results are plotted as mean ± SD (*n* = 3). **d** Expression of CBAP, c-Myc, P53 and HIF1α in Jurkat-derived cell clones. **e** Analysis of concentrations of lactate and α-ketoglutarate in the culture media of Jurkat and CBAP-KO cells. Data are expressed as means ± SD (n = 3; duplicate per measurement). **f** Suppression of p70S6K phosphorylation in cr-Ctrl and leukemic CBAP-KO Jurkat cells treated with the indicated doses of rapamycin for 6 h. Data represent mean ± SD of three independent experiments with duplicates of each condition. **g** Effect of the mTORC1 inhibitor, rapamycin, on Jurkat-derived leukemic cell growth. Data represent mean ± SD of three independent experiments. **h**, **i** Activation of signaling proteins involved in the Akt-TSC2-mTORC1 (**h**) and Raf-MEK-ERK (**i**) signaling pathways in the different Jurkat-derived cell lines, as indicated. Numbers under the lanes represent phosphor-proteins/total proteins normalized to that of cr-Ctrl cells (as 1.0). **j**, **k** Effects of the Akt inhibitor MK2206 (**j**) and the MEK inhibitor U0126 (**k**) on the growth of cr-Ctrl Jurkat and CBAP-KO leukemic Jurkat cells in tissue culture. Data represent mean ± SD of three independent experiments with duplicates of each condition. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001, according to two-tailed unpaired Student\'s *t* tests Loss of CBAP simultaneously attenuates both Raf-MEK-ERK--RSK and mTORC1-S6K signaling {#Sec6} ------------------------------------------------------------------------------------- Since both PI3K-Akt and Raf--MEK--ERK signaling are reported to be crucial for mTORC1 activation \[[@CR12], [@CR14]\], we investigated the potential involvement of CBAP in these signaling pathways. First, CBAP KO resulted in a drastic increase of Akt phosphorylation at residues T308 and S473, whereas downstream mTORC1-S6K-4E-BP1 signaling was downregulated in CBAP-KO cells, as demonstrated by the decreased phosphorylation of TSC2 (T1462, S939) and p70S6K (T389), but not 4EBP1 (T37/46) (Fig. [3h](#Fig3){ref-type="fig"}). The relative phosphorylation of residue S9 of GSK3β compared to total GSK3β levels was not altered (Fig. [3h](#Fig3){ref-type="fig"}). Notably, compared to CBAP-KO cells, phosphorylation of TSC2, p70S6K, and 4EBP1 was all significantly enhanced in CBAP-reconstituted cells (Fig. [3h](#Fig3){ref-type="fig"} and Fig. [S4](#MOESM1){ref-type="media"} for quantification data), whereas Akt phosphorylation in these CBAP-reconstituted cells had returned to the level of control cells (Fig. [3h](#Fig3){ref-type="fig"} and Fig. [S4a](#MOESM1){ref-type="media"}). These data are consistent with the hypothesis proposed by Guertin and Sabatini \[[@CR28], [@CR29]\] that a negative feedback inhibition loop may exist to regulate PI3K/Akt activity as a result of increased p70S6K activity. CBAP deletion also downregulated Raf-MEK-ERK signaling, as judged by decreased phosphorylation of cRaf (at residue S338, but not S259), MEK1/2 (S217/221), ERK1/2 (T202/Y204), and p90RSK (S380) (Fig. [3i](#Fig3){ref-type="fig"}, lane 2, and Supplementary Fig. [S4b](#MOESM1){ref-type="media"}). Restoration of CBAP expression partially restored the phosphorylation levels of these proteins (Fig. [3i](#Fig3){ref-type="fig"}, lane 4, and Supplementary Fig. [S4b](#MOESM1){ref-type="media"}). These data suggest that CBAP plays a critical role in regulating both the Akt-mTORC1 and Raf-MEK-ERK signaling pathways. To further investigate which signaling pathway is essential for T-ALL cell growth, we treated cells with the specific inhibitors MK2206 and U0126 that target the Akt and MEK signaling pathways, respectively. Both inhibitors effectively suppressed tumor growth in tissue cultures in a time- and dose-dependent manner (Fig. [3j, k](#Fig3){ref-type="fig"}), indicating that both pathways are important for cell growth. As for the effect of rapamycin treatment on mTORC1 activation, 1 μM MK2206 or 1 μM U0126 could almost completely inhibit Akt activity or MEK/ERK activity, respectively, in both control and CBAP-KO cells (see below, Fig. [4d, e](#Fig4){ref-type="fig"}), and loss of CBAP always had an additive effect to the inhibitor in terms of suppressing cell growth (Fig. [3j, k](#Fig3){ref-type="fig"}, see also Figs. [S5b](#MOESM1){ref-type="media"} and [S5c](#MOESM1){ref-type="media"}). Furthermore, suppression of leukemia cell growth in Jurkat cell-engrafted leukemic mice by either rapamycin or U0126 treatment or a combination of both further supports the importance of both the Raf-MEK-ERK and Akt-mTORC1 pathways in leukemia proliferation, especially since a combination of both inhibitors had an additive effect in vivo (Supplementary Fig. [S6](#MOESM1){ref-type="media"}).Fig. 4CBAP regulates upstream of Ras/Rac1 activation and TSC2-mTORC1 signaling cascades in Jurkat cells. **a**, **b** Activated Ras (**a**) and activated Rac1 (**b**) were precipitated by performing Ras-RBD and Rac1-PBD pull-down assays, respectively, and were detected by western blot using specific antibodies. Total cell lysate was pre-loaded with GTPγS or GDP as positive and negative controls, respectively, in the assays. **c** Tyrosine phosphorylation of PI3Kp85. Lysates were immunoprecipitated with anti-phosphotyrosine (pTyr) antibody before being subjected to Western blot using anti-PI3Kp85 antibody. **d**--**f** Immunoblotting analysis of signaling molecules in cr-Ctrl and leukemic CBAP-KO Jurkat cells in response to treatment with MK2206 (**d**), U0126 (**e**), or co-treatment with MK2206 and U0126 (**f**). **g** Schematic representation of the crosstalk between the Raf-MEK-ERK--RSK and Akt-TSC2-p70S6K pathways and the effects of CBAP knockout and inhibitors on the Jurkat cell line Crosstalk between the PI3K-Akt and ERK--RSK pathways in T-ALL cells {#Sec7} ------------------------------------------------------------------- Next, we set out to investigate the effect of CBAP on other upstream components involved in the Akt/TSC2 and Raf-MEK-ERK pathways. We measured levels of GTP-loaded Ras and Rac1 by pull-down assays with the Ras-binding domain (RBD) of Raf1 and with the p21-binding domain (PBD) of Pak1 \[[@CR30]\], respectively. Compared to GTPγS-bound Ras (Fig. [4a](#Fig4){ref-type="fig"}) and GTPγS-bound Rac1 (Fig. [4b](#Fig4){ref-type="fig"}), only small amounts of Ras and Rac1 were GTP-loaded (lane 1 vs. lane 3). However, we found that these amounts were further reduced in CBAP-deficient cells compared to cr-Ctrl cells (lane 2 vs. lane 1). Conversely, in accordance with the effect of CBAP deficiency on Akt activity, we found that loss of CBAP increased phosphorylation of the p85 subunit of PI3K (Fig. [4c](#Fig4){ref-type="fig"}). However, it remains to be explored whether these two signaling pathways have a common upstream regulator. ERK \[[@CR31]\] and RSK \[[@CR32]\] have been shown to directly act on TSC2 and mTORC1 phosphorylation, respectively, in other cancer types, and that crosstalk exists between these pathways has been demonstrated \[[@CR12]\]. As this crosstalk may bias our interpretation of the effect of CBAP KO, we investigated the potential crosstalk between these pathways in T-ALL leukemia cells using pathway-specific inhibitors. When control cells were treated with the Akt inhibitor, MK2206, Akt phosphorylation was significantly reduced and phosphorylation levels of TSC2 and p70S6K also decreased, whereas ERK1/2 phosphorylation was not altered (Fig. [4d](#Fig4){ref-type="fig"} and Supplementary Fig. [S4c](#MOESM1){ref-type="media"} for quantification data). However, when we inhibited MEK1/2 in control cells using U0126, ERK1/2 and p90RSK phosphorylation was significantly abrogated and Akt phosphorylation was increased (Fig. [4e](#Fig4){ref-type="fig"}), probably due to relief of the hypothetical cross-inhibitory signal from the Raf-MEK-ERK pathway \[[@CR12]\]. This upregulated Akt phosphorylation in turn led to increased phosphorylation of TSC2 and p70S6K, which was especially evident when cells were treated with 0.1 μM U0126 (Fig. [4e](#Fig4){ref-type="fig"} and Supplementary Fig. [S4d](#MOESM1){ref-type="media"}). Notably, increased phosphorylation of TSC2 and p70S6K was not observed in the absence of CBAP (Fig. [4e](#Fig4){ref-type="fig"}, comparing lanes 4 and 5, and Supplementary Fig. [S4d](#MOESM1){ref-type="media"}) or in the co-treatment with MK2206 (Fig. [4f](#Fig4){ref-type="fig"}, comparing lane 2 to lane 5), suggesting that the crosstalk between the Raf-MEK-ERK and Akt-mTORC1 pathways occurs mainly through the Akt protein or its upstream regulator PI3-K in Jurkat cells (see Fig. [4g](#Fig4){ref-type="fig"}), but does not directly affect TSC2 or mTORC1 proteins \[[@CR31], [@CR32]\]. Taken together, Akt appears to be the predominant kinase controlling both TSC2 phosphorylation and downstream mTORC1 activation in leukemic Jurkat cells. CBAP facilitates TSC2 phosphorylation by Akt according to cell-based assays and in vitro analysis {#Sec8} ------------------------------------------------------------------------------------------------- Our aforementioned data suggest that CBAP is involved in the Akt-mTORC1 signaling pathway by controlling Akt-mediated TSC2 phosphorylation. We further investigated this dependency of Akt-mediated TSC2 phosphorylation on the presence of CBAP in HEK293T cells. We knocked out the *CBAP* gene in HEK293T cells using a CRISPR/Cas9-mediated strategy and then transiently expressed myc-Akt1 and Flag-TSC2/myc-TSC1 plasmids in this cell background (Fig. [5a](#Fig5){ref-type="fig"}, lower panel). We found the phosphorylated level of exogenously expressed Flag-TSC2 to be significantly elevated in the presence of CBAP and exogenous Akt, whereas it was not increased in HEK293T cells lacking either Akt (Fig. [5a](#Fig5){ref-type="fig"}, upper panel, lane 1) or CBAP (Fig. [5a](#Fig5){ref-type="fig"}, upper panel, lane 5), suggesting that CBAP-mediated facilitation of Akt-dependent TSC2 phosphorylation could be recapitulated in HEK293T cells using exogenous proteins. Additionally, we explored whether CBAP directly facilitates Akt-mediated TSC2 phosphorylation using an in vitro kinase assay. As shown in Fig. [5b](#Fig5){ref-type="fig"}, immunoprecipitated phospho-Akt from CBAP-KO cells possessed a limited ability to phosphorylate recombinant Flag-TSC2 protein that had been produced using an in vitro transcription/translation (IVT) system. When bacterially-derived recombinant GST-CBAP protein was added to the system, levels of phosphorylated TSC2 increased in a dose-dependent manner in vitro (Fig. [5b](#Fig5){ref-type="fig"}, lanes 4 and 5). However, when non-phosphorylated Akt was used in the in vitro kinase assay, the enhancing effect of CBAP disappeared (compare lane 4 and lane 6 in Fig. [5b](#Fig5){ref-type="fig"}), suggesting that CBAP directly activates Akt to phosphorylate TSC2. We also monitored the changing GTP-loadings of the small G protein Rheb as an independent measure of TSC2 complex inactivation by upstream Akt signals. Using an antibody that can specifically recognize GTP-loaded Rheb \[[@CR33]\], we directly measured the nucleotide-binding states of Rheb in total cell lysates of leukemic Jurkat cells. As shown in Fig. [5c](#Fig5){ref-type="fig"}, under steady state conditions, the levels of Rheb-GTP (i.e., active Rheb) were decreased in CBAP-KO cells (lane 2) compared to both control cells (lane 1) and CBAP-reconstituted cells (CG5, lane 3). We further explored whether CBAP can regulate the levels of Rheb-GTP in the reconstituted HEK293T cells with exogenous proteins. After transfection with the Akt plasmids shown in Fig. [5d](#Fig5){ref-type="fig"}, cell lysates were immunoprecipitated with the anti-Rheb-GTP antibody and the immunoprecipitates were subjected to immunoblotting with an anti-Flag antibody. We found that there was an increase in the level of the active, GTP-bound, exogenous Flag-Rheb in control HEK293T cells (Fig. [5d](#Fig5){ref-type="fig"}, compare lanes 1 and 2). In contrast, Akt did not increase the levels of Rheb-GTP in the absence of CBAP (Fig. [5d](#Fig5){ref-type="fig"}, compare lanes 3 and 4). Thus, our data strongly suggest that CBAP can directly act on the Akt/TSC/Rheb axis to regulate downstream activation of mTORC1 signaling.Fig. 5CBAP is crucial for Akt-mediated TSC2 phosphorylation and cellular Rheb-GTP levels. **a** CBAP is required for Akt-mediated TSC2 phosphorylation. Various plasmids were transfected into HEK293T cells (Ctrl or CBAP-KO). Flag-TSC2 was immunoprecipitated with anti-Flag antibody and then the immunoprecipites were subjected to immunoblotting. The input levels of proteins are shown. Black and white arrows indicate exogenous and endogenous Akt proteins, respectively. *N* = 2. **b** In vitro Akt kinase activity on TSC2 is increased in the presence of recombinant GST-CBAP protein. An in vitro Akt kinase assay was established using in vitro-translated Flag-TSC2 protein as the substrate. Phospho-Akt (S473) and non-phospho-Akt were immunopurified from CBAP-KO Jurkat cells treated with or without MK2206. Quantification of the levels of phosphorylated TSC2 normalized to total TSC2 protein is indicated above the lanes. One representative picture from two independent experiments was shown. **c** Absence of CBAP is correlated with low levels of Rheb-GTP in Jurkat cells. Endogenous Rheb-GTP levels were evaluated by immunoprecipitation using an antibody that selectively recognizes Rheb-GTP. Lysates were treated with GTPγS or GDP, which were included as positive and negative controls, respectively. **d** CBAP is essential for the Akt-induced increase in Rheb-GTP levels. Ctrl and CBAP-KO HEK293T cells were transfected with the indicated plasmids before Rheb-GTP levels were determined in the lysates as described in (**c**). Expression levels of the transfected plasmids were determined by immunoblotting using tag-specific antibodies. *N* = 2 CBAP is also required for insulin-induced TSC2 phosphorylation and translocation {#Sec9} -------------------------------------------------------------------------------- Since TSC2 functions as a signaling hub for many converging stimuli (including growth factors, stress, and metabolites, among others) and regulates downstream mTORC1-mediated cell metabolism, we wondered whether CBAP can also modulate Akt-dependent TSC2 phosphorylation and translocation via growth factors such as insulin. In CRISPR/Cas9-mediated CBAP-KO Hela cells, we found that insulin-stimulated phosphorylation of TSC2 and p70S6K was diminished but phosphorylation of Akt (S473 and T308) was elevated compared to control cells, suggesting that CBAP is also crucial for mediating insulin-stimulated Akt-mTORC1 signaling (Fig. [6a](#Fig6){ref-type="fig"}). Given that TSC2 phosphorylation has been reported to functionally inactivate the TSC by triggering its translocation into the cytosol and away from Rheb and mTORC1 at the lysosomal membrane \[[@CR20], [@CR34], [@CR35]\], we investigated whether loss of CBAP affects TSC2 protein docking on and off the lysosomal surface in response to insulin stimulation. Through an immunostaining approach, we found that co-localization of endogenous TSC2 and LAMP2 (a well-characterized lysosomal marker) was obvious upon serum starvation and that levels of co-localization were reduced upon re-stimulation with insulin (1 μM, 15 min) in Hela (Fig. [6b](#Fig6){ref-type="fig"}, upper panel) and CBAP-KO Hela cells (Fig. [6b](#Fig6){ref-type="fig"}, lower panel). However, insulin treatment stimulated less lysosomal dissociation of TSC2 in CBAP-KO cells (Fig. [6e](#Fig6){ref-type="fig"}, left panel). Similar insulin-stimulated dissociation of TSC2 from lysosomal compartments, stained with LysoView, was also detected in CBAP-KO cells (Fig. [6c](#Fig6){ref-type="fig"}). Notably, TSC2 cycling off lysosomal compartments was profoundly restored in HA-CBAP-expressing cells in response to insulin signal (Fig. [6d](#Fig6){ref-type="fig"}, Fig. [6e](#Fig6){ref-type="fig"}, right panel). These findings show that CBAP is an integral part of the mechanism by which Akt regulates TSC2 function and localization upon growth factor stimulation.Fig. 6CBAP loss affects insulin-stimulated lysosomal translocation of TSC2. **a** Analysis of insulin-stimulated Akt-TSC2-p70S6K signaling activation in control and CBAP-KO Hela cells. Cells were serum starved for 16 h and then stimulated with insulin for 15 min prior to lysis. Western blots were performed using indicated antibodies. **b**--**d** Hela cells (wild type, CBAP-KO or HA-CBAP-reconstituted) were treated as in (**a**), prior to immunofluorescent co-labeling of TSC2 with LAMP2 (**b**), with LysoView (**c**), or with HA-CBAP plus LysoView (**d**). The data are representative of three independent biological replicates (*n* = 45\~ 95 cells). The degree of co-localization between TSC2 and LAMP2 or LysoView is shown in the right panel. Box represents the median and interquartile range, whereas whiskers represent maximum and minimum values. For the co-localization images, representative magnified insets are shown in the rightmost panel (top: TSC2; middle: LAMP2 or LysoView; bottom: merged). **e** Relative lysosomal co-localization of TSC2 upon insulin stimulation. Statistical data were compiled from results in (**b**) (left panel), or (**c**) and (**d**) (right panel). Error bars denote ± SEM. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001, according to two-tailed unpaired Student\'s *t* tests Discussion {#Sec10} ========== This study highlights the critical role of CBAP in regulating the proliferation of T-ALL, and proposes a CBAP-dependent mode of action for Akt-mediated TSC inactivation. Our model proposes direct involvement of CBAP in Akt-dependent TSC2 phosphorylation, which facilitates dissociation of TSC2 from lysosomal surfaces, thereby relieving the Rheb-mTORC1 signaling axis from suppression by the TSC. Furthermore, loss of CBAP impairs both Rheb-mTORC1 and Raf--MEK--ERK signaling activities, resulting in reductions of leukemia cell migration and growth. Consistently, CBAP-KO T-ALL cells exhibited reduced leukemogenicity and spleen invasiveness when transplanted into immunocompromised mice. Although we cannot completely exclude the possibility of a common mechanism involving CBAP acting upstream of both the Raf-MEK-ERK and Akt-mTORC1 signaling pathways (Fig. [4g](#Fig4){ref-type="fig"}), in this study we have nevertheless clearly demonstrated that CBAP has a direct role in promoting Akt-dependent TSC2 phosphorylation, driving Rheb-mTORC1 signaling and leukemic cell growth. Our previous studies have reported the pro-apoptotic functions of CBAP in cytokine-dependent cell lines \[[@CR22]\] or in primary hematopoietic cells \[[@CR24], [@CR25]\]. However, in the current study, we have discovered an important oncogenic and pro-proliferative role of CBAP in malignant hematological cells, such as T-ALL cells. That two seemingly opposing roles for one protein occur in different cellular microenvironments is not unprecedented. The oncogene c-Myc is a well-known oncoprotein, being overexpressed in B-cell leukemia and other human cancers. However, until very recently, its apparently intrinsic apoptotic properties were not fully appreciated (Prendergast, 1999). The myeloid ecotropic viral integration site 1 (Meis1) protein coordinates with HoxA9 in vivo to drive murine myeloid leukemogenesis. However, Meis1 has an obviously pro-apoptotic function in hematopoietic cell cultures when it is expressed alone, whereas co-expression of Meis1 with HoxA9 completely suppresses cell death \[[@CR36]\]. Similarly, Tribbles homolog 2 functions as an oncogene in inducing murine acute myelogenous leukemia (AML) and cooperates with HoxA9 to accelerate the onset of AML in vivo, which is consistent with the fact that Trib2 is highly expressed in a particular subset of human AML patients \[[@CR37]\]. However, ectopic expression of Trib2 alone in 32D cells (an IL-3-dependent myeloid leukemia cell line) \[[@CR38]\], or in TF-1 cells \[[@CR39]\], induces a strong apoptotic response. Therefore, the two seemingly opposing roles of CBAP may be influenced by a "missing factor" that cooperates with CBAP to control the cellular microenvironment of host cells and determines the biological function of CBAP. This possibility warrants further investigation. The exact mechanism of CBAP-mediated TSC2 phosphorylation remains undetermined. Previous studies have shown that CBAP is involved in ZAP70-dependent Vav1 phosphorylation and β1 integrin signalosome activation in chemokine-induced inside-out signaling \[[@CR24]\]. It is also involved in LAT-PLCγ2-ZAP70 signalosome formation during TCR engagement \[[@CR25]\]. We have previously mapped two discrete binding sites for Vav1 and Zap70 in the N-terminus of CBAP, as well as a β1 integrin binding site in the C-terminal half of the CBAP protein \[[@CR24]\], but their functions remain unknown. Here we have uncovered a similar role for CBAP in facilitating TSC2 phosphorylation by Akt. Since CBAP deficiency results in a reduction of the GTP loading of multiple small G proteins such as Rac1 \[[@CR24]\], cdc42 \[[@CR24]\], Ras and Rheb (this report), we suspect that multiple guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) may be regulated by CBAP. It has been reported that CBAP is a member of the Mab21 subfamily in the nucleotidyl-transferase (NTase) fold protein superfamily \[[@CR23]\]. Proteins of this subfamily are characterized by sharing a common Mab21 core structure composed of an N-terminal NTase domain followed by a C-terminal polyA polymerase/2′−5′-oligoadenylate synthase1 (PAP/OAS1) substrate binding domain \[[@CR23]\]. A crystallographic study of CBAP protein structure would greatly enhance our understanding of how CBAP is involved in the activation of multiple small G proteins, as well as how its structure and function diverge from those of other NTase fold protein superfamily members \[[@CR23], [@CR40]\]. As a therapeutic strategy targeting the mTORC1 pathway, several studies have developed single or dual inhibitors targeting components of the PI3K-Akt-mTORC1 signaling cascade and have showed profound anti-leukemic effects on T-ALL cell lines or in vivo T-ALL models, suggesting the presence of a dominant oncogenic driver in this pathway \[[@CR41], [@CR42]\]. The advantage of targeting CBAP as a therapeutic intervention in the PI3K-Akt-mTORC1 axis is that knockout of the *CBAP* gene in mice resulted in almost no significant acute phenotype and CBAP plays no essential role in cell metabolism or proliferation in primary cells. However, the high metabolic demands of cancer cells apparently require more efficient enzymatic complexes, which may be facilitated by overexpression of CBAP protein. Consequently, a CBAP blocker should effectively suppress cancer cell growth that is dependent on the PI3K-Akt-mTORC1 signaling axis, while leaving other primary normal cells unaffected by systemic therapy. Materials and methods {#Sec11} ===================== Patient samples and primary cells {#Sec12} --------------------------------- Human samples used in this study were approved by the Institutional Review Board (IRB; AS-IRB01-11153 and AS-IRB01-16055) of Academia Sinica (AS). Paraffin-embedded specimens of patient bone marrow were provided by Tri-Service General Hospital (Taipei, Taiwan). Informed consent has been obtained from all subjects. All cases of T-ALL and anemia non-tumor specimens were diagnosed clinically and pathologically and are detailed in Table [1](#Tab1){ref-type="table"}. Human blood cells were separated using a Ficoll gradient and CD3^+^ T cells were sorted using a FACSAria flow cytometer (Becton Dickinson, Franklin Lakes, NJ). Plasmids {#Sec13} -------- Plasmids expressing Flag-tagged TSC2 (\#14129) and Myc-tagged TSC1 (\#12133) were obtained from Addgene (Cambridge, MA). The mammalian Myc-tagged Akt1 expressing vector was generated from the pcDNA3-*Akt1* plasmid by standard PCR-assisted cloning. The full-length *Rheb* gene was cloned from the cDNA of Jurkat cells and was subclonned to generate Flag-tagged Rheb plasmid. Human cell lines and transplantation of NSG mice {#Sec14} ------------------------------------------------ Jurkat, MOLT-4, CCRF-CEM, HSB-2 and HL-60 cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA). Kasumi-1 cell line was a gift from Dr. LT Hsiao obtaining from Bioresource Collection and Research Center, Taiwan. KG-1 cell line was obtained from Dr. PM Chen's collection. For insulin stimulation, Hela cells were treated as described previously \[[@CR20], [@CR35]\]. NOD-scid-IL2RγKO (NSG) mice \[[@CR43]\] were purchased from Jackson Laboratory (Bar Harbor, ME) and maintained in the specific pathogen-free animal facility of the Institute of Biomedical Sciences, AS. Animal experiments were approved by the Institutional Animal Care and Utilization Committee (IACUC) of AS (protocol number: 12-12-443). For tumor transplantation, five millions cells were transplanted by tail vein injection into 6--8-week-old male NSG recipients to generate cohorts of T-ALL leukemic mice for analyses. Immunohistochemistry (IHC) of patient bone marrow sections {#Sec15} ---------------------------------------------------------- IHC of paraffin-embedded bone marrow biopsy specimens was performed with the Cell and Tissue Staining Kit HRP-DAB System (\#CTS002, CTS005, Abingdon, UK) and SignalStain Antibody Diluent (8112, Cell signaling, Danvers, MA) following the vender's instructions. CRISPR/Cas9-mediated knockout and shRNA knockdown of CBAP {#Sec16} --------------------------------------------------------- A CRISPR/Cas9 target site for CBAP co-expression with GFP was designed by Zgenebio Biotech Inc. (Taipei, Taiwan) (<http://crispr.mit.edu>). The target sequence used for CBAP was 5ʹ-GGCCCCAGCTCGGCCGCTCA-3ʹ. GFP^+^-sorted single cells were cultured to establish single-cell clones. Knockout and control (cr-Ctrl) clones were identified by immunoblot. For shRNA-mediated knockdown of CBAP, lentiviral particles bearing specific shRNAs were provided by the National RNAi Core Facility of AS. Two different CBAP shRNAs were used: one targeting the 5′-ACCGAACGGAGAGCGAAGAAA-3′ sequence to produce the sh-CBAP (no. 1) clone, and another targeting 5′-CTGGACCTGGAATCCTGTTAC-3′ to produce the sh-CBAP (no. 2) clone. One non-targeted control shRNA (pLKO TRC025) was used to generate sh-Ctrl. Puromycin was used for selection of stable clones. Leukemia xenograft bioluminescent imaging {#Sec17} ----------------------------------------- Bioluminescent imaging was performed for all animals in the cohort by intraperitoneal injection of D-Luciferin potassium salt (BioVision, Milpitas, CA) at 150 mg/kg in conscious mice. After 7 min, mice were anesthetized (1% isofluorane) for image acquisition (IVIS 200, Caliper Life Sciences, Hopkinton, MA) with a 15 s exposure. The total photon flux^−1^ for bioluminescent imaging was determined using Living Image 4.5 software (Caliper Life Sciences, Hopkinton, MA). Proliferation and cell-cycle analysis {#Sec18} ------------------------------------- Cell proliferation was evaluated using an automated cell counter (Countess, Invitrogen, Grand Island, NY) and the trypan blue exclusion method. For cell-cycle profile analysis, a BrdU/7-ADD staining kit (552598; BD Pharmingen, San Jose, CA) was used. Cell immuno-fluorescence, confocal microscopy and quantification of co-localization {#Sec19} ----------------------------------------------------------------------------------- The immuno-fluorescence experiments and calculation of Manders' co-localization coefficient (MCC) were performed according to a previous report \[[@CR35]\] using a Zeiss LSM 700 confocal microscope (Oberkochen, Germany). For each condition, 3--6 representative confocal images from three independent experiments were used. For calculation of Manders' co-localization coefficient (MCC), automatic Costes thresholding was applied to analyze a total of 45--95 individual cells per condition. Statistical significance was calculated using unpaired Student's *t* test. Measurement of cellular Rheb-GTP levels {#Sec20} --------------------------------------- To measure Rheb-GTP levels, we used a Rheb activation assay kit (81201; New East Biosciences, Malvern, PA) according to the manufacturer's instructions. In vitro akt kinase assay {#Sec21} ------------------------- Akt kinase assays were carried out using a non-radioactive Akt kinase assay kit (9840; Cell Signaling Technology, Danvers, MA) according to the manufacturer's instructions. In vitro transcription/translation (IVT; L5010, Madison, WI) Flag-TSC2 protein was synthesized and used as the substrate. Statistical analysis {#Sec22} -------------------- Animal survival was assessed with Kaplan--Meier plots. The equality of the Kaplan--Meier survival distributions was assessed using the Mantel--Cox log-rank test for statistical significance. For other statistical analyses, *P* values were calculated with a two-tailed Student's *t* test for two-group comparisons using Prism (GraphPad, La Jolla, CA). Differences were considered significant if the *P* value was \< 0.05. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0005. Cell lysis, immunoprecipitation and immunoblots {#Sec23} ----------------------------------------------- All methods for total cell lysis, immunoprecipitation, and Western blotting were described previously \[[@CR24]\]. All antibodies used for this purpose are detailed in supplementary Table [3](#MOESM1){ref-type="media"}. The ImageJ software (Wayne Rasband, NIH) was used to quantify band intensities on the blots. Quantitative reverse transcription PCR {#Sec24} -------------------------------------- Quantitative reverse transcription PCR and cDNA synthesis were performed as described \[[@CR25]\]. The primer sequences used for quantitative reverse transcription PCR of human CBAP were 5′-TGGCAAAGCTCTGTAGACCA-3′ (forward) and 5′-CTGGGCGGAACATAATGTGG-3′ (reverse). Relative fold expression was calculated by the 2^−ΔΔ*C*^~T~ method \[[@CR44]\]. Electronic supplementary material ================================= {#Sec25} Supplementary information Electronic supplementary material ================================= The online version of this article (10.1038/s41388-018-0507-6) contains supplementary material, which is available to authorized users. We thank Dr. Richard Lin at Stony Brook University Medical Center for his careful reading of the manuscript and his suggestions. We thank the National Center for Genome Medicine, National RNAi Core Facility, and the Molecular and Genetic Imaging Core of the Taiwan Mouse Clinic for their technical support. This work was supported by grants from the Ministry of Science and Technology, Taiwan to JJYY (NSC102-2320-B001-007-MY3 and MOST105-2320-B-001-012-MY3), and was partly supported by Tri-Service General Hospital (TSGH-106-01-34). YJC is supported by postdoctoral fellowships MOST103-2811-B-001-090 and MOST105-2811-B-001-044. The authors declare that they have no conflict of interest.

Letter to the Editor, We read with interest the article by Pausepp et al. about 28 patients with suspected mitochondrial disorder (MID) who retrospectively (*n* = 17) or prospectively (*n* = 11) had undergone whole exome sequencing (WES) \[[@bb0005]\]. We have the following comments/concerns. The authors mention that only in 4/28 patients a MID was genetically confirmed \[[@bb0005]\]. However, in one further patient an *ATP6* variant was detected and in another patient mtDNA depletion was detected on muscle biopsy \[[@bb0005]\]. Furthermore, the *PDHA1* carrier should be regarded as a MID \[[@bb0010]\]. Why were these three patients not included in the MID-group? Only in 5 of 28 patients did the authors detect a mutated gene associated with a MID and in 1 patient a possible mitochondrial depletion syndrome (MDS) was diagnosed? Were any of the genes associated with MDS screened for a mutation \[[@bb0015]\]? In how many of the 6 patients with a MID was the family history positive for the disease? In the patient carrying the *ATP6* mutation, no heteroplasmy rates are provided. In which tissue were heteroplasmy rates determined and was the degree of heteroplasmy compatible with the phenotype? Did the mother of this patient also carry the mutation? Spinal muscular atrophy (SMA) should not be diagnosed upon the muscle biopsy findings. Did the patient with "typical" histological features of SMA also carry a deletion/duplication of the *SMN1* gene? Muscle hypotonia was reported in 11 patients \[[@bb0005]\]. Was hypotonia attributed to a central cause or due to involvement of the peripheral nerves or the muscle? Only one patient had neuropathy but 16 had muscle weakness \[[@bb0005]\]. Overall, the study may profit from inclusion of the family history, from provision of heteroplasmy rates for the *ATP6* variant, and from stressing that clinical assessment with or without scores may falsely suggest MID in a significant number (*n* = 21) of patients. Conflict of interest {#s0005} ==================== There are no conflicts of interest. Funding {#s0010} ======= No funding was received. Author contribution {#s0015} =================== JF: design, literature search, discussion, first draft, SZM:literature search, critical review. [^1]: Both authors contributed equally

\section{Introduction} \subsection{Background} Let $k$ be a field of characteristic zero and $X$ a variety over $k$. Following Illusie we can associate to $X$ its \emph{derived de Rham cohomology} as follows: we consider the (Hodge completed) derived de Rham algebra \[ \mathrm{dR}_{X/ k} \coloneqq \Sym(\mathbb L_{X/ k}[-1])^\wedge \] where $(-)^\wedge$ stands for the completion of the usual symmetric algebra \[\Sym(\mathbb L_{X/ Y}[-1]) \in \mathrm{CAlg}_k,\] with respect to its natural Hodge filtration. Furthermore, we can identify the graded pieces of the latter with exterior powers \[ \wedge^i \mathbb L_{X/ Y} [-i], \quad \mathrm{for} \ i \ge 0, \] c.f. \cite[Vol. II, \S VIII]{Illusie_Complexe_1971}. The Hodge completed derived de Rham algebra is thus a natural generalization of the usual de Rham complex for singular varieties over $k$, where we replace the sheaf of differentials \[ \Omega^1_{X/ k}, \] by the (algebraic) cotangent complex $\mathbb L_{X/ k}$ and force a spectral sequence of the form Hodge-to-de Rham to converge. On the other hand, Hartshorne introduced in \cite{hartshorne1975rham} the \emph{algebraic de Rham cohomology} for singular varieties $X/ k$ in terms of formal completions: suppose we are given a closed immersion $i \colon X \hookrightarrow Y$, where $Y$ is a smooth algebraic variety over $k$. Then one can form the \emph{formal completion}, $Y^\wedge_X$, of $Y$ at $X$ along $i$. Inspired by the theory of tubular neighborhoods, Hartshorne defined an algebraic cohomology theory by taking global sections of $Y_X^\wedge$ \[ \Gamma(Y^\wedge_X, \mathcal O_{Y^\wedge_X}). \] Moreover, the cohomology groups so obtained are independent of the choice of the closed embedding $i \colon X\to Y$. In \cite{Bhatt_Derived_Completions}, Bhatt proved a general comparison between the two mentioned notions. More precisely, the author proves a natural multiplicative equivalence of complexes \[ \mathrm{dR}_{X/k} \simeq \Gamma(Y^\wedge_X, \mathcal O_{Y^\wedge_X}), \] c.f. \cite[Proposition 4.16]{Bhatt_Derived_Completions}. In particular, the results of Bhatt imply that the algebraic de Rham cohomology is equipped with a \emph{Hodge filtration}, which is finer than the standard infinitesimal Hodge filtration and the Deligne-Hodge filtration. Futhermore, when $f \colon \Spec A \to \Spec B$ is a closed immersion of affine (derived) schemes, the Hodge filtration is finer than the $I$-adic filtration on the completion \[ Y^\wedge_X \simeq \mathrm{Spf} (B^\wedge_I), \] where $I \coloneqq \mathrm{fib}(B \to A)$. In the particular case where $f$ is a locally complete intersection morphism both the $I$-adic filtration and the Hodge filtration coincide (c.f. \cite[Remark 4.13]{Bhatt_Derived_Completions}). \subsection{Main results} The main goal of the present text is to prove a non-archimedean analogue of the above results. Namely, let $k$ be a non-archimedean field of characteristic $0$, we prove the following: \begin{thm} \label{intro-thm1} Let $f \colon X \to Y$ be a morphism of (locally geometric) derived $k$-analytic stacks. Consider the \emph{Hodge completed derived de Rham complex associated to $f$}, defined as \[\mathrm{dR}_{X/ Y} ^\mathrm{an} \coloneqq \Sym^\mathrm{an}(\mathbb L_{X/ Y} ^\mathrm{an}[-1])^\wedge,\] in $\mathrm{CAlg}_k$. Then one has a natural multiplicative equivalence \[ \mathrm{dR}_{X/ Y} ^\mathrm{an} \simeq \Gamma(Y^\wedge_X, \mathcal O_{Y^\wedge_X}), \] of derived $k$-algebras, where $Y^\wedge_X$ denotes the derived $k$-analytic stack corresponding to the formal completion of $X$ in $Y$ along the morphism $f$. \end{thm} Unfortunately, the methods of B. Bhatt are algebraic in nature and cannot be directly extrapolated to the non-archimedean setting. Instead, we follow closely the approach of Gaitsgory-Rozemblyum given in \cite[\S 9]{Gaitsgory_Study_II}. The main idea consists of defining the \emph{non-archimedean deformation to the normal cone} as a derived $k$-analytic stack \[ \mathcal D^\mathrm{an}_{X/ Y} \in \mathrm{dAnSt}_k, \] mapping naturally to the $k$-analytic affine line $\mathbf A^1_k$. Denote by $p \colon \mathcal D_{X/ Y}^\mathrm{an} \to \mathbf A^1_k$ the natural morphism. Then \cref{intro-thm1} follows immediately from the following more precise result (see \cref{thm:main_thm}): \begin{thm} \label{intro-thm2} Let $f \colon X \to Y$ be a morphism of locally geometric derived $k$-analytic stacks. Then the non-archimedean deformation to the normal cone satisfies the following assertions: \begin{enumerate} \item The fiber of $p \colon \mathcal D_{X/ Y}^\mathrm{an} \to \mathbf A^1_k$ at $\{ 0\} \subseteq \mathbf A^1_k$ identifies naturally with the completion of the shifted analytic tangent bundle \[ \mathbf T^\mathrm{an}_{X/ Y}[1]^\wedge, \] completed along the zero section $s_0 \colon X \to \mathbf T^\mathrm{an}_{X/ Y}[1]$. Moreover for $\lambda \neq 0$ we have a natural identification \[ (\mathcal D_{X/ Y}^\mathrm{an})_\lambda \simeq Y^\wedge_X, \] where $Y^\wedge_X$ denotes the formal completion of $Y$ at $X$ along $f$. \item There exists a natural sequence of morphisms admitting a deformation theory \[ X \times \mathbf A^1_k = X^{(0)} \to X^{(1)} \hookrightarrow \dots \hookrightarrow X^{(n)} \hookrightarrow \dots \to Y \times \mathbf A^1_k, \] such that the colimit of derived $k$-analytic stacks identifies naturally \[ \colim_{n \ge 0} X^{(n)} \simeq \mathcal D_{X/ Y}^\mathrm{an}. \] In particular, the latter induces the usual Hodge filtration on (global sections of) $\mathbf T^\mathrm{an}_{X/ Y}[1]^\wedge$ and it induces a further filtration on (global sections of) the formal completion $Y^\wedge_X$, which we shall also refer to as the \emph{Hodge filtration} on the formal completion $Y^\wedge_X$; \item When $f \colon X \to Y$ is a locally complete intersection morphism of derived $k$-affinoid spaces, the Hodge filtration on $Y^\wedge_X$ identifies with the $I$-adic filtration on global sections. More precisely, let \[A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg}) \quad \mathrm{and} \quad B \coloneqq \Gamma(Y, \mathcal O_Y^\mathrm{alg}),\] denote the corresponding derived global sections derived $k$-algebras. Then the global sections of $Y^\wedge_X$ agree with the completion \[ B^\wedge_I \in \mathrm{CAlg}_k, \quad I \coloneqq \mathrm{fib}(B \to A), \] and the Hodge filtration on $B^\wedge_I$ coincides with the usual $I$-adic filtration. \end{enumerate} \end{thm} For applications, it is desirable to establish \cref{intro-thm2} in such generality. As an example, it is interesting to have at our disposal a natural Hodge filtration for the de Rham cohomology of the moduli of $\ell$-adic continuous representations of an \'etale fundamental group, see \cite{antonio2017moduli} and \cite{antonio2019moduli}. The latter is a locally geometric derived $k$-analytic stack. Notwithstanding, the reader can safely assume that $f$ is simply a morphism of (derived) $k$-analytic spaces. In order to construct the deformation to the normal cone $\mathcal D_{X/ Y}^\mathrm{an}$ we shall need two main ingredients. Namely, a general theory of $k$-analytic formal moduli problems and the relative analytification functor introduced in \cite{Holstein_Analytification_of_mapping_stacks} (see also \cite[\S 6]{Porta_Yu_NQK}). So far, a general theory of analytic formal moduli problems was lacking in the literature. For this reason, we devote the whole \S 2 to develop such framework. Let $X \in \mathrm{dAn}_k$ be a (derived) $k$-analytic space. Denote by $\mathrm{AnNil}_{X/ }^\mathrm{cl}$ the $\infty$-category\xspace of closed embeddings \[ g\colon X \to S, \] where $S \in \mathrm{dAn}_k$, such that $g_\mathrm{red} \colon X_\mathrm{red} \to S_\mathrm{red}$ is an isomorphism of $k$-analytic spaces. We shall define a $k$-analytic formal moduli problem under $X$ (resp. over $X$) as a functor \[ Y \colon (\mathrm{AnNil}^{\mathrm{cl}}_{X/ })^ \mathrm{op} \to \mathcal S, \quad \textrm{(resp. $Y \colon (\mathrm{AnNil}^\mathrm{cl}_{/ X}) ^\mathrm{op} \to \mathcal S$)} \] satisfying some additional requirements, see \cref{defin:analytic_formal_moduli_problems_under} (resp. \cref{defin:analytic_formal_problems_over_X}). It turns out that analytic formal moduli problems can be described in very explicit terms as follows: \begin{thm} \label{intro-thm3} Let $X \in \mathrm{dAn}_k$ denote a derived $k$-analytic space. Then the following assertions hold: \begin{enumerate} \item The $\infty$-category\xspace $\mathrm{AnNil}_{X/ /Y}^\mathrm{cl}$ (resp. $(\mathrm{AnNil}_{/ X}^\mathrm{cl})_{/ Y}$) is filtered and we have a natural equivalence \[ \colim_{S \in \mathrm{AnNil}^\mathrm{cl}_{X/ / Y}} S \simeq Y \quad \textit{resp.} \quad \colim_{X \in (\mathrm{AnNil}_{/ X}^\mathrm{cl})_{/ Y}} S \simeq Y; \] \item The natural morphism $f \colon X \to Y$ (resp. $f \colon Y \to X$) admits a relative (pro-)cotangent complex $\mathbb L_{X/ Y} \in \mathrm{Pro}(\mathrm{Coh}^+(X))$, which completely controls the deformation theory of the morphism $f$; \item In the case where $X$ is a derived $k$-affinoid space, the $\infty$-category\xspace of analytific formal moduli problems $\mathrm{AnFMP}_{X/ }$ is presentable and monadic over the usual $\infty$-category\xspace of ind-coherent sheaves on \[A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg}).\] \end{enumerate} \end{thm} We refer the reader to \cref{cor:formal_moduli_problems_over_X_are_ind_inf_objects}, \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes}, \cref{cor:universal_property_of_relative_cotangent_complex_for_morphisms_between_analytic_FMP} and \cref{prop:conservativity_and_preservation_of_sifted_colimits_of_tangent_complex}, for a detailed treatment of \cref{intro-thm3}. Granting a general deformation theory we are able to construct the deformation $\mathcal D_{X/ Y}^\mathrm{an}$ as a $k$-analytic formal moduli problem under $X$. Furthermore, we are able to extrapolate the main formal properties of the derived deformation to the normal cone in the algebraic setting, proved in \cite[\S 9]{Gaitsgory_Study_II}. The latter is done via a careful analysis of the behaviour of the relative analytification functor, denoted $(-)^\mathrm{an}_Y$, and by means of Noetherian approximation. In particular, when $f \colon X \to Y$ is a morphism of derived $k$-affinoid spaces, we have a natural identification \[ \mathcal D_{X/ Y}^\mathrm{an} \simeq (\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}} )^\mathrm{an}_Y, \] where $X^\mathrm{alg} \coloneqq \Spec A$ and $Y^\mathrm{alg} \coloneqq \Spec B$, with $A$ and $B$ are as in \cref{intro-thm2}. Along the way, we establish a precise comparison between the works of \cite{Bhatt_Derived_Completions} and \cite[\S 9]{Gaitsgory_Study_II}, which we consider to be of relevance for experts in derived algebraic geometry. Moreover, we shall also explicit mention that the techniques employed in the current text, namely Noetherian approximation, allows to construct the deformation to the normal cone and its Hodge filtration as in \cite[\S 9]{Gaitsgory_Study_II} outside the the almost of finite presentation scope, provided that we work under Noetherian assumptions. The latter might be helpful even in purely algebraic contexts. \subsection{Relation with other works and future questions} As previously explained, the content of this text is build upon two major prior works, namely \cite[\S 9]{Gaitsgory_Study_II} and \cite{Bhatt_Derived_Completions}. It follows essentially from \cref{lem:identification_of_Hodge_and_adic_filtrations} that Bhatt's construction of the Hodge filtration on algebraic de Rham cohomology with the approach of Gaitsgory-Rozemblyum (c.f. \cite[\S 9]{Gaitsgory_Study_II}). Such comparison result is not completely obvious. Indeed, in \cite{Bhatt_Derived_Completions} the author produces the Hodge filtration in the general case, by left Kan extending the adic filtration from the case of local complete intersection morphisms, whereas the construction of \cite[\S 9]{Gaitsgory_Study_II} is completely canonical. Therefore, there are two main advantages provided by our comparison result: first it proves the canonicity of Bhatt's approach and secondly it enlightens many important aspects of \cite[\S 9]{Gaitsgory_Study_II}, which were not made completely explicitly. In \cite{grosse2002finiteness}, Grosse-Kl\"onne introduces an \emph{analytic} de Rham cohomology theory for a very large class of rigid $k$-analytic spaces. Let $X$ be a rigid $k$-analytic space, Grosse-Kl\"onne's construction is related to \emph{over-convergent} global sections of formal completions along closed immersion $i \colon X \hookrightarrow Y$, where $Y$ is a smooth rigid $k$-analytic space. Furthermore, the author proves finiteness of over-convergent analytic de Rham cohomology under certain finiteness conditions on $X$. We expect that our derived de Rham cohomology theory, $\mathrm{dR}_{X/k}^\mathrm{an}$, can be compared to the construction in \cite{grosse2002finiteness}. In particular, this would provide a proof of finiteness for derived (over-convergent) analytic de Rham cohomology. Such comparison result would equip us with a Hodge-to-de Rham spectral sequence for over-convergent de Rham cohomology, in great generality. In order to achieve such a comparison one needs to extend the results in this text to the over-convergent setting. We hope to pursue this venue in a future project. Ideally, the deformation to the normal bundle would provide an important tool to study the relationship between de Rham cohomology and \'etale cohomology of $k$-analytic spaces, similar to the algebraic case (see \cite[\S 1, Corollary]{Bhatt_Derived_Completions}). When $k$ is a field of equi-characteristic zero, we expect that a non-smooth extension of the main construction of \cite{achinger2019betti}, in the non-archimedean setting, could be related to the formal completion $Y^\wedge_X$. More interestingly, would be to study the $p$-adic setting. Even though the author currently does not have an idea of how to accomplish this, it might be useful to extrapolate certain results in \cite{bras2018overconvergent} to the singular case, via derived geometry. Another future goal closely related to this work is the study of a rigid cohomology theory for singular algebraic varieties and possibly algebraic stacks over perfect fields of positive characteristic. Our hope is that techniques from derived geometry can be useful to reduce questions about the rigid cohomology of singular algebraic varieties to the free case, via simplicial polynomial resolutions of general $k$-algebras. Finally, we expect that the results in this text provide a first step in a consistent study of $\mathcal D_X$-modules and curved modules outside the smooth case, in the non-archimedean setting. In order to develop such a framework, one has to set the main ingredients of \cite{ben2012loop} in non-archimedean geometry. One such ingredient is the deformation to the normal cone done in the current text. Another important ingredient is a $k$-analytic HKR theorem, which is a work in progress with M. Porta and F. Petit (see the author's thesis \cite{ferreira2019modeles} for a sketch of proof of the latter statement). \subsection{Organization of the paper} In \S 2, we develop a theory of formal moduli problems in the non-archimedean setting. We devote 2.1 to a brief review of the main notions in non-archimedean geometry that will be important for us. We then proceed to \S 2.2 where a careful study of the structure of \emph{nil-isomorphisms} is performed. The notion of nil-isomorphism is basic building block of the theory of analytic formal moduli problems \emph{under} (resp. \emph{over}) a given base. The latter notions are introduced and study at length in \S 2.3 (resp. \S 2.4). In \S 2.4, we establish \emph{pseudo}-nil-descent for pro-almost perfect complexes or in other words pro-coherent complexes. Given a morphism $X \to Y$ which exhibits $X$ as an analytic formal moduli problem, we prove that the $\infty$-category\xspace of $\mathrm{Pro}(\mathrm{Coh}^+(Y))$ does satisfy descent along the usual $*$-upper functoriality, that it is, it can be realized as the totalization of \[\mathrm{Pro}(\mathrm{Coh}^+(X^\bullet)),\] where $X^\bullet$ denotes the \v{C}ech nerve associated to $X \to Y$. The main novelty compared with the main result in \cite[\S 7.2]{Gaitsgory_Study_I} is that we use the entire $\mathrm{Coh}^+$ and the $*$-upper functoriality. Our nil-descent statement is based in the work of Halpern-Leistner and Preygel, c.f. see \cite[Theorem 3.3.1]{preygel_Leistner_Mapping_stacks_properness}. Section 2.6 is devoted to the study of the notion of formal groupoids over a base $X$. We will prove the existence of a natural equivalence between the $\infty$-categories\xspace of analytic formal moduli problems under $X$ and analytic formal groupoids over $X$ (see \cref{thm:Phi_is_an_equivalence}). The content of this equivalence can be interpreted as: every analytic formal moduli problem under $X$ arises as a \emph{classifying formal derived $k$-analytic stack} associated to an analytic formal groupoid (which corresponds to the associated \v{C}ech nerve). This equivalence of $\infty$-categories\xspace is based on the pseudo-nil-descent results, proved earlier. Notice that \cref{thm:Phi_is_an_equivalence}, is a direct non-archimedean analogue of \cite[\S 5, Theorem 2.3.2]{Gaitsgory_Study_II}. In \S 2.6, we study the tangent complex associate to an analytic formal moduli problem under $X$. In particular, we prove that such a functor is monadic, see \cref{prop:conservativity_and_preservation_of_sifted_colimits_of_tangent_complex}. The main bulk of the text lies in \S 3, where we introduce the deformation to the normal cone, $\mathcal D_{X/ Y}$, in the non-archimedean setting. In \S 3.1 we review the algebraic situation. We shall summarize the main algebraic formal properties of $\mathcal D_{X/ Y}$ and then proceed to give a simplification of the formalism developped in \cite[\S 9]{Gaitsgory_Study_II} in the case of closed immersions of derived schemes, see \cref{lem:identification_of_Hodge_and_adic_filtrations}. This will enable us to prove a comparison statement between Bhatt's construction of the Hodge filtration in algebraic de Rham cohomology, c.f. \cite{Bhatt_Derived_Completions} and the work of Gaitsgory-Rozemblyum. In \S 3.2 we introduce the non-archimedean deformation in the local case, via the relative analyticification functor and Noetherian approximation. We devote \S 3.3 to gluing the deformation to the class of morphisms between locally geometric derived $k$-analytic stacks. In particular, our results hold for any derived $k$-analytic space. We then introduce the construction of the \emph{non-archimedean Hodge filtration} in the local, in \S 3.4. This is possible by extending the usual Hodge filtration of Gaitsgory-Rozemblyum to the non-archimedean setting as follows: we first extrapolate the main results in \cite[\S 9.5]{Gaitsgory_Study_II} to the Noetherian setting not necessarily of almost of finite presentation (which was the only case treated in \cite[\S 9]{Gaitsgory_Study_II}) and then to the non-archimedean setting via the relative analytification functor. Finally, in \S 3.4 we glue the non-archimedean Hodge filtration for general morphisms between locally geometric derived $k$-analytic stacks. \subsection{Notations and Conventions} In this text, $k$ denotes a non-archimedean field of characteristic zero. We let $\mathrm{dAff}_k$ and $\mathrm{dAff}_k^\mathrm{laft}$ denote the $\infty$-categories\xspace of affine derived schemes (resp. affine derived schemes almost of finite presentation). We shall denote by $\mathrm{dSt}_k$ the $\infty$-category\xspace of derived $k$-stacks. We shall further denote by $\mathrm{dSt}^\mathrm{laft}_k \subseteq \mathrm{dSt}_k$ the full subcategory spanned by derived $k$-stacks locally almost of finite presentation. Given derived $k$-stacks $X, Y \in \mathrm{dSt}_k$ we shall denote by \[ \Map(X, Y) \in \mathrm{dSt}_k, \] the corresponding mapping stack. If $X$ and $Y$ live over $\mathbb A_k^1$, we then shall denote by \[ \Map_{/ \mathbb A^1_k}(X, Y) \in (\mathrm{dSt}_k)_{/ \mathbb A^1_k}. \] We denote $\mathrm{dAnSt}_k$ the $\infty$-category\xspace of derived $k$-analytic stacks introduced in \cite{Porta_Yu_Derived_non-archimedean_analytic_spaces}. We shall denote by $\mathrm{dAn}_k$ and $\mathrm{dAfd}_k$ the $\infty$-categories\xspace of derived $k$-analytic spaces (resp., derived $k$-affinoid spaces). We will further denote by $\mathrm{An}_k$ the usual ordinary category of (discrete) $k$-analytic spaces as in \cite{Berkovich_Etale_1993}. We shall instead use bold letters for the corresponding notions in the non-archimedean setting. Therefore, we shall denote by \[ \mathbf{Map}(X, Y) \in \mathrm{dAnSt}_k, \] the corresponding $k$-analytic mapping stack, whenever $X, Y \in \mathrm{dAnSt}_k$. Let $\mathcal C$ be a stable $\infty$-category\xspace. We shall denote by $\mathcal C^{\mathrm{fil}}$ the associated $\infty$-category\xspace of \emph{filtered objects in $\mathcal C$}. Similarly, we denote by $\mathcal C^{\mathrm{gr}}$ the $\infty$-category\xspace of graded objects in $\mathcal C$. We shall employ the notations \[ \mathcal C^{\mathrm{gr}, \ge 0} \quad \mathrm{and} \quad \mathcal C^{\mathrm{gr} , =n}, \] the respective full subcategories of positively indexed graded objects in $\mathcal C$ and objects concentrated in a single degree $n$. Notice that the latter $\infty$-category\xspace is equivalent to $\mathcal C$ itself. \subsection{Acknowledgments} The author would like to express his deep gratitude to Mauro Porta for the encouragement to pursue this project and for many commentaries and suggestions during the realization of the present work. The author would also like to thank Marco Robalo for a clarifying remark. \section{Analytic formal moduli problems} \subsection{Preliminaries} Recall the notions of $k$-affinoid/analytic spaces introduced in \cite[Definition 7.3 and Definition 2.5.]{Porta_Yu_Derived_non-archimedean_analytic_spaces}, respectively. \begin{defin} Let $f \colon X \to Y$ be a morphism in the $\infty$-category\xspace $\mathrm{dAn}_k$. We shall say that $f$ is an \emph{affine morphism} if for every morphism $Z \to Y$ in $\mathrm{dAn}_k$ such that $Z$ is a derived $k$-affinoid space, the pullback \[ Z' \coloneqq Z \times_X Y \in \mathrm{dAn}_k, \] is a derived $k$-affinoid space. \end{defin} \begin{defin} Let $f \colon X \to Y$ be a morphism in $\mathrm{dAn}_k$. We shall say that $f$ is an \emph{admissible open immersion} if the induced morphism on $0$-th truncations \[ \mathrm{t}_0(f) \colon \mathrm{t}_0(X) \to \mathrm{t}_0(Y), \] is an admissible open immersion in the sense of \cite[\S 1.3]{Berkovich_Etale_1993}. \end{defin} \begin{defin} Let $f \colon X \to Y$ be a morphism in $\mathrm{An}_k$. We shall say that $f$ is a \emph{finite morphism} if $f$ is affine and for every admissible open covering \[ \coprod_{j \in J} V_j \to Y, \] the base change morphism \[ U_j \coloneqq V_j \times_Y Y \to V_j, \] exihibits the $k$-affinoid algebra $B_j \coloneqq \Gamma(U_j, \mathcal O_{U_j})$ as a finite $A = \Gamma(V_j, \mathcal O_{V_j})$-module. Given $f \colon X \to Y$ in the $\infty$-category\xspace $\mathrm{dAn}_k$, we say that $f$ is \emph{finite} if its truncation $\mathrm{t}_0(f)$ is a finite morphism. \end{defin} \begin{defin} Let $X \in \mathrm{An}_k$ denote an (ordinary) $k$-analytic space. We denote by $\mathcal J_X \subseteq \mathcal O_X$, the \emph{nil-radical ideal} of $\mathcal O_X$, that is the sheaf ideal spanned by nilpotent sections on $X$. We denote by $X_\mathrm{red}$ the $k$-analytic space obtained as the pair $(X, \mathcal O_{X}/ \mathcal J_X)$, which we shall refer to as the \emph{underlying reduced $k$-analytic space associated to $X$}. \end{defin} \begin{rem} Let $X \in \mathrm{An}_k$, then the underlying reduced $X_\mathrm{red} \in \mathrm{An}_k$ is a reduced $k$-analytic space, by construction. \end{rem} \begin{notation} We denote by $\mathrm{An}_k^\mathrm{red} \subseteq \mathrm{An}_k$ the full subcategory spanned by reduced $k$-analytic spaces. We further denote by \[(-)_\mathrm{red} \colon \mathrm{dAn}_k \to \mathrm{An}_k^\mathrm{red},\] the functor obtained by the association \[ Z \in \mathrm{An}_k \mapsto Z_\mathrm{red} \in \mathrm{An}_k^\mathrm{red}. \] \end{notation} We now extend the construction $(-)_\mathrm{red} \colon \mathrm{An}_k \to \mathrm{An}_k^\mathrm{red}$ to the $\infty$-category\xspace of derived $k$-analytic spaces: \begin{defin} Consider the functor $\mathrm{dAn}_k \to \mathrm{An}_k^\mathrm{red}$ defined as the composite \[ (-)_\mathrm{red} \colon \mathrm{dAn}_k \xrightarrow{\mathrm{t}_0(-)} \mathrm{An}_k \xrightarrow{(-)_\mathrm{red}} \mathrm{An}_k^\mathrm{red}. \] Given $X \in \mathrm{dAn}_k$ a derived $k$-analytic space we denote by $X_\mathrm{red} \in \mathrm{An}_k^\mathrm{red}$ the \emph{underlying reduced $k$-analytic space} associated with $X$. \end{defin} \begin{lem} Let $f \colon X \to Y$ be an admissible open immersion of derived $k$-analytic spaces. Then $f_\mathrm{red} \colon X_\mathrm{red} \to Y_\mathrm{red}$ is an admissible open immersion, as well. \end{lem} \begin{proof} By the definitions, it is clear that the truncation \[ \mathrm{t}_0(f) \colon \mathrm{t}_0(X) \to \mathrm{t}_0(Y), \] is an admissible open immersion of ordinary $k$-analytic spaces. In the case of ordinary $k$-analytic spaces the question is local and we reduce ourselves to the affinoid case. Then it is clear that localization in the ordinary category $\mathrm{Afd}_k$ commutes with quotients (as the former is defined via a colimit). \end{proof} \begin{defin} In \cite[Definition 5.41]{Porta_Yu_Representability} the authors introduced the notion of a square-zero extension between derived $k$-analytic spaces. In particular, given a morphism $f \colon Z \to Z'$ in $\mathrm{dAn}_k$, we shall say that $f$ \emph{has the structure of a square-zero extension} if $f$ exhibits $Z'$ as a square-zero extension of $Z$. \end{defin} \begin{rem} \label{rem:construction_of_nilpotent_extensions_as_square_zero_extensions} Let $X \in \mathrm{An}_k$. Let $\mathcal J \subseteq \mathcal O_X$ be an ideal satisfying $\mathcal J^2 = 0$. Consider the fiber sequence \[ \mathcal J \to \mathcal O_X \to \mathcal O_X/\mathcal J, \] in the $\infty$-category\xspace $\mathrm{Coh}^+(X)$. We have an induced natural fiber sequence of the form \[ \mathbb L_{\mathcal O_X}^\mathrm{an} \to \mathbb L_{\mathcal O_X / \mathcal J}^\mathrm{an} \to \mathbb L_{(\mathcal O_X / \mathcal J) / \mathcal O_X}^\mathrm{an}, \] and we have a further identification $\tau_{\le 1} (\mathbb L_{(\mathcal O_X/ \mathcal J) / \mathcal O_X}) \simeq \mathcal J[1]$. For this reason, we obtain a well defined morphism \[ d \colon \mathbb L_{\mathcal O_X/ \mathcal J} \to \mathcal J[1], \] in the derived $\infty$-category\xspace $\mathrm{Mod}_{\mathcal O_X/ \mathcal J}$. This derivation classifies a square-zero extension of $\mathcal O_X/ \mathcal J$ by $\mathcal J[1]$ which can be identified with the object $\mathcal O_X$ itself. In particular, we deduce that $X$ is a square-zero extension of the ordinary $k$-analytic space $(X, \mathcal O_{X}/\mathcal J)$. \end{rem} \begin{rem} Recall the $\infty$-category\xspace $\tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k))$ of $\cT_{\mathrm{an}}(k)$-structured $\infty$-topoi defined in \cite[Definition 2.4]{Porta_Yu_Derived_non-archimedean_analytic_spaces}, where $\cT_{\mathrm{an}}(k)$ denotes the $k$-analytic pre-geometry (see for instance \cite[Construction 2.2]{Porta_Yu_Derived_non-archimedean_analytic_spaces}). Let $\mathcal O \in \mathrm{Str}^\mathrm{loc}_{\cT_{\mathrm{an}}(k)}(\mathcal X)$ be a local $\cT_{\mathrm{an}}(k)$-structure on $\mathcal X$ (c.f. \cite[Definition 2.4]{Porta_Yu_Derived_non-archimedean_analytic_spaces}). Since the pregeometry $\cT_{\mathrm{an}}(k)$ is compatible with $n$-truncations, c.f. \cite[Theorem 3.23]{Porta_Yu_Derived_non-archimedean_analytic_spaces}, it follows that $\pi_0(\mathcal O) \in \mathrm{Str}^\mathrm{loc}_{\cT_{\mathrm{an}}(k)}(\mathcal X)$, as well. Moreover, if $(\mathcal X, \mathcal O) \in \tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k))$ is a $\cT_{\mathrm{an}}(k)$-structured $\infty$-topos\xspace, we define its \emph{underlying reduced $\cT_{\mathrm{an}}(k)$-structured $\infty$-topos\xspace} as the $\cT_{\mathrm{an}}(k)$-structured space \[ (\mathcal X, \pi_0(\mathcal O)/ \mathcal J) \in \tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k)), \] where $\mathcal J \subseteq \pi_0(\mathcal O)$ denotes the ideal sheaf spanned by nilpotent sections on $\pi_0(\mathcal O)$. Moreover, the quotient $\pi_0(\mathcal O)/ \mathcal J$ is considered in the $\infty$-category\xspace of local structures on $\mathcal X$ \[ \pi_0(\mathcal O) / \mathcal J \in \mathrm{Str}^\mathrm{loc}_{\cT_{\mathrm{an}}(k)}(\mathcal X). \] \end{rem} Recall the notion of the underlying algebra functor $(-)^\mathrm{alg} \colon \mathrm{Str}^\mathrm{loc}_{\cT_{\mathrm{an}}(k)}(\mathcal X) \to \mathrm{CAlg}_k(\mathcal X)$ introduced in \cite[Lemma 3.13]{Porta_Yu_Derived_non-archimedean_analytic_spaces}. \begin{lem} \label{lem:derived_k_analytic_space_whose_reduction_is_affinoid_is_also_affinoid} Let $Z \coloneqq (\mathcal Z, \mathcal O_Z) \in \tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k))$ denote a $\cT_{\mathrm{an}}(k)$-structure $\infty$-topos\xspace such that $\pi_0(\mathcal O_Z^\mathrm{alg}) $ is a Noetherian derived $k$-algebra on $\mathcal Z$. Suppose that the reduction $Z_\mathrm{red}$ is equivalent to a derived $k$-affinoid space. Then the truncation $\mathrm{t}_0(Z)$ is isomorphic to an ordinary $k$-affinoid space. If we assume further that for every $i>0$, the homotopy sheaves $\pi_i(\mathcal O_Z)$ are coherent $\pi_0(\mathcal O_Z)$-modules, then $Z$ itself is equivalent to a derived $k$-affinoid space. \end{lem} \begin{proof} The second claim of the Lemma follows readily from the first assertion together with the definitions. We are thus reduced to prove that $\mathrm{t}_0(Z)$ is isomorphic to an ordinary $k$-affinoid space. Let $\mathcal J \subseteq \pi_0(\mathcal O_Z)$, denote the coherent ideal sheaf associated to the closed immersion $Z_\mathrm{red} \hookrightarrow Z$. Notice that the ideal $\mathcal J$ agrees with the nilradical ideal of $\pi_0(\mathcal O_Z)$. Thanks to our assumption that $\pi_0(\mathcal O_Z)$ is a Noetherian derived $k$-algebra on $\mathcal Z$, it follows that there exists a sufficiently large integer $n \ge 2$ such that \[ \mathcal J^n = 0. \] Arguing by induction, we can suppose that $n = 2$, that is to say that \[\mathcal J^2 = 0.\] In particular, \cref{rem:construction_of_nilpotent_extensions_as_square_zero_extensions} implies that the the natural morphism $Z_\mathrm{red} \to Z$ has the structure of a square-zero extension. The assertion now follows from \cite[Proposition 6.1]{Porta_Yu_Representability} and its proof. \end{proof} \begin{rem} We observe that the converse of \cref{lem:derived_k_analytic_space_whose_reduction_is_affinoid_is_also_affinoid} holds true. Indeed, the natural morphism $Z_\mathrm{red} \to Z$ is a closed immersion. In particular, if $Z \in \mathrm{dAfd}_k$ we deduce readily that $Z_\mathrm{red} \in \mathrm{Afd}_k$, as well. \end{rem} \begin{lem} \label{lem:affine_morphisms_are_compatible_with_Zariski_localization_on_the_base} Let $f \colon X \to Y$ be an affine morphism in $\mathrm{dAn}_k$. Suppose we are given an admissible open covering \[ g \colon \coprod_{j \in J} U_j \to Y, \] where for each $j \in J$, $U_j \in \mathrm{dAfd}_k$. For each $j \in J$, let \[ V_j \coloneqq U_j \times_X Y \in \mathrm{dAfd}_k, \] then $\coprod_{j \in J} V_j \to Y$ is an admissible open covering by derived $k$-affinoid spaces. \end{lem} \begin{proof} It is clear from our assumption that $f$ is an affine morphism that for every index $j \in J$, the objects $V_j \in \mathrm{dAfd}_k$. The claim of the Lemma follows immediately from the observation that both the classes of effective epimorphisms of $\infty$-topoi \ and admissible open immersions of derived $k$-analytic spaces are stable under pullbacks, cf. \cite[Proposition 6.2.3.15]{HTT} and \cite[Corollary 5.11, Proposition 5.12]{Porta_Yu_Representability}, respectively. \end{proof} \subsection{Non-archimedean differential geometry} In this \S, we introduce the notion of a nil-isomorphism between derived $k$-analytic spaces and study certain important features of such class of morphisms. The results contained in this paragraph will be of crucial importance to the study of analytic formal moduli problems. \begin{defin} Let $f \colon X \to Y$ be a morphism in $\mathrm{dAn}_k$. We say that $f$ is a \emph{nil-isomorphism} if $f$ is almost of finite presentation and furthermore $f_\mathrm{red} \colon X_\mathrm{red} \to Y_\mathrm{red}$ is an isomorphism of ordinary $k$-analytic spaces. We will denote by $\mathrm{AnNil}_{X/ }$ the full subcategory of $(\mathrm{dAn}_k)_{X/}$ spanned by nil-isomorphisms $X \to Y$. \end{defin} \begin{lem} \label{lem:nil-isos_are_affine_morphisms} Let $f \colon X \to Y$ be a nil-isomorphism of derived $k$-analytic spaces. Then: \begin{enumerate} \item Given any morphism $Z \to Y$ in $\mathrm{dAn}_k$, the base change morphism \[ Z \times_X Y \to Z, \] is an nil-isomoprhism, as well; \item $f$ is an affine morphism; \item $f$ is a finite morphism. \end{enumerate} \end{lem} \begin{proof} To prove (1), it suffices to prove that the functor $(\textrm{-})_\mathrm{red} \colon \mathrm{dAn}_k \to \mathrm{An}_k^{\mathrm{red}}$ commutes with finite limits. The truncation functor \[ \mathrm{t}_0 \colon \mathrm{dAn}_k \to \mathrm{An}_k, \] commutes with finite limits, c.f. \cite[Proposition 6.2 (5)]{Porta_Yu_Derived_non-archimedean_analytic_spaces}. It suffices then to prove that the usual underlying reduced functor \[ (-)_\mathrm{red} \colon \mathrm{An}_k \to \mathrm{An}_k^\mathrm{red}, \] commutes with finite limits. By construction, the latter assertion is equivalent to the claim that the usual complete tensor product of ordinary $k$-affinoid algebras commutes with the operation of taking the quotient by the Jacobson radical, which is immediate. We now prove (2). Let $Z \to Y$ be an admissible open immersion such that $Z$ is a derived $k$-affinoid space. We claim that the pullback $Z \times_X Y$ is again a derived $k$-affinoid space. Thanks to \cref{lem:derived_k_analytic_space_whose_reduction_is_affinoid_is_also_affinoid} we reduce ourselves to prove that $(Z \times_X Y)_\mathrm{red}$ is equivalent to an ordinary $k$-affinoid space. Thanks to (1), we deduce that the induced morphism \[ (Z \times_X Y)_\mathrm{red} \to Z_\mathrm{red}, \] is an isomorphism of ordinary $k$-analytic spaces. In particular, $(Z \times_X Y)_\mathrm{red}$ is a $k$-affinoid space. The result now follows by invoking \cref{lem:derived_k_analytic_space_whose_reduction_is_affinoid_is_also_affinoid} again. To prove (3), we shall show that the induced morphism on the underlying $0$-th truncations $\mathrm{t}_0(X) \to \mathrm{t}_0(Y)$ is a finite morphism of ordinary $k$-affinoid spaces. But this follows immediately from the fact that both $\mathrm{t}_0(X)$ and $\mathrm{t}_0(Y)$ can be obtained from the reduced $X_\mathrm{red}$ by means of a finite sequence of square-zero extensions as in \cref{rem:construction_of_nilpotent_extensions_as_square_zero_extensions}. \end{proof} \begin{defin} A morphism $X \to Y$ be a morphism in $\mathrm{dAn}_k$ is called a \emph{nil-embedding} if the induced morphism of ordinary $k$-analytic spaces $\mathrm{t}_0(X) \to \mathrm{t}_0(Y)$ is a closed immersion with nilpotent ideal of definition. \end{defin} \begin{prop} \label{prop:filtered_colimit_for_nil-embeddings} Let $f \colon X \to Y$ be a nil-embedding of derived $k$-analytic spaces. Then there exists a sequence of morphisms \[X = X_0^0 \hookrightarrow X_0^1 \hookrightarrow \dots \hookrightarrow X_0^n = X_0 \hookrightarrow X_1 \dots X_n \hookrightarrow \dots \hookrightarrow Y,\] such that for each $0 \le i \le n$ and $j \ge 0$, the morphisms $X_0^i \hookrightarrow X_0^{i+1}$ and $X_j \to X_{j+1}$ have the structure of square-zero extensions. Furthermore, the induced morphisms $\mathrm{t}_{\le j}(X_j) \to \mathrm{t}_{\le j}(Y)$ are equivalences of derived $k$-analytic spaces, for every $j \ge 0$. \end{prop} \begin{proof} The proof follows the same scheme of reasoning as \cite[Proposition 5.5.3]{Gaitsgory_Study_II}. For the sake of completeness we present the complete argument here. Consider the induced morphism on the underlying truncations \[ \mathrm{t}_0(f) \colon \mathrm{t}_0(X) \to \mathrm{t}_0(Y). \] By construction, there exists a sufficiently large integer $n \ge 0$ such that \[ \mathcal J^{n+1} = 0, \] where $\mathcal J \subseteq \pi_0(\mathcal O_Y)$ denotes the ideal associated to the nil-embedding $\mathrm{t}_0(f)$. Therefore, we can factor the latter as a finite sequence of square-zero extensions of ordinary $k$-analytic spaces \[ \mathrm{t}_0(X) \hookrightarrow X_0^{\mathrm{ord}, 0} \hookrightarrow \dots \hookrightarrow X^{\mathrm{ord}, n}_0 = \mathrm{t}_0(Y), \] as in the proof of \cref{lem:derived_k_analytic_space_whose_reduction_is_affinoid_is_also_affinoid}. For each $0 \le i \le n$, we set \[ X_0^i \coloneqq X \bigsqcup_{\mathrm{t}_0(X)} X_0^{\mathrm{ord}, i}. \] By construction, we have that the natural morphism $\mathrm{t}_0(X_0^n) \to \mathrm{t}_0(Y)$ is an isomorphism of ordinary $k$-analytic spaces. We now argue by induction on the Postnikov tower associated to the morphism $f \colon X \to Y$. Suppose that for a certain integer $i \ge 0$, we have constructed a derived $k$-analytic space $X_i$ together with morphisms $g_i \colon X \to X_i$ and $h_i \colon X_i \to Y$ such that $f \simeq h_i \circ g_i$ and the induced morphism \[ \mathrm{t}_{\le i}(X_i) \to \mathrm{t}_{\le i}(Y) \] is an equivalence of derived $k$-analytic spaces. We shall proceed as follows: by the assumption that $h_i$ is $(i+1)$-connective, we deduce from \cite[Proposition 5.34]{Porta_Yu_Representability} the existence of a natural equivalence \[ \tau_{\le i}(\mathbb L_{X_i/Y}^\mathrm{an}) \simeq 0, \] in $\mathrm{Mod}_{\mathcal O_{X_i}}$. Consider the natural fiber sequence \[ h_i^* \mathbb L^\mathrm{an}_{Y} \to \mathbb L^\mathrm{an}_{X_i} \to \mathbb L^\mathrm{an}_{X_i/Y}, \] in $\mathrm{Mod}_{\mathcal O_{X_i}}$. The natural morphism \[ \mathbb L^\mathrm{an}_{X_i/ Y} \to \pi_{i+1}(\mathbb L^\mathrm{an}_{X_i/Y})[i+1], \] induces a morphism $\mathbb L^\mathrm{an}_{X_i} \to \pi_{i+1}(\mathbb L^\mathrm{an}_{X_i/Y})[i+1]$, such that the composite \begin{equation} \label{eq:fiber_sequence_of_cotangent_complexes_to_produce_the_existence_of_the_desired_square_zero_extension_approximating_Y_in_degree_i+1} h_i^* \mathbb L^\mathrm{an}_{Y} \to \mathbb L^\mathrm{an}_{X_i} \to \pi_{i+1}(\mathbb L^\mathrm{an}_{X_i/Y})[i+1], \end{equation} is null-homotopic, in $\mathrm{Mod}_{\mathcal O_{X_i}}$. By the universal property of the relative analytic cotangent complex, \eqref{eq:fiber_sequence_of_cotangent_complexes_to_produce_the_existence_of_the_desired_square_zero_extension_approximating_Y_in_degree_i+1} produces a square-zero extension \[ X_i \to X_{i+1}, \] together with a morphism $h_{i+1} \colon X_{i+1} \to Y$, factoring $h_i \colon X_i \to Y$. We are reduced to show that the morphism \[ \mathcal O_Y \to h_{i+1, *}(\mathcal O_{X_{i+1}}), \] is $(i+2)$-connective. Consider the commutative diagram \begin{equation} \label{eq:commutative_diagram_of_fiber_sequences_exhibiting_O_X_i+1_as_an_approximation_of_level_i+1_of_Y} \begin{tikzcd} h_{i, *}(\pi_{i+1}(\mathbb L^\mathrm{an}_{X_i/Y}))[i+1] \ar{r} & h_{i+1, *}(\mathcal O_{X_{i+1}}) \ar{r} & h_{i, *}(\mathcal O_{X_i}) \\ \mathcal I \ar{r} \ar{u}{s_i} & \mathcal O_Y \ar{r} \ar{u} & h_*(\mathcal O_{X_i}) \ar{u} \\ \mathcal J \ar{r}{=} \ar{u} & \mathcal J \ar{r} \ar{u} & 0 \ar{u} \end{tikzcd}, \end{equation} in $\mathrm{Mod}_{\mathcal O_Y}$, where both the vertical and horizontal composites are fiber sequences. By our inductive hypothesis, $\mathcal I$ is $(i+1)$-connective. Moreover, thanks to \cite[Proposition 5.34]{Porta_Yu_Representability} we can identify the natural morphism \[ s_i \colon \mathcal I \to h_{i, *}(\pi_{i+1}(\mathbb L^\mathrm{an}_{X_i/Y}))[i + 1] \] with the natural morphism $\mathcal I \to \tau_{\le i + 1}(\mathcal I)$. We deduce that the fiber of the morphism $s_i$ must be necessarily $(i+2)$-connective. The latter observation combined with the structure of \eqref{eq:commutative_diagram_of_fiber_sequences_exhibiting_O_X_i+1_as_an_approximation_of_level_i+1_of_Y} implies that $h_{i+1} \colon X_{i+1} \to Y$ induces an equivalence of derived $k$-analytic spaces \[ \mathrm t_{\le i+1}(X_{i+1}) \to \mathrm t_{\le i+1}(Y), \] as desired. \end{proof} \begin{cor} Let $X \in \mathrm{dAn}_k$. Then the following assertions hold: \begin{enumerate} \item The natural morphism \[ X_\mathrm{red} \to X, \] in $\mathrm{dAn}_k$, can be \emph{approximated} by successive square-zero extensions; \item For each $n \ge 0$, the natural morphism \[ X_\mathrm{red} \to \mathrm t_{\le n}(X), \] can be \emph{approximated} by a finite number of square-zero extensions. \end{enumerate} \end{cor} \begin{proof} Both the assertions of the Corollary follow readily from \cref{prop:filtered_colimit_for_nil-embeddings} by observing that the canonical morphisms $X_\mathrm{red} \to X$ and $X_\mathrm{red} \to \mathrm t_{\le n}(X)$ have the structure of nil-embeddings and that in the latter case the finiteness assumption on the Postkinov tower forces the finiteness of the approximation sequence. \end{proof} \begin{lem} \label{lem:pullbacks_of_derived_affinoid_spaces_along_finite_morphisms_are_algebraic} Let $f \colon X \to Y$ be a finite morphism of derived $k$-affinoid spaces. Let $Z \to Y$ be an admissible open immersion and denote by \[ A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg}), \quad B \coloneqq \Gamma(Y, \mathcal O_Y^\mathrm{alg}), \quad C \coloneqq \Gamma(Z, \mathcal O_Z^\mathrm{alg}), \] the corresponding derived $k$-algebras of derived global sections. Consider the base change \[ Z' \coloneqq Z \times_Y X \in \mathrm{dAfd}_k. \] Then one has a natural equivalence \[ \Gamma(Z', \mathcal O_{Z'}^\mathrm{alg}) \simeq A \otimes_B C, \] in the $\infty$-category\xspace $\mathrm{CAlg}_k$. \end{lem} \begin{proof} The Lemma is a direct consequence of \cite[Proposition 3.17]{Porta_Yu_Derived_non-archimedean_analytic_spaces} (iii). \end{proof} \begin{lem} \label{lem:Beck_Chevalley_natural_transformation_equivalence} Let $f \colon X \to Y$ be a finite morphism of derived $k$-affinoid spaces and $g \colon Z \to Y$ an admissible open immersion in $\mathrm{dAfd}_k$. Form the pullback diagram \[ \begin{tikzcd} Z' \ar{r}{g'} \ar{d}{f'} & X \ar{d}{f} \\ Z \ar{r}{g} & Y, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Then the commutative diagram \[ \begin{tikzcd} \mathrm{Coh}^+(Y) \ar{r}{f^*} \ar{d}{g^*} & \mathrm{Coh}^+(X) \ar{d}{(g')^*} \\ \mathrm{Coh}^+(Z) \ar{r}{(f')^*} & \mathrm{Coh}^+(Z'), \end{tikzcd} \] is right adjointable. In other words, the Beck-Chevalley natural transformation \[ \alpha \colon g^* \circ f_* \to (f')_* \circ g'_* \] is an equivalence of functors. \end{lem} \begin{proof} Since $f$ is assumed to be a finite morphism of derived $k$-affinoid spaces, it follows from the derived Tate aciclicity theorem, c.f. \cite[Theorem 3.1]{Porta_Yu_Derived_Hom_spaces} that the right adjoint $f_* \colon \mathrm{Coh}^+(X) \to \mathrm{Coh}^+(Y)$ is well defined. The assertion of the Lemma is now an immediate consequence of \cref{lem:pullbacks_of_derived_affinoid_spaces_along_finite_morphisms_are_algebraic} together with \cite[Proposition 2.5.4.5]{Lurie_SAG} and the derived Tate aciclicity theorem. \end{proof} \begin{prop} \label{lem:f^*_admits_a_right_adjoint_whenever_f_is_nil-iso} Let $f \colon S \to S'$ be a nil-isomorphism between derived $k$-analytic spaces. Then the pullback functor \[ f^* \colon \mathrm{Coh}^+(S') \to \mathrm{Coh}^+(S), \] admits a well defined right adjoint, $f_*$. \end{prop} \begin{proof} Since $f \colon S \to S'$ is a nil-isomorphism, we conclude from \cref{lem:nil-isos_are_affine_morphisms} that $f$ is an affine morphism between derived $k$-analytic spaces. By admissible descent of $\mathrm{Coh}^+$, cf. \cite[Theorem 3.7]{Antonio_Porta_Nonarchimedean_Hilbert}, together with \cref{lem:affine_morphisms_are_compatible_with_Zariski_localization_on_the_base} and \cref{lem:Beck_Chevalley_natural_transformation_equivalence} we reduce the statement of the Lemma to the case where both $S$ and $S'$ are equivalent to derived $k$-affinoid spaces. In this case, the result follows by our assumptions on $f$ and \cref{lem:nil-isos_are_affine_morphisms}. \end{proof} \begin{prop} \label{prop:existence_of_pushouts_along_closed_nil-isomorphisms} Let $f \colon X \to Y$ be a nil-embedding of derived $k$-analytic spaces. Let $g \colon X \to Z$ be a finite morphism in $\mathrm{dAn}_k$. The the diagram \[ \begin{tikzcd} X \ar{r}{f} \ar{d}{g} & Y \\ Z \end{tikzcd} \] admits a pushout in $\mathrm{dAn}_k$, denoted $Z'$. Moreover, the natural morphism $Z \to Z'$ is also a nil-embedding. \end{prop} \begin{proof} The $\infty$-category\xspace of $\cT_{\mathrm{an}}(k)$-structured $\infty$-topoi \ $\tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k))$ is a presentable $\infty$-category\xspace. Consider the pushout diagram \[ \begin{tikzcd} X \ar{r}{f} \ar{d}{g} & Y \ar{d} \\ Z \ar{r} & Z', \end{tikzcd} \] in the $\infty$-category\xspace $\tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k))$. By construction, the underlying $\infty$-topos\xspace of $Z'$ can be computed as the pushout in the $\infty$-category\xspace $\tensor*[^\rR]{\Top}{}$ of the induced diagram on the underlying $\infty$-topoi \ of $X$, $Z$ and $Y$. Moreover, since $g$ is a nil-isomorphism it induces an equivalence on underlying $\infty$-topoi \ of both $X$ and $Y$. It follows that the induced morphism $Z \to Z'$ in $\tensor*[^\rR]{\Top}{}(\cT_{\mathrm{an}}(k))$ induces an equivalence on the underlying $\infty$-topoi. Moreover, it follows essentially by construction that we have a natural equivalence \begin{align*} \mathcal O_{Z'} & \simeq g_*(\mathcal O_Y) \times_{g_*(\mathcal O_X)} \mathcal O_Z \\ & \in \mathrm{Str}_{\cT_{\mathrm{an}}(k)}^\mathrm{loc}(Z). \end{align*} As the morphism $g_*(\mathcal O_Y) \to g_*(\mathcal O_X)$ is an effective epimorphism and effective epimorphisms are preserved under fiber products in an $\infty$-topos\xspace, c.f. \cite[Proposition 6.2.3.15]{HTT}, it follows that the natural morphism \[ \mathcal O_{Z'} \to \mathcal O_Z, \] is an effective epimorphism, as well. Consider now the commutative diagram of fiber sequences \[ \begin{tikzcd} \mathcal J ' \ar{r} \ar{d} & \mathcal O_{Z'} \ar{r} \ar{d} & \mathcal O_Z \ar{d} \\ \mathcal J \ar{r} & g_*(\mathcal O_Y) \ar{r} & g_*(\mathcal O_X), \end{tikzcd} \] in the stable $\infty$-category\xspace $\mathrm{Mod}_{\mathcal O_Z'}$. Since the right commutative square is a pullback square it follows that the morphism \[ \mathcal J' \to \mathcal J, \] is an equivalence. In particular, $\pi_0(\mathcal J')$ is a finitely generated nilpotent ideal of $\pi_0(\mathcal O^\mathrm{alg}_{Z'})$. Indeed, finitely generation follows from our assumption that $g$ is a finite morphism. Thanks to \cref{lem:derived_k_analytic_space_whose_reduction_is_affinoid_is_also_affinoid}, it follows that $\mathrm{t}_0(Z')$ is an ordinary $k$-analytic space and the morphism $\mathrm{t}_0(Z') \to \mathrm{t}_0(Z)$ is a nil-embedding. We are thus reduced to show that for every $i>0$, the homotopy sheaf $\pi_i(\mathcal O_{Z'}) \in \mathrm{Coh}^+(\mathrm{t}_0(Z'))$. But this follows immediately from the existence of a fiber sequence \[ \mathcal O_{Z'} \to g_*(\mathcal O_Y) \oplus \mathcal O_Z \to g_*(\mathcal O_X), \] in the $\infty$-category\xspace $\mathrm{Mod}_{\mathcal O_{Z'}}$ together with the fact that $g_*(\mathcal O_Y)$ and $g_*(\mathcal O_Z)$ have coherent homotopy sheaves, by our assumption that $g$ is a finite morphism combined with \cref{lem:nil-isos_are_affine_morphisms}. \end{proof} \begin{cor} \label{lem:pushouts_of_square_zero_extensions_have_the_structure_of_a_square_zero_extension} Let $f \colon S \to S'$ be a square-zero extension and $g \colon S \to T$ a nil-isomorphism in $\mathrm{dAn}_k$. Suppose we are given a pushout diagram \[ \begin{tikzcd} S \ar{r}{f} \ar{d} & S' \ar{d} \\ T \ar{r} & T' \end{tikzcd}, \] in $\mathrm{dAn}_k$. Then the induced morphism $T \to T'$ is a square-zero extension. \end{cor} \begin{proof} Since $g$ is a nil-isomorphism of derived $k$-analytic spaces, \cref{lem:f^*_admits_a_right_adjoint_whenever_f_is_nil-iso} implies that the pullback functor $g^* \colon \mathrm{Coh}^+(T) \to \mathrm{Coh}^+(S)$ admits a well defined right adjoint \[ g_* \colon \mathrm{Coh}^+(S ) \to \mathrm{Coh}^+(T) . \] Let $\mathcal F \in \mathrm{Coh}^+(S)^{\ge 0}$ and $d \colon \mathbb L^\mathrm{an}_S \to \mathcal F[1]$ be a derivation associated with the morphism $f \colon S \to S'$. Consider now the natural composite \[ d ' \colon \mathbb L^\mathrm{an}_T \to g_* (\mathbb L^\mathrm{an}_S) \xrightarrow{g_*(d)} g_* (\mathcal F)[1], \] in the $\infty$-category\xspace $\mathrm{Coh}^+(T)$. By the universal property of the relative analytic cotangent complex, we deduce the existence of a square-zero extension \[ T \to T', \] in the $\infty$-category\xspace $\mathrm{dAn}_k$. Let $X \in \mathrm{dAn}_k$ together with morphisms $S' \to X$ and $T \to X$ compatible with both $f$ and $g$. By the universal property of the relative analytic cotangent complex, the morphism $S' \to X$ induces a uniquely defined (up to a contractible indeterminacy space) morphism \[ \mathbb L^\mathrm{an}_{S/X} \to \mathcal F[1], \] in $\mathrm{Coh}^+(S)$, such that the compositve $\mathbb L^\mathrm{an}_S \to \mathbb L^\mathrm{an}_{S/X} \to \mathcal F[1]$ agrees with $d$. By applying the right adjoint $g_*$ above we obtain a commutative diagram \[ \begin{tikzcd} \mathbb L^\mathrm{an}_T \ar{r}{\mathrm{can}} \ar{d} & \mathbb L^\mathrm{an}_{T/X} \ar{d} \ar{rd}{d''} & \\ g_*(\mathbb L^\mathrm{an}_S) \ar{r}{g_*(\mathrm{can})} & g_*(\mathbb L^\mathrm{an}_{S/X}) \ar{r} & g_*(\mathcal F)[1], \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{Coh}^+(T)$. From this, we conclude again by the universal property of the relative analytic cotangent complex the existence of a uniquely defined natural morphism $T' \to X$ extending both $T \to X$ and $S' \to X$ and compatible with the restriction to $S$. The latter assertion is equivalent to state that the commutative square \[ \begin{tikzcd} S \ar{r} \ar{d} & S' \ar{d} \\ T \ar{r} & T', \end{tikzcd} \] is a pushout diagram in $\mathrm{dAn}_k$. The proof is thus concluded. \end{proof} \begin{construction} \label{const:leq_n_construction} Let $n \ge 0$. We have a well defined functor \[ \mathrm{AnNil}_{\mathrm{t}_{\le n}(X)/ } \to \mathrm{AnNil}_{X/ }, \] given by the formula \[ (\mathrm t_{\le n}(X) \to S) \in \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ } \mapsto ( X \to S \bigsqcup_{\mathrm t_{\le n}(X)} X ). \] Given any functor $F \colon \mathrm{AnNil}_{X/ }\to \mathcal S$, we define $F^{\le n} \colon \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ } \to \mathcal S$ as the functor given on objects by the association \[ (\mathrm t_{\le n}(X) \to S) \in \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ } \mapsto F^{\le n}(S \bigsqcup_{\mathrm t_{\le n}(X)} X) \in \mathcal S. \] It follows from the construction that, for each $n \ge 0$ and $S \in \mathrm{AnNil}_{X/ }$, we have a natural morphism \[ F(S) \to F^{\le n}(\mathrm t_{\le n}(S)), \] in the $\infty$-category\xspace $\mathcal S$. \end{construction} \subsection{Analytic formal moduli problems under a base} We study the $\infty$-category\xspace of $k$-analytic formal moduli problems under a base $X \in \mathrm{dAn}_k$ and explore certain important features of such. The results presented here will prove to be crucial for the study of the deformation to the normal cone in the $k$-analytic setting, which we treat in the next section. We start with the following central definition: \begin{defin} \label{defin:analytic_formal_moduli_problems_under} An \emph{analytic formal moduli problem under $X$} corresponds to the datum of a functor \[F \colon (\mathrm{AnNil}_{X/})^\mathrm{op} \to \mathcal S,\] satisfying the following two conditions: \begin{enumerate} \item $F(X) \simeq *$ in $\mathcal S$; \item Given any $S \in \mathrm{AnNil}^\mathrm{op}_{X/ }$, the natural morphism \[ F(S) \to \lim_{n \ge 0} F^{\le n}(\mathrm t_{\le n}(S)), \] is an equivalence in $\mathcal S$ (see \cref{const:leq_n_construction}). In other words, $Y$ is \emph{convergent}; \item Given any pushout diagram \[\begin{tikzcd} S \ar{r}{f} \ar{d} & S' \ar{d} \\ T \ar{r} & T', \end{tikzcd}\] in the $\infty$-category\xspace $\mathrm{AnNil}_{X/}$, such that $f$ has the structure of a square-zero extension, the induced morphism \[F(T') \to F(T) \times_{F(S)}F(S),\] is an equivalence in $\mathcal S$. \end{enumerate} We shall denote by $\mathrm{AnFMP}_{X/}$ the full subcategory of $\Fun((\mathrm{AnNil}_{X/ })^\mathrm{op}, \mathcal S)$ spanned by analytic formal moduli problems under $X$. \end{defin} \begin{rem} In the previous definition we remark that the functor \[ F^{\le n} \colon \mathrm{AnNil}^\mathrm{op}_{\mathrm t_{\le n}(X)/ } \to \mathcal S, \] is itself an analytic formal moduli problem under $\mathrm t_{\le n}(X)$. \end{rem} We shall give some important examples of formal moduli problems under $X$: \begin{eg} \begin{enumerate} \item Let $X \in \mathrm{dAn}_k$. As in the algebraic case, we can consider the \emph{de Rham pre-stack associated to $X$}, $X_\mathrm{dR} \colon \mathrm{dAfd}_k^\mathrm{op} \to \mathcal S$, determined by the formula \[ X_{\mathrm{dR}}(Z) \coloneqq X(Z_\mathrm{red}), \quad Z \in \mathrm{dAfd}_k. \] We have a natural morphism $X \to X_\mathrm{dR}$ induced from the natural morphism $Z_\mathrm{red} \to Z$. The restriction of $X_\mathrm{dR}$ to $\Fun(\mathrm{AnNil}^\mathrm{op}_{X/ }, \mathcal S)$ via the functor \[ h_* \colon \mathrm{dAnSt}_k \to \mathrm{AnFMP}_{X/ }, \] induced by the inclusion $h \colon \mathrm{AnNil}_{X/ } \subseteq \mathrm{dAn}_k$, is an analytic formal moduli problem under $X$. Moreover, it follows from the construction of $X_\mathrm{dR}$ that the object $h_* (X_\mathrm{dR})$ is equivalent to a final object in $\mathrm{AnFMP}_{X/ }$. \item Let $f \colon X \to Y$ be a morphism in the $\infty$-category\xspace $\mathrm{dAn}_k$. We define the \emph{formal completion of $X$ in $Y$ along $f$} as the pullback \begin{align*} Y^\wedge_X & \coloneqq Y \times_{Y_\mathrm{dR}} X_\mathrm{dR} \\ & \in \mathrm{dAnSt}_k. \end{align*} By construction we have a natural factorization $X \to Y^\wedge_X \to Y$ in $\mathrm{dAnSt}_k$, and moreover the restriction of $X \to Y^\wedge_X$ to the $\infty$-category\xspace $\Fun(\mathrm{AnNil}^\mathrm{op}_{X/}, \mathcal S)$ along the natural functor \[ h_* \colon (\mathrm{dAnSt}_k)_{X/ } \to \mathrm{AnFMP}_{X/ }, \] exhibits $Y^\wedge_X$ as a formal moduli problem under $X$. \item Let $f \colon X \to Y$ be a closed immersion in the $\infty$-category\xspace $\mathrm{dAn}_k$. Consider the shifted tangent bundle associated to $f$ together with the zero section \[ \begin{tikzcd} X \ar{r}{s_0} \arrow[rd, equal] & \mathbf T^\mathrm{an}_{X/ Y}[1] \ar{d}{p} \\ & X. \end{tikzcd} \] The completion $\mathbf T^\mathrm{an}_{X/Y} [1]^\wedge \in \mathrm{AnFMP}_{X/ }$ along $s_0$ will play an important role in what follows. \end{enumerate} \end{eg} \begin{notation} We set $\mathrm{AnNil}_{X/}^\mathrm{cl} \subseteq \mathrm{AnNil}_{X/}$ to be the full subcategory spanned by those objects corresponding to nil-embeddings \[ X \to S, \] in $\mathrm{dAn}_k$. \end{notation} \begin{prop} \label{prop:analytic_FMP_under_X_are_ind_inf_schemes} Let $Y \in \mathrm{AnNil}_{X/}$. The following assertions hold: \begin{enumerate} \item The inclusion functor \[ \mathrm{AnNil}^{\mathrm{cl}}_{X//Y} \hookrightarrow \mathrm{AnNil}_{X//Y} , \] is cofinal. \item The natural morphism \[ \colim_{Z \in \mathrm{AnNil}_{X//Y}^\mathrm{cl}} Z \to Y, \] is an equivalence in $\Fun(\mathrm{AnNil}_{X/}^\mathrm{op}, \mathcal S)$. \item The $\infty$-category\xspace $\mathrm{AnNil}_{X//Y}^\mathrm{cl}$ is filtered. \end{enumerate} \end{prop} \begin{proof} We start by proving claim (1). Let $n \ge 0$, and consider the usual restriction along the natural morphism $X_\mathrm{red} \to \mathrm t_{\le n}(X)$ functor \[\mathbf{res}^{\le n} \colon \mathrm{AnNil}_{\mathrm t_{\le n}(X)/} \to \mathrm{AnNil}_{X_\mathrm{red}/}.\] Such functor admits a well defined left adjoint \[\mathbf{push}^{\le n} \colon \mathrm{AnNil}_{X_\mathrm{red}/} \to \mathrm{AnNil}_{\mathrm t_{\le n}(X)/},\] which is determined by the formula \[ (X_\mathrm{red} \to T) \in \mathrm{AnNil}_{X_\mathrm{red} /} \mapsto (\mathrm t_{\le n}(X) \to T') \in \mathrm{AnNil}_{X/}, \] where we have set \begin{equation} \label{eq:set_definition_of_T'_as_pushout_of_T_along_the_inclusion_X_red_to_X} T' \coloneqq \mathrm t_{\le n}(X) \bigsqcup_{X_\mathrm{red}} T \in \mathrm{AnNil}_{X/}. \end{equation} We claim that $T' \in \mathrm{AnNil}_{\mathrm t_{\le n}(X)/}$ belongs to the full subcategory $\mathrm{AnNil}^\mathrm{cl}_{\mathrm t_{\le n}(X)/} \subseteq \mathrm{AnNil}_{\mathrm t_{\le n}(X)/}$. Indeed, since the structural morphism $X_\mathrm{red} \to T$, is necessarily a nil-embedding we deduce the claim from \cref{prop:existence_of_pushouts_along_closed_nil-isomorphisms}. We shall denote by \[ \mathbf{res}^{\le n}_!(Y) \colon \mathrm{AnNil}^\mathrm{op}_{X_\mathrm{red} /} \to \mathcal S, \] the left Kan extension of $Y$ along the functor $\mathbf{res}^{\le n}$ above. By the colimit formula for left Kan extensions, c.f. \cite[Lemma 4.3.2.13]{HTT}, it follows that $\mathbf{res}^{\le n}_!(Y)$ is given by the formula \[ (X_\mathrm{red} \to T) \in \mathrm{AnNil}_{X_\mathrm{red} /} \mapsto Y^{\le n}(T') \in \mathcal S, \] where $T'$ is as in \eqref{eq:set_definition_of_T'_as_pushout_of_T_along_the_inclusion_X_red_to_X}. We thus have a diagram of functors \[ \mathbf{res}^{\le n} \colon \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ /Y^{\le n}} \rightleftarrows \mathrm{AnNil}_{X_\mathrm{red} // \mathbf{res}^{\le n}_!(Y)} \colon \mathbf{push}^{\le n}, \] where $\mathbf{res}^{\le n}$ is given on objects by the formula \[ (\mathrm t_{\le n}(X) \to S \to Y^{\le n}) \in \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ /Y^{\le n}} \mapsto (X_\mathrm{red} \to S \to \mathbf{res}_!^{\le n}(Y) ) \in \mathrm{AnNil}_{X_\mathrm{red} // \mathbf{res}^{\le n}_!(Y)} \] and the functor $\mathbf{push}^{\le n}$ is given by the association \[ (X_\mathrm{red} \to T \to Y^{\le n}) \in \mathrm{AnNil}_{X_\mathrm{red}/ /Y^{\le n}} \mapsto (\mathrm t_{\le n}(X) \to T \sqcup_{X_\mathrm{red}} \mathrm t_{\le n}(X) \to Y^{\le n}) \in \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ /Y^{\le n}}. \] We claim that the pair $(\mathbf{res}^{\le n}, \mathbf{push}^{\le n})$ forms an adjunction. Indeed, a morphism \[ (X_\mathrm{red} \to S \to \mathbf{res}^{\le n}_!(Y)) \to \mathbf{res}_!^{\le n}(\mathrm t_{\le n}(X) \to T \to Y^{\le n}), \] corresponds to a commutative diagram \[ \begin{tikzcd} X_\mathrm{red} \ar{r} \ar{d}{=} & S \ar{r} \ar{d} & \mathbf{res}_!^{\le n}(Y) \ar{d}{=} \\ X_\mathrm{red} \ar{r} & T \ar{r} & \mathbf{res}_!^{\le n}(Y), \end{tikzcd} \] in the $\infty$-category\xspace $\Fun(\mathrm{AnNil}_{X_\mathrm{red}/ }^\mathrm{op}, \mathcal S)$. The latter datum is equivalent to the datum of a commutative diagram \begin{equation} \label{eq:com_diagram_expliciting_datum_of_res_push_adjunctions} \begin{tikzcd} & & \mathrm t_{\le n}(X) \ar{d} \ar{rd} & \\ X_\mathrm{red} \ar{r} \ar{d} & S \ar{r} \ar{d} & S' \ar{r} \ar{d} & Y^{\le n} \ar{d}{=} \\ X_\mathrm{red} \ar{r} & T \ar{r} & T' \ar{r} & Y^{\le n} \end{tikzcd}. \end{equation} Since the morphism $\mathrm t_{\le n}(X) \to T'$ factors through the structural map \[ \mathrm t_{\le n}(X) \to T, \] we deduce that the datum of \eqref{eq:com_diagram_expliciting_datum_of_res_push_adjunctions} is equivalent to the datum of a commutative diagram \[ \begin{tikzcd} \mathrm t_{\le n}(X) \ar{r} \ar{d} & S' \ar{r} \ar{d} & Y^{\le n} \ar{d}{=} \\ \mathrm t_{\le n}(X) \ar{r} & T \ar{r} & Y^{\le n}, \end{tikzcd} \] which corresponds to a uniquelly well defined morphism \[ \mathbf{push}^{\le n}(X_\mathrm{red} \to S \to \mathbf{res}^{\le n}_!(Y)) \to (\mathrm t_{\le n}(Y) \to T \to Y^{\le n}), \] in the $\infty$-category\xspace $\mathrm{AnNil}_{\mathrm t_{\le n}(X)/ /Y^{\le n}}$. We further observe that for every $n \ge m \ge 0$, the objects \[ \mathbf{res}^{\le n}_!(Y) \quad \mathrm{and} \quad \mathbf{res}^{\le m}_!(Y), \] are equivalent as functors $\mathrm{AnNil}_{X_\mathrm{red}/ } ^\mathrm{op} \to \mathcal S$, we shall denote this functor simply by $\mathbf{res}_!(Y)$. Passing to the limit over $n \ge 0$ we obtain a commutative diagram of the form \[ \begin{tikzcd} \mathrm{AnNil}_{X_\mathrm{red}/ /\mathbf{res}_!(Y)} \ar{rr} \ar{rd} & & \lim_{n \ge 0} \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ /Y^{\le n}} \\ & \mathrm{AnNil}_{X/ /Y} \ar{ur}. \end{tikzcd} \] The horizontal morphism is cofinal since it fits into an adjunction, by our previous considerations. Thanks to \cite[ Corollary 4.1.1.9]{HTT} in order to show that the natural morphism \[ \mathrm{AnNil}_{X_\mathrm{red}/ /\mathbf{res}_!(Y)} \to \mathrm{AnNil}_{X/ /Y}, \] is cofinal, it suffices to prove that $\mathrm{AnNil}_{X/ /Y} \to \lim_{n \ge 0} \mathrm{AnNil}_{\mathrm t_{\le n}(X)/ /Y^{\le n}}$ is itself cofinal. But the latter is an immediate consequence of the fact that derived $k$-analytic spaces are nilcomplete, c.f. \cite[Lemma 7.7]{Porta_Yu_Representability}, combined with assumption (3) in \cref{defin:analytic_formal_moduli_problems_under}. Assertion (1) of the Proposition now follows from the observation that the functor \[ \mathrm{AnNil}_{X_\mathrm{red}/ /\mathbf{res}_!(Y)} \to \mathrm{AnNil}_{X/ /Y}, \] factors through the full subcategory $\mathrm{AnNil}_{X/ /Y}^{\mathrm{cl}} \subseteq \mathrm{AnNil}_{X/ /Y}$. Claim (2) follows immediately from (1) combined with Yoneda Lemma. To prove (3) we shall make use of \cite[Lemma 5.3.1.12]{HTT}. Let \[ F \colon \partial \Delta^n \to \mathrm{AnNil}^\mathrm{cl}_{X//Y}. \] For each $[m] \in \Delta^{n}$, denote by $S_m \coloneqq F([m]) $ in $\mathrm{AnNil}^\mathrm{cl}_{X//Y}$. The pushout \[ S_n \bigsqcup_X S_{n-1}, \] exists in $\mathrm{AnNil}^\mathrm{cl}_{X/}$. We wish to show that $S_n \bigsqcup_X S_{n-1}$ admits a morphism \[S_n \bigsqcup_X S_{n-1} \to Y,\] compatible with the diagram $F$. In order to prove the latter assertion, we observe that \cref{prop:filtered_colimit_for_nil-embeddings} can filter the diagram $F$ by diagrams $F_i \to F$ such that $X \to F_0$ is formed by square-zero extensions and so are each transition morphisms $F_i \to F_{i+1}$. This implies that for every $j \ge 0$, we can find morphisms \[ \mathrm t_{\le j}(S_n) \bigsqcup_{\mathrm t_{\le j}(X)} \mathrm t_{\le j}(S_n-1) \to Y^{\le j}, \] which are compatible for varying $j \ge 0$. Moreover, the fact that $Y$ satisfies condition (2) in \cref{defin:analytic_formal_moduli_problems_under} implies that we can find a well defined morphism \[ S_n \bigsqcup_X S_{n-1} \to Y, \] which is compatible with $F$, as desired. \end{proof} As a Corollary we deduce the following important result: \begin{cor} Let $X \in \mathrm{dAn}_k$, then the $\infty$-category\xspace $\mathrm{AnFMP}_{X/ }$ is presentable. In particular, the latter admits all small colimits. \end{cor} \begin{proof} Consider the fully faithful functor \[ \mathrm{AnNil}_{X/ }^\mathrm{cl} \hookrightarrow \mathrm{AnNil}_{X/ } \to \mathrm{AnFMP}_{X/ }. \] It follows from the definitions that the $\infty$-category\xspace $\mathrm{AnFMP}_{X/ }$ admits filtered colimits. In particular, we obtain a well defined functor \[ F \colon \mathrm{Ind}(\mathrm{AnNil}_{X/ } ^\mathrm{cl}) \to \mathrm{AnFMP}_{X/ }, \] which is further fully faithful, since every the image of every $(X \to S) \in \mathrm{AnNil}_{X/ }$ is compact in $\mathrm{AnFMP}_{X/ }$. It follows from \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes} that $F$ itself is essentially surjective. Since the $\infty$-category\xspace $\mathrm{AnNil}_{X/ }^\mathrm{cl}$ is essentially small we are reduced to show that $\mathrm{AnFMP}_{X/ }$ admits all small colimits. We already know that $\mathrm{AnFMP}_{X/ }$ admits filtered colimits. We shall prove that $\mathrm{AnFMP}_{X/ }$ admits finite colimits as well. As a consequence of \cref{prop:existence_of_pushouts_along_closed_nil-isomorphisms}, we deduce that the $\infty$-category\xspace $\mathrm{AnNil}_{X/ }^\mathrm{cl}$ admits all finite colimits. It is now clear that $\mathrm{AnFMP}_{X/ }$ admits finite colimits as well, and the proof is concluded. \end{proof} \begin{defin} Let $Y \in \mathrm{AnFMP}_{X/}$ denote an analytic formal moduli problem under $X$. The \emph{relative pro-analytic cotangent complex of $Y$ under $X$} is defined as the pro-object \begin{align*} \mathbb L^\mathrm{an}_{X/Y} & \coloneqq \{ \mathbb L^\mathrm{an}_{X/Z} \}_{Z \in \mathrm{AnNil}^\mathrm{cl}_{X//Y}} \\ & \in \mathrm{Pro}(\mathrm{Coh}^+(X)), \end{align*} where, for each $Z \in \mathrm{AnNil}^\mathrm{cl}_{X//Y}$ \[\mathbb L^\mathrm{an}_{X/Z} \in \mathrm{Coh}^+(X),\] denotes the usual relative analytic cotangent complex associated to the structural morphism $X \to Z$ in $\mathrm{AnNil}^\mathrm{cl}_{X//Y}$. \end{defin} \begin{rem} Let $Y \in \mathrm{AnFMP}_{X/}$. For a general $Z \in \mathrm{dAn}_k$, there exists a natural morphism \[ \mathbb L^\mathrm{an}_X \to \mathbb L^\mathrm{an}_{X/Z} , \] in the $\infty$-category\xspace $\mathrm{Coh}^+(X)$. Passing to the limit over $Z \in \mathrm{AnNil}^\mathrm{cl}_{X//Z}$, we obtain a natural map \[ \mathbb L^\mathrm{an}_X \to \mathbb L^\mathrm{an}_{X/Y}, \] in $\mathrm{Pro}(\mathrm{Coh}^+(X))$, as well. \end{rem} The following result justifies our choice of terminology for the object $\mathbb L^\mathrm{an}_{X/Y} \in \mathrm{Pro}(\mathrm{Coh}^+(X))$: \begin{lem} \label{lem:pro_cot_complex_classifies_nil_extensions_for_analytic_moduli_problems} Let $Y \in \mathrm{AnFMP}_{X/}$. Let $X \hookrightarrow S$ be a square-zero extension associated to an analytic derivation \[ d \colon \mathbb L^\mathrm{an}_S \to \mathcal F [1] , \] where $\mathcal F \in \mathrm{Coh}^+(X)^{\ge 0}$. Then there exists a natural morphism \[ \Map_{\mathrm{AnFMP}_{X/}}(S, Y) \to \Map_{\mathrm{Pro}(\mathrm{Coh}^+(X))}(\mathbb L^\mathrm{an}_{X/Y}, \mathcal F) \times_{\Map_{\mathrm{Coh}^+(X)}(\mathbb L^\mathrm{an}, \mathcal F)} \{ d \} \] which is furthermore an equivalence in the $\infty$-category\xspace $\mathcal S$. \end{lem} \begin{proof} Thanks to \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes} combined with the Yoneda Lemma we can identify the space of liftings of the map $X \to Y$ along $X \to S$ with the mapping space \[ \Map_{\mathrm{AnFMP}_{X/}}(S, Y) \simeq \colim_{Z \in \mathrm{AnNil}_{X//Y}} \Map_{\mathrm{AnNil}_{X/}} (S, Z). \] Fix $Z \in \mathrm{AnNil}_{X//Y}^\mathrm{cl}$. Then we have a natural identification of mapping spaces \begin{align} \label{eq:identification_of_universal_property_of_rel_an_cotagent_complex} \Map_{\mathrm{AnNil}_{X/}} (S, Z) & \simeq \Map_{(\mathrm{dAn}_k)_{X/}} (S, Z) \\ & \simeq \Map_{\mathrm{Coh}^+(X)}(\mathbb L^\mathrm{an}_{X/Z}, \mathcal F) \times_{\Map_{\mathrm{Coh}^+(X)}(\mathbb L^\mathrm{an}_X, \mathcal F)} \{ d \}, \end{align} see \cite[\S 5.4]{Porta_Yu_Representability} for a justification of the latter assertion. Passing to the colimit over $Z \in \mathrm{AnNil}_{X//Y}^\mathrm{cl}$, we conclude thanks to the formula for mapping spaces in pro-$\infty$-categories\xspace that we have a natural equivalence \[ \Map_{\mathrm{AnFMP}_{X/}}(S, Y) \simeq \Map_{\mathrm{Pro}(\mathrm{Coh}^+(X))}(\mathbb L^\mathrm{an}_{X/Y}, \mathcal F) \times_{\Map_{\mathrm{Coh}^+(X)}(\mathbb L^\mathrm{an}, \mathcal F)} \{ d \}, \] as desired. \end{proof} \begin{construction} \label{rem:morphisms_of_AnFMP_induce_transition_morphisms_on_relative_analytic_cot_complexes} Let $f \colon Y \to Z$ denote a morphism in $\mathrm{AnFMP}_{X/}$. Then, for every $S \in \mathrm{AnNil}_{X/ /Y}^\mathrm{cl}$, the induced morphism \[ S \to Z, \] in $\mathrm{AnFMP}_{X/}$ factors necessarily through some $S' \in \mathrm{AnNil}^\mathrm{cl}_{X/ /Z}$. For this reason, we obtain a natural morphism \[ \mathbb L^\mathrm{an}_{X/S'} \to \mathbb L^\mathrm{an}_{X/S}, \] in the $\infty$-category\xspace $\mathrm{Coh}^+(X)$. Passing to the limit over $S \in \mathrm{AnNil}^\mathrm{cl}_{X//Y}$ we obtain a canonically defined morphism \[ \theta (f) \colon \mathbb L^\mathrm{an}_{X/Z} \to \mathbb L^\mathrm{an}_{X/Y}, \] in $\mathrm{Pro}(\mathrm{Coh}^+(X))$. Moreover, this association is functorial and thus we obtain a well defined functor \[ \mathbb L^\mathrm{an}_{X/ \bullet} \colon \mathrm{AnFMP}_{X/ } \to \mathrm{Pro}(\mathrm{Coh}^+(X)), \] given by the formula \[ (X \to Y) \in \mathrm{AnFMP}_{X/ } \mapsto \mathbb L^\mathrm{an}_{X/ Y} \in \mathrm{Pro}(\mathrm{Coh}^+(X)). \] \end{construction} \begin{prop} \label{prop:conservativity_of_relative_an_cot_complex} Let $X \in \mathrm{dAn}_k$ be a derived $k$-analytic space. Then the functor \[ \mathbb L^\mathrm{an}_{X/ \bullet} \colon \mathrm{AnFMP}_{X/} \to \mathrm{Pro}(\mathrm{Coh}^+(X)), \] obtained via \cref{rem:morphisms_of_AnFMP_induce_transition_morphisms_on_relative_analytic_cot_complexes,rem:morphisms_of_AnFMP_induce_transition_morphisms_on_relative_analytic_cot_complexes}, is conservative. \end{prop} \begin{proof} Let $f \colon Y \to Z $ be a morphism in $\mathrm{AnFMP}_{X/}$. Thanks to \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes} we are reduced to show that given any \[ S \in \mathrm{AnNil}_{X//Z}^\mathrm{cl}, \] the structural morphism $g_S \colon X \to S$ admits a unique extension $S \to Y$ which factors the structural morphism $X \to Z$. Thanks to \cref{prop:filtered_colimit_for_nil-embeddings} we can reduce ourselves to the case where $X \to S$ has the structure of a square-zero extension. In this case, the result follows from \cref{lem:pro_cot_complex_classifies_nil_extensions_for_analytic_moduli_problems} combined with our hypothesis. \end{proof} Our goal now is to give an alternative description of analytic formal moduli problems under $X \in \mathrm{dAn}_k$, in terms of derived $k$-analytic stacks: \begin{construction} \label{const:anFMP_as_ind_inf_schemes} Consider the $\infty$-category\xspace of derived $k$-analytic stacks, $\mathrm{dAnSt}_k$. We have a natural functor \[ h \colon \mathrm{AnNil}_{X/} \to \mathrm{dAn}_k \hookrightarrow \mathrm{dAnSt}_k. \] Therefore, given any derived $k$-analytic stack $Y$ equipped with a morphism $X \to Y$, one can consider its restriction to the $\infty$-category\xspace $\mathrm{AnNil}_{X/}$: \[ Y \circ h \colon \mathrm{AnNil}_{X/} ^\mathrm{op} \to \mathcal S. \] We have thus a natural restriction functor \[ h_* \colon \mathrm{dAnSt}_k \to \Fun(\mathrm{AnNil}_{X/} ^\mathrm{op}, \mathcal S). \] On the other hand, \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes} allows us to define a natural functor \[ F \colon \mathrm{AnNil}_{X/} ^\mathrm{op} \to \mathrm{dAnSt}_k \] via the formula \[ (X \to Y) \in \mathrm{AnFMP}_{X/ } \mapsto \colim_{S \in \mathrm{AnNil}_{X/ /Y}^\mathrm{cl}} S, \] the colimit being computed in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. The latter agrees with the left Kan extension of the functor \[ h \colon \mathrm{AnNil}_{X/ } \to \mathrm{dAnSt}_k, \] along the natural inclusion functor $\mathrm{AnNil}_{X/ } \hookrightarrow \mathrm{AnFMP}_{X/ }$. In particular, any analytic formal moduli under $X$ when regarded as a derived $k$-analytic stack can be realized as an \emph{ind}-\emph{inf}-object, i.e. it can be written as a filtered colimit of nil-embeddings $X \to Z$. We refer the reader to \cite[\S1]{Gaitsgory_Study_II} for a precise meaning of the latter notion in the algebraic setting. \end{construction} \begin{defin} Let $f \colon X \to Y$ be a morphism in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. We shall say that $f$ has a \emph{deformation theory} if it satisfies the following conditions: \begin{enumerate} \item Both $X$ and $Y$ is \emph{nilcomplete}, c.f. \cite[Definition 7.4]{Porta_Yu_Representability}; \item $Y$ is \emph{infinitesimally cartesian} if it satisfies \cite[Definition 7.3]{Porta_Yu_Representability}; \item The morphism $f \colon X \to Y$ admits a relative \emph{analytic pro-cotangent complex}, i.e., if it satisfies \cite[Definition 7.6]{Porta_Yu_Representability} under the weaker assumption that the corresponding derivation functor is pro-corepresentable. \end{enumerate} \end{defin} \begin{prop} \label{prop:sufficient_conditions_for_a_prestack_to_be_equiv_to_an_analytic_FMP} Let $Y \in (\mathrm{dAnSt}_k)_{X/}$. Assume further that $Y$ admits a deformation theory. Then $Y$ is equivalent to an analytic formal moduli problem under $X$. \end{prop} \begin{proof} We must prove that given a pushout diagram \[ \begin{tikzcd} S \ar{r}{f} \ar{d}{g} & S' \ar{d} \\ T \ar{r} & T' \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{AnNil}_{X/}$, where $f$ has the structure of a square-zero extension, then the natural morphism \[ Y(T') \to Y(T) \times_{Y(S)} Y(S'), \] is an equivalence in the $\infty$-category\xspace $\mathcal S$. Suppose further that $S \hookrightarrow S'$ is associated to some analytic derivation \[ d \colon \mathbb L^\mathrm{an}_S \to \mathcal F[1], \] for some $\mathcal F \in \mathrm{Coh}^+(S)^{\ge 0}$. Thanks to \cref{lem:pushouts_of_square_zero_extensions_have_the_structure_of_a_square_zero_extension} we deduce that the induced morphism $T \to T'$ admits a structure of a square-zero extension, as well. Then, by our assumptions that $Y$ is infinitesimally cartesian and it admits a relative pro-cotangent complex, we obtain a chain of natural equivalences of the form \begin{align*} Y(T') & \simeq \bigsqcup_{f \colon T \to Y} \Map_{T/ }(T', Y) \\ & \simeq \bigsqcup_{f \colon T \to Y} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(T))_{\mathbb L^\mathrm{an}_T/ }}(\mathbb L^\mathrm{an}_{T/ Y}, g_*(\mathcal F)[1]) \\ & \simeq \bigsqcup_{f \colon T \to Y} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(S))_{g^* \mathbb L^\mathrm{an}_T/ }}(g^* \mathbb L^\mathrm{an}_{T/ Y}, \mathcal F[1]) \\ & \simeq \bigsqcup_{f \colon T \to Y} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(S))_{\mathbb L^\mathrm{an}_S/ }}(\mathbb L^\mathrm{an}_{S/ Y}, \mathcal F[1]) \\ & \simeq \bigsqcup_{f \colon T \to Y} \Map_{S/ }(S', Y) \\ & \simeq Y(T) \times_{Y(S)} Y(S'), \end{align*} where only the fourth equivalence requires an additional justification, namely: it follows from the existence of a commutative diagram between fiber sequences \[ \begin{tikzcd} g^* f^*\mathbb L^\mathrm{an}_Y \ar{r} \ar{d}{=} & g^* \mathbb L^\mathrm{an}_{T} \ar{r} \ar{d} & g^* \mathbb L^\mathrm{an}_{T/Y} \ar{d} \\ (f\circ g)^*\mathbb L^\mathrm{an}_Y \ar{r} & \mathbb L^\mathrm{an}_{S} \ar{r} & \mathbb L^\mathrm{an}_{S/Y}, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(S))$ combined with the fact that the derivation $d_T \colon \mathbb L^\mathrm{an}_T \to g_*(\mathcal F)[1]$ is induced from \[ d \colon \mathbb L^\mathrm{an}_S \to \mathcal F[1], \] as in the proof of \cref{lem:pushouts_of_square_zero_extensions_have_the_structure_of_a_square_zero_extension}. The result now follows. \end{proof} \begin{prop} \label{prop:stacks_under_X_with_deformation_theory_are_analytic_FMP} Let $Z \in (\mathrm{dAnSt}_k)_{X/ }$ such that the structural morphism $X \to Z$ is a nil-isomorphism and assume that $Z$ admits a deformation theory. Then the natural morphism \[ \colim_{S \in \mathrm{AnNil}_{X/ /Z}^\mathrm{cl}} S \to Z, \] in the $\infty$-category\xspace $(\mathrm{dAnSt}_k)_{/X}$, is an equivalence. \end{prop} \begin{proof} We shall prove that for every derived $k$-analytic space $T \in \mathrm{dAn}_k$, any diagram of the form \[ \begin{tikzcd} X \ar{rr}{f} \ar{rd}{g} & & Z \\ & T \ar{ru}{h} & \end{tikzcd}, \] factors through an object \[ X \to S \to Z, \] in $\mathrm{AnNil}_{X/ /Z}^\mathrm{cl}$. Consider the commutative diagram \begin{equation} \label{eq:comm_diagram_T_T_red_X_to_Z} \begin{tikzcd} X_{\mathrm{red}} \ar{r} \ar{d} & T_\mathrm{red} \ar{d} \ar{dr} & \\ X \ar{r} & T \ar{r} & Z, \end{tikzcd} \end{equation} in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Since $Z_\mathrm{red} \simeq X_\mathrm{red}$ we obtain that $T_\mathrm{red} \to Z$ factors necessarily through the colimit \[ \colim_{S \in \mathrm{AnNil}^\mathrm{cl}_{X/ /Z}} S \in \mathrm{AnPreStk}. \] Assume first that $T$ is bounded, i.e. $T \in \mathrm{dAn}_k^{< \infty}$. Then we can construct $T$ out of $T_\mathrm{red}$ via a finite sequence of square-zero extensions, as in \cref{prop:filtered_colimit_for_nil-embeddings}. Therefore, in order to construct a factorization \[ T \to S \to Z, \] in $\mathrm{AnPreStk}_{X/}$, we reduce ourselves to the case where the morphism $T_\mathrm{red} \to T$ is itself a square-zero extension. In this case, let \[ d \colon \mathbb L^\mathrm{an}_{T_\mathrm{red}} \to \mathcal F[1], \] where $\mathcal F \in \mathrm{Coh}^+(T_\mathrm{red})^{\ge 0}$ be the associated derivation. The existence of the diagram \eqref{eq:comm_diagram_T_T_red_X_to_Z} implies that we have a commutative diagram of the form \[ \begin{tikzcd} g^*\mathbb L^\mathrm{an}_{T_\mathrm{red}} \ar{r} & \mathbb L^\mathrm{an}_{X_\mathrm{red}} \ar{r} & \mathbb L^\mathrm{an}_{X_\mathrm{red}/ T_\mathrm{red}} \\ f^* \mathbb L^\mathrm{an}_{Z} \ar{r} \ar{u} & \mathbb L^\mathrm{an}_{X_\mathrm{red}} \ar{u} \ar{r}& \mathbb L^\mathrm{an}_{X_\mathrm{red}/ Z} \ar{u}, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(X))$. For this reason, the limit-colimit formula for mapping spaces in pro-$\infty$-categories\xspace implies that the natural morphism \[ \mathbb L^\mathrm{an}_{X_\mathrm{red}/ Z} \to \mathbb L^\mathrm{an}_{X_\mathrm{red}/ T_\mathrm{red}}, \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(X))$ factors necessarily via a morphism of the form \[ \mathbb L^\mathrm{an}_{X_\mathrm{red}/ S} \to \mathbb L^\mathrm{an}_{X_\mathrm{red}/ T_\mathrm{red}}, \] for some suitable $S \in \mathrm{AnNil}^\mathrm{cl}_{X/ /Z}$. Thus the existence problem \[ \begin{tikzcd} T_\mathrm{red} \ar{r} \ar{d} & T \arrow[d, dashrightarrow] \ar{rd} & \\ X_\mathrm{red} = S_\mathrm{red} \ar{r} & S \ar{r} & Z, \end{tikzcd} \] admits a solution $T \to S \to Z$, as desired. If $T \in \mathrm{dAn}_k$ is a general derived $k$-analytic space, we reduce ourselves to the bounded case using the fact that $Z$ is nilcomplete. \end{proof} \begin{cor} The functor \[ F \colon \mathrm{AnFMP}_{X/ } \to (\mathrm{dAnSt}_k)_{X/ }, \] is fully faithful. Moreover, its essential image coincides with those $Z \in (\mathrm{dAnSt}_k)_{X/ }$ which admit deformation theory. \end{cor} \begin{proof} Let $(\mathrm{dAnSt}_k)^{\mathrm{def}}_{X/ } \subseteq (\mathrm{dAnSt}_k)_{X/ }$ denote the full subcategory spanned by derived $k$-analytic stacks under $X$ admitting a deformation theory. It is clear that the natural functor \[ F \colon \mathrm{AnFMP}_{X/ } \to (\mathrm{dAnSt}_k)_{X/ }, \] factors through the full subcategory $(\mathrm{dAnSt}_k)_{X/ }^\mathrm{def}$. Moreover, the restriction functor \[ \mathrm{res} \colon (\mathrm{dAnSt}_k)_{X/ }^\mathrm{def} \to \Fun(\mathrm{AnNil}_{X/ }^\mathrm{op}, \mathcal S), \] factors through $\mathrm{AnFMP}_{X/ } \subseteq \Fun(\mathrm{AnNil}_{X/ }^\mathrm{op}, \mathcal S)$. Moreover, \cref{prop:stacks_under_X_with_deformation_theory_are_analytic_FMP} implies that the restriction functor that $F$ and $\mathrm{res}$ are mutually inverse functors, proving the claim. \end{proof} \subsection{Analytic formal moduli problems over a base} Let $X \in \mathrm{dAn}_k$ denote a derived $k$-analytic space. In \cite[Definition 6.11]{Porta_Yu_NQK} the authors introduced the $\infty$-category\xspace of \emph{analytic formal moduli problems over $X$}, which we shall review: \begin{notation} Let $X \in \mathrm{dAn}_k$. We shall denote by $\mathrm{AnNil}_{/X}$ the full subcategory of $(\mathrm{dAn}_k)_{/X}$ spanned by nil-isomorphisms \[ Z \to X, \] in the $\infty$-category\xspace $\mathrm{dAn}_k$. \end{notation} \begin{defin} \label{defin:analytic_formal_problems_over_X} We denote by $\mathrm{AnFMP}_{/ X} \subseteq \Fun(\mathrm{AnNil}_{/ X} ^\mathrm{op}, \mathcal S)$ the full subcategory spanned by those functors $Y \colon \mathrm{AnNil}_{/ X} ^\mathrm{op} \to \mathcal S$ satisfying the following: \begin{enumerate} \item $Y(X_\mathrm{red}) \simeq *$; \item The natural morphism \[ Y(S) \to \lim_{n \ge 1} Y(\mathrm t_{\le n}(S)), \] induced by the natural inclusion morphisms $\mathrm t_{\le n}(S) \to S$ for each $n \ge 0$, is an equivalence in $\mathcal S$; \item For each pushout diagram \[ \begin{tikzcd} S \ar{r}{f} \ar{d}{g} & S' \ar{d} \\ T \ar{r} & T', \end{tikzcd} \] in $\mathrm{AnNil}_{/ X}$, for which $f$ has the structure of a square-zero extension, the canonical morphism \[ Y(T') \to Y(T) \times_{Y(S)} Y(S'), \] is an equivalence in $\mathcal S$. \end{enumerate} \end{defin} \begin{defin} We shall denote by $\mathrm{AnNil}_{/X}^\mathrm{cl} \subseteq \mathrm{AnNil}_{/X}$ the faithful subcategory in wich we allow morphisms \[ i \colon S \to S' , \] where $i$ is a nil-embedding in $\mathrm{dAn}_k$. \end{defin} We start with the analogue of \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes} in the setting of analytic formal moduli problems over $X$: \begin{prop} \label{prop:required_conditions_for_formal_moduli_problems} Let $Y \in \mathrm{AnFMP}_{/X}$. The following assertions hold: \begin{enumerate} \item The inclusion functor \[ (\mathrm{AnNil}^{\mathrm{cl}}_{/X})_{/Y} \to (\mathrm{AnNil}_{/X})_{/Y}, \] is cofinal. \item The natural morphism \[ \colim_{Z \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} Z \to Y, \] is an equivalence in the $\infty$-category\xspace $\mathrm{AnFMP}_{/X}$. \item The $\infty$-category\xspace $\mathrm{AnNil}_{/X}^\mathrm{cl}$ is filtered. \end{enumerate} We shall refer to objects in $\mathrm{AnFMP}_{/ X}$ as formal moduli problems over $X$. \end{prop} \begin{proof} We first prove assertion (1). Let $S \to Z$ be a morphism in $(\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}$. Consider the pushout diagram \begin{equation} \label{eq:diagram_pushout_of_nil_isomorphisms_with_ltv_being_the_reduced_subspace} \begin{tikzcd} S_\mathrm{red} \ar{r} \ar{d} & S \ar{d} \\ Z \ar{r} & Z', \end{tikzcd} \end{equation} in the $\infty$-category\xspace $\mathrm{AnNil}_{/X}$ whose existence is guaranteed by \cref{prop:existence_of_pushouts_along_closed_nil-isomorphisms}. Since the upper horizontal morphism in \eqref{eq:diagram_pushout_of_nil_isomorphisms_with_ltv_being_the_reduced_subspace} is a nil-embedding combined with the fact that $Y$ is itself convergent, we can reduce ourselves via \cref{prop:filtered_colimit_for_nil-embeddings} to the case where the latter is an actual square-zero extension. Since $Y$ is assumed to be an analytic formal moduli problem over $X$ we then deduce that the canonical morphism \begin{align*} Y(Z') & \to Y(Z) \times_{Y(S_\mathrm{red})} Y(S) \\ &\simeq Y(Z) \times Y(S), \end{align*} is an equivalence (we implicitly used above the fact that $S_\mathrm{red} \simeq X_\mathrm{red}$). As a consequence the object $(Z' \to X)$ in $\mathrm{AnNil}_{/X}$ admits an induced morphism $Z' \to Y$ making the required diagram commute. Thanks to \cref{prop:existence_of_pushouts_along_closed_nil-isomorphisms} we deduce that both $S \to Z'$ and $Z \to Z'$ are nil-embeddings. Therefore, we can factor the diagram \[ \begin{tikzcd} S \ar{rr} \ar{rd} & & Z \ar{dl} \\ & Y & \end{tikzcd} \] via a closed nil-isomorphism $Z \to Z'$. As a consequence, we deduce readily that the inclusion functor \[(\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y} \to (\mathrm{AnNil}_{/X})_{/Y},\] is cofinal. Assertion (2) is now an immediate consequence of (1). We now prove (3). Let \[\theta \colon K \to (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y},\] be a functor where $K$ is a finite $\infty$-category\xspace. We must show that $\theta$ can be extended to a functor \[\theta^{\rhd} \colon K^{\rhd} \to (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}.\] Thanks to \cref{prop:filtered_colimit_for_nil-embeddings} we are allowed to reduce ourselves to the case where morphisms indexed by $K$ are square-zero extensions. The result now follows from the fact that $Y$ being an analytic moduli problem sends finite colimits along square-zero extensions to finite limits. \end{proof} \begin{lem} \label{formal_moduli_under_induce_formal_moduli_over_via_base_change} Let $X \in \mathrm{dAn}_k$. Given any $Y \in \mathrm{AnFMP}_{X/ }$, then for each $i= 0, 1$ the $i$-th projection morphism \[ p_i \colon X \times_Y X \to X, \] computed in the $\infty$-category\xspace $\mathrm{dAnSt}_k$ lies in the essential image of $\mathrm{AnFMP}_{/X}$ via the canonical functor $\mathrm{AnFMP}_{/ X} \to (\mathrm{dAnSt}_k)_{/ X}$. \end{lem} \begin{proof} Consider the pullback diagram \[ \begin{tikzcd} X \times_Y X \ar{r}{p_1} \ar{d}{p_0} & X \ar{d} \\ X \ar{r} & Y , \end{tikzcd} \] computed in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Thanks to \cref{prop:analytic_FMP_under_X_are_ind_inf_schemes} together with the fact that fiber products commute with filtered colimis in the $\infty$-category\xspace $\mathrm{dAnSt}_k$, we deduce that \[ X \times_Y X \simeq \colim_{Z \in \mathrm{AnNil}^\mathrm{cl}_{X//Y}} X \times_Z X, \] in $\mathrm{dAnSt}_k$. It is clear that $(p_i \colon X \times_Z X \to X)$ lies in the essential image of $ \mathrm{AnFMP}_{/X}$, for each $Z \in (\mathrm{AnNil}_{/ X} ^\mathrm{cl})_{/ Y}$ and $i = 0, 1$. Thus also the filtered colimit \[ (p_i \colon X \times_Y X \to X) \in \mathrm{AnFMP}_{/X}, \quad \mathrm{for \ } i = 0, 1, \] as desired. \end{proof} Just as in the previous section we deduce that every analytic formal moduli problem over $X$ admits the structure of an \emph{ind}-\emph{inf}-object in $\mathrm{AnPreStk}_k$: \begin{cor} \label{cor:formal_moduli_problems_over_X_are_ind_inf_objects} Let $Y \in (\mathrm{dAnSt}_k)_{/X}$. Then $Y$ is equivalent to an analytic formal moduli problem over $X$ if and only if there exists a presentation \[Y \simeq \colim_{i \in I} Z_i,\] where $I$ is a filtered $\infty$-category\xspace and for every $i \to j$ in $I$, the induced morphism \[ Z_i \to Z_j, \] is a closed embedding of derived $k$-affinoid spaces that are nil-isomorphic to $X$. \end{cor} \begin{proof} It follows immediately from \cref{prop:required_conditions_for_formal_moduli_problems} (2). \end{proof} \begin{defin} Let $Y \in \mathrm{AnFMP}_{/X}$. We define the $\infty$-category\xspace of \emph{coherent modules on $Y$}, denoted $\mathrm{Coh}^+(Y)$, as the limit \[ \mathrm{Coh}^+(Y) \coloneqq \lim_{Z \in (\mathrm{dAn}_k)_{/Y}} \mathrm{Coh}^+(Z), \] computed in the $\infty$-category\xspace $\mathrm{Cat}_{\infty}^{\mathrm{st}}$. We define the $\infty$-category\xspace of \emph{pseudo-pro-coherent modules on $Y$}, denoted $\mathrm{Pro}^{\mathrm{ps}}(\mathrm{Coh}^+(Y))$, as \[ \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y)) \coloneqq \lim_{Z \in (\mathrm{AnNil}_{/X}^\mathrm{cl})_{/Y}} \mathrm{Pro}(\mathrm{Coh}^+(Z)), \] where the limit is computed in the $\infty$-category\xspace $\mathrm{Cat}_{\infty}^{\mathrm{st}}$. \end{defin} \begin{defin} Let $Y \in \mathrm{AnFMP}_{/X}$, $Z \in \mathrm{dAfd}_k$ and let $\mathcal F \in \mathrm{Coh}^+(Z)^{\ge 0}$. Suppose furthermore that we are given a morphism $f \colon Z \to Y$. We define the \emph{tangent space of $Y$ at $f$ twisted by $\mathcal F$} as the fiber \[ \mathbb T^\mathrm{an}_{Y, Z, \mathcal F,f} \coloneqq \mathrm{fib}_f\big( Y(Z[\mathcal F]) \to Y(Z) \big) \in \mathcal S. \] Whenever the morphism $f$ is clear from the context, we shall drop the subscript $f$ above and denote the tangent space simply by $\mathbb T^\mathrm{an}_{Y, Z, \mathcal F}$. \end{defin} \begin{rem} \label{rem:construction_of_analytic_cotangent_complex_of_analytic_FMP_over_X} Let $Y \in \mathrm{AnFMP}_{/X}$. The equivalence of ind-objects \[ Y \simeq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} S, \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$, implies that, for any $Z \in \mathrm{dAfd}_k$, one has an equivalence of mapping spaces \[ \Map_{\mathrm{dAnSt}_k}(Z, Y) \simeq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} \Map_{\mathrm{AnPreStk}}(Z,S ). \] For this reason, given any morphism $f \colon Z \to Y$ and any $\mathcal F \in \mathrm{Coh}^+(Z)^{\ge 0}$, we can identify the tangent space $\mathbb T^\mathrm{an}_{Y, Z, \mathcal F}$ with the filtered colimit of spaces \begin{align} \label{eq:description_of_cotangent_complex_of_a_formal_moduli_problem_in_terms_of_its_tangent_space} \mathbb T^\mathrm{an}_{Y, Z, \mathcal F} & \simeq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{Z/ /Y}} \mathrm{fib}_f \big( S(Z[\mathcal F]) \to S(Z) \big) \\ & \simeq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{Z/ /Y}} \mathbb T^\mathrm{an}_{S, Z , \mathcal F } \\ & \simeq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{Z/ /Y}} \Map_{\mathrm{Coh}^+(Z)} (f_{S,Z}^* (\mathbb L^\mathrm{an}_S), \mathcal F), \end{align} where $f_{S, Z} \colon Z \to S$ is a transition morphism, in $(\mathrm{dAn}_k)_{/X}$, factoring $f \colon Z \to Y$ such that \[(S \to X) \in \mathrm{AnNil}^\mathrm{cl}_{/X}.\] The final equivalence in \eqref{eq:description_of_cotangent_complex_of_a_formal_moduli_problem_in_terms_of_its_tangent_space}, follows from \cite[Lemma 7.7]{Porta_Yu_Representability}. Therefore, we deduce that the analytic formal moduli problem $Y \in \mathrm{AnFMP}_{/X}$ admits an \emph{absolute pro-cotangent complex} given as \[ \mathbb L^\mathrm{an}_Y \coloneqq \{ f^*_{S,Z}( \mathbb L^\mathrm{an}_S ) \}_{Z, S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} \in \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y)). \] \end{rem} \begin{cor} Let $Y \in \mathrm{AnFMP}_{/X}$. Then its absolute cotangent complex $\mathbb L^\mathrm{an}_Y$ classifies analytic deformations on $Y$. More precisely, given any morphism $Z \to Y$ where $Z \in \mathrm{dAfd}_k$ and $\mathcal F \in \mathrm{Coh}^+(Z)^{\ge 0}$ one has a natural equivalence of mapping spaces \[ \mathbb T^\mathrm{an}_{Y, Z, \mathcal F} \simeq \Map_{\mathrm{Pro}(\mathrm{Coh}^+(Y))}(\mathbb L^\mathrm{an}_Y, \mathcal F). \] \end{cor} \begin{proof} It follows immediately from the natural equivalences displayed in \eqref{eq:description_of_cotangent_complex_of_a_formal_moduli_problem_in_terms_of_its_tangent_space} combined with the description of mapping spaces in $\infty$-categories\xspace of pro-objects. \end{proof} We now introduce the notion of square-zero extensions of analytic formal moduli problems over $X$: \begin{construction} \label{const:square_zero_extensions_of_analytic_FMP_over_X} Let $(f \colon Y \to X) \in \mathrm{AnFMP}_{/X}$. Let $d \colon \mathbb L^\mathrm{an}_Y \to \mathcal F[1]$ be an \emph{analytic derivation} in $\mathrm{Pro}(\mathrm{Coh}^+(Y))$, where $\mathcal F \in \mathrm{Coh}^+(Y)^{\ge 0}$, such that \[ \mathcal F \simeq f^*(\mathcal F'), \] for some suitable object $\mathcal F' \in \mathrm{Coh}^+(X)^{\ge 0}$. Thanks to \cref{rem:construction_of_analytic_cotangent_complex_of_analytic_FMP_over_X} one has the following sequence of natural equivalences of mapping spaces \begin{align} \label{eq:mapping_space_of_derivations} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(Y))} (\mathbb L^\mathrm{an}_Y , \mathcal F[1]) & \simeq \lim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} \colim_{S' \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{S//Y}} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(S))}(f_{S, S'}^*(\mathbb L^\mathrm{an}_{S'}), g_{S}^*(\mathcal F')[1]) \\ & \simeq \lim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} \colim_{S' \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{S//Y}} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(S))}(\mathbb L^\mathrm{an}_{S'}, (f_{S, S'})_{ *} g_S^*(\mathcal F')[1]), \end{align} where $g_{S} \colon S \to X$ denotes the structural morphism in $\mathrm{AnNil}^\mathrm{cl}_{/X}$ and $f_{S, S'} \colon S \to S'$ a given transition morphism in the $\infty$-category\xspace $(\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}$. For this reason, we can form the filtered colimit \[ Y' \coloneqq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} \colim_{S' \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{S//Y}} \widebar S' \in \mathrm{dAnSt}_k, \] where $S' \to \overline{S}'$ denotes the square-zero extension induced from $d$ together with \eqref{eq:mapping_space_of_derivations}. By construction, one has a natural morphism $Y \hookrightarrow Y'$ in the $\infty$-category\xspace $(\mathrm{dAnSt}_k)_{/ X}$. Moreover, thanks to \cref{prop:sufficient_conditions_for_a_prestack_to_be_equiv_to_an_analytic_FMP} it follows that $Y' \in \mathrm{AnFMP}_{/X}$. \end{construction} \begin{defin} Let $Y \in \mathrm{AnFMP}_{/X}$. Suppose we are given an analytic derivation \[ d \colon \mathbb L^\mathrm{an}_Y \to \mathcal F [1], \] in $\mathrm{Pro}(\mathrm{Coh}^+(Y))$ where $\mathcal F \in \mathrm{Coh}^+(Y)^{\ge 0}$ is such that $\mathcal F \simeq f^*(\mathcal F')$, for some $\mathcal F' \in \mathrm{Coh}^+(X)^{\ge 0}$. We shall say that the induced morphism \[ h \colon Y \to Y', \] defined in \cref{const:square_zero_extensions_of_analytic_FMP_over_X}, is a \emph{square-zero extension} of $Y$ associated to the analytic derivation $d$. \end{defin} \begin{cor} \label{cor:construction_of_square_zero_extensions_for_analytic_FMP_using_univ_property_of_cotangent_complex} Let $Y \in \mathrm{AnFMP}_{/X}$. Let $h \colon X \hookrightarrow S$ denote a square-zero extension in $\mathrm{dAn}_k$. Then the space of cartesian squares \[ \begin{tikzcd} Y \ar{r}{h'} \ar{d}{f} & Y' \ar{d}{g} \\ X \ar{r}{h} & S, \end{tikzcd} \] such that $h' \colon Y \to Y'$ is a square-zero extension and $g \colon Y' \to S$ exhibits the former as an analytic formal moduli problem over $S$ is naturally equivalent to the space of factorizations \[ f^* \mathbb L^\mathrm{an}_X \to \mathbb L^\mathrm{an}_Y \to f^*( \mathcal F')[1], \] in $\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y))$, of the analytic derivation $d \colon \mathbb L^\mathrm{an}_X \to \mathcal F'[1]$ associated to the morphism $h$ above. \end{cor} \begin{proof} By the universal property of filtered colimits together with the fact that these preserve fiber products we reduce the statement to the case where $Y \in \mathrm{AnNil}_{/X}$ and thus $Y' \in \mathrm{AnNil}_{/S}$, in which case the statement follows immediately by the universal property of the relative analytic cotangent complex. \end{proof} \begin{cor} \label{cor:universal_property_of_relative_cotangent_complex_for_morphisms_between_analytic_FMP} Let $f \colon Z \to X$ be a morphism in the $\infty$-category\xspace $\mathrm{dAn}_k$. Suppose we are given analytic formal moduli problems \[ f \colon Y \to X \quad \mathrm{and} \quad g \colon \widetilde Z \to Z \] together with a commutative diagram \[ \begin{tikzcd} \widetilde Z \ar{r}{s} \ar{d} & Y \ar{d} \\ Z \ar{r}{f} & X, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Let $d \colon \mathbb L^\mathrm{an}_Z \to \mathcal F[1]$, where $\mathcal F \in \mathrm{Coh}^+(Z)^{\ge 0}$, be an analytic derivation corresponding to a square-zero extension morphism $Z \to Z'$ in the $\infty$-category\xspace $\mathrm{dAn}_k$. Assume that $d$ induces a square-zero extension $\widetilde{d} \colon \mathbb L^\mathrm{an}_{\widetilde Z} \to \mathcal F[1]$ and let $h \colon \widetilde Z \hookrightarrow \widetilde Z'$ be the induced square-zero extension in $\mathrm{dAnSt}_k$ such that we have a cartesian diagram \[ \begin{tikzcd} \widetilde Z \ar{r} \ar{d} & \widetilde Z' \ar{d} \\ Z \ar{r} & Z' \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Then the space of factorizations \[ s \colon \widetilde Z \to \widetilde Z' \to Y, \] is naturally equivalent to the space of factorizations \[ \widetilde{d} \colon \mathbb L^\mathrm{an}_{\widetilde Z} \to \mathbb L^\mathrm{an}_{\widetilde Z/ Y} \to \mathcal F[1] , \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(\widetilde Z))$. \end{cor} \begin{proof} The statement holds true in the case where $\widetilde Z \in \mathrm{AnNil}_{/Z}$ and $Y \in \mathrm{AnNil}_{/X}$, by the universal property of the relative cotangent complex. The general case is reduced to the previous one by a standard argument with ind-objects in $\mathrm{dAnSt}_k$. \end{proof} \subsection{Non-archimedean nil-descent for almost perfect complexes} In this \S, we prove that the $\infty$-category\xspace $\mathrm{Coh}^+(X)$, for $X \in \mathrm{dAn}_k$ satisfies nil-descent with respect to morphims $Y \to X$, which exhibit the former as an analytic formal moduli problem over $X$. \begin{prop} \label{prop:nil_descent_for_Coh^+} Let $f \colon Y \to X$, where $X \in \mathrm{dAn}_k$ and $Y \in \mathrm{AnFMP}_{/X}$. Consider the \v{C}ech nerve $Y^\bullet \colon \mathbf \Delta ^\mathrm{op} \to \mathrm{dAnSt}_k$ associated to $f$. Then the natural functor \[ f_\bullet^* \colon \mathrm{Coh}^+(X) \to \lim_{\bm{\Delta} }(\mathrm{Coh}^+(Y^\bullet)), \] is an equivalence of $\infty$-categories\xspace. \end{prop} \begin{proof} Consider the natural equivalence of derived $k$-analytic stacks \[ Y \simeq \colim_{Z \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} Z. \] Then, by definition one has a natural equivalence \[ \mathrm{Coh}^+(Y) \simeq \lim_{Z \in (\mathrm{AnNil}^\mathrm{cl}_{/X})_{/Y}} \mathrm{Coh}^+(Z), \] of $\infty$-categories\xspace. In particular, since totalizations commute with cofiltered limits in $\mathrm{Cat}_\infty$, it follows that we can suppose from the beginning that $Y \simeq Z$ for some $Z \in \mathrm{AnNil}_{/X}$. In this case, the morphism $f \colon Y \to X$ is affine. In particular, the fact that $\mathrm{Coh}^+(-)$ satisfies descent along admissible open immersions, combined with \cref{lem:affine_morphisms_are_compatible_with_Zariski_localization_on_the_base} we further reduce ourselves to the case where both $X$ and $Y$ are derived $k$-affinoid spaces. In this case, by Tate acyclicity theorem it follows that letting $A \coloneqq \Gamma(X, \mathcal O_X ^\mathrm{alg})$ and $B \coloneqq \Gamma(Y, \mathcal O_Y^\mathrm{alg}),$ the pullback functor $f^*$ can be identified with the usual base change functor \[ \mathrm{Coh}^+(A) \to \mathrm{Coh}^+(B). \] In this case, it follows that $B$ is nil-isomophic to $A$. Moreover, since the latter are noetherian derived $k$-algebras the statement of the proposition follows due to \cite[Theorem 3.3.1]{preygel_Leistner_Mapping_stacks_properness}. \end{proof} We now deduce \emph{pseudo-pro-nil-descent} for moprhisms of the form $Y \to X$, which exhibit $Y$ as an analytic formal moduli problem over $X$: \begin{cor} \label{cor:pseudo_nil-descent_for_pro_Coh^+} Let $X \in \mathrm{dAn}_k$ and $f \colon Y \to X$ a morphism in $\mathrm{dAnSt}_k$ which exhibits $Y$ as an analytic formal moduli problem over $X$. Then the natural functor \[ f_\bullet^* \colon \mathrm{Pro}(\mathrm{Coh}^+ (X)) \to \lim_{\bm{\Delta}}(\mathrm{Pro}^\mathrm{ps}\mathrm{Coh}^+(Y^\bullet/X)), \] is fully faithful, where $Y^\bullet$ denotes the \v{C}ech nerve associated to the morphism $f$. Moreover, the essential image of the functor $f_\bullet^*$ identifies canonically with the full subcategory \[ \lim_{\bm{\Delta}}'\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(X)) \subseteq \lim_{\bm{\Delta}} \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y^\bullet/ X)), \] spanned by those $\{\mathcal F_{i, [n]} \}_{i \in I^\mathrm{op}, [n]} \in \lim_{\bm{\Delta}}(\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y^\bullet/X)))$, for some filtered $\infty$-category\xspace $I$, which belong to the essential image of the natural functor \[ \lim_{\bm{\Delta}} \Fun(I^\mathrm{op}, \mathrm{Coh}^+(Y^\bullet/X)) \to \lim_{\bm{\Delta}} \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y^\bullet/X)) . \] \end{cor} \begin{proof} By the very definition of the $\infty$-category\xspace $\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(Y))$, we reduce ourselves as in \cref{prop:nil_descent_for_Coh^+} to the case where $Y = S$, for some $S \in \mathrm{AnNil}_{/X}$. In this case, it follows readily from \cref{prop:nil_descent_for_Coh^+} that the natural functor \[ f_\bullet^* \colon \mathrm{Pro}(\mathrm{Coh}^+(X)) \to \lim_{\bm{\Delta}} \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(S^\bullet/X)), \] is fully faithful. We now proceed to prove the second claim of the corollary. Notice that, \cref{lem:f^*_admits_a_right_adjoint_whenever_f_is_nil-iso} implies that there exists a well defined right adjoint \[ f_* \colon \mathrm{Coh}^+(S) \to \mathrm{Coh}^+(X), \] to the usual pullback functor $f^* \colon \mathrm{Coh}^+(X) \to \mathrm{Coh}^+(S)$. We can extend the right adjoint $f_*$ to a well defined functor \[ f_* \colon \mathrm{Pro}(\mathrm{Coh}^+(S)) \to \mathrm{Pro}(\mathrm{Coh}^+(X)), \] which commutes with cofiltered limits. For this reason, we have a well defined functor \[ f_{\bullet, *} \colon \lim_{\bm{\Delta}}(\mathrm{Pro}(\mathrm{Coh}^+(S^\bullet/X))) \to \mathrm{Pro}(\mathrm{Coh}^+(X)), \] which further commutes with cofiltered limits. Denote by $\mathcal D \coloneqq \lim_{\bm{\Delta}}(\mathrm{Pro}(\mathrm{Coh}^+(S^\bullet/X)))$. We claim that $ f_{\bullet, *}$ is a right adjoint to $f_\bullet^*$ above. Indeed, given any $\{ \mathcal F_i \}_{i \in I^\mathrm{op}} \in \mathrm{Pro}(\mathrm{Coh}^+(X))$ and $\{ \mathcal G_{j, [n]} \}_{j \in J_{[n]} ^\mathrm{op}, [n] \in \bm{\Delta} ^\mathrm{op}} \in \lim_{\bm{\Delta}}(\mathrm{Pro}(\mathrm{Coh}^+(S^\bullet/X)))$, we compute \begin{align*} \Map_{\mathcal D}( f_\bullet^*( \{ \mathcal F_i \}_{i \in I^\mathrm{op}}), \{ \mathcal G_{j, [n]} \}_{j \in J^\mathrm{op}_{[n]}, [n] \in \bm{\Delta} ^\mathrm{op}}) & \simeq \lim_{[n] \in \bm{\Delta}} \Map_{\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(S^{[n]}))} \bigg( \{f_{[n]}^\bullet(\mathcal F_i) \}_{i \in I^\mathrm{op}}, \{ \mathcal G_{i, [n]} \}_{i \in I^\mathrm{op}_{[n]}} \bigg) \\ \lim_{[n] \in \bm{\Delta} ^\mathrm{op}} \lim_{j \in J^\mathrm{op}_{[n]}} \mathrm{colim}_{i \in I} \Map_{\mathrm{Coh}^+(S^{[n]})} ( f_{[n]}^*(\mathcal F_i), \mathcal G_{i, [n]}) & \simeq \lim_{[n] \in \bm{\Delta}} \lim_{j \in J^\mathrm{op}_{[n]}} \colim_{i \in I} \Map_{\mathrm{Coh}^+(X)} (\mathcal F_i, f_{[n], *}(\mathcal G_{i, [n]})) \\ \lim_{[n] \in \bm{\Delta} ^\mathrm{op}} \Map_{\mathrm{Pro}(\mathrm{Coh}^+(X))}( \{\mathcal F_i\}_{i \in I^\mathrm{op}}, \{f_{[n], *}(\mathcal G_{i, [n]}) \}_{i \in I_{[n]} ^\mathrm{op}}) & \simeq \Map_{\mathrm{Pro}(\mathrm{Coh}^+(X))}( \{\mathcal F_i\}_{i \in I^\mathrm{op}}, \lim_{[n] \in \bm{\Delta}} \{f_{[n], *}(\mathcal G_{i, [n]}) \}_{i \in I_{[n]} ^\mathrm{op}}), \end{align*} as desired. It is clear that the functor $f_{\bullet }^*$ above factors through the full subcategory \[ \lim_{\bm{\Delta}}'(\mathrm{Pro}^\mathrm{ps}( \mathrm{Coh}^+(S^\bullet / X))) \subseteq \lim_{\bm{\Delta}}(\mathrm{Pro}(\mathrm{Coh}^+(S^\bullet/X))). \] For this reason, the pair $(f_\bullet^*, f_{\bullet, *})$ restricts to a well defined adjunction \[ f^*_{\bullet} \colon \mathrm{Pro}(\mathrm{Coh}^+(X)) \rightleftarrows \lim_{\bm{\Delta}}'(\mathrm{Pro}(\mathrm{Coh}^+(S^\bullet/ X))) \colon f_{\bullet, *}. \] In order to conclude, we will show that the functor \[ f_{\bullet, *} \colon \lim_{\bm{\Delta}}'(\mathrm{Pro}(\mathrm{Coh}^+(S^\bullet/X))) \to \mathrm{Pro}(\mathrm{Coh}^+(X)) , \] is conservative. Since both the $\infty$-categories\xspace $\mathrm{Pro}(\mathrm{Coh}^+(X))$ and $\lim_{\bm{\Delta} }'(\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(YS\bullet/X)))$ are stable, we are reduced to prove that given any \[ \{ \mathcal G_{i, [n]} \}_{i \in I^\mathrm{op}} \in \lim_{\bm{\Delta}}'(\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(S^\bullet/X))), \] such that \begin{equation} \label{eq:conservativity_of_lim_f_bullet_*} \lim_{[n] \in \bm{\Delta} } f_{\bullet, *}( \{ \mathcal G_{i, [n]} \}_{i \in I^\mathrm{op}}) \simeq 0, \end{equation} we necessarily have \[ \{ \mathcal G_{i, [n]} \}_{i \in I^\mathrm{op}} \simeq 0 , \] in $\lim_{\bm{\Delta}}'(\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(S^\bullet / X)))$. Assume then \eqref{eq:conservativity_of_lim_f_bullet_*}. Under our hypothesis, for each index $i \in I$, the object $\{ \mathcal G_{i, [n]} \}_{ [n] \in \bm{\Delta}}$ satisfies descent datum and thanks to \cref{prop:nil_descent_for_Coh^+} it produces a uniquely well defined object \[ \mathcal G_i \in \mathrm{Pro}(\mathrm{Coh}^+(X)), \] such that for every $[n] \in \bm{\Delta}$, one has a natural equivalence of the form \begin{align*} f_{[n]}^* (\mathcal G_i) & \simeq \mathcal G_{i , [n]} \\ & \in \mathrm{Coh}^+(S^{[n]}). \end{align*} We deduce then that \begin{align*} f^*_{\bullet}(\{ \mathcal G_i \}_{i \in I^\mathrm{op}}) & \simeq \{\mathcal G_{i, [n]} \}_{i \in I^\mathrm{op}, [n]} \\ & \simeq 0, \end{align*} in $\lim'_{\bm{\Delta}} \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(S^\bullet/ X))$, as desired. \end{proof} We now use the pseudo-pro-nil-descent for $\mathrm{Pro}(\mathrm{Coh}^+(X))$ to compute relative analytic cotangent complexes of analytic formal moduli problems over $X$: \begin{cor} \label{cor:analytic_relative_cotangent_complex_defines_cartesian_sections_in_the_totalization} Let $f \colon Z \to X$ be a morphism in $\mathrm{dAn}_k$. Suppose we are given a pullback square \[ \begin{tikzcd} \widetilde Z \ar{r}{h} \ar{d} & Y \ar{d} \\ Z \ar{r} & X, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$, where $( Y \to X) \in \mathrm{AnFMP}_{/X}$ and $(g \colon\widetilde Z \to Z) \in \mathrm{AnFMP}_{/Z}$. Then the lax-object \[ \{ \mathbb L^\mathrm{an}_{\widetilde Z^{[n]} / Y^{[n]}} \} \in \underset{\mathrm{lax}, \bm{\Delta}}{\lim}(\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(\widetilde Z^\bullet/Z))), \] defines a cartesian section \[ \{ \mathbb L^\mathrm{an}_{\widetilde Z^{[n]}/ Y^{[n]}} \} \in \lim_{\bm{\Delta}}\mathrm{Pro}(\mathrm{Coh}^+((\widetilde Z)^\bullet /Z)), \] which belongs to the essential image of the natural functor \[ g^*_\bullet \colon \mathrm{Pro}(\mathrm{Coh}^+(Z)) \to \lim_{\bm{\Delta}}\mathrm{Pro}(\mathrm{Coh}^+(\widetilde Z^\bullet / Z)). \] \end{cor} \begin{proof} We first show that the object \[\{ \mathbb L^\mathrm{an}_{(\widetilde Z)^{[n]}/ Y^{[n]}} \} \in \underset{\mathrm{lax}, \bm{\Delta}}{\lim}\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+((\widetilde Z)^\bullet/ Z)),\] defines a cartesian section in \[ \lim_{\bm{\Delta}} \mathrm{Pro}(\mathrm{Coh}^+((\widetilde Z)^\bullet / Z)). \] In order to show this assertion, it is sufficient to prove for every $[n ] \in \bm{\Delta}$, that we have a natural equivalence \[ p_{i, n, n+1}^*(\mathbb L^\mathrm{an}_{\widetilde Z^{[n]} / Y^{[n]}}) \simeq \mathbb L^\mathrm{an}_{\widetilde Z^{[n+1]}/ Y^{[n+1]}}, \] in the $\infty$-category\xspace $\mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+((\widetilde Z)^{[n+1]}))$, for each projection morphism \[ p_{i, n, n+1} \colon \widetilde{Z}^{[n+1]} \to \widetilde{Z}^{[n]}, \] in the \v{C}ech nerve associated to the morphism $g$. The latter claim is an immediate consequence of the base change property for the relative analytic cotangent complex whenever $Y \in \mathrm{AnNil}_{/X}$ (and thus so do $\widetilde Z \in \mathrm{AnNil}_{/Z})$), c.f. \cite[Proposition 5.12]{Porta_Yu_Representability}. In the general case where $Y \in \mathrm{AnFMP}_{/X}$, we reduce to the previous case by combining \cref{prop:required_conditions_for_formal_moduli_problems} with the observation that filtered colimits commute with finite limits in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. We now prove the second assertion of the Corollary: thanks to the characterization of the essential image of natural functor \[ g^*_{\bullet} \colon \mathrm{Pro}(\mathrm{Coh}^+(Z)) \to \lim_{\bm{\Delta}} \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+((\widetilde Z)^\bullet /Z)), \] provided in \cref{cor:pseudo_nil-descent_for_pro_Coh^+}, we are reduced to show that for each $[n] \in \bm{\Delta}$, we have a natural equivalence of pro-objects \[ \mathbb L^\mathrm{an}_{\widetilde Z^{[n]} / Y^{[n]}} \simeq \{ \mathbb L^\mathrm{an}_{\widetilde S^{[n]}/ S^{[n]}} \}_{\widetilde S \in (\mathrm{AnNil}_{/ Z})_{/\widetilde Z}, \ S \in (\mathrm{AnNil}_{/X})_{/ Y}}, \] where $\tilde{S} \coloneqq S \times_X Z$, for each $S \in (\mathrm{AnNil}^\mathrm{cl}_{/ X})_{/ Y}$.The latter statement follows readily from the first part of the proof combined with a standard inductive argument. \end{proof} \subsection{Non-archimedean formal groupoids} Let $X \in \mathrm{dAn}_k$. We start with the definition of the notion of \emph{analytic formal groupoids over $X$}: \begin{defin}We denote by $\mathrm{AnFGrpd}(X)$ the full subcategory of the $\infty$-category\xspace of simplicial objects \[ \Fun( \bm{\Delta} ^\mathrm{op}, \mathrm{AnFMP}_{/X}), \] spanned by those objects $F \colon \mathbf \Delta ^\mathrm{op} \to \mathrm{AnFMP}_{/X}$ satisfiying the following requirements: \begin{enumerate} \item $F([0]) \simeq X$ ; \item For each $n \ge 1$, the morphism \[ F([n]) \to F([1]) \times_{F([0])} \dots \times_{F([0])} F([1]) , \] induced by the morphisms $s^i \colon [1] \to [n]$ given by $(0,1) \mapsto (i, i+1)$, is an equivalence in $\mathrm{AnFMP}_{/X}$. \end{enumerate} We shall refer to objects in $\mathrm{AnFGrpd}(X)$ as \emph{analytic formal groupoids over $X$}. \end{defin} \begin{rem} Note that \cref{prop:required_conditions_for_formal_moduli_problems} implies that fiber products exist in $\mathrm{AnFMP}_{/X}$. Therefore, the previous definition is reasonable. \end{rem} \begin{construction} \label{const:formal_completion_construction_Phi} Thanks to \cref{formal_moduli_under_induce_formal_moduli_over_via_base_change}, there exists a well defined functor $\Phi \colon \mathrm{AnFMP}_{X/} \to \mathrm{AnFGrpd}(X)$ given by the formula \[ (X \xrightarrow{f} Y ) \in \mathrm{AnFMP}_{X/ } \mapsto Y^\wedge_X \in \mathrm{AnFGrpd}(X), \] where we shall denote by $Y^\wedge_X \in \mathrm{AnFGrpd}(X)$ the \v{C}ech nerve of the morphism $f$ computed in $\mathrm{AnFMP}_{/ X}$. The latter defines a formal groupoid over $X$ admitting \[ \begin{tikzcd} \dots \ar[r, shift left=2] \ar[r, shift left=0.75] \ar[r, shift left=-0.75] \ar[r, shift left=-2] & X \times_Y X \times_Y X \ar[r, shift left=-1] \ar[r, shift left=1] \ar[r] & X \times_Y X \ar[r, shift left=-0.5ex] \ar[r, shift left=0.5ex] & X \end{tikzcd}, \] as simplicial presentation. We shall denote the later simplicial object simply by $X^{\times_Y \bullet} \in \mathrm{AnFGrpd}(X)$. \end{construction} \begin{rem} Let $(X \to Y) \in \mathrm{AnFMP}_{X/ }$ and consider the corresponding analytic formal groupoid $Y^\wedge_X \in \mathrm{AnFMP}(X)$. The diagonal morphism \[ \Delta \colon X \to X \times_Y X, \] in $\mathrm{AnFMP}_{X/ }$ induces a well defined morphism \[ X \to X^{\times_Y \bullet} , \] in $\Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{AnFMP}_{X/ })$, where $X^{\times_Y \bullet}$ denotes the \v{C}ech nerve of the morphism $X \to Y$ computed in the $\infty$-category\xspace $\mathrm{AnFMP}_{X/ }$. \end{rem} \begin{construction} \label{const:formal_classifying_stack_construction} Let $\mathcal G \in \mathrm{AnFGrpd}(X)$. Consider the \emph{classifying derived $k$-analytic stack}, $\mathrm B_X(\mathcal G)^{\mathrm{pre}} \in \mathrm{dAnSt}_k$, obtained as the geometric realization of the simplicial object $\mathcal G$, regarded naturally as a functor \[ \mathcal G \colon \bm{\Delta} ^\mathrm{op} \to \mathrm{dAnSt}_k, \] via the natural composite $\mathrm{AnFMP}_{/ X} \to (\mathrm{dAnSt}_k)_{/ X} \to \mathrm{dAnSt}_k$. Given any $Z \in \mathrm{dAfd}_k$, the \emph{space of $Z$-points of $\mathrm B_X(\mathcal G)^{\mathrm{pre}}$}, \[ \mathrm B_X(\mathcal G)^\mathrm{pre}(Z), \] can be identified with the space whose objects correspond to the datum of: \begin{enumerate} \item A morphism $\widetilde Z \to X$, where $\widetilde Z \in \mathrm{dAnSt}_k$, such that \[ \widetilde Z \simeq Z \times_{\mathrm B_X(\mathcal G)^\mathrm{pre}} X; \] \item A morphism of groupoid-objects \[\widetilde Z \times_Z \widetilde Z \to \mathcal G,\] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. \end{enumerate} We now define $\mathrm B_X(\mathcal G) \to \mathrm B^\mathrm{pre}_X(\mathcal G)$ as the sub-object spanned by those connected components of $\mathrm B_X(\mathcal G)^\mathrm{pre}$ corresponding to morphisms $\widetilde Z \to Z$ in \cref{const:formal_classifying_stack_construction} (1) which exhibit $\widetilde Z \in \mathrm{AnFMP}_{/Z}$. Denote by \[ \mathrm{can} \colon \mathrm B_X(\mathcal G) \to \mathrm B_X(\mathcal G)^\mathrm{pre}, \] the canonical morphism. It follows from the construction that the natural morphism \[ X \to \mathrm B_X(\mathcal G)^\mathrm{pre}, \] factors as $X \to \mathrm B_X(\mathcal G) \xrightarrow{\mathrm{can}} \mathrm B_X(\mathcal G)^\mathrm{pre}$. \end{construction} We are able to prove that the object $\mathrm B_X(\mathcal G)$ admits a deformation theory: \begin{lem} \label{lem:B_X(G)_is_formal} The natural morphism $X \to \mathrm B_X(\mathcal G)$ exhibits the latter as an object in the $\infty$-category\xspace $\mathrm{AnFMP}_{X/}$ of analytic formal moduli problems under $X$. \end{lem} \begin{proof} Thanks to \cref{prop:sufficient_conditions_for_a_prestack_to_be_equiv_to_an_analytic_FMP} it suffices to prove that $\mathrm B_X(\mathcal G)$ is infinitesimally cartesian and it admits furthermore a pro-cotagent complex. The fact that $\mathrm B_X(\mathcal G)$ is infinitesimally cartesian follows from the modular description of $\mathrm B_X(\mathcal G)$ combined with the fact that $\mathcal G$ is infinitesimally cartesian, as well. Similarly, $\mathrm B_X(\mathcal G)$ being nilcomplete follows again from its modular description combined with the fact that analytic formal moduli problems are nilcomplete. We are thus required to show that $\mathrm B_X(\mathcal G)$ admits a \emph{global} pro-cotangent complex. Let $Z \in \mathrm{dAn}_k$ and suppose we are given an arbitrary morphism \[ q \colon Z \to \mathrm B_X(\mathcal G), \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Thanks to \cref{cor:pseudo_nil-descent_for_pro_Coh^+} combined with \cref{cor:analytic_relative_cotangent_complex_defines_cartesian_sections_in_the_totalization} it follows that the object \[ \{ \mathbb L^\mathrm{an}_{\widetilde Z^{[n]} / \mathcal G^{[n]}} \}_{[n] \in \bm{\Delta}} \in \lim_{\bm{\Delta}} \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(\widetilde Z^\bullet / Z)), \] defines a well defined object $ (\mathbb L^{\mathrm{an}}_{Z/ \mathrm B_X(\mathcal G)})' \in \mathrm{Pro}(\mathrm{Coh}^+(Z))$. Moreover, it is clear that there exists a natural morphism \[ \theta \colon \mathbb L^\mathrm{an}_Z \to (\mathbb L^{\mathrm{an} '}_{Z / \mathrm B_X(\mathcal G)})', \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(Z))$, as this holds in each level of the totalization. Let \[ q^* (\mathbb L^{\mathrm{an}}_{\mathrm B_X(\mathcal G)})' \coloneqq \mathrm{fib}(\theta), \] computed in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(Z))$. We claim that $q^* (\mathbb L^{\mathrm{an} }_{\mathrm B_X(\mathcal G)})'$ identifies with the analytic cotangent complex of $\mathrm B_X(\mathcal G)$ at the point $q \colon Z \to \mathrm B_X(\mathcal G)$. Let \[ Z \hookrightarrow Z', \] denote a square-zero extension which corresponds to a certain analytic derivation \[ d \colon \mathbb L^\mathrm{an}_Z \to \mathcal F[1], \] for some $\mathcal F \in \mathrm{Coh}^+(Z)^{\ge 0}$. Using \cref{cor:construction_of_square_zero_extensions_for_analytic_FMP_using_univ_property_of_cotangent_complex} we deduce that the space of cartesian squares of the form \[ \begin{tikzcd} \widetilde Z \ar{r} \ar{d} & \widetilde Z' \ar{d} \\ Z \ar{r} & Z' \end{tikzcd} \] where the morphism $\widetilde Z \to \widetilde Z'$ is a square-zero extension in the $\infty$-category\xspace $\mathrm{dAnSt}_k$ is equivalent to the space of factorizations \[ d \colon g^* \mathbb L^\mathrm{an}_Z \to \mathbb L^\mathrm{an}_{\widetilde Z} \xrightarrow{{d'}} g^*(\mathcal F)[1], \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(\widetilde Z))$. Apply the same reasoning to the each object in the \v{C}ech nerve \[ \widetilde Z^\bullet \to Z. \] Furthermore, \cref{cor:universal_property_of_relative_cotangent_complex_for_morphisms_between_analytic_FMP} implies that the space of factorizations \[ \widetilde Z^\bullet \to (\widetilde Z')^\bullet \to \mathcal G^\bullet, \] identifies with the space of factorizations \[ d' \colon \mathbb L^\mathrm{an}_{\widetilde Z^\bullet} \to \mathbb L^\mathrm{an}_{\widetilde Z^\bullet/ \mathcal G} \to g^*(\mathcal F)[1], \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(\widetilde Z))$. \cref{cor:analytic_relative_cotangent_complex_defines_cartesian_sections_in_the_totalization} implies that the above factorization space can be identified with the space of factorizations \[ d \colon \mathbb L^\mathrm{an}_Z \to (\mathbb L^{\mathrm{an}}_{Z/ \mathrm B_X(\mathcal G)})' \to \mathcal F[1]. \] This implies that $(\mathbb L^{\mathrm{an}}_{Z/ \mathrm B_X(\mathcal G)})'$ satisfies the universal property of the relative analytic pro-cotangent complex associated to $X \to \mathrm B_X(\mathcal G)$, as desired. \end{proof} \begin{thm} \label{thm:Phi_is_an_equivalence} The functor $\Phi \colon \mathrm{AnFMP}_{/X} \to \mathrm{AnFGrpd}(X)$ of \cref{const:formal_completion_construction_Phi} is an equivalence of $\infty$-categories\xspace. \end{thm} \begin{proof} Let $\mathcal G \in \mathrm{AnFGrpd}(X)$. Thanks to \cref{lem:B_X(G)_is_formal}, we have a well defined functor \[ \mathrm B_X(-) \colon \mathrm{AnFGrpd}(X) \to \mathrm{AnFMP}_{X/ }, \] given on objects by the association $\mathcal G \in \mathrm{AnFGrpd}(X) \mapsto \mathrm B_X(\mathcal G) \in \mathrm{AnFMP}_{X/ }$. Thanks to (1) in \cref{const:formal_classifying_stack_construction} it follows that one has a canonical equivalence \[ X \times_{\mathrm B_X(\mathcal G)} X \simeq \mathcal G, \] in $\mathrm{dAnSt}_k$. This shows that the construction \[ \mathrm B_X(\mathcal G) \colon \mathrm{AnFGrpd}(X) \to \mathrm{AnFMP}_{X/}, \] is a right inverse to $\Phi$. As a consequence the functor $\Phi$ is essentially surjective. Thanks to \cref{prop:conservativity_of_relative_an_cot_complex} we are reduced to show that the canonical morphism \[ Y \to \mathrm B_X(X \times_Y X), \] induces an equivalence on the associated relative analytic cotangent complexes. The claim is an immediate consequence of the description of $\mathbb L^\mathrm{an}_{X/ \mathrm B_X(X \times_Y X)}$ provided in \cref{lem:B_X(G)_is_formal} together with \cref{cor:analytic_relative_cotangent_complex_defines_cartesian_sections_in_the_totalization}. \end{proof} \begin{rem} It follows from \cref{thm:Phi_is_an_equivalence} that given $(X \to Y) \in \mathrm{AnFMP}_{X/ }$, we can identify the latter with the geometric realization of the associated \v{C}ech nerve, the latter regarded as a simplicial object in $\mathrm{AnFMP}_{X/ }$ via the diagonal morphisms. \end{rem} \subsection{The affinoid case} Let $X \in \mathrm{dAfd}_k$ denote a derived $k$-affinoid space. Thanks to derived Tate aciclycity theorem, cf. \cite[Theorem 3.1]{Porta_Yu_Derived_Hom_spaces} the \emph{global sections functor} \[ \Gamma \colon \mathrm{Coh}^+(X) \to \mathrm{Coh}^+(A), \] where $A \coloneqq \Gamma(X, \mathcal O_X ^\mathrm{alg}) \in \mathrm{CAlg}_k$, is an equivalence of $\infty$-categories\xspace. Since ordinary $k$-affinoid algebras are Noetherian, we deduce that $A \in \mathrm{CAlg}_k$ is a Noetherian derived $k$-algebra. \begin{notation} Let $X \in \mathrm{dAfd}_k$ and $A \coloneqq \Gamma(X, \mathcal O_X)$. We denote by \[ \mathrm{FMP}_{/\Spec A} \in \mathrm{Cat}_\infty, \] the $\infty$-category\xspace of \emph{algebraic formal moduli problems over $\Spec A$}, (c.f. \cite[Definition 6.11]{Porta_Yu_NQK}). \end{notation} \begin{thm}$\mathrm{(}$\cite[Theorem 6.12]{Porta_Yu_NQK}$\mathrm )$ \label{thm:equivalence_between_analytic_and_algebraic_formal_moduli_problems_over} Let $X \in \mathrm{dAfd}_k$ and $A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg}) \in \mathrm{CAlg}_k$. Then the induced functor \[ (-) ^\mathrm{an} \colon \mathrm{FMP}_{/ \Spec A} \to \mathrm{AnFMP}_{/X}, \] is an equivalence of $\infty$-categories\xspace. \end{thm} As an immediate consequence, we obtain the following result: \begin{cor} \label{cor:equivalence_between_pointed_analytic_and_algebraic_formal_moduli_problems_over} Let $X \in \mathrm{dAfd}_k$ and $A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg})$. Then one has an equivalence of $\infty$-categories\xspace \[ \mathrm{FMP}_{\Spec A/ /\Spec A} \to \mathrm{AnFMP}_{X/ /X} , \] of pointed algebraic formal moduli problems over $\Spec A$ and pointed analytic formal moduli problems over $X$, respectively. \end{cor} \begin{proof} It is an immediate consequence of \cref{thm:equivalence_between_analytic_and_algebraic_formal_moduli_problems_over}. Indeed, equivalences of $\infty$-categories\xspace with final objects induce natural equivalences on the associated $\infty$-categories\xspace of pointed objects. \end{proof} \begin{lem} \label{lem:Fgroupoids_to_pointed_objects_is_conservative_and_commutes_with_sifted_colimits} Consider the natural functor \[ F \colon \mathrm{AnFGrpd}(X) \to \mathrm{AnFMP}_{X/ /X}, \] given on objects by the formula $\mathcal G \in \mathrm{AnFGrpd}(X) \mapsto \mathcal G([1]) \in \mathrm{Ptd}(\mathrm{AnFMP}_{/ X})$. Then $F$ is conservative and commutes with sifted colimits. \end{lem} \begin{proof} The proof of \cite[Corollary 5.2.2.4]{Gaitsgory_Study_II} applies in our setting to show that the functor $F \colon \mathrm{AnFGrpd}(X) \to \mathrm{Ptd}(\mathrm{AnFMP}_{/ X})$ commutes with sifted colimits. We are reduced to prove that $F$ is also conservative. Let $f \colon \mathcal G \to \mathcal G'$ be a morphism in $\mathrm{AnFGrpd}(X)$. The equivalence of $\infty$-categories\xspace \[\mathrm B_X(\bullet) \colon \mathrm{AnFGrpd}(X) \to \mathrm{AnFMP}_{X/ },\] of \cref{thm:Phi_is_an_equivalence} implies that the morphism $f$ can be obtained as the \v{C}ech nerve of a morphism \[ \widetilde{f} \colon \mathrm B_X(\mathcal G) \to \mathrm B_X(\mathcal G'), \] in $\mathrm{AnFMP}_{X/ }$. For this reason, for every $[n] \in \bm{\Delta}$, the morphism \[f_{[n]} \colon \mathcal G([n]) \to \mathcal G'([n]),\] is obtained as (an iterated) pullback of \[f_{[1]} \colon \mathcal G([1]) \to \mathcal G'([1]).\] Therefore, under the assumption that $F(F) \simeq f_{[1]}$ is an equivalence in $\mathrm{AnFMP}_{X/ /X}$ we deduce that $f$ itself must be an equivalence of analytic formal groupoids, as it is each of its components. \end{proof} \begin{rem} Let $(X \xrightarrow{f} Y) \in \mathrm{AnFMP}_{X/ }$. Consider the diagram \[ \begin{tikzcd} X \ar{r}{\Delta} \ar[rd, equal] & X \times_Y X \arrow[d, "p_0", shift left=2] \arrow{d}[swap]{p_1} \\ & X \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$, where $\Delta \colon X \to X \times_Y X$ denotes the usual \emph{diagonal embedding}. We then obtain a natural fiber sequence associated to the above diagram of the form \begin{equation} \label{eq:fiber_sequence_for_rel_cot_complexes_along_diagonal_and_projections} \Delta^* \mathbb L^\mathrm{an}_{X \times_Y X/ X} \to \mathbb L^\mathrm{an}_{X/X} \to \mathbb L^\mathrm{an}_{X/ X \times_Y X}. \end{equation} Notice further that by \cite[Proposition 5.12]{Porta_Yu_Representability} one has an equivalence \[ \mathbb L^\mathrm{an}_{X \times_Y X/ X} \simeq p_i^* \mathbb L^\mathrm{an}_{X/Y}, \] for $i =0, 1$. We further deduce that \[\Delta^* \mathbb L^\mathrm{an}_{X \times_Y X/ X} \simeq \mathbb L^\mathrm{an}_{X/Y},\] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^+(X))$. Moreover, since $\mathbb L^\mathrm{an}_{X/ X} \simeq 0$, we obtain from the fiber sequence \eqref{eq:fiber_sequence_for_rel_cot_complexes_along_diagonal_and_projections} a natural equivalence \[ \mathbb L^\mathrm{an}_{X/ X \times_Y X} \simeq \mathbb L^\mathrm{an}_{X / Y} [1], \] in $\mathrm{Pro}(\mathrm{Coh}^+(X))$. Moreover, we can identify the $\mathbb L^\mathrm{an}_{X \times_Y X / X}$ with the pro-object \[ \mathbb L^\mathrm{an}_{X/ X \times_Y X } \simeq \{ \mathbb L^\mathrm{an}_{X/ X \times_S X} \}_{S \in \mathrm{AnNil}_{X//Y}^\mathrm{cl}} , \] where $\mathbb L^\mathrm{an}_{X/ X\times_S X} \in \mathrm{Coh}^+(X)$ denotes the relative analytic cotangent complex associated to the closed embedding \[ X \to X \times_S X, \] for $S \in \mathrm{AnNil}_{X/Y}^\mathrm{cl}$. Thanks to \cite[Corollary 5.33]{Porta_Yu_Representability} we deduce that \[ \mathbb L^\mathrm{an}_{X/X\times_SX} \simeq \mathbb L_{A/ A \otimes_{B_S} A} , \] in $\mathrm{Coh}^+(A)$, where $B_S = \Gamma(S, \mathcal O^\mathrm{alg}_S)$, where we have a natural identification \[ A \widehat{\otimes}_{B_S} A \simeq A \otimes_{B_S} A, \] since the morphism $A \to B_S$ is finite. \end{rem} \begin{lem} Let $X \in \mathrm{dAfd}_k$ be a derived $k$-affinoid space. Then the derived $k$-algebra of global sections \[ A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg}), \] admits a dualizing module (see \cite[Definition 4.2.5]{DAG-XIV} for the definition of the latter notion). \end{lem} \begin{proof} This is an immediate consequence of the following facts: \begin{enumerate} \item Every regular $k$-algebra $R$ admits a dualizing module, c.f. \cite[\href{https://stacks.math.columbia.edu/tag/0AWX}{Tag 0AWX}]{stacks-project}; \item Every quotient of an algebra $R$ which admits a dualizing module admits itself a dualizing module, c.f. \cite[\href{https://stacks.math.columbia.edu/tag/0A7I}{Tag 0A7I}]{stacks-project}. \item The ordinary affinoid $k$-algebra $\pi_0(A)$ can be realized as a quotient of a Tate algebra on $n$-generators, $k \langle T_1, \dots, T_n \rangle$. The latter being regular, we deduce from the previous items that $\pi_0(A)$ itself admits a dualizing module (cf. \cite[\href{https://stacks.math.columbia.edu/tag/0AWX}{Tag 0AWX}]{stacks-project}). \item Thanks to \cite[Theorem 4.3.5]{DAG-XIV} it follows that $A$ itself admits a dualizing module. \end{enumerate} The proof is thus concluded. \end{proof} \begin{lem} Let $X \in \mathrm{dAfd}_k$ be a bounded derived $k$-affinoid space and let $\omega_A \in \mathrm{Mod}_A$ denote a dualizing module for $A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg})$. Then $\omega_A \in \mathrm{Coh}^b(A)$, where the latter denotes the full subcategory of (bounded) \emph{coherent} $A$-modules. \end{lem} \begin{proof} By definition it follows that for every $i \in \mathbb Z$, $\pi_i(\omega_A)$ is finitely generated as a discrete $\pi_0(A)$-module. We are thus reduced to show that $\omega_A$ is bounded. Thanks to \cite[Theorem 4.2.7]{DAG-XIV} it follows that \[ \omega_A \simeq \underline{\Map}_{\mathrm{Mod}_A}(A, \omega_A), \] is truncated. Moreover, by definition it follows that $\omega_A \in \mathrm{Mod}_A$ is of finite injective dimension. In particular, for every $j \ge 0$, we have that \[ \underline{\Map}_{\mathrm{Mod}_A}(\pi_j(A), \omega_A), \] is bounded. Under our assumption that $X \in \mathrm{dAfd}_k$ is bounded it follows that $A$ itself is a bounded derived $k$-algebra and therefore by a standard argument on Postnikov towers, we deduce that \[ \underline{\Map}_{\mathrm{Mod}_A}(A, \omega_A) \simeq \omega_A, \] is bounded as well. \end{proof} \begin{rem} \label{rem:dualizing_module_on_truncations} Let $X \in \mathrm{dAfd}_k$ be a derived $k$-affinoid algebra. If $X$ is not bounded then neither it is $A \in \mathrm{CAlg}_k$. For this reason, a dualizing module $\omega_A \in \mathrm{Mod}_A$ is not in general bounded. Nonetheless, the latter is always truncated. Let $m \in \mathbb Z$ be such that $\omega_A \in \mathrm{Mod}_A$ is $m$-truncated. Thanks to the proof of \cite[Theorem 4.3.5]{DAG-XIV}, we deduce that we have a natural equivalence \[ \omega_A \simeq \colim_{n \ge 0} \omega_{\tau_{\le n}(A)}, \] in the $\infty$-category\xspace $\mathrm{Mod}_A$, where for each $n \ge 0$, $\omega_{\tau_{\le n}(A)} \in \mathrm{Mod}_{\tau_{\le n}(A)}$ is a suitable $m$-truncated dualizing module for the $n$-th truncation $\tau_{\le n}(A)$. \end{rem} \begin{defin} Let $X \in \mathrm{dAfd}_k$ we define its $\infty$-category\xspace of \emph{ind-coherent sheaves} as \[ \mathrm{Ind}\mathrm{Coh}(X) \coloneqq \mathrm{Ind}(\mathrm{Coh}^b(A)). \] \end{defin} \begin{defin} Let $X \in \mathrm{dAfd}_k$ be a derived $k$-affinoid space. Whenever $X$ is bounded we shall denote $\omega_X \in \mathrm{Ind}\mathrm{Coh}(X)$ the image of a fixed dualizing module for $A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg})$ under the natural inclusion \[ \mathrm{Coh}^b(X) \subseteq \mathrm{Ind}\mathrm{Coh}(X). \] In the unbounded case, we shall define \[ \omega_X \coloneqq \colim_{n \ge 0} \omega_{\mathrm t_{\le n}(X)} \in \mathrm{Ind}\mathrm{Coh}(X), \] where the $\{ \omega_{\mathrm t_{\le n}(X)} \}_{n \ge 0}$ denotes a compatible sequence of dualizing modules for the consecutive truncations of $X$. \end{defin} \begin{notation}Let $X \in \mathrm{dAfd}_k$ be a derived $k$-affinoid space together with a dualizing module $\omega_X \in \mathrm{Ind}\mathrm{Coh}(X)$. We shall denote by \[ \mathbf D^\mathrm{Serre}_{X} \colon \mathrm{Ind}(\mathrm{Coh}^b(X)^\mathrm{op}) \to \mathrm{Ind}\mathrm{Coh}(X), \] the associated \emph{Serre duality functor}, see \cite[\S 2.4]{Antonio_Koszul}. \end{notation} \begin{rem} Let $(X \to Y) \in \mathrm{AnFMP}_{X/ }$. The pro-cotangent complex $\mathbb L_{X/ Y} ^\mathrm{an} \in \mathrm{Pro}(\mathrm{Coh}^+(X))$ can be naturally regarded as an object in the full subcategory $\mathrm{Pro}(\mathrm{Coh}^b(X))$ of pro-objects of bounded almost perfect $\mathcal O_X$-modules, c.f. \cite[Lemma 4.6]{Antonio_Koszul}. \end{rem} Notice that we have an equivalence of $\infty$-categories\xspace $\mathrm{Pro}(\mathrm{Coh}^b(X)) ^\mathrm{op} \simeq \mathrm{Ind}(\mathrm{Coh}^b(X) ^\mathrm{op})$. We now introduce the central notion of the \emph{Serre tangent complex}: \begin{defin}[Serre Tangent complex] Let $Y \in \mathrm{AnFMP}_{X/}$. We define the \emph{relative analytic Serre tangent complex} of $X \to Y$ as the object \begin{align*} \mathbb T^\mathrm{an}_{X/ Y} & \coloneqq \mathbf D^\mathrm{Serre}_{X}(\mathbb L^\mathrm{an}_{X/Y}) \\ & \simeq \colim_{S \in \mathrm{AnNil}^\mathrm{cl}_{X/ /Y}} \mathbf D^\mathrm{Serre}_X(\mathbb L^\mathrm{an}_{X/S}), \end{align*} in $\mathrm{Ind}\mathrm{Coh}(X)$. \end{defin} \begin{rem} The previous definition depends on the choice of a dualizing module for $X$. Nonetheless, given two different choices, these differ only by an invertible $A$-module, c.f. \cite[Proposition 2.4]{Antonio_Koszul}. \end{rem} The following result will play a major role in the study of the deformation to the normal bundle: \begin{prop} \label{prop:conservativity_and_preservation_of_sifted_colimits_of_tangent_complex} The functor $\mathbb T^\mathrm{an}_{X/ \bullet} \colon \mathrm{AnFMP}_{X/} \to \mathrm{QCoh}(X)$ given on objects by the formula \[ (X \to Y) \in \mathrm{AnFMP}_{X/} \mapsto \mathbb T^\mathrm{an}_{X/Y} \in \mathrm{Ind}\mathrm{Coh}(X), \] is conservative and commutes with sifted colimits. \end{prop} \begin{proof} Observe that \cref{lem:Fgroupoids_to_pointed_objects_is_conservative_and_commutes_with_sifted_colimits} combined with \eqref{eq:fiber_sequence_for_rel_cot_complexes_along_diagonal_and_projections} imply that it suffices to prove that the right vertical functor in the diagram \begin{equation} \label{eq:comm_pointed_formal_moduli_problems_Tangent_and_analytification} \begin{tikzcd} \mathrm{FMP}_{\Spec A/ / \Spec A} \ar{r}{(-)^\mathrm{an}_X}\ar{d}{\mathbb T_{\Spec A/ \bullet}} & \mathrm{AnFMP}_{X/ / X} \ar{d}{\mathbb T^\mathrm{an}_{X/ \bullet}} \\ \mathrm{Ind}\mathrm{Coh}(A) \ar{r}{(-)^\mathrm{an}} & \mathrm{Ind}\mathrm{Coh}(X), \end{tikzcd} \end{equation} commutes with sifted colimits and is further conservative. The diagram is commutative as a consequence of \cite[Lemma 6.9 (2)]{Porta_Yu_NQK} combined with the definition of Serre duality in $\mathrm{Ind}\mathrm{Coh}(X)$. Moreover, \cite[Corollary 4.31]{Antonio_Koszul} implies that \[ \mathbb T_{\Spec A/ \bullet} \colon \mathrm{FMP}_{\Spec A/ / \Spec A} \to \mathrm{Ind}\mathrm{Coh}(A), \] is both conservative and commutes with sifted colimits. Furthermore, the bottom horizontal functor in \eqref{eq:comm_pointed_formal_moduli_problems_Tangent_and_analytification} is an equivalence of $\infty$-categories\xspace, see for instance \cite[Theorem 4.5]{Porta_Yu_NQK}. Thanks to \cref{cor:equivalence_between_pointed_analytic_and_algebraic_formal_moduli_problems_over}, we further deduce that the upper horizontal functor in \eqref{eq:comm_pointed_formal_moduli_problems_Tangent_and_analytification} is an equivalence, and the result follows. \end{proof} \section{Non-archimedean Deformation to the normal bundle} In this \S, we introduce the construction of the deformation to the normal cone in the setting of derived $k$-analytic geometry. This construction has already been performed in the literature in the particular case of the natural inclusion morphism \[ i \colon \mathrm{t}_0(X) \to X, \quad X \in \mathrm{dAn}_k, \] c.f \cite{Porta_Yu_NQK}. On the other hand, the algebraic situation is largely understood mainly due to \cite{Gaitsgory_Study_II}. \subsection{General construction in the algebraic case} We start by recalling the definition of the simplicial object \[ \mathrm{B}^\bullet_{\mathrm{scaled}} \in \Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{dSt}_k), \] introduced in \cite[\S 9.2.2]{Gaitsgory_Study_II}. Namely, for each $[n] \in \bm{\Delta}$, the object $\mathrm{B}^{n}_\mathrm{scaled}$ is obtained by gluing $n+1$ copies of $\mathbb A^1_k$ together along $0 \in \mathbb A^1_k$. Moreover, the transition morphisms \[ p_{i, n} \colon \mathrm{B}^{n+1}_\mathrm{scaled} \to \mathrm{B}^n_{\mathrm{scaled}}, \quad \mathrm{for} \ i \in \{0, \dots, n\} , \] collapse two given different irreducible components of $\mathrm B^{n+1}_\mathrm{scaled}$ into $\mathrm B^n_{\mathrm{scaled}}$. More explicitly, for $n=0$, we have \[ \mathrm B_\mathrm{scaled}^0 = \mathbb A^1_k, \] and, for $n = 1$, $\mathrm B_\mathrm{scaled}^1 = \Spec k[x, y]/ (x^2 - y^2)$. \begin{construction} \label{construction:def_to_the_normal_bundle} Let $f \colon X \to Y$ denote a morphism between locally geometric derived $k$-stacks in $\mathrm{dSt}^\mathrm{laft}_k$. Consider the formal completion of $Y$ on $X$ along the morphism $f$ \[ Y^\wedge_X \in \mathrm{dSt}_k \] In \cite[\S 9.3]{Gaitsgory_Study_II}, the authors introduced the \emph{parametrized deformation to the normal bundle associated to $f \colon X \to Y$}, as the pullback \begin{equation} \label{eq:parametrized_deformation} \begin{tikzcd} \mathcal D^\bullet_{X/Y} \ar{r} \ar{d} & Y^\wedge_X \times \mathbb A^1_k \ar{d} \\ \Map_{/ \mathbb A^1_k}(\mathrm{B}^\bullet_{\mathrm{scaled}}, X \times \mathbb A^1_k) \ar{r} & \Map_{/ \mathbb A^1_k}(\mathrm{B}^\bullet_{\mathrm{scaled}}, Y^\wedge_X \times \mathbb A^1_k), \end{tikzcd} \end{equation} where both $X \times \mathbb A^1_k$ and $Y^\wedge_X \times \mathbb A^1_k$ are considered as constant simplicial objects in the $\infty$-category\xspace $\mathrm{dSt}_k$. As a consequence of \cite[Theorem 9.2.3.4]{Gaitsgory_Study_II}, it follows that each component of the simplicial object $\mathcal D_{X/Y}^\bullet$ admits a deformation theory relative to $X$. In particular, the object $\mathcal D^\bullet_{X/ Y}$ defines a formal groupoid over the stack $X \times \mathbb A^1_k$. Moreover, Theorem 5.2.3.4 in loc. cit. allows us to associate to $\mathcal D^\bullet_{X/Y}$ a formal moduli problem under $X \times \mathbb A^1_k$ \[ \mathcal D_{X/Y} \in \mathrm{FMP}_{X \times \mathbb A^1_k/ / Y^\wedge_X \times \mathbb A^1_k}, \] obtained via the construction provided in \S 5.2.4 in loc. cit. More explicitly, the object $\mathcal D_{X/ Y} \in \mathrm{FMP}_{X \times \mathbb A^1_k/ }$ is computed as the sifted colimit of the simplicial diagram \[ \mathcal D_{X/ Y}^\bullet \in \Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{FMP}_{X \times \mathbb A^1_k/ }) , \] the colimit being computed in $\mathrm{FMP}_{X \times \mathbb A^1_k/ }$. We can furthermore consider $\mathcal D_{X/Y}$ naturally as an object in $(\mathrm{dSt}^\mathrm{laft}_k)_{X \times \mathbb A^1_k/ / Y^\wedge_X \times \mathbb A^1_k}$. \end{construction} \begin{construction} Let $f \colon X \to Y$ a morphism of locally geometric derived $k$-stacks in $\mathrm{dSt}_k^\mathrm{laft}$. In \cite[\S 9.2.5]{Gaitsgory_Study_II} the authors constructed an explicit left-lax action of the monoid-scheme object $\mathbb A^1_k$ (with respect to \emph{multiplication}) on the deformation to the normal bundle $\mathcal D_{X/ Y}$. The above action implies that the structure sheaf of $\mathcal D_{X/ Y}$ is equipped with a (negatively indexed) filtration. \end{construction} \begin{notation} We shall denote by $p \colon \mathcal D_{X/ Y} \to \mathbb A^1_k$ the natural composite morphism \[ \mathcal D_{X/ Y} \to Y^\wedge_X \times \mathbb A^1_k \to \mathbb A^1_k, \] in the $\infty$-category\xspace $\mathrm{dSt}_k^\mathrm{laft}$. \end{notation} We shall now describe formal geometric properties of the deformation to the normal bundle $\mathcal D_{X/Y} \in (\mathrm{dSt}^\mathrm{laft}_k)_{X \times \mathbb A^1_k/ /Y^\wedge_X \times \mathbb A^1_k}$: \begin{prop} \label{prop:algebraic_properties_of_deformation} Let $f \colon X \to Y$ denote a morphism of locally geometric derived $k$-stacks in the $\infty$-category\xspace $\mathrm{dSt}_k^\mathrm{laft}$. The following assertions hold: \begin{enumerate} \item The fiber of the morphism $p \colon \mathcal D_{X/Y} \to \mathbb A^1_k$ at the fiber $\{0 \} \subseteq \mathbb A^1_k$ identifies naturally with the formal completion \[\mathrm T_{X/Y}[1]^\wedge \in \mathrm{FMP}_{X/ },\] of the shifted tangent bundle $\mathrm T_{X/Y}[1] \to X$ along the zero section \[ s_0 \colon X \to \mathrm T_{X/Y}[1]. \] \item For $\lambda \in \mathbb A^1_k$ with $\lambda \neq 0$, the fiber $(\mathcal D_{X/Y})_{\lambda}$ canonically identifies with the formal completion \[ Y^\wedge_X \in \mathrm{dSt}^\mathrm{laft}_k, \] of $X$ in $Y$ along the morphism $f$. \item (Hodge Filtration) There exists a natural sequence of morphisms \[ X \times \mathbb A^1_k = X^{(0)} \to X^{(1)} \to \dots \to X^{(n)} \to \dots \to Y, \] admitting a deformation theory, in $(\mathrm{dSt}_k^\mathrm{laft})_{X\times\mathbb A^1_k/ /Y\times\mathbb A^1_k}$. For each $n \ge 0$, the relative tangent complex \[ \mathbb T_{X^{(n)} / Y } \in \mathrm{Ind}\mathrm{Coh}(X^{(n)}), \] has first non-zero associated graded piece in degree $n$ and the latter identifies naturally with \[ i_{n, *}^{\mathrm{Ind}\mathrm{Coh}} ( \Sym^{n+1} (\mathbb T_{X/ Y} [1])[-1])) \in \mathrm{Ind}\mathrm{Coh}(X^{(n)}). \] Dually, the pro-relative cotangent complex $\mathbb L_{X/ Y} \in \mathrm{Pro}(\mathrm{Coh}(X^{(n)}))$ is equipped with a decreasing filtration, starting in degree $n$, and the corresponding associated $n$-th graded piece identifies naturally with \[ i_{n, *}(\Sym^{n+1}(\mathbb L_{X/ Y}[-1])[1]) \in \mathrm{Pro}(\mathrm{Coh}^b(X^{(n)})). \] \item Assume that $f \colon X \to Y$ is a closed immersion of derived schemes locally almost of finite presentation then, for each $n \ge 0$, the morphism \[ X^{(n)} \to X^{(n+1)}, \] has the structure of a square-zero extension associated to a canonical morphism \[d \colon \mathbb L_{X^{(n)}} \to \mathbb L_{X^{(n)}/ Y} \to i_{n, *} (\Sym^{n+1}(\mathbb L_{X/ Y}[-1])[1]),\] in the $\infty$-category\xspace $\mathrm{Coh}^+(X^{(n)})$, where \[ i_n \colon X \times \mathbb A^1_k \to X^{(n)} \] denotes the structural morphism. In particular, if $X$ is a derived scheme almost of finite presentation, then so are the $X^{(n)}$, for each $n \ge 0$. \item There exists a natural morphism \[\colim_{n} X^{(n)} \to \mathcal D_{X/Y},\] in the $\infty$-category\xspace $\mathrm{FMP}_{X \times \mathbb A^1_k/ /Y^\wedge_X \times\mathbb A^1_k}$. Moreover, the latter is an equivalence of derived $k$-stacks almost of finite presentation. \end{enumerate} \end{prop} \begin{proof} Assertion (1) follows formally from \cite[\S 9, Proposition 2.3.6]{Gaitsgory_Study_II}. Assertion (2) follows from the observation that the fiber of the simplicial object $\mathcal D_{X/ Y}^\bullet$ at $\lambda \neq 0$ can be identified with the \v{C}ech nerve of the (completion) of the morphism $f$ \[ X^{\times_{Y^\wedge_X} \bullet} \in \Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{dSt}_k^\mathrm{laft}). \] Therefore, its colimit taken in $\mathrm{FMP}_{X \times \mathbb A^1_k/}$ agrees with the formal completion $Y^\wedge_X \in \mathrm{FMP}_{X \times \mathbb A^1_k/ }$. The first part of assertion (3) follows formally from \cite[\S 9, Theorem 5.1.3]{Gaitsgory_Study_II}. For each $n \ge 0$, denote by \[i_n \colon X \times \mathbb A^1_k \to X^{(n)},\] the structural morphism. The latter is a proper morphism due to \cite[\href{https://stacks.math.columbia.edu/tag/0CYK}{Tag 0CYK}]{stacks-project}. The statement concerning the relative cotangent complex follows formally from \cite[\S 9, Theorem 5.1.3]{Gaitsgory_Study_II} by applying the Serre duality functor and combining \cite[Corollary 9.5.9 (b)]{Gaitsgory_IndCoh} with \cite[Proposition 3.1.3]{Gaitsgory_IndCoh} and \cite[Corollary 1.4.4.2]{Gaitsgory_Study_II} to produce a natural identification \[ \mathbf D^\mathrm{Serre}_X \big((i_{n, *}^{\mathrm{Ind}\mathrm{Coh}}(\Sym(\mathbb T_{X/ Y}[1])[-1]) \big) \simeq i_{n, *} \big(\Sym(\mathbb L_{X/ Y}[-1])[1] \big), \] in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^b(X))$. Assertion (5) is an immediate consequence of \cite[\S 9, Proposition 5.2.2]{Gaitsgory_Study_II}. We shall now deduce claim (4) of the Proposition: it follows from Theorem 9.5.1.3, in loc. cit., that the (Serre) tangent complex \[ \mathbb T_{X^{(n)}/ Y } \in \mathrm{Ind}\mathrm{Coh}(X^{(n)}), \] admits a natural (increasing) filtration whose $n$-th piece identifies with \[i_{n, *}^\mathrm{IndCoh}(\Sym^{n+1}(\mathbb T_{X/Y}[1]))[-1] \in \mathrm{Ind}\mathrm{Coh}(X^{(n)}).\] For this reason, we have a structural morphism \[ i_{n, *}^\mathrm{IndCoh}(\Sym^{n+1}(\mathbb T_{X/Y}[1]))[-1] \to \mathbb T_{X^{(n)}/ Y}, \] in the $\infty$-category\xspace $\mathrm{Ind}\mathrm{Coh}(X^{(n)})$. Consider then the natural composite \[ i_{n, *}^\mathrm{IndCoh}( \Sym^{n+1}(\mathbb T_{X/ Y}[1])[-1])) \to \mathbb T_{X^{(n)}/ Y} \to \mathbb T_{X^{(n)}}, \] in the $\infty$-category\xspace $\mathrm{Ind}\mathrm{Coh}(X)$. Using the equivalence of $\infty$-categories\xspace between Lie algebroids in $\mathrm{Ind}\mathrm{Coh}(X)$ and the $\infty$-category\xspace $\mathrm{FMP}_{X/ }$, c.f. \cite[\S 8.5]{Gaitsgory_Study_II}, one produces then a canonical morphism \[ X^{(n)} \to X^{(n+1)}, \] in the $\infty$-category\xspace $\mathrm{FMP}_{X \times \mathbb A^1_k/ }$. In the case where $f \colon X \to Y$ is a closed immersion of derived schemes locally almost of finite presentation the latter construction can be adapted in terms of the (usual) cotangent complex formalism: thanks to \cite[Corollary 8.4.3.2]{Lurie_Higher_algebra}, the relative cotangent complex \[ \mathbb L_{X/ Y} \in \mathrm{Coh}^+(X), \] is $1$-connective. In particular, the shift $\mathbb L_{X/ Y}[-1]$ is $0$-connective. By applying the usual Serre duality functor (c.f. \cite[\S 9]{Gaitsgory_IndCoh}) we obtain a well defined fiber sequence \begin{equation} \label{eq:fiber_seq_cotangent_complex_for_Hodge_filtration2} \mathbb L_{X^{(n)}} \to \mathbb L_{X^{(n)}/ Y} \to i_{n,*}\big( \Sym^{n+1}(\mathbb L_{X/ Y}[1])[-1]) \big) , \end{equation} in the $\infty$-category\xspace $\mathrm{Pro}(\mathrm{Coh}^b(X))$. Moreover, under our assumptions, it follows that \eqref{eq:fiber_seq_cotangent_complex_for_Hodge_filtration} lies in the full subcategory \[\mathrm{Coh}^+(X) \subseteq \mathrm{Pro}(\mathrm{Coh}^b(X)),\] via the equivalence of $\infty$-categories\xspace provided in \cite[Corollary 1.4.4.2]{Gaitsgory_Study_II}. Since the right hand side of \eqref{eq:fiber_seq_cotangent_complex_for_Hodge_filtration2} is $1$-connective, it follows from \cite[\S 8, 5.5]{Gaitsgory_Study_II} that the extension \[ X^{(n)} \to X^{(n+1)}, \quad \mathrm{for} \ n \ge 0, \] can be identified with the (usual) square-zero extension of $X^{(n)}$ by means of the derivation \eqref{eq:fiber_seq_cotangent_complex_for_Hodge_filtration2}. This proves the second part of claim (3) and the proof of the proposition is thus concluded. \end{proof} \begin{rem} \label{rem:simplification_of_deformation_in_the_closed_immersion} Assume that $f \colon X \to Y$ is a closed immersion of derived schemes locally almost of finite presentation. Then \cref{construction:def_to_the_normal_bundle} can be simplified by taking directly $Y$ instead of the formal completion $Y^\wedge_X$ in the defining pullback square for \eqref{eq:parametrized_deformation}. Indeed, we claim that the simplicial object obtained as the fiber product \[ \begin{tikzcd} (\mathcal D_{X/ Y}^\bullet) ' \ar{r} \ar{d} & Y \times \mathbb A^1_k \ar{d}\\ \Map_{/ \mathbb A^1_k}(\mathrm B^\bullet_\mathrm{scaled}, X\times \mathbb A^1_k) \ar{r} & \Map_{/ \mathbb A^1_k} (\mathrm B^\bullet_\mathrm{scaled}, Y \times \mathbb A^1_k), \end{tikzcd} \] in $\Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{dSt}_k^\mathrm{laft})$, agrees with $\mathcal D^\bullet_{X/ Y}$. Observe that we have a natural identification \[ (\mathcal D_{X/ Y}^\bullet)' \times_{\mathbb A^1_k} \mathbb G_m \simeq X^{\times_Y \bullet} , \] and the latter agrees with the formal groupoid associated with $(X \to Y^\wedge_X) \in \mathrm{FMP}_{X \times \mathbb A^1_k}$. Moreover, we have a natural identification \[ \mathcal D_{X/ Y}' \times_{\mathbb A^1_k} \{0 \} \simeq \mathrm T^\bullet_{X/ Y}, \] where $\mathrm T^\bullet_{X/ Y}$ denotes the groupoid object associated to the usual shifted relative tangent bundle $\mathrm T_{X/ Y}[1]$. Under our assumption that $f \colon X \to Y$ is a closed immersion it follows from \cite[Corollary 8.4.3.2]{Lurie_Higher_algebra} that the relative cotangent complex \[ \mathbb L_{X/ Y} \in \mathrm{Coh}^+(X), \] is $1$-connective. As a consequence, we deduce that the natural morphism $X \to \mathrm T^\bullet_{X/Y}$ is a termwise nil-isomorphism. As a consequence, we conclude immediately that $\mathrm T^\bullet_{X/ Y}$ agrees with the formal groupoid, over $X$, associated to the formal moduli problem \[ (X \to \mathbb T_{X/ Y}[1]^\wedge) \in \mathrm{FMP}_{X/ }. \] \end{rem} \begin{rem} Consider the sequence of deformations in \cref{prop:algebraic_properties_of_deformation}, $\{ X^{(n)} \}_{n \ge 0}$. The latter defines a filtration on the global sections of the formal completion $Y^\wedge_X$, which we shall refer to as the \emph{Hodge filtration associated to the morphism $f$}. Therefore, \cref{prop:algebraic_properties_of_deformation} can be interpreted as a spreading out result of the Hodge filtration from de Rham cohomology to the global sections of the formal completion. \end{rem} \begin{rem} The left-lax action of the multiplicative monoid $\mathbb A^1_k$ can be made explicit at the fiber of the morphism $p \colon \mathcal D_{X/ Y} \to \mathbb A^1_k$ at $\{ 0\} \subseteq \mathbb A^1_k$. Indeed, under the natural identification \[ (\mathcal D_{X/ Y})_0 \simeq \mathrm T_{X/ Y}^\wedge[1] , \] we obtain that the filtration on $\mathcal D_{X/ Y}$ induces the natural filtration on $\mathrm T_{X/ Y}^\wedge[1]$ which is obtained by considering \[ \mathbb T_{X/ Y} \in \mathrm{Ind}\mathrm{Coh}(X)^{\mathrm{gr}, =1} \subseteq \mathrm{Ind}\mathrm{Coh}(X)^{\mathrm{gr}, \ge 0}, \] using notations as in \cite[\S 9.2.5.2]{Gaitsgory_Study_II}. Moreover, the construction of the Hodge filtration in \cref{prop:algebraic_properties_of_deformation} (3) is naturally $\mathbb A^1_k$ left-lax equivariant and the equivalence in \cref{prop:algebraic_properties_of_deformation} (4) is $\mathbb A^1_k$ left-lax equivariant, as well. \end{rem} Our goal now is to identify the Hodge filtration on $Y^\wedge_X$, in the case where $f \colon X \to Y$ is a closed immersion: \begin{prop} \label{lem:identification_of_Hodge_and_adic_filtrations} Let $f \colon X \to Y$ be a morphism of affine derived schemes. Denote by $A = \Gamma(X, \mathcal O_X)$ and $B = \Gamma(Y, \mathcal O_Y)$, the corresponding derived global sections and let $I \coloneqq \mathrm{fib}(B \to A)$ denote the fiber of the induced morphism of derived $k$-algebras $B \to A$. The following assertions hold: \begin{enumerate} \item If $f \colon X \to Y$ be a locally of complete intersection closed morphism in the $\infty$-category\xspace $(\mathrm{dAff}_k)^\mathrm{laft}$, then the Hodge filtration on the formal completion $Y^\wedge_X$ constructed in \cref{prop:algebraic_properties_of_deformation} identifies with the usual $I$-adic filtration on $B^\wedge_I$, by taking derived global sections. \item Assume that $f \colon X \to Y$ is a closed immersion. Then the Hodge filtration, $\{ \mathrm{Fil}^n_H \}$, on the derived global sections \[\Gamma(Y^\wedge_X,\mathcal O_{Y^\wedge_X}) \simeq B^\wedge_I,\] produces, for each $n \ge 1$, natural equivalences \[ B/ \mathrm{Fil}_H^n \simeq \mathrm{dR}_{A/ B}/ \mathrm{Fil}_H^n, \] of derived $k$-algebras. In particular, we obtain a natural equivalence of derived $k$-algebras \[ B^\wedge_I \simeq \lim_{n \ge 1} \mathrm{dR}_{A/ B} / \mathrm{Fil}_H^n. \] \end{enumerate} \end{prop} \begin{proof} We first prove claim (2) of the Proposition. Since $f \colon X \to Y$ is a closed immersion between affines we deduce that the relative cotangent complex $\mathbb L_{X/ Y} \in \mathrm{Coh}^+(X)$ is $1$-connective. For this reason, the sequence morphisms \[ X \times \mathbb A^1_k = X^{(0)} \hookrightarrow X^{(1)} \hookrightarrow \dots \hookrightarrow X^{(n)} \hookrightarrow \dots, \] of \cref{prop:algebraic_properties_of_deformation} (4) correspond to successive square-zero extensions. Moreover, it follows from \cite[Corollary 9.5.2.5]{Gaitsgory_Study_II} that, after applying the Serre duality functor on $\mathrm{Ind}\mathrm{Coh}$, one has an equivalence \[ \mathcal O_{Y^\wedge_X} \simeq \lim_{n \ge 0} \mathcal O_{(X^{(n)})_\lambda}, \] in $\mathrm{CAlg}_k$, for any for $\lambda \neq 0$. Henceforth, at the level of derived global sections, one obtains a natural identification \[ B^\wedge_I \simeq \lim_{n \ge 0} \Gamma((X^{(n)})_\lambda, (\mathcal O_{X^{(n)}})_\lambda), \] in the $\infty$-category\xspace $\mathrm{CAlg}_k$. Similarly, thanks to the proof of \cite[\S 9, Theorem 5.1.3]{Gaitsgory_Study_II} in the case of vector groups (c.f. \cite[\S 9.5.5]{Gaitsgory_Study_II}) we deduce a natural equivalence \[ \mathrm{dR}_{A/ B} \simeq \lim_{n \ge 0}\Gamma((X^{(n)})_0, \mathcal O_{(X^{(n)})_0}), \] in $\mathrm{CAlg}_k$. By the naturality of the construction of \cite[\S 9.5.1]{Gaitsgory_Study_II} combined with the argument provided in \cite[\S 9.5.5]{Gaitsgory_Study_II} to the reduction to the case of vector groups, we deduce that \[ p \colon X^{(n)} \to \mathbb A^1_k, \] has constant fibers. Indeed, for $n = 0$, the natural morphism \[ X^{(0)} \to X^{(1)}, \] corresponds, by construction, to the natural square-zero extension \[ \mathbb L_A \to \mathbb L_{A/ B} , \] classifying the extension \[ \mathbb L_{A/ B}[-1] \to \Sym^{\le 1}(\mathbb L_{A/ B}[-1]) \to A, \] of $A$-modules. Assuming the result for $n \ge 0$, we have that \[ \mathbb L_{A^{(n)}/ B} \in \mathrm{Coh}^+(A^{(n)}), \] where $A^{(n)} \coloneqq \Gamma(X^{(n)}, \mathcal O_{X^{(n)}})$, identifies with the relative cotangent complex of the natural morphism \[ B \to \Sym^{\le n}(\mathbb L_{A/ B}[-1]), \] produced by induction and the naturality of the construction. Moreover, thanks to \cite[\S 9.5.5]{Gaitsgory_Study_II} the relative cotangent complex \[ \mathbb L_{\Sym^{\le n}(\mathbb L_{A/ B}[-1])/ B} \in \mathrm{Coh}^+(\Sym^{\le n}(\mathbb L_{A/ B}[-1])), \] is equipped with a decreasing filtration, starting in degree $n$, whose $n$-th piece identifies with \[ \Sym^{n+1}(\mathbb L_{A/ B}[-1])[1] \in \mathrm{Coh}^+(\Sym^{\le n}(\mathbb L_{A/ B}[-1])). \] For this reason, the derivation \[ \mathbb L_{A^{(n)}} \to \mathbb L_{A^{(n)}/ B} \to \Sym^{n+1}(\mathbb L_{A/ B}[-1])[1] , \] identifies with the natural derivation \[ \mathbb L_{\Sym^{\le n}(\mathbb L_{A/ B}[-1])[1])/ B} \to \Sym^{n+1}(\mathbb L_{A/ B} [1]) , \] classifying the extension \[ \Sym^{n+1}(\mathbb L_{A/ B}[-1]) \to \Sym^{\le n+1}(\mathbb L_{A/ B}[-1]) \to \Sym^{\le n}(\mathbb L_{A/ B}[-1]). \] The claim now follows by induction on $n \ge 0$. As a consequence of the previous considerations we deduce that \[ \Gamma((X^{(n)})_\lambda, (\mathcal O_{X^{(n)}})_\lambda) \simeq \Gamma((X^{(n)})_0, (\mathcal O_{X^{(n)}})_0), \] for every $\lambda \in \mathbb A^1_k$, and therefore we have natural equivalences \[ B^\wedge_I \simeq \mathrm{dR}_{A/ B} \quad \mathrm{and} \quad B/ \mathrm{Fil}_H^n \simeq \mathrm{dR}_{A/ B}/ \mathrm{Fil}^n_H, \] in $\mathrm{CAlg}_k$, as desired. We now prove statement (1) of the Proposition. Assume first that $A$ and $B$ are ordinary $k$-algebras and the (classical) ideal $I \subseteq B$ is generated by a regular sequence. In this case, we have an identification \[ \mathbb L_{A/ B} \simeq I/ I^2 [1], \] see for instance \cite[\href{https://stacks.math.columbia.edu/tag/08SJ}{Tag 08SJ}]{stacks-project}. In particular, the $n$-th graded piece of the Hodge filtration in \cref{prop:algebraic_properties_of_deformation} (3) can be identified with \[ \Sym^n(\mathbb L_{A/ B}[-1]) \simeq I^n/ I^{n+1}, \] where the latter equivalence follows again by the fact that $I$ is generated by a regular sequence in $\pi_0(B)$. In particular, we deduce, by induction on $n \ge 1$, a natural identification between the fiber sequence \[ \Sym^{n+1}(\mathbb L_{A/ B}[-1]) \to \Sym^{\le n+1}(\mathbb L_{A/ B}[-1]) \to \Sym^{\le n}(\mathbb L_{A/ B}[-1]), \] and the the $I$-adic one \[ I^n/ I^{n+1} \to B/ I^{n+1} \to B/ I^n, \] as $B$-modules. By naturality of \cite[Theorem 9.5.1.3]{Gaitsgory_Study_II} and induction on $n \ge 1$ it follows that we have natural identifications \[ X^{(n)} \simeq \Spec (A/ I^{n+1}) , \] of affine derived schemes, as desired. The assertion in general follows along the same reasoning noticing that \[ \mathbb L_{A/ B} \in \mathrm{Mod}_A, \] is concentrated in homological degrees $[1, 0]$. \end{proof} \begin{rem} It follows from \cite[\S 9, Theorem 5.5.4]{Gaitsgory_Study_II}, that in the situation of \cref{lem:identification_of_Hodge_and_adic_filtrations}, the natural composite morphism \[ \Sym^n(\mathbb L_{A/ B} [-1]) \to \Sym^{ \le n}(\mathbb L_{A/ B}[-1]) \to \Sym^{n+1}(\mathbb L_{A/ B}[-1]), \] corresponds to the usual de Rham differential, where $\Sym^{ \le n}(\mathbb L_{A/ B}[-1]) \to \Sym^{n+1}(\mathbb L_{A/ B}[-1])$ classifies the natural extension \[ \Sym^{n+1}(\mathbb L_{A/ B} [-1]) \to \Sym^{ \le n +1 }(\mathbb L_{A/ B}[-1]) \to \Sym^{\le n}(\mathbb L_{A/ B}[-1]), \] associated to the $n$-th piece of the Hodge filtration, \end{rem} \begin{rem} Let $ f\colon X \to Y$ be a closed immersion of affine derived schemes. Let $A \coloneqq \Gamma(X, \mathcal O_X)$ and $B \coloneqq \Gamma(Y, \mathcal O_Y)$. In \cite[Proposition 4.16]{Bhatt_Derived_Completions}, the author proves a similar statement to \cref{lem:identification_of_Hodge_and_adic_filtrations}. It turns out that both filtrations on $B^\wedge_I$ agree in the case of \cite{Bhatt_Derived_Completions} or in the situation of \cite[\S 9]{Gaitsgory_Study_II}. A comparison can be stated as follows: it is immediate that both the filtrations of Bhatt and Gaitsgory-Rozemblyum on $B^\wedge_I$, denoted respectively \[ \mathrm{Fil}^n_B \quad \mathrm{and} \quad \mathrm{Fil}^n_H, \] agree in the case where $f$ is a local complete intersection morphism. Moreover, it follows from the fact that the cotangent complex commutes with sifted colimits that, for each $n \ge 0$, the natural morphisms \begin{equation} \label{eq:de_Rham_differential} \Sym^{\le n}(\mathbb L_{A/ B}[-1]) \to \Sym^{n+1} (\mathbb L_{A/ B}[-1]) [1] \end{equation} are stable under sifted colimits as well. Consider the simplicial model structure in the simplicial category of pairs $(A, I)$ where $A$ is a simplicial $k$-algebra and $I \subseteq A$ a simplicial ideal given by the description: a pair $(A, I)$ is a fibration (resp., trivial fibration) if and only if both $A$ and $I$ are simultaneously fibrations (resp., trivial fibrations) of simplicial sets. Moreover, the cofibrant objects correspond to pairs $(P, J)$ where, for each $[n] \in \bm{\Delta}$, $P_n$ is a polynomial $k$-algebra on a set $X_n$ and $J_n$ an ideal defined by a subset $Y_n \subseteq X_n$, both preserved by degeneracies and the relative situation. The $\infty$-categorical localization at the class of weak equivalences agrees furthermore with the $\infty$-category\xspace $\Fun_\mathrm{closed}(\Delta^1, \mathrm{CAlg}_k)$. In particular, considering a simplicial resolution $(P_\bullet, I_\bullet)$ for the morphism $B \to A$ consisting of polynomial algebras and regular ideals we deduce that \[ \mathrm{Fil}^n_H \simeq \mathrm{Fil}^n_B, \quad \mathrm{for} \ n \ge 0, \] in the general case, as well. \end{rem} \subsection{The construction of the deformation in the affinoid case} Consider the object \[ \mathbf{B}^{\mathrm{an}, \bullet}_{\mathrm{scaled}} \colon \bm{\Delta} ^\mathrm{op} \to (\mathrm{dAnSt}_k)_{/ \mathbf A^1_k}, \] obtained as the analytification of the simplicial object $\mathrm{B}^\bullet_{\mathrm{scaled}} \in \Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{dSt}^\mathrm{laft}_k)$ described in the previous section. Our goal in this section, is to construct the deformation to the normal cone in the non-archimedean setting, in the case where $Y$ is derived $k$-affinoid. We shall further assume that \[ f \colon X \to Y, \] exhibits $X$ as an analytic formal moduli problem over $Y$. In particular, $X$ admits a deformation theory and we can consider the relative cotangent complex \[ \mathbb L^\mathrm{an}_{X/ Y} \in \mathrm{Pro}^\mathrm{ps}(\mathrm{Coh}^+(X)). \] \begin{defin} We define the \emph{parametrized non-archimedean deformation to the normal bundle} via the pullback diagram \[ \begin{tikzcd} \mathcal D_{X/Y}^{\mathrm{an}, \bullet} \ar{r} \ar{d} & Y \times \mathbf A^1_k \ar{d} \\ \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf{B}_\mathrm{scaled}^{\mathrm{an}, \bullet}, X \times \mathbf A^1_k) \ar{r} & \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf{B}_{\mathrm{scaled}}^{\mathrm{an, \bullet}}, Y \times \mathbf A^1_k) \end{tikzcd}, \] computed in the $\infty$-category\xspace $\mathrm{Fun}(\bm{\Delta} ^\mathrm{op}, \mathrm{dAnSt}_k)$. \end{defin} \begin{rem} As in the algebraic case, the object $\mathbf{B}^{\mathrm{an}, \bullet}_{\mathrm{scaled}}$ admits a left-lax action of the multplicative monoid $\mathbf A^1_k \in \mathrm{dAnSt}_k$. This action induces a natural left-lax action of $\mathbf A^1_k$ on the deformation $\mathcal D_{X/ Y}^{\mathrm{an}, \bullet}$, as well. \end{rem} \begin{rem} \label{rem:reduction_step_closed_ims} It follows immediately from the definition of $\mathcal D_{X/ Y}^{\mathrm{an}, \bullet}$ that the latter commutes with filtered colimits in $X \in \mathrm{dAnSt}_k$. Moreover, \cref{prop:required_conditions_for_formal_moduli_problems} implies that the natural morphism \[ \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{/ X})_{/ Y}} \mathcal D_{S/ Y}^{\mathrm{an}, \bullet} \to \mathcal D_{X/ Y}^{\mathrm{an}, \bullet}, \] is an equivalence in $\mathrm{dAnSt}_k$. For this reason, we will often reduce the construction to the case where $f \colon X \to Y$ is a nil-isomorphism of derived $k$-affinoid spaces. \end{rem} \begin{rem} Let $f\colon X \to Y$ be a nil-isomorphism in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Then we can consider the diagram \[ \mathrm{id}_Y \colon Y \to X \bigsqcup_{X_\mathrm{red}} Y \to Y, \] which exhibits $(X \xrightarrow{f} Y)$ as a retrat of the induced morphism $(X \xrightarrow{g} X \underset{X_\mathrm{red}}{\sqcup}Y)$, both regarded as objects in $\mathrm{AnFMP}_{X/ }$. In this case, it follows by the naturality of the parametrized Hodge filtration that we have a retract diagram \[ \mathcal D^\bullet_{X/ Y} \to \mathcal D^\bullet_{X/ X \underset{X_\mathrm{red}}{\bigsqcup} Y} \to \mathcal D^\bullet_{X/ Y}, \] of simplicial objects in $\mathrm{AnFMP}_{X \times \mathbf A^1_k/ }$. This observation will allow us to perform reduction arguments by replacing the nil-isomorphism $f\colon X \to Y$ by the nil-embedding $g \colon X \to X \underset{X_\mathrm{red}}{\sqcup} Y$. \end{rem} Let $f \colon X \to Y$ be a nil-isomorphism in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Thanks to \cite[Lemma 6.9.]{Porta_Yu_NQK}, we deduce that the induced morphism \[ f^\mathrm{alg} \colon X^\mathrm{alg} \to Y^\mathrm{alg}, \] is again a nil-isomorphism of affine derived schemes. We shall need a few preparations: \begin{lem} \label{lem:relative_anlaytification_of_closed_immersions_are_compatible_with_alg_construction} Let $Y \in \mathrm{dAfd}_k$ and $(f \colon X \to Y) \in \mathrm{AnFMP}_{/Y}$. Then one has a natural equivalence \[ (f ^\mathrm{alg})^\mathrm{an}_Y \simeq f, \] in the $\infty$-category\xspace $\Fun(\bm{\Delta}^\mathrm{op}, \mathrm{dAfd}_k)$. \end{lem} \begin{proof} The statement of the Lemma is a direct consequence of \cite[Theorem 6.12]{Porta_Yu_NQK}. \end{proof} \begin{lem} \label{lem:Noetherian_approximation_of_nil_isomorphisms} Let $f^\mathrm{alg} \colon X^\mathrm{alg} \to Y^\mathrm{alg}$ be a closed embedding of derived schemes. There exists a filtered $\infty$-category\xspace $\mathcal I$ and a diagram \[ F \colon \mathcal I ^\mathrm{op} \to \Fun(\Delta^1, \mathrm{dAff}^\mathrm{laft}_k), \] such that, for each $\alpha \in \mathcal I$, we have that \[ F(\alpha) \coloneqq (f_\alpha \colon X_\alpha \to Y_\alpha), \] is a closed immersion in the $\infty$-category\xspace $\mathrm{dAff}_k^\mathrm{laft}$ and such that \[ f \simeq \lim_{\mathcal I^\mathrm{op}} F, \] in the $\infty$-category\xspace $\Fun(\Delta^1, \mathrm{dAff}_k)$. \end{lem} \begin{proof} Consider the full subcategory $\Fun_\mathrm{closed}(\Delta^1, \mathrm{CAlg}_k) \subseteq \Fun (\Delta^1, \mathrm{CAlg}_k)$ spanned by morphisms $A \to B$ such that the induced homomorphism of ordinary rings \[ \pi_0(A) \to \pi_0(B), \] is surjective. As in the proof of \cref{prop:algebraic_properties_of_deformation} the $\infty$-category\xspace $\Fun_\mathrm{closed}(\Delta^1, \mathrm{CAlg}_k)$ is obtained as an $\infty$-categorical localization at weak equivalences of the simplicial model category whose objects correspond to pairs $(C, I)$ where $C$ is a simplicial $k$-algebra and $I \subseteq C$ a simplicial ring. Moreover, thanks to \cite[\S 2 IV, Theorem 4]{Quillen_Homotopical_1967} it follows that finite projective generators in the latter correspond to pairs of the form $(P, I)$ where $P$ is some polynomial algebra in a finite number of generators (concentrated in non-negatively homologically degrees) and $I$ an ideal spanned by a regular sequence. In particular, finite projective generators in $\Fun_\mathrm{closed}(\Delta^1, \mathrm{CAlg}_k)$ correspond to morphisms $g \colon P \to Q$ where $P$ is a finite free derived $k$-algebra and the morphism $g$ is a complete intersection morphism. As in the proof of \cite[Proposition 8.2.5.27]{Lurie_Higher_algebra} we then deduce that the $\infty$-category\xspace $\mathrm{Fun}_\mathrm{closed}(\Delta^1, \mathrm{CAlg}_k)$ is compactly generated by morphisms $g \colon P \to Q$ which can be obtained from finite projective generators via a finite sequence of retracts and finite colimits. Arguing as in \cite[Proposition 8.2.5.27]{Lurie_Higher_algebra}, we are able to describe the set of compact generators of $\Fun_\mathrm{closed}(\Delta^1, \mathrm{CAlg}_k)$: they correspond to locally of finite presentation morphisms between locally finite presentation derived $k$-algebras. In particular, we can find a presentation of \[ f^\mathrm{alg} \colon X^\mathrm{alg} \to Y^\mathrm{alg}, \] by closed immersions between almost finite presentation affine derived schemes \[ f_\alpha \colon X_\alpha \to Y_\alpha, \quad \mathrm{for \ } \alpha \in \mathcal I^\mathrm{op}, \] where $\mathcal I$ is a filtered $\infty$-category\xspace, as desired. \end{proof} \begin{rem} Let $f \colon X \to Y$ be a nil-embedding in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Find a presentation of $f^\mathrm{alg}$ by closed immersions between almost of finite presentation affine derived schemes of the form \[ \lim_{\alpha \in I^\mathrm{op}}(f_\alpha \colon X_\alpha \to Y_\alpha). \] Consider the object $\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet \in \Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{dAff}_k)$ as in \cref{construction:def_to_the_normal_bundle}. It is clear from the descritption of $\mathcal D_{X^\mathrm{alg}/Y^\mathrm{alg}}^\bullet$ given in \cref{construction:def_to_the_normal_bundle} combined with \cref{rem:simplification_of_deformation_in_the_closed_immersion} that one has a natural equivalence of derived stacks \[ \mathcal D_{X^\mathrm{alg}/Y^\mathrm{alg}}^\bullet \simeq \lim_{\alpha \in I^\mathrm{op}} \mathcal D_{X_\alpha^\mathrm{alg}/ Y_\alpha^\mathrm{alg}}^\bullet, \] in the $\infty$-category\xspace $\mathrm{Fun}(\bm{\Delta} ^\mathrm{op}, \mathrm{dSt}_k)$. \end{rem} \begin{lem} \label{lem:analytification_of_simplicial_object_deformation} Let $Y \in \mathrm{dAfd}_k$. Consider a morphism $f \colon X \to Y$ in $\mathrm{dAnSt}_k$ which exhibits $X$ as an analytic formal moduli problem over $Y$. Then one has a natural equivalence \[ \theta_{X/ Y} \colon \mathcal D_{X/Y}^{\mathrm{an}, \bullet} \simeq (\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet)^\mathrm{an}_Y , \] where $(-)_Y^\mathrm{an}$ denotes the relative analytification with respect to $Y$. \end{lem} \begin{proof} We first observe that both $\mathcal D_{X/Y}^{\mathrm{an}, \bullet}$ and $(\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet)^\mathrm{an}_Y$ are stable under filtered colimits in $X$. For this reason, we reduce ourselves to the case where $f \colon X \to Y$ itself is a nil-isomorphism in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Similarly, $\theta_{X/ Y}$ is stable under retracts. Therefore, we are allowed to replace the morphism $X \to Y$ by \[ X \to Y \underset{X_\mathrm{red}}{\bigsqcup} X, \] and therefore assume that $f \colon X \to Y$ is a nil-embedding. As in \cref{lem:Noetherian_approximation_of_nil_isomorphisms}, write the nil-embedding between affine derived schemes \[ f \colon X^\mathrm{alg} \to Y^\mathrm{alg}, \] as a cofiltered limit of closed immersions \[\lim_{\alpha \in I^\mathrm{op}} f_\alpha \colon \lim_{\alpha \in I^\mathrm{op}} X_\alpha^\mathrm{alg} \to \lim_{\alpha \in I^\mathrm{op}} Y_\alpha^\mathrm{alg},\] where for each index $\alpha \in I$, both $X_\alpha$ and $Y_\alpha$ are affine derived schemes almost of finite presentation. Since the natural projection morphism \[ \mathrm{B}_\mathrm{scaled}^\bullet \to \mathbb A^1_k, \] where $\mathbb A^1_k$ is considered as a constant simplicial object in $\mathrm{dSt}_k$, is a proper morphism, we deduce from \cite[Theorem 6.13]{Holstein_Analytification_of_mapping_stacks} that for every $\alpha$, the natural morphisms \begin{align*} \Map_{/\mathbb A^1_k}(\mathrm{B}^\bullet_\mathrm{scaled}, X_\alpha^\mathrm{alg} \times \mathbb A^1_k)^\mathrm{an} & \to \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf{B}^{\bullet, \mathrm{an}}_\mathrm{scaled} , (X_\alpha^\mathrm{alg})^\mathrm{an} \times \mathbf A^1_k) \\ \Map_{/\mathbb A^1_k}(\mathrm{B}^\bullet_\mathrm{scaled}, Y_\alpha^\mathrm{alg} \times \mathbb A^1_k)^\mathrm{an} & \to \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf{B}^{\bullet, \mathrm{an}}_\mathrm{scaled} , (Y_\alpha^\mathrm{alg})^\mathrm{an} \times \mathbf A^1_k) \end{align*} are equivalences in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Therefore, the natural morphism \[ (\mathcal D_{X^\mathrm{alg}_\alpha/Y^\mathrm{alg}_\alpha}^\bullet )^\mathrm{an} \to \mathcal D_{(X_\alpha ^\mathrm{alg})^\mathrm{an}/ (Y_\alpha ^\mathrm{alg})^\mathrm{an}}^{\bullet, \mathrm{an}}, \] is an equivalence in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Observe further that for every $\alpha \in A$ the mapping stacks \[ \Map_{/ \mathbb A^1_k}(\mathrm{B}^\bullet_\mathrm{scaled}, X_\alpha^\mathrm{alg} \times \mathbb A^1_k) \quad \mathrm{and} \quad \Map_{/ \mathbb A^1_k}(\mathrm{B}^\bullet_\mathrm{scaled}, Y_\alpha^\mathrm{alg} \times \mathbb A^1_k) \] are affine schemes and therefore it follows by the construction of the analytification functor \[ (-)^\mathrm{an} \colon \mathrm{dAff}_k \to \mathrm{dAnSt}_k, \] as a right Kan extension of the usual analytification functor \[ (-)^\mathrm{an} \colon \mathrm{dAff}^\mathrm{laft}_k \to \mathrm{dAn}_k, \] that we have natural equivalences \begin{align*} ( \lim_\alpha \Map_{/\mathbb A^1_k}(\mathrm{B}^\bullet_\mathrm{scaled}, X_\alpha^\mathrm{alg} \times \mathbb A^1_k)) ^\mathrm{an} & \simeq \mathbf{Map}_{/\mathbb A^1_k}(\mathrm{B}^{\bullet, \mathrm{an}}_\mathrm{scaled}, (X^\mathrm{alg})^\mathrm{an}_Y \times \mathbf A^1_k) \\ ( \lim_\alpha \Map_{/\mathbb A^1_k}(\mathrm{B}^\bullet_\mathrm{scaled}, Y_\alpha^\mathrm{alg} \times \mathbb A^1_k)) ^\mathrm{an} & \simeq \mathbf{Map}_{/\mathbb A^1_k}(\mathrm{B}^{\bullet, \mathrm{an}}_\mathrm{scaled}, (Y^\mathrm{alg})^\mathrm{an}_Y \times \mathbf A^1_k). \end{align*} in the $\infty$-category\xspace $(\mathrm{dAnSt}_k)_{X \times \mathbb A^1/ /Y \times \mathbb A^1_k}$. The result now follows from the existence of a commutative cube \[ \begin{tikzcd}[column sep=0.125in,row sep=0.125in] (\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet)^\mathrm{an}_Y \ar{rr} \ar{dd} \ar{rd} & & Y \times \mathbf A^1_k \ar{rd} \ar{dd} & \\ & (\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet)^\mathrm{an} \ar{rr} \ar{dd} & & (Y^\mathrm{alg} \times \mathbb A^1_k)^\mathrm{an} \ar{dd} \\ \mathbf{Map}_{/\mathbf A^1_k}(\mathbf{B}^\bullet, X \times \mathbf A^1_k) \ar{rr} \ar{rd} & & \mathbf{Map}_{/\mathbf A^1_k}(\mathbf{B}^\bullet, Y \times \mathbf A^1_k) \ar{rd} \\ & \mathbf{Map}_{/\mathbf A^1_k}(\mathbf{B}^\bullet, (X^\mathrm{alg})^\mathrm{an} \times \mathbf A^1_k) \ar{rr} & & \mathbf{Map}_{/\mathbf A^1_k}(\mathbf{B}^\bullet, (Y^\mathrm{alg})^\mathrm{an} \times \mathbf A^1_k) \end{tikzcd} \] whose top and front squares are fiber products in $\mathrm{dAnSt}_k$, and thus so it is the back square, as desired. \end{proof} \begin{cor} \label{cor:analytic_def_fiber_at_0_is_tangent} With notations as above, one has a canonical equivalence \[ (\mathcal D^{\bullet, \mathrm{an}}_{X/Y})_0 \simeq (\mathbf T^{\mathrm{an}, \bullet}_{X/Y})^\wedge , \] where the latter denotes the commutative group object associated to the formal completion of the tangent bundle of $f$ along the zero section $s_0 \colon X \to \mathbf T^{\mathrm{an}, \bullet}_{X/Y}$. \end{cor} \begin{proof} The result follows from \cite[Proposition 9.2.3.6]{Gaitsgory_Study_II} combined with the fact that relative analytification commutes with tangent bundles and formal completions, see the proof of \cite[Lemma 5.31]{Holstein_Analytification_of_mapping_stacks} and \cite[Corollary 5.20]{Holstein_Analytification_of_mapping_stacks}. \end{proof} The following result is an immediate consequence of \cref{lem:analytification_of_simplicial_object_deformation}: \begin{lem} \label{lem:deformation_theory_for_D^an_bullet_X/Y} For each $[n] \in \bm{\Delta}$, the object $\mathcal D_{X/Y}^{\mathrm{an}, [n]} \in (\mathrm{dAnSt}_k)_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k}$ admits a deformation theory. \end{lem} \begin{proof} We shall prove that each component of the simplicial object \[\mathcal D^{ \mathrm{an}, \bullet}_{X/ Y} \in \Fun(\bm{\Delta} ^\mathrm{op}, \mathrm{AnFMP}_{X \times \mathbf A^1_k/ /Y\times\mathbf A^1_k}),\] admits a deformation theory. By \cite[Lemma 2.3.2]{Gaitsgory_Study_II}, it follows that $\mathcal D^\bullet_{X^\mathrm{alg}/ /Y^\mathrm{alg}}$ is an object in $\mathrm{FMP}_{X^\mathrm{alg}/ /Y^\mathrm{alg}}$. The result now follows by applying the relative analytification functor $(-)_Y^\mathrm{an}$ together with \cite[Proposition 6.10]{Porta_Yu_NQK}. \end{proof} \begin{rem} \label{rem:D_X/Y_lives_over_and_under_XxA^1_as_anFMP} Let $(X \xrightarrow{f} Y) \in \mathrm{AnFMP}_{/ Y}$, with $Y \in \mathrm{dAfd}_k$. It follows immediately from \cref{lem:deformation_theory_for_D^an_bullet_X/Y} that the datum \[ (X \times \mathbf A^1_k \to \mathcal D^{\bullet, \mathrm{an}}_{X/ Y} \to Y \times \mathbf A^1_k) \in (\mathrm{dAnSt}_k)_{X \times \mathbf A^1_k/ /Y\times\mathbf A^1_k}, \] belongs to the full subcategory $\mathrm{AnFMP}_{X\times\mathbf A^1_k/ /Y\times\mathbf A^1_k}$. \end{rem} \begin{construction} The $\infty$-category\xspace $\mathrm{AnFMP}_{X\times\mathbf A^1_k/ /Y\times\mathbf A^1_k}$ is presentable and in particular it admits sifted colimits. Thanks to \cref{lem:deformation_theory_for_D^an_bullet_X/Y}, we can consider the object \[ \mathcal D^\mathrm{an}_{X/Y} \coloneqq \colim_{\bm{\Delta} ^\mathrm{op}} \mathcal D^{\mathrm{an}, \bullet}_{X/Y} \in \mathrm{AnFMP}_{X\times\mathbf A^1_k/ /Y\times\mathbf A^1_k}. \] Similarly, we consider the sifted colimit \[ \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}} \coloneqq \colim_{\bm{\Delta} ^\mathrm{op}} \mathcal D^\bullet_{X^\mathrm{alg}/ Y^\mathrm{alg}} \in \mathrm{FMP}_{X^\mathrm{alg} \times \mathbb A^1_k/ /Y^\mathrm{alg} \times \mathbb A^1_k} , \] computed in the $\infty$-category\xspace $\mathrm{FMP}_{X^\mathrm{alg}\times\mathbb A^1_k/ /Y^\mathrm{alg}\times\mathbb A^1_k}$. We can consider the latter as an object in \[ \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}} \in \mathrm{dSt}_{X^\mathrm{alg} \times \mathbb A^1_k/ /Y^\mathrm{alg} \times \mathbb A^1_k}, \] and therefore consider its relative analytification $(\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}})^\mathrm{an}_Y \in \mathrm{dAnSt}_{X^\mathrm{alg} \times \mathbf A^1_k/ /Y^\mathrm{alg} \times \mathbf A^1_k}$. Thanks to \cref{lem:analytification_of_simplicial_object_deformation} it follows that we have a natural morphism \[ \theta_{X/ Y} \colon \mathcal D^\mathrm{an}_{X/ Y} \to (\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}})^\mathrm{an}_Y, \] in the $\infty$-category\xspace $(\mathrm{dAnSt}_k)_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k}$. \end{construction} Our next goal is to prove that the morphism $\theta_{X/ Y}$ is an equivalence of deformations. In order to prove the latter statement, we shall need a preliminary lemma: \begin{lem} \label{lem:Noetherian_approximation_of_the_deformation_to_the_normal_bundle} Let $f \colon X \to Y$ be a nil-embedding in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Consider approximation of the nil-embedding morphism $f^\mathrm{alg}$ \[ \lim_{\alpha \in I^\mathrm{op}} f_\alpha \colon \lim_{\alpha \in I^\mathrm{op}} X_\alpha \to \lim_{\alpha \in I^\mathrm{op}} Y_\alpha, \] as in \cref{lem:Noetherian_approximation_of_nil_isomorphisms}. Then, we have a natural morphism of the form \begin{equation} \label{eq:morphism_theta} \theta \colon \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}} \to \lim_{\alpha \in I^\mathrm{op}} \mathcal D_{X_\alpha/ Y_\alpha}, \end{equation} which is furthermore an equivalence in the $\infty$-category\xspace $\mathrm{AnFMP}_{X \times \mathbb A^1_k / Y ^\mathrm{alg} \times \mathbb A^1_k}$ \end{lem} \begin{proof} It is clear that the natural morphisms $X_\alpha \to \mathcal D_{X_\alpha/ Y_\alpha}$ assemble into a morphism \[ X ^\mathrm{alg} \simeq \lim_{\alpha \in I^\mathrm{op}} X_\alpha \to \lim_{\alpha \in I^\mathrm{op}} \mathcal D_{X_\alpha/ Y_\alpha}, \] which admits a deformation theory, therefore the morphism \[X^\mathrm{alg} \to \lim_{\alpha \in I^\mathrm{op}} \mathcal D_{X_\alpha/ Y_\alpha},\] exhibits $\lim_{\alpha \in I^\mathrm{op}} \mathcal D_{X_\alpha/ Y_\alpha}$ as an object in the $\infty$-category\xspace $\mathrm{FMP}_{X^\mathrm{alg} \times \mathbb A^1_k/ }$. Notice that \cref{thm:Phi_is_an_equivalence} holds true in this setting, proved in an analogous way, to provide us with an equivalence of $\infty$-categories\xspace \[ \mathrm B_X(\bullet) \colon \mathrm{FGrpd}(X^\mathrm{alg} \times \mathbb A^1_k) \to \mathrm{FMP}_{X^\mathrm{alg} \times \mathbb A^1_k/ }, \] where $\mathrm{FGrp}(X^\mathrm{alg} \times \mathbb A^1_k)$ denotes the $\infty$-category\xspace of formal groupoids over $X^\mathrm{alg} \times \mathbb A^1_k \in \mathrm{dSt}_k$. For this reason, we are reduced to show the existence of a natural equivalence between formal groupoids over $X^\mathrm{alg} \times \mathbb A^1_k$, \[ \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet \simeq X^{\times_{\lim_\alpha \mathcal D_{X_\alpha/ Y_\alpha}} \bullet}, \] where the right hand side denotes the \v{C}ech nerve of the morphism $X \to \lim_\alpha \mathcal D_{X_\alpha/ Y_\alpha}$. Since limits commute with limits in the $\infty$-category\xspace $\mathrm{dAnSt}_k$, we obtain a chain of natural equivalences of the form \begin{align*} (X^\mathrm{alg})^{\times_{\lim_{\alpha} \mathcal D_{X_\alpha/ Y_\alpha}}\bullet} & \simeq \lim_{\alpha } \big(X_\alpha^{\times_{\mathcal D_{X_\alpha/ Y_\alpha}} \bullet} \big) \\ & \simeq \lim_{\alpha } \mathcal D_{X_\alpha/ Y_\alpha}^\bullet \\ & \simeq \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet, \end{align*} in the $\infty$-category\xspace $\mathrm{FGrp}(X)$. Only the the second equivalence needs a justification: for each $\alpha \in I$, we have natural identifications \[ \mathcal D_{X_\alpha/ Y_\alpha} \simeq \mathrm B_{X_\alpha}( \mathcal D_{X_\alpha/ Y_\alpha}^\bullet) , \] by construction, where $\mathrm B_{X_\alpha} (-)$ is as in \cite[\S 5.2]{Gaitsgory_Study_II}. Therefore, we deduce by adjunction that \[ X^{\times_{\mathcal D_{X_\alpha/ Y_\alpha} }\bullet} \simeq \mathcal D_{X_\alpha/ Y_\alpha}^\bullet, \] is an equivalence in the $\infty$-category\xspace $\mathrm{FGrpd}(X_\alpha)$, as well. The proof is thus concluded. \end{proof} The following result implies that the relative analytification commutes with the deformation to the normal bundle: \begin{prop} \label{prop:rel_analytification_preserves_the_deformation} The natural morphism of \eqref{eq:morphism_theta}, \[ \theta_{X/ Y}\colon\mathcal D^\mathrm{an}_{X/Y}\to(\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}})^\mathrm{an}_Y, \] is an equivalence of derived $k$-analytic stacks. \end{prop} \begin{proof} Since the morphism $\theta_{X/ Y}$ commutes with filtered colimits in $X$, we reduce the statement of the Proposition to the case where $X \in \mathrm{AnNil}_{/ Y}$. In this case, we have that $Y \times \mathbf A^1_k \in \mathrm{AnFMP}_{X \times \mathbf A^1_k/ }$. By naturality of the morphism $\theta_{X/ Y}$ we are allowed to prove the statement of the Proposition up to a retract. For this reason, we can replace $Y$ by $Y \underset{X_\mathrm{red}}{\sqcup} X$ and therefore assume that $f \colon X\to Y$ is a nil-embedding. Consider now the relative analytification functor \[ (-)^\mathrm{an}_Y \colon \mathrm{FMP}_{/ Y^\mathrm{alg} \times \mathbb A^1_k} \to \mathrm{AnFMP}_{/ Y \times \mathbf A^1_k}, \] introduced in \cite[\S 6.1]{Porta_Yu_NQK}. Thanks to \cite[Theorem 6.12]{Porta_Yu_NQK} the natural functor displayed above is an equivalence of $\infty$-categories\xspace. Observe further that we have a well defined functor \begin{equation} \label{eq:rel_analytification_functor_as} (-)^\mathrm{an}_Y \colon \mathrm{FMP}_{X^\mathrm{alg} \times \mathbb A^1_k/ /Y^\mathrm{alg} \times \mathbb A^1_k} \to \mathrm{AnFMP}_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k}, \end{equation} induced by the usual relative analytification functor. Indeed, we have that \[ X \times \mathbf A^1_k \simeq (X^\mathrm{alg})^\mathrm{an}_Y \times \mathbf A^1_k, \] as the pair$((-)^\mathrm{alg}, (-)^\mathrm{an}_Y)$ forms an equivalence itself. It is further clear that \eqref{eq:rel_analytification_functor_as} is an equivalence of $\infty$-categories\xspace as well. In particular, it commutes with all small colimits. Therefore, we have a chain of natural equivalences \begin{align*} (\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}})^\mathrm{an}_Y & \simeq (\colim_{\bm{\Delta} ^\mathrm{op}} \mathcal D_{X^\mathrm{alg}/Y^\mathrm{alg}}^\bullet) ^\mathrm{an}_Y \\ & \simeq \colim_{\bm{\Delta} ^\mathrm{op}}(\mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}^\bullet)^\mathrm{an}_Y \\ & \simeq \colim_{\bm{\Delta} ^\mathrm{op}} \mathcal D_{X/ Y}^{\mathrm{an}, \bullet}, \end{align*} in $\mathrm{AnFMP}_{X \times \mathbf A^1_k/ / Y\times \mathbf A^1_k}$, thanks to \cref{prop:rel_analytification_preserves_the_deformation}. The conclusion now follows from the observation that the forgetful functor \[ \mathrm{AnFMP}_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k} \to \mathrm{AnFMP}_{X \times \mathbf A^1_k/ } , \] commutes with colimits and it is moreover conservative, thus it reflects sifted colimits. \end{proof} \begin{lem} \label{lem:identification_of_non-archimedean_fibers} Consider the natural projection morphism \[ q \colon \mathcal D_{X/ Y}^\mathrm{an} \to \mathbf A^1_k. \] Then its fiber at $\lambda \neq 0$ coincides with the formal completion \[ Y^\wedge_X, \] and its fiber at $\{ 0 \} \subseteq \mathbf A^1_k$ with the completion of the shifted tangent bundle $\mathbf T^\mathrm{an}_{X/ Y}[1]$ along the zero section $s_0 \colon X \to \mathbf T^\mathrm{an}_{X/ Y}[1]$. \end{lem} \begin{proof} The above assertions follow immediately from \cref{prop:rel_analytification_preserves_the_deformation}, \cref{cor:analytic_def_fiber_at_0_is_tangent} and \cref{prop:algebraic_properties_of_deformation}. \end{proof} \begin{construction} \label{const:pullbacks_of_deformations} Let $Y \in \mathrm{dAfd}_k$ and $(X \xrightarrow{f} Y) \in \mathrm{AnFMP}_{/ Y}$. Denote by $g \colon U \to Y$ a morphism in $\mathrm{dAfd}_k$. Consider the pullback diagram \[ \begin{tikzcd} X_U \ar{r} \ar{d} & U \ar{d} \\ X \ar{r}{f} & Y, \end{tikzcd} \] computed in the $\infty$-category\xspace $\mathrm{dAfd}_k$. It follows from the definitions that the morphism $X_U \to U$ admits a deformation theory and that we have a natural pullback square of simplicial objects \[ \begin{tikzcd} \mathcal D_{X_U/ U}^{\mathrm{an}, \bullet} \ar{r} \ar{d} & \mathcal D_{X/Y}^{\mathrm{an}, \bullet} \ar{d} \\ U \ar{r} & Y, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. For this reason, we obtain a natural commutative diagram \[ \begin{tikzcd} \mathcal D_{X_U/ U}^\mathrm{an} \ar{r} \ar{d} & \mathcal D_{X/ Y} ^\mathrm{an} \ar{d} \\ U \ar{r} & Y, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. Similarly, \cite[Proposition 3.17]{Porta_Yu_Derived_non-archimedean_analytic_spaces} implies that we have a pullback diagram \[ \begin{tikzcd} X_U^\mathrm{alg} \ar{r} \ar{d} & U ^\mathrm{alg} \ar{d} \\ X^\mathrm{alg} \ar{r}{f^\mathrm{alg}} & Y^\mathrm{alg} \end{tikzcd}, \] in the $\infty$-category\xspace $\mathrm{dAff}_k$. Reasoning as above, we have a natural commutative square \[ \begin{tikzcd} \mathcal D_{X_U^\mathrm{alg}/ U^\mathrm{alg}} \ar{r} \ar{d} & \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}} \ar{d} \\ U^\mathrm{alg} \ar{r} & Y ^\mathrm{alg}, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dSt}_k$. \end{construction} \begin{prop} \label{prop:gluing_the_deformation} The commutative square \[ \begin{tikzcd} \mathcal D_{X_U/ U}^\mathrm{an} \ar{r} \ar{d} & \mathcal D_{X/ Y} ^\mathrm{an} \ar{d} \\ U \ar{r} & Y, \end{tikzcd} \] of \cref{const:pullbacks_of_deformations}, is a pullback square in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. \end{prop} \begin{proof} Since the pullback diagram above is preserved under filtered colimits in $X$, we can assume without loss of generality that $f \colon X\to Y$ is a nil-isomorphism. Similarly, we are allowed to replace the retract $ \colon X \to Y$ by the nil-embedding \[ g \colon \to X \to Y \underset{X_\mathrm{red}}{\bigsqcup} X. \] In order to show the assertion of the proposition, we are reduced to show that the natural morphism \[ \mathcal D_{X_U/ U}^\mathrm{an} \to \mathcal D^\mathrm{an}_{X/ Y} \times_Y U, \] is an equivalence in the $\infty$-category\xspace $\mathrm{AnFMP}_{X_U/ /U}$. Moreover, \cref{prop:rel_analytification_preserves_the_deformation} reduce us to show that the natural morphism \[ \mathcal D_{X_U^\mathrm{alg}/ U^\mathrm{alg}} \to \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}} \times_{Y^\mathrm{alg}}U^\mathrm{alg}, \] is an equivalence in $\mathrm{dSt}_k$ (see also \cref{prop:rel_analytification_preserves_the_deformation}). Moreover, \cref{lem:Noetherian_approximation_of_the_deformation_to_the_normal_bundle} allows us to perform Noetherian approximation on the nil-isomorphism $f ^\mathrm{alg} \colon X^\mathrm{alg} \to Y^\mathrm{alg}$. For this reason, we can find an approximation of the morphism $f \colon X ^\mathrm{alg} \to Y^\mathrm{alg}$ an approximation of the form \[ \lim_{\alpha \in I^\mathrm{op}} ( f_\alpha \colon X_\alpha \to Y_\alpha ), \] where $I$ is a filtered $\infty$-category\xspace and for each $\alpha \in I$, the morphism $f_\alpha$ is a closed immersion of affine derived schemes almost of finite presentation over $k$. Similarly, find an almost of finite presentation approximation \[ U ^\mathrm{alg} \simeq \lim_{\beta \in J^\mathrm{op}} U_\beta. \] By almost finite presentation we deduce that for every $\alpha \in I$ there exists an index $\beta(\alpha) \in J$ such that the composite \begin{equation} \label{eq:factorization} U^\mathrm{alg} \to Y^\mathrm{alg} \to Y_\alpha, \end{equation} factors as \[U^\mathrm{alg} \to U_{\beta(\alpha)} \to Y_\alpha,\] for a well defined morphism $U_{\beta(\alpha)} \to Y_\alpha$ in $\mathrm{dAff}_k^\mathrm{laft}$. Let $\mathcal K$ denote the filtered subcategory of the product $I \times J$ spanned by those pairs $(\alpha, \beta) \in I \times J$ such that the composite displayed in \eqref{eq:factorization} factors as $U_\beta \to Y_\alpha$. We thus have that the morphism \[ U ^\mathrm{alg} \to Y^\mathrm{alg} , \] can be written as $\lim_{(\gamma_1, \gamma_2) \in \mathcal K} (U_{\gamma_1} \to Y_{\gamma_2})$. For each $(\gamma_1, \gamma_2) \in \mathcal K$ consider the deformations to the normal bundle \[ \mathcal D_{X_{\gamma_2}/ Y_{\gamma_2}} \quad \mathrm{and} \quad \mathcal D_{X_{U_{\gamma_2}}/ U_{\gamma_2}}, \] where $X_{U_{\gamma_2}}$ is defined as the pullback of the diagram \[ U_{\gamma_1} \to Y_{\gamma_2} \leftarrow X_{\gamma_2}. \] We claim that for each $(\gamma_1, \gamma_2) \in \mathcal K$, we have a natural equivalence \[ \mathcal D_{X_{U_{\gamma_1}}/ U_{\gamma_1}} \simeq \mathcal D_{X_{\gamma_2}/ Y_{\gamma_2}} \times_{Y_{\gamma_2}} U_{\gamma_1}, \] of derived $k$-stacks almost of finite presentation. Indeed, by conservativity of the relative tangent complex, c.f. \cite[\S 5, Theorem 2.3.5]{Gaitsgory_Study_II}, it suffices to show that \[ \mathbb T_{X_{U_{\gamma_1}}/ \mathcal D_{X_{U_{\gamma_1}}/ U_{\gamma_1}}} \to \mathbb T_{X_{U_{\gamma_1}}/ \mathcal D_{X_{\gamma_2}/ Y_{\gamma_2}} \times_{Y_{\gamma_2}} U_{\gamma_1}}, \] is an equivalence in the $\infty$-category\xspace $\mathrm{Ind}\mathrm{Coh}(X_{U_{\gamma_1}})$. Thanks to \cite[\S 5, Corollary 2.3.6]{Gaitsgory_Study_II}, we are reduced to show that the natural morphism of simplicial objects \[ \{ \mathbb T_{X_{U_{\gamma_1}}/ \mathcal D_{X_{U_{\gamma_1}}/ U_{\gamma_1}}^{\bullet}} \} \to \{ \mathbb T_{X_{U_{\gamma_1}}/ \mathcal D_{X_{\gamma_2}/ Y_{\gamma_2}}^{\bullet} \times_{Y_{\gamma_2}} U_{\gamma_1}} \}, \] is an equivalence in $\Fun(\bm{\Delta}^\mathrm{op}, \mathrm{Ind}\mathrm{Coh}(X_{U_{\gamma_1}}))$. The latter assertion further reduce us to show that the commutative diagram \[ \begin{tikzcd} \mathcal D_{X_{U_{\gamma_1}}/ U_{\gamma_1}}^{ \bullet} \ar{r} \ar{d} & \mathcal D_{X_{\gamma_2}/ Y_{\gamma_2}}^{\bullet} \ar{d} \\ U_{\gamma_1} \ar{r} & Y_{\gamma_2} \end{tikzcd} \] is a pullback diagram component-wise in $\mathrm{dAff}_k^\mathrm{laft}$. By unwinding the definitions, it suffices to prove that the commutative diagram of simplicial objects \[ \begin{tikzcd} \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf B_\mathrm{scaled}^\bullet, X_{U_{\gamma_1}} \times \mathbf A^1_k) \ar{r} \ar{d} & \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf B_\mathrm{scaled}^\bullet, U_{\gamma_1} \times \mathbf A^1_k) ) \ar{d} \\ \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf B_\mathrm{scaled}^\bullet, X_{{\gamma_2}} \times \mathbf A^1_k) \ar{r} & \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf B_\mathrm{scaled}^\bullet, Y_{\gamma_2} \times \mathbf A^1_k) ) \end{tikzcd} \] is a pullback square. But the latter assertion is obvious as derived $k$-analytic mapping stacks commute with fiber products in $\mathrm{dAnSt}_k$. \end{proof} \subsection{Gluing the Deformation} In this \S, we globalize the results proved so far in \S 3.2. Let $f \colon X \to Y$ be a morphism of locally geometric derived $k$-analytic stacks. Consider as before the \emph{deformation to the normal bundle of the morphism $f$} constructed via the pullback diagram \[ \begin{tikzcd} \mathcal D^{\mathrm{an}, \bullet}_{X/ Y} \ar{r} \ar{d} & Y^\wedge_X \times \mathbf A^1_k \ar{d} \\ \mathbf{Map}_{/ \mathbf A^1_k} (\mathbf B^{\mathrm{an}, \bullet}_\mathrm{scaled}, X \times \mathbf A^1_k) \ar{r} & \mathbf{Map}_{/ \mathbf A^1_k}(\mathbf B^{\mathrm{an},\bullet}_{\mathrm{scaled}}, Y^\wedge_X \times \mathbf A^1_k), \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. As in the previous \S, one can show that the simplicial object \[ \mathcal D^{\mathrm{an}, \bullet}_{X/ Y} \in \mathrm{AnFMP}_{X \times \mathbf A^1_k/ /Y^\wedge_X \times \mathbf A^1_k}. \] Let now $g \colon U \to Y^\wedge_X$ be a morphism in $\mathrm{dAnSt}_k$, where $U \in \mathrm{dAfd}_k$. Consider the pullback diagram \[ \begin{tikzcd} X_U \ar{r}{g'} \ar{d} & X \ar{d}{f} \\ U \ar{r}{g} & Y^\wedge_X, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. We have: \begin{lem} The morphism $X_U \to U$ admits a deformation theory, and thus exhibits $X_U$ as an object in $\mathrm{AnFMP}_{/U}$. \end{lem} \begin{proof} It is clear that $X_U$ is both nilcomplete and infinitesimally cartesian as a derived $k$-analytic stack. It suffices thus to show that the structural morphism $X_U \to U$ admits a cotangent complex. We claim that $\mathbb L_{X_U/ U}$ identifies with \[ (g')^* \mathbb L_{X/ Y} \in \mathrm{Coh}^+(X_U). \] Indeed, let $Z \to X_U$ be any morphism with $h \colon Z \in \mathrm{dAfd}_k$. Then we obtain that \[ h^* (g')^* \mathbb L_{X/ Y} \simeq (g' \circ h)^* (\mathbb L_{X/ Y}), \] in $\mathrm{Coh}^+(Z)$, which corepresents the functor \[ \mathrm{Der}_{X/ Y}(Z, -) \colon \mathrm{Coh}^+(Z) \to \mathcal S, \] see \cite[Definition 7.6]{Porta_Yu_Representability} for the definition of the latter. Since fiber products commute with fibers, we have a natural identification \[ \mathrm{Der}_{X_U}(Z, -) \simeq \mathrm{Der}_{X} (Z, -) \times_{\mathrm{Der}_{Y}(Z, -)} \mathrm{Der}_U(Z, -). \] We thus conclude that \[ \mathrm{Der}_{X_U/ U}(Z, -) \simeq \mathrm{fib} \big(\mathrm{Der}_{X_U}(Z, -) \to \mathrm{Der}_{U}(Z, -)\big) , \] identifies naturally with \[ \mathrm{Der}_{X/ Y}(Z, -) \simeq \mathrm{fib} \big(\mathrm{Der}_{X}(Z, -) \to \mathrm{Der}_{Y}(Z, -)\big) . \] The claim of the lemma now follows from the fact that $\mathrm{Der}_{X/ Y}(Z, -) \colon \mathrm{Coh}^+(Z) \to \mathcal S$ is corepresentable by $h^* (g')^*\mathbb L_{X/ Y}$, as desired. \end{proof} Thanks to the above lemma we conclude that the canonical map $X_U \to U$ exhibits $X_U$ as an analytic formal moduli problem over $U$. We are thus in the case of the previous section. The following result implies that the deformation to the normal bundle in the non-archimedean setting glues: \begin{prop} \label{prop:gluing_def} The simplicial object \[ \mathcal D_{X/ Y}^{\mathrm{an}, \bullet} \colon \bm{\Delta} ^\mathrm{op} \to \mathrm{AnFMP}_{X/ /Y}, \] admits a colimit $\mathcal D_{X/ Y}^\mathrm{an} \in \mathrm{AnFMP}_{X/ }$. \end{prop} \begin{proof} Let $(Y^\wedge_X)^\mathrm{afd}$ denote the $\infty$-category\xspace consisting of morphisms \[ U \to Y^\wedge_X, \] where $U$ is a derived $k$-affinoid space. We have a natural equivalence of $\infty$-categories\xspace \[ \Psi \colon (\mathrm{dAnSt}_k)_{/ Y} \to \lim_{U \in (Y^\wedge_X)^\mathrm{afd}} (\mathrm{dAnSt}_k)_{/U}. \] We deduce from the construction of $\mathcal D^{\mathrm{an}, \bullet}_{X/ Y}$ that the simplicial object $\mathcal D^{\mathrm{an}, \bullet}_{X/ Y}$ satisfies \begin{align*} \Psi(\mathcal D^{\mathrm{an}, \bullet}_{X/ Y}) & \simeq \{ \mathcal D^{\mathrm{an}, \bullet}_{X_{U}/ U} \} \\ & \in \lim_{U \in (Y^\wedge_X)^\mathrm{afd}} (\mathrm{dAnSt}_k)_{/ U}. \end{align*} For each $U \in (Y^\wedge_X)^\mathrm{afd}$ the $\infty$-categories\xspace $\mathrm{AnFMP}_{X_U/ /U}$ are presentable. For this reason, we can consider the geometric realization \[ \mathcal D_{X_U/ U} ^\mathrm{an} \in \mathrm{AnFMP}_{X_U / U}, \] for every $[n] \in \bm{\Delta}$. Thanks to \cref{prop:gluing_the_deformation} we deduce that the above deformations glue to form a uniquely defined object \[ \mathcal D^\mathrm{an}_{X/ Y} \in \mathrm{dAnSt}_k, \] satisfiying the relation \begin{align*} \Psi(\mathcal D^\mathrm{an}_{X/ Y}) & \simeq \{ \mathcal D^\mathrm{an}_{X_{U}/ U} \} \\ & \in \lim_{U \in (Y^\wedge_X)^\mathrm{afd}} (\mathrm{dAnSt}_k)_{/ U}. \end{align*} It is clear from the definitions that $\mathcal D^\mathrm{an}_{X/ Y} \in \mathrm{AnFMP}_{X/ /Y}$. We claim that the latter is a colimit of the diagram \[ \mathcal D^{\mathrm{an}, \bullet}_{X/ Y}. \] We need to show that for every $Z \in \mathrm{AnFMP}_{X/ /Y}$ together with a morphism \[ \mathcal D^{\mathrm{an}, \bullet}_{X/ Y} \to Z, \] then there exists a uniquely defined (up to a contractible space of choices) morphism \[ \mathcal D^\mathrm{an}_{X/ Y} \to Z, \] in the $\infty$-category\xspace $\mathrm{AnFMP}_{X/ /Y}$. Moreover, we are reduced to check this property after base change along any $U \to Y^\wedge_X$, in which case the assertion follows immediately from the construction. \end{proof} \begin{defin} Let $f\colon X \to Y$ be a morphism of locally geometric derived $k$-analytic stacks. Then the \emph{deformation to the normal bundle associated to $f$} is by definition the object $\mathcal D_{X/ Y} \in \mathrm{AnFMP}_{X\times \mathbf A^1_k/ /Y\times\mathbf A^1_k}$, as in \cref{prop:gluing_def}. \end{defin} \subsection{The Hodge filtration} Let $f \colon X \to Y$ be a morphism between locally geometric derived $k$-analytic stacks. In this \S, we will describe the construction of the Hodge filtration on the deformation to the normal bundle $\mathcal D_{X/ Y}^\mathrm{an}$ associated to $f$. We first deal with the $k$-affinoid case: \begin{construction} \label{const:construction_of_Hodge_filtration_in_the_lafp_case} Let $f \colon X \to Y$ be a nil-embedding in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Consider the induced morphism \[ f ^\mathrm{alg} \colon X^\mathrm{alg} \to Y^\mathrm{alg}, \] where $X ^\mathrm{alg} = \Spec A$ and $Y^\mathrm{alg} = \Spec B$, with \[A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg}) \quad \mathrm{and} \quad B \coloneqq \Gamma(Y, \mathcal O_Y ^\mathrm{alg}).\] The morphism $f^\mathrm{alg}$ is a nil-embedding of affine derived schemes (combined \cite[Lemma 6.9]{Porta_Yu_NQK} and \cite[Proposition 3.17]{Porta_Yu_Derived_non-archimedean_analytic_spaces}). Consider then the nil-embedding \[ g \coloneqq f ^\mathrm{alg} \times \mathrm{id}_{\mathbb A^1_k} \colon X \times \mathbb A^1_k \to Y \times \mathbb A^1_k, \] in $\mathrm{dAff}_k$. By Noetherian approximation, we can write $g$ as an inverse limit of the form \[ \lim_{\alpha \in I ^\mathrm{op}} g_\alpha \colon \lim_{\alpha \in I ^\mathrm{op}} X_\alpha \times \mathbb A^1_k \to \lim_{\alpha \in I ^\mathrm{op}} Y_\alpha \times \mathbb A^1_k, \] where $I$ is a filtered $\infty$-category\xspace and for each index $\alpha \in I$, we have that \[ g_\alpha \colon X_\alpha \times \mathbb A^1_k \to Y_\alpha \times \mathbb A^1_k, \] is a closed immersion in the $\infty$-category\xspace $\mathrm{dAff}_k^\mathrm{laft}$. Fix some $\alpha \in I$. Thanks to \cref{prop:algebraic_properties_of_deformation}, there exists a sequence of square-zero extensions of the form \[ X_\alpha \times \mathbb A^1_k = X^{(0)}_\alpha \hookrightarrow X_\alpha^{(1)} \hookrightarrow \dots \hookrightarrow X_\alpha^{(n)} \hookrightarrow \dots \to Y_\alpha \times \mathbb A^1_k, \] such that each term comes equipped with a natural left-lax action of multiplicative monoid $\mathbb A^1_k \in \mathrm{dSt}_k$. \end{construction} \begin{lem} \label{lem:naturality_of_Hodge_filtration_w.r.t_Noetherian_approximation} Let $n \ge 0$, and let $\alpha \to \beta$ be a morphism in $I ^\mathrm{op}$. Then the transition morphism \[ X_\alpha \times \mathbb A^1_k \to X_\beta \times \mathbb A^1_k, \] lifts to a well defined induced morphism \[ X_\alpha^{(n)} \to X_\beta^{(n)}, \] in $\mathrm{dAff}_k^\mathrm{laft}$. \end{lem} \begin{proof} The result follows immediately from the naturality of the construction in \cite[\S 9.5.1]{Gaitsgory_Study_II}. \end{proof} We now introduce the (algebraic) Hodge filtration associated with the closed immersion $f^\mathrm{alg} \colon X^\mathrm{alg} \to Y^\mathrm{alg}$: \begin{defin} \label{defin:algebraic_Hodge_filtration} Let $f \colon X \to Y$ be a nil-isomorphism in the $\infty$-category\xspace $\mathrm{dAfd}_k$. Consider the morphism $g \coloneqq f \times \mathrm{id} \colon X^\mathrm{alg} \times \mathbb A^1_k \to Y^\mathrm{alg} \times \mathbb A^1_k$ above. \cref{lem:naturality_of_Hodge_filtration_w.r.t_Noetherian_approximation} implies that for each $n \ge 0$, we have a well defined object \[ X^{\mathrm{alg}, (n)} \coloneqq \lim_{\alpha \in I^\mathrm{op}} X_\alpha^{(n)} \in \mathrm{dAff}_k, \] which fits into a sequence of square-zero extensions \[ X\times \mathbb A^1_k = X^{ \mathrm{alg}, (0)} \hookrightarrow X^{\mathrm{alg}, (1)} \hookrightarrow \dots \hookrightarrow X^{\mathrm{alg}, (n)} \hookrightarrow \dots \to Y^\mathrm{alg}, \] in $\mathrm{dAff}_k$. We shall refer to the sequence of the $X^{\mathrm{alg}, (n)}$ as the \emph{algebraic Hodge filtration} associated to the morphism $f^\mathrm{alg}$. In the more general case, where $f \colon X \to Y$ exhibits $X$ as an analytic formal moduli problem we define, for each $n \ge 0$, the \emph{$n$-th piece of the Hodge filtration} as \[ X^{(n)} \coloneqq \colim_{S \in (\mathrm{AnNil}^\mathrm{cl}_{X/ /Y})} S^{\mathrm{alg}, (n)}, \] the filtered colimit being computed in the $\infty$-category\xspace $\mathrm{AnFMP}_{X \times \mathbf A^1_k/ }$. \end{defin} \begin{construction} Let $f \colon X \to Y$ be a nil-embedding in the $\infty$-category\xspace $\mathrm{dAfd}_k$. It follows from \cref{prop:algebraic_properties_of_deformation} (4) that we have a natural morphism \begin{align} \label{eq:map_Hodge_filtration_to_deformation} \theta_{X/ Y} \colon \colim_{n \ge 0} X^{\mathrm{alg}, (n)} & \to \lim_{\alpha \in I^\mathrm{op}} \mathcal D_{X_\alpha/ Y_\alpha} \\ & \simeq \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}, \end{align} in the $\infty$-category\xspace $\mathrm{FMP}_{X \times \mathbb A^1_k/ /Y \times \mathbb A^1_k}$. Passing to filtered colimits we produce a natural morphism as in \eqref{eq:map_Hodge_filtration_to_deformation} in the case where $(X \xrightarrow{f} Y) \in \mathrm{AnFMP}_{/ Y}$ and $Y \in \mathrm{dAfd}_k$. \end{construction} The following result implies that the Hodge filtration associated to $f^\mathrm{alg}$ does not depend on choices: \begin{prop} \label{cor:commutation_between_limit_and_colimit_on_Hodge_filtration} Let $(X \xrightarrow{f} Y) \in \mathrm{AnFMP}_{/ Y}$ and $Y \in \mathrm{dAfd}_k$. Then the natural morphism \[ \theta_{X/ Y} \colon \colim_{n \ge 0} X^{\mathrm{alg}, (n)} \to \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}, \] is an equivalence of derived $k$-stacks. \end{prop} \begin{proof} Since both sides of $\theta_{X/ Y}$ are stable under filtered colimits it suffices to treat the case where $f \colon X \to Y$ is a nil-isomorphism of derived $k$-affinoid spaces. We observe that $X \to Y$ exhibits $Y$ as a retract of the morphism \[ X \to X \underset{X_\mathrm{red}}{\bigsqcup} Y. \] Since $\theta_{X/ Y}$ is stable under retracts, we are further reduced to the case where $f$ is a nil-embedding. In this case, the relative cotangent complex \[ \mathbb L_{X^\mathrm{alg}/ Y^\mathrm{alg}} \simeq \mathbb L^\mathrm{an}_{X/ Y}, \] is $1$-connective, see \cite[Lemma 6.9]{Porta_Yu_NQK}. The proof of \cref{lem:Noetherian_approximation_of_nil_isomorphisms} allow us to produce a presentation \[ \lim_{\alpha \in I^\mathrm{op}} (f_\alpha \colon X_\alpha \to Y_\alpha), \] of the morphism $f^\mathrm{alg}$ by closed immersions $f_\alpha \colon X_\alpha \to Y_\alpha$ of affine derived schemes almost of finite presentation parametrized by a filtered $\infty$-category\xspace $I$. The proof of \cref{lem:identification_of_Hodge_and_adic_filtrations}, implies that, for each $\alpha \in I$, the natural morphism \[ X_\alpha^{(n)} \to X_\alpha^{(n+1)}, \] exhibits $X_\alpha^{(n+1)}$ as a square-zero extension of $X_\alpha^{(n)}$ via a natural morphism \[ \mathbb L_{X_\alpha^{(n)}} \to i_{n, *} \Sym^{n+1}(\mathbb L_{X_\alpha/ Y_\alpha}[-1])[1], \] in the $\infty$-category\xspace $\mathrm{Coh}^+(X_\alpha^{(n)})$. In particular, we deduce that, for each $n \ge 0$, the natural morphisms \[ X_\alpha \times \mathbb A^1_k \to X_\alpha^{(n)}, \] are nil-embeddings of affine derived schemes and so are the natural morphisms \[ X ^\mathrm{alg} \times \mathbb A^1_k \to X^{\mathrm{alg}, (n)}. \] We are now able to show that $\theta_{X/ Y}$ is an equivalence in the $\infty$-category\xspace $\mathrm{dSt}_k$. Thanks to \cite[Corollary 4.4.1.3]{Lurie_SAG} combined with \cite[Corollary 4.5.1.3]{Lurie_SAG}, the relative cotangent complex satisfies \[ \mathbb L_{X^\mathrm{alg} \times \mathbb A^1_k/ X^{(n)}} \simeq \colim_{\alpha \in I} h_\alpha^* \mathbb L_{X_\alpha \times \mathbb A^1_k/ X^{(n)}_\alpha} , \] in the $\infty$-category\xspace $\mathrm{QCoh}(X^\mathrm{alg} \times \mathbb A^1_k)$, where $h_\alpha \colon X \to X_\alpha$ denotes the corresponding transition morphisms. Similarly, we have that \[ \mathbb L_{X^\mathrm{alg} \times \mathbb A^1_k/ Y \times \mathbb A^1_k} \simeq \colim_{\alpha \in I} h_\alpha^* \mathbb L_{X_\alpha \times \mathbb A^1_k / Y_\alpha \times \mathbb A^1_k} , \] in the $\infty$-category\xspace $\mathrm{QCoh}(X^\mathrm{alg} \times \mathbb A^1_k)$. Moreover, the latter equivalences are compatible with the left-lax actions of the multiplicative monoid $\mathbb A^1_k \in \mathrm{dSt}_k$ on \[ X^{\mathrm{alg}, (n)} \quad \mathrm{and} \quad X^{(n)}_\alpha, \quad \mathrm{for \ each} \ \alpha \in I, \] over $X^\mathrm{alg} \times \mathbb A^1_k$ (resp. $X_\alpha \times \mathbb A^1_k$). Let $\lambda \in \mathbb A^1_k$ be such that $\lambda \neq 0$. By passing to Serre duals, we deduce from \cref{lem:identification_of_Hodge_and_adic_filtrations} that, for each $\alpha \in I$ and $n \ge 0$, the morphism \begin{equation} \label{eq:cot_complex_for_alpha} \mathbb L_{ (X_\alpha^{(n)})_\lambda} \to \Sym^{n+1}(\mathbb L_{X_\alpha / Y_\alpha}[-1])[1], \end{equation} classifies the square-zero extension associated to the fiber sequence \[ \Sym^{n+1}(\mathbb L_{X_\alpha/ Y_\alpha}[-1]) \to \Sym^{\le n+1} (\mathbb L_{X_\alpha/ Y_\alpha}[-1]) \to \Sym^{\le n} ( \mathbb L_{X_\alpha/ Y_\alpha}[-1]). \] Since \eqref{eq:cot_complex_for_alpha} are stable under filtered colimits, we deduce, for each $n \ge 0$, that the morphism \[ \mathbb L_{X^{\mathrm{alg}, (n)}} \to \Sym^{n+1}(\mathbb L_{X^\mathrm{alg}/ Y^\mathrm{alg}}[-1])[1], \] classifies the square-zero extension given by \[ \Sym^{n+1}(\mathbb L_{X^\mathrm{alg}/ Y^\mathrm{alg}}[-1]) \to \Sym^{\le n+1}(\mathbb L_{X^\mathrm{alg}/ Y^\mathrm{alg}}[-1]) \to \Sym^{\le n}(\mathbb L_{X^\mathrm{alg}/ Y^\mathrm{alg}} [-1]). \] Thanks to \cite[\S 9.5.5.2]{Gaitsgory_Study_II} combined with an analogous Noetherian approximation reasoning as the one employed before we obtain a natural equivalence \[ \mathbb L_{\colim_{n \ge 0}X^{\mathrm{alg}, (n)}_\lambda} \simeq \mathbb L_{X^\mathrm{alg}/ Y^\mathrm{alg}}. \] In particular, thanks to the algebraic version of \cref{prop:conservativity_of_relative_an_cot_complex} we deduce that the natural morphism \[ \colim_{n \ge 0} X^{\mathrm{alg}, (n)} \to \mathcal D_{X^\mathrm{alg}/ Y^\mathrm{alg}}, \] is an equivalence in $\mathrm{FMP}_{X ^\mathrm{alg}}$, for any $\lambda \mathbb A^1_k$ such that $\lambda \neq 0$. For $\lambda = 0$, the precise same reasoning applies using \cite[\S 9, Theorem 5.5.4]{Gaitsgory_Study_II} for the case of vector groups. The proof is thus concluded. \end{proof} We now introduce the \emph{non-archimedean Hodge filtration:} \begin{defin} Let $Y \in \mathrm{dAfd}_k$ and $(X \xrightarrow{f} Y) \in \mathrm{AnFMP}_{/Y}$. For each $n \ge 0$, we define the square-zero extension \[ X \times \mathbf A^1_k \hookrightarrow X^{(n)}, \] as the relative analytification, $(-) ^\mathrm{an}_Y$, of the square-zero extension \[ X ^\mathrm{alg} \times \mathbb A^1_k \hookrightarrow X^{\mathrm{alg}, (n)}, \] introduced in \cref{defin:algebraic_Hodge_filtration}. By construction, for each $n \ge 0$, we have structural morphisms \[ X^{(n)} \to Y \times \mathbf A^1_k. \] We shall refer to the sequence \[ X \times \mathbf A^1_k \coloneqq X^{(0)} \hookrightarrow X^{(1)} \hookrightarrow \dots \hookrightarrow X^{(n)} \hookrightarrow \dots \to Y \times \mathbf A^1_k, \] as the \emph{non-archimedean Hodge filtration associated to the morphism $f$}. \end{defin} Putting together the above results we can easily deduce: \begin{cor} \label{cor:Hodge_filtration_in_the_non-archimedean_setting} There exists a natural morphism \[ \colim_{n \ge 0} X^{(n)} \to \mathcal D^\mathrm{an}_{X/ Y}, \] which is furthermore an equivalence in the $\infty$-category\xspace $\mathrm{AnFMP}_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k}$. \end{cor} \begin{proof} Since the natural functor \[ \mathrm{AnFMP}_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k} \to (\mathrm{dAnSt}_k)_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k}, \] commutes with filtered colimits, we are reduced to prove the statement of the Corollary in the $\infty$-category\xspace $(\mathrm{dAnSt}_k)_{X \times \mathbf A^1_k/ /Y \times \mathbf A^1_k}$. The result is now an immediate consequence of \cref{prop:rel_analytification_preserves_the_deformation} and the fact that relative analytification commutes with filtered colimits (as it is defined as left Kan extension). \end{proof} \begin{cor} Let $f \colon X \to Y$ be a closed immersion of derived $k$-affinoid spaces. Denote by $A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg})$ and $B \coloneqq \Gamma(Y, \mathcal O_Y^\mathrm{alg})$ and $I \coloneqq \mathrm{fib}(B \to A)$. Then the Hodge filtration on $\mathcal D_{X/ Y}^\mathrm{an}$ induces a natural filtration on $B^\wedge_I$, \{$\mathrm{Fil}_H^{n, \mathrm{an}} \}_{n \ge 0}$, together with natural equivalences \[ B/ \mathrm{Fil}^n_H \simeq \Sym^{\le n, \mathrm{an}}(\mathbb L_{X/ Y}^\mathrm{an}[-1]), \] in the $\infty$-category\xspace $\mathrm{CAlg}_k$. \end{cor} \begin{proof} The claim of the proof follows from \cref{lem:identification_of_Hodge_and_adic_filtrations} (2) combined with Noetherian approximation and the fact that the relative analytification functor sends the relative cotangent complex $\mathbb L_{X/ Y}$ to $\mathbb L_{X/ Y}^\mathrm{an}$, c.f. \cite[Theorem 5.21]{Porta_Yu_Representability}. \end{proof} We now globalize the Hodge filtration to geometric derived $k$-analytic stacks: \begin{construction} Let $f \colon X \to Y$ be a morphism of locally geometric derived $k$-analytic stacks. Consider the formal completion \[ X \to Y^{\wedge}_X \to Y, \] of the morphism $f$. Let \[ g \colon U \to Y^\wedge_X, \] be a morphism in the $\infty$-category\xspace $\mathrm{dAnSt}_k$, such that $U \in \mathrm{dAfd}_k$. Form the pullback diagram \[ \begin{tikzcd} X_U \ar{r} \ar{d} & U \ar{d} \\ X \ar{r}{f} & Y^\wedge_X \end{tikzcd} \] in $\mathrm{dAnSt}_k$. Let $V \to U$ be a morphism of derived $k$-affinoid spaces. Consider the pullback diagram \[ \begin{tikzcd} X_V \ar{r} \ar{d} & X_U \ar{d} \\ V \ar{r} & U, \end{tikzcd} \] in the $\infty$-category\xspace $\mathrm{dAfd}_k$. By naturality of the Hodge filtration we deduce that, for each $n \ge 0$, we have natural commutative diagrams \begin{equation} \label{eq:gluing_diagram_of_Hodge_filtrations} \begin{tikzcd} X_V^{(n)} \ar{r} \ar{d} & X_U^{(n)} \ar{d} \\ V \ar{r} & U, \end{tikzcd} \end{equation} of the $n$-th pieces of the Hodge filtrations on $\mathcal D_{X_U/ U}$ and $\mathcal D_{X_V/ V}$, respectively. \end{construction} \begin{lem} \label{lem:preservation_of_Hodge_filtration_under_pullback} The commutative square in \eqref{eq:gluing_diagram_of_Hodge_filtrations} is a pullback square in the $\infty$-category\xspace $\mathrm{dAfd}_k$. \end{lem} \begin{proof} As in the proof of \cref{cor:commutation_between_limit_and_colimit_on_Hodge_filtration}, we can reduce the statement to the case where $X_U \to U$ is a nil-embedding in the $\infty$-category\xspace $\mathrm{dAfd}_k$ in which case so it is $X_V \to V$. Thanks to \cref{lem:relative_anlaytification_of_closed_immersions_are_compatible_with_alg_construction} it suffices to prove that for each $n \ge 0$, the induced diagram \[ \begin{tikzcd} X_V^{\mathrm{alg}, (n)} \ar{r} \ar{d} & X_U^{\mathrm{alg}, (n)} \ar{d} \\ V ^\mathrm{alg} \ar{r} & U^\mathrm{alg} \end{tikzcd}, \] is a pullback square in $\mathrm{dAff}_k$. By a standard argument of Noetherian approximation, we might assume that $U' \coloneqq U^\mathrm{alg} $ and $V' \coloneqq V^\mathrm{alg}$ are both affine derived schemes almost of finite presentation. We observe that for each $n \ge 0$, the morphisms \[ g_n \colon X_{V'}^{(n)} \to X_{U'}^{(n)}, \] are left-lax $\mathbb A^1_k$-equivariant. For this reason, they induce morphisms \[ g_{n, *}^\mathrm{IndCoh}( \mathbb T_{X^{(n)}_{V'}/ V'})) \to \mathbb T_{X^{(n)}_{U'} / U'} , \] in the $\infty$-category\xspace $\mathrm{Ind}\mathrm{Coh}(X_{V'}^{(n)})^\mathrm{fil}$. In particular, we have an induced morphism at the $n$-th piece of the filtration \[ g_{n, *}^\mathrm{IndCoh}\big( \mathrm{Sym}^{n+1}(\mathbb T_{X^{(n)}_{U'}/ U'}[-1])[1]\big) \to \Sym^{n+1}\big( \mathbb T_{X^{(n)}_{V'} / V'}[-1]\big)[1], \] (c.f. \cite[Theorem 9.5.1.3]{Gaitsgory_Study_II}). The result is now a direct consequence of \cref{prop:algebraic_properties_of_deformation} (3) combined with \cite[Proposition 5.12]{Porta_Yu_Representability} and \cite[Proposition 2.5.4.5]{Lurie_SAG}. \end{proof} \begin{construction} Let $f \colon X \to Y$ be a locally geometric derived $k$-analytic stack. Denote by $(Y^\wedge_X)^\mathrm{afd}$ the $\infty$-category\xspace of morphisms in $\mathrm{dAnSt}_k$ \[ U \to Y^\wedge_X, \] where $U$ is derived $k$-affinoid. Consider the relative analytification functor \begin{align*} \lim_{U \in (Y^\wedge_X)^\mathrm{afd}} (-)^\mathrm{an}_U \colon\lim_{U \in (Y^\wedge_X)^{\mathrm{afd}}} (\mathrm{dSt}_k)_{/ U^\mathrm{alg} \times \mathbb A^1_k} & \to \lim_{U \in (Y^\wedge_X)^{\mathrm{afd}}} (\mathrm{dAnSt}_k)_{/ U \times \mathbf A^1_k} \\ & \simeq (\mathrm{dAnSt}_k)_{/ Y^\wedge_X \times \mathbf A^1_k}. \end{align*} Thanks to \cref{lem:preservation_of_Hodge_filtration_under_pullback}, for each $n \ge 0$, the algebraic Hodge filtration defines a well defined object in the limit \[ \{ X^{\mathrm{alg}, (n)}_{U} \}_{U \in (Y^\wedge_X)^\mathrm{afd}} \in \lim_{n \ge 0} (\mathrm{dSt}_k)_{/ U^\mathrm{alg}}. \] Therefore, after taking its relative analytification we produce well defined objects \[X^{(n)} \in (\mathrm{dAnSt}_k)_{Y^\wedge_X \times \mathbf A^1_k},\] which we shall refer to as the \emph{Hodge filtration associated to the morphism $f$}. Moreover, it follows essentially by construction that the latter restricts to the usual Hodge filtration, for each \[ g \colon U \to Y^\wedge_X, \] in $(Y^\wedge_X)^\mathrm{afd}$. Moreover, by construction we have a natural morphism \[ \colim_{n \ge 0} X^{(n)} \to \mathcal D_{X/ Y} ^\mathrm{an}, \] which is an equivalence in the $\infty$-category\xspace $\mathrm{dAnSt}_k$. \end{construction} We can thus summarize the previous results in the form of a main theorem: \begin{thm} \label{thm:main_thm} Let $f \colon X \to Y$ be a morphism of locally geometric derived $k$-analytic stacks. Then the following assertions hold: \begin{enumerate} \item There exists a deformation to the normal bundle $\mathcal D_{X/ Y}^\mathrm{an} \in (\mathrm{dAnSt}_k)_{\mathbf A^1_k}$ such that its fiber at $\{0 \} \subseteq \mathbf A^1_k$ coincides with the shifted $k$-analytic tangent bundle \[ \mathbb T_{X/Y}^\mathrm{an}[1]^\wedge , \] completed at the zero section $s_0 \colon X \to \mathbb T^\mathrm{an}_{X/ Y}[1]$. Moreover, its fiber at $\lambda \neq 0$ coincides with the formal completion $Y^\wedge_X$ of $Y$ at $X$ along $f$; \item The object $\mathcal D_{X/ Y}^\mathrm{an}$ admits a left-lax equivariant action of the (multiplicative) monoid-object $\mathbf A^1_k$ in $\mathrm{dAnSt}_k$; \item There exists a sequence of left-lax $\mathbf A^1_k$-equivariant morphisms admitting a deformation theory \[ X \times \mathbf A^1_k = X^{(0)} \hookrightarrow X^{(1)} \hookrightarrow \dots \hookrightarrow X^{(n)} \hookrightarrow \dots \to Y \times \mathbf A^1_k. \] Assume further that $f\colon X \to Y$ is a closed immersion of derived $k$-analytic spaces then, for each $n \ge 0$, the relative $k$-analytic cotangent complex \[ \mathbb L^\mathrm{an}_{X^{(n)}/ Y} \in \mathrm{Coh}^+(X^{(n)}), \] is equipped with a (decreasing) filtration such that its $n$-th piece identifies canonically with $\Sym^{n+1}(\mathbb L^\mathrm{an}_{X/ Y}[-1])[1]$. Moreover, for each $n \ge 0$, the morphisms $X^{(n)} \to X^{(n+1)}$ are square-zero extensions obtained via a canonical composite \[ \mathbb L^\mathrm{an}_{X^{(n)}} \to \mathbb L^\mathrm{an}_{X^{(n)}/ Y} \to \Sym^{n+1}(\mathbb L_{X/ Y}^\mathrm{an}[-1])[1], \] in $\mathrm{Coh}^+(X^{(n)})$; \item We have a natural morphism \[ \colim_{n \ge 0} X^{(n)} \to \mathcal D_{X/ Y}^\mathrm{an}, \] which is furthermore an equivalence in the $\infty$-category\xspace $\mathrm{dAnSt}_k$; \item Assume that $f \colon X \to Y$ is a locally complete intersection morphism of derived $k$-affinoid spaces with $A \coloneqq \Gamma(X, \mathcal O_X^\mathrm{alg})$ and $B \coloneqq \Gamma(Y, \mathcal O_Y^\mathrm{alg})$. Then the corresponding filtration on (derived) global sections of the formal completion $Y^{\wedge}_X$ (via points (1) and (3)) identifies canonically with the $I$-adic filtration on $B$, where $I \coloneqq \mathrm{fib}(B \to A)$. \end{enumerate} \end{thm} \begin{proof} Claim (1) follows immediately from \cref{lem:identification_of_non-archimedean_fibers}. Assertion (2) follows immediately from \cref{prop:rel_analytification_preserves_the_deformation}, as in the algebraic case, the deformation $\mathcal D_{X^\mathrm{alg}/ Y}$ admits a natural left-lax $\mathbb A^1_k$-equivariant action. The statement in point (4) is essentially the content of \cref{cor:Hodge_filtration_in_the_non-archimedean_setting} and point (3) follows from the construction of the Hodge filtration in the non-archimedean setting combined with Noetherian approximation (for the relative cotangent complex) and \cref{prop:algebraic_properties_of_deformation} (3). Finally, claim (4) follows readily from \cref{lem:identification_of_Hodge_and_adic_filtrations} and the fact that both the Hodge filtration and the $I$-adic filtrations are compatible via relative analytification. \end{proof} \bibliographystyle{alpha}

INTRODUCTION ============ The emergence of CRISPR-Cas technologies ([@R1]--[@R3]) enabled detailed genomic studies and brought a targeted therapy of genetic diseases into closer reach. The fidelity of the Cas nuclease, i.e., selectivity for the single-guide RNA (sgRNA)--matching genomic target locus as compared to OFF-target sites exhibiting partial complementarity to the RNA guide, is a key parameter to be considered for CRISPR applications. While fidelity varies between Cas orthologs ([@R4]--[@R7]) and strongly depends on the sgRNA design ([@R8]--[@R10]), target locus sequence ([@R5], [@R6], [@R11]), and mode of delivery ([@R12]), generalizable strategies to reduce OFF-target editing are highly desired. Previous studies used directed evolution or structure-guided protein engineering to identify point mutations in the Cas enzyme that reduce OFF-target editing ([@R13]--[@R19]). Complementary efforts devised rules for the design of target-specific sgRNAs ([@R8]--[@R10]). While generally very powerful, these strategies demand users to use specific CRISPR-Cas components and are often limited to a single Cas9 ortholog. Anti-CRISPR (Acr) proteins, i.e., naturally occurring CRISPR-Cas inhibitors ([@R20], [@R21]), offer flexible strategies to regulate CRISPR-Cas activity and thereby to enhance the specificity of genome perturbations. Among these is AcrIIA4, a potent inhibitor of the *Streptococcus pyogenes* (*Spy*)Cas9 ([@R22]), which binds Cas9-sgRNA complexes with subnanomolar affinity ([@R23]) and impairs DNA targeting as well as nuclease function ([@R24]). Recent data show that administering AcrIIA4 shortly after *Spy*Cas9-sgRNA delivery can reduce OFF-target editing ([@R25]), likely due to the slower editing kinetics at OFF-target sites as compared to perfect targets ([@R26], [@R27]). This strategy, however, has essential limitations. Sequential delivery is highly sensitive with respect to the delivery efficacy. At 50% transfection rate, for instance, only half of the cells that received Cas9/gRNA in the first transfection will also receive the Acr in the second transfection. In the other half, Cas9 would, undesirably, remain active, resulting in off-target effects. Moreover, the requirement of two separate, precisely timed delivery steps (one for Cas9-sgRNA and one for the Acr) is difficult to implement in a number of relevant application settings, e.g., in a therapeutic scenario. To address these limitations, we here used a combination of mathematical modeling and experiments to determine Cas9 activity profiles that strongly favor ON-target over OFF-target editing events. We first show that artificially attenuated anti-CRISPR proteins either coexpressed with or fused to Cas9 can be used to fine-tune Cas9 activity to selected levels, thereby strongly increasing target specificity. Then, by calibrating our mathematical model with the obtained experimental data and additional time-lapse measurements, we quantitatively characterized ON- and OFF-target editing efficiencies depending on the target locus properties and time integral of Cas9 activity. Our original method facilitates the in silico prediction and subsequent implementation of Cas9 activity profiles that effectively insulate ON- and OFF-target editing events. RESULTS ======= Fine-tuning Cas9 achieves kinetic insulation of ON- and OFF-target editing events --------------------------------------------------------------------------------- To investigate the possibility of insulating ON- and OFF-target editing events by fine-tuning Cas9 activity, we first devised a simple mathematical model consisting of coupled ordinary differential equations (ODEs). Our model captures the major molecular steps underlying Cas9-mediated editing in cells, namely, (i) transient expression of sgRNA and Cas9 after transfection, (ii) formation of Cas9-sgRNA complexes, (iii) binding of the complex to a genomic target locus, and (iv) target locus cleavage ([Fig. 1A](#F1){ref-type="fig"} and table S1, see Materials and Methods for details). In this simple model, the level of Cas9-mediated target cleavage mainly depends on two parameters: the time integral of active Cas9-sgRNA complexes present in a cell and the affinity of the Cas9-sgRNA complex to a given genomic locus. High affinity of Cas9-sgRNA to a given locus, as would be expected for perfect target sites, would thereby result in a high percentage of gene-edited cells ([Fig. 1B](#F1){ref-type="fig"}). In contrast, lower affinities, as would be expected for OFF-target loci, require larger time integrals of active Cas9-sgRNA complexes ([Fig. 1B](#F1){ref-type="fig"}). Notably, at sufficiently large time frames, the editing of ON-target and OFF-target loci will both reach saturation. Our model qualitatively predicts that by fine-tuning the amount of (active) Cas9-sgRNA complex to specific levels, editing at "high-affinity" loci (ON-targets) can be insulated from editing at "low-affinity" loci (OFF-targets) ([Fig. 1B](#F1){ref-type="fig"}). {#F1} We hypothesized that anti-CRISPR proteins such as AcrIIA4 could provide a simple means to fine-tune Cas9 activity to selected levels and, therefore, to test our model prediction. We thus cotransfected human embryonic kidney (HEK) 293T cells with vectors encoding AcrIIA4, Cas9, and a previously reported sgRNA targeting the human AAVS1 locus, which exhibits particularly strong OFF-target editing at two additional loci ([Fig. 1C](#F1){ref-type="fig"}) ([@R28]). During transfection, we used relatively low AcrIIA4 vector doses (\~3- to 130-fold excess of Cas9 and sgRNA vector), as ON-target editing would be completely blocked at higher Acr doses ([@R25], [@R29]). Seventy-two hours after transfection, we measured the frequency of insertions and deletions (InDels) at the AAVS1 locus and relevant OFF-target loci using T7 endonuclease assay and tracking of indels by decomposition (TIDE) sequencing. In line with the model prediction, we observed a potent reduction in OFF-target editing but only mild reduction in ON-target editing at selected Acr vector doses ([Fig. 1, D and E](#F1){ref-type="fig"}, and fig. S1). To test whether this effect was independent of the specific cellular context and compatible with different modes of delivery, we packaged the different component of our system (Cas9, sgRNA, and AcrIIA4) into adeno-associated virus (AAV) vectors ([Fig. 1C](#F1){ref-type="fig"}), which are prime vector candidates for gene therapy applications ([@R30]). For our experiments, we chose AAV serotype-2 (AAV2) that is able to efficiently transduce various cell lines ([@R31]). We coinfected HEK 293T, HeLa (cervix carcinoma), and Huh-7 (hepatocellular carcinoma) cells with AAV2 particles encoding (i) Cas9, (ii) an sgRNA targeting the AAVS1 locus, or (iii) a previously reported AcrIIA4 variant ([@R29]) and measured InDel frequencies at the ON- and OFF-target loci. Again, at low Acr vector doses, we observed potent ON-target editing, while OFF-target editing was effectively suppressed (fig. S2). Next, we investigated whether the identical strategy could also improve specificity when editing a different target site, namely, hemoglobin subunit beta (HBB). While separation of ON- and OFF-target editing was rather difficult when applying transient transfection for delivery of Cas9, AcrIIA4, and the HBB-targeting RNA guide (fig. S3), AAV-mediated delivery selectively limited OFF-target editing ([Fig. 1F](#F1){ref-type="fig"} and fig. S1). This notable difference between delivery methods is likely due to the more homogeneous expression of constructs from AAV vectors as compared to the rather heterogeneous expression expected after transient transfection. This, in turn, allows a more precise fine-tuning of Cas9 activity in individual cells and thereby a more efficient kinetic insulation of ON- and OFF-target editing events. Cas-Acr fusions improve genome editing fidelity ----------------------------------------------- While coexpression of Acrs as shown above offers a highly flexible strategy to improve Cas9 specificity without the necessity of altering Cas9 or the sgRNA itself, this approach is rather sensitive with respect to the Acr dose. Moreover, the amounts of Cas9, sgRNA, and Acr and thus the ratio of the Cas9-sgRNA complex to Acr will vary between individual cells after co-delivery into a population of cells. Thus, there will be a considerable fraction of cells, in which inhibition is either too weak to reduce OFF-target editing or too strong to allow ON-target editing, both of which is undesired. We hypothesized that a more robust fine-tuning of Cas9 activity could be achieved by covalently linking Acrs to Cas9 via genetic fusion, thereby eliminating the problem of varying Acr to Cas9-sgRNA complex ratios. In this configuration, which in the following we refer to as Cas-Acr, every Cas9 molecule carries its own inhibitory domain and therefore can exist in an active or an inactive state. At equilibrium, the fractions of molecules populating the active or inactive states depend on the strength of the fused Acr, i.e., by modulating the Acr strength, Cas9 activity can be fine-tuned to desired levels ([Fig. 2A](#F2){ref-type="fig"}). As one might expect, fusing wild-type AcrIIA4 to Cas9 blocks Cas9 activity (almost) entirely ([Fig. 2, B to G](#F2){ref-type="fig"}, Cas9 wt samples). Thus, to enable the envisaged fine-tuning, we used a previously reported set of AcrIIA4 domain insertion mutants (fig. S4) ([@R29]) as well as AcrIIA4 point mutants ([@R32]), which display various Cas9 inhibition potencies when coexpressed with Cas9. We then fused these attenuated AcrIIA4 variants to the Cas9 C terminus via long (40 residue) glycine-serine linkers and prescreened the resulting 10 Cas-Acr variants using the previously used AAVS1 and HBB locus targeting sgRNAs. As hoped, a number of Cas-Acr variants not only showed ON-target editing efficiencies comparable to wild-type Cas9 but also displayed strongly reduced OFF-target editing (fig. S5). We then selected three Cas-Acr variants (Ins. 5, N39A, and D14A/G38A in fig. S5) that showed different levels of specificity gain and compared their ON- and OFF-target editing frequencies with that of wild-type Cas9 using five different sgRNAs. Genome editing specificity was strongly improved for all Cas-Acr variants as we observed in T7 endonuclease experiments ([Fig. 2, B to G](#F2){ref-type="fig"}, and fig. S6) and further confirmed by targeted amplicon sequencing (fig. S7). In several cases, e.g., for HEK, RUNX, and EMX, this improvement came at the cost of reduced ON-target editing ([Fig. 2, B to G](#F2){ref-type="fig"}, and figs. S6 and S7). Using a Cas-Acr fusion based on a particularly weak inhibitor (AcrIIA4 mutant D14A/Y15A) not only improved ON-target editing for these sgRNAs but also markedly increased OFF-target editing ([Fig. 3](#F3){ref-type="fig"} and fig. S8; Cas-Acr samples). This suggests an intrinsic trade-off between the gain in specificity and reduction in ON-target editing that can be achieved, which is dependent on the used sgRNA. {#F2} {#F3} Next, we compared side-by-side our Cas-Acr variants to the latest generation of high-fidelity Cas9s, namely, HypaCas9 ([@R19]), xCas9 ([@R15]), and Sniper-Cas9 ([@R14]). We found that the high-fidelity Cas9 benchmarks showed a very diverse behavior when combined with different sgRNAs ([Fig. 3](#F3){ref-type="fig"} and fig. S8). Sniper-Cas9, for example, was potent and specific when using the HBB sgRNA but showed strong off-target editing when combined with the AAVS1 and RUNX sgRNAs. HypaCas9 and xCas9, on the other hand, performed particularly well in combination with the EMX sgRNA. HypaCas9, however, showed diminished ON-target editing for HBB and RUNX, and xCas9 showed particularly prominent off-targeted editing for AAVS1. The Cas-Acr fusions achieved highest specificity on AAVS1 but were outperformed by at least one of the benchmarks on the other three loci. Together, these results suggest that (i) kinetic insulation can be very powerful on specific loci (e.g., AAVS1) and (ii) even the latest generation of high-fidelity Cas9 variants still show strong OFF-target editing for some sgRNAs, an issue that might be addressable, at least in part, via kinetic insulation (see Discussion). A quantitative model of Cas-Acr action explains locus-dependent specificity gains --------------------------------------------------------------------------------- To quantitatively characterize the relation between ON-target editing efficiency and specificity in detail in the context of our Cas-Acr fusion approach, we extended our initial model by including the inhibitory states of Cas-Acr variants ([Fig. 4A](#F4){ref-type="fig"}). In particular, the model explains the transient expression of sgRNA, Cas9 or Cas-Acr mRNA, and Cas9 or Cas-Acr protein in transfected cells. Cas9 and active as well as inactive Cas-Acr proteins can be reversibly bound to sgRNA molecules. Cas-Acr is reversibly inactivated by the fused Acr. Thereby, the model effectively describes how the ratio between activation and inactivation rates of Cas-Acr variants is related to the time integral of active complexes of Cas-Acr:sgRNA (see Materials and Methods and tables S1, S6, and S7 for details). {#F4} The model was calibrated with experimental data on editing frequencies after transient expression of Cas9, Cas-Acr containing unmodified AcrIIA4, as well as Cas-Acr variants "Ins. 5," "N39A," and "D14A/G38A" ([Fig. 4B](#F4){ref-type="fig"} and fig. S9; see fig. S10 for the complete set of model fits and data and Materials and Methods for details). Moreover, the model was calibrated with time-lapse measurements of Cas9--green fluorescent protein (GFP) and mCherry-AcrIIA4 expression recorded by life-cell fluorescence microscopy (fig. S9). For parameter estimation, the model was fitted to time-resolved ON- and OFF-target editing efficiencies as observed for the AAVS1-targeting sgRNA in combination with different Cas-Acr variants as well as wild-type Cas9 (fig. S9). The model was further fitted to ON- and OFF-target efficiencies measured for the EMX1, RUNX1, and HEK locus when using wild-type Cas9 as well as ON-target editing frequencies measured for the different Cas-Acr variants. Corresponding OFF-target editing data for the Cas-Acr variants were used for model validation. Simulations using the calibrated model predicted the experimentally measured OFF-target rates in the Cas-Acr validation dataset with high precision ([Fig. 4C](#F4){ref-type="fig"} and fig. S10). Last, the calibrated model was used to quantitatively dissect the kinetic insulation of ON- and OFF-target editing events by Cas-Acr. Simulated editing efficiencies at ON- and OFF-target sites followed sigmoidal curves dependent on the strength of the Cas9-fused inhibitor ([Fig. 4, D and E](#F4){ref-type="fig"}, and fig. S11). Notably, inhibitor strengths of the Cas-Acr variants D14A/G38A, Ins. 5, and N39A are all in the regions of the maximal slope of the ON-target editing efficiency curves but below the region of maximal slopes of the OFF-target editing efficiency curves for the studied sgRNAs, explaining why these variants are well suited for insulation of ON- and OFF-target editing events. According to parameter estimates, transition rates to the inhibited state of the Cas-Acr variants carrying AcrIIA4 mutants were decreased by factors between 16 and 19 relative to the Cas-Acr variant containing wild-type AcrIIA4, explaining why these variants still enable potent ON-target editing (table S7). To further characterize the capability of tuning the activity of Cas9, we simulated the ratio between ON- and OFF-target editing efficiencies ([Fig. 4, E and F](#F4){ref-type="fig"}). The dependence of this ratio on the strength of the Cas9-fused inhibitor was reflected by sigmoidal curves for each of the edited genes ([Fig. 4E](#F4){ref-type="fig"}). Notably, inhibitor strengths of the variants Ins. 5, N39A, and D14A/G38A were in the upper-to-medium part of the sigmoidal curves ([Fig. 4E](#F4){ref-type="fig"}). Together, these data show that the Cas-Acr variants hit the desired "sweet spot" in the Cas9 activity profile characterized by efficient insulation of ON- and OFF-target events ([Fig. 4F](#F4){ref-type="fig"}). DISCUSSION ========== The specificity of Cas nucleases is a critical parameter to consider when applying the CRISPR technology in both basic research and gene therapy. Using a combination of mathematical modeling and wet-lab experiments, we here showed that Cas9 activity can be fine-tuned to selected levels by either coexpression of or covalent fusion to (attenuated) anti-CRISPR proteins, thereby selectively limiting off-target editing. From a mechanistic point of view, our approach harnesses a simple principle derived from enzyme kinetics, i.e., we increase the competition between optimal and suboptimal substrates (ON- and OFF-target sites, respectively) by reducing the pool of active enzyme (Cas9) to desired levels. The editing kinetics at ON- and OFF-target loci is dependent on physical constraints (e.g., affinity of Cas9-sgRNA to respective loci), which are specific to each sgRNA and target locus. The greater the difference is between editing kinetics at ON- and OFF-target sites, the easier it is to kinetically insulate ON- and OFF-target editing events. This explains why, for AAVS1, OFF-target editing can be reduced without affecting ON-target editing, while for other loci such as EMX and HEK, reduction in OFF-target editing will---to some extent---also affect the ON-target editing efficiency. Still, even in the latter cases, the reduction in OFF-target editing is greater than that in on-target editing, i.e., overall, there is a gain in specificity. While fine-tuning of Cas9 activity could, in principle, also be achieved by either reducing the Cas9 expression level or the time in which Cas9 is active, both of these strategies are more difficult to put into practice, at least when delivering genetic constructs encoding the different components. Reducing the expression level would typically require reducing vector doses, which might unintendedly reduce transfection/transduction rates and also increase heterogeneity, both of which is highly undesired. Confining the time in which Cas9 is active either requires external control, e.g., via chemicals ([@R33], [@R34]) or light ([@R29], [@R35]), or depends on synthetic circuits mediating a negative feedback, which might be more difficult to tweak toward desired levels of Cas9 activity ([@R36]). In contrast, our Cas-Acr approach is simple and compatible with different modes of delivery and functions robustly for various loci and in different cell lines. In addition, our calibrated model of gene editing by Cas-Acr variants can inform the optimization of future gene editing experiments. If ON- and OFF-targeting efficiencies resulting from gene editing with wild-type Cas9 are known, the model can be used to predict ON- and OFF-targeting efficiencies for Cas-Acr variants to select an optimal construct. Furthermore, our model can be used to predict the maximally achievable increase in the specificity for different genes and sgRNAs. Thereby, our model can assist the implementation of the kinetic insulation principle developed in this work. ON- and OFF-target editing would be expected to follow specific kinetic trajectories for practically any Cas enzyme, as the basic physical properties that contribute to the different kinetics (e.g., locus-specific affinity of the Cas-sgRNA complex) apply to any CRISPR nuclease. We thus speculate that the principle of kinetic insulation applied in this work should be easily transferrable to other CRISPR-Cas systems. Moreover, the ongoing rapid discovery and characterization of anti-CRISPR proteins improve our ability to fine-tune the activity of Cas enzymes in time and space ([@R29], [@R37]). Last, we note that the strategies developed in this work, in particular the Cas-Acr fusion variants, are not meant to replace existing high-fidelity CRISPR-Cas variants, the latter of which provide a great resource to the community. On the contrary, we believe that in the future, a combination of several approaches, such as engineered Cas enzymes, improved sgRNAs and, additionally, kinetic control, e.g., via attenuated Acr variants as shown here, will likely be applied to maximize efficiency and specificity in CRISPR genome editing. Together, our Cas-Acr constructs in combination with the calibrated mathematical model represent a powerful resource to enhance the precision of CRISPR-Cas genome perturbations in living cells by fine-tuning Cas9 activity. MATERIALS AND METHODS ===================== Plasmids -------- All vectors were created by classical restriction enzyme cloning. Oligonucleotides as well as synthetic, double-stranded DNA fragments (gBlocks) were obtained from Integrated DNA Technologies. A list of all constructs used or created in this study is shown in table S3, and annotated vector sequences (GenBank files) are provided in data file S1. Vectors expressing Cas9, Cas9 fused to GFP (Cas9-GFP), wild-type AcrIIA4, different AcrIIA4-LOV2 hybrids, or a U6 promoter--driven sgRNA bearing the improved F+E scaffold ([@R38]) have been previously reported by us ([@R29], [@R37]) (see Addgene no. 113033-113039). The mCherry-AcrIIA4 vector was created by fusing an mCherry coding sequence to the N terminus of wild-type AcrIIA4 using overlap extension polymerase chain reaction (PCR). A construct expressing Cas9 fused to wild-type AcrIIA4 via a 40-residue glycine-serine (GS) linker was created by cloning a synthetic DNA fragment encoding the GS linker--AcrIIA4 fragment into vector CMV-*Spy*Cas9 (Addgene no. 103033) via Eco RI/Hind III. The AcrIIA4 fragment in the resulting construct was subsequently replaced by PCR fragments encoding AcrIIA4-LOV2 fusions or AcrIIA4 point mutants via Bam HI/Hind III. To generate the AcrIIA4-LOV2 PCR fragments, our previously reported AcrIIA4-LOV2 vectors were used as template ([@R29]). The AcrIIA4 point mutants were created by first amplifying a vector encoding wild-type AcrIIA4 (Addgene no. 113037) with 5′-phosphorylated primers introducing the point mutation(s). The resulting vectors were then used as template to generate PCR fragments encoding AcrIIA4 mutants. sgRNA expression vectors were created by inserting target complementary sequences into vector pAAV--RSV--GFP--U6--sgRNA scaffold (Addgene no. 113039) by oligo cloning via Bbs I. BPK4410, a human expression plasmid for SpCas9 Cluster 1 (HypaCas9), was a gift from J. Doudna and K. Joung (Addgene plasmid no. 101178; <http://n2t.net/addgene:101178>; RRID:Addgene_101178). xCas9 3.7 was a gift from D. Liu (Addgene plasmid no. 108379; <http://n2t.net/addgene:108379>; RRID:Addgene_108379). p3s-Sniper-Cas9 was a gift from J. Lee (Addgene plasmid no. 113912; <http://n2t.net/addgene:113912>; RRID:Addgene_113912). In all cloning procedures, PCRs were performed using Q5 Hot Start High-Fidelity DNA Polymerase \[New England Biolabs (NEB)\] followed by agarose gel electrophoresis to analyze PCR products. Bands of the expected size were cut out from the gel, and the DNA was purified by using the QIAquick Gel Extraction Kit (Qiagen). Restriction digests and ligations were performed with corresponding enzymes from NEB by applying the manufacturer's protocols. Following ligation, plasmids were transformed into chemically competent Top10 cells, and plasmids were extracted and purified using the QIAamp DNA Mini or Plasmid Plus Midi Kit (all from Qiagen). Cell culture ------------ Before use, all cell lines were authenticated and tested negative for mycoplasma contamination via a commercial service (Multiplexion, Heidelberg). Cells were maintained at 5% CO~2~ and at 37°C in a humidified incubator and passaged every 2 to 4 days, i.e., when reaching 70 to 90% confluency. HEK 293T and HeLa cells were cultivated in 1× Dulbecco's modified Eagle's medium supplemented with 2 mM [l]{.smallcaps}-glutamine, penicillin (100 U/ml), streptomycin (100 μg/ml) (all Thermo Fisher Scientific), and 10% (v/v) fetal calf serum (Biochrom AG). The Huh-7 medium was additionally supplemented with 1 mM nonessential amino acids (Thermo Fisher Scientific). AAV lysate production --------------------- Low-passage HEK 293T cells were used for the production of AAV-containing cell lysates. Cells were seeded into six-well plates (CytoOne) at a density of 350,000 cells per well. The following day, cells were triple-transfected with (i) an AAV helper plasmid carrying AAV2 rep and cap genes, (ii) an adenoviral plasmid providing helper functions for AAV production, and (iii) the AAV vector plasmid using 1.33 μg of each construct and 8 μl of TurboFect Transfection Reagent (Thermo Fisher Scientific) per well. The AAV vector plasmid encoded either (i) a U6 promoter--driven sgRNA targeting the AAVS1 locus as well as an RSV promoter--driven GFP (used as transduction reporter), (ii) Cas9, or (iii) the AcrIIA4 variant (LOV2-AcrIIA4 Insertion 3 in table S2; Addgene no. 113036). Three days after transfection, cells were collected in 300 μl of phosphate-buffered saline (PBS) and subjected to five freeze-thaw cycles by alternating between snap-freezing in liquid nitrogen and 37°C in a water bath. Centrifugation at 18,000*g* was applied for 10 min to remove cell debris, and the supernatant containing AAV particles was stored at 4°C until use. T7 endonuclease assay, TIDE sequencing, and targeted amplicon sequencing ------------------------------------------------------------------------ Table S4 shows the genomic ON-target/OFF-target sites relevant to this study. For transfection-based T7 assays, HEK 293T cells were seeded at a density of 12,500 cells per well and a culture volume of 100 μl per well into 96-well plates (Eppendorf). The following day, cells were transfected with jetPRIME (Polyplus-transfection) using 0.3 μl of jetPrime reagent per well and as detailed in the following. For experiments shown in [Fig. 1E](#F1){ref-type="fig"} and figs. S2 and S3, cells were cotransfected with (i) 66 ng of Cas9 expression construct, (ii) 66 ng of sgRNA constructs, and (iii) different doses of Acr construct as indicated in the figures. To keep the total amount of DNA transfected constant between all samples, DNA was topped up to 200 ng per well using an irrelevant vector. For experiments shown in [Fig. 2](#F2){ref-type="fig"} and figs. S4, S5, S6, and S7C, cells were cotransfected with (i) 66 ng of Cas9 or Cas-Acr vector, (ii) 66 ng of sgRNA expression construct, and (iii) 66 ng of an irrelevant stuffer DNA. For transduction-based T7 assays, HEK 293T cells were seeded at a density of 3500 cells per well, and HeLa and Huh-7 cells were seeded at a density of 3000 cells per well into 96-well plates. The following day, cells were cotransduced with 33 μl of Cas9 AAV lysate, 33 μl of sgRNA AAV lysate, and the indicated volume of AcrIIA4 AAV lysate. The transduction volume was always topped up with PBS to a total volume of 100 μl. The transduction was repeated 24 hours after the first transduction. Seventy-two hours after transfection or after (first) transduction, the medium was aspirated and cells were lysed using DirectPCR lysis reagent (VIAGEN Biotech) supplemented with proteinase K (Sigma-Aldrich). For T7 assays and TIDE sequencing, the genomic target locus and relevant off-target loci were PCR-amplified with primers flanking the corresponding ON-target/OFF-target sites (table S5) using Q5 Hot Start High-Fidelity DNA Polymerase (NEB). For TIDE sequencing analysis, PCR amplicons were purified from 1% agarose gels using the QIAquick Gel Extraction Kit (Qiagen) followed by Sanger sequencing (Eurofins, Germany). Percentages of modified sequences were quantified using the TIDE web tool (<https://tide.deskgen.com/>). For T7 assays, five microliters of PCR amplicon was diluted 1:4 in buffer 2 (NEB), and then heated up to 95°C and slowly cooled down to room temperature to allow heteroduplex formation using nexus GSX1 Mastercycler (Eppendorf) and the following temperature steps: 95°C/5 min, 95° to 85°C at −2°C per second, 85° to 25°C at −0.1°C per second. Then, 0.5 μl of T7 endonuclease (NEB) was added; samples were mixed and incubated for 15 min at 37°C. Next, gel loading dye (NEB) supplemented with 1% GelRed (Biotium) was added and samples were then loaded onto 2% tris-borate-EDTA agarose gels. Voltage (100 V) was applied for 40 min to resolve DNA fragments. The Gel iX20 system equipped with a 2.8-megapixel/14-bit scientific-grade charge-coupled device camera (INTAS) was used for gel documentation. To calculate the InDel percentages from the gel images, T7 bands were quantified using the ImageJ (<http://imagej.nih.gov/ij/>) gel analysis tool. Peak areas were measured, and percentages of insertions and deletions \[InDel (%)\] were calculated using the formula indel (%) = 100 × (1 − (1 − fraction cleaved)^½^), whereas the fraction cleaved = ∑(cleavage product bands)/∑(cleavage product bands + PCR input band). Full-length T7 assay gel images are shown in fig. S12. For targeted amplicon sequencing, a first-step PCR was performed by PCR amplifying the genomic ON-target/OFF-target loci with primers carrying 5′ Illumina Nextera sequencing adaptors (forward: 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-\[locus-specific sequence\]-3′; reverse: 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-\[locus-specific sequence\]-3′) (table S5). The second-step PCR for introducing barcodes, sequencing on an Illumina MiSeq machine and downstream bioinformatics for quality control, and calling of CRISPR-induced InDels was performed via the CRISPR-Cas9 commercial sequencing service (Microsynth) using their in-house pipelines. Fluorescence microscopy and image analysis ------------------------------------------ Cells were seeded into eight-well Glass Bottom μ-Slides (ibidi) at a density of 9000 cells per well for HeLa and 10,000 cells per well for HEK 293T and a volume of 300 μl of medium per well. The following day, cells were cotransfected with (i) 25 ng of Cas9-GFP, 25 ng of sgRNA AAVS1 construct, and 25 ng of stuffer DNA (pBluescript) or (ii) 25 ng of Cas9-GFP, 25 ng of mCherry-AcrIIA4, and 25 ng of sgRNA AAVS1 construct using 0.2 μl of JetPrime per well. Imaging was performed at 12, 18, 24, 48, and 72 hours after transfection using a Leica SP8 confocal laser scanning microscope equipped with automated CO~2~ and temperature control; an ultraviolet, argon, and solid-state laser; as well as an HCX PL APO 40× oil objective (numerical aperture = 0.7). The identical imaging settings were applied to all samples as detailed in the following. GFP fluorescence was recorded using the 488-nm laser line for excitation, and the detection wavelength was set to 493 to 578 nm. mCherry fluorescence was recorded using the 552-nm laser line for excitation, and the detection wavelength was set to 578 to 789 nm. Laser power was 0.25%, and gain was set to 800 V. For each field of view, a 40-μm Z-stack (40 slices) was recorded, and five fields of view were recorded per sample and time point. A single-plane bright-field image was recorded in parallel. A previously reported HeLa reference cell line expressing known GFP and mCherry molecule numbers per cell ([@R39]) was subjected to the identical imaging conditions. For image analysis, cells were manually segmented using the freehand selection tool in ImageJ using the bright-field channel, and the area of each cell was measured. The segments were then applied to measure mean fluorescence in z-projections of the GFP and mCherry stacks. The number of fluorescent molecules per cell was then calculated using the following formula$$\text{FM}(\text{sample}) = \frac{A(\text{sample}) \cdot I(\text{sample})}{A(\text{ref}) \cdot I(\text{ref})} \cdot \text{FM}(\text{ref})$$whereby FM(sample) and FM(ref) represent the number of fluorescent molecules, *A*(sample) and *A*(ref) represent the cell area, and *I*(sample) and *I*(ref) represent the fluorescence intensity, after background subtraction, in a particular cell in the sample cell or reference (ref) cell line, respectively. Mathematical modeling and parameter estimation ---------------------------------------------- To quantitatively describe gene editing dynamics by Cas9 or Cas-Acr variants, an ODE model was developed. The model describes the transient expression of sgRNAs, Cas9 or Cas-Acr mRNAs, and Cas9 or Cas-Acr proteins, binding of sgRNAs to Cas9 or Cas-Acr variants, activation and inhibition of Cas-Acr variants, as well as gene editing by active complexes of Cas9 or Cas-Acr variants and sgRNAs. A model without Cas-Acr species was used for initial simulations (table S1). This model consisted of nine equations containing a total of 11 parameters. Three types of models were defined for simultaneous model fitting to experimental data: (i) a model describing turnover of plasmids, mRNAs, and proteins, consisting of 7 equations; (ii) a Cas9 model consisting of 39 equations; and (iii) Cas-Acr models containing 47 equations (table S6 and data file S2). A total of 32 parameters were estimated by model fitting to 75 data points. In the following, model assumptions and steps to iteratively refine the model shall be described. The experimental dataset comprised measurements related to protein turnover and gene editing. However, several reactions in between were experimentally inaccessible. For this reason, we tried to limit the problem of parameter unidentifiability by parsimoniously defining model parameters. Taking into account that the sizes of plasmids for expressing sgRNAs, Cas9, or Cas-Acr variants were of the same order of magnitude, the same degradation rate was assumed for all plasmids. Furthermore, the model assumes the same degradation rate *k*~deg,C~ for Cas9 and all Cas-Acr species (Cas-Acr, Cas-Acr~inh~, Cas-Acr:sgRNA, and Cas-Acr~inh~:sgRNA) independent on their activation state and sgRNA binding. Similarly, degradation of different sgRNAs was described by one parameter, *k*~deg,gRNA~. If Cas-Acr as part of complexes with sgRNA is degraded, it is assumed that sgRNA remains within the cell. Thereby, the model pertains flexibility regarding a potential sgRNA-rescuing effect of Cas9 in consistence with the observation that otherwise very short-lived sgRNA is protected from degradation after binding to Cas9 ([@R40]). We assumed that binding of sgRNA to Cas9 or Cas-Acr variants was fast compared to other processes such as translation or gene editing. A quasi-steady state was enforced by fixing the binding parameter *k*~gRNA,on~ to a large value and effectively only estimating the dissociation constant *K*~d,gRNA~ = *k*~gRNA,off~/*k*~gRNA,on~. At first, we tried to fit the model with equal *K*~d,gRNA~ values for the sgRNAs targeting four different genes. We realized that estimating *K*~d,gRNA~ individually for sgRNAs resulted in a substantially improved model fit, indicated by a difference in the Akaike information criterion of ΔAIC = 53. This implies that affinities to Cas9 or Cas-Acr variants varied between sgRNAs. Similarly, we first assumed the same parameter for the maximal editing efficiency for experiments in all targeted genes. In the model, this parameter served as initial value *D*~tot~ for the fraction of unedited genes. In case that all target sites in transfected cells can be edited, this parameter equals the percentage of transfected cells expressing sgRNA and Cas9 or Cas-Acr variants. Estimating this parameter individually for the four edited genes, *D*~tot,*i*~ with *i* = 1\...4 for AAVS1, EMX1, RUNX1, and HEK, improved the model fit considerably (ΔAIC = 42). For Cas-Acr variants, a common activation parameter but individual inactivation parameters were defined. Inhibitor strengths for Cas-Acr variants with mutated AcrIIA4 (Ins. 5, N39A, and D14A/G38A) were estimated relative to Cas-Acr wt with unmodified AcrIIA4. To this end, inhibition parameters for Cas-Acr variants were defined as a product between the common parameter *k*~inh,CascAID~ and parameters γ*~j~* with *j* = 1\...4 for Cas-Acr wt, Ins. 5, N39A, and D14A/G38A, and γ~1~ ≡ 1 for Cas-Acr wt (table S6). It was observed before that mismatches between gRNAs and target sites take influence on the unbinding rather than on the binding kinetics of Cas9-gRNA complexes ([@R40]). For this reason, individual parameters *k*~off,target,*i*~ were estimated for the unbinding of active Cas9:sgRNA or Cas-Acr:sgRNA complexes from target sites, whereas the common binding parameter *k*~on,target~ was defined for all genes. To explain differences between ON-target and OFF-target editing, factors ϕ~OFF\ target,*i*~ between unbinding rates of Cas9:sgRNA or Cas-Acr:sgRNA complexes for ON- and OFF-targets were estimated separately for the four genes. Besides the model variables *D~i~*, the concentrations of plasmids for expression of gRNA (\[*P*~gRNA~\]), coexpression of Cas9 and Acr (\[*P*~Cas9\ +\ Acr~\]), or expression of Cas9 or Cas-Acr variants alone (\[*P*~C~\]) were the only model species with nonzero initial values. Because plasmid concentrations in cells were not experimentally accessible, they were treated in the model as dimensionless magnitudes, and initial concentrations of \[*P*~gRNA~\] and \[*P*~Cas9\ +\ Acr~\] were fixed to 1. As described in table S6, the initial concentration of the plasmid for Cas9 expression in the turnover model, \[*P*~C~\]~0~, was furthermore associated with the initial plasmid concentration in the Cas9 and Cas-Acr models because the same plasmid amounts were used in experiments described by these models. Residuals between model observables and experimental measurements were weighted by the SEM if replicates for data points were available. Protein expression measurements were determined from averages of *n* = 50 cells. Quadruplicates were measured for AAVS1 editing efficiencies in case of Cas9 and all Cas-Acr variants at 72 hours. Triplicates were measured for EMX1, RUNX1, and HEK editing efficiencies. Single measurements were available for AAVS1 editing efficiencies at 24 and 48 hours. In this case, residuals were weighted using an error model. To this end, the linear error model ε = *m*~1~*y* + *m*~2~ was fitted to all SEM values and editing efficiencies *y* measured with replicates, resulting in parameter estimates *m*~1~ = 0.054 and *m*~2~ = 0.681. Model simulations were performed with custom scripts in MATLAB (The MathWorks, Natick, MA, USA). For parameter estimations, the MATLAB toolbox PottersWheel ([www.potterswheel.de](http://www.potterswheel.de)) was used ([@R41]). A total of 500 multistart local optimizations were conducted followed by profile likelihood estimation to determine parameter confidence intervals. Parameter estimates, parameter bounds, and parameter confidence intervals are listed in table S7. For simulating the model parts documented in table S6 using the parameter estimates listed in table S7, MATLAB files are available as supplementary data (data file S2). Supplementary Material ====================== ###### http://advances.sciencemag.org/cgi/content/full/6/6/eaay0187/DC1 ###### Download PDF ###### Data file S1 ###### Data file S2 ###### Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity We thank the Synthetic Biology group for helpful discussions and comments on the manuscript. We further acknowledge support by the state of Baden-Württemberg through bwHPC. **Funding:** This study was funded by the Helmholtz Association, the German Research Council (DFG), and the Federal Ministry of Education and Research (BMBF). S.M.K. was supported by the BMBF-funded Heidelberg Center for Human Bioinformatics (HD-HuB) within the German Network for Bioinformatics Infrastructure (de.NBI). M.D.H. was supported by a Helmholtz International Graduate School for Cancer Research scholarship (DKFZ, Heidelberg). **Author contributions:** D.N. conceived the study and designed the experiments. S.A. and M.D.H. carried out experiments and performed data analysis. S.A., S.M.K., M.D.H., and D.N. interpreted data. S.M.K. performed mathematical modeling. A.H. performed initial tests on the Cas-Acr constructs. R.E. and D.N. jointly directed the work. S.M.K. and D.N. wrote the manuscript with input from all authors. **Competing interests:** S.A., S.M.K., M.D.H., A.H., R.E., and D.N. are inventors on a patent application related to this work filed by the German Cancer Research Center (no. EP19186590.6, filed on 16 July 2019). The authors declare no other competing interests. **Data and materials availability:** Cas-Acr and sgRNA expression vectors will be made available via Addgene. For constructs created in this study, annotated vector sequences (GenBank files) are provided in data file S1. Scripts for model simulation in MATLAB are provided in data file S2. Additional data related to this paper may be requested from the authors. Supplementary material for this article is available at <http://advances.sciencemag.org/cgi/content/full/6/6/eaay0187/DC1> Fig. S1. Coexpressing mild doses of Acr with Cas9 improves genome editing specificity. Fig. S2. Kinetic insulation of ON- and OFF-target editing events upon AAV-mediated delivery. Fig. S3. Kinetic insulation of ON- and OFF-target editing upon transient transfection is difficult for the HBB sgRNA. Fig. S4. Screen of AcrIIA4 variants weakened by domain insertion. Fig. S5. Screen of Cas-Acr fusion variants. Fig. S6. Evaluation of editing specificity with Cas-Acr fusions. Fig. S7. Targeted amplicon sequencing analysis of Cas-Acr editing specificity. Fig. S8. Comparison of Cas-Acr fusions to other Cas9 high-fidelity variants by TIDE sequencing. Fig. S9. Kinetics of Cas9 and Acr expression and corresponding ON- and OFF-target editing. Fig. S10. Estimation of Cas9, AcrIIA4, and Cas-Acr protein levels and model fits. Fig. S11. Kinetic insulation of ON- and OFF-target editing events by Cas-Acr variants. Fig. S12. Supplementary gel images. Table S1. Equations of the Cas9 gene editing model visualized in [Fig. 1A](#F1){ref-type="fig"}. Table S2. Overview of AcrIIA4-LOV2 hybrids from Bubeck *et al.* ([@R29]) used in this study. Table S3. Plasmids used and constructed in this study. Table S4. sgRNA ON- and OFF-target sequences. Table S5. Primers used for genomic PCRs. Table S6. Equations of the Cas-Acr gene editing model visualized in [Fig. 4A](#F4){ref-type="fig"}. Table S7. Parameter estimates and confidence intervals. Data file S1. Annotated vector sequences (GenBank files). Data file S2. Scripts for model simulations in MATLAB. [View/request a protocol for this paper from *Bio-protocol*](https://en.bio-protocol.org/rap.aspx?eid=10.1126/sciadv.aay0187). [^1]: These authors contributed equally to this work.

\section{Homotopy operators for the foliated complex}\label{subsection: homotopy operators} In this section we prove Lemma \ref{lemma: infinite time pullback} and Proposition \ref{lemma: homotopies}. In Subsection \ref{section: definition}, we construct the homotopy operators as the infinite flow of a specific vector field, and then we reduce Lemma \ref{lemma: infinite time pullback} and Proposition \ref{lemma: homotopies} to their more concrete versions: Lemma \ref{convergence of the flow} and Lemma \ref{well-defined}. We prove these results in Subsection \ref{section: convergence of the flow} by using a detailed analysis of the flow of the vector field, which is provided in Subsection \ref{subsection_analysis_flow}. \subsection{Construction of the homotopy operators}\label{section: definition} In order to construct the homotopy operators from Proposition \ref{lemma: homotopies}, we build a foliated homotopy between the identity map and the retraction $r_{\Sk}$. We will do this using the flow of the vector field $W\in \mathfrak{X}^1(\mathfrak{sl}_2(\C))$ given by: \begin{align}\label{W} W_A=&\frac{1}{4}[A,[A,A^*]]. \end{align} Here the bracket denotes the standard Lie bracket on $\mathfrak{sl}_2(\C)$ and we think of $W$ as a real vector field. \begin{lemma}\label{lemma: properties vector field} The vector field $W$ has the following properties: \begin{enumerate}[(1)] \item $W$ vanishes precisely on $\Sk$. \item $W$ is tangent to the foliation: $\Lie_W f=0$. \item $W$ is $SU(2)$-invariant. \item $\Lie_W(R^2 )\leq 0$, with equality only along $\Sk$. \end{enumerate} \end{lemma} \begin{proof} \begin{enumerate}[(1)] \item For the norm of $W$ we get: \begin{equation*} \begin{array}{rcl} |W_A|^2& = & \frac{1}{16}\tr([A,[A,A^*]][[A,A^*],A^*]\\ & \stackrel{\eqref{eq:invariant polynomials a}}{=} & \frac{1}{16}\tr(4(f\cdot A^*+AA^*A)(\overline{f}\cdot A+A^*AA^*))\\ &\stackrel{\eqref{eq:invariant polynomials a}}{=} & \frac{1}{4}\tr(\nf^2(A^*A-2AA^*)+(AA^*)^3)\\ &=&\frac{1}{4}\tr(AA^*((AA^*)^2-\nf^2))\\ &\stackrel{\eqref{eq:invariant polynomials aah}}{=}&\frac{1}{4}\tr(AA^*)(\tr(AA^*)^2-4\nf^2)\\ &=&\frac{1}{8}R^2 (R^4-4\nf^2) \end{array} \end{equation*} which is zero iff $A\in \Sk$ due to Lemma \ref{lemma: characterization skeleton}. \item A straightforward calculation for $A\in \spl \setminus S_0$ gives: \begin{equation*} \begin{array}{ccl} \Lie_W f &=& \frac{\dif}{\dif t}f(A+tW_A)|_{t=0} \\ & =&\frac{\dif}{\dif t}\det(A+tW_A)|_{t=0}\\ &=&\det(A)\tr(A^{-1}W_A)\\ &=&\frac{1}{4}\det(A)\tr([A,A^*]-A^{-1}[A,A^*]A)\\ &=&0 \end{array} \end{equation*} Since $\spl \setminus S_0$ is dense, (2) holds everywhere on $\spl$. \item Straightforward. \item We check this again by a direct calculation: \begin{equation*} \begin{array}{ccl} \Lie_W (R^2)&=& \frac{\dif}{\dif t}\tr((A+tW_A)(A^*+tW_A^*))|_{t=0}\\ &=&\frac{1}{4}\tr([A,[A,A^*]]A^*+A[[A,A^*],A^*])\\ &=&\frac{1}{4}\tr(4(\nf^2\mathds{1}-(AA^*)^2))\\ &\stackrel{\eqref{eq:invariant polynomials aah}}{=}&4\nf^2 -R^4\\ &\stackrel{\eqref{eq:norm-fiber inequality}}{\leq} &0 \end{array} \end{equation*} with equality iff $A\in \Sk$ again due to Lemma \ref{lemma: characterization skeleton}.\qedhere \end{enumerate} \end{proof} The last property in Lemma \ref{lemma: properties vector field} implies that the flow lines starting at a point inside the closed ball $\overline{B}_r(0)$ are trapped inside that ball; hence the flow is defined for all positive time, and will be denoted by: \begin{equation*} \begin{array}{cccc} \phi:&\R_{\geq 0}\times\ \mathfrak{sl}_2(\C) &\to&\mathfrak{sl}_2(\C)\\ &(t,A)&\mapsto&\phi_t(A). \end{array} \end{equation*} The above properties of $W$ imply that: \begin{itemize} \item $\phi_t$ fixes $\Sk$; \item $\phi_t^*(f)=f$; \item $\phi_t$ is $SU(2)$-equivariant. \end{itemize} In particular, $\phi_t^*$ preserves the complex $(\CC^{\bullet},\dif)$. Also $i_W$ preserves $\CC^{\bullet}$: since $\Lie_W f=0$, we have that $\Lie_{W}f_1=i_W\dif f_1=0$ and $\Lie_W f_2=i_W\dif f_2=0$. Next, Cartan's magic formula implies the homotopy relation \begin{equation}\label{eq: at time t} \phi_t^*(\alpha)-\alpha=\dif \circ h_t(\alpha)+h_t\circ \dif(\alpha), \end{equation} for all $\alpha\in \Omega^{\bullet}_0(\spl)$, where \[h_t:\Omega^{\bullet}_0(\spl)\to \Omega^{\bullet-1}_0(\spl), \ \ h_t(\alpha)=\int_0^{t}i_W\phi_s^*(\alpha)\dif s.\] By the discussion above, note that also $h_t$ preserves $\CC^{\bullet}$. In order to prove Proposition \ref{lemma: homotopies} we will take the limit as $t\to\infty$ in \eqref{eq: at time t}. In the following subsection we will give explicit formulas for $\phi_t$, which imply the point-wise limit: \begin{align}\label{infinity now} \lim_{t\to\infty}\phi_t(A)=r_{\Sk}(A), \ \ \ \forall\ A\in \mathfrak{sl}_2(\C). \end{align} The following results are much more involved, and their proofs will occupy the rest of this section: \begin{lemma}\label{convergence of the flow} On $\mathfrak{sl}_2(\C)\backslash S_0$, we have that \[\lim_{t\to\infty}\phi_t=r_{\Sk}\] with respect to the compact-open $C^{\infty}$-topology. \end{lemma} \begin{lemma}\label{well-defined} For any $\alpha\in \Omega_{0}^{\bullet}(\mathfrak{sl}_2(\C))$, the following limit exists: \begin{align}\label{limit h} h_{\Sk}(\alpha):=\lim_{t \to \infty}{h_{t}(\alpha)}\in \Omega_{0}^{\bullet-1}(\mathfrak{sl}_2(\C)), \end{align} with respect to the compact-open $C^{\infty}$-topology. Moreover, $h_{\Sk}$ satisfies property $SLB$ for $(0,5,35)$. \end{lemma} Recall that the existence of a limit with respect to the compact-open $C^{\infty}$-topology means that all partial derivatives converge uniformly on compact subsets; more details are given in Subsection \ref{subsubsection_limits}. The results above suffice to complete our proofs: \begin{proof}[Proofs of Lemma \ref{lemma: infinite time pullback} and Proposition \ref{lemma: homotopies}] Since the limit \eqref{limit h} is uniform on compact subsets with respect to all $C^k$-topologies, $h_{\Sk}$ satisfies \begin{align*} \dif h_{\Sk}(\alpha)&=\lim_{t \to \infty}{\dif h_{t}(\alpha)}. \end{align*} From \eqref{eq: at time t}, we obtain that for any $\alpha\in \Omega_0^{\bullet}(\mathfrak{sl}_2(\C))$ \[\lim_{t\to\infty}\phi_t^*(\alpha)=\alpha+\dif h_{\Sk}(\alpha)+h_{\Sk}(\dif \alpha)\] holds for the compact-open $C^{\infty}$-topology. On the other hand, on $\mathfrak{sl}_2(\C)\backslash S_0$, $\lim_{t\to\infty}\phi_t=r_{\Sk}$, and since this limit is also with respect to the compact-open $C^{\infty}$-topology, we have that \[\lim_{t\to\infty}\phi_t^*(\alpha)|_{\mathfrak{sl}_2(\C)\backslash S_0}=r_{\Sk}^*(\alpha)|_{\mathfrak{sl}_2(\C)\backslash S_0}.\] Therefore, $r_{\Sk}^*(\alpha)|_{\mathfrak{sl}_2(\C)\backslash S_0}$ extends to a smooth form on $\mathfrak{sl}_2(\C)$, which we denote by $p_{\Sk}(\alpha)$. This implies Lemma \ref{lemma: infinite time pullback} and the homotopy equation: \[p_{\Sk}(\alpha)-\alpha=\dif h_{\Sk}(\alpha)+h_{\Sk}(\dif \alpha).\] Finally, since $h_t$ commutes with $e_{\varphi}$, and this condition is closed, we have that $h_{\Sk}(\CC^{\bullet})\subset \CC^{\bullet-1}$. Thus, the above relation holds on $\CC^{\bullet}$, and so we obtain also Proposition \ref{lemma: homotopies}. \end{proof} \subsection{The analysis of the flow}\label{subsection_analysis_flow} In this subsection we analyse the flow $\phi_t$ of the vector field $W$ from \eqref{W}. \subsubsection{An explicit formula for the flow}\label{subsection:explicit flow} The result will be expressed in terms of the function: \begin{align*} & g:\R_{\ge 0}\times \mathfrak{sl}_2(\C) \to \herm(\C) \\ & g_t(A):=\left(\mathds{1}+\frac{\tanh(\nf t)}{\nf}AA^*\right)^{\frac{1}{2}} \end{align*} and $g_t(A)$ is defined for $f(A)=0$ by continuity as $\left(\mathds{1}+t AA^*\right)^{\frac{1}{2}}$. Here we use the square root of a positive definite Hermitian matrix, as in Subsection \ref{subsubsec_retraction}. Note also that $g$ is a smooth function; this follows because $\tanh(u)/u$ is an even function, and therefore it is a smooth function of $u^2$. Finally, note that, for $f(A)\neq 0$, $\lim_{t\to \infty}g_t(A)=g_{\infty}(A)$. We give now an explicit formula for the flow and for the evolution along the flow lines of the norm and of the measure of ``a-normality": \begin{lemma}\label{le:flow} The flow of $W$ starting at $A\in \mathfrak{sl}_2(\C)$ is given by: \begin{equation}\label{eq:A_t} A_t:=\phi_t(A)= g_t(A)^{-1}A g_t(A), \end{equation} for $t\geq 0$, and moreover, $A_t$ satisfies: \begin{align} R_t^2&:=\tr(A_tA_t^*)=2\nf\frac{2\nf\tanh(2\nf t)+ R^2}{2\nf+R^2\tanh(2\nf t)}\label{eq:R_t^2}\\ K_t&:=[A_t,A_t^*]= \frac{2\nf}{2\nf\cosh(2\nf t)+R^2\sinh(2\nf t)}[A,A^*]\label{eq: commutator flow} \end{align} \end{lemma} \begin{proof} First we prove \eqref{eq:R_t^2}. In the proof of Lemma \ref{lemma: properties vector field} (4), we have seen that $\mathcal{L}_W(R^2)=4|f|^2-R^4$. Therefore, $x_t:=R_t^2$ satisfies the following ODE: \begin{equation}\label{eq:ODE} x'_t=a^2-x_t^2, \end{equation} where $a=2|f|$. The solution of this ODE starting at $x_0=x$ is: \begin{equation}\label{sol_ODE} x_t=\frac{a\tanh(a t)+ x}{1+\tanh(a t)\frac{x}{a}}=\frac{\dif }{\dif t}\ln\Big(\cosh(at)+\sinh(at)\frac{x}{a}\Big). \end{equation} The second expression will be used later, and the first yields \eqref{eq:R_t^2}. To prove equation \eqref{eq:A_t}, we first calculate the positive semi-definite Hermitian matrices $S_t:= A_tA_t^*\ge 0$. Using the definition of $W$ \eqref{W} and the characteristic equations \eqref{eq:invariant polynomials a}, we obtain the following ODE for $S_t$: \begin{align*} S'_t&=\frac{1}{4}\big( [A_t,[A_t,A_t^*]]A_t^*+A_t[[A_t,A_t^*],A_t^*]\big)\\ &=\frac{1}{4}\big(2 (A_t)^2(A_t^*)^2-4(A_tA_t^*)^2+A_t(A_t^*)^2A_t+A_t^*(A_t)^2A_t^*\big)\\ &=\nf^2 \mathds{1}-S_t^2. \end{align*} This is an ODE of the same form as \eqref{eq:ODE}, but instead of being in $\R$ it is in the commutative algebra spanned by $\mathds{1}$ and $AA^*$, and one can easily see that the solution is of the same form as \eqref{sol_ODE}: \[S_t =\frac{ \nf \tanh(\nf t)\mathds{1}+AA^*}{ \mathds{1}+\frac{\tanh(\nf t)}{\nf}AA^*} =\frac{\dif }{\dif t}\ln\Big(\cosh(\nf t)\mathds{1}+\frac{\sinh(\nf t)}{\nf}AA^*\Big).\] In writing this formulas we use that any smooth function $\xi:\R_{>0}\to \R$ ``extends" to a smooth function on $\xi:\herm(\mathbb{C})\to \mathrm{Herm}(\mathbb{C})$, which follows from ``basic functional calculus''. For a diagonal matrix, the extension acts by applying $\xi$ to each diagonal entry, and in general, one uses that the extension is invariant under conjugation by unitary matrices. Next, we note that the defining ODE for $A_t$ can be written in using $S_t$: \begin{align*} A'_t&=\frac{1}{4}[A_t,[A_t,A_t^*]]\\ &=\frac{1}{4}\big( (A_t)^2A_t^*-2A_tA_t^*A_t+A_t^*(A_t)^2\big)\\ &=\frac{1}{2}[A_t,S_t], \end{align*} where we used the characteristic equation \eqref{eq:invariant polynomials a}. Now, define \[X_t:=\frac{1}{2}\int_0^t{S_s \dif s}=\frac{1}{2}\ln\Big(\cosh(\nf t)\mathds{1}+\frac{\sinh(\nf t)}{\nf}AA^*\Big).\] The matrices $X_t ,X'_t $ belong to the commutative subalgebra of $\mathfrak{gl}_2(\C)$ generated by $AA^*$, and therefore they commute, which implies that: \[\frac{\dif}{\dif t}e^{X_t}=X'_t e^{X_t}=e^{X_t}X'_t.\] Therefore: \[\frac{\dif}{\dif t}e^{X_t}A_te^{-X_t}=e^{X_t}([X'_t,A_t]+A'_t)e^{-X_t}=e^{X_t}(\frac{1}{2}[S_t,A_t]+A'_t)e^{-X_t}=0,\] and so we obtain a closed formula: \[A_t=e^{-X_t}Ae^{X_t}.\] The formula \eqref{eq:A_t} from the statement follows because: \[e^{X_t}=\Big(\cosh(\nf t)\mathds{1}+\frac{\sinh(\nf t)}{\nf}AA^*\Big)^{\frac{1}{2}}= \sqrt{\cosh(\nf t)} g_t(A). \] Finally, in order to prove \eqref{eq: commutator flow}, we calculate the derivative of the commutator $K_t$ using the definition of $W$ \eqref{W}: \begin{align*} K'_t&=\frac{1}{4}\big( [[A_t,[A_t,A_t^*]],A_t^*]+[A_t,[[A_t,A_t^*],A_t^*]]\big)\\ &=\frac{1}{2}\big( (A_t)^2(A_t^*)^2-2(A_tA_t^*)^2+2(A_t^*A_t)^2-(A_t^*A_t)^2\big)\\ &=-R_t^2K_t, \end{align*} where we have used the characteristic equations \eqref{eq:invariant polynomials a} and \eqref{eq:invariant polynomials aah}. This ODE has as solution: \[K_t=e^{-\int_{0}^tR^2_s\dif s}K_0.\] Using the second form of \eqref{sol_ODE}, this expression becomes \eqref{eq: commutator flow}. \end{proof} \subsubsection{Estimates for the flow and its derivative} To write the estimates, it will be convenient to introduce the following smooth function: \begin{equation}\label{varsigma} \epsilon_t:=\frac{1}{\cosh(2|f|t)+\frac{\sinh(2\nf t)}{2\nf}R^2}, \end{equation} which appeared in the formula \eqref{eq: commutator flow}, i.e.\ $K_t=\epsilon_t [A,A^*]$. The following notation will be very useful. For $u\in \frac{1}{2}\N_{0}$ and $v\in \N_{0}$, let \[\mu_{u,v}:=\sum_{j=0}^{p}t^{u-\frac{j}{2}}R^{v-j}, \ \ p:=\mathrm{min}(2u,v).\] The following inequalities is immediate: \begin{equation}\label{submult} \mu_{u,v}\, \mu_{u',v'}\leq C \mu_{u+u', v+v'} \end{equation} for some constants $C=C(u,u',v,v')$. In particular: \begin{equation*} R^{v'}\mu_{u,v}=\mu_{0,v'}\mu_{u,v}\leq \mu_{u, v+v'}. \end{equation*} Also, for $w\in \frac{1}{2}\N_0$, note that \begin{equation}\label{submult1} \mu_{u,v}\leq \mu_{u+w, v+2w}. \end{equation} We will use these inequalities later on. In this section, for convenience, we rename the coordinates $(x_i,y_i)$ on $\spl$ from Subsection \ref{section: formal poisson} as $(x_i,x_{i+3})$. Then we obtain partial derivative operators $D^a$, for $a\in \N_0^6$, acting on functions in $C^{\infty}(\spl)$ (see Appendix \ref{subsection: derivatives}). As before, we denote $A_t:=\phi_t(A)$. \begin{proposition}\label{lemma:bounds on the flow} For any $a\in \N_0^6$ with $n= \lvert a\rvert$ there is $C=C(a)$ such that: \begin{align*} \lvert D^a(A_t)\rvert\, &\le\, C\,\mu_{2n+\frac{1}{2},3n+2},\\ \lvert D^a (A'_{t})\rvert\, &\le\, C\, \epsilon_t\, \mu_{2n+\frac{1}{2},3n+4}. \end{align*} \end{proposition} \subsubsection{Proof of Proposition \ref{lemma:bounds on the flow}} The proof is split into several steps, which occupy the rest of this section. First, we introduce some auxiliary quantities. Any smooth even function $a(x)$ on $\R$ can be written as $a(x)=b(x^2)$, for a smooth function $b$ on $\R_{\geq 0}$. Using this fact, we introduce 3 functions $\theta_1,\theta_2$ and $\theta_3$ on $\R_{\geq 0}$ defined by: \begin{equation}\label{theta_tanh} \theta_1(x^2)=\frac{\tanh(x)}{x},\qquad \theta_2(x^2)=\cosh(x),\qquad \theta_3(x^2)=\frac{\sinh(x)}{x}. \end{equation} The derivatives of these functions satisfy: \begin{lemma}\label{lemma:estimate theta} For $n\geq 0$, there is $C=C(n)$, such that for all $x\geq 0$: \begin{align*} |\theta_1^{(n)}(x^2)|&\leq C\frac{1}{(1+x)^{2n+1}},\\ |\theta_2^{(n)}(x^2)|&\leq C\frac{\cosh(x)}{(1+x)^{n}},\\ |\theta_3^{(n)}(x^2)|&\leq C\frac{\cosh(x)}{(1+x)^{n+1}}. \end{align*} \end{lemma} \begin{proof} It suffices to show the first inequality for $x\geq 1$, and this is equivalent to showing that the following function is bounded: \[|x^{2n+1}\theta_1^{(n)}(x^2)|.\] We prove this by induction. For $n=0$, this follows using $|\tanh(x)|\leq 1$. Taking $n\geq 1$ derivatives in the defining equation of $\theta_1$ from \eqref{theta_tanh}, and multiplying by $x^n$, one obtains an expression of the form: \[x^{2n+1}\theta_1^{(n)}(x^2)=\sum_{1\leq i\leq \frac{n+1}{2}}c_{n,i}x^{2(n-i)+1}\theta_1^{(n-i)}(x^2)+\frac{x^n}{2^n}\tanh^{(n)}(x).\] By induction, the elements of the sum are bounded. Next, using that \[\tanh'(x)=1-\tanh(x)^2 \quad \textrm{and} \quad \tanh^{(2)}(x)=-2\tanh'(x)\tanh(x),\] we can write $\tanh^{(n)}(x)=\tanh'(x)P_n(\tanh(x))$, where $P_n$ is a polynomial. Clearly, $P_n(\tanh(x))$ and also $x^n\tanh'(x)=\frac{x^n}{\cosh{(x)}}$ are bounded functions, which concludes the proof of the first inequality. The second inequality is easier: taking $n$ derivatives in the defining equation of $\theta_2$ from \eqref{theta_tanh}, we obtain \[x^{n}\theta_2^{(n)}(x^2)=\sum_{n/2\leq i<n}c_{n,i}x^{2i-n}\theta_2^{(i)}(x^2)+\frac{1}{2^n}\cosh^{(n)}(x).\] Using induction, the terms on the right are bounded by $\cosh(x)$, which is enough to conclude the proof of the second inequality. The third follows in the same way as the second. \end{proof} First, we estimate the derivatives of $\nf^2$: \begin{lemma}\label{lemma:norm f estimate} There exists $0<C$ such that for any $a\in \N_0^6$ with $n=\lvert a \rvert$: \[ \lvert D^a (\nf^2)\rvert \le C \begin{cases} \nf\cdot R &\text{ if } n= 1\\ R^{4-n}&\text{ if } 2\le n \le 4\\ 0 &\text{ else.} \end{cases}\] \end{lemma} \begin{proof} The cases $n\neq 1$ follow because $f$ is a homogeneous polynomial of degree 2. The case $n=1$, follows by applying the Leibniz rule in the decomposition $|f|^2=f\overline{f}$. \end{proof} Next, we estimate the size of $g_t$: \begin{lemma}\label{lemma:gt norm} There is a constant $C$ such that for any $A\in \spl$, we have: \[ \lvert g_t(A)\rvert\leq C\mu_{\frac{1}{2},1} \quad \textrm{and}\quad \lvert g_t^{-1}(A)\rvert \leq C.\] \end{lemma} \begin{proof} By the characteristic equation \eqref{eq:invariant polynomials aah} the eigenvalues of $AA^*$ satisfy: \[\lambda_{-}+\lambda_{+}=R^2,\quad \lambda_{-}\lambda_{+}=|f|^2.\] The eigenvalues of $g_t(A)^2$ are \[1+\frac{\tanh(\nf t)}{\nf}\lambda_{\pm},\] therefore, using also Lemma \ref{lemma:estimate theta}, we obtain: \begin{align*} |g_t(A)|&=\sqrt{\tr(g_t(A)^2)}=\Big(2+\frac{\tanh(\nf t)}{\nf}R^2\Big)^{\frac{1}{2}}\\ &\leq C\Big(1+\frac{tR^2}{1+t\nf}\Big)^{\frac{1}{2}}\leq C\sqrt{1+tR^2}. \end{align*} The first inequality follows now from the following: \[\sqrt{1+tR^2}\leq 1+t^{\frac{1}{2}}R=\mu_{\frac{1}{2},1}.\] Similarly, we have that: \begin{align*} \tr(g_t(A)^{-2})&=\frac{1}{1+\frac{\tanh(\nf t)}{\nf}\lambda_{-}}+\frac{1}{1+\frac{\tanh(\nf t)}{\nf}\lambda_+}\\ &=\frac{2+\frac{\tanh(\nf t)}{\nf}R^2}{1+\frac{\tanh(\nf t)}{\nf}R^2+\tanh(\nf t)^2}\\ &\leq 2 \end{align*} which implies the second inequality. \end{proof} We calculate the size of the derivatives of $g_t^2$: \begin{lemma}\label{lemma:gt estimate} For any $a\in \N_0^6$ with $0<n=\lvert a\rvert$ there is a constant $C=C(a)$ such that: \[\lvert D^a(g_t^2(A))\rvert \le C \mu_{n+1,n+2}.\] \end{lemma} \begin{proof} Using the general chain rule (see Appendix \ref{subsection: derivatives}) and Lemma \ref{lemma:estimate theta}, we first calculate: \[|D^a(t\theta_1(t^2|f|^2))|\leq C\sum_{k=1}^n\Big(\frac{t}{1+t|f|}\Big)^{2k+1}{\sum}' \prod_{j=1}^{k} D^{a^{j}}(\nf^2),\] where $\sum '$ sums over all non-trivial $a^j$ with $a=\sum_{j=1}^{k}{a^j}$. Clearly, only the terms with $1\le \vert a^j\rvert \le 4$ are non-zero. Denote by $k_p$ the number of $a^j$'s with $\vert a^j\rvert=p$. Then using Lemma \ref{lemma:norm f estimate}, we obtain: \[ |\prod_{j=1}^{k} D^{a^{j}}(\nf^2)|\le C |f|^{k_1}R^{k_1}R^{4k_2-2k_2}R^{4k_3-3k_3}R^{4k_4-4k_4}=C|f|^{k_1}R^{4k-n-2k_1},\] where we have also used that $k=\sum k_p$ and $n=\sum p k_p$. These decompositions immediately imply that $l:=2k-k_1$ satisfies $m:=\mathrm{max}(k,n/2)\leq l\leq M:=\mathrm{min}(n,2k)$. Therefore, we obtain: \begin{align*} |D^a(t\theta_1(t^2|f|^2))|&\leq C\sum_{k=1}^n\sum_{m\leq l\leq M}\Big(\frac{t}{1+t|f|}\Big)^{2k+1}|f|^{2k-l}R^{2l-n}\\ &= C\sum_{k=1}^n\sum_{m\leq l\leq M}\Big(\frac{t|f|}{1+t|f|}\Big)^{2k-l} \Big(\frac{t}{1+t|f|}\Big)^{l+1} R^{2l-n}\\ &\leq C\sum_{\frac{n}{2}\leq l\leq n}t^{l+1}R^{2l-n}\\ &\leq C\mu_{n+1,n}. \end{align*} Next, we apply the Leibniz rule in $g_t^2(A)= \mathds{1} +t\theta(t^2|f|^2) AA^*$, and obtain: \begin{align*} |D^a(g_t^2(A))|&\leq\sum_{b+c=a}|D^b(t\theta_1(t^2|f|^2))||D^{c}(AA^*)|\\ &\leq C\sum_{q=0}^2\mu_{n-q+1,n-q}\,\mu_{0,2-q}\\ &\leq C\sum_{q=0}^2\mu_{n-q+1,n+2-2q}\\ &\leq C\mu_{n+1,n+2} \end{align*} where for the first terms we have use the inequalities from above, and, because $AA^*$ is a homogeneous polynomial of degree two, that the second term is non-zero only for $q=|c|\leq 2$, and in these cases \[|D^{c}(AA^*)|\leq CR^{2-q}=C\mu_{0,2-q},\] and finally, the inequalities for the polynomials $\mu_{k,m}$ \eqref{submult} and \eqref{submult1}. \end{proof} \begin{lemma}\label{corollary:g deriv estimate} For any $a\in \N_0^6$ with $n=\lvert a\rvert>0$ there is a constant $C=C(a)$ such that: \begin{align*} \lvert D^a(g_t^{\pm 1}(A))\rvert \le &\, C \mu_{2n,3n}. \end{align*} \end{lemma} \begin{proof} Note that by the chain rule (see Appendix \ref{subsection: derivatives}) we have: \[ D^a(g_t(A))=\sum_{1\leq k\leq n}D^k(x^{\pm \frac{1}{2}})(g_t^2(A)){\sum}' \prod_{j=1}^{k} D^{a^{j}}(g_t^2(A))\] where $\sum '$ sums over all non-trivial $a^j$ with $a=\sum_{j=1}^{k}{a^j}$. The first part can be estimated using Lemma \ref{lemma:gt norm} by a constant: \begin{align*} \lvert D^k(x^{\pm \frac{1}{2}})(g_t^2(A))\rvert \leq &\ C\lvert g_t^{-2k\pm 1}(A)\rvert \leq C. \end{align*} For the second part we set $n_j:=\lvert a^j\rvert $ and use Lemma \ref{lemma:gt estimate} and \eqref{submult} to get: \begin{align*} \lvert\prod_{j=1}^{k}D^{a^{j}}(g_t^2(A))\rvert\le &\, C \prod_{j=1}^{k}\mu_{n_j+1,n_j+2}\\ \le &\, C \mu_{n+k,n+2k}\\ \le &\, C \mu_{2n,3n}. \end{align*} Combining these, we obtain the conclusion. \end{proof} \begin{proof}[Proof of the first part of Proposition \ref{lemma:bounds on the flow}] We use the Leibniz rule to obtain \begin{align*} D^a (A_t)=& \ \sum_{a^1+a^2+a^3=a}D^{a^1}(g_t^{-1}(A))D^{a^2}(A) D^{a^3}(g_t(A)). \end{align*} Denote by $n_j:=|a^j|$. Clearly, $n_2=0$ or $n_2=1$. To each term, we apply either Lemma \ref{lemma:gt norm} or \ref{corollary:g deriv estimate}. By Lemma \ref{lemma:gt norm}, the inequality from Lemma \ref{corollary:g deriv estimate} for $g_t^{-1}(A)$ holds also for $n_1=0$, and therefore we only need to consider separately the case when $n_3=0$ and $n_3>0$. In the first case, we obtain: \begin{align*} |D^{a^1}(g_t^{-1}(A))||D^{a^2}(A)| |g_t(A)|&\leq C(\mu_{2n,3n}R+\mu_{2n-2,3n-3})\mu_{\frac{1}{2},1}\\ &\leq C \mu_{2n+\frac{1}{2},3n+2}. \end{align*} For the case with $n_3>0$, we also obtain: \begin{align*} |D^{a^1}(g_t^{-1}(A))||D^{a^2}(A)| |D^{a^3}(g_t(A))| \leq & C(\mu_{2n_1,3n_1}R\mu_{2(n-n_1),3(n-n_1)}\\ &+ \mu_{2n_1,3n_1}\mu_{2(n-n_1-1),3(n-n_1-1)})\\ \leq& C(\mu_{2n,3n}R+ \mu_{2n-2,3n-3})\\ \leq& C\mu_{2n,3n+1}\\ \leq &C \mu_{2n+\frac{1}{2},3n+2}.\qedhere \end{align*} \end{proof} Next, we estimate the derivatives of the commutator: \begin{lemma}\label{lemma:bounds on the commutator} For any $a\in \N_0^6$ with $n=\lvert a\rvert $ there is a constant $C=C(a)$ such that: \[ \lvert D^a(K_t)\rvert\le C \epsilon_t\, \mu_{2n,3n+2}.\] \end{lemma} \begin{proof} First we estimate $\varsigma_t:=\epsilon_t^{-1}$. For this, we write: \[\varsigma_t=\theta_2(4\nf^2t^2 )+tR^2\theta_3(4\nf^2t^2),\] and estimate the two components. Applying Lemma \ref{lemma:estimate theta} and an argument similar to the proof of Lemma \ref{lemma:gt estimate}, we obtain that: \begin{align*} |D^a(\theta_2(4\nf^2 t^2))|&\leq C \sum_{k=1}^n|\theta_2^{(k)}(4\nf^2 t^2)|t^{2k}{\sum}'\prod_{j=1}^k |D^{a^j}(|f|^2)|\\ &\leq C \cosh(2|f|t) \sum_{k=1 }^n \sum_{m\leq l\leq M} \Big(\frac{t^2}{1+\nf t}\Big)^k|f|^{2k-l}R^{2l-n}\\ &= C \cosh(2|f|t) \sum_{k=1 }^n \sum_{m\leq l\leq M} \Big(\frac{t|f|}{1+\nf t}\Big)^{2k-l}\frac{t^lR^{2l-n}}{(1+|f|t)^{l-k}}\\ &\leq C \cosh(2|f|t) \sum_{n/2\leq l\leq n} t^lR^{2l-n}\\ &\leq C \cosh(2|f|t)\mu_{n,n}, \end{align*} where $m=\mathrm{max}(k, n/2)$ and $M:=\mathrm{min}(n,2k)$ and $n=|a|$. By a similar argument, we have that: \begin{align*} |D^a(t\theta_3(4\nf^2 t^2))|&\leq C \sum_{k=1}^n|\theta_3^{(k)}(4\nf^2 t^2)|t^{2k+1}{\sum}'\prod_{j=1}^k |D^{a^j}(|f|^2)|\\ &\leq C \cosh(2|f|t) \sum_{k=1 }^n \sum_{m\leq l\leq M} \Big(\frac{t|f|}{1+\nf t}\Big)^{2k-l}\frac{t^{l+1}R^{2l-n}}{(1+|f|t)^{l+1-k}}\\ &\leq C \cosh(2|f|t) \sum_{n/2\leq l\leq n} t^{l+1}R^{2l-n}\\ &\leq C \cosh(2|f|t)\mu_{n+1,n}. \end{align*} Therefore, applying the Leibniz rule, we obtain: \begin{align*} |D^a(tR^2\theta_3(4\nf^2t^2))|&\leq C\sum_{a^1+a^2=a}|D^{a^1}(R^2)||D^{a^2}(t\theta_3(4\nf^2t^2))|\\ &\leq C\cosh(2|f|t) \sum_{q=0}^2R^{2-q}\mu_{n+1-q,n-q}\\ &\leq C\cosh(2|f|t) \sum_{q=0}^2\mu_{n+1-q,n+2-2q}\\ &\leq C\cosh(2|f|t)\mu_{n+1,n+2}. \end{align*} Combining the estimates obtained so far, and using \eqref{submult1}, we obtain: \[|D^a(\varsigma_t)|\leq C \cosh(2|f|t) \mu_{n+1,n+2}. \] Using this inequality, the chain rule, that and $\cosh(2\nf t)\leq \varsigma_t$, we get: \begin{align*} \lvert D^{a}(\epsilon_t)\rvert \le& C \sum_{1\leq k\leq n}\varsigma_t^{-k-1} {\sum}' \prod_{j=1}^{k} |D^{a^{j}}(\varsigma)|\\ \le & C\epsilon_t \sum_{1\leq k\leq n} {\sum}'\prod_{j=1}^k\mu_{n_j+1,n_j+2}\\ \le & C\epsilon_t \sum_{1\leq k\leq n} \mu_{n+k,n+2k}\\ \le & C \epsilon_t \mu_{2n,3n} \end{align*} where ${\sum}'$ is over all non-trivial decompositions $a=\sum_{j=1}^{k}a^{j}$, and $n_j=|a^j|$. Recall from \eqref{eq: commutator flow} that $K_t=\varsigma^{-1}[A,A^*]$. By applying the Leibniz rule in this equality, and using the inequality above, we obtain the conclusion: \begin{align*} |D^a(K_t)|&\leq \sum_{a=a^1+a^2}|D^{a^1}(\epsilon_t) ||D^{a^2}([A,A^*])|\\ &\leq C \epsilon_t \sum_{q=0}^2\mu_{2n-2q,3n-3q}R^{2-q}\\ &\leq C\epsilon_t \sum_{q=0}^2\mu_{2n-2q,3n-4q+2}\\ &\leq C\epsilon_t \mu_{2n,3n+2}.\qedhere \end{align*} \end{proof} \begin{proof}[Proof of the second part of Proposition \ref{lemma:bounds on the flow}] In $A_t'=\frac{1}{4}[A_t,K_t]$ we use the Leibniz rule, then the first part of Proposition \ref{lemma:bounds on the flow}, then Lemma \ref{lemma:bounds on the commutator}, and we obtain the inequality from the statement: \begin{align*} |D^a (A'_{t})|&\leq C \sum_{a^1+a^2=a}|D^{a^1}(A_t)||D^{a^2}(K_t)|\nonumber \\ &\leq C\epsilon_t\sum_{n_1+n_2=n}\, \mu_{2n_1+\frac{1}{2},3n_1+2} \mu_{2n_2,3n_2+2}\nonumber \\ &\leq C\, \epsilon_t\, \mu_{2n+\frac{1}{2},3n+4}.\qedhere \end{align*} \end{proof} \subsection{Proofs of Lemma \ref{convergence of the flow} and Lemma \ref{well-defined}}\label{section: convergence of the flow} In the proof below we apply the criterion for the existence of limits of smooth families of functions from Appendix \ref{subsubsection_limits}. \subsubsection{Proof of Lemma \ref{convergence of the flow}} The set $\spl\backslash S_0=\{|f|>0\}$ is covered by the compact sets: \[K(r,\delta):=\{R\leq r\}\cap \{|f|\geq \delta \}\subset \spl,\ \ \delta, r>0.\] By the criterion in Appendix \ref{subsubsection_limits}, we need to bound the partial derivatives of $A'_t$ uniformly on $K(r,\delta)$ by an integrable function. By Lemma \ref{lemma:bounds on the flow} \[\lvert D^a (A'_{t})\rvert \le C\epsilon_t\,\mu_{2n+\frac{1}{2},3n+4}\le C (1+r)^{3n+4}e^{-2\delta t}t^{2n+\frac{1}{2}},\] for $t\geq 1$, where we used that \[\epsilon_t\leq \cosh^{-1}(2|f|t)\leq e^{-2|f|t}\leq e^{-2\delta t}.\] Since the right hand side is an integrable function, the conclusion follows. \subsubsection{A crucial inequality} The following inequality will play a crucial role in the proof of Lemma \ref{well-defined}: \begin{lemma}\label{lemma: finite integrals} For any $q\geq 1$ there is a constant $C=C(q)$ such that: \[\epsilon_t\, R_t^{2q}\leq C \frac{R^{2q}}{(1+tR^2)^{q}},\] for all $t\geq 0$ and all $A\in \spl$. \end{lemma} \begin{proof} The inequality is equivalent to \begin{align}\label{eq:inequality rewrite} \Big(\frac{1}{\cosh(2|f|t)+\frac{\sinh(2\nf t)}{2\nf}R^2}\Big)^{\frac{1}{q}}\Big(\frac{R_t}{R}\Big)^2\leq \frac{C}{1+R^{2}t}. \end{align} Denote $x:=2 \nf t$ and $y:=R^2t$. Then by Lemma \ref{le:flow}, we have: \[ \Big(\frac{R_t}{R}\Big)^2= \frac{\cosh(x)+\frac{x}{y}\sinh(x)}{\cosh(x)+\frac{y}{x}\sinh(x)}.\] Using \eqref{eq:norm-fiber inequality}, i.e.\ that $x\leq y$, we have that: \[ \Big(\frac{R_t}{R}\Big)^2\leq \frac{\cosh(x)+\sinh(x)}{\cosh(x)+\frac{y}{x}\sinh(x)}= \frac{e^x}{\cosh(x)+\frac{y}{x}\sinh(x)}.\] Therefore, \eqref{eq:inequality rewrite} follows if we prove: \[ \frac{e^x}{\big(\cosh(x)+\frac{y}{x}\sinh(x)\big)^{1+\frac{1}{q}}}\leq \frac{C}{1+y}\] for $0\leq x\leq y$. Clearly, it suffices to show this for $y\geq 1$, and on this domain this follows if we show that the function \[l(x,y):=\frac{ye^x}{\big(\cosh(x)+\frac{y}{x}\sinh(x)\big)^{1+\frac{1}{q}}}\] is bounded on $0\leq x\leq y$. We have that: \[\partial_yl(x,y)=\frac{e^x(\cosh(x)-y\frac1q\frac{\sinh(x)}{x}) }{\big(\cosh(x)+\frac{y}{x}\sinh(x)\big)^{2+\frac{1}{q}}}.\] Therefore, for a fixed $x$, the $l(x,y)$ attains its maximum in \[y_x:=\frac{qx}{\tanh(x)}\geq x.\] We have that \[l(x,y_x)=\frac{q}{(1+q)^{1+\frac{1}{q}}}\frac{xe^x}{\sinh(x)\cosh(x)^{\frac{1}{q}}}.\] Since $l(x,y)\leq l(x,y_x)$, and \[\lim_{x\to 0}l(x,y_x)=l(0,q)=\frac{q}{(1+q)^{1+\frac{1}{q}}}, \quad \lim_{x\to \infty}l(x,y_x)=0,\] is follows that $l(x,y)$ is bounded, which completes the proof. \end{proof} \subsubsection{Estimates for the pullback} Next, we estimate the pullback under $\phi_t$ of flat forms. We will prove all estimates on the closed ball $\overline{B}_r\subset \spl$ of radius $r>0$ centered at the origin. We will use the norms $\fnorm{\cdot}_{n,k,r}$ on flat forms $\Omega^i_0(\overline{B}_r)$ defined in \eqref{eq: flat norms}. \begin{lemma}\label{pullback estimates} For every $a\in \N^6_0$ with $n=|a|$, any $j,l\in \N_0$ there is a constant $C$ such that for any flat form $\alpha\in \Omega^{d}_0(\overline{B_r})$ and any $t\geq 0$: \begin{align*} |D^a(\phi_t^*(\alpha))|&\leq C R_t^{j+l}\mu_{\frac{5}{2}(n+d),5(n+d)}\fnorm{\alpha}_{n+l,j,r}. \end{align*} \end{lemma} \begin{proof} \underline{Step 1}: We first prove the estimate for $n=d=0$, i.e., for $g\in C^{\infty}_0(\overline{B_r})$ and for $a=0\in \N_0^6$. For $l=0$, the estimate follows \[|\phi_t^*(g)|=R_t^{j}\frac{|\phi_t^*(g)|}{R_t^{j}} \le R_t^{j}\fnorm{g}_{0,j,r}. \] For $l\geq 1$, we use Taylor's formula with integral remainder to write \[g(A)=\sum_{|b|=l}A^{b}\int_{0}^1l(1-s)^{l-1}(D^{b} g)(sA)\dif s,\] where we used that $g$ is flat at the origin, and we denoted $A^{b}=\prod_{i=1}^6 x_i^{b_i}$ in the coordinates introduced in Subsection \ref{subsection: derivatives}. Therefore we obtain: \begin{align}\label{eq: integral remainder} \phi_t^*(g)(A)=\sum_{|b|=l}A_t^{b}\int_{0}^1l(1-s)^{l-1}(D^{b} g)(sA_t)\dif s. \end{align} We clearly have that \[|A_t^{b}|\leq R_t^{l}.\] For any $j\in \N_0$, we have that \[|(D^{b} g)(sA_t)|\leq (sR_t)^{j}\fnorm{g}_{l,j,r}.\] Using these inequalities in \eqref{eq: integral remainder}, we obtain the estimate in this case: \begin{equation}\label{eq:Step1} |\phi_t^*(g)|\leq CR_t^{l+j}\fnorm{g}_{l,j,r}. \end{equation} \noindent\underline{Step 2}: we prove now the estimate for a flat function $g$ and $a\in \N^6_0$ with $1\le n=|a|$. We use the chain rule (see Appendix \ref{subsection: derivatives}) to write: \[D^a(g\circ \phi_t)=\sum_{1\leq |b|\leq n}D^b(g)(A_t)\ {\sum}'\prod_{i=1}^{6}\prod_{j=1}^{b_i}D^{a^{ij}}(x_{i,t}), \] where $b=(b_i)_{i=1}^6$ and $\sum'$ is the sum over all non-trivial decompositions: \[a=\sum_{i=1}^6\sum_{j=1}^{b_i}a^{ij}.\] We apply \eqref{eq:Step1} with $l\leftarrow n-|b|+l$ to estimate the first term: \begin{align*} |D^b(g)(A_t)|&\leq C R_t^{n-|b|+l+j}\fnorm{g}_{n+l,j,r}. \end{align*} We estimate the second term using Proposition \ref{lemma:bounds on the flow} \begin{align*} \big|\prod_{i=1}^6\prod_{j=1}^{b_i}D^{a^{ij}}(x_{i,t})\big|&\leq C \prod_{i=1}^6\prod_{j=1}^{b_i} \mu_{2|a^{ij}|+\frac{1}{2},3|a^{i,j}|+2}\\ &\leq C\mu_{2n+\frac{1}{2}|b|,3n+2|b|}. \end{align*} The second case follows by using these two estimates, and the inequalities: \begin{align*} R_t^{n-|b|}&\leq R^{n-|b|}=\mu_{0,n-|b|}\\ \mu_{0,n-|b|}\mu_{2n+\frac{1}{2}|b|,3n+2|b|}&\leq C\mu_{2n+\frac{1}{2}|b|,4n+|b|}\leq C\mu_{\frac{5}{2}n,5n}. \end{align*} \noindent\underline{Step 3}: let $\alpha\in \Omega^d_0(\overline{B}_r)$, $d\geq 1$, and $a\in \N^6_0$. Note that the coefficients of $\phi_t^*(\alpha)$ are sums of elements of the form \[g\circ \phi_t\cdot M(\phi_t),\] where $g\in C^{\infty}_0(\overline{B}_r)$ is a coefficient of $\alpha$ and $M(\phi_t)$ denotes the determinant of a minor of rank $d$ of the Jacobian matrix of $\phi_t$. By the Leibniz rule: \[D^a(g\circ \phi_t\cdot M(\phi_t))=\sum_{b+c=a}D^b(g\circ \phi_t)D^c(M(\phi_t)).\] For the first term, we apply Step 2 with $n\leftarrow |b|$ and $l\leftarrow |c|+l$: \begin{align*} |D^b(g\circ \phi_t)|&\leq C R_t^{|c|+l+j} \mu_{\frac{5|b|}{2},5|b|}\fnorm{\alpha}_{n+l,j,r}\\ &\leq C R_t^{l+j} \mu_{\frac{5|b|}{2},5|b|+|c|}\fnorm{\alpha}_{n+l,j,r}. \end{align*} Note that $M(\phi_t)$ is a homogeneous polynomial of degree $d$ in the first order partial derivatives of the components $x_{i,t}$ of $\phi_t$. By Proposition \ref{lemma:bounds on the flow} each partial derivative satisfies: \[\Big|D^{c}\Big(\frac{\partial x_{i,t}}{\partial x_j}\Big)\Big|\leq C \mu_{2|c|+\frac{5}{2},3|c|+5}.\] Therefore, by applying the Leibniz rule and \eqref{submult}, we obtain: \[|D^c M(\phi_t)|\leq C \mu_{2|c|+\frac{5}{2}d,3|c|+5d}.\] The estimate follows by combing these two estimates and using that: \[ \mu_{\frac{5|b|}{2},5|b|+|c|} \mu_{2|c|+\frac{5}{2}d,3|c|+5d}\leq \mu_{2n+\frac{|b|+5d}{2},4n+|b|+5d}\leq \mu_{\frac{5}{2}(n+d),5(n+d)}.\qedhere\] \end{proof} \subsubsection{Proof of Lemma \ref{well-defined}} Let $\alpha\in \Omega^d_0(\spl)$. As explained in Subsection \ref{subsubsection_limits}, for each $r>0$, we need to bound the partial derivatives of $h'_t(\alpha)$ uniformly on the balls $\overline{B}_r$ by an integrable function. Let $a\in \N^6_0$, with $n=|a|$. First, we show that for any $j\geq 2$ there is a constant $C=C(n,j)$ such that: \begin{equation}\label{important_equation} |D^a(h'_t(\alpha))|\leq C\, R^{3+j}(1+tR^2)^{\frac{5(n+d)+1-j}{2}}\fnorm{\alpha}_{n,j,r}. \end{equation} For this recall that \[h'_t(\alpha)=i_{W}\phi_t^*(\alpha)=\phi_t^*(i_W\alpha)=\sum_{i=1}^6x'_{i,t}\,\phi_t^*(\alpha_i),\] where $\alpha_i=i_{\partial_{x_i}}\alpha$ and $x'_{i,t}$ are denote the entries of the matrix $A'_t$. First we apply the Leibniz rule: \[D^a(x_{i,t}'\,\phi_t^*(\alpha_i))=\sum_{b+c=a}D^b(x_{i,t}') D^c(\phi_t^*(\alpha_i)).\] By using Proposition \ref{lemma:bounds on the flow}, we obtain: \[|D^b(x'_{i,t})|\leq C\, \epsilon_t\, \mu_{2|b|+\frac{1}{2}, 3|b|+4}.\] By applying Lemma \ref{pullback estimates} with $n\leftarrow n-|b|=|c|$ and $l\leftarrow |b|$, we obtain: \begin{align*} |D^c(\phi_t^*(\alpha_i))| &\leq C R_t^{|b|+j}\mu_{\frac{5}{2}(|c|+d),5(|c|+d)}\fnorm{\alpha}_{n,j,r}\\ &\leq C R_t^{j}\mu_{\frac{5}{2}(|c|+d),5(|c|+d)+|b|}\fnorm{\alpha}_{n,j,r}. \end{align*} When we combine these inequalities, we first note that: \begin{align*} \mu_{2|b|+\frac{1}{2}, 3|b|+4}\mu_{\frac{5}{2}(|c|+d),5(|c|+d)+|b|}&\leq C\mu_{2n+\frac{1}{2}(|c|+5d+1),4n+|c|+5d+4}\\ &\leq \mu_{\frac{1}{2}(5(n+d)+1),5(n+d)+4}. \end{align*} Thus, we obtain: \begin{equation} |D^a(h'_t(\alpha))|\leq C\,\epsilon_t\, R_t^j\mu_{\frac{1}{2}p,p+3}\fnorm{\alpha}_{n,j,r}, \end{equation} where $p=5(n+d)+1$. Next, note that: \[\mu_{\frac{p}{2},p+3}=\sum_{j=0}^pt^{\frac{p-j}{2}}R^{p-j+3}\leq R^3(1+t^{\frac{1}{2}}R)^{p}\leq C R^3(1+tR^2)^{\frac{p}{2}}, \] where we have use that $(1+t^{\frac{1}{2}}R)\leq \sqrt{2}(1+tR^2)^{\frac{1}{2}}$. Using this and Lemma \ref{lemma: finite integrals} with $q=\frac{j}{2}\geq 1$, we obtain \eqref{important_equation}. For $j=5(n+d+1)$, \eqref{important_equation} gives: \begin{align*} |D^a(h'_t(\alpha))|\leq C\, \frac{R^{j+3}}{(1+tR^2)^2}\fnorm{\alpha}_{n,j,r}\leq C\, r^{j-1}t^{-2}\fnorm{\alpha}_{n,j,r}. \end{align*} The right-hand side is integrable over $t\in [1,\infty)$. Therefore by Appendix \ref{subsubsection_limits}, $h_t(\alpha)$ converges as $t\to\infty$ in all $C^n$-norms on $\overline{B}_r$ to a smooth form $h_{\Sk}(\alpha)$. This form is flat at the origin, because flatness is $C^{\infty}$-closed. Next, for $j=5(n+d+1)+k$, \eqref{important_equation} gives: \begin{align*} |D^a(h'_t(\alpha))|&\leq C\, \frac{R^{5(n+d+1)+3+k}}{(1+tR^2)^{2+\frac{k}{2}}}\fnorm{\alpha}_{n,5(n+d+1)+k,r}\\ &\leq C\,r^{5(n+d+1)+1} \frac{R^{2+k}}{(1+tR^2)^{2}}\fnorm{\alpha}_{n,5(n+d+1)+k,r}. \end{align*} Since $\int_0^{\infty}\frac{R^{2}\dif t}{(1+tR^2)^{2}}=1$, we obtain: \begin{align*} |D^a(h_t(\alpha))|&= \Big|\int_0^t D^a(h'_s(\alpha))\dif s\Big|\\ &\leq C\, r^{5(n+d+1)+1}R^k\fnorm{\alpha}_{n,5(n+d+1)+k,r}. \end{align*} And so: \begin{align*} \frac{|D^a(h_t(\alpha))|}{R^k}&\leq C\, r^{5(n+d+1)+1}\fnorm{\alpha}_{n,5(n+d+1)+k,r}. \end{align*} This implies that: \begin{align*} \fnorm{h_t(\alpha)}_{n,k,r} \leq C\, (1+r)^{5(n+d+1)+1}\fnorm{\alpha}_{n,5(n+d+1)+k,r}. \end{align*} Taking $\lim_{t\to\infty}$ on the left implies that $h_{\Sk}$ satisfies property SLB for $(0,5,35)$. \section{Flat foliated cohomology of $\spl$}\label{section flat foli} In this section we define the flat foliated cohomology of the singular foliation $\F$ on $\spl$. For the calculation of this cohomology, we first apply an averaging argument for the compact subgroup $SU(2)\subset SL(2,\C)$. The more involved part of the calculation uses a so-called \emph{cohomological skeleton} for the foliation $\F$, i.e., a subvariety that contains the cohomological information of the closed leaves. A retraction to the cohomological skeleton is further used to build homotopy operators for the flat foliated complex. This is based on Lemma \ref{lemma: infinite time pullback} and Proposition \ref{lemma: homotopies}, whose proofs we delay to Section \ref{subsection: homotopy operators}. The flat foliated cohomology and the homotopy operators will be the building blocks for the computation of flat Poisson cohomology and the existence of ``good'' homotopy operators for the flat Poisson complex. These will play a crucial role in the proof of the linearization theorem. \subsection{The statement and explanations of the results}\label{section: foliated ch} The singular foliation $\F$ of $(\spl,\pi)$ restricts on $\spl\backslash\{0\}$ to a regular, corank two, unimodular foliation. In this subsection we first recall the foliated de Rham complex of a regular foliation. Then we adapt this notion to introduce the flat foliated complex of $\F$ on $\spl$, which gives rise to flat foliated cohomology. We also state the main results of Section \ref{section flat foli}: we describe the flat foliated cohomology groups and claim the existence of homotopy operators. The proofs of these results will occupy the rest of Section \ref{section flat foli} and Section \ref{subsection: homotopy operators}. \subsubsection{Foliated cohomology} We first look at a regular foliation $\mathcal{F}$ on a manifold $M$, and we denote the \textbf{complex of foliated forms} by \[(\Omega^{\bullet}(\mathcal{F}), \dif_{\mathcal{F}})\ \ \ \text{ where }\ \ \Omega^{\bullet}(\mathcal{F}):=\Gamma(\wedge^{\bullet} T^*\mathcal{F}).\] This complex consists of smooth families of differential forms along the leaves of $\mathcal{F}$, and $\dif_{\mathcal{F}}$ is the leafwise de Rham differential. The resulting cohomology is called the \textbf{foliated cohomology} of $\F$, denoted $H^{\bullet}(\F)$. The normal bundle to $\F$, denoted by $\nu:=TM/T\F$, carries the \textbf{Bott connection} \[\nabla:\Gamma(T\F)\times \Gamma(\nu)\to \Gamma(\nu),\ \ \ \ \nabla_X(\overline{V}):=\overline{[X,V]},\] which, via the usual formula for the exterior derivative, induces a differential on $\nu$-valued forms $(\Omega^{\bullet}(\F,\nu),\dif_{\nabla})$. This yields the cohomology of $\F$ with values in $\nu$, denoted $H^{\bullet}(\F,\nu)$. Similarly, the dual connection on $\nu^*$ gives rise to a connection on the exterior powers $\wedge^{q}\nu^*$, and we obtain the complexes $(\Omega^{\bullet}(\F,\wedge^{q}\nu^*),\dif_{\nabla})$, with cohomology groups $H^{\bullet}(\F,\wedge^{q}\nu^*)$. In particular, for $q=\mathrm{codim}(\F)$, we have a canonical isomorphism \[(\Omega^{\bullet}(\F,\wedge^q\nu^*),\dif_{\nabla})\simeq (\CC^{\bullet},\dif),\] where $(\CC^{\bullet},\dif)$ is the subcomplex of $(\Omega^{\bullet+q}(M),\dif)$, defined by: \[ \CC^{p}:=\big\{\alpha\in\Omega^{p+q}(M)\, |\, \forall\, v_1,\ldots,v_p\in T_x\F\, :\, i_{v_1}\ldots i_{v_p}\alpha\in \wedge^q\nu_x^*\big\}.\] Assume that $\F$ is coorientable and let $\varphi\in \Gamma(\wedge^q\nu^*)\subset \Omega^q(M)$ be a defining $q$-form for $\F$, i.e., $\varphi$ is nowhere zero and $T\F=\ker (\varphi)$. Then the subcomplex $\CC^{\bullet}$ admits the alternative description: \[(\CC^{\bullet},\dif)=(e_{\varphi}(\Omega^{\bullet}(M)),\dif) \subset (\Omega^{\bullet+q}(M),\dif),\] where $e_{\varphi}(-)=\varphi\wedge (-)$ denotes the exterior product with $\varphi$. The foliation $\F$ is called \textbf{unimodular} if there exists a defining $q$-form $\varphi$ which is closed: $\dif \varphi=0$. Such a form is parallel for the dual of the Bott connection, and it induces an isomorphism of complexes: \begin{align}\label{eq: cochain isomorphism} (\Omega^{\bullet}(\F),\dif_{\F})\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} (\Omega^{\bullet}(\F,\wedge^q \nu^*),\dif_{\nabla}), \ \ \eta\mapsto \varphi \otimes \eta. \end{align} Therefore, in this case, the subcomplex $\CC^{\bullet}$ can be used to calculate the foliated cohomology of $\F$. \subsubsection{Flat foliated cohomology of $\spl$} Note that on $\spl\setminus\{0\}$ the regular foliation $\F|_{\spl\setminus\{0\}}$ is unimodular with defining $2$-form \[\varphi:=\dif f_1\wedge \dif f_2,\quad \textrm{where}\quad f=f_1+i f_2.\] We denote by $\Omega_0^{\bullet}(\spl)$ the set of differential forms that are flat at the origin, i.e., all partial derivatives of the coefficients vanish at the origin. Motivated by the discussion in the previous subsection, we introduce: \begin{definition}\label{definition: flat foliated ch} We call the cohomology of the complex \begin{equation}\label{ffcomplex} (\CC^{\bullet}:=e_{\varphi}(\Omega^{\bullet}_0(\spl)),\dif) \end{equation} the \textbf{flat foliated cohomology} of $\spl$, and we denote it by $H^{\bullet}_0(\F)$. \end{definition} The rest of the section is devoted to the calculation of the groups $H^{\bullet}_0(\F)$. \subsubsection{The foliated cohomology away from $S_0$}\label{subsection:away from S_0} To gain some geometric intuition, let us first discuss the foliated cohomology of $\F$ restricted to the open set $\spl\backslash S_0$. Here, the foliation is given by a the fibers of a locally trivial fibration: \[ f:\spl \setminus S_0 \to \C^{\times}:= \C\setminus \{0\}.\] For any such locally trivial fibration $p:E\to B$ with connected fibers, if the cohomology groups of the fibers are finite-dimensional, then they fit into a smooth vector bundle: \[\mathcal{H}^{\bullet}\to B,\quad \mathcal{H}^{k}_b:=H^{k}(p^{-1}(b)).\] The global sections of $\mathcal{H}^{\bullet}$ can be identified with the cohomology of the simple foliation $\mathcal{F}(p)$ associated to the submersion $p$: \[H^{\bullet}(\mathcal{F}(p))\simeq \Gamma(\mathcal{H}^{\bullet}).\] In our case, the fibers $f^{-1}(z)=S_z$, for $z\in \C^{\times}$, are all diffeomorphic to $T^*S^2$, which is homotopy equivalent to $S^2$. Hence, we have that \[H^{k}(\F|_{\spl\backslash S_0})\simeq \Gamma(\mathcal{H}^k)=0,\quad \textrm{for } k\notin \{0,2\},\] and clearly \[H^{0}(\F|_{\spl\backslash S_0})\simeq C^{\infty}(\C^{\times}).\] The situation in degree 2 is a bit more involved, because the rank 1 vector bundle $\mathcal{H}^2\to \C^{\times}$ is non-trivial. The leafwise symplectic structures $\omega_1$ and $\omega_2$, associated to the Poisson structures $\pi_1$ and $\pi_2$ from \eqref{eq: real identification}, induce sections \[[\omega_1], [\omega_2]\in \Gamma(\mathcal{H}^2).\] We will see that the vanishing loci of these sections are the positive real half-line and the negative real half-line, respectively: \begin{align*} &[\omega_1(z)]=0\in H^2(f^{-1}(z))\iff\quad z\in (0,\infty),\\ &[\omega_2(z)]=0\in H^2(f^{-1}(z))\iff\quad z\in (-\infty,0). \end{align*} So, at any point in $\C^{\times}$ at least one of $[\omega_1]$ and $[\omega_2]$ is non-zero, and therefore they span all sections: \[\Gamma(\mathcal{H}^2)=\big\{g_1[\omega_1]+g_2[\omega_2]\ |\ g_1,g_2\in C^{\infty}(\C^{\times})\big\}.\] Because $\mathrm{rank}(\mathcal{H}^2)=1$, the two sections are not independent, and we will prove that they satisfy the relation: \begin{align}\label{relation:omega's} (|z|-x)[\omega_1] = -y[\omega_2] \end{align} where $z=x+iy$. The second foliated cohomology is given by: \[H^{2}(\F|_{\spl\backslash S_0})\simeq \Gamma(\mathcal{H}^2)\simeq \frac{C^{\infty}(\C^{\times})\oplus C^{\infty}(\C^{\times})}{\big\{(g_1,g_2)\ |\ yg_1=(|z|-x) g_2\big\}}.\] \subsubsection{The twisted module}\label{subsection: twisted module} In the previous subsection, we dealt with the non-trivial line bundle $\mathcal{H}^2\to \C^{\times}$. This bundle does not extend smoothly at the origin. However, to express flat foliated cohomology, we use as inspiration the description of $\Gamma(\mathcal{H}^2)$ above to make sense of its ``space of sections flat at the origin". The following $C_0^{\infty}(\C)$-module will play a crucial role in this paper: \begin{align}\label{eq: definition M} \mathcal{M}\subset C^{\infty}_0(\C)\oplus C^{\infty}_0(\C),\quad \mathcal{M}:=\{(g_1,g_2)\, |\, yg_1=-(|z|+x)g_2\}. \end{align} For later use, let us give some properties of the module $\mathcal{M}$. \begin{proposition}\label{proposition: twisted module} The following hold: \begin{enumerate}[(1)] \item We have an isomorphism of $C_0^{\infty}(\C)$-modules $J:\mathcal{M}\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \mathcal{K}$, where \[\mathcal{K}\subset C^{\infty}_0(\C)\oplus C^{\infty}_0(\C),\quad \mathcal{K}:=\{(g_1,g_2)\, |\, yg_1=(|z|-x)g_2\},\] given by $J(g_1,g_2)=(-g_2,g_1)$. \item We have the direct sum decomposition: \[\mathcal{M}\oplus \mathcal{K}= C^{\infty}_0(\C)\oplus C^{\infty}_0(\C).\] \end{enumerate} \end{proposition} \begin{proof} For item (1), one uses the relation $(|z|-x)(|z|+x)=y^2$. The direct sum decomposition corresponds to the projections: \begin{align} p_{\mathcal{M}}:C^{\infty}_0(\C)&\oplus C^{\infty}_0(\C)\to \mathcal{M},\quad p_{\mathcal{K}}:C^{\infty}_0(\C)\oplus C^{\infty}_0(\C)\to \mathcal{K},\nonumber\\ p_{\mathcal{M}}(g_1,g_2)&:=\frac{1}{2|z|}\left((|z|+x)g_1-y g_2, -yg_1 + (|z|-x)g_2\right),\label{eq: projection m}\\ p_{\mathcal{K}}(g_1,g_2)&:=\frac{1}{2|z|}\left((|z|-x)g_1+y g_2, yg_1 + (|z|+x)g_2\right).\nonumber \qedhere \end{align} \end{proof} \subsubsection{The description of the flat foliated cohomology}\label{section: result ffch} In this subsection we describe the groups $H^{\bullet}_0(\F)$. Because of the flatness condition at the origin, which we impose on the forms, the singularity of the foliation will bring no contributions in cohomology. In fact, with some adaptations, the discussion from the previous subsection can be extended to describe the flat foliated cohomology. In degree zero, we obtain smooth functions on $\spl$ that are constant along the leaves of $\F$ and flat at $0$. Of course, these are precisely the Casimir functions of $(\spl,\pi)$ (described in Proposition \ref{prop:Casimirs}) that are flat at 0. We have the following isomorphism: \[C_0^{\infty}(\C)\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} H^{0}_{0}(\F)\quad \quad g \mapsto e_{\varphi}(g \circ f).\] To represent the second cohomology classes, we will need the following: \begin{lemma}\label{lemma: extension omega} For $i=1,2$, there exist 2-forms $\tilde{\omega}_i\in \Omega^2(\spl \setminus \{0\})$ that extend the leafwise symplectic forms $\omega_i$ \[\omega_i =\tilde{\omega}_i|_{T\F}\quad \textrm{on}\quad \spl \setminus \{0\},\] and such that, when multiplied with $R^2=\mathrm{tr}(AA^*)$, become smooth at $0$: \[ R^2 \cdot \tilde{\omega}_i \in \Omega^2(\spl).\] \end{lemma} \begin{proof} In the coordinates from Subsection \ref{section: formal poisson}, the extensions are defined as: \begin{align*} \tilde{\omega}_1:&=\frac{2}{R^2}\sum_{c.p.} \big( x_1 (\dif y_2\wedge \dif y_3-\dif x_{2}\wedge\dif x_3) -y_1 (\dif x_2\wedge \dif y_3+ \dif y_2 \wedge\dif x_3)\big)\\ &=\frac{1}{|z|^2}\sum_{c.p.} \Re \big(-z_1 \dif \overline{z}_2\wedge\dif \overline{z}_3\big)\\ \tilde{\omega}_2:&=\frac{2}{R^2}\sum_{c.p.}\big(y_1(\dif y_2\wedge\dif y_3 -\dif x_{2}\wedge\dif x_{3}) +x_1 (\dif x_{2}\wedge\dif y_3+ \dif y_2\wedge\dif x_{3})\big)\\ &=\frac{1}{|z|^2}\sum_{c.p.} \Im \big(-z_1 \dif \overline{z}_2\wedge\dif \overline{z}_3\big) \end{align*} where $\sum_{c.p.}$ denotes the sum over all cyclic permutations of the indexes $1,2,3$. A direct calculation shows that they satisfy: \[\pi_i^{\sharp} \circ \tilde{\omega}_i^{\flat} \circ \pi_i^{\sharp} = \pi_i^{\sharp}.\] Another way to describe $\tilde{\omega}_i$ is as following: we define the two vector fields $V_1,V_2\in \mathfrak{X}^1(\spl \setminus\{0\})$ by \begin{align}\label{eq: v} V_1:=\frac{1}{R^2}\sum_{i=1}^{3}(x_{i}\partial_{x_i}-y_{i}\partial_{y_i})\quad \text{ and }\quad V_2:= \frac{1}{R^2}\sum_{i=1}^{3}(x_i\partial_{y_i}+y_i\partial_{x_i}) \end{align} The vector fields $V_1$ and $V_2$ trivialize the normal bundle of $\F$ away from the origin as they satisfy the relations \begin{align}\label{eq:v transversality} \dif f_j(V_i)=\delta_{ij}. \end{align} The 2-form $\tilde{\omega}_i$ is the unique extension of $\omega_i $ satisfying \[ i_{V_j}\tilde{\omega}_i=0 \ \ \ \ \ \text{ for }\ j \in \{1,2\}.\qedhere\] \end{proof} The extensions from the lemma have only mild singularities at the origin, in particular, for any flat function $h\in C^{\infty}_0(\spl)$, \[h\cdot \tilde{\omega}_i\in \Omega^{2}_0(\spl).\] The following result describes the flat foliated cohomology of $\F$, and to state it we use the $C^{\infty}_0(\C)$-modules $\mathcal{M}$ and $\mathcal{K}$ from the previous subsection. The proof will occupy the rest of Section \ref{section flat foli} and Section \ref{subsection: homotopy operators}. \begin{proposition}\label{proposition:flat foliated ch} For $k\notin \{0,2\}$, $H^k_0(\F)\simeq 0$, and \begin{itemize} \item for $k=0$, we have the isomorphism: \begin{equation}\label{eq: zero fol iso} \begin{array}{cccc} &C_0^{\infty}(\C)&\xrightarrow{\simeq} & H^{0}_{0}(\F)\\ &g&\mapsto &e_{\varphi}(g \circ f) \end{array} \end{equation} \item for $k=2$, we have a surjective map \begin{equation} \label{eq: quotient} \begin{array}{cccc} &C_0^{\infty}(\C)\oplus C^{\infty}_0(\C)&\to & H^{2}_{0}(\F) \\ &(g_1,g_2)&\mapsto & [e_{\varphi}(g_1\circ f\cdot \tilde{\omega}_1 +g_2\circ f\cdot \tilde{\omega}_2)] \end{array} \end{equation} with kernel $\mathcal{K}$. Hence \eqref{eq: quotient} restricts to a $C^{\infty}_0(\C)$-linear isomorphism \begin{equation}\label{eq:2nd:flat:foliated} \mathcal{M} \xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} H^{2}_{0}(\F). \end{equation} \end{itemize} \end{proposition} \begin{remark} Note that the 2-forms \[e_{\varphi}(g_1\circ f\cdot \tilde{\omega}_1 +g_2\circ f\cdot \tilde{\omega}_2)\in \Omega^{4}_0(\spl)\] are independent of the chosen extensions. However, the explicit extensions were needed in order to show that these forms are indeed part of our complex. \end{remark} \subsubsection{Good homotopy operators} In the second part of the paper we prove Theorem \ref{theorem: nondegenerate} using the Nash-Moser method. For this, mere descriptions of the cohomology will not suffice. We will need to construct so-called \emph{homotopy operators}, which play the role of partial inverses to the differential. To be of use in the analysis part, these maps need to satisfy a locality condition with respect to closed balls around the origin and certain estimates. We collect these properties in the following: \begin{definition}\label{definition: property H} Let $V$ and $W$ be two vector bundles over an inner product space $H$ (we will only use $H=\spl$ and $H=\C$). Consider vector subspaces of sections \[\mathscr{V}\subset \Gamma_0(V)\quad \textrm{and}\quad \mathscr{W}\subset \Gamma_0(W),\] where $\Gamma_0(\cdot)$ denotes the space of sections that are flat at the origin. Let $\iota_r:\overline{B}_r\to H$ denotes the inclusion of the closed ball of radius $r>0$ and denote $\mathscr{V}_r:=\iota_r^*(\mathscr{V})$ and $\mathscr{W}_r:=\iota_r^*(\mathscr{W})$. After choosing trivializations of $V$ and $W$, we have norms $\fnorm{\cdot}_{n,k,r}$ on $\mathscr{V}_r$ and $\mathscr{W}_r$, defined for $s\in \mathscr{V}_r$ by \begin{align}\label{eq: flat norms} \fnorm{s}_{n,k,r}:= \sup_{x\in \overline{B}_r}\ \sup_{a\in \N^m_0\, :\, |a|\le n}|x|^{-k}|D^a s(x)| \ \in \ [0,\infty). \end{align} We say that a linear operator: \[\ell:\mathscr{V}\to \mathscr{W}\] satisfies \textbf{property SLB} for some $(a,b,c)\in \N_0^3$ (SLB from semi-local and bounded), if it induces linear operators $\ell_r$, for $r>0$, such that the diagrams: \begin{equation}\label{eq: property H diagram} \begin{tikzpicture}[baseline= (a).base] \node[scale=.9] (a) at (0,0){ \begin{tikzcd} \mathscr{V}\arrow{r}{\ell}\arrow{d}[swap]{\iota_r^*}& \mathscr{W} \arrow{d}{\iota_r^*}\\ \mathscr{V}_r\arrow{r}{\ell_{r}}&\mathscr{W}_r \end{tikzcd} }; \end{tikzpicture} \end{equation} commute, and such that the following estimates hold \begin{align}\label{eq: property H estimate} \fnorm{\ell_{r}(\alpha)}_{n,k,r}\le C\, \fnorm{\alpha}_{n+a,k+bn+c,r},\quad \forall\, \alpha\in \mathscr{V}_r, \end{align} for all $n,k\in \N_0$, where $C=C(r,n,k)$ depends continuously on $r$. \end{definition} \begin{example} Note that any linear partial differential operator $\ell$ of degree $d$ satisfies the SLB property of $(d,0,0)$. \end{example} \begin{remark} Throughout the paper we will encounter many operators which satisfy the SLB property and we will keep track of the triples $(a,b,c)\in \N^3_0$ which appear. However, the reader may ignore their precise values, the only important thing for our proof is that the SLB property holds for some $(a,b,c)$. \end{remark} \begin{remark} The seminorms $\fnorm{\cdot}_{n,k,r}$ defined in \eqref{eq: flat norms} are equivalent to the seminorms $|\cdot|_{n,k,r}$ defined in \eqref{eq: flat norms 2} (see Subsection \ref{subsec: equivalent seminorms}). \end{remark} This type of operators are closed under composition. \begin{lemma}\label{lemma: slb property} Let $U, V$ and $W$ be three vector bundles over an inner product space $H$ and consider two linear operators: \begin{align*} \ell_1 : \mathscr{U}\subset \Gamma_0(U)\to \mathscr{V}\subset \Gamma_0(V) \quad \textrm{and}\quad \ell_2:\mathscr{V}\subset \Gamma_0(V)\to \mathscr{W}\subset \Gamma_0(W). \end{align*} If $\ell_i$ satisfies property SLB for $(a_i,b_i,c_i)$, $i=1,2$, then the operator $\ell_2\circ \ell_1$ satisfies property SLB for $(a_1+a_2,b_1+b_2, a_2b_1 +c_1+c_2)$. \end{lemma To calculate the flat foliated cohomology, we will reduce the complex from \eqref{ffcomplex} to quasi-isomorphic subcomplexes. It will be useful to package this procedure into the following standard notion (see, e.g., \cite{LS87}): \begin{definition}\label{definition: dr} A \textbf{deformation retraction} of a complex $(C^{\bullet},d)$ consists of a \textbf{cochain projection}, i.e., a cochain map \begin{align*} p:(C^{\bullet},d) \to (C^{\bullet},d) \quad \textrm{such that}\quad p\circ p=p, \end{align*} together with \textbf{cochain homotopies} between $p$ and $\mathrm{id}_{C}$, i.e., linear maps \begin{align*} h:C^{\bullet+1}\to C^{\bullet} \quad \textrm{such that}\quad p-\mathrm{id}_{C}= h\circ d+d\circ h. \end{align*} \end{definition} The conditions in the definition imply that the maps: \[(C^{\bullet},d)\stackrel{p}{\to}(p(C^{\bullet}),d)\quad \textrm{and}\quad (p(C^{\bullet}),d)\stackrel{\mathrm{incl}}{\hookrightarrow}(C^{\bullet},d)\] are inverses to each other in cohomology, thus we have an isomorphism: \[H^{\bullet}(C)\simeq H^{\bullet}(p(C)).\] The following is the quantitative version of Proposition \ref{proposition:flat foliated ch} as it gives homotopy operators for the complex $(\CC^{\bullet},\dif)$ computing the flat foliated cohomology from \eqref{ffcomplex}. The proof will be given later. \begin{proposition}\label{proposition: property H fol} There exists a deformation retraction $(p_{\F},h_{\F})$ for the complex $(\CC^{\bullet},\dif)$ such that: \begin{enumerate}[(1)] \item $\dif\circ p_{\F}=0$; \item $h_{\F}$ satisfies property SLB for $(0,5,35)$. \end{enumerate} \end{proposition} The first condition says that the differential vanishes on $p_{\F}(\CC^{\bullet})$. Thus, from the discussion above, every cohomology class has a unique representative in $p_{\F}(\CC^{\bullet})$, and so we have an isomorphism: \[p_{\F}(\CC^{\bullet})\simeq H^{\bullet}_{0}(\F).\] The second condition together with the homotopy relation imply that also $p_{\F}$ satisfies property SLB, but for $(1,5,40)$. In particular all these operators can be restricted to closed balls centered at the origin. \subsection{Averaging the $SU(2)$-action}\label{section: su2 average} The operators from Proposition \ref{proposition: property H fol} will be constructed in two steps. In this subsection, we perform the first step: we average with respect to the action of $SU(2)\subset SL(2,\C)$. Consider the operator \[p_{SU(2)}:\Omega^{\bullet}(\spl)\to \Omega^{\bullet}(\spl),\] \[\alpha\mapsto \int_{SU(2)}\Ad_{U}^*(\alpha)\mu(U),\] where we integrate with respect to the normalized Haar measure $\mu$ on $SU(2)$. We show that $p_{SU(2)}$ induces a deformation retraction of the subcomplex computing flat foliated cohomology. \begin{proposition}\label{proposition: invariance skeleton} There are operators $h_{SU(2)}$ such that $(p_{SU(2)},h_{SU(2)})$ is a deformation retraction of $(\Omega^{\bullet}(\spl),\dif)$. Moreover, this pair restricts to a deformation retraction of $(\CC^{\bullet},\dif)$, and both restricted maps satisfy property SLB for $(0,0,0)$. \end{proposition} \begin{remark} The proof follows a general method for constructing homotopy operators for actions of compact and connected groups on complexes, which we have learned from \cite{VV14}. We have discussed this method in some greater generality in \cite{thesis_Florian}, here we apply it explicitly to the case of $SU(2)$. \end{remark} \begin{proof} It follows easily that $p_{SU(2)}$ is a cochain projection of the complex $(\Omega^{\bullet}(\spl),\dif)$ whose image is the $SU(2)$-invariant subcomplex. Next, consider the pullback of the Haar measure (which we regard as a volume form, after choosing an orientation) to $\mathfrak{su}(2)$ via the exponential: \[ \lambda:=\exp^*(\mu)\in \Omega^3(\mathfrak{su}(2)).\] One easily checks (see e.g.\ \cite[Section 1.5]{DK}) that the exponential map of $SU(2)$ restricts to a diffeomorphism: \[\exp:\mathcal{I}\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} SU(2)\backslash\{-\mathds{1}\},\] where $\mathcal{I}\subset \mathfrak{su}(2)$ denotes the open ball of radius $\sqrt{2}\pi$ with respect to the norm $|X|=\sqrt{\mathrm{tr}(XX^*)}$ and on the boundary it satisfies \[\exp (\partial\mathcal{I})=\{-\mathds{1}\}.\] This allows us to write: \[p_{SU(2)}(\alpha)=\int_{SU(2)}\Ad_{U}^*(\alpha)\mu(U) =\int_{\overline{\mathcal{I}}}\Ad_{\exp(X)}^*(\alpha)\lambda(X). \] Denote by $\mathrm{ad}_X\in \mathfrak{X}^1(\spl)$ the vector field whose flow is $\Ad_{\exp(tX)}$, i.e.\ \[\mathrm{ad}_X(A):=[X,A].\] Then, using Cartan's formula, we have that: \[\frac{\dif}{\dif t}\Ad_{\exp(tX)}^*(\alpha)=\dif \Ad_{\exp(tX)}^* i_{\mathrm{ad}_X}(\alpha)+ \Ad_{\exp(tX)}^* i_{\mathrm{ad}_X}\dif (\alpha). \] This implies that: \begin{align*} p_{SU(2)}(\alpha)-\alpha =&\int_{\overline{\mathcal{I}}}\big(\Ad_{\exp(X)}^*(\alpha)-\alpha\big)\lambda(X)\\ =&\int_{\overline{\mathcal{I}}}\int_0^1 \frac{\dif}{\dif t}\Ad_{\exp(tX)}^*(\alpha)\, \dif t\lambda(X)\\ =&\dif \int_{\overline{\mathcal{I}}}\int_0^1 \Ad_{\exp(tX)}^* i_{\mathrm{ad}_X}(\alpha)\dif t\lambda(X)\\ &+\int_{\overline{\mathcal{I}}}\int_0^1 \Ad_{\exp(tX)}^* i_{\mathrm{ad}_X}(\dif \alpha)\dif t\lambda(X). \end{align*} Thus, if we define: \[h_{SU(2)}(\beta):=\int_{\overline{\mathcal{I}}}\int_0^1 \Ad_{\exp(tX)}^* i_{\mathrm{ad}_X}(\beta)\dif t\lambda(X), \] then we obtain the homotopy relation: \[p_{SU(2)}(\alpha)-\alpha=\dif h_{SU(2)}(\alpha)+h_{SU(2)}(\dif \alpha).\] Next, let us note that both $p_{SU(2)}$ and $h_{SU(2)}$ preserve \[\CC^{\bullet}=e_{\varphi}(\Omega^{\bullet}_0(\spl))\subset \Omega^{\bullet+2}(\spl).\] This follows because $\varphi=\dif f_1\wedge\dif f_2$ is $SU(2)$-invariant, and also satisfies $i_{\mathrm{ad}_X}\varphi=0$, and because the action fixes the origin. Next, since the $SU(2)$-action preserves the metric on $\spl$, it follows that both operators induce operators above closed balls around the origin, i.e.\ the first condition of property SLB holds. The inequalities from the second condition follow by using the explicit form of the norms. \end{proof} \subsection{The ``cohomological skeleton'' $\mathfrak{S}$} \label{section: skeleton} The main ingredient to calculate the flat foliated cohomology is what we call the ``cohomological skeleton'' $\mathfrak{S}$ associated with the foliation $\F$. One may think of $\Sk$ as an object that contains the cohomological information of the closed leaves of $\F$. In our case, we will see that this is satisfied by the set of normal matrices, and so we define the \textbf{cohomological skeleton} as \begin{align*} \Sk :=\{ A\in \spl |[A,A^*]=0\}. \end{align*} This subsection is divided as follows. We first give an alternative descriptions of $\Sk$, then we give an explicit continuous projection map $r_{\Sk}$ from $\mathfrak{sl}_2(\C)$ onto $\Sk$ and study its properties, then we show that the smooth locus of $\Sk$ is an embedded submanifold and we find a desingularization for $\Sk$. \subsubsection{Characterizations of $\Sk$} To give other descriptions of $\Sk$, we first recall some basic linear algebra. Since any $A\in \spl$ satisfies its own characteristic equation, we have \begin{equation}\label{eq:invariant polynomials a} \begin{array}{rcc} A^2 = -f\mathds{1}, \ & &\ (A^*)^2=-\overline{f}\mathds{1}, \end{array} \end{equation} The standard norm squared on $\mathfrak{sl}_2(\C)$ is given by \begin{align}\label{eq:norm} R^2=R(A) ^2&:= |A|^2= \tr(A A^*). \end{align} For $A\in \spl$, the characteristic equation of $AA^*$ is: \begin{align}\label{eq:invariant polynomials aah} (AA^*)^2- R^2 AA^*+\nf^2\mathds{1}=0. \end{align} Since $AA^*$ has real eigenvalues, the discriminant of this equation is positive, which implies the following very useful inequality: \begin{equation}\label{eq:norm-fiber inequality} 2\nf\leq R^2. \end{equation} Normal matrices can be described as follows. \begin{lemma}\label{lemma: characterization skeleton} For $A\in \spl$ the following are equivalent: \begin{enumerate}[(1)] \item $A\in \Sk$ \item $A$ is unitarily diagonizable \item $R^2=2|f|$ \item $AA^*=\nf \mathds{1}$. \end{enumerate} \end{lemma} \begin{proof} The equivalence (1)$\iff$ (2) is the content of the spectral theorem. Next, by Schur's decomposition theorem, any $A\in \spl$ is unitary equivalent to an upper triangular matrix $\Lambda$: \[ A=U\Lambda U^{*}, \quad U\in SU(2), \quad \Lambda =\begin{pmatrix} \lambda_{11} & \lambda_{12} \\ 0&-\lambda_{11} \end{pmatrix}\] Using this, we obtain the following expression for $|f|$: \begin{align*} \nf =\det(AA^*)^{\frac{1}{2}} = \det(\Lambda \Lambda^*)^{\frac{1}{2}}=|\lambda_{11}|^2 \end{align*} and for the norm of $A$ we find: \begin{align*} R^2 =|A|^2=\tr(AA^*)=\tr(\Lambda \Lambda^*) = 2|\lambda_{11}|^2+ |\lambda_{12}|^2. \end{align*} Thus, $R^2=2|f|$ if and only if $\lambda_{12}=0$, i.e., $\Lambda$ is diagonal. This proves the implication (3) $\implies$ (2). The other implications: \[ (2)\ \ \implies \ \ (4)\ \ \implies \ \ (3) \] are immediate. \end{proof} \subsubsection{The retraction to the cohomological skeleton}\label{subsubsec_retraction} The goal of this subsection is to define a continuous retraction $r_{\Sk}$ from $\spl$ onto $\Sk$ and study its properties. In Section \ref{subsection: homotopy operators} we will realize $r_{\Sk}$ as the infinite flow of a vector field. First, we introduce the smooth function: \begin{equation*} \begin{array}{cccc} g_{\infty} :&\spl \setminus S_0&\to &\herm(\C) \\ & A&\mapsto&\left(\mathds{1}+\frac{1}{\nf}AA^*\right)^{\frac{1}{2}} \end{array} \end{equation*} where $\herm(\C)$ denotes the set of positive definite Hermitian $2\times 2$-matrices. In defining this map, we used the diffeomorphism: \[\sqrt{\cdot}: \herm(\C)\to \herm(\C).\] Note that elements in $\herm(\C)$ are invertible. Define the retraction: \begin{align}\label{retract} r_{\Sk}&:\spl \to \Sk\subset \spl\nonumber \\ r_{\Sk} (A)&:= \begin{cases} g_{\infty}(A)^{-1}Ag_{\infty}(A)&\text{ if } f(A)\ne 0\\ 0&\text{ if } f(A)= 0 \end{cases} \end{align} \begin{lemma}\label{lemma:properties of p} The map $r_{\Sk}$ is a projection onto $\Sk$: \[r_{\Sk}(\spl)=\Sk \quad \textrm{and}\quad r_{\Sk}|_{\Sk}=\mathrm{id}_{\Sk},\] and has the following properties: it is continuous on $\spl$ and smooth on $\spl\setminus S_0$, it is $SU(2)$-equivariant and it preserves the fibers of $f$. \end{lemma} \begin{proof} We first check that the image of $r_{\Sk}$ lies indeed inside of $\Sk$. Note that by \eqref{eq:invariant polynomials a} we have the identity \begin{align*} A \ g_{\infty}(A)^{2}A^* =&\ AA^*+\nf \mathds{1} = \nf \, g_{\infty}(A)^{2}, \end{align*} and therefore: \begin{equation}\label{eq: retraction well-defined} r_{\Sk}(A)r_{\Sk}(A)^* = \ g_{\infty}(A)^{-1}A \ g_{\infty}(A)^{2}A^* g_{\infty}(A)^{-1}= \nf\, \mathds{1}. \end{equation} We easily obtain that $r_{\Sk}$ preserves $f$ \[f(r_{\Sk}(A))=\det (r_{\Sk}(A))= \det (A) =f(A),\] and therefore Lemma \ref{lemma: characterization skeleton} (4) and \eqref{eq: retraction well-defined} imply that $r_{\Sk}(A)\in \Sk$. Next, for $A\in \Sk\backslash S_0$, again by Lemma \ref{lemma: characterization skeleton} (4), we have that $g_{\infty}(A)=\sqrt{2}\mathds{1}$, and so $r_{\Sk}(A)=A$. Since $\Sk\cap S_0=\{0\}$, we conclude that $r_{\Sk}|_{\Sk}=\id_{\Sk}$. Using again \eqref{eq: retraction well-defined} we obtain \[ \lvert r_{\Sk}(A)\rvert^2 =2\nf,\] which proves continuity of $r_{\Sk}$ at points in $S_0\subset \spl$. Continuity and smoothness on the set $\spl\setminus S_0$ follow from the formula of $r_{\Sk}$ on this set. That $r_{\Sk}$ is $SU(2)$-equivarients follows immediately. \end{proof} \subsubsection{The cochain projection associated to $r_{\Sk}$} Even though $r_{\Sk}$ is not smooth along $S_0$, we will show in Section \ref{subsection: homotopy operators} that it induces a pullback map on flat forms: \begin{lemma}\label{lemma: infinite time pullback} For every $\alpha \in \Omega_{0}^{\bullet}(\spl)$, the form $r_{\Sk}^*(\alpha)|_{\spl\backslash S_0}$ extends to a smooth form on $\spl$, which is flat at $0$: \[p_{\Sk}(\alpha)\in \Omega^{\bullet}_0(\spl).\] \end{lemma} By Lemma \ref{lemma:properties of p}, $r_{\Sk}^2=r_{\Sk}$, and therefore $p_{\Sk}$ is a cochain projection: \[p_{\Sk}:(\Omega^{\bullet}_0(\spl),\dif)\to (\Omega^{\bullet}_0(\spl),\dif).\] The same lemma also implies that $p_{\Sk}$ commutes with $e_{\varphi}$ (it suffices to check this away from $S_0$), therefore $p_{\Sk}$ restricts to a cochain projection of $(\CC^{\bullet},\dif)$. The proof of the following proposition will occupy most of Section \ref{subsection: homotopy operators}: \begin{proposition}\label{lemma: homotopies} There are operators $h_{\Sk}$ such that $(p_{\Sk},h_{\Sk})$ is a deformation retraction of $(\Omega^{\bullet}_0(\spl),\dif)$. Moreover, this pair restricts to a deformation retraction of $(\CC^{\bullet},\dif)$, and $h_{\Sk}$ satisfies property SLB for $(0,5,35)$. \end{proposition} By combining the operators from Propositions \ref{proposition: invariance skeleton} and \ref{lemma: homotopies} we obtain the deformation retraction from Proposition \ref{proposition: property H fol} (for such compositions, see e.g.\ \cite[Lemma 2.4]{LS87}) \begin{corollary}\label{corollary:chain:proj} The pair $(p_{\F},h_{\F})$ defined by \[p_{\F}:=p_{SU(2)}\circ p_{\Sk} \quad \text{and}\quad h_{\F}:=p_{SU(2)}\circ h_{\Sk}+h_{SU(2)}\] is a deformation retraction for the complex $(\CC^{\bullet},\dif)$, and $h_{\F}$ satisfies property SLB for $(0,5,35)$. \end{corollary} \begin{proof} By Lemma \ref{lemma:properties of p}, $r_{\Sk}$ is $SU(2)$-equivariant, and this implies that $p_{\Sk}$ and $p_{SU(2)}$ commute. Hence $p_{\F}$ is a cochain projection. The homotopy relation follows easily: \begin{align*} p_{\F}-\mathrm{id}=&p_{SU(2)}(p_{\Sk}-\mathrm{id})+p_{SU(2)}-\mathrm{id}\\ =&p_{SU(2)}(\dif h_{\Sk}+h_{\Sk}\dif )+\dif h_{SU(2)}+ h_{SU(2)}\dif \\ =&\dif (p_{SU(2)} h_{\Sk}+ h_{SU(2)})+(p_{SU(2)}h_{\Sk}+h_{SU(2)})\dif\\ =&\dif h_{\F }+ h_{\F}\dif. \end{align*} Property SLB for the original operators implies it for $h_{\F}$. \end{proof} In the following subsections, we will see that $\dif\circ p_{\F}=0$, which will conclude the proof of Proposition \ref{proposition: property H fol}. \subsubsection{A desingularization of $\Sk$}\label{section: descing skeleton} The skeleton $\Sk$ is a smooth submanifold away from $0$. In this subsection, we construct a desingularization for $\Sk$. First note that, by Lemma \ref{lemma: characterization skeleton} (2), $\Sk$ is precisely the image of the map: \begin{equation*}\label{eq:surjective map} \begin{array}{cccc} \widehat{\rho}:&SU(2)\times \C &\to &\spl \\ &(U,\lambda)&\mapsto& U \begin{pmatrix} i\lambda&0\\ 0&-i\lambda \end{pmatrix}U^* \end{array} \end{equation*} This map is invariant under the right action on $SU(2)$ of the subgroup \[\Big\{ \begin{pmatrix} z&0\\ 0&\overline{z} \end{pmatrix}\, |\, z\in S^1 \Big\}.\] Therefore, the map descends to a map on the quotient: \[\rho: S^2\times \C \to \spl,\] where we identify $SU(2)/S^1\simeq S^2$ via the Hopf fibration: \begin{equation}\label{eq:Hopf} \begin{pmatrix} a&b\\ -\overline{b}&\overline{a} \end{pmatrix} \mapsto (\lvert a\rvert^2 -\lvert b\rvert^2,\Im(-2ab),\Re(-2ab)), \end{equation} where we regard $S^2\subset \R^3$. For later use, let us note that, if we use coordinates $w=(w_1,w_2,w_3)\in S^2\subset \R^3$, then $\rho$ is given by \begin{equation}\label{eq:cohomology map} \rho(w,\lambda)=\begin{pmatrix} i\lambda \cdot w_1 &\lambda \cdot (-w_2+iw_3)\\ \lambda \cdot (w_2+iw_3)&-i\lambda \cdot w_1 \end{pmatrix} \end{equation} \begin{lemma}\label{lemma:identification of skeleton} The map $\rho$ has the following properties: \begin{enumerate}[(1)] \item $\rho$ is $SU(2)$-equivariant for the natural left action on $S^2\simeq SU(2)/S^1$ and the action on $\spl$ by conjugation; \item $f\circ \rho(w,\lambda)=\lambda^2$, and so the preimages of the leaves of $\F$ are given by \[\rho^{-1}(S_z)=S^2\times\big\{\pm\sqrt{z}\big\},\] where $\pm\sqrt{z}$ are the two square roots of $z\in \C$; \item $\rho$ descends to a smooth map \[\underline{\rho}:S^2\times_{\Z_2}\C\to \spl,\] where $\Z_2$ acts on $S^2\times \C\subset \R^5$ by multiplication with $-1$; \item the regular part of the skeleton $\Sk^{\textrm{reg}}:=\Sk\backslash\{0\}$ is an embedded submanifold of $\spl$ and $\underline{\rho}$ restricts to a diffeomorphism: \begin{equation}\label{eq:desingularization} \underline{\rho}:S^2\times_{\Z_2}\C^{\times}\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \Sk^{\text{reg}}. \end{equation} \end{enumerate} \end{lemma} \begin{remark} We think of the map $\underline{\rho}:S^2\times_{\Z_2}\C\to \Sk$ as a \textbf{desingularization} of the skeleton. However, for calculations it will be more convenient to use the map $\rho$. \end{remark} \begin{proof} Items (1), (2) and (3) are immediate. An easy way to show that $\Sk^{\textrm{reg}}$ is an embedded submanifold is to note that, because $\Sk=\mathrm{im}(\widehat{\rho})$, it follows that $\Sk^{\mathrm{reg}}$ is the preimage under the submersion: \[\mathrm{pr}:\spl\backslash\{0\}\to \mathbb{CP}(\spl)\] of a (compact!) orbit of the induced $SU(2)$-action. For the last part, we first show that \eqref{eq:desingularization} is a bijection. Surjectivity follows because the image of $\widehat{\rho}$ is $\Sk$. To show injectivity, we need to understand when two elements $(U,\lambda),(\tilde{U},\tilde{\lambda})\in SU(2)\times \C $ have the same image under $\widehat{\rho}$. First, by comparing the determinants, we have that $\lambda=\pm \tilde{\lambda}$. For $\lambda =\tilde{\lambda}\ne 0$, note that the centralizer of the matrix \[\begin{pmatrix} \lambda &0 \\ 0& -\lambda \end{pmatrix}\] in $SU(2)$ the subgroup \[S^1\simeq \Big\{ V(\mu):= \begin{pmatrix} \mu&0\\ 0&\overline{\mu} \end{pmatrix} | \ \mu \in S^1\Big \}.\] In the case $\lambda =-\tilde{\lambda}\ne 0$ we use that \[ \begin{pmatrix} \lambda &0 \\ 0& -\lambda \end{pmatrix}= \gamma \begin{pmatrix} -\lambda &0 \\ 0& \lambda \end{pmatrix}\gamma^*, \quad \text{where}\quad \gamma :=\begin{pmatrix} 0&1\\ -1&0 \end{pmatrix}\] Using these, we obtain for $\lambda\neq 0$: \[ \widehat{\rho}(U,\lambda)=\widehat{\rho}(\tilde{U},\tilde{\lambda}) \ \ \Longleftrightarrow \ \ \exists\, \mu \in S^1 , i\in \{0,1\}\, : \, (\tilde{U},\tilde{\lambda} )=(UV(\mu)\gamma^i ,(-1)^i\lambda).\] By first taking the quotient modulo $S^1$, and identifying $SU(2)/S^1\simeq S^2$ via \eqref{eq:Hopf}, we obtain that $\widehat{\rho}$ descends to $\rho$. Next, using the relation \[ V(\mu)\gamma = \gamma V(-\overline{\mu}).\] we obtain that the right action of $\gamma$ on $SU(2)$ induces a well-defined $\Z_2$-action on $SU(2)/S^1$, which under the map \eqref{eq:Hopf} becomes multiplication by $-1$ on $S^2$. Hence, we obtain for $\lambda\neq 0$ that: \[\rho(w,\lambda)=\rho(\tilde{w},\tilde{\lambda}) \ \ \Longleftrightarrow \ \ (\tilde{w},\tilde{\lambda} )=(\pm w ,\pm \lambda).\] This implies that \eqref{eq:desingularization} is injective. Next, it is easy to see that the restriction of $\rho$ to $S^2\times \C^{\times}$ is an immersion. This implies that the map from \eqref{eq:desingularization} is an injective immersion whose image is $\Sk^{\mathrm{reg}}$. But since $\Sk^{\mathrm{reg}}$ is an embedded submanifold, it follows that \eqref{eq:desingularization} is a diffeomorphism. \end{proof} \subsubsection{Using the desingularization to calculate cohomology}\label{subsection:desing} By Corollary \ref{corollary:chain:proj}, the flat foliated cohomology $H^{\bullet}_0(\F)$ can be computed using the subcomplex $p_{\F}(\CC^{\bullet})\subset \CC^{\bullet}$. In this subsection, we will describe this subcomplex by using the desingularization map $\rho$. As a consequence we obtain the description of the flat foliated cohomology from Proposition \ref{proposition:flat foliated ch} and also conclude the proof of Proposition \ref{proposition: property H fol}. To describe the result, we first discuss the behavior of flat functions on $\C$ under pullback along the map: \[\sigma:\C\to \C, \quad \sigma(\lambda)=-\lambda.\ Consider the eigenspaces: \[C^{\infty}_{0,\pm \sigma}(\C):=\{g\in C^{\infty}_0(\C)\,|\, g=\pm \sigma^*(g)\},\] The following properties of these spaces will be proven in Appendix \ref{eigenspaces}: \begin{lemma}\label{lemma:pullbacks and invariant functions} \begin{enumerate}[(1)] \item The following map is an isomorphism of rings: \[C^{\infty}_0(\C)\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} C^{\infty}_{0,\sigma}(\C)\] \[g\mapsto g\circ \mathrm{sq}, \quad \textrm{where}\quad \mathrm{sq}(\lambda):=\lambda^2.\] \item The following map is surjective: \begin{equation*} \begin{array}{cccc} & C^{\infty}_0(\C)\oplus C^{\infty}_0(\C) &\to &C^{\infty}_{0,-\sigma}(\C)\\ &(g_1,g_2)&\mapsto &-\lambda_1\cdot g_1\circ \mathrm{sq}+\lambda_2\cdot g_2\circ \mathrm{sq}, \end{array} \end{equation*} where $\lambda_1+i\lambda_2=\lambda$, and its kernel is given by $\mathcal{K}$. \item The map from (2) restricts to a linear isomorphism: \[\mathcal{M} \xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} C^{\infty}_{0,-\sigma}(\C).\] \end{enumerate} \end{lemma} \vspace{-5pt} Next, we introduce the complex: \[(\DD^{\bullet},\dif)\subset (\Omega^{\bullet+2}(S^2\times \C),\dif) \] given by \begin{equation}\label{eq: foliated complex skeleton} \DD^{k} = \left\{\begin{array}{lr} C^{\infty}_{0,\sigma}(\C)\, \rho^*(\varphi), & \text{for } k=0\\ \quad\quad \quad 0, & \text{for } k=1\\ C^{\infty}_{0,-\sigma}(\C)\, \rho^*(\varphi)\wedge \omega_{S^2}, & \text{for } k=2 \end{array}\right. \end{equation} where we regard functions on $\C$ as functions on $S^2\times\C$ via the pullback along the second projection and $\omega_{S^2}$ is the standard area form on $S^2$ \begin{align}\label{eq: standard form s2} \omega_{S^2}= \sum_{c.p.}w_1 \dif w_2\wedge \dif w_3 \end{align} Clearly, $\DD^{\bullet}$ consists only of closed forms. Note that, by Lemma \ref{lemma:identification of skeleton} (2), \begin{equation}\label{eq:pull back of varphi} \rho^*(\varphi)=4(\lambda_1^2+\lambda_2^2)\dif \lambda_1\wedge \dif \lambda_2. \end{equation} We have the following: \begin{proposition}\label{proposition: chain isomorphism} The map $\rho^*$ restricts to a cochain isomorphism: \[\rho^*:(p_{\F}(\CC^{\bullet}),\dif)\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} (\mathscr{D}^{\bullet},\dif=0).\] \end{proposition} \begin{proof} We split the proof into several steps: \smallskip \noindent\underline{Step 1}: Injectivity. Let $\alpha\in p_{\F}(\CC^{\bullet})$ such that $\rho^*(\alpha)=0$. Recall that, by Lemma \ref{lemma:identification of skeleton}, $\rho:S^2\times \C^{\times}\to \Sk^{\textrm{reg}}$ is a 2-to-1 covering map, and therefore $i^*(\alpha)=0$, where $i:\Sk^{\textrm{reg}}\hookrightarrow\spl$ denotes the inclusion. Since $r_{\Sk}(\spl\backslash S_0)=\Sk^{\textrm{reg}}$, it follows that $r_{\Sk}^*(\alpha)|_{\spl\backslash S_0}=0$, and so $p_{\Sk}(\alpha)=0$. Since $\alpha\in p_{\F}(\CC^{\bullet})$, we have that: \[\alpha=p_{\F}(\alpha)=p_{SU(2)}\circ p_{\Sk}(\alpha)=0.\] This proves injectivity. \smallskip \noindent\underline{Step 2}: $\mathrm{Im}(\rho^*)\subset \mathscr{B}^{\bullet}$, where we denote \begin{align*} \mathscr{B}^{\bullet}:=e_{\rho^*(\varphi)}(\Omega^{\bullet}_0(S^2\times \C))^{SU(2)\times \Z_2}\subset \Omega^{\bullet+2}(S^2\times \C), \end{align*} and the subscript $_0$ stands for forms flat at $S^2\times\{0\}$. Note that, since the action of $SU(2)\times \Z_2$ on $S^2\times\C$ preserves the submanifold $S^2\times \{0\}$, the subcomplex in \eqref{eq: foliated complex skeleton} is well-defined. Note that also $\rho^*(\varphi)$ is $\Z_2$-invariant. Step 2 is a consequence of the following facts: elements in $p_{\F}(\CC^{\bullet})$ are $SU(2)$-invariant, all elements in the image of $\rho^*$ are $\Z_2$-invariant, elements in $p_{\F}(\CC^{\bullet})$ are flat at the origin and $\rho(S^2\times \{0\})=0$. \smallskip \noindent\underline{Step 3}: $\DD^{\bullet}=\mathscr{B}^{\bullet}$. Clearly, $\DD^{\bullet}\subset \mathscr{B}^{\bullet}$. For the converse, note that \[\Omega^k(S^2)^{SU(2)} = \left\{\begin{array}{lr} \R, & \text{for } k=0\\ 0, & \text{for } k=1\\ \R\, \omega_{S^2}, & \text{for } k=2 \end{array}\right.\] Next, note that if we evaluate any $\alpha \in \mathscr{B}^{k}$ along $S^2\times \{\lambda\}$, we obtain: \[ \alpha|_{S^2\times \{\lambda\}} = \rho^*(\varphi)_{\lambda}\wedge \beta,\] with $\beta\in \Omega^k(S^2)^{SU(2)}$. This implies that $\mathscr{B}^1=0$. For $k=0$ we immediately obtain $\alpha=h\, \rho^*(\varphi)$, with $h\in C^{\infty}_{0,\sigma}(\C)$. For $k=2$, we obtain that $\alpha=h\, \rho^*(\varphi)\wedge \omega_{S^2}$. Since $\gamma^*(\omega_{S^2})=-\omega_{S^2}$, where $\gamma(w)=-w$, it follows that $h\in C^{\infty}_{0,-\sigma}(\C)$. \smallskip \noindent\underline{Step 4}: $\DD^{\bullet}\subset \mathrm{Im}(\rho^*)$. In degree 0, by Lemma \ref{lemma:pullbacks and invariant functions}, every element in $\DD^0$ can be written as $e_{\rho^*(\varphi)}(g\circ \mathrm{sq})$, for some $g\in C^{\infty}_0(\C)$. By Lemma \ref{lemma:identification of skeleton} (2): \begin{equation* \rho^*(e_{\varphi}(g\circ f))=e_{\rho^*(\varphi)}(g\circ \mathrm{sq}). \end{equation*} Next, since $f$ is $SU(2)$-invariant and $r_{\Sk}$ preserves $f$, we have that \[p_{\F}(e_{\varphi}(g\circ f))=e_{\varphi}(g\circ f),\] which proves the statement in degree 0. For degree 2, we recall first the explicit form of $\rho$ from \eqref{eq:cohomology map} \begin{align}\label{eq:cohomology map explicit} \rho(w_1,w_2,w_3,\lambda)=(z_1,z_2,z_3), \quad z_j = \lambda\cdot w_j \end{align} where we use the coordinates $z_j=x_j+iy_j$ on $\spl$ from Section \ref{section: formal poisson}. Using these in the explicit formula for $\tilde{\omega}_{i}$ from Lemma \ref{lemma: extension omega}, we have: \begin{align*} \rho^*(\tilde{\omega}_1+i\tilde{\omega}_2)&=\rho^*\Big(-\frac{1}{|z|^2}\sum_{c.p.} z_1 \dif \overline{z}_2\wedge\dif \overline{z}_3\Big)\\ &=-\frac{1}{|\lambda|^2}\sum_{c.p.} w_1 \lambda (\overline{\lambda} \dif w_2 +w_2\dif\overline{\lambda})\wedge (\overline{\lambda} \dif w_3 +w_3\dif\overline{\lambda})\\ &=-\sum_{c.p.} \overline{\lambda}\, w_1 \dif w_2\wedge \dif w_3+ w_1(w_3\dif w_2-w_2\dif w_3)\wedge\dif \overline{\lambda}\\ &=-\overline{\lambda}\,\omega_{S^2}. \end{align*} Hence, we obtain: \begin{equation}\label{eq:pullback forms} \begin{array}{rcl} \rho^*(\tilde{\omega}_1)&=&-\lambda_1\, \omega_{S^2}\\ \rho^*(\tilde{\omega}_2)&=&\lambda_2\, \omega_{S^2}. \end{array} \end{equation} Consider an element \[\alpha=e_{\rho^*(\varphi)}(h\cdot \omega_{S^2})\in\DD^2,\quad \textrm{with}\quad h\in C^{\infty}_{0,-\sigma}(\C).\] By Lemma \ref{lemma:pullbacks and invariant functions}, there are two flat functions $g_1,g_2\in C^{\infty}_0(\C)$ such that \[h=-\lambda_1\cdot g_1\circ \mathrm{sq}+\lambda_2\cdot g_2\circ \mathrm{sq}.\] Define the form \[\eta:=e_{\varphi}\big(g_1\circ f\cdot \tilde{\omega}_1+g_2\circ f \cdot\tilde{\omega}_2\big)\in \CC^2.\] By Lemma \ref{lemma:identification of skeleton} (2) and \eqref{eq:pullback forms}, we have that: \[\rho^*(\eta)=\alpha.\] The proof will be concluded once we show that: \begin{equation}\label{eq:final:to:prove} \rho^*(p_{\F}(\eta))=\alpha. \end{equation} First, since $\eta$ is closed, we have that: \[p_{\F}(\eta)-\eta=\dif h_{\F}(\eta),\] and so \begin{equation}\label{eq:homotopy on eta} \rho^*(p_{\F}(\eta))-\alpha= \dif \rho^*(h_{\F}(\eta)). \end{equation} Next, since $\rho^*(p_{\F}(\eta))\in \mathscr{D}^2$, there exists $\tilde{h}\in C^{\infty}_{0,-\sigma}(\C)$ such that \[\rho^*(p_{\F}(\eta))=e_{\rho^*(\varphi)}(\tilde{h}\cdot \omega_{S_2}\big).\] Next, since $h_{\F}(\eta)\in \CC^1$, we can write \[\rho^*(h_{\F}(\eta))=e_{\rho^*(\varphi)}(\theta),\] for some $\theta\in \Omega^1(S^2\times \C)$. Thus equation \eqref{eq:homotopy on eta} can be written as: \[e_{\rho^*(\varphi)}\big((\tilde{h}-h)\cdot\omega_{S^2}-\dif \theta \big)=0.\] Next, using the form of $\rho^*(\varphi)$ from \eqref{eq:pull back of varphi}, we contract the last equation with $\partial_{\lambda_1}$ and $\partial_{\lambda_2}$, then divide it by $4|\lambda|^2$, and we pull it back via the embedding $i_{\lambda}:S^2\hookrightarrow S^2\times\C$, $w\mapsto (w,\lambda)$; we obtain: \[(\tilde{h}(\lambda)-h(\lambda))\cdot\omega_{S^2}=\dif i_{\lambda}^*(\theta).\] Passing to cohomology, this implies that $\tilde{h}=h$, and so \eqref{eq:final:to:prove} holds. \end{proof} We can prove now the two statements about flat foliated cohomology: \begin{proof}[Proof of Proposition \ref{proposition: property H fol}] By Proposition \ref{proposition: chain isomorphism}, $\dif=0$ on $p_{\F}(\CC^{\bullet})$. The rest of the statement was already proven in Corollary \ref{corollary:chain:proj}. \end{proof} \begin{proof}[Proof of Proposition \ref{proposition:flat foliated ch}] Because $p_{\F}$ is a deformation retraction of $(\CC^{\bullet},\dif)$ and because $\dif\circ p_{\F}=0$, we have that every flat foliated cohomology class has a unique representative in $p_{\F}(\CC^{\bullet})$; thus, by Proposition \ref{proposition: chain isomorphism}, we have the isomorphisms: \[H^{k}_0(\F)\simeq p_{\F}(\CC^{k})\simeq \DD^{k}.\] This implies that $H^{k}_0(\F)=0$, for $k\notin\{0,2\}$. The case $k=0$ follows from the proof of Proposition \ref{proposition: chain isomorphism}, where we have seen that the set \[\{e_{\varphi}(g\circ f)\, |\, g\in C^{\infty}_0(\C)\}\] is fixed under $p_{\F}$ and that $\rho^*$ maps this set isomorphically to $\DD^{0}$. Of course, this case follows also from Proposition \ref{prop:Casimirs}, because $H^0_0(\F)$ consists of Casimir functions of $(\spl,\pi)$ that are flat at the origin (times $\varphi$). Finally, let $k=2$. For $g_1,g_2\in C^{\infty}_0(\C)$, denote by \[\eta(g_1,g_2):=e_{\varphi}(g_1\circ f\cdot \tilde{\omega}_1+g_2\circ f\cdot\tilde{\omega}_2)\in \CC^2.\] Consider the map: \[\alpha: C^{\infty}_0(\C)\oplus C^{\infty}_0(\C)\to \DD^2,\] \[(g_1,g_2)\mapsto \rho^*\circ p_{\F}(\eta(g_1,g_2)).\] By the proof of Proposition \ref{proposition: chain isomorphism}, $\alpha$ is given by \[\alpha(g_1,g_2)=(-\lambda_1\cdot g_1\circ \mathrm{sq}+\lambda_2\cdot g_2\circ \mathrm{sq})\rho^*(\varphi)\wedge\omega_{S^2}.\] By part (2) of Lemma \ref{lemma:pullbacks and invariant functions}: \[\ker(\alpha)=\mathcal{K},\] and by part (3), $\alpha$ restricts to an isomorphism between the spaces: \[ \alpha|_{\mathcal{M}}:\mathcal{M}\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \DD^2.\] By combining the following: \begin{itemize} \item[-]$\rho^*:p_{\F}(\CC^2)\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \DD^2$ is an isomorphism; \item[-] every class in $H^2_0(\F)$ has a unique representative in $p_{\F}(\CC^2)$; \item[-] $\eta(g_1,g_2)$ and $p_{\F}(\eta(g_1,g_2))$ are in the same cohomology class; \end{itemize} the statement follows. \end{proof} \section{Flat Poisson cohomology of $\spl$}\label{section: flat PC} In this section we compute the flat Poisson cohomology groups of $(\spl,\pi)$ and we build cochain homotopy operators for the flat Poisson complex which satisfy property SLB (see Theorem \ref{main theorem}). The section is structured as follows. In Subsection \ref{section: Poisson cohomology in terms of foliated cohomology} we build an isomorphism which describes the flat Poisson complex in terms of the flat foliated complex and the transverse variation of the leafwise symplectic form (see Proposition \ref{proposition:PCH as forms}). For this, we use the description of the Poisson complex as the de Rham complex of a Lie algebroid, and the spectral sequence for computing cohomology of regular Lie algebroids. In Subsection \ref{section: perturbation Lemma} we use the Perturbation Lemma and the explicit description of flat foliated cohomology to construct cochain homotopies for the aforementioned complex (see Proposition \ref{proposition: homotopy}). Combining these results, we obtain a description of the flat Poisson cohomology in Theorem \ref{main theorem}. In Subsection \ref{section: algebra} we explain the algebraic structure of Poisson cohomology. \subsection{Poisson cohomology in terms of foliated cohomology}\label{section: Poisson cohomology in terms of foliated cohomology} In this subsection we describe the flat Poisson complex of $\spl$ in terms of the flat foliated complex of $\F$. For this, we use the spectral sequence associated to a regular Poisson manifold, which has been introduced in \cite{Vaisman} and \cite{KV1} (see also \cite[Section 2.4]{DZ}). Here, we use the more general setting of Lie algebroids of \cite{mack05}. We can adapt these techniques to our non-regular case by working with sections that are flat at the singularity, Recall that the linear Poisson structure $\pi$ is regular away from the origin with underlying foliation $\F$. For simplicity, let us denote: \[\spl^{\times}:=\spl\backslash \{0\}\] The vector fields $V_1$ and $V_2$ on $\spl^{\times}$, defined in \eqref{eq: v}, form a basis of the normal bundle $\nu$ to $\F$. Since these vector fields are projectable with respect to $f$ (see \eqref{eq:v transversality}), it follows that they preserve the foliation: \begin{align}\label{eq: flat} [V_i,Y]\in \Gamma(T\F|_{\spl^{\times}}), \quad \forall\, Y\in \Gamma(T\F|_{\spl^{\times}}). \end{align} We make use of the extension $\tilde{\omega}_1$ of the leafwise symplectic form on $\F$ from Lemma \ref{lemma: extension omega}. This is uniquely determined such that its kernel is spanned by $V_1$ and $V_2$. For $i=1,2$, define: \begin{align}\label{eq: gammai} \gamma_i:=i_{V_i}\dif \tilde{\omega}_1\in \Omega^2(\spl^{\times}). \end{align} The restriction $\gamma_i|_{\F}$, for $i=1,2$, is the \emph{variation of the leafwise symplectic form} $\omega_1$ in the direction of $V_i$ (as foliated forms): \[\gamma_i\big|_{\F}=\frac{\dif}{\dif t}\Big|_{t=0}(\varphi_{V_i}^t)^*\omega_1.\] In particular, it follows that $\gamma_i|_{\F}\in \Omega^2(\F)$ are closed foliated 2-forms. Recall that the singularity of $\tilde{\omega}_1$ at the origin is very ``mild", and the same holds for $\gamma_i$. Therefore the product with $\gamma_i$ gives a well-defined map: \[e_{\gamma_i}:\CC^{p}\to \CC^{p+2},\quad \eta\mapsto \gamma_i\wedge \eta.\] \begin{proposition}\label{proposition:PCH as forms} There is an isomorphism of complexes \[\tilde{a}:(\mathfrak{X}_0^{\bullet}(\spl),\dif_{\pi})\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} (\bigoplus_{p+q=\bullet}\CC^{p}\otimes \wedge^q\R^2, \dif +\delta),\] where $\dif$ acts only on the first component $\CC^{\bullet}$ as the exterior derivative and \begin{align*} \delta:\CC^{p}\otimes \wedge^q\R^2&\to \CC^{p+2}\otimes \wedge^{q-1}\R^2,\\ \delta(\eta\otimes e_{i})&=(-1)^p\gamma_i\wedge \eta,\quad\quad i=1,2,\\ \delta(\eta\otimes e_{1}\wedge e_2)&=(-1)^p\big(\gamma_1\wedge\eta\otimes e_2- \gamma_2\wedge\eta\otimes e_1\big), \end{align*} where $e_{1},e_2$ is the standard basis of $\R^2$. Moreover, the operators $\tilde{a}$, $\tilde{a}^{-1}$ and $\delta$ satisfy property SLB for $(0,0,2)$, $(0,0,4)$ and $(0,0,3)$, respectively. \end{proposition} The rest of this subsection is devoted to the proof of this proposition. \subsubsection{Cohomology of regular abelian Lie algebroids} Proposition \ref{proposition:PCH as forms} can be understood as giving an explicit description of the first page of a natural spectral sequence associated to Poisson cohomology, which was introduced for regular Poisson manifolds already in \cite{Vaisman}. The natural framework for this are Lie algebroids (see \cite{mack05}), and, for clarity, we place our discussion in this more general setting. However, we will use these results only for the cotangent Lie algebroid of a regular Poisson manifold. As a reference to the theory of Lie algebroids, see \cite{mack05}. Recall that any Lie algebroid $(A,[\cdot,\cdot],\sharp)$ has an associated de Rham complex \[(\Omega^{\bullet}(A):=\Gamma(\wedge^{\bullet}A^*),\dif_A).\] Consider a Lie algebroid $(A,[\cdot,\cdot],\sharp)$ over $M$ with the following properties: \begin{itemize} \item $A$ is \textbf{regular}, i.e., the anchor $\sharp$ has constant rank. Then $M$ has a regular foliation $\F$ with $T\F=\im \sharp \subset TM$, the kernel $K:=\ker \sharp$ is a Lie subalgebroid, and we have a short exact sequence of Lie algebroids \begin{align}\label{eq: lad ses} 0 \to K \xrightarrow{j} A \xrightarrow{\sharp} T\F \to 0 \end{align} \item $K$ is an \textbf{abelian} Lie algebroid. Therefore, the bracket on $A$ induce a representation of $T\F$ on $K$. \end{itemize} To such a Lie algebroid one associates the \textbf{extension class} \[[\gamma] \in H^2(\F,K),\] which measures the failure of the short exact sequence \eqref{eq: lad ses} to split as a sequence of Lie algebroids. Using a vector bundle splitting $\sigma: T\F \to A$ of \eqref{eq: lad ses}, an explicit representative of the extension class is given by: \[ \gamma(Y_1,Y_2):= [\sigma(Y_1),\sigma(Y_2)] -\sigma([Y_1,Y_2]) \] where $Y_1,Y_2\in \Gamma(T\F)$. The class $[\gamma]$ is independent of the choice of the splitting. For such a representative, we have an induced map: \begin{align} &\qquad \qquad \qquad i_{\gamma}: \Omega^p(\F,\wedge^qK^*) \to \Omega^{p+2}(\F,\wedge^{q-1}K^*) \nonumber \\ i_{\gamma}(\beta)&\,(Y_1 , \dots ,Y_{p+2})(V_1, \dots ,V_{q-1}) :=\label{eq: contraction gamma}\\ &\sum_{i<j}(-1)^{i+j}\beta(Y_1, \dots, \hat{Y}_i,\dots ,\hat{Y}_j,\dots ,Y_{p+2})(\gamma(Y_i,Y_j),V_1,\dots, V_{q-1})\nonumber \end{align} where $V_i \in \Gamma(K)$, $Y_j\in \Gamma(T\F)$. We have the following: \begin{proposition}\label{proposition: ladcx} A splitting $\sigma:T\F \to A$ of \eqref{eq: lad ses} induces an isomorphism \begin{align*} (\Omega^{\bullet}(A), \dif_A)\simeq \big(\bigoplus_{p+q=\bullet}\Omega^{p}(\F,\wedge^{q} K^*), \delta_1+\delta_2\big), \end{align*} where $\delta_1$ is the standard differential on foliated forms with values in $\wedge^{q}K^*$ \begin{align*} \delta_1=\dif_{\F}:\Omega^{p}(\F,\wedge^{q}K^*)\to \Omega^{p+1}(\F,\wedge^{q}K^*) \end{align*} and $\delta_2$ is the cup product with the representative of the extension class: \begin{align*} \delta_2=(-1)^{p}i_{\gamma}:\Omega^{p}(\F,\wedge^{q}K^*)\to \Omega^{p+2}(\F,\wedge^{q-1}K^*). \end{align*} \end{proposition} \begin{proof} We follow \cite[Section 7.4]{mack05} where most of the statement is proven. A splitting $\sigma : T\F \to A$ of \eqref{eq: lad ses} induces surjective maps \begin{align}\label{eq: surjection ladch} &\qquad \qquad a^{p,q}:\Omega^{p+q}(A) \to \Omega^{p}(\F,\wedge^q K^*)\\ a^{p,q}(\alpha)&\,(Y_1, \dots ,Y_p) (V_1, \dots V_q):= \alpha(\sigma(Y_1),\dots , \sigma(Y_p),V_1,\dots, V_q)\nonumber \end{align} for $V_i \in \Gamma(K)$ and $Y_j\in \Gamma(T\F)$. Let $\kappa = \id-\sigma \circ \sharp:A\to K$ be the induced projection. A right inverse for $a^{p,q}$ is given by: \begin{align}\label{eq: ri ladch} &\qquad \qquad b^{p,q}: \Omega^{p}(\F,\wedge^q K^*)\to \Omega^{p+q}_p(A)\\ b^{p,q}(\beta)&\,(X_1, \dots ,X_{p+q}):= \nonumber \\ &\sum_{\tau\in S_{p,q}}\sign(\tau)\beta(\sharp(X_{\tau_{1}}),\dots,\sharp(X_{\tau_{p}}))(\kappa(X_{\tau_{p+1}}),\dots,\kappa(X_{\tau_{p+q}})),\nonumber \end{align} where the sum is over all $(p,q)$ shuffles $\tau$. The isomorphism from the statement is $\oplus_{p+q=\bullet}a^{p,q}$, with inverse $\oplus_{p+q=\bullet}b^{p,q}$. We calculate the components of the differential under this isomorphism: \begin{align*} \delta_{i}:= a^{p+i,q+1-i}\circ \dif_A \circ b^{p,q}, \quad i\in \N_0. \end{align*} For $i=0$ and $i=1$ these are given in \cite[Proposition 7.4.3 \& 7.4.4]{mack05}, namely, $\delta_{0}=0$ because $K$ is assumed to be abelian and the different sign for $\delta_1$ comes from the fact that we multiplied both $a^{p,q}$ and $b^{p,q}$ with a factor of $(-1)^{pq}$. For $\delta_{2}$ we use a proof given for $q=1$ in \cite[Theorem 7.4.11]{mack05} for foliated cohomology. We adapt the computation there to general $q$ and foliated forms as follows. Let $\beta\in \Omega^p(\F,\wedge^qK^*)$. We need to prove that \begin{align*} (a^{p+2,q-1}\circ \dif_A\circ b^{p,q})(\beta)=&\ (-1)^{p}i_{\gamma}(\beta) \end{align*} Let $V_i\in \Gamma(K)$ and $Y_j\in \Gamma(T\F)$. For the computation we use the notation \begin{equation*} \begin{array}{rlcrl} \mathcal{V} :=& V_1,\dots ,V_{q-1}&\ & \mathcal{Y}:=& Y_1,\dots,Y_{p+2} \\ \mathcal{V}_i :=& V_1,\dots,\hat{V}_i,\dots ,V_{q-1}&\ & \mathcal{Y}_i:=& Y_1,\dots,\hat{Y}_i,\dots ,Y_{p+2} \\ \mathcal{V}_{ij}:=& V_1,\dots,\hat{V}_i,\dots,\hat{V}_j,\dots ,V_{q-1} & & \mathcal{Y}_{ij}:=& Y_1,\dots,\hat{Y}_i,\dots, \hat{Y}_j,\dots ,Y_{p+2} \end{array} \end{equation*} where the hat stands for omitting the element and by $\sigma(\mathcal{Y}_i)$ we mean $\sigma$ applied to each element, and similarly for $\sigma(\mathcal{Y}_{ij})$. Then we compute that \begin{align*} (a^{p+2,q-1}\circ &\, \dif_A\circ b^{p,q})(\beta)(\mathcal{Y})(\mathcal{V}) =(\dif_A\circ b^{p,q})(\beta)(\sigma(\mathcal{Y}),\mathcal{V})\\ =&\sum_{1\le i<j\le p+2}(-1)^{i+j}(b^{p,q}(\beta))([\sigma(Y_i),\sigma(Y_j)],\sigma(\mathcal{Y}_{ij}),\mathcal{V})\\ &+\sum_{\substack{1\le i\le q-1\\ 1\le j\le p+2}}(-1)^{p+1+i+j}(b^{p,q}(\beta))([\sigma(Y_i),V_j],\sigma(\mathcal{Y}_i),\mathcal{V}_j)\\ &+\sum_{1\le i<j\le q-1}(-1)^{i+j}(b^{p,q}(\beta))([V_i,V_j],\sigma(\mathcal{Y}),\mathcal{V}_{ij}) \\ &+\sum_{1\le i\le p+2}(-1)^{i+1}\Lie_{Y_i}((b^{p,q}(\beta))(\sigma(\mathcal{Y}_{i}),\mathcal{V}))\\ =&\sum_{1\le i<j\le p+2}(-1)^{i+j+p}\beta(\mathcal{Y}_{ij})(\gamma(Y_i, Y_j),\mathcal{V})\\ =&\, (-1)^{p} i_{\gamma}(\beta)(\mathcal{Y})(\mathcal{V}) \end{align*} Note that only the first sum yields non-zero contributions to the third equality as all the other terms do not have enough sections of $K$ to be non-zero, and we have $\kappa\circ \sigma =0$. By a similar computation $\delta_{i}=0$, for $3\le i$. \end{proof} We obtain a slight improvement of results in \cite[Section 7.4]{mack05}, which is classical for Lie algebras (see e.g.\ \cite[Theorem 8]{Hoch1953}): \begin{corollary}\label{corollary: ladch} For a regular Lie algebroid $K\hookrightarrow A\twoheadrightarrow T\F$ with abelian isotropy $K$, there is a natural spectral sequence which converges to the Lie algebroid cohomology of $A$: \[ H^p(\F,\wedge^q K^*)\Rightarrow H^{p+q}(A).\] Moreover, the differential on the second page is given by the cup product with the extension class: \[(-1)^{p}i_{[\gamma]}:H^p(\F,\wedge^q K^*)\to H^{p+2}(\F,\wedge^{q-1} K^*).\] \end{corollary} \begin{proof} The natural, convergent spectral sequence was obtained in \cite[Theorem 7.4.6]{mack05}; it is associated with the filtration \begin{align}\label{eq: filtration} \Omega^{p+q}_{p}(A):= \{\beta\in \Omega^{p+q}(A)| i_{V_0}\dots i_{V_q}\beta =0 \text{ for all } V_j\in \Gamma(K)\}. \end{align} Under the isomorphism from Proposition \ref{proposition: ladcx}, this filtration corresponds to \[\bigoplus_{0\leq i\leq q} \Omega^{p+i}(\F,\wedge^{q-i}K^*).\] The explicit formula for the differential on the second page follows from the proposition. \end{proof} \subsubsection{Poisson cohomology via Lie algebroids} Given a Poisson manifold $(M,\pi)$ one has a naturally associated Lie algebroid structure on the cotangent bundle $T^*M$ with the anchor map $\pi^{\sharp}:T^*M \to TM$ and the bracket given by \[ [\alpha,\beta]_{\pi}:= \Lie _{\pi^{\sharp}(\alpha)}(\beta)-\Lie _{\pi^{\sharp}(\beta)}(\alpha)-\dif \pi(\alpha,\beta).\] We denote this Lie algebroid by $T^*_{\pi}M$. The complex computing Lie algebroid cohomology of $T^*_{\pi}M$ can be identified with the complex computing the Poisson cohomology of $(M,\pi)$: \begin{align*} (\Omega^{\bullet}(T^*_{\pi}M),\dif) = (\mathfrak{X}^{\bullet}(M),\dif_{\pi}). \end{align*} From now on we will assume that $(M,\pi)$ is \textbf{regular}. Then we are in the setting of the previous subsection, i.e., the Lie algebroid $T^*_{\pi}M$ fits into the short exact sequence \begin{align}\label{eq: ses poisson lad} 0\to \nu^* \hookrightarrow T^*_{\pi}M\twoheadrightarrow T\F\to 0 \end{align} where $T\F=\im \pi^{\sharp}$ and $\nu^*$ is the conormal bundle of $\F$, which is an abelian ideal. The leafwise symplectic form will be denoted by: \[\omega\in \Omega^2(\F).\] A splitting $\sigma:T\F\to T^*_{\pi}M$ of \eqref{eq: ses poisson lad} induces an extension $\tilde{\omega}\in \Omega^2(M)$ of $\omega$, uniquely determined by $\ker\tilde{\omega}=\ker (\sigma^*:TM\to T^*\F)$. The representative $\gamma$ of the extension class in $H^2(\F,\nu^*)$ of \eqref{eq: ses poisson lad} corresponding to $\sigma$ is then: \begin{align*} \gamma(Y_1,Y_2)=i_{Y_2}i_{Y_1} \dif\tilde{\omega}\in \Gamma(\nu^*), \end{align*} for $Y_1,Y_2\in \Gamma(T\F)$. This follows by a standard calculation using the formula of the Lie bracket on $T^*_{\pi}M$ and that $ \sigma(v)=i_v\tilde{\omega}$. \smallskip We apply this discussion to the linear Poisson structure $\pi$ restricted to \[\spl^{\times}:=\spl\backslash\{0\}.\] The extension $\tilde{\omega}_1$ of the leafwise symplectic structure from Lemma \ref{lemma: extension omega} corresponds to the splitting $\sigma$ whose image annihilates the vector fields $V_1$ and $V_2$ defined in \eqref{eq: v}. We obtain linear maps \begin{align*} a^{p,q}:\mathfrak{X}^{p+q}(\spl^{\times}) \to \Omega^p(\F|_{\spl^{\times}}, \wedge^q\nu) \end{align*} as described in \eqref{eq: surjection ladch} with right inverses given by \begin{align*} b^{p,q}:\Omega^p(\F|_{\spl^{\times}}, \wedge^q\nu)\to \mathfrak{X}^{p+q}(\spl^{\times}) \end{align*} as described in \eqref{eq: ri ladch}. The normal vector fields $V_1$ and $V_2$ induce a flat frame of the normal bundle, and so give an isomorphism $\nu\simeq \R^2\times{\spl^{\times}}$ of $T\F$-representations. \begin{lemma}\label{lemma: maps mpq} There are linear isomorphisms: \[m^{p,q}:\Omega^p(\F|_{\spl^{\times}}, \wedge^q\nu)\simeq e_{\varphi}(\Omega^p(\spl^{\times}))\otimes \wedge^q\R^2, \] under which the operators $\delta_1=\dif_{\F}$ and $\delta_2=(-1)^{p}i_{\gamma}$ correspond to the operators $\dif$ and $\delta$ from Proposition \ref{proposition:PCH as forms}. \end{lemma} \begin{proof} Any form $\eta\in \Omega^{p}(\F|_{\spl^{\times}}, \wedge^{\bullet}\nu)$ can be uniquely written as \[\eta=\eta_0+\eta_1\otimes [V_1] +\eta_2\otimes[V_2]+\eta_{3}\otimes[V_1\wedge V_2],\quad \eta_i\in \Omega^{p}(\F|_{\spl^{\times}}).\] The isomorphism $m=\oplus_{p,q} m^{p,q}$ sends such a form to: \[m(\eta)=e_{\varphi}(\eta_0)+e_{\varphi}(\eta_1)\otimes e_1+e_{\varphi}(\eta_2)\otimes e_2+ e_{\varphi}(\eta_3)\otimes e_1\wedge e_2,\] where $e_1,e_2$ is the standard basis of $\R^2$. That $\dif_{\F}$ corresponds to $\dif$ follows because $\dif_{\F}[V_i]=0$ (see \eqref{eq: flat}) and because $\dif \varphi=0$. Using \eqref{eq: contraction gamma} we obtain \begin{align*} \delta_2(\eta)&=(-1)^p(i_{\gamma}\eta_0+i_{\gamma}\eta_1\otimes [V_1]+i_{\gamma}\eta_2\otimes [V_2]+i_{\gamma}\eta_3\otimes[V_1\wedge V_2])\\ &=(-1)^p(e_{\gamma_1}(\eta_1)+e_{\gamma_2}(\eta_2)+e_{\gamma_1}(\eta_3)\otimes[V_2]-e_{\gamma_2}(\eta_3)\otimes[V_1]) \end{align*} since $\gamma$ can be written as \[\gamma=\gamma_1|_{\F}\otimes \dif f_1+\gamma_2|_{\F}\otimes \dif f_2.\] This implies the statement. \end{proof} Due to the mild singularities of $V_1$, $V_2$ and $\tilde{\omega}_1$ at the origin, the maps $m^{p,q}\circ a^{p,q}$ induce well-defined, surjective maps between the complexes of flat multivector fields and flat foliated forms: \begin{align}\label{eq: tilde a} \tilde{a}^{p,q}:\mathfrak{X}^{p+q}_{0}(\spl) \to \CC^p\otimes \wedge^q \R^2. \end{align} These maps have right inverses induced by $b^{p,q}\circ (m^{p,q})^{-1}$ which we denote \begin{align}\label{eq: tilde b} \tilde{b}^{p,q}: \CC^p\otimes \wedge^q\R^2\to \mathfrak{X}^{p+q}_{0}(\spl). \end{align} Putting these maps together into \[\tilde{a}:=\oplus_{p,q}\tilde{a}^{p,q}\quad \textrm{and} \quad \tilde{b}:=\oplus_{p,q}\tilde{b}^{p,q}\] we obtain the linear isomorphism from Proposition \ref{proposition:PCH as forms} and its inverse. That these maps intertwine the Poisson differential and the differential $\dif+\delta$ follows from Proposition \ref{proposition: ladcx} and Lemma \ref{lemma: maps mpq}. To conclude the proof of Proposition \ref{proposition:PCH as forms} we need to show that the map $\tilde{a}$, $\tilde{b}$ and $\delta$ satisfy the claimed SLB property. For this, let us note that these operators are induced by vector bundle maps with a singularity at the origin. For example, $\tilde{a}^{1,1}$ is induced by the vector bundle map: \begin{align*} &A^{1,1}:\wedge^{2}T(\spl^{\times})\to \wedge^{3} T^*(\spl^{\times})\otimes \R^2,\\ &A^{1,1}(w)=-\sum_{i=1}^2\varphi\wedge \tilde{\omega}_1^{\flat}(i_{\dif f_i}w)\otimes e_i. \end{align*} Similarly, $\tilde{a}^{4,0}$ is induced by the vector bundle map: \begin{align*} &A^{4,0}:\wedge^{4}T(\spl^{\times})\to \wedge^{6} T^*(\spl^{\times}),\\ &A^{4,0}(w)=\varphi\wedge (\otimes^4 \tilde{\omega}_1^{\flat})(w). \end{align*} The maps $\tilde{b}^{p,q}$ are restrictions of singular vector bundle maps. For example, $\tilde{b}^{2,1}$ is induced by the restriction of the map: \begin{align*} &B^{2,1}:\wedge^{4} T^*(\spl^{\times})\otimes \R^2\to \wedge^{3}T(\spl^{\times}),\\ &B^{2,1}\Big(\sum_{i=1}^2\alpha_i\otimes e_i\Big)= \sum_{i=1}^2(\otimes^2\pi^{\sharp})(i_{V_1\wedge V_2}\alpha_i)\wedge V_i. \end{align*} Similarly, $\tilde{b}^{0,2}$ comes from the map: \begin{align*} &B^{0,2}:\wedge^{2} T^*(\spl^{\times})\otimes \wedge^2\R^2\to \wedge^{2}T(\spl^{\times}),\\ &B^{0,2}\big(\beta\otimes e_1\wedge e_2\big)= i_{V_1\wedge V_2}(\beta)\, V_1\wedge V_2. \end{align*} A similar description holds also for $\delta$. These vector bundle maps fit in the setting of the following lemma. \begin{lemma}\label{lemma:singular:vb:maps} Let $V$ and $W$ be two vector bundles over an inner product space $H$. Consider a vector bundle map with a singularity at the origin, i.e., a vector bundle map: \[\Phi:V|_{H\backslash\{0\}}\to W|_{H\backslash\{0\}}.\] Assume that the singularity is such that, for some $l\geq 0$, $R^{l}\Phi$ is smooth and that it vanishes at the origin up to order $d\geq 0$, where $R$ denotes the induced norm on $H$. Then $\Phi$ induces a linear operator between flat sections: \[\Phi_{*}:\Gamma_0(V) \to \Gamma_0(W),\] which satisfies property SLB for $(0,0,\mathrm{max}(l-d,0))$. \end{lemma} \begin{proof} Without loss of generality we may assume that the vector bundles $V$ and $W$ are trivial. Therefore, $\Phi$ is described by a matrix of the form \begin{align*} \Phi = \begin{pmatrix} \frac{1}{R^{l}}\phi_{ij} \end{pmatrix} \end{align*} where $\phi_{ij}\in C^{\infty}(H)$ vanish up to order $d$ at the origin. It is enough to show that for $\phi\in C^{\infty}(H)$ vanishing at the origin up to order $d$, we have: \begin{align*} \fnorm{\frac{1}{R^{l}}\phi\, g}_{n,k,r}\le C\fnorm{g}_{n,\mathrm{max}(0,k+l-d),r} \end{align*} for all $g\in C^{\infty}_0(H)$, $n,k\in \N_0$, $r>0$ and a constant $C$. First, by the equivalence of norms from Lemma \ref{lemma: equivalence}, we have that: \begin{align*} \fnorm{\frac{1}{R^{l}}\phi\, g}_{n,k,r}\le C\fnorm{\phi\, g}_{n,k+l,r}. \end{align*} By the general Leibniz rule we obtain for $a\in \N_0^{\dim(V)}$ with $|a|=n$ that \begin{align*} D^a (\phi\, g) & =\sum_{a^1+a^2=a} D^{a^1}\phi\, D^{a^2}g. \end{align*} Next, Taylor's formula with integral remainder for $|a^2|<n$ yields: \[ D^{a^2}g(x)=\sum_{|b|=|a^1|}x^{b}\int_{0}^1|a^1|(1-s)^{|a^1|-1}(D^{b+a^2} g)(sx)\dif s.\] Combining these yields for $x\in B_r\subset H$ and any $m=k+l\in \N_0$ the estimate \begin{align*} \frac{|D^a \phi g|}{R^{m}} (x) &\le \sum_{a^1+a^2=a} \frac{1}{R^{m}}|D^{a^1}\phi||D^{a^2}g |(x)\\ &\le C\Big(\sum_{0<|b|= n- |a^2|}\frac{R^{\max(|b|,d)}}{R^{m}}\int_{0}^1(1-s)^{|b|-1}|D^{b+a^2} g|(sx)\dif s\\ &\qquad \quad + \frac{R^{d}}{R^{m}}|D^ag|(x)\Big)\\ &\le C\Big(\sum_{0<|b|= n- |a^2|}\int_{0}^1\frac{s^{\max(0,m-d)}(1-s)^{|b|-1}}{(sR)^{\max(0,m-d)}}|D^{b+a^2} g|(sx)\dif s\\ &\qquad \quad + \frac{1}{R^{\max(0,m-d)}}|D^ag|(x)\Big)\\ &\le C \,\fnorm{g}_{n,\max(0,m-d),r}. \qedhere \end{align*} \end{proof} The lemma implies that the maps $\tilde{a}$, $\tilde{b}$ and $\delta$ satisfy the claimed SLB properties. This follows by analyzing the singularities of our vector bundle maps, for which we obtain: \begin{itemize} \item[-] for $A^{p,q}$: $l=2p$, $d=p+q+2$; hence $l-d\leq 2$; \item[-] for $B^{p,q}$: $l=4+2q$, $d=p+q+2$; hence $l-d\leq 4$; \item[-] for the map inducing $\delta$: $l=6$ and $d=3$; hence $l-d=3$. \end{itemize} This concludes the proof of Proposition \ref{proposition:PCH as forms}. \subsection{Cochain homotopies}\label{section: perturbation Lemma} By Proposition \ref{proposition:PCH as forms}, the complex \begin{equation}\label{eq:beautiful:complex} \Big(\bigoplus_{p+q=\bullet}\CC^{p}\otimes \wedge^{q}\R^2,\dif +\delta\Big) \end{equation} computes the flat Poisson cohomology of $(\spl,\pi)$. This complex admits the filtration by the $p$-degree, as in Corollary \ref{corollary: ladch}. The second page of the associated spectral sequence is given by: \begin{equation*} \begin{tikzpicture}[baseline= (a).base] \node[scale=1] (a) at (0,0){ \begin{tikzcd}[row sep=small] H^0_0(\F)\otimes\wedge^2\R^2\arrow{rrd}{\phantom{1}i_{[\gamma]}}&0&H^2_0(\F)\otimes\wedge^{2}\R^2 \\ H^0_0(\F)\otimes\wedge^1\R^2\arrow{rrd}{\phantom{1}i_{[\gamma]}}&0&H^2_0(\F)\otimes\wedge^{1}\R^2\\ H^0_0(\F)\otimes\wedge^{0}\R^2 &0&H^2_0(\F)\otimes\wedge^{0}\R^2 \end{tikzcd} }; \end{tikzpicture} \end{equation*} where we used that $H^{p}_0(\F)=0$, for $p\notin\{0,2\}$. In particular, all differentials on higher pages vanish, and so the cohomology is determined by the third page. The kernel and cokernel of the maps $i_{[\gamma]}$ will be calculated explicitly in the Subsections \ref{section: cohomology second page} and \ref{section: HE data}. This will provide the complete description of the Poisson cohomology in Subsection \ref{section: flat pch}. The construction of homotopy operators will be obtained by applying the Perturbation Lemma, which is done in the first subsection. \subsubsection{The Perturbation Lemma} For the proof of Theorem \ref{theorem: nondegenerate} it does not suffice to calculate the Poisson cohomology, but we need explicit cochain homotopies satisfying estimates as in Definition \ref{definition: property H}. In this subsection we show how the deformation retraction $(p_{\F},h_{\F})$ of $(\CC^{\bullet},\dif)$ induces a deformation retraction of the complex \eqref{eq:beautiful:complex}. For this we use the Perturbation Lemma following \cite{Cr04} and the terminology therein, which we first recall. \begin{definition} A \textbf{homotopy equivalence data} (HE data): \begin{align}\label{eq: he data} (B,\mathrm{b} )\stackrel[\iota]{p }{\leftrightarrows} (C,\dif),h \end{align} consists of two complexes $(B,\mathrm{b})$ and $(C,\dif)$ together with two quasi-isomorphisms $p$ and $\iota$, and a cochain homotopy $h$ between $\iota \circ p$ and the identity, i.e., \begin{align*} \iota \circ p -\id = h\circ \dif +\dif \circ h \end{align*} \end{definition} \begin{remark} Note that any deformation retraction (see Definition \ref{definition: dr}) defines an HE data. In particular, by Proposition \ref{proposition: property H fol} we have the HE data \begin{align*} (p_{\F}(\CC),0 )\stackrel[\iota]{p_{\F} }{\leftrightarrows} (\CC,\dif),h_{\F} \end{align*} \end{remark} Given an HE data one considers perturbations of this data as follows: \begin{definition} A \textbf{perturbation} $\delta$ of an HE data as in \eqref{eq: he data} is a map on $C$ of the same degree as $\dif$ such that $\dif+\delta$ is a differential: \begin{align*} (\dif+\delta)^2=0. \end{align*} The perturbation $\delta$ is called \textbf{small} if $(\id - \delta h)$ is invertible. Then we set \begin{align*} A:= (\id -\delta \circ h)^{-1}\circ \delta. \end{align*} The \textbf{perturbation data} of the small perturbation $\delta$ is the data: \begin{align}\label{eq: perturbation data} (B,\tilde{\mathrm{b}})\stackrel[\tilde{\iota}]{ \tilde{p}}{\leftrightarrows} (C,\dif +\delta),\tilde{h} \end{align} \begin{equation*} \begin{array}{rclcrcl} \tilde{\iota} &=& (\id +h\circ A)\circ \iota, &\ \ \ \ \ & \tilde{p}&=& p\circ (\id +A\circ h), \\ \tilde{h} &=& h\circ (\id +A\circ h),& &\tilde{\mathrm{b}} &=&\mathrm{b} +p\circ A\circ \iota. \end{array} \end{equation*} \end{definition} The main statement in \cite{Cr04} states: \begin{lemma}\label{lemma: perturbation lemma} If $\delta$ is a small perturbation of an HE data as in \eqref{eq: he data}, then the associated perturbation data \eqref{eq: perturbation data} is an HE data. \end{lemma} We apply the Perturbation Lemma to our complex $(\CC\otimes \wedge \R^2, \dif+\delta)$, which we regard as a perturbation of the differential $\dif$, admitting the deformation retraction $(p_{\F},h_{\F})$. Here we extend all these operators from $\CC$ to $\CC\otimes \wedge \R^2$ by $- \otimes \id_{\wedge\R^2}$. These maps fit in the diagram: \begin{equation}\label{eq: complex diag} \begin{tikzpicture}[baseline= (a).base] \node[scale=.9] (a) at (0,0){ \begin{tikzcd} \CC^0\otimes\wedge^2\R^2\arrow[bend left=5]{r}{\dif}\arrow{rrd}{\delta}&\CC^1\otimes\wedge^2\R^2\arrow[bend left=5]{r}{\dif}\arrow[bend left=5]{l}\arrow{rrd}{\delta}&\CC^2\otimes\wedge^2\R^2\arrow[bend left=5]{r}{\dif}\arrow[bend left=5]{l}&\CC^3\otimes\wedge^2\R^2\arrow[bend left=5]{l}{h_{\F}} \\ \CC^0\otimes\wedge^1\R^2\arrow[bend left=5]{r}{\dif}\arrow{rrd}{\delta}&\CC^1\otimes\wedge^1\R^2\arrow[bend left=5]{r}\arrow[bend left=5]{l}\arrow{rrd}{\delta}&\CC^2\otimes\wedge^1\R^2\arrow[bend left=5]{r}\arrow[bend left=5]{l}&\CC^3\otimes\wedge^1\R^2 \arrow[bend left=5]{l}{h_{\F}} \\ \CC^0\otimes\wedge^0\R^2\arrow[bend left=5]{r}{\dif}&\CC^1\otimes\wedge^0\R^2\arrow[bend left=5]{r}\arrow[bend left=5]{l}{h_{\F}}&\CC^2\otimes\wedge^0\R^2\arrow[bend left=5]{r}\arrow[bend left=5]{l}{h_{\F}}&\CC^3\otimes\wedge^0\R^2\arrow[bend left=5]{l}{h_{\F}} \end{tikzcd} }; \end{tikzpicture} \end{equation} As an immediate consequence of the Perturbation Lemma we obtain: \begin{corollary}\label{corollary: homotopy} The complex $(\CC\otimes \wedge\R^2,\dif+\delta)$ admits the HE data \begin{align*} (p_{\F}(\CC)\otimes \wedge\R^2,\tilde{\delta})\stackrel[\tilde{\iota}]{\tilde{p}}{\leftrightarrows}(\CC\otimes \wedge\R^2 ,\dif+ \delta),\tilde{h} \end{align*} where the maps $\tilde{\iota}$, $\tilde{p}$ and $\tilde{h}$ are given by \begin{align*} \tilde{\iota} =&\ \sum_{i=0}^2 (h_{\F}\circ \delta)^i\circ \iota,\ \ \ \ \ \ \ \tilde{p} = p_{\F}+p_{\F}\circ \delta\circ h_{\F},\\ \tilde{h}=&\ h_{\F}\circ \sum_{i=0}^2 (\delta\circ h_{\F})^i, \ \ \ \ \ \ \tilde{\delta} = p_{\F}\circ \delta. \end{align*} The maps $\tilde{\iota}$, $\tilde{p}$ and the homotopy $\tilde{h}$ satisfy property SLB for $(0,10,76)$, $(1,10,83)$ and $(0,15,111)$, respectively. \end{corollary} \begin{proof} From Proposition \ref{proposition: property H fol} we know that the complex $(C^{\bullet},\dif)$ given by \begin{align}\label{eq: complex short} C^k := \underset{p+q=k}{\bigoplus} \CC^p\otimes \wedge ^q\R^2 \end{align} admits the HE data \begin{align*} (p_{\F}(C),0)\stackrel[\iota]{p_{\F} }{\leftrightarrows}(C,\dif),h_{\F} \end{align*} Note that $\delta$ is a small perturbation of $\dif$ since $\delta \circ h_{\F}$ is nilpotent: \begin{align*} (\delta \circ h_{\F})^3=0 \end{align*} and hence \begin{align*} (\id -\delta\circ h_{\F})^{-1}=\sum_{i=0}^2 (\delta\circ h_{\F})^i. \end{align*} Hence we can apply Lemma \ref{lemma: perturbation lemma}. The formulas for $\tilde{\iota}$, $\tilde{p}$, $\tilde{h}$ and $\tilde{\delta}$ follow now immediately, by looking at the $(p,q)$ degrees and using that $p_{\F}(\CC^{p})=0$, for $p\notin \{0,2\}$, by Proposition \ref{proposition:flat foliated ch}. By Proposition \ref{proposition:PCH as forms}, $\delta$ satisfies property SLB for $(0,0,3)$ and, by Proposition \ref{proposition: property H fol} and the remark following it, $p_{\F}$ and $h_{\F}$ satisfy property SLB for $(1,5,40)$ and $(0,5,35)$, respectively. Therefore, by Lemma \ref{lemma: slb property}, the operators $\tilde{\iota}$, $\tilde{p}$ and $\tilde{h}$ satisfy the claimed SLB properties. \end{proof} \subsubsection{The differential $\tilde{\delta}$ and its partial inverses}\label{section: cohomology second page} Corollary \ref{corollary: homotopy} reduces the calculation of the cohomology of the complex $(\CC\otimes \wedge\R^2,\dif +\delta)$ and the construction of ``good'' homotopy operators for it, to the similar questions for the complex $(p_{\F}(\CC)\otimes \wedge\R^2,\tilde{\delta})$: \begin{equation}\label{eq: diagram} \begin{tikzpicture}[baseline= (a).base] \node[scale=1] (a) at (0,0){ \begin{tikzcd}[row sep=small] p_{\F}(\CC^0)\otimes\wedge^2\R^2\arrow{rrd}{\phantom{1}\tilde{\delta}}&0&p_{\F}(\CC^2)\otimes\wedge^{2}\R^2 \\ p_{\F}(\CC^0)\otimes\wedge^1\R^2\arrow{rrd}{\phantom{1}\tilde{\delta}}&0&p_{\F}(\CC^2)\otimes\wedge^{1}\R^2\\ p_{\F}(\CC^0)\otimes\wedge^{0}\R^2 &0&p_{\F}(\CC^2)\otimes\wedge^{0}\R^2 \end{tikzcd} }; \end{tikzpicture} \end{equation} Here we only pictured the non-trivial differentials and spaces. In this section we determine these differentials explicitly, we compute partial inverses to them, and give estimates for the latter. \begin{lemma}\label{lemma: second differential degree one} The map $\tilde{\delta}$ in degree $(0,q)\to (2,q-1)$ is given by \begin{align*} \tilde{\delta}: p_{\F}(\CC^0)\otimes \wedge^q\R^2&\to p_{\F}(\CC^2)\otimes \wedge^{q-1}\R^2\\ e_{\varphi}(g\circ f)\otimes e_i&\mapsto \frac{(-1)^{i+1}}{2\nf} p_{\F}(e_{\varphi}(g\circ f)\wedge \tilde{\omega}_i)\otimes 1\\ e_{\varphi}(g\circ f)\otimes e_1\wedge e_2&\mapsto \frac{1}{2\nf}\sum_{i=1}^{2} p_{\F}(e_{\varphi}(g\circ f)\wedge \tilde{\omega}_i)\otimes e_{3-i} \end{align*} with $g\in C^{\infty}_0(\C)$, where we used the isomorphism \eqref{eq: zero fol iso}. \end{lemma} \begin{proof} We prove the result in two steps.\\ \noindent\underline{Step 1}: By Proposition \ref{proposition: chain isomorphism}, the map $\rho^*$ from \eqref{eq:cohomology map} fits into a commutative diagram \begin{equation*} \begin{tikzpicture}[baseline= (a).base] \node[scale=.9] (a) at (0,0){ \begin{tikzcd} p_{\F}(\CC^0)\otimes\wedge^q\R^2\arrow{d}{\simeq}\arrow{d}[swap]{\rho^*}\arrow{r}{\tilde{\delta}}&p_{\F}(\CC^{2})\otimes\wedge^{q-1}\R^2\arrow{d}{\simeq}\arrow{d}[swap]{\rho^*}\\ \mathscr{D}^0\otimes\wedge^q\R^2\arrow{r}{\delta_{\mathscr{D}}}&\mathscr{D}^{2}\otimes\wedge^{q-1}\R^2 \end{tikzcd} }; \end{tikzpicture} \end{equation*} We claim that the map $\delta_{\mathscr{D}}$ is given by \begin{align}\label{eq:delta:on:skeleton} -\frac{\lambda_1}{2|\lambda|^2}e_{\omega_{S^2}}\otimes i_{\varepsilon^1}- \frac{\lambda_2}{2|\lambda|^2}e_{\omega_{S^2}}\otimes i_{\varepsilon^2} \end{align} where $\lambda=\lambda_1+i\lambda_2$ are the coordinates on $\C$ and $\varepsilon^i\in (\R^2)^*$ denotes the dual basis to $e_i\in \R^2$. For this, we first recall from \eqref{eq:pullback forms} that \[ \rho^*\tilde{\omega}_1 =-\lambda_1\cdot \omega_{S^2}\in \Omega^2(S^2\times \C)^{SU(2)\times \Z_2}\] Hence we obtain \[ \rho^*\dif\tilde{\omega}_1 =-\omega_{S^2}\wedge \dif \lambda_1.\] Next, we define \begin{align}\label{eq: w} W_1:= \frac{\lambda_1\partial_{\lambda_1}-\lambda_2\partial_{\lambda_2}}{2|\lambda |^2}\quad \text{and}\quad W_2:= \frac{\lambda_2\partial_{\lambda_1}+\lambda_1\partial_{\lambda_2}}{2|\lambda |^2}. \end{align} Using \eqref{eq:cohomology map explicit} it is easy to check that $V_i$ and $W_i$ are $\rho$-related, i.e., \begin{align*} \rho_*(W_i)=V_i|_{\Sk\backslash\{0\}} \end{align*} From the definition of the $\gamma_i$ in \eqref{eq: gammai} we obtain \[ \rho^*\gamma_i = \frac{-\lambda_i}{2|\lambda|^2}\omega_{S^2}.\] Recall from Proposition \ref{proposition:PCH as forms} that $\delta=e_{\gamma_1}\otimes i_{\epsilon^1}+e_{\gamma_2}\otimes i_{\epsilon^2}$. This implies that for $\xi\in p_{\F}(\CC^0)\otimes\wedge^q\R^2$, we have that $\delta_{0}\rho^*(\xi)=\rho^*\delta(\xi)$, where $\delta_0$ is the operator in \eqref{eq:delta:on:skeleton}. On the other hand $\tilde{\delta}(\xi)-\delta(\xi)=\dif h_{\F} \delta(\xi)$. Note that $h_{\F}\delta(\xi)$ is $SU(2)$-invariant, and therefore \[\rho^*(h_{\F}\delta(\xi))\in e_{\rho^*(\varphi)}(\Omega^1(S^2\times \C)^{SU(2)\times \mathbb{Z}_2})\otimes \wedge^{q-1} \R^2=0.\] Thus $\rho^*\tilde{\delta}(\xi)=\rho^*\delta(\xi)=\delta_0\rho^*(\xi)$, and this concludes the proof of the claim. \noindent\underline{Step 2}: The map $\tilde{\delta}$ in degree $(0,1)\to (2,0)$ is obtained as the composition of the following maps. The map $\rho^*$ identifies $p_{\F}(\CC^0)$ with $\mathscr{D}^0$ by \begin{align*} e_{\varphi}(g \circ f)\otimes e_i&\ \mapsto e_{\rho^*(\varphi)}(g \circ \mathrm{sq})\otimes e_i \end{align*} Then we use the map $\delta_{\mathscr{D}}$ from Step 1 to get \begin{align*} e_{\rho^*(\varphi)}(g \circ \mathrm{sq})\otimes e_i&\, \mapsto -\frac{\lambda_i}{2|\lambda|} g (\lambda^2)\, e_{\rho^*(\varphi)}(\omega_{S^2})\otimes 1 \end{align*} By \eqref{eq:pullback forms}, the inverse of $\rho^*$ in the diagram in Step 1 is given by: \begin{align*} -\frac{\lambda_i}{2|\lambda|}g (\lambda^2)\, e_{\rho^*(\varphi)}(\omega_{S^2})\otimes 1&\, \mapsto \frac{(-1)^{i+1}}{2\nf}p_{\F}( e_{\varphi}(g \circ f)\wedge \tilde{\omega}_{i})\otimes 1 \end{align*} So we obtain the form of $\tilde{\delta}$ from the statement. The case $(0,2)\to (2,1)$ follows similarly. \end{proof} To obtain homotopy operators for the Poisson complex, we need explicit inverses for the map $\tilde{\delta}$. \begin{lemma}\label{lemma: right inverse} A right inverse for $\tilde{\delta}$ in degree $(0,1)\to (2,0)$ is given by \begin{align}\label{eq: right inverse map} &\mathscr{R}: p_{\F}(\CC^2)\otimes \wedge^0\R^2 \to p_{\F}(\CC^0)\otimes \wedge^1\R^2 \\ &\sum_{i=1}^2 p_{\F}(e_{\varphi}(g_i\circ f)\wedge \tilde{\omega}_i) \otimes 1 \mapsto 2\nf \sum_{i=1}^2 (-1)^{i+1} e_{\varphi}(g_i\circ f)\otimes e_i\nonumber \end{align} with $(g_1,g_2)\in \mathcal{M}$. \end{lemma} \begin{proof} By Propositions \ref{proposition:flat foliated ch} and \ref{proposition: property H fol}, every element in $p_{\F}(\CC^2)$ is of the form \begin{align*} \sum_{i=1}^2 p_{\F}(e_{\varphi}(g_i\circ f) \wedge \tilde{\omega}_i), \quad \text{ for unique }\ (g_1,g_2)\in \mathcal{M}. \end{align*} Hence $\mathscr{R}$ is well-defined, and it is clearly an right inverse to $\tilde{\delta}$. \end{proof} Next, we describe a left inverse for $\tilde{\delta}$ in degree $(0,2)\to (2,1)$. For this we will use the following: \begin{lemma}\label{lemma: trivial module 3} We have an isomorphism of $C^{\infty}_0(\C)$-modules: \[C^{\infty}_0(\C)\oplus C^{\infty}_0(\C) \simeq p_{\F}(\CC^2)\otimes \R^2.\] More explicitly, for every element $\xi\in p_{\F}(\CC^2)\otimes\R^2$ there exist unique elements $g_1,g_2\in C^{\infty}_0(\C)$ such that \begin{align}\label{eq: trivialization in (2,1)} \xi= g_1\circ f\cdot b_1 +g_2\circ f\cdot b_2, \end{align} where $b_1$ and $b_2$ are the sections on the set $\spl\setminus S_0$ given by: \begin{align*} b_1 :=&\,e_{\varphi}\big(p_{\F}(\tilde{\omega}_1)\otimes e_1 - p_{\F}(\tilde{\omega}_2)\otimes e_2\big)\\ b_2 :=&\,e_{\varphi}\big(p_{\F}(\tilde{\omega}_2)\otimes e_1 + p_{\F}(\tilde{\omega}_1)\otimes e_2\big). \end{align*} \end{lemma} \begin{proof} First recall that by Proposition \ref{proposition: twisted module} and Proposition \ref{proposition:flat foliated ch} we have the isomorphisms of $C^{\infty}_0(\C)$-modules: \begin{equation}\label{eq:composition of isomorphisms} C^{\infty}_0(\C)\oplus C^{\infty}_0(\C)=\mathcal{M}\oplus \mathcal{K}\simeq \mathcal{M}\oplus \mathcal{M} \simeq p_{\F}(\CC^2)\otimes \R^2. \end{equation} The statement follows by applying these isomorphism to a basis on the left. More explicitly, consider the map $\chi:C^{\infty}_0(\C)\oplus C^{\infty}_0(\C)\to p_{\F}(\CC^2)$ given by \[\chi(g_1,g_2):=\sum_{i=1}^2 p_{\F}(e_{\varphi}(g_i\circ f) \wedge \tilde{\omega}_i).\] We know that $\ker \chi=\mathcal{K}$ and its restriction to $\mathcal{M}$ is an isomorphism. Denote $J(g_1,g_2)=(-g_2,g_1)$. Using that $\id=p_{\mathcal{M}}+ p_{\mathcal{K}}$ and that $J(\mathcal{M})=\mathcal{K}$, we obtain the isomorphism from the statement: \begin{align*} (g_1,g_2)\mapsto& (\chi \circ p_{\mathcal{M}}(g_1,g_2))\otimes e_1 + (\chi \circ (-J)\circ p_{\mathcal{\mathcal{K}}}(g_1,g_2))\otimes e_2=\\ &= \chi (g_1,g_2)\otimes e_1+ \chi(g_2,-g_1)\otimes e_2=\\ &=g_1\circ f \cdot b_1+ g_2\circ f\cdot b_2.\qedhere \end{align*} \end{proof} With the notation from the lemma, $\tilde{\delta}$ in degree $(0,2)\to (2,1)$ becomes: \begin{align}\label{eq: delta degree 2} \tilde{\delta}(e_{\varphi}(g\circ f)\otimes e_1\wedge e_2)= \frac{1}{2|f|}g\circ f\cdot b_2. \end{align} Therefore, the lemma implies the following: \begin{lemma}\label{lemma: second differential degree two} A left inverse of $\tilde{\delta}$ in degree $(0,2)\to (2,1)$ is given by \begin{align}\label{eq: left inverse} \mathscr{L}&: p_{\F}(\CC^2)\otimes \wedge^1\R^2 \to p_{\F}(\CC^0)\otimes \wedge^2\R^2 \\ &\sum_{i=1}^2 g_i\circ f\cdot b_i\mapsto 2\nf\, e_{\varphi}(g_2\circ f)\otimes e_1\wedge e_2.\nonumber \end{align} \end{lemma} Next, we estimate these maps. \begin{lemma}\label{lemma: r} The maps $\mathscr{R}$ and $\mathscr{L}$ satisfy property SLB for $(0,1,2)$. \end{lemma} \begin{proof} In order to obtain the estimate for the map $\mathscr{R}$ \eqref{eq: right inverse map}, we write it as a composition of several maps which we estimate one by one: \begin{equation}\label{eq: op contraction} \begin{array}{ccccccc} p_{\F}(\CC^2)&\xrightarrow{\rho^*}&\mathscr{D}^{2}&\xrightarrow{\zeta }&\mathscr{D}^{0} \otimes \R^2&\xrightarrow{(\rho^*)^{-1}\otimes \id }&p_{\F}(\CC^0)\otimes \R^2 \end{array} \end{equation} where we use the cochain isomorphism $\rho^*$ from Proposition \ref{proposition: chain isomorphism}, and \[ \zeta :=-2\lambda_1 i_{\pi_{S^2}}\otimes e_1-2\lambda_2 i_{\pi_{S^2}}\otimes e_2\] with $\pi_{S^2}=\omega_{S^2}^{-1}$ the Poisson structure on $S^2$ dual to $\omega_{S^2}$. Next, let us see that this composition is indeed $\mathscr{R}$. Using \eqref{eq:pullback forms} for $\rho^*(\tilde{\omega}_i)$ and \eqref{eq:final:to:prove} we obtain for $(g_1,g_2)\in \mathcal{M}$ that \begin{align*} \sum_{i=1}^2g_i\circ f\cdot e_{\varphi}(p_{\F}(\tilde{\omega}_i))\mapsto &\ \sum_{i=1}^2(-1)^{i}\lambda_i g_i\circ \mathrm{sq}\cdot \rho^*(\varphi)\wedge \omega_{S^2}\\ \mapsto &\ 2\sum_{j=1}^2(-1)^{j+1}(|z|\cdot g_j)\circ \mathrm{sq}\cdot \rho^*(\varphi)\otimes e_j\\ \mapsto &\ 2\nf \sum_{j=1}^2(-1)^{j+1} e_{\varphi}(g_j\circ f)\otimes e_j \end{align*} Here we used for the second map that \begin{align*} (g_1,g_2)\in \mathcal{M} \quad \Longleftrightarrow \quad \lambda_2 g_1\circ \mathrm{sq}=-\lambda_1 g_2\circ \mathrm{sq} \end{align*} by pulling back the relation in \eqref{eq: definition M} by $\mathrm{sq}:\C\to \C$ and hence, for $j=1,2$: \begin{align*} -\lambda_j\sum_{i=1}^2(-1)^{i}\lambda_i g_i\circ \mathrm{sq}=(-1)^{j+1}|\lambda|^2\cdot g_j\circ\mathrm{sq} =(-1)^{j+1}(|z|\cdot g_j)\circ \mathrm{sq}. \end{align*} In the following we estimate each of the maps in \eqref{eq: op contraction} separately.\\ \noindent\underline{Step 1}: We have for $\beta\in \Omega_0^{\bullet}(\spl)$ the inequality \begin{align}\label{Step four crazy Lemma} \fnorm{\rho^*(\beta)}_{n,k,\frac{r}{\sqrt{2}}}^{S^2\times \C}\le C\cdot \fnorm{\beta}_{n,k,r} \end{align} for a constant $C=C(n,k,r)$ depending continuously on $r>0$. Here the semninorms on the left are defined as follows. Equip the $n$-th jet bundle of the vector bundle \begin{align*} \wedge^\bullet T^*(S^2\times\C)\to S^2\times\C \end{align*} with a norm $|\cdot|^{jet}$. Then, for $\alpha \in \Omega^{\bullet}_0(S^2\times \C)$, define: \begin{align*} \fnorm{\alpha}_{n,k,s}^{S^2\times \C}:= \sup_{(w,\lambda)\in S^2\times\overline{B}_s}\ |\lambda|^{-k}|j^n\alpha(w,\lambda)|^{jet}. \end{align*} We obtain \eqref{Step four crazy Lemma} by compactness of $S^2$ and using \begin{align*} \sqrt{2}|\lambda| = R\circ \rho (w,\lambda), \end{align*} which follows by Lemma \ref{lemma: characterization skeleton} (3) and by Lemma \ref{lemma:identification of skeleton} (2). \noindent\underline{Step 2}: Note that for $\alpha\in \mathscr{D}^2$ we have \begin{align}\label{Step three crazy Lemma} \fnorm{\zeta (\alpha)}_{n,k,s}^{\C} \le C\cdot \fnorm{\alpha}_{n,k,s}^{S^2\times \C} \end{align} for a constant $C(n,k,s)$ depending continuously on $0<s$. Here we used the seminorms $\fnorm{\cdot }_{n,k,s}^{\C}$ on $C^{\infty}_0(\C)$, defined as in \eqref{eq: flat norms}. \noindent\underline{Step 3}: We show that for $g\in C^{\infty}_0(\C)$ we have \begin{align}\label{Step one in crazy lemma} \fnorm{g\circ f\cdot \varphi }_{n,k,r}\le C\cdot \fnorm{g\circ \mathrm{sq}\cdot \rho^*(\varphi) }^{\C}_{n,k+n+2,\frac{r}{\sqrt{2}}}. \end{align} Clearly, we have that: \begin{align*} \fnorm{g\circ f\cdot \varphi}_{n,k,r}\le C\cdot \fnorm{g\circ f}_{n,k,r} \end{align*} By the explicit form of the vector fields $W_1$ and $W_2$ from \eqref{eq: w}, we have that, for any $g\in C^{\infty}_0(\C)$, and for $i=1,2$: \begin{align*} (\partial_i g)\circ \mathrm{sq} = \Lie_{W_i} (g\circ \mathrm{sq}). \end{align*} For all $u\in C^{\infty}_0(\C)$ and $i=1,2$ we have: \begin{align}\label{eq:norm of Lie W} \fnorm{\Lie_{W_i}u}_{n,k,s}^{\C}\le C\cdot \fnorm{u}_{n+1,k+1,s}^{\C}. \end{align} This follows by Lemma \ref{lemma:singular:vb:maps} applied to the coefficients of $W_i$. Using the general chain rule from Subsection \ref{subsection: derivatives} and $2\nf\le R^2$ from \eqref{eq:norm-fiber inequality}, we obtain for $a\in \N_0^6$, $k\in \N_0$, $0< R \le r$ and $g\in C^{\infty}_0(\C)$ that \[\frac{|D^a(g\circ f)|}{R^k} \le C\cdot \frac{1}{\nf^{\frac{k}{2}}} \sum_{1\leq |b|\leq |a|}|D^b( g)\circ f|.\] By $2\nf\le R^2$ and by applying $f$ to diagonal matrices, we note that: \[f(\overline{B}_r)=\overline{B}_{r^2/2}.\] For $A\in \overline{B}_r$, let $\lambda\in \overline{B}_{r/\sqrt{2}}$ such that $f(A)=\lambda^2$. Then the above gives: \begin{align*} \frac{|D^a(g\circ f)|}{R^k} \le &\ C\cdot \frac{1}{|\lambda|^{k}} \sum_{1\leq |b|\leq |a|}|D^b( g)\circ \mathrm{sq}|\\ = &\ C\cdot \frac{1}{|\lambda|^{k}}\sum_{1\leq |b|\leq |a|}|\Lie_{W_1}^{b_1}\Lie_{W_2}^{b_2} (g\circ \mathrm{sq})|\\ \le &\ C\cdot\sum_{1\leq |b|\leq |a|}\fnorm{\Lie_{W_1}^{b_1}\Lie_{W_2}^{b_2} (g\circ \mathrm{sq})}_{0,k,\frac{r}{\sqrt{2}}}^{\C}\\ \le &\ C\cdot \fnorm{g\circ \mathrm{sq}}_{|a|,k+|a|,\frac{r}{\sqrt{2}}}^{\C}, \end{align*} where in the last step we used \eqref{eq:norm of Lie W} inductively. This proves \eqref{Step one in crazy lemma} using Lemma \ref{lemma:singular:vb:maps} and the form of $\rho^*(\varphi)$ \eqref{eq:pull back of varphi}. Applying the estimates from Step 1 to 3 in reverse order proves that the map $\mathscr{R}$ satisfies property SLB for $(0,1,2)$. To estimate $\mathscr{L}$ we denote by $e_{e_j}$ and $i_{\varepsilon^j}$ the exterior and interior product on $\wedge^q\R^2$ with $e_j$ and $\varepsilon^j$, respectively. We claim that: \begin{align*} \mathscr{L}=-(\id\otimes e_{e_1})\circ \mathscr{R}\circ (\id \otimes i_{\varepsilon ^1})-( \id\otimes e_{e_2})\circ \mathscr{R}\circ (\id \otimes i_{\varepsilon^2}) \end{align*} For this, consider an arbitrary element $g_1\circ f\cdot b_1+g_2\circ f\cdot b_2\in p_{\F}(\CC^2)\otimes \R^2$. Then applying the first operator in the sum, we obtain: \begin{align*} g_1\circ f\cdot b_1+g_2\circ f\cdot b_2\ \ \stackrel{\id\otimes i_{\varepsilon^1}}{\mapsto}\quad \, & g_1\circ f\cdot p_{\F}(e_{\varphi}(\tilde{\omega}_1))+g_2\circ f \cdot p_{\F}(e_{\varphi}(\tilde{\omega}_2))\\ =\qquad & \big(\frac{1}{2|z|}((|z|+x)g_1-yg_2)\big)\circ f\cdot p_{\F}(e_{\varphi}(\tilde{\omega}_1))\\ &+\big(\frac{1}{2|z|}((|z|-x)g_2-yg_1)\big)\circ f \cdot p_{\F}(e_{\varphi}(\tilde{\omega}_2))\\ \stackrel{-(\id\otimes e_{e_1})\circ \mathscr{R}}{\mapsto} &\,((|z|-x)g_2-yg_1)\circ f\cdot \varphi\otimes e_1\wedge e_2, \end{align*} where in the equality we have used the projection $p_{\mathcal{M}}$. Similarly, for the second operator, one obtains: \begin{align*} g_1\circ f\cdot b_1+g_2\circ f\cdot b_2\ \ \stackrel{\id\otimes i_{\varepsilon^2}}{\mapsto}\quad \, & -g_1\circ f\cdot p_{\F}(e_{\varphi}(\tilde{\omega}_2))+g_2\circ f \cdot p_{\F}(e_{\varphi}(\tilde{\omega}_1))\\ =\qquad & \big(\frac{1}{2|z|}((|z|+x)g_2+yg_1)\big)\circ f\cdot p_{\F}(e_{\varphi}(\tilde{\omega}_1))\\ & -\big(\frac{1}{2|z|}((|z|-x)g_1+yg_2)\big)\circ f \cdot p_{\F}(e_{\varphi}(\tilde{\omega}_2))\\ \stackrel{-(\id\otimes e_{e_2})\circ \mathscr{R}}{\mapsto} &\,((|z|+x)g_2+yg_1)\circ f\cdot \varphi\otimes e_1\wedge e_2, \end{align*} which yields the claim. Since $\mathscr{L}$ is obtained by combining $\mathscr{R}$ with the exterior and interior products by $e_i$ and $\varepsilon^i$, respectively, it follows that $\mathscr{L}$ also satisfies property SLB for $(0,1,2)$. \end{proof} \subsubsection{A homotopy equivalence data}\label{section: HE data} Corollary \ref{corollary: homotopy} reduces the complex $(\CC^{\bullet}\otimes \wedge^{\bullet}\R^2,\dif +\delta)$, and the construction of ``good'' homotopy operators for it, to the complex $(p_{\F}(\CC^{\bullet})\otimes \wedge^{\bullet}\R^2,\tilde{\delta})$. The previous subsection allows us to deal with the latter. \begin{corollary}\label{proposition: homotopy} The complex $(p_{\F}(\CC^{\bullet})\otimes \wedge^{\bullet}\R^2,\tilde{\delta})$ admits the HE data \begin{align}\label{eq: HE data E} (\widetilde{\mathscr{E}}^{\bullet},0)\stackrel[\iota ]{p}{\leftrightarrows}(p_{\F}(\CC)\otimes \wedge\R^2,\tilde{\delta}),h \end{align} where $\widetilde{\mathscr{E}}$ is the subcomplex given by \begin{align* \widetilde{\mathscr{E}}^k:= \begin{cases} p_{\F}(\CC^0)\otimes \wedge^0\R^2 &\text{ for } k=0\\ \ker \tilde{\delta}&\text{ for } k=1\\ \mathrm{coker}\, \tilde{\delta}&\text{ for } k=3\\ p_{\F}(\CC^2)\otimes \wedge^2\R^2 &\text{ for } k=4\\ 0&\text{ for }k=2,5,6 \end{cases} \end{align*} satisfying \begin{align*} p \circ \iota =\id_{\widetilde{\mathscr{E}}}, \end{align*} and $h$ satisfy property SLB for $(0,1,2)$. \end{corollary} \begin{proof} The maps $\iota$ are the standard inclusions. We give the maps $p$ and $h$ in every degree. \\ \noindent\textbf{In degree $0$}: The map $p=\id$ and $h=0$.\\ \noindent\textbf{In degree $1$}: The map $p$ is defined by \begin{align*} p:= \id -\mathscr{R}\circ \tilde{\delta} \end{align*} and the map $h$ is given by \begin{equation*} \begin{array}{cccc} h:& p_{\F}(\CC^0)\otimes \wedge ^2\R^2\oplus\, 0 \oplus p_{\F}(\CC^2)\otimes \wedge ^0\R^2&\to & p_{\F}(\CC^0)\otimes \wedge ^1\R^2\oplus\, 0 \\ & (\alpha^{0,2},0,\alpha^{2,0})&\mapsto &(-\mathscr{R}(\alpha^{2,0}),0) \end{array} \end{equation*} \noindent\textbf{In degree $2$}: Here $p=0$ and $h$ is defined by \begin{equation*} \begin{array}{cccc} h:& 0\oplus p_{\F}(\CC^2)\otimes \wedge ^1\R^2\oplus \, 0&\to &p_{\F}(\CC^0)\otimes \wedge ^2\R^2\oplus\, 0 \oplus p_{\F}(\CC^2)\otimes \wedge ^0\R^2 \\ & (0,\alpha^{2,1},0)&\mapsto &(-\mathscr{L}(\alpha^{2,1}),0,0) \end{array} \end{equation*} where the map $\mathscr{L}$ is given in \eqref{eq: left inverse}. \noindent\textbf{In degree $3$}: The projection map $p$ is given by \begin{align*} p := \id -\tilde{\delta}\circ \mathscr{L} \end{align*} and $h$ is the zero map.\\ \noindent\textbf{In degree $4$}: Here $p=\id$ and $h=0$. Finally, by Lemma \ref{lemma: r}, $h$ has property SLB for $(0,1,2)$. \end{proof} \subsubsection{The flat Poisson cohomology of $\spl$}\label{section: flat pch} As a corollary of the previous subsections, we obtain the description of the flat Poisson cohomology groups of $(\spl,\pi)$ together with a deformation retraction to a complex with trivial differential. The algebraic structure of the flat Poisson cohomology groups is discussed in Subsection \ref{section: algebra}. \begin{theorem}\label{main theorem} The flat Poisson complex $(\mathfrak{X}^{\bullet}_0(\spl),\dif_{\pi})$ admits HE data \[ \begin{tikzcd}[every arrow/.append style={shift right}] (\mathscr{E}^{\bullet},0) \arrow{r}[swap]{\iota _{\spl}} &(\mathfrak{X}^{\bullet}_0(\spl) ,\dif_{\pi}),h_{\spl} \arrow{l}[swap]{p_{\spl}} \end{tikzcd}\] where $\mathscr{E}$ is given by \begin{align* \mathscr{E}^k:= \begin{cases} C^{\infty}_0(\C) &\text{ for } k=0,3\\ \mathcal{M}&\text{ for } k=1,4\\ 0&\text{ for }k=2,5,6 \end{cases} \end{align*} such that \[ p_{\spl}\circ \iota_{\spl}=\id_{\mathscr{E}},\] and such that the maps $\iota_{\spl}\circ p_{\spl}$ and $h_{\spl}$ satisfies property SLB for $(2,21,188)$ and $(1,21,167)$, respectively. In particular, the map $\iota_{\spl}$ induces an isomorphism of $C^{\infty}_0(\mathbb{C})$-modules \begin{equation}\label{eq: isoPC} I^{\bullet}:\mathscr{E}^{\bullet}\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} H^{\bullet}_0(\spl,\pi) \end{equation} and in degree $2$ we have the homotopy relation \begin{align*} \id_{\mathfrak{X}^{2}_0(\spl)}=h_{\spl}\circ \dif_{\pi}+\dif_{\pi}\circ h_{\spl} \end{align*} \end{theorem} \begin{proof} Note that we have an isomorphism $\epsilon:\mathscr{E}^{\bullet}\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \widetilde{\mathscr{E}}^{\bullet}$ given as follows:\\ \noindent\textbf{In degree $0$}, $\epsilon$ is the isomorphism from \eqref{eq: zero fol iso}.\\ \noindent\textbf{In degree $1$}, $\epsilon$ is given by \begin{align}\label{eq: kernel 01} \epsilon: \quad \mathcal{M}\quad &\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \qquad\qquad \ker \tilde{\delta} \\ (g_1,g_2) &\mapsto \ e_{\varphi}(g_2\circ f)\otimes e_1 + e_{\varphi}( g_1\circ f) \otimes e_2\nonumber \end{align} That this map is a well-defined isomorphism follows by Lemma \ref{lemma: second differential degree one}, the description of the kernel of the map \eqref{eq: quotient} in Proposition \ref{proposition:flat foliated ch}, and the isomorphism $\mathcal{M}\simeq \mathcal{K}$ from Proposition \ref{proposition: twisted module}.\\ \noindent\textbf{In degree $3$}, $\epsilon$ is given by \begin{align}\label{eq: iso degree 3} \epsilon: C^{\infty}_{0}(\C)&\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \quad \mathrm{coker}\, \tilde{\delta} \\ g&\mapsto\ g\circ f\cdot e_{\varphi}(b_1) \nonumber \end{align} This is an isomorphism by Lemma \ref{lemma: trivial module 3} and \eqref{eq: delta degree 2}.\\ \noindent\textbf{In degree $4$}, $\epsilon$ is given by \begin{align}\label{eq: iso degree 4} \epsilon: \mathcal{M}&\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} p_{\F}(\CC^2)\otimes \wedge^2\R^2 \\ (g_1,g_2)\mapsto &\sum_{i=1}^2 p_{\F}(g_i\circ f\cdot e_{\varphi}(\tilde{\omega}_i))\otimes e_1\wedge e_2\nonumber \end{align} which, by Proposition \ref{proposition:flat foliated ch}, is an isomorphism. The HE data is obtained from the cochain isomorphism $\tilde{a}$ in Proposition \ref{proposition:PCH as forms}, the isomorphism $\epsilon$ and the HE data from Corollary \ref{corollary: homotopy} and Corollary \ref{proposition: homotopy}. By using that HE data behave functorial \cite[Lemma 2.4]{LS87}, the formulas for the composition yield: \begin{align*} \iota_{\spl}:= \tilde{a}^{-1}\circ \tilde{\iota} \circ \iota\circ \epsilon,& \qquad p_{\spl}:= \epsilon^{-1}\circ p\circ \tilde{p} \circ \tilde{a} \\ h_{\spl}=\tilde{a}^{-1}\, \circ &\, (\tilde{\iota}\circ h\circ \tilde{p}+\tilde{h})\circ \tilde{a}. \end{align*} That these form an HE data, can be checked directly: \begin{align*} \iota _{\spl} \circ p_{\spl}-\id =&\ \tilde{a}^{-1}\circ \tilde{\iota}\circ \iota\circ p \circ \tilde{p}\circ \tilde{a}-\id\\ =&\ \tilde{a}^{-1}\circ \tilde{\iota}\circ (\iota \circ p -\id ) \circ \tilde{p}\circ \tilde{a}+\tilde{a}^{-1}\circ\big(\tilde{\iota} \circ \tilde{p}- \id\big)\circ \tilde{a}\\ =&\ \tilde{a}^{-1}\circ \big( \tilde{\iota}\circ (\tilde{\delta}\circ h+h\circ \tilde{\delta} ) \circ \tilde{p}\big) \circ \tilde{a} \\ &\ +\tilde{a}^{-1}\circ\big((\dif +\delta) \circ \tilde{h} +\tilde{h}\circ (\dif+\delta)\big)\circ \tilde{a}\\ =&\ \tilde{a}^{-1}\circ \big( (\dif+ \delta) \circ \big( \tilde{\iota}\circ h\circ \tilde{p}+\tilde{h}\big)\big)\circ \tilde{a}\\ &\ + \tilde{a}^{-1}\circ \big( \tilde{\iota}\circ h\circ \tilde{p}+\tilde{h}\big) \circ (\dif+\delta)\big)\circ \tilde{a}\\ =&\ \tilde{a}^{-1}\circ (\dif+ \delta)\circ \tilde{a}\circ h_{\spl} + h_{\spl}\circ \tilde{a}^{-1}\circ (\dif+ \delta)\circ \tilde{a}\\ =&\ \dif_{\pi}\circ h_{\spl}+h_{\spl}\circ \dif_{\spl}. \end{align*} Finally, Proposition \ref{proposition:PCH as forms}, Corollary \ref{corollary: homotopy}, Corollary \ref{proposition: homotopy} and Lemma \ref{lemma: slb property} imply that $h_{\spl}$ satisfy the SLB property for $(1,21,188)$. Since $\dif_{\pi}$ satisfies the SLB property for $(1,0,0)$, again Lemma \ref{lemma: slb property} implies the claimed SLB property for $\iota_{\spl}\circ p_{\spl}$. \end{proof} \subsection{The proof of Theorem \ref{theorem: PC}}\label{section: algebra} In degree 0, the isomorphism was already proven in Proposition \ref{prop:Casimirs}. For the other degrees, we will give an explicit description for the isomorphism $I^{\bullet}$ in \eqref{eq: isoPC}. First of all, to identify the $C^{\infty}(\C)$-module structure, note that the maps $I^{\bullet}$ are $C^{\infty}(\C)$-linear (where we identify $H^{0}(\spl,\pi)\simeq C^{\infty}(\C)$). First, we claim that, for $(g_1,g_2)\in \mathcal{M}$ the class $I^1(g_1,g_2)\in H^1_0(\spl,\pi)$ acts on $C^{\infty}(\C)$ via the derivation \[\frac{1}{2|z|}(g_1\cdot Y_1+ g_2\cdot Y_2)\in \mathfrak{out}(\spl,\pi).\] Note that this suffices to obtain the description from the theorem of the first Poisson cohomology group: it shows that the claimed map is an isomorphism, and since the Lie bracket is determined by the action on functions, it follows that the isomorphism preserves the Lie bracket. Indeed, applying the maps $\epsilon$ in \eqref{eq: kernel 01}, the inclusion $\iota$ in Corollary \ref{proposition: homotopy} and $\tilde{\iota}$ in Corollary \ref{corollary: homotopy}, we obtain that \[ I^1(g_1,g_2)=\tilde{a}^{-1} (\epsilon(g_1,g_2)+h_{\F}\circ \delta(\epsilon(g_1,g_2))).\] Note that, since $h_{\F}\circ \delta(\epsilon(g_1,g_2))\in \CC^1\otimes \wedge^0\R^2$, we have that, for $i=1,2$: \[ i_{\dif f_i} (\tilde{a}^{-1} \circ h_{\F}\circ \delta(\epsilon(g_1,g_2)))=0.\] By definition of $\tilde{a}^{-1}$ in \eqref{eq: tilde b} and of $\epsilon$ we get for the first term \begin{equation}\label{eq: deg 1 top part} \tilde{a}^{-1} (\epsilon(g_1,g_2))= g_2\circ f\cdot V_1+g_1\circ f\cdot V_2. \end{equation} By using \eqref{eq:v transversality}, we conclude that $I^1(g_1,g_2)$ acts on $C^{\infty}(\C)$ as: \[g_2\cdot \partial_x+ g_1\cdot \partial_y=\frac{1}{2|z|}(g_1\cdot Y_1+ g_2\cdot Y_2),\] where in the last step we used the relation \eqref{eq: definition M} defining $\mathcal{M}$. In degree $3$ we want to show that every class in $H^3(\spl,\pi)$ is uniquely associated to $(g_1,[g_2])\in C^{\infty}(\C)\oplus C^{\infty}(\C)/C^{\infty}_0(\C)$ via: \[[g_1\circ f\cdot C_{\mathcal{R}}+g_2\circ f \cdot C_{\mathcal{I}}] \in H^3(\spl,\pi).\] Note that by Proposition \ref{ses smooth formal} and the formal Poisson cohomology in Proposition \ref{formal cohomology sl2} we only need to show that any flat cohomology class is uniquely determined by a $g\in C^{\infty}_0(\C)$ via \[[g\circ f\cdot C_{\mathcal{R}}] \in H^3_0(\spl,\pi).\] To obtain this result we note that the cocycle $C_{\mathcal{R}}$ satisfies for $i=1,2$ that \begin{align}\label{eq: max trans 3} i_{\dif f_i} (C_{\mathcal{R}})= \pi_i. \end{align} Hence the only non-trivial parts of $\tilde{a}(C_{\mathcal{R}})$ are in bi-degrees $(2,1)$ and $(3,0)$, see \eqref{eq: complex diag}. Moreover, using the relations: \begin{align}\label{eq: bivector to forms} \tilde{\omega}_1^{\flat}(\pi_1)= -\tilde{\omega}_1 \quad \textrm{ and } \quad \tilde{\omega}_1^{\flat}(\pi_2)= \tilde{\omega}_2, \end{align} which can be checked directly, we obtain: \begin{align*} \big(\tilde{a}(g\circ f\cdot C_{\mathcal{R}})\big)^{(2,1)}=&\, \tilde{a}(g\circ f\cdot (V_1\wedge \pi_1 +V_2\wedge \pi_2))\\ =& \, g\circ f\cdot e_{\varphi}\big(-\tilde{\omega}_1\otimes e_1 + \tilde{\omega}_2\otimes e_2\big) \end{align*} Applying the map $\tilde{p}$ from Corollary \ref{corollary: homotopy} we note that the only non trivial part is the $(2,1)$-part (see \eqref{eq: diagram}). Hence we get using \eqref{eq: iso degree 3} that \begin{align*} \tilde{p}\circ \tilde{a}(g\circ f\cdot C_{\mathcal{R}})=&\, p_{\F}\otimes \id\big(g\circ f\cdot e_{\varphi}(-\tilde{\omega}_1\otimes e_1 + \tilde{\omega}_2\otimes e_2)\big)\\ =&\, -g\circ f \cdot b_1 =\epsilon(-g). \end{align*} Therefore the statement holds by Theorem \ref{main theorem}. Next we show that in degree $4$ we have an isomorphism: \[[X]\in H^1(\spl,\pi)\quad \leftrightarrow \quad [X\wedge C_\mathcal{R}]\in H^4(\spl,\pi).\] From \eqref{eq: deg 1 top part} and \eqref{eq: max trans 3} we get for $(g_1,g_2)\in \mathcal{M}$ that \[ i_{\dif f_1\wedge \dif f_2}(I(g_1,g_2)\wedge C_{\mathcal{R}})= g_2\circ f\cdot \pi_2- g_1\circ f\cdot \pi_1 \] and therefore using \eqref{eq: bivector to forms}, Corollary \ref{corollary: homotopy} and \eqref{eq: iso degree 4} we obtain \[ \tilde{p}\circ \tilde{a}(I(g_1,g_2)\wedge C_{\mathcal{R}})=\epsilon(g_1,g_2),\] which implies the claim by Theorem \ref{main theorem}. Finally, we prove the relation \[[[X,C_{\mathcal{R}}]]=[[X,C_{\mathcal{I}}]]=0\in H^3(\spl,\pi)\] for any $[X]\in H^1(\spl,\pi)$. For the proof we need the following lemma. {\color{red} \begin{lemma}\label{lemma: second differential} The bracket $[\pi_2,\cdot]$ corresponds under $\tilde{p}\circ \tilde{a}$ to a map $\tilde{\delta}_2$ {\color{red} induced by $\tilde{a}\circ \dif_{\pi_{2}}\circ \tilde{a}^{-1}$} on the complex $p_{\F}(\CC)\otimes \wedge \R^2$, which is in degree $(0,1)\to (2,0)$ given by \begin{align*} e_{\varphi}(g\circ f)\otimes e_i&\mapsto \frac{1}{2\nf} p_{\F}(e_{\varphi}(g\circ f)\wedge \tilde{\omega}_{3-i})\otimes 1 \end{align*} \end{lemma} {\color{red} why is there an induced differential on $p_{\F}(\CC)\otimes \wedge \R^2$??} \begin{proof} We apply the discussion in Section \ref{section: Poisson cohomology in terms of foliated cohomology} and Section \ref{section: perturbation Lemma} to the Lie algebroid associated with $\pi_2$ and the splitting $\tilde{\omega}_2$. In particular, these yields isomorphism $\tilde{a}_2$ and $\tilde{b}_2$ from Proposition \ref{proposition:PCH as forms}. Lemma \ref{lemma: second differential degree one} implies that the map $\tilde{\delta}_2$ induced by $\dif_{\pi_2}$ under these identifications is on $p_{\F}(\CC)\otimes\wedge\R^2$ given by \begin{align*} e_{\varphi}(g\circ f)\otimes e_i&\mapsto -\frac{1}{2\nf} p_{\F}(e_{\varphi}(g\circ f)\wedge \tilde{\omega}_{3-i})\otimes 1 \end{align*} To obtain the result note that for any $g\in C^{\infty}_0(\C)$ and $i=1,2$ we have \[ \tilde{p}\circ \tilde{a}\circ \dif _{\pi_2}(g\circ f\cdot V_i)=\tilde{\delta}_2(e_{\varphi}(g\circ f)\otimes e_i). \] Moreover, for a flat vector field $T$ which is tangent to the foliation we obtain that \[ \tilde{p}\circ \tilde{a} \] This is equivalent to show that \begin{align*} \tilde{\omega}_1^{\flat}\circ \pi^{\sharp}_2 (\tilde{\omega}_i)=-\tilde{\omega}_i \qquad \text{for }i=1,2. \end{align*} which follows from \eqref{eq: bivector to forms} and \begin{equation*} \tilde{\omega}_2^{\flat}(\pi_1)= \tilde{\omega}_1 \quad \textrm{ and } \quad \tilde{\omega}_2^{\flat}(\pi_2)= -\tilde{\omega}_2.\qedhere \end{equation*} \end{proof} To show that the first bracket is trivial in cohomology note that using \eqref{eq: deg 1 top part} and \eqref{eq: max trans 3} we obtain \begin{align*} \iota_{\dif f_j}([I^1(g_1,g_2),-C_{\mathcal{R}}])=&\ -\sum_{i=1}^2\partial_ig_{3-j} \circ f\cdot \pi_i+ g_{3-i} \circ f\cdot [\pi_j,V_i] \end{align*} To obtain the corresponding cohomology class we look at its image in $p_{\F}(\CC^2)\wedge^1\R^2$ using $\tilde{a}$ from Proposition \ref{proposition:PCH as forms} and $\tilde{p}$ from Corollary \ref{corollary: homotopy}. We obtain for the image the expresssion \begin{align*} -\sum_{i,j=1}^2(-1)^{i}\partial_ig_{3-j} \circ f\cdot e_{\varphi}(p_{\F}(\tilde{\omega}_i))\otimes e_j+g_{3-i} \circ f\cdot \tilde{\delta}_j(e_i)\otimes e_j \end{align*} where $\tilde{\delta}_1=\tilde{\delta}$ and $\tilde{\delta}_2$ are the maps from Lemma \ref{lemma: second differential degree one} and Lemma \ref{lemma: second differential}, respectively. Using the formulas for $\tilde{\delta}_j$ for $j=1,2$ and the identification in the proof of Lemma \ref{lemma: trivial module 3} we obtain for the sum of the second term that \begin{align*} -\frac{xg_2+yg_1}{2|z|^2} \circ f\cdot b_1 -\frac{xg_1-yg_2}{2|z|^2} \circ f\cdot b_2 &\, \overset{\eqref{eq: projection m}}{=}\sum_{i=1}^2(-1)^{i+1}\frac{g_{3-i}}{2|z|}\circ f \cdot b_i \end{align*} For the sum over the first term we use the identifications from the proof of Lemma \ref{lemma: trivial module 3} to obtain the expression \begin{align*} \frac{1}{2\nf}\cdot\sum_{i=1}^2&\, \Big(\frac{|z|+x}{y}\Big)^{2-i} \big( y\partial_x +(|z|-x)\partial_y\big) g_{3-i}\circ f \cdot b_1 \\ + \frac{1}{2\nf}\cdot\sum_{i=1}^2&\, (-1)^{i}\Big(\frac{|z|+x}{y}\Big)^{i-1} \big( y\partial_x +(|z|-x)\partial_y\big) g_{3-i}\circ f \cdot b_2 \end{align*} Note that the $b_2$-term is trivial in cohomology. For the $b_1$-term we use that $(g_1,g_2)\in \mathcal{M}$ and the explicit formula for the projection $p_{\mathcal{M}}$ in \eqref{eq: projection m} to obtain \begin{align} (|z|+x)\partial_x g_2 =&\ \frac{y}{|z|^2}\cdot \Big( xg_1 -yg_2 \Big) -y\partial_x g_1\label{eq: differentiate in M1}\\ (|z|-x)\partial_y g_1 =&\, -\frac{x}{|z|^2}\cdot \Big( yg_1 +xg_2 \Big) -y\partial_y g_2\label{eq: differentiate in M2} \end{align} which implies that the first bracket in (????) is zero. For the second bracket we first note that we have \begin{align* i_{\dif f_1} (C_{\mathcal{I}})= \pi_2 \quad\text{ and }\quad i_{\dif f_2} (C_{\mathcal{I}})= -\pi_1. \end{align*} Therefore, we argue as for $C_{\mathcal{R}}$ to obtain \begin{align*} (p_{\F}\otimes \id)\circ \tilde{a}(g\circ f \cdot C_{\mathcal{I}})=&\, g\circ f \cdot b_2 \end{align*} for any $g\in C^{\infty}_0(\C)$. and the following lemma. A similar computation yields that the second bracket is zero. } \section*{Introduction to Part II} The Nash-Moser method, developed in \cite{Nash} and \cite{Mosera,Moserb}, is a powerful tool for solving PDEs, which can be understood as an inverse function theorem for non-linear differential operators whose linearization is invertible, but the inverse ``loses derivatives''. In order to apply the Nash-Moser method to the problem of linearization for Poisson structures with linear part corresponding to a Lie algebra $\g$, as was done by Conn in the compact semisimple case \cite{Conn85}, one would need linear operators: \begin{align}\label{eq: homotopy maps:general:Lie algebra} \mathfrak{X}^1( \overline{B}_R) \xleftarrow{h^1} \mathfrak{X}^2( \overline{B}_R)\xleftarrow{h^2}\mathfrak{X}^3( \overline{B}_R), \end{align} where $\overline{B}_R\subset \g^*$ is the closed ball of radius $R>0$ around the origin, which satisfying the homotopy equation: \begin{align}\label{eq: homotopy relation} W = h^2\circ \dif_{\pi_{\g}}(W) +\dif_{\pi_{\g}}\circ h^1(W), \end{align} for all $W\in \mathfrak{X}^2(\overline{B}_R)$, and, for some fixed $d\in \N_0$, inequalities of the sort: \begin{align}\label{eq: tame estimate} \norm{h^{i}(W)}_{n,R}\le C\cdot \norm{W}_{n+d,R}, \end{align} for all $W\in \mathfrak{X}^{i+1}(\overline{B}_R)$, all $n\in \N_0$ and some constants $C=C(n)$. Here $\norm{\cdot}_{n,R}$ are usual $C^n$-norms on multivector fields on $\overline{B}_R$. These types of estimates are standard for applying the Nash-Moser method; see e.g.\ \cite{Ham}, where they are called ``tame'' estimates. In Theorem C of Part I of the paper, we constructed explicit homotopy operators for the Lie algebra $\spl$. In contrast to the compact semisimple case from Conn's paper, our operators are defined only on the subcomplex of multivector fields that are flat at the origin: \begin{align}\label{eq: homotopy maps} \mathfrak{X}^1_0( \mathfrak{sl}_2(\C)^*) \xleftarrow{h^1} \mathfrak{X}^2_0( \mathfrak{sl}_2(\C)^*)\xleftarrow{h^2}\mathfrak{X}^3_0( \mathfrak{sl}_2(\C)^*) \end{align} These still satisfy the homotopy relation \eqref{eq: tame estimate}, for all flat bivector fields $W\in \mathfrak{X}^{i+1}_0( \mathfrak{sl}_2(\C)^*)$. Moreover, as shown in Part I, they satisfy the SLB property, meaning that they induced homotopy operators on the balls of radius $R>0$: \begin{align}\label{eq: homotopy maps for r} \mathfrak{X}^1_0(\overline{B}_R) \xleftarrow{h^1} \mathfrak{X}^2_0( \overline{B}_R)\xleftarrow{h^2}\mathfrak{X}^3_0( \overline{B}_R), \end{align} which satisfy, for some integers $a,b,c\in \N_0$, estimates of the following type: \begin{align}\label{eq: property H estimate} |h^i(W)|_{n,k,R}\le C\, |W|_{n+a,k+bn+c,R}, \end{align} for all $W\in \mathfrak{X}^{i+1}(\overline{B}_R)$ and all $n,k\in \N_0$, where $C=C(R,n,k)$ depends continuously on $R$. The double-indexed norms $|\cdot|_{n,k,R}$ are natural to the space of multivector fields that are flat at the origin, and are defined as a type of weighted $C^n$-norms: \begin{align}\label{eq: flat norms 2} |W|_{n,k,R}:= \norm{\frac{1}{|x|^k}W}_{n,R}, \end{align} for $W\in \mathfrak{X}^{i}_0(\overline{B}_r)$. We will show in Subsection \ref{subsec: equivalent seminorms}, that these norms are equivalent to the norms $\fnorm{\cdot}_{n,k,R}$, defined in Part I. The main result of Part II is the following linearization result for Poisson structures with linear Taylor expansion: \begin{theorem}\label{theorem: rigidity:qualitative} Let $(\mathfrak{g}^*,\pi_{\mathfrak{g}})$ be the linear Poisson structure associated to the Lie algebra $\mathfrak{g}$. Assume that, for some closed ball $\overline{B}_R\subset \mathfrak{g}^*$ around 0, there exist linear operators on the flat Poisson complex over $\overline{B}_R$, as in \eqref{eq: homotopy maps for r}, satisfying the homotopy relation \eqref{eq: homotopy relation} and the estimates \eqref{eq: property H estimate}, for some integers $a,b,c\in \N_0$. Then for any Poisson structure $\pi$ defined on $\overline{B}_R$ and satisfying \[ j^{\infty}_0(\pi-\pi_{\mathfrak{g}})=0,\] there exists $r>0$ and an open Poisson embedding \[ \Phi: (B_r,\pi)\hookrightarrow (B_R,\pi_{\mathfrak{g}})\] such that $\Phi(0)=0$ and $j^{\infty}_0(\Phi-\id)=0$. \end{theorem} In Section \ref{section: flat linearization} we will use Theorem C from Part I, Theorem \ref{theorem: rigidity:qualitative}, and Weinstein's formal linearization theorem for semisimple Lie algebras \cite{Wein83}, to deduce Theorem A in Part I, i.e., that $\spl$ is a Poisson non-degenerate Lie algebra. Of course, the same argument implies Conn's theorem \cite{Conn85}, and can be used for any semisimple Lie algebra $\g$ for which the Poisson linearization question is still open (see the Introduction to Part I), provided the second Poisson cohomology of $\g^*$ vanishes and one can construct homotopy operators on its flat Poisson complex that satisfy estimates of the type \eqref{eq: property H estimate}. \medskip We will use the Nash-Moser method to prove Theorem \ref{theorem: rigidity}, which is a quantitative and stronger version of Theorem \ref{theorem: rigidity:qualitative}. For this, we had to make specific adaptation of the method, which we explain here. First, note that the estimates \eqref{eq: property H estimate} together with the trivial estimates $|\cdot|_{n,k,r}\leq \norm{\cdot}_{n+k,r}$ (Corollary \ref{corollary: degree shift}) imply that, for some $p$ and $d$, our operators satisfy: \begin{align}\label{eq: bad estimate} \norm{h^{i}(W)}_{n,r} \le C\cdot \norm{W}_{p\cdot n +d,r}. \end{align} It has been shown in \cite{LoZe} that the Nash-Moser method still works under these assumptions for $p<2$, and that the method fails for $p\geq 2$, which unfortunately is the case for us. In order to make better use of inequalities \eqref{eq: property H estimate}, note that the loss of derivatives is ``tame'' in $n$, but the price we have to pay is accumulated in the weight $k$. We manage to use the Nash-Moser method as in \cite{LoZe} for the estimates of the form \eqref{eq: property H estimate} by using the following idea. For a large $q$, if we consider the family of norms \[ \oldnorm{W}_{n,r}:=|W|_{n,q\cdot n,r},\] then the estimates \eqref{eq: property H estimate} imply estimates of type \eqref{eq: bad estimate}: \[\oldnorm{ h^{i}(W)}_{n,r} \le C\cdot \oldnorm{ W}_{p\cdot n +d,r}, \] where $p\in (1,2)$, as in \cite{LoZe} (e.g.\ $p=\tfrac{3}{2}$, for $q=2b$, $d=a+c$). The other crucial ingredient in the Nash-Moser method is the use of a family of smoothing operators $\{S_{t}\}_{t>1}$ which approximate the identity operator when $t\to \infty$. In the classical setting, such operators are obtained by convolution with mollifiers, and their construction goes back to the work of Nash \cite{Nash}. However, the smoothing operators we found in the literature do not preserve the space of flat functions. We managed to construct smoothing operators which do preserve flatness by making use of the following observation: under the inversion map, $x\mapsto x/|x|^2$, flatness at $0$ corresponds to Schwartz-like behavior at infinity. In Appendix \ref{section: functional analysis} we build a 2-parametric family of smoothing operators corresponding to the 2-parametric family of weighted norms \eqref{eq: flat norms 2} on flat multivector fields. \medskip The Nash-Moser method for flat functions, developed in the paper, should be useful in many other settings. For example, several local form problems in differential geometry can be split into a formal part and a flat part. The formal problem is at the level of formal power series, and can often be treated using algebraic methods. The flat problem is of an analytic nature, and can potentially be approached with the tools developed here. \section{A quantitative linearization theorem}\label{section: flat linearization} First, we show how to obtain the main result of this paper, namely that $\spl$ is Poisson non-degenerate, from the results of Part I and Theorem \ref{theorem: rigidity:qualitative}: \begin{proof}[Proof: (Theorem C $+$ Theorem \ref{theorem: rigidity:qualitative}) $\implies$ Theorem A] Since $\spl$ is semi\-simple, $\pi_{\spl}$ is formally non-degenerate \cite[Theorem 6.1]{Wein83}. Theorem C provides the homotopy operators needed to apply Theorem \ref{theorem: rigidity:qualitative}, and obtain Theorem A. \end{proof} Note that Theorem \ref{theorem: rigidity:qualitative} gives no information about the size of the ball on which the Poisson structure $\pi$ is linearizable. Below we give a more quantitative version of the result, which states that the size of this ball can be predetermined, if $\pi$ is close enough to $\pi_{\mathfrak{g}}$. It will be this version of the theorem that we will prove with the Nash-Moser technique. \begin{theorem}\label{theorem: rigidity} Under the assumptions of Theorem \ref{theorem: rigidity:qualitative} the following holds. There exists $N\geq 0$ such that for any $r\in (0,R)$ there exists $\delta(r)>0$ such that for every Poisson structure $\pi$ on $\overline{B}_R$ satisfying \[ j^{\infty}_0(\pi-\pi_{\mathfrak{g}})=0 \ \ \ \ \ \text{ and } \ \ \ \ \ \norm{\pi-\pi_{\mathfrak{g}}}_{N,R}\le \delta(r),\] there exists an open Poisson embedding \[ \Phi: (B_r,\pi)\hookrightarrow (B_R,\pi_{\mathfrak{g}})\] satisfying $\Phi(0)=0$ and $j^{\infty}_0(\Phi-\id)=0$. \end{theorem} We show now that it will be sufficient to prove this result: \begin{proof}[Proof: Theorem \ref{theorem: rigidity} $\implies$ Theorem \ref{theorem: rigidity:qualitative}] Let $m_t:\overline{B}_{R}\to \overline{B}_{t R}$ denote scalar multiplication by $t>0$, i.e.\ $m_t(x):=tx$. For $t\in (0,1]$, define a path of Poisson bivectors $\pi_t\in \mathfrak{X}^2(\overline{B}_R)$ via \[ \pi_t:= t\cdot m_{t}^*\pi.\] Note that the path extends smoothly at $t=0$ with $\pi_0=\pi_{\mathfrak{g}}$. By continuity, there exists a $t>0$ such that \[ \norm{\pi_{t}-\pi_{\mathfrak{g}}}_{N,R}\le \delta(R/2) .\] Therefore, by Theorem \ref{theorem: rigidity} for $r=R/2$, there exists an open embedding $\Phi:B_{R/2}\hookrightarrow B_{R}$ such that $\Phi^*(\pi_{t})=\pi_{\g}$. Using linearity of $\pi_{\g}$ we have: \[ \pi_{\g}=\frac{1}{t} m^*_{\frac{1}{t}}\pi_{\g}=\frac{1}{t}m_{\frac{1}{t}}^*(\Phi^*(t\cdot m_t^*(\pi)))=(m_t\circ \Phi\circ m_{\frac{1}{t}})^*(\pi).\] Hence we obtain an open Poisson embedding \[ m_{t} \circ \Phi \circ m_{\frac{1}{t}}:(B_{tR/2},\pi_{\g})\hookrightarrow (B_{tR},\pi)\] which fixes the origin to infinite order. \end{proof} The homotopy operators described in the following remark will be used in the proof of Theorem \ref{theorem: rigidity}. \begin{remark}\label{remark: homotopy ops} Theorems \ref{theorem: rigidity:qualitative} and \ref{theorem: rigidity} assume the existence of homotopy operators only on the ball $\overline{B}_R$. However, because the Poisson structure is linear, by using rescaling, we obtain homotopy operators on each ball of radius $r>0$: \begin{align* \mathfrak{X}^1_0(\overline{B}_r)\xleftarrow{h^1_r} \mathfrak{X}^2_0(\overline{B}_r)\xleftarrow{h^2_r} \mathfrak{X}^3_0(\overline{B}_r) \end{align*} where \begin{align}\label{eq: homotopy on general ball} h^i_r:= \frac{r}{R}\cdot m^*_{\frac{R}{r}}\circ h^i\circ m^*_{\frac{r}{R}}. \end{align} These operators also satisfy inequalities as in the statement, with constants $C(n,k,r)$ depending continuously on $r>0$. Note however that these operators might not satisfy the SLB, because they are not necessarily compatible with the restriction maps, i.e., $h^{i}_r(W|_r)$ might be different from $h^i_R(W)|_r$, for $W\in \mathfrak{X}^{i+1}_0(\overline{B}_R)$ and $R>r$. \end{remark} \section{The sketch of the Nash-Moser algorithm}\label{section: flat NM} We explain schematically the algorithm. Given $\pi$, our aim is to find a diffeomorphism $\Phi$ such that $\Phi^*(\pi)=\pi_{\g}$. Consider the map \begin{equation*} \begin{array}{ccc} (\pi_{\mathfrak{g}}+\mathfrak{X}^2_0(\g^*))\times \mathfrak{X}^1_0(\g^*)& \to & \mathfrak{X}^2_0(\g^*) \\ (\pi=\pi_{\mathfrak{g}}+Z,X)&\mapsto &\phi_X^*(\pi)-\pi_{\g} \end{array} \end{equation*} where $\phi_X$ denotes the time-one flow of $X$. We think about the problem as follows: given $Z$ we need to find $X$ which minimizes the output of this map. For the sake of this argument, we assume that we work in a Banach space with norm $|\cdot |$. Moreover, we assume that $Z$ is small in this norm, and we are looking for an $X$ which is also small. We denote this schematically as: \[ |Z|\leq \mathcal{O}(\epsilon),\qquad |X|\leq \mathcal{O}(\epsilon).\] Then the pullback along the flow $\phi_X$ can be expanded as: \[ \phi_X^*=\id +\Lie_X +\mathcal{O}(\epsilon^2).\] This allows us to estimate \begin{align*} |\phi_X^*(\pi)-\pi_{\mathfrak{g}}|\le &\ |\phi_X^*(\pi_{\mathfrak{g}})-\pi_{\mathfrak{g}}-\Lie_X \pi_{\mathfrak{g}}|+|\phi_X^*(Z)-Z|+|Z-\dif_{\pi_{\mathfrak{g}}}X|\\ \le &\ |Z-\dif_{\pi_{\mathfrak{g}}}X| +\mathcal{O}(\epsilon^2). \end{align*} The cohomological flavour of the problem is now evident: we would like to find a ``primitive'' of $Z$. Assume that $H^2(\g^*,\pi_{\g})=0$, and that we have continuous homotopy operators $h^i:\mathfrak{X}_0^{i+1}(\g^*)\to \mathfrak{X}_0^i(\g^*)$, $i=1,2$. Then $X:=h^1(Z)$ satisfies $X\in \mathcal{O}(\epsilon)$ and \begin{align*} Z-\dif_{\pi_{\mathfrak{g}}}X=&\ Z-\dif_{\pi_{\mathfrak{g}}}h^1(Z) = h^2([\pi_{\mathfrak{g}},Z]) =-\frac{1}{2}h^2([Z,Z])\in \mathcal{O}(\epsilon^2), \end{align*} where we used the homotopy relation and we have rewritten the Poisson equation for $\pi=\pi_{\mathfrak{g}}+Z$ as a Maurer-Cartan equation for $Z$: \[ [\pi,\pi]=0 \ \ \ \ \Leftrightarrow \ \ \ \ \dif_{\pi_{\mathfrak{g}}}Z+\frac{1}{2}[Z,Z]=0.\] This allows us to conclude that \begin{align*} |\phi_X^*(\pi)-\pi_{\mathfrak{g}}|\le \mathcal{O}(\epsilon^2). \end{align*} We define the following algorithm \[ \pi_{i+1}:=\phi_{X_{i}}^*(\pi_{i}) \ \ \ \ \ \text{ with } \ \ \ X_i:=h^1(\pi_i-\pi_{\mathfrak{g}}). \] From the discussion above we obtain \[ |\pi_{i+1}-\pi_{\mathfrak{g}}|\le C\, \epsilon^{2^i} \ \ \ \ \ \text{ and } \ \ \ \ \ \sum_{i\geq 0} |X_i|< \infty. \] Therefore $\Phi:= \phi_{X_0}\circ\phi_{X_1} \circ \dots$ converges to a diffeomorphism satisfying \[\Phi^*(\pi)=\pi_{\mathfrak{g}}.\] To implement this algorithm for smooth flat functions, several problems need to be overcome. First, the flows will be defined only on smaller domains, so we need to decrease the size of the balls in every step in a controlled way. The second problem is that, instead of Banach spaces, we work with the Fr\'echet space of flat functions, with the family of norms $\fnorm{\cdot}_{n,k,r}$. In order to compensate for the ``loss of derivatives'' in the estimate \eqref{eq: property H estimate} of the homotopy operator, we modify the iteration using a version of Nash's smoothing operators adapted to the flat setting. \section{Prerequisites}\label{section: prerequisits} The purpose of this section is to establish all the tools needed for the Nash-Moser method. Namely, we give estimates for the Schouten-Nijenhuis bracket, for the flow of vector fields and for the pullback operation via flows. Throughout this section $B_r\subset \R^m$ denotes the open ball of radius $r$ at the origin, and $\overline{B}_r$ its closure. On the Fr\'echet space $\mathfrak{X}^{\bullet}(\overline{B}_r)$ of multivector fields on $\overline{B}_r$, we use standard $C^n$-norms $\norm{\cdot}_{n,r}$, and on the Fr\'echet space of multivector fields flat at the origin $\mathfrak{X}^{\bullet}_0(\overline{B}_r)$, we use the norms $\fnorm{\cdot}_{n,k,r}$ recalled in Appendix \ref{subsec: equivalent seminorms}. We use the notation for partial derivatives $D^a$, $a\in \N_0^m$, from Appendix B in Part I. A useful tool is the following trivial inequality: \begin{align}\label{eq: convex} x^{\lambda}y^{1-\lambda}\le &\ x+y \ \ \ \ \text{ for }\ x,y\in [0,\infty) , \ \lambda\in [0,1] \end{align} \subsection{The Schouten-Nijenhuis bracket} We begin with the estimates for the Schouten-Nijenhuis bracket of (flat) multivector fields with respect to the weighted norms: \begin{lemma}\label{lemma: SN} The Schouten-Nijenhuis bracket satisfies the estimate \begin{align*} \fnorm{[V,W]}_{n,k+l,r}\le &\ C (\fnorm{V}_{0,k,r}\fnorm{W}_{n+1,l,r}+\fnorm{V}_{n+1,k,r}\fnorm{W}_{0,l,r}) \end{align*} for all $V,W\in\mathfrak{X}^{\bullet}_0(\overline{B}_r)$ and $k,l,n\in \N_0 $, with constants $C=C(n,k,l,r)>0$ depending continuously on $r>0$. The inequality also holds for $W\in\mathfrak{X}^{\bullet}(\overline{B}_r)$, if we take $l=0$. \end{lemma} \begin{proof} For $V\in\mathfrak{X}^{\bullet}_0(\overline{B}_r)$, $W\in\mathfrak{X}^{\bullet}(\overline{B}_r)$ and $a\in \N_0^m$ with $|a|=n$, we have \begin{align*} \frac{|D^{a}[V,W](z)|}{|z|^{k+l}} \le &\ \sum_{|b_1| +|b_2|=n+1} \frac{|D^{b_1}V(z)|}{|z|^k}\frac{|D^{b_2}W(z)|}{|z|^l}. \end{align*} Using the interpolation inequalities in \eqref{eq: standard interpolation} and \eqref{eq: interpolation t} we have for $1\le i\le n$ \begin{align*} \fnorm{W}_{i,l,r}\le &\ C\fnorm{W}_{0,l,r}^{\frac{n+1-i}{n+1}}\fnorm{W}_{n+1,l,r}^{\frac{i}{n+1}}\\ \fnorm{V}_{n+1-i,k,r}\le &\ C\fnorm{V}_{n+1,k,r}^{\frac{n+1-i}{n+1}}\fnorm{V}_{0,k,r}^{\frac{i}{n+1}} \end{align*} Applying inequality \eqref{eq: convex}, these give the estimate from the statement \begin{align*} \fnorm{[V,W]}_{n,k+l,r}\le &\ C \sum_{i=0}^{n+1}\fnorm{V}_{n+1-i,k,r}\fnorm{W}_{i,l,r}\\ \le&\ C \sum_{i=0}^{n+1} (\fnorm{V}_{n+1,k,r}\fnorm{W}_{0,l,r})^{\frac{n+1-i}{n+1}}(\fnorm{V}_{0,k,r}\fnorm{W}_{n+1,l,r})^{\frac{i}{n+1}}\\ \le&\ C(\fnorm{V}_{0,k,r}\fnorm{W}_{n+1,l,r} +\fnorm{V}_{n+1,k,r}\fnorm{W}_{0,l,r})\qedhere \end{align*} \end{proof} \subsection{Estimates for flows in the flat setting} In this subsection we prove estimates for the pullback of (flat) multivector fields by flows of flat vector fields with respect to the weighted norms. The proof is based on the proof of \cite[Lemmas 3.10 and 3.11]{Marcut} which provide similar estimates for the usual $C^n$-norms. \begin{lemma}\label{lemma: flow} There exists $\theta>0$ such that for all $0<s<r$ and all flat vector fields $Y\in \mathfrak{X}^1_0(\overline{B}_r)$ with \[\norm{Y}_{0,r}<(r-s)\theta \quad \text{ and }\quad \norm{Y}_{1,r}<\theta \] the flow of $Y$ is well-defined for $t\in [0,1]$ as a map \[ \phi ^t_Y:\overline{B}_s\to B_r.\] Moreover, the following hold for all $n,k\in\N_0$: \begin{enumerate}[(a)] \item The time-one flow $\phi_Y:=\phi^1_Y$ satisfies: \[\norm{\phi_Y-\id}_{n,s} \le C \norm{Y}_{n,r}\] where $C=C(n,r)$ depends continuously on $r$. \item The pullback along $\phi_Y$ of flat multivector fields satisfies: \begin{align*} \fnorm{\phi_Y^*(V)}_{n,k,s} \le &\ C (\fnorm{V}_{n,k,r}+\fnorm{V}_{0,k,r}\norm{Y}_{n+1,r} ) \end{align*} for all $V\in \mathfrak{X}_0^{\bullet}(\overline{B}_r)$, where $C=C(k,n,r)$ depends continuously on $r$. \item For any multivector field $W\in \mathfrak{X}^{\bullet}(\overline{B}_r)$ we have the following inequalities: \begin{align*} \fnorm{\phi_Y^*(W)-W|_{\overline{B}_s}}_{n,k,s} \le \ C_W & (\fnorm{Y}_{n+1,k,r}+\fnorm{Y}_{1,k,r}\norm{Y}_{n+1,r})\\ \le \ C_W & \fnorm{Y}_{n+1,k,r}(1+\norm{Y}_{n+1,r})\\ \fnorm{\phi_Y^*(W)-W|_{\overline{B}_s}-\phi_Y^*([Y,W])}_{n,k,s}&\leq\\ \leq\ C_W ( \fnorm{Y}_{n+1,k,r}&\norm{Y}_{1,r} +\fnorm{Y}_{1,k,r}\norm{Y}_{n+2,r}) \end{align*} where $C_W=C_W(k,n,r)$ depends continuously on $r$, and also on $W$. \end{enumerate} \end{lemma} \begin{remark} There are sharper versions for the estimates in item (c) in the lemma, which give a precise dependence on $W$; for example: \begin{align*} \fnorm{\phi_Y^*(W)-W|_{\overline{B}_s}}_{n,k,s} \le \ C (\fnorm{Y}_{n+1,k,r}\norm{W}_{0,r}&+\fnorm{Y}_{0,k,r}\norm{W}_{n+1,r}\\ \ \ \ \ \ +\fnorm{Y}_{1,k,r}\norm{W}_{1,r}&\norm{Y}_{n+1,r}). \end{align*} However, for our purposes the estimates in the lemma will be sufficient. \end{remark} \begin{proof} By \cite[Lemma 3.10]{Marcut}, there exists $\theta>0$ such that item (a) holds. For such a $\theta$, let $Y$ satisfy the assumptions and write its flow as \[ \phi_Y:= \id +g_Y:\overline{B}_s\to B_r\] To show the estimate in (b) let $V\in \mathfrak{X}_0^{p}(\overline{B}_r)$ for some $p\in \N_0$. Write $V=V^J\partial_J$, where this sum runs over all $J=\{1\leq j_1<\ldots< j_p\leq m\}$ and $\partial_J=\partial_{j_1}\wedge \ldots \wedge \partial_{j_p}$. The pullback $\phi_Y^*(V)$ can be written as \[ \phi_Y^*(V)|_x=V^J(x+g_Y(x))\phi^*_Y(\partial_J)|_x\] Using Cramer's rule, there exists polynomials $Q_J^I$ such that \[\phi^*_Y(\partial_J)|_x= Q_J^I(\dif g_Y(x))\det (\id +\dif g_Y(x))^{-p}\partial_I|_x.\] Hence we get the expression \[\phi_Y^*(V)|_x=V^J(x+g_Y(x))Q_J^I(\dif g_Y(x))\det (\id +\dif g_Y(x))^{-p}\partial_I|_x\] For $a\in \N_0^m$ with $n=|a|$ we can estimate $D^{a}\phi_Y^*(V)|_x$ by estimating the coefficients \[ D^{a}(V^J\big(x+g_Y(x))Q_J^I(\dif g_Y(x))\det (\id +\dif g_Y(x))^{-p}\big)\] for any $I$ and $J$. Such a term is a sum of elements of the form: \begin{equation}\label{eq: derivative multivector} \begin{array}{rcl} D^{b}(V^J)(x+g_Y(x))D^{b^1}(g_Y)(x)\dots D^{b^q}(g_Y)(x)\det (\id +\dif g_Y(x))^{-\tilde{p}} \end{array} \end{equation} with coefficients depending only on $a$, and with indices satisfying: \[ 0\le q ,\ \ \ p\le \tilde{p},\ \ \ 1\le |b^i| , \ \ \ |b| +\sum_{i=1}^q (|b^i|-1)=n\] By (a) we have $\norm{g_Y}_{1,s}\le C \cdot \theta $, and hence, by possibly shrinking $\theta$, we have \[ \det (\id + \dif g_Y(x))^{-1} \le 2.\] Next, note that by the Taylor expansion formula we get \[|\phi_Y(x)|\le |x|C(1+\norm{g_Y}_{1,s})\le C|x|. \] and so for $x\ne 0$ we obtain \[ \frac{1}{|x|}\le \frac{C}{|\phi_Y (x)|}.\] Hence after dividing \eqref{eq: derivative multivector} by $|x|^k$ we can bound the terms there by \[ C \sum_{j,j_1,\dots j_q}\fnorm{V}_{j,k,r}\norm{g_Y}_{j_1+1,s}\dots \norm{g_Y}_{j_q+1,s}\] where the indices $j\geq 0$ and $j_i\geq 0$ satisfy \[j+j_1+\ldots +j_q=n.\] For the terms with $q>0$ we apply first (a) and then the interpolation inequality \eqref{eq: standard interpolation} to each $\norm{Y}_{j_l+1,r}$ and obtain: \[ \fnorm{\phi_Y^*(V)}_{n,k,s}\le C\Big(\fnorm{V}_{n,k,r} +\sum_{j=0}^{n}\fnorm{V}_{j,k,r}\norm{Y}_{n-j+1,r}\Big).\] By applying \eqref{eq: interpolation t} to $\fnorm{V}_{j,k,r}$ and \eqref{eq: standard interpolation} to $\norm{Y}_{n-j+1,r}$ we get \begin{equation*} \begin{array}{rcl} \fnorm{V}_{j,k,r}&\le &C \fnorm{V}_{0,k,r}^{1-\frac{j}{n}}\fnorm{V}_{n,k,r}^{\frac{j}{n}}\\ \norm{Y}_{n+1-j,r}&\le &C \norm{Y}_{1,r}^{\frac{j}{n}}\norm{Y}_{n+1,r}^{1-\frac{j}{n}}\ \le\ C\norm{Y}_{n+1,r}^{1-\frac{j}{n}} \end{array} \end{equation*} Hence we get the estimate \begin{equation*} \begin{array}{rcl} \fnorm{V}_{j,k,r}\norm{Y}_{n-j+1}&\le &C ((\fnorm{V}_{0,k,r}\norm{Y}_{n+1,r})^{1-\frac{j}{n}}\fnorm{V}_{n,k,r}^{\frac{j}{n}}\\ &\stackrel{\eqref{eq: convex}}{\le} &C (\fnorm{V}_{n,k,r}+\fnorm{V}_{0,k,r}\norm{Y}_{n+1,r}) \end{array} \end{equation*} which implies (b). For (c) let $W\in\mathfrak{X}^p(\overline{B}_r)$ and denote by $W_t$ the multivector field \[ W_t:=(\phi_Y^t)^*(W)-W|_{\overline{B}_s}. \] Then we have $W_0 =0$, $W_1 =\phi_Y^*(W)-W|_{\overline{B}_s}$ and \[ \frac{\dif}{\dif t}W_t= (\phi_Y^t)^*([Y,W]).\] Therefore we can write \[ \phi_Y^*(W)-W|_{\overline{B}_s}=\int_0^1(\phi_Y^t)^*([Y,W])\dif t\] Since $Y$ is flat at the origin, so is $[Y,W]$ and hence (b) implies \begin{align*} \fnorm{\phi_Y^*(W)-W|_{\overline{B}_s}}_{n,k,s}\le&\ C (\fnorm{[Y,W]}_{n,k,r}+\fnorm{[Y,W]}_{0,k,r}\norm{Y}_{n+1,r}) \end{align*} Applying Lemma \ref{lemma: SN} yields the first inequalities \begin{align*} \fnorm{\phi_Y^*(W)-W|_{\overline{B}_s}}_{n,k,s}\le &\ C_W (\fnorm{Y}_{n+1,k,r}+\fnorm{Y}_{1,k,r}\norm{Y}_{n+1,r})\\ \le &\ C_W \fnorm{Y}_{n+1,k,r}(1+\norm{Y}_{n+1,r}) \end{align*} For the last inequality in (c) we introduce \[ W_t:=(\phi_Y^t)^*(W)-W|_{\overline{B}_s} -t(\phi_Y^t)^*([Y,W])\] Then $W_0 =0$, $W_1 =\phi_Y^*(W)-W|_{\overline{B}_s} -\phi_Y^*([Y,W])$ and \[ \frac{\dif}{\dif t}W_t= -t(\phi_Y^t)^*([Y,[Y,W]]).\] implying that \[ W_1 =-\int_0^1t(\phi_Y^t)^*([Y,[Y,W])\dif t\] Since $Y$ is flat at the origin, so is $[Y,[Y,W]]$. Hence (b) yields \begin{align*} \fnorm{W_1}_{n,k,s}\le &\ C(\fnorm{[Y,[Y,W]]}_{n,k,r}+\fnorm{[Y,[Y,W]]}_{0,k,r}\norm{Y}_{n+1,r}) \end{align*} Applying Lemma \ref{lemma: SN} to the brackets gives \begin{align*} \fnorm{[Y,[Y,W]]}_{n,k,r} \le &\ C_W (\fnorm{Y}_{n+1,k,r}\norm{[Y,W]}_{0,r}+\fnorm{Y}_{0,k,r}\norm{[Y,W]}_{n+1,r})\\ \le &\ C_W (\fnorm{Y}_{n+1,k,r}\norm{Y}_{1,r}+\fnorm{Y}_{0,k,r}\norm{Y}_{n+2,r})\\ \fnorm{[Y,[Y,W]]}_{0,k,r} \le &\ C_W \fnorm{Y}_{1,k,r}\norm{Y}_{2,r} \end{align*} By the standard interpolation inequality \eqref{eq: standard interpolation} we have \[\norm{Y}_{2,r}\norm{Y}_{n+1,r}\le C \norm{Y}_{n+2,r} \] and hence we obtain the last estimate in (c): \begin{align*} \fnorm{W_1}_{n,k,s} \le &\ C_W (\fnorm{Y}_{n+1,k,r}\norm{Y}_{1,r}+\fnorm{Y}_{1,k,r}\norm{Y}_{n+2,r})\qedhere \end{align*} \end{proof} \section{The algorithm}\label{section: welldefined} The aim of this section is to set up the algorithm underlying the proof of Theorem \ref{theorem: rigidity}. The algorithm is based on the fast convergence method by Nash-Moser as used by Conn \cite{Conn85} and later by the first author in \cite{Marcut}. Throughout this section we assume the setting of Theorem \ref{theorem: rigidity}. In the estimates below we will use $C$ to denote several different constants, arising from different estimates established so far (e.g., smoothing operator, homotopy operators, interpolation inequalities, estimates for the flow, etc.). In principle, these numbers depend continuously on the radius $\rho$ of the ball we are working on. However, since $\rho\in[r,R]$, we may ignore this dependence. \subsection{The definition of the algorithm} To define the algorithm we denote by $h^i_{\rho}$, for $i=1,2$ and ${\rho}\in [r,R]$ the homotopy operators from \eqref{eq: homotopy on general ball} on the flat Poisson complex in degree two. These satisfy the estimates \begin{align}\label{eq: homotopy family estimate flat} \fnorm{h^i_{\rho}(W)}_{n,k,{\rho}} &\le C\fnorm{W}_{n+a,k+bn+c,{\rho}}\nonumber \\ &\le C\fnorm{W}_{n+p-1,k+(p-1)n,\rho} \end{align} for all $W\in\mathfrak{X}^{i+1}_0(\overline{B}_{\rho})$, for some $C=C(n,k)$, where we have denoted: \[p:=\mathrm{max}(a+c+1,b+1,22),\] and have used Corollary \ref{corollary: degree shift}. We define the constants \begin{equation}\label{eq: parameters} \begin{array}{ccccccc} \begin{matrix} x_a:=p \\ y_a:= p^2 \end{matrix}& \qquad &\begin{matrix} x_b:=13 p \\y_b:= 13 p^2 \end{matrix}& \qquad &\begin{matrix} x_c:= 2p\\ y_c:= 130 p^2 \end{matrix} &\qquad &\alpha:= 50p^2. \end{array} \end{equation} For the given $0<r<R$ we define the sequences \[r_{i}:=r+\frac{R-r}{i+1},\quad t_{i}:=t_0^{(3/2)^i},\quad i\geq 0,\] where $t_0>1$ will be fixed later. Note that by choice of the $r_i$ we have \[ r<r_{i+1}<r_i\le R, \ \ \ \ \ \text{ for all } \ i\geq 0.\] We extend the smoothing operators $\{S_{t,s,r}\}_{0<r,t,s}$ from Subsection \ref{section:combined:smoothing} to flat vector fields, by applying them to coefficients. We define: \[S_i:=S_{t_i^{12p},t_i,r_i}:\mathfrak{X}^1_0(\overline{B}_{r_i})\to\mathfrak{X}^1_0(\overline{B}_{r_i}).\] Note that $1\le t_i$ for all $i\in \N_0$. Hence by Corollary \ref{corollary: smoothing flat functions} the operators $S_i$ satisfy, for $j,k,l,n\in\N_0$ and $X\in \mathfrak{X}_0(\overline{B}_{r_i})$, the estimates \begin{align} \fnorm{S_i(X)}_{n+l,k+j,r_i} \le &\ C \cdot t_i^{{12p}l+j} \fnorm{X}_{n,k+2 l,r_i}\label{eq: smoothing 1}\\ \fnorm{(S_i-\id)(X)}_{n,k+2l,r_i} \le &\ C \cdot (t_i^{-{12p}l} \fnorm{X}_{n+l,k,r_i}+t_i^{-j}\fnorm{X}_{n,k+2l+j,r_i})\label{eq: smoothing 2} \end{align} For the algorithm we define the sequences \[ \{X_i\in\mathfrak{X}^1_0(\overline{B}_{r_i})\}_{i\geq 0}, \ \ \ \ \ \ \{\pi_i\in \mathfrak{X}^2(\overline{B}_{r_i})\}_{i\geq 0}, \] by the following recursive procedure: \[ \pi_0:=\pi, \ \ \ \ \ Z_i:=\pi_i-\pi_{\g}|_{\overline{B}_{r_i}}, \ \ \ \ X_i:=S_i(h^1_{r_i}(Z_i)), \ \ \ \ \ \pi_{i+1}:=\phi_{X_i}^*(\pi_i).\] This is almost the iteration described in Subsection \ref{section: flat NM}, with the modifications that we have inserted the smoothing operators to account for the loss of derivatives, and the domains change from step to step. We will prove by induction the following statements: the flat bivector $Z_i\in \mathfrak{X}^2_0(\overline{B}_{r_i})$ satisfies the inequalities \begin{align} \fnorm{Z_i}_{x_a,y_a,r_i}&\, \le t_i^{-\alpha}\label{eq: ai}\tag{$a_i$}\\ \fnorm{Z_i}_{x_b,y_b,r_i}&\, \le t_i^{\alpha}\label{eq: bi}\tag{$b_i$}\\ \fnorm{Z_{i}}_{x_c,y_c,r_i}&\, \le t_i^{\alpha}\label{eq: ci}\tag{$c_i$}, \end{align} and, the time-one flow of $X_i$ is defined as a map \begin{equation}\label{eq: di} \phi_{X_i}:\overline{B}_{r_{i+1}}\to B_{r_i}\tag{$d_i$} \end{equation} From here on we assume that $\pi$ satisfies, for $\bullet=a,b,c$, the inequality: \begin{align}\label{eq: starting assumption} \fnorm{Z_0}_{x_\bullet,y_\bullet,R}=\fnorm{\pi -\pi_{\g}|_R}_{x_\bullet,y_\bullet,R}<t_0 ^{-\alpha}, \end{align} This follows from the assumption of Theorem \ref{theorem: rigidity} and by using Corollary \ref{corollary: degree shift}: \[\fnorm{\pi -\pi_{\g}|_R}_{x_\bullet,y_\bullet,R}\leq C\fnorm{\pi -\pi_{\g}|_R}_{x_\bullet+y_\bullet,0,R}\leq C\delta, \] if we choose $N=\mathrm{max}(x_a+y_a,x_b+y_b,x_c+y_c)$ and $\delta<C^{-1}t_0^{-\alpha}$. \subsection{The algorithm is well-defined} The constant $t_0>1$ will be chosen such that it is larger than a finite number of quantities which will appear in the proof. \begin{lemma}\label{lemma: well-definedness} There exists $t_0> 1$ such that $(a_i)-(d_i)$ hold for all $i\in \N_0$. \end{lemma} \begin{proof} Note that $(a_0) - (c_0)$ follow from \eqref{eq: starting assumption}. We show \begin{align*} (a_i)&\ \Rightarrow (d_i) \\ (a_i)\land (b_i)\land (c_i)\land (d_i)&\ \Rightarrow (a_{i+1})\land (b_{i+1})\land (c_{i+1}). \end{align*} The following estimate will be used repeatedly: \begin{lemma} For all $0\leq l \le n$ and $0 \leq j\le k+2l$, we have: \begin{equation}\label{eq: Xk estimate} \fnorm{X_i}_{n,k,r_i}\le C t^{{12p}l+j}_i\fnorm{Z_i}_{n-l+p-1,k+2l-j +(p-1)(n-l),r_i}. \end{equation} \end{lemma} \begin{proof} We use \eqref{eq: smoothing 1} and \eqref{eq: homotopy family estimate flat}: \begin{align*} \fnorm{X_i}_{n,k,r_i}&\, =\fnorm{S_i(h^1_{r_i}(Z_i))}_{n,k,r_i} \le C t^{{12p}l+j}_i\fnorm{h^1_{r_i}(Z_i)}_{ n-l,k+2l-j,r_i}\\ &\,\le C t^{{12p}l+j}_i\fnorm{Z_i}_{n-l+p-1,k+2l-j +(p-1)(n-l),r_i}\qedhere \end{align*} \end{proof} Note that, by choosing $t_0$ sufficiently large, we have \[t_i^{-1}\le r_i-r_{i+1}=\frac{R-r}{(i+1)(i+2)}, \quad \textrm{for all}\ \ i\geq 0.\] By using \eqref{eq: Xk estimate} for $l=j=0$ and \eqref{eq: ai} we get: \begin{align}\label{eq: xo} \fnorm{X_i}_{1,0,r_i}&\,\le C \fnorm{Z_i}_{p,p-1,r_i}\quad \ \le \ C t^{-\alpha}_i\\ &\, \leq C t_i^{ 1-\alpha}(r_i-r_{i+1}) \quad < \ \theta \cdot (r_i-r_{i+1}),\nonumber \end{align} where in the last step we have used that $t_i^{1-\alpha}\leq t_0^{1-\alpha}< \theta/C$, and $\theta$ is the constant from Lemma \ref{lemma: flow}. This inequality and Lemma \ref{lemma: flow} imply \eqref{eq: di}. $\noindent{\underline{(c_{i+1})}:}$ we use estimates (b) and (c) in Lemma \ref{lemma: flow} to obtain \begin{align} \fnorm{Z_{i+1}}_{x_c,y_c,r_{i+1}}= &\ \fnorm{\phi_{X_i}^*(Z_i)+\phi_{X_i}^*(\pi_{\g})-\pi_{\g}}_{x_c,y_c,r_{i+1}}\nonumber\\ \le &\ C\Big(\fnorm{Z_i}_{x_c,y_c,r_i} (1+\fnorm{X_i}_{x_c+1,0,r_i})\label{eq: ek estimate}\\ &\ \ \ +\fnorm{X_i}_{x_c+1,y_c,r_i}(1+\fnorm{X_i}_{x_c+1,0,r_i})\Big)\nonumber \end{align} Using \eqref{eq: Xk estimate} with $l=x_c$ and $j=0$ and that: \[p= x_a\qquad p-1+2x_c\leq y_a,\qquad {12p}x_c\leq \alpha, \] the term $\fnorm{X_i}_{x_c+1,0,r_i}$ can be estimated by \begin{equation}\label{eq: Xkb1 estimate} \fnorm{X_i}_{x_c+1,0,r_i}\ \stackrel{\eqref{eq: Xk estimate}}{\le}\ C t_i^{{12p}x_c}\fnorm{Z_i}_{x_a,y_a,r_i} \ \stackrel{\eqref{eq: ai}}{\le} \ Ct_i^{{12p}x_c-\alpha } \quad \le \quad C. \end{equation} Applying \eqref{eq: Xk estimate} with $l=p$ and $j=(p-1)(x_c-p+1)+2p$ we obtain \begin{equation}\label{eq: k mixed} \fnorm{X_i}_{x_c+1,y_c,r_i} \stackrel{\eqref{eq: Xk estimate}}{\le} Ct_i^{({12p}+2)p+(p-1)(x_c-p+1)}\fnorm{Z_i}_{x_c,y_c,r_i} \end{equation} Hence we get from \eqref{eq: ek estimate} the estimate \begin{align*} \fnorm{Z_{i+1}}_{x_c,y_c,r_{i+1}}\quad \le \quad & C(1+t_i^{({12p}+2)p+(p-1)(x_c-p+1)})\fnorm{Z_i}_{x_c,y_c,r_i}\\ \stackrel{\eqref{eq: ci}}{\le}\ \ & Ct_i^{13p^2+2p-1+\alpha}\ \ \le \ \ Ct_i^{-\epsilon} t_{i+1}^{\alpha} \ \ \le \ \ Ct_0^{-\epsilon }t_{i+1}^{\alpha} \end{align*} where we have used that: \begin{equation}\label{eq: random ie2} 13p^2+2p-1< \frac{1}{2}\alpha, \end{equation} and we have denoted by $\epsilon>0$ a number smaller than the difference. By taking $t_0$ large, enough, we can make $Ct_0^{-\epsilon}<1$, and so $(c_{i+1})$ holds. We will use tacitly a similar argumentation later on.\\ $\noindent{\underline{(b_{i+1})}:}$ we use again estimates (b) and (c) in Lemma \ref{lemma: flow} to obtain \begin{align} \fnorm{Z_{i+1}}_{x_b,y_b,r_{i+1}}= &\ \fnorm{\phi_{X_i}^*(Z_i)+\phi_{X_i}^*(\pi_{\g})-\pi_{\g}}_{x_b,y_b,r_{i+1}}\nonumber\\ \le &\ C\big(\fnorm{Z_i}_{x_b,y_b,r_i}+\fnorm{X_i}_{x_b+1,y_b,r_i}\label{eq: ck estimate}\\ &\ \ +(\fnorm{Z_i}_{0,y_b,r_i}+\fnorm{X_i}_{1,y_b,r_i})\fnorm{X_i}_{x_b+1,0,r_i}\big)\nonumber \end{align} For the first term in \eqref{eq: ck estimate} we immediately get \begin{equation*} \fnorm{Z_i}_{x_b,y_b,r_i}\stackrel{\eqref{eq: bi}}{\le} Ct^{\alpha}_i \quad \le \quad Ct_0^{-\epsilon}t^{\alpha}_{i+1} \end{equation*} The second term is estimated exactly as \eqref{eq: k mixed} and by using \eqref{eq: bi}: \begin{align*} \fnorm{X_i}_{x_b+1,y_b,r_i} \stackrel{\eqref{eq: Xk estimate}}{\le} & Ct_i^{ ({12p}+2)p+(p-1)(x_b-p+1)}\fnorm{Z_i}_{x_b,y_b,r_i} \\ \stackrel{\eqref{eq: bi}}{\le } \ & Ct_i^{24p^2-9p-1+\alpha}\le \ C t_0^{-\epsilon} t^{\alpha }_{i+1} \end{align*} where we have used that: \begin{equation*} 24p^2-9p-1< \frac{1}{2}\alpha . \end{equation*} We move to the last term. Using \eqref{eq: Xk estimate} with $l=p-1$ and $j=0$ we obtain: \begin{equation}\label{eq: Xkq1 estimate} \fnorm{X_i}_{x_b+1,0,r_i}\stackrel{\eqref{eq: Xk estimate}}{\le} Ct_i^{12p^2} \fnorm{Z_i}_{x_b,2p+(p-1)(x_b-p+1),r_i} \stackrel{\eqref{eq: bi}}{\le} Ct_i^{{12p^2}+\alpha} \end{equation} where we used that \[2p+(p-1)(x_b-p+1)\le y_b.\] Using \eqref{eq: Xk estimate} for $l=j=0$ and interpolation in the weights, we obtain \begin{align}\label{eq: X1 estimate} \fnorm{X_i}_{1,y_b,r_i} \quad \stackrel{\eqref{eq: Xk estimate}}{\le} \quad & C\fnorm{Z_i}_{p,y_b+p-1,r_i}\nonumber \\ \stackrel{\eqref{eq: interpolation s}}{\le}\quad & C \fnorm{Z_i}_{p,y_a,r_i}^{\frac{y_c-y_b-p+1}{y_c-y_a}}\fnorm{Z_i}_{p,y_c,r_i}^{\frac{y_b+p-1-y_a}{y_c-y_a}}\\ \stackrel{\eqref{eq: ai},\eqref{eq: ci}}{\le}&Ct_i^{-\alpha \frac{y_c+y_a-2(y_b+p-1)}{y_c-y_a}}\nonumber \end{align} The above also yields: \begin{align} \fnorm{Z_i}_{0,y_b,r_i}\quad \le\quad & \fnorm{Z_i}_{p,y_b+p-1,r_i} \le \ C t_{i}^{-\alpha \frac{y_c+y_a-2(y_b+p-1)}{y_c-y_a}} \label{eq: z1q2} \end{align} Combining \eqref{eq: Xkq1 estimate}, \eqref{eq: X1 estimate} and \eqref{eq: z1q2}, the last term in \eqref{eq: ck estimate} is bounded by \begin{align*} C t_i^{{12p^2}+2\alpha \frac{y_b-y_a+p-1}{y_c-y_a}} \ \le \ Ct_0^{-\epsilon} t_{i+1}^{\alpha} \end{align*} where we have used that \[12p^2+2\alpha \frac{y_b-y_a+p-1}{y_c-y_a}< \frac{3}{2}\alpha.\] Adding up these inequalities, we obtain that $(b_{i+1})$ holds.\\ $\noindent{\underline{(a_{i+1})}:}$ we write $Z_{i+1}=V_i +\phi_{X_i}^*(U_i)$, where \begin{equation}\label{eq: split Z} V_i:= \phi_{X_i}^*(\pi_{\g})-\pi_{\g}-\phi_{X_i}^*([X_i,\pi_{\g}]), \quad \text{ and }\quad U_i:=Z_i -[\pi_{\g},X_i]. \end{equation} Applying (c) in Lemma \ref{lemma: flow} we obtain for $V_i$ the estimate \begin{align}\label{eq: vi estimate} \fnorm{V_i}_{x_a,y_a,r_{i+1}} \ \le \ C( \fnorm{X_i}_{x_a+1,y_a,r_i}\fnorm{X_i}_{1,0,r_i}+\fnorm{X_i}_{1,y_a,r_i}\fnorm{X_i}_{x_a+2,0,r_i}) \end{align} Applying \eqref{eq: Xk estimate} with $l=p$ and $j=3p-1$ yields the estimate \begin{align}\label{eq: Xsas} \fnorm{X_i}_{x_a+1,y_a,r_i}&\ \stackrel{\eqref{eq: Xk estimate}}{\le} Ct^{12p^2+3p-1}_i\fnorm{Z_i}_{x_a,y_a,r_i}\nonumber \\ &\ \ \stackrel{\eqref{eq: ai}}{\le}\ Ct^{12p^2+3p-1-\alpha}_i. \end{align} From \eqref{eq: Xk estimate} for $l=0$ and $j=p-1$ we obtain \begin{equation}\label{eq: Xsasb} \fnorm{X_i}_{1,y_a,r_i}\stackrel{\eqref{eq: Xk estimate}}{\le} Ct^{p-1}_i\fnorm{Z_i}_{x_a,y_a,r_i}\stackrel{\eqref{eq: ai}}{\le}Ct^{p-1-\alpha}_i \end{equation} Using \eqref{eq: Xk estimate} with $l=p+1$ and $j=0$ provides for $\fnorm{X_i}_{x_a+2,0,r_i}$ the estimate \begin{equation}\label{eq: Xs0} \fnorm{X_i}_{x_a+2,0,r_i} \stackrel{\eqref{eq: Xk estimate}}{\le} Ct^{12p(p+1)}_i\fnorm{Z_i}_{x_a,3p+1,r_i} \stackrel{\eqref{eq: ai}}{\le}Ct^{{12p}(p+1)-\alpha}_i \end{equation} where we used that $3p+1\leq y_a$. Combining \eqref{eq: vi estimate}, \eqref{eq: xo} and \eqref{eq: Xsas} - \eqref{eq: Xs0} we obtain for $V_i$ the estimate \begin{align}\label{eq: Vk} \fnorm{V_i}_{x_a,y_a,r_{i+1}} \ &\le \ C (t^{12p^2+3p-1-2\alpha}_i+ t^{{12p}(p+1)+p-1-2\alpha}_i )\nonumber\\ &\le \ C t_i^{12p^2+13p-1-2\alpha}\ \le \ Ct^{-\epsilon}_0 t^{-\alpha }_{i+1} \end{align} where we have used: \begin{equation}\label{eq: not very strict inequality} 12p^2 +13p-1 < \frac{1}{2} \alpha. \end{equation} For $\phi_{X_i}^*(U_i)$ we use Lemma \ref{lemma: flow} (b), \eqref{eq: Xs0} and $12p(p+1)\leq \alpha$ to obtain \begin{align}\label{eq: Uk estimate} \fnorm{\phi^*_{X_i}(U_i)}_{x_a,y_a,r_{i+1}}\le &\ C\fnorm{U_i}_{x_a,y_a,r_i}(1+\fnorm{X_i}_{x_a+1,0,r_i}) \nonumber \\ \le& \ C\fnorm{U_i}_{x_a,y_a,r_i} \end{align} To estimate this term, we write $U_i$ as \begin{align}\label{eq: uk representation} U_i& \,= Z_i-[\pi_{\g},X_i] = [\pi_{\g},(\id-S_i)(h^1_{r_i}(Z_i))]-\frac{1}{2}h^2_{r_i}([Z_i,Z_i]) \end{align} where we used the homotopy identity and that $\pi_i$ is Poisson, i.e. \begin{align*} \dif_{\pi_{\g}}Z_i +\frac{1}{2}[Z_i,Z_i]=0. \end{align*} For the first term we apply the Lemma \ref{lemma: SN} to get \begin{equation}\label{eq: uk1} \fnorm{[\pi_{\g},(\id-S_i)(h^1_{r_i}(Z_i))]}_{x_a,y_a,r_i} \le C \, \fnorm{(\id-S_i)(h^1_{r_i}(Z_i))}_{x_a+1,y_a,r_i} \end{equation} Using the second smoothing inequality \eqref{eq: smoothing 2} with the parameters \[ l:=11p \qquad \text{ and }\qquad j:=y_c-2p^2\geq 0\] and the bound for the homotopy operators \eqref{eq: homotopy family estimate flat}, we get: \begin{align} \fnorm{(\id-S_i)(h^1_{r_i}(Z_i))}&_{x_a+1,y_a,r_i} \nonumber\\ \le C \big(&t_i^{-132p^2}\, \fnorm{h^1_{r_i}(Z_i)}_{x_b-p+1,y_a-22p,r_i}\nonumber\\ +&\, t_i^{-y_c+2p^2}\fnorm{h^1_{r_i}(Z_i)}_{x_a+1,y_c-p^2,r_i}\big)\nonumber \\ \le C \big(&t_i^{-132p^2}\, \fnorm{Z_i}_{x_b,y_a +(p-1)(x_b-p+1)-22p,r_i}\nonumber\\ +&\, t_i^{-y_c+2p^2}\fnorm{Z_i}_{x_a+p,y_c-1,r_i}\big)\label{eq: uk1e}\\ \le C( t_i^{-132p^2}&\, \fnorm{Z_i}_{x_b,y_b,r_i} +t_i^{-y_c+2p^2}\fnorm{Z_i}_{x_c,y_c,r_i})\nonumber\\ \le C( t_i^{-132p^2}&\,+t_i^{-y_c+2p^2})t_i^{\alpha} \ \le \ Ct_0^{-\epsilon}t_{i+1}^{-\alpha}\nonumber \end{align} where we used \eqref{eq: bi}, \eqref{eq: ci}, the relations \begin{align*} 22p \le y_a, \qquad x_a+p = x_c,\qquad y_a +(p-1)(x_b-p+1)-22p\le y_b, \end{align*} and that we have \begin{align*} -132p^2&\ < \ -\frac{5}{2}\alpha, \qquad \text{ and } \qquad \ -y_c+2p^2\ < \ -\frac{5}{2}\alpha. \end{align*} For the second term in \eqref{eq: uk representation} we estimate the Schouten-Nijenhuis bracket similarly as in the proof of Lemma \ref{lemma: SN} to obtain \begin{align}\label{eq: uk2} \fnorm{\frac{1}{2}h^2_{r_i}([Z_i,Z_i])}_{x_a,y_a,r_i}&\, \le C \fnorm{[Z_i,Z_i]}_{x_a+p-1,y_a+(p-1)x_a,r_i} \nonumber\\ &\, \le C \sum_{j=0}^{x_a}\fnorm{Z_i}_{x_a-j,y_a,r_i} \fnorm{Z_i}_{p+j,(p-1)x_a,r_i}\nonumber\\ &\, \le C \fnorm{Z_i}_{x_a,y_a,r_i} \fnorm{Z_i}_{p+x_a,y_a,r_i} \\ &\, \le Ct_i^{-\alpha}\fnorm{Z_i}_{x_a,y_a,r_i}^{1-\frac{p}{x_b-x_a}}\fnorm{Z_i}_{x_b,y_a,r_i}^{\frac{p}{x_b-x_a}}\nonumber\\ &\, \le C t_i^{-2\alpha(1-\frac{p}{x_b-x_a})}\, \le Ct_0^{-\epsilon}t_{i+1}^{-\alpha}\nonumber \end{align} where we used the interpolation \eqref{eq: interpolation t} and the relations \[ (p-1)x_a\le y_a\le y_b, \qquad 4p< (x_b-x_a). \] Finally, using \eqref{eq: Xs0}, \eqref{eq: uk1e} and \eqref{eq: uk2} we can estimate \eqref{eq: Uk estimate} by \begin{align*} \fnorm{\phi^*_{X_i}(U_i)}_{x_a,y_a,r_{i+1}}\le &\ C\fnorm{U_i}_{x_a,y_a,r_i}\ \le \ C t^{-\epsilon}_0t_{i+1}^{-\alpha} \end{align*} This estimate together with \eqref{eq: Vk} proves $(a_{i+1})$ and hence Lemma \ref{lemma: well-definedness}. \end{proof} \begin{remark} The constant $t_0>1$ will be chosen according to Lemma \ref{lemma: well-definedness}, and such that it satisfies two more estimates, which will be explained in Subsection \ref{subsection:Convergence}. \end{remark} \section{Proof of Theorem \ref{theorem: rigidity}}\label{section: convergence} The goal of this section is to complete the proof of Theorem \ref{theorem: rigidity}. In order to achieve this we use methods developed in \cite{LoZe} to show the the sequence \[ \Phi_i :=\phi_{X_0} \circ \dots \circ \phi_{X_i}|_{\overline{B}_r} : \overline{B}_r \to B_R \] converges to local diffeomorphism which is moreover Poisson map. \subsection{Improved estimates} We assume that $\pi$ satisfies \eqref{eq: starting assumption}. An important difference to the previous section is that the various constants $C>0$ may depend on $\pi$. In the following we prove versions of the estimates \eqref{eq: ai}-\eqref{eq: ci} for general degrees. We start with the one of type \eqref{eq: ci}. \begin{lemma}\label{lemma: ekc} For all $y\in \N_0$ there exists $C=C_{y}(\pi)>0$ such that \begin{align}\label{eq: ekc} \fnorm{Z_i}_{x_c,y,r_i}\, \le\, C\, t_{i}^{\alpha \end{align} for all $i\in \N_0$. \end{lemma} \begin{proof} Note that for $i=0$, there is nothing to prove. We now use an iteration in $i$ and basically redo the estimate for \eqref{eq: ci} in the proof of Lemma \ref{lemma: well-definedness}. Similar as in \eqref{eq: ek estimate} we apply the estimates (b) and (c) in Lemma \ref{lemma: flow} and \eqref{eq: Xkb1 estimate} to obtain \begin{align*} \fnorm{Z_{i+1}}_{x_c,y,r_{i+1}}\le C(\fnorm{Z_i}_{x_c,y,r_i} +\fnorm{X_i}_{x_c+1,y,r_i}). \end{align*} For the second term we use that equation \eqref{eq: k mixed} holds for general $y$, and we obtain the recursive formula: \begin{equation*} \fnorm{Z_{i+1}}_{x_c,y,r_{i+1}}\le C\, t_i^{s}\fnorm{Z_{i}}_{x_c,y,r_{i}}, \end{equation*} where $s:=11p^2+4p+1+(p-1)x_c$. Iterating this inequality, we obtain: \begin{align*} \fnorm{Z_{i+1}}_{x_c,y,r_{i+1}}&\le C^{i+1}(t_0\cdot\ldots \cdot t_i)^{s}\fnorm{Z_{0}}_{x_c,y,r_{0}}\\ &= C^{i+1}t_0^{s(1+\frac{3}{2}+\ldots +\frac{3^{i}}{2^i})}\fnorm{Z_{0}}_{x_c,y,r_{0}}\\ &\leq C^{i+1}t_{i+1}^{2s}\fnorm{Z_{0}}_{x_c,y,r_{0}}\\ & \leq (C^{i+1}t_{i+1}^{-\epsilon})t_{i+1}^{\alpha}\fnorm{Z_{0}}_{x_c,y,r_{0}}\\ & \leq Ct_{i+1}^{\alpha}\fnorm{Z_{0}}_{x_c,y,r_{0}}. \end{align*} where we have used that, by \eqref{eq: random ie2} $s<\frac{1}{2}\alpha$ and that $C^{i+1}t_{i+1}^{-\epsilon}$ can be bounded independently of $i$. \end{proof} In all degrees, we have: \begin{lemma}\label{lemma: ckc} For all $x,y \in \N_0$ there exists $C=C_{x,y}(\pi)>0$ such that \begin{align}\label{eq: ckc} \fnorm{Z_i}_{x,y,r_i}\le C t_{i}^{\alpha+ 2(x-x_c)(p-1)} \end{align} for all $i\in \N_0$. \end{lemma} \begin{proof} The proof is similar to the one of the previous lemma. Using estimates (b) and (c) in Lemma \ref{lemma: flow} we get \begin{align}\label{eq: ckc estimate} \fnorm{Z_{i+1}}_{x,y,r_{i+1}}\le &\ C(\fnorm{Z_i}_{x,y,r_i}+\fnorm{Z_i}_{0,y,r_i}\fnorm{X_i}_{x+1,0,r_i}\nonumber\\ &\ \ \ +\fnorm{X_i}_{x+1,y,r_i}+\fnorm{X_i}_{1,y,r_i}\fnorm{X_i}_{x+1,0,r_i}) \\ \le &\ C(\fnorm{Z_i}_{x,y,r_i}+\fnorm{X_i}_{x+1,y,r_i}(1+\fnorm{Z_i}_{0,y,r_i}+\fnorm{X_i}_{1,y,r_i})).\nonumber \end{align} As in \eqref{eq: k mixed}, we estimate the term $\fnorm{X_i}_{x+1,y,r_i}$ by: \begin{equation*} \fnorm{X_i}_{x+1,y,r_i} \le \ Ct_i^{11p^2+4p+1+(p-1)x}\fnorm{Z_i}_{x,y,r_i}. \end{equation*} Next, we have that: \begin{align*} \fnorm{X_i}_{1,y,r_i} & \stackrel{\eqref{eq: Xk estimate}}{\le} C\fnorm{Z_i}_{p,y+p+1,r_i} \\ & \stackrel{\eqref{eq: interpolation s}}{\le} C \fnorm{Z_i}_{x_a,y_a,r_i}^{\frac{y+y_a-p+1}{2y}}\fnorm{Z_i}_{x_a,2y+y_a,r_i}^{\frac{y+p-1-y_a}{2y}}\\ &\stackrel{\eqref{eq: ai},\eqref{eq: ekc}}{\le} C t_i^{-\alpha\frac{y_a-p+1}{y}}\leq C, \end{align*} where we have assumed that $y+p-1\geq y_a$ -- otherwise apply \eqref{eq: ai} as the second step. The above also implies: \begin{align*} \fnorm{Z_i}_{0,y,r_i} \leq C. \end{align*} Using the last three inequalities in \eqref{eq: ckc estimate}, we obtain: \begin{equation*} \fnorm{Z_{i+1}}_{x,y,r_{i+1}} \le \ Ct_i^{s+(x-x_c)(p-1)}\fnorm{Z_i}_{x,y,r_i}, \end{equation*} where, $s=11p^2+4p+1+(p-1)x_c$. As in the proof of the previous lemma, we iterate this relation, and we obtain the result. \end{proof} We give now a new version of \eqref{eq: ai}: \begin{lemma}\label{lemma: bkc} For all $N \in \N_0 $ there exists $C=C_N(\pi)>0$ such that \begin{align} \fnorm{Z_i}_{x_a,y_a,r_i}\le&\ C t_{i}^{-N}\label{eq: bkc} \end{align} for all $i\in \N_0$. \end{lemma} \begin{proof} By \eqref{eq: ai} it holds for $N=\alpha$. We show that the estimate for $N\geq \alpha$ implies the estimate for $N+1$. For this, we go again through the estimates in the proof of \eqref{eq: ai}. So we write $Z_{i+1}=V_i +\phi_{X_i}^*(U_i)$ as defined in \eqref{eq: split Z}. To estimate $V_i$ we replace \eqref{eq: ai} by inequality \eqref{eq: bkc} in the proof of inequalities \eqref{eq: xo}, \eqref{eq: Xs0}, \eqref{eq: Xsas} and \eqref{eq: Xsasb}, and then obtain: \begin{align*} \fnorm{X_i}_{1,0,r_i}&\,\le C t^{-N}_i\\ \fnorm{X_i}_{x_a+2,0,r_i}&\, \le Ct^{{12p}(p+1)-N}_i\\ \fnorm{X_i}_{x_a+1,y_a,r_i}&\, \le Ct^{12p^2+3p-1-N}_i\\ \fnorm{X_i}_{1,y_a,r_i}&\, \le Ct^{p-1-N}_i \end{align*} Hence we can estimate $V_i$ using \eqref{eq: vi estimate} to obtain: \begin{equation}\label{eq: vi final} \fnorm{V_i}_{x_a,y_a,r_{i+1}} \ \le \ \ C t_i^{12p^2+13p-1-2N}\ \le C t_{i+1}^{-(N+1)}, \end{equation} where we used the fact that \[ 12p^2+13p-1-2N\leq -\frac{3}{2}(N+1),\] which holds for $N=\alpha$, and so it holds also for $N\geq \alpha$. To estimate $\phi_{X_i}^*(U_i)$, we use \eqref{eq: Uk estimate}, we write $U_i$ as the sum \eqref{eq: uk representation}, and estimate each term separately. For the first term, we apply \eqref{eq: uk1}, then the smoothing inequality in \eqref{eq: smoothing 2}, and then homotopy inequality \eqref{eq: homotopy family estimate flat}, and, denoting $u:=x_a+p$ and $v:=y_a+(p-1)(x_a+1)$, we obtain: \begin{align*} \fnorm{(\id-S_i)(h^1_{r_i}(Z_i))}_{x_a+1,y_a,r_i} \le C \big(&t_i^{-{12p}l}\, \fnorm{Z_i}_{u+l,v+(p-3)l,r_i}+t_i^{-j}\fnorm{Z_i}_{u,v+j,r_i}\big)\\ \stackrel{\eqref{eq: ckc}}{\le} C \big(& t_i^{-{12p}l+\alpha+2(p-1)(u+l-x_c)} + t_i^{-j+\alpha+2(p-1)(u-x_c)}\big)\\ = C \big(& t_i^{-(10p+2)l+e} + t_i^{-j+f}\big), \end{align*} for some constants $e,f$. Since $l,j\geq 0$ are arbitrary, we can take them large enough so that: \begin{equation}\label{eq: u1 final} \fnorm{(\id-S_i)(h^1_{r_i}(Z_i))}_{x_a+1,y_a,r_i}\leq Ct_{i+1}^{-(N+1)}. \end{equation} To estimate the other term of $U_i$, we use \eqref{eq: uk2}, the interpolation inequality \eqref{eq: interpolation t}, equation \eqref{eq: ckc} and the induction assumption: \begin{align*} \fnorm{\frac{1}{2}h^2_{r_i}([Z_i,Z_i])}_{x_a,y_a,r_i}&\, \le C \fnorm{Z_i}_{x_a,y_a,r_i} \fnorm{Z_i}_{p+x_a,y_a,r_i} \\ &\, \le Ct_i^{-N}\fnorm{Z_i}_{x_a,y_a,r_i}^{\frac{x-x_a-p}{x-x_a}}\fnorm{Z_i}_{x,y_a,r_i}^{\frac{p}{x-x_a}}\\ &\, \le Ct_i^{-N(2-\frac{p}{x-x_a})+(\alpha+2(p-1)(x-x_c))\frac{p}{x-x_a}} \end{align*} We claim that, for large $x$ the exponent of the right-hand side is smaller than $-(N+1)\frac{3}{2}$. Note that, the limit at $x\to \infty$ of the exponent is: \[-2N+2p(p-1).\] So it suffices to note that: \[4p(p-1)+3< N,\] which holds because $N\geq\alpha$. Hence \begin{align} \fnorm{\frac{1}{2}h^2_{r_i}([Z_i,Z_i])}_{x_a,y_a,r_i} \le \ Ct_{i+1}^{-(N+1)} \label{eq: uk2c final} \end{align} Finally, combining \eqref{eq: Uk estimate}, \eqref{eq: u1 final} and \eqref{eq: uk2c final} we obtain \begin{align*} \fnorm{\phi^*_{X_i}(U_i)}_{x_a,y_a,r_{i+1}}\le &\ C\fnorm{U_i}_{x_a,y_a,r_i} \le Ct_{i+1}^{-(N+1)} \end{align*} which finishes the proof. \end{proof} \subsection{Convergence}\label{subsection:Convergence} To show convergence of the sequence we constructed, we use the following: \begin{lemma}\label{lemma: sigman} For every $n\in \N$ the sum \[ \sum_{i\geq 0}\norm{X_i}_{n,r_i} <\infty\] Moreover, for $n=1$, we have \[ \sum_{i\geq 0}\norm{X_i}_{1,r_i}\le C\cdot t_0^{-1} \] \end{lemma} \begin{proof} The statement for $n=1$ follows directly from \eqref{eq: xo}. Note that by \eqref{eq: Xk estimate} and Corollary \ref{corollary: degree shift}, we have that: \[ \norm{X_i }_{n,r_i}\ \le \ C \fnorm{Z_i}_{n+p-1,(p-1)n,r_i}\ \le \ C\norm{Z_i}_{pn+p-1,r_i}. \] So it suffices to show that $\sum_{i}\norm{Z_i}_{n,r_i}<\infty$, for all $n$. \begin{align*} \norm{Z_i}_{n,r_i} &\ \ \ \stackrel{\eqref{eq: interpolation t}}{\le} \ \ \ C \norm{Z_i}_{x_a,r_i}^{\frac{x_a}{n}} \norm{Z_i}_{x_a+n,r_i}^{\frac{n-x_a}{n}}\\ &\stackrel{\eqref{eq: ckc},\eqref{eq: bkc}}{\le} C t_i^{-N\frac{x_a}{n}+\frac{n-x_a}{n}(\alpha +2(p-1)(x_a+n-x_c))}, \end{align*} and so by choosing $N$ large enough, we obtain the conclusion. \end{proof} Next, we recall some facts and estimates for diffeomorphisms (for proofs see \cite[Section 3.2]{Marcut}). \begin{lemma}\label{lemma: diffeo} There exists $\theta>0$ such that, if $\Phi \in C^{\infty}(\overline{B}_r,\R^m)$ satisfies $\norm{\Phi-\id}_{1,r} <\theta$, then $\Phi $ is a diffeomorphism onto its image. \end{lemma} \begin{lemma}\label{lemma: converging diffeo} There exists $\theta>0$ such that for all sequences of maps \[ \{\phi_i\in C^{\infty}(\overline{B}_{r_{i+1}},B_{r_{i}})\}_{i\geq 0}\] with $0<r\le r_{i+1} \le r_{i}<R$, which satisfy the estimates \[ \sigma_0 := \sum_{ i\geq 0}\norm{\phi_i-\id}_{0,r_{i+1}}<\theta, \ \ \ \ \text{ and } \ \ \ \ \sigma_n:=\sum_{ i\geq 0}\norm{\phi_i -\id}_{n,r_{i+1}}<\infty,\] the sequence of maps \[ \Phi_i:=\phi_0\circ \phi_1 \circ \dots \circ \phi_i |_{\overline{B}_r} :\overline{B}_r\to B_R,\] converges in all $C^n$-norms to a smooth map $\Phi\in C^{\infty}(\overline{B}_r,B_R)$ which satisfies \[ \norm{\Phi-\id}_{n,r}\le C \sigma_{n}e^{C\sigma_n},\] for some constant $0<C=C_n$. \end{lemma} Lemma \ref{lemma: flow} and Lemma \ref{lemma: sigman} imply that our vector fields satisfy: \begin{align*} \sum_{i\geq 0}\norm{\phi_{X_i}-\mathrm{Id}}_{1,r_{i+1}}&\leq\, C \sum_{i\geq 0}\norm{X_i}_{1,r_{i+1}}\leq C\cdot t^{-1}_0\\ \sum_{i\geq 0}\norm{\phi_{X_i}-\mathrm{Id}}_{n,r_{i+1}}&\leq\, C \sum_{i\geq 0}\norm{X_i}_{n,r_{i+1}}< \infty. \end{align*} Note that the constant in the first inequality is independent of $\pi$, as it comes from \eqref{eq: xo} and Lemma \ref{lemma: flow}. Therefore, we can make $t_0$ large enough, so that also the first condition of Lemma \ref{lemma: converging diffeo} holds: $\sigma_0<\theta$. Hence \[ \Phi_i:=\phi_{X_0} \circ \dots \circ \phi_{X_i}|_{\overline{B}_r}:\overline{B}_r\to B_R\] converges uniformly in all $C^n$-norms to a map $\Phi:\overline{B}_r \to B_R$ which satisfies \[ \norm{\Phi-\id}_{1,r}\le Ct_0^{-1}.\] Again, this constant is independent of $\pi$, so by possibly increasing $t_0$, Lemma \ref{lemma: diffeo} implies that $\Phi$ is a diffeomorphism onto its image. The convergence of $\Phi_i$ to $\Phi$ in the $C^1$-topology implies that $\Phi^*_i(\pi)$ convergence in the $C^0$-topology to $\Phi^*(\pi)$. As \[Z_i|_{\overline{B}_r}=\Phi^*_i(\pi)-\pi_{\g}|_{\overline{B}_r}\xrightarrow{i\to \infty}0\] in the $C^0$-topology we conclude that $\Phi^*(\pi)=\pi_{\g}|_{\overline{B}_r}$. Hence $\Phi$ is a Poisson map and a diffeomorphism onto its image: \[ \Phi:(\overline{B}_r,\pi_{\g})\to (B_R,\pi)\] This concludes the proof of Theorem \ref{theorem: rigidity}. \section{Smoothing operators for flat functions}\label{section: functional analysis} In this appendix we collect general properties on the space of flat functions on a closed ball $\overline{B}_r$, for which we develop the necessary tools to apply the Nash-Moser method in the flat framework. Most importantly, we obtain smoothing operators for this space with respect to the norms $\fnorm{\cdot}_{n,k,r}$. These operators depend on two parameters $t,s$, corresponding to the two indexes $n,k$ of the norms. For their construction, we observe that flatness at the corresponds under inversion in the sphere to Schwartz-like behavior at infinity. This allows us to use the original construction due to Nash \cite{Nash} of smoothing operators on the space of Schwartz functions. Finally, we prove interpolation inequalities for the $\fnorm{\cdot}_{n,k,r}$ norms. \subsection{The space of flat functions}\label{subsec: equivalent seminorms} Let $B_r\subset \R^m$ be the open ball of radius $0<r$ centered at the origin. On the space of smooth functions $C^{\infty}(\overline{B}_r)$ we have the usual $C^n$-norms: \[ \norm{f}_{n,r}:= \sup_{x\in \overline{B}_r}\ \sup_{a\in \N_0^m:\ |a|\le n}|D^af(x)|.\] Denote the space of functions on $\overline{B}_r$ that are flat at the origin by: \[C^{\infty}_0(\overline{B}_r):=\{f\in C^{\infty}(\overline{B}_r)\, |\, \forall\, a \in \N_0^m : D^{a}f(0)=0\}.\] Flat functions have the following behavior at the origin: \[\forall\, a\in \N^m_0,\, k\in \N_0\ :\ \lim_{|x| \to 0}|x|^{-k}|D^{a}f(x)|=0.\] Therefore we may define for flat functions the norms: \begin{align}\label{defintion:norms:appendix:flat} \fnorm{f}_{n,k,r}:= \sup_{x\in \overline{B}_r}\ \sup_{a\in \N_0^m:\ |a|\le n}|x|^{-k}|D^af(x)| \end{align} for $k,n\in \N_0$ and $f\in C^{\infty}_0(\overline{B}_r)$. We obtain the Fr\'echet space: \[\big(C^{\infty}_0(\overline{B}_r),\{ \fnorm{\cdot}_{n,k,r}\}_{k,n\in \N_0}\big).\] This space carries also the norms introduced in \eqref{eq: flat norms 2}: \begin{align*} |f|_{n,k,r}:=\norm{\frac{1}{|x|^{k}}f}_{n,\overline{B}_r}=\sup_{x\in \overline{B}_r}\sup_{a\in \N_0^m : |a|\le n}|D^a|x|^{-k}f(x)| \end{align*} The following result is very useful: \begin{lemma}\label{lemma: equivalence} The norms $|\cdot |_{n,k,r}$ and $\fnorm{\cdot}_{n,k,r}$ are equivalent: \[ C^{-1}|f |_{n,k,r} \le \fnorm{f}_{n,k,r}\le C|f |_{n,k,r}\] for a constant $0<C=C(k,n)$. \end{lemma} \begin{proof} Using Taylor's formula with integral remainder of order $d$ for $f\in C^{\infty}_0(\overline{B}_r)$ and that $f$ is flat, we obtain: \begin{align}\label{eq: taylor} |f(x)|\le &\ C \sum_{b\in \N_0^m:\, |b|=d}|x|^{d}\int_{0}^1(1-s)^{d-1}|D^{b} f(sx)|\dif s. \end{align} Using this we obtain, for all $k,l,n\in \N_0$, the inequality \begin{align}\label{ineq:stupid} \fnorm{f}_{n,k+l,r}\le C\fnorm{f}_{n+l,k,r}. \end{align} Using the Leibniz rule, we may write for $a\in \N_0^m$ with $|a|=n$ \begin{align}\label{ineq:intelligent} D^{a}(|x|^{-k}f(x))=&\ |x|^{-k}D^{a}(f)(x)+\sum_{|b| <n }P_b(x)|x|^{-k-2(n-|b|)}D^b(f)(x) \end{align} for homogeneous polynomials $P_b$ of degree $n-|b|$. This and \eqref{ineq:stupid} yield: \[ | D^{a}(|x|^{-k}f(x))|\le C \sum_{0\le i\le n}\fnorm{f}_{i,k+n-i,r}\le C \fnorm{f}_{n,k,r},\] for any $a\in \N_0^m$ with $|a|=n$. This proves the first part of the statement. For the other inequality, we first note that, by the Leibniz rule, we have: \begin{align*} D^{a}(|x|^{-k-l}f(x))= &\ \sum_{a^1+a^2=a}D^{a^1}(|x|^{-l})D^{a^2}(|x|^{-k}f(x)). \end{align*} The first term in the product can be estimated by: \[ |D^{a^1}(|x|^{-l})|\le C |x|^{-l-|a^1|}.\] By applying \eqref{eq: taylor} the term $D^{a^2}(|x|^{-k}f(x))$ can be bounded by: \begin{align*} C \sum_{ |b|=l+|a^1|}|x|^{l+|a^1|} \int_{0}^1(1-s)^{l+|a^1|-1}|D^{a^2+b}(|\cdot|^{-k} f)(sx)|\dif s. \end{align*} Combining these estimates yields \begin{align}\label{eq: strange taylor} |f|_{n,k+l,r}\le &\ C |f|_{n+l,k,r} \end{align} We prove the second inequality from the statement by induction on $n\in \N_0$. For $n=0$ and any $k\in \N_0$, we clearly have that \[ \fnorm{f}_{0,k,r}=|f|_{0,k,r}.\] Let us assume that the second inequality holds for all $k\in \N_0$ and all $n'<n$. Using \eqref{ineq:intelligent} and \eqref{eq: strange taylor}, we obtain that it holds also for $n$: \begin{align*} \fnorm{f}_{n,k,r}&\leq |f|_{n,k,r} +C \sum_{0\le i<n}\fnorm{f}_{i,k+n-i,r}\\ & \leq |f|_{n,k,r} +C\sum_{0\le i<n}|f|_{i,k+n-i,r}\le\, C |f|_{n,k,r}.\qedhere \end{align*} \end{proof} The lemma together with \eqref{eq: strange taylor} imply: \begin{corollary}\label{corollary: degree shift} For all $k,l,n\in \N_0$ and $f\in C^{\infty}_0(\overline{B}_r)$ we have \begin{align*} \fnorm{f}_{n,k+l,r}\le &\ C \fnorm{f}_{n+l,k,r} \end{align*} for a constant $0<C=C(k,l,n)$. \end{corollary} \subsection{Schwartz functions vs.\ flat functions}\label{section: Schwartz flat iso} Recall that the space of Schwartz functions is defined as \[\mathcal{S}(\R^m):=\{f\in C^{\infty}(\R^m;\C)\, |\, \forall\, k,n\in \N_0:\norm{f}_{n,k}<\infty\},\] where we denote \begin{align}\label{eq: Schwartz norm} \norm{f}_{n,k}:=\sup_{ x\in \R^m}\sup_{\substack{a\in \N_0^m:\ |a|\le n\\ l\in \N_0:\ l\le k}} \lvert x\rvert^{l}\lvert D^{a}f(x)\rvert \ \in \ [0,\infty]. \end{align} With these norms, the space of Schwartz functions becomes a Fr\'echet space \[\big(\mathcal{S}(\R^m),\{\norm{\cdot}_{n,k}\}_{k,n\in \N_0}\big).\] The defining property of Schwartz functions is their behavior at infinity: \begin{equation}\label{eq: behavior at infinity} \forall\, a\in \N^m_0,\, k\in \N_0 :\ \lim_{|x| \to \infty}|x|^{k}|D^{a}f(x)|=0. \end{equation} We refer to functions with this property as Schwartz-like at infinity, although they might not be defined on all of $\R^m$. We define norms on $C^{\infty}_0(\R^m;\C)$ similarly to \eqref{defintion:norms:appendix:flat}: \[ \fnorm{f}_{n,k}:= \sup_{x\in \R^m\setminus \{0\}}\ \sup_{\substack{a\in \N_0^m:\ |a|\le n\\ l\in \N_0:\ l\le k}}|x|^{-l}|D^af(x)| \ \in \ [0,\infty]\] for $k,n\in \N_0$. We denote the space of functions that are Schwartz-like at infinity and flat at the origin by $\mathcal{S}_0(\R^m)=\mathcal{S}(\R^m)\cap C^{\infty}_0(\R^m;\C)$. Then \[(\mathcal{S}_0(\R^m),\{\norm{\cdot}_{n,k},\fnorm{\cdot}_{n,k}\}_{k,n\in \N_0})\] is a Fr\'echet space. In order to compare the property of being Schwartz-like at infinity with that of being flat at the origin, we use the inversion $\rho$ on $\R^m \setminus\{0\}$ in the sphere of radius one, i.e., the map \begin{equation}\label{eq: inversion} \begin{array}{cccc} \rho:& \R^m \setminus\{0\}&\to&\R^m \setminus\{0\} \\ & x&\mapsto& \frac{x}{|x|^2} \end{array} \end{equation} Note that $\rho^2 =\id$. This map satisfies the following: \begin{proposition}\label{proposition: inversion} The map $\rho$ induces a continuous linear involution \[ \rho^* : \ \mathcal{S}_0(\R^m) \to \mathcal{S}_0(\R^m) \] which satisfies the following estimates \[ \fnorm{\rho^*(f)}_{n,k} \le C \norm{f}_{n,k+2n} \qquad \text{ and }\qquad \norm{\rho^*(f)}_{n,k+2n} \le C \fnorm{f}_{n,k}\] where $0<C=C(k,n)$ for $k,n\in \N_0$. \end{proposition} \begin{proof} In the proof we will use the inequalities: \begin{equation}\label{eq: size of rho} \forall\, x\neq 0 :\, |D^a\rho(x)|\leq C |x|^{-|a|-1}, \end{equation} for $a\in \N^m_0$ with $C=C(a)>0$. Let $f\in \mathcal{S}_0(\R^m)$. The fact that $\rho^*(f)$ is well-defined, i.e., that it extends flatly over the origin and is Schwartz like at infinity, will follow once we prove the inequalities from the statement. The inequalities become equalities for $n=0$ and $k\in \N_0$: \begin{align*} \fnorm{\rho^*(f)}_{0,k} =&\ \sup_{x\in \R^m\setminus \{0\}}\ \sup_{l\le k}|x|^{-l}|f(\rho(x))| \\ =&\ \sup_{y\in \R^m\setminus \{0\}}\ \sup_{l\le k} |y|^{l}|f(y)|= \norm{f}_{0,k}, \end{align*} where we used $y=\rho(x)\in \R^m\setminus \{0\}$. For every $a \in \N_0^m$ with $|a|=n>0$, by using the general chain rule and \eqref{eq: size of rho}, we have for all $x\in \R^m\setminus \{0\}$: \begin{equation}\label{eq: flat norm estimate} \begin{aligned} |D^{a}\rho^*(f)(x)|=&\ |\sum_{1\le|b|\le n}D^{b}(f)(\rho(x)){\sum}'\prod_{i=1}^{m}\prod_{j=1}^{b_i}D^{a_{ij}}(\rho)(x)|\\ \le&\ C \sum_{1\le|b|\le n}\frac{|D^{b}(f)(\rho(x))|}{|x|^{n+|b|}} \end{aligned} \end{equation} where $C =C(a)$ and the sum ${\sum}'$ runs over all $a_{ij}\in \N_0^m$ with \[ |a_{ij}|\ne 0 \ \ \ \ \ \text{ and }\ \ \ \ \ \ \sum a_{ij}=a.\] Hence, by multiplying with $|x|^l$, for $l\leq k$, and setting $y=\rho(x)$, we obtain: \begin{align*} \fnorm{D^{a}(\rho^*(f))}_{0,k} \le&\ C \norm{f}_{n,k+2n} \end{align*} which implies the first inequality. We prove now the second inequality. Let $a\in \N^m_0$ with $|a|=n>0$ and $k\in \N_0$. We use \eqref{eq: flat norm estimate} and the Taylor formula with integral remainder in \eqref{eq: taylor} for $d=n-|b|$ to obtain, for any $x\in \R^m\setminus \{0\}$ and $y=\rho(x)$, the following: \begin{equation*} \begin{aligned} |x|^{2n+k}|D^{a}\rho^*(f)(x)| \le&\ C \sum_{1\le|b|\le n}|D^{b}(f)(\rho(x))||x|^{k+n-|b|}\\ = &\ C \sum_{1\le|b|\le n}|D^{b}(f)(y)||y|^{|b|-k-n}\\ \le &\ C (\sum_{1\le|b|< n}\sum_{|\tilde{b}|=n-|b|}|y|^{-k} \int_{0}^1(1-s)^{|\tilde{b}|-1}|D^{b+\tilde{b}} f(sy)|\dif s\\ &\ \ \ \ \ +\fnorm{f}_{n,k})\\ \le &\ C \fnorm{f}_{n,k}(1+\sum_{1\le|b|< n}\int_{0}^1s^k(1-s)^{n-|b|-1}\dif s)\\ \le &\ C\fnorm{f}_{n,k}. \end{aligned} \end{equation*} This implies the second inequality from the statement. \end{proof} Let $C_r\subset \R^m$ denote the complement of the ball of radius $r>0$, i.e., \[C_r:=\R^m\setminus B_r\] and consider smooth functions on $C_r$ which are Schwartz-like at infinity: \[ \mathcal{S}(C_r ):=\{f\in C^{\infty}(C_r;\C)\, |\, \forall\, k,n\in \N_0:\norm{f}_{n,k,r}<\infty\}.\] Here the norms are defined for $k,n\in \N_0$ as in \eqref{eq: Schwartz norm}: \[\norm{f}_{n,k,r}:=\sup_{ x\in C_r}\sup_{a\in \N^m_0: \, |a|\le n}\lvert x\rvert^k \lvert D^{a}f(x)\rvert.\] For every $0<r$, we obtain the Fr\'echet space: \[\big(\mathcal{S}(C_r ),\{\norm{\cdot}_{n,k,r}\}_{k,n\in \N_0}\big).\] \begin{corollary}\label{corollary: inversion r} The map $\rho $ induces a continuous linear isomorphism \[\rho_{B}^*:= (\rho |_{\overline{B}_r})^* : \mathcal{S}(C_{1/r})\to C^{\infty}_0(\overline{B}_r,\C)\] with continuous inverse $\rho_C^*:= (\rho|_{C_{{1/r}}})^*$. Moreover, the map $\rho_B^* $ satisfies \begin{align*} \fnorm{\rho_B^*(f)}_{n,k,r} \le &\ C \norm{f}_{n,k+2n,1/r} \end{align*} for $k,n\in\N_0$ and $f\in \mathcal{S}(C_{1/r})$ and similarly $\rho_C^*$ satisfies the estimate \begin{align*} \norm{\rho_C^*(g)}_{n,k+2n,1/r} \le&\ C \fnorm{g}_{n,k,r} \end{align*} for $k,n \in\N_0$, $g\in C^{\infty}_0(\overline{B}_r,\C)$ and a constant $C=C(k,n)$. \end{corollary} \begin{proof} The proof of the previous proposition applies by working with $\overline{B}_r$ and $C_{1/r}$ instead of the whole space. \end{proof} We will need the following version of Whitney's Extension Theorem: \begin{lemma}\label{lemma: extension} There exists a linear map \[\epsilon : C^{\infty}_0(\overline{B}_1,\C)\hookrightarrow \mathcal{S}_0(\R^m)\] such that, for each $f\in C_0^{\infty}(\overline{B}_1;\C)$, the function $\epsilon(f)$ is a compactly supported extension of $f$: \[ \epsilon(f)|_{\overline{B}_1}=f.\] Moreover, the extension operator satisfies: \begin{align*} \fnorm{\epsilon(f)}_{n,k}\le &\ C \fnorm{f}_{n,k, 1} \end{align*} for all $n,k\in \N_0$ and constants $C=C(k,n)$. \end{lemma} \begin{proof} Such extension results go back to Whitney's Extension Theorem \cite{WY}; for manifolds with boundary see \cite{Seeley}, and for the state of the art results see \cite{Baldi}. Our statement for the usual $C^n$-norms follows from the proof of the more general statement by Hamilton in \cite[Corollary II.1.3.7]{Ham}. By using the methods there, we can derive an explicit formula for the map $\epsilon$ \[ \epsilon(f)(x):=\begin{cases} f(x) &\text{ if } |x|\le 1\\ \chi(\frac{1}{|x|})\int_0^{\infty}\phi(t)(\chi f)(\frac{x}{|x|^{1+t}})\dif t&\text{ if } 1\le |x| \end{cases}\] for $f\in C^{\infty}_0(\overline{B}_1)$. Here $\chi\in C^{\infty}([0,\infty))$ denotes a function which satisfies \[ \chi(u)=\begin{cases} 0&\text{ if } u\le \frac{1}{4}\\ 1&\text{ if } \frac{1}{2}\le u \end{cases}\] and $\phi\in C^{\infty}([0,\infty))$ satisfies \[ \int_0^{\infty}\phi(t)t^n\dif t=(-1)^n \qquad \forall \ n\in\N_0.\] Since by \cite{Ham} the operator $\epsilon$ satisfies the estimates with respect to the $C^n$-norms, it can be easily shown that it satisfies also the estimates from the statement. \end{proof} \section{The Poisson cohomology of $\mathfrak{sl}_2(\C)$}\label{section: main result} In Subsection \ref{section: linear Poisson} we recall the interpretation of Poisson cohomology of a linear Poisson structure in terms of Lie algebra cohomology. We will see that for a semisimple Lie algebra $\g$ the Poisson cohomology of its associated linear Poisson structure can be described by its flat and formal Poisson cohomology. In Subsection \ref{section: setting} we fix some notation for the Lie algebra $\spl$, and then describe the symplectic foliation and the algebra of Casimirs. In Subsection \ref{section: formal poisson} we compute the formal Poisson cohomology groups of the linear Poisson structure associated with the real Lie algebra $\spl$. Finally, in Subsection \ref{section: PC statement}, we give the description of the Poisson cohomology groups of $\spl$, which will be proven in the following three sections. \subsection{Poisson cohomology of linear Poisson structures}\label{section: linear Poisson} A Poisson structure on a vector space is called linear if the set of linear functions is closed under the Poisson bracket. Such Poisson structures are in one-to-one correspondence with Lie algebra structures on the dual vector space via \eqref{eq: linear Poisson}. Explicitly, for a Lie algebra $(\g,[\cdot,\cdot])$, the Poisson structure $\pi$ on $\mathfrak{g}^*$ is determined by the condition that the map $l:\mathfrak{g}\to C^{\infty}(\mathfrak{g}^*)$, which identifies $\g$ with $(\mathfrak{g}^*)^*$, is a Lie algebra homomorphism: \[\{l_X,l_Y\}_{\pi}=l_{[X,Y]},\ where $\{\cdot,\cdot\}_{\pi}$ is the Poisson bracket on $C^{\infty}(\mathfrak{g}^*)$ corresponding to $\pi$. In particular, $C^{\infty}(\mathfrak{g}^*)$ becomes a $\mathfrak{g}$-representation, with $X\cdot h:=\{l_X,h\}$. Moreover, the Poisson complex of $(\mathfrak{g}^*,\pi)$ is isomorphic to the Chevalley-Eilenberg complex of $\g$ with coefficients in $C^{\infty}(\mathfrak{g}^*)$ \cite[Prop 7.14]{Laurent2013} \begin{equation}\label{iso_complexes} (\mathfrak{X}^{\bullet}(\mathfrak{g}^*),\dif_{\pi})\simeq (\wedge^{\bullet}\mathfrak{g}^*\otimes C^{\infty}(\mathfrak{g}^*),\dif_{EC}). \end{equation} This identification allows for the use of techniques from Lie theory in the calculation of Poisson cohomology. Under the isomorphism \eqref{iso_complexes}, the subcomplex of multivector fields on $\mathfrak{g}^*$ that are flat at $0$ corresponds to the Eilenberg-Chevalley complex of $\mathfrak{g}$ with coefficients in the subrepresentation $C_0^{\infty}(\mathfrak{g}^*)\subset C^{\infty}(\mathfrak{g}^*)$ consisting of smooth functions that are flat at zero: \begin{align}\label{eq: multivector fields identification} \mathfrak{X}^{\bullet}_0(\mathfrak{g}^*)\simeq \wedge^{\bullet}\mathfrak{g}^*\otimes C^{\infty}_0(\mathfrak{g}^*). \end{align} We call the cohomology of this complex the \textbf{flat Poisson cohomology} and denote it by $H^{\bullet}_0(\mathfrak{g}^*,\pi)$. The quotient complex is naturally identified with \[(\wedge^{\bullet} \mathfrak{g}^*\otimes \R[[\mathfrak{g}]],\dif_{EC}),\] where $\R[[\mathfrak{g}]]:=C^{\infty}(\mathfrak{g}^*)/C^{\infty}_0(\mathfrak{g}^*)$ is the ring of formal power series of functions on $\mathfrak{g}^*$. The resulting cohomology will be called the \textbf{formal Poisson cohomology at} $0\in \mathfrak{g}^*$ denoted by $H^{\bullet}_{F}(\mathfrak{g}^* ,\pi )$. By the above, this is isomorphic to the cohomology of $\mathfrak{g}$ with coefficients in $\R[[\mathfrak{g}]]$, i.e\ \[H^{\bullet}_{F}(\mathfrak{g}^*,\pi)\simeq H^{\bullet}(\mathfrak{g},\R[[\mathfrak{g}]]).\] Moreover, the short exact sequence \begin{align*} 0\to C^{\infty}_0(\mathfrak{g}^*)\to C^{\infty}(\mathfrak{g}^*)\stackrel{j^{\infty}_0}{\longrightarrow} \R[[\g]]\to 0, \end{align*} induces a long exact sequence in cohomology: \begin{equation}\label{jet} \ldots \stackrel{j^{\infty}_0}{\to} H^{\bullet-1}_{F}(\mathfrak{g}^*,\pi)\stackrel{\partial}{\to} H^{\bullet}_{0}(\mathfrak{g}^*,\pi)\to H^{\bullet}(\mathfrak{g}^*,\pi)\stackrel{j^{\infty}_0}{\to}H^{\bullet}_{F}(\mathfrak{g}^*,\pi )\stackrel{\partial}{\to}\ldots \end{equation} If the Lie algebra $\g$ is semisimple, we can say more: \begin{proposition}\cite[Corollary 4.5]{MZ}\label{ses smooth formal} For a semisimple Lie algebra $\g$, the Poisson cohomology of $(\mathfrak{g}^*,\pi)$ fits into the short exact sequence \[0\to H^{\bullet}_0(\mathfrak{g}^*,\pi)\to H^{\bullet}(\mathfrak{g}^*,\pi)\stackrel{j^{\infty}_0}{\to} H^{\bullet}_F(\mathfrak{g}^*,\pi)\to 0.\] \end{proposition} Elements in the $0$-th Poisson cohomology are called \emph{Casimir functions} \[\Cas(\mathfrak{g}^*,\pi):=H^0(\mathfrak{g}^*,\pi).\] These are the same as functions on $\mathfrak{g}^*$ that are invariant under the coadjoint action. The flat and the formal Casimir functions will be denoted: \[\Cas_0(\mathfrak{g}^*,\pi) \quad \textrm{and}\quad \Cas_F(\mathfrak{g}^*,\pi).\] The formal Poisson cohomology of semisimple Lie algebras is well-known: \begin{proposition}\label{formal cohomology} \cite[Proposition 4.2 \& 4.3]{MZ} Let $(\mathfrak{g}^*,\pi)$ be the linear Poisson structure associated to a semisimple Lie algebra $\mathfrak{g}$. \begin{enumerate} \item There exist $n=\dim \mathfrak{g} - \max \mathrm{rank}(\pi)$ algebraically independent homogeneous polynomials $f_1 ,\dots , f_n$ such that \begin{align*} \Cas_F(\mathfrak{g}^*,\pi)=\R[[f_1 ,\dots ,f_n ]] \subset \R[[\mathfrak{g}]]. \end{align*} Here $\R[[f_1,\dots ,f_n]]$ denotes formal power series in the polynomials $f_j$. \item For the formal Poisson cohomology of $\g$ at $0$ we have that: \begin{align*} H^{\bullet}_{F}(\mathfrak{g}^*,\pi)&\simeq H^{\bullet}(\g)\otimes \Cas _{F}(\mathfrak{g}^*,\pi). \end{align*} \end{enumerate} \end{proposition} In the next subsections we will use these results for $\spl$. \subsection{The foliation and the Casimirs}\label{section: setting} In this subsection we describe the linear Poisson structure associated with the real Lie algebra $\spl$ in terms of its complex counterpart, and we discuss its symplectic foliation and the algebra of Casimir functions. We consider the following complex coordinates on $\spl$: \begin{equation}\label{eq: identification} \C^3\simeq \mathfrak{sl}_2(\C)\quad (z_1,z_2,z_3)\mapsto A:= \begin{pmatrix} iz_1 &-z_2+iz_3 \\ z_2+iz_3&-iz_1 \end{pmatrix} \end{equation} Throughout the paper we identify $\spl\simeq \spl^*$ via the trace form: \[\spl\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \spl^*, \quad A\mapsto \big(B\mapsto \mathrm{tr}(A\cdot B)\big).\] We use this identification to regard the linear Poisson structure associated with the \emph{complex} Lie algebra $\spl$ as a complex Poisson structure on $\spl$. In the coordinates from above, this becomes: \begin{align}\label{eq:complex basis} \pi_{\C} &:=z_1\partial_{z_2} \wedge \partial_{z_3} +z_2 \partial_{z_3} \wedge \partial_{z_1} +z_3\partial_{z_1}\wedge \partial_{z_2} \end{align} The real and the imaginary part of $\pi_{\C}$ yield two Poisson structures \begin{align}\label{eq: real identification} \pi=\pi_{1}:=4\cdot \Re (\pi_{\C}), \ \ \ \ \pi_{2} =4\cdot \Im(\pi_{\C}) \end{align} The constant $4$ ensures that the linear Poisson structure associated with the \emph{real} Lie algebra $\spl$ is: \[(\spl,\pi).\] We denote the corresponding \emph{singular symplectic foliation} by: \[(\mathcal{F},\omega_{1}).\] From general properties of complex Poisson structures (see \cite{LGStXu}), it follows that the leaves of $\mathcal{\F}$ coincide with the adjoint orbits on $\mathfrak{sl}_2(\C)$, and agree also with the leaves of $\pi_2$ and of $\pi_{\C}$. The leaves can be described using the level sets of the basic, complex-valued Casimir function: \begin{align}\label{eq:casimir} &f=f_1+ i\, f_2 :\spl\to \C,\nonumber \\ &f(A):= \det (A)=z_1^2+z_2^2+z_3^2. \end{align} More precisely, the leaves are the following families of submanifolds: \[S_{z}:=f^{-1}(z), \ \ z\in \C \setminus\{ 0\},\] and the singular cone $S_0:=f^{-1}(0)$ decomposes into two leaves: \[\{0\} \ \ \ \ \ \textrm{ and }\ \ \ \ \ S^{\text{reg}}_{0}:=f^{-1}(0)\setminus \{0\}. \] The map $f$ generates all Casimir functions on $\spl$: \begin{proposition}\label{prop:Casimirs} The algebra of Casimir functions of $(\spl,\pi)$ is isomorphic to the algebra of smooth functions on $\C$, via the map: \begin{equation*} f^*:C^{\infty}(\C)\xrightarrow{\raisebox{-0.2 em}[0pt][0pt]{\smash{\ensuremath{\sim}}}} \Cas(\mathfrak{sl}_2(\C),\pi),\quad g\mapsto g\circ f. \end{equation*} \end{proposition} \begin{proof} Clearly, the assignment is well-defined and injective. Surjectivity follows because $f$ restricts to a surjective submersion on the open dense set $\mathfrak{sl}_2(\C)\setminus \{0\}$, whose fibers are precisely the leaves. \end{proof} \begin{remark} The \textbf{leaf-space} of $\F$, denoted $\spl/\mathcal{F}$, is obtained by identifying points in $\spl$ that belong to the same leaf. The \textbf{regular leaf-space} $(\spl\backslash\{0\})/\mathcal{F}$ has a smooth structure such that the quotient map is a submersion. In fact, $f|_{\mathfrak{sl}_2(\C)\setminus \{0\}}$ descends to a diffeomorphism: \[ (\spl\backslash\{0\})/\mathcal{F}\simeq \C.\] Therefore, Proposition \ref{prop:Casimirs} implies that the restriction map \[\Cas(\mathfrak{sl}_2(\C),\pi)\to C^{\infty}\big((\spl\backslash\{0\})/\F\big)\] is an isomorphism from the algebra of Casimirs to the algebra of smooth functions on the regular leaf-space. \end{remark} \subsection{Formal Poisson cohomology of $\mathfrak{sl}_2(\C)$}\label{section: formal poisson} We compute the formal Poisson cohomology of $(\mathfrak{sl}_2(\C),\pi)$. For this, we introduce the real coordinates $\{x_j,y_j\}_{j=1}^3$ on $\mathfrak{sl}_2(\C)$: \[ z_j:= x_j+i\cdot y_{j}, \quad \text{ for } j\in \{1,2,3\}.\] By Proposition \ref{formal cohomology}, the invariant polynomials on $\mathfrak{sl}_2(\C)$ are generated by the functions $f_{1}$ and $f_{2}$ from $f=f_1+i\cdot f_2$ in \eqref{eq:casimir}. Therefore, in order to determine the formal Poisson cohomology of $(\mathfrak{sl}_2(\C),\pi)$, we need to calculate the Lie algebra cohomology of $\spl$. We obtain the following result. \begin{proposition}\label{formal cohomology sl2} The formal Poisson cohomology groups of $(\mathfrak{sl}_2(\C),\pi)$ at the origin are given by \[H^k_F(\mathfrak{sl}_2(\C),\pi)= \begin{cases} \R[[f_1,f_2]]& \text{ if }k=0\\ \R[[f_1,f_2]]\cdot C_{\mathcal{R}} \oplus \R[[f_1,f_2]]\cdot C_{\mathcal{I}}& \text{ if } k=3\\ \R[[f_1,f_2]]\cdot C_{\mathcal{R}}\wedge C_{\mathcal{I}}& \text{ if } k=6\\ 0& \text{ else} \end{cases}\] where $C_{\mathcal{R}}$ and $C_{\mathcal{I}}$ are $\frac{4}{3}$ of the real and imaginary part of the Cartan three-form, respectively. Explicitly: \begin{align*} C_{\mathcal{R}}=&\ \frac{1}{2}( \partial_{x_1}\partial_{x_2}\partial_{x_3}-\partial_{y_1}\partial_{y_2}\partial_{x_3}-\partial_{x_1}\partial_{y_2}\partial_{y_3}-\partial_{y_1}\partial_{x_2}\partial_{y_3})\\ C_{\mathcal{I}}=&\ \frac{1}{2} ( \partial_{y_1}\partial_{y_2}\partial_{y_3}-\partial_{y_1}\partial_{x_2}\partial_{x_3}-\partial_{x_1}\partial_{y_2}\partial_{x_3}-\partial_{x_1}\partial_{x_2}\partial_{y_3}) \end{align*} \end{proposition} \begin{proof} By Propositions \ref{formal cohomology} we have \[H^{\bullet}_F(\mathfrak{sl}_2(\C),\pi)= H^{\bullet}(\spl)\otimes \R[[f_1,f_2]].\] From standard Lie theory we know that $H^{\bullet}(\mathfrak{sl}_2(\C))$ is isomorphic to a free exterior algebra with two generators in degree three (see \cite{Chev50} or also \cite[Corollary 3.7]{Sol02}). The complex-valued Cartan three-form is given by \begin{align*} 3\, \partial_{z_1}\partial_{z_2}\partial_{z_3} \end{align*} Hence taking $\frac{4}{3}$ of the real and imaginary part yields $C_{\mathcal{R}}$ and $C_{\mathcal{I}}$, respectively. Note that $C_{\mathcal{R}},C_{\mathcal{I}}\in(\wedge^{3}\spl)^{\spl}$ and from \cite[Theorem 19.1]{Chev1948} we know that every element in $H^{\bullet}(\spl)$ has a unique $\spl$-invariant representative. As a result we obtain for the Lie algebra cohomology $H^{\bullet}(\spl)$: \begin{align*} H^0(\spl) &=\R,\\ H^{3}(\spl)&=\R\cdot C_{\mathcal{R}} \oplus \R\cdot C_{\mathcal{I}}, \\ H^{6}(\spl)&=\R\cdot C_{\mathcal{R}}\wedge C_{\mathcal{I}} \end{align*} and $H^{k}(\spl)=0$ in all other degrees. \end{proof} \subsection{Poisson cohomology of $\spl$}\label{section: PC statement} Recall that Poisson cohomology is a module over the space of Casimir functions, which, for $\spl$, is isomorphic to $C^{\infty}(\C)$ (see Proposition \ref{prop:Casimirs}). We will describe the Poisson cohomology groups as modules over this algebra, and we will also describe the induced Schouten Nijenhuis bracket. The following two vector fields on $\C\setminus \{0\}$ will play an important role: \begin{align*} Y_1:=-y\partial_x+ (|z|+x)\partial_y \quad \text{ and }\quad Y_2:= (|z|-x)\partial_x -y\partial_y, \end{align*} where we used the coordinate $z=x+i\cdot y$ on $\C$. These satisfy, the relations \begin{align* [Y_1,Y_2]=Y_2 \qquad \textrm{and} \qquad (|z|-x)\cdot Y_1 = -y\cdot Y_2. \end{align*} The mild singularities of these vector fields imply that, when multiplied with flat functions, they became smooth, flat vector fields on $\C$. Motivated by the theorem below, we denote the resulting $C^{\infty}(\C)$-module by: \begin{equation}\label{eq:flat:module:of:vector:fields} \mathfrak{out}(\spl,\pi):=\{g_1Y_1+g_2Y_2\, |\, g_1,g_2\in C^{\infty}_0(\C)\} \subset \mathfrak{X}^1_0(\C). \end{equation} The bracket relation above shows that $\mathfrak{out}(\spl,\pi)$ is a Lie subalgebra of the algebra of flat vector fields. The second relation above shows that we have an isomorphism of $C^{\infty}(\C)$-modules: \[ \mathfrak{out}(\spl,\pi)\simeq \frac{C_0^{\infty}(\C)\oplus C^{\infty}_0(\C)}{\big\{(g_1,g_2)\ |\ yg_1=(|z|-x) g_2\big\}}. \] This module will appear more frequently in the paper (see Subsection \ref{subsection: twisted module}). We are ready now to describe the Poisson cohomology. \begin{theorem}\label{theorem: PC} The Poisson cohomology groups of $(\spl,\pi)$ are \begin{itemize} \item $H^0(\spl,\pi)\simeq C^{\infty}(\C)$, via the isomorphism: \[g\circ f\in H^0(\spl,\pi) \qquad \leftrightarrow \qquad g\in C^{\infty}(\C);\] \item $H^1(\spl,\pi)\simeq \mathfrak{out}(\spl,\pi)$, as $C^{\infty}(\C)$-modules and as Lie algebras, via the natural action of $H^1(\spl,\pi)$ on Casi\-mirs; i.e., \[[X]\in H^1(\spl,\pi) \qquad \leftrightarrow \qquad Y\in \mathfrak{out}(\spl,\pi)\] if and only if, for all $g\in C^{\infty}(\C)$: \[\Lie_X(g\circ f)=\Lie_Y(g)\circ f;\] \item $H^2(\spl,\pi)=0$; \item $H^3(\spl,\pi)\simeq C^{\infty}(\C)\oplus C^{\infty}(\C)/C^{\infty}_0(\C) $ as $C^{\infty}(\C)$-modules, where to $(g_1,[g_2])\in C^{\infty}(\C)\oplus C^{\infty}(\C)/C^{\infty}_0(\C)$ we associate: \[[g_1\circ f\cdot C_{\mathcal{R}}+g_2\circ f \cdot C_{\mathcal{I}}] \in H^3(\spl,\pi);\] \item $H^4(\spl,\pi)\simeq H^1(\spl,\pi)$, via the isomorphism: \[[X]\in H^1(\spl,\pi)\quad \leftrightarrow \quad [X\wedge C_\mathcal{R}]\in H^4(\spl,\pi);\] \item $H^5(\spl,\pi)=0$; \item $H^6(\spl,\pi)\simeq C^{\infty}(\C)/C^{\infty}_0(\C)$, via the isomorphism: \[[g\circ f\cdot C_{\mathcal{R}}\wedge C_{\mathcal{I}}]\in H^6(\spl,\pi) \qquad \leftrightarrow \qquad [g]\in C^{\infty}(\C)/C^{\infty}_0(\C).\] \end{itemize} \end{theorem} Note that the wedge product on $H^{\bullet}(\spl,\pi)$ is determined from the descriptions in the theorem. The Schouten bracket is determined by the isomorphism of Lie algebras from $H^1(\spl,\pi)\simeq \mathfrak{out}(\spl,\pi)$, the usual Leibniz rule, and the following relations: for any $[X]\in H^1(\spl,\pi)$, \[[[X,C_{\mathcal{R}}]]=[[X,C_{\mathcal{I}}]]=0\in H^3(\spl,\pi).\] The proof of Theorem \ref{theorem: PC} will be completed in Subsection \ref{section: algebra}, where we also prove the above relation. \subsection{Convolution, Fourier theory and regularization}\label{section: recall ft} In this subsection we recall some basics of Fourier theory which will be used to construct the smoothing operators. An important operation on the Schwartz space is the \textbf{convolution} of two functions $f,g\in \mathcal{S}(\R^m)$, defined by: \[(f*g)(x):=\int_{\R^m}f(x-y)g(y)\dif y \] We have that $f*g\in \mathcal{S}(\R^m)$ and for any $a\in \N_0^m$ we have \[ D^a(f*g)=(D^af)*g=f*(D^a g).\] Recall also the \textbf{Fourier transform} \[ \hat{f}(\xi):= \Big(\frac{1}{\sqrt{2\pi}}\Big)^{m} \int_{\R^m} f(x) e^{-i x\cdot \xi }\dif x,\] which is an automorphism of $\mathcal{S}(\R^m)$ with inverse: \[ f(x)=\Big(\frac{1}{\sqrt{2\pi}}\Big)^{m} \int_{\R^m} \hat{f}(\xi) e^{i x\cdot\xi }\dif \xi . \] The Fourier transform satisfies the following properties: \begin{equation}\label{eq: fundamental prop fourier} \begin{array}{rclcrcl} \hat{\hat{f}}(x)&=&f(-x) &\text{ and }&\widehat{f_{\lambda}}(\xi) &=& \hat{f}(\frac{\xi}{\lambda}), \\ \hat{f}(\xi)&=&\bar{\hat{f}}(-\xi) \ \ \ & \Leftrightarrow& \ \ \ f&\in& \mathcal{S}(\R^m;\R),\\ \widehat{D^a f}&=&(i\xi)^a\hat{f}& \text{ and }& \widehat{x^a f} &=&(-i)^{|a|}D^a\hat{f},\\ \widehat{f*g} &=& (\sqrt{2\pi})^m \hat{f}\cdot \hat{g}& \text{ and }& \widehat{f\cdot g}& =& (\sqrt{2\pi})^m\hat{f}*\hat{g} \end{array} \end{equation} for $f\in \mathcal{S}(\R^m)$, $\lambda \in \C^{\times}$, $a\in \N_0^m$ and $f_{\lambda}$ is defined by $f_{\lambda}(x):= \lambda^m f(\lambda \cdot x)$. \subsection{Smoothing operators on the Schwartz space}\label{section: smoothing nash} In this subsection we follow Nash \cite{Nash} to construct smoothing operators $\tilde{S}_t$ on the Schwartz space $\mathcal{S}(\R^m)$ for $0<t$. Nash proves estimates of $\tilde{S}_t$ for the standard norms $\norm{\cdot}_n$. Our goal is to provide estimates of $\tilde{S}_t$ with respect to the norms $\norm{\cdot}_{n,k}$ for all $k,n\in \N_0$. Fix a function $\chi \in C^{\infty}(\R)$ such that \begin{align}\label{eq: bump} \chi(u)=\begin{cases} 1&\text{ if } u\le 1\\ \text{monotone decreasing } &\text{ if } u\in (1,2)\\ 0&\text{ if }2\le u \end{cases} \end{align} We define the function $K\in \mathcal{S}(\R^m)$ by its Fourier transform \begin{align*} \hat{K}(\xi):=\Big(\frac{1}{\sqrt{2\pi}}\Big)^m \prod_{i=1}^m\chi(|\xi_i|). \end{align*} In the definition of $K$, we deviate slightly from Nash's construction, in an unessential way. The constant in the definition of $K$ ensures that: \[ \int_{\R^m}K(x)=1.\] For $t>0$, set $K_t(x):=t^mK(t\cdot x)$. Define the \textbf{smoothing operator} by \begin{equation*} \begin{array}{cccc} \tilde{S}_t:&\mathcal{S}(\R^m)&\to &\mathcal{S}(\R^m)\\ &f&\mapsto& K_t * f \end{array} \end{equation*} \begin{remark} Note that $\tilde{S}_t$ preserves the $\R$-valued functions by \eqref{eq: fundamental prop fourier}. Therefore, so will all the other smoothing operators which we build below. \end{remark} We show that these operators are indeed smoothings: \begin{lemma}\label{eq: first smoothing original} The operators $\tilde{S}_t$ satisfy: \begin{align*} \norm{\tilde{S}_t(f)}_{n+l,k}\le C t^{l}\norm{f}_{n,k} \end{align*} for all $f\in \mathcal{S}(\R^m)$, all $k,l,n\in \N_0$ and all $1\leq t$, with $C=C(k,l,n)$. \end{lemma} \begin{proof} For the proof note that for any $a\in \N_0^m$ we have \[ D^aK_t(x)=t^{m+|a|}D^a(K)(tx).\] Let $k, l, n\in \N_0$, and let $a\in \N^m_0$ with $|a|=n+l$. Decompose $a=a^1+a^2$, with $|a^1|=l$ and $|a^2|=n$. Using \eqref{eq: fundamental prop fourier} we obtain for any $f\in \mathcal{S}(\R^m)$: \begin{align*} |x|^k|D^{a}(K_t&\, *f)(x)| = |x|^k||(D^{a^1}(K_t) *D^{a^2}(f))(x)|\\ =& \ t^{l+m}|x|^{k}|\int_{\R^m}D^{a^1}(K)(t(x-y))D^{a^2}(f)(y)\dif y|\\ \le & \ C t^{l+m}\Big(\int_{\R^m}|D^{a^1}(K)(t(x-y))||y|^{k}|D^{a^2}(f)(y)|\dif y\\ & \ +t^{-k}\int_{\R^m}(t|x-y|)^{k}|D^{a^1}(K)(t(x-y))||D^{a^2}(f)(y)|\dif y\Big) \end{align*} where we used the estimate \begin{align}\label{eq: triangle} |x|^k=|x-y+y|^k\le C(|x-y|^k + |y|^k) \end{align} for some constant $0<C(k)$. We estimate the first term by \begin{align*} t^{l+m}\int_{\R^m}|D^{a^1}(K)&\,(t(x-y))||y|^{k}|D^{a^2}(f)(y)|\dif y\\ \le &\ t^l \norm{f}_{n,k} \int_{\R^m}|D^{a^1}(K)(z)|\dif z\ \le C t^l \norm{f}_{n,k} \end{align*} where we used the change of coordinates given by $z=t(x-y)$. The second term can similarly be estimated by using also that $t^{-k}\leq 1$: \begin{align*} t^{l+m}\int_{\R^m}(t|x-y|)^{k}&\,|D^{a^1}(K)(t(x-y))||D^{a^2}(f)(y)|\dif y\\ \le &\ t^{l} \norm{f}_{n,0} \int_{\R^m}|z|^k|D^{a^1}(K)(z)|\dif z \ \le C t^{l} \norm{f}_{n,k}. \end{align*} This proves the statement. \end{proof} Next we show that the family $\tilde{S}_t$ approximates the identity as $t\to \infty$. \begin{lemma}\label{eq: second smoothing original} The operators $\tilde{S}_t$ satisfy: \begin{align*} \norm{(\id - \tilde{S}_t)(f)}_{n,k}\le C t^{-l} \norm{f}_{n+l,k} \end{align*}for all $f\in \mathcal{S}(\R^m)$, all $k,l,n\in \N_0$ and all $t\geq 1$, with $C=C(k,l,n)$. \end{lemma} \begin{proof} First we claim that, for any $f\in \mathcal{S}(\R^m)$: \begin{align*} \norm{f-\tilde{S}_t(f)}_{n,k}\xrightarrow{t\to \infty}0 \qquad \forall \ k,n\in\N_0. \end{align*} Note that, since $K$ is Schwartz function, for every $\eta>0$ we have \begin{align*} \int_{|y|\geq \eta}|K_t(y)|\dif y =\int_{|x|\geq t \eta}|K(x)|\dif x \xrightarrow{t\to \infty} 0 \end{align*} Let $\varepsilon>0$. For $R:= \norm{f}_{0,k+1}/\varepsilon$, we have that: \begin{align*} \sup_{x\in\R^m\setminus B_{R}} |x|^k|f(x)|\le \varepsilon \end{align*} For $x\in \R^m\setminus B_{2R}$, by using \eqref{eq: triangle}, we obtain \begin{align*} |x|^k |(f-K_t*f)(x)|&\ = |x|^k|\int_{\R^m}K_t(y)(f(x-y)-f(x))\dif y|\\ &\ \leq C\int_{B_{R}}(1+|y|^k|x-y|^{-k})|x-y|^k|K_t(y)f(x-y)|\dif y\\ &\ \quad + |x|^k|f(x)|\int_{B_{R}}|K_t(y)|\dif y\\ &\ \quad + |x|^k|\int_{\R^m\backslash B_{R}}K_t(y)(f(x-y)-f(x))\dif y|\\ &\ \le C\varepsilon +2\norm{f}_{0,0}|x|^k\int_{\R^m\setminus B_{R}}|K_t(y)|\dif y \xrightarrow{t\to \infty} \varepsilon C. \end{align*} Choose $\delta>0$ such that for all $x\in \overline{B}_{2R}$ and $y\in \overline{B}_{\delta}$: \begin{align*} (2R)^k|f(x)-f(x-y)|\le \varepsilon \end{align*} Then, for $x\in \overline{B}_{2R}$, we obtain: \begin{align*} |x|^k |(f-K_t*f)(x)|&\le |x|^k|\int_{\R^m}K_t(y)(f(x-y)-f(x))\dif y|\\ &\le \varepsilon +2\norm{f}_{0,0}|x|^k\int_{\R^m\setminus B_{\delta}}|K_t(y)|\dif y \xrightarrow{t\to \infty}\varepsilon \end{align*} This implies the claim made at the beginning. In order to obtain the desired estimate we use the estimate \begin{align*} \norm{\tilde{S}_{t_2}(f)-\tilde{S}_{t_1}(f)}_{n,k}\le \int_{t_1}^{t_2} \norm{\partial_t\tilde{S}_t(f)}_{n,k}\dif t \end{align*} for the limit $t_2\to \infty$. Taking the derivative with respect to $t$ of $\tilde{S}_t(f)$ gives \[ \partial_t(K_t*f)=(\partial_tK_t)*f.\] Note that the Fourier transform of $\partial_t K_t$ is given by \begin{equation*} \widehat{\partial_tK_t}(\xi)=\partial_t \hat{K_t}(\xi)=\partial_t \hat{K}(\xi/t)= -t^{-2}\sum_{j=1}^m|\xi_j|\chi^{(1)}(\frac{|\xi_j|}{t})\prod_{i\ne j}^m\chi(\frac{|\xi_i|}{t}) \end{equation*} We set $L:=\partial_tK_t|_{t=1}$. Similar as for $K_t$ we have \[ \partial_tK_t(x)=t^{m-1}L(t\cdot x)\] We decompose $L$ in the following way: define the functions $\hat{L}_j$ by \begin{equation*} \hat{L}_j(\xi):=|\xi_j|\chi^{(1)}(|\xi_j|)\prod_{i\ne j}^m\chi(|\xi_i|)\ \ \ \ \ \ \text{ for }\ j\in \{1,\dots,m\}. \end{equation*} Note that the $L_j$ satisfy the following properties \begin{align*} L=\sum_{j=1}^mL_j, \qquad \hat{L}_j(\xi)=\bar{\hat{L}}_j(-\xi), \end{align*} and that $\hat{L}_j$ is supported in $[-2,2]^m$ and vanishes for $|\xi_j|\leq 1$. Therefore we may define for $l\geq 0$ the functions $L_j^l$ via their Fourier transforms: \[ \hat{L}_j^l := \big(\frac{1}{i\cdot \xi_j}\big) ^l \cdot \hat{L}_j\ \in \mathcal{S}(\R^m). \] By \eqref{eq: fundamental prop fourier} the kernels $L_j^l$ satisfy for $k<l\in \N_0$ the following properties: \begin{equation*} \begin{array}{c} \partial_j^kL_j^l=L_j^{l-k}\ \ \ \ \ \ \ \ \ \hat{L}_j^l(\xi)=\bar{\hat{L}}_j^l(-\xi) \end{array} \end{equation*} Hence we obtain for all $l, n\in \N_0$, all $f\in \mathcal{S}(\R^m)$ and any $a\in \N_0^m$ with $|a|=n$ the estimate \begin{alignat*}{3} & |D^{a}(\partial_t K_t *f)(x)|&&\ =&&\ |(\partial_t K_t *D^a(f))(x)|\\ & &&\ =&&\ t^{m-1}|\int_{\R^m}L(t(x- y))D^a(f)(y)\dif y|\\ & && \ =&& \ t^{-1}|\int_{\R^m}\sum_{j=1}^mL_j(z)D^{a}(f)(x-\frac{z}{t})\dif z|\\ & && \ =&& \ t^{-1}|\int_{\R^m}\sum_{j=1}^m\partial_{j}^l(L_j^l)(z)D^{a}(f)(x-\frac{z}{t}))\dif z|\\ & && \ =&& \ t^{-1}|\int_{\R^m}\sum_{j=1}^mL_j^l(z)\partial_{j}^l(D^{a}(f)(x-\frac{z}{t}))\dif z|\\ & && \ =&& \ t^{-l-1}|\int_{\R^m}\sum_{j=1}^mL_j^l(z)D^{a+l\cdot e_j}(f)(x-\frac{z}{t})\dif z|\\ & && \leq && t^{m-l-1}\sum_{j=1}^m \int_{\R^m}|L_{j}^l(t(x-y))||D^{a+l\cdot e_j}(f)(y)|\dif y \end{alignat*} where we used the change of coordinates given by $z=t(x-y)$ and $e_j $ denotes the $j$-th standard vector in $\R^m$. Using \eqref{eq: triangle} as in the proof of the previous lemma we obtain, for $k\geq 0$: \begin{align*} |x|^k|D^{a}(\partial_t K_t &*f)(x)| \leq t^{m-l-1}|x|^{k}\sum_{j=1}^m \int_{\R^m}|L_{j}^l(t(x-y))||D^{a+l\cdot e_j}(f)(y)|\dif y\\ \leq\ &\ Ct^{m-l-1}\sum_{j=1}^m \int_{\R^m}|x-y|^{k}|L_{j}^l(t(x-y))||D^{a+l\cdot e_j}(f)(y)|\dif y\\ +\ &\ Ct^{m-l-1}\sum_{j=1}^m \int_{\R^m}|L_{j}^l(t(x-y))||y|^{k}|D^{a+l\cdot e_j}(f)(y)|\dif y\\ \leq \ &\ C\cdot t^{-l-1}(\norm{f}_{n+l,k}+t^{-k}\norm{f}_{n+l,0}) \end{align*} which, using $t\geq 1$, leads to the estimate \begin{align*} \norm{\partial_t K_t*f}_{n,k}\le C\cdot t^{-l-1}\norm{f}_{n+l,k}. \end{align*} Hence integration from $t$ to $\infty$ yields the statement. \end{proof} \subsection{Smoothing operators for flat functions}\label{section: smoothing flat} In this section we use the smoothing operators on the Schwartz space from the previous section to construct smoothing operators $S_{t,r}$ on the space $C^{\infty}_0(\overline{B}_r)$. We define also a second family of operators $T_{s,r}$ on $ C^{\infty}_0(\overline{B}_r)$, which can be thought of as smoothing operators with respect to the $k$-index of the norms $\fnorm{\cdot}_{n,k,r}$. Finally, by combining these two, we build smoothing operators $S_{s,t,r}$ on $ C^{\infty}_0(\overline{B}_r)$ for $s,t>0$. \subsubsection{Smoothing in the derivatives} We first define $S_{t,1}:C^{\infty}_0(\overline{B}_1)\to C^{\infty}_0(\overline{B}_1)$ as the composition of the maps \begin{equation*} \begin{tikzpicture}[baseline= (a).base] \node[scale=.85] (a) at (0,0){ \begin{tikzcd} C^{\infty}_0(\overline{B}_1)\arrow{r}{\epsilon}& \mathcal{S}_0(\R^m)\arrow{r}{\rho^*}& \mathcal{S}_0(\R^m)\arrow{r}{\tilde{S}_{t}}& \mathcal{S}(\R^m)\arrow{r}{\iota^*}& \mathcal{S}(C_1)\arrow{r}{\rho_{B}^*}& C^{\infty}_0(\overline{B}_1) \end{tikzcd} }; \end{tikzpicture} \end{equation*} where $\iota: C_1 \hookrightarrow \R^m$ is the inclusion and $\rho_B^*$ was defined in Corollary \ref{corollary: inversion r}. For $0<r $ denote by $m_r :\R^m\to\R^m $ the multiplication by $r$, i.e. \[m_r(x) := \ r\cdot x\] Then we define the operators $S_{t,r}$ by \begin{equation*} \begin{array}{cccc} S_{t,r}: & C^{\infty}_0(\overline{B}_r)&\to & C^{\infty}_0(\overline{B}_r)\\ &f &\mapsto& m_{\frac{1}{r}}^* \circ S_{t,1} \circ m_r^*(f) \end{array} \end{equation*} \begin{proposition}\label{proposition: derivatiave smoothing} The operators $S_{t,r}$ satisfy: \begin{align*} \fnorm{S_{t,r}(f)}_{n+l,k,r} \le &\ C t^{l}\fnorm{f}_{n,k+2 l,r}\\ \fnorm{(S_{t,r}-\id)(f)}_{n,k+2l,r} \le &\ C t^{-l}\fnorm{f}_{n+l,k,r} \end{align*} for all $f\in C^{\infty}_0(\overline{B}_r)$, all $k,l,n\in \N_0$ and all $t\geq 1$, with $C=C(k,l,n,r)$ depending continuously on $r>0$. \end{proposition} \begin{proof} By applying Corollary \ref{corollary: inversion r}, Lemma \ref{eq: first smoothing original}, Proposition \ref{proposition: inversion} and Lemma \ref{lemma: extension}, we obtain the following estimate for $S_{t,1}$: \begin{align*} \fnorm{S_{t,1}(f)}_{n+l,k,1} = &\ \fnorm{\rho_B^* \circ \iota^* \circ \tilde{S}_{t}\circ \rho^*\circ \epsilon (f)}_{n+l,k,1}\\ \le &\ C \norm{\tilde{S}_{t}\circ \rho^*\circ \epsilon (f)}_{n+l,k+2(n+l)}\\ \le &\ C t^{l}\norm{\rho^*\circ \epsilon (f)}_{n,k+2(n+l)}\\ \le&\ C t^{l}\fnorm{\epsilon(f)}_{n,k+2l}\le C t^{l}\fnorm{f}_{n,k+2l,1} \end{align*} Similarly, by using Lemma \ref{eq: second smoothing original} instead of Lemma \ref{eq: first smoothing original}, we obtain that \begin{align*} \fnorm{(S_{t,1}-\id)(f)}_{n,k+2l,1}= &\ \fnorm{\rho_B^* \circ \iota^* \circ (\tilde{S}_{t}-\id) \circ \rho^* \circ \epsilon (f)}_{n,k+2l,1}\\ \le &\ C \norm{(\tilde{S}_{t}-\id)\circ \rho^*\circ \epsilon (f)}_{n,k+2(n+l)}\\ \le &\ C t^{-l}\norm{\rho^*\circ \epsilon (f)}_{n+l,k+2(n+l)}\\ \le &\ C t^{-l}\fnorm{\epsilon(f)}_{n+l,k}\le C t^{-l}\fnorm{f}_{n+l,k,1} \end{align*} In order to obtain the bounds for $S_{t,r}$ note that for $f\in C^{\infty}_0(\overline{B}_R)$: \[ \fnorm{f\circ m_r}_{n,k,R/r}\le \mathrm{max}(1,r^n) r^{k}\fnorm{f}_{n,k,R}\] and we have a similar inequality for $m_{1/r}$. This shows that $C=C(k,l,n, r)$ can be taken to depend continuously on $0<r$. \end{proof} \subsubsection{Smoothing in the weights} To define the operators $T_{s,r}:C^{\infty}_0(\overline{B}_r)\to C^{\infty}_0(\overline{B}_r)$ we proceed similarly as above. First we define $T_{s,1}$, for $s>0$, by \begin{equation*} \begin{array}{cccc} T_{s,1}:&C^{\infty}_0(\overline{B}_1)&\to & C^{\infty}_0(\overline{B}_1) \\ & f&\mapsto &\chi( s |x|)f(x) \end{array} \end{equation*} where $\chi\in C^{\infty}(\R)$ is such that \begin{align*} \chi(u)=\begin{cases} 0&\text{ if } u\le 1\\ 1&\text{ if } 2\le u \end{cases} \end{align*} The operators $T_{s,r}$ are then given by \begin{equation*} \begin{array}{cccc} T_{s,r}: & C^{\infty}_0(\overline{B}_r)&\to & C^{\infty}_0(\overline{B}_r)\\ &f &\mapsto& m_{\frac{1}{r}}^*\circ T_{s,1} \circ m_r^*(f) \end{array} \end{equation*} For these operators, we obtain the following estimates. \begin{proposition}\label{proposition: weight smoothing} The operators $T_{s,r}$ satisfy: \begin{align*} \fnorm{T_{s,r}(f)}_{n,k+j,r} \le &\ C s^{j}\fnorm{f}_{n,k,r}\\ \fnorm{(T_{s,r}-\id)(f)}_{n,k,r} \le &\ C s^{-j}\fnorm{f}_{n,k+j,r} \end{align*} for all $f\in C^{\infty}_0(\overline{B}_r)$, all $j,k,n\in \N_0$ and all $s>0$ with $C=C(j,k,n,r)$ depending continuously on $r>0$. \end{proposition} \begin{proof} We proof the statement for $T_{s,1}$, from which the general case $T_{s,r}$ follows as in the proof of the previous proposition. For $a\in \N_0^m$ with $|a|=n>0$, and $l\in \mathbb{Z}$ we have: \begin{align}\label{eq: boundedness} (s|x|)^{l}|D^{a}(\chi(s|x|))| \le &\ C|x|^{-n}\sum_{1\le |b|\le n}(s|x|)^{|b|+l}|(D^{b}\chi)(s|x|)|\leq C |x|^{-n}, \end{align} where we use that, for all $i\in \Z$, $b \in \N_0^m$ with $|b|>0$: \[ \sup_{y\in \R }|y|^i|D^{b}\chi(y)| <\infty.\] Note that \eqref{eq: boundedness} holds also for $a=0$ if $l\leq 0$. Let $j,k,n\in \N_0 $ and $a\in \N_0^m$ with $|a|=n$. By using the above inequality and the Taylor formula with integral remainder from \eqref{eq: taylor}, we obtain: \begin{align*} |x|&\,^{-k-j}|D^aT_{s,1}(f)(x)|\le |x|^{-k-j} \sum_{a^1+a^2=a}|D^{a^1}(\chi(s|x|))||D^{a^2}f(x)|\\ = &\ s^{j}|x|^{-k}\sum_{a^1+a^2=a}(s|x|)^{-j}|D^{a^1}(\chi(s|x|))||D^{a^2}f(x)|\\ \le &\ C s^{j}|x|^{-k}\sum_{a^1+a^2=a}|x|^{-|a^1|}|D^{a^2}f(x)|\\ \le &\ Cs^{j} \Big(\fnorm{f}_{n,k,1}+\sum_{\substack{a^1+a^2=a\\0<|b|=|a^1|}}\int_0^1(u|x|)^{-k}u^{k}(1-u)^{|a^1|-1}|D^{a^2+b}(f)(ux)|\dif u \Big)\\ \le &\ C s^{j}\fnorm{f}_{n,k,1}, \end{align*} for all $f\in C^{\infty}_0(\overline{B}_1)$. This implies the first inequality. For the second inequality, we write \[(T_{s,1}f-f)(x)=\kappa(s|x|) f(x),\quad \textrm{where}\quad \kappa(u):=1- \chi(u).\] Note that \eqref{eq: boundedness} holds with $\chi$ replaced by $\kappa$, for all $a$ with $|a|=n>0$ and all $l\in \mathbb{Z}$, and for $a=0$ it holds for $l\geq 0$. Therefore we can apply the same steps as in the proof of the first part, but with $-j\leq 0$ instead of $j\geq 0$, and we obtain the second inequality from the statement. \end{proof} \subsubsection{Combined smoothing operators}\label{section:combined:smoothing} By composing the operators $S_{t,r}$ and $T_{s,r}$, we obtain the smoothing operators $S_{t,s,r}$ for $s,t,r>0$ via: \[S_{t,s,r}:=T_{s,r} \circ S_{t,r} : C^{\infty}_0(\overline{B}_r)\to C^{\infty}_0(\overline{B}_r).\] For these operators we obtain the estimates \begin{corollary}\label{corollary: smoothing flat functions} The operators $S_{t,s,r}$ satisfy \begin{align*} \fnorm{S_{t,s,r}(f)}_{n+l,k+j,r} \le &\ C s^jt^{l}\fnorm{f}_{n,k+2 l,r}\\ \fnorm{(S_{t,s,r}-\id)(f)}_{n,k+2l,r} \le &\ C (t^{-l}\fnorm{f}_{n+l,k,r} +s^{-j}\fnorm{f}_{n,k+2l+j,r}) \end{align*} for all $f\in C^{\infty}_0(\overline{B}_r)$, all $j,k,l,n\in \N_0$, all $s>0$ and $t\geq 1$, with $C=C(j,k,n,l,r)$ depending continuously on $r>0$. \end{corollary} \begin{proof} For the first inequality we may directly apply Proposition \ref{proposition: derivatiave smoothing} and Proposition \ref{proposition: weight smoothing}. To prove the second inequality we use that \begin{align*} \fnorm{(S_{t,s,r}-\id)(f)}_{n,k+2l,r} \le &\ \fnorm{(T_{s,r}\circ (S_{t,r}-\id)(f)}_{n,k+2l,r}\\ &\ +\fnorm{(T_{s,r}-\id)(f)}_{n,k+2l,r}. \end{align*} Now applying again Proposition \ref{proposition: derivatiave smoothing} and \ref{proposition: weight smoothing} yields the result. \end{proof} \subsection{Interpolation inequalities}\label{section: interpolation} First recall the interpolation inequalities with respect to the standard $C^n$ norms $\norm{\cdot}_{n,r}$ for functions on $\overline{B}_r$ (see e.g., \cite{Ham}): \begin{lemma} We have that \begin{align}\label{eq: standard interpolation} \norm{f}_{n,r}\le &\ C \norm{f}^{\frac{l_2}{l_1+l_2}}_{n-l_1,r}\norm{f}^{\frac{l_1}{l_1+l_2}}_{n+l_2,r} \end{align} for all $f\in C^{\infty}_0(\overline{B}_r)$, all $l_1, l_2, n\in \N_0$, with $l_1\leq n$, with $C=C(n,l_1,l_2,r)$ depending continuously on $r>0$. \end{lemma} The equivalence of norms from Lemma \ref{lemma: equivalence} implies \begin{corollary} We have that \begin{align}\label{eq: interpolation t} \fnorm{f}_{n,k,r}\le \ C \fnorm{f}^{\frac{l_2}{l_1+l_2}}_{n-l_1,k,r}\fnorm{f}^{\frac{l_1}{l_1+l_2}}_{n+l_2,k,r} \end{align} for all $f\in C^{\infty}_0(\overline{B}_r)$, all $k,l_1, l_2, n\in \N_0$, with $l_1\leq n$, with $C=C(n,k,l_1,l_2,r)$ depending continuously on $r>0$. \end{corollary} \begin{proof} The result follows by applying the previous lemma to the function $|x|^{-k}f(x)$ and Lemma \ref{lemma: equivalence}. \end{proof} We also have the interpolation inequalities in the weight index, which we prove using the corresponding smoothing operators: \begin{lemma} We have that \begin{align}\label{eq: interpolation s} \fnorm{f}_{n,k,r}\le &\ C \fnorm{f}^{\frac{j_2}{j_1+j_2}}_{n,k-j_1,r}\fnorm{f}^{\frac{j_1}{j_1+j_2}}_{n,k+j_2,r} \end{align} for all $f\in C^{\infty}_0(\overline{B}_r)$, all $k,j_1, j_2, n\in \N_0$, with $j_1\leq k$, where the constants $C=C(n,k,j_1,j_2,r)$ depend continuously on $r>0$. \end{lemma} \begin{proof} The argument is standard (see e.g.\ \cite[Corollary III.1.4.2]{Ham}). By Proposition \ref{proposition: weight smoothing}: \begin{align*} \fnorm{f}_{n,k,r}\le &\ \fnorm{T_{s,r}(f)}_{n,k,r} +\fnorm{(T_{s,r}-\id)(f)}_{n,k,r}\\ \le &\ C ( s^{j_{1}}\fnorm{f}_{n,k-j_1,r} +s^{-j_2}\fnorm{f}_{n,k+j_2,r}). \end{align*} The result follows by setting \[ s:= (\fnorm{f}_{n,k-j_1,r}^{-1}\fnorm{f}_{n,k+j_2,r})^{\frac{1}{j_1+j_2}}.\qedhere\] \end{proof} \section{Some decompositions of smooth functions on $\C$}\label{eigenspaces} In this section, we will prove Lemma \ref{lemma:pullbacks and invariant functions}. We will use the notation from Subsection \ref{subsection:desing} for the eigenspaces of the pullback along the maps $\sigma=-\mathrm{id}_{\C}$ and $\tau=$ conjugation. As the operators $\sigma^*$ and $\tau^*$ commute they preserve their respective eigenspaces. We use similar notation for their common eigenspaces, for example: \[C^{\infty}_{\sigma,-\tau}(\C):=\{g\in C^{\infty}(\C)\,|\, g=\sigma^*(g)=-\tau^*(g)\},\] and similarly for functions flat at the origin. We have the following decomposition of smooth functions: \begin{lemma}\label{lemma:eigenspaces} Any function $g\in C^{\infty}(\C)$ can be written uniquely as: \[ g= g_0 + x\cdot g_x +y\cdot g_y +xy\cdot g_{xy}\] where $g_0,g_x,g_y,g_{xy}\in C^{\infty}_{\sigma,\tau}(\C)$ and similarly for functions flat at the origin. \end{lemma} \begin{proof} The four functions are constructed by the usual projections onto the common eigenspaces of $\sigma^*$ and $\tau^*$, namely: \begin{align*} g_{0}:=&\frac{1}{4}(\mathrm{id}+\sigma^*)(\mathrm{id}+\tau^*)(g)\\ x\cdot g_{x}:=&\frac{1}{4}(\mathrm{id}-\sigma^*)(\mathrm{id}+\tau^*)(g)\\ y\cdot g_{y}:=&\frac{1}{4}(\mathrm{id}-\sigma^*)(\mathrm{id}-\tau^*)(g)\\ xy\cdot g_{xy}:=&\frac{1}{4}(\mathrm{id}+\sigma^*)(\mathrm{id}-\tau^*)(g). \end{align*} That these functions are indeed smooth follows from Hadamard's lemma. For example, in the first case, the function \[h:=\frac{1}{4}(\mathrm{id}-\sigma^*)(\mathrm{id}+\tau^*)(g)\] satisfies $h(0,y)=0$, and therefore, by Hadamard's lemma, $h=xg_x$, with $g_x\in C^{\infty}(\C)$. \end{proof} Flat functions invariant under $\sigma$ and $\tau$ can be described more explicitly: \begin{lemma}\label{lemma: lambda casimir} The map defined by \begin{equation*} \begin{array}{ccc} C^{\infty}(\R^2_{\ge 0} ) &\to &C_{\sigma,\tau}^{\infty}(\C), \\ g &\mapsto & \widetilde{g}(x,y):= g(x^2 ,y^2) \end{array} \end{equation*} is an isomorphism of rings, and similarly for functions flat at the origin. \end{lemma} \begin{proof} Clearly, we only need to check that this map is surjective. For this, consider $\widetilde{g}\in C_{\sigma,\tau}^{\infty}(\C)$. We need to show that the function: \[g:\R^2_{\geq 0}\to \R, \quad g(p,q)=\widetilde{g}(\sqrt{p},\sqrt{q}),\] which is smooth on $\R^2_{>0}$, is smooth also on $\big(\{0\}\times \R_{\geq 0}\big)\cup \big(\R_{\geq 0}\times\{0\}\big)$. For this it suffices to check that all its partial derivatives extend continuously. Note that, for $p,q>0$, we have that \[ \partial_p^i\partial_q^j g(p,q)= \Big(\frac{\partial_x}{2x}\Big)^{i}\Big(\frac{\partial_y}{2y}\Big)^{j}\widetilde{g}(x,y)\big|_{x=\sqrt{p},y=\sqrt{q}}.\] Therefore, the proof will be complete once we show that the functions \[\Big(\frac{\partial_x}{2x}\Big)^{i}\Big(\frac{\partial_y}{2y}\Big)^{j}\widetilde{g}(x,y)\] extend smoothly to $\R^2$. First, because $\widetilde{g}$ is invariant under $\sigma^*$ and $\tau^*$, we have that $\partial_xg(0,y)=0$ and $\partial_yg(x,0)=0$. Therefore, by Hadamard's lemma, \[\frac{\partial_x\widetilde{g}}{2x}, \frac{\partial_y\widetilde{g}}{2y}\in C^{\infty}(\C).\] Moreover, note that these functions are also invariant under $\sigma^*$ and $\tau^*$, and so we can iterate this observation, and obtain that, for all $i,j\geq 0$, \begin{align*} \Big(\frac{\partial_x}{2x}\Big)^{i}\Big(\frac{\partial_y}{2y}\Big)^{j}\widetilde{g}\in C^{\infty}_{\sigma,\tau}(\C). \end{align*} This concludes the proof. \end{proof} \begin{proof}[Proof of Lemma \ref{lemma:pullbacks and invariant functions}] First, we show that the map from (1) is an isomorphism. Since $\mathrm{sq}:\C\to \C$ is surjective, the map is clearly injective. For surjectivity, consider first $h\in C^{\infty}_{0,\sigma,\tau}(\C)$. By Lemma \ref{lemma: lambda casimir}, we can write \[h(\lambda_1,\lambda_2)=k(2\lambda_1^2,2\lambda_2^2),\] for some $k\in C^{\infty}_0(\R^2_{\geq 0})$. Define: \[g:\C\to \R,\quad g(z)=k(|z|+x,|z|-x), \quad z=x+yi\in \C.\] Clearly, $g$ is smooth on $\C^{\times}$. Because $k$ is flat at $0$, it is easy to see that all partial derivatives of $g$ extend continuously as $0$ at $z=0$. Therefore $g\in C^{\infty}_0(\C)$. Clearly, $g$ is also $\tau^*$-invariant. Finally, note that \[g(\lambda^2)=k(2\lambda_1^2,2\lambda_2^2)=h(\lambda). \] For a general element $h\in C^{\infty}_{0,\sigma}(\C)$, by Lemma \ref{lemma:eigenspaces}, we can find $h_0,h_1\in C^{\infty}_{0,\sigma,\tau}(\C)$ such that \[h(\lambda)=h_0(\lambda)+2\lambda_1\lambda_2\cdot h_1(\lambda).\] By the first part, we can write $h_i(\lambda)=g_i(\lambda^2)$, with $g_i\in C^{\infty}_{0,\sigma,\tau}(\C)$. Thus \[h(\lambda)=g(\lambda^2),\quad \textrm{with}\quad g\in C^{\infty}_0(\C),\] where $g(z)=g_1(z)+y\cdot g_2(z)$, for $z=x+iy$. This proves (1). Next, we show that the map from (2) is surjective. Let $h\in C^{\infty}_{0,-\sigma}(\C)$. By Lemma \ref{lemma:eigenspaces}, we can write: \[h(\lambda)=-\lambda_1\cdot h_1(\lambda)+\lambda_2\cdot h_2(\lambda),\] with $h_i\in C^{\infty}_{0,\sigma,\tau}(\C)$. Again by the first part, there are $g_i\in C^{\infty}_{0,\tau}(\C)$ such that $h_i(\lambda)=g_i(\lambda^2)$, and so \[h(\lambda)=-\lambda_1\cdot g_1(\lambda^2)+\lambda_2\cdot g_2(\lambda^2).\] This proves surjectivity. To show understand the kernel, let $g_i\in C^{\infty}_{0}(\C)$ such that \[-\lambda_1\cdot g_1(\lambda^2)+\lambda_2\cdot g_2(\lambda^2)=0.\] Note that this is equivalent to: \[2\lambda_1\lambda_2\cdot g_1(\lambda^2)=2\lambda_2^2\cdot g_2(\lambda^2).\] If we denote $z=\lambda^2$, then $2\lambda_1\lambda_2=y$ and $2\lambda_2^2=|z|-x$. Thus the above identity is equivalent to \begin{equation}\label{eq:relation:for:kernel} y\cdot g_1(z)=(|z|-x)\cdot g_2(z), \quad \forall z\in \C. \end{equation} This concludes the proof of (2). Item (3) follows from Proposition \ref{proposition: twisted module}. \end{proof}

Introduction ============ Diabetes mellitus is a chronic metabolic disorder[@b1-ijn-7-1189] characterized by loss of glucose homeostasis caused by defects in insulin secretion and action, resulting in impaired glucose metabolism.[@b2-ijn-7-1189] Epidemiological studies and clinical trials strongly support the notion of hyperglycemia as the main cause of coronary heart disease, cerebrovascular disease, renal failure, limb amputation, neurological complications, premature death, and lipid abnormalities in diabetics. Diabetes mellitus has reached epidemic proportions among the challenging unresolved health problems of the 21st century. The number of people suffering from the disease worldwide is increasing at an alarming rate, with a projected 366 million people likely to be diabetic by the year 2030 compared with the estimate of 191 million people in 2000.[@b3-ijn-7-1189] By convention, diabetes has been classified as type 1 (insulin-dependent) or type 2 (non-insulin-dependent). At present, controlling blood sugar levels by dietary modification, physical exercise, insulin therapy, and oral medications is advised.[@b4-ijn-7-1189] However, several hypoglycemic agents used for the treatment of diabetes are reported to have adverse effects, including liver problems, lactic acidosis, and diarrhea.[@b5-ijn-7-1189] Thus, use of these drugs may be limited depending on their pharmacokinetic properties, secondary failure rates, and side effects.[@b6-ijn-7-1189],[@b7-ijn-7-1189] The pathogenesis of diabetes mellitus and the possibility of its management with existing therapeutic agents without any side effects has been the subject of great interest in recent years.[@b8-ijn-7-1189] Researchers in the field of nanotechnology are gaining new insights into its versatile applications in the treatment of various diseases, including diabetes mellitus. Nanotechnology is an attractive area of research related to production of nanoparticles of variable size, shape, and chemical composition, with controlled dispersity, as well as their possible benefits in clinical medicine.[@b9-ijn-7-1189] The rapid development of nanotechnology worldwide has been accompanied by massive generation and widespread use of engineered nanomaterials. Biosynthesis of nanoparticles, as a representative intersection of nanotechnology and biotechnology, has been the focus of increasing attention due to the growing need to develop environmentally friendly technologies for materials synthesis.[@b10-ijn-7-1189] To date, nanoparticles have been extensively used in various applications, including drug discovery[@b11-ijn-7-1189] and tissue engineering.[@b12-ijn-7-1189] Research into the preparation and biological applicability of noble metal nanoparticles with a nearly monodispersed size distribution and arbitrarily variable size and geometry has attracted considerable research interest.[@b13-ijn-7-1189] Gold nanoparticles have a growing role in medical biotechnology.[@b14-ijn-7-1189] Production of nanoparticles can be achieved mainly through chemical, physical, and biological methods. Biological methods for nanoparticle synthesis using plants or plant extracts have been suggested as possible ecofriendly alternatives to chemical and physical methods.[@b15-ijn-7-1189] Since time immemorial, many medicinal plants have been used as dietary adjuncts and in the treatment of numerous diseases without proper knowledge of their function. Although phytotherapy continues to be used in a number of countries, few plants have undergone scientific or medical scrutiny.[@b16-ijn-7-1189] Phytochemically mediated synthesis of gold nanoparticles marks a potential advance in the drug discovery era. A range of medicinal plants and plant extracts has been used for biological synthesis of gold nanoparticles. Singh et al[@b17-ijn-7-1189] reported a green biogenic approach for the synthesis of gold and silver nanoparticles using aqueous leaf extracts of *Zingiber officinale*, with nanoparticles formed in the average size range of 10 nm. Synthesis of gold nanoparticles from the extract of the *Mirabilis jalapa* flower[@b18-ijn-7-1189] showed formation of gold nanoparticles with a characteristic size of 100 nm and spherical in shape. Biomass of *Stevia rebaudiana* was used for synthesis of gold nanoparticles extracellularly, with nanoparticles in the size range of 8--20 nm.[@b19-ijn-7-1189] Huang et al evaluated the prospect of using sundried *Cinnamom camphora* leaf for the synthesis of nanosized noble metals of gold and silver under ambient conditions.[@b20-ijn-7-1189] Aqueous extracts of *Withania coagulans*,[@b21-ijn-7-1189] *Cichorium endivia*,[@b22-ijn-7-1189] *Sesbania sesban* (L),[@b23-ijn-7-1189] *Scoparia dulcis*,[@b24-ijn-7-1189] and *Trichosanthes dioica*,[@b25-ijn-7-1189] as well as the combination of *Cassia auriculata* and *Aegle marmelos*[@b26-ijn-7-1189] were shown to have hypoglycemic and hypolipidemic effects in animals with experimentally induced diabetes. From the results of the different investigations mentioned above, it is evident that plants act as a natural reservoir for medicinal agents and avoid the common side effects of synthetic chemicals. In this study, green synthesis of gold nanoparticles and aqueous extracts was done from the stem bark of one such potential plant, *Cassia fistula* (*C. fistula*), for investigation of its hypoglycemic activity. *C. fistula*, a member of the Leguminosae family, has been extensively used in traditional Indian medicine. Different parts of *C. fistula* are reported to have hepatoprotective, anti-inflammatory, antitussive, antifungal, antitumor, antioxidant, and antibacterial activity.[@b27-ijn-7-1189] According to the different assays, the barks are known to have a higher antioxidant potential than other parts of the plant. The hypoglycemic and hypocholesterolemic effects of hexane extracts from *C. fistula* were studied by Nirmala et al,[@b28-ijn-7-1189] who found a significant decrease in blood glucose levels and improvements in the lipid profile in comparison with the standard reference drug, insulin. These results suggest that the stem barks of hexane extracts from *C. fistula* possess strong antidiabetic activity. *C. fistula* plant organs are known to be an important source of secondary metabolites. The stem bark of the plant acts as a reservoir for lupeol, β-sitosterol, and hexacosanol.[@b29-ijn-7-1189] Rani and Kalidhar reported the presence of oxyanthraquinone and dihydroxyanthraquinone in the bark of the *C. fistula* plant.[@b30-ijn-7-1189] Stem bark of *C. fistula* has a high phenol, flavonoid, and proanthocyanidin phytochemical content.[@b31-ijn-7-1189] The present study investigated and compared the hypoglycemic effect of aqueous extract and gold nanoparticles synthesized from the stem bark of *C. fistula* in streptozotocin-induced diabetic rats, based on biochemical parameters. Materials and methods ===================== *C. fistula* belongs to the Leguminosae family. The bark of the *C. fistula* plant was obtained from a local market. The plant was taxonomically identified and a voucher specimen of the same plant (No HC-15) was authenticated and deposited in our department for future reference. The freshly collected barks were chopped, shade-dried, and coarsely powdered for further extraction. Preparation of *C. fistula* aqueous stem bark extract ----------------------------------------------------- We added 12 mL of double distilled water to a 250 mL beaker in a magnetic stirrer for 10 minutes, after which we added 60 mg of the weighed plant powder to the water under continuous stirring, and then boiled the mixture at 60°C for 15 minutes. The extract obtained was passed through a Whatman filter and used for further experimental work. Green synthesis of gold nanoparticles from *C. fistula* stem bark ----------------------------------------------------------------- The chemicals used for bioreduction of gold to gold nanoparticles (HAuCl~4~-chloroaurate) were purchased from Sigma- Aldrich (St, Louis, MO). Preparation of the gold nanoparticles was done according to the method described by Katti et al[@b31-ijn-7-1189] with slight modifications. Finely coarse powder of *C. fistula* stem bark was used for phytochemical-mediated synthesis of the gold nanoparticles, whereby 60 mg of bark powder was added to 12 mL of double distilled water and continuously stirred; 50 mL of 1 mM aqueous HAuCl~4~ was subsequently added to the mixture whilst stirring. There was an immediate change in color from brown to ruby red, indicating formation of green gold nanoparticles. The extract was passed through a Whatman filter and the sample was characterized for the size and shape of the nanoparticles formed. Characterization of phytochemically synthesized gold nanoparticles ------------------------------------------------------------------ Bioreduction of the gold nanoparticles was monitored using an ultraviolet-visible spectrophotometer. To deduce whether functional groups were present in the sample, Fourier transform infrared (FTIR) spectroscopy was performed. Qualitative analysis was confirmed by scanning electron microscopy. Ultraviolet visible spectroscopy analysis ----------------------------------------- Biological reduction of gold to gold nanoparticles was periodically monitored by the method described by Katti et al using a Lambda UV-650 spectrophotometer (Perkin Elmer, Melville, NY). The ultraviolet-visible spectrophotometer readings were recorded in the nanometer range of 190--900 nm. The samples were diluted with 2 mL of deionized water and absorbance values were recorded for the samples. FTIR spectroscopy analysis -------------------------- The synthesized gold nanoparticles were lyophilized and mixed with KBr pellets, and then subjected to a wide range of FTIR spectral analyses (Spectrum RX1, Perkin Elmer). Different peaks were obtained for the test samples. Scanning electron microscopy of *C. fistula* gold nanoparticles --------------------------------------------------------------- The synthesized green gold nanoparticles were characterized using scanning electron microscopy (300-N; Hitachi, Tokyo, Japan). A single drop of the sample was placed on the sample stage, and the aqueous solvent was allowed to evaporate for 5 minutes. The dried sample was coated with gold using an ion sputter-coater with a gold target, and further analyzed for size and shape at different magnifications. Experimental animals -------------------- Adult male albino Wistar rats weighing 150--200 g bred in the animal division of the King's Institute, Chennai, were used in this study. The animals were acclimatized under appropriate light and dark conditions and fed a standard commercial pellet diet (Sai Enterprises, Chennai, India) and water ad libitum. The experimental protocol was approved by the institution's animal ethics committee. Chemical compounds ------------------ Streptozotocin was purchased from Sigma Aldrich for experimental induction of diabetes. A freshly prepared solution of streptozotocin (60 mg/kg body weight \[bw\]) in 0.1 M citrate buffer (pH 4.5) was injected intraperitoneally. Seventy-two hours after injection of streptozotocin, rats with blood glucose levels in the range of 175--300 mg/dL were used for further treatment and analysis, while those rats with blood sugar levels outside the specified range were excluded. Insulin, the standard reference drug, was used for comparison of diabetic animals treated with the plant extract and those treated with the gold nanoparticles. Insulin 3 IU/kg bw/day was administered to the rats with streptozotocin-induced diabetes. Study design ------------ Thirty-five rats (30 surviving diabetic rats and five normal rats) were used in this experiment. The rats were divided into seven groups, each containing five rats. Group 1 comprised normal control rats given distilled water only; Group 2 comprised normal rats given aqueous extract of *C. fistula* (60 mg/kg bw) dissolved in 12 mL of double distilled water via an intragastric tube for 30 days; Group 3 comprised normal rats given phytochemically synthesized gold nanoparticles containing *C. fistula* (60 mg/kg bw) continuously via gastric intubation for 30 days; Group 4 comprised diabetic controls given a single intraperitoneal injection of streptozotocin (60 mg/kg), with only distilled water given throughout the experimental period; Group 5 comprised diabetic rats treated with the aqueous extract of *C. fistula* (60 mg/kg bw) dissolved in 12 mL of double distilled water, given daily via an intragastric tube for 30 days; Group 6 comprised diabetic rats treated with phytochemically synthesized gold nanoparticles of *C. fistula* (60 mg/kg bw) given continuously via gastric intubation for 30 days; and Group 7 comprised diabetic rats treated with insulin 3 IU/kg bw throughout the testing period. The body weight of each animal was recorded before and after induction of diabetes, and after administration of the study treatment. Serum glucose level test was done to determine blood sugar levels. Blood samples were drawn from the tail vein during the course of the experiment. At the end of the experimental period (30 days), the rats were anesthetized with chloroform following a 12-hour fast. Blood samples were drawn by cardiac puncture into plain tubes. The blood samples were centrifuged at 3500 rpm for 20 minutes using a refrigerated centrifuge at 4°C (Remi Laboratory Instruments, Mumbai, India). The serum collected was stored at −20°C until needed. Laboratory measurements ----------------------- Serum glucose level test was done on the normal, diabetic, and treated diabetic rats on days 1, 15, and 30 of the experimental period to determine blood glucose levels in the animals. The blood samples collected were centrifuged at 3500 rpm for 20 minutes and serum glucose levels were determined using the glucose oxidase-peroxidase method[@b32-ijn-7-1189] (Coral Clinical Systems, Goa, India). Blood samples were examined to determine glycosylated hemoglobin (HbA~1c~) levels using the ion exchange resin method[@b33-ijn-7-1189] with kits purchased from Diotek India Ltd, Mumbai, India. Assays for aspartate transaminase and alanine transaminase were done using the ultraviolet kinetic (International Federation of Clinical Chemistry) method[@b34-ijn-7-1189],[@b35-ijn-7-1189] with commercial kits (Autopak) obtained from Bayer Diagnostics Baroda, India. An alkaline phosphatase assay was also performed using the p-nitro phenyl phosphate method with Autopak diagnostic kits. Serum albumin was determined using the bromcresol green method with an Autopak kit. The total protein present in serum was estimated by the Biuret method[@b36-ijn-7-1189] using an Autopak kit. Globulin levels were calculated from total protein and albumin measurements. Serum urea,[@b37-ijn-7-1189] creatinine,[@b38-ijn-7-1189] and uric acid[@b39-ijn-7-1189] levels were determined using diagnostic kits from Biosystems, Barcelona, Spain. Serum lipid profiles[@b40-ijn-7-1189] were determined using reagent kits purchased from (Piramel Health care, Mumbai, India). Statistical analysis -------------------- The statistical analysis was performed using SPSS software (v 17; SPSS Inc, Chicago, IL). The values were analyzed by one-way analysis of variance followed by Duncan's multiple range test. The results are represented as the mean ± standard error of the mean for five rats. *P* values \< 0.05 were considered to be statistically significant. Results ======= The results of the ultraviolet-visible spectroscopic analysis of the aqueous extract and gold nanoparticles from the *C. fistula* plant are shown in [Figure 1A](#f1a-ijn-7-1189){ref-type="fig"} and [B](#f1b-ijn-7-1189){ref-type="fig"}. The characteristic absorbance peak for the aqueous plant extract was obtained at 236 nm whereas the absorbance peak observed for the gold nanoparticles was at 529 nm. [Figure 2A](#f2a-ijn-7-1189){ref-type="fig"} and [B](#f2b-ijn-7-1189){ref-type="fig"} represents the FTIR spectral analysis for both the aqueous and gold nanoparticles. Characteristic functional groups responsible for formation of the particles in the samples were recorded. Scanning electron microscopic images are shown in [Figure 3](#f3-ijn-7-1189){ref-type="fig"}. [Figure 3A](#f3-ijn-7-1189){ref-type="fig"} shows the gold nanoparticles formed as a result of reduction of gold ions. The image was taken at a magnification of 3000×. [Figure 3B](#f3-ijn-7-1189){ref-type="fig"} shows a closer view of the nanoparticles formed at a magnification of 8000×. [Figure 3C](#f3-ijn-7-1189){ref-type="fig"} shows the shape of the nanoparticles formed. Particles of different shapes were formed as a result of reduction of gold ions to gold nanoparticles by *C. fistula* (16,000×). [Figure 3D](#f3-ijn-7-1189){ref-type="fig"} shows the varying sizes of the nanoparticles, which were in the range of 55.2--98.4 nm (23,000×). The body weights of the different groups of animals were in the range of 150--200 g ([Figure 4](#f4-ijn-7-1189){ref-type="fig"}). There was a reduction in body weight after induction of diabetes by streptozotocin. The mean body weight of the animals after 30 days of treatment with aqueous extract, gold nanoparticles, and insulin was 151.60 ± 10.27 g, 178.80 ± 9.78 g, and 178.00 ± 2.00 g, respectively. The weight of the non-diabetic rats when treated with aqueous extract and with gold nanoparticles remained the same. The serum glucose levels for the normal, diabetic, and treated diabetic animals are shown in [Figure 5](#f5-ijn-7-1189){ref-type="fig"}. The initial mean serum glucose levels for the seven groups of rats were in the range of 95--110 mg/dL. Fasting serum glucose levels after administration of streptozotocin showed an increase in blood glucose levels. On treating the animals with the aqueous extract or gold nanoparticles for Mean HbA~1c~ levels in normal rats were 6.49% ± 0.13% ([Figure 6](#f6-ijn-7-1189){ref-type="fig"}). There was a significant increase in total hemoglobin in the diabetic control rats (13.59% ± 0.28%). After treatment with the aqueous extract or the gold nanoparticles, the animals showed a decrease in HbA~1c~ levels to 11.45% ± 0.28% and 10.40% ± 0.23%, respectively. The diabetic rats also treated with insulin showed a restoration in HbA~1c~ levels. In rats treated with gold nanoparticles, HbA~1c~ levels were found to be in the near normal range. A decrease in aspartate transaminase, alanine transaminase, and alkaline phosphatase levels and an increase in concentrations of albumin, globulin, and total protein were found in the diabetic rats treated with aqueous extract and gold nanoparticles, as shown in [Figure 7](#f7-ijn-7-1189){ref-type="fig"}. There was a significant increase in serum albumin, globulin, and total protein content in the treated diabetic rats compared with the diabetic controls. The mean total protein content in rats treated with the aqueous extract was 5.60 ± 0.56 mg%, which was slightly lower than the total protein content in rats treated with the gold nanoparticles (6.41 ± 0.41 mg%). There was a marked decrease in aspartate transaminase levels in the treated diabetic rats when compared with the diabetic control rats whose aspartate transaminase level was found to be 99.8 ± 1.68 mg%. Serum alanine transaminase levels are shown in [Figure 7](#f7-ijn-7-1189){ref-type="fig"}, and indicate a significant reduction in mean activity from 95.78 ± 0.83 to 84.34 ± 2.02 mg% in comparison with alanine transaminase levels in the untreated diabetic rats, which had a higher mean enzyme activity at 118.78 ± 1.49 mg%. The rats also treated with insulin had lower enzyme levels. The animals treated with gold nanoparticles showed a highly significant decrease in alanine transaminase to near normal levels, similar to that seen in the insulin-treated rats. [Figure 7](#f7-ijn-7-1189){ref-type="fig"} shows that alkaline phosphatase underwent a significant reduction to near normal levels in response to treatment with the aqueous extract or gold nanoparticles of *C. fistula* after continuous administration for 30 days. The maximum decrease was observed in rats also receiving insulin, with the next largest decrease in alkaline phosphatase activity seen in the group treated with gold nanoparticles. Serum urea, creatinine, and uric acid levels are shown in [Figure 8](#f8-ijn-7-1189){ref-type="fig"}, and were comparatively high in the diabetic control rats. On continuous treatment with *C. fistula,* there was a highly significant decrease in urea, creatinine, and uric acid levels in diabetic rats treated with the aqueous extract or gold nanoparticles, and a return to near normal levels. Lipid profiles (total cholesterol, triglycerides, low-density lipoprotein, very low-density lipoprotein, and high-density lipoprotein) for the normal, treated nondiabetic rats, diabetic controls, and treated diabetic rats are shown in [Figure 9](#f9-ijn-7-1189){ref-type="fig"}. The serum lipid profile reached a peak in diabetic control rats, whereas the level of high-density lipoprotein decreased. After continuous treatment with the plant extract for 30 days, rats with streptozotocin-induced diabetes showed a marked decrease in cholesterol levels with a significant increase in high-density lipoprotein. Discussion ========== The present work was carried out to compare the efficacy of phytochemically synthesized green gold nanoparticles with that of an aqueous extract of *C. fistula* as hypoglycemic treatment for diabetes mellitus and its complications. Biochemical parameters were assessed to support the proposed hypothesis. Diabetes mellitus is a common metabolic disease characterized by increased circulating glucose concentrations. It is associated with a variety of microvascular, macrovascular, neurological, and infectious complications, including abnormal carbohydrate, fat, and protein metabolism. Streptozotocin-induced diabetes is a well documented model of experimental diabetes, providing a relevant example of endogenous chronic oxidative stress due to hyperglycemia.[@b41-ijn-7-1189] Streptozotocin is often used to induce diabetes mellitus in experimental animals because of its toxic effect on pancreatic β cells.[@b42-ijn-7-1189],[@b43-ijn-7-1189] In the present study, a single intraperitoneal injection of streptozotocin 60 mg/kg bw was administered to the experimental animals resulting in toxicity to β cells, with emergence of clinical diabetes within 2--4 days.[@b44-ijn-7-1189] Nanotechnology can be defined as research on the design, synthesis, and structural manipulation of particles with dimensions smaller than 100 nm. Biosynthesis of gold nanoparticles with the help of medicinal plants has come into the limelight in nanobiotechnology due to the growing need to develop environmental friendly benign technologies. Plants are an excellent source of secondary metabolites, and have been found to be cost-effective and ecofriendly for the large-scale synthesis of nanoparticles.[@b45-ijn-7-1189] In this study, *C. fistula* was used for preparation of an aqueous extract and also for bioreduction of gold ions into gold nanoparticles. The reduction of chloroaurate ions to nanoparticles was more rapid upon addition of the plant biomass to the aqueous solution of HAuCl[@b4-ijn-7-1189]. Au ^3+^, according to Padma and Bajpai,[@b18-ijn-7-1189] is a soft metal which binds to a biomass mainly via amino and sulfhydryl groups, which are considered to be soft ligands and carry more positive charge at low pH values, making them available for the binding and reduction of Au^3+^ to gold. Investigators have previously reported that formation of pure metallic nanoparticles and bimetallic nanoparticles by the reduction of metal ions is possibly facilitated by reducing sugars and/or terpenoids. In this study, reduction of chloroaurate ions could have occurred due to the presence of secondary metabolites, such as lupeol, β-sitosterol, and hexacosanol, in the stem bark of *C. fistula*. Ultraviolet-visible spectroscopy is an indirect method for determining the reduction of gold ions to gold nanoparticles. In certain metals, such as silver and gold, plasmon resonance is responsible for their unique and remarkable optical phenomena. [Figure 1A](#f1a-ijn-7-1189){ref-type="fig"} and [B](#f1b-ijn-7-1189){ref-type="fig"} show ultraviolet-visible spectra for aqueous extract and gold nanoparticles from *C. fistula*. The surface plasmon resonance band was obtained at 236 nm for the aqueous extract whereas the characteristic peak occurred at around 529 nm after 2 hours of reaction time for the phytochemically synthesized gold nanoparticles. Fierascu et al[@b46-ijn-7-1189] investigated the synthesis of gold nanoparticles from neem extract, which possessed a characteristic absorption peak at 525 nm. The bioreduction of gold ions occurred at much more rapid rate, and Shankar et al[@b47-ijn-7-1189] reported that the surface plasmon band arises from existence of free electrons in the conduction band due to the small particle size. The surface plasmon resonance peak in the ultraviolet absorption spectrum is shown by these plasmon resonant particles.[@b48-ijn-7-1189] To determine whether specific functional groups could be responsible for the bioreduction, FTIR spectra for the aqueous extract and gold nanoparticles were obtained. [Figure 2A](#f2a-ijn-7-1189){ref-type="fig"} and [B](#f2b-ijn-7-1189){ref-type="fig"} represent the FTIR spectral data for aqueous extract and gold nanoparticle samples from the stem bark of *C. fistula*. The vibrational spectrum for a molecule of the aqueous extract is shown in [Figure 2A](#f2a-ijn-7-1189){ref-type="fig"}. Several absorption peaks are centered around 3432.79, 2074.74, 1636.68, 1366.44, 1228.63, and 673.76 cm^−1^, which are attributable to the stretching vibrations of the O--H group at 3432.71 cm^−1^. Other characteristic stretching modes are found at 2074.74 cm^−1^ for N--H amines, 1636.68 cm^−1^ for C--C stretch (in the ring), 1366.44 cm^−1^ for the C--H bend, and C--O stretch mode at 1228.63 cm^−1^ and C--Br stretch at 673.76 cm^−1^. FTIR spectral data for the biosynthesized gold nanoparticles of *C. fistula* ([Figure 2B](#f2b-ijn-7-1189){ref-type="fig"}) are attributable to the O--H group at 3430.49 cm^−1^. A C--H stretch exists in the region of 2850--3000 cm^−1^. Peaks at 1627.15 cm^−1^, 1517.72 cm^−1^, and 1455.61 cm^−1^ can be assigned to N--H bending, N--O asymmetric stretching, and C--C stretching (in the ring). Stretching at 1248.11 cm^−1^ and 1113.35 cm^−1^ contributes to the C--N stretching mode (aliphatic amines). Agnieszka et al[@b49-ijn-7-1189] reported a characteristic stretch at 3437 cm^−1^ from a hydroxyl group through synthetic preparation of gold nanoparticles using the sodium citrate reduction method.[@b50-ijn-7-1189] [Figure 3A--D](#f3-ijn-7-1189){ref-type="fig"} represents the surface architecture of gold nanoparticles as a result of bioreduction of *C. fistula*, captured at different magnifications under a scanning electron microscope. At high resolution values, the nanoparticles were found to be polydispersed with rectangular and triangular shapes. The average size of the nanoparticles was in the range of 55.2--98.4 nm. Our scanning electron microscopy results are consistent with those of Elavazhagan and Arunachalam,[@b51-ijn-7-1189] who reported formation of gold nanoparticles in the size range of 50--80 nm on reduction by *Memecylon edule* leaf biomass. In our present study, biochemical parameters were unchanged in nondiabetic rats treated with the aqueous extract of *C. fistula* and gold nanoparticles synthesized from the same plant. There was a significant decrease in body weight in the animals with streptozotocin-induced diabetes. This finding is consistent with that of Shirwaikar et al[@b52-ijn-7-1189] who reported that diabetes mellitus is attributable to gluconeogenesis associated with a characteristic loss of body weight as a result of increased muscle wasting and loss of tissue proteins; this might also be attributable to dehydration and fat catabolism, as reported by Hakim et al.[@b53-ijn-7-1189] Oral administration of aqueous extract and biosynthetic gold nanoparticles achieved a remarkable improvement in body weight. There was a better body weight increment in animals treated with the gold nanoparticles than in those treated with the aqueous extract. The possible underlying mechanism for this gain in body weight is the effect of controlling muscle wasting, ie, reversal of antagonism.[@b54-ijn-7-1189] Serum glucose levels increased in rats with streptozotocin-induced diabetes but not in nondiabetic rats. Streptozotocin is used to induce diabetes mellitus via a selective cytotoxic effect on pancreatic β cells, triggering endogenous release of insulin and a consequent increase in blood glucose levels. [@b55-ijn-7-1189] Our findings are in accordance with those of several other investigators in animals with streptozotocin-induced diabetes. In the present study, animals with streptozotocin-induced diabetes showed marked reductions in blood glucose levels after 4 weeks of continuous administration of aqueous extract or gold nanoparticles. Possible underlying mechanisms by which the plant material controlled the increasing blood glucose levels are potentiation of pancreatic secretion of insulin from β cells in the islets of Langerhans[@b56-ijn-7-1189] and increased transport of blood glucose to peripheral tissues.[@b57-ijn-7-1189] Our results are in accordance with those of Nirmala et al,[@b28-ijn-7-1189] who reported an increase in insulin secretion and decreased blood glucose levels in animals with streptozotocin-induced diabetes treated with hexane extracts of stem bark from *C. fistula*. The glucose-lowering effect of the experimental treatments was compared with that of insulin. Insulin was found to be more effective than the aqueous extract and gold nanoparticles in reducing blood glucose levels. The gold nanoparticles were the most effective after insulin in lowering blood glucose levels. Our findings are consistent with those of Bharathmanikanth et al,[@b58-ijn-7-1189] who treated diabetic rats with gold nanoparticles at a dose of 2.5 mg/kg. In controlled or poorly controlled diabetes, there is increased glycosylation of a number of proteins, including hemoglobin.[@b59-ijn-7-1189] Increased serum HbA~1c~ levels in rats with streptozotocin-induced diabetes suggest an increased rate of alkylation and free radical formation. In this study, there was a significant decrease in HbA~1c~ levels down to the near normal range in diabetic animals treated with the *C. fistula* aqueous extract or gold nanoparticles. Our HbA~1c~ data corroborate those of Oluba et al,[@b60-ijn-7-1189] who reported that *Ganoderma lucidum* extracts achieve a significant reduction in HbA~1c~, which could have possibly occurred as a result of antioxidant activity in the plants. Oral administration of the aqueous extract and gold nanoparticles had an effect on HbA~1c~, by preventing its elevation. *C. fistula* may also possess antioxidant activity, which would have scavenged free radicals, leading to a significant decrease in HbA~1c~ in diabetic rats. Gold nanoparticles derived from *C. fistula* were found to be effective in restoring HbA~1c~ to normal levels, probably as a result of efficient scavenging activity. The increased transaminase levels indicate hepatic dysfunction in animals with streptozotocin-induced diabetes. Aspartate transaminase and alanine transaminase are released when injury involves organelles such as the mitochondria. [@b61-ijn-7-1189] Transaminases mediate the catalysis of amino transfer reactions, and are vital markers of liver injury in clinical diagnostics.[@b62-ijn-7-1189] Alkaline phosphatase is a hydrolase enzyme located in the cytoplasm,[@b63-ijn-7-1189] and is responsible for removing phosphate from nucleotides and proteins released due to hepatic cellular damage. Assessment of marker enzyme (aspartate transaminase, alanine transaminase, and alkaline phosphatase) levels in streptozotocin-induced diabetic rats showed an elevation resulting from leakage of enzymes into the bloodstream.[@b64-ijn-7-1189] In the present investigation, there was a progressive increment in aspartate transaminase, alanine transaminase, and alkaline phosphatase levels in the diabetic rats. Gold nanoparticles are believed to play a protective role in the decrease of transaminase levels. Our results are in line with those of Patrick et al[@b65-ijn-7-1189] and Mahmoud et al,[@b66-ijn-7-1189] who reported an inhibitory effect of different plant extracts on transaminase activity. Serum albumin and globulin levels were markedly decreased in the diabetic control group. Total protein levels are significantly decreased in rats with streptozotocin-induced diabetes due to increased protein catabolism.[@b67-ijn-7-1189] The present study found that daily administration of an aqueous extract or gold nanoparticle sample from *C. fistula* to diabetic rats gradually increased their protein levels, and that the gold nanoparticles had a pronounced effect on protein content, with results for total protein being in accordance with those of Akah et al[@b68-ijn-7-1189] who reported that fraction 6 of *Vernonia amygdalina* leaf extracts was capable of normalizing total protein and albumin levels in rats with streptozotocin-induced diabetes. Diabetes affects both glucose and lipid metabolism.[@b69-ijn-7-1189] The abnormally high concentration of serum lipids in diabetes is mainly due to an increase in mobilization of free fatty acids from peripheral fat depots.[@b70-ijn-7-1189] The present investigation shows an increase in serum lipoproteins (total cholesterol, triglycerides, low-density lipoprotein, very low-density lipoprotein). Such an increase in lipid content increases the risk of coronary heart disease and atherosclerosis. Treatment of animals with streptozotocin-induced diabetes with gold nanoparticles from *C. fistula* and also with its aqueous extract returned lipid levels back to near normal. This improvement may be attributable to the cardioprotective properties of β sitosterol, a plant sterol present in the stem bark of *C. fistula*. Our data on the lipid profile run parallel with the results of Nirmala et al[@b28-ijn-7-1189] who reported an improved lipid profile in rats with streptozotocin-induced diabetes treated with hexane extracts from *C. fistula* stem bark. The lipid-lowering effects of gold nanoparticles were found to be more effective than those of the aqueous extract. High-density lipoprotein levels were significantly increased, indicating a reversed atherogenic risk which might be due to increased activity of lecithin cholesterol acyltransferase, which in turn contributes to regulation of serum lipids.[@b71-ijn-7-1189] Diabetic hyperglycemia produces elevation of plasma levels of urea and creatinine which are considered to be significant markers of renal dysfunction.[@b72-ijn-7-1189] Urea, creatinine, and uric acid levels were elevated in diabetic rats during the present experiment, indicating impaired renal function. On administering gold nanoparticles and aqueous extracts for 30 days, serum urea, creatinine and uric acid levels steadily returned to near normal. These results are in agreement with those of Daisy et al[@b73-ijn-7-1189] who reported that renal markers in serum were decreased on administration of crude hexane extracts from *Costus speciosus* to animals with streptozotocin-induced diabetes. Administering gold nanoparticles orally to diabetic rats decreased serum urea, creatinine, and uric acid more effectively, and could be explained by the regenerative ability of the renal tubules.[@b74-ijn-7-1189] Conclusion ========== Reduction of gold ions by *C. fistula* stem bark resulted in the formation of stable nanoparticles with different morphologies. Use of gold nanoparticles synthesized from *C. fistula* stem bark for the treatment of rats with streptozotocin-induced diabetes reduced serum blood glucose concentrations, induced favorable changes in body weight, improved transaminase activity, achieved a better lipid profile, and reversed renal dysfunction to a greater extent that did aqueous extracts from the same plant. This study indicates that phytochemically synthesized gold nanoparticles are better hypoglycemic agents in the treatment of diabetes mellitus and its associated complications. **Disclosure** The authors report no conflicts of interest in this work. {#f1a-ijn-7-1189} {#f1b-ijn-7-1189} {#f2a-ijn-7-1189} {#f2b-ijn-7-1189} {#f3-ijn-7-1189} {#f4-ijn-7-1189} {#f5-ijn-7-1189} {#f6-ijn-7-1189} {#f7-ijn-7-1189} {#f8-ijn-7-1189} {#f9-ijn-7-1189}

MELANOMA OF THE SKIN {#s1} ==================== In the United States, more than 68,000 new cases of melanoma were estimated to be diagnosed in 2010, continuing the trend of increased melanoma incidence seen over the past 40 years \[[@R1]\]. Melanoma is the fifth most commonly diagnosed type of cancer in men and seventh most common in women \[[@R1]\]. The lifetime risk of an American developing invasive melanoma is 1 in 55 as compared to 1 in 1,500 in the 1930s \[[@R2], [@R3]\]. More than 80% of melanomas are diagnosed at an early clinical stage (before regional metastasis) with more than 95% 5-year survival rates for patient\'s with localized melanoma \[[@R2], [@R4]\]. However, when melanoma has spread to regional lymph nodes or metastasized to other organs, there is a significant decrease in survival. The 5-year survival rate for melanoma patients with distant metastasis is significantly decreased to 15% \[[@R2]\]. Therefore, it is imperative to determine the molecular events that lead to melanoma metastasis in search for possible therapeutic molecular targets to curtail the disease. Early stage melanoma is easily treatable and highly curable with surgical resection \[[@R5]\]. However, once melanoma has metastasized, there are limited and ineffective treatment options available for patients \[[@R5], [@R6]\]. Decarbazine (DTIC) is the only FDA-approved chemotherapeutic agent for the treatment of metastatic melanoma despite response rates of only 15-20% \[[@R5], [@R6]\]. Furthermore, the duration of the response to DTIC is not sustained, often lasting as brief as 5 months, with only 5% of patients showing a complete response \[[@R7], [@R8]\]. Clinical studies utilizing adjuvant immunotherapies with interferon α for high-risk stages II and III melanoma, as well as treatment with high-dose interleukin (IL)-2 for stage IV melanoma, showed limited response rates of less than 15% \[[@R9]-[@R12]\]. Identification of melanoma oncogenes, tumor suppressor genes and information gathered from microarrays have advanced our understanding of the molecular mechanisms of melanoma \[[@R6]\]. Further studies in these areas will allow for a clearer understanding of the process of melanoma progression that might lead to the development of urgently needed clinical therapies for metastatic melanoma. Our laboratory has been studying novel targets involved in the progression of melanoma to develop better therapeutic targets for metastatic melanoma. One of these genes that plays a key role in the progression from non-metastatic to metastatic melanoma is the thrombin receptor, Protease Activated Receptor-1 (PAR-1). PAR-1 {#s2} ===== PAR-1 has been found to be involved in the progression of several cancers including breast \[[@R13], [@R14]\], colon \[[@R15], [@R16]\] prostate \[[@R17], [@R18]\] and melanoma \[[@R19]-[@R22]\]. As such, PAR-1 has significant roles not only in coagulation, wound healing and inflammation, but also in the progression of several cancer types. PAR-1 was first identified by Vu et al. in 1991 \[[@R23]\] and remains the most studied and best characterized protease-activated receptor. The thrombin receptor belongs to a family of seven transmembrane G-protein-coupled receptors with a unique method of activation. Unlike typical ligand-binding interactions that occur with other types of G-protein receptors, PAR-1 activation occurs through proteolytic cleavage of the N-terminal domain of the receptor by serine proteases. Although thrombin is the most effective and potent activator of PAR-1, activation can occur through other ligands, such as coagulation factor Xa, trypsin, granzyme A and plasmin \[[@R24], [@R25]\]. PAR-1 can also be proteolytically cleaved and activated by matrix metalloprotease-1 (MMP-1) in breast cancer cells \[[@R26]\]. PAR-1 activation by thrombin involves the anion-binding exosite of thrombin binding to the PAR-1 amino terminus in an acidic region spanning amino acids 51 to 63 \[[@R23]\]. This highly acidic region, termed the hirudin-like binding site, is similar to the amino acid sequence of the leech anticoagulant peptide, hirudin \[[@R27]\]. This region increases the affinity and potency of thrombin for PAR-1 \[[@R27]\]. PAR-1 also contains a thrombin cleavage site between Arginine at position 41 and Serine at position 42 in the PAR-1 sequence. Thrombin proteolytically cleaves the PAR-1 N-terminus in an irreversible manner, thereby forming a new amino terminus with Serine 42 acting as a tethered ligand to activate the receptor \[[@R23], [@R28]\] (Figure [1](#F1){ref-type="fig"}) {#F1} Once activated, PAR-1 signals through the activated G-protein subtypes, Gαq, Gαi, Gα12,13, and Gβγ resulting in downstream activation of several signal transduction pathways, such as the phosphoinositide-3 (PI-3) kinase, the mitogen-activated protein (MAPK) kinase, Rho kinases, as well as increases intracellular Ca^2+^ and activation of protein kinase C (PKC) \[[@R29]\] (Figure [1](#F1){ref-type="fig"}). PAR-1 is primarily involved in mediating the effects of thrombin, which is recognized as a potent mitogen in cancer and tumor metastasis through sustained ERK 1/2 activation \[[@R30]\]. Protease-Activated Receptors can also signal in response to proteases that stem from the tumor and the tumor microenvironments such as MMP-1 \[[@R26]\]. Activation of PAR-1 by thrombin also results in overexpression and secretion of pro-angiogenic and invasive factors such as IL-8, VEGF, PDGF2 and MMP-2 \[[@R31]\]. PAR-1 IN MELANOMA {#s3} ================= Thrombin generation occurs through multiple pathways including the activation of coagulation factors often seen in several cancer types, thereby leading to PAR-1 signaling \[[@R31]\]. In melanoma, as well as in other cancers, tissue factor (TF), an initiator of the coagulation cascade, has been found to be upregulated \[[@R32]\]. This results in expression of thrombin by activation of the coagulation factor X through expression of tissue factor \[[@R32]\]. Furthermore, several studies have also demonstrated that TF is constitutively expressed in melanoma cells and can activate thrombin in a coagulation-independent manner, thereby promoting melanoma metastasis through PAR-1 activation \[[@R33], [@R34]\]. Moreover, thrombin activation results in the cleavage of fibrinogen into fibrin. These fibrin deposits are located in the tumor microenvironment and store active thrombin that is released upon degradation of fibrin by plasmin \[[@R31], [@R35], [@R36]\]. In an experimental murine lung metastasis model of melanoma, B16F10 murine melanoma cells transfected with the PAR-1 gene resulted in a 40-fold increase in pulmonary metastasis, thus demonstrating that PAR-1 was the rate-limiting factor in thrombin-enhanced pulmonary metastasis \[[@R37]\]. Conversely, when B16F10 cells were treated with a specific thrombin inhibitor, cell migration was suppressed and in vivo metastasis was decreased \[[@R38]\]. PAR-1 has also been found to be overexpressed in human metastatic melanoma cell lines as compared to non-metastatic cell lines \[[@R21]\]. Furthermore overexpression of PAR-1 is predominantly seen in malignant melanoma tumor specimens and in metastatic lesions as compared to benign nevi and normal skin by immunohistochemistry \[[@R20]\]. Utilizing an automated quantification laser scanning cytometer on a tissue microarray platform, our laboratory has also found a significantly higher percentage of PAR-1 positive cells in metastatic melanoma as compared to both dysplastic nevi and primary melanomas \[[@R22]\]. TRANSCRIPTIONAL REGULATION OF PAR-1 IN MELANOMA {#s4} =============================================== The transition from the radial growth phase to the vertical growth phase in the progression of human melanoma is associated with the loss of the transcription factor Activator Protein-2α \[[@R39]-[@R41]\]. Loss of AP-2α correlates with a concomitant increases in PAR-1 expression \[[@R21]\]. Analysis of the PAR-1 promoter region reveals multiple AP-2α and SP-1 binding sites as well as two overlapping SP-1 and AP-2α transcription factor binding motifs within the proximal 3\' region, thereby suggesting that these transcription factors mediate PAR-1 promoter activity \[[@R42]\]. Utilizing ChIP analysis, Tellez et al. demonstrated that AP-2α is bound to the PAR-1 promoter in low and non-metastatic melanoma cell lines while SP-1 is bound to PAR-1 in metastatic melanoma cell lines \[[@R21]\]. Furthermore, it was seen that AP-2α and SP-1 bind in a mutually exclusive manner in one of the overlapping binding regions \[[@R21]\]. Thus, in melanoma, the low levels of AP-2α enable SP-1 to bind to its motif in the PAR-1 promoter, which results in PAR-1 gene activation. Non-metastatic melanoma cells express AP-2α. In these cells, the PAR-1 promoter is bound by the AP-2α transcription factor thereby suppressing PAR-1 gene expression \[[@R21]\]. IN VIVO EFFECTS OF SILENCING PAR-1 {#s5} ================================== Recently, utilizing lentiviral based shRNA, we stably silenced PAR-1 by more than 80% in two human metastatic melanoma cell lines, A375SM and C8161 (high expressors of PAR-1), and injected these cells subcutaneously (to assess tumor growth) and intravenously (to assess experimental lung metastasis formation). We found significant decreases in tumor growth of PAR-1-silenced melanoma cells as compared to cells transduced with a non-targeting (NT) control shRNA. Moreover, significant inhibition of experimental lung metastasis formation was detected in PAR-1-silenced cells \[[@R43]\]. Although significant differences were seen in vivo, the use of a lentiviral delivery system as a therapeutic modality for the delivery of shRNA in melanoma or other cancers brings about several problems including the possibility of viral integration into an area where off-target gene expression can be affected thereby leading to the development of diseases or cancer. Furthermore, the shuttling system that moves the shRNA from the nucleus into the cytoplasm for processing and gene silencing has the potential to be overwhelmed, such that exportin-5, involved in shRNA and miRNA shuttling, might be overloaded and fail to export essential miRNAs or other factors needed for normal cell functioning \[[@R44]\]. Moreover, for shRNA to be processed, Dicer must be present in cells. Merritt et al. found that Dicer expression was variable among ovarian cancer specimens and further demonstrate that low-Dicer expressing cells failed to significantly silence target genes when utilizing shRNA \[[@R45]\]. For effective use of lentiviral based shRNA, the consistent expression of Dicer must be present for gene silencing to occur. Thus, the use of viruses as a delivery tool for clinical therapies has several adverse effects including toxicities, overwhelming nuclear export mechanisms, as well as unwanted and unpredictable genetic alterations after viral integration \[[@R46], [@R47]\]. In recent years, much research has gone into finding not only effective but also safer alternative technologies to deliver siRNA to tumors including nano-liposomes \[[@R47], [@R48]\]. Liposomes are lipid vesicles that allow for the entrapment of not only siRNA but also various types of drugs or small molecules. By incorporating siRNAs into liposomes, they are protected from degradation and thus, the half-life and potency of the siRNA is increased \[[@R49]\]. Within the last 5 years, the use of siRNA packaged into neutral 1,2 dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) liposomes have been utilized effectively in viv*o* against EphA2 and FAK to treat ovarian cancer \[[@R50], [@R51]\] as well as neuropilin 2 for the treatment of colorectal carcinoma \[[@R52]\]. These studies demonstrated effective silencing of target genes with limited toxicities utilizing low-dose siRNA-DOPC delivered via intraperitoneal injections \[[@R48], [@R50]\]. The liposomes were found to rapidly enter the liver, spleen, kidney and reticuloendothelial system (RES) along with the target tissue \[[@R47]\]. Nevertheless, the target genes were silenced in vivo, demonstrating the effectiveness of this delivery system as a potential therapeutic modality in cancer and other diseases. Although we showed that metastatic melanoma cell lines transduced with lentiviral-based PAR-1 shRNA lost their potential in forming melanoma tumors and metastatic lung colonies, the goal of most melanoma research is now aimed at developing therapies from the benchside to the clinic. Because of this, we wanted to use siRNA-DOPC nano-liposomes as an alternative delivery system that is safer and more feasible, yet effective. Similar to the results obtained using lentiviral based silencing of PAR-1, we saw a significant decrease in melanoma tumor growth and experimental lung metastasis in melanoma tumor-bearing mice treated with PAR siRNA-DOPC as compared to NT siRNA-DOPC-treated mice \[[@R43]\]. Moreover, Tumors from PAR-1 siRNA-DOPC and NT siRNA-DOPC-treated mice were analyzed for invasive and angiogenic factors including MMP-2, IL-8 and VEGF. Immunohistochemical analysis revealed a decrease in these angiogenic and invasive factors after PAR-1 silencing. Furthermore, through CD31 staining, we observed a decrease in the number of blood vessels in PAR-1-silenced tumors as compared to NT siRNA-DOPC treated mice. In contrast, blood vessels were largely dilated in NT siRNA-DOPC tumors. It is important to note that the PAR-1 siRNA entrapped in the DOPC liposomes is not targeted specifically to the tumor cells. Our experiments however, utilized a PAR-1 sequence specific for human PAR-1 that would not recognize murine PAR-1. Furthermore, PAR-1 is not expressed on mouse platelets and plays no role in platelet aggregation. Although this was beneficial for our experimental design, it did not allow us to determine possible side effects of systemic delivery of PAR-1 siRNA in terms of platelet aggregation or coagulation. Nevertheless, the use of PAR-1 siRNA might still offer a plausible therapeutic target as PAR-1 does not interfere with thrombin generating fibrin (which subsequently forms a clot) nor does it interfere with other mechanisms that activate platelets, such as coming into contact with collagen from damaged blood vessels \[[@R53]\]. Furthermore, platelets can be activated by PAR-4 at higher concentrations of thrombin \[[@R29]\]. Therefore, a decrease in PAR-1 might not have such severe effects on coagulation as compared with other antithrombotic agents \[[@R53]\]. This could be corroborated by silencing the human PAR-1 equivalent in mice, PAR-3, with systemically delivered siRNA-DOPC in vivo. Nevertheless, we sought to elucidate novel downstream target genes of PAR-1 that might not only increase our understanding of the mechanisms by which PAR-1 affects melanoma growth and metastasis, but might also be targeted by siRNA-DOPC therapies. REGULATION OF CONNEXIN 43 BY PAR-1 {#s6} ================================== To identify downstream target genes of PAR-1 that might contribute to the metastatic phenotype of melanoma, our laboratory performed cDNA microarray studies. This strategy led us to identify Connexin 43 (Cx-43) as a target gene of PAR-1 \[[@R54]\]. Intracellular membrane channels called connexins not only allow for the passage of molecules less than 1.2 kD to pass between adjacent cells but have also been described to function as membrane proteins with adhesive properties \[[@R55], [@R56]\]. The attachment of tumor cells in transition from a primary site to a secondary organ site requires the attachment as well as the migration of tumor cells through the vascular endothelium. This communication between tumor cells and endothelial cells has been shown to be mediated by connexins and are critical to tumor cell extravasation at the metastatic site \[[@R57]-[@R59]\]. Increased Cx-43 expression has been observed in several cancers, including breast cancer \[[@R60]\] and gliomas \[[@R55]\]. In fact, decreased Cx-43 expression reduced adhesion of breast cancer cells to the pulmonary endothelium. \[[@R61]\]. In melanoma, increased coupling of Cx-43-expressing murine melanoma cells to vascular endothelial cells was previously reported \[[@R57]\]. However, the mechanism by which Connexin 43 was regulated had not been described. Utilizing our stably transduced PAR-1 shRNA cells, we found a significant decrease in Cx-43 expression after PAR-1 silencing as a result of decreased binding of SP-1 and AP-1 to the Connexin 43 promoter \[[@R54]\]. Moreover, we found that silencing PAR-1 results in decreased binding of metastatic melanoma cell lines to human vascular endothelial cells and to human dermal microvascular endothelial cells. Upon re-expressing PAR-1 in PAR-1-silenced cell lines, an increase in attachment was observed. To corroborate that the changes in attachment were due to Connexin 43, we stably silenced Cx-43 in metastatic melanoma cell lines and found decreased attachment of melanoma cells to endothelial cells. This was the first report of PAR-1 regulating Cx-43 expression adding an alternative mechanism to how PAR-1 contributes to the metastatic melanoma phenotype \[[@R54]\]. However, the role of Connexin 43 in melanoma remains controversial. In contrast, to our findings, Cx-43 had previously been found to be decreased in human melanoma cells \[[@R62], [@R63]\]. These studies focused on the early events involved in melanoma progression in which melanocytes come into contact with keratinocytes via Cx-43 and Cx-26. They further showed that melanoma cells having low Connexin levels were less able to attach to keratinocytes thereby losing their regulation. These studies did not utilize melanoma cells that had developed the capability of metastasizing and in route to the metastatic site. Once melanoma cells are in the circulation, some acquire the capability of arresting and extravasating through the vascular endothelium of the metastatic site. Connexin 43 is crucial for the communication between endothelial cells and tumor cells and plays a role in tumor cell adherence and diapedesis \[[@R54], [@R64]\]. PAR-1 REGULATES THE MASPIN TUMOR SUPPRESSOR GENE {#s7} ================================================ One of the other genes identified in our cDNA microarray following PAR-1 silencing was Maspin. Maspin was increased by more than 45-fold as compared to NT shRNA transduced melanoma cells \[[@R65]\]. Maspin is a member of the serine protease inhibitor (serpin) family first isolated from human mammary epithelial cells \[[@R66]\]. Inhibitory serpins bind proteases to its functional domain, the reactive site loop (RSL). The RSL then undergoes cleavage by the protease which causes a conformational change (a stressed to relaxed conformation) in the serine protease inhibitor \[[@R67], [@R68]\]. The relaxed-state serpin complex inactivates the protease \[[@R67]\]. Maspin was first identified as an inhibitor of tissue-type plasminogen activator \[[@R69]\] and urokinase-type plasminogen activator (uPA) \[[@R70], [@R71]\]. However, other studies have shown that Maspin does not have a direct serine protease inhibitor function, as its functional domain, the reactive site loop, does not undergo a stressed to relax conformational change essential for protease inhibition by serpins \[[@R67], [@R72]\]. Recently, Denk et al., proposed that in malignant melanoma, Maspin does function as an inhibitory serpin as it blocks matrix-degrading proteases \[[@R73]\]. Maspin expression has been found to be decreased or lost in several malignancies and is associated with decreased aggressiveness in prostate cancer and breast cancer \[[@R74], [@R75]\]. Mammary cancer cells that were transfected with Maspin resulted in decreased tumor growth and metastasis in vivo \[[@R76]\]. On the contrary, Maspin has been found to be overexpressed in several cancers, including bladder \[[@R77]\], lung \[[@R78]\], and pancreatic \[[@R79]\] cancers. Furthermore, in ovarian cancer and colon carcinoma, overexpression of Maspin correlates with nuclear translocation \[[@R73], [@R80], [@R81]\]. As such, Maspin also seems to have a role as a transcriptional regulator by increasing expression of tumor supportive genes \[[@R73], [@R80]\]. The nuclear Maspin found in ovarian cancer seems to inhibit the tumor suppressor cytoplasmic functions of Maspin \[[@R73], [@R81]\]. Thus, the role of Maspin in cancer seems to be tumor type specific and depends on its intracellular localization. Maspin was recently found to be a tumor suppressor in melanoma. Metastatic melanoma cells were found to have decreased expression levels of Maspin as compared to normal human epidermal melanocytes \[[@R73]\]. Furthermore, this study found that when Maspin was re-expressed in melanoma cells, there was a significant reduction in their invasive capacity. The mechanism of Maspin regulation, however, has not been described for melanoma. It has been hypothesized that the loss of Maspin in metastatic melanoma tumor specimens might be attributed to an increase in p53, as there is evidence showing overexpression of p53 in metastatic melanoma specimens \[[@R82]-[@R84]\]. Furthermore, in several cancers such as breast and prostate cancers, an inverse correlation between p53 and Maspin expression has been suggested \[[@R85], [@R86]\]. However, Webber and colleagues found no correlation between p53 and Maspin expression when analyzing metastatic melanoma specimens. Thus, the mechanism for Maspin regulation in melanoma has yet to be elucidated \[[@R84]\]. Our laboratory recently published our findings on PAR-1 regulation of the Maspin tumor suppressor gene in melanoma \[[@R65]\]. We found an inverse correlation between PAR-1 and Maspin expression. Highly metastatic melanoma cell lines have high PAR-1 expression and low Maspin levels. Likewise, silencing PAR-1 via lentiviral shRNA, results in increased Maspin expression levels through increased binding of two transcription factors known to regulate Maspin, c-Jun and Ets-1. Interestingly, we did not see a difference in protein expression of c-Jun and Ets-1 after PAR-1 silencing. Rather, we found that silencing PAR-1 inhibits phospho- p38 MAPK which releases the inhibition of the histone acetlytransferase CBP/p300. The increased HAT activity allows for increased binding of Ets-1 and c-Jun to the Maspin promoter and subsequently increased Maspin expression. Our studies further found that the increased in Maspin expression results in a decrease in invasion by inhibiting MMP-2 expression and activity (Figure [2](#F2){ref-type="fig"}). In vivo studies utilizing Maspin expression vectors showed a significant decrease in melanoma tumor growth and experimental lung metastasis as well as decreased MMP-2, VEGF, and Maspin expression levels from tumor sections. To further corroborate that PAR-1 was regulating Maspin expression in vivo, we stably silenced Maspin in PAR-1-silenced cell lines and showed that levels of melanoma tumor growth and experimental lung metastasis were similar to Non-Targeting shRNA-transduced control cells. Furthermore, levels of Maspin, VEGF and MMP-2 were also increased to levels similar to NT-transduced cells \[[@R65]\]. {#F2} CLINICAL IMPLICATIONS {#s8} ===================== Identifying PAR-1 and its downstream target genes, Connexin 43 and Maspin, as factors involved in melanoma progression is essential, as current therapies for metastatic melanoma are not efficient. The only FDA approved chemotherapeutic agent is Decarbazine even with dismal response rates of 15% \[[@R5], [@R6]\]. Furthermore, the duration of the response to DTIC is not sustained, often lasting as brief as 5 months \[[@R5], [@R7], [@R8]\]. Adjuvant therapies with interferon α or IL-2 for high stage melanoma patients also have limited response rate of less than 20% \[[@R9]-[@R12]\]. Our studies suggest that targeting PAR-1 can potentially be used as a target for human melanoma therapy. Furthermore, PAR-1 regulates multiple genes essential for melanoma growth and metastasis such as Connexin 43 which could also potentially serve as novel targets for melanoma therapies. Nevertheless using a single target for therapy has not had success in melanoma. Combining PAR-1 targeted therapy with chemotherapy, anti-angiogenic drugs, pro-apoptotic drugs, or even HDAC inhibitors could potentiate the anti-tumor and anti-metastatic effects seen in our PAR-1 studies. Finding the right combination of therapies to effectively treat metastatic melanoma remains one of the biggest challenges in melanoma research, especially in melanoma cells that do not harbor the BRAF V600E mutation. Although our studies focus on the effects of PAR-1 on melanoma progression, several other cancers such as breast, prostate, colon and pancreatic cancers have been found to have increased PAR-1 expression with increased progression of disease. As such, targeting PAR-1 in these cancers could also have therapeutic potential. Taken together our studies show that PAR-1 plays a major role in melanoma progression and that targeting PAR-1 or its downstream target genes could help in treating metastatic melanoma and could have potential benefits in treating several other cancer types as well. This work was supported by National Institutes of Health (NIH) Grant R01 CA76098, NIH Specialized Programs of Research Excellence in Skin Cancer Grant P50-CA093459 (to M.B.E.), and a McCarthy Fellowship in Skin Cancer Research (to G.J.V.). The authors declare no conflict of interest.

Introduction {#s1} ============ Periodical sound patterns such as rhythmic music induce a sensation of temporal recurrence called pulse [@pone.0008151-Madison1]. This is employed by humans for achieving precise synchronisation or entrainment among individuals in music performance, dance, drill, and various ritual behaviours [@pone.0008151-McNeil1]. Pulse is a periodic process that enables proactive timing by predicting the time of future events rather than reacting to them with a time lag of at least 100 ms [@pone.0008151-Kauranen1]. This makes precise synchronisation and co-ordination among individuals possible in the absence of any other common control system [@pone.0008151-Merker1]. While pulse events typically coincide with conspicuous physical events in the sensory signal, such as louder or more frequent sounds, the pulse is in fact a subjective process. Pulse events may occur at points in time when there is no physical stimulus, if implied by the stimulus pattern as a whole [@pone.0008151-Toiviainen1], as well as in the absence of an external signal altogether [@pone.0008151-Madison2]. Music is the most common example of a sound pattern with multiple temporal levels, in contrast to which the typical signal of a metronome can be characterised as a one-level pattern that physically contains only one level at which to attribute pulse. Even in response to one-level patterns may the pulse be perceived at other levels than the physical one, determined in part by temporal limits of the neural system [@pone.0008151-Guttman1], [@pone.0008151-Mates1]. This so-called subjective rhythmisation [@pone.0008151-Bolton1] is typically attributed to multiples corresponding to every second, third, or fourth sound etcetera if the physical intervals are short, and to subdivisions of intervals into two, three, or more equal subintervals if the physical intervals are long. Although repetition of equal time intervals (i.e. isochrony) is the central principle for predictive timing, this simple information is apparently used in a flexible and complex way that accommodates not only fractions and subdivisions of intervals, but also momentary [@pone.0008151-Madison1] and gradual [@pone.0008151-Madison3] changes of intervals. The scope of this flexibility remains largely uncharted, and the underlying mechanisms are a matter for speculation [@pone.0008151-Gibbon1], [@pone.0008151-Hary1], [@pone.0008151-Ivry1], [@pone.0008151-Lewis1]. Temporal synchronisation among individuals is rare in the animal kingdom, which indicates that is has few instrumental uses. In addition to humans it is nevertheless found in a few species of insects and reptiles, for example, for which its function is to increase the salience or geographic reach of a signal by summation over simultaneously signalling individuals. This is in turn used for attracting migrating females [@pone.0008151-Buck1], [@pone.0008151-Greenfield1], warning conspecifics for predators [@pone.0008151-Attenborough1], or confusing the auditory localising ability of bats preying on a species of tree frog [@pone.0008151-Tuttle1], for example. The underlying mechanisms are in general poorly understood, although the synchronising behaviour of fireflies has been subject to quite detailed study [@pone.0008151-Ermentrout1]--[@pone.0008151-Buck3]. These examples show that the ability and motivation for entrainment is not merely a curiosity but may serve a distinct adaptive function whenever its function has been identified. For humans, however, no obvious adaptive function has been recognised for entrainment, although it is obviously a key element in music performance and other group behaviours mentioned above. While neither these behaviours are unanimously attributed to an adaptive value, music and entrainment in various guises has been suggested to be related to group cohesion [@pone.0008151-Freeman1], the evolution of language [@pone.0008151-Mithen1], hominid speciation by means of natural selection [@pone.0008151-Merker2], and costly signalling of mate quality in the context of sexual selection [@pone.0008151-Miller1]. Be that as it may; human entrainment capabilities serve important functions in humans\' present state of affairs, and have long attracted scientific inquiry [@pone.0008151-Merker1], [@pone.0008151-Dietze1], [@pone.0008151-Meumann1]. Given that human processing of isochronous sequences accommodates multiplication and subdivision of intervals it is not surprising that music is also characterised by this multiple temporal level structure, as defined by metre and different note values. The present illusion is based on a generalisation of this property. While the presence of each level typically varies throughout a piece of real music, the present pattern features physical events corresponding to all levels within a perceptually relevant range. The pattern consists of sounds with brief isochronous inter onset intervals (IOI) on the order of 50 ms. Every second sound event is louder than the intervening ones, which gives the impression of a second temporal level with half the rate of the first one. Increasing the loudness of every second event of the second level likewise yields a third level, and so forth. In addition to this, the intervals are continuously increased or decreased by a factor of 2^±1^ across the pattern length, that is, either halving or doubling the interval. These principle properties are illustrated in [Figure 1](#pone-0008151-g001){ref-type="fig"}, which for clarity of presentation depicts an example 96-event pattern rather than the 786-event patterns used in the experiment. The ordinal position of sound events in the pattern is indicated by the angular scale, and their IOI by the radial scale. The size of the points represents the relative loudness of events. It is manipulated so as to obscure the boundaries between pattern repetitions, which might otherwise distract listeners and make the illusion less powerful (cf. Shepard\'s circularity in the perception of pitch illusion [@pone.0008151-Shepard1]). All these features are detailed in [Materials and Methods](#s3){ref-type="sec"}. {#pone-0008151-g001} It was predicted that participants would accurately synchronise with one level in the pattern and follow the gradual interval change therein, but would continue to the next higher or lower level at pattern boundaries, depending on the direction of the change. This illusion was evaluated by a sensori-motor synchronisation experiment in which human participants were asked to beat a drumstick against an electronic sensor plate in synchrony with their perceived pulse. Results and Discussion {#s2} ====================== Responses demonstrated epochs of consistent synchronisation with sounds corresponding to one specific level, seamless continuation to an adjacent level at the pattern boundary, and occasional switching to another level when beat IOIs become very short or long. All these features occurred in almost every trial (N = 76), and are examplified by one trial with increasing intervals in [Figure 2A](#pone-0008151-g002){ref-type="fig"} ([Audio file S2](#pone.0008151.s004){ref-type="supplementary-material"}) and one trial with decreasing intervals in [Figure 2B](#pone-0008151-g002){ref-type="fig"} ([Audio file S4](#pone.0008151.s006){ref-type="supplementary-material"}). The course of each example trial is represented by a clockwise trajectory with its first and last response intervals indicated, in [Figure 2A](#pone-0008151-g002){ref-type="fig"} for a trial with increasing intervals from the center (short intervals) to the circumference (long intervals), and in [Figure 2B](#pone-0008151-g002){ref-type="fig"} from the circumference to the center. Filled circles denote each response according to its closest corresponding event position in the stimulus pattern on the angular scale and to its IOI on the radial scale. When trajectories overlap (i.e., when synchronization to the same level has occurred more than once in the same trial) points are connected with lines to guide the eye. One response sequence corresponds to five revolutions, since the whole stimulus sequence in each trial consisted of five seamlessly repeated patterns. The illusory temporal levels that emerge as an effect of the manipulation of stimulus IOI and loudness are represented by the helical alternating dotted and solid lines numbered with Arabic numerals, whose meeting points coincide with the boundaries between repeated patterns at the zenit of the figure. Since the angular scale represents pattern position, and the time between successive events continuosly changes by a factor 2^±1^ across one pattern, time proper is nonlinear along this scale. This is evident at the boundaries between repeated patterns, where the distance between points to the right of the boundary is double the number of pattern events of the immediately preceding points to the left, although they in fact are separated by almost the same amount of time. The lines with arrows between levels indicate switches in the response interval, consecutively numbered with Roman numerals. Note that the stimulus pattern depicted in [Figure 1](#pone-0008151-g001){ref-type="fig"} cannot be seen in these diagrams because it would be outside the radial scale (below 100 ms). {#pone-0008151-g002} As can be seen, no switches coincide with the boundary between repeated patterns, which was indeed rarely the case among all trials. This suggests that participants did neither notice the boundary between pattern repetitions nor find any portion of the pattern more or less difficult to synchronise with. When interviewed after the session did no participant report having noticed any breakpoints in the stimulus sequence. On the contrary, several participants spontaneously reported being puzzled by making such large changes in beat rate without the stimulus essentially changing. To quantify this issue, the 351 switches that occurred across all 76 trials were sorted in 16 bins according to their pattern position; one bin for each 48 adjacent positions of the total 768. No significant difference in the frequency of switches was found among bins (χ^2^ = 13.64, *df* = 15, *p* = 0.55), a histogram of which showed no tendency for frequencies to increase close to the start or end of the pattern ([Figure S1](#pone.0008151.s001){ref-type="supplementary-material"}). Within these features of the response sequences, demonstrating the illusion, the beat IOI varied among trials and participants in accordance with the unconstrained task. Participants did accurately synchronise with IOIs longer than 8 s ([Fig. 2A](#pone-0008151-g002){ref-type="fig"}) and shorter than 200 ms ([Fig. 2B](#pone-0008151-g002){ref-type="fig"}), while many trials exhibited a more narrow range. Across all trials, central tendencies in IOI for switches were close to 0.5 s for decreasing IOIs (M = 511, Md = 461, min = 160, max = 1070 ms) and close to 2 s for increasing IOIs (M = 2197, Md = 1778, min = 713, max = 8650 ms). Most aspects of the switching behaviour are summarised in [Figure 3](#pone-0008151-g003){ref-type="fig"}, in which the ratio between the last IOI before the switch and the first IOI after the switch is plotted as a function of IOI before the switch. To render a clearer depiction of the results only switches with a relatively high effect size (Hedges\' g\>3.0) are included (N = 209) in order to exclude switches to a similar IOI (ratio ∼1), and axis scales are logarithmic. First, decreasing intervals (circles) lead to short IOIs that tend to be switched to the double IOI (2.0), while increasing intervals (squares) lead to long IOIs that tend to be switched to half or ¼ of the interval (0.5 or 0.25), as exemplified in [Figure 2](#pone-0008151-g002){ref-type="fig"}. Second, more extreme IOIs tend to be associated with larger switch ratios, in other words a tendency towards a preferred range of IOIs close to 500 ms [@pone.0008151-McDougall1]. This is particularly evident for increasing intervals, where IOIs above 4 s are exclusively divided in four at the switch. Third, switch IOIs along the abscissa for decreasing intervals suggest a bimodal distribution with central tendencies close to 300 and 600 ms, respectively, which is also reflected by the difference between the mean (511 ms) and the median (461 ms). This indicates the employment of two different strategies on behalf of the participants; either to switch within the comfortable range of IOIs between 400 and 800 ms [@pone.0008151-Fraisse1], or to hold on until approaching the motor limit close to 200 ms [@pone.0008151-Kauranen1]. {#pone-0008151-g003} The illusion was also demonstrated by the differences between increasing and decreasing sequences in both response and switch IOIs, which are - in contrast to the 2^±1^ stimulus change - on average on the order of 2^±2^. The central tendencies are 2197/511 = 4.30 for the mean IOI and 1778/461 = 3.86 for for the median IOI. It should be noted that this behaviour occurred spontaneously to the open-ended instruction to beat in synchrony with the perceived pulse and feel free to change the beat rate to a more natural one at any time. The mean change would conceivably have been much larger, in accord with the behaviour of some participants, if the instruction would have been to maintain the "same" rate, which in the case of this pattern sequence would amount to following the illusory change for even longer epochs. Indeed, switches from one level to another were interspersed among long epochs subject to the illusion, and the actually produced IOIs therefore covered an even wider range than did the switch IOIs. In particular did a number of the response sequences with increasing intervals exhibit few or no switches at all, as exemplified by [Figure 2A](#pone-0008151-g002){ref-type="fig"}. All 19 participants produced beat sequences with local mean IOIs longer than 2 s, and many participants produced IOIs longer than 3 s (N = 17), 5 s (N = 11), and 8 s (N = 6). Illusions offer insight into the working principles of perceptual and cognitive systems. Apart from the illusory phenomenon per se, their unstability and sensitivity to subtle stimulus properties can be employed for examining more general questions that may be difficult to address with normal stimuli. There are numerous visual illusions but only a handful auditory ones [@pone.0008151-Anonymous1]. Shepard tones [@pone.0008151-Shepard1] and the present infinite tempo change create the only "impossible" percepts while other auditory illusions involve hearing what is not physically present or choosing among ambiguous percepts (but cf. [@pone.0008151-Risset1], and references therein). The present data provide a striking demonstration of pulse and its subjective nature, characteristic for the proactive, predictive, and hypothesis-testing character of brain function in general [@pone.0008151-Friston1], [@pone.0008151-Konen1]. Specifically, the beat rate is apparently a function of both the immediate stimulus properties, which determine the possible specific time points to synchronise with bottom-up, and the recent behaviour history, which determines the level to synchronise with top-down. In other words, the pulse seems to function as a top-down hypothesis about future intervals, which assimilates contradictory sensory information if the discrepancy is not too large, but accommodates information that consistently disagrees with the hypothesis. In this case the ±0.13 percent (1/768) continuous stimulus interval change was readily accommodated into the prediction that the next interval was almost similar to the previous one, rather than determined by the local stimulus properties. It has previously been demonstrated that people can accurately synchronize with sound events across a wide range of change from ±0.077 to ±0.67 percent per interval in one-level sequences [@pone.0008151-Madison3]. When local variability is applied to a stimulus sequence, in terms of unpredictable lengthening and shortening of otherwise isochronous intervals, the mean threshold for perceiving pulse was 8.6 percent across a group of listeners, as compared to a 3.5 percent threshold for detecting such deviations [@pone.0008151-Madison1]. Although such ample margins may seem to suggest that synchronisation is correspondingly inexact, this is not the case. When deviations are relatively small, they are reflected in the immediately following response interval even when they are below the detection threshold [@pone.0008151-Madison4], [@pone.0008151-Thaut1], although the proportion of the deviation reflected seems to decrease for larger (10--50%) deviations [@pone.0008151-Repp1]. This seems to reflect another strategy for facilitating synchronisation, namely to rely more on the internal pulse when the signal is a poor predictor, but follow the signal closely when it is a reliable predictor of isochrony [@pone.0008151-Repp2]. The signal might be anything from rhythmic music or a multilevel pattern to the movements of another individual. There is evidence that the pulse mechanism is in place already within the first year of life [@pone.0008151-PhillipsSilver1]. The present results demonstrate proactive synchronisation, and hence temporal integration, of events separated by up to 8 s, while proactive synchronisation is impossible for one-level sequences with IOIs from 2.4 s and up [@pone.0008151-Mates1]. Participants must therefore have utilised sound events intervening the level of their beats, at least for beat IOIs longer than 2 s. This demonstrates that although the pulse takes on a dominating role for the top-down interpretation of ambiguous stimuli, it does not preclude the influence of other information. These trade-off characteristics and their underlying mechanisms are a challenge for future research. Extant synchronisation models cannot account for this duality since they are confined to one level [@pone.0008151-Hary1], [@pone.0008151-Large1], [@pone.0008151-Vorberg1]. Interestingly, however, both the present behaviours and type of stimuli are sufficiently well-defined to allow precise formal manipulation and modelling, and may therefore serve as a micro-world system for exploring general information-processing principles in ecologic, dynamical interaction. The multilevel pattern could be applied to examine a number of issues that have been difficult to assess with traditional methods. It features a large and multi-dimensional stimulus space including base IOI, direction, rate of change, and the number of pattern repetitions. In the present study both directions were used but only one level of rate change (1/768≈0.13% per interval). In addition, sound events belonging to specific levels in the multilevel structure can be individually varied in time, loudness or excluded altogether, and their sound properties altered. Finally, all these aspects can be manipulated in the course of stimulus presentation, thereby adapting to a multitude of design requirements including dynamical, on-line change of parameters. For example, manipulating the relative sound levels in a multilevel structure makes it possible to vary perceived event rate while keeping the overall density of perceived events constant, which may be particularly useful for keeping activity related to sensory processing constant in brain imaging experiments. More generally, multilevel patterns may be more ecologically valid than the metronome-like clicks widely used both in basic research and clinical assessment [@pone.0008151-Patel1]. They are likely to provide a more motivating stimulus by virtue of recruiting larger neural networks, in analogy with so-called rippled sound profiles [@pone.0008151-Chi1] that comprise both a wide harmonic spectrum (analoguous to the multiple levels) and pitch sweeping (analoguous to the rate change). This property might be particularly valuable for use with children and clinical populations such as ADHD, who may be less able to focus sustained attention to demanding laboratory tasks. Materials and Methods {#s3} ===================== Ethics Statement {#s3a} ---------------- All participants signed a written informed consent, were treated in accordance with the Declaration of Helsinki, and received a reward equivalent to USD 10. The study protocol was approved by the local ethics research committee at the University of Uppsala. Stimuli {#s3b} ------- The principle features of the illusive stimulus sequence are illustrated in [Figures 1](#pone-0008151-g001){ref-type="fig"} and [S2](#pone.0008151.s002){ref-type="supplementary-material"}. [Figure S2A](#pone.0008151.s002){ref-type="supplementary-material"} shows the first 68 events of the multilevel structure. The temporal level (which basically controls loudness in the sound pattern) is shown on the ordinate, as a function of position in the pattern on the abscissa: every other event corresponds to level 0 (2^0^), every second event to level 1 (2^1^), and so forth. Only levels up to 6 fit within the range of the abscissa, so levels 7 (2^7^ =  every 128th event) and 8 (2^8^ = 256th event) are not shown. Four different stimulus sequences were used. Each sequence had either increasing or decreasing intervals and a base IOI (mean IOI for level 0) of either 49 or 64 ms. They are available in mp3 format as [Audio file S1](#pone.0008151.s003){ref-type="supplementary-material"} (increasing IOIs with 49 ms base IOI) [Audio file S2](#pone.0008151.s004){ref-type="supplementary-material"} (increasing IOIs, 64 ms), [Audio file S3](#pone.0008151.s005){ref-type="supplementary-material"} (decreasing, 49 ms), and [Audio file S4](#pone.0008151.s006){ref-type="supplementary-material"} (decreasing, 64 ms). The stimulus sequences were implemented with a pattern consisting of 768 events numbered 0--767, in which each event was assigned to one of 9 temporal levels according to , . The IOI from each stimulus event to the next one was computed as , where B is the base IOI. Two base IOIs were used in order to further assess possible effects of pattern position on the salience of the perceived pulse. The fraction between the two base IOIs (49 and 64 ms) was 1.30, which was chosen so as to be unharmonic with the inherent 2^±1^ relation and its aggregates in the multilevel pattern (e.g., 3/2 = 1.5). This means that the same IOIs occurred at pattern positions separated by 30 percent of the pattern length across patterns with different base IOI. The mean switch IOIs were not affected by base IOI, neither for decreasing (t = 1.19, df = 295, p = .55) nor increasing intervals (t = 1.44, df = 145, p = .59), which indicates that perceived rate was unaffected by pattern position per se. The equations yield sound patterns in which the first and last IOIs were ∼32.67 and ∼65.29 ms for 49 ms base IOI and ∼42.67 and ∼85.28 for 64 ms base IOI. Expected pulse IOIs at pattern boundaries were powers of 2 within the manageable range for synchronisation, e.g. 261, 523, 1045, and 2091 ms for 49 ms base IOI and 341, 683, and 1365 ms for 64 ms base IOI. Each stimulus sequence consisted of 5 identical patterns presented in succession, which means that the maximum possible change in pulse rate was a factor of 32 (2^5^). Each sequence comprised 3840 events and a total duration of 188.16 s for 49 ms base IOI or 245.76 s for 64 ms base IOI. Loudness was controlled by the note velocity parameter in the MIDI protocol [@pone.0008151-1], which can assume values between 0 and 127, and was computed as . Loudness was further transformed in both hardware and software for adaptation to the hearing range. As these particulars are specific for the equipment used, the actual sound pressure level (SPL) in the headphones are recorded in a table that can be obtained on request. Essentially, SPL for the fastest level varied from 35 and 39 dBA, which encompassed the auditory detection threshold under the actual circumstances, and the SPL for the slowest level was ∼79 dBA. The room where the experiment took place had a 36 dBA background noise, mainly from the ventilation system, that was reduced to 31 dBA in the headphones. [Figure S2B](#pone.0008151.s002){ref-type="supplementary-material"} illustrates the loudness manipulation by means of a short example with increasing intervals (slowing rate). This example is only 96 events in order to convey the principles withouth cluttering the graph, but is computed with the same IOI and velocity equations as were the 768-event stimulus patterns used in the experiment. Increasing IOIs between sound events appear as longer distances between events from left to right, since the abscissa represents real time. The ordinate represents the loudness manipulation, showing that (a) the loudness of each level at the beginning of the pattern corresponds with an adjacent level at the end of the pattern, (b) loudness is a sigmoid function of level, such that it changes less from start to end for the fastest and slowest levels than for intermediate levels, (c) loudness is divided among all levels such that the fastest level transgresses the auditory threshold within the pattern, which masks its appearance (for increasing IOIs) or disappearance (for decreasing IOIs) at the pattern boundary. These devices are similar to those applied in Roger Shepard\'s circularity in pitch illusion [@pone.0008151-Shepard1]. Apparatus {#s3c} --------- A PC with the real-time operating system FreeDOS was programmed to generate stimulus events and collect responses by means of an *MPU-401*--compatible MIDI interface connected to an Alesis DM5 synthesiser module. The temporal resolution of this system is 1 ms [@pone.0008151-Madison5]. Stimuli consisted of a percussion instrument sound (Prc/021 ShakerLo) presented through sound-attenuating Peltor HTB7A headphones. Responses were obtained by beating a drumstick against a *ddrum* drum pad equipped with a piezoelectric sensor (Clavia musical instruments, Stockholm). Participants {#s3d} ------------ Nineteen nonmusicians participated, ten women and nine men aged 19 to 35 years (M = 24.5). None had any previous experience with similar experiments, had received music tuition, or had played a musical intrument in a systematic fashion. Procedure {#s3e} --------- Each individual session lasted 45--55 minutes and comprised instructions and 5 brief training trials together with the experimenter, followed by 28 static (without rate change) trials, 4 rate change trials, and then another 26 static trials performed alone. The static trials were not considered here. A critical part of the instruction was to beat the drum pad in synchrony with the perceived pulse, and to feel free to change the beat rate to a more natural one at any time. Data Analysis {#s3f} ------------- Data consisted of IOIs of response beats and the identity (level and postion) of the pattern events closest in time to each beat. One important aspect of the participants\' behaviour was at what positions in the stimulus sequence they switched from one beat rate to another. To detect switches from one consistent beat IOI to another one in an objective fashion, a routine based on Hedges\' effect size *g* was implemented in Statistica v. 7 visual basic (Statsoft Inc.). It computes local means and variances and compares them for each position in order to find local maxima. For each response beat interval sequence X, M~1~ and s~1~ ^2^ were computed for X~i~ to X~i+9~, and M~2~ and s~2~ ^2^ were computed for X~i+10~ to X~i+20~. The effect size of the difference between these means was computed as . The difference M~1~--M~2~ was also multiplied with direction (-1 for decreasing intervals and 1 for increasing intervals) which excluded switches in the "wrong" direction. The initial *g* ~1~ was stored as maximum *g* (*g* ~max~) and the position i advanced one step. Subsequent larger values of *g* replaced *g* ~max~ until *g* ~i~\<g~max~, which indicated that *g* ~i-1~ was a local maximum and that a switch to a different mean IOI had occurred. If in these cases *g* was greater than a lower cut-off of 0.3, the sequence position and the mean IOIs before and after this position were stored, *g* ~max~ was reset to 0, and the process re-continued. This procedure yielded 606 switches within the total 26,850 response intervals. However, some of these referred to switches in IOI within the same level in the pattern, and were therefore not relevant for testing possible correspondence between switch positions and pattern boundaries. Analyses showed that a cut-off of g\>1.4 yielded switches (N = 351) that mostly referred to different levels in the pattern, i.e. differences with a factor 2^±1^ or greater. Supporting Information {#s4} ====================== ###### Histogram of sequence positions at which the 351 switches with g\>1.4 occurred. (0.34 MB TIF) ###### Click here for additional data file. ###### Additional graphical representations of the stimulus pattern. See text for explanations. (0.09 MB TIF) ###### Click here for additional data file. ###### Increasing intervals with 49 ms mean IOI (3.09 MB MP3) ###### Click here for additional data file. ###### Increasing intervals with 64 ms mean IOI (3.88 MB MP3) ###### Click here for additional data file. ###### Decreasing intervals with 49 ms mean IOI (3.11 MB MP3) ###### Click here for additional data file. ###### Decreasing intervals with 64 ms mean IOI (3.84 MB MP3) ###### Click here for additional data file. Part of this work was conducted at the Department of Psychology at Uppsala University, and I thank Björn Merker for the best of sparring. I also thank Linus Holm, Bo Molander, Lars Nyberg, and Louise Rönnqvist for helpful comments on a previous version of this paper. An anonymous referee indicated a few papers by J.-C. Risset that mention a tempo illusion (see [@pone.0008151-Risset1] and references therein). The author is named as an inventor on a Swedish patent (SE 529 032 C2) and patent applications for the U.S. (US20080091414), the United Kingdom (GB2441259), and Australia (PCT/SE2006/050117) regarding the use of the type of stimulus patterns used in this study for therapeutic purposes. **Competing Interests:**This could be argued to be an "interest" but it is no "conflict". The author gauges that the following facts have not in any way affected the conduct, direction, or presentation of this research. The author is named as an inventor on a Swedish patent (SE 529 032 C2) and patent applications for the U.S. (US20080091414), the United Kingdom (GB2441259), and Australia (PCT/SE2006/050117) regarding the use of the type of stimulus patterns used in this study for therapeutic purposes. Note that these patent documents do not describe the particular pattern used in the experiment and do not mention the behavioural and psychological aspects that are the focus of the ms. **Funding:**Part of this research was supported by The Bank of Sweden Tercentenary Foundation (<http://www.rj.se/>), through grant P2002:0791; Musical pulse in human timing and coordination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. [^1]: Conceived and designed the experiments: GM. Performed the experiments: GM. Analyzed the data: GM. Contributed reagents/materials/analysis tools: GM. Wrote the paper: GM.

\section{Introduction} \label{sec:intro} We are intended to discuss the probabilistic interpretation of the backward Wigner equation \cite{Wigner1932, CarruthersZachariasen1983, ShaoXiong2019}, arising from the recently developed particle-based simulation of the Wigner quantum dynamics \cite{NedjalkovSchwahaSelberherr2013, Wagner2016, MuscatoWagner2016, ShaoXiong2019}. The backward Wigner equation is a partial integro-differential equation defined in phase space $(\bm{x}, \bm{k}) \in \mathbb{R}^n \times \mathbb{R}^n$ with an ``initial'' condition $\varphi_T \in L^2(\mathbb{R}^n \times \mathbb{R}^n)$. \begin{align} &\frac{\partial }{\partial t}\varphi(\bm{x}, \bm{k}, t) + \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}} \varphi(\bm{x}, \bm{k}, t) = \Theta_{V}[\varphi](\bm{x}, \bm{k}, t), ~~0 \le t\le T, \label{eq.backward_Wigner}\\ & \varphi(\bm{x}, \bm{k}, T) = \varphi_T(\bm{x}, \bm{k}), \end{align} Here $\varphi(\bm{x}, \bm{k},t)$ is the dual Wigner function, $m$ is the mass, $\hbar$ represents the reduced Planck constant and the pseudo-differential operator (PDO) $\Theta_{V}$ reads \begin{equation}\label{def.pseudo_differential_operator} \Theta_V[\varphi](\bm{x}, \bm{k}, t) = \frac{1}{\mathbbm{i} \hbar (2\pi)^n}\int_{\mathbb{R}^n \times \mathbb{R}^n} \mathbbm{e}^{\mathbbm{i}(\bm{k}-\bm{k}^{\prime})\cdot \bm{y}} D_V(\bm{x}, \bm{y}, t) \varphi(\bm{x}, \bm{k}^{\prime}, t) \D \bm{y} \D \bm{k}^{\prime}, \end{equation} with $D_V(\bm{x}, \bm{y}, t) = V(\bm{x}-\bm{y}/{2}, t) - V(\bm{x} + \bm{y}/{2}, t)$ (i.e., the central difference of the external potential $V(\bm{x}, t)$). Obviously, $D_V(\bm{x}, \bm{y}, t)$ is anti-symmetric in {$\bm{y}$-variable}, \begin{equation}\label{eq:anti} D_V(\bm{x}, \bm{y}, t) = -D_V(\bm{x}, -\bm{y}, t). \end{equation} It is well known that $\Theta_V$, a nonlocal operator with an anti-symmetric symbol, actually characterizes a deformation of the classical Poisson bracket \cite{Kontsevich2003} and exactly reflects the nonlocal nature of quantum mechanics \cite{tatarskiui1983,WeinbubFerry2018,ChenXiongShao2019,ChenShaoCai2019}. The subsequent analysis will be based on two equivalent representations of the PDO. The first form is the kernel {representation:} \begin{align} \Theta_V[\varphi](\bm{x}, \bm{k}, t) & = \int_{\mathbb{R}^n} V_W(\bm{x}, \bm{k}-\bm{k}^{\prime}, t) \varphi(\bm{x}, \bm{k}^{\prime}, t) \D \bm{k}^{\prime} \label{def.first_form_PDO}, \end{align} with the real-valued kernel function $V_W$ (termed the Wigner kernel) \begin{equation}\label{def.Wigner_kernel} \begin{split} V_W(\bm{x}, \bm{k}, t) &= \frac{1}{\mathbbm{i} \hbar (2 \pi)^n} \int_{\mathbb{R}^n} (V(\bm{x}-\frac{\bm{y}}{2}, t) - V(x + \frac{\bm{y}}{2}, t)) \mathbbm{e}^{\mathbbm{i} \bm{k} \cdot \bm{y}} \D \bm{y} \\ & = \frac{1}{\mathbbm{i} \hbar \pi^n}\mathcal{F}_{\bm{x} \to \bm{k}}V(2\bm{k}, t) \mathbbm{e}^{2 \mathbbm{i} \bm{k} \cdot \bm{x}} - \frac{1}{\mathbbm{i} \hbar \pi^n}\mathcal{F}_{\bm{x} \to \bm{k}}V(-2\bm{k}, t) \mathbbm{e}^{-2\mathbbm{i} \bm{k}\cdot \bm{x}} \\ & = {2^n} \psi(2\bm{k}, t) \mathbbm{e}^{2\mathbbm{i} \bm{k} \cdot \bm{z(\bm{x}})} - {2^n} \psi(-2\bm{k}, t) \mathbbm{e}^{-2\mathbbm{i} \bm{k} \cdot \bm{z}(\bm{x})}. \end{split} \end{equation} Here $\mathcal{F}_{\bm{x} \to \bm{k}}V(\bm{k},t)=\int_{\mathbb{R}^n} V(\bm{x},t) \mathbbm{e}^{-\mathbbm{i}\bm{k}\cdot\bm{x}}\mathrm{d} \bm{x}$ denotes the Fourier transform of the potential function $V(\bm{x}, t)$ in $\bm{x}$-variable, and \begin{equation} \psi(\bm{k}, t) = \frac{1}{\mathbbm{i} \hbar (2\pi)^n}\mathbbm{e}^{\mathbbm{i} \bm{k} \cdot (\bm{x} -\bm{z}(\bm{x}))} \mathcal{F}_{\bm{x} \to \bm{k}}V(\bm{k}, t). \end{equation} It is realized that the kernel is anti-symmetric in $\bm{k}$-variable \begin{equation}\label{eq.anti_symmetry} V_W(\bm{x}, \bm{k} -\bm{k}^{\prime} , t) = -V_W(\bm{x}, \bm{k}^{\prime}-\bm{k}, t). \end{equation} due to the anti-symmetry of $D_V$ (see Eq.~\eqref{eq:anti}). The second form is the oscillatory integral representation: \begin{equation}\label{def.second_form_PDO} \Theta_V[\varphi](\bm{x}, \bm{k}, t) = \int_{\mathbb{R}^n} \mathbbm{e}^{\mathbbm{i} \bm{z}(\bm{x}) \cdot \bm{k}^{\prime}} \psi(\bm{k}^{\prime}, t)(\varphi(\bm{x}, \bm{k} - \frac{\bm{k}^{\prime}}{2}, t) - \varphi(\bm{x}, \bm{k} + \frac{\bm{k}^{\prime}}{2}, t)) \D \bm{k}^{\prime}, \end{equation} which facilitates the derivation of its asymptotic expansion (see Theorem \ref{thm.stationary_phase_approximation}). In order to extend $\Theta_V$ to a bounded operator from $L^2(\mathbb{R}^{2n})$ to itself, say, there exists a uniform upper bound $K_V$ such that \begin{equation}\label{eq.PDO_bound} \Vert \Theta_V[\varphi](t) \Vert_2 \le K_V \Vert \varphi(t) \Vert_2, \end{equation} {we make the following assumptions for a finite time interval $ [0, T]$}. \begin{itemize} \item[\textbf{(A1):}] $\varphi \in C([0, T], L^2(\mathbb{R}^n \times \mathbb{R}^n))$ and is localized in $(\bm{x}, \bm{k})$-space for any $t\in [0, T]$, with the {\it minimal} compact support denoted by $\mathcal{X} \times \mathcal{K} \subset \mathbb{R}^n \times \mathbb{R}^n$. \item[\textbf{(A2):}] Suppose either of the following conditions holds: \begin{itemize} \item[(1)] $\psi \in C([0, T], C^\infty(\mathbb{R}^n) \cap L^1(\mathbb{R}^n) )$; \item[(2)] $\psi \in C([0, T], C^{\infty}(\mathbb{R}^n \setminus \{0\}) \cap L^1_{loc}(\mathbb{R}^n))$, \end{itemize} and there exist a radial function $\Psi(|\bm{k}|) \in L^1_{loc}(\mathbb{R}^n)$, such that $|\psi(\bm{k}, t)| \le \Psi(|\bm{k}|)$ in $\mathbb{R}^n \setminus \{0\}$ and {$\Psi(|\bm{k}|) \le C_{n, \alpha} |\bm{k}|^{-n+\alpha}$ holds} for sufficiently large $|\bm{k}|$ and {given constants $C_{n, \alpha}$ and $\alpha \in (0, n)$}; \end{itemize} {Here $\Vert \cdot \Vert_ p$ is short for $L^p_{\bm{x}} \times L^p_{\bm{k}}$ norm, say, $\Vert \varphi(t) \Vert_{L^p_{\bm{x}} \times L^p_{\bm{k}}}= (\int_{\mathbb{R}^{n} \times \mathbb{R}^{n}} | \varphi(\bm{x}, \bm{k}, t) |^p \D \bm{x} \D \bm{k})^{{1}/{p}}$.} The prototypes for the latter condition in {\bf (A2)} arise from quantum molecular systems and fractional diffusion problems \cite{DuGunzburgerLehoucqZhou2012, Toniazzi2018}. When the potential is of the Coulomb type $V(\bm{x}) = |\bm{x} - \bm{x}_A|^{-1}$, it is easy to verify that $\psi(\bm{k}) \propto |\bm{k}|^{-n+1}$ and $\bm{z}(\bm{x}) = \bm{x} -\bm{x}_A$, so that the symbol functions may have singularities at $\bm{k} = 0$ and $\bm{k} = \infty$. Therefore, we need to {focus on the weakly singular convolution \cite{bk:Kress2014}}, instead of solely treating it in the classical symbol class $C([0, T], S^0(\mathbb{R}^n \times \mathbb{R}^n))$. Now we turn to the probabilistic perspective. The starting point of the stochastic solution is to cast Eq.~\eqref{eq.backward_Wigner} into its equivalent integral formulation by adding a term $-\gamma_0 \cdot \varphi(\bm{x}, \bm{k}, t)$ on both sides of Eq.~\eqref{eq.backward_Wigner} \cite{ShaoXiong2019}, \begin{equation}\label{def.backward_renewal_type_equation} \begin{split} \varphi(\bm{x}, \bm{k}, t)=&(1-\mathcal{G}(T-t)) \varphi_T(\bm{x}(T-t), k) +\int_t^T \D \mathcal{G}(t^{\prime}-t) \\ & \times \int_{\mathbb{R}^n} (-\frac{V_W(\bm{x}(t^{\prime}-t), \bm{k}^{\prime}, t^{\prime})}{\gamma_0}+\delta(\bm{k}^{\prime}))\varphi(\bm{x}(t^{\prime}-t), \bm{k} - \bm{k}^{\prime}, t^{\prime}) \D \bm{k} ^{\prime}, \end{split} \end{equation} the derivation of which will be put in Section~\ref{sec:pre}. {The constant} parameter $\gamma_0$ turns out to be the intensity of an exponential distribution as follows, \begin{equation}\label{eq:measure2} \mathcal{G}(t^{\prime}-t)= 1- \mathbbm{e}^{-\gamma_0 (t^{\prime}-t)}, \quad \D \mathcal{G}(t^{\prime}-t) = \gamma_0 \mathbbm{e}^{-\gamma_0 (t^{\prime}-t)}, \quad t^{\prime} \ge t. \end{equation} The main problem is how to resolve the negative values of kernel $V_W$. In constrast to nonlocal operators with nonnegative and symmetric kernels \cite{DuGunzburgerLehoucqZhou2012, DuToniazziZhou2018, Toniazzi2018}, the existing stochastic approach is based on the unique Hahn-Jordan decomposition (HJD) \cite{bk:Kallenberg2002}: \begin{align} \Theta_{V}[\varphi](\bm{x}, \bm{k}, t) &= \Theta^+_{V}[\varphi](\bm{x}, \bm{k}, t) - \Theta^-_{V}[\varphi](\bm{x}, \bm{k}, t) , \label{eq.PDO_splitting} \\ \Theta_V^{\pm}[\varphi](\bm{x}, \bm{k}, t) &= \int_{\mathbb{R}^n} V_W^\pm(\bm{x}, \bm{k}-\bm{k}^{\prime}, t) \varphi(\bm{x}, \bm{k}^{\prime}, t) \D \bm{k}^{\prime}, \\ V_W^{\pm}(\bm{x}, \bm{k}, t) &= \max\{ \pm V_W(\bm{x}, \bm{k}, t), 0 \}, \end{align} so that $V_W^\pm \in C([0, T], L^1_{loc}(\mathbb{R}^{n}\times \mathbb{R}^n))$ become positive semi-definite kernels. Moreover, {we assume that there exists a uniform normalizing bound $\breve{\xi}$ for $(\bm{x}, \bm{k}) \in \mathcal{X} \times 2\mathcal{K}$}, \begin{equation}\label{eq.PDO_plus_bound} \gamma_0 \ge \breve{\xi} = \max_{0 \le t \le T} \max_{x \in \mathcal{X}} \int_{\mathbb{R}^n } V_W^\pm (\bm{x}, \bm{k}, t) \mathbbm{1}_{\{ \bm{k} \in 2\mathcal{K} \}} \D \bm{k}. \end{equation} It follows that the probabilistic interpretation is to seek a branching random walk model (BRW) such that its first moment satisfies the renewal-type Wigner (W) equation \eqref{def.backward_renewal_type_equation} \cite{SellierNedjalkovDimov2014, Wagner2016, ShaoXiong2019}, dubbed WBRW-HJD hereafter. Such model describes a mass distribution of a random cloud starting at $Q= (\bm{x}, \bm{k})$ and frozen at random states and exhibiting both random motion and random growth. The random variable is a family history $\Omega$, a denumerable random sequence corresponding to a unique family tree \cite{bk:Harris1963}, and $\mathscr{B}_{\Omega}$ is the Borel extension of cylinder sets on $\Omega$. The particles in the family history $\Omega$ move according to the following five rules. \begin{itemize} \item[(1)](Markov property) The motion of each particle is described by a {right continuous Markov process}. \item[(2)](Memoryless life-length) The particle at $(\bm{x}, \bm{k}, t)$ dies in the age time interval $(t, t+\tau) $ with probability $1 - \mathbbm{e}^{-\gamma_0 \tau}$. \item[(3)](Frozen state) The particle at $(\bm{x}, \bm{k},t)$ is frozen at the state $(\bm{x}(T-t), \bm{k})$ when its life-length $\tau \ge T-t$. \item[(4)](Branching property) The particles at $(\bm{x}, \bm{k}, t)$, carrying a weight $w$, dies at age $t+\tau$ at state $(\bm{x}(\tau), \bm{k})$ when $\tau < T - t$, and produces at most five new offsprings at states $(\bm{x}_{(1)}, \bm{k}_{(1)})$, $(\bm{x}_{(2)}, \bm{k}_{(2)}) \cdots (\bm{x}_{(5)}, \bm{k}_{(5)})$, endowed with updated weights $w_{(1)}$, $w_{(2)}, \cdots, w_{(5)}$, respectively. \label{def.Branching_property} \item[(5)](Independence) The only interaction between the particles is that the birth time and state of offsprings coincide with the death time and state of their parent. \end{itemize} We are able to define a probability measure on the measurable space $(\Omega, \mathscr{B}_{\Omega})$ and thus the stochastic process based on a specific setting of the transition kernels and particle weights in the fourth rule (vide post). Roughly speaking, WBRW-HJD can be categorized into the weighted-particle (wp) \cite{ShaoXiong2019} and signed-particle (sp) \cite{SellierNedjalkovDimov2014,Wagner2016,XiongShao2019} implementations, denoted by $\mathrm{X}_t^\mathrm{w}$ and $\mathrm{X}_t^\mathrm{s}$ associated with the probability laws $\Pi_Q^\mathrm{w}$ and $\Pi_Q^\mathrm{s}$, respectively. It has been shown in \cite{ShaoXiong2019} that (taking $\mathrm{X}_t^\mathrm{w}$ as an example), \begin{equation}\label{eq.expection_X_t} \Pi_Q^\mathrm{w} \mathrm{X}_t^\mathrm{w} = \varphi(\bm{x}, \bm{k}, t) \end{equation} holds on some kind of probability space $(\Omega, \mathscr{B}_{\Omega},\Pi_Q^\mathrm{w})$, where $\Pi_Q^\mathrm{w} \mathrm{X}_t^\mathrm{w}$ means the expectation of $\mathrm{X}_t^\mathrm{w}$ with respect to the probability measure $\Pi_Q^\mathrm{w}$. However, {to the best of} our knowledge, the related variance estimation has not been established. To this end, our first contribution is to estimate the variance of WBRW-HJD, as stated in Theorem \ref{thm.variance_estimate}. \begin{theorem}[Variance of WBRW-HJD] \label{thm.variance_estimate} Suppose {\bf(A1)} and {\bf (A2)} are satisfied and let $\gamma_1 = 2K_V\gamma_0+2\breve{\xi}^2$. Then the variances of $\mathrm{X}_t^\mathrm{w}$ and $\mathrm{X}_t^\mathrm{s}$ satisfy \begin{align} \Vert \Pi_{Q}^\mathrm{w} (\mathrm{X}_t^\mathrm{w} - \varphi(t))^2 \Vert_1 &\le (1+\frac{\gamma_1}{\gamma_0}(T-t) )\mathbbm{e}^{2\max(K_V, \frac{\breve{\xi}^2}{\gamma_0}) (T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi(t) \Vert_2^2, \label{eq.wbrw_wp_variance_estimate}\\ \Vert \Pi_{Q}^\mathrm{s} (\mathrm{X}_t^\mathrm{s} - \varphi(t))^2\Vert_1 &\le (1+\frac{\gamma_1}{\gamma_0}(T-t) ) \mathbbm{e}^{2\breve{\xi}(T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi(t) \Vert_2^2. \label{eq.wbrw_sp_variance_estimate} \end{align} \end{theorem} Two key observations are readily seen from Theorem \ref{thm.variance_estimate}. One is the exponential rate for spWBRW-HJD is $2\breve{\xi}$, {that} depends on the volume of the support $\mathcal{K}$ and thus cannot be improved. {This poses a huge challenge for high dimensional problems since $\breve{\xi}$ usually depends on $n$ exponentially.} By contrast, the rate for wpWBRW-HJD can be reduced by increasing $\gamma_0$, and the optimal exponential rate is $2K_V$. Definitely, $K_V$ is usually far less than $\breve{\xi}$, implied by Eqs.~\eqref{eq.PDO_bound} and \eqref{eq.PDO_plus_bound}. In this sense, the latter outperforms the former. The other is the large exponential rates $2\breve{\xi}^2/\gamma_0$ and $2\breve{\xi}$, {introduced by HJD \eqref{eq.PDO_splitting}, lead to a rapid growth of variance. Such phenomenon is called ``numerical sign problem'' \cite{LohJrGubernatis1990} as the Hahn-Jordan decomposition of a signed measure totally ignores the near-cancellation of positive and negative weights}. Our second contribution is to formulate a new class of BRW solutions, dubbed WBRW-SPA, to diminish the variance growth. The motivation comes from the stationary phase method, a useful technique in microlocal analysis \cite{bk:Sogge2014-AM188}, which makes full use of the essential contribution from the localized parts (see Theorem 2). As a consequence, the upper bounds in Eqs.~\eqref{eq.wbrw_wp_variance_estimate} and \eqref{eq.wbrw_sp_variance_estimate} can be significantly reduced especially in the region where the module $|\bm{z}(\bm{x})|$ is sufficiently large (see Theorem \ref{SPA_thm.variance_estimate}). \begin{theorem}[Stationary phase approximation]\label{thm.stationary_phase_approximation} Suppose $|\bm{z}(\bm{x})| \ne 0$ and the amplitude function $\psi \in C([0, T], C_0^{\infty}(\mathbb{R}^n \setminus \{0\}) \cap L^1_{loc}(\mathbb{R}^n))$. Then for a sufficiently large $\lambda_0$, we have a stationary phase approximation $\Theta^{\lambda_0}_V[\varphi]$ to PDO \begin{align} \Theta_V[\varphi](\bm{x}, \bm{k}, t) &= \Theta_V^{\lambda_0}[\varphi](\bm{x}, \bm{k}, t) + \mathcal{O}(\lambda_0^{-{n}/{2}}), \\ \Theta^{\lambda_0}_V[\varphi](\bm{x}, \bm{k}, t) &= \Lambda^{< \lambda_0}[\varphi] (\bm{x}, \bm{k},t) + \Lambda_+^{>\lambda_0}[\varphi] (\bm{x}, \bm{k},t) + \Lambda_-^{>\lambda_0}[\varphi] (\bm{x}, \bm{k},t), \label{def.stationary_phase_approximation} \end{align} where \begin{align*} \Lambda^{<\lambda_0}[\varphi] (\bm{x}, \bm{k},t) &= \int_{B(\frac{\lambda_0}{|\bm{z}(\bm{x})|})} \mathbbm{e}^{\mathbbm{i} \bm{z}(\bm{x}) \cdot \bm{k}^{\prime}} \psi(\bm{k}^{\prime}, t) \Delta_{\bm{k}^{\prime}}[\varphi](\bm{x}, \bm{k}, t) \D \bm{k}^{\prime}, \\ \Lambda_\pm^{>\lambda_0}[\varphi] (\bm{x}, \bm{k}, t) &= \int_{\frac{\lambda_0}{|\bm{z}(\bm{x})|}}^{+\infty} \mathbbm{e}^{\pm\mathbbm{i} r |\bm{z}(\bm{x})|}\left(\frac{ 2\pi}{\pm \mathbbm{i} r |\bm{z}(\bm{x})|}\right)^{\frac{n-1}{2}} r^{n-1}{\psi}(r\sigma_\pm, t) \Delta_{r\sigma_\pm} [\varphi](\bm{x}, \bm{k}, t) \D r, \end{align*} in the sense that there exists a positive constant $C$, which depends on $\psi$ and its first derivate but is independent on $\lambda_0$, such that \begin{equation}\label{eq.error_estimate_stationary_phase_method} \Vert \Theta_V[\varphi](t) - \Theta_V^{\lambda_0}[\varphi](t) \Vert_2 \le C \lambda_0^{-{n}/{2}} \Vert \varphi(t) \Vert_{L^2_{\bm{x}} \times H^1_{\bm{k}}}. \end{equation} Here the norm is $\Vert \varphi(t) \Vert_{L^2_{\bm{x}} \times H^1_{\bm{k}}} = \Vert \varphi(t) \Vert_2 + \Vert \nabla_{\bm{k}}\varphi(t) \Vert_2$ and $B(r)$ is a closed ball with radius $r$ centered at the origin, $\sigma_\pm$ (short for $\sigma_\pm(\bm{x}))$ represent two critical points on the $(n-1)$-dimensional unit spherical surface with normal vectors pointing in (or opposite to) the direction of $\bm{z}(\bm{x})=(z_1,z_2,\ldots,z_n)$, which can be parameterized by \begin{equation*} \sigma_{\pm}= (\cos\vartheta_1^\pm, \sin\vartheta_1^\pm \cos\vartheta_2^\pm, \ldots, \sin\vartheta_1^\pm\cdots \sin\vartheta_{n-2}^\pm\cos\vartheta_{n-1}^\pm, \sin\vartheta_1^\pm\cdots \sin\vartheta_{n-1}^\pm), \end{equation*} with \begin{equation}\label{def.critical_point} \begin{split} \vartheta_i^\pm &= \textup{arccot}(\pm z_i/\sqrt{z_{i+1}^2 +\cdots +z_n^2}) \in [0,\pi], ~~ i=1,2,\ldots, n-2, \\ \vartheta_{n-1}^\pm &= 2\hspace{0.05cm}\textup{arccot}(\pm(z_{n-1} +\sqrt{z_{n-1}^2 + z_{n}^2})/z_n) \in [0, 2\pi), \end{split} \end{equation} and $\Delta_{\bm{k}^{\prime}}$ is the central difference operator \begin{equation} \Delta_{\bm{k}^{\prime}} [\varphi](\bm{x}, \bm{k}, t) = \varphi(\bm{x}, \bm{k} - \frac{\bm{k}^{\prime}}{2} , t) - \varphi(\bm{x}, \bm{k} + \frac{\bm{k}^{\prime}}{2} , t). \end{equation} \end{theorem} Intuitively speaking, the parameter $\lambda_0$ serves as a filter to decompose PDO into a low-frequency component $\Lambda^{<\lambda_0}$ and a high-frequency one, the leading terms of which are $\Lambda_\pm^{>\lambda_0}$, and use the resulting nonlocal operator $\Theta_V^{\lambda_0}$ to directly formulate WBRW-SPA, instead of $\Theta_V$ as adopted in WBRW-HJD. Specifically, we still use HJD to deal with $\Lambda^{<\lambda_0}$ and tackle $\Lambda_+^{>\lambda_0}+\Lambda_-^{>\lambda_0}$ by another two branches of particles, yielding two stochastic processes: the ``wp'' implementation $\mathrm{Y}_t^\mathrm{w}$ and the ``sp'' implementation $\mathrm{Y}_t^\mathrm{s}$, associated with the probability measures $ \mathsf{\Pi}^\mathrm{w}_{Q}$ and $\mathsf{\Pi}^\mathrm{s}_{Q}$, respectively. In order to estimate the effect of low-frequency parts, we further need the following assumptions. \begin{itemize} \item[\textbf{(A3):}] $\varphi \in C([0, T], L^2(\mathbb{R}^n) \times H^1(\mathbb{R}^n))$ and is localized in $(\bm{x}, \bm{k})$-space for any $t\in [0, T]$ with the {\it minimal} compact support denoted by $\mathcal{X} \times \mathcal{K} \subset \mathbb{R}^n \times \mathbb{R}^n$; \item[\textbf{(A4):}] For the positive constant $\breve{\xi}$ in Eq.~\eqref{eq.PDO_plus_bound} there exist positive constants $\lambda_0 > 1$ and $\alpha_\ast < 1$ such that \begin{equation}\label{eq.VW_plus_truncated_2} \alpha_\ast \breve{\xi} = \max_{0\le t\le T} \max_{\bm{x} \in \mathcal{X}} \int_{\mathbb{R}^n } V_W^\pm (\bm{x}, \bm{k}, t) {\mathbbm{1}_{\{ |2\bm{k}| < {\lambda_0}/{|\bm{z}(\bm{x})|}\}} } \D \bm{k}. \end{equation} \end{itemize} The assumption {\bf (A4)} { indicates that the normalizing bound for $V_W^\pm$ can be diminished when $\bm{k}$ is restricted in a smaller domain, which holds if $\min_{\bm{x} \in \mathcal{X}}|\bm{z}(\bm{x})|$ is large enough}. For instance, $V(\bm{x}) = |\bm{x} - \bm{x}_A|^{-1}$, it requires the displacement {$\min_{\bm{x} \in \mathcal{X}} |\bm{x} - \bm{x}_A|$} is sufficiently large. Accordingly, we are able to show that the first moment of WBRW-SPA turns out to be an asymptotic approximation to the solution of Eq.~\eqref{eq.backward_Wigner}. We also study its deviation from the dual Wigner function $\varphi$ by estimating the second moment (also termed ``variance'' hereafter) and find that, in contrast to Eqs.~\eqref{eq.wbrw_wp_variance_estimate} and \eqref{eq.wbrw_sp_variance_estimate}, the exponential growth rate in the upper bound is suppressed, so that a moderate increase of variance can be achieved. \begin{theorem}[WBRW-SPA]\label{SPA_thm.variance_estimate} Suppose {\bf (A2)}-{\bf (A4)} are satisfied and let $\gamma_2 = \alpha_\ast \breve{\xi}^2$. Then for a sufficient large $\lambda_0$, there exist a weighted-particle branching random walk model $\mathrm{Y}_t^\mathrm{w}$ and a signed-particle one $\mathrm{Y}_t^\mathrm{s}$ on the probability spaces $(\Omega, \mathscr{B}_{\Omega}, \mathsf{\Pi}^\mathrm{w}_{Q})$ and $(\Omega, \mathscr{B}_{\Omega}, \mathsf{\Pi}^\mathrm{s}_{Q})$, respectively, such that \begin{equation}\label{eq.expection_Y_t} \mathsf{\Pi}_{Q}^\mathrm{w} \mathrm{Y}_t^\mathrm{w}= \mathsf{\Pi}_{Q}^\mathrm{s} \mathrm{Y}_t^\mathrm{s} = \varphi(\bm{x}, \bm{k}, t) + \mathcal{O}(\lambda_0^{-{n}/{2}}), \end{equation} and their variances satisfy \begin{align} \label{eq.wbrw_spa_wp_variance_estimate} \Vert \mathsf{\Pi}_{Q}^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi(t))^2 \Vert_1 &\lesssim (1+\frac{4\gamma_2}{\gamma_0}(T-t))\mathbbm{e}^{2\max(K_V, \frac{\alpha_\ast \breve{\xi}^2}{\gamma_0}) (T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi(t) \Vert_2^2 , \\ \label{eq.wbrw_spa_sp_variance_estimate} \Vert \mathsf{\Pi}_{Q}^\mathrm{s} (\mathrm{Y}_t^\mathrm{s} - \varphi(t))^2 \Vert_1 &\lesssim (1+2(K_V+ \frac{\gamma_2}{\gamma_0})(T-t))\mathbbm{e}^{2\alpha_\ast \breve{\xi}(T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi(t) \Vert_2^2. \end{align} \end{theorem} The rest is organized as follows. Section \ref{sec:pre} briefly reviews the basic of the Wigner equation. Section \ref{sec:spa} derives the $L^2$-boundedness and the stationary phase approximation to PDO. WBRW-HJD and WBRW-SPA are analyzed in Sections \ref{sec:WBRW-HJD} and \ref{sec:WBRW-SPA}, respectively. In Section \ref{sec:num}, a typical numerical experiment is performed to verify our theoretical analysis. This paper is concluded in Section \ref{sec:con}. \section{The Wigner equation} \label{sec:pre} The Wigner equation, introduced by Wigner in his pioneering work \cite{Wigner1932}, provides a fundamental phase space description of quantum mechanics, and quantum behavior is completely characterized by the {nonlocal} pseudo-differential operator $\Theta_V[f]$ defined in Eq.~\eqref{def.pseudo_differential_operator}. Mathematically speaking, it is a partial integro-differential equation defined in phase space $(\bm{x}, \bm{k}) \in \mathbb{R}^n \times \mathbb{R}^n$ \begin{equation} \begin{split} &\frac{\partial }{\partial t}f(\bm{x}, \bm{k}, t)+\frac{\hbar \bm{k}}{m} \cdot \nabla_{x} f(\bm{x}, \bm{k}, t)=\Theta_{V}\left[f\right](\bm{x}, \bm{k}, t), ~~0 \le t \le T, \\ & f(\bm{x}, \bm{k}, 0) = f_0(\bm{x}, \bm{k}), \end{split} \label{eq.Wigner} \end{equation} with an initial value $f_0 \in L^2(\mathbb{R}^n \times \mathbb{R}^n)$. The weak formulation of the Wigner equation is of great importance since any quantum observable $\langle \hat{A} \rangle(t)$ can be expressed by its Weyl symbol $A_W(\bm{x}, \bm{k})$ averaged by the Wigner function \cite{tatarskiui1983}, namely, $\langle \hat{A} \rangle(t) = \langle A_W, f(t) \rangle$ with \begin{equation} \langle f(t), \varphi(t) \rangle = \int_{\mathbb{R}^n \times \mathbb{R}^n}f(\bm{x}, \bm{k}, t) \varphi(\bm{x}, \bm{k}, t) \D \bm{x} \D \bm{k}. \end{equation} Thus it motivates to study the dual system \cite{CarruthersZachariasen1983} and derive the adjoint equation of Eq.~\eqref{eq.Wigner} under a non-degenerate inner product: \begin{equation}\label{def.nd_inner_product} \langle f, \varphi \rangle_T = \int_0^T \langle f(t), \varphi(t) \rangle \D t = \int_{\mathbb{R}^n \times \mathbb{R}^n \times [0,T]} f(\bm{x}, \bm{k}, t) \varphi(\bm{x}, \bm{k}, t) \D \bm{x} \D \bm{k} \D t, \end{equation} where $T$ is a fixed time instant and $\varphi \in C([0,T], L^2(\mathbb{R}^n \times \mathbb{R}^n))$ is a test function with a compact support in $\mathbb{R}^n \times \mathbb{R}^n$. Using the anti-symmetry \eqref{eq.anti_symmetry} of the Wigner kernel, we have \begin{equation} \langle \Theta_V[f], \varphi \rangle = - \langle f, \Theta_V[\varphi] \rangle \end{equation} and integration by parts directly leads to \begin{equation*} \begin{split} \langle \frac{\partial f}{\partial t} + \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}} f - \Theta_{V}[f], \varphi \rangle_T & = \langle \frac{\partial f}{\partial t} , \varphi\rangle_T + \langle \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}} f, \varphi \rangle_T - \langle \Theta_{V}[f], \varphi \rangle_T\\ &\hspace{-0.08cm} = \langle f_T, \varphi_T \rangle - \langle f_0, \varphi_0 \rangle - \langle f, \frac{\partial \varphi}{\partial t} + \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}} \varphi - \Theta_{V}[\varphi] \rangle_T, \end{split} \end{equation*} where $f_T$ and $\varphi_T$ are short for $f(\bm{x}, \bm{k}, T)$ and $\varphi(\bm{x}, \bm{k}, T)$, respectively. Therefore the adjoint correspondence, i.e., the backward Wigner equation \eqref{eq.backward_Wigner}, is immediately derived by setting \begin{equation}\label{eq.averaged} \langle \varphi_T, f_T \rangle = \langle \varphi_0, f_0 \rangle. \end{equation} Formally, Eq.~\eqref{eq.averaged} allows us to evaluate the quantum mechanical observable $\langle \varphi_T, f_T\rangle$ {\sl only by the {``initial''} data} \cite{ShaoXiong2019}. The backward Wigner equation \eqref{eq.backward_Wigner} can be cast into a renewal-type equation by adding a term $-\gamma_0 \cdot \varphi(\bm{x}, \bm{k}, t)$ on both sides, \begin{equation} \frac{\partial}{\partial t} \varphi (\bm{x}, \bm{k}, t) + \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}} \varphi(\bm{x}, \bm{k}, t) - \gamma_0 \cdot \varphi(\bm{x}, \bm{k}, t) = \Theta_{V}[\varphi](\bm{x}, \bm{k}, t) - \gamma_0 \cdot \varphi(\bm{x}, \bm{k}, t), \end{equation} with $\gamma_0$ being a prescribed constant (see Eq.~\eqref{eq.PDO_plus_bound}), and the mild solution reads \begin{equation*} \begin{split} \varphi(\bm{x}, \bm{k}, t) &= \mathbbm{e}^{(T-t) \mathcal{A}} \varphi_T(\bm{x}, \bm{k}) - \int_t^T \mathbbm{e}^{(t^{\prime}-t) \mathcal{A}}(\Theta_V[\varphi](\bm{x}, \bm{k}, t^{\prime}) - \gamma_0 \cdot \varphi(\bm{x}, \bm{k}, t^{\prime})) \D t^{\prime}, \end{split} \end{equation*} by the variation-of-constant formula \cite{bk:Pazy1983}. Here $\mathbbm{e}^{\Delta t \mathcal{A}}$ is short for the semigroup generated by $ \mathcal{A} = \hbar \bm{k}/m \cdot \nabla_{\bm{x}} - \gamma_0$, and its action on a given function can be now readily performed. For instance, we have \begin{equation}\label{forward_semi_group} \mathbbm{e}^{(t^{\prime}-t) \mathcal{A}} g(\bm{x}, \bm{k}, t^{\prime}) = \mathbbm{e}^{-\gamma_0(t^{\prime}-t)} g(\bm{x}(t^{\prime}-t), \bm{k}, t^{\prime}), \quad t^{\prime} \ge t, \end{equation} where $\bm{x}(\Delta t) = \bm{x} + \hbar \bm{k} \Delta t/m$ gives the {\sl forward-in-time trajectory} of $(\bm{x}, \bm{k})$ with a positive time increment $\Delta t$. That is, the backward renewal-type equation Eq.~\eqref{def.backward_renewal_type_equation} is thus verified. \section{$L^2$-boundedness and stationary phase approximation} \label{sec:spa} Before proceeding to the probabilistic aspect, we first need to establish the $L^2$-boundedness of $\Theta_V$ under the assumptions (\textbf{A1}) and (\textbf{A2}). For $\psi \in C([0, T], L^1(\mathbb{R}^n))$, Eq.~\eqref{eq.PDO_bound} is readily verified by Young's convolution inequality, whereas the $L^2$-boundedness for weakly singular kernels is obtained {by the Hardy-Littlewood-Sobolev theorem} \cite{bk:LuDingYan2007}. After that, we present the stationary phase approximation and detail its remainder estimate. Suppose $(\textbf{A1})$ and the second condition of $(\textbf{A2})$ hold, then $L^p(\mathbb{R}^{2n}) \subset L^2(\mathbb{R}^{2n})$ for $1\le p < 2$ due to the H\"{o}lder's inequality: \begin{equation}\label{eq.L2_embedding} \Vert \varphi(t) \Vert_p = \Vert \varphi(t) \cdot \mathbbm{1}_{\mathcal{X}} \cdot \mathbbm{1}_{\mathcal{K}}\Vert_p \le \Vert \mathbbm{1}_{\mathcal{X}} \cdot \mathbbm{1}_{\mathcal{K}} \Vert_{\frac{2p}{2-p}} \Vert \varphi(t) \Vert_2 < \infty \end{equation} as $\mathcal{X} \times \mathcal{K}$ has a finite measure. Next we introduce a smooth cut-off function $\chi_{\varepsilon, R}(r) \in C^\infty([0, +\infty))$: \begin{equation}\label{def.smooth_function} \chi_{\varepsilon, R}(r) = \left\{ \begin{split} &1, \quad r \in [\varepsilon, 2R], \\ &0, \quad r \in [0, \varepsilon/2)\cup(3R,+\infty), \end{split} \right. \end{equation} and let $\psi_{\varepsilon} = \psi \cdot \chi_{\varepsilon, R}(|\bm{k}|)$, $\psi_{\infty} = \psi \cdot (1-\chi_{\varepsilon, R}(|\bm{k}|)) \cdot \mathbbm{1}_{\{|\bm{k}| \ge 2R\}}$. Here {$\varepsilon$ is introduced to remove the singularity at $\bm{k} = 0$} and $R$ is chosen sufficient large to ensure {$\Psi(|\bm{k}|) \le C_{n, \alpha}|\bm{k}|^{-n+\alpha}$, as stated in assumption ${\bf (A2)}$}. Then it is readily verified that the truncated operator $\Theta^\varepsilon_V[\varphi]$ has the following estimate \begin{equation}\label{def.pdo_L2_bound} \begin{split} \Vert \Theta_V^\varepsilon[\varphi](t) \Vert_{L^2_{\bm{k}}} & \le 2^{n+1}\Vert \int_{\mathbb{R}^n} \mathbbm{e}^{2\mathbbm{i}(\bm{k} - \bm{k}^{\prime}) \cdot \bm{z}(\bm{x})} (\psi_\varepsilon + \psi_\infty)(2(\bm{k} - \bm{k}^{\prime}), t) \varphi(\bm{x}, \bm{k}^{\prime}, t) \D \bm{k}^{\prime} \Vert_{L^2_{\bm{k}}} \\ &\le 2^{n+1}\Vert \int_{\mathbb{R}^n} \psi_\varepsilon(2(\bm{k} - \bm{k}^{\prime}), t) (\mathbbm{e}^{-2\mathbbm{i} \bm{k}^{\prime} \cdot \bm{z}(\bm{x})} \varphi(\bm{x}, \bm{k}^{\prime}, t)) \D \bm{k}^{\prime} \Vert_{L^2_{\bm{k}}} \\ &\quad + 2^{n+1}\Vert \int_{\mathbb{R}^n} \psi_\infty(2(\bm{k} - \bm{k}^{\prime}), t) (\mathbbm{e}^{-2\mathbbm{i} \bm{k}^{\prime} \cdot \bm{z}(\bm{x})} \varphi(\bm{x}, \bm{k}^{\prime}, t)) \D \bm{k}^{\prime} \Vert_{L^2_{\bm{k}}}. \end{split} \end{equation} The first term is bounded from $L^2(\mathbb{R}^{2n})$ to itself as $\Psi$ is locally integrable, say, \begin{equation} \Vert \int_{\mathbb{R}^n} \psi_\varepsilon(2(\bm{k} - \bm{k}^{\prime}), t) (\mathbbm{e}^{-2\mathbbm{i} \bm{k}^{\prime} \cdot \bm{z}(\bm{x})} \varphi(\bm{x}, \bm{k}^{\prime}, t)) \D \bm{k}^{\prime} \Vert_{L^2_{\bm{k}}} \le \Vert \Psi \cdot \chi_{\varepsilon, R} \Vert_{L^1_{\bm{k}}} \cdot \Vert \varphi(t) \Vert_{L^2_{\bm{k}}}, \end{equation} and the bound is independent of $\varepsilon$. The second term is also bounded from $L^2(\mathbb{R}^{2n})$ to $L^p(\mathbb{R}^{2n})$, with $1/p = 1/2 + \alpha/n$, owing to {the Hardy-Littlewood-Sobelev theorem}, \begin{equation} \begin{split} &\Vert \int_{\mathbb{R}^n} \psi_\infty(2(\bm{k} - \bm{k}^{\prime}), t) (\mathbbm{e}^{-2\mathbbm{i} \bm{k}^{\prime} \cdot \bm{z}(\bm{x})} \varphi(\bm{x}, \bm{k}^{\prime}, t)) \D \bm{k}^{\prime} \Vert_{L^2_{\bm{k}}} \\ &\le \Vert \int_{\mathbb{R}^n} \frac{\chi_{2R, +\infty}(2|\bm{k} - \bm{k}^{\prime}|) \cdot |\varphi(\bm{x}, \bm{k}^{\prime}, t)|}{2^{n-\alpha}|\bm{k} - \bm{k}^{\prime}|^{n-\alpha}} \D \bm{k}^{\prime} \Vert_{L^2_{\bm{k}}} \le C_{p} \Vert \varphi(t) \Vert_{L^p_{\bm{k}}} \le \tilde{C}_p \Vert \varphi(t) \Vert_{L^2_{\bm{k}}}. \end{split} \end{equation} Now let $\varepsilon \to 0$ in Eq.~\eqref{def.pdo_L2_bound}. By combining Eq.~\eqref{eq.L2_embedding}, we obtain that there exists a uniform $K_V$ such that \begin{equation} \Vert \Theta_V[\varphi](t) \Vert_2 \le K_V \Vert \varphi(t) \Vert_2. \end{equation} A remarkable feature of the oscillatory integral operator is the decay property as the integrand becomes more and more oscillating. As stated by H\"{o}rmander's theorem \cite{bk:Sogge2014-AM188,bk:Stein2016-PMS43}, when $\psi$ is sufficiently smooth and compactly supported, it has a sharp estimate for a sufficiently large $|\bm{z}(\bm{x})|$ \begin{equation}\label{eq.Hormander_estimate} \Vert \Theta_V[\varphi](\bm{x}, \bm{k}, t) \Vert_{L^2_{\bm{k}}} \le C |\bm{z}(\bm{x})|^{-n/2} \Vert \varphi(t) \Vert_{L^2_{\bm{k}}}. \end{equation} The physical meaning of Eq.~\eqref{eq.Hormander_estimate} is also clear. When we consider the two-body interacting potential like $V(\bm{x}) = V(|\bm{x} - \bm{x}_A|)$, $\bm{z}(\bm{x}) = \bm{x} - \bm{x}_A$ turns out to be the spatial displacement between two bodies, so that the estimate \eqref{eq.Hormander_estimate} characterizes the decay rate of quantum interaction as the distance $|\bm{z}(\bm{x})|$ increases. A similar result like Eq.~\eqref{eq.Hormander_estimate} can also be found in our framework, and the decay property will be fully utilized by the stationary phase method as presented in Theorem \ref{thm.stationary_phase_approximation}, which is definitely ignored by HJD \eqref{eq.PDO_splitting}. \begin{proof}[Proof of Theorem \ref{thm.stationary_phase_approximation}] It starts by splitting the wavevector $\bm{k}$ into its modulus and orientation parts $\bm{k}^{\prime} = r\sigma$ with the modulus $r=|\bm{k}^\prime|>0$ and the orientation $\sigma=(\sigma_1,\sigma_2,\ldots,\sigma_n) \in \mathbb{S}^{n-1}$, {where $\mathbb{S}^{n-1}$ denotes the $(n-1)$-dimensional spherical surface}, and focusing on the high-frequency component \begin{equation}\label{eq:high} \Theta_V[\varphi] - \Lambda^{<\lambda_0}[\varphi] = \int_{\frac{\lambda_0}{|\bm{z}(\bm{x})|}}^{+\infty} r^{n-1}\D r \int_{\mathbb{S}^{n-1}}\D \sigma ~\mathbbm{e}^{\mathbbm{i} r |\bm{z}(\bm{x})| \bm{z}^{\prime} \cdot \sigma} \psi(r\sigma, t) \Delta_{r\sigma}[\varphi](\bm{x}, \bm{k}, t ), \end{equation} where $\sigma = (\sigma_{1}, \cdots, \sigma_{n})$ represents the orientation of $\bm{z}(\bm{x})$, $\bm{z}^{\prime} = \bm{z}/|\bm{z}|$ and $\D \sigma$ denotes the induced Lebesgue measure on $\mathbb{S}^{n-1}$. After choosing the equatorial plane normal to $\bm{z}^{\prime}$, the unit sphere $\mathbb{S}^{n-1}$ can be decomposed into an upper hemisphere $\mathbb{S}_+^{n-1}$ and a lower one $\mathbb{S}_-^{n-1}$ satisfying $\pm \bm{z}^{\prime} \in \mathbb{S}_\pm^{n-1}$. Accordingly, the inner surface integral of the first kind over $\mathbb{S}^{n-1}$ in Eq.~\eqref{eq:high} equals to the sum of those over $\mathbb{S}_+^{n-1}$ and $\mathbb{S}_-^{n-1}$. Without loss of generality, it suffices to assume that $\bm{z}^{\prime} = (0, \dots, 0, 1)$, which be realized by a rotation otherwise. Let us start from the graph \begin{equation} \mathbb{S}_{\pm}^{n-1} = \{\sigma\in\mathbb{R}^n \big| \sigma_n = \pm\phi(\sigma_1, \dots, \sigma_{n-1}), \sigma_i\in[-1,1], i=1,\ldots,n-1\}, \end{equation} with \begin{equation} \phi(\sigma_1, \dots, \sigma_{n-1}) = \sqrt{1- \sigma_1^2 - \dots - \sigma_{n-1}^2} \end{equation} and take the surface integral of the first kind over the upper hemisphere as an example. Now the phase function of the integrand becomes \begin{equation} S(\bm{x}, r, \sigma_1,\ldots,\sigma_{n-1}) = r |\bm{z}(\bm{x})| \bm{z}^{\prime} \cdot \sigma = r|\bm{z}(\bm{x})| \phi(\sigma_1, \dots, \sigma_{n-1}). \end{equation} For such phase function, it can be easily verified that there is only one critical point $\sigma_+ = (0, \dots, 0, 1)$ satisfying {$(\nabla_\sigma S)(\sigma_+) = 0$}, and the determinant of its Hessian matrix at $\sigma_+$ turns out to be \begin{equation} \textup{det} (\textup{Hess}(S)(\sigma_+)) = \mathop{\textup{det}}_{1\le j, k \le n-1} \left(\frac{\partial^2 S}{\partial \sigma_j \partial \sigma_k}(\sigma_+)\right) = (-r|\bm{z}(\bm{x})|)^{n-1}. \end{equation} In consequence, applying the stationary phase method \cite{bk:Stein2016-PMS43} leads directly to \begin{equation*} \begin{split} & \int_{\mathbb{S}^{n-1}_+} \mathbbm{e}^{\mathbbm{i} S(\bm{x}, r, \sigma)} \psi(r\sigma, t) \Delta_{r \sigma}[\varphi](\bm{x}, \bm{k}, t )\D \sigma \\ & = \mathbbm{e}^{\mathbbm{i} S(\bm{x}, r, \sigma_+)}\left(\frac{(2\pi\mathbbm{i})^{n-1}}{\textup{det}(\textup{Hess}(S)(\sigma_+))}\right)^{\frac{1}{2}} \psi(r\sigma_+, t) \Delta_{r \sigma_+}[\varphi](\bm{x}, \bm{k}, t ) + R_{\sigma_+}(\bm{x}, \bm{k}, r, t) \\ & = \mathbbm{e}^{\mathbbm{i} r |\bm{z}(\bm{x})|}\left(\frac{2\pi}{\mathbbm{i} r |\bm{z}(\bm{x})|}\right)^{\frac{n-1}{2}} \psi(r\sigma_+, t) \Delta_{r\sigma_+}[\varphi](\bm{x}, \bm{k}, t) + R_{\sigma_+}(\bm{x}, \bm{k}, r, t), \end{split} \end{equation*} the first term of which exactly recovers the integrand of $\Lambda^{> \lambda_0}_+$ in Eq.~\eqref{def.stationary_phase_approximation}. That is, the asymptotic of the oscillatory integral over the upper hemisphere is governed by the contribution from the critical point $\sigma_+$. It remains to estimate the integral of remainders $\int_{\lambda_0/|\bm{z}(\bm{x})|}^{+\infty} R_{\sigma_\pm}(\bm{x}, \bm{k}, r, t) r^{n-1} \D r$. Since $\psi(\bm{k}, t) \in C([0, T], C^\infty_0(\mathbb{R}^n))$ with its support contained in a compact ball $B(2R)$, we can replace $\psi$ by $\psi \cdot \chi_{\varepsilon, R} $, with $\varepsilon < \lambda_0/|\bm{z}(\bm{x})|$. Now we rewrite $R_{\sigma_+}(\bm{x}, \bm{k}, r, t)$ as \begin{equation}\label{eq.remainder_term} \begin{split} R_{\sigma_\pm}(\bm{x}, \bm{k}, r, t)= &~a_\pm(\bm{x}, r, t) \chi_{\varepsilon, R}(r) \Delta_{r\sigma_\pm}[\varphi](\bm{x}, \bm{k}, t) + b_\pm(\bm{x} , \bm{k}, r, t) \chi_{\varepsilon, R}(r), \end{split} \end{equation} where \begin{align*} &a_\pm(\bm{x}, r, t) = \int_{\mathbb{S}_\pm^{n-1}} \mathbbm{e}^{\mathbbm{i} r |\bm{z}(\bm{x})| \bm{z}^{\prime} \cdot \sigma} \psi(r\sigma, t) \D \sigma - \mathbbm{e}^{\pm \mathbbm{i} r |\bm{z}(\bm{x})|} \left(\frac{2\pi }{\pm \mathbbm{i} r |\bm{z}(\bm{x})|}\right)^{\frac{n-1}{2}} \psi(r\sigma_\pm, t),\\ &b_\pm(\bm{x}, \bm{k}, r, t) = \int_{\mathbb{S}_\pm^{n-1}} \mathbbm{e}^{\mathbbm{i} r|z(\bm{x})| \bm{z}^{\prime} \cdot \sigma} \psi(r\sigma, t) (\Delta_{r\sigma}[\varphi] - \Delta_{r\sigma_\pm}[\varphi]) \D \sigma. \end{align*} According to Theorem 7.7.14 in \cite{bk:Hormander2003}, it has an estimate for $a_\pm$ that \begin{equation} |a_\pm(\bm{x}, r, t)| \le {C}{(r|z(\bm{x}))|^{-\frac{n+1}{2}}} \le C \lambda_0^{-\frac{n+1}{2}}. \end{equation} Thus for the first term in Eq.~\eqref{eq.remainder_term}, it yields that \begin{equation}\label{eq.estimate_first_term} \begin{split} & \Vert \int_{\lambda_0/|\bm{z}(\bm{x})|}^{+\infty} r^{n-1} a_\pm(\bm{x}, r, t) \chi_{\varepsilon, R}(r) \Delta_{r\sigma_\pm}[\varphi](\bm{x}, \bm{k}, t) \D r \Vert_{L^2_{\bm{k}}}^2 \\ &\le \int_{\varepsilon}^{+\infty} r^{n-1} \chi_{\varepsilon, R}(r) |a_\pm(\bm{x}, r, t)|^2 \D r \int_{\varepsilon}^{+\infty} r^{n-1} \chi_{\varepsilon, R}(r) \Vert \Delta_{r\sigma_\pm}[\varphi](\bm{x}, \bm{k}, t) \Vert_{L^2_{\bm{k}}}^2 \D r\\ & \le \frac{2 C^2 R^{2n}}{n^2} \cdot \lambda_0^{-(n+1)} \Vert \varphi(t) \Vert_{L^2_{\bm{k}}}^2. \end{split} \end{equation} For the second term {in Eq.~\eqref{eq.remainder_term}}, it suffices to consider a sufficiently smooth $\varphi$, so that the localization property of oscillatory integrals allows us to only estimate the integral in the neighborhood $U^\pm$ of the stationary phase points $\sigma_\pm = (0, \dots, 0)$. Due to the Morse lemma \cite{bk:Milnor2016}, there exists a diffeomorphism from $U^+$ to a small neighborhood of $\bm{y}_+ = (0, \dots, 0)$. Indeed, since $\phi(0, \dots, 0) = 1$ and $\nabla \phi(0, \dots, 0) = 0$, we have that \begin{equation} \phi(\sigma_1, \dots, \sigma_{n-1}) -1 = \int_0^1 (1-t) \frac{\D^2 \phi}{\D t^2} (t\sigma_1, \dots, t\sigma_{n-1}) \D t = \sum_{i, j} \sigma_i \sigma_j h_{ij}(\sigma_1, \cdots, \sigma_{n-1}), \end{equation} where \begin{equation} h_{ij}(\sigma_1, \cdots, \sigma_{n-1}) = \int_0^1 (1-t) \partial^2_{ij} \phi(t\sigma_1, \dots, t\sigma_{n-1}) \D t. \end{equation} It notes that $H= (h_{ij})$ is a symmetric matrix and nonsingular at $(0, \dots, 0)$, and so is in $U^+$ by continuity, then there exists a nonsingular $n\times n$ matrix $B(\sigma_1, \dots, \sigma_{n-1}) = (b_{ij}(\sigma_1, \dots, \sigma_{n-1}))$ such that $H = B^\tau B$. Therefore, we can introduce the $\bm{y}$-coordinate \begin{equation} \bm{y} = (y_1, \cdots, y_{n-1})^\tau = B(\sigma_1, \cdots, \sigma_{n-1}) (\sigma_1, \cdots, \sigma_{n-1})^\tau \end{equation} so that the phase function turns out to be a quadratic form \begin{equation} S(\bm{x}, r, \sigma) = \tilde{S}(\bm{x}, r, \bm{y}) = r|\bm{z(\bm{x})}| (1 - y_1^2 - \dots - y_{n-1}^2). \end{equation} By the implicit function theorem, the inverse conversion $\sigma_i = \kappa_i(y_1, \dots, y_{n-1}) \in C^\infty(\mathbb{R}^{n-1})$ also exists, which satisfies $\kappa_i(0, \dots, 0) = 0$. Therefore, it further has that \begin{equation} \sigma_i = \kappa_i(y_1, \dots, y_{n-1}) = \int_0^1 \frac{\D \kappa_i}{\D t}(ty_1, \dots, ty_{n-1}) \D t = \sum_{j= 1}^{n-1} y_j \kappa_{ij}(y_1, \dots, y_{n-1}) \end{equation} with a suitable $C^\infty$ function $\kappa_{ij}$ that satisfies $\kappa_{ij}(0, \dots, 0) = \frac{\partial \kappa_i}{\partial y_j}(0, \dots, 0)$. Now we use Taylor's expansion, \begin{equation} \begin{split} &\varphi(\bm{x}, \bm{k} \pm \frac{r\sigma}{2}, t) - \varphi(\bm{x}, \bm{k} \pm \frac{r\sigma_+}{2}, t) \\ & = \pm\frac{1}{2} \sum_{i=1}^{n-1} r \sigma_i \left(\frac{\partial \varphi}{\partial k_i} + \frac{\partial \phi}{\partial \sigma_i} \frac{\partial \varphi}{\partial k_n}\right)(\bm{x}, \bm{k} \pm \frac{r {\sigma_+}}{2}, t) + \mathcal{O}( \sigma^2) \\ & = \pm\frac{1}{2} \sum_{i=1}^{n-1} \sum_{j=1}^{n-1} r y_j \kappa_{ij}(y_1, \dots, y_{n-1})\left(\frac{\partial \varphi}{\partial k_i} + \tilde{\phi_i} \frac{\partial \varphi}{\partial k_n}\right)(\bm{x}, \bm{k} \pm \frac{r {\sigma_+}}{2}, t) + \mathcal{O}(\bm{y}^2), \end{split} \end{equation} with $\tilde{\phi}_i(y_1, \dots, y_{n-1}) = \frac{ \partial \phi}{\partial \sigma_i} (\sigma_1, \dots, \sigma_{n-1})$, and \begin{equation} \Big |\int_{\mathbb{R}^{n-1}} \mathbbm{e}^{- \mathbbm{i} \tilde{S}(\bm{x}, r, \bm{y})} \bm{y}^l \tilde{\psi}(r\bm{y}, t) \D \bm{y} \Big | \le C (r|\bm{z}(\bm{x})|)^{-\frac{n-1}{2} - \frac{|l|}{2}}, \end{equation} for a sufficiently large $r |\bm{z}(\bm{x})|$ and $\tilde{\psi}(r\bm{y}, t) = \psi(r\sigma, t)$ (here we adopt the convection that $\bm{y}^{l} = y_1^{l_1} \dots y_{n-1}^{l_{n-1}}$ for $l_1 + \dots + l_{n-1} = l$) \cite{bk:Stein2016-PMS43}, one can conclude that $L^2$-norm (in {$\bm{k}$-variable}) of the oscillatory integral $b_+(\bm{x}, \bm{k}, r, t)$ is majorized by \begin{equation}\label{eq.estimate_second_term} \Vert b_+(\bm{x}, \bm{k}, r, t) \Vert_{L^2_{\bm{k}}} \le C (r|\bm{z}(\bm{x})|)^{-\frac{n}{2}} \Vert \nabla_{\bm{k}}\varphi(t) \Vert_{L^2_{\bm{k}}} \cdot \chi_{\varepsilon, R}(r) + \mathcal{O}\left((r|\bm{z}(\bm{x})|)^{-\frac{n+1}{2}}\right). \end{equation} Combining Eqs.~\eqref{eq.estimate_first_term} and \eqref{eq.estimate_second_term}, we arrive at \begin{equation} \begin{split} \big \Vert \int_{\frac{\lambda_0}{|\bm{z}(\bm{x})|}}^{+\infty} R_{\sigma_+}(\bm{x}, \bm{k}, r, t) r^{n-1} \D r \big \Vert_{L^2_{\bm{k}}} & \le C\lambda_0^{-\frac{n}{2}} \Vert \varphi(t) \Vert_{H^1_{\bm{k}}} \int_{\frac{\lambda_0}{|\bm{z}(\bm{x})|}}^{+\infty} r^{n-1}\chi_{\varepsilon, R}(r) \D r \\ &\lesssim \lambda_0^{-\frac{n}{2}} \Vert \varphi(t) \Vert_{H^1_{\bm{k}}}, \end{split} \end{equation} which implies Eq.~\eqref{eq.error_estimate_stationary_phase_method}. \end{proof} \section{Variance estimation of WBRW-HJD} \label{sec:WBRW-HJD} From this section we initialize our discussion on the probabilistic aspect. The probabilistic interpretation of Eq.~\eqref{eq.backward_Wigner} borrows several ideas from the renewal theory, as the exponential distribution $\mathcal{G}(t^{\prime}- t)$ characterizes the arrival time of the random jump and the Wigner kernel $V_W$ the transition of states. The main difficulty lies in the possible negative values of the Wigner kernel $V_W$ because it cannot be regarded as a transition kernel directly. Nonetheless, when the HJD is adopted and the split Wigner kernels $V_W^\pm$ can be normalized, the existing BRW models are naturally introduced and the corresponding first moments solve the Wigner equation \eqref{eq.backward_Wigner}. Furthermore, the probabilistic interpretation of the inner product \eqref{eq.averaged} is also readily established through a straightforward extension of the probability space. Under Assumption {\textbf{(A1)}}, it suffices to replace the Wigner kernels by the truncated ones $V_{W, R}^\pm$ \begin{equation}\label{def.truncated_wigner_kernel} V_{W,R}^\pm(\bm{x}, \bm{k}, t) = V_W^\pm(\bm{x}, \bm{k}, t) \chi_{0, R}(|\bm{k}|) \end{equation} with $B(2R)$ the {\sl minimal} ball that satisfies $\mathcal{K} \subset B(2R)$. Now the truncated Wigner kernels are integrable in $\mathbb{R}^n$, \begin{equation} \xi(\bm{x}, t) = \int_{\mathbb{R}^n} V^+_{W, R}(\bm{x}, \bm{k}, t) \D \bm{k} = \int_{\mathbb{R}^n} V^-_{W, R}(\bm{x}, \bm{k}, t) \D \bm{k} < \infty, \end{equation} and the anti-symmetry relation \eqref{eq.anti_symmetry} is applied in the second equality. Indeed, $V^\pm_{W, R}$ play a role of transition kernels for two branches since \begin{equation} V_{W}(\bm{x}, \bm{k}, t) \chi_{0, R}(|\bm{k}|) = \gamma_0 \frac{\xi(\bm{x}, t)}{\gamma_0} \left[ \frac{V^+_{W, R}(\bm{x}, \bm{k}, t)}{\xi(\bm{x}, t)} - \frac{V^-_{W, R}(\bm{x}, \bm{k}, t) }{\xi(\bm{x}, t)} \right], \label{eq.Wigner_kernel_split} \end{equation} where the auxiliary constant $\gamma_0$, i.e., the intensity of the exponential distribution (see Eq.~\eqref{eq:measure2}), is chosen such that \begin{equation}\label{gamma0} \gamma_0 \ge \displaystyle{\max_{t\in[0, T]} {\max_{\bm{x}} \xi(\bm{x}, t)}}, \end{equation} {which has already been stated in Eq.~\eqref{eq.PDO_plus_bound}}. It deserves to mention that the normalizing function $\xi(\bm{x}, t) $ is monotonically non-decreasing as $R$ increases. Based on different interpretations of the multiplicative functional $\xi(\bm{x}, t)/\gamma_0$, we propose two kinds of stochastic branching walk models, termed the weighted-particle model \cite{ShaoXiong2019} and the signed-particle model \cite{XiongShao2019}, respectively. The former is to interpret $\xi(\bm{x}, t)/\gamma_0$ as the weight function, while the latter is to treat it as the probability to generate offsprings. The main result has been illustrated in Theorem \ref{thm.variance_estimate} and revealed the {discrepancy in variances}. In fact, choosing a larger $\gamma_0$ leads to a variance reduction in the weighted-particle model, but does not influence that of the signed-particle counterpart. It should be noted that the content until Definition \ref{def.stochastic_process} below has been well delineated in \cite{ShaoXiong2019} and we just brief it here for the sake of descriptive integrality. In order to identify the objects in a family history, we need a sequence. Beginning with an ancestor, denoted by $\langle 0 \rangle$, and we can denote its $i$-th children by $\langle i \rangle$. Similarly, we can denote the $j$-th child of $i$-the child by $\langle i j \rangle$, and thus $ \langle i_1 i_2\cdots i_n \rangle$ means $i_n$-th child of $i_{n-1}$-th child of $\cdots$ of the $i_2$-child of the $i_1$-th child, with $i_n \in \left\{1, 2, 3\right\}$. The ancestor $\langle 0 \rangle$ is omitted here and hereafter for brevity. The branching particle system considered involves four basic elements: the life-length $\tau$, the position $\bm{x}$, the wavevector $\bm{k}$ and the particle weight $w$. \begin{definition}\label{def.family_history} A family history $\omega$ stands for a random sequence \begin{equation}\label{Def:family_history} \omega=\{(\tau_0, Q_0, w_0); (\tau_{1}, Q_{1}, w_{1}); (\tau_{2}, Q_{2}, {w_{2}}); (\tau_{3} ,Q_{3}, w_3); (\tau_{11}, Q_{11}, w_{11}); \cdots\}, \end{equation} where $Q_i$ stands for $(\bm{x}_i, \bm{k}_i)$ and the tuple $(\tau_i, Q_{i}, w_i)=(\tau_{i}, \bm{x}_{i}, \bm{k}_{i}, w_i)$ appears in a definite order of enumeration. $\tau_{i}$, $\bm{x}_i$, $\bm{k}_i$, $w_i$ denote the life-length, starting position, wavevector and particle weight of the $i$-th particle, respectively. The exact order of $(\tau_i, Q_{i}, w_i)$ is immaterial but is supposed to be fixed. The collection of all family histories is denoted by $\Omega$. \end{definition} \begin{definition} For $\omega=\{(\tau_0, Q_{0}, w_0); (\tau_1, Q_{1}, w_1); (\tau_2, Q_{2}, w_2); (\tau_3, Q_{3}, w_3); \cdots\}$, the subfamily $\omega_{i}$ is the family history of $\langle i \rangle$ and its descendants, as defined by $\omega_{i}=\{(\tau_i, Q_{i}, w_i); (\tau_{i1}, Q_{i1}, w_{i1}); (\tau_{i2}, Q_{i2}, w_{i2}), (\tau_{i3}, Q_{i3}, w_{i3}); \cdots\}$. The collection of $\omega_i$ is denoted by $\Omega_i$. \end{definition} The particles are frozen when hitting the first exit time $T$. \begin{definition}\label{def:frozen} Suppose the family history $\omega$ starts at time $t$ and define the stopping time, termed the arrival time $t_{i}$ of a branching-and-jump event, recursively as \begin{equation} t_{0} = t, ~~t_{i_1} = t+\tau_0, ~~t_{i_1i_2\cdots i_n} = t_{i_1i_2\cdots i_{n-1}}+\tau_{i_1i_2\cdots i_{n-1}}. \end{equation} Then a particle $\langle i_{1}i_{2}\cdots i_{n}\rangle$ is said to be frozen at $T$ if the following conditions hold \begin{equation} t_{i_1 i_2 \cdots i_{n}} < T ~~\textup{and}~~ t_{i_1 i_2 \cdots i_{n}} + \tau_{i_1 i_2 \cdots i_{n}} \ge T. \end{equation} In particular, when $t+\tau_0\ge T$, the ancestor particle $\langle 0 \rangle$ is frozen. The collection of frozen particles starting at $t$ is denoted by $\mathcal{E}_t(\omega)$. \end{definition} Hereafter we assume that all particles in the branching particle system will move until reaching the frozen states, and still use $\Omega$ to denote the collection of the family history of all frozen particles. Next we will illustrate the probability laws $\Pi_Q^\mathrm{w}$ and $\Pi_Q^\mathrm{s}$ of a random cloud initially concentrated at $Q = (\bm{x}, \bm{k})$. In general, the position and wavevector of the ancestor particle $\langle 0 \rangle$ are set to be $Q_0 = Q$. Now consider the probability of event $\mathrm{E}$ (starting at time $t$ at state $Q$) \begin{equation} \mathrm{E} = \{ \tau_0 \in \mathcal{T}_0, (\tau_{i_1}, \bm{k}_{i_1}) \in \mathcal{T}_1 \times \mathcal{K}_1, \cdots, (\tau_{i_1\cdots i_n}, \bm{k}_{i_1 \cdots i_n }) \in \mathcal{T}_n\times \mathcal{K}_n\} \end{equation} for any Borel set $\mathcal{T}_i$ on $[0, +\infty)$ and $\mathcal{K}_i$ on $ \mathbb{R}^n$, then the probability laws are given by \begin{equation}\label{def.probability_law} \begin{split} \hspace*{-0.05cm} \Pr(\mathrm{E}) = &\int_{\mathcal{T}_0} \textup{d} \mathcal{G}(\tau_0) \int_{\mathcal{K}_1} \textup{d}\bm{k}_{i_1} \mathrm{K}_{i_1}^{t_{i_1}, \bm{x}_{i_1}}(\bm{k}_{i_1};\bm{k}) \int_{\mathcal{T}_1} \textup{d} \mathcal{G}(\tau_{i_1}) \int_{\mathcal{K}_2} \textup{d}\bm{k}_{i_1 i_2} \mathrm{K}_{i_1 i_2}^{t_{i_1 i_2}, \bm{x}_{i_1 i_2}}(\bm{k}_{i_1 i_2};\bm{k}_{i_1}) \\ & \times \cdots \times \int_{\mathcal{K}_n} \textup{d}\bm{k}_{i_1\cdots i_n} \mathrm{K}^{t_{i_1\cdots i_{n}}, \bm{x}_{i_1\cdots i_{n}}}_{i_1 \cdots i_n}(\bm{k}_{i_1 \cdots i_{n}}; \bm{k}_{i_1 \cdots i_{n-1}}) \int_{\mathcal{T}_n} \textup{d} \mathcal{G}(\tau_{i_1\cdots i_n}), \end{split} \end{equation} where $\bm{x}_{i_1\cdots i_{n}} = \bm{x}_{i_1\cdots i_{n-1}}(\tau_{i_1\cdots i_{n-1}})$ with the transition kernels $\mathrm{K}_{i_1 \cdots i_m}^{t^{\prime}, \bm{x}^{\prime}}(\bm{k}; \bm{k}^{\prime})$ given by \begin{equation}\label{def.transition_kernel} \mathrm{K}_{i_1 \cdots i_m}^{t^{\prime}, \bm{x}^{\prime}}(\bm{k}; \bm{k}^{\prime}) = \left\{ \begin{split} &\frac{V_{W, R}^+(\bm{x}^{\prime}, (-1)^{i_m}(\bm{k} - \bm{k}^{\prime}), t^{\prime})}{\xi(\bm{x}^{\prime}, t^{\prime})}, &\quad &i_m = 1,2,\\ & \delta(\bm{k} - \bm{k}^{\prime}), &\quad &i_m = 3. \end{split} \right. \end{equation} The difference lies in the setting of particle weight $w_{i_1 \cdots i_m}$. \begin{itemize} \item[(1)] For the weighted particle model, \begin{equation}\label{def.wp_particle_weight} w_{i_1\cdots i_m} = \left\{ \begin{split} &\frac{\xi(\bm{x}_{i_1\cdots i_m}, t_{i_1\cdots i_m})}{\gamma_0} \cdot \mathbbm{1}_{\mathcal{K}}(\bm{k}_{i_1\cdots i_m}) , &\quad i_m &= 1,2\\ &1, &\quad i_m &= 3, \end{split} \right. \end{equation} \item[(2)] For the signed particle model, for $i_m = 1$ and $2$, \begin{equation}\label{def.sp_particle_weight} w_{i_1\cdots i_m} = \left\{ \begin{split} &1, \quad \textup{with} ~\Pr = \frac{\xi(\bm{x}_{i_1\cdots i_m}, t_{i_1\cdots i_m})}{\gamma_0} \cdot \mathbbm{1}_{\mathcal{K}}(\bm{k}_{i_1\cdots i_m}), \\ &0, \quad \textup{otherwise}, \end{split} \right. \end{equation} and $w_{i_1\cdots i_m} = 1$ for $i_m = 3$. \end{itemize} The setting of initial particle weight $w_0$ depends on the situation. At this stage, it suffices to take $w_0 = 1$. However, later we will show that the initial particle weights may take values in $\{-1, 1\}$, resulting from the importance sampling according to the initial Wigner function $f_0$. Now we illustrate the construction of the stochastic processes $\mathrm{X}_t^\mathrm{w}$ and $\mathrm{X}_t^\mathrm{s}$. \begin{definition} \label{def.stochastic_process} Suppose $(\bm{x}_i, \bm{k}_i)$ is the starting state of a frozen particle $i$ in a given family history $\omega$, and let $\delta_{(\bm{x}, \bm{k})}$ be the Dirac measure concentrated at state $(\bm{x}, \bm{k})$. Then the weighted-particle WBRW is given by \begin{equation}\label{def.wpWBRW} \mathrm{X}_t^\mathrm{w}(\omega) = \langle \varphi_T, \sum_{i \in \mathcal{E}_t(\omega)} \hat{w}_{i} \cdot \delta_{(\bm{x}_{i}(T-t_i), \bm{k}_{i})} \rangle = \sum_{i \in \mathcal{E}_t(\omega)} \hat{w}_i \cdot \varphi_T(\bm{x}_i(T-t_i), \bm{k}_i), \end{equation} the cumulative weight $\hat{w}_i \in [-1, 1]$ for $i = \langle i_1 i_2 \cdots i_n \rangle$ is defined by the product of the particle weights $w_{i_1\cdots i_m}$, \begin{equation} \hat{w}_{i} = \prod_{m=1}^n (-1)^{i_m+1}w_{i_1\cdots i_m} , \quad |w_{i_1\cdots i_m}| \le 1, \end{equation} where $w_{i_1\cdots i_m}$ are given by \eqref{def.wp_particle_weight}. Similarly, the signed-particle WBRW is given by \begin{equation}\label{def.spWBRW} \mathrm{X}_t^\mathrm{s}(\omega) = \langle \varphi_T, \sum_{i \in \mathcal{E}_t(\omega)} \hat{s}_{i} \cdot \delta_{(\bm{x}_{i}(T-t_i), \bm{k}_{i})} \rangle = \sum_{i \in \mathcal{E}_t(\omega)} \hat{s}_i \cdot \varphi_T(\bm{x}_i(T-t_i), \bm{k}_i), \end{equation} where cumulative weight $\hat{s}_i \in \{-1, 0, 1\}$ for $i = \langle i_1 i_2 \cdots i_n \rangle$ is defined by \begin{equation} \hat{s}_i = \prod_{m=1}^n (-1)^{i_m+1} w_{i_1\cdots i_m}, \quad w_{i_1\cdots i_m} \in \{-1, 0, 1\}, \end{equation} where $w_{i_1\cdots i_m}$ are given by \eqref{def.sp_particle_weight}. \end{definition} According to Eq.~\eqref{def.probability_law}, it's easy to verify the Markov property of $\Pi_Q^\mathrm{w}$, which also holds for $\Pi_Q^\mathrm{s}$. \begin{equation}\label{def.Markov_property} \begin{split}\mathrm \mathrm{\Pi}^\mathrm{w}_{Q} X^\mathrm{w}_t X^\mathrm{w}_{t+\tau_0} & =\Pi_Q^\mathrm{w} X^\mathrm{w}_t (\Pi^\mathrm{w}_{Q_{i_1}} X^\mathrm{w}_{t+\tau_0}) \\ & = \int_{\Omega} \left(X^\mathrm{w}_t(\omega) \int_{\Omega_{i_1}} X^\mathrm{w}_{t+\tau_0}(\omega_{i_1}) \Pi^\mathrm{w}_{Q_{i_1}} (\D \omega_{i_1})\right)\mathrm{\Pi}^\mathrm{w}_{Q}(\D \omega). \end{split} \end{equation} \begin{definition} \label{def:mom} The first moments of $\mathrm{X}_t^\mathrm{w}$ and $\mathrm{X}_t^\mathrm{s}$ are denoted by \begin{equation} \phi_\mathrm{w}^{(1)}(\bm{x}, \bm{k}, t) =\Pi_Q^\mathrm{w} \mathrm{X}_t^\mathrm{w}, \quad \phi_\mathrm{s}^{(1)}(\bm{x}, \bm{k}, t) =\Pi_Q^\mathrm{s} \mathrm{X}_t^\mathrm{s}, \end{equation} and the second moments are \begin{equation} \phi_\mathrm{w}^{(2)}(\bm{x}, \bm{k}, t) =\Pi_Q^\mathrm{w} (\mathrm{X}_t^\mathrm{w})^2, \quad \phi_\mathrm{s}^{(2)}(\bm{x}, \bm{k}, t) =\Pi_Q^\mathrm{s} (\mathrm{X}_t^\mathrm{s})^2, \end{equation} In addition, the variances are defined as \begin{align}\label{def.Xt_second_moment} & \Delta \phi^{(2)}_\mathrm{w}(\bm{x}, \bm{k}, t)= \Pi_Q^\mathrm{w} (\mathrm{X}_t^\mathrm{w} - \phi_\mathrm{w}^{(1)}(\bm{x}, \bm{k}, t))^2,\\ & \Delta \phi^{(2)}_\mathrm{s}(\bm{x}, \bm{k}, t) = \Pi_Q^\mathrm{s} ((\mathrm{X}_t^\mathrm{s} - \phi_\mathrm{s}^{(1)}(\bm{x}, \bm{k}, t))^2. \end{align} \end{definition} Before proceeding to the proof of Theorem \ref{thm.variance_estimate}, we require the following two lemmas. \begin{lemma}[Backward Gr\"{o}nwall's inequality]\label{lemma.Gronwall_ineq} Suppose $\beta > 0$ and $u$ satisfies the integral inequality \begin{equation} u(t) \le \alpha(t) + (1+\frac{\beta}{\gamma_0} ) \int_t^T \D \mathcal{G}(t^{\prime} - t) u(t^{\prime}), \end{equation} then \begin{equation}\label{eq.Gronwall_ineq} u(t) \le \alpha(t) + (\gamma_0 + \beta) \int_t^T \mathbbm{e}^{\beta( t^{\prime} - t)}\alpha(t^{\prime}) \D t^{\prime} \end{equation} \end{lemma} \begin{proof} Let \begin{equation}\label{eq.conversion} \tilde{u}(t) = \mathbbm{e}^{-\gamma_0 t} u(t), \quad \tilde{\alpha}(t) = \mathbbm{e}^{-\gamma_0 t} \alpha(t), \end{equation} it yields \begin{equation} \tilde{u}(t) \le \tilde{\alpha}(t) + (\gamma_0 + \beta) \int_t^T \tilde{u}(t^{\prime}) \D t^{\prime}. \end{equation} By the Gr\"{o}nwall's inequality, we have \begin{equation}\label{eq.Gronwall_ineq_2} \tilde{u}(t) \le \tilde{\alpha}(t) + (\gamma_0 + \beta) \int_t^T \mathbbm{e}^{\gamma_0(t^{\prime}-t)+ \beta( t^{\prime} - t) }\tilde{\alpha}(t^{\prime}) \D t^{\prime}. \end{equation} Substituting Eq.~\eqref{eq.conversion} into Eq.~\eqref{eq.Gronwall_ineq_2} yields Eq.~\eqref{eq.Gronwall_ineq}. \end{proof} \begin{lemma}[Prior $L^2$-estimate]\label{lemma.L2_estimate} Suppose $\varphi_T \in L^2(\mathbb{R}^{n} \times \mathbb{R}^{n})$ and the pseudo-differential operator $\Theta_V$ is bounded from $L^2(\mathbb{R}^{n} \times \mathbb{R}^{n})$ to itself, say, $\Vert \Theta_V[\varphi](t) \Vert_2 \le K_V \Vert \varphi(t) \Vert_2 $, then for a given $T < \infty$, \begin{equation}\label{eq.L2_estimate} \Vert \varphi (t) \Vert_2 \le \mathbbm{e}^{K_V(T-t)} \Vert \varphi_T \Vert_2, \quad t \in [0, T]. \end{equation} \end{lemma} \begin{proof} The operator semigroup $T(t) = \mathbbm{e}^{t(\mathcal{A}+\gamma_0)}$ is an isometry from $L^{2}(\mathbb{R}^n)$ to itself. Thus by the triangular inequality and the extended Minkowski's inequality, it has that \begin{equation}\label{eq.prior_L2_estimate} \begin{split} \Vert \varphi(t) \Vert_2 & \le \mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert_2 + \Vert \int_t^T \D \mathcal{G}(t^{\prime}-t) \{-\frac{\Theta_V[\varphi](t^{\prime})}{\gamma_0}+ \varphi(t^{\prime}) \} \Vert_2\\ & \le \mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert_2 + \int_t^T \D \mathcal{G}(t^{\prime}-t) \{\Vert -\frac{\Theta_V[\varphi](t^{\prime})}{\gamma_0} + \varphi(t^{\prime}) \Vert_2\} \\ &\le \mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert_2 + (1+\frac{K_V}{\gamma_0})\int_t^T \D \mathcal{G}(t^{\prime}-t)~ \Vert \varphi(t^{\prime}) \Vert_2. \end{split} \end{equation} Thus by the Lemma \ref{lemma.Gronwall_ineq}, we arrive at \begin{equation} \frac{\Vert \varphi(t) \Vert_2}{\Vert \varphi_T \Vert_2} \le \mathbbm{e}^{-\gamma_0(T-t)} + (\gamma_0+K_V)\int_t^T \mathbbm{e}^{K_V(t^{\prime}-t) -\gamma_0(T-t^{\prime})}\D t^{\prime} = \mathbbm{e}^{K_V (T-t)}. \end{equation} \end{proof} \begin{proof}[Proof of the first part of Theorem \ref{thm.variance_estimate}] We first consider the weighted-particle part. To estimate $\Delta \phi_\mathrm{w}^{(2)}(\bm{x}, \bm{k}, t)$, it starts from the fact that \begin{equation} \mathrm{\Pi}^\mathrm{w}_{Q} (\mathrm{X}_t^\mathrm{w})^2 = \Pi_Q^\mathrm{w} \left( \mathbbm{1}_{\mathrm{E}_t} (\mathrm{X}_t^\mathrm{w})^2 \right) +\Pi_Q^\mathrm{w} \left( \mathbbm{1}_{\mathrm{E}_t^c} (\mathrm{X}_t^\mathrm{w})^2 \right), \end{equation} where the events are $\mathrm{E}_t=\left\{\tau_0: t+\tau_0\ge T\right\}\cap\Omega$ and $\mathrm{E}_t^c=\left\{\tau_0: t+\tau_0 < T\right\}\cap\Omega$. The second term is expanded as \begin{equation*} \begin{split} &\mathrm{\Pi}^\mathrm{w}_{Q} \left( \mathbbm{1}_{\mathrm{E}_t^c} (\mathrm{X}_t^\mathrm{w})^2 \right) = \sum_{i=1}^3 \int_{ \mathrm{E}_t^c} \left( w^2_i\int_{\Omega_i} (X_{t+\tau_0}^\mathrm{w})^2(\omega_i) \Pi^\mathrm{w}_{Q_i}(\D \omega_i) \right)\Pi_Q^\mathrm{w}(\D \omega) \\ &+ \sum_{i \ne j} \int_{\mathrm{E}_t^c} \left( (-1)^{i+j}w_i w_j \int_{\Omega_i} X^\mathrm{w}_{t+\tau_0}(\omega_i) \Pi^\mathrm{w}_{Q_i}(\D \omega_i) \int_{\Omega_j} X^\mathrm{w}_{t+\tau_0} (\omega_j) \Pi^\mathrm{w}_{Q_j}(\D \omega_j) \right)\mathrm{\Pi}^\mathrm{w}_{Q}(\D \omega). \end{split} \end{equation*} Thus the second moment {$\Pi^\mathrm{w}_Q (\mathrm{X}_t^\mathrm{w})^2$} satisfies the following renewal-type equation. \begin{equation}\label{def.wpWBRW_renewal_eq} \begin{split} \mathrm{\Pi}^\mathrm{w}_{Q} (\mathrm{X}_t^\mathrm{w})^2 = & \mathbbm{e}^{- \gamma_0(T-t)} \varphi^2_T(\bm{x}(T-t), \bm{k}) + \int_{0}^{T-t} \D \mathcal{G}(\tau_0) B_\mathrm{w}[\phi_\mathrm{w}^{(2)}](\bm{x}(\tau_0), \bm{k}, t+\tau_0)\\ &+ \int_{0}^{T-t} \D \mathcal{G}(\tau_0) C(\bm{x}(\tau_0), \bm{k}, t+\tau_0), \end{split} \end{equation} where the operator $B_\mathrm{w}$ (the diagonal component) is given by \begin{equation*} \begin{split} B_\mathrm{w}[\phi_\mathrm{w}^{(2)}](\bm{x}, \bm{k}, t) = \frac{\xi(\bm{x}, t)}{\gamma^2_0} \Theta^-_V[\phi_\mathrm{w}^{(2)}](\bm{x}, \bm{k}, t) + \frac{\xi(\bm{x}, t)}{\gamma^2_0} \Theta^+_V[\phi_\mathrm{w}^{(2)}](\bm{x}, \bm{k} , t) + \phi_\mathrm{w}^{(2)}(\bm{x}, \bm{k}, t), \end{split} \end{equation*} and the correlated term $C(\bm{x}, \bm{k}, t)$ reads \begin{equation*} C(\bm{x}, \bm{k}, t) = -\frac{2}{\gamma_0} \Theta_V[\varphi](\bm{x}, \bm{k}, t) \cdot \varphi(\bm{x}, \bm{k}, t) -\frac{2}{\gamma_0^2} \Theta_V^-[\varphi](\bm{x}, \bm{k}, t) \cdot \Theta_V^+[\varphi](\bm{x}, \bm{k}, t). \end{equation*} By the triangular inequality and Young's inequality, it's readily to verify that $B_\mathrm{w}$ is bounded operator from $L^1(\mathbb{R}^{n}) \times L^1_0(\mathbb{R}^{n})$ to itself, \begin{equation}\label{eq.B_w_bound} \begin{split} \Vert B_\mathrm{w}[\phi_\mathrm{w}^{(2)}](t) \Vert_1 &\le \frac{\breve{\xi}}{\gamma^2_0} \Vert \Theta_V^-[\phi_\mathrm{w}^{(2)}](t) \Vert_1 + \frac{\breve{\xi}}{\gamma^2_0} \Vert \Theta_V^+[\phi_\mathrm{w}^{(2)}](t) \Vert_1 + \Vert \phi_\mathrm{w}^{(2)}(t) \Vert_1 \\ & \le (1+\frac{2\breve{\xi}^2}{\gamma_0^2}) \Vert \phi_\mathrm{w}^{(2)}(t) \Vert_1. \end{split} \end{equation} Also, by Cauchy-Schwarz inequality, it yields \begin{equation}\label{eq.C_bound} \begin{split} \Vert C(t) \Vert_1 &\le \frac{2}{\gamma_0} \Vert \Theta_V[\varphi](t) \Vert_2 \cdot \Vert \varphi(t) \Vert_2 + \frac{2}{\gamma_0^2}\Vert \Theta^-_V[\varphi](t) \Vert_2 \cdot \Vert \Theta^+_V[\varphi](t) \Vert_2\\ &\le \frac{2K_V}{\gamma_0} \Vert \varphi(t) \Vert_2^2 + \frac{2\breve{\xi^2}}{\gamma_0^2} \Vert \varphi(t) \Vert_2^2. \end{split} \end{equation} Next we turn to analyze the $L^1$-boundness of $\Delta \phi^{(2)}_\mathrm{w}(\bm{x}, \bm{k}, t)$, which satisfies the following renewal-type equation according to Eq.~\eqref{def.wpWBRW_renewal_eq}, \begin{equation}\label{eq.wpBRW_variation} \begin{split} \Delta \phi^{(2)}_\mathrm{w}(\bm{x}, \bm{k}, t) =& \mathbbm{e}^{-\gamma_0(T-t)} \varphi^2_T(\bm{x}(T-t), \bm{k}) -\varphi^2(\bm{x}, \bm{k}, t) \\ &+ \int_{0}^{T-t} \D \mathcal{G}(\tau)( B_\mathrm{w}[\varphi^2](\bm{x}(\tau), \bm{k}, t+\tau) + C(\bm{x}(\tau), \bm{k}, t+\tau))\\ &+ \int_{0}^{T-t} \D \mathcal{G}(\tau) B_\mathrm{w}[\Delta \phi_\mathrm{w}^{(2)}](\bm{x}(\tau), \bm{k}, t+\tau). \end{split} \end{equation} By integrating Eq.~\eqref{eq.wpBRW_variation} in $\mathbb{R}^n \times \mathbb{R}^n$ and using the triangular inequality, the extended Minkowski's inequality and Eq.~\eqref{eq.B_w_bound}, it has \begin{equation}\label{eq.variation_inequality} \begin{split} \Vert \Delta \phi_\mathrm{w}^{(2)}(t) \Vert_1 \le& ~\mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert^2_2 - \Vert \varphi(t) \Vert_2^2 +\int_t^T \D \mathcal{G}(t^{\prime}-t) \Vert C(t^{\prime}) \Vert_1\\ & +\int_t^T \D \mathcal{G}(t^{\prime}-t) ( \Vert B_\mathrm{w}[\varphi^2](t^{\prime}) \Vert_1 + \Vert B_\mathrm{w}[\Delta \phi_\mathrm{w}^{(2)}](t^{\prime}) \Vert_1 ) \\ \le&~\mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert^2_2 - \Vert \varphi(t) \Vert_2^2 +\int_t^T \D \mathcal{G}(t^{\prime}-t) \Vert C(t^{\prime}) \Vert_1\\ &+ (1+\frac{2 \breve{\xi}^2}{\gamma_0^2}) \int_t^T \D \mathcal{G}(t^{\prime}-t) ( \Vert \Delta \phi_\mathrm{w}^{(2)}(t^{\prime}) \Vert_1 + \Vert \varphi(t^{\prime}) \Vert_2 ). \end{split} \end{equation} In addition, according to Eqs.~\eqref{eq.B_w_bound} and \eqref{eq.C_bound} and Lemma \ref{lemma.L2_estimate}, it yields \begin{equation}\label{eq.C_L1_bound} \begin{split} \int_t^{T}\D \mathcal{G}(t^{\prime}-t) \Vert C(t^{\prime}) \Vert_1 &\le \frac{2K_V\gamma_0 +2\breve{\xi}^2}{\gamma_0} \int_t^T \mathbbm{e}^{2K_V(T-t^{\prime})} \mathbbm{e}^{-\gamma_0(t^{\prime}-t)} \D t^{\prime} \cdot \Vert \varphi_T \Vert^2_2\\ & = \frac{(2K_V\gamma_0 +2\breve{\xi}^2)(\mathbbm{e}^{2K_V(T-t)} - \mathbbm{e}^{-\gamma_0(T-t)})}{(2K_V+\gamma_0)\gamma_0} \Vert \varphi_T \Vert_2^2. \end{split} \end{equation} Let \begin{equation} {u(t) = \frac{\Vert \Delta \phi_\mathrm{w}^{(2)}(t) \Vert_1 + \Vert \varphi(t) \Vert_2^2}{\Vert \varphi_T \Vert_2^2}}, \quad \alpha_0 = \frac{2K_V\gamma_0 + 2\breve{\xi}^2}{(2K_V+\gamma_0)\gamma_0}, \end{equation} then Eq.~\eqref{eq.variation_inequality} is cast into \begin{equation} u(t) \le \alpha_0 \mathbbm{e}^{2K_V(T-t)} + (1-\alpha_0) \mathbbm{e}^{-\gamma_0(T-t)} + (1+\frac{2\breve{\xi}^2}{\gamma_0^2})\int_t^T \D \mathcal{G}(t^{\prime}-t) u(t^{\prime}). \end{equation} By using Lemma \ref{lemma.Gronwall_ineq}, it yields \begin{equation}\label{key_estimate_ut} u(t) \le \frac{K_V \gamma_0 + \breve{\xi}^2}{K_V \gamma_0 - \breve{\xi}^2} \mathbbm{e}^{2K_V(T-t)} - \frac{2\breve{\xi}^2}{K_V\gamma_0 -\breve{\xi}^2} \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)}. \end{equation} Here we use the following relations \begin{align*} &(\gamma_0+\frac{2\breve{\xi}^2}{\gamma_0})\int_t^T \mathbbm{e}^{2K_V(T-t^{\prime})} \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(t^{\prime}-t)}\D t^{\prime} = \frac{\gamma_0^2+2\breve{\xi}^2}{2K_V\gamma_0 - 2\breve{\xi}^2} (\mathbbm{e}^{2K_V(T-t)} - \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)}),\\ &(\gamma_0+\frac{2\breve{\xi}^2}{\gamma_0})\int_t^T \mathbbm{e}^{-\gamma_0(T-t^{\prime})} \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(t^{\prime}-t)}\D t^{\prime} = \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)} - \mathbbm{e}^{-\gamma_0(T-t)}. \end{align*} Consequently, the $L^1$-boundedness of $\Vert \Delta \phi_\mathrm{w}^{(2)}(t) \Vert_1$ for $t \in [0, T]$ is obtained. \begin{equation*}\label{eq.wp_variation_L1_bound} \Vert \Delta \phi_\mathrm{w}^{(2)}(t) \Vert_1 \le \left(\frac{K_V \gamma_0 + \breve{\xi}^2}{K_V \gamma_0 - \breve{\xi}^2} \mathbbm{e}^{2K_V(T-t)} - \frac{2\breve{\xi}^2}{K_V\gamma_0 -\breve{\xi}^2} \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)}\right) \Vert \varphi_T\Vert_2^2 - \Vert \varphi(t) \Vert_2^2. \end{equation*} Finally, when $K_V\gamma_0 > \breve{\xi}^2$, it has \begin{equation*}\label{eq.wp_variation_L1_bound_2} \begin{split} \frac{\Vert \Delta \phi_\mathrm{w}^{(2)}(t) \Vert_1}{\Vert \varphi_T \Vert_2^2} &\le \mathbbm{e}^{2K_V(T-t)} - \frac{\Vert \varphi(t) \Vert_2^2}{\Vert \varphi_T \Vert_2^2} + \frac{2\breve{\xi}^2}{K_V\gamma_0 - \breve{\xi}^2}\mathbbm{e}^{2K_V(T-t)}(1-\mathbbm{e}^{-2(K_V-\frac{\breve{\xi}^2}{\gamma_0})(T-t)}) \\ & \le \mathbbm{e}^{2K_V(T-t)} - \frac{\Vert \varphi(t) \Vert_2^2}{{\Vert \varphi_T \Vert_2^2}} + \frac{4\breve{\xi}^2(T-t)}{\gamma_0} \mathbbm{e}^{2K_V(T-t)}, \end{split} \end{equation*} so that the variance is governed by the leading term $\mathbbm{e}^{2K_V(T-t)}$. In contrast, when $K_V\gamma_0 < \breve{\xi}^2$, \begin{equation*} \begin{split} \frac{\Vert \Delta \phi_\mathrm{w}^{(2)}(t) \Vert_1}{\Vert \varphi_T \Vert_2^2} &\le \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)} - \frac{\Vert \varphi(t) \Vert_2^2}{\Vert \varphi_T \Vert_2^2} + \frac{\breve{\xi}^2+K_V\gamma_0}{\breve{\xi}^2 - K_V\gamma_0 }\mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)}(1-\mathbbm{e}^{-2(\frac{\breve{\xi}^2}{\gamma_0}-K_V)(T-t)}) \\ & \le \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)} - \frac{\Vert \varphi(t) \Vert_2^2}{{\Vert \varphi_T \Vert_2^2}} + \frac{2(\breve{\xi}^2+K_V \gamma_0)(T-t)}{\gamma_0} \mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)}, \end{split} \end{equation*} so that the variance is governed by the leading term $\mathbbm{e}^{\frac{2\breve{\xi}^2}{\gamma_0}(T-t)}$ instead. In this way, we have completed the proof for the weighted-particle model. \end{proof} The proof for the signed-particle situation is quite similar and we only need to outline the differences. \begin{proof}[Proof of the second part of Theorem \ref{thm.variance_estimate}] The first step is to derive the renewal-type equation for the second moment. Since \begin{equation*} \begin{split} &\mathrm{\Pi}^\mathrm{s}_{Q} \mathbbm{1}_{\mathrm{E}_t^c} (\mathrm{X}_t^\mathrm{s})^2 = \sum_{i=1}^3 \int_{\mathrm{E}_t^c} \left( w^2_i\int_{\Omega_i} (\mathrm{X}_{t+\tau_0}^s)^2(\omega_i) \Pi^\mathrm{s}_{Q_i}(\D \omega_i) \right)\Pi_Q^\mathrm{s}(\D \omega)\\ &+ \sum_{i \ne j} \int_{\mathrm{E}_t^c} \left((-1)^{i+j}w_i w_j \int_{\Omega_i} \mathrm{X}^s_{t+\tau_0}(\omega_i) \Pi^\mathrm{s}_{Q_i}(\D \omega_i) \int_{\Omega_j} \mathrm{X}^s_{t+\tau_0} (\omega_j) \Pi^\mathrm{s}_{Q_j}(\D \omega_j)\right)\mathrm{\Pi}^\mathrm{s}_{Q}(\D \omega) \end{split} \end{equation*} it's readily obtained that \begin{equation} \begin{split} \mathrm{\Pi}^\mathrm{s}_{Q} (\mathrm{X}_t^\mathrm{s})^2 = & \mathbbm{e}^{- \gamma_0(T-t)} \varphi^2_T(\bm{x}(T-t), k) + \int_{0}^{T-t} \D \mathcal{G}(\tau_0) B_\mathrm{s}[\phi_\mathrm{s}^{(2)}](\bm{x}(\tau_0), \bm{k}, t+\tau_0)\\ &+ \int_{0}^{T-t} \D \mathcal{G}(\tau_0) C(\bm{x}(\tau_0), \bm{k}, t+\tau_0), \end{split} \end{equation} Accordingly, the operator $B_s$ is given by \begin{equation}\label{eq.L1_bound_Bs} B_\mathrm{s}[\phi_\mathrm{s}^{(2)}](\bm{x}, \bm{k}, t) = \frac{1}{\gamma_0}\Theta^-_V[\phi_\mathrm{s}^{(2)}](\bm{x}, \bm{k} , t) + \frac{1}{\gamma_0}\Theta^+_V[\phi_\mathrm{s}^{(2)}](\bm{x}, \bm{k} , t) + \phi_\mathrm{s}^{(2)}(\bm{x}, \bm{k}, t), \end{equation} which is also a bounded operator from $L^1(\mathbb{R}^{n}\times \mathbb{R}^n)$ to itself, \begin{equation}\label{eq.bound_Bs} \Vert B_s [\phi_\mathrm{s}^{(2)}](t) \Vert_1 \le (1+\frac{2\breve{\xi}}{\gamma_0}) \Vert \phi_\mathrm{s}^{(2)}(t) \Vert_1. \end{equation} Second, the renewal-type equation for the variance $\Delta \phi_\mathrm{s}^{(2)}(\bm{x}, \bm{k}, t)$ \begin{equation} \begin{split} \Delta \phi^{(2)}_s(\bm{x}, \bm{k}, t) =& ~\mathbbm{e}^{-\gamma_0(T-t)} \varphi^2_T(\bm{x}(T-t), k) -\varphi^2(\bm{x}, \bm{k}, t) \\ &+ \int_{0}^{T-t} \D \mathcal{G}(\tau) ( B_\mathrm{s}[\varphi^2](\bm{x}(\tau), \bm{k}, t+\tau) + C(\bm{x}(\tau), \bm{k}, t+\tau) ) \\ &+ \int_{0}^{T-t} \D \mathcal{G}(\tau) B_\mathrm{s}[\Delta \phi_\mathrm{s}^{(2)}](\bm{x}(\tau), \bm{k}, t+\tau), \end{split} \end{equation} then by the extended Minkowski's inequality and Eq.~\eqref{eq.L1_bound_Bs}, it yields. \begin{equation}\label{eq.sp_variation_inequality} \begin{split} \Vert \Delta \phi_\mathrm{s}^{(2)}(t) \Vert_1 \le &~\mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert^2_2 - \Vert \varphi(t) \Vert_2^2+\int_t^T \D \mathcal{G}(t^{\prime}-t) \Vert C(t^{\prime}) \Vert_1\\ &+ (1+\frac{2 \breve{\xi}}{\gamma_0}) \int_t^T \D \mathcal{G}(t^{\prime}-t) ( \Vert \Delta \phi_\mathrm{s}^{(2)}(t^{\prime}) \Vert_1 + \Vert \varphi(t^{\prime}) \Vert_2 ). \end{split} \end{equation} By the Lemma \ref{lemma.Gronwall_ineq} and Eqs.~\eqref{eq.C_bound} and \eqref{eq.bound_Bs}, we obtain \begin{equation*} \begin{split} \frac{\Vert \Delta \phi_\mathrm{s}^{(2)}(t) \Vert_1}{\Vert \varphi_T \Vert^2} +\frac{\Vert \varphi(t) \Vert_2^2}{\Vert \varphi_T \Vert_2^2} &\le \frac{\breve{\xi}\gamma_0 +\breve{\xi}^2}{\breve{\xi}\gamma_0 - K_V \gamma_0}\mathbbm{e}^{2\breve{\xi}(T-t)} - \frac{\breve{\xi}^2+K_V \gamma_0}{\breve{\xi}\gamma_0 - K_V \gamma_0} \mathbbm{e}^{2K_V(T-t)} \\ &\le \mathbbm{e}^{2\breve{\xi}(T-t)} + \frac{\breve{\xi}^2 +K_V\gamma_0}{\breve{\xi}\gamma_0 - K_V\gamma_0} \mathbbm{e}^{2\breve{\xi}(T-t)}(1 -\mathbbm{e}^{-2(\breve{\xi} -K_V)(T-t)}) \\ &\le (1+2(K_V+\frac{\breve{\xi}^2}{\gamma_0})(T-t) ) \mathbbm{e}^{2\breve{\xi}(T-t)}, \end{split} \end{equation*} {which completes the proof}. \end{proof} We are interested in the asymptotic behavior of the variances when $\gamma_0 \to \infty$. For the weighted-particle model, we have \begin{equation} \Vert \Pi_Q^\mathrm{w} (\mathrm{X}_t^\mathrm{w} - \varphi(t))^2 \Vert_1 \lesssim \mathbbm{e}^{2K_V (T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi(t) \Vert_2^2, \end{equation} so that the variance is uniformly bounded as $\gamma_0$ increases. Whereas for the signed-particle counterpart, \begin{equation} \Vert \Pi_Q^\mathrm{s} (\mathrm{X}_t^\mathrm{s} - \varphi(t))^2 \Vert_1\lesssim (1+2K_V (T-t))\mathbbm{e}^{2\breve{\xi}(T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi(t) \Vert_2^2. \end{equation} The leading term is $\mathbbm{e}^{2\breve{\xi}(T-t)}$, regardless of the choice of $\gamma_0$. \begin{remark} It notes that Eq.~\eqref{eq.PDO_plus_bound} holds directly when $V_W^+(\bm{x}, \bm{k}, t)$ is integrable with respect to $\bm{k}$ for any $\bm{x} \in \mathbb{R}^n$ and $t\in [0, T]$, owing to {Young's inequality}. In this situation, we only require $\varphi \in C([0, T], L^2(\mathbb{R}^n) \times L^2(\mathbb{R}^n))$. \end{remark} So far we have given the probabilistic interpretation of the mild solution of the backward Wigner equation by introducing the stochastic process $(\mathrm{X}_t^\mathrm{w},\Pi_Q^\mathrm{w})$ and $(X_t^\mathrm{s}, \Pi^\mathrm{s}_Q)$ on $\mathscr{B}_{\Omega}$ for a given initial state $(\bm{x}, \bm{k})$. The probabilistic interpretation of the weak solution of the Wigner equation \eqref{eq.Wigner} can be constructed by an extension of the probability spaces $(\Omega, \mathscr{B}_{\Omega}, \Pi^w_Q)$ and $(\Omega, \mathscr{B}_{\Omega}, \Pi^s_Q)$, \begin{equation} \hat{\Omega} = \mathbb{R}^n \times \mathbb{R}^n \times \Omega, ~~ \hat{\mathscr{B}}_{\Omega} = \mathsf{R}^n \otimes \mathsf{R}^n \otimes \mathscr{B}_{\Omega}, ~~ \Pi^\mathrm{w} = \lambda_0 \otimes\Pi_Q^\mathrm{w}, ~~ \Pi^\mathrm{s} = \lambda_0 \otimes\Pi_Q^\mathrm{s} \end{equation} where $\mathsf{R}^n \otimes \mathsf{R}^n \otimes \mathscr{B}_{\Omega}$ is the product Borel extension of $\hat{\Omega}$ and the probability measure $\lambda_0$ is given by \begin{equation} \D \lambda_0 = f_I(\bm{x}, \bm{k}) \D \bm{x} \D \bm{k}, \quad f_I = |f_0|/{\Vert f_0 \Vert_1}, \end{equation} and \begin{align} \Pi^\mathrm{w} X^\mathrm{w}_t = \lambda_0 \otimes\Pi_Q^\mathrm{w}(X^\mathrm{w}_t) &= \int_{\mathbb{R}^{n} \times \mathbb{R}^{n}} f_I(\bm{x}, \bm{k}) \left(\int_{\Omega} X^\mathrm{w}_t(\omega)\Pi_Q^\mathrm{w} (\D \omega)\right)\D \bm{x} \D \bm{k},\\ \Pi^\mathrm{s} X^\mathrm{s}_t = \lambda_0 \otimes\Pi_Q^\mathrm{s}(X^\mathrm{s}_t) &= \int_{\mathbb{R}^{n} \times \mathbb{R}^{n}} f_I(\bm{x}, \bm{k}) \left(\int_{\Omega} X^\mathrm{s}_t(\omega)\Pi_Q^\mathrm{s} (\D \omega)\right) \D \bm{x} \D \bm{k}. \end{align} Thus the inner product $\langle \varphi_T, f_T \rangle = \langle \varphi_0, f_0 \rangle$ can be represented by \begin{equation} \langle \varphi_T, f_T \rangle ={\Pi}^\mathrm{w} (s \cdot X^\mathrm{w}_0) = {\Pi}^\mathrm{s} (s \cdot X^\mathrm{s}_0), \end{equation} where $s$ is short for the particle sign function \begin{equation} s(\bm{x}, \bm{k}) = f_0(\bm{x}, \bm{k})/f_I(\bm{x}, \bm{k}). \end{equation} According to Theorem \ref{thm.variance_estimate}, it's readily to obtain the variance estimation for the inner product problem. \begin{definition} The variances of {$\Pi^\mathrm{w} (s \cdot X)$ and $\Pi^\mathrm{s}(s \cdot X)$} are defined by that \begin{equation} \textup{Var}\left({\Pi}^\mathrm{w} (s \cdot \mathrm{X}_t^\mathrm{w})\right) = \lambda_0 \otimes\Pi_Q^\mathrm{w} (s\cdot \mathrm{X}_t^\mathrm{w} - \lambda_0 \otimes\Pi_Q^\mathrm{w}(s\cdot \mathrm{X}_t^\mathrm{w}))^2 \end{equation} and \begin{equation} \textup{Var}\left({\Pi}^\mathrm{s} (s \cdot \mathrm{X}_t^\mathrm{s})\right) = \lambda_0 \otimes\Pi_Q^\mathrm{s}(s\cdot \mathrm{X}_t^\mathrm{s} - \lambda_0 \otimes\Pi_Q^\mathrm{s}(s\cdot \mathrm{X}_t^\mathrm{s}))^2, \end{equation} respectively. \end{definition} Now we prove the bounds of the variance for both the weighted-particle model and the signed-particle model. \begin{theorem}[Variance estimation for the inner product problem]\label{thm.variance_estimation} Suppose $\Vert f_I \Vert_\infty < \infty$ and there exists a positive constant $M_s>0$ such that $s \le M_s$ holds almost surely in $\mathbb{R}^{2n}$, then for the weighted-particle model, \begin{equation}\label{eq.wp_variance_estimation} \textup{Var}\left({\Pi}^\mathrm{w} (s \cdot \mathrm{X}_t^\mathrm{w})\right) \le 2 M_s^2 \Vert f_I \Vert_\infty (1 + (K_V+\frac{\breve{\xi}^2}{\gamma_0})(T-t))\mathbbm{e}^{2\max(K_V, \frac{\breve{\xi}^2}{\gamma_0})(T-t)} \Vert \varphi_T \Vert_2^2, \end{equation} and for the signed-particle model, it has that \begin{equation}\label{eq.sp_variance_estimation} \textup{Var}\left({\Pi}^\mathrm{s} (s \cdot \mathrm{X}_t^\mathrm{w})\right) \le 2M_s^2 \Vert f_I \Vert_\infty (1+ (K_V+\frac{\breve{\xi}^2}{\gamma_0})(T-t))\mathbbm{e}^{2\breve{\xi}(T-t)} \Vert \varphi_T \Vert_2^2. \end{equation} \end{theorem} \begin{proof} It starts by a direct calculation \begin{equation*} \textup{Var}\left({\Pi}^\mathrm{w} (s \cdot \mathrm{X}_t^\mathrm{w})\right) = \lambda_0 \otimes\Pi_Q^\mathrm{w} (s^2 \cdot (\mathrm{X}_t^\mathrm{w})^2) - (\lambda_0 \otimes\Pi_Q^\mathrm{w}(s \cdot \mathrm{X}_t^\mathrm{w}))^2. \end{equation*} The first term reads \begin{equation*} \begin{split} \lambda_0 \otimes\Pi_Q^\mathrm{w}(s^2 \cdot (\mathrm{X}_t^\mathrm{w})^2) = & \int_{\mathbb{R}^{2n}} \frac{f_0^2(\bm{x}, \bm{k})}{f_I(\bm{x}, \bm{k})} \left(\int_{\Omega} (\mathrm{X}_t^\mathrm{w})^2(\omega)\mathrm{\Pi}^\mathrm{w}_{Q}(\D \omega) - \varphi^2(\bm{x}, \bm{k}, t) \right) \D \bm{x} \D \bm{k} \\ &+ \int_{\mathbb{R}^{2n} } \frac{f_0^2(\bm{x}, \bm{k}) }{f_I(\bm{x}, \bm{k}) } \varphi^2(\bm{x}, \bm{k}, t) \D \bm{x} \D \bm{k}, \end{split} \end{equation*} and the second term is \begin{equation*} \lambda_0\otimes\Pi_Q^\mathrm{w}(s \cdot \mathrm{X}_t^\mathrm{w}) = \int_{\mathbb{R}^{n} \times \mathbb{R}^{n}} f_0(\bm{x}, \bm{k}) \varphi(\bm{x}, \bm{k}, t) \D \bm{x} \D \bm{k}. \end{equation*} Due to {H\"{o}lder's inequality}, it has that \begin{equation*} \int_{\mathbb{R}^{n} \times \mathbb{R}^{n}} \frac{f_0^2(\bm{x}, \bm{k})}{f_I(\bm{x}, \bm{k}) } \varphi^2(\bm{x}, \bm{k}, t) \D \bm{x} \D \bm{k} \le M_s^2 \Vert f_I \Vert_\infty \Vert \varphi(t) \Vert_2^2 \le M_s^2 \Vert f_I \Vert_\infty (\mathbbm{e}^{2K_V (T-t)} \Vert \varphi_T \Vert_2^2), \end{equation*} so that \begin{equation*} \textup{Var}\left({\Pi}^\mathrm{w} (s \cdot \mathrm{X}_t^\mathrm{w})\right) \le M_s^2 \Vert f_I \Vert_\infty (\Vert {\Delta \phi_\mathrm{w}^{(2)}(t)} \Vert_1 + \mathbbm{e}^{2K_V (T-t)} \Vert \varphi_T \Vert_2^2). \end{equation*} Thus according to Theorem \ref{thm.variance_estimation}, it yields Eq.~\eqref{eq.wp_variance_estimation}. {The proof} of Eq.~\eqref{eq.sp_variance_estimation} is similar and omitted for brevity. \end{proof} Theorem \ref{thm.variance_estimation} points out the {``numerical sign problem''} in the stochastic Wigner simulation \cite{SellierNedjalkovDimov2014, ShaoXiong2019, MuscatoWagner2016,XiongShao2019}, namely, the negative weights induced by $V_W = V_W^+ - V_W^-$ results in the exponential growth of the statistical errors, as well as the simulation cost along with the growth of particle number. However, the weighted-particle implementation allows the reduction of variance by increasing the parameter $\gamma_0$, thereby ameliorating the ``sign problem''. By contrast, the signed-particle implementation, although {with lower computational costs}, actually sacrifices the accuracy to some extent. \section{The WBRW-SPA model} \label{sec:WBRW-SPA} Until now we have analyzed a class of branching random walk models based on HJD \eqref{eq.PDO_splitting}. The potential weakness of HJD lies in the fact that the near-cancelation of positive and negative parts of the oscillatory integral is totally neglected, leading to a rapid growth of variance in the related stochastic models. In this section, we try to formulate a new class of branching random walk models based on $\Theta^{\lambda_0}_V$, instead of $\Theta_V$. Intuitively speaking, we would like to {capture} the major contribution from the leading term of the asymptotic expansion and throw away the high-order terms that may contribute less to the oscillatory integrals. The main result of this section is presented in Theorem \ref{SPA_thm.variance_estimate}. It is presented that the resulting stochastic processes gain a substantial {reduction} in variance, at the cost of introducing some biases. According to Eqs.~\eqref{def.critical_point}, it is readily to verify that $\sigma_+(x) = -\sigma_-(x)$. Therefore, as $\psi(\bm{k}, t) = \psi^\ast(-\bm{k}, t)$, it has that $\psi(r\sigma_+, t) =\psi^\ast(r\sigma_-, t)$ and then the imaginary part of the stationary phase approximation vanishes, say, \begin{equation}\label{eq.PDO_real_property} \begin{split} &\Lambda_+^{>\lambda_0}[\varphi](\bm{x}, \bm{k}, t) +\Lambda_-^{>\lambda_0}[\varphi](\bm{x}, \bm{k}, t) \\ &= 2\int_{{\lambda_0}/{|\bm{z}(\bm{x})|}}^{+\infty} \textup{Im}\left[\mathbbm{e}^{ \mathbbm{i} r |\bm{z}(\bm{x})|} \left(\frac{2\pi}{\mathbbm{i} r |\bm{z}(\bm{x})|}\right)^{\frac{n-1}{2}} r^{n-1} \psi(r\sigma_+, t)\right] \Delta_{r\sigma_+} [\varphi](\bm{x}, \bm{k}, t) \D r \\ & = 2\int_{{\lambda_0}/{|\bm{z}(\bm{x})|}}^{+\infty} \textup{Im}\left[ \zeta(r, \bm{x}, t)\right] \cdot r^{n-1}\Psi(r)\chi_{0, R}(r) \cdot \Delta_{r\sigma_+} [\varphi](\bm{x}, \bm{k}, t) \D r, \end{split} \end{equation} where $\textup{Im}[z]$ denotes the imaginary part of $z$ and $\zeta(r, \bm{x}, t)$ is given by that \begin{equation} \zeta(r, \bm{x}, t) = \mathbbm{e}^{\mathbbm{i} r |\bm{z}(\bm{x})|} \left(\frac{2\pi}{ \mathbbm{i} r |\bm{z}(\bm{x})|}\right)^{\frac{n-1}{2}} \frac{\psi(r\sigma_+, t)}{\Psi(r)}. \end{equation} Under the assumption {({\textbf{A3}})}, we have that \begin{equation} \breve{\eta} = \int_{0}^{+\infty} r^{n-1} \Psi(r) \chi_{0, R}(r) \D r < \infty. \end{equation} The corresponding probability laws $\mathsf{\Pi}^\mathrm{w}_{Q}$ and $\mathsf{\Pi}^\mathrm{s}_{Q}$ are characterized in a similar pattern as in Eq.~\eqref{def.probability_law}, with an alternative setting of the transition density $\tilde{\mathrm{K}}_{i_1 \cdots i_m}^{t^{\prime}, \bm{x}^{\prime}}(\bm{k}; \bm{k}^{\prime})$ and the particle weight $w_{i_1 \cdots i_m}$. The definition of $\tilde{\mathrm{K}}_{i_1 \cdots i_m}^{t^{\prime}, \bm{x}^{\prime}}(\bm{k}; \bm{k}^{\prime})$ is given by that \begin{equation} \tilde{\mathrm{K}}_{i_1 \cdots i_m}^{t^{\prime}, \bm{x}^{\prime}}(\bm{k}; \bm{k}^{\prime}) = \left\{ \begin{split} &\frac{V_{W, R}^+(\bm{x}^{\prime}, (-1)^{i_m}(\bm{k} - \bm{k}^{\prime}), t^{\prime})}{\xi(\bm{x}^{\prime}, t^{\prime})}, &\quad &i_m = 1,2,\\ &\frac{r^{n-1} \Psi(r) \chi_{0, R}(r)}{\breve{\eta}} \cdot \delta(\sigma - \sigma_+(\bm{x}^{\prime})) \Big |_{\bm{k} = \bm{k}^{\prime} + \frac{(-1)^{i_m}}{2}r\sigma } , &\quad &i_m = 3, 4, \\ & \delta(\bm{k} - \bm{k}^{\prime}), &\quad &i_m = 5, \end{split} \right. \end{equation} in the sense that for $i_m = 3$ or $4$, \begin{equation*} \begin{split} &\Pr(\bm{k}_{i_1 \cdots i_m} - \bm{k}_{i_1 \cdots i_{m-1}}\in \frac{\mathcal{K}_{i_m}}{2}) = \int_{\mathcal{K}_{i_m}} \D \bm{k}_{i_1 \cdots i_m} ~ \tilde{\mathrm{K}}^{i_1 \cdots i_m}_{t_{i_1 \cdots i_m}, \bm{x}_{i_1 \cdots i_m}}(\bm{k}_{i_1 \cdots i_{m}}; \bm{k}_{i_1 \cdots i_{m-1}}) \\ & = \int_{E_{i_m}} \frac{r_{i_1 \cdots i_m}^{n-1}\Psi(r_{i_1 \cdots i_m}) \chi_{0, R}(r_{i_1 \cdots i_m})}{ \breve{\eta}} \cdot \delta(\sigma_{i_1 \cdots i_m} - \sigma_+(\bm{x}_{i_1 \cdots i_m})) \D r_{i_1 \cdots i_m} \D \sigma_{i_1 \cdots i_m}, \end{split} \end{equation*} where $E_{i_m}$ is the conversion of $\mathcal{K}_{i_m}$ under the spherical coordinate. For brevity, we adopt the following notations: $r_{i_1\cdots i_m} = 2 \left| \bm{k}_{i_1\cdots i_m} - \bm{k}_{i_1 \cdots i_{m-1}} \right| $, $\zeta_{i_1 \cdots i_m} = \zeta( r_{i_1\cdots i_m}, \bm{x}_{i_1\cdots i_m}, t_{i_1\cdots i_m})$ and $\bm{z}_{i_1 \cdots i_m} = \bm{z}(\bm{x}_{i_1 \cdots i_m})$. Let $\sigma_{i_1 \cdots i_m}$ be \begin{equation} \sigma_{i_1 \cdots i_m} = \left\{ \begin{split} &\frac{\xi(\bm{x}_{i_1\cdots i_m}, t_{i_1\cdots i_m})}{\gamma_0} \cdot \mathbbm{1}_{\{r_{i_1\cdots i_m} \le \frac{2 \lambda_0}{|\bm{z}_{i_1\cdots i_m}|}\}}, &i_m = 1, 2,\\ &\frac{2\breve{\eta}}{\gamma_0} \cdot \big| \textup{Im} \left[ \zeta_{i_1 \cdots i_m} \right] \big| \cdot \mathbbm{1}_{\{r_{i_1\cdots i_m} > \frac{\lambda_0}{|\bm{z}_{i_1\cdots i_m}|}\}}, &i_m = 3, 4. \end{split} \right. \end{equation} Then the particle weight $w_{i_1\cdots i_m}$ reads that \begin{itemize} \item[(1)] For the weighted particle model, \begin{equation}\label{def_wbrw_spa_w} w_{i_1\cdots i_m} = \left\{ \begin{split} &\sigma_{i_1 \cdots i_m} \cdot \mathbbm{1}_{\mathcal{K}}(\bm{k}_{i_1\cdots i_m}), \quad &i_m &= 1, 2,\\ &\sigma_{i_1 \cdots i_m} \cdot \textup{sgn}\left(\textup{Im}[\zeta_{i_1\cdots i_m}]\right) \cdot \mathbbm{1}_{\mathcal{K}}(\bm{k}_{i_1\cdots i_m}), \quad &i_m &= 3, 4, \\ &1, \quad &i_m &= 5. \end{split} \right. \end{equation} \item[(2)] For the signed particle model, \begin{equation}\label{def_wbrw_spa_s} w_{i_1\cdots i_m} = \left\{ \begin{split} &1, &\textup{with} ~\Pr = \sigma_{i_1 \cdots i_m} \cdot \mathbbm{1}_{\mathcal{K}}(\bm{k}_{i_1\cdots i_m}), ~~i_m = 1, 2,\\ &\textup{sgn}\left(\textup{Im}[\zeta_{i_1\cdots i_m}]\right), &\textup{with} ~\Pr = \sigma_{i_1 \cdots i_m} \cdot \mathbbm{1}_{\mathcal{K}}(\bm{k}_{i_1\cdots i_m}), ~~ i_m = 3, 4, \\ &0, &\textup{otherwise} , \end{split} \right. \end{equation} and $w_{i_1\cdots i_m} = 1$ for $i_m = 5$. \end{itemize} Here $\textup{sgn}(x) = 1$ for $x > 0$, $\textup{sgn}(x) = -1$ for $x < 0$ and $\textup{sgn}(x) = 0$ for $x = 0$. \begin{definition}\label{def.stochastic_process_SPA} Suppose $(\bm{x}_i, \bm{k}_i)$ is the starting state of a frozen particle $i$ in a given family history $\omega$, and let $\delta_{(\bm{x}, \bm{k})}$ be the Dirac measure concentrated at state $(\bm{x}, \bm{k})$. Then the weighted-particle WBRW-SPA is given by that \begin{equation}\label{def.wpWBRW_SPA} \mathrm{Y}_t^\mathrm{w}(\omega) = \langle \varphi_T, \sum_{i \in \mathcal{E}_t(\omega)} \tilde{w}_{i} \cdot \delta_{(\bm{x}_{i}(T-t_i), \bm{k}_{i})} \rangle = \sum_{i \in \mathcal{E}_t(\omega)} \tilde{w}_i \cdot \varphi_T(\bm{x}_i(T-t_i), \bm{k}_i), \end{equation} the cumulative weight $\tilde{w}_i \in [-1, 1]$ for $i = \langle i_1 i_2 \cdots i_n \rangle$ is defined by the product of the particle weights $w_{i_1\cdots i_m}$ \begin{equation} \tilde{w}_{i} = \prod_{m=1}^n (-1)^{i_m +1} w_{i_1\cdots i_m} , \quad |w_{i_1\cdots i_m}| \le 1, \end{equation} where $w_{i_1\cdots i_m}$ are defined in Eq.~\eqref{def_wbrw_spa_w}. Similarly, the signed-particle WBRW-SPA is given by that \begin{equation}\label{def.spWBRW_SPA} \mathrm{Y}_t^\mathrm{s}(\omega) = \langle \varphi_T, \sum_{i \in \mathcal{E}_t(\omega)} \tilde{s}_{i} \cdot \delta_{(\bm{x}_{i}(T-t_i), \bm{k}_{i})} \rangle = \sum_{i \in \mathcal{E}_t(\omega)} \tilde{s}_i \cdot \varphi_T(\bm{x}_i(T-t_i), \bm{k}_i), \end{equation} where cumulative weight $\tilde{s}_i \in \{-1, 0, 1\}$ for $i = \langle i_1 i_2 \cdots i_n \rangle$ is defined by the product of the particle weight $w_{i_1\cdots i_m}$, \begin{equation} \tilde{s}_i = \prod_{m=1}^n (-1)^{i_m+1} w_{i_1\cdots i_m}, \quad w_{i_1\cdots i_m} = \{-1,0, 1\}, \end{equation} where $w_{i_1\cdots i_m}$ are defined in Eq.~\eqref{def_wbrw_spa_s}. \end{definition} \begin{definition} The first moments of $\mathrm{Y}_t^\mathrm{w}$ and $\mathrm{Y}_t^\mathrm{s}$ are denoted by \begin{equation} \Phi_\mathrm{w}^{(1)}(\bm{x}, \bm{k}, t) = \mathsf{\Pi}^\mathrm{w}_{Q} \mathrm{Y}_t^\mathrm{w}, \quad \Phi_\mathrm{s}^{(1)}(\bm{x}, \bm{k}, t) = \mathsf{\Pi}^\mathrm{s}_{Q} \mathrm{Y}_t^\mathrm{s}, \end{equation} and the second moments are \begin{equation} \Phi_\mathrm{w}^{(2)}(\bm{x}, \bm{k}, t) = \mathsf{\Pi}^\mathrm{w}_{Q} (\mathrm{Y}_t^\mathrm{w})^2, \quad \Phi_\mathrm{s}^{(2)}(\bm{x}, \bm{k}, t) = \mathsf{\Pi}^\mathrm{s}_{Q} (\mathrm{Y}_t^\mathrm{s})^2, \end{equation} In addition, the variances are defined as \begin{align}\label{def.Yt_second_moment} & \Delta \Phi^{(2)}_\mathrm{w}(\bm{x}, \bm{k}, t)= \mathsf{\Pi}^\mathrm{w}_{Q} (\mathrm{Y}_t^\mathrm{w} - \Phi_\mathrm{w}^{(1)}(\bm{x}, \bm{k}, t))^2,\\ & \Delta \Phi^{(2)}_\mathrm{s}(\bm{x}, \bm{k}, t) = \mathsf{\Pi}^\mathrm{s}_{Q} (\mathrm{Y}_t^\mathrm{s} -{\Phi_\mathrm{s}^{(1)}(\bm{x}, \bm{k}, t))^2}. \end{align} \end{definition} Now we sketch the proof of Theorem \ref{SPA_thm.variance_estimate}. The first step is to prove that both $\Phi_\mathrm{w}^{(1)}(\bm{x}, \bm{k}, t)$ and $\Phi_\mathrm{s}^{(1)}(\bm{x}, \bm{k}, t)$ are solutions of the modified backward Wigner equation, \begin{equation}\label{eq.modified_backward_Wigner} \left\{ \begin{split} &\frac{\partial }{\partial t}\varphi_{\lambda_0}(\bm{x}, \bm{k}, t) + \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}} \varphi_{\lambda_0}(\bm{x}, \bm{k}, t) = \Theta^{\lambda_0}_{V}\left[\varphi_{\lambda_0}\right](\bm{x}, \bm{k}, t), ~~t \le T,\\ & \varphi_{\lambda_0}(\bm{x}, \bm{k}, T) = \varphi_T(\bm{x}, \bm{k}). \end{split} \right. \end{equation} The second step is to estimate the variances of the resulting stochastic models. Finally, by comparing $\varphi$ and $\varphi_{\lambda_0}$, we arrive at the final result. \begin{theorem}[The first moments of WBRW-SPA]\label{thm_first_moment_wbrw_spa} Suppose the assumptions ${\bf (A3)}$ are satisfied. Then for a fixed $\lambda_0$, there exists $\varphi_{\lambda_0} \in C([0, T], L^2(\mathbb{R}^n) \times L^2_0(\mathbb{R}^n))$ such that \begin{equation} \Phi_\mathrm{w}^{(1)}(\bm{x}, \bm{k}, t) = \Phi_\mathrm{w}^{(2)}(\bm{x}, \bm{k}, t) = \varphi_{\lambda_0}(\bm{x}, \bm{k}, t), \end{equation} and $\varphi_{\lambda_0}$ satisfies the following {estimate:} \begin{equation}\label{spa_bias_estimate} \Vert \varphi(t) - \varphi_{\lambda_0}(t) \Vert_2 \le C \lambda_0^{-{n}/{2}} \max_{t \in [0, T]} \Vert \varphi(t) \Vert_{L_{\bm{x}}^2 \times H_{\bm{k}}^1}. \end{equation} \end{theorem} \begin{proof} Consider the events $\mathrm{E}_t = \{\tau_0: t+\tau_0 \ge T \}$ and $\mathrm{E}_t^c = \{\tau: t+\tau_0 < T \}$. \begin{equation} \mathsf{\Pi}_Q^\mathrm{w}\left(\mathbbm{1}_{\mathrm{E}_t}(\omega)\right) = \mathbbm{e}^{-\gamma_0(T-t)}\varphi_T(\bm{x}(T-t), k), \end{equation} Suppose the event $\mathrm{E}_t^c$ occurs, then for the family history $\omega = (Q_0; \omega_1, \cdots, \omega_5)$, it has that \begin{equation}\label{eq.expansion_Y_t_w} \mathrm{Y}_t^\mathrm{w}(\omega) = \sum_{i=1}^4 (-1)^{i+1}\zeta_{i} \cdot \mathrm{Y}_t^\mathrm{w}(\omega_i) + \mathrm{Y}_t^\mathrm{w}(\omega_5). \end{equation} Now we calculate $\mathrm{\Pi}_Q^\mathrm{w} \mathrm{Y}_t^\mathrm{w}$ for the first family $\omega_1$. Owing to the fact that $r_i$ are independent, for the Hahn-Jordan decomposition $\Lambda^{<\lambda_0} = \Lambda_+^{<\lambda_0} - \Lambda_-^{<\lambda_0}$, it has that \begin{equation}\label{eq.spa_first_stochastic_representation} \int_0^{T-t} \frac{\Lambda_-^{<\lambda_0}[\Phi_\mathrm{w}^{(1)}](\bm{x}(\tau), \bm{k}, t+\tau)}{\gamma_0} \D \mathcal{G}(\tau) = \int_{\mathrm{E}_t^c} (-1)^{1+1} \zeta_1 \cdot \mathrm{Y}_t^\mathrm{w}(\omega_1) \mathrm{\Pi}_Q^\mathrm{w}(\D \omega) \end{equation} since \begin{equation*} \begin{split} & \int_{\mathrm{E}_t^c} \frac{\xi(\bm{x}(\tau), t + \tau)}{\gamma_0} \left( \int_{\Omega_1}\mathbbm{1}_{\{r_1 < \lambda_0/|{2\bm{z}_1}|\} } \cdot \mathrm{Y}_t^\mathrm{w}(\omega_1) \mathsf{\Pi}^\mathrm{w}_{Q_1}(\D \omega_1) \right) \mathsf{\Pi}_Q^\mathrm{w}(\D \omega) = \\ &\int_0^{T-t} \D \mathcal{G}(\tau)\int_{B(\frac{\lambda_0}{|{2\bm{z}_1}|})}\D \bm{k}_1 \frac{\xi(\bm{x}(\tau) , t+\tau)}{\gamma_0} \frac{V^-_W(\bm{x}(\tau), \bm{k}_1, t+\tau)}{\xi(\bm{x}(\tau), t+\tau)} \mathrm{\Phi}_\mathrm{w}^{(1)}(\bm{x}(\tau), \bm{k}-{\bm{k}_1}, t+\tau) . \end{split} \end{equation*} where $\bm{z}_i$ is short for $\bm{z}(\bm{x}_i) = \bm{z}(\bm{x}(\tau))$. For the third family $\omega_3$, it yields that \begin{equation}\label{eq.spa_third_stochastic_representation} \int_0^{T-t} \frac{\Lambda_-^{ > \lambda_0}[\Phi_\mathrm{w}^{(1)}](\bm{x}(\tau), \bm{k}, t+\tau)}{\gamma_0} \D \mathcal{G}(\tau) = \int_{\mathrm{E}_t^c} (-1)^{1+3} \zeta_3 \cdot \mathrm{Y}_t^\mathrm{w}(\omega_3) \mathrm{\Pi}_Q^\mathrm{w}(\D \omega) \end{equation} since \begin{equation*} \begin{split} &\int_{ \mathrm{E}_t^c} (-1)^{1+3} \zeta_3 \cdot \mathrm{Y}_t^\mathrm{w}(\omega_3) \mathsf{\Pi}_Q^\mathrm{w}(\D \omega) \\ &=\int_{\mathrm{E}_t^c} \frac{2\breve{\eta} }{\gamma_0}\left(\int_{\Omega_3} \textup{Im}[\sigma_3] \cdot \mathbbm{1}_{\{r_3 > \lambda_0/|\bm{z}_3|\}} \cdot \mathrm{Y}_t^\mathrm{w}(\omega_3) \mathsf{\Pi}_{Q_3}^\mathrm{w}(\D \omega_3) \right) \mathsf{\Pi}_Q^\mathrm{w}(\D \omega)\\ &=\int_0^{T-t} \D \mathcal{G}(\tau) \int_{{\lambda_0}/{|\bm{z}_3|}}^{+\infty} \D r_3 ~ \frac{2\breve{\eta}}{\gamma_0} \cdot \textup{Im}\left[ \mathbbm{e}^{\mathbbm{i} r_{3}|\bm{z}_3|} \left(\frac{2\pi}{\mathbbm{i} r_{3} |\bm{z}_3|}\right)^{\frac{n-1}{2}}\frac{\psi(r_3\sigma_+(\bm{x}(\tau)), t+\tau)}{\Psi(r_3)}\right] \\ & \quad \times \frac{r_3^{n-1}\Psi(r_3)}{ \breve{\eta}}\mathrm{\Phi}_\mathrm{w}^{(1)}(\bm{x}(\tau), \bm{k} - \frac{r_3 \sigma_+(\bm{x}(\tau))}{2}, t+\tau) . \end{split} \end{equation*} The other terms are tackled in a similar pattern. Summing over five terms recovers $-\Theta_V^{\lambda_0}[\varphi] +\gamma_0 \cdot \varphi$. The proof for the signed-particle model is similar and thus omitted for brevity. For the second part, let $\varepsilon(\bm{x}, \bm{k}, t) = \varphi_{\lambda_0}(\bm{x}, \bm{k}, t) - \varphi(\bm{x}, \bm{k}, t)$. According to Eqs.\eqref{eq.backward_Wigner} and \eqref{eq.modified_backward_Wigner}, it is observed that $\varepsilon(\bm{x}, \bm{k}, t)$ satisfies the following equation \begin{equation}\label{def_error_equation} \frac{\partial }{\partial t}\varepsilon(\bm{x}, \bm{k}, t) + \frac{\hbar \bm{k}}{m} \cdot \nabla_{\bm{x}}\varepsilon(\bm{x}, \bm{k}, t) = \Theta^{\lambda_0}_V[\varepsilon](\bm{x}, \bm{k}, t) + (\Theta_V - \Theta^{\lambda_0}_V)[\varphi](\bm{x}, \bm{k}, t). \end{equation} with {$\varepsilon(\bm{x}, \bm{k}, T) = 0$}. It's easy to verify by Eq.~\eqref{eq.prior_L2_estimate} that \begin{equation*} \begin{split} \Vert \varepsilon(t) \Vert_2 & \le \int_t^T \D \mathcal{G}(t^{\prime} -t) \Vert \Theta_V[\varphi](t^{\prime}) - \Theta_V^{\lambda_0}[\varphi](t^{\prime}) \Vert_2 + (1+\frac{K_V}{\gamma_0}) \int_t^T \D \mathcal{G}(t^{\prime}-t) \Vert \varepsilon(t^{\prime}) \Vert_2 \\ & \le (1 - \mathbbm{e}^{-\gamma_0 (T-t)}) \max_{t \in [0, T]} \lambda_0^{-\frac{n}{2}} \Vert \varphi(t) \Vert_{L^2_{\bm{x}} \times H^1_{\bm{k}}} + (1+\frac{K_V}{\gamma_0}) \int_t^T \D \mathcal{G}(t^{\prime}-t) \Vert \varepsilon(t^{\prime}) \Vert_2 \\ & \le \frac{\lambda_0^{-\frac{n}{2}} (\gamma_0 + K_V)\mathbbm{e}^{K_V(T-t)}}{K_V} \max_{t \in [0, T]} \Vert \varphi(t) \Vert_{L^2_{\bm{x}} \times H^1_{\bm{k}}} \end{split} \end{equation*} The second inequality uses the remainder estimate \eqref{eq.error_estimate_stationary_phase_method} in Theorem \ref{thm.stationary_phase_approximation} and the third equality is derived by Lemma \ref{lemma.Gronwall_ineq}. \end{proof} The next step is to estimate the upper bounds for the variances, as illustrated by the following theorem. When the assumption (\textbf{A4}) holds, by Young's inequality, the HJD of the operator $\Lambda^{<\lambda_0}$, denoted by $\Lambda^{<\lambda_0}_\pm$, is bounded from $L^p(\mathbb{R}^n) \times L_0^p(\mathbb{R}^n)$ to itself, \begin{equation}\label{eq.PDO_plus_bound_improve} \Vert \Lambda^{\lambda_0}_\pm [\varphi](t) \Vert_p \le \alpha_\ast \breve{\xi} \Vert \varphi(t) \Vert_p, \quad p = 1, 2. \end{equation} \begin{theorem}[Variances of WBRW-SPA] Suppose the assumptions {{\bf (A2)}-{\bf (A4)} }are satisfied for a sufficiently large $\lambda_0$ and {$\gamma_2 = \alpha_\ast \breve{\xi}^2$}. Then we have that \begin{equation} \label{eq.wbrw_spa_wp_variance_estimate_1} \Vert \mathsf{\Pi}_{Q}^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi_{\lambda_0}(t))^2 \Vert_1 \lesssim (1+\frac{4\gamma_2}{\gamma_0}(T-t)) \mathbbm{e}^{2\max(K_V, \frac{\alpha_\ast \breve{\xi}^2}{\gamma_0}) (T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi_{\lambda_0}(t) \Vert_2^2 \end{equation} and \begin{equation} \label{eq.wbrw_spa_sp_variance_estimate_1} \Vert \mathsf{\Pi}_{Q}^\mathrm{s} (\mathrm{Y}_t^\mathrm{s} - \varphi_{\lambda_0}(t))^2 \Vert_1 \lesssim (1+2(K_V+ \frac{\gamma_2}{\gamma_0})(T-t))\mathbbm{e}^{2\alpha_\ast \breve{\xi}(T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi_{\lambda_0}(t) \Vert_2^2. \end{equation} \end{theorem} \begin{proof} According to Eqs.~\eqref{def_wbrw_spa_w} and \eqref{eq.expansion_Y_t_w}, the renewal-type equation for the second moment of $\mathrm{Y}_t^\mathrm{w}$ reads that \begin{equation} \mathsf{\Pi}^\mathrm{w}_{Q} (\mathrm{Y}_t^\mathrm{w})^2 = \mathsf{\Pi}^\mathrm{w}_{Q} \left( \mathbbm{1}_{\mathrm{E}_t} (\mathrm{Y}_t ^\mathrm{w})^2 \right) + \mathsf{\Pi}^\mathrm{w}_{Q} \left( \mathbbm{1}_{\mathrm{E}_t^c} (\mathrm{Y}_t ^\mathrm{w})^2 \right), \end{equation} where the second term on the right hand side reads \begin{equation*} \begin{split} &\mathsf{\Pi}^\mathrm{w}_{Q} \left( \mathbbm{1}_{\mathrm{E}_t^c} (\mathrm{Y}_t^\mathrm{w})^2 \right) = \sum_{i=1}^5 \int_{\mathrm{E}_t^c} \left( \int_{\Omega_i} w^2_i \cdot (\mathrm{Y}_{t+\tau_0}^\mathrm{w}(\omega_i))^2 \mathsf{\Pi}^\mathrm{w}_{Q_i}(\D \omega_i) \right) \mathsf{\Pi}^\mathrm{w}_{Q}(\D \omega) \\ &+\sum_{i \ne j} \int_{\mathrm{E}_t^c} \left((-1)^{i+j} \int_{\Omega_i} w_i \mathrm{Y}^\mathrm{w}_{t+\tau_0}(\omega_i) \mathsf{\Pi}^\mathrm{w}_{Q_i}(\D \omega_i) \int_{\Omega_j} w_j \mathrm{Y}^\mathrm{w}_{t+\tau_0} (\omega_j) \mathsf{\Pi}^\mathrm{w}_{Q_j}(\D \omega_j)\right) \mathsf{\Pi}^\mathrm{w}_{Q}(\D \omega). \end{split} \end{equation*} Now we define an operator $B_\mathrm{w}^{\lambda_0}$ and verify its $L^1$-boundedness, \begin{equation}\label{def.B_w_lambda_0} B_\mathrm{w}^{\lambda_0}[\Phi_\mathrm{w}^{(2)}](\bm{x}(\tau_0), \bm{k}, t+\tau_0) = \sum_{i=1}^5 \int_{\Omega_i} w^2_i \cdot (\mathrm{Y}_{t+\tau_0}^\mathrm{w})^2(\omega_i) \mathsf{\Pi}^\mathrm{w}_{Q_i}(\D \omega_i) . \end{equation} Since $|\textup{Im}[\zeta(r_3, \bm{x}(\tau), t+\tau)] |^2 \le \left({2\pi}/{\lambda_0}\right)^{n-1}$, it has that \begin{equation}\label{ineq.asymp_term} \begin{split} & \Vert \int_{ \mathrm{E}_t^c} \left( \int_{\Omega_3} w^2_3 \cdot (\mathrm{Y}_{t+\tau_0}^\mathrm{w}(\omega_3) )^2\mathsf{\Pi}^\mathrm{w}_{Q_3}(\D \omega_3) \right) \mathsf{\Pi}^\mathrm{w}_{Q}(\D \omega) \Vert_{L^1_{\bm{k}}} \\ & \le \frac{4\breve{\eta}}{\gamma_0^2} (\frac{2\pi}{\lambda_0})^{n-1} \Vert \int_{\frac{\lambda_0}{|\bm{z}_3|}}^{+\infty} r_3^{n-1} \Psi(r_3) \chi_{0, R}(r_3) \cdot \Phi_\mathrm{w}^{(2)}(\bm{x}(\tau), \bm{k} - \frac{r_3\sigma_+(\bm{x}(\tau))}{2}, t+\tau) \D r_3 \Vert_{L^1_{\bm{k}}} \\ & \lesssim \frac{4\breve{\eta}^2}{\gamma_0^2} (\frac{2\pi}{\lambda_0})^{n-1} \Vert \Phi_\mathrm{w}^{(2)}(\bm{x}(\tau), \bm{k}, t +\tau) \Vert_{L^1_{\bm{k}}}. \end{split} \end{equation} Combining Eqs.~\eqref{eq.PDO_plus_bound_improve} and \eqref{ineq.asymp_term}, we obtain that \begin{equation} \Vert B_\mathrm{w}^{\lambda_0}[\Phi_\mathrm{w}^{(2)}](t) \Vert_1 \le (1+ \frac{2 \alpha_\ast\breve{\xi}^2}{\gamma_0^2} + \frac{8\breve{\eta}^2}{\gamma_0^2} (\frac{2\pi}{\lambda_0})^{n-1}) \Vert \Phi_\mathrm{w}^{(2)}(t) \Vert_1. \end{equation} Thus for a sufficiently large $\lambda_0$ (such as $\breve{\eta}^2 (\frac{2\pi}{\lambda_0})^{n-1} \ll \breve{\xi}^2)$, it further yields that \begin{equation}\label{eq_Bw_estimate_asymptotic} \Vert B_\mathrm{w}^{\lambda_0}[\Phi_\mathrm{w}^{(2)}](t) \Vert_1 \lesssim (1 + \frac{2\alpha_\ast \breve{\xi}^2}{\gamma_0^2}) \Vert \Phi_\mathrm{w}^{(2)}(t) \Vert_1 + \mathcal{O}(\lambda_0^{-(n-1)}), \end{equation} For the non-diagonal terms, we define correlated terms $C_{ij}^{\lambda_0}(\bm{x}, \bm{k}, t)$ as \begin{equation} C_{ij}^{\lambda_0}(\bm{x}(\tau_0), \bm{k}, t+\tau_0) = (-1)^{i+j} \int_{\Omega_i} w_i \mathrm{Y}^\mathrm{w}_{t+\tau_0}(\omega_i) \mathsf{\Pi}^\mathrm{w}_{Q_i}(\D \omega_i) \int_{\Omega_j} w_j \mathrm{Y}^\mathrm{w}_{t+\tau_0} (\omega_j) \mathsf{\Pi}^\mathrm{w}_{Q_j}(\D \omega_j), \end{equation} in which each term can be calculated in the similar way as in Eqs.~\eqref{eq.spa_first_stochastic_representation} and \eqref{eq.spa_third_stochastic_representation}. In fact, by using Young's inequality and Cauchy-Schwarz inequality, $C^{\lambda_0}(\bm{x}, \bm{k}, t) = \sum_{i < j}C_{ij}^{\lambda_0}(\bm{x}, \bm{k}, t)$ can be estimated by \begin{equation}\label{eq_C_estimate_asymptotic} \begin{split} \Vert C^{\lambda_0}(t) \Vert_1 \le & \frac{\Vert \Lambda_+^{< \lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 \cdot \Vert \Lambda_-^{<\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 }{\gamma_0^2} + \frac{\Vert \Lambda_+^{>\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 \cdot \Vert \Lambda_-^{>\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 }{\gamma_0^2} \\ &+ \frac{\Vert \Lambda_+^{< \lambda_0}[\varphi_{\lambda_0}](t) - \Lambda_-^{< \lambda_0}[\varphi_{\lambda_0}](t) \Vert_2 \cdot \Vert \Lambda_-^{>\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 }{\gamma_0^2} \\ &+ \frac{\Vert \Lambda_+^{< \lambda_0}[\varphi_{\lambda_0}](t) - \Lambda_-^{< \lambda_0}[\varphi_{\lambda_0}](t) \Vert_2 \cdot\Vert \Lambda_+^{>\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 }{\gamma_0^2} \\ & + \frac{\Vert \Lambda_+^{>\lambda_0}[\varphi_{\lambda_0}](t) - \Lambda_-^{>\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 \cdot\Vert \varphi_{\lambda_0}(t) \Vert_2^2 }{\gamma_0} \\ & + \frac{\Vert \Lambda_+^{<\lambda_0}[\varphi_{\lambda_0}](t) - \Lambda_-^{<\lambda_0}[\varphi_{\lambda_0}](t)\Vert_2 \cdot\Vert \varphi_{\lambda_0}(t) \Vert_2 }{\gamma_0} \\ \le & \left(\frac{\alpha_\ast^2 \breve{\xi}^2}{\gamma_0^2} + \left(\frac{4\breve{\eta}^2}{\gamma_0^2}(\frac{2\pi}{\lambda_0})^{\frac{n-1}{2}} + \frac{4K_V \breve{\eta}}{\gamma_0^2} + \frac{4\breve{\eta}}{\gamma_0}\right) (\frac{2\pi}{\lambda_0})^{\frac{n-1}{2}} + \frac{K_V}{\gamma_0}\right) \Vert \varphi_{\lambda_0}(t) \Vert_2^2 \\ \lesssim & (\frac{ \alpha_{\ast}\breve{\xi}^2}{\gamma_0^2} + \frac{ K_V}{\gamma_0}) \Vert \varphi_{\lambda_0}(t) \Vert_2^2 + \mathcal{O}(\lambda_0^{-\frac{n-1}{2}}). \end{split} \end{equation} In addition, since \begin{equation} \Vert \Theta_V^{\lambda_0}[\varphi_{\lambda_0}](t) \Vert_2 \le K_V \Vert \varphi_{\lambda_0}(t) \Vert_2 + C\lambda_0^{-\frac{n-1}{2}} \Vert \varphi_{\lambda_0}(t) \Vert_2, \end{equation} according to Lemma \ref{lemma.L2_estimate}, it yields that \begin{equation}\label{eq_L2_estimate_asymptotic} \Vert \varphi_{\lambda_0}(t) \Vert_2 \lesssim \mathbbm{e}^{K_V(T-t)} \Vert \varphi_T \Vert_2 + \mathcal{O}(\lambda_0^{-\frac{n-1}{2}}). \end{equation} Combining Eqs.~\eqref{eq_Bw_estimate_asymptotic}, \eqref{eq_C_estimate_asymptotic} and \eqref{eq_L2_estimate_asymptotic}, we have the following result \begin{equation}\label{eq.SPA_variation_inequality} \begin{split} \Vert \Delta \Phi_\mathrm{w}^{(2)}(t) \Vert_1 &\lesssim \mathbbm{e}^{-\gamma_0(T-t)} \Vert \varphi_T \Vert^2_2 - \Vert \varphi_{\lambda_0}(t) \Vert_2^2 +2 \int_t^T \D \mathcal{G}(t^{\prime}-t) \Vert C^{\lambda_0}(t^{\prime}) \Vert_1\\ &+ (1+\frac{2 \alpha_\ast \breve{\xi}^2}{\gamma_0^2}) \int_t^T \D \mathcal{G}(t^{\prime}-t) \left\{ \Vert \Delta \Phi_\mathrm{w}^{(2)}(t^{\prime}) \Vert_1 + \Vert \varphi_{\lambda_0}(t^{\prime}) \Vert_2 \right\} + \mathcal{O}(\lambda_0^{-\frac{n-1}{2}}). \end{split} \end{equation} Notice that by replacing $\breve{\xi}$ in Eqs.~\eqref{eq.variation_inequality} and \eqref{key_estimate_ut} by $\sqrt{\alpha_\ast} \breve{\xi}$, we can further obtain the following estimate for Eq.~\eqref{eq.SPA_variation_inequality}, \begin{equation}\label{eq.wp_spa_variation_L1_bound} \begin{split} \Vert \Delta \Phi_\mathrm{w}^{(2)}(t) \Vert_1 \lesssim &\left(\frac{K_V \gamma_0 + \alpha_\ast \breve{\xi}^2}{K_V \gamma_0 - \alpha_\ast \breve{\xi}^2} \mathbbm{e}^{2K_V(T-t)} - \frac{2\alpha_\ast \breve{\xi}^2}{K_V\gamma_0 -\alpha_\ast \breve{\xi}^2} \mathbbm{e}^{\frac{2\alpha_\ast \breve{\xi}^2}{\gamma_0}(T-t)}\right) \Vert \varphi_T\Vert_2^2 \\ &- \Vert \varphi_{\lambda_0}(t) \Vert_2^2 + \mathcal{O}(\lambda_0^{-\frac{n-1}{2}}). \end{split} \end{equation} Therefore, for the weighted particle model, it has that \begin{equation}\label{eq.bound_wp_spa_variation} \Vert \Delta \Phi_\mathrm{w}^{(2)}(t) \Vert_1 \lesssim (1+\frac{4\alpha_\ast \breve{\xi}^2}{\gamma_0}(T-t))\mathbbm{e}^{2\max(K_V, \frac{\alpha_ \ast \breve{\xi}^2}{\gamma_0}) (T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi_{\lambda_0}(t) \Vert_2^2 + \mathcal{O}(\lambda_0^{-\frac{n-1}{2}}). \end{equation} Similarly, we can obtain the estimate of the variance for the signed-particle model, \begin{equation} \Vert \Delta \Phi_\mathrm{s}^{(2)}(t) \Vert_1 \lesssim (1+(2K_V+ \frac{2 \alpha_\ast \breve{\xi}^2}{\gamma_0})(T-t))\mathbbm{e}^{2\alpha_\ast\breve{\xi}(T-t)} \Vert \varphi_T \Vert_2^2 - \Vert \varphi_{\lambda_0}(t) \Vert_2^2 + \mathcal{O}(\lambda_0^{-\frac{n-1}{2}}). \end{equation} When $\lambda_0$ is sufficiently large, we can throw way the remainder term $\mathcal{O}(\lambda_0^{-\frac{n-1}{2}})$ and arrive at Eqs.~\eqref{eq.wbrw_spa_wp_variance_estimate_1} and \eqref{eq.wbrw_spa_sp_variance_estimate_1}. \end{proof} As the last step, we complete the proof of Theorem \ref{SPA_thm.variance_estimate}. \begin{proof}[Proof of Theorem \ref{SPA_thm.variance_estimate}] Since \begin{equation*} \begin{split} \mathsf{\Pi}_Q^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi(\bm{x}, \bm{k}, t))^2 =& \mathsf{\Pi}_Q^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi_{\lambda_0}(\bm{x}, \bm{k}, t) + \varphi_{\lambda_0}(\bm{x}, \bm{k}, t) - \varphi(\bm{x}, \bm{k}, t))^2 \\ =& \mathsf{\Pi}_Q^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi_{\lambda_0}(\bm{x}, \bm{k}, t))^2 + (\varphi_{\lambda_0}(\bm{x}, \bm{k}, t) - \varphi(\bm{x}, \bm{k}, t))^2\\ &+ 2 \mathsf{\Pi}_Q^\mathrm{w}(\mathrm{Y}_t^\mathrm{w} - \varphi_{\lambda_0}(\bm{x}, \bm{k}, t)) \cdot (\varphi_{\lambda_0}(\bm{x}, \bm{k}, t) - \varphi(\bm{x}, \bm{k}, t)). \end{split} \end{equation*} By the {extended Minkowski's inequality and the Cauchy-Schwarz inequality}, it has that \begin{equation*} \label{eq.triangular_inequality} \begin{split} \Vert \mathsf{\Pi}_Q^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi(\bm{x}, \bm{k}, t))^2 \Vert_1 \le & \Vert \mathsf{\Pi}_Q^\mathrm{w} (\mathrm{Y}_t^\mathrm{w} - \varphi_{\lambda_0}(\bm{x}, \bm{k}, t))^2 \Vert_1 + \Vert \varphi_{\lambda_0}(t) - \varphi(t) \Vert_2^2\\ &+ 2 \Vert \mathsf{\Pi}_Q^\mathrm{w}(\mathrm{Y}_t^\mathrm{w} - \varphi_{\lambda_0}(t))\Vert_2 \cdot \Vert \varphi_{\lambda_0}(t) - \varphi(t))\Vert_2. \end{split} \end{equation*} The first term is bounded by Eq.~\eqref{eq.bound_wp_spa_variation}. The estimate $\Vert \varphi_{\lambda_0}(t) - \varphi(t) \Vert_2^2$ in the second term is given by Eq.~\eqref{spa_bias_estimate}. And the third term is zero due to Theorem \ref{thm_first_moment_wbrw_spa}. Thus it finalizes the proof of Eq.~\eqref{eq.wbrw_spa_wp_variance_estimate}. The proof of Eq.~\eqref{eq.wbrw_spa_sp_variance_estimate} is similar and omitted here for brevity. \end{proof} Theorem \ref{SPA_thm.variance_estimate} implies that the variance of the inner product problem can be reduced by chopping the $\bm{x}$-support and adopting the WBRW-SPA for the region in which the distance $|\bm{z}(\bm{x})|$ between two interacting bodies is sufficiently large (as stated in the assumption {\bf (A4)}). The price to pay is to introduce some asymptotic biases, which may be negligible when $\alpha_\ast$ is sufficiently small. In Section \ref{sec:num}, we will show that all the results in our theoretical analysis can be {verified} in numerical experiments. \section{Numerical validation} \label{sec:num} This section is devoted to the numerical validation of our theoretical results. The prototype model is the quantum system under the two-body interaction. Here we take the two-dimensional Morse potential as an example. \begin{equation}\label{morse} V(\bm{x}) = - 2\mathbbm{e}^{-\kappa(|\bm{x}-\bm{x}_A|- r_0)} + \mathbbm{e}^{-2\kappa(|\bm{x}-\bm{x}_A|- r_0)}. \end{equation} In this case, $\bm{z}(\bm{x}) = (z_1, z_2) = \bm{x} - \bm{x}_A$ and $\psi(\bm{k})$ reads that \begin{equation} \psi(\bm{k}) = \frac{1}{\mathbbm{i} \hbar} \left[ - \frac{2\kappa \mathbbm{e}^{\kappa r_0}c_2 }{(|\bm{k}|^2 + \kappa^2)^{3/2}} + \frac{2\kappa \mathbbm{e}^{2\kappa r_0}c_2}{(|\bm{k}|^2 + 4\kappa^2)^{3/2}} \right]. \end{equation} Thus the pseudo-differential operator is given by that \begin{equation}\label{pdo_2d_morse} \begin{split} \Theta_V[\varphi](\bm{x}, \bm{k}, t) = & - \frac{\kappa \mathbbm{e}^{\kappa r_0} c_2}{\hbar} \int_{0}^{2\pi} \D \vartheta \int_{0}^{+\infty} \D r~ \frac{r \sin(2\bm{z}(\bm{x}) \cdot \bm{k}^{\prime})}{\sqrt{r^2+(\kappa/2)^2}} \frac{\Delta_{r\sigma}[\varphi](\bm{x}, \bm{k}, t)}{r^2 + (\kappa/2)^2} \\ &+ \frac{\kappa \mathbbm{e}^{2\kappa r_0} c_2}{\hbar} \int_{0}^{2\pi} \D \vartheta \int_{0}^{+\infty} \D r~ \frac{r \sin(2\bm{z}(\bm{x}) \cdot \bm{k}^{\prime})}{\sqrt{r^2+\kappa^2}} \frac{\Delta_{r\sigma}[\varphi](\bm{x}, \bm{k}, t)}{r^2 + \kappa^2} , \end{split} \end{equation} where $\bm{k}^{\prime} = r\sigma = (r \cos \vartheta, r\sin \vartheta)$ and $c_2 = \Gamma(3/2)\pi^{-3/2} \approx 0.1592$. The stationary phase approximation to PDO reads \begin{equation} \begin{split} \Theta^{\lambda_0}_V[\varphi](\bm{x}, \bm{k}, t) = & \int_{B(\frac{\lambda_0}{|\bm{z}(\bm{x})|})} \mathbbm{e}^{\mathbbm{i} \bm{z}(\bm{x}) \cdot \bm{k}^{\prime}} \psi(\bm{k}^{\prime}) ( \varphi(\bm{x}, \bm{k} - \frac{\bm{k}^{\prime}}{2}, t) - \varphi(\bm{x}, \bm{k}+\frac{\bm{k}^{\prime}}{2}, t) ) \D \bm{k}^{\prime} \\ &+2\int_{\frac{\lambda_0}{|\bm{z}(\bm{x})|}}^{+\infty} \textup{Im}\left[\mathbbm{e}^{\mathbbm{i} r |\bm{z}(\bm{x})|} \left(\frac{2\pi}{\mathbbm{i} r |\bm{z}(\bm{x})|}\right)^{\frac{1}{2}}\right] r{\psi}(r\sigma_+) \Delta_{r\sigma_+} [\varphi](\bm{x}, \bm{k}, t) \D r, \end{split} \end{equation} where $\vartheta^+ =\textup{atan2}(z_2/z_1)$. The variances can be monitored within the implementation of the Monte Carlo algorithm in \cite{ShaoXiong2019}. Here we adopt the Gaussian wavepacket of the form \eqref{def.Gaussian_wave_packet} as the initial {condition:} \begin{equation}\label{def.Gaussian_wave_packet} f_0(x_1, x_2, k_1, k_2) = \frac{1}{\pi^2}\mathbbm{e}^{-0.5(x_1-8)^2 - 0.5(x_2-12)^2 - 2(k_1 - 0.5)^2 - 2(k_2 + 0.5)^2}. \end{equation} Other parameters are set as: $\bm{x}_A = (10, 10), r_0 = 0.5, \kappa = 0.5$, $\hbar = m = 1$, $T=2$. We simulate the $10^5$ independent family trees and measure the $L^2$-error \cite{XiongShao2019}, which is proportional to the variance. The numerical solutions obtained by the highly accurate deterministic scheme are adopted as the reference \cite{XiongChenShao2016}. \begin{figure}[!h] \centering \subfigure[Variance of WBRW-HJD.]{\includegraphics[width=0.64\textwidth,height=0.40\textwidth]{sp.pdf} \label{fig_a}}\\ \centering \subfigure[Variance of wp-SPA and sp-SPA.]{\includegraphics[width=0.64\textwidth,height=0.40\textwidth]{spa.pdf} \label{fig_b}} \\ \centering \subfigure[Variance of sp-SPA under different $\lambda_0$.]{\includegraphics[width=0.64\textwidth,height=0.40\textwidth]{lambda.pdf} \label{fig_c}} \caption{\small The variances are monitored in the Monte Carlo simulations. The exponential growth of variances is observed. The choice of $\gamma_0$ has a great influence on the variance of both the weighted-particle WBRW-HJD (wp-HJD) and WBRW-SPA (wp-SPA), while it has little influence on that of the signed-particle counterparts (sp-HJD, sp-SPA). The variances are clearly reduced when the stationary phase approximation is adopted, but the results are not very satisfactory when $\lambda_0$ is either too large or too small.} \label{fig:variance} \end{figure} Fig.~\ref{fig_a} makes a comparison between the weighted-particle WBRW-HJD (wp-HJD) and the signed-particle one (sp-HJD). The variance of the weighted-particle model can be reduced by choosing a larger $\gamma_0$, while this does not hold for the signed-particle counterpart. Fig.~\ref{fig_b} compares the WBRW-HJD and WBRW-SPA when $\lambda_0 = 8$. It's readily seen that the variances of both weighted-particle WBRW-SPA (wp-SPA) and the signed-particle counterpart (sp-SPA) are diminished when the stationary phase method is adopted, while the variance of the signed-particle model is still independent of the choice of $\gamma_0$. Finally, Fig.~\ref{fig_c} compares sp-SPA under different settings of $\lambda_0$. It is found that the reduction of variance might not be significant for too large $\lambda_0$ as $\alpha_\ast$ may be very close to 1, while the errors in the asymptotic expansion become dominated for too small $\lambda_0$. A reasonable choice of $\lambda_0$ (such as $\lambda_0 = 2$) can strike a balance between the bias and variance. All of these observations perfectly coincide with our main theoretical results. \section{Conclusion and discussion} \label{sec:con} In this paper, we have analyzed two classes of branching random walk (BRW) solutions to the Wigner (W) equation, including WBRW-HJD based on the Hahn-Jordan decomposition (HJD): $\Theta_V = \Theta^+_V - \Theta^-_V$, and WBRW-SPA based on the stationary phase approximation (SPA). The main idea is to split the nonlocal operator with anti-symmetric kernels into two parts and explain each of them as the generator of jump process of one branch of weighted particles. We have shown that although the first moment of WRBW-HJD recovers the solution of the Wigner equation, the $L^1$-bounds for the variances grows exponentially in time with the rate depending on the norm of $\Theta^\pm_V$, which is inconsistent with the decay rate of the pseudo-differential operator. By contrast, the WBRW-SPA is able to capture the essential contributions from the localized parts and the variance of the resulting stochastic model can be diminished, at the cost of introducing a little bias. These results are of great importance in applications, such as tackling a general form of nonlocal problems. In particular, it ameliorates the {numerical sign problem} in high dimensional {situation}, which may involves multiple pairs of potentials and high dimensional oscillatory integrals. Our ongoing work is to apply the WBRW-SPA to study the quantum dynamics under the Coulomb interaction, such as the Hydrogen atom. \section*{Acknowledgement} This research was supported by the National Natural Science Foundation of China (Nos.~11822102, 11421101) and High-performance Computing Platform of Peking University. SS is partially supported by Beijing Academy of Artificial Intelligence (BAAI). YX is partially supported by The Elite Program of Computational and Applied Mathematics for PhD Candidates in Peking University.

\section{Introduction} In many scientific problems, it is of interest to determine whether two particular functions are equal to each other. In many settings these functions are unknown and may be viewed as features of a data-generating mechanism from which observations can be collected. As such, these functions can be learned from available data, and estimates of these respective functions can then be compared. To reduce the risk of deriving misleading conclusions due to model misspecification, it is appealing to employ flexible statistical learning tools to estimate the unknown functions. Unfortunately, inference is usually extremely difficult when such techniques are used, because the resulting estimators tend to be highly irregular. In such cases, conventional techniques for constructing confidence intervals or computing p-values are generally invalid, and a more careful construction, as exemplified by the work presented in this article, is required. To formulate the problem statistically, suppose that $n$ independent observations $O_1,\ldots,O_n$ are drawn from a distribution $P_0$ known only to lie in the nonparametric statistical model, denoted by $\mathscr{M}$. Let $\mathscr{O}$ denote the support of $P_0$, and suppose that $P\mapsto R_P$ and $P\mapsto S_P$ are parameters mapping from $\mathscr{M}$ onto the space of univariate bounded real-valued measurable functions defined on $\mathscr{O}$, i.e. $R_P$ and $S_P$ are elements of the space of univariate bounded real-valued measurable functions defined on $\mathscr{O}$. For brevity, we will write $R_0\triangleq R_{P_0}$ and $S_0\triangleq S_{P_0}$. Our objective is to test the null hypothesis \[\mathscr{H}_0: R_0(O)\stackrel{d}{=}S_0(O)\] versus the complementary alternative $\mathscr{H}_1: \mbox{not }\mathscr{H}_0$, where $O$ follows the distribution $P_0$ and the symbol $\eqd$ denotes equality in distribution. We note that $R_0(O)\eqd S_0(O)$ if $R_0\equiv S_0$, i.e. $R_0(O)=S_0(O)$ almost surely, but not conversely. The case where $S_0\equiv 0$ is of particular interest since then the null simplifies to $\mathscr{H}_0 : R_0\equiv 0$. Because $P_0$ is unknown, $R_0$ and $S_0$ are not readily available. Nevertheless, the observed data can be used to estimate $P_0$ and hence each of $R_0$ and $S_0$. The approach we propose will apply to functionals within a specified class described later. Before presenting our general approach, we describe some motivating examples. Consider the data structure $O=(W,A,Y)\sim P$, where $W$ is a collection of covariates, $A$ is binary treatment indicator, and $Y$ is a bounded outcome, i.e., there exists a universal $c$ such that, for all $P\in\mathcal{M}$, $P(|Y|\le c) = 1$. Note that, in our examples, the condition that $Y$ is bounded cannot easily be relaxed, as the parameter from \cite{Grettonetal2006} on which we will base our testing procedure requires that the quantities under consideration have compact support. \begin{enumerate} \item[] \hspace{-.2in}\textbf{\hypertarget{ex:1}{Example 1}:} Testing a null conditional average treatment effect. If $R_P(o)\triangleq E_P\left(Y\mid A=1,W=w\right)-E_P\left(Y\mid A=0,W=w\right)$ and $S_P\equiv 0$, the null hypothesis corresponds to the absence of a conditional average treatment effect. This definition of $R_P$ corresponds to the so-called blip function introduced by \cite{Robins04}, which plays a critical role in defining optimal personalized treatment strategies \citep{Chakraborty&Moodie2013}. \item[] \hspace{-.2in}\textbf{\hypertarget{ex:2}{Example 2}:} Testing for equality in distribution of regression functions in two populations. Suppose the setting of the previous example, but where $A$ represents membership to population $0$ or $1$. If $R_P(o)\triangleq E_P\left(Y\mid A=1,W=w\right)$ and $S_P(o)\triangleq E_P\left(Y\mid A=0,W=w\right)$, the null hypothesis corresponds to the outcome having the conditional mean functions, applied to a random draw of the covariate, having the same distribution in these two populations. We note here that our formulation considers selection of individuals from either population as random rather than fixed so that population-specific sample sizes (as opposed to the total sample size) are themselves random. The same interpretation could also be used for the previous example, now testing if the two regression functions are equivalent. \item[] \hspace{-.2in}\textbf{\hypertarget{ex:3}{Example 3}:} Testing a null covariate effect on average response. Suppose now that the data unit only consists of $O\triangleq (W,Y)$. If $R_P(o)\triangleq E_P\left(Y\mid W=w\right)$ and $S_P\equiv 0$, the null hypothesis corresponds to the outcome $Y$ having conditional mean zero in all strata of covariates. This may be interesting when zero has a special importance for the outcome, such as when the outcome is the profit over some period. \item[] \hspace{-.2in}\textbf{\hypertarget{ex:4}{Example 4}:} Testing a null variable importance. Suppose again that $O\triangleq (W,Y)$ and $W\triangleq (W(1),W(2),\ldots,W(K))$. Denote by $W(-k)$ the vector $(W(i):1\leq i\leq K, i\neq k)$. Setting $R_P(o)\triangleq E_P\left(Y\mid W=w\right)$ and $S_P(o)\triangleq E_P\left(Y\mid W(-k)=w(-k)\right)$, the null hypothesis corresponds to $W(k)$ having null variable importance in the presence of $W(-k)$ with respect to the conditional mean of $Y$ given $W$ in the sense that $E_{P}\left(Y\mid W\right)=E_P\left(Y\mid W(-k)\right)$ almost surely. This is true because if $R_0(W)\eqd S_0(W(-k))$, the latter random variables have equal variance and so \begin{align*} E_{P_0}&\left\{Var_{P_0}\left[R_0(W)\mid W(-k)\right]\right\}\ \\ &=\ Var_{P_0}\left[R_0(W)\right]-Var_{P_0}\left\{E_{P_0}\left[R_0(W)\mid W(-k)\right]\right\}\\ &=\ Var_{P_0}\left[R_0(W)\right]-Var_{P_0}\left[S_0(W(-k))\right]\ =\ 0\ , \end{align*} implying that $Var_{P_0}\left[R_0(W)\mid W(-k)\right]=0$ almost surely. Thus, a test of $R_P(O)\eqd S_P(O)$ is equivalent to a test of almost sure equality between $R_P$ and $S_P$ in this example. We will show in \secref{sec:illustr} that our approach cannot be directly applied to this example, but that a simple extension yields a valid test. \end{enumerate} \cite{Grettonetal2006} investigated the related problem of testing equality between two distributions in a two-sample problem. They proposed estimating the maximum mean discrepancy (hereafter referred to as MMD), a non-negative numeric summary that equals zero if and only if the two distributions are equal. They also investigated related problems using this technique \citep[see, e.g.,][]{Grettonetal2009,Grettonetal2012,Sejdinovicetal2013}. In this work, we also utilize the MMD as a parsimonious summary of equality but consider the more general problem wherein the null hypothesis relies on unknown functions $R_0$ and $S_0$ indexed by the data-generating distribution $P_0$. Other investigators have proposed omnibus tests of hypotheses of the form $\mathscr{H}_0$ versus $\mathscr{H}_1$ in the literature. In the setting of \hyperlink{ex:1}{Example 1} above, the work presented in \cite{Racineetal2006} and \cite{Lavergneetal2015} is particularly relevant. The null hypothesis of interest in these papers consists of the equality $E_{P_0}\left(Y\mid A,W\right)=E_{P_0}\left(Y\mid W\right)$ holding almost surely. If individuals have a nontrivial probability of receiving treatment in all strata of covariates, this null hypothesis is equivalent to $\mathscr{H}_0$. In both these papers, kernel smoothing is used to estimate the required regression functions. Therefore, key smoothness assumptions are needed for their methods to yield valid conclusions. The method we present does not hinge on any particular class of estimators and therefore does not rely on this condition. To develop our approach, we use techniques from the higher-order pathwise differentiability literature \citep[see, e.g.,][]{Pfanzagl1985,RobinsetTchetgenvanderVaart08,vanderVaart2014,Caroneetal2014}. Despite the elegance of the theory presented by these various authors, it has been unclear whether these higher-order methods are truly useful in infinite-dimensional models since most functionals of interest fail to be even second-order pathwise differentiable in such models. This is especially troublesome in problems in which under the null the first-order derivative of the parameter of interest (in an appropriately defined sense) vanishes, since then there seems to be no theoretical basis for adjusting parameter estimates to recover parametric rate asymptotic behavior. At first glance, the MMD parameter seems to provide one such disappointing example, since its first-order derivative indeed vanishes under the null. The latter fact is a common feature of problems wherein the null value of the parameter is on the boundary of the parameter space. It is also not an entirely surprising phenomenon, at least heuristically, since the MMD achieves its minimum of zero under the null hypothesis. Nevertheless, we are able to show that this parameter is indeed second-order pathwise differentiable under the null hypothesis -- this is a rare finding in infinite-dimensional models. As such, we can employ techniques from the recent higher-order pathwise differentiability literature to tackle the problem at hand. To the best of our knowledge, this is the first instance in which these techniques are directly used (without any form of approximation) to resolve an open methodological problem. This paper is organized as follows. In \secref{sec:rep}, we formally present our parameter of interest, the squared MMD between two unknown functions, and establish asymptotic representations for this parameter based on its higher-order differentiability, which, as we formally establish, holds even when the MMD involves estimation of unknown nuisance parameters. In \secref{sec:est}, we discuss estimation of this parameter, discuss the corresponding hypothesis test and study its asymptotic behavior under the null. We study the consistency of our proposed test under fixed and local alternatives in \secref{sec:local}. We revisit our examples in \secref{sec:illustr} and provide an additional example in which we can still make progress using our techniques even though our regularity conditions fails. In \secref{sec:num}, we present results from a simulation study to illustrate the finite-sample performance of our test, and we end with concluding remark in \secref{sec:concl}. Appendix A reviews higher-order pathwise differentiability. Appendix B gives a summary of the empirical $U$-process results from \cite{Nolan&Pollard1988} that we build upon. All proofs can be found in Appendix C. \section{Properties of maximum mean discrepancy}\label{sec:rep} \subsection{Definition} For a distribution $P$ and mappings $T$ and $U$, we define \begin{align} \Phi^{TU}(P)\triangleq \iint e^{-\left[T_P(o_1)-U_P(o_2)\right]^2}dP(o_1)dP(o_2) \label{eq:Phidef} \end{align} and set $\Psi(P)\triangleq \Phi^{RR}(P) - 2\Phi^{RS}(P) + \Phi^{SS}(P)$. The MMD between the distributions of $R_P(O)$ and $S_P(O)$ when $O\sim P$ is given by $\sqrt{\Psi(P)}$ and is always well-defined because $\Psi(P)$ is non-negative. Indeed, denoting by $\psi_0$ the true parameter value $\Psi(P_0)$, Theorem 3 of \cite{Grettonetal2006} establishes that $\psi_0$ equals zero if $\mathscr{H}_0$ holds and is otherwise strictly positive. Though the study in \cite{Grettonetal2006} is restricted to two-sample problems, their proof of this result is only based upon properties of $\Psi$ and therefore holds regardless of the sample collected. Their proof relies on the fact that two random variables $X$ and $Y$ with compact support are equal in distribution if and only if $E[f(Y)]=E[f(X)]$ for every continuous function $f$, and uses techniques from the theory of Reproducing Kernel Hilbert Spaces \citep[see, e.g.,][for a general exposition]{Berlinet&ThomasAgnan2011}. We invite interested readers to consult \cite{Grettonetal2006} -- and, in particular, Theorem 3 therein -- for additional details. The definition of the MMD we utilize is based on the univariate Gaussian kernel with unit bandwidth, which is appropriate in view of \cite{Steinwart2002}. The results we present in this paper can be generalized to the MMD based on a Gaussian kernel of arbitrary bandwidth by simply rescaling the mappings $R$ and $S$. \subsection{First-order differentiability} To develop a test of $\mathscr{H}_0$, we will first construct an estimator $\psi_n$ of $\psi_0$. In order to avoid restrictive model assumptions, we wish to use flexible estimation techniques in estimating $P_0$ and therefore $\psi_0$. To control the operating characteristics of our test, it will be crucial to understand how to generate a parametric-rate estimator of $\psi_0$. For this purpose, it is informative to first investigate the pathwise differentiability of $\Psi$ as a parameter from $\mathscr{M}$ to $\mathbb{R}$. So far, we have not specified restrictions on the mappings $P\mapsto R_P$ and $P\mapsto S_P$. However, in our developments, we will require these mappings to satisfy certain regularity conditions. Specifically, we will restrict our attention to elements of the class $\mathscr{S}$ of all mappings $T$ for which there exists some measurable function $X^T$ defined on $\mathscr{O}$, e.g. $X^T(o)=X^T(w,a,y)=w$, such that \begin{enumerate}[label=(S\arabic*)] \item $T_P$ is a measurable mapping with domain $\{X^T(o) : o\in\mathscr{O} \}$ and range contained in $[-b,b]$ for some $0\leq b<\infty$ independent of $P$; \label{it:Sbdd} \item for all submodels $dP_t/dP= 1+th$ with bounded $h$ with $Ph=0$, there exists some $\delta>0$ and a set $\mathscr{O}_1\subseteq \mathscr{O}$ with $P_0(\mathscr{O}_1)=1$ such that, for all $(o,t_1)\in\mathscr{O}_1\times (-\delta,\delta)$, $t\mapsto T_{P_t}(x^T)$ is twice differentiable at $t_1$ with uniformly bounded (in $x^T$) first and second derivatives;\label{it:Sderivsbdd} \item for any $P\in\mathscr{M}$ and submodel $dP_t/dP= 1+th$ for bounded $h$ with $Ph=0$, there exists a function $D_P^T : \mathcal{O}\rightarrow\mathbb{R}$ uniformly bounded (in $P$ and $o$) such that $\int D_P^T(o)dP(o| x^T)=0$ for almost all $o\in\mathscr{O}$ and \[\left.\frac{d}{dt}T_{P_t}(x^T)\right|_{t=0}= \int D_P^T(o) h(o) dP(o|x^T)\ .\] \label{it:Spd}\end{enumerate} \condref{it:Sbdd} ensures that $T$ is bounded and only relies on a summary measure of an observation $O$. \condref{it:Sderivsbdd} ensures that we will be able to interchange differentiation and integration when needed. \condref{it:Spd} is a conditional (and weaker) version of pathwise differentiability in that the typical inner product representation only needs to hold for the conditional distribution of $O$ given $X^T$ under $P_0$. We will verify in \secref{sec:illustr} that these conditions hold in the context of the motivating examples presented earlier. \begin{remark} \label{rem:restrictiveconds} As a caution to the reader, we warn that simultaneously satisfying \ref{it:Sbdd} and \ref{it:Spd} may at times be restrictive. For example, if the observed data unit is $O\triangleq (W(1),W(2),Y)$, the parameter \[T_P(o)\triangleq E_P\left[Y\mid W(1)=w(1),W(2)=w(2)\right]-E_P\left[Y\mid W(1)=w(1)\right]\] cannot generally satisfy both conditions. In Section 5, we discuss this example further and provide a means to tackle this problem using the techniques we have developed. In concluding remarks, we discuss a weakening of our conditions, notably by replacing $\mathscr{S}$ by the linear span of elements in $\mathscr{S}$. Consideration of this larger class significantly complicates the form of the estimator we propose in \secref{sec:est}.\qed \end{remark} We are now in a position to discuss the pathwise differentiability of $\Psi$. For any elements $T,U\in\mathscr{S}$, we define \begin{align*} \Gamma_P^{TU}(o_1,o_2)\triangleq& \bigg[2\left[T_P(o_1)-U_P(o_2)\right]\left[D_P^U(o_2) -D_P^T(o_1)\right] + 1 \\ &- \left\{4\left[T_P(o_1)-U_P(o_2)\right]^2-2\right\}D_P^T(o_1)D_P^U(o_2)\bigg]e^{-[T_P(o_1)-U_P(o_2)]^2}\ . \end{align*} and set $\Gamma_P\triangleq \Gamma_P^{RR} - \Gamma_P^{RS} - \Gamma_P^{SR} + \Gamma_P^{SS}$. Note that $\Gamma_P$ is symmetric for any $P\in\mathscr{M}$. For brevity, we will write $\Gamma_0^{TU}$ and $\Gamma_0$ to denote $\Gamma_{P_0}^{TU}$ and $\Gamma_{P_0}$, respectively. The following theorem characterizes the first-order behavior of $\Psi$ at an arbitrary $P\in\mathscr{M}$. \begin{theorem}[First-order pathwise differentiability of $\Psi$ over $\mathscr{M}$] \label{thm:pd1} If $R,S\in\mathscr{S}$, the parameter $\Psi:\mathscr{M}\rightarrow \mathbb{R}$ is pathwise differentiable at $P\in\mathscr{M}$ with first-order canonical gradient given by $D_1^{\Psi}(P)(o)\triangleq 2\left[\int \Gamma_P(o,o_2)dP(o_2)-\Psi(P)\right]$. \end{theorem} Under some conditions, it is straightforward to construct an asymptotically linear estimator of $\psi_0$ with influence function $D_1^\Psi(P_0)$, that is, an estimator $\psi_n$ of $\psi_0$ such that \begin{align*} \psi_n-\psi_0&= \frac{1}{n}\sum_{i=1}^n D_{1}^{\Psi}(P_0)(O_i) + o_{P_0}(n^{-1/2})\ . \end{align*} For example, the one-step Newton-Raphson bias correction procedure \citep[see, e.g.,][]{Pfanzagl1982} or targeted minimum loss-based estimation \citep[see, e.g.,][]{vanderLaan&Rose11} can be used for this purpose. If the above representation holds and the variance of $D_1^{\Psi}(P_0)(O)$ is positive, then $\sqrt{n}\left(\psi_n-\psi_0\right)\rightsquigarrow N(0,\sigma_0^2)$, where the symbol $\rightsquigarrow$ denotes convergence in distribution and we write $\sigma_0^2\triangleq P_0\left[D_1^{\Psi}(P_0)^2\right]$. If $\sigma_0$ is strictly positive and can be consistently estimated, Wald-type confidence intervals for $\psi_0$ with appropriate asymptotic coverage can be constructed. The situation is more challenging if $\sigma_0=0$. In this case, $\sqrt{n}\left(\psi_n-\psi_0\right)\rightarrow 0$ in probability and typical Wald-type confidence intervals will not be appropriate. Because $D_1^{\Psi}(P_0)(O)$ has mean zero under $P_0$, this happens if and only if $D_1^{\Psi}(P_0)\equiv 0$. The following lemma provides necessary and sufficient conditions under which $\sigma_0=0$. \begin{corollary}[First-order degeneracy under $\mathscr{H}_0$] \label{cor:D1degen} If $R,S\in\mathscr{S}$, it will be the case that $\sigma_0=0$ if and only if either \hypertarget{it:condH0}{(i)} $\mathscr{H}_0$ holds, or \hypertarget{it:conddegen}{(ii)} $R_0(O)$ and $S_0(O)$ are degenerate, i.e. almost surely constant but not necessarily equal, with $D_0^R\equiv D_0^S$. \end{corollary} The above results rely in part on knowledge of $D_0^R$ and $D_0^S$. It is useful to note that, in some situations, the computation of $D_P^T(o)$ for a given $T\in\mathscr{S}$ and $P\in\mathscr{M}$ can be streamlined. This is the case, for example, if $P\mapsto T_P$ is invariant to fluctuations of the marginal distribution of $X^T$, as it seems \ref{it:Spd} may suggest. Consider obtaining iid samples of increasing size from the conditional distribution of $O$ given $X^T=x^T$ under $P$, so that all individuals have observed $X^T=x^T$. Consider the fluctuation submodel $dP_t(o|x^T)\triangleq \left[1 + th(o)\right]dP(o|x^T)$ for the conditional distribution, where $h$ is uniformly bounded and $\int h(o)dP(o|x^T)=0$. Suppose that (i) $P\mapsto T_P(x^T)$ is differentiable at $t=0$ with respect to the above submodel and (ii) this derivative satisfies the inner product representation \begin{align*} \left.\frac{d}{dt}T_{P_t}(x^T)\right|_{t=0}&= \int \tilde{D}_P^T(o|x^T)h(o)dP(o|x^T) \end{align*} for some uniformly bounded function $o\mapsto \tilde{D}_P^T(o|x^T)$ with $\int \tilde{D}_P^T(o|x^T)dP(o|x^T)=0$. If the above holds for all $x^T$, we may take $D_P^T(o)=\tilde{D}_P^T(o|x^T)$ for all $o$ with $X^T(o)=x^T$. If $D_P^T$ is uniformly bounded in $P$, \ref{it:Spd} then holds. In summary, the above discussion suggests that, if $T$ is invariant to fluctuations of the marginal distribution of $X^T$, \ref{it:Spd} can be expected to hold if there exists a regular, asymptotically linear estimator of each $T_P(x^T)$ under iid sampling from the conditional distribution of $O$ given $X^T=x^T$ implied by $P$. \begin{remark} If $T$ is invariant to fluctuations of the marginal distribution of $X^T$, one can also expect \ref{it:Spd} to hold if $P\mapsto \int T_P(X^T(o))dP(o)$ is pathwise differentiable with canonical gradient uniformly bounded in $P$ and $o$ in the model in which the marginal distribution of $X$ is known. The canonical gradient in this model is equal to $D_P^T$.\qed \end{remark} \subsection{Second-order differentiability and asymptotic representation}\label{sec:2ndorder} As indicated above, if $\sigma_0=0$, the behavior of $\Psi$ around $P_0$ cannot be adequately characterized by a first-order analysis. For this reason, we must investigate whether $\Psi$ is second-order differentiable. As we discuss below, under $\mathscr{H}_0$, $\Psi$ is indeed second-order pathwise differentiable at $P_0$ and admits a useful second-order asymptotic representation. \begin{theorem}[Second-order pathwise differentiability under $\mathscr{H}_0$] \label{thm:pd2} If $R,S\in\mathscr{S}$ and $\mathscr{H}_0$ holds, the parameter $\Psi:\mathscr{M}\rightarrow\mathbb{R}$ is second-order pathwise differentiable at $P_0$ with second-order canonical gradient $D_2^{\Psi}(P_0)\triangleq 2\Gamma_0$. \end{theorem} It is easy to confirm that $\Gamma_0$, and thus $D_2^{\Psi}$, is one-degenerate under $\mathscr{H}_0$ in the sense that $\int \Gamma_0(o,o_2)dP_0(o_2)=\int \Gamma_0(o_1,o)dP_0(o_1)=0$ for all $o$. This is shown as follows. For any $T,U\in\mathscr{S}$, the law of total expectation conditional on $X^U$ and fact that $\int D_0^U(o)dP_0(o|x^U)=0$ yields that \begin{align*} \int &\Gamma_0^{TU}(o,o_2)dP_0(o_2) \\ &= \int \left\{1-2\left[T_0(o)-U_0(o_2)\right]D_0^T(o)\right\}e^{-\left[T_0(o)-U_0(o_2)\right]^2}dP_0(o_2), \end{align*} where we have written $\Gamma_0^{TU}$ to denote $\Gamma_{P_0}^{TU}$. Since $\int f(R_0(o))dP_0(o)=\int f(S_0(o))dP_0(o)$ for each measurable function $f$ when $S_0(O)\eqd T_0(O)$, this then implies that $\int \Gamma_0^{RS}(o,o_2)dP_0(o_2)=\int \Gamma_0^{RR}(o,o_2)dP(o_2)$ and $\int \Gamma_0^{SR}(o,o_2)dP_0(o_2)=\int \Gamma_0^{SS}(o,o_2)dP_0(o_2)$ under $\mathscr{H}_0$. Hence, it follows that $\int \Gamma_0(o,o_2)dP_0(o_2)=0$ under $\mathscr{H}_0$ for any $o$. If second-order pathwise differentiability held in a sufficiently uniform sense over $\mathscr{M}$, we would expect \begin{align} \operatorname{Rem}_P^\Psi\ \triangleq \ \Psi(P)-\Psi(P_0)-(P-P_0)D_1^\Psi(P)+\frac{1}{2}(P-P_0)^2D_2^\Psi(P) \label{rem} \end{align} to be a third-order remainder term. However, second-order pathwise differentiability has only been established under the null, and in fact, it appears that $\Psi$ may not generally be second-order pathwise differentiable under the alternative. As such, $D_2^\Psi$ may not even be defined under the alternative. In writing \eqref{rem}, we either naively set $D_2^\Psi(P)\triangleq 2\Gamma_P$, which is not appropriately centered to be a candidate second-order gradient, or instead take $D_2^\Psi$ to be the centered extension \begin{align*} (o_1,o_2)\mapsto 2\left[\Gamma_P(o_1,o_2)-\int \Gamma_P(o_1,o)dP(o)-\int \Gamma_P(o,o_2)dP(o)+P^2\Gamma_P\right]. \end{align*} Both of these choices yield the same expression above because the product measure $(P-P_0)^2$ is self-centering. The need for an extension renders it a priori unclear whether as $P$ tends to $P_0$ the behavior of $\operatorname{Rem}_P^\Psi$ is similar to what is expected under more global second-order pathwise differentiability. Using the fact that $\Psi(P)=P^2\Gamma_P$, we can simplify the expression in \eqref{rem} to \begin{equation}\operatorname{Rem}_P^\Psi\ =\ P_0^2\Gamma_P-\psi_0\ . \label{simpleremainder} \end{equation} As we discuss below, this remainder term can be bounded in a useful manner, which allows us to determine that it is indeed third-order. For all $T\in\mathscr{S}$, $P\in\mathscr{M}$ and $o\in\mathscr{O}$, we define \begin{align*} \operatorname{Rem}_P^T(o)\ \triangleq \ T_P(o)-T_0(o) + \int D_P^T(o_1)\left[dP(o_1|x^T)-dP_0(o_1|x^T)\right] \end{align*} as the remainder from the linearization of $T$ based on the conditional gradient $D_P^T$. Typically, $\operatorname{Rem}_P^T(o)$ is a second-order term. Further consideration of this term in the context of our motivating examples is described in \secref{sec:illustr}. Furthermore, we define \begin{align*} L_P^{RS}(o)\ &\triangleq \ \max\left\{|\operatorname{Rem}_P^R(o)|,|\operatorname{Rem}_P^S(o)|\right\} \\ M_P^{RS}(o)\ &\triangleq \ \max\left\{|R_P(o)-R_0(o)|,|S_P(o)-S_0(o)|\right\} . \end{align*} For any given function $f : \mathcal{O}\rightarrow\mathbb{R}$, we denote by $\norm{f}_{p,P_0}\triangleq \left[\int |f(o)|^pdP_0(o)\right]^{1/p}$ the $L^p(P_0)$-norm and use the symbol $\lesssim$ to denote `less than or equal to up to a positive multiplicative constant'. The following theorem provides an upper bound for the remainder term of interest. \begin{theorem}[Upper bounds on remainder term] \label{thm:remthirdorder} For each $P\in\mathscr{M}$, the remainder term admits the following upper bounds: \begin{align*} \mbox{Under }\mathscr{H}_0:\ \ &|\operatorname{Rem}_P^{\Psi}|\ \lesssim\ K_{0P}\triangleq \twonorm{L_P^{RS}} \twonorm{M_P^{RS}} + \onenorm{L_P^{RS}}^2 + \fournorm{M_P^{RS}}^4\\ \mbox{Under }\mathscr{H}_1:\ \ &|\operatorname{Rem}_P^{\Psi}|\ \lesssim\ K_{1P}\triangleq \onenorm{L_P^{RS}} + \twonorm{M_P^{RS}}^2\ . \end{align*} \end{theorem} To develop a test procedure, we will require an estimator of $P_0$, which will play the role of $P$ in the above expressions. It is helpful to think of parametric model theory when interpreting the above result, with the understanding that certain smoothing methods, such as higher-order kernel smoothing, can achieve near-parametric rates in certain settings. In a parametric model, we could often expect $\norm{L_P^{RS}}_{p,P_0}$ and $\norm{M_P^{RS}}_{p,P_0}$ to be $O_{P_0}(n^{-1})$ and $O_{P_0}(n^{-1/2})$, respectively, for $p\ge 1$. Thus, the above theorem suggests that the approximation error may be $O_P(n^{-3/2})$ in a parametric model under $\mathscr{H}_0$. In some examples, it is reasonable to expect that $L_P^{RS}\equiv 0$ for a large class of distributions $P$. In such cases, the upper bound on $\operatorname{Rem}_P^{\Psi}$ simplifies to $\fournorm{M_P^{RS}}^4$ under $\mathscr{H}_0$, which under a parametric model is often $O_{P_0}(n^{-2})$. \section{Proposed test: formulation and inference under the null} \label{sec:est} \subsection{Formulation of test} We begin by constructing an estimator of $\psi_0$ from which a test can then be devised. Using the fact that $\Psi(P)=P^2\Gamma_P$, as implied by \eqref{simpleremainder}, we note that if $\Gamma_0$ were known, the U-statistic $\mathbb{U}_n\Gamma_0$ would be a natural estimator of $\psi_0$, where $\mathbb{U}_n$ denotes the empirical measure that places equal probability mass on each of the $n(n-1)$ points $(O_i,O_j)$ with $i\neq j$. In practice, $\Gamma_0$ is unknown and must be estimated. This leads to the estimator $\psi_n\triangleq \mathbb{U}_n\Gamma_n$, where we write $\Gamma_n\triangleq \Gamma_{\hat{P}_n}$ for some estimator $\hat{P}_n$ of $P_0$ based on the available data. Since a large value of $\psi_n$ is inconsistent with $\mathscr{H}_0$, we will reject $\mathscr{H}_0$ if and only if $\psi_n>c_n$ for some appropriately chosen cutoff $c_n$. In the nonparametric model considered, it may be necessary, or at the very least desirable, to utilize a data-adaptive estimator $\hat{P}_n$ of $P_0$ when constructing $\Gamma_n$. Studying the large-sample properties of $\psi_n$ may then seem particularly daunting since at first glance we may be led to believe that the behavior of $\psi_n-\psi_0$ is dominated by $P_0^2\left(\Gamma_n-\Gamma_0\right)$. However, this is not the case. As we will see, under some conditions, $\psi_n-\psi_0$ will approximately behave like $\left(\mathbb{U}_n-P_0^2\right)\Gamma_0$. Thus, there will be no contribution of $\hat{P}_n$ to the asymptotic behavior of $\psi_n-\psi_0$. Though this result may seem counterintuitive, it arises because $\Psi(P)$ can be expressed as $P^2\Gamma_P$ with $\Gamma_P$ a second-order gradient (or rather an extension thereof) up to a proportionality constant. More concretely, this surprising finding is a direct consequence of \eqref{simpleremainder}. As further support that $\psi_n$ is a natural test statistic, even when a data-adaptive estimator $\hat{P}_n$ of $P_0$ has been used, we note that $\psi_n$ could also have been derived using a second-order one-step Newton-Raphson construction, as described in \cite{RobinsetTchetgenvanderVaart08}. The latter is given by \[\psi_{n,NR}\triangleq \Psi(\hat{P}_n)+P_nD^\Psi_1(\hat{P}_n)+\frac{1}{2}\mathbb{U}_nD^\Psi_2(\hat{P}_n)\ ,\] where we use the centered extension of $D_2^\Psi$ as discussed in \secref{sec:2ndorder}. Here and throughout, $P_n$ denotes the empirical distribution. It is straightforward to verify that indeed $\psi_{n}=\psi_{n,NR}$. \subsection{Inference under the null} \label{sec:typeIctrl} \subsubsection{Asymptotic behavior} For each $P\in\mathscr{M}$, we let $\tilde{\Gamma}_P$ be the $P_0$-centered modification of $\Gamma_P$ given by \begin{align*} \tilde{\Gamma}_P(o_1,o_2)\triangleq \Gamma_P(o_1,o_2) - \int \Gamma_P(o_1,o)dP_0(o) - \int \Gamma_P(o,o_2)dP_0(o) + P_0^2 \Gamma_P \end{align*} and denote $\tilde{\Gamma}_{P_0}$ by $\tilde{\Gamma}_0$. While $\tilde{\Gamma}_0=\Gamma_0$ under $\mathscr{H}_0$, this is not true more generally. Below, we use $\operatorname{Rem}_n^{\Psi}$ and $\tilde{\Gamma}_n$ to respectively denote $\operatorname{Rem}_P^{\Psi}$ and $\tilde{\Gamma}_P$ evaluated at $P=\hat{P}_n$. Straightforward algebraic manipulations allows us to write \begin{align} \psi_n-\psi_0\ &=\ \mathbb{U}_n\Gamma_n-\psi_0\ =\ \mathbb{U}_n\Gamma_n-P_0^2\Gamma_n+P_0^2\Gamma_n-\psi_0 \nonumber\\ &=\ \left(\mathbb{U}_n-P_0^2\right)\Gamma_n + \operatorname{Rem}_n^{\Psi} \nonumber \\ &=\ \mathbb{U}_n \Gamma_0 + 2\left(P_n-P_0\right)P_0 \Gamma_n + \mathbb{U}_n\left(\tilde{\Gamma}_n-\Gamma_0\right) + \operatorname{Rem}_n^{\Psi}\ . \label{eq:nullexpansion} \end{align} Our objective is to show that $n\left(\psi_n-\psi_0\right)$ behaves like $n\mathbb{U}_n \Gamma_0$ as $n$ gets large under $\mathscr{H}_0$. In view of \eqref{eq:nullexpansion}, this will be true, for example, under conditions ensuring that \begin{enumerate}[label=C\arabic*)] \item $n(P_n-P_0)P_0 \Gamma_n=o_{P_0}(1)$\ \ (empirical process and consistency conditions); \label{it:1ordempproc} \item $n\mathbb{U}_n \left(\tilde{\Gamma}_n-\Gamma_0\right)=o_{P_0}(1)$\ \ ($U$-process and consistency conditions); \label{it:2ordempproc} \item $n\operatorname{Rem}_n^{\Psi}=o_{P_0}(1)$\ \ (consistency and rate conditions). \label{it:remnegl} \end{enumerate} We have already argued that \ref{it:remnegl} is reasonable in many examples of interest, including those presented in this paper. \cite{Nolan&Pollard1987,Nolan&Pollard1988} developed a formal theory that controls terms of the type appearing in \ref{it:2ordempproc}. In Appendix B.1 we restate specific results from these authors which are useful to study \ref{it:2ordempproc}. Finally, the following lemma gives sufficient conditions under which \ref{it:1ordempproc} holds. We first set $K_{1n}\triangleq \onenorm{L_{\hat{P}_n}^{RS}} + \twonorm{M_{\hat{P}_n}^{RS}}^2$. \begin{lemma}[Sufficient conditions for \ref{it:1ordempproc}] \label{lem:firstordnegl} Suppose that $o_1\mapsto \int \Gamma_n(o_1,o)dP_0(o)/K_{1n}$, defined to be zero if $K_{1n}=0$, belongs to a $P_0$-Donsker class \citep{vanderVaartWellner1996} with probability tending to $1$. Then, under $\mathscr{H}_0$, \[ (P_n-P_0)P_0 \Gamma_n= O_{P_0}\left(\frac{K_{1n}}{\sqrt{n}}\right) \] and thus \ref{it:1ordempproc} holds whenever $K_{1n}=o_{P_0}(n^{-1/2})$. \end{lemma} The following theorem describes the asymptotic distribution of $n\psi_n$ under the null hypothesis whenever conditions \ref{it:1ordempproc}, \ref{it:2ordempproc} and \ref{it:remnegl} are satisfied. \begin{theorem}[Asymptotic distribution under $\mathscr{H}_0$] \label{thm:asympt} Suppose that \ref{it:1ordempproc}, \ref{it:2ordempproc} and \ref{it:remnegl} hold. Then, under $\mathscr{H}_0$, \[ n\psi_n= n \mathbb{U}_n \Gamma_0 + o_{P_0}(1)\rightsquigarrow \sum_{k=1}^\infty \lambda_k \left(Z_k^2-1\right) , \] where $\{\lambda_k\}_{k=1}^{\infty}$ are the eigenvalues of the integral operator $h(o)\mapsto \int \Gamma_0(o_1,o)h(o)dP_0(o_1)$ repeated according to their multiplicity, and $\{Z_k\}_{k=1}^\infty$ is a sequence of independent standard normal random variables. Furthermore, all of these eigenvalues are nonnegative under $\mathscr{H}_0$. \end{theorem} We note that by employing a sample splitting procedure -- namely, estimating $\Gamma_0$ on one portion of the sample and constructing the $U$-statistic based on the remainder of the sample -- it is possible to eliminate the $U$-process conditions required for \ref{it:2ordempproc}. In such a case, satisfaction of \ref{it:2ordempproc} only requires convergence of $\tilde{\Gamma}_n$ to $\Gamma_0$ with respect to the $L^2(P_0^2)$-norm. \begin{remark}In \hyperlink{ex:3}{Example 3}, sample splitting may prove particularly important when the estimator of $E_{P_0}\left(Y\mid W=w\right)$ is chosen as the minimizer of an empirical risk since in finite samples the bias induced by using the same residuals $y-E_{\hat{P}_n}\left(Y\mid W=w\right)$ as those in the definition of $D_{\hat{P}_n}^R(o)$ may be significant. Thus, without some form of sample splitting, the finite sample performance of $\psi_n$ may be poor even under the conditions stated in Appendix B.1.\qed \end{remark} \subsubsection{Estimation of the test cutoff} \label{sec:estcutoff} As indicated above, our test consists of rejecting $\mathscr{H}_0$ if and only if $\psi_n$ is larger than some cutoff $c_n$. We wish to select $c_n$ to yield a non-conservative test at level $\alpha\in(0,1)$. In view of \autoref{thm:asympt}, denoting by $q_{1-\alpha}$ the $1-\alpha$ quantile of the described limit distribution, the cutoff $c_n$ should be chosen to be $q_{1-\alpha}/n$. We thus reject $\mathscr{H}_0$ if and only if $n\psi_n>q_{1-\alpha}$. As described in the following corollary, $q_{1-\alpha}$ admits a very simple form when $S_P\equiv 0$ for all $P$. \begin{corollary}[Asymptotic distribution under $\mathscr{H}_0$, $S$ degenerate] \label{cor:Seq0} Suppose that \ref{it:1ordempproc}, \ref{it:2ordempproc} and \ref{it:remnegl} hold, that $S_P\equiv 0$ for all $P\in\mathscr{M}$, and that $\sigma_R^2\triangleq Var_{P_0}\left[D_0^R(O)\right]>0$. Then, under $\mathscr{H}_0$, \[ \frac{n\psi_n}{2\sigma_R^2}\rightsquigarrow Z^2-1, \] where $Z$ is a standard normal random variable. It follows then that $q_{1-\alpha}=2\sigma_R^2 (z^2_{1-\alpha/2}-1)$, where $z_{1-\alpha/2}$ is the $(1-\alpha/2)$ quantile of the standard normal distribution. \end{corollary} The above corollary gives an expression for $q_{1-\alpha}$ that can easily be consistently estimated from the data. In particular, one can use $\hat{q}_{1-\alpha}\triangleq 2(z_{1-\alpha/2}^2-1) P_n D^R(\hat{P}_n)^2$ as an estimator of $q_{1-\alpha}$, whose consistency can be established under a Glivenko-Cantelli and consistency condition on the estimator of $D_0^R$. However, in general, such a simple expression will not exist. \cite{Grettonetal2009} proposed estimating the eigenvalues $\nu_k$ of the centered Gram matrix and then computing $\hat{\lambda}_k\triangleq \nu_k/n$. In our context, the eigenvalues $\nu_k$ are those of the $n\times n$ matrix $G\triangleq \{G_{ij}\}_{1\leq i,j\leq n}$ with entries defined as \begin{equation} G_{ij}\ \triangleq \ \Gamma_n(O_i,O_j) - \frac{1}{n}\sum_{k=1}^{n}\Gamma_n(O_k,O_j) - \frac{1}{n}\sum_{\ell=1}^{n}\Gamma_n(O_i,O_\ell) + \frac{1}{n^2}\sum_{k=1}^{n}\sum_{\ell=1}^{n}\Gamma_n(O_k,O_\ell)\ . \label{eq:gram} \end{equation} Given these $n$ eigenvalue estimates $\hat{\lambda}_{1},...,\hat{\lambda}_n$, one could then simulate from $\sum_{k=1}^n \hat{\lambda}_k (Z_k^2-1)$ to approximate $\sum_{k=1}^\infty \lambda_k (Z_k^2-1)$. While this seems to be a plausible approach, a formal study establishing regularity conditions under which this procedure is valid is beyond the scope of this paper. We note that it also does not fall within the scope of results in \cite{Grettonetal2009} since their kernel does not depend on estimated nuisance parameters. We refer the reader to \cite{Franz2006} for possible sufficient conditions under which this approach may be valid. In practice, it suffices to give a data-dependent asymptotic upper bound on $q_{1-\alpha}$. We will refer to $\hat{q}_{1-\alpha}^{ub}$, which depends on $P_n$, as an asymptotic upper bound of $q_{1-\alpha}$ if \begin{align} \limsup_{n\rightarrow\infty} P_0^n\left(n\psi_n>\hat{q}_{1-\alpha}^{ub}\right)\ \le\ 1-\alpha\ .\label{eq:cutoffub} \end{align} If $q_{1-\alpha}$ is consistently estimated, one possible choice of $\hat{q}_{1-\alpha}^{ub}$ is this estimate of $q_{1-\alpha}$ -- the inequality above would also become an equality provided the conclusion of \autoref{thm:asympt} holds. It is easy to derive a data-dependent upper bound with this property using Chebyshev's inequality. To do so, we first note that \begin{align*} Var_{P_0}\left[\sum_{k=1}^\infty \lambda_k \left(Z_k^2-1\right)\right]\ =\ \sum_{k=1}^\infty \lambda_k^2 Var_{P_0}\left(Z_k^2\right)\ =\ 2\sum_{k=1}^\infty \lambda_k^2\ =\ 2P_0^2\Gamma_0^2\ , \end{align*} where we have interchanged the variance operation and the limit using the $L^2$ martingale convergence theorem and the last equality holds because $\lambda_k$, $k=1,2,\ldots$, are the eigenvalues of the Hilbert-Schmidt integral operator with kernel $\tilde{\Gamma}_0$. Under mild regularity conditions, $P_0^2\Gamma_0^2$ can be consistently estimated using $\mathbb{U}_n \Gamma_n^2$. Provided $P_0^2\Gamma_0^2>0$, we find that \begin{align} \left(2\mathbb{U}_n\Gamma_n^2\right)^{-1/2}n\psi_n\rightsquigarrow \left(2P_0^2 \Gamma_0^2\right)^{-1/2}\sum_{k=1}^\infty \lambda_k \left(Z_k^2-1\right)\ , \label{eq:var1} \end{align} where the limit variate has mean zero and unit variance. The following theorem gives a valid choice of $\hat{q}_{0.95}^{ub}$. \begin{theorem} Suppose that \ref{it:1ordempproc}, \ref{it:2ordempproc} and \ref{it:remnegl} hold. Then, under $\mathscr{H}_0$ and provided $\mathbb{U}_n \Gamma_n^2\rightarrow P_0^2 \Gamma_0^2>0$ in probability, $\hat{q}_{0.95}^{ub}\triangleq 6.2\cdot \left(\mathbb{U}_n \Gamma_n^2\right)^{1/2}>q_{0.95}$ is a valid upper bound in the sense of \eqref{eq:cutoffub}.\end{theorem} The proof of the result follows immediately by noting that $P(X>t)\leq (1+t^2)^{-1}$ for any random variable $X$ with mean zero and unit variance in view of the one-sided Chebyshev's inequality. This illustrates concretely that we can obtain a consistent test that controls type I error. In practice, we recommend either using the result of \autoref{cor:Seq0} whenever possible or estimating the eigenvalues of the matrix in (\ref{eq:gram}). We note that the condition $\sigma_R^2>0$ holds in many but not all examples of interest. Fortunately, the plausibility of this assumption can be evaluated analytically. In \secref{sec:illustr}, we show that this condition does not hold in \hyperlink{ex:4}{Example 4} and provide a way forward despite this. \section{Asymptotic behavior under the alternative} \label{sec:local} \subsection{Consistency under a fixed alternative} \label{sec:testconsistent} We present two analyses of the asymptotic behavior of our test under a fixed alternative. The first relies on $\hat{P}_n$ providing a good estimate of $P_0$. Under this condition, we give an interpretable limit distribution that provides insight into the behavior of our estimator under the alternative. As we show, surprisingly, $\hat{P}_n$ need not be close to $P_0$ to obtain an asymptotically consistent test, even if the resulting estimate of $\psi_0$ is nowhere near the truth. In the second analysis, we give more general conditions under which our test will be consistent if $\mathscr{H}_1$ holds. \subsubsection{Nuisance functions have been estimated well} As we now establish, our test has power against all alternatives $P_0$ except for the fringe cases discussed in \autoref{cor:D1degen} with $\Gamma_0$ one-degenerate. We first note that \[\psi_n-\psi_0\ =\ \mathbb{U}_n \Gamma_n-\psi_0\ =\ 2(P_n-P_0) P_0 \Gamma_n+ \mathbb{U}_n \tilde{\Gamma}_n+ \operatorname{Rem}_P^\Psi \ .\] When scaled by $\sqrt{n}$, the leading term on the right-hand side follows a mean zero normal distribution under regularity conditions. The second summand is typically $O_{P_0}(n^{-1})$ under certain conditions, for example, on the entropy of the class of plausible realizations of the random function $(o_1,o_2)\mapsto \Gamma_n(o_1,o_2)$ \citep{Nolan&Pollard1987,Nolan&Pollard1988}. In view of the second statement in \autoref{thm:remthirdorder}, the third summand is a second-order term that will often be negligible, even after scaling by $\sqrt{n}$. As such, under certain regularity conditions, the leading term in the representation above determines the asymptotic behavior of $\psi_n$, as described in the following theorem. \begin{theorem}[Asymptotic distribution under $\mathscr{H}_1$] \label{thm:altasdist} Suppose that $K_{1n}=o_{P_0}(n^{-1/2})$, that $\mathbb{U}_n \tilde{\Gamma}_n=o_{P_0}(n^{-1/2})$, and furthermore, that $o\mapsto \int \Gamma_n(o_1,o)dP_0(o)$ belongs to a fixed $P_0$-Donsker class with probability tending to $1$ while $\twonorm{P_0\left(\Gamma_n-\Gamma_0\right)}=o_{P_0}(1)$. If $\mathscr{H}_1$ holds, we have that $ \sqrt{n}\left(\psi_n-\psi_0\right)\rightsquigarrow N\left(0,\tau^2\right)$, where $\tau^2\triangleq 4Var_{P_0}\left[\int \Gamma_0(O,o)dP_0(o)\right]$. \end{theorem} In view of the results of \secref{sec:rep}, $\tau^2$ coincides with $\sigma_0^2$, the efficiency bound for regular, asymptotically linear estimators in a nonparametric model. Hence, $\psi_n$ is an asymptotically efficient estimator of $\psi_0$ under $\mathscr{H}_1$. Sufficient conditions for $\int \Gamma_n(o_1,o)dP_0(o)$ to belong to a fixed $P_0$-Donsker class with probability approaching one are given in Appendix B.2. The following corollary is trivial in light of \autoref{thm:altasdist}. It establishes that the test $n\psi_n>\hat{q}_{1-\alpha}^{ub}$ is consistent against (essentially) all alternatives provided the needed components of the likelihood are estimated sufficiently well. \begin{corollary}[Consistency under a fixed alternative] \label{cor:testconsistent} Suppose the conditions of \autoref{thm:altasdist}. Furthermore, suppose that $\tau^2>0$ and $\hat{q}_{1-\alpha}^{ub}=o_{P_0}(n)$. Then, under $\mathscr{H}_1$, the test $n\psi_n>\hat{q}_{1-\alpha}^{ub}$ is consistent in the sense that \[ \lim_{n\rightarrow\infty}P_0^n\left(n\psi_n>\hat{q}_{1-\alpha}^{ub}\right)=1\ . \] \end{corollary} The requirement that $\hat{q}_{1-\alpha}^{ub}=o_{P_0}(n)$ is very mild given that $q_{1-\alpha}$ will be finite whenever $R,S\in\mathscr{S}$. As such, we would not expect $\hat{q}_{1-\alpha}^{ub}$ to get arbitrarily large as sample size grows, at least beyond the extent allowed by our corollary. This suggests that most non-trivial upper bounds satisfying (\ref{eq:cutoffub}) will yield a consistent test. \subsubsection{Nuisance functions have not been estimated well} We now consider the case where the nuisance functions are not estimated well, in the sense that the consistency conditions of \autoref{thm:altasdist} do not hold. In particular, we argue that failure of these conditions does not necessarily undermine the consistency of our test. Let $\hat{q}_{1-\alpha}^{ub}$ be the estimated cutoff for our test, and suppose that $\hat{q}_{1-\alpha}^{ub}=o_{P_0}(n)$. Suppose also that $P_0^2\Gamma_n$ is asymptotically bounded away from zero in the sense that, for some $\delta>0$, $P_0^n\left(P_0^2\Gamma_n>\delta\right)$ tends to one. This condition is reasonable given that $P_0^2 \Gamma_0>0$ if $\mathscr{H}_1$ holds and $\hat{P}_n$ is nevertheless a (possibly inconsistent) estimator of $P_0$. Assuming that $[\mathbb{U}_n-P_0^2]\Gamma_n=O_{P_0}(n^{-1/2})$, which is true under entropy conditions on $\Gamma_n$ \citep{Nolan&Pollard1987,Nolan&Pollard1988}, we have that \[P_0^n\left(n\psi_n > \hat{q}_{1-\alpha}^{ub}\right)\ =\ P_0^n\left(\sqrt{n}[\mathbb{U}_n-P_0^2]\Gamma_n>\frac{\hat{q}_{1-\alpha}^{ub}}{\sqrt{n}}-\sqrt{n}P_0^2 \Gamma_n\right)\longrightarrow 1\ . \]We have accounted for the random $n^{-1/2}\hat{q}_{1-\alpha}^{ub}$ term as in the proof of \autoref{cor:testconsistent}. Of course, this result is less satisfying than \autoref{thm:altasdist}, which provides a concrete limit distribution. \subsection{Consistency under a local alternative} \label{sec:loccons} We consider local alternatives of the form \begin{align*} dQ_n(o)&=\left[1 + n^{-1/2}h_n(o)\right] dP_0(o), \end{align*} where $h_n\rightarrow h$ in $L_0^2(P_0)$ for some non-degenerate $h$ and $P_0$ satisfies the null hypothesis $\mathscr{H}_0$. Suppose that the conditions of \autoref{thm:asympt} hold. By Theorem 2.1 of \cite{Gregory1977}, we have that \begin{align*} n\mathbb{U}_n \Gamma_0\ \overset{Q_n}{\rightsquigarrow}\ \sum_{k=1}^\infty \lambda_k\left[\left(Z_k+\langle f_k ,h \rangle\right)^2-1\right], \end{align*} where $\mathbb{U}_n$ is the $U$-statistic empirical measure from a sample of size $n$ drawn from $Q_n$, $\langle\cdot,\cdot\rangle$ is the inner product in $L^2(P_0)$, $Z_k$ and $\lambda_k$ are as in \autoref{thm:asympt}, and $f_k$ is the eigenfunction corresponding to eigenvalue $\lambda_k$ described in \autoref{thm:asympt}. By the contiguity of $Q_n$, the conditions of \autoref{thm:asympt} yield that the result above also holds with $\mathbb{U}_n \Gamma_0$ replaced by $\mathbb{U}_n \Gamma_n$, our estimator applied to a sample of size $n$ drawn from $Q_n$. If each $\lambda_k$ is non-negative, the limiting distribution under $Q_n$ stochastically dominates the asymptotic distribution under $P_0$, and furthermore, if $\langle f_k ,h \rangle\not=0$ for some $k$ with $\lambda_k>0$, this dominance is strict. It is straightforward to show that, under the conditions of \autoref{thm:asympt}, the above holds if and only if $\liminf_{n}\sqrt{n}\Psi(Q_n)>0$, that is, if the sequence of alternatives is not too hard. Suppose that $\hat{q}_{1-\alpha}$ is a consistent estimate of $q_{1-\alpha}$. By Le Cam's third lemma, $\hat{q}_{1-\alpha}$ is consistent for $q_{1-\alpha}$ even when the estimator is computed on samples of size $n$ drawn from $Q_n$ rather than $P_0$. This proves the following theorem. \begin{theorem}[Consistency under a local alternative] Suppose that the conditions of \autoref{thm:asympt} hold. Then, under $\mathscr{H}_0$ and provided $\liminf_{n\rightarrow\infty}\sqrt{n}\Psi(Q_n)>0$, the proposed test is locally consistent in the sense that $\lim_{n\rightarrow\infty}Q_n\left(n\psi_n>\hat{q}_{1-\alpha}\right)>\alpha$, where $\hat{q}_{1-\alpha}$ is a consistent estimator of $q_{1-\alpha}$. \end{theorem} \section{Illustrations} \label{sec:illustr} We now return to each of our examples. We first show that Examples 1, 2 and 3 satisfy the regularity conditions described in \secref{sec:rep}. Specifically, we show that all involved parameters $R$ and $S$ belong to $\mathscr{S}$ under reasonable conditions. Furthermore, we determine explicit remainder terms for the asymptotic representation used in each example and describe conditions under which these remainder terms are negligible. For any $T\in\mathscr{S}$, we will use the shorthand notation $\dot{T}_{\tilde{t}}(x^T)\triangleq \left.\frac{d}{d t}T_{P_t}(x^T)\right|_{t=\tilde{t}}$ for $\tilde{t}$ in a neighborhood of zero.\\ \noindent \textbf{\hyperlink{ex:1}{Example 1}} (Continued). The parameter $S$ with $S_P\equiv 0$ belongs to $\mathscr{S}$ trivially, with $D_P^S\equiv 0$. \condref{it:Sbdd} holds with $x^R(o)=w$. \condref{it:Sderivsbdd} holds using that $R_t(w)$ equals \begin{align} \sum_{a=0}^1 (-1)^{a+1}\int y\left\{\frac{1 + th_1(w,a,y) + t^2h_2(w,a,y)}{1 + tE_{P_0}[h_1(w,A,Y)] + t^2E_{P_0}[h_2(w,A,Y)]}\right\}dP_0(y| a,w)\ . \label{eq:Rtdiffblip} \end{align} Since we must only consider $h_1$ and $h_2$ uniformly bounded, for $t$ sufficiently small, we see that $R_t(w)$ is twice continuously differentiable with uniformly bounded derivatives. \condref{it:Spd} is satisfied by \[ D_P^R(o)\triangleq \frac{2a-1}{P\left(A=a\mid W=w\right)}\left\{y-E_{P}\left[Y\mid A=a,W=w\right]\right\} \] and $D_P^S\equiv 0$. If $\min_a P\left(A=a\mid W\right)$ is bounded away from zero with probability $1$ uniformly in $P$, it follows that $(P,o)\mapsto D_P^R(o)$ is uniformly bounded. Clearly, we have that $\operatorname{Rem}_P^S\equiv 0$. We can also verify that $\operatorname{Rem}_P^R(o)$ equals \begin{align*} \sum_{\tilde{a}=0}^1 (-1)^{\tilde{a}}E_{P_0}&\Big\{\left[1-\frac{P_0\left(A=\tilde{a}\mid W\right)}{P\left(A=\tilde{a}\mid W\right)}\right] \\ &\;\;\;\;\times\left[E_P\left(Y\mid A,W\right)-E_{P_0}\left(Y\mid A,W\right)\right] \Big| A=\tilde{a},W=w\Big\}. \end{align*} The above remainder is double robust in the sense that it is zero if either the treatment mechanism (i.e., the probability of $A$ given $W$) or the outcome regression (i.e., the expected value of $Y$ given $A$ and $W$) is correctly specified under $P$. In a randomized trial where the treatment mechanism is known and specified correctly in $P$, we have that $\operatorname{Rem}_P^R\equiv 0$ and thus $L_P^{RS}\equiv 0$. More generally, an upper bound for $\operatorname{Rem}_P^R$ can be found using the Cauchy-Schwarz inequality to relate the rate of $\twonorm{\operatorname{Rem}_P^R}$ to the product of the $L^2(P_0)$-norm for the difference between each of the treatment mechanism and the outcome regression under $P$ and $P_0$.\\ \noindent \textbf{\hyperlink{ex:2}{Example 2}} (Continued). For \ref{it:Sbdd} we take $x^R=x^S=w$. \condref{it:Sderivsbdd} can be verified using an expression similar to that in (\ref{eq:Rtdiffblip}). \condref{it:Spd} is satisfied by \begin{align*} D_P^R(o)\ &\triangleq \ \frac{a}{P\left(A=a\mid W=w\right)}\left[y-E_{P}\left(Y\mid A=a,W=w\right)\right] \\ D_P^S(o)\ &\triangleq \ \frac{1-a}{P\left(A=a\mid W=w\right)}\left[y-E_{P}\left(Y\mid A=a,W=w\right)\right]\ . \end{align*} If $\min_a P\left(A=a\mid W\right)$ is bounded away from zero with probability $1$ uniformly in $P$, both $(P,o)\mapsto D_P^R(o)$ and $(P,o)\mapsto D_P^S(o)$ are uniformly bounded. Similarly to \hyperlink{ex:1}{Example 1}, we have that $\operatorname{Rem}_P^R(o)$ is equal to \begin{align*} E_{P_0}\left\{\left[1-\frac{P_0\left(A=1\mid W\right)}{P\left(A=1\mid W\right)}\right]\left[E_P\left(Y\mid A,W\right)-E_{P_0}\left(Y\mid A,W\right)\right]\ \middle|\ A=1,W=w\right\}. \end{align*} The remainder $\operatorname{Rem}_P^S(o)$ is equal to the above display but with $A=1$ replaced by $A=0$. The discussion about the double robust remainder term from \hyperlink{ex:1}{Example 1} applies to these remainders as well.\\ \noindent \textbf{\hyperlink{ex:3}{Example 3}} (Continued). The parameter $S$ is the same as in \hyperlink{ex:1}{Example 1}. The parameter $R$ satisfies \ref{it:Sbdd} with $x^R(o)=w$ and \ref{it:Sderivsbdd} by an identity analogous to that used in \hyperlink{ex:1}{Example 1}. \condref{it:Spd} is satisfied by $D_P^R(o)\triangleq y-E_P\left(Y\mid W=w\right)$. By the bounds on $Y$, $(P,o)\mapsto D_P^R(o)$ is uniformly bounded. Here, the remainder terms are both exactly zero: $\operatorname{Rem}_P^R\equiv \operatorname{Rem}_P^S\equiv 0$. Thus, we have that $L_P^{RS}\equiv 0$ in this example.\\ The requirement that $Var_{P_0}\left[D_0^R(O)\right]>0$ in \autoref{cor:Seq0}, and more generally that there exist a nonzero eigenvalue $\lambda_j$ for the limit distribution in \autoref{thm:asympt} to be non-degenerate, may at times present an obstacle to our goal of obtaining asymptotic control of the type I error. This is the case for \hyperlink{ex:4}{Example 4}, which we now discuss further. Nevertheless, we show that with a little finesse the type I error can still be controlled at the desired level for the given test. In fact, the test we discuss has type I error converging to zero, suggesting it may be noticeably conservative in small to moderate samples. \\ \noindent \textbf{\hyperlink{ex:4}{Example 4}} (Continued). In this example, one can take $x^R=w$ and $x^S=w(-k)$. Furthermore, it is easy to show that \begin{align*} D_P^R(o)&= Y-E_P[Y|W=w] \\ D_P^S(o)&= Y-E_P[Y|W(-k)=w(-k)]\ . \end{align*} The first-order approximations for $R$ and $S$ are exact in this example as the remainder terms $\operatorname{Rem}_P^R$ and $\operatorname{Rem}_P^S$ are both zero. However, we note that if $E_P\left(Y\mid W\right)= E_P\left(Y\mid W(-k)\right)$ almost surely, it follows that $D_P^R\equiv D_P^S$. This implies that $\Gamma_0\equiv 0$ almost surely under $\mathscr{H}_0$. As such, under the conditions of \autoref{thm:asympt}, all of the eigenvalues in the limit distribution of $n\psi_n$ in \autoref{thm:asympt} are zero and $n\psi_n\rightarrow 0$ in probability. We are then no longer able to control the type I error at level $\alpha$, rendering our proposed test invalid. Nevertheless, there is a simple albeit unconventional way to repair this example. Let $A$ be a Bernoulli random variable, independent of all other variables, with fixed probability of success $p\in(0,1)$. Replace $S_P$ with $o\mapsto E_P\left(Y\mid A=1,W(-k)=w(-k)\right)$ from \hyperlink{ex:2}{Example 2}, yielding then \[ D_P^S(o)=\frac{a}{p}\left[y-E_{P}\left(Y\mid A,W(-k)=w(-k)\right)\right]\ .\] It then follows that $D_0^R\not\equiv D_0^S$ and in particular $\Gamma_0$ is no longer constant. In this case, the limit distribution given in \autoref{thm:asympt} is non-degenerate. Consistent estimation of $q_{1-\alpha}$ thus yields a test that asymptotically controls type I error. Given that the proposed estimator $\psi_n$ converges to zero faster than $n^{-1}$, the probability of rejecting the null approaches zero as sample size grows. In principle, we could have chosen any positive cutoff given that $n\psi_n\rightarrow 0$ in probability, but choosing a more principled cutoff seems judicious. Because $p$ is known, the remainder term $\operatorname{Rem}_{P}^S$ is equal to zero. Furthermore, in view of the independence between $A$ and all other variables, one can estimate $E_{P_0}\left(Y\mid A=0,W(-k)\right)$ by regressing $Y$ on $W(-k)$ using all of the data without including the covariate $A$. In future work, it may also be worth checking to see if the parameter is third-order differentiable under the null, and if so whether or not this allows us to construct an $\alpha$-level test without resorting to an artificial source of randomness. \section{Simulation studies} \label{sec:num} In simulation studies, we have explored the performance of our proposed test in the context of Examples 1, 2 and 3, and have also compared our method to the approach of \cite{Racineetal2006} for which software is readily available -- see, e.g., the \texttt{R} package \texttt{np} \citep{Hayfield&Racine2008}. We report the results of our simulation studies in this section. \subsection{Simulation scenario 1} We use an observed data structure $(W,A,Y)$, where $W\triangleq (W_1,W_2,\ldots,W_5)$ is drawn from a standard 5-dimensional normal distribution, $A$ is drawn according to a $\textnormal{Bernoulli}(0.5)$ distribution, and $Y=\mu(A,W) + 5\xi(A,W)$, where the different forms of the conditional mean function $\mu(a,w)$ are given in \tabref{tab:EYAW}, and $\xi(a,w)$ is a random variate following a Beta distribution with shape parameters $\alpha=3\operatorname{expit}(aw_2)$ and $\beta=2\operatorname{expit}[(1-a)w_1]$ shifted to have mean zero, where $\operatorname{expit}(x)=1/(1+\exp(-x))$. We performed tests of the null in which $\mu(1,W)$ is equal to $\mu(0,W)$ almost surely and in distribution, as presented in Examples 1 and 2, respectively. Our estimate $\hat{P}_n$ of $P_0$ was constructed using the knowledge that $P_0\left(A=1\mid W\right)=1/2$, as would be available, for example, in the context of a randomized trial. The conditional mean function $\mu(a,w)$ was estimated using the ensemble learning algorithm Super Learner \citep{vanderLaan&Polley&Hubbard07}, as implemented in the \texttt{SuperLearner} package \citep{SuperLearner2013}. This algorithm was implemented using $10$-fold cross-validation to determine the best convex combination of regression function candidates minimizing mean-squared error using a candidate library consisting of \texttt{SL.rpart}, \texttt{SL.glm.interaction}, \texttt{SL.glm}, \texttt{SL.earth}, and \texttt{SL.nnet}. We used the results of \autoref{cor:Seq0} to evaluate significance for \hyperlink{ex:1}{Example 1}, and the eigenvalue approach presented in \secref{sec:estcutoff} to evaluate significance for \hyperlink{ex:2}{Example 2}, where we used all of the positive eigenvalues for $n=125$ and the largest $200$ positive eigenvalues for $n>125$ using the \texttt{rARPACK} package \citep{Qiu&May2014}. We ran 1,000 Monte Carlo simulations with samples of size $125$, $250$, $500$, $1000$, and $2000$, except for the \texttt{np} package, which we only ran for $500$ Monte Carlo simulations due to its burdensome computation time. For \hyperlink{ex:1}{Example 1} we compared our approach with that of \cite{Racineetal2006} using the \texttt{npsigtest} function from the \texttt{np} package. This requires first selecting a bandwidth, which we did using the \texttt{npregbw} function, specifying that we wanted a local linear estimator and the bandwidth to be selected using the \texttt{cv.aic} method \citep{Hayfield&Racine2008}. \begin{table} \caption{\label{tab:EYAW}Conditional mean function in each of three simulation settings within simulation scenario 1. Here, $m(a,w)\triangleq 0.2\left(w_1^2 + w_2 - 2w_3w_4\right)$, and the third and fourth columns indicate, respectively, whether $\mu(1,W)$ and $\mu(0,W)$ are equal in distribution or almost surely.} \centering \begin{tabular}{l l c c} \hline & $\mu(a,w)$ & $\eqd$ & ${\buildrel {a.s.} \over =}$ \\ \hline\hline Simulation 1a & $m(a,w)$ & $\times$ & $\times$ \\ \hline Simulation 1b & $m(a,w) + 0.4[aw_3 + (1-a)w_4]$ & $\times$ & \\ \hline Simulation 1c & $m(a,w) + 0.8aw_3$ & & \\ \hline \end{tabular} \end{table} \begin{figure} \centering \includegraphics[width=0.6\textwidth]{sim1_prob.pdf} \caption{\label{fig:sim1prob}Empirical probability of rejecting the null when testing the null hypothesis that $\mu(1,W)-\mu(0,W)$ is almost surely equal to zero (Example 1) in Simulation 1. \tabref{tab:EYAW} indicates that the null is true in Simulation 1a, and the alternative is true in Simulations 1b and 1c.} \end{figure} \figref{fig:sim1prob} displays the empirical coverage of our approach as well as that resulting from use of the \texttt{np} package. At smaller sample sizes, our method does not appear to control type I error near the nominal level. This is likely because we use an asymptotic result to compute the cutoff, even when the sample size is small. Nevertheless, as sample size grows, the type I error of our test approaches the nominal level. We note that in \cite{Racineetal2006}, unlike in our proposal, the bootstrap was used to evaluate the significance of the proposed test. It will be interesting to see if applying a bootstrap procedure at smaller sample sizes improves our small-sample results. At larger sample sizes, it appears that the method of \citeauthor{Racineetal2006} slightly outperforms our approach in terms of power in simulation scenarios 1a and 1b. In \figref{fig:sim1distr}, the empirical null rejection probability of our test is displayed for simulation scenarios 1a, 1b and 1c. In particular, we observe that our method is able to control type I error for Simulations 1a and 1b when testing the hypothesis that $\mu(1,W)$ is equal in distribution to $\mu(0,W)$. Also, the power of our test increases with sample size, as one would expect. We are not aware of any other test devised for this hypothesis. \begin{figure} \centering \includegraphics[width=0.6\textwidth]{sim1_distr.pdf} \caption{\label{fig:sim1distr}Empirical probability of rejecting the null when testing the null hypothesis that $\mu(1,W)$ is equal in distribution to $\mu(0,W)$ (Example 2) in Simulation 1. \tabref{tab:EYAW} indicates that the null is true in Simulations 1a and 1b, and the alternative is true in Simulation 1c.} \end{figure} \subsection{Simulation scenario 2: comparison with \cite{Racineetal2006}} We reproduced a simulation study from Section 4.1 of \cite{Racineetal2006} at sample size $n=100$. In particular, we let $Y=1 +\beta A(1+W_2^2) + W_1 + W_2 + \epsilon$, where $A$, $W_1$, and $W_2$ are drawn independently from $\textnormal{Bernoulli}(0.5)$, $\textnormal{Bernoulli}(0.5)$, and $N(0,1)$ distributions, respectively. The error term $\epsilon$ is unobserved and drawn from a $N(0,1)$ distribution independently of all observed variables. The parameter $\beta$ was varied over values $-0.5,-0.4,...,0.4,0.5$ to achieve a range of distributions. The goal is to test whether $E_{0}\left(Y\mid A,W\right)=E_{0}\left(Y\mid W\right)$ almost surely, or equivalently, that $\mu(1,W)-\mu(0,W)=0$ almost surely. Due to computational constraints, we only ran the `Bootstrap I test' to evaluate significance of the method of \cite{Racineetal2006}. As the authors report, this method is anticonservative relative to their `Bootstrap II test' and indeed achieves lower power (but proper type I error control) in their simulations. Except for two minor modifications, our implementation of the method in \hyperlink{ex:1}{Example 1} is similar to that as for Simulation 1. For a fair comparison with \cite{Racineetal2006}, in this simulation study, we estimated $P_0\left(A=1\mid W\right)$ rather than treating it as known. We did this using the same Super Learner library and the `\texttt{family=binomial}' setting to account for the fact that $A$ is binary. We also scaled the function $\mu(1,w)-\mu(0,w)$ by a factor of $5$ to ensure most of the probability mass of $R_0$ falls between $-1$ and $1$ (around $99\%$ when $\beta=0$) -- this is equivalent to selecting a bandwidth of $1/5$ for the Gaussian kernel in the definition of the MMD. We also considered a bandwidth of $5/2$: the results were essentially identical and therefore omitted here. We note that even with scaling the variable $Y$ is not bounded as our regularity conditions require. Nonetheless, an evaluation of our method under violations of our assumptions can itself be very informative. \begin{figure} \centering \includegraphics[width=0.6\textwidth]{sim2.pdf} \caption{\label{fig:sim2}Empirical probability of rejecting the null when testing the null hypothesis that $\mu(1,W)-\mu(0,W)$ is almost surely equal to zero in Simulation 2.} \end{figure} \figref{fig:sim2} displays the empirical null rejection probability of our test as well as that of \cite{Racineetal2006}. In this setup, used by the authors themselves to showcase their test procedure, our method outperforms their proposal, both in terms of type I error control and power. \subsection{Simulation scenario 3: higher dimensions} We also explored the performance of our method as extended to tackle higher-dimensional hypotheses, as discussed in \secref{sec:concl}. To do this, we used the same distribution as for Simulation 1 but with $Y$ now a 20-dimensional random variable. Our objective here was to test $\mu(1,W)-\mu(0,W)$ is equal to $(0,0,\ldots,0)$ in probability, where $\mu(a,w)\triangleq (\mu_1(a,w),\mu_2(a,w),\ldots,\mu_{20}(a,w))$ with $\mu_j(a,w)\triangleq E_0\left(Y_j\mid A=a,W=w\right)$. Conditional on $A$ and $W$, the coordinates of $Y$ are independent. We varied the number of coordinates that represent signal and noise. For signal coordinate $j$, given $A$ and $W$, $20Y_j$ was drawn from the same conditional distribution as $Y$ give $A$ and $W$ in Simulation 1c. For noise coordinate $j$, given $A$ and $W$, $20Y_j$ was drawn from the same conditional distribution as $Y$ given $A$ and $W$ in Simulation 1a. Relative to Simulation 1, we have scaled each coordinate of the outcome to be one twentieth the size of the outcome in Simulation 1. Apart from the Gaussian kernel with bandwidth one, which we have adopted throughout this paper, we considered defining the MMD with a Gaussian kernel with bandwidth $1/2$. Alternatively, this could be viewed as considering bandwidths $1/20$ and $1/40$ if the outcome had not been scaled by $1/20$. We ran the same Super Learner to estimate $\mu(1,w)$ as in Simulation 1, and we again treated the probability of treatment given covariates as known. We evaluated significance by estimating all of the positive eigenvalues of the centered Gram matrix for $n=125$ and the largest $200$ positive eigenvalues of the centered Gram matrix for $n> 125$. \begin{figure} \centering \includegraphics[width=0.8\textwidth]{sim3.pdf} \caption{\label{fig:sim3}Probability of rejecting the null when testing the null hypothesis that $\mu(1,W)-\mu(0,W)$ is almost surely equal to zero in Simulation 3.} \end{figure} In \figref{fig:sim3}, the empirical null rejection probability is displayed for our proposed MMD method based on bandwidths 1 and 1/2. Our proposal appears to control type I error well at moderate to large sample sizes (i.e., $n\ge 500$). We did not include the results for sample size $125$ in the figure because type I error control was too poor. In particular, for zero signal coordinates, the probability of rejection was $0.24$ for bandwidth $1$ and $0.33$ for bandwidth $1/2$. For a signal of $5$, the empirical probability of rejection decreases between a sample size of $250$ and $500$, likely due to the poor type I error control at sample size $250$. Nonetheless, this simulation shows that, overall, our method indeed has increasing power as sample size grows or as the number of coordinates $j$ for which $\mu_j(1,W)-\mu_j(0,W)$ not equal to zero in probability increases. This figure also highlights that the bandwidth may be an important determinant of finite-sample power, therefore warranting further scrutiny in future work. \section{Concluding remarks} \label{sec:concl} We have presented a novel approach to test whether two unknown functions are equal in distribution. Our proposal explicitly allows, and indeed encourages, the use of flexible, data-adaptive techniques for estimating these unknown functions as an intermediate step. Our approach is centered upon the notion of maximum mean discrepancy, as introduced in \cite{Grettonetal2006}, since the MMD provides an elegant means of contrasting the distributions of these two unknown quantities. In their original paper, these authors showed that the MMD, which in their context tests whether two probability distributions are equal using $n$ random draws from each distribution, can be estimated using a $U$- or $V$-statistic. Under the null hypothesis, this $U$- or $V$-statistic is degenerate and converges to the true parameter value quickly. Under the alternative, it converges at the standard $n^{-1/2}$ rate. Because this parameter is a mean over a product distribution from which the data were observed, it is not surprising that a $U$- or $V$-statistic yields a good estimate of the MMD. What is surprising is that we were able to construct an estimator with these same rates even when the null hypothesis involves unknown functions that can only be estimated at slower rates. To accomplish this, we used recent developments from the higher-order pathwise differentiability literature. This appears to be the first use of these developments to address an open methodological problem. Our simulation studies indicate that our asymptotic results are meaningful in finite samples, and that in specific examples for which other methods exist, our methods generally perform at least as well as these established, tailor-made methods. Of course, the great appeal of our proposal is that it applies to a much wider class of problems. We conclude with several possible extensions of our method that may increase further its applicability and appeal. \begin{enumerate} \item Although this condition is satisfied in all but one of our examples, requiring $R$ and $S$ to be in $\mathscr{S}$ can be somewhat restrictive. Nevertheless, it appears that this condition may be weakened by instead requiring membership to $\mathscr{S}^*$, the class of all parameters $T$ for which there exist some $M<\infty$ and elements $T^1,T^2,\ldots,T^M$ in $\mathscr{S}$ such that $T=\sum_{m=1}^{M}T^m$. While the results in our paper can be established in a similar manner for functions in this generalized class, the expressions for the involved gradients are quite a bit more complicated. Specifically, we find that, for $T,U\in\mathscr{S}^*$ with $T=\sum_{m=1}^{M}T^m$ and $U=\sum_{\ell=1}^{L}U^\ell$, the quantity $\Gamma_P^{TU}(o_1,o_2)$ equals \begin{align*} &e^{-[T_P(o_1)-U_P(o_2)]^2} \\ &+\sum_{\ell=1}^L E_{P}\left\{2\left[T_P(o_1)-U_P(O)\right]e^{-[T_P(o_1)-U_P(O)]^2}\middle|X^{U^\ell}=x_2^{U^\ell}\right\} D_P^{U^\ell}(o_2) \\ &\ \ -\sum_{m=1}^M E_{P}\left\{2\left[T_P(O)-U_P(o_2)\right]e^{-[T_P(O)-U_P(o_2)]^2}\middle|X^{T^m}=x_1^{T^m}\right\} D_P^{T^m}(o_1) \\ &\ \ -\sum_{\ell=1}^L \sum_{m=1}^M E_{P^2}\Big[\left\{4\left[T_P(O_1)-U_P(O_2)\right]^2-2\right\}e^{-[T_P(O_1)-U_P(O_2)]^2} \\ &\hspace{1in}\Big|X_1^{T^\ell}=x_1^{T^\ell},X_2^{U^m}=x_2^{U^m}\Big]D_P^{T^\ell}(o_1) D_P^{U^m}(o_2)\ . \end{align*} In particular, we note the need for conditional expectations with respect to $X^{R^m}$ and $X^{S^m}$ in the definition of $\Gamma$, which could render the implementation of our method more difficult. While we believe this extension is promising, its practicality remains to be investigated. \item While our paper focuses on univariate hypotheses, our results can be generalized to higher dimensions. Suppose that $P\mapsto R_P$ and $P\mapsto S_P$ are $\mathbb{R}^d$-valued functions on $\mathscr{O}$. The class $\mathscr{S}_d$ of allowed such parameters can be defined similarly as $\mathscr{S}$, with all original conditions applying componentwise. The MMD for the vector-valued parameters $R$ and $S$ using the Gaussian kernel is given by $\Psi_d(P)\triangleq \Phi_d^{RR}(P)-2\Phi_d^{RS}(P)+\Phi_d^{SS}(P)$, where for any $T,U\in\mathscr{S}_d$ we set \[\Phi_d^{TU}(P)\triangleq \iint e^{-\|T_P(o_1)-U_P(o_2)\|^2}dP(o_1)dP(o_2)\ .\] It is not difficult to show then that, for any $T,U\in\mathscr{S}_d(P_0)$, $\Gamma_{d,P}^{TU}(o_1,o_2)$ is given by \begin{align*} \Big[2&\left[T_P(o_1)-U_P(o_2)\right]'\left[D_P^U(o_2) -D_P^T(o_1)\right] + 1 \\ &\;- 2D_P^T(o_1)'\left\{2\left[T_P(o_1)-U_P(o_2)\right] \left[T_P(o_1)-U_P(o_2)\right]'-\textnormal{Id}\right\}D_P^U(o_2)\Big] \\ &\;\times e^{-\norm{T_P(o_1)-U_P(o_2)}^2}, \end{align*} where $\textnormal{Id}$ denotes the $d$-dimensional identity matrix and $A'$ denotes the transpose of a given vector $A$. Using these objects, the method and results presented in this paper can be replicated in higher dimensions rather easily. \item Our results can be used to develop confidence sets for infinite dimensional parameters by test inversion. Consider a parameter $T$ satisfying our conditions. Then one can test if $R_0\triangleq T_0-f$ is equal in distribution to zero for any fixed function $f$ that does not rely on $P$. Under the conditions given in this paper, a $1-\alpha$ confidence set for $T_0$ is given by all functions $f$ for which we do not reject $\mathscr{H}_0$ at level $\alpha$. The blip function from \hyperlink{ex:1}{Example 1} is a particularly interesting example, since a confidence set for this parameter can be mapped into a confidence set for the sign of the blip function, i.e. the optimal individualized treatment strategy \citep{Robins04}. We would hope that the omnibus nature of the test implies that the confidence set does not contain functions $f$ that are ``far away'' from $T_0$, contrary to a test which has no power against certain alternatives. Formalization of this claim is an area of future research. \item To improve upon our proposal for nonparametrically testing variable importance via the conditional mean function, as discussed in \secref{sec:illustr}, it may be fruitful to consider the related Hilbert Schmidt independence criterion \citep{Grettonetal2005}. Higher-order pathwise differentiability may prove useful to estimate and infer about this discrepancy measure. \end{enumerate} \section*{Acknowledgement} The authors thank Noah Simon for helpful discussions. Alex Luedtke was supported by the Department of Defense (DoD) through the National Defense Science \& Engineering Graduate Fellowship (NDSEG) Program. Marco Carone was supported by a Genentech Endowed Professorship at the University of Washington. Mark van der Laan was supported by NIH grant R01 AI074345-06. \setcounter{equation}{0} \renewcommand{\theequation}{A.\arabic{equation}} \newtheorem{apptheorem}{Theorem} \renewcommand{\theapptheorem}{A.\arabic{apptheorem}} \newtheorem{appcorollary}{Corollary} \renewcommand{\theappcorollary}{A.\arabic{appcorollary}} \newtheorem{applemma}{Lemma} \renewcommand{\theapplemma}{A.\arabic{applemma}} \section*{Appendix A: Pathwise differentiability} \label{sec:pd} We now review first- and second-order pathwise differentiability. Define the following fluctuation submodel through $P_0$: \begin{align*} dP_t(o)&\triangleq \left(1 + th_1(o) + t^2 h_2(o)\right)dP_0(o), \\ &\mbox{ where }P_0 h_j = 0\textrm{ and }\sup_{o\in\mathcal{O}}|h_j(o)|<\infty, j=1,2. \end{align*} The function $h_1$ is a score, and the closure of the linear span of all such scores yields the unrestricted tangent space $L_0^2(P_0)$, i.e. the set of $P_0$ mean zero functions in $L^2(P_0)$. Note that it is the resulting (first-order) tangent space that is important, as all differentiability properties discussed in this appendix are equivalent for any set of functions $h_1$ that yield the same tangent space. Hence, the restriction that $\sup_{o\in\mathcal{O}}|h_1(o)|<\infty$, while convenient, will have no impact on the resulting differentiability properties. The second-order tangent space is also determined by the first-order tangent space (see \citealp{Caroneetal2014} and the references therein). Let $\psi_t\triangleq \Psi(P_t)$. The parameter $\Psi$ is called (first-order) pathwise differentiable at $P_0$ if there exists a $D_1^{\Psi}\in L_0^2(P_0)$ such that \begin{align*} \psi_t-\psi_0&= t P_0 D_1^{\Psi} h_1 + o(t). \end{align*} We call $D_1^{\Psi}$ the first-order canonical gradient of $\Psi$ at $P_0$, where we note that $D_1^\Psi(O)$ is almost surely unique because $\mathcal{M}$ is nonparametric. The canonical gradient $D_1^{\Psi}$ depends on $P_0$ but this is omitted in the notation because we will only discuss pathwise differentiability at $P_0$. A function $f : \mathcal{O}^2\rightarrow\mathbb{R}$ is called ($P$) one-degenerate if it is symmetric and $P f(o,\cdot)=0$. We will use the notation $P^2 f = E_{P^2}[f(O_1,O_2)]$. The parameter $\Psi$ is called second-order pathwise differentiable at $P_0$ if there exists some symmetric, one-degenerate, $P_0^2$ square integrable function $D_2^{\Psi}$ such that \begin{align*} \psi_t-\psi_0=& t P_0 D_1^{\Psi} h_1 + \frac{1}{2}t^2 P_0 D_1^{\Psi}h_2 + \frac{1}{2}t^2\int\int D_2^{\Psi}(o_1,o_2)h_1(o_1)h_1(o_2)dP_0(o_2)dP_0(o_1) + o(t^2). \end{align*} \section*{Appendix B: Empirical Process Results} \label{app:bdUproc} We now present two results from empirical process theory, the first of which can be used to control the $U$-processes that we deal with in the main text when $\mathscr{H}_0$ holds, and the second of which can be used to establish an empirical process condition that is used when $\mathscr{H}_1$ holds. Before giving an overview of the empirical process theory that we use, we review the notion of a covering number. Let $\mu$ be a probability measure over $\mathcal{Z}$. For a class of functions $f : \mathcal{Z}\rightarrow \mathbb{R}$ with envelope $F$ (i.e., $|f(z)|\le F(z)$ for all $z\in\mathcal{Z}$), where $0<\norm{F}_{2,\mu}<\infty$, define the covering number $N(\epsilon,\mu,\mathcal{F},F)$ as the cardinality of the smallest subcollection $\mathcal{F}^*\subseteq\mathcal{F}$ such that, for all $f\in\mathcal{F}$, $\min_{f^*\in\mathcal{F}^*}\norm{f-f^*}_{2,\mu}\le \epsilon \norm{F}_{2,\mu}$. \subsection*{Appendix B.1: Bounding $U$-processes} When $\mathscr{H}_0$ holds, our proofs rely on $\mathbb{U}_n(\tilde{\Gamma}_n-\Gamma_0)=o_{P_0}(n^{-1})$ for our method to control the type I error rate. This rate turns out to be plausible, but requires techniques which are different from the now classical empirical process techniques which can be used to establish that $(P_n-P_0)(f_n-f_0)=o_{P_0}(n^{-1/2})$ provided $P_0(f_n-f_0)^2\rightarrow 0$ in probability. We ignore measurability concerns in this appendix with the understanding that minor modifications are needed to make these results rigorous. We remind the reader that a function $g : \mathcal{O}^2\rightarrow\mathbb{R}$ is called one-degenerate if and only if $g$ is symmetric in its arguments and $P_0 g(o,\cdot)=0$ for all $o\in\mathcal{O}$. Let $\mathcal{G}$ denote a collection of one-degenerate functions mapping from $\mathcal{O}^2$ to $\mathbb{R}$, where $\sup_g|g(o_1,o_2)|<G(o_1,o_2)$ for all $o_1,o_2$ and some envelope function $G\in L^2(P_0)$. Suppose we wish to estimate some $g_0\in \mathcal{G}$. We are given a sequence of estimates $\hat{g}_n\in\mathcal{G}$ that is consistent for $g_0$. Our objective is to show that \begin{align*} n\mathbb{U}_n (\hat{g}_n-g_0)=o_{P_0}(1). \end{align*} The uniform entropy integral of $\mathcal{G}$ is given by \begin{align} J(t,\mathcal{G},G)&\triangleq \sup_Q \int_0^t \log N(\epsilon,Q,\mathcal{G},G) d\epsilon, \label{eq:entrint} \end{align} where the supremum is over all distributions $Q$ with support $\mathcal{O}^2$ and $\norm{G}_{Q,2}>0$. We note that the above definition of the entropy integral upper bounds the covering integral given by \cite{Nolan&Pollard1987}, which considers a particular choice of $Q$. The entropy integral above lacks the square root around the logarithm in the integral that is seen in the standard definition of the uniform entropy integral used to bound empirical processes \citep[see, e.g.,][]{vanderVaartWellner1996}. For each $g\in\mathcal{G}$, let $H_g$ represent the Hilbert-Schmidt operator on $L^2(P_0)$ given by $(H_g f)(o) = P g(o,\cdot)f(\cdot)$. Let $\{W_j : j=1,2,...\}$ be a sequence of i.i.d. standard normal random variables and $\{w_j : j=1,2,...\}$ be an orthonormal basis of $L^2(P_0)$. Let $\tilde{Q}$ be a process on $\mathcal{G}$ defined by \begin{align*} \tilde{Q}(g)=\sum_{j=1}^\infty \langle H_g w_j,w_j\rangle(W_j^2-1) + \sum_{i\not=j} \langle H_g w_j,w_i\rangle W_i W_j. \end{align*} A functional $M : \mathcal{G}\rightarrow\mathbb{R}$ is said to belong to $C(\mathcal{G},P_0^2)$ if $g\mapsto M(g)$ is uniformly continuous for the $L^2(P_0^2)$ seminorm and $\sup_{\mathcal{G}}|M(g)|<\infty$. We have modified the statement from \cite{Nolan&Pollard1988} slightly to apply to the entropy integral given in (\ref{eq:entrint}). We omit an analogue to condition (ii) from \citeauthor{Nolan&Pollard1988}'s statement of the theorem below because it is implied by our strengthening of their condition (i). \begin{apptheorem}[Theorem 7, \citealp{Nolan&Pollard1988}] \label{thm:nolanpollard2} Suppose that the one-degenerate class $\mathcal{G}$ satisfies \begin{enumerate}[label=(\roman*')] \item $J(1,\mathcal{G},G)<\infty$; \label{it:nolanpollardi} \stepcounter{enumi} \item $\sup_Q \log N(\epsilon,Q\times P_0,\mathcal{G},G)<\infty$ for each $\epsilon>0$, where the supremum is over distributions $Q$ with support $\mathcal{O}$. \label{it:nolanpollardiii} \end{enumerate} Then there is a version of $\tilde{Q}$ with continuous sample paths in $C(\mathcal{G},P_0\times P_0)$ and $n\mathbb{U}_n$ converges in distribution to $\tilde{Q}$. \end{apptheorem} We will use the following corollary to control the cross-terms. \begin{appcorollary} Suppose that $\mathcal{G}$ satisfies the conditions of \autoref{thm:nolanpollard2} and $\hat{g}_n$ is a sequence of one-degenerate random functions that take their values in $\mathcal{G}$ such that $P_0^2(\hat{g}_n-g_0)^2\rightarrow 0$ in probability for some $g_0\in \mathcal{G}$. Then $n\mathbb{U}_n(\hat{g}_n-g_0)\rightarrow 0$ in probability. \end{appcorollary} The proof relies on the continuity of sample paths of (a version of) $\tilde{Q}$. The proof is omitted, but we refer the reader to the proof of Lemma 19.24 in \cite{vanderVaart98} for the analogous empirical process result. \subsection*{Appendix B.2: Controlling $\int \Gamma_n(\cdot,o)dP_0(o)$} We now give sufficient conditions under which $o\mapsto \int \Gamma_n(o_1,o)dP_0(o)$ belongs to a fixed Donsker class with probability approaching one. We recall from \cite{vanderVaartWellner1996} that a class $\mathcal{F}$ of functions mapping from $\mathscr{O}$ to $\mathbb{R}$ is Donsker if its uniform entropy integral is finite, which holds if its covering number grows sufficiently slowly as the approximation becomes arbitrarily precise. Let $\mathcal{G}_2$ be some class of functions $g : \mathscr{O}^2\rightarrow[-M,M]$, $M<\infty$, that contains $\{(o_1,o_2)\mapsto \Gamma_n(o_1,o_2) : \Gamma_n\}$. Without loss of generality, we suppose that $M=1$. We take the constant function $G_2\equiv 1$ as envelope for $\mathcal{G}_2$. Let $\mathcal{G}_1\triangleq \{o_1\mapsto \int g_2(o_1,o_2)dP_0(o_2): g_2\in\mathcal{G}_2\}$, and note that this class similarly has envelope $G_1\equiv 1$. The main observation of this subappendix is that \begin{align} \sup_{Q_1} N(\epsilon,Q_1,\mathcal{G}_1,G_1)\le \sup_{Q_2} N(\epsilon,Q_2,\mathcal{G}_2,G_2),\label{eq:coveringnums} \end{align} where the supremum on the left is over all distributions $Q_1$ on $\mathscr{O}$ such that $\norm{G_1}_{2,Q_1}>0$ and the supremum on the right is over all distributions $Q_2$ on $\mathscr{O}^2$ such that $\norm{G}_{2,Q_2}>0$. If we can show this, then the uniform entropy integrals are also ordered \citep[Section~2.5 in][]{vanderVaartWellner1996}: \begin{align} \int_0^\infty \sup_{Q_1} \sqrt{\log N(\epsilon,Q_1,\mathcal{G}_1,G_1)} d\epsilon\le \int_0^\infty \sup_{Q_2} \sqrt{\log N(\epsilon,Q_2,\mathcal{G}_2,G_2)} d\epsilon, \label{eq:entropyints} \end{align} where the left- and right-hand sides are the uniform entropy integrals of $\mathcal{G}_1$ and $\mathcal{G}_2$, respectively. Hence, it will suffice to show that the right-hand side is finite. This can be accomplished using the variety of techniques given in Chapter 2 of \cite{vanderVaartWellner1996}. We now establish \eqref{eq:coveringnums}. Fix a measure $Q_1$ over $\mathscr{O}$. Let $Q_2$ represent the product measure $Q_1\times P_0$. Fix $\epsilon>0$. Let $g_{2,1},\ldots,g_{2,m}$ be an $\epsilon\norm{G_2}_{2,Q_2}$ cover of $\mathcal{G}_2$ under $\norm{\cdot}_{2,Q_2}$ so that $\min_j \norm{g_2-g_{2,j}}_{2,Q_2}<\epsilon\norm{G_2}_{2,Q_2}$, where we take $m$ to be equal to its minimal possible value $N(\epsilon,Q_2,\mathcal{G}_2,G_2)$. For each $j$, let $g_{1,j}\equiv \int g_{2,j}(o_1,o_2) dP_0(o_2)$. Fix $g_1\in \mathcal{G}_1$. Recall that, by the definition of $\mathcal{G}_1$, there exists a $g_2\in\mathcal{G}_2$ such that $g_1(\cdot)=\int g_2(\cdot,o)dP_0(o)$. Let $j^*$ be such that $\norm{g_2-g_{2,j^*}}_{2,Q_2}\le \epsilon\norm{G_2}_{2,Q_2}$ for this $g_2$. Observe that \begin{align*} \norm{g_1-g_{1,j^*}}_{2,Q_1}^ &= \int \left(\int \left[g_2(o_1,o_2)-g_{2,j^*}(o_1,o_2)\right]dP_0(o_2)\right)^2 dQ_1(o_1) \\ &\le \int \left[g_2(o_1,o_2)-g_{2,j^*}(o_1,o_2)\right]^2 dQ_2(o_1,o_2) = \norm{g_2-g_{2,j^*}}_{2,Q_2}^2. \end{align*} By the choice of $j^*$, it follows that $\norm{g_1-g_{1,j^*}}_{2,Q_1}\le \epsilon \norm{G_2}_{2,Q_2}=\epsilon \norm{G_1}_{2,Q_1}$, where we used that $G_1\equiv 1$ and $G_2\equiv 1$. That is, $g_{1,1},\ldots,g_{1,m}$ is an $\epsilon \norm{G_1}_{2,Q_1}$ cover of $\mathcal{G}_1$ under $\norm{\cdot}_{2,Q_1}$. Thus, $N(\epsilon,Q_1,\mathcal{G}_1,G_1)\le m$. Recalling that we took $m=N(\epsilon,Q_2,\mathcal{G}_2,G_2)$, we have shown that $N(\epsilon,Q_1,\mathcal{G}_1,G_1)\le N(\epsilon,Q_2,\mathcal{G}_2,G_2)$. As $Q_1$ was arbitrary, for each $Q_1$ with support $\mathscr{O}$ there exists a $Q_2$ with support $\mathscr{O}^2$ such that the the preceding inequality holds. Hence, \eqref{eq:coveringnums} holds, and thus so too does the uniform entropy integral ordering \eqref{eq:entropyints}. \section*{Appendix C: proofs} For any $T\in\mathscr{S}$, we will use the shorthand notation $T_t\triangleq T_{P_t}$, $\left.\frac{d}{dt}T_t\right|_{t=\tilde{t}}\triangleq \dot{T}_{\tilde{t}}$ and $\left.\frac{d^2}{dt^2}T_t\right|_{t=\tilde{t}}\triangleq \ddot{T}_{\tilde{t}}$. Throughout the appendix we use the following fluctuation submodel through $P_0$ for pathwise differentiability proofs: \begin{align} dP_t(o)&\triangleq \left(1 + th_1(o) + t^2 h_2(o)\right)dP_0(o), \nonumber \\ &\mbox{ where }P_0 h_j = 0\textrm{ and }\sup_{o\in\mathcal{O}}|h_j(o)|<\infty, j=1,2. \label{eq:fluctsubmod} \end{align} \subsection*{Proofs for \secref{sec:rep}} We give two lemmas before proving \autoref{thm:pd1}. \begin{applemma} \label{lem:phidt} For any $T,U\in\mathscr{S}$ and any fluctuation submodel $dP_t=\left(1+th_1+t^2h_2\right)dP_0$, we have that, for all $\tilde{t}$ in a neighborhood of zero, \begin{align*} \dot{\Phi}^{TU}_{\tilde{t}}\ &=\ \int\left[\int e^{-[T_{\tilde{t}}(x_1^T)-U_{\tilde{t}}(x_2^U)]^2} dP_{\tilde{t}}(x_1^T)\right]\left[h_1(o_2) + 2\tilde{t}h_2(o_2)\right]dP_0(o_2) \\ &\hspace{.2in}+ \int\left[\int e^{-[T_{\tilde{t}}(x_1^T)-U_{\tilde{t}}(x_2^U)]^2} dP_{\tilde{t}}(x_2^U)\right]\left[h_1(o_1) + 2\tilde{t}h_2(o_1)\right]dP_0(o_1) \\ &\hspace{.2in}-2\iint \left[T_{\tilde{t}}(x_1^T)-U_{\tilde{t}}(x_2^U)\right]\left[\left.\frac{d}{dt}T_t(x_1^T)\right|_{t=\tilde{t}}-\left.\frac{d}{dt}U_t(x_2^U)\right|_{t=\tilde{t}}\right] e^{-[T_{\tilde{t}}(x_1^T)-U_{\tilde{t}}(x_2^U)]^2} dP_{\tilde{t}}(x_2^U)dP_{\tilde{t}}(x_1^T). \end{align*} \end{applemma} \begin{proof}[Proof of \autoref{lem:phidt}] We have that \begin{align*} \dot{\Phi}^{TU}_{\tilde{t}}\ &=\ \frac{d}{dt}\left.\iint e^{-[T_t(x_1^T)-U_t(x_2^U)]^2} \left\{\prod_{j=1}^2\left[1+th_1(o_j)+t^2h_2(o_j)\right]\right\}dP_0(o_2)dP_0(o_1)\right|_{t=\tilde{t}} \\ &=\ \iint \frac{d}{dt}\left.e^{-[T_t(x_1^T)-U_t(x_2^U)]^2} \left\{\prod_{j=1}^2\left[1+th_1(o_j)+t^2h_2(o_j)\right]\right\}\right|_{t=\tilde{t}}dP_0(o_2)dP_0(o_1)\ , \end{align*} where the derivative is passed under the integral in view of \ref{it:Sderivsbdd}. The result follows by the chain rule. \end{proof} For each $T,U\in\mathscr{S}$, define \begin{align*} D^{TU}(o)\ &\triangleq \ -2\Phi^{TU}(P_0) + \int \left\{2\left[U_0(o_1)-T_0(o)\right]D_0^T(o) + 1\right\} e^{-[T_0(o)-U_0(o_1)]^2} dP_0(o_1) \\ &\hspace{0.5in}+ \int \left\{2\left[T_0(o_1)-U_0(o)\right]D_0^U(o) + 1\right\} e^{-[T_0(o_1)-U_0(o)]^2} dP_0(o_1)\ . \end{align*} We have omitted the dependence of $D^{TU}$ on $P_0$ in the notation. We first give a key lemma about the parameter $\Phi^{TU}$. \begin{applemma}[First-order canonical gradient of $\Phi^{TU}$] \label{lem:phiuv} Let $T$ and $U$ be members of $\mathscr{S}$. Then $\Phi^{TU}$ has canonical gradient $D^{TU}$ at $P_0$. \end{applemma} \begin{proof}[Proof of \autoref{lem:phiuv}] To consider first-order behavior it suffices to consider fluctuation submodels in which $h_2(o)=0$ for all $o$. We first derive the first-order pathwise derivative of the parameter $\Phi^{TU}$ at $P_0$. Applying the preceding lemma at $\tilde{t}=0$ yields that \begin{align*} \frac{d}{dt}&\Phi^{TU}(P_t)\Big|_{t=0}= \int\left[\int e^{-[T_0(x_1^T)-U_0(x_2^U)]^2} dP_0(x_1^T)\right]h_1(o_2)dP_0(o_2) \\ &+ \int\left[\int e^{-[T_0(x_1^T)-U_0(x_2^U)]^2} dP_0(x_2^U)\right]h_1(o_1)dP_0(o_1) \\ &-2\int\int (T_0(x_1^T)-U_0(x_2^U))(\dot{T}_0(x_1^T)-\dot{U}_0(x_2^U))e^{-[T_0(x_1^T)-U_0(x_2^U)]^2} dP_0(x_2^U)dP_0(x_1^T). \end{align*} The first two terms in the last equality are equal to \begin{align*} \textrm{First term}&= \int \left(E_{P_0}\left[e^{-[T_0(X^T)-U_0(x^U)]^2}\right]-E_{P_0^2}\left[e^{-[T_0(X_1^T)-U_0(X_2^U)]^2}\right]\right)h_1(o)dP_0(o) \\ \textrm{Second term}&= \int \left(E_{P_0}\left[e^{-[T_0(x^T)-U_0(X^U)]^2}\right]-E_{P_0^2}\left[e^{-[T_0(X_1^T)-U_0(X_2^U)]^2}\right]\right)h_1(o)dP_0(o). \end{align*} We now look to find the portion of the canonical gradient given by the third term. We have that \begin{align*} -2\int\int&(T_0(x_1^T)-U_0(x_2^U))\dot{T}_0(x_1^T)e^{-[T_0(x_1^T)-U_0(x_2^U)]^2} dP_0(x_2^U)dP_0(x_1^T) \\ &= \int 2E_{P_0}\left[ (U_0(X^U)-T_0(x^T)) e^{-[T_0(x^T)-U_0(X^U)]^2} \right]D_0^T(o)h_1(o)dP_0(o) \\ 2\int\int&(T_0(x_1^T)-U_0(x_2^U))\dot{U}_0(x_2^U)e^{-[T_0(x_1^T)-U_0(x_2^U)]^2} dP_0(x_2^U)dP_0(x_1^T) \\ &= \int 2E_{P_0}\left[ (T_0(X^T)-U_0(x^U)) e^{-[T_0(X^T)-U_0(x^U)]^2} \right]D_0^U(o)h_1(o)dP_0(o). \end{align*} Collecting terms, a first-order Taylor expansion of $t\mapsto \Phi^{TU}(P_t)$ about $t=0$ yields that \begin{align*} \Phi^{TU}(P_t) - \Phi^{TU}(P_0)&= tE_{P_0}\left[D^{TU}(O)h_1(O)\right]+ o(t). \end{align*} Thus $\Phi^{TU}$ has canonical gradient $D^{TU}$ at $P_0$. \end{proof} The proof of \autoref{thm:pd1} is simple given the above lemma. \begin{proof}[Proof of \autoref{thm:pd1}] \autoref{lem:phiuv}, the fact that $\Psi(P)\triangleq \Phi^{RR}(P) - 2\Phi^{RS}(P) + \Phi^{SS}(P)$, and the linearity of differentiation immediately yield that the canonical gradient of $\Psi$ can be written as $D^{RR} - 2 D^{RS} + D^{SS}$. Straightforward calculations show that this is equivalent to $o\mapsto 2[P_0 \Gamma_0(o,\cdot)-\psi_0]$. \end{proof} We will use the following lemma in the proof of \autoref{cor:D1degen} to prove that $R_0(O)$ and $S_0(O)$ are degenerate if $D_1^{\Psi}\equiv 0$ and $\mathscr{H}_0$ does not hold. Because we were unable to find the proof that the $U$-statistic kernel for estimating the MMD of two variables $X$ and $Y$ is degenerate if and only if $\mathscr{H}_0$ holds or $X$ and $Y$ are degenerate, we give a proof here that applies in a more general setting than that which we consider in this paper. \begin{applemma} \label{lem:RSdegen} Let $Q$ be a distribution over $(X,Y)\in\mathcal{Z}^2$, where $\mathcal{Z}$ is a compact metric space. Let $(x,y)\mapsto k(x,y)$ be a universal kernel on this metric space, i.e. a kernel for which the resulting reproducing kernel Hilbert space $\mathcal{H}$ is dense in the set of continuous funtions on $\mathcal{Z}$ with respect to the supremum metric. Further, suppose that $E_Q\sqrt{k(X,X)}$ and $E_Q\sqrt{k(Y,Y)}$ are finite. Finally, suppose that the marginal distribution of $X$ under $Q$ is different from the marginal distribution of $Y$ under $Q$. There exists some fixed constant $C$ such that \begin{align} \int \langle \phi(x_1)-\phi(y_1),\phi(x_2)-\phi(y_2)\rangle_{\mathcal{H}} dQ(x_2,y_2)=C \label{eq:canonical} \end{align} for ($Q$ almost) all $(x_1,y_1)\in\mathcal{Z}^2$ if and only if the joint distribution of $(X,Y)$ under $Q$ is degenerate at a single point. Above $\langle\cdot,\cdot\rangle_{\mathcal{H}}$ and $\phi(z)\triangleq k(z,\cdot)$ are the inner product and the feature map in $\mathcal{H}$, respectively. \end{applemma} \begin{proof} If $Q$ is degenerate then clearly (\ref{eq:canonical}) holds. If (\ref{eq:canonical}) holds, then our assumption that $X$ has a different marginal distribution than $Y$ tells us that $C>0$ \citep{Grettonetal2012}. Hence, for almost all $(x_1,y_1)$, \begin{align*} \langle\phi(x_1)-\phi(y_1),\mu_X-\mu_Y\rangle_{\mathcal{H}} - \langle\mu_X-\mu_Y,\mu_X-\mu_Y\rangle_{\mathcal{H}}=0, \end{align*} where $\mu_X$ and $\mu_Y$ in $\mathcal{H}$ have the property that $\langle\mu_X,f\rangle_{\mathcal{H}}=E_Q f(X)$ and $\langle\mu_Y,f\rangle_{\mathcal{H}}=E_Q f(Y)$ for all $f\in\mathcal{H}$ \citep[Lemma 3 in][]{Grettonetal2012}. The above holds if and only if $\phi(x_1)-\phi(y_1)=\mu_X-\mu_Y$. Noting that $\mu_X-\mu_Y$ does not rely on $x_1,y_1$, it follows that $\phi(x_1)-\phi(y_1)$ must not rely on $x_1,y_1$ for all $(x_1,y_1)$ in some $Q$ probability one set $\mathcal{D}\subseteq\mathcal{Z}^2$. Fix a continuous function $f : \mathcal{Z}\rightarrow\mathbb{R}$ and $x_1,y_1\in\mathcal{D}$. For any $\epsilon>0$, the universality of $\mathcal{H}$ ensures that there exists an $f_{\epsilon}\in\mathcal{H}$ such that $\norm{f_{\epsilon}-f}_{\infty}\le\epsilon$. By the triangle inequality, \begin{align*} \left|f(x_1)-f(y_1) - f_{\epsilon}(x_1)+f_{\epsilon}(y_1)\right|&\le 2\epsilon. \end{align*} Because $\phi(x_1)-\phi(y_1)$ is constant and $f\in\mathcal{H}$, $\langle\phi(x_1)-\phi(y_1),f_{\epsilon}\rangle_{\mathcal{H}}=f_{\epsilon}(x_1)-f_{\epsilon}(y_1)$ does not rely on $x_1,y_1$ for any $\epsilon$. Furthermore, the fact that $f_{\epsilon}$ converges to $f$ in supremum norm ensures that $|f_{\epsilon}(x_1)-f_{\epsilon}(y_1)|$ converges to a fixed quantity $K$ (which does not rely on $x_1$ or $y_1$) as $\epsilon\rightarrow 0$. Applying this to the above yields that $f(x_1)-f(y_1)=K$. As $f$ was an arbitrary continuous function and $X_1\not\equiv Y_1$, we can apply this relation to $z\mapsto z$ and $z\mapsto z^2$ to show that $x_1-y_1$ and $x_1+y_1$ do not rely on the choice of $(x_1,y_1)\in\mathcal{D}$. Hence $(x_1-y_1 + x_1 + y_1)/2=x_1$ and $(x_1 + y_1 - y_1 + x_1)/2=y_1$ do not rely on the choice of $(x_1,y_1)\in\mathcal{D}$. This can only occur if $(x_1,y_1)$ are constant over the probability $1$ set $\mathcal{D}$, i.e. if $Q$ is degenerate. \end{proof} For the two-sample problem in \cite{Grettonetal2012}, one can take $Q$ to be a product distribution of the marginal distribution of $X$ and the marginal distribution of $Y$. \begin{proof}[Proof of \autoref{cor:D1degen}] We first prove sufficiency. If \hyperlink{it:condH0}{(i)} holds, then $2D^{RS}=D^{RR} + D^{SS}$. It follows that $D_1^{\Psi}\equiv 0$ under $\mathscr{H}_0$. Now suppose \hyperlink{it:conddegen}{(ii)} holds. It is a simple matter of algebra to verify that $D_1^{RR}\equiv D_1^{RS}\equiv D_1^{SS}\equiv 0$. Hence $D_1^{\Psi}\equiv 0$, yielding the sufficiency of the stated conditions. We now show the necessity of the stated conditions. Suppose that $\sigma_0=0$ and $\mathscr{H}_0$ does not hold. It is easy to verify that \begin{align*} \tilde{D}_1^{\Psi}\triangleq&\; E_{P_0}\left[e^{-[R_0(O)-R_0(o)]^2}\right] + E_{P_0}\left[e^{-[S_0(O)-S_0(o)]^2}\right] \nonumber \\ &-E_{P_0}\left[e^{-[R_0(O)-S_0(o)]^2}\right] - E_{P_0}\left[e^{-[R_0(o)-S_0(O)]^2}\right]-\psi_0 \end{align*} is a first-order gradient in the model where $R_0$ and $S_0$ are known (possibly an inefficient gradient depending on the form of $R$ and $S$). Call the variance of this gradient $\tilde{\sigma}_0$. As the model where $R_0$ and $S_0$ are known is a submodel of the (locally) nonparametric model, $\tilde{\sigma}_0\le \sigma_0$, and hence $\tilde{\sigma}_0=0$ and $\tilde{D}_1^{\Psi}\equiv 0$. Now, if $\tilde{\sigma}_0=0$ and $\mathscr{H}_0$ does not hold, then \autoref{lem:RSdegen} shows that $R_0(O)$ and $S_0(O)$ are degenerate. Finally, $\tilde{D}_1^{\Psi}\equiv 0$ and the degeneracy of $R_0(O)$ and $S_0(O)$ shows that for almost all $o$, \begin{align*} D_1^{\Psi}(o)&= 2D^{RS}(o) = 2(s_0-r_0)\left(D_0^R(o)-D_0^S(o)\right) e^{-[r_0-s_0]^2}, \end{align*} where we use $r_0$ and $s_0$ to denote the (probability $1$) values of $R_0(O)$ and $S_0(O)$. The above is zero almost surely if and only if $D_0^R\equiv D_0^S$. Thus $\sigma_0=0$ only if \hyperlink{it:condH0}{(i)} or \hyperlink{it:conddegen}{(ii)} holds. \end{proof} We give the following lemma before proving \autoref{thm:pd2}. Before giving the lemma, we define the function $\Pi : \mathscr{S}\rightarrow\mathbb{R}$. Suppressing the dependence on $P_0$ and $h_1$, $h_2$, for all $V\in\mathscr{S}$ and $t\not=0$ we define \begin{align*} \Pi(V)&\triangleq 2\int\int \Big[2 (V_0(o_2)-V_0(o_1)) \dot{V}_0(o_2)h_1(o_2) + 2 (V_0(o_2)-V_0(o_1))^2 \dot{V}_0(o_2)^2 \\ &\hspace{5em}+ h_2(o_2) - \dot{V}_0(o_2)^2 + (V_0(o_2)-V_0(o_1))\ddot{V}_0(o_2)\Big]e^{-[V_0(o_2)-V_0(o_1)]^2} dP_0(o_2) dP_0(o_1). \end{align*} \begin{applemma} \label{lem:phi2d} For any fluctuation submodel consistent with (\ref{eq:fluctsubmod}), $T,U\in\mathscr{S}$ with $T_0(O)\eqd U_0(O)$, and $t\in\mathbb{R}$ sufficiently close to zero, we have that \begin{align*} \frac{d^2}{dt^2}\Phi^{TU}(P_t)\Big|_{t=0}=&\; 2\int\int \Gamma_0^{TU}(o_1,o_2) h_1(o_1)h_1(o_2)dP_0(o_2)dP_0(o_1) + \Pi(T) + \Pi(U). \end{align*} \end{applemma} \begin{proof} Let $H_t(o)\triangleq 1 + th_1(o) + t^2h_2(o)$ and $\dot{H}_t(o)\triangleq h_1(o) + 2th_2(o)$. \begin{align} \frac{d^2}{dt^2}\Phi^{TU}(P_t)\Big|_{t=0}=&\; \frac{d}{dt}\int\int \Big[H_t(o_1)\dot{H}_t(o_2) + \dot{H}_t(o_1) H_t(o_2) \nonumber \\ &\hspace{5em}-2 (T_{t}(o_1)-U_{t}(o_2))\left(\dot{T}_t(o_1)-\dot{U}_t(o_2)\right) H_t(o_1) H_t(o_2)\Big] \nonumber \\ &\hspace{4em}\times e^{-[T_{t}(o_1)-U_{t}(o_2)]^2} dP_0(o_2)dP_0(o_1)\Big|_{t=0} \label{eq:messyprodrule} \end{align} We will pass the derivative inside the integral using \ref{it:Sderivsbdd} and apply the product rule. The first term we need to consider is \begin{align*} \frac{d}{dt}&\Big[H_t(o_1)\dot{H}_t(o_2) + \dot{H}_t(o_1) H_t(o_2)-2 (T_{t}(o_1)-U_{t}(o_2))\left(\dot{T}_t(o_1)-\dot{U}_t(o_2)\right) H_t(o_1) H_t(o_2)\Big]\Big|_{t=0} \\ =&\; 2\left[h_2(o_1) + h_1(o_1)h_1(o_2) + h_2(o_2)\right] - 2\left(\dot{T}_0(o_1)-\dot{U}_0(o_2)\right)^2 -2 (T_0(o_1)-U_0(o_2))\left(\ddot{T}_0(o_1)-\ddot{U}_0(o_2)\right) \\ &\hspace{2em} -2 (T_0(o_1)-U_0(o_2))\left(\dot{T}_0(o_1)-\dot{U}_0(o_2)\right) \left(h_1(o_1)+h_1(o_2)\right). \end{align*} The second is \begin{align*} \left.\frac{d}{dt}e^{-[T_{t}(o_1)-U_{t}(o_2)]^2}\right|_{t=0}&= -2 (T_0(o_1)-U_0(o_2))\left(\dot{T}_0(o_1)-\dot{U}_0(o_2)\right)e^{-[T_0(o_1)-U_0(o_2)]^2}. \end{align*} Returning to (\ref{eq:messyprodrule}), this shows that $\frac{d^2}{dt^2}\Phi^{TU}(P_t)\Big|_{t=0}$ is equal to \begin{align*} &2\int\int \Big[-2 (T_0(o_1)-U_0(o_2)) \dot{T}_0(o_1)h_1(o_1) + 2 (T_0(o_1)-U_0(o_2))^2 \dot{T}_0(o_1)^2 \\ &\hspace{4.5em} + h_2(o_1) - \dot{T}_0(o_1)^2 - (T_0(o_1)-U_0(o_2))\ddot{T}_0(o_1)\Big] e^{-[T_0(o_1)-U_0(o_2)]^2} dP_0(o_2)dP_0(o_1) \\ &+2\int\int \Big[2 (T_0(o_1)-U_0(o_2)) \dot{U}_0(o_2)h_1(o_2) + 2 (T_0(o_1)-U_0(o_2))^2 \dot{U}_0(o_2)^2 \\ &\hspace{4.5em} + h_2(o_2) - \dot{U}_0(o_2)^2 + (T_0(o_1)-U_0(o_2))\ddot{U}_0(o_2)\Big] e^{-[T_0(o_1)-U_0(o_2)]^2} dP_0(o_2)dP_0(o_1) \\ &+2\int\int \Big[2(T_0(o_1)-U_0(o_2))\left(\dot{U}_0(o_2)h_1(o_1)-\dot{T}_0(o_1)h_1(o_2)\right) \\ &\hspace{4em} - \left(4(T_0(o_1)-U_0(o_2))^2-2\right) \dot{T}_0(o_1) \dot{U}_0(o_2) + h_1(o_1)h_1(o_2)\Big]e^{-[T_0(o_1)-U_0(o_2)]^2} dP_0(o_2)dP_0(o_1). \end{align*} The expression inside the second pair of integrals only depends on $o_1$ through $T(o_1)$. Thus we can rewrite this term as $E_{P_0}[f(T(O_1))]$ for a fixed function $f$ that relies on $P_0$, $h_1$, $h_2$, and $U$. Under $\mathscr{H}_0$, we can rewrite this term as $E_{P_0}[f(U(O_1))]$. That is, we can replace each $T(O_1)$ in the second pair of integrals with $U(O_1)$. This yields $\Pi(U)$. Switching the roles of $o_1$ and $o_2$ in the first pair of integrals above and applying Fubini's theorem shows that \begin{align*} 2\int\int \Big[&2 (T_0(o_2)-U_0(o_1)) \dot{T}_0(o_2)h_1(o_2) + 2 (T_0(o_2)-U_0(o_1))^2 \dot{T}_0(o_2)^2 \\ &+ h_2(o_2) - \dot{T}_0(o_2)^2 + (T_0(o_2)-U_0(o_1))\ddot{T}_0(o_2)\Big] e^{-[T_0(o_2)-U_0(o_1)]^2} dP_0(o_2) dP_0(o_1). \end{align*} By the same arguments used to for the second pair of integrals, the above expression is equal to $\Pi(T)$ under $\mathscr{H}_0$. By \ref{it:Spd}, the third pair of integrals can be rewritten as \begin{align*} &2\int\int \Big[2(T_0(o_1)-U_0(o_2))\left(D_0^U(o_2) -D_0^T(o_1)\right) - \left(4(T_0(o_1)-U_0(o_2))^2-2\right)D_0^T(o_1)D_0^U(o_2) + 1\Big] \\ &\hspace{4em}\times e^{-[T_0(o_1)-U_0(o_2)]^2} h_1(o_1)h_1(o_2)dP_0(o_2)dP_0(o_1). \end{align*} \end{proof} \begin{proof}[Proof of \autoref{thm:pd2}] We start by noting that $\left.\frac{1}{2}\frac{d^2}{dt^2}\psi_t\right|_{t=0}$ is equal to \begin{align*} \frac{1}{2}&\left[\left.\frac{d^2}{dt^2}\Phi^{TT}(P_t)\right|_{t=0} + \left.\frac{d^2}{dt^2}\Phi^{UU}(P_t)\right|_{t=0} - \left.\frac{d^2}{dt^2}\Phi^{TU}(P_t)\right|_{t=0} - \left.\frac{d^2}{dt^2}\Phi^{UT}(P_t)\right|_{t=0}\right] \\ =&\; \int\int \left[\Gamma_0^{RR}(o_1,o_2) + \Gamma_0^{SS}(o_1,o_2) - \Gamma_0^{RS}(o_1,o_2) - \Gamma_0^{SR}(o_1,o_2)\right] h_1(o_1)h_1(o_2)dP_0(o_2)dP_0(o_1) \\ =& \frac{1}{2}\int\int D_2^{\Psi}(o_1,o_2)h_1(o_1)h_1(o_2)dP_0(o_2)dP_0(o_1), \end{align*} where the penultimate equality makes use of \autoref{lem:phi2d}. It is easy to verify that $D_2^{\Psi}(o_1,o_2)=D_2^{\Psi}(o_2,o_1)$ for all $o_1,o_2$. The arguments given below the theorem statement in the main text establish the one-degeneracy of $\Gamma_0$ under $\mathscr{H}_0$ show that $E_{P_0}[D_2^{\Psi}(O,o)]= E_{P_0}[D_2^{\Psi}(o,O)] = 0$ for all $o\in\mathcal{O}$ under $\mathscr{H}_0$. \condref{it:Sderivsbdd} ensures that $\norm{D_2^{\Psi}}_{2,P_0^2}<\infty$, and thus $D_2^{\Psi}$ is $P_0^2$ square integrable and one-degenerate. Because the first pathwise derivative is zero under the null, we have that \begin{align*} \psi_t - \psi_0&= \frac{1}{2}t^2 \int \int D_2^{\Psi}(o_1,o_2) h(o_1) h(o_2) dP_0(o_1)dP_0(o_2) + o(t^2). \end{align*} Thus $D_2^{\Psi}$ is a second-order canonical gradient of $\Psi$ at $P_0$. \end{proof} We give a lemma before proving \autoref{thm:remthirdorder}. \begin{applemma} \label{lem:phi2ndorder} Fix $P\in\mathscr{M}$. For all $T,U\in\mathscr{S}$, let \begin{align*} \operatorname{Rem}_P^{\Phi^{TU}}\triangleq&\; \twonorm{L_P^{TU}}\twonorm{M_P^{TU}} + \onenorm{\operatorname{Rem}_P^T}\onenorm{\operatorname{Rem}_P^U} + \fournorm{M_P^{TU}}^4. \end{align*} There exists a mapping $\zeta(P,P_0,\cdot) : \mathscr{S}\rightarrow\mathbb{R}$ such that, for all $T,U\in\mathscr{S}$ for which $T_0(O)\eqd U_0(O)$, \begin{align*} \Big|P_0^2\Gamma_P^{TU}-\Phi^{TU}(P_0) - \zeta(P,P_0,T) - \zeta(P,P_0,U)\Big|&\lesssim \operatorname{Rem}_P^{\Phi^{TU}} \end{align*} \end{applemma} \begin{proof}[Proof of \autoref{lem:phi2ndorder}] In this proof we use $F(P,P_0,T,U)$ to denote any constant which can be written as $\tilde{\zeta}(P,P_0,T)+\tilde{\zeta}(P,P_0,U)$ for expressions $\tilde{\zeta}(P,P_0,T)$ and $\tilde{\zeta}(P,P_0,U)$ which satisfy $\tilde{\zeta}(P,P_0,T)=\tilde{\zeta}(P,P_0,U)$ whenever $T=U$. We will write $c_1 F(P,P_0,T,U) + c_2 F(P,P_0,T,U) = F(P,P_0,T,U)$ for any real numbers $c_1,c_2$. We then fix $\zeta$ to be the final instance of $\tilde{\zeta}$ upon exiting the proof. Fix $T,U\in\mathscr{S}$. Let $b_0(o_1,o_2)\triangleq T_0(o_1)-U_0(o_2)$ and $b(o_1,o_2)\triangleq T_P(o_1)-U_P(o_2)$ for any $o_1,o_2$. For ease of notation, in the expected values below we will write $B$ and $B_0$ to refer to $b(O_1,O_2)$ and $b_0(O_1,O_2)$, respectively. We also write $T$ for $T_P(O_1)$, $T_0$ for $T_0(O_1)$, $\operatorname{Rem}_P^T$ for $\operatorname{Rem}_P^T(O_1)$, $U$ for $U_P(O_2)$, $U_0$ for $U_0(O_2)$, and $\operatorname{Rem}_P^U$ for $\operatorname{Rem}_P^U(O_2)$. We have that \begin{align*} P_0^2\Gamma_P^{TU}-\Phi^{TU}(P_0)=&\; E_{P_0^2}\left[e^{-B^2} - e^{-B_0^2}\right] + E_{P_0^2}\left[2B\left(D_P^U(O_2) -D_P^T(O_1)\right) e^{-B^2}\right] \\ &-E_{P_0^2}\left[\left(4B^2-2\right)D_P^T(O_1)D_P^U(O_2) e^{-B^2} \right] \\ =&\; E_{P_0^2}\left[e^{-B^2} - e^{-B_0^2}\right] - E_{P_0^2}\left[2B\left(B_0-B\right) e^{-B^2}\right] \\ &+ E_{P_0^2}\left[2B\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right) e^{-B^2}\right] -E_{P_0^2}\left[\left(4B^2-2\right)\left[T-T_0\right]\left[U-U_0\right] e^{-B^2} \right] \\ &-E_{P_0^2}\left[\left(4B^2-2\right)\left(\left[T-T_0\right]\operatorname{Rem}_P^U + \operatorname{Rem}_P^T\left[U-U_0\right]\right) e^{-B^2} \right] \\ &-E_{P_0^2}\left[\left(4B^2-2\right)\operatorname{Rem}_P^T \operatorname{Rem}_P^U e^{-B^2} \right]. \end{align*} A third-order Taylor expansion of $b_0\mapsto \exp(-b_0^2)$ about $b_0=b$ yields \begin{align*} e^{-b^2}-e^{-b_0^2}=&2b(b_0-b)e^{-b^2} - \left(2b^2-1\right)(b_0-b)^2e^{-b^2} + \frac{2}{3}b\left(2b^2-3\right)(b_0-b)^3e^{-b^2} + O\left((b_0-b)^4\right), \end{align*} where the magnitude of the $O((b_0-b)^4)$ term is uniformly bounded above by $C(b_0-b)^4$ for some constant $C>0$ when $b_0$ and $b$ fall in $[-1,1]$. For the second-order term, we have \begin{align*} E_{P_0^2}\left[-\left(2B^2-1\right)(B_0-B)^2e^{-B^2}\right]=&\;E_{P_0^2}\left[\left(4B^2-2\right)\left(T-T_0\right)\left(U-U_0\right)e^{-B^2}\right] \\ &-E_{P_0^2}\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)\left(2B^2-1\right)e^{-B^2}\right]. \end{align*} Thus we have that \begin{align} P_0^2\Gamma_P^{TU}-\Phi^{TU}(P_0) \nonumber=&\, E_{P_0^2}\left[2B\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right) e^{-B^2}\right] \nonumber \\ &+ O\left(\fournorm{B-B_0}^4\right) - E_{P_0^2}\left[\left(4B^2-2\right)\operatorname{Rem}_P^T \operatorname{Rem}_P^U e^{-B^2} \right] \nonumber \\ &-E_{P_0^2}\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)\left(2B^2-1\right)e^{-B^2}\right] \nonumber \\ &+ \frac{2}{3}E_{P_0}\left[B\left(2B^2-3\right)(B_0-B)^3e^{-B^2}\right]. \label{eq:almosthere} \end{align} A Taylor expansion of $f_1(z)= 2ze^{-z^2}$ shows that there exists a $\tilde{B}_1(o_1,o_2)$ that falls between $B(o_1,o_2)$ and $B_0(o_1,o_2)$ for all $o_1,o_2$ such that \begin{align} E_{P_0^2}\left[2B\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right) e^{-B^2}\right] =&\, E_{P_0^2}\left[\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right)\left(2B_0e^{-B_0^2} + (B-B_0)\dot{f}_1(\tilde{B})\right)\right] \nonumber \\ =&\, F(P,P_0,T,U) + E_{P_0^2}\left[\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right)(B-B_0)\dot{f}_1(\tilde{B})\right], \label{eq:taylor1} \end{align} where the second equality holds under $\mathscr{H}_0$. The boundedness of $\dot{f}_1$ in $[-2,2]$, the triangle inequality, and the Cauchy-Schwarz inequality yield \begin{align} E_{P_0^2}&\left|\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right)(B-B_0)\dot{f}_1(\tilde{B})\right| \lesssim E_{P_0^2}\left|\left(\operatorname{Rem}_P^U -\operatorname{Rem}_P^T\right)(B-B_0)\right| \nonumber \\ &\lesssim E_{P_0^2}\left|L_P^{TU}(O_1)M_P^{TU}(O_2)\right| + E_{P_0}\left|L_P^{TU}\right|E_{P_0}\left|M_P^{TU}\right| \lesssim \twonorm{L_P^{TU}}\twonorm{M_P^{TU}}. \label{eq:cs} \end{align} A Taylor expansion of $f_2(z)= (2z^2-1)e^{-z^2}$ yields that there exists a $\tilde{B}_2$ that falls between $B$ and $B_0$ such that \begin{align*} E_{P_0^2}&\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)\left(2B^2-1\right)e^{-B^2}\right] \\ =&\, E_{P_0^2}\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)\left(2B_0^2-1\right)e^{-B_0^2}\right] \\ &+ 2E_{P_0^2}\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)(B-B_0)\left(B(2B^2-3)\right)e^{-B^2}\right] \\ &+ E_{P_0^2}\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)(B-B_0)^2\frac{\ddot{f}_2(\tilde{B}_2)}{2}\right]. \end{align*} The first line on the right is equal to $F(P,P_0,T,U)$ under $\mathscr{H}_0$. By the triangle inequality and the boundedness of $\ddot{f}_2$ on $[-2,2]$, the third line satisfies \begin{align} E_{P_0^2}&\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)(B-B_0)^2\frac{\ddot{f}_2(\tilde{B}_2)}{2}\right] \lesssim \sum_{k=0}^4 E_{P_0^2}\left|\left[T-T_0\right]^k \left[U-U_0\right]^{4-k}\right| \nonumber\\ &\lesssim \sum_{k=0}^4 E_{P_0}\left|[M_P^{TU}]^k\right| E_{P_0}\left|[M_P^{TU}]^{4-k}\right| \lesssim \fournorm{M_P^{TU}}^4. \label{eq:fkg} \end{align} The final inequality above holds by the FKG inequality \citep{Fortuinetal1971}. It follows that \begin{align} E_{P_0^2}&\left[\left(\left[T-T_0\right]^2 + \left[U-U_0\right]^2\right)\left(2B^2-1\right)e^{-B^2}\right] + \frac{2}{3}E_{P_0}\left[B\left(2B^2-3\right)(B_0-B)^3e^{-B^2}\right] \nonumber \\ =&\, \frac{4}{3}E_{P_0^2}\left[\left(\left[T-T_0\right]^3 - \left[U-U_0\right]^3\right)B(2B^2-3)e^{-B^2}\right] + F(P,P_0,T,U) + O(\fournorm{M_P^{TU}}^4) \nonumber \\ =&\, F(P,P_0,T,U) + O(\fournorm{M_P^{TU}}^4), \label{eq:taylor2} \end{align} where the final equality holds under $\mathscr{H}_0$ by a Taylor expansion of $z\mapsto z(2z^2-3)e^{-z^2}$ and analogous calculations to those used in (\ref{eq:fkg}). We note that the second equality above uses a different $F$ and a different big-O term than the line above, and that the big-O term can be upper bounded by $C\fournorm{M_P^{TU}}^4$ for a constant $C>0$. Plugging (\ref{eq:taylor1}), (\ref{eq:cs}), and (\ref{eq:taylor2}) into (\ref{eq:almosthere}), applying the triangle inequality, and using the bounds on $B$ gives the result. \end{proof} We give a lemma before proving \autoref{thm:remthirdorder}. \begin{applemma} \label{lem:Kbd} Let $K_P\triangleq \onenorm{L_P^{RS}} + \twonorm{M_P^{RS}}^2$ for all $P\in\mathscr{M}$. If $\mathscr{H}_0$ holds, then for all $P\in\mathscr{M}$, \begin{align*} \sup_{o_1\in\mathcal{O}'} \left|P_0 \Gamma_P(o_1,\cdot)\right|\lesssim K_P, \end{align*} where $\mathcal{O}'\subseteq \mathcal{O}$ is some $P_0$ probability $1$ set. More generally, for all $P_0\in\mathscr{M}$, \begin{align*} \left|P_0^2 \Gamma_P-\psi_0\right|&\lesssim K_P. \end{align*} \end{applemma} \begin{proof}[Proof of \autoref{lem:Kbd}] For $T,U\in\mathscr{S}$, we have that \begin{align*} \Gamma_P^{TU}=&\, \left[1+ 2(T_P-U_P) D_P^U\right]e^{-[T_P-U_P]^2} -2\left[(T_P-U_P) + \left(2(T_P-U_P)^2-1\right)D_P^U\right]D_P^Te^{-[T_P-U_P]^2}. \end{align*} Above we have omitted the dependence of $\Gamma^{TU}$ on $(o_1,o_2)$, $T$ and $D_P^T$ on $o_1$, and $U$ and $D_P^U$ on $o_2$. For $P_0$ almost all $o_1\in\mathcal{O}$, $P_0\Gamma_P^{TU}(o_1,\cdot)$ is equal to \begin{align*} P_0&\left[1+ 2(T_P(o_1)-U_P)(U_P-U_0)\right]e^{-[T_P(o_1)-U_P]^2} + O\left(\onenorm{\operatorname{Rem}_P^U}\right) \\ &-2P_0\left[(T_P(o_1)-U_P) + \left(2(T_P(o_1)-U_P)^2-1\right)(U_P-U_0)\right]D_P^T(o_1)e^{-[T_P(o_1)-U_P]^2} \end{align*} where the magnitude of the big-O remainder term is upper bounded by $C\onenorm{\operatorname{Rem}_P^U}$ for a constant $C>0$ which does not depend on $o_1$. Taylor expansions of the first and third terms above yield \begin{align*} P_0\Gamma_P^{TU}(o_1,\cdot)=&\, P_0 e^{-[T_P(o_1)-U_0]^2} -2P_0(T_P(o_1)-U_0)D_P^T(o_1)e^{-[T_P(o_1)-U_0]^2} \\ &+ O\left(\onenorm{\operatorname{Rem}_P^U}\right) + O\left(\twonorm{U_P-U_0}^2\right), \end{align*} where the magnitude of the big-O term can be upper bounded by $C\twonorm{U_P-U_0}^2$. If $T_0(O)\eqd U_0(O)$, then \begin{align*} P_0\Gamma_P^{TU}(o_1,\cdot)=&\, P_0 e^{-[T_P(o_1)-T_0]^2} -2P_0(T_P(o_1)-T_0)D_P^T(o_1)e^{-[T_P(o_1)-T_0]^2} \\ &+ O\left(\onenorm{\operatorname{Rem}_P^U}\right) + O\left(\twonorm{U_P-U_0}^2\right). \end{align*} Recall that $T,U\in\mathscr{S}$ were arbitrary. Using that $\Gamma_P\triangleq \Gamma_P^{RR}-\Gamma_P^{RS}-\Gamma_P^{SR}+\Gamma_P^{SS}$ and applying the triangle inequality gives the first result. We now turn to the second result. For any $T,U\in\mathscr{S}$ and $P\in\mathscr{M}$, we have that \begin{align*} P_0^2 \Gamma_P^{TU}=& \Big[2(T_P-U_P)\left(U_0-U_P -T_0 + T_P\right) + 1 \\ &\;- \left(4(T_P-U_P)^2-2\right)(U_P-U_0)(T_P-T_0)\Big]e^{-[T_P-U_P]^2} + O\left(\onenorm{L_P^{TU}}\right) \\ =& \left[2(T_P-U_P)\left(U_0-U_P -T_0 + T_P\right) + 1\right]e^{-[T_P-U_P]^2} + O\left(\onenorm{L_P^{TU}}\right) + O\left(\twonorm{M_P^{TU}}^2\right) \\ =& \Phi^{TU}(P_0) + O\left(\onenorm{L_P^{TU}}\right) + O\left(\twonorm{M_P^{TU}}^2\right), \end{align*} where the final equality holds by a first-order Taylor expansion of $(t,u)\mapsto e^{-[t-u]^2}$. The fact that $\Gamma_P\triangleq\Gamma_P^{RR} - 2\Gamma_P^{RS} + \Gamma_P^{SS}$ yields the result. \end{proof} \begin{proof}[Proof of \autoref{thm:remthirdorder}] Fix $P\in\mathscr{M}$ and let $P_0$ satisfy $\mathscr{H}_0$. We have that \begin{align*} P_0^2\Gamma_P-\psi_0=&\, P_0^2 \Gamma_P^{RR} - \Phi^{RR}(P_0) + P_0^2 \Gamma_P^{SS} - \Phi^{SS}(P_0) - \left[P_0^2 \Gamma_P^{RS} - \Phi^{RS}(P_0)+P_0^2 \Gamma_P^{SR} - \Phi^{SR}(P_0)\right]. \end{align*} Taking the absolute value of both sides, applying the triangle inequality, and using \autoref{lem:phi2ndorder} yields \begin{align*} \left|P_0^2\Gamma_P-\psi_0\right|&\lesssim \operatorname{Rem}_P^{\Phi^{RR}} + \operatorname{Rem}_P^{\Phi^{SS}} + 2\operatorname{Rem}_P^{\Phi^{RS}}\lesssim \onenorm{L_P^{RS}}^2 + \fournorm{M_P^{RS}}^4 + \twonorm{L_P^{RS}} \twonorm{M_P^{RS}}, \end{align*} where the final inequality uses the maximum in the definition of $L_P^{RS}$ and $M_P^{RS}$. The inequality for when $P_0$ satisfies $\mathscr{H}_1$ is proven in \autoref{lem:Kbd}. \end{proof} \subsection{Proofs for \secref{sec:est}} \begin{proof}[Proof of \autoref{lem:firstordnegl}] By the first result of \autoref{lem:Kbd}, $\left|P_0 \Gamma_n(o_1,\cdot)\right|\lesssim K_n$ for $P_0$ almost all $o_1\in\mathcal{O}'$. We have that \begin{align*} \left|(P_n-P_0)P_0 \Gamma_n\right|&= K_n \left|(P_n-P_0)\left(\frac{P_0 \Gamma_n}{K_n}\right)\right|. \end{align*} The fact that $\left\{o_1\mapsto \frac{P_0 \Gamma_n(o_1,\cdot)}{K_n} : \hat{P}_n\right\}$ belongs to a $P_0$ Donsker class with probability approaching $1$, where $\hat{P}_n$ varies over the set of its possible realizations, yields that $(P_n-P_0)\left(\frac{P_0 \Gamma_n}{K_n}\right)=O_{P_0}(n^{-1/2})$ \citep{vanderVaartWellner1996}, and thus the right-hand side above is $O_{P_0}(K_n/\sqrt{n})$. If $K_n=o_{P_0}(n^{-1/2})$, then this yields that the right-hand side above is $o_{P_0}(n^{-1})$. \end{proof} \begin{proof}[Proof of \autoref{thm:asympt}] Plugging \ref{it:1ordempproc}, \ref{it:2ordempproc}, and \ref{it:remnegl} into (\ref{eq:nullexpansion}) yields \begin{align} \psi_n-\psi_0&= \mathbb{U}_n \Gamma_0 + o_{P_0}(n^{-1}). \label{eq:fixedVstat} \end{align} By Section 5.5.2 of \cite{Serfling1980} and the fact that $\Gamma_0$ is $P_0$ degenerate and uniformly bounded, $n\mathbb{U}_n \Gamma_0\rightsquigarrow \sum_{k=1}^\infty \lambda_k (Z_k^2-1)$. We now prove that all of the eigenvalues of $h(o)\mapsto E_{P_0}\left[\tilde{\Gamma}_0(O,o)h(O)\right]$ are nonnegative. Consider a submodel $\{P_t : t\}$ with first-order score $h_1\in L^2(P_0)$ and second-order score $h_2\equiv 0$. By the second-order pathwise differentiability of $\Psi$, \begin{align*} \frac{\psi_t-\psi_0}{t^2}&= \frac{1}{2} \int \int D_2^{\Psi}(o_1,o_2)h_1(o_1)h_1(o_2)dP_0(o_1)dP_0(o_2) + o(1). \end{align*} The left-hand side is nonnegative for all $t\not=0$ since $\psi_t\ge 0=\psi_0$ under $\mathscr{H}_0$. Thus taking the limit inferior as $t\rightarrow 0$ of both sides shows that \begin{align*} \frac{1}{2} \int \int D_2^{\Psi}(o_1,o_2)h_1(o_1)h_1(o_2)dP_0(o_1)dP_0(o_2)&\ge 0. \end{align*} Using that $\tilde{\Gamma}_0=\Gamma_0$ under $\mathscr{H}_0$ and $\Gamma_0=\frac{1}{2}D_2^{\Psi}$, we have that $\langle o\mapsto E_{P_0}[\tilde{\Gamma}_0(O,o)h_1(O)],h_1 \rangle\ge 0$, where the inner product is that of $L^2(P_0)$. For any $h_1\in L^2(P_0)$, it is well known that one can choose a submodel $P_t$ with first-order score $h_1\in L^2(P_0)$. Hence the above relation holds for all $h_1\in L^2(P_0)$ and all of the eigenvalues of $h(o)\mapsto E_{P_0}\left[\tilde{\Gamma}_0(O,o)h(O)\right]$ are nonnegative. \end{proof} \begin{proof}[Proof of \autoref{cor:Seq0}] In this case $\Gamma_0(o_1,o_2)=2D_0^R(o_1)D_0^R(o_2)$ under $\mathscr{H}_0$. The central limit theorem yields that $\sigma_1^{-1}\sqrt{n} (P_n-P_0) D_0^R\rightsquigarrow Z$. By the continuous mapping theorem, $\sigma_1^{-2}n(P_n-P_0)^2 \Gamma_0/2\rightsquigarrow Z^2$. Now use that \begin{align*} \frac{n \mathbb{U}_n \Gamma_0}{2\sigma_1^2}&= \frac{n}{2\sigma_1^2(n-1)}\left[n(P_n-P_0)^2 \Gamma_0 - \frac{1}{n}\sum_{i=1}^n \Gamma_0(O_i,O_i)\right] \\ &= \frac{n}{2\sigma_1^2(n-1)}\left[n(P_n-P_0)^2 \Gamma_0 - \frac{2}{n}\sum_{i=1}^n D_0^R(O_i)^2\right]. \end{align*} The above quantity converges in distribution to $Z^2 - 1$ by the weak law of large numbers and Slutsky's theorem. \end{proof} \begin{proof}[Proof of \autoref{thm:altasdist}] We have \begin{align*} \psi_n&= 2(P_n-P_0) P_0 \Gamma_n + P_0^2 \Gamma_n + \mathbb{U}_n \tilde{\Gamma}_n \\ &= 2(P_n-P_0) P_0 \Gamma_0 + P_0^2 \Gamma_n + \mathbb{U}_n \tilde{\Gamma}_n + 2(P_n-P_0) P_0\left(\Gamma_n-\Gamma_0\right). \end{align*} By assumption, $\mathbb{U}_n \tilde{\Gamma}_n=o_{P_0}(n^{-1/2})$. The final term is $o_{P_0}(n^{-1/2})$ by the Donsker condition and the consistency condition \citep{vanderVaartWellner1996}. By the second result of \autoref{lem:Kbd} and the assumption that $K_n=o_{P_0}(n^{-1/2})$, this yields that \begin{align*} \psi_n-\psi_0=&\, 2(P_n-P_0) P_0 \Gamma_0 + o_{P_0}(n^{-1/2}). \end{align*} Multiplying both sides by $\sqrt{n}$, and applying the central limit theorem yields the result. \end{proof} \begin{proof}[Proof of \autoref{cor:testconsistent}] We have that \begin{align*} P_0^n\left\{n\psi_n\le \hat{q}_{1-\alpha}^{ub}\right\}&= P_0^n\left\{\frac{\sqrt{n}(\psi_n-\psi_0)}{\sigma_0}\le \frac{\hat{q}_{1-\alpha}^{ub}n^{-1/2} - \sqrt{n}\psi_0}{\sigma_0}\right\} \end{align*} Fix $0<\epsilon<\psi_0$. The right-hand side is equal to \begin{align*} P_0^n&\left\{\frac{\sqrt{n}(\psi_n-\psi_0)}{\sigma_0}\le \frac{\hat{q}_{1-\alpha}^{ub}n^{-1/2} - \sqrt{n}\psi_0}{\sigma_0}\textnormal{ and }\hat{q}_{1-\alpha}^{ub}n^{-1}\le \epsilon\right\} + o(1) \\ &\le P_0^n\left\{\frac{\sqrt{n}(\psi_n-\psi_0)}{\sigma_0}\le \frac{\sqrt{n}(\epsilon-\psi_0)}{\sigma_0}\textnormal{ and }\hat{q}_{1-\alpha}^{ub}n^{-1}\le \epsilon\right\} + o(1) \\ &\le P_0^n\left\{\frac{\sqrt{n}(\psi_n-\psi_0)}{\sigma_0}\le \frac{\sqrt{n}(\epsilon-\psi_0)}{\sigma_0}\right\} + o(1) = Pr\left\{Z\le \frac{\sqrt{n}(\epsilon-\psi_0)}{\sigma_0}\right\} + o(1), \end{align*} where $Z\sim N(0,1)$. The final equality holds by \autoref{thm:altasdist} and the well known result about the uniform convergence of distribution functions at continuity points when random variables converge in distribution \citep[see, e.g., Theorem 5.6 in][]{Boos&Stefanski2013}. The result follows by noting that $(\epsilon-\psi_0)/\sigma_0$ is negative and that $\lim_{z\rightarrow-\infty}Pr(Z\le z)=0$. \end{proof}

\section{Lock-Freedom and Complexity Analysis} \else \subsection{Lock-Freedom and Complexity Analysis} \fi \fi It is easy to see that each $DWrite_q(x)$ operation performs only two shared memory steps (a read of $A[q]$ and a write to $X$). Hence, the implementation of the $DWrite$ method is wait-free. However, a $DRead_q()$ operation by a process $q$ may not terminate if it is ``interrupted'' by infinitely many $DWrite$ operations. But note that in each iteration of the repeat-until loop process $q$ writes the same pair $(p,s)$ to $A[q]$ in line~\ref{announce1} that it previously read in line~\ref{regread1} from the second and third component of $X$. Hence, if $q$ executes sufficiently many steps while $X$ does not change, then $q$ will eventually read the same pair from $X$ in line~\ref{regread1}, from $A[q]$ in line~\ref{annread}, and from $X$ again in line~\ref{regread2}. After that, $q$'s $DRead$ terminates. Thus, in any transcript in which $q$ takes sufficiently many steps, either its $DRead$ terminates, or a $DWrite$ terminates. \ifthesis We proceed by providing a precise analysis of the amortized complexity of Algorithm~\ref{slaba}. \fi \ifea This proves that Algorithm~\ref{slaba} is lock-free. A more precise analysis yields the following result. \fi \iffull \begin{lemma}\label{lemma:dreadrestart} Let $dr$ be a $DRead_q()$ operation by process $q$. Let $xr_1, xr_2,$ and $xr_3$ be three consecutive $X.Read()$ operations on line~\ref{regread1} by $dr$. Then there exists a $DWrite$ operation that linearizes in $\bigl(time(xr_1), time(xr_3)\bigr)$. \end{lemma} \begin{proof} If the values returned by $xr_1$ and $xr_2$ are not equal, then some $X.Write$ operation occurs in the interval $\bigl(time(xr_1), time(xr_2)\bigr)$. Then by Observation~\ref{obs:dwritelinatwrite}, a $DWrite$ operation linearizes in $\bigl(time(xr_1), time(xr_2)\bigr)$. Now suppose $xr_1$ and $xr_2$ return the same tuple $(x, p, s)$. Then $dr$ performs an $A[q].Write(p, s)$ operation on line~\ref{announce1} after $xr_1$, and $A[q]$ is not modified again before line~\ref{annread} is performed by $dr$ following $xr_2$. Hence, the $A[q].Read()$ operation on line~\ref{annread} performed by $dr$ following $xr_2$ returns $(p, s)$. If the $X.Read()$ operation on line~\ref{regread2} performed by $dr$ following $xr_2$ returns $(x, p, s)$, then by the loop-guard on line~\ref{repeatcond}, $dr$ terminates after this iteration of the main loop. This is a contradiction, since $dr$ must restart the repeat-until loop after $xr_2$ in order to perform $xr_3$. Therefore, the $X.Read()$ operation on line~\ref{regread2} performed by $dr$ following $xr_2$ returns $(x', p', s') \neq (x, p, s)$. Then some $X.Write(x', p', s')$ must occur after $time(xr_2)$ and before the following execution of line~\ref{regread2} by $dr$, and hence in the interval $\bigl(time(xr_1), time(xr_3)\bigr)$. By Observation~\ref{obs:dwritelinatwrite}, there is a $DWrite_{p'}(x')$ operation that linearizes in this interval. \end{proof} \fi \begin{theorem}\label{thm:ABA-complexity} \begin{enumerate}[label=(\alph{*})] \item Each $DWrite()$ performs at most two shared memory operations; and\label{thm:ABA-complexity_write} \item for any transcript that contains $r$ $DRead$ and $w$ $DWrite$ invocations, the total number of steps devoted to $DRead$ operations is $O(\min (r,n)\cdot w+r)$.\label{thm:ABA-complexity_read} \end{enumerate} In particular, the implementation is lock-free and has amortized step complexity $O(n)$. \end{theorem} \iffull \begin{proof} Part~\ref{thm:ABA-complexity_write} follows immediately from the pseudocode (Algorithm~\ref{slaba}). By Lemma~\ref{lemma:dreadrestart}, each process reads $X$ on line~\ref{regread1} at most $3w + 1$ times during a single $DRead$ operation. This immediately shows that the total number of steps devoted to $DRead$ operations is $O(r \cdot (w + 1))$. This proves part~\ref{thm:ABA-complexity_read} for the case $r\leq n$. We now consider the case $r>n$. For any process let $r_p$ denote the number of $DRead$ invocations by process $p$. Further, for $i\in\{1,\dots,r_p\}$ let $k_{p,i}$ denote the total number of times process $p$ reads $X$ in line~\ref{regread1} during its $i$-th $DRead$ operation. From Lemma~\ref{lemma:dreadrestart} we obtain $\sum_i k_{p,i}=O(w + r_p)$ for each process $p$. Using $r=\sum_p r_p$ we obtain that the total number of times all processes read $X$ during all $DRead$ operations is \begin{displaymath} \sum_{p}\sum_{i=1}^{r_p}k_{p,i} = \sum_p O(w + r_p) = O(n\cdot w + r) \end{displaymath} This proves part~\ref{thm:ABA-complexity_read} for the case $r>n$. \end{proof} \fi Theorems~\ref{thm:ABA-safety} and~\ref{thm:ABA-complexity} yield Theorem~\ref{thm:main-ABA}. \ifthesis \section{Remarks} \else \subsection{Remarks} \fi In this section, we presented the first strongly linearizable implementation of an ABA-detecting register by modifying a previous linearizable implementation by Aghazadeh and Woelfel \cite{ABAreg,zahrathesis}. An obvious extension of this work would examine the possibility of a wait-free strongly linearizable implementation of an ABA-detecting register. However, we strongly suspect that such an implementation is impossible. Denysyuk and Woelfel showed that there is no wait-free strongly linearizable implementation of a counter (defined in Section~\ref{chapter:intro}) from registers, and by reduction this implies that no such implementations exist for snapshots or max-registers, either \cite{WaitVsLock}. The authors first assume there exists a wait-free implementation of a counter, then define a history in which a $Read$ operation takes an infinite number of steps, but the return value of the $Read$ is never determined; this contradicts the wait-freedom of the implementation. We believe a similar argument could be applied to the ABA-detecting register. For this paper, our efforts were concentrated on the snapshot implementation; the strongly-linearizable ABA-detecting register was incidental. The analysis we performed on our snapshot implementation is not affected by the fact that the ABA-detecting register implementation is only lock-free (as opposed to wait-free). Hence, we did not dedicate much time or effort to designing a wait-free strongly linearizable ABA-detecting register (or proving the impossibility of such an implementation). However, we would like to study this issue further. In fact, it would be interesting to know if \emph{any} nontrivial type has a wait-free strongly linearizable implementation from registers. \section{Lock-Freedom and Complexity Analysis}\label{compslss} \else \subsection{Lock-Freedom and Complexity Analysis} \label{compslss} \fi To simplify our analysis of the amortized complexity of our strongly linearizable snapshot object implementation, we first present a modification to Algorithm~\ref{slss}. The pseudocode of this implementation is provided in Algorithm~\ref{slsswithseq}. Our modification adds a sequence number field to each entry of the snapshot object; that is, each entry of the snapshot object stores a pair $(x, s)$, where $x \in D$ is a value, and $s$ is an unbounded sequence number. Initially, the snapshot contains the vector $\bigl((\bot, 0), \ldots, (\bot, 0)\bigr)$. Each process also stores a local sequence number (called $seq$ in Algorithm~\ref{slsswithseq}), which is incremented every time the process updates the snapshot object on line~\ref{seq:Supdate}. Following this, process $p$ performs an $S.update_p(x, seq)$ operation on line~\ref{seq:Supdate}, which stores the pair $(x, seq)$ in the $p$-th entry of the snapshot object. The remainder of the modified implementation is essentially identical to Algorithm~\ref{slss}. Note that $S.scan()$ and $R.DRead()$ operations now return vectors of pairs. That is, if $X$ is returned by some $S.scan()$ or $R.DRead()$ operation, then $X = \bigl((x_1, s_1), \ldots, (x_n, s_n)\bigr)$, such that each $x_i \in D$ is a value, and each $s_i$ is a sequence number. We use $vals(X)$ to denote the vector of values stored by $X$ (i.e. $vals(X) = (x_1, \ldots, x_n)$). \begin{algorithm}[h] \caption{Modified Strongly Linearizable Snapshot Object} \label{slsswithseq} \SetKwProg{Fn}{Function}{:}{} \nonl\textbf{shared:}\; \nonl\quad atomic snapshot object $S = \bigl((\bot, 0), \ldots, (\bot, 0)\bigr)$\; \nonl\quad atomic ABA-detecting register $R = \bigl((\bot, 0), \ldots, (\bot, 0)\bigr)$\; \nonl\; \nonl\textbf{local} (to each process):\; \nonl\quad Integer $seq = 0$\; \nonl\; \nonl\Fn{SLupdate$_p(x)$} { $seq \gets seq + 1$\; \label{seq:seqinc} $S.update_p(x, seq)$\; \label{seq:Supdate} $s \gets S.scan()$\; \label{seq:SLUscan} $R.DWrite_p(s)$\; \label{seq:SLUDWrite} } \nonl\; \nonl\Fn{SLscan$_p()$} { \Repeat{$(vals(s_1) = vals(\ell) = vals(s_2)) \; \mathbf{and} \; !c_2$} { $(s_1, c_1) \gets R.DRead_p()$\; \label{seq:DRead1} $\ell \gets S.scan()$\; \label{seq:SLSscan} $(s_2, c_2) \gets R.DRead_p()$\; \label{seq:DRead2} \If{$!(vals(s_1) = vals(\ell) = vals(s_2))$} { \label{seq:EQcond} $R.DWrite_p(\ell)$\; \label{seq:SLSDWrite} } } \label{seq:CHcond} \Return $s_2$ } \end{algorithm} Note that Algorithm~\ref{slsswithseq} also uses an atomic snapshot object for $S$ rather than a linearizable one. This is acceptable for our analysis because we aim to express the amortized complexity of Algorithm~\ref{slsswithseq} in terms of the number of operation invocations on $S$ and $R$, without regard for how $S$ or $R$ are implemented. This simplification allows us to avoid using the notion of interpreted value from Section~\ref{sec:interpvalue}. Instead, for any transcript $T \in \mathcal{T}$, we may simply reference the \emph{value} stored by $S$ at any particular time $t$ of $T$. Since $update$ operations on $S$ are atomic, the value of $S$ at any particular step of $T$ is well-defined. Since Algorithm~\ref{slsswithseq} uses unbounded sequence numbers, the implementation uses unbounded space. However, since Algorithm~\ref{slsswithseq} performs exactly the same shared memory operations as in Algorithm~\ref{slss}, it is easy to see that these implementations have the same amortized complexity. Hence, while our analysis is performed directly on Algorithm~\ref{slsswithseq}, all of the results in this section may also be applied to Algorithm~\ref{slss}. We first introduce some notation that will simplify our argument throughout this section. Let $X$ be a vector that is returned by some $S.scan()$ or $R.DRead()$ operation. For a process $p$ and an entry $X[p]$ of $X$, define $seq(X[p])$ as the second entry of the pair stored in $X[p]$ (i.e. the sequence number stored by $X[p]$). Define $seq(X) = \sum_{i = 1}^{n} seq(X[i])$. We first observe that as the underlying snapshot object $S$ is modified, $seq$ values of subsequent $S.scan()$ operations never decrease. For the sake of clarity, when we say $X = Y$, for some vectors $X$ and $Y$, we mean $vals(X) = vals(Y)$ and $seq(X) = seq(Y)$. For the remainder of this section, fix a transcript $T$ on Algorithm~\ref{slsswithseq}. \begin{observation}\label{obsnolookback} Suppose that the value of $S$ is $X$ at time $t$ in $T$. If the value of $S$ is $X'$ at time $u \geq t$ of $T$, then \begin{enumerate}[label=(\alph*)] \item $seq(X'[p]) \geq seq(X[p])$, for every process $p$, and\label{obsnolookback:entry} \item $seq(X') \geq seq(X)$.\label{obsnolookback:whole} \end{enumerate} \end{observation} \begin{proof} Part \ref{obsnolookback:entry} follows from the fact that each process that performs an $SLupdate$ operation increments its local $seq$ variable on line~\ref{seq:seqinc}, prior to invoking the $S.update$ operation on line~\ref{seq:Supdate}. Part \ref{obsnolookback:whole} follows trivially from part \ref{obsnolookback:entry}. \end{proof} \begin{observation}\label{obsEQ} Let $X_1$ and $X_2$ be vectors returned by two $S.scan()$ operations in $T$. If $seq(X_1) = seq(X_2)$, then $X_1 = X_2$. \end{observation} \begin{proof} Let $op_1$ and $op_2$ be two complete $S.scan()$ operations that return $X_1$ and $X_2$ respectively, such that $seq(X_1) = seq(X_2)$. Without loss of generality, suppose $time(op_1) \leq time(op_2)$. To derive a contradiction, suppose that $X_1 \neq X_2$. Thus, some $S.update$ operation by $p$ must happen in the interval $\bigl(time(op_1), time(op_2)\bigr)$, for some process $p$. Since the sequence numbers written by subsequent $S.update$ operations by $p$ always increase (by the increment on line~\ref{seq:seqinc}), \begin{equation} X_1[p] < X_2[p].\label{obsEQ:entry} \end{equation} By Observation~\ref{obsnolookback}~\ref{obsnolookback:entry}, $X_1[q] \leq X_2[q]$ for every process $q$. This, combined with (\ref{obsEQ:entry}), implies that $seq(X_1) < seq(X_2)$, which is a contradiction. \end{proof} \begin{observation}\label{obsmorerecent} Suppose that at time $t$, the value of $S$ is $X$, while $R$ contains a vector $X'$. Then $seq(X) \geq seq(X')$. \end{observation} \begin{proof} Notice that the only $R.DWrite(X')$ statements present in Algorithm~\ref{slss} acquire $X'$ from some previous $S.scan()$ operation. Hence, $seq(X') \geq seq(X)$ by Observation~\ref{obsnolookback}~\ref{obsnolookback:whole}. \end{proof} \begin{lemma}\label{lemmaoldstate} Let $sc$ be the first $S.scan()$ operation that returns $X$ (that is, no $S.scan()$ operation $sc'$ such that $time(sc') < time(sc)$ returns $X$). Suppose there are $k$ operations \begin{displaymath} R.DWrite(X_1), R.DWrite(X_2), \ldots, R.DWrite(X_k) \end{displaymath} that happen after $time(sc)$ in $T$, such that $seq(X_i) < seq(X)$ for all $i \in \{1, \ldots, k\}$. Then $k \leq n - 1$. \end{lemma} \begin{proof} By Observation~\ref{obsnolookback}, any $S.scan()$ operation in $T$ that is invoked after $time(sc)$ returns a vector $Y$ with $seq(Y) \geq seq(X)$. Thus, \ifspringer \begin{equation} \begin{split} &\text{any $S.scan()$ operation that returns a vector $X'$} \\ &\text{with $seq(X') < seq(X)$ must be invoked before} \\ &\text{$time(sc)$.}\label{lemmaoldstate:oldscan} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{any $S.scan()$ operation that returns a vector $X'$ with $seq(X') < seq(X)$ must be} \\ &\text{invoked before $time(sc)$.}\label{lemmaoldstate:oldscan} \end{split} \end{equation} \fi Note that each $R.DWrite$ statement in Algorithm~\ref{slsswithseq} is preceded by an $S.scan$ statement in the same method (i.e. the $R.DWrite$ on line~\ref{seq:SLUDWrite} in the $SLupdate$ method is preceded by the $S.scan$ on line~\ref{seq:SLUscan}, and the $R.DWrite$ on line~\ref{seq:SLSDWrite} in the $SLscan$ method is preceded by the $S.scan$ on line~\ref{seq:SLSscan}). Furthermore, \ifspringer \begin{equation} \small \begin{split} &\text{for any vector $Y$ and any $R.DWrite_p(Y)$ operation} \\ &\text{$dw$ by $p$, the latest $S.scan()$ operation by $p$ that is} \\ &\text{invoked before $dw$ returns $Y$.}\label{lemmaoldstate:scanbeforedwrite} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{for any vector $Y$ and any $R.DWrite_p(Y)$ operation $dw$ by $p$, the latest $S.scan()$ operation} \\ &\text{by $p$ that is invoked before $dw$ returns $Y$.}\label{lemmaoldstate:scanbeforedwrite} \end{split} \end{equation} \fi Together, (\ref{lemmaoldstate:oldscan}) and (\ref{lemmaoldstate:scanbeforedwrite}) imply the following: for any $R.DWrite(X')$ operation $dw$ by $p$ such that $seq(X') < seq(X)$, the latest $S.scan()$ operation invoked by $p$ before $dw$ must have been invoked before $time(sc)$. This immediately implies that \ifspringer \begin{equation} \small \begin{split} &\text{each process performs at most one $R.DWrite(X')$} \\ &\text{operation that happens after $time(sc)$, with} \\ &\text{$seq(X') < seq(X)$}.\label{lemmaoldstate:katmostn} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{each process performs at most one $R.DWrite(X')$ operation that happens after $time(sc)$,} \\ &\text{with $seq(X') < seq(X)$}.\label{lemmaoldstate:katmostn} \end{split} \end{equation} \fi Suppose $sc$ is performed by process $q$. Since each process performs operations sequentially, (\ref{lemmaoldstate:oldscan}) and (\ref{lemmaoldstate:scanbeforedwrite}) together imply that no $R.DWrite_q(X')$ operation by $q$ happens after $time(sc)$. This combined with (\ref{lemmaoldstate:katmostn}) implies the statement in the lemma. \end{proof} \begin{lemma}\label{lemmabetweenwrites} Suppose that the value of $S$ is $X$ at some step $t$ in $T$. Let $sc_Y \in T$ be an $S.scan()$ operation that returns $Y$ with $seq(Y) > seq(X)$, such that there does not exist an $S.scan()$ operation $sc_{Y'}$ that returns a vector $Y'$ with $seq(Y') > seq(X)$ and $time(sc_{Y'}) < time(sc_Y)$. Then, \begin{enumerate}[label=(\alph*)] \item for any pair of $R.DWrite_p(X)$ operations $dw_1, dw_2$ by $p$ on line~\ref{seq:SLSDWrite} (i.e. during $SLscan$ operations) such that $time(dw_1) < time(dw_2) < time(sc_Y)$, there exists an $R.DWrite(X')$ operation that happens in $\bigl(time(dw_1), time(dw_2)\bigr)$, with $seq(X') < seq(X)$, and\label{lemmabetweenwrites:pair} \item if $dw_1, \ldots, dw_k$ is a sequence of operations \\ $R.DWrite_p(X_1), \ldots, R.DWrite_p(X_k)$ performed by $p$ such that $seq(X_1) = \ldots = seq(X_k) = seq(X)$, then $k\leq 2n$.\label{lemmabetweenwrites:sequence} \end{enumerate} \end{lemma} \begin{proof}[Proof of Lemma~\ref{lemmabetweenwrites}~\ref{lemmabetweenwrites:pair}] Since $dw_2$ writes the vector $X$, by the pseudocode in Algorithm~\ref{slsswithseq} the latest $S.scan()$ operation on line~\ref{seq:SLSscan} that was invoked by $p$ prior to $time(dw_2)$ must have returned $X$. Let $V_1$ and $V_2$ be the vectors returned by the last executions of $R.DRead_p()$ by process $p$ prior to $time(dw_2)$ on lines \ref{seq:DRead1} and \ref{seq:DRead2}, respectively. By the condition on line~\ref{seq:EQcond}, either $vals(V_1) \neq vals(X)$ or $vals(V_2) \neq vals(X)$. Then either $V_1 \neq X$ or $V_2 \neq X$. In either case, since $dw_1$ writes $X$ to $R$, there must exist an $R.DWrite(X')$ operation $dw_{X'}$ (with $X' \neq X$, and either $X' = V_1$ or $X' = V_2$) that happens after $time(dw_1)$, but before the $R.DRead_p()$ operation that returns a vector distinct from $X$. Hence, \begin{equation} time(dw_{X'}) \in \bigl(time(dw_1), time(dw_2)\bigr).\label{lemmabetweenwrites:interval} \end{equation} Since all $R.DWrite$ operations in Algorithm~\ref{slsswithseq} write the result of some previous $S.scan()$ operation to $R$, there must be an $S.scan()$ operation $sc_{X'}$ that returns $X'$ and happens prior to $time(dw_{X'})$. Then by (\ref{lemmabetweenwrites:interval}), $time(sc_{X'}) < time(dw_2)$, and therefore $time(sc_{X'}) < time(sc_Y)$. By the assumption of the lemma, $seq(X') \leq seq(X)$. Since $X' \neq X$, $seq(X') \neq seq(X)$ by the contrapositive of Observation~\ref{obsEQ}, and therefore $seq(X') < seq(X)$. \end{proof} \begin{proof}[Proof of Lemma~\ref{lemmabetweenwrites}~\ref{lemmabetweenwrites:sequence}] Suppose $dw_i$ is performed by an $SLupdate$ operation $up$ by $p$, for some $i \in \{1, \ldots, k\}$. First assume that $i > 1$. Then \begin{equation} \text{$R$ contains $X_{i-1}$ at $time(dw_{i-1})$.}\label{lemmabetweenwrites:attimedwrite} \end{equation} Since $SLupdate$ operations perform at most a single $R.DWrite$ operation (line~\ref{seq:SLUDWrite}), \begin{equation} time(dw_{i-1}) < time(inv(up)).\label{lemmabetweenwrites:dwritebeforeup} \end{equation} Suppose that the value of $S$ at $time(dw_{i-1})$ is $V_1$. Then by (\ref{lemmabetweenwrites:attimedwrite}) and Observation~\ref{obsmorerecent}, $seq(V_1) \geq seq(X_{i-1}) = seq(X)$. If the value of $S$ at $time(inv(up))$ is $V_2$, then by (\ref{lemmabetweenwrites:dwritebeforeup}) and Observation~\ref{obsnolookback}~\ref{obsnolookback:whole} $seq(V_2) \geq seq(V_1) \geq seq(X)$. By the increment on line~\ref{seq:seqinc}, $p$ increases the sequence number of the vector stored by $S$ when it performs the $S.update$ operation on line~\ref{seq:Supdate} during $up$. Then the vector $X'$ returned by the $S.scan()$ operation performed by $up$ on line~\ref{SLUscan} satisfies $seq(X') > seq(V_2) \geq seq(X)$. By the pseudocode of Algorithm~\ref{slsswithseq}, $dw_i$ is an $R.DWrite_p(X')$ operation (i.e. $X_i = X'$), which contradicts the assumption that $seq(X_i) = seq(X)$. Therefore, $i = 1$, and \ifspringer \begin{equation} \small \begin{split} &\text{only a single member of the sequence may belong} \\ &\text{to an $SLupdate$ operation.}\label{lemmabetweenwrites:belongtoslupdate} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{only a single member of the sequence may belong to an $SLupdate$ operation.}\label{lemmabetweenwrites:belongtoslupdate} \end{split} \end{equation} \fi By (\ref{lemmabetweenwrites:belongtoslupdate}), $dw_2, \ldots, dw_k$ are all performed by $SLscan$ operations (on line~\ref{seq:SLSDWrite}). Let $sc_X$ be the earliest $S.scan()$ operation in $T$ that returns $X$ (i.e. there does not exist an $S.scan()$ operation $sc_X'$ which returns $X$ such that $time(sc_X') < time(sc_X)$). Since $seq(X_i) = seq(X)$, Observation~\ref{obsEQ} implies that $X_i = X$, for all $i \in \{1, \ldots, k\}$. Hence, since every $R.DWrite$ operation writes a vector returned by some earlier $S.scan()$ operation, \begin{equation} \text{$time(sc_X) < time(dw_i)$ for all $i \in \{1, \ldots, k\}$.}\label{lemmabetweenwrites:afterscan} \end{equation} By Lemma~\ref{lemmabetweenwrites}~\ref{lemmabetweenwrites:pair}, for every pair of consecutive operations $dw_i, dw_{i+1}$ that happen before $time(sc_Y)$, there exists an $R.DWrite(X')$ operation that happens in $\bigl(time(dw_i), time(dw_{i+1})\bigr)$ with $seq(X') < seq(X)$. By Lemma~\ref{lemmaoldstate} there are at most $n - 1$ such $R.DWrite(X')$ operations that happen after $time(sc_X)$. Combining this with (\ref{lemmabetweenwrites:afterscan}), we obtain the following: \ifspringer \begin{equation} \small \begin{split} &\text{There are at most $n$ $R.DWrite_p(X_i)$ operations} \\ &\text{performed during $SLscan$ operations that happen} \\ &\text{before $time(sc_Y)$.}\label{lemmabetweenwrites:beforescy} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{There are at most $n$ $R.DWrite_p(X_i)$ operations performed during $SLscan$ operations} \\ &\text{that happen before $time(sc_Y)$.}\label{lemmabetweenwrites:beforescy} \end{split} \end{equation} \fi By Lemma~\ref{lemmaoldstate}, \ifspringer \begin{equation} \small \begin{split} &\text{there are at most $n - 1$ $R.DWrite_p(X_i)$ operations} \\ &\text{performed during $SLscan$ operations that happen} \\ &\text{after $time(sc_Y)$.}\label{lemmabetweenwrites:afterscy} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{there are at most $n - 1$ $R.DWrite_p(X_i)$ operations performed during $SLscan$ operations} \\ &\text{that happen after $time(sc_Y)$.}\label{lemmabetweenwrites:afterscy} \end{split} \end{equation} \fi Combining (\ref{lemmabetweenwrites:belongtoslupdate}), (\ref{lemmabetweenwrites:beforescy}), and (\ref{lemmabetweenwrites:afterscy}) yields $k \leq 2n$. \end{proof} \begin{lemma}\label{lem:sequence_numbers_per_scan} Let $op \in \Gamma(T)$ be an operation by process $p$, and suppose $op$ performs a sequence of $S.scan()$ operations $sc_1, sc_2, \ldots, sc_k$, such that $sc_i$ returns a vector $X_i$ for all $i \in \{1, \ldots, k\}$, and $seq(X_1) = \ldots = seq(X_k)$. Then $k\leq 2n^2 + 1$. \end{lemma} \begin{proof} Clearly, every $SLupdate$ operation performs at most one $S.scan()$ operation. Suppose $op$ is an $SLscan$ operation. Since $seq(X_1) = \ldots = seq(X_k)$, by Observation~\ref{obsEQ} $X_1 = \ldots = X_k$. Let $X = X_1 = \ldots = X_k$. Consider some $sc_i$ operation, with $i \in \{1, \ldots, k-1\}$. Operation $op$ must restart its main loop after $sc_i$, and so the condition on line~\ref{seq:CHcond} must hold at the end of the iteration of the main loop during which $sc_i$ is performed by $p$. There are two cases: \begin{enumerate}[label=(\roman*)] \item The vectors of values compared on line~\ref{seq:CHcond} are unequal. Then by the condition on line~\ref{seq:CHcond}, process $p$ performs an $R.DWrite_p(X)$ on line~\ref{SLSDWrite} following $sc_i$. \item The Boolean flag returned by the $R.DRead_p()$ operation performed by $p$ on line~\ref{seq:DRead2} following $sc_i$ is $true$ (but the vectors of values compared on line~\ref{CHcond} are equal). Then, by the sequential specification of ABA-detecting registers, some $R.DWrite(X)$ operation occurs after the $R.DRead()$ operation performed by $p$ on line~\ref{seq:DRead1} prior to $sc_i$, and before the $R.DRead()$ operation performed by $p$ on line~\ref{seq:DRead2} following $sc_i$. \end{enumerate} In both cases, some $R.DWrite(X)$ operation happens during the iteration of the main loop in which $sc_i$ is performed. Lemma~\ref{lemmabetweenwrites}~\ref{lemmabetweenwrites:sequence} ensures that each process $p$ performs at most $2n$ $R.DWrite_p(X)$ operations. Since there are $n$ processes, we obtain $k - 1\leq 2n^2$, and hence $k \leq 2n^2 + 1$. \end{proof} \fi \ifea In (FULL PAPER)\todo{this} we also provide an amortized analysis of the complexity of our implementation. The result is expressed in terms of the number of operations on the snapshot object $S$ and the ABA-detecting register $R$. \fi \begin{theorem}\label{thm:slss-complexity} \begin{enumerate}[label=(\alph{*})] \item Each $SLupdate$ performs at most one $S.update$, one $S.scan$, and one \ifspringer \else \\ \fi $R.DWrite$ operation.\label{thm:slss-complexity:A} \item For any transcript that contains $u$ $SLupdate$ and $s$ $SLscan$ invocations, the total number of operation invocations on $S$ and $R$ during $SLscan$ operations is $O(s+n^3u)$.\label{thm:slss-complexity:B} \end{enumerate} In particular, the implementation is lock-free provided that $S$ and $R$ are. \end{theorem} \iffull \begin{proof} Part~\ref{thm:slss-complexity:A} follows immediately from the pseudocode of Algorithm~\ref{slss}. We now prove part~\ref{thm:slss-complexity:B}. For any process let $s_p$ denote the number of $SLscan$ invocations by process $p$. Further, for $i\in\{1,\dots,s_p\}$ let $k_{p,i}$ denote the total number of times process $p$ calls $S.scan()$ in line~\ref{seq:SLSscan} during its $i$-th $SLscan()$ operation. From Lemma~\ref{lem:sequence_numbers_per_scan} we obtain $\sum_{i=1}^{s_p}k_{p,i}=O(un^2+s_p)$ for each process $p$. Using $s=\sum_p s_p$ we obtain that the total number of $S.scan()$ calls during all $SLscan()$ operations is \begin{displaymath} \sum_{p}\sum_{i=1}^{s_p}k_{p,i} = O\left(\sum_p un^2+s_p\right) = O(s+un^3). \end{displaymath} \end{proof} \fi As mentioned previously, we can use any lock-free or wait-free linearizable snapshot implementation for $S$. Instead of an atomic ABA-detecting register $R$, we can use the lock-free strongly linearizable one from \ifthesis Chapter \else Section \fi \ref{slabasection}. Thus, Theorems~\ref{thm:main-ABA}, \ref{stronglin}, and~\ref{thm:slss-complexity} yield Theorem~\ref{thm:main-snapshot}. \ifthesis \section{Remarks} \else \subsection{Remarks} \fi In this section we presented the first lock-free strongly linearizable implementation of a snapshot object that requires only bounded space. The time complexity of our implementation is unfortunate; even with a small number of processes, the use of our implementation seems impractical due to its $O(n^3)$ runtime. However, when contention is low (i.e. there are few overlapping calls to $SLupdate$ and $SLscan$), our snapshot implementation performs reasonably well. Notice that in a low-contention scenario, $SLscan$ operations are seldom forced to repeat their main loop, and therefore their runtime is dominated by the $S.scan$ call on line~\ref{SLSscan}. Hence, choosing a reasonably efficient linearizable snapshot implementation for $S$ results in an efficient strongly linearizable snapshot. However, when contention is high and the number of processes is sufficiently large (and $SLupdate$ is called sufficiently often), it becomes increasingly likely that $SLscan$ operations \emph{never} terminate, as they are interrupted infinitely often by $S.update$ or $R.DWrite$ calls performed during other concurrent $SLupdate$ or $SLscan$ operations. A natural extension of this work would aim to develop more efficient implementations. Previous strongly linearizable implementations of counters and max-registers (such as the lock-free modification of the max-register in \cite{PossImposs}) required an unbounded number of unbounded registers. Our bounded snapshot implementation can be used to implement a lock-free strongly linearizable counter or max-register using only a bounded number of registers. Note that these implementations still inherently require registers to store unbounded values, since the state space of both counters and (unbounded) max-registers is infinite. \chapter{Conclusion} \else \section{Discussion} \fi We have provided a lock-free strongly linearizable implementation of a snapshot object using atomic multi-reader multi-writer registers as base objects. We used this implementation to demonstrate that any simple object also has a lock-free strongly linearizable implementation from atomic multi-reader multi-writer registers. The class of simple types seems to be a large subset of the types that have wait-free linearizable implementations from atomic registers. We are not aware of any classifications of non-simple types that are also known to have wait-free linearizable implementations from registers. Additionally, we have not yet explored the characteristics of objects that enable wait-free strongly linearizable implementations from registers. As we briefly discussed in Section~\ref{sectionGEN}, the general construction defined by Aspnes and Herlihy \cite{generalwaitfree} uses unbounded space. This is a result of the fact that each operation constructs a new node, and nodes added to the shared precedence graph are never reclaimed. The storage of unbounded precedence graphs also affects the liveness properties satisfied by the algorithm; while Algorithm~\ref{gen} is wait-free, it is not \emph{bounded} wait-free. That is, there is no constant that bounds the number of steps required by any operation. This is because each operation must calculate a linearization by topologically ordering an ever-expanding precedence graph. It would be interesting to know if this construction could be bounded, for example, by ``pruning'' the precedence graph at certain stages of the algorithm. This might be accomplished by storing \emph{states}, rather than operations, in each entry of the shared snapshot object. Regarding strong linearizability, little is known about the power of primitives with higher consensus numbers than registers and snapshots. As mentioned in Section~\ref{chapter:intro}, Golab, Higham, and Woelfel showed that standard universal constructions using consensus objects are strongly linearizable \cite{stronglin}. Therefore, it is possible to develop wait-free strongly linearizable implementations of any type in systems that have access to atomic compare-and-swap (CAS) or load-linked/store-conditional (LL/SC) objects. We would like to know if there are efficient strongly linearizable implementations of useful types from such powerful base objects. Perhaps many existing implementations of types from CAS or LL/SC objects are already strongly linearizable; in this case, it would be interesting to identify such implementations and prove that they are strongly linearizable. Attiya, Casta\~{n}eda, and Hendler showed that a wait-free strongly linearizable implementation of an $n$-process queue or stack can be used to solve $n$-consensus \cite{ACH2018a}. Their proof is quite simple; suppose we have access to a wait-free strongly linearizable queue. To solve consensus, each process first writes its value to a single-writer register, then enqueues its identifier to the queue, and finally takes a snapshot of the shared memory locations used by the queue to obtain a local copy of the object. Following this, a process simulates a dequeue on its local copy of the queue to obtain the process identifier $p$, and then decides on the value proposed by $p$. Since the queue is strongly linearizable, at some point every process agrees on the ``head'' of the queue, which implies that each process obtains the same identifier from its dequeue operation. This result immediately implies that there is no strongly linearizable implementation of an $n$-process queue or stack using base objects with consensus number less than $n$. We would like to know if a similar result holds for other types with consensus number 2, such as read-modify-write types. \ifthesis In Section~\ref{sec:relwork} we mentioned that strong linearizability is a form of strong observational refinement, a result presented by Attiya and Enea~\cite{AE2019a}. In this same paper, it is also shown that strong observational refinement is equivalent to the well-studied concept of forward simulations, originally formalized by Lynch and Vaandrager~\cite{lynch1995forward}. A forward simulation is a relation between the states of two types, where every outgoing transition of one type may be simulated by some sequence of steps of the other. Since strong observational refinement and forward simulations are equivalent, an object $O$ of type $\mathscr{T}$ is strongly linearizable if and only if there exists a forward simulation from $O$ to an atomic object of type $\mathscr{T}$ \cite{AE2019a}. It would be interesting to know whether this equivalence admits simpler proof methodologies. Additionally, in cases where strongly linearizable implementations are either impossible or inefficient, we would like to study the feasibility of developing implementations which are strong refinements of non-atomic (i.e. concurrent) specifications. \fi Our research was initially motivated by the following conjecture: every type that has a wait-free linearizable implementation from atomic registers has a wait-free strongly linearizable implementation from atomic snapshot objects. \ifthesis For readable types, a solution seems to be near. Anderson and Moir's \cite{andersonMoir} assertion that dynamic resiliency is necessary for the existence of a wait-free linearizable implementation of a readable type from registers is accurate; therefore, dynamic resiliency is also necessary for the existence of a wait-free strongly linearizable implementation of a readable type from atomic snapshot objects. There is one final gap left to fill: the space between simple and dynamically resilient types. As mentioned in Chapter~\ref{sec:dynamic}, all simple types are dynamically resilient, but not all dynamically resilient types are simple. It is possible that dynamically resilient readable types that are not simple have no wait-free linearizable implementations from registers; at the very least, we suspect that implementations of such types would differ considerably from the scan-compute-write strategy used by Aspnes and Herlihy. \else\iffull While we have not definitively proven or disproven this conjecture, it seems that the class of simple types is a large subset of the set of types that have wait-free linearizable implementations from registers. A natural extension of this work would aim to discover non-simple types that have wait-free linearizable implementations from registers; if no such types exist, then combined with Theorem~\ref{thm:main-general-construction} this would prove our conjecture. \fi \fi \ifthesis A summary of relevant knowns/unknowns is provided in Table~\ref{tab:results}. \clearpage \renewcommand{\arraystretch}{2.0} \begin{table} \centering \begin{tabular}{p{3.5cm}p{3.5cm}lp{4cm}} Base Objects & S.L. Object & Liveness Property & Implementation \\ \hline Atomic registers & ABA-detecting register & Lock-freedom & Bounded implementation by Theorem~\ref{thm:main-ABA} \\ Atomic registers & Snapshot & Wait-freedom & Proven impossible \cite{WaitVsLock} \\ Atomic registers & Snapshot & Lock-freedom & Unbounded implementation in \cite{WaitVsLock}, bounded implementation by Theorem~\ref{thm:main-snapshot} \\ S.L. max-register, versioned object of type $\mathscr{T}$ & Type $\mathscr{T}$ & Lock-freedom & Unbounded implementation in \cite{WaitVsLock} \\ Atomic snapshots & Simple types & Wait-freedom & Unbounded implementation in \cite{generalwaitfree}, proof of S.L. Chapter~\ref{sectionGEN} \\ S.L. snapshots & Simple types & Lock-freedom & Unbounded implementation by Theorem~\ref{thm:main-general-construction} \\ Atomic snapshots & Dynamically resilient readable types (as defined in Chapter~\ref{sec:dynamic} and \cite{andersonMoir}) & Lock/Wait-freedom & Unknown \\ Atomic snapshots & Any type that has a wait-free linearizable implementation from atomic registers & Lock/Wait-freedom & Unknown \\ Consensus object & Any type & Wait-freedom & Standard universal constructions \cite{stronglin} \end{tabular} \caption{A summary of relevant results and further directions. The table should be interpreted as follows: the first column contains a set of base objects $B$, the second column contains a type $T$, and the third column contains a liveness property $L$. The fourth column contains an answer to the following question: does type $T$ have a strongly linearizable implementation from $B$ that satisfies $L$? In all cases above ``atomic registers'' refers to atomic \emph{multi-writer} registers. S.L. stands for either strong linearizability or strongly linearizable.}\label{tab:results} \end{table} \fi \ifea Anderson and Moir \cite{andersonMoir} define a class of \emph{readable} objects\todo{``readable'' is a placeholder name here}, which support a single operation that returns the entire state of the object, along with a set of update operations that do not return anything and may modify the state of the object. Anderson and Moir claim that a ``resiliency condition'' is necessary and sufficient for the existence of a wait-free implementation of an object from registers. This condition is similar to Aspnes and Herlihy's definition of simple types, and Anderson and Moir claim that the sufficiency of the resiliency condition follows from the general construction in \cite{generalwaitfree}. However, the resiliency condition is dynamic in the sense that, after a particular history two invocations may commute, while after another history these same two invocations may no longer commute, while instead one overwrites the other. Hence, while all simple objects satisfy Anderson and Moir's resiliency condition, it is not true that all objects which satisfy the resiliency condition are simple. Therefore, Anderson and Moir's claim that a readable object has a wait-free implementation from registers if the object satisfies the resiliency condition remains unproven. Note that if Anderson and Moir's claim was true, combined with our results this would imply that a readable object has a lock-free strongly linearizable implementation from atomic multi-reader multi-writer registers if and only if it satisfies the resiliency condition. \fi \chapter{Preliminaries}\label{defsection} \else \section{Preliminaries}\label{defsection} \fi We consider an asynchronous shared memory system with $n$ processes, each of which has a unique identifier in $\{1, \dots, n\}$. \iffull More precisely, processes communicate by performing operations on shared \emph{objects}, which are each an instance of a \emph{type}. A type may be defined as a state machine. That is, if $\mathscr{T}$ is a type, then $\mathscr{T} = (\mathcal{S}, s_0, \mathcal{O}, \mathcal{R}, \delta)$, where $\mathcal{S}$ is a set of \emph{states}, $s_0 \in \mathcal{S}$ is an \emph{initial state}, $\mathcal{O}$ is a set of \emph{invocation descriptions}, $\mathcal{R}$ is a set of \emph{responses}, and $\delta : \mathcal{S} \times \mathcal{O} \rightarrow \mathcal{S} \times \mathcal{R}$ is a \emph{transition function}. An invocation description $invoke \in \mathcal{O}$ applied to an object of type $\mathscr{T}$ in state $s \in \mathcal{S}$ returns a value $resp \in \mathcal{R}$ and causes the object to enter state $s'$, where $\delta(invoke, s) = (resp, s')$. Throughout this paper, we only consider types for which $\delta(invoke, s)$ is defined for every invocation description $invoke$ and for every state $s$. An invocation consists of a name, a set of arguments, and a process identifier (indicating the process that performs the invocation). The \emph{sequential specification} of $\mathscr{T}$ is the set of allowable sequences of invocation/response pairs. We may define the sequential specification of $\mathscr{T}$ inductively;\todo{refine this definition} that is, a sequence $(invoke_1, resp_1), \ldots, (invoke_k, resp_k)$ is in the sequential specification of $\mathscr{T}$ if either (1) it is empty, or (2) $(invoke_1, resp_1), \ldots, (invoke_{k-1}, resp_{k-1})$ is in the sequential specification of $\mathscr{T}$, and $\delta(invoke_k, s_k) = (resp_k, s)$, for some state $s$, where $s_k$ is the state reached after applying the invocations $invoke_1, \ldots, invoke_{k-1}$ in order. We define types using a descriptive approach; that is, instead of explicitly providing an automaton, we describe the values that an object stores, the invocation descriptions it supports, and how these invocation descriptions change the stored values in sequential executions. We present invocation descriptions using pseudocode; for instance, $op_p(x, y)$ denotes an invocation description named $op$, with $x$ and $y$ as arguments, and with $p$ as the associated process identifier. Objects that are provided by the system are called \emph{base objects}. \fi \ifea More precisely, processes communicate by performing operations on shared objects. \fi An operation $op$ consists of an \emph{invocation event}, denoted $inv(op)$, and possibly a \emph{response event}, denoted $rsp(op)$. Processes perform operations sequentially. \iffull An invocation event is a tuple $(O, M, id)$, where $O$ is an object instance, $M$ is a invocation description, and $id$ is a unique integer that identifies the invocation event. A response event is a pair $(r, id)$, where $r$ is a return value, and $id$ is an integer. An invocation event $(O, M, id_i)$ \emph{matches} a response event $(r, id_j)$ (and vice versa) if and only if $id_i = id_j$. \fi A \emph{transcript} is a sequence of \emph{steps}, each of which is either an invocation event or a response event of some operation. If $T$ and $U$ are transcripts, we use $T \circ U$ to denote the concatenation of $T$ and $U$. A \emph{projection} of a transcript $T$ onto an object $O$, denoted $T|O$, is the sequence of steps in $T$ that are performed on $O$. Similarly, a projection of a transcript $T$ onto a process $p$, denoted $T|p$, is the sequence of invocation and response events by process $p$. \iffull We say $e \in T$, for some invocation or response event $e$ and some transcript $T$, if $e$ is a member of the sequence defined by $T$. As a shorthand, we say $op \in T$, for an operation $op$ and a transcript $T$, if $inv(op) \in T$. \fi An operation $op$ is \emph{pending} in some transcript $T$ if $T$ contains its invocation but no matching response. If an operation $op \in T$ is not pending in $T$, then it is \emph{complete}. A transcript $T$ is \emph{complete} if, for every operation $op \in T$, $op$ is complete. Otherwise, $T$ is \emph{incomplete}. An operation $op$ is \emph{atomic} in a transcript $T$ if $inv(op)$ is immediately followed by $rsp(op)$ in $T$. A transcript $T$ is \emph{well-formed} if $T$ is empty, or for every $p \in \{1, \ldots, n\}$, $T|p = i \circ T_1 \circ r \circ T_2$, where $i$ is some invocation event, $T_1$ and $T_2$ are well-formed transcripts, $T_1$ is complete, and $r$ is either a response event that matches $i$, or $r$ is empty. Throughout this paper, we assume all transcripts are well-formed. An object $O$ is \emph{atomic} if every operation in any transcript on $O$ is atomic. \ifea We say an object $O$ is \emph{implemented} if each operation invocation on $O$ is associated with a \emph{method}, which is a sequence of invocation descriptions. A process $p$ that executes an operation on an implemented object $O$, such that $inv(op)$ is associated with a method $M$, sequentially executes each invocation step described by $M$. \fi \iffull We say an object $O$ of type $\mathscr{T}$ is \emph{implemented} if each invocation description provided by $\mathscr{T}$ is associated with a \emph{method}, which is a sequence of invocations. A process $p$ that executes an operation invocation $inv(op)$ on an implemented object $O$, such that the invocation description of $inv(op)$ is associated with a method $M$, sequentially executes each invocation step described by $M$. \fi During the execution of this method, other processes may also take steps, which interleave with the steps taken by $p$. The order of operations in a transcript is a partial order, since some operations may overlap. Operation $op_1$ \emph{happens before} operation $op_2$ in transcript $T$, or $op_1 \xrightarrow{T} op_2$, if and only if $rsp(op_1)$ occurs before $inv(op_2)$ in $T$. Operations $op_1, op_2 \in T$, for some transcript $T$, are \emph{concurrent} if $op_1$ does not happen before $op_2$, and $op_2$ does not happen before $op_1$. A \emph{history} is a transcript such that, for every process $p$, every operation in $H|p$ is atomic. A history may be considered a sequence of ``high-level'' invocation and response events. A \emph{completion} of a history $H$ is a complete history $H'$ that is constructed from $H$ as follows: for each pending operation $op$ in $H$, either a response for $op$ is appended to $H'$, or $op$ is removed from $H'$. A \textit{sequential history} is a history that contains no concurrent operations. Suppose $S = inv(op_1) \circ rsp(op_1) \circ \ldots \circ inv(op_k) \circ rsp(op_k)$ is a sequential history on an object $O$ of type $\mathscr{T}$, where $inv(op_i) = (O, invoke_i, id_i)$ and $rsp(op_i) = (O, resp_i, id_i)$ for every $i \in \{1, \ldots, k\}$. Then $S$ is \emph{valid} if and only if $(invoke_1, resp_1), \ldots, (invoke_k, resp_k)$ is in the sequential specification of $\mathscr{T}$. If $T$ is a transcript, the \emph{interpreted history} $\Gamma(T)$ consists of all ``high-level'' steps that exist in $T$. That is, $\Gamma(T)$ can be constructed by removing, for every process $p$, every step that appears after $inv(op)$ and not after $rsp(op)$, for any operation $op \in T$ with process identifier $p$. If $\mathcal{T}$ is a set of transcripts, then $\Gamma(\mathcal{T}) = \{\Gamma(T)\;:\;T \in \mathcal{T}\}$. Linearizability was originally defined by Herlihy and Wing~\cite{linearizability}. The following definition is taken from the textbook by Herlihy and Shavit \cite{MultiProcProgramming}: a history $H$ is \textit{linearizable} if it has a completion $H'$ such that there is a sequential history $S$ with the following properties: \begin{itemize} \item All operations in $H'$ are present in $S$, with identical invocations and responses; \item the sequential history $S$ is valid; and \item the happens-before order of operations in $S$ extends the happens-before order of operations in $H'$. \end{itemize} We call a sequential history $S$ that satisfies the above properties a \emph{linearization} of $H$. An implementation of an object is linearizable if every history in the set of possible histories on the object is linearizable. That is, if $O$ is some object and $\mathcal{H}$ is the set of possible histories on $O$, then $O$ is linearizable if and only if for all $H \in \mathcal{H}$, $H$ is linearizable. If $\mathcal{H}$ is a set of histories, and $f$ is a function such that, for every $H \in \mathcal{H}$, $f(H)$ is a linearization of $H$, then $f$ is called a \emph{linearization function} for the set $\mathcal{H}$. We often refer to the \emph{time} at which particular steps are executed; this simply refers to the step's position in a transcript. That is, if $e$ is a step in a transcript $T$, then $time_T(e) = t$ if the $t$-th element of $T$ is $e$. Where $T$ is clear from context, we simply write $time(e) = t$. If $e$ is a step that is not present in a transcript $T$, then let $time_T(e) = \infty$. For the sake of brevity, if $am$ is an atomic operation in a transcript $T$, then we say $am$ \emph{happens} at $time(rsp(am))$. If $op$ is a complete operation whose implementation contains an atomic operation on line~$x$, we use $op^x$ to denote $rsp(am)$, where $am$ is the operation invoked by the final call to line~$x$ performed by $op$. Another characterization of linearizability relies on the notion of \emph{linearization points}. Let $O$ be a linearizable object. Then, for any transcript $T$, a \emph{linearization point function} $pt$ for $O$ maps operations in $\Gamma(T|O)$ to points in time in $T$, such that \begin{enumerate}[label=(\roman*)] \item for every operation $op \in \Gamma(T|O)$, \ifspringer \\ \else\fi $pt(op) \in \bigl[time_T(inv(op)), time_T(rsp(op))\bigr]$, and \item there exists a linearization $S$ of $\Gamma(T|O)$ such that for every operation $op \in \Gamma(T|O)$ such that $pt(op) \neq \infty$, $op \in S$, and for every pair of operations $op_1, op_2 \in S$, if $op_1 \xrightarrow{S} op_2$ then $pt(op_1) \leq pt(op_2)$. \end{enumerate} Intuitively, a linearization point is a point in time between the invocation and response of an operation $op$ at which $op$ ``appears'' to take effect. In any transcript containing operations on a linearizable object $O$, each operation on $O$ can be assigned a linearization point between its invocation and response, such that the sequential history that results from ordering each operation on $O$ by these points is valid. The \textit{prefix closure} of a set of transcripts $\mathcal{T}$, denoted $close(\mathcal{T})$, is the set of all transcripts $S$ such that there exists a transcript $T$ such that $S \circ T \in \mathcal{T}$. A \textit{strong linearization function} $f$ for a set of transcripts $\mathcal{T}$ has the following properties~\cite{stronglin}: \begin{itemize} \item The function $f$ is a linearization function for the set of histories $\Gamma(close(\mathcal{T}))$. \item For any two transcripts $S, T \in \mathcal{T}$ such that $S$ is a prefix of $T$, $f(S)$ is a prefix of $f(T)$. That is, $f$ is \textit{prefix-preserving}. \end{itemize} An implementation $O$ of a type $\mathscr{T}$ is called \textit{strongly linearizable} if and only if the set of all transcripts on instances of $O$ has a strong linearization function. \ifea An implementation of a type is \emph{wait-free} if each operation terminates within a finite number of the calling process' steps. It is \emph{lock-free}, if some operation terminates provided that some process takes sufficiently many steps. \else Let $\mathcal{T}$ be the set of transcripts of an implementation $S$ of some type $\mathscr{T}$. A \emph{continuation} of a transcript $T$ is a transcript $U$ such that $T \circ U$ is well-formed and $T \circ U \in \mathcal{T}$. Then $S$ is \emph{wait-free} if, for every transcript $T \in \mathcal{T}$ and every pending operation $op \in \Gamma (T)$ by process $p$, every continuation $U$ of $T$ that contains an infinite number of steps by $p$ has a finite prefix $U'$ such that $rsp(op) \in U'$. The implementation $S$ is \emph{lock-free} if, for every transcript $T \in \mathcal{T}$ such that $\Gamma (T)$ contains at least one pending operation, for every infinite continuation $U$ of $T$, there exists an $op \in \Gamma (T)$ that is pending in $T$ such that, for some finite prefix $U'$ of $U$, $rsp(op) \in U'$. Intuitively, an implementation is wait-free if each pending operation by process $p$ responds within a finite number of steps by $p$, and an implementation is lock-free if some pending operation responds provided that some process takes sufficiently many steps. \fi \chapter{General Construction}\label{sectionGEN} \else \section{General Construction}\label{sectionGEN} \fi Aspnes and Herlihy \cite{generalwaitfree} defined the large class of \emph{simple} types, and demonstrated that any type in this class has a wait-free linearizable implementation from atomic multi-reader multi-writer registers. Simple types require that any pair of operations either commute, or one overwrites the other (see below for a formal definition). Algorithm~\ref{gen} depicts Aspnes and Herlihy's general wait-free linearizable implementation of an arbitrary simple type $\mathscr{T}$. Processes communicate only through an atomic snapshot object, $root$ (which can be replaced with a wait-free linearizable implementation from registers). Suppose $\mathscr{T}$ supports the set of invocation descriptions $\mathcal{O}$. Then for every $invoke \in \mathcal{O}$, $invoke$ is implemented by the $execute(invoke)$ method. Aspnes and Herlihy proved that Algorithm~\ref{gen} is linearizable with respect to the sequential specification of the simulated type $\mathscr{T}$. We prove that it is in fact strongly linearizable, and thus it remains strongly linearizable if $root$ is a strongly linearizable snapshot object. Thus, using our lock-free snapshot implementation from \ifthesis Chapter \else Section \fi \ref{sectionSLSS} for $root$ yields Theorem~\ref{thm:main-general-construction}. Throughout this \ifthesis chapter, \else section, \fi we only consider types $\mathscr{T} = (\mathcal{S}, s_0, \mathcal{O}, \mathcal{R}, \delta)$ such that, for every $s \in \mathcal{S}$ and for every $invoke \in \mathcal{O}$, $\delta(s, invoke)$ is defined. Two sequential histories $H$ and $H'$ are \emph{equivalent} if, for any sequential history $S$, $H \circ S$ is valid if and only if $H' \circ S$ is valid. The invocation events $inv(op_1)$ and $inv(op_2)$ \emph{commute} if, for all sequential histories $H$ such that $H \circ op_1$ and $H \circ op_2$ are valid, $H \circ op_1 \circ op_2$ and $H \circ op_2 \circ op_1$ are valid and equivalent. The invocation event $inv(op_2)$ \emph{overwrites} $inv(op_1)$ if, for all sequential histories $H$ such that $H \circ op_1$ and $H \circ op_2$ are valid, $H \circ op_1 \circ op_2$ is valid and equivalent to $H \circ op_2$. As a shorthand, we say $op_1$ commutes with (resp. overwrites) an operation $op_2$ if $inv(op_1)$ commutes with (resp. overwrites) $inv(op_2)$. An invocation description $invoke_1$ commutes with (resp. overwrites) the invocation description $invoke_2$ if, for all invocation events $inv(op_1) = (O, invoke_1, id_1)$ and $inv(op_2) = (O, invoke_2, id_2)$, $inv(op_1)$ commutes with (resp. overwrites) $inv(op_2)$. These properties allow us to describe the class of \emph{simple} types. \begin{definition} Let $\mathscr{T}$ be a type that supports a set of invocation descriptions $\mathcal{O}$. Then $\mathscr{T}$ is \emph{simple} if, for every pair of invocation descriptions $invoke_1, invoke_2 \in \mathcal{O}$, either $invoke_1$ and $invoke_2$ commute, or one overwrites the other. \end{definition} For the rest of this section, let $\mathscr{T} = (\mathcal{S}, s_0, \mathcal{O}, \mathcal{R}, \delta)$ be some simple type, and let $O$ be an object of type $\mathscr{T}$ implemented by Algorithm~\ref{gen}; that is, each invocation description $invoke \in \mathcal{O}$ is implemented by the $execute(invoke)$ method. Let $\mathcal{T}$ be the set of all transcripts on $O$. For ease of notation, for every operation $ex$ on $O$ let $invoc(ex)$ denote the invocation description of $ex$; that is, if $inv(ex) = (O, invoke, id)$, then $invoc(ex) = invoke$. Algorithm~\ref{gen} maintains a representation of a graph in a shared snapshot object called $root$. Each entry of the $root$ variable contains a reference to an instance of type $node$, which has three fields: $invocation$, $response$, and $preceding$. The $invocation$ and $response$ fields contain an invocation description and response, respectively. The $preceding$ field is an array containing $n$ references to nodes. For a node $x$, $x.preceding[i]$ contains either $\bot$ or a pointer to a node $y$. A \emph{precedence graph} $G = (V, E)$ of a history $H$ is a directed graph whose vertices are operations, such that for any $op_1, op_2 \in V$ there is a directed path of length at least 1 from $op_1$ to $op_2$ in $G$ if and only if $op_1 \xrightarrow{H} op_2$. Notice that the happens-before relation is the transitive closure of $G$. The following notion of \emph{dominance} is used to break ties between mutually overwriting operations. \begin{definition}\label{defdominate} An invocation event $inv(op_2)$ of process $p$ \emph{dominates} $inv(op_1)$ of process $q$ if either \begin{enumerate}[label=(\arabic*)] \item $inv(op_2)$ overwrites $inv(op_1)$ but not vice-versa, or \item $inv(op_1)$ and $inv(op_2)$ overwrite each other and $p > q$. \end{enumerate} \end{definition} An invocation description $invoke_2$ of process $p$ dominates $invoke_1$ of process $q$ if, for all pairs of invocation events $inv(op_1) = (O, invoke_1, id_1)$ and $inv(op_2) = (O, invoke_2, id_2)$, $inv(op_2)$ dominates $inv(op_1)$. A \emph{linearization graph} $lingraph(G)$ is constructed by adding directed edges to the precedence graph $G$ as follows: First, an arbitrary topological order $op_1,\dots,op_k$ of $G$ is fixed. Then all pairs $(i,j)$, $1\leq i<j\leq k$, are considered in lexicographical order, and if one of the two invocation descriptions in $\{op_i,op_j\}$ dominates the other, an edge is added from the dominated operation to the dominating one, provided that edge does not close a cycle. A precise description of the construction of a linearization graph is provided in the $lingraph$ method of Algorithm~\ref{gen}. Suppose $T \in \mathcal{T}$ is a transcript on $O$. Let $ex \in \Gamma(T)$ be an operation on $O$ by process $p$. Process $p$ begins $ex$ by performing a $root.scan()$ operation on line~\ref{scan}. This $root.scan()$ operation returns a vector $view$ of references to nodes. In line~\ref{gen:constprec} process $p$ computes a precedence graph $G$ of operations on $O$ using a straightforward graph search, starting with the nodes stored in $view$ (we will explain the $precgraph$ method in more detail later). It then calculates a sequential history $H$ on line~\ref{lin} by topologically sorting a linearization graph $lingraph(G)$. Now $p$ constructs a new node $x$ that stores the invocation description $invoc(ex)$, and creates the invocation event $inv(op) = (O, invoc(ex), id)$, for some integer $id$. Process $p$ then constructs a response event $rsp(op) = (resp, id)$ such that $H \circ inv(op) \circ rsp(op)$ is valid with respect to the sequential specification of $\mathscr{T}$ (lines~\ref{createentry}-\ref{getresp}). The existence of the response $resp$ is guaranteed by our assumption that for every $s \in \mathcal{S}$ and every $invoke \in \mathcal{O}$, $\delta(s, invoke)$ is defined. Note that the node referenced by $view[q]$ is the most recent node written to $root$ by process $q$ prior to the $root.scan()$ operation performed by $ex$. For every process $q \in \{1, \ldots, n\}$, $p$ stores $view[q]$ in $x.preceding[q]$ on line~\ref{setprec}. Finally, $p$ writes the address of the constructed node to the snapshot object on line~\ref{slupdate}. For any operation $ex \in \Gamma(T)$ such that $ex^{\ref{slupdate}} \in T$, let $node(ex)$ be the node constructed by $ex$ (i.e. $node(ex)$ is the node whose address is written to $root$ during $ex^{\ref{slupdate}}$). Since each operation instantiates a new node instance, and each node reference remains in the shared precedence graph representation forever, the algorithm uses unbounded space. \begin{algorithm} \caption{\small Implementation of a simple type~\cite{generalwaitfree}} \label{gen} \SetKwProg{Fn}{Function}{:}{} \SetKwFor{Struct}{struct}{:}{} \nonl\Struct{node} { \nonl invocation description, $invocation \in \mathcal{O}$\; \nonl response, $response \in \mathcal{R}$\; \nonl pointers to nodes, $preceding[1 \ldots n]$\; } \nonl\textbf{shared}\; \nonl\quad atomic snapshot object $root = (null, \ldots, null)$\; \nonl\; \nonl\Fn{lingraph$(G)$} { let $op_1, \ldots, op_k$ be a topological sort of $G$\; $L \gets G$\; \For{$i \in \{1, \ldots, k-1\}$} { \For{$j \in \{i+1, \ldots, k\}$} { \If{$op_i$ dominates $op_j$ and adding $(op_j, op_i)$ to $L$ does not complete a cycle} { add $(op_j, op_i)$ to $L$\; } \If{$op_j$ dominates $op_i$ and adding $(op_i, op_j)$ to $L$ does not complete a cycle} { add $(op_i, op_j)$ to $L$\; } } } \Return $L$ } \nonl\; \nonl\Fn{execute$_p(invoke)$}{ $view \gets root.scan()$\; \label{scan} $G \gets precgraph(view)$\; \label{gen:constprec} $H \gets$ topological sort of $lingraph(G)$\; \label{lin} initialize a new $node$ $e = \{\bot, \bot, \bot\}$\; \label{createentry} $e.invocation \gets invoke$\; \label{invoc} $inv(op) \gets (O, invoke, id)$\; \label{invevent} $rsp(op) \gets (resp, id)$ such that $H \circ inv(op) \circ rsp(op)$ is valid; \label{getresp} $e.response \gets resp$\; \For{$i \in \{1, \ldots, n\}$}{ \label{precloop} $e.preceding[i] \gets view[i]$ \label{setprec} } $root.update_p($address of $e)$\; \label{slupdate} \Return $e.response$ } \end{algorithm} We proceed by first outlining an argument for the linearizability of Algorithm~\ref{gen}. On line~\ref{getresp}, an operation ensures that it calculates a valid response with respect to the sequential history $H$ constructed on line~\ref{lin}. Then assuming that $H$ is valid, the algorithm is correct as long as writing out a node constructed by a pending operation does not invalidate the response of some concurrent operation. Suppose $ex_1$ and $ex_2$ are concurrent operations. For this example, assume no other operations are concurrent with either $ex_1$ or $ex_2$. Hence, both $ex_1$ and $ex_2$ construct the same precedence graph (call it $G$) on line~\ref{gen:constprec}. For simplicity, assume that $ex_1$ and $ex_2$ both compute the same topological ordering (call it $H$) of $lingraph(G)$ on line~\ref{lin} (one of the key results of Aspnes and Herlihy \cite{generalwaitfree} is that every pair of topological orderings of any linearization graph are equivalent --- we state this result more formally in Section~\ref{sec:genproofsl}). Hence, on lines \ref{invevent} and \ref{getresp} $ex_1$ and $ex_2$ construct operations $op_1$ and $op_2$, respectively, such that $H \circ op_1$ and $H \circ op_2$ are valid. Since the simulated type is simple, either $invoc(ex_1)$ and $invoc(ex_2)$ commute, or one overwrites the other. If $invoc(ex_1)$ and $invoc(ex_2)$ commute, then it does not matter which node is written to $root$ first, since $H \circ op_1 \circ op_2$ and $H \circ op_2 \circ op_1$ are both valid and equivalent, by definition of commutativity. If $invoc(ex_2)$ overwrites $invoc(ex_1)$, then again it does not matter which operation writes its node to $root$ first, since any operation that views the precedence graph after both $ex_1$ and $ex_2$ have written their nodes to $root$ adds a dominance edge from $op_1$ to $op_2$ in the linearization graph. Hence, in any topological ordering of this linearization graph $op_1$ occurs immediately before $op_2$ (recall our assumption that no other operations are concurrent with either $ex_1$ or $ex_2$). Since $H \circ op_1 \circ op_2$ is valid by the definition of overwriting, the responses of both $op_1$ and $op_2$ are valid. A symmetric argument applies if $invoc(ex_1)$ overwrites $invoc(ex_2)$. We now outline the intuition behind our strong linearization function for Algorithm~\ref{gen}; a full proof of the strong linearizability of Algorithm~\ref{gen} is provided in Section~\ref{sec:genproofsl}. Suppose $T \in \mathcal{T}$ is a transcript, and let $ex \in \Gamma(T)$ be an operation by process $p$. After $p$ performs the $root.scan()$ operation on line~\ref{scan} during $ex$, the response of $ex$ is entirely determined, since it is chosen based on the contents of the precedence graph constructed from $view$ on line~\ref{gen:constprec}. If during $ex$, an operation $ex'$ writes its constructed node to $root$, and $invoc(ex')$ dominates $invoc(ex)$, then $ex$ may be linearized immediately before $ex'$, since $ex$ no longer has any effect on the responses calculated by subsequent operations. Hence, operations may only linearize when some node is written to $root$ on line~\ref{slupdate}, as it is entirely determined which operations linearize when a particular node is written to the graph (i.e. all concurrent operations that are dominated by the writing operation). \iffull \ifthesis \section{Storing a Precedence Graph}\label{sec:storeprecgraph} \else \subsection{Storing a Precedence Graph}\label{sec:storeprecgraph} \fi In this section we prove that a precedence graph may be extracted from $root$. More specifically, we show that for any vector $view$ returned by a $root.scan()$ operation, $precgraph(view)$ returns a precedence graph of some history (the implementation of $precgraph$ is provided in Algorithm~\ref{alg:precgraph}). The $precgraph(view)$ method begins by performing a $nodegraph(view)$ operation on line~\ref{precgraph:getnodegraph}, which returns a graph whose vertices are nodes. A $nodegraph(view)$ operation begins with a straightforward graph search starting from the nodes present in $view$. First, a process $p$ performing a $nodegraph(view)$ operation initializes an empty graph $G = (V, E)$ and an empty queue $queue$ (lines \ref{precgraph:initgraph} and \ref{precgraph:initqueue}). Next, $p$ adds all nodes referenced in $view$ to both $queue$ and the vertex set $V$ during the loop on line~\ref{precgraph:initloop}. The main loop of the $nodegraph$ method begins on line~\ref{precgraph:mainloop}, and continues until all nodes have been removed from $queue$. During the main loop, $p$ first removes a node $node(ex)$ from $queue$ on line~\ref{precgraph:dequeue}. For each node $node(ex')$ referenced in $node(ex).preceding$, $p$ adds the edge $\bigl(node(ex'), node(ex)\bigr)$ to $E$ on line~\ref{precgraph:addedge}; if $node(ex')$ is not present in $V$, then $p$ adds $node(ex')$ to $queue$ and $V$ on lines \ref{precgraph:addtoqueue} and \ref{precgraph:vaddmain}. After the main while-loop has terminated, the $nodegraph(view)$ operation returns the computed graph $G$. In the $precgraph(view)$ method, after the $nodegraph(view)$ operation has responded, process $p$ computes a topological ordering $node(ex_1), \ldots, node(ex_k)$ of the vertices in $G$. Next, process $p$ initializes an array $id[1\ldots n] = [1, \ldots, 1]$ on line~\ref{precgraph:initid}. Process $p$ then begins a for-loop on line~\ref{precgraph:opforloop}; during this loop, $p$ computes an operation on $O$ for each node present in $G$. That is, for each $node(ex_i)$ present in the topological ordering of $G$, $p$ constructs an operation $op_i$, with $inv(op_i) = (O, node(ex_i).invocation), opid)$, and $rsp(op_i) = (node(ex_i), opid)$, where $opid$ is an integer. The operation identifier $opid$ is computed on line~\ref{precgraph:opid}, where it is assigned the value $(id[p]\cdot n) + (p-1)$, where $p$ is the process that performed $ex_i$. The final statement of the loop increments $id[p]$ by 1. In general, the operation constructed for the $j$-th node in the topological ordering of $G$ which was written by process $p$ is assigned the identifier $(j \cdot n) + (p-1)$. This way, each operation constructed during the loop is assigned a unique identifier (note that if $ex_j$ is performed by process $p$, and $inv(ex_j)$ has the identifier $opid$, then $opid \equiv (p-1) \pmod{n}$). After the for-loop, on line~\ref{precgraph:replaceverts} $p$ replaces each $node(ex_i) \in V$ with $op_i$ (each edge is replaced similarly on line~\ref{precgraph:replaceedges}). \begin{algorithm}\label{alg:precgraph} \caption{Extraction of a precedence graph from a vector of node references.} \SetKwProg{Fn}{Function}{:}{} \nonl\Fn{precgraph$(view)$} { $G = (V, E) \gets nodegraph(view)$\; \label{precgraph:getnodegraph} let $node(ex_1), \ldots, node(ex_k)$ be a topological sort of $G$\; \label{precgraph:lettopsort} let $id[1\ldots n] = [1, \ldots, 1]$\; \label{precgraph:initid} \For{$i \in \{1, \ldots, k\}$} { \label{precgraph:opforloop} suppose $ex_i$ is by process $p$\; let $opid = (id[p]\cdot n) + (p-1)$\; \label{precgraph:opid} let $inv(op_i) = (O, node(ex_i).invocation, opid)$\; \label{precgraph:invevent} let $rsp(op_i) = (node(ex_i).response, opid)$\; \label{precgraph:rspevent} $id[p] \gets id[p] + 1$\; \label{precgraph:idinc} } replace $node(ex_i) \in V$ with $op_i$, for all $i \in \{1, \ldots, k\}$\;\label{precgraph:replaceverts} replace each $\bigl(node(ex_i), node(ex_j)\bigr) \in E$ with $(op_i, op_j)$\;\label{precgraph:replaceedges} \Return $G$ } \nonl\; \nonl\Fn{nodegraph$(view)$} { let $G = (V, E)$ be an empty graph\; \label{precgraph:initgraph} let $queue$ be an empty queue\; \label{precgraph:initqueue} \For{$v \in view$} { \label{precgraph:initloop} \If{$v \neq null$} { let $node(ex)$ be the node addressed by $v$\; enqueue $node(ex)$ to $queue$\; $V \gets V \cup \{node(ex)\}$\; \label{precgraph:vaddinit} } } \While{$queue$ is not empty} { \label{precgraph:mainloop} dequeue $node(ex)$ from $queue$\; \label{precgraph:dequeue} \For{each $node(ex')$ referenced in $node(ex).preceding$} { \label{precgraph:neighbours} $E \gets E \cup \bigl\{(node(ex'), node(ex))\bigr\}$\; \label{precgraph:addedge} \If{$node(ex') \not\in V_N$} { \label{precgraph:checkinv} enqueue $node(ex')$ to $queue$\; \label{precgraph:addtoqueue} $V \gets V \cup \{node(ex')\}$\; \label{precgraph:vaddmain} } } } \label{precgraph:endloop} \Return $G$ } \end{algorithm} Let $T \in \mathcal{T}$ be a transcript, and let $\mathcal{G}(T) = (V_T, E_T)$ be a graph such that \begin{align*} \ifspringer \small \else\fi \text{$V_T$} &\small\text{$\;= \{node(ex)\, :\, ex^{\ref{slupdate}} \in T\}$, and} \\ \small\text{$E_T$} &\small\text{$\,= \Bigl\{\bigl(node(ex_1), node(ex_2)\bigr)\, :\, node(ex_1), node(ex_2) \in V_T$} \\ &\small\text{$\qquad \wedge \; \exists p \in \{1, \ldots, n\} \text{ s.t. } node(ex_2).preceding[p] =$} \\ &\small\text{$\qquad$address of $node(ex_1)\Bigr\}$.} \end{align*} We will show that if $root$ contains the vector $view$ after all steps in $T$ are performed, then $nodegraph(view) = \mathcal{G}(T)$. \begin{observation}\label{obs:edgeearlier} If $\bigl(node(ex_1), node(ex_2)\bigr) \in E_T$, \ifspringer \\ \else\fi then $time(ex_1^{\ref{slupdate}}) < time(ex_2^{\ref{scan}})$. \end{observation} \begin{proof} Since $\bigl(node(ex_1), node(ex_2)\bigr) \in E_T$, by the definition of $E_T$ $node(ex_2).preceding[p]$ must contain the address of $node(ex_1)$, for some process $p$. On line~\ref{createentry} of Algorithm~\ref{gen}, each operation initializes its own node, and only modifies the fields of that node. Hence, only $ex_2$ modifies the $preceding$ field of $node(ex_2)$. Thus, $ex_2$ must place the address of $node(ex_1)$ into $node(ex_2).preceding[p]$ when it performs line~\ref{setprec} (during the $p$-th iteration of the for-loop on line~\ref{precloop}). Therefore, the address of $node(ex_1)$ must be in $view[p]$, where $view$ is the vector returned by $ex_2^{\ref{scan}}$. Then by the sequential specification of snapshot objects, $time(ex_1^{\ref{slupdate}}) < time(ex_2^{\ref{scan}})$. \end{proof} \begin{observation}\label{obs:pathearlier} If there is a path of length at least 1 from $node(ex_1)$ to $node(ex_2)$ in $\mathcal{G}(T)$, then $time(ex_1^{\ref{slupdate}}) < time(ex_2^{\ref{scan}})$. \end{observation} \begin{proof} If the length of the path from the vertex $node(ex_1)$ to the vertex $node(ex_2)$ is 1, then the observation immediately follows from Observation~\ref{obs:edgeearlier}. Now \ifspringer \begin{equation}\label{obs:pathearlier:indhyp} \begin{split} &\text{assume that the observation holds for any path of} \\ &\text{length $k \geq 1$.} \end{split} \end{equation} \else \begin{equation}\label{obs:pathearlier:indhyp} \text{assume that the observation holds for any path of length $k \geq 1$.} \end{equation} \fi Suppose that there is a path of length $k+1$ from $node(ex_1)$ to $node(ex_2)$. Let $node(ex_\ell)$ be the second-last node on this path. So \ifspringer \begin{gather} \begin{split} &\text{there is a path from $node(ex_1)$ to $node(ex_\ell)$ of} \\ &\text{length $k$, and} \label{obs:pathearlier:kpath} \end{split}\\ \text{$\bigl(node(ex_\ell), node(ex_2)\bigr) \in E_T$.}\label{obs:pathearlier:edge} \end{gather} \else \begin{gather} \text{there is a path from $node(ex_1)$ to $node(ex_\ell)$ of length $k$, and} \label{obs:pathearlier:kpath} \\ \text{$\bigl(node(ex_\ell), node(ex_2)\bigr) \in E_T$.}\label{obs:pathearlier:edge} \end{gather} \fi By (\ref{obs:pathearlier:indhyp}) and (\ref{obs:pathearlier:kpath}), \begin{equation} time(ex_1^{\ref{slupdate}}) < time(ex_\ell^{\ref{scan}}).\label{obs:pathearlier:1beforeell} \end{equation} By (\ref{obs:pathearlier:edge}) and Observation~\ref{obs:edgeearlier}, \begin{equation} time(ex_\ell^{\ref{slupdate}}) < time(ex_2^{\ref{scan}}).\label{obs:pathearlier:ellbefore2} \end{equation} By the pseudocode of the $execute$ method in Algorithm~\ref{gen}, $time(ex_\ell^{\ref{scan}}) < time(ex_\ell^{\ref{slupdate}})$. This, along with (\ref{obs:pathearlier:1beforeell}) and (\ref{obs:pathearlier:ellbefore2}), imply that $time(ex_1^{\ref{slupdate}}) < time(ex_2^{\ref{scan}})$. Hence, the observation follows by induction. \end{proof} \begin{observation}\label{obs:procseq} For some process $p$, let $ex_1 \circ \ldots \circ ex_k$ be the longest prefix of $\Gamma(T)|p$ with $ex_k^{\ref{slupdate}} \in T$. Then for any $i, j \in \{1, \ldots, k\}$ such that $i < j$, there is a path of length $j - i$ from $node(ex_i)$ to $node(ex_j)$. \end{observation} \begin{proof} It suffices to show that, for any $i \in \{1, \ldots, k-1\}$, $\bigl(node(ex_i), node(ex_{i+1})\bigr) \in E_T$. Since $ex_i$ and $ex_{i+1}$ are both performed by $p$, they are performed in sequence. Hence, $time(ex_i^{\ref{slupdate}}) < time(ex_{i+1}^{\ref{scan}})$, and since each operation performs only a single $root.update$ operation (line~\ref{slupdate}), there is no $root.update$ operation by $p$ that happens in $\bigl(time(ex_i^{\ref{slupdate}}), time(ex_{i+1}^{\ref{scan}})\bigr)$. Then if $view$ is the vector returned by $ex_{i+1}^{\ref{scan}}$, $view[p]$ contains the address of $node(ex_i)$. Therefore, $ex_{i+1}$ places the address of $node(ex_i)$ into $node(ex_{i+1}).preceding[p]$ on line~\ref{setprec} (during the $p$-th iteration of the for-loop on line~\ref{precloop}). Then by the definition of $E_T$, $\bigl(node(ex_i), node(ex_{i+1})\bigr) \in E_T$. \end{proof} \begin{observation}\label{obs:nodeseq} Let $ex_q, ex_p \in \Gamma(T)$ be operations by processes $q$ and $p$, respectively, with $ex_q^{\ref{slupdate}}, ex_p^{\ref{slupdate}} \in T$. If $time(ex_q^{\ref{slupdate}}) < time(ex_p^{\ref{scan}})$, then there is a path from $node(ex_q)$ to $node(ex_p)$ in $\mathcal{G}(T)$. \end{observation} \begin{proof} If $q = p$, then the observation statement follows from Observation~\ref{obs:procseq}. Now assume $q \neq p$. Suppose $ex_{q,1}, \ldots, ex_{q,k}$ is the sequence of $execute$ operations by $q$ in $\Gamma(T)$. Let $ex_{q,i}$ be the final operation in this sequence with $time(ex_{q,i}^{\ref{slupdate}}) < time(ex_p^{\ref{scan}})$ (the existence of $ex_{q,i}$ is guaranteed by the observation assumption). That is, \ifspringer \begin{equation} \begin{split} &\text{there is no $j \in \{i+1, \ldots, k\}$ such that} \\ &\text{$time(ex_{q,j}^{\ref{slupdate}}) < time(ex_p^{\ref{scan}})$.}\label{obs:nodeseq:lateproc} \end{split} \end{equation} \else \begin{equation} \text{there is no $j \in \{i+1, \ldots, k\}$ such that $time(ex_{q,j}^{\ref{slupdate}}) < time(ex_p^{\ref{scan}})$.}\label{obs:nodeseq:lateproc} \end{equation} \fi Let $view$ be the vector returned by $ex_p^{\ref{scan}}$. By (\ref{obs:nodeseq:lateproc}) and the fact that $time(ex_{q,i}^{\ref{slupdate}}) < time(ex_p^{\ref{scan}})$, \begin{equation} \text{$view[q]$ contains the address of $node(ex_{q,i})$.}\label{obs:nodeseq:address} \end{equation} By (\ref{obs:nodeseq:address}), $ex_p$ places the address of $node(ex_{q,i})$ into $node(ex_p).preceding[q]$ on line~\ref{setprec}. Then by definition of $E_T$, \begin{equation} \bigl(node(ex_{q,i}), node(ex_p)\bigr) \in E_T.\label{obs:nodeseq:edge} \end{equation} If $ex_q = ex_{q,i}$, then the observation statement is implied by (\ref{obs:nodeseq:edge}). Otherwise, if $ex_q = ex_{q,j} \neq ex_{q,i}$, then $j < i$ by (\ref{obs:nodeseq:lateproc}) along with the observation assumption that $time(ex_q^{\ref{slupdate}}) < time(ex_p^{\ref{scan}})$. Hence, by Observation~\ref{obs:procseq}, there is a path from $node(ex_q)$ to $node(ex_{q,i})$ in $\mathcal{G}(T)$. By this and (\ref{obs:nodeseq:edge}), there is a path from $node(ex_q)$ to $node(ex_p)$ in $\mathcal{G}(T)$. \end{proof} \begin{observation}\label{obs:rootprecgraph} Suppose $T \in \mathcal{T}$ is a transcript. Suppose that, after all steps in $T$ are performed in order, $root$ contains the vector $view$. Let $G = (V, E) = nodegraph(view)$. Then for every operation $ex \in \Gamma(T)$ such that $ex^{\ref{slupdate}} \in T$, \begin{enumerate}[label=(\alph*)] \item $node(ex) \in V$, and\label{obs:rootprecgraph:A} \item for every $node(ex')$ referenced in $node(ex).preceding$, $\bigl(node(ex'), node(ex)\bigr) \in E$.\label{obs:rootprecgraph:B} \end{enumerate} That is, $nodegraph(view) = \mathcal{G}(T)$. \end{observation} \begin{proof} To prove part~\ref{obs:rootprecgraph:A}, we show that for every process $p$, each node whose address is written to $root$ during $T$ is added to $V$ in the calculation of $nodegraph(view)$. Let $ex_1, \ldots, ex_k \in \Gamma(T)$ be the (nonempty) sequence of operations by $p$ such that $ex_i^{\ref{slupdate}} \in T$, for every $i \in \{1, \ldots, k\}$. (If there are no such operations by process $p$, then $V$ trivially contains all nodes written to $root$ by $p$ in $T$.) Note that $view[p]$ contains a reference to $node(ex_k)$. Hence, in the computation of $nodegraph(view)$, $node(ex_k)$ is added to $V$ on line~\ref{precgraph:vaddinit}. Now \ifspringer \begin{equation} \begin{split} &\text{assume that for some $j \in \{2, \ldots, k\}$,} \\ &\text{$node(ex_j) \in V$.}\label{obs:precgraph:ih} \end{split} \end{equation} \else \begin{equation} \text{assume that for some $j \in \{2, \ldots, k\}$, $node(ex_j) \in V$.}\label{obs:precgraph:ih} \end{equation} \fi We proceed by showing that $node(ex_{j-1}) \in V$. By Observation~\ref{obs:procseq}, there exists a path of length 1 (i.e. an edge) from $node(ex_{j-1})$ to $node(ex_j)$ in $\mathcal{G}(T)$. Then \ifspringer \begin{equation} \begin{split} &\text{$node(ex_j).preceding[p]$ contains a reference to} \\ &\text{$node(ex_{j-1})$.}\label{obs:precgraph:inprec} \end{split} \end{equation} \else \begin{equation} \text{$node(ex_j).preceding[p]$ contains a reference to $node(ex_{j-1})$.}\label{obs:precgraph:inprec} \end{equation} \fi Due to (\ref{obs:precgraph:ih}), in the computation of $nodegraph(view)$, $node(ex_j)$ must have been added to $V$ on either line~\ref{precgraph:vaddinit} or line~\ref{precgraph:vaddmain}. In either case, $node(ex_j)$ is added to $queue$ on the previous line. Since the while-loop on line~\ref{precgraph:mainloop} does not terminate until $queue$ is empty, $node(ex_j)$ is eventually dequeued from $queue$ on line~\ref{precgraph:dequeue}. By (\ref{obs:precgraph:inprec}), the for-loop on line~\ref{precgraph:neighbours} eventually reaches $node(ex_{j-1})$. Hence, at the if-statement on line~\ref{precgraph:checkinv}, either $node(ex_{j-1}) \in V$ already, or $node(ex_{j-1})$ is added to $V$ on line~\ref{precgraph:vaddmain}. Therefore, $node(ex_{j-1}) \in V$, and by induction we conclude that $node(ex_1), \ldots, node(ex_k) \in V$. This completes the proof of part~\ref{obs:rootprecgraph:A}. Due to \ref{obs:rootprecgraph:A}, and the fact that each node is added to $queue$ before it is added to $V$ during the calculation of $nodegraph(view)$, \ifspringer \begin{equation} \small \begin{split} &\text{for every $ex \in \Gamma(T)$ such that $ex^{\ref{slupdate}} \in T$, $node(ex)$ is} \\ &\text{dequeued from $queue$ on line~\ref{precgraph:dequeue} at some point} \\ &\text{during the computation of $nodegraph(view)$.}\label{obs:precgraph:dequeue} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{for every $ex \in \Gamma(T)$ such that $ex^{\ref{slupdate}} \in T$, $node(ex)$ is dequeued from $queue$ on line~\ref{precgraph:dequeue}} \\ &\text{at some point during the computation of $nodegraph(view)$.}\label{obs:precgraph:dequeue} \end{split} \end{equation} \fi When $node(ex)$ is dequeued from $queue$ on line~\ref{precgraph:dequeue}, for every $node(ex')$ that is referenced in $node(ex).preceding$, the edge $\bigl(node(ex'), node(ex)\bigr)$ is added to $E$ (if it is not already present in $E$) on line~\ref{precgraph:addedge}; part~\ref{obs:rootprecgraph:B} follows from this along with (\ref{obs:precgraph:dequeue}). \end{proof} Let $T \in \mathcal{T}$ be a transcript such that $root$ contains the vector $view$ after all steps of $T$ are performed in order. Let $oper(ex)$ denote the operation on $O$ with $inv\bigl(oper(ex)\bigr) = \bigl(O, node(ex).invocation, (j\cdot n) + (p-1)\bigr)$ and $rsp\bigl(oper(ex)\bigr) = \bigl(node(ex).response, (j\cdot n) + (p-1)\bigr)$, where $ex$ is the $j$-th operation by $p$ in $\Gamma(T)$. \begin{observation}\label{obs:operations} Consider the operation $op_i$ computed from $node(ex_i)$ on lines \ref{precgraph:invevent} and \ref{precgraph:rspevent} during the computation of $precgraph(view)$, for any $i \in \{1, \ldots, k\}$. Then $op_i = oper(ex_i)$. \end{observation} \begin{proof} Suppose $ex_i$ is the $j$-th operation performed by $p$ in $\Gamma(T)$. Let the $nodegraph(view)$ operation on line~\ref{precgraph:getnodegraph} return the graph $G$. Consider the topological ordering $node(ex_1), \cdots, node(ex_k)$ of $G$ constructed on line~\ref{precgraph:lettopsort}; let $node(ex_{p,1}), \ldots, node(ex_{p,\ell})$ be the subsequence of $node(ex_1), \cdots, node(ex_k)$ consisting of all and only those nodes constructed by $p$. Observation~\ref{obs:procseq} implies that $ex_i = ex_{p,j}$, as otherwise there would be a backwards edge among the sequence $node(ex_{p,1}), \ldots, node(ex_{p,\ell})$ in $G$. Hence, $node(ex_i)$ is the $j$-th node by process $p$ that is encountered during the for-loop on line~\ref{precgraph:opforloop} (that is, each of $node(ex_{p,1}), \ldots, node(ex_{p,j-1})$ is encountered during the for-loop prior to $node(ex_{p,j}) = node(ex_i)$). On line~\ref{precgraph:invevent}, the invocation description of $op_i$ is set to $node(ex_i).invocation$, and on line~\ref{precgraph:rspevent}, the response of $op_i$ is set to $node(ex_i).response$. Now consider $opid$, the operation identifier calculated for $op_i$ on line~\ref{precgraph:opid}. Since $ex_i$ is the $j$-th node by process $p$ that is encountered during the for-loop on line~\ref{precgraph:opforloop}, $id[p]$ has been incremented $j-1$ times by the time $op_i$ is constructed. Hence, $opid = (id[p]\cdot n) + (p-1) = (j\cdot n) + (p-1)$. Therefore, $inv(op_i) = \bigl(O, node(ex_i).invocation, (j\cdot n) + (p-1)\bigr) = inv\bigl(oper(ex_i)\bigr)$, and $rsp(op_i) = \bigl(node(ex_i).response, (j\cdot n) + (p-1)\bigr) = rsp\bigl(oper(ex_i)\bigr)$. \end{proof} By Observation~\ref{obs:operations} and the replacements performed on line~\ref{precgraph:replaceverts}, if $V$ is the vertex set of the graph returned by $precgraph(view)$, then $V = \{oper(ex)\; :\; node(ex)$ is in $\mathcal{G}(T)\}$. We will use this fact without referencing Observation~\ref{obs:operations} for the remainder of the section. Let $H$ be a history on an object $O$ of type $\mathscr{T}$ obtained from $T|root$ by doing the following for each step $t$ of $T|root$: \begin{enumerate}[label=(\roman*)] \item If $t = time(ex^{\ref{scan}})$ for some operation $ex$ by process $p$, then replace this step by the invocation event $inv\bigl(oper(ex)\bigr)$ in $H$. \item If $t = time(ex^{\ref{slupdate}})$ for some operation $ex$ by process $p$, then replace this step by the response event $rsp\bigl(oper(ex)\bigr)$ in $H$. \item If $t = time\bigl(inv(op)\bigr)$, where $op$ is any $root.scan$ or $root.update$ operation, remove this step from $H$. \end{enumerate} \begin{lemma} The graph $precgraph(view)$ is a precedence graph of the history $H$. \end{lemma} \begin{proof} Suppose $oper(ex_1) \xrightarrow{H} oper(ex_2)$. By definition of happens-before order, this implies that $rsp\bigl(oper(ex_1)\bigr)$ occurs before $inv\bigl(oper(ex_2)\bigr)$ in $H$. Then by the construction rules for $H$, $time_{T|root}(ex_1^{\ref{slupdate}}) < time_{T|root}(ex_2^{\ref{scan}})$, and hence $time_T(ex_1^{\ref{slupdate}}) < time_T(ex_2^{\ref{scan}})$. Therefore, there is a path from $node(ex_1)$ to $node(ex_2)$ in $\mathcal{G}(T)$ by Observation~\ref{obs:nodeseq}. Then by the replacements performed on lines \ref{precgraph:replaceverts} and \ref{precgraph:replaceedges}, there is a path from $oper(ex_1)$ to $oper(ex_2)$ in $precgraph(view)$. Now suppose there is a path from $oper(ex_1)$ to $oper(ex_2)$ in $precgraph(view)$. Then there is a path from $node(ex_1)$ to $node(ex_2)$ in $\mathcal{G}(T)$. By Observation~\ref{obs:pathearlier}, $time_T(ex_1^{\ref{slupdate}}) < time_T(ex_2^{\ref{scan}})$. This immediately implies that \begin{equation} time_{T|root}(ex_1^{\ref{slupdate}}) < time_{T|root}(ex_2^{\ref{scan}}).\label{precgraphofhistory} \end{equation} By the construction rules for $H$, $rsp(ex_1^{\ref{slupdate}})$ is replaced with $rsp\bigl(op_1\bigr)$ in $H$, and $rsp(ex_2^{\ref{scan}})$ is replaced with $inv\bigl(oper(ex_2)\bigr)$ in $H$. By this and (\ref{precgraphofhistory}), $rsp\bigl(oper(ex_1)\bigr)$ occurs before $inv\bigl(oper(ex_2)\bigr)$ in $H$, so $oper(ex_1) \xrightarrow{H} oper(ex_2)$. \end{proof} Throughout the remainder of this section, for any transcript $T \in \mathcal{T}$ such that $root$ contains the vector $view$ after all steps in $T$ are performed in order, we refer to $precgraph(view)$ as the precedence graph \emph{induced by} $\mathcal{G}(T)$. For operations $oper(ex_1), oper(ex_2)$ in a precedence graph $G$, we say $oper(ex_1)$ \emph{precedes} $oper(ex_2)$ in $G$ if and only if there is a path from $oper(ex_1)$ to $oper(ex_2)$ in $G$. If there is no path between operations $oper(ex_1)$ and $oper(ex_2)$ in $G$, then we say $oper(ex_1)$ and $oper(ex_2)$ are \emph{concurrent} in $G$. If $T \in \mathcal{T}$ is a transcript such that $G$ is the precedence graph induced by $\mathcal{G}(T)$, then following two observations are immediate from Observation~\ref{obs:pathearlier} and Observation~\ref{obs:nodeseq}, respectively: \begin{observation}\label{obs:opprecede} An operation $oper(ex_1)$ precedes \ifspringer operation \else\fi $oper(ex_2)$ in $G$ if and only if $time(ex_1^{\ref{slupdate}}) < time(ex_2^{\ref{scan}})$. \end{observation} \begin{observation}\label{obs:opconcurrent} The operations $oper(ex_1), oper(ex_2)$ are concurrent in $G$ if and only if \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=(\roman*)] \item $time(ex_2^{\ref{scan}}) < time(ex_1^{\ref{slupdate}})$, and \item $time(ex_1^{\ref{scan}}) < time(ex_2^{\ref{slupdate}})$. \end{enumerate} \end{observation} \ifthesis \section{Proof of Strong Linearizability}\label{sec:genproofsl} \else \subsection{Proof of Strong Linearizability}\label{sec:genproofsl} \fi Notice that we cannot use Aspnes and Herlihy's linearization function (i.e. topological orderings of linearization graphs) to prove strong linearizability, since this function is not prefix preserving. This is because operations may be written to the ``middle'' of the linearization graph; we clarify this argument with an example. Consider a transcript $T$ containing only the operations $ex$ and $ex'$. Suppose $invoc(ex')$ dominates $invoc(ex)$. While $ex$ is pending, suppose $ex'$ writes its constructed node to $root$. Let $T'$ be the prefix of $T$ that ends with the response of the $root.update$ operation by $ex'$ on line~\ref{slupdate}. Suppose that $ex$ completes its operation in $T$. Let $G'$ be the precedence graph induced by $\mathcal{G}(T')$, and let $G$ be the precedence graph induced by $\mathcal{G}(T)$. Then $lingraph(G')$ only contains $oper(ex')$, while $lingraph(G)$ contains both operations along with a dominance edge from $oper(ex)$ to $oper(ex')$ . Hence, $oper(ex')$ is the only topological ordering of $lingraph(G')$, while $oper(ex) \circ oper(ex')$ is the only topological ordering of $lingraph(G)$. This demonstrates how operations can unavoidably be written to the middle of the linearization order. For this reason, we must define our own linearization function for Algorithm~\ref{gen}. Let $T \in \mathcal{T}$ be some transcript. Let $ex_1, \ldots, ex_k$ be a sequence consisting of all operations in $\Gamma(T)$, such that for any $i, j \in \{1, \ldots, k\}$ with $i < j$, $invoc(ex_j)$ does not dominate $invoc(ex_i)$ (such an ordering is guaranteed to exist, since dominance is a strict partial order). For every $i \in \{1, \ldots, k\}$, let $pt_T(ex_i)$ be defined inductively as follows: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{I-\arabic*},ref={I-\arabic*}] \item If $i = 1$, then define \begin{equation*} pt_T(ex_i) = time(ex_i^{\ref{slupdate}}). \end{equation*}\label{def:base} \item If $i > 1$, then let $Dom_i$ be the set of all operations $ex_h$ such that $h < i$ and $invoc(ex_h)$ dominates $invoc(ex_i)$. Define \ifspringer \begin{equation*} \small \begin{split} \text{$pt_T(ex_i) = \min \Bigl($} &\text{$\bigl\{pt(ex_h)\; :\; ex_h \in Dom_i \wedge time(ex_i^{\ref{scan}}) <$} \\ &\text{$pt(ex_h)\bigr\} \cup \bigl\{time(ex_i^{\ref{slupdate}})\bigr\}\Bigr)$.} \end{split} \end{equation*}\label{def:inductive} \else \begin{equation*} \text{$pt_T(ex_i) = \min \Bigl($} \text{$\bigl\{pt(ex_h)\; :\; ex_h \in Dom_i \wedge time(ex_i^{\ref{scan}}) <$ $pt(ex_h)\bigr\} \cup \bigl\{time(ex_i^{\ref{slupdate}})\bigr\}\Bigr)$.} \end{equation*}\label{def:inductive} \fi \end{enumerate} In \ref{def:inductive}, we emphasize that $Dom_i \subseteq \{ex_1, \ldots ex_{i-1}\}$; this ensures that \ref{def:base} and \ref{def:inductive} together form a proper inductive definition. However, note that if $ex_h$ dominates $ex_i$, then it is guaranteed that $h < i$ since $ex_1, \ldots, ex_k$ is ordered by dominance. That is, every operation whose invocation dominates $invoc(ex_i)$ must be earlier in the sequence $ex_1, \ldots, ex_k$ than $ex_i$. Therefore, the following property is guaranteed for any $ex \in \Gamma(T)$: \ifspringer \begin{equation}\label{ptdefinition} \small \begin{split} pt_T(ex) = \min \Bigl(&\bigl\{time(ex^{\ref{slupdate}})\bigr\} \cup \bigl\{pt(ex')\; :\; \\ &\text{$invoc(ex')$ dominates $invoc(ex)$}\;\wedge \\ &time(ex^{\ref{scan}}) < pt(ex')\bigr\}\Bigr). \end{split} \end{equation} \else \begin{equation}\label{ptdefinition} \begin{split} pt_T(ex) = \min \Bigl(&\bigl\{time(ex^{\ref{slupdate}})\bigr\} \cup \\ &\bigl\{pt(ex')\; :\; \text{$invoc(ex')$ dominates $invoc(ex)$}\;\wedge\; time(ex^{\ref{scan}}) < pt(ex')\bigr\}\Bigr). \end{split} \end{equation} \fi To simplify our proofs, we decompose property (\ref{ptdefinition}) into the following two rules: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{J-\arabic*},ref={J-\arabic*}] \item If there is an operation $ex' \in \Gamma(T)$ such that $invoc(ex')$ dominates $invoc(ex)$ and $time(ex^{\ref{scan}}) < pt_T(ex') < pt_T(ex^{\ref{slupdate}})$, then let $ex_0$ be such an operation with minimal $pt_T$ value. Then $pt_T(ex) = pt_T(ex_0)$.\label{gen:ptrdom} \item If no such operation $ex'$ exists, then $pt_T(ex) = time(ex^{\ref{slupdate}})$. Recall that if $ex^{\ref{slupdate}} \not\in T$, then $time(ex^{\ref{slupdate}}) = \infty$.\label{gen:ptrself} \end{enumerate} If $pt_T(ex) \neq \infty$ for some operation $ex$, then we say $ex$ \emph{linearizes} at $pt_T(ex)$. Also, if $T$ is clear from context, then we shorten $pt_T(ex)$ to $pt(ex)$. Let $f(T)$ be a sequential history consisting of all and only those operations $ex_1, ex_2 \in \Gamma(T)$ by processes $q$ and $p$, respectively, with $pt(ex_1) \neq \infty$ and $pt(ex_2) \neq \infty$, such that $ex_1 \xrightarrow{f(T)} ex_2$ if and only if \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{K-\arabic*},ref={K-\arabic*}] \item operation $ex_1$ linearizes before $ex_2$ (i.e. $pt(ex_1) < pt(ex_2)$), or\label{gen:rulelin} \item operations $ex_1$ and $ex_2$ linearize at the same time (i.e. $pt(ex_1) = pt(ex_2)$) and $invoc(ex_2)$ dominates $invoc(ex_1)$, or\label{gen:ruledom} \item operations $ex_1$ and $ex_2$ linearize at the same time (i.e. $pt(ex_1) = pt(ex_2)$), $invoc(ex_2)$ does not dominate $invoc(ex_1)$, $invoc(ex_1)$ does not dominate $invoc(ex_2)$, and $q < p$.\label{gen:rulecomm} \end{enumerate} Since dominance is a strict partial order \cite{generalwaitfree}, \ref{gen:ruledom} and \ref{gen:rulecomm} impose a total order on the set of operations that linearize at any step of $T$. \begin{observation}\label{obs:genptin} For every $ex \in \Gamma(T)$, $pt(ex)$ is in the interval $\bigl(time(ex^{\ref{scan}}), time(ex^{\ref{slupdate}})\bigr]$. \end{observation} \begin{proof} If $pt(ex)$ satisfies \ref{gen:ptrdom}, then $pt(ex)$ is in the interval $\bigl(time(ex^{\ref{scan}}), time(ex^{\ref{slupdate}})\bigr)$ explicitly. Otherwise, if $pt(ex)$ satisfies \ref{gen:ptrself}, then $pt(ex) = time(ex^{\ref{slupdate}})$. \end{proof} \begin{observation}\label{obs:genptltdom} Let $ex_1 \in \Gamma(T)$ be an operation. If there exists an $ex_2 \in \Gamma(T)$ such that $time(ex_1^{\ref{scan}}) < pt(ex_2)$ and $invoc(ex_2)$ dominates $invoc(ex_1)$, then \ifspringer \\ \else\fi $pt(ex_1) \leq pt(ex_2)$. \end{observation} \begin{proof} This is trivial if $pt(ex_2) = \infty$. If $time(ex_1^{\ref{slupdate}}) \leq pt(ex_2)$, then the observation follows from Observation~\ref{obs:genptin}. Suppose $pt(ex_2) < time(ex_1^{\ref{slupdate}})$. Let $ex_3 \in \Gamma(T)$ be an operation that satisfies the following statements: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=(\roman*)] \item $time(ex_1^{\ref{scan}}) < pt(ex_3) < time(ex_1^{\ref{slupdate}})$,\label{obs:lemmaroman1} \item $invoc(ex_3)$ dominates $invoc(ex_1)$, and\label{obs:lemmaroman2} \item $invoc(ex_3)$ has the lowest possible $pt$ value of any operation that satisfies \ref{obs:lemmaroman1} and \ref{obs:lemmaroman2}. \end{enumerate} Hence, $pt(ex_3) \leq pt(ex_2)$, and $pt(ex_1) = pt(ex_3)$ by \ref{gen:ptrdom}. \end{proof} \begin{observation}\label{obs:genlinimpliesupdate} Suppose $ex_1$ is an operation such that $pt(ex_1) < time(ex_1^{\ref{slupdate}})$. Then there exists an operation $ex_2$ such that $invoc(ex_2)$ dominates $invoc(ex_1)$ and $pt(ex_1) = pt(ex_2) = time(ex_2^{\ref{slupdate}})$. \end{observation} \begin{proof} Since dominance is a strict partial order, there is a maximal element in the set of operations that linearize at $pt(ex_1)$. That is, there exists an operation $ex_2$ with $pt(ex_2) = pt(ex_1)$, such that there is no operation $ex_3$ with $pt(ex_3) = pt(ex_1)$ and $invoc(ex_3)$ dominates $invoc(ex_2)$. Therefore, $pt(ex_2)$ does not satisfy \ref{gen:ptrdom}. Hence, $pt(ex_2)$ must satisfy \ref{gen:ptrself}, meaning $pt(ex_2) = time(ex_2^{\ref{slupdate}})$. \end{proof} \begin{lemma}\label{lemma:forcedom} Let $T \in \mathcal{T}$ be a transcript, where $G$ is the precedence graph induced by $\mathcal{G}(T)$. Suppose $ex_1, ex_2 \in \Gamma(T)$ are operations such that \begin{gather} \text{$oper(ex_1)$ and $oper(ex_2)$ are concurrent in $G$,}\label{assumconcur} \\ \text{$invoc(ex_1)$ dominates $invoc(ex_2)$, and}\label{assumdom} \\ \text{$ex_1 \xrightarrow{f(T)} ex_2$.}\label{assumprec} \end{gather} Then there exists an operation $ex_3 \in \Gamma(T)$ such that $invoc(ex_3)$ dominates $invoc(ex_1)$ and $oper(ex_3)$ precedes $oper(ex_2)$ in $G$. \end{lemma} \begin{proof} If $pt(ex_1) = pt(ex_2)$, then $ex_2 \xrightarrow{f(T)} ex_1$ by \ref{gen:ruledom}. This contradicts (\ref{assumprec}), so $pt(ex_1) \neq pt(ex_2)$. If $pt(ex_1) > pt(ex_2)$, then $ex_2 \xrightarrow{f(T)} ex_1$ by \ref{gen:rulelin}. Again this contradicts (\ref{assumprec}), so \begin{equation} pt(ex_1) < pt(ex_2).\label{lemma:forcedom:ptless} \end{equation} By (\ref{assumconcur}) and Observation~\ref{obs:opconcurrent} \begin{gather} time(ex_1^{\ref{scan}}) < time(ex_2^{\ref{slupdate}})\text{, and}\label{lemma:forcedom:i1less} \\ time(ex_2^{\ref{scan}}) < time(ex_1^{\ref{slupdate}}).\label{lemma:forcedom:i2less} \end{gather} Suppose that $time(ex_2^{\ref{scan}}) < pt(ex_1)$. Using this and (\ref{assumdom}), $pt(ex_2) \leq pt(ex_1)$ by Observation~\ref{obs:genptltdom}. This contradicts (\ref{lemma:forcedom:ptless}). Hence, \begin{equation} pt(ex_1) < time(ex_2^{\ref{scan}}).\label{lemma:forcedom:pti1less} \end{equation} By (\ref{lemma:forcedom:i2less}), (\ref{lemma:forcedom:pti1less}), and Observation~\ref{obs:genlinimpliesupdate}, there exists an operation $ex_3$ such that \begin{gather} \text{$invoc(ex_3)$ dominates $invoc(ex_1)$, and}\label{lemma:forcedom:invoc3dom} \\ \text{$pt(ex_3) = pt(ex_1) = time(ex_3^{\ref{slupdate}})$.}\label{lemma:forcedom:invoc3pt} \end{gather} By (\ref{lemma:forcedom:pti1less}) and (\ref{lemma:forcedom:invoc3pt}), $time(ex_3^{\ref{slupdate}}) < time(ex_2^{\ref{scan}})$, which implies that $oper(ex_3)$ precedes $oper(ex_2)$ in $G$ by Observation~\ref{obs:opprecede}. This, combined with (\ref{lemma:forcedom:invoc3dom}) and (\ref{lemma:forcedom:invoc3pt}), imply the statement of the lemma. \end{proof} The key result of Aspnes and Herlihy \cite{generalwaitfree} is stated below (note that we have combined two results from \cite{generalwaitfree} --- specifically, Lemma~11 and Theorem~17): \begin{lemma}\label{herl:linresult} For any transcript $T \in \mathcal{T}$, where $G$ is the precedence graph induced by $\mathcal{G}(T)$, any topological ordering of $lingraph(G)$ is a linearization of $\Gamma(T)$. \end{lemma} We proceed to show that $f$ is a linearization function by demonstrating that if $f(T) = ex_1 \circ \ldots \circ ex_k$, then $oper(ex_1) \circ \ldots \circ oper(ex_k)$ is a topological ordering of $lingraph(G)$, where $G$ is the precedence graph induced by $\mathcal{G}(T)$, for any transcript $T \in \mathcal{T}$. There are two facts that make our task nontrivial. First, $f(T)$ may contain operations whose constructed nodes are not present in $\mathcal{G}(T)$. We claim that these operations are overwritten before they are added to the shared precedence graph, and the responses that are eventually calculated for each of these operations are valid for their position in the linearization order. Second, it is not immediately apparent that the order of $oper(ex_1) \circ \ldots \circ oper(ex_k)$ satisfies the dominance order that is present in a topological ordering of $lingraph(G)$. The following lemma is taken directly from Aspnes and Herlihy \cite{generalwaitfree}. \begin{lemma}\label{herl:dombuffer} Let $T \in \mathcal{T}$ be a transcript, where $G$ is the precedence graph induced by $\mathcal{G}(T)$, and let $L_1 \circ oper(ex_1) \circ L_2$ be a topological sort of $lingraph(G)$. If there exists $oper(ex_2) \in L_2$ that is concurrent with $oper(ex_1)$ in $G$, and $oper(ex_1)$ dominates $oper(ex_2)$, then there is $oper(ex_3) \in L_2$ such that $invoc(ex_3)$ dominates $invoc(ex_1)$ and $oper(ex_3)$ precedes $oper(ex_2)$ in $G$. \end{lemma} \begin{lemma}\label{lemma:nodominversion} Let $T \in \mathcal{T}$ be a transcript, where $G$ is the precedence graph induced by $\mathcal{G}(T)$, and let $L$ be some topological ordering of $lingraph(G)$. There is no pair of operations $ex_1, ex_2 \in f(T)$ such that \begin{gather} ex_1 \xrightarrow{f(T)} ex_2,\label{linfirst} \\ oper(ex_2) \xrightarrow{L} oper(ex_1)\text{, and}\label{firstintopsort} \\ \text{$invoc(ex_1)$ dominates $invoc(ex_2)$.}\label{hdom} \end{gather} \end{lemma} \begin{proof} Suppose there are a pair of operations $ex_1, ex_2 \in f(T)$ satisfying (\ref{linfirst})-(\ref{hdom}), and let $ex_1$ be the first operation in $f(T)$ for which these properties are satisfied. That is, \ifspringer \begin{equation} \begin{split} &\text{there is no pair of operations $ex_1', ex_2' \in f(T)$} \\ &\text{that satisfy (\ref{linfirst})-(\ref{hdom}), with $ex_1' \xrightarrow{f(T)} ex_1$.}\label{ex1isfirst} \end{split} \end{equation} \else \begin{equation} \begin{split} \text{there is no pair of operations $ex_1', ex_2' \in f(T)$ that satisfy (\ref{linfirst})-(\ref{hdom}), with $ex_1' \xrightarrow{f(T)} ex_1$.}\label{ex1isfirst} \end{split} \end{equation} \fi If $oper(ex_2)$ precedes $oper(ex_1)$ in $G$, then $time(ex_2^{\ref{slupdate}}) < time(ex_1^{\ref{scan}})$ by Observation~\ref{obs:opprecede}. But by Observation~\ref{obs:genptin} this would imply that $pt(ex_2) < pt(ex_1)$, which would mean $ex_2 \xrightarrow{f(T)} ex_1$ by \ref{gen:rulelin}. This contradicts (\ref{linfirst}). Hence, \begin{equation} \text{$oper(ex_2)$ does not precede $oper(ex_1)$ in $G$.}\label{lemma:nodominversion:100} \end{equation} If $oper(ex_1)$ precedes $oper(ex_2)$ in $G$, then this contradicts (\ref{firstintopsort}), since $L$ is a topological sort of $lingraph(G)$. Therefore, \begin{equation} \text{$oper(ex_1)$ does not precede $oper(ex_2)$ in $G$.}\label{lemma:nodominversion:200} \end{equation} By (\ref{lemma:nodominversion:100}) and (\ref{lemma:nodominversion:200}), $oper(ex_1)$ and $oper(ex_2)$ are concurrent in $G$. By this, (\ref{linfirst}), (\ref{hdom}), and Lemma~\ref{lemma:forcedom} there exists an operation $ex_j$ such that \begin{gather} \text{$invoc(ex_j)$ dominates $invoc(ex_1)$,}\label{lemma:nodominversion:300} \\ \text{$pt(ex_j) = pt(ex_1) = time(ex_j^{\ref{slupdate}})$, and}\label{lemma:nodominversion:400} \\ \text{$oper(ex_j)$ precedes $oper(ex_2)$ in $G$.}\label{lemma:nodominversion:500} \end{gather} By (\ref{lemma:nodominversion:300}), (\ref{lemma:nodominversion:400}), and \ref{gen:ruledom}, \begin{equation} ex_1 \xrightarrow{f(T)} ex_j\label{lemma:nodominversion:600} \end{equation} By (\ref{lemma:nodominversion:500}) and the fact that $L$ is a topological sort of $lingraph(G)$, \begin{equation} oper(ex_j) \xrightarrow{L} oper(ex_2).\label{lemma:nodominversion:700} \end{equation} By Observation~\ref{obs:genptin}, $time(ex_j^{\ref{scan}}) < pt(ex_j) \leq time(ex_j^{\ref{slupdate}})$ and $time(ex_1^{\ref{scan}}) < pt(ex_1) \leq time(ex_1^{\ref{slupdate}})$. This along with (\ref{lemma:nodominversion:400}) implies that $time(ex_j^{\ref{scan}}) < time(ex_1^{\ref{slupdate}})$ and $time(ex_1^{\ref{scan}}) < time(ex_j^{\ref{slupdate}})$. By this and Observation~\ref{obs:opconcurrent}, \begin{equation} \text{$oper(ex_j)$ and $oper(ex_1)$ are concurrent in $G$.}\label{lemma:nodominversion:800} \end{equation} By (\ref{firstintopsort}), (\ref{lemma:nodominversion:700}), and the transitivity of happens-before order, \begin{equation} oper(ex_j) \xrightarrow{L} oper(ex_1).\label{lemma:nodominversion:900} \end{equation} By (\ref{lemma:nodominversion:300}), (\ref{lemma:nodominversion:800}), (\ref{lemma:nodominversion:900}), and Lemma~\ref{herl:dombuffer}, there exists an operation $oper(ex_i)$ such that \begin{gather} oper(ex_j) \xrightarrow{L} oper(ex_i) \xrightarrow{L} oper(ex_1), \label{ellprimedombuffer} \\ \text{$invoc(ex_i)$ dominates $invoc(ex_j)$, and}\label{invocellprimedominates} \\ \text{$oper(ex_i)$ precedes $oper(ex_1)$ in $G$.}\label{ellprimeprec} \end{gather} By (\ref{ellprimeprec}) and Observation~\ref{obs:opprecede}, $time(ex_i^{\ref{slupdate}}) < time(ex_1^{\ref{scan}})$. This along with Observation~\ref{obs:genptin} implies that $pt(ex_i) < pt(ex_1)$. Hence, by \ref{gen:rulelin}, \begin{equation} ex_i \xrightarrow{f(T)} ex_1.\label{ellprimelinfirst} \end{equation} By (\ref{lemma:nodominversion:600}), (\ref{ellprimelinfirst}), and the transitivity of happens-before order, \begin{equation} ex_i \xrightarrow{f(T)} ex_j.\label{ellprimelinbeforeell} \end{equation} Together, (\ref{ellprimedombuffer}), (\ref{invocellprimedominates}), and (\ref{ellprimelinbeforeell}) imply that $ex_i$ and $ex_j$ satisfy (\ref{linfirst})-(\ref{hdom}). By (\ref{ellprimelinfirst}), this contradicts (\ref{ex1isfirst}). Hence, there is no pair of operations that satisfies (\ref{linfirst})-(\ref{hdom}). \end{proof} \begin{lemma}\label{lemma:genprefpres} The function $f$ is prefix-preserving. \end{lemma} \begin{proof} Let $T \in \mathcal{T}$ be a transcript. Consider each step $t$ of $T$, and some operation $ex \in \Gamma (T)$ by $p$. By Observation~\ref{obs:genptin} are two cases: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=(\roman*)] \item Suppose $pt(ex) < time(ex^{\ref{slupdate}})$. Then by Observation~\ref{obs:genlinimpliesupdate}, there exists an operation $ex_\ell$ such that $pt(ex) = pt(ex_\ell) = time(ex_\ell^{\ref{slupdate}})$. Hence, $pt(ex) = t$ if and only if $time(ex_\ell^{\ref{slupdate}}) = t$. \item Suppose $pt(ex) = time(ex^{\ref{slupdate}})$. Then $pt(ex) = t$ if and only if $time(ex^{\ref{slupdate}}) = t$. \end{enumerate} Thus, at step $t$ it is entirely determined which operations linearize at $t$. That is, whether $t$ satisfies $t = pt(op)$ can be deduced solely by examining the step at time $t$ of $T$. By this and the fact that \ref{gen:ruledom} and \ref{gen:rulecomm} impose a total order on the set of operations that linearize at each point in time in $T$, $f$ is prefix-preserving. \end{proof} We now address the fact that $f(T)$ may contain operations that are not in the precedence graph $G$ induced by $\mathcal{G}(T)$. We aim to show that if $f(T) = ex_1 \circ \ldots \circ ex_k$, then $oper(ex_1) \circ \ldots \circ oper(ex_k)$ is a topological ordering of $G$; this does not hold if $oper(ex_1) \circ \ldots \circ oper(ex_k)$ contains operations that are not present in $G$. To resolve this issue, we define a notion of a ``completion'' of a transcript (recall that completion is only defined for histories), which we call $fill$. For any transcript $T \in \mathcal{T}$, $fill(T)$ is constructed by allowing every incomplete operation present in $f(T)$ to finish (see below for a precise definition). If $ex \in f(T)$ is an operation by $p$, and $ex$ is incomplete in $T$, then let the $p$-solo \emph{completion} of $ex$ in $T$ be the transcript $T_p$ such that $(T \circ T_p) \in \mathcal{T}$, $T_p$ contains only steps by $p$, and the final step of $T_p$ is $rsp(ex)$. Note that the existence of $T_p$ is guaranteed by the fact that Algorithm~\ref{gen} is wait-free. Additionally, since $ex \in f(T)$, $pt(ex) \neq \infty$, and therefore $ex^{\ref{scan}} \in T$ by Observation~\ref{obs:genptin}. Since the response of $ex$ is entirely determined by the vector returned by $ex^{\ref{scan}}$ (by examination of the $execute$ method of Algorithm~\ref{gen}), the response of $ex$ is entirely determined in $T$ (that is, no future steps by any process can change the response of $ex$). Therefore, if $(T \circ T') \in \mathcal{T}$ and $T'$ contains no steps by $p$, then $(T \circ T' \circ T_p) \in \mathcal{T}$. For any transcript $T \in \mathcal{T}$, let $fill(T)$ be a transcript constructed from $T$ as follows: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{F-\arabic*},ref={F-\arabic*}] \item Initially, let $T' = T$. \item For every operation $ex \in f(T)$ by process $p$ that is incomplete in $T$, append the $p$-solo completion of $ex$ in $T$ to $T'$. That is, if $T_p$ is the $p$-solo completion of $ex$ in $T$, then let $T' = T' \circ T_p$.\label{lemma:genlinstep2} \item Let $fill(T) = T'$. \end{enumerate} \begin{observation}\label{obs:filltranscript} For any $T \in \mathcal{T}$, \begin{enumerate}[label=(\alph*)] \item $f(T) = f\bigl(fill(T)\bigr)$, and\label{obs:filla} \item if $f(T) = ex_1 \circ \ldots \circ ex_k$, then the precedence graph $G'$ induced by $\mathcal{G}\bigl( fill(T)\bigr)$ contains all and only those operations in $\bigl\{oper(ex_1), \ldots, oper(ex_k)\bigr\}$.\label{obs:fillb} \end{enumerate} \end{observation} \begin{proof} Let $T \in \mathcal{T}$, and for ease of notation let $T' = fill(T)$. Since \ref{lemma:genlinstep2} only appends steps in the construction of $T'$, $T$ is a prefix of $T'$. By this and Lemma~\ref{lemma:genprefpres}, \begin{equation} \text{$f(T)$ is a prefix of $f(T')$.}\label{genlin:prefix} \end{equation} Suppose $f(T) \neq f(T')$. By this and (\ref{genlin:prefix}), $f(T') = f(T) \circ ex_{\ell_1} \circ \ldots \circ ex_{\ell_k}$, for some nonempty sequence of operations $ex_{\ell_1}, \ldots, ex_{\ell_k}$ with \begin{equation} \text{$ex_{\ell_i} \not\in f(T)$ for all $i \in \{1, \ldots, k\}$.}\label{genlin:exnotin} \end{equation} Due to (\ref{genlin:exnotin}) and the fact that \ref{lemma:genlinstep2} only adds steps of operations in $f(T)$, \ifspringer \begin{equation} \begin{split} &\text{no steps of $ex_{\ell_i}$ are added in the construction} \\ &\text{of $T'$, for any $i \in \{1, \ldots, k\}$.}\label{genlin:nosteps} \end{split} \end{equation} \else \begin{equation} \text{no steps of $ex_{\ell_i}$ are added in the construction of $T'$, for any $i \in \{1, \ldots, k\}$.}\label{genlin:nosteps} \end{equation} \fi Suppose $pt_{T'}(ex_{\ell_1}) = time_{T'}(ex_{\ell_1}^{\ref{slupdate}})$. Since $ex_{\ell_1} \in f(T')$, it must be the case that $pt_{T'}(ex_{\ell_1}) \neq \infty$, and therefore $time_{T'}(ex_{\ell_1}^{\ref{slupdate}}) \neq \infty$. By this and (\ref{genlin:nosteps}), $ex_{\ell_1}^{\ref{slupdate}} \in T$. Then $ex_{\ell_1} \in f(T)$, which is a contradiction. Therefore, $pt_{T'}(ex_{\ell_1}) < time_{T'}(ex_{\ell_1}^{\ref{slupdate}})$. Then by Observation~\ref{obs:genlinimpliesupdate} there exists an operation $ex_\alpha \in \Gamma(T')$ such that \begin{gather} \small\text{$pt_{T'}(ex_{\ell_1}) = pt_{T'}(ex_\alpha) = time_{T'}(ex_\alpha^{\ref{slupdate}})$ in $T'$, and}\label{genlin:ptex} \\ \text{$invoc(ex_\alpha)$ dominates $invoc(ex_{\ell_1})$.}\label{genlin:invocex} \end{gather} By (\ref{genlin:ptex}), (\ref{genlin:invocex}), and \ref{gen:ruledom}, \begin{equation} \text{$ex_{\ell_1} \xrightarrow{f(T')} ex_\alpha$.}\label{genlin:onebeforeell} \end{equation} Since $pt_{T'}(ex_{\ell_1}) \neq \infty$, $time_{T'}(ex_\alpha^{\ref{slupdate}}) \neq \infty$ by (\ref{genlin:ptex}). This, along with (\ref{genlin:nosteps}), implies that $ex_\alpha^{\ref{slupdate}} \in T$. Hence, $ex_\alpha \in f(T)$. This, along with (\ref{genlin:prefix}) and (\ref{genlin:onebeforeell}) imply that $ex_{\ell_1} \in f(T)$, which is a contradiction. Therefore, we have arrived at a contradiction in all cases, and our initial supposition is false. That is, $f(T) = f(T')$, which concludes the proof of part~\ref{obs:filla}. Let $G'$ be the precedence graph induced by $\mathcal{G}(T')$. During the construction of $T'$, \ref{lemma:genlinstep2} ensures that, for every operation $ex \in f(T)$, $ex$ is complete. In particular, \begin{equation} \text{for every operation $ex \in f(T)$, $ex^{\ref{slupdate}} \in T'$.}\label{genlin:everyopin} \end{equation} By definition, $\mathcal{G}(T')$ contains every $node(ex)$ such that $ex^{\ref{slupdate}} \in T'$, and therefore $G'$ contains every $oper(ex)$ such that $ex^{\ref{slupdate}} \in T'$. This, together with (\ref{genlin:everyopin}), implies part~\ref{obs:fillb}. \end{proof} \begin{lemma}\label{lemma:generallinearizable} For any transcript $T \in \mathcal{T}$, $f(T)$ is a linearization of $\Gamma(T)$. \end{lemma} \begin{proof} Let $T' = fill(T)$, and let $G'$ be the precedence graph induced by $\mathcal{G}(T')$. Suppose $f(T') = ex_1 \circ \ldots \circ ex_k$. The only difference between the sequences $ex_1, \ldots, ex_k$ and $oper(ex_1), \ldots, oper(ex_k)$ are operation identifiers, so $f(T')$ is equivalent to the history $oper(ex_1) \circ \ldots \circ oper(ex_k)$. Hence, if we prove that $oper(ex_1) \circ \ldots \circ oper(ex_k)$ is a linearization of $\Gamma(T')$, this implies that $f(T')$ is also a linearization of $\Gamma(T')$. To accomplish this, it suffices to demonstrate that $oper(ex_1) \circ \ldots \circ oper(ex_k)$ is a topological ordering of $lingraph(G')$ by Lemma~\ref{herl:linresult}. More specifically, we show that the sequential history $oper(ex_1) \circ \ldots \circ oper(ex_k)$ has no ``back-edges''; that is, there are no edges $\bigl(oper(ex_j), oper(ex_i)\bigr)$ in $lingraph(G')$ such that $j > i$. First note that by Observation~\ref{obs:filltranscript}~\ref{obs:fillb}, $G'$ contains all and only those operations $oper(ex_i)$ such that $ex_i \in f(T)$. Since $f(T) = f(T')$ by Observation~\ref{obs:filltranscript}~\ref{obs:filla}, this implies that \begin{equation} \text{$ex \in f(T')$ if and only if $oper(ex)$ is in $G'$.}\label{genlin:sameops} \end{equation} Let $L$ be a topological ordering of $lingraph(G')$. Let $i, j \in \{1, \ldots, k\}$ with $i < j$. Hence, \begin{equation} ex_i \xrightarrow{f(T')} ex_j.\label{genlin:funcorder} \end{equation} By (\ref{genlin:sameops}), $oper(ex_i), oper(ex_j)$ are in $G'$, and hence $oper(ex_i), oper(ex_j)$ are in $lingraph(G')$. Suppose that \ifspringer \begin{equation} \begin{split} &\text{there exists an edge from $oper(ex_j)$ to} \\ &\text{$oper(ex_i)$ in $lingraph(G')$.}\label{genlin:existedge} \end{split} \end{equation} \else \begin{equation} \text{there exists an edge from $oper(ex_j)$ to $oper(ex_i)$ in $lingraph(G')$.}\label{genlin:existedge} \end{equation} \fi Suppose $oper(ex_j)$ precedes $oper(ex_i)$ in $G'$. By Observation~\ref{obs:opprecede}, $time(ex_j^{\ref{slupdate}}) < time(ex_i^{\ref{scan}})$. This implies that $pt(ex_j) < pt(ex_i)$ by Observation~\ref{obs:genptin}. By \ref{gen:rulelin}, $ex_j \xrightarrow{f(T')} ex_i$, which contradicts (\ref{genlin:funcorder}). Therefore, \begin{equation} \text{$oper(ex_j)$ does not precede $oper(ex_i)$ in $G'$.}\label{genlin:notprecede} \end{equation} By (\ref{genlin:existedge}) and the fact that $L$ is a topological ordering of $lingraph(G')$, \begin{equation} oper(ex_j) \xrightarrow{L} oper(ex_i).\label{genlin:precinL} \end{equation} Due to (\ref{genlin:existedge}) and (\ref{genlin:notprecede}), there must be a dominance edge from $oper(ex_j)$ to $oper(ex_i)$ in $lingraph(G')$. That is, \begin{equation} \text{$invoc(ex_i)$ dominates $invoc(ex_j)$.}\label{genlin:dom} \end{equation} But (\ref{genlin:funcorder}), (\ref{genlin:precinL}), and (\ref{genlin:dom}) contradict Lemma~\ref{lemma:nodominversion}. Hence, no ``back-edges'' exist in $lingraph(G')$ among the sequential history $oper(ex_1) \circ \ldots \circ oper(ex_k)$. Along with (\ref{genlin:sameops}), this implies that $oper(ex_1) \circ \ldots \circ oper(ex_k)$ is a topological ordering of $lingraph(G')$. By Lemma~\ref{herl:linresult}, $oper(ex_1) \circ \ldots \circ oper(ex_k)$ is a linearization of $\Gamma(T')$. Since $oper(ex_1) \circ \ldots \circ oper(ex_k)$ and $f(T')$ are equivalent, $f(T')$ is also a linearization of $\Gamma(T')$. By Observation~\ref{obs:filltranscript}~\ref{obs:filla}, \begin{equation} \text{$f(T)$ is a linearization of $\Gamma(T')$.}\label{genlin:fTislin} \end{equation} By construction of $T'$, every operation $ex \in f(T)$ is present and complete in $T'$ (and in $\Gamma(T')$), and every complete operation $ex \in \Gamma(T')$ is in $f(T)$ by Observation~\ref{obs:genptin}. That is, \begin{equation} \text{$ex \in \Gamma(T')$ is incomplete if and only if $ex \not\in f(T)$.}\label{genlin:incifonlyif} \end{equation} Let $H_C$ be the completion of $\Gamma(T')$ obtained by removing all incomplete operations from $\Gamma(T')$. By (\ref{genlin:incifonlyif}), \begin{equation} \text{$H_C$ and $f(T)$ contain precisely the same operations.}\label{genlin:hcfTsame} \end{equation} Since $H_C$ is a completion of $\Gamma(T')$, $ex_1 \xrightarrow{H_C} ex_2$ implies that $ex_1 \xrightarrow{\Gamma(T')} ex_2$. By this, (\ref{genlin:fTislin}), and (\ref{genlin:hcfTsame}), $f(T)$ is a linearization of $H_C$. Since the construction of $T'$ adds no new ``high-level'' invocations (i.e. invocations that are not present in $\Gamma(T)$) to $\Gamma(T')$, $H_C$ is also a completion of $\Gamma(T)$. Hence, since $f(T)$ is a linearization of $H_C$, $f(T)$ is a linearization of $\Gamma(T)$. \end{proof} \begin{theorem}\label{theorem:genstronglin} Algorithm~\ref{gen} is strongly linearizable. \end{theorem} \begin{proof} Lemma~\ref{lemma:generallinearizable} shows that $f$ is a linearization function for $\Gamma(\mathcal{T})$, and Lemma~\ref{lemma:genprefpres} shows that $f$ is prefix preserving. Hence, $f$ is a strong linearization function for $\mathcal{T}$. \end{proof} Theorems \ref{thm:main-snapshot} and \ref{theorem:genstronglin}, along with the fact that strong linearizability is composable, yield Theorem~\ref{thm:main-general-construction}. \fi \ifthesis \section{Remarks} \else \subsection{Remarks} \fi In this section, we proved that Aspnes and Herlihy's general construction for simple types \cite{generalwaitfree} is strongly linearizable. Typically, proving strong linearizability is only marginally more difficult than proving linearizability; as long as one chooses linearization points for each operation carefully, it is easy to show that a linearization function satisfies the prefix-preservation property. With this claim in mind, the length of this section might be perplexing, since Aspnes and Herlihy have already shown that Algorithm~\ref{gen} is linearizable \cite{generalwaitfree}. However, their linearization function is inherently not prefix-preserving, since operations may be written to the ``middle'' of the linearization graph (as discussed at the beginning of Section~\ref{sec:genproofsl}). Hence, in Section~\ref{sec:genproofsl} we were forced to start from scratch, defining our own linearization function that satisfies the prefix-preservation property. A considerable amount of effort was also spent on proving that the shared snapshot object $root$ always contains a representation of a particular precedence graph. This is an invariant that was taken for granted in \cite{generalwaitfree}; for the sake of completeness, we decided to prove it formally in Section~\ref{sec:storeprecgraph}. We also note that Aspnes and Herlihy's construction requires unbounded memory, since operations are never removed from the shared precedence graph. This is unfortunate, since the general construction does not benefit from the fact that our snapshot implementation requires only bounded space. Aspnes and Herlihy claim that ``for any particular data type, it should be possible to apply type-specific optimizations to discard most of the precedence graph'' \cite{generalwaitfree}. It would be interesting to study types for which such a simplification could be used to bound the space of Aspnes and Herlihy's construction. Moreover, it may be possible to adjust Aspnes and Herlihy's algorithm so that it only requires bounded space for any simple type. For instance, this might be achieved by storing states, rather than operations, inside the nodes of a precedence graph. \chapter{Introduction}\label{chapter:intro} \else \section{Introduction}\label{chapter:intro} \fi In general, correctness properties for concurrent objects are defined by the sequential behaviours they preserve. That is, overlapping operations on concurrent objects are expected to respond as they would in some sequential execution on the object. Linearizability, a particularly popular correctness condition, requires that concurrent executions correspond to sequential histories that preserve the real-time order of operations. Intuitively, operations on a linearizable implementation appear to take effect (i.e. linearize) at some atomic step between their invocation and response. Linearizable implementations adequately preserve the sequential behaviour of their atomic counterparts; that is, any execution of a linearizable implementation ``appears'' to be a sequential execution of atomic operations. However, some subtle guarantees are lost with linearizable object implementations. For instance, it has been shown that the probability distribution over the execution outcomes of a randomized algorithm can change when atomic objects are replaced with linearizable implementations \cite{stronglin}. More generally, linearizability does not preserve any property that cannot be expressed as a set of allowable sequences of operations \cite{mclean:tracesets}. To address these shortcomings, Golab, Higham, and Woelfel~\cite{stronglin} defined the notion of strong linearizability, and showed that replacing atomic objects with strongly linearizable implementations does not change the probability distribution of the algorithm's outcome under a \emph{strong adversary}. A strong adversary has the power to schedule executions with complete knowledge of the system state, including all previous random operations (coin flips). Strong linearizability requires that, once an operation has linearized, its position in the linearization order does not change in the future. That is, operations cannot be retroactively inserted into the linearization order. Strongly linearizable objects can simplify randomized algorithm design, which provides motivation for developing strongly linearizable implementations or proving their non-existence. \ifthesis We use a well-known implementation of a \emph{counter} (provided for reference in Algorithm~\ref{alg:lincounter}) to concretely demonstrate the difference between atomicity and linearizability in randomized algorithms. A counter is a type that stores a single integer (initially 0) and supports two operations: $Inc()$, which increases the stored value by $1$, and $Read()$, which returns the stored value. \begin{algorithm}[h] \caption{A linearizable counter implementation} \label{alg:lincounter} \SetKwProg{Fn}{Function}{:}{} \nonl\textbf{shared:}\; \nonl\quad register $R[1 \ldots n] = [0, \ldots, 0]$\; \nonl\; \Fn{Inc$_p()$}{ $x \gets R[p].Read()$\; $R[p].Write(x + 1)$\; } \nonl\; \Fn{Read$()$}{ $s \gets 0$\; \For{$i \in \{1, \ldots, n\}$}{ $s \gets s + R[i].Read()$\; } \Return $s$ } \end{algorithm} In this implementation, every process $p$ has an associated single-writer register $R[p]$. To perform an $Inc_p()$ operation, process $p$ reads $R[p]$ to obtain the value $x$, then writes the value $x + 1$ to $R[p]$. A $Read()$ operation iteratively reads all of the registers in the array $R$ and returns the sum of all of these values. Consider the following programs for the processes $p$, $q$, $r$, where $O$ is a counter object: \begin{align*} p &= O.Inc_p(),\; c \gets Flip() \\ q &= O.Inc_q() \\ r &= O.Read() \end{align*} Note that the $Flip()$ operation picks a value uniformly and at random from the set $\{0, 1\}$. We proceed by describing a strong adversary that aims to make $r$'s $O.Read()$ operation return the randomly-selected value $c$. First, suppose $O$ is an atomic counter. Since $c$ is either $0$ or $1$, the strong adaptive adversary should never schedule $r$'s $O.Read()$ operation after both $O.Inc()$ operations (since the $O.Read()$ would return $2$ in this circumstance). Hence, the adversary may schedule $r$'s $O.Read()$ operation either before or after a single $O.Inc()$ operation (it does not matter whether this operation is performed by $p$ or $q$). Therefore, $r$'s $O.Read()$ operation returns $c$ with probability $\frac{1}{2}$. Now suppose $O$ is implemented by Algorithm~\ref{alg:lincounter}. By scheduling operations as in Figure~\ref{fig:counterexec}, the adversary can force $r$'s $O.Read()$ operation to return $c$ with probability $1$. \begin{figure}[H] \centering \begin{tikzpicture} \node at (0,0) (p){$p:$}; \node at (0,-2) (q){$q:$}; \node at (0,-4) (r){$r:$}; \draw[black,thick] (2.6,0) -- (4.6,0) node[pos=0,linpt,fill=black]{} node[pos=1,linpt,fill=black]{} node[pos=0.5,label=above:\textcolor{black}{$O.Inc_p()$}]{}; \node[circle,draw,fill=black,inner sep = 0pt,minimum size=5pt,label=above:\textcolor{black}{$c \gets Flip()$}] at (6,0) {}; \draw[->,black,thick] (7,-1.95) -- (8,-1.25); \node at (6.5,-1.5) (ifc1){if $c = 1$}; \draw[->,black,thick] (7,-2.05) -- (8,-2.75); \node at (6.5,-2.5) (ifc0){if $c = 0$}; \draw[black,thick] (8.2,-1.25) -- (10.2,-1.25) node[pos=0,linpt,fill=black]{} node[pos=1,linpt,fill=black]{} node[pos=0.5,label=above:\textcolor{black}{$O.Inc_q()$}]{}; \draw[black,thick] (11.7,-2.75) -- (13.7,-2.75) node[pos=0,linpt,fill=black]{} node[pos=1,linpt,fill=black]{} node[pos=0.5,label=above:\textcolor{black}{$O.Inc_q()$}]{}; \draw[black,thick] (1,-4) -- (13,-4) node[pos=0,linpt,fill=black]{} node[pos=1,linpt,fill=black]{} node[pos=0.5,label=above:\textcolor{black}{$O.Read()$}]{} node[circle,draw,fill=black,inner sep = 0pt,minimum size=5pt,pos=0.115,label=below:\textcolor{black}{$R[p].Read()$}]{} node[circle,draw,fill=black,inner sep = 0pt,minimum size=5pt,pos=0.84,label=below:\textcolor{black}{$R[q].Read()$}]{}; \end{tikzpicture} \caption{After observing the result of $p$'s $O.Flip()$ operation, the strong adaptive adversary can decide whether $r$'s $O.Read()$ operation returns $0$ or $1$.}\label{fig:counterexec} \end{figure} In the execution in Figure~\ref{fig:counterexec}, process $r$ first reads $0$ from $R[p]$ during its $O.Read()$ operation. Following this, $p$ performs its entire $O.Inc_p()$ operation, writing $1$ to $R[p]$ in the process. After this, $p$ performs its $Flip()$ operation, which stores either $0$ or $1$ in the variable $c$. If $c = 0$, then the adversary allows $r$'s $O.Read()$ operation to terminate and return the value $0$. Otherwise, if $c = 1$, then the adversary allows $q$ to perform its entire $O.Inc_q()$ operation, writing $1$ to $R[q]$ in the process. Afterwards, the adversary allows $r$'s $O.Read()$ operation to run until termination; the $O.Read()$ operation reads $1$ from $R[q]$, and ultimately returns the value $1$. Therefore, in both cases $r$'s $O.Read()$ operation returns the value $c$. The execution in Figure~\ref{fig:counterexec} demonstrates how a strong adversary may be given additional power when atomic base objects are replaced with linearizable implementations. \fi \ifthesis \section{Related Work}\label{sec:relwork} \else \subsection{Related Work}\label{sec:relwork} \fi The notion of strong linearizability was originally introduced by Golab, Higham, and Woelfel~\cite{stronglin}. Strongly linearizable implementations are not only linearizable, but they also exhibit the ``prefix-preservation'' property. This extra condition ensures that the linearization order of operations does not change retroactively. Such implementations are resilient against strong adaptive adversaries, which have the power to schedule executions with complete knowledge of the system state, including all previous random operations (coin flips). In fact, it is known that strong linearizability is necessary to curtail the power of the strong adversary to influence the probability distribution of execution outcomes \cite{stronglin}. Importantly, strong linearizability, like traditional linearizability, is a local property. Roughly speaking, a correctness property is local if the system satisfies the property provided that each object in the system satisfies the property \cite{MultiProcProgramming}. Hence, since strong linearizability is local, if every object in the set $\{O_1, \ldots, O_k\}$ is strongly linearizable, then any execution obtained by performing operations on any subset of $\{O_1, \ldots O_k\}$ is also strongly linearizable \cite{stronglin,AE2019a}. Strong linearizability is also composable, meaning a strongly linearizable implementation $O$ that uses an atomic base object $B$ of type $\mathscr{T}$ remains strongly linearizable when $B$ is replaced by $B'$, where $B'$ is a strongly linearizable implementation of $\mathscr{T}$ \cite{stronglin, AE2019a}. Locality and composability can simplify distributed algorithm design, as we will see in Section~\ref{sectionSLSS} and Section~\ref{sectionGEN} of this paper. More generally, Attiya and Enea recently showed \cite{AE2019a} that strong linearizability is a specific form of strong observational refinement. Traditional refinement \cite{Lynch:Simulations:1994} is a relationship between concrete objects and their specifications; that is, an object $O_1$ (i.e. a concrete object) refines an object $O_2$ (i.e. a specification) if the set of traces (i.e. sequences of possible actions) of $O_1$ is a subset of the set of traces of $O_2$. An object $O_1$ is said to \emph{observationally} refine $O_2$ if every observation that can be made by a program using $O_1$ (i.e. effects of operation calls on $O_1$ that are observable by the program) could also be made by the same program using $O_2$ instead of $O_1$. Finally, $O_1$ \emph{strongly} observationally refines $O_2$ if, for every schedule of a program that uses $O_1$, there exists a schedule for the same program that uses $O_2$ instead of $O_1$, such that the program makes precisely the same observations in both scenarios. It has been shown \cite{Bouajjani:Observation:2015} that observational refinement and linearizability are equivalent when the specification (i.e. $O_2$) is atomic. Similarly, strong observational refinement is equivalent to strong linearizability when the specification is atomic \cite{AE2019a}. Strong observational refinements are designed to preserve hyperproperties, which are sets of sets of sequences of program observations. Hyperproperties are a generalization of the notion of ``execution outcomes'', mentioned previously. It is known that refinement (and observational refinement) preserves trace properties, which are sets of sequences of actions, but it does not preserve hyperproperties in general \cite{AE2019a}. This provides further insight into the deficiencies of linearizability described by Golab, Higham, and Woelfel \cite{stronglin}. Since strong observational refinements preserve the hyperproperties satisfied by their specifications, this implies that strongly linearizable implementations preserve the hyperproperties satisfied by their atomic counterparts. Unless otherwise noted we assume the standard asynchronous shared memory system, where $n$ processes with unique IDs in $\{1,\dots,n\}$ communicate through atomic read and write operations on shared (multi-reader multi-writer) registers. Almost all prior work on strong linearizability has focused on this model. However, it is known that standard wait-free universal constructions (e.g. \cite{uniConstSL}) using $n$-process consensus objects are also strongly linearizable \cite{stronglin}. Therefore, there exists a strongly linearizable implementation of any type using atomic compare-and-swap objects, for example. On the other hand, Attiya, Casta\~{n}eda, and Hendler \cite{ACH2018a} have shown that any wait-free strongly linearizable implementation of a queue or a stack for $n$ processes along with atomic registers can solve $n$-process consensus. Hence, any $n$-process wait-free strongly linearizable implementation of a queue or stack cannot be implemented from base objects with consensus number less than $n$. Early results on strong linearizability have largely been negative (i.e. impossibility results). Helmi, Higham, and Woelfel~\cite{PossImposs} have shown that essentially no non-trivial object has a deterministic wait-free strongly linearizable implementation from \emph{single-writer} registers. Denysyuk and Woelfel~\cite{WaitVsLock} showed that for several fundamental types, including single-writer snapshots (defined below), counters, and unbounded max-registers, there exist no strongly linearizable wait-free implementations, even from multi-writer registers. While many published results on strong linearizability (especially for lock/wait-free implementations) are discouraging, some fundamental types are known to have strongly linearizable implementations. For instance, Helmi, Higham, and Woelfel~\cite{PossImposs} describe a strongly linearizable wait-free implementation of a bounded max-register from multi-reader multi-writer registers \cite{maxRegisters}. A simple modification of this algorithm, which we describe in more detail in Section~\ref{sec:unboundedslss}, results in a strongly linearizable lock-free implementation of an unbounded max-register from unbounded multi-reader multi-writer registers. Helmi, Higham, Woelfel~\cite{PossImposs} also demonstrate that there is a strongly linearizable obstruction-free implementation of a consensus object from multi-reader single-writer registers. This implies that any type has a strongly linearizable obstruction-free implementation from multi-reader single-writer registers. Denysyuk and Woelfel~\cite{WaitVsLock} have shown that there exists a universal lock-free strongly linearizable construction for versioned objects, which store version numbers that increase with each atomic update operation (a more detailed explanation of this construction, and of versioned objects, is provided in Section~\ref{sec:unboundedslss}). This construction uses the unbounded modification of the max-register from \cite{PossImposs}, and therefore requires an unbounded number of registers. The algorithm inherently requires unbounded space, since the version number of the object must increase with each update. The snapshot type \cite{snapshot} is a fundamental primitive in distributed algorithm design \cite{generalwaitfree,Abrahamson,afek1999instancy,borowsky1993immediate,gawlick1992concurrent,herlihy1993asynchronous}. In this paper, we consider only single-writer snapshots, which contain an $n$-component vector of values. For any $p \in \{1, \ldots, n\}$, the $p$-th component of a single-writer snapshot is writable only by process $p$. An $update_p(x)$ invocation by process $p$ changes the contents of the $p$-th component of the snapshot object to $x$. The snapshot type also supports a $scan$ invocation, which returns the entire stored vector. That is, the $scan$ invocation allows processes to obtain a consistent view of multiple single-writer memory cells; if a $scan$ invocation returns a vector $V$, then the snapshot object must have contained exactly $V$ at some point in its execution interval. There are many wait-free linearizable implementations of the snapshot type from registers \cite{snapshot,aspnes2013snapshot,attiya1995snapshot,attiya1998snapshot,inoue1994snapshot}, but due to the results of Denysyuk and Woelfel~\cite{WaitVsLock}, it is known that none of these implementations are strongly linearizable. \ifthesis \section{Results} \else \subsection{Results} \fi An ABA-detecting register stores a single value from some domain $D$, and supports $DWrite$ and $DRead$ invocations. A $DWrite(x)$ invocation writes value $x\in D$, and a $DRead$ invocation returns the latest written value together with a Boolean flag. This flag indicates whether there has been a $DWrite$ operation since the previous $DRead$ by the same process. This type was originally defined by Aghazadeh and Woelfel \cite{ABAreg}, who also gave a wait-free linearizable implementation from $O(n)$ bounded registers. ABA-detecting registers are used to combat the ABA problem, which occurs when two $DRead$ operations with interleaving $DWrite$ operations return the same value; in this scenario the reading process is unable to distinguish between the actual execution and a different execution in which no $DWrite$ operations occur between the two $DRead$ operations. In Section~\ref{slabasection} we show that Aghazadeh and Woelfel's wait-free linearizable ABA-detecting register is not strongly linearizable, and modify it to achieve strong linearizability. Our implementation sacrifices wait-freedom for lock-freedom. \begin{theorem}\label{thm:main-ABA} There is a lock-free strongly linearizable implementation of an ABA-detecting register from $O(n)$ registers of size $O(\log n+\log|D|)$. \end{theorem} The \emph{amortized} step complexity of our implementation is $O(n)$ (an object has amortized step complexity $k$, if all processes combined execute at most $k\cdot \ell$ steps in any execution that comprises $\ell$ operation invocations). Moreover, each $DWrite$ needs only $O(1)$ steps, and each $DRead$ has constant step complexity in the absence of contention. As mentioned previously, Denysyuk and Woelfel \cite{PossImposs} sacrificed wait-freedom for lock-freedom to obtain a strongly linearizable snapshot implementation using an unbounded number of registers. In Section~\ref{sectionSLSS} we give the first such implementation that needs only bounded space. \begin{theorem}\label{thm:main-snapshot} There is a lock-free strongly linearizable implementation of a snapshot object from $O(n)$ registers of size $O(\log n+\log |D|)$. \end{theorem} We provide an analysis of our implementation, showing that the amortized step complexity is $O(n^3)$. Our algorithm uses as base objects a linearizable snapshot object $S$, so the step complexity heavily depends on the implementation of $S$. But in the absence of contention, each $update$ and $scan$ operation of the strongly linearizable snapshot needs only a constant number of operations on $S$ in addition to a constant number of register accesses. Aspnes and Herlihy \cite{generalwaitfree} defined a large class of types with wait-free linearizable implementations. Any two operations of this type must either commute (meaning the system configuration obtained after both operations have been executed consecutively is independent of the order of the two operations), or one operation overwrites the other (meaning that the system configuration obtained after the overwriting operation has been performed is not affected by whether or not the other operation is executed immediately before it). In this paper we refer to such types as \emph{simple} types. Aspnes and Herlihy \cite{generalwaitfree} describe a general wait-free construction of any simple type. Their algorithm uses an atomic snapshot object, which may be replaced by a linearizable implementation to obtain a wait-free linearizable implementation of any simple type from registers. In Section~\ref{sectionGEN} we prove that Aspnes and Herlihy's construction is also strongly linearizable. Combining this with Theorem~\ref{thm:main-snapshot}, and using the composability of strong linearizability, we obtain the following: \begin{theorem}\label{thm:main-general-construction} Any simple type has a lock-free strongly linearizable implementation from registers. \end{theorem} Aspnes and Herlihy introduce the notion of \emph{linearization graphs}, which are directed acyclic graphs whose nodes are operations (we will define these structures more formally in \ifthesis Chapter~\ref{sectionGEN}). \else Section~\ref{sectionGEN}). \fi Aspnes and Herlihy define a linearization function based on topological orderings of these linearization graphs. However, since operations may be written to the ``middle'' of a linearization graph (i.e. an operation might have outgoing edges immediately as it is written to the graph), this linearization function is not prefix-preserving. Hence, even though we do not modify the algorithm beyond the snapshot object replacement, the proof of strong linearizability is involved. \ifthesis Anderson and Moir \cite{andersonMoir} define a class of \emph{readable} objects, which support a single read operation that returns the entire state of the object, along with a set of update operations that do not return anything and may modify the state of the object. Anderson and Moir claim that a ``dynamic resiliency condition'' is necessary and sufficient for the existence of a wait-free linearizable implementation of an object from registers. This condition is similar to Aspnes and Herlihy's definition of simple types, and Anderson and Moir claim that the sufficiency of the dynamic resiliency condition follows from the general construction in \cite{generalwaitfree}. In Chapter~\ref{sec:dynamic} we show that Anderson and Moir's notion of dynamic resiliency is not equivalent to Aspnes and Herlihy's notion of simple types by defining a dynamically resilient type which is not simple. Therefore, Anderson and Moir's claim that a readable object has a wait-free implementation from registers if the object satisfies the resiliency condition remains unproven. Note that if Anderson and Moir's claim was true, combined with Theorem~\ref{thm:main-general-construction} this would imply that a readable object has a lock-free strongly linearizable implementation from atomic multi-reader multi-writer registers if and only if it satisfies the dynamic resiliency condition. \fi \chapter{A Strongly Linearizable ABA-Detecting Register}\label{slabasection} \else \section{A Strongly Linearizable ABA-Detecting Register}\label{slabasection} \fi An ABA-detecting register \cite{ABAreg} is a type that stores a single value $R$ from some domain $D$, and supports the invocation descriptions $DWrite_q(x)$ for $x\in D$, and $DRead_q()$ with the following sequential specification: Initially, $R=\bot\in D$, and a $DWrite_q(x)$ invocation changes the value of $R$ to $x$. Invocation $DRead_q()$ returns a pair $(x,a)\in D\times\{true,false\}$, where $x$ is the value of $R$, and $a$ is $true$ if and only if $q$ performed an earlier $DRead_q()$ operation, and a $DWrite_p$ was performed by some process $p$ since $q$'s last $DRead_q()$. \ifthesis \section{A Linearizable ABA-Detecting Register} \else \subsection{A Linearizable ABA-Detecting Register} \fi Aghazadeh and Woelfel~\cite{ABAreg} presented a wait-free linearizable ABA-detecting register, which is included here as Algorithm~\ref{linaba} for reference. For a detailed description of the algorithm and a proof of its linearizability, see \cite{zahrathesis, ABAreg}. This algorithm works by associating each write with a process identifier and a sequence number. Processes are also responsible for ``announcing'' the sequence numbers they read into a global array of single-writer registers. That is, if process $p$ reads process identifier $q$ and sequence number $s$, then it writes the pair $(q, s)$ to the $p$-th entry of the announcement array $A$; a writer does not use a sequence number if it is paired with their process identifier in this announcement array. A writer also does not use any sequence number that is present in a local queue, called $usedQ$ in Algorithm~\ref{linaba}, which is a queue of $n + 1$ values. This queue stores the previous $n + 1$ sequence numbers chosen by the writing process, and it initially contains $n + 1$ elements valued $\bot$. Finally, if a write occurs during a read operation, the reader sets a local flag. This flag is used to delegate the task of acknowledging the modification to the reading process' next read operation. \begin{algorithm} \small \caption{A linearizable ABA-detecting register \cite{ABAreg}} \label{linaba} \SetKwProg{Fn}{Function}{:}{} \nonl\textbf{shared:}\; \nonl\quad register $X = (\bot, \bot, \bot)$\; \nonl\quad register $A[0 \ldots n-1] = ((\bot, \bot), \ldots , (\bot, \bot))$\; \nonl\; \nonl\textbf{local} (to each process):\; \nonl\quad Boolean $b = False$\; \nonl\quad Queue $usedQ[n+1] = (\bot, \ldots , \bot)$\; \nonl\quad Set $na = \{\}$\; \nonl\quad Integer $c = 0$\; \nonl\; \nonl\Fn{DWrite$_p(x)$} { $s \leftarrow GetSeq()$\; \label{getseq} $X.Write(x, p, s)$\; \label{linwritelin} } \nonl\; \nonl\Fn{GetSeq$_p()$} { $(r, s_r) \leftarrow A[c].Read()$\; \If{$r = p$} { $na \leftarrow (na \setminus \{(c, i) \; | \; i \in \mathbb{N}\}) \cup (c, s_r)$\; } \Else { $na \leftarrow na \setminus \{(c, i) \; | \; i \in \mathbb{N}\}$\; } $c \leftarrow (c + 1)$ mod $n$\; choose arbitrary $s \in \bigl(\{0, \ldots , 2n+1\}$ $\setminus (\{i \; | \; (j, i) \in na\} \cup usedQ)\bigr)$\; \label{chooseseq} $usedQ.enq(s)$\; \label{enqseq} $usedQ.deq()$\; \label{deqseq} \Return $s$ } \nonl\; \nonl\Fn{DRead$_q()$} { $(x, p, s) \leftarrow X.Read()$\; \label{linfirstread} $(r, s_r) \leftarrow A[q].Read()$\; \label{linannread} $A[q].Write(p, s)$\; \label{linannounce} $(x', p', s') \leftarrow X.Read()$\; \label{linsecondread} \If{$(p, s) = (r, s_r)$} { \label{linretifstatement} $ret \leftarrow (x, b)$\; \label{linretsetb} } \Else { $ret \leftarrow (x, True)$\; \label{linretsettrue} } \If{$(x, p, s) = (x', p', s')$} { \label{linflagifstatement} $b \leftarrow False$\; \label{linfalseflag} } \Else { $b \leftarrow True$\; \label{lintrueflag} } \Return $ret$ } \end{algorithm} \begin{observation}\label{obslinabanotsl} The ABA-detecting register in Algorithm~\ref{linaba} is not strongly linearizable. \end{observation} Algorithm~\ref{linaba} is not strongly linearizable because the point at which a $DRead$ operation takes effect depends on whether or not a $DWrite$ operation executes line~\ref{linwritelin} between lines \ref{linfirstread} and \ref{linsecondread} of the $DRead$; that is, if a process sets its $b$ flag during a $DRead$ operation, then it must linearize on line~\ref{linfirstread}, since the following read will detect any $DWrite$ operations that occur between lines \ref{linfirstread} and \ref{linsecondread}. Conversely, if a process does not set its $b$ flag during a $DRead$ operation, then this operation is responsible for detecting any $DWrite$ operations that occur between lines \ref{linfirstread} and \ref{linsecondread}, and it must therefore linearize on line~\ref{linsecondread}. This behaviour allows a scheduler to insert a $DRead$ operation in front of $DWrite$ operations that have already taken effect. \ifea A more formal proof of Observation~\ref{obslinabanotsl} is included in (FULL PAPER)\todo{this}. \fi \ifthesis We prove Observation~\ref{obslinabanotsl} by describing an execution between two processes, $p$ and $q$. From this execution, we generate several possible transcripts. Assuming the implementation is strongly linearizable, this set of constructed transcripts must have a strong linearization function. We conclude the proof by showing that such a function cannot exist. \fi \iffull \begin{proof}[Proof of Observation~\ref{obslinabanotsl}] Consider an execution of Algorithm~\ref{linaba} where process $p$ executes two $DRead_p$ operations $dr_1$ and $dr_2$, and process $q$ executes an infinite sequence of $DWrite_q(x)$ operations $dw_1, dw_2, \ldots$ for some value $x$. Let $dw_i, dw_{i+1}$ be two consecutive $DWrite_q(x)$ operations by $q$, and let $s$ be the sequence number chosen by $dw_i$ on line~\ref{chooseseq}. Since $q$ performs a $usedQ.enq(s)$ operation on line~\ref{enqseq} of $dw_i$, and $usedQ$ contains $n+2$ elements after this operation, $usedQ$ contains $s$ after the $usedQ.deq()$ operation performed by $q$ on line~\ref{deqseq} of $dw_i$. Following the $usedQ.deq()$ operation in $dw_i$, $usedQ$ is not modified again until line~\ref{enqseq} is executed by $q$ during $dw_{i+1}$. Hence, $usedQ$ contains $s$ while $q$ selects a sequence number on line~\ref{chooseseq} of $dw_{i+1}$. Thus, the sequence number chosen by $dw_{i+1}$ is different from $s$. We have shown that \ifspringer \begin{equation} \begin{split} &\text{no two consecutive $DWrite$ operations by $q$} \\ &\text{choose the same sequence number.}\label{distinct_seq} \end{split} \end{equation} \else \begin{equation} \text{no two consecutive $DWrite$ operations by $q$ choose the same sequence number.}\label{distinct_seq} \end{equation} \fi Additionally, since sequence numbers are chosen from a finite set of integers, in the infinite sequence of $DWrite$ operations by $q$, \ifspringer \begin{equation} \begin{split} &\text{there are distinct operations $dw_i$ and $dw_j$ that} \\ &\text{choose the same sequence number.}\label{repeat_seq} \end{split} \end{equation} \else \begin{equation} \text{there are distict operations $dw_i$ and $dw_j$ that choose the same sequence number.}\label{repeat_seq} \end{equation} \fi Let $dw_i, dw_j$ be two distinct $DWrite_q(x)$ operations in the infinite sequence performed by $q$ (assume $i < j$), both of which choose the same sequence number $s$. Note that (\ref{distinct_seq}) guarantees that $dw_{i+1}$ chooses a sequence number $s' \neq s$, and hence $dw_{i+1} \neq dw_j$. The following transcripts $S$, $T_1$, and $T_2$ are possible transcripts produced by the programs described for $p$ and $q$: \ifspringer \begin{align*} &S = dw_1 \circ \ldots \circ dw_i \circ \\ &\qquad (dr_1 \text{ to the end of line \ref{linannread}}) \circ dw_{i+1} \\ &T_1 = S \circ dw_{i+2} \circ \ldots \circ dw_j \circ \\ &\qquad (dr_1 \text{ from line \ref{linannounce} to completion}) \circ dr_2 \\ &T_2 = S \circ (dr_1 \text{ from line \ref{linannounce} to completion}) \circ dr_2 \end{align*} \else \begin{align*} &S = dw_1 \circ \ldots \circ dw_i \circ (dr_1 \text{ to the end of line \ref{linannread}}) \circ dw_{i+1} \\ &T_1 = S \circ dw_{i+2} \circ \ldots \circ dw_j \circ (dr_1 \text{ from line \ref{linannounce} to completion}) \circ dr_2 \\ &T_2 = S \circ (dr_1 \text{ from line \ref{linannounce} to completion}) \circ dr_2 \end{align*} \fi To derive a contradiction, assume that Algorithm~\ref{linaba} is strongly linearizable. Then there must be a strong linearization function for $\{S, T_1, T_2\}$; let $f$ be such a strong linearization function. Since $dw_i$ executes an $X.Write(x, q, s)$ operation on line~\ref{linwritelin}, and no later $X.Write$ operations occur before $dr_1$ executes the $X.Read()$ operation on line~\ref{linfirstread} during $S$, \ifspringer \begin{equation} \begin{split} &\text{the $X.Read()$ operation performed by $dr_1$ on} \\ &\text{line~\ref{linfirstread} in $S$ returns $(x, q, s)$.}\label{dr1_firstread} \end{split} \end{equation} \else \begin{equation} \text{the $X.Read()$ operation performed by $dr_1$ on line~\ref{linfirstread} in $S$ returns $(x, q, s)$.}\label{dr1_firstread} \end{equation} \fi Since $dw_1, \ldots, dw_i$ are performed in sequence, and because each of these operations respond before any other operation is invoked in all of the above transcripts, each of $f(S)$, $f(T_1)$, and $f(T_2)$ must begin with $dw_1 \circ \ldots \circ dw_i$. Suppose $dr_1$ linearizes prior to $dw_{i+1}$ in $S$. That is, suppose \begin{equation}\tag{A-1} f(S) = dw_1 \circ \ldots \circ dw_i \circ dr_1 \circ dw_{i+1}.\label{suppose_linfirst} \end{equation} The following table summarizes the steps that affect the return value of $dr_2$ in $T_1$: \begin{table}[H] \centering \begin{tabular}{ccll} \textbf{Line \#} & \textbf{Operation} & \textbf{Code Statement} & \textbf{Response} \\ \ref{linwritelin} & $dw_j$ & $X.Write(x, q, s)$ & --- \\ \ref{linannounce} & $dr_1$ & $A[p].Write(q, s)$ & --- \\ \ref{linsecondread} & $dr_1$ & $X.Read()$ & $(x, q, s)$ \\ \ref{linfalseflag} & $dr_1$ & $b \gets False$ & --- \\ \ref{linfirstread} & $dr_2$ & $X.Read()$ & $(x, q, s)$ \\ \ref{linannread} & $dr_2$ & $A[p].Read()$ & $(q, s)$ \\ \ref{linsecondread} & $dr_2$ & $X.Read()$ & $(x, q, s)$ \\ \ref{linretsetb} & $dr_2$ & $ret \gets (x, False)$& --- \end{tabular} \end{table} Since $dr_1$ reads $(x, q, s)$ on line~\ref{linfirstread} and line~\ref{linsecondread}, $dr_1$ sets its $b$ flag to $False$ on line~\ref{linfalseflag} in $T_1$. Since $dr_2$ reads $(x, q, s)$ on line~\ref{linfirstread} and line~\ref{linsecondread}, by the condition on line~\ref{linretifstatement} $dr_2$ executes $ret \gets (x, b)$ on line~\ref{linretsetb} in $T_1$. Hence, \begin{equation}\tag{A-2} \text{$dr_2$ returns $(x, False)$ in $T_1$.}\label{dr2_retfalse} \end{equation} By (\ref{suppose_linfirst}), the fact that $dw_{i+2}, \ldots, dw_j$, and $dr_2$ are performed sequentially in $T_1$, and our supposition that $f$ is prefix-preserving, \begin{equation}\tag{A-3} f(T_1) = dw_1 \circ \ldots \circ dw_i \circ dr_1 \circ dw_{i+1} \circ \ldots \circ dw_j \circ dr_2.\label{t1_linearization} \end{equation} However, the history in (\ref{t1_linearization}) is not valid, since there is at least one $DWrite$ operation between $dr_1$ and $dr_2$, but $dr_2$ returns $(x, False)$ by (\ref{dr2_retfalse}). Now suppose that $dr_1$ does not linearize prior to $dw_{i+1}$ in $S$. That is, suppose \ifspringer \begin{equation}\tag{B-1} \begin{split} &\text{either $f(S) = dw_1 \circ \ldots \circ dw_{i+1}$ or} \\ &\text{$f(S) = dw_1 \circ \ldots \circ dw_{i+1} \circ dr_1$.}\label{suppose_linsecond} \end{split} \end{equation} \else \begin{equation}\tag{B-1} \text{either $f(S) = dw_1 \circ \ldots \circ dw_{i+1}$ or $f(S) = dw_1 \circ \ldots \circ dw_{i+1} \circ dr_1$.}\label{suppose_linsecond} \end{equation} \fi The following table summarizes the steps that affect the return value of $dr_2$ in $T_2$: \begin{table}[H] \centering \begin{tabular}{ccll} \textbf{Line \#} & \textbf{Operation} & \textbf{Code Statement} & \textbf{Response} \\ \ref{linwritelin} & $dw_{i+1}$ & $X.Write(x, q, s')$ & --- \\ \ref{linannounce} & $dr_1$ & $A[p].Write(q, s)$ & --- \\ \ref{linfirstread} & $dr_2$ & $X.Read()$ & $(x, q, s')$ \\ \ref{linannread} & $dr_2$ & $A[p].Read()$ & $(q, s)$ \\ \ref{linretsettrue} & $dr_2$ & $ret \gets (x, True)$ & --- \end{tabular} \end{table} Due to (\ref{dr1_firstread}), $dr_1$ executes an $A[p].Write(q, s)$ operation on line~\ref{linannounce} in $T_2$. Hence, the $A[p].Read()$ operation performed by $dr_2$ on line~\ref{linannread} in $T_2$ must return $(q, s)$. Since the $X.Read()$ operation performed by $dr_2$ on line~\ref{linfirstread} returns $(x, q, s')$, and $s \neq s'$, $dr_2$ executes the $ret \gets (x, True)$ statement on line~\ref{linretsettrue} by the condition on line~\ref{linretifstatement} in $T_2$. Therefore, \begin{equation}\tag{B-2} \text{$dr_2$ returns $(x, True)$ in $T_2$.}\label{dr2_rettrue} \end{equation} By (\ref{suppose_linsecond}), the fact that $dr_1$ and $dr_2$ are performed sequentially, and our assumption that $f$ is prefix-preserving, \begin{equation}\tag{B-3} f(T_2) = dw_1 \circ \ldots \circ dw_{i+1} \circ dr_1 \circ dr_2.\label{t2_linearization} \end{equation} However, the history in (\ref{t2_linearization}) is not valid, since there are no $DWrite$ operations between $dr_1$ and $dr_2$, but $dr_2$ returns $(x, True)$ by (\ref{dr2_rettrue}). Thus, no strong linearization function can be defined over the set $\{S, T_1, T_2\}$, which proves the observation. \end{proof} \fi \ifthesis \section{Making the Algorithm Strongly Linearizable} \else \subsection{Making the Algorithm Strongly Linearizable} \fi Algorithm~\ref{linaba} can be modified in order to make the implementation strongly linearizable. Our modification to the $DRead$ method of the linearizable ABA-detecting register is provided in Algorithm~\ref{slaba}. The $GetSeq$ and $DWrite_p$ methods are the same as in \cite{zahrathesis}. Our strategy is to ``stretch'' $DRead$ operations until a period of quiescence is observed by the reading process. Our new $DRead$ method performs the same sequence of reads as in Algorithm~\ref{linaba}; however, each $DRead$ is now responsible for acknowledging all concurrent $DWrite$ operations, rather than delegating this task to the next $DRead$ by the same process. Processes no longer maintain a local $b$ flag; instead, each $DRead$ operation begins by initializing a flag called $changed$ to $False$ on line~\ref{changeinit}, before starting a repeat-until loop. During an iteration of the repeat-until loop by a $DRead$ operation, a process $p$ that notices a difference in the values read from $X$ on line~\ref{regread1} and line~\ref{regread2}, or that $A[p]$ does not contain the same value as $X$, sets $changed$ to $True$ on line~\ref{changed} before repeating its sequence of reads. A process $p$ performing a $DRead$ operation also announces the process identifier/sequence number pair read from $X$ on line~\ref{regread1} to $A[p]$ on line~\ref{announce1}. As before, the purpose of this announcement is to prevent $DWrite$ operations from choosing sequence numbers that have been observed recently. When $p$ sees that its sequence of reads all return the same value, it can safely return this value along with the $changed$ flag. In that case, $p$'s return value is consistent with the state of the ABA-detecting register at the point of $p$'s last shared memory operation, i.e., when it reads $X$ for the last time. Hence, each $DRead$ method may now always be linearized at the time of its final read operation. Similarly, $DWrite$ operations linearize at their final shared memory operation, which is when they write to $X$. It is easy to see that if all operations can linearize with their final shared memory operation, the corresponding linearization function is prefix-preserving, and thus the object is strongly linearizable. \begin{algorithm} \caption{$DRead$ of a strongly linearizable ABA-Detecting register} \label{slaba} \SetKwProg{Fn}{Function}{:}{} \nonl\Fn{DRead$_q$} { $changed = False$\; \label{changeinit} \Repeat{$(p, s) = (r, s_r)\;\mathbf{and}\; (x, p, s) = (x', p', s')$} { \label{slaba:repeatloop} $(x, p, s) \gets X.Read()$\; \label{regread1} $(r, s_r) \gets A[q].Read()$\; \label{annread} $A[q].Write(p, s)$\; \label{announce1} $(x', p', s') \gets X.Read()$\; \label{regread2} \If{$(p, s) \neq (r, s_r)\;\mathbf{or}\; (x, p, s) \neq (x', p', s')$} { \label{EQcondABA} $changed \gets True$\; \label{changed} } } \label{repeatcond} $\mathbf{return}\;(x', changed)$\; } \end{algorithm} \ifea We now outline an argument that Algorithm~\ref{slaba} is strongly linearizable. For complete proofs of correctness, see (FULL PAPER)\todo{this}. \fi We now provide a formal argument that Algorithm~\ref{slaba} is strongly linearizable. For any operation $op$ in a transcript $T$ on an instance of the implementation in Algorithm~\ref{slaba}, let $pt(op)$ be defined as follows: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{Q-\arabic*},ref={Q-\arabic*}] \item If $op$ is a $DRead$ operation, then let $pt(op) = time(op^{\ref{regread2}})$.\label{slaba:ptr1} \item If $op$ is a $DWrite$ operation, then let $pt(op) = time(op^{\ref{linwritelin}})$.\label{slaba:ptr2} \end{enumerate} \ifea Recall that if $op^{\ref{regread2}} \not\in T$, then $time(op^{\ref{regread2}}) = \infty$ (and the same holds for $op^{\ref{linwritelin}}$. If $pt(op) \neq \infty$ for some operation $op$, then we say $op$ \emph{linearizes} at $pt(op)$. If $T$ is a transcript on some instance of the object implementation in Algorithm~\ref{slaba}, then we claim $H$ is a linearization of $T$, where $H$ is a sequential history composed of operations in $\Gamma(T)$ ordered by their corresponding $pt$ values. That is, if $op_i$ and $op_j$ are operations in $\Gamma(T)$ and $pt(op_i) < pt(op_j)$, then $op_i \xrightarrow{H} op_j$. There is no pair of operations $op_i, op_j \in \Gamma(T)$ such that $pt(op_i) = pt(op_j) \neq \infty$, because, for every operation $op \in \Gamma(T)$, if $pt(op) \neq \infty$ then the step at $pt(op)$ is performed by $op$ (see \ref{slaba:ptr1} and \ref{slaba:ptr2}). Let $f$ be a function that maps every transcript on Algorithm~\ref{slaba} to a sequential history as described above (the existence of such a function is trivial). The following two lemmas are stated here without proof: \begin{lemma}\label{lemma:dwritelinatwrite} If an $X.Write(x, p, s)$ operation happens at time $t$, then there exists a $DWrite_p(x)$ operation $dw$ by $p$ such that $pt(dw) = t$. \end{lemma} \fi \iffull Let $\mathcal{T}$ represent the set of all possible transcripts of Algorithm~\ref{slaba}. For every transcript $T \in \mathcal{T}$, define a sequential history $f(T)$ that orders operations according to $pt$, and excludes all operations $op$ for which $pt(op) = \infty$. That is, for any two operations $op_1, op_2 \in \Gamma (T)$ such that $pt(op_1) \neq \infty$ and $pt(op_2) \neq \infty$, $op_1 \xrightarrow{f(T)} op_2$ if and only if $pt(op_1) < pt(op_2)$. Note that there is no pair of operations $op_i, op_j \in \Gamma(T)$ such that $pt(op_i) = pt(op_j) \neq \infty$, because, for every operation $op \in \Gamma(T)$, if $pt(op) \neq \infty$ then the step of $T$ at $pt(op)$ is performed by $op$ (see \ref{slaba:ptr1} and \ref{slaba:ptr2}). For the remainder of Section~\ref{slabasection}, let $T \in \mathcal{T}$ be some finite transcript of some ABA-detecting register implemented by Algorithm~\ref{slaba}. The following observation is immediate from the implementation of Algorithm~\ref{slaba} and \ref{slaba:ptr2}: \begin{observation}\label{obs:dwritelinatwrite} If an $X.Write(x, p, s)$ operation happens at time $t$, then there exists a $DWrite_p(x)$ operation $dw$ by $p$ such that $pt(dw) = t$. \end{observation} The following observations are immediately obtained from Claims~5.9 and~5.10 in \cite{zahrathesis}: \begin{observation}\label{obs:from_thesis} \begin{enumerate}[label=(\alph*)] \item Consider two $GetSeq$ calls $g_1$ and $g_2$ by some process $p$, where $g_1$ is invoked before $g_2$. If $g_1$ and $g_2$ return the same sequence number $s$, then $p$ completes at least $n$ $GetSeq$ calls between $g_1$ and $g_2$.\label{obs:from_thesis_sameseq} \item Suppose $X=(x,p,s)\neq(\bot,\bot,\bot)$ at some point $t$, and $A[p]=s$ throughout $[t,t']$, where $t'\geq t$. Then process $p$ does not write $(x',p,s)$ to $X$ during $(t,t']$ for any $x'\in D$.\label{obs:from_thesis_announce} \end{enumerate} \end{observation} \fi \begin{lemma}\label{lemma:nointerfereABA} Let $dr$ be a complete $DRead_q()$ operation performed by process $q$, and suppose at least one $DWrite$ $dw$ linearizes after $time(dr^{\ref{regread1}})$ and before $q$ invokes any other $DRead()$ operation following $dr$. Let $p$ be the process executing $dw$, and $s$ the sequence number associated with $dw$. Then \begin{enumerate}[label=(\alph*)] \item\label{lemma:nointA} $A[q]\neq (p,s)$ at $time(dr^{\ref{annread}})$; and \item\label{lemma:nointB} $pt(dw)\not\in\bigl[time(dr^{\ref{regread1}}),time(dr^{\ref{regread2}})\bigr]$. \end{enumerate} \end{lemma} \iffull \begin{proof} We first prove \ref{lemma:nointA}. For the purpose of a contradiction, assume $A[q]=(p,s)$ at $time(dr^{\ref{annread}})$. Since $q$ executes $dr^{\ref{annread}}$ in its final iteration of the repeat-until loop, it follows from the if-condition in line~\ref{repeatcond} that \ifspringer \begin{equation}\label{eq:noInterfereABA:100} \begin{split} &\text{at $time(dr^{\ref{regread1}})$ process $q$ reads $(x,p,s)$ from $X$} \\ &\text{for some value $x\in D$}. \end{split} \end{equation} \else \begin{equation}\label{eq:noInterfereABA:100} \text{at $time(dr^{\ref{regread1}})$ process $q$ reads $(x,p,s)$ from $X$ for some value $x\in D$}. \end{equation} \fi Therefore, $q$ writes $(p,s)$ to $A[q]$ in $dr^{\ref{announce1}}$. Since $A[q]=(p,s)$ prior to that write, and only process $q$ can write to $A[q]$ (and only in line~\ref{announce1}), it follows that $A[q]=(p,s)$ throughout the final iteration of the repeat-until loop of $dr$. Moreover, the value of $A[q]$ remains unchanged until $q$ invokes another $DRead_q()$ operation. By the lemma assumption, $pt(dw)$ occurs before $q$'s next $DRead_q()$ invocation, so \begin{equation}\label{eq:noInterfereABA:200} \text{$A[q]=(p,s)$ throughout $\bigl[time(dr^{\ref{regread1}}),pt(dw)]$}. \end{equation} By the assumption of the lemma and the fact that $dw$ linearizes when $q$ performs line~\ref{linwritelin} by \ref{slaba:ptr2}, \ifspringer \begin{equation}\label{eq:noInterfereABA:300} \begin{split} &\text{at $pt(dw)$ process $p$ writes $(y,p,s)$ to $X$,} \\ &\text{for some $y\in D$.} \end{split} \end{equation} \else \begin{equation}\label{eq:noInterfereABA:300} \text{at $pt(dw)$ process $p$ writes $(y,p,s)$ to $X$, for some $y\in D$.} \end{equation} \fi Statements (\ref{eq:noInterfereABA:100}), (\ref{eq:noInterfereABA:200}), and (\ref{eq:noInterfereABA:300}) contradict Observation~\ref{obs:from_thesis} \ref{obs:from_thesis_announce}. This completes the proof of part \ref{lemma:nointA} of this lemma. \sloppypar We now prove part \ref{lemma:nointB}. Suppose the statement is not true. Then let $dw$ be the $DWrite$ with the latest linearization point $pt(dw)\in\bigl[time(dr^{\ref{regread1}}),time(dr^{\ref{regread2}})\bigr]$. Recall that process $p$ executes $dw$, and $s$ is the sequence number used. That is, at $pt(dw)$ process $p$ writes a triple $(x,p,s)$ to $X$, for some $x\in D$. Since each write to $X$ occurs at the linearization point of some $DWrite$ operation, and no other $DWrite$ linearizes in $\bigl(pt(dw),time(dr^{\ref{regread2}})\bigr]$, we have that $X=(x,p,s)$ at point $time(dr^{\ref{regread2}})$. Thus, process $q$ reads $(x,p,s)$ from $X$ in line~\ref{regread2} during its final iteration of the repeat-until loop of $dr$. Then by the loop-guard in line~\ref{repeatcond}, $q$ reads $(p,s)$ from $A[q]$ in line~\ref{annread}, i.e., when it executes $dr^{\ref{annread}}$. This contradicts part \ref{lemma:nointA} of this lemma. \end{proof} \fi \ifea We now show that ordering operations in $T$ by their respective $pt$ values results in a valid sequential history. We accomplish this by first showing that, for any complete $DRead$ operation $dr$ by process $p$, the second component of the tuple returned by $dr$ is $True$ if and only if some $DWrite$ operation linearizes before $pt(dr)$, but after $dr'$, where $dr'$ is the $DRead$ operation by $p$ that is performed immediately before $dr$. To complete our argument, we also show that a $DRead$ operation returns the value written by the $DWrite$ operation that linearized most recently. \fi \begin{lemma} \label{validityABA} Let $dr_1, dr_2$ be two complete $DRead$ operations in $T$ by process $q$, with $dr_1 \xrightarrow{T} dr_2$, where $dr_1$ is the latest $DRead$ operation performed by $q$ that precedes $dr_2$. Suppose $dr_2$ returns $(val, a)$ for some value $val$ and $a \in \{True, False\}$. Then $a = True$ if and only if some $DWrite$ operation linearizes in the interval $\bigl(pt(dr_1), pt(dr_2)\bigr)$. \end{lemma} \begin{proof} First, suppose $a = True$. Then $q$ executes line~\ref{changed} during $dr_2$. Since the if condition on line~\ref{EQcondABA} is satisfied if and only if the loop-guard on line~\ref{repeatcond} is false, $q$ must execute line~\ref{changed} on the first iteration of the repeat-until loop on line~\ref{slaba:repeatloop} during $dr_2$. Let $(x, p, s)$ and $(x', p', s')$ be the tuples returned by the $X.Read()$ operations $xr$ and $xr'$ performed during the first iteration of the loop on line~\ref{regread1} and line~\ref{regread2}, respectively. Also let $(r, s_r)$ be the pair returned by the $A[q].Read()$ operation $ar$ performed during the first iteration of the loop on line~\ref{annread}. Since $dr_1$ and $dr_2$ are performed in sequence, $xr$, $xr'$, and $ar$ all happen after $pt(dr_1)$. Additionally, since $pt(dr_2) = time(dr_2^{\ref{regread2}})$ (i.e. $dr_2$ linearizes at its \emph{final} execution of line~\ref{regread2}), and $dr_2$ performs the repeat-until loop on line~\ref{slaba:repeatloop} more than once, \begin{equation} \text{$xr$, $xr'$, and $ar$ all happen in $\bigl(pt(dr_1), pt(dr_2)\bigr)$.}\label{slaba:ininterval} \end{equation} By the condition on line~\ref{EQcondABA}, there are two cases: \begin{enumerate}[label=(\roman*)] \item Let $(x, p, s) \neq (x', p', s')$. Since $xr'$ returns $(x', p', s')$, there is an $X.Write(x', p', s')$ operation that happens in $\bigl(time(xr), time(xr')\bigr)$. Hence, by (\ref{slaba:ininterval}) and Observation~\ref{obs:dwritelinatwrite} there exists a $DWrite_{p'}(x')$ operation that linearizes in $\bigl(pt(dr_1), pt(dr_2)\bigr)$. \item Let $(p, s) \neq (r, s_r)$. Assume that $dr_1$ writes $(p_1, s_1)$ to $A[q]$ in its final call to line~\ref{announce1}. By the loop-guard on line~\ref{repeatcond}, \begin{equation} \text{$dr_1^{\ref{regread2}}$ returns $(x_1, p_1, s_1)$.}\label{slaba:lastread} \end{equation} Since $q$ performs $dr_2$ immediately after $dr_1$, and $q$ is the only process that can write to $A[q]$, $(r, s_r) = (p_1, s_1)$. But since $(p, s) \neq (r, s_r)$ by assumption, $(x, p, s) \neq (x_1, p_1, s_1)$. Due to~(\ref{slaba:lastread}), there must be an $X.Write(x, p, s)$ operation that happens in the interval $\bigl(time(dr_1^{\ref{regread2}}), time(xr)\bigr)$. By Observation~\ref{obs:dwritelinatwrite}, there exists a $DWrite$ operation that linearizes in $\bigl(time(dr_1^{\ref{regread2}}), time(xr)\bigr)$, and by (\ref{slaba:ininterval}), this $DWrite$ linearizes in $\bigl(pt(dr_1), pt(dr_2)\bigr)$. \end{enumerate} Now suppose $a = False$. Assume, for the sake of a contradiction, that some $DWrite$ linearizes in $\bigl(pt(dr_1), pt(dr_2)\bigr)$. Let $dw$ be the $DWrite$ operation that linearizes at the latest time in this interval. Suppose $dw$ is a $DWrite_{p_1}(x_1)$ by process $p_1$ with associated sequence number $s_1$. Due to Lemma~\ref{lemma:nointerfereABA}~\ref{lemma:nointB}, we know that no $DWrite$ can linearize in the interval $\bigl[time(dr_2^{\ref{regread1}}), time(dr_2^{\ref{regread2}})\bigr]$. Thus, \begin{equation}\label{dwisadwrite} \text{$dw$ linearizes in $\bigl(time(dr_1^{\ref{regread2}}), time(dr_2^{\ref{regread1}})\bigr)$.} \end{equation} Since $dw$ is the final $DWrite$ operation that linearizes prior to $dr_2^{\ref{regread2}}$, \begin{equation}\label{Xstaysthesame} X = (x_1, p_1, s_1)\text{ throughout }\bigl[pt(dw), pt(dr_2)\bigr]. \end{equation} If $dr_2$ performs the repeat-until loop on line~\ref{slaba:repeatloop} more than once, then since the loop-guard on line~\ref{CHcond} is true if and only if the condition line~\ref{EQcondABA} is true, $q$ sets $changed$ to $True$ during $dr_2$, which is a contradiction. Hence, $dr_2$ must perform only one iteration of the repeat-until loop. By (\ref{dwisadwrite}) and (\ref{Xstaysthesame}), the $X.Read()$ operation $dr_2^{\ref{regread1}}$ must return $(x_1, p_1, s_1)$. Also, $q$ reads $(p_1, s_1)$ from $A[q]$ during $dr_2^{\ref{annread}}$, as otherwise the loop would repeat by the loop-guard on line~\ref{CHcond}. Hence, the last write to $A[q]$ prior to $dr_2^{\ref{annread}}$ must have been an $A[q].Write(p_1, s_1)$ operation. Since $q$ only performs one iteration of the repeat-until loop during $dr_2$, and thus does not write anything to $A[q]$ prior to $dr_2^{\ref{annread}}$ while executing $dr_2$, $q$ must have written $(p_1, s_1)$ to $A[q]$ in the final iteration of the repeat-until loop of $dr_1$ (i.e. during $dr_1^{\ref{announce1}}$). Since the repeat-until loop of $dr_1$ also terminated after that write, $q$ must have read $(p_1, s_1)$ from $A[q]$ during $dr_1^{\ref{annread}}$. This, along with (\ref{dwisadwrite}), contradicts Lemma~\ref{lemma:nointerfereABA}~\ref{lemma:nointA}. \end{proof} \ifea The following lemma completes our argument that the sequential history of operations ordered by $pt$ is valid. Again, it is stated here without proof. \fi \begin{lemma} \label{lemma:valvalidityABA} Let $dr$ be a complete $DRead_p()$ operation that returns $(val, a)$ for some $val \in D$, $val \neq \bot$, and some $a \in \{True, False\}$. Then \begin{enumerate}[label=(\arabic*)] \item there is some $DWrite$ operation that linearizes prior to $pt(dr)$, and\label{lemma:valvalidityABA_exist} \item if $dw$ is a $DWrite_q(x)$ operation, and no $DWrite$ operation linearizes in $\bigl(pt(dw), pt(dr)\bigr]$, then $x = val$.\label{lemma:valvalidityABA_latest} \end{enumerate} \end{lemma} \iffull \begin{proof} We first prove \ref{lemma:valvalidityABA_exist}. Since $dr$ returns $(val, a)$, the first component of $X$ contains $val$ at $time(dr^{\ref{regread2}}) = pt(dr)$. Hence, some $X.Write(val, p, s)$ operation occurs before $pt(dr)$, for some process identifier $p$ and some sequence number $s$. Then by Observation~\ref{obs:dwritelinatwrite}, there is some $DWrite_p(val)$ operation that linearizes prior to $pt(dr)$. We now prove \ref{lemma:valvalidityABA_latest}. Let $dw$ be defined as in the statement of \ref{lemma:valvalidityABA_latest}. Since $dw$ linearizes when it writes $x$ to $X$, and no $DWrite$ linearizes in the interval $\bigl(pt(dw), pt(dr)\bigr]$, the first component of $X$ contains $x$ throughout the interval $\bigl(pt(dw), pt(dr)\bigr]$. \end{proof} \begin{theorem} \label{linABAthm} The sequential history $f(T)$ is a linearization of the interpreted history $\Gamma (T)$. \end{theorem} \begin{proof} First note that for any operation $op \in \Gamma(T)$, $pt(op) \in \bigl[inv(op), rsp(op)\bigr]$, since $pt(op)$ is assigned directly to a line of code that is executed by $op$ for both $DWrite$ and $DRead$ operations. Thus, $f(T)$ preserves the happens-before order of the interpreted history $\Gamma (T)$. Lemma~\ref{validityABA} and Lemma~\ref{lemma:valvalidityABA} ensure that the history $f(T)$ is valid with respect to the sequential specification of ABA-detecting registers. Thus, $f(T)$ is a linearization of $\Gamma (T)$. \end{proof} \fi \ifea Together, Lemma~\ref{validityABA} and Lemma~\ref{valvalidityABA} imply the following: \begin{lemma}\label{slaba:linearizable} Algorithm~\ref{slaba} is linearizable. \end{lemma} We also obtain the following through a simple argument, which we omit here: \fi \begin{lemma} \label{prefABA} The function $f$ is prefix-preserving. \end{lemma} \iffull \begin{proof} Consider each step $t$ of $T$, and some operation $op \in \Gamma (T)$. Then $pt(op) = t$ if \begin{enumerate}[label=(\roman*)] \item operation $op$ is some $DWrite$ operation, and $t$ is the step at which $op$ executes line~\ref{linwritelin} (this case follows from \ref{slaba:ptr2}), or \item operation $op$ is some $DRead$ operation, and $t$ is the final step at which $op$ executes line~\ref{regread2}. Note that whether $t$ is the final execution of line~\ref{regread2} is entirely determined at step $t$, since all of the values compared on line~\ref{repeatcond} are stored in local memory at $t$ (this case follows from \ref{slaba:ptr2}). \end{enumerate} Thus, at step $t$ it is entirely determined which operations $op$ satisfy $pt(op) = t$. That is, whether $t$ satisfies $t = pt(op)$ depends entirely on steps that occur at or before $t$, and not on steps that occur after $t$. Hence, if $T$ is a prefix of $T' \in \mathcal{T}$, then $f(T)$ is a prefix of $f(T')$. \end{proof} \fi \ifea By Lemma~\ref{slaba:linearizable} and Lemma~\ref{prefABA}, we obtain the following theorem: \fi \begin{theorem}\label{thm:ABA-safety} The implementation represented by Algorithm~\ref{slaba} is strongly linearizable. \end{theorem} \iffull \begin{proof} Theorem~\ref{linABAthm} shows that the sequential history $f(T)$ is a linearization of the interpreted history $\Gamma (T)$. Furthermore, Theorem~\ref{prefABA} shows that $f$ is prefix-preserving. Thus, $f$ is a strong linearization function for $\mathcal{T}$. \end{proof} \fi \chapter{A Strongly Linearizable Snapshot}\label{sectionSLSS} \else \section{A Strongly Linearizable Snapshot} \label{sectionSLSS} \fi \ifea A \emph{(single-writer) snapshot} \cite{snapshot} is a type that stores a vector $S\in D^n$, where $D$ is some domain, and supports the operations $update_q(x)$ and $scan_q()$. Operation $update_q(x)$ replaces the $q$-th element of the vector with value $x$ and operation $scan_q()$ returns the vector. \else A \emph{(single-writer) snapshot} \cite{snapshot} is a type that provides the invocation descriptions $update_q(x)$ and $scan()$. A snapshot object has, for each process $p \in \{1, \ldots, n\}$, an \emph{entry} that stores a value from some finite domain $D$. That is, the snapshot object contains a vector $X \in D^n$, which is initially $(\bot, \ldots, \bot)$. The $update_p(x)$ invocation, for any value $x \in D \setminus \{\bot\}$, changes the $p$-th entry of $X$ to $x$, and the $scan()$ invocation returns the vector $X$. We emphasize that the value $\bot$ strictly signifies the initial state of each entry; that is, once an entry of the snapshot contains a value $x \neq \bot$, no process may change the value of this entry back to $\bot$. \fi We use brackets to denote individual entries in vectors and snapshot objects. More precisely, for any vector $X = (x_1, \ldots, x_k)$ and any $p \in \{1, \ldots, k\}$, $X[p] = x_p$. Additionally, if $O$ is a snapshot object, then $O[p]$ denotes the $p$-th entry of the object (i.e. the entry that is writeable by process $p$). \ifthesis \section{Unbounded Implementation}\label{sec:unboundedslss} \else \subsection{Unbounded Implementation}\label{sec:unboundedslss} \fi Denysyuk and Woelfel \cite{WaitVsLock} define a general lock-free construction for \emph{versioned} objects, each storing a version number. A versioned object has an atomic update operation, which increases the object's version number every time it is invoked. A versioned object also supports a read operation which returns the state of the object along with its version number. The simple lock-free linearizable algorithm based on clean double collects from \cite{snapshot} can be transformed into a versioned snapshot object easily, by adding a sequence number field to each component that is incremented with each update of the component. The version number of the entire object may be obtained by calculating the sum of the sequence numbers of every component. The strongly linearizable construction of a versioned object also uses a strongly linearizable bounded max-register described by Helmi, Higham, and Woelfel \cite{PossImposs}. Denysyuk and Woelfel augment the max-register implementation such that it stores a pair $(x, y)$. The augmented max-register supports a $maxRead()$ invocation, which returns the pair $(x, y)$, and a $maxWrite(x', y')$ invocation, which replaces the stored pair $(x, y)$ with $(x', y')$ provided that $x' > x$. Denysyuk and Woelfel's construction uses a single instance of a versioned object $S$ of type $\mathscr{T}$, along with a single instance of an augmented max-register $R$. A strongly linearizable object $S'$ of type $\mathscr{T}$ is obtained as follows: to perform an $S'.update(x)$ operation, a process executes an $S.update(x)$ operation, reads $S$ to obtain the pair $(y, v)$, and finally performs an $R.maxWrite(v, y)$ operation (note that $v$ represents the version number of the object). To execute an $S'.read()$ operation, a process performs an $R.maxRead()$ operation to obtain the pair $(v, y)$, and returns the value $y$. The fact that this algorithm is strongly linearizable follows from a simple argument. Let $up$ be some $S'.update(x)$ operation. Suppose that $S'$ has version number $v$ immediately after $up$ performs its $S.update(x)$ operation. Then $up$ may be linearized as soon as some $R.maxWrite(v', y)$ operation, with $v' \geq v$, linearizes. If multiple $S'.update$ operations linearize at the same step, then these operations may be ordered by the times at which their atomic $S.update$ operations responded. An $S'.read()$ operation may be linearized as soon as its $R.maxRead()$ operation linearizes. Since each operation on $S'$ can be linearized at the same step as an operation on $R$, then $S'$ is strongly linearizable because $R$ is strongly linearizable. \ifthesis As mentioned previously, the construction uses an implementation of a \emph{bounded} max-register, which means that the version number of the strongly linearizable object is bounded. Hence, without further modification, the algorithm only supports a finite number of update operations on the constructed object. The bounded max-register implementation from \cite{PossImposs} is included here as Algorithm~\ref{maxreg} for reference. \begin{algorithm}[h] \caption{A strongly linearizable bounded max-register \cite{PossImposs}} \label{maxreg} \SetKwProg{Fn}{Function}{:}{} \nonl\textbf{shared:}\; \nonl\quad register $R[0 \ldots B+1] = [0, \ldots, 0]$\; \nonl\; \nonl\textbf{local:}\; \nonl\quad Integer $t = 0$\; \nonl\; \nonl\Fn{maxWrite$(x)$} { \For{$i = 1 \ldots x$} { \label{maxreg:writeloop} $R[i] = x$\; \label{maxreg:writetoreg} } } \nonl\; \nonl\Fn{maxRead$()$} { \Repeat{$true$} { \label{maxreg:readloop} $maxWrite(t)$\; \label{maxreg:readwrite} $r \gets R[t+1]$\; \label{maxreg:readnext} \If{$r = 0$} { \Return $t$ \label{maxreg:returnt} } \Else { $t \gets r$\; \label{maxreg:updatet} } } } \end{algorithm} The bounded max-register can store a value up to some constant $B$. The implementation uses a shared array $R$ of $B + 2$ registers of size $\log |D|$. A $maxWrite(x)$ operation, for some $x \in D$, writes the value $x$ to the registers $R[1], \ldots, R[x]$ in the loop on line~\ref{maxreg:writeloop}. A process $p$ performing a $maxRead()$ repeatedly helps pending $maxWrite$ operations by performing a $maxWrite(t)$ operation on line~\ref{maxreg:readwrite}, where $t$ is an integer that is local to each process. Following this, $p$ checks the contents of register $R[t+1]$; if the register contains $0$, then the $maxRead()$ operation immediately terminates and returns $t$ on line~\ref{maxreg:returnt}. Otherwise, $p$ replaces the value $t$ with the value observed in $R[t+1]$ on line~\ref{maxreg:updatet}, before restarting the $maxRead()$ operation. Notice that for each process $p$, $t$ stores the largest value in $R$ that has been observed by $p$. For any $i \in \{1, \ldots, B+1\}$, $R[i]$ may only contain a value $v > 0$ if some $maxWrite(v)$ operation writes to $R[i]$ on line~\ref{maxreg:writetoreg}. Hence, when a $maxRead()$ operation helps pending calls to $maxWrite$ on line~\ref{maxreg:readwrite}, it is guaranteed that a $maxWrite(t)$ operation was invoked at some prior point in time. A $maxWrite(x)$ operation may be linearized at the first step at which some $R[x].Write(x')$ operation occurs (for some value $x' \geq x$). If $R[x] \geq x$ at the invocation of some $maxWrite(x)$ operation, then it may be linearized immediately as it is invoked. A $maxRead()$ operation may be linearized as soon as it reads $0$ from $R[t+1]$ on line~\ref{maxreg:readnext}. This selection of linearization points results in a prefix-preserving function because each of these points depends only on past events (that is, at any particular step of a transcript on Algorithm~\ref{maxreg} it is entirely determined which operations linearize at that step). The implementation of $maxWrite$ is wait-free because each $maxWrite(x)$ operation performs $x$ iterations of the loop on line~\ref{maxreg:writeloop}, and $x \leq B$ for some constant $B$. Similarly, the implementation of $maxRead$ is wait-free because each $maxRead()$ operation performs at most $B$ iterations of the loop on line~\ref{maxreg:readloop} (this follows from a simple argument based on the fact that $t$ increases during every execution of line~\ref{maxreg:updatet}), and every operation invoked during the repeat-until loop is wait-free. Algorithm~\ref{maxreg} may be transformed into an unbounded implementation of a max-register with a simple modification: let $R$ be an unbounded array of (unbounded) registers, and leave the implementations of $maxWrite$ and $maxRead$ unchanged. The $maxWrite$ implementation remains wait-free, since each $maxWrite(x)$ operation still only performs $x$ iterations of the loop on line~\ref{maxreg:writeloop}. However, a $maxRead()$ operation might never terminate if it is interrupted by infinitely many $maxWrite$ operations that write increasing values. Hence, the modification is only lock-free. However, the modified max-register may still be used in the lock-free construction of Denysyuk and Woelfel. Notice that the implementation of $S'.update$ remains wait-free, and each $S'.update$ operation invokes only a single $maxWrite$ operation. Hence, if a $maxRead()$ performed during an $S'.read()$ operation $rd$ never terminates, the $maxRead()$ operation must continually read increasing values on line~\ref{maxreg:readnext}. This implies that infinitely many $maxWrite$ operations, which write increasing values, must terminate during $rd$. Since the contents of the max-register may only be increased by calls to $maxWrite$ performed during $S'.update$ operations, this implies that an infinite number of $S'.update$ operations terminate during $rd$. The outline of this argument is similar to the formal proofs of correctness provided in Section~\ref{compslss}. \fi \iffull \ifthesis \section{Interpreted Value}\label{sec:interpvalue} \else \subsection{Interpreted Value}\label{sec:interpvalue} \fi Suppose $O$ is an instance of a snapshot object, and let $T$ be a transcript that contains operations on $O$. If $O$ is atomic, then it is easy to determine the value of $O$ at any step $t$ of $T$, since $update$ operations on $O$ take effect instantaneously. However, if $O$ is a linearizable implementation of a snapshot object (in particular, if $update$ operations on $O$ are non-atomic), then the value of $O$ at any step $t$ of $T$ is not well-defined. To address this issue, we begin by introducing the notion of \emph{interpreted value}, which allows us to reason about the contents of a linearizable object $O$ at every step of $T$. Let $T$ be a fixed transcript, and let $O$ be some linearizable snapshot object. Let $pt$ be a linearization point function for $O$ (recall that for any transcript $T$, $pt$ maps operations in $\Gamma(T|O)$ to points in time in $T$). The \emph{interpreted value} of $O[p]$ induced by $pt$ at time $t$ of $T$ is $x$ if and only if one of the following statements hold: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{T-\arabic*},ref={T-\arabic*}] \item There is an $O.update_p(x)$ operation $up \in \Gamma(T|O)$ by $p$ such that $pt(up) < t$, and there does not exist any $O.update_p(x')$ operation $up' \in \Gamma(T|O)$ by $p$ such that $pt(up) < pt(up') \leq t$, for any $x' \neq x$.\label{def:interp1} \item There is no such $O.update_p(x)$ operation by $p$ in $\Gamma(T|O)$, and $x = \bot$.\label{def:interp2} \end{enumerate} When $pt$ and $T$ are clear from context, we say that the interpreted value of $O[p]$ at time $t$ is $x$. Intuitively, if the interpreted value of $O[p]$ at time $t$ is $x$, then any $scan$ operation $sc \in \Gamma(T)$ such that $pt(sc) = t$ must return a vector with $x$ in its $p$-th entry (this simply follows from the sequential specification of the snapshot type, along with the assumption that $S$ is a linearization of $\Gamma(T)$). Note that by the definition above, if $up_1$ and $up_2$ are two consecutive $O.update$ operations by process $p$ such that $up_1$ and $up_2$ write distinct values and $pt(up_2) \neq \infty$, then the interpreted value of $O[p]$ at $pt(up_2)$ is $\bot$. However, if $up_1$ and $up_2$ both write the same value $v$, then the interpreted value of $O[p]$ at $pt(up_2)$ is $v$. \begin{observation}\label{obs:interpvalue} Let $T$ be a transcript, let $O$ be a linearizable snapshot object, and let $pt$ be a linearization point function for $O$. Suppose the interpreted value of $O[p]$ induced by $pt$ at time $t \neq \infty$ of $T$ is $x \neq \bot$. Then for every $scan$ operation $sc$ such that $pt(sc) = t$, $sc$ returns a vector $(x_1, \ldots, x_n)$ such that $x_p = x$. \end{observation} \begin{proof} Since the interpreted value of $O[p]$ at time $t$ is $x \neq \bot$, by \ref{def:interp1} there exists an $O.update_p(x)$ operation $up \in \Gamma(T|O)$ by $p$ such that \ifspringer \begin{gather} \text{$pt(up) < t$, and}\label{obs:interpless} \\ \begin{split} &\text{no $O.update_p(x')$ operation $up' \in \Gamma(T|O)$ by $p$} \\ &\text{satisfies $pt(up) < pt(up') \leq t$, for any $x' \neq x$.}\label{obs:interpnoop} \end{split} \end{gather} \else \begin{gather} \text{$pt(up) < t$, and}\label{obs:interpless} \\ \text{no $O.update_p(x')$ operation $up' \in \Gamma(T|O)$ by $p$ satisfies $pt(up) < pt(up') \leq t$, for any $x' \neq x$.}\label{obs:interpnoop} \end{gather} \fi By the definition of linearization point functions, there exists a linearization $S$ of $\Gamma(T|O)$ such that, \ifspringer \begin{gather} \begin{split} &\text{for any $op \in \Gamma(T|O)$ such that $pt(op) \neq \infty$,} \\ &\text{$op \in S$, and}\label{obs:interpopins} \end{split} \\ \begin{split} &\text{for any $op_1, op_2 \in S$, if $op_1 \xrightarrow{S} op_2$ then} \\ &\text{$pt(op_1) \leq pt(op_2)$.}\label{obs:interpextend} \end{split} \end{gather} \else \begin{gather} \text{for any $op \in \Gamma(T|O)$ such that $pt(op) \neq \infty$, $op \in S$, and}\label{obs:interpopins} \\ \text{for any $op_1, op_2 \in S$, if $op_1 \xrightarrow{S} op_2$ then $pt(op_1) \leq pt(op_2)$.}\label{obs:interpextend} \end{gather} \fi From the lemma statement, $pt(sc) = t$ and $t \neq \infty$. By this, (\ref{obs:interpless}), and (\ref{obs:interpopins}), $up, sc \in S$. Since $pt(up) < pt(sc)$, $up \xrightarrow{S} sc$ by contrapositive of (\ref{obs:interpextend}). Suppose there exists an $O.update_p(x')$ operation $up' \in S$ by $p$ such that \begin{gather} \text{$x \neq x'$, and}\label{obs:interpxneqxprime} \\ \text{$up \xrightarrow{S} up' \xrightarrow{S} sc$.}\label{obs:interpSorder} \end{gather} By (\ref{obs:interpextend}) and (\ref{obs:interpSorder}), \begin{gather} \text{$pt(up) \leq pt(up')$, and}\label{obs:interpupbeforeupprime} \\ \text{$pt(up') \leq pt(sc)$.}\label{obs:interpupprimebeforesc} \end{gather} Note that by definition of linearization point functions, \begin{gather} \text{$pt(up) \in \bigl[time_T(inv(up)), time_T(rsp(up))\bigr]$, and}\label{obs:interpupinitsoperation} \\ \text{$pt(up') \in \bigl[time_T(inv(up')), time_T(rsp(up'))\bigr]$.}\label{obs:interpuppriminitsoperation} \end{gather} By (\ref{obs:interpupinitsoperation}), (\ref{obs:interpuppriminitsoperation}), the fact that processes perform operations sequentially, and (\ref{obs:interpupbeforeupprime}), \begin{equation} \text{$pt(up) < pt(up')$.}\label{obs:interpupstrictbeforeupprime} \end{equation} Together, (\ref{obs:interpxneqxprime}), (\ref{obs:interpupprimebeforesc}), and (\ref{obs:interpupstrictbeforeupprime}) contradict (\ref{obs:interpnoop}). Hence, there is no $O.update_p(x')$ operation $up' \in S$ by $p$ such that $up \xrightarrow{S} up' \xrightarrow{S} sc$, for any $x' \neq x$. By this, the fact that $up \xrightarrow{S} sc$, and the fact that $S$ is a linearization of $\Gamma(T|O)$, the sequential specification of the snapshot type requires that $sc$ returns a vector $(x_1, \ldots, x_n)$ with $x_p = x$. \end{proof} \begin{observation}\label{obs:interpintervalafter} Let $T$ be a transcript, let $O$ be a linearizable snapshot object, and let $pt$ be a linearization point function for $O$. Suppose $up$ is some $O.update_p(x)$ operation by $p$ such that $pt(up) \neq \infty$. If there is no $O.update_p(x')$ operation $up'$ by $p$ with $x' \neq x$ such that $pt(up') \in \bigl(pt(up), t\bigr]$ for some time $t > pt(up)$, then the interpreted value of $O[p]$ is $x$ throughout $\bigl(pt(up), t\bigr]$. \end{observation} \begin{proof} This follows trivially from \ref{def:interp1}. \end{proof} \fi \ifthesis \section{Bounded Implementation}\label{sec:boundedslss} \else \subsection{Bounded Implementation} \fi Golab, Higham, and Woelfel \cite{stronglin} have shown that the wait-free snapshot implementation designed by Afek, Attiya, Dolev, Gafni, Merritt, and Shavit~\cite{snapshot} is not strongly linearizable. Previous strongly linearizable implementations of snapshot objects are either not lock-free \cite{PossImposs}, or use an unbounded number of registers \cite{WaitVsLock}. We design a strongly linearizable implementation of a single-writer snapshot object using a linearizable instance of a single-writer snapshot object, along with an atomic ABA-detecting register. The linearizable snapshot object used by our implementation can be any lock-free or wait-free linearizable implementation of a snapshot object. To achieve a strongly linearizable snapshot object that uses bounded space, we must ensure that the underlying linearizable snapshot implementation also uses only bounded space. For the sake of concreteness, we use an implementation by Attiya and Rachman~\cite{attiya1998snapshot}, which is wait-free and linearizable. The bounded implementation presented in \cite{attiya1998snapshot} uses $O(n^3)$ registers of size $O(\log n + \log |D|)$ to represent views of the snapshot object (where $D$ is the set of values that may be stored by a component), plus $O(n^5)$ registers of size $O(\log n)$ to manage sequence numbers. This implementation therefore has space complexity $O(n^3(\log n + \log |D|) + n^5\log n)$. The algorithm performs $O(n\log n)$ operations on MRSW registers during any $scan$ or $update$ operation. Let $S$ be an instance of this bounded wait-free linearizable snapshot object implementation. Our algorithm also uses a shared atomic ABA-detecting register $R$. The snapshot object $S$ is used to hold the contents of the strongly linearizable snapshot object, while the ABA-detecting register $R$ contains a vector of size $n$ that represents the state of $S$ at some previous point in time. Since strong linearizability is a composable property \cite{stronglin,AE2019a}, we can replace the atomic ABA-detecting register $R$ with our strongly linearizable one from Section~\ref{slabasection}. In order to clearly distinguish between operations on the linearizable snapshot object $S$, and the implemented strongly linearizable snapshot, we call the operations on the latter one $SLupdate$ and $SLscan$. Pseudocode for our implementation is presented in Algorithm~\ref{slss}. \begin{algorithm} \caption{A strongly linearizable snapshot object} \label{slss} \SetKwProg{Fn}{Function}{:}{} \nonl\textbf{shared:}\; \nonl\quad linearizable snapshot object $S = (\bot, \ldots, \bot)$\; \nonl\quad atomic ABA-detecting register $R = (\bot, \ldots, \bot)$\; \nonl\; \nonl\Fn{SLupdate$_p(x)$} { $S.update_p(x)$\; \label{Supdate} $s \gets S.scan()$\; \label{SLUscan} $R.DWrite_p(s)$\; \label{SLUDWrite} } \nonl\; \nonl\Fn{SLscan$_p()$} { \Repeat{$(s_1 = \ell = s_2) \; \mathbf{and} \; !c_2$} { \label{slssrepeat} $(s_1, c_1) \gets R.DRead_p()$\; \label{DRead1} $\ell \gets S.scan()$\; \label{SLSscan} $(s_2, c_2) \gets R.DRead_p()$\; \label{DRead2} \If{$!(s_1 = \ell = s_2)$} { \label{EQcond} $R.DWrite_p(\ell)$\; \label{SLSDWrite} } } \label{CHcond} \Return $s_2$ } \end{algorithm} We employ a similar strategy as in the unbounded implementation, but the role of the max-register is now filled by the ABA-detecting register. The $SLupdate$ operation is nearly identical to the update operation of the unbounded implementation by Denysyuk and Woelfel: to perform an $SLupdate_p(x)$ operation, for some $x \in D$, a process $p$ first performs an $S.update_p(x)$ operation on line~\ref{Supdate}, changing the contents of the $p$-th entry of $S$ to $x$. Process $p$ then performs an $S.scan()$ operation on line~\ref{SLUscan}, and finally writes the result of this call to $R$ on line~\ref{SLUDWrite}. Since components of the snapshot object are single-writer, the vector returned by this $S.scan()$ operation must contain $x$ in its $p$-th entry. An $SLscan_p()$ operation, for some process $p$, is ``stretched'' until a period of time is observed during which the underlying objects $S$ and $R$ are not modified. This way, we force the operation to observe as many $SLupdate$ operations as possible before allowing it to respond. The method works by repeatedly performing an $R.DRead_p()$ operation on line~\ref{DRead1}, then an $S.scan()$ operation on line~\ref{SLSscan}, and finally another $R.DRead_p()$ operation on line~\ref{DRead2}. We will often refer to this sequence of operations as the \emph{main loop} of the $SLscan$ method. Process $p$ continues to perform this sequence of operations until the same vector is returned by all of these calls. Whenever $p$ observes that the contents of $R$ and $S$ are inconsistent, $p$ helps pending $SLupdate$ operations by writing the previously-taken snapshot of $S$ to $R$ on line~\ref{SLSDWrite} before resuming its main loop. When $p$ observes that the $S.scan()$ operation and the two $R.DRead_p()$ operations return the same vector, $p$ will make sure that $R$ was not changed between its most recent pair of $R.DRead_p()$ operations by checking the boolean flag returned by the second $DRead$ on line~\ref{CHcond}; if this flag is false, then $p$ can safely return the value that was returned by its final $DRead$. Thus, process $p$ continues to perform its main loop until it observes that no process interferes during its most recently executed sequence of read operations. Both $SLscan$ and $SLupdate$ operations work to stabilize the contents of $S$ and $R$. The idea is that the underlying snapshot object $S$ always contains the most recent state of the object, and operations write the state of $S$ that they observed most recently to $R$ (on both line~\ref{SLUDWrite} for $SLupdate$ operations and line~\ref{SLSDWrite} for $SLscan$ operations). A pending $SLupdate_p(x)$ operation by process $p$ can be linearized as soon as some concurrent $SLscan$ operation returns a vector that contains $x$ in its $p$-th entry. The key is that we choose a linearization point for this $SLupdate$ operation at which the interpreted value of $S[p]$ is $x$ and the value of $R[p]$ is $x$. We choose to linearize $SLscan$ operations on their last read of shared memory. That is, an $SLscan$ operation linearizes at its final execution of the $R.DRead$ operation on line~\ref{DRead2}. Our choice of linearization points results in a strong linearization function because $SLscan$ operations always linearize at their final shared memory step, and when an $SLscan$ operation linearizes, it is already determined which $SLupdate$ operations are caused to linearize by this $SLscan$ operation. Hence, no operations can be retroactively inserted anywhere in the established linearization order. \ifthesis We now give an informal explanation of why the ABA-detecting register and the conditional statement on line~\ref{CHcond} are helpful in Algorithm~\ref{slss}. The snapshot object implementation in Algorithm~\ref{ssnoABA} is a modification of Algorithm~\ref{slss}, which replaces the ABA-detecting register with an atomic multi-reader multi-writer register. The remaining details of the algorithm are nearly unchanged, besides method names (e.g. $DRead$ is now simply $Read$). Notice that the Boolean flag test of $c_2$ from line~\ref{CHcond} has been removed from line~\ref{noaba:CHcond} (since the $R.Read()$ operation does not return a Boolean flag). \begin{algorithm} \caption{A snapshot object implemented without ABA-detecting registers} \label{ssnoABA} \SetKwProg{Fn}{Function}{:}{} \nonl\textbf{shared:}\; \nonl\quad linearizable snapshot object $S = (\bot, \ldots, \bot)$\; \nonl\quad atomic multi-reader multi-writer register $R = (\bot, \ldots, \bot)$\; \nonl\; \nonl\Fn{SLupdate$_p(x)$} { $S.update_p(x)$\; \label{noaba:Supdate} $s \gets S.scan()$\; \label{noaba:SLUscan} $R.Write(s)$\; \label{noaba:SLUDWrite} } \nonl\; \nonl\Fn{SLscan$_p()$} { \Repeat{$s_1 = \ell = s_2$} { \label{noaba:slssrepeat} $s_1 \gets R.Read()$\; \label{noaba:DRead1} $\ell \gets S.scan()$\; \label{noaba:SLSscan} $s_2 \gets R.Read()$\; \label{noaba:DRead2} \If{$!(s_1 = \ell = s_2)$} { \label{noaba:EQcond} $R.Write(\ell)$\; \label{noaba:SLSDWrite} } } \label{noaba:CHcond} \Return $s_2$ } \end{algorithm} Consider the following programs for the processes $q$, $p$, and $r$: \begin{itemize} \item Process $q$ performs an $SLupdate_q(1)$ operation $up_1$ followed by an $SLupdate_q(2)$ operation $up_2$. \item Process $p$ performs an $SLscan_p()$ operation $sc_p$. \item Process $r$ performs an $SLscan_r()$ operation $sc_r$. \end{itemize} Define the following transcripts on Algorithm~\ref{ssnoABA}: \begin{align*} &S = up_1 \circ (sc_r\text{ to the end of line~\ref{noaba:SLSscan}}) \circ \\ &\qquad(sc_p\text{ to the end of line~\ref{noaba:SLSscan}}) \circ up_2 \circ (sc_r\text{ to the end of line~\ref{noaba:EQcond}}) \\ &T_1 = S \circ (sc_r\text{ to the end of line~\ref{noaba:SLSDWrite}}) \circ (sc_p\text{ to completion}) \\ &T_2 = S \circ (sc_p\text{ to completion}) \end{align*} The $SLupdate_q(1)$ operation $up_1$ completes before any other operation is invoked in $S$. Therefore, when $sc_p$ and $sc_r$ run to the end of line~\ref{noaba:SLSscan} during $S$, they both see $1$ in entry $q$ of the vectors returned on lines \ref{noaba:DRead1} and \ref{noaba:SLSscan} (we disregard the entries for $p$ and $r$ in this example, since neither process performs any $SLupdate$ operations). The second time $sc_r$ runs during $S$, to the end of line~\ref{noaba:EQcond}, it sees $2$ in entry $q$ of the vector returned on line~\ref{noaba:DRead2} (since $up_2$ completed before the $R.Read()$ operation by $sc_r$ on line~\ref{noaba:DRead2} was invoked). Then $sc_r$ must enter the conditional block on line~\ref{noaba:EQcond}. Hence, at the end of $S$, $r$ is poised perform an $R.Write(X)$ operation on line~\ref{noaba:SLSDWrite}, where $X[q] = 1$. In transcript $T_1$, $sc_r$ is allowed to complete its $R.Write(X)$ operation. Hence, when $sc_p$ completes in transcript $T_1$, it reads a vector with $1$ in entry $q$ in line~\ref{noaba:DRead2}. Therefore, $sc_p$ does not enter the conditional block on line~\ref{noaba:EQcond}, since the vectors it viewed on lines \ref{noaba:DRead1}, \ref{noaba:SLSscan}, and \ref{noaba:DRead2} were all equal. Then $sc_p$ returns a vector that contains $1$ in entry $q$. Hence, $sc_p$ must linearize after $up_1$, but before $up_2$ in any linearization of $\Gamma(T_1)$. In transcript $T_2$, $sc_p$ completes without $sc_r$ performing its $R.Write(X)$ operation. In this case, since $up_2$ performs an $R.Write(Y)$ operation on line~\ref{noaba:SLUDWrite}, with $Y[q] = 2$, $sc_p$ reads a vector with $2$ in entry $q$ on line~\ref{noaba:DRead2}. Hence, $sc_p$ restarts its loop, reads a vector with $2$ in entry $q$ in lines \ref{noaba:DRead1}, \ref{noaba:SLSscan}, and \ref{noaba:DRead2}, and then terminates and returns a vector with $2$ in entry $q$. Therefore, $sc_p$ must linearize after both $up_1$ and $up_2$ in any linearization of $\Gamma(T_2)$. Consider the linearization $L_1 = up_1 \circ sc_p \circ up_2$ of $S$. Then $L_1$ is not a prefix of any linearization of $\Gamma(T_2)$, since $sc_p$ must linearize after both $up_1$ and $up_2$ in any linearization of $\Gamma(T_2)$. Now consider the linearization $L_2 = up_1 \circ up_2$ of $S$. Then $L_2$ is not a prefix of any linearization of $\Gamma(T_1)$, since $sc_p$ must linearize after $up_1$ but before $up_2$ in any linearization of $\Gamma(T_1)$. This example provides intuition into why Algorithm~\ref{ssnoABA} is not strongly linearizable. In the remainder of this section we show that Algorithm~\ref{slss} is strongly linearizable, demonstrating that using ABA-detecting registers suffices to solve the problem we illustrated with this example. \fi \ifea We now outline an argument that Algorithm~\ref{slss} is strongly linearizable. For complete proofs of correctness, see (FULL PAPER)\todo{this}. Since $S$ is a linearizable implementation of a snapshot object, its value at any particular step of a transcript is not well-defined. Hence, we introduce the notion of an \emph{interpreted value}, which simplifies our arguments. Let $T$ be a transcript on an instance of Algorithm~\ref{slss}. Let $H$ be a linearization of $\Gamma(T|S)$, and let $pt_S$ be a function that maps operations in $\Gamma(T|S)$ to linearization points. More precisely, for any $op \in \Gamma(T|S)$, $pt_S(op) \in [time_T(inv(op)), time_T(rsp(op))]$, and $op_i \xrightarrow{H} op_j$ if and only if either $pt_S(op_i) < pt_S(op_j)$, or $pt_S(op_i) = pt_S(op_j)$, $op_i$ is an $update$ operation, and $op_j$ is a $scan$ operation. Then the interpreted value of $S[p]$ at step $t$ of $T$ is $x$ if there exists an $update_p(x)$ operation $up$ by $p$ such that $pt_S(up) \leq t$, and there is no $update_p(x')$ operation $up'$ by $p$ such that $pt_S(up) < pt_S(up') \leq t$. The interpreted value of $S$ at step $t$ is a vector $X \in D^n$ if, for every $p \in \{1, \ldots, n\}$, the interpreted value of $S[p]$ at step $t$ is $X[p]$. \fi For any operation $op$ in a transcript $T$ on some instance of the implementation provided in Algorithm~\ref{slss}, we define $pt(op)$ as follows: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{R-\arabic*},ref={R-\arabic*}] \item\label{ptr1} Suppose $op$ is some $SLscan$ operation. Then $pt(op)$ is the time at which the final shared memory step is performed by $op$. That is, $pt(op) = time(op^{\ref{DRead2}})$. \item\label{ptr2} Suppose $op$ is some $SLupdate_p(x)$ operation for some $x \in D$. If $T$ contains an $SLscan$ operation $sc$ such that $pt(sc) \neq \infty$, $time(inv(op)) < pt(sc)$, and $sc$ returns a vector whose $p$-th entry contains $x$, then let $sc_0$ be such an $SLscan$ operation with minimum possible $pt$ value. Let $t = pt(sc_0)$ if $sc_0$ exists, or $t = \infty$ otherwise. Then $pt(op) = \min \bigl(t, time(op^{\ref{SLUDWrite}})\bigr)$. Recall that if $op^{\ref{SLUDWrite}} \not\in T$, then $time(op^{\ref{SLUDWrite}}) = \infty$. \end{enumerate} If $pt(op) \neq \infty$ for some operation $op$, then we say $op$ \emph{linearizes} at $pt(op)$. \ifea If $T$ is a transcript on some instance of the object implementation in Algorithm~\ref{slss}, then we claim $H$ is a linearization of $T$, where $H$ is a sequential history composed of operations in $\Gamma(T)$ ordered by their corresponding $pt$ values. That is, if $op_i$ and $op_j$ are operations in $\Gamma(T)$ performed by processes $p$ and $q$ respectively, and $pt(op_i) < pt(op_j)$, then $op_i \xrightarrow{H} op_j$. If $pt(op_i) = pt(op_j)$, then $op_i \xrightarrow{H} op_j$ if either $op_j$ is an $SLscan$ operation and $op_i$ is an $SLupdate$ operation, or both operations are of the same type and $p < q$. Also, for any operation $op \in T$ such that $pt(op) = \infty$, omit $op$ from $H$. Let $f$ be a function that maps every transcript on Algorithm~\ref{slss} to a sequential history as described above (the existence of such a function is trivial). \fi \iffull Let $\mathcal{T}$ represent the set of all possible transcripts on some instance of the object implementation from Algorithm~\ref{slss}. For every transcript $T \in \mathcal{T}$ define a sequential history $f(T)$, such that for every pair of distinct operations $op_1, op_2 \in \Gamma (T)$ by processes $p_1$ and $p_2$ respectively, with $pt(op_1) \neq \infty$ and $pt(op_2) \neq \infty$, $op_1 \xrightarrow{f(T)} op_2$ if and only if \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=\textbf{U-\arabic*},ref={U-\arabic*}] \item operation $op_1$ linearizes before $op_2$ (i.e. $pt(op_1) < pt(op_2)$), or \item operations $op_1$ and $op_2$ have the same linearization point (i.e. $pt(op_1) = pt(op_2)$), they both have the same invocation description (i.e. they are either both $SLupdate$ operations or both $SLscan$ operations), and $p_1 < p_2$, or\label{ptsorttiebreaker} \item operations $op_1$ and $op_2$ have the same linearization point (i.e. $pt(op_1) = pt(op_2)$), $op_1$ is an $SLupdate$ operation, and $op_2$ is an $SLscan$ operation. \end{enumerate} Note that $f(T)$ does not contain any operation $op \in \Gamma (T)$ for which $pt(op) = \infty$. For the remainder of Section~\ref{sectionSLSS}, let $T \in \mathcal{T}$ be some finite transcript on a snapshot object $O$ implemented by Algorithm~\ref{slss}. Additionally, fix a linearization point function $pt_S$ for $S$, where $S$ is the linearizable snapshot object used by Algorithm~\ref{slss}. By definition of linearization point functions, there exists a linearization $L$ of $\Gamma(T|S)$ such that \ifspringer \begin{gather} \begin{split} &\text{for every $op \in \Gamma(T|S)$ such that $pt_S(op) \neq \infty$,} \\ &\text{$op \in L$, and}\label{linptfunctions:in} \end{split} \\ \begin{split} &\text{for every $op_1, op_2 \in L$, if $op_1 \xrightarrow{L} op_2$ then} \\ &\text{$pt_S(op_1) \leq pt_S(op_2)$.}\label{linptfunction:prec} \end{split} \end{gather} \else \begin{gather} \text{for every $op \in \Gamma(T|S)$ such that $pt_S(op) \neq \infty$, $op \in L$, and}\label{linptfunctions:in} \\ \text{for every $op_1, op_2 \in L$, if $op_1 \xrightarrow{L} op_2$ then $pt_S(op_1) \leq pt_S(op_2)$.}\label{linptfunction:prec} \end{gather} \fi \fi \ifea The following four lemmas are stated here without proof: \fi \begin{lemma} \label{slss:ptinmethod} For any operation $op \in \Gamma(T)$, $pt(op) \in \bigl[time(inv(op)), time(rsp(op))\bigr]$. \end{lemma} \iffull \begin{proof} Let $op \in \Gamma(T)$ be some $SLscan_p()$ operation by $p$. Then $pt(op) = time(op^{\ref{DRead2}})$ by \ref{ptr1}. Hence, $pt(op) \in \bigl[time(inv(op)), time(rsp(op))\bigr]$. Let $op \in \Gamma(T)$ be some $SLupdate_{p}(x_p)$ operation by $p$ for some value $x_p \in D$. By \ref{ptr2}, $pt(op)$ is explicitly defined as a time after $time(inv(op))$ and not after $time(rsp(op))$, which immediately implies the lemma. \end{proof} \fi \begin{lemma}\label{lemma:scanforcesuptolin} Suppose $up \in \Gamma(T)$ is some $SLupdate_p(x)$ operation by $p$, for some value $x \in D$. If there exists an $SLscan()$ operation $sc \in \Gamma(T)$ with $time(inv(up)) < pt(sc)$ and $sc$ returns some vector with $x$ in its $p$-th entry, then $pt(up) \leq pt(sc)$. \end{lemma} \begin{proof} This is trivially true if $pt(sc) = \infty$. Otherwise, the lemma follows from \ref{ptr2}. \end{proof} \begin{lemma}\label{lemma:eanowrite} Let $op \in \Gamma(T)$ be some complete $SLscan_p()$ operation by some process $p$. Then no $R.DWrite$ operation happens in the interval $\bigl[time(op^{\ref{DRead1}}), time(op^{\ref{DRead2}})\bigr]$. \end{lemma} \iffull \begin{proof} This follows directly from the sequential specification of ABA-detecting registers and the if-statement on line~\ref{CHcond}. \end{proof} \fi \begin{lemma}\label{lemmaEQatlin} Let $up \in \Gamma(T)$ be some $SLupdate_p(x)$ operation with $pt(up) \neq \infty$, for some process $p$ and some $x \in D$. Then the interpreted value of $S[p]$ induced by $pt_S$ is $x$ and $R[p] = x$ at $pt(up)$. \end{lemma} \iffull \begin{proof} There are two cases: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=(\roman*)] \item Operation $up$ linearizes at $time(up^{\ref{SLUDWrite}})$ (i.e. $pt(up) = time(up^{\ref{SLUDWrite}})$). Let $up_u$ be the $S.update_p(x)$ operation performed by $up$ on line~\ref{Supdate}. Since entries of $S$ are single-writer, and the $SLupdate$ method only contains a single $S.update$ call, \ifspringer \begin{equation} \begin{split} &\text{the interpreted value of $S[p]$ is $x$ throughout} \\ &\text{the interval $\bigl(pt_S(up_u), time(rsp(up))\bigr]$.}\label{lemmaEQ:interpinterval} \end{split} \end{equation} \else \begin{equation} \text{the interpreted value of $S[p]$ is $x$ throughout the interval $\bigl(pt_S(up_u), time(rsp(up))\bigr]$.}\label{lemmaEQ:interpinterval} \end{equation} \fi By definition of linearization point functions, \begin{equation} \text{$pt_S(up_u) \in \bigl[time(inv(up_u)), time(rsp(up_u))\bigr]$.}\label{lemmaEQ:ptsupuininterval} \end{equation} By (\ref{lemmaEQ:ptsupuininterval}) and the fact that processes perform operations sequentially, $pt_S(up_u) < time(up^{\ref{SLUDWrite}})$. By this and (\ref{lemmaEQ:interpinterval}), \ifspringer \begin{equation} \begin{split} &\text{the interpreted value of $S[p]$ is $x$ at} \\ &\text{$time(up^{\ref{SLUDWrite}})$.}\label{lemmaEQatlin:interp} \end{split} \end{equation} \else \begin{equation} \text{the interpreted value of $S[p]$ is $x$ at $time(up^{\ref{SLUDWrite}})$.}\label{lemmaEQatlin:interp} \end{equation} \fi Let $sc_u$ be the $S.scan()$ operation performed by $up$ on line~\ref{SLUscan}. Again, since processes perform operations sequentially and $pt_S(up_u)$ and $pt_S(sc_u)$ both occur between the invocations and responses of $up_u$ and $sc_u$, respectively, $pt_S(up_u) < pt_S(sc_u)$. By this, (\ref{lemmaEQ:interpinterval}), and Observation~\ref{obs:interpvalue}, $sc_u$ returns a vector whose $p$-th entry contains $x$. Then the vector written to $R$ by $up$ on line~\ref{SLUDWrite} contains $x$ in its $p$-th entry. Hence, \begin{equation} \text{$R[p] = x$ at $time(up^{\ref{SLUDWrite}})$.}\label{lemmaEQatlin:value} \end{equation} By (\ref{lemmaEQatlin:interp}), (\ref{lemmaEQatlin:value}), and the assumption that $pt(up) = time(up^{\ref{SLUDWrite}})$, we obtain the claim in the lemma statement. \item Operation $up$ linearizes before $time(up^{\ref{SLUDWrite}})$ (that is, $pt(up) < time(up^{\ref{SLUDWrite}})$). Then by \ref{ptr2} there is some $SLscan$ operation $sc$ that returns a vector whose $p$-th entry contains $x$ while $up$ is pending, and $pt(sc) = pt(up)$. By this and the fact that $pt(sc) = time(sc^{\ref{DRead2}})$ by \ref{ptr1}, \begin{equation} \text{$time(inv(up)) < time(sc^{\ref{DRead2}})$.}\label{lemmaEQ:upinvbeforeread} \end{equation} Since $sc$ linearizes at its final execution of line~\ref{DRead2}, the vectors returned by the $R.DRead()$ operations on line~\ref{DRead1} and line~\ref{DRead2}, along with the vector returned by the $S.scan()$ operation on line~\ref{SLSscan}, must satisfy the condition on line~\ref{CHcond}. In particular, if $sc_s$ is the final $S.scan()$ operation performed by $sc$, then \begin{equation} \text{$sc_s$ returns a vector with $x$ in its $p$-th entry.}\label{lemmaEQ:scsreturns} \end{equation} Since $L$ is a linearization of $\Gamma(T|S)$, by (\ref{lemmaEQ:scsreturns}) and the sequential specification of the snapshot type, there exists an $S.update_p(x)$ operation $up_{u_x}$ by $p$ such that \ifspringer \begin{gather} \text{$up_{u_x} \xrightarrow{L} sc_s$, and}\label{lemmaEQ:upleqsc} \\ \begin{split} &\text{there is no $S.update_p(x')$ operation $up_u'$ by $p$} \\ &\text{such that $x \neq x'$ and $up_{u_x} \xrightarrow{L} up_u' \xrightarrow{L} sc_s$.}\label{lemmaEQ:thereisnoup} \end{split} \end{gather} \else \begin{gather} \text{$up_{u_x} \xrightarrow{L} sc_s$, and}\label{lemmaEQ:upleqsc} \\ \text{there is no $S.update_p(x')$ operation $up_u'$ by $p$ such that $x \neq x'$ and $up_{u_x} \xrightarrow{L} up_u' \xrightarrow{L} sc_s$.}\label{lemmaEQ:thereisnoup} \end{gather} \fi Applying (\ref{linptfunction:prec}) to (\ref{lemmaEQ:upleqsc}), \begin{equation} \text{$pt_S(up_{u_x}) \leq pt_S(sc_s)$.}\label{lemEQ:ptsupuxleqptsscs} \end{equation} Suppose that $up_{u_x}$ is performed by an $SLupdate_p(x)$ operation other than $up$. There is no $S.update_p(x')$ operation $up_u'$ by $p$ such that $x' \neq x$ and $pt_S(up_{u_x}) < pt_S(up_u') < pt_S(sc_s)$, since, using the contrapositive of (\ref{linptfunction:prec}), this would contradict (\ref{lemmaEQ:thereisnoup}). Also, there cannot exist such an $up_u'$ by $p$ such that $pt_S(up_{u_x}) = pt_S(up_u')$, since $up_{u_x}$ and $up_u'$ must both linearize between their respective invocations and responses by the definition of linearization point functions. Now suppose there exists an $S.update_p(x')$ operation $up_u'$ by $p$ such that $x' \neq x$ and \begin{equation} \text{$pt_S(sc_s) \leq pt_S(up_u') < time(inv(up))$.}\label{lemEQ:ptsscsleqptsupuprime} \end{equation} Let $up'$ be the $SLupdate_p(x')$ operation that performs $up_u'$ on line~\ref{Supdate}. Clearly, $up' \neq up$, since $x \neq x'$. Since processes perform operations sequentially, $time(rsp(up')) < time(inv(up))$. But by this, (\ref{lemmaEQ:upinvbeforeread}), and (\ref{lemEQ:ptsscsleqptsupuprime}), $up'$ must perform its $R.DWrite$ operation from line~\ref{SLUDWrite} in the interval $\bigl[pt_S(sc_s), time(sc^{\ref{DRead2}})\bigr)$, and hence in the interval $\bigl[time(sc^{\ref{DRead1}}), time(sc^{\ref{DRead2}})\bigr]$. This contradicts Lemma~\ref{lemma:eanowrite}, and therefore \ifspringer \begin{equation} \small \begin{split} &\text{no $S.update_p(x')$ operation $up_u'$ by $p$ with $x' \neq x$} \\ &\text{satisfies $pt_S(up_u') \in \bigl[pt_S(up_{u_x}), time(inv(up))\bigr)$.}\label{lemEQ:nosupdatexprime} \end{split} \end{equation} \else \begin{equation} \begin{split} &\text{no $S.update_p(x')$ operation $up_u'$ by $p$ with $x' \neq x$ satisfies} \\ &\text{$pt_S(up_u') \in \bigl[pt_S(up_{u_x}), time(inv(up))\bigr)$.}\label{lemEQ:nosupdatexprime} \end{split} \end{equation} \fi Since $up$ only performs a single $S.update_p(x)$ operation, and $up$ does not perform any $S.update_p(x')$ operations for any $x' \neq x$, by (\ref{lemEQ:nosupdatexprime}) and Observation~\ref{obs:interpintervalafter}, \ifspringer \begin{equation} \begin{split} &\text{the interpreted value of $S[p]$ is $x$ throughout} \\ &\text{$\bigl(pt_S(up_{u_x}), time(rsp(up))\bigr]$.}\label{lemmaEQatlin:interprangeupdate} \end{split} \end{equation} \else \begin{equation} \text{the interpreted value of $S[p]$ is $x$ throughout $\bigl(pt_S(up_{u_x}), time(rsp(up))\bigr]$.}\label{lemmaEQatlin:interprangeupdate} \end{equation} \fi If $up_{u_x}$ is performed by $p$ during $up$, then (\ref{lemmaEQatlin:interprangeupdate}) is implied by the fact that $up$ only performs a single $S.update$ operation, along with Observation~\ref{obs:interpintervalafter}. Notice that, since processes perform operations sequentially, $pt_S(sc_s) < time(sc^{\ref{DRead2}})$. Thus, $pt_S(sc_s) < pt(up)$. By this, (\ref{lemEQ:ptsupuxleqptsscs}), and (\ref{lemmaEQatlin:interprangeupdate}) \begin{equation} \text{the interpreted value of $S[p]$ is $x$ at $pt(up)$.}\label{lemmaEQatlin:interpvalatpt} \end{equation} Since $sc$ linearizes at the time of its final $R.DRead()$ operation on line~\ref{DRead2}, and $sc$ returns a vector with $x$ in its $p$-th entry, \begin{equation} \text{$R[p] = x$ at $pt(sc) = pt(up)$.}\label{lemmaEQatlin:valueatpt} \end{equation} By (\ref{lemmaEQatlin:interpvalatpt}) and (\ref{lemmaEQatlin:valueatpt}) we obtain the claim in the lemma statement. \end{enumerate} \end{proof} \fi \begin{lemma}\label{updateexists} Let $sc \in \Gamma(T)$ be some $SLscan_q()$ operation by process $q$ such that $pt(sc) \neq \infty$, which returns $(x_1, x_2, \ldots , x_n)$. Then $x_p \neq \bot$ if and only if there exists some $SLupdate_p(x_p)$ operation $up \in \Gamma(T)$, for some $x_p \in D$, such that $pt(up) \leq pt(sc)$. \end{lemma} \iffull \begin{proof} Let $sc_s$ be the final $S.scan()$ operation performed by $sc$. Since $sc$ returns $(x_1, \ldots, x_n)$, \begin{gather} \text{$sc_s$ returns $(x_1, \ldots, x_n)$, and}\label{lem:upinscanreturns} \\ \text{$R[p] = x_p$ at $time(sc^{\ref{DRead2}}) = pt(sc)$.}\label{lem:upindreadreturns} \end{gather} Additionally, since $pt(sc) \neq \infty$ by the lemma assumption, and $pt(sc) = time(sc^{\ref{DRead2}})$ by \ref{ptr1}, $sc_s$ is complete in $T$. Using this, along with the fact that $pt_S(sc_s) \in \bigl[time(inv(sc_s)), time(rsp(sc_s))\bigr]$ by the definition of linearization point functions, we obtain \begin{equation} \text{$pt_S(sc_s) \neq \infty$.}\label{lem:updateexistsptscsneqinfty} \end{equation} By (\ref{linptfunctions:in}) and (\ref{lem:updateexistsptscsneqinfty}), \begin{equation} \text{$sc_s \in L$.}\label{lem:updatescsinl} \end{equation} Suppose $x_p \neq \bot$ for some process $p$. Then by (\ref{lem:upinscanreturns}), (\ref{lem:updatescsinl}), and the sequential specification of snapshot objects (along with the fact that $L$ is a linearization of $\Gamma(T|S)$), there must exist an $S.update_p(x_p)$ operation $up_u$ by $p$ such that $up_u \xrightarrow{L} sc_s$. By this and (\ref{linptfunction:prec}), \begin{equation} \text{$pt(up_u) \leq pt(sc_s)$.}\label{lem:updateupuleqscs} \end{equation} Let $up_u$ be invoked by the $SLupdate_p(x_p)$ operation $up$. Since $up$ is invoked before $pt(sc)$, $pt(up) \leq pt(sc)$ by Lemma~\ref{lemma:scanforcesuptolin}. Now suppose $x_p = \bot$. To derive a contradiction, suppose that some $SLupdate_p(x)$ operation $up$ linearizes at or before $pt(sc)$, for some $x \in D$ such that $x \neq \bot$. That is, \begin{equation} \text{$pt(up) \leq pt(sc)$.}\label{lem:upineq1} \end{equation} By Lemma~\ref{lemmaEQatlin}, \begin{gather} \text{the interpreted value of $S[p]$ at $pt(up)$ is $x$, and}\label{lem:upinInterp} \\ \text{$R[p] = x$ at $pt(up)$.}\label{lem:upinRcontainsatlin} \end{gather} By (\ref{lem:upindreadreturns}) and our assumption that $x_p = \bot$, $R[p] = \bot$ at $pt(sc)$. This along with (\ref{lem:upineq1}) and (\ref{lem:upinRcontainsatlin}) implies that there must exist an $R.DWrite_q(X)$ operation $dw$ by some process $q$ with $X[p] = \bot$, such that \begin{equation} \text{$pt(up) < time(dw) \leq pt(sc)$.}\label{lem:upinBetween} \\ \end{equation} By (\ref{lem:upinBetween}) and Lemma~\ref{lemma:eanowrite}, \begin{equation} pt(up) < time(dw) < time(sc^{\ref{DRead1}}).\label{lem:upinBeforeRead} \end{equation} By (\ref{lem:upinInterp}) and the definition of interpreted value, there exists an $S.update_p(x)$ operation $up_u$ by $p$ such that \begin{equation} \text{$pt_S(up_u) < pt(up)$.}\label{lem:upinptupultptup} \end{equation} Using (\ref{lem:upinBeforeRead}), (\ref{lem:upinptupultptup}), along with the fact that $pt_S(sc_s) \in \bigl[time(inv(sc_s)), time(rsp(sc_s))\bigr]$ by the definition of linearization point functions, we obtain \begin{equation} \text{$pt_S(up_u) < pt_S(sc_s)$.}\label{lem:upuhappensbeforescs} \end{equation} By (\ref{lem:upuhappensbeforescs}) and the contrapositive of (\ref{linptfunction:prec}), $up_u \xrightarrow{L} sc_s$. Since there are no $S.update_q(\bot)$ operations for any process $q$ by assumption, $up_u \xrightarrow{L} sc_s$ implies that $sc_s$ returns some vector with $x' \neq \bot$ in its $p$-th entry. This along with our assumption that $x_p = \bot$ contradicts (\ref{lem:upinscanreturns}). \end{proof} \fi \ifea We now show that ordering operations in $T$ by their respective $pt$ values results in a valid sequential history. We accomplish this by showing that, for any complete $SLscan$ operation $sc$, each component of the vector returned by $sc$ contains the value written by the $SLupdate$ operation that linearized most recently (relative to $pt(sc)$). \fi \begin{lemma} \label{validity} Let $sc$ be some complete $SLscan_q()$ operation in $T$ by process $q$ that returns $(x_1, \ldots , x_n)$, and suppose $x_p \neq \bot$ for some process $p$. Then there is some $SLupdate_p(x_p)$ operation $up_{x_p}$ such that $pt(up_{x_p}) \leq pt(sc)$, and there is no $SLupdate_p(x)$ operation $up_x$ such that $pt(up_{x_p}) < pt(up_x) \leq pt(sc)$, for any $x \in D$. \end{lemma} \begin{proof} Let $up_{x_p}$ be the last $SLupdate_p(x_p)$ operation by $p$ that linearizes at or before $pt(sc)$ (Lemma~\ref{updateexists} guarantees that such an operation exists). To derive a contradiction, suppose that some $SLupdate_p(x)$ operation by $p$ with $x \neq x_p$ exists, which linearizes in the interval $\bigl(pt(up_{x_p}), pt(sc)\bigr]$. Let $up_x$ be the latest such operation. So $pt(up_{x_p}) < pt(up_x) \leq pt(sc)$. Additionally, since $sc$ returns a vector with $x_p$ in its $p$-th entry, and $up_x$ writes $x \neq x_p$, $up_x$ does not linearize at $pt(sc)$ by \ref{ptr1} and \ref{ptr2} (note that at most a single $SLscan$ operation may linearize at any step, since each $SLscan$ linearizes at one of its own steps by \ref{ptr1}). Hence, \begin{equation} pt(up_{x_p}) < pt(up_x) < pt(sc).\label{lemval:ineq} \end{equation} By Lemma~\ref{lemmaEQatlin}, \begin{gather} \text{the interpreted value of $S[p]$ is $x$ at $pt(up_x)$, and}\label{lemval:interp} \\ \text{$R[p] = x$ at $pt(up_x)$.}\label{lemval:register} \end{gather} Let $sc_\ell$ be the final $S.scan()$ operation performed by $sc$. Since processes perform operations sequentially, and $pt_S(sc_\ell) \in \bigl[time(inv(sc_\ell)), time(rsp(sc_\ell))\bigr]$ by definition of linearization point functions, \begin{equation} time(sc^{\ref{DRead1}}) < pt_S(sc_\ell) < time(sc^{\ref{DRead2}}).\label{lemval:timeseq} \end{equation} There are two cases: \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=(\roman*)] \item Operation $up_x$ linearizes after $sc_\ell$. That is, \begin{equation} pt(up_x) > pt_S(sc_\ell).\label{lemval:afterscan} \end{equation} By \ref{ptr1}, \begin{equation} pt(sc) = time(sc^{\ref{DRead2}}).\label{lemval:linatread} \end{equation} By (\ref{lemval:timeseq}) and (\ref{lemval:afterscan}), $time(sc^{\ref{DRead1}}) < pt(up_x)$. By (\ref{lemval:ineq}) and (\ref{lemval:linatread}), $pt(up_x) < time(sc^{\ref{DRead2}})$. Hence, \begin{equation} time(sc^{\ref{DRead1}}) < pt(up_x) < time(sc^{\ref{DRead2}}).\label{lemval:upindanger} \end{equation} By (\ref{lemval:register}) and the fact that $sc^{\ref{DRead2}}$ returns a vector with $x_p$ in its $p$-th entry, there is an $R.DWrite(X)$ operation $dw$, with $X[p] = x_p$, such that \begin{equation} pt(up_x) < time(dw) < time(sc^{\ref{DRead2}}).\label{lemval:dwrite} \end{equation} But by (\ref{lemval:upindanger}) and (\ref{lemval:dwrite}), \ifspringer \begin{equation*} \text{$time(dw) \in \bigl(time(sc^{\ref{DRead1}}), time(sc^{\ref{DRead2}})\bigr)$,} \end{equation*} \else $time(dw) \in \bigl(time(sc^{\ref{DRead1}}), time(sc^{\ref{DRead2}})\bigr)$, \fi which contradicts Lemma~\ref{lemma:eanowrite}. \item Operation $up_x$ linearizes not after $sc_\ell$. That is, \begin{equation} pt(up_x) \leq pt_S(sc_\ell).\label{lemval:beforescan} \end{equation} By (\ref{lemval:interp}) and the definition of interpreted values, there must exist an $S.update_p(x)$ operation $up_{u_x}$ by $p$ such that \ifspringer \begin{gather} \text{$pt_S(up_{u_x}) < pt(up_x)$, and}\label{lemval:ptupuxltptupx} \\ \begin{split} &\text{there is no $S.update_p(x')$ operation $up_{u_x}'$ by $p$} \\ &\text{with $x' \neq x$ and} \\ &\text{$pt_S(up_{u_x}) < pt_S(up_{u_x}') \leq pt(up_x)$.}\label{lemval:theredoesnotexistan} \end{split} \end{gather} \else \begin{gather} \text{$pt_S(up_{u_x}) < pt(up_x)$, and}\label{lemval:ptupuxltptupx} \\ \begin{split} &\text{there is no $S.update_p(x')$ operation $up_{u_x}'$ by $p$ with $x' \neq x$ and} \\ &\text{$pt_S(up_{u_x}) < pt_S(up_{u_x}') \leq pt(up_x)$.}\label{lemval:theredoesnotexistan} \end{split} \end{gather} \fi By (\ref{lemval:beforescan}) and (\ref{lemval:ptupuxltptupx}), $pt_S(up_{u_x}) < pt_S(sc_\ell)$. Then by contrapositive of (\ref{linptfunction:prec}), \begin{equation} \text{$up_{u_x} \xrightarrow{L} sc_\ell$.}\label{lemval:upuxbeforescell} \end{equation} Since $sc$ returns a vector with $x_p \neq x$ in its $p$-th entry, $sc_\ell$ must also return a vector with $x_p \neq x$ in its $p$-th entry. By this, (\ref{lemval:upuxbeforescell}), the fact that $L$ is a linearization of $\Gamma(T|S)$, and the sequential specification of the snapshot type, there must exist an $S.update_p(x_p)$ operation $up_{u_p}$ by $p$ such that \begin{equation} \text{$up_{u_x} \xrightarrow{L} up_{u_p} \xrightarrow{L} sc_\ell$.}\label{lemval:upuxbeforeupupbeforesc} \end{equation} By (\ref{linptfunction:prec}) and (\ref{lemval:upuxbeforeupupbeforesc}), \begin{gather} \text{$pt_S(up_{u_x}) \leq pt_S(up_{u_p})$, and}\label{lemval:ptsupuxleqptsupup} \\ \text{$pt_S(up_{u_p}) \leq pt_S(sc_\ell)$.}\label{lemval:ptsupupleqptsscell} \end{gather} Note that by definition of linearization point functions, \begin{gather} \small \text{$pt_S(up_{u_x}) \in \bigl[time(inv(up_{u_x})), time(rsp(up_{u_x}))\bigr]$,}\label{lemval:ptsupuxininterval} \\ \small \text{$pt_S(up_{u_p}) \in \bigl[time(inv(up_{u_p})), time(rsp(up_{u_p}))\bigr]$.}\label{lemval:ptsupupininterval} \end{gather} By (\ref{lemval:ptsupuxininterval}), (\ref{lemval:ptsupupininterval}), and the fact that both $up_{u_x}$ and $up_{u_p}$ are performed by $p$, $pt_S(up_{u_x}) < pt_S(up_{u_p})$. By this and (\ref{lemval:theredoesnotexistan}), \begin{equation} \text{$pt(up_x) < pt_S(up_{u_p})$.}\label{ptupxltptupup} \end{equation} Due to (\ref{lemval:ineq}) and the fact that $up_{x_p}$ and $up_x$ are performed by $p$, the $S.update_p(x_p)$ operation by $up_{x_p}$ linearizes before the invocation of $up_x$. This along with (\ref{ptupxltptupup}) implies that $up_{u_p}$ is performed during some $SLupdate_p(x_p)$ operation $up_{x_p}'$ by $p$ such that $up_{x_p}' \neq up_{x_p}$. Then by Lemma~\ref{lemma:scanforcesuptolin}, \begin{equation} \text{$pt(up_{x_p}') \leq pt(sc)$.}\label{ptupxpLSKDJFSDLKFJlksdjf} \end{equation} Additionally, since $up_{x_p}$ and $up_{x_p}'$ are both performed by $p$, they are performed in sequence. This along with (\ref{ptupxpLSKDJFSDLKFJlksdjf}) contradicts the fact that $up_{x_p}$ is the final $SLupdate_p(x_p)$ operation by $p$ that linearizes not after $pt(sc)$. \end{enumerate} \end{proof} \ifea Together, Lemma~\ref{slss:ptinmethod} and Lemma~\ref{validity} imply the following: \fi \begin{lemma} \label{slss:linearizable} Algorithm~\ref{slss} is linearizable. \end{lemma} \iffull \begin{proof} Lemma~\ref{slss:ptinmethod} ensures that $f$ preserves the happens-before order of the interpreted history $\Gamma (T)$. Lemma~\ref{validity} ensures that Algorithm~\ref{slss} satisfies the sequential specification of a snapshot object, and therefore $f(T)$ is a valid sequential history. Thus, $f(T)$ is a linearization of the interpreted history $\Gamma (T)$. \end{proof} \fi \ifea We also obtain the following through a simple argument, which we omit here: \fi \begin{lemma} \label{slss:prefpres} The function $f$ is prefix-preserving. \end{lemma} \iffull \begin{proof} Consider each time $t$ of $T$, and some operation $op \in \Gamma (T)$ by $p$. Then $pt(op) = t$ if \begin{enumerate}[labelindent=0pt,labelwidth=\widthof{\ref{def:interp2}},itemindent=1em,leftmargin=!,label=(\roman*)] \item operation $op$ is some $SLscan_p()$ operation and $op^{\ref{DRead2}}$ happens at $t$ (this case follows from \ref{ptr1}), or \item operation $op$ is some $SLupdate_{p}(x_p)$ operation for some value $x_p \in D$, and $t$ is the first point in time not before $time(inv(op))$ that satisfies $t = time(sc^{\ref{DRead2}})$ for some $SLscan()$ operation $sc$, and $sc^{\ref{DRead2}}$ returns a vector whose $p$-th entry contains $x_p$ (this case follows from both \ref{ptr1} and \ref{ptr2}), or \item operation $op$ is some $SLupdate_p(x_p)$ operation for some value $x_p \in D$ that did not linearize at any step prior to $t$, and $op^{\ref{SLUDWrite}}$ happens at $t$ (this case follows from \ref{ptr2}). \end{enumerate} Thus, at step $t$ it is entirely determined which operations linearize at $t$. That is, for any operation $op \in \Gamma(T)$, whether $pt(op) = t$ or not can be decided soley based on previous steps (i.e. steps earlier than $t$) in $T$. Additionally, once it is determined that $pt(op) = t$, $pt(op)$ does not change with any future step (i.e. steps later than $t$) of $T$. Along with the fact that processes perform operations sequentially, Observation~\ref{slss:ptinmethod} implies that for any time $t$ of $T$, the set of operations $Op$ that linearize at $t$ contains at most one operation by each process. Therefore, \ref{ptsorttiebreaker} imposes a total order on the operations in $Op$. Hence, if $T$ is a prefix of $T' \in \mathcal{T}$, then $f(T)$ is a prefix of $f(T')$. \end{proof} \fi \ifea By Lemma~\ref{slss:linearizable} and Lemma~\ref{slss:prefpres}, we obtain the following theorem: \fi \begin{theorem} \label{stronglin} The snapshot object implemented by Algorithm~\ref{slss} is strongly linearizable. \end{theorem} \iffull \begin{proof} Lemma~\ref{slss:linearizable} shows that the sequential history $f(T)$ is a linearization of $\Gamma (T)$. Furthermore, Lemma~\ref{slss:prefpres} proves that $f$ is prefix-preserving. Thus, $f$ is a strong linearization function for $\mathcal{T}$. \end{proof} \fi

\section{Line list} \begin{longtable}{c c c c c c c c c c} \label{tab:cluster}\\ \toprule Wavelength & Element & Exc. Pot. & $\log gf$ & \multicolumn{3}{c}{EW [\si{\milli\angstrom}]}\\ $[\si{\angstrom}]$ & & [eV] & & NGC\,6819-KIC5024327 & M67-EPIC211415732 & NGC\,188-085\\ \midrule \endhead \bottomrule \endfoot 5052.1350 & 6.0 & 7.685 & -1.433 & 12.0 & 10.3 & 11.1 \\ 6154.2170 & 11.0 & 2.102 & -1.600 & 81.5 & 82.1 & 92.7 \\ 6160.7420 & 11.0 & 2.104 & -1.260 & 105.4 & 107.6 & 111.4 \\ 5711.0910 & 12.0 & 4.346 & -1.742 & 129.6 & 133.7 & 138.9 \\ 6318.7010 & 12.0 & 5.108 & -2.020 & 68.0 & 71.3 & 77.3 \\ 6319.2280 & 12.0 & 5.108 & -2.242 & 49.5 & 51.3 & 55.4 \\ 6319.4790 & 12.0 & 5.108 & -2.719 & 25.0 & 26.2 & 29.5 \\ 6696.0110 & 13.0 & 3.143 & -1.562 & 76.9 & 78.7 & 89.9 \\ 6698.6440 & 13.0 & 3.143 & -1.830 & 54.0 & 55.0 & 65.4 \\ 5517.5420 & 14.0 & 5.082 & -2.554 & 22.5 & 24.5 & 24.7 \\ 5645.6010 & 14.0 & 4.929 & -2.120 & 56.9 & 54.7 & 58.7 \\ 5665.5710 & 14.0 & 4.920 & -2.040 & 66.2 & 65.3 & 68.4 \\ 5684.4830 & 14.0 & 4.954 & -1.700 & 78.7 & 74.0 & 73.9 \\ 5690.4270 & 14.0 & 4.929 & -1.840 & 66.1 & 65.7 & 65.3 \\ 5701.1040 & 14.0 & 4.929 & -2.080 & 53.7 & 56.2 & 55.6 \\ 5793.0610 & 14.0 & 4.929 & -2.060 & 62.4 & 62.9 & 65.4 \\ 6125.0010 & 14.0 & 5.613 & -1.580 & 44.8 & 43.7 & 43.7 \\ 6142.4760 & 14.0 & 5.619 & -1.530 & 41.5 & 40.5 & 42.1 \\ 6145.0050 & 14.0 & 5.616 & -1.450 & 45.6 & 44.5 & 46.1 \\ 6243.8070 & 14.0 & 5.616 & -1.270 & 59.2 & 53.6 & 60.2 \\ 6244.4610 & 14.0 & 5.616 & -1.340 & 52.8 & 56.1 & 64.2 \\ 6721.8170 & 14.0 & 5.861 & -1.090 & 62.7 & 58.2 & 42.5 \\ 6741.5880 & 14.0 & 5.984 & -1.750 & 24.0 & 23.0 & - \\ 6045.9620 & 16.0 & 7.867 & -1.820 & 20.0 & 17.8 & 19.5 \\ 6743.5720 & 16.0 & 7.866 & -0.920 & - & 10.5 & - \\ 5260.3920 & 20.0 & 2.521 & -1.820 & 64.4 & 69.5 & 69.7 \\ 5512.9870 & 20.0 & 2.932 & -0.300 & 109.6 & 114.3 & 116.2 \\ 5867.5590 & 20.0 & 2.932 & -1.630 & 54.2 & 58.2 & 61.8 \\ 6161.2750 & 20.0 & 2.523 & -1.293 & 114.0 & 113.1 & - \\ 6166.4290 & 20.0 & 2.521 & -1.136 & 111.1 & 109.6 & - \\ 6455.5940 & 20.0 & 2.523 & -1.320 & 107.1 & 102.9 & 111.2 \\ 4913.6340 & 22.0 & 1.873 & 0.161 & 92.4 & 95.8 & 101.1 \\ 5062.1150 & 22.0 & 2.160 & -0.420 & 47.9 & 59.1 & 62.9 \\ 5113.4500 & 22.0 & 1.443 & -0.820 & 77.3 & 79.2 & 84.9 \\ 5145.4740 & 22.0 & 1.460 & -0.600 & 83.9 & 91.8 & 99.4 \\ 5219.7100 & 22.0 & 0.021 & -2.292 & 99.7 & 105.4 & 115.1 \\ 5282.3990 & 22.0 & 1.053 & -1.640 & 70.3 & 75.4 & 85.5 \\ 5295.7840 & 22.0 & 1.066 & -1.680 & 65.4 & 70.2 & 77.5 \\ 5490.1530 & 22.0 & 1.460 & -0.950 & 78.3 & 80.7 & 88.3 \\ 5648.5680 & 22.0 & 2.495 & -0.350 & 44.2 & 44.4 & 54.3 \\ 5739.4730 & 22.0 & 2.249 & -0.724 & 38.0 & 41.6 & 49.2 \\ 5922.1090 & 22.0 & 1.046 & -1.450 & 89.1 & 91.5 & 105.4 \\ 5965.8060 & 22.0 & 1.879 & -0.540 & - & - & 109.1 \\ 6091.1710 & 22.0 & 2.267 & -0.430 & 61.9 & 63.3 & 72.8 \\ 6126.2100 & 22.0 & 1.066 & -1.360 & 89.4 & 92.9 & 104.5 \\ 6258.0990 & 22.0 & 1.443 & -0.340 & 106.3 & 117.6 & - \\ 6554.2140 & 22.0 & 1.443 & -1.210 & 79.9 & 86.5 & 94.8 \\ 5211.5410 & 22.1 & 2.590 & -1.456 & 50.0 & 49.1 & 45.0 \\ 5336.7950 & 22.1 & 1.582 & -1.600 & 104.4 & 103.9 & 106.9 \\ 5418.7740 & 22.1 & 1.582 & -2.080 & 80.2 & 83.8 & 81.6 \\ 5490.7010 & 22.1 & 1.566 & -2.730 & 54.7 & 55.2 & - \\ 5670.8510 & 23.0 & 1.081 & -0.578 & 98.4 & 104.4 & 119.1 \\ 4801.0440 & 24.0 & 3.121 & -0.140 & 84.6 & 85.7 & 89.4 \\ 4936.3560 & 24.0 & 3.113 & -0.280 & 78.8 & 82.6 & 87.4 \\ 4964.9460 & 24.0 & 0.941 & -2.490 & 94.1 & 95.8 & 103.1 \\ 5214.1410 & 24.0 & 3.369 & -0.753 & 37.7 & 33.8 & 39.5 \\ 5238.9700 & 24.0 & 2.709 & -1.410 & 44.9 & 45.3 & 52.3 \\ 5272.0110 & 24.0 & 3.449 & -0.482 & 51.7 & 58.2 & 60.8 \\ 5287.1810 & 24.0 & 3.438 & -0.957 & 33.1 & 34.0 & 37.1 \\ 5300.7580 & 24.0 & 0.983 & -2.120 & 117.7 & 116.8 & - \\ 5304.1830 & 24.0 & 3.463 & -0.730 & 41.1 & 39.1 & 45.9 \\ 5318.7770 & 24.0 & 3.438 & -0.720 & 42.5 & 41.9 & - \\ 5329.1530 & 24.0 & 2.913 & -0.194 & 113.3 & 113.8 & - \\ 5628.6390 & 24.0 & 3.422 & -0.790 & 41.9 & 44.0 & 46.4 \\ 5783.0650 & 24.0 & 3.323 & -0.450 & 68.5 & 67.4 & 74.2 \\ 5783.8690 & 24.0 & 3.322 & -0.335 & 94.8 & 95.6 & 102.2 \\ 6330.0830 & 24.0 & 0.941 & -2.880 & 90.1 & 95.8 & 108.0 \\ 6661.0550 & 24.0 & 4.193 & -0.365 & 31.3 & 29.9 & 36.7 \\ 5237.3200 & 24.1 & 4.073 & -1.155 & 64.1 & 63.0 & 62.3 \\ 5246.7610 & 24.1 & 3.713 & -2.436 & 27.4 & 26.2 & - \\ 5058.5100 & 26.0 & 3.642 & -2.750 & 32.0 & 36.6 & 41.9 \\ 5180.0650 & 26.0 & 4.473 & -1.120 & 84.7 & 82.5 & 87.6 \\ 5196.0670 & 26.0 & 4.256 & -0.590 & 92.5 & 97.6 & 100.5 \\ 5197.9470 & 26.0 & 4.301 & -1.480 & 55.8 & 59.4 & 58.3 \\ 5223.1930 & 26.0 & 3.635 & -2.243 & 58.4 & 58.9 & 64.4 \\ 5243.7830 & 26.0 & 4.256 & -0.930 & 85.0 & 86.8 & 89.6 \\ 5253.0310 & 26.0 & 2.279 & -3.849 & 61.7 & 65.8 & 70.1 \\ 5288.5290 & 26.0 & 3.695 & -1.550 & 94.4 & 94.7 & 97.7 \\ 5294.5560 & 26.0 & 3.640 & -2.680 & 42.0 & 43.0 & 48.4 \\ 5295.3190 & 26.0 & 4.415 & -1.530 & 54.4 & 53.5 & 55.3 \\ 5321.1170 & 26.0 & 4.435 & -1.261 & 68.1 & 66.4 & 71.0 \\ 5326.1570 & 26.0 & 3.573 & -2.210 & 77.1 & 77.5 & 84.5 \\ 5386.3370 & 26.0 & 4.154 & -1.700 & 60.5 & 61.3 & 64.0 \\ 5401.2970 & 26.0 & 4.320 & -1.720 & 60.7 & 59.4 & 70.3 \\ 5441.3440 & 26.0 & 4.312 & -1.590 & 58.2 & 60.6 & 62.4 \\ 5460.8790 & 26.0 & 3.071 & -3.530 & 30.6 & 34.3 & 38.4 \\ 5461.5500 & 26.0 & 4.445 & -1.612 & 51.7 & 53.6 & 56.6 \\ 5464.2810 & 26.0 & 4.143 & -1.582 & 70.4 & 72.7 & 71.4 \\ 5470.0970 & 26.0 & 4.445 & -1.610 & 49.5 & 52.0 & 55.3 \\ 5494.4680 & 26.0 & 4.076 & -1.960 & 59.3 & 61.8 & 64.9 \\ 5522.4500 & 26.0 & 4.209 & -1.400 & 71.2 & 71.7 & 72.2 \\ 5525.5520 & 26.0 & 4.230 & -1.184 & 87.0 & 86.7 & 84.2 \\ 5538.5200 & 26.0 & 4.217 & -1.559 & 60.8 & 68.9 & 72.8 \\ 5539.2820 & 26.0 & 3.642 & -2.610 & 43.8 & 50.0 & 57.0 \\ 5546.5140 & 26.0 & 4.371 & -1.080 & 82.8 & 82.0 & 87.8 \\ 5552.6990 & 26.0 & 4.956 & -1.800 & 18.2 & 16.8 & 18.0 \\ 5560.2140 & 26.0 & 4.435 & -1.000 & 74.8 & 76.1 & 74.0 \\ 5587.5800 & 26.0 & 4.143 & -1.650 & 67.6 & 69.7 & 71.9 \\ 5608.9850 & 26.0 & 4.209 & -2.360 & 34.8 & 33.9 & 38.2 \\ 5611.3590 & 26.0 & 3.635 & -2.960 & 34.0 & 34.8 & 36.3 \\ 5618.6370 & 26.0 & 4.209 & -1.260 & 79.2 & 77.6 & 81.4 \\ 5619.6020 & 26.0 & 4.386 & -1.480 & 66.5 & 63.7 & 71.0 \\ 5635.8270 & 26.0 & 4.256 & -1.560 & 66.1 & 65.9 & 69.6 \\ 5636.7020 & 26.0 & 3.640 & -2.530 & 51.8 & 55.7 & 60.0 \\ 5651.4720 & 26.0 & 4.473 & -1.780 & 41.2 & 42.6 & 44.4 \\ 5652.3160 & 26.0 & 4.260 & -1.760 & 53.7 & 54.4 & 59.6 \\ 5677.6910 & 26.0 & 4.103 & -2.680 & 23.3 & 22.3 & 28.1 \\ 5679.0260 & 26.0 & 4.652 & -0.680 & 81.2 & 79.7 & 81.1 \\ 5680.2340 & 26.0 & 4.186 & -2.370 & 35.0 & 33.3 & 39.3 \\ 5705.4650 & 26.0 & 4.301 & -1.455 & 69.5 & 72.1 & 74.1 \\ 5717.8300 & 26.0 & 4.284 & -0.990 & 94.3 & 93.9 & 98.0 \\ 5731.7650 & 26.0 & 4.256 & -1.060 & 89.7 & 90.8 & 92.3 \\ 5741.8480 & 26.0 & 4.256 & -1.640 & 60.2 & 62.3 & 67.0 \\ 5742.9520 & 26.0 & 4.178 & -2.320 & 35.8 & 36.1 & 41.9 \\ 5752.0330 & 26.0 & 4.548 & -0.867 & 79.1 & 81.1 & 82.2 \\ 5760.3490 & 26.0 & 3.642 & -2.450 & 60.4 & 60.2 & 58.4 \\ 5775.0790 & 26.0 & 4.220 & -1.040 & 89.9 & 92.4 & 96.1 \\ 5853.1480 & 26.0 & 1.485 & -5.170 & 53.6 & 56.6 & 63.1 \\ 5855.0770 & 26.0 & 4.608 & -1.540 & 44.7 & 47.0 & 46.4 \\ 5856.0840 & 26.0 & 4.294 & -1.550 & 65.3 & 65.7 & 67.2 \\ 5859.5860 & 26.0 & 4.548 & -0.388 & 99.3 & 99.3 & 100. \\ 5861.1040 & 26.0 & 4.283 & -2.400 & 25.7 & 26.0 & 28.2 \\ 5881.2700 & 26.0 & 4.608 & -1.770 & 40.0 & 40.0 & 42.6 \\ 5927.7860 & 26.0 & 4.652 & -1.020 & 66.7 & 68.3 & 67.8 \\ 5929.6720 & 26.0 & 4.548 & -1.170 & 68.5 & 69.4 & 70.3 \\ 5983.6800 & 26.0 & 4.548 & -0.558 & 97.8 & 97.2 & 95.7 \\ 6007.9590 & 26.0 & 4.652 & -0.620 & 87.7 & 87.1 & 89.2 \\ 6027.0510 & 26.0 & 4.076 & -1.020 & 99.1 & 99.9 & 103. \\ 6056.0000 & 26.0 & 4.733 & -0.340 & 97.0 & 95.0 & 99.0 \\ 6079.0050 & 26.0 & 4.652 & -0.960 & 71.4 & 75.3 & 73.6 \\ 6082.7020 & 26.0 & 2.223 & -3.550 & 93.8 & 94.2 & 98.9 \\ 6093.6370 & 26.0 & 4.608 & -1.340 & 57.9 & 57.2 & 59.3 \\ 6094.3630 & 26.0 & 4.652 & -1.610 & 44.2 & 43.3 & 45.6 \\ 6096.6570 & 26.0 & 3.984 & -1.810 & 74.1 & 75.3 & 75.1 \\ 6098.2460 & 26.0 & 4.558 & -1.800 & 42.8 & 42.0 & 43.3 \\ 6120.2410 & 26.0 & 0.915 & -5.930 & 51.1 & 54.2 & 64.5 \\ 6159.3600 & 26.0 & 4.608 & -1.890 & 34.9 & 34.8 & 38.4 \\ 6165.3520 & 26.0 & 4.143 & -1.430 & 81.2 & 78.2 & 83.0 \\ 6187.3840 & 26.0 & 2.831 & -4.190 & 25.8 & 26.0 & 29.1 \\ 6187.9790 & 26.0 & 3.943 & -1.660 & 87.2 & 85.0 & 87.4 \\ 6220.7740 & 26.0 & 3.881 & -2.370 & 52.8 & 53.8 & 57.4 \\ 6226.7240 & 26.0 & 3.883 & -2.110 & 61.8 & 64.0 & 64.8 \\ 6271.2760 & 26.0 & 3.332 & -2.763 & 63.5 & 65.1 & 68.3 \\ 6311.4890 & 26.0 & 2.831 & -3.150 & 74.8 & 73.1 & 80.0 \\ 6315.8000 & 26.0 & 4.076 & -1.650 & 73.4 & 76.5 & 80.1 \\ 6330.8360 & 26.0 & 4.733 & -1.170 & 59.7 & 58.9 & 60.5 \\ 6380.7400 & 26.0 & 4.186 & -1.280 & 89.3 & 89.7 & 99.1 \\ 6392.5260 & 26.0 & 2.279 & -3.956 & 67.2 & 68.0 & 76.0 \\ 6436.3790 & 26.0 & 4.186 & -2.410 & 33.7 & 33.4 & 35.0 \\ 6496.4590 & 26.0 & 4.795 & -0.520 & 90.1 & 91.0 & 94.0 \\ 6556.7730 & 26.0 & 4.795 & -1.705 & 33.5 & 38.1 & 36.3 \\ 6581.1840 & 26.0 & 1.485 & -4.750 & 91.6 & 91.2 & - \\ 6591.2930 & 26.0 & 4.593 & -2.030 & 27.3 & 24.9 & 30.6 \\ 6608.0060 & 26.0 & 2.279 & -3.990 & 68.3 & 70.2 & 73.8 \\ 6624.9980 & 26.0 & 1.011 & -5.330 & 97.3 & 93.7 & - \\ 6627.5340 & 26.0 & 4.548 & -1.500 & 58.0 & 58.8 & 64.0 \\ 6699.1240 & 26.0 & 4.593 & -2.170 & 26.0 & 22.7 & 30.7 \\ 6703.5480 & 26.0 & 2.758 & -3.010 & 90.2 & 90.3 & 96.0 \\ 6713.7220 & 26.0 & 4.795 & -1.440 & 47.9 & 44.6 & 44.4 \\ 6725.3370 & 26.0 & 4.103 & -2.220 & 44.4 & 45.1 & 49.5 \\ 6726.6500 & 26.0 & 4.607 & -1.010 & 75.2 & 74.5 & 76.7 \\ 6733.1340 & 26.0 & 4.638 & -1.440 & 54.5 & 54.4 & 56.0 \\ 6739.5030 & 26.0 & 1.557 & -4.934 & 67.3 & 70.3 & 77.8 \\ 6745.9470 & 26.0 & 4.076 & -2.730 & 23.3 & 24.4 & 27.6 \\ 6752.7050 & 26.0 & 4.638 & -1.244 & 66.3 & 69.6 & 73.8 \\ 6786.8420 & 26.0 & 4.191 & -1.920 & 58.7 & 57.6 & 59.0 \\ 5197.5830 & 26.1 & 3.230 & -2.230 & 86.9 & 90.3 & 81.9 \\ 5234.6390 & 26.1 & 3.221 & -2.180 & 92.2 & 88.3 & 86.1 \\ 5264.8120 & 26.1 & 3.230 & -3.130 & 55.7 & 61.3 & 52.9 \\ 5325.5630 & 26.1 & 3.221 & -3.210 & 54.7 & 54.4 & 53.4 \\ 5425.2550 & 26.1 & 3.199 & -3.290 & 51.0 & 52.5 & 47.0 \\ 5991.3590 & 26.1 & 3.153 & -3.590 & 47.8 & 47.4 & 47.2 \\ 6084.1030 & 26.1 & 3.199 & -3.800 & 35.0 & 35.2 & 34.4 \\ 6149.2380 & 26.1 & 3.889 & -2.750 & 43.9 & 43.7 & 42.5 \\ 6247.5480 & 26.1 & 3.892 & -2.350 & 54.4 & 55.7 & 52.7 \\ 6369.4500 & 26.1 & 2.891 & -4.180 & 32.2 & 32.9 & 28.9 \\ 6432.6670 & 26.1 & 2.891 & -3.630 & 57.9 & 55.9 & 52.3 \\ 6456.3690 & 26.1 & 3.903 & -2.080 & 70.1 & 70.4 & 63.1 \\ 4935.8440 & 28.0 & 3.941 & -0.350 & 70.5 & 78.6 & 76.3 \\ 5010.9510 & 28.0 & 3.635 & -0.870 & 67.9 & 73.4 & 71.6 \\ 5094.4190 & 28.0 & 3.833 & -1.090 & 44.1 & 47.7 & 48.3 \\ 5102.9870 & 28.0 & 1.676 & -2.810 & 95.5 & 97.5 & 100.8 \\ 5155.1330 & 28.0 & 3.898 & -0.640 & 68.4 & 73.3 & 69.3 \\ 5197.1780 & 28.0 & 3.898 & -1.240 & 53.1 & 57.0 & 60.1 \\ 5468.1130 & 28.0 & 3.847 & -1.630 & 28.2 & 30.4 & 31.6 \\ 5578.7210 & 28.0 & 1.676 & -2.790 & 113.9 & 115.4 & - \\ 5589.3590 & 28.0 & 3.898 & -1.200 & 51.4 & 51.0 & 50.8 \\ 5643.0820 & 28.0 & 4.165 & -1.237 & 32.5 & 33.4 & 35.4 \\ 5748.3480 & 28.0 & 1.676 & -3.280 & 87.4 & 93.1 & 98.3 \\ 5760.8290 & 28.0 & 4.105 & -0.780 & 64.4 & 64.6 & 64.6 \\ 5805.2150 & 28.0 & 4.167 & -0.696 & 65.2 & 64.4 & 68.4 \\ 5996.7240 & 28.0 & 4.236 & -1.040 & 43.1 & 43.5 & 45.7 \\ 6007.3070 & 28.0 & 1.676 & -3.364 & 78.2 & 78.7 & 85.9 \\ 6086.2740 & 28.0 & 4.266 & -0.470 & 68.2 & 69.6 & 71.0 \\ 6111.0630 & 28.0 & 4.088 & -0.800 & 62.1 & 62.9 & 69.8 \\ 6128.9700 & 28.0 & 1.676 & -3.330 & 83.9 & 82.7 & 95.2 \\ 6130.1290 & 28.0 & 4.266 & -0.930 & 40.4 & 41.9 & 46.7 \\ 6176.8030 & 28.0 & 4.088 & -0.210 & 92.1 & 93.4 & 97.2 \\ 6177.2390 & 28.0 & 1.826 & -3.540 & 54.5 & 65.1 & 72.6 \\ 6204.5930 & 28.0 & 4.088 & -1.110 & 49.8 & 51.5 & 57.2 \\ 6223.9690 & 28.0 & 4.105 & -0.950 & 54.9 & 53.9 & 56.7 \\ 6322.1490 & 28.0 & 4.153 & -1.220 & 36.3 & 39.1 & 37.9 \\ 6327.5900 & 28.0 & 1.676 & -3.100 & 103.6 & 108.0 & 110.7 \\ 6378.2420 & 28.0 & 4.153 & -0.830 & 60.2 & 60.0 & 65.3 \\ 6482.7810 & 28.0 & 1.935 & -2.830 & 103.0 & 107.7 & 114.9 \\ 6586.2960 & 28.0 & 1.951 & -2.800 & 102.6 & 01.0 & 111.7 \\ 6598.5780 & 28.0 & 4.236 & -0.940 & 45.2 & 47.3 & 53.4 \\ 6635.0990 & 28.0 & 4.419 & -0.770 & 50.1 & 50.6 & 49.7 \\ 6772.2930 & 28.0 & 3.658 & -0.930 & 81.6 & 83.7 & 86.0 \\ 4722.1810 & 30.0 & 4.030 & -0.338 & 77.3 & 83.4 & 82.8 \\ 4810.5470 & 30.0 & 4.078 & -0.137 & 80.6 & 78.7 & 74.6 \\ 4883.6980 & 39.1 & 1.084 & 0.070 & 96.4 & 96.7 & 94.3 \\ 4900.1290 & 39.1 & 1.033 & -0.090 & 94.4 & 95.9 & 96.1 \\ 5728.8940 & 39.1 & 1.839 & -1.270 & 13.8 & 13.7 & 10.0 \\ \end{longtable} \section{Introduction} Several large spectroscopic surveys such as RAVE \citep{Steinmetz2006}, APOGEE \citep{Majewski2015}, the Gaia-ESO survey \citep[GES,][]{Gilmore2012,Randich2013} and GALAH \citep{DeSilva2015} are being carried out to better understand the structure, kinematics and evolution of stars and our Galaxy. Massive amounts of data are obtained every day that require a swift, precise, and accurate analysis in order to support the scientific goals of the aforementioned surveys. To achieve this, pipelines have been constructed that analyze the data in a homogeneous way, e.g. ASPCAP \citep{Perez2015} for the case of APOGEE. These pipelines are normally tested against {\it benchmark stars}: stars that have been observed and analyzed by more than one method and have extremely high quality data. In the case of atmospheric parameters, examples of benchmark stars can be targets that have either abundances determined to a high level of precision \citep[e.g.,][]{Jofre2014}, effective temperatures measured by interferometry \citep[e.g.,][]{Casagrande2014}, and ideally also an independent estimate of surface gravity. In the latter case, the advent of asteroseismology as a tool for Galactic archaeology has opened a new window of opportunities via its synergies with large spectroscopic surveys by providing precise measurements of $\log\,g$ for thousands of stars across the Milky Way \citep[see e.g.,][just to name a few examples]{Miglio2013,Casagrande2016,SilvaAguirre2018,Pinsonneault2018} Many different methods are available for spectroscopic analyses of optical stellar spectra, varying from fitting synthethic spectra to observed spectra to classical equivalent width methods. For each of these there are also different options for programs, where e.g. Spectroscopy Made Easy \citep[SME,][]{Valenti1996} is widely applied for synthetic fitting using a chi-square minimization algorithm and MOOG \citep{Sneden1973} is widely used for the classical equivalent width approach. It is well known that these different options do not always yield the same result and the extent of the differences can be significant. For a comparison of spectral synthesis methods, which we will not explore further here, see e.g. \citet{Lebzelter2012}. For a comparison of equivalent width studies in the Gaia-ESO framework, see e.g. \citet{Smiljanic2014}, where agreement between multiple determinations of atmospheric parameters for the same star are better than \SI{82}{K}, \SI{0.19}{dex} and \SI{0.10}{dex} for $\rm T_{eff}$, $\log g$ and $\rm [Fe/H]$, respectively. For larger comparisons of both spectral synthesis methods and equivalent width methods see e.g. \citet{Jofre2014,Hinkel2016} where more detailed discussions on this and efforts to understand the causes of variations between stellar abundance measurement techniques can be found. Both studies have a list of stellar spectra analyzed with different methods and with and without restrictions on stellar parameters and line list. \citet{Casamiquela2017} studied the differences between spectral synthesis and equivalent widths by analyzing data of red clump stars in several open clusters and found an offset between the two methods in metallicity of $0.07 \pm \SI{0.05}{dex}$. Moreover, the choice of absorption lines can highly affect the result. Even when choosing only lines that have the best measured atomic parameters and are not blended to any level of significance, strikingly different results in atmospheric parameters can be obtained, see e.g. \citet{Doyle2017} who find variations up to \SI{50}{K}. This paper also aims at highlighting this issue. To perform an accurate spectroscopic analysis, it is necessary to know the level of systematic uncertainties incurred when a particular selection of e.g. synthetic fitting method or equivalent width measurement program is made. This can be achieved by a detailed comparison of the results provided by these combinations when analyzing the same spectra, if additionally an empirical measurement of a stellar property exists. For example \citet{Smiljanic2014} and \citet{Casamiquela2017} used cluster membership as an independent constraint to evaluate the results. In this paper, we take one step further in this direction by not only including cluster studies but also asteroseismology in comparison with spectroscopic results obtained when varying one source of systematic uncertainty at the time. In this paper, we have chosen the method of measuring equivalent widths of individual absorption lines and requiring excitation and ionization equilibria to hold when performing a differential anlysis. We compare several combinations of line lists and programs to measure equivalent widths in order to understand the systematic uncertainties within the line by line spectroscopic analysis. We carry out a detailed fundamental parameter and abundance analysis of three targets, one in each of the three open clusters (NGC\,6819, M67 and NGC\,188), based on high-resolution and high signal-to-noise (S/N) spectroscopic data from FIES (FIbre-fed Echelle Spectrograph) at the Nordic Optical Telescope (NOT). The targets have been selected to be in the same evolutionary phase (helium-core-bruning) to make the analysis as homogeneous as possible. In the case of NGC\,6819 and M67 there is also asteroseismic data available from the \textit{Kepler} \citep{Borucki1997} and K2 missions \citep{Howell2014}. Asteroseismology provides $\log g$ values with much higher precision than what can normally be achieved with spectroscopy, which can greatly help constrain the spectroscopic analysis \citep[see e.g.][where asteroseismology has been used to calibrate the spectroscopic surface gravity by RAVE and APOGEE, respectively]{,Valentini2016,Pinsonneault2015}. It has however been shown that when doing a fully differential spectroscopic analysis of very high quality data, precision levels comparable to asteroseismology are achievable. \citet{Nissen2015} did a differential analysis of solar twins to the Sun with very high quality spectra, $R=115,000$ and S/N levels above 600, where an average uncertainty on the surface gravity of only \SI{0.012}{dex} is obtained. This work was also compared and found to be in excellent agreement with a similar analysis by \citet{Ramirez2014b} who achieved a surface gravity precision of \SI{0.019}{dex} for spectra of $R=83,000$ and S/N levels above 400. It is however important to note that this high level of precision is only achievable between stars of similar spectral type. We have chosen stars in open clusters, because they can be assumed to originate from the same molecular cloud and are therefore expected to have similar chemical composition and age. This also implies that by studying one confirmed member of a cluster, we get information about an entire population of stars. Open clusters have been the subject of extensive studies throughout the years, and therefore our results can be compared to literature values. This also has implications for other fields in astrophysics; clusters can be used as calibrators when studying galaxies, distances in the Universe and age scales for stars. In order to exploit this fully, we need precisely determined properties of cluster stars involving different observing techniques to secure the accuracy. The data used in our analysis for both NGC\,6819 and NGC\,188 is of higher quality, resolution and signal-to-noise (S/N), than previously used. To our knowledge, there is no high-resolution data (R>65,000) that also have S/N>100 for NGC\,188 in the literature \citep[see e.g][for previous studies of this cluster]{Randich2003,Friel2010,Casamiquela2017}. Especially, the higher quality data will allow us to better determine the metallicity of NGC\,6819, on which there still is not a full consensus in the literature even though it is an otherwise very well studied cluster by asteroseismology because it is in the \textsl{Kepler} field. Previous determinations of the metallicity have been done by e.g. \citet{Bragaglia2001} and \citet{Lee-Brown2015} who, respectively, analyzed three targets with $R \sim 40,000$ yielding [Fe/H] = $0.09 \pm $\SI{0.03}{dex} and 200 targets with $R \sim 13,000$ yielding [Fe/H] = $-0.02 \pm $\SI{0.02}{dex}. \section{Observations} \label{sec:obs} We have gathered data for confirmed members \citep{Hole2009,Yadav2008,Stetson2004} in the helium core-burning phase, one in each of the three open clusters; NGC\,6819, M67 and NGC\,188. M67 is a very well studied nearby solar-like cluster, which has also been observed with the K2 mission, and that target will serve as a benchmark in the analysis. All targets are seen to be in the helium-core-burning evolutionary phase from color-magnitude diagrams, see Fig.~\ref{fig:cmd}. Futhermore the two targets in M67 and NGC\,6819 are also confirmed by asteroseismology to be in the helium-core-burning phase \citep{Corsaro2012,Stello2016}. The observations and data reduction are presented and described in more detail in section 2 and Table A.1 of \citet{Slumstrup2017}. Briefly, the spectra were obtained during period 47 and 51 at the Nordic Optical Telescope (NOT) with the FIbre-fed Echelle Spectrograph (FIES). The covered wavelength range is \SI{3700}{\angstrom}-\SI{7300}{\angstrom}, with high resolution ($R=67,000$) and high S/N (above 100), which was estimated from the rms variation of the flux in a region around \SI{6150}{\angstrom} for each spectrum. The co-added spectrum for each star was normalized order by order using RAINBOW\footnote{\scriptsize \url{http://sites.google.com/site/vikingpowersoftware}}, which uses synthetic spectra with atmospheric parameters close to the expected for the target to guide the user to identify continuum points in the observed spectrum. These are then fitted with a spline function, which the spectrum is divided by to normalize it. After this careful normalization, the orders are merged and the spectrum is shifted to laboratory wavelength to secure the line identification in the further analysis. \section{Prior information} \label{sec:prior} To have a starting point for the spectroscopic analysis, we use photometry and asteroseismology to give first guesses on effective temperature, $T_\text{eff}$, surface gravity, $\log g$, and metallicity, [Fe/H]. \begin{figure*} \centering \includegraphics[width=.30\textwidth]{CMDngc6819.pdf} \includegraphics[width=.30\textwidth]{CMDm67.pdf} \includegraphics[width=.30\textwidth]{CMDngc188.pdf} \caption{From left to right: The CMDs for NGC\,6819 and M67 with photometry from \citet{Hole2009, Yadav2008} respectively and lastly a CMD for NGC\,188 with photometry from the \citet{Stetson2004} standard fields. The target star for each cluster is marked with a red star.} \label{fig:cmd} \end{figure*} First guesses of effective temperature for the three targets were calculated with the metallicity dependent color-temperature relations by \citet{Ramirez2005}, which are based on the infrared flux method. The optical photometry used is presented in Fig.~\ref{fig:cmd} and the infrared photometry is from the 2MASS catalog \citep{Skrutskie2006}. The reddening values \citep[presented in Table 1 of][]{Slumstrup2017} used for these calculations are from \citet{Rosvick1998,Taylor2007,Meibom2009} for NGC\,6819, M67 and NGC\,188 respectively. Results for each filter combination are presented in Table~\ref{tab:coltemp}. \begin{table}\small \centering \caption{\textsl{Temperatures from temperature-color calibrations.}} \begin{threeparttable} \begin{tabular}{l c c c c c c} \toprule Target & $B-V$ & $V-I$ & $V-K$ & $V-J$ & $V-H$ & avg\\ \midrule NGC6819 & 4749 & - & 4685 & 4659 & 4698 & 4698 $\pm$ 33\\ M67 & 4643 & 4736 & 4697 & 4763 & 4749 & 4718 $\pm$ 43\\ NGC188 & 4650 & 4610 & 4618 & 4651 & 4656 & 4637 $\pm$ 19\\ \bottomrule \end{tabular} \end{threeparttable} \label{tab:coltemp} \end{table} The initial guesses on the temperatures were taken as averages of the different filter combinations for each target (last column of Table~\ref{tab:coltemp}). The uncertainties on the photometric temperatures are only the scatter between the different color-temperature relations for each target and do not take into account the uncertainty in the relations themselves and should only be taken as a guide. With the frequency of maximum power, $\nu_\text{max}$ from asteroseismology and $T_\text{eff}$ from photometry, the surface gravity can be calculated using the scaling relation (\cite{Brown1991}, \cite{Kjeldsen1995}): \begin{align} \log g = \log \left( \left( \frac{\nu_\text{max}}{3100} \right) \cdot \left( \frac{T_\text{eff}}{5777} \right) ^{1/2} \right) + 4.44 \ . \label{eq:seis} \end{align} This relation is extrapolated from the Sun. Since we apply it here for giants, deviations should be expected, which have been quantified in the literature with, e.g. binary studies, parallaxes and comparisons to interferometry. Asteroseismic masses have been shown to be accurate to better than 8\% \citep{Stello2016,Miglio2016,Brogaard2017} and radius better than 4\% \citep{Huber2012,SilvaAguirre2012,White2013,Huber2017,SilvaAguirre2017,Sahlholdt2018}. Assuming a stellar mass of \SI{1.2}{M_\odot} and radius of \SI{10}{R_\odot}, this translates to an accuracy on $\log g$ better than \SI{0.04}{dex}. Even with only three months of data for the M67 target with K2, the precision is still better than what has been achieved for giants with normal spectroscopic methods in the literature that often suffer from systematic errors on the order of \SI{0.2}{dex} \citep[e.g.][to name a few]{Bruntt2011,Thygesen2012a,Heiter2015} , the exception being a strictly differential analyses described in the introduction. This provides the strongest constraint to the spectroscopic analysis. NGC\,6819 is in the Kepler field with asteroseismic measurements available from extensive photometric time series \citep{Corsaro2012,Handberg2017}. M67 is in field 5 of the K2 mission, which also provides asteroseismology but with lower S/N \citep{Stello2016}, as only three months of time series data has been acquired compared to the four year extent of the nominal Kepler mission. There are no oscillation measurements available for NGC\,188, but because there is a binary system near the main sequence turn-off in this cluster it is still possible to calculate an estimate of the surface gravity from photometry \citep{Nissen1997} to a higher precision than for field stars with no strong mass constraints: \begin{align} \log \frac{g}{g_\odot} = 4.44 + \log \frac{M}{M_\odot} + 4 \cdot \log \frac{T_\text{eff}}{5777} + 0.4 \cdot \left( V - 3.1E \left( B-V \right) \right) \nonumber \\ + 0.4 \cdot BC + 2 \cdot \log \left( \frac{1}{d} \right) + 0.12 \ , \label{eq:logg} \end{align} where $M$ is the mass. $M_\text{NGC\,188} = 1.1 M_\odot$ is found by using a turn-off mass in the cluster of $1.1 M_\odot$ \citep{Meibom2009} and assuming the evolution and mass loss after the turn-off advances as in NGC\,6791 the mass difference between the turn-off and red clump will correspond to the mass loss on the red giant branch \citep{Brogaard2012,Miglio2012}. $V$ is the $V$-band magnitude, $BC$ is the bolometric correction and $d$ is the distance calculated as \begin{align} d = 10^{\left( 1 + \frac{\mu - 3.1 \cdot E \left( B-V \right)}{5} \right)} \ . \end{align} The apparent distance modulus in the $V$-band, $\mu = (m-M)_V$, is the difference between the apparent and absolute magnitude. The reddening and distance modulus for NGC\,188 are from \citet{Meibom2009} and presented in Table 1 of \citet{Slumstrup2017}. An empirical relation for the bolometric correction in Eq. \ref{eq:logg} applicable for stars with $T_\text{eff}$~<~\SI{5012}{K} is given in \cite{Torres2010}: \begin{align} BC = a + b \left( \log T_\text{eff} \right) + c \left( \log T_\text{eff} \right)^2 + d \left( \log T_\text{eff} \right) ^3 \ , \end{align} where $a,b,c,d$ are coefficients given in the article. The surface gravities from asteroseismology and photometry for the three targets are: NGC\,6819: $\log g = 2.55 \pm$\SI{0.02}{dex}, M67: $\log g = 2.48 \pm$\SI{0.06}{dex}, NGC\,188: $\log g = 2.45 \pm$\SI{0.14}{dex}. \section{Comparison of methods} To achieve a robust result, we did several realizations of the spectroscopic analysis using different combinations of line lists and equivalent width measurement programs and compared the outcome to determinations from asteroseismology and photometry. Due to the high accuracy of the asteroseismic $\log g$ as mentioned in Sec.~\ref{sec:prior}, we have used this as the main calibrator throughout the analysis. In the following section we describe the analysis carried out in detail, where we have used the M67 target as a benchmark and SPECTRUM \citep{Gray1994} to calculate atmospheric parameters from equivalent widths (see discussion in Sec.~\ref{sec:param}). When asteroseismology is available the $\log g$ value can be held fixed in the spectroscopic analysis, which is often the chosen approach when possible. This can result in ionization equilibrium between FeI and FeII not being reached in the spectroscopic analysis, but In most cases it will not have a large impact on the effective temperature because excitation balance, which is used to obtain $T_\text{eff}$, depends on the excitation potentials and abundances of FeI lines, which are only mildly sensitive to pressure changes in the atmosphere. Instead of fixing the $\log g$ value during our spectroscopic analysis, we used it as a reference when choosing our preferred combination of line list and equivalent width measurement program to make the spectroscopic results self consistent and in agreement with asteroseismology. \citet{Doyle2017} investigated the effect of fixing $\log g$ in the spectroscopic analysis of a set of FGK stars, that already had accurate parameters determined from other methods, and found that fixing the surface gravity did not improve the precision on the other spectroscopic parameters, they find an average difference in determined $T_\text{eff}=3\pm$\SI{13}{K}. This is however in contrast to \citet{Hawkins2016} and \citet{Valentini2016} who both find better precision on the other atmospheric parameters when fixing the $\log g$ to the asteroseismic. \subsection{Line lists} \label{sec:line} To test the impact of choosing different combinations of absorption lines, we adopt one equivalent width measurement program (DAOSPEC, see discussion in Sec.~\ref{sec:program}) . When choosing a line list, several considerations have to be made. The lines should not be blended, they should have well determined atomic parameters, they should cover a range of excitation potentials to get a robust effective temperature determination. Furthermore, they should preferably be weak enough to be on the linear part of their curve of growth, yet strong enough to yield a significant determination, again covering a range of line strengths. We ensured our lines were not blended by evaluating each individual transition for our range of atmospheric parameters with the online tool for the Vienna Atomic Line Database \citep[VALD,][]{Piskunov1995}. Based on our S/N values of 100-150, we decided that a possible blend should be stronger than 5\% to be considered significant. This however only concerns atmospheric blends. A separate issue is that of telluric blends, which are in the rest frame of the Earth and can therefore not be evaluated with a tool like VALD. In order to avoid telluric blends, we chose to avoid parts of the spectrum with well-known telluric absorption lines. We were careful in choosing absorption lines with only reliably determined atomic parameters, but there are however still lines that do not yield the expected element abundances, e.g. Fe lines in the Sun not giving solar metallicity when using solar atmospheric parameters. This is the reason to use the so-called astrophysical oscillator strengths, $\log \-gf$ values as an attempt to minimize effects from our lack of knowledge on atomic parameters. These are calibrated to the Sun by analyzing a solar spectrum taken with the same instrumental setup as the data and then adjusting the $\log \-gf$ values until each absorption line yields the expected solar chemical abundance. This can result in an increase on the precision of the metallicity by a factor of two when using calibrated values compared to laboratory values. It is however important to note that these values will give more precise results by construction, but in doing so a bias can possibly be introduced in the analysis and care must be taken. Figure~\ref{fig:labvsastro} shows this comparison for two sets of results for the M67 target using the same line list and program for measuring equivalent widths, where one considers laboratory $\log \-gf$ values and the other astrophysical values. The kernel density estimator (KDE) plot on the right shows that not only is the scatter larger for the laboratory values (\SI{39}{K} compared to \SI{18}{K}), but also the resulting atmospheric parameters change: the chemical composition, effective temperature and surface gravity increase when using laboratory values by $\Delta$[Fe/H] = +0.05, $\Delta T_\text{eff}$ = \SI{+100}{K} and $\Delta \log g = +0.27$, respectively (the difference between the two bottom results in Fig.~\ref{fig:comp_res}). The value for the surface gravity of the M67 target is in poor agreement with the results from asteroseismology ($\log g_\text{seis} = 2.48 \pm 0.06$ as shown in Fig.~\ref{fig:logg}), and photometry ($\rm T_{eff,phot} = 4718 \pm \SI{43}{K}$ as shown in Table~\ref{tab:coltemp}). For the other two targets, NGC\,6819 and NGC\,188, the trend goes in the same direction but is more pronounced: $\Delta$[Fe/H] = +0.02, $\Delta T_\text{eff}$ = \SI{+160}{K} and $\Delta \log g = +0.35$ for NGC\,188 and $\Delta$[Fe/H] = +0.03, $\Delta T_\text{eff}$ = \SI{+170}{K} and $\Delta \log g = +0.38$ for NGC\,6819. We therefore chose to use the calibrated $\log \-gf$ values in our analysis. \citet{Doyle2017} finds similar trends when comparing laboratory and solar calibrated $\log gf$ values, that [Fe/H] is systematically higher with laboratory values, however their discrepancy on effective temperature is much smaller, <\SI{10}{K}. \begin{figure*} \centering \includegraphics[width=.8\textwidth]{labvsastro.pdf} \caption{Comparison of results using DAOSPEC and the line list based on \citet{Carraro2014a} for laboratory (blue) vs astrophysical (green) $\log \-gf$ values for the M67 target. The right plot is a KDE illustrating the scatter in the two samples.} \label{fig:labvsastro} \end{figure*} As mentioned earlier in this section, the absorption lines have to preferably be weak enough to be on the linear part of the Curve of Growth (COG), which describes how the equivalent width of a line changes as the number of absorbers increase due to a change in a specific atmospheric parameter, e.g. abundance of the element in question, $T_\text{eff}$ or $\log g$. For the three stars analyzed here, the linear part of the COG corresponds to lines with an equivalent width up to about \SI{100}{\milli\angstrom}. Figure~\ref{fig:comp_ew} shows a comparison between equivalent width measurements of the same lines but with different programs (more on this in Sec.~\ref{sec:program}). Especially in the left plot of Fig.~\ref{fig:comp_ew} it becomes apparent why stronger lines should be left out when possible: the scatter increases significantly for the stronger lines (around $\sim$\SI{90}{\milli\angstrom} and above). For instance, when including the stronger lines for the M67 target with astrophysical $\log gf$ values the atmospheric parameters changed as well: $T_\text{eff}$ goes from \SI{4680}{K} to \SI{4650}{K} ($\Delta T_\text{eff}$=\SI{-30}{K}), $\log g$ from \SI{2.43}{dex} to \SI{2.30}{dex} ($\Delta \log g$= \SI{-0.13}{dex}) and [Fe/H] from -0.03 to 0.00 ($\Delta$[Fe/H]=0.03). For some elements with only a few good absorption lines in the optical part of the spectrum for a given atmospheric parameter range, the requirement of \SI{100}{\milli\angstrom} can be difficult to reach. In our case, a few lines with higher equivalent widths than the \SI{100}{\milli\angstrom} limit were used for elements other than Fe due to the lower number of lines available. \begin{figure*} \centering \includegraphics[width=.45\textwidth]{AresvsDaospec.pdf} \includegraphics[width=.45\textwidth]{TamevsDaospec.pdf} \caption{Comparison of EWs for the M67 target measured with three routines. Left: ARES vs DAOSPEC with an average offset of \SI{4.8}{\milli\angstrom} Right: TAME vs. DAOSPEC with an average offset of \SI{5.9}{\milli\angstrom}. In the spectroscopic analysis, Fe lines above \SI{100}{\milli\angstrom} are discarded.} \label{fig:comp_ew} \end{figure*} The higher the S/N of the spectrum, the weaker the chosen lines can be because the depth of the line has to be significant compared to the noise level of the spectrum. Given our S/N levels, we set the lower limit at \SI{10}{\milli\angstrom}. \subsubsection*{Golden lines} \cite{Jofre2014} collected results for a set of Benchmark stars studied in the framework of the Gaia-ESO collaboration using many different pipelines to study systematic differences in the analysis. They created a list of "golden lines" (presented in Fig.~\ref{fig:linelists}), which are FeI and FeII lines all with well determined atomic data that are on the linear part of the COG for all of their benchmark stars. These include FGK dwarfs and FGKM giants. Measurements of the strength of all the lines in the golden line list by several different groups agree within 2$\sigma$. Using only the golden lines for the FGK giants, the final scatter on the metallicity results from the different pipelines is around \SI{0.08}{dex}. This is a good place to start when choosing lines and we tested this line list on the M67 target. It resulted in the atmospheric parameters $T_\text{eff}$=\SI{4820}{\kelvin}, $\log g$=\SI{2.85}{dex} and [Fe/H]=\SI{-0.02}{dex} (see Fig.~\ref{fig:comp_res}, which shows the results from all the different combinations of line lists and programs considered in our study). The temperature is significantly higher than predicted from photometry (see Table~\ref{tab:coltemp}), but the deciding part is the surface gravity that is much higher than the \SI{2.48}{dex} predicted from asteroseismology. Even though an uncertainty on $\log g$ from spectroscopy of 0.2-\SI{0.3}{dex} is common, a deviation from the asteroseismic $\log g$ of almost \SI{0.4}{dex} allows us to discard this line list for the targets analyzed here. \subsubsection*{Other line lists} \begin{figure*} \centering \includegraphics[width=\textwidth]{sum_lines_sub.pdf} \caption{The Excitation Potential of each line list plotted as a function of the wavelength. The color coding shows the equivalent widths measured with DAOSPEC. The circles are FeI lines and the triangles are FeII lines. The grey open circles and triangles in the top four panels are common lines with the bottom panel.} \label{fig:linelists} \end{figure*} We tested other line lists as well based on \citet{Carraro2014a}, \citet{Bragaglia2001}, \citet{Friel2010} and \citet{Tsantaki2013} (from here on: C14, B01, F10 and T13 respectively). They are all presented in Fig.~\ref{fig:linelists} that shows the excitation potential of all the lines plotted as a function of wavelength color coded by the equivalent width. C14, B01 and F10 are all selected for cool giants, whereas T13 is for cool dwarfs. The lines in common from T13, F10, Golden and B01 with C14 are plotted with grey open symbols to highlight the differences between the line lists. From this it can be seen, that the main difference between them is the wavelength coverage. They all have mostly higher excitation potential lines (3 > eV > 5) and all span the entire range in line strengths. A few differences in the line lists stand out that could potentially trace the differences between the results: The F10 line list has the most even distribution of excitation potentials, which increases the stability of the results for $\rm T_{eff}$. It does however have significantly fewer lines than the other line lists, which overall decreases the precision on the results. The B01 and Golden line lists only have one and two lines respectively with excitation potential below \SI{2}{eV}, which makes the $\rm T_{eff}$ determination less accurate and because this has a strong effect on determination of the other parameters, the accuracy on these will also decrease. Care should however be taken with strong lines at low excitation potentials as these are more sensitive to 3D effects \citep[see][]{Bergemann2012}. The amount of FeII lines also has a strong effect on precision and accuracy of the surface gravity determinations, where especially the Golden line list stands out, as it has only six FeII lines below \SI{100}{\milli \angstrom}, which could be the explanation for the discrepancy with the asteroseismic surface gravity with this line list. A recent review on the accuracy and precision of stellar parameters is presented in \cite{Jofre2018}, where also the effects of line selection is discussed in more detail. Other differences on the obtained atmospheric parameters as a result of line selection could also be issues with the atomic parameters. Even though we have ensured all the lines have the best known atomic parameters, there could still be problems, as the theoretical calculations and laboratory measurements of transitions in iron is very difficult to carry out due to the complexity of the iron atom. Calibrating each line to the Sun would in principle remove these effects but due to the differences in atmospheric conditions between the Sun and our stars, this could add new problems. This is why it could also be a solution to calibrate to a well-known giant as e.g. Arcturus, but that would also add uncertainties to the analysis due to the uncertainty on the metallicity of Arcturus. \subsubsection*{Chosen line list} The results using the different line lists with DAOSPEC are presented in Fig.~\ref{fig:comp_res}. Based on the surface gravity determined from seismology, the final choice of Fe lines is comprised of the line list from C14 with astrophysical $\log gf$ values based on \citet{Grevesse1998} solar abundances and discarding lines stronger than $\sim$\SI{100}{\milli\angstrom}. The choice of non-Fe lines for the final determination of abundances is based on C14 and \citet{Nissen2015} plus a few additional lines as described in Sec.~3 of \citet{Slumstrup2017}. The C14 Fe line list with laboratory oscillator strengths yields a $\log g$ value within $\sim 3\sigma$ of the asteroseismic one, but with a much higher scatter as shown in Fig.~\ref{fig:labvsastro} and it was therefore discarded. The F10 line list also returns a $\log g$ value close to the asteroseismic one. Nevertheless, this line list has fewer usable absorption lines than the others (42 FeI and FeII lines compared to 109 with C14), which gives significantly larger uncertainties (see Fig.~\ref{fig:comp_res}) and a lower stability of the analysis (see discussion on this in Section~\ref{sec:uncertainty}). \subsection{Equivalent Widths} \label{sec:program} The optimal way to measure equivalent widths is to do a manual line by line analysis, e.g. using routines such as \textit{splot} in IRAF. This can however be very time consuming since preferably one wants many lines for each target and therefore more automatic routines are often used. We tested three different programs that measure equivalent widths in a more automatic way with less user interaction; DAOSPEC \citep{Stetson2008}, ARES \citep{Sousa2007} and TAME \citep{Kang2012}. Comparisons of equivalent width measurements between the three different programs for the M67 target is shown in Fig.~\ref{fig:comp_ew}. TAME can be run in both with and without user interaction for the line fitting. The results we are comparing with here is with a manual user set continuum. When line profile fitting it is possible to choose between Gauss and Voigt profiles, where Voigt profiles should be used for the stronger lines. As mentioned previously, we have chosen not to work with stronger lines and therefor the comparison here is only for lines that can be fitted with a Gauss profile. TAME measures equivalent widths 5-\SI{7}{\milli\angstrom} higher than DAOSPEC. When using M67 as the test target the measured equivalent widths results in an effective temperature higher than that expected from photometry by \SI{130}{K} and a surface gravity deviating from that expected from asteroseismology by $\Delta \log g=+$\SI{0.30}{dex} (see Fig.~\ref{fig:comp_res}). This led us to discard this program. ARES fits lines with a Gaussian profile (for stronger lines, there are other options, but this was not relevant here) and does an automatic continuum placement locally around the absorption line aided by a parameter that depends on the S/N of the spectrum, which must be set by the user. In \citet{Sousa2008} a table is given with values of this parameter for different S/N levels. We varied this parameter to test its effect on the results in the range corresponding to 90<S/N<200. The impact on the effective temperature was on the order of $\sim\SI{30}{K}$ and on the surface gravity it was $\sim$\SI{0.1}{dex}. These are not large variations and we therefore chose to only use the surface gravity as a calibrator due to the much stronger external constraint on this parameter. The result closest to the seismic $\log g$ value was obtained when using the parameter corresponding to a S/N between 100 and 125 (the estimated S/N for the M67 spectrum is around 135); the resulting value was however larger than the asteroseismic one by $\Delta \log g =+$\SI{0.20}{dex}. As mentioned in the previous section and shown on Fig.~\ref{fig:comp_ew}, the scatter on the line strength measurement increases for stronger lines (above $\sim$\SI{90}{\milli\angstrom}). For the targets in this project this was not very significant as we had enough well measured weaker lines and therefore did not have to include stronger lines, where perhaps fitting Voigt profiles instead of Gaussians become relevant. In other cases however it can be important to the point that removing the trend between the element abundance vs. reduced equivalent width to determine the microturbulence is impossible. The microturbulence will instead have to be calculated from a scaling relation, see e.g. \citet{Bruntt2012}. \citet{Sousa2007} did a comparison between DAOSPEC and ARES and found that on average, DAOSPEC measures the equivalent widths \SI{1.9}{\milli\angstrom} lower than ARES. In our study, the equivalent widths from ARES are 4-\SI{6}{\milli\angstrom} higher (left panel of Fig.~\ref{fig:comp_ew}), which is most likely mainly due to continuum placement, as ARES on average places the continuum ${\sim}$1\% higher than DAOSPEC for our spectrum. Exactly why the difference between ARES and DAOSPEC in our analysis is larger than that of \citet{Sousa2007} could be caused by a variety of reasons, e.g different line selection, different spectral types analyzed or the continuum placement, because as mentioned previously, the parameter used by ARES in the continuum placement for our spectrum, had to be set for a slightly lower S/N than the actual S/N of the spectrum. The final choice of program fell on DAOSPEC, which also fits absorption lines with a Gaussian profile. The continuum is placed automatically around the absorption lines. It was chosen because as shown in Fig.~\ref{fig:comp_res} and \ref{fig:logg}, the measurement of absorption lines yielded results consistent with the more precise and accurate $\log g$ value from asteroseismology. A similar comparison can be performed with the effective temperature from photometry, which shows the same trend as Fig.~\ref{fig:logg}, but with systematically smaller deviations due to the larger uncertainty on the effective temperature from photometry. Even though the photometric effective temperature is less precise than the spectroscopic, it is reassuring that the results showing the best agreement with the asteroseismic $\log g$ are also the ones in closest agreement with the photometric $T_\text{eff}$. This further supports the choice of program and line list. An additional check of our measured equivalent widths was to apply our method to a solar spectrum. We used a reflected light spectrum of Vesta observed with the same setup as our targets (FIES in the high-resolution mode). We compare our results using DAOSPEC + C14 to solar equivalent widths measurements done by \citet{Scott2014}, and found very good agreement on the absorption lines we have in common. The average difference is \SI{-0.4}{\milli\angstrom} with a scatter of $\sim$\SI{3}{\milli\angstrom}. It should be noted, that since we have not measured the equivalent widths on the same exact solar spectrum, small differences can be expected. We found a few of our lines to be blended to an amount that makes them questionable to use in the solar case, which led us to also discard these lines in our analysis of the giants (N. Grevesse, private communication). After removing these lines, we end up with the following atmospheric parameters for the Sun: $T_\text{eff} =$ \SI{5770}{K}, $\log g = $ \SI{4.35}{dex}, $v_\text{mic} = $ \SI{0.90}{km/s}, [Fe/H] = \SI{-0.05}{dex}. The small difference to the actual solar atmospheric parameters could arise from the selection of absorption lines, which is tailored to more evolved stars than the Sun. \begin{figure*} \centering \includegraphics[width=.95\textwidth]{res_compare.pdf} \caption{Comparison of atmospheric parameters for the M67 target with different combinations of line list and program to measure equivalent widths. Left: $T_\text{eff}$ variations. Center: $\log g$ variations. Right: [Fe/H] variations. The final choice of line list and program is the bottom row marked with a triangle. The dashed line in the middle plot is the asteroseismic $\log g$, see Fig.~\ref{fig:logg} for a comparison.} \label{fig:comp_res} \end{figure*} \begin{figure} \centering \includegraphics[width=.9\columnwidth]{logg_sigma.pdf} \caption{Deviation from the asteroseismic $\log g$ value for the M67 target for each method combination (center plot in Fig~\ref{fig:comp_res}). Full agreement with the asteroseismic $\log g$ is marked with the vertical line and the two dashed lines are $3\sigma$ deviations. The final choice of line list and program is the bottom row marked with a triangle.} \label{fig:logg} \end{figure} \section{Atmospheric parameters and abundances} \label{sec:param} From the comparisons described in the previous section, we chose an iron line list based on C14 and DAOSPEC to measure the equivalent widths. To calculate atmospheric parameters from the measured equivalent widths we use SPECTRUM \citep{Gray1994}. This routine carries out computations of atmospheric parameters under the assumptions of LTE and a plane-parallel atmosphere. SPECTRUM comes with auxiliary programs including ABUNDANCE, which is a routine for computing elemental abundances from equivalent widths of individual absorption lines using the COG method (as explained in Sec.~\ref{sec:line}). One of the required inputs for a spectroscopic analysis is a stellar atmosphere model, where we have used a large grid of Kurucz-Castelli ATLAS9 models (\cite{Castelli2004}) interpolated to get the required atmospheric properties. These are 1D plane-parallel model atmospheres that divide the atmosphere of the star into many subsequent layers. Within each layer, the atmosphere is in hydrostatic equilibrium and energy transport is radiative. According to \cite{Asplund2005,Mashonkina2011} non-LTE effects are not relevant for FeII lines and mostly relevant for FeI lines in low metallicity stars ([Fe/H]<\-1.0). Thanks to the online tool INSPECT available at \url{www.inspect-stars.net} it is possible to check non-LTE corrections for individual lines given a line strength and atmospheric parameters. The data are from studies by \citet{Lind2012,Bergemann2012} and for the eight of our FeII and seven of our FeI lines where data are available, we get average changes in FeII of <\SI{-0.01}{dex} and in FeI of ${\sim}$\SI{0.01}{dex}. This is within the internal precision of our analysis and therefore we have chosen not to include non-LTE effects. 3D LTE effects on spectral line formation was discussed by \citet{Collet2007}, where fictitious lines at \SI{3500}{\angstrom} and \SI{5000}{\angstrom} were studied for different stellar atmospheres. For the atmosphere similar to the stars in this study ($\rm T_{eff}=\SI{4697}{K}, \log g=\SI{2.2}{dex}, v_{mic}=\SI{1.5}{km/s} and [Fe/H]=0.0$) the 3D-1D LTE corrections to the Fe abundance for the \SI{5000}{\angstrom} fictitious line vary between \SI{-0.1}{dex} and \SI{+0.2}{dex} depending on the excitation potential and the equivalent width of the line \citep[see Fig.~5 in][]{Collet2007}. We cannot apply these corrections here, as it could be anywhere in the range, also consistent with zero, but should however be kept in mind. Lines at \SI{6000}{\angstrom} have been calculated in the same way since that study and for our range of atmospheric parameters, the possible changes to the lines are within our uncertainties (R. Collet, private communication). More recently, studies of 3D non-LTE effects on the iron abundance have been carried out by \citet{Amarsi2016} however only for metal-poor stars ($\rm [Fe/H]<\SI{-1.5}{dex}$). The trend found is that the corrections needed decrease with increasing metallicity \citep[see Fig.~4 in][]{Amarsi2016}. One should in general not extrapolate the results outside the parameter range studied. If however the trend were to continue towards solar metallicity, the corrections needed for our targets would probably be close to or within the internal precision on our result. Another necessary input is a set of atomic and molecular data, where we chose to use the \citet{Grevesse1998} values for the solar atomic abundances. We also tested MARCS atmosphere models, but found very little to no difference in the results with typical changes below \SI{10}{K}, \SI{0.01}{dex} and \SI{0.01}{dex} for effective temperature, surface gravity and metallicity respectively. This has previously been studied in detail by e.g. \citet{Gustafsson2008} and we will not explore it further here. The determination of atmospheric parameters was done by requiring that: 1) [Fe/H] has no systematic dependence on the excitation potential of the FeI lines, i.e. requiring that the atmosphere is in excitation equilibrium, 2) [Fe/H] has no systematic dependence on the strength of the FeI lines and 3) the mean [Fe/H] values derived from FeI and FeII lines are consistent, i.e. requiring the atmosphere to be in ionization equilibrium. The value of [Fe/H] as a function of excitation potential is sensitive to the effective temperature, and is sensitive to the microturbulence as a function of the reduced equivalent widths of the lines ($\log (\text{EW})/\lambda$) because the microturbulence has a larger effect on stronger lines. The surface gravity is determined through its effect on the electron pressure in the stellar atmosphere with the ionization equilibrium between FeI and FeII, as the FeII lines are much more sensitive to pressure changes than the FeI lines. This is however also affected by the effective temperature and metallicity, which makes it necessary to make a number of iterations. For the NGC\,6819 and M67 targets, we also calculated a new asteroseismic $\log g$ with the newly found effective temperatures. The possible variation on the effective temperature is however low enough, that the asteroseismic $\log g$ was not significantly affected. The final results for the atmospheric parameters are presented in Table~\ref{tab:param_spec} (all targets) and Fig.~\ref{fig:comp_res} (for M67, labelled Daospec + C14). \subsection{Metallicity of NGC\,6819} As mentioned previously, an asteroseismic value of $\log g$ is also available for the NGC\,6819 target which allows us to use it as a calibrator for our method. When the spectroscopic analysis was done for this star with the same setup as for the M67 target, the obtained spectroscopic $\log g$ (\SI{2.52}{dex}) was in excellent agreement with the prediction from asteroseismology (\SI{2.55}{dex}, see Sec.~\ref{sec:prior}). The final [Fe/H] for NGC\,6819 was found to be $-0.02\pm$\SI{0.01}{dex} which is on the low end of the previously found values in the literature; in agreement with the result from \citet{Lee-Brown2015} ([Fe/H]=$-0.02\pm$\SI{0.02}{dex}) and slightly lower than that from \citet{Bragaglia2001} ([Fe/H]=$0.09\pm$\SI{0.03}{dex}). As can be seen from Fig.\ref{fig:comp_res} the final combination of line list and program gives results in the lower end of the range obtained for all three atmospheric parameters for the M67 target and this is also the case for the NGC\,6819 target. If we instead use the combination of ARES + C14, we get $\rm [Fe/H] = +0.11 \pm 0.01$ which is in better agreement with the high-resolution study from \citet{Bragaglia2001} who did not have asteroseismology available to constrain the surface gravity. We however also discarded this combination for NGC\,6819 because the obtained surface gravity is too high ($\log g = 2.65$) to be in agreement with asteroseismology. When doing this comparison it is important to note that within a cluster, the spread in abundances of stars can be on the order of the different results for the NGC\,6819 target we find \citep[see e.g.][for a study on abundance scatter in the Hyades]{Liu2016} and since our target is not in either of the two other NGC\,6819 studies mentioned here, a direct comparison cannot be done. The individual abundances for all three targets are listed in Table~\ref{tab:abund}. As expected from other studies \citep{Bragaglia2001,Friel2010,Onehag2014} there is no clear sign of alpha enhancement and the abundances are mostly close to solar, with a few exceptions such as Titanium for NGC\,6819. The Magnesium and Yttrium abundances were discussed in more detail in \citet{Slumstrup2017} because it has been shown by e.g. \citet{Nissen2017} that [Y/Mg] is tightly correlated with age for solar-like stars. \begin{table*}\small \centering \caption{\textsl{Atmospheric parameters and abundances with only internal uncertainties from spectroscopy with DAOSPEC + C14. The analysis presented in this paper shows that to a different setup, differences could be up towards $\sim$\SI{170}{\kelvin} for $T_\text{eff}$, $\sim$\SI{0.4}{dex} for $\log g$, and $\sim$\SI{0.25}{dex} for the metallicity, which should be kept in mind when comparing to other results.}} \begin{threeparttable} \begin{tabular}{l c c c c c c } \toprule Target & $T_\text{eff}$ [K] & $\log g$ & $v_\text{mic}$ [km/s] & $[$Fe/H] & $n$\tnote{*} & $[\alpha$/Fe] \\ \midrule NGC\,6819-KIC5024327 & 4695 $\pm$ 18 & 2.52 $\pm$ 0.05 & 1.19 $\pm$ 0.05 & -0.02 $\pm$ 0.01 & 97/12 & -0.02 $\pm$ 0.02\\ M67-EPIC211415732 & 4680 $\pm$ 18 & 2.43 $\pm$ 0.04 & 1.21 $\pm$ 0.05 & -0.03 $\pm$ 0.01 & 97/12 & 0.03 $\pm$ 0.02\\ NGC\,188-5085 & 4580 $\pm$ 23 & 2.51 $\pm$ 0.06 & 1.17 $\pm$ 0.06 & 0.04 $\pm$ 0.01 & 95/12 & 0.00 $\pm$ 0.02\\ \bottomrule \end{tabular} \footnotesize \begin{tablenotes} \item[*] The number of FeI/FeII lines used. \end{tablenotes} \end{threeparttable} \label{tab:param_spec} \end{table*} \begin{table}\small \centering \caption{\textsl{Individual Abundances}} \begin{threeparttable} \begin{tabular}{l c c c c} \toprule & NGC\,6819 & M67 & NGC\,188 & $n$\tnote{*}\\ \midrule $[$Na/Fe] & 0.10 $\pm$ 0.00 & 0.18 $\pm$ 0.04 & 0.15 $\pm$ 0.03 & 2\\ $[$Mg/Fe] & -0.05 $\pm$ 0.03 & 0.06 $\pm$ 0.03 & 0.04 $\pm$ 0.04 & 4\\ $[$Al/Fe] & 0.02 $\pm$ 0.05 & 0.11 $\pm$ 0.06 & 0.14 $\pm$ 0.07 & 2\\ $[$Si/Fe] & 0.09 $\pm$ 0.04 & 0.14 $\pm$ 0.04 & 0.14 $\pm$ 0.04 & 14\\ $[$Ca/Fe] & -0.11 $\pm$ 0.06 & -0.01 $\pm$ 0.05 & -0.09 $\pm$ 0.08 & 7\\ $[$Ti/Fe] & -0.24 $\pm$ 0.05 & -0.11 $\pm$ 0.03 & -0.12 $\pm$ 0.04 & 19\\ $[$Cr/Fe] & -0.08 $\pm$ 0.04 & -0.02 $\pm$ 0.04 & -0.03 $\pm$ 0.05 & 18\\ $[$Ni/Fe] & 0.00 $\pm$ 0.03 & 0.09 $\pm$ 0.03 & 0.12 $\pm$ 0.03 & 32\\ $[$Zn/Fe] & -0.17 $\pm$ 0.04 & -0.07 $\pm$ 0.14 & -0.11 $\pm$ 0.19 & 2\\ $[$Y/Fe] & 0.03 $\pm$ 0.04 & 0.07 $\pm$ 0.05 & -0.02 $\pm$ 0.06 & 3\\ \bottomrule \end{tabular} \footnotesize \begin{tablenotes} \item[*] The number of absorption lines used in the determination. \end{tablenotes} \end{threeparttable} \label{tab:abund} \end{table} \section{Internal uncertainties} \label{sec:uncertainty} In this paper we have discussed possible differences and the effect on stellar atmospheric parameters from choice of line list, atomic parameters and methods to measure the equivalent widths. On top of these there is the internal precision of the method itself. When determining $T_\text{eff}$ and microturbulence, $v_\text{mic}$, the uncertainty on the final zero-slopes of [Fe/H] vs. excitation potential and [Fe/H] vs. reduced equivalent width (e.g. Fig.~\ref{fig:labvsastro}) can be easily calculated. To find the internal uncertainty on $T_\text{eff}$ and microturbulence, these parameters are varied until a $3\sigma$ difference is produced in one of the two slopes or in the difference between FeI and FeII abundances. The change in $T_\text{eff}$ or microturbulence is then divided by the highest produced difference to give the final $1\sigma$ uncertainty, which corresponds to the internal uncertainty for these parameters listed in Table ~\ref{tab:param_spec}. To calculate the internal $\log g$ uncertainty we can use the difference between FeI and FeII abundances determined as: $\Delta \text{[Fe/H]} / \sigma_{\Delta \text{[Fe/H]}}$ where \begin{align} \sigma_{\Delta \text{[Fe/H]}} = \sqrt{\left( \frac{\sigma_{\text{FeI}}}{\sqrt{n_\text{FeI}-1}} \right) ^2 + \left( \frac{\sigma_{\text{FeII}}}{\sqrt{n_\text{FeII}-1}} \right) ^2} \ . \end{align} Here, $\sigma_\text{FeI,II}$ is the RMS scatter on the measured abundances of each ionization stage and $n_\text{FeI,II}$ is the amount of lines used for the measurements. Once again, we vary $\log g$ until a $3\sigma$ difference is produced in one of the two slopes or in the difference between FeI and FeII abundances. The internal uncertainty on [Fe/H] listed in Table~\ref{tab:param_spec} corresponds to the standard error of the mean. Another way of characterizing the internal uncertainties is to test the stability of the results. This can be done with a sensitivity analysis, which is a test of how sensitive the final metallicity is to changes in the other atmospheric parameters. This was done for the M67 target and the results are presented in Table~\ref{tab:sens}. It was only done for one target because the quality of the spectra for each star and their atmospheric parameters are so similar that the sensitivity can be assumed to be almost the same for all of them. Comparison of these results to the internal uncertainties in Table~\ref{tab:param_spec} reveals that the stability of the analysis is high, because the internal uncertainties are much lower than the the variation in the atmospheric parameters in the sensitivity analysis. \begin{table}\small \centering \caption{\textsl{Sensitiviy of the metallicity to the other atmospheric parameters for the M67 target.}} \begin{threeparttable} \begin{tabular}{l c c c} \toprule & +100 K $T_\text{eff}$ & + 0.1 dex $\log g $ & +0.1 km/s $v_\text{mic}$\\ \midrule $\Delta [$Fe/H] & +0.03 dex & +0.02 dex & -0.03 dex \\ \bottomrule \end{tabular} \footnotesize \end{threeparttable} \label{tab:sens} \end{table} On top of the internal uncertainties described in this section, there is significant scatter arising from using different approaches (e.g. line lists, measurements of equivalent widths etc.) as discussed in this paper. This is often not characterized, but instead an extra \SI{0.1}{dex} is simply added to the internal uncertainty on [Fe/H] and 0.1-\SI{0.2}{dex} for $\log g$, while a systematic uncertainty of about \SI{100}{\kelvin} is typically added for the effective temperature \citep[see e.g. ][]{Smalley2005,Bruntt2010,Bruntt2012}. Our analysis shows that the differences can be much larger than this, from Fig.~\ref{fig:comp_res}: $\sim$\SI{170}{\kelvin} for $T_\text{eff}$, $\sim$\SI{0.4}{dex} for $\log g$, and $\sim$\SI{0.25}{dex} for the metallicity. This should be kept in mind when comparing to other results that make use of a different combination of line list, program for measuring line strengths and atomic data. \section{Conclusion} We have presented a detailed spectroscopic study of three targets in three open clusters, NGC\,6819, M67 and NGC\,188, all in the same evolutionary stage and observed with the exact same instrumental setup. To our knowledge the data for the NGC\,6819 and NGC\,188 targets are of higher quality (higher resolution and higher S/N) than previously studied as described in the introduction. Along with this, we had asteroseismic data available for the two targets in NGC\,6819 and M67, which allowed us to use the M67 target as a benchmark in the analysis and the NGC\,6819 target to show the method was properly calibrated. In turn, it helped in choosing between different combinations of line lists and equivalent width measurement tools. Testing the different line lists and programs for measuring equivalent widths allowed us to characterize systematic differences within the method of a line by line spectroscopic analysis utilizing excitation and ionization equilibria in the stellar atmosphere. The differences found on the atmospheric parameters for the M67 target with the different combinations were shown in Fig.~\ref{fig:comp_res}, where the scatter found in effective temperature is $\sim$\SI{170}{\kelvin}, $\sim$\SI{0.4}{dex} in surface gravity, and $\sim$\SI{0.25}{dex} in metallicity. The spread on the results for surface gravity is particularly high compared to the internal uncertainty obtained by each combination of line list and equivalent width measurement program. Asteroseismology allowed us to choose the most robust option for this type of targets, which was the combination of DAOSPEC and the line list based on C14. This was also the result in closets agreement with the effective temperature from photometry. In the current era of large spectroscopic surveys, this study highlights the possible pitfalls still existing in high precision spectroscopic analysis and why it is of crucial importance to have external constraints to calibrate the results to achieve high accuracy. Using this setup, we also established the metallicity of NGC\,6819, an old open cluster in the \textsl{Kepler} field, to be close to solar, [Fe/H]=-0.02$\pm$\SI{0.01}{dex}. This result is on the lower end of previous determinations of the iron abundance for this cluster \citep[see e.g.][]{Bragaglia2001,Lee-Brown2015}, and it highlights the importance of carefully selecting and measuring adequate absorption lines with good atomic data for a specific set of targets. \begin{acknowledgements} We thank the anonymous referee for her/his careful revision of the manuscript and constructive comments that helped improve the quality of the paper. We thank Remo Collet for fruitful discussion on 3D effects. We thank Mikkel N. Lund for help with the figures. This work has made use of the VALD database, operated at Uppsala University, the Institute of Astronomy RAS in Moscow, and the University of Vienna. This research has made use of the SIMBAD database, operated at CDS, Strasbourg, France. Funding for the Stellar Astrophysics Centre is provided by The Danish National Research Foundation (Grant DNRF106). V.S.A. acknowledges support from VILLUM FONDEN (research grant 10118) and the Independent Research Fund Denmark (Research grant 7027-00096B). \end{acknowledgements} \bibliographystyle{aa}

\section{Introduction\label{intro:sec}} For the last couple of years, the search for the origin of cosmic rays, from GeV-energies up to super-EeV events has started to make rapid progress. First Supernova remnants have been identified as hadronic sources \cite{fermi_w44,fermi_ic443,tobias_sugar2015} and first evidence for an astrophysical high-energy neutrino signal has been announced recently \cite{icecube_evidence2013}. The results from gamma-rays and neutrinos are extremely important first steps in order to have a full identification of the sources for the entire diffuse cosmic ray flux. The theoretical interpretation of the signatures crucially rely on the precise modeling of the sources. This concerns both the prediction of the signal of gamma-ray and neutrino sources, as well as the interpretation of the spectral energy distribution of sources with dominant non-thermal signatures. One central ingredient for these calculations is the ratio between cosmic ray electrons and protons. The ratio is typically assumed to be fixed to a one hundred times higher proton than electron luminosity for galactic sources (see e.g.\ \cite{beck_krause2005}). When discussing the sources of ultra high energy cosmic rays, which can accelerate particles up to $10^{21}$~eV, see e.g.\ \cite{waxman_bahcall1997,becker2014}, it is assumed that the electron luminosity is somewhat higher than for galactic sources, i.e.\ electron to proton luminosity is 1:10. These values, that are on average supported by astrophysical observations, can also be derived following a theoretical argument also described in e.g.\ \cite{schlickeiser2002}: Stochastic acceleration predicts a power-law behavior in momentum, \begin{equation} \frac{dN_i}{dp_i}\propto p_{i}^{-\alpha_{i}} \end{equation} with $i=e,\,p$ (electrons or protons). It is now assumed that the same total number of electrons and protons are accelerated, $N_p=N_e$ with $N_i=\int dN_i/dT_i\,dT_i$. Here, $T_i=\sqrt{m_{i}^{2}\cdot c^4+p_{i}^{2}\cdot c^2}-m_{i}\cdot c^2$ is the kinetic energy of the particles with a minimum kinetic energy of $T_0=10$~keV. Assuming further that the two populations have the same spectral index $\alpha_e=\alpha_p=:\alpha$, the expected ratio scales with the masses of the two species: \begin{equation} \frac{dN_{e}/dp_{e}}{dN_{p}/dp_{p}}=\left(\frac{m_e+\frac{T_0}{2\cdot c^2}}{m_p+\frac{T_0}{2\cdot c^2}}\right)^{(\alpha-1)/2}\approx\left(\frac{m_e}{m_p}\right)^{(\alpha-1)/2} \label{eq:ApproxdN} \end{equation} The last step requires $T_0\ll m_e\cdot c^2,\,m_p\cdot c^2$. This makes the approximation in Eq.\ \ref{eq:ApproxdN} independent of the minimum energy. In contrast to that the exact solution depends strongly on the minimum energy and a possible difference in the minimum energies for protons and electrons as we will show later. With a spectral index of $\alpha\approx 2.2$, which is an approximate value to be expected from diffusive shock acceleration (see e.g.\ \cite{schlickeiser2002} for a summary), one finds a ratio of the order of \begin{equation} \widetilde{K}_{\rm ep}:=\frac{dN_{e}/dp_{e}}{dN_{p}/dp_{p}}\approx \frac{1}{100} \quad . \label{diffratio:equ} \end{equation} Note that for equal spectral indices, $\alpha_e=\alpha_p=\alpha$, the value remains the same for each value of $p_e=p_p$ and it is independent of momentum and thus of energy. Once the indices differ from each other even slightly, this is not the case. As a physical measure, two approaches can be pursued: either, in order to be independent of the energy scale, the total luminosities of electrons and protons can be compared: \begin{equation} K_{\rm ep}:=L_e/L_p \label{eq:DefKep} \end{equation} with \begin{equation} L_{\rm i}=\int_{T_{0,i}}^{T_{\max,i}}dT_{i}\,\frac{dN_i}{dT_i}\cdot T_i\,. \end{equation} Alternatively, the differential number ratio as defined in Eq.\ (\ref{diffratio:equ}) can be used. Here, it needs to be reviewed carefully for each case at what energies the two particle populations are observed. Considering the observation of electrons and hadrons that presumably originate in our own Galaxy, i.e.\ cosmic rays from below the knee and directly observed electrons, the ratio for the total luminosities of the two particle populations comes very close to $1:100$. For extragalactic sources, however, the comparison between the central source candidates (Active Galactic Nuclei (AGN) and Gamma-ray bursts (GRBs)) rather suggest a ratio of $1:10$ \cite{waxman_bahcall1997}. These back-of-the envelope calculations have their pitfalls as well, of course, as they rely on the comparison of the spectra after transport, including all loss processes. When an integral over source regions in which losses are differentially important the effective spectral index for the electrons can be steeper by a factor of 1 compared to protons from the same region (\citep{Kardashev1962}). In particular when concerning the electron spectra, that means that a fraction of the total number of particles is actually lost as they enter a non-relativistic regime and the numbers are not easily comparable with the calculation presented above. Even without these difficulties, the electron-to-proton fraction that is observed strongly depends on the choice of the lower integration limit. As the propagated electron and proton spectra naturally have very different spectral behavior, the luminosities are compared rather than the differential values. This adds a further uncertainty in the calculation. These considerations emphasize that also from the observational point of view, the number ratios of $1:100$ or $1:10$ for extragalactic sources needs to be treated with care. One prominent example is the choice of lower integration limit for the luminosity of ultra high energy cosmic rays. In order to obtain the ratio $1:10$, it is assumed that the lower threshold is at the ankle, i.e.\ at $E_{\min}=10^{18.5}$~eV. It can, however, be possible that there is a significant part of the UHECR source flux even below the ankle, as also discussed by \cite{ahlers2011}, which would enhance the typically assumed ratio. If we assume $E_{\min}=10^{17.3}$~eV as the beginning of the extragalactic part of the spectrum as the KASCADE Grande data \cite{Apel2013, Apel2014} suggests the ratio would decrease to $1:25$. This is discussed in more detail in section \ref{ssec:ExtragalacticSources}. From the theoretical point of view, first results from PIC simulations show that the acceleration of protons and electrons in shock fronts yields differences in the spectral behavior \cite{sironi_spitkovsky2011}. If the acceleration itself does not only depend on the charge but also on the Larmor radius of the particles such differences are expected. Radio observations of SNRs can also be used to show that the electron and proton spectra at the source differ significantly from each other \cite{snr_matthias}. However, this concerns the loss-dominated electrons and it is not trivial to compare these values to the spectra immediately after acceleration, which is needed as an input for our calculations (see also \cite{eichmann_beckertjus2016}). Given the arguments from above, we revisit the theoretical calculation of the electron-to-proton ratio in more general terms as was done before in order to examine the possible range for individual source classes. The assumptions we use are the following: \begin{enumerate} \item We assume a power-law behavior in momentum for both species, \begin{equation} \frac{dN_i}{dp_{i}}=A_i\cdot p^{-\alpha_i} \label{eq:powerLaw}\,. \end{equation} This type of spectral behavior is expected from diffusive shock acceleration processes and is in agreement with the observed spectrum of leptonic and hadronic cosmic rays, see e.g.\ \cite{gaisser1990} for a review. \item We drop the assumption of equal spectral indices ($\alpha_e\neq \alpha_p$), as the acceleration process itself may depend on the particle masses as suggested in PIC simulations (see e.g.\ \cite{Sironi2011}). This implies that the ratio of electrons to protons becomes energy dependent when considering it in $dN_i/dp_i$: $\widetilde{K}_{\rm ep}=\widetilde{K}_{\rm ep}(E_{\rm p},\,E_{\rm e})$. We therefore also calculate the ratio of total luminosities $K_{\rm ep}$ as a true observational measure for the electron-to-proton ratio given in Eq.\ \ref{eq:DefKep}. \item We assume that the total number of particles accelerated in a source is the same for electrons and protons: \begin{equation} N_{p}=N_{e}\,. \end{equation} This assumption is supported by the following argument: The overall particle number, accelerated and non-accelerated, is the same for protons and electrons due to charge balance $N_{\mathrm tot, p}=N_{\mathrm tot, e}$. If we assume the particles to be in a thermal equilibrium in the absence acceleration, the number of particles $N_i$ above a certain energy threshold $T_0$ is the same for protons and electrons. A plasma in a thermal equilibrium is described by a Maxwellian distribution with equal temperature for protons and electrons, which leads to: \begin{equation} N_i = N_{tot, i}\cdot\int_{T_0}^\infty 2 \sqrt{E/ \pi} (k_b T)^{3/2} \exp{\left( -\frac{E}{k_b T} \right)} \mathrm{d}E \, . \label{eq:Maxwell} \end{equation} Therefore, the number of particles above threshold energy $T_0$ is independent of the particle mass. \item We use a general lower kinematic energy threshold which is not necessarily the same for protons and electrons, $T_{0,e}\neq T_{0,p}$. The value of this lower kinematic threshold depends on the theory that is used to describe the acceleration process and does not necessarily describe the boundary between the thermal and non-thermal populations. The derivation of a consistent value for the minimum energy is beyond the scope of this paper but some ideas are discussed in section \ref{results:sec}. In the case of unmodified Maxwellian distributions this would introduces a charge imbalance for the accelerated particles (see Eq. \ref{eq:Maxwell}). Different acceleration mechanisms for electrons and protons due to other plasma wave scattering processes might also lead to different numbers of accelerated particles. In a generalized approach such a charge imbalance could be treated consistently via the introduction of a new parameter $\eta$: \begin{equation} \eta=\frac{N_e}{N_p}= \frac{N_{tot, e}-N_{low, e}}{N_{tot, p}-N_{low, p}}\\ = (1-\int_{0}^{T_{0, e}} P_e(E) \mathrm{d}E) / (1-\int_{0}^{T_{0, p}} P_p(E) \mathrm{d}E) \label{eq:eta} \, , \end{equation} where $P_i$ describes the energy density distribution below the threshold energy for effective acceleration $T_{0,i}$. \end{enumerate} In previous work, \cite{persic_rephaeli2014} apply an approach similar to ours, dropping the assumption of equal indices. There are several differences in this work as compared to \cite{persic_rephaeli2014}: (1) While \cite{persic_rephaeli2014} focus on starburst galaxies in their values for the calculation, we systematically investigate the electron-to-proton ratio for sources up to the cosmic ray knee ($E_{\max} \sim 10^{15}$~eV) and those that contribute up to the end of the cosmic ray spectrum at $10^{21}$~eV. (2) We discuss both differential ratios for the energy-dependent spectra and the ratio of the luminosities. (3) We present an analytical solution to the calculation which can be applied to calculations for cosmic ray source candidates in the future. This should be possible for most sources, as we do not use any specific information for any source class in order to keep the approach as general as possible. (4) We allow for different minimum energies $T_{0, {\rm i}}$ which accounts for different effective acceleration thresholds for protons and electrons due to their different gyro-radii (see e.g.\ \cite{Bell1978_I, Bell1978_II}). This paper is organized as follows: In Section \ref{calc:sec}, the calculation of the electron-to-proton ratio is presented. In contrast to most of the previous calculations, we perform a full calculation of the total luminosities in electrons and protons as a physical measure, rather than the approximation of the ratio of differential spectra at a fixed energy. The central theoretical results in terms of quantitative deviation from the typically used approximation of equal indices are discussed in Section \ref{results:sec}. In Section \ref{discussion:sec}, we discuss how our result matches current observations concerning potential extragalactic and Galactic cosmic ray sources. We also discuss the implications of this result on the interpretation of neutrino, gamma-ray and magnetic field data within current astrophysical cosmic ray interaction models. In Section \ref{sum:sec}, we summarize our result and give an outlook to future applications. \newpage \section{Acceleration theory: calculation of the electron-to-proton ratio \label{calc:sec}} In most literature the ratio of differential particle numbers $\frac{\mathrm{d}N_e}{\mathrm{d}p_e}\big/\frac{\mathrm{d}N_p}{\mathrm{d}p_p}$ and the ratio of the total luminosities $K_{ep}$ is used equivalently. In addition, a ratio of $K_{ep}=1/100$ is usually applied, assuming spectral indices of $\alpha_e=\alpha_p=2.2$. These assumptions are not reflected in reality. In \cite{snr_matthias}, for instance, it is shown that the assumption of equal spectral indices does not need to hold. Here, we calculate the ratio of luminosities, leading to the prediction of the electron-to-proton ratio for different combinations of indices. In this section, we separate the calculation into two parts: derivation of an effective normalization ratio $A_{ep}=A_{\rm e}/(A_{\rm p} \eta)$ with $A_i$ as it is defined in Eq.\ \ref{eq:powerLaw} and the remaining part of the integral to determine the ratio of luminosities $K_{\rm ep}$. We further provide estimates of the ratio of the different particle spectra as a function of the primary energies, $\widetilde{K}_{\rm ep}(E_{\rm p},\,E_{\rm e})$. \subsection{Normalization ratio \label{norm:subsec}} As a first step of the calculations the ratio of normalizations constants $A_{\rm e}$ and $A_{\rm p}$ corrected by the factor $\eta$ is derived. We follow the calculations of \cite{schlickeiser2002}, without applying any approximations and allowing for different spectral indices for electrons and protons, i.e.\ $\alpha_e\neq \alpha_p$ but in addition we account for a possible difference in the number of accelerated particles (see Eq. \ref{eq:eta}). Using the assumption that the total particle number for protons and electrons is the same, one obtains: \begin{align} \eta\cdot N_{\rm p} &= N_{\rm e} \\ \eta\cdot\frac{A_{\rm p}}{\alpha_{\rm p}-1}(T_{0, {\rm p}}^2+2T_{0, {\rm p}}m_{\rm p})^{-\frac{\alpha_{\rm p}-1}{2}} &= \frac{A_{\rm e}}{\alpha_{\rm e}-1}(T_{0, {\rm e}}^2+2T_{0, {\rm e}}m_{\rm e})^{-\frac{\alpha_{\rm e}-1}{2}}\, . \end{align} This leads directly to the following relation which cannot be simplified any further: \begin{equation} A_{ep}=\frac{A_{\rm e}}{A_{\rm p}}\cdot\eta^{-1}=\frac{{(\alpha_{\rm e}-1)}(T_{0, {\rm p}}^2+2T_{0, {\rm p}}m_{\rm p})^{-\frac{\alpha_{\rm p}-1}{2}}}{{(\alpha_{\rm p}-1)}(T_{0, {\rm e}}^2+2T_{0, {\rm e}}m_{\rm e})^{-\frac{\alpha_{\rm e}-1}{2}}}\cdot\eta^{-1}\, . \label{eq:norm} \end{equation} \subsection{Integration\label{integral:subsec}} The integration in (\ref{eq:Ltot2}) is performed over the kinetic energy $T$ so we start with rewriting the differential particle numbers. \begin{equation} \frac{{\rm d}N_i}{{\rm d}T_i}=\frac{\partial{N_i}}{\partial{p_i}} \cdot \frac{{\rm d}p_i}{{\rm d}T_i}\\ =A_{{\rm i}}\cdot(T_i+m_i)\cdot(T_i^2+2T_im_i)^{-\frac{\alpha_i+1}{2}} \label{eq:dN} \end{equation} Substituting relation (\ref{eq:dN}) into the formula for the total luminosity $L_{\rm tot}$ (\ref{eq:Ltot2}) we get: \begin{equation} L_{\rm tot,i}=\int_{T_{0,i}}^{T_{\max,i}}dT_{i}\,A_{\rm i}\cdot(T_{\rm i}+m_{\rm i})\cdot(T_{\rm i}^2+2T_{\rm i}m_{\rm i})^{-\frac{\alpha_{\rm i}+1}{2}}\cdot T_i := A_{\rm i} \cdot L^0_{\rm tot,i}\, .\label{eq:Ltot2} \end{equation} The integral $L^0_{\rm tot,i}$ can be separated into four parts, yielding: \begin{align} L^0_{\rm tot, i}&=\int_0^{T_{\rm max, i}} {\rm d}T\, T^2\cdot(T^2+2mT)^{-a} - \int_0^{T_{0, {\rm i}}} {\rm d}T\, T^2\cdot(T^2+2mT)^{-a} \notag \\ &+ \int_0^{T_{\rm max, i}} {\rm d}T\, Tm\cdot(T^2+2mT)^{-a} - \int_0^{T_{0, {\rm i}}} {\rm d}T\, Tm\cdot(T^2+2mT)^{-a} \end{align} where $a=(\alpha+1)/(2)$. This is possible in such a way that each of these integrals is analytically well defined and converges for nearly all physically interesting parameters. These integrals can be transformed into integrals with a well known solution in form of hypergeometric functions ${_2}F_1(a, b; c; z)$ \cite{ABR72}: \begin{equation} \int_0^1{\rm d}t\, t^{b-1}\cdot(1-t)^{c-b-1}\cdot(1-tz)^{-a} = \frac{\Gamma(b)\Gamma(c-b)}{\Gamma(a)}\cdot{_2}F_1(a, b; c; z)\, . \label{eq:Abramowitz} \end{equation} The analytic continuation of the hypergeometric function for $z\gg 1$ converges if the physical parameter fulfills $\alpha\notin Z$ \cite{WOL}. Subsequent to the fixing of $a,b,c$ and $z$ we obtain the following result: \begin{align} L^0_{\rm tot, i}(m,a) = \frac{(2m)^{-a}}{(3-a)(2-a)}\cdot &\left[(2-a)\cdot T_{\rm max, i}^{3-a} \cdot {_2}F_1\left(a, 3-a; 4-a; -\frac{T_{\rm max, i}}{2m}\right)\right. \notag \\ &+ (a-2)\cdot T_{0, {\rm i}}^{3-a}\cdot {_2}F_1\left(a, 3-a; 4-a; -\frac{T_{0, {\rm i}}}{2m}\right) \notag \\ &+ (3-a)\cdot mT_{\rm max, i}^{2-a}\cdot {_2}F_1\left(a, 2-a; 3-a; -\frac{T_{\rm max, i}}{2m}\right) \notag \\ &+ \left.(a-3)\cdot mT_{0, {\rm i}}^{2-a}\cdot {_2}F_1\left(a, 2-a; 3-a; -\frac{T_{0, {\rm i}}}{2m}\right) \right]\label{eq:L0tot} \end{align} Finally, the luminosity ratio of electrons and protons can be expressed as \begin{align} K_{ep}=A_{\rm ep}\cdot\frac{L^0_{\rm tot, i}(m_{\rm e},\frac{\alpha_{\rm e}+1}{2})}{L^0_{\rm tot, i}(m_{\rm p},\frac{\alpha_{\rm p}+1}{2})} \, . \end{align} It is worth noticing that no algebraic approximations are necessary to obtain this result. This is in contrast to the approximated ratio, based on the calculation of the comparison of the differential particle fluxes, where it is usually assumed that the minimum kinetic energy is much smaller than the particle masses, $T_0\ll m_e,\,m_p$, see e.g.\ \cite{schlickeiser2002}. When we calculate $K_{\rm ep}$ for the same parameters as given in \cite{persic_rephaeli2014} we derive very similar results. \subsection{Differential particle number\label{number:subsec}} For certain scenarios, it can be more useful to work with the ratio of the differential particle flux, which we define as \begin{equation} \widetilde{K}_{\rm ep}(p_e,\,p_p)=\frac{\frac{{\mathrm d}N_{\rm e}}{\mathrm{d}p_{\rm e}}(p_e)}{\frac{{\mathrm d}N_{\rm p}}{\mathrm{d}p_{\rm p}}(p_p)} \end{equation} and can be rewritten as: \begin{equation} \widetilde{K}_{\rm ep}(T_{\rm{e}}, T_{\rm{p}})=A_{{\rm ep}}\cdot \frac{T_{\rm e}+m_{\rm e}}{T_{\rm p}+m_{\rm p}}\cdot\frac{{(T_{\rm e}^2+2T_{\rm e}m_{\rm e})}^{-\frac{\alpha_{\rm e}+1}{2}}}{({T_{\rm p}^2+2T_{\rm p}m_{\rm p})}^{-\frac{\alpha_{\rm p}+1}{2}}} \quad . \end{equation} Proton and electron spectra are directly linked to their photon (or neutrino) emission spectra. Hadronic interactions produce neutral and charged pions and kaons, which lead to high-energy photon and neutrino emission, while synchrotron radiation, Inverse Compton processes and bremsstrahlung are the main channels for electromagnetic radiation from electrons (see \cite{snr_matthias} and references therein). It is often the case that broadband information is not available, but that correlation studies are done in a limited frequency band. As an example, for the mono-chromatic approximation of synchrotron radiation, a single observed frequency at radio wavelengths can be approximated as coming from one energy (or momentum $p_e$) in the energy spectrum and a similar approximation can be done in the case of the correlation between hadronic gamma-rays and protons (momentum $p_{\rm p}$). The choice of frequency in both cases depends on the available data and therefore, it is realistic that $p_e\neq p_p$. For each individual case, it is therefore important to define beforehand to which frequencies or frequency range the calculation relates. Concrete astrophysical examples are discussed in this paper in Section \ref{discussion:sec}. \newpage \section{Results \label{results:sec}} In this section, we investigate the uncertainties of the ratios of electrons and protons considering the normalization ratio $A_{\rm e,p}$, the differential number ratio, $\widetilde{K}_{\rm ep}$, and the luminosity ratio, $K_{\rm ep}$. Consequences for the modeling of galactic and extragalactic cosmic ray sources are discussed in Section \ref{discussion:sec}. \subsection{Normalization} \label{ssec:Normalization} According to the common approach the minimum energy for the normalization ratio $A_{\rm e,p}$ is fixed to $T_0=10$~keV (e.g.\ \cite{schlickeiser2002, persic_rephaeli2014}). However, it is plausible that an equal minimum energy does not need to hold at all acceleration sides. If the minimum energy for an effective acceleration is connected to the gyro-radius it will differ significantly for protons and electrons. Bell showed in \cite{Bell1978_II} that the minimum energy for accelerated electrons should be higher than for protons because they are more likely scattered inside the shock front which prevents an efficient acceleration. It should be mentioned that other authors, like Morlino, show that also a spread of the minimum energy is possible, due to the injection of electrons coming from high energy ions \citep{Morlino2009}. Furthermore, Malkov and V\"olk did some calculations on the transition between the thermal and the accelerated spectrum based on diffusive particle acceleration at parallel shocks which might be a good starting point for further research on the transition region \cite{Malkov1995}. Before we looked into the consequences of different minimum energies for protons and electrons we examined the influence of a varying but equal minimum energy. In \cite{Bell1978_II} the relation between the shock speed $v_{\rm shock}$ and the minimum energy $T_0$ is given by: \begin{equation} T_0 = 4\cdot\left(\frac{1}{2}mv_{\rm shock}^2\right)\, .\label{eq:ShockSpeed} \end{equation} In Fig.\ \ref{fig:Norm} the normalization ratio $A_{\rm ep}$ is shown for different minimum energies and some exemplary combinations of spectral indices. On the two axes the minimum energy $T_0$ and the corresponding shock speed $v_{\rm shock}$ are displayed. It is clearly visible that only shock velocities above a few thousand kilometers per second, $v_{\rm shock}\gtrapprox 5000$~km/s have a significant influence on the normalization ratio. The normalization ratio is nearly constant for equal minimum energies up to $T_{0, {\rm i}}\leq0.1$~MeV. For higher energies the ratio increases with a power law behavior. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_01} \caption{The shock speed is calculated corresponding to \cite{Bell1978_II} and Eq. \ref{eq:ShockSpeed}.}\label{fig:Norm} } \end{figure} Figure \ref{fig:Norm_Contour} shows the normalization ratio for different minimum energies. We assume, here and for all other figures and calculations, that $\eta=1$ to emphasize the influence of the different minimum energies and not the influence of different particle numbers. Here it is clearly visible that different acceleration mechanisms or efficiency scales have an significant impact on the normalization ratio. Therefore, it is mandatory to look into the details of the acceleration process to correctly use the formulas provided in this paper. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_02} \caption{Normalization ratio $A_{\rm e,p}$ for different minimum energies for protons and electrons, $T_{0,{\rm p}}\neq T_{0,{\rm e}}$.}\label{fig:Norm_Contour} } \end{figure} For further investigations of $K_{\rm ep}$ and $\widetilde{K}_{\rm ep}$ we use the conventional minimum energy of $T_{0, {\rm e}}=T_{0, {\rm p}}=T_0=10$~keV, if not otherwise stated. \subsection{Luminosity ratio $K_{\rm ep}$} The luminosity ratio depends on the maximum energy used for the integration. Here, we present the results for galactic sources, accelerating particles up to at least the knee, i.e.\ we consider a maximum energy of $10^{6}$~GeV$<E_{\max}=E_{p, \max}=E_{e, \max}<10^{8}$~GeV (see e.g.\ \cite{biermann1993,biermann_apj2010}), as well as for extragalactic sources, accelerating particles to beyond the ankle, i.e.\ $E_{\max} \sim 10^{12}$~GeV. As we consider protons here, the acceleration might be somewhat less than $10^{11}$~GeV and we consider a range of $10^{8}$~GeV$<E_{\max}=E_{p, \max}=E_{e, \max}<10^{10}$~GeV to account for the fact that a possible present fraction of heavy nuclei would dominate the spectrum with their maximum energy at the highest energies of $10^{12}$~GeV. \paragraph{Galactic Cosmic Rays} \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_03} \caption{The luminosity ratio $K_{\rm ep}$ does not dependent strongly on the maximum energy $T_{\rm {max}}=T_{\rm{p, max}}=T_{\rm{e, max}}$ but some differences between equal (solid lines) and different (dashed lines) indices are visible.}\label{kep_gal} } \end{figure} The luminosity ratios for galactic sources are shown in Fig.\ \ref{kep_gal}, as a function of the maximum energy. The standard approach is to take equal spectral indices for electrons and protons, i.e.\ $\alpha_e=\alpha_p=\alpha$. In the figure, we show the variation of indices in the range $2.0<\alpha<2.3$. For equal indices, we find that the luminosity ratio does not vary with the maximum energy at all, but gives different values depending on the choice of the spectral index, i.e.\ between $0.04<K_{\rm ep}<0.07$. When applying a slight difference between the spectral indices, i.e.\ $\Delta\alpha=\alpha_e-\alpha_p=-0.1$ the ratio becomes significantly larger and slightly energy dependent. In that case, the ratio is rather in the range of $K_{\rm ep}\sim 0.10-0.11$ when the kinetic energy is about $T=10^{6}-10^8$~GeV. For the opposite case, meaning $\Delta \alpha =+0.1$, the ratio becomes significantly smaller and the energy dependence is less pronounced. Here, the ratio is in the range of $K_{\rm ep}\sim 0.012-0.03$ when the kinetic energy is about $T=10^{6}-10^8$~GeV. Figure \ref{kep_gal_contour} shows a contour plot in more general terms, i.e.\ the luminosity ratio for arbitrary spectral index combinations for absolute values of $2.0<\alpha_e,\,\alpha_p<2.3$ for a maximum energy of $T=10^{6}$~GeV. Thus, the figure includes at maximum a relatively large difference between the spectral indices of $|\Delta\alpha|=0.3$. In these most extreme cases, the ratio varies between $0.004<K_{\rm ep}<0.6$ for $T=10^{6}$~GeV. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_04} \caption{Galactic luminosity ratio $K_{\rm ep}$ at a fixed maximum kinetic energy of $T_{\max}=10^{6}$~GeV and for arbitrary spectral index combinations in the range of $2.0<\alpha_{\rm e},\,\alpha_{\rm p}<2.3$. The red star indicates the conventional ratio with $\alpha_{\rm e, p}=2.2$.}\label{kep_gal_contour} } \end{figure} \paragraph{Extragalactic Cosmic Rays} \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_05} \caption{Luminosity ratio $K_{\rm ep}(T_{\max})$ for different pairs of spectral indices $\alpha_e,\,\alpha_p$. Equal spectral indices (solid lines) lead to the same constant ratio as for the galactic energy range. A difference in the spectral indices (dashed lines) of $\delta \alpha=-0.1(+0.1)$ leads to a ratio about one order of magnitude higher (lower). Furthermore, some index combinations lead to a energy dependent behavior.}\label{kep_extragal} } \end{figure} For extragalactic sources, results for the maximum energy dependent luminosity ratio are shown in Fig.\ \ref{kep_extragal}, in the same way as for galactic sources. Here, the luminosity ratio in the case of equal indices varies between $0.03<K_{\rm ep}<0.07$, just as for galactic sources, as there is no energy dependence. Again, for a difference in the spectral indices of protons and electrons of $\Delta\alpha=-0.1(+0.1)$, the ratio becomes larger (smaller) and energy dependent, so that it lies in a range $K_{\rm ep}\sim 0.10-0.12 (0.009-0.03)$. Due to the moderate energy dependence of $K_{\rm ep}$ for the case of $\alpha_e\neq \alpha_p$, the ratio is slightly higher for extragalactic sources as compared to galactic ones. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_06} \caption{Luminosity ratio $K_{\rm ep}$ at a fixed maximum kinetic energy of $T_{\max}=10^{10}$~GeV and for arbitrary spectral index combinations in the range of $2.0<\alpha_e,\,\alpha_p<2.3$. The red star indicates the conventional ratio with $\alpha_{\rm e, p}=2.2$.}\label{kep_extragal_contour} } \end{figure} The contour plot for a fixed maximum energy of $10^{10}$~GeV and spectral indices in the range $2.0<\alpha_e,\,\alpha_p<2.3$ is shown in Fig.\ \ref{kep_extragal_contour}. The standard value of $(\alpha_e,\,\alpha_p)=(2.2,\,2.2)$ is indicated as a star. For the most extreme deviations of $|\Delta\alpha|=0.3$, the results range from $0.0026<K_{\rm ep}<0.8$. A difference between the indices of $0.3$ is rather large, so it is expected that the actual variation is significantly smaller, i.e.\ rather as we discuss it in Fig.\ \ref{kep_extragal}. Here, it becomes obvious that the energy dependence of the luminosity ratio turns out to be rather weak so that the ranges for galactic and extragalactic sources actually are comparable. \paragraph{Different minimum energies} In this paragraph we show exemplarily how the luminosity ratio $K_{\rm ep}$ is influenced by different minimum energies for protons and electrons, $T_{0,{\rm p}}\neq T_{0,{\rm e}}$. Since the exact principle of the acceleration mechanism at the sources of cosmic rays is not yet completely understood and a variety of different theories exist a difference in the minimum energies is in principle possible. For this example we decided to use the approach given in \cite{Bell1978_I, Bell1978_II}. Here, the main assumption is that particles will only be efficiently accelerated if they do scatter inside the shock front. Meaning the gyro-radius of the particles has to be larger than the thickness of the shock front. Due to the mass difference this leads to the fact that the minimum energy of the electrons has to be about three orders of magnitudes larger than the one of the protons. In Fig.\ \ref{fig:GalConDiff} the influence of a higher electron minimum energy is shown. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_07} \caption{The difference in the minimum energies shifts the whole co-domain of $K_{\rm ep}$ to lower values compared to Fig.\ \ref{kep_gal_contour}. Furthermore, the influence of $\alpha_{\rm e}$ is less strongly.}\label{fig:GalConDiff} } \end{figure} In addition to the particular case described in Fig.\ \ref{fig:GalConDiff} the difference in the influence of the minimum energy and spectral indices is shown in Fig.\ \ref{fig:GalConRatio}. Here, the minimum electron energy is fixed to an arbitrary value of $T_{0,{\rm e}}=1000\,$~keV and the electron spectral index is set to $a_{\rm e}=2.1$. On the first axis we used the ratio of the minimum energies $T_{0,{\rm p}}/T_{0,{\rm e}}$ and on the second axis the difference of the spectral indices $\Delta \alpha=\alpha_{\rm e} -\alpha_{\rm p}$ to display the impact of these parameter sets. It shows that the different minimum energies have a large impact on the value of $K_{\rm ep}$. Hence, a detailed knowledge of the acceleration process and the injection condition in particular is needed, in order to fix the luminosity ratio. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_08} \caption{It is clear that different minimum energies have an impact on the luminosity ratio for all combinations of spectral indices. With increasing $T_{0,{\rm p}}/T_{0,{\rm p}}$ the influence of the spectral index difference $\Delta a$ decreases.}\label{fig:GalConRatio} } \end{figure} \subsection{Differential particle number ratio $\widetilde{K}_{\rm ep}$} Different calculations for astrophysical non-thermal emission make use of a delta-functional approach by, for instance, coupling one frequency in the synchrotron spectrum of electrons to a single electron energy. Such approaches require the differential treatment of the ratio: \begin{equation} \widetilde{K}_{\rm ep}(T_{\rm{e}}, T_{\rm{p}})=A_{{\rm ep}}\cdot \frac{T_{\rm e}+m_{\rm e}}{T_{\rm p}+m_{\rm p}}\cdot\frac{{(T_{\rm e}^2+2T_{\rm e}m_{\rm e})}^{-\frac{\alpha_{\rm e}+1}{2}}}{({T_{\rm p}^2+2T_{\rm p}m_{\rm p})}^{-\frac{\alpha_{\rm p}+1}{2}}} \label{eq:ktildeep}\quad . \end{equation} For sufficiently high kinetic energies $T\gg m_{\rm p}$ and $T_{\rm e}=T_{\rm p}=T$, the differential ratio $\widetilde{K}_{\rm ep}$ is proportional to the kinetic energy to the power of the difference of spectral indices: $\widetilde{K}_{\rm ep}\propto T^{\alpha_{\rm p}-\alpha_{\rm e}}$. \paragraph{Galactic Cosmic Rays} Figure \ref{ktildeep_gal} shows the differential number ratio as a function of energy for galactic sources and different spectral indices. Again, the result is independent of energy for equal proton and electron spectral indices, but it varies with the exact chosen value of the index. In case of a differential treatment, the range of values is $0.008<\widetilde{K}_{\rm ep}<0.023$. The behavior becomes energy dependent when allowing for different proton and electron spectral indices. First we analyze the conservative case of a fixed index difference $\Delta\alpha=-0.1(+0.1)$, where the value of $\widetilde{K}_{\rm ep}$ varies in the range $0.035 (0.0008)<\widetilde{K}_{\rm ep}<0.23 (0.005)$, depending on the exact index and maximum energy. This behavior is shown in Fig.\ \ref{ktildeep_gal}. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_09} \caption{The particle number ratio $\widetilde{K}_{\rm ep}$ for typical galactic source energies. Even for the lowest energies the asymptotic behavior ($\widetilde{K}_{\rm ep}={\rm const} (\propto T^{-\Delta\alpha}))$ is already pronounced.}\label{ktildeep_gal} } \end{figure} The contour plot in Fig.\ \ref{ktildeep_contour_gal} shows the non-conservative case, when allowing for free indices of $2.0<\alpha_i<2.3$. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_10} \caption{The particle number ratio $\widetilde{K}_{\rm ep}$. The red star indicates the conventional ratio with $\alpha_{\rm e, p}=2.2$.}\label{ktildeep_contour_gal} } \end{figure} Here a range of $3\cdot10^{-5}<\widetilde{K}_{\rm ep}<5.8$ is possible for a maximum energy of $T=10^{6}$~GeV. This range is much larger than for $K_{\rm ep}$, because of the strong energy dependence $\widetilde{K}_{\rm ep} \propto (T/{\rm MeV})^{\alpha_{\rm p}-\alpha_{\rm e}}$. This strong dependence leads to a simple approximation of $K_{\rm ep}$, which corresponds to the first order Taylor approximation of the formula \ref{eq:ktildeep}: \begin{align} \widetilde{K}_{\rm ep}(T, T) \approx A_{\rm ep} \cdot \left(\frac{T}{{\rm MeV}}\right)^{\alpha_{\rm p}-\alpha_{\rm e}} \quad , \end{align} which is very accurate and should be sufficient in most cases. \paragraph{Extragalactic Cosmic Rays} The differential particle number ratio $\widetilde{K}_{\rm ep}$ for extragalactic sources does not differ from galactic sources in the case of equal indices. For slight differences in the spectral behavior of $\Delta\alpha = -0.1(+0.1)$ the spread of $\widetilde{K}_{\rm ep}$ is nearly the same as for galactic sources but the absolute value is, due to the energy dependence, higher. The graphs in Fig.\ \ref{ktildeep_exgal} show a variation of $\widetilde{K}_{\rm ep}$ in the energy range from $T=10^8-10^{10}$ GeV from $0.11 (0.0005)< \widetilde{K}_{\rm ep} < 0.37 (0.0016)$. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_11} \caption{The particle number ratio $\widetilde{K}_{\rm ep}$ for different maximum energies typical for extragalactic sources. The energy dependence is clearly visible in the case of differing indices}\label{ktildeep_exgal} } \end{figure} Finally the restriction of a fixed difference in the spectral behavior is dropped and the full width of theoretically allowed spectra is calculated. The results are shown in figure \ref{ktildeep_contour_exgal}. This figure shows that very significant differences from the well known value of $\widetilde{K}_{\rm ep}=1/100$, if one allows for slightly bigger variation in the indices. The values cover the whole range from $7.7\cdot10^{-6} <\widetilde{K}_{\rm ep} < 92.3 $. \begin{figure} \centering{ \includegraphics[height=.35\textheight]{Figure_12} \caption{The particle number ratio $\widetilde{K}_{\rm ep}$ if no restriction on the differences in the spectral indices are made. The red star indicates the conventional ratio with $\alpha_{\rm e, p}=2.2$.}\label{ktildeep_contour_exgal} } \end{figure} \paragraph{Different minimum energies} The influence of different minimum energies $T_{0,{\rm p}}\neq T_{0,{\rm e}}$ on the differential particle number ratio $\widetilde{K}_{\rm ep}$ is limited to the change of the normalization ratio $A_{\rm e,p}$ according to Eq. \ref{eq:ktildeep}. Therefore, we refer the reader to section \ref{ssec:Normalization} to examine the change of $\widetilde{K}_{\rm ep}$ with varying minimum energies since the general shape of the Figs. \ref{ktildeep_gal}, \ref{ktildeep_contour_gal}, \ref{ktildeep_exgal} and \ref{ktildeep_contour_exgal} is not changed. \newpage \section{Discussion of the results\label{discussion:sec}} The central conclusion from the results above, independent on the examined source, is that there is a significant difference in the absolute values of the electron to proton ratio when considering the differential number and the integral luminosity measure. The differential number ratio is directly given by $A_{\rm ep}$ in the case of equal electron and proton spectral indices. The luminosity measure, on the other hand, is modified even for equal indices by a factor $L_{\rm tot}^{0}\left(m_e\right)/L_{\rm tot}^{0}\left(m_p\right)$. The change in the results is striking, as we receive values that are a factor $5$ higher for the luminosity measure as compared to the differential value. This is an important piece of information when trying to compare theoretical and experimental values. From astrophysical observations, the number derived often corresponds to an integral value. For instance, when estimating the galactic or extragalactic values for the electron to proton ratio, it is not possible to use differential values, as the spectral behavior of the cosmic rays is modified by transport. The only possibility is to use the luminosity measure, i.e.\ integrating over the energy range that seems relevant in the given context. The number of $K_{\rm ep}=0.01$ is derived for the Milky Way by comparing the total electron and proton luminosities at Earth (see e.\ g.\ the proton and electron fluxes given by the AMS collaboration \cite{AMS_Proton, AMS_electron}). The number of $K_{\rm ep}=0.1$ is derived when comparing the cosmic ray luminosity above the knee with radio emission from active galaxies or gamma-ray bursts, assuming that the radio emission comes from electrons that are co-accelerated with the hadronic cosmic rays (see e.\ g.\ \cite{saba2014, waxman_bahcall1997}). There is a central difficulty connected to this insight: the luminosity ratio bears the uncertainties of the choice of integration limits, both for the experimental number and the theoretical calculation. And as the energy spectra compared in observations contain two large uncertainties for the estimation of the luminosity ratio: (1) the spectra are modified by transport effects (mostly losses by radiation processes and/or diffusion) and this also effects the energy range; (2) the hadronic cosmic ray spectrum is a mixture of different sources, it is clearly composed of both a Galactic population and an extragalactic one. In particular for the estimate of the extragalactic population (or even populations), it is important to know how much these sources contribute towards low energies, as it is the lower integration threshold that determines the total luminosity. Further, there are theoretical calculations that actually request the differential number ratio $\widetilde{K}_{\rm ep}$, but instead the value derived from the observational data, i.e.\ the luminosity ratio $K_{\rm ep}$, is used. In the following paragraphs, we will discuss the different source classes and how our findings effect the calculations that rely on the electron to proton ratio. \subsection{Galactic cosmic rays} In \cite{snr_matthias}, a sample of 24 remnants with spectral information from radio up to $>$~GeV energies has been examined statistically, with a large fraction of sources being likely to have a dominant hadronic signature at high gamma-ray energies \cite{snr_matthias}. Here, the hadronic spectra tend to show spectral indices around $\alpha_p\approx 2.3$, while the electron spectra scatter around $\alpha_e\approx 2.0$. This result is striking, as it is expected that the electron spectra should rather be steeper than the proton spectra due to the larger energy loss processes that the electrons suffer from. Standard particle acceleration theory suggests the same spectral behavior for protons and electrons. However, the experimental data cited above refer to different momenta where already very tiny deviations from the standard theory may imply such differences. A non-uniform behavior of the spectral indices is supported by observations, e.g.\ the CREAM data \cite{CreamData}. Furthermore, this sample only represents a subclass of well-identified SNRs with a broad range of spectral indices. In addition the observed spectra are modified through loss processes. Despite these facts it is shown that a treatment of equal spectral indices might not work for individual sources. Furthermore, the temporal development of supernova remnants (see e.g.\ \cite{cox1972,cristofari2013}) results in a change in maximum energy of the non-thermal particle spectra $T_{\max}=T_{\max}(t)$. According to the findings in this paper, this should also change the electron to proton ratio. However, this change might be negligible when compared to the uncertainties in the determination of the ratio from the electron and proton spectral indices. The derivation of the luminosity ratio from astrophysical data has to be taken with care, since it is determined from the ratio of the diffuse flux of electrons and protons in the Galaxy, i.e.\ \begin{equation} K_{\rm ep}=\frac{L_{\rm e, obs}}{L_{\rm CR, obs}} \end{equation} There are two central uncertainties in this calculation: \begin{itemize} \item The proton luminosity is determined above 1 GeV, as the spectrum is modified by ionization losses in the interstellar medium and by solar modulation at lower energies. In theory, acceleration is effective from above $T_{0}\approx 10$ keV , which we also use in our calculation. As the cosmic ray spectrum decreases with energy as $\approx E_{\rm CR}^{-2.7}$, the integral luminosity behaves as $E_{\min}^{-0.7}$. For protons, below one GeV, there is a break in the spectrum, as the power-law behavior is in momentum and not in kinetic energy, so the contribution that is added will increase weaker than $E_{\min}^{-0.7}$. Still, an increase of the proton luminosity by a factor of a few can be expected. \item The electron luminosity observed at Earth is highly loss-dominated: electrons lose large parts of their energy to synchrotron, inverse compton and bremsstrahlung losses on their way to Earth. This implies that part of the energy budget of cosmic electrons is lost to the thermal pool. It is therefore expected that the total non-thermal electron luminosity of the Galaxy is significantly higher than observed at Earth, which increases the electron to proton luminosity ratio. \end{itemize} \subsection{Magnetic fields and starburst galaxies} Many authors try to derive the magnetic field strength of other galaxies. Starburst regions are of special interest because of their large star forming rate. These environments allow for example to probe the role of magnetic fields in the early universe \cite{Adebahr2013}. An example for the derivation of magnetic fields in nearby starburst galaxies is given by \cite{Adebahr2013} and \cite{Heesen2009}. They calculate the mean magnetic field strength in M 82 and NGC 253 from observational data. In order to derive the magnetic field strength from the observed synchrotron emission spectra of the electron component Beck \& Krause provide in \cite{beck_krause2005} formulas for the equipartition magnetic field in a galaxy, depending on the differential number ratio: \begin{equation} B_{\rm eq} = \left\{\frac{4\pi(2\alpha+1)\cdot (\widetilde{K}_{\rm ep}+1)\cdot I_{\nu}\cdot E_{\rm p}^{1-2\alpha}\cdot \left(\frac{\nu}{\nu_{0}}\right)^{\alpha}}{(2\alpha-1)\cdot b(\alpha)\cdot l \cdot (2/3)^{(\alpha+1)/2}}\right\}^{(\alpha+3)^{-1}}\,. \end{equation} Here, $\alpha$ is the synchrotron spectral index, which is connected to the electron spectral index as $p_e = 2\alpha+1$. $I_{\nu}$ is the synchrotron intensity, $\nu_0$ is a reference frequency and $b(\alpha)$ is a function that depends weakly on $\alpha$. Both parameters are defined in \cite{beck_krause2005}, and the exact definitions are not important in this context as we want to discuss the dependence on $\widetilde{K}_{\rm ep}$, which is $B_{\rm eq}\propto \left(\widetilde{K}_{\rm ep}+1\right)^{(\alpha+3)^{-1}}$. For typical values of $\alpha\approx 0.5-1$, the behavior is close to $B_{\rm eq}\propto \left(\widetilde{K}_{\rm ep}+1\right)^{1/4}$. For values between $\widetilde{K}_{\rm ep} \approx 0.01 - 0.1$, which we find to be realistic, the difference in the calculation is 2\% or less. Thus, any possible change in the ratio due to a more propper description of the underlying theory is negligible. However, if very extreme differences in the spectral indices of electrons to protons should be present for some reason, for instance $\Delta \alpha =\pm 0.3$, the differential number density varies between $10^{-5}<\widetilde{K}_{\rm ep}<10$ for galactic sources. In that case, the results change by over 50\%. There are no indications at this point that the differences in the spectra can be that large, but it cannot be excluded at this point either. Lacki \& Beck \cite{lacki_beck2013} revised the above calculation for those galaxies that are loss-dominated, i.e.\ where the observed synchrotron radiation predominantly comes from electrons produced in cosmic ray interactions with the interstellar medium. This is the case for starburst galaxies with high cosmic ray fluxes and high densities. In the calorimetric case, the primary to secondary ratio $\kappa = n_{\rm sec.}/(n_{\rm sec.} + n_{\rm prim.})$ becomes $1$. This means it is independent on any theoretical argument of how electrons are accelerated with respect to protons. However, Eichmann \& Tjus \cite{eichmann_beckertjus2016} used recently a more rigorous description of the transport and loss processes in starburst regions. Taking diffusion and advection as well as several different loss processes for protons and electrons into account they could show that some reasonable parameter configurations are dominated by primary electrons. Although most, including the best-fit, models show a domination by secondary electrons a dominating primary electron component is not ruled out. These arguments suggest a treatment of $\widetilde{K}_{\rm ep}$ as described above also in the case of starburst regions, especially for configurations with low target densities (up to $n_{\rm target}=1/{\rm cm}^3$). \subsection{Extragalactic sources of ultrahigh energy cosmic rays} \label{ssec:ExtragalacticSources} Since we have now strong evidence that M82 is the source of the TA hot spot \cite{Abbasi2014, Fargion2015} one may take tidal disruption events in starburst galaxies as possible sources of UHECR into account. Furthermore, Gamma-ray bursts (GRBs) have long been discussed as one of the few source classes being able to surpass the Hillas-limit for $10^{20}$~eV cosmic rays, necessary to explain the cosmic ray flux above the ankle \cite{waxman_bahcall1997}. Recently, strong limits on the parameter space of the average Lorentz factor $\Gamma$ of GRBs and the electron to proton luminosity fraction $K_{\rm ep}$ \cite{icecube_nature_grbs}. Here, the model of photohadronic neutrino production as first presented in \cite{waxman_bahcall1997} and later refined in e.g.\ \cite{guetta2004,becker2006,icecube22} was used in order to derive limits to the above mentioned parameter space from the fact that no neutrinos were observed in an analysis of 117 bursts detected at gamma-ray energies (keV-MeV region). The photohadronic neutrino production model in GRBs was further revised in \cite{winter_prl}, where it was shown that a more detailed treatment of the particle physics lead to a generally lower diffuse flux. For all these calculations, the electron to proton fraction was fixed to $K_{\rm ep}=1/10$, as an approximate value derived from observations. As we have shown in this paper, this value is well supported by theory, {\it if} the spectral indices of protons and electrons are only slightly different. If they are the same, the ratio will rather be smaller, $K_{\rm ep} \sim 0.01$, which actually would enhance the neutrino flux. One of the arguments to use $K_{\rm ep} \approx 0.1$ for the calculation of extragalactic sources is that this number is supported by observations. To derive this number, the luminosity of the cosmic ray spectrum above the ankle is compared to the total radio luminosity of the object, i.e.\ $L_{\rm CR}(E_{\rm CR}>10^{9.5}\,{\rm GeV})/L_{\rm radio}(\nu_{\min},\nu_{\max})$. It turns out to be $0.1$ both when considering gamma-ray bursts and active galaxies. This number is, however, highly uncertain. The extragalactic cosmic ray spectrum might continue towards lower energies, which would increase the nominator in the ratio, thus increasing the ratio itself: \begin{equation} K_{\rm ep}(\rm extragal)=\frac{L_{\rm e}}{L_{\rm CR}^{\rm tot,extrag}} =\eta_{\rm obs}^{-1}\cdot \frac{L_{\rm e}}{L_{\rm CR}} \end{equation} with $L_{\rm CR}^{\rm tot,extrag}=\eta_{\rm obs}\cdot L_{\rm CR}(L_{\rm CR}^{\rm tot,extrag}/L_{\rm e})$ and $\eta_{\rm obs}>1$. On the other hand, only a fraction of the total energy in electrons might be transferred to synchrotron radiation, and in addition, the radio component only represents a part of the total energy, i.e.\ $L_{e}=\chi(B,\nu_{\min},\nu_{\max})\cdot L_{\rm radio}>L_{\rm radio}$. Thus, the luminosity ratio becomes \begin{equation} K_{\rm ep}(\rm extrag)=\frac{\chi(B,\nu_{\min},\nu_{\max})}{\eta_{\rm obs}}\cdot \frac{L_{\rm CR}}{L_{\rm e}}\,. \end{equation} The same arguments that are used for GRBs are also used when determining the neutrino flux for active galactic nuclei (AGN), see e.g.\ \cite{becker2008} for a review. In \cite{becker2014}, $\chi$ was determined to be $\chi\approx 100$ for magnetic field values below about 1 Gauss \cite{becker2014}. $\eta_{\rm obs}$, on the other hand, can be equally large, as the cosmic ray spectrum behaves as $E^{-2.7}$ above the ankle. Thus, the cosmic ray luminosity scales with $E_{\min}^{-0.7}$. Reducing the minimum energy by one, two or three orders of magnitude would result in $\eta_{\rm obs}=5,\,25,\,125$, respectively and thus bringing us back to the original number. \newpage \section{Summary and Outlook\label{sum:sec}} In this paper, we reinvestigate the ratio of electrons to protons from a theoretical perspective. In particular, we drop the assumption of equal spectral indices for electrons and protons and distinguish between the ratio of differential energy spectra, $\widetilde{K}_{\rm ep}$ and the luminosity ratio $K_{\rm ep}$. These two definitions are often used as equivalent in the literature. As we can show in this paper, they differ significantly from each other and it is therefore necessary to precisely define how the ratio is used in calculations. In this paper, we present an analytic solution for the luminosity ratio, which can be directly compared to the measured electron and proton luminosity ratio at Earth. Our results lead to the following main conclusions: \begin{enumerate} \item The luminosity ratio is typically higher than the differential ratio, i.e.\ $K_{\rm ep}>\widetilde{K}_{\rm ep}$. This is the case even for equal electron and proton indices, as $\widetilde{K}_{\rm ep}$ is directly given by the ratio of spectral normalizations of the two species, while the luminosity ratio $K_{\rm ep}$ is modified by the ratio of the integral luminosities of the two particle fluxes. Typical values lie around $K_{\rm ep} \sim 0.008-0.1$, and can thus be significantly larger than the value that is typically assumed for sources of galactic cosmic rays, i.e.\ $K_{\rm ep}\sim 0.01$. The differential values vary with energy if the spectral behavior of protons and electrons differ from each other. In the case of same spectral indices in the range $2.0<\alpha<2.3$, the differential ratio is $0.008<\widetilde{K}_{\rm ep}<0.23$, while it can vary significantly more for different spectral indices. For different minimum energies of electrons and protons $K_{\rm ep}$ and $\widetilde{K}_{\rm ep}$ change significantly. However, an equal but varying minimum energy up to $T_0\lessapprox 0.1\,$~MeV has a negligible influence. \item Those ratios of electrons to protons derived from observations typically represent luminosity measures. Even those need to be taken with care, as they are given for certain energy ranges, where cosmic ray phenomena are observable. As an example, the flux of extragalactic hadronic cosmic rays is detected above $3\cdot 10^{18}$~eV, where it is quite clear that the flux must come from extragalactic sources. This energy value is usually used as a lower integration threshold when deriving the required electron to proton ratio of extragalactic sources. However, it is likely that the extragalactic component continues toward lower energies, even if it might be subdominant compared to the Galactic component at these energies, it will still contribute significantly to the complete electron to proton ratio. Thus, theoretical and experimental electron to proton ratios can only be compared when taking these uncertainties into account. \item In particular, calculations of neutrino fluxes for neutrino emission from gamma-ray bursts and active galaxies rely on the estimate of the luminosity ratio. The typical value used here is $K_{\rm ep} = 0.1$ as derived from observations. This number is highly uncertain in both directions as discussed above. From theoretical arguments as presented in this paper, we would rather expect it to be a factor of a few smaller if electron and proton indices are the same, i.e.\ around $K_{\rm ep} \approx 0.01$, which would increase the expected neutrino flux with respect to the presented calculations (e.g.\ \cite{guetta2004,becker2006,Huemmer2012,becker2014}). \item The calculation of magnetic fields from synchrotron depends on the differential ratio $\widetilde{K}_{\rm ep}$ \cite{beck_krause2005}. As the dependence is relatively weak, a change in the number from the typical value of $\widetilde{K}_{\rm ep}=0.01$ only becomes significant when allowing for strong differences between the spectral behavior of electrons and protons. A difference in the spectral index of $\Delta \alpha=0.3$ would result in a $\approx 50\%$ change in the equation to determine the B-field. In sources where the secondary electron population from cosmic ray interactions becomes dominant \cite{lacki_beck2013}, the effect should be negligible. \end{enumerate} In the future, these results can be applied to concrete sources. For those cases, the absolute proton and electron luminosities can be used as an additional criterion to further constrain a possible range of values, as each individual source carries a maximum energy budget that actually can be transferred to cosmic rays. We consider this paper as a first, general study of the phenomena that can be applied more concretely in the future to individual galactic and extragalactic sources, but also when considering the investigation of source populations. \newpage \section*{Acknowledgments} The authors would like to thank Matthias Mandelartz, Micha{\l} Ostrowski, Isaac Saba, Florian Schuppan and Walter Winter for valuable discussions. Furthermore, the authors would like to thank the anonymous reviewer for the valuable comments. This work is supported by the DFG-research unit {\it FOR1048, ``Instabilities, turbulence and transport in cosmic magnetic fields''} and the RAPP Center (Ruhr Astroparticle and Plasma Physics Center), funded by the MERCUR project St-2014-040. LM was partially funded by the Deutsche Studentenf\"orderung of the Konrad Adenauer Stiftung. Further support comes from the research department of plasmas with complex interactions (Bochum). \newpage

\section{Introduction} Chinese spelling correction (CSC) is a task to detect and correct spelling mistakes in Chinese sentences. It has always been an important Chinese NLP task and also gradually becomes an indispensable sub-module for many downstream tasks, such as search query correction \citep{JianfengGao2010ALS}, named entity recognition \citep{wan2011named}, and machine translation \citep{zheng2020opportunistic}. Further exploring the process of input, unlike alphabetic languages, the input of Chinese characters must rely on an input method (or \textbf{i}nput \textbf{m}ethod \textbf{e}ditor, commonly abbreviated IME \footnote{https://en.wikipedia.org/wiki/Input\_method}). Among all Chinese IMEs, pinyin IME \footnote{https://en.wikipedia.org/wiki/Pinyin\_input\_method} is the most popular one, used by more than \textbf{97\%} of Chinese people \citep{chen2000new, zhang2021correcting}. We can infer that most spelling errors are made by people when they input through pinyin IME, such as typing the wrong pinyin, clicking the wrong words, etc. It will be more practical and valuable to pay attention to this scenario. Therefore, this paper focuses on spelling errors generated by pinyin IME. \begin{CJK*}{UTF8}{gbsn} \begin{figure}[t!] \centering \includegraphics[width=0.5\textwidth]{./image/problem.jpg} \caption{It is hard to repoduce the sampled spelling error from SIGHAN (misspelling “错误” as “错勿”) by pinyin IME, no matter what input form is used.} \label{Fig:problem} \end{figure} \end{CJK*} However, there is still no professional benchmark dataset for errors generated by pinyin IME. In this situation, previous research all use SIGHAN13-15 \citep{ShihHungWu2013ChineseSC, LiangChihYu2014OverviewOS, YuenHsienTseng2015IntroductionTS} as baseline datasets, but they cannot accurately evaluate the real performances of CSC systems. (1) The main reason is that errors in SIGHAN datasets come from mistakes in essays written by teenage students (SIGHAN13) or Chinese as a foreign language (CFL) learners (SIGHAN14-15), which has a big gap with errors generated by native speakers through pinyin IME. For example, as shown in Figure \ref{Fig:problem}, many errors in SIGHAN would hardly occur if people use pinyin IME because the modern pinyin IME always has a strong language model and would not recommend very unreasonable candidate words. (2) In addition, sentences in SIGHAN datasets are in traditional Chinese, and even after converting to Simplified Chinese, there is still a big difference in the expression. (3) The data size is too small, for example, SIGHAN13 has only 1,000 test samples, which may make the evaluation results unreliable. \begin{CJK*}{UTF8}{gbsn} \begin{figure}[t!] \centering \includegraphics[width=0.45\textwidth]{./image/example.jpg} \caption{A real post of official media in Sina Weibo, where the “效力于” is misspelled as "效力与".} \label{Fig:example} \end{figure} \end{CJK*} Therefore, in the paper, we first present a \textbf{C}hinese \textbf{S}pelling \textbf{C}orrection \textbf{D}ataset for errors generated by pinyin \textbf{IME} (CSCD-IME). It contains 40,000 manually labeled data, which is ten times larger than SIGHAN datasets. As far as we know, this is also the largest dataset for the CSC task. As shown in Figure \ref{Fig:example}, sentences in the dataset are all real posts of official media (such as Sina Sports) on Sina Weibo and all in Simplified Chinese. We could believe that these errors are generated by editors in the process of typing through pinyin IME, which is consistent with errors made by native speakers in the real input scenario. In order to study the error distribution in depth, we design a tagging system at the pinyin and semantic levels. The comparative analysis shows that the error distribution of CSCD-IME is quite different from existing datasets, with a much higher proportion of word-level errors. In previous research, additional pseudo data is usually used to improve the performance of CSC systems, which is often constructed by ASR based methods \citep{wang2018hybrid} or confusion set based methods \citep{liu2021plome, zhang2021correcting}. However, these construction methods still have a gap with the real Chinese input scene. Therefore, we propose a novel pseudo-data construction method based on pinyin IME. Specifically, we simulate the input process through pinyin IME and add sampled noise to generate pseudo data. In this way, pseudo data can be constructed at scale and high quality. In the end, we experiment with several strong CSC baseline models and perform a series analysis. Experiments show that CMCD-IME is a challenging dataset and our proposed pseudo-data construction method can better fit the real error distribution than previous methods and improve the performance of CSC systems. We also discover how to better use pseudo data, and provide a useful strategy in the appendix, including the data scale, the data source, and the training strategy. \begin{table*} \centering \begin{tabular}{cccccccc} \hline \textbf{Dataset} & \textbf{train size} & \textbf{dev size} & \textbf{test size} & \textbf{all size} & \textbf{avg len.} & \textbf{err. ratio} & \textbf{avg err./sent.} \\ \hline SIGHAN13 & 700 & - & 1,000 & 1,700 & 60.94 & 77.11\% & 1.20 \\ SIGHAN14 & 3,437 & - & 1,062 & 4,499 & 49.66 & 86.19\% & 1.52 \\ SIGHAN15 & 2,339 & - & 1,100 & 3,439 & 31.10 & 81.82\% & 1.33 \\ \hline CSCD-IME & 30,000 & 5,000 & 5,000 & \textbf{40,000} & 57.42 & 46.02\% & 1.09 \\ \hline \end{tabular} \caption{Data statistics, including the size of the training set, the size of development set, the size of the test set, the size of the all dataset, the averaged number of characters per sentence, the ratio of error sentences, and the averaged error characters in each error sentence.} \label{Tab:statistic} \end{table*} \section{Related Work} \textbf{CSC Dataset}: CSC datasets can be divided into two categories according to the user group: CFL learners and native speakers. Among them, the former has richer data resources, including SIGHAN14-15 \citep{LiangChihYu2014OverviewOS, YuenHsienTseng2015IntroductionTS}, NLPCC2018 \citep{YuanyuanZhao2018OverviewOT}, NLPTEA2020 \citep{GaoqiRao2020OverviewON} and YACLC \citep{wang2021yaclc}. Although the latter has a broader application scenario, the related data sources are fewer, only SIGHAN13 \citep{ShihHungWu2013ChineseSC} and CTC2021 \citep{zhao2022overview}. Moreover, these two datasets are very small, with almost 1,000 test sentences. In addition, SIGHAN13 is a traditional Chinese dataset, and CTC2021 is a Chinese grammar correction dataset. These are all different from the real scenario of Simplified Chinese spelling error correction. \textbf{CSC Data Augmentation}: In order to make up for the lack of labeled data, previous studies usually build additional pseudo data to increase the performance. The mainstream method is based on the confusion set \citep{liu2021plome, zhang2021correcting, zhang2020spelling}, the pseudo data constructed in this way is extensive in size but relatively low in quality because of the big gap from the true error distribution. Another relatively high-quality construction method is based on ASR or OCR method \citep{wang2018hybrid}. However, this method requires additional labeled ASR or OCR data and is inconsistent with the pinyin IME based input scenario. \textbf{CSC models}: In recent years, BERT-style \citep{devlin2018bert} models have dominated the research of the CSC task \citep{hong2019faspell, liu2022craspell, zhu2022mdcspell, huang2021phmospell,zhang2020spelling, bao2020chunk, liu2021plome}. However, due to the lack of large-scale and high-quality datasets, the performance of these models is greatly limited. \section{CSCD-IME} In this section, we will show how to build the CSCD-IME and discover the error distribution. \subsection{Data Collection} Our goal is to build a dataset that fits the real Chinese spelling error correction scenario where most spelling errors are generated by pinyin IME. We cleverly discovered a large-scale data source with this feature: LCSTS \citep{hu2015lcsts}, which is a large-scale Chinese short text summarization dataset. Sentences in this dataset all come from posts of popular Chinese media on Sina Weibo, such as People’s Daily. These accounts are verified on Weibo and labeled with a blue ‘V’. There are usually special editors responsible for editing and publishing news and information. We can infer that these editors generally use pinyin IME to publish posts, so spelling errors in this editing progress are generated by pinyin IME, which is consistent with our target scenario. In addition, LCSTS is a large-scale and general dataset, including over 2 million posts and covering multiple domains such as politics, economics, military, movies, games, etc. Therefore, we use LCSTS as our data source. \begin{CJK*}{UTF8}{gbsn} \begin{table*} \centering \begin{tabular}{l|l|p{10cm}} \hline \multicolumn{2}{c|}{\textbf{Tags}} & \multicolumn{1}{c}{\textbf{Description}} \\ \hline \multirow{10}{*}{Pinyin} & same pinyin & \tabincell{l}{the pinyin of the correct is the same with of the wrong \\ e.g. 现\textcolor{red}{再}(zai) -> 现\textcolor{blue}{在}(zai); \textit{now} } \\ \cline{2-3} & fuzzy pinyin & \tabincell{l}{the pinyin of the correct is the fuzzy pinyin of the wrong \\ e.g. 现\textcolor{red}{宅}(\textcolor{red}{zh}ai) -> 现\textcolor{blue}{在}(\textcolor{blue}{z}ai); \textit{now} }\\ \cline{2-3} & similar pinyin & \tabincell{l}{the edit distance of two pinyin is 1 \\ e.g. 现\textcolor{red}{砸}(za) -> 现\textcolor{blue}{在}(za\textcolor{blue}{i}); \textit{now} } \\ \cline{2-3} & dissimilar pinyin & \tabincell{l}{the edit distance of two pinyin is greater than 1 \\ e.g. 现\textcolor{red}{太}(\textcolor{red}{t}ai) -> 现\textcolor{blue}{在}(\textcolor{blue}{z}ai); \textit{now} } \\ \hline \multirow{10}{*}{Semantic} & entity word & \tabincell{l}{the correct word is a named entity, such as a place name \\ e.g. \textcolor{red}{卢}(lu)山 -> \textcolor{blue}{庐}(lu)山; \textit{Lushan Mountain}} \\ \cline{2-3} & normal word & \tabincell{l}{the wrong word is a valid Chinese word\\ e.g. 开心地\textcolor{red}{驴友}(lv, you) -> 开心地\textcolor{blue}{旅游}(lv, you); \textit{travel happily}} \\ \cline{2-3} & special char & \tabincell{l}{the error is a Chinese high-frequency error-prone character\\ e.g. 开心\textcolor{red}{的}(de)旅游 -> 开心\textcolor{blue}{地}(de)旅游; \textit{travel happily}} \\ \cline{2-3} & normal char & \tabincell{l}{the wrong word is not a valid Chinese word or the length is 1\\ e.g. 开心地旅\textcolor{red}{有}(you) -> 开心地旅\textcolor{blue}{游}(you); \textit{travel happily}} \\ \hline \end{tabular} \caption{The tagging system at pnyin level and semantic level.} \label{Tab:tag_system} \end{table*} \end{CJK*} \subsection{Data Selection} \label{section:selection} We split posts in LCSTS into sentence levels and obtain over 8 million sentences. Obviously, it is not realistic to manually label all these sentences, and most of the sentences are completely correct, so we use an error detection model and rules to filter out these correct sentences. \textbf{Detection Model}: Given a source sequence ${\rm \bf X} = (x_{w_{1}}, x_{w_{2}}, ..., x_{w_{N}})$, the detection model is to check whether a character $w_{i}(1 \leq i \leq N)$ is correct or not. We use the label 1 and 0 to mark the misspelled character and the correct character, respectively. The detection model can be formalized as follows: \begin{equation} {\rm \bf y_{d}} = sigmoid(W^{T}(E({\rm \bf e}))) \end{equation} where ${\rm \bf e} = (e_{w_1}, e_{w_2}, ..., e_{w_N})$ is the word embedding and ${E(*)}$ is the pre-trained encoder. The output ${\rm \bf y_{d}} = (y_{d_{1}}, y_{d_2}, ..., y_{d_N})$ is a probability sequence, and $y_{d_{i}} \in (0,1)$ means the probability that character $x_{w_i}$ is erroneous. \textbf{Training}: We follow the successful experience \citep{wang2020combining} of the NLPTEA2020 task \citep{rao2020overview} and use a Chinese ELECTRA-Large discriminator model \footnote{https://github.com/ymcui/Chinese-ELECTRA} \citep{clark2020electra} to initialize the detection model. Following previous research, we train the detection model on SIGHAN13-15's training data and Wang's pseudo data \citep{wang2018hybrid} and save the best checkpoint by SIGHAN13-15's test data. \textbf{Filtering}: We then use the trained detection model to filter out correct sentences. For the input sentence, we can obtain the error probability of each character ${\rm \bf y_{d}} = (y_{d_{1}}, y_{d_2}, ..., y_{d_N})$. \begin{CJK*}{UTF8}{gbsn} Previous studies have shown that the detection model will not work well on special high-frequency characters (such as “的”, “地”, “得” etc.) because of the poor labeling of these characters in SIGHAN \citep{xu2021read}, and is also easy to over-check low-frequency entity words (such as person names, place names, etc.) \citep{zhang2020spelling}. Therefore, we use a Chinese lexical analysis tool (LAC) \citep{jiao2018LAC} to detect these special and entity characters in the input sentence and divide characters into three categories: $C_{speicial}, C_{entity}, C_{normal}$. \end{CJK*} We then calculate the maximum error probability of characters in each category (if the category is empty, the maximum probability is 0), and only if all the max error probabilities of each category are less than the corresponding threshold is the sentence considered correct. This can be formalized as follows: \begin{equation} \left\{ \begin{aligned} & max(\{y_{d_{i}} | w_{i} \in C_{special}\}) < \delta_{special} \\ & max(\{y_{d_{i}} | w_{i} \in C_{entity}\}) < \delta_{entity} \\ & max(\{y_{d_{i}} | w_{i} \in C_{normal}\}) < \delta_{normal} \end{aligned} \right. \end{equation} where $\delta_{special}$, $\delta_{entity}$ and $\delta_{normal}$ are thresholds. We use the above method to filter out about 91.2\% of the sentences and keep about 700,000 sentences that may have spelling errors. We randomly select 2,000 filtered sentences to check whether these sentences are really correct, and the result shows that the accuracy is 99.2\%, which is in line with our expectations. For the rest of about 700,000 sentences, we cumulatively selected about 50,000 random sentences for manual annotation. \subsection{Data Annotation} We recruit a group of educated native speakers for data annotation, and each sentence will be annotated twice by different people to ensure the annotation quality. Specifically, the annotator needs to detect and correct spelling errors in the sentence and give the final correct sentence. In order to further clear the labeling rules and reduce objections, sentences that may be ambiguous \citep{zhang2022mucgec} will be discarded directly. There are three scenarios: (1) The sentence is very unsmooth, and the annotator does not understand the meaning of the sentence; (2) There are multiple possible correction results for the typo in the sentence, and no unique correction result with a pinyin edit distance less than 2 could be found; (3) The sentence contains complex grammatical errors. Therefore, the sentence that is not discarded during the labeling process is semantically clear and has a unique correction result. In the end, we obtain 40,000 labeled and qualified sentences, which make up the \textbf{CSCD-IME} dataset. The whole dataset is randomly divided into the training set, development set, and test set according to the ratio of 6:1:1. \begin{figure*}[htbp] \centering \includegraphics[width=0.95\textwidth]{./image/pinyin.png} \includegraphics[width=0.95\textwidth]{./image/semantic.png} \caption{The comparison of error distribution (\%) at pinyin level (above) and semantic level (below). If the proportion is less than 2\%, the specific value is not indicated in the figure.} \label{fig:analysis} \end{figure*} \subsection{Basic Statistics Analysis} \label{section:statistic} As shown in Table \ref{Tab:statistic}, the data size of CSCD-IME is much larger than existing datasets. In terms of the averaged sentence length and averaged errors in sentences, CSCD-IME is closer to SIGHAN13, with a longer sentence length and fewer errors because both SIGHAN13 and CSCD-IME are datasets for native speakers, whereas SIGGHAN14 and SIGHAN15 are datasets for CFL learners. As for the proportion of positive and negative samples, CSCD-IME is more balanced. \subsection{Error Distribution Analysis} \label{section:analysis} In order to analyze the error distribution of spelling mistakes produced by pinyin IME in depth, we first design a tagging system at pinyin level and semantic level, and then conduct the error distribution study on CSCD-IME and previous datasets. \textbf{Tag defination}: As shown in Table \ref{Tab:tag_system}, we design four pinyin-level and four semantic-level tags. For pinyin-level tags, we define different tags according to the degree of pinyin similarity between the wrong and the correct character. In practice, we use pypinyin\footnote{https://github.com/mozillazg/python-pinyin} to obtain the pinyin info and add the pinyin-level tag. Note that for \textit{fuzzy pnyin}, we follow the definition of Sogou IME \footnote{https://pinyin.sogou.com/help.php?list=3\&q=5}. As for semantic-level tags, they can be roughly divided into two categories: word-level tags (\textit{entity word} and \textit{normal word}) and character-level tags (\textit{special char} and \textit{normal char}). In practice, we first seg the corrected sentence by LAC \citep{jiao2018LAC} and get the corresponding word of the wrong character. For a given word, we then add the semantic tag based on LAC's POS tag and an entity dictionary. \begin{CJK*}{UTF8}{gbsn} Note that the \textit{special char} refers to “他/她/它/的/地/得”. \end{CJK*} \textbf{Pinyin-level analysis}: As shown in the upper part of Figure \ref{fig:analysis}, in all four datasets, the \textit{same pinyin} error is the largest proportion and the \textit{dissimilar pinyin} error is the smallest one. Compared with SIGHAN datasets, this feature of CSCD-IME is more prominent, it has higher proportion of \textit{same pinyin} errors (up to 82.4\%) and lower percentage of \textit{dissimilar pinyin} errors (only 2.2\%). This is because pinyin IME could auto fix the pinyin typoes based on the input context \citep{jia2014joint}. \textbf{Semantic-level analysis}: As shown in the lower part of Figure \ref{fig:analysis}, the proportion of \textit{special char} error in CSCD-IME and SIGHAN13 is lower than that in SIGHAN14 and SIGHAN15, this means native speakers could make fewer \textit{special char} errors than CFL learners. It also can be observed that the percentage of the word-level errors (\textit{entity word} and \textit{normal word}) in CSCD-IME is significantly higher than those in SIGHAN datasets and is nearly doubled. This is because if we input through the whole word (Figure \ref{Fig:problem}(b)), pinyin IME will generally recommend a valid word rather than a very strange “word”. Note that \textbf{the high proportion of word-level errors} is the most important feature of CSCD-IME. This is also the biggest difference with SIGHAN datasets and makes CSCD-IME challenging. We will conduct a deep analysis between word-level and character-level errors in Section~\ref{section:exp}. \begin{figure*}[t!] \centering \includegraphics[width=0.9\textwidth]{./image/pseudo.jpg} \caption{The process of generating pseudo data by pinyin IME (the orange box indicates the selected noise).} \label{Fig:pseudo} \end{figure*} \section{Data Augmentation} It is expensive to manually label data for the CSC task \citep{wang2018hybrid}, so how to construct pseudo data has always been a valuable topic. In this section, we propose a novel method to construct large-scale and high-quality pseudo data. \subsection{Data Preparation} The basic principle of pseudo-data construction is to add noise to correct sentences and generate sentences with spelling errors, so we need to prepare completely correct sentences first. In fact, this kind of text data is common on the Internet, such as sentences in Wikipedia or classic books, which also ensures that we could build \textbf{large-scale} dataset. In practice, we better choose the in-domain text that is relevant to the actual application scenario. \subsection{Noise Simulation} Given a correct sentence, we use the pinyin IME to simulate the input of this sentence and add noise in the input process to construct pseudo data. We first sample a pinyin noise $\upsilon_{pinyin}$, a token granularity noise $\upsilon_{token}$, and a number of errors noise $\upsilon_{num}$. As discussed in Section~\ref{section:analysis}, the $\upsilon_{pinyin}$ could be one of \textit{same pinyin}, \textit{fuzzy pinyin}, \textit{similar pinyin} and \textit{dissimilar pinyin}, the $\upsilon_{token}$ could be one of \textit{word} and \textit{character}, and the $\upsilon_{num}$ is a number greater than 0. For the convenience of expression, we use \textit{token} to represent the Chinese character or word. We can obtain the distribution of $\upsilon_{pinyin}$, $\upsilon_{token}$, and $\upsilon_{num}$ from the prior knowledge of the scene or the labeled data. In the generation process, we first determine the number of errors to generate based on the sampled $\upsilon_{num}$. For each error, as shown in Figure \ref{Fig:pseudo}, we randomly select a word (Figure \ref{Fig:pseudo}(a-c)) or a character (Figure \ref{Fig:pseudo}(d-e)) from the correct sentence based on the sampled $\upsilon_{token}$. Then we first type the correct text \textbf{before} the selected token, and enter correct (Figure \ref{Fig:pseudo}(a)) or wrong pinyin (Figure \ref{Fig:pseudo}(c)) of the selected token based on the sampled $\upsilon_{pinyin}$. If the first token recommended by pinyin IME is the correct token, we randomly select the second or the third token as noise (Figure \ref{Fig:pseudo}(b)). If not, we directly select the first token as noise (Figure \ref{Fig:pseudo}(a)). Finally, we replace the correct token with the noise token in the original sentence. \subsection{Language Model Filtering} \label{lm-filter} It can be observed that the pseudo data generated by this method may also be correct sentences (Figure \ref{Fig:pseudo}(b)), so we use an n-gram language model (LM) to perform secondary filtering. Specifically, we calculate the perplexity (PPL) value of the generated sentence and the original sentence, and only when the PPL value is relatively improved by $\delta$ after adding the noise do we consider the generated noise is indeed erroneous. This can be formalized as follows: \begin{equation} \frac{PPL(noised) - PPL(origin)}{PPL(origin)} > \delta \end{equation} In practice, the value of $\delta$ is adjusted by the selected language model. This additional step ensures that we could build a \textbf{high-quality} dataset. Finally, based on the correct sentences from the LCSTS dataset (Section~\ref{section:selection}), the error distribution from the CSCD-IME dataset (Section~\ref{section:statistic}, \ref{section:analysis}) and the Google pinyin IME \footnote{https://en.wikipedia.org/wiki/Google\_Pinyin}, we build a large-scale and high-quality pseudo dataset \textit{LCSTS-IME-2M}, including 2 million sentences. \begin{table*} \small \centering \bgroup \setlength\tabcolsep{0.6em} \def1.2{1.2} \begin{tabular}{l|ccc|ccc|ccc|ccc} \hline \multirow{3}{*}{Models} & \multicolumn{6}{c|}{Sentence-level} & \multicolumn{6}{c}{Character-level} \\ \cline{2-13} & \multicolumn{3}{|c|}{Detection} & \multicolumn{3}{|c|}{Correction} & \multicolumn{3}{|c|}{Detection} & \multicolumn{3}{|c}{Correction} \\ \cline{2-13} & P & R & F1 & P & R & F1 & P & R & F1 & P & R & F1 \\ \hline {\footnotesize BERT} & 79.16 & 65.83 & 71.88 & 70.55 & 58.66 & 64.06 & 83.00 & 67.01 & 74.15 & 73.59 & 59.41 & 65.75 \\ {\footnotesize +\textit{LCSTS-ime-2M}} & 78.98 & 73.60 & 76.20 & 75.63 & 70.47 & 72.96 & 82.19 & 75.75 & 78.84 & 78.84 & 72.67 & 75.63 \\ \cline{2-13} {\footnotesize +\textit{Wang-cs-271K}} & 79.76 & 59.53 & 68.17 & 74.40 & 55.54 & 63.60 & 83.99 & 59.77 & 69.84 & 77.60 & 55.22 & 64.53 \\ {\footnotesize +\textit{Wang-asr-271K}} & 78.18 & 64.39 & 70.62 & 74.01 & 60.96 & 66.86 & 81.67 & 65.23 & 72.53 & 77.07 & 61.55 & 68.44 \\ {\footnotesize +\textit{Wang-ime-271K}} & 79.72 & 64.18 & 71.11 & 76.86 & 61.88 & 68.56 & 82.9 & 65.39 & 73.11 & 79.84 & 62.98 & \textbf{70.41} \\ \cline{2-13} {\footnotesize *\textit{Wang-cs-271K}} & 37.21 & 22.10 & 27.73 & 25.22 & 14.98 & 18.80 & 39.69 & 23.22 & 29.30 & 26.50 & 15.51 & 19.57 \\ {\footnotesize *\textit{Wang-asr-271K}} & 52.27 & 44.42 & 48.03 & 43.79 & 37.21 & 40.23 & 55.87 & 46.32 & 50.65 & 46.56 & 38.61 & 42.22 \\ {\footnotesize *\textit{Wang-ime-271K}} & 52.41 & 44.33 & 48.04 & 46.87 & 39.64 & 42.95 & 56.07 & 49.72 & 52.70 & 49.69 & 44.07 & \textbf{46.71} \\ \hline {\footnotesize soft-masked BERT} & 80.87 & 64.78 & 71.94 & 74.42 & 59.62 & 66.20 & \textbf{84.46} & 65.35 & 73.68 & 77.50 & 59.97 & 67.62 \\ {\footnotesize +\textit{LCSTS-ime-2M}} & 79.19 & \textbf{74.86} & \textbf{76.97} & 75.75 & \textbf{71.60} & 73.62 & 82.39 & \textbf{77.93} & \textbf{80.10} & 78.63 & \textbf{74.37} & 76.44 \\ \cline{2-13} {\footnotesize +\textit{Wang-cs-271K}} & 79.74 & 62.22 & 69.9 & 75.52 & 58.92 & 66.19 & 83.33 & 62.50 & 71.43 & 78.59 & 58.94 & 67.36 \\ {\footnotesize +\textit{Wang-asr-271K}} & 79.17 & 66.52 & 72.30 & 75.66 & 63.57 & 69.09 & 83.21 & 67.64 & 74.62 & 79.47 & 64.6 & 71.26 \\ {\footnotesize +\textit{Wang-ime-271K}} & 79.96 & 66.87 & 72.83 & 77.21 & 64.57 & 70.32 & 83.57 & 68.63 & 75.37 & 80.64 & 66.22 & \textbf{72.72} \\ \cline{2-13} {\footnotesize *\textit{Wang-cs-271K}} & 37.23 & 17.54 & 23.85 & 23.87 & 11.25 & 15.29 & 34.54 & 18.55 & 24.14 & 22.02 & 11.83 & 15.39 \\ {\footnotesize *\textit{Wang-asr-271K}} & 46.74 & 38.86 & 42.44 & 41.41 & 34.43 & 37.60 & 47.32 & 41.97 & 44.49 & 42.02 & 37.26 & 39.50 \\ {\footnotesize *\textit{Wang-ime-271K}} & 56.03 & 51.63 & 53.74 & 51.55 & 47.50 & 49.45 & 59.22 & 57.40 & 58.30 & 54.69 & 53.01 & \textbf{53.84} \\ \hline {\footnotesize PLOME} & 79.78 & 57.23 & 66.65 & 78.09 & 56.01 & 65.23 & 83.48 & 57.99 & 68.44 & 81.49 & 56.61 & 66.81 \\ {\footnotesize +\textit{LCSTS-ime-2M}} & \textbf{81.20} & 72.21 & 76.44 & \textbf{79.05} & 70.30 & \textbf{74.42} & 84.21 & 73.81 & 78.67 & \textbf{82.00} & 71.88 & \textbf{76.60} \\ \hline \end{tabular} \egroup \caption{The performance (\%) of baseline models on CSCD-IME with or without different pseudo datasets. Note that "+" means pretraining on pseudo data and then finetuning on CSCD-IME's training data, and "*" means no finetuning step, evaluating directly after pretraining on pseudo data.} \label{Tab:result} \end{table*} \begin{table} \small \centering \def1.2{1.2} \begin{tabular}{cccc} \hline Models & char level & word level & $\Delta$ \\ \hline BERT & 72.82 & 71.07 & -1.75 \\ soft-masked BERT & 75.09 & 72.71 & -2.38 \\ PLOME & 77.77 & 72.78 & \textbf{-4.99} \\ \hline \end{tabular} \caption{The f1-score (\%) of correction at character level on character-level errors and word-level errors, and the decline of the latter compared with the former.} \label{Tab:word-level} \end{table} \section{Experiment} \label{section:exp} In this section, we provide the benchmark of CSCD-IME and verify the effectiveness of our pseudo-data construction method. \subsection{Basic Settings} The basic experimental setup includes data, evaluation methods, and baseline models. \textbf{Data}: We use CSCD-IME as the basic dataset, including the training set, development set, and test set. Note that for pseudo data, we conduct two-step training: pretraining and then finetuning, using only pseudo data in the pretraining step, and only manually labeled data in the finetuning step. \textbf{Metrics}: We use the f1-score of detection and correction at sentence level and character level as evaluation metrics. The sentence-level metrics follow the calculation in FASPell \citep{hong2019faspell}. As for character-level metrics, we \textbf{do not} follow the method in SpellGCN \citep{cheng2020spellgcn}. We calculate \textbf{all} characters for correction metric instead of only those been correctly detected characters. \textbf{Baselines}: We choose the following three strong baseline models. \textit{BERT} \citep{devlin2018bert} directly fine-tunes the standard masked language model to generate fixed-length corrections. \textit{Soft-Masked BERT} \citep{zhang2020spelling} utilizes a detection model to help the correction model learn the right context. \textit{PLOME} \citep{liu2021plome} integrates the phonetic and visual features into the pre-trained model, and it has an additional pretraining step on a large-scale confusion set based pseudo dataset. \subsection{CSCD-IME Benchmark} In this part, we provide basic benchmark performances of CSCD-IME, including two versions: without any pseudo data and with large-scale pseudo data \textit{LCSTS-IME-2M}. As shown in Table \ref{Tab:result}, if we don't add any pseudo data, the overall f1-score of correction at character level could be only nearly 67\%; when introducing 2 million pseudo data, the performance could increase a lot, but the best is still just over 76\%. There is still a big room for improvement. We further analyze the model's performance (without any pseudo data version) on different semantic tags. Note that here we only analyze errors with \textit{same pinyin} to reduce the impact of pinyin. As shown in Table \ref{Tab:word-level}, all three models perform worse on word-level errors than on character-level errors, and the maximum gap could reach 5\%. The iteration of the CSC model in recent years, for example, from \textit{BERT} to \textit{PLOME}, reflects in the improvement of character-level errors but no improvement in word-level errors. For word-level errors, the model should have a strong understanding of context and entities, so these errors are more difficult and require further effort. Compared with existing datasets, the biggest feature of CSCD-IME is the high proportion of word-level errors, so from this point of view, CSCD-IME is challenging. \subsection{Comparition of Pseudo Datasets} In this subsection, we compare pseudo datasets constructed by different methods. Note that \textit{PLOM} already has a pretraining step on large-scale pseudo data, so this baseline is not used here. We choose existing ASR(/OCR)-based pseudo data \citep{wang2018hybrid} as experiment dataset, including over 271K sentences, abbreviated as \textit{Wang-asr-271K}. This pseudo dataset is also the most famous one, which is always used to improve performance in previous research. We further extract correct sentecnes from \textit{Wang-asr-271K} to construct confusion set based pseudo data \textit{Wang-cs-271K} and pinyin IME based pseudo data \textit{Wang-ime-271K}. As shown in Table \ref{Tab:result}, our proposed pinyin IME based pseudo-data construction method is more effective than all existing methods. Compared with \textit{Wang-asr-271K} and \textit{Wang-cs-271K}, adding \textit{Wang-ime-271K} (ours) always obtain the best f1-score on both sentence-level and character-level metrics. To observe the effect of each method more clearly, if we \textbf{only} use pseudo data in the training progress, our method would significantly outperform other methods. The key to the quality of pseudo data is the error distribution of pseudo data, as shown in Figure \ref{fig:analysis-pseudo}, our method can better fit the real scene. More analysis can be checked in Appendix \ref{pseudo-analysis}. \subsection{Impact of LM Post-Filtering} \begin{table} \small \centering \def1.2{1.2} \begin{tabular}{cccc} \hline LM threshold ($\delta$) & precision & recall & f1 \\ \hline w/o & 41.17 & 40.66 & 40.91 \\ -20\% & 44.52 & \textbf{49.01} & 46.66 \\ 0\% & 49.69 & 44.07 & \textbf{46.71} \\ 20\% & 50.64 & 26.46 & 34.76 \\ 50\% & \textbf{57.52} & 9.38 & 16.12 \\ \hline \end{tabular} \caption{The correction results (\%) at character level for pseudo data with different LM filtering strategies.} \label{Tab:ngram} \end{table} In this part, we investigate the effect of LM filtering in Section \ref{lm-filter}. We reconstruct \textit{Wang-ime-271K} and adopt different LM filtering strategies. We choose the basic \textit{BERT} model to conduct the experiment, and \textbf{only} use pseudo data in the training progress to more clearly study the differences. As shown in Table \ref{Tab:ngram}, if we do not use LM filtering, more unexcepted noises will be introduced, for example, the generated pseudo data may also be a completely correct sentence. However, when the threshold is too low, even less than 0, the generated errors will be more confused, and the model would have good recall but poor precision. In contrast, if the threshold is too high, the generated errors are relatively simple, and the precision is better, but the recall is lower. Therefore, LM filtering is necessary and we also need to choose a moderate threshold. \subsection{Error Analysis} \begin{CJK*}{UTF8}{gbsn} We detailed analyze errors that can not be correctly handled in \textbf{all} three baseline models and summarize these errors into the following three main types. The over-correction of expressions with low-frequency \citep{liu2022craspell}. Since the backbone model is BERT and its pre-trained task is masked token recovering, these CSC models tend to overcorrect valid low-frequency expressions to more frequent expressions, such as people's names, place names, new Internet words, etc. For instance, “墨尔本\textcolor{blue}{矩形}体育场” (Melbourne Rectangular Stadium) is a location entity and is over-corrected as “墨尔本\textcolor{red}{巨形}体育场” (Melbourne Mega Stadium). The missing correction of expressions requires strong contextual reasoning ability. If the wrong word in the sentence is a high-frequency word, the model needs to combine the semantic information of the context to correct it. For example, for the sentence “几辆车停在原地争执，后面的车辆也无法\textcolor{red}{进程}” (since several cars parked and argued, cars behind could not enter the city), where the wrong word “\textcolor{red}{进程}” (process) is a common word, but it is wrong to fill in this sentence, based on the context, it should be “\textcolor{blue}{进城}” (enter the city) here. The failing correction of grammar-related errors. The CSC task also contains a certain number of grammar-related errors, such as the use of function words, auxiliary words, and verb-object fixed collocations, and these baseline models cannot effectively handle such errors. For example, for the phrase “准确\textcolor{red}{的}传达情绪” (convey emotions accurately), the auxiliary word between the adverb and the verb should be “\textcolor{blue}{地}” not “\textcolor{red}{的}” according to Chinese grammar rules. \end{CJK*} \section{Conclusion} In this paper, we focus on the most common mistakes in practical CSC applications, i.e., spelling errors generated by pinyin IME. We first build a new dataset CSCD-IME for this field, which is also the largest dataset for the CSC task. Furthermore, we propose a novel method to construct large-scale and high-quality pseudo data based on pinyin IME. A series of analyses and experiments show that CSCD-IME holds a particular error distribution and is a challenging dataset. Our proposed pseudo-data construction method can better fit this real error distribution and is more efficient than all previous methods. We hope this data resource and our discovery will advance follow-up research.

\section{Introduction} \subsection{Quantum Random Walks} Quantum walks are quantum versions of classical random walks, but because of interference, which is missing in the classical walks, their behavior can be very different \cite{davidovich,aharonov} (for reviews, see \cite{reitzner1,manoucheri}). They have proven useful in a number of algorithmic applications, one of which is searches on graphs \cite{shenvi,potocek,aaronson,lovett,childs,reitzner3,lee,feldman,hillery,hillery2,cottrell,cottrell2}. Initially the searches were for distinguished vertices, that is vertices whose behavior is different than that of the other, normal vertices \cite{shenvi,potocek,aaronson,lovett,childs,reitzner3}. This has since been generalized to searches with non-uniform unmarked edges \cite{lee}, extra edges \cite{feldman,hillery2}, connections between graphs \cite{hillery}, and even a general subgraph \cite{cottrell,cottrell2}. A more recent application of quantum walks is in state transfer, where the objective is to use the quantum walk to transfer the particle from a starting vertex to a final vertex, with high probability. It was shown that using a coined quantum walk, a perfect state transfer can be achieved for a star graph and complete graph with self-loops \cite{stefanak}, as well as analysis on a complete bipartite graph \cite{stefanak2}. With the recent experimental realization of discrete-time walks \cite{perets,schmitz,karski,schreiber,peruzzo,schreiber2}, it is hoped that these and other quantum walk applications may some day soon be tested experimentally. Similar to the premise of state transfers, it has been shown that it is possible to use a quantum walk to find a path between two marked vertices \cite{reitzner2}. In that study, the graph consisted of $M$ linked star graphs. Each star had $N$ edges emanating from a central hub with each edge connected to an additional vertex, which was called an external vertex, to distinguish it from the hub vertex. The stars were arrayed in a line. The first and last stars each had a distinguished vertex, labelled START on the first star and FINISH on the last star. Each star was connected to its neighbor at one vertex, but it was not known which vertex on star $j$, $1 \leq j \leq N-1$, was connected to which vertex on star $j+1$. A classical search would take of order $\mathcal{O}(MN$) steps to find the path between START and FINISH, while the quantum walk only took of order $\mathcal{O}(M\sqrt{N}$) steps. Here we want to extend the study of finding paths to tree graphs. \subsection{N-Tree Maze} The focus of this paper is to explore the possibility of using quantum walks as a means of searching complex mazes that can be represented as nodes and connections on a graph $\mathcal{G}$. To do this, we explore its effectiveness on a specific type of graph, an N-Tree maze. An N-Tree maze is illustrated in figure \ref{binarytree1}. From the viewpoint of a solver, the maze consists of junctions with $N$ identical choices. Beyond each choice is another identical junction with $N$ choices, and so on. The maze is characterized as $M$-layers deep, thus to correctly find the exit one must make $M$ correct choices in succession. The figure below would be categorized as $N$=2, $M$=4. If an incorrect path is chosen at any point, it is impossible to know exactly where the mistake was made without backtracking and exhausting all possible paths. \begin{figure}[H] \centering \includegraphics[scale=0.3]{Binary_Tree_Diagram} \caption{An N-Tree Maze, where $N$=2 (also referred to as a 'Binary Tree') and $M$=4. F is always located at an end node at the deepest layer.} \label{binarytree1} \end{figure} The goal of searching through these graphs is to locate the specified final node F. For this discussion, it is assumed that the location S, the starting node, is known. The location of F is unknown, but $N$ and $M$ are given. The layout of this paper is as follows. In Section 2, we discuss how a classical computer searches through the maze, and introduce the formalism by which a quantum computer searches using a quantum walk. In Section 3, we discuss the resulting quantum system after implementing the quantum walk, and the way probabilities are distributed throughout the maze. In Section 4, we analyze the various ways one can use the quantum walk to search for F. In particular, we analyze the effectiveness of using the probability concentrated on the edges connected to F, versus using the probability concentrated along the entire path from S to F. In section 5, we derive an expression for the number of trials needed to find F with high probability. And lastly in Section 6, we provide approximate solutions to N-Tree mazes by studying the systems' eigenvalues and eigenstates. We conclude by numerically solving for a form for $\mathcal{U}(N,M)$, the function that gives the number of steps need to prepare a maze of size $N,M$. \section{Classical vs Quantum Searches On A Maze} \subsection{Classical Search Schemes} For a general maze that can be specified through nodes and connections (also referred to as vertices and edges) on a graph $\mathcal{G}$, often times the best classical search algorithm is a "depth-first" or "breadth-first" search. The two techniques only differ in how they traverse the maze, but share the same underlying principles. The algorithms search recursively through the maze, where one "step" amounts to moving one node at a time and keeping a list of all connected nodes as well as ones previously visited. If we turn our attention to N-Tree mazes, $M$ layers deep, the search best suited for this maze geometry is a depth-first search. Since the general structure of the maze is known (no internal loops or irregularities) and only the location of F is unknown, the minimum number of steps to reach F is M, while the maximum is $E$, the total number of edges. $E$ is equal to $(N^{M+1}-1)/(N-1)$, thus the average number of steps needed is of the order $\mathcal{O}$ ($ N^{M} $). The real merit of any quantum search algorithm will then be to do better than this scaling. Once begun, the classical search will always find F, given enough time. The algorithm moves through the maze and checks all the end nodes in succession, each one with a probability of $\frac{1}{N^{M}}$. Figure \ref{classicalprob} shows the probability of finding the correct final node as a function of steps, searching on a 'Binary Tree' ($N$=2), $M$=3. In this example there are 8 possible end nodes where F could be, thus each jump in the graph corresponds to the algorithm checking one of these nodes. \begin{figure}[H] \centering \includegraphics[scale=0.45]{Classic_Prob_Steps} \caption{The probability of successfully locating F as a function of steps, using a classical depth-first search. Each time an end node is checked, the result is a spike in probability.} \label{classicalprob} \end{figure} As the size of these tree mazes get larger, a linear approximation becomes more accurate. We will use these linear approximations to compare classical vs quantum algorithms, and their probabilities of finding the correct final node. On average, the algorithm must check 50 \% of the final nodes before finding the correct one, thus the average number of steps needed is of the order $\mathcal{O}$ ($ N^{M} $). The real merit of any quantum search algorithm will then be to do better than this scaling. \subsection{Quantum Search using a Random Walk} To compete with the classical depth-first search, we will use a scattering quantum walk algorithm on the same graph geometry. Using this formalism, the particle resides on the edges of the graph, and can be thought of as being scattered by the nodes. The Hilbert space $\mathcal{H}$ is spanned by $2E$ orthonormal states, two states per edge of the graph. In particular, suppose we have two nodes $A$ and $B$ connected by an edge. Then there is a state $|A,B\rangle$ which represents the particle scattering into node $B$, coming from node $A$, and vice versa for state $|B,A\rangle$. The scattering walk is a discrete-time quantum walk. The evolution of the system is given by a unitary operator $U$ that advances the walk one time step. This $U$ is obtained by combining the actions of local unitary operations, one for each vertex, which describe the scattering at their respective vertices. In particular, they relate the state entering the vertex at one time step to the state(s) leaving the vertex at the next time step. For a vertex connected to $n$ edges, with $n\geq 3$, the action of $U$ is given by \begin{equation} U|j,A\rangle = -r|Aj\rangle + t \sum_{k=1,k\neq j}^{n} |A,k\rangle , \end{equation} where $1\leq j \leq n$, and \begin{eqnarray} t &=& \frac{2}{n} \nonumber \\ r &=& \frac{n-2}{n} . \end{eqnarray} The constants $t$ and $r$ can be thought of as transmission and reflection coefficients, respectively. In the special case of end nodes, defined by a node with only 1 connection, $t = 0$ and $r = e^{i\theta}$. For these nodes, $r$ can be any complex number of modulus one, but for our purposes we will only consider the cases where $r$ is equal to either $1$ or $-1$. Specifically, we let the final node F reflect with $-1$, while all other end nodes (including S) reflect with $1$. Now having defined $\mathcal{H}$ and the evolution of the system, we must choose the initial state of the system. We start with an equal superposition of all states, reflecting the fact that we have no \emph{a priori} knowledge of the location of F. The fact that $U$ acts differently on F drives the quantum system into a nonuniform distribution of probabilities, which is then probed by making a measurement on the system. \section{ Quantum Walk on N-Tree Mazes } In this section we will present results of using a quantum walk on N-Tree mazes. We look at two significant features that arise: 1) The concentration of probability on the correct final node F, and 2) The concentration of probability on the all the states making up the path from S to F. These results are generated numerically. Later we will try to gain a better understanding of them by looking at eigenstates of $U$, also numerically, in section 6. In both cases, we find a cyclic rise and fall in probabilities. Figure \ref{probabilityshape} shows an example of these trends. \begin{figure}[H] \centering \includegraphics[scale=0.39]{N3_M10_Probability} \caption{Dashed Line: The concentration of probability on states representing the edge connected to F. Solid Line: The sum of the probabilities of the states representing the edges connecting S to F (except the two states directly connected to S)} \label{probabilityshape} \end{figure} The location of these peaks (the number of unitary steps needed) increases with maze size, both $N$ and $M$. We discuss this in detail in section 6, but for a rough sense of magnitude, one needs of the order $\mathcal{O}$($N^{\frac{M}{2}}$) unitary steps to reach the peak in probability. \subsection{ Probability Concentration on F } By letting the correct final node reflect with -1, and all other final nodes with +1, the result is peaks in probability where F is significantly more probable than any other final node. These peaks come in regular cycles, but only the first peak is ever considered in this discussion. For these first peaks, the table below shows the maximum probability of measuring F for various $N$ and $M$ values. \begin{figure}[H] \centering \includegraphics[scale=0.7]{N_M_Peak_F} \caption{Peak Probabilities for measuring a state represented by the edge connected to F.} \label{Fpeak} \end{figure} As shown, the peak probability decreases as $N$ and $M$ get larger, which translates to more trials on average before finding F. However, since this decrease in probability gets smaller as the maze size increases, the effectiveness of using these probabilities for searches will still prove useful. \subsection{Probability Concentration on the Path} Looking at figure \ref{Fpeak}, we see that at the first peak, the probability that the particle making the walk is on one of the states connected to F is quite low. By contrast, figure \ref{Pathpeak} below reveals that the probability of finding the particle on one of the states connecting S to F (including the states connected to F) is quite high. This result was also shown in \cite{reitzner2}, where using the same type of quantum walk, nearly all of the probability in the system became concentrated along the path connecting a series of stars. For our N-Tree mazes, Figure \ref{Pathpeak} below shows the maximum probability of measuring a state along the correct path for various $N$ and $M$ values. \begin{figure}[H] \centering \includegraphics[scale=0.65]{N_M_Peak_Path} \caption{Peak probabilities for measuring a state along the correct path, which are states along the path connecting S to F.} \label{Pathpeak} \end{figure} When we focus our attention to the states connecting S to F, we find that the overall peak probability increases with larger $N$ and $M$. Thus, as the size of the maze increases, it becomes more probable that a state along the correct path is measured. In numerical tests, this trend continued as $N$ and $M$ increase, with the path probability approaching 1 as $N$ and $M$ become very large. If we look at the breakdown of the peak path probability, figure \ref{probdistribution} shows an example of how the individual states each contribute. Most importantly, even with individual fluctuations, all the states along the path peak around the same time, giving rise to the overall shape depicted in figure \ref{probabilityshape}. \begin{figure}[H] \centering \includegraphics[scale=0.28]{M15_Paths_Plot} \caption{Plotted are the probabilities of the 8 closest edges (two states per edge) to F as a function of unitary steps. The states bunched together at the top are closest to F.} \label{probdistribution} \end{figure} The curves that are all very closely clustered together near the top are the states closest to the final node F, while the curves corresponding to lower peak values are closer to S. So when a measurement is made at the moment of the peak path probability, we get a sort of blending of all the correct path state probabilities, slightly favoring states closer to F. This fact will become meaningful in the next section, when we analyze the use of the path probability as a means to search for F. \section{Comparing Algorithms and Speeds} Here we will lay out a few possible algorithm schemes that take advantage of the quantum system, and we compare their effectiveness in finding F. There are two main disadvantages that exclusively plague the quantum algorithms: 1) The system must run a pre-determined number of unitary steps before each measurement. 2) All measurements are probabilistic, so any measurements that fails to find F means that the entire quantum system must be prepared again. We will see that the most effective algorithms work to minimize these disadvantages. For the quantum algorithm that will come later in this section, we will always be preparing our quantum systems for a peak path measurement. Let us define $\mathcal{U}(N,M)$ as the function that gives us the prescribed number of unitary steps needed to prepare our quantum system for this peak path measurement, for any $N$ and $M$. A complete form fot this function will be given in section 6. For now, we would like to use $\mathcal{U}(N,M)$ as a metric for defining "average speed", which we shall use throughout this paper. Rather than expressing speed in terms of steps, let us define average speed (for both classical and quantum) as: the ratio of the average number of steps needed to find F to $\mathcal{U}(N,M)$. Using this definition, for a given maze of size $N$ and $M$, the fastest a quantum algorithm can find F is 1. This is because we are always constrained to prepare our quantum system, for a peak measurement, at least once. Thus the theoretical limit of 1 would then correspond to a 100\% success rate of finding F on the first measurement. \subsection{ Classical Search Speed } The classical search algorithm works like opening doors, checking each final node to see if it's the correct door, and if not moving onto the next one. Initially, all final nodes have equal probability of being correct, with each wrong node reducing the sample space by 1. Thus, the average speed of the algorithm is determined by the average number of nodes we need to check. As depicted in figure \ref{classicalprob}, a linear approximation is sufficient, especially for larger mazes. Equation \ref{p(steps)} gives the linear function corresponding to the probability of success as a function of steps. \begin{equation} \label{p(steps)} P(\textrm{steps}) = \frac{\textrm{steps}}{E} = \frac{\textrm{steps}}{\sum_{i=0}^{M} N^M } \end{equation} By setting P(steps) = $\frac{1}{2}$, we get the average number of steps needed for a classical search: Steps$_{avg}$ = $\frac{E}{2}$. Thus, the classical depth-first search algorithm needs to, on average, step through roughly half the maze before finding the correct final node, which scales like $\mathcal{O}(N^{M})$ \subsection{Searching for F Directly} Suppose we are only interested in searching for the correct final node, discarding all other measurement results. This method is analogous to the Grover search, however, here our chance of success decreases with the size of the maze. As a result, larger mazes will on average expect more failures. Compounded with the fact that larger mazes require more unitary steps to prepare, this type of search suffers drastically from both disadvantages previously mentioned. Nevertheless, we shall see that searching for F directly does indeed provide a speedup over the classical search. Provided that we know when to probe the quantum system for the maximum probability of measuring F, say given by $\mathcal{U}_{F}(N,M)$, this type of search is analogous to rolling dice. We prepare and probe the quantum system over and over until F is found. If we let p be the probability of measuring F, then our probability of success as a function of trials, $T$, is of the form given in equation \ref{p(t)}. And the average number of trials is given by equation \ref{Tavg}. \begin{eqnarray} P_{success}(T) &=& 1 - (1-p)^{T} \label{p(t)} \\ T_{average} &=& \frac{1}{p} \label{Tavg} \end{eqnarray} If we take the number of trials, and multiply by the number of unitary steps it takes to prepare the quantum system, this gives us our relation between success probabilities and steps. Figure \ref{classicalvsF} shows a comparison of these probabilities for the case $N$=2, $M$=15. \begin{figure}[H] \centering \includegraphics[scale=0.38]{C_v_Q_Probability_F15} \caption{Dashed Line: Probability of success as a function of steps for a classical depth-first search. Solid Line: Probability of success as a function of steps using a quantum system to search for F directly. The dashes along the x-axis mark the point for the average number of steps of the two searches respectively} \label{classicalvsF} \end{figure} Since the two types of probabilities are very different, opening doors versus rolling a dice, one must be cautious in comparing the two. Figure \ref{classicalvsF} suggests that the quantum search is favorable in practically all regions, but when put into practice we want to avoid falling for a Monte Carlo fallacy, thinking the quantum search is faster than it actually is. For this reason, the average number of steps needed to find F for the two searches are marked along the x-axis. In terms of average speed, as defined earlier, we take these average numbers of steps and divide them by $\mathcal{U}_{F}(N,M)$. We then find that the classical search has an average speed of 21.4 while the quantum search is 11.2, thus resulting in a speedup of 1.9. For the quantum search, the average speed can also be viewed as the average number of times the system will need to be prepared. Figure \ref{Fspeedup} below shows the speedups (ratio of classical to quantum average speeds) for $N$=2, for various $M$. \begin{figure}[H] \centering \includegraphics[scale=0.46]{N2_F_Speedup} \caption{Plotted are the speedups of quantum over classical searches, for $N$=2, as a function $M$. These speedups are the result of using the 'search for F directly' algorithm, analogous to a Grover search} \label{Fspeedup} \end{figure} Thus, we do indeed get a speedup by imitating the Grover ideology and searching for F directly. We find that the speedup increases exponentially with the size of the maze. Next, we will show that we can do much better by utilizing what else the quantum system has to offer, specifically the huge peak probability of the correct path. \subsection{Moving Through The Maze} The major shortcoming of the pervious search scheme is the amount of wasted steps. Every time a measurement doesn't yield the correct final node, it is discarded. Rather than simply starting over, it would be better if we could extract some kind of meaningful information from these "failed" measurements. This is preciously what our next quantum algorithm proposes to do, use the information from previous measurements to guide future ones. To do this, we probe the system when measuring a state along the correct path has the highest probability, rather than maximizing for measuring F. This is because we are anticipating that most measurements will not find F, so instead we will hedge our bets towards the measurement being along the correct path. Since we will choose to probe at a different time, we need to first make sure that we aren't sacrificing our search for F (which is the ultimate goal) by probing when the path is most probable. Figure \ref{FatPathpeak} shows a comparison of the probability of measuring F, when the system is prepared for maximal F probability versus maximal path probability, for $N$=2. \begin{figure}[H] \centering \includegraphics[scale=0.40]{F_Prob_at_Path_Peak} \caption{Circles: Plotted are the probabilities of measuring F, when the system is prepared to maximize the probability of F. Triangles: Plotted are the probabilities of measuring F, when the system is prepared to maximize the probability of measuring a state along the correct path.} \label{FatPathpeak} \end{figure} At lower $M$'s, particularly 5 and 6, we see a significant decrease in probability for measuring F. However, as the size of the maze increases, we get virtually no loss in probability for F. Thus, for larger mazes, we do not sacrifice anything by probing for a peak path measurement. Now in order to make use of the following algorithm scheme, it is assumed that we have flexible control over our quantum system. Namely, we have the ability to turn nodes "on" or "off". Specifically, nodes that previously had multiple connections when "on", now act as end nodes with only one connection when "off". Figure \ref{binarytree2} below shows an example. Suppose the edge marked with a star was the result of the first measurement, the node connected to that edge, closer to S, is then turned "off." The result is that all the subsequent nodes behind it are "frozen out," illustrated by the grey dash lines. The remaining edges and nodes form a new graph $\mathcal{G}$ and Hilbert space $\mathcal{H}$. Changing the geometry of the system is accompanied with a change to the unitary operator U, to properly operate on the new system $\mathcal{H}$. In practice, we will only ever tweak our system at one location, after a measurement has been made. But doing so will always result in freezing out a large section of the initial maze. \begin{figure}[H] \centering \includegraphics[scale=0.24]{Flexible_Nodes} \caption{Following a measurement (marked by the star), we then turn a single node "off" and consequently freeze out edges and nodes behind it (illustrated as grey-dashed lines). These frozen out edges and nodes no longer affect the active quantum system (illustrated as black-solid lines), and are no longer in the Hilbert space $\mathcal{H}$ or Unitary operator. } \label{binarytree2} \end{figure} Now we are equipped to discuss the core idea proposed by this paper: "moving" through the quantum system. By movement, we mean changing our quantum system after we make a measurement, to reflect the algorithm's scheme for searching through the maze. As shown in figure 10, the result of a measurement dictates which nodes we turn off, or in other words where we "move" through the maze. In example given, the measurement results in a movement from an $M$=4 maze, down to $M$=2. From there, the process is repeated until one of two outcomes occurs: the correct final node F is measured, or an incorrect final node is measured. In the latter case, we must start over from the very beginning, turning on all nodes and preparing the original full maze. The benefits of moving from an $M$ to a smaller $M$' (where $M$' $<$ $M$) layered maze are as follows: 1) Each preparation of the system will cost fewer unitary steps to reach the peak probability 2) Each measurement will have a higher probability of measuring the correct final node (except for a few cases at lower $M$'s). Thus, if one can successfully move through the maze in increments towards the correct final node, both of the main disadvantages of the quantum algorithm are minimized simultaneously. However, the trade-off for movement is the potential new risk of measurement leading to an incorrect step. Any algorithm that utilizes movement through the maze must also have a means of correcting for a movement in a wrong direction, otherwise they could become permanently stuck. We will refer to such an event as stepping into a "dead tree," and analyze its impact on the algorithm next. \subsection{Moving Into a dead tree} Let us discuss the event in which a measurement results in a movement in the wrong direction, into a dead tree. Based on the probabilities shown in figure \ref{Pathpeak}, such an even has a small occurrence rate, but is nevertheless worth analyzing. Our interest is how quickly the algorithm finds a final node, and effectively exits the dead tree by resetting the problem back to the initial maze. When a measurement yields a state that is not along the correct path, the solver has no way of knowing. Thus, following the protocol of the algorithm, one would move to the smaller maze and apply the prescribed number of unitary operations based on $\mathcal{U}(N,M)$. However, since the special node F is no longer in the system, the result of the quantum walk leaves all the states equally probable. But since the structure of each maze is heavily weighted by states closer to the end (refer to figure 1), having all the states be equally probable is a huge advantage for measuring a final node or ones closest to a final node. As it turns out, the overall loss in speed for misstepping is very negligible. Figure \ref{deadspeed} shows the average speed for which the algorithm exits a dead tree, for $N$=2. \begin{figure}[H] \centering \includegraphics[scale=0.39]{Jumping_Dead_Speed} \caption{The average speed by which the algorithm measures a final node, and effectively exits the dead tree.} \label{deadspeed} \end{figure} We can see that as $M$ becomes larger, the average number of wasted steps approaches $\mathcal{U}(N,M)$. Because of this, the risk of dead trees slowing down the search algorithm becomes very minimal. In addition, this slowdown of approximately $\mathcal{U}(N,M)$ steps occurs based on the size of the maze \textit{at} the measurement, which in most cases is much smaller than the initial maze size. The largest cost in speed from a misstep actually occurs after the dead tree, when the initial maze, which has the largest $\mathcal{U}(N,M)$, must be prepared again. \subsection{Results for Following the Measurement Algorithm} Recall from figure \ref{probdistribution} that states closer to the correct final node, along the path, have slightly larger peak probabilities. Thus, when a state along the path is measured, the resulting layer is on average over half the distance to the final node. After which, each successive measurement does the same. Combine this style of movement with the fact that the maze sizes and $\mathcal{U}$(N,M) scale exponentially, and the result is a powerful searching algorithm. Figure \ref{allspeeds} shows the average speed of this algorithm in finding F, as well as the classical and searching for F directly algorithms. \begin{figure}[H] \centering \includegraphics[scale=0.4]{All_Speeds} \caption{Plotted are the average speeds for finding the correct final node F, for all the algorithms discussed: jumping (circles with dashed lines), search for F directly (triangles with dashed lines), classical (squares with solid lines)} \label{allspeeds} \end{figure} The results show that the movement algorithm outperforms all previous searches. Most notably, as the size of the maze increases, its speed slowly trends toward 1, the theoretical limit. In addition, the fact that the speeds are under 2 means that on average the algorithm finds the correct final node without ever making a misstep. Thus we see the true strength of relying on path probabilities to help guide our quantum searches. In summary, the quantum algorithm that makes use of movement, and by extension avoids wasting information, outperforms those which don't. In quantum systems where a projective measurement completely collapses the wave function, it is ideal if one can use the information gained from prior experiments to help dictate future ones. For the movement algorithm, the only instances where a measurement yields no information are from measuring S, or measuring a wrong final node. Whether or not any useful information can be extracted when an incorrect final node is measured, we do not know. We will leave this as an open question for possible future work, and next turn our attention towards some analytical solutions for N-Tree mazes. \section{Number of trials} Let us examine how many trials the movement algorithm will need to find F. In an $N$-Tree maze, which is $M$ layers deep, the correct path from S to F has $M+1$ edges. We will label them with the coordinate $x$, where $1\leq x \leq M+1$. The edge connected to S is $x=1$, $x=2$ is the next edge on the correct path, and $x=M+1$ is the edge connected to F. We shall assume that the probability of the particle being on the correct path is $p$. This probability is close to one, and we will assume that it is independent of the size of the tree, which is a reasonable approximation for all but the smallest trees. We begin by finding the probability of a measurement sequence $x_{1}$, $x_{2}$, $\ldots ,x_{n}$, where $x_{1} \leq x_{2} \leq \ldots x_{n}$, because when we find $x_{j}$, we turn off the tree below this point and only search above it. We assume that each edge on the correct path is equally probable, which our numerical calculations show is a good approximation (In actuality, we know that edges closer to F have slightly higher probabilities). Letting $p_{n}(x_{1},x_{2}, \ldots x_{n})$ be the probability for finding the sequence $x_{1}$, $x_{2}$, $\ldots ,x_{n}$, we find that \begin{eqnarray} p_{1}(x_{1}) & = & \frac{p}{M+1} \nonumber \\ p_{2}(x_{1},x_{2}) & = & \frac{p}{M+1} \frac{p}{M-x_{1}+2} , \end{eqnarray} and in general \begin{equation} p_{n}(x_{1},x_{2}, \ldots x_{n}) = \frac{p^{n}}{M+1}\prod_{j=1}^{n-1} \frac{1}{M-x_{j}+2} . \end{equation} Now let $P_{succ}(y)$ be the probability of getting the edge connected to F on the $y^{\rm th}$ trial, but not before. We have that \begin{eqnarray} P_{succ}(1) & = & \frac{p}{M+1} \nonumber \\ P_{succ}(2) & = & \sum_{x_{1}=1}^{M} p_{2}(x_{1},M+1) \nonumber \\ P_{succ}(y) & = & \sum_{x_{1}=1}^{M} \sum_{x_{2}=x_{1}}^{M} \ldots \sum_{x_{y-1}=x_{y-2}}^{M} \nonumber \\ & & p_{n}(x_{1},x_{2}, \ldots x_{y-1},M+1) . \end{eqnarray} It is possible to approximate the sums in the above expressions by integrals. For example, for $y=3$, we find \begin{eqnarray} P_{succ}(3) & = & \frac{p^{3}}{M+1} \sum_{x_{1}=1}^{M} \sum_{x_{2}=x_{1}}^{M} \frac{1}{M-x_{1}+2} \frac{1}{M-x_{2}+2} \nonumber \\ & \simeq & \frac{p^{3}}{M+1} \int_{0}^{M} dx_{1} \int_{x_{1}}^{M} dx_{2} \frac{1}{M-x_{1}+2} \nonumber \\ & & \frac{1}{M-x_{2}+2} \nonumber \\ & = & \frac{p^{3}}{M+1} \frac{1}{2} \left[ \ln \left(\frac{M+2}{2}\right)\right]^{2} . \end{eqnarray} In general we have that \begin{equation} P_{succ}(y) = \frac{1}{M+1} \frac{p^{y}}{(y-1)!} \left[ \ln \left(\frac{M+2}{2}\right)\right]^{y-1} . \end{equation} The probability of finding F on one of the first $z$ trials is \begin{eqnarray} \label{trial-find} P_{find}(z) & = & \sum_{y=1}^{z} P_{succ}(y) \nonumber \\ & = & \frac{p}{M+1} \sum_{y=1}^{z} \frac{p^{y-1}}{(y-1)!} \left[ \ln \left(\frac{M+2}{2}\right)\right]^{y-1} . \end{eqnarray} Now consider the sum $f(n,h)=\sum_{k=0}^{N} h^{k}/k!$, for $h>0$. The terms in the sum initially increase as $n$ increases, reaching a maximum when $n$ is the greatest integer less than $h$. After that, they decrease. This suggests that if we choose $n$ to be several times $h$, then the sum will be approximately equal to $e^{h}$. In more detail, using the Stirling approximation, $k!\geq k^{k}e^{-k}$, so \begin{eqnarray} \sum_{k=n+1}^{\infty} \frac{h^{k}}{k!} & \leq & \sum_{k=n+1}^{\infty} \left(\frac{he}{k}\right)^{k} \nonumber \\ & \leq & \left(\frac{he}{k}\right)^{n+1}\sum_{k=0}^{\infty} \left(\frac{he}{n}\right)^{k} \nonumber \\ & = & \left(\frac{he}{k}\right)^{n+1} \frac{1}{1-(he/n)} , \end{eqnarray} assuming $(he/n)<1$. If we choose $n=rhe$, then the bound is $(1/r)^{rhe}[r/(r-1)]$. So for $he$ of order one, we can choose an $r$ of] order one that will make the above sum small and set $f(n,h)\simeq e^{h}$. Therefore, in Eq.\ (\ref{trial-find}), choosing $z$ to be of the order $p\ln [(M+2)/2]$, we have \begin{equation} P_{find} \simeq \frac{p(M+2)}{2(M+1)} . \end{equation} Consequently, we will need of the order $p\ln [(M+2)/2]$ trials to find F with high probability. \section{Finding Eigenvalues and Eigenvectors} We have now shown how one can effectively use the path probabilities to find F more quickly (section 4), as well as how the movement algorithm leads to fewer trials need (section 5). Returning to the final point made in the Follow the Measurement section, for larger mazes the average number of steps needed to solve the maze approached the limit of $\mathcal{U}(N,M)$. These results were found numerically, using the exact maximum path probability. But in general for any N-Tree maze, of any size, we would like some form for $\mathcal{U}(N,M)$ that we can use. In order to do so, we are interested in the eigenvectors and eigenvalues of the operator $U$, which advances the walk one step. This operator acts on a space of dimension $2E$, but we can reduce this by using symmetry. Since we start from an initial state of the system in which all edges have the same amplitude, and we are interested only in later states of the system that can be reached from this initial state by the action of $U$, there will be some edges that always will have the same amplitude. This means that we only need to consider an equal superposition of the corresponding edge states, thereby reducing the dimension of the system. For example, in the tree in Fig.\ref{binarytree1}, the two edges to the left of $F$ will always have the same amplitude, and the four edges to the right of $F$ will have the same amplitude. In both cases, we can replace multiple edges with a single effective edge. Doing so in an N-Tree maze, with $M$ layers, allows us to consider a subspace of dimension $(M+1)(M+2)/2$. From here, we let a computer to find the eigenvectors and eigenvalues of the matrix of $U$ expressed in the basis of effective edge states. \subsection{Eigenvector and Eigenvalue Characteristics.} When we let a computer solve for the eigenvalues and eigenvectors, it is found that everything comes in pairs. Specifically: 1) All eigenvalues come in pairs of complex conjugates. 2) All eigenvectors come in pairs, where the values in each vector come in corresponding complex conjugates. 3) $\langle u_{i}^{\ast} | \Psi_{\textrm{initial}} \rangle = \langle u_i | \Psi_{\textrm{initial}} \rangle^{\ast}$, where $|u_{i}\rangle$ is an eigenvector of $U$. This is a result of the fact that in the basis we are using, the matrix elements of $U$ are real. This implies that the coefficients in the characteristic equation of the matrix are real, hence point 1). For point 2), note that if $U|u_{i}\rangle = \lambda |u_{i}\rangle$, then since $U$ is represented by a real matrix, taking the complex conjugate of both sides gives us that $ |u_{i}^{\ast}\rangle$ is the eigenvector corresponding to $\lambda^{\ast}$. Point 3) follows from the fact that the components of $|\Psi_{init}\rangle$ are real. Letting $\lambda_{i}$ and $| u_{i} \rangle$ be the eigenvalues and eigenvectors of of the matrix $U$, we can represent the evolution of our system: \begin{equation} U^{n}|\Psi_{\textrm{initial}}\rangle = \sum_{i=1}^{d} \beta_{i} (\lambda_{i})^{n} | u_{i} \rangle \end{equation} where $\beta_{i}$ is the overlap of the eigenvector with the initial state \begin{equation} \label{betadef} \beta_{i} = \langle u_i | \Psi_{\textrm{initial}} \rangle \end{equation} Since the dimensions of the matrix corresponding to $U$ can be quite large as $M$ gets large, one would hope that only a handful of the $\beta$s are dominant, so that smaller terms can be dropped. This indeed turns out to be the case, as all of the $\beta$'s are small enough to be ignored except for two (a corresponding pair of complex conjugates). Keeping only the largest pair of $\beta$'s and dropping all other terms, our approximate solution becomes: \begin{equation} \label{approxeigenform} U^{n}| \Psi_{\textrm{initial}} \rangle= \beta e^{i\theta_{\lambda} n} |u \rangle + \beta^{*} e^{-i\theta_{\lambda} n} |u^{*} \rangle \end{equation} where $e^{i \theta_{\lambda}}$ is equivalent to the eigenvalue $\lambda_i$, expressed in polar form. Now suppose we are interested in the behavior of a particular state in our original basis. Using the result from equation \ref{approxeigenform}, we can reconstruct a given state, say $|\Phi \rangle $, as follow: Let z$_{\phi}=\langle\Phi |u\rangle$, and let W$_{\phi}$($n$) be the amplitude of state $|\Phi \rangle $ after $n$ unitary steps, that is $W_{\phi}(n)=\langle\Phi |U^{n}|\Psi_{initial}\rangle$. Then we have \begin{equation} W_{\phi}(n) = \beta e^{i\theta_{\lambda} n} z_{\phi} + \beta^{*} e^{-i\theta_{\lambda} n} z_{\phi}^{*} \end{equation} If we rewrite $\beta$ and z$_{\phi}$ in polar form: \begin{eqnarray} &=& |\beta| \cdot |z_{\phi}| \cdot (e^{i(\theta_{\beta} + \theta_{z} + \theta_{\lambda}n)}+ e^{-i(\theta_{\beta} + \theta_{z} + \theta_{\lambda}n)}) \nonumber \\ &=& |\beta| \cdot |z_{\phi}| \cdot 2\textrm{cos}(\theta_{\beta} + \theta_{z} + \theta_{\lambda}n) \label{cosapprox} \end{eqnarray} Thus, we get exactly the cyclic form we found numerically. By using the two dominant $\beta$'s, we get the result of equation \ref{cosapprox}, which is that the amplitude of each state behaves sinusoidally as a function of unitary steps. Each edge state can be written as a cosine, with an initial angle of $\theta_{\beta} + \theta_{z}$, that increases by $\theta_{\lambda}n$ after $n$ steps. Equation \ref{cosapprox} above is general for all of the states in the system. However, we are primarily interested in the states that make up the correct path from S to F, say $| \alpha \rangle$. For these states, a more appropriate representation will be: \begin{eqnarray} | \alpha \rangle &=& |\beta| \cdot |z_{\phi}| \cdot 2\textrm{sin}([\theta_{\beta} + \theta_{z} + \frac{\pi}{2}] + \theta_{\lambda}n) \nonumber \\ & \approx & |\beta| \cdot |z_{\phi}| \cdot 2\textrm{sin}( \theta_{\lambda}n) \label{sinapprox} \\ \nonumber \end{eqnarray} This is because for the states along the path, we find numerically that the quantity $[\theta_{\beta} + \theta_{z}]$ is near -$\frac{\pi}{2}$. As a result, the states along the path behave like a sin function, reaching their peak amplitude when $n$ is $\mathcal{O}$($\frac{\pi}{2\theta_{\lambda}}$), offset just slightly by the small initial angle $[\theta_{\beta} + \theta_{z} + \frac{\pi}{2}]$. In addition to producing the observed sinusoidal nature, this approximation also tells us that all the states along the path should peak around the same time, which we indeed see. Figure \ref{analyticalapprox} below shows a comparison of the approximation given in equation \ref{sinapprox} versus the true value found numerically, as a function of unitary steps. As we can see, for a relatively small maze, the approximation is very close to the true value. For larger $N$ and $M$ values, the approximation becomes even better. \begin{figure}[H] \centering \includegraphics[scale=0.38]{Analytical_v_Numerical} \caption{Dashed Line: Probability of the path states using the approximation in equation \ref{sinapprox} Solid Line: Actual probability of the path, generated numerically.} \label{analyticalapprox} \end{figure} \subsection{ Extracting Information for Higher Trends } Using the approximation from the previous section, our real interest is to learn the form of $\mathcal{U}(N,M)$, the function that tells us the required number of unitary steps for a peak path probability. With $\mathcal{U}(N,M)$ in hand, we can extend the search potential of the previously laid out algorithms to any sized maze. To get $\mathcal{U}(N,M)$, we are going to use the eigenangles $\theta_{\lambda}$ from the previous section. We will first get the function $\epsilon(N,M)$, which gives the eigenangle $\theta_{\lambda}$ corresponding to the most dominant $\beta$'s, for any $N$ and $M$. With the eigenangles $\epsilon(N,M)$, we can then use the approximation in equation \ref{sinapprox} to find the peak probability. When a 3D plot is made of the $\epsilon(N,M)$, with $N$ and $M$ on the x and y axes and the value of $\theta_{\lambda}$ on the z, we find an exponentially decreasing function in both $N$ and $M$. Looking at the 3D plot in slices for when we set $M$ to a constant value, we can see recognizable trends for $\theta_{\lambda}$ as a function of just $N$. These trends are of the form y = Ax$^\textrm{B}$, where A and B are constants, and are plotted below in figure \ref{eigenangles}. \begin{figure}[H] \centering \includegraphics[scale=0.48]{Eigenangles_Plot} \caption{Dots: eigenangles $\theta_{\lambda}$, plotted as a function of $N$. Red line: Power fit curve of the form y = Ax$^\textrm{B}$ } \label{eigenangles} \end{figure} This reveals that our function is of the form: \begin{equation} \mathlarger{\epsilon}(N,M) = \textrm{A}(M) \cdot N ^ { \textrm{B}(M) } \end{equation} Note that $\mathlarger{\epsilon}(N,M)$ here is in degrees. Using the best-fit solutions, shown in figure \ref{eigenangles}, we can analyze the forms for A($M$) and B($M$). Doing so reveals: \begin{eqnarray} \textrm{A}(M) &=& \alpha \cdot M ^ {\beta} \nonumber \\ \textrm{B}(M) &=& \rho + \gamma \cdot M \end{eqnarray} where $\alpha$, $\beta$, $\rho$, and $\gamma$ are all constants. So we find that A($M$) also takes the form of a power function, while B($M$) is linear. Putting everything together, we now have our approximate form for $\mathlarger{\epsilon}(N,M)$, and more importantly $\mathcal{U}(N,M)$: \begin{equation} \mathcal{U}(N,M) = \frac{90}{\mathlarger{\mathlarger{\epsilon}}(N,M)} = \frac{90}{\alpha} \cdot M^{-\beta} N^{ -\rho - \gamma \cdot M } \end{equation} where \begin{eqnarray} \alpha &\approx& 47.87 \hspace{1cm} \beta \approx -.551 \nonumber \\ \rho &\approx& .077 \hspace{1.2cm} \gamma \approx -.498 \label{regressionconstants} \end{eqnarray} These constants are all found numerically, using regression fitting. Their exact values may vary slightly by using larger sets of data to generate the regression fits. However, the values provided were generated using $N$ and $M$ up to 15. When tested to see if they reproduce the same peak path probabilities found numerically earlier, they do indeed produce the same peak probabilities, typically within 1-2\% of the exact peak. \subsection{ Final Remarks } In conclusion, we have found an approximate form for $\mathcal{U}(N,M)$ through analytical results. Using the regression constants from equation \ref{regressionconstants}, we see that the quantum system peaks around the order $\mathcal{O}(M^{.55} N ^{.5 M}$). Comparing this to the classical speed $\mathcal{O}( N^{M}$), we see a Grover-like speedup. But this speedup is only possible by utilizing the "Follow the Measurement" algorithm, which provides us the fastest means of finding F. Specifically, as shown in figure \ref{allspeeds}, the jumping algorithm provides us with an average solving speed that is a small multiple of $\mathcal{U}(N,M)$, roughly 1.5 times for mazes we studied. For larger mazes the $\ln M$ factor from Section V should manifest itself. However, multiplying $\mathcal{U}(N,M)$ by $\ln M$ provides only an upper bound on the number of steps in the quantum algorithm, because it does not take into account that the size of the trees decreases as we jump up the path. For this reason, we can truly compare the two solving speeds, and say that the quantum walk provides a definitive speedup over the classical one. The number of steps in the quantum algorithm has an upper bound of the order $\mathcal{O}(M^{.55} N ^{.5M} \ln M)$. while the number of steps in the classical algorithm is $\mathcal{O}( N ^{M}$). \section{Conclusion} We have developed a modification of the Grover search, where the probability accumulates on a path instead of on a marked vertex. However, when faced with the task of finding a special vertex, hidden in the deepest layer of an N-Tree maze, we have shown that making use of the probabilities of the states leading to the special vertex results in the fastest search. In particular, to capitalize on the system's high density of probability along the correct path, it is necessary incorporate changing the graph, which we called ``movement,'' into the quantum algorithm. The ability to ``mov'' while searching for the special vertex, is analogous to the core element of the classical search. Our efforts were focused solely on N-Tree mazes due to their high symmetry, and resulting high peak path probabilities. We would like to note that in addition to only F reflecting with -1, we also examined the case where both S and F reflect with -1, but found that letting S be a special vertex results in a less than ideal probability distributions for searches. It was shown analytically that using the movement algorithm to search for F, one needs on average fewer trials to find F. In addition, by using computational tools to examine the eigenvalues and eigenstates of the various mazes' quantum systems, we provided an equation that reveals the underlying sinusoidal nature of the time-behavior of the system, to very close approximation. And by using these approximations, we were able to produce an approximate form to $\mathcal{U}(N,M)$. Using $\mathcal{U}(N,M)$ along with the average speeds found numerically in section 4, we have ultimately shown that the average solving speed of the quantum algorithm utilizing movement has an upper bound of the order $\mathcal{O}(M^{.55} N ^{.5M}\ln M$), a speedup over the classical speed of $\mathcal{O}( N^{M}$). \begin{acknowledgements} This research was supported by a grant from the John Templeton Foundation. \end{acknowledgements}

\section{Introduction} \label{sec:introduction} Reinforcement learning has been applied to solving challenging planning and control problems~\cite{mnih2015human, arulkumaran2017deep}. Despite a significant amount of recent progress, solving long-horizon problems remains a significant challenge due to the combinatorial explosion of possible strategies. One promising approach to addressing these issues is to leverage \emph{programs} to guide the behavior of the agents~\cite{psketch, pagent}. In this paradigm, the user provides a sequence of high-level instructions designed to guide the agent. For instance, the program might encode intermediate subgoals that the agent should aim to achieve, but leave the reinforcement learning algorithm to discover how exactly to achieve these subgoals. In addition, to handle partially observable environments, these programs might encode conditionals that determine the course of action based on the agent's observations. The primary drawback of these approaches is that the user becomes burdened with providing such a program for every new task. Not only is this process time-consuming for the user, but a poorly written program may hamper learning. A natural question is whether we can automatically \emph{synthesize} these programs. That is, rather than require the user to provide the program, we instead have them provide a high-level specification that encodes only the desired goal. Then, our framework automatically synthesizes a program that achieves this specification. Finally, this program is used to guide the reinforcement learning algorithm. \begin{figure*} \centering \begin{subfigure}[]{0.08\textwidth} \centering \includegraphics[width=\textwidth]{figures/symbols.pdf} \vspace{0.5em} \end{subfigure} \begin{subfigure}[]{0.44\textwidth} \centering \includegraphics[width=\textwidth]{figures/step0.pdf} \caption{} \label{fig:map} \end{subfigure} \begin{subfigure}[]{0.44\textwidth} \centering \includegraphics[width=\textwidth]{figures/step20.pdf} \caption{} \label{fig:replan} \end{subfigure} \caption{ (a) An initial state for the craft environment. Bright regions are observed and dark ones are unobserved. This map has two \emph{zones} separated by a stone boundary (blue line). The first zone contains the agent, 2 irons, and 1 wood; the second contains 1 iron and 1 gem. The goal is to get the gem. The agent represents the high-level structure of the map (e.g., resources in each zone) as \emph{abstraction variables}. The ground truth abstraction variables are in the top-right; we only show the counts of gems, irons, and woods in each zone and the zone containing the agent. The two thought bubbles below are abstract variables hallucinated by the agent based on the observed parts of the map. In both, the zone that the agent is in contains a gem, so the synthesized program is ``get gem''. However, this program cannot achieve the goal. (b) The state after the agent took 20 actions, failed to obtain the gem, and is now synthesizing a new program. They have explored more of the map, so the hallucinations are more accurate, and the new program is a valid strategy for obtaining the gem. } \end{figure*} The key challenge to realizing our approach is how to handle partially observable environments. In the fully observed setting, the program synthesis problem reduces to STRIPS planning~\cite{fikes1971strips}---i.e., search over the space of possible plans to find one that achieves the goal. However, these techniques are hard to apply in settings where the environment is initially unknown. To address this challenge, we propose an approach called \emph{model predictive program synthesis (MPPS)}. At a high level, our approach synthesizes the guiding program based on a conditional generative model of the environment, but in a way that is robust to the uncertainty in this model. In particular, for a user-provided goal specification $\phi$, the agent chooses its actions using the following three steps: \begin{itemize}[topsep=0pt,itemsep=0ex,partopsep=1ex,parsep=1ex] \item {\bf Hallucinator:} First, inspired by world-models~\cite{world-models}, the agent keeps track of a conditional generative model $g$ over possible realizations of the unobserved portions of the environment. \item {\bf Synthesizer:} Next, given the world predicted by $g$, the agent synthesizes a program $p$ that achieves $\phi$ assuming this prediction is accurate. Since world predictions are stochastic in nature, it samples multiple predicted worlds and computes the program that maximizes the probability of success according to these samples. \item {\bf Executor:} Finally, the agent executes the strategy encoded by $p$ for a fixed number of steps $N$. Concretely, $p$ is a sequence of components $p=c_1;...;c_k$, where each component is an \emph{option} $c_\tau=(\pi_\tau,\beta_\tau)$~\cite{sutton1999between}, which says to execute policy $\pi_\tau$ until condition $\beta_\tau$ holds. \end{itemize} If $\phi$ is not satisfied after $N$ steps, then the above process is repeated. Since the hallucinator now has more information (assuming the agent has explored more of the environment), the agent now has a better chance of achieving its goal. Importantly, the agent is implicitly encouraged to explore since it must do so to discover whether the current program can successfully achieve the goal $\phi$. Similar to~\citet{pagent}, the user instantiates our framework in a new domain by providing a set of \emph{prototype components} $\tilde{c}$, where $\tilde{c}$ is a logical formula encoding a useful subtask for that domain. For instance, $\tilde{c}$ may encode that the agent should navigate to a goal position. The user does not need to provide a policy to achieve $\tilde{c}$; our framework uses reinforcement learning to automatically train such a policy $c$. Our executor reuses these policies $c$ to solve different tasks in varying environments within the same domain. In particular, for a new task and/or environment, the user only needs to provide a specification $\phi$, which is a logical formula encoding the goal of that task. We instantiate this approach in the context of a 2D Minecraft-inspired environment~\cite{psketch, Sohn18, pagent}, which we call the ``craft environment'', and a ``box-world'' environment \cite{drrl}. We demonstrate that our approach significantly outperforms existing approaches for partially observable environments, while performing essentially as well as using handcrafted programs to guide the agent. In addition, we demonstrate that the policy we learn can be transferred to a continuous variant of the craft environment, where the agent is replaced by a MuJoCo~\cite{mujoco} ant. \textbf{Related work.} There has been recent interest in program-guided reinforcement learning, where a program encoding high-level instructions on how to achieve the goal (essentially, a sequence of options) is used to guide the agent. \citet{psketch} uses programs to guide agents that are initially unaware of \emph{any} semantics of the programs (i.e., the program is just a sequence of symbols), with the goal of understanding whether the structure of the program alone is sufficient to improve learning. \citet{jothimurugan2019composable} enables users to write specifications in a high-level language based on temporal logic. Then, they show how to translate these specifications into shaped reward functions to guide learning. Most closely related is recent work~\cite{pagent} that has demonstrated how program semantics can be used to guide reinforcement learning in the craft environment. As with this work, we assume that the user provides semantics of each option in the program (i.e., the subgoal that should be achieved by that option), but not an actual policy implementing this option (which is learned using reinforcement learning). However, we do not assume that the user provides the program, just the overall goal. More broadly, our work fits into the literature on combining high-level planning with reinforcement learning. In particular, there is a long literature on planning with options~\cite{sutton1999between} (also known as \emph{skills}~\cite{hausman2018learning}), including work on inferring options~\cite{stolle2002learning}. However, these approaches cannot be applied to MDPs with continuous state and action spaces or to partially observed MDPs. Recent work has addressed the former~\cite{abel2020value,jothimurugan2021abstract} by combining high-level planning with reinforcement learning to handle low-level control, but not the latter, whereas our work tackles both challenges. Similarly, classical planning algorithms such as STRIPS~\cite{fikes1971strips} cannot handle uncertainty in the realization of the environment. There has also been work on \emph{replanning}~\cite{stentz1995focussed} to handle small changes to an initially known environment, but they cannot handle environments that are initially completely unknown. Alternatively, there has been work on hierarchical planning in POMDPs~\cite{charlin2007automated,toussaint2008hierarchical}, but these are not designed to handle continuous state and action spaces. We leverage program synthesis~\cite{solar2008program} in conjunction with the world models approach~\cite{world-models} to address these issues. Finally, there has broadly been recent interest in using program synthesis to learn programmatic policies that are more interpretable~\cite{verma2018programmatically,inala2021neurosymbolic}, verifiable~\cite{bastani2018verifiable,verma2019verifiable}, and generalizable~\cite{inala2020synthesizing}. In contrast, we are not directly synthesizing the policy, but a program to guide the policy. \section{Motivating Example} Figure \ref{fig:map} shows a 2D Minecraft-inspired crafting game. In this grid world, the agent can navigate and collect resources (e.g., wood), build tools (e.g., a bridge) at workshops using collected resources, and use the tools to achieve subtasks (e.g., use a bridge to cross water). The agent can only observe the $5\times 5$ grid around its current position; since the environment is static, it also memorizes locations it has seen before. A single task consists of a randomly generated map (i.e., the environment) and goal (i.e., obtain a certain resource or build a certain tool). To instantiate our framework, we provide prototype components that specify high-level behaviours such as getting wood or using toolshed to build a bridge. Figure \ref{fig:dsl} shows the domain-specific language that encodes the set of prototypes. For each prototype, we need to provide a logical formula $\tilde{c}$ that formally specifies its desired behavior. Rather than specifying behavior over concrete state $s$, we instead specify it over \emph{abstraction variables} that encode subsets of the state space. For instance, we divide the map into \textit{zones} that are regions separated by obstacles such as water and stone. As an example, the map in Figure \ref{fig:map} has two zones: the region containing the agent and the region blocked off by stones. Then, the zone the agent is currently in is represented by an abstraction variable $z$---i.e., the states $s$ where the agent is in zone $i$ is represented by the logical predicate $z=i$. The prototype components are logical formulas over these abstraction variables---e.g., the prototype for ``get wood'' is \begin{align*} \forall i, j\;.\; & ( z^- = i \wedge z^+ = j ) \Rightarrow ( b_{i,j}^- = \text{connected} ) \\ &~\wedge ( \rho^+_{j,\text{wood}} = \rho_{j,\text{wood}}^- - 1 ) \wedge ( \iota^+_{\text{wood}} = \iota_{\text{wood}}^- + 1 ). \end{align*} In this formula, $b_{i,j}$ indicates whether zones $i$ and $j$ are connected, $\rho_{i,r}$ denotes the count of resource $r$ in zone $i$, and $\iota_r$ denotes the count of resource $r$ in the agent's inventory. The $+$ and $-$ superscripts on each abstraction variable indicates that it represents the initial state of the agent before the execution of the prototype and the final state of the agent after the execution of the prototype, respectively. Thus, this formula says that (i) the agent goes from zone $i$ to $j$, (ii) $i$ and $j$ are connected, (iii) the count of wood in the agent's inventory increases by one, and (iv) the count of wood in zone $j$ decreases by one. All of the prototype components we use are summarized in Appendix \ref{append:semantics}. Before solving any tasks, for each prototype $\tilde{c}$, our framework uses reinforcement learning to train a component $c$ that implements $\tilde{c}$---i.e., an option $c=(\pi,\beta)$ that attempts to satisfy the behavior encoded by the logical formula $\tilde{c}$. To solve a new task, the user provides a logical formula $\phi$ encoding the goal of this task. Then, the agent acts in the environment to try achieve $\phi$. For example, Figure \ref{fig:map} shows the initial state of an agent where the task is to obtain a gem. First, based on the observations so far, the agent $\pi$ uses the hallucinator $g$ to predict multiple potential worlds, each of which represents a possible realization of the full map. One convenient aspect of our approach is that rather than predicting concrete states, it suffices to predict the abstraction variables used in the prototype components $\tilde{c}$ and goal specification $\phi$. For instance, Figure \ref{fig:map} shows two samples of the world predicted by $g$; here, the only values it predicts are the number of zones in the map, the type of the boundary between the zones, and the counts of the resources and workshops in each zone. In this example, the first predicted world contains two zones, and the second contains one zone. Note that in both predicted worlds, there is a gem located in same zone as the agent. Next, $\pi$ synthesizes a program $p$ that achieves the goal in the maximum possible number of predicted worlds. The synthesized program in Figure \ref{fig:map} is a single component ``get gem'', which is an option that searches the current zone (or zones already connected with the current zone) for a gem. Note that this program achieves the goal for the predicted worlds shown in Figure \ref{fig:map}. Finally, the agent executes the program $p=c_1;...;c_k$ for a fixed number $N$ of steps. In particular, it executes the policy $\pi_\tau$ of component $c_\tau=(\pi_\tau,\beta_\tau)$ until $\beta_\tau$ holds, upon which it switches to executing $c_{\tau+1}$. In our example, there is only one component ``get gem'', so it executes the policy for this component until the agent finds a gem. In this case, the agent fails to achieve $\phi$ since there is no gem in the same zone as the agent. Thus, the agent repeats the above process. Since the agent now has more observations, $g$ more accurately predicts the world. For instance, Figure \ref{fig:replan} shows the intermediate step when the agent does the first replanning. Note that it now correctly predicts that the only gem is in the second zone. As a result, the newly synthesized program is \begin{align*} p=&\overbrace{\text{get wood};\text{use workbench};\text{get iron};\text{use factory};}^{\text{for building axe}}\\ &\text{use axe};\text{get gem}. \end{align*} That is, it builds an axe to break the stone so it can get to the zone containing the gem. Finally, the agent executes this new program, which successfully finds the gem. \begin{figure} \centering \input{dsl} \caption{Prototype components for the craft environment; the three kinds of prototypes are get resource ($R$), use tool ($T$), and use workshop ($W$). } \label{fig:dsl} \end{figure} \section{Problem Formulation} \label{sec:prelmiinaries} \textbf{POMDP.} We consider a partially observed Markov decision process (POMDP) with states $\mathcal{S}\subseteq \mathbb{R}^n$, actions $\mathcal{A}\subseteq\mathbb{R}^m$, observations $\mathcal{O}\subseteq\mathbb{R}^q$, initial state distribution $\mathcal{P}_0$, observation function $h: \mathcal{S} \rightarrow \mathcal{O}$, and transition function $f: \mathcal{S} \times \mathcal{A} \rightarrow \mathcal{S}$. Given initial state $s_0 \sim \mathcal{P}_0$, policy $\pi:\mathcal{S}\to\mathcal{A}$, and time horizon $T\in\mathbb{N}$, the generated trajectory is $(s_0, a_0, s_1, a_1, \dots, s_T, a_T)$, where $o_t = h(s_t)$, $a_t = \pi(o_t)$, and $s_{t+1} = f(s_t, a_t)$. We assume that the state includes the unobserved parts of the environment---e.g., in our craft environment, it represents both the entire map as well as the agent's current position. \textbf{Programs.} We consider programs $p=c_1;...;c_k$ that are composed of \emph{components} $c_\tau\in C$. Each component $c$ represents an option $c=(\pi,\beta)$, where $\pi:\mathcal{O}\to\mathcal{A}$ is a policy and $\beta:\mathcal{O}\to\{0,1\}$. To execute $p$, the agent uses the options $c_1,...,c_k$ in sequence. To use option $c_\tau=(\pi_\tau,\beta_\tau)$, it takes actions $\pi_\tau(o)$ until $\beta_\tau(o)=1$; at this point, the agent switches to option $c_{\tau+1}$ and continues this process. \textbf{User-provided prototype components.} Rather than have the user directly provide the components $C$ used in our programs, we instead have them provide \emph{prototype components} $\tilde{c}\in\tilde{C}$. Importantly, prototypes can be shared across closely related tasks. Each prototype component is a logical formula that encodes the expected desired behavior of a component. More precisely, $\tilde{c}$ is a logical formula over variables $s^-$ and $s^+$, where $s^-$ denotes the initial state before executing the option and $s^+$ denotes the final state after executing the option. For instance, the prototype component \begin{align*} \tilde{c}\equiv(s^-=s_0\Rightarrow s^+=s_1)\vee(s^-=s_2\Rightarrow s^+=s_3) \end{align*} says that if the POMDP is currently in state $s_0$, then $c$ should transition it to $s_1$, and if it is currently in state $s_2$, then $c$ should transition it to $s_3$. Rather than directly define $\tilde{c}$ over the states $s$, we can instead define it over \emph{abstraction variables} that represent subsets of the state space. This approach can improve scalability of our synthesis algorithm---e.g., it enables us to operate over continuous state spaces as long as the abstraction variables themselves are discrete. \textbf{User-provided specification.} To specify a task, the user provides a specification $\phi$, which is a logical formula over states $s$; in general, $\phi$ may not directly refer to $s$ but to other variables that represent subsets of $\mathcal{S}$. Our goal is to design an agent that achieves any given $\phi$ (i.e., act in the POMDP to reach a state that satisfies $\phi$) as quickly as possible. \section{Model Predictive Program Synthesis} \begin{figure} \centering \includegraphics[width=0.45\textwidth]{figures/schematic-2.pdf} \caption{Architecture of our agent (the blue box).} \label{fig:schematic} \end{figure} We describe the architecture of our agent, depicted in Figure \ref{fig:schematic}. It is composed of three parts: the \textit{hallucinator} $g$, which predicts possible worlds; the \textit{synthesizer}, which generates a program $p$ that succeeds with high probability according to worlds sampled from $g$; and the \textit{executor}, which uses $p$ to act in the POMDP. These parts are run once every $N$ steps to generate a program $p$ to execute for the subsequent $N$ steps, until the user-provided specification $\phi$ is achieved. \textbf{Hallucinator.} First, the hallucinator is a conditional generative model trained to predict the environment given the observation so far. For simplicity, we assume the observation $o$ on the current step already encodes all observations so far. Since our craft environment is static, $o$ simply encodes the portion of the map that has been revealed so far, with a special symbol indicating parts that are unknown. To be precise, the hallucinator $g$ encodes a distribution $g(s\mid o)$, which is trained to approximate the actual distribution $P(s\mid o)$. Then, at each iteration (i.e., once every $N$ steps), our agent samples $m$ worlds $\hat{s}_1,...,\hat{s}_m\sim g(\cdot\mid o)$. We choose $g$ to be a conditional variational auto-encoder (CVAE) \cite{cvae}. When using abstract variables to represent the states, we can have $g$ directly predict the values of these abstract variables instead of having $g$ predict the concrete state. Intuitively, this approach works since as described below, the synthesizer only needs to know the values of the abstract variables to generate a program. \textbf{Synthesizer.} The synthesizer aims to compute the program that maximizes the probability of satisfying the goal $\phi$: \begin{align} p^*&=\operatorname*{\arg\max}_p\mathbb{E}_{P(s\mid o)}[p\text{ solves }\phi\text{ for }s] \nonumber \\ &\approx\operatorname*{\arg\max}_p\frac{1}{m}\sum_{j=1}^m\mathbbm{1}[p\text{ solves }\phi\text{ for }\hat{s}_j], \label{eqn:monte-carlo} \end{align} where the $\hat{s}_j$ are samples from $g$. The objective (\ref{eqn:monte-carlo}) can be expressed as a MaxSAT problem~\cite{maxsat}. In particular, suppose for now that we are searching over programs $p=c_1;...;c_k$ of fixed length $k$. Then, consider the constrained optimization problem \begin{align} \label{eqn:maxsat} \operatorname*{\arg\max}_{\xi_1,...,\xi_k}\frac{1}{m}\sum_{j=1}^m\exists s_1^-,s_1^+,...,s_k^-,s_k^+\;.\;\psi_j, \end{align} where $\xi_\tau$ and $s_\tau^\delta$ (for $\tau\in\{1,...,k\}$ and $\delta\in\{-,+\}$) are the optimization variables. Intuitively, $\xi_1,...,\xi_k$ encodes the program $p=c_1;...;c_k$, and $\psi_j$ encodes the event that $p$ solves $\phi$ for world $\hat{s}_j$. In particular, we have \begin{align*} \psi_j\equiv\psi_{j,\text{start}}\wedge\left[\bigwedge_{\tau=1}^k\psi_{j,\tau}\right]\wedge\left[\bigwedge_{\tau=1}^{k-1}\psi_{j,\tau}'\right]\wedge\psi_{j,\text{end}}, \end{align*} where \begin{align*} \psi_{j,\text{start}}\equiv(s_1^-=\hat{s}_j) \end{align*} encodes that the initial state is $\hat{s}_j$, \begin{align*} \psi_{j,\tau}\equiv\big((\xi_\tau=\tilde{c})\Rightarrow\tilde{c}(s_\tau^-,s_\tau^+)\big) \end{align*} encodes that if the $\tau$th component has prototype $\tilde{c}$, then the $\tau$th component should transition the system from $s_\tau^-$ to $s_\tau^+$, \begin{align*} \psi_{j,\tau}'\equiv(s_\tau^+=s_{\tau+1}^-) \end{align*} encodes that the final state of component $\tau$ should equal the initial state of component $\tau+1$, and \begin{align*} \psi_{j,\text{end}}\equiv\phi(s_j^+) \end{align*} encodes that the final state of the last component should satisfy the user-provided goal $\phi$. We use a MaxSAT solver to solve (\ref{eqn:maxsat})~\cite{z3}. Given a solution $\xi_1=\tilde{c}_1,...,\xi_k=\tilde{c}_k$, the synthesizer returns the corresponding program $p=c_1;...;c_k$. We incrementally search for longer and longer programs, starting from $k=1$ and incrementing $k$ until either we find a program that achieves at least a minimum objective value, or we reach a maximum program length $k_{\textrm{max}}$, at which point we use the best program found so far. \textbf{Executor.} The executor runs the synthesized program $p=c_1;...;c_k$ for the subsequent $N$ steps. It iteratively uses each component $c_\tau=(\pi_\tau,\beta_\tau)$, starting from $\tau=1$. In particular, it uses action $a_t=\pi_\tau(o_t)$ at each time step $t$, where $o_t$ is the observation on that step. It does so until $\beta_\tau(o_t)=1$, at which point it increments $\tau\gets\tau+1$. Finally, it continues until either it has completed running the program (i.e., $\beta_k(o_t)=1$), or after $N$ time steps. In the former case, by construction, the goal $\phi$ has been achieved, so the agent terminates. In the latter case, the agent iteratively reruns the above three steps based on the current observation to synthesize a new program. At this point, the hallucinator likely has additional information about the environment, so the new program has a greater chance of achieving $\phi$. \section{Learning Algorithm} \label{sec:learning} Next, we describe our algorithm for learning the parameters of models used by our agent. In particular, there are two parts that need to be learned: (i) we need to learn parameters of the conditional variational auto-encoder (CVAE) hallucinator $g$, and (ii) we need to learn the components $c$ based on the user-provided prototype components $\tilde{c}$. \textbf{Hallucinator.} We choose the hallucinator $g$ to be a conditional variational auto-encoder (CVAE)~\cite{cvae} trained to estimate the distribution $P(s\mid o)$ of states given the current observation. First, we obtain samples ${(o_t, s_t)}$ using rollouts collected using a random agent. Then, we train the CVAE using the standard evidence lower bound (ELBo) on the log likelihood~\cite{kingma2013auto}: \begin{align} \label{eqn:cvae} \ell(\theta, \tilde{\theta}) &= \mathbb{E}_{P(s,o)}\Big[\mathbb{E}_{h_{\tilde{\theta}}(z \mid s, o)} [ \log g_\theta(s\mid z, o)] \\ &\qquad\qquad\quad - D_{\text{KL}}(h_{\tilde{\theta}}(z\mid s, o) \;\|\; \mathcal{N}(z;0,1))\Big], \nonumber \end{align} where $h_{\tilde{\theta}}$ is the encoder and $g_{\theta}$ is the decoder: \begin{align*} h_{\tilde{\theta}}(z\mid s,o)&=\mathcal{N}(z;\tilde{\mu}_{\tilde{\theta}}(s,o),\tilde{\sigma}_{\tilde{\theta}}(s,o)^2\cdot I) \\ g_{\theta}(s\mid z,o)&=\mathcal{N}(s;\mu_\theta(z,o),\sigma_\theta(z,o)^2\cdot I), \end{align*} where $\mu_\theta$, $\sigma_\theta$, $\tilde{\mu}_{\tilde{\theta}}$, and $\tilde{\sigma}_{\tilde{\theta}}$ are neural networks, and $I$ is the identity matrix. We train $h_{\tilde{\theta}}$ and $g_{\theta}$ by jointly optimizing (\ref{eqn:cvae}), and then choose the hallucinator to be $g=g_{\theta}$. \textbf{Executor.} Our framework uses reinforcement learning to learn components $c$ that implement the user-provided prototype components $\tilde{c}$. The learned components $c\in C$ can be shared across multiple tasks. Our approach is based on neural module networks for reinforcement learning \citet{psketch}. In particular, we train a neural module $\pi$ for each component $c$. In addition, we construct a monitor $\beta$ that checks when to terminate execution, and take $c=(\pi,\beta)$. First, $\beta$ is constructed from $\tilde{c}$---in particular, it returns whether $\tilde{c}$ is satisfied based on the current observation $o$. Note that we have assumed that $\tilde{c}$ can be checked based only on $o$; this assumption holds for all prototypes in our craft environment. If it does not hold, we additionally train $\pi$ to explore in a way that enables it to check $\tilde{c}$. Now, to train the policies $\pi$, we generate random initial states $s$ and goal specifications $\phi$. For training, we use programs synthesized from the fully observed environments; such a program $p$ is guaranteed to achieve $\phi$ from $s$. We use this approach since it avoids the need to run the synthesizer repeatedly during training. Then, we sample a rollout $\{((o_1, a_1, r_1),...,(o_T, a_T, r_T))\}$ by using the executor in conjunction with the program $p$ and the current options $c_\tau=(\pi_\tau,\beta_\tau)$ (where $\pi_\tau$ is randomly initialized). We give the agent a reward $\tilde{r}$ on each time step where achieves the subgoal of a single component $c_{\tau}$---i.e., the executor increments $\tau\gets\tau+1$. Then, we use actor-critic reinforcement learning~\cite{ac} to update the parameters of each policy $\pi$. Finally, as in \citet{psketch}, we use curriculum learning to speed up training---i.e., we train using goals that can be achieved with shorter programs first. \section{Experiments} In this section, we describe empirical evaluations of our approach. As we show, it significantly outperforms non-program-guided baselines, while performing essentially as well as an oracle that is given the ground truth program. \begin{figure*} \centering \begin{subfigure}[]{0.22\textwidth} \centering \includegraphics[width=\textwidth]{figures/avg_rewards.pdf} \caption{} \label{fig:reward-curve} \end{subfigure} \begin{subfigure}[]{0.22\textwidth} \centering \includegraphics[width=\textwidth]{figures/avg_finish_times.pdf} \caption{} \label{fig:time-curve} \end{subfigure} \begin{subfigure}[]{0.22\textwidth} \centering \includegraphics[width=\textwidth]{figures/avg_rewards_box.pdf} \caption{} \label{fig:box-reward-curve} \end{subfigure} \begin{subfigure}[]{0.22\textwidth} \centering \includegraphics[width=\textwidth]{figures/avg_finish_times_box.pdf} \caption{} \label{fig:box-finish-time} \end{subfigure} \begin{subfigure}[]{0.09\textwidth} \centering \includegraphics[width=\textwidth]{figures/legend.pdf} \vspace{0.5em} \end{subfigure} \caption{ (a,b) Training curves for 2D-craft environment. (c,d) Training curves for the box-world environment. (a,c) The average reward on the test set over the course of training; the agent gets a reward of 1 if it successfully finishes the task in the time horizon, and 0 otherwise. (b,d) The average number of steps taken to complete the task on the test set. We show our approach (``Ours''), the program guided agent (``Oracle''), the end-to-end neural policy (``End-to-end''), world models (``World models''), and relational deep RL (``Relational'').} \label{fig:curve} \end{figure*} \begin{figure} \centering \begin{subfigure}[]{0.22\textwidth} \centering \includegraphics[width=\textwidth]{figures/ant-craft.png} \caption{} \label{fig:ant-craft} \end{subfigure} \begin{subfigure}[]{0.23\textwidth} \centering \includegraphics[width=\textwidth]{figures/box-map.pdf} \caption{} \label{fig:box} \end{subfigure} \caption{ (a) The Ant-craft environment. The policy needs to control the ant to perform the crafting tasks. (b) The box-world environment. The grey pixel denotes the agent. The goal is to get the white key. The unobserved parts of the map is marked with ``x''. The key currently held by the agent is shown in the top-left corner. In this map, the number of boxes in the path to the goal is 4, and it contains 1 distractor branch.} \label{fig:box-curve} \end{figure} \subsection{Benchmarks} \textbf{2D-craft.} We consider a 2D Minecraft-inspired crafting game based on the ones in \citet{psketch, pagent} (Figure \ref{fig:map}). A map in this domain is an $8\times8$ grid, where each grid cell either is empty or contains a resource (e.g., wood or gold), an obstacle (e.g., water or stone), or a workshop. In each episode, we randomly sample a map from a predefined distribution, a random initial position for the agent, and a random task (one of 14 possibilities, each of which involves getting a certain resource or building a certain tool). The more complicated tasks may require the agent to build intermediate tools (e.g., a bridge or an axe) to reach initially inaccessible regions to achieve its goal. In contrast to prior work, our agent does not initially observe the entire map; instead, they can only observe grid cells in a $5\times 5$ square around them. Since the environment is static, any previously visited cells remain visible. The agent has a discrete action space, including move actions in four directions, and a special ``use'' action that can pick a resource, use a workshop, or use a tool. The maximum length of each episode $T=100$. \textbf{Ant-craft.} Next, we consider a variant of 2D-craft where the agent is replaced with a MuJoCo \cite{mujoco} ant \cite{ant} (illustrated in Figure \ref{fig:ant-craft}). For simplicity, we do not model the physics of the interaction between the ant and its environment---e.g., the ant automatically picks up resources in the grid cell it currently occupies. The policy needs to learn the continuous control to walk the ant as well as the strategy to perform the tasks. This environment is designed to demonstrate that our approach can be applied to continuous control tasks. \textbf{Box-world.} Finally, we consider the box-world environment \cite{drrl}, which requires abstract relational reasoning. It is a $12\times12$ grid world with locks and boxes randomly scattered throughout (visualized in Figure \ref{fig:box}). Each lock occupies a single grid cell, and the box it locks occupies the adjacent grid cell. The box contains a key that can open a subsequent lock. Each lock and box is colored; the key needed to open a lock is contained in the box of the same color. The agent is given a key to get started, and its goal is to unlock the box of a given color. The agent can move in the room in four directions; it opens a lock for which it has the key simply by walking over it, at which point it can pick up the adjacent key. We assume that once the agent has the key of a given color, it can unlock multiple locks of that color. We modify the original environment to be partially observable; in particular, the agent can observe a $7\times7$ grid around them (as well as the previously observed grid cells). In each episode, we sample a random configuration of the map, where the number of boxes in the path to the goal is randomly chosen between 1 to 4, and the number of ``distractor branches'' (i.e., boxes that the agent can open but does not help them reach the goal) is also randomly chosen between 1 to 4. \subsection{Baselines} \textbf{End-to-end.} An end-to-end neural policy trained with the same actor-critic algorithm and curriculum learning as discussed in Section \ref{sec:learning}. It uses one actor network per task. \textbf{World models.} The world models approach \cite{world-models} handles partial observability by using a generative model to predict the future. It trains a V model (VAE) and an M model (MDN-RNN) to learn a compressed spatial and temporal representation of the environment. The V model takes the observations at each step $t$ and encodes it into a latent vector $z_t$. The M model is a recurrent model that takes the latent vectors $z_1,...,z_t$ as input and predicts $z_{t+1}$. The latent states of the M model and the latent vectors $z_t$ from the V model together form the world model features, which are used as inputs to the controller (C model). \textbf{Program guided agent.} This technique uses a program to guide the agent policy~\cite{pagent}. Unlike our approach, the ground truth programs (i.e., a program guaranteed to achieve the goal) is provided to the agent at the beginning; we synthesize this program using the full map (i.e., including parts of the map that are unobserved by the agent). This baseline can be viewed as an oracle since it is strictly more powerful than our approach. \textbf{Relational Deep RL.} For the box-world environment, we also compare with the relational deep RL approach~\cite{drrl}, which replaces the policy network with a relational module based on the multi-head attention mechanism \cite{transformer} operating over the map features. The output of the relational module is used as input to an MLP network that computes the action. \begin{figure} \centering \begin{subfigure}[]{0.23\textwidth} \centering \includegraphics[width=\textwidth]{figures/optim.pdf} \caption{} \end{subfigure} \begin{subfigure}[]{0.23\textwidth} \centering \includegraphics[width=\textwidth]{figures/ablation.pdf} \caption{} \end{subfigure} \caption{Comparison of behaviors between the optimistic approach (left) and our MPPS approach (right), in a scenario where goal is to get the gem. (a) This state is the point at which the optimistic approach first synthesizes the correct program instead of the (incorrect) one ``get gem''. It only does so after the agent has observed all the squares in its current zone (the green arrows show the agent's trajectory so far). (b) The initial state of our MPPS strategy. It directly synthesizes the correct program, since the hallucinator knows the gem is most likely in the other zone. Thus, the agent completes the task much more quickly.} \vspace{-0.5em} \label{fig:ablation} \end{figure} \subsection{Implementation Details} \textbf{2D-craft environment.} For our approach, we use a CVAE as the hallucinator with MLPs (a hidden layer of dimension 200) for the encoder and the decoder. We pre-train the CVAE on 100 rollouts with 100 timesteps in each rollout---i.e., 10,000 $(s, o)$ pairs. We use the Z3 SMT solver \cite{z3} to solve the MAXSAT synthesis formula. We set the number of sample completions $m=3$, and the number of steps to replan $N=20$. We use the same architecture for the actor networks and critic networks across our approach and all baselines: for actor networks, we use MLP with a hidden layer of dimension 128, and for critic networks, we use MLP with a hidden layer of dimension 32. We train each model on 400K episodes, and evaluate on a test set containing 10 scenarios per task. \textbf{Ant-craft.} We first pre-train a goal following policy for the ant: given a randomly chosen goal position, this policy controls the ant to move to that position. We use the soft actor-critic algorithm \cite{sac} for pre-training. The executor in our approach, as well as our baseline policies, outputs actions that are translated into the goal positions as inputs to this ant controller. We let the ant controller run for 50 timesteps in the simulator to execute each move action from the upper-stream policies. We initialize each policy with the trained model from the 2D-craft environment, and fine-tune it on the Ant-craft environment for 40K episodes. \textbf{Box-world.} Following \citet{drrl}, we use a one-layer CNN with 32 kernels of size $3\times3$ to process the raw map inputs before feeding into the downstream networks across all approaches. For the programs in our approach, we have a prototype component for each color, where the desired behavior of the component is to get the key of that color. The full definition of the prototype components we use for box-world is in Appendix \ref{append:box-semantics}. For the hallucinator CVAE, we use the same architecture as in the craft environment with a hidden dimension of 300, and trained with 100k $(s, o)$ pairs. For the synthesizer, we set $m=3$ and $N=10$. We train each model for 200K episodes, and evaluate on a test set containing 10 scenarios per level. Each level has a specific number of boxes in the path to the goal (i.e., the goal length). Our test set contains four levels with goal lengths between 1 to 4. \begin{table} \centering\small \begin{tabular}{ccc} \toprule {} & {\bf Avg. reward} & {\bf Avg. finish step} \\ \midrule End-to-end & 0.49 & 60.7 \\ World models & 0.50 & 59.3 \\ Ours & \textbf{0.93} & 26.7 \\ Oracle & \textbf{0.93} & \textbf{25.9} \\ \bottomrule \end{tabular} \caption{Average rewards and average completion times (i.e., number of steps) on the test set for Ant-craft environment, for the best policy found for each approach.} \vspace{-0.5em} \label{tab:ant} \end{table} \subsection{Results} \label{sec:results} \textbf{2D-craft.} Figures \ref{fig:reward-curve} \& \ref{fig:time-curve} show the training curves of each approach. As can be seen, our approach learns a substantially better policy than the unsupervised baselines; it solves a larger percentage of test scenarios as well as using shorter time. Compared with program guided agent (i.e., the oracle), our approach achieves a similar average reward with slightly longer average finish time. These results demonstrate that our approach significantly outperforms non-program-guided baselines, while performing nearly as well as an oracle that knows the ground truth program. \textbf{Ant-craft.} Table \ref{tab:ant} shows results for the best policy found using each approach. As before, our approach significantly outperforms the baseline approaches while performing comparably with the oracle approach. \textbf{Box-world.} Figure \ref{fig:box-reward-curve} \& \ref{fig:box-finish-time} shows the training curves. As before, our approach performs substantially better than the baselines, and achieves a similar performance as the program guided agent (i.e., the oracle). \begin{table}[] \centering\small \begin{tabular}{ccc} \toprule {} & {\bf Avg. reward} & {\bf Avg. finish step} \\ \midrule Optimistic & 0.60 & 53.7 \\ Ours & \textbf{0.79} & 41.8 \\ Oracle & \textbf{0.79} & \textbf{37.7} \\ \bottomrule \end{tabular} \caption{Comparison to optimistic ablation on challenging tasks for the 2D-craft environment.} \label{tab:optim} \end{table} \subsection{Optimistic Ablation} Finally, we compare our model predictive program synthesis with an alternative, \emph{optimistic} synthesis strategy: it considers the unobserved parts of the map to be possibly in any configurations, and synthesizes the shortest program as long as it works on any of these possibilities. We compare on the most challenging tasks for 2D-craft (i.e., get gold or get gem), since for these tasks, the ground truth program depends heavily on the map. We show results in Table \ref{tab:optim}. As can be seen, our approach significantly outperforms the optimistic synthesis approach, and performs comparably to the oracle. Finally, in Figure \ref{fig:ablation}, we illustrate the difference in behavior between our approach and the optimistic strategy. \iffalse We also study the effect of varying the number of sample completions $N$ used for the MAXSAT synthesis. Table \ref{tab:n-sample} shows how the performance of the policy and the synthesis time vary with $N$. We can see that (as $N$ increases, more accurately capture the distribution)... \fi \section{Conclusion} We have proposed an algorithm for synthesizing programs to guide reinforcement learning. Our algorithm, called model predictive program synthesis, handles partially observed environments by leveraging the world models approach, where it learns a generative model over the remainder of the world conditioned on the observations thus far. In particular, it synthesizes a guiding program that accounts for the uncertainty in the world model. Our experiments demonstrate that our approach significantly outperforms non-program-guided approaches, while performing comparably to an oracle that is given access to the ground truth program. These results demonstrate that our approach can obtain the benefits of program-guided reinforcement learning without requiring the user to provide a guiding program for every new task and world configurations. \section{Prototype Components for Craft} \label{append:semantics} In this section, we describe the prototype components (i.e., logical formulas encoding option pre/postconditions) that we use for the craft environment. First, recall that the domain-specific language that encodes the set of prototypes for the craft environment is \input{dsl} Also, the set of possible artifacts (objects that can be made in some workshop using resources or other artifacts) in the craft environment is \begin{align*} A = \left\{\begin{array}{c} \text{bridge},~\text{axe},~\text{plank},~\text{stick},~\text{cloth}, \\ \text{rope},~\text{bed},~\text{shears},~\text{ladder} \end{array}\right\}. \end{align*} We define the following abstraction variables: \begin{itemize}[topsep=0pt,itemsep=0ex,partopsep=1ex,parsep=1ex] \item \textbf{Zone:} $z=i$ indicates the agent is in zone $i$ \item \textbf{Boundary:} $b_{i,j}=b$ indicates how zones $i$ and $j$ are connected, where \begin{align*} b\in\{\text{connected},\text{water},\text{stone},\text{not adjacent}\} \end{align*} \item \textbf{Resource:} $\rho_{i,r}=n$ indicates that there are $n$ units of resource $r$ in zone $i$ \item \textbf{Workshop:} $\omega_{i,r}=b$, where $b\in\{\text{true},\text{false}\}$, indicates whether there exists a workshop $r$ in zone $i$ \item \textbf{Inventory:} $\iota_r=n$ indicates that there are $n$ objects $r$ (either a resource or an artifact) in the agent's inventory \end{itemize} We use $z^-, b^-, \rho^-, \omega^-, \iota^-$ and $z^+, b^+, \rho^+, \omega^+, \iota^+$ to denote the initial state and final state for a prototype components, respectively. Now, the logical formulae for each prototype components are defined as follows. \textbf{(1) ``get $r$'' (for any resource $r\in R$).} First, we have the following prototype component telling the agent to obtain a specific resource $r$: \begin{align*} \forall i, j\;.\; & ( z^- = i \wedge z^+ = j ) \Rightarrow ( b_{i,j}^- = \text{connected} ) \\ &~\wedge ( \rho^+_{j,r} = \rho_{j,r}^- - 1 ) \wedge ( \iota^+_{r} = \iota_{r}^- + 1 ) \wedge \mathcal{Q}. \end{align*} Here, $\mathcal{Q}$ refers to the conditions that the other fields of the abstract state stay the same---i.e., \begin{align*} &(b^+ = b^-) \wedge (\omega^+ = \omega^-) \wedge (\iota_{\setminus r}^+ = \iota_{\setminus r}^-) \\ & \qquad \wedge (\rho_{\setminus (j,r)}^+ = \rho_{\setminus (j,r)}^-), \end{align*} where $\iota_{\setminus r}$ means all the other fields in $\iota$ except $\iota_{r}$, and similarly for $\rho_{\setminus (j,r)}$. In particular $\mathcal{Q}$ addresses the \emph{frame problem} from classical planning. \textbf{(2) ``use $r$'' (for any workshop $r \in W$).} Next, we have a prototype component telling the agent to use a workshop to create an artifact. To do so, we introduce a set of auxiliary variables to denote the number of artifacts made in this component: $m_o = n$ indicates that $n$ units of artifact $o$ is made, the set of artifacts that can be made at workshop $r$ as $A_r$, and the number of units of ingredient $q$ needed to make 1 unit of artifact $o$ as $k_{o, q}$, where $q\in R \cup A$; note that $\{A_r\}$ and $\{k_{o, q}\}$ come from the rule of the game. Then, the logical formula for ``use $r$'' is \begin{align*} \forall i &, j\;.\; ( z^- = i \wedge z^+ = j ) \Rightarrow ( b_{i,j}^- = \text{connected} ) \\ &~\wedge ( w_{j, r} = \text{true} ) \wedge \left( \sum_{o\in A_r} m_o \geq 1 \right) \wedge \left( \sum_{o\notin A_r} m_o = 0 \right) \\ &~\wedge \left( \forall q \in R, ~\iota_q^+ = \iota_q^- - \sum_{o \in A_r} k_{o,q} m_o \right) \\ &~\wedge \left( \forall q \in A, ~\iota_q^+ = \iota_q^- - \sum_{o \in A_r} k_{o,q} m_o + m_q \right) \\ &~\wedge \left( \forall o \in A_r, ~\lnot\left( \bigwedge_{q} \iota_q^+ \geq k_{o,q} \right) \right) \\ &~\wedge \mathcal{Q}, \end{align*} where \begin{align*} \mathcal{Q} &= (b^+ = b^-) \wedge (\omega^+ = \omega^-) \wedge (\rho^+ = \rho^-). \end{align*} This formula reflects the game setting that when the agent uses a workshop, it will make the artifacts until the ingredients in the inventory are depleted. \textbf{(3) ``use r'' ($r=$ bridge/axe).} Next, we have the following prototype component for telling the agent to use a tool. The formula for this prototype component encodes the logic of zone connectivity. In particular, it is \begin{align*} \forall i &, j\;.\; ( z^- = i \wedge z^+ = j ) \Rightarrow ( b_{i,j}^- = \text{water/stone} ) \\ &~\wedge ( b_{i,j}^+ = \text{connected} ) \wedge ( \iota_r^+ = \iota_r^- - 1 ) \\ &~\wedge \Big( \forall i', j', ~(b_{i',j'}^+ = \text{connected}) \Rightarrow \\ &\qquad\qquad\qquad \big( ( b_{i',j'}^- = \text{connected} ) \lor \mathcal{X} \big) \Big) \\ &~\wedge \Big( \forall i', j', ~(b_{i',j'}^+ \neq \text{connected}) \Rightarrow ( b_{i',j'}^+ = b_{i',j'}^- ) \Big) \\ &~\wedge \mathcal{Q}, \end{align*} where \begin{align*} \mathcal{X} &= ( b_{i', i}^- = \text{connected} \lor b_{i', j}^- = \text{connected} )\\ &~~~\wedge ( b_{j', i}^- = \text{connected} \lor b_{j', j}^- = \text{connected} ) \\ \mathcal{Q} &= (\omega^+ = \omega^-) \wedge (\rho^+ = \rho^-) \wedge ( \iota_{\setminus r}^+ = \iota_{\setminus r}^- ). \end{align*} \section{Prototype Components for Box World} \label{append:box-semantics} In this section, we describe the prototype components for the box world. They are all of the form ``get $k$'', where $k \in K$ is a color in the set of possible colors in the box world. First, we define the following abstraction variables: \begin{itemize}[topsep=0pt,itemsep=0ex,partopsep=1ex,parsep=1ex] \item \textbf{Box}: $b_{k_1, k_2} = n$ indicates that there are $n$ boxes with key color $k_1$ and lock color $k_2$ in the map \item \textbf{Loose key}: $\ell_k = b$, where $b\in \{\text{true}, \text{false}\}$, indicates whether there exists a loose key of color $k$ in the map \item \textbf{Agent's key}: $\iota_k = b$, where $b\in \{\text{true}, \text{false}\}$, indicates whether the agent holds a key of color $k$ \end{itemize} As in the craft environment, we use $ b^-, \ell^-, \iota^-$ and $ b^+, \ell^+, \iota^+$ to denote the initial state and final state for a prototype components, respectively. Since the configurations of the map in the box world can only contain at most one loose key, we add cardinality constraints $\text{Card}(\ell) \leq 1$, where $\text{Card}(\cdot)$ counts the number of variables that are true. Then, the logical formula defining the prototype component ``get $k$'' is \begin{align*} &\mathcal{X} \lor \mathcal{Y}, \end{align*} where \begin{align*} \mathcal{X} &= \ell_k^- \wedge \iota_k^+ \wedge ( \text{Card}(l^+) = 0 ) \wedge ( b^+ = b^- ) \\ \mathcal{Y} &= ( \text{Card}(\iota^-) = 1 ) \wedge \iota_k^+ \wedge \lnot \iota_k^- \wedge (l^+ = l^-) \wedge \\ &\qquad\left( \forall k_1\;.\; \iota_{k_1}^- \Rightarrow \left( ( b_{k, k_1}^+ = b_{k, k_1}^- - 1 ) \wedge ( b_{\setminus(k, k_1)}^+ = b_{\setminus(k, k_1)}^- ) \right) \right) \end{align*} In particular, $\mathcal{X}$ encodes the desired behavior when the agent picks up a loose key $k$, and $\mathcal{Y}$ encodes the desired behavior when the agent unlocks a box to get key $k$. \iffalse \section{Additional Results} \label{append:results} \begin{figure}[h] \centering \begin{subfigure}[]{0.35\textwidth} \centering \includegraphics[width=\textwidth]{figures/avg_finish_times_box.pdf} \end{subfigure} \begin{subfigure}[]{0.1\textwidth} \centering \includegraphics[width=\textwidth]{figures/legend_box.pdf} \vspace{2em} \end{subfigure} \caption{Average finishing time (number of steps taken to complete the task) on the test set, for box world. } \label{fig:box-finish-time} \end{figure} \fi